Citrus Sinensis ID: 012765

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------390-------400-------410-------420-------430-------440-------450-------
Protein Sequence
MAVQETGVVKAQVEKNEKEKIPGTDSPRGVLEIPVTGTDSDSSSSSCGSSSSPEKSTPQRAVNRESGGWKSMIDSIKKKSVVRRFSVIPLLTNYELTKKNLWKKLGRLQIPEDDDADDGGSVPIVRHSWKNFDFAELAAATDNFNSENLIGKGGHAEVYKGCLPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSNFKELVDPRLADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQLLRGEGGQTDLKPKPSARRTVILDGSDEEYSSTCYLKDLNRHMQLALE
Secondary Structure (PSIPRED)
ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccHHHHHHccccccEEccccHHHHHHHHHHHHHHcccccccccccccccccccccccccccccHHHHHHHHcccccccccccccccccEEEEcccccEEEEEEcccccccccccHHHHHHHHHHHHHccccccccEEEEEEcccEEEEEEccccccHHHHHccccccccHHHHHHHHHHHHHHHHHHHccccccccccccccccccccccccccccccccccccccccccEEEcccccccccccHHHHccccccccccccHHHHHHHHHHHcccccccccHHHHHHHHHHHHcccccccccccccccccHHHHHHHHHHHHHHccccccccccHHHHHHHHcccccccccccccccccccccccccccccccccHHHHHHHHHHHcc
Secondary Structure Prediction (SSPRO)
cccccccEEEEEEEcccccccccccccccccEEccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHccccccccccccccccccccccccccEEcHHHHHHHHccccHHcccccccccEEEEcEcccccEEEEEEEcccccccccHHHHHHHHHHHHHHHHHHHHHHHEEEEEcccEEEEEEEcccccHHHHHccccccccHHHHHHHHHHHHHHHHHHHHcccccEEcccccHHHEEEcccccEEEccccccEEcccccccccEEEEEEccccccHHHHHcccccccHHHHHHHHEEHHHHcccccccccHHHHHHHHHHHHHcccHHHHccHHHcccccHHHHHHHHHHHHHHccccHcccccHHHHHHHHcccccccccccccccccccccccccccccccccHHHHHHHHHHHcc
Coil and Loop (DISEMBL)
MAVQETGVVKAQVEknekekipgtdsprgvleipvtgtdsdssssscgsssspekstpqravnresggwkSMIDSIKKKSVVRRfsviplltnyeLTKKNLWKKLgrlqipedddaddggsvpivrhswknfdfAELAAatdnfnsenligkgghaevykgclpdgeVVAVKKIIKNAKEDEERISDFLSELGIvahinhpnaakligfstenGFHLVLQflphgslssllfgstecLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFglakwlpdnwshhivfpiegtfgylspeyfmhgivdekTDVFAFGVLLLELITGRRAVDSRRQSLVIwakpllqtsnfkelvdprladaYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQLLRgeggqtdlkpkpsarrtvildgsdeeysstcYLKDLNRHMQLALE
Flexible Loop (DISEMBL)
mavqetgvvkaqveknekekipgtdsprgvleipvtgtdsdssssscgsssspekstpqravnresggwksmidsikkksvvrrfsviplltnyeltkknLWKKLGRLQIPEDDDADDGGSVPIVRHSWKNFDFAELAAATDNFNSENLIGKGGHAEVYKGCLPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITgrravdsrRQSLViwakpllqtsnfkelvdpRLADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQLLRGEggqtdlkpkpsarrtvildgsdeeysstcylkdlNRHMQLALE
Low Complexity Region (SEG)
MAVQETGVVKAQVEKNEKEKIPGTDSPRGVLEIPVtgtdsdssssscgssssPEKSTPQRAVNRESGGWKSMIDSIKKKSVVRRFSVIPLLTNYELTKKNLWKKLGRLQIPEDDDADDGGSVPIVRHSWKNFDFAELAAATDNFNSENLIGKGGHAEVYKGCLPDGEvvavkkiiknakEDEERISDFLSELGIVAHINHPNAAKLIGFSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLhhdchrriihrdiKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSNFKELVDPRLADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQLLRGEGGQTDLKPKPSARRTVILDGSDEEYSSTCYLKDLNRHMQLALE
Disordered region (IsUnstruct)
***********************************************************************MIDSIKKKSVVRRFSVIPLLTNYELTKKNLWKKLGRLQI***********VPIVRHSWKNFDFA******************GHAEVYKGCLPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSNFKELVDPRLADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQLL**********************************************
Disordered Region (DISOPRED)
*********************************************************************************VRRFSVIPLLTNYELT*****************************HSWKNFDFAELAAATDNFNSENLIGKGGHAEVYKGCLPDGEVVAVKKII***********DFLSELGIVAHINHPNAAKLIGFSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSNFKELVDPRLADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQLLRGEG***********************************HMQLAL*
Disordered Region (DISEMBL)
MAVQETGVVKAQVEKNEKEKIPGTDSPRGVLEIPV*******************************GGWKSMIDSIKKKSVVRRFSVIPLLTNYELTKKNLWKKLGRLQIPEDDDADDGGSVPIVRHSWKNFDFAELAAATDNFNSENLIGKGGHAEVYKGCLPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSNFKELVDPRLADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQLLRGEGGQTDLKPKPSARRTVILDGSDEEYSSTCYLKDLNRHMQLALE
Disordered Region (DISPRO)
**VQETGVVKAQVEKNEKEKIPGTDSPRGVLEIPVTGTDSDSSSSSCGSSSSPEKSTPQRAVNR****WKSMIDSIKKKSVVRRFSVIPLLTNYELTKKNLWKKL**********************SWKNFDFAELAAATDNFNSENLIGKGGHAEVYKGCLPDGEVVAVKKIIKN*KEDEERISDFLSELGIVAHINHPNAAKLIGFSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSNFKELVDPRLADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQLLRGE*GQ****************************************
Transmembrane Helix (TMHMM)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Transmembrane Helix (MEMSAT)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (MEMSAT_SVM)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooohhhhhhhhhhhhhhhhiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (Phobius)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MAVQETGVVKAQVEKNEKEKIPGTDSPRGVLEIPVTGTDSDSSSSSCGSSSSPEKSTPQRAVNRESGGWKSMIDSIKKKSVVRRFSVIPLLTNYELTKKNLWKKLGRLQIPEDDDADDGGSVPIVRHSWKNFDFAELAAATDNFNSENLIGKGGHAEVYKGCLPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSNFKELVDPRLADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQLLRGEGGQTDLKPKPSARRTVILDGSDEEYSSTCYLKDLNRHMQLALE
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	457	2.2.26 [Sep-21-2011]
Q8H1D6	467	Receptor-like cytosolic s	no	no	0.842	0.824	0.639	1e-149
Q8RXC8	460	Receptor-like cytosolic s	no	no	0.713	0.708	0.546	1e-100
Q5XF57	579	Probable receptor-like se	no	no	0.610	0.481	0.523	2e-88
Q9ZNQ8	633	Proline-rich receptor-lik	no	no	0.702	0.507	0.419	1e-66
Q8GX23	670	Proline-rich receptor-lik	no	no	0.743	0.507	0.403	5e-66
Q9LV48	652	Proline-rich receptor-lik	no	no	0.717	0.503	0.398	4e-65
Q9C821	509	Proline-rich receptor-lik	no	no	0.702	0.630	0.404	2e-64
Q9C660	762	Proline-rich receptor-lik	no	no	0.597	0.358	0.456	3e-64
Q9LK03	717	Proline-rich receptor-lik	no	no	0.704	0.449	0.396	2e-63
Q9LS95	700	Putative proline-rich rec	no	no	0.704	0.46	0.428	3e-63

>sp|Q8H1D6|RBK1_ARATH Receptor-like cytosolic serine/threonine-protein kinase RBK1 OS=Arabidopsis thaliana GN=RBK1 PE=1 SV=1

 Score =  528 bits (1360), Expect = e-149,   Method: Compositional matrix adjust.
 Identities = 250/391 (63%), Positives = 318/391 (81%), Gaps = 6/391 (1%)

Query: 69  WKSMIDSIKKKSVVRRFSVIPLLTNYELTKKNLWKKLGRLQIPEDDDADDGGSVPIVRHS 128
           W  MI+SIKKKS+ RRFSVIPLL +YELT+KNL +K  +L   E   A    +  + + S
Sbjct: 81  WNKMIESIKKKSM-RRFSVIPLLASYELTRKNLRRKQPKLTPSES--AFTCEAFFMAKPS 137

Query: 129 WKNFDFAELAAATDNFNSENLIGKGGHAEVYKGCLPDGEVVAVKKIIKNAKEDEERISDF 188
           W+NF + ELA ATD FN EN+IGKGGHAEVYKG L +GE VA+KK++ +AKE+EER+SDF
Sbjct: 138 WRNFTYEELAVATDYFNPENMIGKGGHAEVYKGVLINGETVAIKKLMSHAKEEEERVSDF 197

Query: 189 LSELGIVAHINHPNAAKLIGFSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIAL 248
           LSELGI+AH+NHPNAA+L GFS++ G H VL++ P+GSL+S+LFGS ECLEW IRYK+AL
Sbjct: 198 LSELGIIAHVNHPNAARLRGFSSDRGLHFVLEYAPYGSLASMLFGSEECLEWKIRYKVAL 257

Query: 249 GIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEG 308
           GIA+GL YLH+ C RRIIHRDIKASNILL+ DYEAQISDFGLAKWLP+NW HH+VFPIEG
Sbjct: 258 GIADGLSYLHNACPRRIIHRDIKASNILLNHDYEAQISDFGLAKWLPENWPHHVVFPIEG 317

Query: 309 TFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDS-RRQSLVIWAKPLLQTSNFK 367
           TFGYL+PEYFMHGIVDEK DVFAFGVLLLE+IT RRAVD+  RQS+V WAKP L+ ++ +
Sbjct: 318 TFGYLAPEYFMHGIVDEKIDVFAFGVLLLEIITSRRAVDTASRQSIVAWAKPFLEKNSME 377

Query: 368 ELVDPRLADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQLLRGEGGQTDLKPKPSAR 427
           ++VDPRL + ++  EM+R MLTAS+C+HH++ MRP MTR++QLLRGE G  +L+ K +  
Sbjct: 378 DIVDPRLGNMFNPTEMQRVMLTASMCVHHIAAMRPDMTRLVQLLRGEDGPAELQQK-AGE 436

Query: 428 RTVILDGSD-EEYSSTCYLKDLNRHMQLALE 457
           RT+ ++  D ++++S+ YL +L RH QL +E
Sbjct: 437 RTMSVNACDLQDHTSSSYLNELRRHRQLLME 467

Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1

>sp|Q8RXC8|RBK2_ARATH Receptor-like cytosolic serine/threonine-protein kinase RBK2 OS=Arabidopsis thaliana GN=RBK2 PE=1 SV=1

 Score =  365 bits (936), Expect = e-100,   Method: Compositional matrix adjust.
 Identities = 183/335 (54%), Positives = 240/335 (71%), Gaps = 9/335 (2%)

Query: 128 SWKNFDFAELAAATDNFNSENLIGKGGHAEVYKGCLPDGEVVAVKKIIKNAKEDEERISD 187
           S +NF  +++  ATDNF+ EN+IG+GG+A+VY+G LP+G+++AVK++ K   +  E+ ++
Sbjct: 127 SLQNFSISDIEIATDNFSPENIIGRGGYADVYQGILPEGKLIAVKRLTKGTPD--EQTAE 184

Query: 188 FLSELGIVAHINHPNAAKLIGFSTENGFHLVLQFLPHGSLSSLLFGSTEC-LEWTIRYKI 246
           FLSELGI+AH++HPN AK IG   E G HLV +  P GSL SLL G ++  L W+ RY +
Sbjct: 185 FLSELGIIAHVDHPNTAKFIGCCIEGGMHLVFRLSPLGSLGSLLHGPSKYKLTWSRRYNV 244

Query: 247 ALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPI 306
           ALG A+GL YLH  C RRIIHRDIKA NILL+ED++ QI DFGLAKWLP   +HH V   
Sbjct: 245 ALGTADGLVYLHEGCQRRIIHRDIKADNILLTEDFQPQICDFGLAKWLPKQLTHHNVSKF 304

Query: 307 EGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSNF 366
           EGTFGY +PEYFMHGIVDEKTDVFAFGVLLLELITG  A+D  +QSLV+WAKPLL+    
Sbjct: 305 EGTFGYFAPEYFMHGIVDEKTDVFAFGVLLLELITGHPALDESQQSLVLWAKPLLERKAI 364

Query: 367 KELVDPRLADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQLLRGEGGQTDLKPKPSA 426
           KELVDP L D Y+  E+ R   TAS+CI   S +RP+M++V++LL G      + P+ + 
Sbjct: 365 KELVDPSLGDEYNREELIRLTSTASLCIDQSSLLRPRMSQVVELLLGHEDVV-MTPREAK 423

Query: 427 RRTVILDGSDE-----EYSSTCYLKDLNRHMQLAL 456
            + +    S+E     EY+ST YL DL+R  ++AL
Sbjct: 424 IKMMQRTYSEELLDSVEYNSTKYLGDLDRIREVAL 458

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q5XF57|Y5576_ARATH Probable receptor-like serine/threonine-protein kinase At5g57670 OS=Arabidopsis thaliana GN=At5g57670 PE=2 SV=1

 Score =  326 bits (835), Expect = 2e-88,   Method: Compositional matrix adjust.
 Identities = 147/281 (52%), Positives = 207/281 (73%), Gaps = 2/281 (0%)

Query: 132 FDFAELAAATDNFNSENLIGKGGHAEVYKGCLPDGEVVAVKKIIKNAKEDEERISDFLSE 191
           F + E++ AT++F+  N++G GG++EVY+G L DG  +AVK++ K +  D  +  +FL+E
Sbjct: 255 FTYNEISKATNDFHQGNIVGIGGYSEVYRGDLWDGRRIAVKRLAKESG-DMNKEKEFLTE 313

Query: 192 LGIVAHINHPNAAKLIGFSTENGFHLVLQFLPHGSLSSLLF-GSTECLEWTIRYKIALGI 250
           LGI++H++HPN A L+G   E G +LV +F  +G+L S L       L+W +RYKIA+G+
Sbjct: 314 LGIISHVSHPNTALLLGCCVEKGLYLVFRFSENGTLYSALHENENGSLDWPVRYKIAVGV 373

Query: 251 AEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEGTF 310
           A GL YLH  C+ RIIHRDIK+SN+LL  DYE QI+DFGLAKWLP+ W+HH V P+EGTF
Sbjct: 374 ARGLHYLHKRCNHRIIHRDIKSSNVLLGPDYEPQITDFGLAKWLPNKWTHHAVIPVEGTF 433

Query: 311 GYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSNFKELV 370
           GYL+PE  M G +DEKTD++AFG+LLLE+ITGRR V+  ++ +++WAKP ++T N  ELV
Sbjct: 434 GYLAPESLMQGTIDEKTDIYAFGILLLEIITGRRPVNPTQKHILLWAKPAMETGNTSELV 493

Query: 371 DPRLADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQLL 411
           DP+L D YD  +M + +LTAS C+     +RP MT+VL+LL
Sbjct: 494 DPKLQDKYDDQQMNKLVLTASHCVQQSPILRPTMTQVLELL 534

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9ZNQ8|PERK4_ARATH Proline-rich receptor-like protein kinase PERK4 OS=Arabidopsis thaliana GN=PERK4 PE=1 SV=1

 Score =  254 bits (648), Expect = 1e-66,   Method: Compositional matrix adjust.
 Identities = 141/336 (41%), Positives = 203/336 (60%), Gaps = 15/336 (4%)

Query: 132 FDFAELAAATDNFNSENLIGKGGHAEVYKGCLPDGEVVAVKKIIKNAKEDEERISDFLSE 191
           F + ELAAAT  F   NL+G+GG   V+KG LP G+ VAVK +   + + E    +F +E
Sbjct: 272 FTYQELAAATGGFTDANLLGQGGFGYVHKGVLPSGKEVAVKSLKAGSGQGER---EFQAE 328

Query: 192 LGIVAHINHPNAAKLIGFSTENGFH-LVLQFLPHGSLSSLLFGST-ECLEWTIRYKIALG 249
           + I++ ++H     L+G+   +G   LV +F+P+ +L   L G     +E++ R +IALG
Sbjct: 329 VDIISRVHHRYLVSLVGYCIADGQRMLVYEFVPNKTLEYHLHGKNLPVMEFSTRLRIALG 388

Query: 250 IAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEGT 309
            A+GL YLH DCH RIIHRDIK++NILL  +++A ++DFGLAK   DN + H+   + GT
Sbjct: 389 AAKGLAYLHEDCHPRIIHRDIKSANILLDFNFDAMVADFGLAKLTSDNNT-HVSTRVMGT 447

Query: 310 FGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVD---SRRQSLVIWAKPL----LQ 362
           FGYL+PEY   G + EK+DVF++GV+LLELITG+R VD   +   +LV WA+PL    L+
Sbjct: 448 FGYLAPEYASSGKLTEKSDVFSYGVMLLELITGKRPVDNSITMDDTLVDWARPLMARALE 507

Query: 363 TSNFKELVDPRLADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQLLRGEGGQTDLKP 422
             NF EL D RL   Y+  EM R +  A+  I H    RP+M+++++ L GE     L  
Sbjct: 508 DGNFNELADARLEGNYNPQEMARMVTCAAASIRHSGRKRPKMSQIVRALEGEVSLDALNE 567

Query: 423 --KPSARRTVILDGSDEEYSSTCYLKDLNRHMQLAL 456
             KP         G+  +YS T Y  D+ +  Q+AL
Sbjct: 568 GVKPGHSNVYGSLGASSDYSQTSYNADMKKFRQIAL 603

Required during abscisic acid (ABA)-mediated activation of Ca(2+) channels. Regulates ABA signaling pathways. Modulates the expression of genes related to cell elongation and ABA signaling during root growth.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q8GX23|PERK5_ARATH Proline-rich receptor-like protein kinase PERK5 OS=Arabidopsis thaliana GN=PERK5 PE=2 SV=1

 Score =  252 bits (643), Expect = 5e-66,   Method: Compositional matrix adjust.
 Identities = 147/364 (40%), Positives = 211/364 (57%), Gaps = 24/364 (6%)

Query: 106 GRLQIPEDDDADDGGSVPIVRHSWKNFDFAELAAATDNFNSENLIGKGGHAEVYKGCLPD 165
           GR  IP    A  G       H+   F + EL+ AT+ F   NL+G+GG   V+KG LP 
Sbjct: 281 GRTAIPSPQAATLG-------HNQSTFTYDELSIATEGFAQSNLLGQGGFGYVHKGVLPS 333

Query: 166 GEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTENGFHL-VLQFLPH 224
           G+ VAVK +   + + E    +F +E+ I++ ++H +   L+G+    G  L V +F+P+
Sbjct: 334 GKEVAVKSLKLGSGQGER---EFQAEVDIISRVHHRHLVSLVGYCISGGQRLLVYEFIPN 390

Query: 225 GSLSSLLFG-STECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEA 283
            +L   L G     L+W  R KIALG A GL YLH DCH RIIHRDIKA+NILL   +E 
Sbjct: 391 NTLEFHLHGKGRPVLDWPTRVKIALGSARGLAYLHEDCHPRIIHRDIKAANILLDFSFET 450

Query: 284 QISDFGLAKWLPDNWSHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGR 343
           +++DFGLAK   DN++ H+   + GTFGYL+PEY   G + +K+DVF+FGV+LLELITGR
Sbjct: 451 KVADFGLAKLSQDNYT-HVSTRVMGTFGYLAPEYASSGKLSDKSDVFSFGVMLLELITGR 509

Query: 344 RAVD---SRRQSLVIWAKPLL----QTSNFKELVDPRLADAYDLAEMKRAMLTASVCIHH 396
             +D       SLV WA+PL     Q  ++ +L DPRL   Y   EM +    A+  I H
Sbjct: 510 PPLDLTGEMEDSLVDWARPLCLKAAQDGDYNQLADPRLELNYSHQEMVQMASCAAAAIRH 569

Query: 397 LSTMRPQMTRVLQLLRGEGGQTDLK--PKPSARRTVILDGS-DEEYSSTCYLKDLNRHMQ 453
            +  RP+M+++++ L G+    DL    +P  + T +  GS   EY ++ Y  D+ +  +
Sbjct: 570 SARRRPKMSQIVRALEGDMSMDDLSEGTRP-GQSTYLSPGSVSSEYDASSYTADMKKFKK 628

Query: 454 LALE 457
           LALE
Sbjct: 629 LALE 632

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9LV48|PERK1_ARATH Proline-rich receptor-like protein kinase PERK1 OS=Arabidopsis thaliana GN=PERK1 PE=1 SV=1

 Score =  249 bits (635), Expect = 4e-65,   Method: Compositional matrix adjust.
 Identities = 138/346 (39%), Positives = 210/346 (60%), Gaps = 18/346 (5%)

Query: 124 IVRHSWKNFDFAELAAATDNFNSENLIGKGGHAEVYKGCLPDGEVVAVKKIIKNAKEDEE 183
           ++  S   F + EL+ AT+ F+  NL+G+GG   V+KG LP G+ VAVK++   + + E 
Sbjct: 260 VLGFSKSTFTYEELSRATNGFSEANLLGQGGFGYVHKGILPSGKEVAVKQLKAGSGQGER 319

Query: 184 RISDFLSELGIVAHINHPNAAKLIGFSTENGFH--LVLQFLPHGSLSSLLFGSTE-CLEW 240
              +F +E+ I++ ++H +   LIG+    G    LV +F+P+ +L   L G     +EW
Sbjct: 320 ---EFQAEVEIISRVHHRHLVSLIGYCMA-GVQRLLVYEFVPNNNLEFHLHGKGRPTMEW 375

Query: 241 TIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSH 300
           + R KIALG A+GL YLH DC+ +IIHRDIKASNIL+   +EA+++DFGLAK   D  + 
Sbjct: 376 STRLKIALGSAKGLSYLHEDCNPKIIHRDIKASNILIDFKFEAKVADFGLAKIASDTNT- 434

Query: 301 HIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRR----QSLVIW 356
           H+   + GTFGYL+PEY   G + EK+DVF+FGV+LLELITGRR VD+       SLV W
Sbjct: 435 HVSTRVMGTFGYLAPEYAASGKLTEKSDVFSFGVVLLELITGRRPVDANNVYVDDSLVDW 494

Query: 357 AKPLL----QTSNFKELVDPRLADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQLLR 412
           A+PLL    +  +F+ L D ++ + YD  EM R +  A+ C+ H +  RP+M+++++ L 
Sbjct: 495 ARPLLNRASEEGDFEGLADSKMGNEYDREEMARMVACAAACVRHSARRRPRMSQIVRALE 554

Query: 413 GEGGQTDLKP--KPSARRTVILDGSDEEYSSTCYLKDLNRHMQLAL 456
           G    +DL    +P         G   +Y ++ Y  D+ +  ++AL
Sbjct: 555 GNVSLSDLNEGMRPGHSNVYSSYGGSTDYDTSQYNDDMIKFRKMAL 600

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9C821|PEK15_ARATH Proline-rich receptor-like protein kinase PERK15 OS=Arabidopsis thaliana GN=PERK15 PE=1 SV=1

 Score =  247 bits (630), Expect = 2e-64,   Method: Compositional matrix adjust.
 Identities = 137/339 (40%), Positives = 208/339 (61%), Gaps = 18/339 (5%)

Query: 132 FDFAELAAATDNFNSENLIGKGGHAEVYKGCLPDGEVVAVKKIIKNAKEDEERISDFLSE 191
           F + +L+ AT NF++ NL+G+GG   V++G L DG +VA+K++   + + E    +F +E
Sbjct: 131 FTYEDLSKATSNFSNTNLLGQGGFGYVHRGVLVDGTLVAIKQLKSGSGQGER---EFQAE 187

Query: 192 LGIVAHINHPNAAKLIGFSTENGFHL-VLQFLPHGSLSSLLFGSTE-CLEWTIRYKIALG 249
           +  ++ ++H +   L+G+       L V +F+P+ +L   L       +EW+ R KIALG
Sbjct: 188 IQTISRVHHRHLVSLLGYCITGAQRLLVYEFVPNKTLEFHLHEKERPVMEWSKRMKIALG 247

Query: 250 IAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEGT 309
            A+GL YLH DC+ + IHRD+KA+NIL+ + YEA+++DFGLA+   D    H+   I GT
Sbjct: 248 AAKGLAYLHEDCNPKTIHRDVKAANILIDDSYEAKLADFGLARSSLDT-DTHVSTRIMGT 306

Query: 310 FGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRR-----QSLVIWAKPL---- 360
           FGYL+PEY   G + EK+DVF+ GV+LLELITGRR VD  +      S+V WAKPL    
Sbjct: 307 FGYLAPEYASSGKLTEKSDVFSIGVVLLELITGRRPVDKSQPFADDDSIVDWAKPLMIQA 366

Query: 361 LQTSNFKELVDPRLADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQLLRGEGGQTDL 420
           L   NF  LVDPRL + +D+ EM R +  A+  + H +  RP+M+++++   G     DL
Sbjct: 367 LNDGNFDGLVDPRLENDFDINEMTRMVACAAASVRHSAKRRPKMSQIVRAFEGNISIDDL 426

Query: 421 KPKPSARRTVI--LDGSDEEYSSTCYLKDLNRHMQLALE 457
               +  ++ I  LDGS  +YSST Y +DL +  ++A E
Sbjct: 427 TEGAAPGQSTIYSLDGS-SDYSSTQYKEDLKKFKKMAFE 464

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9C660|PEK10_ARATH Proline-rich receptor-like protein kinase PERK10 OS=Arabidopsis thaliana GN=PERK10 PE=1 SV=2

 Score =  246 bits (628), Expect = 3e-64,   Method: Compositional matrix adjust.
 Identities = 132/289 (45%), Positives = 185/289 (64%), Gaps = 16/289 (5%)

Query: 132 FDFAELAAATDNFNSENLIGKGGHAEVYKGCLPDGEVVAVKKI-IKNAKEDEERISDFLS 190
           F + EL  AT+ F+ ENL+G+GG   VYKG LPD  VVAVK++ I   + D E    F +
Sbjct: 418 FSYEELVIATNGFSDENLLGEGGFGRVYKGVLPDERVVAVKQLKIGGGQGDRE----FKA 473

Query: 191 ELGIVAHINHPNAAKLIGFS-TENGFHLVLQFLPHGSLSSLLFGS-TECLEWTIRYKIAL 248
           E+  ++ ++H N   ++G+  +EN   L+  ++P+ +L   L  + T  L+W  R KIA 
Sbjct: 474 EVDTISRVHHRNLLSMVGYCISENRRLLIYDYVPNNNLYFHLHAAGTPGLDWATRVKIAA 533

Query: 249 GIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEG 308
           G A GL YLH DCH RIIHRDIK+SNILL  ++ A +SDFGLAK   D  + HI   + G
Sbjct: 534 GAARGLAYLHEDCHPRIIHRDIKSSNILLENNFHALVSDFGLAKLALD-CNTHITTRVMG 592

Query: 309 TFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRR----QSLVIWAKPLL--- 361
           TFGY++PEY   G + EK+DVF+FGV+LLELITGR+ VD+ +    +SLV WA+PLL   
Sbjct: 593 TFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSNA 652

Query: 362 -QTSNFKELVDPRLADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQ 409
            +T  F  L DP+L   Y   EM R +  A+ CI H +T RP+M+++++
Sbjct: 653 TETEEFTALADPKLGRNYVGVEMFRMIEAAAACIRHSATKRPRMSQIVR 701

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9LK03|PERK2_ARATH Proline-rich receptor-like protein kinase PERK2 OS=Arabidopsis thaliana GN=PERK2 PE=2 SV=3

 Score =  243 bits (621), Expect = 2e-63,   Method: Compositional matrix adjust.
 Identities = 134/338 (39%), Positives = 207/338 (61%), Gaps = 16/338 (4%)

Query: 132 FDFAELAAATDNFNSENLIGKGGHAEVYKGCLPDGEVVAVKKIIKNAKEDEERISDFLSE 191
           F++ EL+ AT+ F+  NL+G+GG   V+KG L +G+ VAVK++ + + + E    +F +E
Sbjct: 342 FNYEELSRATNGFSEANLLGQGGFGYVFKGMLRNGKEVAVKQLKEGSSQGER---EFQAE 398

Query: 192 LGIVAHINHPNAAKLIGFSTENGFHL-VLQFLPHGSLSSLLFGSTE-CLEWTIRYKIALG 249
           +GI++ ++H +   L+G+   +   L V +F+P+ +L   L G     +EW+ R KIA+G
Sbjct: 399 VGIISRVHHRHLVALVGYCIADAQRLLVYEFVPNNTLEFHLHGKGRPTMEWSSRLKIAVG 458

Query: 250 IAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEGT 309
            A+GL YLH +C+ +IIHRDIKASNIL+   +EA+++DFGLAK   D  + H+   + GT
Sbjct: 459 SAKGLSYLHENCNPKIIHRDIKASNILIDFKFEAKVADFGLAKIASDT-NTHVSTRVMGT 517

Query: 310 FGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRR----QSLVIWAKPLL---- 361
           FGYL+PEY   G + EK+DVF+FGV+LLELITGRR +D        SLV WA+PLL    
Sbjct: 518 FGYLAPEYASSGKLTEKSDVFSFGVVLLELITGRRPIDVNNVHADNSLVDWARPLLNQVS 577

Query: 362 QTSNFKELVDPRLADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQLLRGEGGQTDLK 421
           +  NF+ +VD +L + YD  EM R +  A+ C+   +  RP+M +V ++L G    +DL 
Sbjct: 578 ELGNFEVVVDKKLNNEYDKEEMARMVACAAACVRSTAPRRPRMDQVARVLEGNISPSDLN 637

Query: 422 P--KPSARRTVILDGSDEEYSSTCYLKDLNRHMQLALE 457
               P         G   +Y S+   + +N+  ++ LE
Sbjct: 638 QGITPGHSNVYGSSGGSTDYDSSQDNEGMNKFRKVGLE 675

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9LS95|PERK6_ARATH Putative proline-rich receptor-like protein kinase PERK6 OS=Arabidopsis thaliana GN=PERK6 PE=2 SV=2

 Score =  243 bits (619), Expect = 3e-63,   Method: Compositional matrix adjust.
 Identities = 144/336 (42%), Positives = 211/336 (62%), Gaps = 14/336 (4%)

Query: 132 FDFAELAAATDNFNSENLIGKGGHAEVYKGCLPDGEVVAVKKIIKNAKEDEERISDFLSE 191
           F + ELAAAT  F+   L+G+GG   V+KG LP+G+ +AVK +   + + E    +F +E
Sbjct: 325 FTYDELAAATQGFSQSRLLGQGGFGYVHKGILPNGKEIAVKSLKAGSGQGER---EFQAE 381

Query: 192 LGIVAHINHPNAAKLIGFSTENGFH-LVLQFLPHGSLSSLLFG-STECLEWTIRYKIALG 249
           + I++ ++H     L+G+    G   LV +FLP+ +L   L G S + L+W  R KIALG
Sbjct: 382 VDIISRVHHRFLVSLVGYCIAGGQRMLVYEFLPNDTLEFHLHGKSGKVLDWPTRLKIALG 441

Query: 250 IAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEGT 309
            A+GL YLH DCH RIIHRDIKASNILL E +EA+++DFGLAK   DN + H+   I GT
Sbjct: 442 SAKGLAYLHEDCHPRIIHRDIKASNILLDESFEAKVADFGLAKLSQDNVT-HVSTRIMGT 500

Query: 310 FGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVD---SRRQSLVIWAKPLL----Q 362
           FGYL+PEY   G + +++DVF+FGV+LLEL+TGRR VD       SLV WA+P+     Q
Sbjct: 501 FGYLAPEYASSGKLTDRSDVFSFGVMLLELVTGRRPVDLTGEMEDSLVDWARPICLNAAQ 560

Query: 363 TSNFKELVDPRLADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQLLRGEGGQTDLKP 422
             ++ ELVDPRL + Y+  EM + +  A+  + H +  RP+M+++++ L G+    DL  
Sbjct: 561 DGDYSELVDPRLENQYEPHEMAQMVACAAAAVRHSARRRPKMSQIVRALEGDATLDDLSE 620

Query: 423 KPSARRTVILD-GSDEEYSSTCYLKDLNRHMQLALE 457
              A ++  L  GS  +Y S+ Y  D+ +  ++AL+
Sbjct: 621 GGKAGQSSFLGRGSSSDYDSSTYSADMKKFRKVALD 656

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	457
359497396	472	PREDICTED: receptor-like cytosolic serin	0.989	0.957	0.652	1e-166
255585670	463	BRASSINOSTEROID INSENSITIVE 1-associated	0.936	0.924	0.664	1e-163
224094965	421	predicted protein [Populus trichocarpa]	0.879	0.954	0.687	1e-162
449431922	498	PREDICTED: receptor-like cytosolic serin	0.960	0.881	0.618	1e-155
449517933	458	PREDICTED: receptor-like cytosolic serin	0.960	0.958	0.618	1e-155
297797585	453	hypothetical protein ARALYDRAFT_496787 [	0.912	0.920	0.645	1e-153
26452369	456	unknown protein [Arabidopsis thaliana] g	0.925	0.927	0.638	1e-153
30698132	456	protein kinase family protein [Arabidops	0.925	0.927	0.638	1e-153
356566175	484	PREDICTED: receptor-like cytosolic serin	0.964	0.911	0.610	1e-152
356523967	477	PREDICTED: receptor-like cytosolic serin	0.923	0.884	0.622	1e-151

>gi|359497396|ref|XP_003635501.1| PREDICTED: receptor-like cytosolic serine/threonine-protein kinase RBK1-like [Vitis vinifera] gi|297739417|emb|CBI29579.3| unnamed protein product [Vitis vinifera]

 Score =  590 bits (1522), Expect = e-166,   Method: Compositional matrix adjust.
 Identities = 299/458 (65%), Positives = 365/458 (79%), Gaps = 6/458 (1%)

Query: 3   VQETGVVKAQVEKNEKEKIPGTDSPRGVLEIPVTGTDSDSSSSSCGSSSSPEKSTPQRAV 62
            +E   ++ Q    +++     +SPRGVLEIPV G DSD S+ S  SSSS +KST  + +
Sbjct: 18  TKEKPEIRPQDGSKKQDSSDDQNSPRGVLEIPVLGGDSDHSTCSSCSSSSNDKSTVHQEL 77

Query: 63  NRES--GGWKSMIDSIKKKSVVRRFSVIPLLTNYELTKKNLWKKLGRLQIPEDDDADDGG 120
            RE+    WKS+  ++KKKSV RRFS IP L  +EL++ +L +KL R++  ED  + +G 
Sbjct: 78  VRETHRSHWKSLFGALKKKSV-RRFSTIPSLAGHELSRISLRRKLARIRSAEDPISVEG- 135

Query: 121 SVPIVRHSWKNFDFAELAAATDNFNSENLIGKGGHAEVYKGCLPDGEVVAVKKIIKNAKE 180
            +P+ + SW++FD+AELAAATDNF+SENLIGKGGHAEVY+GCL DG++VAVKK++K  KE
Sbjct: 136 -MPVPKPSWRSFDYAELAAATDNFSSENLIGKGGHAEVYRGCLSDGQLVAVKKLMKKEKE 194

Query: 181 DEERISDFLSELGIVAHINHPNAAKLIGFSTENGFHLVLQFLPHGSLSSLLFGSTECLEW 240
           DEER  DFLSELGI+AHI+HPNAA+LIGF  + G HLVLQF P GSL+S+L G+TE LEW
Sbjct: 195 DEERTGDFLSELGIIAHIDHPNAARLIGFGVDGGLHLVLQFSPQGSLASVLHGTTESLEW 254

Query: 241 TIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSH 300
            IR+K+A+G+AEGLQYLH  CHRRIIHRDIKASNILL++DY+ QISDFGLAKWLPD W+H
Sbjct: 255 KIRFKVAVGVAEGLQYLHQGCHRRIIHRDIKASNILLTQDYQPQISDFGLAKWLPDKWAH 314

Query: 301 HIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPL 360
           H+VFPIEGTFGYL+PEYFMHGIVDEKTDVFAFGVLLLELITGR AVDS RQSLVIWAKPL
Sbjct: 315 HVVFPIEGTFGYLAPEYFMHGIVDEKTDVFAFGVLLLELITGRHAVDSSRQSLVIWAKPL 374

Query: 361 LQTSNFKELVDPRLADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQLLRGEGGQTDL 420
           L  ++ KEL D RL D YDL EMKRAMLTAS+CIHH S+MRP+M RV+QLLRGEG   + 
Sbjct: 375 LDANDVKELADSRLGDCYDLGEMKRAMLTASMCIHHSSSMRPEMNRVVQLLRGEGKSPEP 434

Query: 421 KPKPSARRTVILDGSD-EEYSSTCYLKDLNRHMQLALE 457
           K K +  R +ILD SD  +Y+ T YL+DLNRHM+L LE
Sbjct: 435 KQKSNVGRALILDDSDLADYTPTSYLRDLNRHMELVLE 472

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|255585670|ref|XP_002533520.1| BRASSINOSTEROID INSENSITIVE 1-associated receptor kinase 1 precursor, putative [Ricinus communis] gi|223526617|gb|EEF28864.1| BRASSINOSTEROID INSENSITIVE 1-associated receptor kinase 1 precursor, putative [Ricinus communis]

 Score =  580 bits (1496), Expect = e-163,   Method: Compositional matrix adjust.
 Identities = 295/444 (66%), Positives = 351/444 (79%), Gaps = 16/444 (3%)

Query: 26  SPRGVLEIPVTGTDSDSSSSSCGSS----------SSPEKSTPQRAVNRESGGWKSMIDS 75
           SPR VLEIP+ GTDSD SSSS  ++          SSPEK   +   N     WK M+D+
Sbjct: 24  SPRCVLEIPILGTDSDHSSSSFSTTSSSEDSTEKLSSPEKLESREGTNLSQ--WKQMLDA 81

Query: 76  IKKKSVVRRFSVIPLLTNYEL-TKKNLWKKLGRLQIPEDDDADDGGSVPIVRHSWKNFDF 134
            KKKS+ RRFSVIPLLTNY+L  KK+L +K+ R+Q    D   D   + I + SW+NFDF
Sbjct: 82  FKKKSM-RRFSVIPLLTNYDLIAKKSLKRKINRIQ-SSADVVIDLDCIQITKPSWRNFDF 139

Query: 135 AELAAATDNFNSENLIGKGGHAEVYKGCLPDGEVVAVKKIIKNAKEDEERISDFLSELGI 194
           AEL AATD+F+SENLIG+GGHA+VYKGCL DG+VVAVKKI+K  KEDE RI DFLSELGI
Sbjct: 140 AELEAATDHFSSENLIGEGGHAQVYKGCLSDGQVVAVKKIMKTEKEDENRIGDFLSELGI 199

Query: 195 VAHINHPNAAKLIGFSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGL 254
           +AHINHPNAAKL+GFS + G HLVL++LP GSL+S+LFG  E LEW  R K+A+GIAEGL
Sbjct: 200 IAHINHPNAAKLLGFSIDGGLHLVLEYLPQGSLASVLFGGAESLEWEKRIKVAVGIAEGL 259

Query: 255 QYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEGTFGYLS 314
           +YLHHDCHRRIIHRDIKASNILL+EDYEAQISDFGLAKWLP+NW HHIVFPIEGTFGYL+
Sbjct: 260 RYLHHDCHRRIIHRDIKASNILLTEDYEAQISDFGLAKWLPENWLHHIVFPIEGTFGYLA 319

Query: 315 PEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSNFKELVDPRL 374
           PEYFMHGIV+EKTDVF+FGVLLLE+ITGR AVDS RQSL +WAKPLL+ +  KE+ DP+L
Sbjct: 320 PEYFMHGIVNEKTDVFSFGVLLLEIITGRHAVDSSRQSLAMWAKPLLEENQVKEVADPQL 379

Query: 375 ADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQLLRGEGGQTDLKPKPSARRTVILDG 434
              YD  EMKRAM TAS+CI+HL +MRP M +V+QLLRGE    +++ K +A R V++DG
Sbjct: 380 GSDYDPVEMKRAMFTASMCINHLPSMRPHMNQVVQLLRGEEAPMEMQQKSNAGRAVMVDG 439

Query: 435 SD-EEYSSTCYLKDLNRHMQLALE 457
            D ++Y+ T YL DLNRHMQL LE
Sbjct: 440 CDLQDYTCTSYLNDLNRHMQLVLE 463

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224094965|ref|XP_002310307.1| predicted protein [Populus trichocarpa] gi|222853210|gb|EEE90757.1| predicted protein [Populus trichocarpa]

 Score =  577 bits (1487), Expect = e-162,   Method: Compositional matrix adjust.
 Identities = 281/409 (68%), Positives = 336/409 (82%), Gaps = 7/409 (1%)

Query: 54  EKSTPQR-AVNRESGG--WKSMIDSIKKKSVVRRFSVIPLLTNYE-LTKKNLWKKLGRLQ 109
           EK  P+R  + RES G  WK ++DS KKKSV RRFSVIPL++ YE + +KNL +KL R+Q
Sbjct: 15  EKLVPERTGILRESNGIQWKQILDSFKKKSV-RRFSVIPLISTYETIARKNLRRKLARIQ 73

Query: 110 IPEDDDADDGGSVPIVRHSWKNFDFAELAAATDNFNSENLIGKGGHAEVYKGCLPDGEVV 169
              D   D  G +   + SW+NFD+ EL AATDNF+SENLIG+GGHA+VYKGCL DG+VV
Sbjct: 74  HSADVFIDYEG-IMAPKPSWRNFDYLELEAATDNFSSENLIGEGGHAKVYKGCLSDGQVV 132

Query: 170 AVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTENGFHLVLQFLPHGSLSS 229
           AVKK++K  K++E+R+ DFLSELGI+AHINHPNAA+L+GFS ++G HLVL+FLPHGSL+S
Sbjct: 133 AVKKLMKTEKQEEDRVGDFLSELGIIAHINHPNAARLLGFSIDSGLHLVLEFLPHGSLAS 192

Query: 230 LLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFG 289
           +L G ++CLEW  R+K+ALGIAEGLQYLHHDC RRIIHRDIKASNILL+ ++EAQISDFG
Sbjct: 193 VLHGGSDCLEWKKRFKVALGIAEGLQYLHHDCPRRIIHRDIKASNILLNANFEAQISDFG 252

Query: 290 LAKWLPDNWSHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSR 349
           LAKWLP+NW HHIVFPIEGTFGYL+PEYFMHGIVDEKTDVFA+GVLLLE+ITGRRAVDS 
Sbjct: 253 LAKWLPENWIHHIVFPIEGTFGYLAPEYFMHGIVDEKTDVFAYGVLLLEIITGRRAVDSS 312

Query: 350 RQSLVIWAKPLLQTSNFKELVDPRLADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQ 409
           RQSLV+WAKPLL+ +N KEL DPRL D YD  EMK AM TA +CIHHL   RP M RV+Q
Sbjct: 313 RQSLVMWAKPLLEANNAKELADPRLGDDYDPIEMKHAMFTALMCIHHLPNTRPHMIRVVQ 372

Query: 410 LLRGEGGQTDLKPKPSARRTVILDGSD-EEYSSTCYLKDLNRHMQLALE 457
           LLRGEG   + K K +A R V+LDG D ++Y+ T YLKDLNRHMQL +E
Sbjct: 373 LLRGEGAPVEFKQKTNAGRAVLLDGCDLQDYTCTTYLKDLNRHMQLVME 421

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|449431922|ref|XP_004133749.1| PREDICTED: receptor-like cytosolic serine/threonine-protein kinase RBK1-like [Cucumis sativus]

 Score =  554 bits (1427), Expect = e-155,   Method: Compositional matrix adjust.
 Identities = 284/459 (61%), Positives = 354/459 (77%), Gaps = 20/459 (4%)

Query: 15  KNEKEKIPGTDSPRGVLEIPVTGTDSDSSSSSCGSS---------SSPEKSTPQRAVNRE 65
           K E+E +   +SPRGV EIP+ GTDSD S SS G           +  EK+    A+ +E
Sbjct: 44  KGEEEFVCDENSPRGVFEIPIVGTDSDQSESSSGDGGGEDGEGTLTVAEKALLPGALLQE 103

Query: 66  SGG--WKSMIDSIKKKSVVRRFSVIPLLT-NYELTKKNLWKKLGRLQIPEDDDADDGGSV 122
            GG  WK+MI  IKKKSV  RFS IPLL  +YE+++KN  +KL R++    D+   G  +
Sbjct: 104 VGGIPWKAMIGCIKKKSV-WRFSTIPLLAASYEISRKNFKRKLARIR--SADEGITGDDI 160

Query: 123 PIVRHSWKNFDFAELAAATDNFNSENLIGKGGHAEVYKGCLPDGEVVAVKKIIKNAKEDE 182
           P  + SW+N+ FAEL+AAT+NF+ ENL+GKGG AEVYKGCL DG++VAVK+++K  KE+E
Sbjct: 161 PFCKPSWRNYGFAELSAATNNFSPENLLGKGGQAEVYKGCLSDGQIVAVKRLMKKEKENE 220

Query: 183 ERISDFLSELGIVAHINHPNAAKLIGFSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTI 242
           ER +DFLSELGI+AHINHPNAA+L+GF  E+G +LVL+F+P+GS +S LFG+ E LEW I
Sbjct: 221 ERTADFLSELGIIAHINHPNAARLLGFGIESGLYLVLEFIPYGSFASALFGA-EPLEWNI 279

Query: 243 RYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSHHI 302
           R+K+ALG+AEGL YLH +C RRIIHRDIKASNILL+E+YE  ISDFGLAKWLP+NW+HH+
Sbjct: 280 RFKVALGVAEGLNYLHRECPRRIIHRDIKASNILLAENYEPLISDFGLAKWLPENWAHHV 339

Query: 303 VFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQ 362
           VFPIEGTFGYL+PEYFMHGIVDE+TDVFAFGVLLLELITGRRAVDS RQSLVIWAKPLL 
Sbjct: 340 VFPIEGTFGYLAPEYFMHGIVDERTDVFAFGVLLLELITGRRAVDSSRQSLVIWAKPLLD 399

Query: 363 TSNFKELVDPRLADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQLLRGEGGQTD-LK 421
            ++FKEL DP+L D YD  EM R ML AS+CI+H S+MRP M RV+QLL+GE G  D LK
Sbjct: 400 NNSFKELTDPKLGDNYDQTEMGRTMLAASMCINHSSSMRPHMNRVVQLLKGEDGPLDQLK 459

Query: 422 PKP-SARRTVILDGSD-EEYS-STCYLKDLNRHMQLALE 457
            K     R+++L+  D E+Y+ ++ YL DLNRH +L LE
Sbjct: 460 HKSMDGDRSLLLEACDLEDYTNNSSYLNDLNRHRELVLE 498

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|449517933|ref|XP_004165998.1| PREDICTED: receptor-like cytosolic serine/threonine-protein kinase RBK1-like [Cucumis sativus]

 Score =  553 bits (1425), Expect = e-155,   Method: Compositional matrix adjust.
 Identities = 284/459 (61%), Positives = 354/459 (77%), Gaps = 20/459 (4%)

Query: 15  KNEKEKIPGTDSPRGVLEIPVTGTDSDSSSSSCGSS---------SSPEKSTPQRAVNRE 65
           K E+E +   +SPRGV EIP+ GTDSD S SS G           +  EK+    A+ +E
Sbjct: 4   KGEEEFVCDENSPRGVFEIPIVGTDSDQSESSSGDGGGEDGEGTLTVAEKALLPGALLQE 63

Query: 66  SGG--WKSMIDSIKKKSVVRRFSVIPLLT-NYELTKKNLWKKLGRLQIPEDDDADDGGSV 122
            GG  WK+MI  IKKKSV R FS IPLL  +YE+++KN  +KL R++    D+   G  +
Sbjct: 64  VGGIPWKAMIGCIKKKSVWR-FSTIPLLAASYEISRKNFKRKLARIR--SADEGITGDDI 120

Query: 123 PIVRHSWKNFDFAELAAATDNFNSENLIGKGGHAEVYKGCLPDGEVVAVKKIIKNAKEDE 182
           P  + SW+N+ FAEL+AAT+NF+ ENL+GKGG AEVYKGCL DG++VAVK+++K  KE+E
Sbjct: 121 PFCKPSWRNYGFAELSAATNNFSPENLLGKGGQAEVYKGCLSDGQIVAVKRLMKKEKENE 180

Query: 183 ERISDFLSELGIVAHINHPNAAKLIGFSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTI 242
           ER +DFLSELGI+AHINHPNAA+L+GF  E+G +LVL+F+P+GS +S LFG+ E LEW I
Sbjct: 181 ERTADFLSELGIIAHINHPNAARLLGFGIESGLYLVLEFIPYGSFASALFGA-EPLEWNI 239

Query: 243 RYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSHHI 302
           R+K+ALG+AEGL YLH +C RRIIHRDIKASNILL+E+YE  ISDFGLAKWLP+NW+HH+
Sbjct: 240 RFKVALGVAEGLNYLHRECPRRIIHRDIKASNILLAENYEPLISDFGLAKWLPENWAHHV 299

Query: 303 VFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQ 362
           VFPIEGTFGYL+PEYFMHGIVDE+TDVFAFGVLLLELITGRRAVDS RQSLVIWAKPLL 
Sbjct: 300 VFPIEGTFGYLAPEYFMHGIVDERTDVFAFGVLLLELITGRRAVDSSRQSLVIWAKPLLD 359

Query: 363 TSNFKELVDPRLADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQLLRGEGGQTD-LK 421
            ++FKEL DP+L D YD  EM R ML AS+CI+H S+MRP M RV+QLL+GE G  D LK
Sbjct: 360 NNSFKELTDPKLGDNYDQTEMGRTMLAASMCINHSSSMRPHMNRVVQLLKGEDGPLDQLK 419

Query: 422 PKP-SARRTVILDGSD-EEYS-STCYLKDLNRHMQLALE 457
            K     R+++L+  D E+Y+ ++ YL DLNRH +L LE
Sbjct: 420 HKSMDGDRSLLLEACDLEDYTNNSSYLNDLNRHRELVLE 458

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|297797585|ref|XP_002866677.1| hypothetical protein ARALYDRAFT_496787 [Arabidopsis lyrata subsp. lyrata] gi|297312512|gb|EFH42936.1| hypothetical protein ARALYDRAFT_496787 [Arabidopsis lyrata subsp. lyrata]

 Score =  548 bits (1412), Expect = e-153,   Method: Compositional matrix adjust.
 Identities = 280/434 (64%), Positives = 338/434 (77%), Gaps = 17/434 (3%)

Query: 26  SPRGVLEIPVTGTDSDSSSSSCGSSSSPE-------KSTPQRAVNRESGGWKSMIDSIKK 78
           SPR VLEIP   +DSD+SSSS   SS           +TP    +     W  MI+SIKK
Sbjct: 29  SPRCVLEIPAMSSDSDNSSSSSSCSSCSPDKSSSPLSTTPTNVSSFHQ--WNKMIESIKK 86

Query: 79  KSVVRRFSVIPLLTNYELTKKNLWKKLGRLQIPEDDDADDGGSVPIVRHSWKNFDFAELA 138
           KS+ RRFSVIPLL +YELT+KN+ +KL     P  ++  D   + + + SW+NF F EL 
Sbjct: 87  KSI-RRFSVIPLLASYELTRKNMRRKLS----PCSENEFDCDQILVTKPSWRNFTFDELV 141

Query: 139 AATDNFNSENLIGKGGHAEVYKGCLPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHI 198
           AATDNFN EN+IGKGGHAEVYKG LPDGE VA+KK+ ++AKE EER+SDFLSELGI+AH+
Sbjct: 142 AATDNFNPENMIGKGGHAEVYKGVLPDGETVAIKKLTRHAKEVEERVSDFLSELGIIAHV 201

Query: 199 NHPNAAKLIGFSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLH 258
           NHPNAA+L GFS + G H VL++ PHGSL+SLLFGS ECL+W  RYK+ALGIA+GL YLH
Sbjct: 202 NHPNAARLRGFSCDRGLHFVLEYAPHGSLASLLFGSEECLDWKKRYKVALGIADGLSYLH 261

Query: 259 HDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEGTFGYLSPEYF 318
           +DC RRIIHRDIKASNILLS+DYEAQISDFGLAKWLP+NW HHIVFPIEGTFGYL+PEYF
Sbjct: 262 NDCPRRIIHRDIKASNILLSQDYEAQISDFGLAKWLPENWPHHIVFPIEGTFGYLAPEYF 321

Query: 319 MHGIVDEKTDVFAFGVLLLELITGRRAVDS-RRQSLVIWAKPLLQTSNFKELVDPRLADA 377
           MHGIVDEKTDVFAFGVLLLE+ITGRRAVD+  RQS+V+WAKPLL+ ++ +E+VDP+L + 
Sbjct: 322 MHGIVDEKTDVFAFGVLLLEIITGRRAVDTASRQSIVMWAKPLLEKNSVEEIVDPQLGND 381

Query: 378 YDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQLLRGEGGQTDLKPKPSARRTVILDGSDE 437
           +D  EMKR M TAS+CIHH+STMRP M R++QLLRG+    +   KP   RTV LD  D 
Sbjct: 382 FDEIEMKRVMQTASMCIHHVSTMRPDMNRLVQLLRGDDQLAE--QKPGGARTVSLDDCDL 439

Query: 438 EYSSTCYLKDLNRH 451
           +++S+ YL DL RH
Sbjct: 440 DHTSSSYLNDLTRH 453

Source: Arabidopsis lyrata subsp. lyrata

Species: Arabidopsis lyrata

Genus: Arabidopsis

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|26452369|dbj|BAC43270.1| unknown protein [Arabidopsis thaliana] gi|28951057|gb|AAO63452.1| At5g65530 [Arabidopsis thaliana]

 Score =  547 bits (1410), Expect = e-153,   Method: Compositional matrix adjust.
 Identities = 279/437 (63%), Positives = 338/437 (77%), Gaps = 14/437 (3%)

Query: 26  SPRGVLEIPVTGTDSDSSSSSCGSSSSPE----KSTPQRAVNRESGGWKSMIDSIKKKSV 81
           SPR VLEIPV  +DSD+SSS    S         +TP    +     W  MI+SIKKKS+
Sbjct: 29  SPRCVLEIPVMSSDSDNSSSCSSCSPDKSSSPLSTTPPNVSSFHQ--WNKMIESIKKKSI 86

Query: 82  VRRFSVIPLLTNYELTKKNLWKKLGRLQIPEDDDADDGGSVPIVRHSWKNFDFAELAAAT 141
            RRFSVIPLL +YELT+K    KL     P  ++  D   + + + SW+NF F EL AAT
Sbjct: 87  -RRFSVIPLLASYELTRKKKQPKLS----PCSENDFDCDQILVAKPSWRNFTFDELVAAT 141

Query: 142 DNFNSENLIGKGGHAEVYKGCLPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHP 201
           DNFN EN+IGKGGHAEVYKG LPDGE VA+KK+ ++AKE EER+SDFLSELGI+AH+NHP
Sbjct: 142 DNFNPENMIGKGGHAEVYKGVLPDGETVAIKKLTRHAKEVEERVSDFLSELGIIAHVNHP 201

Query: 202 NAAKLIGFSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDC 261
           NAA+L GFS + G H VL++  HGSL+SLLFGS ECL+W  RYK+A+GIA+GL YLH+DC
Sbjct: 202 NAARLRGFSCDRGLHFVLEYSSHGSLASLLFGSEECLDWKKRYKVAMGIADGLSYLHNDC 261

Query: 262 HRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEGTFGYLSPEYFMHG 321
            RRIIHRDIKASNILLS+DYEAQISDFGLAKWLP++W HHIVFPIEGTFGYL+PEYFMHG
Sbjct: 262 PRRIIHRDIKASNILLSQDYEAQISDFGLAKWLPEHWPHHIVFPIEGTFGYLAPEYFMHG 321

Query: 322 IVDEKTDVFAFGVLLLELITGRRAVDS-RRQSLVIWAKPLLQTSNFKELVDPRLADAYDL 380
           IVDEKTDVFAFGVLLLE+ITGRRAVD+  RQS+V+WAKPLL+ +N +E+VDP+L + +D 
Sbjct: 322 IVDEKTDVFAFGVLLLEIITGRRAVDTDSRQSIVMWAKPLLEKNNMEEIVDPQLGNDFDE 381

Query: 381 AEMKRAMLTASVCIHHLSTMRPQMTRVLQLLRGEGGQTDLKPKPSARRTVILDGSDEEYS 440
            EMKR M TAS+CIHH+STMRP M R++QLLRG+    +   KP   RTV LD  D +++
Sbjct: 382 TEMKRVMQTASMCIHHVSTMRPDMNRLVQLLRGDDQLAE--QKPGGARTVSLDDCDLDHT 439

Query: 441 STCYLKDLNRHMQLALE 457
           S+ YL DL RH QL++E
Sbjct: 440 SSSYLNDLTRHRQLSME 456

Source: Arabidopsis thaliana

Species: Arabidopsis thaliana

Genus: Arabidopsis

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|30698132|ref|NP_201356.2| protein kinase family protein [Arabidopsis thaliana] gi|332010684|gb|AED98067.1| protein kinase family protein [Arabidopsis thaliana]

 Score =  546 bits (1408), Expect = e-153,   Method: Compositional matrix adjust.
 Identities = 279/437 (63%), Positives = 337/437 (77%), Gaps = 14/437 (3%)

Query: 26  SPRGVLEIPVTGTDSDSSSSSCGSSSSPE----KSTPQRAVNRESGGWKSMIDSIKKKSV 81
           SPR VLEIPV  +DSD+SSS    S         +TP    +     W  MI+SIKKKS+
Sbjct: 29  SPRCVLEIPVMSSDSDNSSSCSSCSPDKSSSPLSTTPPNVSSFHQ--WNKMIESIKKKSI 86

Query: 82  VRRFSVIPLLTNYELTKKNLWKKLGRLQIPEDDDADDGGSVPIVRHSWKNFDFAELAAAT 141
            RRFSVIPLL +YELT+K    KL     P  ++  D   + + + SW+NF F EL AAT
Sbjct: 87  -RRFSVIPLLASYELTRKKKQPKLS----PCSENDFDCDQILVAKPSWRNFTFDELVAAT 141

Query: 142 DNFNSENLIGKGGHAEVYKGCLPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHP 201
           DNFN EN+IGKGGHAEVYKG LPDGE VA+KK+ ++AKE EER+SDFLSELGI+AH+NHP
Sbjct: 142 DNFNPENMIGKGGHAEVYKGVLPDGETVAIKKLTRHAKEVEERVSDFLSELGIIAHVNHP 201

Query: 202 NAAKLIGFSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDC 261
           NAA+L GFS + G H VL++  HGSL+SLLFGS ECL+W  RYK+A+GIA+GL YLH+DC
Sbjct: 202 NAARLRGFSCDRGLHFVLEYSSHGSLASLLFGSEECLDWKKRYKVAMGIADGLSYLHNDC 261

Query: 262 HRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEGTFGYLSPEYFMHG 321
            RRIIHRDIKASNILLS+DYEAQISDFGLAKWLP++W HHIVFPIEGTFGYL+PEYFMHG
Sbjct: 262 PRRIIHRDIKASNILLSQDYEAQISDFGLAKWLPEHWPHHIVFPIEGTFGYLAPEYFMHG 321

Query: 322 IVDEKTDVFAFGVLLLELITGRRAVDS-RRQSLVIWAKPLLQTSNFKELVDPRLADAYDL 380
           IVDEKTDVFAFGVLLLE+ITGRRAVD+  RQS+V+WAKPLL+ +N +E+VDP+L + +D 
Sbjct: 322 IVDEKTDVFAFGVLLLEIITGRRAVDTDSRQSIVMWAKPLLEKNNMEEIVDPQLGNDFDE 381

Query: 381 AEMKRAMLTASVCIHHLSTMRPQMTRVLQLLRGEGGQTDLKPKPSARRTVILDGSDEEYS 440
            EMKR M TAS+CIHH+STMRP M R++QLLRG+    +   KP   RTV LD  D +++
Sbjct: 382 TEMKRVMQTASMCIHHVSTMRPDMNRLVQLLRGDDQLAE--QKPGGARTVSLDDCDLDHT 439

Query: 441 STCYLKDLNRHMQLALE 457
           S+ YL DL RH QL +E
Sbjct: 440 SSSYLNDLTRHRQLLME 456

Source: Arabidopsis thaliana

Species: Arabidopsis thaliana

Genus: Arabidopsis

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356566175|ref|XP_003551310.1| PREDICTED: receptor-like cytosolic serine/threonine-protein kinase RBK1-like [Glycine max]

 Score =  543 bits (1400), Expect = e-152,   Method: Compositional matrix adjust.
 Identities = 278/455 (61%), Positives = 349/455 (76%), Gaps = 14/455 (3%)

Query: 15  KNEKEKIPGTD-----SPRGVLEIPVTGTDSDSS-SSSCGSSSSPEKSTPQRAVNRESGG 68
           +N+K+++   D     SPR V  +P++GTDSDS+ SS+ G           +A   +S  
Sbjct: 32  QNQKKEVVACDDDVLASPRDVFGVPISGTDSDSTGSSNYGGGPGSPGLGQNQAAQAQSQQ 91

Query: 69  WKSMIDSIKKKSVVRRFSVIPLLT-NYELTKKNLWKKLGRLQ-IPEDDDADDGGSVPIV- 125
           W++MID ++ KSV RRFS IPLL  +YE+++K+L  KL R++   EDDD D G ++  + 
Sbjct: 92  WRAMIDVLRFKSV-RRFSTIPLLAASYEISRKSLRNKLARIRPANEDDDFDGGINIDGIS 150

Query: 126 -RHSWKNFDFAELAAATDNFNSENLIGKGGHAEVYKGCLPDGEVVAVKKIIKNAKEDEER 184
            + SW+NF +A+LA ATD+F+ ENL+GKGGHAEVYKG L DG+VVAVK+I++N KE E+R
Sbjct: 151 TKPSWRNFSYADLAVATDDFSPENLLGKGGHAEVYKGYLADGQVVAVKRIMRNEKEAEDR 210

Query: 185 ISDFLSELGIVAHINHPNAAKLIGFSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRY 244
             DFL+ELGI+AHINHPNA +LIGF  +NG + VLQ  PHGSLSSLLFGS ECLEW IR+
Sbjct: 211 AGDFLTELGIIAHINHPNATRLIGFGIDNGLYFVLQLAPHGSLSSLLFGS-ECLEWKIRF 269

Query: 245 KIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVF 304
           K+A+G+A+GLQYLHHDC RRIIHRDIKASNILL+E+ EA+ISDFGLAKWL D   HH+VF
Sbjct: 270 KVAVGVAKGLQYLHHDCPRRIIHRDIKASNILLNENNEAEISDFGLAKWLADKCDHHVVF 329

Query: 305 PIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSR-RQSLVIWAKPLLQT 363
           PIEGTFGYL+PEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDS  R+SLV WAKPLL  
Sbjct: 330 PIEGTFGYLAPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSNSRESLVKWAKPLLDA 389

Query: 364 SNFKELVDPRLADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQLLRGEGGQTDLKPK 423
              +E+VDPRL D YDLAEMK  M TAS+CIHH+S+ RP M +V+QLL+GE    +L   
Sbjct: 390 KLIEEIVDPRLEDKYDLAEMKCVMATASLCIHHMSSKRPYMNQVVQLLKGEKVPNELNQN 449

Query: 424 PSARRTVILDGSD-EEYSSTCYLKDLNRHMQLALE 457
            SA R++++D  D E+Y+ + YL DLNRH QL +E
Sbjct: 450 SSAPRSLLIDACDLEDYTCSNYLNDLNRHKQLLME 484

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356523967|ref|XP_003530605.1| PREDICTED: receptor-like cytosolic serine/threonine-protein kinase RBK1-like [Glycine max]

 Score =  542 bits (1397), Expect = e-151,   Method: Compositional matrix adjust.
 Identities = 274/440 (62%), Positives = 343/440 (77%), Gaps = 18/440 (4%)

Query: 27  PRGVLEIPVTGTDSDSS-SSSCGSSSSPEKSTPQRAVNRESGGWKSMIDSIKKKSVVRRF 85
           PR V  +P+ G DSDS+ SS+ G   SP          + S  W++MID ++ KSV RRF
Sbjct: 47  PRDVFGVPILGMDSDSTGSSNYGGPGSPGLG------QKHSQQWRAMIDVLRFKSV-RRF 99

Query: 86  SVIPLLT-NYELTKKNLWKKLGRLQIP---EDDDADDGGSVPIV--RHSWKNFDFAELAA 139
           S IPLL  +YE+++K+L  KL R+ +P   EDDD + G  +  +  + SW+NF +A+LAA
Sbjct: 100 STIPLLAASYEISRKSLRNKLARI-LPANEEDDDLNLGIDIDDISTKPSWRNFSYADLAA 158

Query: 140 ATDNFNSENLIGKGGHAEVYKGCLPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHIN 199
           ATD+F+  NL+GKGGHAEVYKGCL DG+VVAVK++++N KE E +  DFL+ELGI+AHIN
Sbjct: 159 ATDDFSPVNLLGKGGHAEVYKGCLADGQVVAVKRLMRNEKEIEGKAGDFLTELGIIAHIN 218

Query: 200 HPNAAKLIGFSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHH 259
           HPNA +LIGF  +NG + VLQ  PHGSLSSLLFGS ECLEW IR+K+A+G+A+GLQYLHH
Sbjct: 219 HPNATRLIGFGIDNGLYFVLQLAPHGSLSSLLFGS-ECLEWKIRFKVAVGVAKGLQYLHH 277

Query: 260 DCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEGTFGYLSPEYFM 319
           DC RRIIHRDIKASNILL+++ EA+ISDFGLAKWLPD W+HH+VFPIEGTFGYL+PEYFM
Sbjct: 278 DCPRRIIHRDIKASNILLNQNNEAEISDFGLAKWLPDKWAHHVVFPIEGTFGYLAPEYFM 337

Query: 320 HGIVDEKTDVFAFGVLLLELITGRRAVDSR-RQSLVIWAKPLLQTSNFKELVDPRLADAY 378
           HGIVDEKTDVFAFGVLLLELITGRRAVDS  R+SLVIWAKPLL+    +++VDPRL   Y
Sbjct: 338 HGIVDEKTDVFAFGVLLLELITGRRAVDSNSRESLVIWAKPLLEAKLIEQMVDPRLELKY 397

Query: 379 DLAEMKRAMLTASVCIHHLSTMRPQMTRVLQLLRGEGGQTDLKPKPSARRTVILDGSD-E 437
           DLAEMK AM+TAS+CIHH+S+ RP M +V+QLL+GE    +L    SA R+ ++D  D E
Sbjct: 398 DLAEMKCAMVTASMCIHHMSSKRPYMNQVVQLLKGEEVPIELTQNSSAPRSHLIDACDLE 457

Query: 438 EYSSTCYLKDLNRHMQLALE 457
           +Y+ + YL DLNRH QL +E
Sbjct: 458 DYTCSNYLTDLNRHKQLLME 477

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	457
TAIR|locus:2155700	456	AT5G65530 [Arabidopsis thalian	0.980	0.982	0.569	2.8e-130
TAIR|locus:2142514	467	RBK1 "ROP binding protein kina	0.967	0.946	0.537	2.4e-124
TAIR|locus:2144970	511	AT5G18910 [Arabidopsis thalian	0.842	0.753	0.483	3e-94
TAIR|locus:2162848	429	AT5G35960 [Arabidopsis thalian	0.781	0.832	0.480	1e-88
TAIR|locus:2096209	460	RBK2 "ROP binding protein kina	0.713	0.708	0.504	5.2e-81
TAIR|locus:2044420	392	AT2G18890 [Arabidopsis thalian	0.632	0.737	0.505	6.3e-76
TAIR|locus:2172555	579	AT5G57670 [Arabidopsis thalian	0.628	0.495	0.465	1.8e-71
TAIR|locus:2195975	794	AT1G77280 [Arabidopsis thalian	0.689	0.396	0.384	4.6e-57
TAIR|locus:2093999	700	PERK6 "proline-rich extensin-l	0.704	0.46	0.386	1.4e-55
TAIR|locus:2026957	756	AT1G21590 [Arabidopsis thalian	0.717	0.433	0.378	1.8e-55

TAIR|locus:2155700 AT5G65530 [Arabidopsis thaliana (taxid:3702)]

 Score = 1278 (454.9 bits), Expect = 2.8e-130, P = 2.8e-130
 Identities = 265/465 (56%), Positives = 317/465 (68%)

Query:     1 MAVQETGV-VKAQVEKN-EKEKIPGTD-SPRGVLEIPVXXXXXXXXXXXXX----XXXXP 53
             MAV+E    +K   E    K  +   D SPR VLEIPV                     P
Sbjct:     1 MAVEEMEKKIKGSQETELHKNDLSIEDPSPRCVLEIPVMSSDSDNSSSCSSCSPDKSSSP 60

Query:    54 EKSTPQRAVNRESGGWKSMIDSIKKKSVVRRFSVIPLLTNYELTKKNLWKKLGRLQIPED 113
               +TP    +     W  MI+SIKKKS+ RRFSVIPLL +YELT+K    KL       D
Sbjct:    61 LSTTPPNVSSFHQ--WNKMIESIKKKSI-RRFSVIPLLASYELTRKKKQPKLSPCS-END 116

Query:   114 DDADDGGSVPIVRHSWKNFDFAELAAATDNFNSENLIGKGGHAEVYKGCLPDGEXXXXXX 173
              D D    + + + SW+NF F EL AATDNFN EN+IGKGGHAEVYKG LPDGE      
Sbjct:   117 FDCDQ---ILVAKPSWRNFTFDELVAATDNFNPENMIGKGGHAEVYKGVLPDGETVAIKK 173

Query:   174 XXXXXXEDEERISDFLSELGIVAHINHPNAAKLIGFSTENGFHLVLQFLPHGSLSSLLFG 233
                   E EER+SDFLSELGI+AH+NHPNAA+L GFS + G H VL++  HGSL+SLLFG
Sbjct:   174 LTRHAKEVEERVSDFLSELGIIAHVNHPNAARLRGFSCDRGLHFVLEYSSHGSLASLLFG 233

Query:   234 STECLEWTIRYKIALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKW 293
             S ECL+W  RYK+A+GIA+GL YL             KASNILLS+DYEAQISDFGLAKW
Sbjct:   234 SEECLDWKKRYKVAMGIADGLSYLHNDCPRRIIHRDIKASNILLSQDYEAQISDFGLAKW 293

Query:   294 LPDNWSHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDS-RRQS 352
             LP++W HHIVFPIEGTFGYL+PEYFMHGIVDEKTDVFAFGVLLLE+ITGRRAVD+  RQS
Sbjct:   294 LPEHWPHHIVFPIEGTFGYLAPEYFMHGIVDEKTDVFAFGVLLLEIITGRRAVDTDSRQS 353

Query:   353 LVIWAKPLLQTSNFKELVDPRLADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQLLR 412
             +V+WAKPLL+ +N +E+VDP+L + +D  EMKR M TAS+CIHH+STMRP M R++QLLR
Sbjct:   354 IVMWAKPLLEKNNMEEIVDPQLGNDFDETEMKRVMQTASMCIHHVSTMRPDMNRLVQLLR 413

Query:   413 GEGGQTDLKPKPSARRTVILDGSDEEYSSTCYLKDLNRHMQLALE 457
             G+    +   KP   RTV LD  D +++S+ YL DL RH QL +E
Sbjct:   414 GDDQLAE--QKPGGARTVSLDDCDLDHTSSSYLNDLTRHRQLLME 456

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;IDA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005737 "cytoplasm" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0046777 "protein autophosphorylation" evidence=IDA

TAIR|locus:2142514 RBK1 "ROP binding protein kinases 1" [Arabidopsis thaliana (taxid:3702)]

 Score = 1222 (435.2 bits), Expect = 2.4e-124, P = 2.4e-124
 Identities = 245/456 (53%), Positives = 318/456 (69%)

Query:    12 QVEKNEKEK-IPGTDSPRGVLEIPVXXXXXXXXXXX------XXXXXXPEKSTPQRAVNR 64
             +VE +  +  +  + SPRGVL +                         P  +T +   + 
Sbjct:    16 EVELHRNDLGLEDSSSPRGVLGMVSDSDNSSSSCSSCSSDDKSSSTSSPFSNTTKTVSSS 75

Query:    65 ESG-GWKSMIDSIKKKSVVRRFSVIPLLTNYELTKKNLWKKLGRLQIPEDDDADDGGSVP 123
               G  W  MI+SIKKKS+ RRFSVIPLL +YELT+KNL +K  +L  P +  A    +  
Sbjct:    76 HHGLQWNKMIESIKKKSM-RRFSVIPLLASYELTRKNLRRKQPKLT-PSES-AFTCEAFF 132

Query:   124 IVRHSWKNFDFAELAAATDNFNSENLIGKGGHAEVYKGCLPDGEXXXXXXXXXXXXEDEE 183
             + + SW+NF + ELA ATD FN EN+IGKGGHAEVYKG L +GE            E+EE
Sbjct:   133 MAKPSWRNFTYEELAVATDYFNPENMIGKGGHAEVYKGVLINGETVAIKKLMSHAKEEEE 192

Query:   184 RISDFLSELGIVAHINHPNAAKLIGFSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIR 243
             R+SDFLSELGI+AH+NHPNAA+L GFS++ G H VL++ P+GSL+S+LFGS ECLEW IR
Sbjct:   193 RVSDFLSELGIIAHVNHPNAARLRGFSSDRGLHFVLEYAPYGSLASMLFGSEECLEWKIR 252

Query:   244 YKIALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSHHIV 303
             YK+ALGIA+GL YL             KASNILL+ DYEAQISDFGLAKWLP+NW HH+V
Sbjct:   253 YKVALGIADGLSYLHNACPRRIIHRDIKASNILLNHDYEAQISDFGLAKWLPENWPHHVV 312

Query:   304 FPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSR-RQSLVIWAKPLLQ 362
             FPIEGTFGYL+PEYFMHGIVDEK DVFAFGVLLLE+IT RRAVD+  RQS+V WAKP L+
Sbjct:   313 FPIEGTFGYLAPEYFMHGIVDEKIDVFAFGVLLLEIITSRRAVDTASRQSIVAWAKPFLE 372

Query:   363 TSNFKELVDPRLADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQLLRGEGGQTDLKP 422
              ++ +++VDPRL + ++  EM+R MLTAS+C+HH++ MRP MTR++QLLRGE G  +L+ 
Sbjct:   373 KNSMEDIVDPRLGNMFNPTEMQRVMLTASMCVHHIAAMRPDMTRLVQLLRGEDGPAELQQ 432

Query:   423 KPSARRTVILDGSD-EEYSSTCYLKDLNRHMQLALE 457
             K +  RT+ ++  D ++++S+ YL +L RH QL +E
Sbjct:   433 K-AGERTMSVNACDLQDHTSSSYLNELRRHRQLLME 467

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005737 "cytoplasm" evidence=IDA

GO:0005829 "cytosol" evidence=IDA

GO:0009623 "response to parasitic fungus" evidence=IEP

GO:0009814 "defense response, incompatible interaction" evidence=IEP

GO:0012505 "endomembrane system" evidence=IDA

GO:0051020 "GTPase binding" evidence=IPI

GO:0071369 "cellular response to ethylene stimulus" evidence=IEP

GO:0009612 "response to mechanical stimulus" evidence=RCA

GO:0019722 "calcium-mediated signaling" evidence=RCA

TAIR|locus:2144970 AT5G18910 [Arabidopsis thaliana (taxid:3702)]

 Score = 938 (335.3 bits), Expect = 3.0e-94, P = 3.0e-94
 Identities = 193/399 (48%), Positives = 268/399 (67%)

Query:    66 SGGWK-SMIDSIKKKSVVRRFSVI-PLLTNYELTKKNLWKKLGRLQIPEDDDADDGGSVP 123
             +G W+      +KK S    F+   PL    +LT++   K++    +P    A D   + 
Sbjct:   114 NGHWRRGFFRLLKKGSSAMPFNTFTPLKGVPKLTRRKS-KRIRDNMVPVIP-ALDTDHLF 171

Query:   124 IVRHSWKNFDFAELAAATDNFNSENLIGKGGHAEVYKGCLPDGEXXXXXXXXXXXXEDEE 183
               + SW+NF   ++  AT++++ ENLIG+GG+AEVYKG + DG+            E  E
Sbjct:   172 YFKPSWRNFSLRDIQTATNDYSRENLIGEGGYAEVYKGQMADGQIVAIKKLTRGSAE--E 229

Query:   184 RISDFLSELGIVAHINHPNAAKLIGFSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIR 243
                D+LSELGI+ H++HPN AKLIG+  E G HLVL+  P+GSL+SLL+ + E L W++R
Sbjct:   230 MTMDYLSELGIIVHVDHPNIAKLIGYCVEGGMHLVLELSPNGSLASLLYEAKEKLNWSMR 289

Query:   244 YKIALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSHHIV 303
             YK+A+G AEGL YL             KASNILL++++EAQISDFGLAKWLPD W+HH V
Sbjct:   290 YKVAMGTAEGLYYLHEGCQRRIIHKDIKASNILLTQNFEAQISDFGLAKWLPDQWTHHTV 349

Query:   304 FPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQT 363
               +EGTFGYL PE+FMHGIVDEKTDV+A+GVLLLELITGR+A+DS + S+V+WAKPL++ 
Sbjct:   350 SKVEGTFGYLPPEFFMHGIVDEKTDVYAYGVLLLELITGRQALDSSQHSIVMWAKPLIKE 409

Query:   364 SNFKELVDPRLADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQLLRGEGGQTD-LKP 422
             +  K+LVDP L D YD+ E+ R +  AS+CIH  S  RPQM++V+++LRG+    D L+ 
Sbjct:   410 NKIKQLVDPILEDDYDVEELDRLVFIASLCIHQTSMNRPQMSQVVEILRGDKCSLDKLRE 469

Query:   423 KPSAR--RTV---ILDGSDEEYSSTCYLKDLNRHMQLAL 456
             + +++  RT    +LD  +EEY+ST YL D+NRHM+  L
Sbjct:   470 RENSKLQRTYSEELLD--NEEYNSTRYLNDINRHMETVL 506

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;IDA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005777 "peroxisome" evidence=IDA

GO:0046777 "protein autophosphorylation" evidence=IDA

TAIR|locus:2162848 AT5G35960 [Arabidopsis thaliana (taxid:3702)]

 Score = 861 (308.1 bits), Expect = 1.0e-88, Sum P(2) = 1.0e-88
 Identities = 177/368 (48%), Positives = 245/368 (66%)

Query:    56 STPQRAVNRESGGWKSMIDSIKKKSVVRRFSV-IPLLTNYELTKKNLWKKLGRLQIPEDD 114
             S+ +   N  S  ++ M+  ++ KS     +V IP   N  +  K+ +++   ++     
Sbjct:    49 SSSETVKNPSSSRFRKMVQLLRSKSKKSLENVKIPFHNNGVI--KSSFRRCSSMRENLRF 106

Query:   115 DADDGGSVPIVRHSWKN-FDFAELAAATDNFNSENLIGKGGHAEVYKGCLPDGEXXXXXX 173
              ++D      + HS +  F F++L +AT+NF+ ENLIGKGG+AEVYKG LP+G+      
Sbjct:   107 SSNDSH---FLLHSPRRIFTFSDLKSATNNFSLENLIGKGGYAEVYKGMLPNGQMVAIKR 163

Query:   174 XXXXXXEDEERISDFLSELGIVAHINHPNAAKLIGFSTENGFHLVLQFLPHGSLSSLLFG 233
                     EE I DFLSE+GI+AH+NHPN AKL+G+  E G HLVL+  PHGSL+S+L+ 
Sbjct:   164 LMRG--NSEEIIVDFLSEMGIMAHVNHPNIAKLLGYGVEGGMHLVLELSPHGSLASMLYS 221

Query:   234 STECLEWTIRYKIALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKW 293
             S E ++W+IRYKIALG+AEGL YL             KA+NILL+ D+  QI DFGLAKW
Sbjct:   222 SKEKMKWSIRYKIALGVAEGLVYLHRGCHRRIIHRDIKAANILLTHDFSPQICDFGLAKW 281

Query:   294 LPDNWSHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSL 353
             LP+NW+HHIV   EGTFGYL+PEY  HGIVDEKTDVFA GVLLLEL+TGRRA+D  +QSL
Sbjct:   282 LPENWTHHIVSKFEGTFGYLAPEYLTHGIVDEKTDVFALGVLLLELVTGRRALDYSKQSL 341

Query:   354 VIWAKPLLQTSNFKELVDPRLADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQLLRG 413
             V+WAKPL++ +  +EL+DP LA  Y+  ++K  +L A++ I   S  RP+M++V+++L+G
Sbjct:   342 VLWAKPLMKKNKIRELIDPSLAGEYEWRQIKLVLLAAALSIQQSSIERPEMSQVVEILKG 401

Query:   414 EGGQTDLK 421
                  DLK
Sbjct:   402 N--LKDLK 407

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2096209 RBK2 "ROP binding protein kinases 2" [Arabidopsis thaliana (taxid:3702)]

 Score = 813 (291.2 bits), Expect = 5.2e-81, P = 5.2e-81
 Identities = 169/335 (50%), Positives = 222/335 (66%)

Query:   128 SWKNFDFAELAAATDNFNSENLIGKGGHAEVYKGCLPDGEXXXXXXXXXXXXEDEERISD 187
             S +NF  +++  ATDNF+ EN+IG+GG+A+VY+G LP+G+              +E+ ++
Sbjct:   127 SLQNFSISDIEIATDNFSPENIIGRGGYADVYQGILPEGKLIAVKRLTKGT--PDEQTAE 184

Query:   188 FLSELGIVAHINHPNAAKLIGFSTENGFHLVLQFLPHGSLSSLLFGSTEC-LEWTIRYKI 246
             FLSELGI+AH++HPN AK IG   E G HLV +  P GSL SLL G ++  L W+ RY +
Sbjct:   185 FLSELGIIAHVDHPNTAKFIGCCIEGGMHLVFRLSPLGSLGSLLHGPSKYKLTWSRRYNV 244

Query:   247 ALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPI 306
             ALG A+GL YL             KA NILL+ED++ QI DFGLAKWLP   +HH V   
Sbjct:   245 ALGTADGLVYLHEGCQRRIIHRDIKADNILLTEDFQPQICDFGLAKWLPKQLTHHNVSKF 304

Query:   307 EGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSNF 366
             EGTFGY +PEYFMHGIVDEKTDVFAFGVLLLELITG  A+D  +QSLV+WAKPLL+    
Sbjct:   305 EGTFGYFAPEYFMHGIVDEKTDVFAFGVLLLELITGHPALDESQQSLVLWAKPLLERKAI 364

Query:   367 KELVDPRLADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQLLRGEGGQTDLKPKPSA 426
             KELVDP L D Y+  E+ R   TAS+CI   S +RP+M++V++LL G      + P+ + 
Sbjct:   365 KELVDPSLGDEYNREELIRLTSTASLCIDQSSLLRPRMSQVVELLLGHEDVV-MTPREAK 423

Query:   427 RRTVILDGSDE-----EYSSTCYLKDLNRHMQLAL 456
              + +    S+E     EY+ST YL DL+R  ++AL
Sbjct:   424 IKMMQRTYSEELLDSVEYNSTKYLGDLDRIREVAL 458

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005737 "cytoplasm" evidence=IDA

GO:0051020 "GTPase binding" evidence=IPI

TAIR|locus:2044420 AT2G18890 [Arabidopsis thaliana (taxid:3702)]

 Score = 765 (274.4 bits), Expect = 6.3e-76, P = 6.3e-76
 Identities = 147/291 (50%), Positives = 193/291 (66%)

Query:   126 RHSWKNFDFAELAAATDNFNSENLIGKGGHAEVYKGCL-PDGEXXXXXXXXXXXXEDEER 184
             R  WK F F E+  AT+ F+SENL+G+GG AEVYKG L  +GE            +DE R
Sbjct:    50 RPKWKCFSFQEIYDATNGFSSENLVGRGGFAEVYKGILGKNGEEIAVKRITRGGRDDERR 109

Query:   185 ISDFLSELGIVAHINHPNAAKLIGFSTENGFHLVLQFLPHGSLSSLLFGSTEC-LEWTIR 243
               +FL E+G + H++HPN   L+G   +NG +LV  F   GSL+SLL    +  LEW  R
Sbjct:   110 EKEFLMEIGTIGHVSHPNVLSLLGCCIDNGLYLVFIFSSRGSLASLLHDLNQAPLEWETR 169

Query:   244 YKIALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSHHIV 303
             YKIA+G A+GL YL             K+SN+LL++D+E QISDFGLAKWLP  WSHH +
Sbjct:   170 YKIAIGTAKGLHYLHKGCQRRIIHRDIKSSNVLLNQDFEPQISDFGLAKWLPSQWSHHSI 229

Query:   304 FPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQT 363
              PIEGTFG+L+PEY+ HGIVDEKTDVFAFGV LLELI+G++ VD+  QSL  WAK +++ 
Sbjct:   230 APIEGTFGHLAPEYYTHGIVDEKTDVFAFGVFLLELISGKKPVDASHQSLHSWAKLIIKD 289

Query:   364 SNFKELVDPRLADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQLLRGE 414
                ++LVDPR+ + +DL ++ R    AS+CI   S  RP M  VL++L+GE
Sbjct:   290 GEIEKLVDPRIGEEFDLQQLHRIAFAASLCIRSSSLCRPSMIEVLEVLQGE 340

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2172555 AT5G57670 [Arabidopsis thaliana (taxid:3702)]

 Score = 723 (259.6 bits), Expect = 1.8e-71, P = 1.8e-71
 Identities = 135/290 (46%), Positives = 194/290 (66%)

Query:   132 FDFAELAAATDNFNSENLIGKGGHAEVYKGCLPDGEXXXXXXXXXXXXEDEERISDFLSE 191
             F + E++ AT++F+  N++G GG++EVY+G L DG              D  +  +FL+E
Sbjct:   255 FTYNEISKATNDFHQGNIVGIGGYSEVYRGDLWDGRRIAVKRLAKESG-DMNKEKEFLTE 313

Query:   192 LGIVAHINHPNAAKLIGFSTENGFHLVLQFLPHGSLSSLLFGSTE-CLEWTIRYKIALGI 250
             LGI++H++HPN A L+G   E G +LV +F  +G+L S L  +    L+W +RYKIA+G+
Sbjct:   314 LGIISHVSHPNTALLLGCCVEKGLYLVFRFSENGTLYSALHENENGSLDWPVRYKIAVGV 373

Query:   251 AEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEGTF 310
             A GL YL             K+SN+LL  DYE QI+DFGLAKWLP+ W+HH V P+EGTF
Sbjct:   374 ARGLHYLHKRCNHRIIHRDIKSSNVLLGPDYEPQITDFGLAKWLPNKWTHHAVIPVEGTF 433

Query:   311 GYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSNFKELV 370
             GYL+PE  M G +DEKTD++AFG+LLLE+ITGRR V+  ++ +++WAKP ++T N  ELV
Sbjct:   434 GYLAPESLMQGTIDEKTDIYAFGILLLEIITGRRPVNPTQKHILLWAKPAMETGNTSELV 493

Query:   371 DPRLADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQLLRGEGGQTDL 420
             DP+L D YD  +M + +LTAS C+     +RP MT+VL+LL   G + ++
Sbjct:   494 DPKLQDKYDDQQMNKLVLTASHCVQQSPILRPTMTQVLELLTN-GNEAEI 542

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0002238 "response to molecule of fungal origin" evidence=RCA

TAIR|locus:2195975 AT1G77280 [Arabidopsis thaliana (taxid:3702)]

 Score = 587 (211.7 bits), Expect = 4.6e-57, P = 4.6e-57
 Identities = 130/338 (38%), Positives = 201/338 (59%)

Query:   132 FDFAELAAATDNFNSENLIGKGGHAEVYKGCLPDGEXXXXXXXXXXXXEDEERISDFLSE 191
             F + EL + T NF+++N IGKGG + V++GCL +G             + E+ ++DF++E
Sbjct:   433 FKYKELVSVTSNFSADNFIGKGGSSRVFRGCLSNGRVVAVKILK----QTEDVLNDFVAE 488

Query:   192 LGIVAHINHPNAAKLIGFSTEN-GFHLVLQFLPHGSLSSLLFGSTE---CLEWTIRYKIA 247
             + I+  ++H N   L+GF  E+    LV  +L  GSL   L G+ +      W+ RYK+A
Sbjct:   489 IEIITTLHHKNIISLLGFCFEDHNLLLVYNYLSRGSLEENLHGNKKDPLAFCWSERYKVA 548

Query:   248 LGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIE 307
             +G+AE L YL             K+SNILLS+D+E Q+SDFGLA+W   + +H I   + 
Sbjct:   549 VGVAEALDYLHNTASQPVIHRDVKSSNILLSDDFEPQLSDFGLARWASISTTHIICSDVA 608

Query:   308 GTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSR----RQSLVIWAKPLLQT 363
             GTFGYL+PEYFM+G V++K DV+AFGV+LLEL++GR+ + S     ++SLV+WAKP+L  
Sbjct:   609 GTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLSGRKPISSGCPKGQESLVMWAKPILDD 668

Query:   364 SNFKELVDPRLADAYDLAE--MKRAMLTASVCIHHLSTMRPQMTRVLQLLRGEGGQTDL- 420
               + +L+DP L D  +  +  M+R  L A++CI      RP+M+ VL+LL+G+    +  
Sbjct:   669 GKYSQLLDPSLRDNNNNNDDQMQRMALAATLCIRRSPQARPKMSIVLKLLKGDEDTLEWA 728

Query:   421 --KPKPSARRTVILDGSDEEYSSTCYLKDLNRHMQLAL 456
               +   S+  + +L   DE+    C   +L  H+ LAL
Sbjct:   729 MQQVNSSSEESEML--KDEQ----CQRSNLQSHLNLAL 760

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0002238 "response to molecule of fungal origin" evidence=RCA

TAIR|locus:2093999 PERK6 "proline-rich extensin-like receptor kinase 6" [Arabidopsis thaliana (taxid:3702)]

 Score = 573 (206.8 bits), Expect = 1.4e-55, P = 1.4e-55
 Identities = 130/336 (38%), Positives = 194/336 (57%)

Query:   132 FDFAELAAATDNFNSENLIGKGGHAEVYKGCLPDGEXXXXXXXXXXXXEDEERISDFLSE 191
             F + ELAAAT  F+   L+G+GG   V+KG LP+G+            + E    +F +E
Sbjct:   325 FTYDELAAATQGFSQSRLLGQGGFGYVHKGILPNGKEIAVKSLKAGSGQGER---EFQAE 381

Query:   192 LGIVAHINHPNAAKLIGFSTENGFH-LVLQFLPHGSLSSLLFG-STECLEWTIRYKIALG 249
             + I++ ++H     L+G+    G   LV +FLP+ +L   L G S + L+W  R KIALG
Sbjct:   382 VDIISRVHHRFLVSLVGYCIAGGQRMLVYEFLPNDTLEFHLHGKSGKVLDWPTRLKIALG 441

Query:   250 IAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEGT 309
              A+GL YL             KASNILL E +EA+++DFGLAK   DN +H +   I GT
Sbjct:   442 SAKGLAYLHEDCHPRIIHRDIKASNILLDESFEAKVADFGLAKLSQDNVTH-VSTRIMGT 500

Query:   310 FGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVD---SRRQSLVIWAKPLL----Q 362
             FGYL+PEY   G + +++DVF+FGV+LLEL+TGRR VD       SLV WA+P+     Q
Sbjct:   501 FGYLAPEYASSGKLTDRSDVFSFGVMLLELVTGRRPVDLTGEMEDSLVDWARPICLNAAQ 560

Query:   363 TSNFKELVDPRLADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQLLRGEGGQTDLKP 422
               ++ ELVDPRL + Y+  EM + +  A+  + H +  RP+M+++++ L G+    DL  
Sbjct:   561 DGDYSELVDPRLENQYEPHEMAQMVACAAAAVRHSARRRPKMSQIVRALEGDATLDDLSE 620

Query:   423 KPSARRTVILD-GSDEEYSSTCYLKDLNRHMQLALE 457
                A ++  L  GS  +Y S+ Y  D+ +  ++AL+
Sbjct:   621 GGKAGQSSFLGRGSSSDYDSSTYSADMKKFRKVALD 656

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0051510 "regulation of unidimensional cell growth" evidence=RCA

TAIR|locus:2026957 AT1G21590 [Arabidopsis thaliana (taxid:3702)]

 Score = 572 (206.4 bits), Expect = 1.8e-55, P = 1.8e-55
 Identities = 132/349 (37%), Positives = 200/349 (57%)

Query:    74 DSIKKKSVVRRFSVIPLLTNYELTKKNLWKKLGRLQIPEDDDADDGGSVPIVRHSWKNFD 133
             D +   +V R+ +++P      + K +L    GR   PE+ +    G    +  S + F 
Sbjct:   348 DKLSSSNVERQ-AIVP--DESMIVKCSLDHSSGRF--PENVE----GLQARISTSCQFFT 398

Query:   134 FAELAAATDNFNSENLIGKGGHAEVYKGCLPDGEXXXXXXXXXXXXEDEERISDFLSELG 193
             + EL + T NF ++N IGKGG + V++G LP+G               E  + DF++E+ 
Sbjct:   399 YKELVSVTSNFCADNFIGKGGSSRVFRGYLPNGREVAVKILKRT----ECVLKDFVAEID 454

Query:   194 IVAHINHPNAAKLIGFSTENG-FHLVLQFLPHGSLSSLLFGSTECL---EWTIRYKIALG 249
             I+  ++H N   L+G+  EN    LV  +L  GSL   L G+ + L    W  RYK+A+G
Sbjct:   455 IITTLHHKNVISLLGYCFENNNLLLVYNYLSRGSLEENLHGNKKDLVAFRWNERYKVAVG 514

Query:   250 IAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEGT 309
             IAE L YL             K+SNILLS+D+E Q+SDFGLAKW  ++ +  I   + GT
Sbjct:   515 IAEALDYLHNDAPQPVIHRDVKSSNILLSDDFEPQLSDFGLAKWASESTTQIICSDVAGT 574

Query:   310 FGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSR----RQSLVIWAKPLLQTSN 365
             FGYL+PEYFM+G ++ K DV+A+GV+LLEL++GR+ V+S     + SLV+WAKP+L    
Sbjct:   575 FGYLAPEYFMYGKMNNKIDVYAYGVVLLELLSGRKPVNSESPKAQDSLVMWAKPILDDKE 634

Query:   366 FKELVDPRLADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQLLRGE 414
             + +L+D  L D  +  +M++  L A++CI H    RP M  VL+LL+G+
Sbjct:   635 YSQLLDSSLQDDNNSDQMEKMALAATLCIRHNPQTRPTMGMVLELLKGD 683

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0002238 "response to molecule of fungal origin" evidence=RCA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

No confident hit for EC number transfering in SWISSPROT detected by BLAST

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	0.946
3rd Layer	2.7.11	0.963

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Fail to connect to STRING server

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	457
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	8e-48
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	3e-44
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	5e-44
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	1e-43
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	1e-43
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	5e-43
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	3e-40
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	3e-39
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	6e-39
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	3e-35
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	2e-32
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	1e-30
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	1e-29
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	1e-29
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	9e-29
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	1e-28
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	4e-28
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	2e-27
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	3e-27
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	2e-26
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	1e-25
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	4e-25
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	4e-25
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	8e-25
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	2e-24
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	4e-24
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	4e-24
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	1e-23
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	1e-23
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	2e-23
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	4e-23
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	4e-23
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	6e-23
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	1e-22
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	1e-22
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	1e-22
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	2e-22
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	2e-22
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	4e-22
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	4e-22
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	1e-21
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	1e-21
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	2e-21
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	2e-21
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	4e-21
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	4e-21
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	5e-21
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	5e-21
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	6e-21
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	7e-21
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	9e-21
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	9e-21
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	1e-20
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	1e-20
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	2e-20
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	2e-20
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	2e-20
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	2e-20
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	3e-20
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	6e-20
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	7e-20
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	7e-20
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	9e-20
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	9e-20
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	1e-19
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	2e-19
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	2e-19
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	3e-19
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	3e-19
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	4e-19
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	4e-19
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	4e-19
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	6e-19
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	6e-19
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	6e-19
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	6e-19
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	7e-19
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	1e-18
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	1e-18
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	1e-18
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	1e-18
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	1e-18
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	1e-18
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	2e-18
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	3e-18
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	4e-18
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	4e-18
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	5e-18
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	6e-18
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	6e-18
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	8e-18
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	1e-17
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	2e-17
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	2e-17
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	3e-17
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	3e-17
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	3e-17
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	3e-17
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	5e-17
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	5e-17
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	6e-17
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	9e-17
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	9e-17
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	9e-17
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	2e-16
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	3e-16
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	3e-16
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	3e-16
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	4e-16
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	4e-16
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	6e-16
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	6e-16
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	6e-16
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	9e-16
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	1e-15
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	1e-15
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	1e-15
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	1e-15
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	2e-15
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	2e-15
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	2e-15
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	3e-15
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	3e-15
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	3e-15
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	9e-15
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	1e-14
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	1e-14
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	1e-14
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	1e-14
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	1e-14
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	1e-14
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	2e-14
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	2e-14
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	3e-14
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	3e-14
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	3e-14
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	3e-14
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	5e-14
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	7e-14
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	1e-13
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	2e-13
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	2e-13
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	2e-13
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	3e-13
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	5e-13
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	6e-13
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	6e-13
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	6e-13
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	6e-13
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	8e-13
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	8e-13
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	1e-12
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	1e-12
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	1e-12
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	1e-12
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	1e-12
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	1e-12
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	1e-12
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	2e-12
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	2e-12
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	2e-12
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	2e-12
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	3e-12
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	3e-12
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	4e-12
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	5e-12
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	5e-12
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	6e-12
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	6e-12
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	7e-12
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	7e-12
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	8e-12
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	1e-11
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	1e-11
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	1e-11
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	1e-11
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	1e-11
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	1e-11
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	2e-11
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	2e-11
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	2e-11
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	2e-11
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	3e-11
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	3e-11
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	3e-11
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	3e-11
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	3e-11
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	5e-11
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	6e-11
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	6e-11
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	8e-11
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	9e-11
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	1e-10
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	1e-10
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	1e-10
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	1e-10
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	1e-10
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	1e-10
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	1e-10
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	2e-10
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	2e-10
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	3e-10
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	3e-10
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	3e-10
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	4e-10
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	4e-10
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	4e-10
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	4e-10
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	4e-10
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	4e-10
cd08226	328	cd08226, PK_STRAD_beta, Pseudokinase domain of STE	5e-10
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	5e-10
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	5e-10
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	7e-10
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	8e-10
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	9e-10
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	9e-10
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	9e-10
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	1e-09
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	1e-09
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	1e-09
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	1e-09
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	1e-09
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	1e-09
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	1e-09
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	1e-09
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	1e-09
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	1e-09
cd08227	327	cd08227, PK_STRAD_alpha, Pseudokinase domain of ST	1e-09
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	1e-09
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	2e-09
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	2e-09
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	2e-09
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	2e-09
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	2e-09
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	2e-09
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	2e-09
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	3e-09
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	4e-09
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	4e-09
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	4e-09
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	5e-09
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	6e-09
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	7e-09
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	8e-09
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	9e-09
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	9e-09
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	1e-08
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	1e-08
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	1e-08
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	1e-08
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	2e-08
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	2e-08
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	3e-08
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	4e-08
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	4e-08
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	5e-08
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	5e-08
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	5e-08
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	5e-08
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	5e-08
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	5e-08
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	6e-08
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	7e-08
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	7e-08
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	8e-08
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	1e-07
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	1e-07
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	1e-07
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	3e-07
cd05037	259	cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom	4e-07
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	4e-07
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	4e-07
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	4e-07
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	5e-07
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	8e-07
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	9e-07
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	1e-06
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	2e-06
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	2e-06
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	4e-06
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	8e-06
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	8e-06
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	9e-06
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	1e-05
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	1e-05
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	2e-05
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	3e-05
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	4e-05
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	4e-05
cd05086	268	cd05086, PTKc_Aatyk2, Catalytic domain of the Prot	5e-05
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	8e-05
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	8e-05
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	1e-04
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	2e-04
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	3e-04
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	4e-04
PHA02988	283	PHA02988, PHA02988, hypothetical protein; Provisio	5e-04
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	7e-04
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	9e-04
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	0.001
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	0.004

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  163 bits (414), Expect = 8e-48
 Identities = 73/194 (37%), Positives = 106/194 (54%), Gaps = 11/194 (5%)

Query: 150 IGKGGHAEVYKG-CLPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIG 208
           +G+GG   VY       G+ VA+K I K  ++    + + L E+ I+  +NHPN  KL G
Sbjct: 1   LGEGGFGTVYLARDKKTGKKVAIKIIKK--EDSSSLLEELLREIEILKKLNHPNIVKLYG 58

Query: 209 -FSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIH 267
            F  EN  +LV+++   GSL  LL  +   L      +I L I EGL+YLH      IIH
Sbjct: 59  VFEDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLH---SNGIIH 115

Query: 268 RDIKASNILLSED-YEAQISDFGLAKWLPDNWSHHIVFPIEGTFGYLSPEYFMH-GIVDE 325
           RD+K  NILL  D  + +++DFGL+K L  + S        GT  Y++PE  +  G   E
Sbjct: 116 RDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIV--GTPAYMAPEVLLGKGYYSE 173

Query: 326 KTDVFAFGVLLLEL 339
           K+D+++ GV+L EL
Sbjct: 174 KSDIWSLGVILYEL 187

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  155 bits (394), Expect = 3e-44
 Identities = 80/260 (30%), Positives = 120/260 (46%), Gaps = 22/260 (8%)

Query: 150 IGKGGHAEVYKGC-LPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIG 208
           +G G    VYK      G++VAVK + K +++ ++  +    E+ I+  ++HPN  +LI 
Sbjct: 7   LGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTA-RREIRILRRLSHPNIVRLID 65

Query: 209 FSTENG-FHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIH 267
              +    +LV+++   G L   L      L      KIAL I  GL+YLH      IIH
Sbjct: 66  AFEDKDHLYLVMEYCEGGDLFDYLSRGG-PLSEDEAKKIALQILRGLEYLHS---NGIIH 121

Query: 268 RDIKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEGTFGYLSPEYFMHGI-VDEK 326
           RD+K  NILL E+   +I+DFGLAK L    S   +    GT  Y++PE  + G     K
Sbjct: 122 RDLKPENILLDENGVVKIADFGLAKKL--LKSSSSLTTFVGTPWYMAPEVLLGGNGYGPK 179

Query: 327 TDVFAFGVLLLELITGR---RAVDSRRQSLVIWAKPLLQTSNFKELVDPRLADAYDLAE- 382
            DV++ GV+L EL+TG+      +   Q  +I           +        +A DL + 
Sbjct: 180 VDVWSLGVILYELLTGKPPFSGENILDQLQLIRRILGPPLEFDEPKWSSGSEEAKDLIKK 239

Query: 383 ------MKRAMLTASVCIHH 396
                  KR   TA   + H
Sbjct: 240 CLNKDPSKR--PTAEEILQH 257

Length = 260

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  154 bits (392), Expect = 5e-44
 Identities = 71/201 (35%), Positives = 108/201 (53%), Gaps = 18/201 (8%)

Query: 150 IGKGGHAEVYKGCL-----PDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAA 204
           +G+G   EVYKG L          VAVK + ++A E +  I +FL E  I+  ++HPN  
Sbjct: 7   LGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQ--IEEFLREARIMRKLDHPNVV 64

Query: 205 KLIGFSTENG-FHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHR 263
           KL+G  TE    ++V++++  G L S L  +   L  +     AL IA G++YL     +
Sbjct: 65  KLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGMEYLES---K 121

Query: 264 RIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSHHIV---FPIEGTFGYLSPEYFMH 320
             IHRD+ A N L+ E+   +ISDFGL++ L D+  +       PI     +++PE    
Sbjct: 122 NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIR----WMAPESLKE 177

Query: 321 GIVDEKTDVFAFGVLLLELIT 341
           G    K+DV++FGVLL E+ T
Sbjct: 178 GKFTSKSDVWSFGVLLWEIFT 198

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  153 bits (390), Expect = 1e-43
 Identities = 69/211 (32%), Positives = 105/211 (49%), Gaps = 26/211 (12%)

Query: 148 NLIGKGGHAEVYKG---CLPDGEV-VAVKKIIKNAKEDEERISDFLSELGIVAHINHPNA 203
             +G+G   EVYKG           VAVK + ++A E+E    DFL E  ++  + HPN 
Sbjct: 1   KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEE--RKDFLKEARVMKKLGHPNV 58

Query: 204 AKLIGFSTENG-FHLVLQFLPHGSLSSLL--------FGSTECLEWTIRYKIALGIAEGL 254
            +L+G  TE    +LVL+++  G L   L              L        A+ IA+G+
Sbjct: 59  VRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGM 118

Query: 255 QYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNW----SHHIVFPIEGTF 310
           +YL     ++ +HRD+ A N L+ ED   +ISDFGL++ + D+           PI    
Sbjct: 119 EYLAS---KKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIR--- 172

Query: 311 GYLSPEYFMHGIVDEKTDVFAFGVLLLELIT 341
            +++PE    GI   K+DV++FGVLL E+ T
Sbjct: 173 -WMAPESLKDGIFTSKSDVWSFGVLLWEIFT 202

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  153 bits (389), Expect = 1e-43
 Identities = 71/240 (29%), Positives = 112/240 (46%), Gaps = 13/240 (5%)

Query: 144 FNSENLIGKGGHAEVYKG-CLPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPN 202
           +     +G+G   +VY       G++VA+K I K  K+ ++     L E+ I+  + HPN
Sbjct: 1   YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKK--KKIKKDRERILREIKILKKLKHPN 58

Query: 203 AAKLIG-FSTENGFHLVLQFLPHGSLSSLLFGSTECL-EWTIRYKIALGIAEGLQYLHHD 260
             +L   F  E+  +LV+++   G L  LL      L E   R+     I   L+YLH  
Sbjct: 59  IVRLYDVFEDEDKLYLVMEYCEGGDLFDLL-KKRGRLSEDEARF-YLRQILSALEYLHS- 115

Query: 261 CHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEGTFGYLSPEYFMH 320
             + I+HRD+K  NILL ED   +++DFGLA+ L             GT  Y++PE  + 
Sbjct: 116 --KGIVHRDLKPENILLDEDGHVKLADFGLARQLDPGEKLTTFV---GTPEYMAPEVLLG 170

Query: 321 GIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSNFKELVDPRLADAYDL 380
               +  D+++ GV+L EL+TG+       Q L ++ K       F         +A DL
Sbjct: 171 KGYGKAVDIWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWDISPEAKDL 230

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  151 bits (385), Expect = 5e-43
 Identities = 71/202 (35%), Positives = 108/202 (53%), Gaps = 19/202 (9%)

Query: 150 IGKGGHAEVYKGCL-----PDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAA 204
           +G+G   EVYKG L          VAVK + ++A E +  I +FL E  I+  ++HPN  
Sbjct: 7   LGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQ--IEEFLREARIMRKLDHPNIV 64

Query: 205 KLIGFSTENG-FHLVLQFLPHGSLSS-LLFGSTECLEWTIRYKIALGIAEGLQYLHHDCH 262
           KL+G  TE     +V++++P G L   L     + L  +     AL IA G++YL     
Sbjct: 65  KLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLES--- 121

Query: 263 RRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSHHIV---FPIEGTFGYLSPEYFM 319
           +  IHRD+ A N L+ E+   +ISDFGL++ L D+  + +     PI     +++PE   
Sbjct: 122 KNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIR----WMAPESLK 177

Query: 320 HGIVDEKTDVFAFGVLLLELIT 341
            G    K+DV++FGVLL E+ T
Sbjct: 178 EGKFTSKSDVWSFGVLLWEIFT 199

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  144 bits (366), Expect = 3e-40
 Identities = 67/203 (33%), Positives = 104/203 (51%), Gaps = 13/203 (6%)

Query: 148 NLIGKGGHAEVYKGCLPD-GEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKL 206
            L+G+G    VY     D GE++AVK +   + + EE +     E+ I++ + HPN  + 
Sbjct: 6   ELLGRGSFGSVYLALDKDTGELMAVKSVEL-SGDSEEELEALEREIRILSSLQHPNIVRY 64

Query: 207 IGFS---TENGFHLVLQFLPHGSLSSLL--FGSTECLEWTIRYKIALGIAEGLQYLHHDC 261
            G      +N  ++ L+++  GSLSSLL  FG     E  IR K    I EGL YLH   
Sbjct: 65  YGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLP--EPVIR-KYTRQILEGLAYLHS-- 119

Query: 262 HRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEGTFGYLSPEYFMHG 321
              I+HRDIK +NIL+  D   +++DFG AK L D  +      + GT  +++PE     
Sbjct: 120 -NGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGE 178

Query: 322 IVDEKTDVFAFGVLLLELITGRR 344
                 D+++ G  ++E+ TG+ 
Sbjct: 179 EYGRAADIWSLGCTVIEMATGKP 201

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  141 bits (359), Expect = 3e-39
 Identities = 67/203 (33%), Positives = 107/203 (52%), Gaps = 19/203 (9%)

Query: 150 IGKGGHAEVYKGCL-----PDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAA 204
           +G+G   EVYKG L          VAVK + + A   EE   +FL E  I+  ++HPN  
Sbjct: 7   LGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGA--SEEEREEFLEEASIMKKLSHPNIV 64

Query: 205 KLIGFSTENGFH-LVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHR 263
           +L+G  T+     +V +++P G L   L    E L      ++AL IA+G++YL     +
Sbjct: 65  RLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGMEYLES---K 121

Query: 264 RIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNW----SHHIVFPIEGTFGYLSPEYFM 319
             +HRD+ A N L++E+   +ISDFGL++ + ++           PI+    +++PE   
Sbjct: 122 NFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIK----WMAPESLK 177

Query: 320 HGIVDEKTDVFAFGVLLLELITG 342
            G    K+DV++FGVLL E+ T 
Sbjct: 178 DGKFTSKSDVWSFGVLLWEIFTL 200

Length = 258

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  141 bits (357), Expect = 6e-39
 Identities = 73/198 (36%), Positives = 110/198 (55%), Gaps = 15/198 (7%)

Query: 150 IGKGGHAEVYKG-CLPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIG 208
           IGKGG  EVYK      G+ VA+K I   +KE +E+I   ++E+ I+    HPN  K  G
Sbjct: 8   IGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKI---INEIQILKKCKHPNIVKYYG 64

Query: 209 -FSTENGFHLVLQFLPHGSLSSLLFGSTECL-EWTIRYKIALGIAEGLQYLHHDCHRRII 266
            +  ++   +V++F   GSL  LL  + + L E  I Y +   + +GL+YLH      II
Sbjct: 65  SYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAY-VCKELLKGLEYLHS---NGII 120

Query: 267 HRDIKASNILLSEDYEAQISDFGLAKWLPD-NWSHHIVFPIEGTFGYLSPEYFMHGIVDE 325
           HRDIKA+NILL+ D E ++ DFGL+  L D    + +V    GT  +++PE       D 
Sbjct: 121 HRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTMV----GTPYWMAPEVINGKPYDY 176

Query: 326 KTDVFAFGVLLLELITGR 343
           K D+++ G+  +EL  G+
Sbjct: 177 KADIWSLGITAIELAEGK 194

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  131 bits (331), Expect = 3e-35
 Identities = 64/208 (30%), Positives = 110/208 (52%), Gaps = 19/208 (9%)

Query: 143 NFNSENLIGKGGHAEVYKGC-LPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHP 201
           N+   +LIG+G    VYKG  L  G+ VA+K+I    K  EE +   + E+ ++ ++ HP
Sbjct: 1   NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLE-KIKEEALKSIMQEIDLLKNLKHP 59

Query: 202 NAAKLIGFS-TENGFHLVLQFLPHGSLSSLL-----FGSTECLEWTIRYKIALGIAEGLQ 255
           N  K IG   T +  +++L++  +GSL  ++     F  +        Y +   + +GL 
Sbjct: 60  NIVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLV----AVY-VY-QVLQGLA 113

Query: 256 YLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEGTFGYLSP 315
           YLH    + +IHRDIKA+NIL ++D   +++DFG+A  L D         + GT  +++P
Sbjct: 114 YLHE---QGVIHRDIKAANILTTKDGVVKLADFGVATKLNDV--SKDDASVVGTPYWMAP 168

Query: 316 EYFMHGIVDEKTDVFAFGVLLLELITGR 343
           E          +D+++ G  ++EL+TG 
Sbjct: 169 EVIEMSGASTASDIWSLGCTVIELLTGN 196

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score =  123 bits (312), Expect = 2e-32
 Identities = 80/265 (30%), Positives = 116/265 (43%), Gaps = 20/265 (7%)

Query: 150 IGKGGHAEVYKGCL-PDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIG 208
           +G+G    VYK    P G++ A+KKI  +   DEE     L EL  +     P   K  G
Sbjct: 9   LGQGSSGVVYKVRHKPTGKIYALKKI--HVDGDEEFRKQLLRELKTLRSCESPYVVKCYG 66

Query: 209 -FSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIH 267
            F  E    +VL+++  GSL+ LL      +   +   IA  I +GL YLH    R IIH
Sbjct: 67  AFYKEGEISIVLEYMDGGSLADLL-KKVGKIPEPVLAYIARQILKGLDYLHTK--RHIIH 123

Query: 268 RDIKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEGTFGYLSPEYFMHGIVDEKT 327
           RDIK SN+L++   E +I+DFG++K L +       F   GT  Y+SPE           
Sbjct: 124 RDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTF--VGTVTYMSPERIQGESYSYAA 181

Query: 328 DVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSNFKELVDPRLADAYDLAEMKRAM 387
           D+++ G+ LLE   G+       Q    +   L+Q         P L       E +  +
Sbjct: 182 DIWSLGLTLLECALGKFPFLPPGQ-PSFFE--LMQAICDGPP--PSLPAEEFSPEFRDFI 236

Query: 388 LTASVCIHHLSTMRPQMTRVLQLLR 412
              S C+      RP      +LL+
Sbjct: 237 ---SACLQKDPKKRPS---AAELLQ 255

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  121 bits (304), Expect = 1e-30
 Identities = 73/214 (34%), Positives = 107/214 (50%), Gaps = 17/214 (7%)

Query: 143 NFNSENLIGKGGHAEVYKGCLPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHP- 201
           ++     +G+G   EVY     D ++VA+K + K  +   + +  FL E+ I+A +NHP 
Sbjct: 1   SYRILRKLGEGSFGEVYLA--RDRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPP 58

Query: 202 NAAKLIG-FSTENGFHLVLQFLPHGSLSSLL--FGSTECLEWTIRYKIALGIAEGLQYLH 258
           N  KL   F  E   +LV++++  GSL  LL   G    L  +    I   I   L+YLH
Sbjct: 59  NIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH 118

Query: 259 HDCHRRIIHRDIKASNILLSEDY-EAQISDFGLAKWLPDNWSHHIVF----PIEGTFGYL 313
               + IIHRDIK  NILL  D    ++ DFGLAK LPD  S   +        GT GY+
Sbjct: 119 ---SKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYM 175

Query: 314 SPEYFMHGI---VDEKTDVFAFGVLLLELITGRR 344
           +PE  +          +D+++ G+ L EL+TG  
Sbjct: 176 APEVLLGLSLAYASSSSDIWSLGITLYELLTGLP 209

Length = 384

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score =  116 bits (293), Expect = 1e-29
 Identities = 67/207 (32%), Positives = 100/207 (48%), Gaps = 22/207 (10%)

Query: 148 NLIGKGGHAEVYKGCLP-----DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPN 202
             +G+G   +V            GE VAVK +  N   +E+  SDF  E+ I+  ++H N
Sbjct: 10  KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSL--NHSGEEQHRSDFEREIEILRTLDHEN 67

Query: 203 AAKLIGFSTENGFH---LVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHH 259
             K  G   + G     L++++LP GSL   L    + +        +  I +G+ YL  
Sbjct: 68  IVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGS 127

Query: 260 DCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSHHIV-----FPIEGTFGYLS 314
              +R IHRD+ A NIL+  +   +ISDFGLAK LP++  ++ V      PI   F Y +
Sbjct: 128 ---QRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPI---FWY-A 180

Query: 315 PEYFMHGIVDEKTDVFAFGVLLLELIT 341
           PE          +DV++FGV L EL T
Sbjct: 181 PECLRTSKFSSASDVWSFGVTLYELFT 207

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score =  115 bits (291), Expect = 1e-29
 Identities = 78/234 (33%), Positives = 111/234 (47%), Gaps = 19/234 (8%)

Query: 150 IGKGGHAEVY----KGCLPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAK 205
           +GKG   +V     K     G++ A+K + K      + +   L+E  I++ INHP   K
Sbjct: 1   LGKGSFGKVLLVRKKD---TGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVK 57

Query: 206 LI-GFSTENGFHLVLQFLPHGSLSSLLFGSTE-CL-EWTIRYKIALGIAEGLQYLHHDCH 262
           L   F TE   +LVL++ P G L S L  S E    E   R+  A  I   L+YLH    
Sbjct: 58  LHYAFQTEEKLYLVLEYAPGGELFSHL--SKEGRFSEERARFYAA-EIVLALEYLHS--- 111

Query: 263 RRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEGTFGYLSPEYFMHGI 322
             II+RD+K  NILL  D   +++DFGLAK L    S        GT  YL+PE  +   
Sbjct: 112 LGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSR--TNTFCGTPEYLAPEVLLGKG 169

Query: 323 VDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSNFKELVDPRLAD 376
             +  D ++ GVLL E++TG+    +  +   I+ K L     F E + P   D
Sbjct: 170 YGKAVDWWSLGVLLYEMLTGKPPFYAEDRKE-IYEKILKDPLRFPEFLSPEARD 222

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score =  113 bits (285), Expect = 9e-29
 Identities = 64/216 (29%), Positives = 105/216 (48%), Gaps = 29/216 (13%)

Query: 148 NLIGKGGHAEVYKG-CLPDGEVVAVKKI-IKNAKEDEERISDFLSELGIVAHINHPNAAK 205
             IGKG   +VY      DG++  +K+I + N  E E    D L+E+ I+  +NHPN  K
Sbjct: 6   KQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKERE--DALNEVKILKKLNHPNIIK 63

Query: 206 LIG-FSTENGFHLVLQFLPHGSLSSLL---------FGSTECLEWTIRYKIALGIAEGLQ 255
               F  +    +V+++   G LS  +         F   + L+W ++      +   L+
Sbjct: 64  YYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQ------LCLALK 117

Query: 256 YLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVF--PIEGTFGYL 313
           YLH    R+I+HRDIK  NI L+ +   ++ DFG++K L    S  +     + GT  YL
Sbjct: 118 YLHS---RKILHRDIKPQNIFLTSNGLVKLGDFGISKVL----SSTVDLAKTVVGTPYYL 170

Query: 314 SPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSR 349
           SPE   +   + K+D+++ G +L EL T +   +  
Sbjct: 171 SPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGE 206

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score =  113 bits (285), Expect = 1e-28
 Identities = 63/215 (29%), Positives = 109/215 (50%), Gaps = 27/215 (12%)

Query: 150 IGKGGHAEVYKGC-LPDGEVVAVKKIIKNAKEDEERIS--DFLSELGIVAHINHPNAAKL 206
           +G G    VYKG  +P+GE V +   IK  +E+    +  + L E  ++A ++HP+  +L
Sbjct: 15  LGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRL 74

Query: 207 IGFSTENGFHLVLQFLPHGSLSSLL------FGSTECLEWTIRYKIALGIAEGLQYLHHD 260
           +G    +   L+ Q +P G L   +       GS   L W ++      IA+G+ YL   
Sbjct: 75  LGICLSSQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQ------IAKGMSYLEE- 127

Query: 261 CHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSHHIV----FPIEGTFGYLSPE 316
             +R++HRD+ A N+L+      +I+DFGLAK L  +   +       PI+    +++ E
Sbjct: 128 --KRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIK----WMALE 181

Query: 317 YFMHGIVDEKTDVFAFGVLLLELIT-GRRAVDSRR 350
             +H I   K+DV+++GV + EL+T G +  +   
Sbjct: 182 SILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIP 216

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score =  112 bits (281), Expect = 4e-28
 Identities = 70/221 (31%), Positives = 109/221 (49%), Gaps = 36/221 (16%)

Query: 142 DNFNSENLIGKGGHAEVYKG-CLPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINH 200
           D++    +IG G  A VY   CLP+ E VA+K+I  + ++ +  + +   E+  ++  NH
Sbjct: 1   DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRI--DLEKCQTSVDELRKEVQAMSQCNH 58

Query: 201 PNAAKLIG-FSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALG------IA-- 251
           PN  K    F   +   LV+ +L  GSL  +           ++     G      IA  
Sbjct: 59  PNVVKYYTSFVVGDELWLVMPYLSGGSLLDI-----------MKSSYPRGGLDEAIIATV 107

Query: 252 -----EGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNW--SHHIVF 304
                +GL+YLH +     IHRDIKA NILL ED   +I+DFG++  L D    +  +  
Sbjct: 108 LKEVLKGLEYLHSNGQ---IHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRK 164

Query: 305 PIEGTFGYLSPEYF--MHGIVDEKTDVFAFGVLLLELITGR 343
              GT  +++PE    +HG  D K D+++FG+  +EL TG 
Sbjct: 165 TFVGTPCWMAPEVMEQVHG-YDFKADIWSFGITAIELATGA 204

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score =  109 bits (275), Expect = 2e-27
 Identities = 64/199 (32%), Positives = 102/199 (51%), Gaps = 18/199 (9%)

Query: 149 LIGKGGHAEVYKGCLPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIG 208
            IGKG   +V  G    G+ VAVK +    K+D      FL+E  ++  + HPN  +L+G
Sbjct: 13  TIGKGEFGDVMLGDY-RGQKVAVKCL----KDDSTAAQAFLAEASVMTTLRHPNLVQLLG 67

Query: 209 FSTE-NGFHLVLQFLPHGSLSSLLFG-STECLEWTIRYKIALGIAEGLQYLHHDCHRRII 266
              + N  ++V +++  GSL   L       +    +   AL + EG++YL     +  +
Sbjct: 68  VVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEE---KNFV 124

Query: 267 HRDIKASNILLSEDYEAQISDFGLAKWLPDNWSHHI-VFPIEGTFGYLSPEYFMHGIVDE 325
           HRD+ A N+L+SED  A++SDFGLAK    +        P++ T    +PE         
Sbjct: 125 HRDLAARNVLVSEDLVAKVSDFGLAK--EASQGQDSGKLPVKWT----APEALREKKFST 178

Query: 326 KTDVFAFGVLLLELIT-GR 343
           K+DV++FG+LL E+ + GR
Sbjct: 179 KSDVWSFGILLWEIYSFGR 197

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score =  109 bits (273), Expect = 3e-27
 Identities = 64/201 (31%), Positives = 109/201 (54%), Gaps = 17/201 (8%)

Query: 147 ENLIGKGGHAEVYKGCLPD-GEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAK 205
           ++ +G G + EVY+G        VAVK +    KED   + +FL E  ++  I HPN  +
Sbjct: 11  KHKLGGGQYGEVYEGVWKKYSLTVAVKTL----KEDTMEVEEFLKEAAVMKEIKHPNLVQ 66

Query: 206 LIGFST-ENGFHLVLQFLPHGSLSSLLFGST-ECLEWTIRYKIALGIAEGLQYLHHDCHR 263
           L+G  T E  F+++ +F+ +G+L   L     + +   +   +A  I+  ++YL     +
Sbjct: 67  LLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEK---K 123

Query: 264 RIIHRDIKASNILLSEDYEAQISDFGLAKWLP-DNWSHH--IVFPIEGTFGYLSPEYFMH 320
             IHRD+ A N L+ E++  +++DFGL++ +  D ++ H    FPI+ T    +PE   +
Sbjct: 124 NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWT----APESLAY 179

Query: 321 GIVDEKTDVFAFGVLLLELIT 341
                K+DV+AFGVLL E+ T
Sbjct: 180 NKFSIKSDVWAFGVLLWEIAT 200

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score =  107 bits (270), Expect = 2e-26
 Identities = 68/233 (29%), Positives = 104/233 (44%), Gaps = 45/233 (19%)

Query: 142 DNFNSENLIGKGGHAEVYKGCL-PDGEVVAVK-----KIIKNAKED----EERISDFLSE 191
           D+F    +IG+G  + V         +  A+K     ++IK  K      E+ +   L+ 
Sbjct: 1   DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLN- 59

Query: 192 LGIVAHINHPNAAKLIG-FSTENGFHLVLQFLPHGSLSSLL--FGSTECLEWTIRYKIAL 248
                   HP   KL   F  E   + VL++ P+G L   +  +GS +  E   R+  A 
Sbjct: 60  -------GHPGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYGSLD--EKCTRFYAAE 110

Query: 249 GIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSHH------- 301
            I   L+YLH    + IIHRD+K  NILL +D   +I+DFG AK L  N S         
Sbjct: 111 -ILLALEYLHS---KGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDAT 166

Query: 302 -IVFPIE----------GTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGR 343
            I   IE          GT  Y+SPE        + +D++A G ++ +++TG+
Sbjct: 167 NIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGK 219

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score =  105 bits (264), Expect = 1e-25
 Identities = 68/206 (33%), Positives = 100/206 (48%), Gaps = 21/206 (10%)

Query: 144 FNSENLIGKGGHAEVYKG-CLPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPN 202
           F     IGKG   EVYK       +VVA+K I  + +E E+ I D   E+  ++    P 
Sbjct: 3   FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVI--DLEEAEDEIEDIQQEIQFLSQCRSPY 60

Query: 203 AAKLIGFSTENGFHL--VLQFLPHGSLSSLL----FGSTECLEWTIRYKIALGIAEGLQY 256
             K  G S   G  L  ++++   GS   LL           E  I + I   +  GL+Y
Sbjct: 61  ITKYYG-SFLKGSKLWIIMEYCGGGSCLDLLKPGKLD-----ETYIAF-ILREVLLGLEY 113

Query: 257 LHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEGTFGYLSPE 316
           LH +     IHRDIKA+NILLSE+ + +++DFG++  L    S    F   GT  +++PE
Sbjct: 114 LHEE---GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFV--GTPFWMAPE 168

Query: 317 YFMHGIVDEKTDVFAFGVLLLELITG 342
                  DEK D+++ G+  +EL  G
Sbjct: 169 VIKQSGYDEKADIWSLGITAIELAKG 194

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score =  103 bits (258), Expect = 4e-25
 Identities = 65/211 (30%), Positives = 105/211 (49%), Gaps = 16/211 (7%)

Query: 150 IGKGGHAEVYKGCLPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGF 209
           IG G    V+ G   +   VA+K I + A  +E    DF+ E  ++  ++HP   +L G 
Sbjct: 12  IGSGQFGLVWLGYWLEKRKVAIKTIREGAMSEE----DFIEEAQVMMKLSHPKLVQLYGV 67

Query: 210 STENG-FHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHR 268
            TE     LV +F+ HG LS  L              + L + EG+ YL       +IHR
Sbjct: 68  CTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSN---VIHR 124

Query: 269 DIKASNILLSEDYEAQISDFGLAKWLPDNW---SHHIVFPIEGTFGYLSPEYFMHGIVDE 325
           D+ A N L+ E+   ++SDFG+ +++ D+    S    FP++    + SPE F       
Sbjct: 125 DLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVK----WSSPEVFSFSKYSS 180

Query: 326 KTDVFAFGVLLLELIT-GRRAVDSRRQSLVI 355
           K+DV++FGVL+ E+ + G+   ++R  S V+
Sbjct: 181 KSDVWSFGVLMWEVFSEGKTPYENRSNSEVV 211

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score =  103 bits (259), Expect = 4e-25
 Identities = 68/207 (32%), Positives = 108/207 (52%), Gaps = 16/207 (7%)

Query: 141 TDNFNSENLIGKGGHAEVYKG-CLPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHIN 199
             NF  E  IGKG  + VYK  CL DG VVA+KK+      D +   D L E+ ++  ++
Sbjct: 1   LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60

Query: 200 HPNAAK-LIGFSTENGFHLVLQFLPHGSLSSLL--FGSTECL--EWTIRYKIALGIAEGL 254
           HPN  K L  F   N  ++VL+    G LS ++  F   + L  E TI +K  + +   L
Sbjct: 61  HPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTI-WKYFVQLCSAL 119

Query: 255 QYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWS--HHIVFPIEGTFGY 312
           +++H    +RI+HRDIK +N+ ++     ++ D GL ++     +  H +V    GT  Y
Sbjct: 120 EHMHS---KRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV----GTPYY 172

Query: 313 LSPEYFMHGIVDEKTDVFAFGVLLLEL 339
           +SPE       + K+D+++ G LL E+
Sbjct: 173 MSPERIHENGYNFKSDIWSLGCLLYEM 199

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score =  102 bits (256), Expect = 8e-25
 Identities = 73/223 (32%), Positives = 107/223 (47%), Gaps = 23/223 (10%)

Query: 143 NFNSENLIGKGGHAEVYKGCLP-DGEVVAVKKI---IKNAKEDEERISDFLSELGIVAHI 198
           +F   N IGKG    V+K     D  V A+K+I     N +E EE I     E  ++A +
Sbjct: 1   DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAID----EARVLAKL 56

Query: 199 NHPNAAKLIGFSTENG-FHLVLQFLPHGSLSSLL---FGS--TECLEWTIRYKIALGIAE 252
           +     +      + G  ++V+++  +G L  LL    G    E   W    +I LG   
Sbjct: 57  DSSYIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLG--- 113

Query: 253 GLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEGTFGY 312
            L +LH    ++I+HRDIK+ N+ L      +I D G+AK L DN   +    I GT  Y
Sbjct: 114 -LAHLHS---KKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDN--TNFANTIVGTPYY 167

Query: 313 LSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVI 355
           LSPE       +EK+DV+A GV+L E  TG+   D+  Q  +I
Sbjct: 168 LSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALI 210

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score =  102 bits (256), Expect = 2e-24
 Identities = 60/206 (29%), Positives = 107/206 (51%), Gaps = 25/206 (12%)

Query: 150 IGKGGHAEVYKG-CLPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIG 208
           IG+G + +VYK      GE+VA+KKI    +++   I+  + E+ ++  + HPN  +L  
Sbjct: 7   IGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPIT-AIREIKLLQKLRHPNIVRLKE 65

Query: 209 FSTE---NGFHLVLQFLPHGSLSSLLFGSTECLEWT---IRYKIALGIAEGLQYLHHDCH 262
             T       ++V +++ H  L+ LL   +  +++T   I+      + EGLQYLH    
Sbjct: 66  IVTSKGKGSIYMVFEYMDH-DLTGLL--DSPEVKFTESQIKC-YMKQLLEGLQYLHS--- 118

Query: 263 RRIIHRDIKASNILLSEDYEAQISDFGLAKWL----PDNWSHHIVFPIEGTFGYLSPEYF 318
             I+HRDIK SNIL++ D   +++DFGLA+        ++++ ++     T  Y  PE  
Sbjct: 119 NGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVI-----TLWYRPPELL 173

Query: 319 MHGIV-DEKTDVFAFGVLLLELITGR 343
           +       + D+++ G +L EL  G+
Sbjct: 174 LGATRYGPEVDMWSVGCILAELFLGK 199

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score =  100 bits (252), Expect = 4e-24
 Identities = 63/200 (31%), Positives = 99/200 (49%), Gaps = 18/200 (9%)

Query: 150 IGKGGHAEVYKGCL--PDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLI 207
           +G G    V K  L  P G+++AVK I     E  ++    L EL I+   N P      
Sbjct: 9   LGAGNSGVVSK-VLHRPTGKIMAVKTIRLEINEAIQK--QILRELDILHKCNSPYIVGFY 65

Query: 208 G-FSTENGFHLVLQFLPHGSLSSLLFGSTECLEWT---IRYKIALGIAEGLQYLHHDCHR 263
           G F       + ++++  GSL  +L    E        I  KIA+ + +GL YLH     
Sbjct: 66  GAFYNNGDISICMEYMDGGSLDKIL---KEVQGRIPERILGKIAVAVLKGLTYLHEK--H 120

Query: 264 RIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEGTFGYLSPEYFMHGIV 323
           +IIHRD+K SNIL++   + ++ DFG++  L ++ +   V    GT  Y++PE       
Sbjct: 121 KIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAKTFV----GTSSYMAPERIQGNDY 176

Query: 324 DEKTDVFAFGVLLLELITGR 343
             K+D+++ G+ L+EL TGR
Sbjct: 177 SVKSDIWSLGLSLIELATGR 196

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score =  100 bits (251), Expect = 4e-24
 Identities = 59/203 (29%), Positives = 106/203 (52%), Gaps = 16/203 (7%)

Query: 147 ENLIGKGGHAEVYKGCL--PDGEVVAVK-KIIKNAKEDEERISDFLSELGIVAHINHPNA 203
           E +IG G   EV +G L  P  + + V  K +K    D++R+ DFL+E  I+   +HPN 
Sbjct: 9   EKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRL-DFLTEASIMGQFDHPNI 67

Query: 204 AKLIGFSTE-NGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCH 262
            +L G  T+     ++ +++ +GSL   L  +           +  GIA G++YL    +
Sbjct: 68  IRLEGVVTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNY 127

Query: 263 RRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSHHIV----FPIEGTFGYLSPEYF 318
              +HRD+ A NIL++ +   ++SDFGL++ L D+ + +       PI  T    +PE  
Sbjct: 128 ---VHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWT----APEAI 180

Query: 319 MHGIVDEKTDVFAFGVLLLELIT 341
            +      +DV++FG+++ E+++
Sbjct: 181 AYRKFTSASDVWSFGIVMWEVMS 203

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 99.4 bits (248), Expect = 1e-23
 Identities = 74/233 (31%), Positives = 102/233 (43%), Gaps = 55/233 (23%)

Query: 140 ATDNFNSENLIGKGGHAEVYKGCL--PDGEV----VAVKKIIKNAKEDEERISDFLSELG 193
             D+      +G G   EVY+G     DG+     VAVK + ++  E +E  SDFL E  
Sbjct: 4   PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDE--SDFLMEAL 61

Query: 194 IVAHINHPNAAKLIGFSTE-NGFHLVLQFLPHGSLSSLLFGSTECLEWTIR--------- 243
           I++  NH N  +LIG S E     ++L+ +  G L S L    E      R         
Sbjct: 62  IMSKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFL---RENRPRPERPSSLTMKDL 118

Query: 244 YKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLS---EDYEAQISDFGLAK-------- 292
              A  +A+G +YL        IHRDI A N LL+       A+I+DFG+A+        
Sbjct: 119 LFCARDVAKGCKYLEE---NHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYY 175

Query: 293 ------WLPDNWSHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLEL 339
                  LP  W              + PE F+ GI   KTDV++FGVLL E+
Sbjct: 176 RKGGRAMLPIKW--------------MPPEAFLDGIFTSKTDVWSFGVLLWEI 214

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score = 99.5 bits (248), Expect = 1e-23
 Identities = 66/209 (31%), Positives = 113/209 (54%), Gaps = 19/209 (9%)

Query: 149 LIGKGGHAEVYKGC-LPDGEVVAVKKIIKNAKE---DEERISDFL----SELGIVAHINH 200
           LIGKG +  VY    +  GE++AVK++   A      + R  D +    SE+  +  ++H
Sbjct: 8   LIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDH 67

Query: 201 PNAAKLIGF-STENGFHLVLQFLPHGSLSSLL--FGSTECLEWTIRYKIALGIAEGLQYL 257
            N  + +GF +TE    + L+++P GS+ S L  +G  E  E  +R+     + EGL YL
Sbjct: 68  LNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFE--EQLVRF-FTEQVLEGLAYL 124

Query: 258 HHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEGTFGYLSPE- 316
           H    + I+HRD+KA N+L+  D   +ISDFG++K   D + +     ++G+  +++PE 
Sbjct: 125 HS---KGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEV 181

Query: 317 -YFMHGIVDEKTDVFAFGVLLLELITGRR 344
            +        K D+++ G ++LE+  GRR
Sbjct: 182 IHSYSQGYSAKVDIWSLGCVVLEMFAGRR 210

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 98.9 bits (246), Expect = 2e-23
 Identities = 64/197 (32%), Positives = 107/197 (54%), Gaps = 15/197 (7%)

Query: 150 IGKGGHAEVYKGCLPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGF 209
           IG+G    V +G     E    K  +KN K D    + FL E  ++  ++H N  +L+G 
Sbjct: 14  IGEGEFGAVLQG-----EYTGQKVAVKNIKCDVTAQA-FLEETAVMTKLHHKNLVRLLGV 67

Query: 210 STENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRY-KIALGIAEGLQYLHHDCHRRIIHR 268
              NG ++V++ +  G+L + L      L   I+  + +L +AEG++YL     ++++HR
Sbjct: 68  ILHNGLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLES---KKLVHR 124

Query: 269 DIKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEGTFGYLSPEYFMHGIVDEKTD 328
           D+ A NIL+SED  A++SDFGLA+       +  + P++ T    +PE   H     K+D
Sbjct: 125 DLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKL-PVKWT----APEALKHKKFSSKSD 179

Query: 329 VFAFGVLLLELITGRRA 345
           V+++GVLL E+ +  RA
Sbjct: 180 VWSYGVLLWEVFSYGRA 196

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 97.9 bits (244), Expect = 4e-23
 Identities = 76/280 (27%), Positives = 130/280 (46%), Gaps = 41/280 (14%)

Query: 143 NFNSENLIGKGGHAEVYK-GCLPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHP 201
           +F     +GKG +  VYK   L D +  A+K++   +   +ER  D ++E+ I+A +NHP
Sbjct: 1   DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKER-EDAVNEIRILASVNHP 59

Query: 202 NA-----AKLIGFSTENGFHLVLQFLPHGSLSSLLFGSTEC---LEWTIRYKIALGIAEG 253
           N      A L G    N   +V+++ P G LS  +    +    +     ++I + +  G
Sbjct: 60  NIISYKEAFLDG----NKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRG 115

Query: 254 LQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEGTFGYL 313
           LQ LH    ++I+HRD+K++NILL  +   +I D G++K L  N +   +    GT  Y+
Sbjct: 116 LQALHE---QKILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAKTQI----GTPHYM 168

Query: 314 SPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSNFKELVD-- 371
           +PE +       K+D+++ G LL E+ T     ++R           +Q   +K      
Sbjct: 169 APEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARS----------MQDLRYKVQRGKY 218

Query: 372 PRLADAY--DLAEMKRAMLTASVCIHHLSTMRPQMTRVLQ 409
           P +   Y  DL    R+ML           +RP   ++L 
Sbjct: 219 PPIPPIYSQDLQNFIRSMLQVK------PKLRPNCDKILA 252

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 97.4 bits (242), Expect = 4e-23
 Identities = 71/196 (36%), Positives = 103/196 (52%), Gaps = 17/196 (8%)

Query: 149 LIGKGGHAEVYKGCLPDGEVVAVKKIIKNAKED--EERISDFLSELGIVAHINHPNAAKL 206
           L+GKG   EV+KG L D   VAVK      KED  +E    FLSE  I+   +HPN  KL
Sbjct: 2   LLGKGNFGEVFKGTLKDKTPVAVK----TCKEDLPQELKIKFLSEARILKQYDHPNIVKL 57

Query: 207 IGFSTE-NGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRI 265
           IG  T+    ++V++ +P G   S L    + L+     K AL  A G+ YL     +  
Sbjct: 58  IGVCTQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLES---KNC 114

Query: 266 IHRDIKASNILLSEDYEAQISDFGLAKWLPD---NWSHHIVFPIEGTFGYLSPEYFMHGI 322
           IHRD+ A N L+ E+   +ISDFG+++   D   + S     PI+ T    +PE   +G 
Sbjct: 115 IHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWT----APEALNYGR 170

Query: 323 VDEKTDVFAFGVLLLE 338
              ++DV+++G+LL E
Sbjct: 171 YSSESDVWSYGILLWE 186

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 97.2 bits (242), Expect = 6e-23
 Identities = 66/200 (33%), Positives = 107/200 (53%), Gaps = 18/200 (9%)

Query: 150 IGKGGHAEVYKGCLPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGF 209
           +G G   EV+ G       VA    IK+ K+       FL+E  ++  + HP   +L   
Sbjct: 14  LGAGQFGEVWMGYYNGHTKVA----IKSLKQGSMSPEAFLAEANLMKQLQHPRLVRLYAV 69

Query: 210 STENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKI--ALGIAEGLQYLHHDCHRRIIH 267
            T+   +++ +++ +GSL   L  + E ++ TI   I  A  IAEG+ ++     +  IH
Sbjct: 70  VTQEPIYIITEYMENGSLVDFL-KTPEGIKLTINKLIDMAAQIAEGMAFIER---KNYIH 125

Query: 268 RDIKASNILLSEDYEAQISDFGLAKWLPDN---WSHHIVFPIEGTFGYLSPEYFMHGIVD 324
           RD++A+NIL+SE    +I+DFGLA+ + DN         FPI+ T    +PE   +G   
Sbjct: 126 RDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWT----APEAINYGTFT 181

Query: 325 EKTDVFAFGVLLLELIT-GR 343
            K+DV++FG+LL E++T GR
Sbjct: 182 IKSDVWSFGILLTEIVTYGR 201

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score = 96.7 bits (241), Expect = 1e-22
 Identities = 61/203 (30%), Positives = 102/203 (50%), Gaps = 16/203 (7%)

Query: 144 FNSENLIGKGGHAEVYKGCLPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNA 203
           F  E  +G G   EV++G   +   VA+K I+K+  +D  +  DF  E+  +  + H + 
Sbjct: 8   FTLERKLGSGYFGEVWEGLWKNRVRVAIK-ILKS--DDLLKQQDFQKEVQALKRLRHKHL 64

Query: 204 AKLIGFSTENG-FHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALG--IAEGLQYLHHD 260
             L    +     +++ + +  GSL + L  S E     +   I +   +AEG+ YL   
Sbjct: 65  ISLFAVCSVGEPVYIITELMEKGSLLAFL-RSPEGQVLPVASLIDMACQVAEGMAYLEE- 122

Query: 261 CHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNW--SHHIVFPIEGTFGYLSPEYF 318
             +  IHRD+ A NIL+ ED   +++DFGLA+ + ++   S     P + T    +PE  
Sbjct: 123 --QNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKIPYKWT----APEAA 176

Query: 319 MHGIVDEKTDVFAFGVLLLELIT 341
            HG    K+DV++FG+LL E+ T
Sbjct: 177 SHGTFSTKSDVWSFGILLYEMFT 199

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 97.1 bits (242), Expect = 1e-22
 Identities = 68/202 (33%), Positives = 97/202 (48%), Gaps = 15/202 (7%)

Query: 149 LIGKGGHAEVYKGC---LPD--GEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNA 203
            +GKG    V       L D  GEVVAVKK+        E + DF  E+ I+  + H N 
Sbjct: 11  QLGKGNFGSVELCRYDPLQDNTGEVVAVKKL---QHSTAEHLRDFEREIEILKSLQHDNI 67

Query: 204 AKLIGFSTENG---FHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHD 260
            K  G     G     LV+++LP+GSL   L    E L+       A  I +G++YL   
Sbjct: 68  VKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGS- 126

Query: 261 CHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVF-PIEGTFGYLSPEYFM 319
             +R +HRD+   NIL+  +   +I DFGL K LP +  ++ V  P E    + +PE   
Sbjct: 127 --KRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLT 184

Query: 320 HGIVDEKTDVFAFGVLLLELIT 341
                  +DV++FGV+L EL T
Sbjct: 185 ESKFSVASDVWSFGVVLYELFT 206

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 96.5 bits (240), Expect = 1e-22
 Identities = 67/217 (30%), Positives = 109/217 (50%), Gaps = 32/217 (14%)

Query: 148 NLIGKGGHAEVYKGCLPD------GEV-VAVKKIIKNAKEDEERISDFLSELGIVAHINH 200
           N +G G   EVY+G   D      G + VAVK + K A + E+   +FL E  ++++ NH
Sbjct: 1   NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEK--KEFLKEAHLMSNFNH 58

Query: 201 PNAAKLIGFSTEN-GFHLVLQFLPHGSLSSLLFGS------TECLEWTIRYKIALGIAEG 253
           PN  KL+G    N   +++++ +  G L S L  +         L       I L +A+G
Sbjct: 59  PNIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKG 118

Query: 254 LQYLHHDCHRRIIHRDIKASNILLSE-DYEA----QISDFGLAKWLPDNWSHHI----VF 304
             YL        IHRD+ A N L+SE  Y+A    +I DFGLA+ +  +  +      + 
Sbjct: 119 CVYLEQ---MHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLL 175

Query: 305 PIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELIT 341
           P+     +++PE  + G    ++DV++FGVL+ E++T
Sbjct: 176 PVR----WMAPESLLDGKFTTQSDVWSFGVLMWEILT 208

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score = 96.0 bits (239), Expect = 2e-22
 Identities = 67/248 (27%), Positives = 114/248 (45%), Gaps = 28/248 (11%)

Query: 169 VAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTENG-FHLVLQFLPHGSL 227
           VA+K I + A  ++    DF+ E  ++  ++HPN  +L G  T+     +V +++ +G L
Sbjct: 31  VAIKMIREGAMSED----DFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMANGCL 86

Query: 228 SSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISD 287
            + L      L       +   + E ++YL  +     IHRD+ A N L+ ED   ++SD
Sbjct: 87  LNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNG---FIHRDLAARNCLVGEDNVVKVSD 143

Query: 288 FGLAKWLPDNW---SHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELIT-GR 343
           FGLA+++ D+    S    FP++    +  PE F +     K+DV++FGVL+ E+ + G+
Sbjct: 144 FGLARYVLDDQYTSSQGTKFPVK----WAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGK 199

Query: 344 RAVDSRRQSLVIWAKPLLQTSNFKELVDPRLADAYDLAEMKRAMLTASVCIHHLSTMRPQ 403
              +    S V+ +      S    L  P+LA       M         C H     RP 
Sbjct: 200 MPYERFSNSEVVES-----VSAGYRLYRPKLAPTEVYTIMYS-------CWHEKPEDRPA 247

Query: 404 MTRVLQLL 411
             ++L  L
Sbjct: 248 FKKLLSQL 255

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 96.3 bits (240), Expect = 2e-22
 Identities = 65/221 (29%), Positives = 110/221 (49%), Gaps = 38/221 (17%)

Query: 149 LIGKGGHAEVYKG------CLPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHI-NHP 201
            +G+G   +V K          +   VAVK +  +A E +  +SD +SE+ ++  I  H 
Sbjct: 19  PLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKD--LSDLVSEMEMMKMIGKHK 76

Query: 202 NAAKLIGFSTENG-FHLVLQFLPHGSLSSLL-----------FGSTECLEWTIRYK---- 245
           N   L+G  T+ G  ++V+++  HG+L   L                  E T+  K    
Sbjct: 77  NIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVS 136

Query: 246 IALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFP 305
            A  +A G+++L     ++ IHRD+ A N+L++ED+  +I+DFGLA+ +     HHI + 
Sbjct: 137 FAYQVARGMEFL---ASKKCIHRDLAARNVLVTEDHVMKIADFGLARDI-----HHIDYY 188

Query: 306 IEGTFGYL-----SPEYFMHGIVDEKTDVFAFGVLLLELIT 341
            + T G L     +PE     +   ++DV++FGVLL E+ T
Sbjct: 189 RKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 229

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score = 95.1 bits (237), Expect = 4e-22
 Identities = 66/202 (32%), Positives = 98/202 (48%), Gaps = 21/202 (10%)

Query: 150 IGKGGHAEVYKGCLPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGF 209
           +G G   EV+ G       VAVK +    K        FL E  I+  + H    +L   
Sbjct: 14  LGAGQFGEVWMGTWNGTTKVAVKTL----KPGTMSPEAFLQEAQIMKKLRHDKLVQLYAV 69

Query: 210 STENG-FHLVLQFLPHGSLSSLLF---GSTECLEWTIRYKIALGIAEGLQYLHHDCHRRI 265
            +E    ++V +++  GSL   L    G    L   +   +A  IAEG+ YL     R  
Sbjct: 70  CSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLV--DMAAQIAEGMAYLES---RNY 124

Query: 266 IHRDIKASNILLSEDYEAQISDFGLAKWLPDN---WSHHIVFPIEGTFGYLSPEYFMHGI 322
           IHRD+ A NIL+ E+   +I+DFGLA+ + D+         FPI+ T    +PE   +G 
Sbjct: 125 IHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIKWT----APEAANYGR 180

Query: 323 VDEKTDVFAFGVLLLELIT-GR 343
              K+DV++FG+LL E++T GR
Sbjct: 181 FTIKSDVWSFGILLTEIVTYGR 202

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score = 94.5 bits (235), Expect = 4e-22
 Identities = 64/201 (31%), Positives = 100/201 (49%), Gaps = 18/201 (8%)

Query: 149 LIGKGGHAEVYKGCLPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIG 208
            IGKG   +VYKG L     VAVK        D +R   FL E  I+   +HPN  KLIG
Sbjct: 2   KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKR--KFLQEAEILKQYDHPNIVKLIG 59

Query: 209 FSTENG-FHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIH 267
              +    ++V++ +P GSL + L      L      +++L  A G++YL     +  IH
Sbjct: 60  VCVQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLES---KNCIH 116

Query: 268 RDIKASNILLSEDYEAQISDFGLAKWLPDNWSHHIV------FPIEGTFGYLSPEYFMHG 321
           RD+ A N L+ E+   +ISDFG+++   +    + V       PI+ T    +PE   +G
Sbjct: 117 RDLAARNCLVGENNVLKISDFGMSR--EEEGGIYTVSDGLKQIPIKWT----APEALNYG 170

Query: 322 IVDEKTDVFAFGVLLLELITG 342
               ++DV+++G+LL E  + 
Sbjct: 171 RYTSESDVWSYGILLWETFSL 191

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 93.9 bits (233), Expect = 1e-21
 Identities = 76/276 (27%), Positives = 135/276 (48%), Gaps = 25/276 (9%)

Query: 143 NFNSENLIGKGGHAEVYKG-CLPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHP 201
           NF  E  IG+G  +EVY+  CL D + VA+KK+      D +   D + E+ ++  +NHP
Sbjct: 3   NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHP 62

Query: 202 NAAK-LIGFSTENGFHLVLQFLPHGSLSSLL--FGSTECL--EWTIRYKIALGIAEGLQY 256
           N  K L  F  +N  ++VL+    G LS ++  F   + L  E T+ +K  + +   +++
Sbjct: 63  NVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTV-WKYFVQLCSAVEH 121

Query: 257 LHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWS--HHIVFPIEGTFGYLS 314
           +H    RR++HRDIK +N+ ++     ++ D GL ++     +  H +V    GT  Y+S
Sbjct: 122 MHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV----GTPYYMS 174

Query: 315 PEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSNFKELVDPRL 374
           PE       + K+D+++ G LL E+   +      + +L    + + Q         P  
Sbjct: 175 PERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCD-----YPPLP 229

Query: 375 ADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQL 410
            + Y  +E  R ++  S+CI+     RP +  V Q+
Sbjct: 230 TEHY--SEKLRELV--SMCIYPDPDQRPDIGYVHQI 261

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score = 93.5 bits (233), Expect = 1e-21
 Identities = 57/207 (27%), Positives = 104/207 (50%), Gaps = 22/207 (10%)

Query: 144 FNSENLIGKGGHAEVYKG-CLPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPN 202
           F+    +G+G +  VYK      G+VVA+K +       EE + + + E+ I+   + P 
Sbjct: 5   FDILEKLGEGSYGSVYKAIHKETGQVVAIKVV-----PVEEDLQEIIKEISILKQCDSPY 59

Query: 203 AAKLIG-FSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYK----IALGIAEGLQYL 257
             K  G +       +V+++   GS+S ++    +    T+  +    I     +GL+YL
Sbjct: 60  IVKYYGSYFKNTDLWIVMEYCGAGSVSDIM----KITNKTLTEEEIAAILYQTLKGLEYL 115

Query: 258 HHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPD-NWSHHIVFPIEGTFGYLSPE 316
           H     + IHRDIKA NILL+E+ +A+++DFG++  L D     + V    GT  +++PE
Sbjct: 116 HS---NKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTVI---GTPFWMAPE 169

Query: 317 YFMHGIVDEKTDVFAFGVLLLELITGR 343
                  + K D+++ G+  +E+  G+
Sbjct: 170 VIQEIGYNNKADIWSLGITAIEMAEGK 196

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 93.2 bits (232), Expect = 2e-21
 Identities = 57/206 (27%), Positives = 97/206 (47%), Gaps = 29/206 (14%)

Query: 150 IGKGGHAEVYKGC--LPDGEVVAVK-KIIKNAKEDEERISDFLSELGIVAHINHPNAAKL 206
           +G G    V KG   +  G+ V V  K +K       +  +FL E  ++A ++HP   +L
Sbjct: 3   LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGK-KEFLREASVMAQLDHPCIVRL 61

Query: 207 IGFSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRII 266
           IG        LV++  P G L   L    E     ++ ++A  +A G+ YL     +  +
Sbjct: 62  IGVCKGEPLMLVMELAPLGPLLKYLKKRREIPVSDLK-ELAHQVAMGMAYLES---KHFV 117

Query: 267 HRDIKASNILLSEDYEAQISDFGLAKWL-PDN----------WSHHIVFPIEGTFGYLSP 315
           HRD+ A N+LL   ++A+ISDFG+++ L   +          W      P++    + +P
Sbjct: 118 HRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRW------PLK----WYAP 167

Query: 316 EYFMHGIVDEKTDVFAFGVLLLELIT 341
           E   +G    K+DV+++GV L E  +
Sbjct: 168 ECINYGKFSSKSDVWSYGVTLWEAFS 193

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 92.8 bits (231), Expect = 2e-21
 Identities = 62/206 (30%), Positives = 97/206 (47%), Gaps = 25/206 (12%)

Query: 149 LIGKGGHAEVYKG--CLPDGEVVAVKKIIKNAKED--EERISDFLSELGIVAHINHPNAA 204
            +G G    V +G      G+V+ V   +K  K D   + + DFL E  I+  ++H N  
Sbjct: 2   KLGDGSFGVVRRGEWSTSGGKVIPVA--VKCLKSDKLSDIMDDFLKEAAIMHSLDHENLI 59

Query: 205 KLIGFSTENGFHLVLQFLPHGSLSSLLFGSTECLE--------WTIRYKIALGIAEGLQY 256
           +L G    +   +V +  P GSL        + L          +     A+ IA G++Y
Sbjct: 60  RLYGVVLTHPLMMVTELAPLGSL-------LDRLRKDALGHFLISTLCDYAVQIANGMRY 112

Query: 257 LHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSHHIV-FPIEGTFGYLSP 315
           L     +R IHRD+ A NILL+ D + +I DFGL + LP N  H+++   ++  F + +P
Sbjct: 113 LES---KRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAP 169

Query: 316 EYFMHGIVDEKTDVFAFGVLLLELIT 341
           E          +DV+ FGV L E+ T
Sbjct: 170 ESLRTRTFSHASDVWMFGVTLWEMFT 195

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 92.6 bits (230), Expect = 4e-21
 Identities = 66/212 (31%), Positives = 100/212 (47%), Gaps = 26/212 (12%)

Query: 149 LIGKGGHAEVYKGCLPDGEVVAVKKIIKNAKED---EERISDFLSELGIVAHINHPNAAK 205
           ++G+G    V +G L   +   +K  +K  K D      I +FLSE   +   +HPN  K
Sbjct: 6   ILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMK 65

Query: 206 LIGFSTE----NGFH---LVLQFLPHGSLSSLLFGS-----TECLEWTIRYKIALGIAEG 253
           LIG   E           ++L F+ HG L S L  S      E L      K  + IA G
Sbjct: 66  LIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALG 125

Query: 254 LQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAK--WLPDNWSH-HIV-FPIEGT 309
           ++YL    +R  IHRD+ A N +L ED    ++DFGL+K  +  D +    I   P++  
Sbjct: 126 MEYL---SNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVK-- 180

Query: 310 FGYLSPEYFMHGIVDEKTDVFAFGVLLLELIT 341
             +++ E     +   K+DV+AFGV + E+ T
Sbjct: 181 --WIAIESLADRVYTSKSDVWAFGVTMWEIAT 210

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score = 92.0 bits (229), Expect = 4e-21
 Identities = 60/204 (29%), Positives = 93/204 (45%), Gaps = 9/204 (4%)

Query: 143 NFNSENLIGKGGHAEVYKGCLPD-GEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHP 201
           +F    +IGKG   +V      D  ++ A+K + K    ++  + + L+E  I+  +NHP
Sbjct: 1   HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHP 60

Query: 202 NAAKL-IGFSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHD 260
               L   F  E   +LV+  L  G L   L    +  E  +++ I   I   L+YLH  
Sbjct: 61  FLVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKFWIC-EIVLALEYLHS- 118

Query: 261 CHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEGTFGYLSPEYFMH 320
             + IIHRDIK  NILL E     I+DF +A  +  +    +     GT GY++PE    
Sbjct: 119 --KGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPD---TLTTSTSGTPGYMAPEVLCR 173

Query: 321 GIVDEKTDVFAFGVLLLELITGRR 344
                  D ++ GV   E + G+R
Sbjct: 174 QGYSVAVDWWSLGVTAYECLRGKR 197

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 92.5 bits (230), Expect = 5e-21
 Identities = 74/255 (29%), Positives = 121/255 (47%), Gaps = 49/255 (19%)

Query: 149 LIGKGGHAEVYKG-CLPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINH---PNAA 204
           LIG+G +  VY+G  +P G VVA+K  I N    ++ +SD   E+ +++ +     PN  
Sbjct: 8   LIGRGAYGAVYRGKHVPTGRVVALK--IINLDTPDDDVSDIQREVALLSQLRQSQPPNIT 65

Query: 205 KLIGFSTENGFHL--VLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAE---GLQYLHH 259
           K  G S   G  L  ++++   GS+ +L+      +    +Y I++ I E    L+Y+H 
Sbjct: 66  KYYG-SYLKGPRLWIIMEYAEGGSVRTLMKAG--PIAE--KY-ISVIIREVLVALKYIHK 119

Query: 260 DCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEGTFGYLSPEYFM 319
                +IHRDIKA+NIL++     ++ DFG+A  L  N S    F   GT  +++PE   
Sbjct: 120 V---GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFV--GTPYWMAPEVIT 174

Query: 320 HGIV-DEKTDVFAFGVLLLELITGR---------RAVDSRRQSLVIWAKPLLQTSNFKEL 369
            G   D K D+++ G+ + E+ TG          RA+      L+  +KP          
Sbjct: 175 EGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMM-----LIPKSKP---------- 219

Query: 370 VDPRLADAYDLAEMK 384
             PRL D      ++
Sbjct: 220 --PRLEDNGYSKLLR 232

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 91.8 bits (228), Expect = 5e-21
 Identities = 64/206 (31%), Positives = 104/206 (50%), Gaps = 21/206 (10%)

Query: 148 NLIGKGGHAEVYKGCLPDGEVVAVKKIIK--NAKEDEERISDFLSELGIVAHINHPNAAK 205
            +IGKG    VY G L D +   +   +K  N   D E +  FL E  I+   +HPN   
Sbjct: 1   RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLS 60

Query: 206 LIGFS--TENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALG--IAEGLQYLHHDC 261
           L+G    +E    +VL ++ HG L    F  +E    T++  I  G  +A+G++YL    
Sbjct: 61  LLGICLPSEGSPLVVLPYMKHGDL--RNFIRSETHNPTVKDLIGFGLQVAKGMEYL---A 115

Query: 262 HRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDN--WS----HHIVFPIEGTFGYLSP 315
            ++ +HRD+ A N +L E +  +++DFGLA+ + D   +S         P++    +++ 
Sbjct: 116 SKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVK----WMAL 171

Query: 316 EYFMHGIVDEKTDVFAFGVLLLELIT 341
           E         K+DV++FGVLL EL+T
Sbjct: 172 ESLQTQKFTTKSDVWSFGVLLWELMT 197

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 92.0 bits (228), Expect = 6e-21
 Identities = 77/278 (27%), Positives = 137/278 (49%), Gaps = 25/278 (8%)

Query: 143 NFNSENLIGKGGHAEVYKG-CLPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHP 201
           NF  E  IG+G  +EVY+  CL DG  VA+KK+      D +  +D + E+ ++  +NHP
Sbjct: 3   NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 62

Query: 202 NAAKL-IGFSTENGFHLVLQFLPHGSLSSLL--FGSTECL--EWTIRYKIALGIAEGLQY 256
           N  K    F  +N  ++VL+    G LS ++  F   + L  E T+ +K  + +   L++
Sbjct: 63  NVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTV-WKYFVQLCSALEH 121

Query: 257 LHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWS--HHIVFPIEGTFGYLS 314
           +H    RR++HRDIK +N+ ++     ++ D GL ++     +  H +V    GT  Y+S
Sbjct: 122 MHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV----GTPYYMS 174

Query: 315 PEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSNFKELVDPRL 374
           PE       + K+D+++ G LL E+   +      + +L    K + Q         P  
Sbjct: 175 PERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCD-----YPPLP 229

Query: 375 ADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQLLR 412
           +D Y   E+++ +   ++CI+     RP +T V  + +
Sbjct: 230 SDHYS-EELRQLV---NMCINPDPEKRPDITYVYDVAK 263

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 92.7 bits (230), Expect = 7e-21
 Identities = 64/211 (30%), Positives = 108/211 (51%), Gaps = 26/211 (12%)

Query: 144 FNSENLIGKGGHAEVYKGC-LPDGEVVAVKKIIKNAKE--DEERISDFLSELGIVAHINH 200
           F    ++G G    VYKG  +P+GE V +   IK  +E    +   + L E  ++A +++
Sbjct: 9   FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 68

Query: 201 PNAAKLIGFSTENGFHLVLQFLPHGSLSSLL------FGSTECLEWTIRYKIALGIAEGL 254
           P+  +L+G    +   L+ Q +P G L   +       GS   L W ++      IA+G+
Sbjct: 69  PHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IAKGM 122

Query: 255 QYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWL-PDNWSHHI---VFPIEGTF 310
            YL     RR++HRD+ A N+L+      +I+DFGLAK L  D   +H      PI+   
Sbjct: 123 NYLEE---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIK--- 176

Query: 311 GYLSPEYFMHGIVDEKTDVFAFGVLLLELIT 341
            +++ E  +H I   ++DV+++GV + EL+T
Sbjct: 177 -WMALESILHRIYTHQSDVWSYGVTVWELMT 206

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 91.7 bits (228), Expect = 9e-21
 Identities = 62/201 (30%), Positives = 101/201 (50%), Gaps = 15/201 (7%)

Query: 150 IGKGGHAEVYKGCLPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLI-G 208
           +G G   +VYK    +  + A  KII+   E EE + DF+ E+ I++   HPN   L   
Sbjct: 13  LGDGAFGKVYKAQHKETGLFAAAKIIQ--IESEEELEDFMVEIDILSECKHPNIVGLYEA 70

Query: 209 FSTENGFHLVLQFLPHGSLSSLLFGSTECL-EWTIRYKIALGIAEGLQYLHHDCHRRIIH 267
           +  EN   ++++F   G+L S++      L E  IRY +   + E L +LH     ++IH
Sbjct: 71  YFYENKLWILIEFCDGGALDSIMLELERGLTEPQIRY-VCRQMLEALNFLHS---HKVIH 126

Query: 268 RDIKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEGTFGYLSPEY-----FMHGI 322
           RD+KA NILL+ D + +++DFG++            F   GT  +++PE      F    
Sbjct: 127 RDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFI--GTPYWMAPEVVACETFKDNP 184

Query: 323 VDEKTDVFAFGVLLLELITGR 343
            D K D+++ G+ L+EL    
Sbjct: 185 YDYKADIWSLGITLIELAQME 205

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 91.1 bits (226), Expect = 9e-21
 Identities = 72/277 (25%), Positives = 135/277 (48%), Gaps = 33/277 (11%)

Query: 148 NLIGKGGHAEVYKGCLPDGEVVAVKKII---KNAKEDEERISDFLSELGIVAHINHPNAA 204
            ++GKG +  VY G    G+++AVK++     N    E+       E+ ++  + H N  
Sbjct: 6   EVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIV 65

Query: 205 KLIGFS-TENGFHLVLQFLPHGSLSSLL--FGSTECLEWTIRYKIALGIAEGLQYLHHDC 261
           + +G    +N   + ++F+P GS+SS+L  FG    L   +  K    I +G+ YLH++C
Sbjct: 66  QYLGTCLDDNTISIFMEFVPGGSISSILNRFGP---LPEPVFCKYTKQILDGVAYLHNNC 122

Query: 262 HRRIIHRDIKASNILLSEDYEAQISDFGLAK---WLPDNWSH-HIVFPIEGTFGYLSPEY 317
              ++HRDIK +N++L  +   ++ DFG A+   W+  + +H +++  + GT  +++PE 
Sbjct: 123 ---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEV 179

Query: 318 FMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSNFKELVDPRLADA 377
                   K+D+++ G  + E+ TG+  + S  +   ++          + L+ PRL D+
Sbjct: 180 INESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFY-----IGAHRGLM-PRLPDS 233

Query: 378 YDLAEMKRAMLTASVCIHHLSTMRPQMTR--VLQLLR 412
           +           A++        R Q  R   LQLLR
Sbjct: 234 FS---------AAAIDFVTSCLTRDQHERPSALQLLR 261

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 91.3 bits (226), Expect = 1e-20
 Identities = 79/247 (31%), Positives = 117/247 (47%), Gaps = 25/247 (10%)

Query: 144 FNSENLIGKGGHAEVYKGCLP-DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPN 202
           F     IGKG   EVYKG      EVVA+K I  + +E E+ I D   E+ +++  + P 
Sbjct: 6   FTKLERIGKGSFGEVYKGIDNRTKEVVAIKII--DLEEAEDEIEDIQQEITVLSQCDSPY 63

Query: 203 AAKLIG-FSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDC 261
             +  G +       +++++L  GS   LL      LE T    I   I +GL YLH + 
Sbjct: 64  ITRYYGSYLKGTKLWIIMEYLGGGSALDLL--KPGPLEETYIATILREILKGLDYLHSE- 120

Query: 262 HRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEGTFGYLSPEYFMHG 321
             R IHRDIKA+N+LLSE  + +++DFG+A  L D       F   GT  +++PE     
Sbjct: 121 --RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV--GTPFWMAPEVIKQS 176

Query: 322 IVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIW-----AKPLLQ---TSNFKELV--- 370
             D K D+++ G+  +EL  G           V++     + P L+   +  FKE V   
Sbjct: 177 AYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSPPTLEGQYSKPFKEFVEAC 236

Query: 371 ---DPRL 374
              DPR 
Sbjct: 237 LNKDPRF 243

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score = 90.6 bits (225), Expect = 1e-20
 Identities = 62/211 (29%), Positives = 105/211 (49%), Gaps = 34/211 (16%)

Query: 149 LIGKGGHAEVYKGC-LPDGEVVAVK--KIIKNAKEDEERISDFLSELGIVAHINHPNAAK 205
           L+G G    VY+G  L DG+  AVK   +  + +  +E +     E+ +++ + HPN  +
Sbjct: 7   LLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQ 66

Query: 206 LIGFSTENG-FHLVLQFLPHGSLSSLL--FGS-TECLEWTIRYKIAL---GIAEGLQYLH 258
            +G   E    ++ L+ +P GSL+ LL  +GS  E +       I L    I  GL+YLH
Sbjct: 67  YLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPV-------IRLYTRQILLGLEYLH 119

Query: 259 HDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVF-----PIEGTFGYL 313
               R  +HRDIK +NIL+  +   +++DFG+AK         +V        +G+  ++
Sbjct: 120 D---RNTVHRDIKGANILVDTNGVVKLADFGMAK--------QVVEFSFAKSFKGSPYWM 168

Query: 314 SPEYFMH-GIVDEKTDVFAFGVLLLELITGR 343
           +PE     G      D+++ G  +LE+ TG+
Sbjct: 169 APEVIAQQGGYGLAADIWSLGCTVLEMATGK 199

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score = 90.7 bits (226), Expect = 2e-20
 Identities = 61/215 (28%), Positives = 107/215 (49%), Gaps = 17/215 (7%)

Query: 133 DFAELAAATDNFNSENLIGKGGHAEVYKGC-LPDGEVVAVKKIIKNAKEDEERISDFLSE 191
           D        + + +   IG+G   EVYK      G+ VA+KK+    K+++E I   ++E
Sbjct: 10  DIVSEGDPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLR-KQNKELI---INE 65

Query: 192 LGIVAHINHPNAAKLIG-FSTENGFHLVLQFLPHGSLSSLL-FGSTECLEWTIRYKIALG 249
           + I+    HPN       +   +   +V++++  GSL+ ++        E  I Y +   
Sbjct: 66  ILIMKDCKHPNIVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAY-VCRE 124

Query: 250 IAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSHH--IVFPIE 307
           + +GL+YLH    + +IHRDIK+ NILLS+D   +++DFG A  L    S    +V    
Sbjct: 125 VLQGLEYLHS---QNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSVV---- 177

Query: 308 GTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITG 342
           GT  +++PE         K D+++ G++ +E+  G
Sbjct: 178 GTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEG 212

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 90.9 bits (225), Expect = 2e-20
 Identities = 60/202 (29%), Positives = 102/202 (50%), Gaps = 18/202 (8%)

Query: 149 LIGKGGHAEVYKGC-LPDGEVVAVKKIIK--NAKEDEERISDFLSELGIVAHINHPNAAK 205
           ++G G    VYKG  +P+GE V +   IK  N     +   +F+ E  I+A ++HP+  +
Sbjct: 14  VLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVR 73

Query: 206 LIGFSTENGFHLVLQFLPHGSLSSLL------FGSTECLEWTIRYKIALGIAEGLQYLHH 259
           L+G        LV Q +PHG L   +       GS   L W ++      IA+G+ YL  
Sbjct: 74  LLGVCLSPTIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQ------IAKGMMYLEE 127

Query: 260 DCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEGTFGYLSPEYFM 319
              RR++HRD+ A N+L+      +I+DFGLA+ L  +   +     +    +++ E   
Sbjct: 128 ---RRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIH 184

Query: 320 HGIVDEKTDVFAFGVLLLELIT 341
           +     ++DV+++GV + EL+T
Sbjct: 185 YRKFTHQSDVWSYGVTIWELMT 206

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 90.2 bits (224), Expect = 2e-20
 Identities = 62/198 (31%), Positives = 97/198 (48%), Gaps = 14/198 (7%)

Query: 149 LIGKGGHAEVYKGC--LPDGEVVAVK-KIIKNAKEDEERISDFLSELGIVAHINHPNAAK 205
            IG+G   +VY+G    P+ E +AV  K  KN      R   FL E  I+   +HP+  K
Sbjct: 13  CIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVR-EKFLQEAYIMRQFDHPHIVK 71

Query: 206 LIGFSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRI 265
           LIG  TEN   +V++  P G L S L  +   L+       +  ++  L YL     +R 
Sbjct: 72  LIGVITENPVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLE---SKRF 128

Query: 266 IHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSHHIV---FPIEGTFGYLSPEYFMHGI 322
           +HRDI A N+L+S     ++ DFGL+++L D   +       PI+    +++PE      
Sbjct: 129 VHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIK----WMAPESINFRR 184

Query: 323 VDEKTDVFAFGVLLLELI 340
               +DV+ FGV + E++
Sbjct: 185 FTSASDVWMFGVCMWEIL 202

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 90.4 bits (224), Expect = 2e-20
 Identities = 57/180 (31%), Positives = 95/180 (52%), Gaps = 9/180 (5%)

Query: 166 GEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTE---NGFHLVLQFL 222
           GE VAVK +    +     I+D   E+ I+ ++ H N  K  G  TE   NG  L+++FL
Sbjct: 33  GEQVAVKSL--KPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFL 90

Query: 223 PHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYE 282
           P GSL   L  +   +    + K A+ I +G+ YL     R+ +HRD+ A N+L+  +++
Sbjct: 91  PSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGS---RQYVHRDLAARNVLVESEHQ 147

Query: 283 AQISDFGLAKWLPDNWSHHIVF-PIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELIT 341
            +I DFGL K +  +  ++ V   ++    + +PE  +       +DV++FGV L EL+T
Sbjct: 148 VKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLT 207

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score = 89.5 bits (222), Expect = 3e-20
 Identities = 63/209 (30%), Positives = 110/209 (52%), Gaps = 20/209 (9%)

Query: 149 LIGKGGHAEVYKGC-LPDGEVVAVKKI------IKNAKEDEERISDFLSELGIVAHINHP 201
           LIG G    VY G     GE++AVK++        +       +     E+ ++  + H 
Sbjct: 7   LIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHE 66

Query: 202 NAAKLIGFST-ENGFHLVLQFLPHGSLSSLL--FGSTECLEWTIRYKIALGIAEGLQYLH 258
           N  + +G S   +  ++ L+++P GS+++LL  +G+ E  E  +R  +   I +GL YLH
Sbjct: 67  NIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFE--ETLVRNFVR-QILKGLNYLH 123

Query: 259 HDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDN---WSHHIVFP-IEGTFGYLS 314
           +   R IIHRDIK +NIL+      +ISDFG++K L  N      +   P ++G+  +++
Sbjct: 124 N---RGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMA 180

Query: 315 PEYFMHGIVDEKTDVFAFGVLLLELITGR 343
           PE         K D+++ G L++E++TG+
Sbjct: 181 PEVVKQTSYTRKADIWSLGCLVVEMLTGK 209

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score = 88.8 bits (221), Expect = 6e-20
 Identities = 67/262 (25%), Positives = 112/262 (42%), Gaps = 44/262 (16%)

Query: 150 IGKGGHAEVYKGC-LPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIG 208
           IGKG    V K     DG+++  K+I      ++E+    +SE+ I+  + HPN  +   
Sbjct: 8   IGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEK-QQLVSEVNILRELKHPNIVRYYD 66

Query: 209 --FSTENG-FHLVLQFLPHGSLSSLLFGSTEC---LEWTIRYKIALGIAEGLQYLHHDCH 262
                 N   ++V+++   G L+ L+    +    +E    ++I   +   L      CH
Sbjct: 67  RIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYE----CH 122

Query: 263 RR------IIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEGTFGYLSPE 316
            R      ++HRD+K +NI L  +   ++ DFGLAK L  + S    +   GT  Y+SPE
Sbjct: 123 NRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYV--GTPYYMSPE 180

Query: 317 YFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSNFKELVD----- 371
              H   DEK+D+++ G L+ EL                   P     N  +L       
Sbjct: 181 QLNHMSYDEKSDIWSLGCLIYELCALS---------------PPFTARNQLQLASKIKEG 225

Query: 372 --PRLADAY--DLAEMKRAMLT 389
              R+   Y  +L E+ ++ML 
Sbjct: 226 KFRRIPYRYSSELNEVIKSMLN 247

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score = 89.1 bits (222), Expect = 7e-20
 Identities = 62/206 (30%), Positives = 100/206 (48%), Gaps = 28/206 (13%)

Query: 150 IGKGGHAEVYKG-CLPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIG 208
           +G+G +  VYK      GE+VA+KKI +   E+E   S  L E+ ++  + HPN  KL+ 
Sbjct: 7   LGEGTYGVVYKARDKKTGEIVALKKI-RLDNEEEGIPSTALREISLLKELKHPNIVKLLD 65

Query: 209 -FSTENGFHLVLQFLPHGSLSSLL-FGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRII 266
              TE   +LV ++     L   L           I+  I   +  GL Y H     RI+
Sbjct: 66  VIHTERKLYLVFEYCDM-DLKKYLDKRPGPLSPNLIKS-IMYQLLRGLAYCHS---HRIL 120

Query: 267 HRDIKASNILLSEDYEAQISDFGLAKW--LPDN-WSHHIVFPIEGTFGYLSPEYFMH--- 320
           HRD+K  NIL++ D   +++DFGLA+   +P   ++H +V     T  Y +PE  +    
Sbjct: 121 HRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVV-----TLWYRAPEILLGSKH 175

Query: 321 ---GIVDEKTDVFAFGVLLLELITGR 343
               +     D+++ G +  E+ITG+
Sbjct: 176 YSTAV-----DIWSVGCIFAEMITGK 196

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score = 88.5 bits (220), Expect = 7e-20
 Identities = 63/205 (30%), Positives = 97/205 (47%), Gaps = 14/205 (6%)

Query: 148 NLIGKGGHAEVYKGC-LPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKL 206
           N IG G   +VY    L  GE++AVK  I+    D + I +   E+ ++  + HPN  K 
Sbjct: 6   NKIGGGTFGKVYTAVNLDTGELMAVK-EIRIQDNDPKTIKEIADEMKVLELLKHPNLVKY 64

Query: 207 IGFSTE-NGFHLVLQFLPHGSLSSLL-FGSTECLEWTIRYKIALGIAEGLQYLHHDCHRR 264
            G        ++ +++   G+L  LL  G          Y   L + EGL YLH      
Sbjct: 65  YGVEVHREKVYIFMEYCSGGTLEELLEHGRILDEHVIRVY--TLQLLEGLAYLHS---HG 119

Query: 265 IIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWS--HHIVFPIEGTFGYLSPEYFMHGI 322
           I+HRDIK +NI L  +   ++ DFG A  L +N +     V  + GT  Y++PE    G 
Sbjct: 120 IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGK 179

Query: 323 VDEK---TDVFAFGVLLLELITGRR 344
                   D+++ G ++LE+ TG+R
Sbjct: 180 GKGHGRAADIWSLGCVVLEMATGKR 204

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score = 88.3 bits (219), Expect = 9e-20
 Identities = 62/200 (31%), Positives = 102/200 (51%), Gaps = 17/200 (8%)

Query: 150 IGKGGHAEVYKGCLPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGF 209
           +G G   EV++G   +   VAVK +    K       DFL+E  I+  + HP   +L   
Sbjct: 14  LGAGQFGEVWEGLWNNTTPVAVKTL----KPGTMDPKDFLAEAQIMKKLRHPKLIQLYAV 69

Query: 210 ST-ENGFHLVLQFLPHGSLSSLLFGST-ECLEWTIRYKIALGIAEGLQYLHHDCHRRIIH 267
            T E   ++V + + +GSL   L G     L+      +A  +A G+ YL     +  IH
Sbjct: 70  CTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEA---QNYIH 126

Query: 268 RDIKASNILLSEDYEAQISDFGLAKWLPDN---WSHHIVFPIEGTFGYLSPEYFMHGIVD 324
           RD+ A N+L+ E+   +++DFGLA+ + ++         FPI+ T    +PE  ++    
Sbjct: 127 RDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWT----APEAALYNRFS 182

Query: 325 EKTDVFAFGVLLLELIT-GR 343
            K+DV++FG+LL E++T GR
Sbjct: 183 IKSDVWSFGILLTEIVTYGR 202

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 88.6 bits (219), Expect = 9e-20
 Identities = 66/200 (33%), Positives = 101/200 (50%), Gaps = 9/200 (4%)

Query: 144 FNSENLIGKGGHAEVYKGCLPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNA 203
           F     IGKG   EV+KG     + V   KII + +E E+ I D   E+ +++  + P  
Sbjct: 6   FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKII-DLEEAEDEIEDIQQEITVLSQCDSPYV 64

Query: 204 AKLIG-FSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCH 262
            K  G +  +    +++++L  GS   LL      L+ T    I   I +GL YLH +  
Sbjct: 65  TKYYGSYLKDTKLWIIMEYLGGGSALDLL--EPGPLDETQIATILREILKGLDYLHSE-- 120

Query: 263 RRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEGTFGYLSPEYFMHGI 322
            + IHRDIKA+N+LLSE  E +++DFG+A  L D       F   GT  +++PE      
Sbjct: 121 -KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFV--GTPFWMAPEVIKQSA 177

Query: 323 VDEKTDVFAFGVLLLELITG 342
            D K D+++ G+  +EL  G
Sbjct: 178 YDSKADIWSLGITAIELAKG 197

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 91.8 bits (228), Expect = 1e-19
 Identities = 71/273 (26%), Positives = 125/273 (45%), Gaps = 23/273 (8%)

Query: 145 NSENLIGKGGHAEVYKGCLPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAA 204
             EN+I +G     YKG      +   + ++K   +     S  ++++G    + HPN  
Sbjct: 693 KEENVISRGKKGASYKGKSIKNGM---QFVVKEINDVNSIPSSEIADMG---KLQHPNIV 746

Query: 205 KLIGF-STENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHR 263
           KLIG   +E G +L+ +++   +LS +L      L W  R KIA+GIA+ L++LH  C  
Sbjct: 747 KLIGLCRSEKGAYLIHEYIEGKNLSEVLRN----LSWERRRKIAIGIAKALRFLHCRCSP 802

Query: 264 RIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEGTFGYLSPEYFMHGIV 323
            ++  ++    I++    E  +    L   L  +    I      +  Y++PE      +
Sbjct: 803 AVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTDTKCFI------SSAYVAPETRETKDI 855

Query: 324 DEKTDVFAFGVLLLELITGRRAVDSR---RQSLVIWAKPLLQTSNFKELVDPRLAD--AY 378
            EK+D++ FG++L+EL+TG+   D+      S+V WA+      +    +DP +    + 
Sbjct: 856 TEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDVSV 915

Query: 379 DLAEMKRAMLTASVCIHHLSTMRPQMTRVLQLL 411
           +  E+   M  A  C     T RP    VL+ L
Sbjct: 916 NQNEIVEVMNLALHCTATDPTARPCANDVLKTL 948

Length = 968

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 87.4 bits (217), Expect = 2e-19
 Identities = 60/224 (26%), Positives = 100/224 (44%), Gaps = 53/224 (23%)

Query: 150 IGKGGHAEVYKGC---LPDGEV---VAVKKIIKNAKEDEERISDFLSELGIVAHINHPNA 203
           +G+G    VY+G    +  GE    VA+K + +NA   E    +FL+E  ++   N  + 
Sbjct: 14  LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERI--EFLNEASVMKEFNCHHV 71

Query: 204 AKLIGF-STENGFHLVLQFLPHGSLSSLL-----------FGSTECLEWTIRYKIALGIA 251
            +L+G  ST     +V++ +  G L S L                 L+  I+   A  IA
Sbjct: 72  VRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQM--AAEIA 129

Query: 252 EGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAK--------------WLPDN 297
           +G+ YL     ++ +HRD+ A N +++ED   +I DFG+ +               LP  
Sbjct: 130 DGMAYLAA---KKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 186

Query: 298 WSHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELIT 341
           W              ++PE    G+   K+DV++FGV+L E+ T
Sbjct: 187 W--------------MAPESLKDGVFTTKSDVWSFGVVLWEMAT 216

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 87.2 bits (216), Expect = 2e-19
 Identities = 55/205 (26%), Positives = 105/205 (51%), Gaps = 16/205 (7%)

Query: 149 LIGKGGHAEVYKGC-LPDGEVVAVKKII---KNAKEDEERISDFLSELGIVAHINHPNAA 204
            +G G  +  Y+   +  G ++AVK++      + E EE +     E+ ++A +NHP+  
Sbjct: 7   QLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHII 66

Query: 205 KLIGFSTENG-FHLVLQFLPHGSLSSLL--FGSTECLEWTIRYKIALGIAEGLQYLHHDC 261
           +++G + E+  F+L ++++  GS+S LL  +G+    +  +       +  GL YLH   
Sbjct: 67  RMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGA---FKEAVIINYTEQLLRGLSYLH--- 120

Query: 262 HRRIIHRDIKASNILL-SEDYEAQISDFGLAKWLPDNWSHHIVFP--IEGTFGYLSPEYF 318
             +IIHRD+K +N+L+ S     +I+DFG A  L    +    F   + GT  +++PE  
Sbjct: 121 ENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVL 180

Query: 319 MHGIVDEKTDVFAFGVLLLELITGR 343
                    DV++ G +++E+ T +
Sbjct: 181 RGEQYGRSCDVWSVGCVIIEMATAK 205

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 87.3 bits (216), Expect = 3e-19
 Identities = 53/205 (25%), Positives = 96/205 (46%), Gaps = 24/205 (11%)

Query: 149 LIGKGGHAEVYKGC-LPDGEVVAVKKIIKNAKEDEER-----ISDFLSELGIVAHINHPN 202
           L+G G    V+KG  +P+G+ + +   IK  ++   R     I+D +  +G    ++H  
Sbjct: 14  LLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMG---SLDHAY 70

Query: 203 AAKLIGFSTENGFHLVLQFLPHGSLSSLL------FGSTECLEWTIRYKIALGIAEGLQY 256
             +L+G        LV Q  P GSL   +            L W ++      IA+G+ Y
Sbjct: 71  IVRLLGICPGASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQ------IAKGMYY 124

Query: 257 LHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEGTFGYLSPE 316
           L       ++HR++ A NILL  D   QI+DFG+A  L  +   +     +    +++ E
Sbjct: 125 LEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALE 181

Query: 317 YFMHGIVDEKTDVFAFGVLLLELIT 341
             + G    ++DV+++GV + E+++
Sbjct: 182 SILFGRYTHQSDVWSYGVTVWEMMS 206

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 86.8 bits (215), Expect = 3e-19
 Identities = 65/216 (30%), Positives = 109/216 (50%), Gaps = 27/216 (12%)

Query: 141 TDNFNSENLIGKGGHAEVYKGCLPDGEV-VAVKKIIKNAKEDEERISDFLSELGIVAHIN 199
            D      ++GKG +  VY       +V +A+K+I    + D   +     E+ + +++ 
Sbjct: 7   YDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEI---PERDSRYVQPLHEEIALHSYLK 63

Query: 200 HPNAAKLIGFSTENGFHLV-LQFLPHGSLSSLL---FGSTECLEWTIRYKIALGIAEGLQ 255
           H N  + +G  +ENGF  + ++ +P GSLS+LL   +G  +  E TI +     I EGL+
Sbjct: 64  HRNIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIF-YTKQILEGLK 122

Query: 256 YLHHDCHRRIIHRDIKASNILLSEDYEA--QISDFGLAKWLPDNWSHHIVFPI----EGT 309
           YLH +   +I+HRDIK  N+L++  Y    +ISDFG +K L        + P      GT
Sbjct: 123 YLHDN---QIVHRDIKGDNVLVNT-YSGVVKISDFGTSKRLAG------INPCTETFTGT 172

Query: 310 FGYLSPEYFMHGI--VDEKTDVFAFGVLLLELITGR 343
             Y++PE    G        D+++ G  ++E+ TG+
Sbjct: 173 LQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGK 208

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 86.6 bits (214), Expect = 4e-19
 Identities = 60/199 (30%), Positives = 98/199 (49%), Gaps = 15/199 (7%)

Query: 150 IGKGGHAEVYKGCLPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGF 209
           +G+G   EV+ G       VA+K +       E     FL E  ++  + H    +L   
Sbjct: 14  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA----FLQEAQVMKKLRHEKLVQLYAV 69

Query: 210 STENGFHLVLQFLPHGSLSSLLFGST-ECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHR 268
            +E   ++V +++  GSL   L G   + L       +A  IA G+ Y+        +HR
Sbjct: 70  VSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER---MNYVHR 126

Query: 269 DIKASNILLSEDYEAQISDFGLAKWLPDN---WSHHIVFPIEGTFGYLSPEYFMHGIVDE 325
           D++A+NIL+ E+   +++DFGLA+ + DN         FPI+ T    +PE  ++G    
Sbjct: 127 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWT----APEAALYGRFTI 182

Query: 326 KTDVFAFGVLLLELITGRR 344
           K+DV++FG+LL EL T  R
Sbjct: 183 KSDVWSFGILLTELTTKGR 201

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 86.6 bits (215), Expect = 4e-19
 Identities = 62/198 (31%), Positives = 97/198 (48%), Gaps = 19/198 (9%)

Query: 150 IGKGGHAEVYKG-CLPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIG 208
           IG G + +VYK   +  GE+VA+K +IK   E  +       E+ ++    HPN     G
Sbjct: 11  IGSGTYGDVYKARDIATGELVAIK-VIK--LEPGDDFEIIQQEISMLKECRHPNIVAYFG 67

Query: 209 -FSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAE---GLQYLHHDCHRR 264
            +   +   +V+++   GSL  +   +   L      +IA    E   GL YLH      
Sbjct: 68  SYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLS---ELQIAYVCRETLKGLAYLHE---TG 121

Query: 265 IIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEGTFGYLSPEYF---MHG 321
            IHRDIK +NILL+ED + +++DFG++  L    +    F I GT  +++PE       G
Sbjct: 122 KIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKSF-I-GTPYWMAPEVAAVERKG 179

Query: 322 IVDEKTDVFAFGVLLLEL 339
             D K D++A G+  +EL
Sbjct: 180 GYDGKCDIWALGITAIEL 197

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 87.0 bits (215), Expect = 4e-19
 Identities = 58/196 (29%), Positives = 102/196 (52%), Gaps = 13/196 (6%)

Query: 150 IGKGGHAEVYKGCLPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIG- 208
           +G G   +VYK    +   +A  K+I+   E+E  + D++ E+ I+A  NHP   KL+G 
Sbjct: 20  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEE--LEDYMVEIEILATCNHPYIVKLLGA 77

Query: 209 FSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHR 268
           F  +    ++++F P G++ +++      L       I   + E LQYLH     +IIHR
Sbjct: 78  FYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHS---MKIIHR 134

Query: 269 DIKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEGTFGYLSPEYFMHGIV----- 323
           D+KA N+LL+ D + +++DFG++            F   GT  +++PE  M   +     
Sbjct: 135 DLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFI--GTPYWMAPEVVMCETMKDTPY 192

Query: 324 DEKTDVFAFGVLLLEL 339
           D K D+++ G+ L+E+
Sbjct: 193 DYKADIWSLGITLIEM 208

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 86.4 bits (214), Expect = 6e-19
 Identities = 65/196 (33%), Positives = 99/196 (50%), Gaps = 15/196 (7%)

Query: 151 GKGGHAEVYKGCLPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIG-F 209
           G GG     K  +P G V+A K +   AK    +    L EL I+     P      G F
Sbjct: 16  GNGGSVSKVKH-IPTGTVMAKKVVHIGAKSSVRK--QILRELQIMHECRSPYIVSFYGAF 72

Query: 210 STENGFHLVLQFLPHGSLSSLL--FGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIH 267
             EN   + ++F+  GSL  +    G    +   I  KIA+ + EGL YL+ + HR I+H
Sbjct: 73  LNENNICMCMEFMDCGSLDRIYKKGGP---IPVEILGKIAVAVVEGLTYLY-NVHR-IMH 127

Query: 268 RDIKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEGTFGYLSPEYFMHGIVDEKT 327
           RDIK SNIL++   + ++ DFG++  L ++ +   V    GT  Y+SPE    G    K+
Sbjct: 128 RDIKPSNILVNSRGQIKLCDFGVSGELINSIADTFV----GTSTYMSPERIQGGKYTVKS 183

Query: 328 DVFAFGVLLLELITGR 343
           DV++ G+ ++EL  G+
Sbjct: 184 DVWSLGISIIELALGK 199

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 85.8 bits (212), Expect = 6e-19
 Identities = 61/199 (30%), Positives = 97/199 (48%), Gaps = 15/199 (7%)

Query: 150 IGKGGHAEVYKGCLPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGF 209
           +G G   EV+ G       VAVK +       E     FL E  I+  + H    +L   
Sbjct: 14  LGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPES----FLEEAQIMKKLRHDKLVQLYAV 69

Query: 210 STENGFHLVLQFLPHGSLSSLLF-GSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHR 268
            +E   ++V +++  GSL   L  G    L+      +A  +A G+ Y+        IHR
Sbjct: 70  VSEEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIER---MNYIHR 126

Query: 269 DIKASNILLSEDYEAQISDFGLAKWLPDN---WSHHIVFPIEGTFGYLSPEYFMHGIVDE 325
           D++++NIL+ +    +I+DFGLA+ + DN         FPI+ T    +PE  ++G    
Sbjct: 127 DLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWT----APEAALYGRFTI 182

Query: 326 KTDVFAFGVLLLELITGRR 344
           K+DV++FG+LL EL+T  R
Sbjct: 183 KSDVWSFGILLTELVTKGR 201

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score = 86.2 bits (214), Expect = 6e-19
 Identities = 56/200 (28%), Positives = 95/200 (47%), Gaps = 16/200 (8%)

Query: 150 IGKGGHAEVYKG-CLPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIG 208
           IG+G +  VYK      GE+VA+KKI K   E E      L E+ ++  +NHPN  KL+ 
Sbjct: 7   IGEGTYGVVYKARDKLTGEIVAIKKI-KLRFESEGIPKTALREIKLLKELNHPNIIKLLD 65

Query: 209 -FSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIH 267
            F  +   +LV +F+       +        E  I+      + +GL + H      I+H
Sbjct: 66  VFRHKGDLYLVFEFMDTDLYKLIKDRQRGLPESLIKS-YLYQLLQGLAFCHSH---GILH 121

Query: 268 RDIKASNILLSEDYEAQISDFGLAKWL---PDNWSHHIVFPIEGTFGYLSPE-YFMHGIV 323
           RD+K  N+L++ +   +++DFGLA+        ++H++V     T  Y +PE        
Sbjct: 122 RDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVV-----TRWYRAPELLLGDKGY 176

Query: 324 DEKTDVFAFGVLLLELITGR 343
               D+++ G +  EL++ R
Sbjct: 177 STPVDIWSVGCIFAELLSRR 196

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 86.2 bits (213), Expect = 6e-19
 Identities = 62/206 (30%), Positives = 105/206 (50%), Gaps = 26/206 (12%)

Query: 149 LIGKGGHAEVYKGC-LPDGEVVAVKKIIKNAKEDEERIS--DFLSELGIVAHINHPNAAK 205
           ++G G    VYKG  +PDGE V +   IK  +E+    +  + L E  ++A +  P   +
Sbjct: 14  VLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCR 73

Query: 206 LIGFSTENGFHLVLQFLPHGSLSSLL------FGSTECLEWTIRYKIALGIAEGLQYLHH 259
           L+G    +   LV Q +P+G L   +       GS + L W ++      IA+G+ YL  
Sbjct: 74  LLGICLTSTVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQ------IAKGMSYLEE 127

Query: 260 DCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLP-DNWSHHI---VFPIEGTFGYLSP 315
               R++HRD+ A N+L+      +I+DFGLA+ L  D   +H      PI+    +++ 
Sbjct: 128 ---VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIK----WMAL 180

Query: 316 EYFMHGIVDEKTDVFAFGVLLLELIT 341
           E  +H     ++DV+++GV + EL+T
Sbjct: 181 ESILHRRFTHQSDVWSYGVTVWELMT 206

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 85.9 bits (212), Expect = 7e-19
 Identities = 63/199 (31%), Positives = 100/199 (50%), Gaps = 15/199 (7%)

Query: 150 IGKGGHAEVYKGCLPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGF 209
           +G+G   EV+ G       VA+K +       E     FL E  I+  + H     L   
Sbjct: 14  LGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPEA----FLQEAQIMKKLRHDKLVPLYAV 69

Query: 210 STENGFHLVLQFLPHGSLSSLLF-GSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHR 268
            +E   ++V +F+  GSL   L  G  + L+      +A  IA+G+ Y+        IHR
Sbjct: 70  VSEEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIER---MNYIHR 126

Query: 269 DIKASNILLSEDYEAQISDFGLAKWLPDN---WSHHIVFPIEGTFGYLSPEYFMHGIVDE 325
           D++A+NIL+ ++   +I+DFGLA+ + DN         FPI+ T    +PE  ++G    
Sbjct: 127 DLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWT----APEAALYGRFTI 182

Query: 326 KTDVFAFGVLLLELITGRR 344
           K+DV++FG+LL EL+T  R
Sbjct: 183 KSDVWSFGILLTELVTKGR 201

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 86.3 bits (214), Expect = 1e-18
 Identities = 64/209 (30%), Positives = 105/209 (50%), Gaps = 18/209 (8%)

Query: 143 NFNSENLIGKGGHAEVYKG-CLPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHP 201
            F   N IG+G +  VY+      GE+VA+KK+  + + D   IS  L E+ ++ ++ HP
Sbjct: 8   EFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISS-LREITLLLNLRHP 66

Query: 202 NAAKL----IGFSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYL 257
           N  +L    +G   ++ F LV+++     L+SLL         +    + L +  GLQYL
Sbjct: 67  NIVELKEVVVGKHLDSIF-LVMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQYL 124

Query: 258 HHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSHHI--VFPIEGTFGYLSP 315
           H +    IIHRD+K SN+LL++    +I+DFGLA+     +      + P   T  Y +P
Sbjct: 125 HENF---IIHRDLKVSNLLLTDKGCLKIADFGLAR----TYGLPAKPMTPKVVTLWYRAP 177

Query: 316 EYFMHGIV-DEKTDVFAFGVLLLELITGR 343
           E  +         D++A G +L EL+  +
Sbjct: 178 ELLLGCTTYTTAIDMWAVGCILAELLAHK 206

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 85.5 bits (211), Expect = 1e-18
 Identities = 70/240 (29%), Positives = 110/240 (45%), Gaps = 23/240 (9%)

Query: 144 FNSENLIGKGGHAEVYKGCLPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNA 203
           F     IGKG   EV+KG     + V   KII + +E E+ I D   E+ +++  + P  
Sbjct: 6   FTKLERIGKGSFGEVFKGIDNRTQQVVAIKII-DLEEAEDEIEDIQQEITVLSQCDSPYV 64

Query: 204 AKLIG-FSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAE---GLQYLHH 259
            K  G +       +++++L  GS   LL            ++IA  + E   GL YLH 
Sbjct: 65  TKYYGSYLKGTKLWIIMEYLGGGSALDLLRAGP-----FDEFQIATMLKEILKGLDYLHS 119

Query: 260 DCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEGTFGYLSPEYFM 319
           +   + IHRDIKA+N+LLSE  + +++DFG+A  L D       F   GT  +++PE   
Sbjct: 120 E---KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV--GTPFWMAPEVIQ 174

Query: 320 HGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQ--------TSNFKELVD 371
               D K D+++ G+  +EL  G           V++  P           +  FKE +D
Sbjct: 175 QSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNNPPTLTGEFSKPFKEFID 234

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score = 85.4 bits (212), Expect = 1e-18
 Identities = 63/209 (30%), Positives = 100/209 (47%), Gaps = 28/209 (13%)

Query: 150 IGKGGHAEVY---KGCLPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKL 206
           I KG +  V+   K     G++ A+K I K     + ++   L+E  I++    P   KL
Sbjct: 1   ISKGAYGRVFLAKKKST--GDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKL 58

Query: 207 I-GFSTENGFHLVLQFLPHGSLSSLL--FGSTECLEWTIRYKIALGIAEGLQYLHHDCHR 263
              F  +   +LV+++LP G L+SLL   GS +  E   R  IA  I   L+YLH +   
Sbjct: 59  YYSFQGKKNLYLVMEYLPGGDLASLLENVGSLD--EDVARIYIA-EIVLALEYLHSN--- 112

Query: 264 RIIHRDIKASNILLSEDYEAQISDFGLAK-------WLPDNWSHHIVFPIEGTFGYLSPE 316
            IIHRD+K  NIL+  +   +++DFGL+K          ++        I GT  Y++PE
Sbjct: 113 GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDK-RIVGTPDYIAPE 171

Query: 317 YFM---HGIVDEKTDVFAFGVLLLELITG 342
             +   H    +  D ++ G +L E + G
Sbjct: 172 VILGQGHS---KTVDWWSLGCILYEFLVG 197

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score = 85.4 bits (212), Expect = 1e-18
 Identities = 62/208 (29%), Positives = 97/208 (46%), Gaps = 31/208 (14%)

Query: 150 IGKGGHAEVYK-GCLPDGEVVAVKKIIKNAKEDEERISD-FLSELGIVAHINHPNAAKLI 207
           IG+G H  V+K      GE VA+KK+    +  E  I +  L E+  +    HP   KL+
Sbjct: 8   IGEGAHGIVFKAKDRETGETVALKKV--ALRRLEGGIPNQALREIKALQACQHPYVVKLL 65

Query: 208 GFSTE-NGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRII 266
                 +GF LV++++P   LS +L      L           + +G+ Y+H +    I+
Sbjct: 66  DVFPHGSGFVLVMEYMPS-DLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHAN---GIM 121

Query: 267 HRDIKASNILLSEDYEAQISDFGLAKWL----PDNWSHHIVFPIEGTFGYLSPE------ 316
           HRD+K +N+L+S D   +I+DFGLA+      P  +SH +      T  Y +PE      
Sbjct: 122 HRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQV-----ATRWYRAPELLYGAR 176

Query: 317 -YFMHGIVDEKTDVFAFGVLLLELITGR 343
            Y      D   D++A G +  EL+ G 
Sbjct: 177 KY------DPGVDLWAVGCIFAELLNGS 198

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 85.8 bits (212), Expect = 1e-18
 Identities = 63/226 (27%), Positives = 107/226 (47%), Gaps = 43/226 (19%)

Query: 150 IGKGGHAEVYKGC------LPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNA 203
           +G+G   +V K              VAVK + +NA   E R  D LSE  ++  +NHP+ 
Sbjct: 8   LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELR--DLLSEFNLLKQVNHPHV 65

Query: 204 AKLIGFSTENG-FHLVLQFLPHGSLSSLLFGS-----------------------TECLE 239
            KL G  +++G   L++++  +GSL S L  S                          L 
Sbjct: 66  IKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALT 125

Query: 240 WTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWS 299
                  A  I+ G+QYL      +++HRD+ A N+L++E  + +ISDFGL++ + +  S
Sbjct: 126 MGDLISFAWQISRGMQYL---AEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDS 182

Query: 300 H----HIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELIT 341
           +        P++    +++ E     I   ++DV++FGVLL E++T
Sbjct: 183 YVKRSKGRIPVK----WMAIESLFDHIYTTQSDVWSFGVLLWEIVT 224

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score = 85.3 bits (212), Expect = 1e-18
 Identities = 61/226 (26%), Positives = 102/226 (45%), Gaps = 51/226 (22%)

Query: 143 NFNSENLIGKGGHAEVYKGC-LPDGEVVAVKKIIKNA-KEDEERISDF--LSELGIVAHI 198
            +     +G+G +A VYK      G +VA+KKI     KE ++ I +F  L E+ ++  +
Sbjct: 1   RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGI-NFTALREIKLLQEL 59

Query: 199 NHPNAAKLIG-FSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYK-----------I 246
            HPN   L+  F  ++  +LV +F+            T+ LE  I+ K            
Sbjct: 60  KHPNIIGLLDVFGHKSNINLVFEFME-----------TD-LEKVIKDKSIVLTPADIKSY 107

Query: 247 ALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPD---NWSHHIV 303
            L    GL+YLH      I+HRD+K +N+L++ D   +++DFGLA+         +H +V
Sbjct: 108 MLMTLRGLEYLHS---NWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVV 164

Query: 304 FPIEGTFGYLSPEYFM------HGIVDEKTDVFAFGVLLLELITGR 343
                T  Y +PE          G+     D+++ G +  EL+   
Sbjct: 165 -----TRWYRAPELLFGARHYGVGV-----DMWSVGCIFAELLLRV 200

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 85.2 bits (211), Expect = 2e-18
 Identities = 66/198 (33%), Positives = 99/198 (50%), Gaps = 21/198 (10%)

Query: 150 IGKGGHAEVYKG-CLPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIG 208
           IG G    VY    +   EVVA+KK+  + K+  E+  D + E+  +  + HPN  +  G
Sbjct: 23  IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKG 82

Query: 209 -FSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIH 267
            +  E+   LV+++   GS S +L    + L+      I  G  +GL YLH   H RI H
Sbjct: 83  CYLREHTAWLVMEYCL-GSASDILEVHKKPLQEVEIAAICHGALQGLAYLHS--HERI-H 138

Query: 268 RDIKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIE---GTFGYLSPEYFM---HG 321
           RDIKA NILL+E    +++DFG         S  +V P     GT  +++PE  +    G
Sbjct: 139 RDIKAGNILLTEPGTVKLADFG---------SASLVSPANSFVGTPYWMAPEVILAMDEG 189

Query: 322 IVDEKTDVFAFGVLLLEL 339
             D K DV++ G+  +EL
Sbjct: 190 QYDGKVDVWSLGITCIEL 207

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 83.7 bits (207), Expect = 3e-18
 Identities = 65/248 (26%), Positives = 112/248 (45%), Gaps = 28/248 (11%)

Query: 169 VAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTENG-FHLVLQFLPHGSL 227
           VA+K I + A  +E    DF+ E  ++  ++HP   +L G  T+    ++V +F+ +G L
Sbjct: 31  VAIKAINEGAMSEE----DFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFMENGCL 86

Query: 228 SSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISD 287
            + L      L   +   +   + EG++YL  +     IHRD+ A N L+S     ++SD
Sbjct: 87  LNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERN---SFIHRDLAARNCLVSSTGVVKVSD 143

Query: 288 FGLAKWLPDNW---SHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELIT-GR 343
           FG+ +++ D+    S    FP++    +  PE F       K+DV++FGVL+ E+ T G+
Sbjct: 144 FGMTRYVLDDEYTSSSGAKFPVK----WSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGK 199

Query: 344 RAVDSRRQSLVIWAKPLLQTSNFKELVDPRLADAYDLAEMKRAMLTASVCIHHLSTMRPQ 403
              + +    V+        S    L  P+LA       M         C H     RP 
Sbjct: 200 MPFEKKSNYEVVEM-----ISRGFRLYRPKLASMTVYEVMYS-------CWHEKPEGRPT 247

Query: 404 MTRVLQLL 411
              +L+ +
Sbjct: 248 FAELLRAI 255

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 84.1 bits (208), Expect = 4e-18
 Identities = 62/231 (26%), Positives = 98/231 (42%), Gaps = 52/231 (22%)

Query: 144 FNSENL-----IGKGGHAEVYKG-----CLPDGE-VVAVKKIIKNAKEDEERISDFLSEL 192
           F   NL     +G+G   EV+           GE +V VK +     +DE   S+F  EL
Sbjct: 2   FPRSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKAL--QKTKDENLQSEFRREL 59

Query: 193 GIVAHINHPNAAKLIGFSTENGFH-LVLQFLPHGSLSSLLFGSTECLEW------TIRYK 245
            +   ++H N  +L+G   E   H ++L++   G L   L  +    E       + + K
Sbjct: 60  DMFRKLSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQK 119

Query: 246 IALG--IAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAK----------- 292
           +AL   IA G+ +L +    R +HRD+ A N L+S   E ++S   L+K           
Sbjct: 120 VALCTQIALGMDHLSNA---RFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLR 176

Query: 293 --WLPDNWSHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELIT 341
              +P  W              L+PE         K+DV++FGVL+ E+ T
Sbjct: 177 NALIPLRW--------------LAPEAVQEDDFSTKSDVWSFGVLMWEVFT 213

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 83.7 bits (207), Expect = 4e-18
 Identities = 64/222 (28%), Positives = 106/222 (47%), Gaps = 47/222 (21%)

Query: 150 IGKGGHAEVYKGCL--PDGEVVAVKKIIKNAKEDEE--RISDFLSELGIVAHINHPNAAK 205
           +G+G   +VYKG L  P+  + A    IK  KE+ E     +F  E  +++ + HPN   
Sbjct: 13  LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVC 72

Query: 206 LIGFST-ENGFHLVLQFLPHGSLSSLLF------------------GSTECLEWTIRYKI 246
           L+G  T E    ++ ++L HG L   L                    S +C ++     I
Sbjct: 73  LLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFL---HI 129

Query: 247 ALGIAEGLQYL--HHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWS----- 299
           A+ IA G++YL  HH      +HRD+ A N L+ E    +ISDFGL++   D +S     
Sbjct: 130 AIQIAAGMEYLSSHH-----FVHRDLAARNCLVGEGLTVKISDFGLSR---DIYSADYYR 181

Query: 300 --HHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLEL 339
                + P+     ++ PE  ++G    ++D+++FGV+L E+
Sbjct: 182 VQSKSLLPVR----WMPPEAILYGKFTTESDIWSFGVVLWEI 219

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 83.5 bits (206), Expect = 5e-18
 Identities = 58/196 (29%), Positives = 99/196 (50%), Gaps = 13/196 (6%)

Query: 150 IGKGGHAEVYKGCLPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLI-G 208
           +G G   +VYK    +  V+A  K+I    E+E  + D++ E+ I+A  +HPN  KL+  
Sbjct: 13  LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEE--LEDYMVEIDILASCDHPNIVKLLDA 70

Query: 209 FSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHR 268
           F  EN   ++++F   G++ +++      L       +     E L YLH +   +IIHR
Sbjct: 71  FYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHEN---KIIHR 127

Query: 269 DIKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEGTFGYLSPEYFMHGI-----V 323
           D+KA NIL + D + +++DFG++            F   GT  +++PE  M         
Sbjct: 128 DLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI--GTPYWMAPEVVMCETSKDRPY 185

Query: 324 DEKTDVFAFGVLLLEL 339
           D K DV++ G+ L+E+
Sbjct: 186 DYKADVWSLGITLIEM 201

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 82.8 bits (204), Expect = 6e-18
 Identities = 65/204 (31%), Positives = 102/204 (50%), Gaps = 19/204 (9%)

Query: 147 ENLIGKGGHAEVYKGCLPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKL 206
           E  +G G   EV+         VAVK +    K     +  FL+E  ++  + H    KL
Sbjct: 11  EKKLGAGQFGEVWMATYNKHTKVAVKTM----KPGSMSVEAFLAEANVMKTLQHDKLVKL 66

Query: 207 IGFSTENGFHLVLQFLPHGSLSSLLF---GSTECLEWTIRYKIALGIAEGLQYLHHDCHR 263
               T+   +++ +F+  GSL   L    GS + L   I +  +  IAEG+ ++     R
Sbjct: 67  HAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDF--SAQIAEGMAFIEQ---R 121

Query: 264 RIIHRDIKASNILLSEDYEAQISDFGLAKWLPDN---WSHHIVFPIEGTFGYLSPEYFMH 320
             IHRD++A+NIL+S     +I+DFGLA+ + DN         FPI+ T    +PE    
Sbjct: 122 NYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWT----APEAINF 177

Query: 321 GIVDEKTDVFAFGVLLLELITGRR 344
           G    K+DV++FG+LL+E++T  R
Sbjct: 178 GSFTIKSDVWSFGILLMEIVTYGR 201

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score = 83.3 bits (206), Expect = 6e-18
 Identities = 60/219 (27%), Positives = 103/219 (47%), Gaps = 39/219 (17%)

Query: 150 IGKGGHAEVYKG-C---LPDGE--VVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNA 203
           +G+G   +V+ G C    P+ +  +VAVK  +K    ++ R  DF  E  ++ +  H N 
Sbjct: 13  LGEGAFGKVFLGECYHLEPENDKELVAVK-TLKETASNDAR-KDFEREAELLTNFQHENI 70

Query: 204 AKLIGFSTENG-FHLVLQFLPHGSLSSLL-----------FGSTECLEWTIR--YKIALG 249
            K  G  TE     +V +++ HG L+  L              +   E T+    +IA+ 
Sbjct: 71  VKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQ 130

Query: 250 IAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSH-------HI 302
           IA G+ YL     +  +HRD+   N L+  D   +I DFG+++   D ++        H 
Sbjct: 131 IASGMVYL---ASQHFVHRDLATRNCLVGYDLVVKIGDFGMSR---DVYTTDYYRVGGHT 184

Query: 303 VFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELIT 341
           + PI     ++ PE  M+     ++DV++FGV+L E+ T
Sbjct: 185 MLPIR----WMPPESIMYRKFTTESDVWSFGVVLWEIFT 219

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 82.8 bits (204), Expect = 8e-18
 Identities = 62/199 (31%), Positives = 99/199 (49%), Gaps = 20/199 (10%)

Query: 150 IGKGGHAEVYKGCLPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGF 209
           +G G   EV+ G   +   VAVK +    K     +  FL E  ++  + H    +L   
Sbjct: 14  LGAGQFGEVWMGYYNNSTKVAVKTL----KPGTMSVQAFLEEANLMKTLQHDKLVRLYAV 69

Query: 210 ST-ENGFHLVLQFLPHGSLSSLL---FGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRI 265
            T E   +++ +++  GSL   L    G    L   I +  +  IAEG+ Y+     +  
Sbjct: 70  VTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDF--SAQIAEGMAYIER---KNY 124

Query: 266 IHRDIKASNILLSEDYEAQISDFGLAKWLPDN---WSHHIVFPIEGTFGYLSPEYFMHGI 322
           IHRD++A+N+L+SE    +I+DFGLA+ + DN         FPI+ T    +PE    G 
Sbjct: 125 IHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWT----APEAINFGS 180

Query: 323 VDEKTDVFAFGVLLLELIT 341
              K+DV++FG+LL E++T
Sbjct: 181 FTIKSDVWSFGILLYEIVT 199

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 83.7 bits (207), Expect = 1e-17
 Identities = 71/208 (34%), Positives = 97/208 (46%), Gaps = 29/208 (13%)

Query: 148 NLIGKGGHAEVYKGC-LPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKL 206
           N IG G    VYK    P G + A+K I  N  ED  R      E+ I+  +NHPN  K 
Sbjct: 80  NRIGSGAGGTVYKVIHRPTGRLYALKVIYGN-HEDTVRRQ-ICREIEILRDVNHPNVVKC 137

Query: 207 IGFSTENG-FHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRI 265
                 NG   ++L+F+  GSL        + L       +A  I  G+ YLH    R I
Sbjct: 138 HDMFDHNGEIQVLLEFMDGGSLEGTHIADEQFLA-----DVARQILSGIAYLHR---RHI 189

Query: 266 IHRDIKASNILLSEDYEAQISDFGLAKWL-----PDNWSHHIVFPIEGTFGYLSPEY--- 317
           +HRDIK SN+L++     +I+DFG+++ L     P N S        GT  Y+SPE    
Sbjct: 190 VHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSS-------VGTIAYMSPERINT 242

Query: 318 -FMHGIVDEKT-DVFAFGVLLLELITGR 343
              HG  D    D+++ GV +LE   GR
Sbjct: 243 DLNHGAYDGYAGDIWSLGVSILEFYLGR 270

Length = 353

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 82.4 bits (203), Expect = 2e-17
 Identities = 73/221 (33%), Positives = 108/221 (48%), Gaps = 20/221 (9%)

Query: 128 SWKNFDFAELAAATDN---FNSENLIGKGGHAEVYKGC-LPDGEVVAVKKIIKNAKEDEE 183
           S K+ + AEL    D    F     IG G    VY    +   EVVA+KK+  + K+  E
Sbjct: 8   SLKDPEIAELFFKEDPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNE 67

Query: 184 RISDFLSELGIVAHINHPNAAKLIG-FSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTI 242
           +  D + E+  +  I HPN+ +  G +  E+   LV+++   GS S LL    + L+   
Sbjct: 68  KWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEYC-LGSASDLLEVHKKPLQEVE 126

Query: 243 RYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWL-PDNWSHH 301
              I  G  +GL YLH      +IHRDIKA NILL+E  + +++DFG A    P N    
Sbjct: 127 IAAITHGALQGLAYLHS---HNMIHRDIKAGNILLTEPGQVKLADFGSASIASPAN---- 179

Query: 302 IVFPIEGTFGYLSPEYFM---HGIVDEKTDVFAFGVLLLEL 339
                 GT  +++PE  +    G  D K DV++ G+  +EL
Sbjct: 180 ---SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 217

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score = 81.6 bits (202), Expect = 2e-17
 Identities = 61/210 (29%), Positives = 97/210 (46%), Gaps = 33/210 (15%)

Query: 149 LIGKGGHAEVYKGC--LPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKL 206
           ++G+G +  V K C     GE+VA+KK  K +++DE+     L E+ ++  + H N   L
Sbjct: 8   VVGEGAYGVVLK-CRNKATGEIVAIKKF-KESEDDEDVKKTALREVKVLRQLRHENIVNL 65

Query: 207 I-GFSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEG-------LQYLH 258
              F  +   +LV +++      +LL    E LE        L            LQ + 
Sbjct: 66  KEAFRRKGRLYLVFEYVER----TLL----ELLE---ASPGGLPPDAVRSYIWQLLQAIA 114

Query: 259 HDCHRR-IIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEGTFGYLSPE- 316
           + CH   IIHRDIK  NIL+SE    ++ DFG A+ L    +  +   +  T  Y +PE 
Sbjct: 115 Y-CHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYV-ATRWYRAPEL 172

Query: 317 ---YFMHGIVDEKTDVFAFGVLLLELITGR 343
                 +G   +  DV+A G ++ EL+ G 
Sbjct: 173 LVGDTNYG---KPVDVWAIGCIMAELLDGE 199

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 81.5 bits (201), Expect = 3e-17
 Identities = 62/210 (29%), Positives = 108/210 (51%), Gaps = 20/210 (9%)

Query: 147 ENLIGKGGHAEVYKGCL-PDG--EVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNA 203
           E +IG G   EV +G L   G  E+    K +K+   +++R  DFLSE  I+   +HPN 
Sbjct: 9   EEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQR-RDFLSEASIMGQFDHPNI 67

Query: 204 AKLIGFSTENGFHLVL-QFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCH 262
             L G  T++   +++ +F+ +G+L S L  +           +  GIA G++YL     
Sbjct: 68  IHLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYL---SE 124

Query: 263 RRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSHHIV-------FPIEGTFGYLSP 315
              +HRD+ A NIL++ +   ++SDFGL+++L D+ S            PI  T    +P
Sbjct: 125 MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWT----AP 180

Query: 316 EYFMHGIVDEKTDVFAFGVLLLELIT-GRR 344
           E   +      +DV+++G+++ E+++ G R
Sbjct: 181 EAIAYRKFTSASDVWSYGIVMWEVMSYGER 210

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 81.4 bits (201), Expect = 3e-17
 Identities = 62/199 (31%), Positives = 91/199 (45%), Gaps = 13/199 (6%)

Query: 150 IGKGGHAEVYKGC--LPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKL- 206
           +GKGG  EV   C     G++ A KK+ K   +  +     L+E  I+  ++      L 
Sbjct: 1   LGKGGFGEVC-ACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLA 59

Query: 207 IGFSTENGFHLVLQFLPHGSLSSLLF--GSTECLEWTIRYKIALGIAEGLQYLHHDCHRR 264
             F T++   LV+  +  G L   ++  G     E    +  A  I  GL++LH    RR
Sbjct: 60  YAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAA-QIICGLEHLHQ---RR 115

Query: 265 IIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEGTFGYLSPEYFMHGIVD 324
           I++RD+K  N+LL +    +ISD GLA  L             GT GY++PE     + D
Sbjct: 116 IVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIK---GRAGTPGYMAPEVLQGEVYD 172

Query: 325 EKTDVFAFGVLLLELITGR 343
              D FA G  L E+I GR
Sbjct: 173 FSVDWFALGCTLYEMIAGR 191

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 81.6 bits (201), Expect = 3e-17
 Identities = 81/274 (29%), Positives = 126/274 (45%), Gaps = 32/274 (11%)

Query: 150 IGKGGHAEVYKGC-LPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIG 208
           IG G    VY        EVVAVKK+  + K+  E+  D + E+  +  + HPN  +  G
Sbjct: 29  IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKG 88

Query: 209 -FSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIH 267
            +  E+   LV+++   GS S LL    + L+      I  G  +GL YLH      +IH
Sbjct: 89  CYLKEHTAWLVMEYC-LGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN---MIH 144

Query: 268 RDIKASNILLSEDYEAQISDFGLA-KWLPDNWSHHIVFPIEGTFGYLSPEYFM---HGIV 323
           RDIKA NILL+E  + +++DFG A K  P N          GT  +++PE  +    G  
Sbjct: 145 RDIKAGNILLTEPGQVKLADFGSASKSSPAN-------SFVGTPYWMAPEVILAMDEGQY 197

Query: 324 DEKTDVFAFGVLLLELITGRRAVDSRRQSLVIW-----AKPLLQ----TSNFKELVDPRL 374
           D K DV++ G+  +EL   +  + +      ++       P LQ    T +F+  VD   
Sbjct: 198 DGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLQSNEWTDSFRGFVD--- 254

Query: 375 ADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVL 408
              Y L ++ +    ++  + H    R +  RVL
Sbjct: 255 ---YCLQKIPQERPASAELLRHDFVRRDRPARVL 285

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 81.4 bits (201), Expect = 3e-17
 Identities = 62/232 (26%), Positives = 108/232 (46%), Gaps = 41/232 (17%)

Query: 142 DNFNSENLIGKGGHAEVYK----GCLPDGE--VVAVKKIIKNAKEDEERISDFLSELGIV 195
           +N      IG+G    V++    G LP     +VAVK + + A  D +  +DF  E  ++
Sbjct: 5   NNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQ--ADFQREAALM 62

Query: 196 AHINHPNAAKLIGFSTENG-FHLVLQFLPHGSLS------------SLLFGSTEC----- 237
           A  +HPN  KL+G         L+ +++ +G L+            SL   ++       
Sbjct: 63  AEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGL 122

Query: 238 ----LEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAK- 292
               L  T +  IA  +A G+ YL     R+ +HRD+   N L+ E+   +I+DFGL++ 
Sbjct: 123 NPLPLSCTEQLCIAKQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSRN 179

Query: 293 -WLPDNW--SHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELIT 341
            +  D +  S +   PI     ++ PE   +     ++DV+A+GV+L E+ +
Sbjct: 180 IYSADYYKASENDAIPIR----WMPPESIFYNRYTTESDVWAYGVVLWEIFS 227

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 81.1 bits (201), Expect = 5e-17
 Identities = 61/217 (28%), Positives = 97/217 (44%), Gaps = 39/217 (17%)

Query: 142 DNFNSENLIGKGGHAEVYKGCL----PDGEVVAVK-----KIIKNAKEDEERISDFLSEL 192
           D+F     +G G    V    L      G+  A+K     KI+K  + +       L+E 
Sbjct: 1   DDFEFIKTLGTGSFGRV---MLVRHKGSGKYYALKILSKAKIVKLKQVEH-----VLNEK 52

Query: 193 GIVAHINHPNAAKLIG-FSTENGFHLVLQFLPHGSLSSLL-----FGSTECLEWTIRYKI 246
            I+  I HP    L G F  ++  +LV++++P G L S L     F           Y  
Sbjct: 53  RILQSIRHPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGRFP----EPVARFY-- 106

Query: 247 ALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDN-WSHHIVFP 305
           A  +   L+YLH      I++RD+K  N+LL  D   +I+DFG AK +    ++      
Sbjct: 107 AAQVVLALEYLHS---LDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGRTYT------ 157

Query: 306 IEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITG 342
           + GT  YL+PE  +     +  D +A G+L+ E++ G
Sbjct: 158 LCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAG 194

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 80.1 bits (197), Expect = 5e-17
 Identities = 58/196 (29%), Positives = 94/196 (47%), Gaps = 17/196 (8%)

Query: 150 IGKGGHAEVYKGCL-PDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIG 208
           IG+G   EV+ G L  D   VAVK   +    D +  + FL E  I+   +HPN  +LIG
Sbjct: 3   IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLK--AKFLQEARILKQYSHPNIVRLIG 60

Query: 209 FSTE-NGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIH 267
             T+    ++V++ +  G   + L      L+     ++    A G++YL        IH
Sbjct: 61  VCTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKH---CIH 117

Query: 268 RDIKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEGTF-----GYLSPEYFMHGI 322
           RD+ A N L++E    +ISDFG+++   D      V+   G        + +PE   +G 
Sbjct: 118 RDLAARNCLVTEKNVLKISDFGMSREEEDG-----VYASTGGMKQIPVKWTAPEALNYGR 172

Query: 323 VDEKTDVFAFGVLLLE 338
              ++DV++FG+LL E
Sbjct: 173 YSSESDVWSFGILLWE 188

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 80.4 bits (199), Expect = 6e-17
 Identities = 54/166 (32%), Positives = 82/166 (49%), Gaps = 23/166 (13%)

Query: 140 ATDNFNSENLIGKGGHAEVYKGC-LPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHI 198
            T  F    +IG+G + +VYK      G++VA+K I+   +++EE I     E  I+   
Sbjct: 4   PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIK-IMDIIEDEEEEI---KEEYNILRKY 59

Query: 199 -NHPNAAKLIGFSTENGFH-------LVLQFLPHGSLSSLLFGSTECL-----EWTIRYK 245
            NHPN A   G   +           LV++    GS++ L+ G  +       EW I Y 
Sbjct: 60  SNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEW-IAY- 117

Query: 246 IALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLA 291
           I      GL YLH     ++IHRDIK  NILL+++ E ++ DFG++
Sbjct: 118 ILRETLRGLAYLHE---NKVIHRDIKGQNILLTKNAEVKLVDFGVS 160

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 80.6 bits (199), Expect = 9e-17
 Identities = 65/199 (32%), Positives = 105/199 (52%), Gaps = 12/199 (6%)

Query: 149 LIGKGGHAEVY---KGCLPD-GEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAA 204
           ++G+G   +V+   K   PD G++ A+K + K   +  +R+   + E  I+A +NHP   
Sbjct: 3   VLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKM-ERDILAEVNHPFIV 61

Query: 205 KL-IGFSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHR 263
           KL   F TE   +L+L FL  G L + L       E  +++ +A  +A  L +LH     
Sbjct: 62  KLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLA-ELALALDHLHS---L 117

Query: 264 RIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEGTFGYLSPEYFMHGIV 323
            II+RD+K  NILL E+   +++DFGL+K   D+      F   GT  Y++PE       
Sbjct: 118 GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFC--GTVEYMAPEVVNRRGH 175

Query: 324 DEKTDVFAFGVLLLELITG 342
            +  D ++FGVL+ E++TG
Sbjct: 176 TQSADWWSFGVLMFEMLTG 194

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 80.0 bits (197), Expect = 9e-17
 Identities = 60/220 (27%), Positives = 114/220 (51%), Gaps = 38/220 (17%)

Query: 147 ENLIGKGGHAEVYKGCLP-DGEVV--AVKKIIKNAKEDEERISDFLSELGIVAHI-NHPN 202
           E++IG+G   +V +  +  DG  +  A+K + + A E++ R  DF  EL ++  + +HPN
Sbjct: 7   EDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHR--DFAGELEVLCKLGHHPN 64

Query: 203 AAKLIGFSTENGF-HLVLQFLPHGSLSSLL---------------FGSTECLEWTIRYKI 246
              L+G     G+ ++ +++ P+G+L   L                G+   L      + 
Sbjct: 65  IINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQF 124

Query: 247 ALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPI 306
           A  +A G+QYL     ++ IHRD+ A N+L+ E+  ++I+DFGL++          V+ +
Sbjct: 125 ASDVATGMQYL---SEKQFIHRDLAARNVLVGENLASKIADFGLSR-------GEEVY-V 173

Query: 307 EGTFG-----YLSPEYFMHGIVDEKTDVFAFGVLLLELIT 341
           + T G     +++ E   + +   K+DV++FGVLL E+++
Sbjct: 174 KKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 80.4 bits (198), Expect = 9e-17
 Identities = 57/200 (28%), Positives = 105/200 (52%), Gaps = 31/200 (15%)

Query: 164 PDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHIN-HPNAAKLIGFSTENG-FHLVLQF 221
           PD  V    K++K+   D++ ++D +SE+ ++  I  H N   L+G  T+ G  ++++++
Sbjct: 41  PDQTVTVAVKMLKDNATDKD-LADLISEMELMKLIGKHKNIINLLGVCTQEGPLYVIVEY 99

Query: 222 LPHGSLSSLL-----------FGSTECLEWTIRYK----IALGIAEGLQYLHHDCHRRII 266
              G+L   L           F  T+  E  + +K     A  +A G++YL     RR I
Sbjct: 100 AAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLES---RRCI 156

Query: 267 HRDIKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEGTFG-----YLSPEYFMHG 321
           HRD+ A N+L++ED   +I+DFGLA+ +     H I +  + + G     +++PE     
Sbjct: 157 HRDLAARNVLVTEDNVMKIADFGLARGV-----HDIDYYKKTSNGRLPVKWMAPEALFDR 211

Query: 322 IVDEKTDVFAFGVLLLELIT 341
           +   ++DV++FG+L+ E+ T
Sbjct: 212 VYTHQSDVWSFGILMWEIFT 231

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 78.1 bits (192), Expect = 2e-16
 Identities = 67/214 (31%), Positives = 101/214 (47%), Gaps = 50/214 (23%)

Query: 150 IGKGGHAEVYKGCLPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGF 209
           IGKG   +V  G    G  VAVK I  +A         FL+E  ++  + H N  +L+G 
Sbjct: 14  IGKGEFGDVMLGDY-RGNKVAVKCIKNDATAQA-----FLAEASVMTQLRHSNLVQLLGV 67

Query: 210 STEN--GFHLVLQFLPHGSL--------SSLLFGSTECLEWTIRYKIALGIAEGLQYLHH 259
             E   G ++V +++  GSL         S+L G  +CL      K +L + E ++YL  
Sbjct: 68  IVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGG--DCL-----LKFSLDVCEAMEYLEA 120

Query: 260 DCHRRIIHRDIKASNILLSEDYEAQISDFGLAKW---------LPDNWSHHIVFPIEGTF 310
           +     +HRD+ A N+L+SED  A++SDFGL K          LP  W+           
Sbjct: 121 N---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWT----------- 166

Query: 311 GYLSPEYFMHGIVDEKTDVFAFGVLLLELIT-GR 343
              +PE         K+DV++FG+LL E+ + GR
Sbjct: 167 ---APEALREKKFSTKSDVWSFGILLWEIYSFGR 197

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 79.3 bits (196), Expect = 3e-16
 Identities = 53/163 (32%), Positives = 83/163 (50%), Gaps = 15/163 (9%)

Query: 140 ATDNFNSENLIGKGGHAEVYKG-CLPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHI 198
              ++     +G+G   EVYK   +  G VVA+KKI+ + ++D   I+  L E+ I+  +
Sbjct: 6   KLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITA-LREIKILKKL 64

Query: 199 NHPNAAKLIGFSTENG---------FHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALG 249
            HPN   LI  + E            ++V  ++ H  LS LL   +  L  +      L 
Sbjct: 65  KHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQ 123

Query: 250 IAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAK 292
           + EG+ YLH +    I+HRDIKA+NIL+      +I+DFGLA+
Sbjct: 124 LLEGINYLHEN---HILHRDIKAANILIDNQGILKIADFGLAR 163

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 78.9 bits (194), Expect = 3e-16
 Identities = 60/195 (30%), Positives = 105/195 (53%), Gaps = 32/195 (16%)

Query: 169 VAVKKIIKNAKEDEERISDFLSELGIVAHI-NHPNAAKLIGFSTENG-FHLVLQFLPHGS 226
           VAVK +  +A E +  +SD +SE+ ++  I  H N   L+G  T++G  ++++++   G+
Sbjct: 53  VAVKMLKSDATEKD--LSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGN 110

Query: 227 LSSLL-----------FGSTECLEWTIRYK----IALGIAEGLQYLHHDCHRRIIHRDIK 271
           L   L           +  T+  E  + +K     A  +A G++YL     ++ IHRD+ 
Sbjct: 111 LREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYL---ASKKCIHRDLA 167

Query: 272 ASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEGTFG-----YLSPEYFMHGIVDEK 326
           A N+L++ED   +I+DFGLA+ +     HHI +  + T G     +++PE     I   +
Sbjct: 168 ARNVLVTEDNVMKIADFGLARDI-----HHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQ 222

Query: 327 TDVFAFGVLLLELIT 341
           +DV++FGVLL E+ T
Sbjct: 223 SDVWSFGVLLWEIFT 237

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 78.8 bits (194), Expect = 3e-16
 Identities = 57/180 (31%), Positives = 89/180 (49%), Gaps = 11/180 (6%)

Query: 166 GEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTENG---FHLVLQFL 222
           GE+VAVK + +   +     S +  E+ I+  + H N  K  G  +E G     L+++++
Sbjct: 33  GEMVAVKTLKRECGQQNT--SGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLIMEYV 90

Query: 223 PHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYE 282
           P GSL   L      L   + +  A  I EG+ YLH    +  IHRD+ A N+LL  D  
Sbjct: 91  PLGSLRDYLPKHKLNLAQLLLF--AQQICEGMAYLHS---QHYIHRDLAARNVLLDNDRL 145

Query: 283 AQISDFGLAKWLPDNWSHHIVFPI-EGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELIT 341
            +I DFGLAK +P+   ++ V    +    + + E          +DV++FGV L EL+T
Sbjct: 146 VKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLT 205

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 78.6 bits (193), Expect = 4e-16
 Identities = 64/198 (32%), Positives = 98/198 (49%), Gaps = 21/198 (10%)

Query: 150 IGKGGHAEVYKGC-LPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIG 208
           IG G    VY    + + EVVA+KK+  + K+  E+  D + E+  +  + HPN  +  G
Sbjct: 23  IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG 82

Query: 209 -FSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIH 267
            +  E+   LV+++   GS S LL    + L+      +  G  +GL YLH      +IH
Sbjct: 83  CYLREHTAWLVMEYC-LGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHS---HNMIH 138

Query: 268 RDIKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIE---GTFGYLSPEYFM---HG 321
           RD+KA NILLSE    ++ DFG         S  I+ P     GT  +++PE  +    G
Sbjct: 139 RDVKAGNILLSEPGLVKLGDFG---------SASIMAPANXFVGTPYWMAPEVILAMDEG 189

Query: 322 IVDEKTDVFAFGVLLLEL 339
             D K DV++ G+  +EL
Sbjct: 190 QYDGKVDVWSLGITCIEL 207

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 78.5 bits (193), Expect = 4e-16
 Identities = 64/221 (28%), Positives = 114/221 (51%), Gaps = 40/221 (18%)

Query: 147 ENLIGKGGHAEVYKGCL-PDGEVV--AVKKIIKNAKEDEERISDFLSELGIVAHIN-HPN 202
           +++IG+G   +V K  +  DG  +  A+K++ + A +D+ R  DF  EL ++  +  HPN
Sbjct: 12  QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHR--DFAGELEVLCKLGHHPN 69

Query: 203 AAKLIGFSTENGF-HLVLQFLPHGSLSSLLFGSTECLEWTIRYKIA-------------- 247
              L+G     G+ +L +++ PHG+L   L  S   LE    + IA              
Sbjct: 70  IINLLGACEHRGYLYLAIEYAPHGNLLDFLRKS-RVLETDPAFAIANSTASTLSSQQLLH 128

Query: 248 --LGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFP 305
               +A G+ YL     ++ IHRD+ A NIL+ E+Y A+I+DFGL++          V+ 
Sbjct: 129 FAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR-------GQEVY- 177

Query: 306 IEGTFG-----YLSPEYFMHGIVDEKTDVFAFGVLLLELIT 341
           ++ T G     +++ E   + +    +DV+++GVLL E+++
Sbjct: 178 VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 218

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 77.9 bits (192), Expect = 6e-16
 Identities = 58/215 (26%), Positives = 92/215 (42%), Gaps = 28/215 (13%)

Query: 142 DNFNSENLIGKGGHAEVYKGCLPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHP 201
           +     + +G+G    V K  L +  ++   K I     + +     L EL I      P
Sbjct: 1   EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTI-TTDPNPDLQKQILRELEINKSCKSP 59

Query: 202 NAAKLIGFSTENG---FHLVLQFLPHGSLSSLLFGSTECLEWTIRY------KIALGIAE 252
              K  G   +       + +++   GSL S+     +  +   R       KIA  + +
Sbjct: 60  YIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIY---KKVKKRGGRIGEKVLGKIAESVLK 116

Query: 253 GLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEGTFG- 311
           GL YLH    R+IIHRDIK SNILL+   + ++ DFG+        S  +V  + GTF  
Sbjct: 117 GLSYLHS---RKIIHRDIKPSNILLTRKGQVKLCDFGV--------SGELVNSLAGTFTG 165

Query: 312 ---YLSPEYFMHGIVDEKTDVFAFGVLLLELITGR 343
              Y++PE          +DV++ G+ LLE+   R
Sbjct: 166 TSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNR 200

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 77.5 bits (191), Expect = 6e-16
 Identities = 64/211 (30%), Positives = 100/211 (47%), Gaps = 27/211 (12%)

Query: 149 LIGKGGHAEVYKGCLPDG--EVVAVKKII-------KNAKEDEERISDFLSELGIV-AHI 198
            +G G    VYK    +    ++A+K+I        K+ +E ++ I D +SE+ I+   +
Sbjct: 7   HLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQL 66

Query: 199 NHPNAAKLIGFSTENGFHLVLQFLPHGSLSSLLFGS--------TECLEWTIRYKIALGI 250
            HPN  +      EN    ++  L  G+     F S        TE   W I  ++ L  
Sbjct: 67  RHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLA- 125

Query: 251 AEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEGTF 310
              L+YLH +  +RI+HRD+  +NI+L ED +  I+DFGLAK          +  + GT 
Sbjct: 126 ---LRYLHKE--KRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESK---LTSVVGTI 177

Query: 311 GYLSPEYFMHGIVDEKTDVFAFGVLLLELIT 341
            Y  PE   +    EK DV+AFG +L ++ T
Sbjct: 178 LYSCPEIVKNEPYGEKADVWAFGCILYQMCT 208

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 77.3 bits (190), Expect = 6e-16
 Identities = 63/210 (30%), Positives = 105/210 (50%), Gaps = 24/210 (11%)

Query: 143 NFNSENLIGKGGHAEVY--KGCLPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINH 200
            +     IG+G   ++Y  K    D E   +K+I       +E+ +    E+ ++A + H
Sbjct: 1   RYEIIKKIGEGSFGKIYLAKA-KSDSEHCVIKEIDLTKMPVKEKEAS-KKEVILLAKMKH 58

Query: 201 PNAAKLIGFSTENG-FHLVLQFLPHGSL-------SSLLFGSTECLEWTIRYKIALGIAE 252
           PN         ENG   +V+++   G L         +LF   + L W ++      I+ 
Sbjct: 59  PNIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQ------ISL 112

Query: 253 GLQYLHHDCHRRIIHRDIKASNILLSED-YEAQISDFGLAKWLPDNWSHHIVFPIEGTFG 311
           GL+++H    R+I+HRDIK+ NI LS++   A++ DFG+A+ L D  S  + +   GT  
Sbjct: 113 GLKHIHD---RKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLND--SMELAYTCVGTPY 167

Query: 312 YLSPEYFMHGIVDEKTDVFAFGVLLLELIT 341
           YLSPE   +   + KTD+++ G +L EL T
Sbjct: 168 YLSPEICQNRPYNNKTDIWSLGCVLYELCT 197

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 76.9 bits (189), Expect = 9e-16
 Identities = 63/214 (29%), Positives = 111/214 (51%), Gaps = 30/214 (14%)

Query: 147 ENLIGKGGHAEVYKGCL--PDGEVVAVK-KIIKNAKEDEERISDFLSELGIVAHINHPNA 203
           + +IG G   EV++G L  P  + VAV  K +K    +++R  DFLSE  I+   +H N 
Sbjct: 10  QKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQR-QDFLSEASIMGQFSHHNI 68

Query: 204 AKLIGFSTE-NGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIAL--GIAEGLQYLHHD 260
            +L G  T+     ++ +++ +G+L   L       E++    + +  GIA G++YL   
Sbjct: 69  IRLEGVVTKFKPAMIITEYMENGALDKYLRDHDG--EFSSYQLVGMLRGIAAGMKYL--- 123

Query: 261 CHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEGTFG--------- 311
                +HRD+ A NIL++ + E ++SDFGL++ L D        P EGT+          
Sbjct: 124 SDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLED-------DP-EGTYTTSGGKIPIR 175

Query: 312 YLSPEYFMHGIVDEKTDVFAFGVLLLELIT-GRR 344
           + +PE   +      +DV++FG+++ E+++ G R
Sbjct: 176 WTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGER 209

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 76.5 bits (189), Expect = 1e-15
 Identities = 61/207 (29%), Positives = 96/207 (46%), Gaps = 31/207 (14%)

Query: 150 IGKGGHAEVYKGCL-PDGEVVAVKKIIKN---AKEDEERISDFLSELGIVAHINHPNAAK 205
           +G GG   V    +       A+K + K        +E I    SE  I+   NHP   K
Sbjct: 1   LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHI---FSEKEILEECNHPFIVK 57

Query: 206 LI-GFSTENGFHLVLQFLPHGSLSSLL--FGSTECLEWTIRYKIALGIAEGLQYLHHDCH 262
           L   F  +   ++++++   G L ++L   G  +  E+T R+ IA  +    +YLH+   
Sbjct: 58  LYRTFKDKKYIYMLMEYCLGGELWTILRDRGLFD--EYTARFYIA-CVVLAFEYLHN--- 111

Query: 263 RRIIHRDIKASNILLSEDYEAQISDFGLAKWLPD-NWSHHIVFPIEGTFGYLSPEYFMHG 321
           R II+RD+K  N+LL  +   ++ DFG AK L     +        GT  Y++PE     
Sbjct: 112 RGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWTFC----GTPEYVAPE----- 162

Query: 322 IVDEK-----TDVFAFGVLLLELITGR 343
           I+  K      D ++ G+LL EL+TGR
Sbjct: 163 IILNKGYDFSVDYWSLGILLYELLTGR 189

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 76.1 bits (187), Expect = 1e-15
 Identities = 60/245 (24%), Positives = 116/245 (47%), Gaps = 28/245 (11%)

Query: 169 VAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGF-STENGFHLVLQFLPHGSL 227
           VA+K I    KE      +F+ E  ++  ++H    +L G  + +   ++V +++ +G L
Sbjct: 31  VAIKMI----KEGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSNGCL 86

Query: 228 SSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISD 287
            + L    +  + +   ++   + EG+ YL     ++ IHRD+ A N L+ +    ++SD
Sbjct: 87  LNYLREHGKRFQPSQLLEMCKDVCEGMAYLES---KQFIHRDLAARNCLVDDQGCVKVSD 143

Query: 288 FGLAKWLPDNWSHHIV---FPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELIT-GR 343
           FGL++++ D+     V   FP+     +  PE  ++     K+DV+AFGVL+ E+ + G+
Sbjct: 144 FGLSRYVLDDEYTSSVGSKFPVR----WSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGK 199

Query: 344 RAVDSRRQSLVIWAKPLLQTSNFKELVDPRLADAYDLAEMKRAMLTASVCIHHLSTMRPQ 403
              +    S  +      + S    L  P LA     +E   A++ +  C H  +  RP 
Sbjct: 200 MPYERFNNSETV-----EKVSQGLRLYRPHLA-----SEKVYAIMYS--CWHEKAEERPT 247

Query: 404 MTRVL 408
             ++L
Sbjct: 248 FQQLL 252

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 76.4 bits (188), Expect = 1e-15
 Identities = 55/196 (28%), Positives = 101/196 (51%), Gaps = 28/196 (14%)

Query: 165 DGEVVAVKKI----IKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTENG-FHLVL 219
           DG+   +K+I    +   + +E R      E+ +++++ HPN  +      ENG  ++V+
Sbjct: 24  DGKQYVIKEINISKMSPKEREESR-----KEVAVLSNMKHPNIVQYQESFEENGNLYIVM 78

Query: 220 QFLPHGSL-------SSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKA 272
            +   G L         +LF   + L+W ++      I   L+++H    R+I+HRDIK+
Sbjct: 79  DYCEGGDLYKKINAQRGVLFPEDQILDWFVQ------ICLALKHVHD---RKILHRDIKS 129

Query: 273 SNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAF 332
            NI L++D   ++ DFG+A+ L  N +  +     GT  YLSPE   +   + K+D++A 
Sbjct: 130 QNIFLTKDGTIKLGDFGIARVL--NSTVELARTCIGTPYYLSPEICENRPYNNKSDIWAL 187

Query: 333 GVLLLELITGRRAVDS 348
           G +L E+ T + A ++
Sbjct: 188 GCVLYEMCTLKHAFEA 203

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 76.3 bits (187), Expect = 1e-15
 Identities = 61/219 (27%), Positives = 111/219 (50%), Gaps = 38/219 (17%)

Query: 148 NLIGKGGHAEVYKGCLP-DGEVV--AVKKIIKNAKEDEERISDFLSELGIVAHI-NHPNA 203
           ++IG+G   +V K  +  DG  +  A+K++ + A +D+ R  DF  EL ++  + +HPN 
Sbjct: 1   DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHR--DFAGELEVLCKLGHHPNI 58

Query: 204 AKLIGFSTENGF-HLVLQFLPHGSLSSLL---------------FGSTECLEWTIRYKIA 247
             L+G     G+ +L +++ PHG+L   L                 +   L        A
Sbjct: 59  INLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFA 118

Query: 248 LGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIE 307
             +A G+ YL     ++ IHRD+ A NIL+ E+Y A+I+DFGL++          V+ ++
Sbjct: 119 ADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSR-------GQEVY-VK 167

Query: 308 GTFG-----YLSPEYFMHGIVDEKTDVFAFGVLLLELIT 341
            T G     +++ E   + +    +DV+++GVLL E+++
Sbjct: 168 KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 76.1 bits (187), Expect = 2e-15
 Identities = 62/214 (28%), Positives = 100/214 (46%), Gaps = 30/214 (14%)

Query: 149 LIGKGGHAEVYKGCLPDGEVVAVKKIIKNAKED---EERISDFLSELGIVAHINHPNAAK 205
           ++GKG    V +  L   +    K  +K  K D      I +FL E   +   +HPN  K
Sbjct: 6   MLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIK 65

Query: 206 LIGFSTENGFH-------LVLQFLPHGSLSSLLFGS-------TECLEWTIRYKIALGIA 251
           LIG S  +          ++L F+ HG L + L  S       T  L+  +R+ I   IA
Sbjct: 66  LIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMI--DIA 123

Query: 252 EGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAK--WLPDNWSHHIV--FPIE 307
            G++YL     +  IHRD+ A N +L+E+    ++DFGL+K  +  D +        P++
Sbjct: 124 SGMEYLSS---KNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVK 180

Query: 308 GTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELIT 341
               +L+ E     +    +DV+AFGV + E++T
Sbjct: 181 ----WLALESLADNVYTTHSDVWAFGVTMWEIMT 210

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 76.3 bits (188), Expect = 2e-15
 Identities = 62/205 (30%), Positives = 104/205 (50%), Gaps = 28/205 (13%)

Query: 150 IGKGGHAEVYKGC--LPDGEVVAVKKIIKNAKEDEERISDF-LSELGIVAHINHPNAAKL 206
           IG+G +  V+K C     G++VA+KK +++  ED+  I    L E+ ++  + HPN   L
Sbjct: 9   IGEGSYGVVFK-CRNRETGQIVAIKKFVES--EDDPVIKKIALREIRMLKQLKHPNLVNL 65

Query: 207 IG-FSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLH-HDCHRR 264
           I  F  +   HLV ++  H  L+ L        E  I+ KI     + + + H H+C   
Sbjct: 66  IEVFRRKRKLHLVFEYCDHTVLNELEKNPRGVPEHLIK-KIIWQTLQAVNFCHKHNC--- 121

Query: 265 IIHRDIKASNILLSEDYEAQISDFGLAKWL---PDNWSHHIVFPIEGTFGYLSPEYFMHG 321
            IHRD+K  NIL+++  + ++ DFG A+ L    D+++ ++      T  Y +PE     
Sbjct: 122 -IHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYV-----ATRWYRAPELL--- 172

Query: 322 IVDEK----TDVFAFGVLLLELITG 342
           + D +     DV+A G +  EL+TG
Sbjct: 173 VGDTQYGPPVDVWAIGCVFAELLTG 197

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 76.6 bits (189), Expect = 2e-15
 Identities = 62/236 (26%), Positives = 95/236 (40%), Gaps = 45/236 (19%)

Query: 142 DNFNSENLIGKGGHAEVYKGCL----PDGEVVAVKKIIKNAKEDEERISDFLSELGIVAH 197
           D+F    +IG+G   EV    L      G+V A+K + K+      +I+   +E  I+A 
Sbjct: 1   DDFEVIKVIGRGAFGEV---WLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILAD 57

Query: 198 INHPNAAKLI-GFSTENGFHLVLQFLPHGSLSSLLFGSTECL--EWTIRYKIALGIAEGL 254
            + P   KL   F  E   +LV++++P G L +LL    +    E    Y     IAE +
Sbjct: 58  ADSPWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRK-DVFPEETARFY-----IAELV 111

Query: 255 QYLHHDCHR-RIIHRDIKASNILLSEDYEAQISDFGLAK--------------------- 292
             L    H+   IHRDIK  NIL+  D   +++DFGL K                     
Sbjct: 112 LALDS-VHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFR 170

Query: 293 ------WLPDNWSHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITG 342
                                GT  Y++PE         + D ++ GV+L E++ G
Sbjct: 171 DNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYG 226

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 75.3 bits (185), Expect = 3e-15
 Identities = 56/210 (26%), Positives = 103/210 (49%), Gaps = 11/210 (5%)

Query: 143 NFNSENLIGKGGHAEVYKGCL--PDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINH 200
            +    ++G+G    V+  C    D ++V +K+I       +ER++   +E  ++  ++H
Sbjct: 1   KYEKIRVVGRGAFGIVHL-CRRKADQKLVIIKQIPVEQMTKDERLA-AQNECQVLKLLSH 58

Query: 201 PNAAKLI-GFSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHH 259
           PN  +    F  +    +V+++ P G+L+  +     C        I     + L  LHH
Sbjct: 59  PNIIEYYENFLEDKALMIVMEYAPGGTLAEYI--QKRCNSLLDEDTILHFFVQILLALHH 116

Query: 260 DCHRRIIHRDIKASNILLSEDYE-AQISDFGLAKWLPDNWSHHIVFPIEGTFGYLSPEYF 318
              + I+HRD+K  NILL +     +I DFG++K L    S    + + GT  Y+SPE  
Sbjct: 117 VHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILS---SKSKAYTVVGTPCYISPELC 173

Query: 319 MHGIVDEKTDVFAFGVLLLELITGRRAVDS 348
                ++K+D++A G +L EL + +RA ++
Sbjct: 174 EGKPYNQKSDIWALGCVLYELASLKRAFEA 203

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 75.2 bits (185), Expect = 3e-15
 Identities = 55/207 (26%), Positives = 101/207 (48%), Gaps = 15/207 (7%)

Query: 143 NFNSENLIGKGGHAEVYKGC--LPDGEVVAVKKI--IKNAKEDEERISDFLSELGIVAHI 198
           N+    L+G+G    VY  C  +  G  +AVK++    ++ E ++ ++    E+ ++ ++
Sbjct: 3   NWRRGKLLGQGAFGRVYL-CYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNL 61

Query: 199 NHPNAAKLIGFSTENG-FHLVLQFLPHGSLSSLL--FGSTECLEWTIRYKIALGIAEGLQ 255
            H    +  G   ++    + ++++P GS+   L  +G    L  T+  K    I EG++
Sbjct: 62  QHERIVQYYGCLRDDETLSIFMEYMPGGSVKDQLKAYG---ALTETVTRKYTRQILEGVE 118

Query: 256 YLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVF-PIEGTFGYLS 314
           YLH +    I+HRDIK +NIL       ++ DFG +K L    S       + GT  ++S
Sbjct: 119 YLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMS 175

Query: 315 PEYFMHGIVDEKTDVFAFGVLLLELIT 341
           PE         K DV++ G  ++E++T
Sbjct: 176 PEVISGEGYGRKADVWSVGCTVVEMLT 202

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 74.8 bits (184), Expect = 3e-15
 Identities = 61/214 (28%), Positives = 103/214 (48%), Gaps = 17/214 (7%)

Query: 150 IGKG--GHAEVYKGCLPDGEVVAVKKI-IKNAKEDEERISDFLSELGIVAHINHPN-AAK 205
           +GKG  G A +Y+    D  +V  K++ +    E E R  D L+E+ I++ + HPN  A 
Sbjct: 8   LGKGAFGEATLYRRT-EDDSLVVWKEVNLTRLSEKERR--DALNEIVILSLLQHPNIIAY 64

Query: 206 LIGFSTENGFHLVLQFLPHGSLSSLLFGSTECL---EWTIRYKIALGIAEGLQYLHHDCH 262
              F  +N   + +++   G+L   +      L   E  + Y     I   + Y+H    
Sbjct: 65  YNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQ--IVSAVSYIHKA-- 120

Query: 263 RRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEGTFGYLSPEYFMHGI 322
             I+HRDIK  NI L++    ++ DFG++K L   +S      + GT  Y+SPE      
Sbjct: 121 -GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSM--AETVVGTPYYMSPELCQGVK 177

Query: 323 VDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIW 356
            + K+D++A G +L EL+T +R  D+     ++ 
Sbjct: 178 YNFKSDIWALGCVLYELLTLKRTFDATNPLNLVV 211

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 74.0 bits (182), Expect = 9e-15
 Identities = 56/229 (24%), Positives = 103/229 (44%), Gaps = 39/229 (17%)

Query: 137 LAAATDNFNSENLIGKGGHAEVYKGCLPDGEV-----VAVKKIIKNAKEDEERISDFLSE 191
           +A + D     +L+ +G    ++ G L D +      V VK +  +A E   +++  L E
Sbjct: 1   IAISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASE--IQVTLLLQE 58

Query: 192 LGIVAHINHPNAAKLIGFSTEN-GFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALG- 249
             ++  ++H N   ++    E+     VL   P+ +  +L     +C         AL  
Sbjct: 59  SCLLYGLSHQNILPILHVCIEDGEPPFVL--YPYMNWGNLKLFLQQCRLGEANNPQALST 116

Query: 250 ---------IAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAK-------- 292
                    IA G+ YLH    R +IH+DI A N ++ E+ + +I+D  L++        
Sbjct: 117 QQLVHMAIQIACGMSYLHK---RGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYH 173

Query: 293 WLPDNWSHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELIT 341
            L DN +     P++    +++ E  ++      +DV++FGVLL EL+T
Sbjct: 174 CLGDNENR----PVK----WMALESLVNKEYSSASDVWSFGVLLWELMT 214

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 73.8 bits (181), Expect = 1e-14
 Identities = 60/206 (29%), Positives = 106/206 (51%), Gaps = 21/206 (10%)

Query: 147 ENLIGKGGHAEVYKGCL--PDGEVVAVK-KIIKNAKEDEERISDFLSELGIVAHINHPNA 203
           E +IG G   EV  G L  P    + V  K +K    +++R  DFLSE  I+   +HPN 
Sbjct: 9   EKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQR-RDFLSEASIMGQFDHPNI 67

Query: 204 AKLIGFSTENG-FHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIAL--GIAEGLQYLHHD 260
             L G  T++    +V +++ +GSL + L       ++T+   + +  GIA G++YL   
Sbjct: 68  IHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDG--QFTVIQLVGMLRGIASGMKYLSDM 125

Query: 261 CHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSHHIV-----FPIEGTFGYLSP 315
            +   +HRD+ A NIL++ +   ++SDFGL++ L D+            PI  T    +P
Sbjct: 126 GY---VHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWT----AP 178

Query: 316 EYFMHGIVDEKTDVFAFGVLLLELIT 341
           E   +      +DV+++G+++ E+++
Sbjct: 179 EAIAYRKFTSASDVWSYGIVMWEVMS 204

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 73.5 bits (180), Expect = 1e-14
 Identities = 63/211 (29%), Positives = 103/211 (48%), Gaps = 27/211 (12%)

Query: 150 IGKGGHAEVYKGCLPDGEV---VAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKL 206
           +G+G    V +G L   +    VAVK + K A      + DFLSE   +   +HPN  +L
Sbjct: 7   LGEGEFGSVMEGQLNQDDSILKVAVKTM-KIAICTRSEMEDFLSEAVCMKEFDHPNVMRL 65

Query: 207 IGFSTEN----GFH---LVLQFLPHGSLSSLLFGST--EC---LEWTIRYKIALGIAEGL 254
           IG   +     G+    ++L F+ HG L S L  S   +C   L   +  K    IA G+
Sbjct: 66  IGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGM 125

Query: 255 QYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAK--WLPDNWSHHIV--FPIEGTF 310
           +YL     +  IHRD+ A N +L+E+    ++DFGL+K  +  D +    +   P++   
Sbjct: 126 EYL---SSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVK--- 179

Query: 311 GYLSPEYFMHGIVDEKTDVFAFGVLLLELIT 341
            +++ E     +   K+DV++FGV + E+ T
Sbjct: 180 -WIAIESLADRVYTTKSDVWSFGVTMWEIAT 209

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 73.1 bits (179), Expect = 1e-14
 Identities = 56/197 (28%), Positives = 97/197 (49%), Gaps = 17/197 (8%)

Query: 150 IGKGGHAEVYKG---CLPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKL 206
           +G G    V KG        + VAVK I+KN   D     + L E  ++  +++P   ++
Sbjct: 3   LGSGNFGTVKKGMYKMKKSEKTVAVK-ILKNDNNDPALKDELLREANVMQQLDNPYIVRM 61

Query: 207 IGFSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRII 266
           IG      + LV++    G L+  L  +    E  I  ++   ++ G++YL        +
Sbjct: 62  IGICEAESWMLVMELAELGPLNKFLQKNKHVTEKNIT-ELVHQVSMGMKYLEET---NFV 117

Query: 267 HRDIKASNILLSEDYEAQISDFGLAKWLPDNWSH-----HIVFPIEGTFGYLSPEYFMHG 321
           HRD+ A N+LL   + A+ISDFGL+K L  + ++     H  +P++    + +PE   + 
Sbjct: 118 HRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVK----WYAPECMNYY 173

Query: 322 IVDEKTDVFAFGVLLLE 338
               K+DV++FGVL+ E
Sbjct: 174 KFSSKSDVWSFGVLMWE 190

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 73.3 bits (180), Expect = 1e-14
 Identities = 58/204 (28%), Positives = 100/204 (49%), Gaps = 25/204 (12%)

Query: 150 IGKGGHAEVYKG-CLPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHIN--HPNAAKL 206
           I KG    VY       G+  A+K + K+    + ++++  +E  I+  I    P  AKL
Sbjct: 4   ISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIM-MIQGESPYVAKL 62

Query: 207 I-GFSTENGFHLVLQFLPHGSLSSLL--FGSTECLEWTIRYKIALGIAE---GLQYLHHD 260
              F +++  +LV+++L  G  +SL+   G     +W  +Y     IAE   G++ LH  
Sbjct: 63  YYSFQSKDYLYLVMEYLNGGDCASLIKTLGGLP-EDWAKQY-----IAEVVLGVEDLHQ- 115

Query: 261 CHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEGTFGYLSPEYFMH 320
             R IIHRDIK  N+L+ +    +++DFGL++   +N          GT  YL+PE  + 
Sbjct: 116 --RGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLENKK------FVGTPDYLAPETILG 167

Query: 321 GIVDEKTDVFAFGVLLLELITGRR 344
              D+ +D ++ G ++ E + G  
Sbjct: 168 VGDDKMSDWWSLGCVIFEFLFGYP 191

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 73.7 bits (181), Expect = 1e-14
 Identities = 66/212 (31%), Positives = 108/212 (50%), Gaps = 20/212 (9%)

Query: 143 NFNSENLIGKGGHAEVYKG-CLPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHP 201
           NF     IG+G +  VYK      GEVVA+KKI  +  E E   S  + E+ ++  +NHP
Sbjct: 1   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDT-ETEGVPSTAIREISLLKELNHP 59

Query: 202 NAAKLIG-FSTENGFHLVLQFLPHGSLSSLLFGST-ECLEWTIRYKIALGIAEGLQYLHH 259
           N  KL+    TEN  +LV +FL H  L   +  S    +   +       + +GL +   
Sbjct: 60  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAF--- 115

Query: 260 DCH-RRIIHRDIKASNILLSEDYEAQISDFGLAK--WLP-DNWSHHIVFPIEGTFGYLSP 315
            CH  R++HRD+K  N+L++ +   +++DFGLA+   +P   ++H +V     T  Y +P
Sbjct: 116 -CHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-----TLWYRAP 169

Query: 316 EYFMHG-IVDEKTDVFAFGVLLLELITGRRAV 346
           E  +         D+++ G +  E++T RRA+
Sbjct: 170 EILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 200

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 73.4 bits (181), Expect = 1e-14
 Identities = 49/164 (29%), Positives = 75/164 (45%), Gaps = 32/164 (19%)

Query: 148 NLIGKGGHAEVYKGC-LPDGEVVAVKKIIKNAKEDEERISDF-LSELGIVAHI---NHPN 202
             IG+G +  VYK   L  G  VA+KK+       EE I    L E+ ++  +    HPN
Sbjct: 5   AEIGEGAYGTVYKARDLNTGRFVALKKV--RVPLSEEGIPLSTLREIALLKQLESFEHPN 62

Query: 203 AAKLI----GFSTENGFHLVL----------QFLPHGSLSSLLFGSTECLEWTIRYKIAL 248
             +L+    G  T+    L L           +L       L     E ++  +R     
Sbjct: 63  IVRLLDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCPKPGL---PPETIKDLMRQ---- 115

Query: 249 GIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAK 292
            +  G+ +LH   HR I+HRD+K  NIL++ D + +I+DFGLA+
Sbjct: 116 -LLRGVDFLH--SHR-IVHRDLKPQNILVTSDGQVKIADFGLAR 155

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 73.1 bits (179), Expect = 2e-14
 Identities = 66/256 (25%), Positives = 121/256 (47%), Gaps = 40/256 (15%)

Query: 150 IGKGGHAEV----YKGCLPDGEVVAVKKI-IKNAKEDEERISDFLSELGIVAHINHPN-A 203
           +GKG + EV    ++    DG+   +KK+ ++NA   E + ++   E  +++ + HPN  
Sbjct: 8   VGKGSYGEVSLVRHR---TDGKQYVIKKLNLRNASRRERKAAE--QEAQLLSQLKHPNIV 62

Query: 204 AKLIGFSTENG-FHLVLQFLPHGSL-------SSLLFGSTECLEWTIRYKIALGIAEGLQ 255
           A    +  E+G  ++V+ F   G L          L    + +EW ++      IA  LQ
Sbjct: 63  AYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQ------IAMALQ 116

Query: 256 YLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEGTFGYLSP 315
           YLH    + I+HRD+K  N+ L+     ++ D G+A+ L +     +   + GT  Y+SP
Sbjct: 117 YLHE---KHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCD--MASTLIGTPYYMSP 171

Query: 316 EYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSNFKELVDPRLA 375
           E F +   + K+DV+A G  + E+ T + A +++  + +++           E   P + 
Sbjct: 172 ELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVY--------RIIEGKLPPMP 223

Query: 376 DAYD--LAEMKRAMLT 389
             Y   L E+   ML+
Sbjct: 224 KDYSPELGELIATMLS 239

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 73.5 bits (180), Expect = 2e-14
 Identities = 57/200 (28%), Positives = 107/200 (53%), Gaps = 31/200 (15%)

Query: 164 PDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHI-NHPNAAKLIGFSTENG-FHLVLQF 221
           P+  V    K++K+   D++ +SD +SE+ ++  I  H N   L+G  T++G  ++++++
Sbjct: 41  PNKPVTVAVKMLKDDATDKD-LSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVLVEY 99

Query: 222 LPHGSLSSLL-----------FGSTECLEWTIRYK----IALGIAEGLQYLHHDCHRRII 266
              G+L   L           F + +  E  + +K     A  +A G++YL     ++ I
Sbjct: 100 ASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYL---ASQKCI 156

Query: 267 HRDIKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEGTFG-----YLSPEYFMHG 321
           HRD+ A N+L++ED   +I+DFGLA+ +     H+I +  + T G     +++PE     
Sbjct: 157 HRDLAARNVLVTEDNVMKIADFGLARDV-----HNIDYYKKTTNGRLPVKWMAPEALFDR 211

Query: 322 IVDEKTDVFAFGVLLLELIT 341
           +   ++DV++FGVLL E+ T
Sbjct: 212 VYTHQSDVWSFGVLLWEIFT 231

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 73.0 bits (180), Expect = 3e-14
 Identities = 62/218 (28%), Positives = 101/218 (46%), Gaps = 34/218 (15%)

Query: 142 DNFNSENLIGKGGHAEVYKG-CLPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINH 200
           D +   N I +G +  VY+      GE+VA+KK+ K  KE E      L E+ I+  + H
Sbjct: 5   DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKL-KMEKEKEGFPITSLREINILLKLQH 63

Query: 201 PNAAKL----IGFSTENGFHLVLQFLPHGSLSSLL------FGSTE--CLEWTIRYKIAL 248
           PN   +    +G S  +  ++V++++ H  L SL+      F  +E  CL         L
Sbjct: 64  PNIVTVKEVVVG-SNLDKIYMVMEYVEH-DLKSLMETMKQPFLQSEVKCL--------ML 113

Query: 249 GIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSH--HIVFPI 306
            +  G+ +LH      I+HRD+K SN+LL+     +I DFGLA+           +V   
Sbjct: 114 QLLSGVAHLHD---NWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYTQLVV-- 168

Query: 307 EGTFGYLSPEYFM-HGIVDEKTDVFAFGVLLLELITGR 343
             T  Y +PE  +         D+++ G +  EL+T +
Sbjct: 169 --TLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKK 204

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 72.4 bits (177), Expect = 3e-14
 Identities = 64/215 (29%), Positives = 106/215 (49%), Gaps = 26/215 (12%)

Query: 144 FNSENLIGKGGHAEVYKG-CLPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPN 202
           F    L+G G + +VYKG  +  G++ A+K ++    ++EE I   ++ L   +H  H N
Sbjct: 8   FELVELVGNGTYGQVYKGRHVKTGQLAAIK-VMDVTGDEEEEIKQEINMLKKYSH--HRN 64

Query: 203 AAKLIGF-------STENGFHLVLQFLPHGSLSSLLF---GSTECLEWTIRYKIALGIAE 252
            A   G          ++   LV++F   GS++ L+    G+T   EW I Y I   I  
Sbjct: 65  IATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEW-IAY-ICREILR 122

Query: 253 GLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEGTFGY 312
           GL +LH     ++IHRDIK  N+LL+E+ E ++ DFG++  L         F   GT  +
Sbjct: 123 GLSHLHQ---HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI--GTPYW 177

Query: 313 LSPEYFM-----HGIVDEKTDVFAFGVLLLELITG 342
           ++PE            D K+D+++ G+  +E+  G
Sbjct: 178 MAPEVIACDENPDATYDFKSDLWSLGITAIEMAEG 212

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 74.8 bits (184), Expect = 3e-14
 Identities = 64/223 (28%), Positives = 99/223 (44%), Gaps = 35/223 (15%)

Query: 149 LIGKGGHAEVYKGCLPD-GEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLI 207
           LIGKGG  EVY    P     VA+KKI ++  E+      FL E  I A + HP    + 
Sbjct: 9   LIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPV- 67

Query: 208 GFSTENGFHLVLQFLPH---GSLSSLLFGSTEC--LEWTIRYKIALG--------IAEGL 254
            +S  +    V   +P+    +L SLL    +   L   +  K ++G        I   +
Sbjct: 68  -YSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATI 126

Query: 255 QYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKW--------------LPDNWSH 300
           +Y+H    + ++HRD+K  NILL    E  I D+G A +                +    
Sbjct: 127 EYVHS---KGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYS 183

Query: 301 HIVFP--IEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELIT 341
            +  P  I GT  Y++PE  +     E TD++A GV+L +++T
Sbjct: 184 SMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLT 226

Length = 932

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 72.3 bits (177), Expect = 3e-14
 Identities = 62/234 (26%), Positives = 110/234 (47%), Gaps = 41/234 (17%)

Query: 136 ELAAATDNFNSENLIGKGGHAEVYKGCL-----PDGEVVAVK--KIIKNAKEDEERISDF 188
           EL  +   F  E  +G+    ++YKG L        ++VA+K  K I N ++      +F
Sbjct: 1   ELPLSAVRFMEE--LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQ----WGEF 54

Query: 189 LSELGIVAHINHPNAAKLIGFST-ENGFHLVLQFLPHGSLSSLLF--------GSTECLE 239
             E  ++A ++HPN   L+G  T E    ++ ++L  G L   L         G +   +
Sbjct: 55  QQEASLMAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDED 114

Query: 240 WTIR--------YKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLA 291
            T++          IA+ IA G++YL        +H+D+ A NIL+ E    +ISD GL+
Sbjct: 115 GTVKSSLDHGDFLHIAIQIAAGMEYL---SSHFFVHKDLAARNILIGEQLHVKISDLGLS 171

Query: 292 KWLPDNWSHHI----VFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELIT 341
           + +     + +    + PI     ++ PE  M+G     +D+++FGV+L E+ +
Sbjct: 172 REIYSADYYRVQPKSLLPIR----WMPPEAIMYGKFSSDSDIWSFGVVLWEIFS 221

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 72.4 bits (178), Expect = 5e-14
 Identities = 54/193 (27%), Positives = 90/193 (46%), Gaps = 34/193 (17%)

Query: 169 VAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFST------------ENG-- 214
           VAVK +  +A   +    DFL E+ I++ ++ PN A+L+G  T            ENG  
Sbjct: 49  VAVKVLRPDA--SDNAREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDL 106

Query: 215 --FHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKA 272
             F         G   +    S   L +     +A  IA G++YL        +HRD+  
Sbjct: 107 NQFLQKHVAETSGLACNSKSLSFSTLLY-----MATQIASGMRYLES---LNFVHRDLAT 158

Query: 273 SNILLSEDYEAQISDFGLAKWLPDNWSHHI----VFPIEGTFGYLSPEYFMHGIVDEKTD 328
            N L+ ++Y  +I+DFG+++ L  +  + +      PI     +++ E  + G    K+D
Sbjct: 159 RNCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIR----WMAWESVLLGKFTTKSD 214

Query: 329 VFAFGVLLLELIT 341
           V+AFGV L E++T
Sbjct: 215 VWAFGVTLWEILT 227

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 71.7 bits (176), Expect = 7e-14
 Identities = 51/181 (28%), Positives = 95/181 (52%), Gaps = 18/181 (9%)

Query: 169 VAVKKIIKNAKEDEERISDFLSELGIVAHI-NHPNAAKLIGFSTENG-FHLVLQFLPHGS 226
           VAVK +   A   E      +SEL I++H+ NH N   L+G  T  G   ++ ++  +G 
Sbjct: 68  VAVKMLKPTAHSSEREA--LMSELKIMSHLGNHENIVNLLGACTIGGPILVITEYCCYGD 125

Query: 227 LSSLLFGSTEC-LEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQI 285
           L + L    E  L        +  +A+G+ +L     +  IHRD+ A N+LL+     +I
Sbjct: 126 LLNFLRRKRESFLTLEDLLSFSYQVAKGMAFL---ASKNCIHRDLAARNVLLTHGKIVKI 182

Query: 286 SDFGLAKWLPDNWSHHIV-----FPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELI 340
            DFGLA+ + ++ S+++V      P++    +++PE   + +   ++DV+++G+LL E+ 
Sbjct: 183 CDFGLARDIMND-SNYVVKGNARLPVK----WMAPESIFNCVYTFESDVWSYGILLWEIF 237

Query: 341 T 341
           +
Sbjct: 238 S 238

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 70.8 bits (173), Expect = 1e-13
 Identities = 70/227 (30%), Positives = 105/227 (46%), Gaps = 35/227 (15%)

Query: 137 LAAATDNFNSENLIGKGGHAEVYK-GCLPDGEVVAVKKIIKNAKEDEERISDFLSELGIV 195
           L   TD +     IGKG + +VYK     DG + AVK +   +  DEE      +E  I+
Sbjct: 17  LGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEE----IEAEYNIL 72

Query: 196 AHI-NHPNAAKLIGFSTENG------FHLVLQFLPHGSLSSLLFGSTEC---LEWTIRYK 245
             + NHPN  K  G   +          LVL+    GS++ L+ G   C   L+  +   
Sbjct: 73  QSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISY 132

Query: 246 IALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPD-----NWSH 300
           I  G   GLQ+LH++   RIIHRD+K +NILL+ +   ++ DFG++  L       N S 
Sbjct: 133 ILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTS- 188

Query: 301 HIVFPIEGTFGYLSPEYFM-----HGIVDEKTDVFAFGVLLLELITG 342
                  GT  +++PE            D + DV++ G+  +EL  G
Sbjct: 189 ------VGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDG 229

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 70.4 bits (172), Expect = 2e-13
 Identities = 64/214 (29%), Positives = 99/214 (46%), Gaps = 11/214 (5%)

Query: 144 FNSENLIGKGGHAEVYKGCL--PDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHP 201
           F    ++GKGG  EV   C     G++ A KK+ K   +  +  S  L+E  I+  +N  
Sbjct: 2   FRQYRVLGKGGFGEVC-ACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSR 60

Query: 202 NAAKLI-GFSTENGFHLVLQFLPHGSLSSLLFGSTEC-LEWTIRYKIALGIAEGLQYLHH 259
               L   + T++   LVL  +  G L   ++   E   E       A  I  GL+ LH 
Sbjct: 61  FVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQ 120

Query: 260 DCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEGTFGYLSPEYFM 319
           +   RI++RD+K  NILL +    +ISD GLA  +P+      +    GT GY++PE   
Sbjct: 121 E---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG---QTIKGRVGTVGYMAPEVVK 174

Query: 320 HGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSL 353
           +       D +A G LL E+I G+     R++ +
Sbjct: 175 NERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKI 208

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 70.8 bits (173), Expect = 2e-13
 Identities = 59/207 (28%), Positives = 104/207 (50%), Gaps = 17/207 (8%)

Query: 142 DNFNSENLIGKGGHAEVYK-GCLPDGEVVAVKKI---IKNAKEDEERISDFLSELGIVAH 197
           D+F   + +G G    V+K    P G ++A K I   IK A  ++      + EL ++  
Sbjct: 5   DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQ-----IIRELQVLHE 59

Query: 198 INHPNAAKLIG-FSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQY 256
            N P      G F ++    + ++ +  GSL  +L  +    E  I  K+++ + +GL Y
Sbjct: 60  CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPE-QILGKVSIAVIKGLTY 118

Query: 257 LHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEGTFGYLSPE 316
           L      +I+HRD+K SNIL++   E ++ DFG++  L D+ ++  V    GT  Y+SPE
Sbjct: 119 LREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV----GTRSYMSPE 172

Query: 317 YFMHGIVDEKTDVFAFGVLLLELITGR 343
                    ++D+++ G+ L+E+  GR
Sbjct: 173 RLQGTHYSVQSDIWSMGLSLVEMAIGR 199

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 70.4 bits (173), Expect = 2e-13
 Identities = 59/196 (30%), Positives = 90/196 (45%), Gaps = 29/196 (14%)

Query: 166 GEVVAVKKI------IKNAKEDEERISDFLSELGIVAHINHPN--AAKLIGFSTENGF-- 215
           G+ VA+KKI         AK         L EL I+ H  H N  A + I       F  
Sbjct: 30  GKKVAIKKIPHAFDVPTLAKRT-------LRELKILRHFKHDNIIAIRDILRPPGADFKD 82

Query: 216 -HLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASN 274
            ++V+  L    L  ++       E  IRY     +  GL+Y+H      +IHRD+K SN
Sbjct: 83  VYVVMD-LMESDLHHIIHSDQPLTEEHIRY-FLYQLLRGLKYIHSAN---VIHRDLKPSN 137

Query: 275 ILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIE--GTFGYLSPE--YFMHGIVDEKTDVF 330
           +L++ED E +I DFG+A+ L  + + H  F  E   T  Y +PE    +        D++
Sbjct: 138 LLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPE-YTTAIDMW 196

Query: 331 AFGVLLLELITGRRAV 346
           + G +  E++ GRR +
Sbjct: 197 SVGCIFAEML-GRRQL 211

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 69.5 bits (170), Expect = 3e-13
 Identities = 54/196 (27%), Positives = 96/196 (48%), Gaps = 16/196 (8%)

Query: 150 IGKGGHAEVYKGC-LPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIG 208
           +G G    VYK   L    ++AVK I  +   + ++    +SEL I+   + P      G
Sbjct: 9   LGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQK--QIMSELEILYKCDSPYIIGFYG 66

Query: 209 -FSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIH 267
            F  EN   +  +F+  GSL   ++     +   +  +IA+ + +GL YL      +I+H
Sbjct: 67  AFFVENRISICTEFMDGGSLD--VYRK---IPEHVLGRIAVAVVKGLTYL---WSLKILH 118

Query: 268 RDIKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEGTFGYLSPEYFMHGIVDEKT 327
           RD+K SN+L++   + ++ DFG++  L ++ +   V    GT  Y++PE          +
Sbjct: 119 RDVKPSNMLVNTRGQVKLCDFGVSTQLVNSIAKTYV----GTNAYMAPERISGEQYGIHS 174

Query: 328 DVFAFGVLLLELITGR 343
           DV++ G+  +EL  GR
Sbjct: 175 DVWSLGISFMELALGR 190

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 68.9 bits (169), Expect = 5e-13
 Identities = 65/213 (30%), Positives = 104/213 (48%), Gaps = 41/213 (19%)

Query: 150 IGKGGHAEVYKGC-LPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIG 208
           IG+G +  VYK      GE+VA+KK I+   EDE   S  + E+ ++  +NHPN  +L+ 
Sbjct: 7   IGEGTYGVVYKARDKLTGEIVALKK-IRLETEDEGVPSTAIREISLLKELNHPNIVRLLD 65

Query: 209 -FSTENGFHLVLQFL-----------PHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQY 256
              +EN  +LV +FL           P   L   L  S         Y++  GIA    Y
Sbjct: 66  VVHSENKLYLVFEFLDLDLKKYMDSSPLTGLDPPLIKS-------YLYQLLQGIA----Y 114

Query: 257 LHHDCH-RRIIHRDIKASNILLSEDYEAQISDFGLAKW--LP-DNWSHHIVFPIEGTFGY 312
               CH  R++HRD+K  N+L+  +   +++DFGLA+   +P   ++H +V     T  Y
Sbjct: 115 ----CHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTHEVV-----TLWY 165

Query: 313 LSPEYFMHGIVDEKT--DVFAFGVLLLELITGR 343
            +PE  + G     T  D+++ G +  E++  R
Sbjct: 166 RAPEILL-GSRQYSTPVDIWSIGCIFAEMVNRR 197

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 68.7 bits (168), Expect = 6e-13
 Identities = 48/137 (35%), Positives = 69/137 (50%), Gaps = 9/137 (6%)

Query: 209 FSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHR 268
           F T+   HL+L ++  G L + L+      E  +R  IA  I   L +LH      II+R
Sbjct: 74  FQTDTKLHLILDYVNGGELFTHLYQREHFTESEVRVYIA-EIVLALDHLHQ---LGIIYR 129

Query: 269 DIKASNILLSEDYEAQISDFGLAK-WLPDNWSHHIVFPIEGTFGYLSPEYFMHGIV--DE 325
           DIK  NILL  +    ++DFGL+K +L +       F   GT  Y++PE    G    D+
Sbjct: 130 DIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFC--GTIEYMAPEVIRGGSGGHDK 187

Query: 326 KTDVFAFGVLLLELITG 342
             D ++ GVL  EL+TG
Sbjct: 188 AVDWWSLGVLTFELLTG 204

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 68.9 bits (168), Expect = 6e-13
 Identities = 52/195 (26%), Positives = 103/195 (52%), Gaps = 32/195 (16%)

Query: 169 VAVKKIIKNAKEDEERISDFLSELGIVAHI-NHPNAAKLIGFSTENG-FHLVLQFLPHGS 226
           VAVK +  +A E +  +SD +SE+ ++  I  H N   L+G  T++G  ++++++   G+
Sbjct: 50  VAVKMLKDDATEKD--LSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGN 107

Query: 227 LSSLL-----------FGSTECLEWTIRYKIALG----IAEGLQYLHHDCHRRIIHRDIK 271
           L   L           +      +  + +K  +     +A G++YL     ++ IHRD+ 
Sbjct: 108 LREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYL---ASQKCIHRDLA 164

Query: 272 ASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEGTFG-----YLSPEYFMHGIVDEK 326
           A N+L++E+   +I+DFGLA+ +     ++I +  + T G     +++PE     +   +
Sbjct: 165 ARNVLVTENNVMKIADFGLARDV-----NNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQ 219

Query: 327 TDVFAFGVLLLELIT 341
           +DV++FGVL+ E+ T
Sbjct: 220 SDVWSFGVLMWEIFT 234

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 69.0 bits (169), Expect = 6e-13
 Identities = 67/224 (29%), Positives = 112/224 (50%), Gaps = 37/224 (16%)

Query: 142 DNFNSENLIGKGGHAEVYKGCLPD-GEVVAVKKI-IKNAKEDEERISDFLSELGIVAHIN 199
           D F+    IG+G + +VYK    D GE+VA+KK+ + N KE     +  + E+ I+  +N
Sbjct: 7   DKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITA--IREIKILRQLN 64

Query: 200 HPNAAKL----------IGFSTENG-FHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIAL 248
           H N   L          + F  + G F+LV +++ H  +  L  G     E  I+     
Sbjct: 65  HRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIK-SFMK 123

Query: 249 GIAEGLQYLHHDCHRR-IIHRDIKASNILLSEDYEAQISDFGLAK-WLPDN---WSHHIV 303
            + EGL Y    CH++  +HRDIK SNILL+   + +++DFGLA+ +  +    +++ ++
Sbjct: 124 QLLEGLNY----CHKKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVI 179

Query: 304 FPIEGTFGYLSPEYFMHGIVDEK----TDVFAFGVLLLELITGR 343
                T  Y  PE  +    +E+     DV++ G +L EL T +
Sbjct: 180 -----TLWYRPPELLLG---EERYGPAIDVWSCGCILGELFTKK 215

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 68.8 bits (169), Expect = 6e-13
 Identities = 64/241 (26%), Positives = 98/241 (40%), Gaps = 51/241 (21%)

Query: 142 DNFNSENLIGKGGHAEVY----KGCLPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAH 197
            +F    L+GKG    V+    KG    G++ A+K + K       ++   L+E  I+A 
Sbjct: 1   KHFKKIKLLGKGDVGRVFLVRLKGT---GKLFALKVLDKKEMIKRNKVKRVLTEQEILAT 57

Query: 198 INHPNAAKLIG-FSTENGFHLVLQFLPHGSLSSLL-FGSTECL-EWTIRYKIALGIAEGL 254
           ++HP    L   F TE    LV+ + P G L  LL     +CL E   R+  A  +   L
Sbjct: 58  LDHPFLPTLYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLL-AL 116

Query: 255 QYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWL---------------PDNWS 299
           +YLH      I++RD+K  NILL E     +SDF L+K                   +  
Sbjct: 117 EYLHL---LGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSV 173

Query: 300 HHIVFPIE------------GTFGYLSPEYFMHGIV-----DEKTDVFAFGVLLLELITG 342
           + I                 GT  Y++PE     ++         D +  G+LL E++ G
Sbjct: 174 NSIPSETFSEEPSFRSNSFVGTEEYIAPE-----VISGDGHGSAVDWWTLGILLYEMLYG 228

Query: 343 R 343
            
Sbjct: 229 T 229

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 68.3 bits (167), Expect = 8e-13
 Identities = 55/205 (26%), Positives = 103/205 (50%), Gaps = 20/205 (9%)

Query: 150 IGKGGHAEVYKGC-LPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIG 208
           +GKG +  VYK    P G  +A+K+I    + DE + +  + EL I+     P      G
Sbjct: 9   LGKGNYGSVYKVLHRPTGVTMAMKEI--RLELDESKFNQIIMELDILHKAVSPYIVDFYG 66

Query: 209 -FSTENGFHLVLQFLPHGSLSSLLFGSTECL---EWTIRYKIALGIAEGLQYLHHDCHRR 264
            F  E   ++ ++++  GSL  L  G        E  +R +I   + +GL++L  +    
Sbjct: 67  AFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLR-RITYAVVKGLKFLKEE--HN 123

Query: 265 IIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEGTFGYLSPEYFMHGIVD 324
           IIHRD+K +N+L++ + + ++ DFG++  L  + +   +    G   Y++PE    G  +
Sbjct: 124 IIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKTNI----GCQSYMAPERIKSGGPN 179

Query: 325 E------KTDVFAFGVLLLELITGR 343
           +      ++DV++ G+ +LE+  GR
Sbjct: 180 QNPTYTVQSDVWSLGLSILEMALGR 204

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 68.5 bits (168), Expect = 8e-13
 Identities = 56/211 (26%), Positives = 90/211 (42%), Gaps = 26/211 (12%)

Query: 149 LIGK----GGHAEVYKGCLPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAA 204
           LIGK         + K   P   +VAVKKI  ++   +E +     E+     + HPN  
Sbjct: 5   LIGKCFEDLMIVHLAK-HKPTNTLVAVKKINLDSC-SKEDLKLLQQEIITSRQLQHPNIL 62

Query: 205 K-LIGFSTENGFHLVLQFLPHGSLSSLLFGSTECL----EWTIRYKIALGIAEGLQYLHH 259
             +  F  ++  ++V   + +GS   LL   T       E  I + I   +   L Y+H 
Sbjct: 63  PYVTSFIVDSELYVVSPLMAYGSCEDLL--KTHFPEGLPELAIAF-ILKDVLNALDYIHS 119

Query: 260 DCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWL--PDNWSHHIV-FPIEGTF--GYLS 314
              +  IHR +KAS+ILLS D +  +S    +  +         +  FP        +LS
Sbjct: 120 ---KGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLS 176

Query: 315 PEYF---MHGIVDEKTDVFAFGVLLLELITG 342
           PE     + G  +EK+D+++ G+   EL  G
Sbjct: 177 PEVLQQNLQG-YNEKSDIYSVGITACELANG 206

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 68.1 bits (166), Expect = 1e-12
 Identities = 63/231 (27%), Positives = 111/231 (48%), Gaps = 26/231 (11%)

Query: 128 SWKNFDFAELAAATDNFNSENLIGKGGHAEVYKG-CLPDGEVVAVKKIIKNAKEDEERIS 186
           S  + D + L      F    ++G G + +VYKG  +  G++ A+K ++   +++EE I 
Sbjct: 2   SLDDIDLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIK-VMDVTEDEEEEIK 60

Query: 187 DFLSELGIVAHINHPNAAKLIGF-------STENGFHLVLQFLPHGSLSSLLF---GSTE 236
             ++ L   +H  H N A   G          ++   LV++F   GS++ L+    G+  
Sbjct: 61  LEINMLKKYSH--HRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNAL 118

Query: 237 CLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPD 296
             +W I Y I   I  GL +LH     ++IHRDIK  N+LL+E+ E ++ DFG++  L  
Sbjct: 119 KEDW-IAY-ICREILRGLAHLHA---HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDR 173

Query: 297 NWSHHIVFPIEGTFGYLSPEYFM-----HGIVDEKTDVFAFGVLLLELITG 342
                  F   GT  +++PE            D ++D+++ G+  +E+  G
Sbjct: 174 TVGRRNTFI--GTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEG 222

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 68.3 bits (167), Expect = 1e-12
 Identities = 58/217 (26%), Positives = 105/217 (48%), Gaps = 26/217 (11%)

Query: 142 DNFNSENLIGKGGHAEVY----KGCLPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAH 197
            +F+ ++L+G+G   EV     K     G++ A+K + K+    +E +S F  E  I++ 
Sbjct: 1   KDFDVKSLVGRGHFGEVQVVREKAT---GDIYAMKVMKKSVLLAQETVSFFEEERDILSI 57

Query: 198 INHPNAAKLI-GFSTENGFHLVLQFLPHGSLSSLLFGSTECL-EWTIRYKIALGIAEGLQ 255
            N P   +L   F  ++  +LV+++ P G L SLL    +   E   ++ +A  +   + 
Sbjct: 58  SNSPWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLA-ELVLAIH 116

Query: 256 YLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEGTFGYLSP 315
            +H   +   +HRDIK  N+L+      +++DFG A  L  N   +   P+ GT  Y++P
Sbjct: 117 SVHQMGY---VHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPV-GTPDYIAP 172

Query: 316 EYF---------MHGIVDEKTDVFAFGVLLLELITGR 343
           E            +G+   + D ++ GV+  E+I GR
Sbjct: 173 EVLTTMNGDGKGTYGV---ECDWWSLGVIAYEMIYGR 206

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 67.8 bits (165), Expect = 1e-12
 Identities = 54/213 (25%), Positives = 98/213 (46%), Gaps = 28/213 (13%)

Query: 147 ENLIGKGGHAEVYKGCLPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKL 206
           E   GK   AE Y  C    +++   K +K+A ++  +  DF  E  ++ ++ H +  K 
Sbjct: 15  EGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARK--DFHREAELLTNLQHEHIVKF 72

Query: 207 IGFSTE-NGFHLVLQFLPHGSLSSLLFG-------------STECLEWTIRYKIALGIAE 252
            G   E +   +V +++ HG L+  L                 E  +  + + IA  IA 
Sbjct: 73  YGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLH-IAQQIAA 131

Query: 253 GLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAK--WLPDNW--SHHIVFPIEG 308
           G+ YL     +  +HRD+   N L+ E+   +I DFG+++  +  D +    H + PI  
Sbjct: 132 GMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIR- 187

Query: 309 TFGYLSPEYFMHGIVDEKTDVFAFGVLLLELIT 341
              ++ PE  M+     ++DV++ GV+L E+ T
Sbjct: 188 ---WMPPESIMYRKFTTESDVWSLGVVLWEIFT 217

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 68.2 bits (167), Expect = 1e-12
 Identities = 49/154 (31%), Positives = 81/154 (52%), Gaps = 17/154 (11%)

Query: 150 IGKGGHAEVYKG-CLPDGEVVAVKKII-KNAKEDEERISDFLSELGIVAHINHPNAAKLI 207
           IG+G   EV+K       ++VA+KK++ +N KE     +  L E+ I+  + H N   LI
Sbjct: 20  IGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITA--LREIKILQLLKHENVVNLI 77

Query: 208 GF-----STENG----FHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLH 258
                  +  N     F+LV +F  H  L+ LL         +   K+   +  GL Y+H
Sbjct: 78  EICRTKATPYNRYKGSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIH 136

Query: 259 HDCHRRIIHRDIKASNILLSEDYEAQISDFGLAK 292
            +   +I+HRD+KA+NIL+++D   +++DFGLA+
Sbjct: 137 RN---KILHRDMKAANILITKDGILKLADFGLAR 167

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 69.1 bits (169), Expect = 1e-12
 Identities = 47/172 (27%), Positives = 77/172 (44%), Gaps = 34/172 (19%)

Query: 257 LHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEGTFGYLSPE 316
           +HH   + +IHRDIK++NILL  +   ++ DFG +K      S  +     GT  Y++PE
Sbjct: 156 VHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPE 215

Query: 317 YFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSNFKELVDPRLAD 376
            +      +K D+F+ GVLL EL+T +R  D                 N +E++   LA 
Sbjct: 216 IWRRKPYSKKADMFSLGVLLYELLTLKRPFDG---------------ENMEEVMHKTLAG 260

Query: 377 AYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQLLRGEGGQTDLKPKPSARR 428
            YD                   ++ P+M  ++  L      +D K +PS+ +
Sbjct: 261 RYDPLP---------------PSISPEMQEIVTALL----SSDPKRRPSSSK 293

Length = 496

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 68.5 bits (168), Expect = 1e-12
 Identities = 55/215 (25%), Positives = 102/215 (47%), Gaps = 29/215 (13%)

Query: 142 DNFNSENLIGKGGHAEVYK---GCLPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHI 198
           D + + + +G G + +V          G  VA+KK+ +   +          EL ++ H+
Sbjct: 15  DRYQNLSPVGSGAYGQVCSAFDTKT--GRKVAIKKLSR-PFQSAIHAKRTYRELRLLKHM 71

Query: 199 NHPNAAKLI-------GFSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIA 251
           +H N   L+               +LV   +    L++++    +  +  I++ +   I 
Sbjct: 72  DHENVIGLLDVFTPASSLEDFQDVYLVTHLM-GADLNNIV-KCQKLSDDHIQF-LVYQIL 128

Query: 252 EGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEGTFG 311
            GL+Y+H      IIHRD+K SNI ++ED E +I DFGLA+   D  + ++      T  
Sbjct: 129 RGLKYIHS---AGIIHRDLKPSNIAVNEDCELKILDFGLARHTDDEMTGYVA-----TRW 180

Query: 312 YLSPE---YFMHGIVDEKTDVFAFGVLLLELITGR 343
           Y +PE    +MH   ++  D+++ G ++ EL+TG+
Sbjct: 181 YRAPEIMLNWMH--YNQTVDIWSVGCIMAELLTGK 213

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 68.2 bits (166), Expect = 1e-12
 Identities = 62/227 (27%), Positives = 111/227 (48%), Gaps = 19/227 (8%)

Query: 142 DNFNSENLIGKGGHAEVYK-GCLPDGEVVAVKKI---IKNAKEDEERISDFLSELGIVAH 197
           D+F   + +G G    V K    P G ++A K I   IK A  ++      + EL ++  
Sbjct: 5   DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQ-----IIRELQVLHE 59

Query: 198 INHPNAAKLIG-FSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQY 256
            N P      G F ++    + ++ +  GSL  +L  +    E  I  K+++ +  GL Y
Sbjct: 60  CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPE-EILGKVSIAVLRGLAY 118

Query: 257 LHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEGTFGYLSPE 316
           L      +I+HRD+K SNIL++   E ++ DFG++  L D+ ++  V    GT  Y+SPE
Sbjct: 119 LREK--HQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV----GTRSYMSPE 172

Query: 317 YFMHGIVDEKTDVFAFGVLLLELITGRRAV--DSRRQSLVIWAKPLL 361
                    ++D+++ G+ L+EL  GR  +     ++   I+ +P++
Sbjct: 173 RLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVV 219

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 67.9 bits (166), Expect = 2e-12
 Identities = 62/228 (27%), Positives = 96/228 (42%), Gaps = 36/228 (15%)

Query: 166 GEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLI-GFSTENGFHLVLQFLPH 224
           GE  A+K + K      +++     E  I+  ++HP    ++  F  EN  + +L+F+  
Sbjct: 43  GEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLLEFVVG 102

Query: 225 GSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQ 284
           G L + L  +        ++  A  +    +YLH    + II+RD+K  N+LL      +
Sbjct: 103 GELFTHLRKAGRFPNDVAKFYHA-ELVLAFEYLHS---KDIIYRDLKPENLLLDNKGHVK 158

Query: 285 ISDFGLAKWLPDNWSHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGR- 343
           ++DFG AK +PD       F + GT  YL+PE        +  D +  GVLL E I G  
Sbjct: 159 VTDFGFAKKVPDR-----TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYP 213

Query: 344 ----------------------RAVDSRRQSLVIWAKPLLQTSNFKEL 369
                                    D R + LV   K LLQT + K L
Sbjct: 214 PFFDDTPFRIYEKILAGRLKFPNWFDGRARDLV---KGLLQTDHTKRL 258

Length = 329

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 67.3 bits (164), Expect = 2e-12
 Identities = 59/201 (29%), Positives = 99/201 (49%), Gaps = 16/201 (7%)

Query: 149 LIGKGGHAEVYKGC--LPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKL 206
           +IG+GG  EVY GC     G++ A+K + K   + ++  +  L+E  +++ ++  +   +
Sbjct: 1   IIGRGGFGEVY-GCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFI 59

Query: 207 I----GFSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCH 262
           +     F T +    +L  +  G L   L       E  +R+  A  I  GL+++H+   
Sbjct: 60  VCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRF-YATEIILGLEHMHN--- 115

Query: 263 RRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEGTFGYLSPEYFMHGI 322
           R +++RD+K +NILL E    +ISD GLA        H  V    GT GY++PE    G 
Sbjct: 116 RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV----GTHGYMAPEVLQKGT 171

Query: 323 V-DEKTDVFAFGVLLLELITG 342
             D   D F+ G +L +L+ G
Sbjct: 172 AYDSSADWFSLGCMLFKLLRG 192

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 66.9 bits (163), Expect = 2e-12
 Identities = 67/206 (32%), Positives = 95/206 (46%), Gaps = 26/206 (12%)

Query: 149 LIGKGGHAEVYKGC--LPDGEVVAVK----KIIKNAKEDE-----ERISDFLSELGIVAH 197
           +IG+GG  EVY GC     G++ A+K    K IK  K+ E     ERI   L   G    
Sbjct: 1   IIGRGGFGEVY-GCRKADTGKMYAMKCLDKKRIK-MKQGETLALNERIMLSLVSTGDCPF 58

Query: 198 INHPNAAKLIGFSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYL 257
           I          F T +    +L  +  G L   L       E  +R+  A  I  GL+++
Sbjct: 59  I----VCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRF-YAAEIILGLEHM 113

Query: 258 HHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEGTFGYLSPEY 317
           H+   R +++RD+K +NILL E    +ISD GLA        H  V    GT GY++PE 
Sbjct: 114 HN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV----GTHGYMAPEV 166

Query: 318 FMHGIV-DEKTDVFAFGVLLLELITG 342
              G+  D   D F+ G +L +L+ G
Sbjct: 167 LQKGVAYDSSADWFSLGCMLFKLLRG 192

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 66.5 bits (162), Expect = 2e-12
 Identities = 48/196 (24%), Positives = 94/196 (47%), Gaps = 15/196 (7%)

Query: 150 IGKGGHAEVYKGC--LPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLI 207
           +G G    V KG   +   ++    K++KN  E   R  + + E  I+  +++P   ++I
Sbjct: 3   LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVR-DEMMREAEIMHQLDNPYIVRMI 61

Query: 208 GFSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIH 267
           G        LV++    G L+  L G  + +  +   ++   ++ G++YL     +  +H
Sbjct: 62  GVCEAEALMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEG---KNFVH 118

Query: 268 RDIKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEGTFG-----YLSPEYFMHGI 322
           RD+ A N+LL   + A+ISDFGL+K L  + S++       + G     + +PE      
Sbjct: 119 RDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKA----RSAGKWPLKWYAPECINFRK 174

Query: 323 VDEKTDVFAFGVLLLE 338
              ++DV+++G+ + E
Sbjct: 175 FSSRSDVWSYGITMWE 190

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 66.9 bits (163), Expect = 3e-12
 Identities = 72/296 (24%), Positives = 132/296 (44%), Gaps = 51/296 (17%)

Query: 150 IGKGGHAEVYKGCLPD---GEV---VAVKKIIKNAKEDEERISDFLSELGIVAHINHPNA 203
           +G+G    VY+G   D   GE    VAVK + ++A    ERI +FL+E  ++      + 
Sbjct: 14  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASL-RERI-EFLNEASVMKGFTCHHV 71

Query: 204 AKLIGFSTENGFHLV-LQFLPHGSLSSLLF-------GSTECLEWTIRYKIALG--IAEG 253
            +L+G  ++    LV ++ + HG L S L         +      T++  I +   IA+G
Sbjct: 72  VRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADG 131

Query: 254 LQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSHHI----VFPIEGT 309
           + YL+    ++ +HRD+ A N +++ D+  +I DFG+ + + +   +      + P+   
Sbjct: 132 MAYLNA---KKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRW- 187

Query: 310 FGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSN---F 366
              ++PE    G+    +D+++FGV+L E+ +             +  +P    SN    
Sbjct: 188 ---MAPESLKDGVFTTSSDMWSFGVVLWEITS-------------LAEQPYQGLSNEQVL 231

Query: 367 KELVDPRLADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQLLRGEGGQTDLKP 422
           K ++D    D  D    +R      +C      MRP    ++ LL+      DL P
Sbjct: 232 KFVMDGGYLDQPDNCP-ERVTDLMRMCWQFNPKMRPTFLEIVNLLK-----DDLHP 281

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 66.5 bits (162), Expect = 3e-12
 Identities = 51/196 (26%), Positives = 98/196 (50%), Gaps = 14/196 (7%)

Query: 150 IGKGGHAEVYKGC-LPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAK-LI 207
           IG+G    VY    +  G+ VA+K++    +  +E I   ++E+ ++    HPN    L 
Sbjct: 27  IGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELI---INEILVMRENKHPNIVNYLD 83

Query: 208 GFSTENGFHLVLQFLPHGSLSSLLFGSTE-CLEWTIRYKIALGIAEGLQYLHHDCHRRII 266
            +   +   +V+++L  GSL+ ++   TE C++      +     + L++LH     ++I
Sbjct: 84  SYLVGDELWVVMEYLAGGSLTDVV---TETCMDEGQIAAVCRECLQALEFLHS---NQVI 137

Query: 267 HRDIKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEGTFGYLSPEYFMHGIVDEK 326
           HRDIK+ NILL  D   +++DFG    +    S      + GT  +++PE         K
Sbjct: 138 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVGTPYWMAPEVVTRKAYGPK 195

Query: 327 TDVFAFGVLLLELITG 342
            D+++ G++ +E++ G
Sbjct: 196 VDIWSLGIMAIEMVEG 211

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 66.2 bits (161), Expect = 4e-12
 Identities = 55/211 (26%), Positives = 103/211 (48%), Gaps = 27/211 (12%)

Query: 150 IGKGGHAEVY----KGCLPDG-EVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAA 204
           +G+G    VY    KG + D  E     K +  A    ERI +FL+E  ++   N  +  
Sbjct: 14  LGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERI-EFLNEASVMKEFNCHHVV 72

Query: 205 KLIGFSTENGFHLV-LQFLPHGSLSSLLF-------GSTECLEWTIRYKIALG--IAEGL 254
           +L+G  ++    LV ++ +  G L S L         +      +++  I +   IA+G+
Sbjct: 73  RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGM 132

Query: 255 QYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSHHI----VFPIEGTF 310
            YL+ +   + +HRD+ A N +++ED+  +I DFG+ + + +   +      + P+    
Sbjct: 133 AYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR--- 186

Query: 311 GYLSPEYFMHGIVDEKTDVFAFGVLLLELIT 341
            ++SPE    G+    +DV++FGV+L E+ T
Sbjct: 187 -WMSPESLKDGVFTTYSDVWSFGVVLWEIAT 216

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 65.8 bits (160), Expect = 5e-12
 Identities = 63/233 (27%), Positives = 107/233 (45%), Gaps = 39/233 (16%)

Query: 136 ELAAATDNFNSENLIGKGGHAEVYKGCL----PDGEVVAVK-KIIKNAKEDEERISDFLS 190
           E+  +T  F  E  +G+    +VYKG L    P  +  AV  K +K+  E   R  +F  
Sbjct: 1   EINLSTVRFMEE--LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLR-EEFKH 57

Query: 191 ELGIVAHINHPNAAKLIGFST-ENGFHLVLQFLPHGSLSSLLF--------GSTE----- 236
           E  + + + HPN   L+G  T E    ++  +  H  L   L         GST+     
Sbjct: 58  EAMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTV 117

Query: 237 --CLEWTIRYKIALGIAEGLQYL--HHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAK 292
              LE      I   IA G+++L  HH     ++H+D+   N+L+ +    +ISD GL +
Sbjct: 118 KSTLEPADFVHIVTQIAAGMEFLSSHH-----VVHKDLATRNVLVFDKLNVKISDLGLFR 172

Query: 293 --WLPDNWS--HHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELIT 341
             +  D +    + + PI     ++SPE  M+G     +D++++GV+L E+ +
Sbjct: 173 EVYAADYYKLMGNSLLPIR----WMSPEAIMYGKFSIDSDIWSYGVVLWEVFS 221

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 66.3 bits (162), Expect = 5e-12
 Identities = 34/99 (34%), Positives = 58/99 (58%), Gaps = 6/99 (6%)

Query: 245 KIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVF 304
           KI++ +  GL YL      +I+HRD+K SNIL++   E ++ DFG++  L D+ ++  V 
Sbjct: 103 KISIAVLRGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV- 159

Query: 305 PIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGR 343
              GT  Y+SPE         ++D+++ G+ L+E+  GR
Sbjct: 160 ---GTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGR 195

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 65.9 bits (161), Expect = 6e-12
 Identities = 58/205 (28%), Positives = 102/205 (49%), Gaps = 24/205 (11%)

Query: 150 IGKGGHAEVYKG-CLPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIG 208
           IG+G +  VYKG     G++VA+KKI +   E+E   S  + E+ ++  + HPN   L  
Sbjct: 8   IGEGTYGVVYKGRNKKTGQIVAMKKI-RLESEEEGVPSTAIREISLLKELQHPNIVCLQD 66

Query: 209 -FSTENGFHLVLQFLP---HGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCH-R 263
               E+  +L+ +FL       L SL     + ++  +       I +G+ +    CH R
Sbjct: 67  VLMQESRLYLIFEFLSMDLKKYLDSL--PKGQYMDAELVKSYLYQILQGILF----CHSR 120

Query: 264 RIIHRDIKASNILLSEDYEAQISDFGLAK--WLPDN-WSHHIVFPIEGTFGYLSPEYFMH 320
           R++HRD+K  N+L+      +++DFGLA+   +P   ++H +V     T  Y +PE  + 
Sbjct: 121 RVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHEVV-----TLWYRAPEVLL- 174

Query: 321 GIVDEKT--DVFAFGVLLLELITGR 343
           G     T  D+++ G +  E+ T +
Sbjct: 175 GSPRYSTPVDIWSIGTIFAEMATKK 199

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 65.8 bits (160), Expect = 6e-12
 Identities = 48/190 (25%), Positives = 90/190 (47%), Gaps = 25/190 (13%)

Query: 168 VVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTENG-FHLVLQFLPHGS 226
           +VAVK +  +  +     +DFL E+ I++ + +PN  +L+G    +    ++ +++ +G 
Sbjct: 46  LVAVKMLRADVTKTAR--NDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGD 103

Query: 227 LSSLL-----------FGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNI 275
           L+  L             +   +       +A+ IA G++YL        +HRD+   N 
Sbjct: 104 LNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYL---ASLNFVHRDLATRNC 160

Query: 276 LLSEDYEAQISDFGLAKWLPDNWSHHI----VFPIEGTFGYLSPEYFMHGIVDEKTDVFA 331
           L+   Y  +I+DFG+++ L     + I    V PI     +++ E  + G     +DV+A
Sbjct: 161 LVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIR----WMAWESILLGKFTTASDVWA 216

Query: 332 FGVLLLELIT 341
           FGV L E+ T
Sbjct: 217 FGVTLWEMFT 226

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 65.9 bits (160), Expect = 7e-12
 Identities = 48/196 (24%), Positives = 101/196 (51%), Gaps = 14/196 (7%)

Query: 150 IGKGGHAEVYKGC-LPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLI- 207
           IG+G    V+    +  G+ VA+K+I    +  +E I   ++E+ ++  + +PN    + 
Sbjct: 27  IGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELI---INEILVMKELKNPNIVNFLD 83

Query: 208 GFSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIH 267
            F   +   +V+++L  GSL+ ++  +  C++      +     + L++LH +   ++IH
Sbjct: 84  SFLVGDELFVVMEYLAGGSLTDVV--TETCMDEAQIAAVCRECLQALEFLHAN---QVIH 138

Query: 268 RDIKASNILLSEDYEAQISDFGL-AKWLPDNWSHHIVFPIEGTFGYLSPEYFMHGIVDEK 326
           RDIK+ N+LL  D   +++DFG  A+  P+      +    GT  +++PE         K
Sbjct: 139 RDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMV---GTPYWMAPEVVTRKAYGPK 195

Query: 327 TDVFAFGVLLLELITG 342
            D+++ G++ +E++ G
Sbjct: 196 VDIWSLGIMAIEMVEG 211

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 65.4 bits (159), Expect = 7e-12
 Identities = 61/218 (27%), Positives = 99/218 (45%), Gaps = 19/218 (8%)

Query: 144 FNSENLIGKGGHAEVYKGCL--PDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHP 201
           F    ++GKGG  EV   C     G++ A K++ K   +  +  S  L+E  I+  +N  
Sbjct: 2   FRQYRVLGKGGFGEVC-ACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQ 60

Query: 202 NAAKLI-GFSTENGFHLVLQFLPHGSLSSLLF-----GSTECLEWTIRYKIALGIAEGLQ 255
               L   + T++   LVL  +  G L   ++     G  E  E  + Y  A  I  GL+
Sbjct: 61  FVVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEE--ERALFY--AAEILCGLE 116

Query: 256 YLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEGTFGYLSP 315
            LH +     ++RD+K  NILL +    +ISD GLA  +P+      +    GT GY++P
Sbjct: 117 DLHRE---NTVYRDLKPENILLDDYGHIRISDLGLAVKIPEG---ESIRGRVGTVGYMAP 170

Query: 316 EYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSL 353
           E   +       D +  G L+ E+I G+     R++ +
Sbjct: 171 EVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKV 208

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 65.6 bits (161), Expect = 8e-12
 Identities = 57/219 (26%), Positives = 94/219 (42%), Gaps = 43/219 (19%)

Query: 148 NLIGKGGHAEVYKGC-LPDGEVVAVKKIIKNAKEDEE---RISDFLSELGIVAHINHPNA 203
             IG G +  V        G  VA+KKI  N  +D     RI   L E+ ++ H+ H N 
Sbjct: 6   KPIGSGAYGVVCSAVDKRTGRKVAIKKIS-NVFDDLIDAKRI---LREIKLLRHLRHENI 61

Query: 204 AKLI------GFSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYL 257
             L+           N  ++V + +    L  ++       +  I+Y     I  GL+YL
Sbjct: 62  IGLLDILRPPSPEDFNDVYIVTELMET-DLHKVIKSPQPLTDDHIQY-FLYQILRGLKYL 119

Query: 258 HHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAK------WLPDNWSHHIVFPIEGTFG 311
           H   +  +IHRD+K SNIL++ + + +I DFGLA+            + ++V     T  
Sbjct: 120 H-SAN--VIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVV-----TRW 171

Query: 312 YLSPE-------YFMHGIVDEKTDVFAFGVLLLELITGR 343
           Y +PE       Y       +  D+++ G +  EL+T +
Sbjct: 172 YRAPELLLSSSRY------TKAIDIWSVGCIFAELLTRK 204

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 64.8 bits (158), Expect = 1e-11
 Identities = 45/135 (33%), Positives = 71/135 (52%), Gaps = 18/135 (13%)

Query: 245 KIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVF 304
           KIA+ I + L+YLH      +IHRD+K SN+L++ + + ++ DFG++ +L D+ +  I  
Sbjct: 107 KIAVSIVKALEYLHSKLS--VIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVAKTID- 163

Query: 305 PIEGTFGYLSPEYF-----MHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKP 359
              G   Y++PE         G  D K+DV++ G+ ++EL TGR   DS       W  P
Sbjct: 164 --AGCKPYMAPERINPELNQKGY-DVKSDVWSLGITMIELATGRFPYDS-------WKTP 213

Query: 360 LLQTSNFKELVDPRL 374
             Q     E   P+L
Sbjct: 214 FQQLKQVVEEPSPQL 228

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 65.0 bits (158), Expect = 1e-11
 Identities = 59/201 (29%), Positives = 94/201 (46%), Gaps = 17/201 (8%)

Query: 150 IGKGGHAEVYKGCLPD-GEVVAVKKIIKN--AKEDEERISDFLSELGIVAHINHPNAAKL 206
           +GKGG  EV    + + G++ A KK+ K    K+  E+++  L E  I+  +N P    L
Sbjct: 1   LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMA--LLEKEILEKVNSPFIVNL 58

Query: 207 I-GFSTENGFHLVLQFLPHGSLSSLLFGSTEC---LEWTIRYKIALGIAEGLQYLHHDCH 262
              F ++    LV+  +  G L   ++   E    +E  I Y     I  G+ +LH    
Sbjct: 59  AYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQ--ITCGILHLHS--- 113

Query: 263 RRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEGTFGYLSPEYFMHGI 322
             I++RD+K  N+LL +    ++SD GLA  L D  +   +    GT GY++PE      
Sbjct: 114 MDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT---ITQRAGTNGYMAPEILKEEP 170

Query: 323 VDEKTDVFAFGVLLLELITGR 343
                D FA G  + E++ GR
Sbjct: 171 YSYPVDWFAMGCSIYEMVAGR 191

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 64.9 bits (158), Expect = 1e-11
 Identities = 63/205 (30%), Positives = 92/205 (44%), Gaps = 22/205 (10%)

Query: 150 IGKGGHAEVYKGCL-PDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKL-I 207
           +GKGG  EV    +   G++ A KK+ K   +  +     + E  I+A ++      L  
Sbjct: 1   LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60

Query: 208 GFSTENGFHLVLQFLPHGSLSSLLFGSTE---------CLEWTIRYKIALGIAEGLQYLH 258
            F T+    LV+  +  G L   ++   E            +T +      I  GL++LH
Sbjct: 61  AFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQ------IISGLEHLH 114

Query: 259 HDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEGTFGYLSPEYF 318
               RRII+RD+K  N+LL  D   +ISD GLA  L D  S    +   GT G+++PE  
Sbjct: 115 Q---RRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYA--GTPGFMAPELL 169

Query: 319 MHGIVDEKTDVFAFGVLLLELITGR 343
                D   D FA GV L E+I  R
Sbjct: 170 QGEEYDFSVDYFALGVTLYEMIAAR 194

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 65.1 bits (158), Expect = 1e-11
 Identities = 49/196 (25%), Positives = 99/196 (50%), Gaps = 14/196 (7%)

Query: 150 IGKGGHAEVYKGC-LPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAK-LI 207
           IG+G    VY    +  G+ VA+K++    +  +E I   ++E+ ++    +PN    L 
Sbjct: 27  IGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELI---INEILVMRENKNPNIVNYLD 83

Query: 208 GFSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIH 267
            +   +   +V+++L  GSL+ ++  +  C++      +     + L +LH +   ++IH
Sbjct: 84  SYLVGDELWVVMEYLAGGSLTDVV--TETCMDEGQIAAVCRECLQALDFLHSN---QVIH 138

Query: 268 RDIKASNILLSEDYEAQISDFGL-AKWLPDNWSHHIVFPIEGTFGYLSPEYFMHGIVDEK 326
           RDIK+ NILL  D   +++DFG  A+  P+      +    GT  +++PE         K
Sbjct: 139 RDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV---GTPYWMAPEVVTRKAYGPK 195

Query: 327 TDVFAFGVLLLELITG 342
            D+++ G++ +E++ G
Sbjct: 196 VDIWSLGIMAIEMVEG 211

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 64.8 bits (158), Expect = 1e-11
 Identities = 64/221 (28%), Positives = 100/221 (45%), Gaps = 29/221 (13%)

Query: 144 FNSENLIGKGGHAEVYKGCL----PDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHIN 199
           F    ++GKGG  EV   C       G++ A KK+ K   +  +  +  L+E  I+  +N
Sbjct: 2   FRHYRVLGKGGFGEV---CACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVN 58

Query: 200 HPNAAKLI-GFSTENGFHLVLQFLPHGSLSSLLF-----GSTECLEWTIRYKIALGIAEG 253
                 L   + T++   LVL  +  G L   ++     G  E  E  + Y  A  I  G
Sbjct: 59  SRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDE--ERAVFY--AAEITCG 114

Query: 254 LQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIE---GTF 310
           L+ LH +   RI++RD+K  NILL +    +ISD GLA  +P+         I    GT 
Sbjct: 115 LEDLHRE---RIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE------TIRGRVGTV 165

Query: 311 GYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQ 351
           GY++PE   +       D +  G L+ E+I G+     R++
Sbjct: 166 GYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKE 206

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 64.8 bits (158), Expect = 1e-11
 Identities = 60/217 (27%), Positives = 106/217 (48%), Gaps = 35/217 (16%)

Query: 143 NFNSENLIGKGGHAEVYKG-CLPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHP 201
           NF     +G+G +A VYKG     GE+VA+K+I  +   +E   S  + E+ ++  + H 
Sbjct: 1   NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEI--HLDAEEGTPSTAIREISLMKELKHE 58

Query: 202 NAAKLIG-FSTENGFHLVLQFLP---------HGSLSSLLFGSTECLEWTIRYKIALGIA 251
           N  +L     TEN   LV +++          HG   +L   + +   + +   IA    
Sbjct: 59  NIVRLHDVIHTENKLMLVFEYMDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAF--- 115

Query: 252 EGLQYLHHDCHR-RIIHRDIKASNILLSEDYEAQISDFGLAK--WLPDN-WSHHIVFPIE 307
                    CH  R++HRD+K  N+L+++  E +++DFGLA+   +P N +S+ +V    
Sbjct: 116 ---------CHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVV---- 162

Query: 308 GTFGYLSPEYFMHGIV-DEKTDVFAFGVLLLELITGR 343
            T  Y +P+  +         D+++ G ++ E+ITGR
Sbjct: 163 -TLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGR 198

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 65.0 bits (158), Expect = 2e-11
 Identities = 58/236 (24%), Positives = 102/236 (43%), Gaps = 39/236 (16%)

Query: 142 DNFNSENLIGKGGHAEVYKGCLPD-GEVVAVKKIIKNAKEDEERISDFLSELGIVAHINH 200
           D+F S  +IG+G   EV      D G + A+K + K    ++E+++   +E  I+   + 
Sbjct: 1   DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADG 60

Query: 201 PNAAKLI-GFSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHH 259
               K+   F  +   +L+++FLP G + +LL       E   ++ IA  +   +  +H 
Sbjct: 61  AWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVL-AIDAIHQ 119

Query: 260 DCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWL----------------PDNWS---- 299
                 IHRDIK  N+LL      ++SDFGL   L                P ++S    
Sbjct: 120 ---LGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNM 176

Query: 300 -------------HHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITG 342
                          + +   GT  Y++PE FM    ++  D ++ GV++ E++ G
Sbjct: 177 NSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIG 232

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 64.4 bits (157), Expect = 2e-11
 Identities = 46/155 (29%), Positives = 81/155 (52%), Gaps = 12/155 (7%)

Query: 190 SELGIVAHINHPNAAKLIGFSTENGF-HLVLQFLPHGSLSSLLFGSTECLEWTIRYKIAL 248
           +E  ++  ++HP   +L     +  F +++++++P G L S L  S      T  +  A 
Sbjct: 50  NEKRVLKEVSHPFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLF-YAS 108

Query: 249 GIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPD-NWSHHIVFPIE 307
            I   L+YLH    + I++RD+K  NILL ++   +++DFG AK L D  W+      + 
Sbjct: 109 EIVCALEYLHS---KEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRTWT------LC 159

Query: 308 GTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITG 342
           GT  YL+PE       ++  D +A G+L+ E++ G
Sbjct: 160 GTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVG 194

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 64.4 bits (156), Expect = 2e-11
 Identities = 48/195 (24%), Positives = 98/195 (50%), Gaps = 12/195 (6%)

Query: 150 IGKGGHAEVYKGC-LPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAK-LI 207
           IG+G    VY    +  G+ VA++++    +  +E I   ++E+ ++    +PN    L 
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELI---INEILVMRENKNPNIVNYLD 84

Query: 208 GFSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIH 267
            +   +   +V+++L  GSL+ ++  +  C++      +     + L++LH +   ++IH
Sbjct: 85  SYLVGDELWVVMEYLAGGSLTDVV--TETCMDEGQIAAVCRECLQALEFLHSN---QVIH 139

Query: 268 RDIKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEGTFGYLSPEYFMHGIVDEKT 327
           RDIK+ NILL  D   +++DFG    +    S      + GT  +++PE         K 
Sbjct: 140 RDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRS--TMVGTPYWMAPEVVTRKAYGPKV 197

Query: 328 DVFAFGVLLLELITG 342
           D+++ G++ +E+I G
Sbjct: 198 DIWSLGIMAIEMIEG 212

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 63.9 bits (155), Expect = 2e-11
 Identities = 57/228 (25%), Positives = 112/228 (49%), Gaps = 27/228 (11%)

Query: 166 GEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLI-GFSTENGFHLVLQFLPH 224
           G+ VAVKK+    ++  E +    +E+ I+   +H N   +   +   +   +V++FL  
Sbjct: 47  GKQVAVKKMDLRKQQRRELL---FNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEG 103

Query: 225 GSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQ 284
           G+L+ ++   T   E  I   + L +   L YLH+   + +IHRDIK+ +ILL+ D   +
Sbjct: 104 GALTDIV-THTRMNEEQIA-TVCLSVLRALSYLHN---QGVIHRDIKSDSILLTSDGRIK 158

Query: 285 ISDFG----LAKWLPDNWSHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELI 340
           +SDFG    ++K +P   S      + GT  +++PE         + D+++ G++++E+I
Sbjct: 159 LSDFGFCAQVSKEVPKRKS------LVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMI 212

Query: 341 TGRRAVDSRRQSLVIWAKPLLQTSNFKELVDPRLADAYDLAEMKRAML 388
            G     +          PL      ++ + PR+ D++ ++ + R  L
Sbjct: 213 DGEPPYFNE--------PPLQAMRRIRDNLPPRVKDSHKVSSVLRGFL 252

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 63.6 bits (155), Expect = 3e-11
 Identities = 60/202 (29%), Positives = 98/202 (48%), Gaps = 20/202 (9%)

Query: 149 LIGKGGHAEVYKGCL--PDGEVVAVKKIIKNAKEDEERISDF-LSELGIVAHINHPNAAK 205
           L+G+G +  V K C     G++VA+KK +++  ED++ +    + E+ ++  + H N   
Sbjct: 8   LVGEGSYGMVMK-CKHKETGQIVAIKKFLES--EDDKMVKKIAMREIRMLKQLRHENLVN 64

Query: 206 LIG-FSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRR 264
           LI  F  +   +LV +F+ H  L  L        E  +R K    I  G+++ H      
Sbjct: 65  LIEVFRRKKRLYLVFEFVDHTVLDDLEKYPNGLDESRVR-KYLFQILRGIEFCHSH---N 120

Query: 265 IIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEGTFGYLSPEYFMHGIVD 324
           IIHRDIK  NIL+S+    ++ DFG A+ L       +      T  Y +PE     + D
Sbjct: 121 IIHRDIKPENILVSQSGVVKLCDFGFARTL--AAPGEVYTDYVATRWYRAPELL---VGD 175

Query: 325 EK----TDVFAFGVLLLELITG 342
            K     D++A G L+ E++TG
Sbjct: 176 TKYGRAVDIWAVGCLVTEMLTG 197

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 64.3 bits (157), Expect = 3e-11
 Identities = 49/199 (24%), Positives = 91/199 (45%), Gaps = 19/199 (9%)

Query: 150 IGKGGHAEVYKGCLPD-GEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLI- 207
           +G+GG+ +V+     D GE+VA+K++ K+       +   L+E  I+         KL+ 
Sbjct: 9   VGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLY 68

Query: 208 GFSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIA---LGIAEGLQYLHHDCHRR 264
            F  +   +L ++++P G   +LL       E   R+ +A     +           H  
Sbjct: 69  AFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDA--------LHEL 120

Query: 265 -IIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEGTFGYLSPEYFMHGIV 323
             IHRD+K  N L+      +++DFGL+K +   +++ +V    G+  Y++PE       
Sbjct: 121 GYIHRDLKPENFLIDASGHIKLTDFGLSKGIV-TYANSVV----GSPDYMAPEVLRGKGY 175

Query: 324 DEKTDVFAFGVLLLELITG 342
           D   D ++ G +L E + G
Sbjct: 176 DFTVDYWSLGCMLYEFLCG 194

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 63.8 bits (155), Expect = 3e-11
 Identities = 65/232 (28%), Positives = 108/232 (46%), Gaps = 26/232 (11%)

Query: 137 LAAATDNFNSENLIGKGGHAEVYKGCLP-DGEVVAVKKIIKNAKEDEERISDFLSELGIV 195
             AAT   N E L G+G +A VYKG    +G++VA+K I    +E     +  + E  ++
Sbjct: 1   FGAATSYLNLEKL-GEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTA--IREASLL 57

Query: 196 AHINHPNAAKLIGF-STENGFHLVLQFLPHGSLSSLLFGSTECLE-WTIRYKIALGIAEG 253
             + H N   L     T+     V +++ H  L+  +      L  + +R      +  G
Sbjct: 58  KGLKHANIVLLHDIIHTKETLTFVFEYM-HTDLAQYMIQHPGGLHPYNVRL-FMFQLLRG 115

Query: 254 LQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLA--KWLP-DNWSHHIVFPIEGTF 310
           L Y+H    + I+HRD+K  N+L+S   E +++DFGLA  K +P   +S  +V     T 
Sbjct: 116 LAYIHG---QHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVV-----TL 167

Query: 311 GYLSPEYFMHGIVDEKT--DVFAFGVLLLELITGRRAV----DSRRQSLVIW 356
            Y  P+  + G  D  +  D++  G + +E++ G+ A     D   Q   IW
Sbjct: 168 WYRPPDVLL-GATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIW 218

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 64.3 bits (156), Expect = 3e-11
 Identities = 58/236 (24%), Positives = 101/236 (42%), Gaps = 39/236 (16%)

Query: 142 DNFNSENLIGKGGHAEVYKGCLPD-GEVVAVKKIIKNAKEDEERISDFLSELGIVAHINH 200
           ++F S  +IG+G   EV      D G V A+K + K    ++E++    +E  I+   + 
Sbjct: 1   EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADS 60

Query: 201 PNAAKLI-GFSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHH 259
               K+   F  +   +L+++FLP G + +LL       E   ++ IA  +   +  +H 
Sbjct: 61  LWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVL-AIDSIHQ 119

Query: 260 DCHRRIIHRDIKASNILLSEDYEAQISDFGL----------------------------- 290
                 IHRDIK  N+LL      ++SDFGL                             
Sbjct: 120 ---LGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNM 176

Query: 291 -AKWLPDNWSHH---IVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITG 342
            +K   + W  +   + F   GT  Y++PE FM    ++  D ++ GV++ E++ G
Sbjct: 177 NSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIG 232

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 63.2 bits (154), Expect = 3e-11
 Identities = 50/182 (27%), Positives = 97/182 (53%), Gaps = 19/182 (10%)

Query: 166 GEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIG-FSTENGFHLVLQFLPH 224
           G  VAVKK+  + ++ + R   F +E+ I+    HPN  ++   +   +   +V++FL  
Sbjct: 44  GRQVAVKKM--DLRKQQRRELLF-NEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEG 100

Query: 225 GSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQ 284
           G+L+ ++   T   E  I   + L + + L +LH    + +IHRDIK+ +ILL+ D   +
Sbjct: 101 GALTDIV-THTRMNEEQIAT-VCLAVLKALSFLHA---QGVIHRDIKSDSILLTSDGRVK 155

Query: 285 ISDFG----LAKWLPDNWSHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELI 340
           +SDFG    ++K +P   S      + GT  +++PE         + D+++ G++++E++
Sbjct: 156 LSDFGFCAQVSKEVPRRKS------LVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMV 209

Query: 341 TG 342
            G
Sbjct: 210 DG 211

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 63.3 bits (154), Expect = 5e-11
 Identities = 57/205 (27%), Positives = 101/205 (49%), Gaps = 22/205 (10%)

Query: 149 LIGKGGHAEVYKGCLPDG----EVVAVK-----KIIKNAKEDEERISDFLSELGIVAHIN 199
           ++GKGG+ +V++     G    ++ A+K      I++N K+     +   +E  I+  + 
Sbjct: 3   VLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKD----TAHTKAERNILEAVK 58

Query: 200 HPNAAKLI-GFSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLH 258
           HP    LI  F T    +L+L++L  G L   L      +E T  + ++  I+  L++LH
Sbjct: 59  HPFIVDLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLS-EISLALEHLH 117

Query: 259 HDCHRRIIHRDIKASNILLSEDYEAQISDFGLAK-WLPDNWSHHIVFPIEGTFGYLSPEY 317
               + II+RD+K  NILL      +++DFGL K  + +    H      GT  Y++PE 
Sbjct: 118 Q---QGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHTFC---GTIEYMAPEI 171

Query: 318 FMHGIVDEKTDVFAFGVLLLELITG 342
            M     +  D ++ G L+ +++TG
Sbjct: 172 LMRSGHGKAVDWWSLGALMYDMLTG 196

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score = 62.6 bits (153), Expect = 6e-11
 Identities = 61/209 (29%), Positives = 91/209 (43%), Gaps = 34/209 (16%)

Query: 150 IGKGGHAEVYKGC-LPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHIN-HPNAAKLI 207
           +G G    VY       GE+VA+KK+ K     EE ++  L E+  +  +N HPN  KL 
Sbjct: 7   LGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMN--LREVKSLRKLNEHPNIVKLK 64

Query: 208 GFSTENG-FHLVLQFLPHGSLSSLLFGSTECL--EWTIRYKIALGIAEGLQYLHHDCHRR 264
               EN   + V +++  G+L  L+         E  IR  I   I +GL ++H   H  
Sbjct: 65  EVFRENDELYFVFEYM-EGNLYQLMKDRKGKPFSESVIRS-IIYQILQGLAHIHK--HG- 119

Query: 265 IIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIE---------GTFGYLSP 315
             HRD+K  N+L+S     +I+DFGLA+             I           T  Y +P
Sbjct: 120 FFHRDLKPENLLVSGPEVVKIADFGLAR------------EIRSRPPYTDYVSTRWYRAP 167

Query: 316 EYFMH-GIVDEKTDVFAFGVLLLELITGR 343
           E  +         D++A G ++ EL T R
Sbjct: 168 EILLRSTSYSSPVDIWALGCIMAELYTLR 196

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 63.2 bits (154), Expect = 6e-11
 Identities = 58/207 (28%), Positives = 95/207 (45%), Gaps = 27/207 (13%)

Query: 149 LIGKGGHAEV----YKGCLPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHI-NHPNA 203
           ++GKG   +V     KG     E+ AVK + K+    ++ +   ++E  ++A    HP  
Sbjct: 2   VLGKGSFGKVLLAELKG---TDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFL 58

Query: 204 AKLIG-FSTENGFHLVLQFLPHGSLSSLLFGSTEC----LEWTIRYKIALGIAEGLQYLH 258
            +L   F T++    V++++  G L   +F               Y  A  I  GLQ+LH
Sbjct: 59  TQLHSCFQTKDRLFFVMEYVNGGDL---MFHIQRSGRFDEPRARFY--AAEIVLGLQFLH 113

Query: 259 HDCHRRIIHRDIKASNILLSEDYEAQISDFGLAK--WLPDNWSHHIVFPIEGTFGYLSPE 316
               R II+RD+K  N+LL  +   +I+DFG+ K   L    +        GT  Y++PE
Sbjct: 114 E---RGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTFC----GTPDYIAPE 166

Query: 317 YFMHGIVDEKTDVFAFGVLLLELITGR 343
              +       D +A GVLL E++ G+
Sbjct: 167 ILSYQPYGPAVDWWALGVLLYEMLAGQ 193

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 63.5 bits (154), Expect = 8e-11
 Identities = 85/322 (26%), Positives = 142/322 (44%), Gaps = 51/322 (15%)

Query: 160 KGCLPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAK-LIGFSTENGFHLV 218
           +G  P  +VVA K ++ N   DE + +   SEL  +A  +H    K    F +++   L+
Sbjct: 88  RGSDPKEKVVA-KFVMLN---DERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLI 143

Query: 219 LQFLPHGSLSS---------LLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRD 269
           +++   G L+          L F   E     + Y+I L + E    +H    R+++HRD
Sbjct: 144 MEYGSGGDLNKQIKQRLKEHLPFQEYEV--GLLFYQIVLALDE----VHS---RKMMHRD 194

Query: 270 IKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEGTFGYLSPEYFMHGIVDEKTDV 329
           +K++NI L      ++ DFG +K   D+ S  +     GT  YL+PE +      +K D+
Sbjct: 195 LKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADM 254

Query: 330 FAFGVLLLELITGRRAVD--SRRQSL--VIWAK----PLLQTSNFKELVDPRLADAYDLA 381
           ++ GV+L EL+T  R     S+R+ +  V++ K    P   +S  K L+DP L+    L 
Sbjct: 255 WSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYDPFPCPVSSGMKALLDPLLSKNPALR 314

Query: 382 EMKRAMLTASV----------CIHHLSTMRPQ-MTRVLQLLRGEGGQTDLKPKPSARR-- 428
              + +L               + H  T+ P     +L+ L+  G +    P PS+ R  
Sbjct: 315 PTTQQLLHTEFLKYVANLFQDIVRHSETISPHDREEILRQLQESGERA---PPPSSIRYG 371

Query: 429 ----TVILDGSDEEYSSTCYLK 446
                V   G   +YSS    K
Sbjct: 372 VVTSDVTHGGYLYKYSSDMRWK 393

Length = 478

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 62.3 bits (151), Expect = 9e-11
 Identities = 58/213 (27%), Positives = 95/213 (44%), Gaps = 22/213 (10%)

Query: 143 NFNSENLIGKGGHAEVY---------KGCLPDGEVVAVKKIIKNAKEDEERISDFLSELG 193
           NF    ++G G + +V+          G L   +V+    I++ AK  E       +E  
Sbjct: 1   NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHT----RTERQ 56

Query: 194 IVAHINH-PNAAKL-IGFSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIA 251
           ++ HI   P    L   F T+   HL+L ++  G L + L       E     ++ +   
Sbjct: 57  VLEHIRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKE----QEVQIYSG 112

Query: 252 EGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEGTFG 311
           E +  L H     II+RDIK  NILL  +    ++DFGL+K   ++      +   GT  
Sbjct: 113 EIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVER-AYSFCGTIE 171

Query: 312 YLSPEYFMHGIV--DEKTDVFAFGVLLLELITG 342
           Y++P+    G    D+  D ++ GVL+ EL+TG
Sbjct: 172 YMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTG 204

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 62.0 bits (150), Expect = 1e-10
 Identities = 54/208 (25%), Positives = 96/208 (46%), Gaps = 11/208 (5%)

Query: 143 NFNSENLIGKGGHAEVYKGCLPD-GEVVAVKKIIKN--AKEDEERISDFLSELGIVAHIN 199
           N+    L+G+G    VY     D G  +AVK++  +  + E  + ++    E+ ++ ++ 
Sbjct: 3   NWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLL 62

Query: 200 HPNAAKLIGF---STENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQY 256
           H    +  G      E    + ++ +P GS+   L  S   L   +  K    I EG+ Y
Sbjct: 63  HERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQL-KSYGALTENVTRKYTRQILEGVSY 121

Query: 257 LHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPD-NWSHHIVFPIEGTFGYLSP 315
           LH +    I+HRDIK +NIL       ++ DFG +K L     S   +  + GT  ++SP
Sbjct: 122 LHSN---MIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSP 178

Query: 316 EYFMHGIVDEKTDVFAFGVLLLELITGR 343
           E         K D+++ G  ++E++T +
Sbjct: 179 EVISGEGYGRKADIWSVGCTVVEMLTEK 206

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 62.7 bits (152), Expect = 1e-10
 Identities = 56/210 (26%), Positives = 99/210 (47%), Gaps = 24/210 (11%)

Query: 142 DNFNSENLIGKGGHAEVYKGCLPDGEV--VAVKKIIKNAKEDEERISDFLSELGIVAHIN 199
           ++FN    +G G    V      + +   VA+K+  K+    ++++    SE  I+ +IN
Sbjct: 30  EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYIN 89

Query: 200 HPNAAKLIG-FSTENGFHLVLQFLPHGSLSSLLFGSTE------CLEWTIRYKIALGIAE 252
           HP    L G F  E+  +LVL+F+  G   + L  +        C       +I L I E
Sbjct: 90  HPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCF---YAAQIVL-IFE 145

Query: 253 GLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEGTFGY 312
            LQ L+      I++RD+K  N+LL +D   +++DFG AK +         + + GT  Y
Sbjct: 146 YLQSLN------IVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTR-----TYTLCGTPEY 194

Query: 313 LSPEYFMHGIVDEKTDVFAFGVLLLELITG 342
           ++PE  ++    +  D +  G+ + E++ G
Sbjct: 195 IAPEILLNVGHGKAADWWTLGIFIYEILVG 224

Length = 340

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 62.0 bits (151), Expect = 1e-10
 Identities = 62/210 (29%), Positives = 102/210 (48%), Gaps = 17/210 (8%)

Query: 142 DNFNSENLIGKGGHAEVYKG-CLPDGEVVAVKKIIKNA-KEDEERISDFLSELGIVAHIN 199
           ++  +   IG G   +VYK      G V+AVK++ +   KE+ +RI   L +L +V   +
Sbjct: 15  NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRI---LMDLDVVLKSH 71

Query: 200 H-PNAAKLIG-FSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYL 257
             P   K  G F T++   + ++ L    L  LL      +   I  K+ + I + L YL
Sbjct: 72  DCPYIVKCYGYFITDSDVFICME-LMSTCLDKLLKRIQGPIPEDILGKMTVAIVKALHYL 130

Query: 258 HHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEGTFGYLSPEY 317
             + H  +IHRD+K SNILL      ++ DFG++  L D+ +        G   Y++PE 
Sbjct: 131 K-EKHG-VIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAKT---RSAGCAAYMAPER 185

Query: 318 F----MHGIVDEKTDVFAFGVLLLELITGR 343
                 +   D + DV++ G+ L+EL TG+
Sbjct: 186 IDPPDPNPKYDIRADVWSLGISLVELATGQ 215

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 61.9 bits (150), Expect = 1e-10
 Identities = 51/205 (24%), Positives = 95/205 (46%), Gaps = 14/205 (6%)

Query: 147 ENLIGKGGHAEVYKGCLP---DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNA 203
           E ++G G   E+ +GCL      E+      ++    D++R   FL+E   +   +H N 
Sbjct: 10  ERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRG-FLAEALTLGQFDHSNI 68

Query: 204 AKLIGFSTE-NGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCH 262
            +L G  T  N   +V +++ +G+L S L      L       +  G+A G++YL     
Sbjct: 69  VRLEGVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYL---SE 125

Query: 263 RRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEGTFGYL--SPEYFMH 320
              +H+ + A  +L++ D   +IS F     L ++ S  I   + G    L  +PE   +
Sbjct: 126 MGYVHKGLAAHKVLVNSDLVCKISGFRR---LQEDKSEAIYTTMSGKSPVLWAAPEAIQY 182

Query: 321 GIVDEKTDVFAFGVLLLELIT-GRR 344
                 +DV++FG+++ E+++ G R
Sbjct: 183 HHFSSASDVWSFGIVMWEVMSYGER 207

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 63.7 bits (155), Expect = 1e-10
 Identities = 55/197 (27%), Positives = 96/197 (48%), Gaps = 26/197 (13%)

Query: 166 GEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLI--GFSTENGFHLVLQFLP 223
           G  VA+K +  +A E+E + + F  E  + A + HPN   L+  G +       V +++P
Sbjct: 3   GHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVP 62

Query: 224 HGSLSSLLF--GSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSE-- 279
             +L  +L   G+    E T R  + L + + L   H+   + I+HRD+K  NI++S+  
Sbjct: 63  GRTLREVLAADGALPAGE-TGR--LMLQVLDALACAHN---QGIVHRDLKPQNIMVSQTG 116

Query: 280 -DYEAQISDFGLAKWLPD---------NWSHHIVFPIEGTFGYLSPEYFMHGIVDEKTDV 329
               A++ DFG+   LP            +  ++    GT  Y +PE      V   +D+
Sbjct: 117 VRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVL----GTPTYCAPEQLRGEPVTPNSDL 172

Query: 330 FAFGVLLLELITGRRAV 346
           +A+G++ LE +TG+R V
Sbjct: 173 YAWGLIFLECLTGQRVV 189

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 62.6 bits (152), Expect = 1e-10
 Identities = 43/156 (27%), Positives = 76/156 (48%), Gaps = 14/156 (8%)

Query: 142 DNFNSENLIGKGGHAEV-YKGCLPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINH 200
           ++F++  +IGKG   EV        G++ A+K ++K+    +++++   +E  ++A  + 
Sbjct: 1   EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDS 60

Query: 201 PNAAKL-IGFSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIA---LGIAEGLQY 256
           P    L   F      +L+++FLP G L ++L       E   R+ +A   L I      
Sbjct: 61  PWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIE----- 115

Query: 257 LHHDCHRR-IIHRDIKASNILLSEDYEAQISDFGLA 291
                H+   IHRDIK  NIL+      ++SDFGL+
Sbjct: 116 ---AVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLS 148

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 61.1 bits (148), Expect = 1e-10
 Identities = 42/159 (26%), Positives = 81/159 (50%), Gaps = 19/159 (11%)

Query: 191 ELGIVAHINHPNAAKLI-GFSTENGFHLVLQFLPHGSL-------SSLLFGSTECLEWTI 242
           E  ++A + HPN       F  +   ++V+++   G L          LF     L+W +
Sbjct: 48  EAVLLAKMKHPNIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFV 107

Query: 243 RYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSHHI 302
           +      +  G+Q++H    +R++HRDIK+ NI L+++ + ++ DFG A+ L    ++  
Sbjct: 108 Q------MCLGVQHIHE---KRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYAC 158

Query: 303 VFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELIT 341
            +   GT  Y+ PE + +   + K+D+++ G +L EL T
Sbjct: 159 TYV--GTPYYVPPEIWENMPYNNKSDIWSLGCILYELCT 195

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 61.2 bits (148), Expect = 2e-10
 Identities = 64/226 (28%), Positives = 102/226 (45%), Gaps = 19/226 (8%)

Query: 130 KNFDFAELAAATDNFNSENLIGKGGHAEVYKGC-LPDGEVVAVKKIIKNAKEDEERISDF 188
           K   F      +D +     IGKG + +V+K     +G   AVK I+    + +E I   
Sbjct: 6   KTIIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVK-ILDPIHDIDEEIE-- 62

Query: 189 LSELGIV-AHINHPNAAKLIGF----STENG--FHLVLQFLPHGSLSSLLFGSTECLEWT 241
            +E  I+ A  +HPN  K  G       +NG    LVL+    GS++ L+ G  +  E  
Sbjct: 63  -AEYNILKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERM 121

Query: 242 IRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSHH 301
               IA  + E L  L H    + IHRD+K +NILL+ +   ++ DFG++  L    +  
Sbjct: 122 EEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTS--TRL 179

Query: 302 IVFPIEGTFGYLSPEYF-----MHGIVDEKTDVFAFGVLLLELITG 342
                 GT  +++PE       +    D + DV++ G+  +EL  G
Sbjct: 180 RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDG 225

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 61.5 bits (149), Expect = 2e-10
 Identities = 54/197 (27%), Positives = 95/197 (48%), Gaps = 34/197 (17%)

Query: 168 VVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFS-TENGFHLVLQFLPHGS 226
           +VAVK +  +A ++    +DFL E+ I++ +  PN  +L+G    E+   ++ +++ +G 
Sbjct: 48  LVAVKILRPDANKNAR--NDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGD 105

Query: 227 LSSLL---------------FGSTECLEWTIRYK----IALGIAEGLQYLHHDCHRRIIH 267
           L+  L                    CL   I Y     +AL IA G++YL        +H
Sbjct: 106 LNQFLSSHHLDDKEENGNDAVPPAHCLP-AISYSSLLHVALQIASGMKYL---SSLNFVH 161

Query: 268 RDIKASNILLSEDYEAQISDFGLAKWLPDNWSHHI----VFPIEGTFGYLSPEYFMHGIV 323
           RD+   N L+ E+   +I+DFG+++ L     + I    V PI     +++ E  + G  
Sbjct: 162 RDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIR----WMAWECILMGKF 217

Query: 324 DEKTDVFAFGVLLLELI 340
              +DV+AFGV L E++
Sbjct: 218 TTASDVWAFGVTLWEIL 234

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 60.4 bits (146), Expect = 3e-10
 Identities = 56/195 (28%), Positives = 96/195 (49%), Gaps = 14/195 (7%)

Query: 150 IGKGGHAEVYKG-CLPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIG 208
           +G G + +VYK   L  GE+ AVK IIK    D+   S    E+ +V    H N     G
Sbjct: 17  VGSGTYGDVYKARNLHTGELAAVK-IIKLEPGDD--FSLIQQEIFMVKECKHCNIVAYFG 73

Query: 209 -FSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIH 267
            + +     + +++   GSL  +   +    E  I Y +     +GL YLH    +  +H
Sbjct: 74  SYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAY-VCRETLQGLAYLHS---KGKMH 129

Query: 268 RDIKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEGTFGYLSPEYFM---HGIVD 324
           RDIK +NILL+++ + +++DFG+A  +    +    F   GT  +++PE      +G  +
Sbjct: 130 RDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFI--GTPYWMAPEVAAVEKNGGYN 187

Query: 325 EKTDVFAFGVLLLEL 339
           +  D++A G+  +EL
Sbjct: 188 QLCDIWAVGITAIEL 202

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 60.7 bits (147), Expect = 3e-10
 Identities = 50/189 (26%), Positives = 95/189 (50%), Gaps = 24/189 (12%)

Query: 168 VVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFS-TENGFHLVLQFLPHGS 226
           +VAVK + ++A ++    +DFL E+ I++ +  PN  +L+    T +   ++ +++ +G 
Sbjct: 48  LVAVKMLREDANKNAR--NDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGD 105

Query: 227 LSSLL----------FGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNIL 276
           L+  L                + ++    +A  IA G++YL        +HRD+   N L
Sbjct: 106 LNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSS---LNFVHRDLATRNCL 162

Query: 277 LSEDYEAQISDFGLAKWLPDNWSHHI----VFPIEGTFGYLSPEYFMHGIVDEKTDVFAF 332
           + ++Y  +I+DFG+++ L     + I    V PI     ++S E  + G     +DV+AF
Sbjct: 163 VGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIR----WMSWESILLGKFTTASDVWAF 218

Query: 333 GVLLLELIT 341
           GV L E++T
Sbjct: 219 GVTLWEILT 227

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 60.1 bits (145), Expect = 3e-10
 Identities = 54/208 (25%), Positives = 94/208 (45%), Gaps = 11/208 (5%)

Query: 143 NFNSENLIGKGGHAEVYKGCLPD-GEVVAVKKII--KNAKEDEERISDFLSELGIVAHIN 199
           N+    L+G+G    VY     D G  +A K++     + E  + +S    E+ ++ ++ 
Sbjct: 3   NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQ 62

Query: 200 HPNAAKLIGFSTENG---FHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQY 256
           H    +  G   +       + ++++P GS+   L       E   R K    I EG+ Y
Sbjct: 63  HERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTR-KYTRQILEGMSY 121

Query: 257 LHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPD-NWSHHIVFPIEGTFGYLSP 315
           LH +    I+HRDIK +NIL       ++ DFG +K L     S   +  + GT  ++SP
Sbjct: 122 LHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSP 178

Query: 316 EYFMHGIVDEKTDVFAFGVLLLELITGR 343
           E         K DV++ G  ++E++T +
Sbjct: 179 EVISGEGYGRKADVWSLGCTVVEMLTEK 206

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 60.4 bits (146), Expect = 4e-10
 Identities = 62/216 (28%), Positives = 99/216 (45%), Gaps = 19/216 (8%)

Query: 144 FNSENLIGKGGHAEVYKGCL--PDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHP 201
           F    ++GKGG  EV   C     G++ A KK+ K   +  +  +  L+E  I+  +N  
Sbjct: 2   FRHYRVLGKGGFGEVC-ACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSR 60

Query: 202 NAAKL-IGFSTENGFHLVLQFLPHGSLSSLLF-----GSTECLEWTIRYKIALGIAEGLQ 255
               L   + T++   LVL  +  G L   ++     G  E  +  I Y  A  +  GL+
Sbjct: 61  FVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDE--QRAIFY--AAELCCGLE 116

Query: 256 YLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEGTFGYLSP 315
            L  +   RI++RD+K  NILL +    +ISD GLA  +P+      V    GT GY++P
Sbjct: 117 DLQRE---RIVYRDLKPENILLDDRGHIRISDLGLAVQIPEG---ETVRGRVGTVGYMAP 170

Query: 316 EYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQ 351
           E   +       D +  G L+ E+I G+     R++
Sbjct: 171 EVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKE 206

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 61.0 bits (148), Expect = 4e-10
 Identities = 58/234 (24%), Positives = 94/234 (40%), Gaps = 31/234 (13%)

Query: 112 EDDDADDGGSVPIVRHSWKNFDFAELAAATDNFNSENLIGKGGHAEVYKGCLPDGEVVAV 171
           E DD DD G +P  +        A    A+  +     +  G    V+    P      V
Sbjct: 43  ESDDDDDDGLIPTKQK-------AREVVASLGYTVIKTLTPGSEGRVFVATKPGQPDPVV 95

Query: 172 KKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTENGFHLVLQFLPHGS--LSS 229
            KI +            L E  ++ ++NHP+  ++          +    LPH S  L +
Sbjct: 96  LKIGQKGTT--------LIEAMLLQNVNHPSVIRMKDTLVSGA--ITCMVLPHYSSDLYT 145

Query: 230 LLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFG 289
            L   +  L       I   I EGL+YLH    +RIIHRD+K  NI +++  +  I D G
Sbjct: 146 YLTKRSRPLPIDQALIIEKQILEGLRYLHA---QRIIHRDVKTENIFINDVDQVCIGDLG 202

Query: 290 LAKW---LPDNWSHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELI 340
            A++    P          + GT    +PE       + K D+++ G++L E++
Sbjct: 203 AAQFPVVAPAFLG------LAGTVETNAPEVLARDKYNSKADIWSAGIVLFEML 250

Length = 357

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 60.6 bits (147), Expect = 4e-10
 Identities = 59/196 (30%), Positives = 86/196 (43%), Gaps = 9/196 (4%)

Query: 150 IGKGGHAEVYKGCLP-DGEVVAVKKIIKNAKEDEERISDFLSELGI-VAHINHPNAAKL- 206
           IGKG   +V       DG+  AVK + K A   ++     ++E  + + ++ HP    L 
Sbjct: 3   IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLH 62

Query: 207 IGFSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRII 266
             F T +  + VL ++  G L   L       E   R+  A  IA  L YLH      II
Sbjct: 63  YSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARF-YAAEIASALGYLHS---LNII 118

Query: 267 HRDIKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEGTFGYLSPEYFMHGIVDEK 326
           +RD+K  NILL       ++DFGL K   ++      F   GT  YL+PE       D  
Sbjct: 119 YRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFC--GTPEYLAPEVLRKQPYDRT 176

Query: 327 TDVFAFGVLLLELITG 342
            D +  G +L E++ G
Sbjct: 177 VDWWCLGAVLYEMLYG 192

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 60.5 bits (146), Expect = 4e-10
 Identities = 59/204 (28%), Positives = 95/204 (46%), Gaps = 13/204 (6%)

Query: 149 LIGKGGHAEVYKGCLPDGE-VVAVKKIIKNAKEDEERISDFLSELGIVAHI-NHPNAAKL 206
           +IG+G +A+V    L   E + A+K + K    D+E I    +E  +     NHP    L
Sbjct: 2   VIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL 61

Query: 207 IG-FSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRI 265
              F TE+    V++++  G L   +    +  E   R+  A  I+  L YLH    R I
Sbjct: 62  HSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSA-EISLALNYLHE---RGI 117

Query: 266 IHRDIKASNILLSEDYEAQISDFGLAK--WLPDNWSHHIVFPIEGTFGYLSPEYFMHGIV 323
           I+RD+K  N+LL  +   +++D+G+ K    P + +        GT  Y++PE       
Sbjct: 118 IYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFC----GTPNYIAPEILRGEDY 173

Query: 324 DEKTDVFAFGVLLLELITGRRAVD 347
               D +A GVL+ E++ GR   D
Sbjct: 174 GFSVDWWALGVLMFEMMAGRSPFD 197

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 60.1 bits (145), Expect = 4e-10
 Identities = 53/203 (26%), Positives = 96/203 (47%), Gaps = 14/203 (6%)

Query: 142 DNFNSENLIGKGGHAEVYKG-CLPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINH 200
           ++F     IG G + +VYK   +  GE+ A+K I     ED   +     E+ ++    H
Sbjct: 9   EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQ---QEIIMMKDCKH 65

Query: 201 PNAAKLIG-FSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHH 259
            N     G +   +   + ++F   GSL  +   +    E  I Y ++    +GL YLH 
Sbjct: 66  SNIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAY-VSRETLQGLYYLHS 124

Query: 260 DCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEGTFGYLSPEYFM 319
              +  +HRDIK +NILL+++   +++DFG++  +    +    F   GT  +++PE   
Sbjct: 125 ---KGKMHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFI--GTPYWMAPEVAA 179

Query: 320 ---HGIVDEKTDVFAFGVLLLEL 339
               G  ++  D++A G+  +EL
Sbjct: 180 VERKGGYNQLCDIWAVGITAIEL 202

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 60.8 bits (148), Expect = 4e-10
 Identities = 67/243 (27%), Positives = 110/243 (45%), Gaps = 50/243 (20%)

Query: 142 DNFNSENLIGKGGHAEVYKGCLPD-GEVVAVKKIIKNAKEDEERISDFLSELGIVAHINH 200
           D+F S  +IG+G   EV      D G + A+KK+ K+   ++E+++   +E  I+A  ++
Sbjct: 1   DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADN 60

Query: 201 PNAAKLI-GFSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIA---LGIAEGLQY 256
           P   KL   F  EN  +L++++LP G + +LL       E   R+ IA   L I      
Sbjct: 61  PWVVKLYYSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAI------ 114

Query: 257 LHHDCHR-RIIHRDIKASNILLSEDYEAQISDFGL----------------AKWLPDNWS 299
                H+   IHRDIK  N+LL      ++SDFGL                +  LP N+ 
Sbjct: 115 --DSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFL 172

Query: 300 HHIVFPIE--------------------GTFGYLSPEYFMHGIVDEKTDVFAFGVLLLEL 339
             I  P+                     GT  Y++PE F+    +++ D ++ GV++ E+
Sbjct: 173 DFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEM 232

Query: 340 ITG 342
           + G
Sbjct: 233 LVG 235

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta

 Score = 60.4 bits (146), Expect = 5e-10
 Identities = 60/194 (30%), Positives = 88/194 (45%), Gaps = 23/194 (11%)

Query: 164 PDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTENGFHLVLQ-FL 222
           P G +V V+ I       EE +    +E+ +     HPN        T   +  V+  F+
Sbjct: 23  PTGTLVTVR-ITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFM 81

Query: 223 PHGSLSSLLF-----GSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILL 277
            +GS +SLL      G +E L   I +    G   GL YLH + +   IHR+IKAS+IL+
Sbjct: 82  AYGSANSLLKTYFPEGMSEALIGNILF----GALRGLNYLHQNGY---IHRNIKASHILI 134

Query: 278 SEDYEAQISDFGLAKWLPDNWSHHIV---FPIEGT--FGYLSPEYF---MHGIVDEKTDV 329
           S D    +S       L  N     V   FP   T    +LSPE     ++G  + K+D+
Sbjct: 135 SGDGLVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYG-YNVKSDI 193

Query: 330 FAFGVLLLELITGR 343
           ++ G+   EL TGR
Sbjct: 194 YSVGITACELATGR 207

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 59.6 bits (144), Expect = 5e-10
 Identities = 36/108 (33%), Positives = 56/108 (51%), Gaps = 12/108 (11%)

Query: 232 FGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLA 291
               +  EW I+  +      G+ Y+H    RRI+HRD+KA NI L  +   +I DFG++
Sbjct: 103 LSENQVCEWFIQLLL------GVHYMHQ---RRILHRDLKAKNIFLKNNL-LKIGDFGVS 152

Query: 292 KWLPDNWSHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLEL 339
           + L    S  +     GT  Y+SPE   H   D K+D+++ G +L E+
Sbjct: 153 RLLMG--SCDLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEM 198

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 60.4 bits (146), Expect = 5e-10
 Identities = 58/211 (27%), Positives = 99/211 (46%), Gaps = 19/211 (9%)

Query: 143 NFNSENLIGKGGHAEVY---KGCLPD-GEVVAVKKIIKNAKEDEERISDFL-SELGIVAH 197
           NF    ++G G + +V+   K    D G++ A+K + K A   + +  +   +E  ++ H
Sbjct: 1   NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEH 60

Query: 198 INH-PNAAKL-IGFSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQ 255
           +   P    L   F TE   HL+L ++  G + + L+      E  +R+     I   L+
Sbjct: 61  VRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSG-EIILALE 119

Query: 256 YLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEGTFGYLSP 315
           +LH      I++RDIK  NILL  +    ++DFGL+K           +   GT  Y++P
Sbjct: 120 HLHK---LGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKER-TYSFCGTIEYMAP 175

Query: 316 EYFM----HGIVDEKTDVFAFGVLLLELITG 342
           E       HG   +  D ++ G+L+ EL+TG
Sbjct: 176 EIIRGKGGHG---KAVDWWSLGILIFELLTG 203

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 60.0 bits (145), Expect = 7e-10
 Identities = 53/190 (27%), Positives = 96/190 (50%), Gaps = 28/190 (14%)

Query: 166 GEVVAVKKIIKNAKED--EERISDFLSELGIVAHINHPNAAKLIGFSTE-------NGFH 216
           G  VA+KK+ +  + +   +R      EL ++ H+ H N   L+   T        + F+
Sbjct: 40  GAKVAIKKLYRPFQSELFAKRA---YRELRLLKHMKHENVIGLLDVFTPDLSLDRFHDFY 96

Query: 217 LVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNIL 276
           LV+ F+  G+    L    +  E  I++ +   + +GL+Y+H      IIHRD+K  N+ 
Sbjct: 97  LVMPFM--GTDLGKLMKHEKLSEDRIQF-LVYQMLKGLKYIHA---AGIIHRDLKPGNLA 150

Query: 277 LSEDYEAQISDFGLAKWLPDNWSHHIVFPIEGTFGYLSPEY---FMHGIVDEKTDVFAFG 333
           ++ED E +I DFGLA+      + ++V     T  Y +PE    +MH    +  D+++ G
Sbjct: 151 VNEDCELKILDFGLARQTDSEMTGYVV-----TRWYRAPEVILNWMH--YTQTVDIWSVG 203

Query: 334 VLLLELITGR 343
            ++ E++TG+
Sbjct: 204 CIMAEMLTGK 213

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 59.6 bits (144), Expect = 8e-10
 Identities = 55/204 (26%), Positives = 93/204 (45%), Gaps = 22/204 (10%)

Query: 150 IGKGGHAEVYKGCLPD-GEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIG 208
           IGKG   +VY+    D   + A+K + K     ++ ++  + E  I+       +  ++G
Sbjct: 1   IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60

Query: 209 ----FSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLH-HDCHR 263
               F T++  +LV  ++  G L   L       E   ++ IA  +   L++LH +D   
Sbjct: 61  LKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIA-ELVLALEHLHKYD--- 116

Query: 264 RIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEGTFGYLSPEYFMHGIV 323
            I++RD+K  NILL       + DFGL+K   +   +       GT  YL+PE  +    
Sbjct: 117 -IVYRDLKPENILLDATGHIALCDFGLSK--ANLTDNKTTNTFCGTTEYLAPEVLL---- 169

Query: 324 DEK-----TDVFAFGVLLLELITG 342
           DEK      D ++ GVL+ E+  G
Sbjct: 170 DEKGYTKHVDFWSLGVLVFEMCCG 193

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 59.2 bits (143), Expect = 9e-10
 Identities = 62/203 (30%), Positives = 104/203 (51%), Gaps = 23/203 (11%)

Query: 150 IGKGGHAEVYKG--CLPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLI 207
           +G+G +A VYKG   L D  +VA+K+I    + +E      + E+ ++  + H N   L 
Sbjct: 14  LGEGTYATVYKGRSKLTD-NLVALKEI--RLEHEEGAPCTAIREVSLLKDLKHANIVTLH 70

Query: 208 GF-STENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRR-I 265
               TE    LV ++L    L   L    +C      + + L + + L+ L++ CHRR +
Sbjct: 71  DIIHTEKSLTLVFEYLDK-DLKQYL---DDCGNSINMHNVKLFLFQLLRGLNY-CHRRKV 125

Query: 266 IHRDIKASNILLSEDYEAQISDFGL--AKWLP-DNWSHHIVFPIEGTFGYLSPEYFMHGI 322
           +HRD+K  N+L++E  E +++DFGL  AK +P   +S+ +V     T  Y  P+  + G 
Sbjct: 126 LHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVV-----TLWYRPPDILL-GS 179

Query: 323 VDEKT--DVFAFGVLLLELITGR 343
            D  T  D++  G +  E+ TGR
Sbjct: 180 TDYSTQIDMWGVGCIFYEMSTGR 202

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 59.8 bits (145), Expect = 9e-10
 Identities = 55/219 (25%), Positives = 95/219 (43%), Gaps = 18/219 (8%)

Query: 133 DFAELAAATDNFNSENLIGKGGHAEV----YKGCLPDGEVVAVKKIIKNAKEDEERISDF 188
              +L    ++F+   +IG+G   EV    +K      +V A+K + K         + F
Sbjct: 34  KITKLRMKAEDFDVIKVIGRGAFGEVQLVRHKS---SKQVYAMKLLSKFEMIKRSDSAFF 90

Query: 189 LSELGIVAHINHPNAAKL-IGFSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIA 247
             E  I+AH N     +L   F  +   ++V++++P G L +L+       +W   Y   
Sbjct: 91  WEERDIMAHANSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLMSNYDIPEKWARFYTAE 150

Query: 248 LGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIE 307
           + +A  L  +H       IHRD+K  N+LL +    +++DFG    +  N        + 
Sbjct: 151 VVLA--LDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAV- 204

Query: 308 GTFGYLSPEYFM----HGIVDEKTDVFAFGVLLLELITG 342
           GT  Y+SPE        G    + D ++ GV L E++ G
Sbjct: 205 GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 243

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 59.3 bits (143), Expect = 9e-10
 Identities = 60/204 (29%), Positives = 101/204 (49%), Gaps = 25/204 (12%)

Query: 150 IGKGGHAEVYKG-CLPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIG 208
           +G+G +A V+KG       +VA+K+I    + +E      + E+ ++ ++ H N   L  
Sbjct: 13  LGEGTYATVFKGRSKLTENLVALKEI--RLEHEEGAPCTAIREVSLLKNLKHANIVTLHD 70

Query: 209 F-STENGFHLVLQFLPHGSLSSLL--FGSTECLEWTIRYKIAL-GIAEGLQYLHHDCHRR 264
              TE    LV ++L    L   L   G+   +      KI +  +  GL Y H    R+
Sbjct: 71  IIHTERCLTLVFEYL-DSDLKQYLDNCGNLMSMH---NVKIFMFQLLRGLSYCHK---RK 123

Query: 265 IIHRDIKASNILLSEDYEAQISDFGL--AKWLP-DNWSHHIVFPIEGTFGYLSPEYFMHG 321
           I+HRD+K  N+L++E  E +++DFGL  AK +P   +S+ +V     T  Y  P+  + G
Sbjct: 124 ILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVV-----TLWYRPPDVLL-G 177

Query: 322 IVDEKT--DVFAFGVLLLELITGR 343
             +  T  D++  G +L E+ TGR
Sbjct: 178 STEYSTPIDMWGVGCILYEMATGR 201

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 59.7 bits (144), Expect = 1e-09
 Identities = 36/97 (37%), Positives = 57/97 (58%), Gaps = 13/97 (13%)

Query: 250 IAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEGT 309
           I  GL+Y+H      IIHRD+K SN+ ++ED E +I DFGLA+   D  + ++      T
Sbjct: 129 ILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV-----AT 180

Query: 310 FGYLSPEY---FMHGIVDEKTDVFAFGVLLLELITGR 343
             Y +PE    +MH   ++  D+++ G ++ EL+TGR
Sbjct: 181 RWYRAPEIMLNWMH--YNQTVDIWSVGCIMAELLTGR 215

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 58.9 bits (143), Expect = 1e-09
 Identities = 35/96 (36%), Positives = 54/96 (56%), Gaps = 14/96 (14%)

Query: 253 GLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGL--AKWLPDN-WSHHIVFPIEGT 309
           GL Y H    RR++HRD+K  N+L+SE  E +++DFGL  AK +P   +S+ +V     T
Sbjct: 115 GLAYCHQ---RRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTYSNEVV-----T 166

Query: 310 FGYLSPEYFMHGIVDEKT--DVFAFGVLLLELITGR 343
             Y  P+  + G  +  T  D++  G +  E+ TGR
Sbjct: 167 LWYRPPDVLL-GSTEYSTSLDMWGVGCIFYEMATGR 201

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 59.5 bits (145), Expect = 1e-09
 Identities = 67/225 (29%), Positives = 101/225 (44%), Gaps = 60/225 (26%)

Query: 150 IGKGGHAEVYKG-CLPDGEVVAVKKI---IKNAKEDEER----ISDFLSELGIVAHINHP 201
           +GKG +  V+K       EVVA+KKI    +NA  D +R    I  FL ELG     +HP
Sbjct: 15  LGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNAT-DAQRTFREIM-FLQELG-----DHP 67

Query: 202 NAAKLIG-FSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAE-------- 252
           N  KL+     EN   + L F              E +E  +   I   I E        
Sbjct: 68  NIVKLLNVIKAENDKDIYLVF--------------EYMETDLHAVIRANILEDVHKRYIM 113

Query: 253 -----GLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWL---PDNWSHHIVF 304
                 L+Y+H      +IHRD+K SNILL+ D   +++DFGLA+ L    +N  + ++ 
Sbjct: 114 YQLLKALKYIHS---GNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLT 170

Query: 305 PIEGTFGYLSPE------YFMHGIVDEKTDVFAFGVLLLELITGR 343
               T  Y +PE       +  G+     D+++ G +L E++ G+
Sbjct: 171 DYVATRWYRAPEILLGSTRYTKGV-----DMWSVGCILGEMLLGK 210

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 59.0 bits (143), Expect = 1e-09
 Identities = 44/140 (31%), Positives = 69/140 (49%), Gaps = 16/140 (11%)

Query: 209 FSTENGFHLVLQFLPHGSLSSLLFGSTECL---EWTIRYKIALGIAEGLQYLHHDCHRRI 265
           F T+     V+++L  G L   +F         E   R+  A  I  GLQ+LH    + I
Sbjct: 65  FQTKEHLFFVMEYLNGGDL---MFHIQSSGRFDEARARF-YAAEIICGLQFLHK---KGI 117

Query: 266 IHRDIKASNILLSEDYEAQISDFGLAK--WLPDNWSHHIVFPIEGTFGYLSPEYFMHGIV 323
           I+RD+K  N+LL +D   +I+DFG+ K     +  +        GT  Y++PE       
Sbjct: 118 IYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFC----GTPDYIAPEILKGQKY 173

Query: 324 DEKTDVFAFGVLLLELITGR 343
           +E  D ++FGVLL E++ G+
Sbjct: 174 NESVDWWSFGVLLYEMLIGQ 193

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 59.5 bits (144), Expect = 1e-09
 Identities = 56/211 (26%), Positives = 100/211 (47%), Gaps = 26/211 (12%)

Query: 144 FNSENLIGKGGHAEVYKGC-LPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPN 202
           + S   +G G +  V        GE VA+KK+ +   + E        EL ++ H+ H N
Sbjct: 17  YTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSR-PFQSEIFAKRAYRELTLLKHMQHEN 75

Query: 203 AAKLIGFSTE-------NGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQ 255
              L+   T          F+LV+ ++    L  ++       E  ++Y +   +  GL+
Sbjct: 76  VIGLLDVFTSAVSGDEFQDFYLVMPYM-QTDLQKIM--GHPLSEDKVQYLV-YQMLCGLK 131

Query: 256 YLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEGTFGYLSP 315
           Y+H      IIHRD+K  N+ ++ED E +I DFGLA+      + ++V     T  Y +P
Sbjct: 132 YIHS---AGIIHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVV-----TRWYRAP 183

Query: 316 EY---FMHGIVDEKTDVFAFGVLLLELITGR 343
           E    +MH   ++  D+++ G ++ E++TG+
Sbjct: 184 EVILNWMH--YNQTVDIWSVGCIMAEMLTGK 212

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 58.9 bits (142), Expect = 1e-09
 Identities = 57/213 (26%), Positives = 99/213 (46%), Gaps = 26/213 (12%)

Query: 142 DNFNSENLIGKGGHAEVYKGCL--PDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHIN 199
           + F    ++G+G +  V K C      E+VA+KK  K+++E+EE     L EL ++  + 
Sbjct: 1   NKFEVLGVVGEGAYGVVLK-CRHKETKEIVAIKKF-KDSEENEEVKETTLRELKMLRTLK 58

Query: 200 HPNAAKLI-GFSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIR---YKIALGIAEGLQ 255
             N  +L   F      +LV +++    L  L           +R   Y++   I     
Sbjct: 59  QENIVELKEAFRRRGKLYLVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAI----- 113

Query: 256 YLHHDCHRR-IIHRDIKASNILLSEDYEAQISDFGLAKWLPD----NWSHHIVFPIEGTF 310
              H CH+  I+HRDIK  N+L+S +   ++ DFG A+ L +    N++ ++      T 
Sbjct: 114 ---HWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYV-----ATR 165

Query: 311 GYLSPEYFMHGIVDEKTDVFAFGVLLLELITGR 343
            Y SPE  +     +  D+++ G +L EL  G+
Sbjct: 166 WYRSPELLLGAPYGKAVDMWSVGCILGELSDGQ 198

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 59.1 bits (143), Expect = 1e-09
 Identities = 58/198 (29%), Positives = 93/198 (46%), Gaps = 11/198 (5%)

Query: 149 LIGKGGHAEVYKGCLP-DGEVVAVKKIIKNAKEDEERISDFLSELGIV--AHINHPNAAK 205
           ++GKG   +V    L   G + AVK + K+    ++ +   ++E  I+  A  NHP   +
Sbjct: 2   VLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLAR-NHPFLTQ 60

Query: 206 LI-GFSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRR 264
           L   F T +    V++F+  G L   +  S    E   R+  A  I   L +LH    + 
Sbjct: 61  LYCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARF-YAAEITSALMFLHD---KG 116

Query: 265 IIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEGTFGYLSPEYFMHGIVD 324
           II+RD+K  N+LL  +   +++DFG+ K    N      F   GT  Y++PE     +  
Sbjct: 117 IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFC--GTPDYIAPEILQEMLYG 174

Query: 325 EKTDVFAFGVLLLELITG 342
              D +A GVLL E++ G
Sbjct: 175 PSVDWWAMGVLLYEMLCG 192

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 59.1 bits (143), Expect = 1e-09
 Identities = 55/183 (30%), Positives = 85/183 (46%), Gaps = 33/183 (18%)

Query: 238 LEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWL--- 294
           LE  I Y  +  +A G+++L     R+ IHRD+ A NILLSE+   +I DFGLA+ +   
Sbjct: 172 LEDLISY--SFQVARGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKD 226

Query: 295 PDN-WSHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSL 353
           PD         P++    +++PE     +   ++DV++FGVLL E+            SL
Sbjct: 227 PDYVRKGDARLPLK----WMAPESIFDKVYTTQSDVWSFGVLLWEIF-----------SL 271

Query: 354 VIWAKPLLQT-----SNFKELVDPRLADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVL 408
                P +Q         KE    R A  Y   E+   ML    C H+    RP  + ++
Sbjct: 272 GASPYPGVQIDEEFCRRLKEGTRMR-APEYATPEIYSIMLD---CWHNNPEDRPTFSELV 327

Query: 409 QLL 411
           ++L
Sbjct: 328 EIL 330

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 58.8 bits (142), Expect = 1e-09
 Identities = 56/202 (27%), Positives = 97/202 (48%), Gaps = 17/202 (8%)

Query: 149 LIGKGGHAEVYKGCLP-DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHI-NHPNAAKL 206
           ++GKG   +V+   L    +  A+K + K+    ++ +   + E  +++    HP    L
Sbjct: 2   MLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHL 61

Query: 207 I-GFSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKI--ALGIAEGLQYLHHDCHR 263
              F T+     V+++L  G L   +F    C ++ +      A  I  GLQ+LH    +
Sbjct: 62  YCTFQTKENLFFVMEYLNGGDL---MFHIQSCHKFDLPRATFYAAEIICGLQFLHS---K 115

Query: 264 RIIHRDIKASNILLSEDYEAQISDFGLAK--WLPDNWSHHIVFPIEGTFGYLSPEYFMHG 321
            I++RD+K  NILL  D   +I+DFG+ K   L D  +        GT  Y++PE  +  
Sbjct: 116 GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFC----GTPDYIAPEILLGQ 171

Query: 322 IVDEKTDVFAFGVLLLELITGR 343
             +   D ++FGVLL E++ G+
Sbjct: 172 KYNTSVDWWSFGVLLYEMLIGQ 193

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 59.0 bits (143), Expect = 1e-09
 Identities = 35/106 (33%), Positives = 54/106 (50%), Gaps = 15/106 (14%)

Query: 247 ALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPI 306
           A  IA GL +LH    + II+RD+K  N++L  +   +I+DFG+ K        +I    
Sbjct: 107 AAEIAIGLFFLHS---KGIIYRDLKLDNVMLDAEGHIKIADFGMCK-------ENIFGGK 156

Query: 307 E-----GTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVD 347
                 GT  Y++PE   +    +  D +AFGVLL E++ G+   D
Sbjct: 157 TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFD 202

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha

 Score = 58.8 bits (142), Expect = 1e-09
 Identities = 58/198 (29%), Positives = 89/198 (44%), Gaps = 33/198 (16%)

Query: 164 PDGEVVAVKKIIKNAKEDEERISDFL-SELGIVAHINHPNAAKLIG-FSTENGFHLVLQF 221
           P GE V V++I   A  +E  +  FL  EL +    NHPN       F  +N   +V  F
Sbjct: 23  PTGEYVTVRRINLEACTNE--MVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSF 80

Query: 222 LPHGSLSSLLFG--STECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSE 279
           + +GS   L+         E  I Y I  G+ + L Y+HH  +   +HR +KAS+IL+S 
Sbjct: 81  MAYGSAKDLICTHFMDGMSELAIAY-ILQGVLKALDYIHHMGY---VHRSVKASHILISV 136

Query: 280 DYEAQISDFGL------------AKWLPDNWSHHI-VFPIEGTFGYLSPEYFMHGI--VD 324
           D +  +S  GL             + + D   + + V P      +LSPE     +   D
Sbjct: 137 DGKVYLS--GLRSNLSMINHGQRLRVVHDFPKYSVKVLP------WLSPEVLQQNLQGYD 188

Query: 325 EKTDVFAFGVLLLELITG 342
            K+D+++ G+   EL  G
Sbjct: 189 AKSDIYSVGITACELANG 206

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 58.1 bits (140), Expect = 1e-09
 Identities = 52/206 (25%), Positives = 96/206 (46%), Gaps = 11/206 (5%)

Query: 143 NFNSENLIGKGGHAEVYKGCLPD-GEVVAVKKII--KNAKEDEERISDFLSELGIVAHIN 199
           N+    L+G+G   EVY     D G  +AVK++    +++E  + ++    E+ ++ ++ 
Sbjct: 3   NWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLR 62

Query: 200 HPNAAKLIGF---STENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQY 256
           H    +  G      E    + ++++P GS+   L       E   R +    I +G+ Y
Sbjct: 63  HDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTR-RYTRQILQGVSY 121

Query: 257 LHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNW-SHHIVFPIEGTFGYLSP 315
           LH +    I+HRDIK +NIL       ++ DFG +K +     S   +  + GT  ++SP
Sbjct: 122 LHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSP 178

Query: 316 EYFMHGIVDEKTDVFAFGVLLLELIT 341
           E         K DV++    ++E++T
Sbjct: 179 EVISGEGYGRKADVWSVACTVVEMLT 204

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 58.4 bits (141), Expect = 2e-09
 Identities = 51/200 (25%), Positives = 86/200 (43%), Gaps = 17/200 (8%)

Query: 150 IGKGGHAEVYKGCLPD-GEVVAVKKIIKNAKEDEERISDF--LSELGIVAHINHPNAAKL 206
           IG G +  VYK   P  G  VA+K +     ED   +S    ++ L  +   +HPN  +L
Sbjct: 8   IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRL 67

Query: 207 IGFST------ENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHD 260
           +          E    LV + +     + L       L       +      GL +LH +
Sbjct: 68  MDVCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHAN 127

Query: 261 CHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVF-PIEGTFGYLSPEYFM 319
           C   I+HRD+K  NIL++   + +++DFGLA+     +S  +   P+  T  Y +PE  +
Sbjct: 128 C---IVHRDLKPENILVTSGGQVKLADFGLARI----YSCQMALTPVVVTLWYRAPEVLL 180

Query: 320 HGIVDEKTDVFAFGVLLLEL 339
                   D+++ G +  E+
Sbjct: 181 QSTYATPVDMWSVGCIFAEM 200

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 57.9 bits (141), Expect = 2e-09
 Identities = 55/183 (30%), Positives = 75/183 (40%), Gaps = 36/183 (19%)

Query: 171 VKKIIKNAKEDEERISDFLSELGIVAHI--NHPNAAKL-IGFSTENGFHLVLQFLPHGSL 227
           V+KIIK    +             V  +  ++PN  KL    +T  G  L++ ++  G L
Sbjct: 45  VQKIIKAKNFNAIEPM--------VHQLMKDNPNFIKLYYSVTTLKGHVLIMDYIKDGDL 96

Query: 228 SSLL-----FGSTECLEWTIRYKIALGIAEGLQYLH-HDCHRRIIHRDIKASNILLSEDY 281
             LL         E        KI   + E L  LH H     IIH DIK  N+L     
Sbjct: 97  FDLLKKEGKLSEAEVK------KIIRQLVEALNDLHKH----NIIHNDIKLENVLYDR-A 145

Query: 282 EAQI--SDFGLAKWLPDNWSHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLEL 339
           + +I   D+GL K +    S +     +GT  Y SPE       D   D +A GVL  EL
Sbjct: 146 KDRIYLCDYGLCK-IIGTPSCY-----DGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYEL 199

Query: 340 ITG 342
           +TG
Sbjct: 200 LTG 202

Length = 267

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 58.5 bits (141), Expect = 2e-09
 Identities = 69/221 (31%), Positives = 98/221 (44%), Gaps = 18/221 (8%)

Query: 149 LIGKGGHAEVYKGCLPDGEVV-AVKKIIKNA--KEDEERISDFLSELGIV-AHINHPNAA 204
           +IGKG   +V        E   AVK + K A  K+ EE+    +SE  ++  ++ HP   
Sbjct: 2   VIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEK--HIMSERNVLLKNVKHPFLV 59

Query: 205 KL-IGFSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHR 263
            L   F T +  + VL ++  G L   L      LE   R+  A  IA  L YLH     
Sbjct: 60  GLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARF-YAAEIASALGYLHS---L 115

Query: 264 RIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSHH-IVFPIEGTFGYLSPEYFMHGI 322
            I++RD+K  NILL       ++DFGL K   +N  H+       GT  YL+PE      
Sbjct: 116 NIVYRDLKPENILLDSQGHIVLTDFGLCK---ENIEHNGTTSTFCGTPEYLAPEVLHKQP 172

Query: 323 VDEKTDVFAFGVLLLELITGRRAVDSRRQSLV---IWAKPL 360
            D   D +  G +L E++ G     SR  + +   I  KPL
Sbjct: 173 YDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPL 213

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 58.7 bits (142), Expect = 2e-09
 Identities = 54/193 (27%), Positives = 88/193 (45%), Gaps = 39/193 (20%)

Query: 166 GEVVAVKKIIK------NAKEDEERISDFLSELGIVAHINHPNAAKL--IGFSTENGFHL 217
           G+ VA+KKI+K       AK           EL ++ H+ H N   L  I  S     + 
Sbjct: 35  GQNVAIKKIMKPFSTPVLAKRT-------YRELKLLKHLRHENIISLSDIFISPLEDIYF 87

Query: 218 VLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILL 277
           V + L    L  LL  ++  LE          I  GL+Y+H      ++HRD+K SNIL+
Sbjct: 88  VTELLG-TDLHRLL--TSRPLEKQFIQYFLYQILRGLKYVHS---AGVVHRDLKPSNILI 141

Query: 278 SEDYEAQISDFGLAKWLPDNWSHHIVFPIEGTFGYLSPEYFMHGIV-------DEKTDVF 330
           +E+ + +I DFGLA+ + D     +        GY+S  Y+    +       D + D++
Sbjct: 142 NENCDLKICDFGLAR-IQD---PQMT-------GYVSTRYYRAPEIMLTWQKYDVEVDIW 190

Query: 331 AFGVLLLELITGR 343
           + G +  E++ G+
Sbjct: 191 SAGCIFAEMLEGK 203

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 58.4 bits (141), Expect = 2e-09
 Identities = 62/198 (31%), Positives = 90/198 (45%), Gaps = 14/198 (7%)

Query: 150 IGKGGHAEVYKGCLPDGE-VVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKL-I 207
           IGKG   +V +    D + + A+K I K        ++  L+E  ++A +N P    L  
Sbjct: 1   IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60

Query: 208 GFSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIH 267
            F +    +LVL F+  G L   L           R+  A    E L  L +     +I+
Sbjct: 61  SFQSPEKLYLVLAFINGGELFHHLQREGRFDLSRARFYTA----ELLCALENLHKFNVIY 116

Query: 268 RDIKASNILLSEDYEAQIS--DFGLAKWLPDNWSHHIVFPIEGTFGYLSPEYFM-HGIVD 324
           RD+K  NILL  DY+  I+  DFGL K    +      F   GT  YL+PE  + HG   
Sbjct: 117 RDLKPENILL--DYQGHIALCDFGLCKLNMKDDDKTNTFC--GTPEYLAPELLLGHGYT- 171

Query: 325 EKTDVFAFGVLLLELITG 342
           +  D +  GVLL E++TG
Sbjct: 172 KAVDWWTLGVLLYEMLTG 189

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 58.1 bits (140), Expect = 2e-09
 Identities = 48/182 (26%), Positives = 95/182 (52%), Gaps = 19/182 (10%)

Query: 166 GEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLI-GFSTENGFHLVLQFLPH 224
           G++VAVKK+    ++  E +    +E+ I+    H N  ++   +   +   +V++FL  
Sbjct: 45  GKLVAVKKMDLRKQQRRELL---FNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEG 101

Query: 225 GSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQ 284
           G+L+ ++   T   E  I   + L + + L  LH    + +IHRDIK+ +ILL+ D   +
Sbjct: 102 GALTDIV-THTRMNEEQIA-AVCLAVLKALSVLHA---QGVIHRDIKSDSILLTHDGRVK 156

Query: 285 ISDFG----LAKWLPDNWSHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELI 340
           +SDFG    ++K +P   S      + GT  +++PE         + D+++ G++++E++
Sbjct: 157 LSDFGFCAQVSKEVPRRKS------LVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMV 210

Query: 341 TG 342
            G
Sbjct: 211 DG 212

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 57.8 bits (140), Expect = 2e-09
 Identities = 60/215 (27%), Positives = 97/215 (45%), Gaps = 23/215 (10%)

Query: 144 FNSENL-----IGKGGHAEVYKGCLPD-GEVVAVKKIIKNAKEDEERISDFLSEL-GIVA 196
           F +E+L     IG+G    V K      G ++AVK+I     E E++    L +L  ++ 
Sbjct: 1   FTAEDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQK--RLLMDLDVVMR 58

Query: 197 HINHPNAAKLIGFSTENGFHLVLQFLPHGSLSSL---LFGSTE-CLEWTIRYKIALGIAE 252
             + P   K  G     G   +   L   SL      ++   +  +   I  KIA+   +
Sbjct: 59  SSDCPYIVKFYGALFREGDCWICMELMDISLDKFYKYVYEVLKSVIPEEILGKIAVATVK 118

Query: 253 GLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIE-GTFG 311
            L YL  +    IIHRD+K SNILL  +   ++ DFG++  L D+    I    + G   
Sbjct: 119 ALNYLKEELK--IIHRDVKPSNILLDRNGNIKLCDFGISGQLVDS----IAKTRDAGCRP 172

Query: 312 YLSPEY---FMHGIVDEKTDVFAFGVLLLELITGR 343
           Y++PE          D ++DV++ G+ L E+ TG+
Sbjct: 173 YMAPERIDPSARDGYDVRSDVWSLGITLYEVATGK 207

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 57.7 bits (139), Expect = 3e-09
 Identities = 52/217 (23%), Positives = 97/217 (44%), Gaps = 35/217 (16%)

Query: 150 IGKGGHAEVY----KGCLPDGE--VVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNA 203
           +G+G   +V+       LP+ +  +VAVK + K A E   +  DF  E  ++  + H + 
Sbjct: 13  LGEGAFGKVFLAECHNLLPEQDKMLVAVKAL-KEASESARQ--DFQREAELLTVLQHQHI 69

Query: 204 AKLIGFSTE-NGFHLVLQFLPHGSLSSLLFG------------STECLEWTIRY--KIAL 248
            +  G  TE     +V +++ HG L+  L                   + T+     IA 
Sbjct: 70  VRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIAS 129

Query: 249 GIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSHHI----VF 304
            IA G+ YL        +HRD+   N L+ +    +I DFG+++ +     + +    + 
Sbjct: 130 QIASGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTML 186

Query: 305 PIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELIT 341
           PI     ++ PE  ++     ++D+++FGV+L E+ T
Sbjct: 187 PIR----WMPPESILYRKFTTESDIWSFGVVLWEIFT 219

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 57.4 bits (138), Expect = 4e-09
 Identities = 59/211 (27%), Positives = 102/211 (48%), Gaps = 19/211 (9%)

Query: 142 DNFNSENLIGKGGHAEVYKG-CLPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINH 200
           D++     +G+G +A VYKG    +G++VA+K I    +E+E      + E  ++  + H
Sbjct: 5   DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVI--RLQEEEGTPFTAIREASLLKGLKH 62

Query: 201 PNAAKLIGF-STENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHH 259
            N   L     T+    LV +++ H  L   +      L           +  GL Y+H 
Sbjct: 63  ANIVLLHDIIHTKETLTLVFEYV-HTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQ 121

Query: 260 DCHRRIIHRDIKASNILLSEDYEAQISDFGL--AKWLPDN-WSHHIVFPIEGTFGYLSPE 316
              R I+HRD+K  N+L+S+  E +++DFGL  AK +P + +S+ +V     T  Y  P+
Sbjct: 122 ---RYILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVV-----TLWYRPPD 173

Query: 317 YFMHGIVDEKT--DVFAFGVLLLELITGRRA 345
             + G  +  T  D++  G + +E+I G  A
Sbjct: 174 VLL-GSTEYSTCLDMWGVGCIFVEMIQGVAA 203

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 57.5 bits (139), Expect = 4e-09
 Identities = 59/207 (28%), Positives = 95/207 (45%), Gaps = 19/207 (9%)

Query: 149 LIGKGGHAEVYKGCLPDGEVVAVKKIIKNAK-EDEERISDFLSELGIV-AHINHPNAAKL 206
           +IG+G +A+V    L     +   K+IK     D+E I    +E  +     NHP    L
Sbjct: 2   VIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPF---L 58

Query: 207 IG----FSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCH 262
           +G    F TE+    V++F+  G L   +    +  E   R+  A  I+  L +LH    
Sbjct: 59  VGLHSCFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSA-EISLALNFLHE--- 114

Query: 263 RRIIHRDIKASNILLSEDYEAQISDFGLAK--WLPDNWSHHIVFPIEGTFGYLSPEYFMH 320
           R II+RD+K  N+LL  +   +++D+G+ K    P + +        GT  Y++PE    
Sbjct: 115 RGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTFC----GTPNYIAPEILRG 170

Query: 321 GIVDEKTDVFAFGVLLLELITGRRAVD 347
                  D +A GVL+ E++ GR   D
Sbjct: 171 EDYGFSVDWWALGVLMFEMMAGRSPFD 197

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 57.4 bits (139), Expect = 4e-09
 Identities = 55/210 (26%), Positives = 86/210 (40%), Gaps = 24/210 (11%)

Query: 144 FNSENLIGKGGHAEV----YKGCLPDGEVVAVKKIIKNAKEDEERISDFLSE---LGIVA 196
           F    ++G+G   +V    YK     GE+ A+K + K      + +   + E        
Sbjct: 1   FRCLAVLGRGHFGKVLLAEYK---KTGELYAIKALKKGDIIARDEVESLMCEKRIFETAN 57

Query: 197 HINHPNAAKLIG-FSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQ 255
              HP    L   F TE+    V+++   G L   +          + Y  A  +  GLQ
Sbjct: 58  SERHPFLVNLFACFQTEDHVCFVMEYAAGGDLMMHIHTDVFSEPRAVFY--AACVVLGLQ 115

Query: 256 YLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAK---WLPDNWSHHIVFPIEGTFGY 312
           YLH     +I++RD+K  N+LL  +   +I+DFGL K      D  S        GT  +
Sbjct: 116 YLHE---NKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRTSTFC-----GTPEF 167

Query: 313 LSPEYFMHGIVDEKTDVFAFGVLLLELITG 342
           L+PE           D +  GVL+ E++ G
Sbjct: 168 LAPEVLTETSYTRAVDWWGLGVLIYEMLVG 197

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 57.5 bits (139), Expect = 5e-09
 Identities = 43/158 (27%), Positives = 71/158 (44%), Gaps = 18/158 (11%)

Query: 148 NLIGKGGHAEVYKGC-LPDGEVVAVKK-----IIKNAKEDEERISD------FLSELGIV 195
             +G+G + +V K      G++VA+KK     I  +  +D + +         L EL I+
Sbjct: 15  AHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIM 74

Query: 196 AHINHPNAAKLIGFSTENGF-HLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGL 254
             I H N   L+    E  F +LV+  +    L  ++       E  ++  I L I  GL
Sbjct: 75  NEIKHENIMGLVDVYVEGDFINLVMDIM-ASDLKKVVDRKIRLTESQVKC-ILLQILNGL 132

Query: 255 QYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAK 292
             LH       +HRD+  +NI ++     +I+DFGLA+
Sbjct: 133 NVLHK---WYFMHRDLSPANIFINSKGICKIADFGLAR 167

Length = 335

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 57.0 bits (137), Expect = 6e-09
 Identities = 57/208 (27%), Positives = 96/208 (46%), Gaps = 21/208 (10%)

Query: 149 LIGKGGHAEVYKGCLPDGE-VVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAK-- 205
           +IG+G +A+V    L   + + A+K + K    D+E I    +E     H+    ++   
Sbjct: 2   VIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTE----KHVFEQASSNPF 57

Query: 206 LIG----FSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDC 261
           L+G    F T +   LV++++  G L   +    +  E   R+  A  I   L +LH   
Sbjct: 58  LVGLHSCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARF-YAAEICIALNFLHE-- 114

Query: 262 HRRIIHRDIKASNILLSEDYEAQISDFGLAK--WLPDNWSHHIVFPIEGTFGYLSPEYFM 319
            R II+RD+K  N+LL  D   +++D+G+ K    P + +        GT  Y++PE   
Sbjct: 115 -RGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFC----GTPNYIAPEILR 169

Query: 320 HGIVDEKTDVFAFGVLLLELITGRRAVD 347
                   D +A GVL+ E++ GR   D
Sbjct: 170 GEEYGFSVDWWALGVLMFEMMAGRSPFD 197

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 56.9 bits (137), Expect = 7e-09
 Identities = 49/188 (26%), Positives = 83/188 (44%), Gaps = 17/188 (9%)

Query: 190 SELGIVAHINHPNAAKLIGFSTENGFHLVLQFLPHGSLSSLLFGSTE-CLEWTIRYKIAL 248
           +E  I+  INHP+  +L G  T N F  ++  LP        + + +  +       I  
Sbjct: 132 TEAHILRAINHPSIIQLKGTFTYNKFTCLI--LPRYKTDLYCYLAAKRNIAICDILAIER 189

Query: 249 GIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEG 308
            +   +QYLH +   RIIHRDIKA NI ++   +  + DFG A + P + + +  +   G
Sbjct: 190 SVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACF-PVDINANKYYGWAG 245

Query: 309 TFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAV----------DSRRQSLVIWAK 358
           T    +PE           D+++ G++L E+ T   ++          DS RQ  +I  +
Sbjct: 246 TIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRR 305

Query: 359 PLLQTSNF 366
                + F
Sbjct: 306 SGTHPNEF 313

Length = 391

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 56.6 bits (136), Expect = 8e-09
 Identities = 62/201 (30%), Positives = 86/201 (42%), Gaps = 17/201 (8%)

Query: 149 LIGKGGHAEVYKGCLP-DGEVVAVK----KIIKNAKEDEERISDFLSELGIV-AHINHPN 202
           +IGKG   +V       DG+  AVK    KI+ N KE +      ++E  ++  ++ HP 
Sbjct: 2   VIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKH----IMAERNVLLKNVKHPF 57

Query: 203 AAKL-IGFSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDC 261
              L   F T    + VL F+  G L   L       E   R+  A  IA  L YLH   
Sbjct: 58  LVGLHYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAA-EIASALGYLHS-- 114

Query: 262 HRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEGTFGYLSPEYFMHG 321
              I++RD+K  NILL       ++DFGL K           F   GT  YL+PE     
Sbjct: 115 -INIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFC--GTPEYLAPEVIRKQ 171

Query: 322 IVDEKTDVFAFGVLLLELITG 342
             D   D +  G +L E++ G
Sbjct: 172 PYDNTVDWWCLGAVLYEMLYG 192

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 56.3 bits (136), Expect = 9e-09
 Identities = 48/203 (23%), Positives = 93/203 (45%), Gaps = 20/203 (9%)

Query: 150 IGKGGHAEVYKGC-LPDGEVVAVKKIIKNAKEDEERI-SDFLSELGIVAHINHPNAAKLI 207
           IG+G +  V+K       E+VA+K++     +D+E + S  L E+ ++  + H N  +L 
Sbjct: 8   IGEGTYGTVFKAKNRETHEIVALKRV--RLDDDDEGVPSSALREICLLKELKHKNIVRLY 65

Query: 208 G-FSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCH-RRI 265
               ++    LV ++     L          ++  I       + +GL +    CH   +
Sbjct: 66  DVLHSDKKLTLVFEYCDQ-DLKKYFDSCNGDIDPEIVKSFMFQLLKGLAF----CHSHNV 120

Query: 266 IHRDIKASNILLSEDYEAQISDFGLAK--WLP-DNWSHHIVFPIEGTFGYLSPEYFMHG- 321
           +HRD+K  N+L++++ E +++DFGLA+   +P   +S  +V     T  Y  P+      
Sbjct: 121 LHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAEVV-----TLWYRPPDVLFGAK 175

Query: 322 IVDEKTDVFAFGVLLLELITGRR 344
           +     D+++ G +  EL    R
Sbjct: 176 LYSTSIDMWSAGCIFAELANAGR 198

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 56.5 bits (137), Expect = 9e-09
 Identities = 59/231 (25%), Positives = 93/231 (40%), Gaps = 54/231 (23%)

Query: 144 FNSENLIGKGGHAEVYKGCL---PDGEVVAVKKIIKNAKEDEERIS-DFLSELGIVAHIN 199
           +  E  IG+G +  VYK       DG+  A+KK  K  KE    IS     E+ ++  + 
Sbjct: 2   YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKF-KGDKEQYTGISQSACREIALLRELK 60

Query: 200 HPNAAKLIGFSTENGFHLVLQFLPHGSLS-SLLFGSTEC-LEWTIRY------------- 244
           H N   L+             FL H   S  LLF   E  L   I++             
Sbjct: 61  HENVVSLVEV-----------FLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSM 109

Query: 245 --KIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQ----ISDFGLAKWLPDNW 298
              +   I  G+ YLH +    ++HRD+K +NIL+  +   +    I D GLA+     +
Sbjct: 110 VKSLLWQILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDLGLARL----F 162

Query: 299 SHHIVFPIEG-----TFGYLSPEYFM---HGIVDEKTDVFAFGVLLLELIT 341
           +  +    +      T  Y +PE  +   H    +  D++A G +  EL+T
Sbjct: 163 NAPLKPLADLDPVVVTIWYRAPELLLGARH--YTKAIDIWAIGCIFAELLT 211

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 55.8 bits (134), Expect = 1e-08
 Identities = 52/218 (23%), Positives = 93/218 (42%), Gaps = 35/218 (16%)

Query: 147 ENLIGKGGHAEVYKGCLPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKL 206
           E   GK   AE Y       +++   K +K+      +  DF  E  ++ ++ H +  K 
Sbjct: 15  EGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARK--DFQREAELLTNLQHEHIVKF 72

Query: 207 IGFSTE-NGFHLVLQFLPHGSLSSLL---------------FGSTECLEWTIRYKIALGI 250
            G   + +   +V +++ HG L+  L                 +   L  +    IA  I
Sbjct: 73  YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 132

Query: 251 AEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSH-------HIV 303
           A G+ YL     +  +HRD+   N L+  +   +I DFG+++   D +S        H +
Sbjct: 133 ASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSR---DVYSTDYYRVGGHTM 186

Query: 304 FPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELIT 341
            PI     ++ PE  M+     ++DV++FGV+L E+ T
Sbjct: 187 LPIR----WMPPESIMYRKFTTESDVWSFGVILWEIFT 220

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 56.2 bits (135), Expect = 1e-08
 Identities = 49/179 (27%), Positives = 84/179 (46%), Gaps = 7/179 (3%)

Query: 166 GEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKL-IGFSTENGFHLVLQFLPH 224
           G+  A+K + K     ++ ++  L+E  ++ +  HP    L   F T++    V++++  
Sbjct: 20  GKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNG 79

Query: 225 GSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQ 284
           G L   L       E   R+  A  I   L YLH     +I++RD+K  N++L +D   +
Sbjct: 80  GELFFHLSRERVFSEDRTRFYGA-EIVSALDYLHSG---KIVYRDLKLENLMLDKDGHIK 135

Query: 285 ISDFGLAKWLPDNWSHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGR 343
           I+DFGL K    + +    F   GT  YL+PE           D +  GV++ E++ GR
Sbjct: 136 ITDFGLCKEGITDAATMKTFC--GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 192

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 56.2 bits (135), Expect = 1e-08
 Identities = 34/96 (35%), Positives = 56/96 (58%), Gaps = 11/96 (11%)

Query: 250 IAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWL---PDNWSH-HIVFP 305
           +A G+++L     R+ IHRD+ A NILLSE+   +I DFGLA+ +   PD         P
Sbjct: 183 VARGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLP 239

Query: 306 IEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELIT 341
           ++    +++PE     +   ++DV++FGVLL E+ +
Sbjct: 240 LK----WMAPESIFDKVYTTQSDVWSFGVLLWEIFS 271

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 55.3 bits (133), Expect = 1e-08
 Identities = 58/216 (26%), Positives = 98/216 (45%), Gaps = 38/216 (17%)

Query: 150 IGKGGHAEVYKGCLPDGEVVA---VKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKL 206
           IG G   +V  G    G   A   VK++  +A  DE+ +  FL E+     +NHPN  + 
Sbjct: 3   IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLL--FLQEVQPYRELNHPNVLQC 60

Query: 207 IGFSTEN-GFHLVLQFLPHGSLSSLLFGSTECL----EWTIRYKIALGIAEGLQYLHHDC 261
           +G   E+  + LVL+F P G L + L  +   +    +  +  ++A  +A GL +LH   
Sbjct: 61  LGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA- 119

Query: 262 HRRIIHRDIKASNILLSEDYEAQISDFGLA--KWLPDNW--SHHIVFPIEGTFGYLSPEY 317
               IH D+   N  L+ D   +I D+GLA  ++  D +        P+     +L+PE 
Sbjct: 120 --DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLR----WLAPE- 172

Query: 318 FMHGIVDE------------KTDVFAFGVLLLELIT 341
               +V+             K+++++ GV + EL T
Sbjct: 173 ----LVEIRGQDLLPKDQTKKSNIWSLGVTMWELFT 204

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 55.8 bits (134), Expect = 2e-08
 Identities = 53/215 (24%), Positives = 95/215 (44%), Gaps = 18/215 (8%)

Query: 137 LAAATDNFNSENLIGKGGHAEV----YKGCLPDGEVVAVKKIIKNAKEDEERISDFLSEL 192
           L    ++++   +IG+G   EV    +K      +V A+K + K         + F  E 
Sbjct: 38  LQMKAEDYDVVKVIGRGAFGEVQLVRHKS---SQKVYAMKLLSKFEMIKRSDSAFFWEER 94

Query: 193 GIVAHINHPNAAKLI-GFSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIA 251
            I+A  N P   +L   F  +   ++V++++P G L +L+       +W   Y   + +A
Sbjct: 95  DIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEKWAKFYTAEVVLA 154

Query: 252 EGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEGTFG 311
             L  +H      +IHRD+K  N+LL +    +++DFG    + +         + GT  
Sbjct: 155 --LDAIHS---MGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAV-GTPD 208

Query: 312 YLSPEYFMH----GIVDEKTDVFAFGVLLLELITG 342
           Y+SPE        G    + D ++ GV L E++ G
Sbjct: 209 YISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVG 243

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 54.8 bits (132), Expect = 2e-08
 Identities = 63/218 (28%), Positives = 103/218 (47%), Gaps = 34/218 (15%)

Query: 142 DNFNSENLIGKGGHAEVYKGCLPD---GEVVAVKKIIKNAKEDEERISDFLSELGIVAHI 198
           D +     IG+G +  VYK    D    E +A+KKI +  +EDE   S  + E+ ++  +
Sbjct: 2   DQYEKVEKIGEGTYGVVYKA--RDRVTNETIALKKI-RLEQEDEGVPSTAIREISLLKEM 58

Query: 199 NHPNAAKLIG-FSTENGFHLVLQFL-----PHGSLSSLLFGSTECLEWTIRYKIALGIAE 252
            H N  +L     +E   +LV ++L      H   SS  F     L  T  Y+I  GIA 
Sbjct: 59  QHGNIVRLQDVVHSEKRLYLVFEYLDLDLKKHMD-SSPDFAKNPRLIKTYLYQILRGIAY 117

Query: 253 GLQYLHHDCH-RRIIHRDIKASNILLSEDYEA-QISDFGLAK--WLP-DNWSHHIVFPIE 307
                   CH  R++HRD+K  N+L+     A +++DFGLA+   +P   ++H +V    
Sbjct: 118 --------CHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVV---- 165

Query: 308 GTFGYLSPEYFMHGIVDEKT--DVFAFGVLLLELITGR 343
            T  Y +PE  + G     T  D+++ G +  E++  +
Sbjct: 166 -TLWYRAPEILL-GSRHYSTPVDIWSVGCIFAEMVNQK 201

Length = 294

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 54.6 bits (131), Expect = 3e-08
 Identities = 51/171 (29%), Positives = 81/171 (47%), Gaps = 31/171 (18%)

Query: 250 IAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWL---PDNWSH-HIVFP 305
           +A+G+++L     R+ IHRD+ A NILLSE+   +I DFGLA+ +   PD         P
Sbjct: 188 VAKGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLP 244

Query: 306 IEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSN 365
           ++    +++PE     +   ++DV++FGVLL E+            SL     P ++   
Sbjct: 245 LK----WMAPETIFDRVYTIQSDVWSFGVLLWEIF-----------SLGASPYPGVKIDE 289

Query: 366 -----FKELVDPRLADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQLL 411
                 KE    R  D Y   EM + ML    C H   + RP  + +++ L
Sbjct: 290 EFCRRLKEGTRMRAPD-YTTPEMYQTMLD---CWHGEPSQRPTFSELVEHL 336

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 54.9 bits (132), Expect = 4e-08
 Identities = 44/166 (26%), Positives = 86/166 (51%), Gaps = 28/166 (16%)

Query: 208 GFSTENGFHLVLQFLPHGSLSSLLFGSTECLE----WTIR----YKIALGIAEGLQYLHH 259
           GFS++ G    ++  P  S SS    S +  +    W +      + +  +A+G+ +L  
Sbjct: 172 GFSSQ-GSDTYVEMRPVSSSSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFL-- 228

Query: 260 DCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSHHIV-----FPIEGTFGYLS 314
              +  IHRD+ A N+LL++   A+I DFGLA+ +  N S+++V      P++    +++
Sbjct: 229 -ASKNCIHRDVAARNVLLTDGRVAKICDFGLARDI-MNDSNYVVKGNARLPVK----WMA 282

Query: 315 PEYFMHGIVDEKTDVFAFGVLLLELIT-GRR-----AVDSRRQSLV 354
           PE     +   ++DV+++G+LL E+ + G+       V+S+   +V
Sbjct: 283 PESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMV 328

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 54.2 bits (130), Expect = 4e-08
 Identities = 56/213 (26%), Positives = 99/213 (46%), Gaps = 27/213 (12%)

Query: 143 NFNSENLIGKGGHAEVY----KGCLPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHI 198
           +FN   ++GKG   +V     KG     E+ A+K + K+    ++ +   + E  ++A  
Sbjct: 1   DFNFLMVLGKGSFGKVMLAERKGT---DELYAIKILKKDVVIQDDDVECTMVEKRVLALS 57

Query: 199 NHPNAAKLIG--FSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYK------IALGI 250
             P     +   F T +  + V++++  G L   +       +   R+K       A  I
Sbjct: 58  GKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYQI-------QQVGRFKEPHAVFYAAEI 110

Query: 251 AEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEGTF 310
           A GL +LH    + II+RD+K  N++L  +   +I+DFG+ K   + W         GT 
Sbjct: 111 AIGLFFLHS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCK--ENMWDGVTTKTFCGTP 165

Query: 311 GYLSPEYFMHGIVDEKTDVFAFGVLLLELITGR 343
            Y++PE   +    +  D +AFGVLL E++ G+
Sbjct: 166 DYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 198

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 54.2 bits (130), Expect = 5e-08
 Identities = 49/179 (27%), Positives = 82/179 (45%), Gaps = 7/179 (3%)

Query: 166 GEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKL-IGFSTENGFHLVLQFLPH 224
           G   A+K + K     ++ ++  ++E  ++ +  HP    L   F T +    V+++   
Sbjct: 20  GRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANG 79

Query: 225 GSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQ 284
           G L   L       E   R+  A  I   L+YLH    R +++RDIK  N++L +D   +
Sbjct: 80  GELFFHLSRERVFTEERARFYGA-EIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIK 135

Query: 285 ISDFGLAKWLPDNWSHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGR 343
           I+DFGL K    + +    F   GT  YL+PE           D +  GV++ E++ GR
Sbjct: 136 ITDFGLCKEGISDGATMKTFC--GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 192

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 54.2 bits (130), Expect = 5e-08
 Identities = 64/220 (29%), Positives = 94/220 (42%), Gaps = 16/220 (7%)

Query: 149 LIGKGGHAEVY---KGCLPDGEVVAVKKIIKNAKEDEERISDFLSELGIV-AHINHPNAA 204
           +IGKG   +V    +    DG   AVK + K     ++  +  ++E  ++  ++ HP   
Sbjct: 2   VIGKGSFGKVLLAKRKS--DGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLV 59

Query: 205 KL-IGFSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHR 263
            L   F T    + VL ++  G L   L      LE   R+  A  +A  + YLH     
Sbjct: 60  GLHYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARF-YAAEVASAIGYLHS---L 115

Query: 264 RIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEGTFGYLSPEYFMHGIV 323
            II+RD+K  NILL       ++DFGL K   +       F   GT  YL+PE       
Sbjct: 116 NIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFC--GTPEYLAPEVLRKEPY 173

Query: 324 DEKTDVFAFGVLLLELITGRRAVDSRRQSLV---IWAKPL 360
           D   D +  G +L E++ G     SR  S +   I  KPL
Sbjct: 174 DRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKPL 213

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 54.3 bits (130), Expect = 5e-08
 Identities = 48/179 (26%), Positives = 82/179 (45%), Gaps = 6/179 (3%)

Query: 166 GEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKL-IGFSTENGFHLVLQFLPH 224
           G   A+K + K     ++ ++  L+E  ++ +  HP    L   F T +    V+++   
Sbjct: 20  GRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANG 79

Query: 225 GSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQ 284
           G L   L       E   R+  A  I   L YLH +  + +++RD+K  N++L +D   +
Sbjct: 80  GELFFHLSRERVFSEDRARFYGA-EIVSALDYLHSE--KNVVYRDLKLENLMLDKDGHIK 136

Query: 285 ISDFGLAKWLPDNWSHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGR 343
           I+DFGL K    + +    F   GT  YL+PE           D +  GV++ E++ GR
Sbjct: 137 ITDFGLCKEGIKDGATMKTFC--GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 193

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 54.3 bits (130), Expect = 5e-08
 Identities = 33/94 (35%), Positives = 55/94 (58%), Gaps = 13/94 (13%)

Query: 253 GLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEGTFGY 312
           GL+Y+H      IIHRD+K SN+ ++ED E +I DFGLA+   D  + ++      T  Y
Sbjct: 130 GLKYIHS---AGIIHRDLKPSNVAVNEDCELRILDFGLARQADDEMTGYV-----ATRWY 181

Query: 313 LSPEY---FMHGIVDEKTDVFAFGVLLLELITGR 343
            +PE    +MH   ++  D+++ G ++ EL+ G+
Sbjct: 182 RAPEIMLNWMH--YNQTVDIWSVGCIMAELLKGK 213

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 54.4 bits (131), Expect = 5e-08
 Identities = 34/101 (33%), Positives = 50/101 (49%), Gaps = 17/101 (16%)

Query: 250 IAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLA-KWLPD---NWSHHIVFP 305
           I  GL+YLH      I+HRDIK  N+L++ +   +I DFGLA    PD   + +  +V  
Sbjct: 112 ILRGLKYLHS---AGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVV-- 166

Query: 306 IEGTFGYLSPEYFM---HGIVDEKTDVFAFGVLLLELITGR 343
              T  Y +PE  M   H       D+++ G +  EL+  R
Sbjct: 167 ---TQYYRAPEILMGSRH--YTSAVDIWSVGCIFAELLGRR 202

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 54.2 bits (130), Expect = 5e-08
 Identities = 57/201 (28%), Positives = 96/201 (47%), Gaps = 15/201 (7%)

Query: 149 LIGKGGHAEVYKGCLP-DGEVVAVKKIIKNAKEDEERISDFLSELGIVA-HINHPNAAKL 206
           ++GKG   +V    L   GE  AVK + K+    ++ +   + E  ++A    +P    L
Sbjct: 2   VLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHL 61

Query: 207 I-GFSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAE---GLQYLHHDCH 262
              F T+     V++FL  G L   +F   +   + + Y+     AE   GLQ+LH    
Sbjct: 62  YCTFQTKEHLFFVMEFLNGGDL---MFHIQDKGRFDL-YRATFYAAEIVCGLQFLHS--- 114

Query: 263 RRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEGTFGYLSPEYFMHGI 322
           + II+RD+K  N++L  D   +I+DFG+ K   + +  +      GT  Y++PE      
Sbjct: 115 KGIIYRDLKLDNVMLDRDGHIKIADFGMCK--ENVFGDNRASTFCGTPDYIAPEILQGLK 172

Query: 323 VDEKTDVFAFGVLLLELITGR 343
                D ++FGVLL E++ G+
Sbjct: 173 YTFSVDWWSFGVLLYEMLIGQ 193

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 53.7 bits (129), Expect = 6e-08
 Identities = 56/202 (27%), Positives = 94/202 (46%), Gaps = 17/202 (8%)

Query: 149 LIGKGGHAEVY----KGCLPDGEVVAVKKIIKNAKEDEERISDFLSELGIVA-HINHPNA 203
           ++GKG   +V     KG     EV A+K + K+    ++ +   ++E  I+A    HP  
Sbjct: 2   VLGKGSFGKVMLAELKG---TDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFL 58

Query: 204 AKL-IGFSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLH-HDC 261
             L   F T++    V++++  G L   +  S +  E   R+  A  +   L +LH H  
Sbjct: 59  TALHCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRF-YAAEVTLALMFLHRHG- 116

Query: 262 HRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEGTFGYLSPEYFMHG 321
              +I+RD+K  NILL  +   +++DFG+ K    N      F   GT  Y++PE     
Sbjct: 117 ---VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFC--GTPDYIAPEILQEL 171

Query: 322 IVDEKTDVFAFGVLLLELITGR 343
                 D +A GVL+ E++ G+
Sbjct: 172 EYGPSVDWWALGVLMYEMMAGQ 193

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 54.1 bits (130), Expect = 7e-08
 Identities = 30/97 (30%), Positives = 58/97 (59%), Gaps = 13/97 (13%)

Query: 250 IAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSHHIV-----F 304
           +A+G+ +L     +  IHRD+ A NILL+     +I DFGLA+ +  N S+++V      
Sbjct: 223 VAKGMSFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDI-RNDSNYVVKGNARL 278

Query: 305 PIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELIT 341
           P++    +++PE   + +   ++DV+++G+LL E+ +
Sbjct: 279 PVK----WMAPESIFNCVYTFESDVWSYGILLWEIFS 311

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 53.5 bits (128), Expect = 7e-08
 Identities = 51/207 (24%), Positives = 93/207 (44%), Gaps = 22/207 (10%)

Query: 150 IGKGGHAEVYKG--CLPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHIN---HPNAA 204
           IG+G + +V+K       G  VA+K++     E+   +S  + E+ ++ H+    HPN  
Sbjct: 9   IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLST-IREVAVLRHLETFEHPNVV 67

Query: 205 KLIGFST------ENGFHLVLQFLPHGSLSSLLFGSTE--CLEWTIRYKIALGIAEGLQY 256
           +L    T      E    LV + +    L++ L    E      TI+  +   +  GL +
Sbjct: 68  RLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIK-DMMFQLLRGLDF 125

Query: 257 LHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEGTFGYLSPE 316
           LH     R++HRD+K  NIL++   + +++DFGLA+      +   V     T  Y +PE
Sbjct: 126 LHS---HRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVV---TLWYRAPE 179

Query: 317 YFMHGIVDEKTDVFAFGVLLLELITGR 343
             +        D+++ G +  E+   +
Sbjct: 180 VLLQSSYATPVDLWSVGCIFAEMFRRK 206

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 53.5 bits (128), Expect = 8e-08
 Identities = 56/216 (25%), Positives = 102/216 (47%), Gaps = 25/216 (11%)

Query: 143 NFNSENLIGKGGHAEVY----KGCLPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHI 198
           +FN   ++GKG   +V     KG     E+ A+K + K+    ++ +   + E  ++A  
Sbjct: 1   DFNFLMVLGKGSFGKVMLAERKG---TDELYAIKILKKDVVIQDDDVECTMVEKRVLALQ 57

Query: 199 NHPNAAKLIG--FSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQY 256
           + P     +   F T +  + V++++  G L   +    +  E    +  A  I+ GL +
Sbjct: 58  DKPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVF-YAAEISVGLFF 116

Query: 257 LHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIE-----GTFG 311
           LH    R II+RD+K  N++L  +   +I+DFG+ K        H+V  +      GT  
Sbjct: 117 LHR---RGIIYRDLKLDNVMLDSEGHIKIADFGMCK-------EHMVDGVTTRTFCGTPD 166

Query: 312 YLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVD 347
           Y++PE   +    +  D +A+GVLL E++ G+   D
Sbjct: 167 YIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFD 202

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 52.6 bits (126), Expect = 1e-07
 Identities = 60/219 (27%), Positives = 95/219 (43%), Gaps = 48/219 (21%)

Query: 150 IGKGGHAEVYKGCLPDG---EVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKL 206
           IG G   +V  G +  G     V VK++  +A   E+    FL E      + H N  + 
Sbjct: 3   IGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQM--KFLEEAQPYRSLQHSNLLQC 60

Query: 207 IGFSTE-NGFHLVLQFLPHGSLSSLLFG--STECL--EWTIRYKIALGIAEGLQYLHHDC 261
           +G  TE   + LV++F P G L   L      E +  + T   ++A  IA GL +LH + 
Sbjct: 61  LGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN- 119

Query: 262 HRRIIHRDIKASNILLSEDYEAQISDFGLA--------------KWLPDNWSHHIVFPIE 307
               IH D+   N LL+ D   +I D+GL+               W+P  W         
Sbjct: 120 --NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRW--------- 168

Query: 308 GTFGYLSPEYF--MHG---IVDE--KTDVFAFGVLLLEL 339
                ++PE    +HG   +VD+  +++V++ GV + EL
Sbjct: 169 -----IAPELVDEVHGNLLVVDQTKESNVWSLGVTIWEL 202

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 53.2 bits (128), Expect = 1e-07
 Identities = 49/192 (25%), Positives = 88/192 (45%), Gaps = 25/192 (13%)

Query: 169 VAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTENGFHLVLQFLPHGSLS 228
           VAVKKI      D + +   L E+ I+  ++H N  K+      +G  L         L+
Sbjct: 33  VAVKKI---VLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGSLTELN 89

Query: 229 SLLFGSTECLEWTIRYKIALG-------------IAEGLQYLHHDCHRRIIHRDIKASNI 275
           S+     E +E  +   +  G             +  GL+Y+H      ++HRD+K +N+
Sbjct: 90  SVYIVQ-EYMETDLANVLEQGPLSEEHARLFMYQLLRGLKYIHS---ANVLHRDLKPANV 145

Query: 276 LLS-EDYEAQISDFGLAKWLPDNWSH--HIVFPIEGTFGYLSPEYFMHGIVDEKT-DVFA 331
            ++ ED   +I DFGLA+ +  ++SH  ++   +   + Y SP   +      K  D++A
Sbjct: 146 FINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKW-YRSPRLLLSPNNYTKAIDMWA 204

Query: 332 FGVLLLELITGR 343
            G +  E++TG+
Sbjct: 205 AGCIFAEMLTGK 216

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 52.9 bits (127), Expect = 1e-07
 Identities = 48/179 (26%), Positives = 81/179 (45%), Gaps = 7/179 (3%)

Query: 166 GEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKL-IGFSTENGFHLVLQFLPH 224
           G+  A+K + K     ++ ++  L+E  ++ +  HP    L   F T +    V+++   
Sbjct: 20  GKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANG 79

Query: 225 GSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQ 284
           G L   L       E   R+  A  I   L YLH      +++RD+K  N++L +D   +
Sbjct: 80  GELFFHLSRERVFSEDRARFYGA-EIVSALGYLHS---CDVVYRDLKLENLMLDKDGHIK 135

Query: 285 ISDFGLAKWLPDNWSHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGR 343
           I+DFGL K    + +    F   GT  YL+PE           D +  GV++ E++ GR
Sbjct: 136 ITDFGLCKEGISDGATMKTFC--GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 192

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 51.9 bits (125), Expect = 3e-07
 Identities = 60/222 (27%), Positives = 100/222 (45%), Gaps = 39/222 (17%)

Query: 142 DNFNSENLIGKGGHAEVYKGC-LPDGEVVAVKKIIKNAKEDEERISDF---------LSE 191
             + + + IG+G +  V      P G  VA+KKI           S F         L E
Sbjct: 5   PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKI-----------SPFEHQTFCQRTLRE 53

Query: 192 LGIVAHINHPNAAKL------IGFSTENGFHLVLQFLPHGSLSSLLFGSTECLEWT-IRY 244
           + I+    H N   +        F + N  ++V + +    L  L+   T+ L    I+Y
Sbjct: 54  IKILRRFKHENIIGILDIIRPPSFESFNDVYIVQELME-TDLYKLI--KTQHLSNDHIQY 110

Query: 245 KIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVF 304
            +   I  GL+Y+H      ++HRD+K SN+LL+ + + +I DFGLA+ + D    H  F
Sbjct: 111 FL-YQILRGLKYIHS---ANVLHRDLKPSNLLLNTNCDLKICDFGLAR-IADPEHDHTGF 165

Query: 305 PIE--GTFGYLSPEYFMHGIVDEKT-DVFAFGVLLLELITGR 343
             E   T  Y +PE  ++     K  D+++ G +L E+++ R
Sbjct: 166 LTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNR 207

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 50.9 bits (122), Expect = 4e-07
 Identities = 44/209 (21%), Positives = 84/209 (40%), Gaps = 31/209 (14%)

Query: 150 IGKGGHAEVYKGCL---PDG-------EVVAVKKIIKNAKEDEERISDFLSELGIVAHIN 199
           +G+G    +YKG L    D        EV  V K++ +   D      F     +++ ++
Sbjct: 3   LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSL---AFFETASLMSQLS 59

Query: 200 HPNAAKLIGFSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHH 259
           H +  KL G    +   +V +++  G L   L      +    +  +A  +A  L YL  
Sbjct: 60  HKHLVKLYGVCVRDENIMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLE- 118

Query: 260 DCHRRIIHRDIKASNILLSEDYE-------AQISDFGLAKWLPDNWSHHIVFPIEGTFGY 312
              ++++H ++   NIL++            ++SD G+   +        V  I     +
Sbjct: 119 --DKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIP--ITVLSREERVERIP----W 170

Query: 313 LSPEYFMHGIV--DEKTDVFAFGVLLLEL 339
           ++PE   +G        D ++FG  LLE+
Sbjct: 171 IAPECIRNGQASLTIAADKWSFGTTLLEI 199

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 51.6 bits (123), Expect = 4e-07
 Identities = 52/193 (26%), Positives = 85/193 (44%), Gaps = 42/193 (21%)

Query: 169 VAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTEN-------GFHLVLQF 221
           VAVKK+ +   +++        EL ++  +NH N   L+   T           +LV++ 
Sbjct: 49  VAVKKLSR-PFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMEL 107

Query: 222 ------------LPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRD 269
                       L H  +S LL            Y++  GI    ++LH      IIHRD
Sbjct: 108 MDANLCQVIHMELDHERMSYLL------------YQMLCGI----KHLHS---AGIIHRD 148

Query: 270 IKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEGTFGYLSPEYFMHGIVDEKTDV 329
           +K SNI++  D   +I DFGLA+    N+   ++ P   T  Y +PE  +     E  D+
Sbjct: 149 LKPSNIVVKSDCTLKILDFGLARTACTNF---MMTPYVVTRYYRAPEVILGMGYKENVDI 205

Query: 330 FAFGVLLLELITG 342
           ++ G ++ EL+ G
Sbjct: 206 WSVGCIMGELVKG 218

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 51.1 bits (122), Expect = 4e-07
 Identities = 55/204 (26%), Positives = 97/204 (47%), Gaps = 25/204 (12%)

Query: 150 IGKGGHAEVYKGCLPDGE-VVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIG 208
           +G+G +A V+KG     E +VA+K+I    + +E      + E+ ++  + H N   L  
Sbjct: 14  LGEGTYATVFKGRSKLTENLVALKEI--RLEHEEGAPCTAIREVSLLKDLKHANIVTLHD 71

Query: 209 F-STENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIAL---GIAEGLQYLHHDCHRR 264
              T+    LV ++L       L     +C      + + +    I  GL Y    CHRR
Sbjct: 72  IVHTDKSLTLVFEYLD----KDLKQYMDDCGNIMSMHNVKIFLYQILRGLAY----CHRR 123

Query: 265 -IIHRDIKASNILLSEDYEAQISDFGL--AKWLP-DNWSHHIVFPIEGTFGYLSPEYFM- 319
            ++HRD+K  N+L++E  E +++DFGL  AK +P   +S+ +V     T  Y  P+  + 
Sbjct: 124 KVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVV-----TLWYRPPDVLLG 178

Query: 320 HGIVDEKTDVFAFGVLLLELITGR 343
                 + D++  G +  E+ +GR
Sbjct: 179 SSEYSTQIDMWGVGCIFFEMASGR 202

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 51.8 bits (124), Expect = 4e-07
 Identities = 44/156 (28%), Positives = 65/156 (41%), Gaps = 6/156 (3%)

Query: 190 SELGIVAHINHPNAAKLI-GFSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIAL 248
            E+ I+  I+H     LI  +  ++   +V+        + +       LE  I   I  
Sbjct: 135 REIDILKTISHRAIINLIHAYRWKSTVCMVMPKYKCDLFTYVDRSGPLPLEQAI--TIQR 192

Query: 249 GIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEG 308
            + E L YLH    R IIHRD+K  NI L E   A + DFG A  L  +      +   G
Sbjct: 193 RLLEALAYLHG---RGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYGWSG 249

Query: 309 TFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRR 344
           T    SPE         KTD+++ G++L E+     
Sbjct: 250 TLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNV 285

Length = 392

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 50.8 bits (121), Expect = 5e-07
 Identities = 46/182 (25%), Positives = 91/182 (50%), Gaps = 19/182 (10%)

Query: 166 GEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLI-GFSTENGFHLVLQFLPH 224
           G  VAVK +    ++  E +    +E+ I+    H N  ++   +       ++++FL  
Sbjct: 46  GRQVAVKMMDLRKQQRRELL---FNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQG 102

Query: 225 GSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQ 284
           G+L+ ++   T   E  I   +   + + L YLH    + +IHRDIK+ +ILL+ D   +
Sbjct: 103 GALTDIV-SQTRLNEEQIA-TVCESVLQALCYLHS---QGVIHRDIKSDSILLTLDGRVK 157

Query: 285 ISDFG----LAKWLPDNWSHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELI 340
           +SDFG    ++K +P   S      + GT  +++PE         + D+++ G++++E++
Sbjct: 158 LSDFGFCAQISKDVPKRKS------LVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMV 211

Query: 341 TG 342
            G
Sbjct: 212 DG 213

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score = 50.0 bits (120), Expect = 8e-07
 Identities = 53/201 (26%), Positives = 94/201 (46%), Gaps = 22/201 (10%)

Query: 150 IGKGGHAEVYKG-CLPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHIN-HPNAAKLI 207
           IG+G  +EV K      G+  A+K + K+ K  E+  +  L E+  +  ++ HPN  +LI
Sbjct: 7   IGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNN--LREIQALRRLSPHPNILRLI 64

Query: 208 GF---STENGFHLVLQFLPHGSLSSLLFGSTECL-EWTIRYKIALGIAEGLQYLHHDCHR 263
                       LV + L   +L  L+ G    L E  ++      + + L ++H +   
Sbjct: 65  EVLFDRKTGRLALVFE-LMDMNLYELIKGRKRPLPEKRVK-SYMYQLLKSLDHMHRN--- 119

Query: 264 RIIHRDIKASNILLSEDYEAQISDFGLAKWLPDN--WSHHIVFPIEGTFGYLSPEYFM-H 320
            I HRDIK  NIL+ +D   +++DFG  + +     ++ +I      T  Y +PE  +  
Sbjct: 120 GIFHRDIKPENILI-KDDILKLADFGSCRGIYSKPPYTEYI-----STRWYRAPECLLTD 173

Query: 321 GIVDEKTDVFAFGVLLLELIT 341
           G    K D++A G +  E+++
Sbjct: 174 GYYGPKMDIWAVGCVFFEILS 194

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 51.0 bits (122), Expect = 9e-07
 Identities = 43/149 (28%), Positives = 72/149 (48%), Gaps = 14/149 (9%)

Query: 150 IGKGGHAEVY---KGCLPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKL 206
           I +G   +VY   K    + ++ AVK + K    ++  +    +E   +A    P    L
Sbjct: 12  ISRGAFGKVYLGRKKN--NSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHL 69

Query: 207 I-GFSTENGFHLVLQFLPHGSLSSLL--FGSTECLEWTIRYKIALGIAEGLQYLHHDCHR 263
                + N  +LV+++L  G + SLL  +G  +  E      I+  +A  L YLH     
Sbjct: 70  YYSLQSANNVYLVMEYLIGGDVKSLLHIYGYFD--EEMAVKYIS-EVALALDYLHR---H 123

Query: 264 RIIHRDIKASNILLSEDYEAQISDFGLAK 292
            IIHRD+K  N+L+S +   +++DFGL+K
Sbjct: 124 GIIHRDLKPDNMLISNEGHIKLTDFGLSK 152

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 50.4 bits (120), Expect = 1e-06
 Identities = 32/124 (25%), Positives = 63/124 (50%), Gaps = 13/124 (10%)

Query: 223 PHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYE 282
           P  +    L   +  L +      +  +A G+++L     +  +HRD+ A N+L+ E   
Sbjct: 221 PERTRRDTLINESPALSYMDLVGFSYQVANGMEFL---ASKNCVHRDLAARNVLICEGKL 277

Query: 283 AQISDFGLAKWLPDNWSHHI-----VFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLL 337
            +I DFGLA+ +  + S++I       P++    +++PE   + +    +DV++FG+LL 
Sbjct: 278 VKICDFGLARDIMRD-SNYISKGSTFLPLK----WMAPESIFNNLYTTLSDVWSFGILLW 332

Query: 338 ELIT 341
           E+ T
Sbjct: 333 EIFT 336

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score = 49.6 bits (118), Expect = 2e-06
 Identities = 42/154 (27%), Positives = 72/154 (46%), Gaps = 8/154 (5%)

Query: 150 IGKGGHAEVYKGCLPD-GEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLI- 207
           +G G   EV   C  D   + A+K + K    +  +++   +E  I+A  ++    KL  
Sbjct: 9   LGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYY 68

Query: 208 GFSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIH 267
            F  ++  + V+ ++P G + SLL       E   R+ IA  +   ++ +H       IH
Sbjct: 69  SFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIA-ELTLAIESVHK---MGFIH 124

Query: 268 RDIKASNILLSEDYEAQISDFGLAKWLPDNWSHH 301
           RDIK  NIL+  D   +++DFGL       W+H+
Sbjct: 125 RDIKPDNILIDLDGHIKLTDFGLCTGF--RWTHN 156

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 50.1 bits (119), Expect = 2e-06
 Identities = 56/222 (25%), Positives = 92/222 (41%), Gaps = 54/222 (24%)

Query: 182 EERISDFLSELGIVAHINHPNAAKLIGF---STENGFHLVLQFLPHGSLSS------LLF 232
           E   S  + E+ ++  + H N  + I           +++++F   G LS        +F
Sbjct: 53  EREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMF 112

Query: 233 GSTECLEWTIRYKIALGIAEGLQYLHH----DCHRRIIHRDIKASNILLSEDYE------ 282
           G  E  E  I   I   +   L Y H+        R++HRD+K  NI LS          
Sbjct: 113 GKIE--EHAI-VDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKIT 169

Query: 283 -----------AQISDFGLAKWLP-DNWSHHIVFPIEGTFGYLSPEYFMHGI--VDEKTD 328
                      A+I DFGL+K +  ++ +H  V    GT  Y SPE  +H     D+K+D
Sbjct: 170 AQANNLNGRPIAKIGDFGLSKNIGIESMAHSCV----GTPYYWSPELLLHETKSYDDKSD 225

Query: 329 VFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSNFKELV 370
           ++A G ++ EL +G+               P  + +NF +L+
Sbjct: 226 MWALGCIIYELCSGK--------------TPFHKANNFSQLI 253

Length = 1021

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 48.5 bits (115), Expect = 4e-06
 Identities = 53/216 (24%), Positives = 93/216 (43%), Gaps = 18/216 (8%)

Query: 136 ELAAATDNFNSENLIGKGGHAEV----YKGCLPDGEVVAVKKIIKNAKEDEERISDFLSE 191
           +L    +++    +IG+G   EV    +K      +V A+K + K         + F  E
Sbjct: 37  DLRMKAEDYEVVKVIGRGAFGEVQLVRHKST---RKVYAMKLLSKFEMIKRSDSAFFWEE 93

Query: 192 LGIVAHINHPNAAKLI-GFSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGI 250
             I+A  N P   +L   F  +   ++V++++P G L +L+       +W   Y   + +
Sbjct: 94  RDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVL 153

Query: 251 AEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEGTF 310
           A  L  +H       IHRD+K  N+LL +    +++DFG    +           + GT 
Sbjct: 154 A--LDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV-GTP 207

Query: 311 GYLSPEYFMH----GIVDEKTDVFAFGVLLLELITG 342
            Y+SPE        G    + D ++ GV L E++ G
Sbjct: 208 DYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 243

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 47.4 bits (113), Expect = 8e-06
 Identities = 30/91 (32%), Positives = 49/91 (53%), Gaps = 6/91 (6%)

Query: 253 GLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEGTFGY 312
           G+++LH      IIHRD+K SNI++  D   +I DFGLA+    ++    + P   T  Y
Sbjct: 130 GIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM---MTPYVVTRYY 183

Query: 313 LSPEYFMHGIVDEKTDVFAFGVLLLELITGR 343
            +PE  +     E  D+++ G ++ E+I G 
Sbjct: 184 RAPEVILGMGYKENVDIWSVGCIMGEMIRGT 214

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 47.4 bits (113), Expect = 8e-06
 Identities = 55/207 (26%), Positives = 88/207 (42%), Gaps = 20/207 (9%)

Query: 150 IGKGGHAEV----YKGCLPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHI-NHPNAA 204
           +G+G +  V          + E VA+KKI  N    +      L EL ++ H   H N  
Sbjct: 8   LGQGAYGIVCSARNAET-SEEETVAIKKI-TNVFSKKILAKRALRELKLLRHFRGHKNIT 65

Query: 205 KLIG-----FSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHH 259
            L           N  +L  + L    L  ++       +   +  I   I  GL+Y+H 
Sbjct: 66  CLYDMDIVFPGNFNELYL-YEELMEADLHQIIRSGQPLTDAHFQSFI-YQILCGLKYIHS 123

Query: 260 DCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIE--GTFGYLSPEY 317
                ++HRD+K  N+L++ D E +I DFGLA+   +N   +  F  E   T  Y +PE 
Sbjct: 124 ---ANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATRWYRAPEI 180

Query: 318 FMHGIVDEKT-DVFAFGVLLLELITGR 343
            +      K  DV++ G +L EL+  +
Sbjct: 181 MLSFQSYTKAIDVWSVGCILAELLGRK 207

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 47.3 bits (112), Expect = 9e-06
 Identities = 62/250 (24%), Positives = 114/250 (45%), Gaps = 38/250 (15%)

Query: 148 NLIGKGGHAEVYKG-CLPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKL 206
           N+IG G    VY+  C+   E VA+KK++++ +           EL I+ ++NH N   L
Sbjct: 72  NIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKNR-------ELLIMKNLNHINIIFL 124

Query: 207 IGF--------STENGF-HLVLQFLPHGSLSSLLFGS--TECLEWTIRYKIALGIAEGLQ 255
             +        + +N F ++V++F+P      +   +     L   +    +  +   L 
Sbjct: 125 KDYYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALA 184

Query: 256 YLHHDCHRRIIHRDIKASNILLSED-YEAQISDFGLAKWLPDNWSHHIVFPIEGTFGYLS 314
           Y+H    + I HRD+K  N+L+  + +  ++ DFG AK L        V  I   F Y +
Sbjct: 185 YIHS---KFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLA--GQRSVSYICSRF-YRA 238

Query: 315 PEYFMHGIVDEKT--DVFAFGVLLLELI------TGRRAVDSRRQSLVIWAKPLLQTSNF 366
           PE  M G  +  T  D+++ G ++ E+I      +G+ +VD   + + +   P   T + 
Sbjct: 239 PE-LMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTP---TEDQ 294

Query: 367 KELVDPRLAD 376
            + ++P  AD
Sbjct: 295 LKEMNPNYAD 304

Length = 440

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 47.1 bits (112), Expect = 1e-05
 Identities = 56/241 (23%), Positives = 94/241 (39%), Gaps = 55/241 (22%)

Query: 150 IGKGGHAEVYKGCLPDGEVV-AVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLI- 207
           IG G   EV      D   + A+K + K       + +   +E  I+A  ++    KL  
Sbjct: 9   IGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYY 68

Query: 208 GFSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIH 267
            F  ++  + V+ ++P G + SLL       E   R+ IA  +   ++ +H       IH
Sbjct: 69  SFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDLARFYIA-ELTCAIESVHK---MGFIH 124

Query: 268 RDIKASNILLSEDYEAQISDFGLA---KW-------------------LPDNWS------ 299
           RDIK  NIL+  D   +++DFGL    +W                     + WS      
Sbjct: 125 RDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCR 184

Query: 300 -----------------HHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITG 342
                            H +V    GT  Y++PE  +     +  D ++ GV+L E++ G
Sbjct: 185 LKPLERRRKRQHQRCLAHSLV----GTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVG 240

Query: 343 R 343
           +
Sbjct: 241 Q 241

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 46.6 bits (110), Expect = 1e-05
 Identities = 30/91 (32%), Positives = 50/91 (54%), Gaps = 6/91 (6%)

Query: 253 GLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEGTFGY 312
           G+++LH      IIHRD+K SNI++  D   +I DFGLA+    ++   ++ P   T  Y
Sbjct: 138 GIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF---MMTPYVVTRYY 191

Query: 313 LSPEYFMHGIVDEKTDVFAFGVLLLELITGR 343
            +PE  +     E  D+++ G ++ E+I G 
Sbjct: 192 RAPEVILGMGYKENVDIWSVGCIMGEMIKGG 222

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 46.2 bits (109), Expect = 2e-05
 Identities = 25/96 (26%), Positives = 54/96 (56%), Gaps = 11/96 (11%)

Query: 250 IAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSH----HIVFP 305
           +A G+++L     +  +HRD+ A N+LL++    +I DFGLA+ +  + ++        P
Sbjct: 246 VARGMEFL---ASKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLP 302

Query: 306 IEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELIT 341
           ++    +++PE     +    +DV+++G+LL E+ +
Sbjct: 303 VK----WMAPESIFDNLYTTLSDVWSYGILLWEIFS 334

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 45.4 bits (108), Expect = 3e-05
 Identities = 18/40 (45%), Positives = 29/40 (72%), Gaps = 3/40 (7%)

Query: 253 GLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAK 292
           GL+Y+H      ++HRD+K SN+LL+ + + +I DFGLA+
Sbjct: 120 GLKYIHS---ANVLHRDLKPSNLLLNANCDLKICDFGLAR 156

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 45.5 bits (107), Expect = 4e-05
 Identities = 28/88 (31%), Positives = 49/88 (55%), Gaps = 6/88 (6%)

Query: 253 GLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEGTFGY 312
           G+++LH      IIHRD+K SNI++  D   +I DFGLA+    ++   ++ P   T  Y
Sbjct: 131 GIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF---MMTPYVVTRYY 184

Query: 313 LSPEYFMHGIVDEKTDVFAFGVLLLELI 340
            +PE  +     E  D+++ G ++ E++
Sbjct: 185 RAPEVILGMGYKENVDIWSVGCIMGEMV 212

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 45.2 bits (107), Expect = 4e-05
 Identities = 49/220 (22%), Positives = 92/220 (41%), Gaps = 31/220 (14%)

Query: 142 DNFNSENLIGKGGHAEVYKGC-LPDGEVVAVKKIIKNAKEDEERI-SDFLSELGIVAHIN 199
           D +     IG+G + +VYK      G++VA+KK     + DEE I    L E+ ++  ++
Sbjct: 1   DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKK--TRLEMDEEGIPPTALREISLLQMLS 58

Query: 200 H-PNAAKLIGF-STENG-----FHLVLQFLPHGSLSSLLF----GSTECLEWTIRYKIAL 248
                 +L+     E        +LV ++L    L   +     G    L          
Sbjct: 59  ESIYIVRLLDVEHVEEKNGKPSLYLVFEYL-DSDLKKFMDSNGRGPGRPLPAKTIKSFMY 117

Query: 249 GIAEGLQYLHHDCHRR-IIHRDIKASNILLSEDYEA-QISDFGLAKWLP---DNWSHHIV 303
            + +G+ +    CH+  ++HRD+K  N+L+ +     +I+D GL +       +++H IV
Sbjct: 118 QLLKGVAH----CHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIV 173

Query: 304 FPIEGTFGYLSPEYFMHGI-VDEKTDVFAFGVLLLELITG 342
                T  Y +PE  +         D+++ G +  E+   
Sbjct: 174 -----TLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRK 208

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

 Score = 44.5 bits (105), Expect = 5e-05
 Identities = 51/205 (24%), Positives = 87/205 (42%), Gaps = 38/205 (18%)

Query: 156 AEVYKGCLPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTEN-G 214
           +E+Y         V VK++  NA   E+  ++FL +      + HPN  + +G   E   
Sbjct: 14  SEIYTD--TGVARVVVKELKANASSKEQ--NEFLQQGDPYRILQHPNILQCLGQCVEAIP 69

Query: 215 FHLVLQFLPHGSLSSLL------FGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHR 268
           + LV ++   G L S L        +++ L      ++A  IA G+ ++H       +H 
Sbjct: 70  YLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQ---RMACEIAAGVTHMHK---HNFLHS 123

Query: 269 DIKASNILLSEDYEAQISDFGLAKWLPDNWSH-------HIVFPIEGTFGYLSPEYF--M 319
           D+   N  L+ D   ++ D+G+    P  +             P+     +L+PE     
Sbjct: 124 DLALRNCFLTSDLTVKVGDYGIG---PSRYKEDYIETEDDKCVPLR----WLAPELVGEF 176

Query: 320 HG--IVDEKT---DVFAFGVLLLEL 339
           HG  I  E+T   +V+A GV L EL
Sbjct: 177 HGGLITAEQTKPSNVWALGVTLWEL 201

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 44.0 bits (104), Expect = 8e-05
 Identities = 49/190 (25%), Positives = 83/190 (43%), Gaps = 24/190 (12%)

Query: 170 AVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIG-FSTENGFHLVLQFLPHGSLS 228
           A+KKI K       +I     E  I+    +P    +   F T+    +V++++  G  +
Sbjct: 30  AMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVMEYVEGGDCA 89

Query: 229 SLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDF 288
           +LL           R   A  +   L+YLH+     I+HRD+K  N+L++     +++DF
Sbjct: 90  TLLKNIGALPVDMARMYFAETVL-ALEYLHN---YGIVHRDLKPDNLLITSMGHIKLTDF 145

Query: 289 GLAKW----LPDN-WSHHI-----------VFPIEGTFGYLSPEYFMHGIVDEKTDVFAF 332
           GL+K     L  N +  HI           V    GT  Y++PE  +     +  D +A 
Sbjct: 146 GLSKIGLMSLTTNLYEGHIEKDTREFLDKQVC---GTPEYIAPEVILRQGYGKPVDWWAM 202

Query: 333 GVLLLELITG 342
           G++L E + G
Sbjct: 203 GIILYEFLVG 212

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 44.2 bits (104), Expect = 8e-05
 Identities = 55/210 (26%), Positives = 91/210 (43%), Gaps = 15/210 (7%)

Query: 142 DNFNSENLIGKGGHAEVYKGCLPDGEVVAVKKIIKNAKEDEERISD--FLSELGIVAHIN 199
           D+F    +IG+G   EV    +   E +   KI+ N  E  +R     F  E  ++ + +
Sbjct: 1   DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKIL-NKWEMLKRAETACFREERNVLVNGD 59

Query: 200 HPNAAKL-IGFSTENGFHLVLQFLPHGSLSSLLFGSTECL-EWTIRYKIALGIAEGLQYL 257
                 L   F  EN  +LV+ +   G L +LL    + L E   R+ IA    E +  +
Sbjct: 60  CQWITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIA----EMVLAI 115

Query: 258 HHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEGTFGYLSPEY 317
           H       +HRDIK  N+LL  +   +++DFG    +  + +      + GT  Y+SPE 
Sbjct: 116 HSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAV-GTPDYISPEI 174

Query: 318 FM-----HGIVDEKTDVFAFGVLLLELITG 342
                   G    + D ++ GV + E++ G
Sbjct: 175 LQAMEDGMGKYGPECDWWSLGVCMYEMLYG 204

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 43.9 bits (103), Expect = 1e-04
 Identities = 57/212 (26%), Positives = 98/212 (46%), Gaps = 19/212 (8%)

Query: 142 DNFNSENLIGKGGHAEVYKGCLPDGEVVAVKKIIKNAKEDEERISD--FLSELGIVAHIN 199
           ++F    +IG+G   EV    L + + V   KI+ N  E  +R     F  E  ++ + +
Sbjct: 1   EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKIL-NKWEMLKRAETACFREERDVLVNGD 59

Query: 200 HPNAAKL-IGFSTENGFHLVLQFLPHGSLSSLLFGSTECL-EWTIRYKIA-LGIA-EGLQ 255
           +     L   F  EN  +LV+ +   G L +LL    + L E   R+ +A + IA + + 
Sbjct: 60  NQWITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVH 119

Query: 256 YLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEGTFGYLSP 315
            LH+      +HRDIK  NIL+  +   +++DFG    L ++ +      + GT  Y+SP
Sbjct: 120 QLHY------VHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAV-GTPDYISP 172

Query: 316 EYFM-----HGIVDEKTDVFAFGVLLLELITG 342
           E         G    + D ++ GV + E++ G
Sbjct: 173 EILQAMEDGKGKYGPECDWWSLGVCMYEMLYG 204

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score = 42.7 bits (100), Expect = 2e-04
 Identities = 39/147 (26%), Positives = 67/147 (45%), Gaps = 18/147 (12%)

Query: 166 GEVVAVKKIIKNA--------KED---EERISDFLSELGIVAHINHPNAAKLI-GFSTEN 213
           GEV   +K+   A        K+D     +++   +E  I+A  ++    +L   F  ++
Sbjct: 15  GEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKD 74

Query: 214 GFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKAS 273
             + V+ ++P G + SLL       E   R+ IA  +   ++ +H       IHRDIK  
Sbjct: 75  NLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIA-ELTCAVESVHK---MGFIHRDIKPD 130

Query: 274 NILLSEDYEAQISDFGLAKWLPDNWSH 300
           NIL+  D   +++DFGL       W+H
Sbjct: 131 NILIDRDGHIKLTDFGLCTGF--RWTH 155

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 42.4 bits (99), Expect = 3e-04
 Identities = 55/240 (22%), Positives = 96/240 (40%), Gaps = 61/240 (25%)

Query: 150 IGKGGHAEVYKGCLPDGEV---VAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKL 206
           +G+G +  VYK    DG+     A+K+I     E          E+ ++  + HPN   L
Sbjct: 9   VGRGTYGHVYKAKRKDGKDDRDYALKQI-----EGTGISMSACREIALLRELKHPNVISL 63

Query: 207 ---------------IGFSTENGFHLVLQF------------LPHGSLSSLLFGSTECLE 239
                            ++  + +H++ +F            LP G + SLL+       
Sbjct: 64  QKVFLSHADRKVWLLFDYAEHDLWHII-KFHRASKANKKPVQLPRGMVKSLLYQ------ 116

Query: 240 WTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILL----SEDYEAQISDFGLAKWLP 295
                     I +G+ YLH +    ++HRD+K +NIL+     E    +I+D G A+   
Sbjct: 117 ----------ILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFN 163

Query: 296 DNWSHHI-VFPIEGTFGYLSPEYFMHGIVDEKT-DVFAFGVLLLELITGRRAVDSRRQSL 353
                   + P+  TF Y +PE  +      K  D++A G +  EL+T       R++ +
Sbjct: 164 SPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDI 223

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 42.2 bits (99), Expect = 4e-04
 Identities = 25/85 (29%), Positives = 43/85 (50%), Gaps = 3/85 (3%)

Query: 254 LQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEGTFGYL 313
           + Y+H +    IIHRDIK  N+L++   +  + DFG A +   +WS    + I GT    
Sbjct: 273 IDYIHGE---GIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYGIAGTVDTN 329

Query: 314 SPEYFMHGIVDEKTDVFAFGVLLLE 338
           +PE           D+++ G+++ E
Sbjct: 330 APEVLAGDPYTPSVDIWSAGLVIFE 354

Length = 461

>gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional

 Score = 41.7 bits (98), Expect = 5e-04
 Identities = 47/212 (22%), Positives = 98/212 (46%), Gaps = 20/212 (9%)

Query: 142 DNFNSEN--LIGKGGHAEVYKGCLPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHIN 199
           D+ +     LI +     +YKG   + + V ++   K  K  +  I    +E+  +  I+
Sbjct: 18  DDIDKYTSVLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRID 76

Query: 200 HPNAAKLIGFSTENGFHL-----VLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGL 254
             N  K+ GF  +    L     +L++   G L  +L    + L +  +  +A+   +GL
Sbjct: 77  SNNILKIYGFIIDIVDDLPRLSLILEYCTRGYLREVLDKEKD-LSFKTKLDMAIDCCKGL 135

Query: 255 QYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEGTFGYLS 314
             L+   ++   ++++ + + L++E+Y+ +I   GL K L      ++ F +     Y S
Sbjct: 136 YNLYKYTNKP--YKNLTSVSFLVTENYKLKIICHGLEKILSSPPFKNVNFMV-----YFS 188

Query: 315 PEYFMHGIVDEKT---DVFAFGVLLLELITGR 343
            +  ++ I  E T   D+++ GV+L E+ TG+
Sbjct: 189 YK-MLNDIFSEYTIKDDIYSLGVVLWEIFTGK 219

Length = 283

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 41.3 bits (97), Expect = 7e-04
 Identities = 57/214 (26%), Positives = 93/214 (43%), Gaps = 23/214 (10%)

Query: 142 DNFNSENLIGKGGHAEVYKGCLPD-GEVVAVKKIIKNAKEDEERISDFLSELGIVAHINH 200
           D+F    +IG+G   EV    + + G+V A+K + K         + F  E  ++ + + 
Sbjct: 1   DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDR 60

Query: 201 PNAAKL-IGFSTENGFHLVLQFLPHGSLSSLLFGSTECL-EWTIRYKIA---LGIAEGLQ 255
                L   F  EN  +LV+ +   G L +LL    + L E   R+ +A   L I     
Sbjct: 61  RWITNLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAI----- 115

Query: 256 YLHHDCHR-RIIHRDIKASNILLSEDYEAQISDFG-LAKWLPDNWSHHIVFPIEGTFGYL 313
                 H+   +HRDIK  N+LL ++   +++DFG   + L D      V    GT  Y+
Sbjct: 116 ---DSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNV--AVGTPDYI 170

Query: 314 SPEYFM-----HGIVDEKTDVFAFGVLLLELITG 342
           SPE         G    + D ++ GV + E++ G
Sbjct: 171 SPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYG 204

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 40.8 bits (95), Expect = 9e-04
 Identities = 51/223 (22%), Positives = 92/223 (41%), Gaps = 27/223 (12%)

Query: 150 IGKGGHAEVYKGCLPDGE---VVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNA--- 203
           +G+G +  VYK    DG+     A+K+I     E          E+ ++  + HPN    
Sbjct: 9   VGRGTYGHVYKAKRKDGKDEKEYALKQI-----EGTGISMSACREIALLRELKHPNVIAL 63

Query: 204 AKLIGFSTENGFHLVLQFLPHGSLSSLLFGSTE-------CLEWTIRYKIALGIAEGLQY 256
            K+    ++    L+  +  H     + F            L  ++   +   I +G+ Y
Sbjct: 64  QKVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHY 123

Query: 257 LHHDCHRRIIHRDIKASNILL----SEDYEAQISDFGLAKWLPDNWSHHI-VFPIEGTFG 311
           LH +    ++HRD+K +NIL+     E    +I+D G A+           + P+  TF 
Sbjct: 124 LHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFW 180

Query: 312 YLSPEYFMHGIVDEKT-DVFAFGVLLLELITGRRAVDSRRQSL 353
           Y +PE  +      K  D++A G +  EL+T       R++ +
Sbjct: 181 YRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDI 223

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 40.8 bits (95), Expect = 0.001
 Identities = 44/178 (24%), Positives = 78/178 (43%), Gaps = 16/178 (8%)

Query: 172 KKIIKNAKEDEERISDFLSELGIVAHINHPNAAKL--IGFSTENGFHLVLQFLPHGSLSS 229
           + I K  K          +E+  +  +NH N  K+  I  S  N + +  ++     L S
Sbjct: 194 RLIAKRVKAGSRAAIQLENEILALGRLNHENILKIEEILRSEANTYMITQKY--DFDLYS 251

Query: 230 LLFGSTECLEWTIR------YKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEA 283
            ++   E  +W  R        I   +   ++Y+H    +++IHRDIK  NI L+ D + 
Sbjct: 252 FMY--DEAFDWKDRPLLKQTRAIMKQLLCAVEYIHD---KKLIHRDIKLENIFLNCDGKI 306

Query: 284 QISDFGLAKWLPDNWSHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELIT 341
            + DFG A    +       +   GT    SPE        E TD+++ G++LL++++
Sbjct: 307 VLGDFGTAMPF-EKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLS 363

Length = 501

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 39.0 bits (91), Expect = 0.004
 Identities = 28/101 (27%), Positives = 50/101 (49%), Gaps = 20/101 (19%)

Query: 253 GLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDN------WSHHIVFPI 306
            L+Y+H      + HRD+K  NIL + D + +I DFGLA+   ++      W+ ++    
Sbjct: 115 ALKYIHTA---NVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYV---- 167

Query: 307 EGTFGYLSPE----YFMHGIVDEKTDVFAFGVLLLELITGR 343
             T  Y +PE    +F         D+++ G +  E++TG+
Sbjct: 168 -ATRWYRAPELCGSFF--SKYTPAIDIWSIGCIFAEVLTGK 205

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	457
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
PTZ00284	467	protein kinase; Provisional	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
KOG0577	948	consensus Serine/threonine protein kinase [Signal	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	100.0
KOG0596	677	consensus Dual specificity; serine/threonine and t	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
KOG3653	534	consensus Transforming growth factor beta/activin	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	100.0
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	100.0
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	100.0
KOG0586	596	consensus Serine/threonine protein kinase [General	100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	100.0
PHA02882	294	putative serine/threonine kinase; Provisional	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	100.0
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	100.0
KOG0690	516	consensus Serine/threonine protein kinase [Signal	100.0
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	100.0
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	100.0
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	100.0
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	100.0
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	100.0
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	100.0
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	100.0
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	100.0
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	100.0
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	100.0
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	100.0
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	100.0
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	100.0
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	100.0
PTZ00024	335	cyclin-dependent protein kinase; Provisional	100.0
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	100.0
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	100.0
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	100.0
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	100.0
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	100.0
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	100.0
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	100.0
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	100.0
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	100.0
KOG2052	513	consensus Activin A type IB receptor, serine/threo	100.0
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	100.0
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	100.0
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	100.0
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	100.0
KOG0696	683	consensus Serine/threonine protein kinase [Signal	100.0
KOG0607	463	consensus MAP kinase-interacting kinase and relate	100.0
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	100.0
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	100.0
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	100.0
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	100.0
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	100.0
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	100.0
PLN03224	507	probable serine/threonine protein kinase; Provisio	99.98
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	99.97
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	99.97
KOG0695	593	consensus Serine/threonine protein kinase [Signal	99.97
KOG1027	903	consensus Serine/threonine protein kinase and endo	99.97
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	99.97
KOG1290	590	consensus Serine/threonine protein kinase [Signal	99.97
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.97
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	99.96
KOG1152	772	consensus Signal transduction serine/threonine kin	99.96
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	99.96
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	99.96
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.96
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	99.96
KOG0576	829	consensus Mitogen-activated protein kinase kinase	99.95
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.95
PLN00181	793	protein SPA1-RELATED; Provisional	99.94
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.94
PRK09188	365	serine/threonine protein kinase; Provisional	99.92
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.92
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.91
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.9
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.89
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.87
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.87
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.86
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.86
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.85
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.85
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.85
PRK12274	218	serine/threonine protein kinase; Provisional	99.85
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.82
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.81
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.81
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.81
PRK10345	210	hypothetical protein; Provisional	99.79
smart00090	237	RIO RIO-like kinase.	99.78
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.76
PRK14879	211	serine/threonine protein kinase; Provisional	99.76
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.75
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.74
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.74
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.72
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.71
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.69
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.62
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.62
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.62
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.48
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.44
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.44
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.36
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.36
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.27
KOG1243	690	consensus Protein kinase [General function predict	99.24
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.23
KOG3087	229	consensus Serine/threonine protein kinase [General	99.21
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.19
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.14
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.12
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	99.04
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	98.94
COG4248	637	Uncharacterized protein with protein kinase and he	98.91
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	98.86
COG0478	304	RIO-like serine/threonine protein kinase fused to	98.8
KOG2137	700	consensus Protein kinase [Signal transduction mech	98.77
PRK09902	216	hypothetical protein; Provisional	98.6
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.6
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.59
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	98.36
KOG0576	829	consensus Mitogen-activated protein kinase kinase	98.34
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	98.31
PF01636	239	APH: Phosphotransferase enzyme family This family	98.19
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	98.12
KOG1235	538	consensus Predicted unusual protein kinase [Genera	98.09
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	98.03
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	98.03
PLN02876	822	acyl-CoA dehydrogenase	97.98
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	97.97
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	97.92
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	97.83
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	97.8
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	97.77
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	97.62
PRK05231	319	homoserine kinase; Provisional	97.59
PRK10593	297	hypothetical protein; Provisional	97.57
PRK09550	401	mtnK methylthioribose kinase; Reviewed	97.48
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	97.44
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	97.37
KOG2268	465	consensus Serine/threonine protein kinase [Signal	97.37
cd05152	276	MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH	97.24
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	97.24
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	97.0
COG3173	321	Predicted aminoglycoside phosphotransferase [Gener	96.62
PLN02756	418	S-methyl-5-thioribose kinase	96.59
TIGR01767	370	MTRK 5-methylthioribose kinase. This enzyme is inv	96.57
KOG1826	2724	consensus Ras GTPase activating protein RasGAP/neu	96.44
PLN02236	344	choline kinase	96.17
KOG2270	520	consensus Serine/threonine protein kinase involved	96.03
PRK12396	409	5-methylribose kinase; Reviewed	95.9
PF03881	288	Fructosamin_kin: Fructosamine kinase; InterPro: IP	95.64
PRK06148	1013	hypothetical protein; Provisional	95.54
COG5072	488	ALK1 Serine/threonine kinase of the haspin family	95.54
TIGR02906	313	spore_CotS spore coat protein, CotS family. Member	95.53
TIGR02904	309	spore_ysxE spore coat protein YsxE. Members of thi	95.42
COG2334	331	Putative homoserine kinase type II (protein kinase	95.31
PLN02421	330	phosphotransferase, alcohol group as acceptor/kina	95.23
KOG1236	565	consensus Predicted unusual protein kinase [Genera	94.85
PRK11768	325	serine/threonine protein kinase; Provisional	94.82
PF07387	308	Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099	94.62
KOG1093	725	consensus Predicted protein kinase (contains TBC a	94.32
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	93.94
PTZ00384	383	choline kinase; Provisional	93.19
PHA03111	444	Ser/Thr kinase; Provisional	93.0

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-56  Score=444.41  Aligned_cols=283  Identities=49%  Similarity=0.825  Sum_probs=252.0

Q ss_pred             ccccccHHHHHHhhcCCCCCceecccCcEEEEEEEeCCCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceee
Q 012765          128 SWKNFDFAELAAATDNFNSENLIGKGGHAEVYKGCLPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLI  207 (457)
Q Consensus       128 ~~~~~~~~~~~~~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~  207 (457)
                      ....|++.++..+|++|...++||+|+||.||+|...+|..||||++.......   ..+|.+|+.++.+++|||+|+++
T Consensus        61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~---~~eF~~Ei~~ls~l~H~Nlv~Ll  137 (361)
T KOG1187|consen   61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQG---EREFLNEVEILSRLRHPNLVKLL  137 (361)
T ss_pred             CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcc---hhHHHHHHHHHhcCCCcCcccEE
Confidence            456799999999999999999999999999999999999999999886544321   34699999999999999999999


Q ss_pred             eeeecCc--eEEEEEecCCCChhhhhhcCCC-CCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEE
Q 012765          208 GFSTENG--FHLVLQFLPHGSLSSLLFGSTE-CLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQ  284 (457)
Q Consensus       208 ~~~~~~~--~~lv~e~~~~gsL~~~l~~~~~-~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~k  284 (457)
                      |||.+.+  .+|||||+++|+|.++|+.... .++|..|++||.++|+||+|||..+...||||||||+|||||+++++|
T Consensus       138 GyC~e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aK  217 (361)
T KOG1187|consen  138 GYCLEGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAK  217 (361)
T ss_pred             EEEecCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEE
Confidence            9998766  7899999999999999988766 899999999999999999999998878999999999999999999999


Q ss_pred             EeeccccccCCC-CCCceeeecc-cccccccChhccccCCCCcchhHHHHHHHHHHHHhCCCCCCcC----Ccchhhhhc
Q 012765          285 ISDFGLAKWLPD-NWSHHIVFPI-EGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSR----RQSLVIWAK  358 (457)
Q Consensus       285 L~DFGl~~~~~~-~~~~~~~~~~-~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLltG~~pf~~~----~~~~~~~~~  358 (457)
                      |+|||+++..+. ....   ... .||.+|+|||++..+..+.|+|||||||+|+||+||+.|.+..    ...+..|+.
T Consensus       218 lsDFGLa~~~~~~~~~~---~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~  294 (361)
T KOG1187|consen  218 LSDFGLAKLGPEGDTSV---STTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAK  294 (361)
T ss_pred             ccCccCcccCCccccce---eeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHH
Confidence            999999977654 2211   112 6999999999999999999999999999999999999988752    344789999


Q ss_pred             cccccCCcccccCchhh-cccCH-HHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCCC
Q 012765          359 PLLQTSNFKELVDPRLA-DAYDL-AEMKRAMLTASVCIHHLSTMRPQMTRVLQLLRGEGG  416 (457)
Q Consensus       359 ~~~~~~~~~~~~d~~l~-~~~~~-~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~  416 (457)
                      +.+.+..+.+++|+.+. ..+.. ..+..+..+|.+|++.+|..||+|.||+++|+.+..
T Consensus       295 ~~~~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~  354 (361)
T KOG1187|consen  295 PLLEEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILS  354 (361)
T ss_pred             HHHHCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhcc
Confidence            99999999999999997 66564 689999999999999999999999999999966543

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-49  Score=374.70  Aligned_cols=249  Identities=29%  Similarity=0.451  Sum_probs=204.8

Q ss_pred             CCCCCceecccCcEEEEEEEeC-CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeee-eecCc-eEEEE
Q 012765          143 NFNSENLIGKGGHAEVYKGCLP-DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGF-STENG-FHLVL  219 (457)
Q Consensus       143 ~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~-~~~~~-~~lv~  219 (457)
                      +.+..+.||+|..|+|||+.++ +++.+|+|.+..+.  +.....++.+|+++++.++||+||.+||. +.++. ..++|
T Consensus        80 dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~--~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~m  157 (364)
T KOG0581|consen   80 DLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNI--DPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICM  157 (364)
T ss_pred             HhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccC--CHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeeh
Confidence            3345689999999999999875 68899999984333  33556799999999999999999999994 45553 88999


Q ss_pred             EecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCCCCCC
Q 012765          220 QFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWS  299 (457)
Q Consensus       220 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~~~~  299 (457)
                      |||.+|+|..++... +.+++....+|+.+|++||.|||..  ++||||||||+|||++..|++||||||.++.+.+.  
T Consensus       158 EYMDgGSLd~~~k~~-g~i~E~~L~~ia~~VL~GL~YLh~~--~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS--  232 (364)
T KOG0581|consen  158 EYMDGGSLDDILKRV-GRIPEPVLGKIARAVLRGLSYLHEE--RKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS--  232 (364)
T ss_pred             hhcCCCCHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhhc--cCeeeccCCHHHeeeccCCCEEeccccccHHhhhh--
Confidence            999999999998654 5589999999999999999999964  89999999999999999999999999999998776  


Q ss_pred             ceeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhccccccCCcccccC---chhhc
Q 012765          300 HHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSNFKELVD---PRLAD  376 (457)
Q Consensus       300 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d---~~l~~  376 (457)
                        ...++.||..|||||.+.+..|+.++||||||+.++|+++|+.||.........|+..      +..+++   |.+..
T Consensus       233 --~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~L------l~~Iv~~ppP~lP~  304 (364)
T KOG0581|consen  233 --IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFEL------LCAIVDEPPPRLPE  304 (364)
T ss_pred             --hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHH------HHHHhcCCCCCCCc
Confidence              3345669999999999999999999999999999999999999998742222222211      122222   22222


Q ss_pred             ccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 012765          377 AYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQ  409 (457)
Q Consensus       377 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~  409 (457)
                      .   ....++..++..||++||.+||++.|+++
T Consensus       305 ~---~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~  334 (364)
T KOG0581|consen  305 G---EFSPEFRSFVSCCLRKDPSERPSAKQLLQ  334 (364)
T ss_pred             c---cCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            2   34567888999999999999999999987

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-48  Score=386.32  Aligned_cols=255  Identities=30%  Similarity=0.449  Sum_probs=208.9

Q ss_pred             CCceecccCcEEEEEEEeCCCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeecCc--eEEEEEecC
Q 012765          146 SENLIGKGGHAEVYKGCLPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTENG--FHLVLQFLP  223 (457)
Q Consensus       146 ~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~--~~lv~e~~~  223 (457)
                      ..+.||+|+||+||+|.+.....||+|++......... ...|.+|+.+|.+++|||||+++|+|.+..  +++||||++
T Consensus        45 ~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~-~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~  123 (362)
T KOG0192|consen   45 IEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDES-RKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMP  123 (362)
T ss_pred             hhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHH-HHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCC
Confidence            34569999999999999955555999998765554444 779999999999999999999999998875  899999999


Q ss_pred             CCChhhhhhc-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC-eeeCCCCCCcEEEcCCC-cEEEeeccccccCCCCCCc
Q 012765          224 HGSLSSLLFG-STECLEWTIRYKIALGIAEGLQYLHHDCHRR-IIHRDIKASNILLSEDY-EAQISDFGLAKWLPDNWSH  300 (457)
Q Consensus       224 ~gsL~~~l~~-~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~-iiHrDlkp~NIll~~~~-~~kL~DFGl~~~~~~~~~~  300 (457)
                      +|+|..+++. ....+++..++.|+.+||+|+.|||+   .+ ||||||||+|||++.++ ++||+|||+++......  
T Consensus       124 ~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~---~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~--  198 (362)
T KOG0192|consen  124 GGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHS---EGPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK--  198 (362)
T ss_pred             CCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhc---CCCeeecccChhhEEEcCCCCEEEECCCccceeecccc--
Confidence            9999999987 47789999999999999999999999   67 99999999999999998 99999999998776532  


Q ss_pred             eeeecccccccccChhccc--cCCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhccccccCCcccccCchhhccc
Q 012765          301 HIVFPIEGTFGYLSPEYFM--HGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSNFKELVDPRLADAY  378 (457)
Q Consensus       301 ~~~~~~~gt~~y~aPE~~~--~~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~  378 (457)
                      .......||..|||||++.  ...|+.|+||||||+++|||+||+.||.............  .         ...++..
T Consensus       199 ~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~--~---------~~~Rp~~  267 (362)
T KOG0192|consen  199 TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVV--V---------GGLRPPI  267 (362)
T ss_pred             ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHH--h---------cCCCCCC
Confidence            1122356999999999999  5689999999999999999999999999755422222211  1         1111111


Q ss_pred             CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCCCC
Q 012765          379 DLAEMKRAMLTASVCIHHLSTMRPQMTRVLQLLRGEGGQ  417 (457)
Q Consensus       379 ~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~  417 (457)
                      .......+..++..||+.||..||++.+|+..|+.+...
T Consensus       268 p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~  306 (362)
T KOG0192|consen  268 PKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSH  306 (362)
T ss_pred             CccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHh
Confidence            112344566777789999999999999999999876543

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=4.3e-49  Score=358.68  Aligned_cols=279  Identities=24%  Similarity=0.370  Sum_probs=217.4

Q ss_pred             hcCCCCCceecccCcEEEEEEE-eCCCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeee--eeecCc-eE
Q 012765          141 TDNFNSENLIGKGGHAEVYKGC-LPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIG--FSTENG-FH  216 (457)
Q Consensus       141 ~~~f~~~~~LG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~--~~~~~~-~~  216 (457)
                      ..+|.+++.||+|+||+|||+. ..+|..+|.|.+.-. ..+.....++..|+.+|++|+|||||++++  |..++. ++
T Consensus        18 l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~-~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evln   96 (375)
T KOG0591|consen   18 LADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFG-MMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLN   96 (375)
T ss_pred             HHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchh-hccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhH
Confidence            3567788999999999999996 568999999998733 344555678999999999999999999998  445555 68


Q ss_pred             EEEEecCCCChhhhhhc---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCC-CeeeCCCCCCcEEEcCCCcEEEeeccccc
Q 012765          217 LVLQFLPHGSLSSLLFG---STECLEWTIRYKIALGIAEGLQYLHHDCHR-RIIHRDIKASNILLSEDYEAQISDFGLAK  292 (457)
Q Consensus       217 lv~e~~~~gsL~~~l~~---~~~~~~~~~~~~i~~qia~aL~yLH~~~~~-~iiHrDlkp~NIll~~~~~~kL~DFGl~~  292 (457)
                      ++||++..|+|..++..   ..+.+++..+|+++.|++.||..+|+...+ -|+||||||.||+|+.+|.+||+|||+++
T Consensus        97 ivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r  176 (375)
T KOG0591|consen   97 IVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGR  176 (375)
T ss_pred             HHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHh
Confidence            99999999999998843   566799999999999999999999994422 38999999999999999999999999999


Q ss_pred             cCCCCCCceeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhccccccCCcccccCc
Q 012765          293 WLPDNWSHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSNFKELVDP  372 (457)
Q Consensus       293 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~  372 (457)
                      .+....+.  .....|||.||+||.+...+|+.|+||||+||++|||+.-++||.+..  +..... ...+.++.     
T Consensus       177 ~l~s~~tf--A~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n--~~~L~~-KI~qgd~~-----  246 (375)
T KOG0591|consen  177 FLSSKTTF--AHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDN--LLSLCK-KIEQGDYP-----  246 (375)
T ss_pred             HhcchhHH--HHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCccccc--HHHHHH-HHHcCCCC-----
Confidence            98765432  345679999999999999999999999999999999999999998752  111111 11111111     


Q ss_pred             hhhcccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCCCCCCCCCCCCccceeecC
Q 012765          373 RLADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQLLRGEGGQTDLKPKPSARRTVILD  433 (457)
Q Consensus       373 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~~~~~~~~~~~~~~~~~  433 (457)
                         +..+.-....+..++..|+..||+.||+.-.++..++..-+......+++.++.+..+
T Consensus       247 ---~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~~l~~~s~~~~~~~~~l~~~E  304 (375)
T KOG0591|consen  247 ---PLPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQSELDGESFQLHRFGARLFEDE  304 (375)
T ss_pred             ---CCcHHHhhhHHHHHHHHHccCCcccCCCcchHHHHHHHHhcccchhHhHHHHhhhhhh
Confidence               1112334566777888899999999999766666665543333344455555555433

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=6.9e-47  Score=377.08  Aligned_cols=249  Identities=28%  Similarity=0.411  Sum_probs=208.6

Q ss_pred             cCCCCCceecccCcEEEEEEEe-CCCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeecCc-eEEEE
Q 012765          142 DNFNSENLIGKGGHAEVYKGCL-PDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTENG-FHLVL  219 (457)
Q Consensus       142 ~~f~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~-~~lv~  219 (457)
                      ..|...++||+|||+.||.+.. ..|+.||+|++.+.........+.+.+|++|.+.|+|||||++++|+++.+ .|+|.
T Consensus        18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL   97 (592)
T KOG0575|consen   18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL   97 (592)
T ss_pred             ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence            5688899999999999999987 789999999998766666666789999999999999999999999777654 68999


Q ss_pred             EecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCCCCCC
Q 012765          220 QFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWS  299 (457)
Q Consensus       220 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~~~~  299 (457)
                      |+|..++|..++. ..+.+++..+..++.||+.||.|||+   .+|||||||..|+||+++.++||+|||||..+..+..
T Consensus        98 ELC~~~sL~el~K-rrk~ltEpEary~l~QIv~GlkYLH~---~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~E  173 (592)
T KOG0575|consen   98 ELCHRGSLMELLK-RRKPLTEPEARYFLRQIVEGLKYLHS---LGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDGE  173 (592)
T ss_pred             EecCCccHHHHHH-hcCCCCcHHHHHHHHHHHHHHHHHHh---cCceecccchhheeecCcCcEEecccceeeeecCccc
Confidence            9999999999986 66779999999999999999999999   8999999999999999999999999999999875422


Q ss_pred             ceeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhccccccCCcccccCchhhcccC
Q 012765          300 HHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSNFKELVDPRLADAYD  379 (457)
Q Consensus       300 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~  379 (457)
                        ...+.+||+.|+|||++....++..+||||+||+||-||.|++||+...-. ..+.+....+..++        .   
T Consensus       174 --rk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vk-ety~~Ik~~~Y~~P--------~---  239 (592)
T KOG0575|consen  174 --RKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVK-ETYNKIKLNEYSMP--------S---  239 (592)
T ss_pred             --ccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHH-HHHHHHHhcCcccc--------c---
Confidence              234578999999999999999999999999999999999999999963211 11111111111111        1   


Q ss_pred             HHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 012765          380 LAEMKRAMLTASVCIHHLSTMRPQMTRVLQ  409 (457)
Q Consensus       380 ~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~  409 (457)
                       .......+++..+|+.||.+|||+.+|+.
T Consensus       240 -~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~  268 (592)
T KOG0575|consen  240 -HLSAEAKDLIRKLLRPNPSERPSLDEVLD  268 (592)
T ss_pred             -ccCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence             22234556788899999999999999987

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=4.7e-47  Score=361.58  Aligned_cols=253  Identities=24%  Similarity=0.340  Sum_probs=202.8

Q ss_pred             HhhcCCCCCceecccCcEEEEEEEe-CCCcEEEEEEEeccchhhH----HHHHHHHHHHHHHhhcCCCCcceeeeeeecC
Q 012765          139 AATDNFNSENLIGKGGHAEVYKGCL-PDGEVVAVKKIIKNAKEDE----ERISDFLSELGIVAHINHPNAAKLIGFSTEN  213 (457)
Q Consensus       139 ~~~~~f~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~----~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~  213 (457)
                      ...+.|.+.+.||+|+||.|-+|.. .+|+.||||++.+......    .....+.+|+++|++|+|||||+++++++..
T Consensus       169 s~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~  248 (475)
T KOG0615|consen  169 SFNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVP  248 (475)
T ss_pred             hhcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecC
Confidence            3567788889999999999999975 4799999999876443331    2334578999999999999999999988776


Q ss_pred             ce-EEEEEecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCC---CcEEEeecc
Q 012765          214 GF-HLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSED---YEAQISDFG  289 (457)
Q Consensus       214 ~~-~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~---~~~kL~DFG  289 (457)
                      +. |+||||+.||+|.+.+... +.+.+.....++.|++.|+.|||+   .||+||||||+|||+..+   ..+||+|||
T Consensus       249 ds~YmVlE~v~GGeLfd~vv~n-k~l~ed~~K~~f~Qll~avkYLH~---~GI~HRDiKPeNILl~~~~e~~llKItDFG  324 (475)
T KOG0615|consen  249 DSSYMVLEYVEGGELFDKVVAN-KYLREDLGKLLFKQLLTAVKYLHS---QGIIHRDIKPENILLSNDAEDCLLKITDFG  324 (475)
T ss_pred             CceEEEEEEecCccHHHHHHhc-cccccchhHHHHHHHHHHHHHHHH---cCcccccCCcceEEeccCCcceEEEecccc
Confidence            65 8999999999999998654 346667777899999999999999   899999999999999866   679999999


Q ss_pred             ccccCCCCCCceeeecccccccccChhccccCC---CCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhccccccCCc
Q 012765          290 LAKWLPDNWSHHIVFPIEGTFGYLSPEYFMHGI---VDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSNF  366 (457)
Q Consensus       290 l~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~~~~~~~~~  366 (457)
                      +|+..+..   ....+.+||+.|.|||++.+..   +..++|+||+||+||-+++|.+||.......           .+
T Consensus       325 lAK~~g~~---sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~-----------sl  390 (475)
T KOG0615|consen  325 LAKVSGEG---SFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDP-----------SL  390 (475)
T ss_pred             hhhccccc---eehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCc-----------cH
Confidence            99988643   3456788999999999998654   3348899999999999999999998632211           11


Q ss_pred             -ccccCchhh--cccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 012765          367 -KELVDPRLA--DAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQ  409 (457)
Q Consensus       367 -~~~~d~~l~--~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~  409 (457)
                       .++......  +....+-.++...++.+||..||++|||+.|+++
T Consensus       391 ~eQI~~G~y~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~  436 (475)
T KOG0615|consen  391 KEQILKGRYAFGPLQWDRISEEALDLINWMLVVDPENRPSADEALN  436 (475)
T ss_pred             HHHHhcCcccccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhc
Confidence             111122221  1223455677889999999999999999999876

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=7.7e-46  Score=353.68  Aligned_cols=201  Identities=31%  Similarity=0.506  Sum_probs=176.4

Q ss_pred             hcCCCCCceecccCcEEEEEEEeC-CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeecCc-eEEE
Q 012765          141 TDNFNSENLIGKGGHAEVYKGCLP-DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTENG-FHLV  218 (457)
Q Consensus       141 ~~~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~-~~lv  218 (457)
                      ..+|.....||+|+||+||+|++. ++..||||.+.+..- .....+.+..|+.+|+.++|||||.+++++..++ .|+|
T Consensus         9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l-~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lV   87 (429)
T KOG0595|consen    9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKL-NKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLV   87 (429)
T ss_pred             cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhcc-CHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEE
Confidence            467888888999999999999864 689999999865532 3445678899999999999999999999776554 6899


Q ss_pred             EEecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCC------CcEEEeeccccc
Q 012765          219 LQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSED------YEAQISDFGLAK  292 (457)
Q Consensus       219 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~------~~~kL~DFGl~~  292 (457)
                      ||||.+|+|..+++..+ .+++.....++.|||.||++||+   ++||||||||.||||+..      -.+||+|||+++
T Consensus        88 MEyC~gGDLs~yi~~~~-~l~e~t~r~Fm~QLA~alq~L~~---~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR  163 (429)
T KOG0595|consen   88 MEYCNGGDLSDYIRRRG-RLPEATARHFMQQLASALQFLHE---NNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFAR  163 (429)
T ss_pred             EEeCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCCcceEEeccCCCCCCCceEEecccchhh
Confidence            99999999999996544 58899999999999999999999   899999999999999864      458999999999


Q ss_pred             cCCCCCCceeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHhCCCCCCcC
Q 012765          293 WLPDNWSHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSR  349 (457)
Q Consensus       293 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLltG~~pf~~~  349 (457)
                      .+.....   ..+.+|++.|||||+++.+.|+.|+|+||+|+|+|++++|+.||+..
T Consensus       164 ~L~~~~~---a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~  217 (429)
T KOG0595|consen  164 FLQPGSM---AETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAE  217 (429)
T ss_pred             hCCchhH---HHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCcccc
Confidence            9976533   34567999999999999999999999999999999999999999953

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=6.9e-46  Score=351.06  Aligned_cols=245  Identities=28%  Similarity=0.365  Sum_probs=197.0

Q ss_pred             hhcCCCCCceecccCcEEEEEEEeC-CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeee-eeecCceEE
Q 012765          140 ATDNFNSENLIGKGGHAEVYKGCLP-DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIG-FSTENGFHL  217 (457)
Q Consensus       140 ~~~~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~-~~~~~~~~l  217 (457)
                      ..++|++.++||+|+||+||.++.+ +++.||+|.+.+..............|..+|.+++||+||+++. |.+.+.+|+
T Consensus        23 ~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLyl  102 (357)
T KOG0598|consen   23 GPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYL  102 (357)
T ss_pred             ChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEE
Confidence            4578999999999999999999754 69999999998766665566788999999999999999999975 778888999


Q ss_pred             EEEecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCCCC
Q 012765          218 VLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDN  297 (457)
Q Consensus       218 v~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~~  297 (457)
                      |++|+.||.|..+|..++. +++..+.-++.+|+.||.|||+   .+||||||||+||||+.+|+++|+|||+++.....
T Consensus       103 Vld~~~GGeLf~hL~~eg~-F~E~~arfYlaEi~lAL~~LH~---~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~  178 (357)
T KOG0598|consen  103 VLDYLNGGELFYHLQREGR-FSEDRARFYLAEIVLALGYLHS---KGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKD  178 (357)
T ss_pred             EEeccCCccHHHHHHhcCC-cchhHHHHHHHHHHHHHHHHHh---CCeeeccCCHHHeeecCCCcEEEeccccchhcccC
Confidence            9999999999999965544 6666555567789999999999   89999999999999999999999999999854332


Q ss_pred             CCceeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhccccccCCcccccCchhhcc
Q 012765          298 WSHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSNFKELVDPRLADA  377 (457)
Q Consensus       298 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~  377 (457)
                      ..  ...+++||+.|||||++.+..|+..+|+||||+++|||++|.+||...+.....-.  ....+      -+ ..+.
T Consensus       179 ~~--~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~--I~~~k------~~-~~p~  247 (357)
T KOG0598|consen  179 GD--ATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDK--ILKGK------LP-LPPG  247 (357)
T ss_pred             CC--ccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHH--HhcCc------CC-CCCc
Confidence            21  22347899999999999999999999999999999999999999987553222111  11111      00 1111


Q ss_pred             cCHHHHHHHHHHHHHhcccCCCCCC
Q 012765          378 YDLAEMKRAMLTASVCIHHLSTMRP  402 (457)
Q Consensus       378 ~~~~~~~~l~~l~~~Cl~~dP~~RP  402 (457)
                      +   .......++...|..||++|.
T Consensus       248 ~---ls~~ardll~~LL~rdp~~RL  269 (357)
T KOG0598|consen  248 Y---LSEEARDLLKKLLKRDPRQRL  269 (357)
T ss_pred             c---CCHHHHHHHHHHhccCHHHhc
Confidence            1   122345677789999999996

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=8e-46  Score=365.79  Aligned_cols=252  Identities=30%  Similarity=0.392  Sum_probs=204.0

Q ss_pred             CCCceecccCcEEEEEEEeCCCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeecCc-eEEEEEecC
Q 012765          145 NSENLIGKGGHAEVYKGCLPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTENG-FHLVLQFLP  223 (457)
Q Consensus       145 ~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~-~~lv~e~~~  223 (457)
                      ..++.||+|-||+||.|.++....||+|.+......    ..+|++|+++|++|+|+|||+++++|..++ ++||||||+
T Consensus       209 ~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~m~----~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~  284 (468)
T KOG0197|consen  209 KLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGSMS----PEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMP  284 (468)
T ss_pred             HHHHHhcCCccceEEEEEEcCCCcccceEEeccccC----hhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecc
Confidence            356889999999999999977779999998765333    347889999999999999999999998866 899999999


Q ss_pred             CCChhhhhhc-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCCCCCCcee
Q 012765          224 HGSLSSLLFG-STECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSHHI  302 (457)
Q Consensus       224 ~gsL~~~l~~-~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~~~~~~~  302 (457)
                      .|+|.++|.. .+..+.....+.++.|||+|++||++   +++|||||.+.|||++++..+||+|||+++.+.++... .
T Consensus       285 ~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes---~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~-~  360 (468)
T KOG0197|consen  285 KGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLES---KNYIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYT-A  360 (468)
T ss_pred             cCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHh---CCccchhhhhhheeeccCceEEEcccccccccCCCcee-e
Confidence            9999999986 66778999999999999999999999   89999999999999999999999999999955444321 1


Q ss_pred             eecccccccccChhccccCCCCcchhHHHHHHHHHHHHh-CCCCCCcCCcchhhhhccccccCCcccccCchhhcccCHH
Q 012765          303 VFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELIT-GRRAVDSRRQSLVIWAKPLLQTSNFKELVDPRLADAYDLA  381 (457)
Q Consensus       303 ~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLlt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~  381 (457)
                      .....-..-|.|||.+..+.++.|||||||||+||||+| |+.||.........            +.++...+-.-...
T Consensus       361 ~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~------------~~le~GyRlp~P~~  428 (468)
T KOG0197|consen  361 SEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVL------------ELLERGYRLPRPEG  428 (468)
T ss_pred             cCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHHH------------HHHhccCcCCCCCC
Confidence            222223557999999999999999999999999999999 88888764332211            11111111111112


Q ss_pred             HHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCCC
Q 012765          382 EMKRAMLTASVCIHHLSTMRPQMTRVLQLLRGEGG  416 (457)
Q Consensus       382 ~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~  416 (457)
                      ....+-+++..||+.+|++|||+..+...|+.+..
T Consensus       429 CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~  463 (468)
T KOG0197|consen  429 CPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFT  463 (468)
T ss_pred             CCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhh
Confidence            33455667788999999999999999999887653

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=3.6e-45  Score=336.17  Aligned_cols=261  Identities=21%  Similarity=0.324  Sum_probs=204.3

Q ss_pred             cCCCCCceecccCcEEEEEEEeC-CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeee-ecCceEEEE
Q 012765          142 DNFNSENLIGKGGHAEVYKGCLP-DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFS-TENGFHLVL  219 (457)
Q Consensus       142 ~~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~-~~~~~~lv~  219 (457)
                      +.|+...++|+|+||.|||++++ +|+.||||++.... ++....+-.++|+.+|++++|+|+|.++.+| ....+++|+
T Consensus         2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Ese-dd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVF   80 (396)
T KOG0593|consen    2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESE-DDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVF   80 (396)
T ss_pred             cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCC-ccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEe
Confidence            45777889999999999999865 59999999987543 3344455678999999999999999999955 456689999


Q ss_pred             EecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCCCCCC
Q 012765          220 QFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWS  299 (457)
Q Consensus       220 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~~~~  299 (457)
                      ||++..-|.+ |......++.....+++.|++.|+.|+|+   .++|||||||+|||++.+|.+||||||+|+.+...  
T Consensus        81 E~~dhTvL~e-Le~~p~G~~~~~vk~~l~Q~l~ai~~cHk---~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~p--  154 (396)
T KOG0593|consen   81 EYCDHTVLHE-LERYPNGVPSELVKKYLYQLLKAIHFCHK---NNCIHRDIKPENILITQNGVVKLCDFGFARTLSAP--  154 (396)
T ss_pred             eecchHHHHH-HHhccCCCCHHHHHHHHHHHHHHhhhhhh---cCeecccCChhheEEecCCcEEeccchhhHhhcCC--
Confidence            9998765544 44445568888899999999999999999   89999999999999999999999999999988642  


Q ss_pred             ceeeecccccccccChhcccc-CCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhh------------------hccc
Q 012765          300 HHIVFPIEGTFGYLSPEYFMH-GIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIW------------------AKPL  360 (457)
Q Consensus       300 ~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~------------------~~~~  360 (457)
                      ....+....|.+|+|||.+.+ -.|+..+||||+||++.||++|.+.|.+..+....+                  ..+.
T Consensus       155 gd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~  234 (396)
T KOG0593|consen  155 GDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPF  234 (396)
T ss_pred             cchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCc
Confidence            234455678999999999987 679999999999999999999999887643322211                  1222


Q ss_pred             cccCCcccccCchhhcccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 012765          361 LQTSNFKELVDPRLADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQ  409 (457)
Q Consensus       361 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~  409 (457)
                      +..-.+++.-++.-...--+.....+++++..||+.||.+|++-.|++.
T Consensus       235 F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~  283 (396)
T KOG0593|consen  235 FHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH  283 (396)
T ss_pred             eeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence            2222333333332222112233446889999999999999999998864

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-43  Score=352.47  Aligned_cols=267  Identities=26%  Similarity=0.369  Sum_probs=214.9

Q ss_pred             HHHHHhhcCCCCCceecccCcEEEEEEEeCCCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeecCc
Q 012765          135 AELAAATDNFNSENLIGKGGHAEVYKGCLPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTENG  214 (457)
Q Consensus       135 ~~~~~~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~  214 (457)
                      .+.++..+.+.+...||+|.||+||+|.+ -| .||||.+......+ +..+.|.+|+..+++-+|.||+-+.|||....
T Consensus       385 ~~WeIp~~ev~l~~rIGsGsFGtV~Rg~w-hG-dVAVK~Lnv~~pt~-~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~  461 (678)
T KOG0193|consen  385 EEWEIPPEEVLLGERIGSGSFGTVYRGRW-HG-DVAVKLLNVDDPTP-EQLQAFKNEVAVLKKTRHENILLFMGACMNPP  461 (678)
T ss_pred             cccccCHHHhhccceeccccccceeeccc-cc-ceEEEEEecCCCCH-HHHHHHHHHHHHHhhcchhhheeeehhhcCCc
Confidence            44455667777889999999999999987 33 69999987655444 47899999999999999999999999999999


Q ss_pred             eEEEEEecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccC
Q 012765          215 FHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWL  294 (457)
Q Consensus       215 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~  294 (457)
                      +.+|..+|.|.+|+.+|+.....++......||+||++|+.|||.   ++|||||||..||+|.++++|||+|||++..-
T Consensus       462 ~AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHA---K~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk  538 (678)
T KOG0193|consen  462 LAIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHA---KNIIHRDLKSNNIFLHEDLKVKIGDFGLATVK  538 (678)
T ss_pred             eeeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhh---hhhhhhhccccceEEccCCcEEEecccceeee
Confidence            999999999999999998888889999999999999999999999   99999999999999999999999999998643


Q ss_pred             CCCCCceeeecccccccccChhcccc---CCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhccccccCCcccccC
Q 012765          295 PDNWSHHIVFPIEGTFGYLSPEYFMH---GIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSNFKELVD  371 (457)
Q Consensus       295 ~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d  371 (457)
                      ..-..........|...|||||+++.   .+|+..+|||||||++|||+||..||.....+-++|+.-.-.       +.
T Consensus       539 ~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGrG~-------l~  611 (678)
T KOG0193|consen  539 TRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGRGY-------LM  611 (678)
T ss_pred             eeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEecccc-------cC
Confidence            21111122233458889999999974   468999999999999999999999999655555555432110       00


Q ss_pred             chhhcccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCC
Q 012765          372 PRLADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQLLRGEG  415 (457)
Q Consensus       372 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~  415 (457)
                      +.+... .....+.+.+|+..||.+++++||.+.+|+..|+.+.
T Consensus       612 pd~s~~-~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~  654 (678)
T KOG0193|consen  612 PDLSKI-RSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELL  654 (678)
T ss_pred             ccchhh-hccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhh
Confidence            111111 1123345566777899999999999999999887763

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.7e-43  Score=338.86  Aligned_cols=262  Identities=26%  Similarity=0.391  Sum_probs=207.4

Q ss_pred             hhcCCCCCceecccCcEEEEEEE-eCCCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeee-eeecCceEE
Q 012765          140 ATDNFNSENLIGKGGHAEVYKGC-LPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIG-FSTENGFHL  217 (457)
Q Consensus       140 ~~~~f~~~~~LG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~-~~~~~~~~l  217 (457)
                      ..+.|++.+.||.|.-++||+|. .+.+..||||++.-....  .....+.+|+..|+.++||||++++. |..+..+++
T Consensus        24 n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~--~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWv  101 (516)
T KOG0582|consen   24 NAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCN--NDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWV  101 (516)
T ss_pred             CccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhh--hhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEE
Confidence            35788899999999999999996 557899999998654333  33778999999999999999999998 667778899


Q ss_pred             EEEecCCCChhhhhhc-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCCC
Q 012765          218 VLQFLPHGSLSSLLFG-STECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPD  296 (457)
Q Consensus       218 v~e~~~~gsL~~~l~~-~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~  296 (457)
                      ||.||.+|++.+++.. -...+++..+..|+++++.||.|||.   +|.||||||+.||||+.+|.|||+|||.+..+.+
T Consensus       102 VmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~---~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~  178 (516)
T KOG0582|consen  102 VMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQ---NGHIHRDVKAGNILIDSDGTVKLADFGVSASLFD  178 (516)
T ss_pred             eehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHh---cCceecccccccEEEcCCCcEEEcCceeeeeecc
Confidence            9999999999999865 33458999999999999999999999   8999999999999999999999999999887755


Q ss_pred             CCCcee-e-ecccccccccChhccc--cCCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhccccccCCcccccCc
Q 012765          297 NWSHHI-V-FPIEGTFGYLSPEYFM--HGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSNFKELVDP  372 (457)
Q Consensus       297 ~~~~~~-~-~~~~gt~~y~aPE~~~--~~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~  372 (457)
                      ...... . ....||++|||||+++  ..+|+.|+||||||++..||++|..||..+....+...+-   ++..+...-.
T Consensus       179 ~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tL---qn~pp~~~t~  255 (516)
T KOG0582|consen  179 SGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTL---QNDPPTLLTS  255 (516)
T ss_pred             cCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHh---cCCCCCcccc
Confidence            432222 1 4567999999999965  4579999999999999999999999998755432221111   1111111111


Q ss_pred             hhhcccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 012765          373 RLADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQ  409 (457)
Q Consensus       373 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~  409 (457)
                      .+..+-+......+.+++..||+.||.+|||+.++++
T Consensus       256 ~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlk  292 (516)
T KOG0582|consen  256 GLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLK  292 (516)
T ss_pred             cCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence            1111112233446778888899999999999999876

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=4.8e-44  Score=351.40  Aligned_cols=254  Identities=24%  Similarity=0.349  Sum_probs=208.8

Q ss_pred             HhhcCCCCCceecccCcEEEEEEEeC-CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhc-CCCCcceeee-eeecCce
Q 012765          139 AATDNFNSENLIGKGGHAEVYKGCLP-DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHI-NHPNAAKLIG-FSTENGF  215 (457)
Q Consensus       139 ~~~~~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~-~~~~~~~  215 (457)
                      ....+|...+.||.|+|++||+|... .++.||||++.+.....+.....+..|-.+|.+| +||.|++||. |.++..+
T Consensus        70 k~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sL  149 (604)
T KOG0592|consen   70 KTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESL  149 (604)
T ss_pred             CChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccce
Confidence            34578889999999999999999854 6999999998776555556667788899999999 8999999997 7777889


Q ss_pred             EEEEEecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCC
Q 012765          216 HLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLP  295 (457)
Q Consensus       216 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~  295 (457)
                      |+|+||+++|+|.+++... +.+++.....++.+|+.||+|||+   .|||||||||+||||++|+++||+|||.++.+.
T Consensus       150 YFvLe~A~nGdll~~i~K~-Gsfde~caR~YAAeIldAleylH~---~GIIHRDlKPENILLd~dmhikITDFGsAK~l~  225 (604)
T KOG0592|consen  150 YFVLEYAPNGDLLDLIKKY-GSFDETCARFYAAEILDALEYLHS---NGIIHRDLKPENILLDKDGHIKITDFGSAKILS  225 (604)
T ss_pred             EEEEEecCCCcHHHHHHHh-CcchHHHHHHHHHHHHHHHHHHHh---cCceeccCChhheeEcCCCcEEEeeccccccCC
Confidence            9999999999999999654 557888888899999999999999   899999999999999999999999999999885


Q ss_pred             CCCCc-----------eeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhccccccC
Q 012765          296 DNWSH-----------HIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTS  364 (457)
Q Consensus       296 ~~~~~-----------~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~~~~~~~  364 (457)
                      .....           .....+.||..|.+||++..+..+..+|+|+||||||+|+.|.+||.+..+.+.. .       
T Consensus       226 ~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliF-q-------  297 (604)
T KOG0592|consen  226 PSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIF-Q-------  297 (604)
T ss_pred             hhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHHH-H-------
Confidence            32211           1124478999999999999999999999999999999999999999976654322 1       


Q ss_pred             CcccccCchhhcccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 012765          365 NFKELVDPRLADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQ  409 (457)
Q Consensus       365 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~  409 (457)
                         ++++-..  .+.......+.+|+...|..||.+|+|..||-+
T Consensus       298 ---kI~~l~y--~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~  337 (604)
T KOG0592|consen  298 ---KIQALDY--EFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKA  337 (604)
T ss_pred             ---HHHHhcc--cCCCCCCHHHHHHHHHHHccCccccccHHHHhh
Confidence               1211111  111122245667888899999999999998876

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=7.4e-44  Score=342.21  Aligned_cols=254  Identities=26%  Similarity=0.449  Sum_probs=197.3

Q ss_pred             cCCCCCceecccCcEEEEEEEeCC-CcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeee-eecC--ceEE
Q 012765          142 DNFNSENLIGKGGHAEVYKGCLPD-GEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGF-STEN--GFHL  217 (457)
Q Consensus       142 ~~f~~~~~LG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~-~~~~--~~~l  217 (457)
                      .+|...+.||+|+||+||++...+ |...|||.+......   ..+.+.+|+.+|.+++|||||+++|. ....  .+++
T Consensus        17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~---~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i   93 (313)
T KOG0198|consen   17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSP---TSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNI   93 (313)
T ss_pred             chhhhhccccCccceEEEEEEecCCCcceeeeeeecccch---hHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEe
Confidence            456677899999999999998654 999999988655222   16678999999999999999999996 3333  4789


Q ss_pred             EEEecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcC-CCcEEEeeccccccCCC
Q 012765          218 VLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSE-DYEAQISDFGLAKWLPD  296 (457)
Q Consensus       218 v~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~-~~~~kL~DFGl~~~~~~  296 (457)
                      .|||+++|+|.+++...+..+++..+..++.||++||.|||+   ++||||||||+|||++. ++.+||+|||++.....
T Consensus        94 ~mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs---~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~  170 (313)
T KOG0198|consen   94 FMEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHS---KGIVHCDIKPANILLDPSNGDVKLADFGLAKKLES  170 (313)
T ss_pred             eeeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh---CCEeccCcccceEEEeCCCCeEEeccCcccccccc
Confidence            999999999999997765579999999999999999999999   89999999999999999 79999999999987763


Q ss_pred             -CCCceeeecccccccccChhccccC-CCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhccccccCCcccccCchh
Q 012765          297 -NWSHHIVFPIEGTFGYLSPEYFMHG-IVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSNFKELVDPRL  374 (457)
Q Consensus       297 -~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l  374 (457)
                       ...........||+.|||||++..+ ..+.++|||||||+++||+||+.||.... ....+..........     |.+
T Consensus       171 ~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~-~~~~~~~~ig~~~~~-----P~i  244 (313)
T KOG0198|consen  171 KGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFF-EEAEALLLIGREDSL-----PEI  244 (313)
T ss_pred             ccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhc-chHHHHHHHhccCCC-----CCC
Confidence             1111223346799999999999863 33459999999999999999999998631 111111111111111     122


Q ss_pred             hcccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 012765          375 ADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQLL  411 (457)
Q Consensus       375 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L  411 (457)
                      ...    ......+++..|+..+|++|||+.++++..
T Consensus       245 p~~----ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hp  277 (313)
T KOG0198|consen  245 PDS----LSDEAKDFLRKCFKRDPEKRPTAEELLEHP  277 (313)
T ss_pred             Ccc----cCHHHHHHHHHHhhcCcccCcCHHHHhhCh
Confidence            111    223445677789999999999999999844

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=3.1e-43  Score=349.64  Aligned_cols=260  Identities=25%  Similarity=0.378  Sum_probs=200.3

Q ss_pred             hhcCCCCCceecccCcEEEEEEEe------CCCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhc-CCCCcceeeeeeec
Q 012765          140 ATDNFNSENLIGKGGHAEVYKGCL------PDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHI-NHPNAAKLIGFSTE  212 (457)
Q Consensus       140 ~~~~f~~~~~LG~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~  212 (457)
                      ..++|.+.+.||+|+||.||+|.+      .+++.||+|++.....  ......+.+|+.++..+ +||||+++++++..
T Consensus         5 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~   82 (338)
T cd05102           5 PRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGAT--ASEHKALMSELKILIHIGNHLNVVNLLGACTK   82 (338)
T ss_pred             chhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccc--hHHHHHHHHHHHHHHHhccCcceeeEEeEecC
Confidence            457889999999999999999963      2357899998864332  23356789999999999 89999999997654


Q ss_pred             C--ceEEEEEecCCCChhhhhhcCC-------------------------------------------------------
Q 012765          213 N--GFHLVLQFLPHGSLSSLLFGST-------------------------------------------------------  235 (457)
Q Consensus       213 ~--~~~lv~e~~~~gsL~~~l~~~~-------------------------------------------------------  235 (457)
                      .  .++++|||+++|+|.+++....                                                       
T Consensus        83 ~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  162 (338)
T cd05102          83 PNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQE  162 (338)
T ss_pred             CCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchh
Confidence            3  3689999999999999885421                                                       


Q ss_pred             ------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCCCCCCceeeeccccc
Q 012765          236 ------ECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEGT  309 (457)
Q Consensus       236 ------~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~~~~~~~~~~~~gt  309 (457)
                            ..+++..++.++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||+++.+.............++
T Consensus       163 ~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~  239 (338)
T cd05102         163 TDDLWKSPLTMEDLICYSFQVARGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLP  239 (338)
T ss_pred             ccccccCCCCHHHHHHHHHHHHHHHHHHHH---CCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCC
Confidence                  236778888999999999999999   89999999999999999999999999999866433221111223456


Q ss_pred             ccccChhccccCCCCcchhHHHHHHHHHHHHh-CCCCCCcCCcchhhhhccccccCCcccccCchhhcccCHHHHHHHHH
Q 012765          310 FGYLSPEYFMHGIVDEKTDVFAFGVLLLELIT-GRRAVDSRRQSLVIWAKPLLQTSNFKELVDPRLADAYDLAEMKRAML  388 (457)
Q Consensus       310 ~~y~aPE~~~~~~~~~ksDvwSlGvll~eLlt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~  388 (457)
                      ..|+|||++.+..++.++|||||||++|||++ |..||.......... .. ......     .....    .....+.+
T Consensus       240 ~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~-~~-~~~~~~-----~~~~~----~~~~~l~~  308 (338)
T cd05102         240 LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFC-QR-LKDGTR-----MRAPE----NATPEIYR  308 (338)
T ss_pred             ccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHH-HH-HhcCCC-----CCCCC----CCCHHHHH
Confidence            78999999999999999999999999999997 999998643221111 11 011100     01111    12235678


Q ss_pred             HHHHhcccCCCCCCCHHHHHHHHhcCC
Q 012765          389 TASVCIHHLSTMRPQMTRVLQLLRGEG  415 (457)
Q Consensus       389 l~~~Cl~~dP~~RPt~~evl~~L~~~~  415 (457)
                      ++.+||+.||.+|||+.+|++.|+.+.
T Consensus       309 li~~cl~~dp~~RPs~~el~~~l~~~~  335 (338)
T cd05102         309 IMLACWQGDPKERPTFSALVEILGDLL  335 (338)
T ss_pred             HHHHHccCChhhCcCHHHHHHHHHHHH
Confidence            999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=3.8e-43  Score=322.17  Aligned_cols=239  Identities=26%  Similarity=0.362  Sum_probs=199.1

Q ss_pred             hcCCCCCceecccCcEEEEEEEeC-CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeee-eeecCceEEE
Q 012765          141 TDNFNSENLIGKGGHAEVYKGCLP-DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIG-FSTENGFHLV  218 (457)
Q Consensus       141 ~~~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~-~~~~~~~~lv  218 (457)
                      .++|+....||.|+||.|.+++.+ +|..+|+|.+.+...-.....+...+|..+|+.+.||+++++++ +...+.+++|
T Consensus        43 l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymv  122 (355)
T KOG0616|consen   43 LQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMV  122 (355)
T ss_pred             hhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEE
Confidence            367888899999999999999865 68999999998776666677889999999999999999999997 5556678999


Q ss_pred             EEecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCCCCC
Q 012765          219 LQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNW  298 (457)
Q Consensus       219 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~~~  298 (457)
                      |||.+||.|.++|+..++ +++....-+|.||+.||+|||+   .+|++|||||+|||||.+|.+||+|||+++.+... 
T Consensus       123 meyv~GGElFS~Lrk~~r-F~e~~arFYAAeivlAleylH~---~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r-  197 (355)
T KOG0616|consen  123 MEYVPGGELFSYLRKSGR-FSEPHARFYAAEIVLALEYLHS---LDIIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR-  197 (355)
T ss_pred             EeccCCccHHHHHHhcCC-CCchhHHHHHHHHHHHHHHHHh---cCeeeccCChHHeeeccCCcEEEEeccceEEecCc-
Confidence            999999999999976544 7777777899999999999999   89999999999999999999999999999987664 


Q ss_pred             CceeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhccccccCCcccccCchhhccc
Q 012765          299 SHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSNFKELVDPRLADAY  378 (457)
Q Consensus       299 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~  378 (457)
                          ..+.+||+.|+|||.+...+|+.++|+|||||++|||+.|.+||..... ..++.+.....-.++..+.+.     
T Consensus       198 ----T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~-~~iY~KI~~~~v~fP~~fs~~-----  267 (355)
T KOG0616|consen  198 ----TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNP-IQIYEKILEGKVKFPSYFSSD-----  267 (355)
T ss_pred             ----EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCCh-HHHHHHHHhCcccCCcccCHH-----
Confidence                3467799999999999999999999999999999999999999987555 344444433333344333332     


Q ss_pred             CHHHHHHHHHHHHHhcccCCCCC
Q 012765          379 DLAEMKRAMLTASVCIHHLSTMR  401 (457)
Q Consensus       379 ~~~~~~~l~~l~~~Cl~~dP~~R  401 (457)
                             +..++...|+.|-.+|
T Consensus       268 -------~kdLl~~LL~vD~t~R  283 (355)
T KOG0616|consen  268 -------AKDLLKKLLQVDLTKR  283 (355)
T ss_pred             -------HHHHHHHHHhhhhHhh
Confidence                   3344555666676666

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.3e-44  Score=346.78  Aligned_cols=260  Identities=26%  Similarity=0.327  Sum_probs=209.5

Q ss_pred             hhcCCCCCceecccCcEEEEEEEe-CCCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcC-CCCcceeeeeeecC--ce
Q 012765          140 ATDNFNSENLIGKGGHAEVYKGCL-PDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHIN-HPNAAKLIGFSTEN--GF  215 (457)
Q Consensus       140 ~~~~f~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~--~~  215 (457)
                      .-++|...+.||.|+||.||+|+. .+|..||||++++....-++  .--++|+..|++++ |||||++.+++.+.  .+
T Consensus         8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee--~~nLREvksL~kln~hpniikL~Evi~d~~~~L   85 (538)
T KOG0661|consen    8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEE--CMNLREVKSLRKLNPHPNIIKLKEVIRDNDRIL   85 (538)
T ss_pred             HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHH--HHHHHHHHHHHhcCCCCcchhhHHHhhccCceE
Confidence            447788899999999999999984 46899999998765444222  24578999999999 99999999955443  58


Q ss_pred             EEEEEecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCC
Q 012765          216 HLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLP  295 (457)
Q Consensus       216 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~  295 (457)
                      ++|||||.. +|+.++....+.+++..+..|+.||++||.|+|.   +|+.|||+||+|||+..+..+||+|||+|+.+.
T Consensus        86 ~fVfE~Md~-NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk---~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~  161 (538)
T KOG0661|consen   86 YFVFEFMDC-NLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHK---HGFFHRDLKPENILISGNDVIKIADFGLAREVR  161 (538)
T ss_pred             eeeHHhhhh-hHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHh---cCcccccCChhheEecccceeEecccccccccc
Confidence            999999954 7999998888899999999999999999999999   899999999999999999899999999999886


Q ss_pred             CCCCceeeecccccccccChhccc-cCCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhc------ccccc-----
Q 012765          296 DNWSHHIVFPIEGTFGYLSPEYFM-HGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAK------PLLQT-----  363 (457)
Q Consensus       296 ~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~------~~~~~-----  363 (457)
                      +...   .+....|.+|+|||++. .+.|+.+.||||+|||++||++-++.|.+..+....|..      +....     
T Consensus       162 SkpP---YTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~  238 (538)
T KOG0661|consen  162 SKPP---YTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGY  238 (538)
T ss_pred             cCCC---cchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHH
Confidence            6532   44566899999999976 677999999999999999999999999886655544421      11111     


Q ss_pred             -------CCcccccCchhhcccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 012765          364 -------SNFKELVDPRLADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQ  409 (457)
Q Consensus       364 -------~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~  409 (457)
                             -.+++.....+..... .....+++++.+|+.+||.+|||+.|.++
T Consensus       239 ~La~~mnf~~P~~~~~~l~~L~p-~~s~~~~~li~~ll~WDP~kRpTA~~al~  290 (538)
T KOG0661|consen  239 NLASAMNFRFPQVKPSPLKDLLP-NASSEAASLIERLLAWDPDKRPTASQALQ  290 (538)
T ss_pred             HHHHHhccCCCcCCCCChHHhCc-ccCHHHHHHHHHHhcCCCccCccHHHHhc
Confidence                   1122222222222222 25677889999999999999999999988

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.5e-44  Score=343.46  Aligned_cols=249  Identities=27%  Similarity=0.396  Sum_probs=204.2

Q ss_pred             hcCCCCCceecccCcEEEEEEEeC-CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeee-eeecCceEEE
Q 012765          141 TDNFNSENLIGKGGHAEVYKGCLP-DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIG-FSTENGFHLV  218 (457)
Q Consensus       141 ~~~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~-~~~~~~~~lv  218 (457)
                      ...|+..+.||+|+||.||+|.+. .++.||+|.+.-..  ..+.++++.+|+.+|++++++||.++|+ |..+..++++
T Consensus        12 ~~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~--~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~Lwii   89 (467)
T KOG0201|consen   12 ELLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEE--AEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWII   89 (467)
T ss_pred             ccccccchhccccccceeeeeeeccccceEEEEEechhh--cchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHH
Confidence            345667789999999999999864 68999999885443  3456789999999999999999999998 6666678899


Q ss_pred             EEecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCCCCC
Q 012765          219 LQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNW  298 (457)
Q Consensus       219 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~~~  298 (457)
                      |||+.+|++.+.|.- +..+.+....-|+.+++.||.|||.   .+.+|||||+.|||+..+|.+||+|||++.++.+..
T Consensus        90 Mey~~gGsv~~lL~~-~~~~~E~~i~~ilre~l~~l~ylH~---~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~  165 (467)
T KOG0201|consen   90 MEYCGGGSVLDLLKS-GNILDEFEIAVILREVLKGLDYLHS---EKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTV  165 (467)
T ss_pred             HHHhcCcchhhhhcc-CCCCccceeeeehHHHHHHhhhhhh---cceecccccccceeEeccCcEEEEecceeeeeechh
Confidence            999999999999843 2334666667788999999999999   899999999999999999999999999999887765


Q ss_pred             CceeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhccccccCCcccccCchhhccc
Q 012765          299 SHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSNFKELVDPRLADAY  378 (457)
Q Consensus       299 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~  378 (457)
                      ...  .++.||+.|||||++.+..|+.|+||||||++.+||++|.+|+.......+            ..++...-.+.+
T Consensus       166 ~rr--~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrv------------lflIpk~~PP~L  231 (467)
T KOG0201|consen  166 KRR--KTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRV------------LFLIPKSAPPRL  231 (467)
T ss_pred             hcc--ccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceE------------EEeccCCCCCcc
Confidence            443  567799999999999988999999999999999999999999987544222            222222222223


Q ss_pred             CHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 012765          379 DLAEMKRAMLTASVCIHHLSTMRPQMTRVLQ  409 (457)
Q Consensus       379 ~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~  409 (457)
                      +......+.+++..||..||+.||++.++++
T Consensus       232 ~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLK  262 (467)
T KOG0201|consen  232 DGDFSPPFKEFVEACLDKNPEFRPSAKELLK  262 (467)
T ss_pred             ccccCHHHHHHHHHHhhcCcccCcCHHHHhh
Confidence            3334445677888899999999999998876

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=7.4e-43  Score=340.46  Aligned_cols=262  Identities=26%  Similarity=0.373  Sum_probs=202.0

Q ss_pred             hcCCCCCceecccCcEEEEEEEe-CCCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeec---CceE
Q 012765          141 TDNFNSENLIGKGGHAEVYKGCL-PDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTE---NGFH  216 (457)
Q Consensus       141 ~~~f~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~---~~~~  216 (457)
                      .+.|+.++.||+|.||.||+|++ .+|+.||+|++....... ....-..+|+.||++|+||||++|.+..++   +.+|
T Consensus       116 ~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~-~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siY  194 (560)
T KOG0600|consen  116 ADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKE-GFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIY  194 (560)
T ss_pred             hHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCC-cchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEE
Confidence            45677788999999999999984 579999999997654332 334467899999999999999999996554   4689


Q ss_pred             EEEEecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCCC
Q 012765          217 LVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPD  296 (457)
Q Consensus       217 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~  296 (457)
                      +|+|||++ +|.-++....-.++..++..++.||+.||.|+|+   ++|+|||||.+|||||.+|.+||+||||++++..
T Consensus       195 lVFeYMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~---~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~  270 (560)
T KOG0600|consen  195 LVFEYMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHS---RGVLHRDIKGSNILIDNNGVLKIADFGLARFYTP  270 (560)
T ss_pred             EEEecccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhh---cCeeeccccccceEEcCCCCEEeccccceeeccC
Confidence            99999976 6677776656678999999999999999999999   9999999999999999999999999999997755


Q ss_pred             CCCceeeecccccccccChhccccC-CCCcchhHHHHHHHHHHHHhCCCCCCcCCcchh--------------hhhcccc
Q 012765          297 NWSHHIVFPIEGTFGYLSPEYFMHG-IVDEKTDVFAFGVLLLELITGRRAVDSRRQSLV--------------IWAKPLL  361 (457)
Q Consensus       297 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~--------------~~~~~~~  361 (457)
                      .... ..+...-|.+|+|||.+.|. .|+.++|+||.||||.||++|++.|.+..+...              .|....+
T Consensus       271 ~~~~-~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kL  349 (560)
T KOG0600|consen  271 SGSA-PYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKL  349 (560)
T ss_pred             CCCc-ccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccccC
Confidence            4322 23445579999999999875 699999999999999999999999987554322              1321111


Q ss_pred             ccC---CcccccCchhhcccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 012765          362 QTS---NFKELVDPRLADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQ  409 (457)
Q Consensus       362 ~~~---~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~  409 (457)
                      ..-   ....-....+.+.+. ......+.++..+|..||.+|.|+.++++
T Consensus       350 P~~~~~kp~~~y~r~l~E~~~-~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~  399 (560)
T KOG0600|consen  350 PHATIFKPQQPYKRRLRETFK-DFPASALDLLEKLLSLDPDKRGTASSALQ  399 (560)
T ss_pred             CcccccCCCCcccchHHHHhc-cCCHHHHHHHHHHhccCccccccHHHHhc
Confidence            100   001111122221111 12234567888899999999999998876

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.2e-42  Score=341.02  Aligned_cols=253  Identities=22%  Similarity=0.301  Sum_probs=202.1

Q ss_pred             HhhcCCCCCceecccCcEEEEEEEe-CCCcEEEEEEEeccchh-h-HHHHHHHHHHHHHHhhcC-CCCcceeeeee-ecC
Q 012765          139 AATDNFNSENLIGKGGHAEVYKGCL-PDGEVVAVKKIIKNAKE-D-EERISDFLSELGIVAHIN-HPNAAKLIGFS-TEN  213 (457)
Q Consensus       139 ~~~~~f~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-~-~~~~~~~~~E~~~l~~l~-hpniv~l~~~~-~~~  213 (457)
                      ....+|.+.+.||+|+||+|+.|.. .++..||+|.+.+.... . ......+.+|+.+++.++ ||||++++.+. ...
T Consensus        14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~   93 (370)
T KOG0583|consen   14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT   93 (370)
T ss_pred             cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence            3457889999999999999999975 46899999966553111 1 123456678999999999 99999999955 455


Q ss_pred             ceEEEEEecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCC-CcEEEeeccccc
Q 012765          214 GFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSED-YEAQISDFGLAK  292 (457)
Q Consensus       214 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~-~~~kL~DFGl~~  292 (457)
                      .+++||||+.+|+|.+++.. ...+.+.....++.|++.|+.|+|+   ++|+||||||+|||++.+ +++||+|||++.
T Consensus        94 ~~~ivmEy~~gGdL~~~i~~-~g~l~E~~ar~~F~Qlisav~y~H~---~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~  169 (370)
T KOG0583|consen   94 KIYIVMEYCSGGDLFDYIVN-KGRLKEDEARKYFRQLISAVAYCHS---RGIVHRDLKPENILLDGNEGNLKLSDFGLSA  169 (370)
T ss_pred             eEEEEEEecCCccHHHHHHH-cCCCChHHHHHHHHHHHHHHHHHHh---CCEeeCCCCHHHEEecCCCCCEEEecccccc
Confidence            68899999999999999987 6668888889999999999999999   899999999999999999 999999999999


Q ss_pred             cCCCCCCceeeecccccccccChhccccCC-CC-cchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhccccccCCccccc
Q 012765          293 WLPDNWSHHIVFPIEGTFGYLSPEYFMHGI-VD-EKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSNFKELV  370 (457)
Q Consensus       293 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~  370 (457)
                      ...  .......+.+||+.|+|||++.+.. |+ .++||||+||+||.|++|..||+..+..... .+.....-.++.++
T Consensus       170 ~~~--~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~-~ki~~~~~~~p~~~  246 (370)
T KOG0583|consen  170 ISP--GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLY-RKIRKGEFKIPSYL  246 (370)
T ss_pred             ccC--CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHH-HHHhcCCccCCCCc
Confidence            874  1112345677999999999999877 86 7899999999999999999999973322211 11111111222222


Q ss_pred             CchhhcccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 012765          371 DPRLADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQ  409 (457)
Q Consensus       371 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~  409 (457)
                      +           ...+..++.+||..||.+|+|+.+|++
T Consensus       247 ~-----------S~~~~~Li~~mL~~~P~~R~t~~~i~~  274 (370)
T KOG0583|consen  247 L-----------SPEARSLIEKMLVPDPSTRITLLEILE  274 (370)
T ss_pred             C-----------CHHHHHHHHHHcCCCcccCCCHHHHhh
Confidence            1           345677889999999999999999984

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=1.4e-42  Score=341.20  Aligned_cols=252  Identities=22%  Similarity=0.329  Sum_probs=198.5

Q ss_pred             HHhhcCCCCCceecccCcEEEEEEEeC-CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeee-eeecCce
Q 012765          138 AAATDNFNSENLIGKGGHAEVYKGCLP-DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIG-FSTENGF  215 (457)
Q Consensus       138 ~~~~~~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~-~~~~~~~  215 (457)
                      +...++|.++..||+|+||.||+|+.+ +|..+|+|++.+........+..++.|-.+|...++|+||++|. |.....+
T Consensus       137 r~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~L  216 (550)
T KOG0605|consen  137 RLSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYL  216 (550)
T ss_pred             cCCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCee
Confidence            345789999999999999999999854 69999999999887777788899999999999999999999987 5566678


Q ss_pred             EEEEEecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCC
Q 012765          216 HLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLP  295 (457)
Q Consensus       216 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~  295 (457)
                      ||||||++||++..+|.. ...+++......+.+++.|+.-||+   .|+|||||||+|+|||..|++||+||||+.-+.
T Consensus       217 YLiMEylPGGD~mTLL~~-~~~L~e~~arfYiaE~vlAI~~iH~---~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~  292 (550)
T KOG0605|consen  217 YLIMEYLPGGDMMTLLMR-KDTLTEDWARFYIAETVLAIESIHQ---LGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLD  292 (550)
T ss_pred             EEEEEecCCccHHHHHHh-cCcCchHHHHHHHHHHHHHHHHHHH---cCcccccCChhheeecCCCCEeeccccccchhh
Confidence            999999999999999954 4557777777777889999999999   899999999999999999999999999985431


Q ss_pred             C-----------------------CCC-----ce-----------------eeecccccccccChhccccCCCCcchhHH
Q 012765          296 D-----------------------NWS-----HH-----------------IVFPIEGTFGYLSPEYFMHGIVDEKTDVF  330 (457)
Q Consensus       296 ~-----------------------~~~-----~~-----------------~~~~~~gt~~y~aPE~~~~~~~~~ksDvw  330 (457)
                      .                       ...     ..                 ......|||.|||||++.+.+|+..+|+|
T Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwW  372 (550)
T KOG0605|consen  293 KKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWW  372 (550)
T ss_pred             hhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHH
Confidence            1                       000     00                 01125699999999999999999999999


Q ss_pred             HHHHHHHHHHhCCCCCCcCCcchhhhhccccccCCcccccCchhhcccCHHHHHHHHHHHHHhcccCCCCCCC
Q 012765          331 AFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSNFKELVDPRLADAYDLAEMKRAMLTASVCIHHLSTMRPQ  403 (457)
Q Consensus       331 SlGvll~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt  403 (457)
                      |||||+||||.|.+||.+.+.... |.+..-  +.      ..+..........+..++|.+|+. ||++|--
T Consensus       373 SLG~ImyEmLvGyPPF~s~tp~~T-~rkI~n--wr------~~l~fP~~~~~s~eA~DLI~rll~-d~~~RLG  435 (550)
T KOG0605|consen  373 SLGCIMYEMLVGYPPFCSETPQET-YRKIVN--WR------ETLKFPEEVDLSDEAKDLITRLLC-DPENRLG  435 (550)
T ss_pred             HHHHHHHHHHhCCCCCCCCCHHHH-HHHHHH--Hh------hhccCCCcCcccHHHHHHHHHHhc-CHHHhcC
Confidence            999999999999999998654321 111100  00      001000011112455677888888 9999976

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-42  Score=343.81  Aligned_cols=249  Identities=22%  Similarity=0.382  Sum_probs=206.2

Q ss_pred             hcCCCCCceecccCcEEEEEEEe-CCCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeee-eeecCceEEE
Q 012765          141 TDNFNSENLIGKGGHAEVYKGCL-PDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIG-FSTENGFHLV  218 (457)
Q Consensus       141 ~~~f~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~-~~~~~~~~lv  218 (457)
                      ...|.....||+|+-|.||.|.. .+++.||||++......   ..+-+++|+.+|+..+|+|||++++ |...+++++|
T Consensus       272 ~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~---~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVV  348 (550)
T KOG0578|consen  272 RSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQP---KKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVV  348 (550)
T ss_pred             hhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCC---chhhhHHHHHHHHhccchHHHHHHHHhcccceeEEE
Confidence            46677778999999999999974 46899999998654433   3447899999999999999999998 7778889999


Q ss_pred             EEecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCCCCC
Q 012765          219 LQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNW  298 (457)
Q Consensus       219 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~~~  298 (457)
                      |||+++|+|.+.+  ....+++.++..|+.++++||.|||.   ++|+|||||.+|||++.+|.+||+|||++..+....
T Consensus       349 MEym~ggsLTDvV--t~~~~~E~qIA~Icre~l~aL~fLH~---~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~  423 (550)
T KOG0578|consen  349 MEYMEGGSLTDVV--TKTRMTEGQIAAICREILQGLKFLHA---RGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQ  423 (550)
T ss_pred             EeecCCCchhhhh--hcccccHHHHHHHHHHHHHHHHHHHh---cceeeeccccceeEeccCCcEEEeeeeeeecccccc
Confidence            9999999999988  34458999999999999999999999   899999999999999999999999999999886654


Q ss_pred             CceeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhccccccCCcccccCchhhccc
Q 012765          299 SHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSNFKELVDPRLADAY  378 (457)
Q Consensus       299 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~  378 (457)
                      .  ......||++|||||++....|++|+||||||++++||+-|.+||-..+.....|...   .+...++-.+.     
T Consensus       424 ~--KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa---~ng~P~lk~~~-----  493 (550)
T KOG0578|consen  424 S--KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIA---TNGTPKLKNPE-----  493 (550)
T ss_pred             C--ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHh---hcCCCCcCCcc-----
Confidence            3  2345679999999999999999999999999999999999999998755544443322   11112222221     


Q ss_pred             CHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 012765          379 DLAEMKRAMLTASVCIHHLSTMRPQMTRVLQ  409 (457)
Q Consensus       379 ~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~  409 (457)
                        .....+.+++.+||+.|+++||++.|+|+
T Consensus       494 --klS~~~kdFL~~cL~~dv~~RasA~eLL~  522 (550)
T KOG0578|consen  494 --KLSPELKDFLDRCLVVDVEQRASAKELLE  522 (550)
T ss_pred             --ccCHHHHHHHHHHhhcchhcCCCHHHHhc
Confidence              12234566778899999999999999987

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=5e-42  Score=337.86  Aligned_cols=257  Identities=25%  Similarity=0.422  Sum_probs=203.7

Q ss_pred             cCCCCCceecccCcEEEEEEEeC-CCc----EEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeecCceE
Q 012765          142 DNFNSENLIGKGGHAEVYKGCLP-DGE----VVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTENGFH  216 (457)
Q Consensus       142 ~~f~~~~~LG~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~  216 (457)
                      .+|+..+.||+|+||.||+|.+. ++.    .||+|.+.....  ......+.+|+.+++.++||||+++++++.....+
T Consensus         7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~~~~   84 (316)
T cd05108           7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATS--PKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQ   84 (316)
T ss_pred             hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCC--HHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCCCce
Confidence            56889999999999999999853 343    389998754322  23456788999999999999999999999888889


Q ss_pred             EEEEecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCCC
Q 012765          217 LVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPD  296 (457)
Q Consensus       217 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~  296 (457)
                      +++||+++|+|.+++......+++...+.++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||+++.+..
T Consensus        85 ~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~---~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~  161 (316)
T cd05108          85 LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEE---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA  161 (316)
T ss_pred             eeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHh---cCeeccccchhheEecCCCcEEEccccccccccC
Confidence            9999999999999997766678999999999999999999999   8999999999999999999999999999987754


Q ss_pred             CCCceeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHh-CCCCCCcCCcchhhhhccccccCCcccccCchhh
Q 012765          297 NWSHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELIT-GRRAVDSRRQSLVIWAKPLLQTSNFKELVDPRLA  375 (457)
Q Consensus       297 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLlt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  375 (457)
                      ...........++..|+|||++.+..++.++|||||||++|||++ |..||.........  .. ......  ...+   
T Consensus       162 ~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~--~~-~~~~~~--~~~~---  233 (316)
T cd05108         162 DEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS--SI-LEKGER--LPQP---  233 (316)
T ss_pred             CCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHH--HH-HhCCCC--CCCC---
Confidence            332222222334678999999999999999999999999999998 99999764322111  00 000000  0000   


Q ss_pred             cccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCC
Q 012765          376 DAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQLLRGEG  415 (457)
Q Consensus       376 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~  415 (457)
                      .    .....+..++.+||..+|.+||++.+++..|..+.
T Consensus       234 ~----~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~  269 (316)
T cd05108         234 P----ICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMA  269 (316)
T ss_pred             C----CCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence            1    11234677889999999999999999999987664

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=1.1e-41  Score=330.45  Aligned_cols=248  Identities=22%  Similarity=0.321  Sum_probs=198.1

Q ss_pred             ceecccCcEEEEEEEeCCCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeec-----CceEEEEEec
Q 012765          148 NLIGKGGHAEVYKGCLPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTE-----NGFHLVLQFL  222 (457)
Q Consensus       148 ~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-----~~~~lv~e~~  222 (457)
                      ..||+|++|.||+|.+ +|+.||+|.+...........+.+.+|+.+|.+++||||+++++++.+     ...+++|||+
T Consensus        26 ~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~  104 (283)
T PHA02988         26 VLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYC  104 (283)
T ss_pred             eEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeC
Confidence            6799999999999998 789999999876544444445788899999999999999999997755     2468999999


Q ss_pred             CCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCCCCCCcee
Q 012765          223 PHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSHHI  302 (457)
Q Consensus       223 ~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~~~~~~~  302 (457)
                      .+|+|.+++... ..+++...+.++.+++.||.|||..  .+++||||||+|||++.++.+||+|||++..+....    
T Consensus       105 ~~g~L~~~l~~~-~~~~~~~~~~i~~~i~~~l~~lH~~--~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~----  177 (283)
T PHA02988        105 TRGYLREVLDKE-KDLSFKTKLDMAIDCCKGLYNLYKY--TNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP----  177 (283)
T ss_pred             CCCcHHHHHhhC-CCCChhHHHHHHHHHHHHHHHHHhc--CCCCCCcCChhhEEECCCCcEEEcccchHhhhcccc----
Confidence            999999999654 4588999999999999999999982  478899999999999999999999999988664432    


Q ss_pred             eecccccccccChhcccc--CCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhccccccCCcccccCchhhcccCH
Q 012765          303 VFPIEGTFGYLSPEYFMH--GIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSNFKELVDPRLADAYDL  380 (457)
Q Consensus       303 ~~~~~gt~~y~aPE~~~~--~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~  380 (457)
                       ....|+..|+|||++.+  ..++.++|||||||++|||++|+.||.........  ........     .+.+    +.
T Consensus       178 -~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~--~~i~~~~~-----~~~~----~~  245 (283)
T PHA02988        178 -FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIY--DLIINKNN-----SLKL----PL  245 (283)
T ss_pred             -ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHH--HHHHhcCC-----CCCC----CC
Confidence             12347899999999876  68999999999999999999999999864322111  00000000     0111    11


Q ss_pred             HHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCC
Q 012765          381 AEMKRAMLTASVCIHHLSTMRPQMTRVLQLLRGEG  415 (457)
Q Consensus       381 ~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~  415 (457)
                      .....+.+++.+||+.||++|||+.+|++.|+..+
T Consensus       246 ~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~  280 (283)
T PHA02988        246 DCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYK  280 (283)
T ss_pred             cCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHH
Confidence            12345778889999999999999999999998654

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=6.1e-42  Score=309.97  Aligned_cols=260  Identities=25%  Similarity=0.349  Sum_probs=202.6

Q ss_pred             cCCCCCceecccCcEEEEEEEe-CCCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeee-eecCceEEEE
Q 012765          142 DNFNSENLIGKGGHAEVYKGCL-PDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGF-STENGFHLVL  219 (457)
Q Consensus       142 ~~f~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~-~~~~~~~lv~  219 (457)
                      ++|...++||+|.||.||+|++ .+|+.||||++......+. .....++|++.|+.++|+||+.++++ -..+++.+|+
T Consensus         2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdG-i~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVf   80 (318)
T KOG0659|consen    2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDG-INRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVF   80 (318)
T ss_pred             chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccC-ccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEE
Confidence            4677789999999999999985 5799999999876543322 23467899999999999999999994 5567789999


Q ss_pred             EecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCCCCCC
Q 012765          220 QFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWS  299 (457)
Q Consensus       220 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~~~~  299 (457)
                      ||++ .+|...+......+....+..++.+++.||+|||+   +.|+||||||.|+|++.+|.+||+|||+++.+.....
T Consensus        81 Efm~-tdLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~---~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~  156 (318)
T KOG0659|consen   81 EFMP-TDLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHS---KWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNR  156 (318)
T ss_pred             Eecc-ccHHHHhcccccccCHHHHHHHHHHHHHHHHHHHh---hhhhcccCCccceEEcCCCcEEeecccchhccCCCCc
Confidence            9995 47899998888889999999999999999999999   8999999999999999999999999999999876543


Q ss_pred             ceeeecccccccccChhccccC-CCCcchhHHHHHHHHHHHHhCCCCCCcCCcc--hhh-h---hccccccC-------C
Q 012765          300 HHIVFPIEGTFGYLSPEYFMHG-IVDEKTDVFAFGVLLLELITGRRAVDSRRQS--LVI-W---AKPLLQTS-------N  365 (457)
Q Consensus       300 ~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDvwSlGvll~eLltG~~pf~~~~~~--~~~-~---~~~~~~~~-------~  365 (457)
                      ...  ...-|.+|+|||.+.|. .|+..+||||.|||+.||+-|.+-|.+..+.  +.. +   ..+..+++       +
T Consensus       157 ~~~--~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpd  234 (318)
T KOG0659|consen  157 IQT--HQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPD  234 (318)
T ss_pred             ccc--cceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCcccccccc
Confidence            322  22479999999998865 5999999999999999999998877763322  111 1   11111111       1


Q ss_pred             c---ccccCchhhcccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 012765          366 F---KELVDPRLADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQ  409 (457)
Q Consensus       366 ~---~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~  409 (457)
                      .   ...-.+.+.. +-......+++++..++..||.+|.|+.|.++
T Consensus       235 Y~~~~~~P~~~~~~-lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~  280 (318)
T KOG0659|consen  235 YVKIQQFPKPPLNN-LFPAASSDALDLLSKMLTYNPKKRITASQALK  280 (318)
T ss_pred             HHHHhcCCCCcccc-ccccccHHHHHHHHhhhccCchhcccHHHHhc
Confidence            1   1111111111 12234455688999999999999999999987

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=2.3e-41  Score=331.24  Aligned_cols=262  Identities=21%  Similarity=0.332  Sum_probs=197.2

Q ss_pred             hcCCCCCceecccCcEEEEEEEeCC-----------------CcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCc
Q 012765          141 TDNFNSENLIGKGGHAEVYKGCLPD-----------------GEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNA  203 (457)
Q Consensus       141 ~~~f~~~~~LG~G~~g~Vy~~~~~~-----------------~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpni  203 (457)
                      .++|.+.+.||+|+||.||+|.+.+                 +..||+|.+.....  ......+.+|+.++.+++||||
T Consensus         4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~ni   81 (304)
T cd05096           4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDAN--KNARNDFLKEVKILSRLKDPNI   81 (304)
T ss_pred             hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCC--HHHHHHHHHHHHHHhhcCCCCe
Confidence            3578889999999999999997532                 34699998865432  2345679999999999999999


Q ss_pred             ceeeeeeec-CceEEEEEecCCCChhhhhhcCC------------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCC
Q 012765          204 AKLIGFSTE-NGFHLVLQFLPHGSLSSLLFGST------------------ECLEWTIRYKIALGIAEGLQYLHHDCHRR  264 (457)
Q Consensus       204 v~l~~~~~~-~~~~lv~e~~~~gsL~~~l~~~~------------------~~~~~~~~~~i~~qia~aL~yLH~~~~~~  264 (457)
                      +++++++.+ +..+++|||+.+|+|.+++....                  ..+++...+.++.||+.||.|||+   .+
T Consensus        82 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~  158 (304)
T cd05096          82 IRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSS---LN  158 (304)
T ss_pred             eEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHH---CC
Confidence            999996654 55789999999999999884321                  246788889999999999999999   89


Q ss_pred             eeeCCCCCCcEEEcCCCcEEEeeccccccCCCCCCceeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHh--C
Q 012765          265 IIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELIT--G  342 (457)
Q Consensus       265 iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLlt--G  342 (457)
                      |+||||||+|||++.++.+||+|||++..+.............++..|+|||++.++.++.++|||||||++|||++  +
T Consensus       159 ivH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~  238 (304)
T cd05096         159 FVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCK  238 (304)
T ss_pred             ccccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccC
Confidence            99999999999999999999999999987644332222223345788999999988899999999999999999987  5


Q ss_pred             CCCCCcCCcch-hhhhccccccCCcccccCchhhcccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 012765          343 RRAVDSRRQSL-VIWAKPLLQTSNFKELVDPRLADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQLLRG  413 (457)
Q Consensus       343 ~~pf~~~~~~~-~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~  413 (457)
                      ..||....... ............. .. ...    ........+.+++.+||+.+|++|||+.+|.+.|++
T Consensus       239 ~~p~~~~~~~~~~~~~~~~~~~~~~-~~-~~~----~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~~  304 (304)
T cd05096         239 EQPYGELTDEQVIENAGEFFRDQGR-QV-YLF----RPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLTE  304 (304)
T ss_pred             CCCCCcCCHHHHHHHHHHHhhhccc-cc-ccc----CCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHhC
Confidence            56776533211 1111111110000 00 000    001122457788999999999999999999998863

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=2.6e-42  Score=339.57  Aligned_cols=247  Identities=27%  Similarity=0.405  Sum_probs=204.0

Q ss_pred             cCCCCCceecccCcEEEEEEEeC-CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeee-eecCceEEEE
Q 012765          142 DNFNSENLIGKGGHAEVYKGCLP-DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGF-STENGFHLVL  219 (457)
Q Consensus       142 ~~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~-~~~~~~~lv~  219 (457)
                      ++|.+.+.||+|+||.||||+.+ +.+.||+|.+.+..+. ...+..+.+|++|++.++|||||.++++ ....++++|.
T Consensus         2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~-~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVt   80 (808)
T KOG0597|consen    2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRN-EKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVT   80 (808)
T ss_pred             cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCc-hHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEe
Confidence            56888899999999999999865 6899999988765444 3457789999999999999999999994 5567789999


Q ss_pred             EecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCCCCCC
Q 012765          220 QFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWS  299 (457)
Q Consensus       220 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~~~~  299 (457)
                      ||+.| +|..+|.. ...++++.+..|+.+++.||.|||+   .+|+|||+||.||||+.+|.+|+||||+++.+...  
T Consensus        81 e~a~g-~L~~il~~-d~~lpEe~v~~~a~~LVsaL~yLhs---~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~--  153 (808)
T KOG0597|consen   81 EYAVG-DLFTILEQ-DGKLPEEQVRAIAYDLVSALYYLHS---NRILHRDMKPQNILLEKGGTLKLCDFGLARAMSTN--  153 (808)
T ss_pred             hhhhh-hHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHh---cCcccccCCcceeeecCCCceeechhhhhhhcccC--
Confidence            99977 99999854 4568999999999999999999999   89999999999999999999999999999988654  


Q ss_pred             ceeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhccccccCCcccccCchhhcccC
Q 012765          300 HHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSNFKELVDPRLADAYD  379 (457)
Q Consensus       300 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~  379 (457)
                      ....+.+.||+.|||||++.++.|+..+|+||||||+||+++|++||.....  ....+....        |+..   +.
T Consensus       154 t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si--~~Lv~~I~~--------d~v~---~p  220 (808)
T KOG0597|consen  154 TSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSI--TQLVKSILK--------DPVK---PP  220 (808)
T ss_pred             ceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHH--HHHHHHHhc--------CCCC---Cc
Confidence            3345667899999999999999999999999999999999999999975221  111111111        1111   11


Q ss_pred             HHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 012765          380 LAEMKRAMLTASVCIHHLSTMRPQMTRVLQ  409 (457)
Q Consensus       380 ~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~  409 (457)
                      ......+.+++...|.+||.+|.|-.+++.
T Consensus       221 ~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~  250 (808)
T KOG0597|consen  221 STASSSFVNFLQGLLIKDPAQRLTWTDLLG  250 (808)
T ss_pred             ccccHHHHHHHHHHhhcChhhcccHHHHhc
Confidence            244556778888899999999999998875

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=1.9e-41  Score=328.83  Aligned_cols=252  Identities=24%  Similarity=0.329  Sum_probs=196.6

Q ss_pred             CCCCCceecccCcEEEEEEEe-CCCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeee-cCceEEEEE
Q 012765          143 NFNSENLIGKGGHAEVYKGCL-PDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFST-ENGFHLVLQ  220 (457)
Q Consensus       143 ~f~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~-~~~~~lv~e  220 (457)
                      .|...+.||+|+||.||+|.. .+|+.||+|.+.............+.+|+.++..++|+||+++++++. ++..+++||
T Consensus         1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e   80 (285)
T cd05631           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence            367789999999999999985 478999999886544333333456889999999999999999998554 455789999


Q ss_pred             ecCCCChhhhhhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCCCCCC
Q 012765          221 FLPHGSLSSLLFGS-TECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWS  299 (457)
Q Consensus       221 ~~~~gsL~~~l~~~-~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~~~~  299 (457)
                      |+++|+|..++... ...+++..+..++.|++.||.|||+   .+|+||||||+|||++.++.++|+|||++........
T Consensus        81 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~  157 (285)
T cd05631          81 IMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQR---ERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGET  157 (285)
T ss_pred             ecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCCe
Confidence            99999998887543 3468899999999999999999999   8999999999999999999999999999987643321


Q ss_pred             ceeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhccccccCCcccccCchhhcccC
Q 012765          300 HHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSNFKELVDPRLADAYD  379 (457)
Q Consensus       300 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~  379 (457)
                         .....||..|+|||++.+..++.++|||||||++|||++|+.||.........-...       ..+....  ..+.
T Consensus       158 ---~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~-------~~~~~~~--~~~~  225 (285)
T cd05631         158 ---VRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVD-------RRVKEDQ--EEYS  225 (285)
T ss_pred             ---ecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHH-------HHhhccc--ccCC
Confidence               223458999999999999999999999999999999999999998643211100000       0000000  0111


Q ss_pred             HHHHHHHHHHHHHhcccCCCCCCC-----HHHHHH
Q 012765          380 LAEMKRAMLTASVCIHHLSTMRPQ-----MTRVLQ  409 (457)
Q Consensus       380 ~~~~~~l~~l~~~Cl~~dP~~RPt-----~~evl~  409 (457)
                      ......+..++.+||+.||.+||+     +.++++
T Consensus       226 ~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~  260 (285)
T cd05631         226 EKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQ  260 (285)
T ss_pred             ccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhc
Confidence            122345678889999999999997     777776

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=1.7e-42  Score=357.89  Aligned_cols=259  Identities=24%  Similarity=0.383  Sum_probs=207.4

Q ss_pred             hhcCCCCCceecccCcEEEEEEEe------CCCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeecC
Q 012765          140 ATDNFNSENLIGKGGHAEVYKGCL------PDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTEN  213 (457)
Q Consensus       140 ~~~~f~~~~~LG~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~  213 (457)
                      .+.+....+.||+|+||+||+|..      ++.+.||||.++.....  +...+|.+|+++++.++|||||+++|+|.++
T Consensus       484 ~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~--~~~~dF~REaeLla~l~H~nIVrLlGVC~~~  561 (774)
T KOG1026|consen  484 PRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAEN--QARQDFRREAELLAELQHPNIVRLLGVCREG  561 (774)
T ss_pred             chhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccH--HHHHHHHHHHHHHHhccCCCeEEEEEEEccC
Confidence            445556678899999999999973      24578999998755433  4567999999999999999999999988877


Q ss_pred             c-eEEEEEecCCCChhhhhhcC---------C----CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcC
Q 012765          214 G-FHLVLQFLPHGSLSSLLFGS---------T----ECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSE  279 (457)
Q Consensus       214 ~-~~lv~e~~~~gsL~~~l~~~---------~----~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~  279 (457)
                      + +++|+|||..|+|.++|+..         +    ..++..+.+.||.|||.|+.||-+   ..+|||||...|+|+.+
T Consensus       562 ~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~---~~FVHRDLATRNCLVge  638 (774)
T KOG1026|consen  562 DPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSS---HHFVHRDLATRNCLVGE  638 (774)
T ss_pred             CeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh---Ccccccchhhhhceecc
Confidence            6 57999999999999999531         1    227788899999999999999999   89999999999999999


Q ss_pred             CCcEEEeeccccccCCCCCCceeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHh-CCCCCCcCC-cchhhhh
Q 012765          280 DYEAQISDFGLAKWLPDNWSHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELIT-GRRAVDSRR-QSLVIWA  357 (457)
Q Consensus       280 ~~~~kL~DFGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLlt-G~~pf~~~~-~~~~~~~  357 (457)
                      +..|||+|||+++.+...+.........-..+|||||.++.++|+++||||||||+|||+++ |+.||.... +..+.. 
T Consensus       639 ~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~-  717 (774)
T KOG1026|consen  639 NLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIEC-  717 (774)
T ss_pred             ceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHHHHH-
Confidence            99999999999998766544433322234678999999999999999999999999999999 999987632 222221 


Q ss_pred             ccccccCCcccccCchhhcccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCCC
Q 012765          358 KPLLQTSNFKELVDPRLADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQLLRGEGG  416 (457)
Q Consensus       358 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~  416 (457)
                                 +-+.++ -.........+-.|+..||+.+|.+||+++||-.+|+....
T Consensus       718 -----------i~~g~l-L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~  764 (774)
T KOG1026|consen  718 -----------IRAGQL-LSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQ  764 (774)
T ss_pred             -----------HHcCCc-ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHh
Confidence                       112222 11122344566778888999999999999999999987643

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=3.7e-41  Score=325.77  Aligned_cols=257  Identities=23%  Similarity=0.372  Sum_probs=202.4

Q ss_pred             cCCCCCceecccCcEEEEEEEeC-CCc----EEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeecCceE
Q 012765          142 DNFNSENLIGKGGHAEVYKGCLP-DGE----VVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTENGFH  216 (457)
Q Consensus       142 ~~f~~~~~LG~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~  216 (457)
                      ++|.+.+.||+|+||+||+|.+. +++    .+++|.+...  .......++..|+.++++++||||+++++++.....+
T Consensus         7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~~~~~   84 (279)
T cd05111           7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDR--SGRQTFQEITDHMLAMGSLDHAYIVRLLGICPGASLQ   84 (279)
T ss_pred             hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccc--cchHHHHHHHHHHHHHhcCCCCCcceEEEEECCCccE
Confidence            56778899999999999999864 454    4677766432  2223446788899899999999999999998888888


Q ss_pred             EEEEecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCCC
Q 012765          217 LVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPD  296 (457)
Q Consensus       217 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~  296 (457)
                      +++||+++|+|.+++......+++..++.++.||+.||.|||+   .+++||||||+|||++.++.+||+|||+++.+..
T Consensus        85 ~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~  161 (279)
T cd05111          85 LVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEE---HRMVHRNLAARNILLKSDSIVQIADFGVADLLYP  161 (279)
T ss_pred             EEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHH---CCEeccccCcceEEEcCCCcEEEcCCccceeccC
Confidence            9999999999999997766778999999999999999999999   8999999999999999999999999999987654


Q ss_pred             CCCceeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHh-CCCCCCcCCcchhhhhccccccCCcccccCchhh
Q 012765          297 NWSHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELIT-GRRAVDSRRQSLVIWAKPLLQTSNFKELVDPRLA  375 (457)
Q Consensus       297 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLlt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  375 (457)
                      ...........++..|+|||++.++.++.++|||||||++|||++ |..||...........   ......  ...+.. 
T Consensus       162 ~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~---~~~~~~--~~~~~~-  235 (279)
T cd05111         162 DDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDL---LEKGER--LAQPQI-  235 (279)
T ss_pred             CCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH---HHCCCc--CCCCCC-
Confidence            332222233456788999999998899999999999999999998 9999976443221100   111110  011111 


Q ss_pred             cccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCC
Q 012765          376 DAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQLLRGEG  415 (457)
Q Consensus       376 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~  415 (457)
                            ....+..++.+||..+|++|||+.|+++.|..+.
T Consensus       236 ------~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~  269 (279)
T cd05111         236 ------CTIDVYMVMVKCWMIDENVRPTFKELANEFTRMA  269 (279)
T ss_pred             ------CCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHH
Confidence                  1124566788999999999999999999988754

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=2.2e-41  Score=341.26  Aligned_cols=257  Identities=21%  Similarity=0.343  Sum_probs=197.4

Q ss_pred             hcCCCCCceecccCcEEEEEEEe------CCCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhc-CCCCcceeeeeeecC
Q 012765          141 TDNFNSENLIGKGGHAEVYKGCL------PDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHI-NHPNAAKLIGFSTEN  213 (457)
Q Consensus       141 ~~~f~~~~~LG~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~  213 (457)
                      .++|++.+.||+|+||.||+|.+      .++..||+|++......  .....+.+|+.++..+ +||||+++++++..+
T Consensus        34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~--~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~  111 (375)
T cd05104          34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHL--TEREALMSELKVLSYLGNHINIVNLLGACTVG  111 (375)
T ss_pred             hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCc--HHHHHHHHHHHHHHHhcCCcceeeeeeeeccC
Confidence            45788899999999999999963      24668999988643322  3345788999999999 899999999976554


Q ss_pred             -ceEEEEEecCCCChhhhhhcCC---------------------------------------------------------
Q 012765          214 -GFHLVLQFLPHGSLSSLLFGST---------------------------------------------------------  235 (457)
Q Consensus       214 -~~~lv~e~~~~gsL~~~l~~~~---------------------------------------------------------  235 (457)
                       ..++||||+++|+|.+++....                                                         
T Consensus       112 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~  191 (375)
T cd05104         112 GPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRS  191 (375)
T ss_pred             CcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccccccc
Confidence             4689999999999999885321                                                         


Q ss_pred             -----------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCCCCC
Q 012765          236 -----------------ECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNW  298 (457)
Q Consensus       236 -----------------~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~~~  298 (457)
                                       ..+++..++.++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||++.......
T Consensus       192 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~  268 (375)
T cd05104         192 GSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIRNDS  268 (375)
T ss_pred             ceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCchhhEEEECCCcEEEecCccceeccCcc
Confidence                             146788889999999999999999   899999999999999999999999999998765432


Q ss_pred             CceeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHh-CCCCCCcCCcchhhhhccccccCCcccccCchhhcc
Q 012765          299 SHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELIT-GRRAVDSRRQSLVIWAKPLLQTSNFKELVDPRLADA  377 (457)
Q Consensus       299 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLlt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~  377 (457)
                      .........++..|+|||++.+..++.++|||||||++|||++ |..||.........+..  .....  ....+    .
T Consensus       269 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~--~~~~~--~~~~~----~  340 (375)
T cd05104         269 NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKM--IKEGY--RMLSP----E  340 (375)
T ss_pred             cccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHH--HHhCc--cCCCC----C
Confidence            2111112234667999999999999999999999999999998 88898753322111110  00000  00001    1


Q ss_pred             cCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 012765          378 YDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQLLRG  413 (457)
Q Consensus       378 ~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~  413 (457)
                         .....+.+++.+||+.||++||++.+|++.|+.
T Consensus       341 ---~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~  373 (375)
T cd05104         341 ---CAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQ  373 (375)
T ss_pred             ---CCCHHHHHHHHHHccCChhHCcCHHHHHHHHHh
Confidence               112356788899999999999999999999985

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=2e-41  Score=341.42  Aligned_cols=258  Identities=22%  Similarity=0.361  Sum_probs=198.5

Q ss_pred             hcCCCCCceecccCcEEEEEEEe------CCCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhc-CCCCcceeeeeeec-
Q 012765          141 TDNFNSENLIGKGGHAEVYKGCL------PDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHI-NHPNAAKLIGFSTE-  212 (457)
Q Consensus       141 ~~~f~~~~~LG~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~-  212 (457)
                      .++|.+.+.||+|+||.||+|..      .++..||+|++......  .....+.+|+.+++.+ +|+||+++++++.. 
T Consensus        37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~  114 (374)
T cd05106          37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHT--DEREALMSELKILSHLGQHKNIVNLLGACTHG  114 (374)
T ss_pred             HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCH--HHHHHHHHHHHHHHhhccCCceeeEeeEecCC
Confidence            45788999999999999999873      23457999988654332  3356788999999999 89999999996655 


Q ss_pred             CceEEEEEecCCCChhhhhhcCC---------------------------------------------------------
Q 012765          213 NGFHLVLQFLPHGSLSSLLFGST---------------------------------------------------------  235 (457)
Q Consensus       213 ~~~~lv~e~~~~gsL~~~l~~~~---------------------------------------------------------  235 (457)
                      +..+++|||+++|+|.+++....                                                         
T Consensus       115 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  194 (374)
T cd05106         115 GPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQS  194 (374)
T ss_pred             CCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccc
Confidence            45689999999999999885321                                                         


Q ss_pred             ------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCCCCCCceee
Q 012765          236 ------------ECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSHHIV  303 (457)
Q Consensus       236 ------------~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~~~~~~~~  303 (457)
                                  ..+++..++.++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||+++.+.........
T Consensus       195 ~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~---~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~  271 (374)
T cd05106         195 SDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLAS---KNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVK  271 (374)
T ss_pred             ccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHH---CCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeec
Confidence                        236778889999999999999999   89999999999999999999999999999876543222222


Q ss_pred             ecccccccccChhccccCCCCcchhHHHHHHHHHHHHh-CCCCCCcCCcchhhhhccccccCCcccccCchhhcccCHHH
Q 012765          304 FPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELIT-GRRAVDSRRQSLVIWAKPLLQTSNFKELVDPRLADAYDLAE  382 (457)
Q Consensus       304 ~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLlt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~  382 (457)
                      ....++..|+|||++.+..++.++|||||||++|||++ |+.||.........+.. ....      ..+.....    .
T Consensus       272 ~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~-~~~~------~~~~~~~~----~  340 (374)
T cd05106         272 GNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKM-VKRG------YQMSRPDF----A  340 (374)
T ss_pred             cCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHH-HHcc------cCccCCCC----C
Confidence            22335667999999998899999999999999999997 99999763322111110 0000      00000011    1


Q ss_pred             HHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q 012765          383 MKRAMLTASVCIHHLSTMRPQMTRVLQLLRGE  414 (457)
Q Consensus       383 ~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~  414 (457)
                      ...+.+++.+||+.+|.+||++.+|++.|+.+
T Consensus       341 ~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~  372 (374)
T cd05106         341 PPEIYSIMKMCWNLEPTERPTFSQISQLIQRQ  372 (374)
T ss_pred             CHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence            24567788899999999999999999999875

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.8e-41  Score=327.83  Aligned_cols=246  Identities=22%  Similarity=0.258  Sum_probs=196.6

Q ss_pred             cCCCCCceecccCcEEEEEEEeC-CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeec-CceEEEE
Q 012765          142 DNFNSENLIGKGGHAEVYKGCLP-DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTE-NGFHLVL  219 (457)
Q Consensus       142 ~~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-~~~~lv~  219 (457)
                      ++|.+.+.||+|+||.||+|... +++.||+|.+.............+.+|+.+++.++||||+++++++.+ +..+++|
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   80 (291)
T cd05612           1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM   80 (291)
T ss_pred             CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence            46888999999999999999865 689999999865433333445678899999999999999999986554 4568999


Q ss_pred             EecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCCCCCC
Q 012765          220 QFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWS  299 (457)
Q Consensus       220 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~~~~  299 (457)
                      ||+++|+|.+++... ..+++.....++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||++....... 
T Consensus        81 e~~~~~~L~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~-  155 (291)
T cd05612          81 EYVPGGELFSYLRNS-GRFSNSTGLFYASEIVCALEYLHS---KEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRT-  155 (291)
T ss_pred             eCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHeEECCCCCEEEEecCcchhccCCc-
Confidence            999999999998653 457888889999999999999999   899999999999999999999999999998764421 


Q ss_pred             ceeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhccccccCCcccccCchhhcccC
Q 012765          300 HHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSNFKELVDPRLADAYD  379 (457)
Q Consensus       300 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~  379 (457)
                          ....||+.|+|||++.+..++.++|||||||++|+|++|+.||......... .......        ..+...+ 
T Consensus       156 ----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~-~~i~~~~--------~~~~~~~-  221 (291)
T cd05612         156 ----WTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIY-EKILAGK--------LEFPRHL-  221 (291)
T ss_pred             ----ccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH-HHHHhCC--------cCCCccC-
Confidence                2345899999999999989999999999999999999999999864322111 0000000        0111111 


Q ss_pred             HHHHHHHHHHHHHhcccCCCCCCC-----HHHHHH
Q 012765          380 LAEMKRAMLTASVCIHHLSTMRPQ-----MTRVLQ  409 (457)
Q Consensus       380 ~~~~~~l~~l~~~Cl~~dP~~RPt-----~~evl~  409 (457)
                         ...+.+++.+||+.||.+||+     +.++++
T Consensus       222 ---~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~  253 (291)
T cd05612         222 ---DLYAKDLIKKLLVVDRTRRLGNMKNGADDVKN  253 (291)
T ss_pred             ---CHHHHHHHHHHcCCCHHHccCCccCCHHHHhc
Confidence               234667889999999999995     777765

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=7.7e-41  Score=323.19  Aligned_cols=258  Identities=23%  Similarity=0.365  Sum_probs=204.0

Q ss_pred             hcCCCCCceecccCcEEEEEEEe-CCCc----EEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeecCce
Q 012765          141 TDNFNSENLIGKGGHAEVYKGCL-PDGE----VVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTENGF  215 (457)
Q Consensus       141 ~~~f~~~~~LG~G~~g~Vy~~~~-~~~~----~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~  215 (457)
                      .++|...+.||.|+||+||+|.+ .++.    .||+|.+.....  ......+.+|+.++..++||||+++++++.....
T Consensus         6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~--~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~   83 (279)
T cd05109           6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTS--PKANKEILDEAYVMAGVGSPYVCRLLGICLTSTV   83 (279)
T ss_pred             hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCC--HHHHHHHHHHHHHHHhcCCCCCceEEEEEcCCCc
Confidence            46788899999999999999974 3444    489998764332  2345678899999999999999999999888888


Q ss_pred             EEEEEecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCC
Q 012765          216 HLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLP  295 (457)
Q Consensus       216 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~  295 (457)
                      +++++|+++|+|.+++......+++..++.++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||+++.+.
T Consensus        84 ~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~---~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~  160 (279)
T cd05109          84 QLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEE---VRLVHRDLAARNVLVKSPNHVKITDFGLARLLD  160 (279)
T ss_pred             EEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccccceEEEcCCCcEEECCCCceeecc
Confidence            99999999999999997666678999999999999999999999   899999999999999999999999999998775


Q ss_pred             CCCCceeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHh-CCCCCCcCCcchhhhhccccccCCcccccCchh
Q 012765          296 DNWSHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELIT-GRRAVDSRRQSLVIWAKPLLQTSNFKELVDPRL  374 (457)
Q Consensus       296 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLlt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l  374 (457)
                      ............++..|+|||.+.+..++.++|||||||++|||++ |..||............   .....     +  
T Consensus       161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~---~~~~~-----~--  230 (279)
T cd05109         161 IDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLL---EKGER-----L--  230 (279)
T ss_pred             cccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH---HCCCc-----C--
Confidence            4322211222235678999999998899999999999999999998 89998754322111100   00000     0  


Q ss_pred             hcccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCC
Q 012765          375 ADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQLLRGEG  415 (457)
Q Consensus       375 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~  415 (457)
                        .........+..++.+||+.||++||++.++++.|+...
T Consensus       231 --~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~  269 (279)
T cd05109         231 --PQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMA  269 (279)
T ss_pred             --CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence              001112345677889999999999999999999987764

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=5.8e-41  Score=322.01  Aligned_cols=256  Identities=20%  Similarity=0.318  Sum_probs=199.4

Q ss_pred             hcCCCCCceecccCcEEEEEEEeC----CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeec-Cce
Q 012765          141 TDNFNSENLIGKGGHAEVYKGCLP----DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTE-NGF  215 (457)
Q Consensus       141 ~~~f~~~~~LG~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-~~~  215 (457)
                      .++|.+.+.||+|+||.||+|.+.    .+..||+|.+......  .....+.+|+.++.+++||||+++++++.. +..
T Consensus         4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~   81 (266)
T cd05064           4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSD--KQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTM   81 (266)
T ss_pred             hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCH--HHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCc
Confidence            356888899999999999999753    3668999988654322  334678999999999999999999996554 557


Q ss_pred             EEEEEecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCC
Q 012765          216 HLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLP  295 (457)
Q Consensus       216 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~  295 (457)
                      ++||||+++|+|.+++......+++..++.++.||+.||.|||+   .+++||||||+|||++.++.++++|||.+....
T Consensus        82 ~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~---~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~  158 (266)
T cd05064          82 MIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSE---MGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDK  158 (266)
T ss_pred             EEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHH---CCEeeccccHhhEEEcCCCcEEECCCccccccc
Confidence            89999999999999997655678999999999999999999999   899999999999999999999999999876543


Q ss_pred             CCCCceeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHh-CCCCCCcCCcchhhhhccccccCCcccccCchh
Q 012765          296 DNWSHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELIT-GRRAVDSRRQSLVIWAKPLLQTSNFKELVDPRL  374 (457)
Q Consensus       296 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLlt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l  374 (457)
                      ..... ......++..|+|||++.+..++.++|||||||++|||++ |..||.........  .. ..+..     ....
T Consensus       159 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~--~~-~~~~~-----~~~~  229 (266)
T cd05064         159 SEAIY-TTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVI--KA-VEDGF-----RLPA  229 (266)
T ss_pred             ccchh-cccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHH--HH-HHCCC-----CCCC
Confidence            22111 1112235678999999999999999999999999999875 99999764322111  00 00000     0001


Q ss_pred             hcccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q 012765          375 ADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQLLRGE  414 (457)
Q Consensus       375 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~  414 (457)
                      ..    .....+.+++.+||+.+|.+||++.+|++.|...
T Consensus       230 ~~----~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~  265 (266)
T cd05064         230 PR----NCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM  265 (266)
T ss_pred             CC----CCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence            11    1234567788999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=8e-41  Score=323.45  Aligned_cols=255  Identities=25%  Similarity=0.418  Sum_probs=199.7

Q ss_pred             cCCCCCceecccCcEEEEEEEeCC------CcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeecC-c
Q 012765          142 DNFNSENLIGKGGHAEVYKGCLPD------GEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTEN-G  214 (457)
Q Consensus       142 ~~f~~~~~LG~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~-~  214 (457)
                      ++|.+.+.||+|+||.||+|....      ...||+|.+.....  ......+.+|+.++..++||||+++++++... .
T Consensus         5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~--~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~   82 (283)
T cd05048           5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAE--PKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQP   82 (283)
T ss_pred             HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCC--HHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCc
Confidence            467888999999999999997533      25799998764332  23456789999999999999999999976554 4


Q ss_pred             eEEEEEecCCCChhhhhhcCC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcC
Q 012765          215 FHLVLQFLPHGSLSSLLFGST---------------ECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSE  279 (457)
Q Consensus       215 ~~lv~e~~~~gsL~~~l~~~~---------------~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~  279 (457)
                      .+++|||+++++|.+++....               ..+++..++.++.|++.||.|||+   .+++|+||||+||+++.
T Consensus        83 ~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~---~~i~H~dlkp~Nil~~~  159 (283)
T cd05048          83 TCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSS---HHFVHRDLAARNCLVGE  159 (283)
T ss_pred             eEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccccccceEEEcC
Confidence            689999999999999885421               457888899999999999999999   89999999999999999


Q ss_pred             CCcEEEeeccccccCCCCCCceeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHh-CCCCCCcCCcchhhhhc
Q 012765          280 DYEAQISDFGLAKWLPDNWSHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELIT-GRRAVDSRRQSLVIWAK  358 (457)
Q Consensus       280 ~~~~kL~DFGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLlt-G~~pf~~~~~~~~~~~~  358 (457)
                      ++.++|+|||++................++..|+|||++.+..++.++|||||||++|||++ |..||........... 
T Consensus       160 ~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~~-  238 (283)
T cd05048         160 GLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEM-  238 (283)
T ss_pred             CCcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH-
Confidence            99999999999986643322222223346788999999988899999999999999999998 9999875332211100 


Q ss_pred             cccccCCcccccCchhhcccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 012765          359 PLLQTSNFKELVDPRLADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQLLRG  413 (457)
Q Consensus       359 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~  413 (457)
                                 +...............+.+++.+||+.||.+||++.+|++.|++
T Consensus       239 -----------i~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05048         239 -----------IRSRQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS  282 (283)
T ss_pred             -----------HHcCCcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence                       00000011112234567788999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8.7e-42  Score=342.03  Aligned_cols=264  Identities=28%  Similarity=0.410  Sum_probs=206.0

Q ss_pred             hhcCCCCCceecccCcEEEEEEEeCC--C--cE-EEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeecCc
Q 012765          140 ATDNFNSENLIGKGGHAEVYKGCLPD--G--EV-VAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTENG  214 (457)
Q Consensus       140 ~~~~f~~~~~LG~G~~g~Vy~~~~~~--~--~~-vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~  214 (457)
                      ..++....++||+|+||.||+|.+..  +  .. ||+|............+.+|++|+++|++++|||||++||++....
T Consensus       155 ~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~  234 (474)
T KOG0194|consen  155 SHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEE  234 (474)
T ss_pred             eccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCC
Confidence            34555667999999999999998643  2  23 8999877544455567889999999999999999999999877766


Q ss_pred             -eEEEEEecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeecccccc
Q 012765          215 -FHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKW  293 (457)
Q Consensus       215 -~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~  293 (457)
                       +++|||+|.||+|.++|......++...++.++.+.|.||.|||+   .++|||||.++|+|++.++.+||+|||+++.
T Consensus       235 Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~---k~~IHRDIAARNcL~~~~~~vKISDFGLs~~  311 (474)
T KOG0194|consen  235 PLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHS---KNCIHRDIAARNCLYSKKGVVKISDFGLSRA  311 (474)
T ss_pred             ccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHH---CCCcchhHhHHHheecCCCeEEeCccccccC
Confidence             578999999999999998877789999999999999999999999   8999999999999999999999999999875


Q ss_pred             CCCCCCceeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHh-CCCCCCcCCcchhhhhccccccCCcccccCc
Q 012765          294 LPDNWSHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELIT-GRRAVDSRRQSLVIWAKPLLQTSNFKELVDP  372 (457)
Q Consensus       294 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLlt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~  372 (457)
                      -..-.....  ...-...|+|||.+..+.|+.++|||||||++||+++ |..||.+.......-           .++..
T Consensus       312 ~~~~~~~~~--~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~-----------kI~~~  378 (474)
T KOG0194|consen  312 GSQYVMKKF--LKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKA-----------KIVKN  378 (474)
T ss_pred             Ccceeeccc--cccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHHHH-----------HHHhc
Confidence            431111110  1124578999999999999999999999999999999 888998744321110           00001


Q ss_pred             hhhcccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCCCCCC
Q 012765          373 RLADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQLLRGEGGQTD  419 (457)
Q Consensus       373 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~~~  419 (457)
                      ...-.........+..+..+||..+|++||+|.+|.+.|+.+.....
T Consensus       379 ~~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~  425 (474)
T KOG0194|consen  379 GYRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKE  425 (474)
T ss_pred             CccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhccc
Confidence            11111111223445556678999999999999999999988765543

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=4.8e-41  Score=332.96  Aligned_cols=246  Identities=25%  Similarity=0.333  Sum_probs=196.4

Q ss_pred             cCCCCCceecccCcEEEEEEEeC-CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeec-CceEEEE
Q 012765          142 DNFNSENLIGKGGHAEVYKGCLP-DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTE-NGFHLVL  219 (457)
Q Consensus       142 ~~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-~~~~lv~  219 (457)
                      ++|.+.+.||+|+||.||+|.+. +++.||+|.+.............+.+|+.++.+++||||+++++++.+ +..+++|
T Consensus        18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   97 (329)
T PTZ00263         18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL   97 (329)
T ss_pred             hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence            67888999999999999999865 589999999865433333445678999999999999999999996554 5578999


Q ss_pred             EecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCCCCCC
Q 012765          220 QFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWS  299 (457)
Q Consensus       220 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~~~~  299 (457)
                      ||+.+|+|.+++... ..+++.....++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||++....... 
T Consensus        98 e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~-  172 (329)
T PTZ00263         98 EFVVGGELFTHLRKA-GRFPNDVAKFYHAELVLAFEYLHS---KDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRT-  172 (329)
T ss_pred             cCCCCChHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHEEECCCCCEEEeeccCceEcCCCc-
Confidence            999999999998653 457888888899999999999999   899999999999999999999999999998764432 


Q ss_pred             ceeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhccccccCCcccccCchhhcccC
Q 012765          300 HHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSNFKELVDPRLADAYD  379 (457)
Q Consensus       300 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~  379 (457)
                          ....||+.|+|||++.+..++.++|||||||++|||++|..||....... .+.........+.        ..+ 
T Consensus       173 ----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~-~~~~i~~~~~~~p--------~~~-  238 (329)
T PTZ00263        173 ----FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFR-IYEKILAGRLKFP--------NWF-  238 (329)
T ss_pred             ----ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHH-HHHHHhcCCcCCC--------CCC-
Confidence                23458999999999999999999999999999999999999997643211 1111000011111        111 


Q ss_pred             HHHHHHHHHHHHHhcccCCCCCCC-----HHHHHH
Q 012765          380 LAEMKRAMLTASVCIHHLSTMRPQ-----MTRVLQ  409 (457)
Q Consensus       380 ~~~~~~l~~l~~~Cl~~dP~~RPt-----~~evl~  409 (457)
                         ...+.+++..||+.||.+||+     +.+++.
T Consensus       239 ---~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~  270 (329)
T PTZ00263        239 ---DGRARDLVKGLLQTDHTKRLGTLKGGVADVKN  270 (329)
T ss_pred             ---CHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence               234567889999999999997     577664

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8.4e-41  Score=331.65  Aligned_cols=254  Identities=21%  Similarity=0.269  Sum_probs=199.9

Q ss_pred             cCCCCCceecccCcEEEEEEEeC-CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeecC-ceEEEE
Q 012765          142 DNFNSENLIGKGGHAEVYKGCLP-DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTEN-GFHLVL  219 (457)
Q Consensus       142 ~~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~-~~~lv~  219 (457)
                      ++|.+.+.||+|+||.||+|.+. +++.||+|++.............+.+|+.++..++||||+++++++.++ ..++||
T Consensus         1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~   80 (333)
T cd05600           1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM   80 (333)
T ss_pred             CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence            36888999999999999999875 5899999998755433334566789999999999999999999866554 568999


Q ss_pred             EecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCCCCCC
Q 012765          220 QFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWS  299 (457)
Q Consensus       220 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~~~~  299 (457)
                      ||+++|+|.+++... ..+++..+..++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||++......  
T Consensus        81 e~~~g~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~~--  154 (333)
T cd05600          81 EYVPGGDFRTLLNNL-GVLSEDHARFYMAEMFEAVDALHE---LGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVTY--  154 (333)
T ss_pred             eCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEECCCCCEEEEeCcCCcccccc--
Confidence            999999999998543 457888889999999999999999   89999999999999999999999999999765441  


Q ss_pred             ceeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhc-cccccCCcccccCchhhccc
Q 012765          300 HHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAK-PLLQTSNFKELVDPRLADAY  378 (457)
Q Consensus       300 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~-~~~~~~~~~~~~d~~l~~~~  378 (457)
                         .....||+.|+|||++.+..++.++|||||||++|||++|..||............ ............++.     
T Consensus       155 ---~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~-----  226 (333)
T cd05600         155 ---ANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPR-----  226 (333)
T ss_pred             ---cCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccccccCCCCCccc-----
Confidence               22345899999999999999999999999999999999999999864322111000 000000000001110     


Q ss_pred             CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 012765          379 DLAEMKRAMLTASVCIHHLSTMRPQMTRVLQL  410 (457)
Q Consensus       379 ~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~  410 (457)
                       ......+.+++.+||..+|.+||++.++++.
T Consensus       227 -~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h  257 (333)
T cd05600         227 -FNLSDEAWDLITKLINDPSRRFGSLEDIKNH  257 (333)
T ss_pred             -cccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence             1223456778889999999999999999873

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=4.4e-42  Score=337.78  Aligned_cols=243  Identities=30%  Similarity=0.463  Sum_probs=201.7

Q ss_pred             CceecccCcEEEEEEEeCCCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeecCc-eEEEEEecCCC
Q 012765          147 ENLIGKGGHAEVYKGCLPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTENG-FHLVLQFLPHG  225 (457)
Q Consensus       147 ~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~-~~lv~e~~~~g  225 (457)
                      ++-||.|+.|.||+|++ .++.||||++..-          -..+++.|++|+||||+.+.|+|...- +|+|||||+.|
T Consensus       129 LeWlGSGaQGAVF~Grl-~netVAVKKV~el----------kETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~G  197 (904)
T KOG4721|consen  129 LEWLGSGAQGAVFLGRL-HNETVAVKKVREL----------KETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQG  197 (904)
T ss_pred             hhhhccCcccceeeeec-cCceehhHHHhhh----------hhhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccc
Confidence            46799999999999998 5689999987432          124688899999999999999887655 67999999999


Q ss_pred             ChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCCCCCCceeeec
Q 012765          226 SLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFP  305 (457)
Q Consensus       226 sL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~~~~~~~~~~  305 (457)
                      .|...|.. +..+.......+..+||.|+.|||.   ..|||||||+-||||+.+..+||+|||-++.+.+..   ....
T Consensus       198 qL~~VLka-~~~itp~llv~Wsk~IA~GM~YLH~---hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~S---TkMS  270 (904)
T KOG4721|consen  198 QLYEVLKA-GRPITPSLLVDWSKGIAGGMNYLHL---HKIIHRDLKSPNILISYDDVVKISDFGTSKELSDKS---TKMS  270 (904)
T ss_pred             cHHHHHhc-cCccCHHHHHHHHHHhhhhhHHHHH---hhHhhhccCCCceEeeccceEEeccccchHhhhhhh---hhhh
Confidence            99999964 4457777888999999999999999   799999999999999999999999999998775542   2345


Q ss_pred             ccccccccChhccccCCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhccccccCCcccccCchhhcccCHHHHHH
Q 012765          306 IEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSNFKELVDPRLADAYDLAEMKR  385 (457)
Q Consensus       306 ~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~  385 (457)
                      +.||..|||||++.+.+.++|+|||||||+|||||||..||.+-+.+.++|..-    .+...+.-       .....+-
T Consensus       271 FaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwGVG----sNsL~Lpv-------PstcP~G  339 (904)
T KOG4721|consen  271 FAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWGVG----SNSLHLPV-------PSTCPDG  339 (904)
T ss_pred             hhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchheeEEecc----CCcccccC-------cccCchH
Confidence            779999999999999999999999999999999999999999988888887642    11111111       1223344


Q ss_pred             HHHHHHHhcccCCCCCCCHHHHHHHHhcCCCCC
Q 012765          386 AMLTASVCIHHLSTMRPQMTRVLQLLRGEGGQT  418 (457)
Q Consensus       386 l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~~  418 (457)
                      +..|+.+||+..|..||++.+|+..|.-.+..+
T Consensus       340 fklL~Kqcw~sKpRNRPSFrqil~HldIa~pel  372 (904)
T KOG4721|consen  340 FKLLLKQCWNSKPRNRPSFRQILLHLDIASPEL  372 (904)
T ss_pred             HHHHHHHHHhcCCCCCccHHHHHHHHhhcCHHH
Confidence            556778899999999999999999997665443

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=4e-40  Score=326.58  Aligned_cols=261  Identities=23%  Similarity=0.351  Sum_probs=199.1

Q ss_pred             hcCCCCCceecccCcEEEEEEEeC-CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeee-cCceEEE
Q 012765          141 TDNFNSENLIGKGGHAEVYKGCLP-DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFST-ENGFHLV  218 (457)
Q Consensus       141 ~~~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~-~~~~~lv  218 (457)
                      .++|++.+.||+|+||.||++.+. ++..+|+|.+.....  ......+.+|+.++++++||||+++++++. ++..++|
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv   81 (331)
T cd06649           4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIK--PAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISIC   81 (331)
T ss_pred             cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccC--HHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEE
Confidence            478999999999999999999865 588899998764322  234567999999999999999999999654 4557899


Q ss_pred             EEecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCCCCC
Q 012765          219 LQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNW  298 (457)
Q Consensus       219 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~~~  298 (457)
                      |||+++++|.+++... ..+++..+..++.|++.||.|||+.  .+|+||||||+|||++.++.+||+|||++..+....
T Consensus        82 ~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~--~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  158 (331)
T cd06649          82 MEHMDGGSLDQVLKEA-KRIPEEILGKVSIAVLRGLAYLREK--HQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM  158 (331)
T ss_pred             eecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhhc--CCEEcCCCChhhEEEcCCCcEEEccCcccccccccc
Confidence            9999999999998543 3578899999999999999999982  369999999999999999999999999987664432


Q ss_pred             CceeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhh--hhccccccCC-----------
Q 012765          299 SHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVI--WAKPLLQTSN-----------  365 (457)
Q Consensus       299 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~--~~~~~~~~~~-----------  365 (457)
                      .    ....||..|+|||++.+..++.++|||||||++|||++|+.||...+.....  ...+......           
T Consensus       159 ~----~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (331)
T cd06649         159 A----NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRPR  234 (331)
T ss_pred             c----ccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccCcccc
Confidence            2    2345899999999999989999999999999999999999999754322111  0000000000           


Q ss_pred             ------------------cccccC----chhhcccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 012765          366 ------------------FKELVD----PRLADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQL  410 (457)
Q Consensus       366 ------------------~~~~~d----~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~  410 (457)
                                        ..++.+    ..............+.+++.+||+.||++|||+.+|++.
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h  301 (331)
T cd06649         235 PPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNH  301 (331)
T ss_pred             cccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence                              000000    000000001123467889999999999999999999873

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=3e-41  Score=323.03  Aligned_cols=249  Identities=32%  Similarity=0.489  Sum_probs=190.7

Q ss_pred             CCceecccCcEEEEEEEeC-----CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeec-CceEEEE
Q 012765          146 SENLIGKGGHAEVYKGCLP-----DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTE-NGFHLVL  219 (457)
Q Consensus       146 ~~~~LG~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-~~~~lv~  219 (457)
                      ..+.||.|+||.||+|.+.     .+..|+||.+...  ........+.+|++.+++++||||++++|++.. +..++|+
T Consensus         3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~--~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~   80 (259)
T PF07714_consen    3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPS--SSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVM   80 (259)
T ss_dssp             EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTT--SSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEE
T ss_pred             EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccc--cccccceeeeecccccccccccccccccccccccccccccc
Confidence            3578999999999999875     3678999988442  223346789999999999999999999998874 4578999


Q ss_pred             EecCCCChhhhhhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCCCCC
Q 012765          220 QFLPHGSLSSLLFGS-TECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNW  298 (457)
Q Consensus       220 e~~~~gsL~~~l~~~-~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~~~  298 (457)
                      ||+++|+|.++|... ...+++..++.|+.||+.||.|||+   .+++|+||+++||+++.++.+||+|||++.......
T Consensus        81 e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~---~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~  157 (259)
T PF07714_consen   81 EYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHS---NNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKS  157 (259)
T ss_dssp             E--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHH---TTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSS
T ss_pred             ccccccccccccccccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccccc
Confidence            999999999999876 6679999999999999999999999   899999999999999999999999999998774332


Q ss_pred             CceeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHh-CCCCCCcCCcchhhhhccccccCCcccccCchhhcc
Q 012765          299 SHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELIT-GRRAVDSRRQSLVIWAKPLLQTSNFKELVDPRLADA  377 (457)
Q Consensus       299 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLlt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~  377 (457)
                      .............|+|||.+....++.++||||||+++|||++ |+.||.........  ... ......         .
T Consensus       158 ~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~--~~~-~~~~~~---------~  225 (259)
T PF07714_consen  158 KYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEII--EKL-KQGQRL---------P  225 (259)
T ss_dssp             SEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHH--HHH-HTTEET---------T
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccccccccccc--ccc-cccccc---------e
Confidence            2222233446778999999998889999999999999999999 77888764332211  111 111100         0


Q ss_pred             cCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 012765          378 YDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQLL  411 (457)
Q Consensus       378 ~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L  411 (457)
                      ........+.+++.+||..+|++||++.+|++.|
T Consensus       226 ~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L  259 (259)
T PF07714_consen  226 IPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL  259 (259)
T ss_dssp             SBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred             eccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence            0111234566789999999999999999999976

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=1.1e-40  Score=329.47  Aligned_cols=243  Identities=21%  Similarity=0.273  Sum_probs=192.2

Q ss_pred             ceecccCcEEEEEEEeC-CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeec-CceEEEEEecCCC
Q 012765          148 NLIGKGGHAEVYKGCLP-DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTE-NGFHLVLQFLPHG  225 (457)
Q Consensus       148 ~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-~~~~lv~e~~~~g  225 (457)
                      ++||+|+||.||++... +|+.||+|++.............+.+|+.+++.++||||+++++++.. +..++||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~   80 (323)
T cd05571           1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence            46999999999999864 689999999875443334455678899999999999999999986554 5578999999999


Q ss_pred             ChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCCCCCCceeeec
Q 012765          226 SLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFP  305 (457)
Q Consensus       226 sL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~~~~~~~~~~  305 (457)
                      +|..++.. ...+++..+..++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||+++.......  ....
T Consensus        81 ~L~~~l~~-~~~~~~~~~~~~~~qi~~~L~~lH~---~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~--~~~~  154 (323)
T cd05571          81 ELFFHLSR-ERVFSEDRARFYGAEIVSALGYLHS---CDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGA--TMKT  154 (323)
T ss_pred             cHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHh---CCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCC--cccc
Confidence            99988854 3457888999999999999999999   8999999999999999999999999999875422211  1223


Q ss_pred             ccccccccChhccccCCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhccccccCCcccccCchhhcccCHHHHHH
Q 012765          306 IEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSNFKELVDPRLADAYDLAEMKR  385 (457)
Q Consensus       306 ~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~  385 (457)
                      ..||+.|+|||++.+..++.++|||||||++|||++|+.||...+..... .......        ..+...    ....
T Consensus       155 ~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~-~~~~~~~--------~~~p~~----~~~~  221 (323)
T cd05571         155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLF-ELILMEE--------IRFPRT----LSPE  221 (323)
T ss_pred             eecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHHH-HHHHcCC--------CCCCCC----CCHH
Confidence            45999999999999999999999999999999999999999764322111 0000000        111111    2335


Q ss_pred             HHHHHHHhcccCCCCCC-----CHHHHHH
Q 012765          386 AMLTASVCIHHLSTMRP-----QMTRVLQ  409 (457)
Q Consensus       386 l~~l~~~Cl~~dP~~RP-----t~~evl~  409 (457)
                      +.+++.+||+.||++||     ++.++++
T Consensus       222 ~~~li~~~L~~dP~~R~~~~~~~~~~ll~  250 (323)
T cd05571         222 AKSLLAGLLKKDPKQRLGGGPEDAKEIME  250 (323)
T ss_pred             HHHHHHHHccCCHHHcCCCCCCCHHHHHc
Confidence            66788899999999999     7888875

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=4.6e-40  Score=313.58  Aligned_cols=250  Identities=25%  Similarity=0.393  Sum_probs=198.2

Q ss_pred             cCCCCCceecccCcEEEEEEEeCCCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeec-CceEEEEE
Q 012765          142 DNFNSENLIGKGGHAEVYKGCLPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTE-NGFHLVLQ  220 (457)
Q Consensus       142 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-~~~~lv~e  220 (457)
                      ++|++.+.||+|+||.||+|.+.++..+|+|.+......    ...+.+|+.++++++||||+++++++.. +..+++||
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e   79 (256)
T cd05114           4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGAMS----EEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTE   79 (256)
T ss_pred             HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCCcc----HHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEE
Confidence            457788999999999999999888888999987543322    3468899999999999999999996654 45789999


Q ss_pred             ecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCCCCCCc
Q 012765          221 FLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSH  300 (457)
Q Consensus       221 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~~~~~  300 (457)
                      |+++|+|.+++......+++..++.++.|++.||.|||+   .+++|+||||+||+++.++.+||+|||+++........
T Consensus        80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~  156 (256)
T cd05114          80 FMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLER---NSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYT  156 (256)
T ss_pred             cCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHH---CCccccccCcceEEEcCCCeEEECCCCCccccCCCcee
Confidence            999999999987655568999999999999999999999   89999999999999999999999999998876433211


Q ss_pred             eeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHh-CCCCCCcCCcchhhhhccccccCCcccccCchhhcccC
Q 012765          301 HIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELIT-GRRAVDSRRQSLVIWAKPLLQTSNFKELVDPRLADAYD  379 (457)
Q Consensus       301 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLlt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~  379 (457)
                      . .....++..|+|||++.+..++.++||||||+++|||++ |+.||............  ....   ....+..     
T Consensus       157 ~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i--~~~~---~~~~~~~-----  225 (256)
T cd05114         157 S-SSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMI--SRGF---RLYRPKL-----  225 (256)
T ss_pred             c-cCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH--HCCC---CCCCCCC-----
Confidence            1 112235568999999988889999999999999999999 89999764432111110  0000   0011111     


Q ss_pred             HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 012765          380 LAEMKRAMLTASVCIHHLSTMRPQMTRVLQLL  411 (457)
Q Consensus       380 ~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L  411 (457)
                        ....+..++.+||+.+|.+||++.++++.|
T Consensus       226 --~~~~~~~li~~c~~~~p~~Rps~~~l~~~l  255 (256)
T cd05114         226 --ASMTVYEVMYSCWHEKPEGRPTFAELLRAI  255 (256)
T ss_pred             --CCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence              123577899999999999999999999987

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=2.5e-40  Score=317.21  Aligned_cols=257  Identities=25%  Similarity=0.373  Sum_probs=201.7

Q ss_pred             hcCCCCCceecccCcEEEEEEEeCC----CcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeec-Cce
Q 012765          141 TDNFNSENLIGKGGHAEVYKGCLPD----GEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTE-NGF  215 (457)
Q Consensus       141 ~~~f~~~~~LG~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-~~~  215 (457)
                      .++|++.+.||+|+||.||+|.+..    ...||+|.+.....  ......+.+|+.+++.++||||+++++++.. +..
T Consensus         3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   80 (266)
T cd05033           3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSS--DKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPV   80 (266)
T ss_pred             hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCC--hHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCce
Confidence            3578899999999999999998642    45789998754332  2345678899999999999999999996654 456


Q ss_pred             EEEEEecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCC
Q 012765          216 HLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLP  295 (457)
Q Consensus       216 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~  295 (457)
                      +++|||+++++|.+++......+++..++.++.|++.||.|||+   .+|+|+||||+||+++.++.++|+|||++....
T Consensus        81 ~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~---~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~  157 (266)
T cd05033          81 MIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSE---MNYVHRDLAARNILVNSNLVCKVSDFGLSRRLE  157 (266)
T ss_pred             EEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCcceEEEcCCCCEEECccchhhccc
Confidence            89999999999999997666678999999999999999999999   899999999999999999999999999998875


Q ss_pred             CCCCceeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHh-CCCCCCcCCcchhhhhccccccCCcccccCchh
Q 012765          296 DNWSHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELIT-GRRAVDSRRQSLVIWAKPLLQTSNFKELVDPRL  374 (457)
Q Consensus       296 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLlt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l  374 (457)
                      ............++..|+|||.+.+..++.++||||||+++|+|++ |..||.........  ........     .+  
T Consensus       158 ~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~--~~~~~~~~-----~~--  228 (266)
T cd05033         158 DSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVI--KAVEDGYR-----LP--  228 (266)
T ss_pred             ccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHHHH--HHHHcCCC-----CC--
Confidence            3222222222335678999999998899999999999999999998 99998653322111  00000000     00  


Q ss_pred             hcccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q 012765          375 ADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQLLRGE  414 (457)
Q Consensus       375 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~  414 (457)
                         ........+.+++.+||+.+|++||++.+|++.|+.+
T Consensus       229 ---~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~  265 (266)
T cd05033         229 ---PPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM  265 (266)
T ss_pred             ---CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence               0111234577899999999999999999999999764

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=2.9e-40  Score=314.07  Aligned_cols=248  Identities=26%  Similarity=0.340  Sum_probs=193.1

Q ss_pred             ceecccCcEEEEEEEeC-CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeec-CceEEEEEecCCC
Q 012765          148 NLIGKGGHAEVYKGCLP-DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTE-NGFHLVLQFLPHG  225 (457)
Q Consensus       148 ~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-~~~~lv~e~~~~g  225 (457)
                      +.||+|+||.||+|.+. +++.+|+|.+....  .......+.+|+.+++.++||||+++++++.. ...++||||++++
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~   78 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETL--PPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGG   78 (252)
T ss_pred             CccCcccCccEEEEEEecCCceEEEEecCccC--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCC
Confidence            36999999999999864 68899999875432  23345678999999999999999999997655 4468999999999


Q ss_pred             ChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCCCCCCceeeec
Q 012765          226 SLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFP  305 (457)
Q Consensus       226 sL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~~~~~~~~~~  305 (457)
                      +|.+++......+++..++.++.|++.||.|||+   .+++||||||+||+++.++.+||+|||++..............
T Consensus        79 ~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~  155 (252)
T cd05084          79 DFLTFLRTEGPRLKVKELIQMVENAAAGMEYLES---KHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGM  155 (252)
T ss_pred             cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHh---CCccccccchheEEEcCCCcEEECccccCcccccccccccCCC
Confidence            9999986655668999999999999999999999   8999999999999999999999999999876543211111111


Q ss_pred             ccccccccChhccccCCCCcchhHHHHHHHHHHHHh-CCCCCCcCCcchhhhhccccccCCcccccCchhhcccCHHHHH
Q 012765          306 IEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELIT-GRRAVDSRRQSLVIWAKPLLQTSNFKELVDPRLADAYDLAEMK  384 (457)
Q Consensus       306 ~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLlt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~  384 (457)
                      ...+..|+|||.+.++.++.++||||||+++|||++ |..||.............  .          ............
T Consensus       156 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~--~----------~~~~~~~~~~~~  223 (252)
T cd05084         156 KQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIE--Q----------GVRLPCPELCPD  223 (252)
T ss_pred             CCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHH--c----------CCCCCCcccCCH
Confidence            123457999999998899999999999999999998 888886533211111100  0          000011112234


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 012765          385 RAMLTASVCIHHLSTMRPQMTRVLQLLR  412 (457)
Q Consensus       385 ~l~~l~~~Cl~~dP~~RPt~~evl~~L~  412 (457)
                      .+.+++.+||+.+|++|||+.+|+++|+
T Consensus       224 ~~~~li~~~l~~~p~~Rps~~~~~~~l~  251 (252)
T cd05084         224 AVYRLMERCWEYDPGQRPSFSTVHQELQ  251 (252)
T ss_pred             HHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence            6778999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.6e-40  Score=316.24  Aligned_cols=254  Identities=25%  Similarity=0.341  Sum_probs=200.8

Q ss_pred             hhcCCCCCceecccCcEEEEEEEeCCCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeec-CceEEE
Q 012765          140 ATDNFNSENLIGKGGHAEVYKGCLPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTE-NGFHLV  218 (457)
Q Consensus       140 ~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-~~~~lv  218 (457)
                      ..++|++.+.||+|+||.||+|.+.+++.||+|.+.....    ....+.+|+.++++++||||+++++++.. +..+++
T Consensus         4 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   79 (261)
T cd05068           4 DRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTM----DPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIV   79 (261)
T ss_pred             chhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCcc----cHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeee
Confidence            3467888999999999999999987788899998864332    23468899999999999999999996654 456899


Q ss_pred             EEecCCCChhhhhhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCCCC
Q 012765          219 LQFLPHGSLSSLLFGST-ECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDN  297 (457)
Q Consensus       219 ~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~~  297 (457)
                      |||+++++|.+++.... ..+++..+..++.|++.||.|||+   .+++||||||+||+++.++.++|+|||++......
T Consensus        80 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~  156 (261)
T cd05068          80 TELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEA---QNYIHRDLAARNVLVGENNICKVADFGLARVIKED  156 (261)
T ss_pred             eecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCCcceEEEcCCCCEEECCcceEEEccCC
Confidence            99999999999986543 468999999999999999999999   89999999999999999999999999999877533


Q ss_pred             CCceeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHh-CCCCCCcCCcchhhhhccccccCCcccccCchhhc
Q 012765          298 WSHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELIT-GRRAVDSRRQSLVIWAKPLLQTSNFKELVDPRLAD  376 (457)
Q Consensus       298 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLlt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  376 (457)
                      .... ......+..|+|||++.+..++.++||||||+++|||++ |+.||............  ....      .    .
T Consensus       157 ~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~--~~~~------~----~  223 (261)
T cd05068         157 IYEA-REGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQV--DQGY------R----M  223 (261)
T ss_pred             cccc-cCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH--HcCC------C----C
Confidence            2111 111223457999999998899999999999999999999 99999764322111000  0000      0    0


Q ss_pred             ccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 012765          377 AYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQLLRG  413 (457)
Q Consensus       377 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~  413 (457)
                      .........+.+++.+||+.+|.+||++.++++.|+.
T Consensus       224 ~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~  260 (261)
T cd05068         224 PCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLED  260 (261)
T ss_pred             CCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence            0111223567789999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.2e-41  Score=301.17  Aligned_cols=250  Identities=27%  Similarity=0.367  Sum_probs=205.7

Q ss_pred             hhcCCCCCceecccCcEEEEEEEeC-CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeec-CceEE
Q 012765          140 ATDNFNSENLIGKGGHAEVYKGCLP-DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTE-NGFHL  217 (457)
Q Consensus       140 ~~~~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-~~~~l  217 (457)
                      ..++|++.+.||+|.||.||.|..+ ++-.||+|++.+..........++.+|+++.+.|+||||.++|+++.+ ...|+
T Consensus        20 ~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyL   99 (281)
T KOG0580|consen   20 TLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYL   99 (281)
T ss_pred             chhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEE
Confidence            4578999999999999999999854 678899999877665555556689999999999999999999996655 45789


Q ss_pred             EEEecCCCChhhhhhc-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCCC
Q 012765          218 VLQFLPHGSLSSLLFG-STECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPD  296 (457)
Q Consensus       218 v~e~~~~gsL~~~l~~-~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~  296 (457)
                      ++||.+.|++...|.. ....+++...+.++.|+|.||.|+|.   +++|||||||+|+|++.++..||+|||-+...+.
T Consensus       100 ilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~---k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p~  176 (281)
T KOG0580|consen  100 ILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHL---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS  176 (281)
T ss_pred             EEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhcc---CCcccCCCCHHHhccCCCCCeeccCCCceeecCC
Confidence            9999999999999974 34458888889999999999999999   8999999999999999999999999998876653


Q ss_pred             CCCceeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhccccccCCcccccCchhhc
Q 012765          297 NWSHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSNFKELVDPRLAD  376 (457)
Q Consensus       297 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  376 (457)
                      .    ...+.+||..|.+||...+..+|..+|+|++|++.||++.|.+||.+... ...+.+....     ++.+|    
T Consensus       177 ~----kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~-~etYkrI~k~-----~~~~p----  242 (281)
T KOG0580|consen  177 N----KRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSH-SETYKRIRKV-----DLKFP----  242 (281)
T ss_pred             C----CceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhh-HHHHHHHHHc-----cccCC----
Confidence            3    23456799999999999999999999999999999999999999997442 2222211111     11111    


Q ss_pred             ccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 012765          377 AYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQ  409 (457)
Q Consensus       377 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~  409 (457)
                         ..-.....+++++|+..+|.+|.+..||+.
T Consensus       243 ---~~is~~a~dlI~~ll~~~p~~r~~l~~v~~  272 (281)
T KOG0580|consen  243 ---STISGGAADLISRLLVKNPIERLALTEVMD  272 (281)
T ss_pred             ---cccChhHHHHHHHHhccCccccccHHHHhh
Confidence               122334567889999999999999999886

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1e-40  Score=336.59  Aligned_cols=246  Identities=24%  Similarity=0.337  Sum_probs=203.9

Q ss_pred             HhhcCCCCCceecccCcEEEEEEEeC-CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcC-CCCcceeee-eeecCce
Q 012765          139 AATDNFNSENLIGKGGHAEVYKGCLP-DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHIN-HPNAAKLIG-FSTENGF  215 (457)
Q Consensus       139 ~~~~~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~-~~~~~~~  215 (457)
                      ...++|..+.+||+|+||+|+++..+ +++.+|||.+++......+.++....|..|+...+ ||.+++++. |.+...+
T Consensus       365 ~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l  444 (694)
T KOG0694|consen  365 LTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHL  444 (694)
T ss_pred             ccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeE
Confidence            45688999999999999999999865 58899999999887777777888899998887775 999999998 5567778


Q ss_pred             EEEEEecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCC
Q 012765          216 HLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLP  295 (457)
Q Consensus       216 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~  295 (457)
                      ++||||+.||++..+  ...+.+++..+.-++..|+.||+|||+   ++|||||||.+|||||.+|.+||+|||+++...
T Consensus       445 ~fvmey~~Ggdm~~~--~~~~~F~e~rarfyaAev~l~L~fLH~---~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m  519 (694)
T KOG0694|consen  445 FFVMEYVAGGDLMHH--IHTDVFSEPRARFYAAEVVLGLQFLHE---NGIIYRDLKLDNLLLDTEGHVKIADFGLCKEGM  519 (694)
T ss_pred             EEEEEecCCCcEEEE--EecccccHHHHHHHHHHHHHHHHHHHh---cCceeeecchhheEEcccCcEEecccccccccC
Confidence            999999999994333  355678888888899999999999999   899999999999999999999999999998654


Q ss_pred             CCCCceeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhccccccCCcccccCchhh
Q 012765          296 DNWSHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSNFKELVDPRLA  375 (457)
Q Consensus       296 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  375 (457)
                      ...  ....+++||+.|||||++.+..|+..+|+|||||+||||+.|..||.+.++....           ..|+..  .
T Consensus       520 ~~g--~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~F-----------dsI~~d--~  584 (694)
T KOG0694|consen  520 GQG--DRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVF-----------DSIVND--E  584 (694)
T ss_pred             CCC--CccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHH-----------HHHhcC--C
Confidence            222  2345688999999999999999999999999999999999999999976553322           111111  1


Q ss_pred             cccCHHHHHHHHHHHHHhcccCCCCCCCH
Q 012765          376 DAYDLAEMKRAMLTASVCIHHLSTMRPQM  404 (457)
Q Consensus       376 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~  404 (457)
                      ..|......+.+.++.++|..+|++|.-+
T Consensus       585 ~~yP~~ls~ea~~il~~ll~k~p~kRLG~  613 (694)
T KOG0694|consen  585 VRYPRFLSKEAIAIMRRLLRKNPEKRLGS  613 (694)
T ss_pred             CCCCCcccHHHHHHHHHHhccCcccccCC
Confidence            22334455667788889999999999876

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=5e-40  Score=321.64  Aligned_cols=261  Identities=23%  Similarity=0.324  Sum_probs=193.7

Q ss_pred             hcCCCCCceecccCcEEEEEEEeC-CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeec-CceEEE
Q 012765          141 TDNFNSENLIGKGGHAEVYKGCLP-DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTE-NGFHLV  218 (457)
Q Consensus       141 ~~~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-~~~~lv  218 (457)
                      .++|.+.+.||+|+||+||+|... +++.||+|.+......  .....+.+|+.+++.++||||+++++++.. ...++|
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv   81 (303)
T cd07869           4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEE--GTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLV   81 (303)
T ss_pred             cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEecccccc--ccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEE
Confidence            478999999999999999999875 6889999988643222  123357789999999999999999996654 456899


Q ss_pred             EEecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCCCCC
Q 012765          219 LQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNW  298 (457)
Q Consensus       219 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~~~  298 (457)
                      |||+. ++|.+++......++...+..++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||++.......
T Consensus        82 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  157 (303)
T cd07869          82 FEYVH-TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQ---RYILHRDLKPQNLLISDTGELKLADFGLARAKSVPS  157 (303)
T ss_pred             EECCC-cCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEECCCCcceeccCCC
Confidence            99985 67888776666668888899999999999999999   899999999999999999999999999987553321


Q ss_pred             CceeeecccccccccChhcccc-CCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhcc--ccccCC---------c
Q 012765          299 SHHIVFPIEGTFGYLSPEYFMH-GIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKP--LLQTSN---------F  366 (457)
Q Consensus       299 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~~--~~~~~~---------~  366 (457)
                      .  ......+|+.|+|||++.+ ..++.++|||||||++|||++|..||.............  ......         .
T Consensus       158 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (303)
T cd07869         158 H--TYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSL  235 (303)
T ss_pred             c--cCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhc
Confidence            1  1223458999999999865 458999999999999999999999998643221111000  000000         0


Q ss_pred             ccc--------cCchhhcccC-HHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 012765          367 KEL--------VDPRLADAYD-LAEMKRAMLTASVCIHHLSTMRPQMTRVLQ  409 (457)
Q Consensus       367 ~~~--------~d~~l~~~~~-~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~  409 (457)
                      ...        ....+....+ ......+.+++..||+.||.+|||+.|+++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~  287 (303)
T cd07869         236 PHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS  287 (303)
T ss_pred             cccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence            000        0000000000 001234668889999999999999999986

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=2.3e-40  Score=329.08  Aligned_cols=258  Identities=25%  Similarity=0.382  Sum_probs=198.6

Q ss_pred             hcCCCCCceecccCcEEEEEEEeC------CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhc-CCCCcceeeeeeec-
Q 012765          141 TDNFNSENLIGKGGHAEVYKGCLP------DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHI-NHPNAAKLIGFSTE-  212 (457)
Q Consensus       141 ~~~f~~~~~LG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~-  212 (457)
                      .++|.+.+.||.|+||.||+|...      +++.||+|++.....  ......+.+|+.++.++ +|+||+++++++.. 
T Consensus         6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~--~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~   83 (337)
T cd05054           6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGAT--ASEYKALMTELKILIHIGHHLNVVNLLGACTKP   83 (337)
T ss_pred             HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCC--HHHHHHHHHHHHHHHhhccCcchhheeeeEecC
Confidence            467889999999999999999632      357899998864332  23356788999999999 89999999996654 


Q ss_pred             -CceEEEEEecCCCChhhhhhcCC--------------------------------------------------------
Q 012765          213 -NGFHLVLQFLPHGSLSSLLFGST--------------------------------------------------------  235 (457)
Q Consensus       213 -~~~~lv~e~~~~gsL~~~l~~~~--------------------------------------------------------  235 (457)
                       ..++++|||+++++|.+++....                                                        
T Consensus        84 ~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  163 (337)
T cd05054          84 GGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGD  163 (337)
T ss_pred             CCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhh
Confidence             34678999999999998884321                                                        


Q ss_pred             ----CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCCCCCCceeeeccccccc
Q 012765          236 ----ECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEGTFG  311 (457)
Q Consensus       236 ----~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~~~~~~~~~~~~gt~~  311 (457)
                          ..+++..+..++.||+.||.|||+   .+|+||||||+|||++.++.++|+|||++..+.............++..
T Consensus       164 ~~~~~~l~~~~~~~~~~qi~~aL~~lH~---~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~  240 (337)
T cd05054         164 ELYKEPLTLEDLISYSFQVARGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLK  240 (337)
T ss_pred             HHhhcCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCcc
Confidence                257889999999999999999999   8999999999999999999999999999987643322111122345678


Q ss_pred             ccChhccccCCCCcchhHHHHHHHHHHHHh-CCCCCCcCCcchhhhhccccccCCcccccCchhhcccCHHHHHHHHHHH
Q 012765          312 YLSPEYFMHGIVDEKTDVFAFGVLLLELIT-GRRAVDSRRQSLVIWAKPLLQTSNFKELVDPRLADAYDLAEMKRAMLTA  390 (457)
Q Consensus       312 y~aPE~~~~~~~~~ksDvwSlGvll~eLlt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~  390 (457)
                      |+|||++.+..++.++|||||||++|||++ |..||......... ... ......     +..    .......+.+++
T Consensus       241 y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~-~~~-~~~~~~-----~~~----~~~~~~~~~~l~  309 (337)
T cd05054         241 WMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEF-CRR-LKEGTR-----MRA----PEYATPEIYSIM  309 (337)
T ss_pred             ccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHH-HHH-HhccCC-----CCC----CccCCHHHHHHH
Confidence            999999999999999999999999999998 99999753221110 000 000000     000    111234577889


Q ss_pred             HHhcccCCCCCCCHHHHHHHHhcC
Q 012765          391 SVCIHHLSTMRPQMTRVLQLLRGE  414 (457)
Q Consensus       391 ~~Cl~~dP~~RPt~~evl~~L~~~  414 (457)
                      .+||+.+|++||++.+|++.|+.+
T Consensus       310 ~~cl~~~p~~RPs~~ell~~l~~~  333 (337)
T cd05054         310 LDCWHNNPEDRPTFSELVEILGDL  333 (337)
T ss_pred             HHHccCChhhCcCHHHHHHHHHHH
Confidence            999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=1.8e-40  Score=330.17  Aligned_cols=247  Identities=23%  Similarity=0.320  Sum_probs=197.1

Q ss_pred             hcCCCCCceecccCcEEEEEEEeCC--CcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeecC-ceEE
Q 012765          141 TDNFNSENLIGKGGHAEVYKGCLPD--GEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTEN-GFHL  217 (457)
Q Consensus       141 ~~~f~~~~~LG~G~~g~Vy~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~-~~~l  217 (457)
                      .++|.+.+.||+|+||.||+|.+..  +..||+|.+.............+.+|+.+++.++||||+++++++.+. .+++
T Consensus        29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l  108 (340)
T PTZ00426         29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYL  108 (340)
T ss_pred             hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEE
Confidence            4678899999999999999997543  368999988654433344456788999999999999999999966554 4689


Q ss_pred             EEEecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCCCC
Q 012765          218 VLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDN  297 (457)
Q Consensus       218 v~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~~  297 (457)
                      ||||+++|+|.+++... ..+++..+..++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||++..+...
T Consensus       109 v~Ey~~~g~L~~~i~~~-~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~~  184 (340)
T PTZ00426        109 VLEFVIGGEFFTFLRRN-KRFPNDVGCFYAAQIVLIFEYLQS---LNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTR  184 (340)
T ss_pred             EEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHH---CCeEccCCCHHHEEECCCCCEEEecCCCCeecCCC
Confidence            99999999999998643 458889999999999999999999   89999999999999999999999999999876432


Q ss_pred             CCceeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhccccccCCcccccCchhhcc
Q 012765          298 WSHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSNFKELVDPRLADA  377 (457)
Q Consensus       298 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~  377 (457)
                      .     ....||+.|+|||++.+..++.++|||||||++|||++|..||......... .........        +...
T Consensus       185 ~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~-~~i~~~~~~--------~p~~  250 (340)
T PTZ00426        185 T-----YTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIY-QKILEGIIY--------FPKF  250 (340)
T ss_pred             c-----ceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHHH-HHHhcCCCC--------CCCC
Confidence            1     2345999999999999888999999999999999999999999864432211 111000000        1111


Q ss_pred             cCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 012765          378 YDLAEMKRAMLTASVCIHHLSTMRP-----QMTRVLQ  409 (457)
Q Consensus       378 ~~~~~~~~l~~l~~~Cl~~dP~~RP-----t~~evl~  409 (457)
                      .+    ..+.+++.+||+.+|++|+     ++.++++
T Consensus       251 ~~----~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~  283 (340)
T PTZ00426        251 LD----NNCKHLMKKLLSHDLTKRYGNLKKGAQNVKE  283 (340)
T ss_pred             CC----HHHHHHHHHHcccCHHHcCCCCCCCHHHHHc
Confidence            12    2356788899999999995     8888876

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=1.1e-39  Score=312.53  Aligned_cols=260  Identities=24%  Similarity=0.390  Sum_probs=205.4

Q ss_pred             cCCCCCceecccCcEEEEEEEeC-CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeee-cCceEEEE
Q 012765          142 DNFNSENLIGKGGHAEVYKGCLP-DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFST-ENGFHLVL  219 (457)
Q Consensus       142 ~~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~-~~~~~lv~  219 (457)
                      ++|++.+.||+|+||.||+|... +++.||+|.+.............+.+|+.+++.++||||+++++++. .+..++++
T Consensus         2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08228           2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL   81 (267)
T ss_pred             cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence            57889999999999999999854 68999999876544344455667899999999999999999998554 45678999


Q ss_pred             EecCCCChhhhhhc---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCCC
Q 012765          220 QFLPHGSLSSLLFG---STECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPD  296 (457)
Q Consensus       220 e~~~~gsL~~~l~~---~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~  296 (457)
                      ||+++++|..++..   ....++....+.++.|++.||.|||+   .+++|+||||+||+++.++.++|+|||++.....
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~  158 (267)
T cd08228          82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhh---CCeeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence            99999999988743   33457888899999999999999999   8999999999999999999999999999887654


Q ss_pred             CCCceeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhccccccCCcccccCchhhc
Q 012765          297 NWSHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSNFKELVDPRLAD  376 (457)
Q Consensus       297 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  376 (457)
                      ...  ......|+..|+|||++.+..++.++|+||||+++|||++|+.||.........+..... ...     .+..  
T Consensus       159 ~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~-~~~-----~~~~--  228 (267)
T cd08228         159 KTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIE-QCD-----YPPL--  228 (267)
T ss_pred             hhH--HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHh-cCC-----CCCC--
Confidence            321  112245888999999998888999999999999999999999999754332222211111 000     1111  


Q ss_pred             ccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCC
Q 012765          377 AYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQLLRGEG  415 (457)
Q Consensus       377 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~  415 (457)
                       ........+.+++.+||+.+|++||++.+|++.|++++
T Consensus       229 -~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~~  266 (267)
T cd08228         229 -PTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMH  266 (267)
T ss_pred             -ChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHhc
Confidence             11122345778899999999999999999999998764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=6e-40  Score=318.63  Aligned_cols=260  Identities=19%  Similarity=0.324  Sum_probs=189.7

Q ss_pred             cCCCCCceecccCcEEEEEEEeC--CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhc---CCCCcceeeeeee-----
Q 012765          142 DNFNSENLIGKGGHAEVYKGCLP--DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHI---NHPNAAKLIGFST-----  211 (457)
Q Consensus       142 ~~f~~~~~LG~G~~g~Vy~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l---~hpniv~l~~~~~-----  211 (457)
                      ++|++.+.||+|+||.||+|...  +++.||+|.+....... .....+.+|+.++..+   +||||+++++++.     
T Consensus         1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~   79 (290)
T cd07862           1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEE-GMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD   79 (290)
T ss_pred             CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCC-CchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCC
Confidence            36888999999999999999863  46889999876443222 1123455666666554   7999999999764     


Q ss_pred             -cCceEEEEEecCCCChhhhhhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeecc
Q 012765          212 -ENGFHLVLQFLPHGSLSSLLFGS-TECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFG  289 (457)
Q Consensus       212 -~~~~~lv~e~~~~gsL~~~l~~~-~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG  289 (457)
                       ...++++|||+. ++|.+++... ...+++..++.++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||
T Consensus        80 ~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~---~~iiH~dlkp~Nil~~~~~~~kl~Dfg  155 (290)
T cd07862          80 RETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFG  155 (290)
T ss_pred             CCCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEEcCCCCEEEcccc
Confidence             234789999996 5888888543 3458899999999999999999999   899999999999999999999999999


Q ss_pred             ccccCCCCCCceeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhh-hccccc---cCC
Q 012765          290 LAKWLPDNWSHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIW-AKPLLQ---TSN  365 (457)
Q Consensus       290 l~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~-~~~~~~---~~~  365 (457)
                      ++.......   ......||..|+|||++.+..++.++|||||||++|||++|+.||.......... ......   ...
T Consensus       156 ~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~  232 (290)
T cd07862         156 LARIYSFQM---ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEED  232 (290)
T ss_pred             ceEeccCCc---ccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhh
Confidence            997664331   1223458999999999988899999999999999999999999998643321110 000000   000


Q ss_pred             cc-------cccCchh---hcccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 012765          366 FK-------ELVDPRL---ADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQ  409 (457)
Q Consensus       366 ~~-------~~~d~~l---~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~  409 (457)
                      ..       ....+..   ...........+.+++.+||+.||++|||+.|+++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~  286 (290)
T cd07862         233 WPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  286 (290)
T ss_pred             chhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence            00       0000000   00001112345668999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=2.8e-40  Score=318.94  Aligned_cols=257  Identities=21%  Similarity=0.354  Sum_probs=197.8

Q ss_pred             hhcCCCCCceecccCcEEEEEEEeC------CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeec-
Q 012765          140 ATDNFNSENLIGKGGHAEVYKGCLP------DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTE-  212 (457)
Q Consensus       140 ~~~~f~~~~~LG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-  212 (457)
                      ..++|++.+.||+|+||.||+|.+.      .+..||+|.+.....  .....++.+|+.+++.++||||+++++++.. 
T Consensus         4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~--~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~   81 (277)
T cd05062           4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAAS--MRERIEFLNEASVMKEFNCHHVVRLLGVVSQG   81 (277)
T ss_pred             cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCC--HHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCC
Confidence            5678999999999999999998743      356799998754322  2334578899999999999999999996655 


Q ss_pred             CceEEEEEecCCCChhhhhhcCC---------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcE
Q 012765          213 NGFHLVLQFLPHGSLSSLLFGST---------ECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEA  283 (457)
Q Consensus       213 ~~~~lv~e~~~~gsL~~~l~~~~---------~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~  283 (457)
                      ...+++|||+++++|.+++....         ..+++..+..++.|++.||.|||+   .+++|+||||+||++++++.+
T Consensus        82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~~vH~dlkp~Nil~~~~~~~  158 (277)
T cd05062          82 QPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTV  158 (277)
T ss_pred             CCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCcchheEEEcCCCCE
Confidence            45689999999999999885422         235778888999999999999999   899999999999999999999


Q ss_pred             EEeeccccccCCCCCCceeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHh-CCCCCCcCCcchhhhhccccc
Q 012765          284 QISDFGLAKWLPDNWSHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELIT-GRRAVDSRRQSLVIWAKPLLQ  362 (457)
Q Consensus       284 kL~DFGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLlt-G~~pf~~~~~~~~~~~~~~~~  362 (457)
                      +|+|||++..+.............++..|+|||++.+..++.++|||||||++|||++ |..||.........  .. ..
T Consensus       159 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~--~~-~~  235 (277)
T cd05062         159 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVL--RF-VM  235 (277)
T ss_pred             EECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHH--HH-HH
Confidence            9999999886644322221122335778999999998899999999999999999999 78888753321111  00 00


Q ss_pred             cCCcccccCchhhcccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 012765          363 TSNFKELVDPRLADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQLLRG  413 (457)
Q Consensus       363 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~  413 (457)
                      ......     .    .......+.+++.+||+.+|++|||+.++++.|++
T Consensus       236 ~~~~~~-----~----~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~  277 (277)
T cd05062         236 EGGLLD-----K----PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE  277 (277)
T ss_pred             cCCcCC-----C----CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence            010000     0    11122457789999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=5.1e-40  Score=319.34  Aligned_cols=260  Identities=21%  Similarity=0.292  Sum_probs=194.1

Q ss_pred             cCCCCCceecccCcEEEEEEEeC-CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeecC-ceEEEE
Q 012765          142 DNFNSENLIGKGGHAEVYKGCLP-DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTEN-GFHLVL  219 (457)
Q Consensus       142 ~~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~-~~~lv~  219 (457)
                      ++|.+.+.||.|+||.||+|... +++.||+|.+......  .....+.+|+.+++.++||||+++++++... ..++||
T Consensus         5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~   82 (288)
T cd07871           5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEE--GAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVF   82 (288)
T ss_pred             ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccC--CcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEE
Confidence            56888999999999999999865 6889999988543222  1234677899999999999999999966554 467999


Q ss_pred             EecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCCCCCC
Q 012765          220 QFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWS  299 (457)
Q Consensus       220 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~~~~  299 (457)
                      ||+.+ +|.+++......+++..+..++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||++........
T Consensus        83 e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~  158 (288)
T cd07871          83 EYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHK---RKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTK  158 (288)
T ss_pred             eCCCc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEECcCcceeeccCCCc
Confidence            99975 8888886666668889999999999999999999   8999999999999999999999999999876543221


Q ss_pred             ceeeecccccccccChhcccc-CCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhc-------------cccccCC
Q 012765          300 HHIVFPIEGTFGYLSPEYFMH-GIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAK-------------PLLQTSN  365 (457)
Q Consensus       300 ~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~-------------~~~~~~~  365 (457)
                        ......+++.|+|||++.+ ..++.++|||||||++|||++|+.||............             .......
T Consensus       159 --~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (288)
T cd07871         159 --TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEE  236 (288)
T ss_pred             --cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchh
Confidence              1123457899999999875 56899999999999999999999999764322111000             0000000


Q ss_pred             cccccCchhhcc----cCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 012765          366 FKELVDPRLADA----YDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQ  409 (457)
Q Consensus       366 ~~~~~d~~l~~~----~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~  409 (457)
                      +.....+.....    ........+.+++..||+.||.+|||+.|+++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~  284 (288)
T cd07871         237 FRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR  284 (288)
T ss_pred             hhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence            111111110000    00011234678899999999999999999975

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=3.5e-40  Score=318.27  Aligned_cols=255  Identities=24%  Similarity=0.343  Sum_probs=198.7

Q ss_pred             hcCCCCCceecccCcEEEEEEEeC------CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeec-C
Q 012765          141 TDNFNSENLIGKGGHAEVYKGCLP------DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTE-N  213 (457)
Q Consensus       141 ~~~f~~~~~LG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-~  213 (457)
                      .++|.+.+.||+|+||.||+|...      ++..||+|.+.....  ......+.+|++++..++||||+++++++.. .
T Consensus         4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~   81 (280)
T cd05049           4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETAS--NDARKDFEREAELLTNFQHENIVKFYGVCTEGD   81 (280)
T ss_pred             hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCC--HHHHHHHHHHHHHHHhcCCCCchheeeEEecCC
Confidence            356788899999999999999753      357899998864433  2235689999999999999999999996554 5


Q ss_pred             ceEEEEEecCCCChhhhhhcCC-------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCC
Q 012765          214 GFHLVLQFLPHGSLSSLLFGST-------------ECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSED  280 (457)
Q Consensus       214 ~~~lv~e~~~~gsL~~~l~~~~-------------~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~  280 (457)
                      ..+++|||+++++|.+++....             ..+++..+..++.|++.||.|||+   .+++||||||+||+++.+
T Consensus        82 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~---~~i~h~dlkp~nili~~~  158 (280)
T cd05049          82 PPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLAS---QHFVHRDLATRNCLVGYD  158 (280)
T ss_pred             CeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhh---CCeeccccccceEEEcCC
Confidence            5789999999999999985432             347888889999999999999999   899999999999999999


Q ss_pred             CcEEEeeccccccCCCCCCceeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHh-CCCCCCcCCcchhhhhcc
Q 012765          281 YEAQISDFGLAKWLPDNWSHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELIT-GRRAVDSRRQSLVIWAKP  359 (457)
Q Consensus       281 ~~~kL~DFGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLlt-G~~pf~~~~~~~~~~~~~  359 (457)
                      +.+||+|||++..+.............++..|+|||++.+..++.++|||||||++|||++ |..||............ 
T Consensus       159 ~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~~-  237 (280)
T cd05049         159 LVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECI-  237 (280)
T ss_pred             CeEEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH-
Confidence            9999999999976543322111122335778999999999999999999999999999998 99998753332211110 


Q ss_pred             ccccCCcccccCchhhcccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 012765          360 LLQTSNFKELVDPRLADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQLLR  412 (457)
Q Consensus       360 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~  412 (457)
                        ......         .........+.+++.+||+.||++||++.||++.|+
T Consensus       238 --~~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~  279 (280)
T cd05049         238 --TQGRLL---------QRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ  279 (280)
T ss_pred             --HcCCcC---------CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence              000000         001112345778899999999999999999999986

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.6e-41  Score=357.58  Aligned_cols=261  Identities=30%  Similarity=0.449  Sum_probs=205.8

Q ss_pred             hcCCCCCceecccCcEEEEEEEeC--CCc----EEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeecCc
Q 012765          141 TDNFNSENLIGKGGHAEVYKGCLP--DGE----VVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTENG  214 (457)
Q Consensus       141 ~~~f~~~~~LG~G~~g~Vy~~~~~--~~~----~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~  214 (457)
                      .++.+....||+|+||.||.|...  +|.    .||+|.+.+...  .....+|++|..+|++++|||||+++|++.+..
T Consensus       691 ~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~--~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~  768 (1025)
T KOG1095|consen  691 RKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSS--EQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSG  768 (1025)
T ss_pred             hhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCC--HHHHHHHHHHHHHHhcCCCcceeeEEEeecCCC
Confidence            455666788999999999999854  343    489998866544  456789999999999999999999999776655


Q ss_pred             -eEEEEEecCCCChhhhhhcC------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEee
Q 012765          215 -FHLVLQFLPHGSLSSLLFGS------TECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISD  287 (457)
Q Consensus       215 -~~lv~e~~~~gsL~~~l~~~------~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~D  287 (457)
                       .++++|||++|+|..+|+..      ...+.....+.|+.+||.|+.||++   +++|||||..+|+||+....+||+|
T Consensus       769 ~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~---~~fvHRDLAaRNCLL~~~r~VKIaD  845 (1025)
T KOG1095|consen  769 PPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLES---KHFVHRDLAARNCLLDERRVVKIAD  845 (1025)
T ss_pred             CcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHh---CCCcCcchhhhheeecccCcEEEcc
Confidence             57888999999999999876      6678999999999999999999999   8999999999999999999999999


Q ss_pred             ccccccCCCCCCceeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHh-CCCCCCcCCcchhhhhccccccCCc
Q 012765          288 FGLAKWLPDNWSHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELIT-GRRAVDSRRQSLVIWAKPLLQTSNF  366 (457)
Q Consensus       288 FGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLlt-G~~pf~~~~~~~~~~~~~~~~~~~~  366 (457)
                      ||+|+.+.............-...|||||.+..+.++.|+|||||||+|||++| |..||.......+..  .....   
T Consensus       846 FGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~--~~~~g---  920 (1025)
T KOG1095|consen  846 FGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLL--DVLEG---  920 (1025)
T ss_pred             cchhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHH--HHHhC---
Confidence            999996544332222211123457999999999999999999999999999999 888998644322211  11111   


Q ss_pred             ccccCchhhcccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCCCCC
Q 012765          367 KELVDPRLADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQLLRGEGGQT  418 (457)
Q Consensus       367 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~~  418 (457)
                           .+|..  .......+.+++.+||+.+|++||++..|++.+..+....
T Consensus       921 -----gRL~~--P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~  965 (1025)
T KOG1095|consen  921 -----GRLDP--PSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAA  965 (1025)
T ss_pred             -----CccCC--CCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhh
Confidence                 12211  1122334557888899999999999999999887765443

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=4.5e-40  Score=318.48  Aligned_cols=255  Identities=24%  Similarity=0.400  Sum_probs=197.2

Q ss_pred             cCCCCCceecccCcEEEEEEEe-----CCCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeec-Cce
Q 012765          142 DNFNSENLIGKGGHAEVYKGCL-----PDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTE-NGF  215 (457)
Q Consensus       142 ~~f~~~~~LG~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-~~~  215 (457)
                      ++|++.+.||+|+||.||+|..     ..+..+++|.+.....  ......+.+|+.+++.++||||+++++++.. ...
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~   82 (283)
T cd05090           5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINN--PQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPV   82 (283)
T ss_pred             hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCC--HHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCce
Confidence            4677889999999999999974     2467899998864322  2345678899999999999999999996554 557


Q ss_pred             EEEEEecCCCChhhhhhcC----------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcC
Q 012765          216 HLVLQFLPHGSLSSLLFGS----------------TECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSE  279 (457)
Q Consensus       216 ~lv~e~~~~gsL~~~l~~~----------------~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~  279 (457)
                      +++|||+++++|.+++...                ...+++...+.++.|++.||.|||+   .+++||||||+|||++.
T Consensus        83 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~i~H~dlkp~nili~~  159 (283)
T cd05090          83 CMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSS---HFFVHKDLAARNILIGE  159 (283)
T ss_pred             EEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHh---cCeehhccccceEEEcC
Confidence            8999999999999988422                1247788889999999999999999   89999999999999999


Q ss_pred             CCcEEEeeccccccCCCCCCceeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHh-CCCCCCcCCcchhhhhc
Q 012765          280 DYEAQISDFGLAKWLPDNWSHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELIT-GRRAVDSRRQSLVIWAK  358 (457)
Q Consensus       280 ~~~~kL~DFGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLlt-G~~pf~~~~~~~~~~~~  358 (457)
                      ++.+||+|||++..+.............++..|+|||++.+..++.++|||||||++|||++ |..||.........-. 
T Consensus       160 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~~~-  238 (283)
T cd05090         160 QLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEM-  238 (283)
T ss_pred             CCcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHH-
Confidence            99999999999987644322222223345678999999988889999999999999999998 9989875332111100 


Q ss_pred             cccccCCcccccCchhhcccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 012765          359 PLLQTSNFKELVDPRLADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQLLRG  413 (457)
Q Consensus       359 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~  413 (457)
                        ......     ......    ....+.+++.+||+.+|.+||++.+|++.|+.
T Consensus       239 --~~~~~~-----~~~~~~----~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05090         239 --VRKRQL-----LPCSED----CPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS  282 (283)
T ss_pred             --HHcCCc-----CCCCCC----CCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence              000000     001111    22356778889999999999999999998864

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.1e-40  Score=324.63  Aligned_cols=241  Identities=25%  Similarity=0.273  Sum_probs=188.7

Q ss_pred             ecccCcEEEEEEEeC-CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeec-CceEEEEEecCCCCh
Q 012765          150 IGKGGHAEVYKGCLP-DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTE-NGFHLVLQFLPHGSL  227 (457)
Q Consensus       150 LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-~~~~lv~e~~~~gsL  227 (457)
                      ||+|+||.||+|... +++.||+|.+.+...........+.+|+.++.+++||||+++++++.+ +..++||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L   80 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL   80 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence            799999999999865 588999999865443334456678899999999999999999986554 557899999999999


Q ss_pred             hhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCCCCCCceeeeccc
Q 012765          228 SSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIE  307 (457)
Q Consensus       228 ~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~~~~~~~~~~~~  307 (457)
                      ..++... ..+++..+..++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||+++.......  ......
T Consensus        81 ~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~---~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~  154 (312)
T cd05585          81 FHHLQRE-GRFDLSRARFYTAELLCALENLHK---FNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDD--KTNTFC  154 (312)
T ss_pred             HHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHh---CCeEeCCCCHHHeEECCCCcEEEEECcccccCccCCC--cccccc
Confidence            9998653 458889999999999999999999   8999999999999999999999999999875432211  123346


Q ss_pred             ccccccChhccccCCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhccccccCCcccccCchhhcccCHHHHHHHH
Q 012765          308 GTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSNFKELVDPRLADAYDLAEMKRAM  387 (457)
Q Consensus       308 gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~  387 (457)
                      ||+.|+|||++.+..++.++|||||||++|||++|+.||........ +.. .....       ..+...    ....+.
T Consensus       155 gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~-~~~-~~~~~-------~~~~~~----~~~~~~  221 (312)
T cd05585         155 GTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEM-YRK-ILQEP-------LRFPDG----FDRDAK  221 (312)
T ss_pred             CCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHHH-HHH-HHcCC-------CCCCCc----CCHHHH
Confidence            89999999999999999999999999999999999999976432211 111 11100       011111    223456


Q ss_pred             HHHHHhcccCCCCCCCH---HHHHH
Q 012765          388 LTASVCIHHLSTMRPQM---TRVLQ  409 (457)
Q Consensus       388 ~l~~~Cl~~dP~~RPt~---~evl~  409 (457)
                      +++.+||+.||.+||++   .+++.
T Consensus       222 ~li~~~L~~dp~~R~~~~~~~e~l~  246 (312)
T cd05585         222 DLLIGLLSRDPTRRLGYNGAQEIKN  246 (312)
T ss_pred             HHHHHHcCCCHHHcCCCCCHHHHHc
Confidence            78889999999999864   55543

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=6.5e-40  Score=317.88  Aligned_cols=262  Identities=21%  Similarity=0.262  Sum_probs=197.0

Q ss_pred             cCCCCCceecccCcEEEEEEEeC-CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeee-cCceEEEE
Q 012765          142 DNFNSENLIGKGGHAEVYKGCLP-DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFST-ENGFHLVL  219 (457)
Q Consensus       142 ~~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~-~~~~~lv~  219 (457)
                      ++|++.+.||+|+||.||+|.+. +++.||+|++...... ......+.+|+.+++.++||||+++++++. ++..++||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   79 (287)
T cd07848           1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEEN-EEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVF   79 (287)
T ss_pred             CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEeccccc-ccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEE
Confidence            46889999999999999999875 5889999988654322 233457889999999999999999998554 45578999


Q ss_pred             EecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCCCCCC
Q 012765          220 QFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWS  299 (457)
Q Consensus       220 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~~~~  299 (457)
                      ||++++.+..+. .....+++..++.++.||+.||.|||+   .+|+||||||+||+++.++.+||+|||++..+.....
T Consensus        80 e~~~~~~l~~~~-~~~~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  155 (287)
T cd07848          80 EYVEKNMLELLE-EMPNGVPPEKVRSYIYQLIKAIHWCHK---NDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSN  155 (287)
T ss_pred             ecCCCCHHHHHH-hcCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCcEEEeeccCccccccccc
Confidence            999987765444 334568889999999999999999999   8999999999999999999999999999987644322


Q ss_pred             ceeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhh-------------ccccccCCc
Q 012765          300 HHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWA-------------KPLLQTSNF  366 (457)
Q Consensus       300 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~-------------~~~~~~~~~  366 (457)
                      . ......||..|+|||++.+..++.++|||||||++|||++|+.||...........             .........
T Consensus       156 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (287)
T cd07848         156 A-NYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRF  234 (287)
T ss_pred             c-cccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchh
Confidence            1 12234589999999999988999999999999999999999999986432111100             000000111


Q ss_pred             ccccCchhhc------ccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 012765          367 KELVDPRLAD------AYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQ  409 (457)
Q Consensus       367 ~~~~d~~l~~------~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~  409 (457)
                      .....+....      .+.......+.+++.+||+.||++|||+.++++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~  283 (287)
T cd07848         235 HGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN  283 (287)
T ss_pred             cccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence            0010010000      000112345888999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=4.2e-40  Score=314.66  Aligned_cols=253  Identities=25%  Similarity=0.396  Sum_probs=200.6

Q ss_pred             hcCCCCCceecccCcEEEEEEEeCCCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeec-CceEEEE
Q 012765          141 TDNFNSENLIGKGGHAEVYKGCLPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTE-NGFHLVL  219 (457)
Q Consensus       141 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-~~~~lv~  219 (457)
                      .++|++.+.||+|+||.||+|...++..||+|.+.....    ..+.+.+|+.+++.++|+||+++++++.+ +..+++|
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   80 (261)
T cd05072           5 RESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTM----SVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIIT   80 (261)
T ss_pred             hHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCch----hHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEE
Confidence            467888999999999999999988888999998754322    24578999999999999999999986554 4568999


Q ss_pred             EecCCCChhhhhhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCCCCC
Q 012765          220 QFLPHGSLSSLLFGS-TECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNW  298 (457)
Q Consensus       220 e~~~~gsL~~~l~~~-~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~~~  298 (457)
                      ||+++++|.+++... ...+++..++.++.|++.||.|||+   .+++||||||+||+++.++.++|+|||++.......
T Consensus        81 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~---~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~  157 (261)
T cd05072          81 EYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIER---KNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNE  157 (261)
T ss_pred             ecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccchhhEEecCCCcEEECCCccceecCCCc
Confidence            999999999998653 4568888999999999999999999   899999999999999999999999999998765432


Q ss_pred             CceeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHh-CCCCCCcCCcchhhhhccccccCCcccccCchhhcc
Q 012765          299 SHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELIT-GRRAVDSRRQSLVIWAKPLLQTSNFKELVDPRLADA  377 (457)
Q Consensus       299 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLlt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~  377 (457)
                      .. ......++..|+|||++.+..++.++|||||||++|+|+| |..||............  .....     .+.. . 
T Consensus       158 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~--~~~~~-----~~~~-~-  227 (261)
T cd05072         158 YT-AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSAL--QRGYR-----MPRM-E-  227 (261)
T ss_pred             ee-ccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHH--HcCCC-----CCCC-C-
Confidence            11 1122335678999999988889999999999999999998 99999754322111110  00000     0100 1 


Q ss_pred             cCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 012765          378 YDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQLLRG  413 (457)
Q Consensus       378 ~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~  413 (457)
                         .....+.+++.+||+.+|++||++.+|++.|+.
T Consensus       228 ---~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  260 (261)
T cd05072         228 ---NCPDELYDIMKTCWKEKAEERPTFDYLQSVLDD  260 (261)
T ss_pred             ---CCCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence               122456788999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=5.8e-40  Score=332.85  Aligned_cols=260  Identities=21%  Similarity=0.316  Sum_probs=200.1

Q ss_pred             hhcCCCCCceecccCcEEEEEEEeC------CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcC-CCCcceeeeeeec
Q 012765          140 ATDNFNSENLIGKGGHAEVYKGCLP------DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHIN-HPNAAKLIGFSTE  212 (457)
Q Consensus       140 ~~~~f~~~~~LG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~  212 (457)
                      ..++|.+.++||+|+||.||+|.+.      .+..||+|++......  ...+.+.+|+.++++++ ||||+++++++.+
T Consensus        35 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~--~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~  112 (400)
T cd05105          35 PRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARS--SEKQALMSELKIMTHLGPHLNIVNLLGACTK  112 (400)
T ss_pred             cccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCCh--HHHHHHHHHHHHHHhcCCCCCeeeEEEEEcc
Confidence            4578889999999999999999752      2347999988654332  33467999999999996 9999999997765


Q ss_pred             -CceEEEEEecCCCChhhhhhcCC--------------------------------------------------------
Q 012765          213 -NGFHLVLQFLPHGSLSSLLFGST--------------------------------------------------------  235 (457)
Q Consensus       213 -~~~~lv~e~~~~gsL~~~l~~~~--------------------------------------------------------  235 (457)
                       +..++||||+++|+|.+++....                                                        
T Consensus       113 ~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  192 (400)
T cd05105         113 SGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPML  192 (400)
T ss_pred             CCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhh
Confidence             45789999999999998875321                                                        


Q ss_pred             ---------------------------------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEE
Q 012765          236 ---------------------------------------ECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNIL  276 (457)
Q Consensus       236 ---------------------------------------~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIl  276 (457)
                                                             ..+++..++.++.||+.||.|||+   .+|+||||||+|||
T Consensus       193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivH~dikp~Nil  269 (400)
T cd05105         193 EIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLAS---KNCVHRDLAARNVL  269 (400)
T ss_pred             hhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChHhEE
Confidence                                                   236777888999999999999999   89999999999999


Q ss_pred             EcCCCcEEEeeccccccCCCCCCceeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHh-CCCCCCcCCcchhh
Q 012765          277 LSEDYEAQISDFGLAKWLPDNWSHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELIT-GRRAVDSRRQSLVI  355 (457)
Q Consensus       277 l~~~~~~kL~DFGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLlt-G~~pf~~~~~~~~~  355 (457)
                      ++.++.+||+|||+++...............++..|+|||++.+..++.++|||||||++|||++ |..||.........
T Consensus       270 l~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~  349 (400)
T cd05105         270 LAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTF  349 (400)
T ss_pred             EeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHHH
Confidence            99999999999999987644322212222346778999999998899999999999999999997 99998753221111


Q ss_pred             hhccccccCCcccccCchhhcccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCC
Q 012765          356 WAKPLLQTSNFKELVDPRLADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQLLRGEG  415 (457)
Q Consensus       356 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~  415 (457)
                      +..  ....     ....    ........+.+++.+||+.+|++||++.+|.++|+.+-
T Consensus       350 ~~~--~~~~-----~~~~----~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~  398 (400)
T cd05105         350 YNK--IKSG-----YRMA----KPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLL  398 (400)
T ss_pred             HHH--HhcC-----CCCC----CCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHc
Confidence            110  0000     0000    01122345778899999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=7.2e-40  Score=312.97  Aligned_cols=253  Identities=24%  Similarity=0.356  Sum_probs=202.4

Q ss_pred             hcCCCCCceecccCcEEEEEEEeCCCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeecCceEEEEE
Q 012765          141 TDNFNSENLIGKGGHAEVYKGCLPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTENGFHLVLQ  220 (457)
Q Consensus       141 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~lv~e  220 (457)
                      .++|++.+.||+|+||.||+|...++..+|+|.+......    ...+.+|+.++++++|+|++++++++.....+++||
T Consensus         5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~~----~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~lv~e   80 (260)
T cd05070           5 RESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMS----PESFLEEAQIMKKLRHDKLVQLYAVVSEEPIYIVTE   80 (260)
T ss_pred             hHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCCC----HHHHHHHHHHHHhcCCCceEEEEeEECCCCcEEEEE
Confidence            4578889999999999999999888888999988654332    246889999999999999999999888888899999


Q ss_pred             ecCCCChhhhhhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCCCCCC
Q 012765          221 FLPHGSLSSLLFGS-TECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWS  299 (457)
Q Consensus       221 ~~~~gsL~~~l~~~-~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~~~~  299 (457)
                      |+++++|.+++... ...+++..++.++.+++.||.|||+   .+++||||||+||++++++.++|+|||++..+.....
T Consensus        81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~  157 (260)
T cd05070          81 YMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIER---MNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEY  157 (260)
T ss_pred             ecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCccceEEEeCCceEEeCCceeeeeccCccc
Confidence            99999999998653 3458999999999999999999999   8999999999999999999999999999987644321


Q ss_pred             ceeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHh-CCCCCCcCCcchhhhhccccccCCcccccCchhhccc
Q 012765          300 HHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELIT-GRRAVDSRRQSLVIWAKPLLQTSNFKELVDPRLADAY  378 (457)
Q Consensus       300 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLlt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~  378 (457)
                      . ......++..|+|||++.+..++.++||||||+++|+|++ |..||...........  ....          .....
T Consensus       158 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~--~~~~----------~~~~~  224 (260)
T cd05070         158 T-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQ--VERG----------YRMPC  224 (260)
T ss_pred             c-cccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH--HHcC----------CCCCC
Confidence            1 1112235668999999988889999999999999999999 8889975332211110  0000          00011


Q ss_pred             CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 012765          379 DLAEMKRAMLTASVCIHHLSTMRPQMTRVLQLLRG  413 (457)
Q Consensus       379 ~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~  413 (457)
                      .......+.+++.+||..+|.+|||+.++.+.|+.
T Consensus       225 ~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  259 (260)
T cd05070         225 PQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED  259 (260)
T ss_pred             CCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence            11223457889999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=2.6e-39  Score=321.06  Aligned_cols=200  Identities=27%  Similarity=0.431  Sum_probs=170.4

Q ss_pred             hcCCCCCceecccCcEEEEEEEeC-CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeec-CceEEE
Q 012765          141 TDNFNSENLIGKGGHAEVYKGCLP-DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTE-NGFHLV  218 (457)
Q Consensus       141 ~~~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-~~~~lv  218 (457)
                      .++|++.+.||.|+||.||++.+. ++..+|+|.+.....  ......+.+|+++++.++||||+++++++.. +..+++
T Consensus         4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv   81 (333)
T cd06650           4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIK--PAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISIC   81 (333)
T ss_pred             hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccC--HHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEE
Confidence            478999999999999999999875 578889887764432  2345678999999999999999999996554 557899


Q ss_pred             EEecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCCCCC
Q 012765          219 LQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNW  298 (457)
Q Consensus       219 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~~~  298 (457)
                      |||+++++|.+++... ..+++.....++.+++.||.|||+.  .+++||||||+|||++.++.+||+|||++..+....
T Consensus        82 ~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~l~~~l~~lH~~--~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~  158 (333)
T cd06650          82 MEHMDGGSLDQVLKKA-GRIPEQILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM  158 (333)
T ss_pred             EecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhc--CCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhhc
Confidence            9999999999998643 3578888899999999999999972  479999999999999999999999999987664332


Q ss_pred             CceeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHhCCCCCCcC
Q 012765          299 SHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSR  349 (457)
Q Consensus       299 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLltG~~pf~~~  349 (457)
                      .    ....|+..|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus       159 ~----~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~  205 (333)
T cd06650         159 A----NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPP  205 (333)
T ss_pred             c----ccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc
Confidence            1    2345899999999999888999999999999999999999999753

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=5e-40  Score=324.79  Aligned_cols=243  Identities=22%  Similarity=0.284  Sum_probs=191.4

Q ss_pred             ceecccCcEEEEEEEeC-CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeee-cCceEEEEEecCCC
Q 012765          148 NLIGKGGHAEVYKGCLP-DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFST-ENGFHLVLQFLPHG  225 (457)
Q Consensus       148 ~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~-~~~~~lv~e~~~~g  225 (457)
                      +.||+|+||.||++... +|+.||+|.+.............+.+|+.+++.++||||+++++++. .+..++||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence            46999999999999864 68999999987644333445667889999999999999999998554 45578999999999


Q ss_pred             ChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCCCCCCceeeec
Q 012765          226 SLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFP  305 (457)
Q Consensus       226 sL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~~~~~~~~~~  305 (457)
                      +|..++... ..+++..+..++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||++........  ....
T Consensus        81 ~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~--~~~~  154 (323)
T cd05595          81 ELFFHLSRE-RVFTEERARFYGAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA--TMKT  154 (323)
T ss_pred             cHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHEEEcCCCCEEecccHHhccccCCCC--cccc
Confidence            998888543 458899999999999999999999   8999999999999999999999999999875422211  1223


Q ss_pred             ccccccccChhccccCCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhccccccCCcccccCchhhcccCHHHHHH
Q 012765          306 IEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSNFKELVDPRLADAYDLAEMKR  385 (457)
Q Consensus       306 ~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~  385 (457)
                      ..||+.|+|||++.+..++.++|||||||++|||++|+.||...+...... .......        .+...+    ...
T Consensus       155 ~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~-~~~~~~~--------~~p~~~----~~~  221 (323)
T cd05595         155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFE-LILMEEI--------RFPRTL----SPE  221 (323)
T ss_pred             ccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHH-HHhcCCC--------CCCCCC----CHH
Confidence            458999999999999999999999999999999999999997643221110 0000011        111112    234


Q ss_pred             HHHHHHHhcccCCCCCC-----CHHHHHH
Q 012765          386 AMLTASVCIHHLSTMRP-----QMTRVLQ  409 (457)
Q Consensus       386 l~~l~~~Cl~~dP~~RP-----t~~evl~  409 (457)
                      +.+++.+||+.||.+||     ++.++++
T Consensus       222 ~~~li~~~L~~dP~~R~~~~~~~~~~~l~  250 (323)
T cd05595         222 AKSLLAGLLKKDPKQRLGGGPSDAKEVME  250 (323)
T ss_pred             HHHHHHHHccCCHHHhCCCCCCCHHHHHc
Confidence            56788899999999998     7888765

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=8.9e-40  Score=312.29  Aligned_cols=249  Identities=21%  Similarity=0.324  Sum_probs=195.9

Q ss_pred             eecccCcEEEEEEEeC---CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeecCceEEEEEecCCC
Q 012765          149 LIGKGGHAEVYKGCLP---DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTENGFHLVLQFLPHG  225 (457)
Q Consensus       149 ~LG~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~lv~e~~~~g  225 (457)
                      .||+|+||.||+|.+.   .+..||+|.+.....  ......+.+|+.++++++||||+++++++.....++||||++++
T Consensus         2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~--~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~lv~e~~~~~   79 (257)
T cd05115           2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENE--KSVRDEMMREAEIMHQLDNPYIVRMIGVCEAEALMLVMEMASGG   79 (257)
T ss_pred             ccCCCCcccEEEEEEecCCCceeEEEEEcccccC--hHHHHHHHHHHHHHHhcCCCCeEEEEEEEcCCCeEEEEEeCCCC
Confidence            3899999999999753   355799998754422  23446789999999999999999999998888889999999999


Q ss_pred             ChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCCCCCCcee-ee
Q 012765          226 SLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSHHI-VF  304 (457)
Q Consensus       226 sL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~~~~~~~-~~  304 (457)
                      +|.+++......+++..++.++.|++.||.|||+   .+++||||||+||+++.++.+||+|||++........... ..
T Consensus        80 ~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~  156 (257)
T cd05115          80 PLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEG---KNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARS  156 (257)
T ss_pred             CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHh---cCeeecccchheEEEcCCCcEEeccCCccccccCCccceeccC
Confidence            9999997666678999999999999999999999   8999999999999999999999999999986644322111 11


Q ss_pred             cccccccccChhccccCCCCcchhHHHHHHHHHHHHh-CCCCCCcCCcchhhhhccccccCCcccccCchhhcccCHHHH
Q 012765          305 PIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELIT-GRRAVDSRRQSLVIWAKPLLQTSNFKELVDPRLADAYDLAEM  383 (457)
Q Consensus       305 ~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLlt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~  383 (457)
                      ...++..|+|||++.+..++.++|||||||++|||++ |..||.........  .. ....         .....+....
T Consensus       157 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~--~~-~~~~---------~~~~~~~~~~  224 (257)
T cd05115         157 AGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVM--SF-IEQG---------KRLDCPAECP  224 (257)
T ss_pred             CCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHH--HH-HHCC---------CCCCCCCCCC
Confidence            1223578999999988889999999999999999996 99999754321111  00 0000         0001111223


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q 012765          384 KRAMLTASVCIHHLSTMRPQMTRVLQLLRGE  414 (457)
Q Consensus       384 ~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~  414 (457)
                      ..+.+++.+||+.+|++||++.+|++.|+..
T Consensus       225 ~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~  255 (257)
T cd05115         225 PEMYALMKDCWIYKWEDRPNFAKVEERMRTY  255 (257)
T ss_pred             HHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence            4566789999999999999999999999764

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.1e-40  Score=330.68  Aligned_cols=255  Identities=24%  Similarity=0.290  Sum_probs=199.6

Q ss_pred             cCCCCCceecccCcEEEEEEEeC-CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeee-cCceEEEE
Q 012765          142 DNFNSENLIGKGGHAEVYKGCLP-DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFST-ENGFHLVL  219 (457)
Q Consensus       142 ~~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~-~~~~~lv~  219 (457)
                      ++|.+.+.||+|+||+||+|... +++.||+|++.............+.+|+.++..++||||+++++++. ++..++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (350)
T cd05573           1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM   80 (350)
T ss_pred             CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence            46889999999999999999865 68999999987544333344567889999999999999999998655 45578999


Q ss_pred             EecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCCCCC-
Q 012765          220 QFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNW-  298 (457)
Q Consensus       220 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~~~-  298 (457)
                      ||+++++|.+++... ..+++..+..++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||++..+.... 
T Consensus        81 e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~---~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~  156 (350)
T cd05573          81 EYMPGGDLMNLLIRK-DVFPEETARFYIAELVLALDSVHK---LGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKD  156 (350)
T ss_pred             cCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEeecCCCCccCcccCc
Confidence            999999999998654 568889999999999999999999   899999999999999999999999999998765432 


Q ss_pred             --------------------------CceeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHhCCCCCCcCCcc
Q 012765          299 --------------------------SHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQS  352 (457)
Q Consensus       299 --------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~  352 (457)
                                                .........||+.|+|||++.+..++.++|||||||++|||++|+.||......
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~  236 (350)
T cd05573         157 REYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQ  236 (350)
T ss_pred             ccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCHH
Confidence                                      001122345899999999999999999999999999999999999999864422


Q ss_pred             hhhhhccccccCCcccccCchhhcccCHHHHHHHHHHHHHhcccCCCCCCC-HHHHHHH
Q 012765          353 LVIWAKPLLQTSNFKELVDPRLADAYDLAEMKRAMLTASVCIHHLSTMRPQ-MTRVLQL  410 (457)
Q Consensus       353 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt-~~evl~~  410 (457)
                      ... .........   +.-+   .  .......+..++..||. +|.+||+ +.++++.
T Consensus       237 ~~~-~~i~~~~~~---~~~p---~--~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h  285 (350)
T cd05573         237 ETY-NKIINWKES---LRFP---P--DPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH  285 (350)
T ss_pred             HHH-HHHhccCCc---ccCC---C--CCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence            111 100000000   0000   0  00023456677888997 9999999 9999873

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=1.8e-40  Score=308.85  Aligned_cols=263  Identities=23%  Similarity=0.325  Sum_probs=200.5

Q ss_pred             hhcCCCCCceecccCcEEEEEEEeC-CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeec---Cce
Q 012765          140 ATDNFNSENLIGKGGHAEVYKGCLP-DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTE---NGF  215 (457)
Q Consensus       140 ~~~~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~---~~~  215 (457)
                      ..++|+.++.|++|+||.||+|.++ +++.||+|+++.......- --.-++|+.+|.+++|||||.+-.+...   ++.
T Consensus        74 sv~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GF-PItsLREIniLl~~~H~NIV~vkEVVvG~~~d~i  152 (419)
T KOG0663|consen   74 SVEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGF-PITSLREINILLKARHPNIVEVKEVVVGSNMDKI  152 (419)
T ss_pred             cHHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCC-cchhHHHHHHHHhcCCCCeeeeEEEEecccccee
Confidence            3467888899999999999999865 6889999998765432211 1245789999999999999999887655   347


Q ss_pred             EEEEEecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCC
Q 012765          216 HLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLP  295 (457)
Q Consensus       216 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~  295 (457)
                      |+||||++. +|.+++..-...+.......+..|++.||.|||.   ..|+|||||++|+|++..|.+||+|||+|+.+.
T Consensus       153 y~VMe~~Eh-DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~---~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~yg  228 (419)
T KOG0663|consen  153 YIVMEYVEH-DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHD---NWILHRDLKTSNLLLSHKGILKIADFGLAREYG  228 (419)
T ss_pred             eeeHHHHHh-hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhh---ceeEecccchhheeeccCCcEEecccchhhhhc
Confidence            899999965 7888887766778888888999999999999999   899999999999999999999999999999987


Q ss_pred             CCCCceeeecccccccccChhccccC-CCCcchhHHHHHHHHHHHHhCCCCCCcCCcchh--------------hhhc--
Q 012765          296 DNWSHHIVFPIEGTFGYLSPEYFMHG-IVDEKTDVFAFGVLLLELITGRRAVDSRRQSLV--------------IWAK--  358 (457)
Q Consensus       296 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~--------------~~~~--  358 (457)
                      +....  .+...-|.+|+|||.+.+. .|++..|+||+|||+.||+++++.|.+..+...              +|..  
T Consensus       229 sp~k~--~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~  306 (419)
T KOG0663|consen  229 SPLKP--YTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYS  306 (419)
T ss_pred             CCccc--CcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCcc
Confidence            76322  2344579999999999875 599999999999999999999999987432211              1211  


Q ss_pred             --cccccCCcccccCchhhcccCHH-HHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 012765          359 --PLLQTSNFKELVDPRLADAYDLA-EMKRAMLTASVCIHHLSTMRPQMTRVLQ  409 (457)
Q Consensus       359 --~~~~~~~~~~~~d~~l~~~~~~~-~~~~l~~l~~~Cl~~dP~~RPt~~evl~  409 (457)
                        +......+.+..-..+...+... ....-.+++...|..||.+|-|+.|.++
T Consensus       307 ~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~  360 (419)
T KOG0663|consen  307 ELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLK  360 (419)
T ss_pred             ccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhc
Confidence              00001111111112222222211 2244567788899999999999999876

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=3.7e-40  Score=341.94  Aligned_cols=259  Identities=24%  Similarity=0.283  Sum_probs=205.4

Q ss_pred             hhcCCCCCceecccCcEEEEEEEeCCC-cEEEEEEEeccchhhHHHHHHHHHHHHHHhhcC-CCCcceeee-eee---c-
Q 012765          140 ATDNFNSENLIGKGGHAEVYKGCLPDG-EVVAVKKIIKNAKEDEERISDFLSELGIVAHIN-HPNAAKLIG-FST---E-  212 (457)
Q Consensus       140 ~~~~f~~~~~LG~G~~g~Vy~~~~~~~-~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~-~~~---~-  212 (457)
                      ...++++.+.|.+|||+.||.|.+..+ ..||+|++...   ++.....+.+|+.+|++|. |+|||.+++ ...   . 
T Consensus        35 g~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~---de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~  111 (738)
T KOG1989|consen   35 GSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN---DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSN  111 (738)
T ss_pred             CCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC---CHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCC
Confidence            345566889999999999999998765 99999998755   4456788999999999996 999999999 321   1 


Q ss_pred             C---ceEEEEEecCCCChhhhhhc-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeec
Q 012765          213 N---GFHLVLQFLPHGSLSSLLFG-STECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDF  288 (457)
Q Consensus       213 ~---~~~lv~e~~~~gsL~~~l~~-~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DF  288 (457)
                      +   ++.|+||||.+|.|.+++.. ....+++..+++|+.++++|+.+||. +..+|||||||-+||||+.+|..|||||
T Consensus       112 ~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~-~~pPiIHRDLKiENvLls~~g~~KLCDF  190 (738)
T KOG1989|consen  112 NGVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHY-LKPPIIHRDLKIENVLLSADGNYKLCDF  190 (738)
T ss_pred             CceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhc-CCCccchhhhhhhheEEcCCCCEEeCcc
Confidence            2   24688999999999999964 22349999999999999999999998 4577999999999999999999999999


Q ss_pred             cccccCCCCC-Cceee------ecccccccccChhcc---ccCCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhc
Q 012765          289 GLAKWLPDNW-SHHIV------FPIEGTFGYLSPEYF---MHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAK  358 (457)
Q Consensus       289 Gl~~~~~~~~-~~~~~------~~~~gt~~y~aPE~~---~~~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~  358 (457)
                      |.++-.-... .....      -...-|+.|+|||.+   .+...++|+|||||||+||-|+....||+......     
T Consensus       191 GSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~la-----  265 (738)
T KOG1989|consen  191 GSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKLA-----  265 (738)
T ss_pred             cccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCccee-----
Confidence            9986542222 11110      012368999999986   46778999999999999999999999999643321     


Q ss_pred             cccccCCcccccCchhhcccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCCCC
Q 012765          359 PLLQTSNFKELVDPRLADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQLLRGEGGQ  417 (457)
Q Consensus       359 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~  417 (457)
                                |++....-.....+...+..||..||+.||.+||++-||++.+-.+...
T Consensus       266 ----------Ilng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~  314 (738)
T KOG1989|consen  266 ----------ILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANK  314 (738)
T ss_pred             ----------EEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcC
Confidence                      2222222222246777888899999999999999999999988766543

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=8.4e-41  Score=329.10  Aligned_cols=251  Identities=24%  Similarity=0.351  Sum_probs=206.9

Q ss_pred             cCCCCCceecccCcEEEEEEEeC-CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeee-eeecCc-eEEE
Q 012765          142 DNFNSENLIGKGGHAEVYKGCLP-DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIG-FSTENG-FHLV  218 (457)
Q Consensus       142 ~~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~-~~~~~~-~~lv  218 (457)
                      ++|..++.+|+|+||.++..+.+ ++..|++|++.-....... .....+|+.+++++.|||||.+.+ |..++. ++++
T Consensus         4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~-r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Iv   82 (426)
T KOG0589|consen    4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPE-RRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIV   82 (426)
T ss_pred             chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchh-hHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEE
Confidence            57888899999999999998754 5789999988655444333 347889999999999999999999 445555 6899


Q ss_pred             EEecCCCChhhhhhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCCCC
Q 012765          219 LQFLPHGSLSSLLFGST-ECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDN  297 (457)
Q Consensus       219 ~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~~  297 (457)
                      |+|++||++.+.+.... ..++++.+..++.|++.|+.|||+   ..|+|||||+.||+++.++.|||+|||+++.+...
T Consensus        83 m~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~---~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~  159 (426)
T KOG0589|consen   83 MEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHE---NRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPE  159 (426)
T ss_pred             EeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHh---hhhhcccchhhhhhccccCceeecchhhhhhcCCc
Confidence            99999999999996654 678999999999999999999998   89999999999999999999999999999998776


Q ss_pred             CCceeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhccccccCCcccccCchhhcc
Q 012765          298 WSHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSNFKELVDPRLADA  377 (457)
Q Consensus       298 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~  377 (457)
                      ..  ......||+.||.||.+.+.+|+.|+|||||||++|||++-+++|...+....+..           +... +...
T Consensus       160 ~~--~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~k-----------i~~~-~~~P  225 (426)
T KOG0589|consen  160 DS--LASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILK-----------INRG-LYSP  225 (426)
T ss_pred             hh--hhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHHHHH-----------Hhhc-cCCC
Confidence            42  23346699999999999999999999999999999999999999997554322211           1111 1112


Q ss_pred             cCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 012765          378 YDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQL  410 (457)
Q Consensus       378 ~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~  410 (457)
                      ........+..++..||..+|..||++.+++.+
T Consensus       226 lp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~  258 (426)
T KOG0589|consen  226 LPSMYSSELRSLVKSMLRKNPEHRPSALELLRR  258 (426)
T ss_pred             CCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence            233445567778889999999999999999874

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=1e-39  Score=311.49  Aligned_cols=248  Identities=23%  Similarity=0.330  Sum_probs=196.5

Q ss_pred             eecccCcEEEEEEEe---CCCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeecCceEEEEEecCCC
Q 012765          149 LIGKGGHAEVYKGCL---PDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTENGFHLVLQFLPHG  225 (457)
Q Consensus       149 ~LG~G~~g~Vy~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~lv~e~~~~g  225 (457)
                      .||+|+||.||+|.+   .++..+|+|++.... ........+.+|+.+++.++||||+++++++.....+++|||++++
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~lv~e~~~~~   80 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDN-NDPALKDELLREANVMQQLDNPYIVRMIGICEAESWMLVMELAELG   80 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCCC-CcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCcEEEEecCCCC
Confidence            589999999999964   357889999875433 2334567889999999999999999999998888889999999999


Q ss_pred             ChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCCCCCCcee-ee
Q 012765          226 SLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSHHI-VF  304 (457)
Q Consensus       226 sL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~~~~~~~-~~  304 (457)
                      +|.+++... ..+++..++.++.|++.||.|||+   .+++||||||.||+++.++.+||+|||++..+........ ..
T Consensus        81 ~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~lH~---~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  156 (257)
T cd05116          81 PLNKFLQKN-KHVTEKNITELVHQVSMGMKYLEE---TNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKT  156 (257)
T ss_pred             cHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecC
Confidence            999998543 458899999999999999999999   8999999999999999999999999999987654432211 11


Q ss_pred             cccccccccChhccccCCCCcchhHHHHHHHHHHHHh-CCCCCCcCCcchhhhhccccccCCcccccCchhhcccCHHHH
Q 012765          305 PIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELIT-GRRAVDSRRQSLVIWAKPLLQTSNFKELVDPRLADAYDLAEM  383 (457)
Q Consensus       305 ~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLlt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~  383 (457)
                      ...++..|+|||.+....++.++|||||||++|||++ |..||............   .....     +.....    ..
T Consensus       157 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i---~~~~~-----~~~~~~----~~  224 (257)
T cd05116         157 HGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMI---ESGER-----MECPQR----CP  224 (257)
T ss_pred             CCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH---HCCCC-----CCCCCC----CC
Confidence            2234578999999988889999999999999999998 99999864332211111   11100     111111    22


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 012765          384 KRAMLTASVCIHHLSTMRPQMTRVLQLLRG  413 (457)
Q Consensus       384 ~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~  413 (457)
                      ..+.+++.+||+.||++||++.+|.+.|++
T Consensus       225 ~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~  254 (257)
T cd05116         225 PEMYDLMKLCWTYGVDERPGFAVVELRLRN  254 (257)
T ss_pred             HHHHHHHHHHhccCchhCcCHHHHHHHHhc
Confidence            456688999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=6.5e-40  Score=324.73  Aligned_cols=243  Identities=22%  Similarity=0.295  Sum_probs=192.3

Q ss_pred             ceecccCcEEEEEEEeC-CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeee-cCceEEEEEecCCC
Q 012765          148 NLIGKGGHAEVYKGCLP-DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFST-ENGFHLVLQFLPHG  225 (457)
Q Consensus       148 ~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~-~~~~~lv~e~~~~g  225 (457)
                      ++||+|+||.||++... +++.||+|++.+...........+.+|+.+++.++||||+++++++. ++..++||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g   80 (328)
T cd05593           1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG   80 (328)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence            46999999999999864 68999999987654444445678889999999999999999998655 45578999999999


Q ss_pred             ChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCCCCCCceeeec
Q 012765          226 SLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFP  305 (457)
Q Consensus       226 sL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~~~~~~~~~~  305 (457)
                      +|..++... ..+++..+..++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||++........  ....
T Consensus        81 ~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~--~~~~  154 (328)
T cd05593          81 ELFFHLSRE-RVFSEDRTRFYGAEIVSALDYLHS---GKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAA--TMKT  154 (328)
T ss_pred             CHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHh---CCeEecccCHHHeEECCCCcEEEecCcCCccCCCccc--cccc
Confidence            998888543 458899999999999999999999   8999999999999999999999999999875432211  1223


Q ss_pred             ccccccccChhccccCCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhccccccCCcccccCchhhcccCHHHHHH
Q 012765          306 IEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSNFKELVDPRLADAYDLAEMKR  385 (457)
Q Consensus       306 ~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~  385 (457)
                      ..||+.|+|||++.+..++.++|||||||++|+|++|+.||...+..... ......        +..+...+    ...
T Consensus       155 ~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~-~~~~~~--------~~~~p~~~----~~~  221 (328)
T cd05593         155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLF-ELILME--------DIKFPRTL----SAD  221 (328)
T ss_pred             ccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHH-HHhccC--------CccCCCCC----CHH
Confidence            56999999999999999999999999999999999999999754322111 000000        01111122    234


Q ss_pred             HHHHHHHhcccCCCCCC-----CHHHHHH
Q 012765          386 AMLTASVCIHHLSTMRP-----QMTRVLQ  409 (457)
Q Consensus       386 l~~l~~~Cl~~dP~~RP-----t~~evl~  409 (457)
                      +..++.+||+.||.+||     ++.++++
T Consensus       222 ~~~li~~~L~~dP~~R~~~~~~~~~~il~  250 (328)
T cd05593         222 AKSLLSGLLIKDPNKRLGGGPDDAKEIMR  250 (328)
T ss_pred             HHHHHHHHcCCCHHHcCCCCCCCHHHHhc
Confidence            56788899999999997     8888876

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=9.5e-40  Score=339.99  Aligned_cols=255  Identities=23%  Similarity=0.306  Sum_probs=200.9

Q ss_pred             HhhcCCCCCceecccCcEEEEEEEe-CCCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeecC----
Q 012765          139 AATDNFNSENLIGKGGHAEVYKGCL-PDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTEN----  213 (457)
Q Consensus       139 ~~~~~f~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~----  213 (457)
                      ...++|.+.+.||+|+||+||+|.. .+|+.||+|.+..... .......+.+|+.++..++|+|+++++..+...    
T Consensus        29 ~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~  107 (496)
T PTZ00283         29 EQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGM-SEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRN  107 (496)
T ss_pred             ccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccC-CHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccC
Confidence            4557899999999999999999975 4689999998865433 234456788999999999999999998744321    


Q ss_pred             -----ceEEEEEecCCCChhhhhhc---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEE
Q 012765          214 -----GFHLVLQFLPHGSLSSLLFG---STECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQI  285 (457)
Q Consensus       214 -----~~~lv~e~~~~gsL~~~l~~---~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL  285 (457)
                           .+++||||+++|+|.+++..   ....+++..+..++.|++.||.|||+   .+|+||||||+|||++.++.+||
T Consensus       108 ~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~---~~IiHrDLKP~NILl~~~~~vkL  184 (496)
T PTZ00283        108 PENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHS---KHMIHRDIKSANILLCSNGLVKL  184 (496)
T ss_pred             cccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEeCCCCEEE
Confidence                 14689999999999998854   23468888999999999999999999   89999999999999999999999


Q ss_pred             eeccccccCCCCCCceeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhccccccCC
Q 012765          286 SDFGLAKWLPDNWSHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSN  365 (457)
Q Consensus       286 ~DFGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~~~~~~~~  365 (457)
                      +|||+++.+.............||+.|+|||++.+..++.++|||||||++|||++|+.||...........  ... ..
T Consensus       185 ~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~--~~~-~~  261 (496)
T PTZ00283        185 GDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHK--TLA-GR  261 (496)
T ss_pred             EecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHH--Hhc-CC
Confidence            999999876543333333345699999999999999999999999999999999999999986432211110  000 00


Q ss_pred             cccccCchhhcccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 012765          366 FKELVDPRLADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQ  409 (457)
Q Consensus       366 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~  409 (457)
                          .++ +..    .....+..++..||+.+|.+||++.++++
T Consensus       262 ----~~~-~~~----~~~~~l~~li~~~L~~dP~~RPs~~ell~  296 (496)
T PTZ00283        262 ----YDP-LPP----SISPEMQEIVTALLSSDPKRRPSSSKLLN  296 (496)
T ss_pred             ----CCC-CCC----CCCHHHHHHHHHHcccChhhCcCHHHHHh
Confidence                000 111    12345678889999999999999999876

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=4e-40  Score=314.63  Aligned_cols=255  Identities=24%  Similarity=0.351  Sum_probs=203.1

Q ss_pred             hhcCCCCCceecccCcEEEEEEEeCCCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeecC-ceEEE
Q 012765          140 ATDNFNSENLIGKGGHAEVYKGCLPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTEN-GFHLV  218 (457)
Q Consensus       140 ~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~-~~~lv  218 (457)
                      ...+|++.+.||.|+||.||+|...++..+|+|.+.....   .....+.+|+.+++.++||||+++++++... ..+++
T Consensus         4 ~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   80 (261)
T cd05148           4 PREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDL---LKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYII   80 (261)
T ss_pred             cHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccch---hhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEE
Confidence            4567889999999999999999988899999998765432   2345788999999999999999999976554 46799


Q ss_pred             EEecCCCChhhhhhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCCCC
Q 012765          219 LQFLPHGSLSSLLFGS-TECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDN  297 (457)
Q Consensus       219 ~e~~~~gsL~~~l~~~-~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~~  297 (457)
                      |||+++++|.+++... ...+++..++.++.||+.||.|||+   .+++|+||+|+||+++.++.+||+|||++......
T Consensus        81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~---~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~  157 (261)
T cd05148          81 TELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEE---QNSIHRDLAARNILVGEDLVCKVADFGLARLIKED  157 (261)
T ss_pred             EeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccCcceEEEcCCceEEEccccchhhcCCc
Confidence            9999999999999653 3468999999999999999999999   89999999999999999999999999999876543


Q ss_pred             CCceeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHh-CCCCCCcCCcchhhhhccccccCCcccccCchhhc
Q 012765          298 WSHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELIT-GRRAVDSRRQSLVIWAKPLLQTSNFKELVDPRLAD  376 (457)
Q Consensus       298 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLlt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  376 (457)
                      ...  .....++..|+|||++.+..++.++||||||+++|+|++ |+.||............  .          .....
T Consensus       158 ~~~--~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~--~----------~~~~~  223 (261)
T cd05148         158 VYL--SSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQI--T----------AGYRM  223 (261)
T ss_pred             ccc--ccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHH--H----------hCCcC
Confidence            211  112335678999999988899999999999999999998 89999754322111000  0          00000


Q ss_pred             ccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q 012765          377 AYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQLLRGE  414 (457)
Q Consensus       377 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~  414 (457)
                      .........+.+++.+||+.+|.+|||+.++++.|+.+
T Consensus       224 ~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~~  261 (261)
T cd05148         224 PCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDNI  261 (261)
T ss_pred             CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence            11112234577889999999999999999999999753

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=1e-39  Score=312.70  Aligned_cols=254  Identities=24%  Similarity=0.351  Sum_probs=202.6

Q ss_pred             hcCCCCCceecccCcEEEEEEEeCCCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeecCceEEEEE
Q 012765          141 TDNFNSENLIGKGGHAEVYKGCLPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTENGFHLVLQ  220 (457)
Q Consensus       141 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~lv~e  220 (457)
                      .++|++.+.||+|+||.||+|.+.++..||+|++......    ...+.+|+.++..++||||+++++++.+...+++||
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~~----~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~lv~e   80 (262)
T cd05071           5 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS----PEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVTE   80 (262)
T ss_pred             hHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCccC----HHHHHHHHHHHHhCCCCCcceEEEEECCCCcEEEEE
Confidence            4568899999999999999998877778999988643221    246889999999999999999999887788899999


Q ss_pred             ecCCCChhhhhhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCCCCCC
Q 012765          221 FLPHGSLSSLLFGS-TECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWS  299 (457)
Q Consensus       221 ~~~~gsL~~~l~~~-~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~~~~  299 (457)
                      |+++|+|.+++... ...+++..+..++.|++.||.|||+   .+++|+||||+||+++.++.++|+|||++..+.....
T Consensus        81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~---~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~  157 (262)
T cd05071          81 YMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY  157 (262)
T ss_pred             cCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHH---CCccccccCcccEEEcCCCcEEeccCCceeecccccc
Confidence            99999999999653 3457899999999999999999999   8999999999999999999999999999987654322


Q ss_pred             ceeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHh-CCCCCCcCCcchhhhhccccccCCcccccCchhhccc
Q 012765          300 HHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELIT-GRRAVDSRRQSLVIWAKPLLQTSNFKELVDPRLADAY  378 (457)
Q Consensus       300 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLlt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~  378 (457)
                      . ......++..|+|||++.+..++.++|||||||++|||+| |..||............  ....          ....
T Consensus       158 ~-~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~--~~~~----------~~~~  224 (262)
T cd05071         158 T-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQV--ERGY----------RMPC  224 (262)
T ss_pred             c-cccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHH--hcCC----------CCCC
Confidence            1 1112336678999999988899999999999999999999 88888754322111000  0000          0011


Q ss_pred             CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q 012765          379 DLAEMKRAMLTASVCIHHLSTMRPQMTRVLQLLRGE  414 (457)
Q Consensus       379 ~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~  414 (457)
                      .......+.+++.+|++.+|++||++.++++.|+..
T Consensus       225 ~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~  260 (262)
T cd05071         225 PPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY  260 (262)
T ss_pred             ccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence            122345677899999999999999999999999753

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=9.6e-40  Score=316.19  Aligned_cols=265  Identities=26%  Similarity=0.405  Sum_probs=199.7

Q ss_pred             CCCCceecccCcEEEEEEEe-----CCCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeecC---ce
Q 012765          144 FNSENLIGKGGHAEVYKGCL-----PDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTEN---GF  215 (457)
Q Consensus       144 f~~~~~LG~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~---~~  215 (457)
                      |...+.||+|+||+||++..     .++..||+|.+.....  ......+.+|+.+++.++||||+++++++...   ..
T Consensus         6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   83 (283)
T cd05080           6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECG--QQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGL   83 (283)
T ss_pred             ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccC--hHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceE
Confidence            37889999999999988652     3578899998864422  23345788999999999999999999976542   36


Q ss_pred             EEEEEecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCC
Q 012765          216 HLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLP  295 (457)
Q Consensus       216 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~  295 (457)
                      +++|||+.+++|.+++..  ..+++..++.++.|++.||.|||+   .+++||||||+||+++.++.++|+|||++..+.
T Consensus        84 ~lv~e~~~~~~l~~~~~~--~~l~~~~~~~i~~~l~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~  158 (283)
T cd05080          84 QLIMEYVPLGSLRDYLPK--HKLNLAQLLLFAQQICEGMAYLHS---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVP  158 (283)
T ss_pred             EEEecCCCCCCHHHHHHH--cCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccChheEEEcCCCcEEEeecccccccC
Confidence            899999999999999854  358999999999999999999999   899999999999999999999999999998765


Q ss_pred             CCCCcee-eecccccccccChhccccCCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhcc---ccccCCcccccC
Q 012765          296 DNWSHHI-VFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKP---LLQTSNFKELVD  371 (457)
Q Consensus       296 ~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~~---~~~~~~~~~~~d  371 (457)
                      ....... .....++..|+|||.+.+..++.++||||||+++|||+||..||.............   ........+.++
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (283)
T cd05080         159 EGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLE  238 (283)
T ss_pred             CcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhhhh
Confidence            4322111 112235667999999988889999999999999999999999987533221111100   000111111111


Q ss_pred             chhhcccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCC
Q 012765          372 PRLADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQLLRGEG  415 (457)
Q Consensus       372 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~  415 (457)
                      ..............+.+++.+||+.+|++|||+.+|++.|+.+.
T Consensus       239 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~  282 (283)
T cd05080         239 RGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH  282 (283)
T ss_pred             cCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence            11111111223456788999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=7.4e-40  Score=316.34  Aligned_cols=259  Identities=23%  Similarity=0.320  Sum_probs=203.7

Q ss_pred             hhcCCCCCceecccCcEEEEEEEeCC-----CcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeec--
Q 012765          140 ATDNFNSENLIGKGGHAEVYKGCLPD-----GEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTE--  212 (457)
Q Consensus       140 ~~~~f~~~~~LG~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~--  212 (457)
                      ..++|.+.++||+|+||.||+|.+.+     +..|++|++....  .......+.+|+.++++++||||+++++++..  
T Consensus         4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~--~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~   81 (280)
T cd05043           4 SRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHA--SEIQVTLLLQESCLLYGLSHQNILPILHVCIEDG   81 (280)
T ss_pred             chhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCC
Confidence            35778889999999999999998755     6888999875433  23446788999999999999999999997665  


Q ss_pred             CceEEEEEecCCCChhhhhhcCC-------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEE
Q 012765          213 NGFHLVLQFLPHGSLSSLLFGST-------ECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQI  285 (457)
Q Consensus       213 ~~~~lv~e~~~~gsL~~~l~~~~-------~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL  285 (457)
                      ...+++++|+++++|..++....       ..+++..++.++.|++.||.|||+   .+++|+||||+||+++.++.+||
T Consensus        82 ~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~---~~i~H~di~p~nil~~~~~~~kl  158 (280)
T cd05043          82 EPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHK---RGVIHKDIAARNCVIDEELQVKI  158 (280)
T ss_pred             CCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccCHhhEEEcCCCcEEE
Confidence            44678999999999999985422       458899999999999999999999   89999999999999999999999


Q ss_pred             eeccccccCCCCCCceeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHh-CCCCCCcCCcchhhhhccccccC
Q 012765          286 SDFGLAKWLPDNWSHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELIT-GRRAVDSRRQSLVIWAKPLLQTS  364 (457)
Q Consensus       286 ~DFGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLlt-G~~pf~~~~~~~~~~~~~~~~~~  364 (457)
                      +|||+++.+.............++..|+|||++.+..++.++|||||||++||+++ |+.||.......  +........
T Consensus       159 ~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~--~~~~~~~~~  236 (280)
T cd05043         159 TDNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFE--MAAYLKDGY  236 (280)
T ss_pred             CCCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHH--HHHHHHcCC
Confidence            99999986644322222222346778999999988889999999999999999999 999997643221  111101110


Q ss_pred             CcccccCchhhcccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCC
Q 012765          365 NFKELVDPRLADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQLLRGEG  415 (457)
Q Consensus       365 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~  415 (457)
                      ...      .    .......+.+++.+||..+|++|||+.+|++.|+.+.
T Consensus       237 ~~~------~----~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~  277 (280)
T cd05043         237 RLA------Q----PINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFH  277 (280)
T ss_pred             CCC------C----CCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence            000      0    0111235678999999999999999999999998765

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-40  Score=321.33  Aligned_cols=260  Identities=25%  Similarity=0.306  Sum_probs=203.2

Q ss_pred             HHHHhhcCCCCCceecccCcEEEEEEEeC-CCcEEEEEEEeccchhhH-----------HHHHHHHHHHHHHhhcCCCCc
Q 012765          136 ELAAATDNFNSENLIGKGGHAEVYKGCLP-DGEVVAVKKIIKNAKEDE-----------ERISDFLSELGIVAHINHPNA  203 (457)
Q Consensus       136 ~~~~~~~~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~-----------~~~~~~~~E~~~l~~l~hpni  203 (457)
                      +.....+.|++...||+|.||.|-+|... +++.||||++.+......           ..++.+.+|+.+|++|+||||
T Consensus        91 ~~~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nV  170 (576)
T KOG0585|consen   91 QDRKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNV  170 (576)
T ss_pred             ccceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCe
Confidence            34456789999999999999999999854 699999999865433211           124688999999999999999


Q ss_pred             ceeeeeeec---CceEEEEEecCCCChhhhhhcCCCC-CCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcC
Q 012765          204 AKLIGFSTE---NGFHLVLQFLPHGSLSSLLFGSTEC-LEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSE  279 (457)
Q Consensus       204 v~l~~~~~~---~~~~lv~e~~~~gsL~~~l~~~~~~-~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~  279 (457)
                      |+|+.+..+   +.+|+|+|||..|.+...=  .... +...+.++++.+++.||.|||.   ++||||||||+|+||++
T Consensus       171 V~LiEvLDDP~s~~~YlVley~s~G~v~w~p--~d~~els~~~Ar~ylrDvv~GLEYLH~---QgiiHRDIKPsNLLl~~  245 (576)
T KOG0585|consen  171 VKLIEVLDDPESDKLYLVLEYCSKGEVKWCP--PDKPELSEQQARKYLRDVVLGLEYLHY---QGIIHRDIKPSNLLLSS  245 (576)
T ss_pred             eEEEEeecCcccCceEEEEEeccCCccccCC--CCcccccHHHHHHHHHHHHHHHHHHHh---cCeeccccchhheEEcC
Confidence            999998765   4589999999998765432  2333 8889999999999999999999   89999999999999999


Q ss_pred             CCcEEEeeccccccCCCCC---CceeeecccccccccChhccccCC----CCcchhHHHHHHHHHHHHhCCCCCCcCCcc
Q 012765          280 DYEAQISDFGLAKWLPDNW---SHHIVFPIEGTFGYLSPEYFMHGI----VDEKTDVFAFGVLLLELITGRRAVDSRRQS  352 (457)
Q Consensus       280 ~~~~kL~DFGl~~~~~~~~---~~~~~~~~~gt~~y~aPE~~~~~~----~~~ksDvwSlGvll~eLltG~~pf~~~~~~  352 (457)
                      +|.+||+|||.+.......   .........||+.|+|||...++.    -+.+.||||+||+||-|+.|+.||-+....
T Consensus       246 ~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~  325 (576)
T KOG0585|consen  246 DGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFEL  325 (576)
T ss_pred             CCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHH
Confidence            9999999999998773321   112233467999999999987632    356889999999999999999999753221


Q ss_pred             hhhhhccccccCCcccccCchhhcccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 012765          353 LVIWAKPLLQTSNFKELVDPRLADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQLL  411 (457)
Q Consensus       353 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L  411 (457)
                                 .-+.+|+...|.-....+....+..++.++|.+||++|.+..+|....
T Consensus       326 -----------~l~~KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hp  373 (576)
T KOG0585|consen  326 -----------ELFDKIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHP  373 (576)
T ss_pred             -----------HHHHHHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecc
Confidence                       112333444443332334556677889999999999999999987643

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=7.5e-40  Score=312.53  Aligned_cols=251  Identities=22%  Similarity=0.345  Sum_probs=198.3

Q ss_pred             cCCCCCceecccCcEEEEEEEeCCCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeecCc-eEEEEE
Q 012765          142 DNFNSENLIGKGGHAEVYKGCLPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTENG-FHLVLQ  220 (457)
Q Consensus       142 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~-~~lv~e  220 (457)
                      ++|.+.+.||+|+||.||+|.+.++..+|+|.+......    ...+.+|+.++.+++||||+++++++.... .+++||
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   79 (256)
T cd05113           4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS----EDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTE   79 (256)
T ss_pred             HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCccc----HHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEE
Confidence            457788999999999999998877777999987643321    346889999999999999999999776554 689999


Q ss_pred             ecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCCCCCCc
Q 012765          221 FLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSH  300 (457)
Q Consensus       221 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~~~~~  300 (457)
                      |+.+++|.+++......+++..++.++.||+.||.|||+   .+++|+||||+||+++.++.+||+|||++.........
T Consensus        80 ~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~  156 (256)
T cd05113          80 YMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLES---KQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYT  156 (256)
T ss_pred             cCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccccCcceEEEcCCCCEEECCCccceecCCCcee
Confidence            999999999987655578999999999999999999999   89999999999999999999999999998866443211


Q ss_pred             eeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHh-CCCCCCcCCcchhhhhccccccCCcccccCchhhcccC
Q 012765          301 HIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELIT-GRRAVDSRRQSLVIWAKPLLQTSNFKELVDPRLADAYD  379 (457)
Q Consensus       301 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLlt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~  379 (457)
                       ......++..|+|||++.+..++.++|||||||++|+|++ |..||............  .....      +....   
T Consensus       157 -~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~--~~~~~------~~~~~---  224 (256)
T cd05113         157 -SSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKV--SQGLR------LYRPH---  224 (256)
T ss_pred             -ecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHH--hcCCC------CCCCC---
Confidence             1112235678999999988889999999999999999999 99998754322111100  00000      00001   


Q ss_pred             HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 012765          380 LAEMKRAMLTASVCIHHLSTMRPQMTRVLQLLR  412 (457)
Q Consensus       380 ~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~  412 (457)
                       .....+.+++.+||+.+|.+||++.+|++.|+
T Consensus       225 -~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~  256 (256)
T cd05113         225 -LASEKVYAIMYSCWHEKAEERPTFQQLLSSIE  256 (256)
T ss_pred             -CCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence             12356778899999999999999999998774

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=1.4e-39  Score=312.67  Aligned_cols=255  Identities=26%  Similarity=0.365  Sum_probs=194.6

Q ss_pred             CCCCceecccCcEEEEEEEeCC-Cc--EEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeec-------C
Q 012765          144 FNSENLIGKGGHAEVYKGCLPD-GE--VVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTE-------N  213 (457)
Q Consensus       144 f~~~~~LG~G~~g~Vy~~~~~~-~~--~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-------~  213 (457)
                      |.+.+.||+|+||.||+|.+.. +.  .+|+|.+..... .......+.+|+.+++.++||||+++++++..       .
T Consensus         1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   79 (272)
T cd05075           1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAIC-TRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYP   79 (272)
T ss_pred             CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcC-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCC
Confidence            3467899999999999998754 33  589987754322 23446788999999999999999999996532       1


Q ss_pred             ceEEEEEecCCCChhhhhhc-----CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeec
Q 012765          214 GFHLVLQFLPHGSLSSLLFG-----STECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDF  288 (457)
Q Consensus       214 ~~~lv~e~~~~gsL~~~l~~-----~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DF  288 (457)
                      ..+++|||+.+|+|..++..     ....+++.....++.|++.||.|||+   .+|+||||||+|||++.++.+||+||
T Consensus        80 ~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Df  156 (272)
T cd05075          80 SPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSS---KSFIHRDLAARNCMLNENMNVCVADF  156 (272)
T ss_pred             CcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHH---CCeeccccchhheEEcCCCCEEECCC
Confidence            35799999999999888732     22357899999999999999999999   89999999999999999999999999


Q ss_pred             cccccCCCCCCceeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHh-CCCCCCcCCcchhhhhccccccCCcc
Q 012765          289 GLAKWLPDNWSHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELIT-GRRAVDSRRQSLVIWAKPLLQTSNFK  367 (457)
Q Consensus       289 Gl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLlt-G~~pf~~~~~~~~~~~~~~~~~~~~~  367 (457)
                      |++..+.............++..|+|||++.+..++.++|||||||++|||++ |..||....... .+. . .......
T Consensus       157 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~-~~~-~-~~~~~~~  233 (272)
T cd05075         157 GLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSE-IYD-Y-LRQGNRL  233 (272)
T ss_pred             CcccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHH-HHH-H-HHcCCCC
Confidence            99987654322111112235678999999998899999999999999999999 788987533211 111 0 1111100


Q ss_pred             cccCchhhcccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q 012765          368 ELVDPRLADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQLLRGE  414 (457)
Q Consensus       368 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~  414 (457)
                      .     .    .......+.+++.+||+.+|++|||+.+|++.|+.+
T Consensus       234 ~-----~----~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~  271 (272)
T cd05075         234 K-----Q----PPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA  271 (272)
T ss_pred             C-----C----CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence            0     0    111234567899999999999999999999999764

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=1.9e-39  Score=314.13  Aligned_cols=267  Identities=27%  Similarity=0.365  Sum_probs=200.3

Q ss_pred             cCCCCCceecccCcEEEEEEEe-----CCCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeec---C
Q 012765          142 DNFNSENLIGKGGHAEVYKGCL-----PDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTE---N  213 (457)
Q Consensus       142 ~~f~~~~~LG~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~---~  213 (457)
                      .+|.+.+.||+|+||.||++..     .++..||+|++....   ......+.+|+.+++.++||||+++++++..   .
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~   80 (284)
T cd05081           4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHST---AEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRR   80 (284)
T ss_pred             ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCC---HHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCC
Confidence            5678889999999999999974     257899999876443   2345678999999999999999999996542   3


Q ss_pred             ceEEEEEecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeecccccc
Q 012765          214 GFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKW  293 (457)
Q Consensus       214 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~  293 (457)
                      .+++++||+++++|.+++......+++..++.++.|++.||.|||+   .+++||||||+||+++.++.+||+|||++..
T Consensus        81 ~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~---~~i~H~dlkp~nili~~~~~~~l~dfg~~~~  157 (284)
T cd05081          81 NLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGS---KRYVHRDLATRNILVESENRVKIGDFGLTKV  157 (284)
T ss_pred             ceEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCCHhhEEECCCCeEEECCCccccc
Confidence            4789999999999999997655668999999999999999999999   8999999999999999999999999999987


Q ss_pred             CCCCCCceee-ecccccccccChhccccCCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhccccccC----Cccc
Q 012765          294 LPDNWSHHIV-FPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTS----NFKE  368 (457)
Q Consensus       294 ~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~~~~~~~----~~~~  368 (457)
                      +......... ....++..|+|||++.+..++.++|||||||++|||++|..++..................    .+.+
T Consensus       158 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (284)
T cd05081         158 LPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIE  237 (284)
T ss_pred             ccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHH
Confidence            7543322111 1122345699999999889999999999999999999998776542221110000000000    0000


Q ss_pred             ccCchhhcccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q 012765          369 LVDPRLADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQLLRGE  414 (457)
Q Consensus       369 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~  414 (457)
                      .+...............+.+++.+||..+|++|||+.+|++.|+.+
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~  283 (284)
T cd05081         238 LLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI  283 (284)
T ss_pred             HHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence            0000000000112234678899999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.8e-40  Score=330.15  Aligned_cols=254  Identities=23%  Similarity=0.340  Sum_probs=194.7

Q ss_pred             cCCCCCceecccCcEEEEEEEeC-CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeec-CceEEEE
Q 012765          142 DNFNSENLIGKGGHAEVYKGCLP-DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTE-NGFHLVL  219 (457)
Q Consensus       142 ~~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-~~~~lv~  219 (457)
                      ++|++.+.||+|+||+||+|... +++.||+|++.............+.+|+.++..++||||+++++++.+ +..++||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~   80 (364)
T cd05599           1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM   80 (364)
T ss_pred             CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence            47889999999999999999865 689999999875433333445678899999999999999999996655 4578999


Q ss_pred             EecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCCCCCC
Q 012765          220 QFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWS  299 (457)
Q Consensus       220 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~~~~  299 (457)
                      ||+++|+|.+++... ..+++..+..++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||++..+.....
T Consensus        81 E~~~~g~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~lH~---~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~  156 (364)
T cd05599          81 EYLPGGDMMTLLMKK-DTFTEEETRFYIAETILAIDSIHK---LGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHR  156 (364)
T ss_pred             CCCCCcHHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeEECCCCCEEEeecccceecccccc
Confidence            999999999998653 458889999999999999999999   8999999999999999999999999999876532211


Q ss_pred             ce------------------------------------eeecccccccccChhccccCCCCcchhHHHHHHHHHHHHhCC
Q 012765          300 HH------------------------------------IVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGR  343 (457)
Q Consensus       300 ~~------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLltG~  343 (457)
                      ..                                    ......||+.|+|||++.+..++.++|||||||++|||++|.
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~  236 (364)
T cd05599         157 TEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGY  236 (364)
T ss_pred             ccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCC
Confidence            00                                    011245899999999999999999999999999999999999


Q ss_pred             CCCCcCCcchhhhhccccccCCcccccCchhhcccCHHHHHHHHHHHHHhcccCCCCCCC---HHHHHH
Q 012765          344 RAVDSRRQSLVIWAKPLLQTSNFKELVDPRLADAYDLAEMKRAMLTASVCIHHLSTMRPQ---MTRVLQ  409 (457)
Q Consensus       344 ~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt---~~evl~  409 (457)
                      .||............  .........  +   ..  ......+.+++.+|+. +|.+|++   +.++++
T Consensus       237 ~Pf~~~~~~~~~~~i--~~~~~~~~~--~---~~--~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~  295 (364)
T cd05599         237 PPFCSDNPQETYRKI--INWKETLQF--P---DE--VPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKS  295 (364)
T ss_pred             CCCCCCCHHHHHHHH--HcCCCccCC--C---CC--CCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhc
Confidence            999864432111100  000000000  0   00  0112344566777886 9999998   888876

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=1.1e-39  Score=311.84  Aligned_cols=254  Identities=26%  Similarity=0.398  Sum_probs=203.6

Q ss_pred             hhcCCCCCceecccCcEEEEEEEeCCCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeecCceEEEE
Q 012765          140 ATDNFNSENLIGKGGHAEVYKGCLPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTENGFHLVL  219 (457)
Q Consensus       140 ~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~lv~  219 (457)
                      ..++|.+.++||+|+||.||+|...+++.||+|.+......    ...+.+|+.++++++|+|+++++++...+..+++|
T Consensus         4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~v~   79 (260)
T cd05067           4 PRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMS----PEAFLAEANLMKQLQHPRLVRLYAVVTQEPIYIIT   79 (260)
T ss_pred             chHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCCc----HHHHHHHHHHHHhcCCcCeeeEEEEEccCCcEEEE
Confidence            45678899999999999999999888999999988654332    34788999999999999999999988888889999


Q ss_pred             EecCCCChhhhhhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCCCCC
Q 012765          220 QFLPHGSLSSLLFGS-TECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNW  298 (457)
Q Consensus       220 e~~~~gsL~~~l~~~-~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~~~  298 (457)
                      ||+.+++|.+++... ...+++..++.++.|++.||.|||+   .+++||||||+||+++.++.++|+|||++.......
T Consensus        80 e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~---~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~  156 (260)
T cd05067          80 EYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIER---KNYIHRDLRAANILVSETLCCKIADFGLARLIEDNE  156 (260)
T ss_pred             EcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhc---CCeecccccHHhEEEcCCCCEEEccCcceeecCCCC
Confidence            999999999988553 3468899999999999999999999   899999999999999999999999999997765322


Q ss_pred             CceeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHh-CCCCCCcCCcchhhhhccccccCCcccccCchhhcc
Q 012765          299 SHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELIT-GRRAVDSRRQSLVIWAKPLLQTSNFKELVDPRLADA  377 (457)
Q Consensus       299 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLlt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~  377 (457)
                      .. ......++..|+|||++.+..++.++||||||+++|||++ |+.||...........  . ...     ....... 
T Consensus       157 ~~-~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~--~-~~~-----~~~~~~~-  226 (260)
T cd05067         157 YT-AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQN--L-ERG-----YRMPRPD-  226 (260)
T ss_pred             cc-cccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHH--H-HcC-----CCCCCCC-
Confidence            11 1112335678999999988889999999999999999999 9999975432111100  0 000     0000111 


Q ss_pred             cCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 012765          378 YDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQLLRG  413 (457)
Q Consensus       378 ~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~  413 (457)
                         .....+.+++.+||+.+|++||++.++++.|+.
T Consensus       227 ---~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  259 (260)
T cd05067         227 ---NCPEELYELMRLCWKEKPEERPTFEYLRSVLED  259 (260)
T ss_pred             ---CCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence               122457789999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=4.1e-40  Score=320.24  Aligned_cols=259  Identities=25%  Similarity=0.398  Sum_probs=200.7

Q ss_pred             HhhcCCCCCceecccCcEEEEEEEeC------CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhc-CCCCcceeeeeee
Q 012765          139 AATDNFNSENLIGKGGHAEVYKGCLP------DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHI-NHPNAAKLIGFST  211 (457)
Q Consensus       139 ~~~~~f~~~~~LG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~  211 (457)
                      ...++|++.+.||+|+||.||+|...      ....+|+|.+.....  ......+.+|+.++.++ +|+||+++++++.
T Consensus         9 ~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~--~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~   86 (293)
T cd05053           9 LPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDAT--EKDLSDLVSEMEMMKMIGKHKNIINLLGVCT   86 (293)
T ss_pred             cCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCC--HHHHHHHHHHHHHHHhhcCCCCeeeEEEEEc
Confidence            34567888999999999999999753      236789998764322  23356788999999999 7999999999665


Q ss_pred             cC-ceEEEEEecCCCChhhhhhc---------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcE
Q 012765          212 EN-GFHLVLQFLPHGSLSSLLFG---------------STECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNI  275 (457)
Q Consensus       212 ~~-~~~lv~e~~~~gsL~~~l~~---------------~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NI  275 (457)
                      .+ .++++|||+++|+|..++..               ....+++..++.++.|++.||.|||+   .+|+||||||+||
T Consensus        87 ~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~---~~ivH~dlkp~Ni  163 (293)
T cd05053          87 QEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLAS---KKCIHRDLAARNV  163 (293)
T ss_pred             CCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHH---CCccccccceeeE
Confidence            54 57899999999999999853               23468899999999999999999999   8999999999999


Q ss_pred             EEcCCCcEEEeeccccccCCCCCCceeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHh-CCCCCCcCCcchh
Q 012765          276 LLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELIT-GRRAVDSRRQSLV  354 (457)
Q Consensus       276 ll~~~~~~kL~DFGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLlt-G~~pf~~~~~~~~  354 (457)
                      +++.++.+||+|||++..+.............++..|+|||++.+..++.++|||||||++|||++ |..||........
T Consensus       164 l~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~  243 (293)
T cd05053         164 LVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEEL  243 (293)
T ss_pred             EEcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHHH
Confidence            999999999999999987654332222222335678999999988899999999999999999998 9999875332111


Q ss_pred             hhhccccccCCcccccCchhhcccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q 012765          355 IWAKPLLQTSNFKELVDPRLADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQLLRGE  414 (457)
Q Consensus       355 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~  414 (457)
                      . .  .....         ............+.+++.+||..+|++|||+.+|++.|+.+
T Consensus       244 ~-~--~~~~~---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~  291 (293)
T cd05053         244 F-K--LLKEG---------YRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRM  291 (293)
T ss_pred             H-H--HHHcC---------CcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHh
Confidence            1 0  00000         00011112234677899999999999999999999999765

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=9.5e-40  Score=317.47  Aligned_cols=256  Identities=25%  Similarity=0.355  Sum_probs=196.5

Q ss_pred             CCCCCceecccCcEEEEEEEeC------CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeec-Cce
Q 012765          143 NFNSENLIGKGGHAEVYKGCLP------DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTE-NGF  215 (457)
Q Consensus       143 ~f~~~~~LG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-~~~  215 (457)
                      +|.+.+.||+|+||.||+|...      ....+++|.+.....  ......+.+|+.+++.++||||+++++++.. +..
T Consensus         1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   78 (290)
T cd05045           1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENAS--SSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPL   78 (290)
T ss_pred             CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCC--HHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCc
Confidence            4778899999999999999752      235688887754332  2335688999999999999999999996554 456


Q ss_pred             EEEEEecCCCChhhhhhcC-----------------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCC
Q 012765          216 HLVLQFLPHGSLSSLLFGS-----------------------TECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKA  272 (457)
Q Consensus       216 ~lv~e~~~~gsL~~~l~~~-----------------------~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp  272 (457)
                      ++++||+.+++|.+++...                       ...+++..++.++.|++.||.|||+   .+++||||||
T Consensus        79 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~---~~ivH~dikp  155 (290)
T cd05045          79 LLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAE---MKLVHRDLAA  155 (290)
T ss_pred             EEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHH---CCeehhhhhh
Confidence            7999999999999987431                       1247888899999999999999999   8999999999


Q ss_pred             CcEEEcCCCcEEEeeccccccCCCCCCceeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHh-CCCCCCcCCc
Q 012765          273 SNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELIT-GRRAVDSRRQ  351 (457)
Q Consensus       273 ~NIll~~~~~~kL~DFGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLlt-G~~pf~~~~~  351 (457)
                      +|||+++++.+||+|||+++...............++..|+|||++.+..++.++||||||+++|||++ |..||.....
T Consensus       156 ~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~  235 (290)
T cd05045         156 RNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAP  235 (290)
T ss_pred             heEEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCH
Confidence            999999999999999999986643322111222345678999999988889999999999999999999 9999975332


Q ss_pred             chhhhhccccccCCcccccCchhhcccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCC
Q 012765          352 SLVIWAKPLLQTSNFKELVDPRLADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQLLRGEG  415 (457)
Q Consensus       352 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~  415 (457)
                      .. .|..           +...............+.+++..||+.+|++||++.++++.|+.+.
T Consensus       236 ~~-~~~~-----------~~~~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~  287 (290)
T cd05045         236 ER-LFNL-----------LKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMM  287 (290)
T ss_pred             HH-HHHH-----------HhCCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHH
Confidence            11 1110           0000000001112245778899999999999999999999998764

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=5.1e-39  Score=307.64  Aligned_cols=260  Identities=27%  Similarity=0.414  Sum_probs=206.0

Q ss_pred             cCCCCCceecccCcEEEEEEEeC-CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeec-CceEEEE
Q 012765          142 DNFNSENLIGKGGHAEVYKGCLP-DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTE-NGFHLVL  219 (457)
Q Consensus       142 ~~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-~~~~lv~  219 (457)
                      ++|++.+.||.|+||.||+|... +|+.||+|.+.............+.+|++++++++|+|++++++++.. +..+++|
T Consensus         2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~   81 (267)
T cd08224           2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL   81 (267)
T ss_pred             CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence            57889999999999999999876 789999998864333333445688999999999999999999995554 5567999


Q ss_pred             EecCCCChhhhhhc---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCCC
Q 012765          220 QFLPHGSLSSLLFG---STECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPD  296 (457)
Q Consensus       220 e~~~~gsL~~~l~~---~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~  296 (457)
                      ||+++++|..++..   ....+++..++.++.+++.||.|||+   .+++|+||+|+||+++.++.++|+|||++..+..
T Consensus        82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~  158 (267)
T cd08224          82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHS---KRIMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHh---CCEecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence            99999999998853   23457899999999999999999999   8999999999999999999999999999876644


Q ss_pred             CCCceeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhccccccCCcccccCchhhc
Q 012765          297 NWSHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSNFKELVDPRLAD  376 (457)
Q Consensus       297 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  376 (457)
                      ....  .....++..|+|||.+.+..++.++|||||||++|+|++|+.||.........+...... ...    .+    
T Consensus       159 ~~~~--~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~----~~----  227 (267)
T cd08224         159 KTTA--AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEK-CDY----PP----  227 (267)
T ss_pred             CCcc--cceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhc-CCC----CC----
Confidence            3211  122348889999999998889999999999999999999999997544322221111000 000    00    


Q ss_pred             ccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCC
Q 012765          377 AYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQLLRGEG  415 (457)
Q Consensus       377 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~  415 (457)
                      .........+.+++.+||..+|++||++.+|+++|+.+.
T Consensus       228 ~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~  266 (267)
T cd08224         228 LPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH  266 (267)
T ss_pred             CChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence            001123346778899999999999999999999998764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=1.3e-39  Score=323.20  Aligned_cols=261  Identities=20%  Similarity=0.286  Sum_probs=191.9

Q ss_pred             CCCCCceecccCcEEEEEEEeC-CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeecC------ce
Q 012765          143 NFNSENLIGKGGHAEVYKGCLP-DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTEN------GF  215 (457)
Q Consensus       143 ~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~------~~  215 (457)
                      +|++.+.||+|+||.||+|... +++.||+|++...... ......+.+|+.+++.++||||+++++++...      .+
T Consensus         1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~   79 (338)
T cd07859           1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEH-VSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDI   79 (338)
T ss_pred             CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhcc-chhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceE
Confidence            4778899999999999999864 6899999988643222 22345788999999999999999999866432      36


Q ss_pred             EEEEEecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCC
Q 012765          216 HLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLP  295 (457)
Q Consensus       216 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~  295 (457)
                      +++|||+. ++|.+++.. ...+++..+..++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||+++...
T Consensus        80 ~lv~e~~~-~~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~  154 (338)
T cd07859          80 YVVFELME-SDLHQVIKA-NDDLTPEHHQFFLYQLLRALKYIHT---ANVFHRDLKPKNILANADCKLKICDFGLARVAF  154 (338)
T ss_pred             EEEEecCC-CCHHHHHHh-cccCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCcEEEccCccccccc
Confidence            89999995 688887754 3458899999999999999999999   899999999999999999999999999997653


Q ss_pred             CCCCc-eeeecccccccccChhcccc--CCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchh-hhhccccccCC---ccc
Q 012765          296 DNWSH-HIVFPIEGTFGYLSPEYFMH--GIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLV-IWAKPLLQTSN---FKE  368 (457)
Q Consensus       296 ~~~~~-~~~~~~~gt~~y~aPE~~~~--~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~-~~~~~~~~~~~---~~~  368 (457)
                      ..... .......||..|+|||++.+  ..++.++|||||||++|||++|+.||........ ...........   ...
T Consensus       155 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (338)
T cd07859         155 NDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISR  234 (338)
T ss_pred             cccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHH
Confidence            32211 11223468999999999865  6789999999999999999999999976432110 00000000000   000


Q ss_pred             c-----------cCchhhcccC---HHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 012765          369 L-----------VDPRLADAYD---LAEMKRAMLTASVCIHHLSTMRPQMTRVLQ  409 (457)
Q Consensus       369 ~-----------~d~~l~~~~~---~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~  409 (457)
                      +           +.........   ......+.+++.+||+.||++|||+.++++
T Consensus       235 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~  289 (338)
T cd07859         235 VRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALA  289 (338)
T ss_pred             hhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhc
Confidence            0           0000000000   011234678899999999999999999987

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=2.8e-40  Score=327.44  Aligned_cols=254  Identities=22%  Similarity=0.292  Sum_probs=198.7

Q ss_pred             cCCCCCceecccCcEEEEEEEeC-CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeec-CceEEEE
Q 012765          142 DNFNSENLIGKGGHAEVYKGCLP-DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTE-NGFHLVL  219 (457)
Q Consensus       142 ~~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-~~~~lv~  219 (457)
                      ++|.+.+.||+|+||+||++... +++.||+|.+.............+.+|+.+++.++||||+++++++.+ +..++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (330)
T cd05601           1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM   80 (330)
T ss_pred             CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence            46889999999999999999864 689999999876544334455678899999999999999999986654 4578999


Q ss_pred             EecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCCCCCC
Q 012765          220 QFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWS  299 (457)
Q Consensus       220 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~~~~  299 (457)
                      ||+++|+|.+++......+++..+..++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||++..+.....
T Consensus        81 e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~---~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~  157 (330)
T cd05601          81 EYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQ---MGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKM  157 (330)
T ss_pred             CCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCeEcccCchHheEECCCCCEEeccCCCCeECCCCCc
Confidence            9999999999997665678999999999999999999999   8999999999999999999999999999987654322


Q ss_pred             ceeeecccccccccChhccc------cCCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhccccccCCcccccCch
Q 012765          300 HHIVFPIEGTFGYLSPEYFM------HGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSNFKELVDPR  373 (457)
Q Consensus       300 ~~~~~~~~gt~~y~aPE~~~------~~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~  373 (457)
                      . ......||+.|+|||++.      ...++.++|||||||++|||++|+.||........ +. ............+  
T Consensus       158 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~-~~-~i~~~~~~~~~~~--  232 (330)
T cd05601         158 V-NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKT-YN-NIMNFQRFLKFPE--  232 (330)
T ss_pred             e-eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHH-HH-HHHcCCCccCCCC--
Confidence            2 222346899999999986      45678999999999999999999999976432211 11 1111110000000  


Q ss_pred             hhcccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 012765          374 LADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQ  409 (457)
Q Consensus       374 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~  409 (457)
                           .......+..++..||+ +|.+||++.++++
T Consensus       233 -----~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~  262 (330)
T cd05601         233 -----DPKVSSDFLDLIQSLLC-GQKERLGYEGLCC  262 (330)
T ss_pred             -----CCCCCHHHHHHHHHHcc-ChhhCCCHHHHhC
Confidence                 01122345667788997 9999999999885

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.6e-39  Score=312.19  Aligned_cols=255  Identities=28%  Similarity=0.394  Sum_probs=197.1

Q ss_pred             CCCCceecccCcEEEEEEEeCC----CcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeecCc-----
Q 012765          144 FNSENLIGKGGHAEVYKGCLPD----GEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTENG-----  214 (457)
Q Consensus       144 f~~~~~LG~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~-----  214 (457)
                      |.+.+.||+|+||.||+|.+..    +..||+|++..... .......+.+|+..++.++||||+++++++....     
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~   79 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIH-TYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKI   79 (273)
T ss_pred             CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcC-CHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccC
Confidence            5678899999999999998542    36799998864332 2344668999999999999999999999664433     


Q ss_pred             --eEEEEEecCCCChhhhhhcC-----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEee
Q 012765          215 --FHLVLQFLPHGSLSSLLFGS-----TECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISD  287 (457)
Q Consensus       215 --~~lv~e~~~~gsL~~~l~~~-----~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~D  287 (457)
                        .++++||+++|+|..++...     ...+++.....++.|++.||.|||+   .+++||||||+||++++++.+||+|
T Consensus        80 ~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~d  156 (273)
T cd05035          80 PKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSN---RNFIHRDLAARNCMLREDMTVCVAD  156 (273)
T ss_pred             cccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHh---CCeeccccchheEEECCCCeEEECC
Confidence              57999999999999887432     2358899999999999999999999   8999999999999999999999999


Q ss_pred             ccccccCCCCCCceeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHh-CCCCCCcCCcchhhhhccccccCCc
Q 012765          288 FGLAKWLPDNWSHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELIT-GRRAVDSRRQSLVIWAKPLLQTSNF  366 (457)
Q Consensus       288 FGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLlt-G~~pf~~~~~~~~~~~~~~~~~~~~  366 (457)
                      ||+++...............++..|+|||++.+..++.++|||||||++|||++ |..||.........  ..... .. 
T Consensus       157 fg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~--~~~~~-~~-  232 (273)
T cd05035         157 FGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIY--DYLRH-GN-  232 (273)
T ss_pred             ccceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHH--HHHHc-CC-
Confidence            999987654332211112235678999999988889999999999999999999 88888753322111  00000 00 


Q ss_pred             ccccCchhhcccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q 012765          367 KELVDPRLADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQLLRGE  414 (457)
Q Consensus       367 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~  414 (457)
                          ....    .......+.+++.+||+.||.+||++.+|++.|+.+
T Consensus       233 ----~~~~----~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~  272 (273)
T cd05035         233 ----RLKQ----PEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI  272 (273)
T ss_pred             ----CCCC----CcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence                0001    112234678888999999999999999999999764

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=1e-39  Score=317.11  Aligned_cols=257  Identities=23%  Similarity=0.345  Sum_probs=199.9

Q ss_pred             hcCCCCCceecccCcEEEEEEEe------CCCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeec-C
Q 012765          141 TDNFNSENLIGKGGHAEVYKGCL------PDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTE-N  213 (457)
Q Consensus       141 ~~~f~~~~~LG~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-~  213 (457)
                      .++|.+.+.||+|+||.||++..      .++..+|+|.+....   ......+.+|+.++++++||||+++++++.. +
T Consensus         4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   80 (288)
T cd05093           4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS---DNARKDFHREAELLTNLQHEHIVKFYGVCVEGD   80 (288)
T ss_pred             hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcC---HHHHHHHHHHHHHHHhCCCCCcceEEEEEecCC
Confidence            35788899999999999999974      234568888775432   2345678999999999999999999997655 4


Q ss_pred             ceEEEEEecCCCChhhhhhcCC------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCC
Q 012765          214 GFHLVLQFLPHGSLSSLLFGST------------ECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDY  281 (457)
Q Consensus       214 ~~~lv~e~~~~gsL~~~l~~~~------------~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~  281 (457)
                      ..+++|||+++++|.+++....            ..+++..++.++.|++.||.|||+   .+++||||||+||+++.++
T Consensus        81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~---~~i~H~dlkp~Nili~~~~  157 (288)
T cd05093          81 PLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLAS---QHFVHRDLATRNCLVGENL  157 (288)
T ss_pred             ccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccCcceEEEccCC
Confidence            5689999999999999985432            248999999999999999999999   8999999999999999999


Q ss_pred             cEEEeeccccccCCCCCCceeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHh-CCCCCCcCCcchhhhhccc
Q 012765          282 EAQISDFGLAKWLPDNWSHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELIT-GRRAVDSRRQSLVIWAKPL  360 (457)
Q Consensus       282 ~~kL~DFGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLlt-G~~pf~~~~~~~~~~~~~~  360 (457)
                      .++|+|||++................++..|+|||++.+..++.++|||||||++|+|++ |..||...........   
T Consensus       158 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~---  234 (288)
T cd05093         158 LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIEC---  234 (288)
T ss_pred             cEEeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH---
Confidence            999999999987644322222222335778999999998899999999999999999998 8999875432211100   


Q ss_pred             cccCCcccccCchhhcccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCC
Q 012765          361 LQTSNFKELVDPRLADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQLLRGEG  415 (457)
Q Consensus       361 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~  415 (457)
                      .......     .....    ....+.+++.+||+.+|.+|||+.+|++.|+.+.
T Consensus       235 i~~~~~~-----~~~~~----~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~  280 (288)
T cd05093         235 ITQGRVL-----QRPRT----CPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLA  280 (288)
T ss_pred             HHcCCcC-----CCCCC----CCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHH
Confidence            0001000     01111    1235788999999999999999999999998775

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=2.8e-39  Score=324.65  Aligned_cols=205  Identities=26%  Similarity=0.405  Sum_probs=173.6

Q ss_pred             cCCCCCceecccCcEEEEEEEeC-CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeec-CceEEEE
Q 012765          142 DNFNSENLIGKGGHAEVYKGCLP-DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTE-NGFHLVL  219 (457)
Q Consensus       142 ~~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-~~~~lv~  219 (457)
                      ++|++.+.||+|+||+||+|... +++.||+|++.+...........+.+|+.++..++||||+++++++.+ ..+++||
T Consensus         1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~   80 (363)
T cd05628           1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM   80 (363)
T ss_pred             CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence            47889999999999999999864 589999999875443334445678899999999999999999986554 4578999


Q ss_pred             EecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCCCCCC
Q 012765          220 QFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWS  299 (457)
Q Consensus       220 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~~~~  299 (457)
                      ||+++|+|.+++... ..+++..+..++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||+++.+.....
T Consensus        81 E~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~lH~---~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~  156 (363)
T cd05628          81 EFLPGGDMMTLLMKK-DTLTEEETQFYIAETVLAIDSIHQ---LGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHR  156 (363)
T ss_pred             cCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHh---CCeEecCCCHHHeEECCCCCEEEeeccCccccccccc
Confidence            999999999998653 458889999999999999999999   8999999999999999999999999999876532110


Q ss_pred             c---------------------------------eeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHhCCCCC
Q 012765          300 H---------------------------------HIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAV  346 (457)
Q Consensus       300 ~---------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLltG~~pf  346 (457)
                      .                                 .......||+.|+|||++.+..++.++|||||||++|||++|+.||
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf  236 (363)
T cd05628         157 TEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPF  236 (363)
T ss_pred             ccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCC
Confidence            0                                 0012346999999999999999999999999999999999999999


Q ss_pred             CcCC
Q 012765          347 DSRR  350 (457)
Q Consensus       347 ~~~~  350 (457)
                      ....
T Consensus       237 ~~~~  240 (363)
T cd05628         237 CSET  240 (363)
T ss_pred             CCCC
Confidence            8644

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=2e-39  Score=310.00  Aligned_cols=252  Identities=25%  Similarity=0.370  Sum_probs=200.9

Q ss_pred             cCCCCCceecccCcEEEEEEEeCCCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeecCceEEEEEe
Q 012765          142 DNFNSENLIGKGGHAEVYKGCLPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTENGFHLVLQF  221 (457)
Q Consensus       142 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~lv~e~  221 (457)
                      ++|.+...||+|+||.||+|.+..+..+|+|.+.....    ....+.+|+.+++.++|||++++++++..+..+++|||
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~v~e~   81 (260)
T cd05069           6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTM----MPEAFLQEAQIMKKLRHDKLVPLYAVVSEEPIYIVTEF   81 (260)
T ss_pred             HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCCc----cHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCcEEEEEc
Confidence            56788899999999999999987777899998754322    13468889999999999999999998888888999999


Q ss_pred             cCCCChhhhhhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCCCCCCc
Q 012765          222 LPHGSLSSLLFGS-TECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSH  300 (457)
Q Consensus       222 ~~~gsL~~~l~~~-~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~~~~~  300 (457)
                      +.+++|.+++... ...+++..+..++.|++.||.|||+   .+++|+||||+||++++++.++|+|||++.........
T Consensus        82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~  158 (260)
T cd05069          82 MGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIER---MNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYT  158 (260)
T ss_pred             CCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCEeecccCcceEEEcCCCeEEECCCccceEccCCccc
Confidence            9999999998653 3457899999999999999999999   89999999999999999999999999999776443211


Q ss_pred             eeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHh-CCCCCCcCCcchhhhhccccccCCcccccCchhhcccC
Q 012765          301 HIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELIT-GRRAVDSRRQSLVIWAKPLLQTSNFKELVDPRLADAYD  379 (457)
Q Consensus       301 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLlt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~  379 (457)
                       ......++..|+|||++.+..++.++||||||+++|||++ |..||...........  .....      .+    ...
T Consensus       159 -~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~--~~~~~------~~----~~~  225 (260)
T cd05069         159 -ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQ--VERGY------RM----PCP  225 (260)
T ss_pred             -ccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH--HHcCC------CC----CCC
Confidence             1112335678999999988889999999999999999999 8999976432211100  00000      00    011


Q ss_pred             HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 012765          380 LAEMKRAMLTASVCIHHLSTMRPQMTRVLQLLRG  413 (457)
Q Consensus       380 ~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~  413 (457)
                      ......+.+++.+||+.+|++||++.+|++.|+.
T Consensus       226 ~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  259 (260)
T cd05069         226 QGCPESLHELMKLCWKKDPDERPTFEYIQSFLED  259 (260)
T ss_pred             cccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence            1233567788899999999999999999999875

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=7.4e-40  Score=320.52  Aligned_cols=257  Identities=24%  Similarity=0.402  Sum_probs=201.7

Q ss_pred             hcCCCCCceecccCcEEEEEEEeC-CCc----EEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeecCce
Q 012765          141 TDNFNSENLIGKGGHAEVYKGCLP-DGE----VVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTENGF  215 (457)
Q Consensus       141 ~~~f~~~~~LG~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~  215 (457)
                      .++|+..+.||+|+||.||+|.+. ++.    .+|+|.+.....  ......+.+|+.+++.++||||+++++++.....
T Consensus         6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~   83 (303)
T cd05110           6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTG--PKANVEFMDEALIMASMDHPHLVRLLGVCLSPTI   83 (303)
T ss_pred             hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCC--HHHHHHHHHHHHHHHhCCCCCcccEEEEEcCCCc
Confidence            466788899999999999999853 444    468887754332  2334578899999999999999999998887778


Q ss_pred             EEEEEecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCC
Q 012765          216 HLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLP  295 (457)
Q Consensus       216 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~  295 (457)
                      ++++||+++|+|.+++......+++..++.++.|++.||.|||+   .+|+|+||||+||+++.++.+||+|||+++.+.
T Consensus        84 ~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~---~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~  160 (303)
T cd05110          84 QLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEE---RRLVHRDLAARNVLVKSPNHVKITDFGLARLLE  160 (303)
T ss_pred             eeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhh---cCeeccccccceeeecCCCceEEcccccccccc
Confidence            89999999999999987666678999999999999999999999   899999999999999999999999999998765


Q ss_pred             CCCCceeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHh-CCCCCCcCCcc-hhhhhccccccCCcccccCch
Q 012765          296 DNWSHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELIT-GRRAVDSRRQS-LVIWAKPLLQTSNFKELVDPR  373 (457)
Q Consensus       296 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLlt-G~~pf~~~~~~-~~~~~~~~~~~~~~~~~~d~~  373 (457)
                      ............++..|+|||++.+..++.++|||||||++|||++ |+.||...... ...+..    ....  ...+ 
T Consensus       161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~~~~----~~~~--~~~~-  233 (303)
T cd05110         161 GDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLE----KGER--LPQP-  233 (303)
T ss_pred             CcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH----CCCC--CCCC-
Confidence            4322211222335678999999998899999999999999999997 89999753321 111111    0000  0000 


Q ss_pred             hhcccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCC
Q 012765          374 LADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQLLRGEG  415 (457)
Q Consensus       374 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~  415 (457)
                        ..    ....+..++..||..+|++||++.++++.|+.+.
T Consensus       234 --~~----~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~  269 (303)
T cd05110         234 --PI----CTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMA  269 (303)
T ss_pred             --CC----CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence              11    1235677889999999999999999999998763

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=1.2e-39  Score=329.49  Aligned_cols=254  Identities=20%  Similarity=0.295  Sum_probs=191.7

Q ss_pred             CCCCCceecccCcEEEEEEEeC-CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeec-CceEEEEE
Q 012765          143 NFNSENLIGKGGHAEVYKGCLP-DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTE-NGFHLVLQ  220 (457)
Q Consensus       143 ~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-~~~~lv~e  220 (457)
                      .|...+.||+|+||+||+|... +++.||+|++.............+.+|+.++..++||||+++++++.+ +.+++|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E   81 (381)
T cd05626           2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD   81 (381)
T ss_pred             CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence            5788899999999999999864 688999999876444444556789999999999999999999996654 45689999


Q ss_pred             ecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCCCCCC-
Q 012765          221 FLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWS-  299 (457)
Q Consensus       221 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~~~~-  299 (457)
                      |+++|+|.+++... ..+++..+..++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||++..+..... 
T Consensus        82 ~~~gg~L~~~l~~~-~~~~e~~~~~~~~qi~~aL~~LH~---~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~  157 (381)
T cd05626          82 YIPGGDMMSLLIRM-EVFPEVLARFYIAELTLAIESVHK---MGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNS  157 (381)
T ss_pred             cCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCcHHHEEECCCCCEEEeeCcCCccccccccc
Confidence            99999999998653 357888888899999999999999   8999999999999999999999999999754311000 


Q ss_pred             --------------------------------------------ceeeecccccccccChhccccCCCCcchhHHHHHHH
Q 012765          300 --------------------------------------------HHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVL  335 (457)
Q Consensus       300 --------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvl  335 (457)
                                                                  ........||+.|+|||++.+..++.++|||||||+
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~i  237 (381)
T cd05626         158 KYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVI  237 (381)
T ss_pred             ccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhhH
Confidence                                                        000123469999999999998899999999999999


Q ss_pred             HHHHHhCCCCCCcCCcchhhhhccccccCCcccccCchhhcccCHHHHHHHHHHHHH--hcccCCCCCCCHHHHHH
Q 012765          336 LLELITGRRAVDSRRQSLVIWAKPLLQTSNFKELVDPRLADAYDLAEMKRAMLTASV--CIHHLSTMRPQMTRVLQ  409 (457)
Q Consensus       336 l~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~--Cl~~dP~~RPt~~evl~  409 (457)
                      +|||++|..||............... .... .+  +. ...++.    .+.+++.+  |+..+|..||++.+|++
T Consensus       238 l~elltG~~Pf~~~~~~~~~~~i~~~-~~~~-~~--~~-~~~~s~----~~~dli~~ll~~~~~~~~R~~~~~~l~  304 (381)
T cd05626         238 LFEMLVGQPPFLAPTPTETQLKVINW-ENTL-HI--PP-QVKLSP----EAVDLITKLCCSAEERLGRNGADDIKA  304 (381)
T ss_pred             HHHHHhCCCCCcCCCHHHHHHHHHcc-cccc-CC--CC-CCCCCH----HHHHHHHHHccCcccccCCCCHHHHhc
Confidence            99999999999864432211111000 0000 00  00 001222    33344444  66777778999999987

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.1e-39  Score=309.18  Aligned_cols=249  Identities=24%  Similarity=0.351  Sum_probs=197.2

Q ss_pred             ceecccCcEEEEEEEeCC----CcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeecCceEEEEEecC
Q 012765          148 NLIGKGGHAEVYKGCLPD----GEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTENGFHLVLQFLP  223 (457)
Q Consensus       148 ~~LG~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~lv~e~~~  223 (457)
                      +.||+|+||.||+|.+..    +..+|+|.+......  .....+.+|+.+++.++||||+++++++.....+++|||+.
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~v~e~~~   78 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA--AGKKEFLREASVMAQLDHPCIVRLIGVCKGEPLMLVMELAP   78 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccch--HHHHHHHHHHHHHHhcCCCCeeeEEEEEcCCceEEEEEeCC
Confidence            469999999999997532    368999987654433  34567899999999999999999999988888999999999


Q ss_pred             CCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCCCCCCcee-
Q 012765          224 HGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSHHI-  302 (457)
Q Consensus       224 ~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~~~~~~~-  302 (457)
                      +++|.+++.... .+++..++.++.|++.||.|||.   .+++|+||||+|||++.++.+||+|||+++.+........ 
T Consensus        79 ~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lh~---~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~  154 (257)
T cd05060          79 LGPLLKYLKKRR-EIPVSDLKELAHQVAMGMAYLES---KHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRA  154 (257)
T ss_pred             CCcHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHhh---cCeeccCcccceEEEcCCCcEEeccccccceeecCCccccc
Confidence            999999996544 68899999999999999999999   8999999999999999999999999999987644322211 


Q ss_pred             eecccccccccChhccccCCCCcchhHHHHHHHHHHHHh-CCCCCCcCCcch-hhhhccccccCCcccccCchhhcccCH
Q 012765          303 VFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELIT-GRRAVDSRRQSL-VIWAKPLLQTSNFKELVDPRLADAYDL  380 (457)
Q Consensus       303 ~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLlt-G~~pf~~~~~~~-~~~~~~~~~~~~~~~~~d~~l~~~~~~  380 (457)
                      .....++..|+|||.+.+..++.++|||||||++|+|++ |..||...+... ..+..   ....   .   ..    ..
T Consensus       155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~---~~~~---~---~~----~~  221 (257)
T cd05060         155 TTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLE---SGER---L---PR----PE  221 (257)
T ss_pred             ccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHH---cCCc---C---CC----CC
Confidence            111223567999999998899999999999999999998 999997643321 11111   0000   0   00    11


Q ss_pred             HHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCC
Q 012765          381 AEMKRAMLTASVCIHHLSTMRPQMTRVLQLLRGEG  415 (457)
Q Consensus       381 ~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~  415 (457)
                      .....+.+++.+||..+|++||++.+|++.|+++.
T Consensus       222 ~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~  256 (257)
T cd05060         222 ECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRDP  256 (257)
T ss_pred             CCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence            12245678899999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=1.3e-39  Score=321.88  Aligned_cols=246  Identities=22%  Similarity=0.314  Sum_probs=189.4

Q ss_pred             CCCCceecccCcEEEEEEEeC-CCcEEEEEEEeccchhhHHHHHHHHHHHHHH---hhcCCCCcceeeeeeec-CceEEE
Q 012765          144 FNSENLIGKGGHAEVYKGCLP-DGEVVAVKKIIKNAKEDEERISDFLSELGIV---AHINHPNAAKLIGFSTE-NGFHLV  218 (457)
Q Consensus       144 f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l---~~l~hpniv~l~~~~~~-~~~~lv  218 (457)
                      |.+.+.||+|+||.||+|.+. +++.||+|.+.+...........+.+|..++   ..++||||+++++++.. +..++|
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv   80 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV   80 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence            567889999999999999864 6899999998754333333345666666554   56789999999996655 457899


Q ss_pred             EEecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCCCCC
Q 012765          219 LQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNW  298 (457)
Q Consensus       219 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~~~  298 (457)
                      |||+++++|..++.  ...+++..+..++.||+.||.|||+   .+++||||||+||+++.++.+||+|||++.......
T Consensus        81 ~E~~~~~~L~~~~~--~~~l~~~~~~~~~~qi~~al~~lH~---~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~~  155 (324)
T cd05589          81 MEYAAGGDLMMHIH--TDVFSEPRAVFYAACVVLGLQYLHE---NKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFG  155 (324)
T ss_pred             EcCCCCCcHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHh---CCeEecCCCHHHeEECCCCcEEeCcccCCccCCCCC
Confidence            99999999988874  3568999999999999999999999   899999999999999999999999999987543221


Q ss_pred             CceeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhccccccCCcccccCchhhccc
Q 012765          299 SHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSNFKELVDPRLADAY  378 (457)
Q Consensus       299 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~  378 (457)
                      .  ......|++.|+|||++.+..++.++|||||||++|||++|+.||...........  ....       .......+
T Consensus       156 ~--~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~--i~~~-------~~~~p~~~  224 (324)
T cd05589         156 D--RTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDS--IVND-------EVRYPRFL  224 (324)
T ss_pred             C--cccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHH--HHhC-------CCCCCCCC
Confidence            1  12335689999999999999999999999999999999999999986443211100  0000       00111111


Q ss_pred             CHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 012765          379 DLAEMKRAMLTASVCIHHLSTMRP-----QMTRVLQ  409 (457)
Q Consensus       379 ~~~~~~~l~~l~~~Cl~~dP~~RP-----t~~evl~  409 (457)
                          ...+..++.+||+.||.+||     ++.++++
T Consensus       225 ----~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~  256 (324)
T cd05589         225 ----SREAISIMRRLLRRNPERRLGSGEKDAEDVKK  256 (324)
T ss_pred             ----CHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhh
Confidence                23456788999999999999     4666655

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=1.6e-39  Score=311.25  Aligned_cols=253  Identities=25%  Similarity=0.390  Sum_probs=198.5

Q ss_pred             cCCCCCceecccCcEEEEEEEeC-CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeec-CceEEEE
Q 012765          142 DNFNSENLIGKGGHAEVYKGCLP-DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTE-NGFHLVL  219 (457)
Q Consensus       142 ~~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-~~~~lv~  219 (457)
                      .+|.+.+.||+|+||.||+|.+. .++.+|+|.+....    .....+.+|+.++..++||||+++++++.. +..+++|
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   81 (263)
T cd05052           6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT----MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIT   81 (263)
T ss_pred             HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCc----hHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEE
Confidence            45777889999999999999865 58899999875432    224578899999999999999999996554 5568999


Q ss_pred             EecCCCChhhhhhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCCCCC
Q 012765          220 QFLPHGSLSSLLFGS-TECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNW  298 (457)
Q Consensus       220 e~~~~gsL~~~l~~~-~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~~~  298 (457)
                      ||+++++|.+++... ...+++..++.++.|++.||.|||+   .+++||||||+||+++.++.+||+|||++.......
T Consensus        82 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~  158 (263)
T cd05052          82 EFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT  158 (263)
T ss_pred             EeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCEeecccCcceEEEcCCCcEEeCCCccccccccce
Confidence            999999999998653 3458999999999999999999999   899999999999999999999999999998765432


Q ss_pred             CceeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHh-CCCCCCcCCcchhhhhccccccCCcccccCchhhcc
Q 012765          299 SHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELIT-GRRAVDSRRQSLVIWAKPLLQTSNFKELVDPRLADA  377 (457)
Q Consensus       299 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLlt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~  377 (457)
                      ... .....++..|+|||++.+..++.++|||||||++|||++ |..||........ +.. ....      ..+.... 
T Consensus       159 ~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~-~~~-~~~~------~~~~~~~-  228 (263)
T cd05052         159 YTA-HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQV-YEL-LEKG------YRMERPE-  228 (263)
T ss_pred             eec-cCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHH-HHH-HHCC------CCCCCCC-
Confidence            211 112224567999999998999999999999999999998 9999875432211 111 0000      0011111 


Q ss_pred             cCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q 012765          378 YDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQLLRGE  414 (457)
Q Consensus       378 ~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~  414 (457)
                         .....+.+++.+||+.+|++||++.++++.|+.+
T Consensus       229 ---~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~  262 (263)
T cd05052         229 ---GCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM  262 (263)
T ss_pred             ---CCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence               1234577889999999999999999999999754

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=3.2e-39  Score=335.40  Aligned_cols=249  Identities=22%  Similarity=0.308  Sum_probs=195.0

Q ss_pred             CCCCCceecccCcEEEEEEEeC-C-CcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeee-cCceEEEE
Q 012765          143 NFNSENLIGKGGHAEVYKGCLP-D-GEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFST-ENGFHLVL  219 (457)
Q Consensus       143 ~f~~~~~LG~G~~g~Vy~~~~~-~-~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~-~~~~~lv~  219 (457)
                      .|.+.+.||+|+||.||+|... + ++.||+|.+....   ......+.+|+.+++.++||||+++++++. .+..++||
T Consensus        68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~---~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~  144 (478)
T PTZ00267         68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLND---ERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIM  144 (478)
T ss_pred             eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCC---HHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEE
Confidence            4788899999999999999754 3 6778888764332   233456788999999999999999999654 45578999


Q ss_pred             EecCCCChhhhhhc---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCCC
Q 012765          220 QFLPHGSLSSLLFG---STECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPD  296 (457)
Q Consensus       220 e~~~~gsL~~~l~~---~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~  296 (457)
                      ||+++|+|.+++..   ....+++..+..++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||+++.+..
T Consensus       145 E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~---~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~  221 (478)
T PTZ00267        145 EYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHS---RKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSD  221 (478)
T ss_pred             ECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHh---CCEEECCcCHHhEEECCCCcEEEEeCcCceecCC
Confidence            99999999988753   23457888899999999999999999   8999999999999999999999999999987654


Q ss_pred             CCCceeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhccccccCCcccccCchhhc
Q 012765          297 NWSHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSNFKELVDPRLAD  376 (457)
Q Consensus       297 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  376 (457)
                      ...........||+.|+|||++.+..++.++|||||||++|||++|+.||............  .. ...    ++ .  
T Consensus       222 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~--~~-~~~----~~-~--  291 (478)
T PTZ00267        222 SVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQV--LY-GKY----DP-F--  291 (478)
T ss_pred             ccccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH--Hh-CCC----CC-C--
Confidence            43322233456999999999999999999999999999999999999999764322111100  00 000    00 0  


Q ss_pred             ccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 012765          377 AYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQ  409 (457)
Q Consensus       377 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~  409 (457)
                        .......+.+++..||+.+|++||++.+++.
T Consensus       292 --~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~  322 (478)
T PTZ00267        292 --PCPVSSGMKALLDPLLSKNPALRPTTQQLLH  322 (478)
T ss_pred             --CccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence              1112235677889999999999999998864

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.3e-39  Score=310.62  Aligned_cols=250  Identities=25%  Similarity=0.363  Sum_probs=197.3

Q ss_pred             cCCCCCceecccCcEEEEEEEeCCCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeecC-ceEEEEE
Q 012765          142 DNFNSENLIGKGGHAEVYKGCLPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTEN-GFHLVLQ  220 (457)
Q Consensus       142 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~-~~~lv~e  220 (457)
                      .+|++.+.||+|+||.||+|.+.++..+|+|.+.+....    ...+.+|+.+++.++||||+++++++... ..+++||
T Consensus         4 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~~----~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   79 (256)
T cd05059           4 SELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAMS----EDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTE   79 (256)
T ss_pred             HHcchhhhhccCCCceEEEeEecCCccEEEEEeccCCCC----HHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEe
Confidence            357788999999999999998877788999987643322    23678899999999999999999976554 4679999


Q ss_pred             ecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCCCCCCc
Q 012765          221 FLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSH  300 (457)
Q Consensus       221 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~~~~~  300 (457)
                      |+++++|.+++......+++..++.++.||+.||.|||+   .+++||||||+||+++.++.+||+|||+++...+....
T Consensus        80 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~  156 (256)
T cd05059          80 YMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLES---NGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYT  156 (256)
T ss_pred             cCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHH---CCcccccccHhhEEECCCCcEEECCcccceeccccccc
Confidence            999999999997655678999999999999999999999   89999999999999999999999999998876443211


Q ss_pred             eeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHh-CCCCCCcCCcchhhhhccccccCCcccccCchhhcccC
Q 012765          301 HIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELIT-GRRAVDSRRQSLVIWAKPLLQTSNFKELVDPRLADAYD  379 (457)
Q Consensus       301 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLlt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~  379 (457)
                      . .....++..|+|||.+.+..++.++||||||+++|||++ |..||............  ...      .......   
T Consensus       157 ~-~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~--~~~------~~~~~~~---  224 (256)
T cd05059         157 S-SQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESV--SAG------YRLYRPK---  224 (256)
T ss_pred             c-cCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH--HcC------CcCCCCC---
Confidence            1 111123457999999998899999999999999999999 89998754322111110  000      0011111   


Q ss_pred             HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 012765          380 LAEMKRAMLTASVCIHHLSTMRPQMTRVLQLL  411 (457)
Q Consensus       380 ~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L  411 (457)
                       .....+.+++.+||+.+|++|||+.+|++.|
T Consensus       225 -~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l  255 (256)
T cd05059         225 -LAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL  255 (256)
T ss_pred             -CCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence             1234677899999999999999999999986

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=4.3e-39  Score=308.51  Aligned_cols=259  Identities=25%  Similarity=0.404  Sum_probs=204.6

Q ss_pred             cCCCCCceecccCcEEEEEEEe-CCCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeee-cCceEEEE
Q 012765          142 DNFNSENLIGKGGHAEVYKGCL-PDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFST-ENGFHLVL  219 (457)
Q Consensus       142 ~~f~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~-~~~~~lv~  219 (457)
                      ++|.+.+.||+|+||.||+|.. .+++.+|+|.+.............+.+|+.+++.++||||+++++++. ++..+++|
T Consensus         2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08229           2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL   81 (267)
T ss_pred             chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence            4678889999999999999985 478999999876544444445568899999999999999999999554 45578999


Q ss_pred             EecCCCChhhhhhc---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCCC
Q 012765          220 QFLPHGSLSSLLFG---STECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPD  296 (457)
Q Consensus       220 e~~~~gsL~~~l~~---~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~  296 (457)
                      ||+++++|.+++..   ....+++..++.++.||+.||.|||+   .+++|+||||+||+++.++.++|+|||++.....
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~  158 (267)
T cd08229          82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence            99999999998753   23458899999999999999999999   8999999999999999999999999999877644


Q ss_pred             CCCceeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhccccccCCcccccCchhhc
Q 012765          297 NWSHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSNFKELVDPRLAD  376 (457)
Q Consensus       297 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  376 (457)
                      ...  ......++..|+|||++.+..++.++|+||||+++|+|++|..||.........+.....      ....+.+. 
T Consensus       159 ~~~--~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~------~~~~~~~~-  229 (267)
T cd08229         159 KTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIE------QCDYPPLP-  229 (267)
T ss_pred             CCc--ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhh------cCCCCCCC-
Confidence            321  112345889999999998888999999999999999999999999754332211111100      01111111 


Q ss_pred             ccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q 012765          377 AYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQLLRGE  414 (457)
Q Consensus       377 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~  414 (457)
                        .......+.+++.+||+.+|++||||.+|++.+++.
T Consensus       230 --~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~  265 (267)
T cd08229         230 --SDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRM  265 (267)
T ss_pred             --cccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhh
Confidence              112334677888999999999999999999998764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=1.3e-39  Score=314.32  Aligned_cols=256  Identities=29%  Similarity=0.380  Sum_probs=195.7

Q ss_pred             hhcCCCCCceecccCcEEEEEEEeC------CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeee-c
Q 012765          140 ATDNFNSENLIGKGGHAEVYKGCLP------DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFST-E  212 (457)
Q Consensus       140 ~~~~f~~~~~LG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~-~  212 (457)
                      ..++|.+.+.||+|+||.||+|.+.      .+..||+|.+.....  ......+.+|+.+++.++|+||+++++++. .
T Consensus         4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~   81 (277)
T cd05036           4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCS--EQDESDFLMEALIMSKFNHQNIVRLIGVSFER   81 (277)
T ss_pred             CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCC--HHHHHHHHHHHHHHHhCCCCCEeeEEEEEccC
Confidence            3567889999999999999999864      356788887653322  233457899999999999999999999554 4


Q ss_pred             CceEEEEEecCCCChhhhhhcCC------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCC---cE
Q 012765          213 NGFHLVLQFLPHGSLSSLLFGST------ECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDY---EA  283 (457)
Q Consensus       213 ~~~~lv~e~~~~gsL~~~l~~~~------~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~---~~  283 (457)
                      ...+++|||+++++|.+++....      ..+++..++.++.||+.||.|||+   .+++||||||+||+++.++   .+
T Consensus        82 ~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~nil~~~~~~~~~~  158 (277)
T cd05036          82 LPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEE---NHFIHRDIAARNCLLTCKGPGRVA  158 (277)
T ss_pred             CCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccchheEEEeccCCCcce
Confidence            55689999999999999985432      258899999999999999999999   8999999999999998764   59


Q ss_pred             EEeeccccccCCCCCCceeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHh-CCCCCCcCCcchhhhhccccc
Q 012765          284 QISDFGLAKWLPDNWSHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELIT-GRRAVDSRRQSLVIWAKPLLQ  362 (457)
Q Consensus       284 kL~DFGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLlt-G~~pf~~~~~~~~~~~~~~~~  362 (457)
                      ||+|||+++.+..............+..|+|||++.+..++.++|||||||++|||++ |..||.........  .....
T Consensus       159 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~--~~~~~  236 (277)
T cd05036         159 KIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVM--EFVTG  236 (277)
T ss_pred             EeccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHH--HHHHc
Confidence            9999999987643221111112223567999999998999999999999999999997 99999764322111  00000


Q ss_pred             cCCcccccCchhhcccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 012765          363 TSNFKELVDPRLADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQLLR  412 (457)
Q Consensus       363 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~  412 (457)
                      ...          ..........+.+++.+||+.+|++||++.+|++.|+
T Consensus       237 ~~~----------~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~  276 (277)
T cd05036         237 GGR----------LDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ  276 (277)
T ss_pred             CCc----------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence            000          0111112345778899999999999999999999885

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=8e-40  Score=316.63  Aligned_cols=254  Identities=21%  Similarity=0.332  Sum_probs=195.7

Q ss_pred             CCCCCceecccCcEEEEEEEeC------CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeec-Cce
Q 012765          143 NFNSENLIGKGGHAEVYKGCLP------DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTE-NGF  215 (457)
Q Consensus       143 ~f~~~~~LG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-~~~  215 (457)
                      +|.+.+.||.|+||.||+|...      .++.||+|++.....  ......+.+|+.++..++||||+++++++.. ...
T Consensus         6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~   83 (283)
T cd05091           6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAE--GPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPL   83 (283)
T ss_pred             HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCC--HHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCce
Confidence            4566789999999999999753      257899998864332  2334578899999999999999999996655 456


Q ss_pred             EEEEEecCCCChhhhhhcC---------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCC
Q 012765          216 HLVLQFLPHGSLSSLLFGS---------------TECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSED  280 (457)
Q Consensus       216 ~lv~e~~~~gsL~~~l~~~---------------~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~  280 (457)
                      ++++||+.+++|..++...               ...+++..++.++.|++.||.|||+   .+++||||||+||+++++
T Consensus        84 ~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~---~gi~H~dlkp~Nil~~~~  160 (283)
T cd05091          84 SMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSS---HHVVHKDLATRNVLVFDK  160 (283)
T ss_pred             EEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHH---cCccccccchhheEecCC
Confidence            7999999999999987421               2347888889999999999999999   899999999999999999


Q ss_pred             CcEEEeeccccccCCCCCCceeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHh-CCCCCCcCCcchhhhhcc
Q 012765          281 YEAQISDFGLAKWLPDNWSHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELIT-GRRAVDSRRQSLVIWAKP  359 (457)
Q Consensus       281 ~~~kL~DFGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLlt-G~~pf~~~~~~~~~~~~~  359 (457)
                      +.+||+|||+++.+.............+++.|+|||++.++.++.++|||||||++|||++ |..||........  ...
T Consensus       161 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~--~~~  238 (283)
T cd05091         161 LNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDV--IEM  238 (283)
T ss_pred             CceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHH--HHH
Confidence            9999999999887644322222223345778999999988889999999999999999998 8888875433211  111


Q ss_pred             ccccCCcccccCchhhcccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 012765          360 LLQTSNFKELVDPRLADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQLLRG  413 (457)
Q Consensus       360 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~  413 (457)
                       .......         .+.......+..++.+||+.+|.+||++.+|++.|+.
T Consensus       239 -i~~~~~~---------~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~  282 (283)
T cd05091         239 -IRNRQVL---------PCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT  282 (283)
T ss_pred             -HHcCCcC---------CCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence             0011110         0111223446788999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=1.4e-39  Score=316.63  Aligned_cols=257  Identities=22%  Similarity=0.331  Sum_probs=199.8

Q ss_pred             cCCCCCceecccCcEEEEEEEeC------CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeecC-c
Q 012765          142 DNFNSENLIGKGGHAEVYKGCLP------DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTEN-G  214 (457)
Q Consensus       142 ~~f~~~~~LG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~-~  214 (457)
                      .+|.+.+.||+|+||.||+|...      ++..+++|.+.....   .....+.+|+.++++++||||+++++++... .
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   81 (291)
T cd05094           5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTL---AARKDFQREAELLTNLQHEHIVKFYGVCGDGDP   81 (291)
T ss_pred             HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccH---HHHHHHHHHHHHHhcCCCCCcceEEEEEccCCc
Confidence            45778899999999999999742      355688887754322   3345788999999999999999999976554 4


Q ss_pred             eEEEEEecCCCChhhhhhcCC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcC
Q 012765          215 FHLVLQFLPHGSLSSLLFGST---------------ECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSE  279 (457)
Q Consensus       215 ~~lv~e~~~~gsL~~~l~~~~---------------~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~  279 (457)
                      .++||||+++++|.+++....               ..+++..++.++.||+.||.|||+   .+++||||||+||+++.
T Consensus        82 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~i~H~dlkp~Nil~~~  158 (291)
T cd05094          82 LIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLAS---QHFVHRDLATRNCLVGA  158 (291)
T ss_pred             eEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccCcceEEEcc
Confidence            689999999999999985422               347899999999999999999999   89999999999999999


Q ss_pred             CCcEEEeeccccccCCCCCCceeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHh-CCCCCCcCCcchhhhhc
Q 012765          280 DYEAQISDFGLAKWLPDNWSHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELIT-GRRAVDSRRQSLVIWAK  358 (457)
Q Consensus       280 ~~~~kL~DFGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLlt-G~~pf~~~~~~~~~~~~  358 (457)
                      ++.++|+|||++................++..|+|||++.+..++.++|||||||++|||+| |..||......... . 
T Consensus       159 ~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~-~-  236 (291)
T cd05094         159 NLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVI-E-  236 (291)
T ss_pred             CCcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHH-H-
Confidence            99999999999976654322222223446788999999999999999999999999999999 99998653321111 0 


Q ss_pred             cccccCCcccccCchhhcccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCCC
Q 012765          359 PLLQTSNFKELVDPRLADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQLLRGEGG  416 (457)
Q Consensus       359 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~  416 (457)
                       ..........         .......+.+++.+||+.+|++||++.+|+++|+.+..
T Consensus       237 -~~~~~~~~~~---------~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~  284 (291)
T cd05094         237 -CITQGRVLER---------PRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGK  284 (291)
T ss_pred             -HHhCCCCCCC---------CccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHh
Confidence             0011111100         11123457789999999999999999999999998854

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=1.9e-39  Score=320.75  Aligned_cols=243  Identities=22%  Similarity=0.270  Sum_probs=189.6

Q ss_pred             CCCCCceecccCcEEEEEEEeC-CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCC-Ccceeeeeee-cCceEEEE
Q 012765          143 NFNSENLIGKGGHAEVYKGCLP-DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHP-NAAKLIGFST-ENGFHLVL  219 (457)
Q Consensus       143 ~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp-niv~l~~~~~-~~~~~lv~  219 (457)
                      +|++.+.||+|+||.||+|... +++.||+|++.+...........+..|..++..++|+ +|+++++++. .+..++||
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (324)
T cd05587           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM   80 (324)
T ss_pred             CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence            5788899999999999999865 5789999998754333334456788899999999765 5778887654 45578999


Q ss_pred             EecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCCCCCC
Q 012765          220 QFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWS  299 (457)
Q Consensus       220 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~~~~  299 (457)
                      ||+++|+|..++... ..+++..+..++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||++........
T Consensus        81 E~~~~g~L~~~~~~~-~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~  156 (324)
T cd05587          81 EYVNGGDLMYHIQQV-GKFKEPHAVFYAAEIAIGLFFLHS---KGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGK  156 (324)
T ss_pred             cCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEEcCCCCEEEeecCcceecCCCCC
Confidence            999999999888543 457888999999999999999999   8999999999999999999999999999875422211


Q ss_pred             ceeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhccccccCCcccccCchhhcccC
Q 012765          300 HHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSNFKELVDPRLADAYD  379 (457)
Q Consensus       300 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~  379 (457)
                        ......||+.|+|||++.+..++.++|||||||++|||+||+.||............. ...        ..+...  
T Consensus       157 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~-~~~--------~~~~~~--  223 (324)
T cd05587         157 --TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIM-EHN--------VSYPKS--  223 (324)
T ss_pred             --ceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHH-cCC--------CCCCCC--
Confidence              1223568999999999999999999999999999999999999998644322111110 000        111111  


Q ss_pred             HHHHHHHHHHHHHhcccCCCCCCCH
Q 012765          380 LAEMKRAMLTASVCIHHLSTMRPQM  404 (457)
Q Consensus       380 ~~~~~~l~~l~~~Cl~~dP~~RPt~  404 (457)
                        ....+.+++.+||+.||.+||+.
T Consensus       224 --~~~~~~~li~~~l~~~P~~R~~~  246 (324)
T cd05587         224 --LSKEAVSICKGLLTKHPAKRLGC  246 (324)
T ss_pred             --CCHHHHHHHHHHhhcCHHHcCCC
Confidence              22356678899999999999986

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=1.9e-39  Score=319.69  Aligned_cols=242  Identities=25%  Similarity=0.326  Sum_probs=186.3

Q ss_pred             ceecccCcEEEEEEEeC-CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhh-cCCCCcceeeeeeec-CceEEEEEecCC
Q 012765          148 NLIGKGGHAEVYKGCLP-DGEVVAVKKIIKNAKEDEERISDFLSELGIVAH-INHPNAAKLIGFSTE-NGFHLVLQFLPH  224 (457)
Q Consensus       148 ~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~-l~hpniv~l~~~~~~-~~~~lv~e~~~~  224 (457)
                      +.||+|+||.||+|... +++.||+|.+.............+..|..++.. .+||||+++++++.. +..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g   80 (316)
T cd05592           1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999864 588999999875443333344556667777764 489999999986554 557899999999


Q ss_pred             CChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCCCCCCceeee
Q 012765          225 GSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVF  304 (457)
Q Consensus       225 gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~~~~~~~~~  304 (457)
                      |+|..++... ..+++.....++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||++.......  ....
T Consensus        81 g~L~~~~~~~-~~~~~~~~~~~~~qi~~al~~LH~---~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~--~~~~  154 (316)
T cd05592          81 GDLMFHIQSS-GRFDEARARFYAAEIICGLQFLHK---KGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE--GKAS  154 (316)
T ss_pred             CcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHH---CCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC--Cccc
Confidence            9999888543 458888889999999999999999   899999999999999999999999999997653322  1223


Q ss_pred             cccccccccChhccccCCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhccccccCCcccccCchhhcccCHHHHH
Q 012765          305 PIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSNFKELVDPRLADAYDLAEMK  384 (457)
Q Consensus       305 ~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~  384 (457)
                      ...||+.|+|||++.+..++.++|||||||++|||++|+.||...+........ ....        +.+...    ...
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i-~~~~--------~~~~~~----~~~  221 (316)
T cd05592         155 TFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSI-LNDR--------PHFPRW----ISK  221 (316)
T ss_pred             cccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHH-HcCC--------CCCCCC----CCH
Confidence            356899999999999989999999999999999999999999864432211110 0000        111111    223


Q ss_pred             HHHHHHHHhcccCCCCCCCHH-HHH
Q 012765          385 RAMLTASVCIHHLSTMRPQMT-RVL  408 (457)
Q Consensus       385 ~l~~l~~~Cl~~dP~~RPt~~-evl  408 (457)
                      .+.+++.+||+.+|.+||++. +++
T Consensus       222 ~~~~ll~~~l~~~P~~R~~~~~~l~  246 (316)
T cd05592         222 EAKDCLSKLFERDPTKRLGVDGDIR  246 (316)
T ss_pred             HHHHHHHHHccCCHHHcCCChHHHH
Confidence            456788899999999999975 454

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.4e-39  Score=314.12  Aligned_cols=252  Identities=25%  Similarity=0.317  Sum_probs=197.0

Q ss_pred             CCCCCceecccCcEEEEEEEeC-CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeec-CceEEEEE
Q 012765          143 NFNSENLIGKGGHAEVYKGCLP-DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTE-NGFHLVLQ  220 (457)
Q Consensus       143 ~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-~~~~lv~e  220 (457)
                      +|++.++||+|+||+||++... +++.||+|.+.............+.+|+.+++.++||||+++++++.. +..+++||
T Consensus         1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (285)
T cd05605           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence            4778899999999999999864 689999998865443333334567889999999999999999986554 55789999


Q ss_pred             ecCCCChhhhhhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCCCCCC
Q 012765          221 FLPHGSLSSLLFGS-TECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWS  299 (457)
Q Consensus       221 ~~~~gsL~~~l~~~-~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~~~~  299 (457)
                      |+++|+|..++... ...+++..+..++.|++.||.|||+   .+++||||||+||++++++.++|+|||++........
T Consensus        81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~  157 (285)
T cd05605          81 LMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHR---ERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGET  157 (285)
T ss_pred             ccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHH---CCcEecCCCHHHEEECCCCCEEEeeCCCceecCCCCc
Confidence            99999999887553 3468999999999999999999999   8999999999999999999999999999987643321


Q ss_pred             ceeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhccccccCCcccccCchhhcccC
Q 012765          300 HHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSNFKELVDPRLADAYD  379 (457)
Q Consensus       300 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~  379 (457)
                         .....|+..|+|||++.+..++.++|||||||++|||++|+.||...........        +...+.. ....+.
T Consensus       158 ---~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~--------~~~~~~~-~~~~~~  225 (285)
T cd05605         158 ---IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREE--------VERRVKE-DQEEYS  225 (285)
T ss_pred             ---cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHH--------HHHHhhh-cccccC
Confidence               1234589999999999988999999999999999999999999986432211000        0000000 001111


Q ss_pred             HHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 012765          380 LAEMKRAMLTASVCIHHLSTMRP-----QMTRVLQ  409 (457)
Q Consensus       380 ~~~~~~l~~l~~~Cl~~dP~~RP-----t~~evl~  409 (457)
                      ......+.+++..||+.||.+||     ++.++++
T Consensus       226 ~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~  260 (285)
T cd05605         226 EKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKA  260 (285)
T ss_pred             cccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhc
Confidence            22334567889999999999999     7778755

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=1.7e-40  Score=313.85  Aligned_cols=254  Identities=25%  Similarity=0.349  Sum_probs=189.7

Q ss_pred             cCCCCCceecccCcEEEEEEEeC-CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeec---C-ce-
Q 012765          142 DNFNSENLIGKGGHAEVYKGCLP-DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTE---N-GF-  215 (457)
Q Consensus       142 ~~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~---~-~~-  215 (457)
                      -.|...+++|.|+||.||+|... +++.||||++..+....       -+|+++|+.++|||||++.-++..   . .. 
T Consensus        24 i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~k-------nrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~   96 (364)
T KOG0658|consen   24 ISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRYK-------NRELQIMRKLDHPNIVRLLYFFSSSTESDEVY   96 (364)
T ss_pred             EEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCcC-------cHHHHHHHhcCCcCeeeEEEEEEecCCCchhH
Confidence            34556789999999999999864 57999999987665432       268999999999999999875432   2 22 


Q ss_pred             -EEEEEecCCCChhhhhhc---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCC-CcEEEeeccc
Q 012765          216 -HLVLQFLPHGSLSSLLFG---STECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSED-YEAQISDFGL  290 (457)
Q Consensus       216 -~lv~e~~~~gsL~~~l~~---~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~-~~~kL~DFGl  290 (457)
                       .+||||++. +|...++.   .+..++.-.+.-+..||++||.|||+   .+|+||||||.|+|+|.+ |.+||||||.
T Consensus        97 lnlVleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~---~~IcHRDIKPqNlLvD~~tg~LKicDFGS  172 (364)
T KOG0658|consen   97 LNLVLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHS---HGICHRDIKPQNLLVDPDTGVLKICDFGS  172 (364)
T ss_pred             HHHHHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHh---cCcccCCCChheEEEcCCCCeEEeccCCc
Confidence             489999986 57777653   24445655566688999999999999   899999999999999976 8999999999


Q ss_pred             cccCCCCCCceeeecccccccccChhccccC-CCCcchhHHHHHHHHHHHHhCCCCCCcCCcc--hhhhhc---------
Q 012765          291 AKWLPDNWSHHIVFPIEGTFGYLSPEYFMHG-IVDEKTDVFAFGVLLLELITGRRAVDSRRQS--LVIWAK---------  358 (457)
Q Consensus       291 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDvwSlGvll~eLltG~~pf~~~~~~--~~~~~~---------  358 (457)
                      |+.+..+....   ....|..|+|||.+.+. .|+.+.||||.||++.||+-|++.|.+....  +....+         
T Consensus       173 AK~L~~~epni---SYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~  249 (364)
T KOG0658|consen  173 AKVLVKGEPNI---SYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTRED  249 (364)
T ss_pred             ceeeccCCCce---eEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHH
Confidence            99986654432   23468999999999875 5999999999999999999999999874322  111111         


Q ss_pred             -----cccccCCcccccCchhhcccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 012765          359 -----PLLQTSNFKELVDPRLADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQ  409 (457)
Q Consensus       359 -----~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~  409 (457)
                           +.-.+-.++++....+...+......+.++++.++|+.+|.+|.++.|++.
T Consensus       250 I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~  305 (364)
T KOG0658|consen  250 IKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALA  305 (364)
T ss_pred             HhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhc
Confidence                 111111222222222211122233456778899999999999999999876

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=2.7e-40  Score=296.58  Aligned_cols=262  Identities=24%  Similarity=0.325  Sum_probs=206.5

Q ss_pred             HhhcCCCCCceecccCcEEEEEEE-eCCCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeec-----
Q 012765          139 AATDNFNSENLIGKGGHAEVYKGC-LPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTE-----  212 (457)
Q Consensus       139 ~~~~~f~~~~~LG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-----  212 (457)
                      ...++|.+.+.||.|||+-||.+. ..++..||+|++.....   +..+..++|++..++++|||++++++++..     
T Consensus        18 In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~---~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~   94 (302)
T KOG2345|consen   18 INNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQ---EDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDG   94 (302)
T ss_pred             EcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccch---HHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccC
Confidence            456889999999999999999997 45789999999976653   446688999999999999999999986432     


Q ss_pred             -CceEEEEEecCCCChhhhhhc---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeec
Q 012765          213 -NGFHLVLQFLPHGSLSSLLFG---STECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDF  288 (457)
Q Consensus       213 -~~~~lv~e~~~~gsL~~~l~~---~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DF  288 (457)
                       ...|+++.|+..|+|.+.+..   .+..+++...+.|+.+|++||.+||+. ..+++||||||.|||+++.+.++|.||
T Consensus        95 ~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~-~~~yAH~DiKP~NILls~~~~~vl~D~  173 (302)
T KOG2345|consen   95 KHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEK-EPPYAHRDIKPANILLSDSGLPVLMDL  173 (302)
T ss_pred             ceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhcc-CCcccccCCCcceeEecCCCceEEEec
Confidence             226899999999999998743   555799999999999999999999993 235999999999999999999999999


Q ss_pred             cccccCCCCCCc-------eeeecccccccccChhccc---cCCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhc
Q 012765          289 GLAKWLPDNWSH-------HIVFPIEGTFGYLSPEYFM---HGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAK  358 (457)
Q Consensus       289 Gl~~~~~~~~~~-------~~~~~~~gt~~y~aPE~~~---~~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~  358 (457)
                      |.++..+-....       ........|..|+|||.+.   +...++++|||||||+||+|+.|..||+..-+.      
T Consensus       174 GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~------  247 (302)
T KOG2345|consen  174 GSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQ------  247 (302)
T ss_pred             cCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhc------
Confidence            999865322110       0112234789999999985   456789999999999999999999999852211      


Q ss_pred             cccccCCc-ccccCchhhcccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q 012765          359 PLLQTSNF-KELVDPRLADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQLLRGE  414 (457)
Q Consensus       359 ~~~~~~~~-~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~  414 (457)
                          ...+ ..+..+.+...-+....+.+.+++..||+.||.+||++.+++..+..+
T Consensus       248 ----GgSlaLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~L  300 (302)
T KOG2345|consen  248 ----GGSLALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDL  300 (302)
T ss_pred             ----CCeEEEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhh
Confidence                1111 122222332222223567788999999999999999999999988764

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=4.4e-39  Score=311.46  Aligned_cols=244  Identities=25%  Similarity=0.326  Sum_probs=190.6

Q ss_pred             ecccCcEEEEEEEeC-CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeee-cCceEEEEEecCCCCh
Q 012765          150 IGKGGHAEVYKGCLP-DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFST-ENGFHLVLQFLPHGSL  227 (457)
Q Consensus       150 LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~-~~~~~lv~e~~~~gsL  227 (457)
                      ||+|+||+||++.+. +++.||+|.+.............+..|+.+++.++||||+++++++. ....+++|||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L   80 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL   80 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence            799999999999864 68999999987554433344567889999999999999999998554 4557899999999999


Q ss_pred             hhhhhc---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCCCCCCceeee
Q 012765          228 SSLLFG---STECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVF  304 (457)
Q Consensus       228 ~~~l~~---~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~~~~~~~~~  304 (457)
                      ..++..   ....+++..+..++.||+.||.|||+   .+|+||||||+||+++.++.++|+|||++..+......  ..
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~--~~  155 (280)
T cd05608          81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQ---RRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSK--TK  155 (280)
T ss_pred             HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCcc--cc
Confidence            887743   33468899999999999999999999   89999999999999999999999999999766543221  22


Q ss_pred             cccccccccChhccccCCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchh--hhhccccccCCcccccCchhhcccCHHH
Q 012765          305 PIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLV--IWAKPLLQTSNFKELVDPRLADAYDLAE  382 (457)
Q Consensus       305 ~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~--~~~~~~~~~~~~~~~~d~~l~~~~~~~~  382 (457)
                      ...||+.|+|||++.+..++.++|||||||++|||++|+.||........  .....         +.....  .+....
T Consensus       156 ~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~---------~~~~~~--~~~~~~  224 (280)
T cd05608         156 GYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQR---------ILNDSV--TYPDKF  224 (280)
T ss_pred             ccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHh---------hcccCC--CCcccC
Confidence            34589999999999999999999999999999999999999975332110  00000         001100  111122


Q ss_pred             HHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 012765          383 MKRAMLTASVCIHHLSTMRP-----QMTRVLQ  409 (457)
Q Consensus       383 ~~~l~~l~~~Cl~~dP~~RP-----t~~evl~  409 (457)
                      ...+.+++.+||+.||++||     ++.++++
T Consensus       225 ~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~  256 (280)
T cd05608         225 SPASKSFCEALLAKDPEKRLGFRDGNCDGLRT  256 (280)
T ss_pred             CHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhc
Confidence            34567788999999999999     6677765

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.3e-40  Score=316.06  Aligned_cols=250  Identities=22%  Similarity=0.346  Sum_probs=208.5

Q ss_pred             hcCCCCCceecccCcEEEEEEEe-CCCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeecC-ceEEE
Q 012765          141 TDNFNSENLIGKGGHAEVYKGCL-PDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTEN-GFHLV  218 (457)
Q Consensus       141 ~~~f~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~-~~~lv  218 (457)
                      ..+|++.+.||+|.||.|-+|.. ..|+.||||.+.+....+++....+.+|++||..|+||||+.+|.++++. ...+|
T Consensus        52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIviv  131 (668)
T KOG0611|consen   52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIV  131 (668)
T ss_pred             hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEE
Confidence            45677889999999999999974 67999999999988888888889999999999999999999999966654 56799


Q ss_pred             EEecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCCCCC
Q 012765          219 LQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNW  298 (457)
Q Consensus       219 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~~~  298 (457)
                      |||..+|.|++|+.. .+.+++.....++.||..|+.|+|.   .+++|||||.+|||||.|+++||+|||++-.+... 
T Consensus       132 MEYaS~GeLYDYiSe-r~~LsErEaRhfFRQIvSAVhYCHk---nrVvHRDLKLENILLD~N~NiKIADFGLSNly~~~-  206 (668)
T KOG0611|consen  132 MEYASGGELYDYISE-RGSLSEREARHFFRQIVSAVHYCHK---NRVVHRDLKLENILLDQNNNIKIADFGLSNLYADK-  206 (668)
T ss_pred             EEecCCccHHHHHHH-hccccHHHHHHHHHHHHHHHHHHhh---ccceecccchhheeecCCCCeeeeccchhhhhccc-
Confidence            999999999999954 4458888888999999999999999   89999999999999999999999999999877554 


Q ss_pred             CceeeecccccccccChhccccCCC-CcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhccccccCCcccccCchhhcc
Q 012765          299 SHHIVFPIEGTFGYLSPEYFMHGIV-DEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSNFKELVDPRLADA  377 (457)
Q Consensus       299 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~  377 (457)
                        ....+++|++-|.+||.+.+..| ++.+|-|||||+||-|+.|..||++.+-....           .++-...... 
T Consensus       207 --kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lv-----------rQIs~GaYrE-  272 (668)
T KOG0611|consen  207 --KFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLV-----------RQISRGAYRE-  272 (668)
T ss_pred             --cHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHH-----------HHhhcccccC-
Confidence              24556889999999999999887 68899999999999999999999985432211           1111111111 


Q ss_pred             cCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 012765          378 YDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQLL  411 (457)
Q Consensus       378 ~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L  411 (457)
                        ++......-++.+||-.||++|.|+.+|....
T Consensus       273 --P~~PSdA~gLIRwmLmVNP~RRATieDiAsHW  304 (668)
T KOG0611|consen  273 --PETPSDASGLIRWMLMVNPERRATIEDIASHW  304 (668)
T ss_pred             --CCCCchHHHHHHHHHhcCcccchhHHHHhhhh
Confidence              11222344578889999999999999998854

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.9e-39  Score=312.13  Aligned_cols=256  Identities=24%  Similarity=0.411  Sum_probs=203.1

Q ss_pred             cCCCCCceecccCcEEEEEEEeC-CCc----EEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeecCceE
Q 012765          142 DNFNSENLIGKGGHAEVYKGCLP-DGE----VVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTENGFH  216 (457)
Q Consensus       142 ~~f~~~~~LG~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~  216 (457)
                      .+|.+.+.||+|+||+||+|.+. +|.    .+|+|.+.....  ......+.+|+.++++++||||+++++++.....+
T Consensus         7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   84 (279)
T cd05057           7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETS--PKANKEILDEAYVMASVDHPHVVRLLGICLSSQVQ   84 (279)
T ss_pred             HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCC--HHHHHHHHHHHHHHHhCCCCCcceEEEEEecCceE
Confidence            56778899999999999999854 333    588887754432  34456889999999999999999999988888889


Q ss_pred             EEEEecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCCC
Q 012765          217 LVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPD  296 (457)
Q Consensus       217 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~  296 (457)
                      ++|||+++|+|.+++......+++..++.++.||+.||.|||+   .+++||||||+||+++.++.+||+|||++..+..
T Consensus        85 ~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~---~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~  161 (279)
T cd05057          85 LITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEE---KRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDV  161 (279)
T ss_pred             EEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHh---CCEEecccCcceEEEcCCCeEEECCCcccccccC
Confidence            9999999999999997766678999999999999999999999   8999999999999999999999999999987754


Q ss_pred             CCCceeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHh-CCCCCCcCCcchhhhhccccccCCcccccCchhh
Q 012765          297 NWSHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELIT-GRRAVDSRRQSLVIWAKPLLQTSNFKELVDPRLA  375 (457)
Q Consensus       297 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLlt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  375 (457)
                      ...........++..|+|||.+....++.++|+||||+++|||++ |+.||.........  ........   ...+   
T Consensus       162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~--~~~~~~~~---~~~~---  233 (279)
T cd05057         162 DEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIP--DLLEKGER---LPQP---  233 (279)
T ss_pred             cccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHH--HHHhCCCC---CCCC---
Confidence            322222222224568999999988899999999999999999999 99999864322111  10000000   0000   


Q ss_pred             cccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q 012765          376 DAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQLLRGE  414 (457)
Q Consensus       376 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~  414 (457)
                      .    .....+..++.+||..+|..||++.++++.|...
T Consensus       234 ~----~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~  268 (279)
T cd05057         234 P----ICTIDVYMVLVKCWMIDAESRPTFKELINEFSKM  268 (279)
T ss_pred             C----CCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence            1    1123466788899999999999999999999876

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=1.9e-39  Score=316.57  Aligned_cols=255  Identities=24%  Similarity=0.360  Sum_probs=194.4

Q ss_pred             cCCCCCceecccCcEEEEEEEeCC-Cc--EEEEEEEeccchhhHHHHHHHHHHHHHHhhc-CCCCcceeeeeeec-CceE
Q 012765          142 DNFNSENLIGKGGHAEVYKGCLPD-GE--VVAVKKIIKNAKEDEERISDFLSELGIVAHI-NHPNAAKLIGFSTE-NGFH  216 (457)
Q Consensus       142 ~~f~~~~~LG~G~~g~Vy~~~~~~-~~--~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~-~~~~  216 (457)
                      ++|++.++||+|+||.||+|...+ +.  .+++|.+.....  ......+.+|+.++.++ +||||+++++++.. +..+
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~   79 (297)
T cd05089           2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFAS--ENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLY   79 (297)
T ss_pred             ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCC--HHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcce
Confidence            578889999999999999998643 33  467877653222  23346789999999999 79999999997655 4478


Q ss_pred             EEEEecCCCChhhhhhcCC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCC
Q 012765          217 LVLQFLPHGSLSSLLFGST---------------ECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDY  281 (457)
Q Consensus       217 lv~e~~~~gsL~~~l~~~~---------------~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~  281 (457)
                      +++||+++++|.+++....               ..+++..++.++.|++.||.|||+   .+++||||||+|||++.++
T Consensus        80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~---~~ivH~dlkp~Nill~~~~  156 (297)
T cd05089          80 IAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSE---KQFIHRDLAARNVLVGENL  156 (297)
T ss_pred             EEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCcCCcceEEECCCC
Confidence            9999999999999985422               347888999999999999999999   8999999999999999999


Q ss_pred             cEEEeeccccccCCCCCCceeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHh-CCCCCCcCCcchhhhhccc
Q 012765          282 EAQISDFGLAKWLPDNWSHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELIT-GRRAVDSRRQSLVIWAKPL  360 (457)
Q Consensus       282 ~~kL~DFGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLlt-G~~pf~~~~~~~~~~~~~~  360 (457)
                      .+||+|||++.........   .....+..|+|||++.+..++.++|||||||++|||++ |..||......... . ..
T Consensus       157 ~~kl~dfg~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~-~-~~  231 (297)
T cd05089         157 ASKIADFGLSRGEEVYVKK---TMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELY-E-KL  231 (297)
T ss_pred             eEEECCcCCCccccceecc---CCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHH-H-HH
Confidence            9999999998643221111   11123557999999988889999999999999999998 99999764322111 0 00


Q ss_pred             cccCCcccccCchhhcccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCCC
Q 012765          361 LQTSNFKELVDPRLADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQLLRGEGG  416 (457)
Q Consensus       361 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~  416 (457)
                      ...      ..+.....    ....+.+++.+||+.+|.+||++.+|++.|+.+..
T Consensus       232 ~~~------~~~~~~~~----~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~  277 (297)
T cd05089         232 PQG------YRMEKPRN----CDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLE  277 (297)
T ss_pred             hcC------CCCCCCCC----CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence            000      00111111    22456788999999999999999999999877654

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9.7e-40  Score=308.19  Aligned_cols=275  Identities=23%  Similarity=0.327  Sum_probs=205.6

Q ss_pred             hhcCCCCCceecccCcEEEEEEEeC-CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeec------
Q 012765          140 ATDNFNSENLIGKGGHAEVYKGCLP-DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTE------  212 (457)
Q Consensus       140 ~~~~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~------  212 (457)
                      ....|...+.||+|+||.|..|.+. +|+.||||++... .......++.++|+++|+.++|+||+.+++....      
T Consensus        20 i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~-F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f   98 (359)
T KOG0660|consen   20 IPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNP-FENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKF   98 (359)
T ss_pred             ccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhh-hhchHHHHHHHHHHHHHHHhcCCCcceEEeeccccccccc
Confidence            4566767889999999999999864 6899999998643 3344557789999999999999999999996543      


Q ss_pred             CceEEEEEecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccc
Q 012765          213 NGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAK  292 (457)
Q Consensus       213 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~  292 (457)
                      .+.|+|+|+| +.+|...+.. +..++......++.||++||.|+|+   .+|+||||||+|+|++.+...||+|||+++
T Consensus        99 ~DvYiV~elM-etDL~~iik~-~~~L~d~H~q~f~YQiLrgLKyiHS---AnViHRDLKPsNll~n~~c~lKI~DFGLAR  173 (359)
T KOG0660|consen   99 NDVYLVFELM-ETDLHQIIKS-QQDLTDDHAQYFLYQILRGLKYIHS---ANVIHRDLKPSNLLLNADCDLKICDFGLAR  173 (359)
T ss_pred             ceeEEehhHH-hhHHHHHHHc-CccccHHHHHHHHHHHHHhcchhhc---ccccccccchhheeeccCCCEEecccccee
Confidence            4578999998 6677777743 3448888988999999999999999   799999999999999999999999999999


Q ss_pred             cCCCCCCceeeecccccccccChhccc-cCCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhc-ccc---ccCCcc
Q 012765          293 WLPDNWSHHIVFPIEGTFGYLSPEYFM-HGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAK-PLL---QTSNFK  367 (457)
Q Consensus       293 ~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~-~~~---~~~~~~  367 (457)
                      ...........+....|.+|.|||.+. ...|+...||||.|||+.||++|++.|.+.+........ ...   ....+.
T Consensus       174 ~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~  253 (359)
T KOG0660|consen  174 YLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQ  253 (359)
T ss_pred             eccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHH
Confidence            886432223345667899999999876 467999999999999999999999999875533221100 000   000000


Q ss_pred             cccCchh---------------hcccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH--HHhcCCCCCCCC
Q 012765          368 ELVDPRL---------------ADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQ--LLRGEGGQTDLK  421 (457)
Q Consensus       368 ~~~d~~l---------------~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~--~L~~~~~~~~~~  421 (457)
                      .+-....               ...+ +......++++.+||..||.+|+|+.|.++  .|.......+.|
T Consensus       254 ~i~s~~ar~yi~slp~~p~~~f~~~f-p~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~hdp~dEP  323 (359)
T KOG0660|consen  254 KIRSEKARPYIKSLPQIPKQPFSSIF-PNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPYHDPEDEP  323 (359)
T ss_pred             HhccHHHHHHHHhCCCCCCCCHHHHc-CCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhhcCCccCC
Confidence            1110000               0000 012234678889999999999999999987  455554444444

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.6e-39  Score=327.99  Aligned_cols=255  Identities=21%  Similarity=0.318  Sum_probs=193.1

Q ss_pred             cCCCCCceecccCcEEEEEEEeC-CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeecC-ceEEEE
Q 012765          142 DNFNSENLIGKGGHAEVYKGCLP-DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTEN-GFHLVL  219 (457)
Q Consensus       142 ~~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~-~~~lv~  219 (457)
                      ++|.+.+.||+|+||+||++... +++.||+|.+.+...........+.+|+.+++.++||||+++++++.++ ..++||
T Consensus         1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~   80 (377)
T cd05629           1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM   80 (377)
T ss_pred             CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence            47888999999999999999754 6899999998654433344566788999999999999999999966654 468999


Q ss_pred             EecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCCCCCC
Q 012765          220 QFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWS  299 (457)
Q Consensus       220 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~~~~  299 (457)
                      ||+++|+|.+++.. ...+++.....++.|++.||.|||+   .+|+||||||+|||++.++.+||+|||+++.+.....
T Consensus        81 E~~~gg~L~~~l~~-~~~~~~~~~~~~~~ql~~aL~~LH~---~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~  156 (377)
T cd05629          81 EFLPGGDLMTMLIK-YDTFSEDVTRFYMAECVLAIEAVHK---LGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHD  156 (377)
T ss_pred             eCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEECCCCCEEEeecccccccccccc
Confidence            99999999999864 3457888888899999999999999   8999999999999999999999999999864321100


Q ss_pred             c------------e---------------------------------eeecccccccccChhccccCCCCcchhHHHHHH
Q 012765          300 H------------H---------------------------------IVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGV  334 (457)
Q Consensus       300 ~------------~---------------------------------~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGv  334 (457)
                      .            .                                 ......||+.|+|||++.+..++.++|||||||
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGv  236 (377)
T cd05629         157 SAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGA  236 (377)
T ss_pred             cccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecch
Confidence            0            0                                 001245899999999999999999999999999


Q ss_pred             HHHHHHhCCCCCCcCCcchhhhhccccccCCcccccCchhhcccCHHHHHHHHHHHHHhcccCCCCC---CCHHHHHHH
Q 012765          335 LLLELITGRRAVDSRRQSLVIWAKPLLQTSNFKELVDPRLADAYDLAEMKRAMLTASVCIHHLSTMR---PQMTRVLQL  410 (457)
Q Consensus       335 ll~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~R---Pt~~evl~~  410 (457)
                      ++|||++|..||......... ... ........+  +   ..  ......+.+++.+||. +|.+|   |++.++++.
T Consensus       237 il~elltG~~Pf~~~~~~~~~-~~i-~~~~~~~~~--p---~~--~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~h  305 (377)
T cd05629         237 IMFECLIGWPPFCSENSHETY-RKI-INWRETLYF--P---DD--IHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKSH  305 (377)
T ss_pred             hhhhhhcCCCCCCCCCHHHHH-HHH-HccCCccCC--C---CC--CCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhcC
Confidence            999999999999764432111 100 000000000  0   00  0112345677888997 66665   599888773

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=5.2e-39  Score=304.93  Aligned_cols=247  Identities=28%  Similarity=0.385  Sum_probs=194.7

Q ss_pred             ceecccCcEEEEEEEeCCCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeecC-ceEEEEEecCCCC
Q 012765          148 NLIGKGGHAEVYKGCLPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTEN-GFHLVLQFLPHGS  226 (457)
Q Consensus       148 ~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~-~~~lv~e~~~~gs  226 (457)
                      ++||+|+||.||+|...+++.+|+|.+.....  ......+.+|+.+++.++||||+++++++... ..+++|||+++++
T Consensus         1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~   78 (250)
T cd05085           1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLP--QELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGD   78 (250)
T ss_pred             CccCCCCCceEEEEEecCCcEEEEEecCCcCC--HHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCc
Confidence            36999999999999988889999998764432  23345788999999999999999999966554 5679999999999


Q ss_pred             hhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCCCCCCceeeecc
Q 012765          227 LSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPI  306 (457)
Q Consensus       227 L~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~~~~~~~~~~~  306 (457)
                      |.+++......+++..++.++.+++.||.|||+   .+++||||||+||+++.++.+||+|||++.......... ....
T Consensus        79 L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~-~~~~  154 (250)
T cd05085          79 FLSFLRKKKDELKTKQLVKFALDAAAGMAYLES---KNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSS-SGLK  154 (250)
T ss_pred             HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccChheEEEcCCCeEEECCCccceecccccccc-CCCC
Confidence            999987656678999999999999999999999   899999999999999999999999999987654322111 1112


Q ss_pred             cccccccChhccccCCCCcchhHHHHHHHHHHHHh-CCCCCCcCCcchhhhhccccccCCcccccCchhhcccCHHHHHH
Q 012765          307 EGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELIT-GRRAVDSRRQSLVIWAKPLLQTSNFKELVDPRLADAYDLAEMKR  385 (457)
Q Consensus       307 ~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLlt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~  385 (457)
                      .++..|+|||++.+..++.++||||||+++|++++ |..||............  .. .     .....    .......
T Consensus       155 ~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~--~~-~-----~~~~~----~~~~~~~  222 (250)
T cd05085         155 QIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQV--EK-G-----YRMSC----PQKCPDD  222 (250)
T ss_pred             CCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHH--Hc-C-----CCCCC----CCCCCHH
Confidence            34567999999998889999999999999999998 99999754322111000  00 0     00000    1112346


Q ss_pred             HHHHHHHhcccCCCCCCCHHHHHHHHh
Q 012765          386 AMLTASVCIHHLSTMRPQMTRVLQLLR  412 (457)
Q Consensus       386 l~~l~~~Cl~~dP~~RPt~~evl~~L~  412 (457)
                      +.+++.+||+.+|++||++.++++.|.
T Consensus       223 ~~~li~~~l~~~p~~Rp~~~~l~~~l~  249 (250)
T cd05085         223 VYKVMQRCWDYKPENRPKFSELQKELA  249 (250)
T ss_pred             HHHHHHHHcccCcccCCCHHHHHHHhc
Confidence            778999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=1.2e-39  Score=322.31  Aligned_cols=244  Identities=22%  Similarity=0.290  Sum_probs=191.0

Q ss_pred             ceecccCcEEEEEEEeC-CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeee-cCceEEEEEecCCC
Q 012765          148 NLIGKGGHAEVYKGCLP-DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFST-ENGFHLVLQFLPHG  225 (457)
Q Consensus       148 ~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~-~~~~~lv~e~~~~g  225 (457)
                      +.||+|+||.||++... +|+.||+|.+.............+.+|+.++..++||||+++++++. .+..++||||+++|
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence            46999999999999854 68999999987544333344567889999999999999999998655 45578999999999


Q ss_pred             ChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCCCCCCceeeec
Q 012765          226 SLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFP  305 (457)
Q Consensus       226 sL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~~~~~~~~~~  305 (457)
                      +|..++.. ...+++..+..++.||+.||.|||+.  .+|+||||||+|||++.++.+||+|||++........  ....
T Consensus        81 ~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~lH~~--~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~--~~~~  155 (325)
T cd05594          81 ELFFHLSR-ERVFSEDRARFYGAEIVSALDYLHSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA--TMKT  155 (325)
T ss_pred             cHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhc--CCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCc--cccc
Confidence            99888754 34588999999999999999999962  6899999999999999999999999999875432211  1223


Q ss_pred             ccccccccChhccccCCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhccccccCCcccccCchhhcccCHHHHHH
Q 012765          306 IEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSNFKELVDPRLADAYDLAEMKR  385 (457)
Q Consensus       306 ~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~  385 (457)
                      ..||+.|+|||++.+..++.++|||||||++|||++|+.||......... .......        ..+...+    ...
T Consensus       156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~-~~i~~~~--------~~~p~~~----~~~  222 (325)
T cd05594         156 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLF-ELILMEE--------IRFPRTL----SPE  222 (325)
T ss_pred             ccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHH-HHHhcCC--------CCCCCCC----CHH
Confidence            45999999999999999999999999999999999999999764322111 0000001        1111112    234


Q ss_pred             HHHHHHHhcccCCCCCC-----CHHHHHH
Q 012765          386 AMLTASVCIHHLSTMRP-----QMTRVLQ  409 (457)
Q Consensus       386 l~~l~~~Cl~~dP~~RP-----t~~evl~  409 (457)
                      +.+++.+||+.||++|+     ++.++++
T Consensus       223 ~~~li~~~L~~dP~~R~~~~~~~~~~il~  251 (325)
T cd05594         223 AKSLLSGLLKKDPKQRLGGGPDDAKEIMQ  251 (325)
T ss_pred             HHHHHHHHhhcCHHHhCCCCCCCHHHHhc
Confidence            66788899999999996     8998875

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=2.9e-39  Score=332.15  Aligned_cols=256  Identities=21%  Similarity=0.317  Sum_probs=188.5

Q ss_pred             hhcCCCCCceecccCcEEEEEEEeC-CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeecC-----
Q 012765          140 ATDNFNSENLIGKGGHAEVYKGCLP-DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTEN-----  213 (457)
Q Consensus       140 ~~~~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~-----  213 (457)
                      ...+|.+.+.||+|+||.||+|... +++.||||++.....       ...+|+.+++.++||||+++++++...     
T Consensus        64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~-------~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~  136 (440)
T PTZ00036         64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQ-------YKNRELLIMKNLNHINIIFLKDYYYTECFKKN  136 (440)
T ss_pred             cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCcc-------hHHHHHHHHHhcCCCCCcceeeeEeecccccC
Confidence            3467889999999999999999864 689999998854321       234699999999999999998854321     


Q ss_pred             ----ceEEEEEecCCCChhhhhh---cCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCC-cEEE
Q 012765          214 ----GFHLVLQFLPHGSLSSLLF---GSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDY-EAQI  285 (457)
Q Consensus       214 ----~~~lv~e~~~~gsL~~~l~---~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~-~~kL  285 (457)
                          .+++||||+++ +|..++.   .....+++..+..++.||+.||.|||+   .+|+||||||+|||++.++ .+||
T Consensus       137 ~~~~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~---~~IiHrDLKp~NILl~~~~~~vkL  212 (440)
T PTZ00036        137 EKNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHS---KFICHRDLKPQNLLIDPNTHTLKL  212 (440)
T ss_pred             CCceEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCcCHHHEEEcCCCCceee
Confidence                14589999985 5666553   244568899999999999999999999   8999999999999999665 6999


Q ss_pred             eeccccccCCCCCCceeeecccccccccChhccccC-CCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhh-hcccccc
Q 012765          286 SDFGLAKWLPDNWSHHIVFPIEGTFGYLSPEYFMHG-IVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIW-AKPLLQT  363 (457)
Q Consensus       286 ~DFGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~-~~~~~~~  363 (457)
                      +|||+++.+.....   .....||+.|+|||++.+. .|+.++|||||||++|||++|..||.+........ ....+..
T Consensus       213 ~DFGla~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~  289 (440)
T PTZ00036        213 CDFGSAKNLLAGQR---SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGT  289 (440)
T ss_pred             eccccchhccCCCC---cccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCC
Confidence            99999987654322   1234589999999998764 68999999999999999999999998643211100 0000000


Q ss_pred             C---------------CcccccCchhhcccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 012765          364 S---------------NFKELVDPRLADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQ  409 (457)
Q Consensus       364 ~---------------~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~  409 (457)
                      .               .+..+....+...+.......+.+++.+||+.||.+|||+.|+++
T Consensus       290 p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~  350 (440)
T PTZ00036        290 PTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALA  350 (440)
T ss_pred             CCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhC
Confidence            0               011111111111111112346778999999999999999999985

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=4.2e-40  Score=329.85  Aligned_cols=248  Identities=24%  Similarity=0.336  Sum_probs=200.6

Q ss_pred             cCCCCCceecccCcEEEEEEEe-CCCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeee-cCceEEEE
Q 012765          142 DNFNSENLIGKGGHAEVYKGCL-PDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFST-ENGFHLVL  219 (457)
Q Consensus       142 ~~f~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~-~~~~~lv~  219 (457)
                      .-|.+.+.||.|+-|.|-.|++ .+|+..|||++.+...........+.+|+-+|+.+.|||++++|++++ ..++|+|+
T Consensus        12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvl   91 (786)
T KOG0588|consen   12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVL   91 (786)
T ss_pred             cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEE
Confidence            3456788999999999999975 579999999997765555555668899999999999999999999555 55688999


Q ss_pred             EecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCCCCCC
Q 012765          220 QFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWS  299 (457)
Q Consensus       220 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~~~~  299 (457)
                      ||+++|.|+++|...+. +++....+++.||+.|+.|+|.   .+|+||||||+|+||+..+++||+|||.|..-..+. 
T Consensus        92 Eyv~gGELFdylv~kG~-l~e~eaa~ff~QIi~gv~yCH~---~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~gk-  166 (786)
T KOG0588|consen   92 EYVPGGELFDYLVRKGP-LPEREAAHFFRQILDGVSYCHA---FNICHRDLKPENLLLDVKNNIKIADFGMASLEVPGK-  166 (786)
T ss_pred             EecCCchhHHHHHhhCC-CCCHHHHHHHHHHHHHHHHHhh---hcceeccCCchhhhhhcccCEeeeccceeecccCCc-
Confidence            99999999999976544 6777778899999999999999   899999999999999999999999999997765543 


Q ss_pred             ceeeecccccccccChhccccCCCC-cchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhccccccCCcccccCchhhccc
Q 012765          300 HHIVFPIEGTFGYLSPEYFMHGIVD-EKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSNFKELVDPRLADAY  378 (457)
Q Consensus       300 ~~~~~~~~gt~~y~aPE~~~~~~~~-~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~  378 (457)
                        ...+.||++.|.|||+++|..|+ .++||||.|||||.||||+.||++.+.... +.  ....+.+.      +..++
T Consensus       167 --lLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~L-Ll--KV~~G~f~------MPs~I  235 (786)
T KOG0588|consen  167 --LLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVL-LL--KVQRGVFE------MPSNI  235 (786)
T ss_pred             --cccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHH-HH--HHHcCccc------CCCcC
Confidence              34456799999999999999884 789999999999999999999995332111 00  01111110      11122


Q ss_pred             CHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 012765          379 DLAEMKRAMLTASVCIHHLSTMRPQMTRVLQ  409 (457)
Q Consensus       379 ~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~  409 (457)
                          ..+...++.+||..||+.|-|+.||++
T Consensus       236 ----s~eaQdLLr~ml~VDp~~RiT~~eI~k  262 (786)
T KOG0588|consen  236 ----SSEAQDLLRRMLDVDPSTRITTEEILK  262 (786)
T ss_pred             ----CHHHHHHHHHHhccCccccccHHHHhh
Confidence                234556788899999999999999998

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=2.4e-39  Score=323.84  Aligned_cols=247  Identities=28%  Similarity=0.418  Sum_probs=187.0

Q ss_pred             cCCCCCceecccCcEEEEEEEeC-CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeec-CceEEEE
Q 012765          142 DNFNSENLIGKGGHAEVYKGCLP-DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTE-NGFHLVL  219 (457)
Q Consensus       142 ~~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-~~~~lv~  219 (457)
                      ++|+..+.||+|+||.||+|.+. +++.||+|.+.....  ......+.+|+.+++.++|+||+++++++.. +.++++|
T Consensus        74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  151 (353)
T PLN00034         74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHE--DTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLL  151 (353)
T ss_pred             HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCc--HHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEE
Confidence            45567789999999999999864 689999998864432  2345678999999999999999999996654 4568999


Q ss_pred             EecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCCCCCC
Q 012765          220 QFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWS  299 (457)
Q Consensus       220 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~~~~  299 (457)
                      ||+.+++|....     ...+..+..++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||++..+.....
T Consensus       152 e~~~~~~L~~~~-----~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~  223 (353)
T PLN00034        152 EFMDGGSLEGTH-----IADEQFLADVARQILSGIAYLHR---RHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMD  223 (353)
T ss_pred             ecCCCCcccccc-----cCCHHHHHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEcCCCCEEEcccccceecccccc
Confidence            999999986532     34567778899999999999999   8999999999999999999999999999987643321


Q ss_pred             ceeeecccccccccChhcccc-----CCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhccccccCCcccccCchh
Q 012765          300 HHIVFPIEGTFGYLSPEYFMH-----GIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSNFKELVDPRL  374 (457)
Q Consensus       300 ~~~~~~~~gt~~y~aPE~~~~-----~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l  374 (457)
                      .  .....||..|+|||++..     ...+.++|||||||++|||++|+.||.......  |......   ......+..
T Consensus       224 ~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~--~~~~~~~---~~~~~~~~~  296 (353)
T PLN00034        224 P--CNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGD--WASLMCA---ICMSQPPEA  296 (353)
T ss_pred             c--ccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcc--HHHHHHH---HhccCCCCC
Confidence            1  123458999999998743     234568999999999999999999997422111  1100000   000000111


Q ss_pred             hcccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 012765          375 ADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQ  409 (457)
Q Consensus       375 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~  409 (457)
                          .......+.+++.+||+.||++|||+.||++
T Consensus       297 ----~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~  327 (353)
T PLN00034        297 ----PATASREFRHFISCCLQREPAKRWSAMQLLQ  327 (353)
T ss_pred             ----CCccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence                1122345678889999999999999999988

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=1.3e-38  Score=310.02  Aligned_cols=261  Identities=23%  Similarity=0.354  Sum_probs=199.6

Q ss_pred             hcCCCCCceecccCcEEEEEEEeCC-----------------CcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCc
Q 012765          141 TDNFNSENLIGKGGHAEVYKGCLPD-----------------GEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNA  203 (457)
Q Consensus       141 ~~~f~~~~~LG~G~~g~Vy~~~~~~-----------------~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpni  203 (457)
                      ..+|.+.+.||+|+||.||+|.+..                 +..||+|.+......  .....+.+|+.++++++||||
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i   81 (296)
T cd05051           4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASD--NAREDFLKEVKILSRLSDPNI   81 (296)
T ss_pred             hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCH--HHHHHHHHHHHHHHhcCCCCE
Confidence            4678899999999999999987542                 245899987654332  445688999999999999999


Q ss_pred             ceeeeeeec-CceEEEEEecCCCChhhhhhcCC----------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCC
Q 012765          204 AKLIGFSTE-NGFHLVLQFLPHGSLSSLLFGST----------ECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKA  272 (457)
Q Consensus       204 v~l~~~~~~-~~~~lv~e~~~~gsL~~~l~~~~----------~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp  272 (457)
                      +++++++.. +..+++|||+++++|..++....          ..+++..++.++.|++.||.|||+   .+++|+||||
T Consensus        82 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~---~~i~H~dlkp  158 (296)
T cd05051          82 ARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLES---LNFVHRDLAT  158 (296)
T ss_pred             eEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHH---cCccccccch
Confidence            999997665 55689999999999999985533          258899999999999999999999   8999999999


Q ss_pred             CcEEEcCCCcEEEeeccccccCCCCCCceeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHh--CCCCCCcCC
Q 012765          273 SNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELIT--GRRAVDSRR  350 (457)
Q Consensus       273 ~NIll~~~~~~kL~DFGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLlt--G~~pf~~~~  350 (457)
                      +||+++.++.++|+|||++..+.............++..|+|||++.+..++.++|||||||++|||++  |..||....
T Consensus       159 ~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~  238 (296)
T cd05051         159 RNCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLT  238 (296)
T ss_pred             hceeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcC
Confidence            999999999999999999987644332222223346778999999988889999999999999999998  677776533


Q ss_pred             cchh-hhhccccccCCcccccCchhhcccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 012765          351 QSLV-IWAKPLLQTSNFKELVDPRLADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQLLR  412 (457)
Q Consensus       351 ~~~~-~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~  412 (457)
                      .... .................      ........+.+++.+||+.+|++|||+.+|++.|+
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~  295 (296)
T cd05051         239 DQQVIENAGHFFRDDGRQIYLP------RPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ  295 (296)
T ss_pred             hHHHHHHHHhccccccccccCC------CccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence            2111 11111110000000000      01112246788999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=4.9e-39  Score=308.48  Aligned_cols=257  Identities=25%  Similarity=0.391  Sum_probs=199.8

Q ss_pred             hcCCCCCceecccCcEEEEEEEeC-CC---cEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeec-Cce
Q 012765          141 TDNFNSENLIGKGGHAEVYKGCLP-DG---EVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTE-NGF  215 (457)
Q Consensus       141 ~~~f~~~~~LG~G~~g~Vy~~~~~-~~---~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-~~~  215 (457)
                      .++|+..+.||+|+||.||+|.+. ++   ..+|+|.+.....  ......+.+|+.++.+++|||++++++++.. +..
T Consensus         4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   81 (268)
T cd05063           4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYT--EKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPA   81 (268)
T ss_pred             hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCC--HHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCc
Confidence            457788899999999999999864 23   3689998754322  2335678999999999999999999996654 456


Q ss_pred             EEEEEecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCC
Q 012765          216 HLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLP  295 (457)
Q Consensus       216 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~  295 (457)
                      +++|||+++++|..++......+++..++.++.|++.||.|||+   .+++|+||||+||+++.++.+||+|||++....
T Consensus        82 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~  158 (268)
T cd05063          82 MIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSD---MNYVHRDLAARNILVNSNLECKVSDFGLSRVLE  158 (268)
T ss_pred             EEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccchhhEEEcCCCcEEECCCccceecc
Confidence            89999999999999997666678999999999999999999999   899999999999999999999999999998765


Q ss_pred             CCCCceee-ecccccccccChhccccCCCCcchhHHHHHHHHHHHHh-CCCCCCcCCcchhhhhccccccCCcccccCch
Q 012765          296 DNWSHHIV-FPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELIT-GRRAVDSRRQSLVIWAKPLLQTSNFKELVDPR  373 (457)
Q Consensus       296 ~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLlt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~  373 (457)
                      ........ .....+..|+|||++.+..++.++|||||||++|||++ |+.||.........  ........        
T Consensus       159 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~--~~i~~~~~--------  228 (268)
T cd05063         159 DDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVM--KAINDGFR--------  228 (268)
T ss_pred             cccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHH--HHHhcCCC--------
Confidence            43221111 11223457999999988889999999999999999998 99999753322111  11000000        


Q ss_pred             hhcccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q 012765          374 LADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQLLRGE  414 (457)
Q Consensus       374 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~  414 (457)
                        ..........+.+++.+||+.+|++||++.+|++.|+++
T Consensus       229 --~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~  267 (268)
T cd05063         229 --LPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL  267 (268)
T ss_pred             --CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence              000111234577899999999999999999999999764

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=4.5e-39  Score=309.22  Aligned_cols=257  Identities=25%  Similarity=0.350  Sum_probs=203.0

Q ss_pred             hcCCCCCceecccCcEEEEEEEeCC----CcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeecCceE
Q 012765          141 TDNFNSENLIGKGGHAEVYKGCLPD----GEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTENGFH  216 (457)
Q Consensus       141 ~~~f~~~~~LG~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~  216 (457)
                      .++|.+.+.||+|+||.||+|.+.+    ...+++|.......  ....+.+.+|+.+++.++||||+++++++.+...+
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~--~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~   82 (270)
T cd05056           5 REDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTS--PSVREKFLQEAYIMRQFDHPHIVKLIGVITENPVW   82 (270)
T ss_pred             hhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCC--HHHHHHHHHHHHHHHhCCCCchhceeEEEcCCCcE
Confidence            3567788999999999999998643    34688887754332  23456889999999999999999999998888889


Q ss_pred             EEEEecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCCC
Q 012765          217 LVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPD  296 (457)
Q Consensus       217 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~  296 (457)
                      ++|||+++++|.+++......+++..++.++.+++.||.|||+   .+++|+||||+||+++.++.++|+|||++.....
T Consensus        83 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~  159 (270)
T cd05056          83 IVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLES---KRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLED  159 (270)
T ss_pred             EEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccccChheEEEecCCCeEEccCceeeeccc
Confidence            9999999999999997655668999999999999999999999   8999999999999999999999999999987654


Q ss_pred             CCCceeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHh-CCCCCCcCCcchhhhhccccccCCcccccCchhh
Q 012765          297 NWSHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELIT-GRRAVDSRRQSLVIWAKPLLQTSNFKELVDPRLA  375 (457)
Q Consensus       297 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLlt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  375 (457)
                      .... ......++..|+|||.+....++.++||||||+++|||++ |..||............  .....      ....
T Consensus       160 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~--~~~~~------~~~~  230 (270)
T cd05056         160 ESYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRI--ENGER------LPMP  230 (270)
T ss_pred             ccce-ecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHH--HcCCc------CCCC
Confidence            3211 1112234567999999988889999999999999999996 99999764332111110  00000      0011


Q ss_pred             cccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCC
Q 012765          376 DAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQLLRGEG  415 (457)
Q Consensus       376 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~  415 (457)
                      ..    ....+.+++.+|+..+|.+|||+.++++.|+.+.
T Consensus       231 ~~----~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~  266 (270)
T cd05056         231 PN----CPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDIL  266 (270)
T ss_pred             CC----CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence            11    2245777889999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=4.4e-39  Score=315.04  Aligned_cols=258  Identities=22%  Similarity=0.343  Sum_probs=199.4

Q ss_pred             hcCCCCCceecccCcEEEEEEEe------CCCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhc-CCCCcceeeeeeec-
Q 012765          141 TDNFNSENLIGKGGHAEVYKGCL------PDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHI-NHPNAAKLIGFSTE-  212 (457)
Q Consensus       141 ~~~f~~~~~LG~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~-  212 (457)
                      .++|.+.+.||+|+||.||+|..      ..+..+|+|.+.....  ......+.+|+.+++++ +||||+++++++.. 
T Consensus        34 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~  111 (302)
T cd05055          34 RNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAH--SSEREALMSELKIMSHLGNHENIVNLLGACTIG  111 (302)
T ss_pred             HHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCC--hHHHHHHHHHHHHHHhccCCCCcceEEEEEecC
Confidence            45788999999999999999963      1355799998764332  23356789999999999 79999999996654 


Q ss_pred             CceEEEEEecCCCChhhhhhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeecccc
Q 012765          213 NGFHLVLQFLPHGSLSSLLFGST-ECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLA  291 (457)
Q Consensus       213 ~~~~lv~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~  291 (457)
                      +..+++|||+++|+|.+++.... ..+++..+..++.|++.||.|||+   .+++|+||||+|||++.++.++|+|||++
T Consensus       112 ~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~~l~dfg~~  188 (302)
T cd05055         112 GPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNVLLTHGKIVKICDFGLA  188 (302)
T ss_pred             CceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeehhhhccceEEEcCCCeEEECCCccc
Confidence            45789999999999999986533 348999999999999999999999   89999999999999999999999999999


Q ss_pred             ccCCCCCCceeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHh-CCCCCCcCCcchhhhhccccccCCccccc
Q 012765          292 KWLPDNWSHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELIT-GRRAVDSRRQSLVIWAKPLLQTSNFKELV  370 (457)
Q Consensus       292 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLlt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~  370 (457)
                      ..+.............++..|+|||++.+..++.++|||||||++|||++ |..||.......... .          .+
T Consensus       189 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~-~----------~~  257 (302)
T cd05055         189 RDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFY-K----------LI  257 (302)
T ss_pred             ccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHH-H----------HH
Confidence            87654322111122345778999999999999999999999999999998 999987533211110 0          00


Q ss_pred             CchhhcccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q 012765          371 DPRLADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQLLRGE  414 (457)
Q Consensus       371 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~  414 (457)
                      +..............+.+++.+||..+|++|||+.+|++.|+..
T Consensus       258 ~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~  301 (302)
T cd05055         258 KEGYRMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ  301 (302)
T ss_pred             HcCCcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence            00000000011124577889999999999999999999999753

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.1e-39  Score=311.19  Aligned_cols=255  Identities=22%  Similarity=0.358  Sum_probs=198.4

Q ss_pred             hcCCCCCceecccCcEEEEEEEeC------CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeecC-
Q 012765          141 TDNFNSENLIGKGGHAEVYKGCLP------DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTEN-  213 (457)
Q Consensus       141 ~~~f~~~~~LG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~-  213 (457)
                      .++|.+.+.||+|+||.||+|...      .+..||+|.+.....  ......+.+|+.++..++||||+++++++..+ 
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~--~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~   82 (277)
T cd05032           5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENAS--MRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQ   82 (277)
T ss_pred             hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccC--HHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCC
Confidence            467888999999999999999754      246899998754432  23345788999999999999999999966554 


Q ss_pred             ceEEEEEecCCCChhhhhhcC---------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEE
Q 012765          214 GFHLVLQFLPHGSLSSLLFGS---------TECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQ  284 (457)
Q Consensus       214 ~~~lv~e~~~~gsL~~~l~~~---------~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~k  284 (457)
                      ..+++|||+++++|.+++...         ...+++..++.++.||+.||.|||+   .+++||||||+||+++.++.+|
T Consensus        83 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~di~p~nill~~~~~~k  159 (277)
T cd05032          83 PTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAA---KKFVHRDLAARNCMVAEDLTVK  159 (277)
T ss_pred             CcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHh---CCccccccChheEEEcCCCCEE
Confidence            468999999999999998542         1246788899999999999999999   8999999999999999999999


Q ss_pred             EeeccccccCCCCCCceeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHh-CCCCCCcCCcchhhhhcccccc
Q 012765          285 ISDFGLAKWLPDNWSHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELIT-GRRAVDSRRQSLVIWAKPLLQT  363 (457)
Q Consensus       285 L~DFGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLlt-G~~pf~~~~~~~~~~~~~~~~~  363 (457)
                      |+|||+++.+.............++..|+|||.+.+..++.++|||||||++|||++ |..||............   ..
T Consensus       160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~---~~  236 (277)
T cd05032         160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFV---ID  236 (277)
T ss_pred             ECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHH---hc
Confidence            999999886644322112223346788999999988889999999999999999998 99998753322111100   01


Q ss_pred             CCcccccCchhhcccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 012765          364 SNFKELVDPRLADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQLLR  412 (457)
Q Consensus       364 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~  412 (457)
                      ....     .....    ....+.+++.+||+.+|++|||+.++++.|+
T Consensus       237 ~~~~-----~~~~~----~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~  276 (277)
T cd05032         237 GGHL-----DLPEN----CPDKLLELMRMCWQYNPKMRPTFLEIVSSLK  276 (277)
T ss_pred             CCCC-----CCCCC----CCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence            1000     01111    1346778999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=2.7e-39  Score=326.99  Aligned_cols=204  Identities=22%  Similarity=0.332  Sum_probs=170.5

Q ss_pred             CCCCCceecccCcEEEEEEEeC-CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeec-CceEEEEE
Q 012765          143 NFNSENLIGKGGHAEVYKGCLP-DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTE-NGFHLVLQ  220 (457)
Q Consensus       143 ~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-~~~~lv~e  220 (457)
                      .|+..+.||+|+||+||+|... +++.||+|.+.+...........+.+|+.+++.++||||+++++++.+ +..++|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E   81 (382)
T cd05625           2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD   81 (382)
T ss_pred             CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence            5788999999999999999864 688999999865443334456688999999999999999999986554 55789999


Q ss_pred             ecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCCCCCC-
Q 012765          221 FLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWS-  299 (457)
Q Consensus       221 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~~~~-  299 (457)
                      |+++|+|.+++... ..+++.....++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||++..+..... 
T Consensus        82 ~~~gg~L~~~l~~~-~~~~e~~~~~~~~qi~~al~~lH~---~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~  157 (382)
T cd05625          82 YIPGGDMMSLLIRM-GIFPEDLARFYIAELTCAVESVHK---MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDS  157 (382)
T ss_pred             CCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEEeECCCCccccccccc
Confidence            99999999988553 457888888899999999999999   8999999999999999999999999999753311000 


Q ss_pred             --------------------------------------------ceeeecccccccccChhccccCCCCcchhHHHHHHH
Q 012765          300 --------------------------------------------HHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVL  335 (457)
Q Consensus       300 --------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvl  335 (457)
                                                                  ........||+.|+|||++.+..++.++|||||||+
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvi  237 (382)
T cd05625         158 KYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVI  237 (382)
T ss_pred             cccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechHH
Confidence                                                        000112468999999999999999999999999999


Q ss_pred             HHHHHhCCCCCCcCC
Q 012765          336 LLELITGRRAVDSRR  350 (457)
Q Consensus       336 l~eLltG~~pf~~~~  350 (457)
                      +|||++|+.||....
T Consensus       238 l~elltG~~Pf~~~~  252 (382)
T cd05625         238 LYEMLVGQPPFLAQT  252 (382)
T ss_pred             HHHHHhCCCCCCCCC
Confidence            999999999998644

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=1.5e-39  Score=328.15  Aligned_cols=254  Identities=20%  Similarity=0.239  Sum_probs=190.3

Q ss_pred             cCCCCCceecccCcEEEEEEEeC-CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeee-cCceEEEE
Q 012765          142 DNFNSENLIGKGGHAEVYKGCLP-DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFST-ENGFHLVL  219 (457)
Q Consensus       142 ~~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~-~~~~~lv~  219 (457)
                      .+|++.+.||+|+||.||+|... +++.||+|.+.............+.+|+.+++.++||||+++++.+. ++.+++||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~   80 (376)
T cd05598           1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM   80 (376)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence            36889999999999999999864 58999999886543333334567889999999999999999998655 45578999


Q ss_pred             EecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCCCCCC
Q 012765          220 QFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWS  299 (457)
Q Consensus       220 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~~~~  299 (457)
                      ||+++|+|.+++... ..++......++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||++..+.....
T Consensus        81 E~~~~g~L~~~i~~~-~~~~~~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~  156 (376)
T cd05598          81 DYIPGGDMMSLLIRL-GIFEEDLARFYIAELTCAIESVHK---MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHD  156 (376)
T ss_pred             eCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCCHHHEEECCCCCEEEEeCCCCcccccccc
Confidence            999999999998653 457888888899999999999999   8999999999999999999999999999753310000


Q ss_pred             -----------------------------------------ceeeecccccccccChhccccCCCCcchhHHHHHHHHHH
Q 012765          300 -----------------------------------------HHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLE  338 (457)
Q Consensus       300 -----------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~e  338 (457)
                                                               ........||+.|+|||++.+..++.++|||||||++||
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilye  236 (376)
T cd05598         157 SKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYE  236 (376)
T ss_pred             ccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeee
Confidence                                                     000112469999999999999999999999999999999


Q ss_pred             HHhCCCCCCcCCcchhhhhccccccCCcccccCchhhcccCHHHHHHHHHHHHHhcccCCCCCC---CHHHHHH
Q 012765          339 LITGRRAVDSRRQSLVIWAKPLLQTSNFKELVDPRLADAYDLAEMKRAMLTASVCIHHLSTMRP---QMTRVLQ  409 (457)
Q Consensus       339 LltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP---t~~evl~  409 (457)
                      |++|+.||................ ..   ...+. ....+    ..+.+++.+|+ .+|.+|+   ++.++++
T Consensus       237 ll~G~~Pf~~~~~~~~~~~i~~~~-~~---~~~~~-~~~~s----~~~~~li~~l~-~~p~~R~~~~t~~ell~  300 (376)
T cd05598         237 MLVGQPPFLADTPAETQLKVINWE-TT---LHIPS-QAKLS----REASDLILRLC-CGAEDRLGKNGADEIKA  300 (376)
T ss_pred             hhhCCCCCCCCCHHHHHHHHhccC-cc---ccCCC-CCCCC----HHHHHHHHHHh-cCHhhcCCCCCHHHHhC
Confidence            999999998654322111100000 00   00000 01122    23344555554 4999999   8888876

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=3.5e-39  Score=318.76  Aligned_cols=243  Identities=23%  Similarity=0.321  Sum_probs=188.5

Q ss_pred             ceecccCcEEEEEEEe----CCCcEEEEEEEeccch-hhHHHHHHHHHHHHHHhhcCCCCcceeeeeee-cCceEEEEEe
Q 012765          148 NLIGKGGHAEVYKGCL----PDGEVVAVKKIIKNAK-EDEERISDFLSELGIVAHINHPNAAKLIGFST-ENGFHLVLQF  221 (457)
Q Consensus       148 ~~LG~G~~g~Vy~~~~----~~~~~vavK~~~~~~~-~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~-~~~~~lv~e~  221 (457)
                      +.||+|+||.||++..    .+++.||+|.+.+... ........+.+|+.+++.++||||+++++++. ++..+++|||
T Consensus         2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~   81 (323)
T cd05584           2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY   81 (323)
T ss_pred             ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence            6799999999999975    3588999999865332 12233456788999999999999999998554 4557899999


Q ss_pred             cCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCCCCCCce
Q 012765          222 LPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSHH  301 (457)
Q Consensus       222 ~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~~~~~~  301 (457)
                      +++++|.+++... ..+.+..+..++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||+++.......  
T Consensus        82 ~~~~~L~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--  155 (323)
T cd05584          82 LSGGELFMHLERE-GIFMEDTACFYLSEISLALEHLHQ---QGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGT--  155 (323)
T ss_pred             CCCchHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCCEEEeeCcCCeecccCCC--
Confidence            9999999988543 456778888899999999999999   8999999999999999999999999999875432211  


Q ss_pred             eeecccccccccChhccccCCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhccccccCCcccccCchhhcccCHH
Q 012765          302 IVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSNFKELVDPRLADAYDLA  381 (457)
Q Consensus       302 ~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~  381 (457)
                      ......||+.|+|||++.+..++.++|||||||++|||++|+.||...+...... . ... ..      ..+...    
T Consensus       156 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~-~-~~~-~~------~~~~~~----  222 (323)
T cd05584         156 VTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTID-K-ILK-GK------LNLPPY----  222 (323)
T ss_pred             cccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHH-H-HHc-CC------CCCCCC----
Confidence            1223458999999999998889999999999999999999999998644321110 0 000 00      011111    


Q ss_pred             HHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 012765          382 EMKRAMLTASVCIHHLSTMRP-----QMTRVLQ  409 (457)
Q Consensus       382 ~~~~l~~l~~~Cl~~dP~~RP-----t~~evl~  409 (457)
                      ....+.+++.+||+.+|++||     ++.++++
T Consensus       223 ~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~  255 (323)
T cd05584         223 LTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQS  255 (323)
T ss_pred             CCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhc
Confidence            123466788999999999999     7777766

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=3.1e-39  Score=316.10  Aligned_cols=259  Identities=23%  Similarity=0.363  Sum_probs=199.2

Q ss_pred             hhcCCCCCceecccCcEEEEEEEeC--------CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhc-CCCCcceeeeee
Q 012765          140 ATDNFNSENLIGKGGHAEVYKGCLP--------DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHI-NHPNAAKLIGFS  210 (457)
Q Consensus       140 ~~~~f~~~~~LG~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~  210 (457)
                      ..++|.+.+.||+|+||.||+|...        ++..+|+|.+.....  ......+.+|+.++..+ +||||+++++++
T Consensus        13 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~--~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~   90 (304)
T cd05101          13 SRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDAT--EKDLSDLVSEMEMMKMIGKHKNIINLLGAC   90 (304)
T ss_pred             cHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccc--hHHHHHHHHHHHHHHhhccCCCchheeEEE
Confidence            3567888899999999999999631        245789998754322  23456889999999999 899999999966


Q ss_pred             ecC-ceEEEEEecCCCChhhhhhcC---------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCc
Q 012765          211 TEN-GFHLVLQFLPHGSLSSLLFGS---------------TECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASN  274 (457)
Q Consensus       211 ~~~-~~~lv~e~~~~gsL~~~l~~~---------------~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~N  274 (457)
                      ... ..+++|||+++|+|.+++...               ...+++..++.++.||+.||.|||+   .+++||||||+|
T Consensus        91 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~---~givH~dlkp~N  167 (304)
T cd05101          91 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLAS---QKCIHRDLAARN  167 (304)
T ss_pred             ecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHH---CCeeecccccce
Confidence            554 467999999999999998542               1347788899999999999999999   899999999999


Q ss_pred             EEEcCCCcEEEeeccccccCCCCCCceeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHh-CCCCCCcCCcch
Q 012765          275 ILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELIT-GRRAVDSRRQSL  353 (457)
Q Consensus       275 Ill~~~~~~kL~DFGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLlt-G~~pf~~~~~~~  353 (457)
                      |+++.++.+||+|||++..+.............++..|+|||++.+..++.++||||||+++|+|++ |..||.......
T Consensus       168 ili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~  247 (304)
T cd05101         168 VLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE  247 (304)
T ss_pred             EEEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHH
Confidence            9999999999999999987754332222222345678999999988889999999999999999998 788886532211


Q ss_pred             hhhhccccccCCcccccCchhhcccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCC
Q 012765          354 VIWAKPLLQTSNFKELVDPRLADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQLLRGEG  415 (457)
Q Consensus       354 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~  415 (457)
                        +.........      .    .........+..++.+||+.+|.+||++.+|++.|+.+.
T Consensus       248 --~~~~~~~~~~------~----~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~  297 (304)
T cd05101         248 --LFKLLKEGHR------M----DKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRIL  297 (304)
T ss_pred             --HHHHHHcCCc------C----CCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHH
Confidence              1111100000      0    001122345677899999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=3.7e-39  Score=318.58  Aligned_cols=243  Identities=23%  Similarity=0.297  Sum_probs=189.7

Q ss_pred             CCCCCceecccCcEEEEEEEeC-CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhc-CCCCcceeeeeeec-CceEEEE
Q 012765          143 NFNSENLIGKGGHAEVYKGCLP-DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHI-NHPNAAKLIGFSTE-NGFHLVL  219 (457)
Q Consensus       143 ~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~-~~~~lv~  219 (457)
                      +|.+.+.||+|+||.||+|... +++.||+|.+.+...........+..|..++..+ +|++|+++++++.. +.+++||
T Consensus         1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05616           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM   80 (323)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence            5788899999999999999865 5789999998764433334445677788888777 58899999986655 4578999


Q ss_pred             EecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCCCCCC
Q 012765          220 QFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWS  299 (457)
Q Consensus       220 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~~~~  299 (457)
                      ||+++|+|..++... ..+++..+..++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||++........
T Consensus        81 E~~~~g~L~~~~~~~-~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~~  156 (323)
T cd05616          81 EYVNGGDLMYQIQQV-GRFKEPHAVFYAAEIAIGLFFLHS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGV  156 (323)
T ss_pred             cCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHH---CCEEecCCCHHHeEECCCCcEEEccCCCceecCCCCC
Confidence            999999999888543 458889999999999999999999   8999999999999999999999999999875432211


Q ss_pred             ceeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhccccccCCcccccCchhhcccC
Q 012765          300 HHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSNFKELVDPRLADAYD  379 (457)
Q Consensus       300 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~  379 (457)
                        ......||+.|+|||++.+..++.++|||||||++|||+||+.||............  .         ....  .+.
T Consensus       157 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i--~---------~~~~--~~p  221 (323)
T cd05616         157 --TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSI--M---------EHNV--AYP  221 (323)
T ss_pred             --ccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHH--H---------hCCC--CCC
Confidence              122356899999999999999999999999999999999999999864432211110  0         0000  011


Q ss_pred             HHHHHHHHHHHHHhcccCCCCCCCH
Q 012765          380 LAEMKRAMLTASVCIHHLSTMRPQM  404 (457)
Q Consensus       380 ~~~~~~l~~l~~~Cl~~dP~~RPt~  404 (457)
                      ......+..++.+||+.+|.+|++.
T Consensus       222 ~~~s~~~~~li~~~l~~~p~~R~~~  246 (323)
T cd05616         222 KSMSKEAVAICKGLMTKHPGKRLGC  246 (323)
T ss_pred             CcCCHHHHHHHHHHcccCHHhcCCC
Confidence            1123456788899999999999985

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=6.2e-39  Score=310.82  Aligned_cols=268  Identities=24%  Similarity=0.354  Sum_probs=200.7

Q ss_pred             cCCCCCceecccCcEEEEEEEe-----CCCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeecC---
Q 012765          142 DNFNSENLIGKGGHAEVYKGCL-----PDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTEN---  213 (457)
Q Consensus       142 ~~f~~~~~LG~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~---  213 (457)
                      ..|.+.+.||+|+||.||++.+     .++..||+|.+.....  ......+.+|+.+++.++|||++++++++...   
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   81 (284)
T cd05079           4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESG--GNHIADLKKEIEILRNLYHENIVKYKGICTEDGGN   81 (284)
T ss_pred             hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCcccc--HHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCC
Confidence            3467889999999999999973     3578899998754322  23456899999999999999999999977653   


Q ss_pred             ceEEEEEecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeecccccc
Q 012765          214 GFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKW  293 (457)
Q Consensus       214 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~  293 (457)
                      ..+++|||+++++|.+++......+++..++.++.||+.||.|||+   .+++||||||+||+++.++.++|+|||++..
T Consensus        82 ~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~---~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~  158 (284)
T cd05079          82 GIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGS---RQYVHRDLAARNVLVESEHQVKIGDFGLTKA  158 (284)
T ss_pred             ceEEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecccchheEEEcCCCCEEECCCccccc
Confidence            4689999999999999986655568999999999999999999999   8999999999999999999999999999987


Q ss_pred             CCCCCCce-eeecccccccccChhccccCCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhccccccCCcccc---
Q 012765          294 LPDNWSHH-IVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSNFKEL---  369 (457)
Q Consensus       294 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~---  369 (457)
                      +....... ......++..|+|||++.+..++.++|||||||++|||++++.|+............+..........   
T Consensus       159 ~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (284)
T cd05079         159 IETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRV  238 (284)
T ss_pred             cccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHH
Confidence            65432211 11234467789999999888899999999999999999998876543111110000000000000000   


Q ss_pred             cCchhhcccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q 012765          370 VDPRLADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQLLRGE  414 (457)
Q Consensus       370 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~  414 (457)
                      +...............+.+++.+||+.+|++||++.+|++.|+.+
T Consensus       239 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~  283 (284)
T cd05079         239 LEEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI  283 (284)
T ss_pred             HHcCccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence            000000000112345688899999999999999999999999764

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=4.8e-39  Score=313.41  Aligned_cols=260  Identities=22%  Similarity=0.340  Sum_probs=195.5

Q ss_pred             hcCCCCCceecccCcEEEEEEEeCC---------------CcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcce
Q 012765          141 TDNFNSENLIGKGGHAEVYKGCLPD---------------GEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAK  205 (457)
Q Consensus       141 ~~~f~~~~~LG~G~~g~Vy~~~~~~---------------~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~  205 (457)
                      .++|.+.+.||+|+||.||++....               ...||+|.+.....  ......+.+|++++++++|||+++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~ei~~l~~l~h~~i~~   81 (295)
T cd05097           4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVT--KTARNDFLKEIKIMSRLKNPNIIR   81 (295)
T ss_pred             hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCC--HHHHHHHHHHHHHHHhCCCCCcCe
Confidence            3578899999999999999986532               23589998764322  234567899999999999999999


Q ss_pred             eeeeeec-CceEEEEEecCCCChhhhhhcCC-----------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCC
Q 012765          206 LIGFSTE-NGFHLVLQFLPHGSLSSLLFGST-----------ECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKAS  273 (457)
Q Consensus       206 l~~~~~~-~~~~lv~e~~~~gsL~~~l~~~~-----------~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~  273 (457)
                      +++++.. +..+++|||+++++|.+++....           ..+++..++.++.|++.||.|||+   .+++|+||||+
T Consensus        82 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~i~H~dlkp~  158 (295)
T cd05097          82 LLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLAS---LNFVHRDLATR  158 (295)
T ss_pred             EEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHh---cCeeccccChh
Confidence            9996654 55689999999999999884321           236788899999999999999999   89999999999


Q ss_pred             cEEEcCCCcEEEeeccccccCCCCCCceeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHh--CCCCCCcCCc
Q 012765          274 NILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELIT--GRRAVDSRRQ  351 (457)
Q Consensus       274 NIll~~~~~~kL~DFGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLlt--G~~pf~~~~~  351 (457)
                      ||+++.++.+||+|||++..+.............++..|+|||++.++.++.++|||||||++|+|++  |..||.....
T Consensus       159 Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~  238 (295)
T cd05097         159 NCLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSD  238 (295)
T ss_pred             hEEEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccCh
Confidence            99999999999999999987644322221222335678999999998899999999999999999998  6677765322


Q ss_pred             chhh-hhccccccC-CcccccCchhhcccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 012765          352 SLVI-WAKPLLQTS-NFKELVDPRLADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQLLR  412 (457)
Q Consensus       352 ~~~~-~~~~~~~~~-~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~  412 (457)
                      .... ......... .......+   .    .....+.+++.+||+.+|++||++.+|++.|+
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~---~----~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~  294 (295)
T cd05097         239 EQVIENTGEFFRNQGRQIYLSQT---P----LCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR  294 (295)
T ss_pred             HHHHHHHHHhhhhccccccCCCC---C----CCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence            1111 000000000 00000000   1    11246788999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=7e-39  Score=309.60  Aligned_cols=246  Identities=22%  Similarity=0.289  Sum_probs=189.3

Q ss_pred             ecccCcEEEEEEEeC-CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeee-cCceEEEEEecCCCCh
Q 012765          150 IGKGGHAEVYKGCLP-DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFST-ENGFHLVLQFLPHGSL  227 (457)
Q Consensus       150 LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~-~~~~~lv~e~~~~gsL  227 (457)
                      ||+|+||+||++... +|+.||+|.+.............+..|++++.+++||||+++++++. +...+++|||+++++|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L   80 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL   80 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence            799999999999864 58999999886433322223345667999999999999999998655 4557899999999999


Q ss_pred             hhhhhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCCCCCCceeeecc
Q 012765          228 SSLLFGS-TECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPI  306 (457)
Q Consensus       228 ~~~l~~~-~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~~~~~~~~~~~  306 (457)
                      ..++... ...+++..+..++.||+.||.|||+   .+++||||||+||+++.++.++|+|||++.......   .....
T Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~---~~~~~  154 (277)
T cd05607          81 KYHIYNVGERGLEMERVIHYSAQITCGILHLHS---MDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK---TITQR  154 (277)
T ss_pred             HHHHHhccccCCCHHHHHHHHHHHHHHHHHHHH---CCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCc---eeecc
Confidence            8887543 3458889999999999999999999   899999999999999999999999999988765432   12234


Q ss_pred             cccccccChhccccCCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchh--hhhccccccCCcccccCchhhcccCHHHHH
Q 012765          307 EGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLV--IWAKPLLQTSNFKELVDPRLADAYDLAEMK  384 (457)
Q Consensus       307 ~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~--~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~  384 (457)
                      .|+..|+|||++.+..++.++|||||||++|||++|+.||........  .....         .....+... ......
T Consensus       155 ~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~---------~~~~~~~~~-~~~~~~  224 (277)
T cd05607         155 AGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRR---------TLEDEVKFE-HQNFTE  224 (277)
T ss_pred             CCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHH---------hhccccccc-cccCCH
Confidence            589999999999988899999999999999999999999975322111  00000         000011000 011233


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHHHHH
Q 012765          385 RAMLTASVCIHHLSTMRPQMTRVLQLL  411 (457)
Q Consensus       385 ~l~~l~~~Cl~~dP~~RPt~~evl~~L  411 (457)
                      .+.+++..||+.||++||++.|+++.+
T Consensus       225 ~~~~li~~~L~~~P~~R~~~~~~~~~~  251 (277)
T cd05607         225 ESKDICRLFLAKKPEDRLGSREKNDDP  251 (277)
T ss_pred             HHHHHHHHHhccCHhhCCCCccchhhh
Confidence            567889999999999999998776433

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=7.2e-39  Score=317.35  Aligned_cols=246  Identities=23%  Similarity=0.275  Sum_probs=189.6

Q ss_pred             ceecccCcEEEEEEEeC-CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhc-CCCCcceeeeeeec-CceEEEEEecCC
Q 012765          148 NLIGKGGHAEVYKGCLP-DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHI-NHPNAAKLIGFSTE-NGFHLVLQFLPH  224 (457)
Q Consensus       148 ~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~-~~~~lv~e~~~~  224 (457)
                      ++||+|+||.||+|... +++.||+|.+.+...........+..|..++..+ +||||+++++++.. +.+++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~   80 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG   80 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence            46999999999999864 6889999998765444444556788999999888 79999999996654 557899999999


Q ss_pred             CChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCCCCCCceeee
Q 012765          225 GSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVF  304 (457)
Q Consensus       225 gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~~~~~~~~~  304 (457)
                      |+|..++... ..+++..+..++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||++.......  ....
T Consensus        81 g~L~~~~~~~-~~l~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~--~~~~  154 (329)
T cd05588          81 GDLMFHMQRQ-RKLPEEHARFYSAEISLALNFLHE---RGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPG--DTTS  154 (329)
T ss_pred             CCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEECCCCCEEECcCccccccccCC--Cccc
Confidence            9998887543 468999999999999999999999   899999999999999999999999999987532211  1123


Q ss_pred             cccccccccChhccccCCCCcchhHHHHHHHHHHHHhCCCCCCcCCcc------hhhhhccccccCCcccccCchhhccc
Q 012765          305 PIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQS------LVIWAKPLLQTSNFKELVDPRLADAY  378 (457)
Q Consensus       305 ~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~------~~~~~~~~~~~~~~~~~~d~~l~~~~  378 (457)
                      ...||..|+|||++.+..++.++|||||||++|||++|+.||......      ...+........      ...+...+
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~------~~~~p~~~  228 (329)
T cd05588         155 TFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEK------QIRIPRSL  228 (329)
T ss_pred             cccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcC------CCCCCCCC
Confidence            356899999999999999999999999999999999999999632110      001100000000      00111112


Q ss_pred             CHHHHHHHHHHHHHhcccCCCCCCC------HHHHHH
Q 012765          379 DLAEMKRAMLTASVCIHHLSTMRPQ------MTRVLQ  409 (457)
Q Consensus       379 ~~~~~~~l~~l~~~Cl~~dP~~RPt------~~evl~  409 (457)
                          ...+..++.+||+.||.+||+      +.++++
T Consensus       229 ----~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~  261 (329)
T cd05588         229 ----SVKASSVLKGFLNKDPKERLGCHPQTGFRDIKS  261 (329)
T ss_pred             ----CHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhc
Confidence                234677889999999999997      566654

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=3.9e-39  Score=318.07  Aligned_cols=238  Identities=24%  Similarity=0.328  Sum_probs=186.1

Q ss_pred             ceecccCcEEEEEEEeC-CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhc-CCCCcceeeeeeec-CceEEEEEecCC
Q 012765          148 NLIGKGGHAEVYKGCLP-DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHI-NHPNAAKLIGFSTE-NGFHLVLQFLPH  224 (457)
Q Consensus       148 ~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~-~~~~lv~e~~~~  224 (457)
                      ++||+|+||+||+|... +++.||+|.+.+...........+..|..++..+ +||||+++++++.. +.+++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~   80 (320)
T cd05590           1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG   80 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999865 5889999998754333334456778888888776 69999999996655 457899999999


Q ss_pred             CChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCCCCCCceeee
Q 012765          225 GSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVF  304 (457)
Q Consensus       225 gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~~~~~~~~~  304 (457)
                      |+|..++... ..+++..+..++.|++.||.|||+   .+|+||||||+|||++.++.+||+|||++........  ...
T Consensus        81 g~L~~~i~~~-~~l~~~~~~~~~~ql~~~L~~lH~---~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~--~~~  154 (320)
T cd05590          81 GDLMFHIQKS-RRFDEARARFYAAEITSALMFLHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGK--TTS  154 (320)
T ss_pred             chHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCC--ccc
Confidence            9999888543 458889999999999999999999   8999999999999999999999999999875422211  122


Q ss_pred             cccccccccChhccccCCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhccccccCCcccccCchhhcccCHHHHH
Q 012765          305 PIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSNFKELVDPRLADAYDLAEMK  384 (457)
Q Consensus       305 ~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~  384 (457)
                      ...||+.|+|||++.+..++.++|||||||++|||++|+.||......... .. .....       ......    ...
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~-~~-i~~~~-------~~~~~~----~~~  221 (320)
T cd05590         155 TFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLF-EA-ILNDE-------VVYPTW----LSQ  221 (320)
T ss_pred             ccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHH-HH-HhcCC-------CCCCCC----CCH
Confidence            346899999999999889999999999999999999999999864432111 10 01000       000111    123


Q ss_pred             HHHHHHHHhcccCCCCCCCH
Q 012765          385 RAMLTASVCIHHLSTMRPQM  404 (457)
Q Consensus       385 ~l~~l~~~Cl~~dP~~RPt~  404 (457)
                      .+.+++.+||+.||.+||++
T Consensus       222 ~~~~li~~~L~~dP~~R~~~  241 (320)
T cd05590         222 DAVDILKAFMTKNPTMRLGS  241 (320)
T ss_pred             HHHHHHHHHcccCHHHCCCC
Confidence            46678899999999999998

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=1.6e-39  Score=327.22  Aligned_cols=255  Identities=22%  Similarity=0.274  Sum_probs=195.9

Q ss_pred             hhcCCCCCceecccCcEEEEEEEeC-CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeecC-ceEE
Q 012765          140 ATDNFNSENLIGKGGHAEVYKGCLP-DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTEN-GFHL  217 (457)
Q Consensus       140 ~~~~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~-~~~l  217 (457)
                      ..++|++.+.||+|+||.||+|... +++.||+|.+.+...........+.+|+.+++.++||||+++++++.++ ..++
T Consensus        41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~l  120 (370)
T cd05596          41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYM  120 (370)
T ss_pred             CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEE
Confidence            4578889999999999999999865 5889999998653322233345678899999999999999999866554 4789


Q ss_pred             EEEecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCCCC
Q 012765          218 VLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDN  297 (457)
Q Consensus       218 v~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~~  297 (457)
                      ||||+++|+|..++..  ..++...+..++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||++..+...
T Consensus       121 v~Ey~~gg~L~~~l~~--~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~  195 (370)
T cd05596         121 VMEYMPGGDLVNLMSN--YDIPEKWARFYTAEVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDAN  195 (370)
T ss_pred             EEcCCCCCcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEEcCCCCEEEEeccceeeccCC
Confidence            9999999999998854  347778888899999999999999   89999999999999999999999999999876432


Q ss_pred             CCceeeecccccccccChhccccC----CCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhccccccCCcccccCch
Q 012765          298 WSHHIVFPIEGTFGYLSPEYFMHG----IVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSNFKELVDPR  373 (457)
Q Consensus       298 ~~~~~~~~~~gt~~y~aPE~~~~~----~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~  373 (457)
                      ... ......||+.|+|||++.+.    .++.++|||||||++|||++|+.||....... .+... ......  +   .
T Consensus       196 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~-~~~~i-~~~~~~--~---~  267 (370)
T cd05596         196 GMV-RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVG-TYSKI-MDHKNS--L---T  267 (370)
T ss_pred             Ccc-cCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHH-HHHHH-HcCCCc--C---C
Confidence            211 11235699999999998653    47899999999999999999999998644321 11110 100000  0   0


Q ss_pred             hhcccCHHHHHHHHHHHHHhcccCCCC--CCCHHHHHH
Q 012765          374 LADAYDLAEMKRAMLTASVCIHHLSTM--RPQMTRVLQ  409 (457)
Q Consensus       374 l~~~~~~~~~~~l~~l~~~Cl~~dP~~--RPt~~evl~  409 (457)
                      ...  .......+..++..||+.+|.+  ||++.++++
T Consensus       268 ~~~--~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~  303 (370)
T cd05596         268 FPD--DIEISKQAKDLICAFLTDREVRLGRNGVDEIKS  303 (370)
T ss_pred             CCC--cCCCCHHHHHHHHHHccChhhccCCCCHHHHhc
Confidence            000  1112345667888999999988  999999976

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=3.6e-39  Score=318.38  Aligned_cols=243  Identities=23%  Similarity=0.288  Sum_probs=189.6

Q ss_pred             ceecccCcEEEEEEEeC-CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhc-CCCCcceeeeeeec-CceEEEEEecCC
Q 012765          148 NLIGKGGHAEVYKGCLP-DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHI-NHPNAAKLIGFSTE-NGFHLVLQFLPH  224 (457)
Q Consensus       148 ~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~-~~~~lv~e~~~~  224 (457)
                      ++||+|+||.||+|... +++.||+|.+.............+..|..++..+ +||||+++++++.. +..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~   80 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG   80 (321)
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence            46999999999999865 5789999998764433334456778888888765 79999999996655 457899999999


Q ss_pred             CChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCCCCCCceeee
Q 012765          225 GSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVF  304 (457)
Q Consensus       225 gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~~~~~~~~~  304 (457)
                      |+|..++... ..+++..+..++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||++........  ...
T Consensus        81 ~~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~--~~~  154 (321)
T cd05591          81 GDLMFQIQRS-RKFDEPRSRFYAAEVTLALMFLHR---HGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGV--TTT  154 (321)
T ss_pred             CcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEEeecccceecccCCc--ccc
Confidence            9999888543 457888889999999999999999   8999999999999999999999999999875432211  123


Q ss_pred             cccccccccChhccccCCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhccccccCCcccccCchhhcccCHHHHH
Q 012765          305 PIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSNFKELVDPRLADAYDLAEMK  384 (457)
Q Consensus       305 ~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~  384 (457)
                      ...||+.|+|||++.+..++.++|||||||++|||++|+.||........... ........     +   ..    ...
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~-i~~~~~~~-----p---~~----~~~  221 (321)
T cd05591         155 TFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFES-ILHDDVLY-----P---VW----LSK  221 (321)
T ss_pred             ccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHH-HHcCCCCC-----C---CC----CCH
Confidence            34589999999999988999999999999999999999999986443221110 00000000     0   11    123


Q ss_pred             HHHHHHHHhcccCCCCCC-------CHHHHHH
Q 012765          385 RAMLTASVCIHHLSTMRP-------QMTRVLQ  409 (457)
Q Consensus       385 ~l~~l~~~Cl~~dP~~RP-------t~~evl~  409 (457)
                      .+.+++..||+.||++||       ++.++++
T Consensus       222 ~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~  253 (321)
T cd05591         222 EAVSILKAFMTKNPNKRLGCVASQGGEDAIKQ  253 (321)
T ss_pred             HHHHHHHHHhccCHHHcCCCCCCCCCHHHHhc
Confidence            566788899999999999       7777765

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=3.3e-39  Score=316.45  Aligned_cols=258  Identities=25%  Similarity=0.366  Sum_probs=197.6

Q ss_pred             hcCCCCCceecccCcEEEEEEEeC--------CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhc-CCCCcceeeeeee
Q 012765          141 TDNFNSENLIGKGGHAEVYKGCLP--------DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHI-NHPNAAKLIGFST  211 (457)
Q Consensus       141 ~~~f~~~~~LG~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~  211 (457)
                      .++|.+.+.||+|+||.||+|...        ++..+|+|.+.....  ......+.+|+.++..+ +||||+++++++.
T Consensus        17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~   94 (307)
T cd05098          17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDAT--EKDLSDLISEMEMMKMIGKHKNIINLLGACT   94 (307)
T ss_pred             hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCC--hHHHHHHHHHHHHHHHhcCCCCEeeEEEEEe
Confidence            367889999999999999999742        235799998864422  23356788999999999 7999999999665


Q ss_pred             c-CceEEEEEecCCCChhhhhhcCC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcE
Q 012765          212 E-NGFHLVLQFLPHGSLSSLLFGST---------------ECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNI  275 (457)
Q Consensus       212 ~-~~~~lv~e~~~~gsL~~~l~~~~---------------~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NI  275 (457)
                      . +..+++|||+++|+|.+++....               ..+++..++.++.|++.||.|||+   .+++||||||+||
T Consensus        95 ~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~---~gi~H~dlkp~Ni  171 (307)
T cd05098          95 QDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNV  171 (307)
T ss_pred             cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHH---CCcccccccHHhe
Confidence            5 45679999999999999986432               347889999999999999999999   8999999999999


Q ss_pred             EEcCCCcEEEeeccccccCCCCCCceeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHh-CCCCCCcCCcchh
Q 012765          276 LLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELIT-GRRAVDSRRQSLV  354 (457)
Q Consensus       276 ll~~~~~~kL~DFGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLlt-G~~pf~~~~~~~~  354 (457)
                      +++.++.+||+|||++................++..|+|||++.+..++.++|||||||++|||++ |..||........
T Consensus       172 ll~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~~~  251 (307)
T cd05098         172 LVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL  251 (307)
T ss_pred             EEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHHHH
Confidence            999999999999999876643221111111224568999999998889999999999999999998 8888865332111


Q ss_pred             hhhccccccCCcccccCchhhcccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCC
Q 012765          355 IWAKPLLQTSNFKELVDPRLADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQLLRGEG  415 (457)
Q Consensus       355 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~  415 (457)
                      .  ..... ..         ...........+.+++.+||+.+|.+||++.+|++.|+.+.
T Consensus       252 ~--~~~~~-~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~  300 (307)
T cd05098         252 F--KLLKE-GH---------RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL  300 (307)
T ss_pred             H--HHHHc-CC---------CCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHH
Confidence            1  10000 00         00111122346667899999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=5e-39  Score=318.52  Aligned_cols=241  Identities=24%  Similarity=0.286  Sum_probs=185.3

Q ss_pred             ceecccCcEEEEEEEeC-CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhc-CCCCcceeeeeee-cCceEEEEEecCC
Q 012765          148 NLIGKGGHAEVYKGCLP-DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHI-NHPNAAKLIGFST-ENGFHLVLQFLPH  224 (457)
Q Consensus       148 ~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~-~~~~~lv~e~~~~  224 (457)
                      ++||+|+||.||+|... +++.||+|.+.+...........+..|+.++.++ +||||+++++++. .+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~   80 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG   80 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence            46999999999999865 5889999998765444444556788899888776 8999999999654 4557899999999


Q ss_pred             CChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCCCCCCceeee
Q 012765          225 GSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVF  304 (457)
Q Consensus       225 gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~~~~~~~~~  304 (457)
                      |+|..++... ..+++..+..++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||+++.......  ...
T Consensus        81 ~~L~~~~~~~-~~l~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~--~~~  154 (329)
T cd05618          81 GDLMFHMQRQ-RKLPEEHARFYSAEISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD--TTS  154 (329)
T ss_pred             CCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCC--ccc
Confidence            9998887543 458899999999999999999999   8999999999999999999999999999875422111  122


Q ss_pred             cccccccccChhccccCCCCcchhHHHHHHHHHHHHhCCCCCCcCCcc------hhhhhccccccCCcccccCchhhccc
Q 012765          305 PIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQS------LVIWAKPLLQTSNFKELVDPRLADAY  378 (457)
Q Consensus       305 ~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~------~~~~~~~~~~~~~~~~~~d~~l~~~~  378 (457)
                      ...||..|+|||++.+..++.++|||||||++|||++|+.||......      ...+........      ...+..  
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~------~~~~p~--  226 (329)
T cd05618         155 TFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEK------QIRIPR--  226 (329)
T ss_pred             cccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcC------CCCCCC--
Confidence            346899999999999999999999999999999999999999631110      000000000000      001111  


Q ss_pred             CHHHHHHHHHHHHHhcccCCCCCCCH
Q 012765          379 DLAEMKRAMLTASVCIHHLSTMRPQM  404 (457)
Q Consensus       379 ~~~~~~~l~~l~~~Cl~~dP~~RPt~  404 (457)
                        .....+..++.+||+.||.+||+.
T Consensus       227 --~~~~~~~~ll~~~L~~dP~~R~~~  250 (329)
T cd05618         227 --SLSVKAASVLKSFLNKDPKERLGC  250 (329)
T ss_pred             --CCCHHHHHHHHHHhcCCHHHcCCC
Confidence              123456688899999999999983

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=8.6e-39  Score=323.74  Aligned_cols=254  Identities=21%  Similarity=0.241  Sum_probs=189.2

Q ss_pred             hcCCCCCceecccCcEEEEEEEeC-CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeec-CceEEE
Q 012765          141 TDNFNSENLIGKGGHAEVYKGCLP-DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTE-NGFHLV  218 (457)
Q Consensus       141 ~~~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-~~~~lv  218 (457)
                      ..+|.+.+.||+|+||.||++.+. +++.||+|...         ...+.+|+.++++++||||+++++++.. ...+++
T Consensus        91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~---------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv  161 (391)
T PHA03212         91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ---------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLI  161 (391)
T ss_pred             cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh---------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEE
Confidence            467999999999999999999864 68899999642         1246789999999999999999996654 446788


Q ss_pred             EEecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCCCCC
Q 012765          219 LQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNW  298 (457)
Q Consensus       219 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~~~  298 (457)
                      +|++. ++|..++... ..+++..++.++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||++.......
T Consensus       162 ~e~~~-~~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~ylH~---~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~  236 (391)
T PHA03212        162 LPRYK-TDLYCYLAAK-RNIAICDILAIERSVLRAIQYLHE---NRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDIN  236 (391)
T ss_pred             EecCC-CCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChHhEEEcCCCCEEEEeCCccccccccc
Confidence            99885 6788777543 457899999999999999999999   899999999999999999999999999997543221


Q ss_pred             CceeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHhCCCCCCcCCcc---------hhhhhcccc--------
Q 012765          299 SHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQS---------LVIWAKPLL--------  361 (457)
Q Consensus       299 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~---------~~~~~~~~~--------  361 (457)
                      . .......||+.|+|||++.+..++.++|||||||++|||++|+.||......         +........        
T Consensus       237 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~  315 (391)
T PHA03212        237 A-NKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPI  315 (391)
T ss_pred             c-cccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCc
Confidence            1 1223456999999999999999999999999999999999999886532110         000000000        


Q ss_pred             -ccCCccccc---------Cchhhccc--CHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 012765          362 -QTSNFKELV---------DPRLADAY--DLAEMKRAMLTASVCIHHLSTMRPQMTRVLQ  409 (457)
Q Consensus       362 -~~~~~~~~~---------d~~l~~~~--~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~  409 (457)
                       ....+..+.         .+......  .......+..++.+||+.||.+|||+.|+++
T Consensus       316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~  375 (391)
T PHA03212        316 DAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLD  375 (391)
T ss_pred             chhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhc
Confidence             000000000         00000000  0112345778899999999999999999986

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=9.7e-39  Score=304.30  Aligned_cols=249  Identities=26%  Similarity=0.409  Sum_probs=199.8

Q ss_pred             hcCCCCCceecccCcEEEEEEEeCCCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeee-cCceEEEE
Q 012765          141 TDNFNSENLIGKGGHAEVYKGCLPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFST-ENGFHLVL  219 (457)
Q Consensus       141 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~-~~~~~lv~  219 (457)
                      .++|.+.+.||.|+||.||+|.. .|+.||+|.+.....    ....+.+|+.+++.++|+||+++++++. ....+++|
T Consensus         5 ~~~~~~~~~ig~g~~g~v~~~~~-~~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~   79 (256)
T cd05039           5 SKELKLGATIGKGEFGDVMLGDY-RGQKVAVKCLKDDST----AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVT   79 (256)
T ss_pred             hhhccceeeeecCCCceEEEEEe-cCcEEEEEEeccchh----HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEE
Confidence            35788899999999999999987 578999998865432    3567899999999999999999999766 55678999


Q ss_pred             EecCCCChhhhhhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCCCCC
Q 012765          220 QFLPHGSLSSLLFGST-ECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNW  298 (457)
Q Consensus       220 e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~~~  298 (457)
                      ||+++++|.+++.... ..+++..+..++.|++.||.|||+   .+++|+||||+||+++.++.++|+|||++.......
T Consensus        80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~---~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~  156 (256)
T cd05039          80 EYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEE---KNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQ  156 (256)
T ss_pred             EecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCccchhcccceEEEeCCCCEEEccccccccccccc
Confidence            9999999999986543 368999999999999999999999   899999999999999999999999999998764332


Q ss_pred             CceeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHh-CCCCCCcCCcchhhhhccccccCCcccccCchhhcc
Q 012765          299 SHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELIT-GRRAVDSRRQSLVIWAKPLLQTSNFKELVDPRLADA  377 (457)
Q Consensus       299 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLlt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~  377 (457)
                      .     ....+..|+|||++....++.++||||||+++|||++ |..||.........-.   .... .    ....   
T Consensus       157 ~-----~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~---~~~~-~----~~~~---  220 (256)
T cd05039         157 D-----SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPH---VEKG-Y----RMEA---  220 (256)
T ss_pred             c-----cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH---HhcC-C----CCCC---
Confidence            1     2234667999999988889999999999999999997 9999875432211100   0000 0    0000   


Q ss_pred             cCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q 012765          378 YDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQLLRGE  414 (457)
Q Consensus       378 ~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~  414 (457)
                       .......+.+++.+||..+|++||++.+++++|+.+
T Consensus       221 -~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~  256 (256)
T cd05039         221 -PEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLALI  256 (256)
T ss_pred             -ccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhcC
Confidence             111234567889999999999999999999999753

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=5e-39  Score=310.89  Aligned_cols=254  Identities=21%  Similarity=0.312  Sum_probs=195.7

Q ss_pred             cCCCCCceecccCcEEEEEEEeC------CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeecC-c
Q 012765          142 DNFNSENLIGKGGHAEVYKGCLP------DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTEN-G  214 (457)
Q Consensus       142 ~~f~~~~~LG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~-~  214 (457)
                      ++|...+.||+|+||.||++...      ++..+|+|.+....   ......+.+|+.+++.++|+||+++++++... .
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   81 (280)
T cd05092           5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS---ESARQDFQREAELLTVLQHQHIVRFYGVCTEGRP   81 (280)
T ss_pred             HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCC---HHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCc
Confidence            46777899999999999999632      35678888765432   23456899999999999999999999976654 4


Q ss_pred             eEEEEEecCCCChhhhhhcCC--------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCC
Q 012765          215 FHLVLQFLPHGSLSSLLFGST--------------ECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSED  280 (457)
Q Consensus       215 ~~lv~e~~~~gsL~~~l~~~~--------------~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~  280 (457)
                      .+++|||+++++|.+++....              ..+++..++.++.||+.||.|||+   .+++||||||+|||++++
T Consensus        82 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~---~~i~H~dlkp~nil~~~~  158 (280)
T cd05092          82 LLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLAS---LHFVHRDLATRNCLVGQG  158 (280)
T ss_pred             eEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHH---CCeecccccHhhEEEcCC
Confidence            689999999999999985432              247889999999999999999999   899999999999999999


Q ss_pred             CcEEEeeccccccCCCCCCceeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHh-CCCCCCcCCcchhhhhcc
Q 012765          281 YEAQISDFGLAKWLPDNWSHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELIT-GRRAVDSRRQSLVIWAKP  359 (457)
Q Consensus       281 ~~~kL~DFGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLlt-G~~pf~~~~~~~~~~~~~  359 (457)
                      +.+||+|||++................+++.|+|||++.+..++.++|||||||++|||++ |..||.............
T Consensus       159 ~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~  238 (280)
T cd05092         159 LVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECIT  238 (280)
T ss_pred             CCEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHHHH
Confidence            9999999999876543322111222335678999999999999999999999999999998 899986533221111100


Q ss_pred             ccccCCcccccCchhhcccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 012765          360 LLQTSNFKELVDPRLADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQLLRG  413 (457)
Q Consensus       360 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~  413 (457)
                        ...      .......    ....+.+++.+||+.+|++||++.+|++.|+.
T Consensus       239 --~~~------~~~~~~~----~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~~  280 (280)
T cd05092         239 --QGR------ELERPRT----CPPEVYAIMQGCWQREPQQRMVIKDIHSRLQA  280 (280)
T ss_pred             --cCc------cCCCCCC----CCHHHHHHHHHHccCChhhCCCHHHHHHHHhC
Confidence              000      0000011    12346788899999999999999999998863

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=1e-38  Score=303.68  Aligned_cols=249  Identities=28%  Similarity=0.398  Sum_probs=198.9

Q ss_pred             CCCCCceecccCcEEEEEEEeC-CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeec-CceEEEEE
Q 012765          143 NFNSENLIGKGGHAEVYKGCLP-DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTE-NGFHLVLQ  220 (457)
Q Consensus       143 ~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-~~~~lv~e  220 (457)
                      +|.+.+.||+|+||.||+|... +++.|++|.+...... ......+.+|+.+++.++|||++++++++.+ +..+++||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   79 (256)
T cd08529           1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMN-RREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVME   79 (256)
T ss_pred             CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCC-HHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEE
Confidence            4778899999999999999864 6899999987543222 3345688999999999999999999996655 45789999


Q ss_pred             ecCCCChhhhhhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCCCCCC
Q 012765          221 FLPHGSLSSLLFGS-TECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWS  299 (457)
Q Consensus       221 ~~~~gsL~~~l~~~-~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~~~~  299 (457)
                      |+++++|.+++... ...+++..++.++.|++.||.|||+   .+++|+||||+||+++.++.++|+|||++..+.....
T Consensus        80 ~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~---~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~  156 (256)
T cd08529          80 YAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHS---KKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTN  156 (256)
T ss_pred             eCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcceEEEeCCCCEEEcccccceeccCccc
Confidence            99999999998664 4568899999999999999999999   8999999999999999999999999999887654322


Q ss_pred             ceeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhccccccCCcccccCchhhcccC
Q 012765          300 HHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSNFKELVDPRLADAYD  379 (457)
Q Consensus       300 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~  379 (457)
                      .  .....|+..|+|||++.+..++.++|+||||+++++|++|+.||............   .....     +.+    .
T Consensus       157 ~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~---~~~~~-----~~~----~  222 (256)
T cd08529         157 F--ANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKI---IRGVF-----PPV----S  222 (256)
T ss_pred             h--hhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHH---HcCCC-----CCC----c
Confidence            1  12245788999999999999999999999999999999999999864422111100   00000     111    1


Q ss_pred             HHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 012765          380 LAEMKRAMLTASVCIHHLSTMRPQMTRVLQ  409 (457)
Q Consensus       380 ~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~  409 (457)
                      ......+.+++.+||+.+|++||++.++++
T Consensus       223 ~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~  252 (256)
T cd08529         223 QMYSQQLAQLIDQCLTKDYRQRPDTFQLLR  252 (256)
T ss_pred             cccCHHHHHHHHHHccCCcccCcCHHHHhh
Confidence            123346778899999999999999999986

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=4.4e-39  Score=320.75  Aligned_cols=259  Identities=26%  Similarity=0.380  Sum_probs=197.2

Q ss_pred             hcCCCCCceecccCcEEEEEEEe------CCCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhc-CCCCcceeeeeeec-
Q 012765          141 TDNFNSENLIGKGGHAEVYKGCL------PDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHI-NHPNAAKLIGFSTE-  212 (457)
Q Consensus       141 ~~~f~~~~~LG~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~-  212 (457)
                      .++|.+.+.||+|+||.||+|.+      .+++.||||++.....  ......+.+|+.++.++ +||||+++++++.. 
T Consensus         6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~   83 (343)
T cd05103           6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT--HSEHRALMSELKILIHIGHHLNVVNLLGACTKP   83 (343)
T ss_pred             hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCC--hHHHHHHHHHHHHHHhccCCccHhhhcceeecC
Confidence            46788999999999999999963      3578999999865432  23356788999999999 68999999996654 


Q ss_pred             -CceEEEEEecCCCChhhhhhcCC--------------------------------------------------------
Q 012765          213 -NGFHLVLQFLPHGSLSSLLFGST--------------------------------------------------------  235 (457)
Q Consensus       213 -~~~~lv~e~~~~gsL~~~l~~~~--------------------------------------------------------  235 (457)
                       ...+++|||+++|+|.+++....                                                        
T Consensus        84 ~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  163 (343)
T cd05103          84 GGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEE  163 (343)
T ss_pred             CCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchh
Confidence             34679999999999999885321                                                        


Q ss_pred             ----------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCCCCCCceeeec
Q 012765          236 ----------ECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFP  305 (457)
Q Consensus       236 ----------~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~~~~~~~~~~  305 (457)
                                ..+++.....++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||++..............
T Consensus       164 ~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~  240 (343)
T cd05103         164 EEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGD  240 (343)
T ss_pred             hhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCC
Confidence                      236777888999999999999999   8999999999999999999999999999987543221111112


Q ss_pred             ccccccccChhccccCCCCcchhHHHHHHHHHHHHh-CCCCCCcCCcchhhhhccccccCCcccccCchhhcccCHHHHH
Q 012765          306 IEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELIT-GRRAVDSRRQSLVIWAKPLLQTSNFKELVDPRLADAYDLAEMK  384 (457)
Q Consensus       306 ~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLlt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~  384 (457)
                      ..++..|+|||++.+..++.++||||||+++|+|++ |..||.......... .. ......     .......    ..
T Consensus       241 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~-~~-~~~~~~-----~~~~~~~----~~  309 (343)
T cd05103         241 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC-RR-LKEGTR-----MRAPDYT----TP  309 (343)
T ss_pred             CCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHH-HH-HhccCC-----CCCCCCC----CH
Confidence            335678999999988899999999999999999997 899987532211110 00 000000     0000111    23


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHHHHHhcCC
Q 012765          385 RAMLTASVCIHHLSTMRPQMTRVLQLLRGEG  415 (457)
Q Consensus       385 ~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~  415 (457)
                      .+.+++..||+.+|++||++.+|++.|+.+.
T Consensus       310 ~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~  340 (343)
T cd05103         310 EMYQTMLDCWHGEPSQRPTFSELVEHLGNLL  340 (343)
T ss_pred             HHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence            4678889999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=3.2e-41  Score=309.56  Aligned_cols=248  Identities=25%  Similarity=0.359  Sum_probs=209.1

Q ss_pred             cCCCCCceecccCcEEEEEEEeC-CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeee-eeecCceEEEE
Q 012765          142 DNFNSENLIGKGGHAEVYKGCLP-DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIG-FSTENGFHLVL  219 (457)
Q Consensus       142 ~~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~-~~~~~~~~lv~  219 (457)
                      +-|.++.+||+|+||.||+|.++ .|+.+|||++.-..     ..+++.+|+.+|.+++.|++|++|| |+...++++||
T Consensus        33 EVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~s-----DLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVM  107 (502)
T KOG0574|consen   33 EVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDT-----DLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVM  107 (502)
T ss_pred             HHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccc-----hHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeeh
Confidence            44667889999999999999754 69999999985442     3568999999999999999999999 88889999999


Q ss_pred             EecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCCCCCC
Q 012765          220 QFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWS  299 (457)
Q Consensus       220 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~~~~  299 (457)
                      |||..|++.+.++...+.+.+..+..|+...+.||+|||.   ..-||||||..||||+.+|.+||+|||.+..+.+...
T Consensus       108 EYCGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~---~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMA  184 (502)
T KOG0574|consen  108 EYCGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHD---LKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMA  184 (502)
T ss_pred             hhcCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHH---HHHHHhhcccccEEEcccchhhhhhccccchhhhhHH
Confidence            9999999999999899999999999999999999999999   8899999999999999999999999999998876533


Q ss_pred             ceeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhccccccCCcccccCchhhcccC
Q 012765          300 HHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSNFKELVDPRLADAYD  379 (457)
Q Consensus       300 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~  379 (457)
                      .  ..++.||+.|||||++..-.|+.++||||||++..||..|++||..-.....++..+-.   ..+.+..|       
T Consensus       185 K--RNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMIPT~---PPPTF~KP-------  252 (502)
T KOG0574|consen  185 K--RNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMIPTK---PPPTFKKP-------  252 (502)
T ss_pred             h--hCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeEeccCC---CCCCCCCh-------
Confidence            2  34567999999999999999999999999999999999999999864443333332211   11111122       


Q ss_pred             HHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 012765          380 LAEMKRAMLTASVCIHHLSTMRPQMTRVLQ  409 (457)
Q Consensus       380 ~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~  409 (457)
                      ......+.+++..||-.+|++|-|+.++++
T Consensus       253 E~WS~~F~DFi~~CLiK~PE~R~TA~~L~~  282 (502)
T KOG0574|consen  253 EEWSSEFNDFIRSCLIKKPEERKTALRLCE  282 (502)
T ss_pred             HhhhhHHHHHHHHHhcCCHHHHHHHHHHhh
Confidence            233456778889999999999999998877

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=7e-39  Score=305.45  Aligned_cols=247  Identities=27%  Similarity=0.405  Sum_probs=195.3

Q ss_pred             cCCCCCceecccCcEEEEEEEeCCCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeee--cCceEEEE
Q 012765          142 DNFNSENLIGKGGHAEVYKGCLPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFST--ENGFHLVL  219 (457)
Q Consensus       142 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~--~~~~~lv~  219 (457)
                      ++|.+.+.||+|+||.||+|.. .|..+|+|.+....     ....+.+|+.++++++|+|++++++++.  ++..+++|
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~-~~~~~~~k~~~~~~-----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~   79 (256)
T cd05082           6 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVT   79 (256)
T ss_pred             HhCeeeeeecccCCCeEEEEEE-cCCcEEEEEeCCCc-----hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEE
Confidence            5788889999999999999976 57889999875332     2357889999999999999999998543  34578999


Q ss_pred             EecCCCChhhhhhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCCCCC
Q 012765          220 QFLPHGSLSSLLFGST-ECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNW  298 (457)
Q Consensus       220 e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~~~  298 (457)
                      ||+++++|.+++.... ..+++..++.++.||+.||.|||+   .+++||||||+||+++.++.+||+|||++.......
T Consensus        80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~  156 (256)
T cd05082          80 EYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEA---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ  156 (256)
T ss_pred             ECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCEeccccchheEEEcCCCcEEecCCccceeccccC
Confidence            9999999999986543 358899999999999999999999   899999999999999999999999999987654322


Q ss_pred             CceeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHh-CCCCCCcCCcchhhhhccccccCCcccccCchhhcc
Q 012765          299 SHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELIT-GRRAVDSRRQSLVIWAKPLLQTSNFKELVDPRLADA  377 (457)
Q Consensus       299 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLlt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~  377 (457)
                      .     ...++..|+|||++.+..++.++|||||||++|||++ |+.||...........   ....     ..+.... 
T Consensus       157 ~-----~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~---~~~~-----~~~~~~~-  222 (256)
T cd05082         157 D-----TGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPR---VEKG-----YKMDAPD-  222 (256)
T ss_pred             C-----CCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHH---HhcC-----CCCCCCC-
Confidence            1     2234668999999988889999999999999999998 9999875332111100   0000     0011111 


Q ss_pred             cCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q 012765          378 YDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQLLRGE  414 (457)
Q Consensus       378 ~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~  414 (457)
                         .....+.+++.+||+.+|++|||+.++++.|+.+
T Consensus       223 ---~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~  256 (256)
T cd05082         223 ---GCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI  256 (256)
T ss_pred             ---CCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence               1234567788999999999999999999999764

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=5.2e-39  Score=312.08  Aligned_cols=258  Identities=22%  Similarity=0.369  Sum_probs=197.3

Q ss_pred             hhcCCCCCceecccCcEEEEEEEeC------CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeec-
Q 012765          140 ATDNFNSENLIGKGGHAEVYKGCLP------DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTE-  212 (457)
Q Consensus       140 ~~~~f~~~~~LG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-  212 (457)
                      ..++|++.+.||+|+||.||+|...      .+..||+|.+.....  ......+.+|+.+++.++||||+++++++.. 
T Consensus         4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~   81 (288)
T cd05061           4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESAS--LRERIEFLNEASVMKGFTCHHVVRLLGVVSKG   81 (288)
T ss_pred             cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCC--HHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCC
Confidence            4678999999999999999999643      245799998754322  2234468899999999999999999996554 


Q ss_pred             CceEEEEEecCCCChhhhhhcCC---------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcE
Q 012765          213 NGFHLVLQFLPHGSLSSLLFGST---------ECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEA  283 (457)
Q Consensus       213 ~~~~lv~e~~~~gsL~~~l~~~~---------~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~  283 (457)
                      +..+++|||+++|+|.+++....         ....+..+..++.|++.||.|||+   .+|+||||||+||+++.++.+
T Consensus        82 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dikp~nili~~~~~~  158 (288)
T cd05061          82 QPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNA---KKFVHRDLAARNCMVAHDFTV  158 (288)
T ss_pred             CCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCCcCCCCChheEEEcCCCcE
Confidence            45789999999999999985421         234667788899999999999999   899999999999999999999


Q ss_pred             EEeeccccccCCCCCCceeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHh-CCCCCCcCCcchhhhhccccc
Q 012765          284 QISDFGLAKWLPDNWSHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELIT-GRRAVDSRRQSLVIWAKPLLQ  362 (457)
Q Consensus       284 kL~DFGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLlt-G~~pf~~~~~~~~~~~~~~~~  362 (457)
                      +|+|||+++...............++..|+|||.+.++.++.++|||||||++|||++ |..||.........  ..   
T Consensus       159 ~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~--~~---  233 (288)
T cd05061         159 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVL--KF---  233 (288)
T ss_pred             EECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHH--HH---
Confidence            9999999886644322111122235678999999998899999999999999999999 78888753321111  00   


Q ss_pred             cCCcccccCchhhcccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q 012765          363 TSNFKELVDPRLADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQLLRGE  414 (457)
Q Consensus       363 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~  414 (457)
                            +.+.... .........+.+++.+||+.+|++|||+.++++.|+..
T Consensus       234 ------~~~~~~~-~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~  278 (288)
T cd05061         234 ------VMDGGYL-DQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDD  278 (288)
T ss_pred             ------HHcCCCC-CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhh
Confidence                  0000000 00111234678899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=3.9e-39  Score=319.51  Aligned_cols=251  Identities=22%  Similarity=0.297  Sum_probs=191.8

Q ss_pred             CCCCCceecccCcEEEEEEEe----CCCcEEEEEEEeccchh-hHHHHHHHHHHHHHHhhc-CCCCcceeeeeeec-Cce
Q 012765          143 NFNSENLIGKGGHAEVYKGCL----PDGEVVAVKKIIKNAKE-DEERISDFLSELGIVAHI-NHPNAAKLIGFSTE-NGF  215 (457)
Q Consensus       143 ~f~~~~~LG~G~~g~Vy~~~~----~~~~~vavK~~~~~~~~-~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~-~~~  215 (457)
                      +|++.+.||+|+||.||++..    .+++.||+|.+.+.... .......+..|+.++..+ +||||+++++++.. +..
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (332)
T cd05614           1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL   80 (332)
T ss_pred             CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence            478889999999999999875    35889999988653322 223345788899999999 59999999986554 456


Q ss_pred             EEEEEecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCC
Q 012765          216 HLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLP  295 (457)
Q Consensus       216 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~  295 (457)
                      +++|||+.+|+|..++... ..+++..+..++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||+++...
T Consensus        81 ~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~---~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~  156 (332)
T cd05614          81 HLILDYVSGGEMFTHLYQR-DNFSEDEVRFYSGEIILALEHLHK---LGIVYRDIKLENILLDSEGHVVLTDFGLSKEFL  156 (332)
T ss_pred             EEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHH---CCcEecCCCHHHeEECCCCCEEEeeCcCCcccc
Confidence            8999999999999988543 458889999999999999999999   899999999999999999999999999998654


Q ss_pred             CCCCceeeecccccccccChhccccC-CCCcchhHHHHHHHHHHHHhCCCCCCcCCcch--hhhhccccccCCcccccCc
Q 012765          296 DNWSHHIVFPIEGTFGYLSPEYFMHG-IVDEKTDVFAFGVLLLELITGRRAVDSRRQSL--VIWAKPLLQTSNFKELVDP  372 (457)
Q Consensus       296 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~--~~~~~~~~~~~~~~~~~d~  372 (457)
                      ..... ......||..|+|||++.+. .++.++|||||||++|||++|+.||.......  .........       .++
T Consensus       157 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~-------~~~  228 (332)
T cd05614         157 SEEKE-RTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILK-------CDP  228 (332)
T ss_pred             ccCCC-ccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhc-------CCC
Confidence            33221 12235699999999998765 47899999999999999999999997432111  111100000       111


Q ss_pred             hhhcccCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 012765          373 RLADAYDLAEMKRAMLTASVCIHHLSTMRP-----QMTRVLQ  409 (457)
Q Consensus       373 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----t~~evl~  409 (457)
                      .+...+    ...+.+++.+||+.||++||     ++.++++
T Consensus       229 ~~~~~~----~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~  266 (332)
T cd05614         229 PFPSFI----GPEAQDLLHKLLRKDPKKRLGAGPQGASEIKE  266 (332)
T ss_pred             CCCCCC----CHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHc
Confidence            111122    23456788899999999999     6677765

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=6.7e-39  Score=311.06  Aligned_cols=257  Identities=25%  Similarity=0.379  Sum_probs=197.7

Q ss_pred             hhcCCCCCceecccCcEEEEEEEeC------CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeec-
Q 012765          140 ATDNFNSENLIGKGGHAEVYKGCLP------DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTE-  212 (457)
Q Consensus       140 ~~~~f~~~~~LG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-  212 (457)
                      ..++|++.+.||+|+||.||+|...      ++..+|+|.+.....  ......+.+|+.++++++||||+++++++.. 
T Consensus         3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~   80 (288)
T cd05050           3 PRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEAS--ADMQADFQREAALMAEFDHPNIVKLLGVCAVG   80 (288)
T ss_pred             ChHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcC--HHHHHHHHHHHHHHHhcCCCchheEEEEEcCC
Confidence            3467889999999999999999753      467899998764332  2334678899999999999999999996655 


Q ss_pred             CceEEEEEecCCCChhhhhhcCC---------------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCC
Q 012765          213 NGFHLVLQFLPHGSLSSLLFGST---------------------ECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIK  271 (457)
Q Consensus       213 ~~~~lv~e~~~~gsL~~~l~~~~---------------------~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlk  271 (457)
                      ...+++|||+++++|.+++....                     ..+++..++.++.|++.||.|||+   .+++|||||
T Consensus        81 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~---~~i~H~dl~  157 (288)
T cd05050          81 KPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSE---RKFVHRDLA  157 (288)
T ss_pred             CccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHh---CCeeccccc
Confidence            45789999999999999985321                     246788889999999999999999   899999999


Q ss_pred             CCcEEEcCCCcEEEeeccccccCCCCCCceeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHh-CCCCCCcCC
Q 012765          272 ASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELIT-GRRAVDSRR  350 (457)
Q Consensus       272 p~NIll~~~~~~kL~DFGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLlt-G~~pf~~~~  350 (457)
                      |+||+++.++.++|+|||++..+..............+..|+|||++.+..++.++|||||||++|||++ |..||....
T Consensus       158 p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~  237 (288)
T cd05050         158 TRNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMA  237 (288)
T ss_pred             HhheEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCC
Confidence            9999999999999999999876543321111112234667999999988899999999999999999998 888886533


Q ss_pred             cchhhhhccccccCCcccccCchhhcccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 012765          351 QSLVIWAKPLLQTSNFKELVDPRLADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQLLRG  413 (457)
Q Consensus       351 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~  413 (457)
                      .....  .. ........     .    .......+.+++.+||+.+|++|||+.||++.|+.
T Consensus       238 ~~~~~--~~-~~~~~~~~-----~----~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~  288 (288)
T cd05050         238 HEEVI--YY-VRDGNVLS-----C----PDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR  288 (288)
T ss_pred             HHHHH--HH-HhcCCCCC-----C----CCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence            21111  00 00111000     0    11123457789999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.3e-38  Score=302.29  Aligned_cols=249  Identities=25%  Similarity=0.337  Sum_probs=194.8

Q ss_pred             ceecccCcEEEEEEEeCCCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeec-CceEEEEEecCCCC
Q 012765          148 NLIGKGGHAEVYKGCLPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTE-NGFHLVLQFLPHGS  226 (457)
Q Consensus       148 ~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-~~~~lv~e~~~~gs  226 (457)
                      ++||.|+||.||++.+.+++.||+|.+......  .....+.+|+.++++++|+||+++++++.+ ...+++|||+.+++
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~   78 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPP--DLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGS   78 (251)
T ss_pred             CccccCCCceEEEEEEeCCCcEEEEeccccCCH--HHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCc
Confidence            469999999999999767999999987654332  345688999999999999999999996554 45789999999999


Q ss_pred             hhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCCCCCCceeeecc
Q 012765          227 LSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPI  306 (457)
Q Consensus       227 L~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~~~~~~~~~~~  306 (457)
                      |.+++......+++..++.++.+++.||.|||+   .+++||||+|+||+++.++.++|+|||++...............
T Consensus        79 l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~---~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~  155 (251)
T cd05041          79 LLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLES---KNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLK  155 (251)
T ss_pred             HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccC
Confidence            999997655678899999999999999999999   89999999999999999999999999999766432211111112


Q ss_pred             cccccccChhccccCCCCcchhHHHHHHHHHHHHh-CCCCCCcCCcchhhhhccccccCCcccccCchhhcccCHHHHHH
Q 012765          307 EGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELIT-GRRAVDSRRQSLVIWAKPLLQTSNFKELVDPRLADAYDLAEMKR  385 (457)
Q Consensus       307 ~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLlt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~  385 (457)
                      .++..|+|||.+.++.++.++|+||||+++|||+| |..||............  ....          ...........
T Consensus       156 ~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~--~~~~----------~~~~~~~~~~~  223 (251)
T cd05041         156 QIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERI--ESGY----------RMPAPQLCPEE  223 (251)
T ss_pred             cceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHH--hcCC----------CCCCCccCCHH
Confidence            23567999999988899999999999999999999 88888653321111000  0000          00001112346


Q ss_pred             HHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 012765          386 AMLTASVCIHHLSTMRPQMTRVLQLLRG  413 (457)
Q Consensus       386 l~~l~~~Cl~~dP~~RPt~~evl~~L~~  413 (457)
                      +.+++.+||+.+|.+|||+.||++.|+.
T Consensus       224 ~~~li~~~l~~~p~~Rp~~~ell~~l~~  251 (251)
T cd05041         224 IYRLMLQCWAYDPENRPSFSEIYNELQI  251 (251)
T ss_pred             HHHHHHHHhccChhhCcCHHHHHHHhhC
Confidence            7788999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=1.1e-38  Score=314.42  Aligned_cols=243  Identities=22%  Similarity=0.312  Sum_probs=186.7

Q ss_pred             ceecccCcEEEEEEEeC-CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhh-cCCCCcceeeeeeec-CceEEEEEecCC
Q 012765          148 NLIGKGGHAEVYKGCLP-DGEVVAVKKIIKNAKEDEERISDFLSELGIVAH-INHPNAAKLIGFSTE-NGFHLVLQFLPH  224 (457)
Q Consensus       148 ~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~-l~hpniv~l~~~~~~-~~~~lv~e~~~~  224 (457)
                      +.||+|+||+||+|.+. +++.||+|.+.............+..|..++.. ++||||+++++++.+ +.+++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~   80 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence            46999999999999865 578999999875433222334566777878765 589999999996554 556799999999


Q ss_pred             CChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCCCCCCceeee
Q 012765          225 GSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVF  304 (457)
Q Consensus       225 gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~~~~~~~~~  304 (457)
                      |+|..++.. ...+++..+..++.|++.||.|||+   .+|+||||||+|||++.++.+||+|||++........  ...
T Consensus        81 g~L~~~l~~-~~~~~~~~~~~~~~qi~~al~~LH~---~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~  154 (316)
T cd05619          81 GDLMFHIQS-CHKFDLPRATFYAAEIICGLQFLHS---KGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDA--KTC  154 (316)
T ss_pred             CcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHh---CCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCC--cee
Confidence            999998854 3457888899999999999999999   8999999999999999999999999999875422211  122


Q ss_pred             cccccccccChhccccCCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhccccccCCcccccCchhhcccCHHHHH
Q 012765          305 PIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSNFKELVDPRLADAYDLAEMK  384 (457)
Q Consensus       305 ~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~  384 (457)
                      ...||..|+|||++.+..++.++|||||||++|||++|+.||......... ......        .+.....    ...
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~-~~i~~~--------~~~~~~~----~~~  221 (316)
T cd05619         155 TFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELF-QSIRMD--------NPCYPRW----LTR  221 (316)
T ss_pred             eecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHH-HHHHhC--------CCCCCcc----CCH
Confidence            345899999999999989999999999999999999999999764322111 000000        1111111    223


Q ss_pred             HHHHHHHHhcccCCCCCCCHH-HHHH
Q 012765          385 RAMLTASVCIHHLSTMRPQMT-RVLQ  409 (457)
Q Consensus       385 ~l~~l~~~Cl~~dP~~RPt~~-evl~  409 (457)
                      .+.+++.+||+.+|++||++. ++.+
T Consensus       222 ~~~~li~~~l~~~P~~R~~~~~~l~~  247 (316)
T cd05619         222 EAKDILVKLFVREPERRLGVKGDIRQ  247 (316)
T ss_pred             HHHHHHHHHhccCHhhcCCChHHHHc
Confidence            466788999999999999997 5543

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=6.2e-39  Score=308.07  Aligned_cols=255  Identities=25%  Similarity=0.397  Sum_probs=197.9

Q ss_pred             cCCCCCceecccCcEEEEEEEeCC-C---cEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeecC-ceE
Q 012765          142 DNFNSENLIGKGGHAEVYKGCLPD-G---EVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTEN-GFH  216 (457)
Q Consensus       142 ~~f~~~~~LG~G~~g~Vy~~~~~~-~---~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~-~~~  216 (457)
                      .+|.+.+.||+|+||.||+|.+.. +   ..||+|.+....  .......+..|+.+++.++||||+++++++.++ ..+
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~   81 (269)
T cd05065           4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGY--TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVM   81 (269)
T ss_pred             HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCC--CHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceE
Confidence            346788999999999999998643 3   369999875432  233456899999999999999999999976554 468


Q ss_pred             EEEEecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCCC
Q 012765          217 LVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPD  296 (457)
Q Consensus       217 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~  296 (457)
                      ++|||+++++|.+++......+++..++.++.|++.||.|||+   .+++|+||||+||+++.++.+||+|||++.....
T Consensus        82 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~---~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~  158 (269)
T cd05065          82 IITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSE---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLED  158 (269)
T ss_pred             EEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccChheEEEcCCCcEEECCCcccccccc
Confidence            9999999999999987666678999999999999999999999   8999999999999999999999999999877644


Q ss_pred             CCCceeeec-cc--ccccccChhccccCCCCcchhHHHHHHHHHHHHh-CCCCCCcCCcchh-hhhccccccCCcccccC
Q 012765          297 NWSHHIVFP-IE--GTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELIT-GRRAVDSRRQSLV-IWAKPLLQTSNFKELVD  371 (457)
Q Consensus       297 ~~~~~~~~~-~~--gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLlt-G~~pf~~~~~~~~-~~~~~~~~~~~~~~~~d  371 (457)
                      ......... ..  .+..|+|||++.+..++.++|||||||++|||++ |..||........ .+..   ......    
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~---~~~~~~----  231 (269)
T cd05065         159 DTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIE---QDYRLP----  231 (269)
T ss_pred             CccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHH---cCCcCC----
Confidence            322111111 11  2357999999998999999999999999999887 9999975332211 1110   000000    


Q ss_pred             chhhcccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q 012765          372 PRLADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQLLRGE  414 (457)
Q Consensus       372 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~  414 (457)
                            ...+....+.+++.+||+.+|.+||++.+|+..|+.+
T Consensus       232 ------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  268 (269)
T cd05065         232 ------PPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM  268 (269)
T ss_pred             ------CcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence                  0111234567889999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=9.2e-39  Score=306.67  Aligned_cols=255  Identities=24%  Similarity=0.370  Sum_probs=198.9

Q ss_pred             cCCCCCceecccCcEEEEEEEeC-C---CcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeec-CceE
Q 012765          142 DNFNSENLIGKGGHAEVYKGCLP-D---GEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTE-NGFH  216 (457)
Q Consensus       142 ~~f~~~~~LG~G~~g~Vy~~~~~-~---~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-~~~~  216 (457)
                      .+|.+.+.||+|+||.||+|.+. +   +..+|+|.+.....  ......+.+|+.++++++||||+++++++.. +..+
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   81 (267)
T cd05066           4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYT--EKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVM   81 (267)
T ss_pred             HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCC--HHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccE
Confidence            56788899999999999999753 2   33789998754332  2345688999999999999999999996654 4567


Q ss_pred             EEEEecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCCC
Q 012765          217 LVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPD  296 (457)
Q Consensus       217 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~  296 (457)
                      ++|||+++++|.+++......+++..++.++.|++.||.|||+   .+++||||||+|||++.++.++|+|||++..+..
T Consensus        82 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~  158 (267)
T cd05066          82 IVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSD---MGYVHRDLAARNILVNSNLVCKVSDFGLSRVLED  158 (267)
T ss_pred             EEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCEeehhhchhcEEECCCCeEEeCCCCccccccc
Confidence            9999999999999997666678999999999999999999999   8999999999999999999999999999987654


Q ss_pred             CCCcee-eecccccccccChhccccCCCCcchhHHHHHHHHHHHHh-CCCCCCcCCcch-hhhhccccccCCcccccCch
Q 012765          297 NWSHHI-VFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELIT-GRRAVDSRRQSL-VIWAKPLLQTSNFKELVDPR  373 (457)
Q Consensus       297 ~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLlt-G~~pf~~~~~~~-~~~~~~~~~~~~~~~~~d~~  373 (457)
                      ...... .....++..|+|||++.+..++.++|+|||||++||+++ |..||....... .....   .....     + 
T Consensus       159 ~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~---~~~~~-----~-  229 (267)
T cd05066         159 DPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIE---EGYRL-----P-  229 (267)
T ss_pred             ccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHh---CCCcC-----C-
Confidence            322111 111223567999999998899999999999999999887 999997533211 11111   00000     0 


Q ss_pred             hhcccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q 012765          374 LADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQLLRGE  414 (457)
Q Consensus       374 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~  414 (457)
                          ........+.+++.+||+.+|.+||+|.++++.|+.+
T Consensus       230 ----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  266 (267)
T cd05066         230 ----APMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL  266 (267)
T ss_pred             ----CCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence                0111234567888999999999999999999999764

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=2.2e-38  Score=308.94  Aligned_cols=262  Identities=22%  Similarity=0.342  Sum_probs=195.6

Q ss_pred             hcCCCCCceecccCcEEEEEEEeC-----------------CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCc
Q 012765          141 TDNFNSENLIGKGGHAEVYKGCLP-----------------DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNA  203 (457)
Q Consensus       141 ~~~f~~~~~LG~G~~g~Vy~~~~~-----------------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpni  203 (457)
                      .++|++.+.||+|+||.||++...                 ++..+|+|.+.....  ......+.+|+.+++.++|+||
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~--~~~~~~~~~E~~~l~~l~~~~i   81 (296)
T cd05095           4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDAN--KNARNDFLKEIKIMSRLKDPNI   81 (296)
T ss_pred             hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCC--HHHHHHHHHHHHHHHhCCCCCc
Confidence            356889999999999999997532                 244689998764322  2345688999999999999999


Q ss_pred             ceeeeeeec-CceEEEEEecCCCChhhhhhcCC----------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCC
Q 012765          204 AKLIGFSTE-NGFHLVLQFLPHGSLSSLLFGST----------ECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKA  272 (457)
Q Consensus       204 v~l~~~~~~-~~~~lv~e~~~~gsL~~~l~~~~----------~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp  272 (457)
                      +++++++.. +..+++|||+++++|.+++....          ..+++...+.++.|++.||.|||+   .+++|+||||
T Consensus        82 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~---~~i~H~dlkp  158 (296)
T cd05095          82 IRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSS---LNFVHRDLAT  158 (296)
T ss_pred             ceEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHH---CCeecccCCh
Confidence            999996655 45689999999999999885422          236778899999999999999999   8999999999


Q ss_pred             CcEEEcCCCcEEEeeccccccCCCCCCceeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHh--CCCCCCcCC
Q 012765          273 SNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELIT--GRRAVDSRR  350 (457)
Q Consensus       273 ~NIll~~~~~~kL~DFGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLlt--G~~pf~~~~  350 (457)
                      +|||++.++.++|+|||++..+.............++..|+|||+..++.++.++|||||||++|||++  |..||....
T Consensus       159 ~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~  238 (296)
T cd05095         159 RNCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLS  238 (296)
T ss_pred             heEEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccC
Confidence            999999999999999999987644322111112234678999999888899999999999999999998  778886533


Q ss_pred             cchhhhh-ccccccCCcccccCchhhcccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 012765          351 QSLVIWA-KPLLQTSNFKELVDPRLADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQLLRG  413 (457)
Q Consensus       351 ~~~~~~~-~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~  413 (457)
                      ....... ....... ......+.     .......+.+++.+||+.||.+||++.+|++.|+.
T Consensus       239 ~~~~~~~~~~~~~~~-~~~~~~~~-----~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~  296 (296)
T cd05095         239 DEQVIENTGEFFRDQ-GRQVYLPK-----PALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE  296 (296)
T ss_pred             hHHHHHHHHHHHhhc-cccccCCC-----CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence            2211110 0000000 00000000     01122467788999999999999999999998863

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=8.5e-39  Score=320.62  Aligned_cols=258  Identities=24%  Similarity=0.314  Sum_probs=193.9

Q ss_pred             hhcCCCCCceecccCcEEEEEEEeC-CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeecC-----
Q 012765          140 ATDNFNSENLIGKGGHAEVYKGCLP-DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTEN-----  213 (457)
Q Consensus       140 ~~~~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~-----  213 (457)
                      ..++|.+.+.||+|+||.||++.+. +|+.||+|++..... .......+.+|+.+++.++||||+++++++...     
T Consensus        19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~   97 (359)
T cd07876          19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQ-NQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEE   97 (359)
T ss_pred             hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEeccccc-chhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccc
Confidence            4588999999999999999999864 589999999865432 223456788999999999999999999976432     


Q ss_pred             --ceEEEEEecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeecccc
Q 012765          214 --GFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLA  291 (457)
Q Consensus       214 --~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~  291 (457)
                        ..+++|||+.+ +|...+.   ..+++..+..++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||++
T Consensus        98 ~~~~~lv~e~~~~-~l~~~~~---~~~~~~~~~~~~~qi~~~L~~LH~---~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a  170 (359)
T cd07876          98 FQDVYLVMELMDA-NLCQVIH---MELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLA  170 (359)
T ss_pred             cceeEEEEeCCCc-CHHHHHh---ccCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEEecCCCc
Confidence              36899999975 4555552   237788888999999999999999   89999999999999999999999999999


Q ss_pred             ccCCCCCCceeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhcccc----------
Q 012765          292 KWLPDNWSHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLL----------  361 (457)
Q Consensus       292 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~~~~----------  361 (457)
                      +......   ......||..|+|||++.+..++.++|||||||++|+|++|+.||...+... .|.....          
T Consensus       171 ~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~-~~~~~~~~~~~~~~~~~  246 (359)
T cd07876         171 RTACTNF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHID-QWNKVIEQLGTPSAEFM  246 (359)
T ss_pred             cccccCc---cCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHhcCCCcHHHH
Confidence            7653322   1223458999999999999999999999999999999999999998643211 1110000          


Q ss_pred             ------------ccC-----CcccccCchhhc---ccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 012765          362 ------------QTS-----NFKELVDPRLAD---AYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQ  409 (457)
Q Consensus       362 ------------~~~-----~~~~~~d~~l~~---~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~  409 (457)
                                  ...     .+.+........   .........+.+++.+||+.||++|||+.|+++
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~  314 (359)
T cd07876         247 NRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALR  314 (359)
T ss_pred             HHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhc
Confidence                        000     000000000000   001112345678999999999999999999988

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=3.6e-39  Score=324.43  Aligned_cols=257  Identities=21%  Similarity=0.274  Sum_probs=194.1

Q ss_pred             HhhcCCCCCceecccCcEEEEEEEeC-CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeecC-ceE
Q 012765          139 AATDNFNSENLIGKGGHAEVYKGCLP-DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTEN-GFH  216 (457)
Q Consensus       139 ~~~~~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~-~~~  216 (457)
                      ...++|++.+.||+|+||.||++... +++.+|+|.+.+...........+.+|+.+++.++||||+++++++.++ ..+
T Consensus        40 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~  119 (370)
T cd05621          40 MKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLY  119 (370)
T ss_pred             CCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEE
Confidence            34578999999999999999999865 5889999988653333333345688999999999999999999966554 578


Q ss_pred             EEEEecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCCC
Q 012765          217 LVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPD  296 (457)
Q Consensus       217 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~  296 (457)
                      +||||+++|+|.+++..  ..+++.....++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||++..+..
T Consensus       120 lv~Ey~~gg~L~~~l~~--~~~~~~~~~~~~~qil~aL~~LH~---~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~  194 (370)
T cd05621         120 MVMEYMPGGDLVNLMSN--YDVPEKWAKFYTAEVVLALDAIHS---MGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDE  194 (370)
T ss_pred             EEEcCCCCCcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHEEECCCCCEEEEecccceeccc
Confidence            99999999999998853  347888888999999999999999   8999999999999999999999999999987643


Q ss_pred             CCCceeeecccccccccChhccccC----CCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhccccccCCcccccCc
Q 012765          297 NWSHHIVFPIEGTFGYLSPEYFMHG----IVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSNFKELVDP  372 (457)
Q Consensus       297 ~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~  372 (457)
                      ... .......||+.|+|||++.+.    .++.++|||||||++|||++|+.||........ +.. ......       
T Consensus       195 ~~~-~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~-~~~-i~~~~~-------  264 (370)
T cd05621         195 TGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGT-YSK-IMDHKN-------  264 (370)
T ss_pred             CCc-eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHH-HHH-HHhCCc-------
Confidence            221 112345699999999998654    378999999999999999999999986432111 111 000000       


Q ss_pred             hhhcccCHHHHHHHHHHHHHhcccCCCC--CCCHHHHHHH
Q 012765          373 RLADAYDLAEMKRAMLTASVCIHHLSTM--RPQMTRVLQL  410 (457)
Q Consensus       373 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~--RPt~~evl~~  410 (457)
                      .+...........+..++..||..++.+  ||++.|+++.
T Consensus       265 ~~~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h  304 (370)
T cd05621         265 SLNFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH  304 (370)
T ss_pred             ccCCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence            0000001112334556777788755543  8899999884

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=1.1e-38  Score=304.95  Aligned_cols=254  Identities=25%  Similarity=0.366  Sum_probs=201.8

Q ss_pred             hhcCCCCCceecccCcEEEEEEEeCCCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeecCceEEEE
Q 012765          140 ATDNFNSENLIGKGGHAEVYKGCLPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTENGFHLVL  219 (457)
Q Consensus       140 ~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~lv~  219 (457)
                      ..++|.+.+.||+|+||.||+|.+.++..+|+|.+....    .....+.+|+.+++.++|+||+++++++.+...+++|
T Consensus         4 ~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~v~   79 (260)
T cd05073           4 PRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS----MSVEAFLAEANVMKTLQHDKLVKLHAVVTKEPIYIIT   79 (260)
T ss_pred             cccceeEEeEecCccceEEEEEEecCCccEEEEecCCCh----hHHHHHHHHHHHHHhcCCCCcceEEEEEcCCCeEEEE
Confidence            457788999999999999999987778889999875432    2345788999999999999999999987777789999


Q ss_pred             EecCCCChhhhhhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCCCCC
Q 012765          220 QFLPHGSLSSLLFGS-TECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNW  298 (457)
Q Consensus       220 e~~~~gsL~~~l~~~-~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~~~  298 (457)
                      ||+++++|.+++... ...+++..++.++.|++.||.|||+   .+++|+||||+||+++.++.+||+|||++..+....
T Consensus        80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~---~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~  156 (260)
T cd05073          80 EFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQ---RNYIHRDLRAANILVSASLVCKIADFGLARVIEDNE  156 (260)
T ss_pred             EeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHh---CCccccccCcceEEEcCCCcEEECCCcceeeccCCC
Confidence            999999999998653 3457888999999999999999999   899999999999999999999999999997664432


Q ss_pred             CceeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHh-CCCCCCcCCcchhhhhccccccCCcccccCchhhcc
Q 012765          299 SHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELIT-GRRAVDSRRQSLVIWAKPLLQTSNFKELVDPRLADA  377 (457)
Q Consensus       299 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLlt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~  377 (457)
                      .. ......++..|+|||++....++.++|+|||||++|++++ |..||............  .....      ...   
T Consensus       157 ~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~--~~~~~------~~~---  224 (260)
T cd05073         157 YT-AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRAL--ERGYR------MPR---  224 (260)
T ss_pred             cc-cccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHH--hCCCC------CCC---
Confidence            11 1112235677999999988889999999999999999999 89999754322111100  00000      000   


Q ss_pred             cCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 012765          378 YDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQLLRG  413 (457)
Q Consensus       378 ~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~  413 (457)
                       .......+..++.+||+.+|++||++.++++.|+.
T Consensus       225 -~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~  259 (260)
T cd05073         225 -PENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD  259 (260)
T ss_pred             -cccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence             11223457788899999999999999999999875

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=8.5e-39  Score=315.33  Aligned_cols=243  Identities=24%  Similarity=0.296  Sum_probs=190.3

Q ss_pred             ceecccCcEEEEEEEeC-CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhc-CCCCcceeeeeeec-CceEEEEEecCC
Q 012765          148 NLIGKGGHAEVYKGCLP-DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHI-NHPNAAKLIGFSTE-NGFHLVLQFLPH  224 (457)
Q Consensus       148 ~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~-~~~~lv~e~~~~  224 (457)
                      +.||+|+||+||+|.+. +++.||+|.+.+...........+..|..++..+ +||||+++++++.. +.+++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~   80 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG   80 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999865 5789999998765433344456778899998877 69999999996554 457899999999


Q ss_pred             CChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCCCCCCceeee
Q 012765          225 GSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVF  304 (457)
Q Consensus       225 gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~~~~~~~~~  304 (457)
                      |+|..++... ..+++..+..++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||++........  ...
T Consensus        81 ~~L~~~~~~~-~~l~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~--~~~  154 (318)
T cd05570          81 GDLMFHIQRS-GRFDEPRARFYAAEIVLGLQFLHE---RGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGV--TTS  154 (318)
T ss_pred             CCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHh---CCeEccCCCHHHeEECCCCcEEecccCCCeecCcCCC--ccc
Confidence            9999888543 458899999999999999999999   8999999999999999999999999999875322111  122


Q ss_pred             cccccccccChhccccCCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhccccccCCcccccCchhhcccCHHHHH
Q 012765          305 PIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSNFKELVDPRLADAYDLAEMK  384 (457)
Q Consensus       305 ~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~  384 (457)
                      ...||..|+|||++.+..++.++|||||||++|+|++|+.||......... .......        .....    ....
T Consensus       155 ~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~-~~i~~~~--------~~~~~----~~~~  221 (318)
T cd05570         155 TFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELF-QSILEDE--------VRYPR----WLSK  221 (318)
T ss_pred             ceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHH-HHHHcCC--------CCCCC----cCCH
Confidence            345899999999999999999999999999999999999999754322111 1000000        00111    1224


Q ss_pred             HHHHHHHHhcccCCCCCCCH-----HHHHH
Q 012765          385 RAMLTASVCIHHLSTMRPQM-----TRVLQ  409 (457)
Q Consensus       385 ~l~~l~~~Cl~~dP~~RPt~-----~evl~  409 (457)
                      .+.+++.+||+.||.+||++     .++++
T Consensus       222 ~~~~li~~~l~~dP~~R~s~~~~~~~~ll~  251 (318)
T cd05570         222 EAKSILKSFLTKNPEKRLGCLPTGEQDIKG  251 (318)
T ss_pred             HHHHHHHHHccCCHHHcCCCCCCCHHHHhc
Confidence            56788999999999999999     77765

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.1e-38  Score=304.72  Aligned_cols=254  Identities=26%  Similarity=0.355  Sum_probs=201.2

Q ss_pred             hhcCCCCCceecccCcEEEEEEEeCCCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeec-CceEEE
Q 012765          140 ATDNFNSENLIGKGGHAEVYKGCLPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTE-NGFHLV  218 (457)
Q Consensus       140 ~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-~~~~lv  218 (457)
                      ..++|.+.+.||+|+||.||+|...+++.+|+|.+......    ...+.+|+.++++++|+||+++++++.. ...+++
T Consensus         4 ~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v   79 (261)
T cd05034           4 PRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTMS----PEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIV   79 (261)
T ss_pred             chhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCccC----HHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEE
Confidence            45788899999999999999999878889999987643322    3468899999999999999999997665 567899


Q ss_pred             EEecCCCChhhhhhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCCCC
Q 012765          219 LQFLPHGSLSSLLFGST-ECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDN  297 (457)
Q Consensus       219 ~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~~  297 (457)
                      |||+++++|.+++.... ..+++..+..++.+++.||.|||+   .+++|+||||+||+++.++.++|+|||++..+...
T Consensus        80 ~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~---~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~  156 (261)
T cd05034          80 TEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLES---RNYIHRDLAARNILVGENLVCKIADFGLARLIEDD  156 (261)
T ss_pred             EeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCcchheEEEcCCCCEEECccccceeccch
Confidence            99999999999996643 468999999999999999999999   89999999999999999999999999998876542


Q ss_pred             CCceeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHh-CCCCCCcCCcchhhhhccccccCCcccccCchhhc
Q 012765          298 WSHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELIT-GRRAVDSRRQSLVIWAKPLLQTSNFKELVDPRLAD  376 (457)
Q Consensus       298 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLlt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  376 (457)
                      ... ......++..|+|||.+.+..++.++||||||+++|+|++ |+.||............  ...      .....  
T Consensus       157 ~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~--~~~------~~~~~--  225 (261)
T cd05034         157 EYT-AREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQV--ERG------YRMPR--  225 (261)
T ss_pred             hhh-hhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH--HcC------CCCCC--
Confidence            111 1112224568999999998889999999999999999999 99999754322111100  000      00000  


Q ss_pred             ccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 012765          377 AYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQLLRG  413 (457)
Q Consensus       377 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~  413 (457)
                        .......+.+++.+||+.+|++||++.++++.|+.
T Consensus       226 --~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~  260 (261)
T cd05034         226 --PPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED  260 (261)
T ss_pred             --CCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence              01113457788999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=9.4e-39  Score=308.59  Aligned_cols=268  Identities=25%  Similarity=0.349  Sum_probs=204.1

Q ss_pred             cCCCCCceecccCcEEEEEEEeC-----CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeec---C
Q 012765          142 DNFNSENLIGKGGHAEVYKGCLP-----DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTE---N  213 (457)
Q Consensus       142 ~~f~~~~~LG~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~---~  213 (457)
                      +.|...+.||+|+||.||+|.+.     ++..+|+|.+......  .....+.+|+.+++.++||||+++++++..   .
T Consensus         4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~--~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~   81 (284)
T cd05038           4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE--QHRSDFEREIEILRTLDHENIVKYKGVCEKPGGR   81 (284)
T ss_pred             hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch--HHHHHHHHHHHHHHhCCCCChheEEeeeecCCCC
Confidence            45677899999999999999853     3688999988654432  345689999999999999999999997665   3


Q ss_pred             ceEEEEEecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeecccccc
Q 012765          214 GFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKW  293 (457)
Q Consensus       214 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~  293 (457)
                      ..+++|||+++++|.+++......+++..++.++.|++.||.|||+   .+++|+||||+||+++.++.++|+|||++..
T Consensus        82 ~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~  158 (284)
T cd05038          82 SLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGS---QRYIHRDLAARNILVESEDLVKISDFGLAKV  158 (284)
T ss_pred             ceEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHhEEEcCCCCEEEcccccccc
Confidence            4689999999999999997666679999999999999999999999   8999999999999999999999999999987


Q ss_pred             CCCCCCcee-eecccccccccChhccccCCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhccccccCC---cccc
Q 012765          294 LPDNWSHHI-VFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSN---FKEL  369 (457)
Q Consensus       294 ~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~~~~~~~~---~~~~  369 (457)
                      ......... .....++..|+|||.+.+..++.++||||||++++||++|..|+.........+.........   +.+.
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (284)
T cd05038         159 LPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLEL  238 (284)
T ss_pred             cccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHH
Confidence            763322211 112235567999999988899999999999999999999999986532221111111000000   0011


Q ss_pred             cCchhhcccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q 012765          370 VDPRLADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQLLRGE  414 (457)
Q Consensus       370 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~  414 (457)
                      +...............+..++.+||+.+|.+|||+.+|+++|+.+
T Consensus       239 ~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i  283 (284)
T cd05038         239 LKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL  283 (284)
T ss_pred             HHcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence            111111111112235677899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=3.7e-38  Score=299.93  Aligned_cols=248  Identities=30%  Similarity=0.449  Sum_probs=198.1

Q ss_pred             ceecccCcEEEEEEEeCC----CcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeec-CceEEEEEec
Q 012765          148 NLIGKGGHAEVYKGCLPD----GEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTE-NGFHLVLQFL  222 (457)
Q Consensus       148 ~~LG~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-~~~~lv~e~~  222 (457)
                      +.||+|+||.||+|....    +..|++|.+.......  ....+.+|+..+..++|+|++++++++.. ...+++|||+
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~   78 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEE--ERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYM   78 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccchh--HHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEec
Confidence            469999999999998653    7889999886544332  46789999999999999999999996655 4568999999


Q ss_pred             CCCChhhhhhcC--------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccC
Q 012765          223 PHGSLSSLLFGS--------TECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWL  294 (457)
Q Consensus       223 ~~gsL~~~l~~~--------~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~  294 (457)
                      ++++|.+++...        ...+++..++.++.|++.||.|||+   .+++|+||+|+||+++.++.++|+|||.+...
T Consensus        79 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~di~p~nili~~~~~~~l~dfg~~~~~  155 (262)
T cd00192          79 EGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLAS---KKFVHRDLAARNCLVGEDLVVKISDFGLSRDV  155 (262)
T ss_pred             cCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHc---CCcccCccCcceEEECCCCcEEEccccccccc
Confidence            999999999765        4678999999999999999999999   89999999999999999999999999999877


Q ss_pred             CCCCCceeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHh-CCCCCCcCCcchhhhhccccccCCcccccCch
Q 012765          295 PDNWSHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELIT-GRRAVDSRRQSLVIWAKPLLQTSNFKELVDPR  373 (457)
Q Consensus       295 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLlt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~  373 (457)
                      .............++..|+|||.+....++.++||||||+++|+|++ |..||.........  ..... ..     ...
T Consensus       156 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~--~~~~~-~~-----~~~  227 (262)
T cd00192         156 YDDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVL--EYLRK-GY-----RLP  227 (262)
T ss_pred             ccccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHH--HHHHc-CC-----CCC
Confidence            65432222233457889999999988899999999999999999999 69999764321111  00000 00     000


Q ss_pred             hhcccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 012765          374 LADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQLLR  412 (457)
Q Consensus       374 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~  412 (457)
                      .    .......+.+++.+||+.+|.+||++.++++.|+
T Consensus       228 ~----~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~  262 (262)
T cd00192         228 K----PEYCPDELYELMLSCWQLDPEDRPTFSELVERLE  262 (262)
T ss_pred             C----CccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence            1    1112356778899999999999999999999874

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=8.2e-39  Score=304.62  Aligned_cols=246  Identities=26%  Similarity=0.425  Sum_probs=197.7

Q ss_pred             cCCCCCceecccCcEEEEEEEeCCCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeecCceEEEEEe
Q 012765          142 DNFNSENLIGKGGHAEVYKGCLPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTENGFHLVLQF  221 (457)
Q Consensus       142 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~lv~e~  221 (457)
                      ++|++.+.||+|+||.||++.. +++.+|+|.+....     ....+.+|+.++..++|||++++++++..+..+++|||
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~-----~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~v~e~   79 (254)
T cd05083           6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV-----TAQAFLEETAVMTKLHHKNLVRLLGVILHNGLYIVMEL   79 (254)
T ss_pred             HHceeeeeeccCCCCceEeccc-CCCceEEEeecCcc-----hHHHHHHHHHHHHhCCCCCcCeEEEEEcCCCcEEEEEC
Confidence            4688899999999999999875 77889999875432     23478899999999999999999998888889999999


Q ss_pred             cCCCChhhhhhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCCCCCCc
Q 012765          222 LPHGSLSSLLFGST-ECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSH  300 (457)
Q Consensus       222 ~~~gsL~~~l~~~~-~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~~~~~  300 (457)
                      +++++|.+++.... ..+++..++.++.|++.||.|||+   .+++||||||+||+++.++.+||+|||++.......  
T Consensus        80 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~--  154 (254)
T cd05083          80 MSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLES---KKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV--  154 (254)
T ss_pred             CCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccccCcceEEEcCCCcEEECCCccceeccccC--
Confidence            99999999986543 357899999999999999999999   899999999999999999999999999987653321  


Q ss_pred             eeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHh-CCCCCCcCCcchhhhhccccccCCcccccCchhhcccC
Q 012765          301 HIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELIT-GRRAVDSRRQSLVIWAKPLLQTSNFKELVDPRLADAYD  379 (457)
Q Consensus       301 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLlt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~  379 (457)
                         .....+..|+|||++.+..++.++|+|||||++|||++ |+.||...........  .....      .+....   
T Consensus       155 ---~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~--~~~~~------~~~~~~---  220 (254)
T cd05083         155 ---DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKEC--VEKGY------RMEPPE---  220 (254)
T ss_pred             ---CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHH--HhCCC------CCCCCC---
Confidence               11224567999999988899999999999999999998 9999976432211110  00000      000011   


Q ss_pred             HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 012765          380 LAEMKRAMLTASVCIHHLSTMRPQMTRVLQLLRG  413 (457)
Q Consensus       380 ~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~  413 (457)
                       .....+.+++.+||+.+|++||++.+|++.|+.
T Consensus       221 -~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  253 (254)
T cd05083         221 -GCPADVYVLMTSCWETEPKKRPSFHKLREKLEK  253 (254)
T ss_pred             -cCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence             123456788999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=6.4e-39  Score=313.97  Aligned_cols=255  Identities=25%  Similarity=0.394  Sum_probs=193.4

Q ss_pred             hcCCCCCceecccCcEEEEEEEeC-CCc--EEEEEEEeccchhhHHHHHHHHHHHHHHhhc-CCCCcceeeeeeec-Cce
Q 012765          141 TDNFNSENLIGKGGHAEVYKGCLP-DGE--VVAVKKIIKNAKEDEERISDFLSELGIVAHI-NHPNAAKLIGFSTE-NGF  215 (457)
Q Consensus       141 ~~~f~~~~~LG~G~~g~Vy~~~~~-~~~--~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~-~~~  215 (457)
                      .++|++.+.||+|+||.||+|.+. ++.  .+++|.+....  .......+.+|+.++.++ +||||+++++++.. +..
T Consensus         6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~   83 (303)
T cd05088           6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA--SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYL   83 (303)
T ss_pred             hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccC--CHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCc
Confidence            357888899999999999999864 454  35676654322  223456788999999999 89999999996655 457


Q ss_pred             EEEEEecCCCChhhhhhcCC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCC
Q 012765          216 HLVLQFLPHGSLSSLLFGST---------------ECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSED  280 (457)
Q Consensus       216 ~lv~e~~~~gsL~~~l~~~~---------------~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~  280 (457)
                      +++|||+++++|.+++....               ..+++..++.++.||+.||.|||+   .+++||||||+|||++.+
T Consensus        84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~---~gi~H~dlkp~Nili~~~  160 (303)
T cd05088          84 YLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGEN  160 (303)
T ss_pred             eEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHh---CCccccccchheEEecCC
Confidence            89999999999999985432               257888999999999999999999   899999999999999999


Q ss_pred             CcEEEeeccccccCCCCCCceeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHh-CCCCCCcCCcchhhhhcc
Q 012765          281 YEAQISDFGLAKWLPDNWSHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELIT-GRRAVDSRRQSLVIWAKP  359 (457)
Q Consensus       281 ~~~kL~DFGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLlt-G~~pf~~~~~~~~~~~~~  359 (457)
                      +.+||+|||++........   .....++..|+|||++.+..++.++|||||||++|||+| |..||.........  ..
T Consensus       161 ~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~--~~  235 (303)
T cd05088         161 YVAKIADFGLSRGQEVYVK---KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELY--EK  235 (303)
T ss_pred             CcEEeCccccCcccchhhh---cccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHHHH--HH
Confidence            9999999999864321110   111124567999999988889999999999999999998 99999753322111  00


Q ss_pred             ccccCCcccccCchhhcccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCC
Q 012765          360 LLQTSNFKELVDPRLADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQLLRGEG  415 (457)
Q Consensus       360 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~  415 (457)
                      ... .     .....    .......+.+++.+||+.+|++||++.++++.|+.+.
T Consensus       236 ~~~-~-----~~~~~----~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~  281 (303)
T cd05088         236 LPQ-G-----YRLEK----PLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML  281 (303)
T ss_pred             Hhc-C-----CcCCC----CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence            000 0     00000    0112235678899999999999999999999987653

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=2.3e-38  Score=301.75  Aligned_cols=249  Identities=28%  Similarity=0.412  Sum_probs=196.3

Q ss_pred             ceecccCcEEEEEEEeCC--C--cEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeecCceEEEEEecC
Q 012765          148 NLIGKGGHAEVYKGCLPD--G--EVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTENGFHLVLQFLP  223 (457)
Q Consensus       148 ~~LG~G~~g~Vy~~~~~~--~--~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~lv~e~~~  223 (457)
                      +.||+|+||.||+|.+.+  +  ..||+|.+......  .....+.+|+.++++++||||+++++++.+...++++||++
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~v~e~~~   78 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS--DIMDDFLKEAAIMHSLDHENLIRLYGVVLTHPLMMVTELAP   78 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH--HHHHHHHHHHHHHhhcCCCCccceeEEEcCCeEEEEEEecC
Confidence            468999999999998643  3  36899988654433  45678999999999999999999999777777889999999


Q ss_pred             CCChhhhhhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCCCCCCcee
Q 012765          224 HGSLSSLLFGST-ECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSHHI  302 (457)
Q Consensus       224 ~gsL~~~l~~~~-~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~~~~~~~  302 (457)
                      +++|.+++.... ..+++...+.++.|++.||.|||+   .+++|+||+|+||+++.++.+||+|||++..+........
T Consensus        79 ~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~  155 (257)
T cd05040          79 LGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLES---KRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYV  155 (257)
T ss_pred             CCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHh---CCccccccCcccEEEecCCEEEecccccccccccccccee
Confidence            999999986654 568999999999999999999999   8999999999999999999999999999987754322211


Q ss_pred             -eecccccccccChhccccCCCCcchhHHHHHHHHHHHHh-CCCCCCcCCcchhhhhccccccCCcccccCchhhcccCH
Q 012765          303 -VFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELIT-GRRAVDSRRQSLVIWAKPLLQTSNFKELVDPRLADAYDL  380 (457)
Q Consensus       303 -~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLlt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~  380 (457)
                       .....++..|+|||++.+..++.++|||||||++|||++ |..||............  ....  .....       ..
T Consensus       156 ~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~--~~~~--~~~~~-------~~  224 (257)
T cd05040         156 MEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKI--DKEG--ERLER-------PE  224 (257)
T ss_pred             cccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH--HhcC--CcCCC-------Cc
Confidence             112346788999999998899999999999999999999 99999653322111000  0000  00000       01


Q ss_pred             HHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 012765          381 AEMKRAMLTASVCIHHLSTMRPQMTRVLQLLR  412 (457)
Q Consensus       381 ~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~  412 (457)
                      .....+.+++.+||+.+|++||++.+|++.|.
T Consensus       225 ~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~  256 (257)
T cd05040         225 ACPQDIYNVMLQCWAHNPADRPTFAALREFLP  256 (257)
T ss_pred             cCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence            12345778899999999999999999999885

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=1.7e-38  Score=307.12  Aligned_cols=250  Identities=23%  Similarity=0.342  Sum_probs=191.3

Q ss_pred             cCCCCCceecccCcEEEEEEEe-CCCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeee-ecCceEEEE
Q 012765          142 DNFNSENLIGKGGHAEVYKGCL-PDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFS-TENGFHLVL  219 (457)
Q Consensus       142 ~~f~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~-~~~~~~lv~  219 (457)
                      ++|.+.++||+|+||.||+|.+ .+++.||+|.+.....  ......+.+|+.++++++||||+++++++ ..+..+++|
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   78 (279)
T cd06619           1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDIT--VELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICT   78 (279)
T ss_pred             CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCC--hHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEE
Confidence            4678889999999999999985 4688999998865422  23345789999999999999999999955 455578999


Q ss_pred             EecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCCCCCC
Q 012765          220 QFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWS  299 (457)
Q Consensus       220 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~~~~  299 (457)
                      ||+++++|..+.     .+++.....++.|++.||.|||+   .+|+|+||||+||+++.++.++|+|||++..+.....
T Consensus        79 e~~~~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~~  150 (279)
T cd06619          79 EFMDGGSLDVYR-----KIPEHVLGRIAVAVVKGLTYLWS---LKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSIA  150 (279)
T ss_pred             ecCCCCChHHhh-----cCCHHHHHHHHHHHHHHHHHHHH---CCEeeCCCCHHHEEECCCCCEEEeeCCcceecccccc
Confidence            999999986542     36788888999999999999999   8999999999999999999999999999976644321


Q ss_pred             ceeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhccccccCCcccccCchhhcccC
Q 012765          300 HHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSNFKELVDPRLADAYD  379 (457)
Q Consensus       300 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~  379 (457)
                          ....||..|+|||++.+..++.++|+||||+++|+|++|+.||...........    .......+.++.......
T Consensus       151 ----~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~  222 (279)
T cd06619         151 ----KTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLM----PLQLLQCIVDEDPPVLPV  222 (279)
T ss_pred             ----cCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccc----hHHHHHHHhccCCCCCCC
Confidence                234589999999999988999999999999999999999999975221100000    000000000000000001


Q ss_pred             HHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 012765          380 LAEMKRAMLTASVCIHHLSTMRPQMTRVLQ  409 (457)
Q Consensus       380 ~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~  409 (457)
                      ......+.+++.+||+.+|.+||++.++++
T Consensus       223 ~~~~~~~~~li~~~l~~~P~~Rp~~~eil~  252 (279)
T cd06619         223 GQFSEKFVHFITQCMRKQPKERPAPENLMD  252 (279)
T ss_pred             CcCCHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence            112235678888999999999999999987

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.7e-38  Score=326.35  Aligned_cols=193  Identities=22%  Similarity=0.325  Sum_probs=163.9

Q ss_pred             hcCCCCCceecccCcEEEEEEEeC-CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeecC-ceEEE
Q 012765          141 TDNFNSENLIGKGGHAEVYKGCLP-DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTEN-GFHLV  218 (457)
Q Consensus       141 ~~~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~-~~~lv  218 (457)
                      ..+|.+.+.||+|+||.||+|.+. .++.||+|....         ..+.+|+.++++++|+|||++++++..+ ..+++
T Consensus       168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~---------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv  238 (461)
T PHA03211        168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY---------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLV  238 (461)
T ss_pred             cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc---------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEE
Confidence            347899999999999999999875 478899995421         2456899999999999999999976554 56789


Q ss_pred             EEecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCCCCC
Q 012765          219 LQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNW  298 (457)
Q Consensus       219 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~~~  298 (457)
                      |+++. ++|..++......+++..++.|+.||+.||.|||+   .+|+||||||+|||++.++.+||+|||+++.+....
T Consensus       239 ~e~~~-~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~---~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~  314 (461)
T PHA03211        239 LPKYR-SDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHG---EGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSW  314 (461)
T ss_pred             EEccC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCEEECcCCHHHEEECCCCCEEEcccCCceeccccc
Confidence            99884 78888886655679999999999999999999999   899999999999999999999999999998764432


Q ss_pred             CceeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHhCCCCC
Q 012765          299 SHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAV  346 (457)
Q Consensus       299 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLltG~~pf  346 (457)
                      .........||..|+|||++.+..++.++|||||||++|||++|..|+
T Consensus       315 ~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~l  362 (461)
T PHA03211        315 STPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASL  362 (461)
T ss_pred             ccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCc
Confidence            222223456999999999999999999999999999999999988664

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.8e-38  Score=301.14  Aligned_cols=254  Identities=23%  Similarity=0.364  Sum_probs=197.6

Q ss_pred             cCCCCCceecccCcEEEEEEEeC-CCcEEEEEEEeccchh--hHHHHHHHHHHHHHHhhcCCCCcceeeeeeecC-ceEE
Q 012765          142 DNFNSENLIGKGGHAEVYKGCLP-DGEVVAVKKIIKNAKE--DEERISDFLSELGIVAHINHPNAAKLIGFSTEN-GFHL  217 (457)
Q Consensus       142 ~~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~-~~~l  217 (457)
                      ++|.+.+.||+|++|.||+|... +++.+|+|.+......  .......+.+|+.++++++||||+++++++.++ ..++
T Consensus         2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   81 (263)
T cd06625           2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI   81 (263)
T ss_pred             CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence            57889999999999999999864 6899999987643221  223456788999999999999999999966554 5679


Q ss_pred             EEEecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCCCC
Q 012765          218 VLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDN  297 (457)
Q Consensus       218 v~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~~  297 (457)
                      ++||+++++|.+++... ..+++.....++.|++.||.|||+   .+++|+||+|+||+++.++.++|+|||++......
T Consensus        82 v~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~  157 (263)
T cd06625          82 FMEYMPGGSVKDQLKAY-GALTETVTRKYTRQILEGVEYLHS---NMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTI  157 (263)
T ss_pred             EEEECCCCcHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEeecccceecccc
Confidence            99999999999988543 457888889999999999999999   89999999999999999999999999998765432


Q ss_pred             CCcee-eecccccccccChhccccCCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhccccccCCcccccCchhhc
Q 012765          298 WSHHI-VFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSNFKELVDPRLAD  376 (457)
Q Consensus       298 ~~~~~-~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  376 (457)
                      ..... .....++..|+|||++.+..++.++||||||+++|||++|+.||.........+...  ...     ..+.+  
T Consensus       158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~--~~~-----~~~~~--  228 (263)
T cd06625         158 CSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIA--TQP-----TNPQL--  228 (263)
T ss_pred             ccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHh--ccC-----CCCCC--
Confidence            21111 123457889999999998889999999999999999999999997643322111110  000     00111  


Q ss_pred             ccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 012765          377 AYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQL  410 (457)
Q Consensus       377 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~  410 (457)
                        .......+..++.+||..+|.+|||+.++++.
T Consensus       229 --~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~  260 (263)
T cd06625         229 --PSHVSPDARNFLRRTFVENAKKRPSAEELLRH  260 (263)
T ss_pred             --CccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence              11223346678889999999999999999863

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=1.1e-38  Score=314.26  Aligned_cols=242  Identities=24%  Similarity=0.291  Sum_probs=186.3

Q ss_pred             ceecccCcEEEEEEEeC-CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhh-cCCCCcceeeeeeec-CceEEEEEecCC
Q 012765          148 NLIGKGGHAEVYKGCLP-DGEVVAVKKIIKNAKEDEERISDFLSELGIVAH-INHPNAAKLIGFSTE-NGFHLVLQFLPH  224 (457)
Q Consensus       148 ~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~-l~hpniv~l~~~~~~-~~~~lv~e~~~~  224 (457)
                      +.||+|+||.||+|.+. +|+.||+|.+.............+..|..++.. ++||||+++++++.+ +..++||||+.+
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~   80 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence            46999999999999865 588999999875433222334566778888765 489999999986554 557899999999


Q ss_pred             CChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCCCCCCceeee
Q 012765          225 GSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVF  304 (457)
Q Consensus       225 gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~~~~~~~~~  304 (457)
                      |+|..++... ..+++..+..++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||+++......  ....
T Consensus        81 g~L~~~i~~~-~~~~~~~~~~~~~qi~~~l~~lH~---~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~~~  154 (316)
T cd05620          81 GDLMFHIQDK-GRFDLYRATFYAAEIVCGLQFLHS---KGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGD--NRAS  154 (316)
T ss_pred             CcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEECCCCCEEeCccCCCeecccCC--Ccee
Confidence            9999888543 457888889999999999999999   899999999999999999999999999987532211  1123


Q ss_pred             cccccccccChhccccCCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhccccccCCcccccCchhhcccCHHHHH
Q 012765          305 PIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSNFKELVDPRLADAYDLAEMK  384 (457)
Q Consensus       305 ~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~  384 (457)
                      ...||..|+|||++.+..++.++|||||||++|||++|+.||........ +......        .+.+...    ...
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~-~~~~~~~--------~~~~~~~----~~~  221 (316)
T cd05620         155 TFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDEL-FESIRVD--------TPHYPRW----ITK  221 (316)
T ss_pred             ccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHH-HHHHHhC--------CCCCCCC----CCH
Confidence            45689999999999999999999999999999999999999976433211 1110001        1111111    123


Q ss_pred             HHHHHHHHhcccCCCCCCCHH-HHH
Q 012765          385 RAMLTASVCIHHLSTMRPQMT-RVL  408 (457)
Q Consensus       385 ~l~~l~~~Cl~~dP~~RPt~~-evl  408 (457)
                      .+.+++.+||+.||++||++. +++
T Consensus       222 ~~~~li~~~l~~dP~~R~~~~~~~~  246 (316)
T cd05620         222 ESKDILEKLFERDPTRRLGVVGNIR  246 (316)
T ss_pred             HHHHHHHHHccCCHHHcCCChHHHH
Confidence            456788899999999999985 555

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=7.8e-39  Score=305.85  Aligned_cols=254  Identities=22%  Similarity=0.258  Sum_probs=203.3

Q ss_pred             cCCCCCceecccCcEEEEEEEeCC-CcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeec-CceEEEE
Q 012765          142 DNFNSENLIGKGGHAEVYKGCLPD-GEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTE-NGFHLVL  219 (457)
Q Consensus       142 ~~f~~~~~LG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-~~~~lv~  219 (457)
                      +.|+.++.||.|.-|+||++.+.+ +..+|+|++.+..........+...|-+||+.++||.++.||+.++. .-.|++|
T Consensus        77 ~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~m  156 (459)
T KOG0610|consen   77 RHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVM  156 (459)
T ss_pred             HHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEE
Confidence            455677899999999999999764 68999999988776666777889999999999999999999995554 5568999


Q ss_pred             EecCCCChhhhhhc-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCCCC-
Q 012765          220 QFLPHGSLSSLLFG-STECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDN-  297 (457)
Q Consensus       220 e~~~~gsL~~~l~~-~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~~-  297 (457)
                      |||+||+|..+++. ..+++++..+.-++.+|+.||+|||.   .|||+|||||+||||-++|++.|+||.|+...... 
T Consensus       157 eyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHm---lGivYRDLKPENILvredGHIMLsDFDLS~~~~~~P  233 (459)
T KOG0610|consen  157 EYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHM---LGIVYRDLKPENILVREDGHIMLSDFDLSLRCPVSP  233 (459)
T ss_pred             ecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHh---hceeeccCCcceeEEecCCcEEeeeccccccCCCCC
Confidence            99999999999865 45678888888889999999999999   99999999999999999999999999997553110 


Q ss_pred             --------------------------------CCc---------------------eeeecccccccccChhccccCCCC
Q 012765          298 --------------------------------WSH---------------------HIVFPIEGTFGYLSPEYFMHGIVD  324 (457)
Q Consensus       298 --------------------------------~~~---------------------~~~~~~~gt~~y~aPE~~~~~~~~  324 (457)
                                                      ...                     .....+.||-.|+|||++.+...+
T Consensus       234 t~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GHg  313 (459)
T KOG0610|consen  234 TLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGHG  313 (459)
T ss_pred             eeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCCC
Confidence                                            000                     001125699999999999999999


Q ss_pred             cchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhccccccCCcccccCchhhcccCHHHHHHHHHHHHHhcccCCCCCCC-
Q 012765          325 EKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSNFKELVDPRLADAYDLAEMKRAMLTASVCIHHLSTMRPQ-  403 (457)
Q Consensus       325 ~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt-  403 (457)
                      .++|+|+|||++|||+.|..||.+.+...           .+..++-..+.-...+..+..+.+||...|.+||.+|-- 
T Consensus       314 sAVDWWtfGIflYEmLyG~TPFKG~~~~~-----------Tl~NIv~~~l~Fp~~~~vs~~akDLIr~LLvKdP~kRlg~  382 (459)
T KOG0610|consen  314 SAVDWWTFGIFLYEMLYGTTPFKGSNNKE-----------TLRNIVGQPLKFPEEPEVSSAAKDLIRKLLVKDPSKRLGS  382 (459)
T ss_pred             chhhHHHHHHHHHHHHhCCCCcCCCCchh-----------hHHHHhcCCCcCCCCCcchhHHHHHHHHHhccChhhhhcc
Confidence            99999999999999999999999754322           122222222222222344566778899999999999988 


Q ss_pred             ---HHHHHH
Q 012765          404 ---MTRVLQ  409 (457)
Q Consensus       404 ---~~evl~  409 (457)
                         +.||-+
T Consensus       383 ~rGA~eIK~  391 (459)
T KOG0610|consen  383 KRGAAEIKR  391 (459)
T ss_pred             ccchHHhhc
Confidence               555543

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=7.4e-39  Score=316.40  Aligned_cols=239  Identities=26%  Similarity=0.294  Sum_probs=184.4

Q ss_pred             ceecccCcEEEEEEEeC-CCcEEEEEEEeccchhhHHHHHHHHHHHH-HHhhcCCCCcceeeeeee-cCceEEEEEecCC
Q 012765          148 NLIGKGGHAEVYKGCLP-DGEVVAVKKIIKNAKEDEERISDFLSELG-IVAHINHPNAAKLIGFST-ENGFHLVLQFLPH  224 (457)
Q Consensus       148 ~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~-~l~~l~hpniv~l~~~~~-~~~~~lv~e~~~~  224 (457)
                      ++||+|+||+||+|... +|+.||+|++.............+..|.. +++.++||||+++++++. .+..++||||+.+
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence            46999999999999865 68999999986543333333445666655 457799999999998654 4557899999999


Q ss_pred             CChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCCCCCCceeee
Q 012765          225 GSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVF  304 (457)
Q Consensus       225 gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~~~~~~~~~  304 (457)
                      |+|..++.. ...+++..+..++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||++.......  ....
T Consensus        81 g~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~---~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~--~~~~  154 (323)
T cd05575          81 GELFFHLQR-ERSFPEPRARFYAAEIASALGYLHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHS--KTTS  154 (323)
T ss_pred             CCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCCHHHeEECCCCcEEEeccCCCcccccCC--Cccc
Confidence            999988854 3457888888999999999999999   899999999999999999999999999987542221  1123


Q ss_pred             cccccccccChhccccCCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhccccccCCcccccCchhhcccCHHHHH
Q 012765          305 PIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSNFKELVDPRLADAYDLAEMK  384 (457)
Q Consensus       305 ~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~  384 (457)
                      ...||+.|+|||++.+..++.++|||||||++|||++|..||...+.....  ......       ...+....    ..
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~--~~i~~~-------~~~~~~~~----~~  221 (323)
T cd05575         155 TFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMY--DNILNK-------PLRLKPNI----SV  221 (323)
T ss_pred             cccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHHH--HHHHcC-------CCCCCCCC----CH
Confidence            346899999999999999999999999999999999999999764321111  000000       01111112    34


Q ss_pred             HHHHHHHHhcccCCCCCCCHH
Q 012765          385 RAMLTASVCIHHLSTMRPQMT  405 (457)
Q Consensus       385 ~l~~l~~~Cl~~dP~~RPt~~  405 (457)
                      .+.+++.+||+.||.+||++.
T Consensus       222 ~~~~li~~~l~~~p~~R~~~~  242 (323)
T cd05575         222 SARHLLEGLLQKDRTKRLGAK  242 (323)
T ss_pred             HHHHHHHHHhhcCHHhCCCCC
Confidence            567788999999999999985

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=1.1e-38  Score=323.37  Aligned_cols=260  Identities=21%  Similarity=0.341  Sum_probs=198.1

Q ss_pred             HhhcCCCCCceecccCcEEEEEEEeC------CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcC-CCCcceeeeeee
Q 012765          139 AATDNFNSENLIGKGGHAEVYKGCLP------DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHIN-HPNAAKLIGFST  211 (457)
Q Consensus       139 ~~~~~f~~~~~LG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~  211 (457)
                      ...++|.+.+.||+|+||.||+|.+.      .+..||+|++......  .....+.+|+.++.++. ||||+++++++.
T Consensus        34 ~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~--~~~~~~~~E~~~l~~l~~H~niv~~~~~~~  111 (401)
T cd05107          34 MPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARS--SEKQALMSELKIMSHLGPHLNIVNLLGACT  111 (401)
T ss_pred             ecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCCh--hHHHHHHHHHHHHHhcCCCCCeEEEEEEEc
Confidence            34466778899999999999999853      3468999998654332  23457889999999997 999999999665


Q ss_pred             c-CceEEEEEecCCCChhhhhhcCC-------------------------------------------------------
Q 012765          212 E-NGFHLVLQFLPHGSLSSLLFGST-------------------------------------------------------  235 (457)
Q Consensus       212 ~-~~~~lv~e~~~~gsL~~~l~~~~-------------------------------------------------------  235 (457)
                      . +..++||||+.+|+|.++++...                                                       
T Consensus       112 ~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  191 (401)
T cd05107         112 KGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVP  191 (401)
T ss_pred             cCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccc
Confidence            5 45789999999999999885421                                                       


Q ss_pred             ------------------------------------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCC
Q 012765          236 ------------------------------------------ECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKAS  273 (457)
Q Consensus       236 ------------------------------------------~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~  273 (457)
                                                                ..+++...+.++.||+.||.|||+   .+++||||||+
T Consensus       192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrdlkp~  268 (401)
T cd05107         192 MQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLAS---KNCVHRDLAAR  268 (401)
T ss_pred             hhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhc---CCcCcccCCcc
Confidence                                                      135667788899999999999999   89999999999


Q ss_pred             cEEEcCCCcEEEeeccccccCCCCCCceeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHh-CCCCCCcCCcc
Q 012765          274 NILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELIT-GRRAVDSRRQS  352 (457)
Q Consensus       274 NIll~~~~~~kL~DFGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLlt-G~~pf~~~~~~  352 (457)
                      |||++.++.+||+|||+++...............++..|+|||++.+..++.++|||||||++|||++ |..||......
T Consensus       269 NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~  348 (401)
T cd05107         269 NVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMN  348 (401)
T ss_pred             eEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCch
Confidence            99999999999999999986543221111122346788999999998889999999999999999998 88898753221


Q ss_pred             hhhhhccccccCCcccccCchhhcccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q 012765          353 LVIWAKPLLQTSNFKELVDPRLADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQLLRGE  414 (457)
Q Consensus       353 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~  414 (457)
                      ...+.. .....      .+....    .....+.+++.+||+.+|.+||++.+|++.|+.+
T Consensus       349 ~~~~~~-~~~~~------~~~~p~----~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~  399 (401)
T cd05107         349 EQFYNA-IKRGY------RMAKPA----HASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDL  399 (401)
T ss_pred             HHHHHH-HHcCC------CCCCCC----CCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence            111100 00000      000011    1234577888999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=1.1e-38  Score=313.86  Aligned_cols=259  Identities=25%  Similarity=0.404  Sum_probs=197.9

Q ss_pred             hcCCCCCceecccCcEEEEEEEeC--------CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhc-CCCCcceeeeeee
Q 012765          141 TDNFNSENLIGKGGHAEVYKGCLP--------DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHI-NHPNAAKLIGFST  211 (457)
Q Consensus       141 ~~~f~~~~~LG~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~  211 (457)
                      .++|.+.+.||+|+||.||+|...        ....+|+|.+.....  ......+.+|+.++..+ +||||+++++++.
T Consensus        11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~   88 (314)
T cd05099          11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNAT--DKDLADLISEMELMKLIGKHKNIINLLGVCT   88 (314)
T ss_pred             HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCC--hHHHHHHHHHHHHHHhccCCCCeeeEEEEEc
Confidence            467788999999999999999642        245688888764322  23456788999999999 6999999999766


Q ss_pred             cCc-eEEEEEecCCCChhhhhhcC---------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcE
Q 012765          212 ENG-FHLVLQFLPHGSLSSLLFGS---------------TECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNI  275 (457)
Q Consensus       212 ~~~-~~lv~e~~~~gsL~~~l~~~---------------~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NI  275 (457)
                      ... .+++|||+++|+|.+++...               ...+++..+..++.||+.||.|||+   .+++||||||+||
T Consensus        89 ~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~---~gi~H~dlkp~Ni  165 (314)
T cd05099          89 QEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLES---RRCIHRDLAARNV  165 (314)
T ss_pred             cCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHH---CCeeeccccceeE
Confidence            544 68999999999999998542               2357888999999999999999999   8999999999999


Q ss_pred             EEcCCCcEEEeeccccccCCCCCCceeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHh-CCCCCCcCCcchh
Q 012765          276 LLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELIT-GRRAVDSRRQSLV  354 (457)
Q Consensus       276 ll~~~~~~kL~DFGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLlt-G~~pf~~~~~~~~  354 (457)
                      |++.++.+||+|||+++...............++..|+|||++.+..++.++|||||||++|||++ |..||........
T Consensus       166 ll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~  245 (314)
T cd05099         166 LVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEEL  245 (314)
T ss_pred             EEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHHH
Confidence            999999999999999987643222111112224567999999998899999999999999999999 8888875332111


Q ss_pred             hhhccccccCCcccccCchhhcccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCCC
Q 012765          355 IWAKPLLQTSNFKELVDPRLADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQLLRGEGG  416 (457)
Q Consensus       355 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~  416 (457)
                      .  .. ......     ...    .......+.+++.+||+.+|++||++.++++.|+.+..
T Consensus       246 ~--~~-~~~~~~-----~~~----~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~  295 (314)
T cd05099         246 F--KL-LREGHR-----MDK----PSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLA  295 (314)
T ss_pred             H--HH-HHcCCC-----CCC----CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHH
Confidence            1  00 000000     000    11122356678899999999999999999999987653

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=4.6e-38  Score=300.50  Aligned_cols=250  Identities=27%  Similarity=0.370  Sum_probs=189.6

Q ss_pred             ceecccCcEEEEEEEeC----CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeee--cCceEEEEEe
Q 012765          148 NLIGKGGHAEVYKGCLP----DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFST--ENGFHLVLQF  221 (457)
Q Consensus       148 ~~LG~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~--~~~~~lv~e~  221 (457)
                      +.||+|+||.||+|.+.    +...+|+|++....  .......+.+|+.+++.++||||+++++++.  ++..+++|||
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~   78 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRIT--DLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPY   78 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCccC--CHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEec
Confidence            46899999999999753    24578999875322  2234568889999999999999999999654  3346899999


Q ss_pred             cCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCCCCCCce
Q 012765          222 LPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSHH  301 (457)
Q Consensus       222 ~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~~~~~~  301 (457)
                      +.+++|.+++........+...+.++.||+.||.|||+   .+++||||||+|||++.++.+||+|||+++.+.......
T Consensus        79 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~  155 (262)
T cd05058          79 MKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLAS---KKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYS  155 (262)
T ss_pred             CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCccccccCcceEEEcCCCcEEECCccccccccCCccee
Confidence            99999999997655567788888999999999999999   899999999999999999999999999997654322111


Q ss_pred             --eeecccccccccChhccccCCCCcchhHHHHHHHHHHHHhC-CCCCCcCCcchhhhhccccccCCcccccCchhhccc
Q 012765          302 --IVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITG-RRAVDSRRQSLVIWAKPLLQTSNFKELVDPRLADAY  378 (457)
Q Consensus       302 --~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLltG-~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~  378 (457)
                        ......++..|+|||++.+..++.++|||||||++|||++| ..||.......  .........      .+....  
T Consensus       156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~--~~~~~~~~~------~~~~~~--  225 (262)
T cd05058         156 VHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFD--ITVYLLQGR------RLLQPE--  225 (262)
T ss_pred             ecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHH--HHHHHhcCC------CCCCCC--
Confidence              11123357789999999888999999999999999999995 55565422211  111001000      000001  


Q ss_pred             CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q 012765          379 DLAEMKRAMLTASVCIHHLSTMRPQMTRVLQLLRGE  414 (457)
Q Consensus       379 ~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~  414 (457)
                        .....+.+++..||+.+|++||++.+|++.|+.+
T Consensus       226 --~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~  259 (262)
T cd05058         226 --YCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQI  259 (262)
T ss_pred             --cCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence              1123577889999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=2e-38  Score=315.86  Aligned_cols=253  Identities=24%  Similarity=0.308  Sum_probs=206.8

Q ss_pred             hhcCCCCCceecccCcEEEEEEEeCC-CcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcC-CCCcceeeeee-ecCceE
Q 012765          140 ATDNFNSENLIGKGGHAEVYKGCLPD-GEVVAVKKIIKNAKEDEERISDFLSELGIVAHIN-HPNAAKLIGFS-TENGFH  216 (457)
Q Consensus       140 ~~~~f~~~~~LG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~~~-~~~~~~  216 (457)
                      ..+.|.+.+.||+|.||.||++..+. |+.+|+|.+.+...........+.+|+.+|+++. |||||.+++.+ ....++
T Consensus        33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~  112 (382)
T KOG0032|consen   33 IKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVY  112 (382)
T ss_pred             ccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEE
Confidence            45678888999999999999998764 9999999997765544445678999999999998 99999999955 555678


Q ss_pred             EEEEecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCC----CcEEEeeccccc
Q 012765          217 LVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSED----YEAQISDFGLAK  292 (457)
Q Consensus       217 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~----~~~kL~DFGl~~  292 (457)
                      +|||++.||.|.+.+...  .+++.....++.||+.++.|||+   .+++||||||+|+|+...    +.+|++|||++.
T Consensus       113 lvmEL~~GGeLfd~i~~~--~~sE~da~~~~~~il~av~~lH~---~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~  187 (382)
T KOG0032|consen  113 LVMELCEGGELFDRIVKK--HYSERDAAGIIRQILEAVKYLHS---LGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAK  187 (382)
T ss_pred             EEEEecCCchHHHHHHHc--cCCHHHHHHHHHHHHHHHHHHHh---CCceeccCCHHHeeeccccCCCCcEEEeeCCCce
Confidence            999999999999999665  38999999999999999999999   899999999999999643    479999999999


Q ss_pred             cCCCCCCceeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhccccccCCcccccCc
Q 012765          293 WLPDNWSHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSNFKELVDP  372 (457)
Q Consensus       293 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~  372 (457)
                      .....   ......+||+.|+|||++....|+..+||||+|+++|.|++|..||.............   ..++      
T Consensus       188 ~~~~~---~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~---~~~~------  255 (382)
T KOG0032|consen  188 FIKPG---ERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAIL---RGDF------  255 (382)
T ss_pred             EccCC---ceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHH---cCCC------
Confidence            88763   23456779999999999998999999999999999999999999999866443332111   0000      


Q ss_pred             hhhcccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 012765          373 RLADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQ  409 (457)
Q Consensus       373 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~  409 (457)
                      .....+-......+-.++..|+..||.+|+|+.++++
T Consensus       256 ~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~  292 (382)
T KOG0032|consen  256 DFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQ  292 (382)
T ss_pred             CCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhc
Confidence            1111112233445667888899999999999999998

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=3.2e-39  Score=318.30  Aligned_cols=239  Identities=24%  Similarity=0.268  Sum_probs=187.2

Q ss_pred             ceecccCcEEEEEEEe----CCCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeec-CceEEEEEec
Q 012765          148 NLIGKGGHAEVYKGCL----PDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTE-NGFHLVLQFL  222 (457)
Q Consensus       148 ~~LG~G~~g~Vy~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-~~~~lv~e~~  222 (457)
                      +.||+|+||.||++..    .+|+.||+|++...... ......+.+|+.++++++||||+++++++.. +..++||||+
T Consensus         2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~   80 (318)
T cd05582           2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLK-VRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFL   80 (318)
T ss_pred             ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhh-hhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCC
Confidence            5799999999999864    35899999998654322 2234467789999999999999999986554 5578999999


Q ss_pred             CCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCCCCCCcee
Q 012765          223 PHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSHHI  302 (457)
Q Consensus       223 ~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~~~~~~~  302 (457)
                      .+|+|.+++... ..+++..+..++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||++........  .
T Consensus        81 ~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~--~  154 (318)
T cd05582          81 RGGDLFTRLSKE-VMFTEEDVKFYLAELALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK--K  154 (318)
T ss_pred             CCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCC--c
Confidence            999999988543 458899999999999999999999   8999999999999999999999999999876543321  1


Q ss_pred             eecccccccccChhccccCCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhccccccCCcccccCchhhcccCHHH
Q 012765          303 VFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSNFKELVDPRLADAYDLAE  382 (457)
Q Consensus       303 ~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~  382 (457)
                      .....||+.|+|||++.+..++.++|||||||++|||++|+.||............. ....        .+...+    
T Consensus       155 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~-~~~~--------~~p~~~----  221 (318)
T cd05582         155 AYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMIL-KAKL--------GMPQFL----  221 (318)
T ss_pred             eecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHH-cCCC--------CCCCCC----
Confidence            233568999999999998889999999999999999999999998644321111100 0000        011111    


Q ss_pred             HHHHHHHHHHhcccCCCCCCCHHH
Q 012765          383 MKRAMLTASVCIHHLSTMRPQMTR  406 (457)
Q Consensus       383 ~~~l~~l~~~Cl~~dP~~RPt~~e  406 (457)
                      ...+..++.+||+.||++||++.+
T Consensus       222 ~~~~~~li~~~l~~~P~~R~~a~~  245 (318)
T cd05582         222 SPEAQSLLRALFKRNPANRLGAGP  245 (318)
T ss_pred             CHHHHHHHHHHhhcCHhHcCCCCC
Confidence            234567888999999999999655

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=1.4e-38  Score=308.73  Aligned_cols=251  Identities=27%  Similarity=0.354  Sum_probs=194.9

Q ss_pred             CCCCceecccCcEEEEEEEeC-CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeee-ecCceEEEEEe
Q 012765          144 FNSENLIGKGGHAEVYKGCLP-DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFS-TENGFHLVLQF  221 (457)
Q Consensus       144 f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~-~~~~~~lv~e~  221 (457)
                      |+..+.||+|+||+||++... +++.||+|.+.............+.+|+.+++.++|+|++++++.+ .++..+++|||
T Consensus         2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (285)
T cd05630           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL   81 (285)
T ss_pred             ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence            667789999999999999864 6899999988654433333445678899999999999999999855 44557899999


Q ss_pred             cCCCChhhhhhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCCCCCCc
Q 012765          222 LPHGSLSSLLFGS-TECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSH  300 (457)
Q Consensus       222 ~~~gsL~~~l~~~-~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~~~~~  300 (457)
                      +++++|.+++... ...+++..+..++.|++.||.|||+   .+|+||||||+||+++.++.++|+|||++........ 
T Consensus        82 ~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~---~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~-  157 (285)
T cd05630          82 MNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQ---ERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT-  157 (285)
T ss_pred             cCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCCCHHHEEECCCCCEEEeeccceeecCCCcc-
Confidence            9999999888543 3458889999999999999999999   8999999999999999999999999999876543321 


Q ss_pred             eeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhccccccCCcccccCchhhcccCH
Q 012765          301 HIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSNFKELVDPRLADAYDL  380 (457)
Q Consensus       301 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~  380 (457)
                        .....|+..|+|||++.+..++.++|||||||++|+|++|+.||.........-.        ...+.+. ....+..
T Consensus       158 --~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~--------~~~~~~~-~~~~~~~  226 (285)
T cd05630         158 --IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREE--------VERLVKE-VQEEYSE  226 (285)
T ss_pred             --ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHH--------HHhhhhh-hhhhcCc
Confidence              1234589999999999999999999999999999999999999986332110000        0000000 0001111


Q ss_pred             HHHHHHHHHHHHhcccCCCCCCC-----HHHHHH
Q 012765          381 AEMKRAMLTASVCIHHLSTMRPQ-----MTRVLQ  409 (457)
Q Consensus       381 ~~~~~l~~l~~~Cl~~dP~~RPt-----~~evl~  409 (457)
                      .....+.+++..||+.||++|||     +.|+++
T Consensus       227 ~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~  260 (285)
T cd05630         227 KFSPDARSLCKMLLCKDPKERLGCQGGGAREVKE  260 (285)
T ss_pred             cCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence            12234667888999999999999     778876

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=2.3e-38  Score=307.22  Aligned_cols=249  Identities=25%  Similarity=0.343  Sum_probs=193.7

Q ss_pred             CCCCceecccCcEEEEEEEeC-CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeee-ecCceEEEEEe
Q 012765          144 FNSENLIGKGGHAEVYKGCLP-DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFS-TENGFHLVLQF  221 (457)
Q Consensus       144 f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~-~~~~~~lv~e~  221 (457)
                      |+..+.||.|+||+||+|.+. +++.+|+|.+.............+.+|+.++..++|+|++++++++ .++..+++|||
T Consensus         2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (285)
T cd05632           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI   81 (285)
T ss_pred             ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence            667789999999999999864 6889999988654433333345678899999999999999998754 45557899999


Q ss_pred             cCCCChhhhhhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCCCCCCc
Q 012765          222 LPHGSLSSLLFGS-TECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSH  300 (457)
Q Consensus       222 ~~~gsL~~~l~~~-~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~~~~~  300 (457)
                      +.+++|..++... ...+++..+..++.|++.||.|||+   .+|+||||||+||+++.++.++|+|||++........ 
T Consensus        82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~---~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~-  157 (285)
T cd05632          82 MNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHR---ENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGES-  157 (285)
T ss_pred             ccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCCHHHEEECCCCCEEEecCCcceecCCCCc-
Confidence            9999999888553 3468999999999999999999999   8999999999999999999999999999876543221 


Q ss_pred             eeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchh--hhhccccccCCcccccCchhhccc
Q 012765          301 HIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLV--IWAKPLLQTSNFKELVDPRLADAY  378 (457)
Q Consensus       301 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~--~~~~~~~~~~~~~~~~d~~l~~~~  378 (457)
                        .....|+..|+|||++.+..++.++|+|||||++|||++|..||........  .+..... ..      ..    .+
T Consensus       158 --~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~-~~------~~----~~  224 (285)
T cd05632         158 --IRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVL-ET------EE----VY  224 (285)
T ss_pred             --ccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhh-cc------cc----cc
Confidence              1234589999999999989999999999999999999999999986432111  0000000 00      00    11


Q ss_pred             CHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHH
Q 012765          379 DLAEMKRAMLTASVCIHHLSTMRPQ-----MTRVLQ  409 (457)
Q Consensus       379 ~~~~~~~l~~l~~~Cl~~dP~~RPt-----~~evl~  409 (457)
                      .......+.+++..||+.||++||+     +.++++
T Consensus       225 ~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~  260 (285)
T cd05632         225 SAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKR  260 (285)
T ss_pred             CccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHc
Confidence            1122334567888899999999999     556655

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=9.3e-39  Score=321.65  Aligned_cols=261  Identities=21%  Similarity=0.260  Sum_probs=196.4

Q ss_pred             HHHHHhhcCCCCCceecccCcEEEEEEEeC-CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeecC
Q 012765          135 AELAAATDNFNSENLIGKGGHAEVYKGCLP-DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTEN  213 (457)
Q Consensus       135 ~~~~~~~~~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~  213 (457)
                      .++....++|++.+.||+|+||.||++... +++.+|+|.+.+...........+.+|+.+++.++||||+++++++.++
T Consensus        36 ~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~  115 (371)
T cd05622          36 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDD  115 (371)
T ss_pred             hhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcC
Confidence            344456689999999999999999999865 5889999988653333333445678899999999999999999866554


Q ss_pred             -ceEEEEEecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccc
Q 012765          214 -GFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAK  292 (457)
Q Consensus       214 -~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~  292 (457)
                       ..++||||+++|+|..++..  ..++...+..++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||++.
T Consensus       116 ~~~~lv~Ey~~gg~L~~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDLkp~NIll~~~~~ikL~DfG~a~  190 (371)
T cd05622         116 RYLYMVMEYMPGGDLVNLMSN--YDVPEKWARFYTAEVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCM  190 (371)
T ss_pred             CEEEEEEcCCCCCcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHH---CCEEeCCCCHHHEEECCCCCEEEEeCCcee
Confidence             46899999999999998854  347888888899999999999999   899999999999999999999999999998


Q ss_pred             cCCCCCCceeeecccccccccChhccccC----CCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhccccccCCccc
Q 012765          293 WLPDNWSHHIVFPIEGTFGYLSPEYFMHG----IVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSNFKE  368 (457)
Q Consensus       293 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~  368 (457)
                      .+...... ......||+.|+|||++.+.    .++.++|||||||++|||++|..||....... .+.. .........
T Consensus       191 ~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~-~~~~-i~~~~~~~~  267 (371)
T cd05622         191 KMNKEGMV-RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVG-TYSK-IMNHKNSLT  267 (371)
T ss_pred             EcCcCCcc-cccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHH-HHHH-HHcCCCccc
Confidence            76433211 12245699999999998653    37899999999999999999999998644321 1111 111110000


Q ss_pred             ccCchhhcccCHHHHHHHHHHHHHhcccCCCC--CCCHHHHHHH
Q 012765          369 LVDPRLADAYDLAEMKRAMLTASVCIHHLSTM--RPQMTRVLQL  410 (457)
Q Consensus       369 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~--RPt~~evl~~  410 (457)
                      +.+       .......+..++..||..++.+  ||++.+|++.
T Consensus       268 ~~~-------~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h  304 (371)
T cd05622         268 FPD-------DNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH  304 (371)
T ss_pred             CCC-------cCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcC
Confidence            101       1122334566788899844433  7889888874

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=5e-38  Score=299.24  Aligned_cols=251  Identities=28%  Similarity=0.449  Sum_probs=198.3

Q ss_pred             cCCCCCceecccCcEEEEEEEeCCCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeec-CceEEEEE
Q 012765          142 DNFNSENLIGKGGHAEVYKGCLPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTE-NGFHLVLQ  220 (457)
Q Consensus       142 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-~~~~lv~e  220 (457)
                      .+|++.+.||.|+||.||+|.+.++..+|+|.+......    ...+.+|++++++++|||++++++++.. ...+++||
T Consensus         4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~~----~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e   79 (256)
T cd05112           4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMS----EEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFE   79 (256)
T ss_pred             hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCCC----HHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEE
Confidence            467788999999999999998877889999987644332    2368889999999999999999996654 45679999


Q ss_pred             ecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCCCCCCc
Q 012765          221 FLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSH  300 (457)
Q Consensus       221 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~~~~~  300 (457)
                      |+.+++|.+++......+++..++.++.+++.||.|||+   .+++|+||||+||+++.++.++|+|||++.........
T Consensus        80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~  156 (256)
T cd05112          80 FMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLES---SNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYT  156 (256)
T ss_pred             cCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHH---CCccccccccceEEEcCCCeEEECCCcceeecccCccc
Confidence            999999999987666678899999999999999999999   89999999999999999999999999998766433211


Q ss_pred             eeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHh-CCCCCCcCCcchhhhhccccccCCcccccCchhhcccC
Q 012765          301 HIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELIT-GRRAVDSRRQSLVIWAKPLLQTSNFKELVDPRLADAYD  379 (457)
Q Consensus       301 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLlt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~  379 (457)
                       ......++..|+|||++.++.++.++||||||+++|||++ |..||............  ...   .....+.+     
T Consensus       157 -~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~--~~~---~~~~~~~~-----  225 (256)
T cd05112         157 -SSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETI--NAG---FRLYKPRL-----  225 (256)
T ss_pred             -ccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHH--hCC---CCCCCCCC-----
Confidence             1112224578999999998899999999999999999998 99999754322111110  000   01111111     


Q ss_pred             HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 012765          380 LAEMKRAMLTASVCIHHLSTMRPQMTRVLQLLR  412 (457)
Q Consensus       380 ~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~  412 (457)
                        ....+.+++.+||+.+|++||++.+|++.|.
T Consensus       226 --~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l~  256 (256)
T cd05112         226 --ASQSVYELMQHCWKERPEDRPSFSLLLHQLA  256 (256)
T ss_pred             --CCHHHHHHHHHHcccChhhCCCHHHHHHhhC
Confidence              1245778999999999999999999999873

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=1.3e-38  Score=318.73  Aligned_cols=259  Identities=22%  Similarity=0.291  Sum_probs=195.1

Q ss_pred             hhcCCCCCceecccCcEEEEEEEeC-CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeecC-----
Q 012765          140 ATDNFNSENLIGKGGHAEVYKGCLP-DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTEN-----  213 (457)
Q Consensus       140 ~~~~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~-----  213 (457)
                      ..++|.+.+.||+|+||.||++.+. .++.||+|++..... .......+.+|+.+++.++||||+++++++...     
T Consensus        15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~   93 (355)
T cd07874          15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQ-NQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEE   93 (355)
T ss_pred             hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCccc-ChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccc
Confidence            4578999999999999999999864 588999998865432 223456788999999999999999999965432     


Q ss_pred             --ceEEEEEecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeecccc
Q 012765          214 --GFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLA  291 (457)
Q Consensus       214 --~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~  291 (457)
                        ..+++|||+.+ ++...+.   ..+++..+..++.|++.||.|||+   .+|+||||||+|||++.++.+||+|||++
T Consensus        94 ~~~~~lv~e~~~~-~l~~~~~---~~l~~~~~~~~~~qi~~aL~~LH~---~givHrDikp~Nill~~~~~~kl~Dfg~~  166 (355)
T cd07874          94 FQDVYLVMELMDA-NLCQVIQ---MELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLA  166 (355)
T ss_pred             cceeEEEhhhhcc-cHHHHHh---hcCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChHHEEECCCCCEEEeeCccc
Confidence              35899999965 5665552   347888888999999999999999   89999999999999999999999999999


Q ss_pred             ccCCCCCCceeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhccc-----------
Q 012765          292 KWLPDNWSHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPL-----------  360 (457)
Q Consensus       292 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~~~-----------  360 (457)
                      +.......   .....||..|+|||++.+..++.++|||||||++|+|++|+.||...+.... +....           
T Consensus       167 ~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~  242 (355)
T cd07874         167 RTAGTSFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQ-WNKVIEQLGTPCPEFM  242 (355)
T ss_pred             ccCCCccc---cCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHHhCCCCHHHH
Confidence            86644321   2234589999999999998999999999999999999999999976432111 10000           


Q ss_pred             -----------cccCCcccccCchh-----h---cccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 012765          361 -----------LQTSNFKELVDPRL-----A---DAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQL  410 (457)
Q Consensus       361 -----------~~~~~~~~~~d~~l-----~---~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~  410 (457)
                                 ........+..+..     .   ..........+.+++.+||+.||++|||+.|+++.
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h  311 (355)
T cd07874         243 KKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH  311 (355)
T ss_pred             HhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence                       00000000000000     0   00011123456789999999999999999999983

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=1.5e-38  Score=303.00  Aligned_cols=251  Identities=29%  Similarity=0.450  Sum_probs=195.5

Q ss_pred             CCCCceecccCcEEEEEEEeCC-CcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeee-cCceEEEEEe
Q 012765          144 FNSENLIGKGGHAEVYKGCLPD-GEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFST-ENGFHLVLQF  221 (457)
Q Consensus       144 f~~~~~LG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~-~~~~~lv~e~  221 (457)
                      |++.+.||+|+||+||++.... ++.||+|.+......... .....+|+.++.+++||||+++++++. ....+++||+
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~-~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~   79 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEE-REENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEY   79 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHH-HHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEE
T ss_pred             CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccc-cchhhhhhhccccccccccccccccccccccccccccc
Confidence            4567899999999999998764 678999998766444332 334566999999999999999999665 4557899999


Q ss_pred             cCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCCCCCCce
Q 012765          222 LPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSHH  301 (457)
Q Consensus       222 ~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~~~~~~  301 (457)
                      +.+++|.+++. ....+++..++.++.||+.||.+||+   .+++|+||||+||+++.++.++|+|||++......  ..
T Consensus        80 ~~~~~L~~~l~-~~~~~~~~~~~~~~~qi~~~L~~Lh~---~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~--~~  153 (260)
T PF00069_consen   80 CPGGSLQDYLQ-KNKPLSEEEILKIAYQILEALAYLHS---KGIVHRDIKPENILLDENGEVKLIDFGSSVKLSEN--NE  153 (260)
T ss_dssp             ETTEBHHHHHH-HHSSBBHHHHHHHHHHHHHHHHHHHH---TTEEESSBSGGGEEESTTSEEEESSGTTTEESTST--TS
T ss_pred             ccccccccccc-cccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccc--cc
Confidence            99999999996 34557999999999999999999999   89999999999999999999999999999764211  12


Q ss_pred             eeecccccccccChhccc-cCCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhccccccCCcccccCchhhcccC-
Q 012765          302 IVFPIEGTFGYLSPEYFM-HGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSNFKELVDPRLADAYD-  379 (457)
Q Consensus       302 ~~~~~~gt~~y~aPE~~~-~~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~-  379 (457)
                      ......++..|+|||++. +..++.++||||||+++++|++|..||............        .......+..... 
T Consensus       154 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~--------~~~~~~~~~~~~~~  225 (260)
T PF00069_consen  154 NFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEII--------EKILKRPLPSSSQQ  225 (260)
T ss_dssp             EBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHH--------HHHHHTHHHHHTTS
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhh--------hhcccccccccccc
Confidence            334456899999999998 788999999999999999999999999864211111100        0000001100000 


Q ss_pred             -HHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 012765          380 -LAEMKRAMLTASVCIHHLSTMRPQMTRVLQ  409 (457)
Q Consensus       380 -~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~  409 (457)
                       ......+.+++..||+.||++||++.++++
T Consensus       226 ~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~  256 (260)
T PF00069_consen  226 SREKSEELRDLIKKMLSKDPEQRPSAEELLK  256 (260)
T ss_dssp             HTTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred             cchhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence             011267888999999999999999999975

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=3.1e-38  Score=339.21  Aligned_cols=260  Identities=25%  Similarity=0.302  Sum_probs=198.7

Q ss_pred             cCCCCCceecccCcEEEEEEEeC-CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeecC-ceEEEE
Q 012765          142 DNFNSENLIGKGGHAEVYKGCLP-DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTEN-GFHLVL  219 (457)
Q Consensus       142 ~~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~-~~~lv~  219 (457)
                      ++|.+.++||+|+||.||+|.+. +|+.||+|++............++.+|+.+++.++||||+++++++.++ ..+++|
T Consensus         2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM   81 (932)
T PRK13184          2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM   81 (932)
T ss_pred             CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence            57889999999999999999865 5899999998755444444456899999999999999999999976554 568999


Q ss_pred             EecCCCChhhhhhcC----------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeecc
Q 012765          220 QFLPHGSLSSLLFGS----------TECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFG  289 (457)
Q Consensus       220 e~~~~gsL~~~l~~~----------~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG  289 (457)
                      ||+++|+|.+++...          ....++..++.++.||+.||.|||+   .+|+||||||+|||++.++.++|+|||
T Consensus        82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs---~GIIHRDLKPeNILLd~dg~vKLiDFG  158 (932)
T PRK13184         82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHS---KGVLHRDLKPDNILLGLFGEVVILDWG  158 (932)
T ss_pred             EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHH---CCccccCCchheEEEcCCCCEEEEecC
Confidence            999999999988531          1234567778999999999999999   899999999999999999999999999


Q ss_pred             ccccCCCCCCc----------------eeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHhCCCCCCcCCcch
Q 012765          290 LAKWLPDNWSH----------------HIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSL  353 (457)
Q Consensus       290 l~~~~~~~~~~----------------~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~  353 (457)
                      ++.........                .......||+.|+|||++.+..++.++|||||||++|||+||+.||.......
T Consensus       159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~k  238 (932)
T PRK13184        159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRK  238 (932)
T ss_pred             cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhh
Confidence            99876211100                00112458999999999999999999999999999999999999997633221


Q ss_pred             hhhhccccccCCcccccCchhhcccCHHHHHHHHHHHHHhcccCCCCCC-CHHHHHHHHhcC
Q 012765          354 VIWAKPLLQTSNFKELVDPRLADAYDLAEMKRAMLTASVCIHHLSTMRP-QMTRVLQLLRGE  414 (457)
Q Consensus       354 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-t~~evl~~L~~~  414 (457)
                      ..+...         +.++.-... .......+.+++.+||+.||++|| ++.++++.|+..
T Consensus       239 i~~~~~---------i~~P~~~~p-~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~  290 (932)
T PRK13184        239 ISYRDV---------ILSPIEVAP-YREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPH  290 (932)
T ss_pred             hhhhhh---------ccChhhccc-cccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence            111110         011100000 011223466788999999999996 567777766654

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=1.9e-38  Score=311.30  Aligned_cols=265  Identities=20%  Similarity=0.306  Sum_probs=195.3

Q ss_pred             cCCCCCceecccCcEEEEEEEeC-CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeee-cCceEEEE
Q 012765          142 DNFNSENLIGKGGHAEVYKGCLP-DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFST-ENGFHLVL  219 (457)
Q Consensus       142 ~~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~-~~~~~lv~  219 (457)
                      ++|.+.+.||+|+||.||+|... +++.||+|.+......  .....+.+|+.++++++||||+++++++. ++..+++|
T Consensus         6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   83 (309)
T cd07872           6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEE--GAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVF   83 (309)
T ss_pred             CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccC--CcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEE
Confidence            56888999999999999999865 5788999988643322  12335778999999999999999999655 45578999


Q ss_pred             EecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCCCCCC
Q 012765          220 QFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWS  299 (457)
Q Consensus       220 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~~~~  299 (457)
                      ||+.+ +|..++......+++..+..++.||+.||.|||+   .+|+||||||+||+++.++.+||+|||++........
T Consensus        84 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  159 (309)
T cd07872          84 EYLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHR---RKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTK  159 (309)
T ss_pred             eCCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEECccccceecCCCcc
Confidence            99975 7888876666668899999999999999999999   8999999999999999999999999999876533221


Q ss_pred             ceeeecccccccccChhcccc-CCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhc-ccc------------ccCC
Q 012765          300 HHIVFPIEGTFGYLSPEYFMH-GIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAK-PLL------------QTSN  365 (457)
Q Consensus       300 ~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~-~~~------------~~~~  365 (457)
                        ......+|..|+|||++.+ ..++.++|||||||++|+|+||+.||...+........ ...            ....
T Consensus       160 --~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (309)
T cd07872         160 --TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDE  237 (309)
T ss_pred             --ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhh
Confidence              1122347899999998865 46899999999999999999999999764422111000 000            0000


Q ss_pred             cccccCchhhc----ccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH--HHhcC
Q 012765          366 FKELVDPRLAD----AYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQ--LLRGE  414 (457)
Q Consensus       366 ~~~~~d~~l~~----~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~--~L~~~  414 (457)
                      ....-.+....    .........+.+++.+||+.||.+|||+.|+++  .++..
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~  292 (309)
T cd07872         238 FKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSL  292 (309)
T ss_pred             hhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhhhc
Confidence            00000000000    000112234678899999999999999999987  44443

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=4.8e-38  Score=299.55  Aligned_cols=238  Identities=21%  Similarity=0.346  Sum_probs=186.9

Q ss_pred             ceecccCcEEEEEEEeCCCc-----------EEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeecCceE
Q 012765          148 NLIGKGGHAEVYKGCLPDGE-----------VVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTENGFH  216 (457)
Q Consensus       148 ~~LG~G~~g~Vy~~~~~~~~-----------~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~  216 (457)
                      +.||+|+||.||+|.+.+..           .+++|.+.....    ....+.+|+.+++.++||||+++++++.....+
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   76 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHR----DSLAFFETASLMSQLSHKHLVKLYGVCVRDENI   76 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchh----hHHHHHHHHHHHHcCCCcchhheeeEEecCCcE
Confidence            46999999999999875432           467776543321    156888999999999999999999977667788


Q ss_pred             EEEEecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCC-------cEEEeecc
Q 012765          217 LVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDY-------EAQISDFG  289 (457)
Q Consensus       217 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~-------~~kL~DFG  289 (457)
                      ++|||+++|+|.+++......+++..++.++.||+.||.|||+   .+|+||||||+|||++.++       .+||+|||
T Consensus        77 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg  153 (259)
T cd05037          77 MVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLED---KKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPG  153 (259)
T ss_pred             EEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhh---CCeecccCccceEEEecCccccCCceeEEeCCCC
Confidence            9999999999999997666578999999999999999999999   8999999999999999887       79999999


Q ss_pred             ccccCCCCCCceeeecccccccccChhccccC--CCCcchhHHHHHHHHHHHHh-CCCCCCcCCcchhhhhccccccCCc
Q 012765          290 LAKWLPDNWSHHIVFPIEGTFGYLSPEYFMHG--IVDEKTDVFAFGVLLLELIT-GRRAVDSRRQSLVIWAKPLLQTSNF  366 (457)
Q Consensus       290 l~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~ksDvwSlGvll~eLlt-G~~pf~~~~~~~~~~~~~~~~~~~~  366 (457)
                      ++......      ....++..|+|||++.+.  .++.++||||||+++|||++ |..||........  ...... .. 
T Consensus       154 ~a~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~--~~~~~~-~~-  223 (259)
T cd05037         154 IPITVLSR------EERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEK--ERFYQD-QH-  223 (259)
T ss_pred             cccccccc------cccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhH--HHHHhc-CC-
Confidence            98865441      122367789999999876  78999999999999999999 5777765322111  000000 00 


Q ss_pred             ccccCchhhcccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 012765          367 KELVDPRLADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQLLR  412 (457)
Q Consensus       367 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~  412 (457)
                            .+ ....   ...+.+++.+||..+|.+|||+.+|++.|+
T Consensus       224 ------~~-~~~~---~~~~~~li~~~l~~~p~~Rpt~~~il~~l~  259 (259)
T cd05037         224 ------RL-PMPD---CAELANLINQCWTYDPTKRPSFRAILRDLN  259 (259)
T ss_pred             ------CC-CCCC---chHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence                  00 0001   156778999999999999999999999873

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=2.2e-38  Score=307.18  Aligned_cols=259  Identities=21%  Similarity=0.318  Sum_probs=187.2

Q ss_pred             CCCCCceecccCcEEEEEEEeC-CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhh---cCCCCcceeeeeeec------
Q 012765          143 NFNSENLIGKGGHAEVYKGCLP-DGEVVAVKKIIKNAKEDEERISDFLSELGIVAH---INHPNAAKLIGFSTE------  212 (457)
Q Consensus       143 ~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~---l~hpniv~l~~~~~~------  212 (457)
                      +|++.+.||+|+||+||+|... +++.||+|.+....... .....+.+|+.+++.   ++||||+++++++..      
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~   79 (288)
T cd07863           1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNED-GLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRE   79 (288)
T ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCC-CCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCC
Confidence            4788899999999999999865 68899999886432221 111234456666655   479999999997643      


Q ss_pred             CceEEEEEecCCCChhhhhhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeecccc
Q 012765          213 NGFHLVLQFLPHGSLSSLLFGS-TECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLA  291 (457)
Q Consensus       213 ~~~~lv~e~~~~gsL~~~l~~~-~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~  291 (457)
                      ...+++|||+.+ +|..++... ...+++..+..++.||+.||.|||+   .+++||||||+|||++.++.+||+|||++
T Consensus        80 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dikp~Nili~~~~~~kl~dfg~~  155 (288)
T cd07863          80 TKVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHA---NCIVHRDLKPENILVTSGGQVKLADFGLA  155 (288)
T ss_pred             ceEEEEEccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEECccCcc
Confidence            236799999974 788877543 3458999999999999999999999   89999999999999999999999999999


Q ss_pred             ccCCCCCCceeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhh--hhccc--cccCCcc
Q 012765          292 KWLPDNWSHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVI--WAKPL--LQTSNFK  367 (457)
Q Consensus       292 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~--~~~~~--~~~~~~~  367 (457)
                      ........   .....||..|+|||++.+..++.++|||||||++|+|++|+.||.........  .....  .......
T Consensus       156 ~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~  232 (288)
T cd07863         156 RIYSCQMA---LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWP  232 (288)
T ss_pred             ccccCccc---CCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCc
Confidence            87643321   12345899999999999889999999999999999999999999754321110  00000  0000000


Q ss_pred             -------cccCchh---hcccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 012765          368 -------ELVDPRL---ADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQ  409 (457)
Q Consensus       368 -------~~~d~~l---~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~  409 (457)
                             ....+..   ...........+.+++.+||+.||++|||+.+++.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~  284 (288)
T cd07863         233 RDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ  284 (288)
T ss_pred             ccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence                   0000000   00001122345678899999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2.8e-38  Score=316.63  Aligned_cols=192  Identities=24%  Similarity=0.372  Sum_probs=161.6

Q ss_pred             HhhcCCCCCceecccCcEEEEEEEeC-CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeecCc-eE
Q 012765          139 AATDNFNSENLIGKGGHAEVYKGCLP-DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTENG-FH  216 (457)
Q Consensus       139 ~~~~~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~-~~  216 (457)
                      ....+|.+.+.||+|+||.||+|... +++.||+|.....         ....|+.++++++||||+++++++.... .+
T Consensus        63 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~---------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  133 (357)
T PHA03209         63 VASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG---------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITC  133 (357)
T ss_pred             hhhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc---------ccHHHHHHHHhCCCCCCcChhheEEeCCeeE
Confidence            34568999999999999999999865 4778999864322         2346899999999999999999665554 67


Q ss_pred             EEEEecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCCC
Q 012765          217 LVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPD  296 (457)
Q Consensus       217 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~  296 (457)
                      +|||++. ++|..++......+++..++.|+.||+.||.|||+   .+|+||||||+|||++.++.+||+|||+++....
T Consensus       134 lv~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~  209 (357)
T PHA03209        134 MVLPHYS-SDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHA---QRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVV  209 (357)
T ss_pred             EEEEccC-CcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEEecCcccccccc
Confidence            8999884 68888887666779999999999999999999999   8999999999999999999999999999875432


Q ss_pred             CCCceeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHhCCCCC
Q 012765          297 NWSHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAV  346 (457)
Q Consensus       297 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLltG~~pf  346 (457)
                      ..   ......||..|+|||++.+..++.++|||||||++|||+++..|+
T Consensus       210 ~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~  256 (357)
T PHA03209        210 AP---AFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI  256 (357)
T ss_pred             Cc---ccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence            21   122345899999999999999999999999999999999865554

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=7.1e-39  Score=321.32  Aligned_cols=206  Identities=26%  Similarity=0.413  Sum_probs=173.2

Q ss_pred             cCCCCCceecccCcEEEEEEEeC-CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeec-CceEEEE
Q 012765          142 DNFNSENLIGKGGHAEVYKGCLP-DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTE-NGFHLVL  219 (457)
Q Consensus       142 ~~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-~~~~lv~  219 (457)
                      ++|+..+.||+|+||+||++... +++.||+|++.............+.+|+.++..++||||+++++++.+ +.+++||
T Consensus         1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~   80 (360)
T cd05627           1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM   80 (360)
T ss_pred             CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            46888999999999999999865 589999999865433334456678899999999999999999985554 5578999


Q ss_pred             EecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCCCCCC
Q 012765          220 QFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWS  299 (457)
Q Consensus       220 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~~~~  299 (457)
                      ||+++|+|.+++... ..+++..+..++.|++.||.|||+   .+|+||||||+|||++.++.+||+|||++..+.....
T Consensus        81 E~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~~L~~lH~---~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~  156 (360)
T cd05627          81 EFLPGGDMMTLLMKK-DTLSEEATQFYIAETVLAIDAIHQ---LGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHR  156 (360)
T ss_pred             eCCCCccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH---CCeEccCCCHHHEEECCCCCEEEeeccCCcccccccc
Confidence            999999999998543 457888889999999999999999   8999999999999999999999999999875532110


Q ss_pred             c---------------------------------eeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHhCCCCC
Q 012765          300 H---------------------------------HIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAV  346 (457)
Q Consensus       300 ~---------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLltG~~pf  346 (457)
                      .                                 .......||+.|+|||++.+..++.++|||||||++|||++|+.||
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf  236 (360)
T cd05627         157 TEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPF  236 (360)
T ss_pred             cccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCC
Confidence            0                                 0012346999999999999999999999999999999999999999


Q ss_pred             CcCCc
Q 012765          347 DSRRQ  351 (457)
Q Consensus       347 ~~~~~  351 (457)
                      .....
T Consensus       237 ~~~~~  241 (360)
T cd05627         237 CSETP  241 (360)
T ss_pred             CCCCH
Confidence            86443

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=7.4e-39  Score=316.69  Aligned_cols=242  Identities=24%  Similarity=0.273  Sum_probs=185.6

Q ss_pred             ceecccCcEEEEEEEeC-CCcEEEEEEEeccchhhHHHHHHHHHHHHH-HhhcCCCCcceeeeee-ecCceEEEEEecCC
Q 012765          148 NLIGKGGHAEVYKGCLP-DGEVVAVKKIIKNAKEDEERISDFLSELGI-VAHINHPNAAKLIGFS-TENGFHLVLQFLPH  224 (457)
Q Consensus       148 ~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~-l~~l~hpniv~l~~~~-~~~~~~lv~e~~~~  224 (457)
                      +.||+|+||+||+|... +|+.||+|++.+...........+..|..+ ++.++||||+++++++ .++..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG   80 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence            46999999999999864 689999999865433333334556666654 6778999999999855 45567899999999


Q ss_pred             CChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCCCCCCceeee
Q 012765          225 GSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVF  304 (457)
Q Consensus       225 gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~~~~~~~~~  304 (457)
                      |+|..++.. ...+++..+..++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||++........  ...
T Consensus        81 ~~L~~~l~~-~~~~~~~~~~~~~~qi~~al~~lH~---~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~--~~~  154 (325)
T cd05604          81 GELFFHLQR-ERSFPEPRARFYAAEIASALGYLHS---INIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSD--TTT  154 (325)
T ss_pred             CCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCC--Ccc
Confidence            999888854 3458888999999999999999999   8999999999999999999999999999875432211  123


Q ss_pred             cccccccccChhccccCCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhccccccCCcccccCchhhcccCHHHHH
Q 012765          305 PIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSNFKELVDPRLADAYDLAEMK  384 (457)
Q Consensus       305 ~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~  384 (457)
                      ...||..|+|||++.+..++.++|||||||++|||++|..||...+..... .. ... .      ...+...    ...
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~-~~-~~~-~------~~~~~~~----~~~  221 (325)
T cd05604         155 TFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMY-DN-ILH-K------PLVLRPG----ASL  221 (325)
T ss_pred             cccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHHH-HH-HHc-C------CccCCCC----CCH
Confidence            356899999999999999999999999999999999999999864322111 00 000 0      0001111    223


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHH
Q 012765          385 RAMLTASVCIHHLSTMRPQMTRVL  408 (457)
Q Consensus       385 ~l~~l~~~Cl~~dP~~RPt~~evl  408 (457)
                      .+..++..||+.+|.+||++.+.+
T Consensus       222 ~~~~ll~~ll~~~p~~R~~~~~~~  245 (325)
T cd05604         222 TAWSILEELLEKDRQRRLGAKEDF  245 (325)
T ss_pred             HHHHHHHHHhccCHHhcCCCCCCH
Confidence            456788899999999999986433

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=2.8e-38  Score=317.42  Aligned_cols=258  Identities=22%  Similarity=0.293  Sum_probs=194.5

Q ss_pred             hhcCCCCCceecccCcEEEEEEEeC-CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeec------
Q 012765          140 ATDNFNSENLIGKGGHAEVYKGCLP-DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTE------  212 (457)
Q Consensus       140 ~~~~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~------  212 (457)
                      ..++|.+.+.||+|+||.||+|... .++.||||++..... .......+.+|+.+++.++||||+++++++..      
T Consensus        22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~  100 (364)
T cd07875          22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQ-NQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEE  100 (364)
T ss_pred             hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCcccc-CchhHHHHHHHHHHHHhcCCCCccccceeecccccccc
Confidence            4578999999999999999999864 588999998865432 22335678899999999999999999986543      


Q ss_pred             -CceEEEEEecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeecccc
Q 012765          213 -NGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLA  291 (457)
Q Consensus       213 -~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~  291 (457)
                       ...++||||+.+ +|...+.   ..+++..+..++.|++.||.|||+   .+|+||||||+|||++.++.+||+|||++
T Consensus       101 ~~~~~lv~e~~~~-~l~~~~~---~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~DfG~a  173 (364)
T cd07875         101 FQDVYIVMELMDA-NLCQVIQ---MELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLA  173 (364)
T ss_pred             cCeEEEEEeCCCC-CHHHHHH---hcCCHHHHHHHHHHHHHHHHHHhh---CCeecCCCCHHHEEECCCCcEEEEeCCCc
Confidence             236899999965 5666663   347788889999999999999999   89999999999999999999999999999


Q ss_pred             ccCCCCCCceeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhcccc----------
Q 012765          292 KWLPDNWSHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLL----------  361 (457)
Q Consensus       292 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~~~~----------  361 (457)
                      +.......   .....||..|+|||++.+..++.++|||||||++|+|++|+.||...+.... +.....          
T Consensus       174 ~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~  249 (364)
T cd07875         174 RTAGTSFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQ-WNKVIEQLGTPCPEFM  249 (364)
T ss_pred             cccCCCCc---ccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHhcCCCCHHHH
Confidence            86644321   2234589999999999999999999999999999999999999976442211 100000          


Q ss_pred             ------------ccC-----CcccccCchhh---cccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 012765          362 ------------QTS-----NFKELVDPRLA---DAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQ  409 (457)
Q Consensus       362 ------------~~~-----~~~~~~d~~l~---~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~  409 (457)
                                  ..+     ....+....+.   ..........+.+++.+||+.||.+|||+.++++
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~  317 (364)
T cd07875         250 KKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ  317 (364)
T ss_pred             HhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence                        000     00000000000   0001112345778999999999999999999988

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=1.2e-38  Score=315.12  Aligned_cols=243  Identities=25%  Similarity=0.287  Sum_probs=184.1

Q ss_pred             ceecccCcEEEEEEEeC-CCcEEEEEEEeccchhhHHHHHHHHHHHH-HHhhcCCCCcceeeeeee-cCceEEEEEecCC
Q 012765          148 NLIGKGGHAEVYKGCLP-DGEVVAVKKIIKNAKEDEERISDFLSELG-IVAHINHPNAAKLIGFST-ENGFHLVLQFLPH  224 (457)
Q Consensus       148 ~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~-~l~~l~hpniv~l~~~~~-~~~~~lv~e~~~~  224 (457)
                      +.||+|+||+||+|.+. +++.||+|.+.............+..|.. +++.++||||+++++++. .+..++||||+.+
T Consensus         1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05602           1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING   80 (325)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence            46999999999999865 57889999886543322233345555554 467789999999998654 4557899999999


Q ss_pred             CChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCCCCCCceeee
Q 012765          225 GSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVF  304 (457)
Q Consensus       225 gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~~~~~~~~~  304 (457)
                      |+|..++... ..+.......++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||++........  ...
T Consensus        81 ~~L~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~---~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~--~~~  154 (325)
T cd05602          81 GELFYHLQRE-RCFLEPRARFYAAEIASALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNG--TTS  154 (325)
T ss_pred             CcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEECCCCCEEEccCCCCcccccCCC--Ccc
Confidence            9999988653 446777778899999999999999   8999999999999999999999999999875432211  123


Q ss_pred             cccccccccChhccccCCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhccccccCCcccccCchhhcccCHHHHH
Q 012765          305 PIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSNFKELVDPRLADAYDLAEMK  384 (457)
Q Consensus       305 ~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~  384 (457)
                      ...||+.|+|||++.+..++.++|||||||++|||++|..||......... .. ... ..      ..+...    ...
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~-~~-i~~-~~------~~~~~~----~~~  221 (325)
T cd05602         155 TFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMY-DN-ILN-KP------LQLKPN----ITN  221 (325)
T ss_pred             cccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHHH-HH-HHh-CC------cCCCCC----CCH
Confidence            356999999999999999999999999999999999999999764332111 00 000 00      001111    223


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHHH
Q 012765          385 RAMLTASVCIHHLSTMRPQMTRVLQ  409 (457)
Q Consensus       385 ~l~~l~~~Cl~~dP~~RPt~~evl~  409 (457)
                      .+.+++..||+.+|.+||++.+.+.
T Consensus       222 ~~~~li~~~l~~~p~~R~~~~~~~~  246 (325)
T cd05602         222 SARHLLEGLLQKDRTKRLGAKDDFM  246 (325)
T ss_pred             HHHHHHHHHcccCHHHCCCCCCCHH
Confidence            4667888999999999999875443

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=6.8e-38  Score=297.97  Aligned_cols=248  Identities=25%  Similarity=0.393  Sum_probs=198.9

Q ss_pred             cCCCCCceecccCcEEEEEEEeCC-CcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeee-cCceEEEE
Q 012765          142 DNFNSENLIGKGGHAEVYKGCLPD-GEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFST-ENGFHLVL  219 (457)
Q Consensus       142 ~~f~~~~~LG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~-~~~~~lv~  219 (457)
                      ++|++.+.||.|+||.||+|...+ ++.+++|.+.....     ...+.+|+.+++.++||||+++++++. ....++++
T Consensus         3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-----~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~   77 (256)
T cd06612           3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED-----LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVM   77 (256)
T ss_pred             ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH-----HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEE
Confidence            678899999999999999998764 78999998754321     568999999999999999999999554 45578999


Q ss_pred             EecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCCCCCC
Q 012765          220 QFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWS  299 (457)
Q Consensus       220 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~~~~  299 (457)
                      ||+.+++|.+++......+++..++.++.|++.||.|||+   .+++|+||+|+||+++.++.++|+|||++........
T Consensus        78 e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~---~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~  154 (256)
T cd06612          78 EYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHS---NKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA  154 (256)
T ss_pred             ecCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcceEEECCCCcEEEcccccchhcccCcc
Confidence            9999999999997667778999999999999999999999   8999999999999999999999999999987654421


Q ss_pred             ceeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhccccccCCcccccCchhhcccC
Q 012765          300 HHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSNFKELVDPRLADAYD  379 (457)
Q Consensus       300 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~  379 (457)
                        ......++..|+|||++.+..++.++||||||+++|+|++|+.||.............        ....+.+.  ..
T Consensus       155 --~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~--------~~~~~~~~--~~  222 (256)
T cd06612         155 --KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIP--------NKPPPTLS--DP  222 (256)
T ss_pred             --ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhc--------cCCCCCCC--ch
Confidence              1122347889999999988899999999999999999999999997533221110000        00000000  01


Q ss_pred             HHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 012765          380 LAEMKRAMLTASVCIHHLSTMRPQMTRVLQ  409 (457)
Q Consensus       380 ~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~  409 (457)
                      ......+.+++.+||+.+|++|||+.+|++
T Consensus       223 ~~~~~~~~~~i~~~l~~~P~~Rps~~~il~  252 (256)
T cd06612         223 EKWSPEFNDFVKKCLVKDPEERPSAIQLLQ  252 (256)
T ss_pred             hhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence            112345677889999999999999999986

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=8.3e-38  Score=306.82  Aligned_cols=260  Identities=23%  Similarity=0.326  Sum_probs=196.2

Q ss_pred             cCCCCCceecccCcEEEEEEEeC-CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeee-cCceEEEE
Q 012765          142 DNFNSENLIGKGGHAEVYKGCLP-DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFST-ENGFHLVL  219 (457)
Q Consensus       142 ~~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~-~~~~~lv~  219 (457)
                      ++|.+.+.||+|+||.||++.+. ++..+|+|.+.....  ......+.+|++++.+++||||+++++++. ++.++++|
T Consensus         1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   78 (308)
T cd06615           1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIK--PAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICM   78 (308)
T ss_pred             CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccC--HHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEe
Confidence            46889999999999999999864 578888888754322  234557889999999999999999998554 55678999


Q ss_pred             EecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCCCCCC
Q 012765          220 QFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWS  299 (457)
Q Consensus       220 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~~~~  299 (457)
                      ||+++++|.+++... ..+++..+..++.||+.||.|||+.  .+++|+||||+|||++.++.+||+|||++..+.....
T Consensus        79 ey~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~--~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~  155 (308)
T cd06615          79 EHMDGGSLDQVLKKA-GRIPENILGKISIAVLRGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA  155 (308)
T ss_pred             eccCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhh--CCEEECCCChHHEEEecCCcEEEccCCCccccccccc
Confidence            999999999998654 5578889999999999999999972  4899999999999999999999999999876644322


Q ss_pred             ceeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhh-hhccccccCC-------------
Q 012765          300 HHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVI-WAKPLLQTSN-------------  365 (457)
Q Consensus       300 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~-~~~~~~~~~~-------------  365 (457)
                          ....|+..|+|||++.+..++.++|||||||++|+|++|+.||...+..... +.........             
T Consensus       156 ----~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (308)
T cd06615         156 ----NSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPP  231 (308)
T ss_pred             ----ccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCCC
Confidence                2345889999999998888999999999999999999999999753322111 0000000000             


Q ss_pred             -------cccccCchhh---ccc-CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 012765          366 -------FKELVDPRLA---DAY-DLAEMKRAMLTASVCIHHLSTMRPQMTRVLQL  410 (457)
Q Consensus       366 -------~~~~~d~~l~---~~~-~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~  410 (457)
                             ..++.+....   +.. .......+.+++.+||..+|++|||+.+|++.
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~  287 (308)
T cd06615         232 DSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKH  287 (308)
T ss_pred             CccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                   0000000000   000 00123357789999999999999999999884

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=4.2e-38  Score=311.58  Aligned_cols=241  Identities=23%  Similarity=0.269  Sum_probs=186.3

Q ss_pred             ceecccCcEEEEEEEeC-CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhc-CCCCcceeeeeeec-CceEEEEEecCC
Q 012765          148 NLIGKGGHAEVYKGCLP-DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHI-NHPNAAKLIGFSTE-NGFHLVLQFLPH  224 (457)
Q Consensus       148 ~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~-~~~~lv~e~~~~  224 (457)
                      ++||+|+||+||+|... +++.||+|++.+...........+.+|+.++.++ +||||+++++++.. +.+++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG   80 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence            46999999999999864 5789999998765444445566788999999888 69999999996654 557899999999


Q ss_pred             CChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCCCCCCceeee
Q 012765          225 GSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVF  304 (457)
Q Consensus       225 gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~~~~~~~~~  304 (457)
                      |+|..++... ..+++..+..++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||++........  ...
T Consensus        81 ~~L~~~~~~~-~~l~~~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~--~~~  154 (327)
T cd05617          81 GDLMFHMQRQ-RKLPEEHARFYAAEICIALNFLHE---RGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGD--TTS  154 (327)
T ss_pred             CcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEEeCCCCEEEeccccceeccCCCC--cee
Confidence            9998887543 458999999999999999999999   8999999999999999999999999999875322111  123


Q ss_pred             cccccccccChhccccCCCCcchhHHHHHHHHHHHHhCCCCCCcCCcc----hhhhhccccccCCcccccCchhhcccCH
Q 012765          305 PIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQS----LVIWAKPLLQTSNFKELVDPRLADAYDL  380 (457)
Q Consensus       305 ~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~----~~~~~~~~~~~~~~~~~~d~~l~~~~~~  380 (457)
                      ...||+.|+|||++.+..++.++|||||||++|||++|+.||......    ...+........      ...+...   
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~------~~~~p~~---  225 (327)
T cd05617         155 TFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEK------PIRIPRF---  225 (327)
T ss_pred             cccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhC------CCCCCCC---
Confidence            456999999999999999999999999999999999999999642110    000000000000      0011111   


Q ss_pred             HHHHHHHHHHHHhcccCCCCCCCH
Q 012765          381 AEMKRAMLTASVCIHHLSTMRPQM  404 (457)
Q Consensus       381 ~~~~~l~~l~~~Cl~~dP~~RPt~  404 (457)
                       ....+.+++.+||+.||.+||++
T Consensus       226 -~~~~~~~li~~~L~~dP~~R~~~  248 (327)
T cd05617         226 -LSVKASHVLKGFLNKDPKERLGC  248 (327)
T ss_pred             -CCHHHHHHHHHHhccCHHHcCCC
Confidence             12345678899999999999985

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=1.5e-38  Score=313.92  Aligned_cols=239  Identities=25%  Similarity=0.290  Sum_probs=183.5

Q ss_pred             ceecccCcEEEEEEEeC-CCcEEEEEEEeccchhhHHHHHHHHHHHH-HHhhcCCCCcceeeeeee-cCceEEEEEecCC
Q 012765          148 NLIGKGGHAEVYKGCLP-DGEVVAVKKIIKNAKEDEERISDFLSELG-IVAHINHPNAAKLIGFST-ENGFHLVLQFLPH  224 (457)
Q Consensus       148 ~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~-~l~~l~hpniv~l~~~~~-~~~~~lv~e~~~~  224 (457)
                      ++||+|+||.||+|... +++.||+|.+.+...........+..|.. +++.++||||+++++++. .+..++||||+++
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG   80 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999864 58899999986543333333445666655 568899999999998554 4557899999999


Q ss_pred             CChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCCCCCCceeee
Q 012765          225 GSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVF  304 (457)
Q Consensus       225 gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~~~~~~~~~  304 (457)
                      ++|..++.. ...+.......++.||+.||.|||+   .+|+||||||+||+++.++.+||+|||++........  ...
T Consensus        81 ~~L~~~l~~-~~~~~~~~~~~~~~qi~~~L~~lH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~--~~~  154 (321)
T cd05603          81 GELFFHLQR-ERCFLEPRARFYAAEVASAIGYLHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEE--TTS  154 (321)
T ss_pred             CCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCCC--ccc
Confidence            999888754 3457778888899999999999999   8999999999999999999999999999875422211  123


Q ss_pred             cccccccccChhccccCCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhccccccCCcccccCchhhcccCHHHHH
Q 012765          305 PIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSNFKELVDPRLADAYDLAEMK  384 (457)
Q Consensus       305 ~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~  384 (457)
                      ...||+.|+|||++.+..++.++|||||||++|||++|..||...+..... . ..... .      ..+    ......
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~-~-~i~~~-~------~~~----~~~~~~  221 (321)
T cd05603         155 TFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMY-D-NILHK-P------LQL----PGGKTV  221 (321)
T ss_pred             cccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHH-H-HHhcC-C------CCC----CCCCCH
Confidence            346899999999999889999999999999999999999999864422111 0 00000 0      001    111234


Q ss_pred             HHHHHHHHhcccCCCCCCCHH
Q 012765          385 RAMLTASVCIHHLSTMRPQMT  405 (457)
Q Consensus       385 ~l~~l~~~Cl~~dP~~RPt~~  405 (457)
                      .+.+++.+||+.+|.+||+..
T Consensus       222 ~~~~li~~~l~~~p~~R~~~~  242 (321)
T cd05603         222 AACDLLVGLLHKDQRRRLGAK  242 (321)
T ss_pred             HHHHHHHHHccCCHhhcCCCC
Confidence            567889999999999999764

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=2.6e-38  Score=318.62  Aligned_cols=260  Identities=22%  Similarity=0.298  Sum_probs=193.0

Q ss_pred             CCCCCceecccCcEEEEEEEeC-CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeecC------ce
Q 012765          143 NFNSENLIGKGGHAEVYKGCLP-DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTEN------GF  215 (457)
Q Consensus       143 ~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~------~~  215 (457)
                      +|++.+.||+|+||.||+|... +++.||+|++..... .......+.+|+.+++.++||||+++++++...      ..
T Consensus         1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~   79 (372)
T cd07853           1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQ-NLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEI   79 (372)
T ss_pred             CCcccceeeeCCCEEEEEEEECCCCCEEEEEecccccc-chHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceE
Confidence            4788999999999999999864 689999998854322 223456788999999999999999999976554      46


Q ss_pred             EEEEEecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCC
Q 012765          216 HLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLP  295 (457)
Q Consensus       216 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~  295 (457)
                      ++|+||+. ++|...+.. ...+++..+..++.||+.||.|||+   .+++||||||+|||++.++.+||+|||++....
T Consensus        80 ~lv~e~~~-~~l~~~~~~-~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~  154 (372)
T cd07853          80 YVVTELMQ-SDLHKIIVS-PQPLSSDHVKVFLYQILRGLKYLHS---AGILHRDIKPGNLLVNSNCVLKICDFGLARVEE  154 (372)
T ss_pred             EEEeeccc-cCHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChHHEEECCCCCEEeccccceeecc
Confidence            89999986 567776643 3468899999999999999999999   899999999999999999999999999998654


Q ss_pred             CCCCceeeecccccccccChhccccC-CCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhh-hccccccCCcccc----
Q 012765          296 DNWSHHIVFPIEGTFGYLSPEYFMHG-IVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIW-AKPLLQTSNFKEL----  369 (457)
Q Consensus       296 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~-~~~~~~~~~~~~~----  369 (457)
                      ..... ......+|..|+|||++.+. .++.++|||||||++|||++|+.||.........- ............+    
T Consensus       155 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~  233 (372)
T cd07853         155 PDESK-HMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSAC  233 (372)
T ss_pred             cCccc-cCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhh
Confidence            33211 12234578999999998764 47999999999999999999999998644221100 0000000000000    


Q ss_pred             -------c-----Cchhhc--ccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 012765          370 -------V-----DPRLAD--AYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQ  409 (457)
Q Consensus       370 -------~-----d~~l~~--~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~  409 (457)
                             .     .+....  .........+.+++.+||+.||.+|||+.|+++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~  287 (372)
T cd07853         234 EGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALA  287 (372)
T ss_pred             HHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhc
Confidence                   0     000000  001112345778999999999999999999987

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=7.5e-38  Score=298.00  Aligned_cols=249  Identities=20%  Similarity=0.293  Sum_probs=196.4

Q ss_pred             CCCCCceecccCcEEEEEEEeC-CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeee-cCceEEEEE
Q 012765          143 NFNSENLIGKGGHAEVYKGCLP-DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFST-ENGFHLVLQ  220 (457)
Q Consensus       143 ~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~-~~~~~lv~e  220 (457)
                      +|++.+.||.|+||.||++... +++.+|+|.+.....  ......+.+|+.+++.++||||+++++++. .+.++++||
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   78 (255)
T cd08219           1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKS--SSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVME   78 (255)
T ss_pred             CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcc--hHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEe
Confidence            4778899999999999999865 688999998754332  233567889999999999999999998554 455789999


Q ss_pred             ecCCCChhhhhhc-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCCCCCC
Q 012765          221 FLPHGSLSSLLFG-STECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWS  299 (457)
Q Consensus       221 ~~~~gsL~~~l~~-~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~~~~  299 (457)
                      |+++++|.+++.. ....++....+.++.||+.||.|||+   .+++|+||||+||+++.++.++|+|||++........
T Consensus        79 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~---~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~  155 (255)
T cd08219          79 YCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHE---KRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA  155 (255)
T ss_pred             eCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCcceEEECCCCcEEEcccCcceeeccccc
Confidence            9999999988854 34457889999999999999999999   8999999999999999999999999999876644321


Q ss_pred             ceeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhccccccCCcccccCchhhcccC
Q 012765          300 HHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSNFKELVDPRLADAYD  379 (457)
Q Consensus       300 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~  379 (457)
                        ......|+..|+|||++.+..++.++|+||||+++|+|++|..||.........+...   .....     .+...  
T Consensus       156 --~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~---~~~~~-----~~~~~--  223 (255)
T cd08219         156 --YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVC---QGSYK-----PLPSH--  223 (255)
T ss_pred             --ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHHHHHHh---cCCCC-----CCCcc--
Confidence              1123458889999999988889999999999999999999999998643222111110   01100     01111  


Q ss_pred             HHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 012765          380 LAEMKRAMLTASVCIHHLSTMRPQMTRVLQL  410 (457)
Q Consensus       380 ~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~  410 (457)
                        ....+.+++.+||+.||++||++.+|+..
T Consensus       224 --~~~~~~~li~~~l~~~P~~Rp~~~~il~~  252 (255)
T cd08219         224 --YSYELRSLIKQMFKRNPRSRPSATTILSR  252 (255)
T ss_pred             --cCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence              22346678899999999999999999874

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=3.1e-38  Score=312.00  Aligned_cols=243  Identities=22%  Similarity=0.289  Sum_probs=188.9

Q ss_pred             CCCCCceecccCcEEEEEEEeC-CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcC-CCCcceeeeeeec-CceEEEE
Q 012765          143 NFNSENLIGKGGHAEVYKGCLP-DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHIN-HPNAAKLIGFSTE-NGFHLVL  219 (457)
Q Consensus       143 ~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~-~~~~lv~  219 (457)
                      +|+..+.||+|+||+||+|... +|+.||+|++.+...........+..|..++..+. |++|+++++++.. +.+++||
T Consensus         1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05615           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM   80 (323)
T ss_pred             CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence            4677899999999999999864 68999999987543333344567788898988886 5678888886554 5578999


Q ss_pred             EecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCCCCCC
Q 012765          220 QFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWS  299 (457)
Q Consensus       220 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~~~~  299 (457)
                      ||+++|+|..++... ..+++..++.++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||++........
T Consensus        81 Ey~~~g~L~~~i~~~-~~l~~~~~~~i~~qi~~al~~lH~---~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~~  156 (323)
T cd05615          81 EYVNGGDLMYHIQQV-GKFKEPQAVFYAAEISVGLFFLHR---RGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGV  156 (323)
T ss_pred             cCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEEeccccccccCCCCc
Confidence            999999999888543 458899999999999999999999   8999999999999999999999999999875432211


Q ss_pred             ceeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhccccccCCcccccCchhhcccC
Q 012765          300 HHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSNFKELVDPRLADAYD  379 (457)
Q Consensus       300 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~  379 (457)
                        ......||+.|+|||++.+..++.++|||||||++|||++|+.||............ ....        ......  
T Consensus       157 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i-~~~~--------~~~p~~--  223 (323)
T cd05615         157 --TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSI-MEHN--------VSYPKS--  223 (323)
T ss_pred             --cccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHH-HhCC--------CCCCcc--
Confidence              122345899999999999889999999999999999999999999864432111100 0000        001111  


Q ss_pred             HHHHHHHHHHHHHhcccCCCCCCCH
Q 012765          380 LAEMKRAMLTASVCIHHLSTMRPQM  404 (457)
Q Consensus       380 ~~~~~~l~~l~~~Cl~~dP~~RPt~  404 (457)
                        ....+.+++.+||+.+|.+|++.
T Consensus       224 --~~~~~~~li~~~l~~~p~~R~~~  246 (323)
T cd05615         224 --LSKEAVSICKGLMTKHPSKRLGC  246 (323)
T ss_pred             --CCHHHHHHHHHHcccCHhhCCCC
Confidence              22356778899999999999985

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=1.2e-38  Score=301.65  Aligned_cols=266  Identities=22%  Similarity=0.287  Sum_probs=195.8

Q ss_pred             cCCCCCceecccCcEEEEEEEe-CCCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCC-cceeeeeeec-C-----
Q 012765          142 DNFNSENLIGKGGHAEVYKGCL-PDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPN-AAKLIGFSTE-N-----  213 (457)
Q Consensus       142 ~~f~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpn-iv~l~~~~~~-~-----  213 (457)
                      ..|...++||+|+||+||+|.. .+|+.||+|++.-.... +..-....+|+.+++.++|+| ||++++++.. +     
T Consensus        11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~-EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~   89 (323)
T KOG0594|consen   11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEE-EGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI   89 (323)
T ss_pred             HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccc-cCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence            4455667899999999999985 46899999998654432 112235679999999999999 9999996544 3     


Q ss_pred             -ceEEEEEecCCCChhhhhhcCC---CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeecc
Q 012765          214 -GFHLVLQFLPHGSLSSLLFGST---ECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFG  289 (457)
Q Consensus       214 -~~~lv~e~~~~gsL~~~l~~~~---~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG  289 (457)
                       .+++|+||+. -+|..++....   ..++...+..++.||+.||.|||+   ++|+||||||.|||++++|.+||+|||
T Consensus        90 ~~l~lvfe~~d-~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~---~~IlHRDLKPQNlLi~~~G~lKlaDFG  165 (323)
T KOG0594|consen   90 GKLYLVFEFLD-RDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHS---HGILHRDLKPQNLLISSSGVLKLADFG  165 (323)
T ss_pred             ceEEEEEEeec-ccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHh---CCeecccCCcceEEECCCCcEeeeccc
Confidence             4679999984 57888886544   457778889999999999999999   899999999999999999999999999


Q ss_pred             ccccCCCCCCceeeecccccccccChhccccC-CCCcchhHHHHHHHHHHHHhCCCCCCcCCcchh--------------
Q 012765          290 LAKWLPDNWSHHIVFPIEGTFGYLSPEYFMHG-IVDEKTDVFAFGVLLLELITGRRAVDSRRQSLV--------------  354 (457)
Q Consensus       290 l~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~--------------  354 (457)
                      +++...-+..  ..+...+|.+|+|||++.+. .|+...||||+|||++||++++..|.+..+...              
T Consensus       166 lAra~~ip~~--~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~  243 (323)
T KOG0594|consen  166 LARAFSIPMR--TYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEK  243 (323)
T ss_pred             hHHHhcCCcc--cccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCcc
Confidence            9986643221  23344589999999999887 799999999999999999999999986433211              


Q ss_pred             hhhccc-cccC--CcccccCchhhcccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH--HhcC
Q 012765          355 IWAKPL-LQTS--NFKELVDPRLADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQL--LRGE  414 (457)
Q Consensus       355 ~~~~~~-~~~~--~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~--L~~~  414 (457)
                      .|.... +.+.  .+..+-.+...............+++.+||+.+|.+|.+++..++.  +..+
T Consensus       244 ~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~  308 (323)
T KOG0594|consen  244 DWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSEL  308 (323)
T ss_pred             CCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhccc
Confidence            111100 0000  1111111110000001112457788999999999999999999885  5444

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.2e-37  Score=315.86  Aligned_cols=258  Identities=23%  Similarity=0.271  Sum_probs=192.3

Q ss_pred             hhcCCCCCceecccCcEEEEEEEeC---CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeee-cCce
Q 012765          140 ATDNFNSENLIGKGGHAEVYKGCLP---DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFST-ENGF  215 (457)
Q Consensus       140 ~~~~f~~~~~LG~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~-~~~~  215 (457)
                      ...+|.+.+.||+|+||.||++...   .+..||+|.+....        ...+|+.+++.++||||+++++++. ....
T Consensus        90 ~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~~--------~~~~E~~il~~l~h~~iv~~~~~~~~~~~~  161 (392)
T PHA03207         90 VRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGGK--------TPGREIDILKTISHRAIINLIHAYRWKSTV  161 (392)
T ss_pred             ccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEeccccc--------cHHHHHHHHHhcCCCCccceeeeEeeCCEE
Confidence            3567999999999999999999743   36789999875431        3457999999999999999998554 4557


Q ss_pred             EEEEEecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCC
Q 012765          216 HLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLP  295 (457)
Q Consensus       216 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~  295 (457)
                      +++||++. ++|..++ .....+++..++.++.||+.||.|||+   .+|+||||||+|||++.++.++|+|||++..+.
T Consensus       162 ~lv~e~~~-~~l~~~l-~~~~~l~~~~~~~i~~ql~~aL~~LH~---~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~  236 (392)
T PHA03207        162 CMVMPKYK-CDLFTYV-DRSGPLPLEQAITIQRRLLEALAYLHG---RGIIHRDVKTENIFLDEPENAVLGDFGAACKLD  236 (392)
T ss_pred             EEEehhcC-CCHHHHH-HhcCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEcCCCCEEEccCccccccC
Confidence            89999885 6788877 344568999999999999999999999   899999999999999999999999999998765


Q ss_pred             CCCCceeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchh--hhhc--cccccC--Cccc-
Q 012765          296 DNWSHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLV--IWAK--PLLQTS--NFKE-  368 (457)
Q Consensus       296 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~--~~~~--~~~~~~--~~~~-  368 (457)
                      ............||+.|+|||++.+..|+.++|||||||++|||++|+.||........  ....  ..+...  .+.. 
T Consensus       237 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~  316 (392)
T PHA03207        237 AHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQN  316 (392)
T ss_pred             cccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCc
Confidence            54333233345699999999999999999999999999999999999999975332100  0000  000000  0000 


Q ss_pred             ----c------cCchhhcccC-------HHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 012765          369 ----L------VDPRLADAYD-------LAEMKRAMLTASVCIHHLSTMRPQMTRVLQL  410 (457)
Q Consensus       369 ----~------~d~~l~~~~~-------~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~  410 (457)
                          +      ........+.       ......+..++.+||..||++|||+.+++..
T Consensus       317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~  375 (392)
T PHA03207        317 GSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL  375 (392)
T ss_pred             cchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence                0      0000000000       0112346678889999999999999999873

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.6e-38  Score=311.87  Aligned_cols=204  Identities=24%  Similarity=0.307  Sum_probs=171.7

Q ss_pred             cCCCCCceecccCcEEEEEEEeC-CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeec-CceEEEE
Q 012765          142 DNFNSENLIGKGGHAEVYKGCLP-DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTE-NGFHLVL  219 (457)
Q Consensus       142 ~~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-~~~~lv~  219 (457)
                      ++|++.+.||+|+||+||++... +++.||+|.+.+...........+.+|+.++..++|+||+++++++.+ +..++||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (331)
T cd05597           1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM   80 (331)
T ss_pred             CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence            47889999999999999999864 589999999865433333445678899999999999999999986554 5578999


Q ss_pred             EecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCCCCCC
Q 012765          220 QFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWS  299 (457)
Q Consensus       220 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~~~~  299 (457)
                      ||+++|+|.+++......+++..+..++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||++..+.....
T Consensus        81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  157 (331)
T cd05597          81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQ---LGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGT  157 (331)
T ss_pred             ecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh---CCeEECCCCHHHEEECCCCCEEEEECCceeecCCCCC
Confidence            9999999999996655678899999999999999999999   8999999999999999999999999999876543322


Q ss_pred             ceeeecccccccccChhcccc-----CCCCcchhHHHHHHHHHHHHhCCCCCCcC
Q 012765          300 HHIVFPIEGTFGYLSPEYFMH-----GIVDEKTDVFAFGVLLLELITGRRAVDSR  349 (457)
Q Consensus       300 ~~~~~~~~gt~~y~aPE~~~~-----~~~~~ksDvwSlGvll~eLltG~~pf~~~  349 (457)
                      . ......||+.|+|||++.+     ..++.++|||||||++|||++|+.||...
T Consensus       158 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~  211 (331)
T cd05597         158 V-QSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAE  211 (331)
T ss_pred             c-cccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCC
Confidence            1 1122358999999999863     45788999999999999999999999753

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=2.6e-38  Score=303.44  Aligned_cols=249  Identities=27%  Similarity=0.414  Sum_probs=191.0

Q ss_pred             ceecccCcEEEEEEEeCC-------CcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeec-CceEEEE
Q 012765          148 NLIGKGGHAEVYKGCLPD-------GEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTE-NGFHLVL  219 (457)
Q Consensus       148 ~~LG~G~~g~Vy~~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-~~~~lv~  219 (457)
                      +.||+|+||.||+|...+       +..+|+|.+.....  ......+.+|+.+++.++||||+++++++.. +..+++|
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   78 (269)
T cd05044           1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGAT--DQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIM   78 (269)
T ss_pred             CccccccceeEEeeeecccccCcccceeehhhhhhcccc--hhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEE
Confidence            369999999999998542       25789997754322  2335678899999999999999999996654 4578999


Q ss_pred             EecCCCChhhhhhcC------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCC-----cEEEeec
Q 012765          220 QFLPHGSLSSLLFGS------TECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDY-----EAQISDF  288 (457)
Q Consensus       220 e~~~~gsL~~~l~~~------~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~-----~~kL~DF  288 (457)
                      ||+++++|.+++...      ...+++..++.++.|++.||.|||+   .+++|+||||+||+++.++     .++|+||
T Consensus        79 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~~~~~~l~df  155 (269)
T cd05044          79 ELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQ---MHFIHRDLAARNCLVSEKGYDADRVVKIGDF  155 (269)
T ss_pred             eccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHh---CCcccCCCChheEEEecCCCCCCcceEECCc
Confidence            999999999998542      2347889999999999999999999   8999999999999999877     8999999


Q ss_pred             cccccCCCCCCceeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHh-CCCCCCcCCcchhhhhccccccCCcc
Q 012765          289 GLAKWLPDNWSHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELIT-GRRAVDSRRQSLVIWAKPLLQTSNFK  367 (457)
Q Consensus       289 Gl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLlt-G~~pf~~~~~~~~~~~~~~~~~~~~~  367 (457)
                      |++..+.............++..|+|||++.++.++.++|||||||++|||++ |..||...........   .....  
T Consensus       156 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~---~~~~~--  230 (269)
T cd05044         156 GLARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQH---VTAGG--  230 (269)
T ss_pred             ccccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHH---HhcCC--
Confidence            99976644322222222335678999999999999999999999999999998 9999875332111100   00000  


Q ss_pred             cccCchhhcccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 012765          368 ELVDPRLADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQLLRG  413 (457)
Q Consensus       368 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~  413 (457)
                             ...........+.+++.+||..+|.+||++.+|++.|+.
T Consensus       231 -------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  269 (269)
T cd05044         231 -------RLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN  269 (269)
T ss_pred             -------ccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence                   000111223456789999999999999999999998863

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=3.6e-38  Score=302.98  Aligned_cols=251  Identities=24%  Similarity=0.379  Sum_probs=194.4

Q ss_pred             HhhcCCCCCceecccCcEEEEEEEeC-CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhc-CCCCcceeeeeeec----
Q 012765          139 AATDNFNSENLIGKGGHAEVYKGCLP-DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHI-NHPNAAKLIGFSTE----  212 (457)
Q Consensus       139 ~~~~~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~----  212 (457)
                      .+++.|++.+.||+|+||.||+|... +++.+|+|.+......    ...+.+|+.++.++ +|+||+++++++..    
T Consensus         3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~----~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~   78 (272)
T cd06637           3 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDE----EEEIKQEINMLKKYSHHRNIATYYGAFIKKNPP   78 (272)
T ss_pred             ChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCcc----HHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCC
Confidence            35677888899999999999999864 5888999988644322    34678899999888 79999999997653    


Q ss_pred             ---CceEEEEEecCCCChhhhhhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeec
Q 012765          213 ---NGFHLVLQFLPHGSLSSLLFGS-TECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDF  288 (457)
Q Consensus       213 ---~~~~lv~e~~~~gsL~~~l~~~-~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DF  288 (457)
                         ...+++|||+.+++|.+++... ...+++..+..++.|++.||.|||+   .+|+|+||||+||+++.++.++|+||
T Consensus        79 ~~~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~---~~ivh~dl~~~nili~~~~~~~l~Df  155 (272)
T cd06637          79 GMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQ---HKVIHRDIKGQNVLLTENAEVKLVDF  155 (272)
T ss_pred             CCCcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCCHHHEEECCCCCEEEccC
Confidence               2367999999999999998653 3468899999999999999999999   89999999999999999999999999


Q ss_pred             cccccCCCCCCceeeecccccccccChhccc-----cCCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhcccccc
Q 012765          289 GLAKWLPDNWSHHIVFPIEGTFGYLSPEYFM-----HGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQT  363 (457)
Q Consensus       289 Gl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~~~~~~  363 (457)
                      |++........  ......|+..|+|||++.     +..++.++|||||||++|||++|+.||.............   .
T Consensus       156 g~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~---~  230 (272)
T cd06637         156 GVSAQLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIP---R  230 (272)
T ss_pred             CCceecccccc--cCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHh---c
Confidence            99876543221  122345889999999986     3468889999999999999999999997543222111110   0


Q ss_pred             CCcccccCchhhcccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 012765          364 SNFKELVDPRLADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQ  409 (457)
Q Consensus       364 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~  409 (457)
                      .......+        ......+.+++.+||+.+|.+|||+.+|++
T Consensus       231 ~~~~~~~~--------~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  268 (272)
T cd06637         231 NPAPRLKS--------KKWSKKFQSFIESCLVKNHSQRPTTEQLMK  268 (272)
T ss_pred             CCCCCCCC--------CCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence            00001111        112235678889999999999999999875

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=1.3e-37  Score=322.82  Aligned_cols=260  Identities=19%  Similarity=0.225  Sum_probs=186.4

Q ss_pred             HHHhhcCCCCCceecccCcEEEEEEEeC-CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcC------CCCcceeeee
Q 012765          137 LAAATDNFNSENLIGKGGHAEVYKGCLP-DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHIN------HPNAAKLIGF  209 (457)
Q Consensus       137 ~~~~~~~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~------hpniv~l~~~  209 (457)
                      +....++|.+.++||+|+||+||+|.+. .++.||||++.....    ....+..|+.++..++      |+++++++++
T Consensus       124 ~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~----~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~  199 (467)
T PTZ00284        124 IDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPK----YTRDAKIEIQFMEKVRQADPADRFPLMKIQRY  199 (467)
T ss_pred             cccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchh----hHHHHHHHHHHHHHHhhcCcccCcceeeeEEE
Confidence            3345688999999999999999999864 578999998854221    1223455666665554      4568888887


Q ss_pred             eecC--ceEEEEEecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCC------
Q 012765          210 STEN--GFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDY------  281 (457)
Q Consensus       210 ~~~~--~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~------  281 (457)
                      +...  .+++||+++ +++|.+++... ..+++..+..|+.||+.||.|||+.  .+||||||||+|||++.++      
T Consensus       200 ~~~~~~~~~iv~~~~-g~~l~~~l~~~-~~l~~~~~~~i~~qi~~aL~yLH~~--~gIiHrDlKP~NILl~~~~~~~~~~  275 (467)
T PTZ00284        200 FQNETGHMCIVMPKY-GPCLLDWIMKH-GPFSHRHLAQIIFQTGVALDYFHTE--LHLMHTDLKPENILMETSDTVVDPV  275 (467)
T ss_pred             EEcCCceEEEEEecc-CCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhc--CCeecCCCCHHHEEEecCCcccccc
Confidence            6543  467888876 77888887543 4588999999999999999999972  4999999999999998765      


Q ss_pred             ----------cEEEeeccccccCCCCCCceeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHhCCCCCCcCCc
Q 012765          282 ----------EAQISDFGLAKWLPDNWSHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQ  351 (457)
Q Consensus       282 ----------~~kL~DFGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLltG~~pf~~~~~  351 (457)
                                .+||+|||++......     .....||+.|+|||++.+..|+.++|||||||++|||++|+.||...+.
T Consensus       276 ~~~~~~~~~~~vkl~DfG~~~~~~~~-----~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~  350 (467)
T PTZ00284        276 TNRALPPDPCRVRICDLGGCCDERHS-----RTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDN  350 (467)
T ss_pred             cccccCCCCceEEECCCCccccCccc-----cccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh
Confidence                      4999999987643222     2235699999999999999999999999999999999999999986443


Q ss_pred             chhh-------------hhccc--------cc-cCCcccccCchhh-------cccCHHHHHHHHHHHHHhcccCCCCCC
Q 012765          352 SLVI-------------WAKPL--------LQ-TSNFKELVDPRLA-------DAYDLAEMKRAMLTASVCIHHLSTMRP  402 (457)
Q Consensus       352 ~~~~-------------~~~~~--------~~-~~~~~~~~d~~l~-------~~~~~~~~~~l~~l~~~Cl~~dP~~RP  402 (457)
                      ....             |....        .. ...+....++...       ..........+++++..||+.||.+||
T Consensus       351 ~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~  430 (467)
T PTZ00284        351 LEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRL  430 (467)
T ss_pred             HHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCC
Confidence            2111             10000        00 0000000011000       000011234577899999999999999


Q ss_pred             CHHHHHH
Q 012765          403 QMTRVLQ  409 (457)
Q Consensus       403 t~~evl~  409 (457)
                      |+.|+++
T Consensus       431 ta~e~L~  437 (467)
T PTZ00284        431 NARQMTT  437 (467)
T ss_pred             CHHHHhc
Confidence            9999987

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=4.7e-38  Score=312.06  Aligned_cols=259  Identities=24%  Similarity=0.367  Sum_probs=198.2

Q ss_pred             hcCCCCCceecccCcEEEEEEEeC--------CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhc-CCCCcceeeeeee
Q 012765          141 TDNFNSENLIGKGGHAEVYKGCLP--------DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHI-NHPNAAKLIGFST  211 (457)
Q Consensus       141 ~~~f~~~~~LG~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~  211 (457)
                      ..+|.+.+.||+|+||.||+|...        .+..||+|.+....  .......+.+|+.++.++ +||||+++++++.
T Consensus        11 ~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~   88 (334)
T cd05100          11 RTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDA--TDKDLSDLVSEMEMMKMIGKHKNIINLLGACT   88 (334)
T ss_pred             HhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEccccc--CHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEc
Confidence            356888999999999999999742        12368999775432  223456889999999999 7999999999766


Q ss_pred             cCc-eEEEEEecCCCChhhhhhcC---------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcE
Q 012765          212 ENG-FHLVLQFLPHGSLSSLLFGS---------------TECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNI  275 (457)
Q Consensus       212 ~~~-~~lv~e~~~~gsL~~~l~~~---------------~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NI  275 (457)
                      .++ .++++||+++|+|.+++...               ...+.+..++.++.|++.||.|||+   .+++||||||+||
T Consensus        89 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~---~givH~dlkp~Ni  165 (334)
T cd05100          89 QDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLAS---QKCIHRDLAARNV  165 (334)
T ss_pred             cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHH---CCeeccccccceE
Confidence            544 68999999999999998542               2347888899999999999999999   8999999999999


Q ss_pred             EEcCCCcEEEeeccccccCCCCCCceeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHh-CCCCCCcCCcchh
Q 012765          276 LLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELIT-GRRAVDSRRQSLV  354 (457)
Q Consensus       276 ll~~~~~~kL~DFGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLlt-G~~pf~~~~~~~~  354 (457)
                      |++.++.+||+|||+++...............++..|+|||++.+..++.++|||||||++|||++ |..||........
T Consensus       166 ll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~  245 (334)
T cd05100         166 LVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEEL  245 (334)
T ss_pred             EEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHHH
Confidence            999999999999999987644322111122234567999999999999999999999999999998 8888875332111


Q ss_pred             hhhccccccCCcccccCchhhcccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCCC
Q 012765          355 IWAKPLLQTSNFKELVDPRLADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQLLRGEGG  416 (457)
Q Consensus       355 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~  416 (457)
                        ...... ...     .    .........+.+++.+||+.+|.+||++.++++.|+.+..
T Consensus       246 --~~~~~~-~~~-----~----~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~  295 (334)
T cd05100         246 --FKLLKE-GHR-----M----DKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLT  295 (334)
T ss_pred             --HHHHHc-CCC-----C----CCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhh
Confidence              111000 000     0    0011123457788999999999999999999999987763

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=5.5e-38  Score=301.92  Aligned_cols=247  Identities=26%  Similarity=0.402  Sum_probs=187.4

Q ss_pred             ceecccCcEEEEEEEeCC-Cc--EEEEEEEeccchhhHHHHHHHHHHHHHHhhc-CCCCcceeeeeeecC-ceEEEEEec
Q 012765          148 NLIGKGGHAEVYKGCLPD-GE--VVAVKKIIKNAKEDEERISDFLSELGIVAHI-NHPNAAKLIGFSTEN-GFHLVLQFL  222 (457)
Q Consensus       148 ~~LG~G~~g~Vy~~~~~~-~~--~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~-~~~lv~e~~  222 (457)
                      ++||+|+||.||+|.+.+ +.  .+++|.+....  .......+.+|+.++.++ +||||+++++++... ..+++|||+
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~   78 (270)
T cd05047           1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA--SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYA   78 (270)
T ss_pred             CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccC--CHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeC
Confidence            469999999999998753 43  46777765322  223345788999999999 799999999976654 468999999


Q ss_pred             CCCChhhhhhcCC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEee
Q 012765          223 PHGSLSSLLFGST---------------ECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISD  287 (457)
Q Consensus       223 ~~gsL~~~l~~~~---------------~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~D  287 (457)
                      ++|+|.+++....               ..+++..++.++.|++.||.|||+   .+++||||||+||++++++.+||+|
T Consensus        79 ~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~---~~i~H~dikp~nili~~~~~~kl~d  155 (270)
T cd05047          79 PHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIAD  155 (270)
T ss_pred             CCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccccceEEEcCCCeEEECC
Confidence            9999999985422               247889999999999999999999   8999999999999999999999999


Q ss_pred             ccccccCCCCCCceeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHh-CCCCCCcCCcchhhhhccccccCCc
Q 012765          288 FGLAKWLPDNWSHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELIT-GRRAVDSRRQSLVIWAKPLLQTSNF  366 (457)
Q Consensus       288 FGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLlt-G~~pf~~~~~~~~~~~~~~~~~~~~  366 (457)
                      ||++........   ......+..|+|||++.+..++.++|||||||++|||++ |..||.........  .......  
T Consensus       156 fgl~~~~~~~~~---~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~--~~~~~~~--  228 (270)
T cd05047         156 FGLSRGQEVYVK---KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELY--EKLPQGY--  228 (270)
T ss_pred             CCCccccchhhh---ccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHH--HHHhCCC--
Confidence            999853321110   111223567999999988889999999999999999997 99999753321110  0000000  


Q ss_pred             ccccCchhhcccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q 012765          367 KELVDPRLADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQLLRGE  414 (457)
Q Consensus       367 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~  414 (457)
                          ....    .......+.+++.+||..+|.+|||+.+++..|+.+
T Consensus       229 ----~~~~----~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~  268 (270)
T cd05047         229 ----RLEK----PLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM  268 (270)
T ss_pred             ----CCCC----CCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHh
Confidence                0000    111223567899999999999999999999999765

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=4.8e-38  Score=313.09  Aligned_cols=258  Identities=22%  Similarity=0.285  Sum_probs=192.1

Q ss_pred             HhhcCCCCCceecccCcEEEEEEEe-CCCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeec-----
Q 012765          139 AATDNFNSENLIGKGGHAEVYKGCL-PDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTE-----  212 (457)
Q Consensus       139 ~~~~~f~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-----  212 (457)
                      ...++|.+.+.||+|+||+||+|.. .+++.||+|++...... ......+.+|+.+++.++||||+++++++..     
T Consensus        12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   90 (343)
T cd07878          12 EVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQS-LIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIE   90 (343)
T ss_pred             hhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhh-hHHHHHHHHHHHHHHhcCCCchhhhhhhhccccccc
Confidence            3568899999999999999999986 46889999988654322 2334567899999999999999999986542     


Q ss_pred             --CceEEEEEecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccc
Q 012765          213 --NGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGL  290 (457)
Q Consensus       213 --~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl  290 (457)
                        ...+++++++ +++|..++.  ...+++..+..++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||+
T Consensus        91 ~~~~~~~~~~~~-~~~l~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivHrdikp~Nil~~~~~~~kl~Dfg~  164 (343)
T cd07878          91 NFNEVYLVTNLM-GADLNNIVK--CQKLSDEHVQFLIYQLLRGLKYIHS---AGIIHRDLKPSNVAVNEDCELRILDFGL  164 (343)
T ss_pred             ccCcEEEEeecC-CCCHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHH---CCeecccCChhhEEECCCCCEEEcCCcc
Confidence              2356778876 788887773  3458899999999999999999999   8999999999999999999999999999


Q ss_pred             cccCCCCCCceeeecccccccccChhcccc-CCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhh--hhccccc-cCCc
Q 012765          291 AKWLPDNWSHHIVFPIEGTFGYLSPEYFMH-GIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVI--WAKPLLQ-TSNF  366 (457)
Q Consensus       291 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~--~~~~~~~-~~~~  366 (457)
                      +.......     ....||..|+|||++.+ ..++.++|||||||++|+|++|+.||...+.....  +...... ....
T Consensus       165 ~~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  239 (343)
T cd07878         165 ARQADDEM-----TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEV  239 (343)
T ss_pred             ceecCCCc-----CCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence            98765432     23458999999999876 56899999999999999999999999754321110  0000000 0000


Q ss_pred             ----------------ccccCchhhcccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 012765          367 ----------------KELVDPRLADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQ  409 (457)
Q Consensus       367 ----------------~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~  409 (457)
                                      .......+...+ ......+.+++.+||+.||.+|||+.|+++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~mL~~dp~~R~s~~ell~  297 (343)
T cd07878         240 LKKISSEHARKYIQSLPHMPQQDLKKIF-RGANPLAIDLLEKMLVLDSDKRISASEALA  297 (343)
T ss_pred             HHhcchhhHHHHhhccccccchhHHHhc-cCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence                            000000000000 001123678899999999999999999986

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=1.5e-38  Score=320.55  Aligned_cols=198  Identities=27%  Similarity=0.395  Sum_probs=168.8

Q ss_pred             hhcCCCCCceecccCcEEEEEEEe-CCCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcC-C-----CCcceeee-eee
Q 012765          140 ATDNFNSENLIGKGGHAEVYKGCL-PDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHIN-H-----PNAAKLIG-FST  211 (457)
Q Consensus       140 ~~~~f~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h-----pniv~l~~-~~~  211 (457)
                      ..-+|.+.++||+|+||+|.+|.+ .+++.||||++++...    ...+...|+.+|..|+ |     -|+|++++ |..
T Consensus       184 i~~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~----f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~f  259 (586)
T KOG0667|consen  184 IAYRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKR----FLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYF  259 (586)
T ss_pred             eEEEEEEEEEecccccceeEEEEecCCCcEEEEEeeccChH----HHHHHHHHHHHHHHHhccCCCCCeeEEEeeecccc
Confidence            344889999999999999999985 4699999999875543    3456778999998886 3     58999999 456


Q ss_pred             cCceEEEEEecCCCChhhhhhc-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCC--CcEEEeec
Q 012765          212 ENGFHLVLQFLPHGSLSSLLFG-STECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSED--YEAQISDF  288 (457)
Q Consensus       212 ~~~~~lv~e~~~~gsL~~~l~~-~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~--~~~kL~DF  288 (457)
                      .+++|+|+|.+ ..+|+++|.. ....++...+..|+.||+.||.+||+   .+|||+||||+||||..-  ..+||+||
T Consensus       260 r~HlciVfELL-~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~---l~IIHcDLKPENILL~~~~r~~vKVIDF  335 (586)
T KOG0667|consen  260 RNHLCIVFELL-STNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHE---LGIIHCDLKPENILLKDPKRSRIKVIDF  335 (586)
T ss_pred             ccceeeeehhh-hhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCChhheeeccCCcCceeEEec
Confidence            67899999977 5689999965 34568999999999999999999999   899999999999999753  47999999


Q ss_pred             cccccCCCCCCceeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHhCCCCCCcCC
Q 012765          289 GLAKWLPDNWSHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRR  350 (457)
Q Consensus       289 Gl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLltG~~pf~~~~  350 (457)
                      |+++......     .....+..|+|||++.+.+|+.+.||||||||++||++|.+.|.+..
T Consensus       336 GSSc~~~q~v-----ytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~n  392 (586)
T KOG0667|consen  336 GSSCFESQRV-----YTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDN  392 (586)
T ss_pred             ccccccCCcc-----eeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCC
Confidence            9999775542     35568999999999999999999999999999999999988887644

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=4.6e-38  Score=304.68  Aligned_cols=262  Identities=25%  Similarity=0.310  Sum_probs=197.5

Q ss_pred             cCCCCCceecccCcEEEEEEEeC-CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeec-CceEEEE
Q 012765          142 DNFNSENLIGKGGHAEVYKGCLP-DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTE-NGFHLVL  219 (457)
Q Consensus       142 ~~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-~~~~lv~  219 (457)
                      ++|++.+.||+|+||+||++... +++.||+|.+.....  ......+.+|+++++.++||||+++++++.. +.+++||
T Consensus         5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   82 (284)
T cd06620           5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAK--SSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCM   82 (284)
T ss_pred             HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCc--chHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEE
Confidence            56778899999999999999864 588999998764432  2335688999999999999999999996554 5578999


Q ss_pred             EecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCCCCCC
Q 012765          220 QFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWS  299 (457)
Q Consensus       220 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~~~~  299 (457)
                      ||+++++|..++.. ...+++.....++.+++.||.|||+.  .+++||||+|+||+++.++.++|+|||++........
T Consensus        83 e~~~~~~L~~~~~~-~~~~~~~~~~~~~~~i~~~l~~LH~~--~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~~  159 (284)
T cd06620          83 EFMDCGSLDRIYKK-GGPIPVEILGKIAVAVVEGLTYLYNV--HRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSIA  159 (284)
T ss_pred             ecCCCCCHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHHh--cCeeccCCCHHHEEECCCCcEEEccCCcccchhhhcc
Confidence            99999999988754 34588999999999999999999972  5899999999999999999999999999875533221


Q ss_pred             ceeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhccccccCCcccccCchhhcccC
Q 012765          300 HHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSNFKELVDPRLADAYD  379 (457)
Q Consensus       300 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~  379 (457)
                          ....|+..|+|||++.+..++.++|||||||++|+|++|+.||......................+..........
T Consensus       160 ----~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (284)
T cd06620         160 ----DTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRLPS  235 (284)
T ss_pred             ----CccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccCCCCCc
Confidence                1245899999999998889999999999999999999999999853321000000000000000011000000001


Q ss_pred             HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 012765          380 LAEMKRAMLTASVCIHHLSTMRPQMTRVLQLLR  412 (457)
Q Consensus       380 ~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~  412 (457)
                      ......+.+++.+||+.||++|||+.||++..-
T Consensus       236 ~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~  268 (284)
T cd06620         236 SDFPEDLRDFVDACLLKDPTERPTPQQLCAMPP  268 (284)
T ss_pred             hhcCHHHHHHHHHHhcCCcccCcCHHHHhcCcc
Confidence            113345778889999999999999999998643

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=1.4e-37  Score=298.69  Aligned_cols=251  Identities=25%  Similarity=0.323  Sum_probs=182.3

Q ss_pred             eecccCcEEEEEEEeCC---CcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeec-CceEEEEEecCC
Q 012765          149 LIGKGGHAEVYKGCLPD---GEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTE-NGFHLVLQFLPH  224 (457)
Q Consensus       149 ~LG~G~~g~Vy~~~~~~---~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-~~~~lv~e~~~~  224 (457)
                      .||+|+||.||+|...+   ...+++|.+....  .......+.+|+..++.++||||+++++++.. ..++++|||+++
T Consensus         2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~   79 (269)
T cd05042           2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASA--TPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPL   79 (269)
T ss_pred             cCCccCCceEEEEEEecCCCCeEEEEeecCccC--ChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCC
Confidence            59999999999997533   3567888764332  22334578899999999999999999996654 457899999999


Q ss_pred             CChhhhhhcCC----CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCCCCCCc
Q 012765          225 GSLSSLLFGST----ECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSH  300 (457)
Q Consensus       225 gsL~~~l~~~~----~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~~~~~  300 (457)
                      |+|.+++....    ...++.....++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||++.........
T Consensus        80 g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~  156 (269)
T cd05042          80 GDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQ---ADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYY  156 (269)
T ss_pred             CcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHh---cCEecccccHhheEecCCCcEEEeccccccccccchhe
Confidence            99999986532    234677788999999999999999   89999999999999999999999999998754332111


Q ss_pred             eeeecccccccccChhcccc-------CCCCcchhHHHHHHHHHHHHh-CCCCCCcCCcchhhhhccccccCCcccccCc
Q 012765          301 HIVFPIEGTFGYLSPEYFMH-------GIVDEKTDVFAFGVLLLELIT-GRRAVDSRRQSLVIWAKPLLQTSNFKELVDP  372 (457)
Q Consensus       301 ~~~~~~~gt~~y~aPE~~~~-------~~~~~ksDvwSlGvll~eLlt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~  372 (457)
                      .......++..|+|||++..       ..++.++|||||||++|||++ |..||............  . ......+.++
T Consensus       157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~--~-~~~~~~~~~~  233 (269)
T cd05042         157 ITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQV--V-REQDIKLPKP  233 (269)
T ss_pred             eccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHH--h-hccCccCCCC
Confidence            11122335677999998743       356889999999999999999 77888754322111110  0 0111122223


Q ss_pred             hhhcccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 012765          373 RLADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQLLR  412 (457)
Q Consensus       373 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~  412 (457)
                      .+...+    ...+..++..|+ .||++|||+.+|++.|.
T Consensus       234 ~~~~~~----~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~  268 (269)
T cd05042         234 QLDLKY----SDRWYEVMQFCW-LDPETRPTAEEVHELLT  268 (269)
T ss_pred             cccccC----CHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence            222222    233445666788 59999999999999873

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=2.5e-37  Score=297.07  Aligned_cols=252  Identities=25%  Similarity=0.296  Sum_probs=185.7

Q ss_pred             ceecccCcEEEEEEEeC---CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeecC-ceEEEEEecC
Q 012765          148 NLIGKGGHAEVYKGCLP---DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTEN-GFHLVLQFLP  223 (457)
Q Consensus       148 ~~LG~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~-~~~lv~e~~~  223 (457)
                      +.||+|+||.||+|...   .+..+|+|.+.....  ......+.+|+.+++.++||||+++++++.+. ..++||||++
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~   78 (269)
T cd05087           1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSAS--VQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCP   78 (269)
T ss_pred             CcccccCCceEEEEEEcCCCCceEEEEEecCCCCC--hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCC
Confidence            35899999999999754   345789998754432  22345788999999999999999999976554 4689999999


Q ss_pred             CCChhhhhhcCC----CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCCCCCC
Q 012765          224 HGSLSSLLFGST----ECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWS  299 (457)
Q Consensus       224 ~gsL~~~l~~~~----~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~~~~  299 (457)
                      +|+|.+++....    ...++..+..++.|++.||.|||+   .+++|+||||+||+++.++.+||+|||++........
T Consensus        79 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~  155 (269)
T cd05087          79 LGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHK---NNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDY  155 (269)
T ss_pred             CCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHH---CCEeccccCcceEEEcCCCcEEECCccccccccCcce
Confidence            999999986422    245677778899999999999999   8999999999999999999999999999876543322


Q ss_pred             ceeeecccccccccChhccccC-------CCCcchhHHHHHHHHHHHHh-CCCCCCcCCcchhhhhccccccCCcccccC
Q 012765          300 HHIVFPIEGTFGYLSPEYFMHG-------IVDEKTDVFAFGVLLLELIT-GRRAVDSRRQSLVIWAKPLLQTSNFKELVD  371 (457)
Q Consensus       300 ~~~~~~~~gt~~y~aPE~~~~~-------~~~~ksDvwSlGvll~eLlt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~d  371 (457)
                      ........++..|+|||++.+.       .++.++||||||+++|||++ |..||...........   ........+.+
T Consensus       156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~---~~~~~~~~~~~  232 (269)
T cd05087         156 YVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTY---TVREQQLKLPK  232 (269)
T ss_pred             eecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHH---HhhcccCCCCC
Confidence            1112223467889999988532       35789999999999999996 9999975432211110   00111112222


Q ss_pred             chhhcccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 012765          372 PRLADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQLLR  412 (457)
Q Consensus       372 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~  412 (457)
                      +.+....    ...+.+++..|+ .+|++|||+.+|+..|+
T Consensus       233 ~~~~~~~----~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~  268 (269)
T cd05087         233 PRLKLPL----SDRWYEVMQFCW-LQPEQRPSAEEVHLLLS  268 (269)
T ss_pred             CccCCCC----ChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence            3222221    223556777898 68999999999999874

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=2e-37  Score=295.04  Aligned_cols=249  Identities=22%  Similarity=0.331  Sum_probs=197.1

Q ss_pred             CCCCCceecccCcEEEEEEEeC-CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeec-C-ceEEEE
Q 012765          143 NFNSENLIGKGGHAEVYKGCLP-DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTE-N-GFHLVL  219 (457)
Q Consensus       143 ~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-~-~~~lv~  219 (457)
                      +|++.+.||+|++|.||++... +++.+|+|++..... .......+.+|+.++++++|+|++++++.+.. + .++++|
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~   79 (257)
T cd08223           1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNA-SRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVM   79 (257)
T ss_pred             CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhc-CHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEe
Confidence            4788999999999999999865 578899998854322 22345578899999999999999999986543 3 368999


Q ss_pred             EecCCCChhhhhhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCCCCC
Q 012765          220 QFLPHGSLSSLLFGS-TECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNW  298 (457)
Q Consensus       220 e~~~~gsL~~~l~~~-~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~~~  298 (457)
                      ||+++++|.+++... ...+++..++.++.+++.||.|||+   .+++|+||||+||+++.++.++|+|||++..+....
T Consensus        80 e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~---~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~  156 (257)
T cd08223          80 GFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHE---KHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC  156 (257)
T ss_pred             cccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCchhEEEecCCcEEEecccceEEecccC
Confidence            999999999988653 3458999999999999999999999   899999999999999999999999999998764432


Q ss_pred             CceeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhccccccCCcccccCchhhccc
Q 012765          299 SHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSNFKELVDPRLADAY  378 (457)
Q Consensus       299 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~  378 (457)
                      .  ......+++.|+|||++.+..++.++||||||+++++|++|+.||...+.....+..  .. ...     +    ..
T Consensus       157 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~--~~-~~~-----~----~~  222 (257)
T cd08223         157 D--MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRI--IE-GKL-----P----PM  222 (257)
T ss_pred             C--ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHH--Hh-cCC-----C----CC
Confidence            2  122345889999999999999999999999999999999999999754422211110  00 000     0    11


Q ss_pred             CHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 012765          379 DLAEMKRAMLTASVCIHHLSTMRPQMTRVLQ  409 (457)
Q Consensus       379 ~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~  409 (457)
                      .......+.+++.+||+.+|++||++.++++
T Consensus       223 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~  253 (257)
T cd08223         223 PKDYSPELGELIATMLSKRPEKRPSVKSILR  253 (257)
T ss_pred             ccccCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence            1123346778999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=1.7e-37  Score=297.34  Aligned_cols=253  Identities=24%  Similarity=0.418  Sum_probs=197.2

Q ss_pred             CCCCCceecccCcEEEEEEEeCCCcEEEEEEEeccch---hhHHHHHHHHHHHHHHhhcCCCCcceeeeeeecCc-eEEE
Q 012765          143 NFNSENLIGKGGHAEVYKGCLPDGEVVAVKKIIKNAK---EDEERISDFLSELGIVAHINHPNAAKLIGFSTENG-FHLV  218 (457)
Q Consensus       143 ~f~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~---~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~-~~lv  218 (457)
                      +|...+.||.|+||+||+|...+++.+|+|.+.....   ........+.+|+.+++.++|+||+++++++.+.. .+++
T Consensus         1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   80 (265)
T cd06631           1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF   80 (265)
T ss_pred             CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence            4778899999999999999988899999998764322   12334567899999999999999999999766554 6799


Q ss_pred             EEecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCCCCC
Q 012765          219 LQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNW  298 (457)
Q Consensus       219 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~~~  298 (457)
                      +||+++++|.+++... ..+++..+..++.|++.||.|||+   .+++|+||+|+||+++.++.++|+|||++.......
T Consensus        81 ~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~  156 (265)
T cd06631          81 MEFVPGGSISSILNRF-GPLPEPVFCKYTKQILDGVAYLHN---NCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVG  156 (265)
T ss_pred             EecCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCcCHHhEEECCCCeEEeccchhhHhhhhcc
Confidence            9999999999998543 357888889999999999999999   899999999999999999999999999987653211


Q ss_pred             C----ceeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhccccccCCcccccCchh
Q 012765          299 S----HHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSNFKELVDPRL  374 (457)
Q Consensus       299 ~----~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l  374 (457)
                      .    ........|+..|+|||++.+..++.++||||||+++|+|++|..||...+.......... ..     ...+.+
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~-~~-----~~~~~~  230 (265)
T cd06631         157 LHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGA-HR-----GLMPRL  230 (265)
T ss_pred             ccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhh-cc-----CCCCCC
Confidence            1    1112234588999999999988899999999999999999999999975432211111000 00     001112


Q ss_pred             hcccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 012765          375 ADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQ  409 (457)
Q Consensus       375 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~  409 (457)
                      ...    ....+..++.+||+.+|++||++.++++
T Consensus       231 ~~~----~~~~~~~~i~~~l~~~p~~Rp~~~~~l~  261 (265)
T cd06631         231 PDS----FSAAAIDFVTSCLTRDQHERPSALQLLR  261 (265)
T ss_pred             CCC----CCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            122    2345677889999999999999999875

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-38  Score=315.37  Aligned_cols=256  Identities=28%  Similarity=0.439  Sum_probs=207.2

Q ss_pred             hcCCCCCceecccCcEEEEEEEeC---CCc--EEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeecCce
Q 012765          141 TDNFNSENLIGKGGHAEVYKGCLP---DGE--VVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTENGF  215 (457)
Q Consensus       141 ~~~f~~~~~LG~G~~g~Vy~~~~~---~~~--~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~  215 (457)
                      .+......+||.|-||.||+|.+-   .|.  .||||.++.+...  +..+.|+.|..+|+.++|||||+++|+|.+...
T Consensus       388 Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~--d~tekflqEa~iMrnfdHphIikLIGv~~e~P~  465 (974)
T KOG4257|consen  388 RELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTP--DDTEKFLQEASIMRNFDHPHIIKLIGVCVEQPM  465 (974)
T ss_pred             hhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCCh--hhHHHHHHHHHHHHhCCCcchhheeeeeeccce
Confidence            344455678999999999999853   233  4788877665444  336799999999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCC
Q 012765          216 HLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLP  295 (457)
Q Consensus       216 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~  295 (457)
                      ++|||.++.|.|..+|..+...++......++.||+.||.|||+   .++|||||...|||+.....+||+|||+++++.
T Consensus       466 WivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeS---krfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~e  542 (974)
T KOG4257|consen  466 WIVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLES---KRFVHRDIAARNILVSSPQCVKLADFGLSRYLE  542 (974)
T ss_pred             eEEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHh---hchhhhhhhhhheeecCcceeeecccchhhhcc
Confidence            99999999999999999888899999999999999999999999   899999999999999999999999999999997


Q ss_pred             CCCCceeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHh-CCCCCCcCCcchhhhhccccccCCcccccCchh
Q 012765          296 DNWSHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELIT-GRRAVDSRRQSLVIWAKPLLQTSNFKELVDPRL  374 (457)
Q Consensus       296 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLlt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l  374 (457)
                      +....... ...-..-|||||.+.-..++.++|||-|||.+||++. |..||.+-....++-..   ++++       ++
T Consensus       543 d~~yYkaS-~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~i---EnGe-------Rl  611 (974)
T KOG4257|consen  543 DDAYYKAS-RGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHI---ENGE-------RL  611 (974)
T ss_pred             ccchhhcc-ccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceEEEe---cCCC-------CC
Confidence            76433322 2223567999999999999999999999999999998 99999863333222111   1111       11


Q ss_pred             hcccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q 012765          375 ADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQLLRGE  414 (457)
Q Consensus       375 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~  414 (457)
                        ...+.....+..+..+||.++|.+||++.+|...|..+
T Consensus       612 --P~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv  649 (974)
T KOG4257|consen  612 --PCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDV  649 (974)
T ss_pred             --CCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHH
Confidence              11222334566788999999999999999998877543

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=7.5e-38  Score=300.91  Aligned_cols=254  Identities=25%  Similarity=0.376  Sum_probs=195.5

Q ss_pred             CCCCceecccCcEEEEEEEeC----CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeecCc-----
Q 012765          144 FNSENLIGKGGHAEVYKGCLP----DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTENG-----  214 (457)
Q Consensus       144 f~~~~~LG~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~-----  214 (457)
                      |.+.+.||+|+||.||+|.+.    +++.+|+|.+...... ....+.+.+|+.+++.++||||+++++++....     
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~   79 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFS-SSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRL   79 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCC-hHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCcc
Confidence            567789999999999999753    3688999988654332 234667899999999999999999999764321     


Q ss_pred             --eEEEEEecCCCChhhhhhcC-----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEee
Q 012765          215 --FHLVLQFLPHGSLSSLLFGS-----TECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISD  287 (457)
Q Consensus       215 --~~lv~e~~~~gsL~~~l~~~-----~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~D  287 (457)
                        .+++++|+.+|+|..++...     ...+++...+.++.||+.||.|||+   .+|+||||||+||+++.++.+||+|
T Consensus        80 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~nili~~~~~~kl~d  156 (273)
T cd05074          80 PIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSS---KNFIHRDLAARNCMLNENMTVCVAD  156 (273)
T ss_pred             cceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCEeecccchhhEEEcCCCCEEECc
Confidence              35788999999998876421     2247888899999999999999999   8999999999999999999999999


Q ss_pred             ccccccCCCCCCceeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHh-CCCCCCcCCcchh-hhhccccccCC
Q 012765          288 FGLAKWLPDNWSHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELIT-GRRAVDSRRQSLV-IWAKPLLQTSN  365 (457)
Q Consensus       288 FGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLlt-G~~pf~~~~~~~~-~~~~~~~~~~~  365 (457)
                      ||+++...............++..|++||.+....++.++|||||||++|||++ |+.||...+.... .+..   ....
T Consensus       157 fg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~---~~~~  233 (273)
T cd05074         157 FGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLI---KGNR  233 (273)
T ss_pred             ccccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHH---cCCc
Confidence            999987644322111122335678999999988889999999999999999999 8888875433211 1110   0000


Q ss_pred             cccccCchhhcccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q 012765          366 FKELVDPRLADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQLLRGE  414 (457)
Q Consensus       366 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~  414 (457)
                            ...    .......+.+++.+||+.+|++||++.++++.|+++
T Consensus       234 ------~~~----~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~  272 (273)
T cd05074         234 ------LKQ----PPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI  272 (273)
T ss_pred             ------CCC----CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence                  000    112234678899999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=2.1e-37  Score=296.88  Aligned_cols=251  Identities=27%  Similarity=0.448  Sum_probs=195.8

Q ss_pred             CCCCCceecccCcEEEEEEEeC-CCcEEEEEEEeccchh------hHHHHHHHHHHHHHHhhcCCCCcceeeeeeec-Cc
Q 012765          143 NFNSENLIGKGGHAEVYKGCLP-DGEVVAVKKIIKNAKE------DEERISDFLSELGIVAHINHPNAAKLIGFSTE-NG  214 (457)
Q Consensus       143 ~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~------~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-~~  214 (457)
                      +|.+...||.|+||.||+|... +++.+|+|.+......      .......+.+|+.++++++||||+++++++.+ +.
T Consensus         1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   80 (267)
T cd06628           1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH   80 (267)
T ss_pred             CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence            4677889999999999999864 5889999987643322      12334678899999999999999999996655 45


Q ss_pred             eEEEEEecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccC
Q 012765          215 FHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWL  294 (457)
Q Consensus       215 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~  294 (457)
                      .+++|||+++++|..++... ..+++..+..++.|++.||.|||+   .+++||||+|+||+++.++.++|+|||+++.+
T Consensus        81 ~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~l~~~l~~lH~---~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~  156 (267)
T cd06628          81 LNIFLEYVPGGSVAALLNNY-GAFEETLVRNFVRQILKGLNYLHN---RGIIHRDIKGANILVDNKGGIKISDFGISKKL  156 (267)
T ss_pred             cEEEEEecCCCCHHHHHHhc-cCccHHHHHHHHHHHHHHHHHHHh---cCcccccCCHHHEEEcCCCCEEecccCCCccc
Confidence            67999999999999998543 457888888999999999999999   89999999999999999999999999998877


Q ss_pred             CCCCCc----eeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhccccccCCccccc
Q 012765          295 PDNWSH----HIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSNFKELV  370 (457)
Q Consensus       295 ~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~  370 (457)
                      ......    .......|+..|+|||.+.+..++.++|+|||||++|+|++|+.||............        ....
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~--------~~~~  228 (267)
T cd06628         157 EANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKI--------GENA  228 (267)
T ss_pred             ccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHH--------hccC
Confidence            532111    1111235788999999999888999999999999999999999999864322111110        0011


Q ss_pred             CchhhcccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 012765          371 DPRLADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQ  409 (457)
Q Consensus       371 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~  409 (457)
                      .+.+..    .....+..++.+||+.+|.+||++.+|++
T Consensus       229 ~~~~~~----~~~~~~~~li~~~l~~~p~~Rp~~~~il~  263 (267)
T cd06628         229 SPEIPS----NISSEAIDFLEKTFEIDHNKRPTAAELLK  263 (267)
T ss_pred             CCcCCc----ccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence            111111    22345667888999999999999999986

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=3.1e-37  Score=295.90  Aligned_cols=252  Identities=24%  Similarity=0.381  Sum_probs=192.7

Q ss_pred             cCCCCCceecccCcEEEEEEEeC-CCcEEEEEEEeccch--hhHHHHHHHHHHHHHHhhcCCCCcceeeeeeec---Cce
Q 012765          142 DNFNSENLIGKGGHAEVYKGCLP-DGEVVAVKKIIKNAK--EDEERISDFLSELGIVAHINHPNAAKLIGFSTE---NGF  215 (457)
Q Consensus       142 ~~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~---~~~  215 (457)
                      .+|...+.||+|+||.||+|... ++..||+|++.....  ........+.+|+.+++.++||||+++++++..   ...
T Consensus         2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (266)
T cd06651           2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL   81 (266)
T ss_pred             CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence            47889999999999999999864 588999998754322  222345678899999999999999999997654   346


Q ss_pred             EEEEEecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCC
Q 012765          216 HLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLP  295 (457)
Q Consensus       216 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~  295 (457)
                      ++++||+++++|.+++... ..+++...+.++.|++.||.|||+   .+++||||+|+||+++.++.++|+|||++..+.
T Consensus        82 ~l~~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~LH~---~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~  157 (266)
T cd06651          82 TIFMEYMPGGSVKDQLKAY-GALTESVTRKYTRQILEGMSYLHS---NMIVHRDIKGANILRDSAGNVKLGDFGASKRLQ  157 (266)
T ss_pred             EEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEECCCCCEEEccCCCccccc
Confidence            7899999999999988643 347888889999999999999999   899999999999999999999999999987654


Q ss_pred             CCCCc-eeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhccccccCCcccccCchh
Q 012765          296 DNWSH-HIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSNFKELVDPRL  374 (457)
Q Consensus       296 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l  374 (457)
                      ..... .......++..|+|||++.+..++.++|||||||++|||++|+.||.............  ..     ...+.+
T Consensus       158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~--~~-----~~~~~~  230 (266)
T cd06651         158 TICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIA--TQ-----PTNPQL  230 (266)
T ss_pred             cccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHh--cC-----CCCCCC
Confidence            32111 11122447889999999998889999999999999999999999998643322111100  00     001111


Q ss_pred             hcccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 012765          375 ADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQ  409 (457)
Q Consensus       375 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~  409 (457)
                      ...    ....+..++ .||..+|++||++.||++
T Consensus       231 ~~~----~~~~~~~li-~~~~~~p~~Rp~~~eil~  260 (266)
T cd06651         231 PSH----ISEHARDFL-GCIFVEARHRPSAEELLR  260 (266)
T ss_pred             chh----cCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence            111    122233344 588899999999999975

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=2e-37  Score=297.08  Aligned_cols=254  Identities=24%  Similarity=0.331  Sum_probs=194.6

Q ss_pred             hcCCCCCceecccCcEEEEEEEe-CCCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeee-cCceEEE
Q 012765          141 TDNFNSENLIGKGGHAEVYKGCL-PDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFST-ENGFHLV  218 (457)
Q Consensus       141 ~~~f~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~-~~~~~lv  218 (457)
                      .++|++.+.||+|+||.||+|.. .+++.||+|++......   ....+.+|+.++.+++||||+++++++. .+..+++
T Consensus         8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~---~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv   84 (267)
T cd06646           8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGD---DFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWIC   84 (267)
T ss_pred             hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccc---hHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEE
Confidence            46788999999999999999986 46889999988643322   2346788999999999999999998654 4556799


Q ss_pred             EEecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCCCCC
Q 012765          219 LQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNW  298 (457)
Q Consensus       219 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~~~  298 (457)
                      |||+++++|.+++.. ...+++..+..++.|++.||.|||+   .+|+||||+|+||+++.++.++|+|||++..+....
T Consensus        85 ~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~  160 (267)
T cd06646          85 MEYCGGGSLQDIYHV-TGPLSELQIAYVCRETLQGLAYLHS---KGKMHRDIKGANILLTDNGDVKLADFGVAAKITATI  160 (267)
T ss_pred             EeCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEECCCCCEEECcCccceeecccc
Confidence            999999999998854 3457889999999999999999999   899999999999999999999999999998764322


Q ss_pred             CceeeecccccccccChhccc---cCCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhccccccCCcccccCchhh
Q 012765          299 SHHIVFPIEGTFGYLSPEYFM---HGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSNFKELVDPRLA  375 (457)
Q Consensus       299 ~~~~~~~~~gt~~y~aPE~~~---~~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  375 (457)
                      ..  .....|+..|+|||.+.   ...++.++|||||||++|||++|+.||...........   .....   +..+...
T Consensus       161 ~~--~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~---~~~~~---~~~~~~~  232 (267)
T cd06646         161 AK--RKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFL---MSKSN---FQPPKLK  232 (267)
T ss_pred             cc--cCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhhee---eecCC---CCCCCCc
Confidence            11  12245888999999874   34578899999999999999999999864322111100   00000   0011111


Q ss_pred             cccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 012765          376 DAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQLL  411 (457)
Q Consensus       376 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L  411 (457)
                      .  .......+.+++.+||+.+|++|||+.+|++.|
T Consensus       233 ~--~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l  266 (267)
T cd06646         233 D--KTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL  266 (267)
T ss_pred             c--ccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence            1  011234677889999999999999999998743

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-37  Score=300.19  Aligned_cols=248  Identities=29%  Similarity=0.405  Sum_probs=197.3

Q ss_pred             cCCCCCceecccCcEEEEEEEeC-CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeee-cCceEEEE
Q 012765          142 DNFNSENLIGKGGHAEVYKGCLP-DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFST-ENGFHLVL  219 (457)
Q Consensus       142 ~~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~-~~~~~lv~  219 (457)
                      ++|+..+.||.|+||.||+|.+. +++.+|+|.+.....  ......+.+|+.+++.++|+|++++++++. +...++++
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   78 (274)
T cd06609           1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEA--EDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIM   78 (274)
T ss_pred             ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeecccc--chHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEE
Confidence            36788899999999999999865 688999998864432  233567889999999999999999999655 45568999


Q ss_pred             EecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCCCCCC
Q 012765          220 QFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWS  299 (457)
Q Consensus       220 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~~~~  299 (457)
                      ||+++++|.+++...  .+++..++.++.|++.||.|||+   .+++|+||+|+||+++.++.++|+|||+++.+.....
T Consensus        79 e~~~~~~L~~~~~~~--~~~~~~~~~~~~ql~~~l~~lh~---~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~  153 (274)
T cd06609          79 EYCGGGSCLDLLKPG--KLDETYIAFILREVLLGLEYLHE---EGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMS  153 (274)
T ss_pred             EeeCCCcHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEEcccccceeeccccc
Confidence            999999999998543  78999999999999999999999   8999999999999999999999999999987754321


Q ss_pred             ceeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhccccccCCcccccCchhhcccC
Q 012765          300 HHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSNFKELVDPRLADAYD  379 (457)
Q Consensus       300 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~  379 (457)
                        ......++..|+|||++.+..++.++||||||+++|+|+||+.||...+.........        ....+.+...  
T Consensus       154 --~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~--------~~~~~~~~~~--  221 (274)
T cd06609         154 --KRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIP--------KNNPPSLEGN--  221 (274)
T ss_pred             --ccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhh--------hcCCCCCccc--
Confidence              1223457889999999998889999999999999999999999997543221111100        0011111111  


Q ss_pred             HHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 012765          380 LAEMKRAMLTASVCIHHLSTMRPQMTRVLQ  409 (457)
Q Consensus       380 ~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~  409 (457)
                       .....+.+++.+||..+|++|||+.++++
T Consensus       222 -~~~~~~~~~l~~~l~~~p~~Rpt~~~il~  250 (274)
T cd06609         222 -KFSKPFKDFVSLCLNKDPKERPSAKELLK  250 (274)
T ss_pred             -ccCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence             02335677889999999999999999987

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-39  Score=322.73  Aligned_cols=251  Identities=25%  Similarity=0.405  Sum_probs=198.1

Q ss_pred             cCCCCCceecccCcEEEEEEEeCCCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeee-eeecCceEEEEE
Q 012765          142 DNFNSENLIGKGGHAEVYKGCLPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIG-FSTENGFHLVLQ  220 (457)
Q Consensus       142 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~-~~~~~~~~lv~e  220 (457)
                      +-|.++..||.|+||.||+|..++...+|.-+++..  ......++++-|++||+.++||+||++++ |+.++.++++.|
T Consensus        32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIet--kseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliE  109 (1187)
T KOG0579|consen   32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIET--KSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIE  109 (1187)
T ss_pred             HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcc--cchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEe
Confidence            445567889999999999998776555544433322  23355789999999999999999999997 899999999999


Q ss_pred             ecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCCCCCCc
Q 012765          221 FLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSH  300 (457)
Q Consensus       221 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~~~~~  300 (457)
                      ||.||-....+..-+..+.+.++..++.|++.||.|||+   .+|||||||+.|||++-+|.++|+|||.+......  .
T Consensus       110 FC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs---~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t--~  184 (1187)
T KOG0579|consen  110 FCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHS---QNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKST--R  184 (1187)
T ss_pred             ecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhh---cchhhhhccccceEEEecCcEeeecccccccchhH--H
Confidence            999999999888888889999999999999999999999   89999999999999999999999999998654322  2


Q ss_pred             eeeecccccccccChhcccc-----CCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhccccccCCcccccCchhh
Q 012765          301 HIVFPIEGTFGYLSPEYFMH-----GIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSNFKELVDPRLA  375 (457)
Q Consensus       301 ~~~~~~~gt~~y~aPE~~~~-----~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  375 (457)
                      .....+.||++|||||++++     .+|+.++||||||++|.||..+.+|-..-....+....   .....+.++.|   
T Consensus       185 qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKi---aKSePPTLlqP---  258 (1187)
T KOG0579|consen  185 QKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKI---AKSEPPTLLQP---  258 (1187)
T ss_pred             hhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHH---hhcCCCcccCc---
Confidence            22345779999999999864     57999999999999999999999997653322111111   11111112222   


Q ss_pred             cccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 012765          376 DAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQ  409 (457)
Q Consensus       376 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~  409 (457)
                          ......+.+++..||..||..||++.++++
T Consensus       259 ----S~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~  288 (1187)
T KOG0579|consen  259 ----SHWSRSFSDFLKRCLVKNPRNRPPAAQLLK  288 (1187)
T ss_pred             ----chhhhHHHHHHHHHHhcCCccCCCHHHHhh
Confidence                122345667788899999999999998876

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=1.6e-37  Score=300.90  Aligned_cols=251  Identities=24%  Similarity=0.428  Sum_probs=194.6

Q ss_pred             cCCCCCceecccCcEEEEEEEeC-CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeee-eecCceEEEE
Q 012765          142 DNFNSENLIGKGGHAEVYKGCLP-DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGF-STENGFHLVL  219 (457)
Q Consensus       142 ~~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~-~~~~~~~lv~  219 (457)
                      ++|++.+.||+|+||.||++... +++.||+|.+....  .......+.+|+.++.+++||||++++++ ...+..+++|
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   78 (286)
T cd06622           1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLEL--DESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCM   78 (286)
T ss_pred             ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEE
Confidence            46788899999999999999875 68999999876432  22335688999999999999999999995 4556678999


Q ss_pred             EecCCCChhhhhhcC--CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCCCC
Q 012765          220 QFLPHGSLSSLLFGS--TECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDN  297 (457)
Q Consensus       220 e~~~~gsL~~~l~~~--~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~~  297 (457)
                      ||+++++|..++...  ...+++..+..++.|++.||.|||+.  .+++|+||||+||+++.++.++|+|||++..+...
T Consensus        79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~--~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~  156 (286)
T cd06622          79 EYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEE--HNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS  156 (286)
T ss_pred             eecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhc--CCEeeCCCCHHHEEECCCCCEEEeecCCcccccCC
Confidence            999999998888553  23689999999999999999999972  58999999999999999999999999998766443


Q ss_pred             CCceeeecccccccccChhccccC------CCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhccccccCCcccccC
Q 012765          298 WSHHIVFPIEGTFGYLSPEYFMHG------IVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSNFKELVD  371 (457)
Q Consensus       298 ~~~~~~~~~~gt~~y~aPE~~~~~------~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d  371 (457)
                      ..    ....++..|+|||++.+.      .++.++|||||||++|+|++|+.||...........        +..+.+
T Consensus       157 ~~----~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~--------~~~~~~  224 (286)
T cd06622         157 LA----KTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQ--------LSAIVD  224 (286)
T ss_pred             cc----ccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHH--------HHHHhh
Confidence            22    223478899999998543      358899999999999999999999975322111100        000111


Q ss_pred             chhhcccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 012765          372 PRLADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQ  409 (457)
Q Consensus       372 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~  409 (457)
                      .. ...........+..++.+||+.+|++||++.+++.
T Consensus       225 ~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~  261 (286)
T cd06622         225 GD-PPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLE  261 (286)
T ss_pred             cC-CCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhc
Confidence            00 00111223445677889999999999999999987

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.8e-39  Score=318.24  Aligned_cols=246  Identities=28%  Similarity=0.400  Sum_probs=201.4

Q ss_pred             CCCCCceecccCcEEEEEEEe-CCCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeecCc-eEEEEE
Q 012765          143 NFNSENLIGKGGHAEVYKGCL-PDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTENG-FHLVLQ  220 (457)
Q Consensus       143 ~f~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~-~~lv~e  220 (457)
                      -|.-+..||.|+||.||-|.+ .+.+.||||++....+.......++++|+..|.+++|||++.+-||+..+. .+||||
T Consensus        27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVME  106 (948)
T KOG0577|consen   27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVME  106 (948)
T ss_pred             HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHH
Confidence            355567899999999999985 468899999998877777777889999999999999999999999776655 579999


Q ss_pred             ecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCCCCCCc
Q 012765          221 FLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSH  300 (457)
Q Consensus       221 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~~~~~  300 (457)
                      ||-| +-.+++.-..+++.+..+..|+.+.+.||.|||+   .+.||||||..||||++.|.|||+|||.+......   
T Consensus       107 YClG-SAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS---~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PA---  179 (948)
T KOG0577|consen  107 YCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHS---HNRIHRDIKAGNILLSEPGLVKLADFGSASIMAPA---  179 (948)
T ss_pred             HHhc-cHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHH---hhHHhhhccccceEecCCCeeeeccccchhhcCch---
Confidence            9954 5566665557778888899999999999999999   89999999999999999999999999998765432   


Q ss_pred             eeeecccccccccChhccc---cCCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhccccccCCcccccCchhhcc
Q 012765          301 HIVFPIEGTFGYLSPEYFM---HGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSNFKELVDPRLADA  377 (457)
Q Consensus       301 ~~~~~~~gt~~y~aPE~~~---~~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~  377 (457)
                         ..+.||++|||||++.   .+.|+-|+||||||++..||.-.++|+-+.+.....|-..   .++     .|.|.  
T Consensus       180 ---nsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIA---QNe-----sPtLq--  246 (948)
T KOG0577|consen  180 ---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIA---QNE-----SPTLQ--  246 (948)
T ss_pred             ---hcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHH---hcC-----CCCCC--
Confidence               3456999999999985   5789999999999999999999999976644333222211   111     12221  


Q ss_pred             cCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 012765          378 YDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQ  409 (457)
Q Consensus       378 ~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~  409 (457)
                       ..+....+.+++..||++-|.+|||..+++.
T Consensus       247 -s~eWS~~F~~Fvd~CLqKipqeRptse~ll~  277 (948)
T KOG0577|consen  247 -SNEWSDYFRNFVDSCLQKIPQERPTSEELLK  277 (948)
T ss_pred             -CchhHHHHHHHHHHHHhhCcccCCcHHHHhh
Confidence             3455667888899999999999999988776

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=1.4e-37  Score=306.05  Aligned_cols=194  Identities=24%  Similarity=0.376  Sum_probs=155.7

Q ss_pred             CceecccCcEEEEEEEeC---CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeec---CceEEEEE
Q 012765          147 ENLIGKGGHAEVYKGCLP---DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTE---NGFHLVLQ  220 (457)
Q Consensus       147 ~~~LG~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~---~~~~lv~e  220 (457)
                      ...||+|+||+||+|...   +++.||+|.+.....     ...+.+|+.++++++||||+++++++..   ...+++||
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e   80 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI-----SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFD   80 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCC-----cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEe
Confidence            368999999999999854   467899998854322     2356789999999999999999996543   33678899


Q ss_pred             ecCCCChhhhhhc--------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEE----cCCCcEEEeec
Q 012765          221 FLPHGSLSSLLFG--------STECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILL----SEDYEAQISDF  288 (457)
Q Consensus       221 ~~~~gsL~~~l~~--------~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll----~~~~~~kL~DF  288 (457)
                      |+. ++|..++..        ....+++..+..++.||+.||.|||+   .+|+||||||+|||+    +.++.+||+||
T Consensus        81 ~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~---~~ivHrDlkp~Nil~~~~~~~~~~~kl~Df  156 (317)
T cd07868          81 YAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHA---NWVLHRDLKPANILVMGEGPERGRVKIADM  156 (317)
T ss_pred             ccC-CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHh---CCEEcCCCCHHHEEEecCCCCcCcEEEeec
Confidence            875 477776532        12357888899999999999999999   899999999999999    45678999999


Q ss_pred             cccccCCCCCCc-eeeecccccccccChhcccc-CCCCcchhHHHHHHHHHHHHhCCCCCCcC
Q 012765          289 GLAKWLPDNWSH-HIVFPIEGTFGYLSPEYFMH-GIVDEKTDVFAFGVLLLELITGRRAVDSR  349 (457)
Q Consensus       289 Gl~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~ksDvwSlGvll~eLltG~~pf~~~  349 (457)
                      |+++........ .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||...
T Consensus       157 G~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~  219 (317)
T cd07868         157 GFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR  219 (317)
T ss_pred             CceeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCC
Confidence            999876543221 11234568999999999876 45899999999999999999999999753

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=1.6e-37  Score=303.00  Aligned_cols=249  Identities=20%  Similarity=0.346  Sum_probs=196.2

Q ss_pred             hcCCCCCceecccCcEEEEEEEe-CCCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeee-cCceEEE
Q 012765          141 TDNFNSENLIGKGGHAEVYKGCL-PDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFST-ENGFHLV  218 (457)
Q Consensus       141 ~~~f~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~-~~~~~lv  218 (457)
                      ..+|++.+.||+|+||.||+|.. .+++.||+|.+......   ....+.+|+.+++.++|||++++++++. ....++|
T Consensus        19 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~---~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv   95 (296)
T cd06654          19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP---KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVV   95 (296)
T ss_pred             ccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcc---hHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEe
Confidence            36788889999999999999985 46889999988654332   2357889999999999999999998554 5567899


Q ss_pred             EEecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCCCCC
Q 012765          219 LQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNW  298 (457)
Q Consensus       219 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~~~  298 (457)
                      |||+++++|.+++..  ..+++..++.++.|++.||.|||+   .+|+||||||+||+++.++.++|+|||++.......
T Consensus        96 ~e~~~~~~L~~~~~~--~~~~~~~~~~i~~ql~~aL~~LH~---~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~  170 (296)
T cd06654          96 MEYLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ  170 (296)
T ss_pred             ecccCCCCHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEcCCCCEEECccccchhccccc
Confidence            999999999998843  457888999999999999999999   899999999999999999999999999987654322


Q ss_pred             CceeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhccccccCCcccccCchhhccc
Q 012765          299 SHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSNFKELVDPRLADAY  378 (457)
Q Consensus       299 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~  378 (457)
                      ..  .....++..|+|||.+.+..++.++|||||||++|+|++|+.||.........+..  .... .     +.+.  .
T Consensus       171 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~--~~~~-~-----~~~~--~  238 (296)
T cd06654         171 SK--RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLI--ATNG-T-----PELQ--N  238 (296)
T ss_pred             cc--cCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHH--hcCC-C-----CCCC--C
Confidence            11  12235889999999998888999999999999999999999999764432111110  0000 0     0000  0


Q ss_pred             CHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 012765          379 DLAEMKRAMLTASVCIHHLSTMRPQMTRVLQ  409 (457)
Q Consensus       379 ~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~  409 (457)
                      .......+.+++.+||..+|++|||+.+|++
T Consensus       239 ~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~  269 (296)
T cd06654         239 PEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ  269 (296)
T ss_pred             ccccCHHHHHHHHHHCcCCcccCcCHHHHhh
Confidence            1122245677889999999999999999987

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=2.9e-37  Score=300.34  Aligned_cols=251  Identities=25%  Similarity=0.394  Sum_probs=195.5

Q ss_pred             hcCCCCCceecccCcEEEEEEEeC-CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeee-eecCceEEE
Q 012765          141 TDNFNSENLIGKGGHAEVYKGCLP-DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGF-STENGFHLV  218 (457)
Q Consensus       141 ~~~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~-~~~~~~~lv  218 (457)
                      .+.|++.+.||.|+||.||+|... +++.+++|.+....   ......+.+|+.+++.++||||++++++ ..++.++++
T Consensus        11 ~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   87 (292)
T cd06644          11 NEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKS---EEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIM   87 (292)
T ss_pred             chhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCC---HHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEE
Confidence            367889999999999999999865 48899999875432   3345678899999999999999999995 455667899


Q ss_pred             EEecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCCCCC
Q 012765          219 LQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNW  298 (457)
Q Consensus       219 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~~~  298 (457)
                      |||+++++|..++......+++..+..++.|++.||.|||+   .+++||||||+||+++.++.++|+|||++.......
T Consensus        88 ~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~  164 (292)
T cd06644          88 IEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHS---MKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTL  164 (292)
T ss_pred             EecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhc---CCeeecCCCcceEEEcCCCCEEEccCccceeccccc
Confidence            99999999988886656678999999999999999999999   899999999999999999999999999987543321


Q ss_pred             CceeeecccccccccChhccc-----cCCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhccccccCCcccccCch
Q 012765          299 SHHIVFPIEGTFGYLSPEYFM-----HGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSNFKELVDPR  373 (457)
Q Consensus       299 ~~~~~~~~~gt~~y~aPE~~~-----~~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~  373 (457)
                      ..  .....++..|+|||++.     ...++.++|||||||++|||++|..||...........  .. ...     .+.
T Consensus       165 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~--~~-~~~-----~~~  234 (292)
T cd06644         165 QR--RDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLK--IA-KSE-----PPT  234 (292)
T ss_pred             cc--cceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHH--Hh-cCC-----Ccc
Confidence            11  12334788999999985     34578899999999999999999999975432111100  00 000     011


Q ss_pred             hhcccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 012765          374 LADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQ  409 (457)
Q Consensus       374 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~  409 (457)
                      +..  .......+.+++.+||..+|++||++.+|++
T Consensus       235 ~~~--~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  268 (292)
T cd06644         235 LSQ--PSKWSMEFRDFLKTALDKHPETRPSAAQLLE  268 (292)
T ss_pred             CCC--CcccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence            100  1112235677889999999999999999976

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=2.7e-37  Score=296.11  Aligned_cols=239  Identities=18%  Similarity=0.312  Sum_probs=183.0

Q ss_pred             ceecccCcEEEEEEEeCC-------------CcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeecC-
Q 012765          148 NLIGKGGHAEVYKGCLPD-------------GEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTEN-  213 (457)
Q Consensus       148 ~~LG~G~~g~Vy~~~~~~-------------~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~-  213 (457)
                      +.||+|+||.||+|....             ...+++|.+....   ......+.+|+.++..++||||+++++++..+ 
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~   77 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSH---RDISLAFFETASMMRQVSHKHIVLLYGVCVRDV   77 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhh---hhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC
Confidence            368999999999997432             2247788754322   23345788899999999999999999976654 


Q ss_pred             ceEEEEEecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCc-------EEEe
Q 012765          214 GFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYE-------AQIS  286 (457)
Q Consensus       214 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~-------~kL~  286 (457)
                      ..+++|||+++++|..++......+++..++.++.||+.||.|||+   .+|+||||||+|||++.++.       ++++
T Consensus        78 ~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~  154 (262)
T cd05077          78 ENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLED---KDLVHGNVCTKNILLAREGIDGECGPFIKLS  154 (262)
T ss_pred             CCEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhh---CCeECCCCCcccEEEecCCccCCCCceeEeC
Confidence            4689999999999998887666678999999999999999999999   89999999999999987654       8999


Q ss_pred             eccccccCCCCCCceeeecccccccccChhccc-cCCCCcchhHHHHHHHHHHHH-hCCCCCCcCCcchhhhhccccccC
Q 012765          287 DFGLAKWLPDNWSHHIVFPIEGTFGYLSPEYFM-HGIVDEKTDVFAFGVLLLELI-TGRRAVDSRRQSLVIWAKPLLQTS  364 (457)
Q Consensus       287 DFGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~ksDvwSlGvll~eLl-tG~~pf~~~~~~~~~~~~~~~~~~  364 (457)
                      |||++......      ....++..|+|||++. +..++.++|||||||++|||+ +|..||...........    ...
T Consensus       155 d~g~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~----~~~  224 (262)
T cd05077         155 DPGIPITVLSR------QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKERF----YEG  224 (262)
T ss_pred             CCCCCccccCc------ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHHHH----Hhc
Confidence            99998655322      1234788899999886 466899999999999999998 58888765322111100    000


Q ss_pred             CcccccCchhhcccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 012765          365 NFKELVDPRLADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQLLR  412 (457)
Q Consensus       365 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~  412 (457)
                      .. ....         .....+..++.+||+.||.+||++.+|++.|+
T Consensus       225 ~~-~~~~---------~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~~  262 (262)
T cd05077         225 QC-MLVT---------PSCKELADLMTHCMNYDPNQRPFFRAIMRDIN  262 (262)
T ss_pred             Cc-cCCC---------CChHHHHHHHHHHcCCChhhCcCHHHHHHhcC
Confidence            00 0000         11235678899999999999999999998763

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=8.1e-38  Score=301.77  Aligned_cols=246  Identities=30%  Similarity=0.420  Sum_probs=194.5

Q ss_pred             CCCCCceecccCcEEEEEEEeC-CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeee-cCceEEEEE
Q 012765          143 NFNSENLIGKGGHAEVYKGCLP-DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFST-ENGFHLVLQ  220 (457)
Q Consensus       143 ~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~-~~~~~lv~e  220 (457)
                      .|+..+.||.|+||.||+|.+. +++.||+|.+.....  ......+.+|+.++++++||||+++++++. .+..++|||
T Consensus         5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   82 (277)
T cd06642           5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIME   82 (277)
T ss_pred             HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccc--hHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEE
Confidence            4556678999999999999864 578899998754332  234568899999999999999999999654 455789999


Q ss_pred             ecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCCCCCCc
Q 012765          221 FLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSH  300 (457)
Q Consensus       221 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~~~~~  300 (457)
                      |+++++|.+++.  ...+++..+..++.|++.||.|||+   .+++|+||+|+||+++.++.++|+|||++..+..... 
T Consensus        83 ~~~~~~L~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~---~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~-  156 (277)
T cd06642          83 YLGGGSALDLLK--PGPLEETYIATILREILKGLDYLHS---ERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI-  156 (277)
T ss_pred             ccCCCcHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHhc---CCeeccCCChheEEEeCCCCEEEccccccccccCcch-
Confidence            999999999884  3457889999999999999999999   8999999999999999999999999999977654321 


Q ss_pred             eeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhccccccCCcccccCchhhcccCH
Q 012765          301 HIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSNFKELVDPRLADAYDL  380 (457)
Q Consensus       301 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~  380 (457)
                       ......++..|+|||++.+..++.++|||||||++|||++|+.||.........+..        .....+.+.    .
T Consensus       157 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~--------~~~~~~~~~----~  223 (277)
T cd06642         157 -KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLI--------PKNSPPTLE----G  223 (277)
T ss_pred             -hhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhh--------hcCCCCCCC----c
Confidence             112235788999999999888999999999999999999999998753322111110        000111111    1


Q ss_pred             HHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 012765          381 AEMKRAMLTASVCIHHLSTMRPQMTRVLQ  409 (457)
Q Consensus       381 ~~~~~l~~l~~~Cl~~dP~~RPt~~evl~  409 (457)
                      .....+.+++.+||+.+|++||++.+|++
T Consensus       224 ~~~~~~~~li~~~l~~~p~~Rp~~~~il~  252 (277)
T cd06642         224 QYSKPFKEFVEACLNKDPRFRPTAKELLK  252 (277)
T ss_pred             ccCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence            22345678889999999999999999998

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=8.3e-38  Score=310.14  Aligned_cols=205  Identities=23%  Similarity=0.297  Sum_probs=171.8

Q ss_pred             cCCCCCceecccCcEEEEEEEeC-CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeec-CceEEEE
Q 012765          142 DNFNSENLIGKGGHAEVYKGCLP-DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTE-NGFHLVL  219 (457)
Q Consensus       142 ~~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-~~~~lv~  219 (457)
                      ++|.+.+.||+|+||+||++... +++.+|+|.+.+...........+.+|+.++..++|+||+++++++.+ +.+++||
T Consensus         1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (332)
T cd05623           1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM   80 (332)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence            47889999999999999999865 478899998865333333445568889999999999999999986554 5578999


Q ss_pred             EecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCCCCCC
Q 012765          220 QFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWS  299 (457)
Q Consensus       220 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~~~~  299 (457)
                      ||+++|+|.+++......+++..+..++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||++..+.....
T Consensus        81 ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~---~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~  157 (332)
T cd05623          81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQ---LHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGT  157 (332)
T ss_pred             eccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHEEECCCCCEEEeecchheecccCCc
Confidence            9999999999997655678999999999999999999999   8999999999999999999999999999876543221


Q ss_pred             ceeeecccccccccChhccc-----cCCCCcchhHHHHHHHHHHHHhCCCCCCcCC
Q 012765          300 HHIVFPIEGTFGYLSPEYFM-----HGIVDEKTDVFAFGVLLLELITGRRAVDSRR  350 (457)
Q Consensus       300 ~~~~~~~~gt~~y~aPE~~~-----~~~~~~ksDvwSlGvll~eLltG~~pf~~~~  350 (457)
                      . ......||+.|+|||++.     ...++.++|||||||++|||++|+.||....
T Consensus       158 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~  212 (332)
T cd05623         158 V-QSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAES  212 (332)
T ss_pred             c-eecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCC
Confidence            1 122345999999999986     3468899999999999999999999998643

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=5.4e-38  Score=338.65  Aligned_cols=260  Identities=23%  Similarity=0.325  Sum_probs=196.9

Q ss_pred             HhhcCCCCCceecccCcEEEEEEEeC-CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeec---Cc
Q 012765          139 AATDNFNSENLIGKGGHAEVYKGCLP-DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTE---NG  214 (457)
Q Consensus       139 ~~~~~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~---~~  214 (457)
                      ...++|.+.+.||+|+||+||+|.+. .+..+|+|.+..... .......+..|+.++..++|||||++++++.+   ..
T Consensus        10 ~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l-~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~   88 (1021)
T PTZ00266         10 SRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGL-KEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQK   88 (1021)
T ss_pred             cccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEecccc-CHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCE
Confidence            45578999999999999999999865 577888888754322 23345688999999999999999999996543   34


Q ss_pred             eEEEEEecCCCChhhhhhc---CCCCCCHHHHHHHHHHHHHHHHHHHhcC----CCCeeeCCCCCCcEEEcC--------
Q 012765          215 FHLVLQFLPHGSLSSLLFG---STECLEWTIRYKIALGIAEGLQYLHHDC----HRRIIHRDIKASNILLSE--------  279 (457)
Q Consensus       215 ~~lv~e~~~~gsL~~~l~~---~~~~~~~~~~~~i~~qia~aL~yLH~~~----~~~iiHrDlkp~NIll~~--------  279 (457)
                      +++||||+++|+|..+|..   ....+++..++.|+.||+.||.|||+..    ..+||||||||+||||+.        
T Consensus        89 lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i  168 (1021)
T PTZ00266         89 LYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKI  168 (1021)
T ss_pred             EEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccc
Confidence            7899999999999998854   2346899999999999999999999832    135999999999999964        


Q ss_pred             ---------CCcEEEeeccccccCCCCCCceeeecccccccccChhcccc--CCCCcchhHHHHHHHHHHHHhCCCCCCc
Q 012765          280 ---------DYEAQISDFGLAKWLPDNWSHHIVFPIEGTFGYLSPEYFMH--GIVDEKTDVFAFGVLLLELITGRRAVDS  348 (457)
Q Consensus       280 ---------~~~~kL~DFGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~ksDvwSlGvll~eLltG~~pf~~  348 (457)
                               .+.+||+|||++..+.....   .....||+.|+|||++.+  ..++.++||||||||||||+||..||..
T Consensus       169 ~~~~~n~ng~~iVKLsDFGlAr~l~~~s~---~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~  245 (1021)
T PTZ00266        169 TAQANNLNGRPIAKIGDFGLSKNIGIESM---AHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHK  245 (1021)
T ss_pred             cccccccCCCCceEEccCCcccccccccc---ccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCc
Confidence                     23489999999987643321   123458999999999864  4589999999999999999999999975


Q ss_pred             CCcchhhhhccccccCCcccccCchhhcccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH--HHhcC
Q 012765          349 RRQSLVIWAKPLLQTSNFKELVDPRLADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQ--LLRGE  414 (457)
Q Consensus       349 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~--~L~~~  414 (457)
                      ........ ......        +.+..   ......+..++..||+.+|.+||++.|++.  .|..+
T Consensus       246 ~~~~~qli-~~lk~~--------p~lpi---~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik~i  301 (1021)
T PTZ00266        246 ANNFSQLI-SELKRG--------PDLPI---KGKSKELNILIKNLLNLSAKERPSALQCLGYQIIKNV  301 (1021)
T ss_pred             CCcHHHHH-HHHhcC--------CCCCc---CCCCHHHHHHHHHHhcCChhHCcCHHHHhccHHHhhc
Confidence            43221111 110000        11100   011245677889999999999999999984  55444

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=3.8e-38  Score=312.48  Aligned_cols=256  Identities=19%  Similarity=0.229  Sum_probs=193.2

Q ss_pred             cCCCCCceecccCcEEEEEEEeC-CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeec-CceEEEE
Q 012765          142 DNFNSENLIGKGGHAEVYKGCLP-DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTE-NGFHLVL  219 (457)
Q Consensus       142 ~~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-~~~~lv~  219 (457)
                      ++|.+.+.||+|+||+||++... +++.||+|.+.+...........+.+|..++..++|+||+++++++.+ +..++||
T Consensus         1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~   80 (331)
T cd05624           1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM   80 (331)
T ss_pred             CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            47889999999999999999865 588999998865333333445568889999999999999999996655 4468999


Q ss_pred             EecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCCCCCC
Q 012765          220 QFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWS  299 (457)
Q Consensus       220 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~~~~  299 (457)
                      ||+++|+|..++......+++..+..++.|++.||.|||+   .+|+||||||+|||++.++.+||+|||++..+.....
T Consensus        81 Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~---~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~  157 (331)
T cd05624          81 DYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQ---LHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGT  157 (331)
T ss_pred             eCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCchHHEEEcCCCCEEEEeccceeeccCCCc
Confidence            9999999999997655678899999999999999999999   8999999999999999999999999999977654322


Q ss_pred             ceeeecccccccccChhcccc-----CCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhccccccCCcccccCchh
Q 012765          300 HHIVFPIEGTFGYLSPEYFMH-----GIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSNFKELVDPRL  374 (457)
Q Consensus       300 ~~~~~~~~gt~~y~aPE~~~~-----~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l  374 (457)
                      . ......||+.|+|||++.+     +.++.++|||||||++|||++|+.||........ +.......... . +.+.+
T Consensus       158 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~-~~~i~~~~~~~-~-~p~~~  233 (331)
T cd05624         158 V-QSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVET-YGKIMNHEERF-Q-FPSHI  233 (331)
T ss_pred             e-eeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHH-HHHHHcCCCcc-c-CCCcc
Confidence            1 1123459999999999875     5688999999999999999999999976432211 11100000000 0 00111


Q ss_pred             hcccCHHHHHHHHHHHHHhcccCCCC--CCCHHHHHH
Q 012765          375 ADAYDLAEMKRAMLTASVCIHHLSTM--RPQMTRVLQ  409 (457)
Q Consensus       375 ~~~~~~~~~~~l~~l~~~Cl~~dP~~--RPt~~evl~  409 (457)
                       .    .....+.+++.+|+..++.+  |+++.++++
T Consensus       234 -~----~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~  265 (331)
T cd05624         234 -T----DVSEEAKDLIQRLICSRERRLGQNGIEDFKK  265 (331)
T ss_pred             -c----cCCHHHHHHHHHHccCchhhcCCCCHHHHhc
Confidence             1    12245566777788765544  567887765

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=3e-37  Score=295.14  Aligned_cols=255  Identities=29%  Similarity=0.407  Sum_probs=198.7

Q ss_pred             cCCCCCceecccCcEEEEEEEeC-CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeee-ecCceEEEE
Q 012765          142 DNFNSENLIGKGGHAEVYKGCLP-DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFS-TENGFHLVL  219 (457)
Q Consensus       142 ~~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~-~~~~~~lv~  219 (457)
                      ++|++.+.||.|+||+||+|... ++..+++|++.......  ....+.+|+.+++.++|+|++++++.+ ..+..++++
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~   78 (267)
T cd06610           1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQT--SVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVM   78 (267)
T ss_pred             CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcch--HHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEE
Confidence            47889999999999999999854 68889999875433322  456899999999999999999999854 455578999


Q ss_pred             EecCCCChhhhhhcC--CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCCCC
Q 012765          220 QFLPHGSLSSLLFGS--TECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDN  297 (457)
Q Consensus       220 e~~~~gsL~~~l~~~--~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~~  297 (457)
                      |++++++|.+++...  ...+++.....++.|++.||.|||+   .+++|+||+|+||++++++.++|+|||++..+...
T Consensus        79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~---~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~  155 (267)
T cd06610          79 PYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHS---NGQIHRDIKAGNILLGEDGSVKIADFGVSASLADG  155 (267)
T ss_pred             eccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHhEEEcCCCCEEEcccchHHHhccC
Confidence            999999999998653  2468899999999999999999999   89999999999999999999999999998876543


Q ss_pred             CCce--eeecccccccccChhccccC-CCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhccccccCCcccccCchh
Q 012765          298 WSHH--IVFPIEGTFGYLSPEYFMHG-IVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSNFKELVDPRL  374 (457)
Q Consensus       298 ~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l  374 (457)
                      ....  ......|+..|+|||++... .++.++|+|||||++|+|++|+.||.............  ..      ..+.+
T Consensus       156 ~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~--~~------~~~~~  227 (267)
T cd06610         156 GDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTL--QN------DPPSL  227 (267)
T ss_pred             ccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHh--cC------CCCCc
Confidence            3221  12234588999999998876 78999999999999999999999997543221111100  00      01111


Q ss_pred             hccc-CHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 012765          375 ADAY-DLAEMKRAMLTASVCIHHLSTMRPQMTRVLQ  409 (457)
Q Consensus       375 ~~~~-~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~  409 (457)
                      .... .......+.+++..||+.||++||++.+|++
T Consensus       228 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~  263 (267)
T cd06610         228 ETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK  263 (267)
T ss_pred             CCccccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence            1110 0123355778899999999999999999986

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=1.6e-37  Score=296.33  Aligned_cols=252  Identities=25%  Similarity=0.357  Sum_probs=198.2

Q ss_pred             CCCCCceecccCcEEEEEEEeC-CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeec---CceEEE
Q 012765          143 NFNSENLIGKGGHAEVYKGCLP-DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTE---NGFHLV  218 (457)
Q Consensus       143 ~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~---~~~~lv  218 (457)
                      +|++.+.||.|+||.||++... +++.+|+|.+..... .......+..|+.+++.++||||+++++++..   ...+++
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~   79 (265)
T cd08217           1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNM-TEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIV   79 (265)
T ss_pred             CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccC-CHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEE
Confidence            4778899999999999999854 688999998865433 23445678899999999999999999986543   336899


Q ss_pred             EEecCCCChhhhhhcC---CCCCCHHHHHHHHHHHHHHHHHHHhcC--CCCeeeCCCCCCcEEEcCCCcEEEeecccccc
Q 012765          219 LQFLPHGSLSSLLFGS---TECLEWTIRYKIALGIAEGLQYLHHDC--HRRIIHRDIKASNILLSEDYEAQISDFGLAKW  293 (457)
Q Consensus       219 ~e~~~~gsL~~~l~~~---~~~~~~~~~~~i~~qia~aL~yLH~~~--~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~  293 (457)
                      |||+++++|.+++...   ...+++..++.++.||+.||.|||..+  ..+++|+||+|+||+++.++.+||+|||++..
T Consensus        80 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~  159 (265)
T cd08217          80 MEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKI  159 (265)
T ss_pred             ehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEeccccccc
Confidence            9999999999998542   456899999999999999999999211  18999999999999999999999999999987


Q ss_pred             CCCCCCceeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhccccccCCcccccCch
Q 012765          294 LPDNWSHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSNFKELVDPR  373 (457)
Q Consensus       294 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~  373 (457)
                      .......  .....++..|+|||++.+..++.++|+||||+++++|++|+.||...+....  ... .....     .+ 
T Consensus       160 ~~~~~~~--~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~--~~~-~~~~~-----~~-  228 (265)
T cd08217         160 LGHDSSF--AKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQL--ASK-IKEGK-----FR-  228 (265)
T ss_pred             ccCCccc--ccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHHHH--HHH-HhcCC-----CC-
Confidence            7554321  2234589999999999988899999999999999999999999986442111  110 00000     01 


Q ss_pred             hhcccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 012765          374 LADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQ  409 (457)
Q Consensus       374 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~  409 (457)
                         .........+.+++.+||+.+|.+||++.+|++
T Consensus       229 ---~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~  261 (265)
T cd08217         229 ---RIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQ  261 (265)
T ss_pred             ---CCccccCHHHHHHHHHHccCCcccCCCHHHHhh
Confidence               112223456778899999999999999999987

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=2.7e-37  Score=296.55  Aligned_cols=254  Identities=24%  Similarity=0.393  Sum_probs=196.9

Q ss_pred             CCCCCceecccCcEEEEEEEeCC--CcEEEEEEEeccc-------hhhHHHHHHHHHHHHHHhh-cCCCCcceeeeeeec
Q 012765          143 NFNSENLIGKGGHAEVYKGCLPD--GEVVAVKKIIKNA-------KEDEERISDFLSELGIVAH-INHPNAAKLIGFSTE  212 (457)
Q Consensus       143 ~f~~~~~LG~G~~g~Vy~~~~~~--~~~vavK~~~~~~-------~~~~~~~~~~~~E~~~l~~-l~hpniv~l~~~~~~  212 (457)
                      +|++.+.||+|+||.||+|.+..  ++.+|+|.+....       ........++.+|+.++.+ ++||||+++++++.+
T Consensus         1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~   80 (269)
T cd08528           1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE   80 (269)
T ss_pred             CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence            47788999999999999998754  7889999875321       1223445678889988865 799999999996554


Q ss_pred             -CceEEEEEecCCCChhhhhhc---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeec
Q 012765          213 -NGFHLVLQFLPHGSLSSLLFG---STECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDF  288 (457)
Q Consensus       213 -~~~~lv~e~~~~gsL~~~l~~---~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DF  288 (457)
                       +..+++|||+++++|.+++..   ....+++..++.++.|++.||.|||+.  .+++|+||+|+||+++.++.++|+||
T Consensus        81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~--~~i~H~dl~~~nil~~~~~~~~l~df  158 (269)
T cd08528          81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKE--KRIVHRDLTPNNIMLGEDDKVTITDF  158 (269)
T ss_pred             CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccC--CceeecCCCHHHEEECCCCcEEEecc
Confidence             556899999999999988743   445688999999999999999999962  67999999999999999999999999


Q ss_pred             cccccCCCCCCceeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhccccccCCccc
Q 012765          289 GLAKWLPDNWSHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSNFKE  368 (457)
Q Consensus       289 Gl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~  368 (457)
                      |++.......   ......|+..|+|||.+.+..++.++||||||+++|+|++|+.||...........  . .....  
T Consensus       159 g~~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~--~-~~~~~--  230 (269)
T cd08528         159 GLAKQKQPES---KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATK--I-VEAVY--  230 (269)
T ss_pred             cceeeccccc---ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHH--H-hhccC--
Confidence            9998664432   22334588999999999988899999999999999999999999975432211100  0 00000  


Q ss_pred             ccCchhhcccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 012765          369 LVDPRLADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQLLR  412 (457)
Q Consensus       369 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~  412 (457)
                        .+..    .......+.+++.+||+.||++||++.||.++++
T Consensus       231 --~~~~----~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~  268 (269)
T cd08528         231 --EPLP----EGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS  268 (269)
T ss_pred             --CcCC----cccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence              0100    1112345677888999999999999999999885

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=1.4e-37  Score=295.64  Aligned_cols=250  Identities=30%  Similarity=0.440  Sum_probs=195.7

Q ss_pred             CCCCceecccCcEEEEEEEeCC-----CcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeec-CceEE
Q 012765          144 FNSENLIGKGGHAEVYKGCLPD-----GEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTE-NGFHL  217 (457)
Q Consensus       144 f~~~~~LG~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-~~~~l  217 (457)
                      |++.+.||.|+||.||++.+.+     +..||+|.+......  .....+..|+..+..++|+||+++++++.. +..++
T Consensus         1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   78 (258)
T smart00219        1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADE--QQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMI   78 (258)
T ss_pred             CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCCh--HHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEE
Confidence            4567899999999999998653     388999988654332  245688999999999999999999996655 55789


Q ss_pred             EEEecCCCChhhhhhcCCCC-CCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCCC
Q 012765          218 VLQFLPHGSLSSLLFGSTEC-LEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPD  296 (457)
Q Consensus       218 v~e~~~~gsL~~~l~~~~~~-~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~  296 (457)
                      +|||+++++|.+++...... +++..++.++.|++.||.|||+   .+++|+||||+||+++.++.++|+|||++.....
T Consensus        79 i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~---~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~  155 (258)
T smart00219       79 VMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLES---KNFIHRDLAARNCLVGENLVVKISDFGLSRDLYD  155 (258)
T ss_pred             EEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhc---CCeeecccccceEEEccCCeEEEcccCCceeccc
Confidence            99999999999998664444 8999999999999999999999   8999999999999999999999999999987755


Q ss_pred             CCCceeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHh-CCCCCCcCCcchhhhhccccccCCcccccCchhh
Q 012765          297 NWSHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELIT-GRRAVDSRRQSLVIWAKPLLQTSNFKELVDPRLA  375 (457)
Q Consensus       297 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLlt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  375 (457)
                      ...... ....++..|+|||.+.+..++.++||||||+++++|++ |..||..........  .... ...     ... 
T Consensus       156 ~~~~~~-~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~--~~~~-~~~-----~~~-  225 (258)
T smart00219      156 DDYYKK-KGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLE--YLKK-GYR-----LPK-  225 (258)
T ss_pred             cccccc-ccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHH--HHhc-CCC-----CCC-
Confidence            422111 12236789999999988889999999999999999998 788887532211110  0000 000     000 


Q ss_pred             cccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 012765          376 DAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQLL  411 (457)
Q Consensus       376 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L  411 (457)
                         .......+.+++.+||..+|++|||+.++++.|
T Consensus       226 ---~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l  258 (258)
T smart00219      226 ---PENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL  258 (258)
T ss_pred             ---CCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence               111234577788999999999999999999865

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=2.7e-37  Score=305.76  Aligned_cols=257  Identities=23%  Similarity=0.314  Sum_probs=189.0

Q ss_pred             CCceeccc--CcEEEEEEEe-CCCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeec-CceEEEEEe
Q 012765          146 SENLIGKG--GHAEVYKGCL-PDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTE-NGFHLVLQF  221 (457)
Q Consensus       146 ~~~~LG~G--~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-~~~~lv~e~  221 (457)
                      +.++||+|  +|++||++.. .+|+.||+|++...... ......+.+|+.+++.++||||+++++++.. +..++||||
T Consensus         2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~   80 (327)
T cd08227           2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACT-NEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSF   80 (327)
T ss_pred             hhhhccccccceEEEEEEeecccCcEEEEEEechhhcc-HHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEec
Confidence            45789999  7899999976 46899999988644322 2334567789999999999999999996554 557899999


Q ss_pred             cCCCChhhhhhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCCCCCCc
Q 012765          222 LPHGSLSSLLFGS-TECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSH  300 (457)
Q Consensus       222 ~~~gsL~~~l~~~-~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~~~~~  300 (457)
                      +++|+|.+++... ...+++..++.++.|++.||.|||+   .+|+||||||+|||++.++.++++||+...........
T Consensus        81 ~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~---~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~  157 (327)
T cd08227          81 MAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHH---MGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQR  157 (327)
T ss_pred             cCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCChhhEEEecCCcEEEcccchhhcccccccc
Confidence            9999999998543 3458899999999999999999999   89999999999999999999999999875443221100


Q ss_pred             -----eeeecccccccccChhcccc--CCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhccccccCCcccccC--
Q 012765          301 -----HIVFPIEGTFGYLSPEYFMH--GIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSNFKELVD--  371 (457)
Q Consensus       301 -----~~~~~~~gt~~y~aPE~~~~--~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d--  371 (457)
                           .......++..|+|||++.+  ..++.++|||||||++|||++|+.||.............   ...+....+  
T Consensus       158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~---~~~~~~~~~~~  234 (327)
T cd08227         158 LRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKL---NGTVPCLLDTT  234 (327)
T ss_pred             ccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHh---cCCcccccccc
Confidence                 00112246778999999876  468999999999999999999999997532211110000   000000000  


Q ss_pred             -----------------c-----------------hhhcccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 012765          372 -----------------P-----------------RLADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQ  409 (457)
Q Consensus       372 -----------------~-----------------~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~  409 (457)
                                       .                 .....+.......+.+++.+||+.||++|||+.++++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~  306 (327)
T cd08227         235 TIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLN  306 (327)
T ss_pred             chhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhc
Confidence                             0                 0000111123346788999999999999999999986

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=3e-37  Score=296.74  Aligned_cols=256  Identities=26%  Similarity=0.426  Sum_probs=196.2

Q ss_pred             CCCCCceecccCcEEEEEEEeC-CCcEEEEEEEeccchh-------hHHHHHHHHHHHHHHhhcCCCCcceeeeeeecC-
Q 012765          143 NFNSENLIGKGGHAEVYKGCLP-DGEVVAVKKIIKNAKE-------DEERISDFLSELGIVAHINHPNAAKLIGFSTEN-  213 (457)
Q Consensus       143 ~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-------~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~-  213 (457)
                      +|...+.||.|+||.||+|... +|+.+|+|.+......       .....+.+.+|+.+++.++|||++++++++... 
T Consensus         2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   81 (272)
T cd06629           2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE   81 (272)
T ss_pred             ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence            4677899999999999999754 6899999987532211       112345788899999999999999999976554 


Q ss_pred             ceEEEEEecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeecccccc
Q 012765          214 GFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKW  293 (457)
Q Consensus       214 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~  293 (457)
                      ..++||||+++++|.+++... ..+++..+..++.||+.||.|||+   .+++||||+|+||+++.++.++|+|||++..
T Consensus        82 ~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~~~nil~~~~~~~~l~d~~~~~~  157 (272)
T cd06629          82 YLSIFLEYVPGGSIGSCLRTY-GRFEEQLVRFFTEQVLEGLAYLHS---KGILHRDLKADNLLVDADGICKISDFGISKK  157 (272)
T ss_pred             ceEEEEecCCCCcHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHhh---CCeeecCCChhhEEEcCCCeEEEeecccccc
Confidence            467999999999999998654 458888889999999999999999   8999999999999999999999999999976


Q ss_pred             CCCCCCceeeecccccccccChhccccCC--CCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhccccccCCcccccC
Q 012765          294 LPDNWSHHIVFPIEGTFGYLSPEYFMHGI--VDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSNFKELVD  371 (457)
Q Consensus       294 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d  371 (457)
                      ..............|+..|+|||++....  ++.++|+||||+++|+|++|..||.........+..  .. ......+.
T Consensus       158 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~--~~-~~~~~~~~  234 (272)
T cd06629         158 SDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKL--GN-KRSAPPIP  234 (272)
T ss_pred             ccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHh--hc-cccCCcCC
Confidence            65432222223345889999999987654  889999999999999999999999754332211110  00 00011111


Q ss_pred             chhhcccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 012765          372 PRLADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQ  409 (457)
Q Consensus       372 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~  409 (457)
                      ...    .......+.+++.+||+.+|++||++.+|++
T Consensus       235 ~~~----~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  268 (272)
T cd06629         235 PDV----SMNLSPVALDFLNACFTINPDNRPTARELLQ  268 (272)
T ss_pred             ccc----cccCCHHHHHHHHHHhcCChhhCCCHHHHhh
Confidence            111    1122356777889999999999999999986

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=1.4e-37  Score=303.93  Aligned_cols=260  Identities=21%  Similarity=0.309  Sum_probs=193.3

Q ss_pred             cCCCCCceecccCcEEEEEEEeC-CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeec-CceEEEE
Q 012765          142 DNFNSENLIGKGGHAEVYKGCLP-DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTE-NGFHLVL  219 (457)
Q Consensus       142 ~~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-~~~~lv~  219 (457)
                      ++|.+.+.||.|+||.||+|... +++.||+|.+......  .....+.+|+.+++.++||||+++++++.. +..+++|
T Consensus         6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~   83 (301)
T cd07873           6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEE--GAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVF   83 (301)
T ss_pred             cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEeccccc--CchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEE
Confidence            57888999999999999999865 5889999988643322  123357789999999999999999996654 4568999


Q ss_pred             EecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCCCCCC
Q 012765          220 QFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWS  299 (457)
Q Consensus       220 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~~~~  299 (457)
                      ||+. ++|..++......+++..+..++.||+.||.|||+   .+++|+||||+||+++.++.++|+|||++........
T Consensus        84 e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~  159 (301)
T cd07873          84 EYLD-KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHR---RKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTK  159 (301)
T ss_pred             eccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCC
Confidence            9997 58888887666678899999999999999999999   8999999999999999999999999999876543221


Q ss_pred             ceeeecccccccccChhccccC-CCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhh-hhcc------------ccccCC
Q 012765          300 HHIVFPIEGTFGYLSPEYFMHG-IVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVI-WAKP------------LLQTSN  365 (457)
Q Consensus       300 ~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~-~~~~------------~~~~~~  365 (457)
                        ......+++.|+|||++.+. .++.++|||||||++|||++|+.||...+..... ....            ......
T Consensus       160 --~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (301)
T cd07873         160 --TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEE  237 (301)
T ss_pred             --cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhcccc
Confidence              11223468899999998654 5788999999999999999999999764321110 0000            000000


Q ss_pred             cccccCchhhc----ccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 012765          366 FKELVDPRLAD----AYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQ  409 (457)
Q Consensus       366 ~~~~~d~~l~~----~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~  409 (457)
                      ....-.+....    .........+.+++.+||+.||.+|||+.|+++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~  285 (301)
T cd07873         238 FKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK  285 (301)
T ss_pred             ccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence            00000010000    000112234678899999999999999999987

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=4.2e-37  Score=296.89  Aligned_cols=248  Identities=27%  Similarity=0.396  Sum_probs=197.4

Q ss_pred             cCCCCCceecccCcEEEEEEEeC-CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeec-CceEEEE
Q 012765          142 DNFNSENLIGKGGHAEVYKGCLP-DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTE-NGFHLVL  219 (457)
Q Consensus       142 ~~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-~~~~lv~  219 (457)
                      ..|+..+.||.|+||.||+|.+. ++..||+|.+.....  ......+.+|+.+++.++||||+++++++.+ ...++||
T Consensus         4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   81 (277)
T cd06640           4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIM   81 (277)
T ss_pred             HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEecccc--HHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence            35667789999999999999865 588999998764322  2345689999999999999999999996655 4468999


Q ss_pred             EecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCCCCCC
Q 012765          220 QFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWS  299 (457)
Q Consensus       220 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~~~~  299 (457)
                      ||+++++|.+++..  ..+++.....++.|++.||.|||+   .+++|+||+|+||+++.++.++|+|||++..+.....
T Consensus        82 e~~~~~~L~~~i~~--~~l~~~~~~~~~~~l~~~l~~lh~---~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~  156 (277)
T cd06640          82 EYLGGGSALDLLRA--GPFDEFQIATMLKEILKGLDYLHS---EKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI  156 (277)
T ss_pred             ecCCCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHh---CCccCcCCChhhEEEcCCCCEEEcccccceeccCCcc
Confidence            99999999998853  457888889999999999999999   8999999999999999999999999999977644321


Q ss_pred             ceeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhccccccCCcccccCchhhcccC
Q 012765          300 HHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSNFKELVDPRLADAYD  379 (457)
Q Consensus       300 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~  379 (457)
                      .  .....++..|+|||++.+..++.++|+|||||++|||++|..||............            .........
T Consensus       157 ~--~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~------------~~~~~~~~~  222 (277)
T cd06640         157 K--RNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLI------------PKNNPPTLT  222 (277)
T ss_pred             c--cccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhh------------hcCCCCCCc
Confidence            1  12235788999999998888999999999999999999999999754322111110            000111222


Q ss_pred             HHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 012765          380 LAEMKRAMLTASVCIHHLSTMRPQMTRVLQL  410 (457)
Q Consensus       380 ~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~  410 (457)
                      ......+.+++..||+.+|++||++.++++.
T Consensus       223 ~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  253 (277)
T cd06640         223 GEFSKPFKEFIDACLNKDPSFRPTAKELLKH  253 (277)
T ss_pred             hhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence            2344567789999999999999999999763

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=2.7e-37  Score=298.92  Aligned_cols=248  Identities=26%  Similarity=0.369  Sum_probs=192.2

Q ss_pred             CCCCceecccCcEEEEEEEeC-CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeee-cCceEEEEEe
Q 012765          144 FNSENLIGKGGHAEVYKGCLP-DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFST-ENGFHLVLQF  221 (457)
Q Consensus       144 f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~-~~~~~lv~e~  221 (457)
                      |++.+.||.|+||.||+|... ++..+++|.+....   ......+.+|+.+++.++|||++++++++. .+..++++||
T Consensus         7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~   83 (282)
T cd06643           7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKS---EEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEF   83 (282)
T ss_pred             HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCC---HHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEe
Confidence            567788999999999999875 47788888775432   234567889999999999999999998554 4557899999


Q ss_pred             cCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCCCCCCce
Q 012765          222 LPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSHH  301 (457)
Q Consensus       222 ~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~~~~~~  301 (457)
                      +++++|..++......+++..+..++.|++.||.|||+   .+++||||||+||+++.++.+||+|||++........  
T Consensus        84 ~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~---~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~--  158 (282)
T cd06643          84 CAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHE---NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ--  158 (282)
T ss_pred             cCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCcccEEEccCCCEEEcccccccccccccc--
Confidence            99999998886656678999999999999999999999   8999999999999999999999999999876543221  


Q ss_pred             eeecccccccccChhccc-----cCCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhccccccCCcccccCchhhc
Q 012765          302 IVFPIEGTFGYLSPEYFM-----HGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSNFKELVDPRLAD  376 (457)
Q Consensus       302 ~~~~~~gt~~y~aPE~~~-----~~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  376 (457)
                      ......++..|+|||++.     +..++.++|||||||++|||++|+.||............  .. .....+..+   .
T Consensus       159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~--~~-~~~~~~~~~---~  232 (282)
T cd06643         159 RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKI--AK-SEPPTLAQP---S  232 (282)
T ss_pred             ccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHH--hh-cCCCCCCCc---c
Confidence            122345889999999984     345788999999999999999999999764322111110  00 000001011   1


Q ss_pred             ccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 012765          377 AYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQ  409 (457)
Q Consensus       377 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~  409 (457)
                          .....+.+++.+||+.+|.+||++.++++
T Consensus       233 ----~~~~~~~~li~~~l~~~p~~Rp~~~~il~  261 (282)
T cd06643         233 ----RWSSEFKDFLKKCLEKNVDARWTTTQLLQ  261 (282)
T ss_pred             ----ccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence                11235677889999999999999999876

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.7e-37  Score=293.19  Aligned_cols=253  Identities=26%  Similarity=0.342  Sum_probs=199.5

Q ss_pred             hcCCCCCceecccCcEEEEEEEeC-CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeee-cCceEEE
Q 012765          141 TDNFNSENLIGKGGHAEVYKGCLP-DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFST-ENGFHLV  218 (457)
Q Consensus       141 ~~~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~-~~~~~lv  218 (457)
                      .++|++.+.||.|+||.||+|... +++.+++|.+.....   .....+.+|+.++++++||||+++++++. ...++++
T Consensus         2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~---~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~   78 (262)
T cd06613           2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPG---DDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIV   78 (262)
T ss_pred             ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCch---hhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEE
Confidence            367888999999999999999864 578899998864432   24568899999999999999999999655 4557899


Q ss_pred             EEecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCCCCC
Q 012765          219 LQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNW  298 (457)
Q Consensus       219 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~~~  298 (457)
                      |||+.+++|..++......++...++.++.|++.||.|||+   .+++|+||+|+||+++.++.++|+|||++.......
T Consensus        79 ~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~---~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~  155 (262)
T cd06613          79 MEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHE---TGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATI  155 (262)
T ss_pred             EeCCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHh---CCceecCCChhhEEECCCCCEEECccccchhhhhhh
Confidence            99999999999887665678999999999999999999999   899999999999999999999999999987664432


Q ss_pred             CceeeecccccccccChhccccC---CCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhccccccCCcccccCchhh
Q 012765          299 SHHIVFPIEGTFGYLSPEYFMHG---IVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSNFKELVDPRLA  375 (457)
Q Consensus       299 ~~~~~~~~~gt~~y~aPE~~~~~---~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  375 (457)
                      .  ......++..|+|||.+.+.   .++.++|+||||+++|+|++|+.||.............   ...+   ..+.+.
T Consensus       156 ~--~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~---~~~~---~~~~~~  227 (262)
T cd06613         156 A--KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLIS---KSNF---PPPKLK  227 (262)
T ss_pred             h--ccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH---hccC---CCcccc
Confidence            1  11234578899999998776   88999999999999999999999997643222111110   0000   001110


Q ss_pred             cccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 012765          376 DAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQ  409 (457)
Q Consensus       376 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~  409 (457)
                        ........+.+++.+||..+|.+|||+.+|+.
T Consensus       228 --~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  259 (262)
T cd06613         228 --DKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ  259 (262)
T ss_pred             --chhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence              11223456788999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.6e-38  Score=310.99  Aligned_cols=242  Identities=20%  Similarity=0.232  Sum_probs=182.7

Q ss_pred             ecccCcEEEEEEEeC-CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhc---CCCCcceeeeeee-cCceEEEEEecCC
Q 012765          150 IGKGGHAEVYKGCLP-DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHI---NHPNAAKLIGFST-ENGFHLVLQFLPH  224 (457)
Q Consensus       150 LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l---~hpniv~l~~~~~-~~~~~lv~e~~~~  224 (457)
                      ||+|+||+||+|... +++.||+|++.+...........+..|..++..+   +||||+++++++. ...+++||||+++
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~   80 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG   80 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence            799999999999865 5899999998654333333445566677777655   6999999998554 5557899999999


Q ss_pred             CChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCCCCCCceeee
Q 012765          225 GSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVF  304 (457)
Q Consensus       225 gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~~~~~~~~~  304 (457)
                      |+|..++.. ...+++..+..++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||++........  ...
T Consensus        81 g~L~~~l~~-~~~~~~~~~~~~~~qil~al~~LH~---~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~--~~~  154 (330)
T cd05586          81 GELFWHLQK-EGRFSEDRAKFYIAELVLALEHLHK---YDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNK--TTN  154 (330)
T ss_pred             ChHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCC--Ccc
Confidence            999988854 3458889999999999999999999   8999999999999999999999999999875432211  123


Q ss_pred             cccccccccChhccccC-CCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhccccccCCcccccCchhhcccCHHHH
Q 012765          305 PIEGTFGYLSPEYFMHG-IVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSNFKELVDPRLADAYDLAEM  383 (457)
Q Consensus       305 ~~~gt~~y~aPE~~~~~-~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~  383 (457)
                      ...||..|+|||++.+. .++.++|||||||++|+|++|+.||......... ........        .+...   ...
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~-~~i~~~~~--------~~~~~---~~~  222 (330)
T cd05586         155 TFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMY-RNIAFGKV--------RFPKN---VLS  222 (330)
T ss_pred             CccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHH-HHHHcCCC--------CCCCc---cCC
Confidence            35699999999998764 4899999999999999999999999764322111 10000000        01000   112


Q ss_pred             HHHHHHHHHhcccCCCCCCC----HHHHHH
Q 012765          384 KRAMLTASVCIHHLSTMRPQ----MTRVLQ  409 (457)
Q Consensus       384 ~~l~~l~~~Cl~~dP~~RPt----~~evl~  409 (457)
                      ..+.+++.+||+.||.+||+    +.++++
T Consensus       223 ~~~~~li~~~L~~~P~~R~~~~~~~~~ll~  252 (330)
T cd05586         223 DEGRQFVKGLLNRNPQHRLGAHRDAVELKE  252 (330)
T ss_pred             HHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence            34567888999999999994    555554

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=1.4e-38  Score=288.78  Aligned_cols=256  Identities=26%  Similarity=0.371  Sum_probs=201.9

Q ss_pred             HHhhcCCCCCceecccCcEEEEEEEeC-CCcEEEEEEEeccch-----hhHHHHHHHHHHHHHHhhc-CCCCcceeeeee
Q 012765          138 AAATDNFNSENLIGKGGHAEVYKGCLP-DGEVVAVKKIIKNAK-----EDEERISDFLSELGIVAHI-NHPNAAKLIGFS  210 (457)
Q Consensus       138 ~~~~~~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-----~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~  210 (457)
                      ......|...++||+|..++|.+++.+ +|+.+|+|++.....     ......+.-.+|+.||+++ .||+|+++.+++
T Consensus        13 ~~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~y   92 (411)
T KOG0599|consen   13 KGFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVY   92 (411)
T ss_pred             hhHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeec
Confidence            445677888899999999999998754 688999998743221     1234456677899999988 699999999987


Q ss_pred             ecCce-EEEEEecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeecc
Q 012765          211 TENGF-HLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFG  289 (457)
Q Consensus       211 ~~~~~-~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG  289 (457)
                      +.+.+ ++|+|.|+.|.|.++|.. .-.+++....+|+.|+.+|+.|||.   ++||||||||+|||++++.++||+|||
T Consensus        93 es~sF~FlVFdl~prGELFDyLts-~VtlSEK~tR~iMrqlfegVeylHa---~~IVHRDLKpENILlddn~~i~isDFG  168 (411)
T KOG0599|consen   93 ESDAFVFLVFDLMPRGELFDYLTS-KVTLSEKETRRIMRQLFEGVEYLHA---RNIVHRDLKPENILLDDNMNIKISDFG  168 (411)
T ss_pred             cCcchhhhhhhhcccchHHHHhhh-heeecHHHHHHHHHHHHHHHHHHHH---hhhhhcccChhheeeccccceEEeccc
Confidence            77664 689999999999999943 3457888888999999999999999   899999999999999999999999999


Q ss_pred             ccccCCCCCCceeeecccccccccChhcccc------CCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhcccccc
Q 012765          290 LAKWLPDNWSHHIVFPIEGTFGYLSPEYFMH------GIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQT  363 (457)
Q Consensus       290 l~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~~~~~~  363 (457)
                      +++.+..+.   .....+||++|+|||.+..      .+|+..+|+||.|||+|.|+.|.+||....+.+...   +..+
T Consensus       169 Fa~~l~~Ge---kLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR---~Ime  242 (411)
T KOG0599|consen  169 FACQLEPGE---KLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLR---MIME  242 (411)
T ss_pred             eeeccCCch---hHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHH---HHHh
Confidence            999987664   3445779999999998853      468889999999999999999999998644332211   1111


Q ss_pred             CCcccccCchhhcccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 012765          364 SNFKELVDPRLADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQ  409 (457)
Q Consensus       364 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~  409 (457)
                      +.+ ++-.|..     .+......+++.+||+.||.+|-|++|+++
T Consensus       243 Gky-qF~speW-----adis~~~KdLIsrlLqVdp~~Ritake~La  282 (411)
T KOG0599|consen  243 GKY-QFRSPEW-----ADISATVKDLISRLLQVDPTKRITAKEALA  282 (411)
T ss_pred             ccc-ccCCcch-----hhccccHHHHHHHHHeeCchhcccHHHHhc
Confidence            111 1111211     123445678899999999999999999876

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=3e-37  Score=347.06  Aligned_cols=258  Identities=28%  Similarity=0.471  Sum_probs=208.6

Q ss_pred             hcCCCCCceecccCcEEEEEEEe-CCCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeecC-ceEEE
Q 012765          141 TDNFNSENLIGKGGHAEVYKGCL-PDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTEN-GFHLV  218 (457)
Q Consensus       141 ~~~f~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~-~~~lv  218 (457)
                      ...|...++||+|+||.||+|.. .++..||+|++......       ...|+..+++++|||||++++++.+. ..++|
T Consensus       689 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-------~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv  761 (968)
T PLN00113        689 LSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI-------PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLI  761 (968)
T ss_pred             HhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc-------cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEE
Confidence            45677889999999999999986 47899999988543221       12457888999999999999977654 46899


Q ss_pred             EEecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCCCCC
Q 012765          219 LQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNW  298 (457)
Q Consensus       219 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~~~  298 (457)
                      |||+++|+|.+++.    .++|..+..|+.||+.||.|||..+..+|+||||||+||+++.++.+++. ||........ 
T Consensus       762 ~Ey~~~g~L~~~l~----~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~-  835 (968)
T PLN00113        762 HEYIEGKNLSEVLR----NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTD-  835 (968)
T ss_pred             EeCCCCCcHHHHHh----cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccccC-
Confidence            99999999999984    37899999999999999999996545899999999999999999888875 6655433221 


Q ss_pred             CceeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHhCCCCCCcC---CcchhhhhccccccCCcccccCchhh
Q 012765          299 SHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSR---RQSLVIWAKPLLQTSNFKELVDPRLA  375 (457)
Q Consensus       299 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLltG~~pf~~~---~~~~~~~~~~~~~~~~~~~~~d~~l~  375 (457)
                           ....+|..|+|||++.+..++.++|||||||++|||+||+.||+..   ......|............++|+.+.
T Consensus       836 -----~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  910 (968)
T PLN00113        836 -----TKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIR  910 (968)
T ss_pred             -----CCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCcccc
Confidence                 1124789999999999999999999999999999999999999642   23445566555555555667777664


Q ss_pred             cc--cCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCCC
Q 012765          376 DA--YDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQLLRGEGG  416 (457)
Q Consensus       376 ~~--~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~  416 (457)
                      ..  .....+..+.+++.+||+.+|++||||.||++.|+.+..
T Consensus       911 ~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~  953 (968)
T PLN00113        911 GDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASR  953 (968)
T ss_pred             CCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhc
Confidence            32  345677788999999999999999999999999988754

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-38  Score=312.56  Aligned_cols=263  Identities=22%  Similarity=0.345  Sum_probs=211.1

Q ss_pred             hhcCCCCCceecccCcEEEEEEEeCCCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeecCc-eEEE
Q 012765          140 ATDNFNSENLIGKGGHAEVYKGCLPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTENG-FHLV  218 (457)
Q Consensus       140 ~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~-~~lv  218 (457)
                      +.+...+.+.||+|-||+|.++....+..||||+++.....+  ...+|.+|+++|.+|+|||||.++|+|..++ +|++
T Consensus       536 PRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~--~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI  613 (807)
T KOG1094|consen  536 PRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKN--ARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMI  613 (807)
T ss_pred             chhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchh--HHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHH
Confidence            445566789999999999999998778999999997765543  3569999999999999999999999776554 6899


Q ss_pred             EEecCCCChhhhhhcCCCC-CCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCCCC
Q 012765          219 LQFLPHGSLSSLLFGSTEC-LEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDN  297 (457)
Q Consensus       219 ~e~~~~gsL~~~l~~~~~~-~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~~  297 (457)
                      +||+++|+|..+|...... ..-.....|+.||+.|++||.+   .++|||||.+.|+|+++++++||+|||.++.+...
T Consensus       614 ~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes---~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg  690 (807)
T KOG1094|consen  614 TEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLES---LNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSG  690 (807)
T ss_pred             HHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHh---hchhhccccccceeecCcccEEecCcccccccccC
Confidence            9999999999999654332 2444556799999999999999   89999999999999999999999999999988777


Q ss_pred             CCceeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHh--CCCCCCc-CCcchhhhhccccccCCcc-cccCch
Q 012765          298 WSHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELIT--GRRAVDS-RRQSLVIWAKPLLQTSNFK-ELVDPR  373 (457)
Q Consensus       298 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLlt--G~~pf~~-~~~~~~~~~~~~~~~~~~~-~~~d~~  373 (457)
                      ......-...-...|||||.+..++++.++|+|+||+++||+++  ...||.. .++..+.-+..++..+... -+..|.
T Consensus       691 ~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~~~~l~~P~  770 (807)
T KOG1094|consen  691 DYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGRQVVLSRPP  770 (807)
T ss_pred             CceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCcceeccCCC
Confidence            66655444445788999999999999999999999999999876  7788876 3333333333334333222 222232


Q ss_pred             hhcccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q 012765          374 LADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQLLRGE  414 (457)
Q Consensus       374 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~  414 (457)
                      +       ....+.+++..||..+.++||++.++...|+..
T Consensus       771 ~-------cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~  804 (807)
T KOG1094|consen  771 A-------CPQGLYELMLRCWRRESEQRPSFEQLHLFLQED  804 (807)
T ss_pred             c-------CcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence            2       233556888999999999999999999988764

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=3.9e-37  Score=295.45  Aligned_cols=252  Identities=25%  Similarity=0.384  Sum_probs=193.9

Q ss_pred             HhhcCCCCCceecccCcEEEEEEEeC-CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeecCc-eE
Q 012765          139 AATDNFNSENLIGKGGHAEVYKGCLP-DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTENG-FH  216 (457)
Q Consensus       139 ~~~~~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~-~~  216 (457)
                      .+++++.....||+|+||.||+|.+. ++..|++|.+.....   .....+.+|+.+++.++|+||+++++++..++ .+
T Consensus         5 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~   81 (268)
T cd06624           5 YEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDS---RYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFK   81 (268)
T ss_pred             cccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCH---HHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEE
Confidence            45566666789999999999999854 578899998754432   33557889999999999999999999766544 67


Q ss_pred             EEEEecCCCChhhhhhcCCCCC--CHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcC-CCcEEEeecccccc
Q 012765          217 LVLQFLPHGSLSSLLFGSTECL--EWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSE-DYEAQISDFGLAKW  293 (457)
Q Consensus       217 lv~e~~~~gsL~~~l~~~~~~~--~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~-~~~~kL~DFGl~~~  293 (457)
                      +++||+++++|.+++......+  ++..+..++.||+.||.|||+   .+|+||||||+||+++. ++.++|+|||++..
T Consensus        82 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~  158 (268)
T cd06624          82 IFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHD---NQIVHRDIKGDNVLVNTYSGVVKISDFGTSKR  158 (268)
T ss_pred             EEEecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEcCCCCeEEEecchhhee
Confidence            9999999999999997654445  788888899999999999999   89999999999999986 67899999999876


Q ss_pred             CCCCCCceeeecccccccccChhccccCC--CCcchhHHHHHHHHHHHHhCCCCCCcCCcch-hhhhccccccCCccccc
Q 012765          294 LPDNWSHHIVFPIEGTFGYLSPEYFMHGI--VDEKTDVFAFGVLLLELITGRRAVDSRRQSL-VIWAKPLLQTSNFKELV  370 (457)
Q Consensus       294 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~ksDvwSlGvll~eLltG~~pf~~~~~~~-~~~~~~~~~~~~~~~~~  370 (457)
                      ......  ......|+..|+|||++.+..  ++.++||||||+++|+|++|+.||...+... ..+......       .
T Consensus       159 ~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~~~-------~  229 (268)
T cd06624         159 LAGINP--CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFK-------I  229 (268)
T ss_pred             cccCCC--ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhhhhc-------c
Confidence            543221  112234789999999986543  7899999999999999999999997533211 111111000       0


Q ss_pred             CchhhcccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 012765          371 DPRLADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQ  409 (457)
Q Consensus       371 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~  409 (457)
                      .+.+    .......+..++.+||+.+|.+|||+.+|++
T Consensus       230 ~~~~----~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~  264 (268)
T cd06624         230 HPEI----PESLSAEAKNFILRCFEPDPDKRASAHDLLQ  264 (268)
T ss_pred             CCCC----CcccCHHHHHHHHHHcCCCchhCCCHHHHHh
Confidence            1111    1122345677889999999999999999986

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=2.9e-37  Score=297.88  Aligned_cols=238  Identities=22%  Similarity=0.301  Sum_probs=182.2

Q ss_pred             eecccCcEEEEEEEeCC-------------------------CcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCc
Q 012765          149 LIGKGGHAEVYKGCLPD-------------------------GEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNA  203 (457)
Q Consensus       149 ~LG~G~~g~Vy~~~~~~-------------------------~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpni  203 (457)
                      .||+|+||.||+|....                         ...|++|.+....   ......+.+|+.+++.++||||
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~~~~~~~~~l~h~ni   78 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSH---RDIALAFFETASLMSQVSHIHL   78 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHH---HHHHHHHHHHHHHHhcCCCCCe
Confidence            69999999999997421                         1347888764322   2334578889999999999999


Q ss_pred             ceeeeeeecCc-eEEEEEecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCC-
Q 012765          204 AKLIGFSTENG-FHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDY-  281 (457)
Q Consensus       204 v~l~~~~~~~~-~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~-  281 (457)
                      +++++++.++. .++||||+++|+|..++......+++..++.++.||+.||.|||+   .+|+||||||+|||++.++ 
T Consensus        79 v~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~iiH~dlkp~Nill~~~~~  155 (274)
T cd05076          79 AFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLED---KNLVHGNVCAKNILLARLGL  155 (274)
T ss_pred             eeEEEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHc---CCccCCCCCcccEEEeccCc
Confidence            99999776554 679999999999999987666678999999999999999999999   8999999999999997643 


Q ss_pred             ------cEEEeeccccccCCCCCCceeeecccccccccChhcccc-CCCCcchhHHHHHHHHHHHH-hCCCCCCcCCcch
Q 012765          282 ------EAQISDFGLAKWLPDNWSHHIVFPIEGTFGYLSPEYFMH-GIVDEKTDVFAFGVLLLELI-TGRRAVDSRRQSL  353 (457)
Q Consensus       282 ------~~kL~DFGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDvwSlGvll~eLl-tG~~pf~~~~~~~  353 (457)
                            .+|++|||++.......      ...++..|+|||++.+ ..++.++|||||||++|||+ +|..||.......
T Consensus       156 ~~~~~~~~kl~d~g~~~~~~~~~------~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~  229 (274)
T cd05076         156 AEGTSPFIKLSDPGVSFTALSRE------ERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSE  229 (274)
T ss_pred             ccCccceeeecCCcccccccccc------ccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHH
Confidence                  38999999876543221      1236788999998865 56899999999999999995 7999987533221


Q ss_pred             hhhhccccccCCcccccCchhhcccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 012765          354 VIWAKPLLQTSNFKELVDPRLADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQLLR  412 (457)
Q Consensus       354 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~  412 (457)
                      .....  ...        ..+....    ...+.+++.+||+.+|++||++.+|++.|.
T Consensus       230 ~~~~~--~~~--------~~~~~~~----~~~~~~li~~cl~~~p~~Rps~~~il~~L~  274 (274)
T cd05076         230 KERFY--EKK--------HRLPEPS----CKELATLISQCLTYEPTQRPSFRTILRDLT  274 (274)
T ss_pred             HHHHH--Hhc--------cCCCCCC----ChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence            11100  000        0011111    134678899999999999999999999873

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=1.9e-37  Score=299.94  Aligned_cols=259  Identities=22%  Similarity=0.318  Sum_probs=191.2

Q ss_pred             CCCCCceecccCcEEEEEEEeC-CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeec-CceEEEEE
Q 012765          143 NFNSENLIGKGGHAEVYKGCLP-DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTE-NGFHLVLQ  220 (457)
Q Consensus       143 ~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-~~~~lv~e  220 (457)
                      +|++.+.||.|+||.||+|... +++.||+|++...... ......+.+|+.++..++||||+++++++.+ +..++|||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e   79 (285)
T cd07861           1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEE-EGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFE   79 (285)
T ss_pred             CceEeeEecccCceEEEEEEECCCCcEEEEEEecccccc-CCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEe
Confidence            4778899999999999999864 6899999987543221 1223567889999999999999999996654 55789999


Q ss_pred             ecCCCChhhhhhcC--CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCCCCC
Q 012765          221 FLPHGSLSSLLFGS--TECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNW  298 (457)
Q Consensus       221 ~~~~gsL~~~l~~~--~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~~~  298 (457)
                      |+. ++|..++...  ...+++..++.++.||+.||.|||+   .+++|+||||+||+++.++.++|+|||++.......
T Consensus        80 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~  155 (285)
T cd07861          80 FLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHS---RRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV  155 (285)
T ss_pred             cCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCCHHHEEEcCCCcEEECcccceeecCCCc
Confidence            997 6788877442  2568899999999999999999999   899999999999999999999999999987654321


Q ss_pred             CceeeecccccccccChhccccC-CCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhc------ccc-------ccC
Q 012765          299 SHHIVFPIEGTFGYLSPEYFMHG-IVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAK------PLL-------QTS  364 (457)
Q Consensus       299 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~------~~~-------~~~  364 (457)
                      .  ......++..|+|||++.+. .++.++|||||||++|+|+||+.||.........+..      +..       ...
T Consensus       156 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (285)
T cd07861         156 R--VYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLP  233 (285)
T ss_pred             c--cccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhH
Confidence            1  11223468899999988654 5789999999999999999999999864432211110      000       000


Q ss_pred             Ccc----cccCchhhcccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 012765          365 NFK----ELVDPRLADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQ  409 (457)
Q Consensus       365 ~~~----~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~  409 (457)
                      ...    .+....+... .......+.+++.+||+.||.+|||+.+|++
T Consensus       234 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~  281 (285)
T cd07861         234 DYKNTFPKWKKGSLRSA-VKNLDEDGLDLLEKMLIYDPAKRISAKKALN  281 (285)
T ss_pred             HHHhhccccCcchhHHh-cCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence            000    0000000000 0012345668999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=8.4e-38  Score=298.59  Aligned_cols=239  Identities=17%  Similarity=0.301  Sum_probs=183.8

Q ss_pred             ceecccCcEEEEEEEeCC--------CcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeec-CceEEE
Q 012765          148 NLIGKGGHAEVYKGCLPD--------GEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTE-NGFHLV  218 (457)
Q Consensus       148 ~~LG~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-~~~~lv  218 (457)
                      +.||+|+||.||+|....        ...+++|.+....   ......+.+|+.+++.++|||++++++++.. ...++|
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv   77 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSH---RNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMV   77 (258)
T ss_pred             CCCCcccchhheeeeecccccccccccchhhHHhhcchh---HHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEE
Confidence            369999999999997532        2347777764322   2334578889999999999999999996554 667899


Q ss_pred             EEecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCc--------EEEeeccc
Q 012765          219 LQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYE--------AQISDFGL  290 (457)
Q Consensus       219 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~--------~kL~DFGl  290 (457)
                      |||+.+|+|..++......+++..++.++.||+.||.|||+   .+|+||||||+||+++.++.        ++++|||+
T Consensus        78 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~  154 (258)
T cd05078          78 QEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLED---KGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGI  154 (258)
T ss_pred             EecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCccceEEEecccccccCCCceEEeccccc
Confidence            99999999999997766678999999999999999999999   89999999999999987765        69999998


Q ss_pred             cccCCCCCCceeeecccccccccChhcccc-CCCCcchhHHHHHHHHHHHHhCC-CCCCcCCcchhhhhccccccCCccc
Q 012765          291 AKWLPDNWSHHIVFPIEGTFGYLSPEYFMH-GIVDEKTDVFAFGVLLLELITGR-RAVDSRRQSLVIWAKPLLQTSNFKE  368 (457)
Q Consensus       291 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDvwSlGvll~eLltG~-~pf~~~~~~~~~~~~~~~~~~~~~~  368 (457)
                      +......      ....++..|+|||++.+ ..++.++||||||+++|||++|. .||...+........  ...     
T Consensus       155 ~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~~~--~~~-----  221 (258)
T cd05078         155 SITVLPK------EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQFY--EDR-----  221 (258)
T ss_pred             ccccCCc------hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHHHH--Hcc-----
Confidence            8655332      12347889999999976 45799999999999999999995 555543222111000  000     


Q ss_pred             ccCchhhcccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 012765          369 LVDPRLADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQLLR  412 (457)
Q Consensus       369 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~  412 (457)
                         ..+...    ....+.+++.+||+.+|++|||+.+|++.|+
T Consensus       222 ---~~~~~~----~~~~~~~li~~~l~~~p~~Rps~~~il~~l~  258 (258)
T cd05078         222 ---HQLPAP----KWTELANLINQCMDYEPDFRPSFRAIIRDLN  258 (258)
T ss_pred             ---ccCCCC----CcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence               011111    1235678899999999999999999999874

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=1.6e-37  Score=300.51  Aligned_cols=260  Identities=19%  Similarity=0.264  Sum_probs=191.2

Q ss_pred             CCCCCceecccCcEEEEEEEeC-CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeee-cCceEEEEE
Q 012765          143 NFNSENLIGKGGHAEVYKGCLP-DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFST-ENGFHLVLQ  220 (457)
Q Consensus       143 ~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~-~~~~~lv~e  220 (457)
                      +|++.+.||+|+||.||+|... +|+.+|+|++...... ......+.+|+.+++.++||||+++++++. ....++++|
T Consensus         1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~-~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   79 (284)
T cd07839           1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDD-EGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFE   79 (284)
T ss_pred             CceeEEEecccCCeEEEEEEECCCCcEEEEEEeeccccc-ccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEe
Confidence            4778899999999999999865 6899999988643221 122346778999999999999999999554 455789999


Q ss_pred             ecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCCCCCCc
Q 012765          221 FLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSH  300 (457)
Q Consensus       221 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~~~~~  300 (457)
                      |+. ++|..++......+++..++.++.||+.||.|||+   .+++||||||+||+++.++.++|+|||++........ 
T Consensus        80 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~---~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~-  154 (284)
T cd07839          80 YCD-QDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHS---HNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVR-  154 (284)
T ss_pred             cCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEEcCCCcEEECccchhhccCCCCC-
Confidence            997 57887776555678999999999999999999999   8999999999999999999999999999986543321 


Q ss_pred             eeeecccccccccChhccccC-CCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhcc--cc------------ccCC
Q 012765          301 HIVFPIEGTFGYLSPEYFMHG-IVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKP--LL------------QTSN  365 (457)
Q Consensus       301 ~~~~~~~gt~~y~aPE~~~~~-~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~~--~~------------~~~~  365 (457)
                       ......++..|+|||++.+. .++.++|||||||++|+|+||..||.........+...  ..            ....
T Consensus       155 -~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (284)
T cd07839         155 -CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPD  233 (284)
T ss_pred             -CcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhccc
Confidence             11223478899999998764 47999999999999999999999865422211111000  00            0000


Q ss_pred             ccc--ccCchhh-cccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 012765          366 FKE--LVDPRLA-DAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQ  409 (457)
Q Consensus       366 ~~~--~~d~~l~-~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~  409 (457)
                      ...  ....... ..........+.+++.+||+.||.+|||+.++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~  280 (284)
T cd07839         234 YKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ  280 (284)
T ss_pred             ccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence            000  0000000 0001122345678899999999999999999975

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=5.9e-39  Score=326.00  Aligned_cols=256  Identities=25%  Similarity=0.384  Sum_probs=210.3

Q ss_pred             cCCCCCceecccCcEEEEEEEeCC----CcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeecCce-E
Q 012765          142 DNFNSENLIGKGGHAEVYKGCLPD----GEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTENGF-H  216 (457)
Q Consensus       142 ~~f~~~~~LG~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~-~  216 (457)
                      ....++++||.|.||+|++|.++.    ...||||.++.....  ....+|+.|+.||.+++||||++|.|+.+.... .
T Consensus       629 s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~Gyte--kqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvM  706 (996)
T KOG0196|consen  629 SCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTE--KQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVM  706 (996)
T ss_pred             hheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccH--HHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeE
Confidence            345677999999999999998752    457999998655443  456799999999999999999999998887776 5


Q ss_pred             EEEEecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCCC
Q 012765          217 LVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPD  296 (457)
Q Consensus       217 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~  296 (457)
                      +|.|||++|+|..+|+.+...+.+-+...++.+||.|+.||-+   .++|||||.+.|||++.+...|++|||+++.+.+
T Consensus       707 IiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsd---m~YVHRDLAARNILVNsnLvCKVsDFGLSRvled  783 (996)
T KOG0196|consen  707 IITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSD---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLED  783 (996)
T ss_pred             EEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhh---cCchhhhhhhhheeeccceEEEeccccceeeccc
Confidence            7779999999999999988889999999999999999999999   8999999999999999999999999999998866


Q ss_pred             CCCceeeecccc--cccccChhccccCCCCcchhHHHHHHHHHHHHh-CCCCCCcCCcchhhhhccccccCCcccccCch
Q 012765          297 NWSHHIVFPIEG--TFGYLSPEYFMHGIVDEKTDVFAFGVLLLELIT-GRRAVDSRRQSLVIWAKPLLQTSNFKELVDPR  373 (457)
Q Consensus       297 ~~~~~~~~~~~g--t~~y~aPE~~~~~~~~~ksDvwSlGvll~eLlt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~  373 (457)
                      +. ....+...|  ..+|.|||.+...+++.++|||||||+|||.++ |..||.....+.++-+            +...
T Consensus       784 d~-~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIka------------Ie~g  850 (996)
T KOG0196|consen  784 DP-EAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKA------------IEQG  850 (996)
T ss_pred             CC-CccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHHHHH------------HHhc
Confidence            54 222222223  468999999999999999999999999999998 9999876433322211            1122


Q ss_pred             hhcccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCC
Q 012765          374 LADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQLLRGEG  415 (457)
Q Consensus       374 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~  415 (457)
                      .+-...++....|-+|+..||++|-.+||++.||+..|.++-
T Consensus       851 yRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklI  892 (996)
T KOG0196|consen  851 YRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLI  892 (996)
T ss_pred             cCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHh
Confidence            222223455667788999999999999999999999998754

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=1.7e-37  Score=300.52  Aligned_cols=260  Identities=23%  Similarity=0.338  Sum_probs=194.3

Q ss_pred             cCCCCCceecccCcEEEEEEEeC-CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeec-CceEEEE
Q 012765          142 DNFNSENLIGKGGHAEVYKGCLP-DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTE-NGFHLVL  219 (457)
Q Consensus       142 ~~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-~~~~lv~  219 (457)
                      ++|++.+.||+|+||.||+|.+. +++.||+|++....... .....+.+|+.+++.++||||+++++++.. +..++++
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   79 (286)
T cd07846           1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDK-MVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVF   79 (286)
T ss_pred             CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcc-hhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEE
Confidence            46888999999999999999875 58999999876543322 334578899999999999999999996655 4468999


Q ss_pred             EecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCCCCCC
Q 012765          220 QFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWS  299 (457)
Q Consensus       220 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~~~~  299 (457)
                      ||+.+++|..+... ...+++..++.++.||+.||.|||+   .+++|+||+|+||++++++.++|+|||++..+.....
T Consensus        80 e~~~~~~l~~~~~~-~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~  155 (286)
T cd07846          80 EFVDHTVLDDLEKY-PNGLDESRVRKYLFQILRGIEFCHS---HNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE  155 (286)
T ss_pred             ecCCccHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCcc
Confidence            99999888876643 3348999999999999999999999   8999999999999999999999999999887644321


Q ss_pred             ceeeecccccccccChhcccc-CCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhc------cccc-------cCC
Q 012765          300 HHIVFPIEGTFGYLSPEYFMH-GIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAK------PLLQ-------TSN  365 (457)
Q Consensus       300 ~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~------~~~~-------~~~  365 (457)
                        ......++..|+|||++.+ ..++.++||||||+++|||++|+.||....... .+..      ....       ...
T Consensus       156 --~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~  232 (286)
T cd07846         156 --VYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDID-QLYHIIKCLGNLIPRHQEIFQKNP  232 (286)
T ss_pred             --ccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHH-HHHHHHHHhCCCchhhHHHhccch
Confidence              1223447889999999875 457889999999999999999999997533211 0000      0000       000


Q ss_pred             -cccccCchhhcc-----cCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 012765          366 -FKELVDPRLADA-----YDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQ  409 (457)
Q Consensus       366 -~~~~~d~~l~~~-----~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~  409 (457)
                       ......+.....     ........+.+++.+||+.+|++||++.+|++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~  282 (286)
T cd07846         233 LFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH  282 (286)
T ss_pred             HhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence             000000000000     00122355788999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=4.6e-37  Score=297.27  Aligned_cols=261  Identities=24%  Similarity=0.342  Sum_probs=194.6

Q ss_pred             cCCCCCceecccCcEEEEEEEeC-CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeec-CceEEEE
Q 012765          142 DNFNSENLIGKGGHAEVYKGCLP-DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTE-NGFHLVL  219 (457)
Q Consensus       142 ~~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-~~~~lv~  219 (457)
                      ++|+....||+|+||.||+|.+. +++.||+|++...... ......+.+|+.+++.++|||++++++++.. ...+++|
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~   79 (286)
T cd07847           1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDD-PVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVF   79 (286)
T ss_pred             CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccC-ccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEE
Confidence            46888899999999999999875 5899999987643221 1223467899999999999999999996554 4578999


Q ss_pred             EecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCCCCCC
Q 012765          220 QFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWS  299 (457)
Q Consensus       220 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~~~~  299 (457)
                      ||++++.|..++.. ...+++..++.++.||+.||.|||+   .+++|+||||+||+++.++.++|+|||++..+.....
T Consensus        80 e~~~~~~l~~~~~~-~~~~~~~~~~~~~~ql~~~l~~LH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~  155 (286)
T cd07847          80 EYCDHTVLNELEKN-PRGVPEHLIKKIIWQTLQAVNFCHK---HNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGD  155 (286)
T ss_pred             eccCccHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCChhhEEEcCCCcEEECccccceecCCCcc
Confidence            99999888777643 3458999999999999999999999   8999999999999999999999999999987654321


Q ss_pred             ceeeecccccccccChhcccc-CCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhc-----cc-------cccCCc
Q 012765          300 HHIVFPIEGTFGYLSPEYFMH-GIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAK-----PL-------LQTSNF  366 (457)
Q Consensus       300 ~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~-----~~-------~~~~~~  366 (457)
                        ......++..|+|||++.+ ..++.++||||||+++|+|++|+.||.........+..     ..       ......
T Consensus       156 --~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (286)
T cd07847         156 --DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQF  233 (286)
T ss_pred             --cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccccc
Confidence              1122347889999999876 45789999999999999999999999764332111110     00       000000


Q ss_pred             -ccccCchhhcccC-----HHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 012765          367 -KELVDPRLADAYD-----LAEMKRAMLTASVCIHHLSTMRPQMTRVLQ  409 (457)
Q Consensus       367 -~~~~d~~l~~~~~-----~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~  409 (457)
                       ..+..+.......     ......+.+++.+||+.+|++||++.|++.
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~  282 (286)
T cd07847         234 FKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE  282 (286)
T ss_pred             cccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence             0000011000000     112345778999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=5.8e-37  Score=298.01  Aligned_cols=246  Identities=26%  Similarity=0.346  Sum_probs=196.8

Q ss_pred             cCCCCCceecccCcEEEEEEEeC-CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeec-CceEEEE
Q 012765          142 DNFNSENLIGKGGHAEVYKGCLP-DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTE-NGFHLVL  219 (457)
Q Consensus       142 ~~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-~~~~lv~  219 (457)
                      ++|++.+.||+|+||.||++.+. +++.+|+|.+.............+.+|++++++++||||+++++++.+ +..+++|
T Consensus         1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   80 (290)
T cd05580           1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM   80 (290)
T ss_pred             CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence            46888999999999999999865 589999998865443334456788999999999999999999996555 4578999


Q ss_pred             EecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCCCCCC
Q 012765          220 QFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWS  299 (457)
Q Consensus       220 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~~~~  299 (457)
                      ||+++++|.+++... ..++...+..++.||+.||.|||+   .+++|+||+|.||+++.++.+||+|||++......  
T Consensus        81 e~~~~~~L~~~~~~~-~~l~~~~~~~~~~qil~~l~~lH~---~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~--  154 (290)
T cd05580          81 EYVPGGELFSHLRKS-GRFPEPVARFYAAQVVLALEYLHS---LDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR--  154 (290)
T ss_pred             ecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC--
Confidence            999999999998554 468889999999999999999999   89999999999999999999999999999876554  


Q ss_pred             ceeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhccccccCCcccccCchhhcccC
Q 012765          300 HHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSNFKELVDPRLADAYD  379 (457)
Q Consensus       300 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~  379 (457)
                         .....+++.|+|||.+.+..++.++||||||+++|+|++|+.||...... ..+.......        ..+...+ 
T Consensus       155 ---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-~~~~~~~~~~--------~~~~~~~-  221 (290)
T cd05580         155 ---TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPI-QIYEKILEGK--------VRFPSFF-  221 (290)
T ss_pred             ---CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHhcCC--------ccCCccC-
Confidence               12345889999999998888999999999999999999999999764421 1111110000        1111111 


Q ss_pred             HHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 012765          380 LAEMKRAMLTASVCIHHLSTMRP-----QMTRVLQ  409 (457)
Q Consensus       380 ~~~~~~l~~l~~~Cl~~dP~~RP-----t~~evl~  409 (457)
                         ...+.+++.+||..+|.+||     ++.++++
T Consensus       222 ---~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~  253 (290)
T cd05580         222 ---SPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKN  253 (290)
T ss_pred             ---CHHHHHHHHHHccCCHHHccCcccCCHHHHHc
Confidence               34566788999999999999     6666653

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=7.8e-37  Score=299.64  Aligned_cols=249  Identities=27%  Similarity=0.400  Sum_probs=195.5

Q ss_pred             hcCCCCCceecccCcEEEEEEEeC-CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeec-CceEEE
Q 012765          141 TDNFNSENLIGKGGHAEVYKGCLP-DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTE-NGFHLV  218 (457)
Q Consensus       141 ~~~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-~~~~lv  218 (457)
                      .+.|...+.||+|+||+||+|... +++.||+|.+.............+.+|+.+++.++|||++++++++.+ +..++|
T Consensus        14 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv   93 (307)
T cd06607          14 EKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLV   93 (307)
T ss_pred             chhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEE
Confidence            356888899999999999999864 689999998865444444556688999999999999999999997655 456799


Q ss_pred             EEecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCCCCC
Q 012765          219 LQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNW  298 (457)
Q Consensus       219 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~~~  298 (457)
                      +||+. |++.+++......+++..+..++.|++.||.|||+   .+++|+||+|+||+++.++.++|+|||++.......
T Consensus        94 ~e~~~-g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~---~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~~  169 (307)
T cd06607          94 MEYCL-GSASDILEVHKKPLQEVEIAAICHGALQGLAYLHS---HERIHRDIKAGNILLTEPGTVKLADFGSASLVSPAN  169 (307)
T ss_pred             HHhhC-CCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCcccEEECCCCCEEEeecCcceecCCCC
Confidence            99986 56777665555668999999999999999999999   899999999999999999999999999987654321


Q ss_pred             CceeeecccccccccChhccc---cCCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhccccccCCcccccCchhh
Q 012765          299 SHHIVFPIEGTFGYLSPEYFM---HGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSNFKELVDPRLA  375 (457)
Q Consensus       299 ~~~~~~~~~gt~~y~aPE~~~---~~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  375 (457)
                            ...++..|+|||++.   ...++.++||||||+++|||++|+.||...+.....+....   ..     .+.+.
T Consensus       170 ------~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~---~~-----~~~~~  235 (307)
T cd06607         170 ------SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ---ND-----SPTLS  235 (307)
T ss_pred             ------CccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhc---CC-----CCCCC
Confidence                  234788999999874   45688999999999999999999999976443222111100   00     01110


Q ss_pred             cccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 012765          376 DAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQL  410 (457)
Q Consensus       376 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~  410 (457)
                         .......+..++.+||+.+|++||++.+|+..
T Consensus       236 ---~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  267 (307)
T cd06607         236 ---SNDWSDYFRNFVDSCLQKIPQDRPSSEELLKH  267 (307)
T ss_pred             ---chhhCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence               11233457788899999999999999999873

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=3.7e-37  Score=293.28  Aligned_cols=251  Identities=23%  Similarity=0.330  Sum_probs=198.1

Q ss_pred             CCCCCceecccCcEEEEEEEe-CCCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeecC-ceEEEEE
Q 012765          143 NFNSENLIGKGGHAEVYKGCL-PDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTEN-GFHLVLQ  220 (457)
Q Consensus       143 ~f~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~-~~~lv~e  220 (457)
                      +|+..+.||.|+||.||.+.. .+++.+++|.+...... ......+.+|+.++++++|+||+++++++.+. ..+++||
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e   79 (256)
T cd08221           1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLS-EKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEME   79 (256)
T ss_pred             CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccc-hhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEE
Confidence            478889999999999999875 46889999987543322 23456788999999999999999999966554 4678999


Q ss_pred             ecCCCChhhhhhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCCCCCC
Q 012765          221 FLPHGSLSSLLFGS-TECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWS  299 (457)
Q Consensus       221 ~~~~gsL~~~l~~~-~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~~~~  299 (457)
                      |+++++|.+++... ...+++..+..++.|++.||.|||+   .+++|+||+|+||+++.++.+||+|||++........
T Consensus        80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~  156 (256)
T cd08221          80 YANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHK---AGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS  156 (256)
T ss_pred             ecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHh---CCccccCCChHhEEEeCCCCEEECcCcceEEcccccc
Confidence            99999999998654 4568899999999999999999999   8999999999999999999999999999987644331


Q ss_pred             ceeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhccccccCCcccccCchhhcccC
Q 012765          300 HHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSNFKELVDPRLADAYD  379 (457)
Q Consensus       300 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~  379 (457)
                        ......++..|+|||++.+..++.++||||||+++|||++|..||............  . ......         ..
T Consensus       157 --~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~--~-~~~~~~---------~~  222 (256)
T cd08221         157 --MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKI--V-QGNYTP---------VV  222 (256)
T ss_pred             --cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHH--H-cCCCCC---------Cc
Confidence              122345899999999998888999999999999999999999999764322111110  0 010000         01


Q ss_pred             HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 012765          380 LAEMKRAMLTASVCIHHLSTMRPQMTRVLQLL  411 (457)
Q Consensus       380 ~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L  411 (457)
                      ......+..++.+||+.+|.+||++.++++.+
T Consensus       223 ~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~  254 (256)
T cd08221         223 SVYSSELISLVHSLLQQDPEKRPTADEVLDQP  254 (256)
T ss_pred             cccCHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence            12234567788899999999999999998753

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=6e-37  Score=297.42  Aligned_cols=253  Identities=26%  Similarity=0.348  Sum_probs=196.8

Q ss_pred             cCCCCCceecccCcEEEEEEEeC-CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeec---CceEE
Q 012765          142 DNFNSENLIGKGGHAEVYKGCLP-DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTE---NGFHL  217 (457)
Q Consensus       142 ~~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~---~~~~l  217 (457)
                      ++|...+.||.|++|.||++.+. +++.+|+|.+......  .....+.+|+++++.++||||+++++++..   +.+++
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~l   78 (287)
T cd06621           1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNP--DLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGI   78 (287)
T ss_pred             CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCch--HHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEE
Confidence            46778899999999999999874 5889999988644322  345678999999999999999999997643   24789


Q ss_pred             EEEecCCCChhhhhhc---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccC
Q 012765          218 VLQFLPHGSLSSLLFG---STECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWL  294 (457)
Q Consensus       218 v~e~~~~gsL~~~l~~---~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~  294 (457)
                      +|||+++++|.+++..   ....++......++.||+.||.|||+   .+++|+||+|+||+++.++.++|+|||++...
T Consensus        79 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~---~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~  155 (287)
T cd06621          79 AMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHS---RKIIHRDIKPSNILLTRKGQVKLCDFGVSGEL  155 (287)
T ss_pred             EEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEecCCeEEEeeccccccc
Confidence            9999999999887642   34557888999999999999999999   89999999999999999999999999998765


Q ss_pred             CCCCCceeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHhCCCCCCcCCc---chhhhhccccccCCcccccC
Q 012765          295 PDNWSHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQ---SLVIWAKPLLQTSNFKELVD  371 (457)
Q Consensus       295 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLltG~~pf~~~~~---~~~~~~~~~~~~~~~~~~~d  371 (457)
                      .....    ....++..|+|||.+.+..++.++|||||||++|+|++|+.||.....   ........ ......     
T Consensus       156 ~~~~~----~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~-----  225 (287)
T cd06621         156 VNSLA----GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSY-IVNMPN-----  225 (287)
T ss_pred             ccccc----ccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHH-HhcCCc-----
Confidence            43322    123478899999999988999999999999999999999999986422   00110000 000000     


Q ss_pred             chhhccc--CHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 012765          372 PRLADAY--DLAEMKRAMLTASVCIHHLSTMRPQMTRVLQ  409 (457)
Q Consensus       372 ~~l~~~~--~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~  409 (457)
                      +.+....  .......+.+++.+||..+|++|||+.||++
T Consensus       226 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~  265 (287)
T cd06621         226 PELKDEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE  265 (287)
T ss_pred             hhhccCCCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence            1111110  1123456788999999999999999999988

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=9.9e-37  Score=292.11  Aligned_cols=252  Identities=22%  Similarity=0.336  Sum_probs=194.3

Q ss_pred             cCCCCCceecccCcEEEEEEEeC-CCcEEEEEEEeccch--hhHHHHHHHHHHHHHHhhcCCCCcceeeeeeecC---ce
Q 012765          142 DNFNSENLIGKGGHAEVYKGCLP-DGEVVAVKKIIKNAK--EDEERISDFLSELGIVAHINHPNAAKLIGFSTEN---GF  215 (457)
Q Consensus       142 ~~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~---~~  215 (457)
                      .+|++.+.||+|+||.||+|... ++..||+|.+.....  ........+.+|+.++.+++||||+++++++.+.   .+
T Consensus         2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (265)
T cd06652           2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL   81 (265)
T ss_pred             CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence            57888999999999999999864 589999998753321  2223456888999999999999999999976543   36


Q ss_pred             EEEEEecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCC
Q 012765          216 HLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLP  295 (457)
Q Consensus       216 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~  295 (457)
                      +++|||+++++|.+++... ..+++.....++.|++.||.|||+   .+++|+||||+||+++.++.++|+|||++..+.
T Consensus        82 ~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~  157 (265)
T cd06652          82 SIFMEHMPGGSIKDQLKSY-GALTENVTRKYTRQILEGVSYLHS---NMIVHRDIKGANILRDSVGNVKLGDFGASKRLQ  157 (265)
T ss_pred             EEEEEecCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEecCCCCEEECcCccccccc
Confidence            7899999999999988543 347888889999999999999999   899999999999999999999999999987654


Q ss_pred             CCCCc-eeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhccccccCCcccccCchh
Q 012765          296 DNWSH-HIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSNFKELVDPRL  374 (457)
Q Consensus       296 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l  374 (457)
                      ..... .......|+..|+|||++.+..++.++|||||||++|||++|+.||............  ....     ..+  
T Consensus       158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~--~~~~-----~~~--  228 (265)
T cd06652         158 TICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKI--ATQP-----TNP--  228 (265)
T ss_pred             cccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHH--hcCC-----CCC--
Confidence            32111 1122345889999999998888999999999999999999999999753322111100  0000     011  


Q ss_pred             hcccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 012765          375 ADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQ  409 (457)
Q Consensus       375 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~  409 (457)
                        .........+..++.+|+. +|++||++.+|++
T Consensus       229 --~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~  260 (265)
T cd06652         229 --VLPPHVSDHCRDFLKRIFV-EAKLRPSADELLR  260 (265)
T ss_pred             --CCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhc
Confidence              1122333456677788884 9999999999986

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4e-37  Score=302.73  Aligned_cols=254  Identities=24%  Similarity=0.301  Sum_probs=198.6

Q ss_pred             cCCCCCceecccCcEEEEEEEeC-CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeecC-ceEEEE
Q 012765          142 DNFNSENLIGKGGHAEVYKGCLP-DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTEN-GFHLVL  219 (457)
Q Consensus       142 ~~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~-~~~lv~  219 (457)
                      ++|...+.||+|+||.||+|... +++.||+|.+.............+..|++++..++||||+++++++..+ ..+++|
T Consensus         1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   80 (316)
T cd05574           1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM   80 (316)
T ss_pred             CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence            46888899999999999999865 4899999998765444334567889999999999999999999966554 468999


Q ss_pred             EecCCCChhhhhhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCCCCC
Q 012765          220 QFLPHGSLSSLLFGS-TECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNW  298 (457)
Q Consensus       220 e~~~~gsL~~~l~~~-~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~~~  298 (457)
                      ||+.+++|.+++... ...+++.....++.|++.||.|||+   .+++|+||||+||+++.++.++|+|||++.......
T Consensus        81 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~  157 (316)
T cd05574          81 DYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHL---LGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEP  157 (316)
T ss_pred             EecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHH---CCeeccCCChHHeEEcCCCCEEEeecchhhcccccc
Confidence            999999999998643 3568999999999999999999999   899999999999999999999999999987653221


Q ss_pred             Cce---------------------------eeecccccccccChhccccCCCCcchhHHHHHHHHHHHHhCCCCCCcCCc
Q 012765          299 SHH---------------------------IVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQ  351 (457)
Q Consensus       299 ~~~---------------------------~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLltG~~pf~~~~~  351 (457)
                      ...                           ......||..|+|||++.+..++.++||||||+++|+|++|+.||...+.
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~  237 (316)
T cd05574         158 PPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNR  237 (316)
T ss_pred             cccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCch
Confidence            100                           01123578899999999988899999999999999999999999975433


Q ss_pred             chhhhhccccccCCcccccCchhhcccCHHHHHHHHHHHHHhcccCCCCCCC----HHHHHH
Q 012765          352 SLVIWAKPLLQTSNFKELVDPRLADAYDLAEMKRAMLTASVCIHHLSTMRPQ----MTRVLQ  409 (457)
Q Consensus       352 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt----~~evl~  409 (457)
                      .... ..          +.+..............+.+++.+||+.+|++||+    +.+++.
T Consensus       238 ~~~~-~~----------~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~  288 (316)
T cd05574         238 DETF-SN----------ILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ  288 (316)
T ss_pred             HHHH-HH----------HhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence            2111 10          11111100001113456788999999999999999    666655

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=4.2e-37  Score=297.87  Aligned_cols=259  Identities=25%  Similarity=0.334  Sum_probs=197.3

Q ss_pred             cHHHHHHhhcCCCCCceecccCcEEEEEEEeC-CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhc-CCCCcceeeeee
Q 012765          133 DFAELAAATDNFNSENLIGKGGHAEVYKGCLP-DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHI-NHPNAAKLIGFS  210 (457)
Q Consensus       133 ~~~~~~~~~~~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~  210 (457)
                      .++.+..+.++|++.+.||+|+||.||+|... +++.+|+|.+.....    ....+.+|+.++..+ +||||+++++++
T Consensus         9 ~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~----~~~~~~~e~~~l~~l~~h~~i~~~~~~~   84 (286)
T cd06638           9 IFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHD----IDEEIEAEYNILKALSDHPNVVKFYGMY   84 (286)
T ss_pred             EeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccc----hHHHHHHHHHHHHHHhcCCCeeeeeeee
Confidence            34455567899999999999999999999864 578999997653221    124677899999998 699999999965


Q ss_pred             e------cCceEEEEEecCCCChhhhhhc---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCC
Q 012765          211 T------ENGFHLVLQFLPHGSLSSLLFG---STECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDY  281 (457)
Q Consensus       211 ~------~~~~~lv~e~~~~gsL~~~l~~---~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~  281 (457)
                      .      ++..+++|||+++++|.+++..   ....+++..+..++.|++.||.|||+   .+++||||||+||+++.++
T Consensus        85 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nili~~~~  161 (286)
T cd06638          85 YKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHV---NKTIHRDVKGNNILLTTEG  161 (286)
T ss_pred             eecccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHh---CCccccCCCHHhEEECCCC
Confidence            3      2346899999999999988743   33467888899999999999999999   8999999999999999999


Q ss_pred             cEEEeeccccccCCCCCCceeeecccccccccChhcccc-----CCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhh
Q 012765          282 EAQISDFGLAKWLPDNWSHHIVFPIEGTFGYLSPEYFMH-----GIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIW  356 (457)
Q Consensus       282 ~~kL~DFGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~  356 (457)
                      .++|+|||++..+.....  ......|+..|+|||++..     ..++.++|||||||++|||++|+.||..........
T Consensus       162 ~~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~  239 (286)
T cd06638         162 GVKLVDFGVSAQLTSTRL--RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALF  239 (286)
T ss_pred             CEEEccCCceeecccCCC--ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHh
Confidence            999999999887643221  1123458999999998753     457899999999999999999999997643211111


Q ss_pred             hccccccCCcccccCchhhcccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 012765          357 AKPLLQTSNFKELVDPRLADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQL  410 (457)
Q Consensus       357 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~  410 (457)
                      ..   .......+.++.   .    ....+..++.+||+.+|++||++.+|++.
T Consensus       240 ~~---~~~~~~~~~~~~---~----~~~~~~~li~~~l~~~p~~Rps~~ell~~  283 (286)
T cd06638         240 KI---PRNPPPTLHQPE---L----WSNEFNDFIRKCLTKDYEKRPTVSDLLQH  283 (286)
T ss_pred             hc---cccCCCcccCCC---C----cCHHHHHHHHHHccCCcccCCCHHHHhhc
Confidence            00   000001111111   1    12346778899999999999999999874

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=4.9e-37  Score=299.79  Aligned_cols=249  Identities=20%  Similarity=0.339  Sum_probs=195.9

Q ss_pred             hcCCCCCceecccCcEEEEEEEe-CCCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeec-CceEEE
Q 012765          141 TDNFNSENLIGKGGHAEVYKGCL-PDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTE-NGFHLV  218 (457)
Q Consensus       141 ~~~f~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-~~~~lv  218 (457)
                      ..+|++.+.||.|+||.||+|.. .+++.||+|.+......   ....+.+|+.+++.++||||+++++++.. +..++|
T Consensus        18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   94 (297)
T cd06656          18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQP---KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVV   94 (297)
T ss_pred             hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccc---hHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEe
Confidence            47788999999999999999985 47999999988654332   23568899999999999999999996654 457899


Q ss_pred             EEecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCCCCC
Q 012765          219 LQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNW  298 (457)
Q Consensus       219 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~~~  298 (457)
                      |||+++++|.+++..  ..+++..+..++.|++.||.|||+   .+++||||||+|||++.++.++|+|||++.......
T Consensus        95 ~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~l~~~L~~LH~---~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~  169 (297)
T cd06656          95 MEYLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALDFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ  169 (297)
T ss_pred             ecccCCCCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEECcCccceEccCCc
Confidence            999999999998843  457888999999999999999999   899999999999999999999999999987654332


Q ss_pred             CceeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhccccccCCcccccCchhhccc
Q 012765          299 SHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSNFKELVDPRLADAY  378 (457)
Q Consensus       299 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~  378 (457)
                      ..  .....+++.|+|||.+.+..++.++|+|||||++|+|++|..||...+........  .. .....+..       
T Consensus       170 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~--~~-~~~~~~~~-------  237 (297)
T cd06656         170 SK--RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI--AT-NGTPELQN-------  237 (297)
T ss_pred             cC--cCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeee--cc-CCCCCCCC-------
Confidence            11  12235888999999999888999999999999999999999999754321111000  00 00000001       


Q ss_pred             CHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 012765          379 DLAEMKRAMLTASVCIHHLSTMRPQMTRVLQ  409 (457)
Q Consensus       379 ~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~  409 (457)
                      .......+.+++.+||+.+|++||++.+|++
T Consensus       238 ~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  268 (297)
T cd06656         238 PERLSAVFRDFLNRCLEMDVDRRGSAKELLQ  268 (297)
T ss_pred             ccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            1112234567888999999999999999988

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=4.7e-37  Score=298.59  Aligned_cols=258  Identities=28%  Similarity=0.393  Sum_probs=198.0

Q ss_pred             cHHHHHHhhcCCCCCceecccCcEEEEEEEeC-CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhc-CCCCcceeeeee
Q 012765          133 DFAELAAATDNFNSENLIGKGGHAEVYKGCLP-DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHI-NHPNAAKLIGFS  210 (457)
Q Consensus       133 ~~~~~~~~~~~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~  210 (457)
                      ....+..+.++|.+.+.||+|+||.||++... +++.+|+|.+.....    ....+.+|+.++.++ +|||++++++++
T Consensus        13 ~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~----~~~~~~~e~~~l~~l~~h~ni~~~~~~~   88 (291)
T cd06639          13 GLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISD----VDEEIEAEYNILQSLPNHPNVVKFYGMF   88 (291)
T ss_pred             hcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEeccccc----HHHHHHHHHHHHHHhcCCCCeEEEEEEE
Confidence            34455567889999999999999999999864 688999998754321    134667889999888 899999999976


Q ss_pred             ec------CceEEEEEecCCCChhhhhhc---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCC
Q 012765          211 TE------NGFHLVLQFLPHGSLSSLLFG---STECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDY  281 (457)
Q Consensus       211 ~~------~~~~lv~e~~~~gsL~~~l~~---~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~  281 (457)
                      ..      +..+++|||+++++|.+++..   ....+++..++.++.|++.||.|||+   .+++|+||||+||+++.++
T Consensus        89 ~~~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dlkp~nili~~~~  165 (291)
T cd06639          89 YKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHN---NRIIHRDVKGNNILLTTEG  165 (291)
T ss_pred             EeccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEEcCCC
Confidence            53      236899999999999998753   34568899999999999999999999   8999999999999999999


Q ss_pred             cEEEeeccccccCCCCCCceeeecccccccccChhccccC-----CCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhh
Q 012765          282 EAQISDFGLAKWLPDNWSHHIVFPIEGTFGYLSPEYFMHG-----IVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIW  356 (457)
Q Consensus       282 ~~kL~DFGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~  356 (457)
                      .+||+|||++..+......  .....|+..|+|||++...     .++.++|||||||++|||++|+.||..........
T Consensus       166 ~~kl~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~  243 (291)
T cd06639         166 GVKLVDFGVSAQLTSTRLR--RNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLF  243 (291)
T ss_pred             CEEEeecccchhccccccc--ccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHH
Confidence            9999999998866432211  1223578899999987543     36899999999999999999999997643321111


Q ss_pred             hccccccCCcccccCchhhcccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 012765          357 AKPLLQTSNFKELVDPRLADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQ  409 (457)
Q Consensus       357 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~  409 (457)
                      ...   ......+.++       ......+.+++.+||+.+|++||++.++++
T Consensus       244 ~~~---~~~~~~~~~~-------~~~~~~l~~li~~~l~~~p~~Rps~~~il~  286 (291)
T cd06639         244 KIP---RNPPPTLLHP-------EKWCRSFNHFISQCLIKDFEARPSVTHLLE  286 (291)
T ss_pred             HHh---cCCCCCCCcc-------cccCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence            100   0101111111       112345778899999999999999999986

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=1.3e-36  Score=289.34  Aligned_cols=249  Identities=24%  Similarity=0.429  Sum_probs=196.2

Q ss_pred             CCCCCceecccCcEEEEEEEeC-CCcEEEEEEEeccch--hhHHHHHHHHHHHHHHhhcCCCCcceeeeeeec-CceEEE
Q 012765          143 NFNSENLIGKGGHAEVYKGCLP-DGEVVAVKKIIKNAK--EDEERISDFLSELGIVAHINHPNAAKLIGFSTE-NGFHLV  218 (457)
Q Consensus       143 ~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-~~~~lv  218 (457)
                      +|+..+.||+|+||.||+|... +++.|++|.+.....  ........+.+|+.+++.++|+||+++++++.. ..++++
T Consensus         1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (258)
T cd06632           1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF   80 (258)
T ss_pred             CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence            4667789999999999999876 789999998754322  223456789999999999999999999997655 456899


Q ss_pred             EEecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCCCCC
Q 012765          219 LQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNW  298 (457)
Q Consensus       219 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~~~  298 (457)
                      +||+++++|.+++... ..+++..+..++.||+.||.|||+   .+++|+||+|+||+++.++.+||+|||++.......
T Consensus        81 ~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~  156 (258)
T cd06632          81 LELVPGGSLAKLLKKY-GSFPEPVIRLYTRQILLGLEYLHD---RNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS  156 (258)
T ss_pred             EEecCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEccCccceeccccc
Confidence            9999999999998543 357889999999999999999999   899999999999999999999999999987764432


Q ss_pred             CceeeecccccccccChhccccCC-CCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhccccccCCcccccCchhhcc
Q 012765          299 SHHIVFPIEGTFGYLSPEYFMHGI-VDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSNFKELVDPRLADA  377 (457)
Q Consensus       299 ~~~~~~~~~gt~~y~aPE~~~~~~-~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~  377 (457)
                         ......|+..|+|||.+.... ++.++|+||||+++|+|++|+.||.........+....  ....     +.+   
T Consensus       157 ---~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~--~~~~-----~~~---  223 (258)
T cd06632         157 ---FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGR--SKEL-----PPI---  223 (258)
T ss_pred             ---cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHh--cccC-----CCc---
Confidence               122345889999999987766 89999999999999999999999976442222211110  0000     011   


Q ss_pred             cCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 012765          378 YDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQ  409 (457)
Q Consensus       378 ~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~  409 (457)
                       .......+.+++.+||+.+|.+||++.+++.
T Consensus       224 -~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~  254 (258)
T cd06632         224 -PDHLSDEAKDFILKCLQRDPSLRPTAAELLE  254 (258)
T ss_pred             -CCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence             1112345567888999999999999999975

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.2e-37  Score=297.07  Aligned_cols=251  Identities=25%  Similarity=0.365  Sum_probs=196.3

Q ss_pred             hcCCCCCceecccCcEEEEEEEeC-CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeee-cCceEEE
Q 012765          141 TDNFNSENLIGKGGHAEVYKGCLP-DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFST-ENGFHLV  218 (457)
Q Consensus       141 ~~~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~-~~~~~lv  218 (457)
                      .++|.+.+.||.|+||.||+|.+. ++..+|+|.+....   ......+.+|+.++++++||||+++++++. ....+++
T Consensus         4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   80 (280)
T cd06611           4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIES---EEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWIL   80 (280)
T ss_pred             hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCC---HHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEE
Confidence            467888999999999999999864 68899999875432   234567889999999999999999999655 4556899


Q ss_pred             EEecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCCCCC
Q 012765          219 LQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNW  298 (457)
Q Consensus       219 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~~~  298 (457)
                      |||+++++|..++......+++..+..++.|++.||.|||+   .+|+|+||+|+||+++.++.++|+|||++.......
T Consensus        81 ~e~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~---~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~  157 (280)
T cd06611          81 IEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHS---HKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTL  157 (280)
T ss_pred             eeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChhhEEECCCCCEEEccCccchhhcccc
Confidence            99999999999987666678999999999999999999999   899999999999999999999999999987654322


Q ss_pred             CceeeecccccccccChhccc-----cCCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhccccccCCcccccCch
Q 012765          299 SHHIVFPIEGTFGYLSPEYFM-----HGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSNFKELVDPR  373 (457)
Q Consensus       299 ~~~~~~~~~gt~~y~aPE~~~-----~~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~  373 (457)
                      ..  .....++..|+|||++.     ...++.++|+||||+++|||++|+.||............   ....     .+.
T Consensus       158 ~~--~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~---~~~~-----~~~  227 (280)
T cd06611         158 QK--RDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKI---LKSE-----PPT  227 (280)
T ss_pred             cc--cceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHH---hcCC-----CCC
Confidence            11  12244889999999875     345788999999999999999999999764322111000   0000     011


Q ss_pred             hhcccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 012765          374 LADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQ  409 (457)
Q Consensus       374 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~  409 (457)
                      +..  .......+.+++..||+.+|.+||++.+|++
T Consensus       228 ~~~--~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  261 (280)
T cd06611         228 LDQ--PSKWSSSFNDFLKSCLVKDPDDRPTAAELLK  261 (280)
T ss_pred             cCC--cccCCHHHHHHHHHHhccChhhCcCHHHHhc
Confidence            100  0112234667888999999999999999977

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=2.3e-37  Score=296.07  Aligned_cols=251  Identities=26%  Similarity=0.410  Sum_probs=197.9

Q ss_pred             cCCCCCceecccCcEEEEEEEeC-CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeee-ecCceEEEE
Q 012765          142 DNFNSENLIGKGGHAEVYKGCLP-DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFS-TENGFHLVL  219 (457)
Q Consensus       142 ~~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~-~~~~~~lv~  219 (457)
                      ++|+..+.||.|+||.||++.+. +++.+|+|.+......  .....+.+|++++++++||||+++++++ .++.+++++
T Consensus         1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   78 (265)
T cd06605           1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINE--AIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICM   78 (265)
T ss_pred             CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccCh--HHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEE
Confidence            36777889999999999999875 5899999988654332  4456889999999999999999999855 455578999


Q ss_pred             EecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCCCCCC
Q 012765          220 QFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWS  299 (457)
Q Consensus       220 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~~~~  299 (457)
                      ||+.+++|.+++......++......++.|++.||.|||+.  .+++|+||||+||+++.++.++|+|||.+........
T Consensus        79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~--~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~  156 (265)
T cd06605          79 EYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEK--HKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLA  156 (265)
T ss_pred             EecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCC--CCeecCCCCHHHEEECCCCCEEEeecccchhhHHHHh
Confidence            99999999999876556788999999999999999999983  6899999999999999999999999999876643322


Q ss_pred             ceeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHhCCCCCCcCCc---chhhhhccccccCCcccccCchhhc
Q 012765          300 HHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQ---SLVIWAKPLLQTSNFKELVDPRLAD  376 (457)
Q Consensus       300 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLltG~~pf~~~~~---~~~~~~~~~~~~~~~~~~~d~~l~~  376 (457)
                      ..    ..++..|+|||++.+..++.++||||||+++|+|++|+.||...+.   ............      ..+.+..
T Consensus       157 ~~----~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~------~~~~~~~  226 (265)
T cd06605         157 KT----FVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNE------PPPRLPS  226 (265)
T ss_pred             hc----ccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcC------CCCCCCh
Confidence            11    4588899999999988999999999999999999999999975421   111111110000      0011111


Q ss_pred             ccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 012765          377 AYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQ  409 (457)
Q Consensus       377 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~  409 (457)
                      .   .....+.+++.+||..+|++|||+.+++.
T Consensus       227 ~---~~~~~~~~li~~~l~~~p~~Rpt~~~ll~  256 (265)
T cd06605         227 G---KFSPDFQDFVNLCLIKDPRERPSYKELLE  256 (265)
T ss_pred             h---hcCHHHHHHHHHHcCCCchhCcCHHHHhh
Confidence            1   13345778889999999999999999975

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-37  Score=303.57  Aligned_cols=249  Identities=21%  Similarity=0.322  Sum_probs=207.6

Q ss_pred             hcCCCCCceecccCcEEEEEEEe-CCCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeee-eecCceEEE
Q 012765          141 TDNFNSENLIGKGGHAEVYKGCL-PDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGF-STENGFHLV  218 (457)
Q Consensus       141 ~~~f~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~-~~~~~~~lv  218 (457)
                      ..-|.+++.||+|.|+.|-+|++ -+|..||||++.+.. .+.-....+.+|+..|+.++|||||++|.+ .+...+|||
T Consensus        17 AGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTK-lD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLi   95 (864)
T KOG4717|consen   17 AGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTK-LDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLI   95 (864)
T ss_pred             eeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccc-cchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEE
Confidence            35577889999999999999974 389999999987643 344456689999999999999999999995 556678999


Q ss_pred             EEecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEc-CCCcEEEeeccccccCCCC
Q 012765          219 LQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLS-EDYEAQISDFGLAKWLPDN  297 (457)
Q Consensus       219 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~-~~~~~kL~DFGl~~~~~~~  297 (457)
                      +|+-.+|+|++++......+.+....+++.||+.|+.|+|+   ..+|||||||+||.+- .-|-+||+|||++-.+..+
T Consensus        96 LELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHq---LHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG  172 (864)
T KOG4717|consen   96 LELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQ---LHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPG  172 (864)
T ss_pred             EEecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhh---hhhhcccCCcceeEEeeecCceEeeeccccccCCCc
Confidence            99999999999998888889999999999999999999999   8999999999999665 5688999999999776544


Q ss_pred             CCceeeecccccccccChhccccCCCC-cchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhccccccCCcccccCchhhc
Q 012765          298 WSHHIVFPIEGTFGYLSPEYFMHGIVD-EKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSNFKELVDPRLAD  376 (457)
Q Consensus       298 ~~~~~~~~~~gt~~y~aPE~~~~~~~~-~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  376 (457)
                      .   ...+.+|+..|-|||.+.+..|+ +++||||||||||.|++|+.||+..+.+.           .+..|+|-... 
T Consensus       173 ~---kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSE-----------TLTmImDCKYt-  237 (864)
T KOG4717|consen  173 K---KLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSE-----------TLTMIMDCKYT-  237 (864)
T ss_pred             c---hhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchh-----------hhhhhhccccc-
Confidence            3   34567899999999999999987 57899999999999999999998644332           22334444321 


Q ss_pred             ccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 012765          377 AYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQ  409 (457)
Q Consensus       377 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~  409 (457)
                       ...-...++.+++..||..||.+|.+..+|+.
T Consensus       238 -vPshvS~eCrdLI~sMLvRdPkkRAslEeI~s  269 (864)
T KOG4717|consen  238 -VPSHVSKECRDLIQSMLVRDPKKRASLEEIVS  269 (864)
T ss_pred             -CchhhhHHHHHHHHHHHhcCchhhccHHHHhc
Confidence             12334567788999999999999999999876

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=4.3e-37  Score=297.33  Aligned_cols=257  Identities=24%  Similarity=0.378  Sum_probs=197.1

Q ss_pred             cHHHHHHhhcCCCCCceecccCcEEEEEEEeC-CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhc-CCCCcceeeeee
Q 012765          133 DFAELAAATDNFNSENLIGKGGHAEVYKGCLP-DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHI-NHPNAAKLIGFS  210 (457)
Q Consensus       133 ~~~~~~~~~~~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~  210 (457)
                      +..++..+.+.|++.+.||.|+||.||+|.+. +++.+|+|.+....    .....+..|+.++.++ +|+||+++++++
T Consensus         7 ~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~----~~~~~~~~e~~~l~~~~~h~~i~~~~~~~   82 (282)
T cd06636           7 DLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE----DEEEEIKLEINMLKKYSHHRNIATYYGAF   82 (282)
T ss_pred             hhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh----HHHHHHHHHHHHHHHhcCCCcEEEEeeeh
Confidence            44555567788999999999999999999864 68899999875432    2234678899999888 799999999976


Q ss_pred             e-------cCceEEEEEecCCCChhhhhhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCc
Q 012765          211 T-------ENGFHLVLQFLPHGSLSSLLFGS-TECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYE  282 (457)
Q Consensus       211 ~-------~~~~~lv~e~~~~gsL~~~l~~~-~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~  282 (457)
                      .       ....+++|||+++|+|.+++... ...+++..++.++.||+.||.|||+   .+++|+||+|+||+++.++.
T Consensus        83 ~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~---~~ivH~dl~~~nili~~~~~  159 (282)
T cd06636          83 IKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHA---HKVIHRDIKGQNVLLTENAE  159 (282)
T ss_pred             hcccccCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCC
Confidence            4       23468999999999999988653 3457888888999999999999999   89999999999999999999


Q ss_pred             EEEeeccccccCCCCCCceeeecccccccccChhccc-----cCCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhh
Q 012765          283 AQISDFGLAKWLPDNWSHHIVFPIEGTFGYLSPEYFM-----HGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWA  357 (457)
Q Consensus       283 ~kL~DFGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~  357 (457)
                      ++|+|||++........  ......|+..|+|||.+.     ...++.++|||||||++|||++|..||...........
T Consensus       160 ~~l~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~  237 (282)
T cd06636         160 VKLVDFGVSAQLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFL  237 (282)
T ss_pred             EEEeeCcchhhhhcccc--CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhh
Confidence            99999999876543211  112345889999999875     34688899999999999999999999975332211111


Q ss_pred             ccccccCCcccccCchhhcccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 012765          358 KPLLQTSNFKELVDPRLADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQ  409 (457)
Q Consensus       358 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~  409 (457)
                              ......+.+..   ......+.+++.+||+.||.+|||+.||++
T Consensus       238 --------~~~~~~~~~~~---~~~~~~~~~li~~cl~~~p~~Rp~~~ell~  278 (282)
T cd06636         238 --------IPRNPPPKLKS---KKWSKKFIDFIEGCLVKNYLSRPSTEQLLK  278 (282)
T ss_pred             --------HhhCCCCCCcc---cccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence                    00000111110   112345778899999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=4.4e-37  Score=302.29  Aligned_cols=193  Identities=25%  Similarity=0.397  Sum_probs=154.7

Q ss_pred             ceecccCcEEEEEEEeC---CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeec---CceEEEEEe
Q 012765          148 NLIGKGGHAEVYKGCLP---DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTE---NGFHLVLQF  221 (457)
Q Consensus       148 ~~LG~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~---~~~~lv~e~  221 (457)
                      ..||+|+||+||+|...   ++..||+|.+.....     ...+.+|+.+++.++||||+++++++..   ...+++|||
T Consensus         7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~   81 (317)
T cd07867           7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI-----SMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDY   81 (317)
T ss_pred             eEeccCCCeeEEEEEecCCCccceEEEEEecCCCC-----cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEee
Confidence            57999999999999864   457899998754322     2356789999999999999999996642   346789999


Q ss_pred             cCCCChhhhhhc--------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEE----cCCCcEEEeecc
Q 012765          222 LPHGSLSSLLFG--------STECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILL----SEDYEAQISDFG  289 (457)
Q Consensus       222 ~~~gsL~~~l~~--------~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll----~~~~~~kL~DFG  289 (457)
                      +.+ +|..++..        ....+++..+..++.||+.||.|||+   .+|+||||||+|||+    +.++.+||+|||
T Consensus        82 ~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG  157 (317)
T cd07867          82 AEH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHA---NWVLHRDLKPANILVMGEGPERGRVKIADMG  157 (317)
T ss_pred             eCC-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHh---CCEEcCCCCHHHEEEccCCCCCCcEEEeecc
Confidence            865 66666532        12347888899999999999999999   899999999999999    456789999999


Q ss_pred             ccccCCCCCCc-eeeecccccccccChhcccc-CCCCcchhHHHHHHHHHHHHhCCCCCCcC
Q 012765          290 LAKWLPDNWSH-HIVFPIEGTFGYLSPEYFMH-GIVDEKTDVFAFGVLLLELITGRRAVDSR  349 (457)
Q Consensus       290 l~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~ksDvwSlGvll~eLltG~~pf~~~  349 (457)
                      +++........ .......||..|+|||++.+ ..++.++|||||||++|||+||+.||...
T Consensus       158 ~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~  219 (317)
T cd07867         158 FARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR  219 (317)
T ss_pred             ceeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccc
Confidence            99876543221 11223458999999999876 45899999999999999999999999753

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=9.9e-37  Score=292.97  Aligned_cols=251  Identities=22%  Similarity=0.308  Sum_probs=182.4

Q ss_pred             eecccCcEEEEEEEeCCC---cEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeecC-ceEEEEEecCC
Q 012765          149 LIGKGGHAEVYKGCLPDG---EVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTEN-GFHLVLQFLPH  224 (457)
Q Consensus       149 ~LG~G~~g~Vy~~~~~~~---~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~-~~~lv~e~~~~  224 (457)
                      .||+|+||.||+|...++   ..+++|.+.....  ......+.+|+.+++.++||||+++++++... ..+++|||+++
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~   79 (268)
T cd05086           2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANAS--SKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCEL   79 (268)
T ss_pred             cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCC--hHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCC
Confidence            599999999999975433   3455665543322  23356899999999999999999999966654 46899999999


Q ss_pred             CChhhhhhcC---CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCCCCCCce
Q 012765          225 GSLSSLLFGS---TECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSHH  301 (457)
Q Consensus       225 gsL~~~l~~~---~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~~~~~~  301 (457)
                      |+|.+++...   ....++...+.++.||+.||.|||+   .+++||||||+|||++.++.++|+|||++..........
T Consensus        80 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~---~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~  156 (268)
T cd05086          80 GDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHK---HNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIE  156 (268)
T ss_pred             CcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHH---CCeeccCCccceEEEcCCccEEecccccccccCcchhhh
Confidence            9999998653   2345667778899999999999999   899999999999999999999999999986432221111


Q ss_pred             eeecccccccccChhcccc-------CCCCcchhHHHHHHHHHHHHh-CCCCCCcCCcchhhhhccccccCCcccccCch
Q 012765          302 IVFPIEGTFGYLSPEYFMH-------GIVDEKTDVFAFGVLLLELIT-GRRAVDSRRQSLVIWAKPLLQTSNFKELVDPR  373 (457)
Q Consensus       302 ~~~~~~gt~~y~aPE~~~~-------~~~~~ksDvwSlGvll~eLlt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~  373 (457)
                      ......++..|+|||++..       ..++.++|||||||++|||++ |..||......... . ... ......+.++.
T Consensus       157 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~-~-~~~-~~~~~~~~~~~  233 (268)
T cd05086         157 TEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVL-N-HVI-KDQQVKLFKPQ  233 (268)
T ss_pred             cccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHH-H-HHH-hhcccccCCCc
Confidence            1123457889999998743       245789999999999999997 56677653322111 1 111 11112233444


Q ss_pred             hhcccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 012765          374 LADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQLLR  412 (457)
Q Consensus       374 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~  412 (457)
                      +...++    ..+.+++..|| .+|++||++.+|++.|.
T Consensus       234 ~~~~~~----~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~  267 (268)
T cd05086         234 LELPYS----ERWYEVLQFCW-LSPEKRATAEEVHRLLT  267 (268)
T ss_pred             cCCCCc----HHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence            443333    34555777799 67999999999999873

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=5.9e-37  Score=300.19  Aligned_cols=258  Identities=20%  Similarity=0.267  Sum_probs=198.0

Q ss_pred             cCCCCCceecccCcEEEEEEEeC-CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeecC-ceEEEE
Q 012765          142 DNFNSENLIGKGGHAEVYKGCLP-DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTEN-GFHLVL  219 (457)
Q Consensus       142 ~~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~-~~~lv~  219 (457)
                      ++|...+.||+|+||.||++... .++.|++|.+.............+.+|+.+++.++||||+++++.+..+ ..+++|
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (305)
T cd05609           1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM   80 (305)
T ss_pred             CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence            46888999999999999999865 5789999988665443344556888999999999999999999965544 468999


Q ss_pred             EecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCCCCCC
Q 012765          220 QFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWS  299 (457)
Q Consensus       220 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~~~~  299 (457)
                      ||+++++|..++... ..+++..+..++.|++.||.|||+   .+++||||||+||+++.++.++|+|||+++.......
T Consensus        81 e~~~g~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~  156 (305)
T cd05609          81 EYVEGGDCATLLKNI-GALPVDMARMYFAETVLALEYLHN---YGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLT  156 (305)
T ss_pred             ecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCchHHEEECCCCCEEEeeCCCccccCcCcc
Confidence            999999999998554 458889889999999999999999   8999999999999999999999999998864211100


Q ss_pred             c-------------eeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhccccccCCc
Q 012765          300 H-------------HIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSNF  366 (457)
Q Consensus       300 ~-------------~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~~~~~~~~~  366 (457)
                      .             .......++..|+|||++.+..++.++|+|||||++|||++|..||.+....... ... ..    
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~-~~~-~~----  230 (305)
T cd05609         157 TNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELF-GQV-IS----  230 (305)
T ss_pred             ccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH-HHH-Hh----
Confidence            0             0011234788999999998889999999999999999999999999754322111 000 00    


Q ss_pred             ccccCchhhcccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 012765          367 KELVDPRLADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQLLRG  413 (457)
Q Consensus       367 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~  413 (457)
                      .....+....    .....+..++.+||+.+|++||++.++.+.|+.
T Consensus       231 ~~~~~~~~~~----~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~  273 (305)
T cd05609         231 DDIEWPEGDE----ALPADAQDLISRLLRQNPLERLGTGGAFEVKQH  273 (305)
T ss_pred             cccCCCCccc----cCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence            0001111111    123346788999999999999998777777755

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=6.6e-37  Score=294.80  Aligned_cols=254  Identities=24%  Similarity=0.342  Sum_probs=195.9

Q ss_pred             cCCCCCceecccCcEEEEEEEeC------CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeecC-c
Q 012765          142 DNFNSENLIGKGGHAEVYKGCLP------DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTEN-G  214 (457)
Q Consensus       142 ~~f~~~~~LG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~-~  214 (457)
                      ++|.+...||+|+||.||+|...      +.+.+++|.+....  .......+.+|+.++++++|+||+++++++.+. .
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   82 (275)
T cd05046           5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTK--DENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEP   82 (275)
T ss_pred             HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCcc--chHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCc
Confidence            67888999999999999999853      34678888775432  223456789999999999999999999977664 4


Q ss_pred             eEEEEEecCCCChhhhhhcCC--------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEe
Q 012765          215 FHLVLQFLPHGSLSSLLFGST--------ECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQIS  286 (457)
Q Consensus       215 ~~lv~e~~~~gsL~~~l~~~~--------~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~  286 (457)
                      .+++|||+++|+|.+++....        ..+++..+..++.|++.||.|||+   .+|+||||||+||+++.++.++|+
T Consensus        83 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~---~~i~H~dlkp~Nili~~~~~~~l~  159 (275)
T cd05046          83 HYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSN---ARFVHRDLAARNCLVSSQREVKVS  159 (275)
T ss_pred             ceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhh---cCcccCcCccceEEEeCCCcEEEc
Confidence            689999999999999986433        158999999999999999999999   899999999999999999999999


Q ss_pred             eccccccCCCCCCceeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHh-CCCCCCcCCcchhhhhccccccCC
Q 012765          287 DFGLAKWLPDNWSHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELIT-GRRAVDSRRQSLVIWAKPLLQTSN  365 (457)
Q Consensus       287 DFGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLlt-G~~pf~~~~~~~~~~~~~~~~~~~  365 (457)
                      |||++........ .......++..|+|||.+.+..++.++||||||+++|+|++ |..||............   ....
T Consensus       160 ~~~~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~---~~~~  235 (275)
T cd05046         160 LLSLSKDVYNSEY-YKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRL---QAGK  235 (275)
T ss_pred             ccccccccCcccc-cccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHH---HcCC
Confidence            9999875532211 11122335778999999988889999999999999999999 78888643221111100   0000


Q ss_pred             cccccCchhhcccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 012765          366 FKELVDPRLADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQLLR  412 (457)
Q Consensus       366 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~  412 (457)
                      .. +       .........+.+++.+||+.+|++||++.+++..|.
T Consensus       236 ~~-~-------~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~  274 (275)
T cd05046         236 LE-L-------PVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG  274 (275)
T ss_pred             cC-C-------CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence            00 0       001112246778999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=100.00  E-value=3e-38  Score=286.82  Aligned_cols=248  Identities=25%  Similarity=0.398  Sum_probs=196.2

Q ss_pred             CCCceecccCcEEEEEEEeC-CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcC-CCCcceeeeee-ecCceEEEEEe
Q 012765          145 NSENLIGKGGHAEVYKGCLP-DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHIN-HPNAAKLIGFS-TENGFHLVLQF  221 (457)
Q Consensus       145 ~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~~~-~~~~~~lv~e~  221 (457)
                      ..+..||.|+.|+|+++... .|..+|||.+.+....  +..++++..+.++...+ .|+||+.+||+ .+.+.++.||.
T Consensus        95 ~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nk--ee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMel  172 (391)
T KOG0983|consen   95 ENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNK--EENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMEL  172 (391)
T ss_pred             hhHHhhcCCCccceEEEEEcccceEEEEEeecccCCH--HHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHH
Confidence            35578999999999999865 5899999998765543  45678999999887665 89999999965 55667788887


Q ss_pred             cCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCCCCCCce
Q 012765          222 LPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSHH  301 (457)
Q Consensus       222 ~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~~~~~~  301 (457)
                      |. ..+..+|....+++++...-++...++.||.||.+.  .+|||||+||+|||+|+.|++||||||++..+.+...+.
T Consensus       173 Ms-~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeK--H~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSkAht  249 (391)
T KOG0983|consen  173 MS-TCAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEK--HGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKAHT  249 (391)
T ss_pred             HH-HHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHh--cceeecccCccceEEccCCCEEeecccccceeecccccc
Confidence            63 345556666677799999889999999999999984  899999999999999999999999999999887765544


Q ss_pred             eeecccccccccChhcccc---CCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhccccccCCcccccCchhhccc
Q 012765          302 IVFPIEGTFGYLSPEYFMH---GIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSNFKELVDPRLADAY  378 (457)
Q Consensus       302 ~~~~~~gt~~y~aPE~~~~---~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~  378 (457)
                      .   ..|.+.|||||.+..   ..|+.++||||||+.++||.||+.||..-+.......+.+-+++       |.|.+..
T Consensus       250 r---sAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~eP-------P~L~~~~  319 (391)
T KOG0983|consen  250 R---SAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNEEP-------PLLPGHM  319 (391)
T ss_pred             c---ccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhcCC-------CCCCccc
Confidence            3   348999999999853   46999999999999999999999999974444333332222111       3332221


Q ss_pred             CHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 012765          379 DLAEMKRAMLTASVCIHHLSTMRPQMTRVLQ  409 (457)
Q Consensus       379 ~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~  409 (457)
                        .....+++++..||+.|+.+||...++++
T Consensus       320 --gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~  348 (391)
T KOG0983|consen  320 --GFSPDFQSFVKDCLTKDHRKRPKYNKLLE  348 (391)
T ss_pred             --CcCHHHHHHHHHHhhcCcccCcchHHHhc
Confidence              14456778888999999999999999887

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=4.7e-37  Score=293.00  Aligned_cols=249  Identities=24%  Similarity=0.289  Sum_probs=198.7

Q ss_pred             CCCCCceecccCcEEEEEEEeC-CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeee-cCceEEEEE
Q 012765          143 NFNSENLIGKGGHAEVYKGCLP-DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFST-ENGFHLVLQ  220 (457)
Q Consensus       143 ~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~-~~~~~lv~e  220 (457)
                      +|.+.+.||.|+||.||+|.+. +++.||+|.+.+...........+.+|++++++++||||+++++++. ....++++|
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (258)
T cd05578           1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD   80 (258)
T ss_pred             CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence            4778899999999999999875 58999999987654444445678999999999999999999998655 455789999


Q ss_pred             ecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCCCCCCc
Q 012765          221 FLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSH  300 (457)
Q Consensus       221 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~~~~~  300 (457)
                      |+.+++|..++... ..+++..+..++.||++||.|||+   .+++|+||+|+||++++++.++|+|||++.......  
T Consensus        81 ~~~~~~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~lh~---~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~--  154 (258)
T cd05578          81 LLLGGDLRYHLSQK-VKFSEEQVKFWICEIVLALEYLHS---KGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT--  154 (258)
T ss_pred             CCCCCCHHHHHHhc-CCcCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeEEcCCCCEEEeecccccccCCCc--
Confidence            99999999998554 468889999999999999999999   899999999999999999999999999988765432  


Q ss_pred             eeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhccccccCCcccccCchhhcccCH
Q 012765          301 HIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSNFKELVDPRLADAYDL  380 (457)
Q Consensus       301 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~  380 (457)
                       ......|+..|+|||++.+..++.++|+||||+++|+|++|..||.........+.......      ..+    ....
T Consensus       155 -~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~------~~~----~~~~  223 (258)
T cd05578         155 -LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQET------ADV----LYPA  223 (258)
T ss_pred             -cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhcc------ccc----cCcc
Confidence             12234588899999999888899999999999999999999999986543211111111110      001    1111


Q ss_pred             HHHHHHHHHHHHhcccCCCCCCCH--HHHH
Q 012765          381 AEMKRAMLTASVCIHHLSTMRPQM--TRVL  408 (457)
Q Consensus       381 ~~~~~l~~l~~~Cl~~dP~~RPt~--~evl  408 (457)
                      .....+.+++.+||+.+|.+||++  +|++
T Consensus       224 ~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~  253 (258)
T cd05578         224 TWSTEAIDAINKLLERDPQKRLGDNLKDLK  253 (258)
T ss_pred             cCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence            123567788899999999999999  6554

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=6.1e-37  Score=296.12  Aligned_cols=249  Identities=25%  Similarity=0.385  Sum_probs=187.7

Q ss_pred             cCCCCCceecccCcEEEEEEEeC-CCcEEEEEEEeccchhhHHHHHHHHHHHHH-HhhcCCCCcceeeeeee-cCceEEE
Q 012765          142 DNFNSENLIGKGGHAEVYKGCLP-DGEVVAVKKIIKNAKEDEERISDFLSELGI-VAHINHPNAAKLIGFST-ENGFHLV  218 (457)
Q Consensus       142 ~~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~-l~~l~hpniv~l~~~~~-~~~~~lv  218 (457)
                      ++|++.+.||+|+||.||+|.+. +|+.||+|++.......  ....+..|+.+ ++.++||||+++++++. ++..+++
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv   78 (283)
T cd06617           1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQ--EQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWIC   78 (283)
T ss_pred             CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcH--HHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEE
Confidence            47888999999999999999865 69999999886543221  23355566665 56678999999999654 5567899


Q ss_pred             EEecCCCChhhhhhc---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCC-CeeeCCCCCCcEEEcCCCcEEEeeccccccC
Q 012765          219 LQFLPHGSLSSLLFG---STECLEWTIRYKIALGIAEGLQYLHHDCHR-RIIHRDIKASNILLSEDYEAQISDFGLAKWL  294 (457)
Q Consensus       219 ~e~~~~gsL~~~l~~---~~~~~~~~~~~~i~~qia~aL~yLH~~~~~-~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~  294 (457)
                      |||++ |+|..++..   ....+++..++.++.||+.||.|||+   . +++||||||+||+++.++.+||+|||++..+
T Consensus        79 ~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~  154 (283)
T cd06617          79 MEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHS---KLSVIHRDVKPSNVLINRNGQVKLCDFGISGYL  154 (283)
T ss_pred             hhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhh---cCCeecCCCCHHHEEECCCCCEEEeeccccccc
Confidence            99996 677776643   33468999999999999999999998   5 8999999999999999999999999999876


Q ss_pred             CCCCCceeeecccccccccChhcccc----CCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhccccccCCccccc
Q 012765          295 PDNWSHHIVFPIEGTFGYLSPEYFMH----GIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSNFKELV  370 (457)
Q Consensus       295 ~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~  370 (457)
                      .....   .....++..|+|||++.+    ..++.++|+|||||++|+|++|+.||............. ..      -.
T Consensus       155 ~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~-~~------~~  224 (283)
T cd06617         155 VDSVA---KTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQV-VE------EP  224 (283)
T ss_pred             ccccc---cccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHH-Hh------cC
Confidence            44321   122347889999998864    457899999999999999999999997533221111100 00      00


Q ss_pred             CchhhcccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 012765          371 DPRLADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQ  409 (457)
Q Consensus       371 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~  409 (457)
                      .+.+..   ......+..++.+||..+|.+||++.+|++
T Consensus       225 ~~~~~~---~~~~~~l~~li~~~l~~~p~~Rp~~~~il~  260 (283)
T cd06617         225 SPQLPA---EKFSPEFQDFVNKCLKKNYKERPNYPELLQ  260 (283)
T ss_pred             CCCCCc---cccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            111110   112345678899999999999999999987

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.2e-38  Score=312.93  Aligned_cols=257  Identities=24%  Similarity=0.379  Sum_probs=203.0

Q ss_pred             HHHhhcCCCCCceecccCcEEEEEEEeCC-CcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeecCc-
Q 012765          137 LAAATDNFNSENLIGKGGHAEVYKGCLPD-GEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTENG-  214 (457)
Q Consensus       137 ~~~~~~~f~~~~~LG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~-  214 (457)
                      .+.-..+....++||-|-||.||.|.|+. .-.||||.++.+..    .+++|+.|..+|+.++|||+|+++|+|+... 
T Consensus       262 WEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtM----eveEFLkEAAvMKeikHpNLVqLLGVCT~EpP  337 (1157)
T KOG4278|consen  262 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPP  337 (1157)
T ss_pred             hhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcch----hHHHHHHHHHHHHhhcCccHHHHhhhhccCCC
Confidence            33444556677899999999999999864 67899998865543    3679999999999999999999999887665 


Q ss_pred             eEEEEEecCCCChhhhhhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeecccccc
Q 012765          215 FHLVLQFLPHGSLSSLLFGST-ECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKW  293 (457)
Q Consensus       215 ~~lv~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~  293 (457)
                      +|+|.|||..|+|.+||+... ..++--..+.++.||+.|+.||..   +++|||||...|+|+.++..+|++|||+++.
T Consensus       338 FYIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEk---knFIHRDLAARNCLVgEnhiVKvADFGLsRl  414 (1157)
T KOG4278|consen  338 FYIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHIVKVADFGLSRL  414 (1157)
T ss_pred             eEEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHH---hhhhhhhhhhhhccccccceEEeeccchhhh
Confidence            678999999999999997643 346777788999999999999999   8999999999999999999999999999999


Q ss_pred             CCCCCCceeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHh-CCCCCCcCCcchhhhhccccccCCcccccCc
Q 012765          294 LPDNWSHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELIT-GRRAVDSRRQSLVIWAKPLLQTSNFKELVDP  372 (457)
Q Consensus       294 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLlt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~  372 (457)
                      +..+..... ....-..-|.|||.+....++.|+|||+|||+|||+.| |..||.+-+.+.+.            .++..
T Consensus       415 MtgDTYTAH-AGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY------------~LLEk  481 (1157)
T KOG4278|consen  415 MTGDTYTAH-AGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVY------------GLLEK  481 (1157)
T ss_pred             hcCCceecc-cCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHH------------HHHhc
Confidence            876532211 11123456999999999999999999999999999999 78888864433221            11111


Q ss_pred             hhhcccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 012765          373 RLADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQLLRG  413 (457)
Q Consensus       373 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~  413 (457)
                      ..+-.-.......+.+++.+||+++|.+||++.||-+.++.
T Consensus       482 gyRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEt  522 (1157)
T KOG4278|consen  482 GYRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFET  522 (1157)
T ss_pred             cccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHH
Confidence            11111112234566778888999999999999999887763

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=1.6e-36  Score=288.49  Aligned_cols=248  Identities=22%  Similarity=0.373  Sum_probs=195.5

Q ss_pred             CCCCCceecccCcEEEEEEEeC-CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeee-cCceEEEEE
Q 012765          143 NFNSENLIGKGGHAEVYKGCLP-DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFST-ENGFHLVLQ  220 (457)
Q Consensus       143 ~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~-~~~~~lv~e  220 (457)
                      +|+..+.||+|+||.||++... +++.+|+|.+...... ......+.+|+.+++.++|||++++++++. ++..++|||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e   79 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMT-KDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVME   79 (256)
T ss_pred             CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccc-cHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEe
Confidence            4778899999999999999864 6889999988654322 234568999999999999999999998554 455789999


Q ss_pred             ecCCCChhhhhhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCC-CcEEEeeccccccCCCCC
Q 012765          221 FLPHGSLSSLLFGS-TECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSED-YEAQISDFGLAKWLPDNW  298 (457)
Q Consensus       221 ~~~~gsL~~~l~~~-~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~-~~~kL~DFGl~~~~~~~~  298 (457)
                      |+++++|.+++... ...+++..++.++.+++.||.|||+   .+++|+||+|+||+++.+ +.++|+|||++.......
T Consensus        80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~---~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~  156 (256)
T cd08220          80 YAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHT---KLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS  156 (256)
T ss_pred             cCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCc
Confidence            99999999999654 3458899999999999999999999   899999999999999855 468999999998775432


Q ss_pred             CceeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhccccccCCcccccCchhhccc
Q 012765          299 SHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSNFKELVDPRLADAY  378 (457)
Q Consensus       299 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~  378 (457)
                      ..   ....++..|+|||.+.+..++.++||||||+++|+|++|+.||...+.....  ..... .....     +..  
T Consensus       157 ~~---~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~--~~~~~-~~~~~-----~~~--  223 (256)
T cd08220         157 KA---YTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALV--LKIMS-GTFAP-----ISD--  223 (256)
T ss_pred             cc---cccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHHH--HHHHh-cCCCC-----CCC--
Confidence            21   2234788999999998888999999999999999999999999764322111  00000 00000     111  


Q ss_pred             CHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 012765          379 DLAEMKRAMLTASVCIHHLSTMRPQMTRVLQ  409 (457)
Q Consensus       379 ~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~  409 (457)
                        .....+.+++.+||+.+|.+|||+.|+++
T Consensus       224 --~~~~~l~~li~~~l~~~p~~Rpt~~~ll~  252 (256)
T cd08220         224 --RYSPDLRQLILSMLNLDPSKRPQLSQIMA  252 (256)
T ss_pred             --CcCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence              12335678889999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=8e-37  Score=292.94  Aligned_cols=252  Identities=23%  Similarity=0.340  Sum_probs=193.0

Q ss_pred             hcCCCCCceecccCcEEEEEEEeC-CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeee-cCceEEE
Q 012765          141 TDNFNSENLIGKGGHAEVYKGCLP-DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFST-ENGFHLV  218 (457)
Q Consensus       141 ~~~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~-~~~~~lv  218 (457)
                      .++|.+.+.||+|+||.||+|... +++.||+|.+.....   .....+.+|+.+++.++||||+++++++. .+..+++
T Consensus         8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~---~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv   84 (267)
T cd06645           8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPG---EDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWIC   84 (267)
T ss_pred             HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCch---hHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEE
Confidence            356778899999999999999864 688999998754432   22346788999999999999999998554 4557899


Q ss_pred             EEecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCCCCC
Q 012765          219 LQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNW  298 (457)
Q Consensus       219 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~~~  298 (457)
                      |||+++++|.+++... ..+++...+.++.|++.||.|||+   .+++|+||||+||+++.++.++|+|||++..+....
T Consensus        85 ~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~  160 (267)
T cd06645          85 MEFCGGGSLQDIYHVT-GPLSESQIAYVSRETLQGLYYLHS---KGKMHRDIKGANILLTDNGHVKLADFGVSAQITATI  160 (267)
T ss_pred             EeccCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEECcceeeeEccCcc
Confidence            9999999999988543 458899999999999999999999   899999999999999999999999999987654322


Q ss_pred             CceeeecccccccccChhccc---cCCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhccccccCCcccccCchhh
Q 012765          299 SHHIVFPIEGTFGYLSPEYFM---HGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSNFKELVDPRLA  375 (457)
Q Consensus       299 ~~~~~~~~~gt~~y~aPE~~~---~~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  375 (457)
                      .  ......|+..|+|||++.   ...++.++|+|||||++|+|++|..||.........+...   ....   ..+...
T Consensus       161 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~---~~~~---~~~~~~  232 (267)
T cd06645         161 A--KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMT---KSNF---QPPKLK  232 (267)
T ss_pred             c--ccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhh---ccCC---CCCccc
Confidence            1  122345899999999874   4568899999999999999999999986533222111110   0000   001110


Q ss_pred             cccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 012765          376 DAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQ  409 (457)
Q Consensus       376 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~  409 (457)
                      ...  .....+.+++.+||+.+|++||++.+|++
T Consensus       233 ~~~--~~~~~~~~li~~~l~~~P~~R~~~~~ll~  264 (267)
T cd06645         233 DKM--KWSNSFHHFVKMALTKNPKKRPTAEKLLQ  264 (267)
T ss_pred             ccC--CCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence            000  11234667889999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=8.4e-37  Score=296.65  Aligned_cols=260  Identities=23%  Similarity=0.313  Sum_probs=192.6

Q ss_pred             cCCCCCceecccCcEEEEEEEeC-CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeecC-ceEEEE
Q 012765          142 DNFNSENLIGKGGHAEVYKGCLP-DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTEN-GFHLVL  219 (457)
Q Consensus       142 ~~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~-~~~lv~  219 (457)
                      ++|+..+.||.|+||.||+|... +++.||+|.+.......  ....+.+|+.+++.++||||+++++++.++ ..++||
T Consensus         5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   82 (291)
T cd07844           5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEG--APFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVF   82 (291)
T ss_pred             cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccC--CchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEE
Confidence            67888999999999999999865 68999999886543221  123567899999999999999999976554 568999


Q ss_pred             EecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCCCCCC
Q 012765          220 QFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWS  299 (457)
Q Consensus       220 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~~~~  299 (457)
                      ||+.+ +|.+++......+++.....++.|++.||.|||+   .+++||||||+||+++.++.+||+|||+++.......
T Consensus        83 e~~~~-~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~  158 (291)
T cd07844          83 EYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQ---RRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSK  158 (291)
T ss_pred             ecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeecccCCHHHEEEcCCCCEEECccccccccCCCCc
Confidence            99985 8998886656678899999999999999999999   8999999999999999999999999999875432211


Q ss_pred             ceeeecccccccccChhcccc-CCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhc--ccccc------------C
Q 012765          300 HHIVFPIEGTFGYLSPEYFMH-GIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAK--PLLQT------------S  364 (457)
Q Consensus       300 ~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~--~~~~~------------~  364 (457)
                        ......++..|+|||++.+ ..++.++||||||+++|+|++|+.||.........+..  .....            .
T Consensus       159 --~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (291)
T cd07844         159 --TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNP  236 (291)
T ss_pred             --cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhcc
Confidence              1112236788999999875 45899999999999999999999999754311111000  00000            0


Q ss_pred             C-----cccccCchhhccc-CHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 012765          365 N-----FKELVDPRLADAY-DLAEMKRAMLTASVCIHHLSTMRPQMTRVLQ  409 (457)
Q Consensus       365 ~-----~~~~~d~~l~~~~-~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~  409 (457)
                      .     ........+.... .......+.+++.+||+.+|.+|||+.++++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~  287 (291)
T cd07844         237 EFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK  287 (291)
T ss_pred             ccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence            0     0000001110000 0111245678899999999999999999875

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=1.1e-36  Score=294.50  Aligned_cols=261  Identities=24%  Similarity=0.322  Sum_probs=196.8

Q ss_pred             CCCCCceecccCcEEEEEEEeC-CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeec-CceEEEEE
Q 012765          143 NFNSENLIGKGGHAEVYKGCLP-DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTE-NGFHLVLQ  220 (457)
Q Consensus       143 ~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-~~~~lv~e  220 (457)
                      +|.+.+.||.|+||.||+|.+. +|+.||+|++...... ......+.+|+.++++++||||+++++++.. ...++|+|
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~-~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e   79 (286)
T cd07832           1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLE-GGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVME   79 (286)
T ss_pred             CceEEeecccCCCcEEEEEEECCCCceEEEEEEEccccc-chhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEec
Confidence            4778899999999999999864 6899999988654322 2334678999999999999999999996554 45679999


Q ss_pred             ecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCCCCCCc
Q 012765          221 FLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSH  300 (457)
Q Consensus       221 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~~~~~  300 (457)
                      |+ +++|.+++......+++..++.++.||+.||.|||+   .+++|+||||+||+++.++.++|+|||++........ 
T Consensus        80 ~~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~-  154 (286)
T cd07832          80 YM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHA---NGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEP-  154 (286)
T ss_pred             cc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC-
Confidence            99 999999987666779999999999999999999999   8999999999999999999999999999987654321 


Q ss_pred             eeeecccccccccChhccccC-CCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhh-hhccccccC------------Cc
Q 012765          301 HIVFPIEGTFGYLSPEYFMHG-IVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVI-WAKPLLQTS------------NF  366 (457)
Q Consensus       301 ~~~~~~~gt~~y~aPE~~~~~-~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~-~~~~~~~~~------------~~  366 (457)
                      .......++..|+|||++.+. .++.++||||||++++||++|..||......... +........            ..
T Consensus       155 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (286)
T cd07832         155 RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDY  234 (286)
T ss_pred             CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcchh
Confidence            112234588999999998654 4689999999999999999998888653321110 000000000            00


Q ss_pred             ccccCchh----hcccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 012765          367 KELVDPRL----ADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQ  409 (457)
Q Consensus       367 ~~~~d~~l----~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~  409 (457)
                      ..+..+..    ......+....+.+++.+||+.+|++||++.++++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~  281 (286)
T cd07832         235 NKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALR  281 (286)
T ss_pred             hcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhh
Confidence            00000000    00000122367788999999999999999999986

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=1.5e-36  Score=295.86  Aligned_cols=261  Identities=22%  Similarity=0.286  Sum_probs=195.5

Q ss_pred             CCCCCceecccCcEEEEEEEeC-CCcEEEEEEEeccchh--hHHHHHHHHHHHHHHhhcCCCCcceeeeeeec-CceEEE
Q 012765          143 NFNSENLIGKGGHAEVYKGCLP-DGEVVAVKKIIKNAKE--DEERISDFLSELGIVAHINHPNAAKLIGFSTE-NGFHLV  218 (457)
Q Consensus       143 ~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-~~~~lv  218 (457)
                      +|...+.||.|+||.||+|... +++.||+|.+......  .......+..|+.+++.++|+||+++++++.+ +..++|
T Consensus         1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (298)
T cd07841           1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV   80 (298)
T ss_pred             CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence            4778889999999999999864 6899999998654432  12234467789999999999999999996655 456899


Q ss_pred             EEecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCCCCC
Q 012765          219 LQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNW  298 (457)
Q Consensus       219 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~~~  298 (457)
                      |||+ +++|..++......+++..++.++.||+.||.|||+   .+++|+||+|+||+++.++.++|+|||++.......
T Consensus        81 ~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~  156 (298)
T cd07841          81 FEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHS---NWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPN  156 (298)
T ss_pred             Eccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCChhhEEEcCCCCEEEccceeeeeccCCC
Confidence            9999 999999986654468999999999999999999999   899999999999999999999999999998765432


Q ss_pred             CceeeecccccccccChhcccc-CCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhccc--cccC---------Cc
Q 012765          299 SHHIVFPIEGTFGYLSPEYFMH-GIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPL--LQTS---------NF  366 (457)
Q Consensus       299 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~~~--~~~~---------~~  366 (457)
                      ..  .....++..|+|||.+.+ ..++.++|||||||++|||++|..||....... ......  ....         ..
T Consensus       157 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~  233 (298)
T cd07841         157 RK--MTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDID-QLGKIFEALGTPTEENWPGVTSL  233 (298)
T ss_pred             cc--ccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHH-HHHHHHHHcCCCchhhhhhcccc
Confidence            11  122346788999998864 457899999999999999999988876533211 000000  0000         00


Q ss_pred             ccccCchhhcc-----cCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 012765          367 KELVDPRLADA-----YDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQL  410 (457)
Q Consensus       367 ~~~~d~~l~~~-----~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~  410 (457)
                      ...........     ........+.+++.+||+.+|.+|||+.+|++.
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~  282 (298)
T cd07841         234 PDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH  282 (298)
T ss_pred             cccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence            00000000000     011224567889999999999999999999984

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4.3e-38  Score=315.94  Aligned_cols=250  Identities=26%  Similarity=0.388  Sum_probs=203.3

Q ss_pred             CCCCCceecccCcEEEEEEEeC--CCc--EEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeecCceEEE
Q 012765          143 NFNSENLIGKGGHAEVYKGCLP--DGE--VVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTENGFHLV  218 (457)
Q Consensus       143 ~f~~~~~LG~G~~g~Vy~~~~~--~~~--~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~lv  218 (457)
                      .....++||+|+||.|++|.|.  +|+  .||||.+......  ....+|++|+.+|.+|+|+|+++|||+..+....+|
T Consensus       111 ~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~--~~mddflrEas~M~~L~H~hliRLyGvVl~qp~mMV  188 (1039)
T KOG0199|consen  111 QIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLN--AIMDDFLREASHMLKLQHPHLIRLYGVVLDQPAMMV  188 (1039)
T ss_pred             HHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccc--hhHHHHHHHHHHHHhccCcceeEEeeeeccchhhHH
Confidence            3445689999999999999875  344  5899988654433  256799999999999999999999999998888999


Q ss_pred             EEecCCCChhhhhhc-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCCCC
Q 012765          219 LQFLPHGSLSSLLFG-STECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDN  297 (457)
Q Consensus       219 ~e~~~~gsL~~~l~~-~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~~  297 (457)
                      +|+++.|+|.+.|+. ....+-......++.|||.|+.||.+   +++|||||...|+||...-.+||+||||.+.+...
T Consensus       189 ~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLes---krlvHRDLAARNlllasprtVKI~DFGLmRaLg~n  265 (1039)
T KOG0199|consen  189 FELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLES---KRLVHRDLAARNLLLASPRTVKICDFGLMRALGEN  265 (1039)
T ss_pred             hhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhhhheecccceeeeecccceeccCCC
Confidence            999999999999987 55567777888899999999999999   89999999999999999889999999999999876


Q ss_pred             CCceeeecc-cccccccChhccccCCCCcchhHHHHHHHHHHHHh-CCCCCCcCCcchhhhhccccccCCcccccCchhh
Q 012765          298 WSHHIVFPI-EGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELIT-GRRAVDSRRQSLVIWAKPLLQTSNFKELVDPRLA  375 (457)
Q Consensus       298 ~~~~~~~~~-~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLlt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  375 (457)
                      ......... .-.+.|+|||.+.+..++.++|||+|||+||||+| |..||.+-....            +.+.+|..-.
T Consensus       266 ed~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~q------------IL~~iD~~er  333 (1039)
T KOG0199|consen  266 EDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQ------------ILKNIDAGER  333 (1039)
T ss_pred             CcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHH------------HHHhcccccc
Confidence            655554332 23567999999999999999999999999999999 778887633322            2222221111


Q ss_pred             cccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 012765          376 DAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQ  409 (457)
Q Consensus       376 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~  409 (457)
                      -.-.....+.+.+++..||.++|++|||+..|.+
T Consensus       334 LpRPk~csedIY~imk~cWah~paDRptFsair~  367 (1039)
T KOG0199|consen  334 LPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIRE  367 (1039)
T ss_pred             CCCCCCChHHHHHHHHHhccCCccccccHHHHHH
Confidence            1112234567788999999999999999999974

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=9.5e-38  Score=307.16  Aligned_cols=255  Identities=20%  Similarity=0.342  Sum_probs=202.4

Q ss_pred             HhhcCCCCCceecccCcEEEEEEEeCCCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcC-CCCcceeeeeeecCc-eE
Q 012765          139 AATDNFNSENLIGKGGHAEVYKGCLPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHIN-HPNAAKLIGFSTENG-FH  216 (457)
Q Consensus       139 ~~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~-~~  216 (457)
                      .....|++++.||+||.+.||++...+.+.||+|++..... +...+.-|.+|+..|.+|+ |.+||++|+|...++ +|
T Consensus       358 Vkg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~-D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lY  436 (677)
T KOG0596|consen  358 VKGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEA-DNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLY  436 (677)
T ss_pred             ECcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhc-CHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEE
Confidence            44677899999999999999999988888999998764433 4456788999999999995 999999999987666 57


Q ss_pred             EEEEecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCCC
Q 012765          217 LVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPD  296 (457)
Q Consensus       217 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~  296 (457)
                      +|||| ...+|..+|.......+.-.+..+..|++.|+.++|.   .+|||.||||.|+|+.. |.+||+|||++..+..
T Consensus       437 mvmE~-Gd~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~---~gIVHSDLKPANFLlVk-G~LKLIDFGIA~aI~~  511 (677)
T KOG0596|consen  437 MVMEC-GDIDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQ---HGIVHSDLKPANFLLVK-GRLKLIDFGIANAIQP  511 (677)
T ss_pred             EEeec-ccccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHH---hceeecCCCcccEEEEe-eeEEeeeechhcccCc
Confidence            88885 4668999997766555523556688999999999999   89999999999999974 5899999999999988


Q ss_pred             CCCceeeecccccccccChhccccCC-----------CCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhccccccCC
Q 012765          297 NWSHHIVFPIEGTFGYLSPEYFMHGI-----------VDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSN  365 (457)
Q Consensus       297 ~~~~~~~~~~~gt~~y~aPE~~~~~~-----------~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~~~~~~~~  365 (457)
                      +.+.-.....+||+.||+||.+....           .+.++||||||||||+|+.|+.||.....   .|+       .
T Consensus       512 DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n---~~a-------K  581 (677)
T KOG0596|consen  512 DTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIIN---QIA-------K  581 (677)
T ss_pred             cccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHH---HHH-------H
Confidence            87776777788999999999885322           45789999999999999999999985321   122       2


Q ss_pred             cccccCchhhcccC-HHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 012765          366 FKELVDPRLADAYD-LAEMKRAMLTASVCIHHLSTMRPQMTRVLQ  409 (457)
Q Consensus       366 ~~~~~d~~l~~~~~-~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~  409 (457)
                      +..+.||.-.-.|. ...-..++.++..||+.||.+||++.++|+
T Consensus       582 l~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLq  626 (677)
T KOG0596|consen  582 LHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQ  626 (677)
T ss_pred             HHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhc
Confidence            33444553321111 111112788899999999999999999987

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=1e-36  Score=290.22  Aligned_cols=249  Identities=22%  Similarity=0.316  Sum_probs=196.3

Q ss_pred             CCCCCceecccCcEEEEEEEeC-CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeec-CceEEEEE
Q 012765          143 NFNSENLIGKGGHAEVYKGCLP-DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTE-NGFHLVLQ  220 (457)
Q Consensus       143 ~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-~~~~lv~e  220 (457)
                      +|++.+.||+|+||.||++... +|+.||+|.+...... ......+.+|+.++++++||||+++++++.. +..++++|
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   79 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMS-PKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMD   79 (256)
T ss_pred             CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCC-hHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEe
Confidence            4788899999999999999854 6899999988643222 2334578999999999999999999996655 45679999


Q ss_pred             ecCCCChhhhhhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCCCCCC
Q 012765          221 FLPHGSLSSLLFGST-ECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWS  299 (457)
Q Consensus       221 ~~~~gsL~~~l~~~~-~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~~~~  299 (457)
                      |+++++|.+++.... ..+++..++.++.|++.||.|||+   .+++|+||+|+||+++.++.++|+|||++........
T Consensus        80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~  156 (256)
T cd08218          80 YCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHD---RKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE  156 (256)
T ss_pred             cCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCEEEeeccceeecCcchh
Confidence            999999999886533 357889999999999999999999   8999999999999999999999999999976644321


Q ss_pred             ceeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhccccccCCcccccCchhhcccC
Q 012765          300 HHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSNFKELVDPRLADAYD  379 (457)
Q Consensus       300 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~  379 (457)
                      .  .....|+..|+|||++.+..++.++|+|||||++++|++|+.||...+........  .. ...     +..    .
T Consensus       157 ~--~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~--~~-~~~-----~~~----~  222 (256)
T cd08218         157 L--ARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKI--IR-GSY-----PPV----S  222 (256)
T ss_pred             h--hhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHH--hc-CCC-----CCC----c
Confidence            1  12234788999999998888999999999999999999999999754322111110  00 000     001    1


Q ss_pred             HHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 012765          380 LAEMKRAMLTASVCIHHLSTMRPQMTRVLQ  409 (457)
Q Consensus       380 ~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~  409 (457)
                      ......+.+++.+||+.+|.+||++.+|++
T Consensus       223 ~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~  252 (256)
T cd08218         223 SHYSYDLRNLVSQLFKRNPRDRPSVNSILE  252 (256)
T ss_pred             ccCCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence            122345678889999999999999999987

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8.8e-37  Score=293.01  Aligned_cols=251  Identities=27%  Similarity=0.386  Sum_probs=195.6

Q ss_pred             hhcCCCCCceecccCcEEEEEEEeC-CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhc-CCCCcceeeeeeecCc---
Q 012765          140 ATDNFNSENLIGKGGHAEVYKGCLP-DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHI-NHPNAAKLIGFSTENG---  214 (457)
Q Consensus       140 ~~~~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~---  214 (457)
                      ++++|++.+.||.|+||.||+|... +++.+++|.+.....    ....+.+|+.+++++ +|+||+++++++....   
T Consensus         4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~----~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~   79 (275)
T cd06608           4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED----EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPG   79 (275)
T ss_pred             chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch----hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCC
Confidence            5688999999999999999999875 578899998764432    235788999999998 7999999999765433   


Q ss_pred             ----eEEEEEecCCCChhhhhhcC---CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEee
Q 012765          215 ----FHLVLQFLPHGSLSSLLFGS---TECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISD  287 (457)
Q Consensus       215 ----~~lv~e~~~~gsL~~~l~~~---~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~D  287 (457)
                          ++++|||+++++|.+++...   ...+++..+..++.|++.||.|||+   .+++|+||+|+||+++.++.++|+|
T Consensus        80 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~---~~i~H~~l~p~ni~~~~~~~~~l~d  156 (275)
T cd06608          80 NDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHE---NKVIHRDIKGQNILLTKNAEVKLVD  156 (275)
T ss_pred             cceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhc---CCcccCCCCHHHEEEccCCeEEECC
Confidence                68999999999999988542   3568899999999999999999999   8999999999999999999999999


Q ss_pred             ccccccCCCCCCceeeecccccccccChhcccc-----CCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhccccc
Q 012765          288 FGLAKWLPDNWSHHIVFPIEGTFGYLSPEYFMH-----GIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQ  362 (457)
Q Consensus       288 FGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~~~~~  362 (457)
                      ||++........  ......|+..|+|||++..     ..++.++|||||||++|+|++|+.||...........  .. 
T Consensus       157 ~~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~--~~-  231 (275)
T cd06608         157 FGVSAQLDSTLG--RRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFK--IP-  231 (275)
T ss_pred             Cccceecccchh--hhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHH--hh-
Confidence            999876543321  1223458899999998753     3478899999999999999999999975322111100  00 


Q ss_pred             cCCcccccCchhhcccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 012765          363 TSNFKELVDPRLADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQ  409 (457)
Q Consensus       363 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~  409 (457)
                           ....+.+..  .......+.+++.+||..||++|||+.+|++
T Consensus       232 -----~~~~~~~~~--~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~  271 (275)
T cd06608         232 -----RNPPPTLKS--PENWSKKFNDFISECLIKNYEQRPFMEELLE  271 (275)
T ss_pred             -----ccCCCCCCc--hhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence                 000111110  1123446778899999999999999999986

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=1.2e-36  Score=297.03  Aligned_cols=248  Identities=21%  Similarity=0.372  Sum_probs=195.3

Q ss_pred             cCCCCCceecccCcEEEEEEEe-CCCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeee-cCceEEEE
Q 012765          142 DNFNSENLIGKGGHAEVYKGCL-PDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFST-ENGFHLVL  219 (457)
Q Consensus       142 ~~f~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~-~~~~~lv~  219 (457)
                      .+|+..+.||.|+||.||+|.. .+++.|++|.+.....   .....+.+|+.+++.++|||++++++++. .+..++++
T Consensus        19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   95 (296)
T cd06655          19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQ---PKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVM   95 (296)
T ss_pred             ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccC---chHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEE
Confidence            4688889999999999999985 4689999998864332   22457889999999999999999999654 45578999


Q ss_pred             EecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCCCCCC
Q 012765          220 QFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWS  299 (457)
Q Consensus       220 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~~~~  299 (457)
                      ||+++++|..++..  ..+++..+..++.|++.||.|||+   .+++|+||||+||+++.++.++|+|||++........
T Consensus        96 e~~~~~~L~~~~~~--~~l~~~~~~~i~~~l~~al~~LH~---~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~  170 (296)
T cd06655          96 EYLAGGSLTDVVTE--TCMDEAQIAAVCRECLQALEFLHA---NQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS  170 (296)
T ss_pred             EecCCCcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEccCccchhcccccc
Confidence            99999999998843  358999999999999999999999   8999999999999999999999999999876543321


Q ss_pred             ceeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhccccccCCcccccCchhhcccC
Q 012765          300 HHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSNFKELVDPRLADAYD  379 (457)
Q Consensus       300 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~  379 (457)
                      .  .....++..|+|||.+.+..++.++|||||||++|+|++|+.||...+........  .. .....+..+   ..  
T Consensus       171 ~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~--~~-~~~~~~~~~---~~--  240 (296)
T cd06655         171 K--RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI--AT-NGTPELQNP---EK--  240 (296)
T ss_pred             c--CCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH--Hh-cCCcccCCc---cc--
Confidence            1  12245888999999998888999999999999999999999999764432111100  00 000000000   11  


Q ss_pred             HHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 012765          380 LAEMKRAMLTASVCIHHLSTMRPQMTRVLQ  409 (457)
Q Consensus       380 ~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~  409 (457)
                        ....+.+++.+||..+|++||++.+|+.
T Consensus       241 --~~~~~~~li~~~l~~dp~~Rpt~~~il~  268 (296)
T cd06655         241 --LSPIFRDFLNRCLEMDVEKRGSAKELLQ  268 (296)
T ss_pred             --CCHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence              1234667889999999999999999986

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=1.1e-36  Score=296.13  Aligned_cols=261  Identities=22%  Similarity=0.309  Sum_probs=195.7

Q ss_pred             cCCCCCceecccCcEEEEEEEeC-CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeec---CceEE
Q 012765          142 DNFNSENLIGKGGHAEVYKGCLP-DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTE---NGFHL  217 (457)
Q Consensus       142 ~~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~---~~~~l  217 (457)
                      ++|+..+.||.|+||.||+|.+. +++.+|+|.+...... ......+.+|+.++++++||||+++++++..   ...++
T Consensus         5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~l   83 (293)
T cd07843           5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEK-EGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYM   83 (293)
T ss_pred             hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeecccc-ccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEE
Confidence            57888899999999999999875 5889999988654332 2223467789999999999999999996654   45789


Q ss_pred             EEEecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCCCC
Q 012765          218 VLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDN  297 (457)
Q Consensus       218 v~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~~  297 (457)
                      +|||+. ++|.+++......+++...+.++.||+.||.|||+   .+++|+||||+||+++.++.++|+|||++......
T Consensus        84 v~e~~~-~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~  159 (293)
T cd07843          84 VMEYVE-HDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHD---NWILHRDLKTSNLLLNNRGILKICDFGLAREYGSP  159 (293)
T ss_pred             EehhcC-cCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCCHHHEEECCCCcEEEeecCceeeccCC
Confidence            999997 48888886655578999999999999999999999   89999999999999999999999999999876553


Q ss_pred             CCceeeecccccccccChhccccC-CCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhh--------------hhc----
Q 012765          298 WSHHIVFPIEGTFGYLSPEYFMHG-IVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVI--------------WAK----  358 (457)
Q Consensus       298 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~--------------~~~----  358 (457)
                      ...  .....++..|+|||.+.+. .++.++|+||||+++|+|++|..||.........              |..    
T Consensus       160 ~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (293)
T cd07843         160 LKP--YTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSEL  237 (293)
T ss_pred             ccc--cccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhcc
Confidence            211  1223478899999998754 4689999999999999999999999754322110              000    


Q ss_pred             cccccCCcccccCchhhcccCHH-HHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 012765          359 PLLQTSNFKELVDPRLADAYDLA-EMKRAMLTASVCIHHLSTMRPQMTRVLQ  409 (457)
Q Consensus       359 ~~~~~~~~~~~~d~~l~~~~~~~-~~~~l~~l~~~Cl~~dP~~RPt~~evl~  409 (457)
                      +..............+...+... ....+.+++.+||+.+|++|||+.|+++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~  289 (293)
T cd07843         238 PGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK  289 (293)
T ss_pred             chhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence            00000000111111111111111 2445678899999999999999999985

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=1.4e-36  Score=295.13  Aligned_cols=262  Identities=22%  Similarity=0.292  Sum_probs=191.7

Q ss_pred             hhcCCCCCceecccCcEEEEEEEeC-CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeecC-ceEE
Q 012765          140 ATDNFNSENLIGKGGHAEVYKGCLP-DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTEN-GFHL  217 (457)
Q Consensus       140 ~~~~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~-~~~l  217 (457)
                      ++.+|.+.+.||+|+||.||+|... +++.||+|.+......  .....+.+|+.+++.++|+||+++++++..+ ..++
T Consensus         3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~l   80 (291)
T cd07870           3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEE--GVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTF   80 (291)
T ss_pred             ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcC--CCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEE
Confidence            4578999999999999999999864 6889999988644322  1223567899999999999999999966554 4679


Q ss_pred             EEEecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCCCC
Q 012765          218 VLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDN  297 (457)
Q Consensus       218 v~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~~  297 (457)
                      ++||+. +++..++......+++..+..++.||+.||.|||+   .+|+|+||||+||+++.++.++|+|||+++.....
T Consensus        81 v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~  156 (291)
T cd07870          81 VFEYMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHG---QHILHRDLKPQNLLISYLGELKLADFGLARAKSIP  156 (291)
T ss_pred             EEeccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChHHEEEcCCCcEEEeccccccccCCC
Confidence            999995 67777765555567888888899999999999999   89999999999999999999999999998765332


Q ss_pred             CCceeeecccccccccChhccccC-CCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhcc----cc----------c
Q 012765          298 WSHHIVFPIEGTFGYLSPEYFMHG-IVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKP----LL----------Q  362 (457)
Q Consensus       298 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~~----~~----------~  362 (457)
                      ...  .....++..|+|||++.+. .++.++|||||||++|+|++|..||.............    ..          .
T Consensus       157 ~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (291)
T cd07870         157 SQT--YSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSK  234 (291)
T ss_pred             CCC--CCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhh
Confidence            111  1223478899999998754 57899999999999999999999997644321111000    00          0


Q ss_pred             cCCc-ccccCchhhccc-----CHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 012765          363 TSNF-KELVDPRLADAY-----DLAEMKRAMLTASVCIHHLSTMRPQMTRVLQ  409 (457)
Q Consensus       363 ~~~~-~~~~d~~l~~~~-----~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~  409 (457)
                      .... ..+.........     .......+.+++.+|+..||.+|||+.|++.
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~  287 (291)
T cd07870         235 LPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL  287 (291)
T ss_pred             cccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence            0000 000000000000     0011345667889999999999999999874

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=5.4e-37  Score=297.58  Aligned_cols=252  Identities=24%  Similarity=0.381  Sum_probs=188.7

Q ss_pred             CCCCCceecccCcEEEEEEEeC-CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcC-CCCcceeeeeee-cCceEEEE
Q 012765          143 NFNSENLIGKGGHAEVYKGCLP-DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHIN-HPNAAKLIGFST-ENGFHLVL  219 (457)
Q Consensus       143 ~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~-~~~~~lv~  219 (457)
                      +|...+.||+|+||.||++... +++.+|+|.+......  .....+.+|+.++.++. ||||+++++++. ++..+++|
T Consensus         5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~   82 (288)
T cd06616           5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDE--KEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICM   82 (288)
T ss_pred             HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccCh--HHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEE
Confidence            4556678999999999999864 5899999988654332  33557889999999996 999999999554 45567889


Q ss_pred             EecCCCChhhh---hhc-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCC
Q 012765          220 QFLPHGSLSSL---LFG-STECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLP  295 (457)
Q Consensus       220 e~~~~gsL~~~---l~~-~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~  295 (457)
                      ||+.. ++..+   +.. ....+++.....++.+++.||.|||+.  .+++||||||+||+++.++.++|+|||++..+.
T Consensus        83 e~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~--~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~  159 (288)
T cd06616          83 ELMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEE--LKIIHRDVKPSNILLDRNGNIKLCDFGISGQLV  159 (288)
T ss_pred             ecccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhc--CCeeccCCCHHHEEEccCCcEEEeecchhHHhc
Confidence            98764 44433   222 235689999999999999999999972  489999999999999999999999999997664


Q ss_pred             CCCCceeeecccccccccChhccccC---CCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhccccccCCcccccCc
Q 012765          296 DNWSHHIVFPIEGTFGYLSPEYFMHG---IVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSNFKELVDP  372 (457)
Q Consensus       296 ~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~  372 (457)
                      .....   ....|+..|+|||++.+.   .++.++|||||||++|+|++|+.||.......... ..... .     ..+
T Consensus       160 ~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~-~~~~~-~-----~~~  229 (288)
T cd06616         160 DSIAK---TRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQL-TQVVK-G-----DPP  229 (288)
T ss_pred             cCCcc---ccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchHHHHH-hhhcC-C-----CCC
Confidence            43221   223488899999998766   68999999999999999999999997543211110 00000 0     011


Q ss_pred             hhhcccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 012765          373 RLADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQ  409 (457)
Q Consensus       373 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~  409 (457)
                      .+...........+.+++.+||+.+|++|||+.+|++
T Consensus       230 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~  266 (288)
T cd06616         230 ILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLE  266 (288)
T ss_pred             cCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            1111111223446778899999999999999999987

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=2e-36  Score=292.15  Aligned_cols=246  Identities=30%  Similarity=0.450  Sum_probs=194.2

Q ss_pred             CCCCCceecccCcEEEEEEEeC-CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeec-CceEEEEE
Q 012765          143 NFNSENLIGKGGHAEVYKGCLP-DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTE-NGFHLVLQ  220 (457)
Q Consensus       143 ~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-~~~~lv~e  220 (457)
                      -|...+.||.|+||.||+|... ++..+|+|.+.....  ......+.+|+.++.+++||||+++++++.. ...++|||
T Consensus         5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   82 (277)
T cd06641           5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME   82 (277)
T ss_pred             hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEE
Confidence            3667789999999999999854 688999998754322  2345688899999999999999999996655 44789999


Q ss_pred             ecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCCCCCCc
Q 012765          221 FLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSH  300 (457)
Q Consensus       221 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~~~~~  300 (457)
                      |+++++|..++.  ...+++..+..++.|++.|+.|||+   .+++|+||+|+||+++.++.++|+|||++..+..... 
T Consensus        83 ~~~~~~l~~~i~--~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~-  156 (277)
T cd06641          83 YLGGGSALDLLE--PGPLDETQIATILREILKGLDYLHS---EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI-  156 (277)
T ss_pred             eCCCCcHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHcc---CCeecCCCCHHhEEECCCCCEEEeecccceecccchh-
Confidence            999999999884  3458899999999999999999999   8999999999999999999999999999876644221 


Q ss_pred             eeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhccccccCCcccccCchhhcccCH
Q 012765          301 HIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSNFKELVDPRLADAYDL  380 (457)
Q Consensus       301 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~  380 (457)
                       ......++..|+|||.+.+..++.++|+|||||++|+|++|..||.............   ...     .+.+..    
T Consensus       157 -~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~---~~~-----~~~~~~----  223 (277)
T cd06641         157 -KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIP---KNN-----PPTLEG----  223 (277)
T ss_pred             -hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHh---cCC-----CCCCCc----
Confidence             1122457889999999988889999999999999999999999997533221111110   000     111111    


Q ss_pred             HHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 012765          381 AEMKRAMLTASVCIHHLSTMRPQMTRVLQ  409 (457)
Q Consensus       381 ~~~~~l~~l~~~Cl~~dP~~RPt~~evl~  409 (457)
                      .....+.+++.+||+.+|.+||++.++++
T Consensus       224 ~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~  252 (277)
T cd06641         224 NYSKPLKEFVEACLNKEPSFRPTAKELLK  252 (277)
T ss_pred             ccCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence            22344667889999999999999999998

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=3.9e-36  Score=296.14  Aligned_cols=251  Identities=27%  Similarity=0.370  Sum_probs=195.5

Q ss_pred             CCCCCceecccCcEEEEEEEeC-CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeecC-ceEEEEE
Q 012765          143 NFNSENLIGKGGHAEVYKGCLP-DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTEN-GFHLVLQ  220 (457)
Q Consensus       143 ~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~-~~~lv~e  220 (457)
                      .|...+.||+|+||.||+|... ++..+|+|.+.............+.+|+.+++.++|||++++++++.++ ..+++||
T Consensus        26 ~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  105 (317)
T cd06635          26 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVME  105 (317)
T ss_pred             hhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEe
Confidence            3667789999999999999864 6889999988654444445566899999999999999999999976554 4679999


Q ss_pred             ecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCCCCCCc
Q 012765          221 FLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSH  300 (457)
Q Consensus       221 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~~~~~  300 (457)
                      |+. |++.+.+......+++..+..++.|++.||.|||+   .+++||||+|+||+++.++.++|+|||++......   
T Consensus       106 ~~~-g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~---~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~---  178 (317)
T cd06635         106 YCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHS---HNMIHRDIKAGNILLTEPGQVKLADFGSASIASPA---  178 (317)
T ss_pred             CCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcccEEECCCCCEEEecCCCccccCCc---
Confidence            996 57777776556678999999999999999999999   89999999999999999999999999998754332   


Q ss_pred             eeeecccccccccChhccc---cCCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhccccccCCcccccCchhhcc
Q 012765          301 HIVFPIEGTFGYLSPEYFM---HGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSNFKELVDPRLADA  377 (457)
Q Consensus       301 ~~~~~~~gt~~y~aPE~~~---~~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~  377 (457)
                         ....|+..|+|||++.   .+.++.++|||||||++|||++|+.||.............           .......
T Consensus       179 ---~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~-----------~~~~~~~  244 (317)
T cd06635         179 ---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIA-----------QNESPTL  244 (317)
T ss_pred             ---ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHH-----------hccCCCC
Confidence               1234888999999974   4568999999999999999999999987543221111100           0000000


Q ss_pred             cCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q 012765          378 YDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQLLRGE  414 (457)
Q Consensus       378 ~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~  414 (457)
                      ........+.+++.+||+.+|.+||++.+|++.+--.
T Consensus       245 ~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~  281 (317)
T cd06635         245 QSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVL  281 (317)
T ss_pred             CCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhh
Confidence            0112234567888999999999999999999855433

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=3e-36  Score=301.50  Aligned_cols=258  Identities=24%  Similarity=0.306  Sum_probs=195.5

Q ss_pred             hhcCCCCCceecccCcEEEEEEEeC-CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeecC-----
Q 012765          140 ATDNFNSENLIGKGGHAEVYKGCLP-DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTEN-----  213 (457)
Q Consensus       140 ~~~~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~-----  213 (457)
                      ..++|...+.||+|+||.||+|... +++.||+|.+.+... .......+.+|+.+++.++||||+++++++...     
T Consensus        14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   92 (353)
T cd07850          14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQ-NVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEE   92 (353)
T ss_pred             hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCcccc-ChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccc
Confidence            4578999999999999999999864 689999998864322 223345678899999999999999999865432     


Q ss_pred             --ceEEEEEecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeecccc
Q 012765          214 --GFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLA  291 (457)
Q Consensus       214 --~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~  291 (457)
                        ..++||||+. ++|...+...   ++...+..++.|++.||.|||+   .+++||||||+||+++.++.+||+|||++
T Consensus        93 ~~~~~lv~e~~~-~~l~~~~~~~---l~~~~~~~~~~ql~~aL~~LH~---~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~  165 (353)
T cd07850          93 FQDVYLVMELMD-ANLCQVIQMD---LDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLA  165 (353)
T ss_pred             cCcEEEEEeccC-CCHHHHHhhc---CCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEECCCCCEEEccCccc
Confidence              3689999996 4777776332   7888889999999999999999   89999999999999999999999999999


Q ss_pred             ccCCCCCCceeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhccc-----------
Q 012765          292 KWLPDNWSHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPL-----------  360 (457)
Q Consensus       292 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~~~-----------  360 (457)
                      ........   .....++..|+|||++.+..++.++|||||||++|+|++|+.||...+... .|....           
T Consensus       166 ~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~  241 (353)
T cd07850         166 RTAGTSFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHID-QWNKIIEQLGTPSDEFM  241 (353)
T ss_pred             eeCCCCCC---CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHH-HHHHHHHhcCCCCHHHH
Confidence            87654322   223457889999999999999999999999999999999999997643211 111000           


Q ss_pred             ----------------cccCCcccccCchhhc----ccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 012765          361 ----------------LQTSNFKELVDPRLAD----AYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQ  409 (457)
Q Consensus       361 ----------------~~~~~~~~~~d~~l~~----~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~  409 (457)
                                      .....+.++....+..    .........+.+++.+||+.||++|||+.|+++
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~  310 (353)
T cd07850         242 SRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQ  310 (353)
T ss_pred             HHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhc
Confidence                            0000011111111100    001123445678999999999999999999987

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=5e-36  Score=283.24  Aligned_cols=248  Identities=30%  Similarity=0.440  Sum_probs=198.5

Q ss_pred             CCCCCceecccCcEEEEEEEeC-CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeec-CceEEEEE
Q 012765          143 NFNSENLIGKGGHAEVYKGCLP-DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTE-NGFHLVLQ  220 (457)
Q Consensus       143 ~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-~~~~lv~e  220 (457)
                      +|...+.||+|++|.||++... +++.+++|++.....   .....+.+|+.+++.++|+|++++++++.. ...++++|
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e   77 (253)
T cd05122           1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK---EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVME   77 (253)
T ss_pred             CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch---hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEe
Confidence            4778899999999999999875 688999998865433   345688999999999999999999996554 55789999


Q ss_pred             ecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCCCCCCc
Q 012765          221 FLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSH  300 (457)
Q Consensus       221 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~~~~~  300 (457)
                      |+++++|.+++......+++..+..++.|++.||.|||.   .+++|+||+|+||+++.++.++|+|||.+........ 
T Consensus        78 ~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~---~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-  153 (253)
T cd05122          78 FCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHS---NGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA-  153 (253)
T ss_pred             cCCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhc---CCEecCCCCHHHEEEccCCeEEEeecccccccccccc-
Confidence            999999999986655678999999999999999999999   8999999999999999999999999999987755431 


Q ss_pred             eeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhccccccCCcccccCchhhcccCH
Q 012765          301 HIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSNFKELVDPRLADAYDL  380 (457)
Q Consensus       301 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~  380 (457)
                        .....++..|+|||++.+..++.++|+||||+++++|++|+.||.............   ......+..+       .
T Consensus       154 --~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~---~~~~~~~~~~-------~  221 (253)
T cd05122         154 --RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIA---TNGPPGLRNP-------E  221 (253)
T ss_pred             --ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHH---hcCCCCcCcc-------c
Confidence              123448889999999988889999999999999999999999998643211111100   0111111111       1


Q ss_pred             HHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 012765          381 AEMKRAMLTASVCIHHLSTMRPQMTRVLQ  409 (457)
Q Consensus       381 ~~~~~l~~l~~~Cl~~dP~~RPt~~evl~  409 (457)
                      .....+.+++.+||+.||++|||+.++++
T Consensus       222 ~~~~~~~~~i~~~l~~~p~~R~t~~~~l~  250 (253)
T cd05122         222 KWSDEFKDFLKKCLQKNPEKRPTAEQLLK  250 (253)
T ss_pred             ccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            11345778889999999999999999986

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-36  Score=294.53  Aligned_cols=267  Identities=28%  Similarity=0.423  Sum_probs=199.5

Q ss_pred             cCCCCCceecccCcEEEEEEEeCCCcEEEEEEEeccchhhHHHHHHHHHHHHHHhh--cCCCCcceeeeeeecC-----c
Q 012765          142 DNFNSENLIGKGGHAEVYKGCLPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAH--INHPNAAKLIGFSTEN-----G  214 (457)
Q Consensus       142 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~--l~hpniv~l~~~~~~~-----~  214 (457)
                      ......++||+|.||.||||.+ +++.||||++..      ...+.|.+|-+|.+.  +.|+||+++++....+     +
T Consensus       210 ~pl~l~eli~~Grfg~V~KaqL-~~~~VAVKifp~------~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~e  282 (534)
T KOG3653|consen  210 DPLQLLELIGRGRFGCVWKAQL-DNRLVAVKIFPE------QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRME  282 (534)
T ss_pred             CchhhHHHhhcCccceeehhhc-cCceeEEEecCH------HHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccc
Confidence            3444668899999999999998 559999998843      334577777777654  5899999999865443     5


Q ss_pred             eEEEEEecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcC------CCCeeeCCCCCCcEEEcCCCcEEEeec
Q 012765          215 FHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDC------HRRIIHRDIKASNILLSEDYEAQISDF  288 (457)
Q Consensus       215 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~------~~~iiHrDlkp~NIll~~~~~~kL~DF  288 (457)
                      ++||++|.+.|+|.++|  ....++|....+|+..+++||+|||+..      +.+|+|||||+.|||+..|++..|+||
T Consensus       283 ywLVt~fh~kGsL~dyL--~~ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDF  360 (534)
T KOG3653|consen  283 YWLVTEFHPKGSLCDYL--KANTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADF  360 (534)
T ss_pred             eeEEeeeccCCcHHHHH--HhccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeecc
Confidence            78999999999999999  4566899999999999999999999864      357999999999999999999999999


Q ss_pred             cccccCCCCCCceeeecccccccccChhccccCC-CC-----cchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhccc--
Q 012765          289 GLAKWLPDNWSHHIVFPIEGTFGYLSPEYFMHGI-VD-----EKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPL--  360 (457)
Q Consensus       289 Gl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-----~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~~~--  360 (457)
                      |++..+.............||.+|||||++.+.. +.     .+.||||+|.+||||++....++.  .....|..++  
T Consensus       361 GLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~--~~vp~Yqlpfe~  438 (534)
T KOG3653|consen  361 GLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADP--GPVPEYQLPFEA  438 (534)
T ss_pred             ceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccC--CCCCcccCchhH
Confidence            9998886554443344467999999999987643 22     358999999999999997765532  1111111111  


Q ss_pred             --cccCCccc--------ccCchhhccc-CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCCCCCC
Q 012765          361 --LQTSNFKE--------LVDPRLADAY-DLAEMKRAMLTASVCIHHLSTMRPQMTRVLQLLRGEGGQTD  419 (457)
Q Consensus       361 --~~~~~~~~--------~~d~~l~~~~-~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~~~  419 (457)
                        -..+.+.+        -..|.+.... .-..+..+.+++..||.+||+.|.|+.=|.+++..+.....
T Consensus       439 evG~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~~  508 (534)
T KOG3653|consen  439 EVGNHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLWE  508 (534)
T ss_pred             HhcCCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccCC
Confidence              11121111        1112111111 11467778999999999999999999999888877765443

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=2.4e-36  Score=289.46  Aligned_cols=255  Identities=23%  Similarity=0.390  Sum_probs=195.5

Q ss_pred             CCCCCceecccCcEEEEEEEe-CCCcEEEEEEEeccch---hhHHHHHHHHHHHHHHhhcCCCCcceeeeeeec-CceEE
Q 012765          143 NFNSENLIGKGGHAEVYKGCL-PDGEVVAVKKIIKNAK---EDEERISDFLSELGIVAHINHPNAAKLIGFSTE-NGFHL  217 (457)
Q Consensus       143 ~f~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-~~~~l  217 (457)
                      +|+..+.||+|+||.||+|.. .+++.+|+|.+.....   ........+.+|+..++.++|+||+++++++.+ +..++
T Consensus         1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   80 (268)
T cd06630           1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL   80 (268)
T ss_pred             CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence            477889999999999999985 4689999998764332   112345688999999999999999999996654 55789


Q ss_pred             EEEecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCC-cEEEeeccccccCCC
Q 012765          218 VLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDY-EAQISDFGLAKWLPD  296 (457)
Q Consensus       218 v~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~-~~kL~DFGl~~~~~~  296 (457)
                      ++||+++++|.+++... ..+++.....++.||+.||.|||+   .+++|+||+|+||+++.++ .++|+|||++..+..
T Consensus        81 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~ql~~al~~LH~---~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~  156 (268)
T cd06630          81 FVEWMAGGSVSHLLSKY-GAFKEAVIINYTEQLLRGLSYLHE---NQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAA  156 (268)
T ss_pred             EEeccCCCcHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEEccccccccccc
Confidence            99999999999988543 457889999999999999999999   8999999999999998776 599999999887654


Q ss_pred             CCCce--eeecccccccccChhccccCCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhccccccCCcccccCchh
Q 012765          297 NWSHH--IVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSNFKELVDPRL  374 (457)
Q Consensus       297 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l  374 (457)
                      .....  ......++..|+|||++.+..++.++|+||||+++++|++|..||...........        ...+.....
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~--------~~~~~~~~~  228 (268)
T cd06630         157 KGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLAL--------IFKIASATT  228 (268)
T ss_pred             ccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHH--------HHHHhccCC
Confidence            31110  11123478899999999888899999999999999999999999974322110000        000000000


Q ss_pred             hcccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 012765          375 ADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQ  409 (457)
Q Consensus       375 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~  409 (457)
                      ...........+..++.+||..+|.+||++.++++
T Consensus       229 ~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~  263 (268)
T cd06630         229 APSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK  263 (268)
T ss_pred             CCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence            11122233456777899999999999999999875

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=4.8e-36  Score=284.54  Aligned_cols=252  Identities=27%  Similarity=0.408  Sum_probs=200.9

Q ss_pred             CCCCCceecccCcEEEEEEEeC-CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeecC---ceEEE
Q 012765          143 NFNSENLIGKGGHAEVYKGCLP-DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTEN---GFHLV  218 (457)
Q Consensus       143 ~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~---~~~lv  218 (457)
                      +|...+.||+|++|.||+|... +++.|++|.+...... ......+.+|+..+++++||||+++++++...   ..+++
T Consensus         1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv   79 (260)
T cd06606           1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDS-EEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIF   79 (260)
T ss_pred             CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccc-hHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEE
Confidence            4677899999999999999876 6899999987654332 34567889999999999999999999976654   56899


Q ss_pred             EEecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCCCCC
Q 012765          219 LQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNW  298 (457)
Q Consensus       219 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~~~  298 (457)
                      +||+.+++|.+++.... .+++..++.++.|++.||.|||+   .+++|+||+|+||+++.++.++|+|||.+.......
T Consensus        80 ~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh~---~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~  155 (260)
T cd06606          80 LEYVSGGSLSSLLKKFG-KLPEPVIRKYTRQILEGLAYLHS---NGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIE  155 (260)
T ss_pred             EEecCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEcCCCCEEEcccccEEeccccc
Confidence            99999999999986544 78999999999999999999999   899999999999999999999999999998776553


Q ss_pred             CceeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhccccccCCcccccCchhhccc
Q 012765          299 SHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSNFKELVDPRLADAY  378 (457)
Q Consensus       299 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~  378 (457)
                      .........++..|+|||.+.+..++.++||||||+++++|++|..||............ .......     +    ..
T Consensus       156 ~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~-~~~~~~~-----~----~~  225 (260)
T cd06606         156 TGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYK-IGSSGEP-----P----EI  225 (260)
T ss_pred             ccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHh-ccccCCC-----c----CC
Confidence            211122345888999999998888999999999999999999999999865421111111 0000000     1    11


Q ss_pred             CHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 012765          379 DLAEMKRAMLTASVCIHHLSTMRPQMTRVLQ  409 (457)
Q Consensus       379 ~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~  409 (457)
                      .......+.+++.+|++.+|++||++.+++.
T Consensus       226 ~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~  256 (260)
T cd06606         226 PEHLSEEAKDFLRKCLRRDPKKRPTADELLQ  256 (260)
T ss_pred             CcccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence            1112456778889999999999999999986

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=1.6e-36  Score=295.46  Aligned_cols=248  Identities=22%  Similarity=0.338  Sum_probs=192.0

Q ss_pred             CCCCCceecccCcEEEEEEEeC-CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeee-ecCceEEEEE
Q 012765          143 NFNSENLIGKGGHAEVYKGCLP-DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFS-TENGFHLVLQ  220 (457)
Q Consensus       143 ~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~-~~~~~~lv~e  220 (457)
                      .|.....||.|+||.||++... ++..||+|.+....   ......+.+|+.+++.++|+||+++++++ ..+..+++||
T Consensus        23 ~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e   99 (292)
T cd06658          23 YLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRK---QQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVME   99 (292)
T ss_pred             HHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecch---HHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEe
Confidence            3444567999999999999864 58899999875432   23355788999999999999999999854 4555789999


Q ss_pred             ecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCCCCCCc
Q 012765          221 FLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSH  300 (457)
Q Consensus       221 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~~~~~  300 (457)
                      |+++++|.+++..  ..+++..++.++.||+.||.|||+   .+++||||||+||+++.++.++|+|||++.........
T Consensus       100 ~~~~~~L~~~~~~--~~l~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~~  174 (292)
T cd06658         100 FLEGGALTDIVTH--TRMNEEQIATVCLSVLRALSYLHN---QGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPK  174 (292)
T ss_pred             CCCCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEcCCCCEEEccCcchhhccccccc
Confidence            9999999998743  357889999999999999999999   89999999999999999999999999998765433211


Q ss_pred             eeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhccccccCCcccccCchhhcccCH
Q 012765          301 HIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSNFKELVDPRLADAYDL  380 (457)
Q Consensus       301 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~  380 (457)
                        .....|+..|+|||++.+..++.++||||||+++|||++|+.||...........        +.....+.+...  .
T Consensus       175 --~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~--------~~~~~~~~~~~~--~  242 (292)
T cd06658         175 --RKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRR--------IRDNLPPRVKDS--H  242 (292)
T ss_pred             --CceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH--------HHhcCCCccccc--c
Confidence              1223488999999999888899999999999999999999999975432211110        001111111111  1


Q ss_pred             HHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 012765          381 AEMKRAMLTASVCIHHLSTMRPQMTRVLQL  410 (457)
Q Consensus       381 ~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~  410 (457)
                      .....+..++..||..+|.+|||+.++++.
T Consensus       243 ~~~~~~~~li~~~l~~~P~~Rpt~~~il~~  272 (292)
T cd06658         243 KVSSVLRGFLDLMLVREPSQRATAQELLQH  272 (292)
T ss_pred             ccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence            122346677888999999999999999973

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=2.1e-36  Score=295.34  Aligned_cols=243  Identities=21%  Similarity=0.295  Sum_probs=190.2

Q ss_pred             CceecccCcEEEEEEEeC-CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeee-ecCceEEEEEecCC
Q 012765          147 ENLIGKGGHAEVYKGCLP-DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFS-TENGFHLVLQFLPH  224 (457)
Q Consensus       147 ~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~-~~~~~~lv~e~~~~  224 (457)
                      ...||+|+||.||+|... +++.||+|.+.....   .....+.+|+.++..++|||++++++++ .++..++++||+++
T Consensus        26 ~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~---~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~  102 (297)
T cd06659          26 YIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQ---QRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQG  102 (297)
T ss_pred             hhhcCCCCceeEEEEEEcCCCCEEEEEEEEeccc---chHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCC
Confidence            457999999999999864 689999998854322   2245688999999999999999999954 45567899999999


Q ss_pred             CChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCCCCCCceeee
Q 012765          225 GSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVF  304 (457)
Q Consensus       225 gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~~~~~~~~~  304 (457)
                      ++|..++..  ..+++..++.++.|++.||.|||+   .+++||||||+||+++.++.++|+|||++..+......  ..
T Consensus       103 ~~L~~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~---~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~~--~~  175 (297)
T cd06659         103 GALTDIVSQ--TRLNEEQIATVCESVLQALCYLHS---QGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPK--RK  175 (297)
T ss_pred             CCHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHeEEccCCcEEEeechhHhhccccccc--cc
Confidence            999987733  457899999999999999999999   89999999999999999999999999998765443221  12


Q ss_pred             cccccccccChhccccCCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhccccccCCcccccCchhhcccCHHHHH
Q 012765          305 PIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSNFKELVDPRLADAYDLAEMK  384 (457)
Q Consensus       305 ~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~  384 (457)
                      ...|+..|+|||++.+..++.++|||||||++|||++|+.||.............   ...     .+....  ......
T Consensus       176 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~---~~~-----~~~~~~--~~~~~~  245 (297)
T cd06659         176 SLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLR---DSP-----PPKLKN--AHKISP  245 (297)
T ss_pred             ceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHh---ccC-----CCCccc--cCCCCH
Confidence            3458899999999998889999999999999999999999997543322111100   000     000000  001123


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHHH
Q 012765          385 RAMLTASVCIHHLSTMRPQMTRVLQ  409 (457)
Q Consensus       385 ~l~~l~~~Cl~~dP~~RPt~~evl~  409 (457)
                      .+.+++.+||+.+|.+||++.+|++
T Consensus       246 ~l~~~i~~~l~~~P~~Rps~~~ll~  270 (297)
T cd06659         246 VLRDFLERMLTREPQERATAQELLD  270 (297)
T ss_pred             HHHHHHHHHhcCCcccCcCHHHHhh
Confidence            4667888999999999999999998

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8e-38  Score=301.17  Aligned_cols=246  Identities=28%  Similarity=0.403  Sum_probs=199.8

Q ss_pred             hcCCCCCceecccCcEEEEEEEe-CCCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCccee-eeeeecCceEEE
Q 012765          141 TDNFNSENLIGKGGHAEVYKGCL-PDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKL-IGFSTENGFHLV  218 (457)
Q Consensus       141 ~~~f~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l-~~~~~~~~~~lv  218 (457)
                      .+.|..-.+||+||||.||-++. .+|+.||.|++.+..........-.++|-.+|.+++.+.||.+ |+|.+.+.+|+|
T Consensus       184 ~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClV  263 (591)
T KOG0986|consen  184 KNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLV  263 (591)
T ss_pred             ccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEE
Confidence            46778889999999999999874 4699999998876655555556678899999999999999999 568889999999


Q ss_pred             EEecCCCChhhhhhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCCCC
Q 012765          219 LQFLPHGSLSSLLFGST-ECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDN  297 (457)
Q Consensus       219 ~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~~  297 (457)
                      +..|.||+|.-+|.+.+ ..+++....-++.+|+.||.+||.   .+||+|||||+|||||+.|+++|+|.|++..+...
T Consensus       264 LtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~---~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g  340 (591)
T KOG0986|consen  264 LTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHR---RRIVYRDLKPENILLDDHGHVRISDLGLAVEIPEG  340 (591)
T ss_pred             EEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHh---cceeeccCChhheeeccCCCeEeeccceEEecCCC
Confidence            99999999999987644 458888888899999999999999   89999999999999999999999999999999877


Q ss_pred             CCceeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhccccccCCcccccCchhh--
Q 012765          298 WSHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSNFKELVDPRLA--  375 (457)
Q Consensus       298 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~--  375 (457)
                      ....   ...||.+|||||++.++.|+...|+|||||+||||+.|+.||.........            +-+|.+..  
T Consensus       341 ~~~~---~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~------------eEvdrr~~~~  405 (591)
T KOG0986|consen  341 KPIR---GRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKR------------EEVDRRTLED  405 (591)
T ss_pred             Cccc---cccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhH------------HHHHHHHhcc
Confidence            5443   335999999999999999999999999999999999999999853321110            01111111  


Q ss_pred             -cccCHHHHHHHHHHHHHhcccCCCCCCCH
Q 012765          376 -DAYDLAEMKRAMLTASVCIHHLSTMRPQM  404 (457)
Q Consensus       376 -~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~  404 (457)
                       ..|+.........+....|+.||.+|.-.
T Consensus       406 ~~ey~~kFS~eakslc~~LL~Kdp~~RLGc  435 (591)
T KOG0986|consen  406 PEEYSDKFSEEAKSLCEGLLTKDPEKRLGC  435 (591)
T ss_pred             hhhcccccCHHHHHHHHHHHccCHHHhccC
Confidence             12233334445556666899999998644

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3e-36  Score=290.54  Aligned_cols=247  Identities=27%  Similarity=0.437  Sum_probs=193.5

Q ss_pred             CCCCCceecccCcEEEEEEEe-CCCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcC---CCCcceeeeeeecC-ceEE
Q 012765          143 NFNSENLIGKGGHAEVYKGCL-PDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHIN---HPNAAKLIGFSTEN-GFHL  217 (457)
Q Consensus       143 ~f~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~---hpniv~l~~~~~~~-~~~l  217 (457)
                      .|+..+.||.|+||.||+|.+ .+++.||+|.+.....  ......+.+|+.+++.++   |||++++++++..+ ..++
T Consensus         2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~l   79 (277)
T cd06917           2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTP--DDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWI   79 (277)
T ss_pred             hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCC--chhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEE
Confidence            467788999999999999986 4689999998754322  233557888999999886   99999999966554 4689


Q ss_pred             EEEecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCCCC
Q 012765          218 VLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDN  297 (457)
Q Consensus       218 v~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~~  297 (457)
                      +|||+++++|.+++..  ..+++...+.++.|++.||.|||+   .+++|+||+|+||+++.++.++|+|||++..+...
T Consensus        80 v~e~~~~~~L~~~~~~--~~l~~~~~~~i~~~i~~~l~~lh~---~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~  154 (277)
T cd06917          80 IMEYAEGGSVRTLMKA--GPIAEKYISVIIREVLVALKYIHK---VGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQN  154 (277)
T ss_pred             EEecCCCCcHHHHHHc--cCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCcCHHHEEEcCCCCEEEccCCceeecCCC
Confidence            9999999999998854  368899999999999999999999   89999999999999999999999999999877544


Q ss_pred             CCceeeecccccccccChhccccC-CCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhccccccCCcccccCchhhc
Q 012765          298 WSHHIVFPIEGTFGYLSPEYFMHG-IVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSNFKELVDPRLAD  376 (457)
Q Consensus       298 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  376 (457)
                      ...  .....|+..|+|||.+.++ .++.++|+||||+++|+|++|..||...........   ....     ..+.+..
T Consensus       155 ~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~---~~~~-----~~~~~~~  224 (277)
T cd06917         155 SSK--RSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMML---IPKS-----KPPRLED  224 (277)
T ss_pred             ccc--cccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhc---cccC-----CCCCCCc
Confidence            321  2234588999999998654 478999999999999999999999976432211100   0000     1111111


Q ss_pred             ccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 012765          377 AYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQ  409 (457)
Q Consensus       377 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~  409 (457)
                      .   .....+.+++.+||+.||++||++.++++
T Consensus       225 ~---~~~~~~~~~i~~~l~~~p~~R~~~~~il~  254 (277)
T cd06917         225 N---GYSKLLREFVAACLDEEPKERLSAEELLK  254 (277)
T ss_pred             c---cCCHHHHHHHHHHcCCCcccCcCHHHHhh
Confidence            1   12345677888999999999999999987

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=2.6e-36  Score=288.14  Aligned_cols=251  Identities=29%  Similarity=0.401  Sum_probs=199.9

Q ss_pred             cCCCCCceecccCcEEEEEEEeC-CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeec-CceEEEE
Q 012765          142 DNFNSENLIGKGGHAEVYKGCLP-DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTE-NGFHLVL  219 (457)
Q Consensus       142 ~~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-~~~~lv~  219 (457)
                      ++|++.+.||.|++|.||+|... +++.|++|++......  .....+.+|+..+.+++|+|++++++++.. +..+++|
T Consensus         1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   78 (264)
T cd06623           1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDE--EFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVL   78 (264)
T ss_pred             CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcch--HHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEE
Confidence            46888899999999999999876 4999999988654332  345689999999999999999999996655 4568999


Q ss_pred             EecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCCCCCC
Q 012765          220 QFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWS  299 (457)
Q Consensus       220 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~~~~  299 (457)
                      ||+++++|.+++... ..+++..++.++.|++.||.|||+.  .+++|+||+|+||+++.++.++|+|||++........
T Consensus        79 e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~l~~~l~~lh~~--~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~  155 (264)
T cd06623          79 EYMDGGSLADLLKKV-GKIPEPVLAYIARQILKGLDYLHTK--RHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLD  155 (264)
T ss_pred             EecCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhcc--CCCccCCCCHHHEEECCCCCEEEccCccceecccCCC
Confidence            999999999998654 5689999999999999999999983  5899999999999999999999999999987654332


Q ss_pred             ceeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHhCCCCCCcCCc-chhhhhccccccCCcccccCchhhccc
Q 012765          300 HHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQ-SLVIWAKPLLQTSNFKELVDPRLADAY  378 (457)
Q Consensus       300 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLltG~~pf~~~~~-~~~~~~~~~~~~~~~~~~~d~~l~~~~  378 (457)
                      ..  ....++..|+|||.+.+..++.++|+||||+++|+|++|+.||..... .......         .+..... ...
T Consensus       156 ~~--~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~---------~~~~~~~-~~~  223 (264)
T cd06623         156 QC--NTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQ---------AICDGPP-PSL  223 (264)
T ss_pred             cc--cceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHH---------HHhcCCC-CCC
Confidence            21  233478899999999988999999999999999999999999986542 0000000         0000000 011


Q ss_pred             CHH-HHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 012765          379 DLA-EMKRAMLTASVCIHHLSTMRPQMTRVLQ  409 (457)
Q Consensus       379 ~~~-~~~~l~~l~~~Cl~~dP~~RPt~~evl~  409 (457)
                      ... ....+.+++.+||..+|++||++.++++
T Consensus       224 ~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~  255 (264)
T cd06623         224 PAEEFSPEFRDFISACLQKDPKKRPSAAELLQ  255 (264)
T ss_pred             CcccCCHHHHHHHHHHccCChhhCCCHHHHHh
Confidence            111 3456778899999999999999999987

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=1.5e-36  Score=298.07  Aligned_cols=263  Identities=21%  Similarity=0.301  Sum_probs=191.1

Q ss_pred             CCCCCceecccCcEEEEEEEeC---CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeecC---ceE
Q 012765          143 NFNSENLIGKGGHAEVYKGCLP---DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTEN---GFH  216 (457)
Q Consensus       143 ~f~~~~~LG~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~---~~~  216 (457)
                      +|.+.+.||+|+||.||+|...   +++.||+|.+.............+.+|+.++..++||||+++++++.+.   ..+
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   80 (316)
T cd07842           1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY   80 (316)
T ss_pred             CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence            4778899999999999999864   4789999998764322222335678899999999999999999976554   468


Q ss_pred             EEEEecCCCChhhhhhc----CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcC----CCcEEEeec
Q 012765          217 LVLQFLPHGSLSSLLFG----STECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSE----DYEAQISDF  288 (457)
Q Consensus       217 lv~e~~~~gsL~~~l~~----~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~----~~~~kL~DF  288 (457)
                      +||||+.+ ++..++..    ....++...++.++.||+.||.|||+   .+|+||||||+||+++.    ++.+||+||
T Consensus        81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~h~dlkp~Nil~~~~~~~~~~~kl~Df  156 (316)
T cd07842          81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHS---NWVLHRDLKPANILVMGEGPERGVVKIGDL  156 (316)
T ss_pred             EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHh---CCEeeCCCCHHHEEEcCCCCccceEEECCC
Confidence            99999875 56665532    12367888999999999999999999   89999999999999999    899999999


Q ss_pred             cccccCCCCCCc-eeeecccccccccChhccccC-CCCcchhHHHHHHHHHHHHhCCCCCCcCCcchh-----------h
Q 012765          289 GLAKWLPDNWSH-HIVFPIEGTFGYLSPEYFMHG-IVDEKTDVFAFGVLLLELITGRRAVDSRRQSLV-----------I  355 (457)
Q Consensus       289 Gl~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~-----------~  355 (457)
                      |++..+...... .......++..|+|||++.+. .++.++|||||||++++|++|+.||........           .
T Consensus       157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (316)
T cd07842         157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLER  236 (316)
T ss_pred             ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHH
Confidence            999876443221 112234578899999988764 589999999999999999999999986443220           0


Q ss_pred             hhcc-----------ccccCCcccc---------cCchhhcccCH--HHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 012765          356 WAKP-----------LLQTSNFKEL---------VDPRLADAYDL--AEMKRAMLTASVCIHHLSTMRPQMTRVLQ  409 (457)
Q Consensus       356 ~~~~-----------~~~~~~~~~~---------~d~~l~~~~~~--~~~~~l~~l~~~Cl~~dP~~RPt~~evl~  409 (457)
                      ....           ..........         ....+...+..  .....+.+++.+||+.||++|||+.|+++
T Consensus       237 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~  312 (316)
T cd07842         237 IFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALE  312 (316)
T ss_pred             HHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence            0000           0000000000         00011110111  22345788999999999999999999975

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=5.8e-36  Score=286.00  Aligned_cols=252  Identities=27%  Similarity=0.444  Sum_probs=196.7

Q ss_pred             CCCCCceecccCcEEEEEEEeC-CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeec-CceEEEEE
Q 012765          143 NFNSENLIGKGGHAEVYKGCLP-DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTE-NGFHLVLQ  220 (457)
Q Consensus       143 ~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-~~~~lv~e  220 (457)
                      +|.+.+.||+|+||.||+|... +++.|++|.+...... ......+.+|+.+++.++|+||+++++++.. +..++++|
T Consensus         1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e   79 (264)
T cd06626           1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDND-PKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFME   79 (264)
T ss_pred             CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccc-hHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEe
Confidence            4778899999999999999864 6889999988654432 3456789999999999999999999997654 45679999


Q ss_pred             ecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCCCCCCc
Q 012765          221 FLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSH  300 (457)
Q Consensus       221 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~~~~~  300 (457)
                      |+++++|.+++... ..+++..+..++.+++.||.|||+   .+++|+||+|+||+++.++.+||+|||++.........
T Consensus        80 ~~~~~~L~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lh~---~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~  155 (264)
T cd06626          80 YCSGGTLEELLEHG-RILDEHVIRVYTLQLLEGLAYLHS---HGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTT  155 (264)
T ss_pred             cCCCCcHHHHHhhc-CCCChHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCc
Confidence            99999999998653 347888899999999999999999   89999999999999999999999999999877543322


Q ss_pred             ee--eecccccccccChhccccCC---CCcchhHHHHHHHHHHHHhCCCCCCcCCcchhh-hhccccccCCcccccCchh
Q 012765          301 HI--VFPIEGTFGYLSPEYFMHGI---VDEKTDVFAFGVLLLELITGRRAVDSRRQSLVI-WAKPLLQTSNFKELVDPRL  374 (457)
Q Consensus       301 ~~--~~~~~gt~~y~aPE~~~~~~---~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~-~~~~~~~~~~~~~~~d~~l  374 (457)
                      ..  .....++..|+|||++.+..   ++.++||||||+++++|++|+.||...+..... +.....        ..+.+
T Consensus       156 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~~--------~~~~~  227 (264)
T cd06626         156 MGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAG--------HKPPI  227 (264)
T ss_pred             ccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhcC--------CCCCC
Confidence            11  11245788999999998766   889999999999999999999999754321111 111000        01111


Q ss_pred             hcccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 012765          375 ADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQ  409 (457)
Q Consensus       375 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~  409 (457)
                      ...  ......+.+++.+||+.+|.+|||+.+++.
T Consensus       228 ~~~--~~~~~~~~~li~~~l~~~p~~R~~~~~i~~  260 (264)
T cd06626         228 PDS--LQLSPEGKDFLDRCLESDPKKRPTASELLQ  260 (264)
T ss_pred             Ccc--cccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence            111  111344567889999999999999999875

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=2.6e-36  Score=288.62  Aligned_cols=244  Identities=22%  Similarity=0.276  Sum_probs=192.4

Q ss_pred             ecccCcEEEEEEEeC-CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeee-cCceEEEEEecCCCCh
Q 012765          150 IGKGGHAEVYKGCLP-DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFST-ENGFHLVLQFLPHGSL  227 (457)
Q Consensus       150 LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~-~~~~~lv~e~~~~gsL  227 (457)
                      ||.|+||.||+|.+. +++.+|+|.+.............+.+|+.+++.++||||+++++++. +...++++||+++++|
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL   80 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence            799999999999875 48999999987655444445678999999999999999999999654 4557899999999999


Q ss_pred             hhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCCCCCCceeeeccc
Q 012765          228 SSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIE  307 (457)
Q Consensus       228 ~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~~~~~~~~~~~~  307 (457)
                      .+++... ..+++..+..++.||+.||.|||+   .+++|+||+|+||+++.++.++|+|||++........   .....
T Consensus        81 ~~~l~~~-~~l~~~~~~~~~~~i~~~l~~lH~---~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~~---~~~~~  153 (262)
T cd05572          81 WTILRDR-GLFDEYTARFYIACVVLAFEYLHN---RGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQK---TWTFC  153 (262)
T ss_pred             HHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCHHHEEEcCCCCEEEeeCCcccccCcccc---ccccc
Confidence            9998653 347888999999999999999999   8999999999999999999999999999987755421   12235


Q ss_pred             ccccccChhccccCCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhccccccCCcccccCchhhcccCHHHHHHHH
Q 012765          308 GTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSNFKELVDPRLADAYDLAEMKRAM  387 (457)
Q Consensus       308 gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~  387 (457)
                      ++..|+|||.+.+..++.++|+||||+++|+|++|..||.............         +.+......+.......+.
T Consensus       154 ~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~~  224 (262)
T cd05572         154 GTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYND---------ILKGNGKLEFPNYIDKAAK  224 (262)
T ss_pred             CCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHH---------HhccCCCCCCCcccCHHHH
Confidence            7889999999988889999999999999999999999998644211111111         1100000111111245678


Q ss_pred             HHHHHhcccCCCCCCC-----HHHHHH
Q 012765          388 LTASVCIHHLSTMRPQ-----MTRVLQ  409 (457)
Q Consensus       388 ~l~~~Cl~~dP~~RPt-----~~evl~  409 (457)
                      .++.+||+.+|++||+     +.|+++
T Consensus       225 ~~i~~~l~~~p~~R~~~~~~~~~~l~~  251 (262)
T cd05572         225 DLIKQLLRRNPEERLGNLKGGIKDIKK  251 (262)
T ss_pred             HHHHHHccCChhhCcCCcccCHHHHhc
Confidence            8999999999999999     566654

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=1.4e-36  Score=301.85  Aligned_cols=269  Identities=21%  Similarity=0.286  Sum_probs=196.7

Q ss_pred             hhcCCCCCceecccCcEEEEEEEeC-CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeecC-----
Q 012765          140 ATDNFNSENLIGKGGHAEVYKGCLP-DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTEN-----  213 (457)
Q Consensus       140 ~~~~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~-----  213 (457)
                      ..++|.+.+.||+|+||.||+|... +|+.||+|.+.....  ......+.+|+.++++++||||+++++++...     
T Consensus         3 ~~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~   80 (336)
T cd07849           3 VGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEH--QTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESF   80 (336)
T ss_pred             cccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEeccccc--chhHHHHHHHHHHHHhCCCCCcCchhheeeccccccc
Confidence            3578999999999999999999854 689999998853221  23345788899999999999999999865443     


Q ss_pred             -ceEEEEEecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccc
Q 012765          214 -GFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAK  292 (457)
Q Consensus       214 -~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~  292 (457)
                       ..++++||+.+ +|..++.  ...+++..+..++.|++.||.|||+   .+|+||||||+||+++.++.+||+|||++.
T Consensus        81 ~~~~lv~e~~~~-~l~~~~~--~~~l~~~~~~~i~~ql~~aL~~LH~---~~ivH~dlkp~Nill~~~~~~kl~dfg~~~  154 (336)
T cd07849          81 NDVYIVQELMET-DLYKLIK--TQHLSNDHIQYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTNCDLKICDFGLAR  154 (336)
T ss_pred             ceEEEEehhccc-CHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEECCCCCEEECccccee
Confidence             35789999864 7777763  3468899999999999999999999   899999999999999999999999999987


Q ss_pred             cCCCCCCce-eeecccccccccChhcccc-CCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhh-hhccccccC---Cc
Q 012765          293 WLPDNWSHH-IVFPIEGTFGYLSPEYFMH-GIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVI-WAKPLLQTS---NF  366 (457)
Q Consensus       293 ~~~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~-~~~~~~~~~---~~  366 (457)
                      ......... ......|+..|+|||++.+ ..++.++|||||||++|+|++|+.||...+..... .........   ..
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~  234 (336)
T cd07849         155 IADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDL  234 (336)
T ss_pred             eccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHH
Confidence            764332211 1123458899999998754 56899999999999999999999999753321100 000000000   00


Q ss_pred             ccccCchhh---------cc-----cCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH--HhcCCC
Q 012765          367 KELVDPRLA---------DA-----YDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQL--LRGEGG  416 (457)
Q Consensus       367 ~~~~d~~l~---------~~-----~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~--L~~~~~  416 (457)
                      ..+.+....         ..     ........+.+++.+||+.+|++|||+.++++.  ++....
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~~  300 (336)
T cd07849         235 NCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYHD  300 (336)
T ss_pred             HHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccCC
Confidence            111110000         00     001123457789999999999999999999985  555443

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=3.8e-36  Score=290.63  Aligned_cols=260  Identities=26%  Similarity=0.327  Sum_probs=194.8

Q ss_pred             CCCCceecccCcEEEEEEEeC-CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeecC---ceEEEE
Q 012765          144 FNSENLIGKGGHAEVYKGCLP-DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTEN---GFHLVL  219 (457)
Q Consensus       144 f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~---~~~lv~  219 (457)
                      |.+.+.||.|+||.||+|... +++.+|+|++.... ........+.+|+.+++.++|||++++++++...   ..++++
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~   79 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMEN-EKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVF   79 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEeccc-ccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEe
Confidence            567789999999999999865 58899999987653 1223345788999999999999999999976654   578999


Q ss_pred             EecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCCCCCC
Q 012765          220 QFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWS  299 (457)
Q Consensus       220 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~~~~  299 (457)
                      ||+++ +|..++......+++..++.++.||+.||.|||+   .+++|+||+|+||++++++.++|+|||++........
T Consensus        80 e~~~~-~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~---~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~  155 (287)
T cd07840          80 EYMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHS---NGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNS  155 (287)
T ss_pred             ccccc-cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCcHHHeEEcCCCCEEEccccceeeccCCCc
Confidence            99975 8888886655678999999999999999999999   8999999999999999999999999999987755421


Q ss_pred             ceeeecccccccccChhcccc-CCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhh-hccccc---cCCcc-------
Q 012765          300 HHIVFPIEGTFGYLSPEYFMH-GIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIW-AKPLLQ---TSNFK-------  367 (457)
Q Consensus       300 ~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~-~~~~~~---~~~~~-------  367 (457)
                      . ......++..|+|||.+.+ ..++.++||||||+++|||++|+.||.........- ......   .....       
T Consensus       156 ~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (287)
T cd07840         156 A-DYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPW  234 (287)
T ss_pred             c-cccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchh
Confidence            1 1122346788999998765 457899999999999999999999997644321100 000000   00000       


Q ss_pred             -------cccCchhhcccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 012765          368 -------ELVDPRLADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQ  409 (457)
Q Consensus       368 -------~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~  409 (457)
                             ......+...+.......+.+++.+||+.+|.+||++.++++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~  283 (287)
T cd07840         235 FENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ  283 (287)
T ss_pred             hhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence                   000001111111112456789999999999999999999986

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-38  Score=284.94  Aligned_cols=253  Identities=24%  Similarity=0.262  Sum_probs=195.2

Q ss_pred             hhcCCCCCceecccCcEEEEEEEe-CCCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeec-CceEE
Q 012765          140 ATDNFNSENLIGKGGHAEVYKGCL-PDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTE-NGFHL  217 (457)
Q Consensus       140 ~~~~f~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-~~~~l  217 (457)
                      +.+.|++-+.||+|.|+.||+... .+|+.+|+|++.-+... ....+++.+|+.|-+.|+|||||++.....+ +-.|+
T Consensus         9 f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~-~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~yl   87 (355)
T KOG0033|consen    9 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLS-ARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYL   87 (355)
T ss_pred             cchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhc-cccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEE
Confidence            567788889999999999999864 57999999987543332 2356789999999999999999999985544 44579


Q ss_pred             EEEecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCC---CcEEEeeccccccC
Q 012765          218 VLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSED---YEAQISDFGLAKWL  294 (457)
Q Consensus       218 v~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~---~~~kL~DFGl~~~~  294 (457)
                      |+|++.|++|..-+... ..+++...-..++||+++|.|+|.   ++|||||+||+|+||...   .-+||+|||++..+
T Consensus        88 vFe~m~G~dl~~eIV~R-~~ySEa~aSH~~rQiLeal~yCH~---n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l  163 (355)
T KOG0033|consen   88 VFDLVTGGELFEDIVAR-EFYSEADASHCIQQILEALAYCHS---NGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEV  163 (355)
T ss_pred             EEecccchHHHHHHHHH-HHHHHHHHHHHHHHHHHHHHHHHh---cCceeccCChhheeeeeccCCCceeecccceEEEe
Confidence            99999999998766443 445666667788999999999999   899999999999999643   34999999999988


Q ss_pred             CCCCCceeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhccccccCCcccccCchh
Q 012765          295 PDNWSHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSNFKELVDPRL  374 (457)
Q Consensus       295 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l  374 (457)
                      .+..   ......||+.|||||++...+|+..+|||+-|||||-|+.|..||.+.+++... ........    -+++. 
T Consensus       164 ~~g~---~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rly-e~I~~g~y----d~~~~-  234 (355)
T KOG0033|consen  164 NDGE---AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLY-EQIKAGAY----DYPSP-  234 (355)
T ss_pred             CCcc---ccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHH-HHHhcccc----CCCCc-
Confidence            7443   334566999999999999999999999999999999999999999975543221 11000000    01111 


Q ss_pred             hcccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 012765          375 ADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQ  409 (457)
Q Consensus       375 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~  409 (457)
                         +-..-.....+++.+||..||.+|-|+.|.+.
T Consensus       235 ---~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~  266 (355)
T KOG0033|consen  235 ---EWDTVTPEAKSLIRRMLTVNPKKRITADEALK  266 (355)
T ss_pred             ---ccCcCCHHHHHHHHHHhccChhhhccHHHHhC
Confidence               11112234557888999999999999987654

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=6.2e-36  Score=289.96  Aligned_cols=251  Identities=24%  Similarity=0.369  Sum_probs=198.7

Q ss_pred             hhcCCCCCceecccCcEEEEEEEeC-CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeee-ecCceEE
Q 012765          140 ATDNFNSENLIGKGGHAEVYKGCLP-DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFS-TENGFHL  217 (457)
Q Consensus       140 ~~~~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~-~~~~~~l  217 (457)
                      ..+.|+..+.||.|+||.||+|.+. +++.+++|.+.....    ....+.+|+.+++.++|+|++++++++ .....++
T Consensus        17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l   92 (286)
T cd06614          17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ----NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWV   92 (286)
T ss_pred             ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch----hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEE
Confidence            4566778899999999999999876 688999998865433    345788999999999999999999855 4556789


Q ss_pred             EEEecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCCCC
Q 012765          218 VLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDN  297 (457)
Q Consensus       218 v~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~~  297 (457)
                      ++||+.+++|.+++......+++..++.++.|++.||.|||+   .+++|+||+|+||+++.++.++|+|||++......
T Consensus        93 v~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~---~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~  169 (286)
T cd06614          93 VMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHS---QNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKE  169 (286)
T ss_pred             EEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCChhhEEEcCCCCEEECccchhhhhccc
Confidence            999999999999997655578999999999999999999999   89999999999999999999999999998765432


Q ss_pred             CCceeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhccccccCCcccccCchhhcc
Q 012765          298 WSHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSNFKELVDPRLADA  377 (457)
Q Consensus       298 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~  377 (457)
                      ..  ......++..|+|||++.+..++.++|+||||+++|+|++|+.||.............   .........+     
T Consensus       170 ~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~---~~~~~~~~~~-----  239 (286)
T cd06614         170 KS--KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLIT---TKGIPPLKNP-----  239 (286)
T ss_pred             hh--hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH---hcCCCCCcch-----
Confidence            21  1122347889999999988889999999999999999999999997543321111100   0000000000     


Q ss_pred             cCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 012765          378 YDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQ  409 (457)
Q Consensus       378 ~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~  409 (457)
                        ......+.+++.+||+.+|..||++.+|++
T Consensus       240 --~~~~~~l~~li~~~l~~~p~~Rpt~~~il~  269 (286)
T cd06614         240 --EKWSPEFKDFLNKCLVKDPEKRPSAEELLQ  269 (286)
T ss_pred             --hhCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence              112245677899999999999999999987

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=5.1e-36  Score=289.98  Aligned_cols=243  Identities=23%  Similarity=0.274  Sum_probs=181.1

Q ss_pred             eecccCcEEEEEEEeC-CCcEEEEEEEeccchhhHHHHHHHHHHHH---HHhhcCCCCcceeeeeee-cCceEEEEEecC
Q 012765          149 LIGKGGHAEVYKGCLP-DGEVVAVKKIIKNAKEDEERISDFLSELG---IVAHINHPNAAKLIGFST-ENGFHLVLQFLP  223 (457)
Q Consensus       149 ~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~---~l~~l~hpniv~l~~~~~-~~~~~lv~e~~~  223 (457)
                      +||+|+||.||++... +++.+|+|.+.+...........+.+|..   ++...+|||++.+++++. ++..++||||++
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   80 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN   80 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence            4899999999999864 58999999886543322222223344443   334457999999998554 556789999999


Q ss_pred             CCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCCCCCCceee
Q 012765          224 HGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSHHIV  303 (457)
Q Consensus       224 ~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~~~~~~~~  303 (457)
                      +++|..++... ..+++.....++.|++.||.|||+   .+++||||||+|||++.++.++|+|||++........    
T Consensus        81 ~~~L~~~i~~~-~~l~~~~~~~i~~qi~~al~~lH~---~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~~----  152 (279)
T cd05633          81 GGDLHYHLSQH-GVFSEKEMRFYATEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP----  152 (279)
T ss_pred             CCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH---CCcCCCCCCHHHEEECCCCCEEEccCCcceeccccCc----
Confidence            99999888543 458999999999999999999999   8999999999999999999999999999876543221    


Q ss_pred             ecccccccccChhcccc-CCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhccccccCCcccccCchhhcccCHHH
Q 012765          304 FPIEGTFGYLSPEYFMH-GIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSNFKELVDPRLADAYDLAE  382 (457)
Q Consensus       304 ~~~~gt~~y~aPE~~~~-~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~  382 (457)
                      ....|+..|+|||.+.+ ..++.++|||||||++|+|++|..||...............      ......+..    ..
T Consensus       153 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~------~~~~~~~~~----~~  222 (279)
T cd05633         153 HASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMT------LTVNVELPD----SF  222 (279)
T ss_pred             cCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHh------hcCCcCCcc----cc
Confidence            22358999999999864 56899999999999999999999999753321111110000      001111111    22


Q ss_pred             HHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 012765          383 MKRAMLTASVCIHHLSTMRP-----QMTRVLQ  409 (457)
Q Consensus       383 ~~~l~~l~~~Cl~~dP~~RP-----t~~evl~  409 (457)
                      ...+..++.+||+.||.+||     ++.++++
T Consensus       223 ~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~  254 (279)
T cd05633         223 SPELKSLLEGLLQRDVSKRLGCLGRGAQEVKE  254 (279)
T ss_pred             CHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHh
Confidence            34566788899999999999     5988877

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=2.5e-36  Score=288.07  Aligned_cols=248  Identities=24%  Similarity=0.335  Sum_probs=193.4

Q ss_pred             ecccCcEEEEEEEeC-CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeee-cCceEEEEEecCCCCh
Q 012765          150 IGKGGHAEVYKGCLP-DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFST-ENGFHLVLQFLPHGSL  227 (457)
Q Consensus       150 LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~-~~~~~lv~e~~~~gsL  227 (457)
                      ||.|+||.||++... +|+.+++|.+.............+.+|+.++.+++||||+++++++. ....++++||+++++|
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL   80 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence            689999999999876 49999999886554444455678999999999999999999998554 4557899999999999


Q ss_pred             hhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCCCCCC------ce
Q 012765          228 SSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWS------HH  301 (457)
Q Consensus       228 ~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~~~~------~~  301 (457)
                      .+++.... .+++..++.++.||+.||.|||+   .+++|+||+|+||+++.++.++|+|||++........      ..
T Consensus        81 ~~~l~~~~-~~~~~~~~~i~~qi~~~L~~lH~---~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~  156 (265)
T cd05579          81 ASLLENVG-SLDEDVARIYIAEIVLALEYLHS---NGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEK  156 (265)
T ss_pred             HHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHH---cCeecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccccc
Confidence            99986543 68999999999999999999999   8999999999999999999999999999876533311      01


Q ss_pred             eeecccccccccChhccccCCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhccccccCCcccccCchhhcccCHH
Q 012765          302 IVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSNFKELVDPRLADAYDLA  381 (457)
Q Consensus       302 ~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~  381 (457)
                      ......++..|+|||.+....++.++||||||+++|+|++|..||............  .. ...      ....  ...
T Consensus       157 ~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~--~~-~~~------~~~~--~~~  225 (265)
T cd05579         157 EDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNI--LN-GKI------EWPE--DVE  225 (265)
T ss_pred             cccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH--hc-CCc------CCCc--ccc
Confidence            122345788999999998888999999999999999999999999754422111000  00 000      0000  001


Q ss_pred             HHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 012765          382 EMKRAMLTASVCIHHLSTMRPQMTRVLQLLR  412 (457)
Q Consensus       382 ~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~  412 (457)
                      ....+..++.+||+.+|.+|||+..|.+.|+
T Consensus       226 ~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~  256 (265)
T cd05579         226 VSDEAIDLISKLLVPDPEKRLGAKSIEEIKN  256 (265)
T ss_pred             CCHHHHHHHHHHhcCCHhhcCCCccHHHHhc
Confidence            2355678899999999999999976666554

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=8e-36  Score=288.00  Aligned_cols=255  Identities=22%  Similarity=0.256  Sum_probs=189.6

Q ss_pred             CCCCceecccCcEEEEEEEeC-CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcC-CCCcceeeeeeec---CceEEE
Q 012765          144 FNSENLIGKGGHAEVYKGCLP-DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHIN-HPNAAKLIGFSTE---NGFHLV  218 (457)
Q Consensus       144 f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~---~~~~lv  218 (457)
                      |++.+.||+|+||.||+|... +++.||+|++....... . .....+|+.++.++. |+|++++++++.+   +..+++
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~-~-~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv   78 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSL-E-QVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALV   78 (282)
T ss_pred             CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCc-h-hhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEE
Confidence            567789999999999999854 68999999876543222 1 224457888888885 9999999996654   457899


Q ss_pred             EEecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCCCCC
Q 012765          219 LQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNW  298 (457)
Q Consensus       219 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~~~  298 (457)
                      |||+. ++|.+.+......+++..++.++.|++.||.|||+   .+++||||+|+||+++. +.+||+|||++..+....
T Consensus        79 ~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~---~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~  153 (282)
T cd07831          79 FELMD-MNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHR---NGIFHRDIKPENILIKD-DILKLADFGSCRGIYSKP  153 (282)
T ss_pred             EecCC-ccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHH---CCceecccCHHHEEEcC-CCeEEEecccccccccCC
Confidence            99997 57888876655678999999999999999999999   89999999999999999 999999999998764432


Q ss_pred             CceeeecccccccccChhcccc-CCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchh-hhhcccc-----------ccCC
Q 012765          299 SHHIVFPIEGTFGYLSPEYFMH-GIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLV-IWAKPLL-----------QTSN  365 (457)
Q Consensus       299 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~-~~~~~~~-----------~~~~  365 (457)
                      ..   ....++..|+|||++.. ..++.++|||||||++|||++|..||...+.... .+.....           ....
T Consensus       154 ~~---~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (282)
T cd07831         154 PY---TEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSR  230 (282)
T ss_pred             Cc---CCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhcccc
Confidence            21   12347889999998654 5578999999999999999999999976432111 1000000           0000


Q ss_pred             -----cccccCchhhcccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 012765          366 -----FKELVDPRLADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQ  409 (457)
Q Consensus       366 -----~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~  409 (457)
                           +.......+.. ........+.+++.+||+.+|++||++.++++
T Consensus       231 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~  278 (282)
T cd07831         231 HMNYNFPSKKGTGLRK-LLPNASAEGLDLLKKLLAYDPDERITAKQALR  278 (282)
T ss_pred             cccccCcccccccHHH-HcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence                 00000000100 01123567889999999999999999999986

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=3.6e-36  Score=291.35  Aligned_cols=262  Identities=24%  Similarity=0.309  Sum_probs=196.8

Q ss_pred             cCCCCCceecccCcEEEEEEEeC-CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeec-CceEEEE
Q 012765          142 DNFNSENLIGKGGHAEVYKGCLP-DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTE-NGFHLVL  219 (457)
Q Consensus       142 ~~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-~~~~lv~  219 (457)
                      ++|++.+.||+|+||.||+|.+. +++.||+|++..... .......+.+|+++++.++|+||+++++++.. +..+++|
T Consensus         1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~   79 (288)
T cd07833           1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESED-DEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVF   79 (288)
T ss_pred             CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcc-cccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEE
Confidence            36888999999999999999865 588999998754322 22334678999999999999999999996655 4578999


Q ss_pred             EecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCCCCCC
Q 012765          220 QFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWS  299 (457)
Q Consensus       220 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~~~~  299 (457)
                      ||+.++.+..+.. ....+++..++.++.||+.||.|||+   .+++|+||+|+||++++++.+||+|||++........
T Consensus        80 e~~~~~~l~~~~~-~~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~  155 (288)
T cd07833          80 EYVERTLLELLEA-SPGGLPPDAVRSYIWQLLQAIAYCHS---HNIIHRDIKPENILVSESGVLKLCDFGFARALRARPA  155 (288)
T ss_pred             ecCCCCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCCEEEEeeecccccCCCcc
Confidence            9999876665553 34558899999999999999999999   8999999999999999999999999999987755432


Q ss_pred             ceeeecccccccccChhccccC-CCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhc-------------cccccC-
Q 012765          300 HHIVFPIEGTFGYLSPEYFMHG-IVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAK-------------PLLQTS-  364 (457)
Q Consensus       300 ~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~-------------~~~~~~-  364 (457)
                      . ......++..|+|||++.+. .++.++||||||+++|+|++|+.||.........+..             ...... 
T Consensus       156 ~-~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (288)
T cd07833         156 S-PLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPR  234 (288)
T ss_pred             c-cccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCcc
Confidence            1 12234578899999999887 8899999999999999999999999754322111110             000000 


Q ss_pred             ----CcccccCchh-hcccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 012765          365 ----NFKELVDPRL-ADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQ  409 (457)
Q Consensus       365 ----~~~~~~d~~l-~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~  409 (457)
                          ......++.. ...+.......+.+++.+||..+|++||++.+|++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  284 (288)
T cd07833         235 FAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ  284 (288)
T ss_pred             ccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence                0001111100 00111112466788999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=3.1e-36  Score=291.48  Aligned_cols=259  Identities=24%  Similarity=0.344  Sum_probs=190.8

Q ss_pred             CCCCCceecccCcEEEEEEEeC-CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeec-CceEEEEE
Q 012765          143 NFNSENLIGKGGHAEVYKGCLP-DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTE-NGFHLVLQ  220 (457)
Q Consensus       143 ~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-~~~~lv~e  220 (457)
                      +|+..+.||.|+||.||+|... +++.||+|++...... ......+.+|++++++++||||+++++++.+ +..+++||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e   79 (284)
T cd07860           1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTET-EGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE   79 (284)
T ss_pred             CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccc-cccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEee
Confidence            4788899999999999999865 6899999987543322 1223578899999999999999999996544 55789999


Q ss_pred             ecCCCChhhhhhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCCCCCC
Q 012765          221 FLPHGSLSSLLFGS-TECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWS  299 (457)
Q Consensus       221 ~~~~gsL~~~l~~~-~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~~~~  299 (457)
                      |+. ++|..++... ...+++..++.++.|++.||.|||+   .+++|+||+|+||+++.++.+||+|||++..+.....
T Consensus        80 ~~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~---~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~  155 (284)
T cd07860          80 FLH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR  155 (284)
T ss_pred             ccc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEEeeccchhhcccCcc
Confidence            995 6788887543 4568999999999999999999999   8999999999999999999999999999876643321


Q ss_pred             ceeeecccccccccChhccccCC-CCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhc-cccccC-------------
Q 012765          300 HHIVFPIEGTFGYLSPEYFMHGI-VDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAK-PLLQTS-------------  364 (457)
Q Consensus       300 ~~~~~~~~gt~~y~aPE~~~~~~-~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~-~~~~~~-------------  364 (457)
                      .  .....++..|+|||++.+.. ++.++||||||+++|||+||+.||............ ......             
T Consensus       156 ~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (284)
T cd07860         156 T--YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPD  233 (284)
T ss_pred             c--cccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHH
Confidence            1  12234688999999887644 688999999999999999999999754322111000 000000             


Q ss_pred             ---CcccccCchhhcccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 012765          365 ---NFKELVDPRLADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQ  409 (457)
Q Consensus       365 ---~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~  409 (457)
                         .+..+....+... .......+.+++.+||+.||.+|||+.++++
T Consensus       234 ~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~  280 (284)
T cd07860         234 YKPSFPKWARQDFSKV-VPPLDEDGRDLLSQMLHYDPNKRISAKAALA  280 (284)
T ss_pred             HHhhcccccccCHHHH-cccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence               0001111100000 0011234567899999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=4.7e-36  Score=285.10  Aligned_cols=247  Identities=25%  Similarity=0.381  Sum_probs=197.7

Q ss_pred             CCCCCceecccCcEEEEEEEeC-CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeee-eecCceEEEEE
Q 012765          143 NFNSENLIGKGGHAEVYKGCLP-DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGF-STENGFHLVLQ  220 (457)
Q Consensus       143 ~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~-~~~~~~~lv~e  220 (457)
                      +|++.+.||.|+||.||++... +++.+|+|.+...... ......+.+|+.+++.++|+||++++++ +.....++++|
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e   79 (256)
T cd08530           1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMS-QKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVME   79 (256)
T ss_pred             CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhcc-HHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEeh
Confidence            4778899999999999999754 6889999988654322 2345678899999999999999999985 44556789999


Q ss_pred             ecCCCChhhhhhc---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCCCC
Q 012765          221 FLPHGSLSSLLFG---STECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDN  297 (457)
Q Consensus       221 ~~~~gsL~~~l~~---~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~~  297 (457)
                      |+++++|..++..   ....+++..++.++.|++.||.|||+   .+++|+||+|+||+++.++.+||+|||++......
T Consensus        80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~---~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~  156 (256)
T cd08530          80 YAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHE---QKILHRDLKSANILLVANDLVKIGDLGISKVLKKN  156 (256)
T ss_pred             hcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCcceEEEecCCcEEEeeccchhhhccC
Confidence            9999999998854   23568899999999999999999999   89999999999999999999999999999877554


Q ss_pred             CCceeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhccccccCCcccccCchhhcc
Q 012765          298 WSHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSNFKELVDPRLADA  377 (457)
Q Consensus       298 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~  377 (457)
                      ..    ....++..|+|||.+.+..++.++|+||||+++|+|++|+.||...+........   .....         ..
T Consensus       157 ~~----~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~---~~~~~---------~~  220 (256)
T cd08530         157 MA----KTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKV---QRGKY---------PP  220 (256)
T ss_pred             Cc----ccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH---hcCCC---------CC
Confidence            22    2234788999999999888999999999999999999999999864432111110   00110         11


Q ss_pred             cCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 012765          378 YDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQ  409 (457)
Q Consensus       378 ~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~  409 (457)
                      ........+..++.+||+.+|++||++.++++
T Consensus       221 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~  252 (256)
T cd08530         221 IPPIYSQDLQNFIRSMLQVKPKLRPNCDKILA  252 (256)
T ss_pred             CchhhCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence            11233456788999999999999999999986

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.7e-37  Score=307.96  Aligned_cols=248  Identities=28%  Similarity=0.412  Sum_probs=195.4

Q ss_pred             ceecccCcEEEEEEEeCC-CcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeecCceE-EEEEecCCC
Q 012765          148 NLIGKGGHAEVYKGCLPD-GEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTENGFH-LVLQFLPHG  225 (457)
Q Consensus       148 ~~LG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~-lv~e~~~~g  225 (457)
                      -+||+|.||+||.|++.+ ...+|||.+....   .+..+-+..|+.+-++|+|.|||+++|.+.+++++ +.||.++||
T Consensus       581 vVLGKGTYG~VYA~RD~~tqvrIaIKEIpekd---sr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGG  657 (1226)
T KOG4279|consen  581 VVLGKGTYGTVYAARDMDTQVRIAIKEIPEKD---SREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGG  657 (1226)
T ss_pred             EEeecCceeEEEeeccccceeEEEeeeccccc---chhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCC
Confidence            369999999999998654 5668888774332   23355788999999999999999999988777765 778999999


Q ss_pred             ChhhhhhcCCCCC--CHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEc-CCCcEEEeeccccccCCCCCCcee
Q 012765          226 SLSSLLFGSTECL--EWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLS-EDYEAQISDFGLAKWLPDNWSHHI  302 (457)
Q Consensus       226 sL~~~l~~~~~~~--~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~-~~~~~kL~DFGl~~~~~~~~~~~~  302 (457)
                      +|.++|+..-+++  ++...-.+..||++||.|||+   ..|||||||-+|||++ -.|.+||+|||-++.+..-.  ..
T Consensus       658 SLSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHe---n~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgin--P~  732 (1226)
T KOG4279|consen  658 SLSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHE---NKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGIN--PC  732 (1226)
T ss_pred             cHHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhh---cceeeccccCCcEEEeeccceEEecccccchhhccCC--cc
Confidence            9999998877776  677777788999999999999   8999999999999997 46899999999998874321  12


Q ss_pred             eecccccccccChhccccC--CCCcchhHHHHHHHHHHHHhCCCCCCcCCcch-hhhhccccccCCcccccCchhhcccC
Q 012765          303 VFPIEGTFGYLSPEYFMHG--IVDEKTDVFAFGVLLLELITGRRAVDSRRQSL-VIWAKPLLQTSNFKELVDPRLADAYD  379 (457)
Q Consensus       303 ~~~~~gt~~y~aPE~~~~~--~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~-~~~~~~~~~~~~~~~~~d~~l~~~~~  379 (457)
                      ..++.||..|||||++..+  +|+.++|||||||++.||.||++||...+..- ..+..-+       .-+.|    ...
T Consensus       733 TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkVGm-------yKvHP----~iP  801 (1226)
T KOG4279|consen  733 TETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKVGM-------YKVHP----PIP  801 (1226)
T ss_pred             ccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhhcc-------eecCC----CCc
Confidence            3345699999999999754  59999999999999999999999997533221 1111110       11223    333


Q ss_pred             HHHHHHHHHHHHHhcccCCCCCCCHHHHHH--HHhcC
Q 012765          380 LAEMKRAMLTASVCIHHLSTMRPQMTRVLQ--LLRGE  414 (457)
Q Consensus       380 ~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~--~L~~~  414 (457)
                      .+.......++.+|+..||..||+++++++  .|+..
T Consensus       802 eelsaeak~FilrcFepd~~~R~sA~~LL~DpFlq~~  838 (1226)
T KOG4279|consen  802 EELSAEAKNFILRCFEPDPCDRPSAKDLLQDPFLQHN  838 (1226)
T ss_pred             HHHHHHHHHHHHHHcCCCcccCccHHHhccCcccccC
Confidence            445566778899999999999999999987  55443

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=8.3e-36  Score=288.35  Aligned_cols=258  Identities=23%  Similarity=0.343  Sum_probs=191.8

Q ss_pred             CCCCCceecccCcEEEEEEEeC-CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeec-CceEEEEE
Q 012765          143 NFNSENLIGKGGHAEVYKGCLP-DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTE-NGFHLVLQ  220 (457)
Q Consensus       143 ~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-~~~~lv~e  220 (457)
                      +|+..+.||.|++|.||+|... +|+.||+|.+......  .....+.+|+.++++++||||+++++++.+ +..+++||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   78 (284)
T cd07836           1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEE--GTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFE   78 (284)
T ss_pred             CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccc--cchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEe
Confidence            5788899999999999999975 5889999988654322  223467789999999999999999996554 55789999


Q ss_pred             ecCCCChhhhhhcCC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCCCCC
Q 012765          221 FLPHGSLSSLLFGST--ECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNW  298 (457)
Q Consensus       221 ~~~~gsL~~~l~~~~--~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~~~  298 (457)
                      |+++ +|.+++....  ..+++..+..++.||+.||.|||+   .+++||||+|+||++++++.++|+|||++.......
T Consensus        79 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~  154 (284)
T cd07836          79 YMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHE---NRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPV  154 (284)
T ss_pred             cCCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCc
Confidence            9985 7888775433  458999999999999999999999   899999999999999999999999999997654321


Q ss_pred             CceeeecccccccccChhccccC-CCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhh------hhccc-------cccC
Q 012765          299 SHHIVFPIEGTFGYLSPEYFMHG-IVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVI------WAKPL-------LQTS  364 (457)
Q Consensus       299 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~------~~~~~-------~~~~  364 (457)
                      .  ......++..|+|||++.+. .++.++|||||||++|+|++|+.||.........      +..+.       ....
T Consensus       155 ~--~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (284)
T cd07836         155 N--TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLP  232 (284)
T ss_pred             c--ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCc
Confidence            1  11223468899999988654 5789999999999999999999999764321100      00000       0000


Q ss_pred             ----CcccccCchhhcccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 012765          365 ----NFKELVDPRLADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQ  409 (457)
Q Consensus       365 ----~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~  409 (457)
                          .+....+... ..........+.+++..|++.||.+||++.++++
T Consensus       233 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~  280 (284)
T cd07836         233 EYKPTFPRYPPQDL-QQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ  280 (284)
T ss_pred             hhcccccCCChHHH-HHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence                0000000000 0011122345778999999999999999999985

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=6.4e-36  Score=292.66  Aligned_cols=261  Identities=23%  Similarity=0.324  Sum_probs=191.5

Q ss_pred             hcCCCCCceecccCcEEEEEEEeC-CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeecC------
Q 012765          141 TDNFNSENLIGKGGHAEVYKGCLP-DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTEN------  213 (457)
Q Consensus       141 ~~~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~------  213 (457)
                      .++|++.+.||+|+||.||+|... +++.||+|.+....... .....+.+|+.++++++||||+++++++...      
T Consensus        11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~   89 (310)
T cd07865          11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKE-GFPITALREIKILQLLKHENVVNLIEICRTKATPYNR   89 (310)
T ss_pred             hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcC-CchhHHHHHHHHHHhCCCCCccceEEEEecccccccC
Confidence            357889999999999999999864 68999999886433221 1223566899999999999999999976542      


Q ss_pred             ---ceEEEEEecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccc
Q 012765          214 ---GFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGL  290 (457)
Q Consensus       214 ---~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl  290 (457)
                         ..+++|||+.+ +|..++......+++..++.++.||+.||.|||+   .+++|+||||+||+++.++.+||+|||+
T Consensus        90 ~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~  165 (310)
T cd07865          90 YKGSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHR---NKILHRDMKAANILITKDGILKLADFGL  165 (310)
T ss_pred             CCceEEEEEcCCCc-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEECCCCcEEECcCCC
Confidence               24899999864 7887776655578999999999999999999999   8999999999999999999999999999


Q ss_pred             cccCCCCCCc--eeeecccccccccChhccccC-CCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhh-hhccc---cc-
Q 012765          291 AKWLPDNWSH--HIVFPIEGTFGYLSPEYFMHG-IVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVI-WAKPL---LQ-  362 (457)
Q Consensus       291 ~~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~-~~~~~---~~-  362 (457)
                      +..+......  .......++..|+|||++.+. .++.++||||||+++|||++|..||......... .....   .. 
T Consensus       166 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (310)
T cd07865         166 ARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITP  245 (310)
T ss_pred             cccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCh
Confidence            9876433221  111223478889999988664 4789999999999999999999999764321100 00000   00 


Q ss_pred             ----cC-------------CcccccCchhhcccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 012765          363 ----TS-------------NFKELVDPRLADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQ  409 (457)
Q Consensus       363 ----~~-------------~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~  409 (457)
                          ..             .........+...   .....+.+++.+||+.||.+|||+.++++
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~---~~~~~~~dli~~~l~~~P~~R~t~~e~l~  306 (310)
T cd07865         246 EVWPGVDKLELFKKMELPQGQKRKVKERLKPY---VKDPHALDLIDKLLVLDPAKRIDADTALN  306 (310)
T ss_pred             hhcccccchhhhhhccCCCccchhhHHhcccc---cCCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence                00             0000000000000   01234568999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=6.1e-36  Score=293.46  Aligned_cols=262  Identities=25%  Similarity=0.317  Sum_probs=193.5

Q ss_pred             hhcCCCCCceecccCcEEEEEEEeC-CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeecC---ce
Q 012765          140 ATDNFNSENLIGKGGHAEVYKGCLP-DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTEN---GF  215 (457)
Q Consensus       140 ~~~~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~---~~  215 (457)
                      ..++|++.+.||.|+||.||+|.+. +|+.||+|.+....... .....+.+|+.++.+++|+|++++++++.+.   ..
T Consensus         5 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   83 (309)
T cd07845           5 SVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERD-GIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSI   83 (309)
T ss_pred             cccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCC-CCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeE
Confidence            3478899999999999999999864 58999999886433221 1123566899999999999999999976543   46


Q ss_pred             EEEEEecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCC
Q 012765          216 HLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLP  295 (457)
Q Consensus       216 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~  295 (457)
                      ++||||+.+ +|.+++......+++..++.++.||+.||.|||+   .+++||||||+||+++.++.+||+|||++....
T Consensus        84 ~lv~e~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~  159 (309)
T cd07845          84 FLVMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHE---NFIIHRDLKVSNLLLTDKGCLKIADFGLARTYG  159 (309)
T ss_pred             EEEEecCCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEECccceeeecC
Confidence            899999964 7888876555678999999999999999999999   899999999999999999999999999998765


Q ss_pred             CCCCceeeecccccccccChhcccc-CCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhc-cccccC---------
Q 012765          296 DNWSHHIVFPIEGTFGYLSPEYFMH-GIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAK-PLLQTS---------  364 (457)
Q Consensus       296 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~-~~~~~~---------  364 (457)
                      .....  .....++..|+|||.+.+ ..++.++|||||||++|||++|+.||............ ......         
T Consensus       160 ~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (309)
T cd07845         160 LPAKP--MTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFS  237 (309)
T ss_pred             CccCC--CCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhh
Confidence            43211  122335788999999865 45799999999999999999999999754322111000 000000         


Q ss_pred             --------CcccccCchhhcccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 012765          365 --------NFKELVDPRLADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQ  409 (457)
Q Consensus       365 --------~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~  409 (457)
                              .........+... .......+.+++.+||+.||++|||+.++++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~ml~~dp~~R~t~~~il~  289 (309)
T cd07845         238 DLPLVGKFTLPKQPYNNLKHK-FPWLSEAGLRLLNFLLMYDPKKRATAEEALE  289 (309)
T ss_pred             cccccccccccCCCCCchHHh-ccccCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence                    0000000000000 0012345667899999999999999999986

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=2.5e-36  Score=299.67  Aligned_cols=263  Identities=21%  Similarity=0.276  Sum_probs=195.3

Q ss_pred             hcCCCCCceecccCcEEEEEEEeC-CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeec-----Cc
Q 012765          141 TDNFNSENLIGKGGHAEVYKGCLP-DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTE-----NG  214 (457)
Q Consensus       141 ~~~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-----~~  214 (457)
                      .++|++.+.||.|+||.||+|... +|+.||+|++...... ......+.+|+.++..++||||+++++++..     ..
T Consensus         4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~   82 (334)
T cd07855           4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDV-PTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKD   82 (334)
T ss_pred             hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEecccccc-ccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCce
Confidence            478999999999999999999864 6899999988653222 2335577889999999999999999986532     34


Q ss_pred             eEEEEEecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccC
Q 012765          215 FHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWL  294 (457)
Q Consensus       215 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~  294 (457)
                      .++||||+. ++|..++... ..+++..+..++.||+.||.|||+   .+++||||||+||+++.++.+||+|||++...
T Consensus        83 ~~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~  157 (334)
T cd07855          83 VYVVMDLME-SDLHHIIHSD-QPLTEEHIRYFLYQLLRGLKYIHS---ANVIHRDLKPSNLLVNEDCELRIGDFGMARGL  157 (334)
T ss_pred             EEEEEehhh-hhHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCcEEecccccceee
Confidence            689999995 6888887543 448999999999999999999999   89999999999999999999999999999776


Q ss_pred             CCCCCc--eeeecccccccccChhcccc-CCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhccccccCC------
Q 012765          295 PDNWSH--HIVFPIEGTFGYLSPEYFMH-GIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSN------  365 (457)
Q Consensus       295 ~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~~~~~~~~------  365 (457)
                      ......  .......|+..|+|||.+.+ ..++.++|||||||++|||++|+.||...+...............      
T Consensus       158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~  237 (334)
T cd07855         158 SSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLN  237 (334)
T ss_pred             cccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhh
Confidence            433221  11123458899999999865 468999999999999999999999997644321111000000000      


Q ss_pred             ------cccccCc-hhhccc-----CHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 012765          366 ------FKELVDP-RLADAY-----DLAEMKRAMLTASVCIHHLSTMRPQMTRVLQ  409 (457)
Q Consensus       366 ------~~~~~d~-~l~~~~-----~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~  409 (457)
                            +.+..+. ......     .......+..++.+||+.+|.+||++.+++.
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~  293 (334)
T cd07855         238 RIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQ  293 (334)
T ss_pred             hhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence                  0000000 000000     1123456788999999999999999999887

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=5.6e-36  Score=291.43  Aligned_cols=260  Identities=21%  Similarity=0.276  Sum_probs=189.4

Q ss_pred             cCCCCCceecccCcEEEEEEEeC-CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeec-CceEEEE
Q 012765          142 DNFNSENLIGKGGHAEVYKGCLP-DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTE-NGFHLVL  219 (457)
Q Consensus       142 ~~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-~~~~lv~  219 (457)
                      ++|++.+.||.|++|+||+|... +++.||+|.+...... ......+.+|+.+++.++||||+++++++.. ...++||
T Consensus         2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   80 (294)
T PLN00009          2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQED-EGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVF   80 (294)
T ss_pred             CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhcccc-ccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEE
Confidence            56888999999999999999865 6889999987543221 1234567889999999999999999996655 5578999


Q ss_pred             EecCCCChhhhhhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcC-CCcEEEeeccccccCCCC
Q 012765          220 QFLPHGSLSSLLFGST-ECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSE-DYEAQISDFGLAKWLPDN  297 (457)
Q Consensus       220 e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~-~~~~kL~DFGl~~~~~~~  297 (457)
                      ||+. ++|..++.... ..+++.....++.||+.||.|||+   .+++|+||+|+||+++. ++.+||+|||++......
T Consensus        81 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~---~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~  156 (294)
T PLN00009         81 EYLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHS---HRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIP  156 (294)
T ss_pred             eccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCcceEEEECCCCEEEEcccccccccCCC
Confidence            9996 57777764432 336788888999999999999999   89999999999999985 557999999999765432


Q ss_pred             CCceeeecccccccccChhcccc-CCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhcc-ccccC-----------
Q 012765          298 WSHHIVFPIEGTFGYLSPEYFMH-GIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKP-LLQTS-----------  364 (457)
Q Consensus       298 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~~-~~~~~-----------  364 (457)
                      ..  ......++..|+|||++.+ ..++.++|||||||++|+|+||..||............. ....+           
T Consensus       157 ~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (294)
T PLN00009        157 VR--TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSL  234 (294)
T ss_pred             cc--ccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccc
Confidence            11  1122346889999999866 457899999999999999999999997643321111100 00000           


Q ss_pred             -C----cccccCchhhcccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 012765          365 -N----FKELVDPRLADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQ  409 (457)
Q Consensus       365 -~----~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~  409 (457)
                       .    ...+....+. .........+.+++.+|++.+|++||++.++++
T Consensus       235 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~  283 (294)
T PLN00009        235 PDYKSAFPKWPPKDLA-TVVPTLEPAGVDLLSKMLRLDPSKRITARAALE  283 (294)
T ss_pred             hhhhhhcccCCCCCHH-HhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence             0    0000000000 001112345678999999999999999999986

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=100.00  E-value=7.5e-36  Score=291.04  Aligned_cols=252  Identities=25%  Similarity=0.399  Sum_probs=189.5

Q ss_pred             hcCCCCCceecccCcEEEEEEEeCC-CcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcC-CCCcceeeeeeec-CceEE
Q 012765          141 TDNFNSENLIGKGGHAEVYKGCLPD-GEVVAVKKIIKNAKEDEERISDFLSELGIVAHIN-HPNAAKLIGFSTE-NGFHL  217 (457)
Q Consensus       141 ~~~f~~~~~LG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~-~~~~l  217 (457)
                      .++|.+.+.||+|+||.||+|.+.+ ++.||+|.+......  .....+..|+.++.+.. ||||+++++++.. ...++
T Consensus        14 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~--~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~   91 (296)
T cd06618          14 LNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNK--EENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFI   91 (296)
T ss_pred             cchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCCh--HHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEE
Confidence            4678889999999999999999764 899999998654322  23446677887776664 9999999996654 45789


Q ss_pred             EEEecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCCCC
Q 012765          218 VLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDN  297 (457)
Q Consensus       218 v~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~~  297 (457)
                      +|||+. +++..++......+++..+..++.||+.||.|||+.  .+|+||||+|+||+++.++.+||+|||++..+...
T Consensus        92 v~e~~~-~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~--~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~  168 (296)
T cd06618          92 CMELMS-TCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEK--HGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDS  168 (296)
T ss_pred             EeeccC-cCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhh--CCEecCCCcHHHEEEcCCCCEEECccccchhccCC
Confidence            999975 467766655455789999999999999999999972  58999999999999999999999999998776443


Q ss_pred             CCceeeecccccccccChhccccCC----CCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhccccccCCcccccCch
Q 012765          298 WSHHIVFPIEGTFGYLSPEYFMHGI----VDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSNFKELVDPR  373 (457)
Q Consensus       298 ~~~~~~~~~~gt~~y~aPE~~~~~~----~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~  373 (457)
                      ...   ....++..|+|||++.+..    ++.++||||||+++|+|++|+.||.................  .     +.
T Consensus       169 ~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~--~-----~~  238 (296)
T cd06618         169 KAK---TRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEE--P-----PS  238 (296)
T ss_pred             Ccc---cCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcCC--C-----CC
Confidence            221   2234788999999987543    78999999999999999999999975322211111110000  0     00


Q ss_pred             hhcccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 012765          374 LADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQ  409 (457)
Q Consensus       374 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~  409 (457)
                      +..  .......+.+++.+||+.+|++||++.++++
T Consensus       239 ~~~--~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~  272 (296)
T cd06618         239 LPP--NEGFSPDFCSFVDLCLTKDHRKRPKYRELLQ  272 (296)
T ss_pred             CCC--CCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            000  0012345778889999999999999999986

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=5.2e-36  Score=285.14  Aligned_cols=249  Identities=25%  Similarity=0.367  Sum_probs=194.3

Q ss_pred             CCCCCceecccCcEEEEEEEeC-CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeecC-ceEEEEE
Q 012765          143 NFNSENLIGKGGHAEVYKGCLP-DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTEN-GFHLVLQ  220 (457)
Q Consensus       143 ~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~-~~~lv~e  220 (457)
                      +|.+.+.||+|+||.||+|... +|..+|+|.+..... .......+.+|+.+++.++|+||+++++++..+ ..++++|
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e   79 (257)
T cd08225           1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKM-PVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVME   79 (257)
T ss_pred             CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhc-cchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEe
Confidence            4778899999999999999865 588999998755322 122345778999999999999999999966554 5689999


Q ss_pred             ecCCCChhhhhhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCC-cEEEeeccccccCCCCC
Q 012765          221 FLPHGSLSSLLFGST-ECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDY-EAQISDFGLAKWLPDNW  298 (457)
Q Consensus       221 ~~~~gsL~~~l~~~~-~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~-~~kL~DFGl~~~~~~~~  298 (457)
                      |+++++|.+++.... ..+++..+..++.|++.||.|||+   .+++|+||||+||++++++ .++|+|||.+.......
T Consensus        80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~  156 (257)
T cd08225          80 YCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHD---RKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSM  156 (257)
T ss_pred             cCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccccCCHHHEEEcCCCCeEEecccccchhccCCc
Confidence            999999999885533 357899999999999999999999   8999999999999999886 46999999998765432


Q ss_pred             CceeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhccccccCCcccccCchhhccc
Q 012765          299 SHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSNFKELVDPRLADAY  378 (457)
Q Consensus       299 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~  378 (457)
                      .  ......|+..|+|||++.+..++.++|+||||++++||++|..||.........  ..... ..    +.+ .    
T Consensus       157 ~--~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~--~~~~~-~~----~~~-~----  222 (257)
T cd08225         157 E--LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLV--LKICQ-GY----FAP-I----  222 (257)
T ss_pred             c--cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHH--HHHhc-cc----CCC-C----
Confidence            1  122245888999999998888999999999999999999999999753321111  11010 00    000 0    


Q ss_pred             CHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 012765          379 DLAEMKRAMLTASVCIHHLSTMRPQMTRVLQ  409 (457)
Q Consensus       379 ~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~  409 (457)
                      .......+.+++.+||..+|++|||+.+|++
T Consensus       223 ~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~  253 (257)
T cd08225         223 SPNFSRDLRSLISQLFKVSPRDRPSITSILK  253 (257)
T ss_pred             CCCCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence            1112245778889999999999999999976

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=6.1e-36  Score=291.06  Aligned_cols=260  Identities=18%  Similarity=0.230  Sum_probs=189.4

Q ss_pred             cCCCCCceecccCcEEEEEEEeC-CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcC-CCCcceeeeeeecCc-----
Q 012765          142 DNFNSENLIGKGGHAEVYKGCLP-DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHIN-HPNAAKLIGFSTENG-----  214 (457)
Q Consensus       142 ~~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~-----  214 (457)
                      ++|++.+.||+|+||.||+|.+. +++.||+|.+...... ......+.+|+.+++.+. ||||+++++++....     
T Consensus         1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~-~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~   79 (295)
T cd07837           1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDE-EGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKP   79 (295)
T ss_pred             CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccc-cCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCc
Confidence            46888999999999999999865 6899999987543221 122346788999999995 699999999655433     


Q ss_pred             -eEEEEEecCCCChhhhhhcC----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcC-CCcEEEeec
Q 012765          215 -FHLVLQFLPHGSLSSLLFGS----TECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSE-DYEAQISDF  288 (457)
Q Consensus       215 -~~lv~e~~~~gsL~~~l~~~----~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~-~~~~kL~DF  288 (457)
                       .+++|||+.+ +|..++...    ...+++..++.++.||+.||.|||+   .+++||||+|+||+++. ++.+||+||
T Consensus        80 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~---~~i~H~dl~~~nil~~~~~~~~kl~df  155 (295)
T cd07837          80 SLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHK---HGVMHRDLKPQNLLVDKQKGLLKIADL  155 (295)
T ss_pred             eEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCChHHEEEecCCCeEEEeec
Confidence             6899999985 788877442    2357999999999999999999999   89999999999999998 889999999


Q ss_pred             cccccCCCCCCceeeecccccccccChhcccc-CCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhc-cccccCC-
Q 012765          289 GLAKWLPDNWSHHIVFPIEGTFGYLSPEYFMH-GIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAK-PLLQTSN-  365 (457)
Q Consensus       289 Gl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~-~~~~~~~-  365 (457)
                      |++.........  .....+++.|+|||++.+ ..++.++||||||+++|+|++|..||.........+.. ....... 
T Consensus       156 g~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~  233 (295)
T cd07837         156 GLGRAFSIPVKS--YTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTE  233 (295)
T ss_pred             ccceecCCCccc--cCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCCh
Confidence            998765332111  112246888999998865 45799999999999999999999999764322111100 0000000 


Q ss_pred             --------------cccccCchhhcccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 012765          366 --------------FKELVDPRLADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQ  409 (457)
Q Consensus       366 --------------~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~  409 (457)
                                    ........+ ..........+.+++.+||..||.+||++.+++.
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~  290 (295)
T cd07837         234 QVWPGVSKLRDWHEFPQWKPQDL-SRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT  290 (295)
T ss_pred             hhCcchhhccchhhcCcccchhH-HHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence                          000000000 0001123345778999999999999999999875

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=1.1e-35  Score=289.70  Aligned_cols=250  Identities=21%  Similarity=0.346  Sum_probs=195.1

Q ss_pred             hcCCCCCceecccCcEEEEEEEeC-CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeee-cCceEEE
Q 012765          141 TDNFNSENLIGKGGHAEVYKGCLP-DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFST-ENGFHLV  218 (457)
Q Consensus       141 ~~~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~-~~~~~lv  218 (457)
                      .++|.+.+.||+|+||.||+|... +++.||+|.+.....   .....+.+|+.+++.++|||++++++++. .+..++|
T Consensus        18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~---~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv   94 (293)
T cd06647          18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQ---PKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVV   94 (293)
T ss_pred             hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccc---hHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEE
Confidence            367888999999999999999854 678899998753322   23457889999999999999999999654 4557899


Q ss_pred             EEecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCCCCC
Q 012765          219 LQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNW  298 (457)
Q Consensus       219 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~~~  298 (457)
                      +||+++++|.+++..  ..+++..+..++.|++.||.|||+   .+++|+||+|+||+++.++.++|+|||++.......
T Consensus        95 ~e~~~~~~L~~~~~~--~~l~~~~~~~i~~~l~~al~~LH~---~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~  169 (293)
T cd06647          95 MEYLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ  169 (293)
T ss_pred             EecCCCCcHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHh---CCEeeccCCHHHEEEcCCCCEEEccCcceecccccc
Confidence            999999999999843  357888899999999999999999   899999999999999999999999999987654332


Q ss_pred             CceeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhccccccCCcccccCchhhccc
Q 012765          299 SHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSNFKELVDPRLADAY  378 (457)
Q Consensus       299 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~  378 (457)
                      .  ......++..|+|||.+.+..++.++|+||||+++|+|++|+.||.............  ...      .+...  .
T Consensus       170 ~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~--~~~------~~~~~--~  237 (293)
T cd06647         170 S--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIA--TNG------TPELQ--N  237 (293)
T ss_pred             c--ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehh--cCC------CCCCC--C
Confidence            1  1122358889999999988889999999999999999999999997643321111000  000      00000  0


Q ss_pred             CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 012765          379 DLAEMKRAMLTASVCIHHLSTMRPQMTRVLQL  410 (457)
Q Consensus       379 ~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~  410 (457)
                      .......+..++.+||..+|++||++.+++..
T Consensus       238 ~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h  269 (293)
T cd06647         238 PEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH  269 (293)
T ss_pred             ccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            11123356678899999999999999999873

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=2.2e-35  Score=286.34  Aligned_cols=246  Identities=22%  Similarity=0.345  Sum_probs=192.5

Q ss_pred             CCCCceecccCcEEEEEEEe-CCCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeee-cCceEEEEEe
Q 012765          144 FNSENLIGKGGHAEVYKGCL-PDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFST-ENGFHLVLQF  221 (457)
Q Consensus       144 f~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~-~~~~~lv~e~  221 (457)
                      |...+.||.|++|.||++.. .+++.+++|++.....   .....+.+|+.+++.++|||++++++++. .+..++++||
T Consensus        21 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~---~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~   97 (285)
T cd06648          21 LDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQ---QRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEF   97 (285)
T ss_pred             hhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccch---hHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEec
Confidence            44457999999999999985 4688999998753322   23456889999999999999999999654 4557899999


Q ss_pred             cCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCCCCCCce
Q 012765          222 LPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSHH  301 (457)
Q Consensus       222 ~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~~~~~~  301 (457)
                      +++++|.+++..  ..+++..++.++.|++.||.|||+   .+++||||+|+||+++.++.++|+|||++......... 
T Consensus        98 ~~~~~L~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~~-  171 (285)
T cd06648          98 LEGGALTDIVTH--TRMNEEQIATVCLAVLKALSFLHA---QGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPR-  171 (285)
T ss_pred             cCCCCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCChhhEEEcCCCcEEEcccccchhhccCCcc-
Confidence            999999998855  458889999999999999999999   89999999999999999999999999988765433211 


Q ss_pred             eeecccccccccChhccccCCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhccccccCCcccccCchhhcccCHH
Q 012765          302 IVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSNFKELVDPRLADAYDLA  381 (457)
Q Consensus       302 ~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~  381 (457)
                       .....|+..|+|||++.+..++.++||||||+++|+|++|+.||...+.....  ......      ..+.+...  ..
T Consensus       172 -~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~--~~~~~~------~~~~~~~~--~~  240 (285)
T cd06648         172 -RKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAM--KRIRDN------LPPKLKNL--HK  240 (285)
T ss_pred             -cccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHH--HHHHhc------CCCCCccc--cc
Confidence             12245889999999998888999999999999999999999999754321111  000000      00111100  11


Q ss_pred             HHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 012765          382 EMKRAMLTASVCIHHLSTMRPQMTRVLQ  409 (457)
Q Consensus       382 ~~~~l~~l~~~Cl~~dP~~RPt~~evl~  409 (457)
                      ....+.+++.+||+.+|++||++.++++
T Consensus       241 ~~~~l~~li~~~l~~~p~~Rpt~~~il~  268 (285)
T cd06648         241 VSPRLRSFLDRMLVRDPAQRATAAELLN  268 (285)
T ss_pred             CCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence            2245778899999999999999999986

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=6.9e-36  Score=288.39  Aligned_cols=243  Identities=26%  Similarity=0.327  Sum_probs=187.5

Q ss_pred             ecccCcEEEEEEEeC-CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeee-cCceEEEEEecCCCCh
Q 012765          150 IGKGGHAEVYKGCLP-DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFST-ENGFHLVLQFLPHGSL  227 (457)
Q Consensus       150 LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~-~~~~~lv~e~~~~gsL  227 (457)
                      ||+|+||+||++... +|+.||+|.+.............+.+|+.+++.++||||+++++++. .+..+++|||+++++|
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL   80 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence            699999999999754 68999999886543333334556788999999999999999998554 4557899999999999


Q ss_pred             hhhhhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCCCCCCceeeecc
Q 012765          228 SSLLFGST-ECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPI  306 (457)
Q Consensus       228 ~~~l~~~~-~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~~~~~~~~~~~  306 (457)
                      .+++.... ..+++..++.++.|++.||.|||+   .+++||||+|+||+++.++.++|+|||++........   ....
T Consensus        81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~---~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~~---~~~~  154 (277)
T cd05577          81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQ---RRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKK---IKGR  154 (277)
T ss_pred             HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEEccCcchhhhccCCc---cccc
Confidence            99886543 358899999999999999999999   8999999999999999999999999999876643211   1223


Q ss_pred             cccccccChhccccCCCCcchhHHHHHHHHHHHHhCCCCCCcCCcch--hhhhccccccCCcccccCchhhcccCHHHHH
Q 012765          307 EGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSL--VIWAKPLLQTSNFKELVDPRLADAYDLAEMK  384 (457)
Q Consensus       307 ~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~--~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~  384 (457)
                      .++..|+|||++.+..++.++||||||+++|+|++|+.||.......  .........       ...    .+......
T Consensus       155 ~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~-------~~~----~~~~~~~~  223 (277)
T cd05577         155 AGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLE-------MAV----EYPDKFSP  223 (277)
T ss_pred             cCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhcccc-------ccc----cCCccCCH
Confidence            47889999999988889999999999999999999999997643210  000000000       000    11111234


Q ss_pred             HHHHHHHHhcccCCCCCC-----CHHHHHH
Q 012765          385 RAMLTASVCIHHLSTMRP-----QMTRVLQ  409 (457)
Q Consensus       385 ~l~~l~~~Cl~~dP~~RP-----t~~evl~  409 (457)
                      .+.+++.+||+.+|.+||     ++.++++
T Consensus       224 ~~~~li~~~l~~~p~~R~~~~~~~~~~ll~  253 (277)
T cd05577         224 EAKDLCEALLQKDPEKRLGCRGGSADEVRE  253 (277)
T ss_pred             HHHHHHHHHccCChhHccCCCcccHHHHHh
Confidence            567888999999999999     5555654

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.3e-35  Score=282.63  Aligned_cols=252  Identities=21%  Similarity=0.329  Sum_probs=194.7

Q ss_pred             cCCCCCceecccCcEEEEEEEeC-CCcEEEEEEEeccc--hhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeecC---ce
Q 012765          142 DNFNSENLIGKGGHAEVYKGCLP-DGEVVAVKKIIKNA--KEDEERISDFLSELGIVAHINHPNAAKLIGFSTEN---GF  215 (457)
Q Consensus       142 ~~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~---~~  215 (457)
                      .+|.+.+.||+|+||.||+|.+. ++..||+|.+....  .........+.+|+.++++++|+||+++++++.+.   .+
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (264)
T cd06653           2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL   81 (264)
T ss_pred             CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence            57889999999999999999864 58999999875321  12234456889999999999999999999976543   36


Q ss_pred             EEEEEecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCC
Q 012765          216 HLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLP  295 (457)
Q Consensus       216 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~  295 (457)
                      ++++||+++++|.+++... ..+++.....++.||+.||.|||+   .+++|+||||+||+++.++.++|+|||+++...
T Consensus        82 ~~v~e~~~~~~L~~~~~~~-~~l~~~~~~~~~~~i~~al~~LH~---~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~  157 (264)
T cd06653          82 SIFVEYMPGGSIKDQLKAY-GALTENVTRRYTRQILQGVSYLHS---NMIVHRDIKGANILRDSAGNVKLGDFGASKRIQ  157 (264)
T ss_pred             EEEEEeCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCEEECccccccccc
Confidence            7899999999999988543 347888888999999999999999   899999999999999999999999999998664


Q ss_pred             CCCCc-eeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhccccccCCcccccCchh
Q 012765          296 DNWSH-HIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSNFKELVDPRL  374 (457)
Q Consensus       296 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l  374 (457)
                      ..... .......++..|+|||++.+..++.++|+|||||++|+|++|+.||.............  ..     -..+.+
T Consensus       158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~--~~-----~~~~~~  230 (264)
T cd06653         158 TICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIA--TQ-----PTKPML  230 (264)
T ss_pred             cccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHHH--cC-----CCCCCC
Confidence            32111 11123458899999999998889999999999999999999999997543221111100  00     001111


Q ss_pred             hcccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 012765          375 ADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQ  409 (457)
Q Consensus       375 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~  409 (457)
                          .......+.+++.+||+ +|..||+..+++.
T Consensus       231 ----p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~  260 (264)
T cd06653         231 ----PDGVSDACRDFLKQIFV-EEKRRPTAEFLLR  260 (264)
T ss_pred             ----CcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence                22233456778888999 5799999998765

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=100.00  E-value=2.3e-35  Score=290.18  Aligned_cols=245  Identities=28%  Similarity=0.411  Sum_probs=191.8

Q ss_pred             CCCCceecccCcEEEEEEEeC-CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeecC-ceEEEEEe
Q 012765          144 FNSENLIGKGGHAEVYKGCLP-DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTEN-GFHLVLQF  221 (457)
Q Consensus       144 f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~-~~~lv~e~  221 (457)
                      |...+.||+|+||+||+|... +++.|++|.+.............+.+|+.+++.++|||++++++++.+. ..+++|||
T Consensus        23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  102 (313)
T cd06633          23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY  102 (313)
T ss_pred             hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence            566788999999999999864 6889999988655444445566888999999999999999999976654 46799999


Q ss_pred             cCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCCCCCCce
Q 012765          222 LPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSHH  301 (457)
Q Consensus       222 ~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~~~~~~  301 (457)
                      +. |++.+++......+++..++.++.||+.||.|||+   .+++|+||+|+||+++.++.+||+|||++......    
T Consensus       103 ~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~---~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~~----  174 (313)
T cd06633         103 CL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHS---HNMIHRDIKAGNILLTEPGQVKLADFGSASKSSPA----  174 (313)
T ss_pred             CC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCChhhEEECCCCCEEEeecCCCcccCCC----
Confidence            95 57777776656678999999999999999999999   89999999999999999999999999998643221    


Q ss_pred             eeecccccccccChhccc---cCCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhccccccCCcccccCchhhccc
Q 012765          302 IVFPIEGTFGYLSPEYFM---HGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSNFKELVDPRLADAY  378 (457)
Q Consensus       302 ~~~~~~gt~~y~aPE~~~---~~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~  378 (457)
                        ....|+..|+|||++.   ...++.++|||||||++|+|++|..||...+..........   ........    .. 
T Consensus       175 --~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~---~~~~~~~~----~~-  244 (313)
T cd06633         175 --NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ---NDSPTLQS----NE-  244 (313)
T ss_pred             --CCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHh---cCCCCCCc----cc-
Confidence              1235888999999974   45688999999999999999999999876443221111100   00111111    11 


Q ss_pred             CHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 012765          379 DLAEMKRAMLTASVCIHHLSTMRPQMTRVLQ  409 (457)
Q Consensus       379 ~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~  409 (457)
                         ....+..++.+||+.+|.+||++.+++.
T Consensus       245 ---~~~~l~~li~~~l~~~P~~Rp~~~~~l~  272 (313)
T cd06633         245 ---WTDSFRGFVDYCLQKIPQERPASAELLR  272 (313)
T ss_pred             ---cCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence               1234667888999999999999999986

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=100.00  E-value=1.1e-35  Score=291.85  Aligned_cols=249  Identities=27%  Similarity=0.396  Sum_probs=192.9

Q ss_pred             cCCCCCceecccCcEEEEEEEeC-CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeecC-ceEEEE
Q 012765          142 DNFNSENLIGKGGHAEVYKGCLP-DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTEN-GFHLVL  219 (457)
Q Consensus       142 ~~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~-~~~lv~  219 (457)
                      +.|...+.||.|+||.||+|... ++..+|+|.+............++.+|+.+++.++|+|++++++++... ..++||
T Consensus        15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   94 (308)
T cd06634          15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM   94 (308)
T ss_pred             HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEE
Confidence            34666788999999999999864 5788999988643333334456788999999999999999999966554 467999


Q ss_pred             EecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCCCCCC
Q 012765          220 QFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWS  299 (457)
Q Consensus       220 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~~~~  299 (457)
                      ||+. |++.+++......+++..+..++.|++.||.|||+   .+++||||+|+||+++.++.++|+|||++......  
T Consensus        95 e~~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~--  168 (308)
T cd06634          95 EYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA--  168 (308)
T ss_pred             EccC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHhEEECCCCcEEECCcccceeecCc--
Confidence            9996 67877775555668899999999999999999999   89999999999999999999999999998765432  


Q ss_pred             ceeeecccccccccChhccc---cCCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhccccccCCcccccCchhhc
Q 012765          300 HHIVFPIEGTFGYLSPEYFM---HGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSNFKELVDPRLAD  376 (457)
Q Consensus       300 ~~~~~~~~gt~~y~aPE~~~---~~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  376 (457)
                          ....++..|+|||++.   ...++.++|||||||++|+|++|..||.............   ...     .+... 
T Consensus       169 ----~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~---~~~-----~~~~~-  235 (308)
T cd06634         169 ----NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIA---QNE-----SPALQ-  235 (308)
T ss_pred             ----ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHh---hcC-----CCCcC-
Confidence                1234788999999974   3567899999999999999999999987543221111110   000     01110 


Q ss_pred             ccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 012765          377 AYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQLL  411 (457)
Q Consensus       377 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L  411 (457)
                        .......+..++.+||+.+|++||++.+|++.-
T Consensus       236 --~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~  268 (308)
T cd06634         236 --SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHR  268 (308)
T ss_pred             --cccccHHHHHHHHHHhhCCcccCCCHHHHhhCc
Confidence              112334567889999999999999999999743

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=6.8e-36  Score=288.96  Aligned_cols=258  Identities=23%  Similarity=0.336  Sum_probs=190.8

Q ss_pred             CCCCceecccCcEEEEEEEeC-CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeec-CceEEEEEe
Q 012765          144 FNSENLIGKGGHAEVYKGCLP-DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTE-NGFHLVLQF  221 (457)
Q Consensus       144 f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-~~~~lv~e~  221 (457)
                      |++.+.||.|++|.||+|.+. +|..||+|++...... ......+.+|+.+++.++|||++++++++.+ +..+++|||
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~   79 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETED-EGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEF   79 (283)
T ss_pred             CchheEecCCCCeEEEEEEEcCCCCEEEEEEeeccccc-ccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEec
Confidence            567889999999999999864 6999999988644321 1223467889999999999999999996655 446799999


Q ss_pred             cCCCChhhhhhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCCCCCCc
Q 012765          222 LPHGSLSSLLFGST-ECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSH  300 (457)
Q Consensus       222 ~~~gsL~~~l~~~~-~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~~~~~  300 (457)
                      +. ++|..++.... ..+++..++.++.|++.||.|||+   .+++||||+|+||+++.++.++|+|||++..+......
T Consensus        80 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~---~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~  155 (283)
T cd07835          80 LD-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHS---HRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRT  155 (283)
T ss_pred             cC-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCccc
Confidence            95 68888885543 468999999999999999999999   89999999999999999999999999999765432211


Q ss_pred             eeeecccccccccChhccccC-CCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhh--ccc-----------cccCC-
Q 012765          301 HIVFPIEGTFGYLSPEYFMHG-IVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWA--KPL-----------LQTSN-  365 (457)
Q Consensus       301 ~~~~~~~gt~~y~aPE~~~~~-~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~--~~~-----------~~~~~-  365 (457)
                        .....++..|+|||++.+. .++.++||||||+++|+|++|+.||.........+.  ...           ..... 
T Consensus       156 --~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (283)
T cd07835         156 --YTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDY  233 (283)
T ss_pred             --cCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhh
Confidence              1122468899999988654 578999999999999999999999975433211110  000           00000 


Q ss_pred             ---cccccCchhhcccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 012765          366 ---FKELVDPRLADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQ  409 (457)
Q Consensus       366 ---~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~  409 (457)
                         +.....+... .........+.+++.+||+.+|.+|||+.++++
T Consensus       234 ~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~  279 (283)
T cd07835         234 KPTFPKWARQDLS-KVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ  279 (283)
T ss_pred             hhhcccccccchh-hhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence               0000000000 001112245778999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-38  Score=287.88  Aligned_cols=249  Identities=25%  Similarity=0.367  Sum_probs=189.4

Q ss_pred             CCceecccCcEEEEEEEe-CCCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhc-CCCCcceeee-eeecCceEEEEEec
Q 012765          146 SENLIGKGGHAEVYKGCL-PDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHI-NHPNAAKLIG-FSTENGFHLVLQFL  222 (457)
Q Consensus       146 ~~~~LG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~-~~~~~~~~lv~e~~  222 (457)
                      -+..||.|+||+|+|-.+ +.|+..|||++......  ....+++.|.+...+- +.||||++|| .+.+++.++.||.|
T Consensus        68 dlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~--keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELM  145 (361)
T KOG1006|consen   68 DLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIE--KEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELM  145 (361)
T ss_pred             HHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccch--HHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHH
Confidence            346799999999999865 46999999999765543  3456888998877554 6899999999 56677788889988


Q ss_pred             CCCChhhhh---hc-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCCCCC
Q 012765          223 PHGSLSSLL---FG-STECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNW  298 (457)
Q Consensus       223 ~~gsL~~~l---~~-~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~~~  298 (457)
                      . .+|..+.   +. ....+++...-.|...++.||.||...  ..|||||+||+||||+..|.+||||||++..+.+..
T Consensus       146 d-~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~--lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~Si  222 (361)
T KOG1006|consen  146 D-ISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEE--LKIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDSI  222 (361)
T ss_pred             h-hhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHH--hhhhhccCChhheEEecCCCEeeecccchHhHHHHH
Confidence            4 3444433   22 445688888888998999999999996  899999999999999999999999999998886654


Q ss_pred             CceeeecccccccccChhccc--cCCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhccccccCCcccccCchhhc
Q 012765          299 SHHIVFPIEGTFGYLSPEYFM--HGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSNFKELVDPRLAD  376 (457)
Q Consensus       299 ~~~~~~~~~gt~~y~aPE~~~--~~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  376 (457)
                      ...   ...|...|||||.+.  ...|+.++||||||++|||+.||+.|+...+........  ...+..     |.+..
T Consensus       223 AkT---~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~--Vv~gdp-----p~l~~  292 (361)
T KOG1006|consen  223 AKT---VDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQ--VVIGDP-----PILLF  292 (361)
T ss_pred             Hhh---hccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHH--HHcCCC-----CeecC
Confidence            322   234888999999985  346999999999999999999999999874432211111  111111     11211


Q ss_pred             ccC-HHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 012765          377 AYD-LAEMKRAMLTASVCIHHLSTMRPQMTRVLQ  409 (457)
Q Consensus       377 ~~~-~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~  409 (457)
                      ... ......+.+.+..||.+|...||...++.+
T Consensus       293 ~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~  326 (361)
T KOG1006|consen  293 DKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKK  326 (361)
T ss_pred             cccccccCHHHHHHHHHHhhcccccCcchhhhhc
Confidence            111 234456777888899999999999998876

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=6.7e-36  Score=296.93  Aligned_cols=264  Identities=22%  Similarity=0.302  Sum_probs=194.6

Q ss_pred             hhcCCCCCceecccCcEEEEEEEeC-CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhc-CCCCcceeeeeeecC---c
Q 012765          140 ATDNFNSENLIGKGGHAEVYKGCLP-DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHI-NHPNAAKLIGFSTEN---G  214 (457)
Q Consensus       140 ~~~~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~---~  214 (457)
                      ..++|++.+.||+|+||.||+|.+. +++.+|+|++...... ......+.+|+.+++++ +||||+++++++...   .
T Consensus         5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~-~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~   83 (337)
T cd07852           5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRN-ATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKD   83 (337)
T ss_pred             hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCc-chhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCce
Confidence            4578889999999999999999865 5889999988543222 22345677899999999 999999999976533   3


Q ss_pred             eEEEEEecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccC
Q 012765          215 FHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWL  294 (457)
Q Consensus       215 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~  294 (457)
                      .++||||+. ++|..++...  .+++..+..++.||+.||.|||+   .+|+|+||||+||+++.++.+||+|||++..+
T Consensus        84 ~~lv~e~~~-~~L~~~~~~~--~~~~~~~~~i~~qi~~~L~~LH~---~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~  157 (337)
T cd07852          84 IYLVFEYME-TDLHAVIRAN--ILEDVHKRYIMYQLLKALKYIHS---GNVIHRDLKPSNILLNSDCRVKLADFGLARSL  157 (337)
T ss_pred             EEEEecccc-cCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCcEEEeeccchhcc
Confidence            689999997 5888887543  67888999999999999999999   89999999999999999999999999999876


Q ss_pred             CCCCCc---eeeecccccccccChhcccc-CCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhh----hcccccc---
Q 012765          295 PDNWSH---HIVFPIEGTFGYLSPEYFMH-GIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIW----AKPLLQT---  363 (457)
Q Consensus       295 ~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~----~~~~~~~---  363 (457)
                      ......   .......|+..|+|||++.+ ..++.++||||||+++|+|++|+.||..........    .......   
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  237 (337)
T cd07852         158 SELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDI  237 (337)
T ss_pred             ccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Confidence            543221   12223458999999998765 457899999999999999999999997533211100    0000000   


Q ss_pred             -----CCcccccC----chhh--cccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 012765          364 -----SNFKELVD----PRLA--DAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQL  410 (457)
Q Consensus       364 -----~~~~~~~d----~~l~--~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~  410 (457)
                           .....+++    ....  ..........+.+++.+||+.+|++|||+.++++.
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~  295 (337)
T cd07852         238 ESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH  295 (337)
T ss_pred             HHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence                 00000000    0000  00001123457789999999999999999999873

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=2.3e-35  Score=292.08  Aligned_cols=258  Identities=24%  Similarity=0.313  Sum_probs=188.5

Q ss_pred             ceeccc--CcEEEEEEEeC-CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeec-CceEEEEEecC
Q 012765          148 NLIGKG--GHAEVYKGCLP-DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTE-NGFHLVLQFLP  223 (457)
Q Consensus       148 ~~LG~G--~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-~~~~lv~e~~~  223 (457)
                      ..||+|  +||+||++.+. +|+.||+|.+...... ....+.+.+|+.+++.++||||+++++++.. +..++++||+.
T Consensus         4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~   82 (328)
T cd08226           4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCT-EEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMA   82 (328)
T ss_pred             HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCC-HHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEeccc
Confidence            456766  99999999864 7999999987654332 2445788999999999999999999996655 45689999999


Q ss_pred             CCChhhhhhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCCCCCCce-
Q 012765          224 HGSLSSLLFGS-TECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSHH-  301 (457)
Q Consensus       224 ~gsL~~~l~~~-~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~~~~~~-  301 (457)
                      +++|.+++... ...+++..+..++.|++.||.|||+   .+++||||||+||+++.++.++++||+.+.......... 
T Consensus        83 ~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~---~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~  159 (328)
T cd08226          83 YGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQ---NGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAK  159 (328)
T ss_pred             CCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcccc
Confidence            99999988653 3458888889999999999999999   899999999999999999999999998654332211110 


Q ss_pred             e----eecccccccccChhccccC--CCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhc---cccccC--------
Q 012765          302 I----VFPIEGTFGYLSPEYFMHG--IVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAK---PLLQTS--------  364 (457)
Q Consensus       302 ~----~~~~~gt~~y~aPE~~~~~--~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~---~~~~~~--------  364 (457)
                      .    .....++..|+|||++.+.  .++.++|||||||++|||++|+.||............   ......        
T Consensus       160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (328)
T cd08226         160 VVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCE  239 (328)
T ss_pred             ccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchh
Confidence            0    0012245679999998763  4789999999999999999999999764322111000   000000        


Q ss_pred             ------------------C-----cccccCchhhcccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 012765          365 ------------------N-----FKELVDPRLADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQ  409 (457)
Q Consensus       365 ------------------~-----~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~  409 (457)
                                        .     .....+..+...........+.+++.+||+.||++|||+.|+++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~  307 (328)
T cd08226         240 ESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLS  307 (328)
T ss_pred             hhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhh
Confidence                              0     00111111112222334567889999999999999999999976

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.3e-35  Score=278.74  Aligned_cols=248  Identities=26%  Similarity=0.437  Sum_probs=198.7

Q ss_pred             CCCCCceecccCcEEEEEEEeC-CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeec-CceEEEEE
Q 012765          143 NFNSENLIGKGGHAEVYKGCLP-DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTE-NGFHLVLQ  220 (457)
Q Consensus       143 ~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-~~~~lv~e  220 (457)
                      +|++.+.||+|++|.||+|... +++.|++|.+...... ......+.+|++++++++|||++++++++.+ +..+++||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e   79 (254)
T cd06627           1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIK-EEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILE   79 (254)
T ss_pred             CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccC-HHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEe
Confidence            4778899999999999999865 5789999988655332 2445689999999999999999999996655 44679999


Q ss_pred             ecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCCCCCCc
Q 012765          221 FLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSH  300 (457)
Q Consensus       221 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~~~~~  300 (457)
                      |+.+++|.+++... ..+++..++.++.|++.||.|||+   .+++||||+|+||+++.++.++|+|||++.........
T Consensus        80 ~~~~~~L~~~~~~~-~~l~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~  155 (254)
T cd06627          80 YAENGSLRQIIKKF-GPFPESLVAVYVYQVLQGLAYLHE---QGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD  155 (254)
T ss_pred             cCCCCcHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCHHHEEECCCCCEEEeccccceecCCCccc
Confidence            99999999988544 568999999999999999999999   89999999999999999999999999999877554321


Q ss_pred             eeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhccccccCCcccccCchhhcccCH
Q 012765          301 HIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSNFKELVDPRLADAYDL  380 (457)
Q Consensus       301 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~  380 (457)
                        .....++..|+|||.+.+..++.++||||||+++++|++|..||.........+.......        +.+...   
T Consensus       156 --~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~--------~~~~~~---  222 (254)
T cd06627         156 --DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQDDH--------PPLPEG---  222 (254)
T ss_pred             --ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhccCC--------CCCCCC---
Confidence              2234588899999999888889999999999999999999999976443322222111100        111111   


Q ss_pred             HHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 012765          381 AEMKRAMLTASVCIHHLSTMRPQMTRVLQ  409 (457)
Q Consensus       381 ~~~~~l~~l~~~Cl~~dP~~RPt~~evl~  409 (457)
                       ....+..++.+||..+|++||++.+++.
T Consensus       223 -~~~~~~~~i~~~l~~~p~~R~~~~~~l~  250 (254)
T cd06627         223 -ISPELKDFLMQCFQKDPNLRPTAKQLLK  250 (254)
T ss_pred             -CCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence             1345667889999999999999999875

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=100.00  E-value=1.7e-35  Score=285.75  Aligned_cols=258  Identities=23%  Similarity=0.311  Sum_probs=195.3

Q ss_pred             CCCCceecccCcEEEEEEEeC-CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeee-ecCceEEEEEe
Q 012765          144 FNSENLIGKGGHAEVYKGCLP-DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFS-TENGFHLVLQF  221 (457)
Q Consensus       144 f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~-~~~~~~lv~e~  221 (457)
                      |.+.+.||.|++|.||+|... +++.+++|.+...... ......+.+|+.+++.++|+||+++++++ ..+..++++||
T Consensus         1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   79 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFES-EGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEF   79 (283)
T ss_pred             CccceeeecCCCceEEEEEcCCCCcEEEEEEecccccc-chhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEec
Confidence            566789999999999999864 6889999988654332 23356788899999999999999999955 44557899999


Q ss_pred             cCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCCCCCCce
Q 012765          222 LPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSHH  301 (457)
Q Consensus       222 ~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~~~~~~  301 (457)
                      +.+ +|..++......+++..++.++.||+.||.|||+   .+++|+||+|+||+++.++.++|+|||.+........  
T Consensus        80 ~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~--  153 (283)
T cd05118          80 MDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHS---HGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVR--  153 (283)
T ss_pred             cCC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHH---CCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCcc--
Confidence            975 8888886655678999999999999999999999   8999999999999999999999999999987755431  


Q ss_pred             eeecccccccccChhccccC-CCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhh-cccccc---CCccccc------
Q 012765          302 IVFPIEGTFGYLSPEYFMHG-IVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWA-KPLLQT---SNFKELV------  370 (457)
Q Consensus       302 ~~~~~~gt~~y~aPE~~~~~-~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~-~~~~~~---~~~~~~~------  370 (457)
                      ......++..|+|||.+.+. .++.++|+||||+++|+|+||+.||........... ......   .....+.      
T Consensus       154 ~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (283)
T cd05118         154 PYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNY  233 (283)
T ss_pred             cccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhh
Confidence            11223478889999998776 789999999999999999999999975442111000 000000   0000000      


Q ss_pred             --------CchhhcccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 012765          371 --------DPRLADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQ  409 (457)
Q Consensus       371 --------d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~  409 (457)
                              +... ..........+.+++.+||+.||.+||++.+++.
T Consensus       234 ~~~~~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~  279 (283)
T cd05118         234 KFSFPKKAGMPL-PKLFPNASPQALDLLSQMLHYDPHKRITAEQALA  279 (283)
T ss_pred             hhhhccccccCH-HHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence                    0000 0111233567889999999999999999999975

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=100.00  E-value=2.8e-35  Score=284.80  Aligned_cols=257  Identities=22%  Similarity=0.320  Sum_probs=189.2

Q ss_pred             CCCCceecccCcEEEEEEEeC-CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhc---CCCCcceeeeeeecCc-----
Q 012765          144 FNSENLIGKGGHAEVYKGCLP-DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHI---NHPNAAKLIGFSTENG-----  214 (457)
Q Consensus       144 f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l---~hpniv~l~~~~~~~~-----  214 (457)
                      |++.+.||.|+||.||+|.+. +++.||+|++....... .....+.+|+.++.++   +|||++++++++....     
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~   79 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEE-GIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDREL   79 (287)
T ss_pred             CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccc-hhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCc
Confidence            567789999999999999976 48999999886443322 2234566777776655   6999999999665433     


Q ss_pred             -eEEEEEecCCCChhhhhhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccc
Q 012765          215 -FHLVLQFLPHGSLSSLLFGST-ECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAK  292 (457)
Q Consensus       215 -~~lv~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~  292 (457)
                       .+++|||+.+ +|.+++.... ..+++..++.++.|++.||.|||+   .+++|+||+|+||+++.++.++|+|||++.
T Consensus        80 ~~~l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~---~~i~h~~l~~~nili~~~~~~~l~dfg~~~  155 (287)
T cd07838          80 KLTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHS---HRIVHRDLKPQNILVTSDGQVKIADFGLAR  155 (287)
T ss_pred             eeEEEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCChhhEEEccCCCEEEeccCcce
Confidence             6799999874 7888775433 358999999999999999999999   899999999999999999999999999987


Q ss_pred             cCCCCCCceeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchh--hhhccccc--------
Q 012765          293 WLPDNWSHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLV--IWAKPLLQ--------  362 (457)
Q Consensus       293 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~--~~~~~~~~--------  362 (457)
                      .+.....   .....++..|+|||++.+..++.++|+|||||++|||++|..||........  .+......        
T Consensus       156 ~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (287)
T cd07838         156 IYSFEMA---LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPR  232 (287)
T ss_pred             eccCCcc---cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCC
Confidence            7644321   1223478889999999988999999999999999999999999875332110  00000000        


Q ss_pred             -----cCCcccccCchhhcccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 012765          363 -----TSNFKELVDPRLADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQ  409 (457)
Q Consensus       363 -----~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~  409 (457)
                           ...+........ ..........+.+++.+||+.||.+||++.+++.
T Consensus       233 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~  283 (287)
T cd07838         233 NVSLPRSSFPSYTPRSF-KSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ  283 (287)
T ss_pred             Ccccchhhcccccccch-hhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence                 000000000000 1111223456778999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=2.2e-36  Score=302.25  Aligned_cols=246  Identities=26%  Similarity=0.371  Sum_probs=201.8

Q ss_pred             hcCCCCCceecccCcEEEEEEEeC-CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeee-ecCceEEE
Q 012765          141 TDNFNSENLIGKGGHAEVYKGCLP-DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFS-TENGFHLV  218 (457)
Q Consensus       141 ~~~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~-~~~~~~lv  218 (457)
                      ...|.+...||+|.|+.|..|.+. ++..||+|.+.+...... ....+.+|+++|..++|||||+++.+. ....+++|
T Consensus        55 vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~-~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV  133 (596)
T KOG0586|consen   55 VGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPS-KRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLV  133 (596)
T ss_pred             ccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChH-HHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEE
Confidence            467888999999999999999754 699999998876555443 345699999999999999999999955 57789999


Q ss_pred             EEecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCCCCC
Q 012765          219 LQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNW  298 (457)
Q Consensus       219 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~~~  298 (457)
                      |||+.+|.+++++...+...+ .....++.|+.+|++|||+   +.|+|||||++||||+.+.++||+|||++..+....
T Consensus       134 ~eya~~ge~~~yl~~~gr~~e-~~ar~~F~q~vsaveYcH~---k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~~  209 (596)
T KOG0586|consen  134 MEYASGGELFDYLVKHGRMKE-KEARAKFRQIVSAVEYCHS---KNIVHRDLKAENILLDENMNIKIADFGFSTFFDYGL  209 (596)
T ss_pred             EEeccCchhHHHHHhcccchh-hhhhhhhHHHHHHHHHHhh---cceeccccchhhcccccccceeeeccccceeecccc
Confidence            999999999999987666444 6677789999999999999   899999999999999999999999999999886442


Q ss_pred             CceeeecccccccccChhccccCCC-CcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhccccccCCcccccCchhhcc
Q 012765          299 SHHIVFPIEGTFGYLSPEYFMHGIV-DEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSNFKELVDPRLADA  377 (457)
Q Consensus       299 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~  377 (457)
                         ...+.+|++.|.|||++.+..| ++.+|+||+|++||-|+.|..||++..               +.++-++.+.+.
T Consensus       210 ---~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~---------------lk~Lr~rvl~gk  271 (596)
T KOG0586|consen  210 ---MLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQN---------------LKELRPRVLRGK  271 (596)
T ss_pred             ---cccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcc---------------cccccchheeee
Confidence               3456789999999999998876 578999999999999999999999522               222333333333


Q ss_pred             cCHH--HHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 012765          378 YDLA--EMKRAMLTASVCIHHLSTMRPQMTRVLQ  409 (457)
Q Consensus       378 ~~~~--~~~~l~~l~~~Cl~~dP~~RPt~~evl~  409 (457)
                      +...  -...+-+++..+|-.+|.+|+++.+|.+
T Consensus       272 ~rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~  305 (596)
T KOG0586|consen  272 YRIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMK  305 (596)
T ss_pred             ecccceeechhHHHHHHhhccCccccCCHHHhhh
Confidence            2211  1223456777889999999999999977

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=100.00  E-value=1.5e-35  Score=289.27  Aligned_cols=264  Identities=25%  Similarity=0.334  Sum_probs=194.1

Q ss_pred             HhhcCCCCCceecccCcEEEEEEEeC-CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeecC----
Q 012765          139 AATDNFNSENLIGKGGHAEVYKGCLP-DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTEN----  213 (457)
Q Consensus       139 ~~~~~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~----  213 (457)
                      ...++|++.+.||.|+||.||+|... +|+.||+|.+....... .....+.+|+.+++.++|||++++++++.+.    
T Consensus         4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~-~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~   82 (302)
T cd07864           4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKE-GFPITAIREIKILRQLNHRNIVNLKEIVTDKQDAL   82 (302)
T ss_pred             hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeeccccc-CchHHHHHHHHHHHhCCCCCeeeeeheecCcchhh
Confidence            45688999999999999999999875 58899999886433221 1234677899999999999999999976543    


Q ss_pred             -------ceEEEEEecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEe
Q 012765          214 -------GFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQIS  286 (457)
Q Consensus       214 -------~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~  286 (457)
                             .+++++||+++ ++...+......+++..+..++.||+.||.|||+   .+|+|+||||+||+++.++.+||+
T Consensus        83 ~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~i~H~dl~p~nili~~~~~~kl~  158 (302)
T cd07864          83 DFKKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHK---KNFLHRDIKCSNILLNNKGQIKLA  158 (302)
T ss_pred             hccccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCcEEeC
Confidence                   47899999976 6777775555568999999999999999999999   899999999999999999999999


Q ss_pred             eccccccCCCCCCceeeecccccccccChhcccc-CCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchh--hhhcccccc
Q 012765          287 DFGLAKWLPDNWSHHIVFPIEGTFGYLSPEYFMH-GIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLV--IWAKPLLQT  363 (457)
Q Consensus       287 DFGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~--~~~~~~~~~  363 (457)
                      |||++..+...... ......++..|+|||++.+ ..++.++|||||||+++||++|+.||........  .........
T Consensus       159 dfg~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~  237 (302)
T cd07864         159 DFGLARLYNSEESR-PYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSP  237 (302)
T ss_pred             cccccccccCCccc-ccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Confidence            99999876543211 1111235778999998865 4578999999999999999999999975332110  000000000


Q ss_pred             --CCcccc--------------cCchhhcccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 012765          364 --SNFKEL--------------VDPRLADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQ  409 (457)
Q Consensus       364 --~~~~~~--------------~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~  409 (457)
                        .....+              ....+..... .....+.+++.+||+.+|.+||++.+|++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~li~~~l~~~P~~Rp~~~~il~  298 (302)
T cd07864         238 CPAVWPDVIKLPYFNTMKPKKQYRRRLREEFS-FIPTPALDLLDHMLTLDPSKRCTAEEALN  298 (302)
T ss_pred             ChhhcccccccccccccccccccccchhhhcC-CCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence              000000              0000000000 11345778999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=1.3e-35  Score=281.63  Aligned_cols=249  Identities=26%  Similarity=0.392  Sum_probs=198.2

Q ss_pred             CCCCCceecccCcEEEEEEEeC-CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeec-CceEEEEE
Q 012765          143 NFNSENLIGKGGHAEVYKGCLP-DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTE-NGFHLVLQ  220 (457)
Q Consensus       143 ~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-~~~~lv~e  220 (457)
                      +|.+.+.||.|+||.||++... +++.+++|++..... .......+.+|+++++.++|||++++++.+.. ...++++|
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e   79 (258)
T cd08215           1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNM-SEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVME   79 (258)
T ss_pred             CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccC-ChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEE
Confidence            4778899999999999999865 588999998865433 22345678899999999999999999985544 55679999


Q ss_pred             ecCCCChhhhhhcC---CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCCCC
Q 012765          221 FLPHGSLSSLLFGS---TECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDN  297 (457)
Q Consensus       221 ~~~~gsL~~~l~~~---~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~~  297 (457)
                      |+++++|.+++...   ...+++..+..++.+++.||.|||+   .+++|+||+|+||+++.++.++|+|||++......
T Consensus        80 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~---~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~  156 (258)
T cd08215          80 YADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHS---RKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSST  156 (258)
T ss_pred             ecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHh---CCEecccCChHHeEEcCCCcEEECCccceeecccC
Confidence            99999999998654   3678999999999999999999999   89999999999999999999999999999876554


Q ss_pred             CCceeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhccccccCCcccccCchhhcc
Q 012765          298 WSHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSNFKELVDPRLADA  377 (457)
Q Consensus       298 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~  377 (457)
                      .  .......|++.|+|||.+.+..++.++|+||||+++++|++|+.||...+.....  .... ....     +.+.. 
T Consensus       157 ~--~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~--~~~~-~~~~-----~~~~~-  225 (258)
T cd08215         157 V--DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELA--LKIL-KGQY-----PPIPS-  225 (258)
T ss_pred             c--ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHH--HHHh-cCCC-----CCCCC-
Confidence            2  1222345888999999998888999999999999999999999999764321111  0000 0000     11111 


Q ss_pred             cCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 012765          378 YDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQ  409 (457)
Q Consensus       378 ~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~  409 (457)
                         .....+..++.+||..+|++|||+.++++
T Consensus       226 ---~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~  254 (258)
T cd08215         226 ---QYSSELRNLVSSLLQKDPEERPSIAQILQ  254 (258)
T ss_pred             ---CCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence               22345677889999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=6.1e-36  Score=312.18  Aligned_cols=203  Identities=22%  Similarity=0.287  Sum_probs=154.5

Q ss_pred             HhhcCCCCCceecccCcEEEEEEEeCC--CcEEEEE--------------EEeccchhhHHHHHHHHHHHHHHhhcCCCC
Q 012765          139 AATDNFNSENLIGKGGHAEVYKGCLPD--GEVVAVK--------------KIIKNAKEDEERISDFLSELGIVAHINHPN  202 (457)
Q Consensus       139 ~~~~~f~~~~~LG~G~~g~Vy~~~~~~--~~~vavK--------------~~~~~~~~~~~~~~~~~~E~~~l~~l~hpn  202 (457)
                      ...++|.+.+.||+|+||+||++....  +...+.|              .+.+...........+.+|+.++++++|||
T Consensus       145 ~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~Hpn  224 (501)
T PHA03210        145 EFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHEN  224 (501)
T ss_pred             hhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCC
Confidence            356789999999999999999986432  2222222              111111112233456889999999999999


Q ss_pred             cceeeeeeecCc-eEEEEEecCCCChhhhhhcCC----CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEE
Q 012765          203 AAKLIGFSTENG-FHLVLQFLPHGSLSSLLFGST----ECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILL  277 (457)
Q Consensus       203 iv~l~~~~~~~~-~~lv~e~~~~gsL~~~l~~~~----~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll  277 (457)
                      |+++++++...+ .+++++++. ++|..++....    ..........|+.||+.||.|||+   .+||||||||+|||+
T Consensus       225 Iv~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~---~gIiHrDLKP~NILl  300 (501)
T PHA03210        225 ILKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHD---KKLIHRDIKLENIFL  300 (501)
T ss_pred             cCcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEE
Confidence            999999766554 578888874 56666664321    123345567899999999999999   899999999999999


Q ss_pred             cCCCcEEEeeccccccCCCCCCceeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHhCCCCC
Q 012765          278 SEDYEAQISDFGLAKWLPDNWSHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAV  346 (457)
Q Consensus       278 ~~~~~~kL~DFGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLltG~~pf  346 (457)
                      +.++.+||+|||++..+...... ......||..|+|||++.+..++.++|||||||++|||++|..++
T Consensus       301 ~~~~~vkL~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p  368 (501)
T PHA03210        301 NCDGKIVLGDFGTAMPFEKEREA-FDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCP  368 (501)
T ss_pred             CCCCCEEEEeCCCceecCccccc-ccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCC
Confidence            99999999999999877543221 122356999999999999999999999999999999999988643

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=100.00  E-value=1.4e-35  Score=285.65  Aligned_cols=251  Identities=26%  Similarity=0.354  Sum_probs=197.9

Q ss_pred             cCCCCCceecccCcEEEEEEEeC-CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcC-CCCcceeeeeee-cCceEEE
Q 012765          142 DNFNSENLIGKGGHAEVYKGCLP-DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHIN-HPNAAKLIGFST-ENGFHLV  218 (457)
Q Consensus       142 ~~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~-~~~~~lv  218 (457)
                      ++|.+.+.||+|+||.||+|... +++.||+|.+.............+.+|+.++.+++ ||||+++++++. .+..+++
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv   80 (280)
T cd05581           1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV   80 (280)
T ss_pred             CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence            46888999999999999999865 68999999886543333344567889999999998 999999999654 4557899


Q ss_pred             EEecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCCCCC
Q 012765          219 LQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNW  298 (457)
Q Consensus       219 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~~~  298 (457)
                      ||++.+++|.+++... ..+++..++.++.|++.||.|||+   .+++|+||+|+||+++.++.++|+|||++.......
T Consensus        81 ~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~ql~~~l~~Lh~---~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~  156 (280)
T cd05581          81 LEYAPNGELLQYIRKY-GSLDEKCTRFYAAEILLALEYLHS---KGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNS  156 (280)
T ss_pred             EcCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHeEECCCCCEEecCCccccccCCcc
Confidence            9999999999998654 368999999999999999999999   899999999999999999999999999988765432


Q ss_pred             Cc------------------eeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhccc
Q 012765          299 SH------------------HIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPL  360 (457)
Q Consensus       299 ~~------------------~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~~~  360 (457)
                      ..                  .......++..|+|||++....++.++|+||||+++++|++|+.||........ ...  
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~-~~~--  233 (280)
T cd05581         157 SPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLT-FQK--  233 (280)
T ss_pred             ccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHH-HHH--
Confidence            21                  112234578899999999888899999999999999999999999986442111 000  


Q ss_pred             cccCCcccccCchhhcccCHHHHHHHHHHHHHhcccCCCCCCCH----HHHHH
Q 012765          361 LQTSNFKELVDPRLADAYDLAEMKRAMLTASVCIHHLSTMRPQM----TRVLQ  409 (457)
Q Consensus       361 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~----~evl~  409 (457)
                              +..  ....+.......+..++.+||+.+|++||++    .++++
T Consensus       234 --------~~~--~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~  276 (280)
T cd05581         234 --------ILK--LEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA  276 (280)
T ss_pred             --------HHh--cCCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence                    000  0001111123456788899999999999999    66654

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>PHA02882 putative serine/threonine kinase; Provisional

Probab=100.00  E-value=1.2e-35  Score=289.55  Aligned_cols=261  Identities=17%  Similarity=0.188  Sum_probs=178.9

Q ss_pred             hhcCCCCCceecccCcEEEEEEEeCC----CcEEEEEEEeccchhhHHH--------HHHHHHHHHHHhhcCCCCcceee
Q 012765          140 ATDNFNSENLIGKGGHAEVYKGCLPD----GEVVAVKKIIKNAKEDEER--------ISDFLSELGIVAHINHPNAAKLI  207 (457)
Q Consensus       140 ~~~~f~~~~~LG~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~--------~~~~~~E~~~l~~l~hpniv~l~  207 (457)
                      ..++|.+.++||+|+||.||+|...+    +..+|+|............        ......+...+..++|+|+++++
T Consensus        10 ~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~   89 (294)
T PHA02882         10 TGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYY   89 (294)
T ss_pred             CCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEE
Confidence            34678899999999999999998654    3455666432211110000        01223344556677899999999


Q ss_pred             eeeecCc-----eEEEEEecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCc
Q 012765          208 GFSTENG-----FHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYE  282 (457)
Q Consensus       208 ~~~~~~~-----~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~  282 (457)
                      +++....     .+++++++. .++.+.+.. ....++..+..|+.|++.||.|||+   .+|+||||||+|||++.++.
T Consensus        90 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~---~~iiHrDiKp~Nill~~~~~  164 (294)
T PHA02882         90 GCGSFKRCRMYYRFILLEKLV-ENTKEIFKR-IKCKNKKLIKNIMKDMLTTLEYIHE---HGISHGDIKPENIMVDGNNR  164 (294)
T ss_pred             EeeeEecCCceEEEEEEehhc-cCHHHHHHh-hccCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCc
Confidence            8654432     245566553 345554432 2335778888999999999999999   89999999999999999999


Q ss_pred             EEEeeccccccCCCCCCc-----eeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHhCCCCCCcCCcch-hhh
Q 012765          283 AQISDFGLAKWLPDNWSH-----HIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSL-VIW  356 (457)
Q Consensus       283 ~kL~DFGl~~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~-~~~  356 (457)
                      ++|+|||+++.+......     .......||+.|+|||++.+..++.++|||||||++|||++|+.||....... ...
T Consensus       165 ~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~  244 (294)
T PHA02882        165 GYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIH  244 (294)
T ss_pred             EEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHH
Confidence            999999999876432111     11122459999999999999999999999999999999999999998642211 110


Q ss_pred             hccccccCCcccccCchhhcccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 012765          357 AKPLLQTSNFKELVDPRLADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQLL  411 (457)
Q Consensus       357 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L  411 (457)
                      ....   .-...+....+...   .....+.+++..|+..+|++||++.+|++.|
T Consensus       245 ~~~~---~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~  293 (294)
T PHA02882        245 AAKC---DFIKRLHEGKIKIK---NANKFIYDFIECVTKLSYEEKPDYDALIKIF  293 (294)
T ss_pred             HhHH---HHHHHhhhhhhccC---CCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence            0000   00011111111111   1134567788889999999999999999876

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.3e-35  Score=281.65  Aligned_cols=245  Identities=23%  Similarity=0.289  Sum_probs=185.5

Q ss_pred             ceecccCcEEEEEEEeC-CCcEEEEEEEeccchhhHHHHHHHHHHHHHH-hhcCCCCcceeeeeeec-CceEEEEEecCC
Q 012765          148 NLIGKGGHAEVYKGCLP-DGEVVAVKKIIKNAKEDEERISDFLSELGIV-AHINHPNAAKLIGFSTE-NGFHLVLQFLPH  224 (457)
Q Consensus       148 ~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l-~~l~hpniv~l~~~~~~-~~~~lv~e~~~~  224 (457)
                      +.||.|+||.||+|... +++.||+|.+.+...........+..|..++ ...+|+|++++++++.. +..++++||+++
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   81 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG   81 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence            56999999999999864 5899999988654332223334455555544 45589999999996655 457899999999


Q ss_pred             CChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCCCCCCceeee
Q 012765          225 GSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVF  304 (457)
Q Consensus       225 gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~~~~~~~~~  304 (457)
                      ++|.+++... ..+++..+..++.||+.||.|||+   .+++|+||+|+||+++.++.++|+|||++......      .
T Consensus        82 ~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~------~  151 (260)
T cd05611          82 GDCASLIKTL-GGLPEDWAKQYIAEVVLGVEDLHQ---RGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLEN------K  151 (260)
T ss_pred             CCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCcEEEeecccceecccc------c
Confidence            9999988543 457888999999999999999999   89999999999999999999999999998755331      1


Q ss_pred             cccccccccChhccccCCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhccccccCCcccccCchhhcccCHHHHH
Q 012765          305 PIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSNFKELVDPRLADAYDLAEMK  384 (457)
Q Consensus       305 ~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~  384 (457)
                      ...++..|+|||.+.+..++.++||||||+++|+|++|..||........ +..........    ....    ......
T Consensus       152 ~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~-~~~~~~~~~~~----~~~~----~~~~~~  222 (260)
T cd05611         152 KFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAV-FDNILSRRINW----PEEV----KEFCSP  222 (260)
T ss_pred             cCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHH-HHHHHhcccCC----CCcc----cccCCH
Confidence            23478899999999888899999999999999999999999976433211 11100000000    0001    111234


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHHHHH
Q 012765          385 RAMLTASVCIHHLSTMRPQMTRVLQLL  411 (457)
Q Consensus       385 ~l~~l~~~Cl~~dP~~RPt~~evl~~L  411 (457)
                      .+..++.+||+.+|++||++.++.+.|
T Consensus       223 ~~~~~i~~~l~~~p~~R~~~~~~~~~l  249 (260)
T cd05611         223 EAVDLINRLLCMDPAKRLGANGYQEIK  249 (260)
T ss_pred             HHHHHHHHHccCCHHHccCCCcHHHHH
Confidence            577899999999999999887666654

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.3e-36  Score=304.20  Aligned_cols=249  Identities=22%  Similarity=0.408  Sum_probs=191.7

Q ss_pred             CCceecccCcEEEEEEEeC-CCcEEEEEEEe-ccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeecCc---eEEEEE
Q 012765          146 SENLIGKGGHAEVYKGCLP-DGEVVAVKKII-KNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTENG---FHLVLQ  220 (457)
Q Consensus       146 ~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~-~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~---~~lv~e  220 (457)
                      ...+||+|+|-+||||.+. +|-.||--.+. ..........++|..|+.+|+.|+||||+++|.+|.+..   ..+|+|
T Consensus        44 ~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTE  123 (632)
T KOG0584|consen   44 FDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITE  123 (632)
T ss_pred             hhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeee
Confidence            3468999999999999874 46666643221 122233455689999999999999999999999665533   468899


Q ss_pred             ecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCC-CcEEEeeccccccCCCCCC
Q 012765          221 FLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSED-YEAQISDFGLAKWLPDNWS  299 (457)
Q Consensus       221 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~-~~~kL~DFGl~~~~~~~~~  299 (457)
                      .+..|+|..|+...+ .++......|+.||+.||.|||++ ..+|||||||.+||+|+.+ |.|||+|+|||+.+.....
T Consensus       124 L~TSGtLr~Y~kk~~-~vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s~a  201 (632)
T KOG0584|consen  124 LFTSGTLREYRKKHR-RVNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKSHA  201 (632)
T ss_pred             cccCCcHHHHHHHhc-cCCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHHHHhhcccc
Confidence            999999999996544 377888899999999999999995 4799999999999999876 8999999999998866543


Q ss_pred             ceeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhcccc--ccCCcccccCchhhcc
Q 012765          300 HHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLL--QTSNFKELVDPRLADA  377 (457)
Q Consensus       300 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~~~~--~~~~~~~~~d~~l~~~  377 (457)
                      ..    ..|||.|||||... ..|++.+||||||+.++||+|+..||..=.....+|.+..-  ....+..+-|      
T Consensus       202 ks----vIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~sl~kV~d------  270 (632)
T KOG0584|consen  202 KS----VIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPAALSKVKD------  270 (632)
T ss_pred             ce----eccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHHHhhccCC------
Confidence            33    45999999999875 88999999999999999999999999753322233322110  0011112222      


Q ss_pred             cCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH--HHhcC
Q 012765          378 YDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQ--LLRGE  414 (457)
Q Consensus       378 ~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~--~L~~~  414 (457)
                            ..+.+++..||.. ...|||+.|+|.  .|...
T Consensus       271 ------Pevr~fIekCl~~-~~~R~sa~eLL~d~Ff~~d  302 (632)
T KOG0584|consen  271 ------PEVREFIEKCLAT-KSERLSAKELLKDPFFDED  302 (632)
T ss_pred             ------HHHHHHHHHHhcC-chhccCHHHHhhChhhccc
Confidence                  3456778889999 999999999997  55554

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=1.4e-35  Score=294.79  Aligned_cols=268  Identities=19%  Similarity=0.259  Sum_probs=197.4

Q ss_pred             hcCCCCCceecccCcEEEEEEEeC-CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeecC------
Q 012765          141 TDNFNSENLIGKGGHAEVYKGCLP-DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTEN------  213 (457)
Q Consensus       141 ~~~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~------  213 (457)
                      .++|.+.+.||+|+||+||+|... +++.||+|.+...... ......+.+|+.+++.++|+||+++++++...      
T Consensus         4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~   82 (337)
T cd07858           4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDN-RIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFN   82 (337)
T ss_pred             ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccc-cchhHHHHHHHHHHHhcCCCCccchHHheecccccccC
Confidence            467889999999999999999864 6899999987643222 22245677899999999999999999966433      


Q ss_pred             ceEEEEEecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeecccccc
Q 012765          214 GFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKW  293 (457)
Q Consensus       214 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~  293 (457)
                      ..++++||+. ++|..++.. ...+++..+..++.|++.||.|||+   .+++||||||+||+++.++.+||+|||++..
T Consensus        83 ~~~lv~e~~~-~~L~~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~---~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~  157 (337)
T cd07858          83 DVYIVYELMD-TDLHQIIRS-SQTLSDDHCQYFLYQLLRGLKYIHS---ANVLHRDLKPSNLLLNANCDLKICDFGLART  157 (337)
T ss_pred             cEEEEEeCCC-CCHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCEEECcCccccc
Confidence            3689999986 678877754 3458999999999999999999999   8999999999999999999999999999987


Q ss_pred             CCCCCCceeeecccccccccChhcccc-CCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhh-hhcc-----------c
Q 012765          294 LPDNWSHHIVFPIEGTFGYLSPEYFMH-GIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVI-WAKP-----------L  360 (457)
Q Consensus       294 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~-~~~~-----------~  360 (457)
                      .....  .......++..|+|||++.+ ..++.++|||||||++|+|++|+.||...+..... ....           .
T Consensus       158 ~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (337)
T cd07858         158 TSEKG--DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGF  235 (337)
T ss_pred             cCCCc--ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhh
Confidence            64432  11223457889999998865 46899999999999999999999999754321100 0000           0


Q ss_pred             cccCCccc-------ccCchhhcccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH--HhcCCCC
Q 012765          361 LQTSNFKE-------LVDPRLADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQL--LRGEGGQ  417 (457)
Q Consensus       361 ~~~~~~~~-------~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~--L~~~~~~  417 (457)
                      ........       ..++..... .......+.+++.+||+.+|++|||+.++++.  ++.....
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~~~  300 (337)
T cd07858         236 IRNEKARRYIRSLPYTPRQSFARL-FPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLHDP  300 (337)
T ss_pred             cCchhhhHHHHhcCcccccCHHHH-cccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhcCc
Confidence            00000000       000000000 11233557789999999999999999999885  6554433

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.7e-35  Score=294.81  Aligned_cols=261  Identities=22%  Similarity=0.309  Sum_probs=192.7

Q ss_pred             hcCCCCCceecccCcEEEEEEEeC-CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeecC------
Q 012765          141 TDNFNSENLIGKGGHAEVYKGCLP-DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTEN------  213 (457)
Q Consensus       141 ~~~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~------  213 (457)
                      .++|.+.+.||+|+||.||+|... +|+.||+|++.+.... ......+.+|+.+++.++||||+++++++...      
T Consensus        14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~   92 (342)
T cd07879          14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQS-EIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEF   92 (342)
T ss_pred             ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCcccc-ccchhHHHHHHHHHHhcCCCCccchhheecccccCCCC
Confidence            478999999999999999999864 6899999988654322 12345678999999999999999999976532      


Q ss_pred             -ceEEEEEecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccc
Q 012765          214 -GFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAK  292 (457)
Q Consensus       214 -~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~  292 (457)
                       .++++++|+.. +|..++   ...+++..+..++.|++.||.|||+   .+++||||||+||+++.++.+||+|||++.
T Consensus        93 ~~~~lv~e~~~~-~l~~~~---~~~~~~~~~~~~~~qi~~aL~~LH~---~~i~H~dlkp~NIll~~~~~~kL~dfg~~~  165 (342)
T cd07879          93 QDFYLVMPYMQT-DLQKIM---GHPLSEDKVQYLVYQMLCGLKYIHS---AGIIHRDLKPGNLAVNEDCELKILDFGLAR  165 (342)
T ss_pred             ceEEEEeccccc-CHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEeeCCCCc
Confidence             35799999864 666554   3357889999999999999999999   899999999999999999999999999987


Q ss_pred             cCCCCCCceeeecccccccccChhcccc-CCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhccc---cccCCccc
Q 012765          293 WLPDNWSHHIVFPIEGTFGYLSPEYFMH-GIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPL---LQTSNFKE  368 (457)
Q Consensus       293 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~~~---~~~~~~~~  368 (457)
                      ......     ....++..|+|||.+.+ ..++.++|||||||++|||++|+.||..............   .....+.+
T Consensus       166 ~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  240 (342)
T cd07879         166 HADAEM-----TGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQ  240 (342)
T ss_pred             CCCCCC-----CCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHH
Confidence            653322     12347889999999876 4689999999999999999999999986442211100000   00000000


Q ss_pred             ----------------ccCchhhcccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH--HHhcCC
Q 012765          369 ----------------LVDPRLADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQ--LLRGEG  415 (457)
Q Consensus       369 ----------------~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~--~L~~~~  415 (457)
                                      .....+...+ ......+.+++.+||+.||.+||++.+++.  .+++..
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~  304 (342)
T cd07879         241 KLEDKAAKSYIKSLPKYPRKDFSTLF-PKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFR  304 (342)
T ss_pred             HhcccchHHHHhhcCCcccchHHHHh-cCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhcc
Confidence                            0000000000 012345678999999999999999999985  365554

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=3.2e-35  Score=284.06  Aligned_cols=256  Identities=23%  Similarity=0.314  Sum_probs=190.8

Q ss_pred             CCCCceecccCcEEEEEEEeC-CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcC-CCCcceeeeeee-cCceEEEEE
Q 012765          144 FNSENLIGKGGHAEVYKGCLP-DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHIN-HPNAAKLIGFST-ENGFHLVLQ  220 (457)
Q Consensus       144 f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~-~~~~~lv~e  220 (457)
                      |.+.+.||+|+||+||+|... +++.|++|++.......  ......+|+..+++++ |||++++++++. ++..++|||
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e   78 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSW--EECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFE   78 (283)
T ss_pred             CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccch--hHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEe
Confidence            567789999999999999975 57889999876543221  1224557899999999 999999999554 455789999


Q ss_pred             ecCCCChhhhhhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCCCCCC
Q 012765          221 FLPHGSLSSLLFGST-ECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWS  299 (457)
Q Consensus       221 ~~~~gsL~~~l~~~~-~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~~~~  299 (457)
                      |+ +|+|.+++.... ..+++..+..++.|++.+|.|||+   .+++|+||+|+||+++.++.++|+|||++........
T Consensus        79 ~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~---~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~  154 (283)
T cd07830          79 YM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHK---HGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP  154 (283)
T ss_pred             cC-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChhhEEEcCCCCEEEeecccceeccCCCC
Confidence            99 889988886543 468999999999999999999999   8999999999999999999999999999987654322


Q ss_pred             ceeeecccccccccChhccc-cCCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhh--------------hccccccC
Q 012765          300 HHIVFPIEGTFGYLSPEYFM-HGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIW--------------AKPLLQTS  364 (457)
Q Consensus       300 ~~~~~~~~gt~~y~aPE~~~-~~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~--------------~~~~~~~~  364 (457)
                         .....++..|+|||++. ...++.++|+||||++++||++|+.||.........+              ........
T Consensus       155 ---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (283)
T cd07830         155 ---YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLAS  231 (283)
T ss_pred             ---cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhc
Confidence               12344788999999875 4557999999999999999999999997543221111              00000000


Q ss_pred             Cc----ccccCchhhcccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 012765          365 NF----KELVDPRLADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQ  409 (457)
Q Consensus       365 ~~----~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~  409 (457)
                      ..    .......+.... ......+.+++.+||+.+|++|||+.|++.
T Consensus       232 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~  279 (283)
T cd07830         232 KLGFRFPQFAPTSLHQLI-PNASPEAIDLIKDMLRWDPKKRPTASQALQ  279 (283)
T ss_pred             cccccccccccccHHHHc-ccCCHHHHHHHHHhcccCcccCCCHHHHhh
Confidence            00    000001010000 111356788999999999999999999976

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8.2e-37  Score=283.25  Aligned_cols=251  Identities=23%  Similarity=0.331  Sum_probs=199.5

Q ss_pred             hhcCCCCCceecccCcEEEEEEEeC-CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceee-eeeecCceEE
Q 012765          140 ATDNFNSENLIGKGGHAEVYKGCLP-DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLI-GFSTENGFHL  217 (457)
Q Consensus       140 ~~~~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~-~~~~~~~~~l  217 (457)
                      .-++|..+++||+|.||.|.+++.+ .++.||+|++++......+....-+.|-.+|...+||.+..+- .|...+.+|+
T Consensus       166 Tm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCF  245 (516)
T KOG0690|consen  166 TMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCF  245 (516)
T ss_pred             ccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEE
Confidence            4578889999999999999999754 6999999999887777777788889999999999999999884 5888888999


Q ss_pred             EEEecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCCCC
Q 012765          218 VLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDN  297 (457)
Q Consensus       218 v~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~~  297 (457)
                      ||||..||.|..+|... +.+++....-+-..|+.||.|||+   ++||.||||.+|+|||.+|++||+|||+++.--..
T Consensus       246 VMeyanGGeLf~HLsre-r~FsE~RtRFYGaEIvsAL~YLHs---~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~~  321 (516)
T KOG0690|consen  246 VMEYANGGELFFHLSRE-RVFSEDRTRFYGAEIVSALGYLHS---RNIVYRDLKLENLLLDKDGHIKITDFGLCKEEIKY  321 (516)
T ss_pred             EEEEccCceEeeehhhh-hcccchhhhhhhHHHHHHhhhhhh---CCeeeeechhhhheeccCCceEeeecccchhcccc
Confidence            99999999999998543 345555555567789999999999   89999999999999999999999999999753221


Q ss_pred             CCceeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhccccccCCcccccCchhhcc
Q 012765          298 WSHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSNFKELVDPRLADA  377 (457)
Q Consensus       298 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~  377 (457)
                        .....+++||+.|+|||++....|+..+|+|.+||++|||++|+.||...+.. ..+...+..+-.++.        .
T Consensus       322 --g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~-kLFeLIl~ed~kFPr--------~  390 (516)
T KOG0690|consen  322 --GDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHE-KLFELILMEDLKFPR--------T  390 (516)
T ss_pred             --cceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchh-HHHHHHHhhhccCCc--------c
Confidence              23455788999999999999999999999999999999999999999864322 111111122222221        1


Q ss_pred             cCHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHH
Q 012765          378 YDLAEMKRAMLTASVCIHHLSTMRPQ-----MTRVLQ  409 (457)
Q Consensus       378 ~~~~~~~~l~~l~~~Cl~~dP~~RPt-----~~evl~  409 (457)
                      .+    .+...++...|..||.+|.-     ++||.+
T Consensus       391 ls----~eAktLLsGLL~kdP~kRLGgGpdDakEi~~  423 (516)
T KOG0690|consen  391 LS----PEAKTLLSGLLKKDPKKRLGGGPDDAKEIMR  423 (516)
T ss_pred             CC----HHHHHHHHHHhhcChHhhcCCCchhHHHHHh
Confidence            12    23345667789999999963     556554

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=100.00  E-value=1.7e-35  Score=289.78  Aligned_cols=263  Identities=25%  Similarity=0.325  Sum_probs=191.9

Q ss_pred             hcCCCCCceecccCcEEEEEEEeC-CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeec-------
Q 012765          141 TDNFNSENLIGKGGHAEVYKGCLP-DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTE-------  212 (457)
Q Consensus       141 ~~~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-------  212 (457)
                      .++|++.+.||.|+||.||+|... +++.+|+|++........ ....+.+|+++++.++||||+++++++..       
T Consensus         7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   85 (311)
T cd07866           7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDG-FPITALREIKILKKLKHPNVVPLIDMAVERPDKSKR   85 (311)
T ss_pred             cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCC-cchhHHHHHHHHHhcCCCCccchhhheecccccccc
Confidence            578999999999999999999865 589999998865432221 12356789999999999999999985432       


Q ss_pred             --CceEEEEEecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccc
Q 012765          213 --NGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGL  290 (457)
Q Consensus       213 --~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl  290 (457)
                        ..++++++|+.+ ++...+......+++..+..++.||++||.|||+   .+++|+||||+||+++.++.++|+|||+
T Consensus        86 ~~~~~~lv~~~~~~-~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~  161 (311)
T cd07866          86 KRGSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLHE---NHILHRDIKAANILIDNQGILKIADFGL  161 (311)
T ss_pred             cCceEEEEEecCCc-CHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEECcCcc
Confidence              125789999865 6777776555679999999999999999999999   8999999999999999999999999999


Q ss_pred             cccCCCCCCce---------eeecccccccccChhccccC-CCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhh---hh
Q 012765          291 AKWLPDNWSHH---------IVFPIEGTFGYLSPEYFMHG-IVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVI---WA  357 (457)
Q Consensus       291 ~~~~~~~~~~~---------~~~~~~gt~~y~aPE~~~~~-~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~---~~  357 (457)
                      +..........         ......+++.|+|||++.+. .++.++|||||||++|||++|+.||.........   +.
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~  241 (311)
T cd07866         162 ARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFK  241 (311)
T ss_pred             chhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence            97654322111         11223468889999987654 5899999999999999999999999753322100   00


Q ss_pred             c---cc------------cccCCcccccCchhhcccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 012765          358 K---PL------------LQTSNFKELVDPRLADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQ  409 (457)
Q Consensus       358 ~---~~------------~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~  409 (457)
                      .   +.            ...........+.+...+ ......+.+++.+||+.+|.+|||+.+++.
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~i~~~l~~~p~~R~t~~ell~  307 (311)
T cd07866         242 LCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERF-GKLGPEGLDLLSKLLSLDPYKRLTASDALE  307 (311)
T ss_pred             HhCCCChhhchhhhhcccccccccCCCCCccHHHHc-ccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence            0   00            000000000111111100 112256778999999999999999999875

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=100.00  E-value=1.9e-36  Score=320.76  Aligned_cols=255  Identities=26%  Similarity=0.377  Sum_probs=184.4

Q ss_pred             HhhcCCCCCceecccCcEEEEEEEeC-CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeecC----
Q 012765          139 AATDNFNSENLIGKGGHAEVYKGCLP-DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTEN----  213 (457)
Q Consensus       139 ~~~~~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~----  213 (457)
                      +-..+|+...+||+||||.||+++.+ ||+.||||++.-..  .......+.+|+..+++|+|||||++|..|.+.    
T Consensus       476 RY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~--s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~  553 (1351)
T KOG1035|consen  476 RYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA--SDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAEL  553 (1351)
T ss_pred             hHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCch--HHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcc
Confidence            45678888999999999999999865 89999999987654  345567899999999999999999998632100    


Q ss_pred             --------------------------------------------------------------------------------
Q 012765          214 --------------------------------------------------------------------------------  213 (457)
Q Consensus       214 --------------------------------------------------------------------------------  213 (457)
                                                                                                      
T Consensus       554 ~~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~t  633 (1351)
T KOG1035|consen  554 TVLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNT  633 (1351)
T ss_pred             ccccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccc
Confidence                                                                                            


Q ss_pred             ------------------------------------ceEEEEEecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHH
Q 012765          214 ------------------------------------GFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYL  257 (457)
Q Consensus       214 ------------------------------------~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yL  257 (457)
                                                          -+|+=||||+..++.+++..+...-.-...|.++.+|++||.|+
T Consensus       634 S~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYI  713 (1351)
T KOG1035|consen  634 SDSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYI  713 (1351)
T ss_pred             cccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHH
Confidence                                                01233556655555555533222113556689999999999999


Q ss_pred             HhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCC----------C------CCCceeeecccccccccChhccccC
Q 012765          258 HHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLP----------D------NWSHHIVFPIEGTFGYLSPEYFMHG  321 (457)
Q Consensus       258 H~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~----------~------~~~~~~~~~~~gt~~y~aPE~~~~~  321 (457)
                      |+   .+||||||||.||+|+++..|||+|||+++...          .      .......+...||.-|+|||++.+.
T Consensus       714 H~---~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~  790 (1351)
T KOG1035|consen  714 HD---QGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDT  790 (1351)
T ss_pred             Hh---CceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccc
Confidence            99   899999999999999999999999999998721          0      0111123456799999999998754


Q ss_pred             ---CCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhccccccCCcccccCchhhcccCHHHHHHHHHHHHHhcccCC
Q 012765          322 ---IVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSNFKELVDPRLADAYDLAEMKRAMLTASVCIHHLS  398 (457)
Q Consensus       322 ---~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP  398 (457)
                         .|+.|+|+||||||++||+.   ||...-+-...  ...+..+.++.-      ..+.......-..++.+++++||
T Consensus       791 ~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsMERa~i--L~~LR~g~iP~~------~~f~~~~~~~e~slI~~Ll~hdP  859 (1351)
T KOG1035|consen  791 SSNKYNSKIDMYSLGIVLFEMLY---PFGTSMERASI--LTNLRKGSIPEP------ADFFDPEHPEEASLIRWLLSHDP  859 (1351)
T ss_pred             ccccccchhhhHHHHHHHHHHhc---cCCchHHHHHH--HHhcccCCCCCC------cccccccchHHHHHHHHHhcCCC
Confidence               49999999999999999995   46542111111  111112222211      11223344445678899999999


Q ss_pred             CCCCCHHHHHH
Q 012765          399 TMRPQMTRVLQ  409 (457)
Q Consensus       399 ~~RPt~~evl~  409 (457)
                      .+|||+.|+|.
T Consensus       860 ~kRPtA~eLL~  870 (1351)
T KOG1035|consen  860 SKRPTATELLN  870 (1351)
T ss_pred             ccCCCHHHHhh
Confidence            99999999886

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=6.5e-35  Score=280.43  Aligned_cols=248  Identities=24%  Similarity=0.246  Sum_probs=185.3

Q ss_pred             HHHHHhhcCCCCCcee--cccCcEEEEEEEeC-CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhh-cCCCCcceeeeee
Q 012765          135 AELAAATDNFNSENLI--GKGGHAEVYKGCLP-DGEVVAVKKIIKNAKEDEERISDFLSELGIVAH-INHPNAAKLIGFS  210 (457)
Q Consensus       135 ~~~~~~~~~f~~~~~L--G~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~-l~hpniv~l~~~~  210 (457)
                      .+.....++|.+.+.+  |.|+||.||++... ++..+|+|.+.......   .     |+..... .+|||++++++++
T Consensus         7 ~~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~---~-----e~~~~~~~~~h~~iv~~~~~~   78 (267)
T PHA03390          7 SELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA---I-----EPMVHQLMKDNPNFIKLYYSV   78 (267)
T ss_pred             HHHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch---h-----hHHHHHHhhcCCCEEEEEEEE
Confidence            3444456777777776  99999999999854 68889999875432111   0     1211111 2799999999855


Q ss_pred             -ecCceEEEEEecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCC-cEEEeec
Q 012765          211 -TENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDY-EAQISDF  288 (457)
Q Consensus       211 -~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~-~~kL~DF  288 (457)
                       ..+..++||||+++++|.+++.... .+++..+..++.||+.||.|||+   .+++||||||+||+++.++ .++|+||
T Consensus        79 ~~~~~~~iv~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~~l~df  154 (267)
T PHA03390         79 TTLKGHVLIMDYIKDGDLFDLLKKEG-KLSEAEVKKIIRQLVEALNDLHK---HNIIHNDIKLENVLYDRAKDRIYLCDY  154 (267)
T ss_pred             ecCCeeEEEEEcCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEEeCCCCeEEEecC
Confidence             4556789999999999999986543 78999999999999999999999   8999999999999999998 9999999


Q ss_pred             cccccCCCCCCceeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhccccccCCccc
Q 012765          289 GLAKWLPDNWSHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSNFKE  368 (457)
Q Consensus       289 Gl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~  368 (457)
                      |++.......      ...++..|+|||++.+..++.++||||||+++|||++|+.||.........+.....       
T Consensus       155 g~~~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~-------  221 (267)
T PHA03390        155 GLCKIIGTPS------CYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLK-------  221 (267)
T ss_pred             ccceecCCCc------cCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHH-------
Confidence            9988764432      234889999999999889999999999999999999999999854332211110000       


Q ss_pred             ccCchhhcccCHHHHHHHHHHHHHhcccCCCCCCC-HHHHHH
Q 012765          369 LVDPRLADAYDLAEMKRAMLTASVCIHHLSTMRPQ-MTRVLQ  409 (457)
Q Consensus       369 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt-~~evl~  409 (457)
                      ......  .........+.+++.+||+.+|.+||+ +.++++
T Consensus       222 ~~~~~~--~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~  261 (267)
T PHA03390        222 RQQKKL--PFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIK  261 (267)
T ss_pred             hhcccC--CcccccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence            000000  000123345677888999999999996 688874

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=100.00  E-value=4.3e-35  Score=292.21  Aligned_cols=263  Identities=22%  Similarity=0.284  Sum_probs=194.2

Q ss_pred             HHHHHHhhcCCCCCceecccCcEEEEEEEe-CCCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeec
Q 012765          134 FAELAAATDNFNSENLIGKGGHAEVYKGCL-PDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTE  212 (457)
Q Consensus       134 ~~~~~~~~~~f~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~  212 (457)
                      ...+..++++|.+.+.||+|+||.||+|.. .+++.||+|++...... ......+.+|+.++.+++||||+++++++..
T Consensus         9 ~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~   87 (345)
T cd07877           9 NKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS-IIHAKRTYRELRLLKHMKHENVIGLLDVFTP   87 (345)
T ss_pred             HHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchh-hHHHHHHHHHHHHHHHcCCCcccceeeeeee
Confidence            445566789999999999999999999985 46899999988654322 2234568889999999999999999986543


Q ss_pred             C-------ceEEEEEecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEE
Q 012765          213 N-------GFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQI  285 (457)
Q Consensus       213 ~-------~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL  285 (457)
                      .       ..+++++++ +++|..++..  ..+++..+..++.||+.||.|||+   .+|+||||||+||+++.++.+||
T Consensus        88 ~~~~~~~~~~~lv~~~~-~~~L~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIll~~~~~~kl  161 (345)
T cd07877          88 ARSLEEFNDVYLVTHLM-GADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKI  161 (345)
T ss_pred             cccccccccEEEEehhc-ccCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCChHHEEEcCCCCEEE
Confidence            2       245666654 7888887743  358899999999999999999999   89999999999999999999999


Q ss_pred             eeccccccCCCCCCceeeecccccccccChhcccc-CCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhh--c-ccc
Q 012765          286 SDFGLAKWLPDNWSHHIVFPIEGTFGYLSPEYFMH-GIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWA--K-PLL  361 (457)
Q Consensus       286 ~DFGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~--~-~~~  361 (457)
                      +|||++......     .....++..|+|||++.+ ..++.++|||||||++|||++|+.||...+.......  . ...
T Consensus       162 ~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~  236 (345)
T cd07877         162 LDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGT  236 (345)
T ss_pred             eccccccccccc-----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Confidence            999998765432     123457899999999866 5688999999999999999999999975332111000  0 000


Q ss_pred             ccCCcc-cccC---------------chhhcccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 012765          362 QTSNFK-ELVD---------------PRLADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQ  409 (457)
Q Consensus       362 ~~~~~~-~~~d---------------~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~  409 (457)
                      ...... .+.+               ...... .......+.+++.+||+.+|.+||++.++++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~  299 (345)
T cd07877         237 PGAELLKKISSESARNYIQSLTQMPKMNFANV-FIGANPLAVDLLEKMLVLDSDKRITAAQALA  299 (345)
T ss_pred             CCHHHHhhcccHhHHHHHHHhcccCCcchhhh-cCCCCHHHHHHHHHHcCCChhhcCCHHHHhc
Confidence            000000 0000               000000 0011335678999999999999999999887

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=100.00  E-value=4.7e-35  Score=282.98  Aligned_cols=243  Identities=24%  Similarity=0.293  Sum_probs=182.0

Q ss_pred             eecccCcEEEEEEEeC-CCcEEEEEEEeccchhhHHHHHHHHHH---HHHHhhcCCCCcceeeeeee-cCceEEEEEecC
Q 012765          149 LIGKGGHAEVYKGCLP-DGEVVAVKKIIKNAKEDEERISDFLSE---LGIVAHINHPNAAKLIGFST-ENGFHLVLQFLP  223 (457)
Q Consensus       149 ~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E---~~~l~~l~hpniv~l~~~~~-~~~~~lv~e~~~  223 (457)
                      +||+|+||.||+|... +++.||+|.+.+...........+..|   +..+...+||||+++++++. .+..++||||+.
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN   80 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence            4899999999999864 588999998865432211112223333   34455568999999998555 455789999999


Q ss_pred             CCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCCCCCCceee
Q 012765          224 HGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSHHIV  303 (457)
Q Consensus       224 ~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~~~~~~~~  303 (457)
                      +++|..++.. ...+++..+..++.|++.||.|||+   .+++||||||+||+++.++.++|+|||++..+.....    
T Consensus        81 g~~L~~~l~~-~~~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~~----  152 (278)
T cd05606          81 GGDLHYHLSQ-HGVFSEAEMRFYAAEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP----  152 (278)
T ss_pred             CCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHH---CCEEcCCCCHHHEEECCCCCEEEccCcCccccCccCC----
Confidence            9999988854 3468999999999999999999999   8999999999999999999999999999876543321    


Q ss_pred             ecccccccccChhccccC-CCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhccccccCCcccccCchhhcccCHHH
Q 012765          304 FPIEGTFGYLSPEYFMHG-IVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSNFKELVDPRLADAYDLAE  382 (457)
Q Consensus       304 ~~~~gt~~y~aPE~~~~~-~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~  382 (457)
                      ....|+..|+|||++.++ .++.++||||||+++|||++|+.||.............      ......+.+...    .
T Consensus       153 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~------~~~~~~~~~~~~----~  222 (278)
T cd05606         153 HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDR------MTLTMAVELPDS----F  222 (278)
T ss_pred             cCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHH------HhhccCCCCCCc----C
Confidence            223589999999998754 68999999999999999999999997642211110000      000011112122    2


Q ss_pred             HHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 012765          383 MKRAMLTASVCIHHLSTMRP-----QMTRVLQ  409 (457)
Q Consensus       383 ~~~l~~l~~~Cl~~dP~~RP-----t~~evl~  409 (457)
                      ...+.+++.+||..+|.+||     ++.++++
T Consensus       223 s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~  254 (278)
T cd05606         223 SPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE  254 (278)
T ss_pred             CHHHHHHHHHHhhcCHHhccCCCCCCHHHHHh
Confidence            34677788899999999999     9999875

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=100.00  E-value=5.1e-35  Score=289.70  Aligned_cols=260  Identities=22%  Similarity=0.276  Sum_probs=193.1

Q ss_pred             HhhcCCCCCceecccCcEEEEEEEeC-CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeec--Cce
Q 012765          139 AATDNFNSENLIGKGGHAEVYKGCLP-DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTE--NGF  215 (457)
Q Consensus       139 ~~~~~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~--~~~  215 (457)
                      .++++|++.+.||.|+||.||+|... +++.||+|++...... ......+.+|+.++..++||||+++++++..  ...
T Consensus         7 ~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~   85 (328)
T cd07856           7 EITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFST-PVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDI   85 (328)
T ss_pred             ccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccc-cchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcE
Confidence            46788999999999999999999854 7899999987653322 1234577889999999999999999996643  457


Q ss_pred             EEEEEecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCC
Q 012765          216 HLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLP  295 (457)
Q Consensus       216 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~  295 (457)
                      ++++||+ +++|..++.  ...+++.....++.|++.||.|||+   .+++||||+|+||+++.++.++|+|||++....
T Consensus        86 ~lv~e~~-~~~L~~~~~--~~~~~~~~~~~~~~ql~~aL~~LH~---~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~  159 (328)
T cd07856          86 YFVTELL-GTDLHRLLT--SRPLEKQFIQYFLYQILRGLKYVHS---AGVVHRDLKPSNILINENCDLKICDFGLARIQD  159 (328)
T ss_pred             EEEeehh-ccCHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEeECCCCCEEeCccccccccC
Confidence            8999987 568888774  3347788888899999999999999   899999999999999999999999999987553


Q ss_pred             CCCCceeeecccccccccChhcccc-CCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchh-------------hhhcccc
Q 012765          296 DNWSHHIVFPIEGTFGYLSPEYFMH-GIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLV-------------IWAKPLL  361 (457)
Q Consensus       296 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~-------------~~~~~~~  361 (457)
                      ...     ....++..|+|||++.+ ..++.++|||||||++|+|++|+.||........             .+.....
T Consensus       160 ~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (328)
T cd07856         160 PQM-----TGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTIC  234 (328)
T ss_pred             CCc-----CCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhcc
Confidence            321     22347888999998765 5689999999999999999999999975432110             0000000


Q ss_pred             ccCCcccccCchhhcccC-----HHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 012765          362 QTSNFKELVDPRLADAYD-----LAEMKRAMLTASVCIHHLSTMRPQMTRVLQL  410 (457)
Q Consensus       362 ~~~~~~~~~d~~l~~~~~-----~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~  410 (457)
                      .......+..-.......     ......+.+++.+||+.+|++|||+.+++..
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~  288 (328)
T cd07856         235 SENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH  288 (328)
T ss_pred             chhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            000000000000000000     0123567788999999999999999999773

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=100.00  E-value=1.1e-34  Score=284.87  Aligned_cols=258  Identities=22%  Similarity=0.260  Sum_probs=187.8

Q ss_pred             CceecccCcEEEEEEEeCCCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeec-CceEEEEEecCCC
Q 012765          147 ENLIGKGGHAEVYKGCLPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTE-NGFHLVLQFLPHG  225 (457)
Q Consensus       147 ~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-~~~~lv~e~~~~g  225 (457)
                      .+.+|.|+++.||++.. +++.||+|++..... .......+.+|+.+++.++|+||+++++++.. +..+++|||++++
T Consensus         7 ~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~-~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~   84 (314)
T cd08216           7 GKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSC-SKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYG   84 (314)
T ss_pred             hHhhcCCceEEEEEecC-CCCEEEEEEEecccc-chhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCC
Confidence            34455566666666654 789999999865422 23456789999999999999999999986554 5568999999999


Q ss_pred             ChhhhhhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCCCCCCc----
Q 012765          226 SLSSLLFGS-TECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSH----  300 (457)
Q Consensus       226 sL~~~l~~~-~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~~~~~----  300 (457)
                      +|.+++... ...+++.....++.|++.||.|||+   .+|+||||||+||+++.++.+||+|||.+..+......    
T Consensus        85 ~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~---~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~  161 (314)
T cd08216          85 SCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHS---KGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVV  161 (314)
T ss_pred             CHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCcceEEEecCCceEEecCccceeecccccccccc
Confidence            999998653 3457888889999999999999999   89999999999999999999999999988765332110    


Q ss_pred             -eeeecccccccccChhcccc--CCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhcc------ccccCC------
Q 012765          301 -HIVFPIEGTFGYLSPEYFMH--GIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKP------LLQTSN------  365 (457)
Q Consensus       301 -~~~~~~~gt~~y~aPE~~~~--~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~~------~~~~~~------  365 (457)
                       .......++..|+|||++.+  ..++.++|||||||++|||++|+.||.............      ......      
T Consensus       162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (314)
T cd08216         162 HDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYED  241 (314)
T ss_pred             ccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhhcC
Confidence             11122346788999999875  358899999999999999999999998543221111000      000000      


Q ss_pred             -ccc----ccCchh----hcccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 012765          366 -FKE----LVDPRL----ADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQ  409 (457)
Q Consensus       366 -~~~----~~d~~l----~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~  409 (457)
                       ...    ..++..    ...........+.+++.+||+.||++|||+.++++
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~  294 (314)
T cd08216         242 SMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLN  294 (314)
T ss_pred             CcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhc
Confidence             000    011111    01112233456788999999999999999999987

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=100.00  E-value=5.2e-35  Score=291.44  Aligned_cols=258  Identities=23%  Similarity=0.307  Sum_probs=192.9

Q ss_pred             HhhcCCCCCceecccCcEEEEEEEe-CCCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeecC----
Q 012765          139 AATDNFNSENLIGKGGHAEVYKGCL-PDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTEN----  213 (457)
Q Consensus       139 ~~~~~f~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~----  213 (457)
                      ...++|.+.+.||+|+||.||+|.. .++..||+|++..... .......+.+|+.+++.++||||+++++++..+    
T Consensus        12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   90 (343)
T cd07880          12 EVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQ-SELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLD   90 (343)
T ss_pred             ccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEeccccc-chHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccc
Confidence            3568899999999999999999985 4689999998854322 223345788999999999999999999966543    


Q ss_pred             ---ceEEEEEecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccc
Q 012765          214 ---GFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGL  290 (457)
Q Consensus       214 ---~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl  290 (457)
                         .+++||+|+ +++|..++.  ...+++..+..++.||+.||.|||+   .+|+||||||+||+++.++.++|+|||+
T Consensus        91 ~~~~~~lv~e~~-~~~l~~~~~--~~~l~~~~~~~i~~qi~~al~~LH~---~gi~H~dlkp~Nill~~~~~~kl~dfg~  164 (343)
T cd07880          91 RFHDFYLVMPFM-GTDLGKLMK--HEKLSEDRIQFLVYQMLKGLKYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGL  164 (343)
T ss_pred             ccceEEEEEecC-CCCHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEeeccc
Confidence               247899988 778887774  3468899999999999999999999   8999999999999999999999999999


Q ss_pred             cccCCCCCCceeeecccccccccChhcccc-CCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhh--c-cccccCCc
Q 012765          291 AKWLPDNWSHHIVFPIEGTFGYLSPEYFMH-GIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWA--K-PLLQTSNF  366 (457)
Q Consensus       291 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~--~-~~~~~~~~  366 (457)
                      +.......     ....+++.|+|||++.+ ..++.++|+||||+++|+|++|+.||...+.......  . .......+
T Consensus       165 ~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  239 (343)
T cd07880         165 ARQTDSEM-----TGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEF  239 (343)
T ss_pred             ccccccCc-----cccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHH
Confidence            98664322     22347889999999876 4588999999999999999999999986432111000  0 00000000


Q ss_pred             c----------------cccCchhhcccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 012765          367 K----------------ELVDPRLADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQ  409 (457)
Q Consensus       367 ~----------------~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~  409 (457)
                      .                ......+. .........+.+++.+|++.||.+|||+.+++.
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~  297 (343)
T cd07880         240 VQKLQSEDAKNYVKKLPRFRKKDFR-SLLPNANPLAVNVLEKMLVLDAESRITAAEALA  297 (343)
T ss_pred             HHhhcchhHHHHHHhccccCcchHH-HhccCCChHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            0                00000000 000112234778999999999999999999984

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=100.00  E-value=3.9e-35  Score=290.38  Aligned_cols=268  Identities=21%  Similarity=0.262  Sum_probs=199.5

Q ss_pred             CCCCCceecccCcEEEEEEEeC-CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeecC------ce
Q 012765          143 NFNSENLIGKGGHAEVYKGCLP-DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTEN------GF  215 (457)
Q Consensus       143 ~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~------~~  215 (457)
                      +|.+.+.||.|+||.||+|... +++.||+|++..... .......+.+|+.+++.++||||+++++++...      ..
T Consensus         1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~   79 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFD-DLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDV   79 (330)
T ss_pred             CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccc-cchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccce
Confidence            4778899999999999999865 489999998865432 223456789999999999999999999976554      47


Q ss_pred             EEEEEecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCC
Q 012765          216 HLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLP  295 (457)
Q Consensus       216 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~  295 (457)
                      +++|+|+. ++|..++... ..+++..++.++.||+.||.|||+   .+|+||||||.|||++.++.++|+|||++....
T Consensus        80 ~lv~e~~~-~~l~~~l~~~-~~l~~~~~~~i~~~l~~~l~~LH~---~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~  154 (330)
T cd07834          80 YIVTELME-TDLHKVIKSP-QPLTDDHIQYFLYQILRGLKYLHS---ANVIHRDLKPSNILVNSNCDLKICDFGLARGVD  154 (330)
T ss_pred             EEEecchh-hhHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEcccCceEeec
Confidence            89999997 4788877543 378999999999999999999999   899999999999999999999999999998775


Q ss_pred             CCCCc-eeeecccccccccChhccccC-CCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhh-cccc-----------
Q 012765          296 DNWSH-HIVFPIEGTFGYLSPEYFMHG-IVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWA-KPLL-----------  361 (457)
Q Consensus       296 ~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~-~~~~-----------  361 (457)
                      ..... .......++..|+|||++.+. .++.++|+||||+++|+|++|+.||........... ....           
T Consensus       155 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  234 (330)
T cd07834         155 PDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFI  234 (330)
T ss_pred             ccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhc
Confidence            54210 112234478899999999877 789999999999999999999999976442211000 0000           


Q ss_pred             ccCCcccccC---chhh---cccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH--HHhcCCC
Q 012765          362 QTSNFKELVD---PRLA---DAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQ--LLRGEGG  416 (457)
Q Consensus       362 ~~~~~~~~~d---~~l~---~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~--~L~~~~~  416 (457)
                      ........+.   ....   ..........+.+++.+||+.+|.+||++.++++  .+++...
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~  297 (330)
T cd07834         235 TSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHD  297 (330)
T ss_pred             cccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhcc
Confidence            0000000000   0000   0000112345778999999999999999999998  3555543

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-35  Score=300.62  Aligned_cols=200  Identities=30%  Similarity=0.447  Sum_probs=170.4

Q ss_pred             CCCCceecccCcEEEEEEEe-CCCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeecCc-------e
Q 012765          144 FNSENLIGKGGHAEVYKGCL-PDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTENG-------F  215 (457)
Q Consensus       144 f~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~-------~  215 (457)
                      |...+.||+||||.||+|+. ..|+.||||.+......  ...+...+|+++|++++|+|||+++++.+...       .
T Consensus        15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~--r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~   92 (732)
T KOG4250|consen   15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSL--RPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLP   92 (732)
T ss_pred             eeehhhhcCCccceeeeecccccccchhHHhhhhhccc--chHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccc
Confidence            34557899999999999994 57999999988654322  33567889999999999999999999766544       5


Q ss_pred             EEEEEecCCCChhhhhhcC--CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEc--CCCc--EEEeecc
Q 012765          216 HLVLQFLPHGSLSSLLFGS--TECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLS--EDYE--AQISDFG  289 (457)
Q Consensus       216 ~lv~e~~~~gsL~~~l~~~--~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~--~~~~--~kL~DFG  289 (457)
                      .++||||.+|+|+..|...  ...+++...+.++..++.||.|||+   .+|+||||||.||++-  ++|+  -||+|||
T Consensus        93 vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrE---n~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG  169 (732)
T KOG4250|consen   93 VLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRE---NGIVHRDLKPGNIVLQIGEDGQSIYKLTDFG  169 (732)
T ss_pred             eEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHH---cCceeccCCCCcEEEeecCCCceEEeeeccc
Confidence            6999999999999999663  3458999999999999999999999   8999999999999884  4444  7999999


Q ss_pred             ccccCCCCCCceeeecccccccccChhccc-cCCCCcchhHHHHHHHHHHHHhCCCCCCcCCc
Q 012765          290 LAKWLPDNWSHHIVFPIEGTFGYLSPEYFM-HGIVDEKTDVFAFGVLLLELITGRRAVDSRRQ  351 (457)
Q Consensus       290 l~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~ksDvwSlGvll~eLltG~~pf~~~~~  351 (457)
                      .|+.+.++.   ......||..|++||.+. .+.|+..+|.|||||++|+++||..||.....
T Consensus       170 ~Arel~d~s---~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~  229 (732)
T KOG4250|consen  170 AARELDDNS---LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGG  229 (732)
T ss_pred             ccccCCCCC---eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCC
Confidence            999987764   445677999999999998 48899999999999999999999999986443

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=1.4e-34  Score=281.92  Aligned_cols=242  Identities=21%  Similarity=0.327  Sum_probs=188.2

Q ss_pred             ceecccCcEEEEEEEeC-CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeee-cCceEEEEEecCCC
Q 012765          148 NLIGKGGHAEVYKGCLP-DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFST-ENGFHLVLQFLPHG  225 (457)
Q Consensus       148 ~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~-~~~~~lv~e~~~~g  225 (457)
                      ..||+|+||.||+|... +++.||+|++....   ......+.+|+.+++.++|+|++++++++. .+..+++|||++++
T Consensus        26 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~  102 (292)
T cd06657          26 IKIGEGSTGIVCIATVKSSGKLVAVKKMDLRK---QQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGG  102 (292)
T ss_pred             HHcCCCCCeEEEEEEEcCCCeEEEEEEecccc---hhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCC
Confidence            57999999999999864 68999999874322   233457889999999999999999998554 55678999999999


Q ss_pred             ChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCCCCCCceeeec
Q 012765          226 SLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFP  305 (457)
Q Consensus       226 sL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~~~~~~~~~~  305 (457)
                      +|.+++..  ..+++.....++.|++.||.|||+   .+++|+||+|+||+++.++.++|+|||++.........  ...
T Consensus       103 ~L~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~---~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~~--~~~  175 (292)
T cd06657         103 ALTDIVTH--TRMNEEQIAAVCLAVLKALSVLHA---QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR--RKS  175 (292)
T ss_pred             cHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEEcccccceeccccccc--ccc
Confidence            99988743  357889999999999999999999   89999999999999999999999999998766443211  122


Q ss_pred             ccccccccChhccccCCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhccccccCCcccccCchhhcccCHHHHHH
Q 012765          306 IEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSNFKELVDPRLADAYDLAEMKR  385 (457)
Q Consensus       306 ~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~  385 (457)
                      ..|+..|+|||++.+..++.++|+||||+++|+|++|..||...........   ..     ....+.+...  ......
T Consensus       176 ~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~---~~-----~~~~~~~~~~--~~~~~~  245 (292)
T cd06657         176 LVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKM---IR-----DNLPPKLKNL--HKVSPS  245 (292)
T ss_pred             cccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH---HH-----hhCCcccCCc--ccCCHH
Confidence            4588999999999888899999999999999999999999975332111000   00     0001111000  011234


Q ss_pred             HHHHHHHhcccCCCCCCCHHHHHH
Q 012765          386 AMLTASVCIHHLSTMRPQMTRVLQ  409 (457)
Q Consensus       386 l~~l~~~Cl~~dP~~RPt~~evl~  409 (457)
                      +..++.+||+.+|.+||++.++++
T Consensus       246 l~~li~~~l~~~P~~R~~~~~ll~  269 (292)
T cd06657         246 LKGFLDRLLVRDPAQRATAAELLK  269 (292)
T ss_pred             HHHHHHHHHhCCcccCcCHHHHhc
Confidence            567788999999999999999987

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.9e-34  Score=272.02  Aligned_cols=238  Identities=30%  Similarity=0.326  Sum_probs=189.5

Q ss_pred             ecccCcEEEEEEEeC-CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeee-ecCceEEEEEecCCCCh
Q 012765          150 IGKGGHAEVYKGCLP-DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFS-TENGFHLVLQFLPHGSL  227 (457)
Q Consensus       150 LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~-~~~~~~lv~e~~~~gsL  227 (457)
                      ||.|+||.||++... +++.+|+|.+.............+..|+.+++.++||||+++++.+ .+...+++|||+++++|
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L   80 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL   80 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence            699999999999865 5899999998766554445667899999999999999999999855 45557899999999999


Q ss_pred             hhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCCCCCCceeeeccc
Q 012765          228 SSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIE  307 (457)
Q Consensus       228 ~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~~~~~~~~~~~~  307 (457)
                      .+++... ..+++...+.++.|++.||.|||+   .+++|+||+|+||+++.++.++|+|||++........  ......
T Consensus        81 ~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lh~---~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~  154 (250)
T cd05123          81 FSHLSKE-GRFSEERARFYAAEIVLALEYLHS---LGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGS--RTNTFC  154 (250)
T ss_pred             HHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCcceEEEcCCCcEEEeecCcceecccCCC--cccCCc
Confidence            9998544 358899999999999999999999   8999999999999999999999999999877644321  122345


Q ss_pred             ccccccChhccccCCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhccccccCCcccccCchhhcccCHHHHHHHH
Q 012765          308 GTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSNFKELVDPRLADAYDLAEMKRAM  387 (457)
Q Consensus       308 gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~  387 (457)
                      ++..|+|||.+.+..++.++|+||||+++|+|++|..||...+..... .......        ..+    .......+.
T Consensus       155 ~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~-~~~~~~~--------~~~----~~~~~~~l~  221 (250)
T cd05123         155 GTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIY-EKILKDP--------LRF----PEFLSPEAR  221 (250)
T ss_pred             CCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHH-HHHhcCC--------CCC----CCCCCHHHH
Confidence            788999999998888999999999999999999999999764431110 0000000        011    111134566


Q ss_pred             HHHHHhcccCCCCCCCHHH
Q 012765          388 LTASVCIHHLSTMRPQMTR  406 (457)
Q Consensus       388 ~l~~~Cl~~dP~~RPt~~e  406 (457)
                      +++.+||..||++||++.+
T Consensus       222 ~~i~~~l~~~p~~R~~~~~  240 (250)
T cd05123         222 DLISGLLQKDPTKRLGSGG  240 (250)
T ss_pred             HHHHHHhcCCHhhCCCccc
Confidence            7889999999999999954

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=100.00  E-value=1.1e-34  Score=281.49  Aligned_cols=255  Identities=22%  Similarity=0.291  Sum_probs=193.4

Q ss_pred             CCCCCceecccCcEEEEEEEe----CCCcEEEEEEEeccchh-hHHHHHHHHHHHHHHhhc-CCCCcceeeeeee-cCce
Q 012765          143 NFNSENLIGKGGHAEVYKGCL----PDGEVVAVKKIIKNAKE-DEERISDFLSELGIVAHI-NHPNAAKLIGFST-ENGF  215 (457)
Q Consensus       143 ~f~~~~~LG~G~~g~Vy~~~~----~~~~~vavK~~~~~~~~-~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~-~~~~  215 (457)
                      +|.+.+.||+|+||.||++..    .++..||+|.+.+.... .......+.+|+.++.++ +||||+++++++. +...
T Consensus         1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~   80 (288)
T cd05583           1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL   80 (288)
T ss_pred             CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence            477889999999999999874    35788999988643222 223345788999999999 5999999998554 4556


Q ss_pred             EEEEEecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCC
Q 012765          216 HLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLP  295 (457)
Q Consensus       216 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~  295 (457)
                      ++||||+++++|..++... ..+++.....++.|++.||.|||+   .+++||||+|.||+++.++.++|+|||++..+.
T Consensus        81 ~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~---~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~  156 (288)
T cd05583          81 HLILDYVNGGELFTHLYQR-EHFTESEVRVYIAEIVLALDHLHQ---LGIIYRDIKLENILLDSEGHVVLTDFGLSKEFL  156 (288)
T ss_pred             EEEEecCCCCcHHHHHhhc-CCcCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEEEECccccccc
Confidence            7999999999999988543 457888888999999999999999   899999999999999999999999999987654


Q ss_pred             CCCCceeeecccccccccChhccccCC--CCcchhHHHHHHHHHHHHhCCCCCCcCCcch--hhhhccccccCCcccccC
Q 012765          296 DNWSHHIVFPIEGTFGYLSPEYFMHGI--VDEKTDVFAFGVLLLELITGRRAVDSRRQSL--VIWAKPLLQTSNFKELVD  371 (457)
Q Consensus       296 ~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~ksDvwSlGvll~eLltG~~pf~~~~~~~--~~~~~~~~~~~~~~~~~d  371 (457)
                      ...... .....|+..|+|||.+.+..  .+.++||||||+++|||++|..||.......  ..+......       ..
T Consensus       157 ~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~-------~~  228 (288)
T cd05583         157 AEEEER-AYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILK-------SK  228 (288)
T ss_pred             cccccc-cccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHc-------cC
Confidence            432211 12245889999999987654  7889999999999999999999996432111  111110000       00


Q ss_pred             chhhcccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 012765          372 PRLADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQLLRG  413 (457)
Q Consensus       372 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~  413 (457)
                      +.....    ....+.+++.+||+.+|++|||+.++.+.|+.
T Consensus       229 ~~~~~~----~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~  266 (288)
T cd05583         229 PPFPKT----MSAEARDFIQKLLEKDPKKRLGANGADEIKNH  266 (288)
T ss_pred             CCCCcc----cCHHHHHHHHHHhcCCHhhccCcchHHHHhcC
Confidence            111111    22345678889999999999999988887755

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=6.3e-37  Score=325.77  Aligned_cols=255  Identities=25%  Similarity=0.370  Sum_probs=195.3

Q ss_pred             HhhcCCCCCceecccCcEEEEEEEe-CCCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeecCc-eE
Q 012765          139 AATDNFNSENLIGKGGHAEVYKGCL-PDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTENG-FH  216 (457)
Q Consensus       139 ~~~~~f~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~-~~  216 (457)
                      ..+-++....+||.|.||.||-|.. ++|...|+|.+.-.... ......+.+|+.++..++|||+|++||+..+.+ .+
T Consensus      1232 nV~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~-~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~ 1310 (1509)
T KOG4645|consen 1232 NVTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSD-HKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVY 1310 (1509)
T ss_pred             cceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccc-cccCcchHHHHHHHHhccCccccccCceeecHHHHH
Confidence            4456677788999999999999984 56999999976443322 344567889999999999999999999887655 56


Q ss_pred             EEEEecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCCC
Q 012765          217 LVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPD  296 (457)
Q Consensus       217 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~  296 (457)
                      +.||||.+|+|.+.+... +..++....-+..|++.|+.|||+   .+||||||||.||+|+.+|-+|++|||.+..+.+
T Consensus      1311 IFMEyC~~GsLa~ll~~g-ri~dE~vt~vyt~qll~gla~LH~---~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~ 1386 (1509)
T KOG4645|consen 1311 IFMEYCEGGSLASLLEHG-RIEDEMVTRVYTKQLLEGLAYLHE---HGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKN 1386 (1509)
T ss_pred             HHHHHhccCcHHHHHHhc-chhhhhHHHHHHHHHHHHHHHHHh---cCceecCCCccceeeecCCcEEeecccceeEecC
Confidence            889999999999998543 334444444567899999999999   8999999999999999999999999999988865


Q ss_pred             CC--CceeeecccccccccChhcccc---CCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhh-hhccccccCCccccc
Q 012765          297 NW--SHHIVFPIEGTFGYLSPEYFMH---GIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVI-WAKPLLQTSNFKELV  370 (457)
Q Consensus       297 ~~--~~~~~~~~~gt~~y~aPE~~~~---~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~-~~~~~~~~~~~~~~~  370 (457)
                      ..  .........||+.|||||++.+   .+...++|||||||+++||+||+.||...+....+ |.......++     
T Consensus      1387 ~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~gh~Pq----- 1461 (1509)
T KOG4645|consen 1387 NAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAAGHKPQ----- 1461 (1509)
T ss_pred             chhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhccCCCC-----
Confidence            42  1122334679999999999975   34667899999999999999999999865543222 2222222222     


Q ss_pred             CchhhcccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 012765          371 DPRLADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQL  410 (457)
Q Consensus       371 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~  410 (457)
                         +....+    ..-.+++..||+.||.+|.++.|+++.
T Consensus      1462 ---~P~~ls----~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1462 ---IPERLS----SEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred             ---Cchhhh----HhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence               222222    223356778999999999999888774

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=1.8e-34  Score=278.40  Aligned_cols=258  Identities=24%  Similarity=0.336  Sum_probs=193.4

Q ss_pred             CCCCceecccCcEEEEEEEeC-CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeec-CceEEEEEe
Q 012765          144 FNSENLIGKGGHAEVYKGCLP-DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTE-NGFHLVLQF  221 (457)
Q Consensus       144 f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-~~~~lv~e~  221 (457)
                      |+..+.||+|+||.||+|... +++.+|+|.+..... .......+..|+.+++.++|+|++++++++.+ +..++++||
T Consensus         1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~   79 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNE-EEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEY   79 (282)
T ss_pred             CeeehcccccCcceEEEeeecCCCcEEEEEEeccccc-cccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecC
Confidence            556788999999999999865 489999998865431 22234567889999999999999999996554 557899999


Q ss_pred             cCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCCCCCCce
Q 012765          222 LPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSHH  301 (457)
Q Consensus       222 ~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~~~~~~  301 (457)
                      +. ++|.+++......+++..+..++.|++.||.|||+   .+++||||+|+||+++.++.++|+|||++........  
T Consensus        80 ~~-~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~--  153 (282)
T cd07829          80 CD-MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHS---HRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR--  153 (282)
T ss_pred             cC-cCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChheEEEcCCCCEEEecCCcccccCCCcc--
Confidence            97 58999986654568999999999999999999999   8999999999999999999999999999987644321  


Q ss_pred             eeecccccccccChhccccC-CCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhh--------------hhcc-cc--cc
Q 012765          302 IVFPIEGTFGYLSPEYFMHG-IVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVI--------------WAKP-LL--QT  363 (457)
Q Consensus       302 ~~~~~~gt~~y~aPE~~~~~-~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~--------------~~~~-~~--~~  363 (457)
                      ......++..|+|||.+.+. .++.++|||||||++|||++|+.||.........              |... ..  ..
T Consensus       154 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (282)
T cd07829         154 TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYK  233 (282)
T ss_pred             ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhccccccc
Confidence            11223357789999998766 7899999999999999999999999764321110              0000 00  00


Q ss_pred             CCcccccCchhhcccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 012765          364 SNFKELVDPRLADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQ  409 (457)
Q Consensus       364 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~  409 (457)
                      ..+........... .......+.+++..||..+|++||++.+++.
T Consensus       234 ~~~~~~~~~~~~~~-~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~  278 (282)
T cd07829         234 PTFPKFPPKDLEKV-LPRLDPEGIDLLSKMLQYNPAKRISAKEALK  278 (282)
T ss_pred             ccccccCccchHHh-cccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence            00111111101000 0112456888999999999999999999975

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=100.00  E-value=1.4e-34  Score=288.20  Aligned_cols=260  Identities=20%  Similarity=0.295  Sum_probs=188.7

Q ss_pred             hcCCCCCceecccCcEEEEEEEeC-CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeecC------
Q 012765          141 TDNFNSENLIGKGGHAEVYKGCLP-DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTEN------  213 (457)
Q Consensus       141 ~~~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~------  213 (457)
                      ..+|.+.+.||.|+||.||+|... +|+.||+|.+.....   .....+.+|+.+++.++||||+++++++...      
T Consensus         4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~---~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~   80 (342)
T cd07854           4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDP---QSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTE   80 (342)
T ss_pred             CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCC---chHHHHHHHHHHHHhcCCCcchhhHhhhccccccccc
Confidence            367889999999999999999864 588999998754432   3345788999999999999999999754432      


Q ss_pred             ---------ceEEEEEecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcC-CCcE
Q 012765          214 ---------GFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSE-DYEA  283 (457)
Q Consensus       214 ---------~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~-~~~~  283 (457)
                               ..+++|||+. ++|..++.  ...+++..+..++.||+.||.|||+   .+++||||||+||+++. ++.+
T Consensus        81 ~~~~~~~~~~~~lv~e~~~-~~L~~~~~--~~~l~~~~~~~~~~qi~~aL~~LH~---~givH~dikp~Nili~~~~~~~  154 (342)
T cd07854          81 DVGSLTELNSVYIVQEYME-TDLANVLE--QGPLSEEHARLFMYQLLRGLKYIHS---ANVLHRDLKPANVFINTEDLVL  154 (342)
T ss_pred             ccccccccceEEEEeeccc-ccHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEEcCCCceE
Confidence                     3679999997 58887774  3458889999999999999999999   89999999999999974 5678


Q ss_pred             EEeeccccccCCCCCCcee-eecccccccccChhcccc-CCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhh--c-
Q 012765          284 QISDFGLAKWLPDNWSHHI-VFPIEGTFGYLSPEYFMH-GIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWA--K-  358 (457)
Q Consensus       284 kL~DFGl~~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~-~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~--~-  358 (457)
                      ||+|||++..+........ .....++..|+|||.+.. ..++.++|||||||++|+|++|+.||...........  . 
T Consensus       155 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~  234 (342)
T cd07854         155 KIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILES  234 (342)
T ss_pred             EECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Confidence            9999999976643221111 112347889999998754 5688999999999999999999999975432111100  0 


Q ss_pred             -cccccCCcccc---cCchhh-----c-----ccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 012765          359 -PLLQTSNFKEL---VDPRLA-----D-----AYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQ  409 (457)
Q Consensus       359 -~~~~~~~~~~~---~d~~l~-----~-----~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~  409 (457)
                       +..........   ....+.     .     .........+.+++.+||+.||.+|||+.+++.
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~  299 (342)
T cd07854         235 VPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALM  299 (342)
T ss_pred             cCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhC
Confidence             00000000000   000000     0     000112245678999999999999999999985

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=100.00  E-value=2.8e-34  Score=278.97  Aligned_cols=251  Identities=24%  Similarity=0.313  Sum_probs=189.1

Q ss_pred             CCCCCceecccCcEEEEEEEe----CCCcEEEEEEEeccchh-hHHHHHHHHHHHHHHhhc-CCCCcceeeeeeecC-ce
Q 012765          143 NFNSENLIGKGGHAEVYKGCL----PDGEVVAVKKIIKNAKE-DEERISDFLSELGIVAHI-NHPNAAKLIGFSTEN-GF  215 (457)
Q Consensus       143 ~f~~~~~LG~G~~g~Vy~~~~----~~~~~vavK~~~~~~~~-~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~-~~  215 (457)
                      +|++.+.||.|+||.||++..    .+|+.||+|.+...... .....+.+.+|+.++.++ +|+||+++++++..+ ..
T Consensus         1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (290)
T cd05613           1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL   80 (290)
T ss_pred             CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence            477889999999999999975    36899999988653322 122345678899999999 599999999866554 46


Q ss_pred             EEEEEecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCC
Q 012765          216 HLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLP  295 (457)
Q Consensus       216 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~  295 (457)
                      ++++||+++++|.+++... ..+++.....++.|++.||.|||+   .+++||||+|+|||++.++.+||+|||++....
T Consensus        81 ~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~al~~lH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~  156 (290)
T cd05613          81 HLILDYINGGELFTHLSQR-ERFKEQEVQIYSGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFH  156 (290)
T ss_pred             EEEEecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeEECCCCCEEEeeCccceecc
Confidence            7999999999999998643 457888888899999999999999   899999999999999999999999999997764


Q ss_pred             CCCCceeeecccccccccChhccccC--CCCcchhHHHHHHHHHHHHhCCCCCCcCCcc--hhhhhccccccCCcccccC
Q 012765          296 DNWSHHIVFPIEGTFGYLSPEYFMHG--IVDEKTDVFAFGVLLLELITGRRAVDSRRQS--LVIWAKPLLQTSNFKELVD  371 (457)
Q Consensus       296 ~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~ksDvwSlGvll~eLltG~~pf~~~~~~--~~~~~~~~~~~~~~~~~~d  371 (457)
                      ..... ......|+..|+|||.+.+.  .++.++||||||+++|+|++|..||......  ...+.......       .
T Consensus       157 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~-------~  228 (290)
T cd05613         157 EDEVE-RAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKS-------E  228 (290)
T ss_pred             ccccc-ccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhcc-------C
Confidence            43211 12234588999999998753  4788999999999999999999999642211  11111111000       0


Q ss_pred             chhhcccCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 012765          372 PRLADAYDLAEMKRAMLTASVCIHHLSTMRP-----QMTRVLQ  409 (457)
Q Consensus       372 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----t~~evl~  409 (457)
                      +.    +.......+..++.+||+.+|++||     ++.+++.
T Consensus       229 ~~----~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~  267 (290)
T cd05613         229 PP----YPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKK  267 (290)
T ss_pred             CC----CCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence            11    1111223556788999999999997     5666654

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=100.00  E-value=9.9e-35  Score=289.37  Aligned_cols=257  Identities=23%  Similarity=0.331  Sum_probs=192.3

Q ss_pred             hhcCCCCCceecccCcEEEEEEEeC-CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeecCc----
Q 012765          140 ATDNFNSENLIGKGGHAEVYKGCLP-DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTENG----  214 (457)
Q Consensus       140 ~~~~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~----  214 (457)
                      ..++|.+...||+|+||.||+|... +++.||+|++...... ......+.+|+.++++++|||++++++++...+    
T Consensus        13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   91 (343)
T cd07851          13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQS-AIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLED   91 (343)
T ss_pred             ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccch-hhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccc
Confidence            4678999999999999999999875 5889999987543222 233456788999999999999999998544322    


Q ss_pred             ---eEEEEEecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeecccc
Q 012765          215 ---FHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLA  291 (457)
Q Consensus       215 ---~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~  291 (457)
                         .++++||+ +++|.+++..  ..+++..++.++.|++.||.|||+   .+|+||||||+||+++.++.++|+|||++
T Consensus        92 ~~~~~lv~e~~-~~~L~~~~~~--~~l~~~~~~~~~~ql~~aL~~LH~---~gi~H~dlkp~Nill~~~~~~kL~dfg~~  165 (343)
T cd07851          92 FQDVYLVTHLM-GADLNNIVKC--QKLSDDHIQFLVYQILRGLKYIHS---AGIIHRDLKPSNIAVNEDCELKILDFGLA  165 (343)
T ss_pred             cccEEEEEecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCCEEEcccccc
Confidence               67888987 6789888843  458999999999999999999999   89999999999999999999999999999


Q ss_pred             ccCCCCCCceeeecccccccccChhcccc-CCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhh-ccccccCC----
Q 012765          292 KWLPDNWSHHIVFPIEGTFGYLSPEYFMH-GIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWA-KPLLQTSN----  365 (457)
Q Consensus       292 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~-~~~~~~~~----  365 (457)
                      ......     .....++..|+|||.+.+ ..++.++|||||||++|||++|+.||.........-. ........    
T Consensus       166 ~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~  240 (343)
T cd07851         166 RHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELL  240 (343)
T ss_pred             cccccc-----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHH
Confidence            876443     122347889999999865 3678999999999999999999999975432111000 00000000    


Q ss_pred             -------ccccc-------CchhhcccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 012765          366 -------FKELV-------DPRLADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQ  409 (457)
Q Consensus       366 -------~~~~~-------d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~  409 (457)
                             ...++       .+.....+ ......+.+++.+||+.+|.+|||+.+|++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~s~~l~dli~~~l~~~P~~Rpt~~ell~  297 (343)
T cd07851         241 QKISSESARNYIQSLPQMPKKDFKEVF-SGANPLAIDLLEKMLVLDPDKRITAAEALA  297 (343)
T ss_pred             hhccchhHHHHHHhccccCCCCHHHHh-ccCCHHHHHHHHHhCCCChhhCCCHHHHhc
Confidence                   00000       00000000 012456788999999999999999999976

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=100.00  E-value=2.8e-34  Score=285.03  Aligned_cols=262  Identities=23%  Similarity=0.255  Sum_probs=189.6

Q ss_pred             cCCC-CCceecccCcEEEEEEEeC-CCcEEEEEEEeccchhhHH-----------HHHHHHHHHHHHhhcCCCCcceeee
Q 012765          142 DNFN-SENLIGKGGHAEVYKGCLP-DGEVVAVKKIIKNAKEDEE-----------RISDFLSELGIVAHINHPNAAKLIG  208 (457)
Q Consensus       142 ~~f~-~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~-----------~~~~~~~E~~~l~~l~hpniv~l~~  208 (457)
                      ++|. +.+.||.|+||+||+|.+. +++.||+|.+.........           ....+.+|+.++..++|+||+++++
T Consensus         8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~   87 (335)
T PTZ00024          8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD   87 (335)
T ss_pred             cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence            4554 4577999999999999865 6899999988653322100           0124778999999999999999999


Q ss_pred             eeec-CceEEEEEecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEee
Q 012765          209 FSTE-NGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISD  287 (457)
Q Consensus       209 ~~~~-~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~D  287 (457)
                      ++.. +..+++|||+. |+|.+++.. ...+++.....++.|++.||.|||+   .+++|+||+|+||+++.++.++|+|
T Consensus        88 ~~~~~~~~~lv~e~~~-~~l~~~l~~-~~~~~~~~~~~~~~ql~~aL~~LH~---~~i~H~dl~~~nill~~~~~~kl~d  162 (335)
T PTZ00024         88 VYVEGDFINLVMDIMA-SDLKKVVDR-KIRLTESQVKCILLQILNGLNVLHK---WYFMHRDLSPANIFINSKGICKIAD  162 (335)
T ss_pred             EEecCCcEEEEEeccc-cCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHh---CCeecccccHHHeEECCCCCEEECC
Confidence            6554 45679999996 688888743 3458889999999999999999999   8999999999999999999999999


Q ss_pred             ccccccCCCCC------------CceeeecccccccccChhccccC-CCCcchhHHHHHHHHHHHHhCCCCCCcCCcchh
Q 012765          288 FGLAKWLPDNW------------SHHIVFPIEGTFGYLSPEYFMHG-IVDEKTDVFAFGVLLLELITGRRAVDSRRQSLV  354 (457)
Q Consensus       288 FGl~~~~~~~~------------~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~  354 (457)
                      ||++.......            .........++..|+|||++.+. .++.++|||||||++|||++|+.||...+....
T Consensus       163 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~  242 (335)
T PTZ00024        163 FGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQ  242 (335)
T ss_pred             ccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence            99997665211            01111223468889999998764 478999999999999999999999986543211


Q ss_pred             h-hhccccccCC---c------------ccccCchhhcccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 012765          355 I-WAKPLLQTSN---F------------KELVDPRLADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQ  409 (457)
Q Consensus       355 ~-~~~~~~~~~~---~------------~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~  409 (457)
                      . ..........   .            .....+..... .......+.+++..||+.+|++||++.+++.
T Consensus       243 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~  312 (335)
T PTZ00024        243 LGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTI-FPNASDDAIDLLQSLLKLNPLERISAKEALK  312 (335)
T ss_pred             HHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHh-CcCCChHHHHHHHHHcCCCchhccCHHHHhc
Confidence            0 0000000000   0            00001111100 0112345778999999999999999999986

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=100.00  E-value=2.2e-34  Score=274.87  Aligned_cols=249  Identities=21%  Similarity=0.330  Sum_probs=187.9

Q ss_pred             CCCCCceecccCcEEEEEEEeCC-CcEEEEEEEeccch--hhHHHHHHHHHHHHHHhhcCCCCcceeeeeee-cCceEEE
Q 012765          143 NFNSENLIGKGGHAEVYKGCLPD-GEVVAVKKIIKNAK--EDEERISDFLSELGIVAHINHPNAAKLIGFST-ENGFHLV  218 (457)
Q Consensus       143 ~f~~~~~LG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~--~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~-~~~~~lv  218 (457)
                      +|.+.+.||+|+||.||++.... +..+++|.+.....  ........+..|+.+++.++||||+++++++. ....+++
T Consensus         1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   80 (260)
T cd08222           1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII   80 (260)
T ss_pred             CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence            47788999999999999997643 44455555433211  11122345677899999999999999998554 4557899


Q ss_pred             EEecCCCChhhhhhc---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCC
Q 012765          219 LQFLPHGSLSSLLFG---STECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLP  295 (457)
Q Consensus       219 ~e~~~~gsL~~~l~~---~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~  295 (457)
                      +||+++++|..++..   ....+++..++.++.|++.||.|||+   .+++|+||+|+||+++. +.++|+|||++....
T Consensus        81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~  156 (260)
T cd08222          81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQ---RRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM  156 (260)
T ss_pred             EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHH---cCccccCCChhheEeec-CCEeecccCceeecC
Confidence            999999999988753   34568999999999999999999999   89999999999999975 579999999987764


Q ss_pred             CCCCceeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhccccccCCcccccCchhh
Q 012765          296 DNWSHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSNFKELVDPRLA  375 (457)
Q Consensus       296 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  375 (457)
                      ....  ......|+..|+|||.+.+..++.++|+||||+++|+|++|..||........  ...... .     ..+.+ 
T Consensus       157 ~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~--~~~~~~-~-----~~~~~-  225 (260)
T cd08222         157 GSCD--LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSV--VLRIVE-G-----PTPSL-  225 (260)
T ss_pred             CCcc--cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHH--HHHHHc-C-----CCCCC-
Confidence            3321  12234578899999999888899999999999999999999999975322111  110000 0     01111 


Q ss_pred             cccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 012765          376 DAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQ  409 (457)
Q Consensus       376 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~  409 (457)
                         .......+.+++.+||..+|++||++.++++
T Consensus       226 ---~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  256 (260)
T cd08222         226 ---PETYSRQLNSIMQSMLNKDPSLRPSAAEILR  256 (260)
T ss_pred             ---cchhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence               1223346778899999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=100.00  E-value=6.8e-34  Score=305.89  Aligned_cols=147  Identities=29%  Similarity=0.412  Sum_probs=128.8

Q ss_pred             cCCCCCceecccCcEEEEEEEeC-CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeee-cCceEEEE
Q 012765          142 DNFNSENLIGKGGHAEVYKGCLP-DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFST-ENGFHLVL  219 (457)
Q Consensus       142 ~~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~-~~~~~lv~  219 (457)
                      ++|.+.+.||+|+||+||+|.+. +++.||+|++.............+..|+.++..++||||+++++++. ....++||
T Consensus         4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm   83 (669)
T cd05610           4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM   83 (669)
T ss_pred             CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence            67889999999999999999875 68999999987654444455668889999999999999999998554 45578999


Q ss_pred             EecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccc
Q 012765          220 QFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAK  292 (457)
Q Consensus       220 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~  292 (457)
                      ||+.+++|..++... ..+++..++.|+.||+.||.|||.   .+|+||||||+|||++.++.+||+|||+++
T Consensus        84 Ey~~g~~L~~li~~~-~~l~~~~~~~i~~qil~aL~yLH~---~gIiHrDLKP~NILl~~~g~vkL~DFGls~  152 (669)
T cd05610          84 EYLIGGDVKSLLHIY-GYFDEEMAVKYISEVALALDYLHR---HGIIHRDLKPDNMLISNEGHIKLTDFGLSK  152 (669)
T ss_pred             eCCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence            999999999988543 457888899999999999999999   899999999999999999999999999985

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=100.00  E-value=3.6e-35  Score=271.03  Aligned_cols=205  Identities=24%  Similarity=0.388  Sum_probs=164.8

Q ss_pred             hcCCCCCceecccCcEEEEEEEeCC-----CcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeee--cC
Q 012765          141 TDNFNSENLIGKGGHAEVYKGCLPD-----GEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFST--EN  213 (457)
Q Consensus       141 ~~~f~~~~~LG~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~--~~  213 (457)
                      ...|+....||+|.||.||+|...+     ...+|+|++....... ..-....+|+.+++.++|||++.+..++.  +.
T Consensus        23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~t-GiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~  101 (438)
T KOG0666|consen   23 LFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGT-GISMSACREIALLRELKHPNVISLVKVFLSHDK  101 (438)
T ss_pred             HHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCC-CcCHHHHHHHHHHHHhcCCcchhHHHHHhccCc
Confidence            4578889999999999999996332     3378999886442221 11235678999999999999999998443  56


Q ss_pred             ceEEEEEecCCCChhhhhhc----CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCC----CcEEE
Q 012765          214 GFHLVLQFLPHGSLSSLLFG----STECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSED----YEAQI  285 (457)
Q Consensus       214 ~~~lv~e~~~~gsL~~~l~~----~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~----~~~kL  285 (457)
                      ..++++||.+. +|...++.    ..+.++......|+.||+.|+.|||+   .-|+||||||.|||+..+    |.+||
T Consensus       102 ~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~---NWvlHRDLKPaNIlvmgdgperG~VKI  177 (438)
T KOG0666|consen  102 KVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHS---NWVLHRDLKPANILVMGDGPERGRVKI  177 (438)
T ss_pred             eEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhh---hheeeccCCcceEEEeccCCccCeeEe
Confidence            67899999866 56666643    33568888999999999999999999   789999999999999887    89999


Q ss_pred             eeccccccCCCCCCce-eeecccccccccChhccccC-CCCcchhHHHHHHHHHHHHhCCCCCCcCC
Q 012765          286 SDFGLAKWLPDNWSHH-IVFPIEGTFGYLSPEYFMHG-IVDEKTDVFAFGVLLLELITGRRAVDSRR  350 (457)
Q Consensus       286 ~DFGl~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~-~~~~ksDvwSlGvll~eLltG~~pf~~~~  350 (457)
                      +|||+++.+.+....- ....+.-|.+|+|||.+.+. .|+.+.||||.|||+.||+|-.+.|...+
T Consensus       178 aDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E  244 (438)
T KOG0666|consen  178 ADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGRE  244 (438)
T ss_pred             ecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchh
Confidence            9999999887653322 22344579999999999875 58999999999999999999998887633

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=100.00  E-value=1.1e-33  Score=280.37  Aligned_cols=260  Identities=22%  Similarity=0.282  Sum_probs=186.9

Q ss_pred             CCCCCceecccCcEEEEEEEeC-C--CcEEEEEEEeccchhhHHHHHHHHHHHHHHhhc-CCCCcceeeeeeec-----C
Q 012765          143 NFNSENLIGKGGHAEVYKGCLP-D--GEVVAVKKIIKNAKEDEERISDFLSELGIVAHI-NHPNAAKLIGFSTE-----N  213 (457)
Q Consensus       143 ~f~~~~~LG~G~~g~Vy~~~~~-~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~-----~  213 (457)
                      +|.+.+.||+|+||.||++... .  +..||+|++..... .......+.+|+.++.++ +||||+++++++..     .
T Consensus         1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~   79 (332)
T cd07857           1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFS-KKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFN   79 (332)
T ss_pred             CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccc-cchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCC
Confidence            4778899999999999999864 3  77899998754322 122345778899999998 59999999985322     2


Q ss_pred             ceEEEEEecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeecccccc
Q 012765          214 GFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKW  293 (457)
Q Consensus       214 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~  293 (457)
                      ..+++++|+. ++|..++.. ...+++..+..++.||+.||.|||+   .+++||||||+||+++.++.+||+|||++..
T Consensus        80 ~~~~~~e~~~-~~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~---~givH~dlkp~Nili~~~~~~kl~Dfg~a~~  154 (332)
T cd07857          80 ELYLYEELME-ADLHQIIRS-GQPLTDAHFQSFIYQILCGLKYIHS---ANVLHRDLKPGNLLVNADCELKICDFGLARG  154 (332)
T ss_pred             cEEEEEeccc-CCHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHeEEcCCCCEEeCcCCCcee
Confidence            3466777765 688888753 4458899999999999999999999   8999999999999999999999999999987


Q ss_pred             CCCCCCc--eeeecccccccccChhcccc-CCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhh-hhccccccC---Cc
Q 012765          294 LPDNWSH--HIVFPIEGTFGYLSPEYFMH-GIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVI-WAKPLLQTS---NF  366 (457)
Q Consensus       294 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~-~~~~~~~~~---~~  366 (457)
                      +......  .......||..|+|||++.+ ..++.++|||||||++|+|++|+.||...+..... .....+...   ..
T Consensus       155 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  234 (332)
T cd07857         155 FSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETL  234 (332)
T ss_pred             cccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence            6432211  11123458999999998765 46899999999999999999999999764321100 000000000   00


Q ss_pred             ccccCc---------------hhhcccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 012765          367 KELVDP---------------RLADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQ  409 (457)
Q Consensus       367 ~~~~d~---------------~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~  409 (457)
                      ..+.++               .+.. ........+.+++.+||+.+|.+|||+.+++.
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~  291 (332)
T cd07857         235 SRIGSPKAQNYIRSLPNIPKKPFES-IFPNANPLALDLLEKLLAFDPTKRISVEEALE  291 (332)
T ss_pred             HhhhhhhHHHHHHhccccCCcchHh-hCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence            000000               0000 00112346778999999999999999999875

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-35  Score=310.69  Aligned_cols=210  Identities=26%  Similarity=0.318  Sum_probs=180.4

Q ss_pred             HHHHHHhhcCCCCCceecccCcEEEEEEEeC-CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceee-eeee
Q 012765          134 FAELAAATDNFNSENLIGKGGHAEVYKGCLP-DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLI-GFST  211 (457)
Q Consensus       134 ~~~~~~~~~~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~-~~~~  211 (457)
                      ..+++...++|.++++||+|+||.|..++++ +++.||+|++.+-..........|..|-.+|.-.+.+-|++++ +|.+
T Consensus        67 v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD  146 (1317)
T KOG0612|consen   67 VKELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQD  146 (1317)
T ss_pred             HHHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcC
Confidence            4556677899999999999999999999865 5899999998764333334456788999999999999999996 5888


Q ss_pred             cCceEEEEEecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeecccc
Q 012765          212 ENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLA  291 (457)
Q Consensus       212 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~  291 (457)
                      +..+|+|||||+||+|..++.... .+++..+.-++..|+.||.-||+   .|+|||||||+|||||..|++||+|||.+
T Consensus       147 ~~~LYlVMdY~pGGDlltLlSk~~-~~pE~~ArFY~aEiVlAldslH~---mgyVHRDiKPDNvLld~~GHikLADFGsC  222 (1317)
T KOG0612|consen  147 ERYLYLVMDYMPGGDLLTLLSKFD-RLPEDWARFYTAEIVLALDSLHS---MGYVHRDIKPDNVLLDKSGHIKLADFGSC  222 (1317)
T ss_pred             ccceEEEEecccCchHHHHHhhcC-CChHHHHHHHHHHHHHHHHHHHh---ccceeccCCcceeEecccCcEeeccchhH
Confidence            888999999999999999996655 68888777788899999999999   99999999999999999999999999999


Q ss_pred             ccCCCCCCceeeecccccccccChhccc----c-CCCCcchhHHHHHHHHHHHHhCCCCCCc
Q 012765          292 KWLPDNWSHHIVFPIEGTFGYLSPEYFM----H-GIVDEKTDVFAFGVLLLELITGRRAVDS  348 (457)
Q Consensus       292 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~----~-~~~~~ksDvwSlGvll~eLltG~~pf~~  348 (457)
                      -.+..+..- ......|||.|++||++.    + +.|++.+|+||+||++|||+.|..||..
T Consensus       223 lkm~~dG~V-~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYa  283 (1317)
T KOG0612|consen  223 LKMDADGTV-RSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYA  283 (1317)
T ss_pred             HhcCCCCcE-EeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchH
Confidence            888654332 234567999999999985    2 5799999999999999999999999985

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=5.4e-35  Score=298.18  Aligned_cols=251  Identities=24%  Similarity=0.385  Sum_probs=201.8

Q ss_pred             CCceecccCcEEEEEEEe-CCC----cEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeecCceEEEEE
Q 012765          146 SENLIGKGGHAEVYKGCL-PDG----EVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTENGFHLVLQ  220 (457)
Q Consensus       146 ~~~~LG~G~~g~Vy~~~~-~~~----~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~lv~e  220 (457)
                      ..++||+|+||+||+|.+ +.|    -+||+|.+......  ....+++.|+-+|++++|||+++++++|....+.||++
T Consensus       700 k~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~--~~s~e~LdeAl~masldHpnl~RLLgvc~~s~~qlvtq  777 (1177)
T KOG1025|consen  700 KDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSP--KASIELLDEALRMASLDHPNLLRLLGVCMLSTLQLVTQ  777 (1177)
T ss_pred             hhceeccccceeEEeeeEecCCceecceeEEEEeeccCCc--hhhHHHHHHHHHHhcCCCchHHHHhhhcccchHHHHHH
Confidence            457899999999999975 334    46888887654332  34568999999999999999999999999988999999


Q ss_pred             ecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCCCCCCc
Q 012765          221 FLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSH  300 (457)
Q Consensus       221 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~~~~~  300 (457)
                      |++.|+|.++++..+..+..+..+.|..|||+|+.|||.   ++++||||...|||+..-..+||.|||+++.+..+...
T Consensus       778 ~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~---qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~e  854 (1177)
T KOG1025|consen  778 LMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEE---QRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEKE  854 (1177)
T ss_pred             hcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHh---cchhhhhhhhhheeecCCCeEEEEecchhhccCccccc
Confidence            999999999999988899999999999999999999999   89999999999999999999999999999988766544


Q ss_pred             eeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHh-CCCCCCcCCcchhhhhccccccCCcccccCchhhcccC
Q 012765          301 HIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELIT-GRRAVDSRRQSLVIWAKPLLQTSNFKELVDPRLADAYD  379 (457)
Q Consensus       301 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLlt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~  379 (457)
                      .......-.+-|||=|.+....|+.++|||||||++|||+| |..|+++....            +++.++....+-.-.
T Consensus       855 y~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~------------eI~dlle~geRLsqP  922 (1177)
T KOG1025|consen  855 YSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAE------------EIPDLLEKGERLSQP  922 (1177)
T ss_pred             ccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHH------------HhhHHHhccccCCCC
Confidence            33333333567999999999999999999999999999999 99998862211            111111111110111


Q ss_pred             HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 012765          380 LAEMKRAMLTASVCIHHLSTMRPQMTRVLQLLRG  413 (457)
Q Consensus       380 ~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~  413 (457)
                      +.....+-.++..||..|+..||+++++...+..
T Consensus       923 piCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~  956 (1177)
T KOG1025|consen  923 PICTIDVYMVMVKCWMIDADSRPTFKELAEEFSR  956 (1177)
T ss_pred             CCccHHHHHHHHHHhccCcccCccHHHHHHHHHH
Confidence            2223345567788999999999999999887754

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-34  Score=266.59  Aligned_cols=244  Identities=20%  Similarity=0.281  Sum_probs=188.3

Q ss_pred             hhcCCCCC-ceecccCcEEEEEEEe-CCCcEEEEEEEeccchhhHHHHHHHHHHHHHHhh-cCCCCcceeeeeeec----
Q 012765          140 ATDNFNSE-NLIGKGGHAEVYKGCL-PDGEVVAVKKIIKNAKEDEERISDFLSELGIVAH-INHPNAAKLIGFSTE----  212 (457)
Q Consensus       140 ~~~~f~~~-~~LG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~-l~hpniv~l~~~~~~----  212 (457)
                      .+++|.+. ++||-|-.|.|..+.. .+|+.+|+|++...        ....+|++.--. -.|||||.+++++.+    
T Consensus        59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds--------~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~  130 (400)
T KOG0604|consen   59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS--------PKARREVELHWMASGHPHIVSIIDVYENSYQG  130 (400)
T ss_pred             chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC--------HHHHhHhhhhhhhcCCCceEEeehhhhhhccC
Confidence            45666553 6899999999998865 46999999987532        245577776533 469999999996543    


Q ss_pred             -CceEEEEEecCCCChhhhhhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcC---CCcEEEee
Q 012765          213 -NGFHLVLQFLPHGSLSSLLFGST-ECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSE---DYEAQISD  287 (457)
Q Consensus       213 -~~~~lv~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~---~~~~kL~D  287 (457)
                       ..+.+|||+|+||.|+..+...+ ..+++..+..|+.||+.|+.|||+   .+|.||||||+|+|.+.   |..+||+|
T Consensus       131 rkcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~---~nIAHRDlKpENLLyt~t~~na~lKLtD  207 (400)
T KOG0604|consen  131 RKCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHS---MNIAHRDLKPENLLYTTTSPNAPLKLTD  207 (400)
T ss_pred             ceeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHh---cchhhccCChhheeeecCCCCcceEecc
Confidence             23568999999999999997644 468999999999999999999999   89999999999999975   45699999


Q ss_pred             ccccccCCCCCCceeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhccccccCCcc
Q 012765          288 FGLAKWLPDNWSHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSNFK  367 (457)
Q Consensus       288 FGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~  367 (457)
                      ||+++.....   ....+.+-|++|.|||++...+|+...|+||+||++|-|++|.+||.+......            .
T Consensus       208 fGFAK~t~~~---~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~ai------------s  272 (400)
T KOG0604|consen  208 FGFAKETQEP---GDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI------------S  272 (400)
T ss_pred             cccccccCCC---ccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccC------------C
Confidence            9999866432   234456689999999999999999999999999999999999999987433110            0


Q ss_pred             cccCchhh-ccc-----C-HHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 012765          368 ELVDPRLA-DAY-----D-LAEMKRAMLTASVCIHHLSTMRPQMTRVLQ  409 (457)
Q Consensus       368 ~~~d~~l~-~~~-----~-~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~  409 (457)
                      .-+..++. +.|     . ..-.+...+++..+|..+|.+|.|+.+++.
T Consensus       273 pgMk~rI~~gqy~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~  321 (400)
T KOG0604|consen  273 PGMKRRIRTGQYEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMD  321 (400)
T ss_pred             hhHHhHhhccCccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhc
Confidence            01111111 000     1 123455667788899999999999999987

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=8.9e-34  Score=300.91  Aligned_cols=260  Identities=24%  Similarity=0.399  Sum_probs=199.5

Q ss_pred             HHhhcCCCCCceecccCcEEEEEEEeC--------CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhc-CCCCcceeee
Q 012765          138 AAATDNFNSENLIGKGGHAEVYKGCLP--------DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHI-NHPNAAKLIG  208 (457)
Q Consensus       138 ~~~~~~f~~~~~LG~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~  208 (457)
                      +...++..+.+.||.|+||.|++|...        ....||||.+......  .....+..|+++|..+ +|+||+.++|
T Consensus       292 e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~--~~~~~~~~El~~m~~~g~H~niv~llG  369 (609)
T KOG0200|consen  292 EIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASS--SEKKDLMSELNVLKELGKHPNIVNLLG  369 (609)
T ss_pred             eechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCc--HHHHHHHHHHHHHHHhcCCcchhhhee
Confidence            344555566679999999999999732        1457999988765554  4567899999999988 5999999999


Q ss_pred             eeec-CceEEEEEecCCCChhhhhhcCC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCC
Q 012765          209 FSTE-NGFHLVLQFLPHGSLSSLLFGST---------------ECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKA  272 (457)
Q Consensus       209 ~~~~-~~~~lv~e~~~~gsL~~~l~~~~---------------~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp  272 (457)
                      +|.. +..++|+||+..|+|..+|+...               ..+.....+.++.|||.|+.||++   .++|||||..
T Consensus       370 ~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~---~~~vHRDLAa  446 (609)
T KOG0200|consen  370 ACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLAS---VPCVHRDLAA  446 (609)
T ss_pred             eeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhh---CCccchhhhh
Confidence            8877 45689999999999999997766               348888899999999999999999   8999999999


Q ss_pred             CcEEEcCCCcEEEeeccccccCCCCCCceeeecccc--cccccChhccccCCCCcchhHHHHHHHHHHHHh-CCCCCCcC
Q 012765          273 SNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEG--TFGYLSPEYFMHGIVDEKTDVFAFGVLLLELIT-GRRAVDSR  349 (457)
Q Consensus       273 ~NIll~~~~~~kL~DFGl~~~~~~~~~~~~~~~~~g--t~~y~aPE~~~~~~~~~ksDvwSlGvll~eLlt-G~~pf~~~  349 (457)
                      .|||+..+..+||+|||+++........... ...|  ...|||||.+....|+.++|||||||+||||+| |..||.+-
T Consensus       447 RNVLi~~~~~~kIaDFGlar~~~~~~~y~~~-~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~  525 (609)
T KOG0200|consen  447 RNVLITKNKVIKIADFGLARDHYNKDYYRTK-SSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGI  525 (609)
T ss_pred             hhEEecCCCEEEEccccceeccCCCCceEec-CCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCC
Confidence            9999999999999999999866544322211 1112  334999999999999999999999999999999 88888752


Q ss_pred             CcchhhhhccccccCCcccccCchhhcccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q 012765          350 RQSLVIWAKPLLQTSNFKELVDPRLADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQLLRGE  414 (457)
Q Consensus       350 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~  414 (457)
                      ......+.  .+..+.  .+-.    +.+-   ..++-.++..||+.+|++||++.++.+.|...
T Consensus       526 ~~~~~l~~--~l~~G~--r~~~----P~~c---~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~  579 (609)
T KOG0200|consen  526 PPTEELLE--FLKEGN--RMEQ----PEHC---SDEIYDLMKSCWNADPEDRPTFSECVEFFEKH  579 (609)
T ss_pred             CcHHHHHH--HHhcCC--CCCC----CCCC---CHHHHHHHHHHhCCCcccCCCHHHHHHHHHHH
Confidence            11111111  111110  0001    1111   23445677789999999999999999999873

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=100.00  E-value=8.8e-35  Score=254.53  Aligned_cols=202  Identities=25%  Similarity=0.423  Sum_probs=167.1

Q ss_pred             HhhcCCCCCceecccCcEEEEEEEe-CCCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhc-CCCCcceeee-eeecCce
Q 012765          139 AATDNFNSENLIGKGGHAEVYKGCL-PDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHI-NHPNAAKLIG-FSTENGF  215 (457)
Q Consensus       139 ~~~~~f~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~-~~~~~~~  215 (457)
                      ...++......||+|+||.|=+-++ .+|+..|+|++.....  .+...+.++|+.+..+. ..|.+|.+|| ++.+++.
T Consensus        43 V~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn--~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdv  120 (282)
T KOG0984|consen   43 VPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVN--SQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDV  120 (282)
T ss_pred             cchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcC--hHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccE
Confidence            3344555667899999999987764 5799999999854333  34566889999987665 6999999998 7888899


Q ss_pred             EEEEEecCCCChhhhh---hcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccc
Q 012765          216 HLVLQFLPHGSLSSLL---FGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAK  292 (457)
Q Consensus       216 ~lv~e~~~~gsL~~~l---~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~  292 (457)
                      ++.||.|. .+|..+.   ...+..+++...-+|+..|++||.|||+.  ..+||||+||+|||++.+|++|+||||++.
T Consensus       121 wIcME~M~-tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~k--L~vIHRDvKPsNiLIn~~GqVKiCDFGIsG  197 (282)
T KOG0984|consen  121 WICMELMD-TSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSK--LSVIHRDVKPSNILINYDGQVKICDFGISG  197 (282)
T ss_pred             EEeHHHhh-hhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHH--hhhhhccCCcceEEEccCCcEEEcccccce
Confidence            99999885 4555554   34677789999999999999999999995  899999999999999999999999999999


Q ss_pred             cCCCCCCceeeecccccccccChhccc----cCCCCcchhHHHHHHHHHHHHhCCCCCCc
Q 012765          293 WLPDNWSHHIVFPIEGTFGYLSPEYFM----HGIVDEKTDVFAFGVLLLELITGRRAVDS  348 (457)
Q Consensus       293 ~~~~~~~~~~~~~~~gt~~y~aPE~~~----~~~~~~ksDvwSlGvll~eLltG~~pf~~  348 (457)
                      .+.+.....   -..|...|||||.+.    ...|+.|+||||||+.+.||.+++.||+.
T Consensus       198 ~L~dSiAkt---~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~  254 (282)
T KOG0984|consen  198 YLVDSIAKT---MDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYES  254 (282)
T ss_pred             eehhhhHHH---HhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccc
Confidence            887654322   134788999999875    34799999999999999999999999986

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-33  Score=270.36  Aligned_cols=264  Identities=25%  Similarity=0.349  Sum_probs=196.1

Q ss_pred             HHhhcCCCCCceecccCcEEEEEEEeCCCcEEEEEEEeccchhhHHHHHHHHHHHHHHhh--cCCCCcceeeeeee--cC
Q 012765          138 AAATDNFNSENLIGKGGHAEVYKGCLPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAH--INHPNAAKLIGFST--EN  213 (457)
Q Consensus       138 ~~~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~--l~hpniv~l~~~~~--~~  213 (457)
                      +.......+.+.||+|.||+||+|.+ -|..||||++...  +    .....+|.+|...  |+|+||+.+++...  .+
T Consensus       207 RTiarqI~L~e~IGkGRyGEVwrG~w-rGe~VAVKiF~sr--d----E~SWfrEtEIYqTvmLRHENILgFIaaD~~~~g  279 (513)
T KOG2052|consen  207 RTIARQIVLQEIIGKGRFGEVWRGRW-RGEDVAVKIFSSR--D----ERSWFRETEIYQTVMLRHENILGFIAADNKDNG  279 (513)
T ss_pred             HhhhheeEEEEEecCccccceeeccc-cCCceEEEEeccc--c----hhhhhhHHHHHHHHHhccchhhhhhhccccCCC
Confidence            34567778889999999999999998 7889999998532  1    2356677777755  59999999998432  22


Q ss_pred             ---ceEEEEEecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhc-----CCCCeeeCCCCCCcEEEcCCCcEEE
Q 012765          214 ---GFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHD-----CHRRIIHRDIKASNILLSEDYEAQI  285 (457)
Q Consensus       214 ---~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~-----~~~~iiHrDlkp~NIll~~~~~~kL  285 (457)
                         +++||.+|.+.|+|+++|.  ...++-...++++..+|.||++||..     .++.|.|||||+.|||+..++...|
T Consensus       280 s~TQLwLvTdYHe~GSL~DyL~--r~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~I  357 (513)
T KOG2052|consen  280 SWTQLWLVTDYHEHGSLYDYLN--RNTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCI  357 (513)
T ss_pred             ceEEEEEeeecccCCcHHHHHh--hccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEE
Confidence               3689999999999999994  46788889999999999999999974     3467999999999999999999999


Q ss_pred             eeccccccCCCCCCc--eeeecccccccccChhccccCC----C--CcchhHHHHHHHHHHHHhC----------CCCCC
Q 012765          286 SDFGLAKWLPDNWSH--HIVFPIEGTFGYLSPEYFMHGI----V--DEKTDVFAFGVLLLELITG----------RRAVD  347 (457)
Q Consensus       286 ~DFGl~~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~----~--~~ksDvwSlGvll~eLltG----------~~pf~  347 (457)
                      +|+||+.........  .......||.+|||||++....    +  -..+||||||+++||++-.          +.||.
T Consensus       358 ADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyy  437 (513)
T KOG2052|consen  358 ADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYY  437 (513)
T ss_pred             eeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcc
Confidence            999999776544211  1134567999999999985422    1  1358999999999999853          24555


Q ss_pred             c---CCcchhhhhccccccCCcccccCchhhccc-CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCC
Q 012765          348 S---RRQSLVIWAKPLLQTSNFKELVDPRLADAY-DLAEMKRAMLTASVCIHHLSTMRPQMTRVLQLLRGEG  415 (457)
Q Consensus       348 ~---~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~-~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~  415 (457)
                      +   .+.+.....+ ..-    .+-+.|.+.+.. +...+..+.+++..||..+|..|-|+-.|-+.|.++.
T Consensus       438 d~Vp~DPs~eeMrk-VVC----v~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~  504 (513)
T KOG2052|consen  438 DVVPSDPSFEEMRK-VVC----VQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLS  504 (513)
T ss_pred             cCCCCCCCHHHHhc-cee----ecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHh
Confidence            3   1111111110 011    111122222211 2367888899999999999999999999988887765

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-33  Score=289.90  Aligned_cols=258  Identities=26%  Similarity=0.376  Sum_probs=206.3

Q ss_pred             cHHHHHHhhcCCCCCceecccCcEEEEEEEe-CCCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhc-CCCCcceeeeee
Q 012765          133 DFAELAAATDNFNSENLIGKGGHAEVYKGCL-PDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHI-NHPNAAKLIGFS  210 (457)
Q Consensus       133 ~~~~~~~~~~~f~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~  210 (457)
                      +++.+...++-|++.+.||.|.+|.||++.. ++++..|+|+.......    -+++..|.++++.+ +|||++.+||++
T Consensus        10 ~~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~----deEiE~eynil~~~~~hpnv~~fyg~~   85 (953)
T KOG0587|consen   10 DLSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDE----EEEIELEYNMLKKYSHHPNVATFYGAF   85 (953)
T ss_pred             chhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccc----cHHHHHHHHHHHhccCCCCcceEEEEE
Confidence            3444455678889999999999999999974 57899999987655433    23667788888776 699999999954


Q ss_pred             e------cCceEEEEEecCCCChhhhhhc-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcE
Q 012765          211 T------ENGFHLVLQFLPHGSLSSLLFG-STECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEA  283 (457)
Q Consensus       211 ~------~~~~~lv~e~~~~gsL~~~l~~-~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~  283 (457)
                      .      ++.++||||||.+|+..+++.+ .+..+.|..+..|+..++.||.+||.   ..+||||||-.||||+.++.+
T Consensus        86 ~k~~~~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~---nkviHRDikG~NiLLT~e~~V  162 (953)
T KOG0587|consen   86 IKKDPGNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHN---NKVIHRDIKGQNVLLTENAEV  162 (953)
T ss_pred             EEecCCCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhh---cceeeecccCceEEEeccCcE
Confidence            3      4568999999999999999865 35678999999999999999999999   899999999999999999999


Q ss_pred             EEeeccccccCCCCCCceeeecccccccccChhccccC-----CCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhc
Q 012765          284 QISDFGLAKWLPDNWSHHIVFPIEGTFGYLSPEYFMHG-----IVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAK  358 (457)
Q Consensus       284 kL~DFGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~  358 (457)
                      ||+|||++..+.....  ...+..||+.|||||++...     .|+..+|+||||++..||.-|.+|+.........+..
T Consensus       163 KLvDFGvSaQldsT~g--rRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~I  240 (953)
T KOG0587|consen  163 KLVDFGVSAQLDSTVG--RRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLI  240 (953)
T ss_pred             EEeeeeeeeeeecccc--cccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccC
Confidence            9999999988865433  23456799999999998643     4788999999999999999999999875543333222


Q ss_pred             cccccCCcccccCchhhcccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 012765          359 PLLQTSNFKELVDPRLADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQ  409 (457)
Q Consensus       359 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~  409 (457)
                      +   .+..+.+..       ...-.+.+.+.++.||..|-++||++.++++
T Consensus       241 p---RNPPPkLkr-------p~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~  281 (953)
T KOG0587|consen  241 P---RNPPPKLKR-------PKKWSKKFNDFISTCLVKDYEQRPSTEELLK  281 (953)
T ss_pred             C---CCCCccccc-------hhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence            1   111111111       2245567888999999999999999998876

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=100.00  E-value=4e-33  Score=263.13  Aligned_cols=219  Identities=21%  Similarity=0.173  Sum_probs=169.8

Q ss_pred             cCcEEEEEEEeC-CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeee-cCceEEEEEecCCCChhhh
Q 012765          153 GGHAEVYKGCLP-DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFST-ENGFHLVLQFLPHGSLSSL  230 (457)
Q Consensus       153 G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~-~~~~~lv~e~~~~gsL~~~  230 (457)
                      |.||.||++.+. +++.||+|++....        .+.+|...+....||||+++++++. .+..+++|||+++|+|.++
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~--------~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~   75 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSS--------EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSH   75 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchh--------hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHH
Confidence            899999999864 68999999986542        1223444455667999999999654 4557899999999999998


Q ss_pred             hhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCCCCCCceeeecccccc
Q 012765          231 LFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEGTF  310 (457)
Q Consensus       231 l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~~~~~~~~~~~~gt~  310 (457)
                      +... ..+++.....++.|++.||.|||+   .+++||||||+||+++.++.++|+|||.+..+....     ....++.
T Consensus        76 l~~~-~~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~-----~~~~~~~  146 (237)
T cd05576          76 ISKF-LNIPEECVKRWAAEMVVALDALHR---EGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC-----DGEAVEN  146 (237)
T ss_pred             HHHh-cCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEEcCCCCEEEecccchhcccccc-----ccCCcCc
Confidence            8543 348899999999999999999999   899999999999999999999999999886654321     1233577


Q ss_pred             cccChhccccCCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhccccccCCcccccCchhhcccCHHHHHHHHHHH
Q 012765          311 GYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSNFKELVDPRLADAYDLAEMKRAMLTA  390 (457)
Q Consensus       311 ~y~aPE~~~~~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~  390 (457)
                      .|+|||.+.+..++.++||||||+++|||++|..|+.......             .......+...    ....+.+++
T Consensus       147 ~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~-------------~~~~~~~~~~~----~~~~~~~li  209 (237)
T cd05576         147 MYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGI-------------NTHTTLNIPEW----VSEEARSLL  209 (237)
T ss_pred             cccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhc-------------ccccccCCccc----CCHHHHHHH
Confidence            8999999988889999999999999999999998876321100             00000011111    224566788


Q ss_pred             HHhcccCCCCCCCHH
Q 012765          391 SVCIHHLSTMRPQMT  405 (457)
Q Consensus       391 ~~Cl~~dP~~RPt~~  405 (457)
                      .+||+.||++||++.
T Consensus       210 ~~~l~~dp~~R~~~~  224 (237)
T cd05576         210 QQLLQFNPTERLGAG  224 (237)
T ss_pred             HHHccCCHHHhcCCC
Confidence            999999999999973

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8.7e-34  Score=285.01  Aligned_cols=239  Identities=23%  Similarity=0.300  Sum_probs=187.7

Q ss_pred             hhcCCCCCceecccCcEEEEEEEe-CCCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhc-CCCCcceeeeeeec-CceE
Q 012765          140 ATDNFNSENLIGKGGHAEVYKGCL-PDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHI-NHPNAAKLIGFSTE-NGFH  216 (457)
Q Consensus       140 ~~~~f~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~-~~~~  216 (457)
                      +++.|.....+|.|+|+.|-.+.. .+++..++|++.+...       +..+|+.++... +||||+++.+.+.+ .+.+
T Consensus       320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~-------~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~  392 (612)
T KOG0603|consen  320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRAD-------DNQDEIPISLLVRDHPNIVKSHDVYEDGKEIY  392 (612)
T ss_pred             cchhhccccccCCCCccceeeeeccccccchhheecccccc-------ccccccchhhhhcCCCcceeecceecCCceee
Confidence            467888888999999999998875 4688999999876522       223466555444 79999999996554 5678


Q ss_pred             EEEEecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEE-cCCCcEEEeeccccccCC
Q 012765          217 LVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILL-SEDYEAQISDFGLAKWLP  295 (457)
Q Consensus       217 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll-~~~~~~kL~DFGl~~~~~  295 (457)
                      +|||.+.++.+.+.+.......  ..+..|+.+|+.|+.|||+   .++|||||||+|||+ +..++++|+|||.++.+.
T Consensus       393 ~v~e~l~g~ell~ri~~~~~~~--~e~~~w~~~lv~Av~~LH~---~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~  467 (612)
T KOG0603|consen  393 LVMELLDGGELLRRIRSKPEFC--SEASQWAAELVSAVDYLHE---QGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELE  467 (612)
T ss_pred             eeehhccccHHHHHHHhcchhH--HHHHHHHHHHHHHHHHHHh---cCeeecCCChhheeecCCCCcEEEEEechhhhCc
Confidence            9999999998888775543322  5666799999999999999   899999999999999 588999999999999876


Q ss_pred             CCCCceeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhccccccCCcccccCchhh
Q 012765          296 DNWSHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSNFKELVDPRLA  375 (457)
Q Consensus       296 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  375 (457)
                      ..     ....+-|..|.|||++....|++++||||||++||+|++|+.||...........              ....
T Consensus       468 ~~-----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~--------------~i~~  528 (612)
T KOG0603|consen  468 RS-----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHT--------------RIQM  528 (612)
T ss_pred             hh-----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchHHHHH--------------hhcC
Confidence            65     2233468899999999999999999999999999999999999986333211111              1111


Q ss_pred             cccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 012765          376 DAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQ  409 (457)
Q Consensus       376 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~  409 (457)
                      +.++........+++.+||+.||.+||+|.++..
T Consensus       529 ~~~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~  562 (612)
T KOG0603|consen  529 PKFSECVSDEAKDLLQQLLQVDPALRLGADEIGA  562 (612)
T ss_pred             CccccccCHHHHHHHHHhccCChhhCcChhhhcc
Confidence            2222333445667889999999999999999865

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-34  Score=282.63  Aligned_cols=203  Identities=23%  Similarity=0.333  Sum_probs=175.0

Q ss_pred             cCCCCCceecccCcEEEEEEEeCCCc-EEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeee-eeecCceEEEE
Q 012765          142 DNFNSENLIGKGGHAEVYKGCLPDGE-VVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIG-FSTENGFHLVL  219 (457)
Q Consensus       142 ~~f~~~~~LG~G~~g~Vy~~~~~~~~-~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~-~~~~~~~~lv~  219 (457)
                      .++..+..||-||||.|=+++..... .+|+|.+++...-+....+.+..|-.+|..++.|.||++|- |-.+...|++|
T Consensus       420 ~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLm  499 (732)
T KOG0614|consen  420 SDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLM  499 (732)
T ss_pred             hhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhH
Confidence            45566678999999999998864433 48999888776666777889999999999999999999997 54555568999


Q ss_pred             EecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCCCCCC
Q 012765          220 QFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWS  299 (457)
Q Consensus       220 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~~~~  299 (457)
                      |-|-||.|+..|+..+. ++.....-++..+++|+.|||+   ++||+|||||+|++|+.+|.+||.|||+++.+..+..
T Consensus       500 EaClGGElWTiLrdRg~-Fdd~tarF~~acv~EAfeYLH~---k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~K  575 (732)
T KOG0614|consen  500 EACLGGELWTILRDRGS-FDDYTARFYVACVLEAFEYLHR---KGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGRK  575 (732)
T ss_pred             HhhcCchhhhhhhhcCC-cccchhhhhHHHHHHHHHHHHh---cCceeccCChhheeeccCCceEEeehhhHHHhccCCc
Confidence            99999999999977655 5555555577789999999999   8999999999999999999999999999999977643


Q ss_pred             ceeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHhCCCCCCcCCc
Q 012765          300 HHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQ  351 (457)
Q Consensus       300 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLltG~~pf~~~~~  351 (457)
                         ..+++||+.|.|||.+.+...+.++|.||||+++|||++|.+||.+.++
T Consensus       576 ---TwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dp  624 (732)
T KOG0614|consen  576 ---TWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDP  624 (732)
T ss_pred             ---eeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCch
Confidence               3457799999999999999999999999999999999999999998654

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.7e-34  Score=271.51  Aligned_cols=246  Identities=23%  Similarity=0.314  Sum_probs=192.2

Q ss_pred             HhhcCCCCCceecccCcEEEEEEEeC-CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhc-CCCCcceeeee-eecCce
Q 012765          139 AATDNFNSENLIGKGGHAEVYKGCLP-DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHI-NHPNAAKLIGF-STENGF  215 (457)
Q Consensus       139 ~~~~~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~-~~~~~~  215 (457)
                      .-..+|..+.+||+|+||.|.+|..+ +.+.||||++++......+..+.-..|-.+|+.. +-|.++++..+ .+-+-+
T Consensus       346 i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRL  425 (683)
T KOG0696|consen  346 IKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRL  425 (683)
T ss_pred             eeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhhe
Confidence            34567888999999999999999755 4678999998876554444455556677777766 46889999884 455678


Q ss_pred             EEEEEecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCC
Q 012765          216 HLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLP  295 (457)
Q Consensus       216 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~  295 (457)
                      |+||||+.||+|-.++.+-++ +.+..+.-+|.+||-||-+||+   ++||+||||.+||||+.+|++||+|||+++.--
T Consensus       426 yFVMEyvnGGDLMyhiQQ~Gk-FKEp~AvFYAaEiaigLFFLh~---kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni  501 (683)
T KOG0696|consen  426 YFVMEYVNGGDLMYHIQQVGK-FKEPVAVFYAAEIAIGLFFLHS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENI  501 (683)
T ss_pred             eeEEEEecCchhhhHHHHhcc-cCCchhhhhhHHHHHHhhhhhc---CCeeeeeccccceEeccCCceEeeecccccccc
Confidence            999999999999888865444 5555666688899999999999   999999999999999999999999999997543


Q ss_pred             CCCCceeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhccccccCCcccccCchhh
Q 012765          296 DNWSHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSNFKELVDPRLA  375 (457)
Q Consensus       296 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  375 (457)
                      -+  .....+++||+.|+|||.+...+|+..+|+|||||+||||+.|++||++.++.....           .|.+... 
T Consensus       502 ~~--~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~-----------aI~ehnv-  567 (683)
T KOG0696|consen  502 FD--GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQ-----------AIMEHNV-  567 (683)
T ss_pred             cC--CcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHH-----------HHHHccC-
Confidence            22  223456789999999999999999999999999999999999999999866543221           1222221 


Q ss_pred             cccCHHHHHHHHHHHHHhcccCCCCCCC
Q 012765          376 DAYDLAEMKRAMLTASVCIHHLSTMRPQ  403 (457)
Q Consensus       376 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt  403 (457)
                       .|......+.+.+....|...|.+|.-
T Consensus       568 -syPKslSkEAv~ickg~ltK~P~kRLG  594 (683)
T KOG0696|consen  568 -SYPKSLSKEAVAICKGLLTKHPGKRLG  594 (683)
T ss_pred             -cCcccccHHHHHHHHHHhhcCCccccC
Confidence             223334455667777788999998853

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-33  Score=260.56  Aligned_cols=254  Identities=24%  Similarity=0.316  Sum_probs=190.3

Q ss_pred             ceecccCcEEEEEEE-eCCCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhc-CCCCcceeeeeeecC-ceEEEEEecCC
Q 012765          148 NLIGKGGHAEVYKGC-LPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHI-NHPNAAKLIGFSTEN-GFHLVLQFLPH  224 (457)
Q Consensus       148 ~~LG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~-~~~lv~e~~~~  224 (457)
                      ++||+|+|+.|--+. ..+|..||||++.+..   .....++.+|++++.++ .|+||+.+++|++++ .+|||||-|.|
T Consensus        84 e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~---gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~G  160 (463)
T KOG0607|consen   84 ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQP---GHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRG  160 (463)
T ss_pred             HHhcCccceeeeeeeeeccchhhhhhhhhcCC---chHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccC
Confidence            679999999998876 5689999999986542   23456889999999998 499999999977655 57899999999


Q ss_pred             CChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCc---EEEeeccccccCCCC----
Q 012765          225 GSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYE---AQISDFGLAKWLPDN----  297 (457)
Q Consensus       225 gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~---~kL~DFGl~~~~~~~----  297 (457)
                      |.|..++.. ...+++..+-.+...|+.||.|||.   ++|.||||||+|||......   +|||||.+..-+...    
T Consensus       161 GplLshI~~-~~~F~E~EAs~vvkdia~aLdFlH~---kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~s  236 (463)
T KOG0607|consen  161 GPLLSHIQK-RKHFNEREASRVVKDIASALDFLHT---KGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCS  236 (463)
T ss_pred             chHHHHHHH-hhhccHHHHHHHHHHHHHHHHHHhh---cCcccccCCccceeecCCCCcCceeeeccccccccccCCCCC
Confidence            999999965 4458888888999999999999999   99999999999999976544   899999887544221    


Q ss_pred             -CCceeeecccccccccChhccc-----cCCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhccccc----cCCcc
Q 012765          298 -WSHHIVFPIEGTFGYLSPEYFM-----HGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQ----TSNFK  367 (457)
Q Consensus       298 -~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~~~~~----~~~~~  367 (457)
                       .......+.+|+..|||||+..     ...|+.+.|.||||||||-|++|.+||.+......-|-.-..-    +.-+.
T Consensus       237 pastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LFe  316 (463)
T KOG0607|consen  237 PASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFE  316 (463)
T ss_pred             CCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHHHH
Confidence             2223344577999999999863     3468999999999999999999999998866665555431110    00011


Q ss_pred             cccCchhhcccC---HHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 012765          368 ELVDPRLADAYD---LAEMKRAMLTASVCIHHLSTMRPQMTRVLQ  409 (457)
Q Consensus       368 ~~~d~~l~~~~~---~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~  409 (457)
                      .|-+... ...+   ........++++..|..++.+|.++.+++.
T Consensus       317 sIQEGkY-eFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vln  360 (463)
T KOG0607|consen  317 SIQEGKY-EFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLN  360 (463)
T ss_pred             HHhccCC-cCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence            1111110 0001   112233455667778899999999888776

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=100.00  E-value=6.5e-32  Score=253.17  Aligned_cols=237  Identities=29%  Similarity=0.390  Sum_probs=186.9

Q ss_pred             CcEEEEEEEeC-CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeec-CceEEEEEecCCCChhhhh
Q 012765          154 GHAEVYKGCLP-DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTE-NGFHLVLQFLPHGSLSSLL  231 (457)
Q Consensus       154 ~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-~~~~lv~e~~~~gsL~~~l  231 (457)
                      +||.||+|... +++.+|+|++........  ...+.+|+..+++++|+|++++++++.. ...++++||+.+++|..++
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~   78 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKK--RERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLL   78 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEecccccccH--HHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHH
Confidence            58999999876 489999998865433221  5688999999999999999999996655 5578999999999999998


Q ss_pred             hcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCCCCCCceeeeccccccc
Q 012765          232 FGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEGTFG  311 (457)
Q Consensus       232 ~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~~~~~~~~~~~~gt~~  311 (457)
                      ..... +++..++.++.+++.++.|||+   .+++|+||+|.||+++.++.++|+|||.+.......   ......++..
T Consensus        79 ~~~~~-~~~~~~~~~~~~l~~~l~~lh~---~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~  151 (244)
T smart00220       79 KKRGR-LSEDEARFYARQILSALEYLHS---NGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG---LLTTFVGTPE  151 (244)
T ss_pred             HhccC-CCHHHHHHHHHHHHHHHHHHHH---cCeecCCcCHHHeEECCCCcEEEccccceeeecccc---ccccccCCcC
Confidence            55333 8889999999999999999999   899999999999999999999999999998775542   2223457889


Q ss_pred             ccChhccccCCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhccccccCCcccccCchhhc-ccCHHHHHHHHHHH
Q 012765          312 YLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSNFKELVDPRLAD-AYDLAEMKRAMLTA  390 (457)
Q Consensus       312 y~aPE~~~~~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~-~~~~~~~~~l~~l~  390 (457)
                      |++||.+.+..++.++||||||+++++|++|..||.............  .        ...... .........+.+++
T Consensus       152 ~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~--~--------~~~~~~~~~~~~~~~~~~~~i  221 (244)
T smart00220      152 YMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKI--G--------KPKPPFPPPEWKISPEAKDLI  221 (244)
T ss_pred             CCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHH--h--------ccCCCCccccccCCHHHHHHH
Confidence            999999988889999999999999999999999997622211111100  0        000000 00000334677899


Q ss_pred             HHhcccCCCCCCCHHHHHH
Q 012765          391 SVCIHHLSTMRPQMTRVLQ  409 (457)
Q Consensus       391 ~~Cl~~dP~~RPt~~evl~  409 (457)
                      .+||..+|++||++.++++
T Consensus       222 ~~~l~~~p~~Rp~~~~~~~  240 (244)
T smart00220      222 RKLLVKDPEKRLTAEEALQ  240 (244)
T ss_pred             HHHccCCchhccCHHHHhh
Confidence            9999999999999999986

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.7e-34  Score=259.64  Aligned_cols=263  Identities=23%  Similarity=0.342  Sum_probs=188.7

Q ss_pred             CCCCCceecccCcEEEEEEEeC-CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeec---------
Q 012765          143 NFNSENLIGKGGHAEVYKGCLP-DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTE---------  212 (457)
Q Consensus       143 ~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~---------  212 (457)
                      .|.-..+||+|.||+||+|... .|+.||+|++.-..... ..-...++|+++|..++|+|++.++..|..         
T Consensus        18 ~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKe-GfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r   96 (376)
T KOG0669|consen   18 KYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKE-GFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDR   96 (376)
T ss_pred             HHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhcccc-CCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccccc
Confidence            3445578999999999999754 58888998654321111 112356789999999999999999986542         


Q ss_pred             CceEEEEEecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccc
Q 012765          213 NGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAK  292 (457)
Q Consensus       213 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~  292 (457)
                      ..+++||.+|+. +|.-+|......++...+.+++.++..||.|+|.   ..|+|||+||.|+||+.+|.+||+|||+++
T Consensus        97 ~t~ylVf~~ceh-DLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr---~kilHRDmKaaNvLIt~dgilklADFGlar  172 (376)
T KOG0669|consen   97 ATFYLVFDFCEH-DLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHR---NKILHRDMKAANVLITKDGILKLADFGLAR  172 (376)
T ss_pred             ceeeeeHHHhhh-hHHHHhcCccccccHHHHHHHHHHHHHHHHHHHH---hhHHhhcccHhhEEEcCCceEEeecccccc
Confidence            237899998865 6777776655678899999999999999999999   899999999999999999999999999997


Q ss_pred             cCCCCC--CceeeecccccccccChhccccC-CCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhh------------
Q 012765          293 WLPDNW--SHHIVFPIEGTFGYLSPEYFMHG-IVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWA------------  357 (457)
Q Consensus       293 ~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~------------  357 (457)
                      .+....  .....+...-|.+|++||.+.+. .|+++.|||+.|||+.||+|+.+.++.....-....            
T Consensus       173 ~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tkev  252 (376)
T KOG0669|consen  173 AFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKEV  252 (376)
T ss_pred             ceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCccc
Confidence            663321  11112334459999999999875 599999999999999999999999987443321111            


Q ss_pred             ccccccCCccccc--CchhhcccC--HHHHH------HHHHHHHHhcccCCCCCCCHHHHHHH
Q 012765          358 KPLLQTSNFKELV--DPRLADAYD--LAEMK------RAMLTASVCIHHLSTMRPQMTRVLQL  410 (457)
Q Consensus       358 ~~~~~~~~~~~~~--d~~l~~~~~--~~~~~------~l~~l~~~Cl~~dP~~RPt~~evl~~  410 (457)
                      ++...+-.+.+-+  .|...+.+.  .+.++      ..+.++..++..||.+|+++.+++..
T Consensus       253 WP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh  315 (376)
T KOG0669|consen  253 WPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNH  315 (376)
T ss_pred             CCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhch
Confidence            1111111111111  000000000  11111      45677788999999999999998763

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-33  Score=274.79  Aligned_cols=242  Identities=22%  Similarity=0.292  Sum_probs=183.6

Q ss_pred             CceecccCcEEEEEEEe-CCCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeee-cCceEEEEEecCC
Q 012765          147 ENLIGKGGHAEVYKGCL-PDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFST-ENGFHLVLQFLPH  224 (457)
Q Consensus       147 ~~~LG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~-~~~~~lv~e~~~~  224 (457)
                      .++||+|-||+||-|.+ ++|+.||||.+.+-.... .....+.+|+.||..++||.||.+-..++ .+..++|||-+.|
T Consensus       569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~-kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~G  647 (888)
T KOG4236|consen  569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPT-KQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHG  647 (888)
T ss_pred             HhhccCCcceeeecceecccCceeeeeeeecccCCC-chHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcc
Confidence            57899999999999975 579999999987654433 23468999999999999999999998554 4556788887755


Q ss_pred             CChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCC---CcEEEeeccccccCCCCCCce
Q 012765          225 GSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSED---YEAQISDFGLAKWLPDNWSHH  301 (457)
Q Consensus       225 gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~---~~~kL~DFGl~~~~~~~~~~~  301 (457)
                      .-|.-.|....+.+++....-++.||+.||.|||-   ++|+|+||||+||||...   ..+||||||+++.+++..   
T Consensus       648 DMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~---knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEks---  721 (888)
T KOG4236|consen  648 DMLEMILSSEKGRLPERITKFLVTQILVALRYLHF---KNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKS---  721 (888)
T ss_pred             hHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhh---cceeeccCCchheeeccCCCCCceeeccccceeecchhh---
Confidence            44444555567778888888888999999999999   899999999999999754   469999999999997753   


Q ss_pred             eeecccccccccChhccccCCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhccccccCCcccccCchhhcccCHH
Q 012765          302 IVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSNFKELVDPRLADAYDLA  381 (457)
Q Consensus       302 ~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~  381 (457)
                      ......||+.|+|||++....|+..-|+||.|||+|--++|..||...++.........       -+..+    ..-.+
T Consensus       722 FRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdIndQIQNAa-------FMyPp----~PW~e  790 (888)
T KOG4236|consen  722 FRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDINDQIQNAA-------FMYPP----NPWSE  790 (888)
T ss_pred             hhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccchhHHhhccc-------cccCC----Cchhh
Confidence            23446699999999999999999999999999999999999999975433221111110       01111    11112


Q ss_pred             HHHHHHHHHHHhcccCCCCCCCHHH
Q 012765          382 EMKRAMLTASVCIHHLSTMRPQMTR  406 (457)
Q Consensus       382 ~~~~l~~l~~~Cl~~dP~~RPt~~e  406 (457)
                      .....++++...|+..=.+|-+...
T Consensus       791 is~~AidlIn~LLqVkm~kRysvdk  815 (888)
T KOG4236|consen  791 ISPEAIDLINNLLQVKMRKRYSVDK  815 (888)
T ss_pred             cCHHHHHHHHHHHHHHHHHhcchHh
Confidence            2334555666666666666766543

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=100.00  E-value=3.2e-32  Score=286.42  Aligned_cols=256  Identities=22%  Similarity=0.289  Sum_probs=166.4

Q ss_pred             hhcCCCCCceecccCcEEEEEEEeC-C----CcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeee-e----
Q 012765          140 ATDNFNSENLIGKGGHAEVYKGCLP-D----GEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIG-F----  209 (457)
Q Consensus       140 ~~~~f~~~~~LG~G~~g~Vy~~~~~-~----~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~-~----  209 (457)
                      ..++|.+.+.||+|+||.||+|.+. +    +..||+|++......     +....+  .+....+.+++.++. +    
T Consensus       130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~-----e~~~~e--~l~~~~~~~~~~~~~~~~~~~  202 (566)
T PLN03225        130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV-----EIWMNE--RVRRACPNSCADFVYGFLEPV  202 (566)
T ss_pred             ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh-----HHHHHH--HHHhhchhhHHHHHHhhhccc
Confidence            5678999999999999999999864 4    689999987542211     111111  122222333333322 1    


Q ss_pred             --eecCceEEEEEecCCCChhhhhhcCCCC-------------------CCHHHHHHHHHHHHHHHHHHHhcCCCCeeeC
Q 012765          210 --STENGFHLVLQFLPHGSLSSLLFGSTEC-------------------LEWTIRYKIALGIAEGLQYLHHDCHRRIIHR  268 (457)
Q Consensus       210 --~~~~~~~lv~e~~~~gsL~~~l~~~~~~-------------------~~~~~~~~i~~qia~aL~yLH~~~~~~iiHr  268 (457)
                        ..+...++++||+.+++|.+++......                   .....+..++.||+.||.|||+   .+|+||
T Consensus       203 ~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~---~gIiHR  279 (566)
T PLN03225        203 SSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHS---TGIVHR  279 (566)
T ss_pred             ccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHH---CCEEeC
Confidence              2345578999999999999988543211                   1123355789999999999999   899999


Q ss_pred             CCCCCcEEEcC-CCcEEEeeccccccCCCCCCceeeecccccccccChhccccC----------------------CCCc
Q 012765          269 DIKASNILLSE-DYEAQISDFGLAKWLPDNWSHHIVFPIEGTFGYLSPEYFMHG----------------------IVDE  325 (457)
Q Consensus       269 Dlkp~NIll~~-~~~~kL~DFGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~~~  325 (457)
                      ||||+|||++. ++.+||+|||+++.+...... ......+++.|+|||.+...                      .++.
T Consensus       280 DLKP~NILl~~~~~~~KL~DFGlA~~l~~~~~~-~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~  358 (566)
T PLN03225        280 DVKPQNIIFSEGSGSFKIIDLGAAADLRVGINY-IPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPD  358 (566)
T ss_pred             cCCHHHEEEeCCCCcEEEEeCCCcccccccccc-CCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCC
Confidence            99999999986 578999999999866433211 22345689999999965322                      2445


Q ss_pred             chhHHHHHHHHHHHHhCCCCCCcCCcchhhhhccccc-cCCcc---cccCch----hhcccCH--HHHHHHHHHHHHhcc
Q 012765          326 KTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQ-TSNFK---ELVDPR----LADAYDL--AEMKRAMLTASVCIH  395 (457)
Q Consensus       326 ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~~~~~-~~~~~---~~~d~~----l~~~~~~--~~~~~l~~l~~~Cl~  395 (457)
                      ++|||||||++|||+++..+++....   .+...+.. .....   ..+.+.    +...++.  .......+++.+||+
T Consensus       359 k~DVwSlGviL~el~~~~~~~~~~~~---~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~  435 (566)
T PLN03225        359 RFDIYSAGLIFLQMAFPNLRSDSNLI---QFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMR  435 (566)
T ss_pred             CcccHHHHHHHHHHHhCcCCCchHHH---HHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHcc
Confidence            67999999999999998776553211   11110000 00000   011111    0000000  011223478999999


Q ss_pred             cCCCCCCCHHHHHH
Q 012765          396 HLSTMRPQMTRVLQ  409 (457)
Q Consensus       396 ~dP~~RPt~~evl~  409 (457)
                      .||.+|||+.++++
T Consensus       436 ~dP~kR~ta~e~L~  449 (566)
T PLN03225        436 FKGRQRISAKAALA  449 (566)
T ss_pred             CCcccCCCHHHHhC
Confidence            99999999999987

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3e-33  Score=268.56  Aligned_cols=260  Identities=27%  Similarity=0.379  Sum_probs=191.7

Q ss_pred             hcCCCCCceecccCcEEEEEEEe-CCCcEEEEEEEeccchh----hHHHHHHHHHHHHHHhhcCCCCcceeeeeee--cC
Q 012765          141 TDNFNSENLIGKGGHAEVYKGCL-PDGEVVAVKKIIKNAKE----DEERISDFLSELGIVAHINHPNAAKLIGFST--EN  213 (457)
Q Consensus       141 ~~~f~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~----~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~--~~  213 (457)
                      .++|-.+++||+|||++||+|.+ ...+.||+|+-.-+..+    .....+...+|..|-+.|+||.||++|+|+.  .+
T Consensus       462 n~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtd  541 (775)
T KOG1151|consen  462 NDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTD  541 (775)
T ss_pred             HHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccc
Confidence            35566778999999999999975 45788999974333222    1233466789999999999999999999654  34


Q ss_pred             ceEEEEEecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcC---CCcEEEeeccc
Q 012765          214 GFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSE---DYEAQISDFGL  290 (457)
Q Consensus       214 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~---~~~~kL~DFGl  290 (457)
                      .+|-|+|||+|.+|..+|.. .+.+++..+..|+.||+.||.||.+- ..+|||-||||.||||..   -|.+||+|||+
T Consensus       542 sFCTVLEYceGNDLDFYLKQ-hklmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeIKITDFGL  619 (775)
T KOG1151|consen  542 SFCTVLEYCEGNDLDFYLKQ-HKLMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEIKITDFGL  619 (775)
T ss_pred             cceeeeeecCCCchhHHHHh-hhhhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccceeEeeecch
Confidence            57899999999999988854 34578888889999999999999984 478999999999999954   47899999999


Q ss_pred             cccCCCCCCc-----eeeecccccccccChhccccC----CCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhcccc
Q 012765          291 AKWLPDNWSH-----HIVFPIEGTFGYLSPEYFMHG----IVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLL  361 (457)
Q Consensus       291 ~~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~----~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~~~~  361 (457)
                      ++.+.++...     .......||.+|++||.+.-+    +.+.|+||||.|||+|..+.|+.||......-.+     +
T Consensus       620 SKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdI-----L  694 (775)
T KOG1151|consen  620 SKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDI-----L  694 (775)
T ss_pred             hhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHH-----H
Confidence            9998765433     123346799999999998643    5788999999999999999999999864332211     1


Q ss_pred             ccCCcccccCchhhcccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 012765          362 QTSNFKELVDPRLADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQ  409 (457)
Q Consensus       362 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~  409 (457)
                      +.+.+.....-...  ..+........++.+||++.-++|-...++..
T Consensus       695 qeNTIlkAtEVqFP--~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~  740 (775)
T KOG1151|consen  695 QENTILKATEVQFP--PKPVVSSEAKAFIRRCLAYRKEDRIDVQQLAC  740 (775)
T ss_pred             hhhchhcceeccCC--CCCccCHHHHHHHHHHHHhhhhhhhhHHHHcc
Confidence            11111111000000  01111223445678899999999987766653

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2e-32  Score=272.64  Aligned_cols=206  Identities=24%  Similarity=0.363  Sum_probs=172.9

Q ss_pred             hcCCCCCceecccCcEEEEEEEe-CCCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeee-eeecCceEEE
Q 012765          141 TDNFNSENLIGKGGHAEVYKGCL-PDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIG-FSTENGFHLV  218 (457)
Q Consensus       141 ~~~f~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~-~~~~~~~~lv  218 (457)
                      ..-|..++.||-|+||+|.+++. ++...||+|.+.+...........+..|-.||+.-+.+-||+||- |.+.+++|+|
T Consensus       628 KSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFV  707 (1034)
T KOG0608|consen  628 KSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFV  707 (1034)
T ss_pred             ccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEE
Confidence            45677788999999999999974 457789999988777776777888999999999999999999986 6677889999


Q ss_pred             EEecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCC---
Q 012765          219 LQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLP---  295 (457)
Q Consensus       219 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~---  295 (457)
                      |+|++||++-.+|.. .+.+++..+.-++.++.+|+++.|.   .|+|||||||+|||||.+|++||+||||++-+.   
T Consensus       708 MdYIPGGDmMSLLIr-mgIFeE~LARFYIAEltcAiesVHk---mGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTH  783 (1034)
T KOG0608|consen  708 MDYIPGGDMMSLLIR-MGIFEEDLARFYIAELTCAIESVHK---MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH  783 (1034)
T ss_pred             EeccCCccHHHHHHH-hccCHHHHHHHHHHHHHHHHHHHHh---ccceecccCccceEEccCCceeeeeccccccceecc
Confidence            999999999998854 4456677666667789999999999   899999999999999999999999999986431   


Q ss_pred             CC------CCc-------------------------------eeeecccccccccChhccccCCCCcchhHHHHHHHHHH
Q 012765          296 DN------WSH-------------------------------HIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLE  338 (457)
Q Consensus       296 ~~------~~~-------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~e  338 (457)
                      +.      ...                               .......||+.|+|||++....|+..+|+||.||||||
T Consensus       784 dskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~e  863 (1034)
T KOG0608|consen  784 DSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYE  863 (1034)
T ss_pred             ccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHH
Confidence            10      000                               00012469999999999999999999999999999999


Q ss_pred             HHhCCCCCCcCC
Q 012765          339 LITGRRAVDSRR  350 (457)
Q Consensus       339 LltG~~pf~~~~  350 (457)
                      |+.|+.||-...
T Consensus       864 m~~g~~pf~~~t  875 (1034)
T KOG0608|consen  864 MLVGQPPFLADT  875 (1034)
T ss_pred             HhhCCCCccCCC
Confidence            999999997633

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=99.98  E-value=1.8e-31  Score=274.58  Aligned_cols=256  Identities=22%  Similarity=0.254  Sum_probs=174.2

Q ss_pred             hhcCCCCCceecccCcEEEEEEEe-----------------CCCcEEEEEEEeccchhhHH-----------HHHHHHHH
Q 012765          140 ATDNFNSENLIGKGGHAEVYKGCL-----------------PDGEVVAVKKIIKNAKEDEE-----------RISDFLSE  191 (457)
Q Consensus       140 ~~~~f~~~~~LG~G~~g~Vy~~~~-----------------~~~~~vavK~~~~~~~~~~~-----------~~~~~~~E  191 (457)
                      ..++|.+.++||+|+||.||+|.+                 ..++.||||++.........           ..+....|
T Consensus       143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE  222 (507)
T PLN03224        143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE  222 (507)
T ss_pred             cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence            467899999999999999999963                 24568999998543221100           01123346


Q ss_pred             HHHHhhcCCCCc-----ceeeeeee---------cCceEEEEEecCCCChhhhhhcCC----------------------
Q 012765          192 LGIVAHINHPNA-----AKLIGFST---------ENGFHLVLQFLPHGSLSSLLFGST----------------------  235 (457)
Q Consensus       192 ~~~l~~l~hpni-----v~l~~~~~---------~~~~~lv~e~~~~gsL~~~l~~~~----------------------  235 (457)
                      +.++.+++|.++     +++++++.         .+..++||||+++++|.++++...                      
T Consensus       223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~  302 (507)
T PLN03224        223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP  302 (507)
T ss_pred             HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence            667777766654     66666654         345789999999999999886421                      


Q ss_pred             -CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCCCCCCceeeecccccccccC
Q 012765          236 -ECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEGTFGYLS  314 (457)
Q Consensus       236 -~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~~~~~~~~~~~~gt~~y~a  314 (457)
                       ..+++..+..++.|++.||.|||+   .+|+||||||+|||++.++.+||+|||++..+....... .....+|+.|+|
T Consensus       303 ~~~~~~~~~~~i~~ql~~aL~~lH~---~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~-~~~g~~tp~Y~a  378 (507)
T PLN03224        303 QDKRDINVIKGVMRQVLTGLRKLHR---IGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFN-PLYGMLDPRYSP  378 (507)
T ss_pred             cccCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCchHhEEECCCCcEEEEeCcCccccccCCccC-ccccCCCcceeC
Confidence             123567788899999999999999   899999999999999999999999999997654332111 111234789999


Q ss_pred             hhccccCC--------------------C--CcchhHHHHHHHHHHHHhCCC-CCCcCC----------cchhhhhcccc
Q 012765          315 PEYFMHGI--------------------V--DEKTDVFAFGVLLLELITGRR-AVDSRR----------QSLVIWAKPLL  361 (457)
Q Consensus       315 PE~~~~~~--------------------~--~~ksDvwSlGvll~eLltG~~-pf~~~~----------~~~~~~~~~~~  361 (457)
                      ||.+....                    |  ..+.||||+||++|+|++|.. ||....          .....|.....
T Consensus       379 PE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~  458 (507)
T PLN03224        379 PEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKG  458 (507)
T ss_pred             hhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhcc
Confidence            99875432                    1  234799999999999999875 665311          11111111000


Q ss_pred             ccCCcccccCchhhcccCHHHHHHHHHHHHHhcccCC---CCCCCHHHHHH
Q 012765          362 QTSNFKELVDPRLADAYDLAEMKRAMLTASVCIHHLS---TMRPQMTRVLQ  409 (457)
Q Consensus       362 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP---~~RPt~~evl~  409 (457)
                      ..      .+-..    .........+++..||..+|   .+|+|+.|+++
T Consensus       459 ~~------~~~~~----~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~  499 (507)
T PLN03224        459 QK------YDFSL----LDRNKEAGWDLACKLITKRDQANRGRLSVGQALS  499 (507)
T ss_pred             cC------CCccc----ccccChHHHHHHHHHhccCCCCcccCCCHHHHhC
Confidence            00      00000    01122345567777888765   68999999886

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=99.97  E-value=4.6e-32  Score=232.66  Aligned_cols=201  Identities=23%  Similarity=0.374  Sum_probs=164.6

Q ss_pred             CCCCCceecccCcEEEEEEEeC-CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeee-eecCceEEEEE
Q 012765          143 NFNSENLIGKGGHAEVYKGCLP-DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGF-STENGFHLVLQ  220 (457)
Q Consensus       143 ~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~-~~~~~~~lv~e  220 (457)
                      +|.-.++||+|.||+||+|+.. +++.||+|++.-....+ ..-...++|+-+++.++|.|||++++. ..+..+.+|+|
T Consensus         3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrldddde-gvpssalreicllkelkhknivrl~dvlhsdkkltlvfe   81 (292)
T KOG0662|consen    3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDE-GVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_pred             chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCC-CCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHH
Confidence            3555678999999999999854 58899999986543332 223467899999999999999999994 55667889999


Q ss_pred             ecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCCCCCCc
Q 012765          221 FLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSH  300 (457)
Q Consensus       221 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~~~~~  300 (457)
                      ||. .+|..+...-.+.++.+....++.|+++||.++|+   .++.||||||.|+|++.+|+.||+|||+++.++-..  
T Consensus        82 ~cd-qdlkkyfdslng~~d~~~~rsfmlqllrgl~fchs---hnvlhrdlkpqnllin~ngelkladfglarafgipv--  155 (292)
T KOG0662|consen   82 FCD-QDLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHS---HNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPV--  155 (292)
T ss_pred             Hhh-HHHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhh---hhhhhccCCcceEEeccCCcEEecccchhhhcCCce--
Confidence            985 46777766667778999999999999999999999   899999999999999999999999999998775432  


Q ss_pred             eeeecccccccccChhccccCC-CCcchhHHHHHHHHHHHHh-CCCCCCcCC
Q 012765          301 HIVFPIEGTFGYLSPEYFMHGI-VDEKTDVFAFGVLLLELIT-GRRAVDSRR  350 (457)
Q Consensus       301 ~~~~~~~gt~~y~aPE~~~~~~-~~~ksDvwSlGvll~eLlt-G~~pf~~~~  350 (457)
                      .......-|.+|.+|.++.+.+ |++..|+||.|||+.||.. |++.|.+.+
T Consensus       156 rcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~d  207 (292)
T KOG0662|consen  156 RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGND  207 (292)
T ss_pred             EeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCc
Confidence            1122234689999999998765 8999999999999999998 555566533

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=99.97  E-value=5e-32  Score=256.93  Aligned_cols=258  Identities=21%  Similarity=0.256  Sum_probs=191.3

Q ss_pred             HhhcCCCCCceecccCcEEEEEEEeC-CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCC--C----Ccceeeeee-
Q 012765          139 AATDNFNSENLIGKGGHAEVYKGCLP-DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINH--P----NAAKLIGFS-  210 (457)
Q Consensus       139 ~~~~~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h--p----niv~l~~~~-  210 (457)
                      ..+.+|.+...+|+|.||.|-.+.+. .+..||||+++.-.    ...+..+-|+++|.++.+  |    -+|.+.+|+ 
T Consensus        86 ~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~----kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFd  161 (415)
T KOG0671|consen   86 ILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVD----KYREAALIEIEVLQKINESDPNGKFRCVQMRDWFD  161 (415)
T ss_pred             ccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHH----HHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhh
Confidence            34789999999999999999998754 47899999774321    223466678999999842  2    256666654 


Q ss_pred             ecCceEEEEEecCCCChhhhhhc-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcC----------
Q 012765          211 TENGFHLVLQFLPHGSLSSLLFG-STECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSE----------  279 (457)
Q Consensus       211 ~~~~~~lv~e~~~~gsL~~~l~~-~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~----------  279 (457)
                      ..+..|+|+|.+ |-++.++|.. ....++..++..|+.|+++++.|||+   .+++|-||||+|||+.+          
T Consensus       162 yrghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~---~kl~HTDLKPENILfvss~~~~~~~~k  237 (415)
T KOG0671|consen  162 YRGHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHD---LKLTHTDLKPENILFVSSEYFKTYNPK  237 (415)
T ss_pred             ccCceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHh---cceeecCCChheEEEeccceEEEeccC
Confidence            567789999976 5688999865 44578999999999999999999999   89999999999999931          


Q ss_pred             ----------CCcEEEeeccccccCCCCCCceeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHhCCCCCCcC
Q 012765          280 ----------DYEAQISDFGLAKWLPDNWSHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSR  349 (457)
Q Consensus       280 ----------~~~~kL~DFGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLltG~~pf~~~  349 (457)
                                +..+||+|||.++......     .....|..|.|||++.+-+|+..+||||+||||.||+||...|+.-
T Consensus       238 ~~~~~~r~~ks~~I~vIDFGsAtf~~e~h-----s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtH  312 (415)
T KOG0671|consen  238 KKVCFIRPLKSTAIKVIDFGSATFDHEHH-----STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTH  312 (415)
T ss_pred             CccceeccCCCcceEEEecCCcceeccCc-----ceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccC
Confidence                      2358999999998765443     2344799999999999999999999999999999999999999864


Q ss_pred             C--cchhhhhcccc----------------ccCC-----------cccccCchhhc----ccCHHHHHHHHHHHHHhccc
Q 012765          350 R--QSLVIWAKPLL----------------QTSN-----------FKELVDPRLAD----AYDLAEMKRAMLTASVCIHH  396 (457)
Q Consensus       350 ~--~~~~~~~~~~~----------------~~~~-----------~~~~~d~~l~~----~~~~~~~~~l~~l~~~Cl~~  396 (457)
                      +  +++......+-                ..+.           .....++....    .....+...|++++..||..
T Consensus       313 en~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~f  392 (415)
T KOG0671|consen  313 ENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEF  392 (415)
T ss_pred             CcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHcc
Confidence            4  32221111000                0000           00000100000    01124556799999999999


Q ss_pred             CCCCCCCHHHHHH
Q 012765          397 LSTMRPQMTRVLQ  409 (457)
Q Consensus       397 dP~~RPt~~evl~  409 (457)
                      ||.+|+|+.|++.
T Consensus       393 DP~~RiTl~EAL~  405 (415)
T KOG0671|consen  393 DPARRITLREALS  405 (415)
T ss_pred             CccccccHHHHhc
Confidence            9999999999875

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=8.6e-32  Score=250.75  Aligned_cols=252  Identities=22%  Similarity=0.268  Sum_probs=188.2

Q ss_pred             hhcCCCCCceecccCcEEEEEEEeC-CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhh-cCCCCcceeeee-eecCceE
Q 012765          140 ATDNFNSENLIGKGGHAEVYKGCLP-DGEVVAVKKIIKNAKEDEERISDFLSELGIVAH-INHPNAAKLIGF-STENGFH  216 (457)
Q Consensus       140 ~~~~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~-l~hpniv~l~~~-~~~~~~~  216 (457)
                      ...+|.+..+||+|+|+.|..+.+. +.+.||+|++++....+.+.+.-...|-.+..+ -+||.+|-+..+ .++..++
T Consensus       248 ~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlf  327 (593)
T KOG0695|consen  248 GLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLF  327 (593)
T ss_pred             ccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEE
Confidence            3578999999999999999999864 578999998877655544445556666666544 479999999985 5566689


Q ss_pred             EEEEecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCCC
Q 012765          217 LVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPD  296 (457)
Q Consensus       217 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~  296 (457)
                      +|.||+++|+|--++... +.++++.+.-+...|+.||.|||+   ++||.||||.+|+||+..|++||+|+|.++.--.
T Consensus       328 fvieyv~ggdlmfhmqrq-rklpeeharfys~ei~lal~flh~---rgiiyrdlkldnvlldaeghikltdygmcke~l~  403 (593)
T KOG0695|consen  328 FVIEYVNGGDLMFHMQRQ-RKLPEEHARFYSAEICLALNFLHE---RGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLG  403 (593)
T ss_pred             EEEEEecCcceeeehhhh-hcCcHHHhhhhhHHHHHHHHHHhh---cCeeeeeccccceEEccCCceeecccchhhcCCC
Confidence            999999999998777543 457777777788899999999999   9999999999999999999999999999875422


Q ss_pred             CCCceeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhccccccCCcccccCchhhc
Q 012765          297 NWSHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSNFKELVDPRLAD  376 (457)
Q Consensus       297 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  376 (457)
                      +  .....+++||+.|+|||.+.+..|+..+|+|+||++++||+.|+.||+--......   ...++.-++-++...++-
T Consensus       404 ~--gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d---~ntedylfqvilekqiri  478 (593)
T KOG0695|consen  404 P--GDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPD---MNTEDYLFQVILEKQIRI  478 (593)
T ss_pred             C--CcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcc---cchhHHHHHHHhhhcccc
Confidence            2  22345678999999999999999999999999999999999999999842211100   000000111122222221


Q ss_pred             ccCHHHHHHHHHHHHHhcccCCCCCC
Q 012765          377 AYDLAEMKRAMLTASVCIHHLSTMRP  402 (457)
Q Consensus       377 ~~~~~~~~~l~~l~~~Cl~~dP~~RP  402 (457)
                        ......+...+....|++||.+|.
T Consensus       479 --prslsvkas~vlkgflnkdp~erl  502 (593)
T KOG0695|consen  479 --PRSLSVKASHVLKGFLNKDPKERL  502 (593)
T ss_pred             --cceeehhhHHHHHHhhcCCcHHhc
Confidence              111223344566778999999875

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=99.97  E-value=5.5e-32  Score=277.83  Aligned_cols=244  Identities=27%  Similarity=0.380  Sum_probs=181.2

Q ss_pred             CCCCCceecccCcEE-EEEEEeCCCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhc-CCCCcceeeeeeecCce-EEEE
Q 012765          143 NFNSENLIGKGGHAE-VYKGCLPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHI-NHPNAAKLIGFSTENGF-HLVL  219 (457)
Q Consensus       143 ~f~~~~~LG~G~~g~-Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~-~lv~  219 (457)
                      -|...+++|.|+.|+ ||+|.+ +|+.||||++...      ...-..+|+..|+.. +|||||++|+...+.+. |+..
T Consensus       510 ~~~~~eilG~Gs~Gt~Vf~G~y-e~R~VAVKrll~e------~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIal  582 (903)
T KOG1027|consen  510 FFSPKEILGYGSNGTVVFRGVY-EGREVAVKRLLEE------FFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIAL  582 (903)
T ss_pred             eeccHHHcccCCCCcEEEEEee-CCceehHHHHhhH------hHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEe
Confidence            345567899999885 799998 7889999988643      233567899999888 59999999998887775 5777


Q ss_pred             EecCCCChhhhhhcCCCC---CCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcC---C--CcEEEeecccc
Q 012765          220 QFLPHGSLSSLLFGSTEC---LEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSE---D--YEAQISDFGLA  291 (457)
Q Consensus       220 e~~~~gsL~~~l~~~~~~---~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~---~--~~~kL~DFGl~  291 (457)
                      |.| ..+|.+++......   ...-..+.+..|++.||++||+   .+||||||||.||||+.   +  ..++|+|||++
T Consensus       583 ELC-~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHs---l~iVHRDLkPQNILI~~~~~~~~~ra~iSDfgls  658 (903)
T KOG1027|consen  583 ELC-ACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHS---LKIVHRDLKPQNILISVPSADGTLRAKISDFGLS  658 (903)
T ss_pred             hHh-hhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHh---cccccccCCCceEEEEccCCCcceeEEecccccc
Confidence            876 55888888653111   1112235678899999999999   89999999999999976   3  46999999999


Q ss_pred             ccCCCCCCc-eeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHhC-CCCCCcCCcchhhhhccccccCCcccc
Q 012765          292 KWLPDNWSH-HIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITG-RRAVDSRRQSLVIWAKPLLQTSNFKEL  369 (457)
Q Consensus       292 ~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLltG-~~pf~~~~~~~~~~~~~~~~~~~~~~~  369 (457)
                      +.+..+... .......||-+|+|||++....-+.++|||||||++|+.++| .+||.+.-...   +..+..+..+..+
T Consensus       659 Kkl~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~---~NIl~~~~~L~~L  735 (903)
T KOG1027|consen  659 KKLAGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQ---ANILTGNYTLVHL  735 (903)
T ss_pred             cccCCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhh---hhhhcCccceeee
Confidence            998665332 224456799999999999988888899999999999999996 89998621110   0011111111111


Q ss_pred             cCchhhcccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 012765          370 VDPRLADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQ  409 (457)
Q Consensus       370 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~  409 (457)
                           ....+  .  ...+++.+|++.+|..||++.+|+.
T Consensus       736 -----~~~~d--~--eA~dLI~~ml~~dP~~RPsa~~VL~  766 (903)
T KOG1027|consen  736 -----EPLPD--C--EAKDLISRMLNPDPQLRPSATDVLN  766 (903)
T ss_pred             -----ccCch--H--HHHHHHHHhcCCCcccCCCHHHHhC
Confidence                 11111  1  5668899999999999999999864

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=99.97  E-value=7.3e-31  Score=249.05  Aligned_cols=262  Identities=23%  Similarity=0.300  Sum_probs=204.0

Q ss_pred             HHHHHHhhcCCCCCceecccCcEEEEEEEeC------CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceee
Q 012765          134 FAELAAATDNFNSENLIGKGGHAEVYKGCLP------DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLI  207 (457)
Q Consensus       134 ~~~~~~~~~~f~~~~~LG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~  207 (457)
                      .+++....++++...++-+|.||.||.|.+.      +.+.|.+|.+......  -....++.|...+..+.|||+..+.
T Consensus       276 ~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~--iQv~~~L~es~lly~~sH~nll~V~  353 (563)
T KOG1024|consen  276 LQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQ--IQVNLLLQESMLLYGASHPNLLSVL  353 (563)
T ss_pred             HHhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccH--HHHHHHHHHHHHHhcCcCCCcccee
Confidence            4566777888999999999999999999653      3455667766544332  3466789999999999999999999


Q ss_pred             eeeec--CceEEEEEecCCCChhhhhhc-------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEc
Q 012765          208 GFSTE--NGFHLVLQFLPHGSLSSLLFG-------STECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLS  278 (457)
Q Consensus       208 ~~~~~--~~~~lv~e~~~~gsL~~~l~~-------~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~  278 (457)
                      +++.+  ...++++.++.-|+|..+|..       ..+.+.-.+...++.|++.|+.|||.   .++||.||...|++|+
T Consensus       354 ~V~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~---~~ViHkDiAaRNCvId  430 (563)
T KOG1024|consen  354 GVSIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHN---HGVIHKDIAARNCVID  430 (563)
T ss_pred             EEEeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHh---cCcccchhhhhcceeh
Confidence            86544  346788899989999999962       12235555667789999999999999   8999999999999999


Q ss_pred             CCCcEEEeeccccccCCCCCCceeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHh-CCCCCCcCCcchhhhh
Q 012765          279 EDYEAQISDFGLAKWLPDNWSHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELIT-GRRAVDSRRQSLVIWA  357 (457)
Q Consensus       279 ~~~~~kL~DFGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLlt-G~~pf~~~~~~~~~~~  357 (457)
                      +...+||+|=.+++.+-..+.+.....-.....||+||.+.+..|+.++|+||||++||||+| |+.|+..-+...... 
T Consensus       431 d~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~-  509 (563)
T KOG1024|consen  431 DQLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEH-  509 (563)
T ss_pred             hheeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHH-
Confidence            999999999999988765555554444445778999999999999999999999999999999 899987544322110 


Q ss_pred             ccccccCCcccccC-chhhcccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 012765          358 KPLLQTSNFKELVD-PRLADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQLLRG  413 (457)
Q Consensus       358 ~~~~~~~~~~~~~d-~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~  413 (457)
                                .+.| .++...  .+...++..++.-||...|++||++.|++.-|.+
T Consensus       510 ----------ylkdGyRlaQP--~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLse  554 (563)
T KOG1024|consen  510 ----------YLKDGYRLAQP--FNCPDELFTVMACCWALLPEERPSFSQLVICLSE  554 (563)
T ss_pred             ----------HHhccceecCC--CCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHH
Confidence                      0111 122222  2345567788888999999999999999987765

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=9.5e-30  Score=247.58  Aligned_cols=256  Identities=18%  Similarity=0.314  Sum_probs=189.4

Q ss_pred             cCCCCCceecccCcEEEEEEEe-CCCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcC-----C---CCcceeeeeeec
Q 012765          142 DNFNSENLIGKGGHAEVYKGCL-PDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHIN-----H---PNAAKLIGFSTE  212 (457)
Q Consensus       142 ~~f~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-----h---pniv~l~~~~~~  212 (457)
                      .+|.+.++||+|.|++||++.+ .+.+.||+|+++...    ...+..+.|+++|++++     |   ..||+|++++..
T Consensus        78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAq----hYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~Fkh  153 (590)
T KOG1290|consen   78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQ----HYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKH  153 (590)
T ss_pred             ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhh----HHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeecccee
Confidence            7889999999999999999985 467899999886432    33456788999998873     3   369999996654


Q ss_pred             C-----ceEEEEEecCCCChhhhhhc-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCC------
Q 012765          213 N-----GFHLVLQFLPHGSLSSLLFG-STECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSED------  280 (457)
Q Consensus       213 ~-----~~~lv~e~~~~gsL~~~l~~-~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~------  280 (457)
                      .     ++|+|+|++ |.+|..++.. .-+.++...+.+|+.||+.||.|||..  .+|||-||||+||||..+      
T Consensus       154 sGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~e--cgIIHTDlKPENvLl~~~e~~~~~  230 (590)
T KOG1290|consen  154 SGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRE--CGIIHTDLKPENVLLCSTEIDPAK  230 (590)
T ss_pred             cCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHh--cCccccCCCcceeeeeccccchhh
Confidence            3     368999988 5567666644 556799999999999999999999997  599999999999999000      


Q ss_pred             --------------------------------------------------------------------------------
Q 012765          281 --------------------------------------------------------------------------------  280 (457)
Q Consensus       281 --------------------------------------------------------------------------------  280 (457)
                                                                                                      
T Consensus       231 ~~~~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~~~~~~~~s~n~~~~~n  310 (590)
T KOG1290|consen  231 DAREAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGIEEEPNQESYNNEPRIN  310 (590)
T ss_pred             hhhhhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhcccccccccccccccccccCCC
Confidence                                                                                            


Q ss_pred             --------------------------------------------------------------------------------
Q 012765          281 --------------------------------------------------------------------------------  280 (457)
Q Consensus       281 --------------------------------------------------------------------------------  280 (457)
                                                                                                      
T Consensus       311 ~~~~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~~~n~~v~p~~~~~~~d  390 (590)
T KOG1290|consen  311 GNESTVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTIASNPLVNPDIPLPECD  390 (590)
T ss_pred             ccccchhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCccccccccccCCCCCCCccc
Confidence                                                                                            


Q ss_pred             CcEEEeeccccccCCCCCCceeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHhCCCCCCcCCcc--------
Q 012765          281 YEAQISDFGLAKWLPDNWSHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQS--------  352 (457)
Q Consensus       281 ~~~kL~DFGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~--------  352 (457)
                      -.+||+|||-++|.....+     ....|..|+|||++.+..|++.+||||++|+++||+||...|+.....        
T Consensus       391 i~vKIaDlGNACW~~khFT-----~DIQTRQYRapEVllGsgY~~~ADiWS~AC~~FELaTGDyLFePhsG~~Y~rDEDH  465 (590)
T KOG1290|consen  391 IRVKIADLGNACWVHKHFT-----EDIQTRQYRAPEVLLGSGYSTSADIWSTACMAFELATGDYLFEPHSGENYSRDEDH  465 (590)
T ss_pred             eeEEEeeccchhhhhhhhc-----hhhhhhhccCcceeecCCCCCchhHHHHHHHHHHhhcCceeecCCCCCCCCccHHH
Confidence            0146777777776544332     334789999999999999999999999999999999999998752111        


Q ss_pred             hhh-----------------hhccccccC-Ccccc-------cCchhh--cccCHHHHHHHHHHHHHhcccCCCCCCCHH
Q 012765          353 LVI-----------------WAKPLLQTS-NFKEL-------VDPRLA--DAYDLAEMKRAMLTASVCIHHLSTMRPQMT  405 (457)
Q Consensus       353 ~~~-----------------~~~~~~~~~-~~~~~-------~d~~l~--~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~  405 (457)
                      +..                 +-+.+++.. .+..|       +...|.  -.++.++...+.+++.-||+.+|++|||+.
T Consensus       466 iA~i~ELLG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fsdFL~PmLef~PeKR~tA~  545 (590)
T KOG1290|consen  466 IALIMELLGKIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFSDFLSPMLEFDPEKRPTAA  545 (590)
T ss_pred             HHHHHHHHhhccHHHHhcCcchHhhhccccceecccccCCCcHHHHHHHHhCCCHHHHHHHHHHHHHHHhcCccccccHH
Confidence            110                 011111111 11111       011111  123567888899999999999999999999


Q ss_pred             HHHH
Q 012765          406 RVLQ  409 (457)
Q Consensus       406 evl~  409 (457)
                      +.++
T Consensus       546 ~cl~  549 (590)
T KOG1290|consen  546 QCLK  549 (590)
T ss_pred             HHhc
Confidence            9986

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.97  E-value=7e-29  Score=226.66  Aligned_cols=210  Identities=35%  Similarity=0.549  Sum_probs=178.9

Q ss_pred             ecccCcEEEEEEEeCC-CcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeec-CceEEEEEecCCCCh
Q 012765          150 IGKGGHAEVYKGCLPD-GEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTE-NGFHLVLQFLPHGSL  227 (457)
Q Consensus       150 LG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-~~~~lv~e~~~~gsL  227 (457)
                      ||.|++|.||++...+ ++.+++|++.......  ....+.+|+..++.+.|++++++++++.. ...++++|++.+++|
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~--~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l   78 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS--LLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSL   78 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchh--HHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcH
Confidence            6899999999998754 8999999886543321  34678999999999999999999997665 556799999999999


Q ss_pred             hhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcC-CCcEEEeeccccccCCCCCCceeeecc
Q 012765          228 SSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSE-DYEAQISDFGLAKWLPDNWSHHIVFPI  306 (457)
Q Consensus       228 ~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~-~~~~kL~DFGl~~~~~~~~~~~~~~~~  306 (457)
                      .+++......+++..++.++.+++.+|.+||+   .+++|+||+|.||+++. ++.++|+|||.+........  .....
T Consensus        79 ~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~---~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~  153 (215)
T cd00180          79 KDLLKENEGKLSEDEILRILLQILEGLEYLHS---NGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS--LLKTI  153 (215)
T ss_pred             HHHHHhccCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc--hhhcc
Confidence            99986543568899999999999999999999   89999999999999999 89999999999987654321  11223


Q ss_pred             cccccccChhccccC-CCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhccccccCCcccccCchhhcccCHHHHHH
Q 012765          307 EGTFGYLSPEYFMHG-IVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSNFKELVDPRLADAYDLAEMKR  385 (457)
Q Consensus       307 ~gt~~y~aPE~~~~~-~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~  385 (457)
                      .+...|++||.+... .++.+.|+|+||+++++|                                            ..
T Consensus       154 ~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l--------------------------------------------~~  189 (215)
T cd00180         154 VGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL--------------------------------------------PE  189 (215)
T ss_pred             cCCCCccChhHhcccCCCCchhhhHHHHHHHHHH--------------------------------------------HH
Confidence            478889999998877 888999999999999999                                            56


Q ss_pred             HHHHHHHhcccCCCCCCCHHHHHHH
Q 012765          386 AMLTASVCIHHLSTMRPQMTRVLQL  410 (457)
Q Consensus       386 l~~l~~~Cl~~dP~~RPt~~evl~~  410 (457)
                      +.+++..|++.+|++||++.++++.
T Consensus       190 ~~~~l~~~l~~~p~~R~~~~~l~~~  214 (215)
T cd00180         190 LKDLIRKMLQKDPEKRPSAKEILEH  214 (215)
T ss_pred             HHHHHHHHhhCCcccCcCHHHHhhC
Confidence            7788899999999999999999874

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=8.2e-31  Score=238.28  Aligned_cols=198  Identities=23%  Similarity=0.373  Sum_probs=158.3

Q ss_pred             CCCCceecccCcEEEEEEEeC-CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeecCc------eE
Q 012765          144 FNSENLIGKGGHAEVYKGCLP-DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTENG------FH  216 (457)
Q Consensus       144 f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~------~~  216 (457)
                      .+..+.||.|+||.||...+. +|+.||+|++.. ....-...+.+.+|+++|.-++|.|+...+++....+      .|
T Consensus        55 i~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pn-vfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiY  133 (449)
T KOG0664|consen   55 IQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPN-VFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELY  133 (449)
T ss_pred             CCCCCcccccceeEEEeccCCCCccchhHhhcch-HHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHH
Confidence            345678999999999999864 799999998753 3333345678999999999999999999988655433      34


Q ss_pred             EEEEecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCCC
Q 012765          217 LVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPD  296 (457)
Q Consensus       217 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~  296 (457)
                      ++.|.| ..+|...+. ....++...+.-++.||++||.|||+   .+|.||||||.|+|++.|...||||||+++....
T Consensus       134 V~TELm-QSDLHKIIV-SPQ~Ls~DHvKVFlYQILRGLKYLHs---A~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~  208 (449)
T KOG0664|consen  134 VLTELM-QSDLHKIIV-SPQALTPDHVKVFVYQILRGLKYLHT---ANILHRDIKPGNLLVNSNCILKICDFGLARTWDQ  208 (449)
T ss_pred             HHHHHH-Hhhhhheec-cCCCCCcchhhhhHHHHHhhhHHHhh---cchhhccCCCccEEeccCceEEecccccccccch
Confidence            555655 345655553 34557777777789999999999999   8999999999999999999999999999987654


Q ss_pred             CCCceeeecccccccccChhccccC-CCCcchhHHHHHHHHHHHHhCCCCCCc
Q 012765          297 NWSHHIVFPIEGTFGYLSPEYFMHG-IVDEKTDVFAFGVLLLELITGRRAVDS  348 (457)
Q Consensus       297 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDvwSlGvll~eLltG~~pf~~  348 (457)
                      +...+. +.-.-|.+|.|||.+++. .|+.+.||||.|||+.||+..+..|+.
T Consensus       209 d~~~hM-TqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQA  260 (449)
T KOG0664|consen  209 RDRLNM-THEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQA  260 (449)
T ss_pred             hhhhhh-HHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhc
Confidence            433332 223358899999999975 599999999999999999988888875

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=99.96  E-value=5.1e-30  Score=253.57  Aligned_cols=200  Identities=22%  Similarity=0.311  Sum_probs=163.7

Q ss_pred             hcCCCCCceecccCcEEEEEEEeC-CCcEEEEEEEeccchhhHHHH-----HHHHHHHHHHhhcC---CCCcceeeeeee
Q 012765          141 TDNFNSENLIGKGGHAEVYKGCLP-DGEVVAVKKIIKNAKEDEERI-----SDFLSELGIVAHIN---HPNAAKLIGFST  211 (457)
Q Consensus       141 ~~~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~-----~~~~~E~~~l~~l~---hpniv~l~~~~~  211 (457)
                      ..+|+..+.+|.|+||.|+.|.++ +...|+||.+.+....-...+     -.+-.|+.||+.++   |+||+++++|++
T Consensus       560 ~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFE  639 (772)
T KOG1152|consen  560 FSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFE  639 (772)
T ss_pred             cccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheee
Confidence            356889999999999999999876 466788887765544322222     23557999999997   999999999888


Q ss_pred             cCceE-EEEEec-CCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeecc
Q 012765          212 ENGFH-LVLQFL-PHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFG  289 (457)
Q Consensus       212 ~~~~~-lv~e~~-~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG  289 (457)
                      ++++| ++||-. ++-+|++++.. ...+++.....|+.||+.|+.+||+   .+|||||||-+|+.++.+|-+||+|||
T Consensus       640 ddd~yyl~te~hg~gIDLFd~IE~-kp~m~E~eAk~IFkQV~agi~hlh~---~~ivhrdikdenvivd~~g~~klidfg  715 (772)
T KOG1152|consen  640 DDDYYYLETEVHGEGIDLFDFIEF-KPRMDEPEAKLIFKQVVAGIKHLHD---QGIVHRDIKDENVIVDSNGFVKLIDFG  715 (772)
T ss_pred             cCCeeEEEecCCCCCcchhhhhhc-cCccchHHHHHHHHHHHhccccccc---cCceecccccccEEEecCCeEEEeecc
Confidence            87765 667644 45578888843 3447888888899999999999999   899999999999999999999999999


Q ss_pred             ccccCCCCCCceeeecccccccccChhccccCCC-CcchhHHHHHHHHHHHHhCCCCCCc
Q 012765          290 LAKWLPDNWSHHIVFPIEGTFGYLSPEYFMHGIV-DEKTDVFAFGVLLLELITGRRAVDS  348 (457)
Q Consensus       290 l~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~ksDvwSlGvll~eLltG~~pf~~  348 (457)
                      .+....++.    ...+.||..|.|||++.+..| +..-|||+||++||.++....||..
T Consensus       716 saa~~ksgp----fd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn  771 (772)
T KOG1152|consen  716 SAAYTKSGP----FDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN  771 (772)
T ss_pred             chhhhcCCC----cceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence            998776653    223559999999999998887 5668999999999999999999863

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=99.96  E-value=5.5e-30  Score=227.64  Aligned_cols=254  Identities=19%  Similarity=0.310  Sum_probs=187.6

Q ss_pred             hhcCCCCCceecccCcEEEEEEE-eCCCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcC-CCCcceeeeeeecCc---
Q 012765          140 ATDNFNSENLIGKGGHAEVYKGC-LPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHIN-HPNAAKLIGFSTENG---  214 (457)
Q Consensus       140 ~~~~f~~~~~LG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~---  214 (457)
                      ..++|++.+.+|+|.|++||.|. ..+.+.++||.++.-      ..+.+.+|+.||..|. ||||+++++...+..   
T Consensus        36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV------kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~Skt  109 (338)
T KOG0668|consen   36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV------KKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKT  109 (338)
T ss_pred             ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechH------HHHHHHHHHHHHHhccCCCCeeehhhhhcCccccC
Confidence            46889999999999999999997 456888999988643      2457889999999996 999999999766543   


Q ss_pred             eEEEEEecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCC-CcEEEeecccccc
Q 012765          215 FHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSED-YEAQISDFGLAKW  293 (457)
Q Consensus       215 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~-~~~kL~DFGl~~~  293 (457)
                      +.+++||+.+.+...+.    ..++...+...+.+++.||.|+|+   .||.|||+||.|++++.. -.++|+|+|++.+
T Consensus       110 paLiFE~v~n~Dfk~ly----~tl~d~dIryY~~elLkALdyCHS---~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEF  182 (338)
T KOG0668|consen  110 PSLIFEYVNNTDFKQLY----PTLTDYDIRYYIYELLKALDYCHS---MGIMHRDVKPHNVMIDHELRKLRLIDWGLAEF  182 (338)
T ss_pred             chhHhhhhccccHHHHh----hhhchhhHHHHHHHHHHHHhHHHh---cCcccccCCcceeeechhhceeeeeecchHhh
Confidence            56999999998876655    234455556688899999999999   899999999999999954 5799999999998


Q ss_pred             CCCCCCceeeecccccccccChhcccc-CCCCcchhHHHHHHHHHHHHhCCCCCCc---CCcchhhhhccccccC-----
Q 012765          294 LPDNWSHHIVFPIEGTFGYLSPEYFMH-GIVDEKTDVFAFGVLLLELITGRRAVDS---RRQSLVIWAKPLLQTS-----  364 (457)
Q Consensus       294 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDvwSlGvll~eLltG~~pf~~---~~~~~~~~~~~~~~~~-----  364 (457)
                      .........   ...+..|..||.+.. ..|+..-|+|||||++..|+..+.||-.   ..++++..++.+-.+.     
T Consensus       183 YHp~~eYnV---RVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl  259 (338)
T KOG0668|consen  183 YHPGKEYNV---RVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYL  259 (338)
T ss_pred             cCCCceeee---eeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHH
Confidence            866543322   336788999999865 4589999999999999999999999853   1222332222111100     


Q ss_pred             -CcccccCchhhc--------c----cC---H-HHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 012765          365 -NFKELVDPRLAD--------A----YD---L-AEMKRAMLTASVCIHHLSTMRPQMTRVLQ  409 (457)
Q Consensus       365 -~~~~~~d~~l~~--------~----~~---~-~~~~~l~~l~~~Cl~~dP~~RPt~~evl~  409 (457)
                       ...--+||...+        .    ..   . -...+.++++...|..|-++|||++|.+.
T Consensus       260 ~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~  321 (338)
T KOG0668|consen  260 NKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMA  321 (338)
T ss_pred             HHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhc
Confidence             000012222211        0    00   0 01245677888899999999999998765

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=99.96  E-value=7.3e-30  Score=249.64  Aligned_cols=266  Identities=23%  Similarity=0.264  Sum_probs=200.9

Q ss_pred             ccHHHHHHhhcCCCCCceecccCcEEEEEEEeC-CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcC------CCCcc
Q 012765          132 FDFAELAAATDNFNSENLIGKGGHAEVYKGCLP-DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHIN------HPNAA  204 (457)
Q Consensus       132 ~~~~~~~~~~~~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~------hpniv  204 (457)
                      |.+...+....+|.+....|+|-|++|.+|.+. .|+.||||++..+...    ...=+.|+++|.+|+      .-+++
T Consensus       422 Yrv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M----~KtGl~EleiLkKL~~AD~Edk~Hcl  497 (752)
T KOG0670|consen  422 YRVRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVM----HKTGLKELEILKKLNDADPEDKFHCL  497 (752)
T ss_pred             EEEehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHH----hhhhhHHHHHHHHhhccCchhhhHHH
Confidence            445556677889999999999999999999865 4889999999766443    335578999999995      34788


Q ss_pred             eeee-eeecCceEEEEEecCCCChhhhhhc--CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCC-
Q 012765          205 KLIG-FSTENGFHLVLQFLPHGSLSSLLFG--STECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSED-  280 (457)
Q Consensus       205 ~l~~-~~~~~~~~lv~e~~~~gsL~~~l~~--~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~-  280 (457)
                      +|+- |...+++|||+|.+ .-+|.+.|..  ..-.+....+..++.|+.-||..|-.   .+|+|.||||+|||+++. 
T Consensus       498 rl~r~F~hknHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~---c~vlHaDIKPDNiLVNE~k  573 (752)
T KOG0670|consen  498 RLFRHFKHKNHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKK---CGVLHADIKPDNILVNESK  573 (752)
T ss_pred             HHHHHhhhcceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHh---cCeeecccCccceEeccCc
Confidence            8885 88889999999976 4578888854  33457777888899999999999998   899999999999999976 


Q ss_pred             CcEEEeeccccccCCCCCCceeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHhCCCCCCcCCcc--hhhhh-
Q 012765          281 YEAQISDFGLAKWLPDNWSHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQS--LVIWA-  357 (457)
Q Consensus       281 ~~~kL~DFGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~--~~~~~-  357 (457)
                      ..+||||||.|.......    .+++.-+..|.|||.+.|-.|+...|+||.||.||||+||+..|.+....  +..+. 
T Consensus       574 ~iLKLCDfGSA~~~~ene----itPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me  649 (752)
T KOG0670|consen  574 NILKLCDFGSASFASENE----ITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFME  649 (752)
T ss_pred             ceeeeccCcccccccccc----ccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHH
Confidence            568999999998775542    34444677899999999999999999999999999999999999763321  11100 


Q ss_pred             ------ccccccC-----------C----------------cccccCc------hhh-----cccCHHHHHHHHHHHHHh
Q 012765          358 ------KPLLQTS-----------N----------------FKELVDP------RLA-----DAYDLAEMKRAMLTASVC  393 (457)
Q Consensus       358 ------~~~~~~~-----------~----------------~~~~~d~------~l~-----~~~~~~~~~~l~~l~~~C  393 (457)
                            ..++...           +                +...+.|      .|.     +.-+...+..+..|+..|
T Consensus       650 ~KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkm  729 (752)
T KOG0670|consen  650 LKGKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKM  729 (752)
T ss_pred             hcCCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHH
Confidence                  0000000           0                0001111      010     111345667788999999


Q ss_pred             cccCCCCCCCHHHHHH
Q 012765          394 IHHLSTMRPQMTRVLQ  409 (457)
Q Consensus       394 l~~dP~~RPt~~evl~  409 (457)
                      |..||++|-|..|.|.
T Consensus       730 l~LdP~KRit~nqAL~  745 (752)
T KOG0670|consen  730 LILDPEKRITVNQALK  745 (752)
T ss_pred             hccChhhcCCHHHHhc
Confidence            9999999999998765

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.96  E-value=1.2e-27  Score=222.26  Aligned_cols=199  Identities=32%  Similarity=0.490  Sum_probs=167.5

Q ss_pred             CCCCceecccCcEEEEEEEeCC-CcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeec-CceEEEEEe
Q 012765          144 FNSENLIGKGGHAEVYKGCLPD-GEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTE-NGFHLVLQF  221 (457)
Q Consensus       144 f~~~~~LG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-~~~~lv~e~  221 (457)
                      |.+.+.||.|++|.||++...+ ++.+++|.+......  .....+.+|+..+..++|+|++++++++.. ...++++|+
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~   78 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE--KQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEY   78 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch--HHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEec
Confidence            4567899999999999998764 889999988654332  245688899999999999999999996655 557899999


Q ss_pred             cCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCCCCCCce
Q 012765          222 LPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSHH  301 (457)
Q Consensus       222 ~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~~~~~~  301 (457)
                      +++++|.+++......+++...+.++.+++.+|.+||+   .+++|+||+|.||+++.++.++|+|||++......... 
T Consensus        79 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~-  154 (225)
T smart00221       79 CEGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHS---LGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAA-  154 (225)
T ss_pred             cCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccc-
Confidence            99999999986544337889999999999999999999   79999999999999999999999999999877554210 


Q ss_pred             eeecccccccccChhcc-ccCCCCcchhHHHHHHHHHHHHhCCCCCCc
Q 012765          302 IVFPIEGTFGYLSPEYF-MHGIVDEKTDVFAFGVLLLELITGRRAVDS  348 (457)
Q Consensus       302 ~~~~~~gt~~y~aPE~~-~~~~~~~ksDvwSlGvll~eLltG~~pf~~  348 (457)
                      ......++..|++||.+ ....++.++|+|+||+++++|++|+.||..
T Consensus       155 ~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~  202 (225)
T smart00221      155 LLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG  202 (225)
T ss_pred             cccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence            12233478889999998 667788899999999999999999999965

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=99.96  E-value=1.7e-29  Score=234.66  Aligned_cols=256  Identities=25%  Similarity=0.323  Sum_probs=189.9

Q ss_pred             hcCCCCCceecccCcEEEEEEEe-CCCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeec-------
Q 012765          141 TDNFNSENLIGKGGHAEVYKGCL-PDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTE-------  212 (457)
Q Consensus       141 ~~~f~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-------  212 (457)
                      ..+|.....+|.|+- .|--|.+ -.++.||+|++... ..+.....+..+|+..+..++|+||++++.+++-       
T Consensus        16 ~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~p-f~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~   93 (369)
T KOG0665|consen   16 PKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRP-FQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEF   93 (369)
T ss_pred             eeeeeeecccCCCCc-eEEecchhhccCceehhhhcCc-cccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHH
Confidence            356667788999988 5555543 25899999998766 3334556788899999999999999999997653       


Q ss_pred             CceEEEEEecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccc
Q 012765          213 NGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAK  292 (457)
Q Consensus       213 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~  292 (457)
                      .+.|+|||+|. .+|...+.   ..++-.....|+.|++.|+.|||+   .+|+||||||+||++..+..+||.|||+++
T Consensus        94 ~e~y~v~e~m~-~nl~~vi~---~elDH~tis~i~yq~~~~ik~lhs---~~IihRdLkPsnivv~~~~~lKi~dfg~ar  166 (369)
T KOG0665|consen   94 QEVYLVMELMD-ANLCQVIL---MELDHETISYILYQMLCGIKHLHS---AGIIHRDLKPSNIVVNSDCTLKILDFGLAR  166 (369)
T ss_pred             HhHHHHHHhhh-hHHHHHHH---HhcchHHHHHHHHHHHHHHHHHHh---cceeecccCcccceecchhheeeccchhhc
Confidence            34689999984 46666664   235566777899999999999999   899999999999999999999999999998


Q ss_pred             cCCCCCCceeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhccccc----------
Q 012765          293 WLPDNWSHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQ----------  362 (457)
Q Consensus       293 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~~~~~----------  362 (457)
                      .....   -..++...|..|.|||++.+..|.+.+||||+||++.||++|+..|.+.+. .-.|.+....          
T Consensus       167 ~e~~~---~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~-idQ~~ki~~~lgtpd~~F~~  242 (369)
T KOG0665|consen  167 TEDTD---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDH-IDQWNKIIEQLGTPDPSFMK  242 (369)
T ss_pred             ccCcc---cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchH-HHHHHHHHHHhcCCCHHHHH
Confidence            65443   234566789999999999988899999999999999999999999885332 2222211110          


Q ss_pred             ------------cC-----CcccccCchh-hccc--CHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 012765          363 ------------TS-----NFKELVDPRL-ADAY--DLAEMKRAMLTASVCIHHLSTMRPQMTRVLQ  409 (457)
Q Consensus       363 ------------~~-----~~~~~~d~~l-~~~~--~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~  409 (457)
                                  .+     .+.+.+...+ ....  +.-....+..++..||-.+|++|-++.++|+
T Consensus       243 qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~  309 (369)
T KOG0665|consen  243 QLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALR  309 (369)
T ss_pred             HhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhc
Confidence                        00     1111111100 0000  1122344567889999999999999999987

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=99.95  E-value=4.3e-29  Score=250.71  Aligned_cols=252  Identities=24%  Similarity=0.365  Sum_probs=194.5

Q ss_pred             hhcCCCCCceecccCcEEEEEEEeC-CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeee-eeecCceEE
Q 012765          140 ATDNFNSENLIGKGGHAEVYKGCLP-DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIG-FSTENGFHL  217 (457)
Q Consensus       140 ~~~~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~-~~~~~~~~l  217 (457)
                      ..++|.....+|.|+||.|||+++. .++..|+|.++-....+   +.-+..|+.+++.++|||||.+++ |-..+.+++
T Consensus        13 P~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd---~~~iqqei~~~~dc~h~nivay~gsylr~dklwi   89 (829)
T KOG0576|consen   13 PQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDD---FSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWI   89 (829)
T ss_pred             CccchhheeeecCCcccchhhhcccccCchhhheeeeccCCcc---ccccccceeeeecCCCcChHHHHhhhhhhcCcEE
Confidence            4578889999999999999999864 68999999887655443   446778999999999999999999 667788999


Q ss_pred             EEEecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCCCC
Q 012765          218 VLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDN  297 (457)
Q Consensus       218 v~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~~  297 (457)
                      +||||.+|+|.+..+. ...+.+.++..++...++||.|||+   .+-+|||||-.|||+++.|.+|+.|||.+..+...
T Consensus        90 cMEycgggslQdiy~~-TgplselqiayvcRetl~gl~ylhs---~gk~hRdiKGanilltd~gDvklaDfgvsaqitat  165 (829)
T KOG0576|consen   90 CMEYCGGGSLQDIYHV-TGPLSELQIAYVCRETLQGLKYLHS---QGKIHRDIKGANILLTDEGDVKLADFGVSAQITAT  165 (829)
T ss_pred             EEEecCCCcccceeee-cccchhHHHHHHHhhhhccchhhhc---CCcccccccccceeecccCceeecccCchhhhhhh
Confidence            9999999999987754 5568888888899999999999999   89999999999999999999999999998876543


Q ss_pred             CCceeeecccccccccChhcc---ccCCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhccccccCCcccccCchh
Q 012765          298 WSHHIVFPIEGTFGYLSPEYF---MHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSNFKELVDPRL  374 (457)
Q Consensus       298 ~~~~~~~~~~gt~~y~aPE~~---~~~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l  374 (457)
                      ...  ...+.||++|||||+.   ..+.|..++|||++|+...||---+.|.-...+.-.   .-++....++   .|.+
T Consensus       166 i~K--rksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~---l~LmTkS~~q---pp~l  237 (829)
T KOG0576|consen  166 IAK--RKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRA---LFLMTKSGFQ---PPTL  237 (829)
T ss_pred             hhh--hhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHH---HHHhhccCCC---CCcc
Confidence            322  3346799999999986   357799999999999999999988877332111100   0001101000   1111


Q ss_pred             hcccCHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 012765          375 ADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVL  408 (457)
Q Consensus       375 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl  408 (457)
                      .+.  ..-...+-+++..|+..+|.+||++.-++
T Consensus       238 kDk--~kws~~fh~fvK~altknpKkRptaeklL  269 (829)
T KOG0576|consen  238 KDK--TKWSEFFHNFVKGALTKNPKKRPTAEKLL  269 (829)
T ss_pred             cCC--ccchHHHHHHHHHHhcCCCccCCChhhhe
Confidence            111  12233455677789999999999986543

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.95  E-value=2.9e-28  Score=221.66  Aligned_cols=248  Identities=19%  Similarity=0.340  Sum_probs=181.8

Q ss_pred             hhcCCCCCceecccCcEEEEEEEeC-CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhc-CCCCcceeee--eeecCce
Q 012765          140 ATDNFNSENLIGKGGHAEVYKGCLP-DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHI-NHPNAAKLIG--FSTENGF  215 (457)
Q Consensus       140 ~~~~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~--~~~~~~~  215 (457)
                      ..+.|.+.+.||+|.||.+.++.++ ..+.+++|.+.+..    ....+|.+|..---.| .|.||+..|+  |...+-+
T Consensus        22 l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~----tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~Y   97 (378)
T KOG1345|consen   22 LEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQ----TTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAY   97 (378)
T ss_pred             hhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcch----hhHHHHHHHhccceeeccchhhhHHHHHHhhcCceE
Confidence            4577889999999999999999865 57788899876543    3356889998765555 4899999997  5566666


Q ss_pred             EEEEEecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEc--CCCcEEEeecccccc
Q 012765          216 HLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLS--EDYEAQISDFGLAKW  293 (457)
Q Consensus       216 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~--~~~~~kL~DFGl~~~  293 (457)
                      .+++||++.|+|.+-+.  ...+.+....+++.|++.||.|+|+   .++||||||.+|||+-  +...+||||||+.+.
T Consensus        98 vF~qE~aP~gdL~snv~--~~GigE~~~K~v~~ql~SAi~fMHs---knlVHRdlK~eNiLif~~df~rvKlcDFG~t~k  172 (378)
T KOG1345|consen   98 VFVQEFAPRGDLRSNVE--AAGIGEANTKKVFAQLLSAIEFMHS---KNLVHRDLKAENILIFDADFYRVKLCDFGLTRK  172 (378)
T ss_pred             EEeeccCccchhhhhcC--cccccHHHHHHHHHHHHHHHHHhhc---cchhhcccccceEEEecCCccEEEeeecccccc
Confidence            79999999999998883  3457777888999999999999999   8999999999999994  335799999999875


Q ss_pred             CCCCCCceeeecccccccccChhcccc---C--CCCcchhHHHHHHHHHHHHhCCCCCCc---CCcchhhhhccccccCC
Q 012765          294 LPDNWSHHIVFPIEGTFGYLSPEYFMH---G--IVDEKTDVFAFGVLLLELITGRRAVDS---RRQSLVIWAKPLLQTSN  365 (457)
Q Consensus       294 ~~~~~~~~~~~~~~gt~~y~aPE~~~~---~--~~~~ksDvwSlGvll~eLltG~~pf~~---~~~~~~~~~~~~~~~~~  365 (457)
                      .+..     +....-+..|.+||....   +  ..++.+|+|.||++++.++||+.||+.   .++....|..  .....
T Consensus       173 ~g~t-----V~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~--w~~rk  245 (378)
T KOG1345|consen  173 VGTT-----VKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQ--WLKRK  245 (378)
T ss_pred             cCce-----ehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHH--Hhccc
Confidence            5432     333445778999997642   2  246789999999999999999999985   2333323221  11111


Q ss_pred             cccccCchhhcccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 012765          366 FKELVDPRLADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQ  409 (457)
Q Consensus       366 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~  409 (457)
                      ..  .-|..-..++    ..++++..+-|..+|++|-...++..
T Consensus       246 ~~--~~P~~F~~fs----~~a~r~Fkk~lt~~~~drcki~~~kk  283 (378)
T KOG1345|consen  246 NP--ALPKKFNPFS----EKALRLFKKSLTPRFKDRCKIWTAKK  283 (378)
T ss_pred             Cc--cCchhhcccC----HHHHHHHHHhcCCcccccchhHHHHH
Confidence            11  1122222223    34555666778999999966655544

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.94  E-value=7.4e-28  Score=264.81  Aligned_cols=194  Identities=18%  Similarity=0.209  Sum_probs=136.0

Q ss_pred             cCC-CCcceeeeeee-------c-CceEEEEEecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeC
Q 012765          198 INH-PNAAKLIGFST-------E-NGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHR  268 (457)
Q Consensus       198 l~h-pniv~l~~~~~-------~-~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHr  268 (457)
                      ++| +||+++++++.       + ..+++++|++ +++|.++|......+++..++.++.||+.||.|||+   .+|+||
T Consensus        29 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~---~gIvHr  104 (793)
T PLN00181         29 LSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHS---QGIVVH  104 (793)
T ss_pred             hhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHh---CCeeec
Confidence            345 57777777551       1 2234566765 679999997656679999999999999999999999   899999


Q ss_pred             CCCCCcEEEcCC-------------------CcEEEeeccccccCCCCCC--------------ceeeecccccccccCh
Q 012765          269 DIKASNILLSED-------------------YEAQISDFGLAKWLPDNWS--------------HHIVFPIEGTFGYLSP  315 (457)
Q Consensus       269 Dlkp~NIll~~~-------------------~~~kL~DFGl~~~~~~~~~--------------~~~~~~~~gt~~y~aP  315 (457)
                      ||||+||||+..                   +.+|++|||+++.......              ........||++||||
T Consensus       105 DlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~AP  184 (793)
T PLN00181        105 NVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSP  184 (793)
T ss_pred             cCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceECh
Confidence            999999999653                   4456666666654211000              0000113578999999


Q ss_pred             hccccCCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhccccccCCcccccCchhhcccCHHHHHHHHHHHHHhcc
Q 012765          316 EYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSNFKELVDPRLADAYDLAEMKRAMLTASVCIH  395 (457)
Q Consensus       316 E~~~~~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~  395 (457)
                      |++.+..|+.++|||||||+||||++|..|+.........+..         ....+..     .........++.+||+
T Consensus       185 E~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~~~~~~~~---------~~~~~~~-----~~~~~~~~~~~~~~L~  250 (793)
T PLN00181        185 EEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSRTMSSLRH---------RVLPPQI-----LLNWPKEASFCLWLLH  250 (793)
T ss_pred             hhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHHHHHHHHH---------hhcChhh-----hhcCHHHHHHHHHhCC
Confidence            9999999999999999999999999998887642211111100         0111111     1112234567788999


Q ss_pred             cCCCCCCCHHHHHH
Q 012765          396 HLSTMRPQMTRVLQ  409 (457)
Q Consensus       396 ~dP~~RPt~~evl~  409 (457)
                      .+|.+||+|.||++
T Consensus       251 ~~P~~Rps~~eil~  264 (793)
T PLN00181        251 PEPSCRPSMSELLQ  264 (793)
T ss_pred             CChhhCcChHHHhh
Confidence            99999999999986

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.94  E-value=1.6e-26  Score=207.72  Aligned_cols=167  Identities=22%  Similarity=0.197  Sum_probs=125.4

Q ss_pred             CChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCCCCCCceeee
Q 012765          225 GSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVF  304 (457)
Q Consensus       225 gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~~~~~~~~~  304 (457)
                      |+|.+++......+++..++.|+.||+.||.|||+   .+      ||+|||++.++.+|+  ||++.......      
T Consensus         1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~---~~------kp~Nil~~~~~~~~~--fG~~~~~~~~~------   63 (176)
T smart00750        1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHR---QA------KSGNILLTWDGLLKL--DGSVAFKTPEQ------   63 (176)
T ss_pred             CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh---cC------CcccEeEcCccceee--ccceEeecccc------
Confidence            68889987666779999999999999999999999   45      999999999999999  99988664421      


Q ss_pred             cccccccccChhccccCCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhccccccCCcccccCchhhcccCHHHH-
Q 012765          305 PIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSNFKELVDPRLADAYDLAEM-  383 (457)
Q Consensus       305 ~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~-  383 (457)
                       ..||+.|||||++.+..++.++|||||||++|||+||+.||............ .....  ... ++.... ...... 
T Consensus        64 -~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~-~~~~~--~~~-~~~~~~-~~~~~~~  137 (176)
T smart00750       64 -SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEI-LLNGM--PAD-DPRDRS-NLESVSA  137 (176)
T ss_pred             -CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHH-HHHHh--ccC-Cccccc-cHHHHHh
Confidence             24899999999999999999999999999999999999999753321111100 00000  000 000000 011111 


Q ss_pred             -HHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q 012765          384 -KRAMLTASVCIHHLSTMRPQMTRVLQLLRGE  414 (457)
Q Consensus       384 -~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~  414 (457)
                       ..+.+++.+||..+|.+||++.++++.+...
T Consensus       138 ~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~  169 (176)
T smart00750      138 ARSFADFMRVCASRLPQRREAANHYLAHCRAL  169 (176)
T ss_pred             hhhHHHHHHHHHhcccccccCHHHHHHHHHHH
Confidence             2588899999999999999999999977543

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.92  E-value=8.3e-25  Score=216.47  Aligned_cols=169  Identities=17%  Similarity=0.147  Sum_probs=130.6

Q ss_pred             HHhhcCCCCCceecccCcEEEEEEEeC--CCcEEEEEEEeccch--hhHHHHHHHHHHHHHHhhcCCCCcce-eeeeeec
Q 012765          138 AAATDNFNSENLIGKGGHAEVYKGCLP--DGEVVAVKKIIKNAK--EDEERISDFLSELGIVAHINHPNAAK-LIGFSTE  212 (457)
Q Consensus       138 ~~~~~~f~~~~~LG~G~~g~Vy~~~~~--~~~~vavK~~~~~~~--~~~~~~~~~~~E~~~l~~l~hpniv~-l~~~~~~  212 (457)
                      ....++|.+.+.||+|+||+||+|.+.  +++.+|||++.....  ........+.+|+.+|.+++|+|++. ++++   
T Consensus        14 ~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~---   90 (365)
T PRK09188         14 PALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT---   90 (365)
T ss_pred             ccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc---
Confidence            345688999999999999999999764  577889998653211  12234557999999999999999985 4432   


Q ss_pred             CceEEEEEecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCC-CCCcEEEcCCCcEEEeecccc
Q 012765          213 NGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDI-KASNILLSEDYEAQISDFGLA  291 (457)
Q Consensus       213 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDl-kp~NIll~~~~~~kL~DFGl~  291 (457)
                      +..++||||+++++|....  ...      ...++.+++.+|.|||+   .+|+|||| ||+|||++.++.+||+|||++
T Consensus        91 ~~~~LVmE~~~G~~L~~~~--~~~------~~~~~~~i~~aL~~lH~---~gIiHrDL~KP~NILv~~~~~ikLiDFGlA  159 (365)
T PRK09188         91 GKDGLVRGWTEGVPLHLAR--PHG------DPAWFRSAHRALRDLHR---AGITHNDLAKPQNWLMGPDGEAAVIDFQLA  159 (365)
T ss_pred             CCcEEEEEccCCCCHHHhC--ccc------hHHHHHHHHHHHHHHHH---CCCeeCCCCCcceEEEcCCCCEEEEECccc
Confidence            4579999999999996321  111      13578899999999999   89999999 999999999999999999999


Q ss_pred             ccCCCCCCcee------eecccccccccChhcccc
Q 012765          292 KWLPDNWSHHI------VFPIEGTFGYLSPEYFMH  320 (457)
Q Consensus       292 ~~~~~~~~~~~------~~~~~gt~~y~aPE~~~~  320 (457)
                      +.+........      .....+++.|+|||++..
T Consensus       160 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~  194 (365)
T PRK09188        160 SVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTP  194 (365)
T ss_pred             eecccCcchhhhhhhhhhhhhhccCccCCcccCCh
Confidence            87754322111      234568889999999854

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.92  E-value=5.3e-25  Score=211.90  Aligned_cols=198  Identities=27%  Similarity=0.368  Sum_probs=159.7

Q ss_pred             HhhcCCCCCceecccCcEEEEEEEeC----CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhc-CCCCcceeeeeeec-
Q 012765          139 AATDNFNSENLIGKGGHAEVYKGCLP----DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHI-NHPNAAKLIGFSTE-  212 (457)
Q Consensus       139 ~~~~~f~~~~~LG~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~-  212 (457)
                      ...+.|..+++||.|.|++||+|.+.    ..+.||+|.+.....     -..+.+|+++|..+ .+.||+++.++... 
T Consensus        33 ~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~-----p~ri~~El~~L~~~gG~~ni~~~~~~~rnn  107 (418)
T KOG1167|consen   33 FISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSS-----PSRILNELEMLYRLGGSDNIIKLNGCFRNN  107 (418)
T ss_pred             hhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccC-----chHHHHHHHHHHHhccchhhhcchhhhccC
Confidence            34577889999999999999999753    467899998865433     23688999999988 59999999996654 


Q ss_pred             CceEEEEEecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCC-CcEEEeecccc
Q 012765          213 NGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSED-YEAQISDFGLA  291 (457)
Q Consensus       213 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~-~~~kL~DFGl~  291 (457)
                      +..++|++|++.....+++..    ++...+...+..++.||.++|.   .|||||||||+|+|.+.. +.-.|+|||++
T Consensus       108 d~v~ivlp~~~H~~f~~l~~~----l~~~~i~~Yl~~ll~Al~~~h~---~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA  180 (418)
T KOG1167|consen  108 DQVAIVLPYFEHDRFRDLYRS----LSLAEIRWYLRNLLKALAHLHK---NGIVHRDIKPSNFLYNRRTQRGVLVDFGLA  180 (418)
T ss_pred             CeeEEEecccCccCHHHHHhc----CCHHHHHHHHHHHHHHhhhhhc---cCccccCCCccccccccccCCceEEechhH
Confidence            557899999999999888844    4567777889999999999999   899999999999999854 67889999999


Q ss_pred             ccCCCC------------------------------------------CCceeeecccccccccChhcccc-CCCCcchh
Q 012765          292 KWLPDN------------------------------------------WSHHIVFPIEGTFGYLSPEYFMH-GIVDEKTD  328 (457)
Q Consensus       292 ~~~~~~------------------------------------------~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksD  328 (457)
                      .+....                                          ..........||++|.|||++.. ...++++|
T Consensus       181 ~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiD  260 (418)
T KOG1167|consen  181 QRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAID  260 (418)
T ss_pred             HHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccc
Confidence            731000                                          00011123569999999999875 45789999


Q ss_pred             HHHHHHHHHHHHhCCCCCCc
Q 012765          329 VFAFGVLLLELITGRRAVDS  348 (457)
Q Consensus       329 vwSlGvll~eLltG~~pf~~  348 (457)
                      |||.|+|++-+++++.||-.
T Consensus       261 iws~GVI~Lslls~~~PFf~  280 (418)
T KOG1167|consen  261 IWSAGVILLSLLSRRYPFFK  280 (418)
T ss_pred             eeeccceeehhhcccccccc
Confidence            99999999999999999864

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.91  E-value=6.3e-23  Score=199.14  Aligned_cols=258  Identities=30%  Similarity=0.422  Sum_probs=194.5

Q ss_pred             CCCCceecccCcEEEEEEEeCCCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCC-CcceeeeeeecCc-eEEEEEe
Q 012765          144 FNSENLIGKGGHAEVYKGCLPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHP-NAAKLIGFSTENG-FHLVLQF  221 (457)
Q Consensus       144 f~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp-niv~l~~~~~~~~-~~lv~e~  221 (457)
                      |.+...||.|+||.||++...  ..+++|.+.............+.+|+.+++.+.|+ +++++++++.... .++++++
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~   79 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY   79 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence            567789999999999999876  78899988765554433567899999999999988 7999999775555 5899999


Q ss_pred             cCCCChhhhhhcCC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCC-cEEEeeccccccCCCCC
Q 012765          222 LPHGSLSSLLFGST--ECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDY-EAQISDFGLAKWLPDNW  298 (457)
Q Consensus       222 ~~~gsL~~~l~~~~--~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~-~~kL~DFGl~~~~~~~~  298 (457)
                      +.++++..++....  ..+.......++.|++.++.|+|+   .+++|||+||+||+++..+ .++++|||++..+....
T Consensus        80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~---~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~  156 (384)
T COG0515          80 VDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHS---KGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPG  156 (384)
T ss_pred             CCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCC
Confidence            99999996664433  268888889999999999999999   7899999999999999988 79999999998665433


Q ss_pred             Cce----eeecccccccccChhcccc---CCCCcchhHHHHHHHHHHHHhCCCCCCcCCcc---hhhhhccccccCC-cc
Q 012765          299 SHH----IVFPIEGTFGYLSPEYFMH---GIVDEKTDVFAFGVLLLELITGRRAVDSRRQS---LVIWAKPLLQTSN-FK  367 (457)
Q Consensus       299 ~~~----~~~~~~gt~~y~aPE~~~~---~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~---~~~~~~~~~~~~~-~~  367 (457)
                      ...    ......||..|+|||.+.+   ..+....|+||+|++++++++|..||......   ...+......... ..
T Consensus       157 ~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (384)
T COG0515         157 STSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLA  236 (384)
T ss_pred             ccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCcccc
Confidence            221    2345679999999999987   57899999999999999999999998764431   1111100000000 00


Q ss_pred             cccCchhhcccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 012765          368 ELVDPRLADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQL  410 (457)
Q Consensus       368 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~  410 (457)
                      .....    .........+..++..|+..+|..|.++.+....
T Consensus       237 ~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~  275 (384)
T COG0515         237 SPLSP----SNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH  275 (384)
T ss_pred             cccCc----cccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence            00000    0001223456678888999999999999877653

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.90  E-value=9.7e-23  Score=201.20  Aligned_cols=259  Identities=20%  Similarity=0.217  Sum_probs=182.7

Q ss_pred             CCCCCceecccCcEEEEEEEeCCC--cEEEEEEEeccchhhHHHHHHHHHHHHHHhhcC----CCCcceeeeee-ecCce
Q 012765          143 NFNSENLIGKGGHAEVYKGCLPDG--EVVAVKKIIKNAKEDEERISDFLSELGIVAHIN----HPNAAKLIGFS-TENGF  215 (457)
Q Consensus       143 ~f~~~~~LG~G~~g~Vy~~~~~~~--~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~----hpniv~l~~~~-~~~~~  215 (457)
                      +|.+...||+|+||.||++.....  ..+|+|..........   ..+..|..++..+.    -+++..+++.. ..+.+
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~---~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~   95 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKP---SVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDF   95 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCC---ccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCce
Confidence            799999999999999999987553  4788887654322211   14566777777775    25888888877 45555


Q ss_pred             -EEEEEecCCCChhhhhhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCC-----CcEEEeec
Q 012765          216 -HLVLQFLPHGSLSSLLFGST-ECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSED-----YEAQISDF  288 (457)
Q Consensus       216 -~lv~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~-----~~~kL~DF  288 (457)
                       ++||+ +.|.+|.++..... +.++..+.+.|+.|++.+|.+||+   .+++||||||.|+++...     ..+.|.||
T Consensus        96 ~~iVM~-l~G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~---~G~iHRDiKp~N~~~g~~~~~~~~~~~llDf  171 (322)
T KOG1164|consen   96 NFIVMS-LLGPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHS---KGFIHRDIKPENFVVGQSSRSEVRTLYLLDF  171 (322)
T ss_pred             eEEEEe-ccCccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHh---cCcccCCcCHHHeeecCCCCcccceEEEEec
Confidence             45555 55889999875443 779999999999999999999999   899999999999999865     35999999


Q ss_pred             cccc--cCCCCCCc------eeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhccc
Q 012765          289 GLAK--WLPDNWSH------HIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPL  360 (457)
Q Consensus       289 Gl~~--~~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~~~  360 (457)
                      |+++  ........      .......||..|+++....+...+.+.|+||++.++.||+.|..||...........   
T Consensus       172 Glar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~---  248 (322)
T KOG1164|consen  172 GLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSK---  248 (322)
T ss_pred             CCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHH---
Confidence            9998  33222110      112345699999999999999999999999999999999999999965332111100   


Q ss_pred             cccCCcccccCchhhcccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCCC
Q 012765          361 LQTSNFKELVDPRLADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQLLRGEGG  416 (457)
Q Consensus       361 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~  416 (457)
                      ............  .....+....   .+...+-..+...+|....+...|+....
T Consensus       249 ~~~~~~~~~~~~--~~~~~~~~~~---~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~  299 (322)
T KOG1164|consen  249 FEKDPRKLLTDR--FGDLKPEEFA---KILEYIDSLDYEDKPDYEKLAELLKDVFD  299 (322)
T ss_pred             HHHHhhhhcccc--ccCCChHHHH---HHHHHhhccCCcCCCCHHHHHHHHHHHHH
Confidence            000000001110  1111223333   33343555889999999999998766543

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.89  E-value=7.9e-24  Score=222.61  Aligned_cols=256  Identities=21%  Similarity=0.260  Sum_probs=182.9

Q ss_pred             CCCceecccCcEEEEEEEeC-CCcEEEEEEEec---cchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeec-CceEEEE
Q 012765          145 NSENLIGKGGHAEVYKGCLP-DGEVVAVKKIIK---NAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTE-NGFHLVL  219 (457)
Q Consensus       145 ~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~---~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-~~~~lv~  219 (457)
                      ....++|.|++|.|+..... ....++.|....   ...........+..|+-+-..+.|||++..+....+ ......|
T Consensus       321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m  400 (601)
T KOG0590|consen  321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM  400 (601)
T ss_pred             CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence            35678999999988877533 333344443221   222222223337778888888999999888774433 3334449


Q ss_pred             EecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCCCCCC
Q 012765          220 QFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWS  299 (457)
Q Consensus       220 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~~~~  299 (457)
                      ||++. +|..++... ..+....+-.++.|++.|+.|||+   .+|.|||+|++|++++.+|.+||+|||.+......+.
T Consensus       401 E~~~~-Dlf~~~~~~-~~~~~~e~~c~fKqL~~Gv~y~h~---~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e  475 (601)
T KOG0590|consen  401 EYCPY-DLFSLVMSN-GKLTPLEADCFFKQLLRGVKYLHS---MGLAHRDLKLENLLVTENGILKIIDFGAASVFRYPWE  475 (601)
T ss_pred             hcccH-HHHHHHhcc-cccchhhhhHHHHHHHHHHHHHHh---cCceeccCccccEEEecCCceEEeecCcceeeccCcc
Confidence            99999 999988543 346777778899999999999999   8999999999999999999999999999987766555


Q ss_pred             c--eeeecccccccccChhccccCCCCcc-hhHHHHHHHHHHHHhCCCCCCcCCcchhhhhccccccCCcccccCchhhc
Q 012765          300 H--HIVFPIEGTFGYLSPEYFMHGIVDEK-TDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSNFKELVDPRLAD  376 (457)
Q Consensus       300 ~--~~~~~~~gt~~y~aPE~~~~~~~~~k-sDvwSlGvll~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  376 (457)
                      .  .......|+..|+|||++.+..|++. .||||.|+++..|++|+.||.........+    .............-..
T Consensus       476 ~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~----~~~~~~~~~~~~~~~~  551 (601)
T KOG0590|consen  476 KNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSF----KTNNYSDQRNIFEGPN  551 (601)
T ss_pred             hhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccch----hhhccccccccccChH
Confidence            4  44566789999999999999999875 799999999999999999998633322111    0000000000111111


Q ss_pred             ccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 012765          377 AYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQ  409 (457)
Q Consensus       377 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~  409 (457)
                      ............++.++|+.+|.+|-|+.+|++
T Consensus       552 ~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~  584 (601)
T KOG0590|consen  552 RLLSLLPRETRIIIYRMLQLDPTKRITIEQILN  584 (601)
T ss_pred             HHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence            112233344566788899999999999999987

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.87  E-value=2.4e-22  Score=185.64  Aligned_cols=174  Identities=13%  Similarity=0.133  Sum_probs=135.8

Q ss_pred             HhhcCCCCCceecccCcEEEEEEEeCCCcEEEEEEEeccchhhHHHHHH------HHHHHHHHhhcCCCCcceeeeeeec
Q 012765          139 AATDNFNSENLIGKGGHAEVYKGCLPDGEVVAVKKIIKNAKEDEERISD------FLSELGIVAHINHPNAAKLIGFSTE  212 (457)
Q Consensus       139 ~~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~------~~~E~~~l~~l~hpniv~l~~~~~~  212 (457)
                      ...++|...++||.|+||.||.+.. ++..+|+|.+.............      +.+|+..+.++.|++|..+.++...
T Consensus        28 ~l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~  106 (232)
T PRK10359         28 FLSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLL  106 (232)
T ss_pred             HhhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeee
Confidence            3578999999999999999999755 67789999987654444444344      5789999999999999999886432


Q ss_pred             ---------CceEEEEEecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcE
Q 012765          213 ---------NGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEA  283 (457)
Q Consensus       213 ---------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~  283 (457)
                               +..+++|||++|.+|.++..     ++.    ....+++.+|..||.   .+++|||++|+||+++.+| +
T Consensus       107 ~~~~~~~~~~~~~lvmEyi~G~tL~~~~~-----~~~----~~~~~i~~~l~~lH~---~gi~H~Dikp~Nili~~~g-i  173 (232)
T PRK10359        107 AERKTLRYAHTYIMLIEYIEGVELNDMPE-----ISE----DVKAKIKASIESLHQ---HGMVSGDPHKGNFIVSKNG-L  173 (232)
T ss_pred             cccccccccCCeEEEEEEECCccHHHhhh-----ccH----HHHHHHHHHHHHHHH---cCCccCCCChHHEEEeCCC-E
Confidence                     24679999999999987641     222    245689999999999   8999999999999999988 9


Q ss_pred             EEeeccccccCCCCCCceeeecccccccccChhccccCCCCcchhHHHHHHHHHHHH
Q 012765          284 QISDFGLAKWLPDNWSHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELI  340 (457)
Q Consensus       284 kL~DFGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLl  340 (457)
                      +|+|||...........              ..+++...|+.++|+|+||+++..+.
T Consensus       174 ~liDfg~~~~~~e~~a~--------------d~~vler~y~~~~di~~lg~~~~~~~  216 (232)
T PRK10359        174 RIIDLSGKRCTAQRKAK--------------DRIDLERHYGIKNEIKDLGYYLLIYK  216 (232)
T ss_pred             EEEECCCcccccchhhH--------------HHHHHHhHhcccccccceeEeehHHH
Confidence            99999988655332111              11344556778999999999987655

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.87  E-value=7.5e-22  Score=179.63  Aligned_cols=143  Identities=17%  Similarity=0.154  Sum_probs=109.8

Q ss_pred             CceecccCcEEEEEEEeCCCcEEEEEEEeccchhhHH-----------------------HHHHHHHHHHHHhhcCCCCc
Q 012765          147 ENLIGKGGHAEVYKGCLPDGEVVAVKKIIKNAKEDEE-----------------------RISDFLSELGIVAHINHPNA  203 (457)
Q Consensus       147 ~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~-----------------------~~~~~~~E~~~l~~l~hpni  203 (457)
                      ...||+|+||.||+|...+|+.||+|++.........                       .......|+..+.++.++++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v   81 (190)
T cd05147           2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI   81 (190)
T ss_pred             CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence            4689999999999999878999999998654221100                       01123459999999988877


Q ss_pred             ceeeeeeecCceEEEEEecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHH-HhcCCCCeeeCCCCCCcEEEcCCCc
Q 012765          204 AKLIGFSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYL-HHDCHRRIIHRDIKASNILLSEDYE  282 (457)
Q Consensus       204 v~l~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yL-H~~~~~~iiHrDlkp~NIll~~~~~  282 (457)
                      .....+... ..++||||++++++...... ...++......++.|++.+|.|| |+   .+|+||||||+|||++ ++.
T Consensus        82 ~~p~~~~~~-~~~iVmE~i~g~~l~~~~~~-~~~~~~~~~~~i~~qi~~~L~~l~H~---~giiHrDlkP~NIli~-~~~  155 (190)
T cd05147          82 PCPEPILLK-SHVLVMEFIGDDGWAAPRLK-DAPLSESKARELYLQVIQIMRILYQD---CRLVHADLSEYNLLYH-DGK  155 (190)
T ss_pred             CCCcEEEec-CCEEEEEEeCCCCCcchhhh-cCCCCHHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEEE-CCc
Confidence            544433332 33899999998877654322 34678888999999999999999 67   7999999999999998 478


Q ss_pred             EEEeeccccccCC
Q 012765          283 AQISDFGLAKWLP  295 (457)
Q Consensus       283 ~kL~DFGl~~~~~  295 (457)
                      ++|+|||++....
T Consensus       156 v~LiDFG~a~~~~  168 (190)
T cd05147         156 LYIIDVSQSVEHD  168 (190)
T ss_pred             EEEEEccccccCC
Confidence            9999999997543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.86  E-value=2.6e-22  Score=182.95  Aligned_cols=246  Identities=20%  Similarity=0.283  Sum_probs=176.0

Q ss_pred             CCceecccCcEEEEEEEeCCCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeec-CceEEEEEecCC
Q 012765          146 SENLIGKGGHAEVYKGCLPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTE-NGFHLVLQFLPH  224 (457)
Q Consensus       146 ~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-~~~~lv~e~~~~  224 (457)
                      ...+|.....|+.|+|+++ |..+++|++.-.... ...-.+|..|.-.|+-+.||||..+++.|.. .++.++..||+.
T Consensus       194 l~tkl~e~hsgelwrgrwq-gndivakil~vr~~t-~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~  271 (448)
T KOG0195|consen  194 LITKLAESHSGELWRGRWQ-GNDIVAKILNVREVT-ARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPF  271 (448)
T ss_pred             hhhhhccCCCccccccccc-Ccchhhhhhhhhhcc-hhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccc
Confidence            3456888899999999994 455666766432221 2233578889999999999999999996654 567899999999


Q ss_pred             CChhhhhhcCCC-CCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEe--eccccccCCCCCCce
Q 012765          225 GSLSSLLFGSTE-CLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQIS--DFGLAKWLPDNWSHH  301 (457)
Q Consensus       225 gsL~~~l~~~~~-~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~--DFGl~~~~~~~~~~~  301 (457)
                      |+|+..|+.... ..+-.+..+++..|++|+.|||+- ..-|.---|.+..+++|++.+++|.  |--++-+.       
T Consensus       272 gslynvlhe~t~vvvd~sqav~faldiargmaflhsl-ep~ipr~~lns~hvmidedltarismad~kfsfqe-------  343 (448)
T KOG0195|consen  272 GSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSL-EPMIPRFYLNSKHVMIDEDLTARISMADTKFSFQE-------  343 (448)
T ss_pred             hHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhc-chhhhhhhcccceEEecchhhhheecccceeeeec-------
Confidence            999999987655 467778889999999999999994 2234444689999999999887773  32222111       


Q ss_pred             eeecccccccccChhccccCCCC---cchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhccccccCCcccccCchhhccc
Q 012765          302 IVFPIEGTFGYLSPEYFMHGIVD---EKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSNFKELVDPRLADAY  378 (457)
Q Consensus       302 ~~~~~~gt~~y~aPE~~~~~~~~---~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~  378 (457)
                        ....-.+.||+||.+...+-+   .++|+|||++++|||.|...||........-.       .-..+-+...+    
T Consensus       344 --~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgm-------kialeglrv~i----  410 (448)
T KOG0195|consen  344 --VGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGM-------KIALEGLRVHI----  410 (448)
T ss_pred             --cccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhh-------hhhhccccccC----
Confidence              112246789999999766543   57899999999999999999998632211110       00112222333    


Q ss_pred             CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q 012765          379 DLAEMKRAMLTASVCIHHLSTMRPQMTRVLQLLRGE  414 (457)
Q Consensus       379 ~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~  414 (457)
                      .+.....+.+++.-|...||.+||.+..|+-+|++.
T Consensus       411 ppgis~hm~klm~icmnedpgkrpkfdmivpilekm  446 (448)
T KOG0195|consen  411 PPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKM  446 (448)
T ss_pred             CCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHh
Confidence            333334556667779999999999999999888753

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.86  E-value=4.4e-22  Score=210.14  Aligned_cols=254  Identities=21%  Similarity=0.223  Sum_probs=173.8

Q ss_pred             CCCCCceecccCcEEEEEEEeCCCcEEEEEEEeccc-hhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeecCc-eEEEEE
Q 012765          143 NFNSENLIGKGGHAEVYKGCLPDGEVVAVKKIIKNA-KEDEERISDFLSELGIVAHINHPNAAKLIGFSTENG-FHLVLQ  220 (457)
Q Consensus       143 ~f~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~-~~lv~e  220 (457)
                      +|...+.||++.|=.|.+|.+++|. |+||++.+.. ...-+...+-+.|++ ...++|||.+++.-+...+. -|+|-+
T Consensus        24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvRq  101 (1431)
T KOG1240|consen   24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVRQ  101 (1431)
T ss_pred             ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHHH
Confidence            5667789999999999999998887 8889876543 222233344445555 56678999999876544333 345556


Q ss_pred             ecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccC--CCCC
Q 012765          221 FLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWL--PDNW  298 (457)
Q Consensus       221 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~--~~~~  298 (457)
                      |+. .+|++.|. .+..+....+.-|+.|++.||..+|.   .+|+|||||.+|||++.-..+.|+||...+..  +.+.
T Consensus       102 yvk-hnLyDRlS-TRPFL~~iEKkWiaFQLL~al~qcH~---~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDN  176 (1431)
T KOG1240|consen  102 YVK-HNLYDRLS-TRPFLVLIEKKWIAFQLLKALSQCHK---LGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDN  176 (1431)
T ss_pred             HHh-hhhhhhhc-cchHHHHHHHHHHHHHHHHHHHHHHH---cCccccccccceEEEeeechhhhhcccccCCccCCCCC
Confidence            653 46777772 23346666777799999999999999   89999999999999999999999999877543  3322


Q ss_pred             Ccee---eecccccccccChhccccC-----------CCCcchhHHHHHHHHHHHHh-CCCCCCcCCcchhhhhcccccc
Q 012765          299 SHHI---VFPIEGTFGYLSPEYFMHG-----------IVDEKTDVFAFGVLLLELIT-GRRAVDSRRQSLVIWAKPLLQT  363 (457)
Q Consensus       299 ~~~~---~~~~~gt~~y~aPE~~~~~-----------~~~~ksDvwSlGvll~eLlt-G~~pf~~~~~~~~~~~~~~~~~  363 (457)
                      ....   ..+...-.+|+|||.+...           ..+++.||||+||+++||++ |++||.-.  ++..|...  . 
T Consensus       177 Padf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LS--QL~aYr~~--~-  251 (1431)
T KOG1240|consen  177 PADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLS--QLLAYRSG--N-  251 (1431)
T ss_pred             cccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHH--HHHhHhcc--C-
Confidence            2211   1122234579999987531           15678999999999999999 68888631  11111110  0 


Q ss_pred             CCcccccCchhhcccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCC
Q 012765          364 SNFKELVDPRLADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQLLRGEG  415 (457)
Q Consensus       364 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~  415 (457)
                      ....+.+-..+       +...+.+++..|++.||.+|-++.+.|+.-+++.
T Consensus       252 ~~~~e~~Le~I-------ed~~~Rnlil~Mi~rdPs~RlSAedyL~~yrG~~  296 (1431)
T KOG1240|consen  252 ADDPEQLLEKI-------EDVSLRNLILSMIQRDPSKRLSAEDYLQKYRGLV  296 (1431)
T ss_pred             ccCHHHHHHhC-------cCccHHHHHHHHHccCchhccCHHHHHHhhhccc
Confidence            00000000000       1113556788899999999999999999876654

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.85  E-value=6.7e-21  Score=178.32  Aligned_cols=198  Identities=22%  Similarity=0.313  Sum_probs=162.9

Q ss_pred             cCCCCCceecccCcEEEEEEE-eCCCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhc-CCCCcceeeeeeecCceE-EE
Q 012765          142 DNFNSENLIGKGGHAEVYKGC-LPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHI-NHPNAAKLIGFSTENGFH-LV  218 (457)
Q Consensus       142 ~~f~~~~~LG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~-lv  218 (457)
                      -.|.+.++||+|+||..|.|. +-++++||||.-.....     .-++..|....+.| ..++|...|-|..++..- ||
T Consensus        28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~-----APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLV  102 (449)
T KOG1165|consen   28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSE-----APQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILV  102 (449)
T ss_pred             ccceeccccccCcceeeecccccccCceEEEEeccccCC-----cchHHHHHHHHHHHcCCCCCCceeeeccccchhhhh
Confidence            457789999999999999997 45899999996543322     22455666666666 468898888887777654 67


Q ss_pred             EEecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCC-----cEEEeecccccc
Q 012765          219 LQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDY-----EAQISDFGLAKW  293 (457)
Q Consensus       219 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~-----~~kL~DFGl~~~  293 (457)
                      +|.+ |.+|.++..-.++.++..+++.||.|++.-++|+|+   +.+|.|||||+|+||...+     .+.|+|||+++.
T Consensus       103 idLL-GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~---k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~  178 (449)
T KOG1165|consen  103 IDLL-GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHE---KDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKE  178 (449)
T ss_pred             hhhh-CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHh---cceeecccCccceeecCCCCCCCceEEEEeccchhh
Confidence            7765 888888876678889999999999999999999999   8999999999999997543     489999999998


Q ss_pred             CCCCCCcee-----eecccccccccChhccccCCCCcchhHHHHHHHHHHHHhCCCCCCc
Q 012765          294 LPDNWSHHI-----VFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDS  348 (457)
Q Consensus       294 ~~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLltG~~pf~~  348 (457)
                      ..+..+...     .....||..||+=....+...+.+-|+=|||-++++.|-|..||++
T Consensus       179 YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQG  238 (449)
T KOG1165|consen  179 YRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQG  238 (449)
T ss_pred             hcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCcccc
Confidence            866544322     2235699999999988999999999999999999999999999987

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.85  E-value=2e-20  Score=170.51  Aligned_cols=145  Identities=20%  Similarity=0.166  Sum_probs=111.8

Q ss_pred             CceecccCcEEEEEEEeCCCcEEEEEEEeccchhh-----------------------HHHHHHHHHHHHHHhhcCCCCc
Q 012765          147 ENLIGKGGHAEVYKGCLPDGEVVAVKKIIKNAKED-----------------------EERISDFLSELGIVAHINHPNA  203 (457)
Q Consensus       147 ~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~-----------------------~~~~~~~~~E~~~l~~l~hpni  203 (457)
                      ...||+|+||+||+|.+.+|+.||||++.......                       ......+..|...+.++.|+++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i   81 (190)
T cd05145           2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV   81 (190)
T ss_pred             CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence            46899999999999998789999999987542110                       0011234678999999999987


Q ss_pred             ceeeeeeecCceEEEEEecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcE
Q 012765          204 AKLIGFSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEA  283 (457)
Q Consensus       204 v~l~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~  283 (457)
                      .....+.... .++||||++++++..... ....++......++.|++.+|.+||+.  .+|+||||||+||+++ ++.+
T Consensus        82 ~~p~~~~~~~-~~lVmE~~~g~~~~~~~l-~~~~~~~~~~~~i~~~l~~~l~~lH~~--~givHrDlkP~NIll~-~~~~  156 (190)
T cd05145          82 PVPEPILLKK-NVLVMEFIGDDGSPAPRL-KDVPLEEEEAEELYEQVVEQMRRLYQE--AGLVHGDLSEYNILYH-DGKP  156 (190)
T ss_pred             CCceEEEecC-CEEEEEEecCCCchhhhh-hhccCCHHHHHHHHHHHHHHHHHHHHh--CCEecCCCChhhEEEE-CCCE
Confidence            5554443333 479999999886543322 223467778889999999999999983  5999999999999999 7899


Q ss_pred             EEeeccccccCCC
Q 012765          284 QISDFGLAKWLPD  296 (457)
Q Consensus       284 kL~DFGl~~~~~~  296 (457)
                      +|+|||++..+..
T Consensus       157 ~liDFG~a~~~~~  169 (190)
T cd05145         157 YIIDVSQAVELDH  169 (190)
T ss_pred             EEEEcccceecCC
Confidence            9999999986644

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.85  E-value=6.5e-21  Score=171.22  Aligned_cols=202  Identities=24%  Similarity=0.329  Sum_probs=163.2

Q ss_pred             hhcCCCCCceecccCcEEEEEEE-eCCCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCC-CCcceeeeeeecCce-E
Q 012765          140 ATDNFNSENLIGKGGHAEVYKGC-LPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINH-PNAAKLIGFSTENGF-H  216 (457)
Q Consensus       140 ~~~~f~~~~~LG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h-pniv~l~~~~~~~~~-~  216 (457)
                      ....|.+++.||.|+||.+|.|. ..+|..||||.-.......     .+.-|..+...|++ ..|..+..|..+..+ .
T Consensus        13 v~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~hp-----qL~yEskvY~iL~~g~GiP~i~~y~~e~~ynv   87 (341)
T KOG1163|consen   13 VGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKHP-----QLLYESKVYRILQGGVGIPHIRHYGTEKDYNV   87 (341)
T ss_pred             eccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCCc-----chhHHHHHHHHhccCCCCchhhhhccccccce
Confidence            45788999999999999999997 4579999999765544432     56677888877765 567777777777666 5


Q ss_pred             EEEEecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCC---CcEEEeecccccc
Q 012765          217 LVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSED---YEAQISDFGLAKW  293 (457)
Q Consensus       217 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~---~~~kL~DFGl~~~  293 (457)
                      +||+.+ |.+|.+++.-..+.++..+.+-++-|++.-++|+|.   +++|||||||+|+|+.-+   ..+.|+|||+++.
T Consensus        88 lVMdLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~---r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKk  163 (341)
T KOG1163|consen   88 LVMDLL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHL---RNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKK  163 (341)
T ss_pred             eeeecc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHh---hccccccCCccceeeccccccceEEEEeccchhh
Confidence            777765 889999887667778999999999999999999999   899999999999999743   4689999999988


Q ss_pred             CCCCCCcee-----eecccccccccChhccccCCCCcchhHHHHHHHHHHHHhCCCCCCcCC
Q 012765          294 LPDNWSHHI-----VFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRR  350 (457)
Q Consensus       294 ~~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLltG~~pf~~~~  350 (457)
                      ..+..+...     -....||..|.+-....+-..+.+-|+-|+|.+|.++.-|..||++-.
T Consensus       164 y~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglk  225 (341)
T KOG1163|consen  164 YRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLK  225 (341)
T ss_pred             hccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccc
Confidence            754332211     123459999998777777778889999999999999999999999743

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.85  E-value=2.7e-20  Score=168.64  Aligned_cols=188  Identities=15%  Similarity=0.044  Sum_probs=139.2

Q ss_pred             CCceecccCcEEEEEEEeCCCcEEEEEEEeccchhhHHH-HHHHHHHHHHHhhcC-CCCcceeeeeeecCceEEEEEecC
Q 012765          146 SENLIGKGGHAEVYKGCLPDGEVVAVKKIIKNAKEDEER-ISDFLSELGIVAHIN-HPNAAKLIGFSTENGFHLVLQFLP  223 (457)
Q Consensus       146 ~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~-~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~~~lv~e~~~  223 (457)
                      +...|++|+||+||.+.. .+..++.+.+.......... ...+.+|+++|++++ |+++++++++   +..+++|+|+.
T Consensus         6 ~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~---~~~~lvmeyI~   81 (218)
T PRK12274          6 VNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW---DGRHLDRSYLA   81 (218)
T ss_pred             cceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE---cCEEEEEeeec
Confidence            567899999999998765 67777777665443321111 125789999999995 5889999886   45789999999


Q ss_pred             CCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCC-CCCcEEEcCCCcEEEeeccccccCCCCCCc--
Q 012765          224 HGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDI-KASNILLSEDYEAQISDFGLAKWLPDNWSH--  300 (457)
Q Consensus       224 ~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDl-kp~NIll~~~~~~kL~DFGl~~~~~~~~~~--  300 (457)
                      |.+|...+..       . ...++.|++.+|.++|+   .+|+|||| ||.|||++.++.++|+|||++.........  
T Consensus        82 G~~L~~~~~~-------~-~~~~~~qi~~~L~~lH~---~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~r  150 (218)
T PRK12274         82 GAAMYQRPPR-------G-DLAYFRAARRLLQQLHR---CGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWMR  150 (218)
T ss_pred             CccHHhhhhh-------h-hHHHHHHHHHHHHHHHH---CcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcchHHH
Confidence            9988654311       1 13477899999999999   89999999 799999999999999999999865433210  


Q ss_pred             --e---e----eecccccccccChhccccC-CCC-cchhHHHHHHHHHHHHhCCCCCCc
Q 012765          301 --H---I----VFPIEGTFGYLSPEYFMHG-IVD-EKTDVFAFGVLLLELITGRRAVDS  348 (457)
Q Consensus       301 --~---~----~~~~~gt~~y~aPE~~~~~-~~~-~ksDvwSlGvll~eLltG~~pf~~  348 (457)
                        .   .    ......++.|++|+...-- ..+ ...++++-|+-+|.++|++.++..
T Consensus       151 ~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~  209 (218)
T PRK12274        151 LLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWE  209 (218)
T ss_pred             HHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccc
Confidence              0   0    0112357778888864321 223 567999999999999999988654

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.82  E-value=1.2e-21  Score=197.77  Aligned_cols=187  Identities=28%  Similarity=0.335  Sum_probs=152.0

Q ss_pred             eecccCcEEEEEEE----eCCCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcC-CCCcceeee-eeecCceEEEEEec
Q 012765          149 LIGKGGHAEVYKGC----LPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHIN-HPNAAKLIG-FSTENGFHLVLQFL  222 (457)
Q Consensus       149 ~LG~G~~g~Vy~~~----~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~-~~~~~~~~lv~e~~  222 (457)
                      ++|.|+||.|+.+.    .+.|..+|+|.+.+......... ....|..++..++ ||.+|++.. +..+...+++++|.
T Consensus         1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~-~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~   79 (612)
T KOG0603|consen    1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRT-HTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFL   79 (612)
T ss_pred             CCCcCCCcchHHHHHhccccccchhhhhccccccccccccc-ccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhc
Confidence            47999999999853    34688899997765443322222 4556777888887 999999975 77888899999999


Q ss_pred             CCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCCCCCCcee
Q 012765          223 PHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSHHI  302 (457)
Q Consensus       223 ~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~~~~~~~  302 (457)
                      .+|.|...+..... +...........++-++.++|+   .+++|||+|++||+++.+|++++.|||+++........  
T Consensus        80 rgg~lft~l~~~~~-f~~~~~~~~~aelaLald~lh~---l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~--  153 (612)
T KOG0603|consen   80 RGGDLFTRLSKEVM-FDELDVAFYLAELALALDHLHK---LGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA--  153 (612)
T ss_pred             ccchhhhccccCCc-hHHHHHHHHHHHHHHHHhhcch---hHHHHhcccccceeecccCccccCCchhhhHhHhhhhc--
Confidence            99999988865444 3334444455678999999999   89999999999999999999999999999877554322  


Q ss_pred             eecccccccccChhccccCCCCcchhHHHHHHHHHHHHhCCCCCCc
Q 012765          303 VFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDS  348 (457)
Q Consensus       303 ~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLltG~~pf~~  348 (457)
                          +||..|||||++.  .....+|.||||++++||+||..||..
T Consensus       154 ----cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~  193 (612)
T KOG0603|consen  154 ----CGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG  193 (612)
T ss_pred             ----ccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch
Confidence                6999999999987  678899999999999999999999986

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.81  E-value=5.4e-20  Score=185.68  Aligned_cols=215  Identities=21%  Similarity=0.363  Sum_probs=157.8

Q ss_pred             HhhcCCCCcceeeeeeecC-ceEEEEEecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCe-eeCCCCC
Q 012765          195 VAHINHPNAAKLIGFSTEN-GFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRI-IHRDIKA  272 (457)
Q Consensus       195 l~~l~hpniv~l~~~~~~~-~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~i-iHrDlkp  272 (457)
                      |+.+.|.|+.+++|.+.++ ..+.|.+|+..|+|.+.+......+++.-...++..|+.||.|||.   ..| .|+.+++
T Consensus         1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~---s~i~~hg~l~s   77 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHN---SPIGYHGALKS   77 (484)
T ss_pred             CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhc---Ccceeeeeecc
Confidence            3568899999999966555 4567789999999999998877789999999999999999999999   344 9999999


Q ss_pred             CcEEEcCCCcEEEeeccccccCCCCCCceeeecccccccccChhccccCC-------CCcchhHHHHHHHHHHHHhCCCC
Q 012765          273 SNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEGTFGYLSPEYFMHGI-------VDEKTDVFAFGVLLLELITGRRA  345 (457)
Q Consensus       273 ~NIll~~~~~~kL~DFGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-------~~~ksDvwSlGvll~eLltG~~p  345 (457)
                      .|++++..+.+||+|||+.................-..-|.|||.+....       .+.++||||||++++|+++.+.|
T Consensus        78 ~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~  157 (484)
T KOG1023|consen   78 SNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGP  157 (484)
T ss_pred             ccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCc
Confidence            99999999999999999987764311111111122345689999987631       46779999999999999999999


Q ss_pred             CCcCCcchh--hhhccccccCCcccccCchhhcccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCCC
Q 012765          346 VDSRRQSLV--IWAKPLLQTSNFKELVDPRLADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQLLRGEGG  416 (457)
Q Consensus       346 f~~~~~~~~--~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~  416 (457)
                      |+.......  ........  .-.....|.+....  +....+..++.+||..+|.+||++.+|-..++.+..
T Consensus       158 ~~~~~~~~~~~eii~~~~~--~~~~~~rP~i~~~~--e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~  226 (484)
T KOG1023|consen  158 FDLRNLVEDPDEIILRVKK--GGSNPFRPSIELLN--ELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINK  226 (484)
T ss_pred             cccccccCChHHHHHHHHh--cCCCCcCcchhhhh--hcchHHHHHHHHhcccChhhCccHHHHHhhhhhhcc
Confidence            986322211  11111111  01112222222111  233368889999999999999999999998877653

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.81  E-value=6.2e-19  Score=167.79  Aligned_cols=231  Identities=19%  Similarity=0.201  Sum_probs=145.6

Q ss_pred             CCCceecccCcEEEEEEEeC-CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCC----------CCcceeee-----
Q 012765          145 NSENLIGKGGHAEVYKGCLP-DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINH----------PNAAKLIG-----  208 (457)
Q Consensus       145 ~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h----------pniv~l~~-----  208 (457)
                      .....||.|+++.||.+.+. +++.+|+|............++.+.+|.-....+.+          -.++..++     
T Consensus        15 ~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i~   94 (288)
T PF14531_consen   15 VRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRIP   94 (288)
T ss_dssp             EEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEET
T ss_pred             EEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEEc
Confidence            34578999999999999976 489999998766555544556777777655544322          12222222     


Q ss_pred             ----eeecC---------ceEEEEEecCCCChhhhh---hcCC---CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCC
Q 012765          209 ----FSTEN---------GFHLVLQFLPHGSLSSLL---FGST---ECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRD  269 (457)
Q Consensus       209 ----~~~~~---------~~~lv~e~~~~gsL~~~l---~~~~---~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrD  269 (457)
                          +....         +.+++|+-+ .++|..++   ....   ..+....++.+..|+++.+++||.   .+++|+|
T Consensus        95 ~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~---~GlVHgd  170 (288)
T PF14531_consen   95 GKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHS---YGLVHGD  170 (288)
T ss_dssp             TS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHH---TTEEEST
T ss_pred             CCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhh---cceEecc
Confidence                11111         224455544 56776664   2211   124455567778899999999999   8999999


Q ss_pred             CCCCcEEEcCCCcEEEeeccccccCCCCCCceeeecccccccccChhccccC--------CCCcchhHHHHHHHHHHHHh
Q 012765          270 IKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEGTFGYLSPEYFMHG--------IVDEKTDVFAFGVLLLELIT  341 (457)
Q Consensus       270 lkp~NIll~~~~~~kL~DFGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--------~~~~ksDvwSlGvll~eLlt  341 (457)
                      |+|+|++++.+|.+.|+||+.....+...     .....+..|.+||.....        .++.+.|.|+||+++|.|++
T Consensus       171 i~~~nfll~~~G~v~Lg~F~~~~r~g~~~-----~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC  245 (288)
T PF14531_consen  171 IKPENFLLDQDGGVFLGDFSSLVRAGTRY-----RCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWC  245 (288)
T ss_dssp             -SGGGEEE-TTS-EEE--GGGEEETTEEE-----EGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHH
T ss_pred             cceeeEEEcCCCCEEEcChHHHeecCcee-----eccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHH
Confidence            99999999999999999999877554321     112356779999976432        47889999999999999999


Q ss_pred             CCCCCCcCCcchhhhhccccccCCcccccCchhhcccCHHHHHHHHHHHHHhcccCCCCC
Q 012765          342 GRRAVDSRRQSLVIWAKPLLQTSNFKELVDPRLADAYDLAEMKRAMLTASVCIHHLSTMR  401 (457)
Q Consensus       342 G~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~R  401 (457)
                      |..||.-.......                +..-.... +-.+.+..++..+|+.||.+|
T Consensus       246 ~~lPf~~~~~~~~~----------------~~~f~~C~-~~Pe~v~~LI~~lL~~~~~~R  288 (288)
T PF14531_consen  246 GRLPFGLSSPEADP----------------EWDFSRCR-DMPEPVQFLIRGLLQRNPEDR  288 (288)
T ss_dssp             SS-STCCCGGGSTS----------------GGGGTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred             ccCCCCCCCccccc----------------cccchhcC-CcCHHHHHHHHHHccCCcccC
Confidence            99999853211100                00111222 444556678888999999987

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.81  E-value=3.4e-19  Score=191.67  Aligned_cols=199  Identities=19%  Similarity=0.190  Sum_probs=156.6

Q ss_pred             HHHhhcCCCCCceecccCcEEEEEEEeCCCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcC---CCCcceeee-eeec
Q 012765          137 LAAATDNFNSENLIGKGGHAEVYKGCLPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHIN---HPNAAKLIG-FSTE  212 (457)
Q Consensus       137 ~~~~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~---hpniv~l~~-~~~~  212 (457)
                      .+...+.|.+.+.||+|+||+||+|...+|+.||+|.-.........-.      .+++.+|+   -+-|..+.. +...
T Consensus       693 ~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WEfYI~------~q~~~RLk~~~~~~~~~~~~a~~~~  766 (974)
T KOG1166|consen  693 FEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWEFYIC------LQVMERLKPQMLPSIMHISSAHVFQ  766 (974)
T ss_pred             eeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCceeeeeh------HHHHHhhchhhhcchHHHHHHHccC
Confidence            4455678888899999999999999988899999998765544422211      22333444   123444443 4456


Q ss_pred             CceEEEEEecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcC-------CCcEEE
Q 012765          213 NGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSE-------DYEAQI  285 (457)
Q Consensus       213 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~-------~~~~kL  285 (457)
                      +..++|++|.+.|+|.+++. ..+.++|...+-++.|++..+..||.   .+|||+||||+|+||..       ..-++|
T Consensus       767 ~~S~lv~ey~~~Gtlld~~N-~~~~m~e~lv~~~~~qml~ive~lH~---~~IIHgDiKPDNfll~~~~~~~~~~~~l~l  842 (974)
T KOG1166|consen  767 NASVLVSEYSPYGTLLDLIN-TNKVMDEYLVMFFSCQMLRIVEHLHA---MGIIHGDIKPDNFLLRREICADSDSKGLYL  842 (974)
T ss_pred             CcceeeeeccccccHHHhhc-cCCCCCchhhhHHHHHHHHHHHHHHh---cceecccCCcceeEeecccCCCCcccceEE
Confidence            66789999999999999996 56678999999999999999999999   89999999999999952       235899


Q ss_pred             eeccccccCCCCCCceeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHhCCCC
Q 012765          286 SDFGLAKWLPDNWSHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRA  345 (457)
Q Consensus       286 ~DFGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLltG~~p  345 (457)
                      +|||.+.-+.--.........++|-.+-.+|...|+.|+..+|.|.|+.+++-||.|+..
T Consensus       843 IDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~  902 (974)
T KOG1166|consen  843 IDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYM  902 (974)
T ss_pred             EecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHH
Confidence            999998665333223344556789999999999999999999999999999999999753

>PRK10345 hypothetical protein; Provisional

Probab=99.79  E-value=1.9e-18  Score=159.00  Aligned_cols=135  Identities=19%  Similarity=0.256  Sum_probs=101.6

Q ss_pred             CCCceecccCcEEEEEEEeCCCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhc-----CCCCcceeeeeeecCc----e
Q 012765          145 NSENLIGKGGHAEVYKGCLPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHI-----NHPNAAKLIGFSTENG----F  215 (457)
Q Consensus       145 ~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-----~hpniv~l~~~~~~~~----~  215 (457)
                      ....+||+|+||.||. .-.++.. +||++......   ....+.+|+.+++.+     +||||+++++++..+.    .
T Consensus         5 ~~~~~LG~G~~~~Vy~-hp~~~~k-~IKv~~~~~~~---~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v   79 (210)
T PRK10345          5 SEQSPLGTGRHRKCYA-HPEDAQR-CIKIVYHRGDG---GDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYV   79 (210)
T ss_pred             CCcceecCCCceEEEE-CCCCcCe-EEEEEeccccc---hHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEE
Confidence            3457899999999996 3334444 68887543222   245789999999999     6799999999766552    2


Q ss_pred             E-EEEEe--cCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHH-HHHHhcCCCCeeeCCCCCCcEEEcC----CCcEEEee
Q 012765          216 H-LVLQF--LPHGSLSSLLFGSTECLEWTIRYKIALGIAEGL-QYLHHDCHRRIIHRDIKASNILLSE----DYEAQISD  287 (457)
Q Consensus       216 ~-lv~e~--~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL-~yLH~~~~~~iiHrDlkp~NIll~~----~~~~kL~D  287 (457)
                      + +|+||  +.+++|.+++...  .+++.  ..++.+++.++ .|||+   .+|+||||||+|||++.    ++.++|+|
T Consensus        80 ~~~I~e~~G~~~~tL~~~l~~~--~~~e~--~~~~~~~L~~l~~yLh~---~~IvhrDlKp~NILl~~~~~~~~~~~LiD  152 (210)
T PRK10345         80 YDVIADFDGKPSITLTEFAEQC--RYEED--VAQLRQLLKKLKRYLLD---NRIVTMELKPQNILCQRISESEVIPVVCD  152 (210)
T ss_pred             EEEEecCCCCcchhHHHHHHcc--cccHh--HHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEeccCCCCCcEEEEE
Confidence            3 67999  5579999999542  35554  24577788777 99999   89999999999999974    34799999


Q ss_pred             cccc
Q 012765          288 FGLA  291 (457)
Q Consensus       288 FGl~  291 (457)
                      |+.+
T Consensus       153 g~G~  156 (210)
T PRK10345        153 NIGE  156 (210)
T ss_pred             CCCC
Confidence            5433

>smart00090 RIO RIO-like kinase

Probab=99.78  E-value=2.3e-18  Score=162.08  Aligned_cols=147  Identities=20%  Similarity=0.142  Sum_probs=111.7

Q ss_pred             cCCCCCceecccCcEEEEEEE--eCCCcEEEEEEEeccchhh--------------------H-HHHHHHHHHHHHHhhc
Q 012765          142 DNFNSENLIGKGGHAEVYKGC--LPDGEVVAVKKIIKNAKED--------------------E-ERISDFLSELGIVAHI  198 (457)
Q Consensus       142 ~~f~~~~~LG~G~~g~Vy~~~--~~~~~~vavK~~~~~~~~~--------------------~-~~~~~~~~E~~~l~~l  198 (457)
                      ..|.+.+.||+|+||.||+|.  ..+|+.||+|.+.......                    . .....+..|+..+.++
T Consensus        28 ~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L  107 (237)
T smart00090       28 ILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRL  107 (237)
T ss_pred             chHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHH
Confidence            347889999999999999998  5689999999886432110                    0 0112456899999999


Q ss_pred             CCCC--cceeeeeeecCceEEEEEecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC-eeeCCCCCCcE
Q 012765          199 NHPN--AAKLIGFSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRR-IIHRDIKASNI  275 (457)
Q Consensus       199 ~hpn--iv~l~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~-iiHrDlkp~NI  275 (457)
                      .+..  +.+++++   ...++||||+.+++|...+... ..........++.||+.+|.+||.   .+ ++||||||+||
T Consensus       108 ~~~~i~~p~~~~~---~~~~lV~E~~~g~~L~~~~~~~-~~~~~~~~~~i~~qi~~~l~~LH~---~g~iiH~Dikp~NI  180 (237)
T smart00090      108 YEAGVPVPKPIAW---RRNVLVMEFIGGDGLPAPRLKD-VEPEEEEEFELYDDILEEMRKLYK---EGELVHGDLSEYNI  180 (237)
T ss_pred             HhcCCCCCeeeEe---cCceEEEEEecCCccccccccc-CCcchHHHHHHHHHHHHHHHHHHh---cCCEEeCCCChhhE
Confidence            7533  4444443   3458999999998887654322 234555567899999999999999   78 99999999999


Q ss_pred             EEcCCCcEEEeeccccccCCC
Q 012765          276 LLSEDYEAQISDFGLAKWLPD  296 (457)
Q Consensus       276 ll~~~~~~kL~DFGl~~~~~~  296 (457)
                      +++ ++.++|+|||.+.....
T Consensus       181 li~-~~~i~LiDFg~a~~~~~  200 (237)
T smart00090      181 LVH-DGKVVIIDVSQSVELDH  200 (237)
T ss_pred             EEE-CCCEEEEEChhhhccCC
Confidence            999 88999999999875433

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.76  E-value=1e-17  Score=153.77  Aligned_cols=147  Identities=21%  Similarity=0.147  Sum_probs=111.6

Q ss_pred             HHHhhcCCCCCceecccCcEEEEEEEeCCCcEEEEEEEeccchhh-------------------HHHHHHHHHHHHHHhh
Q 012765          137 LAAATDNFNSENLIGKGGHAEVYKGCLPDGEVVAVKKIIKNAKED-------------------EERISDFLSELGIVAH  197 (457)
Q Consensus       137 ~~~~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~-------------------~~~~~~~~~E~~~l~~  197 (457)
                      +......|.+.+.||.|+||.||++...+|+.||||++.......                   ......+..|+.++..
T Consensus        10 ~~~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~   89 (198)
T cd05144          10 LVKRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKA   89 (198)
T ss_pred             HHHcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHH
Confidence            333334477889999999999999998889999999865432100                   0111236778889988


Q ss_pred             cCCCC--cceeeeeeecCceEEEEEecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcE
Q 012765          198 INHPN--AAKLIGFSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNI  275 (457)
Q Consensus       198 l~hpn--iv~l~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NI  275 (457)
                      +.|++  ++..++   ....+++|||+++++|......       .....++.+++.++.++|+   .+|+||||||.||
T Consensus        90 l~~~~i~v~~~~~---~~~~~lv~e~~~g~~L~~~~~~-------~~~~~~~~~i~~~l~~lh~---~gi~H~Dl~p~Ni  156 (198)
T cd05144          90 LYEEGFPVPKPID---WNRHAVVMEYIDGVELYRVRVL-------EDPEEVLDEILEEIVKAYK---HGIIHGDLSEFNI  156 (198)
T ss_pred             HHHcCCCCCceee---cCCceEEEEEeCCcchhhcccc-------ccHHHHHHHHHHHHHHHHH---CCCCcCCCCcccE
Confidence            88774  444443   3445899999999998765421       2345688899999999999   8999999999999


Q ss_pred             EEcCCCcEEEeeccccccCCC
Q 012765          276 LLSEDYEAQISDFGLAKWLPD  296 (457)
Q Consensus       276 ll~~~~~~kL~DFGl~~~~~~  296 (457)
                      ++++++.++|+|||++.....
T Consensus       157 ll~~~~~~~liDfg~~~~~~~  177 (198)
T cd05144         157 LVDDDEKIYIIDWPQMVSTDH  177 (198)
T ss_pred             EEcCCCcEEEEECCccccCCC
Confidence            999999999999999865543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.76  E-value=1.5e-17  Score=153.84  Aligned_cols=136  Identities=24%  Similarity=0.347  Sum_probs=109.9

Q ss_pred             ceecccCcEEEEEEEeCCCcEEEEEEEeccchh-----hHHHHHHHHHHHHHHhhcCCCCcceeeeee-ecCceEEEEEe
Q 012765          148 NLIGKGGHAEVYKGCLPDGEVVAVKKIIKNAKE-----DEERISDFLSELGIVAHINHPNAAKLIGFS-TENGFHLVLQF  221 (457)
Q Consensus       148 ~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-----~~~~~~~~~~E~~~l~~l~hpniv~l~~~~-~~~~~~lv~e~  221 (457)
                      +.||+|++|.||+|.. +|..+++|+.......     .......+.+|+.++..+.|+++.....++ .....+++|||
T Consensus         2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~   80 (211)
T PRK14879          2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY   80 (211)
T ss_pred             cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence            5799999999999987 7778999976533221     112234688899999999999887666543 45567899999


Q ss_pred             cCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeecccccc
Q 012765          222 LPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKW  293 (457)
Q Consensus       222 ~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~  293 (457)
                      +++++|.+++....    . .+..++.+++.+|.+||+   .+++|+|++|.|||++ ++.++|+|||++..
T Consensus        81 ~~G~~L~~~~~~~~----~-~~~~i~~~i~~~l~~lH~---~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~  143 (211)
T PRK14879         81 IEGEPLKDLINSNG----M-EELELSREIGRLVGKLHS---AGIIHGDLTTSNMILS-GGKIYLIDFGLAEF  143 (211)
T ss_pred             eCCcCHHHHHHhcc----H-HHHHHHHHHHHHHHHHHh---CCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence            99999999884322    2 677899999999999999   8999999999999999 78999999998764

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.75  E-value=1e-18  Score=184.88  Aligned_cols=211  Identities=24%  Similarity=0.313  Sum_probs=140.2

Q ss_pred             hhcCCCCCceecccCcEEEEEEEeC-CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeecCceEEE
Q 012765          140 ATDNFNSENLIGKGGHAEVYKGCLP-DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTENGFHLV  218 (457)
Q Consensus       140 ~~~~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~lv  218 (457)
                      ...+|..+++|..|+||.||...++ ..+.+|+| +.+..        -+++-  ++.....|.+|              
T Consensus        81 ~e~df~~IklisngAygavylvrh~~trqrfa~k-iNkq~--------lilRn--ilt~a~npfvv--------------  135 (1205)
T KOG0606|consen   81 SESDFNTIKLISNGAYGAVYLVRHKETRQRFAMK-INKQN--------LILRN--ILTFAGNPFVV--------------  135 (1205)
T ss_pred             CccccceeEeeccCCCCceeeeeccccccchhhc-ccccc--------hhhhc--cccccCCccee--------------
Confidence            4578999999999999999999875 46778884 33221        11111  22223334333              


Q ss_pred             EEecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCCCCC
Q 012765          219 LQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNW  298 (457)
Q Consensus       219 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~~~  298 (457)
                            |+-...+.. .+.++..        ++.+++|||+   .+|+|||+||+|.+++.-|.+|++|||+++......
T Consensus       136 ------gDc~tllk~-~g~lPvd--------mvla~Eylh~---ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~  197 (1205)
T KOG0606|consen  136 ------GDCATLLKN-IGPLPVD--------MVLAVEYLHS---YGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSL  197 (1205)
T ss_pred             ------chhhhhccc-CCCCcch--------hhHHhHhhcc---CCeecCCCCCCcceeeecccccccchhhhhhhhhhc
Confidence                  333444422 2223322        2679999999   899999999999999999999999999986532111


Q ss_pred             ------------Ccee-eecccccccccChhccccCCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhccccc-cC
Q 012765          299 ------------SHHI-VFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQ-TS  364 (457)
Q Consensus       299 ------------~~~~-~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~~~~~-~~  364 (457)
                                  ++.. -...+||+.|+|||++....|+..+|+|++|+|+||.+-|..||.+.......  ..+.. ..
T Consensus       198 atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelf--g~visd~i  275 (1205)
T KOG0606|consen  198 ATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELF--GQVISDDI  275 (1205)
T ss_pred             cchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHH--hhhhhhhc
Confidence                        1111 12357999999999999999999999999999999999999999875322110  00000 00


Q ss_pred             CcccccCchhhcccCHHHHHHHHHHHHHhcccCCCCCCCH
Q 012765          365 NFKELVDPRLADAYDLAEMKRAMLTASVCIHHLSTMRPQM  404 (457)
Q Consensus       365 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~  404 (457)
                      ...+-         +.....++..++.+.|+.+|..|--.
T Consensus       276 ~wpE~---------dea~p~Ea~dli~~LL~qnp~~Rlgt  306 (1205)
T KOG0606|consen  276 EWPEE---------DEALPPEAQDLIEQLLRQNPLCRLGT  306 (1205)
T ss_pred             ccccc---------CcCCCHHHHHHHHHHHHhChHhhccc
Confidence            00111         11222345567777899999998643

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.74  E-value=3.5e-19  Score=176.80  Aligned_cols=172  Identities=24%  Similarity=0.354  Sum_probs=127.0

Q ss_pred             eEEEEEecCCCChhhhhhc--CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccc
Q 012765          215 FHLVLQFLPHGSLSSLLFG--STECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAK  292 (457)
Q Consensus       215 ~~lv~e~~~~gsL~~~l~~--~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~  292 (457)
                      +++.|+++...+|.++|..  .....++...+.++.|++.|+.|      ++.+|+|+||.||++..+..+||.|||+..
T Consensus       331 lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y------k~~ihrdlkp~nif~~~d~q~kIgDFgl~t  404 (516)
T KOG1033|consen  331 LYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY------KGLIHRDLKPSNIFFSDDDQLKIGDFGLVT  404 (516)
T ss_pred             hhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh------ccchhhhccccccccccchhhhhhhhhhee
Confidence            5688999999999999954  34457888889999999999999      589999999999999999999999999998


Q ss_pred             cCCCCC----CceeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHh-CCCCCCcCCcchhhhhccccccCCcc
Q 012765          293 WLPDNW----SHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELIT-GRRAVDSRRQSLVIWAKPLLQTSNFK  367 (457)
Q Consensus       293 ~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLlt-G~~pf~~~~~~~~~~~~~~~~~~~~~  367 (457)
                      ......    .....+...||..||+||++.+..|+.|+||||||+||+||+. =..+|+.      .-+...+.++   
T Consensus       405 s~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er------~~t~~d~r~g---  475 (516)
T KOG1033|consen  405 SQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFER------IATLTDIRDG---  475 (516)
T ss_pred             ecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHH------HHhhhhhhcC---
Confidence            876544    1122344569999999999999999999999999999999998 2333321      0011111111   


Q ss_pred             cccCchhhcccCHHHHHHHHHHHHHhcccCCCCCCCHHHH
Q 012765          368 ELVDPRLADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRV  407 (457)
Q Consensus       368 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev  407 (457)
                       +++|....++..     -..++.+++...|.+||++.++
T Consensus       476 -~ip~~~~~d~p~-----e~~ll~~lls~~p~~RP~~~~~  509 (516)
T KOG1033|consen  476 -IIPPEFLQDYPE-----EYTLLQQLLSPSPEERPSAIEV  509 (516)
T ss_pred             -CCChHHhhcCcH-----HHHHHHHhcCCCcccCchHHHH
Confidence             222222222221     1245677999999999955443

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.74  E-value=2.6e-17  Score=150.95  Aligned_cols=133  Identities=21%  Similarity=0.335  Sum_probs=104.7

Q ss_pred             eecccCcEEEEEEEeCCCcEEEEEEEeccchh-----hHHHHHHHHHHHHHHhhcCCCCcceeee-eeecCceEEEEEec
Q 012765          149 LIGKGGHAEVYKGCLPDGEVVAVKKIIKNAKE-----DEERISDFLSELGIVAHINHPNAAKLIG-FSTENGFHLVLQFL  222 (457)
Q Consensus       149 ~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-----~~~~~~~~~~E~~~l~~l~hpniv~l~~-~~~~~~~~lv~e~~  222 (457)
                      +||+|+||.||+|.+ ++..+++|........     .......+.+|+.++..+.|+++..... +......+++|||+
T Consensus         1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~   79 (199)
T TIGR03724         1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI   79 (199)
T ss_pred             CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence            489999999999985 6788999986543211     1122467789999999999887544433 33445568999999


Q ss_pred             CCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccC
Q 012765          223 PHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWL  294 (457)
Q Consensus       223 ~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~  294 (457)
                      ++++|.+.+.....        .++.+++.+|.+||+   .+++|+|++|.||+++ ++.++++|||++...
T Consensus        80 ~g~~l~~~~~~~~~--------~~~~~i~~~l~~lH~---~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~~  139 (199)
T TIGR03724        80 EGKPLKDVIEEGND--------ELLREIGRLVGKLHK---AGIVHGDLTTSNIIVR-DDKLYLIDFGLGKYS  139 (199)
T ss_pred             CCccHHHHHhhcHH--------HHHHHHHHHHHHHHH---CCeecCCCCcceEEEE-CCcEEEEECCCCcCC
Confidence            99999988743211        688999999999999   8999999999999999 789999999988653

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.72  E-value=6.1e-17  Score=170.57  Aligned_cols=139  Identities=21%  Similarity=0.343  Sum_probs=109.3

Q ss_pred             hcCCCCCceecccCcEEEEEEEeCCCcEEEEEEEe-ccch----hhHHHHHHHHHHHHHHhhcCCCCcceeeeeee-cCc
Q 012765          141 TDNFNSENLIGKGGHAEVYKGCLPDGEVVAVKKII-KNAK----EDEERISDFLSELGIVAHINHPNAAKLIGFST-ENG  214 (457)
Q Consensus       141 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~-~~~~----~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~-~~~  214 (457)
                      ...|...+.||+|+||+||+|.+... .+++|+.. +...    ........+.+|+.++..++|++++..+.++. ...
T Consensus       332 ~~~~~~~~~iG~G~~g~Vy~~~~~~~-~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~  410 (535)
T PRK09605        332 KRRKIPDHLIGKGAEADIKKGEYLGR-DAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEE  410 (535)
T ss_pred             ccccCccceeccCCcEEEEEEeecCc-cceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCC
Confidence            44556788999999999999987544 44444332 2111    11123457889999999999999988766544 345


Q ss_pred             eEEEEEecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeecccccc
Q 012765          215 FHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKW  293 (457)
Q Consensus       215 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~  293 (457)
                      .++||||+++++|.+++.         ....++.+++.+|.|||+   .+++||||||+|||+ .++.++|+|||+++.
T Consensus       411 ~~lv~E~~~g~~L~~~l~---------~~~~~~~~i~~~L~~lH~---~giiHrDlkp~NILl-~~~~~~liDFGla~~  476 (535)
T PRK09605        411 KTIVMEYIGGKDLKDVLE---------GNPELVRKVGEIVAKLHK---AGIVHGDLTTSNFIV-RDDRLYLIDFGLGKY  476 (535)
T ss_pred             CEEEEEecCCCcHHHHHH---------HHHHHHHHHHHHHHHHHh---CCCccCCCChHHEEE-ECCcEEEEeCccccc
Confidence            689999999999998874         346789999999999999   899999999999999 677999999999864

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.71  E-value=7.7e-17  Score=154.47  Aligned_cols=194  Identities=22%  Similarity=0.269  Sum_probs=127.5

Q ss_pred             CCCCcceeeeeeec----------------------------CceEEEEEecCCCChhhhhhcCCCCCCHHHHHHHHHHH
Q 012765          199 NHPNAAKLIGFSTE----------------------------NGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGI  250 (457)
Q Consensus       199 ~hpniv~l~~~~~~----------------------------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi  250 (457)
                      .|||||++.+++.+                            ..+|+||..++ .+|..++....  .+.....-|+.|+
T Consensus       274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~-~tLr~yl~~~~--~s~r~~~~~laQl  350 (598)
T KOG4158|consen  274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYR-QTLREYLWTRH--RSYRTGRVILAQL  350 (598)
T ss_pred             CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcch-hhHHHHHhcCC--CchHHHHHHHHHH
Confidence            59999999874321                            12567775553 36777774322  3334445578899


Q ss_pred             HHHHHHHHhcCCCCeeeCCCCCCcEEEc--CCC--cEEEeeccccccCCC-----CCCceeeecccccccccChhccccC
Q 012765          251 AEGLQYLHHDCHRRIIHRDIKASNILLS--EDY--EAQISDFGLAKWLPD-----NWSHHIVFPIEGTFGYLSPEYFMHG  321 (457)
Q Consensus       251 a~aL~yLH~~~~~~iiHrDlkp~NIll~--~~~--~~kL~DFGl~~~~~~-----~~~~~~~~~~~gt~~y~aPE~~~~~  321 (457)
                      ++|+.|||.   ++|.|||+|++|||+.  +|+  ...|+|||++-.-.+     +.... .....|....||||+....
T Consensus       351 LEav~hL~~---hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~-~Vd~GGNa~lmAPEi~ta~  426 (598)
T KOG4158|consen  351 LEAVTHLHK---HGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESD-EVDLGGNAKLMAPEIATAV  426 (598)
T ss_pred             HHHHHHHHH---ccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccc-cccCCCcceecchhhhhcC
Confidence            999999999   8999999999999994  333  478999998743221     01111 1123477889999987532


Q ss_pred             --C----CCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhccccccCCcccccCchhhcccCHHHHHHHHHHHHHhcc
Q 012765          322 --I----VDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSNFKELVDPRLADAYDLAEMKRAMLTASVCIH  395 (457)
Q Consensus       322 --~----~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~  395 (457)
                        +    --.|+|.|+.|.+.||+++...||.+..+..       +...++.+---|.+.....+    .+.+++...|+
T Consensus       427 PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~-------L~~r~Yqe~qLPalp~~vpp----~~rqlV~~lL~  495 (598)
T KOG4158|consen  427 PGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEML-------LDTRTYQESQLPALPSRVPP----VARQLVFDLLK  495 (598)
T ss_pred             CCCceeeccchhhhhhhhhhHHHHhccCCcccccchhe-------echhhhhhhhCCCCcccCCh----HHHHHHHHHhc
Confidence              1    1258999999999999999999998744322       11222222222333333222    34456777899


Q ss_pred             cCCCCCCCHHHHHHH
Q 012765          396 HLSTMRPQMTRVLQL  410 (457)
Q Consensus       396 ~dP~~RPt~~evl~~  410 (457)
                      .||++||+..-....
T Consensus       496 r~pskRvsp~iAANv  510 (598)
T KOG4158|consen  496 RDPSKRVSPNIAANV  510 (598)
T ss_pred             CCccccCCccHHHhH
Confidence            999999997644443

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.69  E-value=2.9e-16  Score=142.42  Aligned_cols=142  Identities=24%  Similarity=0.235  Sum_probs=99.0

Q ss_pred             CceecccCcEEEEEEEeCCCcEEEEEEEeccchhhHHHHH---------------------HHHHHHHHHhhcCCCC--c
Q 012765          147 ENLIGKGGHAEVYKGCLPDGEVVAVKKIIKNAKEDEERIS---------------------DFLSELGIVAHINHPN--A  203 (457)
Q Consensus       147 ~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~---------------------~~~~E~~~l~~l~hpn--i  203 (457)
                      .+.||+|+||+||+|.+.+++.||||.+............                     ....|...+..+.+..  +
T Consensus         2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~   81 (187)
T cd05119           2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV   81 (187)
T ss_pred             CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence            4679999999999999878999999987653322111111                     1134566666654432  4


Q ss_pred             ceeeeeeecCceEEEEEecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcE
Q 012765          204 AKLIGFSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEA  283 (457)
Q Consensus       204 v~l~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~  283 (457)
                      .+++++   ...+++|||++++.+......... .. .....++.+++.++.++|..  .+|+|+||||+||+++ ++.+
T Consensus        82 ~~~~~~---~~~~lv~e~~~g~~~~~~~l~~~~-~~-~~~~~~~~~~~~~l~~lh~~--~~ivH~Dl~p~Nili~-~~~~  153 (187)
T cd05119          82 PKPIDL---NRHVLVMEFIGGDGIPAPRLKDVR-LL-EDPEELYDQILELMRKLYRE--AGLVHGDLSEYNILVD-DGKV  153 (187)
T ss_pred             CceEec---CCCEEEEEEeCCCCccChhhhhhh-hc-ccHHHHHHHHHHHHHHHhhc--cCcCcCCCChhhEEEE-CCcE
Confidence            444443   345899999999654322111100 11 45678899999999999983  6899999999999999 8899


Q ss_pred             EEeeccccccCCC
Q 012765          284 QISDFGLAKWLPD  296 (457)
Q Consensus       284 kL~DFGl~~~~~~  296 (457)
                      +|+|||.+.....
T Consensus       154 ~liDfg~a~~~~~  166 (187)
T cd05119         154 YIIDVPQAVEIDH  166 (187)
T ss_pred             EEEECcccccccC
Confidence            9999999865533

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.62  E-value=4.6e-17  Score=171.63  Aligned_cols=254  Identities=22%  Similarity=0.224  Sum_probs=183.1

Q ss_pred             cCCCCCceecccCcEEEEEEEeC--CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcC-CCCcceeeeeeecCce-EE
Q 012765          142 DNFNSENLIGKGGHAEVYKGCLP--DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHIN-HPNAAKLIGFSTENGF-HL  217 (457)
Q Consensus       142 ~~f~~~~~LG~G~~g~Vy~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~~-~l  217 (457)
                      ..|.+...||+|+|+.|-.....  ....+|+|.+.... ...........|..+-..+. |+|++.+++...+... ++
T Consensus        20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~-~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~   98 (601)
T KOG0590|consen   20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPP-KSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLL   98 (601)
T ss_pred             ccccccccccccccchhhhhhhcCCCcceeeccCCCCCC-CccchhhhcCccccccccccccccccccCCccCCCccccc
Confidence            34556677999999999887653  34456666554332 23344556667888888887 9999999997766664 57


Q ss_pred             EEEecCCCChhhhh-hcCCCCCCHHHHHHHHHHHHHHHHHHH-hcCCCCeeeCCCCCCcEEEcCCC-cEEEeeccccccC
Q 012765          218 VLQFLPHGSLSSLL-FGSTECLEWTIRYKIALGIAEGLQYLH-HDCHRRIIHRDIKASNILLSEDY-EAQISDFGLAKWL  294 (457)
Q Consensus       218 v~e~~~~gsL~~~l-~~~~~~~~~~~~~~i~~qia~aL~yLH-~~~~~~iiHrDlkp~NIll~~~~-~~kL~DFGl~~~~  294 (457)
                      ..++..++++...+ .......+....-..+.|+..++.|+| .   .++.|+||||+|.+++..+ ..++.|||++...
T Consensus        99 ~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~---~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~  175 (601)
T KOG0590|consen   99 SLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPE---NGVTHRDIKPSNSLLDESGSALKIADFGLATAY  175 (601)
T ss_pred             ccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcc---cccccCCCCCccchhccCCCcccCCCchhhccc
Confidence            78999999999888 443323444555568899999999999 6   8999999999999999999 9999999999988


Q ss_pred             CC-CCCceeeecccc-cccccChhccccC-CCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhccccccCCcccccC
Q 012765          295 PD-NWSHHIVFPIEG-TFGYLSPEYFMHG-IVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSNFKELVD  371 (457)
Q Consensus       295 ~~-~~~~~~~~~~~g-t~~y~aPE~~~~~-~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d  371 (457)
                      .. ..........+| ++.|+|||...+. ...+..|+||.|+++.-+++|..|+.........          ...+..
T Consensus       176 ~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~----------~~~~~~  245 (601)
T KOG0590|consen  176 RNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGR----------YSSWKS  245 (601)
T ss_pred             cccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccccccc----------ceeecc
Confidence            77 555555666778 9999999998874 5577899999999999999999998753332211          111111


Q ss_pred             chhh--cccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 012765          372 PRLA--DAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQ  409 (457)
Q Consensus       372 ~~l~--~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~  409 (457)
                      ....  .............+...++..+|..|.+.+++-.
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~  285 (601)
T KOG0590|consen  246 NKGRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKL  285 (601)
T ss_pred             cccccccCccccCChhhhhcccccccCCchhccccccccc
Confidence            1100  0001111223445556678889999999887643

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.62  E-value=6.9e-15  Score=127.38  Aligned_cols=134  Identities=22%  Similarity=0.197  Sum_probs=108.1

Q ss_pred             CCceecccCcEEEEEEEeCCCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCC--CCcceeeeeeec-CceEEEEEec
Q 012765          146 SENLIGKGGHAEVYKGCLPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINH--PNAAKLIGFSTE-NGFHLVLQFL  222 (457)
Q Consensus       146 ~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h--pniv~l~~~~~~-~~~~lv~e~~  222 (457)
                      +.+.||.|.++.||++...+ ..+++|.......     ...+.+|+.++..+.|  .++++++++... +..+++|||+
T Consensus         2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~-----~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~   75 (155)
T cd05120           2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK-----GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWI   75 (155)
T ss_pred             cceecccccccceEEEEecC-CeEEEEecCCCCc-----hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEec
Confidence            45789999999999998744 7899998754332     3467889999999976  588888886554 4568999999


Q ss_pred             CCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeecccccc
Q 012765          223 PHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKW  293 (457)
Q Consensus       223 ~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~  293 (457)
                      .++.+..+        +......++.+++++|.+||.....+++|+|++|.||+++..+.++++|||.+..
T Consensus        76 ~g~~~~~~--------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~  138 (155)
T cd05120          76 EGETLDEV--------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY  138 (155)
T ss_pred             CCeecccC--------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence            88877544        4556667889999999999984334799999999999999989999999998763

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.62  E-value=6.4e-15  Score=138.92  Aligned_cols=136  Identities=17%  Similarity=0.210  Sum_probs=103.0

Q ss_pred             ceec-ccCcEEEEEEEeCCCcEEEEEEEeccch----------hhHHHHHHHHHHHHHHhhcCCCCc--ceeeeeeec-C
Q 012765          148 NLIG-KGGHAEVYKGCLPDGEVVAVKKIIKNAK----------EDEERISDFLSELGIVAHINHPNA--AKLIGFSTE-N  213 (457)
Q Consensus       148 ~~LG-~G~~g~Vy~~~~~~~~~vavK~~~~~~~----------~~~~~~~~~~~E~~~l~~l~hpni--v~l~~~~~~-~  213 (457)
                      .+|| .||.|+||.+.. ++..++||+......          ........+.+|+.++..++|+++  ++.+++... .
T Consensus        37 ~~lg~~~g~gtv~~v~~-~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~  115 (239)
T PRK01723         37 RVVGSAKGRGTTWFVQT-PGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRH  115 (239)
T ss_pred             ceeecCCCCccEEEEEe-CCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeec
Confidence            5687 899999999877 477889997754211          011223568889999999998875  667765332 2


Q ss_pred             c----eEEEEEecCC-CChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeec
Q 012765          214 G----FHLVLQFLPH-GSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDF  288 (457)
Q Consensus       214 ~----~~lv~e~~~~-gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DF  288 (457)
                      .    .++|||++++ .+|..++..  ..++..    .+.+|+.+|.+||+   .+|+||||||.|||++.++.++|+||
T Consensus       116 ~~~~~~~lV~e~l~G~~~L~~~l~~--~~l~~~----~~~~i~~~l~~lH~---~GI~HrDlkp~NILv~~~~~v~LIDf  186 (239)
T PRK01723        116 GLFYRADILIERIEGARDLVALLQE--APLSEE----QWQAIGQLIARFHD---AGVYHADLNAHNILLDPDGKFWLIDF  186 (239)
T ss_pred             CcceeeeEEEEecCCCCCHHHHHhc--CCCCHH----HHHHHHHHHHHHHH---CCCCCCCCCchhEEEcCCCCEEEEEC
Confidence            2    2499999997 688888743  234433    35689999999999   89999999999999999899999999


Q ss_pred             ccccc
Q 012765          289 GLAKW  293 (457)
Q Consensus       289 Gl~~~  293 (457)
                      |.+..
T Consensus       187 g~~~~  191 (239)
T PRK01723        187 DRGEL  191 (239)
T ss_pred             CCccc
Confidence            98764

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.48  E-value=3e-13  Score=138.40  Aligned_cols=144  Identities=21%  Similarity=0.240  Sum_probs=99.6

Q ss_pred             CceecccCcEEEEEEEeCCCcEEEEEEEeccchhhHH-------------------------------------HHHHHH
Q 012765          147 ENLIGKGGHAEVYKGCLPDGEVVAVKKIIKNAKEDEE-------------------------------------RISDFL  189 (457)
Q Consensus       147 ~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~-------------------------------------~~~~~~  189 (457)
                      .+.||.|++|+||+|.+.+|+.||||+........-.                                     ...+|.
T Consensus       122 ~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~  201 (437)
T TIGR01982       122 EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR  201 (437)
T ss_pred             CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence            4689999999999999999999999987654321100                                     001344


Q ss_pred             HHHHHHhhcC----CCCcceeeeee--ecCceEEEEEecCCCChhhhhhcCCCCCCHHHHHHHHHHHHH-HHHHHHhcCC
Q 012765          190 SELGIVAHIN----HPNAAKLIGFS--TENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAE-GLQYLHHDCH  262 (457)
Q Consensus       190 ~E~~~l~~l~----hpniv~l~~~~--~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~-aL~yLH~~~~  262 (457)
                      +|...+.++.    |.+-+.+-.++  .....+++|||++|++|.+.........+   +..++..++. .+..+|.   
T Consensus       202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~~---~~~ia~~~~~~~l~ql~~---  275 (437)
T TIGR01982       202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGLD---RKALAENLARSFLNQVLR---  275 (437)
T ss_pred             HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcCCC---HHHHHHHHHHHHHHHHHh---
Confidence            5555555542    32223322221  23446899999999999887643222222   3346666665 4778888   


Q ss_pred             CCeeeCCCCCCcEEEcCCCcEEEeeccccccCCC
Q 012765          263 RRIIHRDIKASNILLSEDYEAQISDFGLAKWLPD  296 (457)
Q Consensus       263 ~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~  296 (457)
                      .+++|+|++|.||+++.++.++|+|||++..+..
T Consensus       276 ~g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~  309 (437)
T TIGR01982       276 DGFFHADLHPGNIFVLKDGKIIALDFGIVGRLSE  309 (437)
T ss_pred             CCceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence            8999999999999999999999999999876643

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.44  E-value=2.5e-13  Score=127.84  Aligned_cols=201  Identities=17%  Similarity=0.213  Sum_probs=133.2

Q ss_pred             HHHHhhcCCCCcceeeeeeecCce------EEEEEecCCCChhhhhhc---CCCCCCHHHHHHHHHHHHHHHHHHHhcCC
Q 012765          192 LGIVAHINHPNAAKLIGFSTENGF------HLVLQFLPHGSLSSLLFG---STECLEWTIRYKIALGIAEGLQYLHHDCH  262 (457)
Q Consensus       192 ~~~l~~l~hpniv~l~~~~~~~~~------~lv~e~~~~gsL~~~l~~---~~~~~~~~~~~~i~~qia~aL~yLH~~~~  262 (457)
                      +.-|-.+-|.|||+++.|+.+..+      .++.||+..|++..+|+.   ....+......+++.||+.||.|||+ |.
T Consensus       118 FdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs-~~  196 (458)
T KOG1266|consen  118 FDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHS-CD  196 (458)
T ss_pred             HHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhc-cC
Confidence            344556779999999998876543      588899999999999965   23346666667899999999999998 66


Q ss_pred             CCeeeCCCCCCcEEEcCCCcEEEeeccccccCCCC---CCceeeecccccccccChhccccCCCCcchhHHHHHHHHHHH
Q 012765          263 RRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDN---WSHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLEL  339 (457)
Q Consensus       263 ~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~~---~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eL  339 (457)
                      ..|+|+++..+-|++..+|-+|+.- +.-......   ..........+-++|.|||+=..-..+..+|||+||+..+||
T Consensus       197 PpiihgnlTc~tifiq~ngLIkig~-~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlem  275 (458)
T KOG1266|consen  197 PPIIHGNLTCDTIFIQHNGLIKIGS-VAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEM  275 (458)
T ss_pred             CccccCCcchhheeecCCceEEecc-cCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHH
Confidence            8999999999999999999888742 111111000   000011112367889999986666677889999999999999


Q ss_pred             HhCCCCCCcCCcchhhhhccccccCCcccccCchhhcccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 012765          340 ITGRRAVDSRRQSLVIWAKPLLQTSNFKELVDPRLADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQ  409 (457)
Q Consensus       340 ltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~  409 (457)
                      ..+..-..........   ..-....+.-+-++.-+            ..+..|++-.|..||+|.+++.
T Consensus       276 ailEiq~tnseS~~~~---ee~ia~~i~~len~lqr------------~~i~kcl~~eP~~rp~ar~llf  330 (458)
T KOG1266|consen  276 AILEIQSTNSESKVEV---EENIANVIIGLENGLQR------------GSITKCLEGEPNGRPDARLLLF  330 (458)
T ss_pred             HHheeccCCCcceeeh---hhhhhhheeeccCcccc------------CcCcccccCCCCCCcchhhhhc
Confidence            9876432211110000   00000000111111111            2344599999999999998765

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.44  E-value=1.5e-13  Score=139.29  Aligned_cols=257  Identities=20%  Similarity=0.226  Sum_probs=180.7

Q ss_pred             hcCCCCCceecc--cCcEEEEEEEe---CCCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcC-CCCcceeeeeeecCc
Q 012765          141 TDNFNSENLIGK--GGHAEVYKGCL---PDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHIN-HPNAAKLIGFSTENG  214 (457)
Q Consensus       141 ~~~f~~~~~LG~--G~~g~Vy~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~  214 (457)
                      ...|.+...+|.  |.+|.||.+..   .++..+|+|+-......... -..-.+|+...+.++ |+|.++.+..+.+.+
T Consensus       113 ~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~-~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~  191 (524)
T KOG0601|consen  113 DQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLD-SKRKLREFLSHHKIDSHENPVRDSPAWEGSG  191 (524)
T ss_pred             hhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccc-cccccchhhcccccCccccccccCcccccCC
Confidence            345667788999  99999999864   46888999974333221111 112345665556664 999999888777777


Q ss_pred             eEEEEEecCCCChhhhhhcCCCCCCHHHHHHHHHHHHH----HHHHHHhcCCCCeeeCCCCCCcEEEcCC-CcEEEeecc
Q 012765          215 FHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAE----GLQYLHHDCHRRIIHRDIKASNILLSED-YEAQISDFG  289 (457)
Q Consensus       215 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~----aL~yLH~~~~~~iiHrDlkp~NIll~~~-~~~kL~DFG  289 (457)
                      ..+++..+++.+|..+.+.....++....+.++.+...    ||.++|+   .+++|-|+||.||++..+ ...+++|||
T Consensus       192 ~lfiqtE~~~~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs---~~~~~~~~kp~~i~~~~~~~s~~~~df~  268 (524)
T KOG0601|consen  192 ILFIQTELCGESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHS---NNIVHDDLKPANIFTTSDWTSCKLTDFG  268 (524)
T ss_pred             cceeeeccccchhHHhhhcccccCCchhhhhHHhhhhhcccccccccCC---CcccccccchhheecccccceeecCCcc
Confidence            66666556678888888777677888888888888888    9999999   899999999999999999 789999999


Q ss_pred             ccccCCCCCCcee---eecccccccccChhccccCCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhccccccCCc
Q 012765          290 LAKWLPDNWSHHI---VFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSNF  366 (457)
Q Consensus       290 l~~~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~~~~~~~~~  366 (457)
                      +...+.+......   .....|..-|++||.. .+-++...|+|+||.++++..+|...+.....  ..|..    ... 
T Consensus       269 ~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~-~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~--~~W~~----~r~-  340 (524)
T KOG0601|consen  269 LVSKISDGNFSSVFKVSKRPEGDCIYAAKELL-NGLATFASDIFSLGEVILEAILGSHLPSVGKN--SSWSQ----LRQ-  340 (524)
T ss_pred             eeEEccCCccccceeeeecCCCCceEeChhhh-ccccchHhhhcchhhhhHhhHhhcccccCCCC--CCccc----ccc-
Confidence            9998876542222   1223577889999976 56678999999999999999999877654210  11111    000 


Q ss_pred             ccccCchhhcccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCC
Q 012765          367 KELVDPRLADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQLLRGEG  415 (457)
Q Consensus       367 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~  415 (457)
                      ..+-+     .+.......+...+.+++..+|-.|++...+.. |.-+.
T Consensus       341 ~~ip~-----e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~-l~~i~  383 (524)
T KOG0601|consen  341 GYIPL-----EFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTA-LNVIH  383 (524)
T ss_pred             ccCch-----hhhcCcchhhhhHHHHhcCcchhhhhHHHHHhc-ccccc
Confidence            00111     111111122333677799999999998877655 54444

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.36  E-value=3e-12  Score=113.90  Aligned_cols=130  Identities=18%  Similarity=0.098  Sum_probs=93.4

Q ss_pred             CceecccCcEEEEEEEeCCCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcc-eeeeeeecCceEEEEEecCCC
Q 012765          147 ENLIGKGGHAEVYKGCLPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAA-KLIGFSTENGFHLVLQFLPHG  225 (457)
Q Consensus       147 ~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv-~l~~~~~~~~~~lv~e~~~~g  225 (457)
                      .+.|+.|.++.||++.. .+..|++|.......    ....+..|+.++..+.+.+++ +++.+. ....++||||+++.
T Consensus         3 ~~~l~~G~~~~vy~~~~-~~~~~~lK~~~~~~~----~~~~~~~E~~~l~~l~~~~~~P~~~~~~-~~~~~lv~e~i~G~   76 (170)
T cd05151           3 ISPLKGGMTNKNYRVEV-ANKKYVVRIPGNGTE----LLINRENEAENSKLAAEAGIGPKLYYFD-PETGVLITEFIEGS   76 (170)
T ss_pred             eeecCCcccCceEEEEE-CCeEEEEEeCCCCcc----cccCHHHHHHHHHHHHHhCCCCceEEEe-CCCCeEEEEecCCC
Confidence            35789999999999986 477899997644321    122456788888888655544 444443 33457999999998


Q ss_pred             ChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcC--CCCeeeCCCCCCcEEEcCCCcEEEeeccccc
Q 012765          226 SLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDC--HRRIIHRDIKASNILLSEDYEAQISDFGLAK  292 (457)
Q Consensus       226 sL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~--~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~  292 (457)
                      ++....      .   ....++.+++.+|..||...  ...++|+|++|.||+++ ++.++++|||.+.
T Consensus        77 ~l~~~~------~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~  135 (170)
T cd05151          77 ELLTED------F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG  135 (170)
T ss_pred             cccccc------c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence            875431      0   11235678999999999831  12259999999999999 6689999999775

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.36  E-value=3.9e-12  Score=132.02  Aligned_cols=149  Identities=18%  Similarity=0.161  Sum_probs=92.4

Q ss_pred             hcCCCCCceecccCcEEEEEEEeCC-CcEEEEEEEeccchhh---------------------------H----HHHH--
Q 012765          141 TDNFNSENLIGKGGHAEVYKGCLPD-GEVVAVKKIIKNAKED---------------------------E----ERIS--  186 (457)
Q Consensus       141 ~~~f~~~~~LG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~---------------------------~----~~~~--  186 (457)
                      -.+|.. +.||+|++|+||+|.+.+ |+.||||+..++....                           .    +...  
T Consensus       119 F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l  197 (537)
T PRK04750        119 FDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTL  197 (537)
T ss_pred             HHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHH
Confidence            345665 789999999999999877 9999999986542110                           0    1111  


Q ss_pred             ----HHHHHHHHHhhcC----CCCcceeeeee--ecCceEEEEEecCCCChhhhhhcCCCCCCHHHHHHHHHHHHH-HHH
Q 012765          187 ----DFLSELGIVAHIN----HPNAAKLIGFS--TENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAE-GLQ  255 (457)
Q Consensus       187 ----~~~~E~~~l~~l~----hpniv~l~~~~--~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~-aL~  255 (457)
                          ++.+|+..+.++.    +.+.+.+-.++  .....++||||+.|+.+.+.-.-.....+...   ++...+. -+.
T Consensus       198 ~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~---la~~~v~~~~~  274 (537)
T PRK04750        198 HDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKL---LAERGVEVFFT  274 (537)
T ss_pred             HHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHH---HHHHHHHHHHH
Confidence                2334444443332    33333322222  13345799999999999764211111122111   2222111 122


Q ss_pred             HHHhcCCCCeeeCCCCCCcEEEcCCC----cEEEeeccccccCCC
Q 012765          256 YLHHDCHRRIIHRDIKASNILLSEDY----EAQISDFGLAKWLPD  296 (457)
Q Consensus       256 yLH~~~~~~iiHrDlkp~NIll~~~~----~~kL~DFGl~~~~~~  296 (457)
                      .+..   .+++|+|++|.||+++.++    .++++|||++..+..
T Consensus       275 Qif~---~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~  316 (537)
T PRK04750        275 QVFR---DGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK  316 (537)
T ss_pred             HHHh---CCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence            3334   6999999999999999888    999999999987754

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.27  E-value=4.2e-12  Score=128.89  Aligned_cols=247  Identities=23%  Similarity=0.227  Sum_probs=170.7

Q ss_pred             hhcCCCCCceecccCcEEEEEEEe--CCCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhc-CCCCcceeee-eeecCce
Q 012765          140 ATDNFNSENLIGKGGHAEVYKGCL--PDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHI-NHPNAAKLIG-FSTENGF  215 (457)
Q Consensus       140 ~~~~f~~~~~LG~G~~g~Vy~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~-~~~~~~~  215 (457)
                      ...+|..+..||.|.|+.|++...  .++..|++|.+.+......+.+ .-+.|+.+...+ .|.+++.++. |....+.
T Consensus       263 ~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di-~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~  341 (524)
T KOG0601|consen  263 KLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDI-FSLGEVILEAILGSHLPSVGKNSSWSQLRQG  341 (524)
T ss_pred             ecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhh-cchhhhhHhhHhhcccccCCCCCCccccccc
Confidence            456788889999999999999764  3678899998876655443332 234456555555 4888888875 7777777


Q ss_pred             EEEEEecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCC-CcEEEeeccccccC
Q 012765          216 HLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSED-YEAQISDFGLAKWL  294 (457)
Q Consensus       216 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~-~~~kL~DFGl~~~~  294 (457)
                      ++--||+.++++...+ .....+....++.+..|++.++.++|+   ..++|+|+||+||++..+ +.-++.|||++..+
T Consensus       342 ~ip~e~~~~~s~~l~~-~~~~~~d~~~~~~~~~q~~~~l~~i~s---~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~  417 (524)
T KOG0601|consen  342 YIPLEFCEGGSSSLRS-VTSQMLDEDPRLRLTAQILTALNVIHS---KLFVHLDVKPSNILISNDGFFSKLGDFGCWTRL  417 (524)
T ss_pred             cCchhhhcCcchhhhh-HHHHhcCcchhhhhHHHHHhccccccc---hhhhcccccccceeeccchhhhhcccccccccc
Confidence            7778999999877665 223346667778899999999999999   899999999999999886 78899999998653


Q ss_pred             CCCCCceeeecccccccc-cChhccccCCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhccccccCCcccccCch
Q 012765          295 PDNWSHHIVFPIEGTFGY-LSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSNFKELVDPR  373 (457)
Q Consensus       295 ~~~~~~~~~~~~~gt~~y-~aPE~~~~~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~  373 (457)
                      .-.    .......+..| .+|.......+..+.|+||||.-+.+.++|...-....+...+....           -+.
T Consensus       418 ~~~----~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~~~~i~~~~-----------~p~  482 (524)
T KOG0601|consen  418 AFS----SGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQSLTIRSGD-----------TPN  482 (524)
T ss_pred             cee----cccccccccccccchhhccccccccccccccccccccccccCcccCcccccceeeeccc-----------ccC
Confidence            221    11111123334 35555556778899999999999999999876544433222111110           111


Q ss_pred             hhcccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 012765          374 LADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQLL  411 (457)
Q Consensus       374 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L  411 (457)
                      +...     ...+..++..++..++..||.+.++....
T Consensus       483 ~~~~-----~~~~q~~~kv~~~~~~~~~~l~~~l~~~~  515 (524)
T KOG0601|consen  483 LPGL-----KLQLQVLLKVMINPDRKRRPSAVELSLHS  515 (524)
T ss_pred             CCch-----HHhhhhhhhhhcCCccccchhhhhhcccc
Confidence            1111     13344455568899999999887765543

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.24  E-value=3e-10  Score=116.76  Aligned_cols=226  Identities=16%  Similarity=0.140  Sum_probs=141.6

Q ss_pred             CCCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeee-eeecCceEEEEEecCCCChhhhhhcCCCCCCHHH
Q 012765          164 PDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIG-FSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTI  242 (457)
Q Consensus       164 ~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~-~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~  242 (457)
                      .++.+|.|........   .......+-++.|+.++||||+++++ +..++..|+|+|-+.-  |..++...+    ...
T Consensus        35 ~~~~~vsVF~~~~~~~---~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~P--l~~~lk~l~----~~~  105 (690)
T KOG1243|consen   35 ADGGPVSVFVYKRSNG---EVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVRP--LETVLKELG----KEE  105 (690)
T ss_pred             ccCCceEEEEEeCCCc---hhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeecccc--HHHHHHHhH----HHH
Confidence            4677777776654433   33456778888999999999999998 5566778999997632  444443222    333


Q ss_pred             HHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCCCCCCceeeecccccccccChhccccCC
Q 012765          243 RYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEGTFGYLSPEYFMHGI  322 (457)
Q Consensus       243 ~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~  322 (457)
                      ....+.||+.||.|||..  .+++|++|.-..|+++..|..||++|.++............  ..--..|..|+.+....
T Consensus       106 v~~Gl~qIl~AL~FL~~d--~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~~~~--~~~~~s~~~P~~~~~s~  181 (690)
T KOG1243|consen  106 VCLGLFQILAALSFLNDD--CNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAPAKS--LYLIESFDDPEEIDPSE  181 (690)
T ss_pred             HHHHHHHHHHHHHHHhcc--CCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCccccc--chhhhcccChhhcCccc
Confidence            344677999999999975  68999999999999999999999999988654332210000  01122356666543222


Q ss_pred             CCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhccccccCCcccccCchhh---cccCHHHHHHHHHHHHHhcccCCC
Q 012765          323 VDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSNFKELVDPRLA---DAYDLAEMKRAMLTASVCIHHLST  399 (457)
Q Consensus       323 ~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~---~~~~~~~~~~l~~l~~~Cl~~dP~  399 (457)
                        ...|.|-|||+++|++.|.  +.......        ....+++..-....   ......... .++.+..|+..-+-
T Consensus       182 --~s~D~~~Lg~li~el~ng~--~~~~~~~~--------~~~~ipk~~~~~~~k~~~~~~~~r~n-~~~~~~~~~~~~gf  248 (690)
T KOG1243|consen  182 --WSIDSWGLGCLIEELFNGS--LLTKTDLS--------NTGKIPKALIELYCKKLGATELKRPN-KLRFILECRLLGGF  248 (690)
T ss_pred             --cchhhhhHHHHHHHHhCcc--cCcchhhh--------ccCccchhHHHHHHHHhccccccccc-hhhHHHHHHhcccc
Confidence              4579999999999999993  32211100        00001100000000   000011111 45566667777777


Q ss_pred             CCCCHHHHHHHHhcCC
Q 012765          400 MRPQMTRVLQLLRGEG  415 (457)
Q Consensus       400 ~RPt~~evl~~L~~~~  415 (457)
                      .|=-+-+++..|+++.
T Consensus       249 f~n~fvd~~~fLeel~  264 (690)
T KOG1243|consen  249 FRNDFVDTLLFLEELR  264 (690)
T ss_pred             ccchHHHHHHHHHhcc
Confidence            7777777777777764

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.23  E-value=4e-10  Score=102.21  Aligned_cols=140  Identities=14%  Similarity=0.110  Sum_probs=98.1

Q ss_pred             CceecccCcEEEEEEEeCC-------CcEEEEEEEeccchh----------h---------HHHHHH----HHHHHHHHh
Q 012765          147 ENLIGKGGHAEVYKGCLPD-------GEVVAVKKIIKNAKE----------D---------EERISD----FLSELGIVA  196 (457)
Q Consensus       147 ~~~LG~G~~g~Vy~~~~~~-------~~~vavK~~~~~~~~----------~---------~~~~~~----~~~E~~~l~  196 (457)
                      ...||.|--+.||.|...+       +..+|||+..-....          +         ......    ..+|+..|.
T Consensus         2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~   81 (197)
T cd05146           2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK   81 (197)
T ss_pred             CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence            3579999999999997543       479999976321110          0         001112    337999998


Q ss_pred             hcCC--CCcceeeeeeecCceEEEEEecCCCChhh-hhhcCCCCCCHHHHHHHHHHHHHHHHHH-HhcCCCCeeeCCCCC
Q 012765          197 HINH--PNAAKLIGFSTENGFHLVLQFLPHGSLSS-LLFGSTECLEWTIRYKIALGIAEGLQYL-HHDCHRRIIHRDIKA  272 (457)
Q Consensus       197 ~l~h--pniv~l~~~~~~~~~~lv~e~~~~gsL~~-~l~~~~~~~~~~~~~~i~~qia~aL~yL-H~~~~~~iiHrDlkp  272 (457)
                      ++..  -++.+++++   ..-++||||+.++.+.. .+.  ...++......+..+++.+|..| |.   .++||+||++
T Consensus        82 rl~~~Gv~vP~pi~~---~~~~lvME~Ig~~~~~~~~Lk--d~~~~~~~~~~i~~~i~~~l~~l~H~---~glVHGDLs~  153 (197)
T cd05146          82 RMQKAGIPCPEVVVL---KKHVLVMSFIGDDQVPAPKLK--DAKLNDEEMKNAYYQVLSMMKQLYKE---CNLVHADLSE  153 (197)
T ss_pred             HHHHcCCCCCeEEEe---cCCEEEEEEcCCCCccchhhh--ccccCHHHHHHHHHHHHHHHHHHHHh---CCeecCCCCH
Confidence            8853  466677765   45689999997754422 221  11244445567788999999999 77   7999999999


Q ss_pred             CcEEEcCCCcEEEeeccccccCC
Q 012765          273 SNILLSEDYEAQISDFGLAKWLP  295 (457)
Q Consensus       273 ~NIll~~~~~~kL~DFGl~~~~~  295 (457)
                      .|||+. ++.+.|+|||.+....
T Consensus       154 ~NIL~~-~~~v~iIDF~qav~~~  175 (197)
T cd05146         154 YNMLWH-DGKVWFIDVSQSVEPT  175 (197)
T ss_pred             HHEEEE-CCcEEEEECCCceeCC
Confidence            999997 4689999999886543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.21  E-value=2.1e-10  Score=100.46  Aligned_cols=143  Identities=24%  Similarity=0.329  Sum_probs=103.0

Q ss_pred             CCceecccCcEEEEEEEeCCCcEEEEEEEeccc-----hhhHHHHHHHHHHHHHHhhcCCCCccee-eeeeecCceEEEE
Q 012765          146 SENLIGKGGHAEVYKGCLPDGEVVAVKKIIKNA-----KEDEERISDFLSELGIVAHINHPNAAKL-IGFSTENGFHLVL  219 (457)
Q Consensus       146 ~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~-----~~~~~~~~~~~~E~~~l~~l~hpniv~l-~~~~~~~~~~lv~  219 (457)
                      ...+|-+|+-+.|+++.+ .|+.+.||.-....     .+..-...+..+|+.+|.++.--.|.-. +-+++...-+++|
T Consensus        11 ~l~likQGAEArv~~~~~-~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M   89 (229)
T KOG3087|consen   11 SLELIKQGAEARVPRGSF-SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM   89 (229)
T ss_pred             cceeeeccceeeEeeecc-CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence            567899999999999987 77887887432211     1112224567889999988864443333 2344555568999


Q ss_pred             EecCC-CChhhhhhcCCCCCCHHHH-HHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCC---cEEEeeccccc
Q 012765          220 QFLPH-GSLSSLLFGSTECLEWTIR-YKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDY---EAQISDFGLAK  292 (457)
Q Consensus       220 e~~~~-gsL~~~l~~~~~~~~~~~~-~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~---~~kL~DFGl~~  292 (457)
                      ||+++ .++.+++......-..... ..++..|-+.+.-||.   .+|||+||..+||+|..++   .+.|+|||++.
T Consensus        90 E~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~---ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~  164 (229)
T KOG3087|consen   90 EFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHD---NDIIHGDLTTSNILLRSDGNQITPILIDFGLSS  164 (229)
T ss_pred             EeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhh---CCeecccccccceEEecCCCcCceEEEeecchh
Confidence            99987 4677777654443333333 6788999999999999   8999999999999997654   35899999985

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.19  E-value=2.3e-10  Score=106.16  Aligned_cols=141  Identities=17%  Similarity=0.191  Sum_probs=106.7

Q ss_pred             ceecccCcEEEEEEEeCCCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCC--CCcceeeeeeecC----ceEEEEEe
Q 012765          148 NLIGKGGHAEVYKGCLPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINH--PNAAKLIGFSTEN----GFHLVLQF  221 (457)
Q Consensus       148 ~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h--pniv~l~~~~~~~----~~~lv~e~  221 (457)
                      +.|+.|..+.||++...+|..+++|........  .....+..|..++..+.+  .++.+++.+....    ..+++|||
T Consensus         4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~--~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~   81 (223)
T cd05154           4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALL--PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMER   81 (223)
T ss_pred             eecCCCccceEEEEEecCCcceEEEeCCCcccC--cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEE
Confidence            578999999999998766789999986543321  123467889999988875  4467777776653    45799999


Q ss_pred             cCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcC----------------------------------------
Q 012765          222 LPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDC----------------------------------------  261 (457)
Q Consensus       222 ~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~----------------------------------------  261 (457)
                      +++.++...+..  ..++......++.+++.+|.+||+..                                        
T Consensus        82 i~G~~l~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (223)
T cd05154          82 VDGRVLRDRLLR--PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMER  159 (223)
T ss_pred             eCCEecCCCCCC--CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHH
Confidence            999888776521  34666777778888888888888521                                        


Q ss_pred             -------------CCCeeeCCCCCCcEEEcC--CCcEEEeeccccc
Q 012765          262 -------------HRRIIHRDIKASNILLSE--DYEAQISDFGLAK  292 (457)
Q Consensus       262 -------------~~~iiHrDlkp~NIll~~--~~~~kL~DFGl~~  292 (457)
                                   ...++|+|+.|.||+++.  ++.+.|+||+.+.
T Consensus       160 ~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~  205 (223)
T cd05154         160 LLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELAT  205 (223)
T ss_pred             HHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEeccccc
Confidence                         245799999999999998  5668999998765

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.14  E-value=9.4e-12  Score=132.74  Aligned_cols=252  Identities=19%  Similarity=0.230  Sum_probs=164.2

Q ss_pred             HhhcCCCCCceecccCcEEEEEEEeC-CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeee-eeecCceE
Q 012765          139 AATDNFNSENLIGKGGHAEVYKGCLP-DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIG-FSTENGFH  216 (457)
Q Consensus       139 ~~~~~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~-~~~~~~~~  216 (457)
                      ...+.|.+.+-+-+|+++.++.+.-. .|...++|.............+....+-.++-..++|.++.... +-.....+
T Consensus       801 sS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~  880 (1205)
T KOG0606|consen  801 SSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLP  880 (1205)
T ss_pred             CCCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcc
Confidence            45678888889999999999987532 34444444332222111112233344444443345566665554 34556678


Q ss_pred             EEEEecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCCC
Q 012765          217 LVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPD  296 (457)
Q Consensus       217 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~  296 (457)
                      ++++|+.+++|...|+... +.+.......+..+..++.|||.   ..++|+|++|.|++...++..++.|||.......
T Consensus       881 L~~~~~~~~~~~Skl~~~~-~~saepaRs~i~~~vqs~e~L~s---~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~  956 (1205)
T KOG0606|consen  881 LVGHYLNGGDLPSKLHNSG-CLSAEPARSPILERVQSLESLHS---SLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGL  956 (1205)
T ss_pred             hhhHHhccCCchhhhhcCC-CcccccccchhHHHHhhhhcccc---chhhcccccccchhhcccCCcccCcccccccccc
Confidence            9999999999999997655 34433444455678899999999   6799999999999999999999999984322210


Q ss_pred             C-----C----------------Cc--------eeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHhCCCCCC
Q 012765          297 N-----W----------------SH--------HIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVD  347 (457)
Q Consensus       297 ~-----~----------------~~--------~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLltG~~pf~  347 (457)
                      .     .                ..        .......||+.|.+||.+.+......+|+|++|++++|.++|..||.
T Consensus       957 ~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~n 1036 (1205)
T KOG0606|consen  957 IPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFN 1036 (1205)
T ss_pred             ccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCC
Confidence            0     0                00        00122468999999999999999999999999999999999999998


Q ss_pred             cCCcchhhhhccccccCCcccccCchhhccc-CHHHHHHHHHHHHHhcccCCCCCCCHH
Q 012765          348 SRRQSLVIWAKPLLQTSNFKELVDPRLADAY-DLAEMKRAMLTASVCIHHLSTMRPQMT  405 (457)
Q Consensus       348 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~-~~~~~~~l~~l~~~Cl~~dP~~RPt~~  405 (457)
                      ....+...           ..+....+.+.. ..........++...+..+|.+|-.|.
T Consensus      1037 a~tpq~~f-----------~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1037 AETPQQIF-----------ENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred             Ccchhhhh-----------hccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcc
Confidence            74443221           111111111111 111122233455557788888887765

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.12  E-value=1.1e-09  Score=96.52  Aligned_cols=132  Identities=24%  Similarity=0.277  Sum_probs=96.7

Q ss_pred             ceecccCcEEEEEEEeCCCcEEEEEEEeccchh-----hHHHHHHHHHHHHHHhhcCCCCcceeee-eeecCceEEEEEe
Q 012765          148 NLIGKGGHAEVYKGCLPDGEVVAVKKIIKNAKE-----DEERISDFLSELGIVAHINHPNAAKLIG-FSTENGFHLVLQF  221 (457)
Q Consensus       148 ~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-----~~~~~~~~~~E~~~l~~l~hpniv~l~~-~~~~~~~~lv~e~  221 (457)
                      ..+++|+-+.+|.+.+ -|..+++|.-.+....     ..-...+-.+|+.+++++.--.|.-.+= .++.+...++|||
T Consensus         2 ~~i~~GAEa~i~~~~~-~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~   80 (204)
T COG3642           2 DLIKQGAEAIIYLTDF-LGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY   80 (204)
T ss_pred             chhhCCcceeEEeeec-cCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence            4688999999999876 3445677743322221     1122356678999998886544443333 3344456799999


Q ss_pred             cCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccc
Q 012765          222 LPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAK  292 (457)
Q Consensus       222 ~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~  292 (457)
                      ++|..|.+.+...        ...++..|-.-+.-||.   .+|+|+||.++||++..+. +.++|||++.
T Consensus        81 I~G~~lkd~l~~~--------~~~~~r~vG~~vg~lH~---~givHGDLTtsNiIl~~~~-i~~IDfGLg~  139 (204)
T COG3642          81 IEGELLKDALEEA--------RPDLLREVGRLVGKLHK---AGIVHGDLTTSNIILSGGR-IYFIDFGLGE  139 (204)
T ss_pred             eCChhHHHHHHhc--------chHHHHHHHHHHHHHHh---cCeecCCCccceEEEeCCc-EEEEECCccc
Confidence            9999999888443        24677888889999999   8999999999999998764 9999999986

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=99.04  E-value=7.1e-09  Score=103.74  Aligned_cols=166  Identities=18%  Similarity=0.277  Sum_probs=124.7

Q ss_pred             cEEEEEEEe-CCCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeee-----cCceEEEEEecCC-CCh
Q 012765          155 HAEVYKGCL-PDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFST-----ENGFHLVLQFLPH-GSL  227 (457)
Q Consensus       155 ~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~-----~~~~~lv~e~~~~-gsL  227 (457)
                      -.+.||+.. .+|..|++|++.-.....   ......-+++++++.|+|+|++..++.     +..+++||+|+++ ++|
T Consensus       289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~---~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL  365 (655)
T KOG3741|consen  289 SITTYKATSNVDGNAYVLKRLHGDRDQS---TNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTL  365 (655)
T ss_pred             cceeEeeeeccCCceeeeeeeccccccC---cccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchH
Confidence            357899874 489999999983322211   112334577889999999999988433     4457899999987 577


Q ss_pred             hhhhhc--------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeecccccc
Q 012765          228 SSLLFG--------------STECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKW  293 (457)
Q Consensus       228 ~~~l~~--------------~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~  293 (457)
                      .++.+.              .+...++...|.++.|+..||.++|+   .|+..+-|.+.+||++.+..++|+..|+...
T Consensus       366 ~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHs---sGLAck~L~~~kIlv~G~~RIriS~C~i~Dv  442 (655)
T KOG3741|consen  366 YDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHS---SGLACKTLDLKKILVTGKMRIRISGCGIMDV  442 (655)
T ss_pred             HHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHh---cCceeecccHhHeEeeCcceEEEecccceee
Confidence            776543              12246778899999999999999999   8999999999999999999999999888766


Q ss_pred             CCCCCCceeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHhCCCC
Q 012765          294 LPDNWSHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRA  345 (457)
Q Consensus       294 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLltG~~p  345 (457)
                      +..+...                -+.+   ..+-|.=.||.+++.|.||..-
T Consensus       443 l~~d~~~----------------~le~---~Qq~D~~~lG~ll~aLAt~~~n  475 (655)
T KOG3741|consen  443 LQEDPTE----------------PLES---QQQNDLRDLGLLLLALATGTEN  475 (655)
T ss_pred             ecCCCCc----------------chhH---HhhhhHHHHHHHHHHHhhcccc
Confidence            6544211                1111   2356889999999999999653

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.94  E-value=1.1e-08  Score=92.46  Aligned_cols=129  Identities=24%  Similarity=0.234  Sum_probs=82.4

Q ss_pred             EEEEEEeCCCcEEEEEEEeccch-----------------------hhHHHHHHHHHHHHHHhhcCCC--Ccceeeeeee
Q 012765          157 EVYKGCLPDGEVVAVKKIIKNAK-----------------------EDEERISDFLSELGIVAHINHP--NAAKLIGFST  211 (457)
Q Consensus       157 ~Vy~~~~~~~~~vavK~~~~~~~-----------------------~~~~~~~~~~~E~~~l~~l~hp--niv~l~~~~~  211 (457)
                      .||.|...+|..+|+|.......                       ..........+|...|.++..-  ++.+++++. 
T Consensus         1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~-   79 (188)
T PF01163_consen    1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN-   79 (188)
T ss_dssp             EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred             CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence            48999988999999997633211                       1112234677899999999765  566776553 


Q ss_pred             cCceEEEEEecC--CCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHH-HHhcCCCCeeeCCCCCCcEEEcCCCcEEEeec
Q 012765          212 ENGFHLVLQFLP--HGSLSSLLFGSTECLEWTIRYKIALGIAEGLQY-LHHDCHRRIIHRDIKASNILLSEDYEAQISDF  288 (457)
Q Consensus       212 ~~~~~lv~e~~~--~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~y-LH~~~~~~iiHrDlkp~NIll~~~~~~kL~DF  288 (457)
                        .-.+||||+.  +..+..+. ...  ++......++.+++..+.. +|.   .+|+|+||.+.||+++++ .+.|+||
T Consensus        80 --~~~ivME~I~~~G~~~~~l~-~~~--~~~~~~~~~~~~il~~~~~~~~~---~givHGDLs~~NIlv~~~-~~~iIDf  150 (188)
T PF01163_consen   80 --RNVIVMEYIGEDGVPLPRLK-DVD--LSPEEPKELLEEILEEIIKMLHK---AGIVHGDLSEYNILVDDG-KVYIIDF  150 (188)
T ss_dssp             --TTEEEEE--EETTEEGGCHH-HCG--GGGSTHHHHHHHHHHHHHHHHHC---TTEEESS-STTSEEEETT-CEEE--G
T ss_pred             --CCEEEEEecCCCccchhhHH-hcc--ccchhHHHHHHHHHHHHHHHHHh---cCceecCCChhhEEeecc-eEEEEec
Confidence              3479999998  54443332 211  1122334567778885555 467   899999999999999987 9999999


Q ss_pred             cccccCC
Q 012765          289 GLAKWLP  295 (457)
Q Consensus       289 Gl~~~~~  295 (457)
                      |.+....
T Consensus       151 ~qav~~~  157 (188)
T PF01163_consen  151 GQAVDSS  157 (188)
T ss_dssp             TTEEETT
T ss_pred             CcceecC
Confidence            9886543

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=98.91  E-value=6.4e-08  Score=94.79  Aligned_cols=189  Identities=16%  Similarity=0.249  Sum_probs=124.6

Q ss_pred             CCceecccCcEEEEEEEeCCCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhc-CCCCcceeeee------eecCc--eE
Q 012765          146 SENLIGKGGHAEVYKGCLPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHI-NHPNAAKLIGF------STENG--FH  216 (457)
Q Consensus       146 ~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~------~~~~~--~~  216 (457)
                      ....||+|+-+.+|-.-  .-...+.|+.....-....   +   .+..|... .||-+-.-+.|      .-+.+  ..
T Consensus        15 ~gr~LgqGgea~ly~l~--e~~d~VAKIYh~Pppa~~a---q---k~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iG   86 (637)
T COG4248          15 PGRPLGQGGEADLYTLG--EVRDQVAKIYHAPPPAAQA---Q---KVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIG   86 (637)
T ss_pred             CCccccCCccceeeecc--hhhchhheeecCCCchHHH---H---HHHHhccCCCCcchhhhhcccHHHhhCCCccceeE
Confidence            34679999999999642  2122345666544322111   1   22223333 56544332222      11222  34


Q ss_pred             EEEEecCCCC-hhhhhh-----cCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccc
Q 012765          217 LVLQFLPHGS-LSSLLF-----GSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGL  290 (457)
Q Consensus       217 lv~e~~~~gs-L~~~l~-----~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl  290 (457)
                      ++|..+++-. +..++.     ......+|...++++..++.+...||.   .|.+-+|+.++|+|+++++.+.|+|-..
T Consensus        87 flmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~---~Gh~vGDVn~~~~lVsd~~~V~LVdsDs  163 (637)
T COG4248          87 FLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHE---HGHVVGDVNQNSFLVSDDSKVVLVDSDS  163 (637)
T ss_pred             EecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHh---cCCcccccCccceeeecCceEEEEcccc
Confidence            6676665542 222221     122347899999999999999999999   8999999999999999999999998554


Q ss_pred             cccCCCCCCceeeecccccccccChhccc-----cCCCCcchhHHHHHHHHHHHHhC-CCCCCc
Q 012765          291 AKWLPDNWSHHIVFPIEGTFGYLSPEYFM-----HGIVDEKTDVFAFGVLLLELITG-RRAVDS  348 (457)
Q Consensus       291 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~ksDvwSlGvll~eLltG-~~pf~~  348 (457)
                      ...-.++   .......|...|.+||.-.     +..-+...|.|.||+++++|+.| ++||.+
T Consensus       164 fqi~~ng---~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysG  224 (637)
T COG4248         164 FQINANG---TLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSG  224 (637)
T ss_pred             eeeccCC---ceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCc
Confidence            3332222   1223355899999999754     44567889999999999999986 999976

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=98.86  E-value=6.2e-08  Score=92.65  Aligned_cols=141  Identities=14%  Similarity=0.083  Sum_probs=96.5

Q ss_pred             ceecccCcEEEEEEEeCCCcEEEEEEEeccchhh-H-------HHHHHHHHHHHHHhhcCCCC--cceeeeeeec-----
Q 012765          148 NLIGKGGHAEVYKGCLPDGEVVAVKKIIKNAKED-E-------ERISDFLSELGIVAHINHPN--AAKLIGFSTE-----  212 (457)
Q Consensus       148 ~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~-~-------~~~~~~~~E~~~l~~l~hpn--iv~l~~~~~~-----  212 (457)
                      +.+-......|++... +|+.|.||+........ .       .....+.+|...+.+|..-+  ++.++++...     
T Consensus        28 e~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~  106 (268)
T PRK15123         28 EVFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPA  106 (268)
T ss_pred             cEEecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCc
Confidence            3444444445667665 77889999764333210 0       00113678888887774333  3344444432     


Q ss_pred             -CceEEEEEecCCC-ChhhhhhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcC-------CCc
Q 012765          213 -NGFHLVLQFLPHG-SLSSLLFGS-TECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSE-------DYE  282 (457)
Q Consensus       213 -~~~~lv~e~~~~g-sL~~~l~~~-~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~-------~~~  282 (457)
                       ..-++|+|++++. +|.+++... ....+...+..++.+++..+.-||.   .||+|+|+++.|||++.       ++.
T Consensus       107 ~~~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~---~Gi~HgDL~~~NiLl~~~~~~~~~~~~  183 (268)
T PRK15123        107 TRTSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHA---AGINHRDCYICHFLLHLPFPGREEDLK  183 (268)
T ss_pred             cceeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHH---CcCccCCCChhhEEEeccccCCCCCce
Confidence             2357999999986 788887421 2334556677899999999999999   89999999999999975       467


Q ss_pred             EEEeeccccc
Q 012765          283 AQISDFGLAK  292 (457)
Q Consensus       283 ~kL~DFGl~~  292 (457)
                      +.|+||+.+.
T Consensus       184 ~~LIDl~r~~  193 (268)
T PRK15123        184 LSVIDLHRAQ  193 (268)
T ss_pred             EEEEECCccc
Confidence            9999999775

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=98.80  E-value=7.5e-08  Score=89.84  Aligned_cols=137  Identities=23%  Similarity=0.222  Sum_probs=95.6

Q ss_pred             CCCCceecccCcEEEEEEEeCCCcEEEEEEEeccchh-------------------hHHHHHHHHHHHHHHhhcCCC--C
Q 012765          144 FNSENLIGKGGHAEVYKGCLPDGEVVAVKKIIKNAKE-------------------DEERISDFLSELGIVAHINHP--N  202 (457)
Q Consensus       144 f~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-------------------~~~~~~~~~~E~~~l~~l~hp--n  202 (457)
                      ..+.+.||-|--+.||.|..++|.++|||.=.-....                   -.-......+|.++|.+|...  .
T Consensus        93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~  172 (304)
T COG0478          93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK  172 (304)
T ss_pred             HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence            4456889999999999999999999999943211110                   011234567899999988655  6


Q ss_pred             cceeeeeeecCceEEEEEecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCc
Q 012765          203 AAKLIGFSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYE  282 (457)
Q Consensus       203 iv~l~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~  282 (457)
                      +.+.+++..   -.+|||++.+-.|...-.      +....-.|+..|++-+.-+-.   .|+||+|+.+-||++++||.
T Consensus       173 VP~P~~~nR---HaVvMe~ieG~eL~~~r~------~~en~~~il~~il~~~~~~~~---~GiVHGDlSefNIlV~~dg~  240 (304)
T COG0478         173 VPKPIAWNR---HAVVMEYIEGVELYRLRL------DVENPDEILDKILEEVRKAYR---RGIVHGDLSEFNILVTEDGD  240 (304)
T ss_pred             CCCcccccc---ceeeeehcccceeecccC------cccCHHHHHHHHHHHHHHHHH---cCccccCCchheEEEecCCC
Confidence            676666543   368999998876654321      111222344444444444445   79999999999999999999


Q ss_pred             EEEeeccccc
Q 012765          283 AQISDFGLAK  292 (457)
Q Consensus       283 ~kL~DFGl~~  292 (457)
                      +.++||--+.
T Consensus       241 ~~vIDwPQ~v  250 (304)
T COG0478         241 IVVIDWPQAV  250 (304)
T ss_pred             EEEEeCcccc
Confidence            9999996554

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=98.77  E-value=2.1e-09  Score=111.07  Aligned_cols=152  Identities=18%  Similarity=0.305  Sum_probs=101.3

Q ss_pred             HHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCCCCCC-------ceeeecccccccccChhccc
Q 012765          247 ALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWS-------HHIVFPIEGTFGYLSPEYFM  319 (457)
Q Consensus       247 ~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~~~~-------~~~~~~~~gt~~y~aPE~~~  319 (457)
                      +.+++.|+.|+|..  .++||++|.|++|.++.++..||+.|+++........       .....-..-...|.|||++.
T Consensus       105 l~~v~dgl~flh~s--Ak~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~  182 (700)
T KOG2137|consen  105 LGNVADGLAFLHRS--AKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLL  182 (700)
T ss_pred             hhcccchhhhhccC--cceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhc
Confidence            34566999999995  8999999999999999999999999999876544211       11111112356799999999


Q ss_pred             cCCCCcchhHHHHHHHHHHHH-hCCCCCCcCCcchhhhhccccccCCcccccCchhhcccCHHHHHHHHHHHHHhcccCC
Q 012765          320 HGIVDEKTDVFAFGVLLLELI-TGRRAVDSRRQSLVIWAKPLLQTSNFKELVDPRLADAYDLAEMKRAMLTASVCIHHLS  398 (457)
Q Consensus       320 ~~~~~~ksDvwSlGvll~eLl-tG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP  398 (457)
                      +...+.++|+||||+++|.+. .|+..+........ +......        +..-...++.+...++.+=+.+++..++
T Consensus       183 ~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~-~~~~~~~--------~~~~~~~~s~~~p~el~~~l~k~l~~~~  253 (700)
T KOG2137|consen  183 GTTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLS-YSFSRNL--------LNAGAFGYSNNLPSELRESLKKLLNGDS  253 (700)
T ss_pred             cccccccccceeeeeEEEEEecCCcchhhccCCcch-hhhhhcc--------cccccccccccCcHHHHHHHHHHhcCCc
Confidence            888899999999999999999 45555554322211 1111010        0000111122223344445566889999


Q ss_pred             CCCCCHHHHHH
Q 012765          399 TMRPQMTRVLQ  409 (457)
Q Consensus       399 ~~RPt~~evl~  409 (457)
                      .-||++.++..
T Consensus       254 ~~rp~~~~l~~  264 (700)
T KOG2137|consen  254 AVRPTLDLLLS  264 (700)
T ss_pred             ccCcchhhhhc
Confidence            99998876654

>PRK09902 hypothetical protein; Provisional

Probab=98.60  E-value=5.6e-07  Score=82.06  Aligned_cols=140  Identities=13%  Similarity=0.113  Sum_probs=98.6

Q ss_pred             ecccCcEEEEEEEeCCCcEEEEEEEeccchhh---HHHHHHHHHHHHHHhhcCCCC--cceeeeeee--cCc---eEEEE
Q 012765          150 IGKGGHAEVYKGCLPDGEVVAVKKIIKNAKED---EERISDFLSELGIVAHINHPN--AAKLIGFST--ENG---FHLVL  219 (457)
Q Consensus       150 LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~---~~~~~~~~~E~~~l~~l~hpn--iv~l~~~~~--~~~---~~lv~  219 (457)
                      -|+||.+.|++-.. +|+.+-+|+-.......   ......|.+|+..+..+..-+  +.+.+.+..  .+.   -+||+
T Consensus        26 ~~rgG~SgV~r~~~-~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVT  104 (216)
T PRK09902         26 YRRNGMSGVQCVER-NGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVT  104 (216)
T ss_pred             cCCCCcceEEEEEe-CCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEE
Confidence            45789999999776 45578889754211111   123457889999988885322  444442221  121   35888


Q ss_pred             EecCC-CChhhhhhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCc--EEEeecccccc
Q 012765          220 QFLPH-GSLSSLLFGS-TECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYE--AQISDFGLAKW  293 (457)
Q Consensus       220 e~~~~-gsL~~~l~~~-~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~--~kL~DFGl~~~  293 (457)
                      |-+.+ -+|.+++... ....+...+..++.+++..+.-||.   .++.|+|+.+.||+++.++.  ++++||.-++.
T Consensus       105 e~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~---~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~  179 (216)
T PRK09902        105 EDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHS---VNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR  179 (216)
T ss_pred             EeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHH---CCCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence            87765 4777777442 2345777778899999999999999   89999999999999986666  99999986654

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.60  E-value=4.6e-07  Score=83.52  Aligned_cols=125  Identities=21%  Similarity=0.253  Sum_probs=86.9

Q ss_pred             CCcEEEEEEEeccchhh----HHHHHHHHHHHHHHhhcCC--CCcceeeeeeecC-----ceEEEEEecCCC-Chhhhhh
Q 012765          165 DGEVVAVKKIIKNAKED----EERISDFLSELGIVAHINH--PNAAKLIGFSTEN-----GFHLVLQFLPHG-SLSSLLF  232 (457)
Q Consensus       165 ~~~~vavK~~~~~~~~~----~~~~~~~~~E~~~l~~l~h--pniv~l~~~~~~~-----~~~lv~e~~~~g-sL~~~l~  232 (457)
                      .++.+.+|........+    .-......+|...+..|..  =.+++.+++....     ..++|+|++++. +|.+++.
T Consensus        31 ~~~~y~~k~~~~~~~~~~~~~~~~~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~  110 (206)
T PF06293_consen   31 VGRRYYRKRLWNKLRRDRLRFPLRRSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQ  110 (206)
T ss_pred             cceEEEECCeechhccchhhhcccchHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHH
Confidence            45666666543221111    0123356777777766643  2345556654432     236899999885 7888885


Q ss_pred             cCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCC---cEEEeecccccc
Q 012765          233 GSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDY---EAQISDFGLAKW  293 (457)
Q Consensus       233 ~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~---~~kL~DFGl~~~  293 (457)
                      .... .+......++.+++..+.-||.   .+|+|+|+++.|||++.++   .+.|+||+-++.
T Consensus       111 ~~~~-~~~~~~~~ll~~l~~~i~~lH~---~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~  170 (206)
T PF06293_consen  111 QWEQ-LDPSQRRELLRALARLIAKLHD---AGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF  170 (206)
T ss_pred             hhcc-cchhhHHHHHHHHHHHHHHHHH---CcCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence            4222 5556677899999999999999   8999999999999999887   799999997764

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.59  E-value=3.4e-07  Score=94.77  Aligned_cols=143  Identities=21%  Similarity=0.246  Sum_probs=94.2

Q ss_pred             ceecccCcEEEEEEEeCCCcEEEEEEEeccchhhHH-------------------------------------HHHHHHH
Q 012765          148 NLIGKGGHAEVYKGCLPDGEVVAVKKIIKNAKEDEE-------------------------------------RISDFLS  190 (457)
Q Consensus       148 ~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~-------------------------------------~~~~~~~  190 (457)
                      +.|+.++-|+||+|.+.+|+.||||+...+....-.                                     ..-++.+
T Consensus       131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~  210 (517)
T COG0661         131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR  210 (517)
T ss_pred             CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence            679999999999999999999999988654332100                                     0113444


Q ss_pred             HHHHHhhcC-----CCCcceeee--eeecCceEEEEEecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHH-HHHHHhcCC
Q 012765          191 ELGIVAHIN-----HPNAAKLIG--FSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEG-LQYLHHDCH  262 (457)
Q Consensus       191 E~~~l~~l~-----hpniv~l~~--~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~a-L~yLH~~~~  262 (457)
                      |..-+.+++     .+++ ++=.  +...+.-.++|||+.|-.+.+.........+...   ++..++++ +..+-.   
T Consensus       211 EA~n~~~~~~nf~~~~~v-~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~g~d~k~---ia~~~~~~f~~q~~~---  283 (517)
T COG0661         211 EAANAERFRENFKDDPDV-YVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSAGIDRKE---LAELLVRAFLRQLLR---  283 (517)
T ss_pred             HHHHHHHHHHHcCCCCCe-EeceeehhccCCcEEEEEeeCCEecccHHHHHhcCCCHHH---HHHHHHHHHHHHHHh---
Confidence            554444442     2222 2212  2234556799999999888887533334455333   33333332 222223   


Q ss_pred             CCeeeCCCCCCcEEEcCCCcEEEeeccccccCCCC
Q 012765          263 RRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDN  297 (457)
Q Consensus       263 ~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~~  297 (457)
                      .++.|.|..|.||+++.+|.+.+.|||+...+...
T Consensus       284 dgffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~~  318 (517)
T COG0661         284 DGFFHADPHPGNILVRSDGRIVLLDFGIVGRLDPK  318 (517)
T ss_pred             cCccccCCCccceEEecCCcEEEEcCcceecCCHH
Confidence            58999999999999999999999999999877543

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=98.36  E-value=1e-05  Score=74.12  Aligned_cols=139  Identities=18%  Similarity=0.244  Sum_probs=90.9

Q ss_pred             hhcCCCCCceecccCcEEEEEEEeCCCcEEEEEEEeccchhhHHHHHHH------HHHHHHHhhc---CCCCcceeee--
Q 012765          140 ATDNFNSENLIGKGGHAEVYKGCLPDGEVVAVKKIIKNAKEDEERISDF------LSELGIVAHI---NHPNAAKLIG--  208 (457)
Q Consensus       140 ~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~------~~E~~~l~~l---~hpniv~l~~--  208 (457)
                      ...+|...+++-......|.+-.. +|+.+++|.........+.....|      .+.+..+.++   .-..++.++.  
T Consensus        29 ~~~~~~~~kv~k~~~r~~ValIei-~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~  107 (229)
T PF06176_consen   29 LDNNYKIIKVFKNTKRNYVALIEI-DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAA  107 (229)
T ss_pred             HhCCceEEEeecCCCccEEEEEEE-CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeee
Confidence            467788888888877777877665 678899997654433333333222      2333333333   2223333222  


Q ss_pred             ----eeecCceEEEEEecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEE
Q 012765          209 ----FSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQ  284 (457)
Q Consensus       209 ----~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~k  284 (457)
                          +......+++|||++|-.|.+...     ++.    .++..+.+++.-||.   .|+.|+|..|.|++++.+ .++
T Consensus       108 ekk~~~~~~~~~ll~EYIeG~~l~d~~~-----i~e----~~~~ki~~~ikqlH~---~G~~HGD~hpgNFlv~~~-~i~  174 (229)
T PF06176_consen  108 EKKIFRYTSSYVLLMEYIEGVELNDIED-----IDE----DLAEKIVEAIKQLHK---HGFYHGDPHPGNFLVSNN-GIR  174 (229)
T ss_pred             eeeeccceeEEEEEEEEecCeecccchh-----cCH----HHHHHHHHHHHHHHH---cCCccCCCCcCcEEEECC-cEE
Confidence                222233568999999988766531     222    245667888999999   899999999999999865 599


Q ss_pred             Eeeccccc
Q 012765          285 ISDFGLAK  292 (457)
Q Consensus       285 L~DFGl~~  292 (457)
                      ++||+..+
T Consensus       175 iID~~~k~  182 (229)
T PF06176_consen  175 IIDTQGKR  182 (229)
T ss_pred             EEECcccc
Confidence            99998654

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=98.34  E-value=5.4e-08  Score=99.80  Aligned_cols=187  Identities=19%  Similarity=0.126  Sum_probs=130.1

Q ss_pred             CCCCCceecccCcEEEEEEEeCCCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCC-cceeeeeeec-CceEEEEE
Q 012765          143 NFNSENLIGKGGHAEVYKGCLPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPN-AAKLIGFSTE-NGFHLVLQ  220 (457)
Q Consensus       143 ~f~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpn-iv~l~~~~~~-~~~~lv~e  220 (457)
                      -+...+-+++|+++.+||.+....+....+.+...        ....-++++|.+++||| .+..++-++. .-..+.++
T Consensus       243 ws~~fh~fvK~altknpKkRptaeklL~h~fvs~~--------l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~  314 (829)
T KOG0576|consen  243 WSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT--------LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMR  314 (829)
T ss_pred             chHHHHHHHHHHhcCCCccCCChhhheeceeeccc--------hhhHHHHHHHHHccCCCCcccccccCCcccccchhhh
Confidence            33344568899999999987433444445544322        24456788999999999 6666654443 44568888


Q ss_pred             ecCCC-ChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCCCCCC
Q 012765          221 FLPHG-SLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWS  299 (457)
Q Consensus       221 ~~~~g-sL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~~~~  299 (457)
                      ++..+ +-..........+...+...+...-++++.|||+   ..-+|+|    ||+..+ +..+..||+....+.... 
T Consensus       315 i~s~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~---~~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~-  385 (829)
T KOG0576|consen  315 ICSTGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHS---SYKVHRD----NILGSE-EEVKLLDFAVPPQLTRTM-  385 (829)
T ss_pred             hhcCCccccccCChhhHhhhhhhhhhhhhhhccccccccc---ccccCcc----cccccc-cccccccccCCcccCccc-
Confidence            88777 2222221112223333444555666789999998   4568998    887765 589999999988776654 


Q ss_pred             ceeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHhCCCCCCc
Q 012765          300 HHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDS  348 (457)
Q Consensus       300 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLltG~~pf~~  348 (457)
                        ......+|+.++|||+.....++.+.|.|++|.-..++.-|-+|-..
T Consensus       386 --~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~~  432 (829)
T KOG0576|consen  386 --KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRSS  432 (829)
T ss_pred             --ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCCC
Confidence              23345699999999999999999999999999887788878776543

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=98.31  E-value=2.5e-05  Score=72.49  Aligned_cols=157  Identities=22%  Similarity=0.180  Sum_probs=99.1

Q ss_pred             ccHHHHHHhhcCCCCCce---ecccCcEEEEEEEeCCCcEEEEEEEeccchhhHHH---------------------HHH
Q 012765          132 FDFAELAAATDNFNSENL---IGKGGHAEVYKGCLPDGEVVAVKKIIKNAKEDEER---------------------ISD  187 (457)
Q Consensus       132 ~~~~~~~~~~~~f~~~~~---LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~---------------------~~~  187 (457)
                      .+...+....++..+...   |+.|--+.||+|...++..+|+|+...........                     ..-
T Consensus        35 ~t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W  114 (268)
T COG1718          35 RTLETLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAW  114 (268)
T ss_pred             HHHHHHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHH
Confidence            445556666666655554   55677889999988789999999875433221110                     112


Q ss_pred             HHHHHHHHhhcC--CCCcceeeeeeecCceEEEEEecCCC-ChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC
Q 012765          188 FLSELGIVAHIN--HPNAAKLIGFSTENGFHLVLQFLPHG-SLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRR  264 (457)
Q Consensus       188 ~~~E~~~l~~l~--hpniv~l~~~~~~~~~~lv~e~~~~g-sL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~  264 (457)
                      ..+|+.-|.++.  +-.+.+.+++..   -.|||||+... .-.-.|..  -.+.......+..++++.+.-|-..  .+
T Consensus       115 ~~kEf~NL~R~~eAGVrvP~Pi~~~~---nVLvMEfIg~~g~pAP~LkD--v~~e~~e~~~~~~~~v~~~~~l~~~--a~  187 (268)
T COG1718         115 ARKEFRNLKRAYEAGVRVPEPIAFRN---NVLVMEFIGDDGLPAPRLKD--VPLELEEAEGLYEDVVEYMRRLYKE--AG  187 (268)
T ss_pred             HHHHHHHHHHHHHcCCCCCCceeecC---CeEEEEeccCCCCCCCCccc--CCcCchhHHHHHHHHHHHHHHHHHh--cC
Confidence            334555555552  233334444332   36899998654 21222211  1122224455677788888877763  69


Q ss_pred             eeeCCCCCCcEEEcCCCcEEEeeccccccCCC
Q 012765          265 IIHRDIKASNILLSEDYEAQISDFGLAKWLPD  296 (457)
Q Consensus       265 iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~  296 (457)
                      +||+||+.-|||+. ++.+.|+|||-+.....
T Consensus       188 LVHgDLSEyNiL~~-~~~p~iID~~QaV~~~h  218 (268)
T COG1718         188 LVHGDLSEYNILVH-DGEPYIIDVSQAVTIDH  218 (268)
T ss_pred             cccccchhhheEEE-CCeEEEEECccccccCC
Confidence            99999999999999 78999999998865543

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=98.19  E-value=4e-05  Score=71.22  Aligned_cols=140  Identities=19%  Similarity=0.181  Sum_probs=80.8

Q ss_pred             CceecccCcEEEEEEEeCCCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCC--CcceeeeeeecC----ceEEEEE
Q 012765          147 ENLIGKGGHAEVYKGCLPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHP--NAAKLIGFSTEN----GFHLVLQ  220 (457)
Q Consensus       147 ~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp--niv~l~~~~~~~----~~~lv~e  220 (457)
                      ++.|+.|..+.||+....+ ..+++|.....     .....+.+|..++..+...  .+.+++.+....    ..+++|+
T Consensus         2 i~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~-----~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~   75 (239)
T PF01636_consen    2 IRPLSGGFSNRVYRVTTDD-GRYVLKFYRPP-----DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLME   75 (239)
T ss_dssp             EEEEEESSSSEEEEEEETT-SEEEEEEESSH-----HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEE
T ss_pred             CccCCCCCeeeEEEEEECC-cEEEEEEeCCC-----CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEE
Confidence            3578999999999998866 68999986433     2344667788887777433  356666644332    2478999


Q ss_pred             ecCCCChhh----------------hh---hcC---CCCCCHHHH---------HHH------------HHHHHH-HHHH
Q 012765          221 FLPHGSLSS----------------LL---FGS---TECLEWTIR---------YKI------------ALGIAE-GLQY  256 (457)
Q Consensus       221 ~~~~gsL~~----------------~l---~~~---~~~~~~~~~---------~~i------------~~qia~-aL~y  256 (457)
                      ++++..+..                .+   +..   .....+...         ...            ...+.. .+..
T Consensus        76 ~i~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  155 (239)
T PF01636_consen   76 YIPGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQE  155 (239)
T ss_dssp             EESSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHH
T ss_pred             EeccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHH
Confidence            999987776                11   111   111111110         000            112222 3334


Q ss_pred             HHhc----CCCCeeeCCCCCCcEEEc-CCCcEEEeeccccc
Q 012765          257 LHHD----CHRRIIHRDIKASNILLS-EDYEAQISDFGLAK  292 (457)
Q Consensus       257 LH~~----~~~~iiHrDlkp~NIll~-~~~~~kL~DFGl~~  292 (457)
                      ++..    ....++|+|+.|.||+++ +++.+.|+||+.+.
T Consensus       156 ~~~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~  196 (239)
T PF01636_consen  156 LEALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG  196 (239)
T ss_dssp             HHHHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred             HHhhhccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence            4321    236799999999999999 66667899998653

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=98.12  E-value=4.2e-05  Score=71.54  Aligned_cols=136  Identities=15%  Similarity=0.192  Sum_probs=79.7

Q ss_pred             ceecccCcEEEEEEEeCCCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCC--cceeeeeeecCc-eEEEEEecCC
Q 012765          148 NLIGKGGHAEVYKGCLPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPN--AAKLIGFSTENG-FHLVLQFLPH  224 (457)
Q Consensus       148 ~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpn--iv~l~~~~~~~~-~~lv~e~~~~  224 (457)
                      ..||.|..+.||+.   .+..+++|......     ......+|.+++..+..-.  +.+.+++....+ ..++|+++.|
T Consensus         7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~-----~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G   78 (226)
T TIGR02172         7 TQTGEGGNGESYTH---KTGKWMLKLYNPGF-----DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVG   78 (226)
T ss_pred             eeecCCCCcceeEe---cCCCEEEEeCCCCC-----CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCC
Confidence            57899999999984   24567788764322     1234678999998886433  466677765544 4689999988


Q ss_pred             CC-hhhh---------------------hhcC-CCCCCHHHHH-HHHH----------HHHH-HHHHHHhc-CCCCeeeC
Q 012765          225 GS-LSSL---------------------LFGS-TECLEWTIRY-KIAL----------GIAE-GLQYLHHD-CHRRIIHR  268 (457)
Q Consensus       225 gs-L~~~---------------------l~~~-~~~~~~~~~~-~i~~----------qia~-aL~yLH~~-~~~~iiHr  268 (457)
                      .. +...                     ++.. .......... .+..          .+.. ...+|... ....++|+
T Consensus        79 ~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~Hg  158 (226)
T TIGR02172        79 KRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHG  158 (226)
T ss_pred             ccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEec
Confidence            63 1111                     1110 0011111100 0100          0111 12222211 12467899


Q ss_pred             CCCCCcEEEcCCCcEEEeeccccc
Q 012765          269 DIKASNILLSEDYEAQISDFGLAK  292 (457)
Q Consensus       269 Dlkp~NIll~~~~~~kL~DFGl~~  292 (457)
                      |+.|.||++++++ +.|+||+.+.
T Consensus       159 D~~~~Nii~~~~~-~~iIDwe~a~  181 (226)
T TIGR02172       159 DFQIGNLITSGKG-TYWIDLGDFG  181 (226)
T ss_pred             CCCCCcEEEcCCC-cEEEechhcC
Confidence            9999999999888 9999998764

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=98.09  E-value=3.1e-05  Score=80.22  Aligned_cols=143  Identities=21%  Similarity=0.187  Sum_probs=90.2

Q ss_pred             CceecccCcEEEEEEEeCCCcEEEEEEEeccchhh----------------------------HHH------HHHHHHHH
Q 012765          147 ENLIGKGGHAEVYKGCLPDGEVVAVKKIIKNAKED----------------------------EER------ISDFLSEL  192 (457)
Q Consensus       147 ~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~----------------------------~~~------~~~~~~E~  192 (457)
                      .+.||.-+.|+||+|++++|+.||||+-.......                            .+.      .-+|.+|.
T Consensus       166 ~~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA  245 (538)
T KOG1235|consen  166 EEPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA  245 (538)
T ss_pred             cchhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence            46799999999999999999999999764433221                            000      11334444


Q ss_pred             HHHhhc----CCCC------cceeeeeeecCceEEEEEecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHH--HHHHHhc
Q 012765          193 GIVAHI----NHPN------AAKLIGFSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEG--LQYLHHD  260 (457)
Q Consensus       193 ~~l~~l----~hpn------iv~l~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~a--L~yLH~~  260 (457)
                      +-..++    .|-+      |.++| +.....-.|+|||++|..+.+.-.-....++...+   +..+.++  -.-++  
T Consensus       246 ~Nae~~~~~f~~~~~~~~V~VP~Vy-~~~st~RVLtME~~~G~~i~Dl~~i~~~gi~~~~i---~~~l~~~~~~qIf~--  319 (538)
T KOG1235|consen  246 KNAERFRENFKDFSLLTYVLVPKVY-WDLSTKRVLTMEYVDGIKINDLDAIDKRGISPHDI---LNKLVEAYLEQIFK--  319 (538)
T ss_pred             HhHHHHHHHHHhcccccceeCCeeh-hhcCcceEEEEEecCCccCCCHHHHHHcCCCHHHH---HHHHHHHHHHHHHh--
Confidence            333222    3444      22221 22233467999999998777665333444554433   3333222  22223  


Q ss_pred             CCCCeeeCCCCCCcEEEcC----CCcEEEeeccccccCCCC
Q 012765          261 CHRRIIHRDIKASNILLSE----DYEAQISDFGLAKWLPDN  297 (457)
Q Consensus       261 ~~~~iiHrDlkp~NIll~~----~~~~kL~DFGl~~~~~~~  297 (457)
                        .|++|+|=.|.||++..    ++.+.+.|||+...+...
T Consensus       320 --~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~~  358 (538)
T KOG1235|consen  320 --TGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISHK  358 (538)
T ss_pred             --cCCccCCCCCCcEEEecCCCCCccEEEEcccccccccHH
Confidence              58999999999999983    678999999998876543

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=98.03  E-value=4.5e-05  Score=83.78  Aligned_cols=198  Identities=22%  Similarity=0.215  Sum_probs=130.4

Q ss_pred             HHHHHHHHHHHhhcCCCCcceeeeeeecCce-----EEEEEecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHh
Q 012765          185 ISDFLSELGIVAHINHPNAAKLIGFSTENGF-----HLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHH  259 (457)
Q Consensus       185 ~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~-----~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~  259 (457)
                      +....-|+..+.+..|+|++.++.|..+...     .+..+++...++...+.. -...+......+..++.+||.|+|+
T Consensus       226 i~~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~-v~~i~~~~~r~~~~~~~~GL~~~h~  304 (1351)
T KOG1035|consen  226 IQTTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQS-VGSIPLETLRILHQKLLEGLAYLHS  304 (1351)
T ss_pred             HHHHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhh-ccccCHHHHHHHHHHHhhhHHHHHH
Confidence            3445567778888899999999987655432     133477877787777744 3446777777888999999999999


Q ss_pred             cCCCCeeeCCCCCC---cEEEcCCCcEEEe--eccccccCCCCCCceeeecccccccccChhccccCCCCcc--hhHHHH
Q 012765          260 DCHRRIIHRDIKAS---NILLSEDYEAQIS--DFGLAKWLPDNWSHHIVFPIEGTFGYLSPEYFMHGIVDEK--TDVFAF  332 (457)
Q Consensus       260 ~~~~~iiHrDlkp~---NIll~~~~~~kL~--DFGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k--sDvwSl  332 (457)
                         ....|.-+..+   +...+.++...++  ||+.+..+.+.....   ...-+..|.+||......++.+  .|+|.+
T Consensus       305 ---~~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~---~~~~~~~~~~~e~~~~~~~~~~r~~dL~~l  378 (1351)
T KOG1035|consen  305 ---LSLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSF---SDLLAEIRNADEDLKENTAKKSRLTDLWCL  378 (1351)
T ss_pred             ---hccceeEEecccccccccCccceeecchhhhcccccCCCcccch---hhcCccccccccccccccchhhhhhHHHHH
Confidence               44444444444   3334555666666  898887775543221   1224556778887766655444  799999


Q ss_pred             HHHHHHHHhCCCCCCcCCcchhhhhccccccCCcccccCchhhcccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 012765          333 GVLLLELITGRRAVDSRRQSLVIWAKPLLQTSNFKELVDPRLADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQLL  411 (457)
Q Consensus       333 Gvll~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L  411 (457)
                      |.+...+..|..+-.....                  +-+.+... .   ...+......|+..++++|+...+++...
T Consensus       379 gll~~~~~~~~~i~~~~~~------------------~~~~l~~~-~---~~~~~d~~~~~~~~~~~~Rl~~~~ll~~~  435 (1351)
T KOG1035|consen  379 GLLLLQLSQGEDISEKSAV------------------PVSLLDVL-S---TSELLDALPKCLDEDSEERLSALELLTHP  435 (1351)
T ss_pred             HHHHhhhhhcCcccccccc------------------hhhhhccc-c---chhhhhhhhhhcchhhhhccchhhhhhch
Confidence            9999999998765432100                  00111111 1   11334455679999999999999998843

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=98.03  E-value=3.1e-05  Score=70.20  Aligned_cols=101  Identities=22%  Similarity=0.213  Sum_probs=79.9

Q ss_pred             HHHHHHhhcCC-CCcceeeeeeecCceEEEEEecCCCChhhhhh--cCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCee
Q 012765          190 SELGIVAHINH-PNAAKLIGFSTENGFHLVLQFLPHGSLSSLLF--GSTECLEWTIRYKIALGIAEGLQYLHHDCHRRII  266 (457)
Q Consensus       190 ~E~~~l~~l~h-pniv~l~~~~~~~~~~lv~e~~~~gsL~~~l~--~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~ii  266 (457)
                      .|.-++..+.+ +++++++|+|-   -.++.||...+++.....  ..-...+|..+++||.++++.+.+|+......+.
T Consensus         8 ~E~lll~~l~~~~~~pk~lG~CG---~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~~~   84 (188)
T PF12260_consen    8 NEPLLLQLLQGSEPFPKLLGSCG---RFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGFFY   84 (188)
T ss_pred             cHHHHHHHcCCCCCCCCeeeECC---CEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCcEE
Confidence            47777777865 69999999884   367889998776643210  0122468999999999999999999986545688


Q ss_pred             eCCCCCCcEEEcCCCcEEEeecccccc
Q 012765          267 HRDIKASNILLSEDYEAQISDFGLAKW  293 (457)
Q Consensus       267 HrDlkp~NIll~~~~~~kL~DFGl~~~  293 (457)
                      -.|++++|+-+++++++|++|...+..
T Consensus        85 lcDv~~~nfgv~~~~~lk~iDld~v~~  111 (188)
T PF12260_consen   85 LCDVSPDNFGVNDDGRLKLIDLDDVFV  111 (188)
T ss_pred             EeecchHHeEEeCCCcEEEEechhcch
Confidence            899999999999999999999986643

Proteins in this uncharacterised family are described as transmembrane proteins.

>PLN02876 acyl-CoA dehydrogenase

Probab=97.98  E-value=0.00011  Score=81.83  Aligned_cols=78  Identities=12%  Similarity=0.185  Sum_probs=54.5

Q ss_pred             CceecccCcEEEEEEEeCCC---cEEEEEEEeccchhhHHHHHHHHHHHHHHhhcC-CCCc--ceeeeeeecC----ceE
Q 012765          147 ENLIGKGGHAEVYKGCLPDG---EVVAVKKIIKNAKEDEERISDFLSELGIVAHIN-HPNA--AKLIGFSTEN----GFH  216 (457)
Q Consensus       147 ~~~LG~G~~g~Vy~~~~~~~---~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpni--v~l~~~~~~~----~~~  216 (457)
                      ...|+.|.+..+|+....++   ..+++|+........  ....+.+|+.++..+. |.++  .+++.+|.+.    ..+
T Consensus        43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~--~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~f  120 (822)
T PLN02876         43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQ--SAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAF  120 (822)
T ss_pred             EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCc--cHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCce
Confidence            46789999999999876543   367777654322111  1236778999998885 6654  7777877653    478


Q ss_pred             EEEEecCCCC
Q 012765          217 LVLQFLPHGS  226 (457)
Q Consensus       217 lv~e~~~~gs  226 (457)
                      +||||+++..
T Consensus       121 lVME~v~G~~  130 (822)
T PLN02876        121 YIMEYLEGRI  130 (822)
T ss_pred             EEEEecCCcc
Confidence            9999998764

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=97.97  E-value=0.00012  Score=69.26  Aligned_cols=137  Identities=15%  Similarity=0.105  Sum_probs=79.1

Q ss_pred             eecccCc-EEEEEEEeCCCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcC-CCCcceeeeeeecC-ceEEEEEecCCC
Q 012765          149 LIGKGGH-AEVYKGCLPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHIN-HPNAAKLIGFSTEN-GFHLVLQFLPHG  225 (457)
Q Consensus       149 ~LG~G~~-g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~-~~~lv~e~~~~g  225 (457)
                      .|..|.. ..||+.... +..+++|+.....      ...+.+|+.++..+. +--+.+++++...+ ..++||++++|.
T Consensus         5 ~~~~g~~~~~v~~~~~~-~~~~~vk~~~~~~------~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~   77 (244)
T cd05150           5 RVTEGQSGATVYRLDGK-NPGLYLKIAPSGP------TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGV   77 (244)
T ss_pred             ecCCCCCcCeEEEEcCC-CCcEEEEecCCCc------ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCc
Confidence            3445555 789998764 4678888764332      224567887777763 34466777765543 468999999987


Q ss_pred             Chhhhh-------------------hcCC---CCCCH--HHHHHHHH--------------------HHHHHHHHHHhc-
Q 012765          226 SLSSLL-------------------FGST---ECLEW--TIRYKIAL--------------------GIAEGLQYLHHD-  260 (457)
Q Consensus       226 sL~~~l-------------------~~~~---~~~~~--~~~~~i~~--------------------qia~aL~yLH~~-  260 (457)
                      ++....                   +...   ..+..  ...+....                    .+...+..|-.. 
T Consensus        78 ~l~~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  157 (244)
T cd05150          78 PAAALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATR  157 (244)
T ss_pred             cHhHhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhC
Confidence            765331                   1110   01110  00000000                    011112222110 


Q ss_pred             ---CCCCeeeCCCCCCcEEEcCCCcEEEeeccccc
Q 012765          261 ---CHRRIIHRDIKASNILLSEDYEAQISDFGLAK  292 (457)
Q Consensus       261 ---~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~  292 (457)
                         ....++|+|+.|.|||++.++.+.|+||+.+.
T Consensus       158 ~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~  192 (244)
T cd05150         158 PAEEDLVVTHGDACLPNIIVDPGKFSGFIDLGRLG  192 (244)
T ss_pred             CCcCceEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence               12459999999999999998778899998663

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=97.92  E-value=0.00026  Score=64.55  Aligned_cols=131  Identities=23%  Similarity=0.387  Sum_probs=86.8

Q ss_pred             CCceecccCcEEEEEEEeCCCcEEEEEEEeccchh-------------hHHHHHHHHHHHHHHhhcC------CCCccee
Q 012765          146 SENLIGKGGHAEVYKGCLPDGEVVAVKKIIKNAKE-------------DEERISDFLSELGIVAHIN------HPNAAKL  206 (457)
Q Consensus       146 ~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-------------~~~~~~~~~~E~~~l~~l~------hpniv~l  206 (457)
                      ....||+|+.-.||.  +++.....||+.......             ......+..+|+.....+.      +.+|.++
T Consensus         5 ~~~~i~~G~~R~cy~--HP~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~   82 (199)
T PF10707_consen    5 ESDLIAQGGERDCYQ--HPDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRF   82 (199)
T ss_pred             CCcccccCCCceEEE--CCCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccE
Confidence            346899999999997  456666788877655400             0011345556665554444      8899999


Q ss_pred             eee-eecCceEEEEEecCC------CChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcC
Q 012765          207 IGF-STENGFHLVLQFLPH------GSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSE  279 (457)
Q Consensus       207 ~~~-~~~~~~~lv~e~~~~------gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~  279 (457)
                      +|+ .++.+..+|+|.+.+      -+|.+++..  ..++.    .+...+-+-..||-.   ..|+.+|++|.||++..
T Consensus        83 ~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~--~~~~~----~~~~~L~~f~~~l~~---~~Iv~~dl~~~NIv~~~  153 (199)
T PF10707_consen   83 YGFVETNLGLGLVVELIRDADGNISPTLEDYLKE--GGLTE----ELRQALDEFKRYLLD---HHIVIRDLNPHNIVVQR  153 (199)
T ss_pred             eEEEecCCceEEEEEEEECCCCCcCccHHHHHHc--CCccH----HHHHHHHHHHHHHHH---cCCeecCCCcccEEEEe
Confidence            995 566678888887543      256677732  23444    233344455667777   78999999999999964


Q ss_pred             CC----cEEEee
Q 012765          280 DY----EAQISD  287 (457)
Q Consensus       280 ~~----~~kL~D  287 (457)
                      +.    .+.|+|
T Consensus       154 ~~~~~~~lvlID  165 (199)
T PF10707_consen  154 RDSGEFRLVLID  165 (199)
T ss_pred             cCCCceEEEEEe
Confidence            32    577888

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=97.83  E-value=0.0002  Score=67.36  Aligned_cols=72  Identities=11%  Similarity=0.139  Sum_probs=43.4

Q ss_pred             ceecccCcE-EEEEEEeCCCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCC---CcceeeeeeecC----ceEEEE
Q 012765          148 NLIGKGGHA-EVYKGCLPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHP---NAAKLIGFSTEN----GFHLVL  219 (457)
Q Consensus       148 ~~LG~G~~g-~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp---niv~l~~~~~~~----~~~lv~  219 (457)
                      +.|+.|+.. .||+.    +..+++|.....     .....+.+|..++..+...   .+.++++.....    ..+++|
T Consensus         3 ~~~~~gG~~n~vy~~----~~~~VlR~~~~~-----~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~   73 (235)
T cd05155           3 EPVDSGGTDNATFRL----GDDMSVRLPSAA-----GYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVY   73 (235)
T ss_pred             eeccCCCcccceEEc----CCceEEEcCCcc-----chHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEE
Confidence            567777766 59974    235677754321     1234678899888777532   344444433321    237899


Q ss_pred             EecCCCChh
Q 012765          220 QFLPHGSLS  228 (457)
Q Consensus       220 e~~~~gsL~  228 (457)
                      ++++|.++.
T Consensus        74 ~~i~G~~l~   82 (235)
T cd05155          74 RWLEGETAT   82 (235)
T ss_pred             EeecCCCCC
Confidence            999886653

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=97.80  E-value=0.00024  Score=64.40  Aligned_cols=127  Identities=22%  Similarity=0.328  Sum_probs=88.3

Q ss_pred             cCCCCCceecccCc-EEEEEEEeCCCcEEEEEEEec---cc--------hh-h------HHHHHHHHHHHHHHhhcC---
Q 012765          142 DNFNSENLIGKGGH-AEVYKGCLPDGEVVAVKKIIK---NA--------KE-D------EERISDFLSELGIVAHIN---  199 (457)
Q Consensus       142 ~~f~~~~~LG~G~~-g~Vy~~~~~~~~~vavK~~~~---~~--------~~-~------~~~~~~~~~E~~~l~~l~---  199 (457)
                      .+++.++.||.|.- |.||++.. +|+.||+|....   ..        .. .      ......|..|.....+|+   
T Consensus        37 ~~I~flefLg~g~~~~~V~kv~I-~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~  115 (207)
T PF13095_consen   37 DDIEFLEFLGHGSHDGYVFKVEI-DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAG  115 (207)
T ss_pred             CcEeeeeecCCCCceeEEEEEEE-CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhcc
Confidence            67888999999999 99999987 788999998321   00        00 0      023446778887777664   


Q ss_pred             CCCc--ceeeeeeecC-------------------ceEEEEEecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHH
Q 012765          200 HPNA--AKLIGFSTEN-------------------GFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLH  258 (457)
Q Consensus       200 hpni--v~l~~~~~~~-------------------~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH  258 (457)
                      +.++  |+++||..-.                   -..+|.||.+...          .+.    ..-+.+|.+-+..+|
T Consensus       116 ~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~----------~~~----~~~~~~~~~dl~~~~  181 (207)
T PF13095_consen  116 REGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP----------PLQ----IRDIPQMLRDLKILH  181 (207)
T ss_pred             ccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc----------ccc----hhHHHHHHHHHHHHH
Confidence            5566  8999964211                   0236667665543          111    223567888899999


Q ss_pred             hcCCCCeeeCCCCCCcEEEcCCCcEEEeecccc
Q 012765          259 HDCHRRIIHRDIKASNILLSEDYEAQISDFGLA  291 (457)
Q Consensus       259 ~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~  291 (457)
                      .   .+|+-+|+++.|..     .-||+|||.+
T Consensus       182 k---~gI~~~Dv~~~ny~-----~G~lvDfs~~  206 (207)
T PF13095_consen  182 K---LGIVPRDVKPRNYR-----GGKLVDFSSS  206 (207)
T ss_pred             H---CCeeeccCcccccc-----CCEEEecccC
Confidence            9   89999999999986     3478999854

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=97.77  E-value=0.00019  Score=63.27  Aligned_cols=128  Identities=20%  Similarity=0.278  Sum_probs=85.1

Q ss_pred             CCceecccCcEEEEEEEeCCCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcce-eeeeeecCceEEEEEecCC
Q 012765          146 SENLIGKGGHAEVYKGCLPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAK-LIGFSTENGFHLVLQFLPH  224 (457)
Q Consensus       146 ~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~-l~~~~~~~~~~lv~e~~~~  224 (457)
                      ..+.|++|++|.||+|.+ .|..+|+|.-..+.     ....+..|+++|..+.-.++.+ +|.|..+   .+.|||+.|
T Consensus        26 v~~~L~KG~~s~Vyl~~~-~~~~~a~Kvrr~ds-----~r~~l~kEakiLeil~g~~~~p~vy~yg~~---~i~me~i~G   96 (201)
T COG2112          26 VEKELAKGTTSVVYLGEW-RGGEVALKVRRRDS-----PRRNLEKEAKILEILAGEGVTPEVYFYGED---FIRMEYIDG   96 (201)
T ss_pred             hhhhhhcccccEEEEeec-cCceEEEEEecCCc-----chhhHHHHHHHHHHhhhcCCCceEEEechh---hhhhhhhcC
Confidence            457899999999999988 45588888654432     2447888999998887655443 3333332   344999988


Q ss_pred             CChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCC-CCcEEEcCCCcEEEeecccccc
Q 012765          225 GSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIK-ASNILLSEDYEAQISDFGLAKW  293 (457)
Q Consensus       225 gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlk-p~NIll~~~~~~kL~DFGl~~~  293 (457)
                      -.|.+.-...    +-.+    +..+++.-.-|-.   .+|-|+.|. |...+|..++.+.|+||..++.
T Consensus        97 ~~L~~~~~~~----~rk~----l~~vlE~a~~LD~---~GI~H~El~~~~k~vlv~~~~~~iIDFd~At~  155 (201)
T COG2112          97 RPLGKLEIGG----DRKH----LLRVLEKAYKLDR---LGIEHGELSRPWKNVLVNDRDVYIIDFDSATF  155 (201)
T ss_pred             cchhhhhhcc----cHHH----HHHHHHHHHHHHH---hccchhhhcCCceeEEecCCcEEEEEccchhh
Confidence            8877665321    2222    2345555333444   789999886 4445555555999999998863

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=97.62  E-value=0.00083  Score=62.92  Aligned_cols=73  Identities=23%  Similarity=0.233  Sum_probs=45.5

Q ss_pred             ceecccCcEEEEEEEeCC--CcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCC-cceeeeeeecCceEEEEEecCC
Q 012765          148 NLIGKGGHAEVYKGCLPD--GEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPN-AAKLIGFSTENGFHLVLQFLPH  224 (457)
Q Consensus       148 ~~LG~G~~g~Vy~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpn-iv~l~~~~~~~~~~lv~e~~~~  224 (457)
                      +.|..|-...+|+....+  +..|++|........    .....+|+.++..+...+ .+++++... +  .++|||++|
T Consensus         4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~----~~d~~~E~~~~~~l~~~gl~P~v~~~~~-~--~~l~e~i~G   76 (235)
T cd05157           4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTEL----IIDRERELRIHKLLSKHGLAPKLYATFQ-N--GLIYEFIPG   76 (235)
T ss_pred             EEcCCcccceEEEEEcCCCCCCeEEEEEccCCccc----eecHHHHHHHHHHHHhCCCCCeEEEEeC-C--cEEEEeeCC
Confidence            567778888999987654  678888865432211    112346777777774333 444444433 2  379999988


Q ss_pred             CCh
Q 012765          225 GSL  227 (457)
Q Consensus       225 gsL  227 (457)
                      .++
T Consensus        77 ~~l   79 (235)
T cd05157          77 RTL   79 (235)
T ss_pred             CcC
Confidence            665

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>PRK05231 homoserine kinase; Provisional

Probab=97.59  E-value=0.0024  Score=62.86  Aligned_cols=31  Identities=32%  Similarity=0.433  Sum_probs=26.5

Q ss_pred             CCCeeeCCCCCCcEEEcCCCcEEEeeccccc
Q 012765          262 HRRIIHRDIKASNILLSEDYEAQISDFGLAK  292 (457)
Q Consensus       262 ~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~  292 (457)
                      ..+++|+|+.|.||+++.+...-|+||+.+.
T Consensus       186 p~~liHgD~~~~Nil~~~~~~~~iIDf~~~~  216 (319)
T PRK05231        186 PRGVIHADLFRDNVLFEGDRLSGFIDFYFAC  216 (319)
T ss_pred             CcccCCCCCCCCcEEEECCceEEEEeccccc
Confidence            4689999999999999976556899999764

>PRK10593 hypothetical protein; Provisional

Probab=97.57  E-value=0.0019  Score=63.00  Aligned_cols=76  Identities=13%  Similarity=-0.028  Sum_probs=52.7

Q ss_pred             CCceecccCcEEEEEEEeCCCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCC---CCcceeeeeeec----CceEEE
Q 012765          146 SENLIGKGGHAEVYKGCLPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINH---PNAAKLIGFSTE----NGFHLV  218 (457)
Q Consensus       146 ~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h---pniv~l~~~~~~----~~~~lv  218 (457)
                      ..+.||.|..+.||+....++ .+++|... ....    ...+..|...|+.+..   -.+.++++++..    +..++|
T Consensus        18 ~~~~i~~G~~~~vy~~~~~~~-~~~~k~~~-~~~~----~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LV   91 (297)
T PRK10593         18 RVECISEQPYAALWALYDSQG-NPMPLMAR-SFST----PGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLL   91 (297)
T ss_pred             eeeecCCccceeEEEEEcCCC-CEEEEEec-cccc----chHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEE
Confidence            346799999999999876555 46666532 2111    1367788888887743   467888876543    447899


Q ss_pred             EEecCCCCh
Q 012765          219 LQFLPHGSL  227 (457)
Q Consensus       219 ~e~~~~gsL  227 (457)
                      ||++++.++
T Consensus        92 mE~i~G~~~  100 (297)
T PRK10593         92 LERLRGVSV  100 (297)
T ss_pred             EeccCCEec
Confidence            999998754

>PRK09550 mtnK methylthioribose kinase; Reviewed

Probab=97.48  E-value=0.0014  Score=66.19  Aligned_cols=78  Identities=15%  Similarity=0.136  Sum_probs=51.9

Q ss_pred             ceecccCcEEEEEEEeCCC-cEEEEEEEeccchh--h--HHHHHHHHHHHHHHhhcC---CCCcceeeeeeecCceEEEE
Q 012765          148 NLIGKGGHAEVYKGCLPDG-EVVAVKKIIKNAKE--D--EERISDFLSELGIVAHIN---HPNAAKLIGFSTENGFHLVL  219 (457)
Q Consensus       148 ~~LG~G~~g~Vy~~~~~~~-~~vavK~~~~~~~~--~--~~~~~~~~~E~~~l~~l~---hpniv~l~~~~~~~~~~lv~  219 (457)
                      +.||.|.+..||++...+| +.++||........  .  .-...++..|.+.|..+.   ..++++++.+.. ...++||
T Consensus        32 ~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~D~-~~~~lVM  110 (401)
T PRK09550         32 REIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHYDE-ELAVTVM  110 (401)
T ss_pred             eEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEECC-CCCEEEE
Confidence            5799999999999998776 58999975321110  0  112345666777776652   345777777644 4467999


Q ss_pred             EecCCCC
Q 012765          220 QFLPHGS  226 (457)
Q Consensus       220 e~~~~gs  226 (457)
                      |++++..
T Consensus       111 E~L~~~~  117 (401)
T PRK09550        111 EDLSDHK  117 (401)
T ss_pred             ecCCCcc
Confidence            9988643

>TIGR02721 ycfN_thiK thiamine kinase

Probab=97.44  E-value=0.001  Score=63.26  Aligned_cols=135  Identities=15%  Similarity=0.085  Sum_probs=74.0

Q ss_pred             ecccCcEEEEEEEeCCCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCc-ceeeeeeecCceEEEEEecCCCChh
Q 012765          150 IGKGGHAEVYKGCLPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNA-AKLIGFSTENGFHLVLQFLPHGSLS  228 (457)
Q Consensus       150 LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpni-v~l~~~~~~~~~~lv~e~~~~gsL~  228 (457)
                      +..|-.+.+|+... ++..+++|.........   ..+..+|..++..+....+ .+++.+..   -.+||+|++|..+.
T Consensus         4 ~~~G~tn~~y~~~~-~~~~~vlR~~~~~~~~~---~~~r~~E~~~l~~l~~~g~~P~~i~~~~---~~~v~e~i~G~~~~   76 (256)
T TIGR02721         4 LSGGLTNRSWRIEH-PGISFVWRPQSPVCKAL---GVDRQREYQILQALSALGLAPKPILVNE---HWLLVEWLEGEVIT   76 (256)
T ss_pred             CCCcCcCCeEEEEe-CCccEEEeeCCcccccc---cCcHHHHHHHHHHHHhcCCCCceEEEeC---CEEEEEeccCcccc
Confidence            55677889998874 56778888643221110   0134567777777754333 34444432   36899999886553


Q ss_pred             hh-----------------hhcC---CCCCCHHHH-HHHHHH---------HHHHHHHHHhc-----CCCCeeeCCCCCC
Q 012765          229 SL-----------------LFGS---TECLEWTIR-YKIALG---------IAEGLQYLHHD-----CHRRIIHRDIKAS  273 (457)
Q Consensus       229 ~~-----------------l~~~---~~~~~~~~~-~~i~~q---------ia~aL~yLH~~-----~~~~iiHrDlkp~  273 (457)
                      ..                 ++..   ...++.... .....+         +...+..+-..     ....++|+|+.|.
T Consensus        77 ~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~  156 (256)
T TIGR02721        77 LDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAY  156 (256)
T ss_pred             cccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcC
Confidence            21                 1111   111121111 111101         11112222111     1236899999999


Q ss_pred             cEEEcCCCcEEEeeccccc
Q 012765          274 NILLSEDYEAQISDFGLAK  292 (457)
Q Consensus       274 NIll~~~~~~kL~DFGl~~  292 (457)
                      ||++++++ +.|+||..+.
T Consensus       157 Nil~~~~~-~~lIDwE~a~  174 (256)
T TIGR02721       157 NLVVTPQG-LKLIDWEYAS  174 (256)
T ss_pred             cEEEeCCC-CEEEeccccC
Confidence            99999877 7899998764

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=97.37  E-value=0.0024  Score=62.12  Aligned_cols=139  Identities=19%  Similarity=0.175  Sum_probs=80.0

Q ss_pred             CceecccCcEEEEEEEeCCCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCC--Ccceeeee-------eecCceEE
Q 012765          147 ENLIGKGGHAEVYKGCLPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHP--NAAKLIGF-------STENGFHL  217 (457)
Q Consensus       147 ~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp--niv~l~~~-------~~~~~~~l  217 (457)
                      .+.|..|....+|+....+ ..+++|+...  . .   ...+..|+.++..+.+.  .+++++..       ...+..++
T Consensus        19 i~~i~~G~~n~~y~v~~~~-~~~vLr~~~~--~-~---~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~   91 (296)
T cd05153          19 FEGISAGIENTNYFVTTDS-GRYVLTLFEK--V-S---AEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAA   91 (296)
T ss_pred             eecccCccccceEEEEeCC-CcEEEEEcCC--C-C---hHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEE
Confidence            4567778888999987544 4688887643  1 1   12455566666666432  24444431       12344578


Q ss_pred             EEEecCCCChhh----h----------hhcCC----------CCCCHHHHH----------HHHHHHHHHHHHHHh----
Q 012765          218 VLQFLPHGSLSS----L----------LFGST----------ECLEWTIRY----------KIALGIAEGLQYLHH----  259 (457)
Q Consensus       218 v~e~~~~gsL~~----~----------l~~~~----------~~~~~~~~~----------~i~~qia~aL~yLH~----  259 (457)
                      ++++++|..+..    .          ++...          ....|....          .....+..++.++..    
T Consensus        92 l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~  171 (296)
T cd05153          92 LVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPS  171 (296)
T ss_pred             EEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhh
Confidence            999998866432    0          11100          011221110          011122334444443    


Q ss_pred             cCCCCeeeCCCCCCcEEEcCCCcEEEeeccccc
Q 012765          260 DCHRRIIHRDIKASNILLSEDYEAQISDFGLAK  292 (457)
Q Consensus       260 ~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~  292 (457)
                      ....+++|+|+.|.||++++++.+.|+||+.+.
T Consensus       172 ~~~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~  204 (296)
T cd05153         172 DLPRGVIHADLFRDNVLFDGDELSGVIDFYFAC  204 (296)
T ss_pred             cCCCcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence            223579999999999999988777899998764

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only]

Probab=97.37  E-value=0.00028  Score=67.89  Aligned_cols=151  Identities=16%  Similarity=0.171  Sum_probs=96.0

Q ss_pred             cccHHHHHHhhc---CCCCCceecccCcEEEEEEEeCCCcEEEEEEEeccc------hh-------------hHHHHHHH
Q 012765          131 NFDFAELAAATD---NFNSENLIGKGGHAEVYKGCLPDGEVVAVKKIIKNA------KE-------------DEERISDF  188 (457)
Q Consensus       131 ~~~~~~~~~~~~---~f~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~------~~-------------~~~~~~~~  188 (457)
                      -+++-.+.....   -+.+.+.||-|.-+.||.+.+.+|++.++|.-.-..      +.             -.-..-..
T Consensus        78 GyDyLAlktL~~R~~v~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa  157 (465)
T KOG2268|consen   78 GYDYLALKTLSNRGSVESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAA  157 (465)
T ss_pred             cchHHHHHHHHhcchhhhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHH
Confidence            355555544432   356778999999999999999999999998321110      00             01112245


Q ss_pred             HHHHHHHhhcC-CC-CcceeeeeeecCceEEEEEecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCee
Q 012765          189 LSELGIVAHIN-HP-NAAKLIGFSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRII  266 (457)
Q Consensus       189 ~~E~~~l~~l~-hp-niv~l~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~ii  266 (457)
                      .+|+..|+.|. |. -+.+.+++..   -++|||++.+..|...-+    ..+...   +...+..-+--|..   .|+|
T Consensus       158 ~kEfafmkaL~e~gfpVPkpiD~~R---H~Vvmelv~g~Pl~~v~~----v~d~~~---ly~~lm~~Iv~la~---~GlI  224 (465)
T KOG2268|consen  158 TKEFAFMKALYERGFPVPKPIDHNR---HCVVMELVDGYPLRQVRH----VEDPPT---LYDDLMGLIVRLAN---HGLI  224 (465)
T ss_pred             HHHHHHHHHHHHcCCCCCCcccccc---eeeHHHhhcccceeeeee----cCChHH---HHHHHHHHHHHHHH---cCce
Confidence            56777777774 22 2333444332   478899888877765431    122222   23333344445555   7999


Q ss_pred             eCCCCCCcEEEcCCCcEEEeeccccccC
Q 012765          267 HRDIKASNILLSEDYEAQISDFGLAKWL  294 (457)
Q Consensus       267 HrDlkp~NIll~~~~~~kL~DFGl~~~~  294 (457)
                      |+|..--||++.+++.++++||--+...
T Consensus       225 HgDFNEFNimv~dd~~i~vIDFPQmvS~  252 (465)
T KOG2268|consen  225 HGDFNEFNIMVKDDDKIVVIDFPQMVST  252 (465)
T ss_pred             ecccchheeEEecCCCEEEeechHhhcc
Confidence            9999999999999999999999655433

>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2')

Probab=97.24  E-value=0.0049  Score=59.45  Aligned_cols=30  Identities=30%  Similarity=0.524  Sum_probs=25.0

Q ss_pred             CCeeeCCCCCCcEEEcCCCc-EEEeeccccc
Q 012765          263 RRIIHRDIKASNILLSEDYE-AQISDFGLAK  292 (457)
Q Consensus       263 ~~iiHrDlkp~NIll~~~~~-~kL~DFGl~~  292 (457)
                      ..++|+|+.|.||+++.++. .-|+||+.+.
T Consensus       185 ~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~  215 (276)
T cd05152         185 TVLVHGDLHPGHILIDEDARVTGLIDWTEAK  215 (276)
T ss_pred             CeeEeCCCCCCcEEEeCCCCEEEEECcHhcc
Confidence            45899999999999997555 4699999764

MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=97.24  E-value=0.0027  Score=62.00  Aligned_cols=138  Identities=25%  Similarity=0.320  Sum_probs=78.0

Q ss_pred             ceecccCcEEEEEEEeCC-------CcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCC-cceeeeeeecCceEEEE
Q 012765          148 NLIGKGGHAEVYKGCLPD-------GEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPN-AAKLIGFSTENGFHLVL  219 (457)
Q Consensus       148 ~~LG~G~~g~Vy~~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpn-iv~l~~~~~~~~~~lv~  219 (457)
                      +.|..|--..||+....+       ++.+++|+.......    ..+..+|..++..+.... ..++++++.+   .+|+
T Consensus         4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~~----~~~r~~E~~~~~~l~~~g~~P~~~~~~~~---~~v~   76 (302)
T cd05156           4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVEL----LIDRERELVVFARLSERNLGPKLYGIFPN---GRIE   76 (302)
T ss_pred             EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCcc----eechHHHHHHHHHHHhCCCCCceEEEeCC---Cchh
Confidence            345566677899987654       578888875433211    224566777777764333 3445555432   3578


Q ss_pred             EecCCCChhhh-----------------hhcCCCC--------CC--HHHHHH--------------------------H
Q 012765          220 QFLPHGSLSSL-----------------LFGSTEC--------LE--WTIRYK--------------------------I  246 (457)
Q Consensus       220 e~~~~gsL~~~-----------------l~~~~~~--------~~--~~~~~~--------------------------i  246 (457)
                      +|++|..+...                 ++.....        .+  +.....                          +
T Consensus        77 e~i~G~~l~~~~~~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  156 (302)
T cd05156          77 EFIPSRTLTTEELRDPDISAEIARRMAKLHSIVVPLSPEERDLTPAIWKLLKQWLDLAETVIEIVDSDSEKLLEVELSLF  156 (302)
T ss_pred             heeCCCcCCHhHcCCcHHHHHHHHHHHHhhCCCCCCCCCcCcccchHHHHHHHHHHHhhhhhhhcccchhhhhhhhHHHH
Confidence            88887655321                 1111100        00  111100                          0


Q ss_pred             HHHHHHHHHHHHh------cCCCCeeeCCCCCCcEEEcCC----CcEEEeeccccc
Q 012765          247 ALGIAEGLQYLHH------DCHRRIIHRDIKASNILLSED----YEAQISDFGLAK  292 (457)
Q Consensus       247 ~~qia~aL~yLH~------~~~~~iiHrDlkp~NIll~~~----~~~kL~DFGl~~  292 (457)
                      ...+...+.+|-.      .....++|+|+.+.||+++.+    +.+.|+||..+.
T Consensus       157 ~~~~~~~~~~l~~~~~~~~~~~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~  212 (302)
T cd05156         157 LEDEAKYLRFLLESTSEESGSPVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYAS  212 (302)
T ss_pred             HHHHHHHHHHHHhhccCCCCCCceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCC
Confidence            1122222334431      134679999999999999985    789999998764

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=97.00  E-value=0.035  Score=54.37  Aligned_cols=140  Identities=20%  Similarity=0.230  Sum_probs=77.4

Q ss_pred             CceecccCcEEEEEEEeCCCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCC--CCcceeeee-------eecCceEE
Q 012765          147 ENLIGKGGHAEVYKGCLPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINH--PNAAKLIGF-------STENGFHL  217 (457)
Q Consensus       147 ~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h--pniv~l~~~-------~~~~~~~l  217 (457)
                      ...++.|....+|+....+| .+++|+......     ...+..|+.++..|..  -.+++++..       ..++..++
T Consensus        27 i~~~~~G~~n~~y~v~t~~~-~~vLK~~~~~~~-----~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~  100 (307)
T TIGR00938        27 LKGIAEGVENSNYLLTTDVG-RYILTLYEKRVK-----AEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPAC  100 (307)
T ss_pred             ccccCCccccceEEEEeCCC-cEEEEEecCCCC-----HHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEE
Confidence            45677777789999876455 577887643211     1133445555555532  123444331       12344678


Q ss_pred             EEEecCCCChhh-----------h---hhcCCC-----------CCCHHHHH------------HHHHHHHHHHHHHHh-
Q 012765          218 VLQFLPHGSLSS-----------L---LFGSTE-----------CLEWTIRY------------KIALGIAEGLQYLHH-  259 (457)
Q Consensus       218 v~e~~~~gsL~~-----------~---l~~~~~-----------~~~~~~~~------------~i~~qia~aL~yLH~-  259 (457)
                      +++|++|..+..           .   ++....           ...|....            .....+...+.++.. 
T Consensus       101 l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~  180 (307)
T TIGR00938       101 LVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKF  180 (307)
T ss_pred             EEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhh
Confidence            999998854321           0   111000           01111110            001123334555532 


Q ss_pred             ---cCCCCeeeCCCCCCcEEEcCCCcEEEeeccccc
Q 012765          260 ---DCHRRIIHRDIKASNILLSEDYEAQISDFGLAK  292 (457)
Q Consensus       260 ---~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~  292 (457)
                         ....+++|+|+.+.||+++.++.+.|+||+.+.
T Consensus       181 ~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~  216 (307)
T TIGR00938       181 WPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC  216 (307)
T ss_pred             hhhcCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence               234789999999999999988767899998764

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]

Probab=96.62  E-value=0.029  Score=54.92  Aligned_cols=143  Identities=15%  Similarity=0.202  Sum_probs=77.5

Q ss_pred             ceecccCcEEEEEEEeCCCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCC--CcceeeeeeecCc---eEEEEEec
Q 012765          148 NLIGKGGHAEVYKGCLPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHP--NAAKLIGFSTENG---FHLVLQFL  222 (457)
Q Consensus       148 ~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp--niv~l~~~~~~~~---~~lv~e~~  222 (457)
                      +.+..|.--.+|.... .++.+++. .. .............+|+.+++.+.--  -+...+++|.++.   .+.||+++
T Consensus        31 ~~~~~G~sn~t~~~~~-~~~~~vlR-~P-~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~v  107 (321)
T COG3173          31 EEISGGWSNDTFRLGD-TGQKYVLR-KP-PRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWV  107 (321)
T ss_pred             eeccCCcccceEEEec-CCceEEEe-cC-CccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEe
Confidence            3443344445555444 37777777 22 1222223455677788888777532  2334455555444   57999999


Q ss_pred             CCCChhhhhhcCCC-------------------------------------CCCHHHHHHHH--------HHHHHHHHHH
Q 012765          223 PHGSLSSLLFGSTE-------------------------------------CLEWTIRYKIA--------LGIAEGLQYL  257 (457)
Q Consensus       223 ~~gsL~~~l~~~~~-------------------------------------~~~~~~~~~i~--------~qia~aL~yL  257 (457)
                      .|..+...+.....                                     ...|...+..+        -....-..+|
T Consensus       108 eGe~~~~~~~~~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~~Wl  187 (321)
T COG3173         108 EGEVVWSALPPESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLIKWL  187 (321)
T ss_pred             cceeccCcCCcccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHHHHH
Confidence            88433222210000                                     00111111000        0112223444


Q ss_pred             HhcC-----CCCeeeCCCCCCcEEEcCCCcEEEeecccccc
Q 012765          258 HHDC-----HRRIIHRDIKASNILLSEDYEAQISDFGLAKW  293 (457)
Q Consensus       258 H~~~-----~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~  293 (457)
                      +...     ...++|+|+.+.||+++.++.+-+.||+++..
T Consensus       188 ~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~l  228 (321)
T COG3173         188 EANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATL  228 (321)
T ss_pred             HhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEecccccc
Confidence            4421     23699999999999999888899999998863

>PLN02756 S-methyl-5-thioribose kinase

Probab=96.59  E-value=0.048  Score=55.15  Aligned_cols=76  Identities=11%  Similarity=0.069  Sum_probs=48.4

Q ss_pred             CceecccCcEEEEEEEeCCCcEEEEEEEeccchhhH----HHHHHHHHHHHHHhhcC---CCCcceeeeeeecCceEEEE
Q 012765          147 ENLIGKGGHAEVYKGCLPDGEVVAVKKIIKNAKEDE----ERISDFLSELGIVAHIN---HPNAAKLIGFSTENGFHLVL  219 (457)
Q Consensus       147 ~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~----~~~~~~~~E~~~l~~l~---hpniv~l~~~~~~~~~~lv~  219 (457)
                      .+.||.|....||+... .+..++||.-........    ....+...|...|..+.   ..++++++.++.+. .+++|
T Consensus        37 ~~eiggGn~N~VyrV~~-~~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~ded~-~vlvM  114 (418)
T PLN02756         37 IKEVGDGNLNFVYIVVS-SSGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDRTM-ALIGM  114 (418)
T ss_pred             EEEcCCCceeeEEEEEc-CCccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECCCC-CEEEE
Confidence            45789999999999876 455688997542111000    01223344455555543   35788888888844 56789


Q ss_pred             EecCC
Q 012765          220 QFLPH  224 (457)
Q Consensus       220 e~~~~  224 (457)
                      |++++
T Consensus       115 E~L~~  119 (418)
T PLN02756        115 RYLEP  119 (418)
T ss_pred             eecCC
Confidence            99976

>TIGR01767 MTRK 5-methylthioribose kinase

Probab=96.57  E-value=0.017  Score=57.30  Aligned_cols=77  Identities=16%  Similarity=0.092  Sum_probs=45.3

Q ss_pred             eecccCcEEEEEEEeCCC-cEEEEEEEeccchh----hHHHHHHHHHHHHHHhhcC--CCCcceeeeeeecCceEEEEEe
Q 012765          149 LIGKGGHAEVYKGCLPDG-EVVAVKKIIKNAKE----DEERISDFLSELGIVAHIN--HPNAAKLIGFSTENGFHLVLQF  221 (457)
Q Consensus       149 ~LG~G~~g~Vy~~~~~~~-~~vavK~~~~~~~~----~~~~~~~~~~E~~~l~~l~--hpniv~l~~~~~~~~~~lv~e~  221 (457)
                      .||.|....||++...+| +.++||.-......    -.-...+..-|...|....  -|..|+-+-++......++||+
T Consensus         2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~D~e~~~~vMEd   81 (370)
T TIGR01767         2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHFDTEMAVTVMED   81 (370)
T ss_pred             cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEEccccceehHhh
Confidence            479999999999997654 58999964321110    0111234455666665553  3433333334444445689998


Q ss_pred             cCCC
Q 012765          222 LPHG  225 (457)
Q Consensus       222 ~~~g  225 (457)
                      ++..
T Consensus        82 L~~~   85 (370)
T TIGR01767        82 LSHH   85 (370)
T ss_pred             Cccc
Confidence            8653

This enzyme is involved in the methionine salvage pathway in certain bacteria.

>KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms]

Probab=96.44  E-value=0.00049  Score=77.69  Aligned_cols=157  Identities=12%  Similarity=-0.017  Sum_probs=108.4

Q ss_pred             HHHHHHHhhcCCCCcceeee-ee--ecCceEEEEEecCCCChhhhhhcCCCC---CCHHHHHHHHHHHHHHHHHHHhc--
Q 012765          189 LSELGIVAHINHPNAAKLIG-FS--TENGFHLVLQFLPHGSLSSLLFGSTEC---LEWTIRYKIALGIAEGLQYLHHD--  260 (457)
Q Consensus       189 ~~E~~~l~~l~hpniv~l~~-~~--~~~~~~lv~e~~~~gsL~~~l~~~~~~---~~~~~~~~i~~qia~aL~yLH~~--  260 (457)
                      +.|..-++...|+++...+. .-  .....+..++++..|.+.+.+......   +...-+...-.+...+..-+|+.  
T Consensus      1277 l~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tn 1356 (2724)
T KOG1826|consen 1277 LSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTN 1356 (2724)
T ss_pred             hhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhccc
Confidence            34444555678999887765 32  233457889999999999988553322   22222222222224444444442  


Q ss_pred             CCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCCCCCCceeeecccccccccChhccccCCCCcchhHHHHHHHHHHHH
Q 012765          261 CHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELI  340 (457)
Q Consensus       261 ~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLl  340 (457)
                      ...-.+|++||+.|.+|..+..+|+.++|+.+.......  ......+++.|+.|+....-.++.++|+|..|+.+|++.
T Consensus      1357 lg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~~s--f~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~rs 1434 (2724)
T KOG1826|consen 1357 LGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPVLS--FFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLRS 1434 (2724)
T ss_pred             CCccchhhhhhhhccceecCCcccccccccccccCchHh--hhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHHh
Confidence            224478999999999999999999999999984333211  122234788899999988888899999999999999999


Q ss_pred             hCCCCCC
Q 012765          341 TGRRAVD  347 (457)
Q Consensus       341 tG~~pf~  347 (457)
                      -|..+|-
T Consensus      1435 ~~n~~fi 1441 (2724)
T KOG1826|consen 1435 DGNAYFI 1441 (2724)
T ss_pred             cccHHHH
Confidence            9988874

>PLN02236 choline kinase

Probab=96.17  E-value=0.048  Score=54.36  Aligned_cols=138  Identities=19%  Similarity=0.240  Sum_probs=75.2

Q ss_pred             ceecccCcEEEEEEEeCC-----CcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCc-ceeeeeeecCceEEEEEe
Q 012765          148 NLIGKGGHAEVYKGCLPD-----GEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNA-AKLIGFSTENGFHLVLQF  221 (457)
Q Consensus       148 ~~LG~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpni-v~l~~~~~~~~~~lv~e~  221 (457)
                      ..|-.|-...+|+....+     ++.|++|........    .-+-.+|..++..+..-++ .++++++..+   .|.+|
T Consensus        42 ~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~----~idR~~E~~~~~~l~~~gl~P~~~~~~~~g---~v~ef  114 (344)
T PLN02236         42 IPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVEL----FFDRDDEIRTFECMSRHGQGPRLLGRFPNG---RVEEF  114 (344)
T ss_pred             EEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCe----eechHHHHHHHHHHHHcCCCCceEEEECCc---eEEEe
Confidence            345457777899876432     367888866443221    1122567777777754333 3455555333   57888


Q ss_pred             cCCCChhhh-----------------hhcCC----C-CCCHHHHHHHHHH-----------------HHHHHHHHH----
Q 012765          222 LPHGSLSSL-----------------LFGST----E-CLEWTIRYKIALG-----------------IAEGLQYLH----  258 (457)
Q Consensus       222 ~~~gsL~~~-----------------l~~~~----~-~~~~~~~~~i~~q-----------------ia~aL~yLH----  258 (457)
                      +.+.++...                 ++...    . ...+....++..+                 +...+..|.    
T Consensus       115 i~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~  194 (344)
T PLN02236        115 IHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELS  194 (344)
T ss_pred             eCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhc
Confidence            876555311                 11111    0 1112222222211                 111122222    


Q ss_pred             h-cCCCCeeeCCCCCCcEEEcC-CCcEEEeeccccc
Q 012765          259 H-DCHRRIIHRDIKASNILLSE-DYEAQISDFGLAK  292 (457)
Q Consensus       259 ~-~~~~~iiHrDlkp~NIll~~-~~~~kL~DFGl~~  292 (457)
                      . .....++|+|+++.|||+++ ++.+.|+||..+.
T Consensus       195 ~~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~  230 (344)
T PLN02236        195 GDDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYAS  230 (344)
T ss_pred             ccCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhcc
Confidence            1 11246899999999999986 4679999998764

>KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning]

Probab=96.03  E-value=0.13  Score=50.95  Aligned_cols=143  Identities=18%  Similarity=0.187  Sum_probs=89.8

Q ss_pred             CCceecccCcEEEEEEEeCCCcEEEEEEEeccchh---------------------hHHHH--HHHHHHHHHHhhcCCCC
Q 012765          146 SENLIGKGGHAEVYKGCLPDGEVVAVKKIIKNAKE---------------------DEERI--SDFLSELGIVAHINHPN  202 (457)
Q Consensus       146 ~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~---------------------~~~~~--~~~~~E~~~l~~l~hpn  202 (457)
                      +...|..|--+.||.|.-.+|..+|||+.+-....                     +....  --..+|+.-|.+++...
T Consensus       148 inGCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aG  227 (520)
T KOG2270|consen  148 INGCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAG  227 (520)
T ss_pred             cccccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcC
Confidence            34568889999999999889999999976321110                     01101  12334555566665444


Q ss_pred             cceeeeeeecCceEEEEEecCCCChhh-hhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCC
Q 012765          203 AAKLIGFSTENGFHLVLQFLPHGSLSS-LLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDY  281 (457)
Q Consensus       203 iv~l~~~~~~~~~~lv~e~~~~gsL~~-~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~  281 (457)
                      |.-.--+.. .+-.|||+|+....... .|  ..-.+....+..+-.+++.-+.-|...  .++||.||.--|+|+. +|
T Consensus       228 IP~PePIlL-k~hVLVM~FlGrdgw~aPkL--Kd~~ls~~ka~~~Y~~~v~~MR~lY~~--c~LVHADLSEfN~Lyh-dG  301 (520)
T KOG2270|consen  228 IPCPEPILL-KNHVLVMEFLGRDGWAAPKL--KDASLSTSKARELYQQCVRIMRRLYQK--CRLVHADLSEFNLLYH-DG  301 (520)
T ss_pred             CCCCCceee-ecceEeeeeccCCCCcCccc--ccccCChHHHHHHHHHHHHHHHHHHHH--hceeccchhhhhheEE-CC
Confidence            321111111 22358999986433221 22  222345455666677888888888875  5899999999999886 56


Q ss_pred             cEEEeeccccccC
Q 012765          282 EAQISDFGLAKWL  294 (457)
Q Consensus       282 ~~kL~DFGl~~~~  294 (457)
                      .+.|+|.+-+...
T Consensus       302 ~lyiIDVSQSVE~  314 (520)
T KOG2270|consen  302 KLYIIDVSQSVEH  314 (520)
T ss_pred             EEEEEEccccccC
Confidence            8999998877544

>PRK12396 5-methylribose kinase; Reviewed

Probab=95.90  E-value=0.027  Score=56.63  Aligned_cols=78  Identities=15%  Similarity=0.061  Sum_probs=45.8

Q ss_pred             CceecccCcEEEEEEEeCC-CcEEEEEEEeccchhh---HHHHHHHHHHHHHHhhcC--CCCcceeeeeeecCceEEEEE
Q 012765          147 ENLIGKGGHAEVYKGCLPD-GEVVAVKKIIKNAKED---EERISDFLSELGIVAHIN--HPNAAKLIGFSTENGFHLVLQ  220 (457)
Q Consensus       147 ~~~LG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~---~~~~~~~~~E~~~l~~l~--hpniv~l~~~~~~~~~~lv~e  220 (457)
                      ...||.|.-.-||++.+.+ ++.|+||.-.......   .-...+..-|..+|+...  -|..|+-+-++......+|||
T Consensus        34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~D~e~~~~vME  113 (409)
T PRK12396         34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLFDSVMNCCVME  113 (409)
T ss_pred             eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEECcHHhhHHHH
Confidence            4578999999999998743 5679999643211110   112335555666666553  343344333344444557788


Q ss_pred             ecCC
Q 012765          221 FLPH  224 (457)
Q Consensus       221 ~~~~  224 (457)
                      +++.
T Consensus       114 dL~~  117 (409)
T PRK12396        114 DLSD  117 (409)
T ss_pred             hCcc
Confidence            7754

>PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein []

Probab=95.64  E-value=0.13  Score=49.93  Aligned_cols=72  Identities=24%  Similarity=0.314  Sum_probs=42.7

Q ss_pred             CceecccCcEEEEEEEeCCCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhc---CCCCcceeeeeee-cCceEEEEEec
Q 012765          147 ENLIGKGGHAEVYKGCLPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHI---NHPNAAKLIGFST-ENGFHLVLQFL  222 (457)
Q Consensus       147 ~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l---~hpniv~l~~~~~-~~~~~lv~e~~  222 (457)
                      .+.|+.|....+|+.. .+++.+.||.-.....      ..|..|..-|+.|   .--.+++.+++.. ++..+|++||+
T Consensus        22 ~~~v~GG~i~~a~~~~-~~~~~~FvK~~~~~~~------~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l   94 (288)
T PF03881_consen   22 IEPVSGGDINEAYRLD-TDGGSYFVKVNSESGR------DMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFL   94 (288)
T ss_dssp             EEEE--SSSSEEEEEE-TTS-EEEEEEEEGGGC------CHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE--
T ss_pred             eEecCCCChhheEEEE-CCCccEEEEecChhhH------HHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEee
Confidence            4568889999999977 5788899997652211      2456677766666   3455778888654 34568999998


Q ss_pred             CCC
Q 012765          223 PHG  225 (457)
Q Consensus       223 ~~g  225 (457)
                      +.+
T Consensus        95 ~~~   97 (288)
T PF03881_consen   95 EMG   97 (288)
T ss_dssp             ---
T ss_pred             cCC
Confidence            776

Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A.

>PRK06148 hypothetical protein; Provisional

Probab=95.54  E-value=0.2  Score=57.16  Aligned_cols=33  Identities=33%  Similarity=0.458  Sum_probs=27.3

Q ss_pred             CCCCeeeCCCCCCcEEEcCCC--cEE-Eeecccccc
Q 012765          261 CHRRIIHRDIKASNILLSEDY--EAQ-ISDFGLAKW  293 (457)
Q Consensus       261 ~~~~iiHrDlkp~NIll~~~~--~~k-L~DFGl~~~  293 (457)
                      ....+||+|+.+.|||++.++  .+. |+|||.+..
T Consensus       201 Lp~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~  236 (1013)
T PRK06148        201 LPAQVIHNDANDYNILVDADDGERISGLIDFGDAVH  236 (1013)
T ss_pred             CCcceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence            446799999999999999875  555 999998753

>COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning]

Probab=95.54  E-value=0.055  Score=53.33  Aligned_cols=54  Identities=19%  Similarity=0.224  Sum_probs=46.9

Q ss_pred             CCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeecccccc
Q 012765          237 CLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKW  293 (457)
Q Consensus       237 ~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~  293 (457)
                      ...+.+.+.|+.+-+..+.-+...  ..+-|||+.-.||||+ +|++.|+||-+++.
T Consensus       317 ~~~~~e~lsff~s~~sil~~lekk--f~fehrnlt~~niLId-~GnvtLIDfklsRl  370 (488)
T COG5072         317 ADRSEEELSFFWSCISILDILEKK--FPFEHRNLTLDNILID-EGNVTLIDFKLSRL  370 (488)
T ss_pred             cccHHHHHHHHHHHHHHHhhhhhc--CCcccccccccceeee-cCceEEEEeeeeec
Confidence            356788888998888888887774  7899999999999999 99999999999984

>TIGR02906 spore_CotS spore coat protein, CotS family

Probab=95.53  E-value=0.37  Score=46.93  Aligned_cols=29  Identities=34%  Similarity=0.520  Sum_probs=25.3

Q ss_pred             CCeeeCCCCCCcEEEcCCCcEEEeeccccc
Q 012765          263 RRIIHRDIKASNILLSEDYEAQISDFGLAK  292 (457)
Q Consensus       263 ~~iiHrDlkp~NIll~~~~~~kL~DFGl~~  292 (457)
                      .+++|+|+.+.||+++. +.+.|+||+.+.
T Consensus       187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~  215 (313)
T TIGR02906       187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCT  215 (313)
T ss_pred             CceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence            67999999999999987 678999998653

Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers.

>TIGR02904 spore_ysxE spore coat protein YsxE

Probab=95.42  E-value=0.22  Score=48.78  Aligned_cols=31  Identities=19%  Similarity=0.305  Sum_probs=27.9

Q ss_pred             CCCeeeCCCCCCcEEEcCCCcEEEeeccccc
Q 012765          262 HRRIIHRDIKASNILLSEDYEAQISDFGLAK  292 (457)
Q Consensus       262 ~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~  292 (457)
                      ..+++|+|+.+.|+|+++++.+.++||..++
T Consensus       195 ~~~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~  225 (309)
T TIGR02904       195 RTVLVHGKLSLSHFLYDETRGGYFINFEKAS  225 (309)
T ss_pred             ceeeeCCCCcHHhEEEcCCCCEEEEEhhhcc
Confidence            4579999999999999999999999998765

Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat.

>COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only]

Probab=95.31  E-value=0.48  Score=46.81  Aligned_cols=137  Identities=22%  Similarity=0.298  Sum_probs=76.1

Q ss_pred             eecccCcEEEEEEEeCCCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcC---CCCcce---eee--e-eecC--ceEE
Q 012765          149 LIGKGGHAEVYKGCLPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHIN---HPNAAK---LIG--F-STEN--GFHL  217 (457)
Q Consensus       149 ~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~---hpniv~---l~~--~-~~~~--~~~l  217 (457)
                      .|.+ .-..||+....+|+. ++|..... .. .   .++..|+..|..|.   .+-.++   +-|  . ...+  -..-
T Consensus        33 ~l~s-~eN~~f~~~~~~g~~-iLki~~~~-~~-~---~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~  105 (331)
T COG2334          33 GLNS-EENSNFRVQTEDGRY-ILKIYRPG-WT-R---AEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAA  105 (331)
T ss_pred             cccc-ccCceEEEEecCCCe-EEEEecCC-CC-H---HHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEE
Confidence            3444 567799988877776 88876554 22 2   24445555555552   222222   222  1 1222  3456


Q ss_pred             EEEecCCCChhh-h--------------hhc----C-------CCCCCHHH-------------HHHHHHHHHHHHHHHH
Q 012765          218 VLQFLPHGSLSS-L--------------LFG----S-------TECLEWTI-------------RYKIALGIAEGLQYLH  258 (457)
Q Consensus       218 v~e~~~~gsL~~-~--------------l~~----~-------~~~~~~~~-------------~~~i~~qia~aL~yLH  258 (457)
                      +++|++|..+.. .              ++.    .       .....|..             ......++...+..+.
T Consensus       106 lf~~l~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~  185 (331)
T COG2334         106 LFEYLPGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLL  185 (331)
T ss_pred             EEEecCCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHH
Confidence            789999887762 1              110    0       01233431             0112223344444444


Q ss_pred             hc----CCCC---eeeCCCCCCcEEEcCCCc-EEEeeccccc
Q 012765          259 HD----CHRR---IIHRDIKASNILLSEDYE-AQISDFGLAK  292 (457)
Q Consensus       259 ~~----~~~~---iiHrDlkp~NIll~~~~~-~kL~DFGl~~  292 (457)
                      +.    ....   +||+|+.|.||+++.+.. +.++||+-++
T Consensus       186 ~~~~~~lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~  227 (331)
T COG2334         186 ARLPAHLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAG  227 (331)
T ss_pred             hhchhhCCcccceeeecCCCccceeEcCCCCeeeEEEccccc
Confidence            32    1223   999999999999998875 8999999764

>PLN02421 phosphotransferase, alcohol group as acceptor/kinase

Probab=95.23  E-value=0.14  Score=50.63  Aligned_cols=30  Identities=23%  Similarity=0.458  Sum_probs=25.6

Q ss_pred             CeeeCCCCCCcEEEcC-CCcEEEeecccccc
Q 012765          264 RIIHRDIKASNILLSE-DYEAQISDFGLAKW  293 (457)
Q Consensus       264 ~iiHrDlkp~NIll~~-~~~~kL~DFGl~~~  293 (457)
                      -++|+|+.+.|||+++ ++.++++||..+..
T Consensus       183 v~CHnDl~~~NiL~~~~~~~l~lID~EYag~  213 (330)
T PLN02421        183 VFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY  213 (330)
T ss_pred             EEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence            4799999999999975 46899999987753

>KOG1236 consensus Predicted unusual protein kinase [General function prediction only]

Probab=94.85  E-value=0.092  Score=52.56  Aligned_cols=59  Identities=17%  Similarity=0.093  Sum_probs=40.4

Q ss_pred             EEEEecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcC
Q 012765          217 LVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSE  279 (457)
Q Consensus       217 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~  279 (457)
                      ++-+|..+-++..++....  .++..+.+++.-.+.||.-+--.  .+++|.|+.|.||++--
T Consensus       322 l~E~~~~Gl~v~~~v~~~~--~pe~l~kkva~lg~~AllkMl~v--DNFvHaDlHPGNVlirf  380 (565)
T KOG1236|consen  322 LVETYERGLSVLRFVKWKS--QPEALVKKVAKLGVNALLKMLIV--DNFVHADLHPGNVLIRF  380 (565)
T ss_pred             eeeeccccccHHhhhhccc--ChHHHHHHHHHHHHHHHHHHHHh--hcceecccCCCcEEEEe
Confidence            4446777878888774433  34455666776666666544432  58999999999999953

>PRK11768 serine/threonine protein kinase; Provisional

Probab=94.82  E-value=2  Score=42.43  Aligned_cols=29  Identities=28%  Similarity=0.354  Sum_probs=24.4

Q ss_pred             CCCeeeCCCCCCcEEEcCCCcEEEeeccccc
Q 012765          262 HRRIIHRDIKASNILLSEDYEAQISDFGLAK  292 (457)
Q Consensus       262 ~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~  292 (457)
                      ..++||+|+.+.|||++ + .+.|+||+.+.
T Consensus       195 ~~~liHgD~h~~NvL~~-d-~~~iIDFDd~~  223 (325)
T PRK11768        195 RLLRLHGDCHPGNILWR-D-GPHFVDLDDAR  223 (325)
T ss_pred             CccceecCCCchhcccc-C-CcEEEeCCCCC
Confidence            35789999999999995 4 57899999764

>PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length

Probab=94.62  E-value=0.2  Score=46.13  Aligned_cols=122  Identities=12%  Similarity=0.111  Sum_probs=76.1

Q ss_pred             HHHHHHHHHhhcCCCCcceeeeeeecCceEEEEEecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCee
Q 012765          187 DFLSELGIVAHINHPNAAKLIGFSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRII  266 (457)
Q Consensus       187 ~~~~E~~~l~~l~hpniv~l~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~ii  266 (457)
                      -|..+..++++++  .|+++..- ..-.+.++.|.|-....          ..    ..++.-=+.+|.-+|+. ..+.+
T Consensus       104 ~y~nky~v~Armh--GilrL~ND-n~~~yGvIlE~Cy~~~i----------~~----~N~i~agi~~L~~fH~~-~~~~l  165 (308)
T PF07387_consen  104 LYFNKYRVFARMH--GILRLKND-NNYKYGVILERCYKIKI----------NF----SNFITAGIKDLMDFHSE-NQHCL  165 (308)
T ss_pred             hhhhhhhHHHHhh--heeEeecC-CCceeEEEEeeccCccc----------ch----hHHHHHhHHHHHHhhcc-CCCee
Confidence            4577788888765  56777622 22234588887743211          11    11222225678888964 37899


Q ss_pred             eCCCCCCcEEEcCCCcEEEeeccccccCCCCCCceeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHhCC
Q 012765          267 HRDIKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGR  343 (457)
Q Consensus       267 HrDlkp~NIll~~~~~~kL~DFGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLltG~  343 (457)
                      |+|..|+||+-|..|.+||.|-+..-.              .+.-|.--|   ....++++.+-+|=.-++++....
T Consensus       166 HGD~np~NiM~D~~G~lKlVDP~~Ll~--------------~~V~~vN~~---Y~~lT~~aE~~~fv~s~l~~v~~~  225 (308)
T PF07387_consen  166 HGDCNPDNIMCDKFGYLKLVDPVCLLE--------------NQVNMVNIE---YESLTQEAEVKVFVKSCLKLVEKQ  225 (308)
T ss_pred             cCCCChhheeecCCCCEEecChhhhhh--------------heeeEEeee---ccccChHHHHHHHHHHHHHHHHHH
Confidence            999999999999999999999765321              111122211   123467777777777777777644

The function of this family is unknown.

>KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only]

Probab=94.32  E-value=0.061  Score=55.24  Aligned_cols=159  Identities=21%  Similarity=0.297  Sum_probs=87.1

Q ss_pred             HHHHHHHHHhhcCCCCcceeeeeeecCc--eEEEEEecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC
Q 012765          187 DFLSELGIVAHINHPNAAKLIGFSTENG--FHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRR  264 (457)
Q Consensus       187 ~~~~E~~~l~~l~hpniv~l~~~~~~~~--~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~  264 (457)
                      +++.-..+++.+.|+|+..++.+-....  ..+|+|++ +.+|.+.+....  +.      .+...        .   .+
T Consensus        28 ~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~-~~Sled~~~~~~--l~------~~s~~--------~---~~   87 (725)
T KOG1093|consen   28 QILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHY-TMSLEDILKTGN--LK------DESLL--------A---HG   87 (725)
T ss_pred             HHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhh-ccchHHHHHhcc--cc------hhhhc--------c---cc
Confidence            6777788999999999999998766544  34667766 668888874332  11      11111        1   23


Q ss_pred             eeeCCCCCCcEEEcCCCcEEEeeccccccCCCCCCceeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHhCCC
Q 012765          265 IIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRR  344 (457)
Q Consensus       265 iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLltG~~  344 (457)
                      +.|-     |+       ++++| .+..   .               |  |=     ...+|+|||++|.++.|+.-|..
T Consensus        88 ~~~~-----~~-------~~~td-~~~t---~---------------~--~~-----~~~pKsdVwsl~~i~~el~L~~~  129 (725)
T KOG1093|consen   88 VLHL-----NI-------IYITD-HFLT---K---------------Y--PS-----PIGPKSDVWSLGFIILELYLGIS  129 (725)
T ss_pred             ccee-----hh-------hhccc-cccc---c---------------C--CC-----CCCcchhhhhHHHHHHHHHHhhH
Confidence            3332     11       22333 1110   0               0  00     01149999999999999999987


Q ss_pred             CCCcCCcch--hhhhccccccCCcccccCchhhcccCHHHHHHHHHHHHHhcccCCCCCCCHHH
Q 012765          345 AVDSRRQSL--VIWAKPLLQTSNFKELVDPRLADAYDLAEMKRAMLTASVCIHHLSTMRPQMTR  406 (457)
Q Consensus       345 pf~~~~~~~--~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~e  406 (457)
                      -+.......  ....+....+.....+...   ..+..+..+.++.+...|+...|..||...+
T Consensus       130 l~~~~~~s~~l~~i~k~~~~d~~~~~~a~e---~~~~~~~d~~~~~~~~~c~~~~~~ir~l~~~  190 (725)
T KOG1093|consen  130 LEAELTESEYLEILLKYYTDDQELLSTAME---HLIQLLADKKRLPLLKKCLWLEPIIRPLPME  190 (725)
T ss_pred             HHHHHHHHHHHHHHHHhccCchhHHHHHHH---HHHHHhhhHhHHHHhccCCccccccccchhH
Confidence            665422211  1111111111111111101   1223344566788888999999998886543

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=93.94  E-value=0.02  Score=58.43  Aligned_cols=74  Identities=23%  Similarity=0.356  Sum_probs=59.2

Q ss_pred             HHHHHhhcCCCCCceecccCcEEEEEEEeCC-CcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeee
Q 012765          135 AELAAATDNFNSENLIGKGGHAEVYKGCLPD-GEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFS  210 (457)
Q Consensus       135 ~~~~~~~~~f~~~~~LG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~  210 (457)
                      ....+..++|.....+|.|+||+|+.+.... +..+|||++......  ....+.++|...++++.|++++++...+
T Consensus        42 ~~~sr~a~~~e~~~~~~~~g~~~~~~~~n~~d~~~~avkritlkn~e--~s~~rvl~~~~s~a~feh~g~~~~~ha~  116 (516)
T KOG1033|consen   42 VITSREANDFEPGQCLGRGGFGVVFSAQNKADENKYAVKRITLKNRE--ESRSRVLREVSSLAEFEHPGIKRYFHAW  116 (516)
T ss_pred             hhhhhhhccccccccccccCccccCCccccccchhhHHHHhcccchh--hhhhhhhccccchhhhcccchhhheece
Confidence            3356678999999999999999999998654 558999988654443  3345788999999999999999998743

>PTZ00384 choline kinase; Provisional

Probab=93.19  E-value=0.48  Score=47.93  Aligned_cols=29  Identities=28%  Similarity=0.268  Sum_probs=24.0

Q ss_pred             CCeeeCCCCCCcEEEcCCCcEEEeeccccc
Q 012765          263 RRIIHRDIKASNILLSEDYEAQISDFGLAK  292 (457)
Q Consensus       263 ~~iiHrDlkp~NIll~~~~~~kL~DFGl~~  292 (457)
                      ..++|.|+-+.||+.+++ .+.++||-.+.
T Consensus       227 ~VfCHNDL~~gNIL~~~~-~l~lID~EYA~  255 (383)
T PTZ00384        227 VLFCHNDLFFTNILDFNQ-GIYFIDFDFAG  255 (383)
T ss_pred             eeeeeccCCcccEEecCC-CEEEEEecccc
Confidence            568999999999987654 69999997664

>PHA03111 Ser/Thr kinase; Provisional

Probab=93.00  E-value=0.089  Score=51.18  Aligned_cols=37  Identities=30%  Similarity=0.329  Sum_probs=26.3

Q ss_pred             HHHHHHHHHHHHHHHHh-cCCCCeeeCCCCCCcEEEcC
Q 012765          243 RYKIALGIAEGLQYLHH-DCHRRIIHRDIKASNILLSE  279 (457)
Q Consensus       243 ~~~i~~qia~aL~yLH~-~~~~~iiHrDlkp~NIll~~  279 (457)
                      ..-++.||+.-.-.+.+ .|..+++|-||||+|||+-+
T Consensus       281 ikfifLQiaLLyikIYelp~c~nF~H~DLKPdNILiFd  318 (444)
T PHA03111        281 IKFIFLQIALLYIKIYELPCCDNFLHVDLKPDNILIFD  318 (444)
T ss_pred             HHHHHHHHHHHHHhhhcCCCcceeeeccCCCCcEEEec
Confidence            34577788766655533 22467999999999999943

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	457
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		1e-44
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		7e-44
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		6e-33
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		1e-32
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		1e-31
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		2e-31
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		2e-31
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		3e-29
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		6e-15
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		1e-14
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		2e-14
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		2e-14
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		2e-14
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		2e-14
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		3e-14
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		3e-14
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		3e-14
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		3e-14
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		3e-14
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		3e-14
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		3e-14
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		4e-14
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		4e-14
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		4e-14
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		4e-14
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		4e-14
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		4e-14
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		4e-14
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		5e-14
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		5e-14
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		5e-14
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		6e-14
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		6e-14
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		6e-14
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		7e-14
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		1e-13
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		3e-13
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		5e-13
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		6e-13
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		8e-13
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		1e-12
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		1e-12
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		1e-12
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		1e-12
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		1e-12
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		1e-12
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		1e-12
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		2e-12
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		2e-12
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		2e-12
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		2e-12
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		2e-12
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		2e-12
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		2e-12
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		3e-12
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		3e-12
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		3e-12
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		3e-12
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		4e-12
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		4e-12
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		4e-12
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		4e-12
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		4e-12
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		4e-12
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		4e-12
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		4e-12
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		4e-12
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		4e-12
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		4e-12
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		4e-12
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		4e-12
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		4e-12
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		4e-12
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		4e-12
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		4e-12
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		5e-12
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		5e-12
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		5e-12
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		5e-12
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		5e-12
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		6e-12
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		6e-12
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		6e-12
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		6e-12
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		6e-12
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		6e-12
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		6e-12
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		6e-12
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		6e-12
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		7e-12
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		7e-12
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		7e-12
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		7e-12
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		7e-12
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		7e-12
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		7e-12
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		7e-12
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		7e-12
2pl0_A	289	Lck Bound To Imatinib Length = 289		7e-12
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		7e-12
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		7e-12
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		7e-12
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		8e-12
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		8e-12
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		8e-12
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		8e-12
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		8e-12
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		9e-12
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		9e-12
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		9e-12
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		9e-12
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		9e-12
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		9e-12
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		9e-12
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		1e-11
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		1e-11
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		1e-11
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-11
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		1e-11
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		1e-11
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		1e-11
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		1e-11
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		1e-11
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		1e-11
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		1e-11
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		1e-11
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		1e-11
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		1e-11
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		1e-11
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		1e-11
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		2e-11
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		2e-11
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		2e-11
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		2e-11
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		2e-11
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		2e-11
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		2e-11
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		2e-11
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		2e-11
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		2e-11
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		2e-11
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		2e-11
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		2e-11
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		2e-11
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		2e-11
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		2e-11
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		2e-11
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		3e-11
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		3e-11
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		3e-11
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		3e-11
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		3e-11
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		3e-11
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		3e-11
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		3e-11
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		4e-11
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		4e-11
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		5e-11
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		5e-11
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		5e-11
4h58_A	275	Braf In Complex With Compound 3 Length = 275		5e-11
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		5e-11
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		6e-11
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		6e-11
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		6e-11
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		6e-11
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		7e-11
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		8e-11
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		8e-11
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		1e-10
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		1e-10
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		1e-10
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-10
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-10
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		2e-10
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-10
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		2e-10
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		2e-10
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		2e-10
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		2e-10
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		2e-10
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		2e-10
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		2e-10
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		2e-10
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		2e-10
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		2e-10
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		2e-10
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		2e-10
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		4e-10
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		5e-10
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		5e-10
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		5e-10
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		6e-10
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		6e-10
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		6e-10
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		6e-10
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		6e-10
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		7e-10
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		7e-10
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		7e-10
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		7e-10
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		8e-10
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		1e-09
3a4o_X	286	Lyn Kinase Domain Length = 286		1e-09
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		1e-09
3g51_A	325	Structural Diversity Of The Active Conformation Of		2e-09
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		2e-09
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		2e-09
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		2e-09
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		2e-09
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		3e-09
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		3e-09
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		3e-09
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		3e-09
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		3e-09
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		3e-09
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		3e-09
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		4e-09
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		5e-09
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		6e-09
1fvr_A	327	Tie2 Kinase Domain Length = 327		6e-09
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		7e-09
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		7e-09
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		7e-09
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		7e-09
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		7e-09
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		7e-09
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		8e-09
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		8e-09
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		8e-09
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		8e-09
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		8e-09
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		8e-09
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		9e-09
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		9e-09
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		9e-09
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		1e-08
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		1e-08
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		1e-08
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		1e-08
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		1e-08
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		1e-08
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		1e-08
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		1e-08
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		1e-08
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		1e-08
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		1e-08
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		2e-08
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		2e-08
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		2e-08
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		2e-08
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		2e-08
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		2e-08
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		2e-08
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		2e-08
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		2e-08
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		2e-08
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		2e-08
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		2e-08
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		2e-08
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		2e-08
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		2e-08
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		2e-08
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		2e-08
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		2e-08
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		2e-08
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		3e-08
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		3e-08
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		3e-08
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		3e-08
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		3e-08
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		4e-08
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		4e-08
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		4e-08
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		4e-08
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		4e-08
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		4e-08
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		5e-08
4fob_A	353	Crystal Structure Of Human Anaplastic Lymphoma Kina		5e-08
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		5e-08
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		5e-08
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		5e-08
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		5e-08
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		5e-08
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		5e-08
4dce_A	333	Crystal Structure Of Human Anaplastic Lymphoma Kina		6e-08
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		6e-08
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		6e-08
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		6e-08
3lct_A	344	Crystal Structure Of The Anaplastic Lymphoma Kinase		6e-08
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		6e-08
4fnz_A	327	Crystal Structure Of Human Anaplastic Lymphoma Kina		6e-08
3l9p_A	367	Crystal Structure Of The Anaplastic Lymphoma Kinase		6e-08
3aox_A	344	X-Ray Crystal Structure Of Human Anaplastic Lymphom		6e-08
2xp2_A	327	Structure Of The Human Anaplastic Lymphoma Kinase I		6e-08
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		7e-08
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		7e-08
2xb7_A	315	Structure Of Human Anaplastic Lymphoma Kinase In Co		7e-08
4fnx_A	327	Crystal Structure Of The Apo R1275q Anaplastic Lymp		7e-08
2yjs_A	342	Structure Of C1156y Mutant Anaplastic Lymphoma Kina		7e-08
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		7e-08
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		7e-08
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		7e-08
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		8e-08
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		8e-08
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		8e-08
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		8e-08
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		8e-08
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		8e-08
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		8e-08
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		9e-08
3g2f_A	336	Crystal Structure Of The Kinase Domain Of Bone Morp		1e-07
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		1e-07
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		1e-07
2yhv_A	342	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		1e-07
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		1e-07
3a7f_A	303	Human Mst3 Kinase Length = 303		1e-07
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		1e-07
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		1e-07
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		1e-07
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		1e-07
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		1e-07
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		1e-07
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		1e-07
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-07
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		1e-07
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-07
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-07
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		1e-07
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-07
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		1e-07
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		1e-07
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		1e-07
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		1e-07
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		1e-07
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		2e-07
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		2e-07
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		2e-07
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		2e-07
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		2e-07
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		2e-07
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		2e-07
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		2e-07
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		2e-07
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		2e-07
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		2e-07
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		2e-07
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		2e-07
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		2e-07
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		2e-07
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		2e-07
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		2e-07
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		2e-07
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		2e-07
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		2e-07
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		2e-07
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		2e-07
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		2e-07
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		3e-07
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		3e-07
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		3e-07
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		3e-07
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		3e-07
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		3e-07
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		3e-07
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		3e-07
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		3e-07
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		3e-07
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		3e-07
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		3e-07
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		3e-07
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		3e-07
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		3e-07
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		3e-07
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		3e-07
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		3e-07
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		3e-07
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		3e-07
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		3e-07
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		4e-07
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		4e-07
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		4e-07
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		4e-07
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		4e-07
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		4e-07
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		4e-07
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		4e-07
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		4e-07
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		4e-07
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		4e-07
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		4e-07
3b2t_A	311	Structure Of Phosphotransferase Length = 311		4e-07
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		4e-07
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		4e-07
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		4e-07
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		4e-07
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		4e-07
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		5e-07
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		5e-07
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		5e-07
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		5e-07
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		5e-07
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		5e-07
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		5e-07
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		5e-07
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		5e-07
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		5e-07
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		5e-07
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		6e-07
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		6e-07
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		6e-07
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		6e-07
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		6e-07
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		7e-07
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		7e-07
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		7e-07
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		7e-07
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		8e-07
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		8e-07
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		8e-07
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		8e-07
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		8e-07
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		9e-07
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		9e-07
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		9e-07
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		1e-06
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		1e-06
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		1e-06
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		1e-06
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		1e-06
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		1e-06
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		1e-06
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-06
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		1e-06
4fl2_A	636	Structural And Biophysical Characterization Of The		1e-06
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		1e-06
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		1e-06
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		1e-06
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		1e-06
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		1e-06
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		1e-06
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		1e-06
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		1e-06
4fl3_A	635	Structural And Biophysical Characterization Of The		1e-06
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		1e-06
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-06
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		1e-06
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		2e-06
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		2e-06
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		2e-06
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		2e-06
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		2e-06
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		2e-06
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		2e-06
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		2e-06
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		2e-06
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		2e-06
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		2e-06
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		3e-06
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		3e-06
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		3e-06
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		3e-06
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		3e-06
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		3e-06
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		3e-06
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		3e-06
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		3e-06
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		4e-06
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		4e-06
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		4e-06
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		4e-06
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		4e-06
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		4e-06
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		4e-06
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		4e-06
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		5e-06
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		5e-06
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		5e-06
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		6e-06
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		6e-06
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		7e-06
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		7e-06
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		8e-06
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		9e-06
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		1e-05
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		1e-05
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		1e-05
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		1e-05
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		1e-05
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		1e-05
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		1e-05
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		1e-05
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		1e-05
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		1e-05
4ae9_A	343	Structure And Function Of The Human Sperm-specific		1e-05
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		1e-05
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		1e-05
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		1e-05
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		1e-05
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		2e-05
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		2e-05
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		2e-05
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		2e-05
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		2e-05
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		2e-05
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		2e-05
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		2e-05
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		2e-05
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		2e-05
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		2e-05
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		2e-05
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		2e-05
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		2e-05
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		2e-05
4ae6_A	343	Structure And Function Of The Human Sperm-specific		2e-05
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-05
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		3e-05
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		3e-05
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		3e-05
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		3e-05
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		3e-05
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		3e-05
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		3e-05
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		3e-05
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		3e-05
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		4e-05
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		4e-05
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		4e-05
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		4e-05
3kk8_A	284	Camkii Substrate Complex A Length = 284		4e-05
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		4e-05
3kk9_A	282	Camkii Substrate Complex B Length = 282		4e-05
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		4e-05
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		5e-05
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		5e-05
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		5e-05
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		5e-05
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		6e-05
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		6e-05
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		6e-05
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		6e-05
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		7e-05
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		7e-05
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		7e-05
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		7e-05
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		8e-05
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		8e-05
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		8e-05
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		8e-05
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		8e-05
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		8e-05
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		9e-05
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		9e-05
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		9e-05
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		9e-05
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		9e-05
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		9e-05
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		9e-05
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		9e-05
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		1e-04
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		1e-04
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		1e-04
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		1e-04
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		1e-04
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		1e-04
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		1e-04
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		1e-04
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		1e-04
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		1e-04
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		1e-04
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		1e-04
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		1e-04
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		1e-04
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		1e-04
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		1e-04
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		1e-04
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		1e-04
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		1e-04
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		1e-04
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		1e-04
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		1e-04
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		1e-04
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		1e-04
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		1e-04
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		1e-04
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		1e-04
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-04
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		1e-04
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		1e-04
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		1e-04
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		1e-04
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		1e-04
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		1e-04
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		1e-04
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		1e-04
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		1e-04
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		1e-04
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		1e-04
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		1e-04
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		1e-04
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		1e-04
3hec_A	348	P38 In Complex With Imatinib Length = 348		1e-04
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		1e-04
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		1e-04
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		1e-04
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		1e-04
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		1e-04
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		1e-04
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		1e-04
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		1e-04
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		1e-04
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		1e-04
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		1e-04
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		1e-04
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		1e-04
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		1e-04
2oza_B	366	Structure Of P38alpha Complex Length = 366		1e-04
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		1e-04
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		1e-04
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		1e-04
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		1e-04
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		1e-04
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		1e-04
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		2e-04
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		2e-04
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		2e-04
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		2e-04
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		2e-04
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		2e-04
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		2e-04
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		2e-04
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		2e-04
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		2e-04
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		2e-04
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		2e-04
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		2e-04
4exu_A	371	Mapk13, Inactive Form Length = 371		2e-04
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		2e-04
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		2e-04
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		2e-04
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		2e-04
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		2e-04
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		2e-04
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		2e-04
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		3e-04
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		3e-04
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		3e-04
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		3e-04
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		3e-04
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		3e-04
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		3e-04
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		3e-04
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		3e-04
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		3e-04
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		3e-04
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		4e-04
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		4e-04
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		4e-04
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		4e-04
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		4e-04
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		4e-04
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		4e-04
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		4e-04
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		4e-04
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		4e-04
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		5e-04
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		5e-04
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		5e-04
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		5e-04
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		5e-04
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		5e-04
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		6e-04
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		6e-04
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		6e-04
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		7e-04
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		8e-04
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		8e-04
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		8e-04
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		8e-04
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		8e-04
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		8e-04
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		8e-04
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		9e-04
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		9e-04
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		9e-04
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		9e-04
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		9e-04

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score =  177 bits (448), Expect = 1e-44,   Method: Compositional matrix adjust.
 Identities = 112/296 (37%), Positives = 161/296 (54%), Gaps = 13/296 (4%)
Query: 130 KNFDFAELAAATDNFNSENLIGKGGHAEVYKGCLPDGEXXXXXXXXXXXXEDEERISDFL 189
           K F   EL  A+DNF+++N++G+GG  +VYKG L DG             +  E    F 
Sbjct: 26  KRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERXQGGE--LQFQ 83
Query: 190 SELGIVAHINHPNAAKLIGFS-TENGFHLVLQFLPHGSLSSLLFGSTEC---LEWTIRYK 245
           +E+ +++   H N  +L GF  T     LV  ++ +GS++S L    E    L+W  R +
Sbjct: 84  TEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQR 143
Query: 246 IALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFP 305
           IALG A GL YL             KA+NILL E++EA + DFGLAK L D    H+   
Sbjct: 144 IALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK-LMDYKDXHVXXA 202
Query: 306 IEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQS------LVIWAKP 359
           + GT G+++PEY   G   EKTDVF +GV+LLELITG+RA D  R +      L+ W K 
Sbjct: 203 VRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKG 262
Query: 360 LLQTSNFKELVDPRLADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQLLRGEG 415
           LL+    + LVD  L   Y   E+++ +  A +C       RP+M+ V+++L G+G
Sbjct: 263 LLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDG 318

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score =  174 bits (442), Expect = 7e-44,   Method: Compositional matrix adjust.
 Identities = 110/296 (37%), Positives = 158/296 (53%), Gaps = 13/296 (4%)
Query: 130 KNFDFAELAAATDNFNSENLIGKGGHAEVYKGCLPDGEXXXXXXXXXXXXEDEERISDFL 189
           K F   EL  A+DNF ++N++G+GG  +VYKG L DG             +  E    F 
Sbjct: 18  KRFSLRELQVASDNFXNKNILGRGGFGKVYKGRLADGXLVAVKRLKEERTQGGE--LQFQ 75
Query: 190 SELGIVAHINHPNAAKLIGFS-TENGFHLVLQFLPHGSLSSLLFGSTEC---LEWTIRYK 245
           +E+ +++   H N  +L GF  T     LV  ++ +GS++S L    E    L+W  R +
Sbjct: 76  TEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQR 135
Query: 246 IALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFP 305
           IALG A GL YL             KA+NILL E++EA + DFGLAK L D    H+   
Sbjct: 136 IALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK-LMDYKDXHVXXA 194
Query: 306 IEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQS------LVIWAKP 359
           + G  G+++PEY   G   EKTDVF +GV+LLELITG+RA D  R +      L+ W K 
Sbjct: 195 VRGXIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKG 254
Query: 360 LLQTSNFKELVDPRLADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQLLRGEG 415
           LL+    + LVD  L   Y   E+++ +  A +C       RP+M+ V+++L G+G
Sbjct: 255 LLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDG 310

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score =  138 bits (348), Expect = 6e-33,   Method: Compositional matrix adjust.
 Identities = 94/283 (33%), Positives = 145/283 (51%), Gaps = 14/283 (4%)
Query: 134 FAELAAATDNFNSENLIGKGGHAEVYKGCLPDGEXXXXXXXXXXXXEDEERISDFLSELG 193
             +L  AT+NF+ + LIG G   +VYKG L DG             E  + I +F +E+ 
Sbjct: 31  LVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDG---AKVALKRRTPESSQGIEEFETEIE 87
Query: 194 IVAHINHPNAAKLIGFSTE-NGFHLVLQFLPHGSLSSLLFGS---TECLEWTIRYKIALG 249
            ++   HP+   LIGF  E N   L+ +++ +G+L   L+GS   T  + W  R +I +G
Sbjct: 88  TLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIG 147
Query: 250 IAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEGT 309
            A GL YL             K+ NILL E++  +I+DFG++K   +    H+   ++GT
Sbjct: 148 AARGLHYLHTRAIIHRDV---KSINILLDENFVPKITDFGISKKGTELGQTHLXXVVKGT 204
Query: 310 FGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAV----DSRRQSLVIWAKPLLQTSN 365
            GY+ PEYF+ G + EK+DV++FGV+L E++  R A+         +L  WA        
Sbjct: 205 LGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQ 264
Query: 366 FKELVDPRLADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVL 408
            +++VDP LAD      +++   TA  C+   S  RP M  VL
Sbjct: 265 LEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVL 307

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score =  137 bits (346), Expect = 1e-32,   Method: Compositional matrix adjust.
 Identities = 94/283 (33%), Positives = 145/283 (51%), Gaps = 14/283 (4%)
Query: 134 FAELAAATDNFNSENLIGKGGHAEVYKGCLPDGEXXXXXXXXXXXXEDEERISDFLSELG 193
             +L  AT+NF+ + LIG G   +VYKG L DG             E  + I +F +E+ 
Sbjct: 31  LVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDG---AKVALKRRTPESSQGIEEFETEIE 87
Query: 194 IVAHINHPNAAKLIGFSTE-NGFHLVLQFLPHGSLSSLLFGS---TECLEWTIRYKIALG 249
            ++   HP+   LIGF  E N   L+ +++ +G+L   L+GS   T  + W  R +I +G
Sbjct: 88  TLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIG 147
Query: 250 IAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEGT 309
            A GL YL             K+ NILL E++  +I+DFG++K   +    H+   ++GT
Sbjct: 148 AARGLHYLHTRAIIHRDV---KSINILLDENFVPKITDFGISKKGTELDQTHLXXVVKGT 204
Query: 310 FGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAV----DSRRQSLVIWAKPLLQTSN 365
            GY+ PEYF+ G + EK+DV++FGV+L E++  R A+         +L  WA        
Sbjct: 205 LGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQ 264
Query: 366 FKELVDPRLADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVL 408
            +++VDP LAD      +++   TA  C+   S  RP M  VL
Sbjct: 265 LEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVL 307

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  134 bits (336), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 97/304 (31%), Positives = 151/304 (49%), Gaps = 17/304 (5%)
Query: 121 SVPIVRHSWKNFDFAELAAATDNFNSE------NLIGKGGHAEVYKGCLPDGEXXXXXXX 174
           S+ +    + +F F EL   T+NF+        N +G+GG   VYKG + +         
Sbjct: 4   SLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLA 63
Query: 175 XXXXXEDEERISDFLSELGIVAHINHPNAAKLIGFSTE-NGFHLVLQFLPHGSLSSLL-- 231
                  EE    F  E+ ++A   H N  +L+GFS++ +   LV  ++P+GSL   L  
Sbjct: 64  AMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSC 123
Query: 232 FGSTECLEWTIRYKIALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLA 291
              T  L W +R KIA G A G+ +L             K++NILL E + A+ISDFGLA
Sbjct: 124 LDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDI---KSANILLDEAFTAKISDFGLA 180
Query: 292 KWLPDNWSHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQ 351
           +         +   I GT  Y++PE  + G +  K+D+++FGV+LLE+ITG  AVD  R+
Sbjct: 181 RASEKFAQTVMXXRIVGTTAYMAPEA-LRGEITPKSDIYSFGVVLLEIITGLPAVDEHRE 239
Query: 352 S---LVIWAKPLLQTSNFKELVDPRLADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVL 408
               L I  +   +    ++ +D ++ DA D   ++     AS C+H     RP + +V 
Sbjct: 240 PQLLLDIKEEIEDEEKTIEDYIDKKMNDA-DSTSVEAMYSVASQCLHEKKNKRPDIKKVQ 298
Query: 409 QLLR 412
           QLL+
Sbjct: 299 QLLQ 302

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score =  133 bits (335), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 96/296 (32%), Positives = 148/296 (50%), Gaps = 17/296 (5%)
Query: 129 WKNFDFAELAAATDNFNSE------NLIGKGGHAEVYKGCLPDGEXXXXXXXXXXXXEDE 182
           + +F F EL   T+NF+        N +G+GG   VYKG + +                E
Sbjct: 6   FHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTE 65
Query: 183 ERISDFLSELGIVAHINHPNAAKLIGFSTE-NGFHLVLQFLPHGSLSSLL--FGSTECLE 239
           E    F  E+ ++A   H N  +L+GFS++ +   LV  ++P+GSL   L     T  L 
Sbjct: 66  ELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLS 125
Query: 240 WTIRYKIALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWS 299
           W +R KIA G A G+ +L             K++NILL E + A+ISDFGLA+       
Sbjct: 126 WHMRCKIAQGAANGINFLHENHHIHRDI---KSANILLDEAFTAKISDFGLARASEKFAQ 182
Query: 300 HHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQS---LVIW 356
             +   I GT  Y++PE  + G +  K+D+++FGV+LLE+ITG  AVD  R+    L I 
Sbjct: 183 XVMXXRIVGTTAYMAPEA-LRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIK 241
Query: 357 AKPLLQTSNFKELVDPRLADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQLLR 412
            +   +    ++ +D ++ DA D   ++     AS C+H     RP + +V QLL+
Sbjct: 242 EEIEDEEKTIEDYIDKKMNDA-DSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQ 296

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  133 bits (335), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 97/304 (31%), Positives = 151/304 (49%), Gaps = 17/304 (5%)
Query: 121 SVPIVRHSWKNFDFAELAAATDNFNSE------NLIGKGGHAEVYKGCLPDGEXXXXXXX 174
           S+ +    + +F F EL   T+NF+        N +G+GG   VYKG + +         
Sbjct: 4   SLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLA 63
Query: 175 XXXXXEDEERISDFLSELGIVAHINHPNAAKLIGFSTE-NGFHLVLQFLPHGSLSSLL-- 231
                  EE    F  E+ ++A   H N  +L+GFS++ +   LV  ++P+GSL   L  
Sbjct: 64  AMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSC 123
Query: 232 FGSTECLEWTIRYKIALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLA 291
              T  L W +R KIA G A G+ +L             K++NILL E + A+ISDFGLA
Sbjct: 124 LDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDI---KSANILLDEAFTAKISDFGLA 180
Query: 292 KWLPDNWSHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQ 351
           +         +   I GT  Y++PE  + G +  K+D+++FGV+LLE+ITG  AVD  R+
Sbjct: 181 RASEKFAQTVMXSRIVGTTAYMAPEA-LRGEITPKSDIYSFGVVLLEIITGLPAVDEHRE 239
Query: 352 S---LVIWAKPLLQTSNFKELVDPRLADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVL 408
               L I  +   +    ++ +D ++ DA D   ++     AS C+H     RP + +V 
Sbjct: 240 PQLLLDIKEEIEDEEKTIEDYIDKKMNDA-DSTSVEAMYSVASQCLHEKKNKRPDIKKVQ 298
Query: 409 QLLR 412
           QLL+
Sbjct: 299 QLLQ 302

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score =  126 bits (316), Expect = 3e-29,   Method: Compositional matrix adjust.
 Identities = 96/296 (32%), Positives = 141/296 (47%), Gaps = 17/296 (5%)
Query: 129 WKNFDFAELAAATDNFNSE------NLIGKGGHAEVYKGCLPDGEXXXXXXXXXXXXEDE 182
           + +F F EL   T+NF+        N  G+GG   VYKG + +                E
Sbjct: 3   FHSFSFYELKNVTNNFDERPISVGGNKXGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTE 62
Query: 183 ERISDFLSELGIVAHINHPNAAKLIGFSTE-NGFHLVLQFLPHGSLSSLL--FGSTECLE 239
           E    F  E+ + A   H N  +L+GFS++ +   LV  + P+GSL   L     T  L 
Sbjct: 63  ELKQQFDQEIKVXAKCQHENLVELLGFSSDGDDLCLVYVYXPNGSLLDRLSCLDGTPPLS 122
Query: 240 WTIRYKIALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWS 299
           W  R KIA G A G+ +L             K++NILL E + A+ISDFGLA+       
Sbjct: 123 WHXRCKIAQGAANGINFLHENHHIHRDI---KSANILLDEAFTAKISDFGLARASEKFAQ 179
Query: 300 HHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQS---LVIW 356
                 I GT  Y +PE  + G +  K+D+++FGV+LLE+ITG  AVD  R+    L I 
Sbjct: 180 XVXXSRIVGTTAYXAPEA-LRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIK 238
Query: 357 AKPLLQTSNFKELVDPRLADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQLLR 412
            +   +    ++ +D +  DA D   ++     AS C+H     RP + +V QLL+
Sbjct: 239 EEIEDEEKTIEDYIDKKXNDA-DSTSVEAXYSVASQCLHEKKNKRPDIKKVQQLLQ 293

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 65/229 (28%), Positives = 105/229 (45%), Gaps = 20/229 (8%)
Query: 132 FDFAELAAATDN-FNSENLIGKGGHAEVYKGCL-PDGEXXXXXXXXXXXXEDE----ERI 185
           F  + L    DN    E  IGKGG   V+KG L  D              E E    E+ 
Sbjct: 8   FPKSRLPTLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKF 67
Query: 186 SDFLSELGIVAHINHPNAAKLIGFSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYK 245
            +F  E+ I++++NHPN  KL G    N   +V++F+P G L   L      ++W+++ +
Sbjct: 68  QEFQREVFIMSNLNHPNIVKLYGL-MHNPPRMVMEFVPCGDLYHRLLDKAHPIKWSVKLR 126
Query: 246 IALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYE-----AQISDFGLAKWLPDNWSH 300
           + L IA G++Y+             ++ NI L    E     A+++DFGL++      S 
Sbjct: 127 LMLDIALGIEYM-QNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ-----QSV 180
Query: 301 HIVFPIEGTFGYLSPEYF--MHGIVDEKTDVFAFGVLLLELITGRRAVD 347
           H V  + G F +++PE          EK D ++F ++L  ++TG    D
Sbjct: 181 HSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFD 229

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 58/200 (29%), Positives = 97/200 (48%), Gaps = 21/200 (10%)
Query: 150 IGKGGHAEVYKGCLPDGEXXXXXXXXXXXXEDEERISDFLSELGIVAHINHPNAAKLIGF 209
           +G G + EVY G     +            ED   + +FL E  ++  I HPN  +L+G 
Sbjct: 40  LGGGQYGEVYVGVW---KKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 96
Query: 210 ST-ENGFHLVLQFLPHGSLSSLLFGSTEC----LEWTIRYKIALGIAEGLQYLXXXXXXX 264
            T E  F++V +++P+G+L   L    EC    +   +   +A  I+  ++YL       
Sbjct: 97  CTLEPPFYIVTEYMPYGNLLDYL---RECNREEVTAVVLLYMATQISSAMEYLEKKNFIH 153
Query: 265 XXXXXXKASNILLSEDYEAQISDFGLAKWLP-DNWSHH--IVFPIEGTFGYLSPEYFMHG 321
                  A N L+ E++  +++DFGL++ +  D ++ H    FPI+ T    +PE   + 
Sbjct: 154 RDLA---ARNCLVGENHVVKVADFGLSRLMTGDTYTAHAGAKFPIKWT----APESLAYN 206
Query: 322 IVDEKTDVFAFGVLLLELIT 341
               K+DV+AFGVLL E+ T
Sbjct: 207 TFSIKSDVWAFGVLLWEIAT 226

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 60/219 (27%), Positives = 106/219 (48%), Gaps = 23/219 (10%)
Query: 131 NFDFAELAAATDNFNSENLIGKGGHAEVYKGCLPDGEXXXXXXXXXXXXEDEERISDFLS 190
           N+D  E+     +   ++ +G G + EVY+G     +            ED   + +FL 
Sbjct: 4   NYDKWEMERT--DITMKHKLGGGQYGEVYEGVW---KKYSLTVAVKTLKEDTMEVEEFLK 58
Query: 191 ELGIVAHINHPNAAKLIGFST-ENGFHLVLQFLPHGSLSSLLFGSTEC----LEWTIRYK 245
           E  ++  I HPN  +L+G  T E  F+++++F+ +G+L   L    EC    +   +   
Sbjct: 59  EAAVMKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYL---RECNRQEVSAVVLLY 115
Query: 246 IALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLP-DNWSHH--I 302
           +A  I+  ++YL              A N L+ E++  +++DFGL++ +  D ++ H   
Sbjct: 116 MATQISSAMEYLEKKNFIHRDLA---ARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGA 172
Query: 303 VFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELIT 341
            FPI+ T    +PE   +     K+DV+AFGVLL E+ T
Sbjct: 173 KFPIKWT----APESLAYNKFSIKSDVWAFGVLLWEIAT 207

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 57/200 (28%), Positives = 98/200 (49%), Gaps = 21/200 (10%)
Query: 150 IGKGGHAEVYKGCLPDGEXXXXXXXXXXXXEDEERISDFLSELGIVAHINHPNAAKLIGF 209
           +G G + EVY+G     +            ED   + +FL E  ++  I HPN  +L+G 
Sbjct: 26  LGGGQYGEVYEGVW---KKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 82
Query: 210 ST-ENGFHLVLQFLPHGSLSSLLFGSTEC----LEWTIRYKIALGIAEGLQYLXXXXXXX 264
            T E  F+++++F+ +G+L   L    EC    +   +   +A  I+  ++YL       
Sbjct: 83  CTREPPFYIIIEFMTYGNLLDYL---RECNRQEVNAVVLLYMATQISSAMEYLEKKNFIH 139
Query: 265 XXXXXXKASNILLSEDYEAQISDFGLAKWLP-DNWSHH--IVFPIEGTFGYLSPEYFMHG 321
                  A N L+ E++  +++DFGL++ +  D ++ H    FPI+ T    +PE   + 
Sbjct: 140 RDLA---ARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWT----APESLAYN 192
Query: 322 IVDEKTDVFAFGVLLLELIT 341
               K+DV+AFGVLL E+ T
Sbjct: 193 KFSIKSDVWAFGVLLWEIAT 212

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 60/219 (27%), Positives = 106/219 (48%), Gaps = 23/219 (10%)
Query: 131 NFDFAELAAATDNFNSENLIGKGGHAEVYKGCLPDGEXXXXXXXXXXXXEDEERISDFLS 190
           N+D  E+     +   ++ +G G + EVY+G     +            ED   + +FL 
Sbjct: 4   NYDKWEMERT--DITMKHKLGGGQYGEVYEGVW---KKYSLTVAVKTLKEDTMEVEEFLK 58
Query: 191 ELGIVAHINHPNAAKLIGFST-ENGFHLVLQFLPHGSLSSLLFGSTEC----LEWTIRYK 245
           E  ++  I HPN  +L+G  T E  F+++++F+ +G+L   L    EC    +   +   
Sbjct: 59  EAAVMKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYL---RECNRQEVSAVVLLY 115
Query: 246 IALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLP-DNWSHH--I 302
           +A  I+  ++YL              A N L+ E++  +++DFGL++ +  D ++ H   
Sbjct: 116 MATQISSAMEYLEKKNFIHRDLA---ARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGA 172
Query: 303 VFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELIT 341
            FPI+ T    +PE   +     K+DV+AFGVLL E+ T
Sbjct: 173 KFPIKWT----APESLAYNKFSIKSDVWAFGVLLWEIAT 207

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 50/162 (30%), Positives = 84/162 (51%), Gaps = 6/162 (3%)
Query: 183 ERISDFLSELGIVAHINHPNAAKLIGFSTEN-GFHLVLQFLPHGSLSSLLF--GSTECLE 239
           ER+++FL E+ I+  + HPN    +G  T+     +V ++L  GSL  LL   G+ E L+
Sbjct: 76  ERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLD 135
Query: 240 WTIRYKIALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWS 299
              R  +A  +A+G+ YL             K+ N+L+ + Y  ++ DFGL++     + 
Sbjct: 136 ERRRLSMAYDVAKGMNYLHNRNPPIVHRNL-KSPNLLVDKKYTVKVCDFGLSRLKASTFL 194
Query: 300 HHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELIT 341
                   GT  +++PE       +EK+DV++FGV+L EL T
Sbjct: 195 SSKS--AAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELAT 234

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 77/303 (25%), Positives = 117/303 (38%), Gaps = 61/303 (20%)
Query: 132 FDFAELAAATDNFNSENLIGKGGHAEVYKGCLPDGEXXXXXXXXXXXXEDEERISDFLSE 191
            DFAEL         E +IG GG  +VY+      E            +  + I +   E
Sbjct: 4   IDFAELTL-------EEIIGIGGFGKVYRAFWIGDEVAVKAARHDPDEDISQTIENVRQE 56
Query: 192 LGIVAHINHPNAAKLIGFS-TENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGI 250
             + A + HPN   L G    E    LV++F   G L+ +L G     +  + +  A+ I
Sbjct: 57  AKLFAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGKRIPPDILVNW--AVQI 114
Query: 251 AEGLQYLXXXXXXXXXXXXXKASNILLSEDYE--------AQISDFGLAKWLPDNWSHHI 302
           A G+ YL             K+SNIL+ +  E         +I+DFGLA+     W    
Sbjct: 115 ARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAR----EWHRTT 170
Query: 303 VFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGR---RAVDSRRQSLVIWAKP 359
                G + +++PE     +  + +DV+++GVLL EL+TG    R +D            
Sbjct: 171 KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDG----------- 219
Query: 360 LLQTSNFKELVDPRLADAYDLAEMKRAMLTASVCIHHLSTM-----------RPQMTRVL 408
                         LA AY +A  K A+   S C    + +           RP  T +L
Sbjct: 220 --------------LAVAYGVAMNKLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNIL 265
Query: 409 QLL 411
             L
Sbjct: 266 DQL 268

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 64/229 (27%), Positives = 104/229 (45%), Gaps = 20/229 (8%)
Query: 132 FDFAELAAATDN-FNSENLIGKGGHAEVYKGCL-PDGEXXXXXXXXXXXXEDE----ERI 185
           F  + L    DN    E  IGKGG   V+KG L  D              E E    E+ 
Sbjct: 8   FPKSRLPTLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKF 67
Query: 186 SDFLSELGIVAHINHPNAAKLIGFSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYK 245
            +F  E+ I++++NHPN  KL G    N   +V++F+P G L   L      ++W+++ +
Sbjct: 68  QEFQREVFIMSNLNHPNIVKLYGL-MHNPPRMVMEFVPCGDLYHRLLDKAHPIKWSVKLR 126
Query: 246 IALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYE-----AQISDFGLAKWLPDNWSH 300
           + L IA G++Y+             ++ NI L    E     A+++DFG ++      S 
Sbjct: 127 LMLDIALGIEYM-QNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGTSQ-----QSV 180
Query: 301 HIVFPIEGTFGYLSPEYF--MHGIVDEKTDVFAFGVLLLELITGRRAVD 347
           H V  + G F +++PE          EK D ++F ++L  ++TG    D
Sbjct: 181 HSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFD 229

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 64/229 (27%), Positives = 104/229 (45%), Gaps = 20/229 (8%)
Query: 132 FDFAELAAATDN-FNSENLIGKGGHAEVYKGCL-PDGEXXXXXXXXXXXXEDE----ERI 185
           F  + L    DN    E  IGKGG   V+KG L  D              E E    E+ 
Sbjct: 8   FPKSRLPTLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKF 67
Query: 186 SDFLSELGIVAHINHPNAAKLIGFSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYK 245
            +F  E+ I++++NHPN  KL G    N   +V++F+P G L   L      ++W+++ +
Sbjct: 68  QEFQREVFIMSNLNHPNIVKLYGL-MHNPPRMVMEFVPCGDLYHRLLDKAHPIKWSVKLR 126
Query: 246 IALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYE-----AQISDFGLAKWLPDNWSH 300
           + L IA G++Y+             ++ NI L    E     A+++DF L++      S 
Sbjct: 127 LMLDIALGIEYM-QNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFSLSQ-----QSV 180
Query: 301 HIVFPIEGTFGYLSPEYF--MHGIVDEKTDVFAFGVLLLELITGRRAVD 347
           H V  + G F +++PE          EK D ++F ++L  ++TG    D
Sbjct: 181 HSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFD 229

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 60/219 (27%), Positives = 105/219 (47%), Gaps = 23/219 (10%)
Query: 131 NFDFAELAAATDNFNSENLIGKGGHAEVYKGCLPDGEXXXXXXXXXXXXEDEERISDFLS 190
           N+D  E+     +   ++ +G G + EVY+G     +            ED   + +FL 
Sbjct: 9   NYDKWEMERT--DITMKHKLGGGQYGEVYEGVW---KKYSLTVAVKTLKEDTMEVEEFLK 63
Query: 191 ELGIVAHINHPNAAKLIGFST-ENGFHLVLQFLPHGSLSSLLFGSTEC----LEWTIRYK 245
           E  ++  I HPN  +L+G  T E  F+++ +F+ +G+L   L    EC    +   +   
Sbjct: 64  EAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL---RECNRQEVSAVVLLY 120
Query: 246 IALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLP-DNWSHH--I 302
           +A  I+  ++YL              A N L+ E++  +++DFGL++ +  D ++ H   
Sbjct: 121 MATQISSAMEYLEKKNFIHRDLA---ARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGA 177
Query: 303 VFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELIT 341
            FPI+ T    +PE   +     K+DV+AFGVLL E+ T
Sbjct: 178 KFPIKWT----APESLAYNKFSIKSDVWAFGVLLWEIAT 212

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 50/162 (30%), Positives = 84/162 (51%), Gaps = 6/162 (3%)
Query: 183 ERISDFLSELGIVAHINHPNAAKLIGFSTEN-GFHLVLQFLPHGSLSSLLF--GSTECLE 239
           ER+++FL E+ I+  + HPN    +G  T+     +V ++L  GSL  LL   G+ E L+
Sbjct: 76  ERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLD 135
Query: 240 WTIRYKIALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWS 299
              R  +A  +A+G+ YL             K+ N+L+ + Y  ++ DFGL++     + 
Sbjct: 136 ERRRLSMAYDVAKGMNYLHNRNPPIVHRDL-KSPNLLVDKKYTVKVCDFGLSRLKASXFL 194
Query: 300 HHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELIT 341
                   GT  +++PE       +EK+DV++FGV+L EL T
Sbjct: 195 XSKX--AAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELAT 234

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 60/219 (27%), Positives = 105/219 (47%), Gaps = 23/219 (10%)
Query: 131 NFDFAELAAATDNFNSENLIGKGGHAEVYKGCLPDGEXXXXXXXXXXXXEDEERISDFLS 190
           N+D  E+     +   ++ +G G + EVY+G     +            ED   + +FL 
Sbjct: 4   NYDKWEMERT--DITMKHKLGGGQYGEVYEGVW---KKYSLTVAVKTLKEDTMEVEEFLK 58
Query: 191 ELGIVAHINHPNAAKLIGFST-ENGFHLVLQFLPHGSLSSLLFGSTEC----LEWTIRYK 245
           E  ++  I HPN  +L+G  T E  F+++ +F+ +G+L   L    EC    +   +   
Sbjct: 59  EAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL---RECNRQEVSAVVLLY 115
Query: 246 IALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLP-DNWSHH--I 302
           +A  I+  ++YL              A N L+ E++  +++DFGL++ +  D ++ H   
Sbjct: 116 MATQISSAMEYLEKKNFIHRDLA---ARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGA 172
Query: 303 VFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELIT 341
            FPI+ T    +PE   +     K+DV+AFGVLL E+ T
Sbjct: 173 KFPIKWT----APESLAYNKFSIKSDVWAFGVLLWEIAT 207

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 57/200 (28%), Positives = 97/200 (48%), Gaps = 21/200 (10%)
Query: 150 IGKGGHAEVYKGCLPDGEXXXXXXXXXXXXEDEERISDFLSELGIVAHINHPNAAKLIGF 209
           +G G + EVY+G     +            ED   + +FL E  ++  I HPN  +L+G 
Sbjct: 26  LGGGQYGEVYEGVW---KKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 82
Query: 210 ST-ENGFHLVLQFLPHGSLSSLLFGSTEC----LEWTIRYKIALGIAEGLQYLXXXXXXX 264
            T E  F+++ +F+ +G+L   L    EC    +   +   +A  I+  ++YL       
Sbjct: 83  CTREPPFYIITEFMTYGNLLDYL---RECNRQEVNAVVLLYMATQISSAMEYLEKKNFIH 139
Query: 265 XXXXXXKASNILLSEDYEAQISDFGLAKWLP-DNWSHH--IVFPIEGTFGYLSPEYFMHG 321
                  A N L+ E++  +++DFGL++ +  D ++ H    FPI+ T    +PE   + 
Sbjct: 140 RDLA---ARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWT----APESLAYN 192
Query: 322 IVDEKTDVFAFGVLLLELIT 341
               K+DV+AFGVLL E+ T
Sbjct: 193 KFSIKSDVWAFGVLLWEIAT 212

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 60/219 (27%), Positives = 105/219 (47%), Gaps = 23/219 (10%)
Query: 131 NFDFAELAAATDNFNSENLIGKGGHAEVYKGCLPDGEXXXXXXXXXXXXEDEERISDFLS 190
           N+D  E+     +   ++ +G G + EVY+G     +            ED   + +FL 
Sbjct: 9   NYDKWEMERT--DITMKHKLGGGQYGEVYEGVW---KKYSLTVAVKTLKEDTMEVEEFLK 63
Query: 191 ELGIVAHINHPNAAKLIGFST-ENGFHLVLQFLPHGSLSSLLFGSTEC----LEWTIRYK 245
           E  ++  I HPN  +L+G  T E  F+++ +F+ +G+L   L    EC    +   +   
Sbjct: 64  EAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL---RECNRQEVNAVVLLY 120
Query: 246 IALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLP-DNWSHH--I 302
           +A  I+  ++YL              A N L+ E++  +++DFGL++ +  D ++ H   
Sbjct: 121 MATQISSAMEYLEKKNFIHRDLA---ARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGA 177
Query: 303 VFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELIT 341
            FPI+ T    +PE   +     K+DV+AFGVLL E+ T
Sbjct: 178 KFPIKWT----APESLAYNKFSIKSDVWAFGVLLWEIAT 212

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 61/223 (27%), Positives = 106/223 (47%), Gaps = 23/223 (10%)
Query: 127 HSWKNFDFAELAAATDNFNSENLIGKGGHAEVYKGCLPDGEXXXXXXXXXXXXEDEERIS 186
           H   N+D  E+     +   ++ +G G + EVY+G     +            ED   + 
Sbjct: 2   HMSPNYDKWEMERT--DITMKHKLGGGQYGEVYEGVW---KKYSLTVAVKTLKEDTMEVE 56
Query: 187 DFLSELGIVAHINHPNAAKLIGFST-ENGFHLVLQFLPHGSLSSLLFGSTEC----LEWT 241
           +FL E  ++  I HPN  +L+G  T E  F+++ +F+ +G+L   L    EC    +   
Sbjct: 57  EFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL---RECNRQEVNAV 113
Query: 242 IRYKIALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLP-DNWSH 300
           +   +A  I+  ++YL              A N L+ E++  +++DFGL++ +  D ++ 
Sbjct: 114 VLLYMATQISSAMEYLEKKNFIHRDLA---ARNCLVGENHLVKVADFGLSRLMTGDTYTA 170
Query: 301 H--IVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELIT 341
           H    FPI+ T    +PE   +     K+DV+AFGVLL E+ T
Sbjct: 171 HAGAKFPIKWT----APESLAYNKFSIKSDVWAFGVLLWEIAT 209

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 60/219 (27%), Positives = 105/219 (47%), Gaps = 23/219 (10%)
Query: 131 NFDFAELAAATDNFNSENLIGKGGHAEVYKGCLPDGEXXXXXXXXXXXXEDEERISDFLS 190
           N+D  E+     +   ++ +G G + EVY+G     +            ED   + +FL 
Sbjct: 4   NYDKWEMERT--DITMKHKLGGGQYGEVYEGVW---KKYSLTVAVKTLKEDTMEVEEFLK 58
Query: 191 ELGIVAHINHPNAAKLIGFST-ENGFHLVLQFLPHGSLSSLLFGSTEC----LEWTIRYK 245
           E  ++  I HPN  +L+G  T E  F+++ +F+ +G+L   L    EC    +   +   
Sbjct: 59  EAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL---RECNRQEVSAVVLLY 115
Query: 246 IALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLP-DNWSHH--I 302
           +A  I+  ++YL              A N L+ E++  +++DFGL++ +  D ++ H   
Sbjct: 116 MATQISSAMEYLEKKNFIHRDLA---ARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGA 172
Query: 303 VFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELIT 341
            FPI+ T    +PE   +     K+DV+AFGVLL E+ T
Sbjct: 173 KFPIKWT----APESLAYNKFSIKSDVWAFGVLLWEIAT 207

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 60/219 (27%), Positives = 105/219 (47%), Gaps = 23/219 (10%)
Query: 131 NFDFAELAAATDNFNSENLIGKGGHAEVYKGCLPDGEXXXXXXXXXXXXEDEERISDFLS 190
           N+D  E+     +   ++ +G G + EVY+G     +            ED   + +FL 
Sbjct: 6   NYDKWEMERT--DITMKHKLGGGQYGEVYEGVW---KKYSLTVAVKTLKEDTMEVEEFLK 60
Query: 191 ELGIVAHINHPNAAKLIGFST-ENGFHLVLQFLPHGSLSSLLFGSTEC----LEWTIRYK 245
           E  ++  I HPN  +L+G  T E  F+++ +F+ +G+L   L    EC    +   +   
Sbjct: 61  EAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL---RECNRQEVNAVVLLY 117
Query: 246 IALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLP-DNWSHH--I 302
           +A  I+  ++YL              A N L+ E++  +++DFGL++ +  D ++ H   
Sbjct: 118 MATQISSAMEYLEKKNFIHRDLA---ARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGA 174
Query: 303 VFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELIT 341
            FPI+ T    +PE   +     K+DV+AFGVLL E+ T
Sbjct: 175 KFPIKWT----APESLAYNKFSIKSDVWAFGVLLWEIAT 209

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 57/200 (28%), Positives = 97/200 (48%), Gaps = 21/200 (10%)
Query: 150 IGKGGHAEVYKGCLPDGEXXXXXXXXXXXXEDEERISDFLSELGIVAHINHPNAAKLIGF 209
           +G G + EVY+G     +            ED   + +FL E  ++  I HPN  +L+G 
Sbjct: 21  LGGGQYGEVYEGVW---KKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 77
Query: 210 ST-ENGFHLVLQFLPHGSLSSLLFGSTEC----LEWTIRYKIALGIAEGLQYLXXXXXXX 264
            T E  F+++ +F+ +G+L   L    EC    +   +   +A  I+  ++YL       
Sbjct: 78  CTREPPFYIITEFMTYGNLLDYL---RECNRQEVNAVVLLYMATQISSAMEYLEKKNFIH 134
Query: 265 XXXXXXKASNILLSEDYEAQISDFGLAKWLP-DNWSHH--IVFPIEGTFGYLSPEYFMHG 321
                  A N L+ E++  +++DFGL++ +  D ++ H    FPI+ T    +PE   + 
Sbjct: 135 RDLA---ARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWT----APESLAYN 187
Query: 322 IVDEKTDVFAFGVLLLELIT 341
               K+DV+AFGVLL E+ T
Sbjct: 188 KFSIKSDVWAFGVLLWEIAT 207

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 57/200 (28%), Positives = 97/200 (48%), Gaps = 21/200 (10%)
Query: 150 IGKGGHAEVYKGCLPDGEXXXXXXXXXXXXEDEERISDFLSELGIVAHINHPNAAKLIGF 209
           +G G + EVY+G     +            ED   + +FL E  ++  I HPN  +L+G 
Sbjct: 21  LGGGQYGEVYEGVW---KKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 77
Query: 210 ST-ENGFHLVLQFLPHGSLSSLLFGSTEC----LEWTIRYKIALGIAEGLQYLXXXXXXX 264
            T E  F+++ +F+ +G+L   L    EC    +   +   +A  I+  ++YL       
Sbjct: 78  CTREPPFYIITEFMTYGNLLDYL---RECNRQEVNAVVLLYMATQISSAMEYLEKKNFIH 134
Query: 265 XXXXXXKASNILLSEDYEAQISDFGLAKWLP-DNWSHH--IVFPIEGTFGYLSPEYFMHG 321
                  A N L+ E++  +++DFGL++ +  D ++ H    FPI+ T    +PE   + 
Sbjct: 135 RDLA---ARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWT----APESLAYN 187
Query: 322 IVDEKTDVFAFGVLLLELIT 341
               K+DV+AFGVLL E+ T
Sbjct: 188 KFSIKSDVWAFGVLLWEIAT 207

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 75.9 bits (185), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 57/200 (28%), Positives = 97/200 (48%), Gaps = 21/200 (10%)
Query: 150 IGKGGHAEVYKGCLPDGEXXXXXXXXXXXXEDEERISDFLSELGIVAHINHPNAAKLIGF 209
           +G G + EVY+G     +            ED   + +FL E  ++  I HPN  +L+G 
Sbjct: 25  LGGGQYGEVYEGVW---KKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 81
Query: 210 ST-ENGFHLVLQFLPHGSLSSLLFGSTEC----LEWTIRYKIALGIAEGLQYLXXXXXXX 264
            T E  F+++ +F+ +G+L   L    EC    +   +   +A  I+  ++YL       
Sbjct: 82  CTREPPFYIITEFMTYGNLLDYL---RECNRQEVNAVVLLYMATQISSAMEYLEKKNFIH 138
Query: 265 XXXXXXKASNILLSEDYEAQISDFGLAKWLP-DNWSHH--IVFPIEGTFGYLSPEYFMHG 321
                  A N L+ E++  +++DFGL++ +  D ++ H    FPI+ T    +PE   + 
Sbjct: 139 RDLA---ARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWT----APESLAYN 191
Query: 322 IVDEKTDVFAFGVLLLELIT 341
               K+DV+AFGVLL E+ T
Sbjct: 192 KFSIKSDVWAFGVLLWEIAT 211

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 75.9 bits (185), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 57/200 (28%), Positives = 97/200 (48%), Gaps = 21/200 (10%)
Query: 150 IGKGGHAEVYKGCLPDGEXXXXXXXXXXXXEDEERISDFLSELGIVAHINHPNAAKLIGF 209
           +G G + EVY+G     +            ED   + +FL E  ++  I HPN  +L+G 
Sbjct: 228 LGGGQYGEVYEGVW---KKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 284
Query: 210 ST-ENGFHLVLQFLPHGSLSSLLFGSTEC----LEWTIRYKIALGIAEGLQYLXXXXXXX 264
            T E  F+++ +F+ +G+L   L    EC    +   +   +A  I+  ++YL       
Sbjct: 285 CTREPPFYIITEFMTYGNLLDYL---RECNRQEVSAVVLLYMATQISSAMEYLEKKNFIH 341
Query: 265 XXXXXXKASNILLSEDYEAQISDFGLAKWLP-DNWSHH--IVFPIEGTFGYLSPEYFMHG 321
                  A N L+ E++  +++DFGL++ +  D ++ H    FPI+ T    +PE   + 
Sbjct: 342 RNLA---ARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWT----APESLAYN 394
Query: 322 IVDEKTDVFAFGVLLLELIT 341
               K+DV+AFGVLL E+ T
Sbjct: 395 KFSIKSDVWAFGVLLWEIAT 414

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 75.9 bits (185), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 57/200 (28%), Positives = 97/200 (48%), Gaps = 21/200 (10%)
Query: 150 IGKGGHAEVYKGCLPDGEXXXXXXXXXXXXEDEERISDFLSELGIVAHINHPNAAKLIGF 209
           +G G + EVY+G     +            ED   + +FL E  ++  I HPN  +L+G 
Sbjct: 34  LGGGQYGEVYEGVW---KKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 90
Query: 210 ST-ENGFHLVLQFLPHGSLSSLLFGSTEC----LEWTIRYKIALGIAEGLQYLXXXXXXX 264
            T E  F+++ +F+ +G+L   L    EC    +   +   +A  I+  ++YL       
Sbjct: 91  CTREPPFYIITEFMTYGNLLDYL---RECNRQEVNAVVLLYMATQISSAMEYLEKKNFIH 147
Query: 265 XXXXXXKASNILLSEDYEAQISDFGLAKWLP-DNWSHH--IVFPIEGTFGYLSPEYFMHG 321
                  A N L+ E++  +++DFGL++ +  D ++ H    FPI+ T    +PE   + 
Sbjct: 148 RDLA---ARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWT----APESLAYN 200
Query: 322 IVDEKTDVFAFGVLLLELIT 341
               K+DV+AFGVLL E+ T
Sbjct: 201 KFSIKSDVWAFGVLLWEIAT 220

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 57/200 (28%), Positives = 97/200 (48%), Gaps = 21/200 (10%)
Query: 150 IGKGGHAEVYKGCLPDGEXXXXXXXXXXXXEDEERISDFLSELGIVAHINHPNAAKLIGF 209
           +G G + EVY+G     +            ED   + +FL E  ++  I HPN  +L+G 
Sbjct: 19  LGGGQYGEVYEGVW---KKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 75
Query: 210 ST-ENGFHLVLQFLPHGSLSSLLFGSTEC----LEWTIRYKIALGIAEGLQYLXXXXXXX 264
            T E  F+++ +F+ +G+L   L    EC    +   +   +A  I+  ++YL       
Sbjct: 76  CTREPPFYIITEFMTYGNLLDYL---RECNRQEVSAVVLLYMATQISSAMEYLEKKNFIH 132
Query: 265 XXXXXXKASNILLSEDYEAQISDFGLAKWLP-DNWSHH--IVFPIEGTFGYLSPEYFMHG 321
                  A N L+ E++  +++DFGL++ +  D ++ H    FPI+ T    +PE   + 
Sbjct: 133 RDLA---ARNCLVGENHLVKVADFGLSRLMTGDTFTAHAGAKFPIKWT----APESLAYN 185
Query: 322 IVDEKTDVFAFGVLLLELIT 341
               K+DV+AFGVLL E+ T
Sbjct: 186 KFSIKSDVWAFGVLLWEIAT 205

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 60/219 (27%), Positives = 105/219 (47%), Gaps = 23/219 (10%)
Query: 131 NFDFAELAAATDNFNSENLIGKGGHAEVYKGCLPDGEXXXXXXXXXXXXEDEERISDFLS 190
           N+D  E+     +   ++ +G G + EVY+G     +            ED   + +FL 
Sbjct: 5   NYDKWEMERT--DITMKHKLGGGQYGEVYEGVW---KKYSLTVAVKTLKEDTMEVEEFLK 59
Query: 191 ELGIVAHINHPNAAKLIGFST-ENGFHLVLQFLPHGSLSSLLFGSTEC----LEWTIRYK 245
           E  ++  I HPN  +L+G  T E  F+++++F+ +G+L   L    EC    +   +   
Sbjct: 60  EAAVMKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYL---RECNRQEVNAVVLLY 116
Query: 246 IALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLP-DNWSHH--I 302
           +A  I+  ++YL              A N L+ E++  +++DFGL++ +  D  + H   
Sbjct: 117 MATQISSAMEYLEKKNFIHRDLA---ARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGA 173
Query: 303 VFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELIT 341
            FPI+ T    +PE   +     K+DV+AFGVLL E+ T
Sbjct: 174 KFPIKWT----APESLAYNKFSIKSDVWAFGVLLWEIAT 208

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 62/227 (27%), Positives = 107/227 (47%), Gaps = 23/227 (10%)
Query: 123 PIVRHSWKNFDFAELAAATDNFNSENLIGKGGHAEVYKGCLPDGEXXXXXXXXXXXXEDE 182
           P V     N+D  E+     +   ++ +G G + EVY+G     +            ED 
Sbjct: 242 PTVYGVSPNYDKWEMERT--DITMKHKLGGGQYGEVYEGVW---KKYSLTVAVKTLKEDT 296
Query: 183 ERISDFLSELGIVAHINHPNAAKLIGFST-ENGFHLVLQFLPHGSLSSLLFGSTEC---- 237
             + +FL E  ++  I HPN  +L+G  T E  F+++ +F+ +G+L   L    EC    
Sbjct: 297 MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL---RECNRQE 353
Query: 238 LEWTIRYKIALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLP-D 296
           +   +   +A  I+  ++YL              A N L+ E++  +++DFGL++ +  D
Sbjct: 354 VNAVVLLYMATQISSAMEYLEKKNFIHRNLA---ARNCLVGENHLVKVADFGLSRLMTGD 410
Query: 297 NWSHH--IVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELIT 341
            ++ H    FPI+ T    +PE   +     K+DV+AFGVLL E+ T
Sbjct: 411 TYTAHAGAKFPIKWT----APESLAYNKFSIKSDVWAFGVLLWEIAT 453

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 57/200 (28%), Positives = 97/200 (48%), Gaps = 21/200 (10%)
Query: 150 IGKGGHAEVYKGCLPDGEXXXXXXXXXXXXEDEERISDFLSELGIVAHINHPNAAKLIGF 209
           +G G + EVY+G     +            ED   + +FL E  ++  I HPN  +L+G 
Sbjct: 19  LGGGQYGEVYEGVW---KKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 75
Query: 210 ST-ENGFHLVLQFLPHGSLSSLLFGSTEC----LEWTIRYKIALGIAEGLQYLXXXXXXX 264
            T E  F+++++F+ +G+L   L    EC    +   +   +A  I+  ++YL       
Sbjct: 76  CTREPPFYIIIEFMTYGNLLDYL---RECNRQEVSAVVLLYMATQISSAMEYLEKKNFIH 132
Query: 265 XXXXXXKASNILLSEDYEAQISDFGLAKWLP-DNWSHH--IVFPIEGTFGYLSPEYFMHG 321
                  A N L+ E++  +++DFGL++ +  D  + H    FPI+ T    +PE   + 
Sbjct: 133 RDLA---ARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWT----APESLAYN 185
Query: 322 IVDEKTDVFAFGVLLLELIT 341
               K+DV+AFGVLL E+ T
Sbjct: 186 KFSIKSDVWAFGVLLWEIAT 205

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 57/200 (28%), Positives = 96/200 (48%), Gaps = 21/200 (10%)
Query: 150 IGKGGHAEVYKGCLPDGEXXXXXXXXXXXXEDEERISDFLSELGIVAHINHPNAAKLIGF 209
           +G G + EVY+G     +            ED   + +FL E  ++  I HPN  +L+G 
Sbjct: 26  LGGGQYGEVYEGVW---KKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 82
Query: 210 ST-ENGFHLVLQFLPHGSLSSLLFGSTEC----LEWTIRYKIALGIAEGLQYLXXXXXXX 264
            T E  F+++ +F+ +G+L   L    EC    +   +   +A  I+  ++YL       
Sbjct: 83  CTREPPFYIITEFMTYGNLLDYL---RECNRQEVNAVVLLYMATQISSAMEYLEKKNFIH 139
Query: 265 XXXXXXKASNILLSEDYEAQISDFGLAKWLP-DNWSHH--IVFPIEGTFGYLSPEYFMHG 321
                  A N L+ E++  +++DFGL++ +  D  + H    FPI+ T    +PE   + 
Sbjct: 140 RDLA---ARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWT----APESLAYN 192
Query: 322 IVDEKTDVFAFGVLLLELIT 341
               K+DV+AFGVLL E+ T
Sbjct: 193 KFSIKSDVWAFGVLLWEIAT 212

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 57/200 (28%), Positives = 95/200 (47%), Gaps = 21/200 (10%)
Query: 150 IGKGGHAEVYKGCLPDGEXXXXXXXXXXXXEDEERISDFLSELGIVAHINHPNAAKLIGF 209
           +G G   EVY+G     +            ED   + +FL E  ++  I HPN  +L+G 
Sbjct: 19  LGGGQFGEVYEGVW---KKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 75
Query: 210 ST-ENGFHLVLQFLPHGSLSSLLFGSTEC----LEWTIRYKIALGIAEGLQYLXXXXXXX 264
            T E  F+++ +F+ +G+L   L    EC    +   +   +A  I+  ++YL       
Sbjct: 76  CTREPPFYIITEFMTYGNLLDYL---RECNRQEVSAVVLLYMATQISSAMEYLEKKNFIH 132
Query: 265 XXXXXXKASNILLSEDYEAQISDFGLAKWLP-DNWSHH--IVFPIEGTFGYLSPEYFMHG 321
                  A N L+ E++  +++DFGL++ +  D  + H    FPI+ T    +PE   + 
Sbjct: 133 RDLA---ARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWT----APESLAYN 185
Query: 322 IVDEKTDVFAFGVLLLELIT 341
               K+DV+AFGVLL E+ T
Sbjct: 186 KFSIKSDVWAFGVLLWEIAT 205

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 60/223 (26%), Positives = 105/223 (47%), Gaps = 23/223 (10%)
Query: 127 HSWKNFDFAELAAATDNFNSENLIGKGGHAEVYKGCLPDGEXXXXXXXXXXXXEDEERIS 186
           H   N+D  E+     +   ++ +G G + EVY+G     +            ED   + 
Sbjct: 2   HMSPNYDKWEMERT--DITMKHKLGGGQYGEVYEGVW---KKYSLTVAVKTLKEDTMEVE 56
Query: 187 DFLSELGIVAHINHPNAAKLIGFST-ENGFHLVLQFLPHGSLSSLLFGSTEC----LEWT 241
           +FL E  ++  I HPN  +L+G  T E  F+++ +F+ +G+L   L    EC    +   
Sbjct: 57  EFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL---RECNRQEVNAV 113
Query: 242 IRYKIALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLP-DNWS- 299
           +   +A  I+  ++YL              A N L+ E++  +++DFGL++ +  D ++ 
Sbjct: 114 VLLYMATQISSAMEYLEKKNFIHRDLA---ARNCLVGENHLVKVADFGLSRLMTGDTYTA 170
Query: 300 -HHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELIT 341
                FPI+ T    +PE   +     K+DV+AFGVLL E+ T
Sbjct: 171 PAGAKFPIKWT----APESLAYNKFSIKSDVWAFGVLLWEIAT 209

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 96/200 (48%), Gaps = 21/200 (10%)
Query: 150 IGKGGHAEVYKGCLPDGEXXXXXXXXXXXXEDEERISDFLSELGIVAHINHPNAAKLIGF 209
           +G G + EVY+G     +            ED   + +FL E  ++  I HPN  +L+G 
Sbjct: 22  LGGGQYGEVYEGVW---KKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 78
Query: 210 ST-ENGFHLVLQFLPHGSLSSLLFGSTEC----LEWTIRYKIALGIAEGLQYLXXXXXXX 264
            T E  F+++ +F+ +G+L   L    EC    +   +   +A  I+  ++YL       
Sbjct: 79  CTREPPFYIITEFMTYGNLLDYL---RECNRQEVNAVVLLYMATQISSAMEYLEKKNFIH 135
Query: 265 XXXXXXKASNILLSEDYEAQISDFGLAKWLP-DNWS--HHIVFPIEGTFGYLSPEYFMHG 321
                  A N L+ E++  +++DFGL++ +  D ++      FPI+ T    +PE   + 
Sbjct: 136 RDLA---ARNCLVGENHLVKVADFGLSRLMTGDTYTAPAGAKFPIKWT----APESLAYN 188
Query: 322 IVDEKTDVFAFGVLLLELIT 341
               K+DV+AFGVLL E+ T
Sbjct: 189 KFSIKSDVWAFGVLLWEIAT 208

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 62/230 (26%), Positives = 99/230 (43%), Gaps = 24/230 (10%)
Query: 187 DFLSELGIVAHINHPNAAKLIGFSTENG-FHLVLQFLPHGSLSSLLFGSTECLEWTIRYK 245
           DF+ E  ++  ++HP   +L G   E     LV +F+ HG LS  L              
Sbjct: 51  DFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLG 110
Query: 246 IALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNW---SHHI 302
           + L + EG+ YL              A N L+ E+   ++SDFG+ +++ D+    S   
Sbjct: 111 MCLDVCEGMAYLEEACVIHRDLA---ARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGT 167
Query: 303 VFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELIT-GRRAVDSRRQSLVIWAKPLL 361
            FP++    + SPE F       K+DV++FGVL+ E+ + G+   ++R  S V+      
Sbjct: 168 KFPVK----WASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVV-----E 218
Query: 362 QTSNFKELVDPRLADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQLL 411
             S    L  PRLA  +    M         C       RP  +R+L+ L
Sbjct: 219 DISTGFRLYKPRLASTHVYQIMNH-------CWRERPEDRPAFSRLLRQL 261

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/230 (26%), Positives = 99/230 (43%), Gaps = 24/230 (10%)
Query: 187 DFLSELGIVAHINHPNAAKLIGFSTENG-FHLVLQFLPHGSLSSLLFGSTECLEWTIRYK 245
           DF+ E  ++  ++HP   +L G   E     LV +F+ HG LS  L              
Sbjct: 48  DFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLG 107
Query: 246 IALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNW---SHHI 302
           + L + EG+ YL              A N L+ E+   ++SDFG+ +++ D+    S   
Sbjct: 108 MCLDVCEGMAYLEEACVIHRDLA---ARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGT 164
Query: 303 VFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELIT-GRRAVDSRRQSLVIWAKPLL 361
            FP++    + SPE F       K+DV++FGVL+ E+ + G+   ++R  S V+      
Sbjct: 165 KFPVK----WASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVV-----E 215
Query: 362 QTSNFKELVDPRLADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQLL 411
             S    L  PRLA  +    M         C       RP  +R+L+ L
Sbjct: 216 DISTGFRLYKPRLASTHVYQIMNH-------CWKERPEDRPAFSRLLRQL 258

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/230 (26%), Positives = 99/230 (43%), Gaps = 24/230 (10%)
Query: 187 DFLSELGIVAHINHPNAAKLIGFSTENG-FHLVLQFLPHGSLSSLLFGSTECLEWTIRYK 245
           DF+ E  ++  ++HP   +L G   E     LV +F+ HG LS  L              
Sbjct: 48  DFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLG 107
Query: 246 IALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNW---SHHI 302
           + L + EG+ YL              A N L+ E+   ++SDFG+ +++ D+    S   
Sbjct: 108 MCLDVCEGMAYLEEASVIHRDLA---ARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGT 164
Query: 303 VFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELIT-GRRAVDSRRQSLVIWAKPLL 361
            FP++    + SPE F       K+DV++FGVL+ E+ + G+   ++R  S V+      
Sbjct: 165 KFPVK----WASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVV-----E 215
Query: 362 QTSNFKELVDPRLADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQLL 411
             S    L  PRLA  +    M         C       RP  +R+L+ L
Sbjct: 216 DISTGFRLYKPRLASTHVYQIMNH-------CWKERPEDRPAFSRLLRQL 258

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/230 (26%), Positives = 99/230 (43%), Gaps = 24/230 (10%)
Query: 187 DFLSELGIVAHINHPNAAKLIGFSTENG-FHLVLQFLPHGSLSSLLFGSTECLEWTIRYK 245
           DF+ E  ++  ++HP   +L G   E     LV +F+ HG LS  L              
Sbjct: 46  DFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLG 105
Query: 246 IALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNW---SHHI 302
           + L + EG+ YL              A N L+ E+   ++SDFG+ +++ D+    S   
Sbjct: 106 MCLDVCEGMAYLEEACVIHRDLA---ARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGT 162
Query: 303 VFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELIT-GRRAVDSRRQSLVIWAKPLL 361
            FP++    + SPE F       K+DV++FGVL+ E+ + G+   ++R  S V+      
Sbjct: 163 KFPVK----WASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVV-----E 213
Query: 362 QTSNFKELVDPRLADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQLL 411
             S    L  PRLA  +    M         C       RP  +R+L+ L
Sbjct: 214 DISTGFRLYKPRLASTHVYQIMNH-------CWKERPEDRPAFSRLLRQL 256

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/230 (26%), Positives = 99/230 (43%), Gaps = 24/230 (10%)
Query: 187 DFLSELGIVAHINHPNAAKLIGFSTENG-FHLVLQFLPHGSLSSLLFGSTECLEWTIRYK 245
           DF+ E  ++  ++HP   +L G   E     LV +F+ HG LS  L              
Sbjct: 68  DFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLG 127
Query: 246 IALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNW---SHHI 302
           + L + EG+ YL              A N L+ E+   ++SDFG+ +++ D+    S   
Sbjct: 128 MCLDVCEGMAYLEEACVIHRDLA---ARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGT 184
Query: 303 VFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELIT-GRRAVDSRRQSLVIWAKPLL 361
            FP++    + SPE F       K+DV++FGVL+ E+ + G+   ++R  S V+      
Sbjct: 185 KFPVK----WASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVV-----E 235
Query: 362 QTSNFKELVDPRLADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQLL 411
             S    L  PRLA  +    M         C       RP  +R+L+ L
Sbjct: 236 DISTGFRLYKPRLASTHVYQIMNH-------CWKERPEDRPAFSRLLRQL 278

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/230 (26%), Positives = 99/230 (43%), Gaps = 24/230 (10%)
Query: 187 DFLSELGIVAHINHPNAAKLIGFSTENG-FHLVLQFLPHGSLSSLLFGSTECLEWTIRYK 245
           DF+ E  ++  ++HP   +L G   E     LV +F+ HG LS  L              
Sbjct: 49  DFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLG 108
Query: 246 IALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNW---SHHI 302
           + L + EG+ YL              A N L+ E+   ++SDFG+ +++ D+    S   
Sbjct: 109 MCLDVCEGMAYLEEACVIHRDLA---ARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGT 165
Query: 303 VFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELIT-GRRAVDSRRQSLVIWAKPLL 361
            FP++    + SPE F       K+DV++FGVL+ E+ + G+   ++R  S V+      
Sbjct: 166 KFPVK----WASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVV-----E 216
Query: 362 QTSNFKELVDPRLADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQLL 411
             S    L  PRLA  +    M         C       RP  +R+L+ L
Sbjct: 217 DISTGFRLYKPRLASTHVYQIMNH-------CWRERPEDRPAFSRLLRQL 259

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 52/207 (25%), Positives = 92/207 (44%), Gaps = 18/207 (8%)
Query: 144 FNSENLIGKGGHAEVYKGC-LPDGEXXXXXXXXXXXXE--DEERISDFLSELGIVAHINH 200
           F    ++G G    VYKG  +P+GE            E    +   + L E  ++A +++
Sbjct: 18  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 77
Query: 201 PNAAKLIGFSTENGFHLVLQFLPHGSLSSLL------FGSTECLEWTIRYKIALGIAEGL 254
           P+  +L+G    +   L++Q +P G L   +       GS   L W ++      IA+G+
Sbjct: 78  PHVCRLLGICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IAKGM 131
Query: 255 QYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEGTFGYLS 314
            YL              A N+L+      +I+DFGLAK L      +     +    +++
Sbjct: 132 NYLEDRRLVHRDLA---ARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 188
Query: 315 PEYFMHGIVDEKTDVFAFGVLLLELIT 341
            E  +H I   ++DV+++GV + EL+T
Sbjct: 189 LESILHRIYTHQSDVWSYGVTVWELMT 215

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 52/207 (25%), Positives = 92/207 (44%), Gaps = 18/207 (8%)
Query: 144 FNSENLIGKGGHAEVYKGC-LPDGEXXXXXXXXXXXXE--DEERISDFLSELGIVAHINH 200
           F    ++G G    VYKG  +P+GE            E    +   + L E  ++A +++
Sbjct: 19  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 78
Query: 201 PNAAKLIGFSTENGFHLVLQFLPHGSLSSLL------FGSTECLEWTIRYKIALGIAEGL 254
           P+  +L+G    +   L++Q +P G L   +       GS   L W ++      IA+G+
Sbjct: 79  PHVCRLLGICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IAKGM 132
Query: 255 QYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEGTFGYLS 314
            YL              A N+L+      +I+DFGLAK L      +     +    +++
Sbjct: 133 NYLEDRRLVHRDLA---ARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 189
Query: 315 PEYFMHGIVDEKTDVFAFGVLLLELIT 341
            E  +H I   ++DV+++GV + EL+T
Sbjct: 190 LESILHRIYTHQSDVWSYGVTVWELMT 216

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 52/207 (25%), Positives = 92/207 (44%), Gaps = 18/207 (8%)
Query: 144 FNSENLIGKGGHAEVYKGC-LPDGEXXXXXXXXXXXXE--DEERISDFLSELGIVAHINH 200
           F    ++G G    VYKG  +P+GE            E    +   + L E  ++A +++
Sbjct: 20  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 79
Query: 201 PNAAKLIGFSTENGFHLVLQFLPHGSLSSLL------FGSTECLEWTIRYKIALGIAEGL 254
           P+  +L+G    +   L++Q +P G L   +       GS   L W ++      IA+G+
Sbjct: 80  PHVCRLLGICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IAKGM 133
Query: 255 QYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEGTFGYLS 314
            YL              A N+L+      +I+DFGLAK L      +     +    +++
Sbjct: 134 NYLEDRRLVHRDLA---ARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 190
Query: 315 PEYFMHGIVDEKTDVFAFGVLLLELIT 341
            E  +H I   ++DV+++GV + EL+T
Sbjct: 191 LESILHRIYTHQSDVWSYGVTVWELMT 217

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 53/207 (25%), Positives = 91/207 (43%), Gaps = 18/207 (8%)
Query: 144 FNSENLIGKGGHAEVYKGC-LPDGEXXXXXXXXXXXXE--DEERISDFLSELGIVAHINH 200
           F    ++G G    VYKG  +P+GE            E    +   + L E  ++A +++
Sbjct: 14  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 73
Query: 201 PNAAKLIGFSTENGFHLVLQFLPHGSLSSLL------FGSTECLEWTIRYKIALGIAEGL 254
           P+  +L+G    +   L+ Q +P G L   +       GS   L W ++      IAEG+
Sbjct: 74  PHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IAEGM 127
Query: 255 QYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEGTFGYLS 314
            YL              A N+L+      +I+DFGLAK L      +     +    +++
Sbjct: 128 NYLEDRRLVHRDLA---ARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 184
Query: 315 PEYFMHGIVDEKTDVFAFGVLLLELIT 341
            E  +H I   ++DV+++GV + EL+T
Sbjct: 185 LESILHRIYTHQSDVWSYGVTVWELMT 211

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 52/207 (25%), Positives = 92/207 (44%), Gaps = 18/207 (8%)
Query: 144 FNSENLIGKGGHAEVYKGC-LPDGEXXXXXXXXXXXXE--DEERISDFLSELGIVAHINH 200
           F    ++G G    VYKG  +P+GE            E    +   + L E  ++A +++
Sbjct: 17  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 76
Query: 201 PNAAKLIGFSTENGFHLVLQFLPHGSLSSLL------FGSTECLEWTIRYKIALGIAEGL 254
           P+  +L+G    +   L++Q +P G L   +       GS   L W ++      IA+G+
Sbjct: 77  PHVCRLLGICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IAKGM 130
Query: 255 QYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEGTFGYLS 314
            YL              A N+L+      +I+DFGLAK L      +     +    +++
Sbjct: 131 NYLEDRRLVHRDLA---ARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 187
Query: 315 PEYFMHGIVDEKTDVFAFGVLLLELIT 341
            E  +H I   ++DV+++GV + EL+T
Sbjct: 188 LESILHRIYTHQSDVWSYGVTVWELMT 214

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 52/207 (25%), Positives = 92/207 (44%), Gaps = 18/207 (8%)
Query: 144 FNSENLIGKGGHAEVYKGC-LPDGEXXXXXXXXXXXXE--DEERISDFLSELGIVAHINH 200
           F    ++G G    VYKG  +P+GE            E    +   + L E  ++A +++
Sbjct: 21  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 80
Query: 201 PNAAKLIGFSTENGFHLVLQFLPHGSLSSLL------FGSTECLEWTIRYKIALGIAEGL 254
           P+  +L+G    +   L++Q +P G L   +       GS   L W ++      IA+G+
Sbjct: 81  PHVCRLLGICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IAKGM 134
Query: 255 QYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEGTFGYLS 314
            YL              A N+L+      +I+DFGLAK L      +     +    +++
Sbjct: 135 NYLEDRRLVHRDLA---ARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 191
Query: 315 PEYFMHGIVDEKTDVFAFGVLLLELIT 341
            E  +H I   ++DV+++GV + EL+T
Sbjct: 192 LESILHRIYTHQSDVWSYGVTVWELMT 218

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 52/207 (25%), Positives = 92/207 (44%), Gaps = 18/207 (8%)
Query: 144 FNSENLIGKGGHAEVYKGC-LPDGEXXXXXXXXXXXXE--DEERISDFLSELGIVAHINH 200
           F    ++G G    VYKG  +P+GE            E    +   + L E  ++A +++
Sbjct: 18  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 77
Query: 201 PNAAKLIGFSTENGFHLVLQFLPHGSLSSLL------FGSTECLEWTIRYKIALGIAEGL 254
           P+  +L+G    +   L++Q +P G L   +       GS   L W ++      IA+G+
Sbjct: 78  PHVCRLLGICLTSTVQLIMQLMPFGXLLDYVREHKDNIGSQYLLNWCVQ------IAKGM 131
Query: 255 QYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEGTFGYLS 314
            YL              A N+L+      +I+DFGLAK L      +     +    +++
Sbjct: 132 NYLEDRRLVHRDLA---ARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 188
Query: 315 PEYFMHGIVDEKTDVFAFGVLLLELIT 341
            E  +H I   ++DV+++GV + EL+T
Sbjct: 189 LESILHRIYTHQSDVWSYGVTVWELMT 215

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 52/207 (25%), Positives = 91/207 (43%), Gaps = 18/207 (8%)
Query: 144 FNSENLIGKGGHAEVYKGC-LPDGEXXXXXXXXXXXXE--DEERISDFLSELGIVAHINH 200
           F    ++G G    VYKG  +P+GE            E    +   + L E  ++A +++
Sbjct: 51  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIMELREATSPKANKEILDEAYVMASVDN 110
Query: 201 PNAAKLIGFSTENGFHLVLQFLPHGSLSSLL------FGSTECLEWTIRYKIALGIAEGL 254
           P+  +L+G    +   L+ Q +P G L   +       GS   L W ++      IA+G+
Sbjct: 111 PHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IAKGM 164
Query: 255 QYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEGTFGYLS 314
            YL              A N+L+      +I+DFGLAK L      +     +    +++
Sbjct: 165 NYLEDRRLVHRDLA---ARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 221
Query: 315 PEYFMHGIVDEKTDVFAFGVLLLELIT 341
            E  +H I   ++DV+++GV + EL+T
Sbjct: 222 LESILHRIYTHQSDVWSYGVTVWELMT 248

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 50/171 (29%), Positives = 86/171 (50%), Gaps = 9/171 (5%)
Query: 180 EDEERISDFLSELGIVAHINHPNAAKLIGFSTENGFHLVLQFLPHGSLSSLLFGSTECLE 239
           E E     F+ EL  ++ +NHPN  KL G +  N   LV+++   GSL ++L G+     
Sbjct: 41  ESESERKAFIVELRQLSRVNHPNIVKLYG-ACLNPVCLVMEYAEGGSLYNVLHGAEPLPY 99
Query: 240 WTIRYKIA--LGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEA-QISDFGLAKWLPD 296
           +T  + ++  L  ++G+ YL             K  N+LL       +I DFG A  +  
Sbjct: 100 YTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQT 159
Query: 297 NWSHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVD 347
           + +++     +G+  +++PE F      EK DVF++G++L E+IT R+  D
Sbjct: 160 HMTNN-----KGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFD 205

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 50/171 (29%), Positives = 86/171 (50%), Gaps = 9/171 (5%)
Query: 180 EDEERISDFLSELGIVAHINHPNAAKLIGFSTENGFHLVLQFLPHGSLSSLLFGSTECLE 239
           E E     F+ EL  ++ +NHPN  KL G +  N   LV+++   GSL ++L G+     
Sbjct: 40  ESESERKAFIVELRQLSRVNHPNIVKLYG-ACLNPVCLVMEYAEGGSLYNVLHGAEPLPY 98
Query: 240 WTIRYKIA--LGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEA-QISDFGLAKWLPD 296
           +T  + ++  L  ++G+ YL             K  N+LL       +I DFG A  +  
Sbjct: 99  YTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQT 158
Query: 297 NWSHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVD 347
           + +++     +G+  +++PE F      EK DVF++G++L E+IT R+  D
Sbjct: 159 HMTNN-----KGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFD 204

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 52/207 (25%), Positives = 91/207 (43%), Gaps = 18/207 (8%)
Query: 144 FNSENLIGKGGHAEVYKGC-LPDGEXXXXXXXXXXXXE--DEERISDFLSELGIVAHINH 200
           F    ++G G    VYKG  +P+GE            E    +   + L E  ++A +++
Sbjct: 27  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 86
Query: 201 PNAAKLIGFSTENGFHLVLQFLPHGSLSSLL------FGSTECLEWTIRYKIALGIAEGL 254
           P+  +L+G    +   L+ Q +P G L   +       GS   L W ++      IA+G+
Sbjct: 87  PHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IAKGM 140
Query: 255 QYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEGTFGYLS 314
            YL              A N+L+      +I+DFGLAK L      +     +    +++
Sbjct: 141 NYLEDRRLVHRDLA---ARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 197
Query: 315 PEYFMHGIVDEKTDVFAFGVLLLELIT 341
            E  +H I   ++DV+++GV + EL+T
Sbjct: 198 LESILHRIYTHQSDVWSYGVTVWELMT 224

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 49/164 (29%), Positives = 73/164 (44%), Gaps = 7/164 (4%)
Query: 182 EERISDFLSELGIVAHINHPNAAKLIGFSTENG---FHLVLQFLPHGSLSSLLFGSTECL 238
           EE + DF  E+ I+  + H N  K  G     G     L+++FLP+GSL   L    E +
Sbjct: 55  EEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEFLPYGSLREYLQKHKERI 114
Query: 239 EWTIRYKIALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLP-DN 297
           +     +    I +G++YL                NIL+  +   +I DFGL K LP D 
Sbjct: 115 DHIKLLQYTSQICKGMEYLGTKRYIHRDLA---TRNILVENENRVKIGDFGLTKVLPQDK 171
Query: 298 WSHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELIT 341
               +  P E    + +PE          +DV++FGV+L EL T
Sbjct: 172 EXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 215

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 51/178 (28%), Positives = 83/178 (46%), Gaps = 10/178 (5%)
Query: 185 ISDFLSELGIVAHINHPNAAKLIGFSTE---NGFHLVLQFLPHGSLSSLLFGSTECLEWT 241
           I+D   E+ I+ ++ H N  K  G  TE   NG  L+++FLP GSL   L  +   +   
Sbjct: 67  IADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLK 126
Query: 242 IRYKIALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWL-PDNWSH 300
            + K A+ I +G+ YL              A N+L+  +++ +I DFGL K +  D    
Sbjct: 127 QQLKYAVQICKGMDYLGSRQYVHRDLA---ARNVLVESEHQVKIGDFGLTKAIETDKEXX 183
Query: 301 HIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAK 358
            +    +    + +PE  M       +DV++FGV L EL+T     DS    + ++ K
Sbjct: 184 TVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLT---YCDSDSSPMALFLK 238

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 52/207 (25%), Positives = 91/207 (43%), Gaps = 18/207 (8%)
Query: 144 FNSENLIGKGGHAEVYKGC-LPDGEXXXXXXXXXXXXE--DEERISDFLSELGIVAHINH 200
           F    ++G G    VYKG  +P+GE            E    +   + L E  ++A +++
Sbjct: 24  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 83
Query: 201 PNAAKLIGFSTENGFHLVLQFLPHGSLSSLL------FGSTECLEWTIRYKIALGIAEGL 254
           P+  +L+G    +   L+ Q +P G L   +       GS   L W ++      IA+G+
Sbjct: 84  PHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IAKGM 137
Query: 255 QYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEGTFGYLS 314
            YL              A N+L+      +I+DFGLAK L      +     +    +++
Sbjct: 138 NYLEDRRLVHRDLA---ARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 194
Query: 315 PEYFMHGIVDEKTDVFAFGVLLLELIT 341
            E  +H I   ++DV+++GV + EL+T
Sbjct: 195 LESILHRIYTHQSDVWSYGVTVWELMT 221

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 52/207 (25%), Positives = 91/207 (43%), Gaps = 18/207 (8%)
Query: 144 FNSENLIGKGGHAEVYKGC-LPDGEXXXXXXXXXXXXE--DEERISDFLSELGIVAHINH 200
           F    ++G G    VYKG  +P+GE            E    +   + L E  ++A +++
Sbjct: 20  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 79
Query: 201 PNAAKLIGFSTENGFHLVLQFLPHGSLSSLL------FGSTECLEWTIRYKIALGIAEGL 254
           P+  +L+G    +   L+ Q +P G L   +       GS   L W ++      IA+G+
Sbjct: 80  PHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IAKGM 133
Query: 255 QYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEGTFGYLS 314
            YL              A N+L+      +I+DFGLAK L      +     +    +++
Sbjct: 134 NYLEDRRLVHRDLA---ARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 190
Query: 315 PEYFMHGIVDEKTDVFAFGVLLLELIT 341
            E  +H I   ++DV+++GV + EL+T
Sbjct: 191 LESILHRIYTHQSDVWSYGVTVWELMT 217

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 49/162 (30%), Positives = 82/162 (50%), Gaps = 11/162 (6%)
Query: 188 FLSELGIVAHINHPNAAKLIGFSTENGFHLVLQFLPHGSLSSLLFGST-ECLEWTIRYKI 246
           FL E  ++  + H    +L    +E   ++V +++  GSL   L G T + L       +
Sbjct: 57  FLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVTEYMNKGSLLDFLKGETGKYLRLPQLVDM 116
Query: 247 ALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDN-WS--HHIV 303
           +  IA G+ Y+             +A+NIL+ E+   +++DFGLA+ + DN W+      
Sbjct: 117 SAQIASGMAYVERMNYVHRDL---RAANILVGENLVCKVADFGLARLIEDNEWTARQGAK 173
Query: 304 FPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRA 345
           FPI+ T    +PE  ++G    K+DV++FG+LL EL T  R 
Sbjct: 174 FPIKWT----APEAALYGRFTIKSDVWSFGILLTELTTKGRV 211

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 52/207 (25%), Positives = 91/207 (43%), Gaps = 18/207 (8%)
Query: 144 FNSENLIGKGGHAEVYKGC-LPDGEXXXXXXXXXXXXE--DEERISDFLSELGIVAHINH 200
           F    ++G G    VYKG  +P+GE            E    +   + L E  ++A +++
Sbjct: 17  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 76
Query: 201 PNAAKLIGFSTENGFHLVLQFLPHGSLSSLL------FGSTECLEWTIRYKIALGIAEGL 254
           P+  +L+G    +   L+ Q +P G L   +       GS   L W ++      IA+G+
Sbjct: 77  PHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IAKGM 130
Query: 255 QYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEGTFGYLS 314
            YL              A N+L+      +I+DFGLAK L      +     +    +++
Sbjct: 131 NYLEDRRLVHRDLA---ARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 187
Query: 315 PEYFMHGIVDEKTDVFAFGVLLLELIT 341
            E  +H I   ++DV+++GV + EL+T
Sbjct: 188 LESILHRIYTHQSDVWSYGVTVWELMT 214

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 52/207 (25%), Positives = 91/207 (43%), Gaps = 18/207 (8%)
Query: 144 FNSENLIGKGGHAEVYKGC-LPDGEXXXXXXXXXXXXE--DEERISDFLSELGIVAHINH 200
           F    ++G G    VYKG  +P+GE            E    +   + L E  ++A +++
Sbjct: 20  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 79
Query: 201 PNAAKLIGFSTENGFHLVLQFLPHGSLSSLL------FGSTECLEWTIRYKIALGIAEGL 254
           P+  +L+G    +   L+ Q +P G L   +       GS   L W ++      IA+G+
Sbjct: 80  PHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IAKGM 133
Query: 255 QYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEGTFGYLS 314
            YL              A N+L+      +I+DFGLAK L      +     +    +++
Sbjct: 134 NYLEDRRLVHRDLA---ARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 190
Query: 315 PEYFMHGIVDEKTDVFAFGVLLLELIT 341
            E  +H I   ++DV+++GV + EL+T
Sbjct: 191 LESILHRIYTHQSDVWSYGVTVWELMT 217

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 56/198 (28%), Positives = 86/198 (43%), Gaps = 11/198 (5%)
Query: 150 IGKGGHAEVYKGCLPDGEXXXXXXXXXXXXEDEERISDFLSELGIVAHINHPNAAKLIGF 209
           IG G    VYKG                     +++  F +E+G++    H N    +G+
Sbjct: 20  IGSGSFGTVYKG---KWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 76
Query: 210 STENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLXXXXXXXXXXXX 269
           ST+    +V Q+    SL   L  S    E      IA   A G+ YL            
Sbjct: 77  STKPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYL---HAKSIIHRD 133
Query: 270 XKASNILLSEDYEAQISDFGLAKWLPDNWS-HHIVFPIEGTFGYLSPEYFMHGIVDE--- 325
            K++NI L ED   +I DFGLA  +   WS  H    + G+  +++PE       +    
Sbjct: 134 LKSNNIFLHEDNTVKIGDFGLAT-VKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSF 192
Query: 326 KTDVFAFGVLLLELITGR 343
           ++DV+AFG++L EL+TG+
Sbjct: 193 QSDVYAFGIVLYELMTGQ 210

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 52/207 (25%), Positives = 91/207 (43%), Gaps = 18/207 (8%)
Query: 144 FNSENLIGKGGHAEVYKGC-LPDGEXXXXXXXXXXXXE--DEERISDFLSELGIVAHINH 200
           F    ++G G    VYKG  +P+GE            E    +   + L E  ++A +++
Sbjct: 17  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 76
Query: 201 PNAAKLIGFSTENGFHLVLQFLPHGSLSSLL------FGSTECLEWTIRYKIALGIAEGL 254
           P+  +L+G    +   L+ Q +P G L   +       GS   L W ++      IA+G+
Sbjct: 77  PHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IAKGM 130
Query: 255 QYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEGTFGYLS 314
            YL              A N+L+      +I+DFGLAK L      +     +    +++
Sbjct: 131 NYLEDRRLVHRDLA---ARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 187
Query: 315 PEYFMHGIVDEKTDVFAFGVLLLELIT 341
            E  +H I   ++DV+++GV + EL+T
Sbjct: 188 LESILHRIYTHQSDVWSYGVTVWELMT 214

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 52/207 (25%), Positives = 91/207 (43%), Gaps = 18/207 (8%)
Query: 144 FNSENLIGKGGHAEVYKGC-LPDGEXXXXXXXXXXXXE--DEERISDFLSELGIVAHINH 200
           F    ++G G    VYKG  +P+GE            E    +   + L E  ++A +++
Sbjct: 20  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 79
Query: 201 PNAAKLIGFSTENGFHLVLQFLPHGSLSSLL------FGSTECLEWTIRYKIALGIAEGL 254
           P+  +L+G    +   L+ Q +P G L   +       GS   L W ++      IA+G+
Sbjct: 80  PHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IAKGM 133
Query: 255 QYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEGTFGYLS 314
            YL              A N+L+      +I+DFGLAK L      +     +    +++
Sbjct: 134 NYLEDRRLVHRDLA---ARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 190
Query: 315 PEYFMHGIVDEKTDVFAFGVLLLELIT 341
            E  +H I   ++DV+++GV + EL+T
Sbjct: 191 LESILHRIYTHQSDVWSYGVTVWELMT 217

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 52/207 (25%), Positives = 91/207 (43%), Gaps = 18/207 (8%)
Query: 144 FNSENLIGKGGHAEVYKGC-LPDGEXXXXXXXXXXXXE--DEERISDFLSELGIVAHINH 200
           F    ++G G    VYKG  +P+GE            E    +   + L E  ++A +++
Sbjct: 19  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 78
Query: 201 PNAAKLIGFSTENGFHLVLQFLPHGSLSSLL------FGSTECLEWTIRYKIALGIAEGL 254
           P+  +L+G    +   L+ Q +P G L   +       GS   L W ++      IA+G+
Sbjct: 79  PHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IAKGM 132
Query: 255 QYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEGTFGYLS 314
            YL              A N+L+      +I+DFGLAK L      +     +    +++
Sbjct: 133 NYLEDRRLVHRDLA---ARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 189
Query: 315 PEYFMHGIVDEKTDVFAFGVLLLELIT 341
            E  +H I   ++DV+++GV + EL+T
Sbjct: 190 LESILHRIYTHQSDVWSYGVTVWELMT 216

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 52/207 (25%), Positives = 91/207 (43%), Gaps = 18/207 (8%)
Query: 144 FNSENLIGKGGHAEVYKGC-LPDGEXXXXXXXXXXXXE--DEERISDFLSELGIVAHINH 200
           F    ++G G    VYKG  +P+GE            E    +   + L E  ++A +++
Sbjct: 11  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 70
Query: 201 PNAAKLIGFSTENGFHLVLQFLPHGSLSSLL------FGSTECLEWTIRYKIALGIAEGL 254
           P+  +L+G    +   L+ Q +P G L   +       GS   L W ++      IA+G+
Sbjct: 71  PHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IAKGM 124
Query: 255 QYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEGTFGYLS 314
            YL              A N+L+      +I+DFGLAK L      +     +    +++
Sbjct: 125 NYLEDRRLVHRDLA---ARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 181
Query: 315 PEYFMHGIVDEKTDVFAFGVLLLELIT 341
            E  +H I   ++DV+++GV + EL+T
Sbjct: 182 LESILHRIYTHQSDVWSYGVTVWELMT 208

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 48/164 (29%), Positives = 75/164 (45%), Gaps = 7/164 (4%)
Query: 182 EERISDFLSELGIVAHINHPNAAKLIGFSTENG---FHLVLQFLPHGSLSSLLFGSTECL 238
           EE + DF  E+ I+  + H N  K  G     G     L++++LP+GSL   L    E +
Sbjct: 53  EEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERI 112
Query: 239 EWTIRYKIALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNW 298
           +     +    I +G++YL                NIL+  +   +I DFGL K LP + 
Sbjct: 113 DHIKLLQYTSQICKGMEYLGTKRYIHRNLA---TRNILVENENRVKIGDFGLTKVLPQDK 169
Query: 299 SHHIVF-PIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELIT 341
            ++ V  P E    + +PE          +DV++FGV+L EL T
Sbjct: 170 EYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 213

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 48/180 (26%), Positives = 80/180 (44%), Gaps = 17/180 (9%)
Query: 181 DEERISDFLSELGIVAHINHPNAAKLIG-FSTENGFHLVLQFLPHGSLSSLLFGSTECLE 239
           DEE    FL E+ ++  + HPN  K IG    +   + + +++  G+L  ++        
Sbjct: 47  DEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYP 106
Query: 240 WTIRYKIALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWS 299
           W+ R   A  IA G+ YL              + N L+ E+    ++DFGLA+ + D  +
Sbjct: 107 WSQRVSFAKDIASGMAYLHSMNIIHRDL---NSHNCLVRENKNVVVADFGLARLMVDEKT 163
Query: 300 H------------HIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVD 347
                           + + G   +++PE       DEK DVF+FG++L E+I GR   D
Sbjct: 164 QPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEII-GRVNAD 222

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 51/178 (28%), Positives = 83/178 (46%), Gaps = 10/178 (5%)
Query: 185 ISDFLSELGIVAHINHPNAAKLIGFSTE---NGFHLVLQFLPHGSLSSLLFGSTECLEWT 241
           I+D   E+ I+ ++ H N  K  G  TE   NG  L+++FLP GSL   L  +   +   
Sbjct: 55  IADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLK 114
Query: 242 IRYKIALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWL-PDNWSH 300
            + K A+ I +G+ YL              A N+L+  +++ +I DFGL K +  D    
Sbjct: 115 QQLKYAVQICKGMDYLGSRQYVHRDLA---ARNVLVESEHQVKIGDFGLTKAIETDKEXX 171
Query: 301 HIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAK 358
            +    +    + +PE  M       +DV++FGV L EL+T     DS    + ++ K
Sbjct: 172 TVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLT---YCDSDSSPMALFLK 226

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 48/164 (29%), Positives = 73/164 (44%), Gaps = 7/164 (4%)
Query: 182 EERISDFLSELGIVAHINHPNAAKLIGFSTENG---FHLVLQFLPHGSLSSLLFGSTECL 238
           EE + DF  E+ I+  + H N  K  G     G     L++++LP+GSL   L    E +
Sbjct: 55  EEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQAHAERI 114
Query: 239 EWTIRYKIALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLP-DN 297
           +     +    I +G++YL                NIL+  +   +I DFGL K LP D 
Sbjct: 115 DHIKLLQYTSQICKGMEYLGTKRYIHRDLA---TRNILVENENRVKIGDFGLTKVLPQDK 171
Query: 298 WSHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELIT 341
               +  P E    + +PE          +DV++FGV+L EL T
Sbjct: 172 EXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 215

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 52/207 (25%), Positives = 91/207 (43%), Gaps = 18/207 (8%)
Query: 144 FNSENLIGKGGHAEVYKGC-LPDGEXXXXXXXXXXXXE--DEERISDFLSELGIVAHINH 200
           F    ++G G    VYKG  +P+GE            E    +   + L E  ++A +++
Sbjct: 42  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 101
Query: 201 PNAAKLIGFSTENGFHLVLQFLPHGSLSSLL------FGSTECLEWTIRYKIALGIAEGL 254
           P+  +L+G    +   L+ Q +P G L   +       GS   L W ++      IA+G+
Sbjct: 102 PHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IAKGM 155
Query: 255 QYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEGTFGYLS 314
            YL              A N+L+      +I+DFGLAK L      +     +    +++
Sbjct: 156 NYLEDRRLVHRDLA---ARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 212
Query: 315 PEYFMHGIVDEKTDVFAFGVLLLELIT 341
            E  +H I   ++DV+++GV + EL+T
Sbjct: 213 LESILHRIYTHQSDVWSYGVTVWELMT 239

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 52/207 (25%), Positives = 91/207 (43%), Gaps = 18/207 (8%)
Query: 144 FNSENLIGKGGHAEVYKGC-LPDGEXXXXXXXXXXXXE--DEERISDFLSELGIVAHINH 200
           F    ++G G    VYKG  +P+GE            E    +   + L E  ++A +++
Sbjct: 23  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 82
Query: 201 PNAAKLIGFSTENGFHLVLQFLPHGSLSSLL------FGSTECLEWTIRYKIALGIAEGL 254
           P+  +L+G    +   L+ Q +P G L   +       GS   L W ++      IA+G+
Sbjct: 83  PHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IAKGM 136
Query: 255 QYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEGTFGYLS 314
            YL              A N+L+      +I+DFGLAK L      +     +    +++
Sbjct: 137 NYLEDRRLVHRDLA---ARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 193
Query: 315 PEYFMHGIVDEKTDVFAFGVLLLELIT 341
            E  +H I   ++DV+++GV + EL+T
Sbjct: 194 LESILHRIYTHQSDVWSYGVTVWELMT 220

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 49/161 (30%), Positives = 80/161 (49%), Gaps = 11/161 (6%)
Query: 188 FLSELGIVAHINHPNAAKLIGFSTENGFHLVLQFLPHGSLSSLLFGST-ECLEWTIRYKI 246
           FL E  ++  + H    +L    +E   ++V +++  GSL   L G T + L       +
Sbjct: 53  FLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDM 112
Query: 247 ALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDN---WSHHIV 303
           A  IA G+ Y+             +A+NIL+ E+   +++DFGLA+ + DN         
Sbjct: 113 AAQIASGMAYVERMNYVHRDL---RAANILVGENLVCKVADFGLARLIEDNEYTARQGAK 169
Query: 304 FPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRR 344
           FPI+ T    +PE  ++G    K+DV++FG+LL EL T  R
Sbjct: 170 FPIKWT----APEAALYGRFTIKSDVWSFGILLTELTTKGR 206

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 52/207 (25%), Positives = 91/207 (43%), Gaps = 18/207 (8%)
Query: 144 FNSENLIGKGGHAEVYKGC-LPDGEXXXXXXXXXXXXE--DEERISDFLSELGIVAHINH 200
           F    ++G G    VYKG  +P+GE            E    +   + L E  ++A +++
Sbjct: 17  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 76
Query: 201 PNAAKLIGFSTENGFHLVLQFLPHGSLSSLL------FGSTECLEWTIRYKIALGIAEGL 254
           P+  +L+G    +   L+ Q +P G L   +       GS   L W ++      IA+G+
Sbjct: 77  PHVCRLLGICLTSTVQLITQLMPFGXLLDYVREHKDNIGSQYLLNWCVQ------IAKGM 130
Query: 255 QYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEGTFGYLS 314
            YL              A N+L+      +I+DFGLAK L      +     +    +++
Sbjct: 131 NYLEDRRLVHRDLA---ARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 187
Query: 315 PEYFMHGIVDEKTDVFAFGVLLLELIT 341
            E  +H I   ++DV+++GV + EL+T
Sbjct: 188 LESILHRIYTHQSDVWSYGVTVWELMT 214

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 49/161 (30%), Positives = 80/161 (49%), Gaps = 11/161 (6%)
Query: 188 FLSELGIVAHINHPNAAKLIGFSTENGFHLVLQFLPHGSLSSLLFGST-ECLEWTIRYKI 246
           FL E  ++  + H    +L    +E   ++V +++  GSL   L G T + L       +
Sbjct: 226 FLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDM 285
Query: 247 ALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDN---WSHHIV 303
           A  IA G+ Y+             +A+NIL+ E+   +++DFGLA+ + DN         
Sbjct: 286 AAQIASGMAYVERMNYVHRDL---RAANILVGENLVCKVADFGLARLIEDNEYTARQGAK 342
Query: 304 FPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRR 344
           FPI+ T    +PE  ++G    K+DV++FG+LL EL T  R
Sbjct: 343 FPIKWT----APEAALYGRFTIKSDVWSFGILLTELTTKGR 379

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 49/161 (30%), Positives = 80/161 (49%), Gaps = 11/161 (6%)
Query: 188 FLSELGIVAHINHPNAAKLIGFSTENGFHLVLQFLPHGSLSSLLFGST-ECLEWTIRYKI 246
           FL E  ++  + H    +L    +E   ++V +++  GSL   L G T + L       +
Sbjct: 226 FLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDM 285
Query: 247 ALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDN---WSHHIV 303
           A  IA G+ Y+             +A+NIL+ E+   +++DFGLA+ + DN         
Sbjct: 286 AAQIASGMAYVERMNYVHRDL---RAANILVGENLVCKVADFGLARLIEDNEYTARQGAK 342
Query: 304 FPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRR 344
           FPI+ T    +PE  ++G    K+DV++FG+LL EL T  R
Sbjct: 343 FPIKWT----APEAALYGRFTIKSDVWSFGILLTELTTKGR 379

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 47/162 (29%), Positives = 84/162 (51%), Gaps = 13/162 (8%)
Query: 188 FLSELGIVAHINHPNAAKLIGFSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIR--YK 245
           FL+E  ++  + H    +L    T+   +++ +++ +GSL   L  +   ++ TI     
Sbjct: 61  FLAEANLMKQLQHQRLVRLYAVVTQEPIYIITEYMENGSLVDFL-KTPSGIKLTINKLLD 119
Query: 246 IALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDN---WSHHI 302
           +A  IAEG+ ++             +A+NIL+S+    +I+DFGLA+ + DN        
Sbjct: 120 MAAQIAEGMAFIEERNYIHRDL---RAANILVSDTLSCKIADFGLARLIEDNEXTAREGA 176
Query: 303 VFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRR 344
            FPI+ T    +PE   +G    K+DV++FG+LL E++T  R
Sbjct: 177 KFPIKWT----APEAINYGTFTIKSDVWSFGILLTEIVTHGR 214

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 49/161 (30%), Positives = 80/161 (49%), Gaps = 11/161 (6%)
Query: 188 FLSELGIVAHINHPNAAKLIGFSTENGFHLVLQFLPHGSLSSLLFGST-ECLEWTIRYKI 246
           FL E  ++  + H    +L    +E   ++V +++  GSL   L G T + L       +
Sbjct: 309 FLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDM 368
Query: 247 ALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDN---WSHHIV 303
           A  IA G+ Y+             +A+NIL+ E+   +++DFGLA+ + DN         
Sbjct: 369 AAQIASGMAYVERMNYVHRDL---RAANILVGENLVCKVADFGLARLIEDNEYTARQGAK 425
Query: 304 FPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRR 344
           FPI+ T    +PE  ++G    K+DV++FG+LL EL T  R
Sbjct: 426 FPIKWT----APEAALYGRFTIKSDVWSFGILLTELTTKGR 462

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 48/164 (29%), Positives = 73/164 (44%), Gaps = 7/164 (4%)
Query: 182 EERISDFLSELGIVAHINHPNAAKLIGFSTENG---FHLVLQFLPHGSLSSLLFGSTECL 238
           EE + DF  E+ I+  + H N  K  G     G     L++++LP+GSL   L    E +
Sbjct: 51  EEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERI 110
Query: 239 EWTIRYKIALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLP-DN 297
           +     +    I +G++YL                NIL+  +   +I DFGL K LP D 
Sbjct: 111 DHIKLLQYTSQICKGMEYLGTKRYIHRDLA---TRNILVENENRVKIGDFGLTKVLPQDK 167
Query: 298 WSHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELIT 341
               +  P E    + +PE          +DV++FGV+L EL T
Sbjct: 168 EXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 211

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 47/162 (29%), Positives = 84/162 (51%), Gaps = 13/162 (8%)
Query: 188 FLSELGIVAHINHPNAAKLIGFSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIR--YK 245
           FL+E  ++  + H    +L    T+   +++ +++ +GSL   L  +   ++ TI     
Sbjct: 63  FLAEANLMKQLQHQRLVRLYAVVTQEPIYIITEYMENGSLVDFL-KTPSGIKLTINKLLD 121
Query: 246 IALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDN---WSHHI 302
           +A  IAEG+ ++             +A+NIL+S+    +I+DFGLA+ + DN        
Sbjct: 122 MAAQIAEGMAFIEERNYIHRDL---RAANILVSDTLSCKIADFGLARLIEDNEXTAREGA 178
Query: 303 VFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRR 344
            FPI+ T    +PE   +G    K+DV++FG+LL E++T  R
Sbjct: 179 KFPIKWT----APEAINYGTFTIKSDVWSFGILLTEIVTHGR 216

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 47/162 (29%), Positives = 84/162 (51%), Gaps = 13/162 (8%)
Query: 188 FLSELGIVAHINHPNAAKLIGFSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIR--YK 245
           FL+E  ++  + H    +L    T+   +++ +++ +GSL   L  +   ++ TI     
Sbjct: 51  FLAEANLMKQLQHQRLVRLYAVVTQEPIYIITEYMENGSLVDFL-KTPSGIKLTINKLLD 109
Query: 246 IALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDN---WSHHI 302
           +A  IAEG+ ++             +A+NIL+S+    +I+DFGLA+ + DN        
Sbjct: 110 MAAQIAEGMAFIEERNYIHRNL---RAANILVSDTLSCKIADFGLARLIEDNEYTAREGA 166
Query: 303 VFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRR 344
            FPI+ T    +PE   +G    K+DV++FG+LL E++T  R
Sbjct: 167 KFPIKWT----APEAINYGTFTIKSDVWSFGILLTEIVTHGR 204

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 47/162 (29%), Positives = 84/162 (51%), Gaps = 13/162 (8%)
Query: 188 FLSELGIVAHINHPNAAKLIGFSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIR--YK 245
           FL+E  ++  + H    +L    T+   +++ +++ +GSL   L  +   ++ TI     
Sbjct: 61  FLAEANLMKQLQHQRLVRLYAVVTQEPIYIITEYMENGSLVDFL-KTPSGIKLTINKLLD 119
Query: 246 IALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDN---WSHHI 302
           +A  IAEG+ ++             +A+NIL+S+    +I+DFGLA+ + DN        
Sbjct: 120 MAAQIAEGMAFIEERNYIHRDL---RAANILVSDTLSCKIADFGLARLIEDNEYTAREGA 176
Query: 303 VFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRR 344
            FPI+ T    +PE   +G    K+DV++FG+LL E++T  R
Sbjct: 177 KFPIKWT----APEAINYGTFTIKSDVWSFGILLTEIVTHGR 214

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 48/164 (29%), Positives = 73/164 (44%), Gaps = 7/164 (4%)
Query: 182 EERISDFLSELGIVAHINHPNAAKLIGFSTENG---FHLVLQFLPHGSLSSLLFGSTECL 238
           EE + DF  E+ I+  + H N  K  G     G     L++++LP+GSL   L    E +
Sbjct: 55  EEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERI 114
Query: 239 EWTIRYKIALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLP-DN 297
           +     +    I +G++YL                NIL+  +   +I DFGL K LP D 
Sbjct: 115 DHIKLLQYTSQICKGMEYLGTKRYIHRDLA---TRNILVENENRVKIGDFGLTKVLPQDK 171
Query: 298 WSHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELIT 341
               +  P E    + +PE          +DV++FGV+L EL T
Sbjct: 172 EXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 215

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 47/162 (29%), Positives = 84/162 (51%), Gaps = 13/162 (8%)
Query: 188 FLSELGIVAHINHPNAAKLIGFSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIR--YK 245
           FL+E  ++  + H    +L    T+   +++ +++ +GSL   L  +   ++ TI     
Sbjct: 50  FLAEANLMKQLQHQRLVRLYAVVTQEPIYIITEYMENGSLVDFL-KTPSGIKLTINKLLD 108
Query: 246 IALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDN---WSHHI 302
           +A  IAEG+ ++             +A+NIL+S+    +I+DFGLA+ + DN        
Sbjct: 109 MAAQIAEGMAFIEERNYIHRDL---RAANILVSDTLSCKIADFGLARLIEDNEYTAREGA 165
Query: 303 VFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRR 344
            FPI+ T    +PE   +G    K+DV++FG+LL E++T  R
Sbjct: 166 KFPIKWT----APEAINYGTFTIKSDVWSFGILLTEIVTHGR 203

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 47/162 (29%), Positives = 84/162 (51%), Gaps = 13/162 (8%)
Query: 188 FLSELGIVAHINHPNAAKLIGFSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIR--YK 245
           FL+E  ++  + H    +L    T+   +++ +++ +GSL   L  +   ++ TI     
Sbjct: 60  FLAEANLMKQLQHQRLVRLYAVVTQEPIYIITEYMENGSLVDFL-KTPSGIKLTINKLLD 118
Query: 246 IALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDN---WSHHI 302
           +A  IAEG+ ++             +A+NIL+S+    +I+DFGLA+ + DN        
Sbjct: 119 MAAQIAEGMAFIEERNYIHRDL---RAANILVSDTLSCKIADFGLARLIEDNEYTAREGA 175
Query: 303 VFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRR 344
            FPI+ T    +PE   +G    K+DV++FG+LL E++T  R
Sbjct: 176 KFPIKWT----APEAINYGTFTIKSDVWSFGILLTEIVTHGR 213

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 48/164 (29%), Positives = 73/164 (44%), Gaps = 7/164 (4%)
Query: 182 EERISDFLSELGIVAHINHPNAAKLIGFSTENG---FHLVLQFLPHGSLSSLLFGSTECL 238
           EE + DF  E+ I+  + H N  K  G     G     L++++LP+GSL   L    E +
Sbjct: 52  EEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERI 111
Query: 239 EWTIRYKIALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLP-DN 297
           +     +    I +G++YL                NIL+  +   +I DFGL K LP D 
Sbjct: 112 DHIKLLQYTSQICKGMEYLGTKRYIHRDLA---TRNILVENENRVKIGDFGLTKVLPQDK 168
Query: 298 WSHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELIT 341
               +  P E    + +PE          +DV++FGV+L EL T
Sbjct: 169 EXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 212

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 47/162 (29%), Positives = 84/162 (51%), Gaps = 13/162 (8%)
Query: 188 FLSELGIVAHINHPNAAKLIGFSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIR--YK 245
           FL+E  ++  + H    +L    T+   +++ +++ +GSL   L  +   ++ TI     
Sbjct: 55  FLAEANLMKQLQHQRLVRLYAVVTQEPIYIITEYMENGSLVDFL-KTPSGIKLTINKLLD 113
Query: 246 IALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDN---WSHHI 302
           +A  IAEG+ ++             +A+NIL+S+    +I+DFGLA+ + DN        
Sbjct: 114 MAAQIAEGMAFIEERNYIHRDL---RAANILVSDTLSCKIADFGLARLIEDNEXTAREGA 170
Query: 303 VFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRR 344
            FPI+ T    +PE   +G    K+DV++FG+LL E++T  R
Sbjct: 171 KFPIKWT----APEAINYGTFTIKSDVWSFGILLTEIVTHGR 208

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 47/162 (29%), Positives = 84/162 (51%), Gaps = 13/162 (8%)
Query: 188 FLSELGIVAHINHPNAAKLIGFSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIR--YK 245
           FL+E  ++  + H    +L    T+   +++ +++ +GSL   L  +   ++ TI     
Sbjct: 56  FLAEANLMKQLQHQRLVRLYAVVTQEPIYIITEYMENGSLVDFL-KTPSGIKLTINKLLD 114
Query: 246 IALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDN---WSHHI 302
           +A  IAEG+ ++             +A+NIL+S+    +I+DFGLA+ + DN        
Sbjct: 115 MAAQIAEGMAFIEERNYIHRDL---RAANILVSDTLSCKIADFGLARLIEDNEXTAREGA 171
Query: 303 VFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRR 344
            FPI+ T    +PE   +G    K+DV++FG+LL E++T  R
Sbjct: 172 KFPIKWT----APEAINYGTFTIKSDVWSFGILLTEIVTHGR 209

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 51/207 (24%), Positives = 91/207 (43%), Gaps = 18/207 (8%)
Query: 144 FNSENLIGKGGHAEVYKGC-LPDGEXXXXXXXXXXXXE--DEERISDFLSELGIVAHINH 200
           F    ++G G    VYKG  +P+GE            E    +   + L E  ++A +++
Sbjct: 19  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 78
Query: 201 PNAAKLIGFSTENGFHLVLQFLPHGSLSSLL------FGSTECLEWTIRYKIALGIAEGL 254
           P+  +L+G    +   L++Q +P G L   +       GS   L W ++      IA+G+
Sbjct: 79  PHVCRLLGICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IAKGM 132
Query: 255 QYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEGTFGYLS 314
            YL              A N+L+      +I+DFG AK L      +     +    +++
Sbjct: 133 NYLEDRRLVHRDLA---ARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMA 189
Query: 315 PEYFMHGIVDEKTDVFAFGVLLLELIT 341
            E  +H I   ++DV+++GV + EL+T
Sbjct: 190 LESILHRIYTHQSDVWSYGVTVWELMT 216

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 47/162 (29%), Positives = 84/162 (51%), Gaps = 13/162 (8%)
Query: 188 FLSELGIVAHINHPNAAKLIGFSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIR--YK 245
           FL+E  ++  + H    +L    T+   +++ +++ +GSL   L  +   ++ TI     
Sbjct: 64  FLAEANLMKQLQHQRLVRLYAVVTQEPIYIITEYMENGSLVDFL-KTPSGIKLTINKLLD 122
Query: 246 IALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDN---WSHHI 302
           +A  IAEG+ ++             +A+NIL+S+    +I+DFGLA+ + DN        
Sbjct: 123 MAAQIAEGMAFIEERNYIHRDL---RAANILVSDTLSCKIADFGLARLIEDNEXTAREGA 179
Query: 303 VFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRR 344
            FPI+ T    +PE   +G    K+DV++FG+LL E++T  R
Sbjct: 180 KFPIKWT----APEAINYGTFTIKSDVWSFGILLTEIVTHGR 217

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 47/162 (29%), Positives = 84/162 (51%), Gaps = 13/162 (8%)
Query: 188 FLSELGIVAHINHPNAAKLIGFSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIR--YK 245
           FL+E  ++  + H    +L    T+   +++ +++ +GSL   L  +   ++ TI     
Sbjct: 55  FLAEANLMKQLQHQRLVRLYAVVTQEPIYIITEYMENGSLVDFL-KTPSGIKLTINKLLD 113
Query: 246 IALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDN---WSHHI 302
           +A  IAEG+ ++             +A+NIL+S+    +I+DFGLA+ + DN        
Sbjct: 114 MAAQIAEGMAFIEERNYIHRDL---RAANILVSDTLSCKIADFGLARLIEDNEXTAREGA 170
Query: 303 VFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRR 344
            FPI+ T    +PE   +G    K+DV++FG+LL E++T  R
Sbjct: 171 KFPIKWT----APEAINYGTFTIKSDVWSFGILLTEIVTHGR 208

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 47/162 (29%), Positives = 84/162 (51%), Gaps = 13/162 (8%)
Query: 188 FLSELGIVAHINHPNAAKLIGFSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIR--YK 245
           FL+E  ++  + H    +L    T+   +++ +++ +GSL   L  +   ++ TI     
Sbjct: 57  FLAEANLMKQLQHQRLVRLYAVVTQEPIYIITEYMENGSLVDFL-KTPSGIKLTINKLLD 115
Query: 246 IALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDN---WSHHI 302
           +A  IAEG+ ++             +A+NIL+S+    +I+DFGLA+ + DN        
Sbjct: 116 MAAQIAEGMAFIEERNYIHRDL---RAANILVSDTLSCKIADFGLARLIEDNEXTAREGA 172
Query: 303 VFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRR 344
            FPI+ T    +PE   +G    K+DV++FG+LL E++T  R
Sbjct: 173 KFPIKWT----APEAINYGTFTIKSDVWSFGILLTEIVTHGR 210

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 48/164 (29%), Positives = 73/164 (44%), Gaps = 7/164 (4%)
Query: 182 EERISDFLSELGIVAHINHPNAAKLIGFSTENG---FHLVLQFLPHGSLSSLLFGSTECL 238
           EE + DF  E+ I+  + H N  K  G     G     L++++LP+GSL   L    E +
Sbjct: 52  EEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERI 111
Query: 239 EWTIRYKIALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLP-DN 297
           +     +    I +G++YL                NIL+  +   +I DFGL K LP D 
Sbjct: 112 DHIKLLQYTSQICKGMEYLGTKRYIHRDLA---TRNILVENENRVKIGDFGLTKVLPQDK 168
Query: 298 WSHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELIT 341
               +  P E    + +PE          +DV++FGV+L EL T
Sbjct: 169 EXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 212

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 48/164 (29%), Positives = 73/164 (44%), Gaps = 7/164 (4%)
Query: 182 EERISDFLSELGIVAHINHPNAAKLIGFSTENG---FHLVLQFLPHGSLSSLLFGSTECL 238
           EE + DF  E+ I+  + H N  K  G     G     L++++LP+GSL   L    E +
Sbjct: 56  EEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERI 115
Query: 239 EWTIRYKIALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLP-DN 297
           +     +    I +G++YL                NIL+  +   +I DFGL K LP D 
Sbjct: 116 DHIKLLQYTSQICKGMEYLGTKRYIHRDLA---TRNILVENENRVKIGDFGLTKVLPQDK 172
Query: 298 WSHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELIT 341
               +  P E    + +PE          +DV++FGV+L EL T
Sbjct: 173 EXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 216

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 48/164 (29%), Positives = 73/164 (44%), Gaps = 7/164 (4%)
Query: 182 EERISDFLSELGIVAHINHPNAAKLIGFSTENG---FHLVLQFLPHGSLSSLLFGSTECL 238
           EE + DF  E+ I+  + H N  K  G     G     L++++LP+GSL   L    E +
Sbjct: 57  EEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERI 116
Query: 239 EWTIRYKIALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLP-DN 297
           +     +    I +G++YL                NIL+  +   +I DFGL K LP D 
Sbjct: 117 DHIKLLQYTSQICKGMEYLGTKRYIHRDLA---TRNILVENENRVKIGDFGLTKVLPQDK 173
Query: 298 WSHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELIT 341
               +  P E    + +PE          +DV++FGV+L EL T
Sbjct: 174 EXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 217

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 48/164 (29%), Positives = 73/164 (44%), Gaps = 7/164 (4%)
Query: 182 EERISDFLSELGIVAHINHPNAAKLIGFSTENG---FHLVLQFLPHGSLSSLLFGSTECL 238
           EE + DF  E+ I+  + H N  K  G     G     L++++LP+GSL   L    E +
Sbjct: 58  EEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERI 117
Query: 239 EWTIRYKIALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLP-DN 297
           +     +    I +G++YL                NIL+  +   +I DFGL K LP D 
Sbjct: 118 DHIKLLQYTSQICKGMEYLGTKRYIHRDLA---TRNILVENENRVKIGDFGLTKVLPQDK 174
Query: 298 WSHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELIT 341
               +  P E    + +PE          +DV++FGV+L EL T
Sbjct: 175 EXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 218

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 47/162 (29%), Positives = 84/162 (51%), Gaps = 13/162 (8%)
Query: 188 FLSELGIVAHINHPNAAKLIGFSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIR--YK 245
           FL+E  ++  + H    +L    T+   +++ +++ +GSL   L  +   ++ TI     
Sbjct: 65  FLAEANLMKQLQHQRLVRLYAVVTQEPIYIITEYMENGSLVDFL-KTPSGIKLTINKLLD 123
Query: 246 IALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDN---WSHHI 302
           +A  IAEG+ ++             +A+NIL+S+    +I+DFGLA+ + DN        
Sbjct: 124 MAAQIAEGMAFIEERNYIHRDL---RAANILVSDTLSCKIADFGLARLIEDNEYTAREGA 180
Query: 303 VFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRR 344
            FPI+ T    +PE   +G    K+DV++FG+LL E++T  R
Sbjct: 181 KFPIKWT----APEAINYGTFTIKSDVWSFGILLTEIVTHGR 218

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 51/207 (24%), Positives = 91/207 (43%), Gaps = 18/207 (8%)
Query: 144 FNSENLIGKGGHAEVYKGC-LPDGEXXXXXXXXXXXXE--DEERISDFLSELGIVAHINH 200
           F    ++G G    VYKG  +P+GE            E    +   + L E  ++A +++
Sbjct: 21  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 80
Query: 201 PNAAKLIGFSTENGFHLVLQFLPHGSLSSLL------FGSTECLEWTIRYKIALGIAEGL 254
           P+  +L+G    +   L++Q +P G L   +       GS   L W ++      IA+G+
Sbjct: 81  PHVCRLLGICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IAKGM 134
Query: 255 QYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEGTFGYLS 314
            YL              A N+L+      +I+DFG AK L      +     +    +++
Sbjct: 135 NYLEDRRLVHRDLA---ARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMA 191
Query: 315 PEYFMHGIVDEKTDVFAFGVLLLELIT 341
            E  +H I   ++DV+++GV + EL+T
Sbjct: 192 LESILHRIYTHQSDVWSYGVTVWELMT 218

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 48/164 (29%), Positives = 73/164 (44%), Gaps = 7/164 (4%)
Query: 182 EERISDFLSELGIVAHINHPNAAKLIGFSTENG---FHLVLQFLPHGSLSSLLFGSTECL 238
           EE + DF  E+ I+  + H N  K  G     G     L++++LP+GSL   L    E +
Sbjct: 50  EEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERI 109
Query: 239 EWTIRYKIALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLP-DN 297
           +     +    I +G++YL                NIL+  +   +I DFGL K LP D 
Sbjct: 110 DHIKLLQYTSQICKGMEYLGTKRYIHRDLA---TRNILVENENRVKIGDFGLTKVLPQDK 166
Query: 298 WSHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELIT 341
               +  P E    + +PE          +DV++FGV+L EL T
Sbjct: 167 EXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 210

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 48/164 (29%), Positives = 73/164 (44%), Gaps = 7/164 (4%)
Query: 182 EERISDFLSELGIVAHINHPNAAKLIGFSTENG---FHLVLQFLPHGSLSSLLFGSTECL 238
           EE + DF  E+ I+  + H N  K  G     G     L++++LP+GSL   L    E +
Sbjct: 59  EEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERI 118
Query: 239 EWTIRYKIALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLP-DN 297
           +     +    I +G++YL                NIL+  +   +I DFGL K LP D 
Sbjct: 119 DHIKLLQYTSQICKGMEYLGTKRYIHRDLA---TRNILVENENRVKIGDFGLTKVLPQDK 175
Query: 298 WSHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELIT 341
               +  P E    + +PE          +DV++FGV+L EL T
Sbjct: 176 EXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 219

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 68.6 bits (166), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 47/162 (29%), Positives = 84/162 (51%), Gaps = 13/162 (8%)
Query: 188 FLSELGIVAHINHPNAAKLIGFSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIR--YK 245
           FL+E  ++  + H    +L    T+   +++ +++ +GSL   L  +   ++ TI     
Sbjct: 55  FLAEANLMKQLQHQRLVRLYAVVTQEPIYIITEYMENGSLVDFL-KTPSGIKLTINKLLD 113
Query: 246 IALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDN---WSHHI 302
           +A  IAEG+ ++             +A+NIL+S+    +I+DFGLA+ + DN        
Sbjct: 114 MAAQIAEGMAFIEERNYIHRDL---RAANILVSDTLSCKIADFGLARLIEDNEYTAREGA 170
Query: 303 VFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRR 344
            FPI+ T    +PE   +G    K+DV++FG+LL E++T  R
Sbjct: 171 KFPIKWT----APEAINYGTFTIKSDVWSFGILLTEIVTHGR 208

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 68.6 bits (166), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 51/207 (24%), Positives = 91/207 (43%), Gaps = 18/207 (8%)
Query: 144 FNSENLIGKGGHAEVYKGC-LPDGEXXXXXXXXXXXXE--DEERISDFLSELGIVAHINH 200
           F    ++G G    VYKG  +P+GE            E    +   + L E  ++A +++
Sbjct: 19  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 78
Query: 201 PNAAKLIGFSTENGFHLVLQFLPHGSLSSLL------FGSTECLEWTIRYKIALGIAEGL 254
           P+  +L+G    +   L++Q +P G L   +       GS   L W ++      IA+G+
Sbjct: 79  PHVCRLLGICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IAKGM 132
Query: 255 QYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEGTFGYLS 314
            YL              A N+L+      +I+DFG AK L      +     +    +++
Sbjct: 133 NYLEDRRLVHRDLA---ARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMA 189
Query: 315 PEYFMHGIVDEKTDVFAFGVLLLELIT 341
            E  +H I   ++DV+++GV + EL+T
Sbjct: 190 LESILHRIYTHQSDVWSYGVTVWELMT 216

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 68.6 bits (166), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 51/207 (24%), Positives = 91/207 (43%), Gaps = 18/207 (8%)
Query: 144 FNSENLIGKGGHAEVYKGC-LPDGEXXXXXXXXXXXXE--DEERISDFLSELGIVAHINH 200
           F    ++  G    VYKG  +P+GE            E    +   + L E  ++A +++
Sbjct: 24  FKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 83
Query: 201 PNAAKLIGFSTENGFHLVLQFLPHGSLSSLL------FGSTECLEWTIRYKIALGIAEGL 254
           P+  +L+G    +   L++Q +P G L   +       GS   L W ++      IA+G+
Sbjct: 84  PHVCRLLGICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IAKGM 137
Query: 255 QYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEGTFGYLS 314
            YL              A N+L+      +I+DFGLAK L      +     +    +++
Sbjct: 138 NYLEDRRLVHRDLA---ARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 194
Query: 315 PEYFMHGIVDEKTDVFAFGVLLLELIT 341
            E  +H I   ++DV+++GV + EL+T
Sbjct: 195 LESILHRIYTHQSDVWSYGVTVWELMT 221

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 68.6 bits (166), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 48/164 (29%), Positives = 73/164 (44%), Gaps = 7/164 (4%)
Query: 182 EERISDFLSELGIVAHINHPNAAKLIGFSTENG---FHLVLQFLPHGSLSSLLFGSTECL 238
           EE + DF  E+ I+  + H N  K  G     G     L++++LP+GSL   L    E +
Sbjct: 83  EEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERI 142
Query: 239 EWTIRYKIALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLP-DN 297
           +     +    I +G++YL                NIL+  +   +I DFGL K LP D 
Sbjct: 143 DHIKLLQYTSQICKGMEYLGTKRYIHRDLA---TRNILVENENRVKIGDFGLTKVLPQDK 199
Query: 298 WSHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELIT 341
               +  P E    + +PE          +DV++FGV+L EL T
Sbjct: 200 EXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 243

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 94/201 (46%), Gaps = 13/201 (6%)
Query: 149 LIGKGGHAEVYKGCL--PDGEXXXXXXXXXXXXEDEERISDFLSELGIVAHINHPNAAKL 206
           +IG+G    VY G L   DG+             D   +S FL+E  I+   +HPN   L
Sbjct: 37  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 96
Query: 207 IGFS--TENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALG--IAEGLQYLXXXXX 262
           +G    +E    +VL ++ HG L + +   T     T++  I  G  +A+G++YL     
Sbjct: 97  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETH--NPTVKDLIGFGLQVAKGMKYLASKKF 154
Query: 263 XXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDN--WSHHIVFPIEGTFGYLSPEYFMH 320
                    A N +L E +  +++DFGLA+ + D   +S H     +    +++ E    
Sbjct: 155 VHRDLA---ARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQT 211
Query: 321 GIVDEKTDVFAFGVLLLELIT 341
                K+DV++FGVLL EL+T
Sbjct: 212 QKFTTKSDVWSFGVLLWELMT 232

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 48/162 (29%), Positives = 80/162 (49%), Gaps = 11/162 (6%)
Query: 188 FLSELGIVAHINHPNAAKLIGFSTENGFHLVLQFLPHGSLSSLLFGST-ECLEWTIRYKI 246
           FL E  ++  + H    +L    +E   ++V++++  GSL   L G   + L       +
Sbjct: 60  FLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVIEYMSKGSLLDFLKGEMGKYLRLPQLVDM 119
Query: 247 ALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDN---WSHHIV 303
           A  IA G+ Y+             +A+NIL+ E+   +++DFGLA+ + DN         
Sbjct: 120 AAQIASGMAYVERMNYVHRDL---RAANILVGENLVCKVADFGLARLIEDNEXTARQGAK 176
Query: 304 FPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRA 345
           FPI+ T    +PE  ++G    K+DV++FG+LL EL T  R 
Sbjct: 177 FPIKWT----APEAALYGRFTIKSDVWSFGILLTELTTKGRV 214

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 94/201 (46%), Gaps = 13/201 (6%)
Query: 149 LIGKGGHAEVYKGCL--PDGEXXXXXXXXXXXXEDEERISDFLSELGIVAHINHPNAAKL 206
           +IG+G    VY G L   DG+             D   +S FL+E  I+   +HPN   L
Sbjct: 55  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 114
Query: 207 IGFS--TENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALG--IAEGLQYLXXXXX 262
           +G    +E    +VL ++ HG L + +   T     T++  I  G  +A+G++YL     
Sbjct: 115 LGICLRSEGSPLVVLPYMKHGDLRNFIRNETH--NPTVKDLIGFGLQVAKGMKYLASKKF 172
Query: 263 XXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDN--WSHHIVFPIEGTFGYLSPEYFMH 320
                    A N +L E +  +++DFGLA+ + D   +S H     +    +++ E    
Sbjct: 173 VHRDLA---ARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQT 229
Query: 321 GIVDEKTDVFAFGVLLLELIT 341
                K+DV++FGVLL EL+T
Sbjct: 230 QKFTTKSDVWSFGVLLWELMT 250

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 48/164 (29%), Positives = 73/164 (44%), Gaps = 7/164 (4%)
Query: 182 EERISDFLSELGIVAHINHPNAAKLIGFSTENG---FHLVLQFLPHGSLSSLLFGSTECL 238
           EE + DF  E+ I+  + H N  K  G     G     L++++LP+GSL   L    E +
Sbjct: 70  EEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERI 129
Query: 239 EWTIRYKIALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLP-DN 297
           +     +    I +G++YL                NIL+  +   +I DFGL K LP D 
Sbjct: 130 DHIKLLQYTSQICKGMEYLGTKRYIHRDLA---TRNILVENENRVKIGDFGLTKVLPQDK 186
Query: 298 WSHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELIT 341
               +  P E    + +PE          +DV++FGV+L EL T
Sbjct: 187 EXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 230

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 48/164 (29%), Positives = 73/164 (44%), Gaps = 7/164 (4%)
Query: 182 EERISDFLSELGIVAHINHPNAAKLIGFSTENG---FHLVLQFLPHGSLSSLLFGSTECL 238
           EE + DF  E+ I+  + H N  K  G     G     L++++LP+GSL   L    E +
Sbjct: 70  EEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERI 129
Query: 239 EWTIRYKIALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLP-DN 297
           +     +    I +G++YL                NIL+  +   +I DFGL K LP D 
Sbjct: 130 DHIKLLQYTSQICKGMEYLGTKRYIHRDLA---TRNILVENENRVKIGDFGLTKVLPQDK 186
Query: 298 WSHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELIT 341
               +  P E    + +PE          +DV++FGV+L EL T
Sbjct: 187 EXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 230

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 97/207 (46%), Gaps = 15/207 (7%)
Query: 143 NFNSENLIGKGGHAEVYKGCL--PDGEXXXXXXXXXXXXEDEERISDFLSELGIVAHINH 200
           +FN   +IG+G    VY G L   DG+             D   +S FL+E  I+   +H
Sbjct: 30  HFNE--VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 87
Query: 201 PNAAKLIGFS--TENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALG--IAEGLQY 256
           PN   L+G    +E    +VL ++ HG L + +   T     T++  I  G  +A+G++Y
Sbjct: 88  PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETH--NPTVKDLIGFGLQVAKGMKY 145
Query: 257 LXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDN--WSHHIVFPIEGTFGYLS 314
           L              A N +L E +  +++DFGLA+ + D   +S H     +    +++
Sbjct: 146 LASKKFVHRDLA---ARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMA 202
Query: 315 PEYFMHGIVDEKTDVFAFGVLLLELIT 341
            E         K+DV++FGVLL EL+T
Sbjct: 203 LESLQTQKFTTKSDVWSFGVLLWELMT 229

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 94/201 (46%), Gaps = 13/201 (6%)
Query: 149 LIGKGGHAEVYKGCL--PDGEXXXXXXXXXXXXEDEERISDFLSELGIVAHINHPNAAKL 206
           +IG+G    VY G L   DG+             D   +S FL+E  I+   +HPN   L
Sbjct: 56  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 115
Query: 207 IGFS--TENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALG--IAEGLQYLXXXXX 262
           +G    +E    +VL ++ HG L + +   T     T++  I  G  +A+G++YL     
Sbjct: 116 LGICLRSEGSPLVVLPYMKHGDLRNFIRNETH--NPTVKDLIGFGLQVAKGMKYLASKKF 173
Query: 263 XXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDN--WSHHIVFPIEGTFGYLSPEYFMH 320
                    A N +L E +  +++DFGLA+ + D   +S H     +    +++ E    
Sbjct: 174 VHRDLA---ARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQT 230
Query: 321 GIVDEKTDVFAFGVLLLELIT 341
                K+DV++FGVLL EL+T
Sbjct: 231 QKFTTKSDVWSFGVLLWELMT 251

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 97/207 (46%), Gaps = 15/207 (7%)
Query: 143 NFNSENLIGKGGHAEVYKGCL--PDGEXXXXXXXXXXXXEDEERISDFLSELGIVAHINH 200
           +FN   +IG+G    VY G L   DG+             D   +S FL+E  I+   +H
Sbjct: 25  HFNE--VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 82
Query: 201 PNAAKLIGFS--TENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALG--IAEGLQY 256
           PN   L+G    +E    +VL ++ HG L + +   T     T++  I  G  +A+G++Y
Sbjct: 83  PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETH--NPTVKDLIGFGLQVAKGMKY 140
Query: 257 LXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDN--WSHHIVFPIEGTFGYLS 314
           L              A N +L E +  +++DFGLA+ + D   +S H     +    +++
Sbjct: 141 LASKKFVHRDLA---ARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMA 197
Query: 315 PEYFMHGIVDEKTDVFAFGVLLLELIT 341
            E         K+DV++FGVLL EL+T
Sbjct: 198 LESLQTQKFTTKSDVWSFGVLLWELMT 224

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 90/203 (44%), Gaps = 18/203 (8%)
Query: 148 NLIGKGGHAEVYKGC-LPDGEXXXXXXXXXXXXEDE--ERISDFLSELGIVAHINHPNAA 204
            ++G G    VYKG  +P+GE            E    +   +F+ E  I+A ++HP+  
Sbjct: 44  KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLV 103
Query: 205 KLIGFSTENGFHLVLQFLPHGSLSSLL------FGSTECLEWTIRYKIALGIAEGLQYLX 258
           +L+G        LV Q +PHG L   +       GS   L W ++      IA+G+ YL 
Sbjct: 104 RLLGVCLSPTIQLVTQLMPHGCLLEYVHEHKDNIGSQLLLNWCVQ------IAKGMMYLE 157
Query: 259 XXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEGTFGYLSPEYF 318
                        A N+L+      +I+DFGLA+ L  +   +     +    +++ E  
Sbjct: 158 ERRLVHRDLA---ARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECI 214
Query: 319 MHGIVDEKTDVFAFGVLLLELIT 341
            +     ++DV+++GV + EL+T
Sbjct: 215 HYRKFTHQSDVWSYGVTIWELMT 237

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 49/161 (30%), Positives = 79/161 (49%), Gaps = 11/161 (6%)
Query: 188 FLSELGIVAHINHPNAAKLIGFSTENGFHLVLQFLPHGSLSSLLFGST-ECLEWTIRYKI 246
           FL E  ++  I H    +L    +E   ++V +++  GSL   L G   + L       +
Sbjct: 60  FLQEAQVMKKIRHEKLVQLYAVVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDM 119
Query: 247 ALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDN---WSHHIV 303
           A  IA G+ Y+             +A+NIL+ E+   +++DFGLA+ + DN         
Sbjct: 120 AAQIASGMAYVERMNYVHRDL---RAANILVGENLVCKVADFGLARLIEDNEYTARQGAK 176
Query: 304 FPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRR 344
           FPI+ T    +PE  ++G    K+DV++FG+LL EL T  R
Sbjct: 177 FPIKWT----APEAALYGRFTIKSDVWSFGILLTELTTKGR 213

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 48/162 (29%), Positives = 80/162 (49%), Gaps = 11/162 (6%)
Query: 188 FLSELGIVAHINHPNAAKLIGFSTENGFHLVLQFLPHGSLSSLLFGST-ECLEWTIRYKI 246
           FL E  ++  + H    +L    +E   ++V++++  GSL   L G   + L       +
Sbjct: 60  FLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVIEYMSKGSLLDFLKGEMGKYLRLPQLVDM 119
Query: 247 ALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDN---WSHHIV 303
           A  IA G+ Y+             +A+NIL+ E+   +++DFGLA+ + DN         
Sbjct: 120 AAQIASGMAYVERMNYVHRDL---RAANILVGENLVCKVADFGLARLIEDNEYTARQGAK 176
Query: 304 FPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRA 345
           FPI+ T    +PE  ++G    K+DV++FG+LL EL T  R 
Sbjct: 177 FPIKWT----APEAALYGRFTIKSDVWSFGILLTELTTKGRV 214

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 58/217 (26%), Positives = 103/217 (47%), Gaps = 16/217 (7%)
Query: 133 DFAELAAATDNFNSENLIGKGGHAEVYKG--CLPDGEXXXXXXXXXXXXEDEERISDFLS 190
           +FA+   AT N + + ++G G   EV  G   LP  +              E++  DFL 
Sbjct: 37  EFAKELDAT-NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLG 95
Query: 191 ELGIVAHINHPNAAKLIGFSTENG-FHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIAL- 248
           E  I+   +HPN  +L G  T++    +V +++ +GSL S L       ++T+   + + 
Sbjct: 96  EASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL--RKHDAQFTVIQLVGML 153
Query: 249 -GIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIE 307
            GIA G++YL              A NIL++ +   ++SDFGLA+ L D+      +   
Sbjct: 154 RGIASGMKYLSDMGYVHRDLA---ARNILINSNLVCKVSDFGLARVLEDD--PEAAYTTR 208
Query: 308 G---TFGYLSPEYFMHGIVDEKTDVFAFGVLLLELIT 341
           G      + SPE   +      +DV+++G++L E+++
Sbjct: 209 GGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 245

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 97/207 (46%), Gaps = 15/207 (7%)
Query: 143 NFNSENLIGKGGHAEVYKGCL--PDGEXXXXXXXXXXXXEDEERISDFLSELGIVAHINH 200
           +FN   +IG+G    VY G L   DG+             D   +S FL+E  I+   +H
Sbjct: 28  HFNE--VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 85
Query: 201 PNAAKLIGFS--TENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALG--IAEGLQY 256
           PN   L+G    +E    +VL ++ HG L + +   T     T++  I  G  +A+G++Y
Sbjct: 86  PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETH--NPTVKDLIGFGLQVAKGMKY 143
Query: 257 LXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDN--WSHHIVFPIEGTFGYLS 314
           L              A N +L E +  +++DFGLA+ + D   +S H     +    +++
Sbjct: 144 LASKKFVHRDLA---ARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMA 200
Query: 315 PEYFMHGIVDEKTDVFAFGVLLLELIT 341
            E         K+DV++FGVLL EL+T
Sbjct: 201 LESLQTQKFTTKSDVWSFGVLLWELMT 227

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 49/161 (30%), Positives = 80/161 (49%), Gaps = 11/161 (6%)
Query: 188 FLSELGIVAHINHPNAAKLIGFSTENGFHLVLQFLPHGSLSSLLFGST-ECLEWTIRYKI 246
           FL E  ++  + H    +L    +E   ++V +++  GSL   L G T + L       +
Sbjct: 226 FLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVGEYMSKGSLLDFLKGETGKYLRLPQLVDM 285
Query: 247 ALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDN---WSHHIV 303
           A  IA G+ Y+             +A+NIL+ E+   +++DFGLA+ + DN         
Sbjct: 286 AAQIASGMAYVERMNYVHRDL---RAANILVGENLVCKVADFGLARLIEDNEYTARQGAK 342
Query: 304 FPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRR 344
           FPI+ T    +PE  ++G    K+DV++FG+LL EL T  R
Sbjct: 343 FPIKWT----APEAALYGRFTIKSDVWSFGILLTELTTKGR 379

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 97/207 (46%), Gaps = 15/207 (7%)
Query: 143 NFNSENLIGKGGHAEVYKGCL--PDGEXXXXXXXXXXXXEDEERISDFLSELGIVAHINH 200
           +FN   +IG+G    VY G L   DG+             D   +S FL+E  I+   +H
Sbjct: 33  HFNE--VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 90
Query: 201 PNAAKLIGFS--TENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALG--IAEGLQY 256
           PN   L+G    +E    +VL ++ HG L + +   T     T++  I  G  +A+G++Y
Sbjct: 91  PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETH--NPTVKDLIGFGLQVAKGMKY 148
Query: 257 LXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDN--WSHHIVFPIEGTFGYLS 314
           L              A N +L E +  +++DFGLA+ + D   +S H     +    +++
Sbjct: 149 LASKKFVHRDLA---ARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMA 205
Query: 315 PEYFMHGIVDEKTDVFAFGVLLLELIT 341
            E         K+DV++FGVLL EL+T
Sbjct: 206 LESLQTQKFTTKSDVWSFGVLLWELMT 232

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 49/162 (30%), Positives = 79/162 (48%), Gaps = 11/162 (6%)
Query: 188 FLSELGIVAHINHPNAAKLIGFSTENGFHLVLQFLPHGSLSSLLFGST-ECLEWTIRYKI 246
           FL E  ++  + H    +L    +E    +V +++  GSL   L G T + L       +
Sbjct: 50  FLQEAQVMKKLRHEKLVQLYAVVSEEPIXIVTEYMSKGSLLDFLKGETGKYLRLPQLVDM 109
Query: 247 ALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDN---WSHHIV 303
           A  IA G+ Y+             +A+NIL+ E+   +++DFGLA+ + DN         
Sbjct: 110 AAQIASGMAYVERMNYVHRDL---RAANILVGENLVCKVADFGLARLIEDNEXTARQGAK 166
Query: 304 FPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRA 345
           FPI+ T    +PE  ++G    K+DV++FG+LL EL T  R 
Sbjct: 167 FPIKWT----APEAALYGRFTIKSDVWSFGILLTELTTKGRV 204

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 97/207 (46%), Gaps = 15/207 (7%)
Query: 143 NFNSENLIGKGGHAEVYKGCL--PDGEXXXXXXXXXXXXEDEERISDFLSELGIVAHINH 200
           +FN   +IG+G    VY G L   DG+             D   +S FL+E  I+   +H
Sbjct: 32  HFNE--VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 89
Query: 201 PNAAKLIGFS--TENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALG--IAEGLQY 256
           PN   L+G    +E    +VL ++ HG L + +   T     T++  I  G  +A+G++Y
Sbjct: 90  PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETH--NPTVKDLIGFGLQVAKGMKY 147
Query: 257 LXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDN--WSHHIVFPIEGTFGYLS 314
           L              A N +L E +  +++DFGLA+ + D   +S H     +    +++
Sbjct: 148 LASKKFVHRDLA---ARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMA 204
Query: 315 PEYFMHGIVDEKTDVFAFGVLLLELIT 341
            E         K+DV++FGVLL EL+T
Sbjct: 205 LESLQTQKFTTKSDVWSFGVLLWELMT 231

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 97/207 (46%), Gaps = 15/207 (7%)
Query: 143 NFNSENLIGKGGHAEVYKGCL--PDGEXXXXXXXXXXXXEDEERISDFLSELGIVAHINH 200
           +FN   +IG+G    VY G L   DG+             D   +S FL+E  I+   +H
Sbjct: 31  HFNE--VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 88
Query: 201 PNAAKLIGFS--TENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALG--IAEGLQY 256
           PN   L+G    +E    +VL ++ HG L + +   T     T++  I  G  +A+G++Y
Sbjct: 89  PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETH--NPTVKDLIGFGLQVAKGMKY 146
Query: 257 LXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDN--WSHHIVFPIEGTFGYLS 314
           L              A N +L E +  +++DFGLA+ + D   +S H     +    +++
Sbjct: 147 LASKKFVHRDLA---ARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMA 203
Query: 315 PEYFMHGIVDEKTDVFAFGVLLLELIT 341
            E         K+DV++FGVLL EL+T
Sbjct: 204 LESLQTQKFTTKSDVWSFGVLLWELMT 230

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 96/203 (47%), Gaps = 13/203 (6%)
Query: 147 ENLIGKGGHAEVYKGCL--PDGEXXXXXXXXXXXXEDEERISDFLSELGIVAHINHPNAA 204
           E +IG G   EV  G L  P                 E++  DFLSE  I+   +HPN  
Sbjct: 12  EQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVI 71
Query: 205 KLIGFSTENG-FHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIAL--GIAEGLQYLXXXX 261
            L G  T++    ++ +F+ +GSL S L  +    ++T+   + +  GIA G++YL    
Sbjct: 72  HLEGVVTKSTPVMIITEFMENGSLDSFLRQNDG--QFTVIQLVGMLRGIAAGMKYLADMN 129
Query: 262 XXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEG---TFGYLSPEYF 318
                     A NIL++ +   ++SDFGL+++L D+ S        G      + +PE  
Sbjct: 130 YVHRALA---ARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAI 186
Query: 319 MHGIVDEKTDVFAFGVLLLELIT 341
            +      +DV+++G+++ E+++
Sbjct: 187 QYRKFTSASDVWSYGIVMWEVMS 209

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 52/202 (25%), Positives = 90/202 (44%), Gaps = 18/202 (8%)
Query: 149 LIGKGGHAEVYKGC-LPDGEXXXXXXXXXXXXEDE--ERISDFLSELGIVAHINHPNAAK 205
           ++G G    VYKG  +P+GE            E    +   +F+ E  I+A ++HP+  +
Sbjct: 22  VLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVR 81
Query: 206 LIGFSTENGFHLVLQFLPHGSLSSLL------FGSTECLEWTIRYKIALGIAEGLQYLXX 259
           L+G        LV Q +PHG L   +       GS   L W ++      IA+G+ YL  
Sbjct: 82  LLGVCLSPTIQLVTQLMPHGCLLEYVHEHKDNIGSQLLLNWCVQ------IAKGMMYLEE 135
Query: 260 XXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEGTFGYLSPEYFM 319
                       A N+L+      +I+DFGLA+ L  +   +     +    +++ E   
Sbjct: 136 RRLVHRDLA---ARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIH 192
Query: 320 HGIVDEKTDVFAFGVLLLELIT 341
           +     ++DV+++GV + EL+T
Sbjct: 193 YRKFTHQSDVWSYGVTIWELMT 214

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 48/164 (29%), Positives = 73/164 (44%), Gaps = 7/164 (4%)
Query: 182 EERISDFLSELGIVAHINHPNAAKLIGFSTENG---FHLVLQFLPHGSLSSLLFGSTECL 238
           EE + DF  E+ I+  + H N  K  G     G     L++++LP+GSL   L    E +
Sbjct: 52  EEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERI 111
Query: 239 EWTIRYKIALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLP-DN 297
           +     +    I +G++YL                NIL+  +   +I DFGL K LP D 
Sbjct: 112 DHIKLLQYTSQICKGMEYLGTKRYIHRDLA---TRNILVENENRVKIGDFGLTKVLPQDK 168
Query: 298 WSHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELIT 341
               +  P E    + +PE          +DV++FGV+L EL T
Sbjct: 169 EFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 212

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 56/198 (28%), Positives = 85/198 (42%), Gaps = 11/198 (5%)
Query: 150 IGKGGHAEVYKGCLPDGEXXXXXXXXXXXXEDEERISDFLSELGIVAHINHPNAAKLIGF 209
           IG G    VYKG                     +++  F +E+G++    H N    +G+
Sbjct: 32  IGSGSFGTVYKG---KWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 88
Query: 210 STENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLXXXXXXXXXXXX 269
           ST+    +V Q+    SL   L  S    E      IA   A G+ YL            
Sbjct: 89  STKPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYL---HAKSIIHRD 145
Query: 270 XKASNILLSEDYEAQISDFGLAKWLPDNWS-HHIVFPIEGTFGYLSPEYFMHGIVDE--- 325
            K++NI L ED   +I DFGLA      WS  H    + G+  +++PE       +    
Sbjct: 146 LKSNNIFLHEDNTVKIGDFGLAT-EKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSF 204
Query: 326 KTDVFAFGVLLLELITGR 343
           ++DV+AFG++L EL+TG+
Sbjct: 205 QSDVYAFGIVLYELMTGQ 222

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 48/162 (29%), Positives = 80/162 (49%), Gaps = 11/162 (6%)
Query: 188 FLSELGIVAHINHPNAAKLIGFSTENGFHLVLQFLPHGSLSSLLFGST-ECLEWTIRYKI 246
           FL E  ++  + H    +L    +E   ++V +++  GSL   L G T + L       +
Sbjct: 57  FLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVTEYMNKGSLLDFLKGETGKYLRLPQLVDM 116
Query: 247 ALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDN---WSHHIV 303
           +  IA G+ Y+             +A+NIL+ E+   +++DFGLA+ + DN         
Sbjct: 117 SAQIASGMAYVERMNYVHRDL---RAANILVGENLVCKVADFGLARLIEDNEYTARQGAK 173
Query: 304 FPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRA 345
           FPI+ T    +PE  ++G    K+DV++FG+LL EL T  R 
Sbjct: 174 FPIKWT----APEAALYGRFTIKSDVWSFGILLTELTTKGRV 211

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 57/217 (26%), Positives = 103/217 (47%), Gaps = 16/217 (7%)
Query: 133 DFAELAAATDNFNSENLIGKGGHAEVYKG--CLPDGEXXXXXXXXXXXXEDEERISDFLS 190
           +FA+   AT N + + ++G G   EV  G   LP  +              E++  DFL 
Sbjct: 25  EFAKELDAT-NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLG 83
Query: 191 ELGIVAHINHPNAAKLIGFSTENG-FHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIAL- 248
           E  I+   +HPN  +L G  T++    +V +++ +GSL S L       ++T+   + + 
Sbjct: 84  EASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL--RKHDAQFTVIQLVGML 141
Query: 249 -GIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIE 307
            GIA G++YL              A NIL++ +   ++SDFGL++ L D+      +   
Sbjct: 142 RGIASGMKYLSDMGYVHRDLA---ARNILINSNLVCKVSDFGLSRVLEDD--PEAAYTTR 196
Query: 308 G---TFGYLSPEYFMHGIVDEKTDVFAFGVLLLELIT 341
           G      + SPE   +      +DV+++G++L E+++
Sbjct: 197 GGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 233

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 51/207 (24%), Positives = 90/207 (43%), Gaps = 18/207 (8%)
Query: 144 FNSENLIGKGGHAEVYKGC-LPDGEXXXXXXXXXXXXE--DEERISDFLSELGIVAHINH 200
           F    ++G G    VYKG  +P+GE            E    +   + L E  ++A +++
Sbjct: 19  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 78
Query: 201 PNAAKLIGFSTENGFHLVLQFLPHGSLSSLL------FGSTECLEWTIRYKIALGIAEGL 254
           P+  +L+G    +   L+ Q +P G L   +       GS   L W ++      IA+G+
Sbjct: 79  PHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IAKGM 132
Query: 255 QYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEGTFGYLS 314
            YL              A N+L+      +I+DFG AK L      +     +    +++
Sbjct: 133 NYLEDRRLVHRDLA---ARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMA 189
Query: 315 PEYFMHGIVDEKTDVFAFGVLLLELIT 341
            E  +H I   ++DV+++GV + EL+T
Sbjct: 190 LESILHRIYTHQSDVWSYGVTVWELMT 216

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 51/207 (24%), Positives = 90/207 (43%), Gaps = 18/207 (8%)
Query: 144 FNSENLIGKGGHAEVYKGC-LPDGEXXXXXXXXXXXXE--DEERISDFLSELGIVAHINH 200
           F    ++G G    VYKG  +P+GE            E    +   + L E  ++A +++
Sbjct: 24  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 83
Query: 201 PNAAKLIGFSTENGFHLVLQFLPHGSLSSLL------FGSTECLEWTIRYKIALGIAEGL 254
           P+  +L+G    +   L+ Q +P G L   +       GS   L W ++      IA+G+
Sbjct: 84  PHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IAKGM 137
Query: 255 QYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEGTFGYLS 314
            YL              A N+L+      +I+DFG AK L      +     +    +++
Sbjct: 138 NYLEDRRLVHRDLA---ARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMA 194
Query: 315 PEYFMHGIVDEKTDVFAFGVLLLELIT 341
            E  +H I   ++DV+++GV + EL+T
Sbjct: 195 LESILHRIYTHQSDVWSYGVTVWELMT 221

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 48/161 (29%), Positives = 79/161 (49%), Gaps = 11/161 (6%)
Query: 188 FLSELGIVAHINHPNAAKLIGFSTENGFHLVLQFLPHGSLSSLLFGST-ECLEWTIRYKI 246
           FL E  ++  + H    +L    +E   ++V +++  GSL   L G   + L       +
Sbjct: 60  FLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVCEYMSKGSLLDFLKGEMGKYLRLPQLVDM 119
Query: 247 ALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDN---WSHHIV 303
           A  IA G+ Y+             +A+NIL+ E+   +++DFGLA+ + DN         
Sbjct: 120 AAQIASGMAYVERMNYVHRDL---RAANILVGENLVCKVADFGLARLIEDNEYTARQGAK 176
Query: 304 FPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRR 344
           FPI+ T    +PE  ++G    K+DV++FG+LL EL T  R
Sbjct: 177 FPIKWT----APEAALYGRFTIKSDVWSFGILLTELTTKGR 213

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 57/217 (26%), Positives = 103/217 (47%), Gaps = 16/217 (7%)
Query: 133 DFAELAAATDNFNSENLIGKGGHAEVYKG--CLPDGEXXXXXXXXXXXXEDEERISDFLS 190
           +FA+   AT N + + ++G G   EV  G   LP  +              E++  DFL 
Sbjct: 8   EFAKELDAT-NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLG 66
Query: 191 ELGIVAHINHPNAAKLIGFSTENG-FHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIAL- 248
           E  I+   +HPN  +L G  T++    +V +++ +GSL S L       ++T+   + + 
Sbjct: 67  EASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL--RKHDAQFTVIQLVGML 124
Query: 249 -GIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIE 307
            GIA G++YL              A NIL++ +   ++SDFGL++ L D+      +   
Sbjct: 125 RGIASGMKYLSDMGYVHRDLA---ARNILINSNLVCKVSDFGLSRVLEDD--PEAAYTTR 179
Query: 308 G---TFGYLSPEYFMHGIVDEKTDVFAFGVLLLELIT 341
           G      + SPE   +      +DV+++G++L E+++
Sbjct: 180 GGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 216

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 51/207 (24%), Positives = 90/207 (43%), Gaps = 18/207 (8%)
Query: 144 FNSENLIGKGGHAEVYKGC-LPDGEXXXXXXXXXXXXE--DEERISDFLSELGIVAHINH 200
           F    ++  G    VYKG  +P+GE            E    +   + L E  ++A +++
Sbjct: 24  FKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 83
Query: 201 PNAAKLIGFSTENGFHLVLQFLPHGSLSSLL------FGSTECLEWTIRYKIALGIAEGL 254
           P+  +L+G    +   L+ Q +P G L   +       GS   L W ++      IA+G+
Sbjct: 84  PHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IAKGM 137
Query: 255 QYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEGTFGYLS 314
            YL              A N+L+      +I+DFGLAK L      +     +    +++
Sbjct: 138 NYLEDRRLVHRDLA---ARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 194
Query: 315 PEYFMHGIVDEKTDVFAFGVLLLELIT 341
            E  +H I   ++DV+++GV + EL+T
Sbjct: 195 LESILHRIYTHQSDVWSYGVTVWELMT 221

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 51/207 (24%), Positives = 90/207 (43%), Gaps = 18/207 (8%)
Query: 144 FNSENLIGKGGHAEVYKGC-LPDGEXXXXXXXXXXXXE--DEERISDFLSELGIVAHINH 200
           F    ++  G    VYKG  +P+GE            E    +   + L E  ++A +++
Sbjct: 17  FKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 76
Query: 201 PNAAKLIGFSTENGFHLVLQFLPHGSLSSLL------FGSTECLEWTIRYKIALGIAEGL 254
           P+  +L+G    +   L+ Q +P G L   +       GS   L W ++      IA+G+
Sbjct: 77  PHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IAKGM 130
Query: 255 QYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEGTFGYLS 314
            YL              A N+L+      +I+DFGLAK L      +     +    +++
Sbjct: 131 NYLEDRRLVHRDLA---ARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 187
Query: 315 PEYFMHGIVDEKTDVFAFGVLLLELIT 341
            E  +H I   ++DV+++GV + EL+T
Sbjct: 188 LESILHRIYTHQSDVWSYGVTVWELMT 214

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 51/207 (24%), Positives = 90/207 (43%), Gaps = 18/207 (8%)
Query: 144 FNSENLIGKGGHAEVYKGC-LPDGEXXXXXXXXXXXXE--DEERISDFLSELGIVAHINH 200
           F    ++G G    VYKG  +P+GE            E    +   + L E  ++A +++
Sbjct: 17  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 76
Query: 201 PNAAKLIGFSTENGFHLVLQFLPHGSLSSLL------FGSTECLEWTIRYKIALGIAEGL 254
           P+  +L+G    +   L+ Q +P G L   +       GS   L W ++      IA+G+
Sbjct: 77  PHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IAKGM 130
Query: 255 QYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEGTFGYLS 314
            YL              A N+L+      +I+DFG AK L      +     +    +++
Sbjct: 131 NYLEDRRLVHRDLA---ARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMA 187
Query: 315 PEYFMHGIVDEKTDVFAFGVLLLELIT 341
            E  +H I   ++DV+++GV + EL+T
Sbjct: 188 LESILHRIYTHQSDVWSYGVTVWELMT 214

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 53/201 (26%), Positives = 91/201 (45%), Gaps = 9/201 (4%)
Query: 147 ENLIGKGGHAEVYKGCL--PDGEXXXXXXXXXXXXEDEERISDFLSELGIVAHINHPNAA 204
           E +IG G   EV  G L  P                 E++  DFLSE  I+   +HPN  
Sbjct: 38  EQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVI 97
Query: 205 KLIGFSTENG-FHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLXXXXXX 263
            L G  T++    ++ +F+ +GSL S L  +           +  GIA G++YL      
Sbjct: 98  HLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYV 157
Query: 264 XXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEG---TFGYLSPEYFMH 320
                   A NIL++ +   ++SDFGL+++L D+ S        G      + +PE   +
Sbjct: 158 HRDLA---ARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQY 214
Query: 321 GIVDEKTDVFAFGVLLLELIT 341
                 +DV+++G+++ E+++
Sbjct: 215 RKFTSASDVWSYGIVMWEVMS 235

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 48/162 (29%), Positives = 79/162 (48%), Gaps = 11/162 (6%)
Query: 188 FLSELGIVAHINHPNAAKLIGFSTENGFHLVLQFLPHGSLSSLLFGST-ECLEWTIRYKI 246
           FL E  ++  + H    +L    +E   ++V +++  GSL   L G   + L       +
Sbjct: 51  FLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDM 110
Query: 247 ALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDN---WSHHIV 303
           A  IA G+ Y+             +A+NIL+ E+   +++DFGLA+ + DN         
Sbjct: 111 AAQIASGMAYVERMNYVHRDL---RAANILVGENLVCKVADFGLARLIEDNEYTARQGAK 167
Query: 304 FPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRA 345
           FPI+ T    +PE  ++G    K+DV++FG+LL EL T  R 
Sbjct: 168 FPIKWT----APEAALYGRFTIKSDVWSFGILLTELTTKGRV 205

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 56/198 (28%), Positives = 84/198 (42%), Gaps = 11/198 (5%)
Query: 150 IGKGGHAEVYKGCLPDGEXXXXXXXXXXXXEDEERISDFLSELGIVAHINHPNAAKLIGF 209
           IG G    VYKG                     +++  F +E+G++    H N    +G+
Sbjct: 32  IGSGSFGTVYKG---KWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 88
Query: 210 STENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLXXXXXXXXXXXX 269
           ST     +V Q+    SL   L  S    E      IA   A G+ YL            
Sbjct: 89  STAPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYL---HAKSIIHRD 145
Query: 270 XKASNILLSEDYEAQISDFGLAKWLPDNWS-HHIVFPIEGTFGYLSPEYFMHGIVDE--- 325
            K++NI L ED   +I DFGLA      WS  H    + G+  +++PE       +    
Sbjct: 146 LKSNNIFLHEDNTVKIGDFGLAT-EKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSF 204
Query: 326 KTDVFAFGVLLLELITGR 343
           ++DV+AFG++L EL+TG+
Sbjct: 205 QSDVYAFGIVLYELMTGQ 222

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 57/217 (26%), Positives = 103/217 (47%), Gaps = 16/217 (7%)
Query: 133 DFAELAAATDNFNSENLIGKGGHAEVYKG--CLPDGEXXXXXXXXXXXXEDEERISDFLS 190
           +FA+   AT N + + ++G G   EV  G   LP  +              E++  DFL 
Sbjct: 35  EFAKELDAT-NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLG 93
Query: 191 ELGIVAHINHPNAAKLIGFSTENG-FHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIAL- 248
           E  I+   +HPN  +L G  T++    +V +++ +GSL S L       ++T+   + + 
Sbjct: 94  EASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL--RKHDAQFTVIQLVGML 151
Query: 249 -GIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIE 307
            GIA G++YL              A NIL++ +   ++SDFGL++ L D+      +   
Sbjct: 152 RGIASGMKYLSDMGYVHRDLA---ARNILINSNLVCKVSDFGLSRVLEDD--PEAAYTTR 206
Query: 308 G---TFGYLSPEYFMHGIVDEKTDVFAFGVLLLELIT 341
           G      + SPE   +      +DV+++G++L E+++
Sbjct: 207 GGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 243

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 57/217 (26%), Positives = 103/217 (47%), Gaps = 16/217 (7%)
Query: 133 DFAELAAATDNFNSENLIGKGGHAEVYKG--CLPDGEXXXXXXXXXXXXEDEERISDFLS 190
           +FA+   AT N + + ++G G   EV  G   LP  +              E++  DFL 
Sbjct: 37  EFAKELDAT-NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLG 95
Query: 191 ELGIVAHINHPNAAKLIGFSTENG-FHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIAL- 248
           E  I+   +HPN  +L G  T++    +V +++ +GSL S L       ++T+   + + 
Sbjct: 96  EASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL--RKHDAQFTVIQLVGML 153
Query: 249 -GIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIE 307
            GIA G++YL              A NIL++ +   ++SDFGL++ L D+      +   
Sbjct: 154 RGIASGMKYLSDMGYVHRDLA---ARNILINSNLVCKVSDFGLSRVLEDD--PEAAYTTR 208
Query: 308 G---TFGYLSPEYFMHGIVDEKTDVFAFGVLLLELIT 341
           G      + SPE   +      +DV+++G++L E+++
Sbjct: 209 GGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 245

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 47/162 (29%), Positives = 79/162 (48%), Gaps = 11/162 (6%)
Query: 188 FLSELGIVAHINHPNAAKLIGFSTENGFHLVLQFLPHGSLSSLLFGST-ECLEWTIRYKI 246
           FL E  ++  + H    +L    +E   ++V++++  G L   L G   + L       +
Sbjct: 60  FLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVMEYMSKGCLLDFLKGEMGKYLRLPQLVDM 119
Query: 247 ALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDN---WSHHIV 303
           A  IA G+ Y+             +A+NIL+ E+   +++DFGLA+ + DN         
Sbjct: 120 AAQIASGMAYVERMNYVHRDL---RAANILVGENLVCKVADFGLARLIEDNEYTARQGAK 176
Query: 304 FPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRA 345
           FPI+ T    +PE  ++G    K+DV++FG+LL EL T  R 
Sbjct: 177 FPIKWT----APEAALYGRFTIKSDVWSFGILLTELTTKGRV 214

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 48/161 (29%), Positives = 79/161 (49%), Gaps = 11/161 (6%)
Query: 188 FLSELGIVAHINHPNAAKLIGFSTENGFHLVLQFLPHGSLSSLLFGST-ECLEWTIRYKI 246
           FL E  ++  + H    +L    +E   ++V +++  GSL   L G   + L       +
Sbjct: 60  FLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDM 119
Query: 247 ALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDN---WSHHIV 303
           A  IA G+ Y+             +A+NIL+ E+   +++DFGLA+ + DN         
Sbjct: 120 AAQIASGMAYVERMNYVHRDL---RAANILVGENLVCKVADFGLARLIEDNEYTARQGAK 176
Query: 304 FPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRR 344
           FPI+ T    +PE  ++G    K+DV++FG+LL EL T  R
Sbjct: 177 FPIKWT----APEAALYGRFTIKSDVWSFGILLTELTTKGR 213

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 48/162 (29%), Positives = 79/162 (48%), Gaps = 11/162 (6%)
Query: 188 FLSELGIVAHINHPNAAKLIGFSTENGFHLVLQFLPHGSLSSLLFGST-ECLEWTIRYKI 246
           FL E  ++  + H    +L    +E   ++V +++  GSL   L G   + L       +
Sbjct: 49  FLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDM 108
Query: 247 ALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDN---WSHHIV 303
           A  IA G+ Y+             +A+NIL+ E+   +++DFGLA+ + DN         
Sbjct: 109 AAQIASGMAYVERMNYVHRDL---RAANILVGENLVCKVADFGLARLIEDNEYTARQGAK 165
Query: 304 FPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRA 345
           FPI+ T    +PE  ++G    K+DV++FG+LL EL T  R 
Sbjct: 166 FPIKWT----APEAALYGRFTIKSDVWSFGILLTELTTKGRV 203

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 57/217 (26%), Positives = 103/217 (47%), Gaps = 16/217 (7%)
Query: 133 DFAELAAATDNFNSENLIGKGGHAEVYKG--CLPDGEXXXXXXXXXXXXEDEERISDFLS 190
           +FA+   AT N + + ++G G   EV  G   LP  +              E++  DFL 
Sbjct: 37  EFAKELDAT-NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLG 95
Query: 191 ELGIVAHINHPNAAKLIGFSTENG-FHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIAL- 248
           E  I+   +HPN  +L G  T++    +V +++ +GSL S L       ++T+   + + 
Sbjct: 96  EASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL--RKHDAQFTVIQLVGML 153
Query: 249 -GIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIE 307
            GIA G++YL              A NIL++ +   ++SDFGL++ L D+      +   
Sbjct: 154 RGIASGMKYLSDMGYVHRDLA---ARNILINSNLVCKVSDFGLSRVLEDD--PEAAYTTR 208
Query: 308 G---TFGYLSPEYFMHGIVDEKTDVFAFGVLLLELIT 341
           G      + SPE   +      +DV+++G++L E+++
Sbjct: 209 GGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 245

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 57/217 (26%), Positives = 103/217 (47%), Gaps = 16/217 (7%)
Query: 133 DFAELAAATDNFNSENLIGKGGHAEVYKG--CLPDGEXXXXXXXXXXXXEDEERISDFLS 190
           +FA+   AT N + + ++G G   EV  G   LP  +              E++  DFL 
Sbjct: 37  EFAKELDAT-NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLG 95
Query: 191 ELGIVAHINHPNAAKLIGFSTENG-FHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIAL- 248
           E  I+   +HPN  +L G  T++    +V +++ +GSL S L       ++T+   + + 
Sbjct: 96  EASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL--RKHDAQFTVIQLVGML 153
Query: 249 -GIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIE 307
            GIA G++YL              A NIL++ +   ++SDFGL++ L D+      +   
Sbjct: 154 RGIASGMKYLSDMGYVHRDLA---ARNILINSNLVCKVSDFGLSRVLEDD--PEAAYTTR 208
Query: 308 G---TFGYLSPEYFMHGIVDEKTDVFAFGVLLLELIT 341
           G      + SPE   +      +DV+++G++L E+++
Sbjct: 209 GGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 245

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 57/217 (26%), Positives = 103/217 (47%), Gaps = 16/217 (7%)
Query: 133 DFAELAAATDNFNSENLIGKGGHAEVYKG--CLPDGEXXXXXXXXXXXXEDEERISDFLS 190
           +FA+   AT N + + ++G G   EV  G   LP  +              E++  DFL 
Sbjct: 37  EFAKELDAT-NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLG 95
Query: 191 ELGIVAHINHPNAAKLIGFSTENG-FHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIAL- 248
           E  I+   +HPN  +L G  T++    +V +++ +GSL S L       ++T+   + + 
Sbjct: 96  EASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL--RKHDAQFTVIQLVGML 153
Query: 249 -GIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIE 307
            GIA G++YL              A NIL++ +   ++SDFGL++ L D+      +   
Sbjct: 154 RGIASGMKYLSDMGYVHRDLA---ARNILINSNLVCKVSDFGLSRVLEDD--PEAAYTTR 208
Query: 308 G---TFGYLSPEYFMHGIVDEKTDVFAFGVLLLELIT 341
           G      + SPE   +      +DV+++G++L E+++
Sbjct: 209 GGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 245

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 93/201 (46%), Gaps = 13/201 (6%)
Query: 149 LIGKGGHAEVYKGCL--PDGEXXXXXXXXXXXXEDEERISDFLSELGIVAHINHPNAAKL 206
           +IG+G    VY G L   DG+             D   +S FL+E  I+   +HPN   L
Sbjct: 36  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 95
Query: 207 IGFS--TENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALG--IAEGLQYLXXXXX 262
           +G    +E    +VL ++ HG L + +   T     T++  I  G  +A+G++YL     
Sbjct: 96  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETH--NPTVKDLIGFGLQVAKGMKYLASKKF 153
Query: 263 XXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDN--WSHHIVFPIEGTFGYLSPEYFMH 320
                    A N +L E +  +++DFGLA+ + D    S H     +    +++ E    
Sbjct: 154 VHRDLA---ARNCMLDEKFTVKVADFGLARDMYDKEXXSVHNKTGAKLPVKWMALESLQT 210
Query: 321 GIVDEKTDVFAFGVLLLELIT 341
                K+DV++FGVLL EL+T
Sbjct: 211 QKFTTKSDVWSFGVLLWELMT 231

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 55/198 (27%), Positives = 85/198 (42%), Gaps = 11/198 (5%)
Query: 150 IGKGGHAEVYKGCLPDGEXXXXXXXXXXXXEDEERISDFLSELGIVAHINHPNAAKLIGF 209
           IG G    VYKG                     +++  F +E+G++    H N    +G+
Sbjct: 43  IGSGSFGTVYKG---KWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 99
Query: 210 STENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLXXXXXXXXXXXX 269
           ST+    +V Q+    SL   L       E      IA   A+G+ YL            
Sbjct: 100 STKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDL-- 157
Query: 270 XKASNILLSEDYEAQISDFGLAKWLPDNWS-HHIVFPIEGTFGYLSPEYFM---HGIVDE 325
            K++NI L ED   +I DFGLA  +   WS  H    + G+  +++PE            
Sbjct: 158 -KSNNIFLHEDLTVKIGDFGLAT-VKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSF 215
Query: 326 KTDVFAFGVLLLELITGR 343
           ++DV+AFG++L EL+TG+
Sbjct: 216 QSDVYAFGIVLYELMTGQ 233

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 57/217 (26%), Positives = 103/217 (47%), Gaps = 16/217 (7%)
Query: 133 DFAELAAATDNFNSENLIGKGGHAEVYKG--CLPDGEXXXXXXXXXXXXEDEERISDFLS 190
           +FA+   AT N + + ++G G   EV  G   LP  +              E++  DFL 
Sbjct: 37  EFAKELDAT-NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLG 95
Query: 191 ELGIVAHINHPNAAKLIGFSTENG-FHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIAL- 248
           E  I+   +HPN  +L G  T++    +V +++ +GSL S L       ++T+   + + 
Sbjct: 96  EASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL--RKHDAQFTVIQLVGML 153
Query: 249 -GIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIE 307
            GIA G++YL              A NIL++ +   ++SDFGL++ L D+      +   
Sbjct: 154 RGIASGMKYLSDMGFVHRDLA---ARNILINSNLVCKVSDFGLSRVLEDD--PEAAYTTR 208
Query: 308 G---TFGYLSPEYFMHGIVDEKTDVFAFGVLLLELIT 341
           G      + SPE   +      +DV+++G++L E+++
Sbjct: 209 GGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 245

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 50/166 (30%), Positives = 83/166 (50%), Gaps = 15/166 (9%)
Query: 185 ISDFLSELGIVAHINHPNAAKLIGFSTENGFHLVLQFLPHGSLSSLLF---GSTECLEWT 241
           +  FL+E  ++  + H    KL    T+   +++ +F+  GSL   L    GS + L   
Sbjct: 227 VEAFLAEANVMKTLQHDKLVKLHAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKL 286
Query: 242 IRYKIALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDN---W 298
           I +  +  IAEG+ ++             +A+NIL+S     +I+DFGLA+ + DN    
Sbjct: 287 IDF--SAQIAEGMAFIEQRNYIHRDL---RAANILVSASLVCKIADFGLARVIEDNEYTA 341
Query: 299 SHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRR 344
                FPI+ T    +PE    G    K+DV++FG+LL+E++T  R
Sbjct: 342 REGAKFPIKWT----APEAINFGSFTIKSDVWSFGILLMEIVTYGR 383

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 46/162 (28%), Positives = 83/162 (51%), Gaps = 13/162 (8%)
Query: 188 FLSELGIVAHINHPNAAKLIGFSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIR--YK 245
           FL+E  ++  + H    +L    T+   +++ +++ +GSL   L  +   ++ TI     
Sbjct: 55  FLAEANLMKQLQHQRLVRLYAVVTQEPIYIITEYMENGSLVDFL-KTPSGIKLTINKLLD 113
Query: 246 IALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPD---NWSHHI 302
           +A  IAEG+ ++             +A+NIL+S+    +I+DFGLA+ + D         
Sbjct: 114 MAAQIAEGMAFIEERNYIHRDL---RAANILVSDTLSCKIADFGLARLIEDAEXTAREGA 170
Query: 303 VFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRR 344
            FPI+ T    +PE   +G    K+DV++FG+LL E++T  R
Sbjct: 171 KFPIKWT----APEAINYGTFTIKSDVWSFGILLTEIVTHGR 208

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 50/166 (30%), Positives = 83/166 (50%), Gaps = 15/166 (9%)
Query: 185 ISDFLSELGIVAHINHPNAAKLIGFSTENGFHLVLQFLPHGSLSSLLF---GSTECLEWT 241
           +  FL+E  ++  + H    KL    T+   +++ +F+  GSL   L    GS + L   
Sbjct: 54  VEAFLAEANVMKTLQHDKLVKLHAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKL 113
Query: 242 IRYKIALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDN---W 298
           I +  +  IAEG+ ++             +A+NIL+S     +I+DFGLA+ + DN    
Sbjct: 114 IDF--SAQIAEGMAFIEQRNYIHRDL---RAANILVSASLVCKIADFGLARVIEDNEYTA 168
Query: 299 SHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRR 344
                FPI+ T    +PE    G    K+DV++FG+LL+E++T  R
Sbjct: 169 REGAKFPIKWT----APEAINFGSFTIKSDVWSFGILLMEIVTYGR 210

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 57/217 (26%), Positives = 102/217 (47%), Gaps = 16/217 (7%)
Query: 133 DFAELAAATDNFNSENLIGKGGHAEVYKG--CLPDGEXXXXXXXXXXXXEDEERISDFLS 190
           +FA+   AT N + + ++G G   EV  G   LP  +              E++  DFL 
Sbjct: 37  EFAKELDAT-NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLG 95
Query: 191 ELGIVAHINHPNAAKLIGFSTENG-FHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIAL- 248
           E  I+   +HPN  +L G  T++    +V +++ +GSL S L       ++T+   + + 
Sbjct: 96  EASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL--RKHDAQFTVIQLVGML 153
Query: 249 -GIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIE 307
            GIA G++YL              A NIL++ +   ++SDFGL + L D+      +   
Sbjct: 154 RGIASGMKYLSDMGYVHRDLA---ARNILINSNLVCKVSDFGLGRVLEDD--PEAAYTTR 208
Query: 308 G---TFGYLSPEYFMHGIVDEKTDVFAFGVLLLELIT 341
           G      + SPE   +      +DV+++G++L E+++
Sbjct: 209 GGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 245

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 55/198 (27%), Positives = 85/198 (42%), Gaps = 11/198 (5%)
Query: 150 IGKGGHAEVYKGCLPDGEXXXXXXXXXXXXEDEERISDFLSELGIVAHINHPNAAKLIGF 209
           IG G    VYKG                     +++  F +E+G++    H N    +G+
Sbjct: 44  IGSGSFGTVYKG---KWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 100
Query: 210 STENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLXXXXXXXXXXXX 269
           ST+    +V Q+    SL   L       E      IA   A+G+ YL            
Sbjct: 101 STKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDL-- 158
Query: 270 XKASNILLSEDYEAQISDFGLAKWLPDNWS-HHIVFPIEGTFGYLSPEYFM---HGIVDE 325
            K++NI L ED   +I DFGLA  +   WS  H    + G+  +++PE            
Sbjct: 159 -KSNNIFLHEDLTVKIGDFGLAT-VKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSF 216
Query: 326 KTDVFAFGVLLLELITGR 343
           ++DV+AFG++L EL+TG+
Sbjct: 217 QSDVYAFGIVLYELMTGQ 234

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 55/198 (27%), Positives = 85/198 (42%), Gaps = 11/198 (5%)
Query: 150 IGKGGHAEVYKGCLPDGEXXXXXXXXXXXXEDEERISDFLSELGIVAHINHPNAAKLIGF 209
           IG G    VYKG                     +++  F +E+G++    H N    +G+
Sbjct: 18  IGSGSFGTVYKG---KWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 74
Query: 210 STENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLXXXXXXXXXXXX 269
           ST+    +V Q+    SL   L       E      IA   A+G+ YL            
Sbjct: 75  STKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDL-- 132
Query: 270 XKASNILLSEDYEAQISDFGLAKWLPDNWS-HHIVFPIEGTFGYLSPEYFM---HGIVDE 325
            K++NI L ED   +I DFGLA  +   WS  H    + G+  +++PE            
Sbjct: 133 -KSNNIFLHEDLTVKIGDFGLAT-VKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSF 190
Query: 326 KTDVFAFGVLLLELITGR 343
           ++DV+AFG++L EL+TG+
Sbjct: 191 QSDVYAFGIVLYELMTGQ 208

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 67/278 (24%), Positives = 122/278 (43%), Gaps = 25/278 (8%)
Query: 143 NFNSENLIGKGGHAEVYKG-CLPDGEXXXXXXXXXXXXEDEERISDFLSELGIVAHINHP 201
           NF  E  IG+G  +EVY+  CL DG              D +  +D + E+ ++  +NHP
Sbjct: 33  NFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 92
Query: 202 NAAKLIG-FSTENGFHLVLQFLPHGSLSSLL--FGSTECL--EWTIRYKIALGIAEGLQY 256
           N  K    F  +N  ++VL+    G LS ++  F   + L  E T+ +K  + +   L++
Sbjct: 93  NVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTV-WKYFVQLCSALEH 151
Query: 257 LXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWS--HHIVFPIEGTFGYLS 314
           +             K +N+ ++     ++ D GL ++     +  H +V    GT  Y+S
Sbjct: 152 MHSRRVMHRDI---KPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV----GTPYYMS 204
Query: 315 PEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSNFKELVDPRL 374
           PE       + K+D+++ G LL E+   +      + +L    K + Q         P  
Sbjct: 205 PERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCD-----YPPLP 259
Query: 375 ADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQLLR 412
           +D Y  +E  R ++  ++CI+     RP +T V  + +
Sbjct: 260 SDHY--SEELRQLV--NMCINPDPEKRPDVTYVYDVAK 293

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 55/198 (27%), Positives = 85/198 (42%), Gaps = 11/198 (5%)
Query: 150 IGKGGHAEVYKGCLPDGEXXXXXXXXXXXXEDEERISDFLSELGIVAHINHPNAAKLIGF 209
           IG G    VYKG                     +++  F +E+G++    H N    +G+
Sbjct: 21  IGSGSFGTVYKG---KWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 77
Query: 210 STENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLXXXXXXXXXXXX 269
           ST+    +V Q+    SL   L       E      IA   A+G+ YL            
Sbjct: 78  STKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDL-- 135
Query: 270 XKASNILLSEDYEAQISDFGLAKWLPDNWS-HHIVFPIEGTFGYLSPEYFM---HGIVDE 325
            K++NI L ED   +I DFGLA  +   WS  H    + G+  +++PE            
Sbjct: 136 -KSNNIFLHEDLTVKIGDFGLAT-VKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSF 193
Query: 326 KTDVFAFGVLLLELITGR 343
           ++DV+AFG++L EL+TG+
Sbjct: 194 QSDVYAFGIVLYELMTGQ 211

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 55/198 (27%), Positives = 85/198 (42%), Gaps = 11/198 (5%)
Query: 150 IGKGGHAEVYKGCLPDGEXXXXXXXXXXXXEDEERISDFLSELGIVAHINHPNAAKLIGF 209
           IG G    VYKG                     +++  F +E+G++    H N    +G+
Sbjct: 21  IGSGSFGTVYKG---KWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 77
Query: 210 STENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLXXXXXXXXXXXX 269
           ST+    +V Q+    SL   L       E      IA   A+G+ YL            
Sbjct: 78  STKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDL-- 135
Query: 270 XKASNILLSEDYEAQISDFGLAKWLPDNWS-HHIVFPIEGTFGYLSPEYFM---HGIVDE 325
            K++NI L ED   +I DFGLA  +   WS  H    + G+  +++PE            
Sbjct: 136 -KSNNIFLHEDLTVKIGDFGLAT-VKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSF 193
Query: 326 KTDVFAFGVLLLELITGR 343
           ++DV+AFG++L EL+TG+
Sbjct: 194 QSDVYAFGIVLYELMTGQ 211

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 55/198 (27%), Positives = 85/198 (42%), Gaps = 11/198 (5%)
Query: 150 IGKGGHAEVYKGCLPDGEXXXXXXXXXXXXEDEERISDFLSELGIVAHINHPNAAKLIGF 209
           IG G    VYKG                     +++  F +E+G++    H N    +G+
Sbjct: 16  IGSGSFGTVYKG---KWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 72
Query: 210 STENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLXXXXXXXXXXXX 269
           ST+    +V Q+    SL   L       E      IA   A+G+ YL            
Sbjct: 73  STKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDL-- 130
Query: 270 XKASNILLSEDYEAQISDFGLAKWLPDNWS-HHIVFPIEGTFGYLSPEYFM---HGIVDE 325
            K++NI L ED   +I DFGLA  +   WS  H    + G+  +++PE            
Sbjct: 131 -KSNNIFLHEDLTVKIGDFGLAT-VKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSF 188
Query: 326 KTDVFAFGVLLLELITGR 343
           ++DV+AFG++L EL+TG+
Sbjct: 189 QSDVYAFGIVLYELMTGQ 206

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 48/161 (29%), Positives = 78/161 (48%), Gaps = 11/161 (6%)
Query: 188 FLSELGIVAHINHPNAAKLIGFSTENGFHLVLQFLPHGSLSSLLFGST-ECLEWTIRYKI 246
           FL E  ++  + H    +L    +E   ++V +++  GSL   L G   + L       +
Sbjct: 60  FLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDM 119
Query: 247 ALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDN---WSHHIV 303
           A  IA G+ Y+              A+NIL+ E+   +++DFGLA+ + DN         
Sbjct: 120 AAQIASGMAYVERMNYVHRDLA---AANILVGENLVCKVADFGLARLIEDNEYTARQGAK 176
Query: 304 FPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRR 344
           FPI+ T    +PE  ++G    K+DV++FG+LL EL T  R
Sbjct: 177 FPIKWT----APEAALYGRFTIKSDVWSFGILLTELTTKGR 213

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 57/217 (26%), Positives = 102/217 (47%), Gaps = 16/217 (7%)
Query: 133 DFAELAAATDNFNSENLIGKGGHAEVYKG--CLPDGEXXXXXXXXXXXXEDEERISDFLS 190
           +FA+   AT N + + ++G G   EV  G   LP  +              E++  DFL 
Sbjct: 37  EFAKELDAT-NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLG 95
Query: 191 ELGIVAHINHPNAAKLIGFSTENG-FHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIAL- 248
           E  I+   +HPN  +L G  T++    +V + + +GSL S L       ++T+   + + 
Sbjct: 96  EASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFL--RKHDAQFTVIQLVGML 153
Query: 249 -GIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIE 307
            GIA G++YL              A NIL++ +   ++SDFGL++ L D+      +   
Sbjct: 154 RGIASGMKYLSDMGAVHRDLA---ARNILINSNLVCKVSDFGLSRVLEDD--PEAAYTTR 208
Query: 308 G---TFGYLSPEYFMHGIVDEKTDVFAFGVLLLELIT 341
           G      + SPE   +      +DV+++G++L E+++
Sbjct: 209 GGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 245

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 47/161 (29%), Positives = 78/161 (48%), Gaps = 11/161 (6%)
Query: 188 FLSELGIVAHINHPNAAKLIGFSTENGFHLVLQFLPHGSLSSLLFGST-ECLEWTIRYKI 246
           FL E  ++  + H    +L    +E   ++V +++  G L   L G   + L       +
Sbjct: 60  FLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVTEYMSKGCLLDFLKGEMGKYLRLPQLVDM 119
Query: 247 ALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDN---WSHHIV 303
           A  IA G+ Y+             +A+NIL+ E+   +++DFGLA+ + DN         
Sbjct: 120 AAQIASGMAYVERMNYVHRDL---RAANILVGENLVCKVADFGLARLIEDNEYTARQGAK 176
Query: 304 FPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRR 344
           FPI+ T    +PE  ++G    K+DV++FG+LL EL T  R
Sbjct: 177 FPIKWT----APEAALYGRFTIKSDVWSFGILLTELTTKGR 213

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 57/217 (26%), Positives = 102/217 (47%), Gaps = 16/217 (7%)
Query: 133 DFAELAAATDNFNSENLIGKGGHAEVYKG--CLPDGEXXXXXXXXXXXXEDEERISDFLS 190
           +FA+   AT N + + ++G G   EV  G   LP  +              E++  DFL 
Sbjct: 8   EFAKELDAT-NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLG 66
Query: 191 ELGIVAHINHPNAAKLIGFSTENG-FHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIAL- 248
           E  I+   +HPN  +L G  T++    +V + + +GSL S L       ++T+   + + 
Sbjct: 67  EASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFL--RKHDAQFTVIQLVGML 124
Query: 249 -GIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIE 307
            GIA G++YL              A NIL++ +   ++SDFGL++ L D+      +   
Sbjct: 125 RGIASGMKYLSDMGYVHRDLA---ARNILINSNLVCKVSDFGLSRVLEDD--PEAAYTTR 179
Query: 308 G---TFGYLSPEYFMHGIVDEKTDVFAFGVLLLELIT 341
           G      + SPE   +      +DV+++G++L E+++
Sbjct: 180 GGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 216

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 50/203 (24%), Positives = 91/203 (44%), Gaps = 18/203 (8%)
Query: 148 NLIGKGGHAEVYKGC-LPDGEXXXXXXXXXXXXEDEERISD--FLSELGIVAHINHPNAA 204
            ++G G    VYKG  +PDGE            E+    ++   L E  ++A +  P  +
Sbjct: 23  KVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVS 82
Query: 205 KLIGFSTENGFHLVLQFLPHGSLSSLL------FGSTECLEWTIRYKIALGIAEGLQYLX 258
           +L+G    +   LV Q +P+G L   +       GS + L W ++      IA+G+ YL 
Sbjct: 83  RLLGICLTSTVQLVTQLMPYGCLLDHVRENRGRLGSQDLLNWCMQ------IAKGMSYLE 136
Query: 259 XXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEGTFGYLSPEYF 318
                        A N+L+      +I+DFGLA+ L  + + +     +    +++ E  
Sbjct: 137 DVRLVHRDLA---ARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESI 193
Query: 319 MHGIVDEKTDVFAFGVLLLELIT 341
           +      ++DV+++GV + EL+T
Sbjct: 194 LRRRFTHQSDVWSYGVTVWELMT 216

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 57/217 (26%), Positives = 102/217 (47%), Gaps = 16/217 (7%)
Query: 133 DFAELAAATDNFNSENLIGKGGHAEVYKG--CLPDGEXXXXXXXXXXXXEDEERISDFLS 190
           +FA+   AT N + + ++G G   EV  G   LP  +              E++  DFL 
Sbjct: 37  EFAKELDAT-NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLG 95
Query: 191 ELGIVAHINHPNAAKLIGFSTENG-FHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIAL- 248
           E  I+   +HPN  +L G  T++    +V + + +GSL S L       ++T+   + + 
Sbjct: 96  EASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFL--RKHDAQFTVIQLVGML 153
Query: 249 -GIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIE 307
            GIA G++YL              A NIL++ +   ++SDFGL++ L D+      +   
Sbjct: 154 RGIASGMKYLSDMGYVHRDLA---ARNILINSNLVCKVSDFGLSRVLEDD--PEAAYTTR 208
Query: 308 G---TFGYLSPEYFMHGIVDEKTDVFAFGVLLLELIT 341
           G      + SPE   +      +DV+++G++L E+++
Sbjct: 209 GGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 245

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 47/161 (29%), Positives = 78/161 (48%), Gaps = 11/161 (6%)
Query: 188 FLSELGIVAHINHPNAAKLIGFSTENGFHLVLQFLPHGSLSSLLFGST-ECLEWTIRYKI 246
           FL E  ++  + H    +L    +E   ++V +++  GSL   L G   + L       +
Sbjct: 227 FLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDM 286
Query: 247 ALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDN---WSHHIV 303
           A  IA G+ Y+             +A+NIL+ E+   +++DFGL + + DN         
Sbjct: 287 AAQIASGMAYVERMNYVHRDL---RAANILVGENLVCKVADFGLGRLIEDNEYTARQGAK 343
Query: 304 FPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRR 344
           FPI+ T    +PE  ++G    K+DV++FG+LL EL T  R
Sbjct: 344 FPIKWT----APEAALYGRFTIKSDVWSFGILLTELTTKGR 380

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 55/198 (27%), Positives = 84/198 (42%), Gaps = 11/198 (5%)
Query: 150 IGKGGHAEVYKGCLPDGEXXXXXXXXXXXXEDEERISDFLSELGIVAHINHPNAAKLIGF 209
           IG G    VYKG                     +++  F +E+G++    H N    +G+
Sbjct: 16  IGSGSFGTVYKG---KWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 72
Query: 210 STENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLXXXXXXXXXXXX 269
           ST     +V Q+    SL   L       E      IA   A+G+ YL            
Sbjct: 73  STAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDL-- 130
Query: 270 XKASNILLSEDYEAQISDFGLAKWLPDNWS-HHIVFPIEGTFGYLSPEYFM---HGIVDE 325
            K++NI L ED   +I DFGLA  +   WS  H    + G+  +++PE            
Sbjct: 131 -KSNNIFLHEDLTVKIGDFGLAT-VKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSF 188
Query: 326 KTDVFAFGVLLLELITGR 343
           ++DV+AFG++L EL+TG+
Sbjct: 189 QSDVYAFGIVLYELMTGQ 206

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 55/198 (27%), Positives = 84/198 (42%), Gaps = 11/198 (5%)
Query: 150 IGKGGHAEVYKGCLPDGEXXXXXXXXXXXXEDEERISDFLSELGIVAHINHPNAAKLIGF 209
           IG G    VYKG                     +++  F +E+G++    H N    +G+
Sbjct: 36  IGSGSFGTVYKG---KWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 92
Query: 210 STENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLXXXXXXXXXXXX 269
           ST+    +V Q+    SL   L       E      IA   A+G+ YL            
Sbjct: 93  STKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDL-- 150
Query: 270 XKASNILLSEDYEAQISDFGLAKWLPDNWS-HHIVFPIEGTFGYLSPEYFM---HGIVDE 325
            K++NI L ED   +I DFGLA      WS  H    + G+  +++PE            
Sbjct: 151 -KSNNIFLHEDLTVKIGDFGLAT-EKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSF 208
Query: 326 KTDVFAFGVLLLELITGR 343
           ++DV+AFG++L EL+TG+
Sbjct: 209 QSDVYAFGIVLYELMTGQ 226

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 55/198 (27%), Positives = 84/198 (42%), Gaps = 11/198 (5%)
Query: 150 IGKGGHAEVYKGCLPDGEXXXXXXXXXXXXEDEERISDFLSELGIVAHINHPNAAKLIGF 209
           IG G    VYKG                     +++  F +E+G++    H N    +G+
Sbjct: 44  IGSGSFGTVYKG---KWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 100
Query: 210 STENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLXXXXXXXXXXXX 269
           ST+    +V Q+    SL   L       E      IA   A+G+ YL            
Sbjct: 101 STKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDL-- 158
Query: 270 XKASNILLSEDYEAQISDFGLAKWLPDNWS-HHIVFPIEGTFGYLSPEYFM---HGIVDE 325
            K++NI L ED   +I DFGLA      WS  H    + G+  +++PE            
Sbjct: 159 -KSNNIFLHEDLTVKIGDFGLAT-EKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSF 216
Query: 326 KTDVFAFGVLLLELITGR 343
           ++DV+AFG++L EL+TG+
Sbjct: 217 QSDVYAFGIVLYELMTGQ 234

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 64/232 (27%), Positives = 102/232 (43%), Gaps = 29/232 (12%)
Query: 130 KNFDFAELAAATDNF--------NSENLIGKGGHAEVYKGCLPDGEXXXXXXXXXXXXE- 180
           ++ D A LA   D          +S+ +IGKG    VY G   D                
Sbjct: 1   RDLDSALLAEVKDVLIPHERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRI 60
Query: 181 -DEERISDFLSELGIVAHINHPNAAKLIG--FSTENGFHLVLQFLPHGSLSSLLFGSTEC 237
            + +++  FL E  ++  +NHPN   LIG     E   H++L ++ HG L  L F  +  
Sbjct: 61  TEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDL--LQFIRSPQ 118
Query: 238 LEWTIRYKIALG--IAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLP 295
              T++  I+ G  +A G++YL              A N +L E +  +++DFGLA+ + 
Sbjct: 119 RNPTVKDLISFGLQVARGMEYLAEQKFVHRDL---AARNCMLDESFTVKVADFGLARDIL 175
Query: 296 DNWSH------HIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELIT 341
           D   +      H   P++ T    + E         K+DV++FGVLL EL+T
Sbjct: 176 DREYYSVQQHRHARLPVKWT----ALESLQTYRFTTKSDVWSFGVLLWELLT 223

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 93/201 (46%), Gaps = 13/201 (6%)
Query: 149 LIGKGGHAEVYKGCL--PDGEXXXXXXXXXXXXEDEERISDFLSELGIVAHINHPNAAKL 206
           +IG+G    VY G L   DG+             D   +S FL+E  I+   +HPN   L
Sbjct: 35  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 94
Query: 207 IGFS--TENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALG--IAEGLQYLXXXXX 262
           +G    +E    +VL ++ HG L + +   T     T++  I  G  +A+G+++L     
Sbjct: 95  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETH--NPTVKDLIGFGLQVAKGMKFLASKKF 152
Query: 263 XXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNW--SHHIVFPIEGTFGYLSPEYFMH 320
                    A N +L E +  +++DFGLA+ + D    S H     +    +++ E    
Sbjct: 153 VHRDLA---ARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQT 209
Query: 321 GIVDEKTDVFAFGVLLLELIT 341
                K+DV++FGVLL EL+T
Sbjct: 210 QKFTTKSDVWSFGVLLWELMT 230

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 93/201 (46%), Gaps = 13/201 (6%)
Query: 149 LIGKGGHAEVYKGCL--PDGEXXXXXXXXXXXXEDEERISDFLSELGIVAHINHPNAAKL 206
           +IG+G    VY G L   DG+             D   +S FL+E  I+   +HPN   L
Sbjct: 37  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 96
Query: 207 IGFS--TENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALG--IAEGLQYLXXXXX 262
           +G    +E    +VL ++ HG L + +   T     T++  I  G  +A+G+++L     
Sbjct: 97  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETH--NPTVKDLIGFGLQVAKGMKFLASKKF 154
Query: 263 XXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNW--SHHIVFPIEGTFGYLSPEYFMH 320
                    A N +L E +  +++DFGLA+ + D    S H     +    +++ E    
Sbjct: 155 VHRDLA---ARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQT 211
Query: 321 GIVDEKTDVFAFGVLLLELIT 341
                K+DV++FGVLL EL+T
Sbjct: 212 QKFTTKSDVWSFGVLLWELMT 232

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 55/198 (27%), Positives = 84/198 (42%), Gaps = 11/198 (5%)
Query: 150 IGKGGHAEVYKGCLPDGEXXXXXXXXXXXXEDEERISDFLSELGIVAHINHPNAAKLIGF 209
           IG G    VYKG                     +++  F +E+G++    H N    +G+
Sbjct: 16  IGSGSFGTVYKG---KWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 72
Query: 210 STENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLXXXXXXXXXXXX 269
           ST+    +V Q+    SL   L       E      IA   A+G+ YL            
Sbjct: 73  STKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDL-- 130
Query: 270 XKASNILLSEDYEAQISDFGLAKWLPDNWS-HHIVFPIEGTFGYLSPEYFM---HGIVDE 325
            K++NI L ED   +I DFGLA      WS  H    + G+  +++PE            
Sbjct: 131 -KSNNIFLHEDLTVKIGDFGLAT-EKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSF 188
Query: 326 KTDVFAFGVLLLELITGR 343
           ++DV+AFG++L EL+TG+
Sbjct: 189 QSDVYAFGIVLYELMTGQ 206

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 93/201 (46%), Gaps = 13/201 (6%)
Query: 149 LIGKGGHAEVYKGCL--PDGEXXXXXXXXXXXXEDEERISDFLSELGIVAHINHPNAAKL 206
           +IG+G    VY G L   DG+             D   +S FL+E  I+   +HPN   L
Sbjct: 96  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 155
Query: 207 IGFS--TENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALG--IAEGLQYLXXXXX 262
           +G    +E    +VL ++ HG L + +   T     T++  I  G  +A+G+++L     
Sbjct: 156 LGICLRSEGSPLVVLPYMKHGDLRNFIRNETH--NPTVKDLIGFGLQVAKGMKFLASKKF 213
Query: 263 XXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNW--SHHIVFPIEGTFGYLSPEYFMH 320
                    A N +L E +  +++DFGLA+ + D    S H     +    +++ E    
Sbjct: 214 VHRDLA---ARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQT 270
Query: 321 GIVDEKTDVFAFGVLLLELIT 341
                K+DV++FGVLL EL+T
Sbjct: 271 QKFTTKSDVWSFGVLLWELMT 291

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 93/201 (46%), Gaps = 13/201 (6%)
Query: 149 LIGKGGHAEVYKGCL--PDGEXXXXXXXXXXXXEDEERISDFLSELGIVAHINHPNAAKL 206
           +IG+G    VY G L   DG+             D   +S FL+E  I+   +HPN   L
Sbjct: 38  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 97
Query: 207 IGFS--TENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALG--IAEGLQYLXXXXX 262
           +G    +E    +VL ++ HG L + +   T     T++  I  G  +A+G+++L     
Sbjct: 98  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETH--NPTVKDLIGFGLQVAKGMKFLASKKF 155
Query: 263 XXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNW--SHHIVFPIEGTFGYLSPEYFMH 320
                    A N +L E +  +++DFGLA+ + D    S H     +    +++ E    
Sbjct: 156 VHRDLA---ARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQT 212
Query: 321 GIVDEKTDVFAFGVLLLELIT 341
                K+DV++FGVLL EL+T
Sbjct: 213 QKFTTKSDVWSFGVLLWELMT 233

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 93/201 (46%), Gaps = 13/201 (6%)
Query: 149 LIGKGGHAEVYKGCL--PDGEXXXXXXXXXXXXEDEERISDFLSELGIVAHINHPNAAKL 206
           +IG+G    VY G L   DG+             D   +S FL+E  I+   +HPN   L
Sbjct: 42  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 101
Query: 207 IGFS--TENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALG--IAEGLQYLXXXXX 262
           +G    +E    +VL ++ HG L + +   T     T++  I  G  +A+G+++L     
Sbjct: 102 LGICLRSEGSPLVVLPYMKHGDLRNFIRNETH--NPTVKDLIGFGLQVAKGMKFLASKKF 159
Query: 263 XXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNW--SHHIVFPIEGTFGYLSPEYFMH 320
                    A N +L E +  +++DFGLA+ + D    S H     +    +++ E    
Sbjct: 160 VHRDLA---ARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQT 216
Query: 321 GIVDEKTDVFAFGVLLLELIT 341
                K+DV++FGVLL EL+T
Sbjct: 217 QKFTTKSDVWSFGVLLWELMT 237

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 93/201 (46%), Gaps = 13/201 (6%)
Query: 149 LIGKGGHAEVYKGCL--PDGEXXXXXXXXXXXXEDEERISDFLSELGIVAHINHPNAAKL 206
           +IG+G    VY G L   DG+             D   +S FL+E  I+   +HPN   L
Sbjct: 38  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 97
Query: 207 IGFS--TENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALG--IAEGLQYLXXXXX 262
           +G    +E    +VL ++ HG L + +   T     T++  I  G  +A+G+++L     
Sbjct: 98  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETH--NPTVKDLIGFGLQVAKGMKFLASKKF 155
Query: 263 XXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNW--SHHIVFPIEGTFGYLSPEYFMH 320
                    A N +L E +  +++DFGLA+ + D    S H     +    +++ E    
Sbjct: 156 VHRDLA---ARNCMLDEKFTVKVADFGLARDMLDKEFDSVHNKTGAKLPVKWMALESLQT 212
Query: 321 GIVDEKTDVFAFGVLLLELIT 341
                K+DV++FGVLL EL+T
Sbjct: 213 QKFTTKSDVWSFGVLLWELMT 233

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 93/201 (46%), Gaps = 13/201 (6%)
Query: 149 LIGKGGHAEVYKGCL--PDGEXXXXXXXXXXXXEDEERISDFLSELGIVAHINHPNAAKL 206
           +IG+G    VY G L   DG+             D   +S FL+E  I+   +HPN   L
Sbjct: 37  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 96
Query: 207 IGFS--TENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALG--IAEGLQYLXXXXX 262
           +G    +E    +VL ++ HG L + +   T     T++  I  G  +A+G+++L     
Sbjct: 97  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETH--NPTVKDLIGFGLQVAKGMKFLASKKF 154
Query: 263 XXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNW--SHHIVFPIEGTFGYLSPEYFMH 320
                    A N +L E +  +++DFGLA+ + D    S H     +    +++ E    
Sbjct: 155 VHRDLA---ARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQT 211
Query: 321 GIVDEKTDVFAFGVLLLELIT 341
                K+DV++FGVLL EL+T
Sbjct: 212 QKFTTKSDVWSFGVLLWELMT 232

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 49/165 (29%), Positives = 80/165 (48%), Gaps = 9/165 (5%)
Query: 181 DEERISDFLSELGIVAHINHPNAAKLIGFSTENG---FHLVLQFLPHGSLSSLLFGSTEC 237
           D++R  DF  E+ I+  ++     K  G S   G     LV+++LP G L   L      
Sbjct: 53  DQQR--DFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRAR 110
Query: 238 LEWTIRYKIALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDN 297
           L+ +     +  I +G++YL              A NIL+  +   +I+DFGLAK LP +
Sbjct: 111 LDASRLLLYSSQICKGMEYLGSRRCVHRDLA---ARNILVESEAHVKIADFGLAKLLPLD 167
Query: 298 WSHHIVF-PIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELIT 341
             +++V  P +    + +PE     I   ++DV++FGV+L EL T
Sbjct: 168 KDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFT 212

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 49/165 (29%), Positives = 80/165 (48%), Gaps = 9/165 (5%)
Query: 181 DEERISDFLSELGIVAHINHPNAAKLIGFSTENG---FHLVLQFLPHGSLSSLLFGSTEC 237
           D++R  DF  E+ I+  ++     K  G S   G     LV+++LP G L   L      
Sbjct: 54  DQQR--DFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRAR 111
Query: 238 LEWTIRYKIALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDN 297
           L+ +     +  I +G++YL              A NIL+  +   +I+DFGLAK LP +
Sbjct: 112 LDASRLLLYSSQICKGMEYLGSRRCVHRDLA---ARNILVESEAHVKIADFGLAKLLPLD 168
Query: 298 WSHHIVF-PIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELIT 341
             +++V  P +    + +PE     I   ++DV++FGV+L EL T
Sbjct: 169 KDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFT 213

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 63/235 (26%), Positives = 103/235 (43%), Gaps = 14/235 (5%)
Query: 139 AATDNFNSENLIGKGGHAEVY---KGCLPD-GEXXXXXXXXXXXXEDEERISDFLSELGI 194
           A   +F    ++G+G   +V+   K   PD G             +  +R+   + E  I
Sbjct: 25  ADPSHFELLKVLGQGSFGKVFLVRKVTRPDSGHLYAMKVLKKATLKVRDRVRTKM-ERDI 83
Query: 195 VAHINHPNAAKL-IGFSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEG 253
           +A +NHP   KL   F TE   +L+L FL  G L + L       E  +++ +A  +A G
Sbjct: 84  LADVNHPFVVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLA-ELALG 142
Query: 254 LQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEGTFGYL 313
           L +L             K  NILL E+   +++DFGL+K   D+      F   GT  Y+
Sbjct: 143 LDHLHSLGIIYRDL---KPENILLDEEGHIKLTDFGLSKEAIDHEKKAYSFC--GTVEYM 197
Query: 314 SPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDS--RRQSLVIWAKPLLQTSNF 366
           +PE           D +++GVL+ E++TG        R++++ +  K  L    F
Sbjct: 198 APEVVNRQGHSHSADWWSYGVLMFEMLTGSLPFQGKDRKETMTLILKAKLGMPQF 252

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 90/205 (43%), Gaps = 19/205 (9%)
Query: 147 ENLIGKGGHAEVYKGCL--PDGEXXXXXXXXXXXXEDEERISDFLSELGIVAHINHPNAA 204
           E +IG G   EV  G L  P                 E +  DFLSE  I+   +HPN  
Sbjct: 54  EKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNII 113
Query: 205 KLIGFSTENGFHLVL-QFLPHGSLSSLLFGSTECLEWTIRYKIAL--GIAEGLQYLXXXX 261
           +L G  T     +++ +++ +GSL + L   T   ++TI   + +  G+  G++YL    
Sbjct: 114 RLEGVVTRGRLAMIVTEYMENGSLDTFL--RTHDGQFTIMQLVGMLRGVGAGMRYL---S 168
Query: 262 XXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSHHIV-----FPIEGTFGYLSPE 316
                     A N+L+  +   ++SDFGL++ L D+            PI  T    +PE
Sbjct: 169 DLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAXTTTGGKIPIRWT----APE 224
Query: 317 YFMHGIVDEKTDVFAFGVLLLELIT 341
                     +DV++FGV++ E++ 
Sbjct: 225 AIAFRTFSSASDVWSFGVVMWEVLA 249

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 49/165 (29%), Positives = 80/165 (48%), Gaps = 9/165 (5%)
Query: 181 DEERISDFLSELGIVAHINHPNAAKLIGFSTENG---FHLVLQFLPHGSLSSLLFGSTEC 237
           D++R  DF  E+ I+  ++     K  G S   G     LV+++LP G L   L      
Sbjct: 66  DQQR--DFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRAR 123
Query: 238 LEWTIRYKIALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDN 297
           L+ +     +  I +G++YL              A NIL+  +   +I+DFGLAK LP +
Sbjct: 124 LDASRLLLYSSQICKGMEYLGSRRCVHRDLA---ARNILVESEAHVKIADFGLAKLLPLD 180
Query: 298 WSHHIVF-PIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELIT 341
             +++V  P +    + +PE     I   ++DV++FGV+L EL T
Sbjct: 181 KDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFT 225

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 57/227 (25%), Positives = 102/227 (44%), Gaps = 24/227 (10%)
Query: 187 DFLSELGIVAHINHPNAAKLIGF-STENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYK 245
           +F  E   +  ++HP   K  G  S E   ++V +++ +G L + L    + LE +   +
Sbjct: 49  EFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLE 108
Query: 246 IALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSHHIV-- 303
           +   + EG+ +L              A N L+  D   ++SDFG+ +++ D+     V  
Sbjct: 109 MCYDVCEGMAFLESHQFIHRDLA---ARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGT 165
Query: 304 -FPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELIT-GRRAVDSRRQSLVIWAKPLL 361
            FP++ +    +PE F +     K+DV+AFG+L+ E+ + G+   D    S V+     L
Sbjct: 166 KFPVKWS----APEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVV-----L 216
Query: 362 QTSNFKELVDPRLADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVL 408
           + S    L  P LA       + + M +   C H L   RP   ++L
Sbjct: 217 KVSQGHRLYRPHLAS----DTIYQIMYS---CWHELPEKRPTFQQLL 256

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 90/205 (43%), Gaps = 19/205 (9%)
Query: 147 ENLIGKGGHAEVYKGCL--PDGEXXXXXXXXXXXXEDEERISDFLSELGIVAHINHPNAA 204
           E +IG G   EV  G L  P                 E +  DFLSE  I+   +HPN  
Sbjct: 54  EKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNII 113
Query: 205 KLIGFSTENGFHLVL-QFLPHGSLSSLLFGSTECLEWTIRYKIAL--GIAEGLQYLXXXX 261
           +L G  T     +++ +++ +GSL + L   T   ++TI   + +  G+  G++YL    
Sbjct: 114 RLEGVVTRGRLAMIVTEYMENGSLDTFL--RTHDGQFTIMQLVGMLRGVGAGMRYL---S 168
Query: 262 XXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSHHIV-----FPIEGTFGYLSPE 316
                     A N+L+  +   ++SDFGL++ L D+            PI  T    +PE
Sbjct: 169 DLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWT----APE 224
Query: 317 YFMHGIVDEKTDVFAFGVLLLELIT 341
                     +DV++FGV++ E++ 
Sbjct: 225 AIAFRTFSSASDVWSFGVVMWEVLA 249

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 47/162 (29%), Positives = 78/162 (48%), Gaps = 11/162 (6%)
Query: 188 FLSELGIVAHINHPNAAKLIGFSTENGFHLVLQFLPHGSLSSLLF-GSTECLEWTIRYKI 246
           FL E  I+  + H    +L    +E   ++V +++  GSL   L  G    L+      +
Sbjct: 51  FLEEAQIMKKLKHDKLVQLYAVVSEEPIYIVTEYMNKGSLLDFLKDGEGRALKLPNLVDM 110
Query: 247 ALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDN---WSHHIV 303
           A  +A G+ Y+             +++NIL+      +I+DFGLA+ + DN         
Sbjct: 111 AAQVAAGMAYIERMNYIHRDL---RSANILVGNGLICKIADFGLARLIEDNEXTARQGAK 167
Query: 304 FPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRA 345
           FPI+ T    +PE  ++G    K+DV++FG+LL EL+T  R 
Sbjct: 168 FPIKWT----APEAALYGRFTIKSDVWSFGILLTELVTKGRV 205

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 46/166 (27%), Positives = 80/166 (48%), Gaps = 19/166 (11%)
Query: 191 ELGIVAHINHPNAAKLIGFSTENG-FHLVLQFLPHGSL-------SSLLFGSTECLEWTI 242
           E+ ++A++ HPN  +      ENG  ++V+ +   G L         +LF   + L+W +
Sbjct: 73  EVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFV 132
Query: 243 RYKIALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSHHI 302
           +  +AL      + L             K+ NI L++D   Q+ DFG+A+ L  N +  +
Sbjct: 133 QICLALKHVHDRKILHRDI---------KSQNIFLTKDGTVQLGDFGIARVL--NSTVEL 181
Query: 303 VFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDS 348
                GT  YLSPE   +   + K+D++A G +L EL T + A ++
Sbjct: 182 ARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEA 227

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 50/182 (27%), Positives = 89/182 (48%), Gaps = 30/182 (16%)
Query: 182 EERISDFLSELGIVAHI-NHPNAAKLIGFSTENG-FHLVLQFLPHGSLSSLL-------- 231
           E+ +SD +SE+ ++  I  H N   L+G  T++G  ++++++   G+L   L        
Sbjct: 59  EKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGL 118
Query: 232 ---FGSTECLEWTIRYK----IALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQ 284
              +  +   E  +  K     A  +A G++YL              A N+L++ED   +
Sbjct: 119 EYCYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLA---ARNVLVTEDNVMK 175
Query: 285 ISDFGLAKWLPDNWSHHIVFPIEGTFG-----YLSPEYFMHGIVDEKTDVFAFGVLLLEL 339
           I+DFGLA+ +     HHI +  + T G     +++PE     I   ++DV++FGVLL E+
Sbjct: 176 IADFGLARDI-----HHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEI 230
Query: 340 IT 341
            T
Sbjct: 231 FT 232

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 96/207 (46%), Gaps = 22/207 (10%)
Query: 147 ENLIGKGGHAEVYKGCLPDG----EXXXXXXXXXXXXEDEERISDFLSELGIVAHINHPN 202
           + +IG G   EVYKG L       E             +++R+ DFL E GI+   +H N
Sbjct: 49  QKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRV-DFLGEAGIMGQFSHHN 107
Query: 203 AAKLIG-FSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIAL--GIAEGLQYLXX 259
             +L G  S      ++ +++ +G+L   L    +  E+++   + +  GIA G++YL  
Sbjct: 108 IIRLEGVISKYKPMMIITEYMENGALDKFL--REKDGEFSVLQLVGMLRGIAAGMKYLAN 165
Query: 260 XXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSHHIV-----FPIEGTFGYLS 314
                       A NIL++ +   ++SDFGL++ L D+            PI  T    +
Sbjct: 166 MNYVHRDLA---ARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWT----A 218
Query: 315 PEYFMHGIVDEKTDVFAFGVLLLELIT 341
           PE   +      +DV++FG+++ E++T
Sbjct: 219 PEAISYRKFTSASDVWSFGIVMWEVMT 245

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 56/223 (25%), Positives = 97/223 (43%), Gaps = 18/223 (8%)
Query: 129 WKNFDFAELAAATDNFNSENLIGKGGHAEVYKGCL--PDGEXXXXXXXXXXXXEDEERIS 186
           W + +FA+          E +IG G   EV +G L  P  +              E +  
Sbjct: 2   WGSMEFAK-EIDVSYVKIEEVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRR 60
Query: 187 DFLSELGIVAHINHPNAAKLIGFSTENGFHLVL-QFLPHGSLSSLLFGSTECLEWTIRYK 245
           +FLSE  I+    HPN  +L G  T +   ++L +F+ +G+L S L  +           
Sbjct: 61  EFLSEASIMGQFEHPNIIRLEGVVTNSMPVMILTEFMENGALDSFLRLNDGQFTVIQLVG 120
Query: 246 IALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSHHIV-- 303
           +  GIA G++YL              A NIL++ +   ++SDFGL+++L +N S      
Sbjct: 121 MLRGIASGMRYLAEMSYVHRDLA---ARNILVNSNLVCKVSDFGLSRFLEENSSDPTYTS 177
Query: 304 -----FPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELIT 341
                 PI  T    +PE          +D +++G+++ E+++
Sbjct: 178 SLGGKIPIRWT----APEAIAFRKFTSASDAWSYGIVMWEVMS 216

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 50/182 (27%), Positives = 89/182 (48%), Gaps = 30/182 (16%)
Query: 182 EERISDFLSELGIVAHI-NHPNAAKLIGFSTENG-FHLVLQFLPHGSLSSLL-------- 231
           E+ +SD +SE+ ++  I  H N   L+G  T++G  ++++++   G+L   L        
Sbjct: 66  EKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGL 125
Query: 232 ---FGSTECLEWTIRYK----IALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQ 284
              +  +   E  +  K     A  +A G++YL              A N+L++ED   +
Sbjct: 126 EYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLA---ARNVLVTEDNVMK 182
Query: 285 ISDFGLAKWLPDNWSHHIVFPIEGTFG-----YLSPEYFMHGIVDEKTDVFAFGVLLLEL 339
           I+DFGLA+ +     HHI +  + T G     +++PE     I   ++DV++FGVLL E+
Sbjct: 183 IADFGLARDI-----HHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEI 237
Query: 340 IT 341
            T
Sbjct: 238 FT 239

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 50/182 (27%), Positives = 89/182 (48%), Gaps = 30/182 (16%)
Query: 182 EERISDFLSELGIVAHI-NHPNAAKLIGFSTENG-FHLVLQFLPHGSLSSLL-------- 231
           E+ +SD +SE+ ++  I  H N   L+G  T++G  ++++++   G+L   L        
Sbjct: 63  EKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGL 122
Query: 232 ---FGSTECLEWTIRYK----IALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQ 284
              +  +   E  +  K     A  +A G++YL              A N+L++ED   +
Sbjct: 123 EYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLA---ARNVLVTEDNVMK 179
Query: 285 ISDFGLAKWLPDNWSHHIVFPIEGTFG-----YLSPEYFMHGIVDEKTDVFAFGVLLLEL 339
           I+DFGLA+ +     HHI +  + T G     +++PE     I   ++DV++FGVLL E+
Sbjct: 180 IADFGLARDI-----HHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEI 234
Query: 340 IT 341
            T
Sbjct: 235 FT 236

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 50/182 (27%), Positives = 89/182 (48%), Gaps = 30/182 (16%)
Query: 182 EERISDFLSELGIVAHI-NHPNAAKLIGFSTENG-FHLVLQFLPHGSLSSLL-------- 231
           E+ +SD +SE+ ++  I  H N   L+G  T++G  ++++++   G+L   L        
Sbjct: 67  EKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGL 126
Query: 232 ---FGSTECLEWTIRYK----IALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQ 284
              +  +   E  +  K     A  +A G++YL              A N+L++ED   +
Sbjct: 127 EYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLA---ARNVLVTEDNVMK 183
Query: 285 ISDFGLAKWLPDNWSHHIVFPIEGTFG-----YLSPEYFMHGIVDEKTDVFAFGVLLLEL 339
           I+DFGLA+ +     HHI +  + T G     +++PE     I   ++DV++FGVLL E+
Sbjct: 184 IADFGLARDI-----HHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEI 238
Query: 340 IT 341
            T
Sbjct: 239 FT 240

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 48/163 (29%), Positives = 80/163 (49%), Gaps = 19/163 (11%)
Query: 185 ISDFLSELGIVAHINHPNAAKLIGFSTENGFHLVLQFLPHGSLSSLLF---GSTECLEWT 241
           +  FL+E  ++  + H    KL    T+   +++ +F+  GSL   L    GS + L   
Sbjct: 221 VEAFLAEANVMKTLQHDKLVKLHAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKL 280
Query: 242 IRYKIALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSHH 301
           I +  +  IAEG+ ++             +A+NIL+S     +I+DFGLA+         
Sbjct: 281 IDF--SAQIAEGMAFIEQRNYIHRDL---RAANILVSASLVCKIADFGLAR-------VG 328
Query: 302 IVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRR 344
             FPI+ T    +PE    G    K+DV++FG+LL+E++T  R
Sbjct: 329 AKFPIKWT----APEAINFGSFTIKSDVWSFGILLMEIVTYGR 367

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 50/182 (27%), Positives = 89/182 (48%), Gaps = 30/182 (16%)
Query: 182 EERISDFLSELGIVAHI-NHPNAAKLIGFSTENG-FHLVLQFLPHGSLSSLL-------- 231
           E+ +SD +SE+ ++  I  H N   L+G  T++G  ++++++   G+L   L        
Sbjct: 74  EKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGL 133
Query: 232 ---FGSTECLEWTIRYK----IALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQ 284
              +  +   E  +  K     A  +A G++YL              A N+L++ED   +
Sbjct: 134 EYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLA---ARNVLVTEDNVMK 190
Query: 285 ISDFGLAKWLPDNWSHHIVFPIEGTFG-----YLSPEYFMHGIVDEKTDVFAFGVLLLEL 339
           I+DFGLA+ +     HHI +  + T G     +++PE     I   ++DV++FGVLL E+
Sbjct: 191 IADFGLARDI-----HHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEI 245
Query: 340 IT 341
            T
Sbjct: 246 FT 247

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 49/165 (29%), Positives = 78/165 (47%), Gaps = 9/165 (5%)
Query: 181 DEERISDFLSELGIVAHINHPNAAKLIGFSTENG---FHLVLQFLPHGSLSSLLFGSTEC 237
           D++R  DF  E+ I+  ++     K  G S   G     LV+++LP G L   L      
Sbjct: 50  DQQR--DFQREIQILKALHSDFIVKYRGVSYGPGRPELRLVMEYLPSGCLRDFLQRHRAR 107
Query: 238 LEWTIRYKIALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDN 297
           L+ +     +  I +G++YL              A NIL+  +   +I+DFGLAK LP +
Sbjct: 108 LDASRLLLYSSQICKGMEYLGSRRCVHRDLA---ARNILVESEAHVKIADFGLAKLLPLD 164
Query: 298 WSHHIVF-PIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELIT 341
               +V  P +    + +PE     I   ++DV++FGV+L EL T
Sbjct: 165 KDXXVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFT 209

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 50/182 (27%), Positives = 89/182 (48%), Gaps = 30/182 (16%)
Query: 182 EERISDFLSELGIVAHI-NHPNAAKLIGFSTENG-FHLVLQFLPHGSLSSLL-------- 231
           E+ +SD +SE+ ++  I  H N   L+G  T++G  ++++++   G+L   L        
Sbjct: 74  EKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQAREPPGL 133
Query: 232 ---FGSTECLEWTIRYK----IALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQ 284
              +  +   E  +  K     A  +A G++YL              A N+L++ED   +
Sbjct: 134 EYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLA---ARNVLVTEDNVMK 190
Query: 285 ISDFGLAKWLPDNWSHHIVFPIEGTFG-----YLSPEYFMHGIVDEKTDVFAFGVLLLEL 339
           I+DFGLA+ +     HHI +  + T G     +++PE     I   ++DV++FGVLL E+
Sbjct: 191 IADFGLARDI-----HHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEI 245
Query: 340 IT 341
            T
Sbjct: 246 FT 247

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 51/182 (28%), Positives = 88/182 (48%), Gaps = 30/182 (16%)
Query: 182 EERISDFLSELGIVAHI-NHPNAAKLIGFSTENG-FHLVLQFLPHGSLSSLL-------- 231
           E+ +SD +SE+ ++  I  H N   L+G  T++G  ++++++   G+L   L        
Sbjct: 74  EKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGL 133
Query: 232 ---FGSTECLEWTIRYK----IALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQ 284
              F  +   E  +  K     A  +A G++YL              A N+L++ED   +
Sbjct: 134 EFSFNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLA---ARNVLVTEDNVMK 190
Query: 285 ISDFGLAKWLPDNWSHHIVFPIEGTFG-----YLSPEYFMHGIVDEKTDVFAFGVLLLEL 339
           I+DFGLA+ +     HHI    + T G     +++PE     I   ++DV++FGVLL E+
Sbjct: 191 IADFGLARDI-----HHIDXXKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEI 245
Query: 340 IT 341
            T
Sbjct: 246 FT 247

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 50/182 (27%), Positives = 89/182 (48%), Gaps = 30/182 (16%)
Query: 182 EERISDFLSELGIVAHI-NHPNAAKLIGFSTENG-FHLVLQFLPHGSLSSLL-------- 231
           E+ +SD +SE+ ++  I  H N   L+G  T++G  ++++++   G+L   L        
Sbjct: 74  EKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGL 133
Query: 232 ---FGSTECLEWTIRYK----IALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQ 284
              +  +   E  +  K     A  +A G++YL              A N+L++ED   +
Sbjct: 134 EYCYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLA---ARNVLVTEDNVMK 190
Query: 285 ISDFGLAKWLPDNWSHHIVFPIEGTFG-----YLSPEYFMHGIVDEKTDVFAFGVLLLEL 339
           I+DFGLA+ +     HHI +  + T G     +++PE     I   ++DV++FGVLL E+
Sbjct: 191 IADFGLARDI-----HHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEI 245
Query: 340 IT 341
            T
Sbjct: 246 FT 247

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 92/205 (44%), Gaps = 17/205 (8%)
Query: 147 ENLIGKGGHAEVYKGCL--PDGEXXXXXXXXXXXXEDEERISDFLSELGIVAHINHPNAA 204
           E +IG G   EV +G L  P  +              E +  +FLSE  I+    HPN  
Sbjct: 21  EEVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNII 80
Query: 205 KLIGFSTENGFHLVL-QFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLXXXXXX 263
           +L G  T +   ++L +F+ +G+L S L  +           +  GIA G++YL      
Sbjct: 81  RLEGVVTNSMPVMILTEFMENGALDSFLRLNDGQFTVIQLVGMLRGIASGMRYLAEMSYV 140
Query: 264 XXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEGT-------FGYLSPE 316
                   A NIL++ +   ++SDFGL+++L +N S     P E +         + +PE
Sbjct: 141 HRDLA---ARNILVNSNLVCKVSDFGLSRFLEENSSD----PTETSSLGGKIPIRWTAPE 193
Query: 317 YFMHGIVDEKTDVFAFGVLLLELIT 341
                     +D +++G+++ E+++
Sbjct: 194 AIAFRKFTSASDAWSYGIVMWEVMS 218

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 50/201 (24%), Positives = 88/201 (43%), Gaps = 11/201 (5%)
Query: 147 ENLIGKGGHAEVYKG--CLPDGEXXXXXXXXXXXXEDEERISDFLSELGIVAHINHPNAA 204
           E +IG G   EV  G   LP                 E++  DFL E  I+   +HPN  
Sbjct: 48  ERVIGAGEFGEVCSGRLKLPGKRDVAVAIKTLKVGYTEKQRRDFLCEASIMGQFDHPNVV 107
Query: 205 KLIGFSTENG-FHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLXXXXXX 263
            L G  T      +V++F+ +G+L + L              +  GIA G++YL      
Sbjct: 108 HLEGVVTRGKPVMIVIEFMENGALDAFLRKHDGQFTVIQLVGMLRGIAAGMRYLADMGYV 167
Query: 264 XXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEG---TFGYLSPEYFMH 320
                   A NIL++ +   ++SDFGL++ + D+     V+   G      + +PE   +
Sbjct: 168 HRDLA---ARNILVNSNLVCKVSDFGLSRVIEDD--PEAVYTTTGGKIPVRWTAPEAIQY 222
Query: 321 GIVDEKTDVFAFGVLLLELIT 341
                 +DV+++G+++ E+++
Sbjct: 223 RKFTSASDVWSYGIVMWEVMS 243

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 48/164 (29%), Positives = 79/164 (48%), Gaps = 16/164 (9%)
Query: 185 ISDFLSELGIVAHINHPNAAKLIGFST-ENGFHLVLQFLPHGSLSSLLF---GSTECLEW 240
           +  FL E  ++  + H    +L    T E   +++ +++  GSL   L    G    L  
Sbjct: 52  VQAFLEEANLMKTLQHDKLVRLYAVVTREEPIYIITEYMAKGSLLDFLKSDEGGKVLLPK 111
Query: 241 TIRYKIALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDN--- 297
            I +  +  IAEG+ Y+             +A+N+L+SE    +I+DFGLA+ + DN   
Sbjct: 112 LIDF--SAQIAEGMAYIERKNYIHRDL---RAANVLVSESLMCKIADFGLARVIEDNEYT 166
Query: 298 WSHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELIT 341
                 FPI+ T    +PE    G    K+DV++FG+LL E++T
Sbjct: 167 AREGAKFPIKWT----APEAINFGCFTIKSDVWSFGILLYEIVT 206

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 46/160 (28%), Positives = 74/160 (46%), Gaps = 11/160 (6%)
Query: 188 FLSELGIVAHINHPNAAKLIGFSTE--NGFHLVLQFLPHGSLSSLLFG-STECLEWTIRY 244
           FL+E  ++  + H N  +L+G   E   G ++V +++  GSL   L       L      
Sbjct: 52  FLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLL 111
Query: 245 KIALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVF 304
           K +L + E ++YL              A N+L+SED  A++SDFGL K            
Sbjct: 112 KFSLDVCEAMEYLEGNNFVHRDLA---ARNVLVSEDNVAKVSDFGLTKEASSTQDTG-KL 167
Query: 305 PIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRR 344
           P++ T    +PE         K+DV++FG+LL E+ +  R
Sbjct: 168 PVKWT----APEALREAAFSTKSDVWSFGILLWEIYSFGR 203

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 52/179 (29%), Positives = 82/179 (45%), Gaps = 9/179 (5%)
Query: 191 ELGIVAHINHPNAAKL-IGFSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALG 249
           E  I+  +NHP   KL   F TE   +L+L FL  G L + L       E  +++ +A  
Sbjct: 76  ERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLA-E 134
Query: 250 IAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEGT 309
           +A  L +L             K  NILL E+   +++DFGL+K   D+      F   GT
Sbjct: 135 LALALDHLHSLGIIYRDL---KPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFC--GT 189
Query: 310 FGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDS--RRQSLVIWAKPLLQTSNF 366
             Y++PE        +  D ++FGVL+ E++TG        R++++ +  K  L    F
Sbjct: 190 VEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQF 248

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 50/182 (27%), Positives = 89/182 (48%), Gaps = 30/182 (16%)
Query: 182 EERISDFLSELGIVAHI-NHPNAAKLIGFSTENG-FHLVLQFLPHGSLSSLL-------- 231
           E+ +SD +SE+ ++  I  H N   L+G  T++G  ++++++   G+L   L        
Sbjct: 115 EKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGL 174
Query: 232 ---FGSTECLEWTIRYK----IALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQ 284
              +  +   E  +  K     A  +A G++YL              A N+L++ED   +
Sbjct: 175 EYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLA---ARNVLVTEDNVMK 231
Query: 285 ISDFGLAKWLPDNWSHHIVFPIEGTFG-----YLSPEYFMHGIVDEKTDVFAFGVLLLEL 339
           I+DFGLA+ +     HHI +  + T G     +++PE     I   ++DV++FGVLL E+
Sbjct: 232 IADFGLARDI-----HHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEI 286
Query: 340 IT 341
            T
Sbjct: 287 FT 288

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 52/179 (29%), Positives = 82/179 (45%), Gaps = 9/179 (5%)
Query: 191 ELGIVAHINHPNAAKL-IGFSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALG 249
           E  I+  +NHP   KL   F TE   +L+L FL  G L + L       E  +++ +A  
Sbjct: 77  ERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLA-E 135
Query: 250 IAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEGT 309
           +A  L +L             K  NILL E+   +++DFGL+K   D+      F   GT
Sbjct: 136 LALALDHLHSLGIIYRDL---KPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFC--GT 190
Query: 310 FGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDS--RRQSLVIWAKPLLQTSNF 366
             Y++PE        +  D ++FGVL+ E++TG        R++++ +  K  L    F
Sbjct: 191 VEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQF 249

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 52/179 (29%), Positives = 82/179 (45%), Gaps = 9/179 (5%)
Query: 191 ELGIVAHINHPNAAKL-IGFSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALG 249
           E  I+  +NHP   KL   F TE   +L+L FL  G L + L       E  +++ +A  
Sbjct: 76  ERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLA-E 134
Query: 250 IAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEGT 309
           +A  L +L             K  NILL E+   +++DFGL+K   D+      F   GT
Sbjct: 135 LALALDHLHSLGIIYRDL---KPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFC--GT 189
Query: 310 FGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDS--RRQSLVIWAKPLLQTSNF 366
             Y++PE        +  D ++FGVL+ E++TG        R++++ +  K  L    F
Sbjct: 190 VEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQF 248

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 48/164 (29%), Positives = 79/164 (48%), Gaps = 16/164 (9%)
Query: 185 ISDFLSELGIVAHINHPNAAKLIGFST-ENGFHLVLQFLPHGSLSSLLF---GSTECLEW 240
           +  FL E  ++  + H    +L    T E   +++ +F+  GSL   L    G    L  
Sbjct: 51  VQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEFMAKGSLLDFLKSDEGGKVLLPK 110
Query: 241 TIRYKIALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDN--- 297
            I +  +  IAEG+ Y+             +A+N+L+SE    +I+DFGLA+ + DN   
Sbjct: 111 LIDF--SAQIAEGMAYIERKNYIHRDL---RAANVLVSESLMCKIADFGLARVIEDNEYT 165
Query: 298 WSHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELIT 341
                 FPI+ T    +PE    G    K++V++FG+LL E++T
Sbjct: 166 AREGAKFPIKWT----APEAINFGCFTIKSNVWSFGILLYEIVT 205

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 48/196 (24%), Positives = 86/196 (43%), Gaps = 13/196 (6%)
Query: 150 IGKGGHAEVYKGCLPDGEXXXXXXXXXXXXEDEERISDFLSELGIVAHINHPNAAKLI-G 208
           +G G   +VYK    + E            + EE + D++ E+ I+A  +HPN  KL+  
Sbjct: 45  LGDGAFGKVYKA--QNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDA 102
Query: 209 FSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLXXXXXXXXXXX 268
           F  EN   ++++F   G++ +++      L      +I +   + L  L           
Sbjct: 103 FYYENNLWILIEFCAGGAVDAVMLELERPL---TESQIQVVCKQTLDALNYLHDNKIIHR 159
Query: 269 XXKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEGTFGYLSPEYFMHGI-----V 323
             KA NIL + D + +++DFG++            F   GT  +++PE  M         
Sbjct: 160 DLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI--GTPYWMAPEVVMCETSKDRPY 217
Query: 324 DEKTDVFAFGVLLLEL 339
           D K DV++ G+ L+E+
Sbjct: 218 DYKADVWSLGITLIEM 233

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 50/206 (24%), Positives = 90/206 (43%), Gaps = 24/206 (11%)
Query: 148 NLIGKGGHAEVYKGC-LPDGEXXXXXXXXXXXXEDEER-----ISDFLSELGIVAHINHP 201
            ++G G    V+KG  +P+GE            +   R     ++D +  +G    ++H 
Sbjct: 19  KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIG---SLDHA 75
Query: 202 NAAKLIGFSTENGFHLVLQFLPHGSLSSLL------FGSTECLEWTIRYKIALGIAEGLQ 255
           +  +L+G    +   LV Q+LP GSL   +       G    L W ++      IA+G+ 
Sbjct: 76  HIVRLLGLCPGSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQ------IAKGMY 129
Query: 256 YLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEGTFGYLSP 315
           YL              A N+LL    + Q++DFG+A  LP +    +    +    +++ 
Sbjct: 130 YLEEHGMVHRNLA---ARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMAL 186
Query: 316 EYFMHGIVDEKTDVFAFGVLLLELIT 341
           E    G    ++DV+++GV + EL+T
Sbjct: 187 ESIHFGKYTHQSDVWSYGVTVWELMT 212

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 48/196 (24%), Positives = 86/196 (43%), Gaps = 13/196 (6%)
Query: 150 IGKGGHAEVYKGCLPDGEXXXXXXXXXXXXEDEERISDFLSELGIVAHINHPNAAKLI-G 208
           +G G   +VYK    + E            + EE + D++ E+ I+A  +HPN  KL+  
Sbjct: 45  LGDGAFGKVYKA--QNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDA 102
Query: 209 FSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLXXXXXXXXXXX 268
           F  EN   ++++F   G++ +++      L      +I +   + L  L           
Sbjct: 103 FYYENNLWILIEFCAGGAVDAVMLELERPL---TESQIQVVCKQTLDALNYLHDNKIIHR 159
Query: 269 XXKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEGTFGYLSPEYFMHGI-----V 323
             KA NIL + D + +++DFG++            F   GT  +++PE  M         
Sbjct: 160 DLKAGNILFTLDGDIKLADFGVSAKNTRXIQRRDXFI--GTPYWMAPEVVMCETSKDRPY 217
Query: 324 DEKTDVFAFGVLLLEL 339
           D K DV++ G+ L+E+
Sbjct: 218 DYKADVWSLGITLIEM 233

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 50/206 (24%), Positives = 90/206 (43%), Gaps = 24/206 (11%)
Query: 148 NLIGKGGHAEVYKGC-LPDGEXXXXXXXXXXXXEDEER-----ISDFLSELGIVAHINHP 201
            ++G G    V+KG  +P+GE            +   R     ++D +  +G    ++H 
Sbjct: 37  KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIG---SLDHA 93
Query: 202 NAAKLIGFSTENGFHLVLQFLPHGSLSSLL------FGSTECLEWTIRYKIALGIAEGLQ 255
           +  +L+G    +   LV Q+LP GSL   +       G    L W ++      IA+G+ 
Sbjct: 94  HIVRLLGLCPGSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQ------IAKGMY 147
Query: 256 YLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEGTFGYLSP 315
           YL              A N+LL    + Q++DFG+A  LP +    +    +    +++ 
Sbjct: 148 YLEEHGMVHRNLA---ARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMAL 204
Query: 316 EYFMHGIVDEKTDVFAFGVLLLELIT 341
           E    G    ++DV+++GV + EL+T
Sbjct: 205 ESIHFGKYTHQSDVWSYGVTVWELMT 230

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 47/170 (27%), Positives = 74/170 (43%), Gaps = 29/170 (17%)
Query: 188 FLSELGIVAHINHPNAAKLIGFSTE--NGFHLVLQFLPHGSLSSLLFG-STECLEWTIRY 244
           FL+E  ++  + H N  +L+G   E   G ++V +++  GSL   L       L      
Sbjct: 46  FLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLL 105
Query: 245 KIALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAK---------WLP 295
           K +L + E ++YL              A N+L+SED  A++SDFGL K          LP
Sbjct: 106 KFSLDVCEAMEYLEGNNFVHRDLA---ARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLP 162
Query: 296 DNWSHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRA 345
             W+              +PE         K+DV++FG+LL E+ +  R 
Sbjct: 163 VKWT--------------APEALREKKFSTKSDVWSFGILLWEIYSFGRV 198

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 48/174 (27%), Positives = 76/174 (43%), Gaps = 39/174 (22%)
Query: 188 FLSELGIVAHINHPNAAKLIGFSTE--NGFHLVLQFLPHGSLSSLLFG------STECLE 239
           FL+E  ++  + H N  +L+G   E   G ++V +++  GSL   L          +CL 
Sbjct: 233 FLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCL- 291
Query: 240 WTIRYKIALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAK------- 292
                K +L + E ++YL              A N+L+SED  A++SDFGL K       
Sbjct: 292 ----LKFSLDVCEAMEYLEGNNFVHRDLA---ARNVLVSEDNVAKVSDFGLTKEASSTQD 344
Query: 293 --WLPDNWSHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRR 344
              LP  W+              +PE         K+DV++FG+LL E+ +  R
Sbjct: 345 TGKLPVKWT--------------APEALREKKFSTKSDVWSFGILLWEIYSFGR 384

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 46/160 (28%), Positives = 75/160 (46%), Gaps = 11/160 (6%)
Query: 188 FLSELGIVAHINHPNAAKLIGFSTE--NGFHLVLQFLPHGSLSSLLFG-STECLEWTIRY 244
           FL+E  ++  + H N  +L+G   E   G ++V +++  GSL   L       L      
Sbjct: 61  FLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLL 120
Query: 245 KIALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVF 304
           K +L + E ++YL              A N+L+SED  A++SDFGL K          + 
Sbjct: 121 KFSLDVCEAMEYLEGNNFVHRDLA---ARNVLVSEDNVAKVSDFGLTKEASSTQDTGKL- 176
Query: 305 PIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRR 344
           P++ T    +PE         K+DV++FG+LL E+ +  R
Sbjct: 177 PVKWT----APEALREKKFSTKSDVWSFGILLWEIYSFGR 212

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 48/196 (24%), Positives = 86/196 (43%), Gaps = 13/196 (6%)
Query: 150 IGKGGHAEVYKGCLPDGEXXXXXXXXXXXXEDEERISDFLSELGIVAHINHPNAAKLI-G 208
           +G G   +VYK    + E            + EE + D++ E+ I+A  +HPN  KL+  
Sbjct: 45  LGDGAFGKVYKA--QNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDA 102
Query: 209 FSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLXXXXXXXXXXX 268
           F  EN   ++++F   G++ +++      L      +I +   + L  L           
Sbjct: 103 FYYENNLWILIEFCAGGAVDAVMLELERPL---TESQIQVVCKQTLDALNYLHDNKIIHR 159
Query: 269 XXKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEGTFGYLSPEYFMHGI-----V 323
             KA NIL + D + +++DFG++            F   GT  +++PE  M         
Sbjct: 160 DLKAGNILFTLDGDIKLADFGVSAKNTRXIQRRDSFI--GTPYWMAPEVVMCETSKDRPY 217
Query: 324 DEKTDVFAFGVLLLEL 339
           D K DV++ G+ L+E+
Sbjct: 218 DYKADVWSLGITLIEM 233

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 55/224 (24%), Positives = 100/224 (44%), Gaps = 36/224 (16%)
Query: 142 DNFNSENLIGKGGHAEVYKGCLP-DGEXXXXXXXXXXXXEDEERISDFLSELGIVAHI-N 199
           ++   +++IG+G   +V K  +  DG               ++   DF  EL ++  + +
Sbjct: 22  NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 81
Query: 200 HPNAAKLIGFSTENGF-HLVLQFLPHGSLSSLLFGSTECLEWTIRYKIA----------- 247
           HPN   L+G     G+ +L +++ PHG+L   L  S   LE    + IA           
Sbjct: 82  HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKS-RVLETDPAFAIANSTASTLSSQQ 140
Query: 248 -----LGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSHHI 302
                  +A G+ YL              A NIL+ E+Y A+I+DFGL++          
Sbjct: 141 LLHFAADVARGMDYLSQKQFIHRNLA---ARNILVGENYVAKIADFGLSR-------GQE 190
Query: 303 VFPIEGTFG-----YLSPEYFMHGIVDEKTDVFAFGVLLLELIT 341
           V+ ++ T G     +++ E   + +    +DV+++GVLL E+++
Sbjct: 191 VY-VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 233

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 56/215 (26%), Positives = 95/215 (44%), Gaps = 20/215 (9%)
Query: 142 DNFNSENLIGKGGHAEVYKG-CLPDGEXXXXXXXXXXXXEDEERISDFLSELGIVAHINH 200
           D++  + +IG G  A V    C P  E            +    + + L E+  ++  +H
Sbjct: 15  DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTS--MDELLKEIQAMSQCHH 72
Query: 201 PN-AAKLIGFSTENGFHLVLQFLPHGSLSSLLFG-------STECLEWTIRYKIALGIAE 252
           PN  +    F  ++   LV++ L  GS+  ++          +  L+ +    I   + E
Sbjct: 73  PNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLE 132
Query: 253 GLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLP---DNWSHHIVFPIEGT 309
           GL+YL             KA NILL ED   QI+DFG++ +L    D   + +     GT
Sbjct: 133 GLEYLHKNGQIHRDV---KAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGT 189
Query: 310 FGYLSPEYFMHGI--VDEKTDVFAFGVLLLELITG 342
             +++PE  M  +   D K D+++FG+  +EL TG
Sbjct: 190 PCWMAPE-VMEQVRGYDFKADIWSFGITAIELATG 223

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 55/224 (24%), Positives = 100/224 (44%), Gaps = 36/224 (16%)
Query: 142 DNFNSENLIGKGGHAEVYKGCLP-DGEXXXXXXXXXXXXEDEERISDFLSELGIVAHI-N 199
           ++   +++IG+G   +V K  +  DG               ++   DF  EL ++  + +
Sbjct: 25  NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 84
Query: 200 HPNAAKLIGFSTENGF-HLVLQFLPHGSLSSLLFGSTECLEWTIRYKIA----------- 247
           HPN   L+G     G+ +L +++ PHG+L   L  S   LE    + IA           
Sbjct: 85  HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKS-RVLETDPAFAIANSTASTLSSQQ 143
Query: 248 -----LGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSHHI 302
                  +A G+ YL              A NIL+ E+Y A+I+DFGL++          
Sbjct: 144 LLHFAADVARGMDYLSQKQFIHRDLA---ARNILVGENYVAKIADFGLSR-------GQE 193
Query: 303 VFPIEGTFG-----YLSPEYFMHGIVDEKTDVFAFGVLLLELIT 341
           V+ ++ T G     +++ E   + +    +DV+++GVLL E+++
Sbjct: 194 VY-VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 236

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 43/160 (26%), Positives = 68/160 (42%), Gaps = 4/160 (2%)
Query: 183 ERISDFLSELGIVAHINHPNAAKLIGFSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTI 242
           E + DF+ E+  +  ++H N  +L G        +V +  P GSL   L           
Sbjct: 57  EAMDDFIREVNAMHSLDHRNLIRLYGVVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGT 116
Query: 243 RYKIALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSHHI 302
             + A+ +AEG+ YL              A N+LL+     +I DFGL + LP N  H++
Sbjct: 117 LSRYAVQVAEGMGYLESKRFIHRDLA---ARNLLLATRDLVKIGDFGLMRALPQNDDHYV 173
Query: 303 VFPIEGT-FGYLSPEYFMHGIVDEKTDVFAFGVLLLELIT 341
           +       F + +PE          +D + FGV L E+ T
Sbjct: 174 MQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFT 213

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 56/215 (26%), Positives = 95/215 (44%), Gaps = 20/215 (9%)
Query: 142 DNFNSENLIGKGGHAEVYKG-CLPDGEXXXXXXXXXXXXEDEERISDFLSELGIVAHINH 200
           D++  + +IG G  A V    C P  E            +    + + L E+  ++  +H
Sbjct: 10  DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTS--MDELLKEIQAMSQCHH 67
Query: 201 PN-AAKLIGFSTENGFHLVLQFLPHGSLSSLLFG-------STECLEWTIRYKIALGIAE 252
           PN  +    F  ++   LV++ L  GS+  ++          +  L+ +    I   + E
Sbjct: 68  PNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLE 127
Query: 253 GLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLP---DNWSHHIVFPIEGT 309
           GL+YL             KA NILL ED   QI+DFG++ +L    D   + +     GT
Sbjct: 128 GLEYLHKNGQIHRDV---KAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGT 184
Query: 310 FGYLSPEYF--MHGIVDEKTDVFAFGVLLLELITG 342
             +++PE    + G  D K D+++FG+  +EL TG
Sbjct: 185 PCWMAPEVMEQVRG-YDFKADIWSFGITAIELATG 218

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 47/181 (25%), Positives = 85/181 (46%), Gaps = 27/181 (14%)
Query: 185 ISDFLSELGIVAHINHPNAAKLIGFSTENG-FHLVLQFLPHGSLSSLLFGSTEC------ 237
           + D LSE  ++  +NHP+  KL G  +++G   L++++  +GSL   L  S +       
Sbjct: 70  LRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLG 129
Query: 238 ---------LEWTIRYKIALG--------IAEGLQYLXXXXXXXXXXXXXKASNILLSED 280
                    L+      + +G        I++G+QYL              A NIL++E 
Sbjct: 130 SGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLA---ARNILVAEG 186
Query: 281 YEAQISDFGLAKWLPDNWSHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELI 340
            + +ISDFGL++ + +  S+           +++ E     I   ++DV++FGVLL E++
Sbjct: 187 RKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIV 246
Query: 341 T 341
           T
Sbjct: 247 T 247

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 49/188 (26%), Positives = 81/188 (43%), Gaps = 16/188 (8%)
Query: 191 ELGIVAHINHPNAAKLIG-FSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALG 249
           E+ I +H+ HPN  +L G F      +L+L++ P G++    +   + L      + A  
Sbjct: 84  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTV----YRELQKLSKFDEQRTATY 139
Query: 250 IAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEGT 309
           I E    L             K  N+LL    E +I+DFG +   P +    +     GT
Sbjct: 140 ITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRDDLC----GT 195
Query: 310 FGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDS-------RRQSLVIWAKPLLQ 362
             YL PE     + DEK D+++ GVL  E + G+   ++       +R S V +  P   
Sbjct: 196 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFV 255
Query: 363 TSNFKELV 370
           T   ++L+
Sbjct: 256 TEGARDLI 263

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 43/160 (26%), Positives = 68/160 (42%), Gaps = 4/160 (2%)
Query: 183 ERISDFLSELGIVAHINHPNAAKLIGFSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTI 242
           E + DF+ E+  +  ++H N  +L G        +V +  P GSL   L           
Sbjct: 63  EAMDDFIREVNAMHSLDHRNLIRLYGVVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGT 122
Query: 243 RYKIALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSHHI 302
             + A+ +AEG+ YL              A N+LL+     +I DFGL + LP N  H++
Sbjct: 123 LSRYAVQVAEGMGYLESKRFIHRDLA---ARNLLLATRDLVKIGDFGLMRALPQNDDHYV 179
Query: 303 VFPIEGT-FGYLSPEYFMHGIVDEKTDVFAFGVLLLELIT 341
           +       F + +PE          +D + FGV L E+ T
Sbjct: 180 MQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFT 219

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 55/224 (24%), Positives = 100/224 (44%), Gaps = 36/224 (16%)
Query: 142 DNFNSENLIGKGGHAEVYKGCLP-DGEXXXXXXXXXXXXEDEERISDFLSELGIVAHI-N 199
           ++   +++IG+G   +V K  +  DG               ++   DF  EL ++  + +
Sbjct: 15  NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 74
Query: 200 HPNAAKLIGFSTENGF-HLVLQFLPHGSLSSLLFGSTECLEWTIRYKIA----------- 247
           HPN   L+G     G+ +L +++ PHG+L   L  S   LE    + IA           
Sbjct: 75  HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKS-RVLETDPAFAIANSTASTLSSQQ 133
Query: 248 -----LGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSHHI 302
                  +A G+ YL              A NIL+ E+Y A+I+DFGL++          
Sbjct: 134 LLHFAADVARGMDYLSQKQFIHRDLA---ARNILVGENYVAKIADFGLSR-------GQE 183
Query: 303 VFPIEGTFG-----YLSPEYFMHGIVDEKTDVFAFGVLLLELIT 341
           V+ ++ T G     +++ E   + +    +DV+++GVLL E+++
Sbjct: 184 VY-VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 226

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 58.5 bits (140), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 43/160 (26%), Positives = 68/160 (42%), Gaps = 4/160 (2%)
Query: 183 ERISDFLSELGIVAHINHPNAAKLIGFSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTI 242
           E + DF+ E+  +  ++H N  +L G        +V +  P GSL   L           
Sbjct: 53  EAMDDFIREVNAMHSLDHRNLIRLYGVVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGT 112
Query: 243 RYKIALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSHHI 302
             + A+ +AEG+ YL              A N+LL+     +I DFGL + LP N  H++
Sbjct: 113 LSRYAVQVAEGMGYLESKRFIHRDLA---ARNLLLATRDLVKIGDFGLMRALPQNDDHYV 169
Query: 303 VFPIEGT-FGYLSPEYFMHGIVDEKTDVFAFGVLLLELIT 341
           +       F + +PE          +D + FGV L E+ T
Sbjct: 170 MQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFT 209

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 58.5 bits (140), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 53/206 (25%), Positives = 86/206 (41%), Gaps = 16/206 (7%)
Query: 191 ELGIVAHINHPNAAKLIG-FSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALG 249
           E+ I +H+ HPN  +L G F      +L+L++ P G++    +   + L      + A  
Sbjct: 84  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTV----YRELQKLSKFDEQRTATY 139
Query: 250 IAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEGT 309
           I E    L             K  N+LL    E +I+DFG +   P +    +     GT
Sbjct: 140 ITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLC----GT 195
Query: 310 FGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDS-------RRQSLVIWAKPLLQ 362
             YL PE     + DEK D+++ GVL  E + G+   ++       +R S V +  P   
Sbjct: 196 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFV 255
Query: 363 TSNFKELVDPRLADAYDLAEMKRAML 388
           T   ++L+   L        M R +L
Sbjct: 256 TEGARDLISRLLKHNPSQRPMLREVL 281

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 58.5 bits (140), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 43/160 (26%), Positives = 68/160 (42%), Gaps = 4/160 (2%)
Query: 183 ERISDFLSELGIVAHINHPNAAKLIGFSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTI 242
           E + DF+ E+  +  ++H N  +L G        +V +  P GSL   L           
Sbjct: 53  EAMDDFIREVNAMHSLDHRNLIRLYGVVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGT 112
Query: 243 RYKIALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSHHI 302
             + A+ +AEG+ YL              A N+LL+     +I DFGL + LP N  H++
Sbjct: 113 LSRYAVQVAEGMGYLESKRFIHRDLA---ARNLLLATRDLVKIGDFGLMRALPQNDDHYV 169
Query: 303 VFPIEGT-FGYLSPEYFMHGIVDEKTDVFAFGVLLLELIT 341
           +       F + +PE          +D + FGV L E+ T
Sbjct: 170 MQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFT 209

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 58.5 bits (140), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 43/160 (26%), Positives = 68/160 (42%), Gaps = 4/160 (2%)
Query: 183 ERISDFLSELGIVAHINHPNAAKLIGFSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTI 242
           E + DF+ E+  +  ++H N  +L G        +V +  P GSL   L           
Sbjct: 57  EAMDDFIREVNAMHSLDHRNLIRLYGVVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGT 116
Query: 243 RYKIALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSHHI 302
             + A+ +AEG+ YL              A N+LL+     +I DFGL + LP N  H++
Sbjct: 117 LSRYAVQVAEGMGYLESKRFIHRDLA---ARNLLLATRDLVKIGDFGLMRALPQNDDHYV 173
Query: 303 VFPIEGT-FGYLSPEYFMHGIVDEKTDVFAFGVLLLELIT 341
           +       F + +PE          +D + FGV L E+ T
Sbjct: 174 MQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFT 213

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 58.5 bits (140), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 50/188 (26%), Positives = 81/188 (43%), Gaps = 16/188 (8%)
Query: 191 ELGIVAHINHPNAAKLIG-FSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALG 249
           E+ I +H+ HPN  +L G F      +L+L++ P G++    +   + L      + A  
Sbjct: 62  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTV----YRELQKLSRFDEQRTATY 117
Query: 250 IAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEGT 309
           I E    L             K  N+LL  + E +I+DFG +   P +    +     GT
Sbjct: 118 ITELANALSYCHSKRVIHRDIKPENLLLGSNGELKIADFGWSVHAPSSRRDTLC----GT 173
Query: 310 FGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDS-------RRQSLVIWAKPLLQ 362
             YL PE     + DEK D+++ GVL  E + G    ++       RR S V +  P   
Sbjct: 174 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGMPPFEAHTYQETYRRISRVEFTFPDFV 233
Query: 363 TSNFKELV 370
           T   ++L+
Sbjct: 234 TEGARDLI 241

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 58.5 bits (140), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 47/201 (23%), Positives = 88/201 (43%), Gaps = 11/201 (5%)
Query: 147 ENLIGKGGHAEVYKGCL--PDGEXXXXXXXXXXXXEDEERISDFLSELGIVAHINHPNAA 204
           E +IG G   EV  G L  P                 +++  DFLSE  I+   +HPN  
Sbjct: 34  EKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNII 93
Query: 205 KLIGFSTE-NGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLXXXXXX 263
            L G  T+     ++ +++ +GSL + L  +           +  GI  G++YL      
Sbjct: 94  HLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQLVGMLRGIGSGMKYLSDMSAV 153
Query: 264 XXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEG---TFGYLSPEYFMH 320
                   A NIL++ +   ++SDFG+++ L D+      +   G      + +PE   +
Sbjct: 154 HRDLA---ARNILVNSNLVCKVSDFGMSRVLEDD--PEAAYTTRGGKIPIRWTAPEAIAY 208
Query: 321 GIVDEKTDVFAFGVLLLELIT 341
                 +DV+++G+++ E+++
Sbjct: 209 RKFTSASDVWSYGIVMWEVMS 229

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 43/154 (27%), Positives = 67/154 (43%), Gaps = 9/154 (5%)
Query: 191 ELGIVAHINHPNAAKLIG-FSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALG 249
           E+ I +H+ HPN  +L G F      +L+L++ P G +    +   + L      + A  
Sbjct: 63  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPRGEV----YKELQKLSKFDEQRTATY 118
Query: 250 IAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEGT 309
           I E    L             K  N+LL    E +I+DFG +   P +    +     GT
Sbjct: 119 ITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRXXLX----GT 174
Query: 310 FGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGR 343
             YL PE     + DEK D+++ GVL  E + G+
Sbjct: 175 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 208

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 51/203 (25%), Positives = 88/203 (43%), Gaps = 15/203 (7%)
Query: 147 ENLIGKGGHAEVYKG--CLPDGEXXXXXXXXXXXXEDEERISDFLSELGIVAHINHPNAA 204
           E +IG G   EV  G   LP                 E++  DFL E  I+   +HPN  
Sbjct: 27  ERVIGAGEFGEVCSGRLKLPGKRELPVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 86
Query: 205 KLIGFSTENG-FHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLXXXXXX 263
            L G  T++    +V +++ +GSL + L  +           +  GI+ G++YL      
Sbjct: 87  HLEGVVTKSKPVMIVTEYMENGSLDTFLKKNDGQFTVIQLVGMLRGISAGMKYLSDMGYV 146
Query: 264 XXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSHHIV-----FPIEGTFGYLSPEYF 318
                   A NIL++ +   ++SDFGL++ L D+            PI  T    +PE  
Sbjct: 147 HRDLA---ARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWT----APEAI 199
Query: 319 MHGIVDEKTDVFAFGVLLLELIT 341
                   +DV+++G+++ E+++
Sbjct: 200 AFRKFTSASDVWSYGIVMWEVVS 222

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 43/154 (27%), Positives = 67/154 (43%), Gaps = 9/154 (5%)
Query: 191 ELGIVAHINHPNAAKLIG-FSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALG 249
           E+ I +H+ HPN  +L G F      +L+L++ P G +    +   + L      + A  
Sbjct: 63  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPRGEV----YKELQKLSKFDEQRTATY 118
Query: 250 IAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEGT 309
           I E    L             K  N+LL    E +I+DFG +   P +    +     GT
Sbjct: 119 ITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLC----GT 174
Query: 310 FGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGR 343
             YL PE     + DEK D+++ GVL  E + G+
Sbjct: 175 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 208

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 47/201 (23%), Positives = 88/201 (43%), Gaps = 11/201 (5%)
Query: 147 ENLIGKGGHAEVYKGCL--PDGEXXXXXXXXXXXXEDEERISDFLSELGIVAHINHPNAA 204
           E +IG G   EV  G L  P                 +++  DFLSE  I+   +HPN  
Sbjct: 19  EKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNII 78
Query: 205 KLIGFSTE-NGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLXXXXXX 263
            L G  T+     ++ +++ +GSL + L  +           +  GI  G++YL      
Sbjct: 79  HLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQLVGMLRGIGSGMKYLSDMSYV 138
Query: 264 XXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEG---TFGYLSPEYFMH 320
                   A NIL++ +   ++SDFG+++ L D+      +   G      + +PE   +
Sbjct: 139 HRDLA---ARNILVNSNLVCKVSDFGMSRVLEDD--PEAAYTTRGGKIPIRWTAPEAIAY 193
Query: 321 GIVDEKTDVFAFGVLLLELIT 341
                 +DV+++G+++ E+++
Sbjct: 194 RKFTSASDVWSYGIVMWEVMS 214

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 43/154 (27%), Positives = 68/154 (44%), Gaps = 9/154 (5%)
Query: 191 ELGIVAHINHPNAAKLIG-FSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALG 249
           E+ I +H+ HPN  +L G F      +L+L++ P G++    +   + L      + A  
Sbjct: 60  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTV----YRELQKLSKFDEQRTATY 115
Query: 250 IAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEGT 309
           I E    L             K  N+LL    E +I+DFG +   P +    +     GT
Sbjct: 116 ITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRXXLC----GT 171
Query: 310 FGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGR 343
             YL PE     + DEK D+++ GVL  E + G+
Sbjct: 172 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 205

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 47/201 (23%), Positives = 88/201 (43%), Gaps = 11/201 (5%)
Query: 147 ENLIGKGGHAEVYKGCL--PDGEXXXXXXXXXXXXEDEERISDFLSELGIVAHINHPNAA 204
           E +IG G   EV  G L  P                 +++  DFLSE  I+   +HPN  
Sbjct: 13  EKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNII 72
Query: 205 KLIGFSTE-NGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLXXXXXX 263
            L G  T+     ++ +++ +GSL + L  +           +  GI  G++YL      
Sbjct: 73  HLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQLVGMLRGIGSGMKYLSDMSYV 132
Query: 264 XXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEG---TFGYLSPEYFMH 320
                   A NIL++ +   ++SDFG+++ L D+      +   G      + +PE   +
Sbjct: 133 HRDLA---ARNILVNSNLVCKVSDFGMSRVLEDD--PEAAYTTRGGKIPIRWTAPEAIAY 187
Query: 321 GIVDEKTDVFAFGVLLLELIT 341
                 +DV+++G+++ E+++
Sbjct: 188 RKFTSASDVWSYGIVMWEVMS 208

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/206 (25%), Positives = 86/206 (41%), Gaps = 16/206 (7%)
Query: 191 ELGIVAHINHPNAAKLIG-FSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALG 249
           E+ I +H+ HPN  +L G F      +L+L++ P G++    +   + L      + A  
Sbjct: 58  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTV----YRELQKLSKFDEQRTATY 113
Query: 250 IAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEGT 309
           I E    L             K  N+LL    E +I+DFG +   P +    +     GT
Sbjct: 114 ITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTELC----GT 169
Query: 310 FGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDS-------RRQSLVIWAKPLLQ 362
             YL PE     + DEK D+++ GVL  E + G+   ++       +R S V +  P   
Sbjct: 170 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFV 229
Query: 363 TSNFKELVDPRLADAYDLAEMKRAML 388
           T   ++L+   L        M R +L
Sbjct: 230 TEGARDLISRLLKHNPSQRPMLREVL 255

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 44/172 (25%), Positives = 82/172 (47%), Gaps = 8/172 (4%)
Query: 186 SDFLSELGIVAHINHPNAAKLIG-FSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRY 244
           +  + EL ++   N P      G F ++    + ++ +  GSL  +L  +    E  I  
Sbjct: 68  NQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPE-QILG 126
Query: 245 KIALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVF 304
           K+++ + +GL YL             K SNIL++   E ++ DFG++  L D+ ++  V 
Sbjct: 127 KVSIAVIKGLTYLREKHKIMHRDV--KPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV- 183
Query: 305 PIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIW 356
              GT  Y+SPE         ++D+++ G+ L+E+  GR  + S   S+ I+
Sbjct: 184 ---GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIGSGSGSMAIF 232

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 43/154 (27%), Positives = 68/154 (44%), Gaps = 9/154 (5%)
Query: 191 ELGIVAHINHPNAAKLIG-FSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALG 249
           E+ I +H+ HPN  +L G F      +L+L++ P G++    +   + L      + A  
Sbjct: 75  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTV----YRELQKLSKFDEQRTATY 130
Query: 250 IAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEGT 309
           I E    L             K  N+LL    E +I+DFG +   P +    +     GT
Sbjct: 131 ITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLC----GT 186
Query: 310 FGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGR 343
             YL PE     + DEK D+++ GVL  E + G+
Sbjct: 187 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 220

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 50/188 (26%), Positives = 81/188 (43%), Gaps = 16/188 (8%)
Query: 191 ELGIVAHINHPNAAKLIG-FSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALG 249
           E+ I +H+ HPN  +L G F      +L+L++ P G++    +   + L      + A  
Sbjct: 62  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTV----YRELQKLSRFDEQRTATY 117
Query: 250 IAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEGT 309
           I E    L             K  N+LL  + E +I+DFG +   P +    +     GT
Sbjct: 118 ITELANALSYCHSKRVIHRDIKPENLLLGSNGELKIADFGWSVHAPSSRRTTLC----GT 173
Query: 310 FGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDS-------RRQSLVIWAKPLLQ 362
             YL PE     + DEK D+++ GVL  E + G    ++       RR S V +  P   
Sbjct: 174 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGMPPFEAHTYQETYRRISRVEFTFPDFV 233
Query: 363 TSNFKELV 370
           T   ++L+
Sbjct: 234 TEGARDLI 241

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 43/154 (27%), Positives = 68/154 (44%), Gaps = 9/154 (5%)
Query: 191 ELGIVAHINHPNAAKLIG-FSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALG 249
           E+ I +H+ HPN  +L G F      +L+L++ P G++    +   + L      + A  
Sbjct: 59  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTV----YRELQKLSKFDEQRTATY 114
Query: 250 IAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEGT 309
           I E    L             K  N+LL    E +I+DFG +   P +    +     GT
Sbjct: 115 ITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRDTLC----GT 170
Query: 310 FGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGR 343
             YL PE     + DEK D+++ GVL  E + G+
Sbjct: 171 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 204

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 43/154 (27%), Positives = 68/154 (44%), Gaps = 9/154 (5%)
Query: 191 ELGIVAHINHPNAAKLIG-FSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALG 249
           E+ I +H+ HPN  +L G F      +L+L++ P G++    +   + L      + A  
Sbjct: 59  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTV----YRELQKLSKFDEQRTATY 114
Query: 250 IAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEGT 309
           I E    L             K  N+LL    E +I+DFG +   P +    +     GT
Sbjct: 115 ITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLC----GT 170
Query: 310 FGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGR 343
             YL PE     + DEK D+++ GVL  E + G+
Sbjct: 171 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 204

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 43/154 (27%), Positives = 68/154 (44%), Gaps = 9/154 (5%)
Query: 191 ELGIVAHINHPNAAKLIG-FSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALG 249
           E+ I +H+ HPN  +L G F      +L+L++ P G++    +   + L      + A  
Sbjct: 61  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTV----YRELQKLSKFDEQRTATY 116
Query: 250 IAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEGT 309
           I E    L             K  N+LL    E +I+DFG +   P +    +     GT
Sbjct: 117 ITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLC----GT 172
Query: 310 FGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGR 343
             YL PE     + DEK D+++ GVL  E + G+
Sbjct: 173 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 206

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 43/154 (27%), Positives = 68/154 (44%), Gaps = 9/154 (5%)
Query: 191 ELGIVAHINHPNAAKLIG-FSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALG 249
           E+ I +H+ HPN  +L G F      +L+L++ P G++    +   + L      + A  
Sbjct: 58  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTV----YRELQKLSKFDEQRTATY 113
Query: 250 IAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEGT 309
           I E    L             K  N+LL    E +I+DFG +   P +    +     GT
Sbjct: 114 ITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLC----GT 169
Query: 310 FGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGR 343
             YL PE     + DEK D+++ GVL  E + G+
Sbjct: 170 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 203

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 49/188 (26%), Positives = 81/188 (43%), Gaps = 16/188 (8%)
Query: 191 ELGIVAHINHPNAAKLIG-FSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALG 249
           E+ I +H+ HPN  +L G F      +L+L++ P G++    +   + L      + A  
Sbjct: 63  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTV----YRELQKLSKFDEQRTATY 118
Query: 250 IAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEGT 309
           I E    L             K  N+LL    E +I+DFG +   P +    +     GT
Sbjct: 119 ITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLC----GT 174
Query: 310 FGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDS-------RRQSLVIWAKPLLQ 362
             YL PE     + DEK D+++ GVL  E + G+   ++       +R S V +  P   
Sbjct: 175 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFV 234
Query: 363 TSNFKELV 370
           T   ++L+
Sbjct: 235 TEGARDLI 242

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 47/181 (25%), Positives = 84/181 (46%), Gaps = 27/181 (14%)
Query: 185 ISDFLSELGIVAHINHPNAAKLIGFSTENG-FHLVLQFLPHGSLSSLLFGSTEC------ 237
           + D LSE  ++  +NHP+  KL G  +++G   L++++  +GSL   L  S +       
Sbjct: 70  LRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLG 129
Query: 238 ---------LEWTIRYKIALG--------IAEGLQYLXXXXXXXXXXXXXKASNILLSED 280
                    L+      + +G        I++G+QYL              A NIL++E 
Sbjct: 130 SGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLA---ARNILVAEG 186
Query: 281 YEAQISDFGLAKWLPDNWSHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELI 340
            + +ISDFGL++ + +  S            +++ E     I   ++DV++FGVLL E++
Sbjct: 187 RKMKISDFGLSRDVYEEDSXVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIV 246
Query: 341 T 341
           T
Sbjct: 247 T 247

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 43/160 (26%), Positives = 67/160 (41%), Gaps = 4/160 (2%)
Query: 183 ERISDFLSELGIVAHINHPNAAKLIGFSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTI 242
           E + DF+ E+  +  ++H N  +L G        +V +  P GSL   L           
Sbjct: 63  EAMDDFIREVNAMHSLDHRNLIRLYGVVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGT 122
Query: 243 RYKIALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSHHI 302
             + A+ +AEG+ YL              A N+LL+     +I DFGL + LP N  H +
Sbjct: 123 LSRYAVQVAEGMGYLESKRFIHRDLA---ARNLLLATRDLVKIGDFGLMRALPQNDDHXV 179
Query: 303 VFPIEGT-FGYLSPEYFMHGIVDEKTDVFAFGVLLLELIT 341
           +       F + +PE          +D + FGV L E+ T
Sbjct: 180 MQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFT 219

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 43/154 (27%), Positives = 68/154 (44%), Gaps = 9/154 (5%)
Query: 191 ELGIVAHINHPNAAKLIG-FSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALG 249
           E+ I +H+ HPN  +L G F      +L+L++ P G++    +   + L      + A  
Sbjct: 63  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTV----YRELQKLSKFDEQRTATY 118
Query: 250 IAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEGT 309
           I E    L             K  N+LL    E +I+DFG +   P +    +     GT
Sbjct: 119 ITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLC----GT 174
Query: 310 FGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGR 343
             YL PE     + DEK D+++ GVL  E + G+
Sbjct: 175 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 208

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 47/181 (25%), Positives = 84/181 (46%), Gaps = 27/181 (14%)
Query: 185 ISDFLSELGIVAHINHPNAAKLIGFSTENG-FHLVLQFLPHGSLSSLLFGSTEC------ 237
           + D LSE  ++  +NHP+  KL G  +++G   L++++  +GSL   L  S +       
Sbjct: 70  LRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLG 129
Query: 238 ---------LEWTIRYKIALG--------IAEGLQYLXXXXXXXXXXXXXKASNILLSED 280
                    L+      + +G        I++G+QYL              A NIL++E 
Sbjct: 130 SGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMSLVHRDLA---ARNILVAEG 186
Query: 281 YEAQISDFGLAKWLPDNWSHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELI 340
            + +ISDFGL++ + +  S            +++ E     I   ++DV++FGVLL E++
Sbjct: 187 RKMKISDFGLSRDVYEEDSXVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIV 246
Query: 341 T 341
           T
Sbjct: 247 T 247

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 53/206 (25%), Positives = 86/206 (41%), Gaps = 16/206 (7%)
Query: 191 ELGIVAHINHPNAAKLIG-FSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALG 249
           E+ I +H+ HPN  +L G F      +L+L++ P G++    +   + L      + A  
Sbjct: 58  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTV----YRELQKLSKFDEQRTATY 113
Query: 250 IAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEGT 309
           I E    L             K  N+LL    E +I+DFG +   P +    +     GT
Sbjct: 114 ITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLC----GT 169
Query: 310 FGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDS-------RRQSLVIWAKPLLQ 362
             YL PE     + DEK D+++ GVL  E + G+   ++       +R S V +  P   
Sbjct: 170 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFV 229
Query: 363 TSNFKELVDPRLADAYDLAEMKRAML 388
           T   ++L+   L        M R +L
Sbjct: 230 TEGARDLISRLLKHNPSQRPMLREVL 255

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 49/188 (26%), Positives = 81/188 (43%), Gaps = 16/188 (8%)
Query: 191 ELGIVAHINHPNAAKLIG-FSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALG 249
           E+ I +H+ HPN  +L G F      +L+L++ P G++    +   + L      + A  
Sbjct: 58  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTV----YRELQKLSKFDEQRTATY 113
Query: 250 IAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEGT 309
           I E    L             K  N+LL    E +I+DFG +   P +    +     GT
Sbjct: 114 ITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLC----GT 169
Query: 310 FGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDS-------RRQSLVIWAKPLLQ 362
             YL PE     + DEK D+++ GVL  E + G+   ++       +R S V +  P   
Sbjct: 170 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFV 229
Query: 363 TSNFKELV 370
           T   ++L+
Sbjct: 230 TEGARDLI 237

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 43/160 (26%), Positives = 67/160 (41%), Gaps = 4/160 (2%)
Query: 183 ERISDFLSELGIVAHINHPNAAKLIGFSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTI 242
           E + DF+ E+  +  ++H N  +L G        +V +  P GSL   L           
Sbjct: 53  EAMDDFIREVNAMHSLDHRNLIRLYGVVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGT 112
Query: 243 RYKIALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSHHI 302
             + A+ +AEG+ YL              A N+LL+     +I DFGL + LP N  H +
Sbjct: 113 LSRYAVQVAEGMGYLESKRFIHRDLA---ARNLLLATRDLVKIGDFGLMRALPQNDDHXV 169
Query: 303 VFPIEGT-FGYLSPEYFMHGIVDEKTDVFAFGVLLLELIT 341
           +       F + +PE          +D + FGV L E+ T
Sbjct: 170 MQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFT 209

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 49/188 (26%), Positives = 81/188 (43%), Gaps = 16/188 (8%)
Query: 191 ELGIVAHINHPNAAKLIG-FSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALG 249
           E+ I +H+ HPN  +L G F      +L+L++ P G++    +   + L      + A  
Sbjct: 61  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTV----YRELQKLSKFDEQRTATY 116
Query: 250 IAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEGT 309
           I E    L             K  N+LL    E +I+DFG +   P +    +     GT
Sbjct: 117 ITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRDDLC----GT 172
Query: 310 FGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDS-------RRQSLVIWAKPLLQ 362
             YL PE     + DEK D+++ GVL  E + G+   ++       +R S V +  P   
Sbjct: 173 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFV 232
Query: 363 TSNFKELV 370
           T   ++L+
Sbjct: 233 TEGARDLI 240

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 43/154 (27%), Positives = 68/154 (44%), Gaps = 9/154 (5%)
Query: 191 ELGIVAHINHPNAAKLIG-FSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALG 249
           E+ I +H+ HPN  +L G F      +L+L++ P G++    +   + L      + A  
Sbjct: 61  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTV----YRELQKLSKFDEQRTATY 116
Query: 250 IAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEGT 309
           I E    L             K  N+LL    E +I+DFG +   P +    +     GT
Sbjct: 117 ITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRXXLC----GT 172
Query: 310 FGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGR 343
             YL PE     + DEK D+++ GVL  E + G+
Sbjct: 173 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 206

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 49/188 (26%), Positives = 81/188 (43%), Gaps = 16/188 (8%)
Query: 191 ELGIVAHINHPNAAKLIG-FSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALG 249
           E+ I +H+ HPN  +L G F      +L+L++ P G++    +   + L      + A  
Sbjct: 58  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTV----YRELQKLSKFDEQRTATY 113
Query: 250 IAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEGT 309
           I E    L             K  N+LL    E +I+DFG +   P +    +     GT
Sbjct: 114 ITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRXXLC----GT 169
Query: 310 FGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDS-------RRQSLVIWAKPLLQ 362
             YL PE     + DEK D+++ GVL  E + G+   ++       +R S V +  P   
Sbjct: 170 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFV 229
Query: 363 TSNFKELV 370
           T   ++L+
Sbjct: 230 TEGARDLI 237

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 45/158 (28%), Positives = 68/158 (43%), Gaps = 17/158 (10%)
Query: 191 ELGIVAHINHPNAAKLIG-FSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALG 249
           E+ I +H+ HPN  +L G F      +L+L++ P G++    +   + L      + A  
Sbjct: 59  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTV----YRELQKLSKFDEQRTATY 114
Query: 250 IAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSHHI----VFP 305
           I E    L             K  N+LL    E +I+DFG        WS H        
Sbjct: 115 ITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFG--------WSCHAPSSRRTT 166
Query: 306 IEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGR 343
           + GT  YL PE     + DEK D+++ GVL  E + G+
Sbjct: 167 LSGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 204

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 43/154 (27%), Positives = 68/154 (44%), Gaps = 9/154 (5%)
Query: 191 ELGIVAHINHPNAAKLIG-FSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALG 249
           E+ I +H+ HPN  +L G F      +L+L++ P G++    +   + L      + A  
Sbjct: 61  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTV----YRELQKLSKFDEQRTATY 116
Query: 250 IAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEGT 309
           I E    L             K  N+LL    E +I+DFG +   P +    +     GT
Sbjct: 117 ITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRAALC----GT 172
Query: 310 FGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGR 343
             YL PE     + DEK D+++ GVL  E + G+
Sbjct: 173 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 206

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 49/188 (26%), Positives = 81/188 (43%), Gaps = 16/188 (8%)
Query: 191 ELGIVAHINHPNAAKLIG-FSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALG 249
           E+ I +H+ HPN  +L G F      +L+L++ P G++    +   + L      + A  
Sbjct: 58  EVEIQSHLRHPNILRLYGYFHDSTRVYLILEYAPLGTV----YRELQKLSKFDEQRTATY 113
Query: 250 IAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEGT 309
           I E    L             K  N+LL    E +I+DFG +   P +    +     GT
Sbjct: 114 ITELANALSYCHSKKVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRAALC----GT 169
Query: 310 FGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDS-------RRQSLVIWAKPLLQ 362
             YL PE     + DEK D+++ GVL  E + G+   ++       +R S V +  P   
Sbjct: 170 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQDTYKRISRVEFTFPDFV 229
Query: 363 TSNFKELV 370
           T   ++L+
Sbjct: 230 TEGARDLI 237

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 49/188 (26%), Positives = 81/188 (43%), Gaps = 16/188 (8%)
Query: 191 ELGIVAHINHPNAAKLIG-FSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALG 249
           E+ I +H+ HPN  +L G F      +L+L++ P G++    +   + L      + A  
Sbjct: 58  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTV----YRELQKLSKFDEQRTATY 113
Query: 250 IAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEGT 309
           I E    L             K  N+LL    E +I+DFG +   P +    +     GT
Sbjct: 114 ITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTXLC----GT 169
Query: 310 FGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDS-------RRQSLVIWAKPLLQ 362
             YL PE     + DEK D+++ GVL  E + G+   ++       +R S V +  P   
Sbjct: 170 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFV 229
Query: 363 TSNFKELV 370
           T   ++L+
Sbjct: 230 TEGARDLI 237

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 45/208 (21%), Positives = 88/208 (42%), Gaps = 6/208 (2%)
Query: 136 ELAAATDNFNSENLIGKGGHAEVYKGCLPD--GEXXXXXXXXXXXXEDEERISDFLSELG 193
           +   A ++     ++G+G   EVY+G   +  GE               +    F+SE  
Sbjct: 18  QYGIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAV 77
Query: 194 IVAHINHPNAAKLIGFSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEG 253
           I+ +++HP+  KLIG   E    ++++  P+G L   L  +   L+       +L I + 
Sbjct: 78  IMKNLDHPHIVKLIGIIEEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKA 137
Query: 254 LQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEGTFGYL 313
           + YL                NIL++     ++ DFGL++++ D   ++          ++
Sbjct: 138 MAYLESINCVHRDIA---VRNILVASPECVKLGDFGLSRYIEDE-DYYKASVTRLPIKWM 193
Query: 314 SPEYFMHGIVDEKTDVFAFGVLLLELIT 341
           SPE          +DV+ F V + E+++
Sbjct: 194 SPESINFRRFTTASDVWMFAVCMWEILS 221

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 44/195 (22%), Positives = 84/195 (43%), Gaps = 6/195 (3%)
Query: 149 LIGKGGHAEVYKGCLPD--GEXXXXXXXXXXXXEDEERISDFLSELGIVAHINHPNAAKL 206
           ++G+G   EVY+G   +  GE               +    F+SE  I+ +++HP+  KL
Sbjct: 15  ILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKL 74
Query: 207 IGFSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLXXXXXXXXX 266
           IG   E    ++++  P+G L   L  +   L+       +L I + + YL         
Sbjct: 75  IGIIEEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRD 134
Query: 267 XXXXKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEGTFGYLSPEYFMHGIVDEK 326
                  NIL++     ++ DFGL++++ D   ++          ++SPE          
Sbjct: 135 IA---VRNILVASPECVKLGDFGLSRYIEDE-DYYKASVTRLPIKWMSPESINFRRFTTA 190
Query: 327 TDVFAFGVLLLELIT 341
           +DV+ F V + E+++
Sbjct: 191 SDVWMFAVCMWEILS 205

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 44/195 (22%), Positives = 84/195 (43%), Gaps = 6/195 (3%)
Query: 149 LIGKGGHAEVYKGCLPD--GEXXXXXXXXXXXXEDEERISDFLSELGIVAHINHPNAAKL 206
           ++G+G   EVY+G   +  GE               +    F+SE  I+ +++HP+  KL
Sbjct: 19  ILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKL 78
Query: 207 IGFSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLXXXXXXXXX 266
           IG   E    ++++  P+G L   L  +   L+       +L I + + YL         
Sbjct: 79  IGIIEEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRD 138
Query: 267 XXXXKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEGTFGYLSPEYFMHGIVDEK 326
                  NIL++     ++ DFGL++++ D   ++          ++SPE          
Sbjct: 139 IA---VRNILVASPECVKLGDFGLSRYIEDE-DYYKASVTRLPIKWMSPESINFRRFTTA 194
Query: 327 TDVFAFGVLLLELIT 341
           +DV+ F V + E+++
Sbjct: 195 SDVWMFAVCMWEILS 209

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 49/188 (26%), Positives = 81/188 (43%), Gaps = 16/188 (8%)
Query: 191 ELGIVAHINHPNAAKLIG-FSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALG 249
           E+ I +H+ HPN  +L G F      +L+L++ P G++    +   + L      + A  
Sbjct: 62  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTV----YRELQKLSKFDEQRTATY 117
Query: 250 IAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEGT 309
           I E    L             K  N+LL    E +I+DFG +   P +    +     GT
Sbjct: 118 ITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLC----GT 173
Query: 310 FGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDS-------RRQSLVIWAKPLLQ 362
             YL PE     + DEK D+++ GVL  E + G+   ++       +R S V +  P   
Sbjct: 174 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFV 233
Query: 363 TSNFKELV 370
           T   ++L+
Sbjct: 234 TEGARDLI 241

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 43/154 (27%), Positives = 68/154 (44%), Gaps = 9/154 (5%)
Query: 191 ELGIVAHINHPNAAKLIG-FSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALG 249
           E+ I +H+ HPN  +L G F      +L+L++ P G++    +   + L      + A  
Sbjct: 61  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTV----YRELQKLSKFDEQRTATY 116
Query: 250 IAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEGT 309
           I E    L             K  N+LL    E +I+DFG +   P +    +     GT
Sbjct: 117 ITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLC----GT 172
Query: 310 FGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGR 343
             YL PE     + DEK D+++ GVL  E + G+
Sbjct: 173 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 206

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 49/188 (26%), Positives = 81/188 (43%), Gaps = 16/188 (8%)
Query: 191 ELGIVAHINHPNAAKLIG-FSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALG 249
           E+ I +H+ HPN  +L G F      +L+L++ P G++    +   + L      + A  
Sbjct: 57  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTV----YRELQKLSKFDEQRTATY 112
Query: 250 IAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEGT 309
           I E    L             K  N+LL    E +I+DFG +   P +    +     GT
Sbjct: 113 ITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLC----GT 168
Query: 310 FGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDS-------RRQSLVIWAKPLLQ 362
             YL PE     + DEK D+++ GVL  E + G+   ++       +R S V +  P   
Sbjct: 169 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFV 228
Query: 363 TSNFKELV 370
           T   ++L+
Sbjct: 229 TEGARDLI 236

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 43/154 (27%), Positives = 68/154 (44%), Gaps = 9/154 (5%)
Query: 191 ELGIVAHINHPNAAKLIG-FSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALG 249
           E+ I +H+ HPN  +L G F      +L+L++ P G++    +   + L      + A  
Sbjct: 58  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTV----YRELQKLSKFDEQRTATY 113
Query: 250 IAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEGT 309
           I E    L             K  N+LL    E +I+DFG +   P +    +     GT
Sbjct: 114 ITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRAALC----GT 169
Query: 310 FGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGR 343
             YL PE     + DEK D+++ GVL  E + G+
Sbjct: 170 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 203

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 43/154 (27%), Positives = 68/154 (44%), Gaps = 9/154 (5%)
Query: 191 ELGIVAHINHPNAAKLIG-FSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALG 249
           E+ I +H+ HPN  +L G F      +L+L++ P G++    +   + L      + A  
Sbjct: 55  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTV----YRELQKLSKFDEQRTATY 110
Query: 250 IAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEGT 309
           I E    L             K  N+LL    E +I+DFG +   P +    +     GT
Sbjct: 111 ITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLC----GT 166
Query: 310 FGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGR 343
             YL PE     + DEK D+++ GVL  E + G+
Sbjct: 167 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 200

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 43/154 (27%), Positives = 67/154 (43%), Gaps = 9/154 (5%)
Query: 191 ELGIVAHINHPNAAKLIG-FSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALG 249
           E+ I +H+ HPN  +L G F      +L+L++ P G++    +   + L      + A  
Sbjct: 63  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTV----YRELQKLSKFDEQRTATY 118
Query: 250 IAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEGT 309
           I E    L             K  N+LL    E +I+DFG +   P +    +     GT
Sbjct: 119 ITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLC----GT 174
Query: 310 FGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGR 343
             YL PE       DEK D+++ GVL  E + G+
Sbjct: 175 LDYLPPEXIEGRXHDEKVDLWSLGVLCYEFLVGK 208

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 88/210 (41%), Gaps = 25/210 (11%)
Query: 150 IGKGGHAEVYKGCLP----DGEXXXXXXXXXXXXEDEERISDFLSELGIVAHINHPNAAK 205
           +G G   EVY+G +     D                E+   DFL E  I++ +NH N  +
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKLNHQNIVR 98
Query: 206 LIGFSTEN-GFHLVLQFLPHGSLSSLLF------GSTECLEWTIRYKIALGIAEGLQYLX 258
            IG S ++    ++L+ +  G L S L            L       +A  IA G QYL 
Sbjct: 99  CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 158
Query: 259 XXXXXXXXXXXXKASNILLS---EDYEAQISDFGLAKWLPDNWSHH----IVFPIEGTFG 311
                        A N LL+       A+I DFG+A+ +     +      + P++    
Sbjct: 159 ENHFIHRDIA---ARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVK---- 211
Query: 312 YLSPEYFMHGIVDEKTDVFAFGVLLLELIT 341
           ++ PE FM GI   KTD ++FGVLL E+ +
Sbjct: 212 WMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 241

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 46/196 (23%), Positives = 82/196 (41%), Gaps = 12/196 (6%)
Query: 150 IGKGGHAEVYKGCL--PDGEXXXXXXXXXXXXEDEERISDFLSELGIVAHINHPNAAKLI 207
           IG+G   +V++G    P+                +     FL E   +   +HP+  KLI
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 208 GFSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLXXXXXXXXXX 267
           G  TEN   ++++    G L S L      L+       A  ++  L YL          
Sbjct: 78  GVITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDI 137
Query: 268 XXXKASNILLSEDYEAQISDFGLAKWLPDNWSHHIV---FPIEGTFGYLSPEYFMHGIVD 324
               A N+L+S +   ++ DFGL++++ D+  +       PI+    +++PE        
Sbjct: 138 A---ARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIK----WMAPESINFRRFT 190
Query: 325 EKTDVFAFGVLLLELI 340
             +DV+ FGV + E++
Sbjct: 191 SASDVWMFGVCMWEIL 206

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 51/196 (26%), Positives = 82/196 (41%), Gaps = 6/196 (3%)
Query: 182 EERISDFLSELGIVAHINHPNAAKL-IGFSTENGFHLVLQFLPHGSLSSLLFGSTECLEW 240
           E ++     E  +++ ++HP   KL   F  +   +  L +  +G L   +       E 
Sbjct: 73  ENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDET 132
Query: 241 TIRYKIALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSH 300
             R+  A  I   L+YL             K  NILL+ED   QI+DFG AK L      
Sbjct: 133 CTRFYTA-EIVSALEYLHGKGIIHRDL---KPENILLNEDMHIQITDFGTAKVLSPESKQ 188
Query: 301 HIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPL 360
                  GT  Y+SPE        + +D++A G ++ +L+ G     +  + L I+AK +
Sbjct: 189 ARANXFVGTAQYVSPELLTEKSAXKSSDLWALGCIIYQLVAGLPPFRAGNEGL-IFAKII 247
Query: 361 LQTSNFKELVDPRLAD 376
               +F E   P+  D
Sbjct: 248 KLEYDFPEKFFPKARD 263

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 66/261 (25%), Positives = 115/261 (44%), Gaps = 49/261 (18%)
Query: 188 FLSELGIVAHI-NHPNAAKLIGFSTENGFHLVL-QFLPHGSLSSLLFGSTECLEWTIRYK 245
            +SEL I++H+  H N   L+G  T  G  LV+ ++  +G L + L   +  LE    + 
Sbjct: 96  LMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFA 155
Query: 246 IALG-------------IAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAK 292
           IA               +A+G+ +L              A N+LL+  + A+I DFGLA+
Sbjct: 156 IANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVA---ARNVLLTNGHVAKIGDFGLAR 212
Query: 293 WLPDNWSHHIV-----FPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVD 347
            + ++ S++IV      P++    +++PE     +   ++DV+++G+LL E+        
Sbjct: 213 DIMND-SNYIVKGNARLPVK----WMAPESIFDCVYTVQSDVWSYGILLWEIF------- 260
Query: 348 SRRQSLVIWAKP-LLQTSNFKELVDPRLADAYDLAE----MKRAMLTASVCIHHLSTMRP 402
               SL +   P +L  S F +LV     D Y +A+     K        C     T RP
Sbjct: 261 ----SLGLNPYPGILVNSKFYKLVK----DGYQMAQPAFAPKNIYSIMQACWALEPTHRP 312
Query: 403 QMTRVLQLLRGEGGQTDLKPK 423
              ++   L+ E  Q D + +
Sbjct: 313 TFQQICSFLQ-EQAQEDRRER 332

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 46/196 (23%), Positives = 82/196 (41%), Gaps = 12/196 (6%)
Query: 150 IGKGGHAEVYKGCL--PDGEXXXXXXXXXXXXEDEERISDFLSELGIVAHINHPNAAKLI 207
           IG+G   +V++G    P+                +     FL E   +   +HP+  KLI
Sbjct: 18  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 208 GFSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLXXXXXXXXXX 267
           G  TEN   ++++    G L S L      L+       A  ++  L YL          
Sbjct: 78  GVITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDI 137
Query: 268 XXXKASNILLSEDYEAQISDFGLAKWLPDNWSHHIV---FPIEGTFGYLSPEYFMHGIVD 324
               A N+L+S +   ++ DFGL++++ D+  +       PI+    +++PE        
Sbjct: 138 A---ARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIK----WMAPESINFRRFT 190
Query: 325 EKTDVFAFGVLLLELI 340
             +DV+ FGV + E++
Sbjct: 191 SASDVWMFGVCMWEIL 206

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 66/261 (25%), Positives = 115/261 (44%), Gaps = 49/261 (18%)
Query: 188 FLSELGIVAHI-NHPNAAKLIGFSTENGFHLVL-QFLPHGSLSSLLFGSTECLEWTIRYK 245
            +SEL I++H+  H N   L+G  T  G  LV+ ++  +G L + L   +  LE    + 
Sbjct: 96  LMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFA 155
Query: 246 IALG-------------IAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAK 292
           IA               +A+G+ +L              A N+LL+  + A+I DFGLA+
Sbjct: 156 IANSTLSTRDLLHFSSQVAQGMAFLASKNCIHRDVA---ARNVLLTNGHVAKIGDFGLAR 212
Query: 293 WLPDNWSHHIV-----FPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVD 347
            + ++ S++IV      P++    +++PE     +   ++DV+++G+LL E+        
Sbjct: 213 DIMND-SNYIVKGNARLPVK----WMAPESIFDCVYTVQSDVWSYGILLWEIF------- 260
Query: 348 SRRQSLVIWAKP-LLQTSNFKELVDPRLADAYDLAE----MKRAMLTASVCIHHLSTMRP 402
               SL +   P +L  S F +LV     D Y +A+     K        C     T RP
Sbjct: 261 ----SLGLNPYPGILVNSKFYKLVK----DGYQMAQPAFAPKNIYSIMQACWALEPTHRP 312
Query: 403 QMTRVLQLLRGEGGQTDLKPK 423
              ++   L+ E  Q D + +
Sbjct: 313 TFQQICSFLQ-EQAQEDRRER 332

>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 87/210 (41%), Gaps = 25/210 (11%)
Query: 150 IGKGGHAEVYKGCLP----DGEXXXXXXXXXXXXEDEERISDFLSELGIVAHINHPNAAK 205
           +G G   EVY+G +     D                E+   DFL E  I++  NH N  +
Sbjct: 65  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 124
Query: 206 LIGFSTEN-GFHLVLQFLPHGSLSSLLF------GSTECLEWTIRYKIALGIAEGLQYLX 258
            IG S ++    ++L+ +  G L S L            L       +A  IA G QYL 
Sbjct: 125 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 184
Query: 259 XXXXXXXXXXXXKASNILLS---EDYEAQISDFGLAKWLPDNWSHH----IVFPIEGTFG 311
                        A N LL+       A+I DFG+A+ +     +      + P++    
Sbjct: 185 ENHFIHRDIA---ARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVK---- 237
Query: 312 YLSPEYFMHGIVDEKTDVFAFGVLLLELIT 341
           ++ PE FM GI   KTD ++FGVLL E+ +
Sbjct: 238 WMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 267

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 46/196 (23%), Positives = 82/196 (41%), Gaps = 12/196 (6%)
Query: 150 IGKGGHAEVYKGCL--PDGEXXXXXXXXXXXXEDEERISDFLSELGIVAHINHPNAAKLI 207
           IG+G   +V++G    P+                +     FL E   +   +HP+  KLI
Sbjct: 23  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 82
Query: 208 GFSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLXXXXXXXXXX 267
           G  TEN   ++++    G L S L      L+       A  ++  L YL          
Sbjct: 83  GVITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDI 142
Query: 268 XXXKASNILLSEDYEAQISDFGLAKWLPDNWSHHIV---FPIEGTFGYLSPEYFMHGIVD 324
               A N+L+S +   ++ DFGL++++ D+  +       PI+    +++PE        
Sbjct: 143 A---ARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIK----WMAPESINFRRFT 195
Query: 325 EKTDVFAFGVLLLELI 340
             +DV+ FGV + E++
Sbjct: 196 SASDVWMFGVCMWEIL 211

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 46/196 (23%), Positives = 82/196 (41%), Gaps = 12/196 (6%)
Query: 150 IGKGGHAEVYKGCL--PDGEXXXXXXXXXXXXEDEERISDFLSELGIVAHINHPNAAKLI 207
           IG+G   +V++G    P+                +     FL E   +   +HP+  KLI
Sbjct: 20  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 79
Query: 208 GFSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLXXXXXXXXXX 267
           G  TEN   ++++    G L S L      L+       A  ++  L YL          
Sbjct: 80  GVITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDI 139
Query: 268 XXXKASNILLSEDYEAQISDFGLAKWLPDNWSHHIV---FPIEGTFGYLSPEYFMHGIVD 324
               A N+L+S +   ++ DFGL++++ D+  +       PI+    +++PE        
Sbjct: 140 A---ARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIK----WMAPESINFRRFT 192
Query: 325 EKTDVFAFGVLLLELI 340
             +DV+ FGV + E++
Sbjct: 193 SASDVWMFGVCMWEIL 208

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 46/196 (23%), Positives = 82/196 (41%), Gaps = 12/196 (6%)
Query: 150 IGKGGHAEVYKGCL--PDGEXXXXXXXXXXXXEDEERISDFLSELGIVAHINHPNAAKLI 207
           IG+G   +V++G    P+                +     FL E   +   +HP+  KLI
Sbjct: 46  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 105
Query: 208 GFSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLXXXXXXXXXX 267
           G  TEN   ++++    G L S L      L+       A  ++  L YL          
Sbjct: 106 GVITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDI 165
Query: 268 XXXKASNILLSEDYEAQISDFGLAKWLPDNWSHHIV---FPIEGTFGYLSPEYFMHGIVD 324
               A N+L+S +   ++ DFGL++++ D+  +       PI+    +++PE        
Sbjct: 166 A---ARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIK----WMAPESINFRRFT 218
Query: 325 EKTDVFAFGVLLLELI 340
             +DV+ FGV + E++
Sbjct: 219 SASDVWMFGVCMWEIL 234

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 51/196 (26%), Positives = 82/196 (41%), Gaps = 6/196 (3%)
Query: 182 EERISDFLSELGIVAHINHPNAAKL-IGFSTENGFHLVLQFLPHGSLSSLLFGSTECLEW 240
           E ++     E  +++ ++HP   KL   F  +   +  L +  +G L   +       E 
Sbjct: 73  ENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDET 132
Query: 241 TIRYKIALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSH 300
             R+  A  I   L+YL             K  NILL+ED   QI+DFG AK L      
Sbjct: 133 CTRFYTA-EIVSALEYLHGKGIIHRDL---KPENILLNEDMHIQITDFGTAKVLSPESKQ 188
Query: 301 HIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPL 360
                  GT  Y+SPE        + +D++A G ++ +L+ G     +  + L I+AK +
Sbjct: 189 ARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGL-IFAKII 247
Query: 361 LQTSNFKELVDPRLAD 376
               +F E   P+  D
Sbjct: 248 KLEYDFPEKFFPKARD 263

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 46/196 (23%), Positives = 82/196 (41%), Gaps = 12/196 (6%)
Query: 150 IGKGGHAEVYKGCL--PDGEXXXXXXXXXXXXEDEERISDFLSELGIVAHINHPNAAKLI 207
           IG+G   +V++G    P+                +     FL E   +   +HP+  KLI
Sbjct: 21  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 80
Query: 208 GFSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLXXXXXXXXXX 267
           G  TEN   ++++    G L S L      L+       A  ++  L YL          
Sbjct: 81  GVITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDI 140
Query: 268 XXXKASNILLSEDYEAQISDFGLAKWLPDNWSHHIV---FPIEGTFGYLSPEYFMHGIVD 324
               A N+L+S +   ++ DFGL++++ D+  +       PI+    +++PE        
Sbjct: 141 A---ARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIK----WMAPESINFRRFT 193
Query: 325 EKTDVFAFGVLLLELI 340
             +DV+ FGV + E++
Sbjct: 194 SASDVWMFGVCMWEIL 209

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 61/266 (22%), Positives = 103/266 (38%), Gaps = 24/266 (9%)
Query: 150 IGKGGHAEVYKGCLPDGEXXXXXXXXXXXXEDEERISDFLSELGIVAHINHPNAAKLIGF 209
           IG G    VYKG                     E+   F +E+ ++    H N    +G+
Sbjct: 44  IGSGSFGTVYKG---KWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGY 100
Query: 210 STENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLXXXXXXXXXXXX 269
            T++   +V Q+    SL   L       +      IA   A+G+ YL            
Sbjct: 101 MTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDM-- 158
Query: 270 XKASNILLSEDYEAQISDFGLAKWLPDNWS-HHIVFPIEGTFGYLSPEYFM---HGIVDE 325
            K++NI L E    +I DFGLA  +   WS    V    G+  +++PE      +     
Sbjct: 159 -KSNNIFLHEGLTVKIGDFGLAT-VKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSF 216
Query: 326 KTDVFAFGVLLLELITGR---RAVDSRRQSLVIWAKPLLQTSNFKELVDPRLADAYDLAE 382
           ++DV+++G++L EL+TG      +++R Q + +  +             P L+  Y    
Sbjct: 217 QSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRG---------YASPDLSKLYKNCP 267
Query: 383 MKRAMLTASVCIHHLSTMRPQMTRVL 408
                L A  C+  +   RP   ++L
Sbjct: 268 KAMKRLVAD-CVKKVKEERPLFPQIL 292

>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 87/210 (41%), Gaps = 25/210 (11%)
Query: 150 IGKGGHAEVYKGCLP----DGEXXXXXXXXXXXXEDEERISDFLSELGIVAHINHPNAAK 205
           +G G   EVY+G +     D                E+   DFL E  I++  NH N  +
Sbjct: 45  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 104
Query: 206 LIGFSTEN-GFHLVLQFLPHGSLSSLLF------GSTECLEWTIRYKIALGIAEGLQYLX 258
            IG S ++    ++L+ +  G L S L            L       +A  IA G QYL 
Sbjct: 105 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 164
Query: 259 XXXXXXXXXXXXKASNILLS---EDYEAQISDFGLAKWLPDNWSHH----IVFPIEGTFG 311
                        A N LL+       A+I DFG+A+ +     +      + P++    
Sbjct: 165 ENHFIHRDIA---ARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVK---- 217
Query: 312 YLSPEYFMHGIVDEKTDVFAFGVLLLELIT 341
           ++ PE FM GI   KTD ++FGVLL E+ +
Sbjct: 218 WMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 247

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 46/196 (23%), Positives = 82/196 (41%), Gaps = 12/196 (6%)
Query: 150 IGKGGHAEVYKGCL--PDGEXXXXXXXXXXXXEDEERISDFLSELGIVAHINHPNAAKLI 207
           IG+G   +V++G    P+                +     FL E   +   +HP+  KLI
Sbjct: 15  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 74
Query: 208 GFSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLXXXXXXXXXX 267
           G  TEN   ++++    G L S L      L+       A  ++  L YL          
Sbjct: 75  GVITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDI 134
Query: 268 XXXKASNILLSEDYEAQISDFGLAKWLPDNWSHHIV---FPIEGTFGYLSPEYFMHGIVD 324
               A N+L+S +   ++ DFGL++++ D+  +       PI+    +++PE        
Sbjct: 135 A---ARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIK----WMAPESINFRRFT 187
Query: 325 EKTDVFAFGVLLLELI 340
             +DV+ FGV + E++
Sbjct: 188 SASDVWMFGVCMWEIL 203

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 42/154 (27%), Positives = 68/154 (44%), Gaps = 9/154 (5%)
Query: 191 ELGIVAHINHPNAAKLIG-FSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALG 249
           E+ I +H+ HPN  +L G F      +L+L++ P G++    +   + L      + A  
Sbjct: 60  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTV----YRELQKLSKFDEQRTATY 115
Query: 250 IAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEGT 309
           I E    L             K  N+LL    E +I++FG +   P +    +     GT
Sbjct: 116 ITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIANFGWSVHAPSSRRTTLC----GT 171
Query: 310 FGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGR 343
             YL PE     + DEK D+++ GVL  E + G+
Sbjct: 172 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 205

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 88/210 (41%), Gaps = 25/210 (11%)
Query: 150 IGKGGHAEVYKGCLP----DGEXXXXXXXXXXXXEDEERISDFLSELGIVAHINHPNAAK 205
           +G G   EVY+G +     D                E+   DFL E  I++ +NH N  +
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKLNHQNIVR 112
Query: 206 LIGFSTEN-GFHLVLQFLPHGSLSSLLF------GSTECLEWTIRYKIALGIAEGLQYLX 258
            IG S ++    ++L+ +  G L S L            L       +A  IA G QYL 
Sbjct: 113 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 172
Query: 259 XXXXXXXXXXXXKASNILLS---EDYEAQISDFGLAKWLPDNWSHH----IVFPIEGTFG 311
                        A N LL+       A+I DFG+A+ +     +      + P++    
Sbjct: 173 ENHFIHRDI---AARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVK---- 225
Query: 312 YLSPEYFMHGIVDEKTDVFAFGVLLLELIT 341
           ++ PE FM GI   KTD ++FGVLL E+ +
Sbjct: 226 WMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 255

>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 87/210 (41%), Gaps = 25/210 (11%)
Query: 150 IGKGGHAEVYKGCLP----DGEXXXXXXXXXXXXEDEERISDFLSELGIVAHINHPNAAK 205
           +G G   EVY+G +     D                E+   DFL E  I++  NH N  +
Sbjct: 56  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 115
Query: 206 LIGFSTEN-GFHLVLQFLPHGSLSSLLF------GSTECLEWTIRYKIALGIAEGLQYLX 258
            IG S ++    ++L+ +  G L S L            L       +A  IA G QYL 
Sbjct: 116 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 175
Query: 259 XXXXXXXXXXXXKASNILLS---EDYEAQISDFGLAKWLPDNWSHH----IVFPIEGTFG 311
                        A N LL+       A+I DFG+A+ +     +      + P++    
Sbjct: 176 ENHFIHRDIA---ARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVK---- 228
Query: 312 YLSPEYFMHGIVDEKTDVFAFGVLLLELIT 341
           ++ PE FM GI   KTD ++FGVLL E+ +
Sbjct: 229 WMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 258

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 51/209 (24%), Positives = 84/209 (40%), Gaps = 7/209 (3%)
Query: 142 DNFNSENLIGKGGHAEVYKG-CLPDGEXXXXXXXXXXXXEDEERISDFLSELGIVAHINH 200
           ++F   NL+GKG  A VY+   +  G                  +    +E+ I   + H
Sbjct: 11  EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKH 70
Query: 201 PNAAKLIG-FSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLXX 259
           P+  +L   F   N  +LVL+   +G ++  L    +             I  G+ YL  
Sbjct: 71  PSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHS 130
Query: 260 XXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEGTFGYLSPEYFM 319
                        SN+LL+ +   +I+DFGLA  L     H   + + GT  Y+SPE   
Sbjct: 131 HGILHRDLTL---SNLLLTRNMNIKIADFGLATQL--KMPHEKHYTLCGTPNYISPEIAT 185
Query: 320 HGIVDEKTDVFAFGVLLLELITGRRAVDS 348
                 ++DV++ G +   L+ GR   D+
Sbjct: 186 RSAHGLESDVWSLGCMFYTLLIGRPPFDT 214

>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 87/210 (41%), Gaps = 25/210 (11%)
Query: 150 IGKGGHAEVYKGCLP----DGEXXXXXXXXXXXXEDEERISDFLSELGIVAHINHPNAAK 205
           +G G   EVY+G +     D                E+   DFL E  I++  NH N  +
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 98
Query: 206 LIGFSTEN-GFHLVLQFLPHGSLSSLLF------GSTECLEWTIRYKIALGIAEGLQYLX 258
            IG S ++    ++L+ +  G L S L            L       +A  IA G QYL 
Sbjct: 99  CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 158
Query: 259 XXXXXXXXXXXXKASNILLS---EDYEAQISDFGLAKWLPDNWSHH----IVFPIEGTFG 311
                        A N LL+       A+I DFG+A+ +     +      + P++    
Sbjct: 159 ENHFIHRDIA---ARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVK---- 211
Query: 312 YLSPEYFMHGIVDEKTDVFAFGVLLLELIT 341
           ++ PE FM GI   KTD ++FGVLL E+ +
Sbjct: 212 WMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 241

>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 87/210 (41%), Gaps = 25/210 (11%)
Query: 150 IGKGGHAEVYKGCLP----DGEXXXXXXXXXXXXEDEERISDFLSELGIVAHINHPNAAK 205
           +G G   EVY+G +     D                E+   DFL E  I++  NH N  +
Sbjct: 79  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 138
Query: 206 LIGFSTEN-GFHLVLQFLPHGSLSSLLF------GSTECLEWTIRYKIALGIAEGLQYLX 258
            IG S ++    ++L+ +  G L S L            L       +A  IA G QYL 
Sbjct: 139 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 198
Query: 259 XXXXXXXXXXXXKASNILLS---EDYEAQISDFGLAKWLPDNWSHH----IVFPIEGTFG 311
                        A N LL+       A+I DFG+A+ +     +      + P++    
Sbjct: 199 ENHFIHRDIA---ARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVK---- 251
Query: 312 YLSPEYFMHGIVDEKTDVFAFGVLLLELIT 341
           ++ PE FM GI   KTD ++FGVLL E+ +
Sbjct: 252 WMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 281

>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 87/210 (41%), Gaps = 25/210 (11%)
Query: 150 IGKGGHAEVYKGCLP----DGEXXXXXXXXXXXXEDEERISDFLSELGIVAHINHPNAAK 205
           +G G   EVY+G +     D                E+   DFL E  I++  NH N  +
Sbjct: 55  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 114
Query: 206 LIGFSTEN-GFHLVLQFLPHGSLSSLLF------GSTECLEWTIRYKIALGIAEGLQYLX 258
            IG S ++    ++L+ +  G L S L            L       +A  IA G QYL 
Sbjct: 115 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 174
Query: 259 XXXXXXXXXXXXKASNILLS---EDYEAQISDFGLAKWLPDNWSHH----IVFPIEGTFG 311
                        A N LL+       A+I DFG+A+ +     +      + P++    
Sbjct: 175 ENHFIHRDIA---ARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVK---- 227
Query: 312 YLSPEYFMHGIVDEKTDVFAFGVLLLELIT 341
           ++ PE FM GI   KTD ++FGVLL E+ +
Sbjct: 228 WMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 257

>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 87/210 (41%), Gaps = 25/210 (11%)
Query: 150 IGKGGHAEVYKGCLP----DGEXXXXXXXXXXXXEDEERISDFLSELGIVAHINHPNAAK 205
           +G G   EVY+G +     D                E+   DFL E  I++  NH N  +
Sbjct: 38  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 97
Query: 206 LIGFSTEN-GFHLVLQFLPHGSLSSLLF------GSTECLEWTIRYKIALGIAEGLQYLX 258
            IG S ++    ++L+ +  G L S L            L       +A  IA G QYL 
Sbjct: 98  CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 157
Query: 259 XXXXXXXXXXXXKASNILLS---EDYEAQISDFGLAKWLPDNWSHH----IVFPIEGTFG 311
                        A N LL+       A+I DFG+A+ +     +      + P++    
Sbjct: 158 ENHFIHRDI---AARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVK---- 210
Query: 312 YLSPEYFMHGIVDEKTDVFAFGVLLLELIT 341
           ++ PE FM GI   KTD ++FGVLL E+ +
Sbjct: 211 WMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 240

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 55.5 bits (132), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 44/171 (25%), Positives = 77/171 (45%), Gaps = 19/171 (11%)
Query: 185 ISDFLSELGIVAHINHPNAAKLIGFSTENGFH-------LVLQFLPHGSLSSLLFGS--- 234
           I +FL E   +   +HP+ AKL+G S  +          ++L F+ HG L + L  S   
Sbjct: 69  IEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIG 128
Query: 235 ----TECLEWTIRYKIALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGL 290
                  L+  +R+ +   IA G++YL              A N +L+ED    ++DFGL
Sbjct: 129 ENPFNLPLQTLVRFMV--DIACGMEYLSSRNFIHRDLA---ARNCMLAEDMTVCVADFGL 183
Query: 291 AKWLPDNWSHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELIT 341
           ++ +     +      +    +L+ E     +    +DV+AFGV + E++T
Sbjct: 184 SRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMT 234

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 55.5 bits (132), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 60/219 (27%), Positives = 93/219 (42%), Gaps = 17/219 (7%)
Query: 133 DFAELAAATDNFNSENLIGKGGHAEVYKGCLPDGEXXXXXXXXXXXXEDEERISDFLSEL 192
           D  E     D      ++GKG +  VY G   D               D         E+
Sbjct: 13  DLLEYDYEYDENGDRVVLGKGTYGIVYAG--RDLSNQVRIAIKEIPERDSRYSQPLHEEI 70
Query: 193 GIVAHINHPNAAKLIGFSTENGF-HLVLQFLPHGSLSSLL---FGSTECLEWTIRYKIAL 248
            +  H+ H N  + +G  +ENGF  + ++ +P GSLS+LL   +G  +  E TI +    
Sbjct: 71  ALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQ 130
Query: 249 GIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEA--QISDFGLAKWLPDNWSHHIVFPI 306
            I EGL+YL             K  N+L++  Y    +ISDFG +K L         F  
Sbjct: 131 -ILEGLKYL---HDNQIVHRDIKGDNVLINT-YSGVLKISDFGTSKRLAGINPCTETF-- 183
Query: 307 EGTFGYLSPEYFMHGI--VDEKTDVFAFGVLLLELITGR 343
            GT  Y++PE    G     +  D+++ G  ++E+ TG+
Sbjct: 184 TGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGK 222

>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315

Iteration: 1
 Score = 55.5 bits (132), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 87/210 (41%), Gaps = 25/210 (11%)
Query: 150 IGKGGHAEVYKGCLP----DGEXXXXXXXXXXXXEDEERISDFLSELGIVAHINHPNAAK 205
           +G G   EVY+G +     D                E+   DFL E  I++  NH N  +
Sbjct: 30  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 89
Query: 206 LIGFSTEN-GFHLVLQFLPHGSLSSLLF------GSTECLEWTIRYKIALGIAEGLQYLX 258
            IG S ++    ++L+ +  G L S L            L       +A  IA G QYL 
Sbjct: 90  CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 149
Query: 259 XXXXXXXXXXXXKASNILLS---EDYEAQISDFGLAKWLPDNWSHH----IVFPIEGTFG 311
                        A N LL+       A+I DFG+A+ +     +      + P++    
Sbjct: 150 ENHFIHRDI---AARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVK---- 202
Query: 312 YLSPEYFMHGIVDEKTDVFAFGVLLLELIT 341
           ++ PE FM GI   KTD ++FGVLL E+ +
Sbjct: 203 WMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 232

>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 87/210 (41%), Gaps = 25/210 (11%)
Query: 150 IGKGGHAEVYKGCLP----DGEXXXXXXXXXXXXEDEERISDFLSELGIVAHINHPNAAK 205
           +G G   EVY+G +     D                E+   DFL E  I++  NH N  +
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 98
Query: 206 LIGFSTEN-GFHLVLQFLPHGSLSSLLF------GSTECLEWTIRYKIALGIAEGLQYLX 258
            IG S ++    ++L+ +  G L S L            L       +A  IA G QYL 
Sbjct: 99  CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 158
Query: 259 XXXXXXXXXXXXKASNILLS---EDYEAQISDFGLAKWLPDNWSHH----IVFPIEGTFG 311
                        A N LL+       A+I DFG+A+ +     +      + P++    
Sbjct: 159 ENHFIHRDIA---ARNCLLTCPGPGRVAKIGDFGMAQDIYRASYYRKGGCAMLPVK---- 211
Query: 312 YLSPEYFMHGIVDEKTDVFAFGVLLLELIT 341
           ++ PE FM GI   KTD ++FGVLL E+ +
Sbjct: 212 WMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 241

>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 87/210 (41%), Gaps = 25/210 (11%)
Query: 150 IGKGGHAEVYKGCLP----DGEXXXXXXXXXXXXEDEERISDFLSELGIVAHINHPNAAK 205
           +G G   EVY+G +     D                E+   DFL E  I++  NH N  +
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVYSEQDELDFLMEALIISKFNHQNIVR 112
Query: 206 LIGFSTEN-GFHLVLQFLPHGSLSSLLF------GSTECLEWTIRYKIALGIAEGLQYLX 258
            IG S ++    ++L+ +  G L S L            L       +A  IA G QYL 
Sbjct: 113 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 172
Query: 259 XXXXXXXXXXXXKASNILLS---EDYEAQISDFGLAKWLPDNWSHH----IVFPIEGTFG 311
                        A N LL+       A+I DFG+A+ +     +      + P++    
Sbjct: 173 ENHFIHRDI---AARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVK---- 225
Query: 312 YLSPEYFMHGIVDEKTDVFAFGVLLLELIT 341
           ++ PE FM GI   KTD ++FGVLL E+ +
Sbjct: 226 WMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 255

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 88/200 (44%), Gaps = 9/200 (4%)
Query: 144 FNSENLIGKGGHAEVYKGCLPDGEXXXXXXXXXXXXEDEERISDFLSELGIVAHINHPNA 203
           F   + IGKG   EVYKG + +              E E+ I D   E+ +++  + P  
Sbjct: 21  FTKLDRIGKGSFGEVYKG-IDNHTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYI 79
Query: 204 AKLIG-FSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLXXXXX 262
            +  G +       +++++L  GS   LL      LE T    I   I +GL YL     
Sbjct: 80  TRYFGSYLKSTKLWIIMEYLGGGSALDLL--KPGPLEETYIATILREILKGLDYLHSERK 137
Query: 263 XXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEGTFGYLSPEYFMHGI 322
                   KA+N+LLSE  + +++DFG+A  L D       F   GT  +++PE      
Sbjct: 138 IHRDI---KAANVLLSEQGDVKLADFGVAGQLTDTQIKRNXF--VGTPFWMAPEVIKQSA 192
Query: 323 VDEKTDVFAFGVLLLELITG 342
            D K D+++ G+  +EL  G
Sbjct: 193 YDFKADIWSLGITAIELAKG 212

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 46/196 (23%), Positives = 82/196 (41%), Gaps = 12/196 (6%)
Query: 150 IGKGGHAEVYKGCL--PDGEXXXXXXXXXXXXEDEERISDFLSELGIVAHINHPNAAKLI 207
           IG+G   +V++G    P+                +     FL E   +   +HP+  KLI
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 457
Query: 208 GFSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLXXXXXXXXXX 267
           G  TEN   ++++    G L S L      L+       A  ++  L YL          
Sbjct: 458 GVITENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDI 517
Query: 268 XXXKASNILLSEDYEAQISDFGLAKWLPDNWSHHIV---FPIEGTFGYLSPEYFMHGIVD 324
               A N+L+S +   ++ DFGL++++ D+  +       PI+    +++PE        
Sbjct: 518 A---ARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIK----WMAPESINFRRFT 570
Query: 325 EKTDVFAFGVLLLELI 340
             +DV+ FGV + E++
Sbjct: 571 SASDVWMFGVCMWEIL 586

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 42/154 (27%), Positives = 68/154 (44%), Gaps = 9/154 (5%)
Query: 191 ELGIVAHINHPNAAKLIG-FSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALG 249
           E+ I +H+ HPN  +L G F      +L+L++ P G++    +   + L      + A  
Sbjct: 61  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTV----YRELQKLSKFDEQRTATY 116
Query: 250 IAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEGT 309
           I E    L             K  N+LL    E +I++FG +   P +    +     GT
Sbjct: 117 ITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIANFGWSVHAPSSRRTTLC----GT 172
Query: 310 FGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGR 343
             YL PE     + DEK D+++ GVL  E + G+
Sbjct: 173 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 206

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 41/162 (25%), Positives = 77/162 (47%), Gaps = 8/162 (4%)
Query: 186 SDFLSELGIVAHINHPNAAKLIG-FSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRY 244
           +  + EL ++   N P      G F ++    + ++ +  GSL  +L  +    E  I  
Sbjct: 111 NQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPE-QILG 169
Query: 245 KIALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVF 304
           K+++ + +GL YL             K SNIL++   E ++ DFG++  L D+ ++  V 
Sbjct: 170 KVSIAVIKGLTYLREKHKIMHRDV--KPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV- 226
Query: 305 PIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAV 346
              GT  Y+SPE         ++D+++ G+ L+E+  GR  +
Sbjct: 227 ---GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPI 265

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 86/210 (40%), Gaps = 25/210 (11%)
Query: 150 IGKGGHAEVYKGCLP----DGEXXXXXXXXXXXXEDEERISDFLSELGIVAHINHPNAAK 205
           +G G   EVY+G +     D                E+   DFL E  I++  NH N  +
Sbjct: 38  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 97
Query: 206 LIGFSTENGFHLVL-QFLPHGSLSSLLF------GSTECLEWTIRYKIALGIAEGLQYLX 258
            IG S ++    +L + +  G L S L            L       +A  IA G QYL 
Sbjct: 98  CIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 157
Query: 259 XXXXXXXXXXXXKASNILLS---EDYEAQISDFGLAKWLPDNWSHH----IVFPIEGTFG 311
                        A N LL+       A+I DFG+A+ +     +      + P++    
Sbjct: 158 ENHFIHRDI---AARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVK---- 210
Query: 312 YLSPEYFMHGIVDEKTDVFAFGVLLLELIT 341
           ++ PE FM GI   KTD ++FGVLL E+ +
Sbjct: 211 WMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 240

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 90/226 (39%), Gaps = 25/226 (11%)
Query: 128 SWKNFDFAELAAATDNFNSENLIGKGGHAEVYKGCLPDGEXXXXXXXXXXXXEDEERISD 187
            WKN +   +    ++F+   +IG+GG  EVY GC                  D++RI  
Sbjct: 175 QWKNVEL-NIHLTMNDFSVHRIIGRGGFGEVY-GC----RKADTGKMYAMKCLDKKRIKM 228
Query: 188 FLSE---------LGIVAHINHPNAAKL-IGFSTENGFHLVLQFLPHGSLSSLLFGSTEC 237
              E         L +V+  + P    +   F T +    +L  +  G L   L      
Sbjct: 229 KQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVF 288
Query: 238 LEWTIRYKIALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDN 297
            E  +R+  A  I  GL+++             K +NILL E    +ISD GLA      
Sbjct: 289 SEADMRF-YAAEIILGLEHMHNRFVVYRDL---KPANILLDEHGHVRISDLGLACDFSKK 344
Query: 298 WSHHIVFPIEGTFGYLSPEYFMHGIV-DEKTDVFAFGVLLLELITG 342
             H  V    GT GY++PE    G+  D   D F+ G +L +L+ G
Sbjct: 345 KPHASV----GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRG 386

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 41/162 (25%), Positives = 77/162 (47%), Gaps = 8/162 (4%)
Query: 186 SDFLSELGIVAHINHPNAAKLIG-FSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRY 244
           +  + EL ++   N P      G F ++    + ++ +  GSL  +L  +    E  I  
Sbjct: 76  NQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPE-QILG 134
Query: 245 KIALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVF 304
           K+++ + +GL YL             K SNIL++   E ++ DFG++  L D+ ++  V 
Sbjct: 135 KVSIAVIKGLTYLREKHKIMHRDV--KPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV- 191
Query: 305 PIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAV 346
              GT  Y+SPE         ++D+++ G+ L+E+  GR  +
Sbjct: 192 ---GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPI 230

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 90/226 (39%), Gaps = 25/226 (11%)
Query: 128 SWKNFDFAELAAATDNFNSENLIGKGGHAEVYKGCLPDGEXXXXXXXXXXXXEDEERISD 187
            WKN +   +    ++F+   +IG+GG  EVY GC                  D++RI  
Sbjct: 176 QWKNVEL-NIHLTMNDFSVHRIIGRGGFGEVY-GC----RKADTGKMYAMKCLDKKRIKM 229
Query: 188 FLSE---------LGIVAHINHPNAAKL-IGFSTENGFHLVLQFLPHGSLSSLLFGSTEC 237
              E         L +V+  + P    +   F T +    +L  +  G L   L      
Sbjct: 230 KQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVF 289
Query: 238 LEWTIRYKIALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDN 297
            E  +R+  A  I  GL+++             K +NILL E    +ISD GLA      
Sbjct: 290 SEADMRF-YAAEIILGLEHMHNRFVVYRDL---KPANILLDEHGHVRISDLGLACDFSKK 345
Query: 298 WSHHIVFPIEGTFGYLSPEYFMHGIV-DEKTDVFAFGVLLLELITG 342
             H  V    GT GY++PE    G+  D   D F+ G +L +L+ G
Sbjct: 346 KPHASV----GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRG 387

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 90/226 (39%), Gaps = 25/226 (11%)
Query: 128 SWKNFDFAELAAATDNFNSENLIGKGGHAEVYKGCLPDGEXXXXXXXXXXXXEDEERISD 187
            WKN +   +    ++F+   +IG+GG  EVY GC                  D++RI  
Sbjct: 176 QWKNVEL-NIHLTMNDFSVHRIIGRGGFGEVY-GC----RKADTGKMYAMKCLDKKRIKM 229
Query: 188 FLSE---------LGIVAHINHPNAAKL-IGFSTENGFHLVLQFLPHGSLSSLLFGSTEC 237
              E         L +V+  + P    +   F T +    +L  +  G L   L      
Sbjct: 230 KQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVF 289
Query: 238 LEWTIRYKIALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDN 297
            E  +R+  A  I  GL+++             K +NILL E    +ISD GLA      
Sbjct: 290 SEADMRF-YAAEIILGLEHMHNRFVVYRDL---KPANILLDEHGHVRISDLGLACDFSKK 345
Query: 298 WSHHIVFPIEGTFGYLSPEYFMHGIV-DEKTDVFAFGVLLLELITG 342
             H  V    GT GY++PE    G+  D   D F+ G +L +L+ G
Sbjct: 346 KPHASV----GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRG 387

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 90/226 (39%), Gaps = 25/226 (11%)
Query: 128 SWKNFDFAELAAATDNFNSENLIGKGGHAEVYKGCLPDGEXXXXXXXXXXXXEDEERISD 187
            WKN +   +    ++F+   +IG+GG  EVY GC                  D++RI  
Sbjct: 176 QWKNVEL-NIHLTMNDFSVHRIIGRGGFGEVY-GC----RKADTGKMYAMKCLDKKRIKM 229
Query: 188 FLSE---------LGIVAHINHPNAAKL-IGFSTENGFHLVLQFLPHGSLSSLLFGSTEC 237
              E         L +V+  + P    +   F T +    +L  +  G L   L      
Sbjct: 230 KQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVF 289
Query: 238 LEWTIRYKIALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDN 297
            E  +R+  A  I  GL+++             K +NILL E    +ISD GLA      
Sbjct: 290 SEADMRF-YAAEIILGLEHMHNRFVVYRDL---KPANILLDEHGHVRISDLGLACDFSKK 345
Query: 298 WSHHIVFPIEGTFGYLSPEYFMHGIV-DEKTDVFAFGVLLLELITG 342
             H  V    GT GY++PE    G+  D   D F+ G +L +L+ G
Sbjct: 346 KPHASV----GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRG 387

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 55.1 bits (131), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 53/210 (25%), Positives = 88/210 (41%), Gaps = 22/210 (10%)
Query: 144 FNSENL-----IGKGGHAEVYKGCL-PDGEXXXXXXXXXXXXEDEERISDFLSELGIVAH 197
            N E+L     IG+G   EV+ G L  D               D +  + FL E  I+  
Sbjct: 111 LNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLK--AKFLQEARILKQ 168
Query: 198 INHPNAAKLIGFSTENG-FHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQY 256
            +HPN  +LIG  T+    ++V++ +  G   + L      L      ++    A G++Y
Sbjct: 169 YSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEY 228
Query: 257 LXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEGTF-----G 311
           L              A N L++E    +ISDFG+++   D      V+   G        
Sbjct: 229 LESKCCIHRDLA---ARNCLVTEKNVLKISDFGMSREEADG-----VYAASGGLRQVPVK 280
Query: 312 YLSPEYFMHGIVDEKTDVFAFGVLLLELIT 341
           + +PE   +G    ++DV++FG+LL E  +
Sbjct: 281 WTAPEALNYGRYSSESDVWSFGILLWETFS 310

>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 60/230 (26%), Positives = 94/230 (40%), Gaps = 44/230 (19%)
Query: 142 DNFNSENLIGKGGHAEVYKGCLPDGEXXXXXXXXXXXXEDEERISDFLSELGI--VAHIN 199
           DN     LIG+G +  VYKG L +                     +F++E  I  V  + 
Sbjct: 13  DNLKLLELIGRGRYGAVYKGSLDERPVAVKVFSFANR-------QNFINEKNIYRVPLME 65
Query: 200 HPNAAKLI---GFSTENG---FHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEG 253
           H N A+ I      T +G   + LV+++ P+GSL   L  S    +W    ++A  +  G
Sbjct: 66  HDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYL--SLHTSDWVSSCRLAHSVTRG 123
Query: 254 LQYLXXX------XXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIE 307
           L YL                    + N+L+  D    ISDFGL+  L  N    +V P E
Sbjct: 124 LAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGN---RLVRPGE 180
Query: 308 ---------GTFGYLSPEYFMHGIVD--------EKTDVFAFGVLLLELI 340
                    GT  Y++PE  + G V+        ++ D++A G++  E+ 
Sbjct: 181 EDNAAISEVGTIRYMAPE-VLEGAVNLRDXESALKQVDMYALGLIYWEIF 229

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 46/196 (23%), Positives = 81/196 (41%), Gaps = 12/196 (6%)
Query: 150 IGKGGHAEVYKGCL--PDGEXXXXXXXXXXXXEDEERISDFLSELGIVAHINHPNAAKLI 207
           IG+G   +V++G    P+                +     FL E   +   +HP+  KLI
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 208 GFSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLXXXXXXXXXX 267
           G  TEN   ++++    G L S L      L+       A  ++  L YL          
Sbjct: 78  GVITENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDI 137
Query: 268 XXXKASNILLSEDYEAQISDFGLAKWLPDNWSHHIV---FPIEGTFGYLSPEYFMHGIVD 324
               A N+L+S +   ++ DFGL++++ D+          PI+    +++PE        
Sbjct: 138 A---ARNVLVSSNDCVKLGDFGLSRYMEDSTXXKASKGKLPIK----WMAPESINFRRFT 190
Query: 325 EKTDVFAFGVLLLELI 340
             +DV+ FGV + E++
Sbjct: 191 SASDVWMFGVCMWEIL 206

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 88/200 (44%), Gaps = 9/200 (4%)
Query: 144 FNSENLIGKGGHAEVYKGCLPDGEXXXXXXXXXXXXEDEERISDFLSELGIVAHINHPNA 203
           F     IGKG   EV+KG + +              E E+ I D   E+ +++  + P  
Sbjct: 9   FTKLEKIGKGSFGEVFKG-IDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYV 67
Query: 204 AKLIG-FSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLXXXXX 262
            K  G +  +    +++++L  GS   LL      L+ T    I   I +GL YL     
Sbjct: 68  TKYYGSYLKDTKLWIIMEYLGGGSALDLL--EPGPLDETQIATILREILKGLDYLHSEKK 125
Query: 263 XXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEGTFGYLSPEYFMHGI 322
                   KA+N+LLSE  E +++DFG+A  L D       F   GT  +++PE      
Sbjct: 126 IHRDI---KAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTF--VGTPFWMAPEVIKQSA 180
Query: 323 VDEKTDVFAFGVLLLELITG 342
            D K D+++ G+  +EL  G
Sbjct: 181 YDSKADIWSLGITAIELARG 200

>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 86/210 (40%), Gaps = 25/210 (11%)
Query: 150 IGKGGHAEVYKGCLP----DGEXXXXXXXXXXXXEDEERISDFLSELGIVAHINHPNAAK 205
           +G G   EVY+G +     D                E+   DFL E  I++  NH N  +
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 112
Query: 206 LIGFSTENGFHLVL-QFLPHGSLSSLLF------GSTECLEWTIRYKIALGIAEGLQYLX 258
            IG S ++    +L + +  G L S L            L       +A  IA G QYL 
Sbjct: 113 CIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 172
Query: 259 XXXXXXXXXXXXKASNILLS---EDYEAQISDFGLAKWLPDNWSHH----IVFPIEGTFG 311
                        A N LL+       A+I DFG+A+ +     +      + P++    
Sbjct: 173 ENHFIHRDI---AARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVK---- 225
Query: 312 YLSPEYFMHGIVDEKTDVFAFGVLLLELIT 341
           ++ PE FM GI   KTD ++FGVLL E+ +
Sbjct: 226 WMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 255

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 50/196 (25%), Positives = 81/196 (41%), Gaps = 6/196 (3%)
Query: 182 EERISDFLSELGIVAHINHPNAAKL-IGFSTENGFHLVLQFLPHGSLSSLLFGSTECLEW 240
           E ++     E  +++ ++HP   KL   F  +   +  L +  +G L   +       E 
Sbjct: 73  ENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGCLLKYIRKIGSFDET 132
Query: 241 TIRYKIALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSH 300
             R+  A  I   L+YL             K  NILL+ED   QI+DFG AK L      
Sbjct: 133 CTRFYTA-EIVSALEYLHGKGIIHRDL---KPENILLNEDMHIQITDFGTAKVLSPESKQ 188
Query: 301 HIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPL 360
                  GT  Y+SPE        + +D++A G ++ +L+ G     +  + L I+ K +
Sbjct: 189 ARANSFVGTAQYVSPELLTEKSASKSSDLWALGCIIYQLVAGLPPFRAGNEYL-IFQKII 247
Query: 361 LQTSNFKELVDPRLAD 376
               +F E   P+  D
Sbjct: 248 KLEYDFPEKFFPKARD 263

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 88/200 (44%), Gaps = 9/200 (4%)
Query: 144 FNSENLIGKGGHAEVYKGCLPDGEXXXXXXXXXXXXEDEERISDFLSELGIVAHINHPNA 203
           F     IGKG   EV+KG + +              E E+ I D   E+ +++  + P  
Sbjct: 24  FTKLEKIGKGSFGEVFKG-IDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYV 82
Query: 204 AKLIG-FSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLXXXXX 262
            K  G +  +    +++++L  GS   LL      L+ T    I   I +GL YL     
Sbjct: 83  TKYYGSYLKDTKLWIIMEYLGGGSALDLL--EPGPLDETQIATILREILKGLDYLHSEKK 140
Query: 263 XXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEGTFGYLSPEYFMHGI 322
                   KA+N+LLSE  E +++DFG+A  L D       F   GT  +++PE      
Sbjct: 141 IHRDI---KAANVLLSEHGEVKLADFGVAGQLTDTQIKRNXF--VGTPFWMAPEVIKQSA 195
Query: 323 VDEKTDVFAFGVLLLELITG 342
            D K D+++ G+  +EL  G
Sbjct: 196 YDSKADIWSLGITAIELARG 215

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 93/211 (44%), Gaps = 15/211 (7%)
Query: 138 AAATDNFNSENLIGKGGHAEVY--KGCLPDGEXXXXXXXXXXXXEDEERISDFLSELGIV 195
           A  +D +  + ++GKG   EV   K  +   E            +  ++ S  L E+ ++
Sbjct: 22  AIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKES-LLREVQLL 80
Query: 196 AHINHPNAAKLIGFSTENG-FHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGL 254
             ++HPN  KL  F  + G F+LV +    G L   +       E     +I   +  G+
Sbjct: 81  KQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAA-RIIRQVLSGI 139
Query: 255 QYLXXXXXXXXXXXXXKASNILL---SEDYEAQISDFGLAKWLPDNWSHHIVFPIEGTFG 311
            Y+             K  N+LL   S+D   +I DFGL+       S  +   I GT  
Sbjct: 140 TYMHKNKIVHRDL---KPENLLLESKSKDANIRIIDFGLSTHF--EASKKMKDKI-GTAY 193
Query: 312 YLSPEYFMHGIVDEKTDVFAFGVLLLELITG 342
           Y++PE  +HG  DEK DV++ GV+L  L++G
Sbjct: 194 YIAPE-VLHGTYDEKCDVWSTGVILYILLSG 223

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 41/162 (25%), Positives = 77/162 (47%), Gaps = 8/162 (4%)
Query: 186 SDFLSELGIVAHINHPNAAKLIG-FSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRY 244
           +  + EL ++   N P      G F ++    + ++ +  GSL  +L  +    E  I  
Sbjct: 49  NQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPE-QILG 107
Query: 245 KIALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVF 304
           K+++ + +GL YL             K SNIL++   E ++ DFG++  L D+ ++  V 
Sbjct: 108 KVSIAVIKGLTYLREKHKIMHRDV--KPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV- 164
Query: 305 PIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAV 346
              GT  Y+SPE         ++D+++ G+ L+E+  GR  +
Sbjct: 165 ---GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPI 203

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 93/211 (44%), Gaps = 15/211 (7%)
Query: 138 AAATDNFNSENLIGKGGHAEVY--KGCLPDGEXXXXXXXXXXXXEDEERISDFLSELGIV 195
           A  +D +  + ++GKG   EV   K  +   E            +  ++ S  L E+ ++
Sbjct: 28  AIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKES-LLREVQLL 86
Query: 196 AHINHPNAAKLIGFSTENG-FHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGL 254
             ++HPN  KL  F  + G F+LV +    G L   +       E     +I   +  G+
Sbjct: 87  KQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAA-RIIRQVLSGI 145
Query: 255 QYLXXXXXXXXXXXXXKASNILL---SEDYEAQISDFGLAKWLPDNWSHHIVFPIEGTFG 311
            Y+             K  N+LL   S+D   +I DFGL+       S  +   I GT  
Sbjct: 146 TYMHKNKIVHRDL---KPENLLLESKSKDANIRIIDFGLSTHF--EASKKMKDKI-GTAY 199
Query: 312 YLSPEYFMHGIVDEKTDVFAFGVLLLELITG 342
           Y++PE  +HG  DEK DV++ GV+L  L++G
Sbjct: 200 YIAPE-VLHGTYDEKCDVWSTGVILYILLSG 229

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 46/200 (23%), Positives = 91/200 (45%), Gaps = 21/200 (10%)
Query: 150 IGKGGHAEVYKGCLPDGEXXXXXXXXXXXXEDEERISDFLSELGIVAHINHPNAAKLIGF 209
           +G G   +VYK    + E            + EE + D++ E+ I+A  +HP   KL+G 
Sbjct: 27  LGDGAFGKVYKA--KNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGA 84
Query: 210 STENG-FHLVLQFLPHGSLSSLLF----GSTECLEWTIRYKIALGIAEGLQYLXXXXXXX 264
              +G   ++++F P G++ +++     G TE        +I +   + L+ L       
Sbjct: 85  YYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEP-------QIQVVCRQMLEALNFLHSKR 137
Query: 265 XXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEGTFGYLSPEYFMHGIV- 323
                 KA N+L++ + + +++DFG++            F   GT  +++PE  M   + 
Sbjct: 138 IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFI--GTPYWMAPEVVMCETMK 195
Query: 324 ----DEKTDVFAFGVLLLEL 339
               D K D+++ G+ L+E+
Sbjct: 196 DTPYDYKADIWSLGITLIEM 215

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 46/196 (23%), Positives = 81/196 (41%), Gaps = 12/196 (6%)
Query: 150 IGKGGHAEVYKGCL--PDGEXXXXXXXXXXXXEDEERISDFLSELGIVAHINHPNAAKLI 207
           IG+G   +V++G    P+                +     FL E   +   +HP+  KLI
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 208 GFSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLXXXXXXXXXX 267
           G  TEN   ++++    G L S L      L+       A  ++  L YL          
Sbjct: 78  GVITENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDI 137
Query: 268 XXXKASNILLSEDYEAQISDFGLAKWLPDNWSHHIV---FPIEGTFGYLSPEYFMHGIVD 324
               A N+L+S     ++ DFGL++++ D+  +       PI+    +++PE        
Sbjct: 138 A---ARNVLVSATDCVKLGDFGLSRYMEDSTYYKASKGKLPIK----WMAPESINFRRFT 190
Query: 325 EKTDVFAFGVLLLELI 340
             +DV+ FGV + E++
Sbjct: 191 SASDVWMFGVCMWEIL 206

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 88/200 (44%), Gaps = 9/200 (4%)
Query: 144 FNSENLIGKGGHAEVYKGCLPDGEXXXXXXXXXXXXEDEERISDFLSELGIVAHINHPNA 203
           F     IGKG   EV+KG + +              E E+ I D   E+ +++  + P  
Sbjct: 9   FTKLEKIGKGSFGEVFKG-IDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYV 67
Query: 204 AKLIG-FSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLXXXXX 262
            K  G +  +    +++++L  GS   LL      L+ T    I   I +GL YL     
Sbjct: 68  TKYYGSYLKDTKLWIIMEYLGGGSALDLL--EPGPLDETQIATILREILKGLDYLHSEKK 125
Query: 263 XXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEGTFGYLSPEYFMHGI 322
                   KA+N+LLSE  E +++DFG+A  L D       F   GT  +++PE      
Sbjct: 126 IHRDI---KAANVLLSEHGEVKLADFGVAGQLTDTQIKRNXF--VGTPFWMAPEVIKQSA 180
Query: 323 VDEKTDVFAFGVLLLELITG 342
            D K D+++ G+  +EL  G
Sbjct: 181 YDSKADIWSLGITAIELARG 200

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 46/200 (23%), Positives = 91/200 (45%), Gaps = 21/200 (10%)
Query: 150 IGKGGHAEVYKGCLPDGEXXXXXXXXXXXXEDEERISDFLSELGIVAHINHPNAAKLIGF 209
           +G G   +VYK    + E            + EE + D++ E+ I+A  +HP   KL+G 
Sbjct: 19  LGDGAFGKVYKA--KNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGA 76
Query: 210 STENG-FHLVLQFLPHGSLSSLLF----GSTECLEWTIRYKIALGIAEGLQYLXXXXXXX 264
              +G   ++++F P G++ +++     G TE        +I +   + L+ L       
Sbjct: 77  YYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEP-------QIQVVCRQMLEALNFLHSKR 129
Query: 265 XXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEGTFGYLSPEYFMHGIV- 323
                 KA N+L++ + + +++DFG++            F   GT  +++PE  M   + 
Sbjct: 130 IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFI--GTPYWMAPEVVMCETMK 187
Query: 324 ----DEKTDVFAFGVLLLEL 339
               D K D+++ G+ L+E+
Sbjct: 188 DTPYDYKADIWSLGITLIEM 207

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 43/179 (24%), Positives = 84/179 (46%), Gaps = 10/179 (5%)
Query: 186 SDFLSELGIVAHINHPNAAKLIG-FSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRY 244
           +  + EL ++   N P      G F ++    + ++ +  GSL  +L  +    E  I  
Sbjct: 59  NQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPE-EILG 117
Query: 245 KIALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVF 304
           K+++ +  GL YL             K SNIL++   E ++ DFG++  L D+ ++  V 
Sbjct: 118 KVSIAVLRGLAYLREKHQIMHRDV--KPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV- 174
Query: 305 PIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAV--DSRRQSLVIWAKPLL 361
              GT  Y++PE         ++D+++ G+ L+EL  GR  +     ++   I+ +P++
Sbjct: 175 ---GTRSYMAPERLQGTHYSVQSDIWSMGLSLVELAVGRYPIPPPDAKELEAIFGRPVV 230

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 43/167 (25%), Positives = 78/167 (46%), Gaps = 12/167 (7%)
Query: 180 EDEERISDFLSELGIVAHINHPNAAKLIGFSTENG-FHLVLQFLPHGSLSSLLFGSTECL 238
           E EE +  F  E+   + ++H N   +I    E+  ++LV++++   +LS  +  S   L
Sbjct: 50  EKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYI-ESHGPL 108
Query: 239 EWTIRYKIALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDN- 297
                      I +G+++              K  NIL+  +   +I DFG+AK L +  
Sbjct: 109 SVDTAINFTNQILDGIKH---AHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETS 165
Query: 298 --WSHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITG 342
              ++H++    GT  Y SPE       DE TD+++ G++L E++ G
Sbjct: 166 LTQTNHVL----GTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVG 208

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 45/182 (24%), Positives = 88/182 (48%), Gaps = 30/182 (16%)
Query: 182 EERISDFLSELGIVAHI-NHPNAAKLIGFSTENG-FHLVLQFLPHGSLSSLL-------- 231
           EE +SD +SE+ ++  I  H N   L+G  T++G  ++++++   G+L   L        
Sbjct: 81  EEDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGM 140
Query: 232 ---FGSTECLEWTIRYK----IALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQ 284
              +      E  + +K        +A G++YL              A N+L++E+   +
Sbjct: 141 EYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLA---ARNVLVTENNVMK 197
Query: 285 ISDFGLAKWLPDNWSHHIVFPIEGTFG-----YLSPEYFMHGIVDEKTDVFAFGVLLLEL 339
           I+DFGLA+ +     ++I +  + T G     +++PE     +   ++DV++FGVL+ E+
Sbjct: 198 IADFGLARDI-----NNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEI 252
Query: 340 IT 341
            T
Sbjct: 253 FT 254

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 41/162 (25%), Positives = 77/162 (47%), Gaps = 8/162 (4%)
Query: 186 SDFLSELGIVAHINHPNAAKLIG-FSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRY 244
           +  + EL ++   N P      G F ++    + ++ +  GSL  +L  +    E  I  
Sbjct: 49  NQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPE-QILG 107
Query: 245 KIALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVF 304
           K+++ + +GL YL             K SNIL++   E ++ DFG++  L D+ ++  V 
Sbjct: 108 KVSIAVIKGLTYLREKHKIMHRDV--KPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV- 164
Query: 305 PIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAV 346
              GT  Y+SPE         ++D+++ G+ L+E+  GR  +
Sbjct: 165 ---GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPI 203

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 93/211 (44%), Gaps = 15/211 (7%)
Query: 138 AAATDNFNSENLIGKGGHAEVY--KGCLPDGEXXXXXXXXXXXXEDEERISDFLSELGIV 195
           A  +D +  + ++GKG   EV   K  +   E            +  ++ S  L E+ ++
Sbjct: 45  AIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKES-LLREVQLL 103
Query: 196 AHINHPNAAKLIGFSTENG-FHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGL 254
             ++HPN  KL  F  + G F+LV +    G L   +       E     +I   +  G+
Sbjct: 104 KQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAA-RIIRQVLSGI 162
Query: 255 QYLXXXXXXXXXXXXXKASNILL---SEDYEAQISDFGLAKWLPDNWSHHIVFPIEGTFG 311
            Y+             K  N+LL   S+D   +I DFGL+       S  +   I GT  
Sbjct: 163 TYMHKNKIVHRDL---KPENLLLESKSKDANIRIIDFGLSTHF--EASKKMKDKI-GTAY 216
Query: 312 YLSPEYFMHGIVDEKTDVFAFGVLLLELITG 342
           Y++PE  +HG  DEK DV++ GV+L  L++G
Sbjct: 217 YIAPE-VLHGTYDEKCDVWSTGVILYILLSG 246

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 41/162 (25%), Positives = 77/162 (47%), Gaps = 8/162 (4%)
Query: 186 SDFLSELGIVAHINHPNAAKLIG-FSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRY 244
           +  + EL ++   N P      G F ++    + ++ +  GSL  +L  +    E  I  
Sbjct: 49  NQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPE-QILG 107
Query: 245 KIALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVF 304
           K+++ + +GL YL             K SNIL++   E ++ DFG++  L D+ ++  V 
Sbjct: 108 KVSIAVIKGLTYLREKHKIMHRDV--KPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV- 164
Query: 305 PIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAV 346
              GT  Y+SPE         ++D+++ G+ L+E+  GR  +
Sbjct: 165 ---GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPI 203

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 41/162 (25%), Positives = 77/162 (47%), Gaps = 8/162 (4%)
Query: 186 SDFLSELGIVAHINHPNAAKLIG-FSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRY 244
           +  + EL ++   N P      G F ++    + ++ +  GSL  +L  +    E  I  
Sbjct: 49  NQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPE-QILG 107
Query: 245 KIALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVF 304
           K+++ + +GL YL             K SNIL++   E ++ DFG++  L D+ ++  V 
Sbjct: 108 KVSIAVIKGLTYLREKHKIMHRDV--KPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV- 164
Query: 305 PIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAV 346
              GT  Y+SPE         ++D+++ G+ L+E+  GR  +
Sbjct: 165 ---GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPI 203

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 93/211 (44%), Gaps = 15/211 (7%)
Query: 138 AAATDNFNSENLIGKGGHAEVY--KGCLPDGEXXXXXXXXXXXXEDEERISDFLSELGIV 195
           A  +D +  + ++GKG   EV   K  +   E            +  ++ S  L E+ ++
Sbjct: 46  AIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKES-LLREVQLL 104
Query: 196 AHINHPNAAKLIGFSTENG-FHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGL 254
             ++HPN  KL  F  + G F+LV +    G L   +       E     +I   +  G+
Sbjct: 105 KQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAA-RIIRQVLSGI 163
Query: 255 QYLXXXXXXXXXXXXXKASNILL---SEDYEAQISDFGLAKWLPDNWSHHIVFPIEGTFG 311
            Y+             K  N+LL   S+D   +I DFGL+       S  +   I GT  
Sbjct: 164 TYMHKNKIVHRDL---KPENLLLESKSKDANIRIIDFGLSTHF--EASKKMKDKI-GTAY 217
Query: 312 YLSPEYFMHGIVDEKTDVFAFGVLLLELITG 342
           Y++PE  +HG  DEK DV++ GV+L  L++G
Sbjct: 218 YIAPE-VLHGTYDEKCDVWSTGVILYILLSG 247

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 41/162 (25%), Positives = 77/162 (47%), Gaps = 8/162 (4%)
Query: 186 SDFLSELGIVAHINHPNAAKLIG-FSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRY 244
           +  + EL ++   N P      G F ++    + ++ +  GSL  +L  +    E  I  
Sbjct: 49  NQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPE-QILG 107
Query: 245 KIALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVF 304
           K+++ + +GL YL             K SNIL++   E ++ DFG++  L D+ ++  V 
Sbjct: 108 KVSIAVIKGLTYLREKHKIMHRDV--KPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV- 164
Query: 305 PIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAV 346
              GT  Y+SPE         ++D+++ G+ L+E+  GR  +
Sbjct: 165 ---GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPI 203

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 38/150 (25%), Positives = 72/150 (48%), Gaps = 10/150 (6%)
Query: 194 IVAHINHPNAAKLIG-FSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAE 252
           +++ + HP   ++ G F       +++ ++  G L SLL  S        ++  A  +  
Sbjct: 59  MLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKF-YAAEVCL 117
Query: 253 GLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEGTFGY 312
            L+YL             K  NILL ++   +I+DFG AK++PD     + + + GT  Y
Sbjct: 118 ALEYLHSKDIIYRDL---KPENILLDKNGHIKITDFGFAKYVPD-----VTYXLCGTPDY 169
Query: 313 LSPEYFMHGIVDEKTDVFAFGVLLLELITG 342
           ++PE       ++  D ++FG+L+ E++ G
Sbjct: 170 IAPEVVSTKPYNKSIDWWSFGILIYEMLAG 199

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 46/160 (28%), Positives = 71/160 (44%), Gaps = 9/160 (5%)
Query: 186 SDFLSELGIVAHINHPNAAKLIGFSTENG---FHLVLQFLPHGSLSSLLFGSTECLEWTI 242
           S +  E+ I+  + H +  K  G   + G     LV++++P GSL   L     C+    
Sbjct: 55  SGWQREIEILRTLYHEHIVKYKGCCEDQGEKSVQLVMEYVPLGSLRDYL--PRHCVGLAQ 112
Query: 243 RYKIALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSHHI 302
               A  I EG+ YL              A N+LL  D   +I DFGLAK +P+   ++ 
Sbjct: 113 LLLFAQQICEGMAYLHAQHYIHRALA---ARNVLLDNDRLVKIGDFGLAKAVPEGHEYYR 169
Query: 303 VFPI-EGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELIT 341
           V    +    + +PE          +DV++FGV L EL+T
Sbjct: 170 VREDGDSPVFWYAPECLKECKFYYASDVWSFGVTLYELLT 209

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 46/160 (28%), Positives = 71/160 (44%), Gaps = 9/160 (5%)
Query: 186 SDFLSELGIVAHINHPNAAKLIGFSTENG---FHLVLQFLPHGSLSSLLFGSTECLEWTI 242
           S +  E+ I+  + H +  K  G   + G     LV++++P GSL   L     C+    
Sbjct: 56  SGWQREIEILRTLYHEHIVKYKGCCEDQGEKSVQLVMEYVPLGSLRDYL--PRHCVGLAQ 113
Query: 243 RYKIALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSHHI 302
               A  I EG+ YL              A N+LL  D   +I DFGLAK +P+   ++ 
Sbjct: 114 LLLFAQQICEGMAYLHAQHYIHRALA---ARNVLLDNDRLVKIGDFGLAKAVPEGHEYYR 170
Query: 303 VFPI-EGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELIT 341
           V    +    + +PE          +DV++FGV L EL+T
Sbjct: 171 VREDGDSPVFWYAPECLKECKFYYASDVWSFGVTLYELLT 210

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 65/257 (25%), Positives = 113/257 (43%), Gaps = 45/257 (17%)
Query: 188 FLSELGIVAHI-NHPNAAKLIGFSTENGFHLVL-QFLPHGSLSSLLFGSTEC-------- 237
            +SEL I++H+  H N   L+G  T  G  LV+ ++  +G L + L    E         
Sbjct: 96  LMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGR 155
Query: 238 -LEWTIRYKIALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPD 296
            LE       +  +A+G+ +L              A N+LL+  + A+I DFGLA+ + +
Sbjct: 156 PLELRDLLHFSSQVAQGMAFLASKNCIHRDVA---ARNVLLTNGHVAKIGDFGLARDIMN 212
Query: 297 NWSHHIV-----FPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQ 351
           + S++IV      P++    +++PE     +   ++DV+++G+LL E+            
Sbjct: 213 D-SNYIVKGNARLPVK----WMAPESIFDCVYTVQSDVWSYGILLWEIF----------- 256
Query: 352 SLVIWAKP-LLQTSNFKELVDPRLADAYDLAE----MKRAMLTASVCIHHLSTMRPQMTR 406
           SL +   P +L  S F +LV     D Y +A+     K        C     T RP   +
Sbjct: 257 SLGLNPYPGILVNSKFYKLVK----DGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQ 312
Query: 407 VLQLLRGEGGQTDLKPK 423
           +   L+ E  Q D + +
Sbjct: 313 ICSFLQ-EQAQEDRRER 328

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 88/200 (44%), Gaps = 9/200 (4%)
Query: 144 FNSENLIGKGGHAEVYKGCLPDGEXXXXXXXXXXXXEDEERISDFLSELGIVAHINHPNA 203
           F     IGKG   EV+KG + +              E E+ I D   E+ +++  + P  
Sbjct: 29  FTKLEKIGKGSFGEVFKG-IDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYV 87
Query: 204 AKLIG-FSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLXXXXX 262
            K  G +  +    +++++L  GS   LL      L+ T    I   I +GL YL     
Sbjct: 88  TKYYGSYLKDTKLWIIMEYLGGGSALDLL--EPGPLDETQIATILREILKGLDYLHSEKK 145
Query: 263 XXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEGTFGYLSPEYFMHGI 322
                   KA+N+LLSE  E +++DFG+A  L D       F   GT  +++PE      
Sbjct: 146 IHRDI---KAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTF--VGTPFWMAPEVIKQSA 200
Query: 323 VDEKTDVFAFGVLLLELITG 342
            D K D+++ G+  +EL  G
Sbjct: 201 YDSKADIWSLGITAIELARG 220

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 46/196 (23%), Positives = 81/196 (41%), Gaps = 12/196 (6%)
Query: 150 IGKGGHAEVYKGCL--PDGEXXXXXXXXXXXXEDEERISDFLSELGIVAHINHPNAAKLI 207
           IG+G   +V++G    P+                +     FL E   +   +HP+  KLI
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 457
Query: 208 GFSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLXXXXXXXXXX 267
           G  TEN   ++++    G L S L      L+       A  ++  L YL          
Sbjct: 458 GVITENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDI 517
Query: 268 XXXKASNILLSEDYEAQISDFGLAKWLPDNWSHHIV---FPIEGTFGYLSPEYFMHGIVD 324
               A N+L+S     ++ DFGL++++ D+  +       PI+    +++PE        
Sbjct: 518 A---ARNVLVSATDCVKLGDFGLSRYMEDSTYYKASKGKLPIK----WMAPESINFRRFT 570
Query: 325 EKTDVFAFGVLLLELI 340
             +DV+ FGV + E++
Sbjct: 571 SASDVWMFGVCMWEIL 586

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 51/205 (24%), Positives = 86/205 (41%), Gaps = 12/205 (5%)
Query: 144 FNSENL-----IGKGGHAEVYKGCL-PDGEXXXXXXXXXXXXEDEERISDFLSELGIVAH 197
            N E+L     IG+G   EV+ G L  D               D +  + FL E  I+  
Sbjct: 111 LNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLK--AKFLQEARILKQ 168
Query: 198 INHPNAAKLIGFSTENG-FHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQY 256
            +HPN  +LIG  T+    ++V++ +  G   + L      L      ++    A G++Y
Sbjct: 169 YSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEY 228
Query: 257 LXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEGTFGYLSPE 316
           L              A N L++E    +ISDFG+++   D          +    + +PE
Sbjct: 229 LESKCCIHRDLA---ARNCLVTEKNVLKISDFGMSREEADGVXAASGGLRQVPVKWTAPE 285
Query: 317 YFMHGIVDEKTDVFAFGVLLLELIT 341
              +G    ++DV++FG+LL E  +
Sbjct: 286 ALNYGRYSSESDVWSFGILLWETFS 310

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 51/207 (24%), Positives = 87/207 (42%), Gaps = 17/207 (8%)
Query: 149 LIGKGGHAEVYKGCLP--DGEXXXXXXXXXXXXEDEER-ISDFLSELGIVAHINHPNAAK 205
           ++G+G    V +G L   DG                +R I +FLSE   +   +HPN  +
Sbjct: 41  ILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIR 100
Query: 206 LIGFSTENGFH------LVLQFLPHGSLSS-LLFGSTEC----LEWTIRYKIALGIAEGL 254
           L+G   E          ++L F+ +G L + LL+   E     +      K  + IA G+
Sbjct: 101 LLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGM 160
Query: 255 QYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEGTFGYLS 314
           +YL              A N +L +D    ++DFGL+K +     +      +    +++
Sbjct: 161 EYLSNRNFLHRDLA---ARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIA 217
Query: 315 PEYFMHGIVDEKTDVFAFGVLLLELIT 341
            E     +   K+DV+AFGV + E+ T
Sbjct: 218 IESLADRVYTSKSDVWAFGVTMWEIAT 244

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 53/209 (25%), Positives = 79/209 (37%), Gaps = 10/209 (4%)
Query: 142 DNFNSENLIGKGGHAEVYKGCLPDGEXXXXXXXXXXXXEDEERISDFLS-ELGIVAHINH 200
           D+F+    +GKG    VY       +             ++E +   L  E+ I +H+ H
Sbjct: 14  DDFDIVRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRH 73
Query: 201 PNAAKLIG-FSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLXX 259
           PN  ++   F      +L+L+F P G L   L       E     + A  + E    L  
Sbjct: 74  PNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQ----RSATFMEELADALHY 129
Query: 260 XXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEGTFGYLSPEYFM 319
                      K  N+L+    E +I+DFG +   P      +     GT  YL PE   
Sbjct: 130 CHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRXMC----GTLDYLPPEMIE 185
Query: 320 HGIVDEKTDVFAFGVLLLELITGRRAVDS 348
               DEK D++  GVL  E + G    DS
Sbjct: 186 GKTHDEKVDLWCAGVLCYEFLVGMPPFDS 214

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 53/209 (25%), Positives = 79/209 (37%), Gaps = 10/209 (4%)
Query: 142 DNFNSENLIGKGGHAEVYKGCLPDGEXXXXXXXXXXXXEDEERISDFLS-ELGIVAHINH 200
           D+F+    +GKG    VY       +             ++E +   L  E+ I +H+ H
Sbjct: 15  DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRH 74
Query: 201 PNAAKLIG-FSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLXX 259
           PN  ++   F      +L+L+F P G L   L       E     + A  + E    L  
Sbjct: 75  PNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQ----RSATFMEELADALHY 130
Query: 260 XXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEGTFGYLSPEYFM 319
                      K  N+L+    E +I+DFG +   P      +     GT  YL PE   
Sbjct: 131 CHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRXMC----GTLDYLPPEMIE 186
Query: 320 HGIVDEKTDVFAFGVLLLELITGRRAVDS 348
               DEK D++  GVL  E + G    DS
Sbjct: 187 GKTHDEKVDLWCAGVLCYEFLVGMPPFDS 215

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 50/196 (25%), Positives = 81/196 (41%), Gaps = 6/196 (3%)
Query: 182 EERISDFLSELGIVAHINHPNAAKL-IGFSTENGFHLVLQFLPHGSLSSLLFGSTECLEW 240
           E ++     E  +++ ++HP   KL   F  +   +  L +  +G L   +       E 
Sbjct: 50  ENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDET 109
Query: 241 TIRYKIALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSH 300
             R+  A  I   L+YL             K  NILL+ED   QI+DFG AK L      
Sbjct: 110 CTRFYTA-EIVSALEYLHGKGIIHRDL---KPENILLNEDMHIQITDFGTAKVLSPESKQ 165
Query: 301 HIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPL 360
                  GT  Y+SPE        + +D++A G ++ +L+ G     +  + L I+ K +
Sbjct: 166 ARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYL-IFQKII 224
Query: 361 LQTSNFKELVDPRLAD 376
               +F E   P+  D
Sbjct: 225 KLEYDFPEKFFPKARD 240

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 50/196 (25%), Positives = 81/196 (41%), Gaps = 6/196 (3%)
Query: 182 EERISDFLSELGIVAHINHPNAAKL-IGFSTENGFHLVLQFLPHGSLSSLLFGSTECLEW 240
           E ++     E  +++ ++HP   KL   F  +   +  L +  +G L   +       E 
Sbjct: 71  ENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDET 130
Query: 241 TIRYKIALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSH 300
             R+  A  I   L+YL             K  NILL+ED   QI+DFG AK L      
Sbjct: 131 CTRFYTA-EIVSALEYLHGKGIIHRDL---KPENILLNEDMHIQITDFGTAKVLSPESKQ 186
Query: 301 HIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPL 360
                  GT  Y+SPE        + +D++A G ++ +L+ G     +  + L I+ K +
Sbjct: 187 ARANAFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYL-IFQKII 245
Query: 361 LQTSNFKELVDPRLAD 376
               +F E   P+  D
Sbjct: 246 KLEYDFPEKFFPKARD 261

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 54/210 (25%), Positives = 87/210 (41%), Gaps = 14/210 (6%)
Query: 142 DNFNSENLIGKGGHAEVYKGCLPDGEXXXXXXXXXXXXEDEERISDFLSELGIVAHINHP 201
           +NF     IG+G +  VYK                   E E   S  + E+ ++  +NHP
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 202 NAAKLIG-FSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLXXX 260
           N  KL+    TEN  +LV +FL H  L    F     L       I   + + LQ L   
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFL-HQDLKK--FMDASALTGIPLPLIKSYLFQLLQGLAFC 119
Query: 261 XXXXXXXXXXKASNILLSEDYEAQISDFGLAKWL---PDNWSHHIVFPIEGTFGYLSPEY 317
                     K  N+L++ +   +++DFGLA+        ++H +V     T  Y +PE 
Sbjct: 120 HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-----TLWYRAPEI 174
Query: 318 FM-HGIVDEKTDVFAFGVLLLELITGRRAV 346
            +         D+++ G +  E++T RRA+
Sbjct: 175 LLGXKYYSTAVDIWSLGCIFAEMVT-RRAL 203

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 48/170 (28%), Positives = 81/170 (47%), Gaps = 21/170 (12%)
Query: 188 FLSELGIVAHI-NHPNAAKLIGFSTENG--FHLVLQFLPHGSLSSLL------------- 231
            +SEL I+ HI +H N   L+G  T+ G    ++++F   G+LS+ L             
Sbjct: 77  LMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDL 136
Query: 232 FGSTECLEWTIRYKIALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLA 291
           +     LE  I Y  +  +A+G+++L              A NILLSE    +I DFGLA
Sbjct: 137 YKDFLTLEHLIXY--SFQVAKGMEFLASRKXIHRDLA---ARNILLSEKNVVKIXDFGLA 191
Query: 292 KWLPDNWSHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELIT 341
           + +  +  +           +++PE     +   ++DV++FGVLL E+ +
Sbjct: 192 RDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 241

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 50/196 (25%), Positives = 81/196 (41%), Gaps = 6/196 (3%)
Query: 182 EERISDFLSELGIVAHINHPNAAKL-IGFSTENGFHLVLQFLPHGSLSSLLFGSTECLEW 240
           E ++     E  +++ ++HP   KL   F  +   +  L +  +G L   +       E 
Sbjct: 51  ENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDET 110
Query: 241 TIRYKIALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSH 300
             R+  A  I   L+YL             K  NILL+ED   QI+DFG AK L      
Sbjct: 111 CTRFYTA-EIVSALEYLHGKGIIHRDL---KPENILLNEDMHIQITDFGTAKVLSPESKQ 166
Query: 301 HIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPL 360
                  GT  Y+SPE        + +D++A G ++ +L+ G     +  + L I+ K +
Sbjct: 167 ARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYL-IFQKII 225
Query: 361 LQTSNFKELVDPRLAD 376
               +F E   P+  D
Sbjct: 226 KLEYDFPEKFFPKARD 241

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 54/213 (25%), Positives = 88/213 (41%), Gaps = 14/213 (6%)
Query: 139 AATDNFNSENLIGKGGHAEVYKGCLPDGEXXXXXXXXXXXXEDEERISDFLSELGIVAHI 198
            + +NF     IG+G +  VYK                   E E   S  + E+ ++  +
Sbjct: 1   GSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 60
Query: 199 NHPNAAKLIG-FSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYL 257
           NHPN  KL+    TEN  +LV +FL H  L    F     L       I   + + LQ L
Sbjct: 61  NHPNIVKLLDVIHTENKLYLVFEFL-HQDLKK--FMDASALTGIPLPLIKSYLFQLLQGL 117
Query: 258 XXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWL---PDNWSHHIVFPIEGTFGYLS 314
                        K  N+L++ +   +++DFGLA+        ++H +V     T  Y +
Sbjct: 118 AFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-----TLWYRA 172
Query: 315 PEYFM-HGIVDEKTDVFAFGVLLLELITGRRAV 346
           PE  +         D+++ G +  E++T RRA+
Sbjct: 173 PEILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 204

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 41/159 (25%), Positives = 75/159 (47%), Gaps = 8/159 (5%)
Query: 186 SDFLSELGIVAHINHPNAAKLIG-FSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRY 244
           +  + EL ++   N P      G F ++    + ++ +  GSL  +L  +    E  I  
Sbjct: 52  NQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPE-QILG 110
Query: 245 KIALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVF 304
           K+++ + +GL YL             K SNIL++   E ++ DFG++  L D  ++  V 
Sbjct: 111 KVSIAVIKGLTYLREKHKIMHRDV--KPSNILVNSRGEIKLCDFGVSGQLIDEMANEFV- 167
Query: 305 PIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGR 343
              GT  Y+SPE         ++D+++ G+ L+E+  GR
Sbjct: 168 ---GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 203

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 54/210 (25%), Positives = 87/210 (41%), Gaps = 14/210 (6%)
Query: 142 DNFNSENLIGKGGHAEVYKGCLPDGEXXXXXXXXXXXXEDEERISDFLSELGIVAHINHP 201
           +NF     IG+G +  VYK                   E E   S  + E+ ++  +NHP
Sbjct: 7   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 66
Query: 202 NAAKLIG-FSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLXXX 260
           N  KL+    TEN  +LV +FL H  L    F     L       I   + + LQ L   
Sbjct: 67  NIVKLLDVIHTENKLYLVFEFL-HQDLKK--FMDASALTGIPLPLIKSYLFQLLQGLAFC 123
Query: 261 XXXXXXXXXXKASNILLSEDYEAQISDFGLAKWL---PDNWSHHIVFPIEGTFGYLSPEY 317
                     K  N+L++ +   +++DFGLA+        ++H +V     T  Y +PE 
Sbjct: 124 HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-----TLWYRAPEI 178
Query: 318 FM-HGIVDEKTDVFAFGVLLLELITGRRAV 346
            +         D+++ G +  E++T RRA+
Sbjct: 179 LLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 207

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 50/196 (25%), Positives = 81/196 (41%), Gaps = 6/196 (3%)
Query: 182 EERISDFLSELGIVAHINHPNAAKL-IGFSTENGFHLVLQFLPHGSLSSLLFGSTECLEW 240
           E ++     E  +++ ++HP   KL   F  +   +  L +  +G L   +       E 
Sbjct: 74  ENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDET 133
Query: 241 TIRYKIALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSH 300
             R+  A  I   L+YL             K  NILL+ED   QI+DFG AK L      
Sbjct: 134 CTRFYTA-EIVSALEYLHGKGIIHRDL---KPENILLNEDMHIQITDFGTAKVLSPESKQ 189
Query: 301 HIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPL 360
                  GT  Y+SPE        + +D++A G ++ +L+ G     +  + L I+ K +
Sbjct: 190 ARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYL-IFQKII 248
Query: 361 LQTSNFKELVDPRLAD 376
               +F E   P+  D
Sbjct: 249 KLEYDFPEKFFPKARD 264

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 65/253 (25%), Positives = 111/253 (43%), Gaps = 45/253 (17%)
Query: 188 FLSELGIVAHI-NHPNAAKLIGFSTENGFHLVL-QFLPHGSLSSLLFGSTEC-------- 237
            +SEL I++H+  H N   L+G  T  G  LV+ ++  +G L + L    E         
Sbjct: 88  LMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGR 147
Query: 238 -LEWTIRYKIALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPD 296
            LE       +  +A+G+ +L              A N+LL+  + A+I DFGLA+ + +
Sbjct: 148 PLELRDLLHFSSQVAQGMAFLASKNCIHRDVA---ARNVLLTNGHVAKIGDFGLARDIMN 204
Query: 297 NWSHHIV-----FPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQ 351
           + S++IV      P++    +++PE     +   ++DV+++G+LL E+            
Sbjct: 205 D-SNYIVKGNARLPVK----WMAPESIFDCVYTVQSDVWSYGILLWEIF----------- 248
Query: 352 SLVIWAKP-LLQTSNFKELVDPRLADAYDLAE----MKRAMLTASVCIHHLSTMRPQMTR 406
           SL +   P +L  S F +LV     D Y +A+     K        C     T RP   +
Sbjct: 249 SLGLNPYPGILVNSKFYKLVK----DGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQ 304
Query: 407 VLQLLRGEGGQTD 419
           +   L+ E  Q D
Sbjct: 305 ICSFLQ-EQAQED 316

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 50/196 (25%), Positives = 81/196 (41%), Gaps = 6/196 (3%)
Query: 182 EERISDFLSELGIVAHINHPNAAKL-IGFSTENGFHLVLQFLPHGSLSSLLFGSTECLEW 240
           E ++     E  +++ ++HP   KL   F  +   +  L +  +G L   +       E 
Sbjct: 78  ENKVPYVTRERDVMSRLDHPFFVKLYFCFQDDEKLYFGLSYAKNGELLKYIRKIGSFDET 137
Query: 241 TIRYKIALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSH 300
             R+  A  I   L+YL             K  NILL+ED   QI+DFG AK L      
Sbjct: 138 CTRFYTA-EIVSALEYLHGKGIIHRDL---KPENILLNEDMHIQITDFGTAKVLSPESKQ 193
Query: 301 HIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPL 360
                  GT  Y+SPE        + +D++A G ++ +L+ G     +  + L I+ K +
Sbjct: 194 ARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYL-IFQKII 252
Query: 361 LQTSNFKELVDPRLAD 376
               +F E   P+  D
Sbjct: 253 KLEYDFPEKFFPKARD 268

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 47/168 (27%), Positives = 81/168 (48%), Gaps = 17/168 (10%)
Query: 188 FLSELGIVAHI-NHPNAAKLIGFSTENG--FHLVLQFLPHGSLSSLLFGS-TECLEWTIR 243
            +SEL I+ HI +H N   L+G  T+ G    ++++F   G+LS+ L     E + +   
Sbjct: 77  LMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDL 136
Query: 244 YK----------IALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKW 293
           YK           +  +A+G+++L              A NILLSE    +I DFGLA+ 
Sbjct: 137 YKDFLTLEHLICYSFQVAKGMEFLASRKXIHRDLA---ARNILLSEKNVVKICDFGLARD 193
Query: 294 LPDNWSHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELIT 341
           +  +  +           +++PE     +   ++DV++FGVLL E+ +
Sbjct: 194 IYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 241

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 54/210 (25%), Positives = 87/210 (41%), Gaps = 14/210 (6%)
Query: 142 DNFNSENLIGKGGHAEVYKGCLPDGEXXXXXXXXXXXXEDEERISDFLSELGIVAHINHP 201
           +NF     IG+G +  VYK                   E E   S  + E+ ++  +NHP
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 202 NAAKLIG-FSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLXXX 260
           N  KL+    TEN  +LV +FL H  L    F     L       I   + + LQ L   
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFL-HQDLKK--FMDASALTGIPLPLIKSYLFQLLQGLSFC 119
Query: 261 XXXXXXXXXXKASNILLSEDYEAQISDFGLAKWL---PDNWSHHIVFPIEGTFGYLSPEY 317
                     K  N+L++ +   +++DFGLA+        ++H +V     T  Y +PE 
Sbjct: 120 HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-----TLWYRAPEI 174
Query: 318 FM-HGIVDEKTDVFAFGVLLLELITGRRAV 346
            +         D+++ G +  E++T RRA+
Sbjct: 175 LLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 203

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 50/196 (25%), Positives = 81/196 (41%), Gaps = 6/196 (3%)
Query: 182 EERISDFLSELGIVAHINHPNAAKL-IGFSTENGFHLVLQFLPHGSLSSLLFGSTECLEW 240
           E ++     E  +++ ++HP   KL   F  +   +  L +  +G L   +       E 
Sbjct: 48  ENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDET 107
Query: 241 TIRYKIALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSH 300
             R+  A  I   L+YL             K  NILL+ED   QI+DFG AK L      
Sbjct: 108 CTRFYTA-EIVSALEYLHGKGIIHRDL---KPENILLNEDMHIQITDFGTAKVLSPESKQ 163
Query: 301 HIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPL 360
                  GT  Y+SPE        + +D++A G ++ +L+ G     +  + L I+ K +
Sbjct: 164 ARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYL-IFQKII 222
Query: 361 LQTSNFKELVDPRLAD 376
               +F E   P+  D
Sbjct: 223 KLEYDFPEKFFPKARD 238

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 50/196 (25%), Positives = 81/196 (41%), Gaps = 6/196 (3%)
Query: 182 EERISDFLSELGIVAHINHPNAAKL-IGFSTENGFHLVLQFLPHGSLSSLLFGSTECLEW 240
           E ++     E  +++ ++HP   KL   F  +   +  L +  +G L   +       E 
Sbjct: 73  ENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDET 132
Query: 241 TIRYKIALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSH 300
             R+  A  I   L+YL             K  NILL+ED   QI+DFG AK L      
Sbjct: 133 CTRFYTA-EIVSALEYLHGKGIIHRDL---KPENILLNEDMHIQITDFGTAKVLSPESKQ 188
Query: 301 HIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPL 360
                  GT  Y+SPE        + +D++A G ++ +L+ G     +  + L I+ K +
Sbjct: 189 ARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYL-IFQKII 247
Query: 361 LQTSNFKELVDPRLAD 376
               +F E   P+  D
Sbjct: 248 KLEYDFPEKFFPKARD 263

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 50/196 (25%), Positives = 81/196 (41%), Gaps = 6/196 (3%)
Query: 182 EERISDFLSELGIVAHINHPNAAKL-IGFSTENGFHLVLQFLPHGSLSSLLFGSTECLEW 240
           E ++     E  +++ ++HP   KL   F  +   +  L +  +G L   +       E 
Sbjct: 49  ENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDET 108
Query: 241 TIRYKIALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSH 300
             R+  A  I   L+YL             K  NILL+ED   QI+DFG AK L      
Sbjct: 109 CTRFYTA-EIVSALEYLHGKGIIHRDL---KPENILLNEDMHIQITDFGTAKVLSPESKQ 164
Query: 301 HIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPL 360
                  GT  Y+SPE        + +D++A G ++ +L+ G     +  + L I+ K +
Sbjct: 165 ARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYL-IFQKII 223
Query: 361 LQTSNFKELVDPRLAD 376
               +F E   P+  D
Sbjct: 224 KLEYDFPEKFFPKARD 239

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 54/210 (25%), Positives = 87/210 (41%), Gaps = 14/210 (6%)
Query: 142 DNFNSENLIGKGGHAEVYKGCLPDGEXXXXXXXXXXXXEDEERISDFLSELGIVAHINHP 201
           +NF     IG+G +  VYK                   E E   S  + E+ ++  +NHP
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 202 NAAKLIG-FSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLXXX 260
           N  KL+    TEN  +LV +FL H  L    F     L       I   + + LQ L   
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFL-HQDLKK--FMDASALTGIPLPLIKSYLFQLLQGLAFC 119
Query: 261 XXXXXXXXXXKASNILLSEDYEAQISDFGLAKWL---PDNWSHHIVFPIEGTFGYLSPEY 317
                     K  N+L++ +   +++DFGLA+        ++H +V     T  Y +PE 
Sbjct: 120 HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-----TLWYRAPEI 174
Query: 318 FM-HGIVDEKTDVFAFGVLLLELITGRRAV 346
            +         D+++ G +  E++T RRA+
Sbjct: 175 LLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 203

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 54/210 (25%), Positives = 87/210 (41%), Gaps = 14/210 (6%)
Query: 142 DNFNSENLIGKGGHAEVYKGCLPDGEXXXXXXXXXXXXEDEERISDFLSELGIVAHINHP 201
           +NF     IG+G +  VYK                   E E   S  + E+ ++  +NHP
Sbjct: 10  ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 69
Query: 202 NAAKLIG-FSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLXXX 260
           N  KL+    TEN  +LV +FL H  L    F     L       I   + + LQ L   
Sbjct: 70  NIVKLLDVIHTENKLYLVFEFL-HQDLKK--FMDASALTGIPLPLIKSYLFQLLQGLAFC 126
Query: 261 XXXXXXXXXXKASNILLSEDYEAQISDFGLAKWL---PDNWSHHIVFPIEGTFGYLSPEY 317
                     K  N+L++ +   +++DFGLA+        ++H +V     T  Y +PE 
Sbjct: 127 HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-----TLWYRAPEI 181
Query: 318 FM-HGIVDEKTDVFAFGVLLLELITGRRAV 346
            +         D+++ G +  E++T RRA+
Sbjct: 182 LLGXKYYSTAVDIWSLGCIFAEMVT-RRAL 210

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 54/210 (25%), Positives = 87/210 (41%), Gaps = 14/210 (6%)
Query: 142 DNFNSENLIGKGGHAEVYKGCLPDGEXXXXXXXXXXXXEDEERISDFLSELGIVAHINHP 201
           +NF     IG+G +  VYK                   E E   S  + E+ ++  +NHP
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 202 NAAKLIG-FSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLXXX 260
           N  KL+    TEN  +LV +FL H  L    F     L       I   + + LQ L   
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFL-HQDLKK--FMDASALTGIPLPLIKSYLFQLLQGLAFC 118
Query: 261 XXXXXXXXXXKASNILLSEDYEAQISDFGLAKWL---PDNWSHHIVFPIEGTFGYLSPEY 317
                     K  N+L++ +   +++DFGLA+        ++H +V     T  Y +PE 
Sbjct: 119 HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-----TLWYRAPEI 173
Query: 318 FM-HGIVDEKTDVFAFGVLLLELITGRRAV 346
            +         D+++ G +  E++T RRA+
Sbjct: 174 LLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 202

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 44/182 (24%), Positives = 88/182 (48%), Gaps = 30/182 (16%)
Query: 182 EERISDFLSELGIVAHI-NHPNAAKLIGFSTENG-FHLVLQFLPHGSLSSLL-------- 231
           E+ +SD +SE+ ++  I  H N   L+G  T++G  ++++++   G+L   L        
Sbjct: 127 EKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGM 186
Query: 232 ---FGSTECLEWTIRYK----IALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQ 284
              +      E  + +K        +A G++YL              A N+L++E+   +
Sbjct: 187 EYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLA---ARNVLVTENNVMK 243
Query: 285 ISDFGLAKWLPDNWSHHIVFPIEGTFG-----YLSPEYFMHGIVDEKTDVFAFGVLLLEL 339
           I+DFGLA+ +     ++I +  + T G     +++PE     +   ++DV++FGVL+ E+
Sbjct: 244 IADFGLARDI-----NNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEI 298
Query: 340 IT 341
            T
Sbjct: 299 FT 300

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 50/196 (25%), Positives = 81/196 (41%), Gaps = 6/196 (3%)
Query: 182 EERISDFLSELGIVAHINHPNAAKL-IGFSTENGFHLVLQFLPHGSLSSLLFGSTECLEW 240
           E ++     E  +++ ++HP   KL   F  +   +  L +  +G L   +       E 
Sbjct: 71  ENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDET 130
Query: 241 TIRYKIALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSH 300
             R+  A  I   L+YL             K  NILL+ED   QI+DFG AK L      
Sbjct: 131 CTRFYTA-EIVSALEYLHGKGIIHRDL---KPENILLNEDMHIQITDFGTAKVLSPESKQ 186
Query: 301 HIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPL 360
                  GT  Y+SPE        + +D++A G ++ +L+ G     +  + L I+ K +
Sbjct: 187 ARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYL-IFQKII 245
Query: 361 LQTSNFKELVDPRLAD 376
               +F E   P+  D
Sbjct: 246 KLEYDFPEKFFPKARD 261

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 90/203 (44%), Gaps = 17/203 (8%)
Query: 149 LIGKGGHAEVYKGCLPDGEXXXXXXXXXXXXEDEERISDFLSELGIVAHINHPNAAKLIG 208
           ++GKG +  VY G   D               D         E+ +  H+ H N  + +G
Sbjct: 15  VLGKGTYGIVYAG--RDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLG 72
Query: 209 FSTENGF-HLVLQFLPHGSLSSLL---FGSTECLEWTIRYKIALGIAEGLQYLXXXXXXX 264
             +ENGF  + ++ +P GSLS+LL   +G  +  E TI +     I EGL+YL       
Sbjct: 73  SFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQ-ILEGLKYL---HDNQ 128
Query: 265 XXXXXXKASNILLSEDYEA--QISDFGLAKWLPDNWSHHIVFPIEGTFGYLSPEYFMHGI 322
                 K  N+L++  Y    +ISDFG +K L         F   GT  Y++PE    G 
Sbjct: 129 IVHRDIKGDNVLINT-YSGVLKISDFGTSKRLAGINPCTETF--TGTLQYMAPEIIDKGP 185
Query: 323 --VDEKTDVFAFGVLLLELITGR 343
               +  D+++ G  ++E+ TG+
Sbjct: 186 RGYGKAADIWSLGCTIIEMATGK 208

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 54/210 (25%), Positives = 87/210 (41%), Gaps = 14/210 (6%)
Query: 142 DNFNSENLIGKGGHAEVYKGCLPDGEXXXXXXXXXXXXEDEERISDFLSELGIVAHINHP 201
           +NF     IG+G +  VYK                   E E   S  + E+ ++  +NHP
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 202 NAAKLIG-FSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLXXX 260
           N  KL+    TEN  +LV +FL H  L    F     L       I   + + LQ L   
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFL-HQDLKK--FMDASALTGIPLPLIKSYLFQLLQGLAFC 119
Query: 261 XXXXXXXXXXKASNILLSEDYEAQISDFGLAKWL---PDNWSHHIVFPIEGTFGYLSPEY 317
                     K  N+L++ +   +++DFGLA+        ++H +V     T  Y +PE 
Sbjct: 120 HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-----TLWYRAPEI 174
Query: 318 FM-HGIVDEKTDVFAFGVLLLELITGRRAV 346
            +         D+++ G +  E++T RRA+
Sbjct: 175 LLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 203

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 50/196 (25%), Positives = 81/196 (41%), Gaps = 6/196 (3%)
Query: 182 EERISDFLSELGIVAHINHPNAAKL-IGFSTENGFHLVLQFLPHGSLSSLLFGSTECLEW 240
           E ++     E  +++ ++HP   KL   F  +   +  L +  +G L   +       E 
Sbjct: 71  ENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDET 130
Query: 241 TIRYKIALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSH 300
             R+  A  I   L+YL             K  NILL+ED   QI+DFG AK L      
Sbjct: 131 CTRFYTA-EIVSALEYLHGKGIIHRDL---KPENILLNEDMHIQITDFGTAKVLSPESKQ 186
Query: 301 HIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPL 360
                  GT  Y+SPE        + +D++A G ++ +L+ G     +  + L I+ K +
Sbjct: 187 ARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYL-IFQKII 245
Query: 361 LQTSNFKELVDPRLAD 376
               +F E   P+  D
Sbjct: 246 KLEYDFPEKFFPKARD 261

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 50/196 (25%), Positives = 81/196 (41%), Gaps = 6/196 (3%)
Query: 182 EERISDFLSELGIVAHINHPNAAKL-IGFSTENGFHLVLQFLPHGSLSSLLFGSTECLEW 240
           E ++     E  +++ ++HP   KL   F  +   +  L +  +G L   +       E 
Sbjct: 74  ENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDET 133
Query: 241 TIRYKIALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSH 300
             R+  A  I   L+YL             K  NILL+ED   QI+DFG AK L      
Sbjct: 134 CTRFYTA-EIVSALEYLHGKGIIHRDL---KPENILLNEDMHIQITDFGTAKVLSPESKQ 189
Query: 301 HIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPL 360
                  GT  Y+SPE        + +D++A G ++ +L+ G     +  + L I+ K +
Sbjct: 190 ARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYL-IFQKII 248
Query: 361 LQTSNFKELVDPRLAD 376
               +F E   P+  D
Sbjct: 249 KLEYDFPEKFFPKARD 264

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 50/196 (25%), Positives = 81/196 (41%), Gaps = 6/196 (3%)
Query: 182 EERISDFLSELGIVAHINHPNAAKL-IGFSTENGFHLVLQFLPHGSLSSLLFGSTECLEW 240
           E ++     E  +++ ++HP   KL   F  +   +  L +  +G L   +       E 
Sbjct: 73  ENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDET 132
Query: 241 TIRYKIALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSH 300
             R+  A  I   L+YL             K  NILL+ED   QI+DFG AK L      
Sbjct: 133 CTRFYTA-EIVSALEYLHGKGIIHRDL---KPENILLNEDMHIQITDFGTAKVLSPESKQ 188
Query: 301 HIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPL 360
                  GT  Y+SPE        + +D++A G ++ +L+ G     +  + L I+ K +
Sbjct: 189 ARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYL-IFQKII 247
Query: 361 LQTSNFKELVDPRLAD 376
               +F E   P+  D
Sbjct: 248 KLEYDFPEKFFPKARD 263

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 50/196 (25%), Positives = 81/196 (41%), Gaps = 6/196 (3%)
Query: 182 EERISDFLSELGIVAHINHPNAAKL-IGFSTENGFHLVLQFLPHGSLSSLLFGSTECLEW 240
           E ++     E  +++ ++HP   KL   F  +   +  L +  +G L   +       E 
Sbjct: 71  ENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDET 130
Query: 241 TIRYKIALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSH 300
             R+  A  I   L+YL             K  NILL+ED   QI+DFG AK L      
Sbjct: 131 CTRFYTA-EIVSALEYLHGKGIIHRDL---KPENILLNEDMHIQITDFGTAKVLSPESKQ 186
Query: 301 HIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPL 360
                  GT  Y+SPE        + +D++A G ++ +L+ G     +  + L I+ K +
Sbjct: 187 ARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYL-IFQKII 245
Query: 361 LQTSNFKELVDPRLAD 376
               +F E   P+  D
Sbjct: 246 KLEYDFPEKFFPKARD 261

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 54/213 (25%), Positives = 88/213 (41%), Gaps = 14/213 (6%)
Query: 139 AATDNFNSENLIGKGGHAEVYKGCLPDGEXXXXXXXXXXXXEDEERISDFLSELGIVAHI 198
            + +NF     IG+G +  VYK                   E E   S  + E+ ++  +
Sbjct: 3   GSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 62
Query: 199 NHPNAAKLIG-FSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYL 257
           NHPN  KL+    TEN  +LV +FL H  L +  F     L       I   + + LQ L
Sbjct: 63  NHPNIVKLLDVIHTENKLYLVFEFL-HQDLKT--FMDASALTGIPLPLIKSYLFQLLQGL 119
Query: 258 XXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWL---PDNWSHHIVFPIEGTFGYLS 314
                        K  N+L++ +   +++DFGLA+        + H +V     T  Y +
Sbjct: 120 AFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-----TLWYRA 174
Query: 315 PEYFM-HGIVDEKTDVFAFGVLLLELITGRRAV 346
           PE  +         D+++ G +  E++T RRA+
Sbjct: 175 PEILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 206

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 54/210 (25%), Positives = 87/210 (41%), Gaps = 14/210 (6%)
Query: 142 DNFNSENLIGKGGHAEVYKGCLPDGEXXXXXXXXXXXXEDEERISDFLSELGIVAHINHP 201
           +NF     IG+G +  VYK                   E E   S  + E+ ++  +NHP
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 202 NAAKLIG-FSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLXXX 260
           N  KL+    TEN  +LV +FL H  L    F     L       I   + + LQ L   
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFL-HQDLKK--FMDASALTGIPLPLIKSYLFQLLQGLAFC 118
Query: 261 XXXXXXXXXXKASNILLSEDYEAQISDFGLAKWL---PDNWSHHIVFPIEGTFGYLSPEY 317
                     K  N+L++ +   +++DFGLA+        ++H +V     T  Y +PE 
Sbjct: 119 HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-----TLWYRAPEI 173
Query: 318 FM-HGIVDEKTDVFAFGVLLLELITGRRAV 346
            +         D+++ G +  E++T RRA+
Sbjct: 174 LLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 202

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 50/196 (25%), Positives = 81/196 (41%), Gaps = 6/196 (3%)
Query: 182 EERISDFLSELGIVAHINHPNAAKL-IGFSTENGFHLVLQFLPHGSLSSLLFGSTECLEW 240
           E ++     E  +++ ++HP   KL   F  +   +  L +  +G L   +       E 
Sbjct: 73  ENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDET 132
Query: 241 TIRYKIALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSH 300
             R+  A  I   L+YL             K  NILL+ED   QI+DFG AK L      
Sbjct: 133 CTRFYTA-EIVSALEYLHGKGIIHRDL---KPENILLNEDMHIQITDFGTAKVLSPESKQ 188
Query: 301 HIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPL 360
                  GT  Y+SPE        + +D++A G ++ +L+ G     +  + L I+ K +
Sbjct: 189 ARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYL-IFQKII 247
Query: 361 LQTSNFKELVDPRLAD 376
               +F E   P+  D
Sbjct: 248 KLEYDFPEKFFPKARD 263

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 54/210 (25%), Positives = 87/210 (41%), Gaps = 14/210 (6%)
Query: 142 DNFNSENLIGKGGHAEVYKGCLPDGEXXXXXXXXXXXXEDEERISDFLSELGIVAHINHP 201
           +NF     IG+G +  VYK                   E E   S  + E+ ++  +NHP
Sbjct: 10  ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 69
Query: 202 NAAKLIG-FSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLXXX 260
           N  KL+    TEN  +LV +FL H  L    F     L       I   + + LQ L   
Sbjct: 70  NIVKLLDVIHTENKLYLVFEFL-HQDLKK--FMDASALTGIPLPLIKSYLFQLLQGLAFC 126
Query: 261 XXXXXXXXXXKASNILLSEDYEAQISDFGLAKWL---PDNWSHHIVFPIEGTFGYLSPEY 317
                     K  N+L++ +   +++DFGLA+        ++H +V     T  Y +PE 
Sbjct: 127 HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-----TLWYRAPEI 181
Query: 318 FM-HGIVDEKTDVFAFGVLLLELITGRRAV 346
            +         D+++ G +  E++T RRA+
Sbjct: 182 LLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 210

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 55/210 (26%), Positives = 88/210 (41%), Gaps = 14/210 (6%)
Query: 142 DNFNSENLIGKGGHAEVYKGCLPDGEXXXXXXXXXXXXEDEERISDFLSELGIVAHINHP 201
           +NF     IG+G +  VYK                   E E   S  + E+ ++  +NHP
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 202 NAAKLIG-FSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLXXX 260
           N  KL+    TEN  +LV +FL H  L    F     L       I   + + LQ L   
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFL-HQDLKK--FMDASALTGIPLPLIKSYLFQLLQGLAFC 119
Query: 261 XXXXXXXXXXKASNILLSEDYEAQISDFGLAKWL---PDNWSHHIVFPIEGTFGYLSPEY 317
                     K  N+L++ +   +++DFGLA+        ++H +V     T  Y +PE 
Sbjct: 120 HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-----TLWYRAPEI 174
Query: 318 FM-HGIVDEKTDVFAFGVLLLELITGRRAV 346
            +         D+++ G +  E++T RRA+
Sbjct: 175 LLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 203

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 55/210 (26%), Positives = 88/210 (41%), Gaps = 14/210 (6%)
Query: 142 DNFNSENLIGKGGHAEVYKGCLPDGEXXXXXXXXXXXXEDEERISDFLSELGIVAHINHP 201
           +NF     IG+G +  VYK                   E E   S  + E+ ++  +NHP
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 202 NAAKLIG-FSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLXXX 260
           N  KL+    TEN  +LV +FL H  L    F     L       I   + + LQ L   
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFL-HQDLKK--FMDASALTGIPLPLIKSYLFQLLQGLAFC 118
Query: 261 XXXXXXXXXXKASNILLSEDYEAQISDFGLAKWL---PDNWSHHIVFPIEGTFGYLSPEY 317
                     K  N+L++ +   +++DFGLA+        ++H +V     T  Y +PE 
Sbjct: 119 HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-----TLWYRAPEI 173
Query: 318 FM-HGIVDEKTDVFAFGVLLLELITGRRAV 346
            +         D+++ G +  E++T RRA+
Sbjct: 174 LLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 202

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 48/172 (27%), Positives = 80/172 (46%), Gaps = 23/172 (13%)
Query: 188 FLSELGIVAHI-NHPNAAKLIGFSTENG--FHLVLQFLPHGSLSSLL------------- 231
            +SEL I+ HI +H N   L+G  T+ G    ++++F   G+LS+ L             
Sbjct: 79  LMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKPE 138
Query: 232 --FGSTECLEWTIRYKIALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFG 289
             +     LE  I Y  +  +A+G+++L              A NILLSE    +I DFG
Sbjct: 139 DLYKDFLTLEHLIXY--SFQVAKGMEFLASRKXIHRDLA---ARNILLSEKNVVKICDFG 193
Query: 290 LAKWLPDNWSHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELIT 341
           LA+ +  +              +++PE     +   ++DV++FGVLL E+ +
Sbjct: 194 LARDIXKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 54/213 (25%), Positives = 87/213 (40%), Gaps = 14/213 (6%)
Query: 139 AATDNFNSENLIGKGGHAEVYKGCLPDGEXXXXXXXXXXXXEDEERISDFLSELGIVAHI 198
            + +NF     IG+G +  VYK                   E E   S  + E+ ++  +
Sbjct: 2   GSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 61
Query: 199 NHPNAAKLIG-FSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYL 257
           NHPN  KL+    TEN  +LV +FL H  L    F     L       I   + + LQ L
Sbjct: 62  NHPNIVKLLDVIHTENKLYLVFEFL-HQDLKK--FMDASALTGIPLPLIKSYLFQLLQGL 118
Query: 258 XXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWL---PDNWSHHIVFPIEGTFGYLS 314
                        K  N+L++ +   +++DFGLA+        + H +V     T  Y +
Sbjct: 119 AFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-----TLWYRA 173
Query: 315 PEYFM-HGIVDEKTDVFAFGVLLLELITGRRAV 346
           PE  +         D+++ G +  E++T RRA+
Sbjct: 174 PEILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 205

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 69/315 (21%), Positives = 126/315 (40%), Gaps = 27/315 (8%)
Query: 126 RHSWKNFDFAELAAATDN-FNSENLIGKGGHAEVYKGCLPDGEXXXXXXXXXXXXEDEER 184
           R   K  D   L    +  F+    +G+G +  VYK                     E  
Sbjct: 12  RRQLKKLDEDSLTKQPEEVFDVLEKLGEGSYGSVYKAI----HKETGQIVAIKQVPVESD 67
Query: 185 ISDFLSELGIVAHINHPNAAKLIGFSTEN-GFHLVLQFLPHGSLSSLLFGSTECLEWTIR 243
           + + + E+ I+   + P+  K  G   +N    +V+++   GS+S ++    + L     
Sbjct: 68  LQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEI 127
Query: 244 YKIALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSHHIV 303
             I     +GL+YL             KA NILL+ +  A+++DFG+A  L D  +    
Sbjct: 128 ATILQSTLKGLEYLHFMRKIHRDI---KAGNILLNTEGHAKLADFGVAGQLTDXMAKRNX 184
Query: 304 FPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRA---VDSRRQSLVI----- 355
             + GT  +++PE       +   D+++ G+  +E+  G+     +   R   +I     
Sbjct: 185 --VIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPP 242
Query: 356 --WAKPLLQTSNFKELVDPRLADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQLLRG 413
             + KP L + NF + V   L  + +    +RA  TA+  + H      +   +L+ L  
Sbjct: 243 PTFRKPELWSDNFTDFVKQCLVKSPE----QRA--TATQLLQHPFVRSAKGVSILRDLIN 296
Query: 414 EGGQTDLKPKPSARR 428
           E     LK + S +R
Sbjct: 297 EAMDVKLKRQESQQR 311

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 54/213 (25%), Positives = 87/213 (40%), Gaps = 14/213 (6%)
Query: 139 AATDNFNSENLIGKGGHAEVYKGCLPDGEXXXXXXXXXXXXEDEERISDFLSELGIVAHI 198
            + +NF     IG+G +  VYK                   E E   S  + E+ ++  +
Sbjct: 3   GSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 62
Query: 199 NHPNAAKLIG-FSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYL 257
           NHPN  KL+    TEN  +LV +FL H  L    F     L       I   + + LQ L
Sbjct: 63  NHPNIVKLLDVIHTENKLYLVFEFL-HQDLKK--FMDASALTGIPLPLIKSYLFQLLQGL 119
Query: 258 XXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWL---PDNWSHHIVFPIEGTFGYLS 314
                        K  N+L++ +   +++DFGLA+        + H +V     T  Y +
Sbjct: 120 AFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-----TLWYRA 174
Query: 315 PEYFM-HGIVDEKTDVFAFGVLLLELITGRRAV 346
           PE  +         D+++ G +  E++T RRA+
Sbjct: 175 PEILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 206

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 54/213 (25%), Positives = 87/213 (40%), Gaps = 14/213 (6%)
Query: 139 AATDNFNSENLIGKGGHAEVYKGCLPDGEXXXXXXXXXXXXEDEERISDFLSELGIVAHI 198
            + +NF     IG+G +  VYK                   E E   S  + E+ ++  +
Sbjct: 2   GSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 61
Query: 199 NHPNAAKLIG-FSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYL 257
           NHPN  KL+    TEN  +LV +FL H  L    F     L       I   + + LQ L
Sbjct: 62  NHPNIVKLLDVIHTENKLYLVFEFL-HQDLKK--FMDASALTGIPLPLIKSYLFQLLQGL 118
Query: 258 XXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWL---PDNWSHHIVFPIEGTFGYLS 314
                        K  N+L++ +   +++DFGLA+        + H +V     T  Y +
Sbjct: 119 AFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-----TLWYRA 173
Query: 315 PEYFM-HGIVDEKTDVFAFGVLLLELITGRRAV 346
           PE  +         D+++ G +  E++T RRA+
Sbjct: 174 PEILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 205

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 54/213 (25%), Positives = 87/213 (40%), Gaps = 14/213 (6%)
Query: 139 AATDNFNSENLIGKGGHAEVYKGCLPDGEXXXXXXXXXXXXEDEERISDFLSELGIVAHI 198
            + +NF     IG+G +  VYK                   E E   S  + E+ ++  +
Sbjct: 1   GSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 60
Query: 199 NHPNAAKLIG-FSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYL 257
           NHPN  KL+    TEN  +LV +FL H  L    F     L       I   + + LQ L
Sbjct: 61  NHPNIVKLLDVIHTENKLYLVFEFL-HQDLKK--FMDASALTGIPLPLIKSYLFQLLQGL 117
Query: 258 XXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWL---PDNWSHHIVFPIEGTFGYLS 314
                        K  N+L++ +   +++DFGLA+        + H +V     T  Y +
Sbjct: 118 AFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-----TLWYRA 172
Query: 315 PEYFM-HGIVDEKTDVFAFGVLLLELITGRRAV 346
           PE  +         D+++ G +  E++T RRA+
Sbjct: 173 PEILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 204

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 57/211 (27%), Positives = 91/211 (43%), Gaps = 15/211 (7%)
Query: 138 AAATDNFNSENLIGKGGHAEVY--KGCLPDGEXXXXXXXXXXXXEDEERISDFLSELGIV 195
           A  +D +  + ++GKG   EV   K  +   E            +  ++ S  L E+ ++
Sbjct: 22  AIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKES-LLREVQLL 80
Query: 196 AHINHPNAAKLIGFSTENG-FHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGL 254
             ++HPN  KL  F  + G F+LV +    G L   +       E     +I   +  G+
Sbjct: 81  KQLDHPNIXKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAA-RIIRQVLSGI 139
Query: 255 QYLXXXXXXXXXXXXXKASNILL---SEDYEAQISDFGLAKWLPDNWSHHIVFPIEGTFG 311
            Y              K  N+LL   S+D   +I DFGL+     +          GT  
Sbjct: 140 TY---XHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKXKDKI---GTAY 193
Query: 312 YLSPEYFMHGIVDEKTDVFAFGVLLLELITG 342
           Y++PE  +HG  DEK DV++ GV+L  L++G
Sbjct: 194 YIAPE-VLHGTYDEKCDVWSTGVILYILLSG 223

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 54/212 (25%), Positives = 87/212 (41%), Gaps = 14/212 (6%)
Query: 140 ATDNFNSENLIGKGGHAEVYKGCLPDGEXXXXXXXXXXXXEDEERISDFLSELGIVAHIN 199
           + +NF     IG+G +  VYK                   E E   S  + E+ ++  +N
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 200 HPNAAKLIG-FSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLX 258
           HPN  KL+    TEN  +LV +FL H  L    F     L       I   + + LQ L 
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKK--FMDASALTGIPLPLIKSYLFQLLQGLA 117
Query: 259 XXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWL---PDNWSHHIVFPIEGTFGYLSP 315
                       K  N+L++ +   +++DFGLA+        + H +V     T  Y +P
Sbjct: 118 FCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-----TLWYRAP 172
Query: 316 EYFM-HGIVDEKTDVFAFGVLLLELITGRRAV 346
           E  +         D+++ G +  E++T RRA+
Sbjct: 173 EILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 203

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 54/213 (25%), Positives = 87/213 (40%), Gaps = 14/213 (6%)
Query: 139 AATDNFNSENLIGKGGHAEVYKGCLPDGEXXXXXXXXXXXXEDEERISDFLSELGIVAHI 198
            + +NF     IG+G +  VYK                   E E   S  + E+ ++  +
Sbjct: 2   GSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 61
Query: 199 NHPNAAKLIG-FSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYL 257
           NHPN  KL+    TEN  +LV +FL H  L    F     L       I   + + LQ L
Sbjct: 62  NHPNIVKLLDVIHTENKLYLVFEFL-HQDLKK--FMDASALTGIPLPLIKSYLFQLLQGL 118
Query: 258 XXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWL---PDNWSHHIVFPIEGTFGYLS 314
                        K  N+L++ +   +++DFGLA+        + H +V     T  Y +
Sbjct: 119 AFCHSHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-----TLWYRA 173
Query: 315 PEYFM-HGIVDEKTDVFAFGVLLLELITGRRAV 346
           PE  +         D+++ G +  E++T RRA+
Sbjct: 174 PEILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 205

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 54/213 (25%), Positives = 87/213 (40%), Gaps = 14/213 (6%)
Query: 139 AATDNFNSENLIGKGGHAEVYKGCLPDGEXXXXXXXXXXXXEDEERISDFLSELGIVAHI 198
            + +NF     IG+G +  VYK                   E E   S  + E+ ++  +
Sbjct: 4   GSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 63
Query: 199 NHPNAAKLIG-FSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYL 257
           NHPN  KL+    TEN  +LV +FL H  L    F     L       I   + + LQ L
Sbjct: 64  NHPNIVKLLDVIHTENKLYLVFEFL-HQDLKK--FMDASALTGIPLPLIKSYLFQLLQGL 120
Query: 258 XXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWL---PDNWSHHIVFPIEGTFGYLS 314
                        K  N+L++ +   +++DFGLA+        + H +V     T  Y +
Sbjct: 121 AFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-----TLWYRA 175
Query: 315 PEYFM-HGIVDEKTDVFAFGVLLLELITGRRAV 346
           PE  +         D+++ G +  E++T RRA+
Sbjct: 176 PEILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 207

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 50/196 (25%), Positives = 81/196 (41%), Gaps = 6/196 (3%)
Query: 182 EERISDFLSELGIVAHINHPNAAKL-IGFSTENGFHLVLQFLPHGSLSSLLFGSTECLEW 240
           E ++     E  +++ ++HP   KL   F  +   +  L +  +G L   +       E 
Sbjct: 55  ENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDET 114
Query: 241 TIRYKIALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSH 300
             R+  A  I   L+YL             K  NILL+ED   QI+DFG AK L      
Sbjct: 115 CTRFYTA-EIVSALEYLHGKGIIHRDL---KPENILLNEDMHIQITDFGTAKVLSPESKQ 170
Query: 301 HIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPL 360
                  GT  Y+SPE        + +D++A G ++ +L+ G     +  + L I+ K +
Sbjct: 171 ARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYL-IFQKII 229
Query: 361 LQTSNFKELVDPRLAD 376
               +F E   P+  D
Sbjct: 230 KLEYDFPEKFFPKARD 245

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 54/213 (25%), Positives = 87/213 (40%), Gaps = 14/213 (6%)
Query: 139 AATDNFNSENLIGKGGHAEVYKGCLPDGEXXXXXXXXXXXXEDEERISDFLSELGIVAHI 198
            + +NF     IG+G +  VYK                   E E   S  + E+ ++  +
Sbjct: 1   GSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 60
Query: 199 NHPNAAKLIG-FSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYL 257
           NHPN  KL+    TEN  +LV +FL H  L    F     L       I   + + LQ L
Sbjct: 61  NHPNIVKLLDVIHTENKLYLVFEFL-HQDLKK--FMDASALTGIPLPLIKSYLFQLLQGL 117
Query: 258 XXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWL---PDNWSHHIVFPIEGTFGYLS 314
                        K  N+L++ +   +++DFGLA+        + H +V     T  Y +
Sbjct: 118 AFCHSHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-----TLWYRA 172
Query: 315 PEYFM-HGIVDEKTDVFAFGVLLLELITGRRAV 346
           PE  +         D+++ G +  E++T RRA+
Sbjct: 173 PEILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 204

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 54/212 (25%), Positives = 87/212 (41%), Gaps = 14/212 (6%)
Query: 140 ATDNFNSENLIGKGGHAEVYKGCLPDGEXXXXXXXXXXXXEDEERISDFLSELGIVAHIN 199
           + +NF     IG+G +  VYK                   E E   S  + E+ ++  +N
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 200 HPNAAKLIG-FSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLX 258
           HPN  KL+    TEN  +LV +FL H  L    F     L       I   + + LQ L 
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKK--FMDASALTGIPLPLIKSYLFQLLQGLA 117
Query: 259 XXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWL---PDNWSHHIVFPIEGTFGYLSP 315
                       K  N+L++ +   +++DFGLA+        + H +V     T  Y +P
Sbjct: 118 FCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-----TLWYRAP 172
Query: 316 EYFM-HGIVDEKTDVFAFGVLLLELITGRRAV 346
           E  +         D+++ G +  E++T RRA+
Sbjct: 173 EILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 203

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 54/213 (25%), Positives = 87/213 (40%), Gaps = 14/213 (6%)
Query: 139 AATDNFNSENLIGKGGHAEVYKGCLPDGEXXXXXXXXXXXXEDEERISDFLSELGIVAHI 198
            + +NF     IG+G +  VYK                   E E   S  + E+ ++  +
Sbjct: 3   GSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 62
Query: 199 NHPNAAKLIG-FSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYL 257
           NHPN  KL+    TEN  +LV +FL H  L    F     L       I   + + LQ L
Sbjct: 63  NHPNIVKLLDVIHTENKLYLVFEFL-HQDLKK--FMDASALTGIPLPLIKSYLFQLLQGL 119
Query: 258 XXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWL---PDNWSHHIVFPIEGTFGYLS 314
                        K  N+L++ +   +++DFGLA+        + H +V     T  Y +
Sbjct: 120 AFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-----TLWYRA 174
Query: 315 PEYFM-HGIVDEKTDVFAFGVLLLELITGRRAV 346
           PE  +         D+++ G +  E++T RRA+
Sbjct: 175 PEILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 206

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 44/182 (24%), Positives = 88/182 (48%), Gaps = 30/182 (16%)
Query: 182 EERISDFLSELGIVAHI-NHPNAAKLIGFSTENG-FHLVLQFLPHGSLSSLL-------- 231
           E+ +SD +SE+ ++  I  H N   L+G  T++G  ++++++   G+L   L        
Sbjct: 68  EKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGM 127
Query: 232 ---FGSTECLEWTIRYK----IALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQ 284
              +      E  + +K        +A G++YL              A N+L++E+   +
Sbjct: 128 EYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLT---ARNVLVTENNVMK 184
Query: 285 ISDFGLAKWLPDNWSHHIVFPIEGTFG-----YLSPEYFMHGIVDEKTDVFAFGVLLLEL 339
           I+DFGLA+ +     ++I +  + T G     +++PE     +   ++DV++FGVL+ E+
Sbjct: 185 IADFGLARDI-----NNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEI 239
Query: 340 IT 341
            T
Sbjct: 240 FT 241

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 44/182 (24%), Positives = 88/182 (48%), Gaps = 30/182 (16%)
Query: 182 EERISDFLSELGIVAHI-NHPNAAKLIGFSTENG-FHLVLQFLPHGSLSSLL-------- 231
           E+ +SD +SE+ ++  I  H N   L+G  T++G  ++++++   G+L   L        
Sbjct: 81  EKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGM 140
Query: 232 ---FGSTECLEWTIRYK----IALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQ 284
              +      E  + +K        +A G++YL              A N+L++E+   +
Sbjct: 141 EYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLA---ARNVLVTENNVMR 197
Query: 285 ISDFGLAKWLPDNWSHHIVFPIEGTFG-----YLSPEYFMHGIVDEKTDVFAFGVLLLEL 339
           I+DFGLA+ +     ++I +  + T G     +++PE     +   ++DV++FGVL+ E+
Sbjct: 198 IADFGLARDI-----NNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEI 252
Query: 340 IT 341
            T
Sbjct: 253 FT 254

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 44/182 (24%), Positives = 88/182 (48%), Gaps = 30/182 (16%)
Query: 182 EERISDFLSELGIVAHI-NHPNAAKLIGFSTENG-FHLVLQFLPHGSLSSLL-------- 231
           E+ +SD +SE+ ++  I  H N   L+G  T++G  ++++++   G+L   L        
Sbjct: 73  EKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGM 132
Query: 232 ---FGSTECLEWTIRYK----IALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQ 284
              +      E  + +K        +A G++YL              A N+L++E+   +
Sbjct: 133 EYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLA---ARNVLVTENNVMK 189
Query: 285 ISDFGLAKWLPDNWSHHIVFPIEGTFG-----YLSPEYFMHGIVDEKTDVFAFGVLLLEL 339
           I+DFGLA+ +     ++I +  + T G     +++PE     +   ++DV++FGVL+ E+
Sbjct: 190 IADFGLARDI-----NNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEI 244
Query: 340 IT 341
            T
Sbjct: 245 FT 246

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 44/182 (24%), Positives = 88/182 (48%), Gaps = 30/182 (16%)
Query: 182 EERISDFLSELGIVAHI-NHPNAAKLIGFSTENG-FHLVLQFLPHGSLSSLL-------- 231
           E+ +SD +SE+ ++  I  H N   L+G  T++G  ++++++   G+L   L        
Sbjct: 70  EKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGM 129
Query: 232 ---FGSTECLEWTIRYK----IALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQ 284
              +      E  + +K        +A G++YL              A N+L++E+   +
Sbjct: 130 EYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLA---ARNVLVTENNVMK 186
Query: 285 ISDFGLAKWLPDNWSHHIVFPIEGTFG-----YLSPEYFMHGIVDEKTDVFAFGVLLLEL 339
           I+DFGLA+ +     ++I +  + T G     +++PE     +   ++DV++FGVL+ E+
Sbjct: 187 IADFGLARDI-----NNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEI 241
Query: 340 IT 341
            T
Sbjct: 242 FT 243

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 54/212 (25%), Positives = 87/212 (41%), Gaps = 14/212 (6%)
Query: 140 ATDNFNSENLIGKGGHAEVYKGCLPDGEXXXXXXXXXXXXEDEERISDFLSELGIVAHIN 199
           + +NF     IG+G +  VYK                   E E   S  + E+ ++  +N
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 200 HPNAAKLIG-FSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLX 258
           HPN  KL+    TEN  +LV +FL H  L    F     L       I   + + LQ L 
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKK--FMDASALTGIPLPLIKSYLFQLLQGLA 117
Query: 259 XXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWL---PDNWSHHIVFPIEGTFGYLSP 315
                       K  N+L++ +   +++DFGLA+        + H +V     T  Y +P
Sbjct: 118 FCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-----TLWYRAP 172
Query: 316 EYFM-HGIVDEKTDVFAFGVLLLELITGRRAV 346
           E  +         D+++ G +  E++T RRA+
Sbjct: 173 EILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 203

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 50/196 (25%), Positives = 81/196 (41%), Gaps = 6/196 (3%)
Query: 182 EERISDFLSELGIVAHINHPNAAKL-IGFSTENGFHLVLQFLPHGSLSSLLFGSTECLEW 240
           E ++     E  +++ ++HP   KL   F  +   +  L +  +G L   +       E 
Sbjct: 70  ENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDET 129
Query: 241 TIRYKIALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSH 300
             R+  A  I   L+YL             K  NILL+ED   QI+DFG AK L      
Sbjct: 130 CTRFYTA-EIVSALEYLHGKGIIHRDL---KPENILLNEDMHIQITDFGTAKVLSPESKQ 185
Query: 301 HIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPL 360
                  GT  Y+SPE        + +D++A G ++ +L+ G     +  + L I+ K +
Sbjct: 186 ARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYL-IFQKII 244
Query: 361 LQTSNFKELVDPRLAD 376
               +F E   P+  D
Sbjct: 245 KLEYDFPEKFFPKARD 260

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 47/174 (27%), Positives = 80/174 (45%), Gaps = 25/174 (14%)
Query: 188 FLSELGIVAHI-NHPNAAKLIGFSTENG--FHLVLQFLPHGSLSSLL------------- 231
            +SEL I+ HI +H N   L+G  T+ G    ++++F   G+LS+ L             
Sbjct: 114 LMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVA 173
Query: 232 ----FGSTECLEWTIRYKIALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISD 287
               +     LE  I Y  +  +A+G+++L              A NILLSE    +I D
Sbjct: 174 PEDLYKDFLTLEHLICY--SFQVAKGMEFLASRKCIHRDLA---ARNILLSEKNVVKICD 228
Query: 288 FGLAKWLPDNWSHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELIT 341
           FGLA+ +  +  +           +++PE     +   ++DV++FGVLL E+ +
Sbjct: 229 FGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 282

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 54/212 (25%), Positives = 87/212 (41%), Gaps = 14/212 (6%)
Query: 140 ATDNFNSENLIGKGGHAEVYKGCLPDGEXXXXXXXXXXXXEDEERISDFLSELGIVAHIN 199
           + +NF     IG+G +  VYK                   E E   S  + E+ ++  +N
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 200 HPNAAKLIG-FSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLX 258
           HPN  KL+    TEN  +LV +FL H  L    F     L       I   + + LQ L 
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKK--FMDASALTGIPLPLIKSYLFQLLQGLA 117
Query: 259 XXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWL---PDNWSHHIVFPIEGTFGYLSP 315
                       K  N+L++ +   +++DFGLA+        + H +V     T  Y +P
Sbjct: 118 FCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-----TLWYRAP 172
Query: 316 EYFM-HGIVDEKTDVFAFGVLLLELITGRRAV 346
           E  +         D+++ G +  E++T RRA+
Sbjct: 173 EILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 203

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 54/210 (25%), Positives = 86/210 (40%), Gaps = 14/210 (6%)
Query: 142 DNFNSENLIGKGGHAEVYKGCLPDGEXXXXXXXXXXXXEDEERISDFLSELGIVAHINHP 201
           +NF     IG+G +  VYK                   E E   S  + E+ ++  +NHP
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 202 NAAKLIG-FSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLXXX 260
           N  KL+    TEN  +LV +FL H  L    F     L       I   + + LQ L   
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFL-HQDLKK--FMDASALTGIPLPLIKSYLFQLLQGLAFC 118
Query: 261 XXXXXXXXXXKASNILLSEDYEAQISDFGLAKWL---PDNWSHHIVFPIEGTFGYLSPEY 317
                     K  N+L++ +   +++DFGLA+        + H +V     T  Y +PE 
Sbjct: 119 HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-----TLWYRAPEI 173
Query: 318 FM-HGIVDEKTDVFAFGVLLLELITGRRAV 346
            +         D+++ G +  E++T RRA+
Sbjct: 174 LLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 202

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 47/174 (27%), Positives = 80/174 (45%), Gaps = 25/174 (14%)
Query: 188 FLSELGIVAHI-NHPNAAKLIGFSTENG--FHLVLQFLPHGSLSSLL------------- 231
            +SEL I+ HI +H N   L+G  T+ G    ++++F   G+LS+ L             
Sbjct: 77  LMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVA 136
Query: 232 ----FGSTECLEWTIRYKIALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISD 287
               +     LE  I Y  +  +A+G+++L              A NILLSE    +I D
Sbjct: 137 PEDLYKDFLTLEHLICY--SFQVAKGMEFLASRKCIHRDLA---ARNILLSEKNVVKICD 191
Query: 288 FGLAKWLPDNWSHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELIT 341
           FGLA+ +  +  +           +++PE     +   ++DV++FGVLL E+ +
Sbjct: 192 FGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 44/182 (24%), Positives = 88/182 (48%), Gaps = 30/182 (16%)
Query: 182 EERISDFLSELGIVAHI-NHPNAAKLIGFSTENG-FHLVLQFLPHGSLSSLL-------- 231
           E+ +SD +SE+ ++  I  H N   L+G  T++G  ++++++   G+L   L        
Sbjct: 81  EKDLSDLVSEMEMMKMIGKHKNIITLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGM 140
Query: 232 ---FGSTECLEWTIRYK----IALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQ 284
              +      E  + +K        +A G++YL              A N+L++E+   +
Sbjct: 141 EYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLA---ARNVLVTENNVMK 197
Query: 285 ISDFGLAKWLPDNWSHHIVFPIEGTFG-----YLSPEYFMHGIVDEKTDVFAFGVLLLEL 339
           I+DFGLA+ +     ++I +  + T G     +++PE     +   ++DV++FGVL+ E+
Sbjct: 198 IADFGLARDI-----NNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEI 252
Query: 340 IT 341
            T
Sbjct: 253 FT 254

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 54/210 (25%), Positives = 86/210 (40%), Gaps = 14/210 (6%)
Query: 142 DNFNSENLIGKGGHAEVYKGCLPDGEXXXXXXXXXXXXEDEERISDFLSELGIVAHINHP 201
           +NF     IG+G +  VYK                   E E   S  + E+ ++  +NHP
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 202 NAAKLIG-FSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLXXX 260
           N  KL+    TEN  +LV +FL H  L    F     L       I   + + LQ L   
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFL-HQDLKK--FMDASALTGIPLPLIKSYLFQLLQGLAFC 118
Query: 261 XXXXXXXXXXKASNILLSEDYEAQISDFGLAKWL---PDNWSHHIVFPIEGTFGYLSPEY 317
                     K  N+L++ +   +++DFGLA+        + H +V     T  Y +PE 
Sbjct: 119 HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-----TLWYRAPEI 173
Query: 318 FM-HGIVDEKTDVFAFGVLLLELITGRRAV 346
            +         D+++ G +  E++T RRA+
Sbjct: 174 LLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 202

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 50/196 (25%), Positives = 81/196 (41%), Gaps = 6/196 (3%)
Query: 182 EERISDFLSELGIVAHINHPNAAKL-IGFSTENGFHLVLQFLPHGSLSSLLFGSTECLEW 240
           E ++     E  +++ ++HP   KL   F  +   +  L +  +G L   +       E 
Sbjct: 70  ENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDET 129
Query: 241 TIRYKIALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSH 300
             R+  A  I   L+YL             K  NILL+ED   QI+DFG AK L      
Sbjct: 130 CTRFYTA-EIVSALEYLHGKGIIHRDL---KPENILLNEDMHIQITDFGTAKVLSPESKQ 185
Query: 301 HIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPL 360
                  GT  Y+SPE        + +D++A G ++ +L+ G     +  + L I+ K +
Sbjct: 186 ARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYL-IFQKII 244
Query: 361 LQTSNFKELVDPRLAD 376
               +F E   P+  D
Sbjct: 245 KLEYDFPEKFFPKARD 260

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 54/212 (25%), Positives = 87/212 (41%), Gaps = 14/212 (6%)
Query: 140 ATDNFNSENLIGKGGHAEVYKGCLPDGEXXXXXXXXXXXXEDEERISDFLSELGIVAHIN 199
           + +NF     IG+G +  VYK                   E E   S  + E+ ++  +N
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 200 HPNAAKLIG-FSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLX 258
           HPN  KL+    TEN  +LV +FL H  L    F     L       I   + + LQ L 
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKD--FMDASALTGIPLPLIKSYLFQLLQGLA 117
Query: 259 XXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWL---PDNWSHHIVFPIEGTFGYLSP 315
                       K  N+L++ +   +++DFGLA+        + H +V     T  Y +P
Sbjct: 118 FCHSHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-----TLWYRAP 172
Query: 316 EYFM-HGIVDEKTDVFAFGVLLLELITGRRAV 346
           E  +         D+++ G +  E++T RRA+
Sbjct: 173 EILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 203

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 44/182 (24%), Positives = 87/182 (47%), Gaps = 30/182 (16%)
Query: 182 EERISDFLSELGIVAHI-NHPNAAKLIGFSTENG-FHLVLQFLPHGSLSSLL-------- 231
           E+ +SD +SE+ ++  I  H N   L+G  T++G  ++++++   G+L   L        
Sbjct: 81  EKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGM 140
Query: 232 ---FGSTECLEWTIRYK----IALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQ 284
              +      E  + +K        +A G++YL              A N+L++E+   +
Sbjct: 141 EYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLA---ARNVLVTENNVMK 197
Query: 285 ISDFGLAKWLPDNWSHHIVFPIEGTFG-----YLSPEYFMHGIVDEKTDVFAFGVLLLEL 339
           I+DFGLA+ +     ++I +    T G     +++PE     +   ++DV++FGVL+ E+
Sbjct: 198 IADFGLARDI-----NNIDYYKNTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEI 252
Query: 340 IT 341
            T
Sbjct: 253 FT 254

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 31/94 (32%), Positives = 48/94 (51%), Gaps = 1/94 (1%)
Query: 250 IAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNW-SHHIVFPIEG 308
           IA+  Q L             K +NIL+S     ++ DFG+A+ + D+  S      + G
Sbjct: 122 IADACQALNFSHQNGIIHRDVKPANILISATNAVKVVDFGIARAIADSGNSVXQTAAVIG 181
Query: 309 TFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITG 342
           T  YLSPE      VD ++DV++ G +L E++TG
Sbjct: 182 TAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTG 215

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 44/182 (24%), Positives = 88/182 (48%), Gaps = 30/182 (16%)
Query: 182 EERISDFLSELGIVAHI-NHPNAAKLIGFSTENG-FHLVLQFLPHGSLSSLL-------- 231
           E+ +SD +SE+ ++  I  H N   L+G  T++G  ++++++   G+L   L        
Sbjct: 81  EKDLSDLVSEMEMMKMIGKHKNIIHLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGM 140
Query: 232 ---FGSTECLEWTIRYK----IALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQ 284
              +      E  + +K        +A G++YL              A N+L++E+   +
Sbjct: 141 EYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLA---ARNVLVTENNVMK 197
Query: 285 ISDFGLAKWLPDNWSHHIVFPIEGTFG-----YLSPEYFMHGIVDEKTDVFAFGVLLLEL 339
           I+DFGLA+ +     ++I +  + T G     +++PE     +   ++DV++FGVL+ E+
Sbjct: 198 IADFGLARDI-----NNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEI 252
Query: 340 IT 341
            T
Sbjct: 253 FT 254

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 52.4 bits (124), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 41/160 (25%), Positives = 72/160 (45%), Gaps = 10/160 (6%)
Query: 188 FLSELGIVAHINHPNAAKL---IGFSTENGFHLVLQFLPHGSLSSLLFGSTECL-----E 239
            +SE+ ++  + HPN  +    I   T    ++V+++   G L+S++   T+       E
Sbjct: 52  LVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEE 111
Query: 240 WTIRYKIALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWS 299
           + +R    L +A    +              K +N+ L      ++ DFGLA+ L  + S
Sbjct: 112 FVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTS 171
Query: 300 HHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLEL 339
               F   GT  Y+SPE       +EK+D+++ G LL EL
Sbjct: 172 FAKTFV--GTPYYMSPEQMNRMSYNEKSDIWSLGCLLYEL 209

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 52.4 bits (124), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 47/174 (27%), Positives = 80/174 (45%), Gaps = 25/174 (14%)
Query: 188 FLSELGIVAHI-NHPNAAKLIGFSTENG--FHLVLQFLPHGSLSSLL------------- 231
            +SEL I+ HI +H N   L+G  T+ G    ++++F   G+LS+ L             
Sbjct: 79  LMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKEA 138
Query: 232 ----FGSTECLEWTIRYKIALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISD 287
               +     LE  I Y  +  +A+G+++L              A NILLSE    +I D
Sbjct: 139 PEDLYKDFLTLEHLICY--SFQVAKGMEFLASRKCIHRDLA---ARNILLSEKNVVKICD 193
Query: 288 FGLAKWLPDNWSHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELIT 341
           FGLA+ +  +  +           +++PE     +   ++DV++FGVLL E+ +
Sbjct: 194 FGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 247

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 52.4 bits (124), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 53/213 (24%), Positives = 87/213 (40%), Gaps = 14/213 (6%)
Query: 139 AATDNFNSENLIGKGGHAEVYKGCLPDGEXXXXXXXXXXXXEDEERISDFLSELGIVAHI 198
            + +NF     IG+G +  VYK                   E E   S  + E+ ++  +
Sbjct: 3   GSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 62
Query: 199 NHPNAAKLIG-FSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYL 257
           NHPN  KL+    TEN  +LV +FL   S+    F     L       I   + + LQ L
Sbjct: 63  NHPNIVKLLDVIHTENKLYLVFEFL---SMDLKKFMDASALTGIPLPLIKSYLFQLLQGL 119
Query: 258 XXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWL---PDNWSHHIVFPIEGTFGYLS 314
                        K  N+L++ +   +++DFGLA+        + H +V     T  Y +
Sbjct: 120 AFCHSHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-----TLWYRA 174
Query: 315 PEYFM-HGIVDEKTDVFAFGVLLLELITGRRAV 346
           PE  +         D+++ G +  E++T RRA+
Sbjct: 175 PEILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 206

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 54/210 (25%), Positives = 86/210 (40%), Gaps = 14/210 (6%)
Query: 142 DNFNSENLIGKGGHAEVYKGCLPDGEXXXXXXXXXXXXEDEERISDFLSELGIVAHINHP 201
           +NF     IG+G +  VYK                   E E   S  + E+ ++  +NHP
Sbjct: 4   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 63
Query: 202 NAAKLIG-FSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLXXX 260
           N  KL+    TEN  +LV +FL H  L    F     L       I   + + LQ L   
Sbjct: 64  NIVKLLDVIHTENKLYLVFEFL-HQDLKK--FMDASALTGIPLPLIKSYLFQLLQGLAFC 120
Query: 261 XXXXXXXXXXKASNILLSEDYEAQISDFGLAKWL---PDNWSHHIVFPIEGTFGYLSPEY 317
                     K  N+L++ +   +++DFGLA+        + H +V     T  Y +PE 
Sbjct: 121 HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-----TLWYRAPEI 175
Query: 318 FM-HGIVDEKTDVFAFGVLLLELITGRRAV 346
            +         D+++ G +  E++T RRA+
Sbjct: 176 LLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 204

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 41/160 (25%), Positives = 72/160 (45%), Gaps = 10/160 (6%)
Query: 188 FLSELGIVAHINHPNAAKL---IGFSTENGFHLVLQFLPHGSLSSLLFGSTECL-----E 239
            +SE+ ++  + HPN  +    I   T    ++V+++   G L+S++   T+       E
Sbjct: 52  LVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEE 111
Query: 240 WTIRYKIALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWS 299
           + +R    L +A    +              K +N+ L      ++ DFGLA+ L  + S
Sbjct: 112 FVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTS 171
Query: 300 HHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLEL 339
               F   GT  Y+SPE       +EK+D+++ G LL EL
Sbjct: 172 FAKAFV--GTPYYMSPEQMNRMSYNEKSDIWSLGCLLYEL 209

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 47/173 (27%), Positives = 79/173 (45%), Gaps = 24/173 (13%)
Query: 188 FLSELGIVAHI-NHPNAAKLIGFSTENG--FHLVLQFLPHGSLSSLL------------- 231
            +SEL I+ HI +H N   L+G  T+ G    ++++F   G+LS+ L             
Sbjct: 78  LMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTP 137
Query: 232 ---FGSTECLEWTIRYKIALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDF 288
              +     LE  I Y  +  +A+G+++L              A NILLSE    +I DF
Sbjct: 138 EDLYKDFLTLEHLICY--SFQVAKGMEFLASRKCIHRDLA---ARNILLSEKNVVKICDF 192
Query: 289 GLAKWLPDNWSHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELIT 341
           GLA+ +  +              +++PE     +   ++DV++FGVLL E+ +
Sbjct: 193 GLARDIXKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 53/213 (24%), Positives = 87/213 (40%), Gaps = 14/213 (6%)
Query: 139 AATDNFNSENLIGKGGHAEVYKGCLPDGEXXXXXXXXXXXXEDEERISDFLSELGIVAHI 198
            + +NF     IG+G +  VYK                   E E   S  + E+ ++  +
Sbjct: 1   GSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 60
Query: 199 NHPNAAKLIG-FSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYL 257
           NHPN  KL+    TEN  +LV +FL   S+    F     L       I   + + LQ L
Sbjct: 61  NHPNIVKLLDVIHTENKLYLVFEFL---SMDLKKFMDASALTGIPLPLIKSYLFQLLQGL 117
Query: 258 XXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWL---PDNWSHHIVFPIEGTFGYLS 314
                        K  N+L++ +   +++DFGLA+        + H +V     T  Y +
Sbjct: 118 AFCHSHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-----TLWYRA 172
Query: 315 PEYFM-HGIVDEKTDVFAFGVLLLELITGRRAV 346
           PE  +         D+++ G +  E++T RRA+
Sbjct: 173 PEILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 204

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 43/162 (26%), Positives = 68/162 (41%), Gaps = 5/162 (3%)
Query: 182 EERISDFLSELGIVAHINHPNAAKL-IGFSTENGFHLVLQFLPHGSLSSLLFGSTECLEW 240
           E ++     E  +++ ++HP   KL   F  +   +  L +  +G L   +       E 
Sbjct: 76  ENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDET 135
Query: 241 TIRYKIALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSH 300
             R+  A  I   L+YL             K  NILL+ED   QI+DFG AK L      
Sbjct: 136 CTRFYTA-EIVSALEYLHGKGIIHRDL---KPENILLNEDMHIQITDFGTAKVLSPESKQ 191
Query: 301 HIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITG 342
                  GT  Y+SPE        + +D++A G ++ +L+ G
Sbjct: 192 ARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 233

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 47/174 (27%), Positives = 79/174 (45%), Gaps = 25/174 (14%)
Query: 188 FLSELGIVAHI-NHPNAAKLIGFSTENG--FHLVLQFLPHGSLSSLL------------- 231
            +SEL I+ HI +H N   L+G  T+ G    ++++F   G+LS+ L             
Sbjct: 77  LMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVA 136
Query: 232 ----FGSTECLEWTIRYKIALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISD 287
               +     LE  I Y  +  +A+G+++L              A NILLSE    +I D
Sbjct: 137 PEDLYKDFLTLEHLICY--SFQVAKGMEFLASRKCIHRDLA---ARNILLSEKNVVKICD 191
Query: 288 FGLAKWLPDNWSHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELIT 341
           FGLA+ +  +              +++PE     +   ++DV++FGVLL E+ +
Sbjct: 192 FGLARDIXKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 47/174 (27%), Positives = 79/174 (45%), Gaps = 25/174 (14%)
Query: 188 FLSELGIVAHI-NHPNAAKLIGFSTENG--FHLVLQFLPHGSLSSLL------------- 231
            +SEL I+ HI +H N   L+G  T+ G    ++++F   G+LS+ L             
Sbjct: 68  LMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVA 127
Query: 232 ----FGSTECLEWTIRYKIALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISD 287
               +     LE  I Y  +  +A+G+++L              A NILLSE    +I D
Sbjct: 128 PEDLYKDFLTLEHLICY--SFQVAKGMEFLASRKCIHRDLA---ARNILLSEKNVVKICD 182
Query: 288 FGLAKWLPDNWSHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELIT 341
           FGLA+ +  +              +++PE     +   ++DV++FGVLL E+ +
Sbjct: 183 FGLARDIXKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 236

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 53/213 (24%), Positives = 87/213 (40%), Gaps = 14/213 (6%)
Query: 139 AATDNFNSENLIGKGGHAEVYKGCLPDGEXXXXXXXXXXXXEDEERISDFLSELGIVAHI 198
            + +NF     IG+G +  VYK                   E E   S  + E+ ++  +
Sbjct: 2   GSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 61
Query: 199 NHPNAAKLIG-FSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYL 257
           NHPN  KL+    TEN  +LV +FL   S+    F     L       I   + + LQ L
Sbjct: 62  NHPNIVKLLDVIHTENKLYLVFEFL---SMDLKDFMDASALTGIPLPLIKSYLFQLLQGL 118
Query: 258 XXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWL---PDNWSHHIVFPIEGTFGYLS 314
                        K  N+L++ +   +++DFGLA+        + H +V     T  Y +
Sbjct: 119 AFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-----TLWYRA 173
Query: 315 PEYFM-HGIVDEKTDVFAFGVLLLELITGRRAV 346
           PE  +         D+++ G +  E++T RRA+
Sbjct: 174 PEILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 205

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 44/182 (24%), Positives = 87/182 (47%), Gaps = 30/182 (16%)
Query: 182 EERISDFLSELGIVAHI-NHPNAAKLIGFSTENG-FHLVLQFLPHGSLSSLL-------- 231
           E+ +SD +SE+ ++  I  H N   L+G  T++G  ++++ +   G+L   L        
Sbjct: 81  EKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVAYASKGNLREYLRARRPPGM 140
Query: 232 ---FGSTECLEWTIRYK----IALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQ 284
              +      E  + +K        +A G++YL              A N+L++E+   +
Sbjct: 141 EYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLA---ARNVLVTENNVMK 197
Query: 285 ISDFGLAKWLPDNWSHHIVFPIEGTFG-----YLSPEYFMHGIVDEKTDVFAFGVLLLEL 339
           I+DFGLA+ +     ++I +  + T G     +++PE     +   ++DV++FGVL+ E+
Sbjct: 198 IADFGLARDI-----NNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEI 252
Query: 340 IT 341
            T
Sbjct: 253 FT 254

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 53/213 (24%), Positives = 87/213 (40%), Gaps = 14/213 (6%)
Query: 139 AATDNFNSENLIGKGGHAEVYKGCLPDGEXXXXXXXXXXXXEDEERISDFLSELGIVAHI 198
            + +NF     IG+G +  VYK                   E E   S  + E+ ++  +
Sbjct: 3   GSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 62
Query: 199 NHPNAAKLIG-FSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYL 257
           NHPN  KL+    TEN  +LV +FL   S+    F     L       I   + + LQ L
Sbjct: 63  NHPNIVKLLDVIHTENKLYLVFEFL---SMDLKDFMDASALTGIPLPLIKSYLFQLLQGL 119
Query: 258 XXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWL---PDNWSHHIVFPIEGTFGYLS 314
                        K  N+L++ +   +++DFGLA+        + H +V     T  Y +
Sbjct: 120 AFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-----TLWYRA 174
Query: 315 PEYFM-HGIVDEKTDVFAFGVLLLELITGRRAV 346
           PE  +         D+++ G +  E++T RRA+
Sbjct: 175 PEILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 206

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 47/174 (27%), Positives = 79/174 (45%), Gaps = 25/174 (14%)
Query: 188 FLSELGIVAHI-NHPNAAKLIGFSTENG--FHLVLQFLPHGSLSSLL------------- 231
            +SEL I+ HI +H N   L+G  T+ G    ++ +F   G+LS+ L             
Sbjct: 68  LMSELKILIHIGHHLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVA 127
Query: 232 ----FGSTECLEWTIRYKIALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISD 287
               +     LE  I Y  +  +A+G+++L              A NILLSE    +I D
Sbjct: 128 PEDLYKDFLTLEHLICY--SFQVAKGMEFLASRKCIHRDLA---ARNILLSEKNVVKICD 182
Query: 288 FGLAKWLPDNWSHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELIT 341
           FGLA+ +  +  +           +++PE     +   ++DV++FGVLL E+ +
Sbjct: 183 FGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 236

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 51.6 bits (122), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 46/160 (28%), Positives = 73/160 (45%), Gaps = 9/160 (5%)
Query: 186 SDFLSELGIVAHINHPNAAKLIGFSTENG---FHLVLQFLPHGSLSSLLFGSTECLEWTI 242
           S +  E+ I+  + H +  K  G   + G     LV++++P GSL   L   +  L   +
Sbjct: 61  SGWKQEIDILRTLYHEHIIKYKGCCEDQGEKSLQLVMEYVPLGSLRDYLPRHSIGLAQLL 120
Query: 243 RYKIALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSHHI 302
            +  A  I EG+ YL              A N+LL  D   +I DFGLAK +P+   ++ 
Sbjct: 121 LF--AQQICEGMAYLHSQHYIHRNLA---ARNVLLDNDRLVKIGDFGLAKAVPEGHEYYR 175
Query: 303 VFPI-EGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELIT 341
           V    +    + +PE          +DV++FGV L EL+T
Sbjct: 176 VREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLT 215

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 51.6 bits (122), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 30/94 (31%), Positives = 48/94 (51%), Gaps = 1/94 (1%)
Query: 250 IAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNW-SHHIVFPIEG 308
           IA+  Q L             K +NI++S     ++ DFG+A+ + D+  S      + G
Sbjct: 122 IADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIG 181
Query: 309 TFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITG 342
           T  YLSPE      VD ++DV++ G +L E++TG
Sbjct: 182 TAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTG 215

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 51.6 bits (122), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 47/174 (27%), Positives = 79/174 (45%), Gaps = 25/174 (14%)
Query: 188 FLSELGIVAHI-NHPNAAKLIGFSTENG--FHLVLQFLPHGSLSSLL------------- 231
            +SEL I+ HI +H N   L+G  T+ G    ++ +F   G+LS+ L             
Sbjct: 68  LMSELKILIHIGHHLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVA 127
Query: 232 ----FGSTECLEWTIRYKIALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISD 287
               +     LE  I Y  +  +A+G+++L              A NILLSE    +I D
Sbjct: 128 PEDLYKDFLTLEHLICY--SFQVAKGMEFLASRKCIHRDLA---ARNILLSEKNVVKICD 182
Query: 288 FGLAKWLPDNWSHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELIT 341
           FGLA+ +  +  +           +++PE     +   ++DV++FGVLL E+ +
Sbjct: 183 FGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 236

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 30/94 (31%), Positives = 48/94 (51%), Gaps = 1/94 (1%)
Query: 250 IAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNW-SHHIVFPIEG 308
           IA+  Q L             K +NI++S     ++ DFG+A+ + D+  S      + G
Sbjct: 122 IADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIG 181
Query: 309 TFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITG 342
           T  YLSPE      VD ++DV++ G +L E++TG
Sbjct: 182 TAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTG 215

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 50/178 (28%), Positives = 83/178 (46%), Gaps = 33/178 (18%)
Query: 188 FLSELGIVAHI-NHPNAAKLIGFSTENG--FHLVLQFLPHGSLSSLL------------- 231
            +SEL I+ HI +H N   L+G  T+ G    ++++F   G+LS+ L             
Sbjct: 77  LMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVA 136
Query: 232 ----FGSTECLEWTIRYKIALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISD 287
               +     LE  I Y  +  +A+G+++L              A NILLSE    +I D
Sbjct: 137 PEDLYKDFLTLEHLICY--SFQVAKGMEFLASRKCIHRDLA---ARNILLSEKNVVKICD 191
Query: 288 FGLAKWL---PDNWSH-HIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELIT 341
           FGLA+ +   PD         P++    +++PE     +   ++DV++FGVLL E+ +
Sbjct: 192 FGLARDIYKDPDXVRKGDARLPLK----WMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 44/182 (24%), Positives = 87/182 (47%), Gaps = 30/182 (16%)
Query: 182 EERISDFLSELGIVAHI-NHPNAAKLIGFSTENG-FHLVLQFLPHGSLSSLL-------- 231
           E+ +SD +SE+ ++  I  H N   L+G  T++G  ++++++   G+L   L        
Sbjct: 81  EKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGM 140
Query: 232 ---FGSTECLEWTIRYK----IALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQ 284
              +      E  + +K        +A G++YL              A N+L++E+   +
Sbjct: 141 EXSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLA---ARNVLVTENNVMK 197
Query: 285 ISDFGLAKWLPDNWSHHIVFPIEGTFG-----YLSPEYFMHGIVDEKTDVFAFGVLLLEL 339
           I+DFGLA+ +     ++I    + T G     +++PE     +   ++DV++FGVL+ E+
Sbjct: 198 IADFGLARDI-----NNIDXXKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEI 252
Query: 340 IT 341
            T
Sbjct: 253 FT 254

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 30/94 (31%), Positives = 48/94 (51%), Gaps = 1/94 (1%)
Query: 250 IAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNW-SHHIVFPIEG 308
           IA+  Q L             K +NI++S     ++ DFG+A+ + D+  S      + G
Sbjct: 122 IADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIG 181
Query: 309 TFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITG 342
           T  YLSPE      VD ++DV++ G +L E++TG
Sbjct: 182 TAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTG 215

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 46/160 (28%), Positives = 73/160 (45%), Gaps = 9/160 (5%)
Query: 186 SDFLSELGIVAHINHPNAAKLIGFSTENG---FHLVLQFLPHGSLSSLLFGSTECLEWTI 242
           S +  E+ I+  + H +  K  G   + G     LV++++P GSL   L   +  L   +
Sbjct: 61  SGWKQEIDILRTLYHEHIIKYKGCCEDQGEKSLQLVMEYVPLGSLRDYLPRHSIGLAQLL 120
Query: 243 RYKIALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSHHI 302
            +  A  I EG+ YL              A N+LL  D   +I DFGLAK +P+   ++ 
Sbjct: 121 LF--AQQICEGMAYLHAQHYIHRNLA---ARNVLLDNDRLVKIGDFGLAKAVPEGHEYYR 175
Query: 303 VFPI-EGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELIT 341
           V    +    + +PE          +DV++FGV L EL+T
Sbjct: 176 VREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLT 215

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 44/182 (24%), Positives = 87/182 (47%), Gaps = 30/182 (16%)
Query: 182 EERISDFLSELGIVAHI-NHPNAAKLIGFSTENG-FHLVLQFLPHGSLSSLL-------- 231
           E+ +SD +SE+ ++  I  H N   L+G  T++G  ++++++   G+L   L        
Sbjct: 81  EKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGM 140
Query: 232 ---FGSTECLEWTIRYK----IALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQ 284
              +      E  + +K        +A G++YL              A N+L++E+   +
Sbjct: 141 EYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLA---ARNVLVTENNVMK 197
Query: 285 ISDFGLAKWLPDNWSHHIVFPIEGTFG-----YLSPEYFMHGIVDEKTDVFAFGVLLLEL 339
           I+DFGLA+ +     ++I    + T G     +++PE     +   ++DV++FGVL+ E+
Sbjct: 198 IADFGLARDI-----NNIDXXKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEI 252
Query: 340 IT 341
            T
Sbjct: 253 FT 254

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 30/94 (31%), Positives = 48/94 (51%), Gaps = 1/94 (1%)
Query: 250 IAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNW-SHHIVFPIEG 308
           IA+  Q L             K +NI++S     ++ DFG+A+ + D+  S      + G
Sbjct: 122 IADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIG 181
Query: 309 TFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITG 342
           T  YLSPE      VD ++DV++ G +L E++TG
Sbjct: 182 TAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTG 215

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 44/182 (24%), Positives = 87/182 (47%), Gaps = 30/182 (16%)
Query: 182 EERISDFLSELGIVAHI-NHPNAAKLIGFSTENG-FHLVLQFLPHGSLSSLL-------- 231
           E+ +SD +SE+ ++  I  H N   L+G  T++G  ++++ +   G+L   L        
Sbjct: 81  EKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVGYASKGNLREYLRARRPPGM 140
Query: 232 ---FGSTECLEWTIRYK----IALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQ 284
              +      E  + +K        +A G++YL              A N+L++E+   +
Sbjct: 141 EYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLA---ARNVLVTENNVMK 197
Query: 285 ISDFGLAKWLPDNWSHHIVFPIEGTFG-----YLSPEYFMHGIVDEKTDVFAFGVLLLEL 339
           I+DFGLA+ +     ++I +  + T G     +++PE     +   ++DV++FGVL+ E+
Sbjct: 198 IADFGLARDI-----NNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEI 252
Query: 340 IT 341
            T
Sbjct: 253 FT 254

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 38/165 (23%), Positives = 80/165 (48%), Gaps = 23/165 (13%)
Query: 187 DFLSELGIVAHINHPNAAKLIGFST-ENGFHLVLQFLPHGSLSSLL------FGSTECLE 239
           +F+ E  ++ +++H    +L G  T +    ++ +++ +G L + L      F + + LE
Sbjct: 45  EFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLE 104
Query: 240 WTIRYKIALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKW-LPDNW 298
                 +   + E ++YL              A N L+++    ++SDFGL+++ L D +
Sbjct: 105 ------MCKDVCEAMEYLESKQFLHRDLA---ARNCLVNDQGVVKVSDFGLSRYVLDDEY 155
Query: 299 SHHI--VFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELIT 341
           +  +   FP+  +     PE  M+     K+D++AFGVL+ E+ +
Sbjct: 156 TSSVGSKFPVRWS----PPEVLMYSKFSSKSDIWAFGVLMWEIYS 196

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 39/160 (24%), Positives = 78/160 (48%), Gaps = 13/160 (8%)
Query: 187 DFLSELGIVAHINHPNAAKLIGFSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKI 246
           + L+E  ++  +++P   ++IG      + LV++    G L+  L  +    +  I  ++
Sbjct: 417 ELLAEANVMQQLDNPYIVRMIGICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNI-IEL 475
Query: 247 ALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSH-----H 301
              ++ G++YL              A N+LL   + A+ISDFGL+K L  + ++     H
Sbjct: 476 VHQVSMGMKYLEESNFVHRDLA---ARNVLLVTQHYAKISDFGLSKALRADENYYKAQTH 532
Query: 302 IVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELIT 341
             +P++    + +PE   +     K+DV++FGVL+ E  +
Sbjct: 533 GKWPVK----WYAPECINYYKFSSKSDVWSFGVLMWEAFS 568

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 38/165 (23%), Positives = 79/165 (47%), Gaps = 23/165 (13%)
Query: 187 DFLSELGIVAHINHPNAAKLIGFST-ENGFHLVLQFLPHGSLSSLL------FGSTECLE 239
           +F+ E  ++ +++H    +L G  T +    ++ +++ +G L + L      F + + LE
Sbjct: 65  EFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLE 124
Query: 240 WTIRYKIALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWS 299
                 +   + E ++YL              A N L+++    ++SDFGL++++ D+  
Sbjct: 125 ------MCKDVCEAMEYLESKQFLHRDLA---ARNCLVNDQGVVKVSDFGLSRYVLDDEE 175
Query: 300 HHIV---FPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELIT 341
              V   FP+  +     PE  M+     K+D++AFGVL+ E+ +
Sbjct: 176 TSSVGSKFPVRWS----PPEVLMYSKFSSKSDIWAFGVLMWEIYS 216

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 39/160 (24%), Positives = 78/160 (48%), Gaps = 13/160 (8%)
Query: 187 DFLSELGIVAHINHPNAAKLIGFSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKI 246
           + L+E  ++  +++P   ++IG      + LV++    G L+  L  +    +  I  ++
Sbjct: 74  ELLAEANVMQQLDNPYIVRMIGICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNI-IEL 132
Query: 247 ALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSH-----H 301
              ++ G++YL              A N+LL   + A+ISDFGL+K L  + ++     H
Sbjct: 133 VHQVSMGMKYLEESNFVHRDLA---ARNVLLVTQHYAKISDFGLSKALRADENYYKAQTH 189
Query: 302 IVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELIT 341
             +P++    + +PE   +     K+DV++FGVL+ E  +
Sbjct: 190 GKWPVK----WYAPECINYYKFSSKSDVWSFGVLMWEAFS 225

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 39/160 (24%), Positives = 78/160 (48%), Gaps = 13/160 (8%)
Query: 187 DFLSELGIVAHINHPNAAKLIGFSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKI 246
           + L+E  ++  +++P   ++IG      + LV++    G L+  L  +    +  I  ++
Sbjct: 74  ELLAEANVMQQLDNPYIVRMIGICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNI-IEL 132
Query: 247 ALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSH-----H 301
              ++ G++YL              A N+LL   + A+ISDFGL+K L  + ++     H
Sbjct: 133 VHQVSMGMKYLEESNFVHRDLA---ARNVLLVTQHYAKISDFGLSKALRADENYYKAQTH 189
Query: 302 IVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELIT 341
             +P++    + +PE   +     K+DV++FGVL+ E  +
Sbjct: 190 GKWPVK----WYAPECINYYKFSSKSDVWSFGVLMWEAFS 225

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 38/165 (23%), Positives = 79/165 (47%), Gaps = 23/165 (13%)
Query: 187 DFLSELGIVAHINHPNAAKLIGFST-ENGFHLVLQFLPHGSLSSLL------FGSTECLE 239
           +F+ E  ++ +++H    +L G  T +    ++ +++ +G L + L      F + + LE
Sbjct: 49  EFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLE 108
Query: 240 WTIRYKIALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWS 299
                 +   + E ++YL              A N L+++    ++SDFGL++++ D+  
Sbjct: 109 ------MCKDVCEAMEYLESKQFLHRDLA---ARNCLVNDQGVVKVSDFGLSRYVLDDEY 159
Query: 300 HHIV---FPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELIT 341
              V   FP+  +     PE  M+     K+D++AFGVL+ E+ +
Sbjct: 160 TSSVGSKFPVRWS----PPEVLMYSKFSSKSDIWAFGVLMWEIYS 200

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 30/94 (31%), Positives = 48/94 (51%), Gaps = 1/94 (1%)
Query: 250 IAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNW-SHHIVFPIEG 308
           IA+  Q L             K +NI++S     ++ DFG+A+ + D+  S      + G
Sbjct: 139 IADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIG 198
Query: 309 TFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITG 342
           T  YLSPE      VD ++DV++ G +L E++TG
Sbjct: 199 TAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTG 232

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 39/160 (24%), Positives = 78/160 (48%), Gaps = 13/160 (8%)
Query: 187 DFLSELGIVAHINHPNAAKLIGFSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKI 246
           + L+E  ++  +++P   ++IG      + LV++    G L+  L  +    +  I  ++
Sbjct: 64  ELLAEANVMQQLDNPYIVRMIGICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNI-IEL 122
Query: 247 ALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSH-----H 301
              ++ G++YL              A N+LL   + A+ISDFGL+K L  + ++     H
Sbjct: 123 VHQVSMGMKYLEESNFVHRDLA---ARNVLLVTQHYAKISDFGLSKALRADENYYKAQTH 179
Query: 302 IVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELIT 341
             +P++    + +PE   +     K+DV++FGVL+ E  +
Sbjct: 180 GKWPVK----WYAPECINYYKFSSKSDVWSFGVLMWEAFS 215

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 38/160 (23%), Positives = 75/160 (46%), Gaps = 12/160 (7%)
Query: 187 DFLSELGIVAHINHPNAAKLIGFSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKI 246
           + + E  I+  +++P   +LIG        LV++    G L   L G  E +  +   ++
Sbjct: 56  EMMREAQIMHQLDNPYIVRLIGVCQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAEL 115
Query: 247 ALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSHHIV--- 303
              ++ G++YL              A N+LL   + A+ISDFGL+K L  + S++     
Sbjct: 116 LHQVSMGMKYLEEKNFVHRDLA---ARNVLLVNRHYAKISDFGLSKALGADDSYYTARSA 172
Query: 304 --FPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELIT 341
             +P++    + +PE         ++DV+++GV + E ++
Sbjct: 173 GKWPLK----WYAPECINFRKFSSRSDVWSYGVTMWEALS 208

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 39/160 (24%), Positives = 78/160 (48%), Gaps = 13/160 (8%)
Query: 187 DFLSELGIVAHINHPNAAKLIGFSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKI 246
           + L+E  ++  +++P   ++IG      + LV++    G L+  L  +    +  I  ++
Sbjct: 72  ELLAEANVMQQLDNPYIVRMIGICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNI-IEL 130
Query: 247 ALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSH-----H 301
              ++ G++YL              A N+LL   + A+ISDFGL+K L  + ++     H
Sbjct: 131 VHQVSMGMKYLEESNFVHRDLA---ARNVLLVTQHYAKISDFGLSKALRADENYYKAQTH 187
Query: 302 IVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELIT 341
             +P++    + +PE   +     K+DV++FGVL+ E  +
Sbjct: 188 GKWPVK----WYAPECINYYKFSSKSDVWSFGVLMWEAFS 223

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 39/160 (24%), Positives = 78/160 (48%), Gaps = 13/160 (8%)
Query: 187 DFLSELGIVAHINHPNAAKLIGFSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKI 246
           + L+E  ++  +++P   ++IG      + LV++    G L+  L  +    +  I  ++
Sbjct: 416 ELLAEANVMQQLDNPYIVRMIGICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNI-IEL 474
Query: 247 ALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSH-----H 301
              ++ G++YL              A N+LL   + A+ISDFGL+K L  + ++     H
Sbjct: 475 VHQVSMGMKYLEESNFVHRDLA---ARNVLLVTQHYAKISDFGLSKALRADENYYKAQTH 531
Query: 302 IVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELIT 341
             +P++    + +PE   +     K+DV++FGVL+ E  +
Sbjct: 532 GKWPVK----WYAPECINYYKFSSKSDVWSFGVLMWEAFS 567

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 59/240 (24%), Positives = 98/240 (40%), Gaps = 17/240 (7%)
Query: 144 FNSENLIGKGGHAEVYKGCLPDGEXXXXXXXXXXXXEDEERISDFLSELGIVAHINHPNA 203
           F     IGKG   EV+KG + +              E E+ I D   E+ +++  +    
Sbjct: 25  FTKLERIGKGSFGEVFKG-IDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSSYV 83
Query: 204 AKLIG-FSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLXXXXX 262
            K  G +   +   +++++L  GS   LL            ++IA  + E L+ L     
Sbjct: 84  TKYYGSYLKGSKLWIIMEYLGGGSALDLLRAGP-----FDEFQIATMLKEILKGLDYLHS 138
Query: 263 XXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEGTFGYLSPEYFMHGI 322
                   KA+N+LLSE  + +++DFG+A  L D       F   GT  +++PE      
Sbjct: 139 EKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTF--VGTPFWMAPEVIQQSA 196
Query: 323 VDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQ--------TSNFKELVDPRL 374
            D K D+++ G+  +EL  G           V++  P           T +FKE +D  L
Sbjct: 197 YDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNNPPTLVGDFTKSFKEFIDACL 256

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 47/174 (27%), Positives = 78/174 (44%), Gaps = 25/174 (14%)
Query: 188 FLSELGIVAHI-NHPNAAKLIGFSTENG--FHLVLQFLPHGSLSSLL------------- 231
            +SEL I+ HI +H N   L+G  T+ G    ++ +F   G+LS+ L             
Sbjct: 68  LMSELKILIHIGHHLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVA 127
Query: 232 ----FGSTECLEWTIRYKIALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISD 287
               +     LE  I Y  +  +A+G+++L              A NILLSE    +I D
Sbjct: 128 PEDLYKDFLTLEHLICY--SFQVAKGMEFLASRKCIHRDLA---ARNILLSEKNVVKICD 182
Query: 288 FGLAKWLPDNWSHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELIT 341
           FGLA+ +  +              +++PE     +   ++DV++FGVLL E+ +
Sbjct: 183 FGLARDIXKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 236

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 38/160 (23%), Positives = 75/160 (46%), Gaps = 12/160 (7%)
Query: 187 DFLSELGIVAHINHPNAAKLIGFSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKI 246
           + + E  I+  +++P   +LIG        LV++    G L   L G  E +  +   ++
Sbjct: 382 EMMREAQIMHQLDNPYIVRLIGVCQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAEL 441
Query: 247 ALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSHHIV--- 303
              ++ G++YL              A N+LL   + A+ISDFGL+K L  + S++     
Sbjct: 442 LHQVSMGMKYLEEKNFVHRNLA---ARNVLLVNRHYAKISDFGLSKALGADDSYYTARSA 498
Query: 304 --FPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELIT 341
             +P++    + +PE         ++DV+++GV + E ++
Sbjct: 499 GKWPLK----WYAPECINFRKFSSRSDVWSYGVTMWEALS 534

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 39/160 (24%), Positives = 78/160 (48%), Gaps = 13/160 (8%)
Query: 187 DFLSELGIVAHINHPNAAKLIGFSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKI 246
           + L+E  ++  +++P   ++IG      + LV++    G L+  L  +    +  I  ++
Sbjct: 58  ELLAEANVMQQLDNPYIVRMIGICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNI-IEL 116
Query: 247 ALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSH-----H 301
              ++ G++YL              A N+LL   + A+ISDFGL+K L  + ++     H
Sbjct: 117 VHQVSMGMKYLEESNFVHRDLA---ARNVLLVTQHYAKISDFGLSKALRADENYYKAQTH 173
Query: 302 IVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELIT 341
             +P++    + +PE   +     K+DV++FGVL+ E  +
Sbjct: 174 GKWPVK----WYAPECINYYKFSSKSDVWSFGVLMWEAFS 209

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 39/160 (24%), Positives = 78/160 (48%), Gaps = 13/160 (8%)
Query: 187 DFLSELGIVAHINHPNAAKLIGFSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKI 246
           + L+E  ++  +++P   ++IG      + LV++    G L+  L  +    +  I  ++
Sbjct: 52  ELLAEANVMQQLDNPYIVRMIGICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNI-IEL 110
Query: 247 ALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSH-----H 301
              ++ G++YL              A N+LL   + A+ISDFGL+K L  + ++     H
Sbjct: 111 VHQVSMGMKYLEESNFVHRDLA---ARNVLLVTQHYAKISDFGLSKALRADENYYKAQTH 167
Query: 302 IVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELIT 341
             +P++    + +PE   +     K+DV++FGVL+ E  +
Sbjct: 168 GKWPVK----WYAPECINYYKFSSKSDVWSFGVLMWEAFS 203

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 38/165 (23%), Positives = 80/165 (48%), Gaps = 23/165 (13%)
Query: 187 DFLSELGIVAHINHPNAAKLIGFST-ENGFHLVLQFLPHGSLSSLL------FGSTECLE 239
           +F+ E  ++ +++H    +L G  T +    ++ +++ +G L + L      F + + LE
Sbjct: 50  EFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLE 109
Query: 240 WTIRYKIALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKW-LPDNW 298
                 +   + E ++YL              A N L+++    ++SDFGL+++ L D +
Sbjct: 110 ------MCKDVCEAMEYLESKQFLHRDLA---ARNCLVNDQGVVKVSDFGLSRYVLDDEY 160
Query: 299 SHHI--VFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELIT 341
           +  +   FP+  +     PE  M+     K+D++AFGVL+ E+ +
Sbjct: 161 TSSVGSKFPVRWS----PPEVLMYSKFSSKSDIWAFGVLMWEIYS 201

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 38/165 (23%), Positives = 80/165 (48%), Gaps = 23/165 (13%)
Query: 187 DFLSELGIVAHINHPNAAKLIGFST-ENGFHLVLQFLPHGSLSSLL------FGSTECLE 239
           +F+ E  ++ +++H    +L G  T +    ++ +++ +G L + L      F + + LE
Sbjct: 65  EFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLE 124
Query: 240 WTIRYKIALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKW-LPDNW 298
                 +   + E ++YL              A N L+++    ++SDFGL+++ L D +
Sbjct: 125 ------MCKDVCEAMEYLESKQFLHRDLA---ARNCLVNDQGVVKVSDFGLSRYVLDDEY 175
Query: 299 SHHI--VFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELIT 341
           +  +   FP+  +     PE  M+     K+D++AFGVL+ E+ +
Sbjct: 176 TSSVGSKFPVRWS----PPEVLMYSKFSSKSDIWAFGVLMWEIYS 216

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 92/221 (41%), Gaps = 20/221 (9%)
Query: 128 SWKNFDFAELAAATDN---FNSENLIGKGGHAEVYKGC-LPDGEXXXXXXXXXXXXEDEE 183
           S K+ D AEL    D    F+    IG G    VY    + + E            +  E
Sbjct: 37  SLKDPDVAELFFKDDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNE 96
Query: 184 RISDFLSELGIVAHINHPNAAKLIG-FSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTI 242
           +  D + E+  +  + HPN  +  G +  E+   LV+++   GS S LL    + L+   
Sbjct: 97  KWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYC-LGSASDLLEVHKKPLQEVE 155
Query: 243 RYKIALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWL-PDNWSHH 301
              +  G  +GL YL             KA NILLSE    ++ DFG A  + P N    
Sbjct: 156 IAAVTHGALQGLAYLHSHNMIHRDV---KAGNILLSEPGLVKLGDFGSASIMAPAN---- 208
Query: 302 IVFPIEGTFGYLSPEYFM---HGIVDEKTDVFAFGVLLLEL 339
                 GT  +++PE  +    G  D K DV++ G+  +EL
Sbjct: 209 ---XFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 246

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 38/165 (23%), Positives = 80/165 (48%), Gaps = 23/165 (13%)
Query: 187 DFLSELGIVAHINHPNAAKLIGFST-ENGFHLVLQFLPHGSLSSLL------FGSTECLE 239
           +F+ E  ++ +++H    +L G  T +    ++ +++ +G L + L      F + + LE
Sbjct: 56  EFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLE 115
Query: 240 WTIRYKIALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKW-LPDNW 298
                 +   + E ++YL              A N L+++    ++SDFGL+++ L D +
Sbjct: 116 ------MCKDVCEAMEYLESKQFLHRDLA---ARNCLVNDQGVVKVSDFGLSRYVLDDEY 166
Query: 299 SHHI--VFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELIT 341
           +  +   FP+  +     PE  M+     K+D++AFGVL+ E+ +
Sbjct: 167 TSSVGSKFPVRWS----PPEVLMYSKFSSKSDIWAFGVLMWEIYS 207

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 39/160 (24%), Positives = 78/160 (48%), Gaps = 13/160 (8%)
Query: 187 DFLSELGIVAHINHPNAAKLIGFSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKI 246
           + L+E  ++  +++P   ++IG      + LV++    G L+  L  +    +  I  ++
Sbjct: 54  ELLAEANVMQQLDNPYIVRMIGICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNI-IEL 112
Query: 247 ALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSH-----H 301
              ++ G++YL              A N+LL   + A+ISDFGL+K L  + ++     H
Sbjct: 113 VHQVSMGMKYLEESNFVHRDLA---ARNVLLVTQHYAKISDFGLSKALRADENYYKAQTH 169
Query: 302 IVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELIT 341
             +P++    + +PE   +     K+DV++FGVL+ E  +
Sbjct: 170 GKWPVK----WYAPECINYYKFSSKSDVWSFGVLMWEAFS 205

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 40/160 (25%), Positives = 70/160 (43%), Gaps = 10/160 (6%)
Query: 188 FLSELGIVAHINHPNAAKL---IGFSTENGFHLVLQFLPHGSLSSLLFGSTECL-----E 239
            +SE+ ++  + HPN  +    I   T    ++V+++   G L+S++   T+       E
Sbjct: 52  LVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEE 111
Query: 240 WTIRYKIALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWS 299
           + +R    L +A    +              K +N+ L      ++ DFGLA+ L  N  
Sbjct: 112 FVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARIL--NHD 169
Query: 300 HHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLEL 339
                   GT  Y+SPE       +EK+D+++ G LL EL
Sbjct: 170 EDFAKEFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYEL 209

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 58/230 (25%), Positives = 93/230 (40%), Gaps = 24/230 (10%)
Query: 128 SWKNFDFAELAAATDNFNSENLIGKGGHAEVYKGCLPDGEXXXXXXXXXXXXEDEERISD 187
           S    D + L      F    L+G G + +VYKG                  ++EE I  
Sbjct: 10  SLDEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQ 69
Query: 188 FLSELGIVAHINHPNAAKLIGF-------STENGFHLVLQFLPHGSLSSLLF---GSTEC 237
            ++ L   +H  H N A   G          ++   LV++F   GS++ L+    G+T  
Sbjct: 70  EINMLKKYSH--HRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLK 127
Query: 238 LEWTIRYKIALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDN 297
            EW I Y I   I  GL +L             K  N+LL+E+ E ++ DFG++  L   
Sbjct: 128 EEW-IAY-ICREILRGLSHLHQHKVIHRDI---KGQNVLLTENAEVKLVDFGVSAQLDRT 182
Query: 298 WSHHIVFPIEGTFGYLSPEYFM-----HGIVDEKTDVFAFGVLLLELITG 342
                 F   GT  +++PE            D K+D+++ G+  +E+  G
Sbjct: 183 VGRRNTFI--GTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEG 230

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 38/165 (23%), Positives = 79/165 (47%), Gaps = 23/165 (13%)
Query: 187 DFLSELGIVAHINHPNAAKLIGFST-ENGFHLVLQFLPHGSLSSLL------FGSTECLE 239
           +F+ E  ++ +++H    +L G  T +    ++ +++ +G L + L      F + + LE
Sbjct: 50  EFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLE 109
Query: 240 WTIRYKIALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDN-- 297
                 +   + E ++YL              A N L+++    ++SDFGL++++ D+  
Sbjct: 110 ------MCKDVCEAMEYLESKQFLHRDLA---ARNCLVNDQGVVKVSDFGLSRYVLDDEY 160
Query: 298 -WSHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELIT 341
             S    FP+  +     PE  M+     K+D++AFGVL+ E+ +
Sbjct: 161 TSSRGSKFPVRWS----PPEVLMYSKFSSKSDIWAFGVLMWEIYS 201

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 53/225 (23%), Positives = 94/225 (41%), Gaps = 27/225 (12%)
Query: 136 ELAAATDNFNSENLIGKGGHAEVY----KGCLPD-GEXXXXXXXXXXXXEDEERISDFLS 190
           E   A +       +G+G    VY    KG + D  E               ERI +FL+
Sbjct: 4   EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERI-EFLN 62
Query: 191 ELGIVAHINHPNAAKLIGFSTENGFHLV-LQFLPHGSLSSLLFGSTECLE---------W 240
           E  ++   N  +  +L+G  ++    LV ++ +  G L S L      +E          
Sbjct: 63  EASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSL 122
Query: 241 TIRYKIALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSH 300
           +   ++A  IA+G+ YL              A N +++ED+  +I DFG+ + + +    
Sbjct: 123 SKMIQMAGEIADGMAYLNANKFVHRDLA---ARNCMVAEDFTVKIGDFGMTRDIXETDXX 179
Query: 301 HI----VFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELIT 341
                 + P+     ++SPE    G+    +DV++FGV+L E+ T
Sbjct: 180 RKGGKGLLPVR----WMSPESLKDGVFTTYSDVWSFGVVLWEIAT 220

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 53/225 (23%), Positives = 95/225 (42%), Gaps = 27/225 (12%)
Query: 136 ELAAATDNFNSENLIGKGGHAEVY----KGCLPD-GEXXXXXXXXXXXXEDEERISDFLS 190
           E   A +       +G+G    VY    KG + D  E               ERI +FL+
Sbjct: 10  EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERI-EFLN 68
Query: 191 ELGIVAHINHPNAAKLIGFSTENGFHLV-LQFLPHGSLSSLLFGSTECLE---------W 240
           E  ++   N  +  +L+G  ++    LV ++ +  G L S L      +E          
Sbjct: 69  EASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSL 128
Query: 241 TIRYKIALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSH 300
           +   ++A  IA+G+ YL              A N +++ED+  +I DFG+ + + +   +
Sbjct: 129 SKMIQMAGEIADGMAYLNANKFVHRDLA---ARNCMVAEDFTVKIGDFGMTRDIYETDYY 185
Query: 301 HI----VFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELIT 341
                 + P+     ++SPE    G+    +DV++FGV+L E+ T
Sbjct: 186 RKGGKGLLPVR----WMSPESLKDGVFTTYSDVWSFGVVLWEIAT 226

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 53/225 (23%), Positives = 95/225 (42%), Gaps = 27/225 (12%)
Query: 136 ELAAATDNFNSENLIGKGGHAEVY----KGCLPD-GEXXXXXXXXXXXXEDEERISDFLS 190
           E   A +       +G+G    VY    KG + D  E               ERI +FL+
Sbjct: 12  EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERI-EFLN 70
Query: 191 ELGIVAHINHPNAAKLIGFSTENGFHLV-LQFLPHGSLSSLLFGSTECLE---------W 240
           E  ++   N  +  +L+G  ++    LV ++ +  G L S L      +E          
Sbjct: 71  EASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSL 130
Query: 241 TIRYKIALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSH 300
           +   ++A  IA+G+ YL              A N +++ED+  +I DFG+ + + +   +
Sbjct: 131 SKMIQMAGEIADGMAYLNANKFVHRDLA---ARNCMVAEDFTVKIGDFGMTRDIYETDYY 187
Query: 301 HI----VFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELIT 341
                 + P+     ++SPE    G+    +DV++FGV+L E+ T
Sbjct: 188 RKGGKGLLPVR----WMSPESLKDGVFTTYSDVWSFGVVLWEIAT 228

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 53/225 (23%), Positives = 95/225 (42%), Gaps = 27/225 (12%)
Query: 136 ELAAATDNFNSENLIGKGGHAEVY----KGCLPD-GEXXXXXXXXXXXXEDEERISDFLS 190
           E   A +       +G+G    VY    KG + D  E               ERI +FL+
Sbjct: 6   EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERI-EFLN 64
Query: 191 ELGIVAHINHPNAAKLIGFSTENGFHLV-LQFLPHGSLSSLLFGSTECLE---------W 240
           E  ++   N  +  +L+G  ++    LV ++ +  G L S L      +E          
Sbjct: 65  EASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSL 124
Query: 241 TIRYKIALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSH 300
           +   ++A  IA+G+ YL              A N +++ED+  +I DFG+ + + +   +
Sbjct: 125 SKMIQMAGEIADGMAYLNANKFVHRDLA---ARNCMVAEDFTVKIGDFGMTRDIYETDYY 181
Query: 301 HI----VFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELIT 341
                 + P+     ++SPE    G+    +DV++FGV+L E+ T
Sbjct: 182 RKGGKGLLPVR----WMSPESLKDGVFTTYSDVWSFGVVLWEIAT 222

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 53/225 (23%), Positives = 95/225 (42%), Gaps = 27/225 (12%)
Query: 136 ELAAATDNFNSENLIGKGGHAEVY----KGCLPD-GEXXXXXXXXXXXXEDEERISDFLS 190
           E   A +       +G+G    VY    KG + D  E               ERI +FL+
Sbjct: 12  EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERI-EFLN 70
Query: 191 ELGIVAHINHPNAAKLIGFSTENGFHLV-LQFLPHGSLSSLLFGSTECLE---------W 240
           E  ++   N  +  +L+G  ++    LV ++ +  G L S L      +E          
Sbjct: 71  EASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSL 130
Query: 241 TIRYKIALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSH 300
           +   ++A  IA+G+ YL              A N +++ED+  +I DFG+ + + +   +
Sbjct: 131 SKMIQMAGEIADGMAYLNANKFVHRDLA---ARNCMVAEDFTVKIGDFGMTRDIYETDYY 187
Query: 301 HI----VFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELIT 341
                 + P+     ++SPE    G+    +DV++FGV+L E+ T
Sbjct: 188 RKGGKGLLPVR----WMSPESLKDGVFTTYSDVWSFGVVLWEIAT 228

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 53/225 (23%), Positives = 95/225 (42%), Gaps = 27/225 (12%)
Query: 136 ELAAATDNFNSENLIGKGGHAEVY----KGCLPD-GEXXXXXXXXXXXXEDEERISDFLS 190
           E   A +       +G+G    VY    KG + D  E               ERI +FL+
Sbjct: 13  EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERI-EFLN 71
Query: 191 ELGIVAHINHPNAAKLIGFSTENGFHLV-LQFLPHGSLSSLLFGSTECLE---------W 240
           E  ++   N  +  +L+G  ++    LV ++ +  G L S L      +E          
Sbjct: 72  EASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSL 131
Query: 241 TIRYKIALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSH 300
           +   ++A  IA+G+ YL              A N +++ED+  +I DFG+ + + +   +
Sbjct: 132 SKMIQMAGEIADGMAYLNANKFVHRDLA---ARNCMVAEDFTVKIGDFGMTRDIYETDYY 188
Query: 301 HI----VFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELIT 341
                 + P+     ++SPE    G+    +DV++FGV+L E+ T
Sbjct: 189 RKGGKGLLPVR----WMSPESLKDGVFTTYSDVWSFGVVLWEIAT 229

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 53/225 (23%), Positives = 94/225 (41%), Gaps = 27/225 (12%)
Query: 136 ELAAATDNFNSENLIGKGGHAEVY----KGCLPD-GEXXXXXXXXXXXXEDEERISDFLS 190
           E   A +       +G+G    VY    KG + D  E               ERI +FL+
Sbjct: 13  EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERI-EFLN 71
Query: 191 ELGIVAHINHPNAAKLIGFSTENGFHLV-LQFLPHGSLSSLLFGSTECLE---------W 240
           E  ++   N  +  +L+G  ++    LV ++ +  G L S L      +E          
Sbjct: 72  EASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSL 131
Query: 241 TIRYKIALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSH 300
           +   ++A  IA+G+ YL              A N +++ED+  +I DFG+ + + +    
Sbjct: 132 SKMIQMAGEIADGMAYLNANKFVHRDLA---ARNCMVAEDFTVKIGDFGMTRDIXETDXX 188
Query: 301 HI----VFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELIT 341
                 + P+     ++SPE    G+    +DV++FGV+L E+ T
Sbjct: 189 RKGGKGLLPVR----WMSPESLKDGVFTTYSDVWSFGVVLWEIAT 229

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 52/210 (24%), Positives = 87/210 (41%), Gaps = 14/210 (6%)
Query: 142 DNFNSENLIGKGGHAEVYKGCLPDGEXXXXXXXXXXXXEDEERISDFLSELGIVAHINHP 201
           +NF     IG+G +  VYK                   E E   S  + E+ ++  +NHP
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 202 NAAKLIG-FSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLXXX 260
           N  KL+    TEN  +LV + + H  L +  F     L       I   + + LQ L   
Sbjct: 62  NIVKLLDVIHTENKLYLVFEHV-HQDLKT--FMDASALTGIPLPLIKSYLFQLLQGLAFC 118
Query: 261 XXXXXXXXXXKASNILLSEDYEAQISDFGLAKWL---PDNWSHHIVFPIEGTFGYLSPEY 317
                     K  N+L++ +   +++DFGLA+        ++H +V     T  Y +PE 
Sbjct: 119 HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-----TLWYRAPEI 173
Query: 318 FM-HGIVDEKTDVFAFGVLLLELITGRRAV 346
            +         D+++ G +  E++T RRA+
Sbjct: 174 LLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 202

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 39/160 (24%), Positives = 77/160 (48%), Gaps = 13/160 (8%)
Query: 187 DFLSELGIVAHINHPNAAKLIGFSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKI 246
           + L+E  ++  +++P   ++IG      + LV++    G L+  L  +    +  I  ++
Sbjct: 58  ELLAEANVMQQLDNPYIVRMIGICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNI-IEL 116
Query: 247 ALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSH-----H 301
              ++ G++YL              A N+LL   + A+ISDFGL+K L  + +      H
Sbjct: 117 VHQVSMGMKYLEESNFVHRDLA---ARNVLLVTQHYAKISDFGLSKALRADENXYKAQTH 173
Query: 302 IVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELIT 341
             +P++    + +PE   +     K+DV++FGVL+ E  +
Sbjct: 174 GKWPVK----WYAPECINYYKFSSKSDVWSFGVLMWEAFS 209

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 53/225 (23%), Positives = 95/225 (42%), Gaps = 27/225 (12%)
Query: 136 ELAAATDNFNSENLIGKGGHAEVY----KGCLPD-GEXXXXXXXXXXXXEDEERISDFLS 190
           E   A +       +G+G    VY    KG + D  E               ERI +FL+
Sbjct: 19  EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERI-EFLN 77
Query: 191 ELGIVAHINHPNAAKLIGFSTENGFHLV-LQFLPHGSLSSLLFGSTECLE---------W 240
           E  ++   N  +  +L+G  ++    LV ++ +  G L S L      +E          
Sbjct: 78  EASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSL 137
Query: 241 TIRYKIALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSH 300
           +   ++A  IA+G+ YL              A N +++ED+  +I DFG+ + + +   +
Sbjct: 138 SKMIQMAGEIADGMAYLNANKFVHRDLA---ARNCMVAEDFTVKIGDFGMTRDIYETDYY 194
Query: 301 HI----VFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELIT 341
                 + P+     ++SPE    G+    +DV++FGV+L E+ T
Sbjct: 195 RKGGKGLLPVR----WMSPESLKDGVFTTYSDVWSFGVVLWEIAT 235

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 53/225 (23%), Positives = 95/225 (42%), Gaps = 27/225 (12%)
Query: 136 ELAAATDNFNSENLIGKGGHAEVY----KGCLPD-GEXXXXXXXXXXXXEDEERISDFLS 190
           E   A +       +G+G    VY    KG + D  E               ERI +FL+
Sbjct: 41  EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERI-EFLN 99
Query: 191 ELGIVAHINHPNAAKLIGFSTENGFHLV-LQFLPHGSLSSLLFGSTECLE---------W 240
           E  ++   N  +  +L+G  ++    LV ++ +  G L S L      +E          
Sbjct: 100 EASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSL 159
Query: 241 TIRYKIALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSH 300
           +   ++A  IA+G+ YL              A N +++ED+  +I DFG+ + + +   +
Sbjct: 160 SKMIQMAGEIADGMAYLNANKFVHRDLA---ARNCMVAEDFTVKIGDFGMTRDIYETDYY 216
Query: 301 HI----VFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELIT 341
                 + P+     ++SPE    G+    +DV++FGV+L E+ T
Sbjct: 217 RKGGKGLLPVR----WMSPESLKDGVFTTYSDVWSFGVVLWEIAT 257

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 46/172 (26%), Positives = 70/172 (40%), Gaps = 19/172 (11%)
Query: 185 ISDFLSELGIVAHINHPNAAKLIG-FSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIR 243
           +     E+ I+  +NHPN  KL     TE   +LV+++   G +   L       E   R
Sbjct: 57  LQKLFREVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEAR 116
Query: 244 YKIALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSHHIV 303
            K    I   +QY              KA N+LL  D   +I+DFG        +S+   
Sbjct: 117 AKFR-QIVSAVQYCHQKFIVHRDL---KAENLLLDADMNIKIADFG--------FSNEFT 164
Query: 304 F-----PIEGTFGYLSPEYFMHGIVD-EKTDVFAFGVLLLELITGRRAVDSR 349
           F        G+  Y +PE F     D  + DV++ GV+L  L++G    D +
Sbjct: 165 FGNKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQ 216

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 52/225 (23%), Positives = 94/225 (41%), Gaps = 27/225 (12%)
Query: 136 ELAAATDNFNSENLIGKGGHAEVY----KGCLPD-GEXXXXXXXXXXXXEDEERISDFLS 190
           E   A +       +G+G    VY    KG + D  E               ERI +FL+
Sbjct: 9   EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERI-EFLN 67
Query: 191 ELGIVAHINHPNAAKLIGFSTENGFHLV-LQFLPHGSLSSLLFGSTECL---------EW 240
           E  ++   N  +  +L+G  ++    LV ++ +  G L S L      +           
Sbjct: 68  EASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSL 127
Query: 241 TIRYKIALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSH 300
           +   ++A  IA+G+ YL              A N +++ED+  +I DFG+ + + +   +
Sbjct: 128 SKMIQMAGEIADGMAYLNANKFVHRDLA---ARNCMVAEDFTVKIGDFGMTRDIYETDYY 184
Query: 301 HI----VFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELIT 341
                 + P+     ++SPE    G+    +DV++FGV+L E+ T
Sbjct: 185 RKGGKGLLPVR----WMSPESLKDGVFTTYSDVWSFGVVLWEIAT 225

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 46/172 (26%), Positives = 70/172 (40%), Gaps = 19/172 (11%)
Query: 185 ISDFLSELGIVAHINHPNAAKLIG-FSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIR 243
           +     E+ I+  +NHPN  KL     TE   +LV+++   G +   L       E   R
Sbjct: 57  LQKLFREVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEAR 116
Query: 244 YKIALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSHHIV 303
            K    I   +QY              KA N+LL  D   +I+DFG        +S+   
Sbjct: 117 AKFR-QIVSAVQYCHQKFIVHRDL---KAENLLLDADMNIKIADFG--------FSNEFT 164
Query: 304 F-----PIEGTFGYLSPEYFMHGIVD-EKTDVFAFGVLLLELITGRRAVDSR 349
           F        G+  Y +PE F     D  + DV++ GV+L  L++G    D +
Sbjct: 165 FGNKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQ 216

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 46/172 (26%), Positives = 70/172 (40%), Gaps = 19/172 (11%)
Query: 185 ISDFLSELGIVAHINHPNAAKLIG-FSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIR 243
           +     E+ I+  +NHPN  KL     TE   +LV+++   G +   L       E   R
Sbjct: 57  LQKLFREVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEAR 116
Query: 244 YKIALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSHHIV 303
            K    I   +QY              KA N+LL  D   +I+DFG        +S+   
Sbjct: 117 AKFR-QIVSAVQYCHQKFIVHRDL---KAENLLLDADMNIKIADFG--------FSNEFT 164
Query: 304 F-----PIEGTFGYLSPEYFMHGIVD-EKTDVFAFGVLLLELITGRRAVDSR 349
           F        G+  Y +PE F     D  + DV++ GV+L  L++G    D +
Sbjct: 165 FGNKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQ 216

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 82/209 (39%), Gaps = 10/209 (4%)
Query: 142 DNFNSENLIGKGGHAEVYKGCLPDGEXXXXXXXXXXXXEDEERISDFLS-ELGIVAHINH 200
           D+F     +GKG    VY                     ++E +   L  E+ I AH++H
Sbjct: 23  DDFEIGRPLGKGKFGNVYLAREKKSHFIVALKVLFKSQIEKEGVEHQLRREIEIQAHLHH 82
Query: 201 PNAAKLIG-FSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLXX 259
           PN  +L   F      +L+L++ P G L   L  S    E      I   +A+ L Y   
Sbjct: 83  PNILRLYNYFYDRRRIYLILEYAPRGELYKELQKSCTFDEQRTA-TIMEELADALMYCHG 141
Query: 260 XXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEGTFGYLSPEYFM 319
                      K  N+LL    E +I+DFG +   P      +     GT  YL PE   
Sbjct: 142 KKVIHRDI---KPENLLLGLKGELKIADFGWSVHAPSLRRKTMC----GTLDYLPPEMIE 194
Query: 320 HGIVDEKTDVFAFGVLLLELITGRRAVDS 348
             + +EK D++  GVL  EL+ G    +S
Sbjct: 195 GRMHNEKVDLWCIGVLCYELLVGNPPFES 223

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 46/172 (26%), Positives = 70/172 (40%), Gaps = 19/172 (11%)
Query: 185 ISDFLSELGIVAHINHPNAAKLIG-FSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIR 243
           +     E+ I+  +NHPN  KL     TE   +LV+++   G +   L       E   R
Sbjct: 57  LQKLFREVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEAR 116
Query: 244 YKIALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSHHIV 303
            K    I   +QY              KA N+LL  D   +I+DFG        +S+   
Sbjct: 117 AKFR-QIVSAVQYCHQKFIVHRDL---KAENLLLDADMNIKIADFG--------FSNEFT 164
Query: 304 F-----PIEGTFGYLSPEYFMHGIVD-EKTDVFAFGVLLLELITGRRAVDSR 349
           F        G+  Y +PE F     D  + DV++ GV+L  L++G    D +
Sbjct: 165 FGNKLDEFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQ 216

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 48/178 (26%), Positives = 69/178 (38%), Gaps = 31/178 (17%)
Query: 185 ISDFLSELGIVAHINHPNAAKLIG-FSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIR 243
           +     E+ I+  +NHPN  KL     TE   +LV+++   G +   L       E   R
Sbjct: 57  LQKLFREVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEAR 116
Query: 244 YKIALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSHHIV 303
            K    I   +QY              KA N+LL  D   +I+DFG              
Sbjct: 117 AKFR-QIVSAVQYCHQKFIVHRDL---KAENLLLDADMNIKIADFG-------------- 158
Query: 304 FPIEGTFG-----------YLSPEYFMHGIVD-EKTDVFAFGVLLLELITGRRAVDSR 349
           F  E TFG           Y +PE F     D  + DV++ GV+L  L++G    D +
Sbjct: 159 FSNEFTFGNKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQ 216

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 52/225 (23%), Positives = 94/225 (41%), Gaps = 27/225 (12%)
Query: 136 ELAAATDNFNSENLIGKGGHAEVY----KGCLPD-GEXXXXXXXXXXXXEDEERISDFLS 190
           E   A +       +G+G    VY    KG + D  E               ERI +FL+
Sbjct: 19  EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERI-EFLN 77
Query: 191 ELGIVAHINHPNAAKLIGFSTENGFHLV-LQFLPHGSLSSLLFGSTECL---------EW 240
           E  ++   N  +  +L+G  ++    LV ++ +  G L S L      +           
Sbjct: 78  EASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSL 137
Query: 241 TIRYKIALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSH 300
           +   ++A  IA+G+ YL              A N +++ED+  +I DFG+ + + +   +
Sbjct: 138 SKMIQMAGEIADGMAYLNANKFVHRDLA---ARNCMVAEDFTVKIGDFGMTRDIYETDYY 194
Query: 301 HI----VFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELIT 341
                 + P+     ++SPE    G+    +DV++FGV+L E+ T
Sbjct: 195 RKGGKGLLPVR----WMSPESLKDGVFTTYSDVWSFGVVLWEIAT 235

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 64/263 (24%), Positives = 112/263 (42%), Gaps = 51/263 (19%)
Query: 188 FLSELGIVAHI-NHPNAAKLIGFSTENGFHLVL-QFLPHGSLSSLL-------------- 231
            +SEL I++H+  H N   L+G  T  G  LV+ ++  +G L + L              
Sbjct: 96  LMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKRPPGLEYSYNP 155
Query: 232 -FGSTECLEWTIRYKIALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGL 290
                E L        +  +A+G+ +L              A N+LL+  + A+I DFGL
Sbjct: 156 SHNPEEQLSSRDLLHFSSQVAQGMAFLASKNCIHRDVA---ARNVLLTNGHVAKIGDFGL 212
Query: 291 AKWLPDNWSHHIV-----FPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRA 345
           A+ + ++ S++IV      P++    +++PE     +   ++DV+++G+LL E+      
Sbjct: 213 ARDIMND-SNYIVKGNARLPVK----WMAPESIFDCVYTVQSDVWSYGILLWEIF----- 262
Query: 346 VDSRRQSLVIWAKP-LLQTSNFKELVDPRLADAYDLAE----MKRAMLTASVCIHHLSTM 400
                 SL +   P +L  S F +LV     D Y +A+     K        C     T 
Sbjct: 263 ------SLGLNPYPGILVNSKFYKLVK----DGYQMAQPAFAPKNIYSIMQACWALEPTH 312
Query: 401 RPQMTRVLQLLRGEGGQTDLKPK 423
           RP   ++   L+ E  Q D + +
Sbjct: 313 RPTFQQICSFLQ-EQAQEDRRER 334

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 89/216 (41%), Gaps = 20/216 (9%)
Query: 133 DFAELAAATDN---FNSENLIGKGGHAEVYKGC-LPDGEXXXXXXXXXXXXEDEERISDF 188
           D AEL    D    F+    IG G    VY    + + E            +  E+  D 
Sbjct: 3   DVAELFFKDDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDI 62
Query: 189 LSELGIVAHINHPNAAKLIG-FSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIA 247
           + E+  +  + HPN  +  G +  E+   LV+++   GS S LL    + L+      + 
Sbjct: 63  IKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAVT 121
Query: 248 LGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWL-PDNWSHHIVFPI 306
            G  +GL YL             KA NILLSE    ++ DFG A  + P N         
Sbjct: 122 HGALQGLAYLHSHNMIHRDV---KAGNILLSEPGLVKLGDFGSASIMAPAN-------XF 171
Query: 307 EGTFGYLSPEYFM---HGIVDEKTDVFAFGVLLLEL 339
            GT  +++PE  +    G  D K DV++ G+  +EL
Sbjct: 172 VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 207

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 46/160 (28%), Positives = 72/160 (45%), Gaps = 9/160 (5%)
Query: 186 SDFLSELGIVAHINHPNAAKLIGFSTENG---FHLVLQFLPHGSLSSLLFGSTECLEWTI 242
           S +  E+ I+  + H +  K  G   + G     LV++++P GSL   L   +  L   +
Sbjct: 78  SGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHSIGLAQLL 137
Query: 243 RYKIALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSHHI 302
            +  A  I EG+ YL              A N+LL  D   +I DFGLAK +P+    + 
Sbjct: 138 LF--AQQICEGMAYLHAQHYIHRDLA---ARNVLLDNDRLVKIGDFGLAKAVPEGHEXYR 192
Query: 303 VFPI-EGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELIT 341
           V    +    + +PE          +DV++FGV L EL+T
Sbjct: 193 VREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLT 232

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 56/223 (25%), Positives = 88/223 (39%), Gaps = 19/223 (8%)
Query: 137 LAAATD------NFNSENLIGKGGHAEV--YKGCLPDGEXXXXXXXXXXXXEDEERISDF 188
           + +ATD      N+  +  IGKG  A+V   +  L   E             +   +   
Sbjct: 4   ITSATDEQPHIGNYRLQKTIGKGNFAKVKLARHVLTGREVAVKIIDKTQL--NPTSLQKL 61
Query: 189 LSELGIVAHINHPNAAKLIG-FSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIA 247
             E+ I+  +NHPN  KL     TE   +LV+++   G +   L       E   R K  
Sbjct: 62  FREVRIMKILNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFR 121
Query: 248 LGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIE 307
             I   +QY              KA N+LL  D   +I+DFG +         + +    
Sbjct: 122 -QIVSAVQYCHQKYIVHRDL---KAENLLLDGDMNIKIADFGFSNEFT---VGNKLDTFC 174
Query: 308 GTFGYLSPEYFMHGIVD-EKTDVFAFGVLLLELITGRRAVDSR 349
           G+  Y +PE F     D  + DV++ GV+L  L++G    D +
Sbjct: 175 GSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQ 217

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 53/225 (23%), Positives = 94/225 (41%), Gaps = 27/225 (12%)
Query: 136 ELAAATDNFNSENLIGKGGHAEVY----KGCLPD-GEXXXXXXXXXXXXEDEERISDFLS 190
           E   A +       +G+G    VY    KG + D  E               ERI +FL+
Sbjct: 6   EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERI-EFLN 64
Query: 191 ELGIVAHINHPNAAKLIGFSTENGFHLV-LQFLPHGSLSSLLFGSTECLE---------W 240
           E  ++   N  +  +L+G  ++    LV ++ +  G L S L      +E          
Sbjct: 65  EASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSL 124
Query: 241 TIRYKIALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSH 300
           +   ++A  IA+G+ YL              A N  ++ED+  +I DFG+ + + +   +
Sbjct: 125 SKMIQMAGEIADGMAYLNANKFVHRDLA---ARNCXVAEDFTVKIGDFGMTRDIYETDYY 181
Query: 301 HI----VFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELIT 341
                 + P+     ++SPE    G+    +DV++FGV+L E+ T
Sbjct: 182 RKGGKGLLPVR----WMSPESLKDGVFTTYSDVWSFGVVLWEIAT 222

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 53/213 (24%), Positives = 86/213 (40%), Gaps = 28/213 (13%)
Query: 147 ENLIGKGGHAEVYKGCLPDGEXXXXXXXXXXXXEDEERISDFLSELGIVAHINHPNAAKL 206
           E   GK   AE Y  C P+ +             D  R  DF  E  ++ ++ H +  K 
Sbjct: 23  EGAFGKVFLAECYNLC-PEQDKILVAVKTLKDASDNAR-KDFHREAELLTNLQHEHIVKF 80
Query: 207 IGFSTE-NGFHLVLQFLPHGSLSSLLFGS-------------TECLEWTIRYKIALGIAE 252
            G   E +   +V +++ HG L+  L                TE L  +    IA  IA 
Sbjct: 81  YGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTE-LTQSQMLHIAQQIAA 139
Query: 253 GLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAK--WLPDNW--SHHIVFPIEG 308
           G+ YL                N L+ E+   +I DFG+++  +  D +    H + PI  
Sbjct: 140 GMVYLASQHFVHRDLA---TRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIR- 195
Query: 309 TFGYLSPEYFMHGIVDEKTDVFAFGVLLLELIT 341
              ++ PE  M+     ++DV++ GV+L E+ T
Sbjct: 196 ---WMPPESIMYRKFTTESDVWSLGVVLWEIFT 225

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 48.5 bits (114), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 65/266 (24%), Positives = 111/266 (41%), Gaps = 58/266 (21%)
Query: 188 FLSELGIVAHI-NHPNAAKLIGFSTENGFHLVL-QFLPHGSLSSLLFGSTEC-------- 237
            +SEL I++H+  H N   L+G  T  G  LV+ ++  +G L + L    E         
Sbjct: 81  LMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEAMLGPSLAP 140
Query: 238 --------------LEWTIRYKIALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEA 283
                         LE       +  +A+G+ +L              A N+LL+  + A
Sbjct: 141 GQDPEGLDKEDGRPLELRDLLHFSSQVAQGMAFLASKNCIHRDVA---ARNVLLTNGHVA 197
Query: 284 QISDFGLAKWLPDNWSHHIV-----FPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLE 338
           +I DFGLA+ + ++ S++IV      P++    +++PE     +   ++DV+++G+LL E
Sbjct: 198 KIGDFGLARDIMND-SNYIVKGNARLPVK----WMAPESIFDCVYTVQSDVWSYGILLWE 252
Query: 339 LITGRRAVDSRRQSLVIWAKP-LLQTSNFKELVDPRLADAYDLAE----MKRAMLTASVC 393
           +            SL +   P +L  S F +LV     D Y +A+     K        C
Sbjct: 253 IF-----------SLGLNPYPGILVNSKFYKLVK----DGYQMAQPAFAPKNIYSIMQAC 297
Query: 394 IHHLSTMRPQMTRVLQLLRGEGGQTD 419
                T RP   ++   L+ E  Q D
Sbjct: 298 WALEPTHRPTFQQICSFLQ-EQAQED 322

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 48.1 bits (113), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 61/267 (22%), Positives = 108/267 (40%), Gaps = 31/267 (11%)
Query: 149 LIGKGGHAEVYKGCLPDGEX----XXXXXXXXXXXEDEERISDFLSELGIVAHINHPNAA 204
            +GKGG A+ Y+    D +                  +E++S   +E+ I   +++P+  
Sbjct: 49  FLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMS---TEIAIHKSLDNPHVV 105
Query: 205 KLIGFSTENGF-HLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLXXXXXX 263
              GF  ++ F ++VL+     SL  L        E   RY +   I +G+QYL      
Sbjct: 106 GFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTI-QGVQYLHNNRVI 164
Query: 264 XXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEGTFGYLSPEYFMHGIV 323
                  K  N+ L++D + +I DFGLA  +  +        + GT  Y++PE       
Sbjct: 165 HRDL---KLGNLFLNDDMDVKIGDFGLATKIEFDGERKKT--LCGTPNYIAPEVLCKKGH 219
Query: 324 DEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSNFKELVDPRLADAYDLAEM 383
             + D+++ G +L  L+ G               KP  +TS  KE       + Y +   
Sbjct: 220 SFEVDIWSLGCILYTLLVG---------------KPPFETSCLKETYIRIKKNEYSVPRH 264
Query: 384 KRAMLTASV--CIHHLSTMRPQMTRVL 408
              + +A +   +H   T+RP +  +L
Sbjct: 265 INPVASALIRRMLHADPTLRPSVAELL 291

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 43/167 (25%), Positives = 68/167 (40%), Gaps = 9/167 (5%)
Query: 185 ISDFLSELGIVAHINHPNAAKLIG-FSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIR 243
           +     E+ I+  +NHPN  KL     TE   +L++++   G +   L       E   R
Sbjct: 55  LQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEAR 114
Query: 244 YKIALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSHHIV 303
            K    I   +QY              KA N+LL  D   +I+DFG +           +
Sbjct: 115 SKFR-QIVSAVQYCHQKRIVHRDL---KAENLLLDADMNIKIADFGFSNEFTVGGK---L 167
Query: 304 FPIEGTFGYLSPEYFMHGIVD-EKTDVFAFGVLLLELITGRRAVDSR 349
               G+  Y +PE F     D  + DV++ GV+L  L++G    D +
Sbjct: 168 DTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQ 214

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 51/205 (24%), Positives = 83/205 (40%), Gaps = 12/205 (5%)
Query: 142 DNFNSENLIGKGGHAEVYKGCLPDGEXXXXXXXXXXXXEDEERISDFLSELGIVAHINHP 201
           + +N   ++GKG   EV K      +               +  S  L E+ ++  ++HP
Sbjct: 22  ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHP 81
Query: 202 NAAKLIG-FSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLXXX 260
           N  KL       + F++V +    G L   +       E     +I   +  G+ Y+   
Sbjct: 82  NIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAA-RIIKQVFSGITYMHKH 140
Query: 261 XXXXXXXXXXKASNILLS---EDYEAQISDFGLAKWLPDNWSHHIVFPIEGTFGYLSPEY 317
                     K  NILL    +D + +I DFGL+     N          GT  Y++PE 
Sbjct: 141 NIVHRDL---KPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRI---GTAYYIAPE- 193
Query: 318 FMHGIVDEKTDVFAFGVLLLELITG 342
            + G  DEK DV++ GV+L  L++G
Sbjct: 194 VLRGTYDEKCDVWSAGVILYILLSG 218

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 51/205 (24%), Positives = 83/205 (40%), Gaps = 12/205 (5%)
Query: 142 DNFNSENLIGKGGHAEVYKGCLPDGEXXXXXXXXXXXXEDEERISDFLSELGIVAHINHP 201
           + +N   ++GKG   EV K      +               +  S  L E+ ++  ++HP
Sbjct: 22  ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHP 81
Query: 202 NAAKLIG-FSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLXXX 260
           N  KL       + F++V +    G L   +       E     +I   +  G+ Y+   
Sbjct: 82  NIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAA-RIIKQVFSGITYMHKH 140
Query: 261 XXXXXXXXXXKASNILLS---EDYEAQISDFGLAKWLPDNWSHHIVFPIEGTFGYLSPEY 317
                     K  NILL    +D + +I DFGL+     N          GT  Y++PE 
Sbjct: 141 NIVHRDL---KPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRI---GTAYYIAPE- 193
Query: 318 FMHGIVDEKTDVFAFGVLLLELITG 342
            + G  DEK DV++ GV+L  L++G
Sbjct: 194 VLRGTYDEKCDVWSAGVILYILLSG 218

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 51/205 (24%), Positives = 83/205 (40%), Gaps = 12/205 (5%)
Query: 142 DNFNSENLIGKGGHAEVYKGCLPDGEXXXXXXXXXXXXEDEERISDFLSELGIVAHINHP 201
           + +N   ++GKG   EV K      +               +  S  L E+ ++  ++HP
Sbjct: 22  ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHP 81
Query: 202 NAAKLIG-FSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLXXX 260
           N  KL       + F++V +    G L   +       E     +I   +  G+ Y+   
Sbjct: 82  NIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAA-RIIKQVFSGITYMHKH 140
Query: 261 XXXXXXXXXXKASNILLS---EDYEAQISDFGLAKWLPDNWSHHIVFPIEGTFGYLSPEY 317
                     K  NILL    +D + +I DFGL+     N          GT  Y++PE 
Sbjct: 141 NIVHRDL---KPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRI---GTAYYIAPE- 193
Query: 318 FMHGIVDEKTDVFAFGVLLLELITG 342
            + G  DEK DV++ GV+L  L++G
Sbjct: 194 VLRGTYDEKCDVWSAGVILYILLSG 218

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 43/167 (25%), Positives = 67/167 (40%), Gaps = 9/167 (5%)
Query: 185 ISDFLSELGIVAHINHPNAAKLIG-FSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIR 243
           +     E+ I+  +NHPN  KL     TE   +L++++   G +   L       E   R
Sbjct: 58  LQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEAR 117
Query: 244 YKIALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSHHIV 303
            K    I   +QY              KA N+LL  D   +I+DFG +           +
Sbjct: 118 SKFR-QIVSAVQYCHQKRIVHRDL---KAENLLLDADMNIKIADFGFSNEFTVGGK---L 170
Query: 304 FPIEGTFGYLSPEYFMHGIVD-EKTDVFAFGVLLLELITGRRAVDSR 349
               G   Y +PE F     D  + DV++ GV+L  L++G    D +
Sbjct: 171 DAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQ 217

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 61/267 (22%), Positives = 108/267 (40%), Gaps = 31/267 (11%)
Query: 149 LIGKGGHAEVYKGCLPDGEX----XXXXXXXXXXXEDEERISDFLSELGIVAHINHPNAA 204
            +GKGG A+ Y+    D +                  +E++S   +E+ I   +++P+  
Sbjct: 49  FLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMS---TEIAIHKSLDNPHVV 105
Query: 205 KLIGFSTENGF-HLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLXXXXXX 263
              GF  ++ F ++VL+     SL  L        E   RY +   I +G+QYL      
Sbjct: 106 GFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTI-QGVQYLHNNRVI 164
Query: 264 XXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEGTFGYLSPEYFMHGIV 323
                  K  N+ L++D + +I DFGLA  +  +        + GT  Y++PE       
Sbjct: 165 HRDL---KLGNLFLNDDMDVKIGDFGLATKIEFDGERKKX--LCGTPNYIAPEVLCKKGH 219
Query: 324 DEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSNFKELVDPRLADAYDLAEM 383
             + D+++ G +L  L+ G               KP  +TS  KE       + Y +   
Sbjct: 220 SFEVDIWSLGCILYTLLVG---------------KPPFETSCLKETYIRIKKNEYSVPRH 264
Query: 384 KRAMLTASV--CIHHLSTMRPQMTRVL 408
              + +A +   +H   T+RP +  +L
Sbjct: 265 INPVASALIRRMLHADPTLRPSVAELL 291

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 48/178 (26%), Positives = 69/178 (38%), Gaps = 31/178 (17%)
Query: 185 ISDFLSELGIVAHINHPNAAKLIG-FSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIR 243
           +     E+ I+  +NHPN  KL     TE   +LV+++   G +   L       E   R
Sbjct: 50  LQKLFREVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGWMKEKEAR 109
Query: 244 YKIALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSHHIV 303
            K    I   +QY              KA N+LL  D   +I+DFG              
Sbjct: 110 AKFR-QIVSAVQYCHQKFIVHRDL---KAENLLLDADMNIKIADFG-------------- 151
Query: 304 FPIEGTFG-----------YLSPEYFMHGIVD-EKTDVFAFGVLLLELITGRRAVDSR 349
           F  E TFG           Y +PE F     D  + DV++ GV+L  L++G    D +
Sbjct: 152 FSNEFTFGNKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQ 209

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 61/267 (22%), Positives = 108/267 (40%), Gaps = 31/267 (11%)
Query: 149 LIGKGGHAEVYKGCLPDGEX----XXXXXXXXXXXEDEERISDFLSELGIVAHINHPNAA 204
            +GKGG A+ Y+    D +                  +E++S   +E+ I   +++P+  
Sbjct: 33  FLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMS---TEIAIHKSLDNPHVV 89
Query: 205 KLIGFSTENGF-HLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLXXXXXX 263
              GF  ++ F ++VL+     SL  L        E   RY +   I +G+QYL      
Sbjct: 90  GFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTI-QGVQYLHNNRVI 148
Query: 264 XXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEGTFGYLSPEYFMHGIV 323
                  K  N+ L++D + +I DFGLA  +   +       + GT  Y++PE       
Sbjct: 149 HRDL---KLGNLFLNDDMDVKIGDFGLATKI--EFDGERKKDLCGTPNYIAPEVLCKKGH 203
Query: 324 DEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSNFKELVDPRLADAYDLAEM 383
             + D+++ G +L  L+ G               KP  +TS  KE       + Y +   
Sbjct: 204 SFEVDIWSLGCILYTLLVG---------------KPPFETSCLKETYIRIKKNEYSVPRH 248
Query: 384 KRAMLTASV--CIHHLSTMRPQMTRVL 408
              + +A +   +H   T+RP +  +L
Sbjct: 249 INPVASALIRRMLHADPTLRPSVAELL 275

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 42/161 (26%), Positives = 72/161 (44%), Gaps = 10/161 (6%)
Query: 183 ERISDFLSELGIVAHINHPNAAKL-IGFSTENGFHLVLQFLPHGSLSSLLFGSTECLEWT 241
           ++I   L+E  I+  +N P   KL   F   +  ++V++++P G + S L       E  
Sbjct: 83  KQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPH 142
Query: 242 IRYKIALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSHH 301
            R+  A  I    +YL             K  N+L+ +    Q++DFG AK +       
Sbjct: 143 ARF-YAAQIVLTFEYLHSLDLIYRDL---KPENLLIDQQGYIQVTDFGFAKRVKGR---- 194
Query: 302 IVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITG 342
             + + GT  YL+PE  +    ++  D +A GVL+ E+  G
Sbjct: 195 -TWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 48/202 (23%), Positives = 85/202 (42%), Gaps = 21/202 (10%)
Query: 150 IGKGGHAEVYKGCLPDGEXXXXXXXXXXXXEDEERISDFLSELGIVAHINHPNAAKLIG- 208
           +G+G +  VYK     G             EDE   S  + E+ ++  ++HPN   LI  
Sbjct: 29  VGEGTYGVVYKAKDSQGRIVALKRIRLDA-EDEGIPSTAIREISLLKELHHPNIVSLIDV 87
Query: 209 FSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIR---YKIALGIAEGLQYLXXXXXXXX 265
             +E    LV +F+       L    T   +  I+   Y++  G+A   Q+         
Sbjct: 88  IHSERCLTLVFEFMEKDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQH-------RI 140
Query: 266 XXXXXKASNILLSEDYEAQISDFGLAKWL---PDNWSHHIVFPIEGTFGYLSPEYFMHG- 321
                K  N+L++ D   +++DFGLA+       +++H +V     T  Y +P+  M   
Sbjct: 141 LHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVV-----TLWYRAPDVLMGSK 195
Query: 322 IVDEKTDVFAFGVLLLELITGR 343
                 D+++ G +  E+ITG+
Sbjct: 196 KYSTSVDIWSIGCIFAEMITGK 217

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 42/161 (26%), Positives = 72/161 (44%), Gaps = 10/161 (6%)
Query: 183 ERISDFLSELGIVAHINHPNAAKL-IGFSTENGFHLVLQFLPHGSLSSLLFGSTECLEWT 241
           ++I   L+E  I+  +N P   KL   F   +  ++V++++P G + S L       E  
Sbjct: 76  KQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPH 135
Query: 242 IRYKIALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSHH 301
            R+  A  I    +YL             K  N+L+ +    Q++DFG AK +       
Sbjct: 136 ARF-YAAQIVLTFEYLHSLDLIYRDL---KPENLLIDQQGYIQVTDFGFAKRVKGR---- 187
Query: 302 IVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITG 342
             + + GT  YL+PE  +    ++  D +A GVL+ E+  G
Sbjct: 188 -TWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 227

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 48/202 (23%), Positives = 85/202 (42%), Gaps = 21/202 (10%)
Query: 150 IGKGGHAEVYKGCLPDGEXXXXXXXXXXXXEDEERISDFLSELGIVAHINHPNAAKLIG- 208
           +G+G +  VYK     G             EDE   S  + E+ ++  ++HPN   LI  
Sbjct: 29  VGEGTYGVVYKAKDSQGRIVALKRIRLDA-EDEGIPSTAIREISLLKELHHPNIVSLIDV 87
Query: 209 FSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIR---YKIALGIAEGLQYLXXXXXXXX 265
             +E    LV +F+       L    T   +  I+   Y++  G+A   Q+         
Sbjct: 88  IHSERCLTLVFEFMEKDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQH-------RI 140
Query: 266 XXXXXKASNILLSEDYEAQISDFGLAKWL---PDNWSHHIVFPIEGTFGYLSPEYFMHG- 321
                K  N+L++ D   +++DFGLA+       +++H +V     T  Y +P+  M   
Sbjct: 141 LHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVV-----TLWYRAPDVLMGSK 195
Query: 322 IVDEKTDVFAFGVLLLELITGR 343
                 D+++ G +  E+ITG+
Sbjct: 196 KYSTSVDIWSIGCIFAEMITGK 217

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 42/161 (26%), Positives = 72/161 (44%), Gaps = 10/161 (6%)
Query: 183 ERISDFLSELGIVAHINHPNAAKL-IGFSTENGFHLVLQFLPHGSLSSLLFGSTECLEWT 241
           ++I   L+E  I+  +N P   KL   F   +  ++V++++P G + S L       E  
Sbjct: 84  KQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPH 143
Query: 242 IRYKIALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSHH 301
            R+  A  I    +YL             K  N+L+ +    Q++DFG AK +       
Sbjct: 144 ARF-YAAQIVLTFEYLHSLDLIYRDL---KPENLLIDQQGYIQVTDFGFAKRVKGR---- 195
Query: 302 IVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITG 342
             + + GT  YL+PE  +    ++  D +A GVL+ E+  G
Sbjct: 196 -TWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 61/267 (22%), Positives = 108/267 (40%), Gaps = 31/267 (11%)
Query: 149 LIGKGGHAEVYKGCLPDGEX----XXXXXXXXXXXEDEERISDFLSELGIVAHINHPNAA 204
            +GKGG A+ Y+    D +                  +E++S   +E+ I   +++P+  
Sbjct: 49  FLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMS---TEIAIHKSLDNPHVV 105
Query: 205 KLIGFSTENGF-HLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLXXXXXX 263
              GF  ++ F ++VL+     SL  L        E   RY +   I +G+QYL      
Sbjct: 106 GFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTI-QGVQYLHNNRVI 164
Query: 264 XXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEGTFGYLSPEYFMHGIV 323
                  K  N+ L++D + +I DFGLA  +   +       + GT  Y++PE       
Sbjct: 165 HRDL---KLGNLFLNDDMDVKIGDFGLATKI--EFDGERKKDLCGTPNYIAPEVLCKKGH 219
Query: 324 DEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSNFKELVDPRLADAYDLAEM 383
             + D+++ G +L  L+ G               KP  +TS  KE       + Y +   
Sbjct: 220 SFEVDIWSLGCILYTLLVG---------------KPPFETSCLKETYIRIKKNEYSVPRH 264
Query: 384 KRAMLTASV--CIHHLSTMRPQMTRVL 408
              + +A +   +H   T+RP +  +L
Sbjct: 265 INPVASALIRRMLHADPTLRPSVAELL 291

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 42/161 (26%), Positives = 72/161 (44%), Gaps = 10/161 (6%)
Query: 183 ERISDFLSELGIVAHINHPNAAKL-IGFSTENGFHLVLQFLPHGSLSSLLFGSTECLEWT 241
           ++I   L+E  I+  +N P   KL   F   +  ++V++++P G + S L       E  
Sbjct: 83  KQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPH 142
Query: 242 IRYKIALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSHH 301
            R+  A  I    +YL             K  N+L+ +    Q++DFG AK +       
Sbjct: 143 ARF-YAAQIVLTFEYLHSLDLIYRDL---KPENLLIDQQGYIQVTDFGFAKRVKGR---- 194
Query: 302 IVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITG 342
             + + GT  YL+PE  +    ++  D +A GVL+ E+  G
Sbjct: 195 -TWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 53/228 (23%), Positives = 95/228 (41%), Gaps = 19/228 (8%)
Query: 120 GSVPIVRHSWKNFDFAELAAATDNFNSENLIGKGGHAEVYKGCLPDGEXXXXXXXXXXXX 179
           G+  +V   W   D +   A +D F  E+ +G+G  + VY+ C   G             
Sbjct: 33  GTASLVPDYW--IDGSNRDALSDFFEVESELGRGATSIVYR-CKQKGTQKPYALKVLKKT 89
Query: 180 EDEERISDFLSELGIVAHINHPNAAKLIG-FSTENGFHLVLQFLPHGSLSSLLFGSTECL 238
            D++ +    +E+G++  ++HPN  KL   F T     LVL+ +  G     LF      
Sbjct: 90  VDKKIVR---TEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTGGE----LFDRIVEK 142
Query: 239 EWTIRYKIALGIAEGLQYLXXXXXXXXXXXXXKASNILLSE---DYEAQISDFGLAKWLP 295
            +      A  + + L+ +             K  N+L +    D   +I+DFGL+K + 
Sbjct: 143 GYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIV- 201
Query: 296 DNWSHHIVF-PIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITG 342
               H ++   + GT GY +PE         + D+++ G++   L+ G
Sbjct: 202 ---EHQVLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCG 246

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 43/162 (26%), Positives = 73/162 (45%), Gaps = 12/162 (7%)
Query: 183 ERISDFLSELGIVAHINHPNAAKL-IGFSTENGFHLVLQFLPHGSLSSLLFGSTECLEWT 241
           ++I   L+E  I+  +N P   KL   F   +  ++V++++P G + S L       E  
Sbjct: 84  KQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPH 143
Query: 242 IRYKIALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPD-NWSH 300
            R+  A  I    +YL             K  N+L+ +    Q++DFG AK +    W+ 
Sbjct: 144 ARF-YAAQIVLTFEYLHSLDLIYRDL---KPENLLIDQQGYIQVTDFGFAKRVKGRTWT- 198
Query: 301 HIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITG 342
                + GT  YL+PE  +    ++  D +A GVL+ E+  G
Sbjct: 199 -----LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 43/162 (26%), Positives = 73/162 (45%), Gaps = 12/162 (7%)
Query: 183 ERISDFLSELGIVAHINHPNAAKL-IGFSTENGFHLVLQFLPHGSLSSLLFGSTECLEWT 241
           ++I   L+E  I+  +N P   KL   F   +  ++V++++P G + S L       E  
Sbjct: 69  KQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPH 128
Query: 242 IRYKIALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPD-NWSH 300
            R+  A  I    +YL             K  N+L+ +    Q++DFG AK +    W+ 
Sbjct: 129 ARF-YAAQIVLTFEYLHSLDLIYRDL---KPENLLIDQQGYIQVTDFGFAKRVKGRTWT- 183
Query: 301 HIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITG 342
                + GT  YL+PE  +    ++  D +A GVL+ E+  G
Sbjct: 184 -----LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 220

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 42/161 (26%), Positives = 72/161 (44%), Gaps = 10/161 (6%)
Query: 183 ERISDFLSELGIVAHINHPNAAKL-IGFSTENGFHLVLQFLPHGSLSSLLFGSTECLEWT 241
           ++I   L+E  I+  +N P   KL   F   +  ++V++++P G + S L       E  
Sbjct: 84  KQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPH 143
Query: 242 IRYKIALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSHH 301
            R+  A  I    +YL             K  N+L+ +    Q++DFG AK +       
Sbjct: 144 ARF-YAAQIVLTFEYLHSLDLIYRDL---KPENLLIDQQGYIQVTDFGFAKRVKGR---- 195
Query: 302 IVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITG 342
             + + GT  YL+PE  +    ++  D +A GVL+ E+  G
Sbjct: 196 -TWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 42/161 (26%), Positives = 72/161 (44%), Gaps = 10/161 (6%)
Query: 183 ERISDFLSELGIVAHINHPNAAKL-IGFSTENGFHLVLQFLPHGSLSSLLFGSTECLEWT 241
           ++I   L+E  I+  +N P   KL   F   +  ++V++++P G + S L       E  
Sbjct: 84  KQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPH 143
Query: 242 IRYKIALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSHH 301
            R+  A  I    +YL             K  N+L+ +    Q++DFG AK +       
Sbjct: 144 ARF-YAAQIVLTFEYLHSLDLIYRDL---KPENLLIDQQGYIQVTDFGFAKRVKGR---- 195
Query: 302 IVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITG 342
             + + GT  YL+PE  +    ++  D +A GVL+ E+  G
Sbjct: 196 -TWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 44/196 (22%), Positives = 85/196 (43%), Gaps = 14/196 (7%)
Query: 150 IGKGGHAEVYKGC-LPDGEXXXXXXXXXXXXEDEERISDFLSELGIVAHINHPNAAKLI- 207
           IG+G    VY    +  G+              +E I   ++E+ ++    +PN    + 
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELI---INEILVMRENKNPNIVNYLD 84
Query: 208 GFSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLXXXXXXXXXX 267
            +   +   +V+++L  GSL+ ++  +  C++     +IA    E LQ L          
Sbjct: 85  SYLVGDELWVVMEYLAGGSLTDVV--TETCMD---EGQIAAVCRECLQALEFLHSNQVIH 139
Query: 268 XXXKASNILLSEDYEAQISDFGL-AKWLPDNWSHHIVFPIEGTFGYLSPEYFMHGIVDEK 326
              K+ NILL  D   +++DFG  A+  P+      +    GT  +++PE         K
Sbjct: 140 RDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV---GTPYWMAPEVVTRKAYGPK 196
Query: 327 TDVFAFGVLLLELITG 342
            D+++ G++ +E+I G
Sbjct: 197 VDIWSLGIMAIEMIEG 212

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 42/161 (26%), Positives = 72/161 (44%), Gaps = 10/161 (6%)
Query: 183 ERISDFLSELGIVAHINHPNAAKL-IGFSTENGFHLVLQFLPHGSLSSLLFGSTECLEWT 241
           ++I   L+E  I+  +N P   KL   F   +  ++V++++P G + S L       E  
Sbjct: 83  KQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPH 142
Query: 242 IRYKIALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSHH 301
            R+  A  I    +YL             K  N+L+ +    Q++DFG AK +       
Sbjct: 143 ARF-YAAQIVLTFEYLHSLDLIYRDL---KPENLLIDQQGYIQVTDFGFAKRVKGR---- 194
Query: 302 IVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITG 342
             + + GT  YL+PE  +    ++  D +A GVL+ E+  G
Sbjct: 195 -TWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 42/161 (26%), Positives = 72/161 (44%), Gaps = 10/161 (6%)
Query: 183 ERISDFLSELGIVAHINHPNAAKL-IGFSTENGFHLVLQFLPHGSLSSLLFGSTECLEWT 241
           ++I   L+E  I+  +N P   KL   F   +  ++V++++P G + S L       E  
Sbjct: 83  KQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPH 142
Query: 242 IRYKIALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSHH 301
            R+  A  I    +YL             K  N+L+ +    Q++DFG AK +       
Sbjct: 143 ARF-YAAQIVLTFEYLHSLDLIYRDL---KPENLLIDQQGYIQVTDFGFAKRVKGR---- 194
Query: 302 IVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITG 342
             + + GT  YL+PE  +    ++  D +A GVL+ E+  G
Sbjct: 195 -TWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 46/169 (27%), Positives = 65/169 (38%), Gaps = 11/169 (6%)
Query: 185 ISDFLSELGIVAHINHPNAAKL-IGFSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIR 243
           + +   EL I+  + HP    L   F  E    +V+  L  G L   L  +    E T++
Sbjct: 59  VRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVK 118
Query: 244 YKIALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSHHIV 303
               L I E +  L             K  NILL E     I+DF +A  LP       +
Sbjct: 119 ----LFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQ---I 171
Query: 304 FPIEGTFGYLSPEYFMH---GIVDEKTDVFAFGVLLLELITGRRAVDSR 349
             + GT  Y++PE F            D ++ GV   EL+ GRR    R
Sbjct: 172 TTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIR 220

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 42/161 (26%), Positives = 72/161 (44%), Gaps = 10/161 (6%)
Query: 183 ERISDFLSELGIVAHINHPNAAKL-IGFSTENGFHLVLQFLPHGSLSSLLFGSTECLEWT 241
           ++I   L+E  I+  +N P   KL   F   +  ++V++++P G + S L       E  
Sbjct: 104 KQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPH 163
Query: 242 IRYKIALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSHH 301
            R+  A  I    +YL             K  N+L+ +    Q++DFG AK +       
Sbjct: 164 ARF-YAAQIVLTFEYLHSLDLIYRDL---KPENLLIDQQGYIQVTDFGFAKRVKGR---- 215
Query: 302 IVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITG 342
             + + GT  YL+PE  +    ++  D +A GVL+ E+  G
Sbjct: 216 -TWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 255

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 42/161 (26%), Positives = 72/161 (44%), Gaps = 10/161 (6%)
Query: 183 ERISDFLSELGIVAHINHPNAAKL-IGFSTENGFHLVLQFLPHGSLSSLLFGSTECLEWT 241
           ++I   L+E  I+  +N P   KL   F   +  ++V++++P G + S L       E  
Sbjct: 84  KQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPH 143
Query: 242 IRYKIALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSHH 301
            R+  A  I    +YL             K  N+L+ +    Q++DFG AK +       
Sbjct: 144 ARF-YAAQIVLTFEYLHSLDLIYRDL---KPENLLIDQQGYIQVTDFGFAKRVKGR---- 195
Query: 302 IVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITG 342
             + + GT  YL+PE  +    ++  D +A GVL+ E+  G
Sbjct: 196 -TWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 42/161 (26%), Positives = 72/161 (44%), Gaps = 10/161 (6%)
Query: 183 ERISDFLSELGIVAHINHPNAAKL-IGFSTENGFHLVLQFLPHGSLSSLLFGSTECLEWT 241
           ++I   L+E  I+  +N P   KL   F   +  ++V++++P G + S L       E  
Sbjct: 83  KQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPH 142
Query: 242 IRYKIALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSHH 301
            R+  A  I    +YL             K  N+L+ +    Q++DFG AK +       
Sbjct: 143 ARF-YAAQIVLTFEYLHSLDLIYRDL---KPENLLIDQQGYIQVTDFGFAKRVKGR---- 194
Query: 302 IVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITG 342
             + + GT  YL+PE  +    ++  D +A GVL+ E+  G
Sbjct: 195 -TWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 42/161 (26%), Positives = 72/161 (44%), Gaps = 10/161 (6%)
Query: 183 ERISDFLSELGIVAHINHPNAAKL-IGFSTENGFHLVLQFLPHGSLSSLLFGSTECLEWT 241
           ++I   L+E  I+  +N P   KL   F   +  ++V++++P G + S L       E  
Sbjct: 84  KQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPH 143
Query: 242 IRYKIALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSHH 301
            R+  A  I    +YL             K  N+L+ +    Q++DFG AK +       
Sbjct: 144 ARF-YAAQIVLTFEYLHSLDLIYRDL---KPENLLIDQQGYIQVTDFGFAKRVKGR---- 195
Query: 302 IVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITG 342
             + + GT  YL+PE  +    ++  D +A GVL+ E+  G
Sbjct: 196 -TWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 51/213 (23%), Positives = 84/213 (39%), Gaps = 14/213 (6%)
Query: 139 AATDNFNSENLIGKGGHAEVYKGCLPDGEXXXXXXXXXXXXEDEERISDFLSELGIVAHI 198
            + +NF     IG+G +  VYK                   E E   S  + E+ ++  +
Sbjct: 3   GSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 62
Query: 199 NHPNAAKLIG-FSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYL 257
           NHPN  KL+    TEN  +LV +   H       F     L       I   + + LQ L
Sbjct: 63  NHPNIVKLLDVIHTENKLYLVFE---HVDQDLKKFMDASALTGIPLPLIKSYLFQLLQGL 119
Query: 258 XXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWL---PDNWSHHIVFPIEGTFGYLS 314
                        K  N+L++ +   +++DFGLA+        + H +V     T  Y +
Sbjct: 120 AFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-----TLWYRA 174
Query: 315 PEYFM-HGIVDEKTDVFAFGVLLLELITGRRAV 346
           PE  +         D+++ G +  E++T RRA+
Sbjct: 175 PEILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 206

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 44/196 (22%), Positives = 85/196 (43%), Gaps = 14/196 (7%)
Query: 150 IGKGGHAEVYKGC-LPDGEXXXXXXXXXXXXEDEERISDFLSELGIVAHINHPNAAKLI- 207
           IG+G    VY    +  G+              +E I   ++E+ ++    +PN    + 
Sbjct: 29  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELI---INEILVMRENKNPNIVNYLD 85
Query: 208 GFSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLXXXXXXXXXX 267
            +   +   +V+++L  GSL+ ++  +  C++     +IA    E LQ L          
Sbjct: 86  SYLVGDELWVVMEYLAGGSLTDVV--TETCMD---EGQIAAVCRECLQALEFLHSNQVIH 140
Query: 268 XXXKASNILLSEDYEAQISDFGL-AKWLPDNWSHHIVFPIEGTFGYLSPEYFMHGIVDEK 326
              K+ NILL  D   +++DFG  A+  P+      +    GT  +++PE         K
Sbjct: 141 RNIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV---GTPYWMAPEVVTRKAYGPK 197
Query: 327 TDVFAFGVLLLELITG 342
            D+++ G++ +E+I G
Sbjct: 198 VDIWSLGIMAIEMIEG 213

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 42/161 (26%), Positives = 72/161 (44%), Gaps = 10/161 (6%)
Query: 183 ERISDFLSELGIVAHINHPNAAKL-IGFSTENGFHLVLQFLPHGSLSSLLFGSTECLEWT 241
           ++I   L+E  I+  +N P   KL   F   +  ++V++++P G + S L       E  
Sbjct: 76  KQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPH 135
Query: 242 IRYKIALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSHH 301
            R+  A  I    +YL             K  N+L+ +    Q++DFG AK +       
Sbjct: 136 ARF-YAAQIVLTFEYLHSLDLIYRDL---KPENLLIDQQGYIQVTDFGFAKRVKGR---- 187
Query: 302 IVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITG 342
             + + GT  YL+PE  +    ++  D +A GVL+ E+  G
Sbjct: 188 -TWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 227

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 48/178 (26%), Positives = 67/178 (37%), Gaps = 31/178 (17%)
Query: 185 ISDFLSELGIVAHINHPNAAKLIG-FSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIR 243
           +     E+ I   +NHPN  KL     TE   +LV ++   G +   L       E   R
Sbjct: 57  LQKLFREVRIXKVLNHPNIVKLFEVIETEKTLYLVXEYASGGEVFDYLVAHGRXKEKEAR 116
Query: 244 YKIALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSHHIV 303
            K    I   +QY              KA N+LL  D   +I+DFG              
Sbjct: 117 AKFR-QIVSAVQYCHQKFIVHRDL---KAENLLLDADXNIKIADFG-------------- 158
Query: 304 FPIEGTFG-----------YLSPEYFMHGIVD-EKTDVFAFGVLLLELITGRRAVDSR 349
           F  E TFG           Y +PE F     D  + DV++ GV+L  L++G    D +
Sbjct: 159 FSNEFTFGNKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQ 216

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 42/163 (25%), Positives = 69/163 (42%), Gaps = 25/163 (15%)
Query: 190 SELGIVAHINHPNAAKLI-GFSTENGFHLVLQFLPHGSL------SSLLFGSTECLEWTI 242
           +E  I+  + HP    LI  F T    +L+L++L  G L        +    T C  +  
Sbjct: 70  AERNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACF-YLA 128
Query: 243 RYKIALGI--AEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAK-WLPDNWS 299
              +ALG    +G+ Y              K  NI+L+     +++DFGL K  + D   
Sbjct: 129 EISMALGHLHQKGIIY-----------RDLKPENIMLNHQGHVKLTDFGLCKESIHDGTV 177
Query: 300 HHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITG 342
            H      GT  Y++PE  M    +   D ++ G L+ +++TG
Sbjct: 178 THTFC---GTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTG 217

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 44/196 (22%), Positives = 85/196 (43%), Gaps = 14/196 (7%)
Query: 150 IGKGGHAEVYKGC-LPDGEXXXXXXXXXXXXEDEERISDFLSELGIVAHINHPNAAKLI- 207
           IG+G    VY    +  G+              +E I   ++E+ ++    +PN    + 
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELI---INEILVMRENKNPNIVNYLD 84
Query: 208 GFSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLXXXXXXXXXX 267
            +   +   +V+++L  GSL+ ++  +  C++     +IA    E LQ L          
Sbjct: 85  SYLVGDELWVVMEYLAGGSLTDVV--TETCMD---EGQIAAVCRECLQALEFLHSNQVIH 139
Query: 268 XXXKASNILLSEDYEAQISDFGL-AKWLPDNWSHHIVFPIEGTFGYLSPEYFMHGIVDEK 326
              K+ NILL  D   +++DFG  A+  P+      +    GT  +++PE         K
Sbjct: 140 RDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSXMV---GTPYWMAPEVVTRKAYGPK 196
Query: 327 TDVFAFGVLLLELITG 342
            D+++ G++ +E+I G
Sbjct: 197 VDIWSLGIMAIEMIEG 212

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 51/207 (24%), Positives = 82/207 (39%), Gaps = 13/207 (6%)
Query: 141 TDNFNSENLIGKGGHAEVYKGCLPDGEXXXXXXXXXXXXEDEER-ISDFLSELGIVAHIN 199
           +DN++ +  +GKG  + V + C+                +   R       E  I   + 
Sbjct: 28  SDNYDVKEELGKGAFS-VVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQ 86
Query: 200 HPNAAKLIGFSTENGFH-LVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLX 258
           HPN  +L     E  FH LV   +  G L    F      E+      +  I + L+ + 
Sbjct: 87  HPNIVRLHDSIQEESFHYLVFDLVTGGEL----FEDIVAREFYSEADASHCIQQILESIA 142
Query: 259 XXXXXXXXXXXXKASNILLSEDYEA---QISDFGLAKWLPDNWSHHIVFPIEGTFGYLSP 315
                       K  N+LL+   +    +++DFGLA  + D+ + H      GT GYLSP
Sbjct: 143 YCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWH---GFAGTPGYLSP 199
Query: 316 EYFMHGIVDEKTDVFAFGVLLLELITG 342
           E        +  D++A GV+L  L+ G
Sbjct: 200 EVLKKDPYSKPVDIWACGVILYILLVG 226

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 42/161 (26%), Positives = 72/161 (44%), Gaps = 10/161 (6%)
Query: 183 ERISDFLSELGIVAHINHPNAAKL-IGFSTENGFHLVLQFLPHGSLSSLLFGSTECLEWT 241
           ++I   L+E  I+  +N P   KL   F   +  ++V++++P G + S L       E  
Sbjct: 83  KQIEHTLNEKRILQAVNFPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPH 142
Query: 242 IRYKIALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSHH 301
            R+  A  I    +YL             K  N+L+ +    Q++DFG AK +       
Sbjct: 143 ARF-YAAQIVLTFEYLHSLDLIYRDL---KPENLLIDQQGYIQVTDFGFAKRVKGR---- 194
Query: 302 IVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITG 342
             + + GT  YL+PE  +    ++  D +A GVL+ E+  G
Sbjct: 195 -TWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 44/196 (22%), Positives = 85/196 (43%), Gaps = 14/196 (7%)
Query: 150 IGKGGHAEVYKGC-LPDGEXXXXXXXXXXXXEDEERISDFLSELGIVAHINHPNAAKLI- 207
           IG+G    VY    +  G+              +E I   ++E+ ++    +PN    + 
Sbjct: 29  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELI---INEILVMRENKNPNIVNYLD 85
Query: 208 GFSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLXXXXXXXXXX 267
            +   +   +V+++L  GSL+ ++  +  C++     +IA    E LQ L          
Sbjct: 86  SYLVGDELWVVMEYLAGGSLTDVV--TETCMD---EGQIAAVCRECLQALEFLHSNQVIH 140
Query: 268 XXXKASNILLSEDYEAQISDFGL-AKWLPDNWSHHIVFPIEGTFGYLSPEYFMHGIVDEK 326
              K+ NILL  D   +++DFG  A+  P+      +    GT  +++PE         K
Sbjct: 141 RDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSXMV---GTPYWMAPEVVTRKAYGPK 197
Query: 327 TDVFAFGVLLLELITG 342
            D+++ G++ +E+I G
Sbjct: 198 VDIWSLGIMAIEMIEG 213

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 42/161 (26%), Positives = 72/161 (44%), Gaps = 10/161 (6%)
Query: 183 ERISDFLSELGIVAHINHPNAAKL-IGFSTENGFHLVLQFLPHGSLSSLLFGSTECLEWT 241
           ++I   L+E  I+  +N P   KL   F   +  ++V++++P G + S L       E  
Sbjct: 83  KQIEHTLNEKRILQAVNFPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPH 142
Query: 242 IRYKIALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSHH 301
            R+  A  I    +YL             K  N+L+ +    Q++DFG AK +       
Sbjct: 143 ARF-YAAQIVLTFEYLHSLDLIYRDL---KPENLLIDQQGYIQVTDFGFAKRVKGR---- 194
Query: 302 IVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITG 342
             + + GT  YL+PE  +    ++  D +A GVL+ E+  G
Sbjct: 195 -TWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 42/161 (26%), Positives = 72/161 (44%), Gaps = 10/161 (6%)
Query: 183 ERISDFLSELGIVAHINHPNAAKL-IGFSTENGFHLVLQFLPHGSLSSLLFGSTECLEWT 241
           ++I   L+E  I+  +N P   KL   F   +  ++V++++P G + S L       E  
Sbjct: 83  KQIEHTLNEKRILQAVNFPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPH 142
Query: 242 IRYKIALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSHH 301
            R+  A  I    +YL             K  N+L+ +    Q++DFG AK +       
Sbjct: 143 ARF-YAAQIVLTFEYLHSLDLIYRDL---KPENLLIDQQGYIQVTDFGFAKRVKGR---- 194
Query: 302 IVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITG 342
             + + GT  YL+PE  +    ++  D +A GVL+ E+  G
Sbjct: 195 -TWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 43/195 (22%), Positives = 83/195 (42%), Gaps = 12/195 (6%)
Query: 150 IGKGGHAEVYKGC-LPDGEXXXXXXXXXXXXEDEERISDFLSELGIVAHINHPNAAKLI- 207
           IG+G    VY    +  G+              +E I   ++E+ ++    +PN    + 
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELI---INEILVMRENKNPNIVNYLD 84
Query: 208 GFSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLXXXXXXXXXX 267
            +   +   +V+++L  GSL+ ++  +  C++     +IA    E LQ L          
Sbjct: 85  SYLVGDELWVVMEYLAGGSLTDVV--TETCMD---EGQIAAVCRECLQALEFLHSNQVIH 139
Query: 268 XXXKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEGTFGYLSPEYFMHGIVDEKT 327
              K+ NILL  D   +++DFG    +    S      + GT  +++PE         K 
Sbjct: 140 RDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR--SEMVGTPYWMAPEVVTRKAYGPKV 197
Query: 328 DVFAFGVLLLELITG 342
           D+++ G++ +E+I G
Sbjct: 198 DIWSLGIMAIEMIEG 212

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 40/162 (24%), Positives = 69/162 (42%), Gaps = 23/162 (14%)
Query: 190 SELGIVAHINHPNAAKLI-GFSTENGFHLVLQFLPHGSL------SSLLFGSTECLEWTI 242
           +E  I+  + HP    LI  F T    +L+L++L  G L        +    T C  +  
Sbjct: 70  AERNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACF-YLA 128
Query: 243 RYKIALGI--AEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSH 300
              +ALG    +G+ Y              K  NI+L+     +++DFGL K    + + 
Sbjct: 129 EISMALGHLHQKGIIY-----------RDLKPENIMLNHQGHVKLTDFGLCKESIHDGT- 176
Query: 301 HIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITG 342
            +     GT  Y++PE  M    +   D ++ G L+ +++TG
Sbjct: 177 -VTHXFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTG 217

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 57/263 (21%), Positives = 102/263 (38%), Gaps = 18/263 (6%)
Query: 114 DDADDGGSVPIVRHSWKNFDFAELA--AATDNFNSENLIGKGGHAEVY-----KGCLPDG 166
           D  D G  +  V+H  +  +    A     +NF    ++G G + +V+      G     
Sbjct: 24  DGGDGGEQLLTVKHELRTANLTGHAEKVGIENFELLKVLGTGAYGKVFLVRKISGHDTGK 83
Query: 167 EXXXXXXXXXXXXEDEERISDFLSELGIVAHINH-PNAAKL-IGFSTENGFHLVLQFLPH 224
                        +  +      +E  ++ HI   P    L   F TE   HL+L ++  
Sbjct: 84  LYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYING 143
Query: 225 GSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQ 284
           G L    F      E    +++ + + E +  L             K  NILL  +    
Sbjct: 144 GEL----FTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVV 199
Query: 285 ISDFGLAKWLPDNWSHHIVFPIEGTFGYLSPEYFMHGIV--DEKTDVFAFGVLLLELITG 342
           ++DFGL+K    + +    +   GT  Y++P+    G    D+  D ++ GVL+ EL+TG
Sbjct: 200 LTDFGLSKEFVADETER-AYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTG 258
Query: 343 RR--AVDSRRQSLVIWAKPLLQT 363
                VD  + S    ++ +L++
Sbjct: 259 ASPFTVDGEKNSQAEISRRILKS 281

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 42/164 (25%), Positives = 76/164 (46%), Gaps = 25/164 (15%)
Query: 191 ELGIVAHINHPNAAKLIGFSTE-------NGFHLVLQFLPHGSLSSLLFGSTECLEWT-- 241
           EL ++ H+ H N   L+   T        N  +LV   +      + L    +C + T  
Sbjct: 71  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-----GADLNNIVKCQKLTDD 125
Query: 242 -IRYKIALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSH 300
            +++ I   I  GL+Y+             K SN+ ++ED E +I DFGLA+   D  + 
Sbjct: 126 HVQFLI-YQILRGLKYIHSADIIHRDL---KPSNLAVNEDCELKILDFGLARHTDDEMTG 181
Query: 301 HIVFPIEGTFGYLSPEYFMHGI-VDEKTDVFAFGVLLLELITGR 343
           ++      T  Y +PE  ++ +  ++  D+++ G ++ EL+TGR
Sbjct: 182 YV-----ATRWYRAPEIMLNAMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 54/210 (25%), Positives = 83/210 (39%), Gaps = 18/210 (8%)
Query: 141 TDNFNSENLIGKGGHAEVYKGCL--PDGEXXXXX--XXXXXXXEDEERISDFLSELGIVA 196
           TD +     +GKG  + V + C+  P G+               D +++     E  I  
Sbjct: 3   TDEYQLFEELGKGAFS-VVRRCMKIPTGQEYAAKIINTKKLSARDHQKLE---REARICR 58
Query: 197 HINHPNAAKLIGFSTENGFH-LVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQ 255
            + HPN  +L    +E GFH LV   +  G L    F      E+      +  I + L+
Sbjct: 59  LLKHPNIVRLHDSISEEGFHYLVFDLVTGGEL----FEDIVAREYYSEADASHCIQQILE 114
Query: 256 YLXXXXXXXXXXXXXKASNILL---SEDYEAQISDFGLAKWLPDNWSHHIVFPIEGTFGY 312
            +             K  N+LL   S+    +++DFGLA  +         F   GT GY
Sbjct: 115 SVNHCHLNGIVHRDLKPENLLLASKSKGAAVKLADFGLA--IEVQGDQQAWFGFAGTPGY 172
Query: 313 LSPEYFMHGIVDEKTDVFAFGVLLLELITG 342
           LSPE        +  D++A GV+L  L+ G
Sbjct: 173 LSPEVLRKDPYGKPVDMWACGVILYILLVG 202

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 55/236 (23%), Positives = 97/236 (41%), Gaps = 33/236 (13%)
Query: 130 KNFDFAELAAATDNFNSENLIGKGGHAEVYKGCL---PDGEXXXXXXXXXXXXEDEERI- 185
           K     E++ +   F  E  +G+    +VYKG L     GE            + E  + 
Sbjct: 16  KQAKLKEISLSAVRFMEE--LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLR 73
Query: 186 SDFLSELGIVAHINHPNAAKLIGFSTENG-FHLVLQFLPHGSLSSLLF--------GSTE 236
            +F  E  + A + HPN   L+G  T++    ++  +  HG L   L         GST+
Sbjct: 74  EEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTD 133
Query: 237 -------CLEWTIRYKIALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFG 289
                   LE      +   IA G++YL                N+L+ +    +ISD G
Sbjct: 134 DDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLA---TRNVLVYDKLNVKISDLG 190
Query: 290 LAK--WLPDNWS--HHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELIT 341
           L +  +  D +    + + PI     +++PE  M+G     +D++++GV+L E+ +
Sbjct: 191 LFREVYAADYYKLLGNSLLPIR----WMAPEAIMYGKFSIDSDIWSYGVVLWEVFS 242

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 51/207 (24%), Positives = 82/207 (39%), Gaps = 13/207 (6%)
Query: 141 TDNFNSENLIGKGGHAEVYKGCLPDGEXXXXXXXXXXXXEDEER-ISDFLSELGIVAHIN 199
           +DN++ +  +GKG  + V + C+                +   R       E  I   + 
Sbjct: 5   SDNYDVKEELGKGAFS-VVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQ 63
Query: 200 HPNAAKLIGFSTENGFH-LVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLX 258
           HPN  +L     E  FH LV   +  G L    F      E+      +  I + L+ + 
Sbjct: 64  HPNIVRLHDSIQEESFHYLVFDLVTGGEL----FEDIVAREFYSEADASHCIQQILESIA 119
Query: 259 XXXXXXXXXXXXKASNILLSEDYEA---QISDFGLAKWLPDNWSHHIVFPIEGTFGYLSP 315
                       K  N+LL+   +    +++DFGLA  + D+ + H      GT GYLSP
Sbjct: 120 YCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWH---GFAGTPGYLSP 176
Query: 316 EYFMHGIVDEKTDVFAFGVLLLELITG 342
           E        +  D++A GV+L  L+ G
Sbjct: 177 EVLKKDPYSKPVDIWACGVILYILLVG 203

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 42/161 (26%), Positives = 71/161 (44%), Gaps = 10/161 (6%)
Query: 183 ERISDFLSELGIVAHINHPNAAKL-IGFSTENGFHLVLQFLPHGSLSSLLFGSTECLEWT 241
           + I   L+E  I+  +N P   KL   F   +  ++V+++ P G + S L       E  
Sbjct: 83  KEIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPH 142
Query: 242 IRYKIALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSHH 301
            R+  A  I    +YL             K  N+++ +    Q++DFGLAK +       
Sbjct: 143 ARF-YAAQIVLTFEYLHSLDLIYRDL---KPENLMIDQQGYIQVTDFGLAKRVKGR---- 194
Query: 302 IVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITG 342
             + + GT  YL+PE  +    ++  D +A GVL+ E+  G
Sbjct: 195 -TWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 51/207 (24%), Positives = 82/207 (39%), Gaps = 13/207 (6%)
Query: 141 TDNFNSENLIGKGGHAEVYKGCLPDGEXXXXXXXXXXXXEDEER-ISDFLSELGIVAHIN 199
           +DN++ +  +GKG  + V + C+                +   R       E  I   + 
Sbjct: 4   SDNYDVKEELGKGAFS-VVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQ 62
Query: 200 HPNAAKLIGFSTENGFH-LVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLX 258
           HPN  +L     E  FH LV   +  G L    F      E+      +  I + L+ + 
Sbjct: 63  HPNIVRLHDSIQEESFHYLVFDLVTGGEL----FEDIVAREFYSEADASHCIQQILESIA 118
Query: 259 XXXXXXXXXXXXKASNILLSEDYEA---QISDFGLAKWLPDNWSHHIVFPIEGTFGYLSP 315
                       K  N+LL+   +    +++DFGLA  + D+ + H      GT GYLSP
Sbjct: 119 YCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWH---GFAGTPGYLSP 175
Query: 316 EYFMHGIVDEKTDVFAFGVLLLELITG 342
           E        +  D++A GV+L  L+ G
Sbjct: 176 EVLKKDPYSKPVDIWACGVILYILLVG 202

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 54/212 (25%), Positives = 84/212 (39%), Gaps = 18/212 (8%)
Query: 139 AATDNFNSENLIGKGGHAEVYKGCL--PDGEXXXXX--XXXXXXXEDEERISDFLSELGI 194
           + TD +     +GKG  + V + C+  P G+               D +++     E  I
Sbjct: 1   SMTDEYQLFEELGKGAFS-VVRRCMKIPTGQEYAAKIINTKKLSARDHQKLE---REARI 56
Query: 195 VAHINHPNAAKLIGFSTENGFH-LVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEG 253
              + HPN  +L    +E GFH LV   +  G L    F      E+      +  I + 
Sbjct: 57  CRLLKHPNIVRLHDSISEEGFHYLVFDLVTGGEL----FEDIVAREYYSEADASHCIQQI 112
Query: 254 LQYLXXXXXXXXXXXXXKASNILL---SEDYEAQISDFGLAKWLPDNWSHHIVFPIEGTF 310
           L+ +             K  N+LL   S+    +++DFGLA  +         F   GT 
Sbjct: 113 LESVNHCHLNGIVHRDLKPENLLLASKSKGAAVKLADFGLA--IEVQGDQQAWFGFAGTP 170
Query: 311 GYLSPEYFMHGIVDEKTDVFAFGVLLLELITG 342
           GYLSPE        +  D++A GV+L  L+ G
Sbjct: 171 GYLSPEVLRKDPYGKPVDMWACGVILYILLVG 202

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 49/160 (30%), Positives = 73/160 (45%), Gaps = 11/160 (6%)
Query: 189 LSELGIVAHINHPNAAKLIGFSTENGF-HLVLQFLPHGSLSSLLFGSTECLEWTIRYKIA 247
           + EL   A ++ P    L G   E  + ++ ++ L  GSL  L+     CL    R    
Sbjct: 98  VEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLI-KQMGCLP-EDRALYY 155
Query: 248 LGIA-EGLQYLXXXXXXXXXXXXXKASNILLSED-YEAQISDFGLAKWL-PDNWSHHIVF 304
           LG A EGL+YL             KA N+LLS D   A + DFG A  L PD     ++ 
Sbjct: 156 LGQALEGLEYLHTRRILHGDV---KADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLT 212
Query: 305 P--IEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITG 342
              I GT  +++PE  M    D K D+++   ++L ++ G
Sbjct: 213 GDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNG 252

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 41/161 (25%), Positives = 72/161 (44%), Gaps = 10/161 (6%)
Query: 183 ERISDFLSELGIVAHINHPNAAKL-IGFSTENGFHLVLQFLPHGSLSSLLFGSTECLEWT 241
           ++I   L+E  I+  +N P   KL   F   +  ++V++++P G + S L       E  
Sbjct: 83  KQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYMPGGDMFSHLRRIGRFSEPH 142
Query: 242 IRYKIALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSHH 301
            R+  A  I    +YL             K  N+L+ +    +++DFG AK +       
Sbjct: 143 ARF-YAAQIVLTFEYLHSLDLIYRDL---KPENLLIDQQGYIKVADFGFAKRVKGR---- 194
Query: 302 IVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITG 342
             + + GT  YL+PE  +    ++  D +A GVL+ E+  G
Sbjct: 195 -TWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 44/182 (24%), Positives = 85/182 (46%), Gaps = 37/182 (20%)
Query: 189 LSELGIVAHI-NHPNAAKLIGFSTENG-FHLVLQFLPHGSLSSLLFGSTECL-EWTIRYK 245
           +SEL ++  + +H N   L+G  T +G  +L+ ++  +G L + L    E   E  I Y+
Sbjct: 96  MSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYE 155
Query: 246 ---------------------IALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQ 284
                                 A  +A+G+++L              A N+L++     +
Sbjct: 156 NQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLA---ARNVLVTHGKVVK 212
Query: 285 ISDFGLAKWLPDNWSHHIV-----FPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLEL 339
           I DFGLA+ +  + S+++V      P++    +++PE    GI   K+DV+++G+LL E+
Sbjct: 213 ICDFGLARDIMSD-SNYVVRGNARLPVK----WMAPESLFEGIYTIKSDVWSYGILLWEI 267
Query: 340 IT 341
            +
Sbjct: 268 FS 269

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 41/161 (25%), Positives = 72/161 (44%), Gaps = 10/161 (6%)
Query: 183 ERISDFLSELGIVAHINHPNAAKL-IGFSTENGFHLVLQFLPHGSLSSLLFGSTECLEWT 241
           ++I   L+E  I+  +N P   KL   F   +  ++V++++P G + S L       E  
Sbjct: 83  KQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYMPGGDMFSHLRRIGRFSEPH 142
Query: 242 IRYKIALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSHH 301
            R+  A  I    +YL             K  N+L+ +    +++DFG AK +       
Sbjct: 143 ARF-YAAQIVLTFEYLHSLDLIYRDL---KPENLLIDQQGYIKVADFGFAKRVKGR---- 194
Query: 302 IVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITG 342
             + + GT  YL+PE  +    ++  D +A GVL+ E+  G
Sbjct: 195 -TWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 51/207 (24%), Positives = 82/207 (39%), Gaps = 13/207 (6%)
Query: 141 TDNFNSENLIGKGGHAEVYKGCLPDGEXXXXXXXXXXXXEDEER-ISDFLSELGIVAHIN 199
           +DN++ +  +GKG  + V + C+                +   R       E  I   + 
Sbjct: 5   SDNYDVKEELGKGAFS-VVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQ 63
Query: 200 HPNAAKLIGFSTENGFH-LVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLX 258
           HPN  +L     E  FH LV   +  G L    F      E+      +  I + L+ + 
Sbjct: 64  HPNIVRLHDSIQEESFHYLVFDLVTGGEL----FEDIVAREFYSEADASHCIQQILESIA 119
Query: 259 XXXXXXXXXXXXKASNILLSEDYEA---QISDFGLAKWLPDNWSHHIVFPIEGTFGYLSP 315
                       K  N+LL+   +    +++DFGLA  + D+ + H      GT GYLSP
Sbjct: 120 YCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWH---GFAGTPGYLSP 176
Query: 316 EYFMHGIVDEKTDVFAFGVLLLELITG 342
           E        +  D++A GV+L  L+ G
Sbjct: 177 EVLKKDPYSKPVDIWACGVILYILLVG 203

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 49/160 (30%), Positives = 73/160 (45%), Gaps = 11/160 (6%)
Query: 189 LSELGIVAHINHPNAAKLIGFSTENGF-HLVLQFLPHGSLSSLLFGSTECLEWTIRYKIA 247
           + EL   A ++ P    L G   E  + ++ ++ L  GSL  L+     CL    R    
Sbjct: 114 VEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLI-KQMGCLP-EDRALYY 171
Query: 248 LGIA-EGLQYLXXXXXXXXXXXXXKASNILLSED-YEAQISDFGLAKWL-PDNWSHHIVF 304
           LG A EGL+YL             KA N+LLS D   A + DFG A  L PD     ++ 
Sbjct: 172 LGQALEGLEYLHTRRILHGDV---KADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLT 228
Query: 305 P--IEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITG 342
              I GT  +++PE  M    D K D+++   ++L ++ G
Sbjct: 229 GDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNG 268

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 54/230 (23%), Positives = 96/230 (41%), Gaps = 33/230 (14%)
Query: 136 ELAAATDNFNSENLIGKGGHAEVYKGCL---PDGEXXXXXXXXXXXXEDEERI-SDFLSE 191
           E++ +   F  E  +G+    +VYKG L     GE            + E  +  +F  E
Sbjct: 5   EISLSAVRFMEE--LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHE 62
Query: 192 LGIVAHINHPNAAKLIGFSTENG-FHLVLQFLPHGSLSSLLF--------GSTE------ 236
             + A + HPN   L+G  T++    ++  +  HG L   L         GST+      
Sbjct: 63  AMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVK 122
Query: 237 -CLEWTIRYKIALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAK--W 293
             LE      +   IA G++YL                N+L+ +    +ISD GL +  +
Sbjct: 123 SALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLA---TRNVLVYDKLNVKISDLGLFREVY 179
Query: 294 LPDNWS--HHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELIT 341
             D +    + + PI     +++PE  M+G     +D++++GV+L E+ +
Sbjct: 180 AADYYKLLGNSLLPIR----WMAPEAIMYGKFSIDSDIWSYGVVLWEVFS 225

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 49/160 (30%), Positives = 73/160 (45%), Gaps = 11/160 (6%)
Query: 189 LSELGIVAHINHPNAAKLIGFSTENGF-HLVLQFLPHGSLSSLLFGSTECLEWTIRYKIA 247
           + EL   A ++ P    L G   E  + ++ ++ L  GSL  L+     CL    R    
Sbjct: 112 VEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLI-KQMGCLP-EDRALYY 169
Query: 248 LGIA-EGLQYLXXXXXXXXXXXXXKASNILLSED-YEAQISDFGLAKWL-PDNWSHHIVF 304
           LG A EGL+YL             KA N+LLS D   A + DFG A  L PD     ++ 
Sbjct: 170 LGQALEGLEYLHTRRILHGDV---KADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLT 226
Query: 305 P--IEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITG 342
              I GT  +++PE  M    D K D+++   ++L ++ G
Sbjct: 227 GDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNG 266

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 45.4 bits (106), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 47/213 (22%), Positives = 90/213 (42%), Gaps = 31/213 (14%)
Query: 150 IGKGGHAEVYKGCLPD-----GEXXXXXXXXXXXXEDEERISDFLSELGIVAHINHPNAA 204
           +G+G    VY+G   D      E               ERI +FL+E  ++      +  
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERI-EFLNEASVMKGFTCHHVV 83
Query: 205 KLIGFSTENGFHLV-LQFLPHGSLSSLLFG-----------STECLEWTIRYKIALGIAE 252
           +L+G  ++    LV ++ + HG L S L                 L+  I  ++A  IA+
Sbjct: 84  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMI--QMAAEIAD 141
Query: 253 GLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSHHI----VFPIEG 308
           G+ YL              A N +++ D+  +I DFG+ + + +   +      + P+  
Sbjct: 142 GMAYLNAKKFVHRDLA---ARNCMVAHDFTVKIGDFGMTRDIYETAYYRKGGKGLLPVR- 197
Query: 309 TFGYLSPEYFMHGIVDEKTDVFAFGVLLLELIT 341
              +++PE    G+    +D+++FGV+L E+ +
Sbjct: 198 ---WMAPESLKDGVFTTSSDMWSFGVVLWEITS 227

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 45.4 bits (106), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 41/161 (25%), Positives = 72/161 (44%), Gaps = 10/161 (6%)
Query: 183 ERISDFLSELGIVAHINHPNAAKL-IGFSTENGFHLVLQFLPHGSLSSLLFGSTECLEWT 241
           ++I   L+E  I+  +N P   KL   F   +  ++V++++P G + S L       E  
Sbjct: 83  KQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPH 142
Query: 242 IRYKIALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSHH 301
            R+  A  I    +YL             K  N+L+ +    +++DFG AK +       
Sbjct: 143 ARF-YAAQIVLTFEYLHSLDLIYRDL---KPENLLIDQQGYIKVADFGFAKRVKGR---- 194
Query: 302 IVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITG 342
             + + GT  YL+PE  +    ++  D +A GVL+ E+  G
Sbjct: 195 -TWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 45.4 bits (106), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 41/161 (25%), Positives = 71/161 (44%), Gaps = 10/161 (6%)
Query: 183 ERISDFLSELGIVAHINHPNAAKL-IGFSTENGFHLVLQFLPHGSLSSLLFGSTECLEWT 241
           ++I   L+E  I+  +N P   KL   F   +  ++V+++ P G + S L       E  
Sbjct: 83  KQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPH 142
Query: 242 IRYKIALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSHH 301
            R+  A  I    +YL             K  N+++ +    Q++DFG AK +       
Sbjct: 143 ARF-YAAQIVLTFEYLHSLDLIYRDL---KPENLMIDQQGYIQVTDFGFAKRVKGR---- 194
Query: 302 IVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITG 342
             + + GT  YL+PE  +    ++  D +A GVL+ E+  G
Sbjct: 195 -TWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 45.4 bits (106), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 42/164 (25%), Positives = 76/164 (46%), Gaps = 25/164 (15%)
Query: 191 ELGIVAHINHPNAAKLIGFSTE-------NGFHLVLQFLPHGSLSSLLFGSTECLEWT-- 241
           EL ++ H+ H N   L+   T        N  +LV   +      + L    +C + T  
Sbjct: 78  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-----GADLNNIVKCQKLTDD 132
Query: 242 -IRYKIALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSH 300
            +++ I   I  GL+Y+             K SN+ ++ED E +I DFGLA+   D  + 
Sbjct: 133 HVQFLI-YQILRGLKYIHSADIIHRDL---KPSNLAVNEDCELKILDFGLARHTADEMTG 188
Query: 301 HIVFPIEGTFGYLSPEYFMHGI-VDEKTDVFAFGVLLLELITGR 343
           ++      T  Y +PE  ++ +  ++  D+++ G ++ EL+TGR
Sbjct: 189 YV-----ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 45.1 bits (105), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 61/287 (21%), Positives = 113/287 (39%), Gaps = 48/287 (16%)
Query: 150 IGKGGHAEVYKGCLPD-----GEXXXXXXXXXXXXEDEERISDFLSELGIVAHINHPNAA 204
           +G+G    VY+G   D      E               ERI +FL+E  ++      +  
Sbjct: 26  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERI-EFLNEASVMKGFTCHHVV 84
Query: 205 KLIGFSTENGFHLV-LQFLPHGSLSSLLFG-----------STECLEWTIRYKIALGIAE 252
           +L+G  ++    LV ++ + HG L S L                 L+  I  ++A  IA+
Sbjct: 85  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMI--QMAAEIAD 142
Query: 253 GLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSHHI----VFPIEG 308
           G+ YL              A N +++ D+  +I DFG+ + + +   +      + P+  
Sbjct: 143 GMAYLNAKKFVHRNLA---ARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR- 198
Query: 309 TFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSN--- 365
              +++PE    G+    +D+++FGV+L E+ +             +  +P    SN   
Sbjct: 199 ---WMAPESLKDGVFTTSSDMWSFGVVLWEITS-------------LAEQPYQGLSNEQV 242
Query: 366 FKELVDPRLADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQLLR 412
            K ++D    D  D    +R      +C      MRP    ++ LL+
Sbjct: 243 LKFVMDGGYLDQPDNCP-ERVTDLMRMCWQFNPNMRPTFLEIVNLLK 288

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 45.1 bits (105), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 42/164 (25%), Positives = 76/164 (46%), Gaps = 25/164 (15%)
Query: 191 ELGIVAHINHPNAAKLIGFSTE-------NGFHLVLQFLPHGSLSSLLFGSTECLEWT-- 241
           EL ++ H+ H N   L+   T        N  +LV   +      + L    +C + T  
Sbjct: 78  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-----GADLNNIVKCQKLTDD 132
Query: 242 -IRYKIALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSH 300
            +++ I   I  GL+Y+             K SN+ ++ED E +I DFGLA+   D  + 
Sbjct: 133 HVQFLI-YQILRGLKYIHSADIIHRDL---KPSNLAVNEDCELKILDFGLARHTADEMTG 188
Query: 301 HIVFPIEGTFGYLSPEYFMHGI-VDEKTDVFAFGVLLLELITGR 343
           ++      T  Y +PE  ++ +  ++  D+++ G ++ EL+TGR
Sbjct: 189 YV-----ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 45.1 bits (105), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 47/213 (22%), Positives = 90/213 (42%), Gaps = 31/213 (14%)
Query: 150 IGKGGHAEVYKGCLPD-----GEXXXXXXXXXXXXEDEERISDFLSELGIVAHINHPNAA 204
           +G+G    VY+G   D      E               ERI +FL+E  ++      +  
Sbjct: 24  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERI-EFLNEASVMKGFTCHHVV 82
Query: 205 KLIGFSTENGFHLV-LQFLPHGSLSSLLFG-----------STECLEWTIRYKIALGIAE 252
           +L+G  ++    LV ++ + HG L S L                 L+  I  ++A  IA+
Sbjct: 83  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMI--QMAAEIAD 140
Query: 253 GLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSHHI----VFPIEG 308
           G+ YL              A N +++ D+  +I DFG+ + + +   +      + P+  
Sbjct: 141 GMAYLNAKKFVHRDLA---ARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR- 196
Query: 309 TFGYLSPEYFMHGIVDEKTDVFAFGVLLLELIT 341
              +++PE    G+    +D+++FGV+L E+ +
Sbjct: 197 ---WMAPESLKDGVFTTSSDMWSFGVVLWEITS 226

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 45.1 bits (105), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 41/149 (27%), Positives = 67/149 (44%), Gaps = 15/149 (10%)
Query: 200 HPNAAKLIG-FSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKI--ALGIAEGLQY 256
           HP    +   F T+     V+++L  G L   ++    C ++ +      A  I  GLQ+
Sbjct: 78  HPFLTHMFCTFQTKENLFFVMEYLNGGDL---MYHIQSCHKFDLSRATFYAAEIILGLQF 134
Query: 257 LXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAK--WLPDNWSHHIVFPIEGTFGYLS 314
           L             K  NILL +D   +I+DFG+ K   L D  ++       GT  Y++
Sbjct: 135 LHSKGIVYRDL---KLDNILLDKDGHIKIADFGMCKENMLGDAKTNEFC----GTPDYIA 187
Query: 315 PEYFMHGIVDEKTDVFAFGVLLLELITGR 343
           PE  +    +   D ++FGVLL E++ G+
Sbjct: 188 PEILLGQKYNHSVDWWSFGVLLYEMLIGQ 216

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 45.1 bits (105), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 42/164 (25%), Positives = 76/164 (46%), Gaps = 25/164 (15%)
Query: 191 ELGIVAHINHPNAAKLIGFSTE-------NGFHLVLQFLPHGSLSSLLFGSTECLEWT-- 241
           EL ++ H+ H N   L+   T        N  +LV   +      + L    +C + T  
Sbjct: 78  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-----GADLNNIVKCQKLTDD 132
Query: 242 -IRYKIALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSH 300
            +++ I   I  GL+Y+             K SN+ ++ED E +I DFGLA+   D  + 
Sbjct: 133 HVQFLI-YQILRGLKYIHSADIIHRDL---KPSNLAVNEDCELKILDFGLARHTADEMTG 188
Query: 301 HIVFPIEGTFGYLSPEYFMHGI-VDEKTDVFAFGVLLLELITGR 343
           ++      T  Y +PE  ++ +  ++  D+++ G ++ EL+TGR
Sbjct: 189 YV-----ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 45.1 bits (105), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 61/287 (21%), Positives = 113/287 (39%), Gaps = 48/287 (16%)
Query: 150 IGKGGHAEVYKGCLPD-----GEXXXXXXXXXXXXEDEERISDFLSELGIVAHINHPNAA 204
           +G+G    VY+G   D      E               ERI +FL+E  ++      +  
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERI-EFLNEASVMKGFTCHHVV 83
Query: 205 KLIGFSTENGFHLV-LQFLPHGSLSSLLFG-----------STECLEWTIRYKIALGIAE 252
           +L+G  ++    LV ++ + HG L S L                 L+  I  ++A  IA+
Sbjct: 84  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMI--QMAAEIAD 141
Query: 253 GLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSHHI----VFPIEG 308
           G+ YL              A N +++ D+  +I DFG+ + + +   +      + P+  
Sbjct: 142 GMAYLNAKKFVHRNLA---ARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR- 197
Query: 309 TFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSN--- 365
              +++PE    G+    +D+++FGV+L E+ +             +  +P    SN   
Sbjct: 198 ---WMAPESLKDGVFTTSSDMWSFGVVLWEITS-------------LAEQPYQGLSNEQV 241
Query: 366 FKELVDPRLADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQLLR 412
            K ++D    D  D    +R      +C      MRP    ++ LL+
Sbjct: 242 LKFVMDGGYLDQPDNCP-ERVTDLMRMCWQFNPNMRPTFLEIVNLLK 287

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 45.1 bits (105), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 42/164 (25%), Positives = 76/164 (46%), Gaps = 25/164 (15%)
Query: 191 ELGIVAHINHPNAAKLIGFSTE-------NGFHLVLQFLPHGSLSSLLFGSTECLEWT-- 241
           EL ++ H+ H N   L+   T        N  +LV   +      + L    +C + T  
Sbjct: 71  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-----GADLNNIVKCQKLTDD 125
Query: 242 -IRYKIALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSH 300
            +++ I   I  GL+Y+             K SN+ ++ED E +I DFGLA+   D  + 
Sbjct: 126 HVQFLI-YQILRGLKYIHSADIIHRDL---KPSNLAVNEDCELKILDFGLARHTDDEMTG 181
Query: 301 HIVFPIEGTFGYLSPEYFMHGI-VDEKTDVFAFGVLLLELITGR 343
           ++      T  Y +PE  ++ +  ++  D+++ G ++ EL+TGR
Sbjct: 182 YV-----ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 45.1 bits (105), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 55/221 (24%), Positives = 85/221 (38%), Gaps = 15/221 (6%)
Query: 130 KNFDFAELAAAT---DNFNSENLIGKGGHAEVYKGCLPDGEXXXXXXXXXXXXEDEERIS 186
           +N  F  +A  T   D++     +GKG  + V + C+                +   R  
Sbjct: 16  ENLYFQXMATCTRFTDDYQLFEELGKGAFS-VVRRCVKKTPTQEYAAKIINTKKLSARDH 74
Query: 187 DFLS-ELGIVAHINHPNAAKLIGFSTENGFH-LVLQFLPHGSLSSLLFGSTECLEWTIRY 244
             L  E  I   + HPN  +L    +E GFH LV   +  G L    F      E+    
Sbjct: 75  QKLEREARICRLLKHPNIVRLHDSISEEGFHYLVFDLVTGGEL----FEDIVAREYYSEA 130
Query: 245 KIALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEA---QISDFGLAKWLPDNWSHH 301
             +  I + L+ +             K  N+LL+   +    +++DFGLA  +       
Sbjct: 131 DASHCIHQILESVNHIHQHDIVHRDLKPENLLLASKCKGAAVKLADFGLA--IEVQGEQQ 188
Query: 302 IVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITG 342
             F   GT GYLSPE        +  D++A GV+L  L+ G
Sbjct: 189 AWFGFAGTPGYLSPEVLRKDPYGKPVDIWACGVILYILLVG 229

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 45.1 bits (105), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 42/164 (25%), Positives = 76/164 (46%), Gaps = 25/164 (15%)
Query: 191 ELGIVAHINHPNAAKLIGFSTE-------NGFHLVLQFLPHGSLSSLLFGSTECLEWT-- 241
           EL ++ H+ H N   L+   T        N  +LV   +      + L    +C + T  
Sbjct: 71  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-----GADLNNIVKCQKLTDD 125
Query: 242 -IRYKIALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSH 300
            +++ I   I  GL+Y+             K SN+ ++ED E +I DFGLA+   D  + 
Sbjct: 126 HVQFLI-YQILRGLKYIHSADIIHRDL---KPSNLAVNEDCELKILDFGLARHTDDEMTG 181
Query: 301 HIVFPIEGTFGYLSPEYFMHGI-VDEKTDVFAFGVLLLELITGR 343
           ++      T  Y +PE  ++ +  ++  D+++ G ++ EL+TGR
Sbjct: 182 YV-----ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 45.1 bits (105), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 42/164 (25%), Positives = 76/164 (46%), Gaps = 25/164 (15%)
Query: 191 ELGIVAHINHPNAAKLIGFSTE-------NGFHLVLQFLPHGSLSSLLFGSTECLEWT-- 241
           EL ++ H+ H N   L+   T        N  +LV   +      + L    +C + T  
Sbjct: 76  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-----GADLNNIVKCQKLTDD 130
Query: 242 -IRYKIALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSH 300
            +++ I   I  GL+Y+             K SN+ ++ED E +I DFGLA+   D  + 
Sbjct: 131 HVQFLI-YQILRGLKYIHSADIIHRDL---KPSNLAVNEDXELKILDFGLARHTDDEMTG 186
Query: 301 HIVFPIEGTFGYLSPEYFMHGI-VDEKTDVFAFGVLLLELITGR 343
           ++      T  Y +PE  ++ +  ++  D+++ G ++ EL+TGR
Sbjct: 187 YV-----ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 45.1 bits (105), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 42/164 (25%), Positives = 76/164 (46%), Gaps = 25/164 (15%)
Query: 191 ELGIVAHINHPNAAKLIGFSTE-------NGFHLVLQFLPHGSLSSLLFGSTECLEWT-- 241
           EL ++ H+ H N   L+   T        N  +LV   +      + L    +C + T  
Sbjct: 76  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-----GADLNNIVKCQKLTDD 130
Query: 242 -IRYKIALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSH 300
            +++ I   I  GL+Y+             K SN+ ++ED E +I DFGLA+   D  + 
Sbjct: 131 HVQFLI-YQILRGLKYIHSADIIHRDL---KPSNLAVNEDXELKILDFGLARHTDDEMTG 186
Query: 301 HIVFPIEGTFGYLSPEYFMHGI-VDEKTDVFAFGVLLLELITGR 343
           ++      T  Y +PE  ++ +  ++  D+++ G ++ EL+TGR
Sbjct: 187 YV-----ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 45.1 bits (105), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 42/164 (25%), Positives = 76/164 (46%), Gaps = 25/164 (15%)
Query: 191 ELGIVAHINHPNAAKLIGFSTE-------NGFHLVLQFLPHGSLSSLLFGSTECLEWT-- 241
           EL ++ H+ H N   L+   T        N  +LV   +      + L    +C + T  
Sbjct: 71  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-----GADLNNIVKCQKLTDD 125
Query: 242 -IRYKIALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSH 300
            +++ I   I  GL+Y+             K SN+ ++ED E +I DFGLA+   D  + 
Sbjct: 126 HVQFLI-YQILRGLKYIHSADIIHRDL---KPSNLAVNEDCELKILDFGLARHTDDEMTG 181
Query: 301 HIVFPIEGTFGYLSPEYFMHGI-VDEKTDVFAFGVLLLELITGR 343
           ++      T  Y +PE  ++ +  ++  D+++ G ++ EL+TGR
Sbjct: 182 YV-----ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 45.1 bits (105), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 41/149 (27%), Positives = 67/149 (44%), Gaps = 15/149 (10%)
Query: 200 HPNAAKLIG-FSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKI--ALGIAEGLQY 256
           HP    +   F T+     V+++L  G L   ++    C ++ +      A  I  GLQ+
Sbjct: 77  HPFLTHMFCTFQTKENLFFVMEYLNGGDL---MYHIQSCHKFDLSRATFYAAEIILGLQF 133
Query: 257 LXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAK--WLPDNWSHHIVFPIEGTFGYLS 314
           L             K  NILL +D   +I+DFG+ K   L D  ++       GT  Y++
Sbjct: 134 LHSKGIVYRDL---KLDNILLDKDGHIKIADFGMCKENMLGDAKTNXFC----GTPDYIA 186
Query: 315 PEYFMHGIVDEKTDVFAFGVLLLELITGR 343
           PE  +    +   D ++FGVLL E++ G+
Sbjct: 187 PEILLGQKYNHSVDWWSFGVLLYEMLIGQ 215

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 45.1 bits (105), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 42/164 (25%), Positives = 76/164 (46%), Gaps = 25/164 (15%)
Query: 191 ELGIVAHINHPNAAKLIGFSTE-------NGFHLVLQFLPHGSLSSLLFGSTECLEWT-- 241
           EL ++ H+ H N   L+   T        N  +LV   +      + L    +C + T  
Sbjct: 82  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-----GADLNNIVKCQKLTDD 136
Query: 242 -IRYKIALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSH 300
            +++ I   I  GL+Y+             K SN+ ++ED E +I DFGLA+   D  + 
Sbjct: 137 HVQFLI-YQILRGLKYIHSADIIHRDL---KPSNLAVNEDXELKILDFGLARHTDDEMTG 192
Query: 301 HIVFPIEGTFGYLSPEYFMHGI-VDEKTDVFAFGVLLLELITGR 343
           ++      T  Y +PE  ++ +  ++  D+++ G ++ EL+TGR
Sbjct: 193 YV-----ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 231

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 42/164 (25%), Positives = 76/164 (46%), Gaps = 25/164 (15%)
Query: 191 ELGIVAHINHPNAAKLIGFSTE-------NGFHLVLQFLPHGSLSSLLFGSTECLEWT-- 241
           EL ++ H+ H N   L+   T        N  +LV   +      + L    +C + T  
Sbjct: 73  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-----GADLNNIVKCQKLTDD 127
Query: 242 -IRYKIALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSH 300
            +++ I   I  GL+Y+             K SN+ ++ED E +I DFGLA+   D  + 
Sbjct: 128 HVQFLI-YQILRGLKYIHSADIIHRDL---KPSNLAVNEDCELKILDFGLARHTDDEMTG 183
Query: 301 HIVFPIEGTFGYLSPEYFMHGI-VDEKTDVFAFGVLLLELITGR 343
           ++      T  Y +PE  ++ +  ++  D+++ G ++ EL+TGR
Sbjct: 184 YV-----ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 42/164 (25%), Positives = 76/164 (46%), Gaps = 25/164 (15%)
Query: 191 ELGIVAHINHPNAAKLIGFSTE-------NGFHLVLQFLPHGSLSSLLFGSTECLEWT-- 241
           EL ++ H+ H N   L+   T        N  +LV   +      + L    +C + T  
Sbjct: 83  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-----GADLNNIVKCQKLTDD 137
Query: 242 -IRYKIALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSH 300
            +++ I   I  GL+Y+             K SN+ ++ED E +I DFGLA+   D  + 
Sbjct: 138 HVQFLI-YQILRGLKYIHSADIIHRDL---KPSNLAVNEDCELKILDFGLARHTDDEMTG 193
Query: 301 HIVFPIEGTFGYLSPEYFMHGI-VDEKTDVFAFGVLLLELITGR 343
           ++      T  Y +PE  ++ +  ++  D+++ G ++ EL+TGR
Sbjct: 194 YV-----ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 232

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 42/164 (25%), Positives = 76/164 (46%), Gaps = 25/164 (15%)
Query: 191 ELGIVAHINHPNAAKLIGFSTE-------NGFHLVLQFLPHGSLSSLLFGSTECLEWT-- 241
           EL ++ H+ H N   L+   T        N  +LV   +      + L    +C + T  
Sbjct: 83  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-----GADLNNIVKCQKLTDD 137
Query: 242 -IRYKIALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSH 300
            +++ I   I  GL+Y+             K SN+ ++ED E +I DFGLA+   D  + 
Sbjct: 138 HVQFLI-YQILRGLKYIHSADIIHRDL---KPSNLAVNEDCELKILDFGLARHTDDEMTG 193
Query: 301 HIVFPIEGTFGYLSPEYFMHGI-VDEKTDVFAFGVLLLELITGR 343
           ++      T  Y +PE  ++ +  ++  D+++ G ++ EL+TGR
Sbjct: 194 YV-----ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 232

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 42/164 (25%), Positives = 76/164 (46%), Gaps = 25/164 (15%)
Query: 191 ELGIVAHINHPNAAKLIGFSTE-------NGFHLVLQFLPHGSLSSLLFGSTECLEWT-- 241
           EL ++ H+ H N   L+   T        N  +LV   +      + L    +C + T  
Sbjct: 83  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-----GADLNNIVKCQKLTDD 137
Query: 242 -IRYKIALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSH 300
            +++ I   I  GL+Y+             K SN+ ++ED E +I DFGLA+   D  + 
Sbjct: 138 HVQFLI-YQILRGLKYIHSADIIHRDL---KPSNLAVNEDCELKILDFGLARHTDDEMTG 193
Query: 301 HIVFPIEGTFGYLSPEYFMHGI-VDEKTDVFAFGVLLLELITGR 343
           ++      T  Y +PE  ++ +  ++  D+++ G ++ EL+TGR
Sbjct: 194 YV-----ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 232

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 42/164 (25%), Positives = 76/164 (46%), Gaps = 25/164 (15%)
Query: 191 ELGIVAHINHPNAAKLIGFSTE-------NGFHLVLQFLPHGSLSSLLFGSTECLEWT-- 241
           EL ++ H+ H N   L+   T        N  +LV   +      + L    +C + T  
Sbjct: 71  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-----GADLNNIVKCQKLTDD 125
Query: 242 -IRYKIALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSH 300
            +++ I   I  GL+Y+             K SN+ ++ED E +I DFGLA+   D  + 
Sbjct: 126 HVQFLI-YQILRGLKYIHSADIIHRDL---KPSNLAVNEDCELKILDFGLARHTDDEMTG 181
Query: 301 HIVFPIEGTFGYLSPEYFMHGI-VDEKTDVFAFGVLLLELITGR 343
           ++      T  Y +PE  ++ +  ++  D+++ G ++ EL+TGR
Sbjct: 182 YV-----ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 42/164 (25%), Positives = 76/164 (46%), Gaps = 25/164 (15%)
Query: 191 ELGIVAHINHPNAAKLIGFSTE-------NGFHLVLQFLPHGSLSSLLFGSTECLEWT-- 241
           EL ++ H+ H N   L+   T        N  +LV   +      + L    +C + T  
Sbjct: 67  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-----GADLNNIVKCAKLTDD 121
Query: 242 -IRYKIALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSH 300
            +++ I   I  GL+Y+             K SN+ ++ED E +I DFGLA+   D  + 
Sbjct: 122 HVQFLI-YQILRGLKYIHSADIIHRDL---KPSNLAVNEDCELKILDFGLARHTDDEMTG 177
Query: 301 HIVFPIEGTFGYLSPEYFMHGI-VDEKTDVFAFGVLLLELITGR 343
           ++      T  Y +PE  ++ +  ++  D+++ G ++ EL+TGR
Sbjct: 178 YV-----ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 42/164 (25%), Positives = 76/164 (46%), Gaps = 25/164 (15%)
Query: 191 ELGIVAHINHPNAAKLIGFSTE-------NGFHLVLQFLPHGSLSSLLFGSTECLEWT-- 241
           EL ++ H+ H N   L+   T        N  +LV   +      + L    +C + T  
Sbjct: 76  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-----GADLNNIVKCQKLTDD 130
Query: 242 -IRYKIALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSH 300
            +++ I   I  GL+Y+             K SN+ ++ED E +I DFGLA+   D  + 
Sbjct: 131 HVQFLI-YQILRGLKYIHSADIIHRDL---KPSNLAVNEDCELKILDFGLARHTDDEMTG 186
Query: 301 HIVFPIEGTFGYLSPEYFMHGI-VDEKTDVFAFGVLLLELITGR 343
           ++      T  Y +PE  ++ +  ++  D+++ G ++ EL+TGR
Sbjct: 187 YV-----ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 42/164 (25%), Positives = 76/164 (46%), Gaps = 25/164 (15%)
Query: 191 ELGIVAHINHPNAAKLIGFSTE-------NGFHLVLQFLPHGSLSSLLFGSTECLEWT-- 241
           EL ++ H+ H N   L+   T        N  +LV   +      + L    +C + T  
Sbjct: 70  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-----GADLNNIVKCQKLTDD 124
Query: 242 -IRYKIALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSH 300
            +++ I   I  GL+Y+             K SN+ ++ED E +I DFGLA+   D  + 
Sbjct: 125 HVQFLI-YQILRGLKYIHSADIIHRDL---KPSNLAVNEDCELKILDFGLARHTDDEMTG 180
Query: 301 HIVFPIEGTFGYLSPEYFMHGI-VDEKTDVFAFGVLLLELITGR 343
           ++      T  Y +PE  ++ +  ++  D+++ G ++ EL+TGR
Sbjct: 181 YV-----ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 219

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 42/164 (25%), Positives = 76/164 (46%), Gaps = 25/164 (15%)
Query: 191 ELGIVAHINHPNAAKLIGFSTE-------NGFHLVLQFLPHGSLSSLLFGSTECLEWT-- 241
           EL ++ H+ H N   L+   T        N  +LV   +      + L    +C + T  
Sbjct: 71  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-----GADLNNIVKCQKLTDD 125
Query: 242 -IRYKIALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSH 300
            +++ I   I  GL+Y+             K SN+ ++ED E +I DFGLA+   D  + 
Sbjct: 126 HVQFLI-YQILRGLKYIHSADIIHRDL---KPSNLAVNEDCELKILDFGLARHTDDEMTG 181
Query: 301 HIVFPIEGTFGYLSPEYFMHGI-VDEKTDVFAFGVLLLELITGR 343
           ++      T  Y +PE  ++ +  ++  D+++ G ++ EL+TGR
Sbjct: 182 YV-----ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 42/164 (25%), Positives = 76/164 (46%), Gaps = 25/164 (15%)
Query: 191 ELGIVAHINHPNAAKLIGFSTE-------NGFHLVLQFLPHGSLSSLLFGSTECLEWT-- 241
           EL ++ H+ H N   L+   T        N  +LV   +      + L    +C + T  
Sbjct: 71  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-----GADLNNIVKCQKLTDD 125
Query: 242 -IRYKIALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSH 300
            +++ I   I  GL+Y+             K SN+ ++ED E +I DFGLA+   D  + 
Sbjct: 126 HVQFLI-YQILRGLKYIHSADIIHRDL---KPSNLAVNEDCELKILDFGLARHTDDEMTG 181
Query: 301 HIVFPIEGTFGYLSPEYFMHGI-VDEKTDVFAFGVLLLELITGR 343
           ++      T  Y +PE  ++ +  ++  D+++ G ++ EL+TGR
Sbjct: 182 YV-----ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 41/161 (25%), Positives = 71/161 (44%), Gaps = 10/161 (6%)
Query: 183 ERISDFLSELGIVAHINHPNAAKL-IGFSTENGFHLVLQFLPHGSLSSLLFGSTECLEWT 241
           ++I   L+E  I+  +N P   KL   F   +  ++V++++  G + S L       E  
Sbjct: 83  KQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPH 142
Query: 242 IRYKIALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSHH 301
            R+  A  I    +YL             K  N+L+ +    Q++DFG AK +       
Sbjct: 143 ARF-YAAQIVLTFEYLHSLDLIYRDL---KPENLLIDQQGYIQVTDFGFAKRVKGR---- 194
Query: 302 IVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITG 342
             + + GT  YL+PE  +    ++  D +A GVL+ E+  G
Sbjct: 195 -TWXLAGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 47/213 (22%), Positives = 89/213 (41%), Gaps = 31/213 (14%)
Query: 150 IGKGGHAEVYKGCLPD-----GEXXXXXXXXXXXXEDEERISDFLSELGIVAHINHPNAA 204
           +G+G    VY+G   D      E               ERI +FL+E  ++      +  
Sbjct: 22  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERI-EFLNEASVMKGFTCHHVV 80
Query: 205 KLIGFSTENGFHLV-LQFLPHGSLSSLLFG-----------STECLEWTIRYKIALGIAE 252
           +L+G  ++    LV ++ + HG L S L                 L+  I  ++A  IA+
Sbjct: 81  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMI--QMAAEIAD 138
Query: 253 GLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSHHI----VFPIEG 308
           G+ YL              A N +++ D+  +I DFG+ + + +          + P+  
Sbjct: 139 GMAYLNAKKFVHRDLA---ARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVR- 194
Query: 309 TFGYLSPEYFMHGIVDEKTDVFAFGVLLLELIT 341
              +++PE    G+    +D+++FGV+L E+ +
Sbjct: 195 ---WMAPESLKDGVFTTSSDMWSFGVVLWEITS 224

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 42/164 (25%), Positives = 76/164 (46%), Gaps = 25/164 (15%)
Query: 191 ELGIVAHINHPNAAKLIGFSTE-------NGFHLVLQFLPHGSLSSLLFGSTECLEWT-- 241
           EL ++ H+ H N   L+   T        N  +LV   +      + L    +C + T  
Sbjct: 78  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-----GADLNNIVKCQKLTDD 132
Query: 242 -IRYKIALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSH 300
            +++ I   I  GL+Y+             K SN+ ++ED E +I DFGLA+   D  + 
Sbjct: 133 HVQFLI-YQILRGLKYIHSADIIHRDL---KPSNLAVNEDCELKILDFGLARHTDDEMTG 188
Query: 301 HIVFPIEGTFGYLSPEYFMHGI-VDEKTDVFAFGVLLLELITGR 343
           ++      T  Y +PE  ++ +  ++  D+++ G ++ EL+TGR
Sbjct: 189 YV-----ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 42/164 (25%), Positives = 76/164 (46%), Gaps = 25/164 (15%)
Query: 191 ELGIVAHINHPNAAKLIGFSTE-------NGFHLVLQFLPHGSLSSLLFGSTECLEWT-- 241
           EL ++ H+ H N   L+   T        N  +LV   +      + L    +C + T  
Sbjct: 90  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-----GADLNNIVKCQKLTDD 144
Query: 242 -IRYKIALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSH 300
            +++ I   I  GL+Y+             K SN+ ++ED E +I DFGLA+   D  + 
Sbjct: 145 HVQFLI-YQILRGLKYIHSADIIHRDL---KPSNLAVNEDCELKILDFGLARHTDDEMTG 200
Query: 301 HIVFPIEGTFGYLSPEYFMHGI-VDEKTDVFAFGVLLLELITGR 343
           ++      T  Y +PE  ++ +  ++  D+++ G ++ EL+TGR
Sbjct: 201 YV-----ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 239

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 42/164 (25%), Positives = 76/164 (46%), Gaps = 25/164 (15%)
Query: 191 ELGIVAHINHPNAAKLIGFSTE-------NGFHLVLQFLPHGSLSSLLFGSTECLEWT-- 241
           EL ++ H+ H N   L+   T        N  +LV   +      + L    +C + T  
Sbjct: 82  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-----GADLNNIVKCQKLTDD 136
Query: 242 -IRYKIALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSH 300
            +++ I   I  GL+Y+             K SN+ ++ED E +I DFGLA+   D  + 
Sbjct: 137 HVQFLI-YQILRGLKYIHSADIIHRDL---KPSNLAVNEDCELKILDFGLARHTDDEMTG 192
Query: 301 HIVFPIEGTFGYLSPEYFMHGI-VDEKTDVFAFGVLLLELITGR 343
           ++      T  Y +PE  ++ +  ++  D+++ G ++ EL+TGR
Sbjct: 193 YV-----ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 231

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 42/164 (25%), Positives = 76/164 (46%), Gaps = 25/164 (15%)
Query: 191 ELGIVAHINHPNAAKLIGFSTE-------NGFHLVLQFLPHGSLSSLLFGSTECLEWT-- 241
           EL ++ H+ H N   L+   T        N  +LV   +      + L    +C + T  
Sbjct: 81  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-----GADLNNIVKCQKLTDD 135
Query: 242 -IRYKIALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSH 300
            +++ I   I  GL+Y+             K SN+ ++ED E +I DFGLA+   D  + 
Sbjct: 136 HVQFLI-YQILRGLKYIHSADIIHRDL---KPSNLAVNEDCELKILDFGLARHTDDEMTG 191
Query: 301 HIVFPIEGTFGYLSPEYFMHGI-VDEKTDVFAFGVLLLELITGR 343
           ++      T  Y +PE  ++ +  ++  D+++ G ++ EL+TGR
Sbjct: 192 YV-----ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 230

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 42/164 (25%), Positives = 76/164 (46%), Gaps = 25/164 (15%)
Query: 191 ELGIVAHINHPNAAKLIGFSTE-------NGFHLVLQFLPHGSLSSLLFGSTECLEWT-- 241
           EL ++ H+ H N   L+   T        N  +LV   +      + L    +C + T  
Sbjct: 71  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-----GADLNNIVKCQKLTDD 125
Query: 242 -IRYKIALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSH 300
            +++ I   I  GL+Y+             K SN+ ++ED E +I DFGLA+   D  + 
Sbjct: 126 HVQFLI-YQILRGLKYIHSADIIHRDL---KPSNLAVNEDCELKILDFGLARHTDDEMTG 181
Query: 301 HIVFPIEGTFGYLSPEYFMHGI-VDEKTDVFAFGVLLLELITGR 343
           ++      T  Y +PE  ++ +  ++  D+++ G ++ EL+TGR
Sbjct: 182 YV-----ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 42/161 (26%), Positives = 71/161 (44%), Gaps = 10/161 (6%)
Query: 183 ERISDFLSELGIVAHINHPNAAKL-IGFSTENGFHLVLQFLPHGSLSSLLFGSTECLEWT 241
           ++I   L+E  I+  +N P   KL   F   +  ++V++++  G + S L       E  
Sbjct: 70  KQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPH 129
Query: 242 IRYKIALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSHH 301
            R+  A  I    +YL             K  N+L+ E    Q++DFG AK +       
Sbjct: 130 ARF-YAAQIVLTFEYLHSLDLIYRDL---KPENLLIDEQGYIQVTDFGFAKRVKGR---- 181
Query: 302 IVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITG 342
             + + GT  YL+PE  +    ++  D +A GVL+ E+  G
Sbjct: 182 -TWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 221

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 42/164 (25%), Positives = 76/164 (46%), Gaps = 25/164 (15%)
Query: 191 ELGIVAHINHPNAAKLIGFSTE-------NGFHLVLQFLPHGSLSSLLFGSTECLEWT-- 241
           EL ++ H+ H N   L+   T        N  +LV   +      + L    +C + T  
Sbjct: 90  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-----GADLNNIVKCQKLTDD 144
Query: 242 -IRYKIALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSH 300
            +++ I   I  GL+Y+             K SN+ ++ED E +I DFGLA+   D  + 
Sbjct: 145 HVQFLI-YQILRGLKYIHSADIIHRDL---KPSNLAVNEDCELKILDFGLARHTDDEMTG 200
Query: 301 HIVFPIEGTFGYLSPEYFMHGI-VDEKTDVFAFGVLLLELITGR 343
           ++      T  Y +PE  ++ +  ++  D+++ G ++ EL+TGR
Sbjct: 201 YV-----ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 239

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 41/161 (25%), Positives = 71/161 (44%), Gaps = 10/161 (6%)
Query: 183 ERISDFLSELGIVAHINHPNAAKL-IGFSTENGFHLVLQFLPHGSLSSLLFGSTECLEWT 241
           ++I   L+E  I+  +N P   KL   F   +  ++V++++  G + S L       E  
Sbjct: 83  KQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPH 142
Query: 242 IRYKIALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSHH 301
            R+  A  I    +YL             K  N+L+ +    Q++DFG AK +       
Sbjct: 143 ARF-YAAQIVLTFEYLHSLDLIYRDL---KPENLLIDQQGYIQVTDFGFAKRVKGR---- 194
Query: 302 IVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITG 342
             + + GT  YL+PE  +    ++  D +A GVL+ E+  G
Sbjct: 195 -TWXLXGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 42/164 (25%), Positives = 76/164 (46%), Gaps = 25/164 (15%)
Query: 191 ELGIVAHINHPNAAKLIGFSTE-------NGFHLVLQFLPHGSLSSLLFGSTECLEWT-- 241
           EL ++ H+ H N   L+   T        N  +LV   +      + L    +C + T  
Sbjct: 73  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-----GADLNNIVKCQKLTDD 127
Query: 242 -IRYKIALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSH 300
            +++ I   I  GL+Y+             K SN+ ++ED E +I DFGLA+   D  + 
Sbjct: 128 HVQFLI-YQILRGLKYIHSADIIHRDL---KPSNLAVNEDCELKILDFGLARHTDDEMTG 183
Query: 301 HIVFPIEGTFGYLSPEYFMHGI-VDEKTDVFAFGVLLLELITGR 343
           ++      T  Y +PE  ++ +  ++  D+++ G ++ EL+TGR
Sbjct: 184 YV-----ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 42/164 (25%), Positives = 76/164 (46%), Gaps = 25/164 (15%)
Query: 191 ELGIVAHINHPNAAKLIGFSTE-------NGFHLVLQFLPHGSLSSLLFGSTECLEWT-- 241
           EL ++ H+ H N   L+   T        N  +LV   +      + L    +C + T  
Sbjct: 73  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-----GADLNNIVKCQKLTDD 127
Query: 242 -IRYKIALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSH 300
            +++ I   I  GL+Y+             K SN+ ++ED E +I DFGLA+   D  + 
Sbjct: 128 HVQFLI-YQILRGLKYIHSADIIHRDL---KPSNLAVNEDCELKILDFGLARHTDDEMTG 183
Query: 301 HIVFPIEGTFGYLSPEYFMHGI-VDEKTDVFAFGVLLLELITGR 343
           ++      T  Y +PE  ++ +  ++  D+++ G ++ EL+TGR
Sbjct: 184 YV-----ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 42/164 (25%), Positives = 76/164 (46%), Gaps = 25/164 (15%)
Query: 191 ELGIVAHINHPNAAKLIGFSTE-------NGFHLVLQFLPHGSLSSLLFGSTECLEWT-- 241
           EL ++ H+ H N   L+   T        N  +LV   +      + L    +C + T  
Sbjct: 91  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-----GADLNNIVKCQKLTDD 145
Query: 242 -IRYKIALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSH 300
            +++ I   I  GL+Y+             K SN+ ++ED E +I DFGLA+   D  + 
Sbjct: 146 HVQFLI-YQILRGLKYIHSADIIHRDL---KPSNLAVNEDCELKILDFGLARHTDDEMTG 201
Query: 301 HIVFPIEGTFGYLSPEYFMHGI-VDEKTDVFAFGVLLLELITGR 343
           ++      T  Y +PE  ++ +  ++  D+++ G ++ EL+TGR
Sbjct: 202 YV-----ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 240

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 42/164 (25%), Positives = 76/164 (46%), Gaps = 25/164 (15%)
Query: 191 ELGIVAHINHPNAAKLIGFSTE-------NGFHLVLQFLPHGSLSSLLFGSTECLEWT-- 241
           EL ++ H+ H N   L+   T        N  +LV   +      + L    +C + T  
Sbjct: 77  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-----GADLNNIVKCQKLTDD 131
Query: 242 -IRYKIALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSH 300
            +++ I   I  GL+Y+             K SN+ ++ED E +I DFGLA+   D  + 
Sbjct: 132 HVQFLI-YQILRGLKYIHSADIIHRDL---KPSNLAVNEDCELKILDFGLARHTDDEMTG 187
Query: 301 HIVFPIEGTFGYLSPEYFMHGI-VDEKTDVFAFGVLLLELITGR 343
           ++      T  Y +PE  ++ +  ++  D+++ G ++ EL+TGR
Sbjct: 188 YV-----ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 43/159 (27%), Positives = 67/159 (42%), Gaps = 7/159 (4%)
Query: 191 ELGIVAHINHPNAAKLIGFSTENGF-HLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALG 249
           E+ I   + H +     GF  +N F  +VL+     SL  L        E   RY +   
Sbjct: 91  EISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLR-Q 149
Query: 250 IAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEGT 309
           I  G QYL             K  N+ L+ED E +I DFGLA  +  +     V  + GT
Sbjct: 150 IVLGCQYLHRNRVIHRDL---KLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV--LCGT 204
Query: 310 FGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDS 348
             Y++PE         + DV++ G ++  L+ G+   ++
Sbjct: 205 PNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFET 243

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 42/164 (25%), Positives = 76/164 (46%), Gaps = 25/164 (15%)
Query: 191 ELGIVAHINHPNAAKLIGFSTE-------NGFHLVLQFLPHGSLSSLLFGSTECLEWT-- 241
           EL ++ H+ H N   L+   T        N  +LV   +      + L    +C + T  
Sbjct: 76  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-----GADLNNIVKCQKLTDD 130
Query: 242 -IRYKIALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSH 300
            +++ I   I  GL+Y+             K SN+ ++ED E +I DFGLA+   D  + 
Sbjct: 131 HVQFLI-YQILRGLKYIHSADIIHRDL---KPSNLAVNEDCELKILDFGLARHTDDEMTG 186
Query: 301 HIVFPIEGTFGYLSPEYFMHGI-VDEKTDVFAFGVLLLELITGR 343
           ++      T  Y +PE  ++ +  ++  D+++ G ++ EL+TGR
Sbjct: 187 YV-----ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 42/164 (25%), Positives = 76/164 (46%), Gaps = 25/164 (15%)
Query: 191 ELGIVAHINHPNAAKLIGFSTE-------NGFHLVLQFLPHGSLSSLLFGSTECLEWT-- 241
           EL ++ H+ H N   L+   T        N  +LV   +      + L    +C + T  
Sbjct: 94  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-----GADLNNIVKCQKLTDD 148
Query: 242 -IRYKIALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSH 300
            +++ I   I  GL+Y+             K SN+ ++ED E +I DFGLA+   D  + 
Sbjct: 149 HVQFLI-YQILRGLKYIHSADIIHRDL---KPSNLAVNEDCELKILDFGLARHTDDEMTG 204
Query: 301 HIVFPIEGTFGYLSPEYFMHGI-VDEKTDVFAFGVLLLELITGR 343
           ++      T  Y +PE  ++ +  ++  D+++ G ++ EL+TGR
Sbjct: 205 YV-----ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 243

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 47/213 (22%), Positives = 90/213 (42%), Gaps = 31/213 (14%)
Query: 150 IGKGGHAEVYKGCLPD-----GEXXXXXXXXXXXXEDEERISDFLSELGIVAHINHPNAA 204
           +G+G    VY+G   D      E               ERI +FL+E  ++      +  
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERI-EFLNEASVMKGFTCHHVV 83
Query: 205 KLIGFSTENGFHLV-LQFLPHGSLSSLLFG-----------STECLEWTIRYKIALGIAE 252
           +L+G  ++    LV ++ + HG L S L                 L+  I  ++A  IA+
Sbjct: 84  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMI--QMAAEIAD 141
Query: 253 GLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSHHI----VFPIEG 308
           G+ YL              A N +++ D+  +I DFG+ + + +   +      + P+  
Sbjct: 142 GMAYLNAKKFVHRDLA---ARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR- 197
Query: 309 TFGYLSPEYFMHGIVDEKTDVFAFGVLLLELIT 341
              +++PE    G+    +D+++FGV+L E+ +
Sbjct: 198 ---WMAPESLKDGVFTTSSDMWSFGVVLWEITS 227

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 42/164 (25%), Positives = 76/164 (46%), Gaps = 25/164 (15%)
Query: 191 ELGIVAHINHPNAAKLIGFSTE-------NGFHLVLQFLPHGSLSSLLFGSTECLEWT-- 241
           EL ++ H+ H N   L+   T        N  +LV   +      + L    +C + T  
Sbjct: 68  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-----GADLNNIVKCQKLTDD 122
Query: 242 -IRYKIALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSH 300
            +++ I   I  GL+Y+             K SN+ ++ED E +I DFGLA+   D  + 
Sbjct: 123 HVQFLI-YQILRGLKYIHSADIIHRDL---KPSNLAVNEDCELKILDFGLARHTDDEMTG 178
Query: 301 HIVFPIEGTFGYLSPEYFMHGI-VDEKTDVFAFGVLLLELITGR 343
           ++      T  Y +PE  ++ +  ++  D+++ G ++ EL+TGR
Sbjct: 179 YV-----ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 217

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 28/79 (35%), Positives = 39/79 (49%), Gaps = 2/79 (2%)
Query: 271 KASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVF 330
           K  N+LL +D   +ISD GLA  L    +    +   GT G+++PE  +    D   D F
Sbjct: 316 KPENVLLDDDGNVRISDLGLAVELKAGQTKTKGY--AGTPGFMAPELLLGEEYDFSVDYF 373
Query: 331 AFGVLLLELITGRRAVDSR 349
           A GV L E+I  R    +R
Sbjct: 374 ALGVTLYEMIAARGPFRAR 392

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 27/83 (32%), Positives = 41/83 (49%), Gaps = 3/83 (3%)
Query: 271 KASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVF 330
           K  NILL +    +ISD GLA  +P+      +    GT GY++PE   +       D +
Sbjct: 313 KPENILLDDHGHIRISDLGLAVHVPEG---QTIKGRVGTVGYMAPEVVKNERYTFSPDWW 369
Query: 331 AFGVLLLELITGRRAVDSRRQSL 353
           A G LL E+I G+     R++ +
Sbjct: 370 ALGCLLYEMIAGQSPFQQRKKKI 392

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 42/164 (25%), Positives = 76/164 (46%), Gaps = 25/164 (15%)
Query: 191 ELGIVAHINHPNAAKLIGFSTE-------NGFHLVLQFLPHGSLSSLLFGSTECLEWT-- 241
           EL ++ H+ H N   L+   T        N  +LV   +      + L    +C + T  
Sbjct: 71  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-----GADLNNIVKCQKLTDD 125
Query: 242 -IRYKIALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSH 300
            +++ I   I  GL+Y+             K SN+ ++ED E +I DFGLA+   D  + 
Sbjct: 126 HVQFLI-YQILRGLKYIHSADIIHRDL---KPSNLAVNEDCELKILDFGLARHTDDEMTG 181
Query: 301 HIVFPIEGTFGYLSPEYFMHGI-VDEKTDVFAFGVLLLELITGR 343
           ++      T  Y +PE  ++ +  ++  D+++ G ++ EL+TGR
Sbjct: 182 YV-----ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 42/164 (25%), Positives = 76/164 (46%), Gaps = 25/164 (15%)
Query: 191 ELGIVAHINHPNAAKLIGFSTE-------NGFHLVLQFLPHGSLSSLLFGSTECLEWT-- 241
           EL ++ H+ H N   L+   T        N  +LV   +      + L    +C + T  
Sbjct: 91  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-----GADLNNIVKCQKLTDD 145
Query: 242 -IRYKIALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSH 300
            +++ I   I  GL+Y+             K SN+ ++ED E +I DFGLA+   D  + 
Sbjct: 146 HVQFLI-YQILRGLKYIHSADIIHRDL---KPSNLAVNEDCELKILDFGLARHTDDEMTG 201
Query: 301 HIVFPIEGTFGYLSPEYFMHGI-VDEKTDVFAFGVLLLELITGR 343
           ++      T  Y +PE  ++ +  ++  D+++ G ++ EL+TGR
Sbjct: 202 YV-----ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 240

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 40/161 (24%), Positives = 76/161 (47%), Gaps = 19/161 (11%)
Query: 191 ELGIVAHINHPNAAKLIGFSTE-------NGFHLVLQFLPHGSLSSLLFGSTECLEWTIR 243
           EL ++ H+ H N   L+   T        N  +LV   +  G+  + +  S +  +  ++
Sbjct: 71  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKSQKLTDDHVQ 128
Query: 244 YKIALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSHHIV 303
           + I   I  GL+Y+             K SN+ ++ED E +I DFGL +   D  + ++ 
Sbjct: 129 FLI-YQILRGLKYIHSADIIHRDL---KPSNLAVNEDSELKILDFGLCRHTDDEMTGYV- 183
Query: 304 FPIEGTFGYLSPEYFMHGI-VDEKTDVFAFGVLLLELITGR 343
                T  Y +PE  ++ +  ++  D+++ G ++ EL+TGR
Sbjct: 184 ----ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 28/79 (35%), Positives = 39/79 (49%), Gaps = 2/79 (2%)
Query: 271 KASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVF 330
           K  N+LL +D   +ISD GLA  L    +    +   GT G+++PE  +    D   D F
Sbjct: 316 KPENVLLDDDGNVRISDLGLAVELKAGQTKTKGY--AGTPGFMAPELLLGEEYDFSVDYF 373
Query: 331 AFGVLLLELITGRRAVDSR 349
           A GV L E+I  R    +R
Sbjct: 374 ALGVTLYEMIAARGPFRAR 392

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 43/159 (27%), Positives = 67/159 (42%), Gaps = 7/159 (4%)
Query: 191 ELGIVAHINHPNAAKLIGFSTENGF-HLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALG 249
           E+ I   + H +     GF  +N F  +VL+     SL  L        E   RY +   
Sbjct: 89  EISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLR-Q 147
Query: 250 IAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEGT 309
           I  G QYL             K  N+ L+ED E +I DFGLA  +  +     V  + GT
Sbjct: 148 IVLGCQYLHRNRVIHRDL---KLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV--LCGT 202
Query: 310 FGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDS 348
             Y++PE         + DV++ G ++  L+ G+   ++
Sbjct: 203 PNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFET 241

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 41/161 (25%), Positives = 71/161 (44%), Gaps = 10/161 (6%)
Query: 183 ERISDFLSELGIVAHINHPNAAKL-IGFSTENGFHLVLQFLPHGSLSSLLFGSTECLEWT 241
           ++I   L+E  I+  +N P   KL   F   +  ++V++++  G + S L       E  
Sbjct: 83  KQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPH 142
Query: 242 IRYKIALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSHH 301
            R+  A  I    +YL             K  N+L+ +    Q++DFG AK +       
Sbjct: 143 ARF-YAAQIVLTFEYLHSLDLIYRDL---KPENLLIDQQGYIQVTDFGFAKRVKGR---- 194
Query: 302 IVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITG 342
             + + GT  YL+PE  +    ++  D +A GVL+ E+  G
Sbjct: 195 -TWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 42/164 (25%), Positives = 76/164 (46%), Gaps = 25/164 (15%)
Query: 191 ELGIVAHINHPNAAKLIGFSTE-------NGFHLVLQFLPHGSLSSLLFGSTECLEWT-- 241
           EL ++ H+ H N   L+   T        N  +LV   +      + L    +C + T  
Sbjct: 73  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-----GADLNNIVKCQKLTDD 127
Query: 242 -IRYKIALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSH 300
            +++ I   I  GL+Y+             K SN+ ++ED E +I DFGLA+   D  + 
Sbjct: 128 HVQFLI-YQILRGLKYIHSADIIHRDL---KPSNLAVNEDSELKILDFGLARHTDDEMTG 183
Query: 301 HIVFPIEGTFGYLSPEYFMHGI-VDEKTDVFAFGVLLLELITGR 343
           ++      T  Y +PE  ++ +  ++  D+++ G ++ EL+TGR
Sbjct: 184 YV-----ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 40/161 (24%), Positives = 76/161 (47%), Gaps = 19/161 (11%)
Query: 191 ELGIVAHINHPNAAKLIGFSTE-------NGFHLVLQFLPHGSLSSLLFGSTECLEWTIR 243
           EL ++ H+ H N   L+   T        N  +LV   +  G+  + +    +  +  ++
Sbjct: 71  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKXQKLTDDHVQ 128
Query: 244 YKIALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSHHIV 303
           + I   I  GL+Y+             K SN+ ++ED E +I DFGLA+   D  + ++ 
Sbjct: 129 FLI-YQILRGLKYIHSADIIHRDL---KPSNLAVNEDXELKILDFGLARHTDDEMTGYV- 183
Query: 304 FPIEGTFGYLSPEYFMHGI-VDEKTDVFAFGVLLLELITGR 343
                T  Y +PE  ++ +  ++  D+++ G ++ EL+TGR
Sbjct: 184 ----ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 61/287 (21%), Positives = 112/287 (39%), Gaps = 48/287 (16%)
Query: 150 IGKGGHAEVYKGCLPD-----GEXXXXXXXXXXXXEDEERISDFLSELGIVAHINHPNAA 204
           +G+G    VY+G   D      E               ERI +FL+E  ++      +  
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERI-EFLNEASVMKGFTCHHVV 83
Query: 205 KLIGFSTENGFHLV-LQFLPHGSLSSLLFG-----------STECLEWTIRYKIALGIAE 252
           +L+G  ++    LV ++ + HG L S L                 L+  I  ++A  IA+
Sbjct: 84  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMI--QMAAEIAD 141
Query: 253 GLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSHHI----VFPIEG 308
           G+ YL              A N +++ D+  +I DFG+ + + +          + P+  
Sbjct: 142 GMAYLNAKKFVHRDLA---ARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVR- 197
Query: 309 TFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSN--- 365
              +++PE    G+    +D+++FGV+L E+ +             +  +P    SN   
Sbjct: 198 ---WMAPESLKDGVFTTSSDMWSFGVVLWEITS-------------LAEQPYQGLSNEQV 241
Query: 366 FKELVDPRLADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQLLR 412
            K ++D    D  D    +R      +C      MRP    ++ LL+
Sbjct: 242 LKFVMDGGYLDQPDNCP-ERVTDLMRMCWQFNPNMRPTFLEIVNLLK 287

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 27/83 (32%), Positives = 41/83 (49%), Gaps = 3/83 (3%)
Query: 271 KASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVF 330
           K  NILL +    +ISD GLA  +P+      +    GT GY++PE   +       D +
Sbjct: 313 KPENILLDDHGHIRISDLGLAVHVPEG---QTIKGRVGTVGYMAPEVVKNERYTFSPDWW 369
Query: 331 AFGVLLLELITGRRAVDSRRQSL 353
           A G LL E+I G+     R++ +
Sbjct: 370 ALGCLLYEMIAGQSPFQQRKKKI 392

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 42/164 (25%), Positives = 76/164 (46%), Gaps = 25/164 (15%)
Query: 191 ELGIVAHINHPNAAKLIGFSTE-------NGFHLVLQFLPHGSLSSLLFGSTECLEWT-- 241
           EL ++ H+ H N   L+   T        N  +LV   +      + L    +C + T  
Sbjct: 77  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-----GADLNNIVKCQKLTDD 131
Query: 242 -IRYKIALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSH 300
            +++ I   I  GL+Y+             K SN+ ++ED E +I DFGLA+   D  + 
Sbjct: 132 HVQFLI-YQILRGLKYIHSADIIHRDL---KPSNLAVNEDSELKILDFGLARHTDDEMTG 187
Query: 301 HIVFPIEGTFGYLSPEYFMHGI-VDEKTDVFAFGVLLLELITGR 343
           ++      T  Y +PE  ++ +  ++  D+++ G ++ EL+TGR
Sbjct: 188 YV-----ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 42/164 (25%), Positives = 76/164 (46%), Gaps = 25/164 (15%)
Query: 191 ELGIVAHINHPNAAKLIGFSTE-------NGFHLVLQFLPHGSLSSLLFGSTECLEWT-- 241
           EL ++ H+ H N   L+   T        N  +LV   +      + L    +C + T  
Sbjct: 67  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-----GADLNNIVKCQKLTDD 121
Query: 242 -IRYKIALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSH 300
            +++ I   I  GL+Y+             K SN+ ++ED E +I DFGLA+   D  + 
Sbjct: 122 HVQFLI-YQILRGLKYIHSADIIHRDL---KPSNLAVNEDCELKILDFGLARHTDDEMTG 177
Query: 301 HIVFPIEGTFGYLSPEYFMHGI-VDEKTDVFAFGVLLLELITGR 343
           ++      T  Y +PE  ++ +  ++  D+++ G ++ EL+TGR
Sbjct: 178 YV-----ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 41/161 (25%), Positives = 71/161 (44%), Gaps = 10/161 (6%)
Query: 183 ERISDFLSELGIVAHINHPNAAKL-IGFSTENGFHLVLQFLPHGSLSSLLFGSTECLEWT 241
           ++I   L+E  I+  +N P   KL   F   +  ++V++++  G + S L       E  
Sbjct: 83  KQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPH 142
Query: 242 IRYKIALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSHH 301
            R+  A  I    +YL             K  N+L+ +    Q++DFG AK +       
Sbjct: 143 ARF-YAAQIVLTFEYLHSLDLIYRDL---KPENLLIDQQGYIQVTDFGFAKRVKGR---- 194
Query: 302 IVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITG 342
             + + GT  YL+PE  +    ++  D +A GVL+ E+  G
Sbjct: 195 -TWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 42/164 (25%), Positives = 76/164 (46%), Gaps = 25/164 (15%)
Query: 191 ELGIVAHINHPNAAKLIGFSTE-------NGFHLVLQFLPHGSLSSLLFGSTECLEWT-- 241
           EL ++ H+ H N   L+   T        N  +LV   +      + L    +C + T  
Sbjct: 67  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-----GADLNNIVKCQKLTDD 121
Query: 242 -IRYKIALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSH 300
            +++ I   I  GL+Y+             K SN+ ++ED E +I DFGLA+   D  + 
Sbjct: 122 HVQFLI-YQILRGLKYIHSADIIHRDL---KPSNLAVNEDCELKILDFGLARHTDDEMTG 177
Query: 301 HIVFPIEGTFGYLSPEYFMHGI-VDEKTDVFAFGVLLLELITGR 343
           ++      T  Y +PE  ++ +  ++  D+++ G ++ EL+TGR
Sbjct: 178 YV-----ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 41/161 (25%), Positives = 71/161 (44%), Gaps = 10/161 (6%)
Query: 183 ERISDFLSELGIVAHINHPNAAKL-IGFSTENGFHLVLQFLPHGSLSSLLFGSTECLEWT 241
           + I   L+E  I+  +N P   KL   F   +  ++V+++ P G + S L       E  
Sbjct: 83  KEIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPH 142
Query: 242 IRYKIALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSHH 301
            R+  A  I    +YL             K  N+++ +    +++DFGLAK +       
Sbjct: 143 ARF-YAAQIVLTFEYLHSLDLIYRDL---KPENLMIDQQGYIKVTDFGLAKRVKGR---- 194
Query: 302 IVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITG 342
             + + GT  YL+PE  +    ++  D +A GVL+ E+  G
Sbjct: 195 -TWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 42/164 (25%), Positives = 76/164 (46%), Gaps = 25/164 (15%)
Query: 191 ELGIVAHINHPNAAKLIGFSTE-------NGFHLVLQFLPHGSLSSLLFGSTECLEWT-- 241
           EL ++ H+ H N   L+   T        N  +LV   +      + L    +C + T  
Sbjct: 68  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-----GADLNNIVKCQKLTDD 122
Query: 242 -IRYKIALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSH 300
            +++ I   I  GL+Y+             K SN+ ++ED E +I DFGLA+   D  + 
Sbjct: 123 HVQFLI-YQILRGLKYIHSADIIHRDL---KPSNLAVNEDCELKILDFGLARHTDDEMTG 178
Query: 301 HIVFPIEGTFGYLSPEYFMHGI-VDEKTDVFAFGVLLLELITGR 343
           ++      T  Y +PE  ++ +  ++  D+++ G ++ EL+TGR
Sbjct: 179 YV-----ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 217

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 42/164 (25%), Positives = 76/164 (46%), Gaps = 25/164 (15%)
Query: 191 ELGIVAHINHPNAAKLIGFSTE-------NGFHLVLQFLPHGSLSSLLFGSTECLEWT-- 241
           EL ++ H+ H N   L+   T        N  +LV   +      + L    +C + T  
Sbjct: 69  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-----GADLNNIVKCQKLTDD 123
Query: 242 -IRYKIALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSH 300
            +++ I   I  GL+Y+             K SN+ ++ED E +I DFGLA+   D  + 
Sbjct: 124 HVQFLI-YQILRGLKYIHSADIIHRDL---KPSNLAVNEDCELKILDFGLARHTDDEMTG 179
Query: 301 HIVFPIEGTFGYLSPEYFMHGI-VDEKTDVFAFGVLLLELITGR 343
           ++      T  Y +PE  ++ +  ++  D+++ G ++ EL+TGR
Sbjct: 180 YV-----ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 218

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 28/95 (29%), Positives = 47/95 (49%), Gaps = 3/95 (3%)
Query: 247 ALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPI 306
           +  +A G+++L              A NILLSE+   +I DFGLA+ +  N  +      
Sbjct: 205 SFQVARGMEFLSSRKCIHRDLA---ARNILLSENNVVKICDFGLARDIYKNPDYVRKGDT 261
Query: 307 EGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELIT 341
                +++PE     I   K+DV+++GVLL E+ +
Sbjct: 262 RLPLKWMAPESIFDKIYSTKSDVWSYGVLLWEIFS 296

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 41/161 (25%), Positives = 71/161 (44%), Gaps = 10/161 (6%)
Query: 183 ERISDFLSELGIVAHINHPNAAKL-IGFSTENGFHLVLQFLPHGSLSSLLFGSTECLEWT 241
           ++I   L+E  I+  +N P   KL   F   +  ++V++++  G + S L       E  
Sbjct: 83  KQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPH 142
Query: 242 IRYKIALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSHH 301
            R+  A  I    +YL             K  N+L+ +    Q++DFG AK +       
Sbjct: 143 ARF-YAAQIVLTFEYLHSLDLIYRDL---KPENLLIDQQGYIQVTDFGFAKRVKGR---- 194
Query: 302 IVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITG 342
             + + GT  YL+PE  +    ++  D +A GVL+ E+  G
Sbjct: 195 -TWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 28/79 (35%), Positives = 39/79 (49%), Gaps = 2/79 (2%)
Query: 271 KASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVF 330
           K  N+LL +D   +ISD GLA  L    +    +   GT G+++PE  +    D   D F
Sbjct: 316 KPENVLLDDDGNVRISDLGLAVELKAGQTKTKGY--AGTPGFMAPELLLGEEYDFSVDYF 373
Query: 331 AFGVLLLELITGRRAVDSR 349
           A GV L E+I  R    +R
Sbjct: 374 ALGVTLYEMIAARGPFRAR 392

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 28/79 (35%), Positives = 39/79 (49%), Gaps = 2/79 (2%)
Query: 271 KASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVF 330
           K  N+LL +D   +ISD GLA  L    +    +   GT G+++PE  +    D   D F
Sbjct: 316 KPENVLLDDDGNVRISDLGLAVELKAGQTKTKGY--AGTPGFMAPELLLGEEYDFSVDYF 373
Query: 331 AFGVLLLELITGRRAVDSR 349
           A GV L E+I  R    +R
Sbjct: 374 ALGVTLYEMIAARGPFRAR 392

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 40/161 (24%), Positives = 76/161 (47%), Gaps = 19/161 (11%)
Query: 191 ELGIVAHINHPNAAKLIGFSTE-------NGFHLVLQFLPHGSLSSLLFGSTECLEWTIR 243
           EL ++ H+ H N   L+   T        N  +LV   +  G+  + +    +  +  ++
Sbjct: 77  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQ 134
Query: 244 YKIALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSHHIV 303
           + I   I  GL+Y+             K SN+ ++ED E +I DFGLA+   D  + ++ 
Sbjct: 135 FLI-YQILRGLKYIHSADIIHRDL---KPSNLAVNEDCELKILDFGLARHTDDEMTGYV- 189
Query: 304 FPIEGTFGYLSPEYFMHGI-VDEKTDVFAFGVLLLELITGR 343
                T  Y +PE  ++ +  ++  D+++ G ++ EL+TGR
Sbjct: 190 ----ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 41/161 (25%), Positives = 71/161 (44%), Gaps = 10/161 (6%)
Query: 183 ERISDFLSELGIVAHINHPNAAKL-IGFSTENGFHLVLQFLPHGSLSSLLFGSTECLEWT 241
           ++I   L+E  I+  +N P   KL   F   +  ++V++++  G + S L       E  
Sbjct: 78  KQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPH 137
Query: 242 IRYKIALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSHH 301
            R+  A  I    +YL             K  N+L+ +    Q++DFG AK +       
Sbjct: 138 ARF-YAAQIVLTFEYLHSLDLIYRDL---KPENLLIDQQGYIQVTDFGFAKRVKGR---- 189
Query: 302 IVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITG 342
             + + GT  YL+PE  +    ++  D +A GVL+ E+  G
Sbjct: 190 -TWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 229

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 51/214 (23%), Positives = 91/214 (42%), Gaps = 18/214 (8%)
Query: 139 AATDNFNSENLIGKGGHAEVYKGCLPDGEXXXXXXXXXXXXEDEERISDFLSELGIVAHI 198
           +++  F     +G G +A VYKG L                 +E   S  + E+ ++  +
Sbjct: 2   SSSSQFKQLEKLGNGTYATVYKG-LNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKEL 60
Query: 199 NHPNAAKLIG-FSTENGFHLVLQFLPHG---SLSSLLFGST-ECLEWTIRYKIALGIAEG 253
            H N  +L     TEN   LV +F+ +     + S   G+T   LE  +       + +G
Sbjct: 61  KHENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQG 120
Query: 254 LQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAK--WLPDN-WSHHIVFPIEGTF 310
           L +              K  N+L+++  + ++ DFGLA+   +P N +S  +V     T 
Sbjct: 121 LAFCHENKILHRDL---KPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVV-----TL 172
Query: 311 GYLSPEYFMHG-IVDEKTDVFAFGVLLLELITGR 343
            Y +P+  M         D+++ G +L E+ITG+
Sbjct: 173 WYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGK 206

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 40/161 (24%), Positives = 76/161 (47%), Gaps = 19/161 (11%)
Query: 191 ELGIVAHINHPNAAKLIGFSTE-------NGFHLVLQFLPHGSLSSLLFGSTECLEWTIR 243
           EL ++ H+ H N   L+   T        N  +LV   +  G+  + +    +  +  ++
Sbjct: 71  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKXQKLTDDHVQ 128
Query: 244 YKIALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSHHIV 303
           + I   I  GL+Y+             K SN+ ++ED E +I DFGLA+   D  + ++ 
Sbjct: 129 FLI-YQILRGLKYIHSADIIHRDL---KPSNLAVNEDCELKILDFGLARHTDDEMTGYV- 183
Query: 304 FPIEGTFGYLSPEYFMHGI-VDEKTDVFAFGVLLLELITGR 343
                T  Y +PE  ++ +  ++  D+++ G ++ EL+TGR
Sbjct: 184 ----ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 41/161 (25%), Positives = 71/161 (44%), Gaps = 10/161 (6%)
Query: 183 ERISDFLSELGIVAHINHPNAAKL-IGFSTENGFHLVLQFLPHGSLSSLLFGSTECLEWT 241
           ++I   L+E  I+  +N P   KL   F   +  ++V++++  G + S L       E  
Sbjct: 104 KQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPH 163
Query: 242 IRYKIALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSHH 301
            R+  A  I    +YL             K  N+L+ +    Q++DFG AK +       
Sbjct: 164 ARF-YAAQIVLTFEYLHSLDLIYRDL---KPENLLIDQQGYIQVTDFGFAKRVKGR---- 215
Query: 302 IVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITG 342
             + + GT  YL+PE  +    ++  D +A GVL+ E+  G
Sbjct: 216 -TWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 255

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 42/164 (25%), Positives = 76/164 (46%), Gaps = 25/164 (15%)
Query: 191 ELGIVAHINHPNAAKLIGFSTE-------NGFHLVLQFLPHGSLSSLLFGSTECLEWT-- 241
           EL ++ H+ H N   L+   T        N  +LV   +      + L    +C + T  
Sbjct: 77  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-----GADLNNIVKCQKLTDD 131
Query: 242 -IRYKIALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSH 300
            +++ I   I  GL+Y+             K SN+ ++ED E +I DFGLA+   D  + 
Sbjct: 132 HVQFLI-YQILRGLKYIHSADIIHRDL---KPSNLAVNEDCELKILDFGLARHTDDEMTG 187
Query: 301 HIVFPIEGTFGYLSPEYFMHGI-VDEKTDVFAFGVLLLELITGR 343
           ++      T  Y +PE  ++ +  ++  D+++ G ++ EL+TGR
Sbjct: 188 YV-----ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 40/161 (24%), Positives = 71/161 (44%), Gaps = 10/161 (6%)
Query: 183 ERISDFLSELGIVAHINHPNAAKL-IGFSTENGFHLVLQFLPHGSLSSLLFGSTECLEWT 241
           ++I   L+E  I+  +N P   KL   F   +  ++V+++ P G + S L       E  
Sbjct: 83  KQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFXEPH 142
Query: 242 IRYKIALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSHH 301
            R+  A  I    +YL             K  N+++ +    +++DFG AK +       
Sbjct: 143 ARF-YAAQIVLTFEYLHSLDLIYRDL---KPENLMIDQQGYIKVTDFGFAKRVKGR---- 194
Query: 302 IVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITG 342
             + + GT  YL+PE  +    ++  D +A GVL+ E+  G
Sbjct: 195 -TWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 40/161 (24%), Positives = 71/161 (44%), Gaps = 10/161 (6%)
Query: 183 ERISDFLSELGIVAHINHPNAAKL-IGFSTENGFHLVLQFLPHGSLSSLLFGSTECLEWT 241
           ++I   L+E  I+  +N P   KL   F   +  ++V+++ P G + S L       E  
Sbjct: 84  KQIEHTLNEKRILQAVNFPFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFXEPH 143
Query: 242 IRYKIALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSHH 301
            R+  A  I    +YL             K  N+++ +    +++DFG AK +       
Sbjct: 144 ARF-YAAQIVLTFEYLHSLDLIYRDL---KPENLMIDQQGYIKVTDFGFAKRVKGR---- 195
Query: 302 IVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITG 342
             + + GT  YL+PE  +    ++  D +A GVL+ E+  G
Sbjct: 196 -TWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 41/161 (25%), Positives = 71/161 (44%), Gaps = 10/161 (6%)
Query: 183 ERISDFLSELGIVAHINHPNAAKL-IGFSTENGFHLVLQFLPHGSLSSLLFGSTECLEWT 241
           ++I   L+E  I+  +N P   KL   F   +  ++V++++  G + S L       E  
Sbjct: 83  KQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFAEPH 142
Query: 242 IRYKIALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSHH 301
            R+  A  I    +YL             K  N+L+ +    Q++DFG AK +       
Sbjct: 143 ARF-YAAQIVLTFEYLHSLDLIYRDL---KPENLLIDQQGYIQVTDFGFAKRVKGR---- 194
Query: 302 IVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITG 342
             + + GT  YL+PE  +    ++  D +A GVL+ E+  G
Sbjct: 195 -TWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 47/213 (22%), Positives = 89/213 (41%), Gaps = 31/213 (14%)
Query: 150 IGKGGHAEVYKGCLPD-----GEXXXXXXXXXXXXEDEERISDFLSELGIVAHINHPNAA 204
           +G+G    VY+G   D      E               ERI +FL+E  ++      +  
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERI-EFLNEASVMKGFTCHHVV 83
Query: 205 KLIGFSTENGFHLV-LQFLPHGSLSSLLFG-----------STECLEWTIRYKIALGIAE 252
           +L+G  ++    LV ++ + HG L S L                 L+  I  ++A  IA+
Sbjct: 84  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMI--QMAAEIAD 141
Query: 253 GLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSHHI----VFPIEG 308
           G+ YL              A N +++ D+  +I DFG+ + + +          + P+  
Sbjct: 142 GMAYLNAKKFVHRDLA---ARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVR- 197
Query: 309 TFGYLSPEYFMHGIVDEKTDVFAFGVLLLELIT 341
              +++PE    G+    +D+++FGV+L E+ +
Sbjct: 198 ---WMAPESLKDGVFTTSSDMWSFGVVLWEITS 227

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 44/170 (25%), Positives = 76/170 (44%), Gaps = 21/170 (12%)
Query: 245 KIALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVF 304
           KIA+ I + L++L             K SN+L++   + ++ DFG++ +L D+ +  I  
Sbjct: 157 KIAVSIVKALEHLHSKLSVIHRDV--KPSNVLINALGQVKMCDFGISGYLVDSVAKTI-- 212
Query: 305 PIEGTFGYLSPEYFMHGIVDE----KTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPL 360
              G   Y++PE     +  +    K+D+++ G+ ++EL   R   DS       W  P 
Sbjct: 213 -DAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDS-------WGTPF 264
Query: 361 LQTSNFKELVDPRL-ADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQ 409
            Q     E   P+L AD +  AE    +   S C+   S  RP    ++Q
Sbjct: 265 QQLKQVVEEPSPQLPADKFS-AEF---VDFTSQCLKKNSKERPTYPELMQ 310

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 39/160 (24%), Positives = 66/160 (41%), Gaps = 11/160 (6%)
Query: 188 FLSELGIVAHINHPNAAKLI-GFSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKI 246
           F  E  I+A  N P   +L   F  +   ++V++++P G L +L+       +W   Y  
Sbjct: 122 FWEERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEKWAKFY-- 179
Query: 247 ALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPI 306
               AE +  L             K  N+LL +    +++DFG    + +    H    +
Sbjct: 180 ---TAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVHCDTAV 236
Query: 307 EGTFGYLSPEYFMH----GIVDEKTDVFAFGVLLLELITG 342
            GT  Y+SPE        G    + D ++ GV L E++ G
Sbjct: 237 -GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVG 275

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 49/158 (31%), Positives = 71/158 (44%), Gaps = 11/158 (6%)
Query: 191 ELGIVAHINHPNAAKLIGFSTENGF-HLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALG 249
           EL   A +  P    L G   E  + ++ ++ L  GSL  L+     CL    R    LG
Sbjct: 135 ELMACAGLTSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLV-KEQGCLP-EDRALYYLG 192
Query: 250 IA-EGLQYLXXXXXXXXXXXXXKASNILLSED-YEAQISDFGLAKWL-PDNWSHHIVFP- 305
            A EGL+YL             KA N+LLS D   A + DFG A  L PD     ++   
Sbjct: 193 QALEGLEYLHSRRILHGDV---KADNVLLSSDGSHAALCDFGHAVCLQPDGLGKSLLTGD 249
Query: 306 -IEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITG 342
            I GT  +++PE  +    D K DV++   ++L ++ G
Sbjct: 250 YIPGTETHMAPEVVLGRSCDAKVDVWSSCCMMLHMLNG 287

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 49/179 (27%), Positives = 71/179 (39%), Gaps = 22/179 (12%)
Query: 191 ELGIVAHINHPNAAKLIGFSTENGF-HLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALG 249
           E+ I   + H +     GF  +N F  +VL+     SL  L        E   RY +   
Sbjct: 65  EISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLR-Q 123
Query: 250 IAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEGT 309
           I  G QYL             K  N+ L+ED E +I DFGLA  +  +     V  + GT
Sbjct: 124 IVLGCQYLHRNRVIHRDL---KLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV--LCGT 178
Query: 310 FGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSNFKE 368
             Y++PE         + DV++ G ++  L+ G               KP  +TS  KE
Sbjct: 179 PNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVG---------------KPPFETSCLKE 222

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 42/162 (25%), Positives = 72/162 (44%), Gaps = 12/162 (7%)
Query: 183 ERISDFLSELGIVAHINHPNAAKL-IGFSTENGFHLVLQFLPHGSLSSLLFGSTECLEWT 241
           ++I   L+E  I+  +N P   KL   F   +  ++V++++  G + S L       E  
Sbjct: 104 KQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPH 163
Query: 242 IRYKIALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPD-NWSH 300
            R+  A  I    +YL             K  N+L+ +    Q++DFG AK +    W+ 
Sbjct: 164 ARF-YAAQIVLTFEYLHSLDLIYRDL---KPENLLIDQQGYIQVTDFGFAKRVKGATWT- 218
Query: 301 HIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITG 342
                + GT  YL+PE  +    ++  D +A GVL+ E+  G
Sbjct: 219 -----LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 255

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 42/161 (26%), Positives = 70/161 (43%), Gaps = 10/161 (6%)
Query: 183 ERISDFLSELGIVAHINHPNAAKL-IGFSTENGFHLVLQFLPHGSLSSLLFGSTECLEWT 241
           ++I   L+E  I   +N P   KL   F   +  ++VL++ P G + S L       E  
Sbjct: 84  KQIEHTLNEKRIQQAVNFPFLVKLEFSFKDNSNLYMVLEYAPGGEMFSHLRRIGRFSEPH 143
Query: 242 IRYKIALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSHH 301
            R+  A  I    +YL             K  N+L+ +    +++DFG AK +       
Sbjct: 144 ARF-YAAQIVLTFEYLHSLDLIYRDL---KPENLLIDQQGYIKVADFGFAKRVKGR---- 195
Query: 302 IVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITG 342
             + + GT  YL+PE  +    ++  D +A GVL+ E+  G
Sbjct: 196 -TWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 49/158 (31%), Positives = 71/158 (44%), Gaps = 11/158 (6%)
Query: 191 ELGIVAHINHPNAAKLIGFSTENGF-HLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALG 249
           EL   A +  P    L G   E  + ++ ++ L  GSL  L+     CL    R    LG
Sbjct: 116 ELMACAGLTSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLV-KEQGCLP-EDRALYYLG 173
Query: 250 IA-EGLQYLXXXXXXXXXXXXXKASNILLSED-YEAQISDFGLAKWL-PDNWSHHIVFP- 305
            A EGL+YL             KA N+LLS D   A + DFG A  L PD     ++   
Sbjct: 174 QALEGLEYLHSRRILHGDV---KADNVLLSSDGSHAALCDFGHAVCLQPDGLGKDLLTGD 230
Query: 306 -IEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITG 342
            I GT  +++PE  +    D K DV++   ++L ++ G
Sbjct: 231 YIPGTETHMAPEVVLGRSCDAKVDVWSSCCMMLHMLNG 268

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 41/161 (25%), Positives = 71/161 (44%), Gaps = 10/161 (6%)
Query: 183 ERISDFLSELGIVAHINHPNAAKL-IGFSTENGFHLVLQFLPHGSLSSLLFGSTECLEWT 241
           ++I   L+E  I+  +N P   KL   F   +  ++V++++  G + S L       E  
Sbjct: 83  KQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPH 142
Query: 242 IRYKIALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSHH 301
            R+  A  I    +YL             K  N+L+ +    Q++DFG AK +       
Sbjct: 143 ARF-YAAQIVLTFEYLHSLDLIYRDL---KPENLLIDQQGYIQVTDFGFAKRVKGR---- 194
Query: 302 IVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITG 342
             + + GT  YL+PE  +    ++  D +A GVL+ E+  G
Sbjct: 195 -TWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 45/162 (27%), Positives = 70/162 (43%), Gaps = 23/162 (14%)
Query: 203 AAKLIGFSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLXXXX- 261
           AA+  G + E    L+  F   GSL+  L G+   + W     +A  ++ GL YL     
Sbjct: 76  AAEKRGSNLEVELWLITAFHDKGSLTDYLKGNI--ITWNELCHVAETMSRGLSYLHEDVP 133
Query: 262 -------XXXXXXXXXKASNILLSEDYEAQISDFGLAKWL----PDNWSHHIVFPIEGTF 310
                           K+ N+LL  D  A ++DFGLA       P   +H  V    GT 
Sbjct: 134 WCRGEGHKPSIAHRDFKSKNVLLKSDLTAVLADFGLAVRFEPGKPPGDTHGQV----GTR 189
Query: 311 GYLSPEYFMHGIVDE-----KTDVFAFGVLLLELITGRRAVD 347
            Y++PE     I  +     + D++A G++L EL++  +A D
Sbjct: 190 RYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELVSRCKAAD 231

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 41/161 (25%), Positives = 71/161 (44%), Gaps = 10/161 (6%)
Query: 183 ERISDFLSELGIVAHINHPNAAKL-IGFSTENGFHLVLQFLPHGSLSSLLFGSTECLEWT 241
           ++I   L+E  I+  +N P   KL   F   +  ++V++++  G + S L       E  
Sbjct: 83  KQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPH 142
Query: 242 IRYKIALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSHH 301
            R+  A  I    +YL             K  N+L+ +    Q++DFG AK +       
Sbjct: 143 ARF-YAAQIVLTFEYLHSLDLIYRDL---KPENLLIDQQGYIQVTDFGFAKRVKGR---- 194
Query: 302 IVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITG 342
             + + GT  YL+PE  +    ++  D +A GVL+ E+  G
Sbjct: 195 -TWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 41/161 (25%), Positives = 71/161 (44%), Gaps = 10/161 (6%)
Query: 183 ERISDFLSELGIVAHINHPNAAKL-IGFSTENGFHLVLQFLPHGSLSSLLFGSTECLEWT 241
           ++I   L+E  I+  +N P   KL   F   +  ++V++++  G + S L       E  
Sbjct: 84  KQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPH 143
Query: 242 IRYKIALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSHH 301
            R+  A  I    +YL             K  N+L+ +    Q++DFG AK +       
Sbjct: 144 ARF-YAAQIVLTFEYLHSLDLIYRDL---KPENLLIDQQGYIQVTDFGFAKRVKGR---- 195
Query: 302 IVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITG 342
             + + GT  YL+PE  +    ++  D +A GVL+ E+  G
Sbjct: 196 -TWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 41/161 (25%), Positives = 71/161 (44%), Gaps = 10/161 (6%)
Query: 183 ERISDFLSELGIVAHINHPNAAKL-IGFSTENGFHLVLQFLPHGSLSSLLFGSTECLEWT 241
           ++I   L+E  I+  +N P   KL   F   +  ++V++++  G + S L       E  
Sbjct: 83  KQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPH 142
Query: 242 IRYKIALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSHH 301
            R+  A  I    +YL             K  N+L+ +    Q++DFG AK +       
Sbjct: 143 ARF-YAAQIVLTFEYLHSLDLIYRDL---KPENLLIDQQGYIQVTDFGFAKRVKGR---- 194
Query: 302 IVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITG 342
             + + GT  YL+PE  +    ++  D +A GVL+ E+  G
Sbjct: 195 -TWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 41/161 (25%), Positives = 71/161 (44%), Gaps = 10/161 (6%)
Query: 183 ERISDFLSELGIVAHINHPNAAKL-IGFSTENGFHLVLQFLPHGSLSSLLFGSTECLEWT 241
           ++I   L+E  I+  +N P   KL   F   +  ++V++++  G + S L       E  
Sbjct: 83  KQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPH 142
Query: 242 IRYKIALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSHH 301
            R+  A  I    +YL             K  N+L+ +    Q++DFG AK +       
Sbjct: 143 ARF-YAAQIVLTFEYLHSLDLIYRDL---KPENLLIDQQGYIQVTDFGFAKRVKGR---- 194
Query: 302 IVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITG 342
             + + GT  YL+PE  +    ++  D +A GVL+ E+  G
Sbjct: 195 -TWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 40/161 (24%), Positives = 71/161 (44%), Gaps = 10/161 (6%)
Query: 183 ERISDFLSELGIVAHINHPNAAKL-IGFSTENGFHLVLQFLPHGSLSSLLFGSTECLEWT 241
           ++I   L+E  I+  +N P   KL   F   +  ++V+++ P G + S L       E  
Sbjct: 84  KQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPH 143
Query: 242 IRYKIALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSHH 301
            R+  A  I    +YL             K  N+++ +    +++DFG AK +       
Sbjct: 144 ARF-YAAQIVLTFEYLHSLDLIYRDL---KPENLMIDQQGYIKVTDFGFAKRVKGR---- 195
Query: 302 IVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITG 342
             + + GT  YL+PE  +    ++  D +A GVL+ E+  G
Sbjct: 196 -TWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 41/161 (25%), Positives = 71/161 (44%), Gaps = 10/161 (6%)
Query: 183 ERISDFLSELGIVAHINHPNAAKL-IGFSTENGFHLVLQFLPHGSLSSLLFGSTECLEWT 241
           ++I   L+E  I+  +N P   KL   F   +  ++V++++  G + S L       E  
Sbjct: 83  KQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPH 142
Query: 242 IRYKIALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSHH 301
            R+  A  I    +YL             K  N+L+ +    Q++DFG AK +       
Sbjct: 143 ARF-YAAQIVLTFEYLHSLDLIYRDL---KPENLLIDQQGYIQVTDFGFAKRVKGR---- 194
Query: 302 IVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITG 342
             + + GT  YL+PE  +    ++  D +A GVL+ E+  G
Sbjct: 195 -TWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 40/161 (24%), Positives = 76/161 (47%), Gaps = 20/161 (12%)
Query: 191 ELGIVAHINHPNAAKLIGFSTENG-------FHLVLQFLPHGSLSSLLFGSTECLEWTIR 243
           EL ++ H+ H N   L+   T          F+LV+ F+    L  ++    E  E  I+
Sbjct: 91  ELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFM-QTDLQKIM--GMEFSEEKIQ 147
Query: 244 YKIALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSHHIV 303
           Y +   + +GL+Y+             K  N+ ++ED E +I DFGLA+      + ++V
Sbjct: 148 Y-LVYQMLKGLKYIHSAGVVHRDL---KPGNLAVNEDCELKILDFGLARHADAEMTGYVV 203
Query: 304 FPIEGTFGYLSPEYFMHGI-VDEKTDVFAFGVLLLELITGR 343
                T  Y +PE  +  +  ++  D+++ G ++ E++TG+
Sbjct: 204 -----TRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 239

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 40/161 (24%), Positives = 71/161 (44%), Gaps = 10/161 (6%)
Query: 183 ERISDFLSELGIVAHINHPNAAKL-IGFSTENGFHLVLQFLPHGSLSSLLFGSTECLEWT 241
           ++I   L+E  I+  +N P   KL   F   +  ++V+++ P G + S L       E  
Sbjct: 84  KQIEHTLNEKRILQAVNFPFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPH 143
Query: 242 IRYKIALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSHH 301
            R+  A  I    +YL             K  N+++ +    +++DFG AK +       
Sbjct: 144 ARF-YAAQIVLTFEYLHSLDLIYRDL---KPENLMIDQQGYIKVTDFGFAKRVKGR---- 195
Query: 302 IVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITG 342
             + + GT  YL+PE  +    ++  D +A GVL+ E+  G
Sbjct: 196 -TWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 40/161 (24%), Positives = 71/161 (44%), Gaps = 10/161 (6%)
Query: 183 ERISDFLSELGIVAHINHPNAAKL-IGFSTENGFHLVLQFLPHGSLSSLLFGSTECLEWT 241
           ++I   L+E  I+  +N P   KL   F   +  ++V+++ P G + S L       E  
Sbjct: 83  KQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPH 142
Query: 242 IRYKIALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSHH 301
            R+  A  I    +YL             K  N+++ +    +++DFG AK +       
Sbjct: 143 ARF-YAAQIVLTFEYLHSLDLIYRDL---KPENLMIDQQGYIKVTDFGFAKRVKGR---- 194
Query: 302 IVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITG 342
             + + GT  YL+PE  +    ++  D +A GVL+ E+  G
Sbjct: 195 -TWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 40/161 (24%), Positives = 71/161 (44%), Gaps = 10/161 (6%)
Query: 183 ERISDFLSELGIVAHINHPNAAKL-IGFSTENGFHLVLQFLPHGSLSSLLFGSTECLEWT 241
           ++I   L+E  I+  +N P   KL   F   +  ++V+++ P G + S L       E  
Sbjct: 84  KQIEHTLNEKRILQAVNFPFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPH 143
Query: 242 IRYKIALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSHH 301
            R+  A  I    +YL             K  N+++ +    +++DFG AK +       
Sbjct: 144 ARF-YAAQIVLTFEYLHSLDLIYRDL---KPENLMIDQQGYIKVTDFGFAKRVKGR---- 195
Query: 302 IVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITG 342
             + + GT  YL+PE  +    ++  D +A GVL+ E+  G
Sbjct: 196 -TWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 41/161 (25%), Positives = 71/161 (44%), Gaps = 10/161 (6%)
Query: 183 ERISDFLSELGIVAHINHPNAAKL-IGFSTENGFHLVLQFLPHGSLSSLLFGSTECLEWT 241
           ++I   L+E  I+  +N P   KL   F   +  ++V++++  G + S L       E  
Sbjct: 83  KQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPH 142
Query: 242 IRYKIALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSHH 301
            R+  A  I    +YL             K  N+L+ +    Q++DFG AK +       
Sbjct: 143 ARF-YAAQIVLTFEYLHSLDLIYRDL---KPENLLIDQQGYIQVTDFGFAKRVKGR---- 194
Query: 302 IVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITG 342
             + + GT  YL+PE  +    ++  D +A GVL+ E+  G
Sbjct: 195 -TWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 42/164 (25%), Positives = 75/164 (45%), Gaps = 25/164 (15%)
Query: 191 ELGIVAHINHPNAAKLIGFSTE-------NGFHLVLQFLPHGSLSSLLFGSTECLEWT-- 241
           EL ++ H+ H N   L+   T        N  +LV   +      + L    +C + T  
Sbjct: 94  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-----GADLNNIVKCQKLTDD 148
Query: 242 -IRYKIALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSH 300
            +++ I   I  GL+Y+             K SN+ ++ED E +I DFGLA+   D    
Sbjct: 149 HVQFLI-YQILRGLKYIHSADIIHRDL---KPSNLAVNEDCELKILDFGLARHTDDEMXG 204
Query: 301 HIVFPIEGTFGYLSPEYFMHGI-VDEKTDVFAFGVLLLELITGR 343
           ++      T  Y +PE  ++ +  ++  D+++ G ++ EL+TGR
Sbjct: 205 YV-----ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 243

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 41/164 (25%), Positives = 76/164 (46%), Gaps = 25/164 (15%)
Query: 191 ELGIVAHINHPNAAKLIGFSTE-------NGFHLVLQFLPHGSLSSLLFGSTECLEWT-- 241
           EL ++ H+ H N   L+   T        N  +LV   +      + L    +C + T  
Sbjct: 71  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-----GADLNNIVKCQKLTDD 125
Query: 242 -IRYKIALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSH 300
            +++ I   I  GL+Y+             K SN+ ++ED E +I D+GLA+   D  + 
Sbjct: 126 HVQFLI-YQILRGLKYIHSADIIHRDL---KPSNLAVNEDCELKILDYGLARHTDDEMTG 181
Query: 301 HIVFPIEGTFGYLSPEYFMHGI-VDEKTDVFAFGVLLLELITGR 343
           ++      T  Y +PE  ++ +  ++  D+++ G ++ EL+TGR
Sbjct: 182 YV-----ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 41/161 (25%), Positives = 76/161 (47%), Gaps = 19/161 (11%)
Query: 191 ELGIVAHINHPNAAKLIGFSTEN-------GFHLVLQFLPHGSLSSLLFGSTECLEWTIR 243
           EL ++ H+ H N   L+   T +        F+LV+ F+  G+    L    +  E  I+
Sbjct: 74  ELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM--GTDLGKLMKHEKLGEDRIQ 131
Query: 244 YKIALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSHHIV 303
           + +   + +GL+Y+             K  N+ ++ED E +I DFGLA+         +V
Sbjct: 132 F-LVYQMLKGLRYIHAAGIIHRDL---KPGNLAVNEDCELKILDFGLARQADSEMXGXVV 187
Query: 304 FPIEGTFGYLSPEYFMHGIVDEKT-DVFAFGVLLLELITGR 343
                T  Y +PE  ++ +   +T D+++ G ++ E+ITG+
Sbjct: 188 -----TRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 223

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 45/171 (26%), Positives = 68/171 (39%), Gaps = 18/171 (10%)
Query: 190 SELGIVAHINHPNAAKLIGFSTENGF-HLVLQFLPHGSLSSLL---FGSTECLEWTIRYK 245
            E+ I A +NH N  K  G   E    +L L++   G L   +    G  E       ++
Sbjct: 54  KEICINAMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQ 113
Query: 246 IALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFP 305
           +  G+     YL             K  N+LL E    +ISDFGLA     N    ++  
Sbjct: 114 LMAGVV----YLHGIGITHRDI---KPENLLLDERDNLKISDFGLATVFRYNNRERLLNK 166
Query: 306 IEGTFGYLSPEYF----MHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQS 352
           + GT  Y++PE       H    E  DV++ G++L  ++ G    D    S
Sbjct: 167 MCGTLPYVAPELLKRREFHA---EPVDVWSCGIVLTAMLAGELPWDQPSDS 214

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 49/224 (21%), Positives = 88/224 (39%), Gaps = 39/224 (17%)
Query: 150 IGKGGHAEVYK----GCLPDGEXXXXXXXXXXXXEDEERISDFLSELGIVAHINHPNAAK 205
           IG+G    V++    G LP                  +  +DF  E  ++A  ++PN  K
Sbjct: 55  IGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVK 114
Query: 206 LIGF-STENGFHLVLQFLPHGSLSSLLFG---STEC--------------------LEWT 241
           L+G  +      L+ +++ +G L+  L      T C                    L   
Sbjct: 115 LLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCA 174
Query: 242 IRYKIALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAK--WLPDNWS 299
            +  IA  +A G+ YL                N L+ E+   +I+DFGL++  +  D + 
Sbjct: 175 EQLCIARQVAAGMAYLSERKFVHRDL---ATRNCLVGENMVVKIADFGLSRNIYSADYYK 231
Query: 300 H--HIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELIT 341
              +   PI     ++ PE   +     ++DV+A+GV+L E+ +
Sbjct: 232 ADGNDAIPIR----WMPPESIFYNRYTTESDVWAYGVVLWEIFS 271

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 42/164 (25%), Positives = 75/164 (45%), Gaps = 25/164 (15%)
Query: 191 ELGIVAHINHPNAAKLIGFSTE-------NGFHLVLQFLPHGSLSSLLFGSTECLEWT-- 241
           EL ++ H+ H N   L+   T        N  +LV   +      + L    +C + T  
Sbjct: 71  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-----GADLNNIVKCQKLTDD 125
Query: 242 -IRYKIALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSH 300
            +++ I   I  GL+Y+             K SN+ ++ED E +I DFGLA+   D  + 
Sbjct: 126 HVQFLI-YQILRGLKYIHSADIIHRDL---KPSNLAVNEDCELKILDFGLARHTDDEMTG 181
Query: 301 HIVFPIEGTFGYLSPEYFMHGI-VDEKTDVFAFGVLLLELITGR 343
            +      T  Y +PE  ++ +  ++  D+++ G ++ EL+TGR
Sbjct: 182 XV-----ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 44/170 (25%), Positives = 76/170 (44%), Gaps = 21/170 (12%)
Query: 245 KIALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVF 304
           KIA+ I + L++L             K SN+L++   + ++ DFG++ +L D+ +  I  
Sbjct: 113 KIAVSIVKALEHLHSKLSVIHRDV--KPSNVLINALGQVKMCDFGISGYLVDDVAKDI-- 168
Query: 305 PIEGTFGYLSPEYFMHGIVDE----KTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPL 360
              G   Y++PE     +  +    K+D+++ G+ ++EL   R   DS       W  P 
Sbjct: 169 -DAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDS-------WGTPF 220
Query: 361 LQTSNFKELVDPRL-ADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQ 409
            Q     E   P+L AD +  AE    +   S C+   S  RP    ++Q
Sbjct: 221 QQLKQVVEEPSPQLPADKFS-AEF---VDFTSQCLKKNSKERPTYPELMQ 266

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 47/174 (27%), Positives = 74/174 (42%), Gaps = 22/174 (12%)
Query: 180 EDEERISDF----LSELGIVAHINHPNAAKLIG-FSTENGFHLVLQFLPHGSLSSLLFGS 234
           +D + I  F     +E+ ++  ++HPN  KL   F  +  F+LV +F   G L   +   
Sbjct: 81  DDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINR 140
Query: 235 ---TECLEWTIRYKIALGIAEGLQYLXXXXXXXXXXXXXKASNILLSED---YEAQISDF 288
               EC    I  +I  GI     YL             K  NILL         +I DF
Sbjct: 141 HKFDECDAANIMKQILSGIC----YL---HKHNIVHRDIKPENILLENKNSLLNIKIVDF 193
Query: 289 GLAKWLPDNWSHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITG 342
           GL+ +   ++         GT  Y++PE  +    +EK DV++ GV++  L+ G
Sbjct: 194 GLSSFFSKDYKLRDRL---GTAYYIAPE-VLKKKYNEKCDVWSCGVIMYILLCG 243

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 42/164 (25%), Positives = 75/164 (45%), Gaps = 25/164 (15%)
Query: 191 ELGIVAHINHPNAAKLIGFSTE-------NGFHLVLQFLPHGSLSSLLFGSTECLEWT-- 241
           EL ++ H+ H N   L+   T        N  +LV   +      + L    +C + T  
Sbjct: 71  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-----GADLNNIVKCQKLTDD 125
Query: 242 -IRYKIALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSH 300
            +++ I   I  GL+Y+             K SN+ ++ED E +I DFGLA+   D  + 
Sbjct: 126 HVQFLI-YQILRGLKYIHSADIIHRDL---KPSNLAVNEDCELKILDFGLARHTDDEMAG 181
Query: 301 HIVFPIEGTFGYLSPEYFMHGI-VDEKTDVFAFGVLLLELITGR 343
            +      T  Y +PE  ++ +  ++  D+++ G ++ EL+TGR
Sbjct: 182 FV-----ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 42/164 (25%), Positives = 75/164 (45%), Gaps = 25/164 (15%)
Query: 191 ELGIVAHINHPNAAKLIGFSTE-------NGFHLVLQFLPHGSLSSLLFGSTECLEWT-- 241
           EL ++ H+ H N   L+   T        N  +LV   +      + L    +C + T  
Sbjct: 71  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-----GADLNNIVKCQKLTDD 125
Query: 242 -IRYKIALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSH 300
            +++ I   I  GL+Y+             K SN+ ++ED E +I DFGLA+   D  + 
Sbjct: 126 HVQFLI-YQILRGLKYIHSADIIHRDL---KPSNLAVNEDCELKILDFGLARHTDDEMAG 181
Query: 301 HIVFPIEGTFGYLSPEYFMHGI-VDEKTDVFAFGVLLLELITGR 343
            +      T  Y +PE  ++ +  ++  D+++ G ++ EL+TGR
Sbjct: 182 FV-----ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 52/198 (26%), Positives = 79/198 (39%), Gaps = 15/198 (7%)
Query: 150 IGKGGHAEVYKGCLPDGEXXXXXXXXXXXXEDEERISDFLSELGIVAHINHPNAAKLIG- 208
           IG+G +  VYK     GE            EDE   S  + E+ I+  + H N  KL   
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKIRLEK-EDEGIPSTTIREISILKELKHSNIVKLYDV 68
Query: 209 FSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLXXXXXXXXXXX 268
             T+    LV + L    L  LL      LE        L +  G+ Y            
Sbjct: 69  IHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDL- 126
Query: 269 XXKASNILLSEDYEAQISDFGLAKWL---PDNWSHHIVFPIEGTFGYLSPEYFMHGIVDE 325
             K  N+L++ + E +I+DFGLA+        ++H IV     T  Y +P+  M      
Sbjct: 127 --KPQNLLINREGELKIADFGLARAFGIPVRKYTHEIV-----TLWYRAPDVLMGSKKYS 179
Query: 326 KT-DVFAFGVLLLELITG 342
            T D+++ G +  E++ G
Sbjct: 180 TTIDIWSVGCIFAEMVNG 197

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 42/164 (25%), Positives = 75/164 (45%), Gaps = 25/164 (15%)
Query: 191 ELGIVAHINHPNAAKLIGFSTE-------NGFHLVLQFLPHGSLSSLLFGSTECLEWT-- 241
           EL ++ H+ H N   L+   T        N  +LV   +      + L    +C + T  
Sbjct: 67  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-----GADLNNIVKCQKLTDD 121
Query: 242 -IRYKIALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSH 300
            +++ I   I  GL+Y+             K SN+ ++ED E +I DFGLA+   D  + 
Sbjct: 122 HVQFLI-YQILRGLKYIHSADIIHRDL---KPSNLAVNEDCELKILDFGLARHTDDEMAG 177
Query: 301 HIVFPIEGTFGYLSPEYFMHGI-VDEKTDVFAFGVLLLELITGR 343
            +      T  Y +PE  ++ +  ++  D+++ G ++ EL+TGR
Sbjct: 178 FV-----ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 50/177 (28%), Positives = 70/177 (39%), Gaps = 12/177 (6%)
Query: 194 IVAHINHPNAAKL-IGFSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAE 252
           ++ ++ HP    L   F T +  + VL ++  G L   L      LE   R+  A  IA 
Sbjct: 92  LLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARF-YAAEIAS 150
Query: 253 GLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSHH-IVFPIEGTFG 311
            L YL             K  NILL       ++DFGL K   +N  H+       GT  
Sbjct: 151 ALGYLHSLNIVYRDL---KPENILLDSQGHIVLTDFGLCK---ENIEHNSTTSTFCGTPE 204
Query: 312 YLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLV---IWAKPLLQTSN 365
           YL+PE       D   D +  G +L E++ G     SR  + +   I  KPL    N
Sbjct: 205 YLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPN 261

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 52/209 (24%), Positives = 78/209 (37%), Gaps = 16/209 (7%)
Query: 141 TDNFNSENLIGKGGHAEV---YKGCLPDGEXXXXXXXXXXXXEDEERISDFLSELGIVAH 197
           TD +     IGKG  + V    K C                  D +++     E  I   
Sbjct: 3   TDEYQLYEDIGKGAFSVVRRCVKLCTGHEYAAKIINTKKLSARDHQKLE---REARICRL 59
Query: 198 INHPNAAKLIGFSTENGFH-LVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQY 256
           + H N  +L    +E GFH LV   +  G L    F      E+      +  I + L+ 
Sbjct: 60  LKHSNIVRLHDSISEEGFHYLVFDLVTGGEL----FEDIVAREYYSEADASHCIQQILEA 115
Query: 257 LXXXXXXXXXXXXXKASNILLSEDYEA---QISDFGLAKWLPDNWSHHIVFPIEGTFGYL 313
           +             K  N+LL+   +    +++DFGLA  +         F   GT GYL
Sbjct: 116 VLHCHQMGVVHRDLKPENLLLASKCKGAAVKLADFGLA--IEVQGDQQAWFGFAGTPGYL 173
Query: 314 SPEYFMHGIVDEKTDVFAFGVLLLELITG 342
           SPE        +  D++A GV+L  L+ G
Sbjct: 174 SPEVLRKEAYGKPVDIWACGVILYILLVG 202

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 43.1 bits (100), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 46/167 (27%), Positives = 65/167 (38%), Gaps = 19/167 (11%)
Query: 198 INHPNAAKLIG-----FSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAE 252
           + H N  + IG      S +    L+  F   GSLS  L      + W     IA  +A 
Sbjct: 75  MKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFL--KANVVSWNELCHIAETMAR 132
Query: 253 GLQYLXXXX-------XXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFP 305
           GL YL                    K+ N+LL  +  A I+DFGLA       S      
Sbjct: 133 GLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHG 192
Query: 306 IEGTFGYLSPEYFMHGIVDE-----KTDVFAFGVLLLELITGRRAVD 347
             GT  Y++PE     I  +     + D++A G++L EL +   A D
Sbjct: 193 QVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAAD 239

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 42.7 bits (99), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 42/164 (25%), Positives = 75/164 (45%), Gaps = 25/164 (15%)
Query: 191 ELGIVAHINHPNAAKLIGFSTE-------NGFHLVLQFLPHGSLSSLLFGSTECLEWT-- 241
           EL ++ H+ H N   L+   T        N  +LV   +      + L    +C + T  
Sbjct: 100 ELRLLKHMKHENVIGLLDVFTPATSLEEFNDVYLVTHLM-----GADLNNIVKCQKLTDD 154
Query: 242 -IRYKIALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSH 300
            +++ I   I  GL+Y+             K SN+ ++ED E +I DFGLA+   D  + 
Sbjct: 155 HVQFLI-YQILRGLKYIHSADIIHRDL---KPSNLAVNEDCELKILDFGLARHTDDEMTG 210
Query: 301 HIVFPIEGTFGYLSPEYFMHGI-VDEKTDVFAFGVLLLELITGR 343
           ++      T  Y +PE  ++ +  +   D+++ G ++ EL+TGR
Sbjct: 211 YV-----ATRWYRAPEIMLNWMHYNMTVDIWSVGCIMAELLTGR 249

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 42.7 bits (99), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 42/159 (26%), Positives = 66/159 (41%), Gaps = 7/159 (4%)
Query: 191 ELGIVAHINHPNAAKLIGFSTENGF-HLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALG 249
           E+ I   + H +     GF  +N F  +VL+     SL  L        E   RY +   
Sbjct: 67  EISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLR-Q 125
Query: 250 IAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEGT 309
           I  G QYL             K  N+ L+ED E +I DFGLA  +  +        + GT
Sbjct: 126 IVLGCQYLHRNRVIHRDL---KLGNLFLNEDLEVKIGDFGLATKVEYDGERKKT--LCGT 180
Query: 310 FGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDS 348
             Y++PE         + DV++ G ++  L+ G+   ++
Sbjct: 181 PNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFET 219

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 42.7 bits (99), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 42/159 (26%), Positives = 66/159 (41%), Gaps = 7/159 (4%)
Query: 191 ELGIVAHINHPNAAKLIGFSTENGF-HLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALG 249
           E+ I   + H +     GF  +N F  +VL+     SL  L        E   RY +   
Sbjct: 67  EISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLR-Q 125
Query: 250 IAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEGT 309
           I  G QYL             K  N+ L+ED E +I DFGLA  +  +        + GT
Sbjct: 126 IVLGCQYLHRNRVIHRDL---KLGNLFLNEDLEVKIGDFGLATKVEYDGERKKT--LCGT 180
Query: 310 FGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDS 348
             Y++PE         + DV++ G ++  L+ G+   ++
Sbjct: 181 PNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFET 219

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 42.7 bits (99), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 42/159 (26%), Positives = 66/159 (41%), Gaps = 7/159 (4%)
Query: 191 ELGIVAHINHPNAAKLIGFSTENGF-HLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALG 249
           E+ I   + H +     GF  +N F  +VL+     SL  L        E   RY +   
Sbjct: 71  EISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLR-Q 129
Query: 250 IAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEGT 309
           I  G QYL             K  N+ L+ED E +I DFGLA  +  +        + GT
Sbjct: 130 IVLGCQYLHRNRVIHRDL---KLGNLFLNEDLEVKIGDFGLATKVEYDGERKKT--LCGT 184
Query: 310 FGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDS 348
             Y++PE         + DV++ G ++  L+ G+   ++
Sbjct: 185 PNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFET 223

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score = 42.7 bits (99), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 40/161 (24%), Positives = 71/161 (44%), Gaps = 10/161 (6%)
Query: 183 ERISDFLSELGIVAHINHPNAAKL-IGFSTENGFHLVLQFLPHGSLSSLLFGSTECLEWT 241
           ++I   L+E  I+  +N P   KL   F   +  ++V++++  G + S L       E  
Sbjct: 83  KQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPH 142
Query: 242 IRYKIALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSHH 301
            R+  A  I    +YL             K  N+L+ +    Q++DFG AK +       
Sbjct: 143 ARF-YAAQIVLTFEYLHSLDLIYRDL---KPENLLIDQQGYIQVTDFGFAKRVKGR---- 194
Query: 302 IVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITG 342
             + + GT  YL+PE  +    ++  D +A GVL+ ++  G
Sbjct: 195 -TWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYQMAAG 234

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 42.7 bits (99), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 42/164 (25%), Positives = 74/164 (45%), Gaps = 25/164 (15%)
Query: 191 ELGIVAHINHPNAAKLIGFSTE-------NGFHLVLQFLPHGSLSSLLFGSTECLEWT-- 241
           EL ++ H+ H N   L+   T        N  +LV   +      + L    +C + T  
Sbjct: 91  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-----GADLNNIVKCQKLTDD 145
Query: 242 -IRYKIALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSH 300
            +++ I   I  GL+Y+             K SN+ ++ED E +I DFGLA+   D    
Sbjct: 146 HVQFLI-YQILRGLKYIHSADIIHRDL---KPSNLAVNEDCELKILDFGLARHTDDEMXG 201
Query: 301 HIVFPIEGTFGYLSPEYFMHGI-VDEKTDVFAFGVLLLELITGR 343
            +      T  Y +PE  ++ +  ++  D+++ G ++ EL+TGR
Sbjct: 202 XV-----ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 240

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score = 42.7 bits (99), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 40/161 (24%), Positives = 71/161 (44%), Gaps = 10/161 (6%)
Query: 183 ERISDFLSELGIVAHINHPNAAKL-IGFSTENGFHLVLQFLPHGSLSSLLFGSTECLEWT 241
           ++I   L+E  I+  +N P   KL   F   +  ++V++++  G + S L       E  
Sbjct: 83  KQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPH 142
Query: 242 IRYKIALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSHH 301
            R+  A  I    +YL             K  N+++ +    Q++DFG AK +       
Sbjct: 143 ARF-YAAQIVLTFEYLHSLDLIYRDL---KPENLIIDQQGYIQVTDFGFAKRVKGR---- 194
Query: 302 IVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITG 342
             + + GT  YL+PE  +    ++  D +A GVL+ E+  G
Sbjct: 195 -TWXLCGTPEYLAPEIIISKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 42.7 bits (99), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 51/198 (25%), Positives = 79/198 (39%), Gaps = 15/198 (7%)
Query: 150 IGKGGHAEVYKGCLPDGEXXXXXXXXXXXXEDEERISDFLSELGIVAHINHPNAAKLIG- 208
           IG+G +  VYK     GE            EDE   S  + E+ I+  + H N  KL   
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKIRLEK-EDEGIPSTTIREISILKELKHSNIVKLYDV 68
Query: 209 FSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLXXXXXXXXXXX 268
             T+    LV + L    L  LL      LE        L +  G+ Y            
Sbjct: 69  IHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDL- 126
Query: 269 XXKASNILLSEDYEAQISDFGLAKWL---PDNWSHHIVFPIEGTFGYLSPEYFMHGIVDE 325
             K  N+L++ + E +I+DFGLA+        ++H +V     T  Y +P+  M      
Sbjct: 127 --KPQNLLINREGELKIADFGLARAFGIPVRKYTHEVV-----TLWYRAPDVLMGSKKYS 179
Query: 326 KT-DVFAFGVLLLELITG 342
            T D+++ G +  E++ G
Sbjct: 180 TTIDIWSVGCIFAEMVNG 197

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 42.7 bits (99), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 51/198 (25%), Positives = 79/198 (39%), Gaps = 15/198 (7%)
Query: 150 IGKGGHAEVYKGCLPDGEXXXXXXXXXXXXEDEERISDFLSELGIVAHINHPNAAKLIG- 208
           IG+G +  VYK     GE            EDE   S  + E+ I+  + H N  KL   
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKIRLEK-EDEGIPSTTIREISILKELKHSNIVKLYDV 68
Query: 209 FSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLXXXXXXXXXXX 268
             T+    LV + L    L  LL      LE        L +  G+ Y            
Sbjct: 69  IHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDL- 126
Query: 269 XXKASNILLSEDYEAQISDFGLAKWL---PDNWSHHIVFPIEGTFGYLSPEYFMHGIVDE 325
             K  N+L++ + E +I+DFGLA+        ++H +V     T  Y +P+  M      
Sbjct: 127 --KPQNLLINREGELKIADFGLARAFGIPVRKYTHEVV-----TLWYRAPDVLMGSKKYS 179
Query: 326 KT-DVFAFGVLLLELITG 342
            T D+++ G +  E++ G
Sbjct: 180 TTIDIWSVGCIFAEMVNG 197

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 42.7 bits (99), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 42/161 (26%), Positives = 65/161 (40%), Gaps = 18/161 (11%)
Query: 190 SELGIVAHINHPNAAKLIGFSTENGF-HLVLQFLPHGSLSSLL---FGSTECLEWTIRYK 245
            E+ I   +NH N  K  G   E    +L L++   G L   +    G  E       ++
Sbjct: 53  KEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQ 112
Query: 246 IALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFP 305
           +  G+     YL             K  N+LL E    +ISDFGLA     N    ++  
Sbjct: 113 LMAGVV----YLHGIGITHRDI---KPENLLLDERDNLKISDFGLATVFRYNNRERLLNK 165
Query: 306 IEGTFGYLSPEYF----MHGIVDEKTDVFAFGVLLLELITG 342
           + GT  Y++PE       H    E  DV++ G++L  ++ G
Sbjct: 166 MXGTLPYVAPELLKRREFHA---EPVDVWSCGIVLTAMLAG 203

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 42.7 bits (99), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 42/161 (26%), Positives = 65/161 (40%), Gaps = 18/161 (11%)
Query: 190 SELGIVAHINHPNAAKLIGFSTENGF-HLVLQFLPHGSLSSLL---FGSTECLEWTIRYK 245
            E+ I   +NH N  K  G   E    +L L++   G L   +    G  E       ++
Sbjct: 53  KEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQ 112
Query: 246 IALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFP 305
           +  G+     YL             K  N+LL E    +ISDFGLA     N    ++  
Sbjct: 113 LMAGVV----YLHGIGITHRDI---KPENLLLDERDNLKISDFGLATVFRYNNRERLLNK 165
Query: 306 IEGTFGYLSPEYF----MHGIVDEKTDVFAFGVLLLELITG 342
           + GT  Y++PE       H    E  DV++ G++L  ++ G
Sbjct: 166 MXGTLPYVAPELLKRREFHA---EPVDVWSCGIVLTAMLAG 203

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 42/161 (26%), Positives = 65/161 (40%), Gaps = 18/161 (11%)
Query: 190 SELGIVAHINHPNAAKLIGFSTENGF-HLVLQFLPHGSLSSLL---FGSTECLEWTIRYK 245
            E+ I   +NH N  K  G   E    +L L++   G L   +    G  E       ++
Sbjct: 53  KEIXINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQ 112
Query: 246 IALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFP 305
           +  G+     YL             K  N+LL E    +ISDFGLA     N    ++  
Sbjct: 113 LMAGVV----YLHGIGITHRDI---KPENLLLDERDNLKISDFGLATVFRYNNRERLLNK 165
Query: 306 IEGTFGYLSPEYF----MHGIVDEKTDVFAFGVLLLELITG 342
           + GT  Y++PE       H    E  DV++ G++L  ++ G
Sbjct: 166 MXGTLPYVAPELLKRREFHA---EPVDVWSCGIVLTAMLAG 203

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 49/215 (22%), Positives = 85/215 (39%), Gaps = 9/215 (4%)
Query: 140 ATDNFNSENLIGKGGHAEVYKGCLPD-GEXXXXXXXXXXXXEDEERISDFLSELGIVAHI 198
             DNF    ++GKG   +V    + + G+              ++ +   ++E  I++  
Sbjct: 21  GIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLA 80
Query: 199 -NHPNAAKLIG-FSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQY 256
            NHP   +L   F T +    V++F+  G L   +  S    E   R+  A    E +  
Sbjct: 81  RNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAA----EIISA 136
Query: 257 LXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEGTFGYLSPE 316
           L             K  N+LL  +   +++DFG+ K    N      F   GT  Y++PE
Sbjct: 137 LMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTATFC--GTPDYIAPE 194
Query: 317 YFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQ 351
                +     D +A GVLL E++ G    ++  +
Sbjct: 195 ILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENE 229

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 44/164 (26%), Positives = 68/164 (41%), Gaps = 16/164 (9%)
Query: 200 HPNAAKLI-GFSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLX 258
           HP+   LI  + + +   LV   +  G L   L       E   R  I   + E + +L 
Sbjct: 159 HPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETR-SIMRSLLEAVSFLH 217
Query: 259 XXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWL-PDNWSHHIVFPIEGTFGYLSPEY 317
                       K  NILL ++ + ++SDFG +  L P      +     GT GYL+PE 
Sbjct: 218 ANNIVHRDL---KPENILLDDNMQIRLSDFGFSCHLEPGEKLRELC----GTPGYLAPEI 270
Query: 318 F------MHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVI 355
                   H    ++ D++A GV+L  L+ G      RRQ L++
Sbjct: 271 LKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILML 314

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 44/171 (25%), Positives = 67/171 (39%), Gaps = 18/171 (10%)
Query: 190 SELGIVAHINHPNAAKLIGFSTENGF-HLVLQFLPHGSLSSLL---FGSTECLEWTIRYK 245
            E+ I   +NH N  K  G   E    +L L++   G L   +    G  E       ++
Sbjct: 54  KEIXINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQ 113
Query: 246 IALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFP 305
           +  G+     YL             K  N+LL E    +ISDFGLA     N    ++  
Sbjct: 114 LMAGVV----YLHGIGITHRDI---KPENLLLDERDNLKISDFGLATVFRYNNRERLLNK 166
Query: 306 IEGTFGYLSPEYF----MHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQS 352
           + GT  Y++PE       H    E  DV++ G++L  ++ G    D    S
Sbjct: 167 MXGTLPYVAPELLKRREFHA---EPVDVWSCGIVLTAMLAGELPWDQPSDS 214

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 42.4 bits (98), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 50/211 (23%), Positives = 84/211 (39%), Gaps = 20/211 (9%)
Query: 143 NFNSENLIGKGGHAEVYKGCLPDGEXXXXXXXXXXXXEDEERISDFLSELGIVAHINHPN 202
           +F    LIG GG  +V+K                   E  ER    L++L  V +I H N
Sbjct: 12  DFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKLDHV-NIVHYN 70
Query: 203 ------------AAKLIGFSTENGFHLVLQFLPHGSLSSLLFGST-ECLEWTIRYKIALG 249
                       ++K    S      + ++F   G+L   +     E L+  +  ++   
Sbjct: 71  GCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQ 130
Query: 250 IAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEGT 309
           I +G+ Y+             K SNI L +  + +I DFGL   L ++         +GT
Sbjct: 131 ITKGVDYIHSKKLINRDL---KPSNIFLVDTKQVKIGDFGLVTSLKNDGKRX---RSKGT 184
Query: 310 FGYLSPEYFMHGIVDEKTDVFAFGVLLLELI 340
             Y+SPE        ++ D++A G++L EL+
Sbjct: 185 LRYMSPEQISSQDYGKEVDLYALGLILAELL 215

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 42.4 bits (98), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 51/201 (25%), Positives = 80/201 (39%), Gaps = 20/201 (9%)
Query: 150 IGKGGHAEVYKGCLPDGEXXXXXXXXXXXXEDEERISDF-LSELGIVAHINHPNAAKLIG 208
           IG+G +  V+K C                 ED+  I    L E+ ++  + HPN   L+ 
Sbjct: 11  IGEGSYGVVFK-CRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLE 69
Query: 209 -FSTENGFHLVLQFLPHGSLSSL---LFGSTECLEWTIRYKIALGIAEGLQYLXXXXXXX 264
            F  +   HLV ++  H  L  L     G  E L  +I +       + LQ +       
Sbjct: 70  VFRRKRRLHLVFEYCDHTVLHELDRYQRGVPEHLVKSITW-------QTLQAVNFCHKHN 122
Query: 265 XXXXXXKASNILLSEDYEAQISDFGLAKWL--PDNWSHHIVFPIEGTFGYLSPEYFMHGI 322
                 K  NIL+++    ++ DFG A+ L  P ++    V     T  Y SPE  +   
Sbjct: 123 CIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEV----ATRWYRSPELLVGDT 178
Query: 323 -VDEKTDVFAFGVLLLELITG 342
                 DV+A G +  EL++G
Sbjct: 179 QYGPPVDVWAIGCVFAELLSG 199

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 42.4 bits (98), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 44/171 (25%), Positives = 67/171 (39%), Gaps = 18/171 (10%)
Query: 190 SELGIVAHINHPNAAKLIGFSTENGF-HLVLQFLPHGSLSSLL---FGSTECLEWTIRYK 245
            E+ I   +NH N  K  G   E    +L L++   G L   +    G  E       ++
Sbjct: 53  KEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQ 112
Query: 246 IALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFP 305
           +  G+     YL             K  N+LL E    +ISDFGLA     N    ++  
Sbjct: 113 LMAGVV----YLHGIGITHRDI---KPENLLLDERDNLKISDFGLATVFRYNNRERLLNK 165
Query: 306 IEGTFGYLSPEYF----MHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQS 352
           + GT  Y++PE       H    E  DV++ G++L  ++ G    D    S
Sbjct: 166 MXGTLPYVAPELLKRREFHA---EPVDVWSCGIVLTAMLAGELPWDQPSDS 213

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 42.0 bits (97), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 42/161 (26%), Positives = 65/161 (40%), Gaps = 18/161 (11%)
Query: 190 SELGIVAHINHPNAAKLIGFSTENGF-HLVLQFLPHGSLSSLL---FGSTECLEWTIRYK 245
            E+ I   +NH N  K  G   E    +L L++   G L   +    G  E       ++
Sbjct: 53  KEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQ 112
Query: 246 IALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFP 305
           +  G+     YL             K  N+LL E    +ISDFGLA     N    ++  
Sbjct: 113 LMAGVV----YLHGIGITHRDI---KPENLLLDERDNLKISDFGLATVFRYNNRERLLNK 165
Query: 306 IEGTFGYLSPEYF----MHGIVDEKTDVFAFGVLLLELITG 342
           + GT  Y++PE       H    E  DV++ G++L  ++ G
Sbjct: 166 MCGTLPYVAPELLKRREFHA---EPVDVWSCGIVLTAMLAG 203

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 42.0 bits (97), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 42/161 (26%), Positives = 65/161 (40%), Gaps = 18/161 (11%)
Query: 190 SELGIVAHINHPNAAKLIGFSTENGF-HLVLQFLPHGSLSSLL---FGSTECLEWTIRYK 245
            E+ I   +NH N  K  G   E    +L L++   G L   +    G  E       ++
Sbjct: 52  KEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQ 111
Query: 246 IALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFP 305
           +  G+     YL             K  N+LL E    +ISDFGLA     N    ++  
Sbjct: 112 LMAGVV----YLHGIGITHRDI---KPENLLLDERDNLKISDFGLATVFRYNNRERLLNK 164
Query: 306 IEGTFGYLSPEYF----MHGIVDEKTDVFAFGVLLLELITG 342
           + GT  Y++PE       H    E  DV++ G++L  ++ G
Sbjct: 165 MCGTLPYVAPELLKRREFHA---EPVDVWSCGIVLTAMLAG 202

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 42.0 bits (97), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 42/161 (26%), Positives = 65/161 (40%), Gaps = 18/161 (11%)
Query: 190 SELGIVAHINHPNAAKLIGFSTENGF-HLVLQFLPHGSLSSLL---FGSTECLEWTIRYK 245
            E+ I   +NH N  K  G   E    +L L++   G L   +    G  E       ++
Sbjct: 53  KEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQ 112
Query: 246 IALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFP 305
           +  G+     YL             K  N+LL E    +ISDFGLA     N    ++  
Sbjct: 113 LMAGVV----YLHGIGITHRDI---KPENLLLDERDNLKISDFGLATVFRYNNRERLLNK 165
Query: 306 IEGTFGYLSPEYF----MHGIVDEKTDVFAFGVLLLELITG 342
           + GT  Y++PE       H    E  DV++ G++L  ++ G
Sbjct: 166 MCGTLPYVAPELLKRREFHA---EPVDVWSCGIVLTAMLAG 203

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 42.0 bits (97), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 42/161 (26%), Positives = 65/161 (40%), Gaps = 18/161 (11%)
Query: 190 SELGIVAHINHPNAAKLIGFSTENGF-HLVLQFLPHGSLSSLL---FGSTECLEWTIRYK 245
            E+ I   +NH N  K  G   E    +L L++   G L   +    G  E       ++
Sbjct: 53  KEIXINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQ 112
Query: 246 IALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFP 305
           +  G+     YL             K  N+LL E    +ISDFGLA     N    ++  
Sbjct: 113 LMAGVV----YLHGIGITHRDI---KPENLLLDERDNLKISDFGLATVFRYNNRERLLNK 165
Query: 306 IEGTFGYLSPEYF----MHGIVDEKTDVFAFGVLLLELITG 342
           + GT  Y++PE       H    E  DV++ G++L  ++ G
Sbjct: 166 MCGTLPYVAPELLKRREFHA---EPVDVWSCGIVLTAMLAG 203

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 41.6 bits (96), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 44/171 (25%), Positives = 67/171 (39%), Gaps = 18/171 (10%)
Query: 190 SELGIVAHINHPNAAKLIGFSTENGF-HLVLQFLPHGSLSSLL---FGSTECLEWTIRYK 245
            E+ I   +NH N  K  G   E    +L L++   G L   +    G  E       ++
Sbjct: 54  KEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQ 113
Query: 246 IALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFP 305
           +  G+     YL             K  N+LL E    +ISDFGLA     N    ++  
Sbjct: 114 LMAGVV----YLHGIGITHRDI---KPENLLLDERDNLKISDFGLATVFRYNNRERLLNK 166
Query: 306 IEGTFGYLSPEYF----MHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQS 352
           + GT  Y++PE       H    E  DV++ G++L  ++ G    D    S
Sbjct: 167 MCGTLPYVAPELLKRREFHA---EPVDVWSCGIVLTAMLAGELPWDQPSDS 214

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 41.6 bits (96), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 44/170 (25%), Positives = 67/170 (39%), Gaps = 18/170 (10%)
Query: 191 ELGIVAHINHPNAAKLIGFSTENGF-HLVLQFLPHGSLSSLL---FGSTECLEWTIRYKI 246
           E+ I   +NH N  K  G   E    +L L++   G L   +    G  E       +++
Sbjct: 55  EICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQL 114
Query: 247 ALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPI 306
             G+     YL             K  N+LL E    +ISDFGLA     N    ++  +
Sbjct: 115 MAGVV----YLHGIGITHRDI---KPENLLLDERDNLKISDFGLATVFRYNNRERLLNKM 167
Query: 307 EGTFGYLSPEYF----MHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQS 352
            GT  Y++PE       H    E  DV++ G++L  ++ G    D    S
Sbjct: 168 CGTLPYVAPELLKRREFHA---EPVDVWSCGIVLTAMLAGELPWDQPSDS 214

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 41.6 bits (96), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 44/170 (25%), Positives = 67/170 (39%), Gaps = 18/170 (10%)
Query: 191 ELGIVAHINHPNAAKLIGFSTENGF-HLVLQFLPHGSLSSLL---FGSTECLEWTIRYKI 246
           E+ I   +NH N  K  G   E    +L L++   G L   +    G  E       +++
Sbjct: 55  EICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQL 114
Query: 247 ALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPI 306
             G+     YL             K  N+LL E    +ISDFGLA     N    ++  +
Sbjct: 115 MAGVV----YLHGIGITHRDI---KPENLLLDERDNLKISDFGLATVFRYNNRERLLNKM 167
Query: 307 EGTFGYLSPEYF----MHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQS 352
            GT  Y++PE       H    E  DV++ G++L  ++ G    D    S
Sbjct: 168 CGTLPYVAPELLKRREFHA---EPVDVWSCGIVLTAMLAGELPWDQPSDS 214

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 41.6 bits (96), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 44/170 (25%), Positives = 67/170 (39%), Gaps = 18/170 (10%)
Query: 191 ELGIVAHINHPNAAKLIGFSTENGF-HLVLQFLPHGSLSSLL---FGSTECLEWTIRYKI 246
           E+ I   +NH N  K  G   E    +L L++   G L   +    G  E       +++
Sbjct: 55  EICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQL 114
Query: 247 ALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPI 306
             G+     YL             K  N+LL E    +ISDFGLA     N    ++  +
Sbjct: 115 MAGVV----YLHGIGITHRDI---KPENLLLDERDNLKISDFGLATVFRYNNRERLLNKM 167
Query: 307 EGTFGYLSPEYF----MHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQS 352
            GT  Y++PE       H    E  DV++ G++L  ++ G    D    S
Sbjct: 168 CGTLPYVAPELLKRREFHA---EPVDVWSCGIVLTAMLAGELPWDQPSDS 214

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 41.6 bits (96), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 23/73 (31%), Positives = 38/73 (52%), Gaps = 2/73 (2%)
Query: 271 KASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVF 330
           K  N++L  +   +I+DFG+ K   + W         GT  Y++PE   +    +  D +
Sbjct: 469 KLDNVMLDSEGHIKIADFGMCK--ENIWDGVTTKXFCGTPDYIAPEIIAYQPYGKSVDWW 526
Query: 331 AFGVLLLELITGR 343
           AFGVLL E++ G+
Sbjct: 527 AFGVLLYEMLAGQ 539

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 41.6 bits (96), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 41/164 (25%), Positives = 75/164 (45%), Gaps = 25/164 (15%)
Query: 191 ELGIVAHINHPNAAKLIGFSTE-------NGFHLVLQFLPHGSLSSLLFGSTECLEWT-- 241
           EL ++ H+ H N   L+   T        N  +LV   +      + L    +C + T  
Sbjct: 71  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-----GADLNNIVKCQKLTDD 125
Query: 242 -IRYKIALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSH 300
            +++ I   I  GL+Y+             K SN+ ++ED E +I  FGLA+   D  + 
Sbjct: 126 HVQFLI-YQILRGLKYIHSADIIHRDL---KPSNLAVNEDCELKILGFGLARHTDDEMTG 181
Query: 301 HIVFPIEGTFGYLSPEYFMHGI-VDEKTDVFAFGVLLLELITGR 343
           ++      T  Y +PE  ++ +  ++  D+++ G ++ EL+TGR
Sbjct: 182 YV-----ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 41.6 bits (96), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 40/178 (22%), Positives = 82/178 (46%), Gaps = 32/178 (17%)
Query: 188 FLSELGIVAHI-NHPNAAKLIGFSTENGFHLVL-QFLPHGSLSSLLFGSTECLEWT---- 241
            +SEL +++++ NH N   L+G  T  G  LV+ ++  +G L + L    +    +    
Sbjct: 96  LMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSP 155
Query: 242 -------------IRYKIALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDF 288
                             +  +A+G+ +L              A NILL+     +I DF
Sbjct: 156 AIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLA---ARNILLTHGRITKICDF 212
Query: 289 GLAKWLPDNWSHHIV-----FPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELIT 341
           GLA+ + ++ S+++V      P++    +++PE   + +   ++DV+++G+ L EL +
Sbjct: 213 GLARHIKND-SNYVVKGNARLPVK----WMAPESIFNCVYTFESDVWSYGIFLWELFS 265

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 41.6 bits (96), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 43/168 (25%), Positives = 69/168 (41%), Gaps = 19/168 (11%)
Query: 189 LSELGIVAHIN----HPNAAKLIGFSTENGFHLVLQFLPHGSLSSLLFG--STECLEWTI 242
           L   GIV + N         KL   S +   ++ +Q     +L   + G  + E  E ++
Sbjct: 60  LEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSV 119
Query: 243 RYKIALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWL-PDNWSHH 301
              I L IAE +++L             K SNI  + D   ++ DFGL   +  D     
Sbjct: 120 CLHIFLQIAEAVEFLHSKGLMHRDL---KPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQT 176
Query: 302 IVFPIE---------GTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELI 340
           ++ P+          GT  Y+SPE         K D+F+ G++L EL+
Sbjct: 177 VLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELL 224

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 41.6 bits (96), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 44/171 (25%), Positives = 67/171 (39%), Gaps = 18/171 (10%)
Query: 190 SELGIVAHINHPNAAKLIGFSTENGF-HLVLQFLPHGSLSSLL---FGSTECLEWTIRYK 245
            E+ I   +NH N  K  G   E    +L L++   G L   +    G  E       ++
Sbjct: 53  KEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQ 112
Query: 246 IALGIAEGLQYLXXXXXXXXXXXXXKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFP 305
           +  G+     YL             K  N+LL E    +ISDFGLA     N    ++  
Sbjct: 113 LMAGVV----YLHGIGITHRDI---KPENLLLDERDNLKISDFGLATVFRYNNRERLLNK 165
Query: 306 IEGTFGYLSPEYF----MHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQS 352
           + GT  Y++PE       H    E  DV++ G++L  ++ G    D    S
Sbjct: 166 MCGTLPYVAPELLKRREFHA---EPVDVWSCGIVLTAMLAGELPWDQPSDS 213

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	457
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	1e-129
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	1e-112
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	1e-111
3soc_A	322	Activin receptor type-2A; structural genomics cons	8e-69
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	3e-55
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	5e-54
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	2e-52
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	2e-52
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	4e-52
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	1e-51
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	3e-50
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	3e-49
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	4e-48
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	5e-46
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	4e-43
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	6e-43
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	7e-43
3q4u_A	301	Activin receptor type-1; structural genomics conso	3e-42
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	2e-38
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	2e-38
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	3e-38
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	1e-37
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	1e-37
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	2e-37
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	4e-37
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	5e-37
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	1e-36
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	2e-36
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	2e-36
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	3e-36
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	3e-36
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	3e-36
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	5e-36
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	8e-36
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	2e-35
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	2e-35
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	2e-35
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	3e-35
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	5e-35
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	6e-35
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	6e-35
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	1e-34
3pls_A	298	Macrophage-stimulating protein receptor; protein k	1e-34
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	2e-34
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	2e-34
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	3e-34
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	3e-34
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	4e-34
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	5e-34
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	6e-34
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	7e-34
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	1e-33
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	1e-33
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	2e-33
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	2e-33
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	3e-33
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	3e-33
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	4e-33
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	4e-33
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	4e-33
2a19_B	284	Interferon-induced, double-stranded RNA-activated	5e-33
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	1e-32
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	1e-32
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	1e-32
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	2e-32
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	2e-32
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	2e-32
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	2e-32
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	3e-32
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	4e-32
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	4e-32
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	7e-32
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	2e-31
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	2e-31
4aoj_A	329	High affinity nerve growth factor receptor; transf	2e-31
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	5e-31
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	9e-31
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	1e-30
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	1e-30
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	1e-30
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	1e-30
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	1e-30
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	2e-30
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	2e-30
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	2e-30
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	2e-30
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	3e-30
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	4e-30
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	4e-30
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	6e-30
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	8e-30
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	8e-30
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	1e-29
3ork_A	311	Serine/threonine protein kinase; structural genomi	1e-29
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	1e-29
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	1e-29
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	1e-29
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	2e-29
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	2e-29
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	3e-29
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	3e-29
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	4e-29
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	4e-29
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	3e-28
3aln_A	327	Dual specificity mitogen-activated protein kinase;	3e-28
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	3e-28
3fme_A	290	Dual specificity mitogen-activated protein kinase;	5e-28
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	6e-28
3an0_A	340	Dual specificity mitogen-activated protein kinase;	8e-28
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	2e-27
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	2e-27
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	2e-27
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	3e-27
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	5e-27
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	1e-26
2dyl_A	318	Dual specificity mitogen-activated protein kinase	1e-26
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	5e-26
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	9e-26
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	1e-25
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	2e-25
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	1e-24
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	2e-24
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	3e-24
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	4e-24
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	4e-24
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	5e-24
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	2e-23
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	2e-23
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	5e-23
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	7e-23
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	1e-22
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	1e-22
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	2e-22
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	2e-22
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	2e-22
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	3e-22
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	4e-22
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	4e-22
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	5e-22
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	5e-22
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	6e-22
3uqc_A	286	Probable conserved transmembrane protein; structur	8e-22
3bhy_A	283	Death-associated protein kinase 3; death associate	1e-21
3o0g_A	292	Cell division protein kinase 5; kinase activator c	2e-21
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	2e-21
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	2e-21
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	2e-21
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	3e-21
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	3e-21
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	3e-21
3niz_A	311	Rhodanese family protein; structural genomics, str	3e-21
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	3e-21
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	4e-21
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	5e-21
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	9e-21
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	1e-20
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	1e-20
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	1e-20
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	1e-20
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	1e-20
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	2e-20
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	2e-20
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	3e-20
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	3e-20
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	3e-20
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	3e-20
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	4e-20
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	7e-20
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	1e-19
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	2e-19
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	3e-19
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	5e-19
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	1e-18
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	2e-18
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	3e-18
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	3e-18
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	5e-18
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	8e-18
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	1e-17
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	2e-17
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	4e-17
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	9e-17
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	1e-16
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	2e-16
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	2e-16
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	3e-16
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	3e-16
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	1e-15
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	1e-15
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	1e-15
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	7e-07
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	2e-15
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	3e-15
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	5e-15
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	6e-15
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	7e-15
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	2e-14
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	2e-14
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	3e-14
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	6e-14
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	6e-14
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	7e-14
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	1e-13
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	3e-13
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	3e-13
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	3e-13
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	4e-13
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	7e-13
3rp9_A	458	Mitogen-activated protein kinase; structural genom	7e-13
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	1e-12
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	1e-12
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	1e-12
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	1e-12
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	2e-12
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	3e-12
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	3e-12
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	3e-12
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	4e-12
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	5e-12
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	6e-12
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	8e-12
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	1e-11
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	4e-11
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	6e-11
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	1e-10
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	1e-10
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	2e-10
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	5e-10
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	8e-10
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	8e-10
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	3e-09
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	6e-09
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	8e-09
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	3e-08
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	1e-05
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	4e-04

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score =  375 bits (966), Expect = e-129
 Identities = 119/299 (39%), Positives = 175/299 (58%), Gaps = 15/299 (5%)

Query: 128 SWKNFDFAELAAATDNFNSENLIGKGGHAEVYKGCLPDGEVVAVKKIIKNAKEDEERISD 187
             K F   EL  A+DNF+++N++G+GG  +VYKG L DG +VAVK++ +   +  E    
Sbjct: 16  QLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGEL--Q 73

Query: 188 FLSELGIVAHINHPNAAKLIGFSTENGFH--LVLQFLPHGSLSSLLFGSTEC---LEWTI 242
           F +E+ +++   H N  +L GF         LV  ++ +GS++S L    E    L+W  
Sbjct: 74  FQTEVEMISMAVHRNLLRLRGFCMT-PTERLLVYPYMANGSVASCLRERPESQPPLDWPK 132

Query: 243 RYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSHHI 302
           R +IALG A GL YLH  C  +IIHRD+KA+NILL E++EA + DFGLAK +    + H+
Sbjct: 133 RQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDT-HV 191

Query: 303 VFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRR------QSLVIW 356
              + GT G+++PEY   G   EKTDVF +GV+LLELITG+RA D  R        L+ W
Sbjct: 192 TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDW 251

Query: 357 AKPLLQTSNFKELVDPRLADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQLLRGEG 415
            K LL+    + LVD  L   Y   E+++ +  A +C       RP+M+ V+++L G+G
Sbjct: 252 VKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDG 310

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score =  333 bits (856), Expect = e-112
 Identities = 105/308 (34%), Positives = 159/308 (51%), Gaps = 22/308 (7%)

Query: 116 ADDGGSVPIVRHSWKNFDFAELAAATDNFNSENLIGKGGHAEVYKGCLPDGEVVAVKKII 175
            D   S  +V          +L  AT+NF+ + LIG G   +VYKG L DG  VA+K+  
Sbjct: 13  NDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRT 72

Query: 176 KN----AKEDEERISDFLSELGIVAHINHPNAAKLIGFSTENGFH-LVLQFLPHGSLSSL 230
                  +E       F +E+  ++   HP+   LIGF  E     L+ +++ +G+L   
Sbjct: 73  PESSQGIEE-------FETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRH 125

Query: 231 LFGS---TECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISD 287
           L+GS   T  + W  R +I +G A GL YLH      IIHRD+K+ NILL E++  +I+D
Sbjct: 126 LYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITD 182

Query: 288 FGLAKWLPDNWSHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVD 347
           FG++K   +    H+   ++GT GY+ PEYF+ G + EK+DV++FGV+L E++  R A+ 
Sbjct: 183 FGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIV 242

Query: 348 SRR----QSLVIWAKPLLQTSNFKELVDPRLADAYDLAEMKRAMLTASVCIHHLSTMRPQ 403
                   +L  WA         +++VDP LAD      +++   TA  C+   S  RP 
Sbjct: 243 QSLPREMVNLAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPS 302

Query: 404 MTRVLQLL 411
           M  VL  L
Sbjct: 303 MGDVLWKL 310

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score =  330 bits (848), Expect = e-111
 Identities = 104/311 (33%), Positives = 161/311 (51%), Gaps = 27/311 (8%)

Query: 118 DGGSVPIVRHSWKNFDFAELAAATDNFNSE------NLIGKGGHAEVYKGCLPDGEVVAV 171
           +  S+ +    + +F F EL   T+NF+        N +G+GG   VYKG + +   VAV
Sbjct: 1   ENKSLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAV 59

Query: 172 KKIIKNAKE-----DEERISDFLSELGIVAHINHPNAAKLIGFSTENGFH-LVLQFLPHG 225
           KK+            ++    F  E+ ++A   H N  +L+GFS++     LV  ++P+G
Sbjct: 60  KKLAAMVDITTEELKQQ----FDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNG 115

Query: 226 SLSSLLFGSTEC--LEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEA 283
           SL   L        L W +R KIA G A G+ +LH +     IHRDIK++NILL E + A
Sbjct: 116 SLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTA 172

Query: 284 QISDFGLAKWLPDNWSHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGR 343
           +ISDFGLA+         +   I GT  Y++PE  + G +  K+D+++FGV+LLE+ITG 
Sbjct: 173 KISDFGLARASEKFAQTVMTSRIVGTTAYMAPEA-LRGEITPKSDIYSFGVVLLEIITGL 231

Query: 344 RAVDSRR--QSLVIWAKPLLQTS-NFKELVDPRLADAYDLAEMKRAMLTASVCIHHLSTM 400
            AVD  R  Q L+   + +       ++ +D ++ D  D   ++     AS C+H     
Sbjct: 232 PAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMND-ADSTSVEAMYSVASQCLHEKKNK 290

Query: 401 RPQMTRVLQLL 411
           RP + +V QLL
Sbjct: 291 RPDIKKVQQLL 301

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  221 bits (564), Expect = 8e-69
 Identities = 75/308 (24%), Positives = 108/308 (35%), Gaps = 34/308 (11%)

Query: 131 NFDFAELAAATDNFNSENLIGKGGHAEVYKGCLPDGEVVAVKKIIKNAKEDEERISDFLS 190
           +     L   +       +  +G    V+K      E VAVK      K+  +       
Sbjct: 13  DLGTENLYFQSMPLQLLEVKARGRFGCVWKAQ-LLNEYVAVKIFPIQDKQSWQ----NEY 67

Query: 191 ELGIVAHINHPNAAKLIGFSTENGFH-----LVLQFLPHGSLSSLLFGSTECLEWTIRYK 245
           E+  +  + H N  + IG             L+  F   GSLS  L  +   + W     
Sbjct: 68  EVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKANV--VSWNELCH 125

Query: 246 IALGIAEGLQYLHHDCHR-------RIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNW 298
           IA  +A GL YLH D           I HRDIK+ N+LL  +  A I+DFGLA       
Sbjct: 126 IAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGK 185

Query: 299 SHHIVFPIEGTFGYLSPEYFMHGI-----VDEKTDVFAFGVLLLELITGRRAVDSRRQSL 353
           S        GT  Y++PE     I        + D++A G++L EL +   A D      
Sbjct: 186 SAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEY 245

Query: 354 ------VIWAKPLL---QTSNFKELVDPRLADAYDLAEMKRAML-TASVCIHHLSTMRPQ 403
                  I   P L   Q     +   P L D +        +  T   C  H +  R  
Sbjct: 246 MLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLS 305

Query: 404 MTRVLQLL 411
              V + +
Sbjct: 306 AGCVGERI 313

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  184 bits (470), Expect = 3e-55
 Identities = 68/237 (28%), Positives = 117/237 (49%), Gaps = 26/237 (10%)

Query: 120 GSVPIVRHSWKNFDFAELAAATDNFNSENLIGKGGHAEVYKG-CLPDGEVVAVKKIIKNA 178
           G     +         E+         E  IGKGG   V+KG  + D  VVA+K +I   
Sbjct: 4   GGSEFPKSRLPTLADNEI-------EYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGD 56

Query: 179 KEDE----ERISDFLSELGIVAHINHPNAAKLIGFSTENGFHLVLQFLPHGSLSSLLFGS 234
            E E    E+  +F  E+ I++++NHPN  KL G    N   +V++F+P G L   L   
Sbjct: 57  SEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMH-NPPRMVMEFVPCGDLYHRLLDK 115

Query: 235 TECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYE-----AQISDFG 289
              ++W+++ ++ L IA G++Y+ +  +  I+HRD+++ NI L    E     A+++DFG
Sbjct: 116 AHPIKWSVKLRLMLDIALGIEYMQN-QNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFG 174

Query: 290 LAKWLPDNWSHHIVFPIEGTFGYLSPEYFM--HGIVDEKTDVFAFGVLLLELITGRR 344
           L++    + S  +     G F +++PE          EK D ++F ++L  ++TG  
Sbjct: 175 LSQQSVHSVSGLL-----GNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEG 226

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  182 bits (463), Expect = 5e-54
 Identities = 61/201 (30%), Positives = 100/201 (49%), Gaps = 15/201 (7%)

Query: 147 ENLIGKGGHAEVYKGCLPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKL 206
           E ++G+G    V K      + VA+K+I     E E     F+ EL  ++ +NHPN  KL
Sbjct: 13  EEVVGRGAFGVVCKAKW-RAKDVAIKQI-----ESESERKAFIVELRQLSRVNHPNIVKL 66

Query: 207 IGFSTENGFHLVLQFLPHGSLSSLLFGS--TECLEWTIRYKIALGIAEGLQYLHHDCHRR 264
            G        LV+++   GSL ++L G+               L  ++G+ YLH    + 
Sbjct: 67  YGACLNP-VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKA 125

Query: 265 IIHRDIKASNILLSEDYE-AQISDFGLAKWLPDNWSHHIVFPIEGTFGYLSPEYFMHGIV 323
           +IHRD+K  N+LL       +I DFG A  +  + +++      G+  +++PE F     
Sbjct: 126 LIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMTNNK-----GSAAWMAPEVFEGSNY 180

Query: 324 DEKTDVFAFGVLLLELITGRR 344
            EK DVF++G++L E+IT R+
Sbjct: 181 SEKCDVFSWGIILWEVITRRK 201

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  178 bits (454), Expect = 2e-52
 Identities = 72/320 (22%), Positives = 123/320 (38%), Gaps = 49/320 (15%)

Query: 132 FDFAELAAATDNFNSENLIGKGGHAEVYKGCLPDGEVVAVKKIIKNAKEDEERISDFLSE 191
              +E +   DN     LIG+G +  VYKG L D   VAVK      +++      F++E
Sbjct: 3   AAASEPSLDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANRQN------FINE 55

Query: 192 LGI--VAHINHPNAAKLIGFSTENGFH------LVLQFLPHGSLSSLLFGSTECLEWTIR 243
             I  V  + H N A+ I               LV+++ P+GSL   L   T   +W   
Sbjct: 56  KNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHT--SDWVSS 113

Query: 244 YKIALGIAEGLQYLHHD------CHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDN 297
            ++A  +  GL YLH +          I HRD+ + N+L+  D    ISDFGL+  L  N
Sbjct: 114 CRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGN 173

Query: 298 WSHHIVFPIE------GTFGYLSPEYFMHGI-------VDEKTDVFAFGVLLLELITGRR 344
                           GT  Y++PE     +         ++ D++A G++  E+     
Sbjct: 174 RLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCT 233

Query: 345 AV---DSRRQSLVIWAKPLLQTSNFKELVD--------PRLADAYDLAEMKRAML--TAS 391
            +   +S  +  + +   +     F+++          P+  +A+    +    L  T  
Sbjct: 234 DLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIE 293

Query: 392 VCIHHLSTMRPQMTRVLQLL 411
            C    +  R       + +
Sbjct: 294 DCWDQDAEARLTAQXAEERM 313

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  177 bits (452), Expect = 2e-52
 Identities = 62/213 (29%), Positives = 103/213 (48%), Gaps = 20/213 (9%)

Query: 147 ENLIGKGGHAEVYKG-CLPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAK 205
             ++GKG   +  K      GEV+ +K++I+    DEE    FL E+ ++  + HPN  K
Sbjct: 15  GEVLGKGCFGQAIKVTHRETGEVMVMKELIR---FDEETQRTFLKEVKVMRCLEHPNVLK 71

Query: 206 LIGFSTENG-FHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRR 264
            IG   ++   + + +++  G+L  ++        W+ R   A  IA G+ YLH      
Sbjct: 72  FIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHS---MN 128

Query: 265 IIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWS-----HHIVFPIE-------GTFGY 312
           IIHRD+ + N L+ E+    ++DFGLA+ + D  +       +  P         G   +
Sbjct: 129 IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYW 188

Query: 313 LSPEYFMHGIVDEKTDVFAFGVLLLELITGRRA 345
           ++PE       DEK DVF+FG++L E+I    A
Sbjct: 189 MAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNA 221

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  177 bits (450), Expect = 4e-52
 Identities = 63/200 (31%), Positives = 107/200 (53%), Gaps = 8/200 (4%)

Query: 147 ENLIGKGGHAEVYKGCLPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKL 206
           +  IG G    V++     G  VAVK +        ER+++FL E+ I+  + HPN    
Sbjct: 42  KEKIGAGSFGTVHRAEW-HGSDVAVKIL-MEQDFHAERVNEFLREVAIMKRLRHPNIVLF 99

Query: 207 IGFSTENG-FHLVLQFLPHGSLSSLLF--GSTECLEWTIRYKIALGIAEGLQYLHHDCHR 263
           +G  T+     +V ++L  GSL  LL   G+ E L+   R  +A  +A+G+ YLH+  + 
Sbjct: 100 MGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHN-RNP 158

Query: 264 RIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEGTFGYLSPEYFMHGIV 323
            I+HR++K+ N+L+ + Y  ++ DFGL++     +         GT  +++PE       
Sbjct: 159 PIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAA--GTPEWMAPEVLRDEPS 216

Query: 324 DEKTDVFAFGVLLLELITGR 343
           +EK+DV++FGV+L EL T +
Sbjct: 217 NEKSDVYSFGVILWELATLQ 236

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  174 bits (443), Expect = 1e-51
 Identities = 68/207 (32%), Positives = 103/207 (49%), Gaps = 17/207 (8%)

Query: 147 ENLIGKGGHAEVYKGCLPDGEVVAVKKIIKNAKED-EERISDFLSELGIVAHINHPNAAK 205
           E +IG GG  +VY+     G+ VAVK    +  ED  + I +   E  + A + HPN   
Sbjct: 12  EEIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIA 70

Query: 206 LIGFSTENG-FHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRR 264
           L G   +     LV++F   G L+ +L G    +   I    A+ IA G+ YLH +    
Sbjct: 71  LRGVCLKEPNLCLVMEFARGGPLNRVLSGKR--IPPDILVNWAVQIARGMNYLHDEAIVP 128

Query: 265 IIHRDIKASNILLSEDYEAQ--------ISDFGLAKWLPDNWSHHIVFPIEGTFGYLSPE 316
           IIHRD+K+SNIL+ +  E          I+DFGLA+     W         G + +++PE
Sbjct: 129 IIHRDLKSSNILILQKVENGDLSNKILKITDFGLAR----EWHRTTKMSAAGAYAWMAPE 184

Query: 317 YFMHGIVDEKTDVFAFGVLLLELITGR 343
                +  + +DV+++GVLL EL+TG 
Sbjct: 185 VIRASMFSKGSDVWSYGVLLWELLTGE 211

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  169 bits (429), Expect = 3e-49
 Identities = 78/275 (28%), Positives = 118/275 (42%), Gaps = 34/275 (12%)

Query: 150 IGKGGHAEVYKGCLPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGF 209
           IG G    VYKG    G+V AVK +        +++  F +E+G++    H N    +G+
Sbjct: 32  IGSGSFGTVYKGKW-HGDV-AVKML-NVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 88

Query: 210 STENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRD 269
           ST     +V Q+    SL   L  S    E      IA   A G+ YLH    + IIHRD
Sbjct: 89  STAPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLH---AKSIIHRD 145

Query: 270 IKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEGTFGYLSPE---YFMHGIVDEK 326
           +K++NI L ED   +I DFGLA         H    + G+  +++PE            +
Sbjct: 146 LKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQ 205

Query: 327 TDVFAFGVLLLELITGR---RAVDSRRQSLVIWA------KPLLQTSNFKELVDPRLADA 377
           +DV+AFG++L EL+TG+     +++R Q  +I         P L  S  +     R+   
Sbjct: 206 SDVYAFGIVLYELMTGQLPYSNINNRDQ--IIEMVGRGSLSPDL--SKVRSNCPKRMKRL 261

Query: 378 YDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQLLR 412
                M         C+      RP   R+L  + 
Sbjct: 262 -----MAE-------CLKKKRDERPSFPRILAEIE 284

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  165 bits (420), Expect = 4e-48
 Identities = 44/204 (21%), Positives = 84/204 (41%), Gaps = 17/204 (8%)

Query: 147 ENLIGKGGHAEVYKGCLPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKL 206
              + +    E++KG    G  + VK ++K       +  DF  E   +   +HPN   +
Sbjct: 15  LTKLNENHSGELWKGRW-QGNDIVVK-VLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPV 72

Query: 207 IGFSTE---NGFHLVLQFLPHGSLSSLLF-GSTECLEWTIRYKIALGIAEGLQYLHHDCH 262
           +G           L+  ++P+GSL ++L  G+   ++ +   K AL +A G+ +LH    
Sbjct: 73  LGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHT-LE 131

Query: 263 RRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEGTFGYLSPEYFMH-- 320
             I    + + ++++ ED  A+IS   +                     +++PE      
Sbjct: 132 PLIPRHALNSRSVMIDEDMTARISMADVKFSFQSP-------GRMYAPAWVAPEALQKKP 184

Query: 321 -GIVDEKTDVFAFGVLLLELITGR 343
                   D+++F VLL EL+T  
Sbjct: 185 EDTNRRSADMWSFAVLLWELVTRE 208

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  161 bits (409), Expect = 5e-46
 Identities = 61/285 (21%), Positives = 109/285 (38%), Gaps = 43/285 (15%)

Query: 147 ENLIGKGGHAEVYKGCLPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKL 206
             LIGKG   +VY G    GEV A++ I    +++E+++  F  E+       H N    
Sbjct: 38  GELIGKGRFGQVYHGRW-HGEV-AIRLI-DIERDNEDQLKAFKREVMAYRQTRHENVVLF 94

Query: 207 IGFSTENG-FHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRI 265
           +G         ++       +L S++  +   L+     +IA  I +G+ YLH    + I
Sbjct: 95  MGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLH---AKGI 151

Query: 266 IHRDIKASNILLSEDYEAQISDFGLAK----WLPDNWSHHIVFPIEGTFGYLSPEYFMHG 321
           +H+D+K+ N+   ++ +  I+DFGL               +     G   +L+PE     
Sbjct: 152 LHKDLKSKNVFY-DNGKVVITDFGLFSISGVLQAGRREDKLRIQN-GWLCHLAPEIIRQL 209

Query: 322 IV---------DEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWA-----KPLLQTSNFK 367
                       + +DVFA G +  EL        ++    +IW      KP L      
Sbjct: 210 SPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGMKPNLSQIG-- 267

Query: 368 ELVDPRLADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQLLR 412
             +   ++D      +         C       RP  T+++ +L 
Sbjct: 268 --MGKEISDI-----LLF-------CWAFEQEERPTFTKLMDMLE 298

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  153 bits (389), Expect = 4e-43
 Identities = 67/302 (22%), Positives = 114/302 (37%), Gaps = 34/302 (11%)

Query: 147 ENLIGKGGHAEVYKGCLPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKL 206
              IGKG + EV+ G    GE VAVK      +    R     +E+     + H N    
Sbjct: 42  VKQIGKGRYGEVWMGKW-RGEKVAVKVFFTTEEASWFR----ETEIYQTVLMRHENILGF 96

Query: 207 IGFSTENGFH-----LVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDC 261
           I    +         L+  +  +GSL   L   +  L+     K+A     GL +LH + 
Sbjct: 97  IAADIKGTGSWTQLYLITDYHENGSLYDYL--KSTTLDAKSMLKLAYSSVSGLCHLHTEI 154

Query: 262 HRR-----IIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIE--GTFGYLS 314
                   I HRD+K+ NIL+ ++    I+D GLA     + +   + P    GT  Y+ 
Sbjct: 155 FSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMP 214

Query: 315 PE------YFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSNFKE 368
           PE         H       D+++FG++L E+     +     +  + +   +    ++++
Sbjct: 215 PEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYED 274

Query: 369 LVD--------PRLADAYDLAEMKRAML-TASVCIHHLSTMRPQMTRVLQLLRGEGGQTD 419
           + +        P   + +   E  R M    + C  H    R    RV + L       D
Sbjct: 275 MREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSESQD 334

Query: 420 LK 421
           +K
Sbjct: 335 IK 336

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  153 bits (389), Expect = 6e-43
 Identities = 66/295 (22%), Positives = 107/295 (36%), Gaps = 38/295 (12%)

Query: 147 ENLIGKGGHAEVYKGCLPDGEVVAVKKIIKNAKEDEERISDFLSELGI--VAHINHPNAA 204
           +  IGKG   EV++G    GE VAVK               +  E  I     + H N  
Sbjct: 47  QESIGKGRFGEVWRGKW-RGEEVAVKIF------SSREERSWFREAEIYQTVMLRHENIL 99

Query: 205 KLIGFSTENGFH-----LVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHH 259
             I    ++        LV  +  HGSL   L  +   +      K+AL  A GL +LH 
Sbjct: 100 GFIAADNKDNGTWTQLWLVSDYHEHGSLFDYL--NRYTVTVEGMIKLALSTASGLAHLHM 157

Query: 260 DCHRR-----IIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIE--GTFGY 312
           +         I HRD+K+ NIL+ ++    I+D GLA           + P    GT  Y
Sbjct: 158 EIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRY 217

Query: 313 LSPE------YFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSNF 366
           ++PE         H    ++ D++A G++  E+              + +   +    + 
Sbjct: 218 MAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSV 277

Query: 367 KELVD--------PRLADAYDLAEMKRAML-TASVCIHHLSTMRPQMTRVLQLLR 412
           +E+          P + + +   E  R M      C +     R    R+ + L 
Sbjct: 278 EEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLS 332

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  150 bits (382), Expect = 3e-42
 Identities = 65/296 (21%), Positives = 114/296 (38%), Gaps = 42/296 (14%)

Query: 147 ENLIGKGGHAEVYKGCLPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKL 206
              +GKG + EV++G    GE VAVK      ++   R     +EL     + H N    
Sbjct: 13  LECVGKGRYGEVWRGSW-QGENVAVKIFSSRDEKSWFR----ETELYNTVMLRHENILGF 67

Query: 207 IGFSTENGFH-----LVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDC 261
           I     +        L+  +   GSL   L      L+     +I L IA GL +LH + 
Sbjct: 68  IASDMTSRHSSTQLWLITHYHEMGSLYDYL--QLTTLDTVSCLRIVLSIASGLAHLHIEI 125

Query: 262 HRR-----IIHRDIKASNILLSEDYEAQISDFGLAKWLP------DNWSHHIVFPIEGTF 310
                   I HRD+K+ NIL+ ++ +  I+D GLA          D  ++  V    GT 
Sbjct: 126 FGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRV----GTK 181

Query: 311 GYLSPEYFMHGIV------DEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTS 364
            Y++PE     I        ++ D++AFG++L E+     +          +   +    
Sbjct: 182 RYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDP 241

Query: 365 NFKELVD--------PRLADAYDLAEMKRAML-TASVCIHHLSTMRPQMTRVLQLL 411
           +F+++          P + + +       ++      C +   + R    R+ + L
Sbjct: 242 SFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTL 297

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  142 bits (361), Expect = 2e-38
 Identities = 56/206 (27%), Positives = 95/206 (46%), Gaps = 15/206 (7%)

Query: 142 DNFNSENLIGKGGHAEVYKGCLPDGEV-VAVKKIIKNAKEDEERISDFLSELGIVAHINH 200
           ++      IG+G   EV+ G L      VAVK   +     + +   FL E  I+   +H
Sbjct: 114 EDLVLGEQIGRGNFGEVFSGRLRADNTLVAVK-SCRETLPPDLKA-KFLQEARILKQYSH 171

Query: 201 PNAAKLIGFSTENG-FHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHH 259
           PN  +LIG  T+    ++V++ +  G   + L      L      ++    A G++YL  
Sbjct: 172 PNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLES 231

Query: 260 DCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNW----SHHIVFPIEGTFGYLSP 315
              +  IHRD+ A N L++E    +ISDFG+++   D            P++ T    +P
Sbjct: 232 ---KCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWT----AP 284

Query: 316 EYFMHGIVDEKTDVFAFGVLLLELIT 341
           E   +G    ++DV++FG+LL E  +
Sbjct: 285 EALNYGRYSSESDVWSFGILLWETFS 310

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score =  140 bits (355), Expect = 2e-38
 Identities = 62/233 (26%), Positives = 104/233 (44%), Gaps = 23/233 (9%)

Query: 147 ENLIGKGGHAEVYKGCLP-----DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHP 201
              +G+G   +V            GE VAVK +   +  +     D   E+ I+ ++ H 
Sbjct: 26  IRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIA--DLKKEIEILRNLYHE 83

Query: 202 NAAKLIGFSTENGFH---LVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLH 258
           N  K  G  TE+G +   L+++FLP GSL   L  +   +    + K A+ I +G+ YL 
Sbjct: 84  NIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLG 143

Query: 259 HDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSHHIV-----FPIEGTFGYL 313
               R+ +HRD+ A N+L+  +++ +I DFGL K +  +  ++ V      P+       
Sbjct: 144 S---RQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWY---- 196

Query: 314 SPEYFMHGIVDEKTDVFAFGVLLLELIT-GRRAVDSRRQSLVIWAKPLLQTSN 365
           +PE  M       +DV++FGV L EL+T            L +      Q + 
Sbjct: 197 APECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTV 249

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score =  140 bits (355), Expect = 3e-38
 Identities = 58/208 (27%), Positives = 102/208 (49%), Gaps = 19/208 (9%)

Query: 147 ENLIGKGGHAEVYKGCL-PDGE----VVAVKKIIKNAKEDEERISDFLSELGIVAHINHP 201
             ++G G    VYKG   P+GE     VA+K  ++ A   +    + L E  ++A +++P
Sbjct: 20  IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIK-ELREATSPKAN-KEILDEAYVMASVDNP 77

Query: 202 NAAKLIGFSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDC 261
           +  +L+G    +   L+ Q +P G L   +    + +         + IA+G+ YL    
Sbjct: 78  HVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED-- 135

Query: 262 HRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSHHIV----FPIEGTFGYLSPEY 317
            RR++HRD+ A N+L+      +I+DFGLAK L      +       PI+      + E 
Sbjct: 136 -RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM----ALES 190

Query: 318 FMHGIVDEKTDVFAFGVLLLELIT-GRR 344
            +H I   ++DV+++GV + EL+T G +
Sbjct: 191 ILHRIYTHQSDVWSYGVTVWELMTFGSK 218

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score =  138 bits (349), Expect = 1e-37
 Identities = 65/209 (31%), Positives = 94/209 (44%), Gaps = 25/209 (11%)

Query: 147 ENLIGKGGHAEVYKGCLP-----DGEVVAVKKIIKNAKED-EERISDFLSELGIVAHINH 200
              +GKG    V            GEVVAVKK+    +   EE + DF  E+ I+  + H
Sbjct: 15  LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKL----QHSTEEHLRDFEREIEILKSLQH 70

Query: 201 PNAAKLIGFSTENGFH---LVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYL 257
            N  K  G     G     L++++LP+GSL   L    E ++     +    I +G++YL
Sbjct: 71  DNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYL 130

Query: 258 HHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSHHIV-----FPIEGTFGY 312
                +R IHRD+   NIL+  +   +I DFGL K LP +     V      PI      
Sbjct: 131 GT---KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWY--- 184

Query: 313 LSPEYFMHGIVDEKTDVFAFGVLLLELIT 341
            +PE          +DV++FGV+L EL T
Sbjct: 185 -APESLTESKFSVASDVWSFGVVLYELFT 212

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score =  138 bits (350), Expect = 1e-37
 Identities = 64/228 (28%), Positives = 100/228 (43%), Gaps = 33/228 (14%)

Query: 150 IGKGGHAEVYKGCL-----PDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAA 204
           +G+G   +V   C        GE+VAVK +  +A         +  E+ I+  + H +  
Sbjct: 39  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRS--GWKQEIDILRTLYHEHII 96

Query: 205 KLIGFSTENGFH---LVLQFLPHGSLSSLL----FGSTECLEWTIRYKIALGIAEGLQYL 257
           K  G   + G     LV++++P GSL   L     G  + L +      A  I EG+ YL
Sbjct: 97  KYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHSIGLAQLLLF------AQQICEGMAYL 150

Query: 258 HHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSHHIV-----FPIEGTFGY 312
           H    +  IHRD+ A N+LL  D   +I DFGLAK +P+   ++ V      P+      
Sbjct: 151 HA---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWY--- 204

Query: 313 LSPEYFMHGIVDEKTDVFAFGVLLLELIT-GRRAVDSRRQSLVIWAKP 359
            +PE          +DV++FGV L EL+T    +     + L +    
Sbjct: 205 -APECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIA 251

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score =  138 bits (349), Expect = 2e-37
 Identities = 65/208 (31%), Positives = 98/208 (47%), Gaps = 23/208 (11%)

Query: 147 ENLIGKGGHAEVYKGCLP-----DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHP 201
              +GKG    V            GEVVAVKK+ +++ E+  R  DF  E+ I+  + H 
Sbjct: 46  LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKL-QHSTEEHLR--DFEREIEILKSLQHD 102

Query: 202 NAAKLIGFSTENGFH---LVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLH 258
           N  K  G     G     L++++LP+GSL   L    E ++     +    I +G++YL 
Sbjct: 103 NIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG 162

Query: 259 HDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSHHIV-----FPIEGTFGYL 313
               +R IHRD+   NIL+  +   +I DFGL K LP +  ++ V      PI       
Sbjct: 163 T---KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWY---- 215

Query: 314 SPEYFMHGIVDEKTDVFAFGVLLLELIT 341
           +PE          +DV++FGV+L EL T
Sbjct: 216 APESLTESKFSVASDVWSFGVVLYELFT 243

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score =  136 bits (345), Expect = 4e-37
 Identities = 59/208 (28%), Positives = 88/208 (42%), Gaps = 17/208 (8%)

Query: 147 ENLIGKGGHAEVYKGCL--PDGEV--VAVKKIIKNAKEDEERISDFLSELGIVAHINHPN 202
              +G G    V +G    P G+   VAVK +  +     E + DF+ E+  +  ++H N
Sbjct: 23  LEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRN 82

Query: 203 AAKLIGFSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCH 262
             +L G        +V +  P GSL   L             + A+ +AEG+ YL     
Sbjct: 83  LIRLYGVVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLE---S 139

Query: 263 RRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDN-----WSHHIVFPIEGTFGYLSPEY 317
           +R IHRD+ A N+LL+     +I DFGL + LP N        H   P        +PE 
Sbjct: 140 KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWC----APES 195

Query: 318 FMHGIVDEKTDVFAFGVLLLELIT-GRR 344
                    +D + FGV L E+ T G+ 
Sbjct: 196 LKTRTFSHASDTWMFGVTLWEMFTYGQE 223

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  137 bits (346), Expect = 5e-37
 Identities = 63/212 (29%), Positives = 107/212 (50%), Gaps = 16/212 (7%)

Query: 142 DNFNSENLIGKGGHAEVYKG-CLPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINH 200
            NF  E  IG+G  +EVY+  CL DG  VA+KK+      D +  +D + E+ ++  +NH
Sbjct: 32  ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91

Query: 201 PNAAKLIG-FSTENGFHLVLQFLPHGSLSSLL--FGSTECL--EWTIRYKIALGIAEGLQ 255
           PN  K    F  +N  ++VL+    G LS ++  F   + L  E T+  K  + +   L+
Sbjct: 92  PNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVW-KYFVQLCSALE 150

Query: 256 YLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFP--IEGTFGYL 313
           ++H    RR++HRDIK +N+ ++     ++ D GL ++     S        + GT  Y+
Sbjct: 151 HMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFF----SSKTTAAHSLVGTPYYM 203

Query: 314 SPEYFMHGIVDEKTDVFAFGVLLLELITGRRA 345
           SPE       + K+D+++ G LL E+   +  
Sbjct: 204 SPERIHENGYNFKSDIWSLGCLLYEMAALQSP 235

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score =  135 bits (342), Expect = 1e-36
 Identities = 50/207 (24%), Positives = 98/207 (47%), Gaps = 18/207 (8%)

Query: 147 ENLIGKGGHAEVYKGCL--PDGEV-VAVKKIIKNAKEDEERISDFLSELGIVAHINHPNA 203
           +  +G G    V +G       ++ VA+K ++K   E  +   + + E  I+  +++P  
Sbjct: 15  DIELGCGNFGSVRQGVYRMRKKQIDVAIK-VLKQGTEKADT-EEMMREAQIMHQLDNPYI 72

Query: 204 AKLIGFSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHR 263
            +LIG        LV++    G L   L G  E +  +   ++   ++ G++YL     +
Sbjct: 73  VRLIGVCQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYL---EEK 129

Query: 264 RIIHRDIKASNILLSEDYEAQISDFGLAKWLPDN-----WSHHIVFPIEGTFGYLSPEYF 318
             +HRD+ A N+LL   + A+ISDFGL+K L  +           +P++      +PE  
Sbjct: 130 NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWY----APECI 185

Query: 319 MHGIVDEKTDVFAFGVLLLELIT-GRR 344
                  ++DV+++GV + E ++ G++
Sbjct: 186 NFRKFSSRSDVWSYGVTMWEALSYGQK 212

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  135 bits (341), Expect = 2e-36
 Identities = 54/226 (23%), Positives = 93/226 (41%), Gaps = 31/226 (13%)

Query: 142 DNFNSENLIGKGGHAEVYKG-CLPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINH 200
            +F     +G+GG   V++     D    A+K+I    +E        + E+  +A + H
Sbjct: 5   TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELARE--KVMREVKALAKLEH 62

Query: 201 PN-------------AAKLIGFSTENGFHLVLQFLPHGSLSSLLF--GSTECLEWTIRYK 245
           P                KL   S +   ++ +Q     +L   +    + E  E ++   
Sbjct: 63  PGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLH 122

Query: 246 IALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFP 305
           I L IAE +++LH    + ++HRD+K SNI  + D   ++ DFGL   +  +     V  
Sbjct: 123 IFLQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLT 179

Query: 306 IE----------GTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELIT 341
                       GT  Y+SPE         K D+F+ G++L EL+ 
Sbjct: 180 PMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY 225

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score =  138 bits (349), Expect = 2e-36
 Identities = 61/204 (29%), Positives = 101/204 (49%), Gaps = 15/204 (7%)

Query: 142 DNFNSENLIGKGGHAEVYKGCLPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHP 201
           ++   E  +G+G   EV+ G       VA+K +    K        FL E  ++  + H 
Sbjct: 184 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL----KPGTMSPEAFLQEAQVMKKLRHE 239

Query: 202 NAAKLIGFSTENGFHLVLQFLPHGSLSSLLFGST-ECLEWTIRYKIALGIAEGLQYLHHD 260
              +L    +E   ++V +++  GSL   L G T + L       +A  IA G+ Y+   
Sbjct: 240 KLVQLYAVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER- 298

Query: 261 CHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDN---WSHHIVFPIEGTFGYLSPEY 317
                +HRD++A+NIL+ E+   +++DFGLA+ + DN         FPI+ T    +PE 
Sbjct: 299 --MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWT----APEA 352

Query: 318 FMHGIVDEKTDVFAFGVLLLELIT 341
            ++G    K+DV++FG+LL EL T
Sbjct: 353 ALYGRFTIKSDVWSFGILLTELTT 376

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score =  135 bits (342), Expect = 3e-36
 Identities = 58/205 (28%), Positives = 101/205 (49%), Gaps = 19/205 (9%)

Query: 150 IGKGGHAEVYKGCL-PDGE----VVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAA 204
           +G G    VYKG   P+GE     VA+K  ++ A   +    + L E  ++A +++P+  
Sbjct: 23  LGSGAFGTVYKGLWIPEGEKVKIPVAIK-ELREATSPKAN-KEILDEAYVMASVDNPHVC 80

Query: 205 KLIGFSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRR 264
           +L+G    +   L+ Q +P G L   +    + +         + IA+G+ YL     RR
Sbjct: 81  RLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED---RR 137

Query: 265 IIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSHHIV----FPIEGTFGYLSPEYFMH 320
           ++HRD+ A N+L+      +I+DFGLAK L      +       PI+      + E  +H
Sbjct: 138 LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM----ALESILH 193

Query: 321 GIVDEKTDVFAFGVLLLELIT-GRR 344
            I   ++DV+++GV + EL+T G +
Sbjct: 194 RIYTHQSDVWSYGVTVWELMTFGSK 218

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score =  135 bits (341), Expect = 3e-36
 Identities = 53/208 (25%), Positives = 95/208 (45%), Gaps = 19/208 (9%)

Query: 147 ENLIGKGGHAEVYKGCL-PDGE----VVAVKKIIKNAKEDEERISDFLSELGIVAHINHP 201
             ++G G    V+KG   P+GE     V +K +I++    +         +  +  ++H 
Sbjct: 18  LKVLGSGVFGTVHKGVWIPEGESIKIPVCIK-VIEDKSGRQSF-QAVTDHMLAIGSLDHA 75

Query: 202 NAAKLIGFSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDC 261
           +  +L+G    +   LV Q+LP GSL   +      L   +     + IA+G+ YL    
Sbjct: 76  HIVRLLGLCPGSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEE-- 133

Query: 262 HRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDN----WSHHIVFPIEGTFGYLSPEY 317
              ++HR++ A N+LL    + Q++DFG+A  LP +           PI+      + E 
Sbjct: 134 -HGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWM----ALES 188

Query: 318 FMHGIVDEKTDVFAFGVLLLELIT-GRR 344
              G    ++DV+++GV + EL+T G  
Sbjct: 189 IHFGKYTHQSDVWSYGVTVWELMTFGAE 216

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score =  135 bits (341), Expect = 3e-36
 Identities = 64/208 (30%), Positives = 103/208 (49%), Gaps = 23/208 (11%)

Query: 147 ENLIGKGGHAEVYKGCLP-----DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHP 201
            + +GKG    V            G +VAVK++ +++  D++R  DF  E+ I+  ++  
Sbjct: 28  ISQLGKGNFGSVELCRYDPLGDNTGALVAVKQL-QHSGPDQQR--DFQREIQILKALHSD 84

Query: 202 NAAKLIGFSTENGFH---LVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLH 258
              K  G S   G     LV+++LP G L   L      L+ +     +  I +G++YL 
Sbjct: 85  FIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLG 144

Query: 259 HDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSHHIV-----FPIEGTFGYL 313
               RR +HRD+ A NIL+  +   +I+DFGLAK LP +  +++V      PI       
Sbjct: 145 S---RRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWY---- 197

Query: 314 SPEYFMHGIVDEKTDVFAFGVLLLELIT 341
           +PE     I   ++DV++FGV+L EL T
Sbjct: 198 APESLSDNIFSRQSDVWSFGVVLYELFT 225

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score =  138 bits (350), Expect = 5e-36
 Identities = 61/199 (30%), Positives = 99/199 (49%), Gaps = 15/199 (7%)

Query: 147 ENLIGKGGHAEVYKGCLPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKL 206
           E  +G+G   EV+ G       VA+K +    K        FL E  ++  + H    +L
Sbjct: 272 EVKLGQGCFGEVWMGTWNGTTRVAIKTL----KPGTMSPEAFLQEAQVMKKLRHEKLVQL 327

Query: 207 IGFSTENGFHLVLQFLPHGSLSSLLFGST-ECLEWTIRYKIALGIAEGLQYLHHDCHRRI 265
               +E   ++V +++  GSL   L G T + L       +A  IA G+ Y+        
Sbjct: 328 YAVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER---MNY 384

Query: 266 IHRDIKASNILLSEDYEAQISDFGLAKWLPDN---WSHHIVFPIEGTFGYLSPEYFMHGI 322
           +HRD++A+NIL+ E+   +++DFGLA+ + DN         FPI+ T    +PE  ++G 
Sbjct: 385 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWT----APEAALYGR 440

Query: 323 VDEKTDVFAFGVLLLELIT 341
              K+DV++FG+LL EL T
Sbjct: 441 FTIKSDVWSFGILLTELTT 459

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  133 bits (337), Expect = 8e-36
 Identities = 48/206 (23%), Positives = 83/206 (40%), Gaps = 14/206 (6%)

Query: 142 DNFNSENLIGKGGHAEVYKG-CLPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHI-N 199
            +F   + +G G + EV+K     DG + AVK+ +   +  ++R    L+E+G    +  
Sbjct: 57  QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRA-RKLAEVGSHEKVGQ 115

Query: 200 HPNAAKLIG-FSTENGFHLVLQFLPHGSLSSLLFGSTECL-EWTIRYKIALGIAEGLQYL 257
           HP   +L   +      +L  +     SL          L E  +           L +L
Sbjct: 116 HPCCVRLEQAWEEGGILYLQTELC-GPSLQQHCEAWGASLPEAQVW-GYLRDTLLALAHL 173

Query: 258 HHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEGTFGYLSPEY 317
           H    + ++H D+K +NI L      ++ DFGL   L    +  +    EG   Y++PE 
Sbjct: 174 HS---QGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQ---EGDPRYMAPEL 227

Query: 318 FMHGIVDEKTDVFAFGVLLLELITGR 343
                     DVF+ G+ +LE+    
Sbjct: 228 LQGSY-GTAADVFSLGLTILEVACNM 252

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score =  132 bits (333), Expect = 2e-35
 Identities = 58/207 (28%), Positives = 95/207 (45%), Gaps = 21/207 (10%)

Query: 147 ENLIGKGGHAEVYKGCLPDGE----VVAVKKIIKNAKEDEERISDFLSELGIVAHINHPN 202
             +IG+G    VY G L D +      AVK + +     E     FL+E  I+   +HPN
Sbjct: 30  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVS--QFLTEGIIMKDFSHPN 87

Query: 203 AAKLIGFSTENG--FHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHD 260
              L+G    +     +VL ++ HG L + +   T            L +A+G++YL   
Sbjct: 88  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLAS- 146

Query: 261 CHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDN------WSHHIVFPIEGTFGYLS 314
             ++ +HRD+ A N +L E +  +++DFGLA+ + D              P++      +
Sbjct: 147 --KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWM----A 200

Query: 315 PEYFMHGIVDEKTDVFAFGVLLLELIT 341
            E         K+DV++FGVLL EL+T
Sbjct: 201 LESLQTQKFTTKSDVWSFGVLLWELMT 227

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score =  135 bits (342), Expect = 2e-35
 Identities = 62/203 (30%), Positives = 97/203 (47%), Gaps = 16/203 (7%)

Query: 147 ENLIGKGGHAEVYKGCLPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKL 206
           E  +G G   EV+         VAVK +    K     +  FL+E  ++  + H    KL
Sbjct: 193 EKKLGAGQFGEVWMATYNKHTKVAVKTM----KPGSMSVEAFLAEANVMKTLQHDKLVKL 248

Query: 207 IGFSTENGFHLVLQFLPHGSLSSLLFGS-TECLEWTIRYKIALGIAEGLQYLHHDCHRRI 265
               T+   +++ +F+  GSL   L                +  IAEG+ ++     R  
Sbjct: 249 HAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQ---RNY 305

Query: 266 IHRDIKASNILLSEDYEAQISDFGLAKWLPDNW---SHHIVFPIEGTFGYLSPEYFMHGI 322
           IHRD++A+NIL+S     +I+DFGLA+ + DN         FPI+ T    +PE    G 
Sbjct: 306 IHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWT----APEAINFGS 361

Query: 323 VDEKTDVFAFGVLLLELIT-GRR 344
              K+DV++FG+LL+E++T GR 
Sbjct: 362 FTIKSDVWSFGILLMEIVTYGRI 384

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  133 bits (336), Expect = 2e-35
 Identities = 57/210 (27%), Positives = 97/210 (46%), Gaps = 15/210 (7%)

Query: 142 DNFNSENLIGKGGHAEVYKG-CLPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINH 200
           + +     IG+G   +        DG    +K+I  +    +ER  +   E+ ++A++ H
Sbjct: 24  EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKER-EESRREVAVLANMKH 82

Query: 201 PNAAKLIG-FSTENGFHLVLQFLPHGSLSSLLFGSTECL--EWTIRYKIALGIAEGLQYL 257
           PN  +    F      ++V+ +   G L   +      L  E  I     + I   L+++
Sbjct: 83  PNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQIL-DWFVQICLALKHV 141

Query: 258 HHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSHH--IVFPIEGTFGYLSP 315
           H    R+I+HRDIK+ NI L++D   Q+ DFG+A+ L          +    GT  YLSP
Sbjct: 142 HD---RKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACI----GTPYYLSP 194

Query: 316 EYFMHGIVDEKTDVFAFGVLLLELITGRRA 345
           E   +   + K+D++A G +L EL T + A
Sbjct: 195 EICENKPYNNKSDIWALGCVLYELCTLKHA 224

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score =  133 bits (336), Expect = 3e-35
 Identities = 57/207 (27%), Positives = 96/207 (46%), Gaps = 21/207 (10%)

Query: 147 ENLIGKGGHAEVYKGCLPDGE----VVAVKKIIKNAKEDEERISDFLSELGIVAHINHPN 202
             +IG+G    VY G L D +      AVK + +     E     FL+E  I+   +HPN
Sbjct: 94  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVS--QFLTEGIIMKDFSHPN 151

Query: 203 AAKLIGFSTENG--FHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHD 260
              L+G    +     +VL ++ HG L + +   T            L +A+G+++L   
Sbjct: 152 VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLAS- 210

Query: 261 CHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSHHIV------FPIEGTFGYLS 314
             ++ +HRD+ A N +L E +  +++DFGLA+ + D     +        P++      +
Sbjct: 211 --KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWM----A 264

Query: 315 PEYFMHGIVDEKTDVFAFGVLLLELIT 341
            E         K+DV++FGVLL EL+T
Sbjct: 265 LESLQTQKFTTKSDVWSFGVLLWELMT 291

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score =  130 bits (329), Expect = 5e-35
 Identities = 60/203 (29%), Positives = 96/203 (47%), Gaps = 16/203 (7%)

Query: 147 ENLIGKGGHAEVYKGCLPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKL 206
              IG G    V+ G   + + VA+K I    +E      DF+ E  ++  ++HP   +L
Sbjct: 13  VQEIGSGQFGLVHLGYWLNKDKVAIKTI----REGAMSEEDFIEEAEVMMKLSHPKLVQL 68

Query: 207 IGFSTENG-FHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRI 265
            G   E     LV +F+ HG LS  L              + L + EG+ YL       +
Sbjct: 69  YGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYL---EEACV 125

Query: 266 IHRDIKASNILLSEDYEAQISDFGLAKWLPDNW---SHHIVFPIEGTFGYLSPEYFMHGI 322
           IHRD+ A N L+ E+   ++SDFG+ +++ D+    S    FP++      SPE F    
Sbjct: 126 IHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWA----SPEVFSFSR 181

Query: 323 VDEKTDVFAFGVLLLELIT-GRR 344
              K+DV++FGVL+ E+ + G+ 
Sbjct: 182 YSSKSDVWSFGVLMWEVFSEGKI 204

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score =  130 bits (330), Expect = 6e-35
 Identities = 55/209 (26%), Positives = 97/209 (46%), Gaps = 28/209 (13%)

Query: 150 IGKGGHAEVYKGCL--PDGEV-VAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKL 206
           +G G    V KG          VAVK I+KN   D     + L+E  ++  +++P   ++
Sbjct: 25  LGSGNFGTVKKGYYQMKKVVKTVAVK-ILKNEANDPALKDELLAEANVMQQLDNPYIVRM 83

Query: 207 IGFSTENGFHLVLQFLPHGSLSSLL-----FGSTECLEWTIRYKIALGIAEGLQYLHHDC 261
           IG      + LV++    G L+  L           +E          ++ G++YL    
Sbjct: 84  IGICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIEL------VHQVSMGMKYLEE-- 135

Query: 262 HRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSHHIV-----FPIEGTFGYLSPE 316
               +HRD+ A N+LL   + A+ISDFGL+K L  + +++       +P++      +PE
Sbjct: 136 -SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWY----APE 190

Query: 317 YFMHGIVDEKTDVFAFGVLLLELIT-GRR 344
              +     K+DV++FGVL+ E  + G++
Sbjct: 191 CINYYKFSSKSDVWSFGVLMWEAFSYGQK 219

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score =  130 bits (329), Expect = 6e-35
 Identities = 63/204 (30%), Positives = 105/204 (51%), Gaps = 18/204 (8%)

Query: 147 ENLIGKGGHAEVYKGCLPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKL 206
              +G G   EV+ G       VAVK +    K+       FL+E  ++  + H    +L
Sbjct: 18  VERLGAGQFGEVWMGYYNGHTKVAVKSL----KQGSMSPDAFLAEANLMKQLQHQRLVRL 73

Query: 207 IGFSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIR--YKIALGIAEGLQYLHHDCHRR 264
               T+   +++ +++ +GSL   L  +   ++ TI     +A  IAEG+ ++     R 
Sbjct: 74  YAVVTQEPIYIITEYMENGSLVDFL-KTPSGIKLTINKLLDMAAQIAEGMAFIEE---RN 129

Query: 265 IIHRDIKASNILLSEDYEAQISDFGLAKWLPDN---WSHHIVFPIEGTFGYLSPEYFMHG 321
            IHRD++A+NIL+S+    +I+DFGLA+ + DN         FPI+ T    +PE   +G
Sbjct: 130 YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWT----APEAINYG 185

Query: 322 IVDEKTDVFAFGVLLLELIT-GRR 344
               K+DV++FG+LL E++T GR 
Sbjct: 186 TFTIKSDVWSFGILLTEIVTHGRI 209

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score =  134 bits (338), Expect = 1e-34
 Identities = 60/201 (29%), Positives = 106/201 (52%), Gaps = 17/201 (8%)

Query: 147 ENLIGKGGHAEVYKGCLPDGEV-VAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAK 205
           ++ +G G + EVY+G      + VAVK +    KED   + +FL E  ++  I HPN  +
Sbjct: 225 KHKLGGGQYGEVYEGVWKKYSLTVAVKTL----KEDTMEVEEFLKEAAVMKEIKHPNLVQ 280

Query: 206 LIGFSTENG-FHLVLQFLPHGSLSSLLFGST-ECLEWTIRYKIALGIAEGLQYLHHDCHR 263
           L+G  T    F+++ +F+ +G+L   L     + +   +   +A  I+  ++YL     +
Sbjct: 281 LLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK---K 337

Query: 264 RIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNW---SHHIVFPIEGTFGYLSPEYFMH 320
             IHR++ A N L+ E++  +++DFGL++ +  +         FPI+ T    +PE   +
Sbjct: 338 NFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWT----APESLAY 393

Query: 321 GIVDEKTDVFAFGVLLLELIT 341
                K+DV+AFGVLL E+ T
Sbjct: 394 NKFSIKSDVWAFGVLLWEIAT 414

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score =  130 bits (328), Expect = 1e-34
 Identities = 58/207 (28%), Positives = 95/207 (45%), Gaps = 21/207 (10%)

Query: 147 ENLIGKGGHAEVYKGCLPDGE----VVAVKKIIKNAKEDEERISDFLSELGIVAHINHPN 202
           + +IGKG    VY G   D        A+K + +  +  +  +  FL E  ++  +NHPN
Sbjct: 26  DRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQ--VEAFLREGLLMRGLNHPN 83

Query: 203 AAKLIGFSTENG--FHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHD 260
              LIG         H++L ++ HG L   +                L +A G++YL   
Sbjct: 84  VLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAE- 142

Query: 261 CHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDN------WSHHIVFPIEGTFGYLS 314
             ++ +HRD+ A N +L E +  +++DFGLA+ + D          H   P++ T    +
Sbjct: 143 --QKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWT----A 196

Query: 315 PEYFMHGIVDEKTDVFAFGVLLLELIT 341
            E         K+DV++FGVLL EL+T
Sbjct: 197 LESLQTYRFTTKSDVWSFGVLLWELLT 223

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score =  135 bits (340), Expect = 2e-34
 Identities = 49/207 (23%), Positives = 98/207 (47%), Gaps = 18/207 (8%)

Query: 147 ENLIGKGGHAEVYKGCL--PDGEV-VAVKKIIKNAKEDEERISDFLSELGIVAHINHPNA 203
           +  +G G    V +G       ++ VA+K ++K   E  +   + + E  I+  +++P  
Sbjct: 341 DIELGCGNFGSVRQGVYRMRKKQIDVAIK-VLKQGTEKADT-EEMMREAQIMHQLDNPYI 398

Query: 204 AKLIGFSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHR 263
            +LIG        LV++    G L   L G  E +  +   ++   ++ G++YL     +
Sbjct: 399 VRLIGVCQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYL---EEK 455

Query: 264 RIIHRDIKASNILLSEDYEAQISDFGLAKWLPDN-----WSHHIVFPIEGTFGYLSPEYF 318
             +HR++ A N+LL   + A+ISDFGL+K L  +           +P++      +PE  
Sbjct: 456 NFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWY----APECI 511

Query: 319 MHGIVDEKTDVFAFGVLLLELIT-GRR 344
                  ++DV+++GV + E ++ G++
Sbjct: 512 NFRKFSSRSDVWSYGVTMWEALSYGQK 538

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score =  128 bits (325), Expect = 2e-34
 Identities = 49/203 (24%), Positives = 97/203 (47%), Gaps = 16/203 (7%)

Query: 147 ENLIGKGGHAEVYKGCLPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKL 206
              +G G    V  G       VA+K I    KE      +F+ E  ++ +++H    +L
Sbjct: 29  LKELGTGQFGVVKYGKWRGQYDVAIKMI----KEGSMSEDEFIEEAKVMMNLSHEKLVQL 84

Query: 207 IGFSTENG-FHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRI 265
            G  T+     ++ +++ +G L + L       +     ++   + E ++YL     ++ 
Sbjct: 85  YGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLES---KQF 141

Query: 266 IHRDIKASNILLSEDYEAQISDFGLAKWLPDNW---SHHIVFPIEGTFGYLSPEYFMHGI 322
           +HRD+ A N L+++    ++SDFGL++++ D+    S    FP+  +     PE  M+  
Sbjct: 142 LHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWS----PPEVLMYSK 197

Query: 323 VDEKTDVFAFGVLLLELIT-GRR 344
              K+D++AFGVL+ E+ + G+ 
Sbjct: 198 FSSKSDIWAFGVLMWEIYSLGKM 220

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score =  128 bits (324), Expect = 3e-34
 Identities = 55/206 (26%), Positives = 93/206 (45%), Gaps = 17/206 (8%)

Query: 147 ENLIGKGGHAEVYKGCL--PDGEV--VAVKKIIKNAKEDEERISDFLSELGIVAHINHPN 202
              IG+G   +V++G    P+     VA+K       +       FL E   +   +HP+
Sbjct: 20  GRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVRE--KFLQEALTMRQFDHPH 77

Query: 203 AAKLIGFSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCH 262
             KLIG  TEN   ++++    G L S L      L+       A  ++  L YL     
Sbjct: 78  IVKLIGVITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLES--- 134

Query: 263 RRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDN---WSHHIVFPIEGTFGYLSPEYFM 319
           +R +HRDI A N+L+S +   ++ DFGL++++ D+    +     PI+      +PE   
Sbjct: 135 KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWM----APESIN 190

Query: 320 HGIVDEKTDVFAFGVLLLELIT-GRR 344
                  +DV+ FGV + E++  G +
Sbjct: 191 FRRFTSASDVWMFGVCMWEILMHGVK 216

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score =  128 bits (323), Expect = 3e-34
 Identities = 54/203 (26%), Positives = 97/203 (47%), Gaps = 16/203 (7%)

Query: 147 ENLIGKGGHAEVYKGCLPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKL 206
              +G G    V  G       VAVK I    KE      +F  E   +  ++HP   K 
Sbjct: 13  LKELGSGQFGVVKLGKWKGQYDVAVKMI----KEGSMSEDEFFQEAQTMMKLSHPKLVKF 68

Query: 207 IGFSTENG-FHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRI 265
            G  ++    ++V +++ +G L + L    + LE +   ++   + EG+ +L      + 
Sbjct: 69  YGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLES---HQF 125

Query: 266 IHRDIKASNILLSEDYEAQISDFGLAKWLPDNW---SHHIVFPIEGTFGYLSPEYFMHGI 322
           IHRD+ A N L+  D   ++SDFG+ +++ D+    S    FP++ +    +PE F +  
Sbjct: 126 IHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWS----APEVFHYFK 181

Query: 323 VDEKTDVFAFGVLLLELIT-GRR 344
              K+DV+AFG+L+ E+ + G+ 
Sbjct: 182 YSSKSDVWAFGILMWEVFSLGKM 204

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  129 bits (325), Expect = 4e-34
 Identities = 58/221 (26%), Positives = 97/221 (43%), Gaps = 27/221 (12%)

Query: 143 NFNSENLIGKGGHAEVYKG-CLPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHP 201
           ++     +G+GG + V     L DG   A+K+I+ + ++D E       E  +    NHP
Sbjct: 30  HYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEA---QREADMHRLFNHP 86

Query: 202 NAAKLIG-FSTENG----FHLVLQFLPHGSLSSLL---FGSTECL-EWTIRYKIALGIAE 252
           N  +L+     E G      L+L F   G+L + +         L E  I   + LGI  
Sbjct: 87  NILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQIL-WLLLGICR 145

Query: 253 GLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAK-WLPDNWSHHIVFPIE---- 307
           GL+ +H    +   HRD+K +NILL ++ +  + D G                 ++    
Sbjct: 146 GLEAIHA---KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAA 202

Query: 308 --GTFGYLSPEYF---MHGIVDEKTDVFAFGVLLLELITGR 343
              T  Y +PE F    H ++DE+TDV++ G +L  ++ G 
Sbjct: 203 QRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGE 243

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score =  127 bits (322), Expect = 5e-34
 Identities = 57/206 (27%), Positives = 98/206 (47%), Gaps = 17/206 (8%)

Query: 147 ENLIGKGGHAEVYKGCL--PDGEV--VAVKKIIKNAKEDEERISDFLSELGIVAHINHPN 202
             ++G+G   EVY+G      GE   VAVK   K+   D +    F+SE  I+ +++HP+
Sbjct: 17  NRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKE--KFMSEAVIMKNLDHPH 74

Query: 203 AAKLIGFSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCH 262
             KLIG   E    ++++  P+G L   L  +   L+       +L I + + YL     
Sbjct: 75  IVKLIGIIEEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLES--- 131

Query: 263 RRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDN---WSHHIVFPIEGTFGYLSPEYFM 319
              +HRDI   NIL++     ++ DFGL++++ D     +     PI+      SPE   
Sbjct: 132 INCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWM----SPESIN 187

Query: 320 HGIVDEKTDVFAFGVLLLELIT-GRR 344
                  +DV+ F V + E+++ G++
Sbjct: 188 FRRFTTASDVWMFAVCMWEILSFGKQ 213

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score =  128 bits (323), Expect = 6e-34
 Identities = 62/205 (30%), Positives = 108/205 (52%), Gaps = 18/205 (8%)

Query: 147 ENLIGKGGHAEVYKGCLPDGEV-VAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAK 205
           ++ +G G + EVY+G      + VAVK +    KED   + +FL E  ++  I HPN  +
Sbjct: 18  KHKLGGGQYGEVYEGVWKKYSLTVAVKTL----KEDTMEVEEFLKEAAVMKEIKHPNLVQ 73

Query: 206 LIGFSTENG-FHLVLQFLPHGSLSS-LLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHR 263
           L+G  T    F+++ +F+ +G+L   L   + + +   +   +A  I+  ++YL     +
Sbjct: 74  LLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK---K 130

Query: 264 RIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNW---SHHIVFPIEGTFGYLSPEYFMH 320
             IHRD+ A N L+ E++  +++DFGL++ +  +         FPI+ T    +PE   +
Sbjct: 131 NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWT----APESLAY 186

Query: 321 GIVDEKTDVFAFGVLLLELIT-GRR 344
                K+DV+AFGVLL E+ T G  
Sbjct: 187 NKFSIKSDVWAFGVLLWEIATYGMS 211

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  128 bits (323), Expect = 7e-34
 Identities = 40/212 (18%), Positives = 90/212 (42%), Gaps = 25/212 (11%)

Query: 148 NLIGKGGHAEVYKGCLPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAA--K 205
             IG GG ++V++      ++ A+K +    + D + +  + +E+  +  +   +    +
Sbjct: 34  KQIGSGGSSKVFQVLNEKKQIYAIKYVNLE-EADNQTLDSYRNEIAYLNKLQQHSDKIIR 92

Query: 206 LIG-FSTENGFHLVLQFLPHGSLSSLL--FGSTECLEWTIRYKIALGIAEGLQYLHHDCH 262
           L     T+   ++V++   +  L+S L    S +   W  +      + E +  +H    
Sbjct: 93  LYDYEITDQYIYMVMEC-GNIDLNSWLKKKKSID--PWERKS-YWKNMLEAVHTIH---Q 145

Query: 263 RRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEGTFGYLSPEYFM--- 319
             I+H D+K +N L+ +    ++ DFG+A  +  + +  +     GT  Y+ PE      
Sbjct: 146 HGIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMS 204

Query: 320 --------HGIVDEKTDVFAFGVLLLELITGR 343
                      +  K+DV++ G +L  +  G+
Sbjct: 205 SSRENGKSKSKISPKSDVWSLGCILYYMTYGK 236

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  127 bits (321), Expect = 1e-33
 Identities = 64/204 (31%), Positives = 103/204 (50%), Gaps = 17/204 (8%)

Query: 149 LIGKGGHAEVYKG-CLPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLI 207
           ++GKG +  VY G  L +   +A+K+I    + D         E+ +  H+ H N  + +
Sbjct: 29  VLGKGTYGIVYAGRDLSNQVRIAIKEI---PERDSRYSQPLHEEIALHKHLKHKNIVQYL 85

Query: 208 GFSTENG-FHLVLQFLPHGSLSSLL---FGSTECLEWTIRYKIALGIAEGLQYLHHDCHR 263
           G  +ENG   + ++ +P GSLS+LL   +G  +  E TI       I EGL+YLH     
Sbjct: 86  GSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIG-FYTKQILEGLKYLHD---N 141

Query: 264 RIIHRDIKASNILL-SEDYEAQISDFGLAKWLPDNWSHHIVFPIEGTFGYLSPEYFMHGI 322
           +I+HRDIK  N+L+ +     +ISDFG +K L         F   GT  Y++PE    G 
Sbjct: 142 QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETF--TGTLQYMAPEIIDKGP 199

Query: 323 V--DEKTDVFAFGVLLLELITGRR 344
               +  D+++ G  ++E+ TG+ 
Sbjct: 200 RGYGKAADIWSLGCTIIEMATGKP 223

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score =  128 bits (323), Expect = 1e-33
 Identities = 60/210 (28%), Positives = 102/210 (48%), Gaps = 21/210 (10%)

Query: 147 ENLIGKGGHAEVYKGCL--PDGEV---VAVKKIIKNAKEDEERISDFLSELGIVAHINHP 201
           + +IG G   EVYKG L    G+    VA+K +     E +    DFL E GI+   +H 
Sbjct: 49  QKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRV--DFLGEAGIMGQFSHH 106

Query: 202 NAAKLIGFSTENG-FHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHD 260
           N  +L G  ++     ++ +++ +G+L   L              +  GIA G++YL + 
Sbjct: 107 NIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLAN- 165

Query: 261 CHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSHHIV-----FPIEGTFGYLSP 315
                +HRD+ A NIL++ +   ++SDFGL++ L D+            PI  T    +P
Sbjct: 166 --MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWT----AP 219

Query: 316 EYFMHGIVDEKTDVFAFGVLLLELIT-GRR 344
           E   +      +DV++FG+++ E++T G R
Sbjct: 220 EAISYRKFTSASDVWSFGIVMWEVMTYGER 249

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  129 bits (327), Expect = 2e-33
 Identities = 47/211 (22%), Positives = 82/211 (38%), Gaps = 21/211 (9%)

Query: 143 NFNSENLIGKGGHAEVYKGCLPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHIN-HP 201
           +F  ++++G G    +    + D   VAVK+I+       +R      E+ ++   + HP
Sbjct: 25  SFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFSFADR------EVQLLRESDEHP 78

Query: 202 NAAKLIG-FSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHD 260
           N  +           ++ ++     +L   +              +      GL +LH  
Sbjct: 79  NVIRYFCTEKDRQFQYIAIELCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLH-- 135

Query: 261 CHRRIIHRDIKASNILLSEDYE-----AQISDFGLAKWL-PDNWSHHIVFPIEGTFGYLS 314
               I+HRD+K  NIL+S         A ISDFGL K L     S      + GT G+++
Sbjct: 136 -SLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIA 194

Query: 315 PEYF---MHGIVDEKTDVFAFGVLLLELITG 342
           PE              D+F+ G +   +I+ 
Sbjct: 195 PEMLSEDCKENPTYTVDIFSAGCVFYYVISE 225

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  126 bits (318), Expect = 2e-33
 Identities = 63/290 (21%), Positives = 118/290 (40%), Gaps = 48/290 (16%)

Query: 142 DNFNSENLIGKGGHAEVYKG-CLPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINH 200
           +++     IG G +    K     DG+++  K++   +  + E+    +SE+ ++  + H
Sbjct: 6   EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEK-QMLVSEVNLLRELKH 64

Query: 201 PNAAKLIGF---STENGFHLVLQFLPHGSLSSLLFGSTECL----EWTIRYKIALGIAEG 253
           PN  +        T    ++V+++   G L+S++   T+      E  +  ++   +   
Sbjct: 65  PNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVL-RVMTQLTLA 123

Query: 254 LQYLH--HDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWS--HHIVFPIEGT 309
           L+  H   D    ++HRD+K +N+ L      ++ DFGLA+ L  + S     V    GT
Sbjct: 124 LKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFV----GT 179

Query: 310 FGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSNFKEL 369
             Y+SPE       +EK+D+++ G LL EL        +                + KEL
Sbjct: 180 PYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAF---------------SQKEL 224

Query: 370 VD-------PRLADAY--DLAEMKRAMLTASVCIHHLSTMRPQMTRVLQL 410
                     R+   Y  +L E+   ML            RP +  +L+ 
Sbjct: 225 AGKIREGKFRRIPYRYSDELNEIITRMLNLK------DYHRPSVEEILEN 268

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score =  127 bits (320), Expect = 3e-33
 Identities = 61/209 (29%), Positives = 97/209 (46%), Gaps = 20/209 (9%)

Query: 147 ENLIGKGGHAEVYKGCL---PDGEV-VAVKKIIKNAKEDEERISDFLSELGIVAHINHPN 202
           E +IG G   EV  G L      +V VA+K +     E + R  DFLSE  I+   +HPN
Sbjct: 54  EKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRR--DFLSEASIMGQFDHPN 111

Query: 203 AAKLIGFSTENG-FHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDC 261
             +L G  T      +V +++ +GSL + L              +  G+  G++YL    
Sbjct: 112 IIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSD-- 169

Query: 262 HRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSHHIV-----FPIEGTFGYLSPE 316
               +HRD+ A N+L+  +   ++SDFGL++ L D+            PI  T    +PE
Sbjct: 170 -LGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWT----APE 224

Query: 317 YFMHGIVDEKTDVFAFGVLLLELIT-GRR 344
                     +DV++FGV++ E++  G R
Sbjct: 225 AIAFRTFSSASDVWSFGVVMWEVLAYGER 253

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  127 bits (320), Expect = 3e-33
 Identities = 40/212 (18%), Positives = 90/212 (42%), Gaps = 25/212 (11%)

Query: 148 NLIGKGGHAEVYKGCLPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAA--K 205
             IG GG ++V++      ++ A+K +    + D + +  + +E+  +  +   +    +
Sbjct: 15  KQIGSGGSSKVFQVLNEKKQIYAIKYVNLE-EADNQTLDSYRNEIAYLNKLQQHSDKIIR 73

Query: 206 LIG-FSTENGFHLVLQFLPHGSLSSLL--FGSTECLEWTIRYKIALGIAEGLQYLHHDCH 262
           L     T+   ++V++   +  L+S L    S +   W  +      + E +  +H    
Sbjct: 74  LYDYEITDQYIYMVMEC-GNIDLNSWLKKKKSID--PWERKS-YWKNMLEAVHTIH---Q 126

Query: 263 RRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEGTFGYLSPEYFM--- 319
             I+H D+K +N L+ +    ++ DFG+A  +  + +  +     GT  Y+ PE      
Sbjct: 127 HGIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMS 185

Query: 320 --------HGIVDEKTDVFAFGVLLLELITGR 343
                      +  K+DV++ G +L  +  G+
Sbjct: 186 SSRENGKSKSKISPKSDVWSLGCILYYMTYGK 217

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score =  126 bits (319), Expect = 4e-33
 Identities = 58/214 (27%), Positives = 97/214 (45%), Gaps = 27/214 (12%)

Query: 147 ENLIGKGGHAEVYKGCLPDGE----VVAVKKIIKNAKEDEERISDFLSELGIVAHINHPN 202
             ++G+G    V +G L   +     VAVK + K     +  I +FLSE   +   +HPN
Sbjct: 39  GKILGEGEFGSVMEGNLKQEDGTSLKVAVKTM-KLDNSSQREIEEFLSEAACMKDFSHPN 97

Query: 203 AAKLIGFSTENG------FHLVLQFLPHGSLSSLLFGS---TECLEWTIR--YKIALGIA 251
             +L+G   E          ++L F+ +G L + L  S   T      ++   K  + IA
Sbjct: 98  VIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIA 157

Query: 252 EGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDN----WSHHIVFPIE 307
            G++YL    +R  +HRD+ A N +L +D    ++DFGL+K +              P++
Sbjct: 158 LGMEYL---SNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVK 214

Query: 308 GTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELIT 341
                 + E     +   K+DV+AFGV + E+ T
Sbjct: 215 WI----AIESLADRVYTSKSDVWAFGVTMWEIAT 244

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score =  131 bits (331), Expect = 4e-33
 Identities = 58/202 (28%), Positives = 94/202 (46%), Gaps = 16/202 (7%)

Query: 147 ENLIGKGGHAEVYKGCL--PDGEV--VAVKKIIKNAKEDEERISDFLSELGIVAHINHPN 202
              IG+G   +V++G    P+     VA+K   KN   D  R   FL E   +   +HP+
Sbjct: 395 GRCIGEGQFGDVHQGIYMSPENPAMAVAIK-TCKNCTSDSVRE-KFLQEALTMRQFDHPH 452

Query: 203 AAKLIGFSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCH 262
             KLIG  TEN   ++++    G L S L      L+       A  ++  L YL     
Sbjct: 453 IVKLIGVITENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLES--- 509

Query: 263 RRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDN---WSHHIVFPIEGTFGYLSPEYFM 319
           +R +HRDI A N+L+S +   ++ DFGL++++ D+    +     PI+      +PE   
Sbjct: 510 KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWM----APESIN 565

Query: 320 HGIVDEKTDVFAFGVLLLELIT 341
                  +DV+ FGV + E++ 
Sbjct: 566 FRRFTSASDVWMFGVCMWEILM 587

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score =  126 bits (319), Expect = 4e-33
 Identities = 55/212 (25%), Positives = 93/212 (43%), Gaps = 28/212 (13%)

Query: 150 IGKGGHAEVYKGCLPDGE----VVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAK 205
           +GKG    V +  L   +     VAVK +  +     +   +FL E   +   +HP+ AK
Sbjct: 31  LGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDI-EEFLREAACMKEFDHPHVAK 89

Query: 206 LIGFSTENG-------FHLVLQFLPHGSLSSLL-----FGSTECLEWTIRYKIALGIAEG 253
           L+G S  +          ++L F+ HG L + L       +   L      +  + IA G
Sbjct: 90  LVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACG 149

Query: 254 LQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDN----WSHHIVFPIEGT 309
           ++YL     R  IHRD+ A N +L+ED    ++DFGL++ +              P++  
Sbjct: 150 MEYLSS---RNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWL 206

Query: 310 FGYLSPEYFMHGIVDEKTDVFAFGVLLLELIT 341
               + E     +    +DV+AFGV + E++T
Sbjct: 207 ----ALESLADNLYTVHSDVWAFGVTMWEIMT 234

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  125 bits (316), Expect = 5e-33
 Identities = 64/292 (21%), Positives = 117/292 (40%), Gaps = 59/292 (20%)

Query: 142 DNFNSENLIGKGGHAEVYKG-CLPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINH 200
            +F    LIG GG  +V+K     DG+   +K++  N  E  ER      E+  +A ++H
Sbjct: 11  MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYN-NEKAER------EVKALAKLDH 63

Query: 201 PN-----------------AAKLIGFSTENGFHLVLQFLPHGSLSSLLFGSTECL--EWT 241
            N                 ++K    S      + ++F   G+L   +         +  
Sbjct: 64  VNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVL 123

Query: 242 IRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSH- 300
               +   I +G+ Y+H    +++I+RD+K SNI L +  + +I DFGL   L ++    
Sbjct: 124 ALE-LFEQITKGVDYIHS---KKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRT 179

Query: 301 HIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPL 360
                  GT  Y+SPE        ++ D++A G++L EL+                    
Sbjct: 180 RSK----GTLRYMSPEQISSQDYGKEVDLYALGLILAELLHV--------------CDTA 221

Query: 361 LQTSN-FKELVDPRLADAY--DLAEMKRAMLTASVCIHHLSTMRPQMTRVLQ 409
            +TS  F +L D  ++D +      + + +L+           RP  + +L+
Sbjct: 222 FETSKFFTDLRDGIISDIFDKKEKTLLQKLLSKK------PEDRPNTSEILR 267

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score =  125 bits (316), Expect = 1e-32
 Identities = 51/212 (24%), Positives = 98/212 (46%), Gaps = 29/212 (13%)

Query: 150 IGKGGHAEVYKG----CLPDGEV--VAVKKIIKNAKEDEERISDFLSELGIVAHINHPNA 203
           +G+G    VY+G     + D     VA+K + + A   E    +FL+E  ++   N  + 
Sbjct: 33  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERI--EFLNEASVMKEFNCHHV 90

Query: 204 AKLIGFSTENG-FHLVLQFLPHGSLSSLL-----FGSTECLEWTIRYK----IALGIAEG 253
            +L+G  ++     ++++ +  G L S L       +   +           +A  IA+G
Sbjct: 91  VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADG 150

Query: 254 LQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDN----WSHHIVFPIEGT 309
           + YL+     + +HRD+ A N +++ED+  +I DFG+ + + +          + P+   
Sbjct: 151 MAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWM 207

Query: 310 FGYLSPEYFMHGIVDEKTDVFAFGVLLLELIT 341
               SPE    G+    +DV++FGV+L E+ T
Sbjct: 208 ----SPESLKDGVFTTYSDVWSFGVVLWEIAT 235

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score =  127 bits (322), Expect = 1e-32
 Identities = 63/202 (31%), Positives = 94/202 (46%), Gaps = 18/202 (8%)

Query: 147 ENLIGKGGHAEVYKGCLPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKL 206
              IGKG   +V  G    G  VAVK I    K D      FL+E  ++  + H N  +L
Sbjct: 198 LQTIGKGEFGDVMLGDY-RGNKVAVKCI----KNDATA-QAFLAEASVMTQLRHSNLVQL 251

Query: 207 IGFSTENG--FHLVLQFLPHGSLSSLLFGST-ECLEWTIRYKIALGIAEGLQYLHHDCHR 263
           +G   E     ++V +++  GSL   L       L      K +L + E ++YL      
Sbjct: 252 LGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG---N 308

Query: 264 RIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEGTFGYLSPEYFMHGIV 323
             +HRD+ A N+L+SED  A++SDFGL K            P++ T    +PE       
Sbjct: 309 NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST-QDTGKLPVKWT----APEALREKKF 363

Query: 324 DEKTDVFAFGVLLLELIT-GRR 344
             K+DV++FG+LL E+ + GR 
Sbjct: 364 STKSDVWSFGILLWEIYSFGRV 385

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  124 bits (313), Expect = 1e-32
 Identities = 53/202 (26%), Positives = 91/202 (45%), Gaps = 15/202 (7%)

Query: 149 LIGKGGHAEVYKGC-LPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLI 207
            IG+G    VYKG        VA  ++ ++ K  +     F  E  ++  + HPN  +  
Sbjct: 33  EIGRGSFKTVYKGLDTETTVEVAWCEL-QDRKLTKSERQRFKEEAEMLKGLQHPNIVRFY 91

Query: 208 GF-----STENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCH 262
                    +    LV + +  G+L + L    + ++  +       I +GLQ+LH    
Sbjct: 92  DSWESTVKGKKCIVLVTELMTSGTLKTYL-KRFKVMKIKVLRSWCRQILKGLQFLH-TRT 149

Query: 263 RRIIHRDIKASNILLS-EDYEAQISDFGLAKWLPDNWSHHIVFPIEGTFGYLSPEYFMHG 321
             IIHRD+K  NI ++      +I D GLA     +++  ++    GT  +++PE +   
Sbjct: 150 PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAVI----GTPEFMAPEMYEEK 205

Query: 322 IVDEKTDVFAFGVLLLELITGR 343
             DE  DV+AFG+ +LE+ T  
Sbjct: 206 -YDESVDVYAFGMCMLEMATSE 226

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  124 bits (313), Expect = 2e-32
 Identities = 68/205 (33%), Positives = 104/205 (50%), Gaps = 13/205 (6%)

Query: 141 TDNFNSENLIGKGGHAEVYKG-CLPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHIN 199
            + F     IGKG   EV+KG      +VVA+K I  + +E E+ I D   E+ +++  +
Sbjct: 21  EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKII--DLEEAEDEIEDIQQEITVLSQCD 78

Query: 200 HPNAAKLIG-FSTENGFHLVLQFLPHGSLSSLLFGSTECL-EWTIRYKIALGIAEGLQYL 257
            P   K  G +  +    +++++L  GS   LL      L E  I   I   I +GL YL
Sbjct: 79  SPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLL--EPGPLDETQIAT-ILREILKGLDYL 135

Query: 258 HHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEGTFGYLSPEY 317
           H +   + IHRDIKA+N+LLSE  E +++DFG+A  L D       F   GT  +++PE 
Sbjct: 136 HSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFV--GTPFWMAPEV 190

Query: 318 FMHGIVDEKTDVFAFGVLLLELITG 342
                 D K D+++ G+  +EL  G
Sbjct: 191 IKQSAYDSKADIWSLGITAIELARG 215

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  125 bits (315), Expect = 2e-32
 Identities = 62/243 (25%), Positives = 113/243 (46%), Gaps = 19/243 (7%)

Query: 103 KKLGRLQIPEDDDADDGGSVPIVRHSWKNFDFAELAAATDNFNSENLIGKGGHAEVYKGC 162
           KKL  L++ E            +    K  +  +     D+F   + +G G    V+K  
Sbjct: 2   KKLEELELDEQQRKRLEA---FLTQKQKVGELKD-----DDFEKISELGAGNGGVVFKVS 53

Query: 163 L-PDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIG-FSTENGFHLVLQ 220
             P G V+A K I  + +      +  + EL ++   N P      G F ++    + ++
Sbjct: 54  HKPSGLVMARKLI--HLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 111

Query: 221 FLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSED 280
            +  GSL  +L  +    E  +  K+++ + +GL YL      +I+HRD+K SNIL++  
Sbjct: 112 HMDGGSLDQVLKKAGRIPEQILG-KVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSR 168

Query: 281 YEAQISDFGLAKWLPDNWSHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELI 340
            E ++ DFG++  L D+ ++  V    GT  Y+SPE         ++D+++ G+ L+E+ 
Sbjct: 169 GEIKLCDFGVSGQLIDSMANSFV----GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMA 224

Query: 341 TGR 343
            GR
Sbjct: 225 VGR 227

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  123 bits (311), Expect = 2e-32
 Identities = 61/204 (29%), Positives = 95/204 (46%), Gaps = 10/204 (4%)

Query: 142 DNFNSENLIGKGGHAEVYKG-CLPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINH 200
           ++F     +GKG    VY         ++A+K + K   E          E+ I +H+ H
Sbjct: 9   EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 68

Query: 201 PNAAKLIG-FSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHH 259
           PN  +L G F      +L+L++ P G++   L   ++  E      I   +A  L Y H 
Sbjct: 69  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITE-LANALSYCHS 127

Query: 260 DCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEGTFGYLSPEYFM 319
              +R+IHRDIK  N+LL    E +I+DFG +   P +    +     GT  YL PE   
Sbjct: 128 ---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLC----GTLDYLPPEMIE 180

Query: 320 HGIVDEKTDVFAFGVLLLELITGR 343
             + DEK D+++ GVL  E + G+
Sbjct: 181 GRMHDEKVDLWSLGVLCYEFLVGK 204

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score =  123 bits (312), Expect = 2e-32
 Identities = 59/201 (29%), Positives = 98/201 (48%), Gaps = 13/201 (6%)

Query: 149 LIGKGGHAEVYKG-CLPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLI 207
            +G GG + VY          VA+K I    +E EE +  F  E+   + ++H N   +I
Sbjct: 18  KLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMI 77

Query: 208 GFSTENGFH-LVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRII 266
               E+  + LV++++   +LS  +  S   L           I +G+++ H     RI+
Sbjct: 78  DVDEEDDCYYLVMEYIEGPTLSEYI-ESHGPLSVDTAINFTNQILDGIKHAHD---MRIV 133

Query: 267 HRDIKASNILLSEDYEAQISDFGLAKWLPDN---WSHHIVFPIEGTFGYLSPEYFMHGIV 323
           HRDIK  NIL+  +   +I DFG+AK L +     ++H++    GT  Y SPE       
Sbjct: 134 HRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVL----GTVQYFSPEQAKGEAT 189

Query: 324 DEKTDVFAFGVLLLELITGRR 344
           DE TD+++ G++L E++ G  
Sbjct: 190 DECTDIYSIGIVLYEMLVGEP 210

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score =  125 bits (315), Expect = 3e-32
 Identities = 59/233 (25%), Positives = 94/233 (40%), Gaps = 21/233 (9%)

Query: 127 HSWKNFDFAELAAATDN---FNSENLIGKGGH--AEVYKG-CLPDGEVVAVKKIIKNAKE 180
           H  +N  F  +++       +    +IGKG      V      P GE V V+  I     
Sbjct: 7   HHMENLYFQGMSSFLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVR-RINLEAC 65

Query: 181 DEERISDFLSELGIVAHINHPNAAKLIG-FSTENGFHLVLQFLPHGSLSSLL-FGSTECL 238
             E ++    EL +    NHPN       F  +N   +V  F+ +GS   L+     + +
Sbjct: 66  SNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGM 125

Query: 239 -EWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDN 297
            E  I Y I  G+ + L Y+HH      +HR +KAS+IL+S D +  +S       +  +
Sbjct: 126 NELAIAY-ILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMISH 181

Query: 298 WS-----HHIVFPIEGTFGYLSPEYFMHGIV--DEKTDVFAFGVLLLELITGR 343
                  H           +LSPE     +   D K+D+++ G+   EL  G 
Sbjct: 182 GQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGH 234

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score =  125 bits (315), Expect = 4e-32
 Identities = 62/209 (29%), Positives = 102/209 (48%), Gaps = 20/209 (9%)

Query: 147 ENLIGKGGHAEVYKGCL--PDGE--VVAVKKIIKNAKEDEERISDFLSELGIVAHINHPN 202
           + ++G G   EV  G L  P  +   VA+K +     E + R  DFL E  I+   +HPN
Sbjct: 50  DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRR--DFLGEASIMGQFDHPN 107

Query: 203 AAKLIGFSTENG-FHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDC 261
             +L G  T++    +V +++ +GSL S L              +  GIA G++YL    
Sbjct: 108 IIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSD-- 165

Query: 262 HRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNW-----SHHIVFPIEGTFGYLSPE 316
               +HRD+ A NIL++ +   ++SDFGL + L D+      +     PI  T    SPE
Sbjct: 166 -MGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWT----SPE 220

Query: 317 YFMHGIVDEKTDVFAFGVLLLELIT-GRR 344
              +      +DV+++G++L E+++ G R
Sbjct: 221 AIAYRKFTSASDVWSYGIVLWEVMSYGER 249

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  123 bits (311), Expect = 4e-32
 Identities = 52/230 (22%), Positives = 96/230 (41%), Gaps = 35/230 (15%)

Query: 141 TDNFNSENLIGKGGHAEVYKG-CLPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHIN 199
             +F    ++G+G   +V K     D    A+K  I++ +E    I   LSE+ ++A +N
Sbjct: 5   ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIK-KIRHTEEKLSTI---LSEVMLLASLN 60

Query: 200 HPNAAKLIGF--------------STENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYK 245
           H    +                    ++   + +++  +G+L  L+       +    ++
Sbjct: 61  HQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWR 120

Query: 246 IALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFP 305
           +   I E L Y+H    + IIHRD+K  NI + E    +I DFGLAK +  +     +  
Sbjct: 121 LFRQILEALSYIHS---QGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDS 177

Query: 306 IE------------GTFGYLSPEYFM-HGIVDEKTDVFAFGVLLLELITG 342
                         GT  Y++ E     G  +EK D+++ G++  E+I  
Sbjct: 178 QNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYP 227

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  124 bits (313), Expect = 7e-32
 Identities = 39/212 (18%), Positives = 89/212 (41%), Gaps = 25/212 (11%)

Query: 148 NLIGKGGHAEVYKGCLPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAA--K 205
             IG GG ++V++      ++ A+K +    + D + +  + +E+  +  +   +    +
Sbjct: 62  KQIGSGGSSKVFQVLNEKKQIYAIKYVNLE-EADNQTLDSYRNEIAYLNKLQQHSDKIIR 120

Query: 206 LIG-FSTENGFHLVLQFLPHGSLSSLL--FGSTECLEWTIRYKIALGIAEGLQYLHHDCH 262
           L     T+   ++V++   +  L+S L    S +   W  +      + E +  +H    
Sbjct: 121 LYDYEITDQYIYMVMEC-GNIDLNSWLKKKKSID--PWERKS-YWKNMLEAVHTIH---Q 173

Query: 263 RRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEGTFGYLSPEYFM--- 319
             I+H D+K +N L+ +    ++ DFG+A  +  + +  +     G   Y+ PE      
Sbjct: 174 HGIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMS 232

Query: 320 --------HGIVDEKTDVFAFGVLLLELITGR 343
                      +  K+DV++ G +L  +  G+
Sbjct: 233 SSRENGKSKSKISPKSDVWSLGCILYYMTYGK 264

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score =  121 bits (305), Expect = 2e-31
 Identities = 64/204 (31%), Positives = 96/204 (47%), Gaps = 22/204 (10%)

Query: 147 ENLIGKGGHAEVYKGCLPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKL 206
              IGKG   +V  G    G  VAVK I    K D      FL+E  ++  + H N  +L
Sbjct: 26  LQTIGKGEFGDVMLGDY-RGNKVAVKCI----KNDATA-QAFLAEASVMTQLRHSNLVQL 79

Query: 207 IGFSTENG--FHLVLQFLPHGSLSSLL-FGSTECLEWTIRYKIALGIAEGLQYLHHDCHR 263
           +G   E     ++V +++  GSL   L       L      K +L + E ++YL      
Sbjct: 80  LGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG---N 136

Query: 264 RIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSHHIV--FPIEGTFGYLSPEYFMHG 321
             +HRD+ A N+L+SED  A++SDFGL K   +  S       P++ T    +PE     
Sbjct: 137 NFVHRDLAARNVLVSEDNVAKVSDFGLTK---EASSTQDTGKLPVKWT----APEALREK 189

Query: 322 IVDEKTDVFAFGVLLLELIT-GRR 344
               K+DV++FG+LL E+ + GR 
Sbjct: 190 KFSTKSDVWSFGILLWEIYSFGRV 213

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  120 bits (304), Expect = 2e-31
 Identities = 61/211 (28%), Positives = 98/211 (46%), Gaps = 21/211 (9%)

Query: 142 DNFNSENLIGKGGHAEVYKG-CLPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINH 200
           ++F   NL+GKG  A VY+   +  G  VA+K I K A      +    +E+ I   + H
Sbjct: 11  EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKH 70

Query: 201 PNAAKLIG-FSTENGFHLVLQFLPHGSLSSLLFGSTECL-EWTIRYKIALGIAEGLQYLH 258
           P+  +L   F   N  +LVL+   +G ++  L    +   E   R+ +   I  G+ YLH
Sbjct: 71  PSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMH-QIITGMLYLH 129

Query: 259 HDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIE------GTFGY 312
                 I+HRD+  SN+LL+ +   +I+DFG         +  +  P E      GT  Y
Sbjct: 130 S---HGILHRDLTLSNLLLTRNMNIKIADFG--------LATQLKMPHEKHYTLCGTPNY 178

Query: 313 LSPEYFMHGIVDEKTDVFAFGVLLLELITGR 343
           +SPE         ++DV++ G +   L+ GR
Sbjct: 179 ISPEIATRSAHGLESDVWSLGCMFYTLLIGR 209

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score =  122 bits (307), Expect = 2e-31
 Identities = 48/217 (22%), Positives = 88/217 (40%), Gaps = 35/217 (16%)

Query: 150 IGKGGHAEVYKGCLPDGE------VVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNA 203
           +G+G   +V+     +        +VAVK  +K A E   +  DF  E  ++  + H + 
Sbjct: 49  LGEGAFGKVFLAECHNLLPEQDKMLVAVK-ALKEASESARQ--DFQREAELLTMLQHQHI 105

Query: 204 AKLIGFSTENG-FHLVLQFLPHGSLSSLLFGSTECLEWTIRY--------------KIAL 248
            +  G  TE     +V +++ HG L+  L       +                    +A 
Sbjct: 106 VRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVAS 165

Query: 249 GIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDN----WSHHIVF 304
            +A G+ YL        +HRD+   N L+ +    +I DFG+++ +            + 
Sbjct: 166 QVAAGMVYLAG---LHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTML 222

Query: 305 PIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELIT 341
           PI        PE  ++     ++DV++FGV+L E+ T
Sbjct: 223 PIRWM----PPESILYRKFTTESDVWSFGVVLWEIFT 255

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  121 bits (305), Expect = 5e-31
 Identities = 58/219 (26%), Positives = 93/219 (42%), Gaps = 24/219 (10%)

Query: 135 AELAAATDNFNSENLIGKGGHAEVYKGC-LPDGEVVAVKKI-IKNAKEDEERISDFLSEL 192
            E          +  +G+G   EV++      G   AVKK+ ++  + +E       + L
Sbjct: 51  YEYREEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVEELVA---CAGL 107

Query: 193 GIVAHINHPNAAKLIGFSTENG-FHLVLQFLPHGSLSSLL--FGSTECLEWTIRYKIALG 249
                 + P    L G   E    ++ ++ L  GSL  L+   G     E    Y     
Sbjct: 108 ------SSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLP--EDRALY-YLGQ 158

Query: 250 IAEGLQYLHHDCHRRIIHRDIKASNILLSED-YEAQISDFGLAKWLPDNWSHHIVFPIE- 307
             EGL+YLH    RRI+H D+KA N+LLS D   A + DFG A  L  +     +   + 
Sbjct: 159 ALEGLEYLHT---RRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDY 215

Query: 308 --GTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRR 344
             GT  +++PE  M    D K D+++   ++L ++ G  
Sbjct: 216 IPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCH 254

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score =  119 bits (301), Expect = 9e-31
 Identities = 66/216 (30%), Positives = 104/216 (48%), Gaps = 20/216 (9%)

Query: 142 DNFNSENLIGKGGHAEVYKG-CLPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINH 200
           D++  + +IG G  A V    C P  E VA+K+I  N ++ +  + + L E+  ++  +H
Sbjct: 15  DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRI--NLEKCQTSMDELLKEIQAMSQCHH 72

Query: 201 PNAAKLIG-FSTENGFHLVLQFLPHGSLSSLLFGSTECL--------EWTIRYKIALGIA 251
           PN       F  ++   LV++ L  GS+  ++               E TI   I   + 
Sbjct: 73  PNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIAT-ILREVL 131

Query: 252 EGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFP---IEG 308
           EGL+YLH +     IHRD+KA NILL ED   QI+DFG++ +L                G
Sbjct: 132 EGLEYLHKN---GQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVG 188

Query: 309 TFGYLSPEYFMHGIV-DEKTDVFAFGVLLLELITGR 343
           T  +++PE        D K D+++FG+  +EL TG 
Sbjct: 189 TPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGA 224

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  119 bits (300), Expect = 1e-30
 Identities = 46/231 (19%), Positives = 82/231 (35%), Gaps = 40/231 (17%)

Query: 141 TDNFNSENLIGKGGHAEVYKG-CLPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHI- 198
           T  F+    IG G    V+K     DG + A+K+  K      +   + L E+   A + 
Sbjct: 10  TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQ-NALREVYAHAVLG 68

Query: 199 NHPNAAKLIGFSTENGFHL--VLQFLPHGSLSSLLFGSTECL----EWTIRYKIALGIAE 252
            H +  +      E+  H+    ++   GSL+  +  +   +    E  ++  + L +  
Sbjct: 69  QHSHVVRYFSAWAEDD-HMLIQNEYCNGGSLADAISENYRIMSYFKEAELK-DLLLQVGR 126

Query: 253 GLQYLHHDCHRRIIHRDIKASNILLSED-------------------YEAQISDFGLAKW 293
           GL+Y+H      ++H DIK SNI +S                        +I D G    
Sbjct: 127 GLRYIHS---MSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTR 183

Query: 294 LPDNWSHHIVFPIEGTFGYLSPEYFMHGIV-DEKTDVFAFGVLLLELITGR 343
           +            EG   +L+ E          K D+FA  + ++      
Sbjct: 184 ISSPQV------EEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAE 228

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score =  120 bits (302), Expect = 1e-30
 Identities = 66/212 (31%), Positives = 95/212 (44%), Gaps = 29/212 (13%)

Query: 150 IGKGGHAEVYKGCLPDGE------VVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNA 203
           +G G   EVY+G +           VAVK + +   E +E   DFL E  I++  NH N 
Sbjct: 38  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDEL--DFLMEALIISKFNHQNI 95

Query: 204 AKLIGFSTENG-FHLVLQFLPHGSLSSLL------FGSTECLEWTIRYKIALGIAEGLQY 256
            + IG S ++    ++++ +  G L S L            L       +A  IA G QY
Sbjct: 96  VRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 155

Query: 257 LHHDCHRRIIHRDIKASNILLS---EDYEAQISDFGLAKWLPDN----WSHHIVFPIEGT 309
           L        IHRDI A N LL+       A+I DFG+A+ +            + P++  
Sbjct: 156 LEE---NHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWM 212

Query: 310 FGYLSPEYFMHGIVDEKTDVFAFGVLLLELIT 341
                PE FM GI   KTD ++FGVLL E+ +
Sbjct: 213 ----PPEAFMEGIFTSKTDTWSFGVLLWEIFS 240

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score =  119 bits (300), Expect = 1e-30
 Identities = 50/218 (22%), Positives = 91/218 (41%), Gaps = 36/218 (16%)

Query: 150 IGKGGHAEVYKGCLPDGE------VVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNA 203
           +G+G   +V+     +        +VAVK  +K+      +  DF  E  ++ ++ H + 
Sbjct: 23  LGEGAFGKVFLAECYNLSPTKDKMLVAVK-ALKDPTLAARK--DFQREAELLTNLQHEHI 79

Query: 204 AKLIGFSTENG-FHLVLQFLPHGSLSSLL-----------FGSTECLEWTIRYK----IA 247
            K  G   +     +V +++ HG L+  L            G     +  +       IA
Sbjct: 80  VKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIA 139

Query: 248 LGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDN----WSHHIV 303
             IA G+ YL     +  +HRD+   N L+  +   +I DFG+++ +          H +
Sbjct: 140 SQIASGMVYLAS---QHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTM 196

Query: 304 FPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELIT 341
            PI        PE  M+     ++DV++FGV+L E+ T
Sbjct: 197 LPIRWM----PPESIMYRKFTTESDVWSFGVILWEIFT 230

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score =  118 bits (299), Expect = 1e-30
 Identities = 48/221 (21%), Positives = 91/221 (41%), Gaps = 35/221 (15%)

Query: 147 ENLIGKGGHAEVYKGCLPDGE------VVAVKKIIKNAKEDEERISDFLSELGIVAHINH 200
              +G+    +VYKG L           VA+K +   A+       +F  E  + A + H
Sbjct: 14  MEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLRE--EFRHEAMLRARLQH 71

Query: 201 PNAAKLIGFSTENG-FHLVLQFLPHGSLSSLL-----------FGSTECLEWTIRYK--- 245
           PN   L+G  T++    ++  +  HG L   L                 ++  +      
Sbjct: 72  PNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFV 131

Query: 246 -IALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDN----WSH 300
            +   IA G++YL       ++H+D+   N+L+ +    +ISD GL + +          
Sbjct: 132 HLVAQIAAGMEYLSS---HHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLG 188

Query: 301 HIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELIT 341
           + + PI       +PE  M+G     +D++++GV+L E+ +
Sbjct: 189 NSLLPIRWM----APEAIMYGKFSIDSDIWSYGVVLWEVFS 225

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score =  119 bits (301), Expect = 1e-30
 Identities = 60/226 (26%), Positives = 107/226 (47%), Gaps = 50/226 (22%)

Query: 147 ENLIGKGGHAEVYKGCLPDGEV---VAVKKIIKNAKEDEERISDFLSELGIVAHI-NHPN 202
           +++IG+G   +V K  +    +    A+K++ + A +D+ R  DF  EL ++  + +HPN
Sbjct: 30  QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHR--DFAGELEVLCKLGHHPN 87

Query: 203 AAKLIGFSTENG-FHLVLQFLPHGSLSSLL-----------FGSTECLEWTIRYK----I 246
              L+G     G  +L +++ PHG+L   L           F        T+  +     
Sbjct: 88  IINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHF 147

Query: 247 ALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAK-----------WLP 295
           A  +A G+ YL     ++ IHRD+ A NIL+ E+Y A+I+DFGL++            LP
Sbjct: 148 AADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLP 204

Query: 296 DNWSHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELIT 341
             W              ++ E   + +    +DV+++GVLL E+++
Sbjct: 205 VRW--------------MAIESLNYSVYTTNSDVWSYGVLLWEIVS 236

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  119 bits (301), Expect = 2e-30
 Identities = 57/198 (28%), Positives = 88/198 (44%), Gaps = 10/198 (5%)

Query: 149 LIGKGGHAEVYKG-CLPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLI 207
            +GKGG A+ ++       EV A K + K+      +      E+ I   + H +     
Sbjct: 48  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 107

Query: 208 G-FSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRII 266
           G F   +   +VL+     SL  L        E   RY +   I  G QYLH     R+I
Sbjct: 108 GFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLR-QIVLGCQYLHR---NRVI 163

Query: 267 HRDIKASNILLSEDYEAQISDFGLAKWL-PDNWSHHIVFPIEGTFGYLSPEYFMHGIVDE 325
           HRD+K  N+ L+ED E +I DFGLA  +  D     +   + GT  Y++PE         
Sbjct: 164 HRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV---LCGTPNYIAPEVLSKKGHSF 220

Query: 326 KTDVFAFGVLLLELITGR 343
           + DV++ G ++  L+ G+
Sbjct: 221 EVDVWSIGCIMYTLLVGK 238

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score =  118 bits (299), Expect = 2e-30
 Identities = 49/203 (24%), Positives = 81/203 (39%), Gaps = 13/203 (6%)

Query: 147 ENLIGKGGHAEVYKG-CLPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAK 205
             L+G+GG  +VY+        +VA+K + +    D    +    E      +  P+   
Sbjct: 39  RRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVP 98

Query: 206 LIGFSTENGFH-LVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRR 264
           +  F   +G   + ++ +    L+++L      L       I   I   L   H      
Sbjct: 99  IHDFGEIDGQLYVDMRLINGVDLAAML-RRQGPLAPPRAVAIVRQIGSALDAAHA---AG 154

Query: 265 IIHRDIKASNILLSEDYEAQISDFGLAKWLPDN---WSHHIVFPIEGTFGYLSPEYFMHG 321
             HRD+K  NIL+S D  A + DFG+A    D       + V    GT  Y++PE F   
Sbjct: 155 ATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTV----GTLYYMAPERFSES 210

Query: 322 IVDEKTDVFAFGVLLLELITGRR 344
               + D++A   +L E +TG  
Sbjct: 211 HATYRADIYALTCVLYECLTGSP 233

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score =  120 bits (302), Expect = 2e-30
 Identities = 66/212 (31%), Positives = 97/212 (45%), Gaps = 29/212 (13%)

Query: 150 IGKGGHAEVYKGCLPDGE------VVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNA 203
           +G G   EVY+G +           VAVK + +   E +E   DFL E  I++  NH N 
Sbjct: 79  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDEL--DFLMEALIISKFNHQNI 136

Query: 204 AKLIGFSTENG-FHLVLQFLPHGSLSSLL----FGSTECLEWTIR--YKIALGIAEGLQY 256
            + IG S ++    ++L+ +  G L S L       ++     +     +A  IA G QY
Sbjct: 137 VRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 196

Query: 257 LHHDCHRRIIHRDIKASNILLS---EDYEAQISDFGLAKWLPDN----WSHHIVFPIEGT 309
           L        IHRDI A N LL+       A+I DFG+A+ +            + P++  
Sbjct: 197 LEE---NHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWM 253

Query: 310 FGYLSPEYFMHGIVDEKTDVFAFGVLLLELIT 341
                PE FM GI   KTD ++FGVLL E+ +
Sbjct: 254 ----PPEAFMEGIFTSKTDTWSFGVLLWEIFS 281

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  118 bits (297), Expect = 2e-30
 Identities = 61/204 (29%), Positives = 92/204 (45%), Gaps = 10/204 (4%)

Query: 142 DNFNSENLIGKGGHAEVYKG-CLPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINH 200
           D+F+    +GKG    VY      +  ++A+K + K+  E E        E+ I +H+ H
Sbjct: 14  DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRH 73

Query: 201 PNAAKLIG-FSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHH 259
           PN  ++   F      +L+L+F P G L   L       E      +   +A+ L Y H 
Sbjct: 74  PNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEE-LADALHYCHE 132

Query: 260 DCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEGTFGYLSPEYFM 319
              R++IHRDIK  N+L+    E +I+DFG +   P      +     GT  YL PE   
Sbjct: 133 ---RKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRTMC----GTLDYLPPEMIE 185

Query: 320 HGIVDEKTDVFAFGVLLLELITGR 343
               DEK D++  GVL  E + G 
Sbjct: 186 GKTHDEKVDLWCAGVLCYEFLVGM 209

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score =  118 bits (299), Expect = 3e-30
 Identities = 53/220 (24%), Positives = 99/220 (45%), Gaps = 34/220 (15%)

Query: 147 ENLIGKGGHAEVYKGCLPDGE------VVAVKKIIKNAKEDEERISDFLSELGIVAHI-N 199
              +G G   +V +              VAVK +   A  DE+     +SEL I++H+  
Sbjct: 51  GKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKE--ALMSELKIMSHLGQ 108

Query: 200 HPNAAKLIGFSTENG-FHLVLQFLPHGSLSSLLFGSTECLEWTIRY-------------K 245
           H N   L+G  T  G   ++ ++  +G L + L   +  LE    +              
Sbjct: 109 HENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLH 168

Query: 246 IALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDN----WSHH 301
            +  +A+G+ +L     +  IHRD+ A N+LL+  + A+I DFGLA+ + ++       +
Sbjct: 169 FSSQVAQGMAFLAS---KNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGN 225

Query: 302 IVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELIT 341
              P++      +PE     +   ++DV+++G+LL E+ +
Sbjct: 226 ARLPVKWM----APESIFDCVYTVQSDVWSYGILLWEIFS 261

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  122 bits (308), Expect = 4e-30
 Identities = 61/300 (20%), Positives = 109/300 (36%), Gaps = 38/300 (12%)

Query: 149 LIGKGGHAEVYKG--CLPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKL 206
            I  GG   +Y       +G  V +K  + ++  D E  +  ++E   +A + HP+  ++
Sbjct: 87  CIAHGGLGWIYLALDRNVNGRPVVLK-GLVHS-GDAEAQAMAMAERQFLAEVVHPSIVQI 144

Query: 207 IGFSTENGFH------LVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHD 260
             F      H      +V++++   SL          +   I     L I   L YLH  
Sbjct: 145 FNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQKLP-VAEAIA--YLLEILPALSYLHS- 200

Query: 261 CHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEGTFGYLSPEYFMH 320
               +++ D+K  NI+L+E+ + ++ D G    +      ++     GT G+ +PE    
Sbjct: 201 --IGLVYNDLKPENIMLTEE-QLKLIDLGAVSRINS--FGYLY----GTPGFQAPEIVRT 251

Query: 321 GIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTS-NFKELV------DP- 372
           G     TD++  G  L  L       + R    +    P+L+T  ++  L+      DP 
Sbjct: 252 GPTV-ATDIYTVGRTLAALTLDLPTRNGRYVDGLPEDDPVLKTYDSYGRLLRRAIDPDPR 310

Query: 373 -RLADAYDLAEMKRAMLTA--SVCIHHLSTMRPQMTRVLQLLRGEGGQTDLKPKPSARRT 429
            R   A    EM   +      V        RP ++ +    R   G   L         
Sbjct: 311 QRFTTA---EEMSAQLTGVLREVVAQDTGVPRPGLSTIFSPSRSTFGVDLLVAHTDVYLD 367

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  117 bits (295), Expect = 4e-30
 Identities = 57/198 (28%), Positives = 88/198 (44%), Gaps = 10/198 (5%)

Query: 149 LIGKGGHAEVYKG-CLPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLI 207
            +GKGG A+ ++       EV A K + K+      +      E+ I   + H +     
Sbjct: 22  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 81

Query: 208 G-FSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRII 266
           G F   +   +VL+     SL  L        E   RY +   I  G QYLH     R+I
Sbjct: 82  GFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLR-QIVLGCQYLHR---NRVI 137

Query: 267 HRDIKASNILLSEDYEAQISDFGLAKWL-PDNWSHHIVFPIEGTFGYLSPEYFMHGIVDE 325
           HRD+K  N+ L+ED E +I DFGLA  +  D     +   + GT  Y++PE         
Sbjct: 138 HRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV---LCGTPNYIAPEVLSKKGHSF 194

Query: 326 KTDVFAFGVLLLELITGR 343
           + DV++ G ++  L+ G+
Sbjct: 195 EVDVWSIGCIMYTLLVGK 212

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score =  117 bits (296), Expect = 6e-30
 Identities = 61/226 (26%), Positives = 104/226 (46%), Gaps = 43/226 (19%)

Query: 150 IGKGGHAEVYKGCLPDGE------VVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNA 203
           +G+G   +V K      +       VAVK + +NA   E R  D LSE  ++  +NHP+ 
Sbjct: 31  LGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELR--DLLSEFNVLKQVNHPHV 88

Query: 204 AKLIGFSTENG-FHLVLQFLPHGSLSSLL-------------------FGSTECLEWTIR 243
            KL G  +++G   L++++  +GSL   L                          E  + 
Sbjct: 89  IKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALT 148

Query: 244 YK----IALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDN-- 297
                  A  I++G+QYL      +++HRD+ A NIL++E  + +ISDFGL++ + +   
Sbjct: 149 MGDLISFAWQISQGMQYLAE---MKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDS 205

Query: 298 --WSHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELIT 341
                    P++      + E     I   ++DV++FGVLL E++T
Sbjct: 206 YVKRSQGRIPVKWM----AIESLFDHIYTTQSDVWSFGVLLWEIVT 247

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score =  117 bits (294), Expect = 8e-30
 Identities = 55/210 (26%), Positives = 105/210 (50%), Gaps = 17/210 (8%)

Query: 141 TDNFNSENLIGKGGHAEVYKG-CLPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHIN 199
            + +     +G G   +VYK      G + A K I     + EE + D++ E+ I+A  +
Sbjct: 18  NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVI---ETKSEEELEDYIVEIEILATCD 74

Query: 200 HPNAAKLIG-FSTENGFHLVLQFLPHGSLSSLLFGSTECL-EWTIRYKIALGIAEGLQYL 257
           HP   KL+G +  +    ++++F P G++ +++      L E  I+  +   + E L +L
Sbjct: 75  HPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQV-VCRQMLEALNFL 133

Query: 258 HHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEGTFGYLSPEY 317
           H    +RIIHRD+KA N+L++ + + +++DFG++            F   GT  +++PE 
Sbjct: 134 HS---KRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFI--GTPYWMAPEV 188

Query: 318 FMHGIV-----DEKTDVFAFGVLLLELITG 342
            M   +     D K D+++ G+ L+E+   
Sbjct: 189 VMCETMKDTPYDYKADIWSLGITLIEMAQI 218

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score =  117 bits (295), Expect = 8e-30
 Identities = 59/220 (26%), Positives = 102/220 (46%), Gaps = 37/220 (16%)

Query: 150 IGKGGHAEVYKGCL------PDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHI-NHPN 202
           +G+G   +V +              VAVK + + A   E R    +SEL I+ HI +H N
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHR--ALMSELKILIHIGHHLN 92

Query: 203 AAKLIGFSTENG--FHLVLQFLPHGSLSSLL-----------FGSTECLEWTIRYK---- 245
              L+G  T+ G    ++++F   G+LS+ L               +  +  +  +    
Sbjct: 93  VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 152

Query: 246 IALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDN----WSHH 301
            +  +A+G+++L     R+ IHRD+ A NILLSE    +I DFGLA+ +  +        
Sbjct: 153 YSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGD 209

Query: 302 IVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELIT 341
              P++      +PE     +   ++DV++FGVLL E+ +
Sbjct: 210 ARLPLKWM----APETIFDRVYTIQSDVWSFGVLLWEIFS 245

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score =  118 bits (297), Expect = 1e-29
 Identities = 53/221 (23%), Positives = 104/221 (47%), Gaps = 38/221 (17%)

Query: 150 IGKGGHAEVYKGCLPDGE--------VVAVKKIIKNAKEDEERISDFLSELGIVAHI-NH 200
           +G+G   +V        +         VAVK +  +A E +    D +SE+ ++  I  H
Sbjct: 89  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLS--DLVSEMEMMKMIGKH 146

Query: 201 PNAAKLIGFSTENG-FHLVLQFLPHGSLSSLL-----------FGSTECLEWTIRYK--- 245
            N   L+G  T++G  ++++++   G+L   L           +      E  + +K   
Sbjct: 147 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 206

Query: 246 -IALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDN----WSH 300
                +A G++YL     ++ IHRD+ A N+L++E+   +I+DFGLA+ + +      + 
Sbjct: 207 SCTYQLARGMEYLAS---QKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTT 263

Query: 301 HIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELIT 341
           +   P++      +PE     +   ++DV++FGVL+ E+ T
Sbjct: 264 NGRLPVKWM----APEALFDRVYTHQSDVWSFGVLMWEIFT 300

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score =  116 bits (293), Expect = 1e-29
 Identities = 53/207 (25%), Positives = 96/207 (46%), Gaps = 19/207 (9%)

Query: 149 LIGKGGHAEVYKG-CLPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKL- 206
           ++G GG +EV+    L D   VAVK +  +   D      F  E    A +NHP    + 
Sbjct: 19  ILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVY 78

Query: 207 -IGFSTENGFH---LVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCH 262
             G +         +V++++   +L  ++  +   +      ++     + L + H    
Sbjct: 79  DTGEAETPAGPLPYIVMEYVDGVTLRDIV-HTEGPMTPKRAIEVIADACQALNFSHQ--- 134

Query: 263 RRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSH-----HIVFPIEGTFGYLSPEY 317
             IIHRD+K +NI++S     ++ DFG+A+ + D+ +       ++    GT  YLSPE 
Sbjct: 135 NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVI----GTAQYLSPEQ 190

Query: 318 FMHGIVDEKTDVFAFGVLLLELITGRR 344
                VD ++DV++ G +L E++TG  
Sbjct: 191 ARGDSVDARSDVYSLGCVLYEVLTGEP 217

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score =  116 bits (293), Expect = 1e-29
 Identities = 56/205 (27%), Positives = 101/205 (49%), Gaps = 14/205 (6%)

Query: 141 TDNFNSENLIGKGGHAEVYKGC-LPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHIN 199
            + F+    +G+G +  VYK      G++VA+K++       E  + + + E+ I+   +
Sbjct: 28  EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQV-----PVESDLQEIIKEISIMQQCD 82

Query: 200 HPNAAKLIG-FSTENGFHLVLQFLPHGSLSSLLFGSTECL-EWTIRYKIALGIAEGLQYL 257
            P+  K  G +       +V+++   GS+S ++    + L E  I   I     +GL+YL
Sbjct: 83  SPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIAT-ILQSTLKGLEYL 141

Query: 258 HHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEGTFGYLSPEY 317
           H     R IHRDIKA NILL+ +  A+++DFG+A  L D  +        GT  +++PE 
Sbjct: 142 HF---MRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVI--GTPFWMAPEV 196

Query: 318 FMHGIVDEKTDVFAFGVLLLELITG 342
                 +   D+++ G+  +E+  G
Sbjct: 197 IQEIGYNCVADIWSLGITAIEMAEG 221

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score =  117 bits (294), Expect = 1e-29
 Identities = 53/221 (23%), Positives = 104/221 (47%), Gaps = 38/221 (17%)

Query: 150 IGKGGHAEVYKGCLPDGE--------VVAVKKIIKNAKEDEERISDFLSELGIVAHI-NH 200
           +G+G   +V        +         VAVK +  +A E +    D +SE+ ++  I  H
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLS--DLVSEMEMMKMIGKH 100

Query: 201 PNAAKLIGFSTENG-FHLVLQFLPHGSLSSLL-----------FGSTECLEWTIRYK--- 245
            N   L+G  T++G  ++++++   G+L   L           +      E  + +K   
Sbjct: 101 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160

Query: 246 -IALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDN----WSH 300
                +A G++YL     ++ IHRD+ A N+L++E+   +I+DFGLA+ + +      + 
Sbjct: 161 SCTYQLARGMEYLAS---QKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTT 217

Query: 301 HIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELIT 341
           +   P++      +PE     +   ++DV++FGVL+ E+ T
Sbjct: 218 NGRLPVKWM----APEALFDRVYTHQSDVWSFGVLMWEIFT 254

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  117 bits (294), Expect = 1e-29
 Identities = 58/225 (25%), Positives = 92/225 (40%), Gaps = 35/225 (15%)

Query: 147 ENLIGKGGHAEVYKG-CLPDGEVVAVKKIIKNAKEDEERIS---DFLSELGIVAHINHPN 202
             ++ +GG A VY+   +  G   A+K+++ N +E    I     F+ +L       HPN
Sbjct: 33  RRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKL-----SGHPN 87

Query: 203 AAKLIGFS--------TENGFHLVLQFLPHGSLSSLL--FGSTECL-EWTIRYKIALGIA 251
             +    +        T     L+L  L  G L   L    S   L   T+  KI     
Sbjct: 88  IVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVL-KIFYQTC 146

Query: 252 EGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWL----PDNWSHHIVFPIE 307
             +Q++H      IIHRD+K  N+LLS     ++ DFG A  +      +WS      +E
Sbjct: 147 RAVQHMHR-QKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVE 205

Query: 308 ------GTFGYLSPE---YFMHGIVDEKTDVFAFGVLLLELITGR 343
                  T  Y +PE    + +  + EK D++A G +L  L   +
Sbjct: 206 EEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQ 250

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score =  116 bits (293), Expect = 2e-29
 Identities = 53/226 (23%), Positives = 96/226 (42%), Gaps = 43/226 (19%)

Query: 150 IGKGGHAEVYKGCLPDGE------VVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNA 203
           IG+G    V++   P         +VAVK + + A  D +   DF  E  ++A  ++PN 
Sbjct: 55  IGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQA--DFQREAALMAEFDNPNI 112

Query: 204 AKLIGFSTENG-FHLVLQFLPHGSLSSLLFGSTECLEWTIRY------------------ 244
            KL+G         L+ +++ +G L+  L   +     ++ +                  
Sbjct: 113 VKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLS 172

Query: 245 -----KIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDN-- 297
                 IA  +A G+ YL     R+ +HRD+   N L+ E+   +I+DFGL++ +     
Sbjct: 173 CAEQLCIARQVAAGMAYLSE---RKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADY 229

Query: 298 --WSHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELIT 341
                +   PI        PE   +     ++DV+A+GV+L E+ +
Sbjct: 230 YKADGNDAIPIRWM----PPESIFYNRYTTESDVWAYGVVLWEIFS 271

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  116 bits (291), Expect = 2e-29
 Identities = 50/222 (22%), Positives = 93/222 (41%), Gaps = 30/222 (13%)

Query: 142 DNFNSENLIGKGGHAEVYKGC-LPDGEVVAVKKIIK-NAKEDEERISDFLSELGIVAHIN 199
             +   +++G+G  A V++G     G++ A+K     +     +     + E  ++  +N
Sbjct: 9   HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQ---MREFEVLKKLN 65

Query: 200 HPNAAKLIGF---STENGFHLVLQFLPHGSLSSLL--FGSTECL-EWTIRYKIALGIAEG 253
           H N  KL      +T     L+++F P GSL ++L    +   L E      +   +  G
Sbjct: 66  HKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFL-IVLRDVVGG 124

Query: 254 LQYLHHDCHRRIIHRDIKASNILLSEDYEAQ----ISDFGLAKWLPDNWSHHIVFPIEGT 309
           + +L       I+HR+IK  NI+     + Q    ++DFG A+ L D+        + GT
Sbjct: 125 MNHLRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDD---EQFVSLYGT 178

Query: 310 FGYLSPEYFMHGIV--------DEKTDVFAFGVLLLELITGR 343
             YL P+ +   ++            D+++ GV      TG 
Sbjct: 179 EEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score =  117 bits (294), Expect = 3e-29
 Identities = 57/221 (25%), Positives = 104/221 (47%), Gaps = 38/221 (17%)

Query: 150 IGKGGHAEVYKGCLPDGE--------VVAVKKIIKNAKEDEERISDFLSELGIVAHI-NH 200
           +G+G   +V        +         VAVK +  +A E +    D +SE+ ++  I  H
Sbjct: 77  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLS--DLISEMEMMKMIGKH 134

Query: 201 PNAAKLIGFSTENG-FHLVLQFLPHGSLSSLL-----------FGSTECLEWTIRYK--- 245
            N   L+G  T++G  ++++++   G+L   L           +  +   E  +  K   
Sbjct: 135 KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLV 194

Query: 246 -IALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDN----WSH 300
             A  +A G++YL     ++ IHRD+ A N+L++ED   +I+DFGLA+ +        + 
Sbjct: 195 SCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTT 251

Query: 301 HIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELIT 341
           +   P++      +PE     I   ++DV++FGVLL E+ T
Sbjct: 252 NGRLPVKWM----APEALFDRIYTHQSDVWSFGVLLWEIFT 288

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score =  115 bits (291), Expect = 3e-29
 Identities = 51/221 (23%), Positives = 98/221 (44%), Gaps = 38/221 (17%)

Query: 150 IGKGGHAEVYKG----CLPDGEV--VAVKKIIKNAKEDEERISDFLSELGIVAHI-NHPN 202
           +G G   +V +      +       VAVK +  +A   E      +SEL +++++ NH N
Sbjct: 31  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTERE--ALMSELKVLSYLGNHMN 88

Query: 203 AAKLIGFSTENG-FHLVLQFLPHGSLSSLL-------------FGSTECLEWTIRYK--- 245
              L+G  T  G   ++ ++  +G L + L                 E  E  +  +   
Sbjct: 89  IVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLL 148

Query: 246 -IALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDN----WSH 300
             +  +A+G+ +L     +  IHRD+ A NILL+     +I DFGLA+ + ++       
Sbjct: 149 SFSYQVAKGMAFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKG 205

Query: 301 HIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELIT 341
           +   P++      +PE   + +   ++DV+++G+ L EL +
Sbjct: 206 NARLPVKWM----APESIFNCVYTFESDVWSYGIFLWELFS 242

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  116 bits (292), Expect = 4e-29
 Identities = 41/227 (18%), Positives = 92/227 (40%), Gaps = 33/227 (14%)

Query: 142 DNFNSENLIGKGGHAEVYKGCLPDGEVVAVKKIIKNAKEDEERISDFLS----------- 190
           +++     + +G   ++   C  D +  A+KK  K+  E +   +   +           
Sbjct: 31  NDYRIIRTLNQGKFNKIIL-CEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDD 89

Query: 191 ---ELGIVAHINHPNAAKLIG-FSTENGFHLVLQFLPHGSLSSLL--------FGSTECL 238
              EL I+  I +       G  +  +  +++ +++ + S+              +    
Sbjct: 90  FKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIP 149

Query: 239 EWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNW 298
              I+  I   +     Y+H+   + I HRD+K SNIL+ ++   ++SDFG ++++ D  
Sbjct: 150 IQVIKCIIK-SVLNSFSYIHN--EKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKK 206

Query: 299 SHHIVFPIEGTFGYLSPEYFMH--GIVDEKTDVFAFGVLLLELITGR 343
                    GT+ ++ PE+F +       K D+++ G+ L  +    
Sbjct: 207 IKGSR----GTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNV 249

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  116 bits (291), Expect = 4e-29
 Identities = 21/267 (7%), Positives = 58/267 (21%), Gaps = 43/267 (16%)

Query: 112 EDDDADDGGSVPIVRHSWKNFDFAELAAATDNFNSENLIGKGGHAEVYKG-CLPDGEVVA 170
           E     +  +  +   + +    + L+           +  G  + V+    +   E  A
Sbjct: 32  EPAAMVEAVTATVWPQNAETTVDSLLSQGERKLKLVEPLRVGDRSVVFLVRDVERLEDFA 91

Query: 171 VKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLI----------------------- 207
           +K     A+     +          A +   +  +                         
Sbjct: 92  LKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQL 151

Query: 208 --GFSTENGFHLVLQF-LPHGSLSSL------LFGSTECLEWTIRYKIALGIAEGLQYLH 258
             G       + +L        L  L      ++           + +   +      L 
Sbjct: 152 SPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQ 211

Query: 259 HDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEGTFGYLSPEYF 318
               + ++H      N+ +  D    + D      +                 Y   E+ 
Sbjct: 212 S---KGLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTRGP-----ASSVPVTYAPREFL 263

Query: 319 MHG--IVDEKTDVFAFGVLLLELITGR 343
                      + +  G+ +  +    
Sbjct: 264 NASTATFTHALNAWQLGLSIYRVWCLF 290

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score =  112 bits (283), Expect = 3e-28
 Identities = 49/204 (24%), Positives = 96/204 (47%), Gaps = 12/204 (5%)

Query: 141 TDNFNSENLIGKGGHAEVYKG-CLPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHIN 199
              +     IG+G    VY    +  G+ VA++++    +  +E I   ++E+ ++    
Sbjct: 19  KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELI---INEILVMRENK 75

Query: 200 HPNAAKLIG-FSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLH 258
           +PN    +  +   +   +V+++L  GSL+ ++   T   E  I   +     + L++LH
Sbjct: 76  NPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVV-TETCMDEGQIAA-VCRECLQALEFLH 133

Query: 259 HDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEGTFGYLSPEYF 318
                ++IHRDIK+ NILL  D   +++DFG    +    S        GT  +++PE  
Sbjct: 134 S---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV--GTPYWMAPEVV 188

Query: 319 MHGIVDEKTDVFAFGVLLLELITG 342
                  K D+++ G++ +E+I G
Sbjct: 189 TRKAYGPKVDIWSLGIMAIEMIEG 212

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score =  113 bits (284), Expect = 3e-28
 Identities = 58/213 (27%), Positives = 94/213 (44%), Gaps = 19/213 (8%)

Query: 142 DNFNSENLIGKGGHAEVYKG-CLPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAH-IN 199
           ++      IG+G +  V K    P G+++AVK+I   +  DE+     L +L +V    +
Sbjct: 22  EDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRI--RSTVDEKEQKQLLMDLDVVMRSSD 79

Query: 200 HPNAAKLIG-FSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIR----YKIALGIAEGL 254
            P   +  G    E    + ++ +   S           L+  I      KI L   + L
Sbjct: 80  CPYIVQFYGALFREGDCWICMELMS-TSFDKFYKYVYSVLDDVIPEEILGKITLATVKAL 138

Query: 255 QYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEGTFGYLS 314
            +L  +   +IIHRDIK SNILL      ++ DFG++  L D+ +        G   Y++
Sbjct: 139 NHLKEN--LKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAKTRDA---GCRPYMA 193

Query: 315 PEYFMHGIV----DEKTDVFAFGVLLLELITGR 343
           PE           D ++DV++ G+ L EL TGR
Sbjct: 194 PERIDPSASRQGYDVRSDVWSLGITLYELATGR 226

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  114 bits (287), Expect = 3e-28
 Identities = 50/222 (22%), Positives = 93/222 (41%), Gaps = 30/222 (13%)

Query: 142 DNFNSENLIGKGGHAEVYKGC-LPDGEVVAVKKIIK-NAKEDEERISDFLSELGIVAHIN 199
             +   +++G+G  A V++G     G++ A+K     +     +     + E  ++  +N
Sbjct: 9   HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQ---MREFEVLKKLN 65

Query: 200 HPNAAKLIGF---STENGFHLVLQFLPHGSLSSLL--FGSTECL-EWTIRYKIALGIAEG 253
           H N  KL      +T     L+++F P GSL ++L    +   L E      +   +  G
Sbjct: 66  HKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFL-IVLRDVVGG 124

Query: 254 LQYLHHDCHRRIIHRDIKASNILLSEDYEAQ----ISDFGLAKWLPDNWSHHIVFPIEGT 309
           + +L       I+HR+IK  NI+     + Q    ++DFG A+ L D+        + GT
Sbjct: 125 MNHLRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDD---EQFVSLYGT 178

Query: 310 FGYLSPEYFMHGIV--------DEKTDVFAFGVLLLELITGR 343
             YL P+ +   ++            D+++ GV      TG 
Sbjct: 179 EEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score =  111 bits (281), Expect = 5e-28
 Identities = 52/212 (24%), Positives = 99/212 (46%), Gaps = 18/212 (8%)

Query: 142 DNFNSENLIGKGGHAEVYKGC-LPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAH-IN 199
           D+      +G+G +  V K   +P G+++AVK+I       E++    L +L I    ++
Sbjct: 7   DDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQK--RLLMDLDISMRTVD 64

Query: 200 HPNAAKLIG-FSTENGFHLVLQFLPHGSLSSLL---FGSTECLEWTIRYKIALGIAEGLQ 255
            P      G    E    + ++ +   SL           + +   I  KIA+ I + L+
Sbjct: 65  CPFTVTFYGALFREGDVWICMELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALE 123

Query: 256 YLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEGTFGYLSP 315
           +LH      +IHRD+K SN+L++   + ++ DFG++ +L D+ +  I     G   Y++P
Sbjct: 124 HLHSK--LSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDIDA---GCKPYMAP 178

Query: 316 EYFMHGIV----DEKTDVFAFGVLLLELITGR 343
           E     +       K+D+++ G+ ++EL   R
Sbjct: 179 ERINPELNQKGYSVKSDIWSLGITMIELAILR 210

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score =  111 bits (280), Expect = 6e-28
 Identities = 41/217 (18%), Positives = 86/217 (39%), Gaps = 31/217 (14%)

Query: 147 ENLIGKGGHAEVYKGCLPDGEV--------VAVKKIIKNAKEDEERISDFLSELGIVAHI 198
              +G+G   +++KG   +           V +K ++  A  +      F     +++ +
Sbjct: 13  NESLGQGTFTKIFKGVRREVGDYGQLHETEVLLK-VLDKAHRNYSE--SFFEAASMMSKL 69

Query: 199 NHPNAAKLIGFSTENG-FHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYL 257
           +H +     G         LV +F+  GSL + L  +  C+    + ++A  +A  + +L
Sbjct: 70  SHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFL 129

Query: 258 HHDCHRRIIHRDIKASNILLSEDYEAQ--------ISDFGLAKWLPDNWSHHIVFPIEGT 309
                  +IH ++ A NILL  + + +        +SD G++  +       +   I   
Sbjct: 130 EE---NTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPK--DILQERIPWV 184

Query: 310 FGYLSPEYFMHGIV-DEKTDVFAFGVLLLELIT-GRR 344
                PE   +    +  TD ++FG  L E+ + G +
Sbjct: 185 ----PPECIENPKNLNLATDKWSFGTTLWEICSGGDK 217

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score =  111 bits (279), Expect = 2e-27
 Identities = 51/226 (22%), Positives = 97/226 (42%), Gaps = 43/226 (19%)

Query: 150 IGKGGHAEVYKGCLPDGE------VVAVKKIIKNAKEDEERISDFLSELGIVAHI-NHPN 202
           +G G   +V                VAVK + + A   E      +SEL ++  + +H N
Sbjct: 53  LGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSERE--ALMSELKMMTQLGSHEN 110

Query: 203 AAKLIGFSTENG-FHLVLQFLPHGSLSSLL------------------FGSTECLEWTIR 243
              L+G  T +G  +L+ ++  +G L + L                      E     + 
Sbjct: 111 IVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLT 170

Query: 244 YK----IALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDN-- 297
           ++     A  +A+G+++L     +  +HRD+ A N+L++     +I DFGLA+ +  +  
Sbjct: 171 FEDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSN 227

Query: 298 --WSHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELIT 341
                +   P++      +PE    GI   K+DV+++G+LL E+ +
Sbjct: 228 YVVRGNARLPVKWM----APESLFEGIYTIKSDVWSYGILLWEIFS 269

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  112 bits (282), Expect = 2e-27
 Identities = 53/231 (22%), Positives = 87/231 (37%), Gaps = 40/231 (17%)

Query: 142 DNFNSENLIGKGGHAEVYKGCLPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHI-NH 200
           +   SE ++G G    V       G  VAVK+++       +     L E+ ++    +H
Sbjct: 15  NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLI------DFCDIALMEIKLLTESDDH 68

Query: 201 PNAAKLIG-FSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRY------KIALGIAEG 253
           PN  +     +T+   ++ L+     +L  L+       E            +   IA G
Sbjct: 69  PNVIRYYCSETTDRFLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASG 127

Query: 254 LQYLHHDCHRRIIHRDIKASNILLS-------------EDYEAQISDFGLAKWLPDNWSH 300
           + +LH     +IIHRD+K  NIL+S             E+    ISDFGL K L    S 
Sbjct: 128 VAHLH---SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSS 184

Query: 301 HIVFP--IEGTFGYLSPEYFMHGIV-------DEKTDVFAFGVLLLELITG 342
                    GT G+ +PE                  D+F+ G +   +++ 
Sbjct: 185 FRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSK 235

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score =  110 bits (277), Expect = 2e-27
 Identities = 47/204 (23%), Positives = 93/204 (45%), Gaps = 12/204 (5%)

Query: 141 TDNFNSENLIGKGGHAEVYKG-CLPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHIN 199
               +S   IG+G    V        G  VAVK +    ++  E +    +E+ I+    
Sbjct: 44  RLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELL---FNEVVIMRDYQ 100

Query: 200 HPNAAKLIG-FSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLH 258
           H N  ++   +       ++++FL  G+L+ ++       E  I   +   + + L YLH
Sbjct: 101 HFNVVEMYKSYLVGEELWVLMEFLQGGALTDIV-SQVRLNEEQIAT-VCEAVLQALAYLH 158

Query: 259 HDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEGTFGYLSPEYF 318
               + +IHRDIK+ +ILL+ D   ++SDFG    +  +          GT  +++PE  
Sbjct: 159 A---QGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLV--GTPYWMAPEVI 213

Query: 319 MHGIVDEKTDVFAFGVLLLELITG 342
              +   + D+++ G++++E++ G
Sbjct: 214 SRSLYATEVDIWSLGIMVIEMVDG 237

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  114 bits (285), Expect = 3e-27
 Identities = 63/226 (27%), Positives = 91/226 (40%), Gaps = 25/226 (11%)

Query: 141 TDNFNSENLIGKGGHAEVYKGC-LPDGEVVAVKKIIKNA-KEDEERISDFLSELGIVAHI 198
              +  +  +G GG   V +      GE VA+K+  +    ++ ER      E+ I+  +
Sbjct: 13  CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERW---CLEIQIMKKL 69

Query: 199 NHPNAAKLI-------GFSTENGFHLVLQFLPHGSLSSLL--FGSTECL-EWTIRYKIAL 248
           NHPN              +  +   L +++   G L   L  F +   L E  IR  +  
Sbjct: 70  NHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIR-TLLS 128

Query: 249 GIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQ---ISDFGLAKWLPDNWSHHIVFP 305
            I+  L+YLH     RIIHRD+K  NI+L    +     I D G AK L       +   
Sbjct: 129 DISSALRYLHE---NRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQG---ELCTE 182

Query: 306 IEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQ 351
             GT  YL+PE           D ++FG L  E ITG R      Q
Sbjct: 183 FVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQ 228

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score =  112 bits (281), Expect = 5e-27
 Identities = 62/208 (29%), Positives = 98/208 (47%), Gaps = 13/208 (6%)

Query: 141 TDNFNSENLIGKGGHAEVYKG-CLPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHIN 199
           +D +  + ++GKG   EV        G+  AVK I K   + +      L E+ ++  ++
Sbjct: 25  SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD 84

Query: 200 HPNAAKLIG-FSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLH 258
           HPN  KL   F  +  F+LV +    G L   +       E     +I   +  G+ Y+H
Sbjct: 85  HPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAA-RIIRQVLSGITYMH 143

Query: 259 HDCHRRIIHRDIKASNILL---SEDYEAQISDFGLAKWLPDNWSHHIVFPIEGTFGYLSP 315
                +I+HRD+K  N+LL   S+D   +I DFGL+     +          GT  Y++P
Sbjct: 144 ---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKI---GTAYYIAP 197

Query: 316 EYFMHGIVDEKTDVFAFGVLLLELITGR 343
           E   HG  DEK DV++ GV+L  L++G 
Sbjct: 198 EVL-HGTYDEKCDVWSTGVILYILLSGC 224

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score =  108 bits (272), Expect = 1e-26
 Identities = 46/210 (21%), Positives = 86/210 (40%), Gaps = 34/210 (16%)

Query: 141 TDNFNSENLIGKGGHAEVYKGC-LPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHIN 199
              F    ++G G  +EV+       G++ A+K I K+    +  + +   E+ ++  I 
Sbjct: 8   RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLEN---EIAVLKKIK 64

Query: 200 HPNAAKLIG-FSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRY---------KIALG 249
           H N   L   + +   ++LV+Q +  G          E  +  +            +   
Sbjct: 65  HENIVTLEDIYESTTHYYLVMQLVSGG----------ELFDRILERGVYTEKDASLVIQQ 114

Query: 250 IAEGLQYLHHDCHRRIIHRDIKASNILL---SEDYEAQISDFGLAKWLPDNWSHHIVFPI 306
           +   ++YLH      I+HRD+K  N+L     E+ +  I+DFGL+K   +          
Sbjct: 115 VLSAVKYLH---ENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIMSTAC--- 168

Query: 307 EGTFGYLSPEYFMHGIVDEKTDVFAFGVLL 336
            GT GY++PE        +  D ++ GV+ 
Sbjct: 169 -GTPGYVAPEVLAQKPYSKAVDCWSIGVIT 197

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score =  108 bits (272), Expect = 1e-26
 Identities = 52/210 (24%), Positives = 93/210 (44%), Gaps = 16/210 (7%)

Query: 142 DNFNSENLIGKGGHAEVYKG-CLPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAH-IN 199
           ++  +   +G G   +V+K      G V+AVK++      ++E     L +L +V    +
Sbjct: 25  NDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQM--RRSGNKEENKRILMDLDVVLKSHD 82

Query: 200 HPNAAKLIG-FSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLH 258
            P   +  G F T     + ++ +   +            E  +  K+ + I + L YL 
Sbjct: 83  CPYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGPIPERILG-KMTVAIVKALYYLK 141

Query: 259 HDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEGTFGYLSPEYF 318
                 +IHRD+K SNILL E  + ++ DFG++  L D+ +        G   Y++PE  
Sbjct: 142 EK--HGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKDRSA---GCAAYMAPERI 196

Query: 319 MHGIV-----DEKTDVFAFGVLLLELITGR 343
                     D + DV++ G+ L+EL TG+
Sbjct: 197 DPPDPTKPDYDIRADVWSLGISLVELATGQ 226

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  107 bits (269), Expect = 5e-26
 Identities = 37/225 (16%), Positives = 75/225 (33%), Gaps = 28/225 (12%)

Query: 141 TDNFNSENLIGKGGHAEVYKGC------LPDGEVVAVKKIIKNAKEDEERISDFLSELGI 194
           +      +L+G+G  A+VY+          + +   +K + K A   E  I      +  
Sbjct: 64  SKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLK-VQKPANPWEFYI--GTQLMER 120

Query: 195 VAHINHPNAAKLIG-FSTENGFHLVLQFLPHGSLSSLL----FGSTECLEWTIRYKIALG 249
           +         K       +NG  LV +   +G+L + +        + +   +    A+ 
Sbjct: 121 LKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMR 180

Query: 250 IAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEA-----------QISDFGLAKWLPDNW 298
           +   ++ +H      IIH DIK  N +L   +              + D G +  +    
Sbjct: 181 MLYMIEQVHD---CEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFP 237

Query: 299 SHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGR 343
              I      T G+   E   +   + + D F     +  ++ G 
Sbjct: 238 KGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGT 282

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score =  108 bits (272), Expect = 9e-26
 Identities = 56/209 (26%), Positives = 90/209 (43%), Gaps = 14/209 (6%)

Query: 141 TDNFNSENLIGKGGHAEVYKG-CLPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHIN 199
           ++ +     +G G + EV            A+K I K +       S  L E+ ++  ++
Sbjct: 36  SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSS-NSKLLEEVAVLKLLD 94

Query: 200 HPNAAKLIG-FSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLH 258
           HPN  KL   F  +  ++LV++    G L   +    +  E      I   +  G+ YLH
Sbjct: 95  HPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAA-VIIKQVLSGVTYLH 153

Query: 259 HDCHRRIIHRDIKASNILL---SEDYEAQISDFGLAKWLPDNWSHHIVFPIEGTFGYLSP 315
                 I+HRD+K  N+LL    +D   +I DFGL+    +           GT  Y++P
Sbjct: 154 ---KHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERL---GTAYYIAP 207

Query: 316 EYFMHGIVDEKTDVFAFGVLLLELITGRR 344
           E       DEK DV++ GV+L  L+ G  
Sbjct: 208 EVL-RKKYDEKCDVWSIGVILFILLAGYP 235

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score =  105 bits (265), Expect = 1e-25
 Identities = 66/208 (31%), Positives = 101/208 (48%), Gaps = 17/208 (8%)

Query: 141 TDNFNSENLIGKGGHAEVYKG-CLPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHIN 199
              F+    IG G    VY    + + EVVA+KK+  + K+  E+  D + E+  +  + 
Sbjct: 53  EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 112

Query: 200 HPNAAKLIG-FSTENGFHLVLQFLPHGSLSSLLFGSTECL-EWTIRYKIALGIAEGLQYL 257
           HPN  +  G +  E+   LV+++   GS S LL    + L E  I   +  G  +GL YL
Sbjct: 113 HPNTIQYRGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAA-VTHGALQGLAYL 170

Query: 258 HHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEGTFGYLSPE- 316
           H      +IHRD+KA NILLSE    ++ DFG A  +    ++  V    GT  +++PE 
Sbjct: 171 HS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIM--APANSFV----GTPYWMAPEV 221

Query: 317 --YFMHGIVDEKTDVFAFGVLLLELITG 342
                 G  D K DV++ G+  +EL   
Sbjct: 222 ILAMDEGQYDGKVDVWSLGITCIELAER 249

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score =  105 bits (264), Expect = 2e-25
 Identities = 64/233 (27%), Positives = 106/233 (45%), Gaps = 26/233 (11%)

Query: 126 RHSWKNFDFAELAAATDNFNSENLIGKGGHAEVYKG-CLPDGEVVAVKKIIKNAKEDEER 184
             S    D + L      F    L+G G + +VYKG  +  G++ A+K +  +   DE  
Sbjct: 8   ARSLDEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVM--DVTGDE-- 63

Query: 185 ISDFLSELGIVAHI-NHPNAAKLIG-FSTENGFH------LVLQFLPHGSLSSLLFGSTE 236
             +   E+ ++    +H N A   G F  +N         LV++F   GS++ L+  +  
Sbjct: 64  EEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKG 123

Query: 237 CL--EWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWL 294
               E  I Y I   I  GL +LH     ++IHRDIK  N+LL+E+ E ++ DFG++  L
Sbjct: 124 NTLKEEWIAY-ICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQL 179

Query: 295 PDNWSHHIVFPIEGTFGYLSPE-----YFMHGIVDEKTDVFAFGVLLLELITG 342
                    F   GT  +++PE            D K+D+++ G+  +E+  G
Sbjct: 180 DRTVGRRNTFI--GTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEG 230

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score =  103 bits (257), Expect = 1e-24
 Identities = 53/290 (18%), Positives = 100/290 (34%), Gaps = 34/290 (11%)

Query: 135 AELAAATDNFNSENLIGKGGHAEVYKGCLPDGEVVAVKKIIKNAKEDEERISDFLSELGI 194
            +  A  ++                K      E+    +           +     ++  
Sbjct: 55  VKALAKLEHPGIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRR 114

Query: 195 VAHINHPNAAKLIG-FSTENGFHLVLQFLPHGSLSSLL--FGSTECLEWTIRYKIALGIA 251
           +   +  N    +   S +   ++ +Q     +L   +    S E  E  +   I + IA
Sbjct: 115 MDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIA 174

Query: 252 EGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIE---- 307
           E +++LH    + ++HRD+K SNI  + D   ++ DFGL   +  +     V        
Sbjct: 175 EAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYA 231

Query: 308 ------GTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLL 361
                 GT  Y+SPE         K D+F+ G++L EL+        R + +        
Sbjct: 232 THTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMERVRII-------- 283

Query: 362 QTSNFKELVDPRLADAY--DLAEMKRAMLTASVCIHHLSTMRPQMTRVLQ 409
             ++ + L  P L          M + ML          T RP+ T +++
Sbjct: 284 --TDVRNLKFPLLFTQKYPQEHMMVQDML------SPSPTERPEATDIIE 325

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score =  104 bits (262), Expect = 2e-24
 Identities = 58/219 (26%), Positives = 94/219 (42%), Gaps = 23/219 (10%)

Query: 141 TDNFNSENLIGKGGHAEVYKG-CLPDGEVVAVKKIIKN----------AKEDEERISDFL 189
            +++     +G G + EV            A+K I K+           K  E+   +  
Sbjct: 35  GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIY 94

Query: 190 SELGIVAHINHPNAAKLIG-FSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIAL 248
           +E+ ++  ++HPN  KL   F  +  F+LV +F   G L   +    +  E      I  
Sbjct: 95  NEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAA-NIMK 153

Query: 249 GIAEGLQYLHHDCHRRIIHRDIKASNILL---SEDYEAQISDFGLAKWLPDNWSHHIVFP 305
            I  G+ YLH      I+HRDIK  NILL   +     +I DFGL+ +   ++       
Sbjct: 154 QILSGICYLH---KHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRL- 209

Query: 306 IEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRR 344
             GT  Y++PE       +EK DV++ GV++  L+ G  
Sbjct: 210 --GTAYYIAPEVL-KKKYNEKCDVWSCGVIMYILLCGYP 245

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score =  103 bits (260), Expect = 3e-24
 Identities = 61/219 (27%), Positives = 101/219 (46%), Gaps = 34/219 (15%)

Query: 141 TDNFNSENLIGKGGHAEVYKG-CLPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHIN 199
            + +N   ++GKG   EV K       +  AVK I K + ++++  S  L E+ ++  ++
Sbjct: 21  AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKD-TSTILREVELLKKLD 79

Query: 200 HPNAAKLIG-FSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTI---RY------KIALG 249
           HPN  KL       + F++V +    G L           +  I   R+      +I   
Sbjct: 80  HPNIMKLFEILEDSSSFYIVGELYTGGEL----------FDEIIKRKRFSEHDAARIIKQ 129

Query: 250 IAEGLQYLHHDCHRRIIHRDIKASNILL---SEDYEAQISDFGLAKWL-PDNWSHHIVFP 305
           +  G+ Y+H      I+HRD+K  NILL    +D + +I DFGL+     +      +  
Sbjct: 130 VFSGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRI-- 184

Query: 306 IEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRR 344
             GT  Y++PE    G  DEK DV++ GV+L  L++G  
Sbjct: 185 --GTAYYIAPEVL-RGTYDEKCDVWSAGVILYILLSGTP 220

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score =  101 bits (254), Expect = 4e-24
 Identities = 52/252 (20%), Positives = 92/252 (36%), Gaps = 52/252 (20%)

Query: 141 TDNFNSENLIGKGGHAEVYKGC-LPDGEVVAVKKIIKN--AKEDEERISDFLSELGIVAH 197
              ++ +  IG+G +  V          + A+K + KN   + + + +    +E+ ++  
Sbjct: 25  QKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKK 84

Query: 198 INHPNAAKLIG-FSTENGFHLVLQFLPHGSL----------------------------- 227
           ++HPN A+L   +  E    LV++    G L                             
Sbjct: 85  LHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPE 144

Query: 228 ----SSLLFGSTECLEWTIRY------KIALGIAEGLQYLHHDCHRRIIHRDIKASNILL 277
               +                       I   I   L YLH+   + I HRDIK  N L 
Sbjct: 145 CNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHN---QGICHRDIKPENFLF 201

Query: 278 SEDYEAQ--ISDFGLAKWLP--DNWSHHIVFPIEGTFGYLSPE--YFMHGIVDEKTDVFA 331
           S +   +  + DFGL+K     +N  ++ +    GT  +++PE     +     K D ++
Sbjct: 202 STNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWS 261

Query: 332 FGVLLLELITGR 343
            GVLL  L+ G 
Sbjct: 262 AGVLLHLLLMGA 273

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score =  102 bits (255), Expect = 4e-24
 Identities = 26/240 (10%), Positives = 61/240 (25%), Gaps = 54/240 (22%)

Query: 149 LIGKGGHAEVYKGC-LPDGEVVAVKKIIKNAKEDEERISD-------------------- 187
           ++G+       +      GE   V       +     I                      
Sbjct: 80  VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 139

Query: 188 -----FLSELGIVAHINHPNAAKLIG-FSTENGFHLVLQF-LPHGSLSSLL------FGS 234
                F+    +V         ++               +     +L +          +
Sbjct: 140 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 199

Query: 235 TECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWL 294
            + L    R ++ L +   L  LHH     ++H  ++  +I+L +     ++ F      
Sbjct: 200 HKSLVHHARLQLTLQVIRLLASLHH---YGLVHTYLRPVDIVLDQRGGVFLTGFEHLV-- 254

Query: 295 PDNWSHHIVFPIEGTFGYLSPEYFMH-----------GIVDEKTDVFAFGVLLLELITGR 343
            D            + G+  PE                ++    D +A G+++  +    
Sbjct: 255 RDGARVVSS----VSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCAD 310

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score =  102 bits (256), Expect = 5e-24
 Identities = 55/256 (21%), Positives = 89/256 (34%), Gaps = 39/256 (15%)

Query: 106 GRLQIPEDDDADDGGSVPIVRHSWKNFDFAELAAATDNFNS----ENLIGKGGHAEVYKG 161
           G     + D              WK +    +     +          +G G    V++ 
Sbjct: 11  GSKVRGKYDGPKINDYDKFYEDIWKKYVPQPVEVKQGSVYDYYDILEELGSGAFGVVHR- 69

Query: 162 CL--PDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIG-FSTENGFHLV 218
           C+    G V   K I      D+       +E+ I+  ++HP    L   F  +    L+
Sbjct: 70  CVEKATGRVFVAKFINTPYPLDKY---TVKNEISIMNQLHHPKLINLHDAFEDKYEMVLI 126

Query: 219 LQFLPHGSLSSLLFGSTECLEWTIRYKIALG----------IAEGLQYLHHDCHRRIIHR 268
           L+FL  G          E  +        +             EGL+++H      I+H 
Sbjct: 127 LEFLSGG----------ELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHE---HSIVHL 173

Query: 269 DIKASNILLS--EDYEAQISDFGLAKWLPDNWSHHIVFPIEGTFGYLSPEYFMHGIVDEK 326
           DIK  NI+    +    +I DFGLA  L  +    +      T  + +PE      V   
Sbjct: 174 DIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTT---ATAEFAAPEIVDREPVGFY 230

Query: 327 TDVFAFGVLLLELITG 342
           TD++A GVL   L++G
Sbjct: 231 TDMWAIGVLGYVLLSG 246

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  100 bits (251), Expect = 2e-23
 Identities = 28/239 (11%), Positives = 62/239 (25%), Gaps = 53/239 (22%)

Query: 149 LIGKGGHAEVYKGC-LPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAH---------- 197
           ++G+       +      GE   V       +     I     E+  +            
Sbjct: 85  VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 144

Query: 198 ------------INHPNAAKLIGFSTENGFHLVLQF-----LPHGSLSSLL------FGS 234
                       +  P   K+I    +     VL           +L +          +
Sbjct: 145 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 204

Query: 235 TECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWL 294
            + L    R ++ L +   L  LHH     ++H  ++  +I+L +     ++ F      
Sbjct: 205 HKSLVHHARLQLTLQVIRLLASLHH---YGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRD 261

Query: 295 PDNWSHHIVFPIEGTFGYLSPEYFM----------HGIVDEKTDVFAFGVLLLELITGR 343
             +             G+  PE               ++    D +  G+ +  +    
Sbjct: 262 GAS------AVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCAD 314

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score =  100 bits (252), Expect = 2e-23
 Identities = 59/246 (23%), Positives = 105/246 (42%), Gaps = 28/246 (11%)

Query: 118 DGGSVPIVRHSWKNFDFAELAAATDNFNSENL---------IGKGGHAEVYKGC-LPDGE 167
           +   + +     K F F +L     +   + L         +G G   EV         +
Sbjct: 102 NNSEIALSLSRNKVFVFFDLTVDDQSVYPKALRDEYIMSKTLGSGACGEVKLAFERKTCK 161

Query: 168 VVAVKKIIKN-----AKEDEERISDFLSELGIVAHINHPNAAKLIGFSTENGFHLVLQFL 222
            VA++ I K      +  + +   +  +E+ I+  +NHP   K+  F     +++VL+ +
Sbjct: 162 KVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAEDYYIVLELM 221

Query: 223 PHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILL---SE 279
             G L   + G+    E T +      +   +QYLH      IIHRD+K  N+LL    E
Sbjct: 222 EGGELFDKVVGNKRLKEATCK-LYFYQMLLAVQYLH---ENGIIHRDLKPENVLLSSQEE 277

Query: 280 DYEAQISDFGLAKWLPDNWSHHIVFPIEGTFGYLSPEYFMHGIV---DEKTDVFAFGVLL 336
           D   +I+DFG +K L +     ++  + GT  YL+PE  +       +   D ++ GV+L
Sbjct: 278 DCLIKITDFGHSKILGET---SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVIL 334

Query: 337 LELITG 342
              ++G
Sbjct: 335 FICLSG 340

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score = 97.2 bits (243), Expect = 5e-23
 Identities = 55/210 (26%), Positives = 84/210 (40%), Gaps = 31/210 (14%)

Query: 141 TDNFNSENLIGKGGHAEVYKGC-LPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHIN 199
           +DN++ +  +GKG  + V +      G   A K II   K           E  I   + 
Sbjct: 5   SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAK-IINTKKLSARDFQKLEREARICRKLQ 63

Query: 200 HPNAAKLIG-FSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTI---RY------KIALG 249
           HPN  +L      E+  +LV   +  G L           E  +    Y           
Sbjct: 64  HPNIVRLHDSIQEESFHYLVFDLVTGGEL----------FEDIVAREFYSEADASHCIQQ 113

Query: 250 IAEGLQYLHHDCHRRIIHRDIKASNILL---SEDYEAQISDFGLAKWLPDNWSHHIVFPI 306
           I E + Y H      I+HR++K  N+LL   ++    +++DFGLA  + D+         
Sbjct: 114 ILESIAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS---EAWHGF 167

Query: 307 EGTFGYLSPEYFMHGIVDEKTDVFAFGVLL 336
            GT GYLSPE        +  D++A GV+L
Sbjct: 168 AGTPGYLSPEVLKKDPYSKPVDIWACGVIL 197

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score = 98.4 bits (246), Expect = 7e-23
 Identities = 59/215 (27%), Positives = 103/215 (47%), Gaps = 27/215 (12%)

Query: 142 DNFNSENLIGKGGHAEVYKG-CLPDGEVVAVKKI-IKNAKEDEERI-SDFLSELGIVAHI 198
             +   + +G+G  A VYK       ++VA+KKI + +  E ++ I    L E+ ++  +
Sbjct: 10  KRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQEL 69

Query: 199 NHPNAAKLIG-FSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYL 257
           +HPN   L+  F  ++   LV  F+    L  ++  ++  L  +      L   +GL+YL
Sbjct: 70  SHPNIIGLLDAFGHKSNISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYL 128

Query: 258 HHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPD---NWSHHIVFPIEGTFGYLS 314
           H      I+HRD+K +N+LL E+   +++DFGLAK        ++H +V     T  Y +
Sbjct: 129 HQ---HWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVV-----TRWYRA 180

Query: 315 PEYFMH------GIVDEKTDVFAFGVLLLELITGR 343
           PE          G+     D++A G +L EL+   
Sbjct: 181 PELLFGARMYGVGV-----DMWAVGCILAELLLRV 210

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score = 97.8 bits (244), Expect = 1e-22
 Identities = 53/210 (25%), Positives = 89/210 (42%), Gaps = 35/210 (16%)

Query: 141 TDNFNSENLIGKGGHAEVYKG-CLPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHIN 199
           +D F  E+ +G+G  + VY+       +  A+K + K   +         +E+G++  ++
Sbjct: 52  SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKK-----IVRTEIGVLLRLS 106

Query: 200 HPNAAKLIG-FSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTI---RY------KIALG 249
           HPN  KL   F T     LVL+ +  G L           +  +    Y           
Sbjct: 107 HPNIIKLKEIFETPTEISLVLELVTGGEL----------FDRIVEKGYYSERDAADAVKQ 156

Query: 250 IAEGLQYLHHDCHRRIIHRDIKASNILL---SEDYEAQISDFGLAKWLPDNWSHHIVFPI 306
           I E + YLH      I+HRD+K  N+L    + D   +I+DFGL+K +        V   
Sbjct: 157 ILEAVAYLHE---NGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVC-- 211

Query: 307 EGTFGYLSPEYFMHGIVDEKTDVFAFGVLL 336
            GT GY +PE         + D+++ G++ 
Sbjct: 212 -GTPGYCAPEILRGCAYGPEVDMWSVGIIT 240

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score = 96.5 bits (241), Expect = 1e-22
 Identities = 61/210 (29%), Positives = 95/210 (45%), Gaps = 32/210 (15%)

Query: 141 TDNFNSENLIGKGGHAEVYKGC-LPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHIN 199
            + +N   ++GKG   EV K       +  AVK I K A    +  S  L E+ ++  ++
Sbjct: 21  AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINK-ASAKNKDTSTILREVELLKKLD 79

Query: 200 HPNAAKLIG-FSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTI---RY------KIALG 249
           HPN  KL       + F++V +    G L           +  I   R+      +I   
Sbjct: 80  HPNIMKLFEILEDSSSFYIVGELYTGGEL----------FDEIIKRKRFSEHDAARIIKQ 129

Query: 250 IAEGLQYLHHDCHRRIIHRDIKASNILL---SEDYEAQISDFGLAKWLPDNWSHHIVFPI 306
           +  G+ Y+H      I+HRD+K  NILL    +D + +I DFGL+     N     +   
Sbjct: 130 VFSGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN---TKMKDR 183

Query: 307 EGTFGYLSPEYFMHGIVDEKTDVFAFGVLL 336
            GT  Y++PE  + G  DEK DV++ GV+L
Sbjct: 184 IGTAYYIAPE-VLRGTYDEKCDVWSAGVIL 212

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score = 97.8 bits (244), Expect = 2e-22
 Identities = 54/206 (26%), Positives = 95/206 (46%), Gaps = 17/206 (8%)

Query: 143 NFNSENLIGKGGHAEVYKGCL--PDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINH 200
             +   ++G G   +V+K C     G  +A K I     +D+E   +  +E+ ++  ++H
Sbjct: 90  TVSKTEILGGGRFGQVHK-CEETATGLKLAAKIIKTRGMKDKE---EVKNEISVMNQLDH 145

Query: 201 PNAAKLIG-FSTENGFHLVLQFLPHGSLSSLLFGSTECL-EWTIRYKIALGIAEGLQYLH 258
            N  +L   F ++N   LV++++  G L   +   +  L E          I EG++++H
Sbjct: 146 ANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTI-LFMKQICEGIRHMH 204

Query: 259 HDCHRRIIHRDIKASNILLSEDYEAQI--SDFGLAKWLPDNWSHHIVFPIEGTFGYLSPE 316
                 I+H D+K  NIL       QI   DFGLA+         + F   GT  +L+PE
Sbjct: 205 Q---MYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNF---GTPEFLAPE 258

Query: 317 YFMHGIVDEKTDVFAFGVLLLELITG 342
              +  V   TD+++ GV+   L++G
Sbjct: 259 VVNYDFVSFPTDMWSVGVIAYMLLSG 284

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score = 97.4 bits (243), Expect = 2e-22
 Identities = 48/209 (22%), Positives = 82/209 (39%), Gaps = 21/209 (10%)

Query: 141 TDNFNSENLIGKGGHAEVYKGC-LPDGEVVAVKKIIKN--AKEDEERISDFLSELGIVAH 197
            D +    +IGKG  + V +      G+  AVK +              D   E  I   
Sbjct: 23  EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHM 82

Query: 198 INHPNAAKLIG-FSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRY------KIALGI 250
           + HP+  +L+  +S++   ++V +F+       L F   +  +    Y           I
Sbjct: 83  LKHPHIVELLETYSSDGMLYMVFEFMDGA---DLCFEIVKRADAGFVYSEAVASHYMRQI 139

Query: 251 AEGLQYLHHDCHRRIIHRDIKASNILL---SEDYEAQISDFGLAKWLPDNWSHHIVFPIE 307
            E L+Y H      IIHRD+K   +LL         ++  FG+A  L ++    +     
Sbjct: 140 LEALRYCH---DNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGES--GLVAGGRV 194

Query: 308 GTFGYLSPEYFMHGIVDEKTDVFAFGVLL 336
           GT  +++PE        +  DV+  GV+L
Sbjct: 195 GTPHFMAPEVVKREPYGKPVDVWGCGVIL 223

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score = 98.5 bits (246), Expect = 2e-22
 Identities = 48/210 (22%), Positives = 78/210 (37%), Gaps = 30/210 (14%)

Query: 141 TDNFNSENLIGKGGHAEVYKGC-LPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHIN 199
           T+ +     +GKG  + V +   +  G+  A   I        +       E  I   + 
Sbjct: 10  TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARD-HQKLEREARICRLLK 68

Query: 200 HPNAAKLIG-FSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRY---------KIALG 249
           HPN  +L    S E   +L+   +  G          E  E  +                
Sbjct: 69  HPNIVRLHDSISEEGHHYLIFDLVTGG----------ELFEDIVAREYYSEADASHCIQQ 118

Query: 250 IAEGLQYLHHDCHRRIIHRDIKASNILL---SEDYEAQISDFGLAKWLPDNWSHHIVFPI 306
           I E + + H      ++HR++K  N+LL    +    +++DFGLA  +         F  
Sbjct: 119 ILEAVLHCHQ---MGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGE--QQAWFGF 173

Query: 307 EGTFGYLSPEYFMHGIVDEKTDVFAFGVLL 336
            GT GYLSPE        +  D++A GV+L
Sbjct: 174 AGTPGYLSPEVLRKDPYGKPVDLWACGVIL 203

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score = 96.6 bits (241), Expect = 3e-22
 Identities = 56/212 (26%), Positives = 85/212 (40%), Gaps = 35/212 (16%)

Query: 141 TDNFNSENLIGKGGHAEVYKGC-LPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHIN 199
           +DN++ +  +GKG  + V +      G   A K II   K           E  I   + 
Sbjct: 28  SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAK-IINTKKLSARDFQKLEREARICRKLQ 86

Query: 200 HPNAAKLIG-FSTENGFHLVLQFLPHGSLSSLLF------GS-TECLEWTIRYKIALG-- 249
           HPN  +L      E+  +LV   +  G L    F         +E          A    
Sbjct: 87  HPNIVRLHDSIQEESFHYLVFDLVTGGEL----FEDIVAREFYSE--------ADASHCI 134

Query: 250 --IAEGLQYLHHDCHRRIIHRDIKASNILL---SEDYEAQISDFGLAKWLPDNWSHHIVF 304
             I E + Y H      I+HR++K  N+LL   ++    +++DFGLA  + D+       
Sbjct: 135 QQILESIAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS---EAWH 188

Query: 305 PIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLL 336
              GT GYLSPE        +  D++A GV+L
Sbjct: 189 GFAGTPGYLSPEVLKKDPYSKPVDIWACGVIL 220

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score = 98.4 bits (245), Expect = 4e-22
 Identities = 45/208 (21%), Positives = 85/208 (40%), Gaps = 17/208 (8%)

Query: 141 TDNFNSENLIGKGGHAEVYKGCL--PDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHI 198
            D+++    +G G    V++       G   A K ++   + D+E       E+  ++ +
Sbjct: 156 LDHYDIHEELGTGAFGVVHR-VTERATGNNFAAKFVMTPHESDKE---TVRKEIQTMSVL 211

Query: 199 NHPNAAKLIG-FSTENGFHLVLQFLPHGSLSSLLFGSTECL-EWTIRYKIALGIAEGLQY 256
            HP    L   F  +N   ++ +F+  G L   +      + E     +    + +GL +
Sbjct: 212 RHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAV-EYMRQVCKGLCH 270

Query: 257 LHHDCHRRIIHRDIKASNILLSEDYEAQI--SDFGLAKWLPDNWSHHIVFPIEGTFGYLS 314
           +H       +H D+K  NI+ +     ++   DFGL   L    S  +     GT  + +
Sbjct: 271 MHE---NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT---GTAEFAA 324

Query: 315 PEYFMHGIVDEKTDVFAFGVLLLELITG 342
           PE      V   TD+++ GVL   L++G
Sbjct: 325 PEVAEGKPVGYYTDMWSVGVLSYILLSG 352

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score = 95.8 bits (239), Expect = 4e-22
 Identities = 42/212 (19%), Positives = 77/212 (36%), Gaps = 26/212 (12%)

Query: 141 TDNFNSENLIGKGGHAEVYKG-CLPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHIN 199
            + +     +G+G    V++       +    K  +K    D+        E+ I+    
Sbjct: 4   YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAK-FVKVKGTDQV---LVKKEISILNIAR 59

Query: 200 HPNAAKLIG-FSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRY------KIALGIAE 252
           H N   L   F +     ++ +F+    +    F                       + E
Sbjct: 60  HRNILHLHESFESMEELVMIFEFISGLDI----F--ERINTSAFELNEREIVSYVHQVCE 113

Query: 253 GLQYLHHDCHRRIIHRDIKASNILLSEDYEAQ--ISDFGLAKWLPDNWSHHIVFPIEGTF 310
            LQ+LH      I H DI+  NI+      +   I +FG A+ L    +  ++F      
Sbjct: 114 ALQFLHS---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLF---TAP 167

Query: 311 GYLSPEYFMHGIVDEKTDVFAFGVLLLELITG 342
            Y +PE   H +V   TD+++ G L+  L++G
Sbjct: 168 EYYAPEVHQHDVVSTATDMWSLGTLVYVLLSG 199

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score = 98.4 bits (245), Expect = 5e-22
 Identities = 61/208 (29%), Positives = 103/208 (49%), Gaps = 14/208 (6%)

Query: 142 DNFNSENLIGKGGHAEVYKGCLPD-GEVVAVKKIIKNAKEDEERISDFLSE---LGIVAH 197
           ++F+   +IG+GG  EVY     D G++ A+K + K   + ++  +  L+E   L +V+ 
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 248

Query: 198 INHPNAAKLIG-FSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQY 256
            + P    +   F T +    +L  +  G L   L       E  +R+  A  I  GL++
Sbjct: 249 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAA-EIILGLEH 307

Query: 257 LHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEGTFGYLSPE 316
           +H+   R +++RD+K +NILL E    +ISD GLA        H  V    GT GY++PE
Sbjct: 308 MHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV----GTHGYMAPE 360

Query: 317 YFMHGIVDEKT-DVFAFGVLLLELITGR 343
               G+  + + D F+ G +L +L+ G 
Sbjct: 361 VLQKGVAYDSSADWFSLGCMLFKLLRGH 388

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score = 94.6 bits (236), Expect = 5e-22
 Identities = 52/210 (24%), Positives = 82/210 (39%), Gaps = 34/210 (16%)

Query: 141 TDNFNSENLIGKGGHAEVYKG-CLPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHIN 199
              +  EN IG+G   EV            A KKI K   ED +    F  E+ I+  ++
Sbjct: 8   NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVD---RFKQEIEIMKSLD 64

Query: 200 HPNAAKLIG-FSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTI---RY------KIALG 249
           HPN  +L   F      +LV++    G L           E  +    +      +I   
Sbjct: 65  HPNIIRLYETFEDNTDIYLVMELCTGGEL----------FERVVHKRVFRESDAARIMKD 114

Query: 250 IAEGLQYLHHDCHRRIIHRDIKASNILL---SEDYEAQISDFGLAKWLPDNWSHHIVFPI 306
           +   + Y H      + HRD+K  N L    S D   ++ DFGLA          ++   
Sbjct: 115 VLSAVAYCH---KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPG---KMMRTK 168

Query: 307 EGTFGYLSPEYFMHGIVDEKTDVFAFGVLL 336
            GT  Y+SP+    G+   + D ++ GV++
Sbjct: 169 VGTPYYVSPQVL-EGLYGPECDEWSAGVMM 197

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score = 94.2 bits (235), Expect = 6e-22
 Identities = 49/215 (22%), Positives = 87/215 (40%), Gaps = 27/215 (12%)

Query: 141 TDNFNSENLIGKGGHAEVYKGC-LPDGEVVAVKKIIKNA-KEDEERISDFLSELGIVAHI 198
            D F  +  +G G   +V+       G    +K I K+  +   E      +E+ ++  +
Sbjct: 21  DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPME---QIEAEIEVLKSL 77

Query: 199 NHPNAAKLIG-FSTENGFHLVLQFLPHGSLSSLLFGS-TECLEWTIRY------KIALGI 250
           +HPN  K+   F   +  ++V++    G     L                    ++   +
Sbjct: 78  DHPNIIKIFEVFEDYHNMYIVMETCEGGE----LLERIVSAQARGKALSEGYVAELMKQM 133

Query: 251 AEGLQYLHHDCHRRIIHRDIKASNILL---SEDYEAQISDFGLAKWLPDNWSHHIVFPIE 307
              L Y H    + ++H+D+K  NIL    S     +I DFGLA+    +          
Sbjct: 134 MNALAYFH---SQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAA--- 187

Query: 308 GTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITG 342
           GT  Y++PE F    V  K D+++ GV++  L+TG
Sbjct: 188 GTALYMAPEVF-KRDVTFKCDIWSAGVVMYFLLTG 221

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 94.0 bits (234), Expect = 8e-22
 Identities = 25/200 (12%), Positives = 55/200 (27%), Gaps = 41/200 (20%)

Query: 149 LIGKGGHAEVYKGCLPD---GEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAK 205
             G     + ++    D      VA+  +       ++ + + LS    ++ I+ P  A+
Sbjct: 38  FHGGVPPLQFWQA--LDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVAR 95

Query: 206 LIGFSTENGFH-LVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRR 264
           ++          +V +++  GSL  +   S          +    +A      H      
Sbjct: 96  VLDVVHTRAGGLVVAEWIRGGSLQEVADTS---PSPVGAIRAMQSLAAAADAAHR---AG 149

Query: 265 IIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEGTFGYLSPEYFMHGIVD 324
           +       S + +S D        G                       +          +
Sbjct: 150 VALSIDHPSRVRVSID--------GDVVL--------------AYPATMPD-------AN 180

Query: 325 EKTDVFAFGVLLLELITGRR 344
            + D+   G  L  L+  R 
Sbjct: 181 PQDDIRGIGASLYALLVNRW 200

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score = 93.4 bits (233), Expect = 1e-21
 Identities = 56/222 (25%), Positives = 89/222 (40%), Gaps = 38/222 (17%)

Query: 141 TDNFNSENLIGKGGHAEVYKG-CLPDGEVVAVKKIIKNAKEDEERISD---FLSELGIVA 196
            D++     +G G  A V K      G+  A K I K       R         E+ I+ 
Sbjct: 4   EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILR 63

Query: 197 HINHPNAAKLIG-FSTENGFHLVLQFLPHGSLSSLLF------GS-TECLEWTIRYKIAL 248
            I HPN   L   F  +    L+L+ +  G L    F       S TE          A 
Sbjct: 64  EIRHPNIITLHDIFENKTDVVLILELVSGGEL----FDFLAEKESLTE--------DEAT 111

Query: 249 G----IAEGLQYLHHDCHRRIIHRDIKASNILL----SEDYEAQISDFGLAKWLPDNWSH 300
                I +G+ YLH    +RI H D+K  NI+L      +   ++ DFG+A  +      
Sbjct: 112 QFLKQILDGVHYLHS---KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEF 168

Query: 301 HIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITG 342
             +F   GT  +++PE   +  +  + D+++ GV+   L++G
Sbjct: 169 KNIF---GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 207

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score = 93.4 bits (233), Expect = 2e-21
 Identities = 49/210 (23%), Positives = 92/210 (43%), Gaps = 16/210 (7%)

Query: 142 DNFNSENLIGKGGHAEVYKG-CLPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINH 200
             +     IG+G +  V+K       E+VA+K++ +   +DE   S  L E+ ++  + H
Sbjct: 2   QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRV-RLDDDDEGVPSSALREICLLKELKH 60

Query: 201 PNAAKLIG-FSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHH 259
            N  +L     ++    LV +F     L          L+  I       + +GL + H 
Sbjct: 61  KNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHS 119

Query: 260 DCHRRIIHRDIKASNILLSEDYEAQISDFGLAKW--LPDN-WSHHIVFPIEGTFGYLSPE 316
              R ++HRD+K  N+L++ + E ++++FGLA+   +P   +S  +V     T  Y  P+
Sbjct: 120 ---RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVV-----TLWYRPPD 171

Query: 317 YFMHGIV-DEKTDVFAFGVLLLELITGRRA 345
                 +     D+++ G +  EL    R 
Sbjct: 172 VLFGAKLYSTSIDMWSAGCIFAELANAGRP 201

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score = 93.4 bits (233), Expect = 2e-21
 Identities = 53/209 (25%), Positives = 94/209 (44%), Gaps = 19/209 (9%)

Query: 142 DNFNSENLIGKGGHAEVYKGCLPD-GEVVAVKKIIKNAKEDEERI-SDFLSELGIVAHIN 199
           + +   + +G+G +A VYKG       +VA+K+I     E EE      + E+ ++  + 
Sbjct: 2   ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEI---RLEHEEGAPCTAIREVSLLKDLK 58

Query: 200 HPNAAKLIG-FSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLH 258
           H N   L     TE    LV ++L    L   L      +           +  GL Y H
Sbjct: 59  HANIVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCH 117

Query: 259 HDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKW--LPDN-WSHHIVFPIEGTFGYLSP 315
               ++++HRD+K  N+L++E  E +++DFGLA+   +P   + + +V     T  Y  P
Sbjct: 118 R---QKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVV-----TLWYRPP 169

Query: 316 EYFMHGIV-DEKTDVFAFGVLLLELITGR 343
           +  +       + D++  G +  E+ TGR
Sbjct: 170 DILLGSTDYSTQIDMWGVGCIFYEMATGR 198

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score = 94.3 bits (235), Expect = 2e-21
 Identities = 61/211 (28%), Positives = 89/211 (42%), Gaps = 18/211 (8%)

Query: 142 DNFNSENLIGKGGHAEVY----KGCLPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAH 197
           D+F     IGKG   +V            ++ A+K + K    +   + +   EL I+  
Sbjct: 15  DHFEILRAIGKGSFGKVCIVQKND---TKKMYAMKYMNKQKCVERNEVRNVFKELQIMQG 71

Query: 198 INHPNAAKLIG-FSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQY 256
           + HP    L   F  E    +V+  L  G L   L  +    E T++  I   +   L Y
Sbjct: 72  LEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFIC-ELVMALDY 130

Query: 257 LHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEGTFGYLSPE 316
           L +   +RIIHRD+K  NILL E     I+DF +A  LP       +    GT  Y++PE
Sbjct: 131 LQN---QRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITTM---AGTKPYMAPE 184

Query: 317 YFMHGIV---DEKTDVFAFGVLLLELITGRR 344
            F            D ++ GV   EL+ GRR
Sbjct: 185 MFSSRKGAGYSFAVDWWSLGVTAYELLRGRR 215

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score = 93.5 bits (233), Expect = 2e-21
 Identities = 53/218 (24%), Positives = 90/218 (41%), Gaps = 39/218 (17%)

Query: 141 TDNFNSENLIGKGGHAEVYKGC-LPDGEVVAVKKIIK-----NAKEDEERISDFLSELGI 194
            D +     +G G   EV         + VA+K I K      +  + +   +  +E+ I
Sbjct: 9   RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEI 68

Query: 195 VAHINHPNAAKLIGFSTENGFHLVLQFLP----------HGSLSSLLFGSTECLEWTIRY 244
           +  +NHP   K+  F     +++VL+ +           +  L           E T + 
Sbjct: 69  LKKLNHPCIIKIKNFFDAEDYYIVLELMEGGELFDKVVGNKRLK----------EATCK- 117

Query: 245 KIALGIAEGLQYLHHDCHRRIIHRDIKASNILL---SEDYEAQISDFGLAKWLPDNWSHH 301
                +   +QYLH      IIHRD+K  N+LL    ED   +I+DFG +K L +     
Sbjct: 118 LYFYQMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGET---S 171

Query: 302 IVFPIEGTFGYLSPEYFMHGIV---DEKTDVFAFGVLL 336
           ++  + GT  YL+PE  +       +   D ++ GV+L
Sbjct: 172 LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVIL 209

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score = 92.7 bits (231), Expect = 3e-21
 Identities = 53/220 (24%), Positives = 94/220 (42%), Gaps = 40/220 (18%)

Query: 141 TDNFNSENLIGKGGHAEVYKGC-LPDGEVVAVKKIIK------NAKEDEERISDFLSELG 193
            +N+  + ++G+G  + V +    P  +  AVK I        +A+E +E     L E+ 
Sbjct: 16  YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVD 75

Query: 194 IVAHIN-HPNAAKLIG-FSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTI---RY---- 244
           I+  ++ HPN  +L   + T   F LV   +  G          E  ++           
Sbjct: 76  ILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKG----------ELFDYLTEKVTLSEKE 125

Query: 245 --KIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSHHI 302
             KI   + E +  LH      I+HRD+K  NILL +D   +++DFG +  L        
Sbjct: 126 TRKIMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPG---EK 179

Query: 303 VFPIEGTFGYLSPEYFMHGIV------DEKTDVFAFGVLL 336
           +  + GT  YL+PE     +        ++ D+++ GV++
Sbjct: 180 LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIM 219

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score = 94.0 bits (234), Expect = 3e-21
 Identities = 53/212 (25%), Positives = 86/212 (40%), Gaps = 18/212 (8%)

Query: 141 TDNFNSENLIGKGGHAEVYKGCL--PDGEVVAVKKIIK---NAKEDEERISDFLSELGIV 195
            D ++    +G G  A V K C     G   A K I K    A        +   E+ I+
Sbjct: 11  EDFYDIGEELGSGQFAIVKK-CREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSIL 69

Query: 196 AHINHPNAAKLIG-FSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGL 254
             + HPN   L   +       L+L+ +  G L   L       E          I +G+
Sbjct: 70  RQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEAT-SFIKQILDGV 128

Query: 255 QYLHHDCHRRIIHRDIKASNILL----SEDYEAQISDFGLAKWLPDNWSHHIVFPIEGTF 310
            YLH    ++I H D+K  NI+L          ++ DFGLA  + D      +F   GT 
Sbjct: 129 NYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIF---GTP 182

Query: 311 GYLSPEYFMHGIVDEKTDVFAFGVLLLELITG 342
            +++PE   +  +  + D+++ GV+   L++G
Sbjct: 183 EFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score = 93.1 bits (232), Expect = 3e-21
 Identities = 52/212 (24%), Positives = 85/212 (40%), Gaps = 18/212 (8%)

Query: 141 TDNFNSENLIGKGGHAEVYKGCL--PDGEVVAVKKIIK---NAKEDEERISDFLSELGIV 195
            D ++    +G G  A V K C     G   A K I K    A        +   E+ I+
Sbjct: 11  EDFYDIGEELGSGQFAIVKK-CREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSIL 69

Query: 196 AHINHPNAAKLIG-FSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGL 254
             + H N   L   +       L+L+ +  G L   L       E          I +G+
Sbjct: 70  RQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEAT-SFIKQILDGV 128

Query: 255 QYLHHDCHRRIIHRDIKASNILL----SEDYEAQISDFGLAKWLPDNWSHHIVFPIEGTF 310
            YLH    ++I H D+K  NI+L          ++ DFGLA  + D      +F   GT 
Sbjct: 129 NYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIF---GTP 182

Query: 311 GYLSPEYFMHGIVDEKTDVFAFGVLLLELITG 342
            +++PE   +  +  + D+++ GV+   L++G
Sbjct: 183 EFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score = 93.0 bits (232), Expect = 3e-21
 Identities = 56/213 (26%), Positives = 102/213 (47%), Gaps = 27/213 (12%)

Query: 142 DNFNSENLIGKGGHAEVYKGCLPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHP 201
           + +     +G+G +  VYK     G +VA+K+I +   EDE   S  + E+ ++  ++HP
Sbjct: 21  EKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRI-RLDAEDEGIPSTAIREISLLKELHHP 79

Query: 202 NAAKLIG-FSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHD 260
           N   LI    +E    LV +F+    L  +L  +   L+ +        +  G+ + H  
Sbjct: 80  NIVSLIDVIHSERCLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQ- 137

Query: 261 CHRRIIHRDIKASNILLSEDYEAQISDFGLAKW--LPDN-WSHHIVFPIEGTFGYLSPE- 316
              RI+HRD+K  N+L++ D   +++DFGLA+   +P   ++H +V     T  Y +P+ 
Sbjct: 138 --HRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVV-----TLWYRAPDV 190

Query: 317 ------YFMHGIVDEKTDVFAFGVLLLELITGR 343
                 Y          D+++ G +  E+ITG+
Sbjct: 191 LMGSKKY------STSVDIWSIGCIFAEMITGK 217

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score = 93.0 bits (232), Expect = 3e-21
 Identities = 51/213 (23%), Positives = 92/213 (43%), Gaps = 26/213 (12%)

Query: 142 DNFNSENLIGKGGHAEVYKG-CLPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINH 200
           + +     IG+G +  V+K      G++VA+KK    +++D       L E+ ++  + H
Sbjct: 3   EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKF-LESEDDPVIKKIALREIRMLKQLKH 61

Query: 201 PNAAKLIG-FSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHH 259
           PN   L+  F  +   HLV ++  H ++   L      +   +   I     + + + H 
Sbjct: 62  PNLVNLLEVFRRKRRLHLVFEYCDH-TVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHK 120

Query: 260 DCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWL---PDNWSHHIVFPIEGTFGYLSPE 316
                 IHRD+K  NIL+++    ++ DFG A+ L    D +   +      T  Y SPE
Sbjct: 121 ---HNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVA-----TRWYRSPE 172

Query: 317 YFMH------GIVDEKTDVFAFGVLLLELITGR 343
             +        +     DV+A G +  EL++G 
Sbjct: 173 LLVGDTQYGPPV-----DVWAIGCVFAELLSGV 200

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score = 92.7 bits (231), Expect = 4e-21
 Identities = 50/219 (22%), Positives = 92/219 (42%), Gaps = 34/219 (15%)

Query: 142 DNFNSENLIGKGGHAEVYKG-CLPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINH 200
           D +     +G+G + EVYK       E VA+K+I +   E+E      + E+ ++  + H
Sbjct: 34  DRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRI-RLEHEEEGVPGTAIREVSLLKELQH 92

Query: 201 PNAAKLIG-FSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHH 259
            N  +L       +  HL+ ++  +  L   +  + +     I+      +  G+ + H 
Sbjct: 93  RNIIELKSVIHHNHRLHLIFEYAEN-DLKKYMDKNPDVSMRVIK-SFLYQLINGVNFCHS 150

Query: 260 DCHRRIIHRDIKASNILLSEDYEAQ-----ISDFGLAKW--LPDN-WSHHIVFPIEGTFG 311
              RR +HRD+K  N+LLS    ++     I DFGLA+   +P   ++H I+     T  
Sbjct: 151 ---RRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEII-----TLW 202

Query: 312 YLSPE-------YFMHGIVDEKTDVFAFGVLLLELITGR 343
           Y  PE       Y          D+++   +  E++   
Sbjct: 203 YRPPEILLGSRHY------STSVDIWSIACIWAEMLMKT 235

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score = 91.8 bits (229), Expect = 5e-21
 Identities = 63/207 (30%), Positives = 99/207 (47%), Gaps = 15/207 (7%)

Query: 142 DNFNSENLIGKGGHAEVYKGCLPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHP 201
           + ++    IG+G +  VYK     GE  A+KKI +  KEDE   S  + E+ I+  + H 
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKI-RLEKEDEGIPSTTIREISILKELKHS 60

Query: 202 NAAKLIG-FSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHD 260
           N  KL     T+    LV + L    L  LL      LE        L +  G+ Y H  
Sbjct: 61  NIVKLYDVIHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHD- 118

Query: 261 CHRRIIHRDIKASNILLSEDYEAQISDFGLAKW--LPDN-WSHHIVFPIEGTFGYLSPEY 317
             RR++HRD+K  N+L++ + E +I+DFGLA+   +P   ++H IV     T  Y +P+ 
Sbjct: 119 --RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIV-----TLWYRAPDV 171

Query: 318 FMHGIV-DEKTDVFAFGVLLLELITGR 343
            M         D+++ G +  E++ G 
Sbjct: 172 LMGSKKYSTTIDIWSVGCIFAEMVNGT 198

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score = 91.9 bits (229), Expect = 9e-21
 Identities = 57/223 (25%), Positives = 89/223 (39%), Gaps = 40/223 (17%)

Query: 141 TDNFNSENLIGKGGHAEVYKGCL--PDGEVVAVKKIIK---NAKEDEERISDFLSELGIV 195
            D +++   +G G  A V K C     G   A K I K    +        D   E+ I+
Sbjct: 10  DDYYDTGEELGSGQFAVVKK-CREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSIL 68

Query: 196 AHINHPNAAKLIG-FSTENGFHLVLQFLPHGSLSSLLF------GS-TECLEWTIRYKIA 247
             I HPN   L   +  +    L+L+ +  G L    F       S TE        + A
Sbjct: 69  KEIQHPNVITLHEVYENKTDVILILELVAGGEL----FDFLAEKESLTE--------EEA 116

Query: 248 LG----IAEGLQYLHHDCHRRIIHRDIKASNILLS----EDYEAQISDFGLAKWLPDNWS 299
                 I  G+ YLH     +I H D+K  NI+L          +I DFGLA  +     
Sbjct: 117 TEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE 173

Query: 300 HHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITG 342
              +F   GT  +++PE   +  +  + D+++ GV+   L++G
Sbjct: 174 FKNIF---GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score = 91.5 bits (228), Expect = 1e-20
 Identities = 53/214 (24%), Positives = 95/214 (44%), Gaps = 28/214 (13%)

Query: 142 DNFNSENLIGKGGHAEVYKG-CLPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINH 200
           + + +  L+G+G +  V K      G +VA+KK    + +D+      + E+ ++  + H
Sbjct: 25  EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKF-LESDDDKMVKKIAMREIKLLKQLRH 83

Query: 201 PNAAKLIG-FSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHH 259
            N   L+     +  ++LV +F+ H ++   L      L++ +  K    I  G+ + H 
Sbjct: 84  ENLVNLLEVCKKKKRWYLVFEFVDH-TILDDLELFPNGLDYQVVQKYLFQIINGIGFCHS 142

Query: 260 DCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWL---PDNWSHHIVFPIEGTFGYLSPE 316
                IIHRDIK  NIL+S+    ++ DFG A+ L    + +   +      T  Y +PE
Sbjct: 143 ---HNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVA-----TRWYRAPE 194

Query: 317 -------YFMHGIVDEKTDVFAFGVLLLELITGR 343
                  Y    +     DV+A G L+ E+  G 
Sbjct: 195 LLVGDVKYGK-AV-----DVWAIGCLVTEMFMGE 222

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score = 91.2 bits (227), Expect = 1e-20
 Identities = 56/232 (24%), Positives = 94/232 (40%), Gaps = 50/232 (21%)

Query: 139 AATDNFNS---------ENLIGKGGHAEVYKG-CLPDGEVVAVKKIIKNAKEDEERISDF 188
            +TD+F+          E+++G+G HA V     L   +  AVK I K       R+   
Sbjct: 1   GSTDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRV--- 57

Query: 189 LSELGIVAHI-NHPNAAKLIG-FSTENGFHLVLQFLPHGSLSSLLF------GS-TECLE 239
             E+ ++     H N  +LI  F  E+ F+LV + +  GS+               E   
Sbjct: 58  FREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSI----LSHIHKRRHFNE--- 110

Query: 240 WTIRY--KIALGIAEGLQYLHHDCHRRIIHRDIKASNILL---SEDYEAQISDFGLAKWL 294
                   +   +A  L +LH+   + I HRD+K  NIL    ++    +I DF L   +
Sbjct: 111 ---LEASVVVQDVASALDFLHN---KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGI 164

Query: 295 PDNWSHHIVFPIE-----GTFGYLSPEYFMHGIV-----DEKTDVFAFGVLL 336
             N     +   E     G+  Y++PE            D++ D+++ GV+L
Sbjct: 165 KLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVIL 216

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score = 91.5 bits (228), Expect = 1e-20
 Identities = 46/208 (22%), Positives = 85/208 (40%), Gaps = 30/208 (14%)

Query: 150 IGKGGHAEVYKG-CLPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINH-PNAAKLI 207
           +G+G  A V +      G+  A K  +K  +  ++  ++ L E+ ++      P    L 
Sbjct: 37  LGRGKFAVVRQCISKSTGQEYAAK-FLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLH 95

Query: 208 G-FSTENGFHLVLQFLPHGSL----SSLLFGS-TECLEWTIRYKIALG----IAEGLQYL 257
             +   +   L+L++   G +       L    +E           +     I EG+ YL
Sbjct: 96  EVYENTSEIILILEYAAGGEIFSLCLPELAEMVSE--------NDVIRLIKQILEGVYYL 147

Query: 258 HHDCHRRIIHRDIKASNILL---SEDYEAQISDFGLAKWLPDNWSHHIVFPIEGTFGYLS 314
           H      I+H D+K  NILL       + +I DFG+++ +        +    GT  YL+
Sbjct: 148 HQ---NNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIM---GTPEYLA 201

Query: 315 PEYFMHGIVDEKTDVFAFGVLLLELITG 342
           PE   +  +   TD++  G++   L+T 
Sbjct: 202 PEILNYDPITTATDMWNIGIIAYMLLTH 229

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score = 91.2 bits (227), Expect = 1e-20
 Identities = 47/206 (22%), Positives = 83/206 (40%), Gaps = 36/206 (17%)

Query: 146 SENLIGKGGHAEVYKGC-LPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHI-NHPNA 203
            +  +G+G  +   K       +  AVK I K  + + ++      E+  +     HPN 
Sbjct: 15  KDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQK------EITALKLCEGHPNI 68

Query: 204 AKLIG-FSTENGFHLVLQFLPHGSLSSLLF------GS-TECLEWTIRY--KIALGIAEG 253
            KL   F  +    LV++ L  G     LF         +E           I   +   
Sbjct: 69  VKLHEVFHDQLHTFLVMELLNGGE----LFERIKKKKHFSE------TEASYIMRKLVSA 118

Query: 254 LQYLHHDCHRRIIHRDIKASNILL---SEDYEAQISDFGLAKWLPDNWSHHIVFPIEGTF 310
           + ++H      ++HRD+K  N+L    +++ E +I DFG A+  P +  +  +     T 
Sbjct: 119 VSHMH---DVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPD--NQPLKTPCFTL 173

Query: 311 GYLSPEYFMHGIVDEKTDVFAFGVLL 336
            Y +PE       DE  D+++ GV+L
Sbjct: 174 HYAAPELLNQNGYDESCDLWSLGVIL 199

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score = 92.9 bits (231), Expect = 2e-20
 Identities = 60/206 (29%), Positives = 96/206 (46%), Gaps = 11/206 (5%)

Query: 142 DNFNSENLIGKGGHAEVYKGCLPD-GEVVAVKKIIKNAKEDEERISDFLSELGIVAHINH 200
           + F    ++GKGG  EV    +   G++ A KK+ K   +  +  +  L+E  I+  +N 
Sbjct: 184 NTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNS 243

Query: 201 PNAAKLI-GFSTENGFHLVLQFLPHGSLSSLLFGSTECL--EWTIRYKIALGIAEGLQYL 257
                L   + T++   LVL  +  G L   ++   +    E    +  A  I  GL+ L
Sbjct: 244 RFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAA-EICCGLEDL 302

Query: 258 HHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEGTFGYLSPEY 317
           H     RI++RD+K  NILL +    +ISD GLA  +P+      +    GT GY++PE 
Sbjct: 303 HR---ERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG---QTIKGRVGTVGYMAPEV 356

Query: 318 FMHGIVDEKTDVFAFGVLLLELITGR 343
             +       D +A G LL E+I G+
Sbjct: 357 VKNERYTFSPDWWALGCLLYEMIAGQ 382

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score = 90.5 bits (225), Expect = 2e-20
 Identities = 49/205 (23%), Positives = 85/205 (41%), Gaps = 18/205 (8%)

Query: 149 LIGKGGHAEVYKGC-LPDGEVVAVKKIIKNAKEDEERISDFLS---ELGIVAHINH--PN 202
           L+G GG   VY G  + D   VA+K + K+   D   + +      E+ ++  ++     
Sbjct: 50  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 109

Query: 203 AAKLIG-FSTENGFHLVLQF-LPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHD 260
             +L+  F   + F L+L+   P   L   +       E   R      + E +++ H+ 
Sbjct: 110 VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELAR-SFFWQVLEAVRHCHN- 167

Query: 261 CHRRIIHRDIKASNILL-SEDYEAQISDFGLAKWLPDNWSHHIVFPIEGTFGYLSPEYFM 319
               ++HRDIK  NIL+     E ++ DFG    L D           GT  Y  PE+  
Sbjct: 168 --CGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFD----GTRVYSPPEWIR 221

Query: 320 HGIVD-EKTDVFAFGVLLLELITGR 343
           +         V++ G+LL +++ G 
Sbjct: 222 YHRYHGRSAAVWSLGILLYDMVCGD 246

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score = 90.9 bits (226), Expect = 3e-20
 Identities = 60/320 (18%), Positives = 116/320 (36%), Gaps = 51/320 (15%)

Query: 40  SDSSSSSCGSSSSPEKSTPQRAVNRESGGWKSMIDSIKKKSVVRRFSVIPLLTNYELTKK 99
               SS   +  + E+   +R +          ++  ++++ +R     P  +   L + 
Sbjct: 4   HHHHSSGVDNKFNKERRRARREIRHLPN-----LNREQRRAFIRSLRDDPSQSANLLAEA 58

Query: 100 NLWKKLGRLQIPEDDDADDGGSVPIVRHSWKNFDFAELAAATDNFNSENLIGKGGHAEVY 159
                              G    +   +    +F         ++ +++IG+G  + V 
Sbjct: 59  KKLNDAQPKGTENLYFQSMGPEDELPDWAAAK-EF------YQKYDPKDVIGRGVSSVVR 111

Query: 160 KGC-LPDGEVVAVKKIIKN-----AKEDEERISDFLSELGIVAHI-NHPNAAKLIG-FST 211
           +      G   AVK +         ++ EE       E  I+  +  HP+   LI  + +
Sbjct: 112 RCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYES 171

Query: 212 ENGFHLVLQFLPHGSLSSLLFGSTECLEWTI---RY------KIALGIAEGLQYLHHDCH 262
            +   LV   +  G          E  ++              I   + E + +LH    
Sbjct: 172 SSFMFLVFDLMRKG----------ELFDYLTEKVALSEKETRSIMRSLLEAVSFLHA--- 218

Query: 263 RRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEGTFGYLSPE------ 316
             I+HRD+K  NILL ++ + ++SDFG +  L        +  + GT GYL+PE      
Sbjct: 219 NNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPG---EKLRELCGTPGYLAPEILKCSM 275

Query: 317 YFMHGIVDEKTDVFAFGVLL 336
              H    ++ D++A GV+L
Sbjct: 276 DETHPGYGKEVDLWACGVIL 295

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score = 90.8 bits (226), Expect = 3e-20
 Identities = 52/212 (24%), Positives = 86/212 (40%), Gaps = 38/212 (17%)

Query: 141 TDNFNSENLIGKGGHAEVYKGC-LPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAH-I 198
           TD +  +  IG G ++   +          AVK II  +K D         E+ I+    
Sbjct: 21  TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVK-IIDKSKRDPTE------EIEILLRYG 73

Query: 199 NHPNAAKLIG-FSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYK---------IAL 248
            HPN   L   +      ++V + +  G L          L+  +R K         +  
Sbjct: 74  QHPNIITLKDVYDDGKYVYVVTELMKGGEL----------LDKILRQKFFSEREASAVLF 123

Query: 249 GIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQ----ISDFGLAKWLPDNWSHHIVF 304
            I + ++YLH    + ++HRD+K SNIL  ++        I DFG AK L     + ++ 
Sbjct: 124 TITKTVEYLHA---QGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAE--NGLLM 178

Query: 305 PIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLL 336
               T  +++PE       D   D+++ GVLL
Sbjct: 179 TPCYTANFVAPEVLERQGYDAACDIWSLGVLL 210

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score = 90.3 bits (225), Expect = 3e-20
 Identities = 49/222 (22%), Positives = 90/222 (40%), Gaps = 36/222 (16%)

Query: 142 DNFNSENLIGKGGHAEVYKG--CLPDGEVVAVKKIIKNAKEDE--------ERISDFLSE 191
             +     IG+G + +V+K       G  VA+K++ +    +E        E ++  L  
Sbjct: 11  QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRV-RVQTGEEGMPLSTIRE-VA-VLRH 67

Query: 192 LGIVAHINHPNAAKLI------GFSTENGFHLVLQFLPHGSLSSLL--FGSTECLEWTIR 243
           L       HPN  +L           E    LV + +    L++ L           TI+
Sbjct: 68  L---ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIK 123

Query: 244 YKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKW--LPDNWSHH 301
             +   +  GL +LH     R++HRD+K  NIL++   + +++DFGLA+        +  
Sbjct: 124 -DMMFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSV 179

Query: 302 IVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGR 343
           +V     T  Y +PE  +        D+++ G +  E+   +
Sbjct: 180 VV-----TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score = 89.9 bits (224), Expect = 3e-20
 Identities = 50/225 (22%), Positives = 83/225 (36%), Gaps = 36/225 (16%)

Query: 140 ATDNFNSENLIGKGGHAEVYKG-CLPDGEVVAVKKIIKNAKEDEER----------ISDF 188
           AT  +     IG G +  VYK      G  VA+K + +                  ++  
Sbjct: 7   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSV-RVPNGGGGGGGLPISTVREVA-L 64

Query: 189 LSELGIVAHINHPNAAKLI------GFSTENGFHLVLQFLPHGSLSSLL--FGSTECLEW 240
           L  L       HPN  +L+          E    LV + +    L + L           
Sbjct: 65  LRRL---EAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAE 120

Query: 241 TIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKW--LPDNW 298
           TI+  +      GL +LH      I+HRD+K  NIL++     +++DFGLA+        
Sbjct: 121 TIK-DLMRQFLRGLDFLHA---NCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMAL 176

Query: 299 SHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGR 343
           +  +V     T  Y +PE  +        D+++ G +  E+   +
Sbjct: 177 TPVVV-----TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 216

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score = 89.6 bits (223), Expect = 4e-20
 Identities = 59/217 (27%), Positives = 94/217 (43%), Gaps = 32/217 (14%)

Query: 142 DNFNSENLIGKGGHAEVY----KGCLPDGEVVAVK-----KIIKNAKEDEERISDFLSEL 192
           ++F    ++G+G  + V               A+K      IIK  +     +     E 
Sbjct: 30  EDFKFGKILGEGSFSTVVLARELA---TSREYAIKILEKRHIIK--ENKVPYV---TRER 81

Query: 193 GIVAHINHPNAAKLIG-FSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIA 251
            +++ ++HP   KL   F  +   +  L +  +G L   +       E   R+  A  I 
Sbjct: 82  DVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA-EIV 140

Query: 252 EGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEGTFG 311
             L+YLH    + IIHRD+K  NILL+ED   QI+DFG AK L             GT  
Sbjct: 141 SALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQ 197

Query: 312 YLSPEYFMHGIVDEK-----TDVFAFGVLLLELITGR 343
           Y+SPE     ++ EK     +D++A G ++ +L+ G 
Sbjct: 198 YVSPE-----LLTEKSACKSSDLWALGCIIYQLVAGL 229

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score = 89.2 bits (222), Expect = 7e-20
 Identities = 58/223 (26%), Positives = 104/223 (46%), Gaps = 36/223 (16%)

Query: 139 AATDNFNSENLIGKGGHAEVYKG-CLPDGEVVAVKKIIKNAKEDEERI-SDFLSELGIVA 196
           +++  F     +G G +A VYKG     G  VA+K++     + EE   S  + E+ ++ 
Sbjct: 2   SSSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEV---KLDSEEGTPSTAIREISLMK 58

Query: 197 HINHPNAAKLIG-FSTENGFHLVLQFLPHGSLSSLL-----FGSTECLEWTIRYKIALGI 250
            + H N  +L     TEN   LV +F+ +  L   +       +   LE  +       +
Sbjct: 59  ELKHENIVRLYDVIHTENKLTLVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQL 117

Query: 251 AEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKW--LPDN-WSHHIVFPIE 307
            +GL + H     +I+HRD+K  N+L+++  + ++ DFGLA+   +P N +S  +V    
Sbjct: 118 LQGLAFCHE---NKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVV---- 170

Query: 308 GTFGYLSPE-------YFMHGIVDEKTDVFAFGVLLLELITGR 343
            T  Y +P+       Y          D+++ G +L E+ITG+
Sbjct: 171 -TLWYRAPDVLMGSRTY------STSIDIWSCGCILAEMITGK 206

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score = 88.5 bits (220), Expect = 1e-19
 Identities = 59/207 (28%), Positives = 90/207 (43%), Gaps = 20/207 (9%)

Query: 149 LIGKGGHAEVYKGC-LPDGEVVAVKKIIKNAKEDEERISDFLS---ELGIVAHIN----H 200
           L+GKGG   V+ G  L D   VA+K I +N       +SD ++   E+ ++  +     H
Sbjct: 38  LLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGH 97

Query: 201 PNAAKLIG-FSTENGFHLVLQF-LPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLH 258
           P   +L+  F T+ GF LVL+  LP   L   +       E   R      +   +Q+ H
Sbjct: 98  PGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSR-CFFGQVVAAIQHCH 156

Query: 259 HDCHRRIIHRDIKASNILLSEDY-EAQISDFGLAKWLPDNWSHHIVFPIEGTFGYLSPEY 317
               R ++HRDIK  NIL+      A++ DFG    L D           GT  Y  PE+
Sbjct: 157 S---RGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYTDFD----GTRVYSPPEW 209

Query: 318 FMHGIVD-EKTDVFAFGVLLLELITGR 343
                       V++ G+LL +++ G 
Sbjct: 210 ISRHQYHALPATVWSLGILLYDMVCGD 236

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score = 89.8 bits (223), Expect = 2e-19
 Identities = 64/227 (28%), Positives = 101/227 (44%), Gaps = 26/227 (11%)

Query: 129 WKNFDFAELAAATDNFNSENLIGKGGHAEVY----KGCLPDGEVVAVKKIIKN---AKED 181
           WK  +   +    D F    ++G+GG  EV+    K     G++ A KK+ K     ++ 
Sbjct: 174 WKWLEAQPMGE--DWFLDFRVLGRGGFGEVFACQMKA---TGKLYACKKLNKKRLKKRKG 228

Query: 182 EERISDFLSELGIVAHINHPNAAKLI-GFSTENGFHLVLQFLPHGSLSSLLFGSTECL-- 238
            +     + E  I+A ++      L   F T+    LV+  +  G +   ++   E    
Sbjct: 229 YQGA---MVEKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPG 285

Query: 239 --EWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPD 296
             E    +  A  I  GL++LH    R II+RD+K  N+LL +D   +ISD GLA  L  
Sbjct: 286 FQEPRAIFYTA-QIVSGLEHLHQ---RNIIYRDLKPENVLLDDDGNVRISDLGLAVELKA 341

Query: 297 NWSHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGR 343
             +    +   GT G+++PE  +    D   D FA GV L E+I  R
Sbjct: 342 GQTKTKGYA--GTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAAR 386

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score = 87.7 bits (218), Expect = 3e-19
 Identities = 56/226 (24%), Positives = 93/226 (41%), Gaps = 40/226 (17%)

Query: 142 DNFNSENLIGKGGHAEVYKG-CLPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINH 200
             +     IG+G   EV+K      G+ VA+KK+     E E      L E+ I+  + H
Sbjct: 17  SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKV-LMENEKEGFPITALREIKILQLLKH 75

Query: 201 PNAAKLIG---------FSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIA 251
            N   LI             +   +LV  F  H  L+ LL         +   ++   + 
Sbjct: 76  ENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLL 134

Query: 252 EGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLA-------KWLPDNWSHHIVF 304
            GL Y+H     +I+HRD+KA+N+L++ D   +++DFGLA          P+ +++ +V 
Sbjct: 135 NGLYYIHR---NKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVV- 190

Query: 305 PIEGTFGYLSPE-------YFMHGIVDEKTDVFAFGVLLLELITGR 343
               T  Y  PE       Y          D++  G ++ E+ T  
Sbjct: 191 ----TLWYRPPELLLGERDY------GPPIDLWGAGCIMAEMWTRS 226

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score = 86.6 bits (215), Expect = 5e-19
 Identities = 59/199 (29%), Positives = 91/199 (45%), Gaps = 15/199 (7%)

Query: 150 IGKGGHAEVYKGC-LPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIG 208
           IGKG  A+V     +  G  VA+K II   + +   +     E+ I+  +NHPN  KL  
Sbjct: 23  IGKGNFAKVKLARHILTGREVAIK-IIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFE 81

Query: 209 -FSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRR-II 266
              TE   +L++++   G +   L       E   R      I   +QY    CH++ I+
Sbjct: 82  VIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEAR-SKFRQIVSAVQY----CHQKRIV 136

Query: 267 HRDIKASNILLSEDYEAQISDFGL-AKWLPDNWSHHIVFPIEGTFGYLSPEYFMHGIVD- 324
           HRD+KA N+LL  D   +I+DFG   ++              G   Y +PE F     D 
Sbjct: 137 HRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAFC----GAPPYAAPELFQGKKYDG 192

Query: 325 EKTDVFAFGVLLLELITGR 343
            + DV++ GV+L  L++G 
Sbjct: 193 PEVDVWSLGVILYTLVSGS 211

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score = 87.1 bits (216), Expect = 1e-18
 Identities = 52/216 (24%), Positives = 90/216 (41%), Gaps = 25/216 (11%)

Query: 142 DNFNSENLIGKGGHAEVY----KGCLPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAH 197
           ++F    +IG+G   EV     K      +V A+K + K         + F  E  ++ +
Sbjct: 74  EDFEILKVIGRGAFGEVAVVKLKN---ADKVFAMKILNKWEMLKRAETACFREERDVLVN 130

Query: 198 INHPNAAKLIG-FSTENGFHLVLQFLPHGSLSSLLFGSTECL-EWTIRYKIALGIAEGLQ 255
            +      L   F  +N  +LV+ +   G L +LL    + L E   R+ +A  +   + 
Sbjct: 131 GDSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLA-EMVIAID 189

Query: 256 YLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDN---WSHHIVFPIEGTFGY 312
            +H       +HRDIK  NIL+  +   +++DFG    L ++    S   V    GT  Y
Sbjct: 190 SVHQ---LHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAV----GTPDY 242

Query: 313 LSPEYFMHGIVDEKT-----DVFAFGVLLLELITGR 343
           +SPE        +       D ++ GV + E++ G 
Sbjct: 243 ISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGE 278

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score = 84.2 bits (209), Expect = 2e-18
 Identities = 43/221 (19%), Positives = 85/221 (38%), Gaps = 48/221 (21%)

Query: 149 LIGKGGHAEVYKGC-LPDGEVVAVKKI----IKNAKEDEERISDFLSELGIVAHINHPNA 203
           L+G+G + +V +          AVK +    ++     E  +     E+ ++  + H N 
Sbjct: 12  LLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVK---KEIQLLRRLRHKNV 68

Query: 204 AKL---IGFSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALG----------- 249
            +L   +    +   ++V+++   G     +              +              
Sbjct: 69  IQLVDVLYNEEKQKMYMVMEYCVCGMQE--MLD-----------SVPEKRFPVCQAHGYF 115

Query: 250 --IAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIE 307
             + +GL+YLH    + I+H+DIK  N+LL+     +IS  G+A+ L    +       +
Sbjct: 116 CQLIDGLEYLHS---QGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQ 172

Query: 308 GTFGYLSPEYFM-----HGIVDEKTDVFAFGVLLLELITGR 343
           G+  +  PE         G    K D+++ GV L  + TG 
Sbjct: 173 GSPAFQPPEIANGLDTFSG---FKVDIWSAGVTLYNITTGL 210

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score = 84.2 bits (209), Expect = 3e-18
 Identities = 56/226 (24%), Positives = 97/226 (42%), Gaps = 39/226 (17%)

Query: 149 LIGKGGHAEVYKGC-LPDGEVVAVK-----KIIKNAKEDEERISDFLS------------ 190
            IGKG +  V       D    A+K     K+I+ A                        
Sbjct: 20  EIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGP 79

Query: 191 ------ELGIVAHINHPNAAKL---IGFSTENGFHLVLQFLPHGSLSSLLFGSTECL-EW 240
                 E+ I+  ++HPN  KL   +    E+  ++V + +  G +  +   + + L E 
Sbjct: 80  IEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVP--TLKPLSED 137

Query: 241 TIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSH 300
             R      + +G++YLH+   ++IIHRDIK SN+L+ ED   +I+DFG++     +   
Sbjct: 138 QAR-FYFQDLIKGIEYLHY---QKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGS--D 191

Query: 301 HIVFPIEGTFGYLSPEYF--MHGIVD-EKTDVFAFGVLLLELITGR 343
            ++    GT  +++PE       I   +  DV+A GV L   + G+
Sbjct: 192 ALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQ 237

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score = 85.5 bits (212), Expect = 3e-18
 Identities = 61/222 (27%), Positives = 89/222 (40%), Gaps = 35/222 (15%)

Query: 142 DNFNSENLIGKGGHAEVY----KGCLPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAH 197
           D+F    +IG+G  +EV     K     G+V A+K + K        +S F  E  ++ +
Sbjct: 61  DDFEILKVIGRGAFSEVAVVKMKQ---TGQVYAMKIMNKWDMLKRGEVSCFREERDVLVN 117

Query: 198 INHPNAAKLI-GFSTENGFHLVLQFLPHGSLSSLL--FGSTECLEWTIRYKIALGIAE-- 252
            +     +L   F  EN  +LV+++   G L +LL  FG     E    Y     +AE  
Sbjct: 118 GDRRWITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFY-----LAEIV 172

Query: 253 -GLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAK---WLPDNWSHHIVFPIEG 308
             +  +H       +HRDIK  NILL      +++DFG            S   V    G
Sbjct: 173 MAIDSVHR---LGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAV----G 225

Query: 309 TFGYLSPEYFM-HGIVDEKT------DVFAFGVLLLELITGR 343
           T  YLSPE     G            D +A GV   E+  G+
Sbjct: 226 TPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQ 267

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score = 83.9 bits (208), Expect = 5e-18
 Identities = 40/208 (19%), Positives = 77/208 (37%), Gaps = 38/208 (18%)

Query: 146 SENLIGKGGHAEVYKG-CLPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHI-NHPNA 203
           S+ ++G G + +V +      G+  A+K +         +      E+         P+ 
Sbjct: 33  SKQVLGLGVNGKVLECFHRRTGQKCALKLLYD--SPKARQ------EVDHHWQASGGPHI 84

Query: 204 AKLIGF-----STENGFHLVLQFLPHGSL-------SSLLFGSTECLEWTIRYKIALGIA 251
             ++         +    ++++ +  G L           F   E        +I   I 
Sbjct: 85  VCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREA------AEIMRDIG 138

Query: 252 EGLQYLHHDCHRRIIHRDIKASNILL---SEDYEAQISDFGLAKWLPDNWSHHIVFPIEG 308
             +Q+LH      I HRD+K  N+L     +D   +++DFG AK    N           
Sbjct: 139 TAIQFLH---SHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQTPC----Y 191

Query: 309 TFGYLSPEYFMHGIVDEKTDVFAFGVLL 336
           T  Y++PE       D+  D+++ GV++
Sbjct: 192 TPYYVAPEVLGPEKYDKSCDMWSLGVIM 219

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score = 84.0 bits (208), Expect = 8e-18
 Identities = 54/215 (25%), Positives = 91/215 (42%), Gaps = 26/215 (12%)

Query: 142 DNFNSENLIGKGGHAEVY----KGCLPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAH 197
           +++    +IG+G   EV     K      +V A+K + K         + F  E  I+A 
Sbjct: 69  EDYEVVKVIGRGAFGEVQLVRHKS---TRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAF 125

Query: 198 INHPNAAKLIG-FSTENGFHLVLQFLPHGSLSSLLFGSTECL-EWTIRYKIALGIAEGLQ 255
            N P   +L   F  +   ++V++++P G L +L+  S   + E   R+  A  +   L 
Sbjct: 126 ANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLM--SNYDVPEKWARFYTA-EVVLALD 182

Query: 256 YLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDN---WSHHIVFPIEGTFGY 312
            +H       IHRD+K  N+LL +    +++DFG    +           V    GT  Y
Sbjct: 183 AIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV----GTPDY 235

Query: 313 LSPEYFM----HGIVDEKTDVFAFGVLLLELITGR 343
           +SPE        G    + D ++ GV L E++ G 
Sbjct: 236 ISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGD 270

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score = 82.8 bits (205), Expect = 1e-17
 Identities = 47/211 (22%), Positives = 90/211 (42%), Gaps = 18/211 (8%)

Query: 143 NFNSENLIGKGGHAEVYKG-CLPDGEVVAVK-----KIIKNAKEDEERISDFLSELGIVA 196
            +++ + +G G    V+        + V VK     K++++   ++ ++     E+ I++
Sbjct: 25  KYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILS 84

Query: 197 HINHPNAAKLIG-FSTENGFHLVLQFLPHGS-LSSLLFGSTECLEWTIRYKIALGIAEGL 254
            + H N  K++  F  +  F LV++    G  L + +       E      I   +   +
Sbjct: 85  RVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLAS-YIFRQLVSAV 143

Query: 255 QYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGL-AKWLPDNWSHHIVFPIEGTFGYL 313
            YL     + IIHRDIK  NI+++ED+  ++ DFG  A        +       GT  Y 
Sbjct: 144 GYLR---LKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTFC----GTIEYC 196

Query: 314 SPEYFMHGIVD-EKTDVFAFGVLLLELITGR 343
           +PE  M       + ++++ GV L  L+   
Sbjct: 197 APEVLMGNPYRGPELEMWSLGVTLYTLVFEE 227

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score = 82.3 bits (204), Expect = 2e-17
 Identities = 57/213 (26%), Positives = 92/213 (43%), Gaps = 29/213 (13%)

Query: 142 DNFNSENLIGKGGHAEVY----KGCLPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAH 197
           D F+    +G G    V     K     G   A+K + K      ++I   L+E  I+  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKE---SGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 97

Query: 198 INHPNAAKLIG-FSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQY 256
           +N P   KL   F   +  ++V++++  G + S L       E   R+  A  I    +Y
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAA-QIVLTFEY 156

Query: 257 LHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDN-WSHHIVFPIEGTFGYLSP 315
           LH      +I+RD+K  N+L+ +    Q++DFG AK +    W+      + GT   L+P
Sbjct: 157 LHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWT------LCGTPEALAP 207

Query: 316 EYFMHGIVDEK-----TDVFAFGVLLLELITGR 343
           E     I+  K      D +A GVL+ E+  G 
Sbjct: 208 E-----IILSKGYNKAVDWWALGVLIYEMAAGY 235

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score = 80.3 bits (199), Expect = 4e-17
 Identities = 59/203 (29%), Positives = 85/203 (41%), Gaps = 19/203 (9%)

Query: 149 LIGKGGHAEVYKGC-LPDGEVVAVKKIIKNAKED-EERISDFLSELGIVAHINHPNAAKL 206
            +G+G + EV         E VAVK +      D  E I     E+ I   +NH N  K 
Sbjct: 14  TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIK---KEICINKMLNHENVVKF 70

Query: 207 IG-FSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYK----IALGIAEGLQYLHHDC 261
            G     N  +L L++   G L   +       E   +      +A     G+ YLH   
Sbjct: 71  YGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA-----GVVYLHG-- 123

Query: 262 HRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEGTFGYLSPEYFMHG 321
              I HRDIK  N+LL E    +ISDFGLA     N    ++  + GT  Y++PE     
Sbjct: 124 -IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 182

Query: 322 IVD-EKTDVFAFGVLLLELITGR 343
               E  DV++ G++L  ++ G 
Sbjct: 183 EFHAEPVDVWSCGIVLTAMLAGE 205

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score = 81.0 bits (200), Expect = 9e-17
 Identities = 38/169 (22%), Positives = 65/169 (38%), Gaps = 28/169 (16%)

Query: 142 DNFNSENL-IGKGGHAEVYKGC---LPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAH 197
           D F  E   +G+G +  VYK       D +  A+K+I     E          E+ ++  
Sbjct: 20  DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQI-----EGTGISMSACREIALLRE 74

Query: 198 INHPNAAKL---IGFSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALG----- 249
           + HPN   L        +    L+  +  H  L  ++             ++  G     
Sbjct: 75  LKHPNVISLQKVFLSHADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSL 133

Query: 250 ---IAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQ----ISDFGLA 291
              I +G+ YLH      ++HRD+K +NIL+  +   +    I+D G A
Sbjct: 134 LYQILDGIHYLHA---NWVLHRDLKPANILVMGEGPERGRVKIADMGFA 179

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score = 80.5 bits (199), Expect = 1e-16
 Identities = 47/193 (24%), Positives = 75/193 (38%), Gaps = 27/193 (13%)

Query: 114 DDADDGGSVPIVRHSWKNFDFAELAAATDNFNSENLIGKGGHAEVYKG-CLPDGEVVAVK 172
            D D      +V    +  D  +      ++    +IG G    VY+      GE+VA+K
Sbjct: 30  RDKDGSKVTTVVATPGQGPDRPQ----EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIK 85

Query: 173 KIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTENG-------FHLVLQFLP-- 223
           K+     +D+        EL I+  ++H N  +L  F   +G        +LVL ++P  
Sbjct: 86  KV----LQDKRFK---NRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPET 138

Query: 224 -HGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSED-Y 281
            +                 ++      +   L Y+H      I HRDIK  N+LL  D  
Sbjct: 139 VYRVARHYSRAKQTLPVIYVKL-YMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTA 194

Query: 282 EAQISDFGLAKWL 294
             ++ DFG AK L
Sbjct: 195 VLKLCDFGSAKQL 207

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 80.2 bits (198), Expect = 2e-16
 Identities = 54/207 (26%), Positives = 90/207 (43%), Gaps = 13/207 (6%)

Query: 142 DNFNSENLIGKGGHAEVY----KGCLPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAH 197
           + F    L+GKG   +V     K     G   A+K + K     ++ ++  L+E  ++ +
Sbjct: 148 NEFEYLKLLGKGTFGKVILVKEKA---TGRYYAMKILKKEVIVAKDEVAHTLTENRVLQN 204

Query: 198 INHPNAAKLIG-FSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQY 256
             HP    L   F T +    V+++   G L   L       E   R+  A  I   L Y
Sbjct: 205 SRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGA-EIVSALDY 263

Query: 257 LHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEGTFGYLSPE 316
           LH +  + +++RD+K  N++L +D   +I+DFGL K          +    GT  YL+PE
Sbjct: 264 LHSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCK--EGIKDGATMKTFCGTPEYLAPE 319

Query: 317 YFMHGIVDEKTDVFAFGVLLLELITGR 343
                      D +  GV++ E++ GR
Sbjct: 320 VLEDNDYGRAVDWWGLGVVMYEMMCGR 346

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score = 78.9 bits (195), Expect = 2e-16
 Identities = 59/203 (29%), Positives = 85/203 (41%), Gaps = 19/203 (9%)

Query: 149 LIGKGGHAEVYKGC-LPDGEVVAVKKIIKNAKED-EERISDFLSELGIVAHINHPNAAKL 206
            +G+G + EV         E VAVK +      D  E I     E+ I   +NH N  K 
Sbjct: 14  TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIK---KEICINKMLNHENVVKF 70

Query: 207 IG-FSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYK----IALGIAEGLQYLHHDC 261
            G     N  +L L++   G L   +       E   +      +A     G+ YLH   
Sbjct: 71  YGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA-----GVVYLHG-- 123

Query: 262 HRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEGTFGYLSPEYFMHG 321
              I HRDIK  N+LL E    +ISDFGLA     N    ++  + GT  Y++PE     
Sbjct: 124 -IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 182

Query: 322 IVD-EKTDVFAFGVLLLELITGR 343
               E  DV++ G++L  ++ G 
Sbjct: 183 EFHAEPVDVWSCGIVLTAMLAGE 205

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 78.3 bits (194), Expect = 3e-16
 Identities = 54/218 (24%), Positives = 100/218 (45%), Gaps = 39/218 (17%)

Query: 142 DNFNSENLIGKGGHAEVY----KGCLPDGEVVAVK-----KIIKNAKEDEERISDFLSEL 192
            +F     +G G    V+    +    +G   A+K      +++   +  E       E 
Sbjct: 6   QDFQILRTLGTGSFGRVHLIRSRH---NGRYYAMKVLKKEIVVR--LKQVEHT---NDER 57

Query: 193 GIVAHINHPNAAKLIG-FSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIA 251
            +++ + HP   ++ G F       +++ ++  G L SLL  S        ++  A  + 
Sbjct: 58  LMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAA-EVC 116

Query: 252 EGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDN-WSHHIVFPIEGTF 310
             L+YLH    + II+RD+K  NILL ++   +I+DFG AK++PD  ++      + GT 
Sbjct: 117 LALEYLHS---KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYT------LCGTP 167

Query: 311 GYLSPEYFMHGIVDEK-----TDVFAFGVLLLELITGR 343
            Y++PE     +V  K      D ++FG+L+ E++ G 
Sbjct: 168 DYIAPE-----VVSTKPYNKSIDWWSFGILIYEMLAGY 200

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score = 78.9 bits (195), Expect = 3e-16
 Identities = 41/167 (24%), Positives = 68/167 (40%), Gaps = 19/167 (11%)

Query: 141 TDNFNSENLIGKGGHAEVYKG-CLPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHIN 199
            D F  E + G+G    V  G     G  VA+KK+I++      R    L  +  +A ++
Sbjct: 22  MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQD-PRFRNRE---LQIMQDLAVLH 77

Query: 200 HPNAAKLIGF---STENGF-----HLVLQFLP---HGSLSSLLFGSTECLEWTIRYKIAL 248
           HPN  +L  +     E        ++V++++P   H    +            I+     
Sbjct: 78  HPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKV-FLF 136

Query: 249 GIAEGLQYLHHDCHRRIIHRDIKASNILL-SEDYEAQISDFGLAKWL 294
            +   +  LH      + HRDIK  N+L+   D   ++ DFG AK L
Sbjct: 137 QLIRSIGCLHLPSV-NVCHRDIKPHNVLVNEADGTLKLCDFGSAKKL 182

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score = 76.1 bits (188), Expect = 1e-15
 Identities = 52/206 (25%), Positives = 87/206 (42%), Gaps = 26/206 (12%)

Query: 149 LIGKGGHAEVYKGC-LPDGEVVAVKKIIK---NAKEDEERISDFLSELGIVAHINHPNAA 204
            +G G   +V  G     G  VAVK + +    + +   +I     E+  +    HP+  
Sbjct: 18  TLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIK---REIQNLKLFRHPHII 74

Query: 205 KLIG-FSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHR 263
           KL    ST   F +V++++  G L   +       E   R ++   I   + Y    CHR
Sbjct: 75  KLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEAR-RLFQQILSAVDY----CHR 129

Query: 264 R-IIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEGTF----GYLSPEYF 318
             ++HRD+K  N+LL     A+I+DFGL+  + D            T      Y +PE  
Sbjct: 130 HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLR-------TSCGSPNYAAPEVI 182

Query: 319 MHGIVD-EKTDVFAFGVLLLELITGR 343
              +    + D+++ GV+L  L+ G 
Sbjct: 183 SGRLYAGPEVDIWSCGVILYALLCGT 208

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score = 77.5 bits (191), Expect = 1e-15
 Identities = 44/209 (21%), Positives = 80/209 (38%), Gaps = 41/209 (19%)

Query: 147 ENLIGKGGHAEVYKG-CLPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHI-NHPNAA 204
             ++G G + +V +       E  A+K +         R      E+ +       P+  
Sbjct: 67  SQVLGLGINGKVLQIFNKRTQEKFALKMLQD--CPKARR------EVELHWRASQCPHIV 118

Query: 205 KLIGF-----STENGFHLVLQFLPHGSL-------SSLLFGSTECLEWTIRY--KIALGI 250
           +++       +      +V++ L  G L           F  TE      R   +I   I
Sbjct: 119 RIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAF--TE------REASEIMKSI 170

Query: 251 AEGLQYLHHDCHRRIIHRDIKASNILL---SEDYEAQISDFGLAKWLPDNWSHHIVFPIE 307
            E +QYLH      I HRD+K  N+L      +   +++DFG AK    +   + +    
Sbjct: 171 GEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSH---NSLTTPC 224

Query: 308 GTFGYLSPEYFMHGIVDEKTDVFAFGVLL 336
            T  Y++PE       D+  D+++ GV++
Sbjct: 225 YTPYYVAPEVLGPEKYDKSCDMWSLGVIM 253

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 76.9 bits (189), Expect = 1e-15
 Identities = 32/101 (31%), Positives = 54/101 (53%), Gaps = 11/101 (10%)

Query: 245 KIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDN----WSH 300
             +  +A+G+++L     R+ IHRD+ A NILLSE    +I DFGLA+ +  +       
Sbjct: 197 CYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKG 253

Query: 301 HIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELIT 341
               P++      +PE     +   ++DV++FGVLL E+ +
Sbjct: 254 DARLPLKWM----APETIFDRVYTIQSDVWSFGVLLWEIFS 290

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 49.9 bits (119), Expect = 7e-07
 Identities = 38/168 (22%), Positives = 65/168 (38%), Gaps = 19/168 (11%)

Query: 142 DNFNSENLIGKGGHAEVYKGCL------PDGEVVAVKKIIKNAKEDEERISDFLSELGIV 195
           D       +G+G   +V +              VAVK + + A   E R    +SEL I+
Sbjct: 22  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHR--ALMSELKIL 79

Query: 196 AHI-NHPNAAKLIGFSTENG--FHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAE 252
            HI +H N   L+G  T+ G    ++++F   G+LS+ L         + R +      +
Sbjct: 80  IHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYL--------RSKRNEFVPYKTK 131

Query: 253 GLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSH 300
           G ++     +   I  D+K     ++    +  S F   K L D    
Sbjct: 132 GARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEE 179

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score = 76.0 bits (188), Expect = 2e-15
 Identities = 63/214 (29%), Positives = 101/214 (47%), Gaps = 26/214 (12%)

Query: 142 DNFNSENLIGKGGHAEVY---KGCLPD-GEVVAVKKIIKNA--KEDEERISDFLSELGIV 195
             F    ++G+G   +V+   K    D  ++ A+K + K      D  R      E  I+
Sbjct: 24  SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRT---KMERDIL 80

Query: 196 AHINHPNAAKLI-GFSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGL 254
             +NHP   KL   F TE   +L+L FL  G L + L       E  +++ +A  +A  L
Sbjct: 81  VEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLA-ELALAL 139

Query: 255 QYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEGTFGYLS 314
            +LH      II+RD+K  NILL E+   +++DFGL+K           +   GT  Y++
Sbjct: 140 DHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSK--ESIDHEKKAYSFCGTVEYMA 194

Query: 315 PEYFMHGIVDEKT-----DVFAFGVLLLELITGR 343
           PE     +V+ +      D ++FGVL+ E++TG 
Sbjct: 195 PE-----VVNRRGHTQSADWWSFGVLMFEMLTGT 223

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score = 75.8 bits (187), Expect = 3e-15
 Identities = 52/217 (23%), Positives = 98/217 (45%), Gaps = 32/217 (14%)

Query: 141 TDNFNSENLIGKGGHAEVYKG-CLPDGEVVAVKKIIK--NAKEDEERISDFLSELGIVAH 197
              + S   +G G +  V        GE VA+KK+ +   ++   +R      EL ++ H
Sbjct: 23  PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRA---YRELLLLKH 79

Query: 198 INHPNAAKLI-------GFSTENGFHLVLQFLP---HGSLSSLLFGSTECLEWTIRYKIA 247
           + H N   L+              F+LV+ F+       +           E  I+Y + 
Sbjct: 80  MQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGLKF------SEEKIQY-LV 132

Query: 248 LGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIE 307
             + +GL+Y+H      ++HRD+K  N+ ++ED E +I DFGLA+      + ++V    
Sbjct: 133 YQMLKGLKYIHS---AGVVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVV---- 185

Query: 308 GTFGYLSPEYFM-HGIVDEKTDVFAFGVLLLELITGR 343
            T  Y +PE  +     ++  D+++ G ++ E++TG+
Sbjct: 186 -TRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 74.9 bits (185), Expect = 5e-15
 Identities = 60/217 (27%), Positives = 102/217 (47%), Gaps = 30/217 (13%)

Query: 142 DNFNSENLIGKGGHAEVY---KGCLPD-GEVVAVK-----KIIKNAKEDEERISDFLSEL 192
           + F    ++GKGG+ +V+   K    + G++ A+K      I++NAK D        +E 
Sbjct: 17  ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAK-DTAHT---KAER 72

Query: 193 GIVAHINHPNAAKLI-GFSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIA 251
            I+  + HP    LI  F T    +L+L++L  G L   L      +E T  + +A  I+
Sbjct: 73  NILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLA-EIS 131

Query: 252 EGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEGTFG 311
             L +LH    + II+RD+K  NI+L+     +++DFGL K         +     GT  
Sbjct: 132 MALGHLHQ---KGIIYRDLKPENIMLNHQGHVKLTDFGLCK--ESIHDGTVTHTFCGTIE 186

Query: 312 YLSPEYFMHGIVDEKT-----DVFAFGVLLLELITGR 343
           Y++PE     I+         D ++ G L+ +++TG 
Sbjct: 187 YMAPE-----ILMRSGHNRAVDWWSLGALMYDMLTGA 218

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score = 75.7 bits (186), Expect = 6e-15
 Identities = 47/218 (21%), Positives = 88/218 (40%), Gaps = 33/218 (15%)

Query: 141 TDNFNSENLIGKGGHAEVYKG-CLPDGEVVAVKKIIK--NAKEDEERISDFLSELGIVAH 197
              + +   IG G    V           VA+KK+ +    +   +R      EL ++  
Sbjct: 61  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRA---YRELVLMKC 117

Query: 198 INHPNAAKLI-------GFSTENGFHLVLQFLP---HGSLSSLLFGSTECLEWTIRYKIA 247
           +NH N   L+               +LV++ +       +   L          + Y++ 
Sbjct: 118 VNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL---DHERMSYLLYQML 174

Query: 248 LGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDN--WSHHIVFP 305
            G    +++LH      IIHRD+K SNI++  D   +I DFGLA+    +   + ++V  
Sbjct: 175 CG----IKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV-- 225

Query: 306 IEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGR 343
              T  Y +PE  +     E  D+++ G ++ E++  +
Sbjct: 226 ---TRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score = 75.1 bits (185), Expect = 7e-15
 Identities = 54/218 (24%), Positives = 94/218 (43%), Gaps = 32/218 (14%)

Query: 141 TDNFNSENLIGKGGHAEVYKGCLPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINH 200
              + +  +IG G    V++  L + + VA+KK++++ K  + R      EL I+  + H
Sbjct: 39  EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQD-KRFKNR------ELQIMRIVKH 91

Query: 201 PNAAKLIGF-------STENGFHLVLQFLP---HGSLSSLLFGSTECLEWTIRYKIALGI 250
           PN   L  F         E   +LVL+++P   + +               I+      +
Sbjct: 92  PNVVDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKL-YMYQL 150

Query: 251 AEGLQYLHHDCHRRIIHRDIKASNILLSED-YEAQISDFGLAKWL-PDNWS-HHIVFPIE 307
              L Y+H      I HRDIK  N+LL       ++ DFG AK L     +  +I     
Sbjct: 151 LRSLAYIH---SIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSYIC---- 203

Query: 308 GTFGYLSPEYFMHGIVDEKT--DVFAFGVLLLELITGR 343
            +  Y +PE  + G  +  T  D+++ G ++ EL+ G+
Sbjct: 204 -SRYYRAPE-LIFGATNYTTNIDIWSTGCVMAELMQGQ 239

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 73.4 bits (181), Expect = 2e-14
 Identities = 55/212 (25%), Positives = 96/212 (45%), Gaps = 24/212 (11%)

Query: 142 DNFNSENLIGKGGHAEV----YKGCLPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAH 197
           ++F+   L+GKG   +V     K     G   A+K + K     ++ ++  ++E  ++ +
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKA---TGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN 61

Query: 198 INHPNAAKLIG-FSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQY 256
             HP    L   F T +    V+++   G L   L       E   R+  A  I   L+Y
Sbjct: 62  TRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGA-EIVSALEY 120

Query: 257 LHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEGTFGYLSPE 316
           LH    R +++RDIK  N++L +D   +I+DFGL K          +    GT  YL+PE
Sbjct: 121 LHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKTFCGTPEYLAPE 175

Query: 317 YFMHGIVDEKT-----DVFAFGVLLLELITGR 343
                ++++       D +  GV++ E++ GR
Sbjct: 176 -----VLEDNDYGRAVDWWGLGVVMYEMMCGR 202

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 73.1 bits (180), Expect = 2e-14
 Identities = 55/206 (26%), Positives = 97/206 (47%), Gaps = 27/206 (13%)

Query: 150 IGKGGHAEVYKG-CLPDGEVVAVKKIIK--NAKEDEERISDFLSELGIVAHINHPNAAKL 206
           +G G +  V        G  VA+KK+ +   ++   +R      EL ++ H+ H N   L
Sbjct: 33  VGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRA---YRELRLLKHMRHENVIGL 89

Query: 207 I-------GFSTENGFHLVLQFLPHGSLSSLLFGSTECLEWT-IRYKIALGIAEGLQYLH 258
           +              F+LV+ F+    L  L+    E L    I++ +   + +GL+Y+H
Sbjct: 90  LDVFTPDETLDDFTDFYLVMPFMGT-DLGKLM--KHEKLGEDRIQF-LVYQMLKGLRYIH 145

Query: 259 HDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEGTFGYLSPEYF 318
                 IIHRD+K  N+ ++ED E +I DFGLA+      + ++V     T  Y +PE  
Sbjct: 146 A---AGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGYVV-----TRWYRAPEVI 197

Query: 319 M-HGIVDEKTDVFAFGVLLLELITGR 343
           +      +  D+++ G ++ E+ITG+
Sbjct: 198 LNWMRYTQTVDIWSVGCIMAEMITGK 223

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score = 73.2 bits (180), Expect = 3e-14
 Identities = 49/202 (24%), Positives = 79/202 (39%), Gaps = 20/202 (9%)

Query: 149 LIGKGGHAEVYKG-CLPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLI 207
            IG G              E+VAVK  I+     +E +     E+     + HPN  +  
Sbjct: 27  DIGSGNFGVARLMRDKLTKELVAVK-YIERGAAIDENVQ---REIINHRSLRHPNIVRFK 82

Query: 208 G-FSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRR-I 265
               T     +++++   G L   +  +    E   R+     +  G+ Y    CH   I
Sbjct: 83  EVILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQ-QLLSGVSY----CHSMQI 137

Query: 266 IHRDIKASNILLSEDYEAQ--ISDFGLAKW-LPDNWSHHIVFPIEGTFGYLSPEYFMHGI 322
            HRD+K  N LL      +  I DFG +K  +  +     V    GT  Y++PE  +   
Sbjct: 138 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV----GTPAYIAPEVLLRQE 193

Query: 323 VD-EKTDVFAFGVLLLELITGR 343
            D +  DV++ GV L  ++ G 
Sbjct: 194 YDGKIADVWSCGVTLYVMLVGA 215

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score = 72.0 bits (177), Expect = 6e-14
 Identities = 49/215 (22%), Positives = 91/215 (42%), Gaps = 27/215 (12%)

Query: 141 TDNFNSENLIGKGGHAEVYKG-CLPDGEVVAVKKIIK--NAKEDEERISDFLSELGIVAH 197
              + +   IG G    V           VA+KK+ +    +   +R      EL ++  
Sbjct: 24  LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRA---YRELVLMKC 80

Query: 198 INHPNAAKLI-------GFSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGI 250
           +NH N   L+               ++V++ +   +L  ++    E     + Y +   +
Sbjct: 81  VNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDA-NLCQVI--QMELDHERMSY-LLYQM 136

Query: 251 AEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDN--WSHHIVFPIEG 308
             G+++LH      IIHRD+K SNI++  D   +I DFGLA+    +   + ++V     
Sbjct: 137 LCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV----- 188

Query: 309 TFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGR 343
           T  Y +PE  +     E  D+++ G ++ E+I G 
Sbjct: 189 TRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 223

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 73.1 bits (179), Expect = 6e-14
 Identities = 57/213 (26%), Positives = 98/213 (46%), Gaps = 25/213 (11%)

Query: 142 DNFNSENLIGKGGHAEV----YKGCLPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAH 197
            +FN   ++GKG   +V     KG     E+ AVK + K+    ++ +   + E  ++A 
Sbjct: 341 TDFNFLMVLGKGSFGKVMLSERKG---TDELYAVKILKKDVVIQDDDVECTMVEKRVLAL 397

Query: 198 IN-HPNAAKLIG-FSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQ 255
               P   +L   F T +  + V++++  G L   +       E    +  A  IA GL 
Sbjct: 398 PGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAA-EIAIGLF 456

Query: 256 YLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEGTFGYLSP 315
           +L     + II+RD+K  N++L  +   +I+DFG+ K    +      F   GT  Y++P
Sbjct: 457 FLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFC--GTPDYIAP 511

Query: 316 EYFMHGIVDEKT-----DVFAFGVLLLELITGR 343
           E     I+  +      D +AFGVLL E++ G+
Sbjct: 512 E-----IIAYQPYGKSVDWWAFGVLLYEMLAGQ 539

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score = 71.7 bits (176), Expect = 7e-14
 Identities = 52/218 (23%), Positives = 94/218 (43%), Gaps = 34/218 (15%)

Query: 149 LIGKGGHAEVYKGC--LPDGEVVAVKKIIKNAK------EDEERISDFLSELGIVAHINH 200
            +G G  + V+     + +   VA+K I++  K      EDE ++   +++       + 
Sbjct: 26  KLGWGHFSTVWL-AKDMVNNTHVAMK-IVRGDKVYTEAAEDEIKLLQRVNDADNTKE-DS 82

Query: 201 PNAAKLIG------FSTENGFHLVLQFLPHG-SLSSLL--FGSTECLEWTIRYKIALGIA 251
             A  ++           NG H+V+ F   G +L +L+  +         ++ +I+  + 
Sbjct: 83  MGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVK-QISKQLL 141

Query: 252 EGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQ------ISDFGLAKWLPDNWSHHIVFP 305
            GL Y+H  C   IIH DIK  N+L+      +      I+D G A W  +++++ I   
Sbjct: 142 LGLDYMHRRC--GIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQ-- 197

Query: 306 IEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGR 343
              T  Y SPE  +        D+++   L+ ELITG 
Sbjct: 198 ---TREYRSPEVLLGAPWGCGADIWSTACLIFELITGD 232

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 71.2 bits (175), Expect = 1e-13
 Identities = 54/214 (25%), Positives = 101/214 (47%), Gaps = 25/214 (11%)

Query: 141 TDNFNSENLIGKGGHAEVYKG-CLPDGEVVAVKKIIK--NAKEDEERISDFLSELGIVAH 197
            + + + + +G G +  V        G  VAVKK+ +   +    +R      EL ++ H
Sbjct: 28  PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRT---YRELRLLKH 84

Query: 198 INHPNAAKLI-------GFSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGI 250
           + H N   L+            N  +LV   +    L++++    +  +  +++ +   I
Sbjct: 85  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGA-DLNNIV-KCQKLTDDHVQF-LIYQI 141

Query: 251 AEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEGTF 310
             GL+Y+H      IIHRD+K SN+ ++ED E +I DFGLA+   D  + ++      T 
Sbjct: 142 LRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGYVA-----TR 193

Query: 311 GYLSPEYFM-HGIVDEKTDVFAFGVLLLELITGR 343
            Y +PE  +     ++  D+++ G ++ EL+TGR
Sbjct: 194 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score = 70.6 bits (173), Expect = 3e-13
 Identities = 51/203 (25%), Positives = 87/203 (42%), Gaps = 20/203 (9%)

Query: 149 LIGKGGHAEVYKGC-LPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLI 207
            +G G   +V  G     G  VAVK + +      + +     E+  +    HP+  KL 
Sbjct: 23  TLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLY 82

Query: 208 G-FSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRR-I 265
              ST +   +V++++  G L   +  +    E   R ++   I  G+ Y    CHR  +
Sbjct: 83  QVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESR-RLFQQILSGVDY----CHRHMV 137

Query: 266 IHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEGTF----GYLSPEYFMHG 321
           +HRD+K  N+LL     A+I+DFGL+  + D            T      Y +PE     
Sbjct: 138 VHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLR-------TSCGSPNYAAPEVISGR 190

Query: 322 IVD-EKTDVFAFGVLLLELITGR 343
           +    + D+++ GV+L  L+ G 
Sbjct: 191 LYAGPEVDIWSSGVILYALLCGT 213

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 69.9 bits (170), Expect = 3e-13
 Identities = 35/212 (16%), Positives = 52/212 (24%), Gaps = 50/212 (23%)

Query: 140 ATDNFNSENLIGKGGHAEVYKGCLPDGEVVAVKKIIKNAKED--------------EERI 185
            T+       IG+G   EV++    D   VA+K I     +               E  I
Sbjct: 18  PTEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIII 76

Query: 186 SDFLSELGIVAHINHPNAAKLIGFS-------------------------------TENG 214
           S  LS L             L                                    ++ 
Sbjct: 77  SKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQ 136

Query: 215 FHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASN 274
             +VL+F   G    L    T+         I   +   L            HRD+   N
Sbjct: 137 LFIVLEFEFGGI--DLEQMRTKLSSLATAKSILHQLTASLAVAEASLR--FEHRDLHWGN 192

Query: 275 ILLSEDYEAQISDFGLAKWLPDNWSHHIVFPI 306
           +LL +    ++      K          V  I
Sbjct: 193 VLLKKTSLKKLHYTLNGKSSTIPSCGLQVSII 224

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 69.6 bits (171), Expect = 3e-13
 Identities = 60/222 (27%), Positives = 96/222 (43%), Gaps = 36/222 (16%)

Query: 142 DNFNSENLIGKGGHAEVY---KGCLPD-GEVVAV----KKIIKNAKEDEERISDFLSELG 193
           +NF    ++G G + +V+   K    D G++ A+    K  I    +  E      +E  
Sbjct: 54  ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHT---RTERQ 110

Query: 194 IVAHINH-PNAAKLIG-FSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIA 251
           ++ HI   P    L   F TE   HL+L ++  G L + L       E  ++  +   I 
Sbjct: 111 VLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVG-EIV 169

Query: 252 EGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAK---WLPDNWSHHIVFPIEG 308
             L++LH      II+RDIK  NILL  +    ++DFGL+K         ++       G
Sbjct: 170 LALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFC----G 222

Query: 309 TFGYLSPEYFMHGIVDEKT-------DVFAFGVLLLELITGR 343
           T  Y++P+     IV           D ++ GVL+ EL+TG 
Sbjct: 223 TIEYMAPD-----IVRGGDSGHDKAVDWWSLGVLMYELLTGA 259

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score = 68.5 bits (168), Expect = 7e-13
 Identities = 43/208 (20%), Positives = 87/208 (41%), Gaps = 31/208 (14%)

Query: 149 LIGKGGHAEVYKGC-LPDGEVVAVKKIIKNAKEDEERISDFLS-ELGIVAHINHPNAAKL 206
            +G+G   +V         + VA+K  I      +  +   +  E+  +  + HP+  KL
Sbjct: 16  TLGEGSFGKVKLATHYKTQQKVALK-FISRQLLKKSDMHMRVEREISYLKLLRHPHIIKL 74

Query: 207 IG-FSTENGFHLVLQF---------LPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQY 256
               +T     +V+++         +    ++          E   R      I   ++Y
Sbjct: 75  YDVITTPTDIVMVIEYAGGELFDYIVEKKRMT----------EDEGRRFFQ-QIICAIEY 123

Query: 257 LHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEGTFGYLSPE 316
            H     +I+HRD+K  N+LL ++   +I+DFGL+  + D    + +    G+  Y +PE
Sbjct: 124 CHR---HKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDG---NFLKTSCGSPNYAAPE 177

Query: 317 YFMHGIVD-EKTDVFAFGVLLLELITGR 343
                +    + DV++ G++L  ++ GR
Sbjct: 178 VINGKLYAGPEVDVWSCGIVLYVMLVGR 205

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 69.1 bits (169), Expect = 7e-13
 Identities = 43/161 (26%), Positives = 74/161 (45%), Gaps = 19/161 (11%)

Query: 141 TDNFNSENLIGKGGHAEVYKG-CLPDGEVVAVKKIIKNAKEDE---ERISDFLSELGIVA 196
            D +   +LIG G +  V +     +  VVA+KKI     ED    +RI   L E+ I+ 
Sbjct: 52  PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKI-LRVFEDLIDCKRI---LREIAILN 107

Query: 197 HINHPNAAKLI------GFSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGI 250
            +NH +  K++           +  ++VL+         L        E  I+  +   +
Sbjct: 108 RLNHDHVVKVLDIVIPKDVEKFDELYVVLEIADS-DFKKLFRTPVYLTELHIKT-LLYNL 165

Query: 251 AEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLA 291
             G++Y+H      I+HRD+K +N L+++D   ++ DFGLA
Sbjct: 166 LVGVKYVHS---AGILHRDLKPANCLVNQDCSVKVCDFGLA 203

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score = 68.1 bits (167), Expect = 1e-12
 Identities = 48/224 (21%), Positives = 90/224 (40%), Gaps = 34/224 (15%)

Query: 141 TDNFNSENLIGKGGHAEVYKGCLPDGEVVAVKKIIKNAKEDEERISDF---------LSE 191
              +  +  I  G +  V  G   +G  VA+K++  N   D   ++           L E
Sbjct: 21  QSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRV-FNTVSDGRTVNILSDSFLCKRVLRE 79

Query: 192 LGIVAHINHPNAAKLI------GFSTENGFHLVLQFLPHGSLSSLLFGSTECL-EWTIRY 244
           + ++ H +HPN   L            +  +LV + +    L+ ++      +    I+Y
Sbjct: 80  IRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQRIVISPQHIQY 138

Query: 245 KIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWL--PDNWSHHI 302
                I  GL  LH      ++HRD+   NILL+++ +  I DF LA+      N +H++
Sbjct: 139 -FMYHILLGLHVLHE---AGVVHRDLHPGNILLADNNDITICDFNLAREDTADANKTHYV 194

Query: 303 VFPIEGTFGYLSPE---YFMHGIVDEKTDVFAFGVLLLELITGR 343
                    Y +PE    F      +  D+++ G ++ E+   +
Sbjct: 195 T-----HRWYRAPELVMQFKG--FTKLVDMWSAGCVMAEMFNRK 231

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 68.0 bits (167), Expect = 1e-12
 Identities = 56/215 (26%), Positives = 97/215 (45%), Gaps = 29/215 (13%)

Query: 142 DNFNSENLIGKGGHAEV----YKGCLPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAH 197
            +FN   ++GKG   +V     KG     E+ AVK + K+    ++ +   + E  ++A 
Sbjct: 20  TDFNFLMVLGKGSFGKVMLSERKG---TDELYAVKILKKDVVIQDDDVECTMVEKRVLAL 76

Query: 198 I-NHPNAAKLIG-FSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQ 255
               P   +L   F T +  + V++++  G L   +       E    +  A  IA GL 
Sbjct: 77  PGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAA-EIAIGLF 135

Query: 256 YLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAK--WLPDNWSHHIVFPIEGTFGYL 313
           +L     + II+RD+K  N++L  +   +I+DFG+ K        +        GT  Y+
Sbjct: 136 FLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFC----GTPDYI 188

Query: 314 SPEYFMHGIVDEKT-----DVFAFGVLLLELITGR 343
           +PE     I+  +      D +AFGVLL E++ G+
Sbjct: 189 APE-----IIAYQPYGKSVDWWAFGVLLYEMLAGQ 218

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 68.0 bits (167), Expect = 1e-12
 Identities = 62/216 (28%), Positives = 98/216 (45%), Gaps = 31/216 (14%)

Query: 142 DNFNSENLIGKGGHAEVY----KGCLPDGEVVAVKKIIKN---AKEDEERISDFLSELGI 194
           DNF    ++GKG   +V     K     G++ AVK + K+     +D E     ++E  I
Sbjct: 23  DNFEFIRVLGKGSFGKVMLARVKE---TGDLYAVKVLKKDVILQDDDVECT---MTEKRI 76

Query: 195 VAHI-NHPNAAKLIG-FSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAE 252
           ++   NHP   +L   F T +    V++F+  G L   +  S    E   R+  A  I  
Sbjct: 77  LSLARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAA-EIIS 135

Query: 253 GLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEGTFGY 312
            L +LH    + II+RD+K  N+LL  +   +++DFG+ K      +        GT  Y
Sbjct: 136 ALMFLHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCK--EGICNGVTTATFCGTPDY 190

Query: 313 LSPEYFMHGIVDEKT-----DVFAFGVLLLELITGR 343
           ++PE     I+ E       D +A GVLL E++ G 
Sbjct: 191 IAPE-----ILQEMLYGPAVDWWAMGVLLYEMLCGH 221

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 67.8 bits (166), Expect = 1e-12
 Identities = 38/197 (19%), Positives = 70/197 (35%), Gaps = 53/197 (26%)

Query: 141 TDNFNSENLIGKGGHAEVYKG-CLPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHIN 199
           +  ++    +G G    V +   +  G+  A+KK++++ +           EL I+  ++
Sbjct: 6   SKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR----YK---NRELDIMKVLD 58

Query: 200 HPNAAKLIGFSTENGFHLVLQFLPHGSLSSLLFGS-----------------------TE 236
           H N  KL+ +    G        P    + L   +                        E
Sbjct: 59  HVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIME 118

Query: 237 CLEWT----IRYKIALG--------------IAEGLQYLHHDCHRRIIHRDIKASNILL- 277
            +  T    ++  I  G              +   + ++H      I HRDIK  N+L+ 
Sbjct: 119 YVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHS---LGICHRDIKPQNLLVN 175

Query: 278 SEDYEAQISDFGLAKWL 294
           S+D   ++ DFG AK L
Sbjct: 176 SKDNTLKLCDFGSAKKL 192

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 67.6 bits (165), Expect = 2e-12
 Identities = 52/239 (21%), Positives = 84/239 (35%), Gaps = 75/239 (31%)

Query: 169 VAVKKIIKNAKEDEERISDFLSELGIVAHI-----NHPNAAKLIG------FSTENGFHL 217
           VA+K ++K+A+   E   D   E+ ++  +     N PN   ++        S  NG H+
Sbjct: 65  VAMK-VVKSAEHYTETALD---EIRLLKSVRNSDPNDPNREMVVQLLDDFKISGVNGTHI 120

Query: 218 VLQFLPHG-SLSSLL--FGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASN 274
            + F   G  L   +            ++ KI   + +GL YLH  C   IIH DIK  N
Sbjct: 121 CMVFEVLGHHLLKWIIKSNYQGLPLPCVK-KIIQQVLQGLDYLHTKCR--IIHTDIKPEN 177

Query: 275 ILL-------------------------------------------------SEDYEAQI 285
           ILL                                                 +E  + +I
Sbjct: 178 ILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKI 237

Query: 286 SDFGLAKWLPDNWSHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRR 344
           +D G A W+  +++  I      T  Y S E  +    +   D+++   +  EL TG  
Sbjct: 238 ADLGNACWVHKHFTEDIQ-----TRQYRSLEVLIGSGYNTPADIWSTACMAFELATGDY 291

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 66.9 bits (164), Expect = 3e-12
 Identities = 55/216 (25%), Positives = 97/216 (44%), Gaps = 31/216 (14%)

Query: 142 DNFNSENLIGKGGHAEV----YKGCLPDGEVVAVKKIIKN---AKEDEERISDFLSELGI 194
           ++F    ++GKG   +V    +K      +  A+K + K+     +D E     + E  +
Sbjct: 17  EDFILHKMLGKGSFGKVFLAEFKK---TNQFFAIKALKKDVVLMDDDVECT---MVEKRV 70

Query: 195 VAH-INHPNAAKLIG-FSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAE 252
           ++    HP    +   F T+     V+++L  G L   +    +       +  A  I  
Sbjct: 71  LSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAA-EIIL 129

Query: 253 GLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEGTFGY 312
           GLQ+LH    + I++RD+K  NILL +D   +I+DFG+ K   +           GT  Y
Sbjct: 130 GLQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCK--ENMLGDAKTNTFCGTPDY 184

Query: 313 LSPEYFMHGIVDEKT-----DVFAFGVLLLELITGR 343
           ++PE     I+  +      D ++FGVLL E++ G+
Sbjct: 185 IAPE-----ILLGQKYNHSVDWWSFGVLLYEMLIGQ 215

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 66.9 bits (164), Expect = 3e-12
 Identities = 59/218 (27%), Positives = 100/218 (45%), Gaps = 35/218 (16%)

Query: 142 DNFNSENLIGKGGHAEVY----KGCLPDGEVVAVKKIIK---NAKEDEERISDFLSELGI 194
            +F+   +IG+G +A+V     K       + A+K + K   N  ED + +    +E  +
Sbjct: 9   QDFDLLRVIGRGSYAKVLLVRLKK---TDRIYAMKVVKKELVNDDEDIDWV---QTEKHV 62

Query: 195 VAHI-NHPNAAKLIG-FSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAE 252
                NHP    L   F TE+    V++++  G L   +    +  E   R+  A  I+ 
Sbjct: 63  FEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSA-EISL 121

Query: 253 GLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAK--WLPDNWSHHIVFPIEGTF 310
            L YLH    R II+RD+K  N+LL  +   +++D+G+ K    P + +        GT 
Sbjct: 122 ALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFC----GTP 174

Query: 311 GYLSPEYFMHGIVDEKT-----DVFAFGVLLLELITGR 343
            Y++PE     I+  +      D +A GVL+ E++ GR
Sbjct: 175 NYIAPE-----ILRGEDYGFSVDWWALGVLMFEMMAGR 207

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score = 66.2 bits (162), Expect = 3e-12
 Identities = 34/160 (21%), Positives = 58/160 (36%), Gaps = 34/160 (21%)

Query: 150 IGKGGHAEVYKG-CLPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHI-NHPNAAKLI 207
           +G G + +V +       E  A+K +         R      E+ +       P+  +++
Sbjct: 26  LGLGINGKVLQIFNKRTQEKFALKMLQD--CPKARR------EVELHWRASQCPHIVRIV 77

Query: 208 GF-----STENGFHLVLQFLPHGSL-------SSLLFGSTECLEWTIRYKIALGIAEGLQ 255
                  +      +V++ L  G L           F   E        +I   I E +Q
Sbjct: 78  DVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREA------SEIMKSIGEAIQ 131

Query: 256 YLHHDCHRRIIHRDIKASNILL---SEDYEAQISDFGLAK 292
           YLH      I HRD+K  N+L      +   +++DFG AK
Sbjct: 132 YLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 168

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score = 66.1 bits (162), Expect = 4e-12
 Identities = 43/219 (19%), Positives = 91/219 (41%), Gaps = 39/219 (17%)

Query: 141 TDNFNSENLIGKGGHAEVYKG-CLPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHI- 198
            D++     +G+G ++EV++   + + E V VK +       +++I     E+ I+ ++ 
Sbjct: 35  QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKIL---KPVKKKKI---KREIKILENLR 88

Query: 199 NHPNAAKLIG-FSTENGFHLVL--QFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQ 255
             PN   L             L  + + +     L    T+   + IR+ +   I + L 
Sbjct: 89  GGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTD---YDIRFYM-YEILKALD 144

Query: 256 YLHHDCHRRIIHRDIKASNILL-SEDYEAQISDFGLAKWL--PDNWSHHIVFPIEGTFGY 312
           Y H      I+HRD+K  N+++  E  + ++ D+GLA++      ++  +      +  +
Sbjct: 145 YCHS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVA-----SRYF 196

Query: 313 LSPE-------YFMHGIVDEKTDVFAFGVLLLELITGRR 344
             PE       Y      D   D+++ G +L  +I  + 
Sbjct: 197 KGPELLVDYQMY------DYSLDMWSLGCMLASMIFRKE 229

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 66.1 bits (162), Expect = 5e-12
 Identities = 60/216 (27%), Positives = 95/216 (43%), Gaps = 31/216 (14%)

Query: 142 DNFNSENLIGKGGHAEVY----KGCLPDGEVVAVKKIIKN---AKEDEERISDFLSELGI 194
            +F+   +IGKG   +V     K    +    AVK + K     K++E+ I   +SE  +
Sbjct: 38  SDFHFLKVIGKGSFGKVLLARHKA---EEVFYAVKVLQKKAILKKKEEKHI---MSERNV 91

Query: 195 VA-HINHPNAAKLIG-FSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAE 252
           +  ++ HP    L   F T +  + VL ++  G L   L      LE   R+  A  IA 
Sbjct: 92  LLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAA-EIAS 150

Query: 253 GLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEGTFGY 312
            L YLH      I++RD+K  NILL       ++DFGL K   +   +       GT  Y
Sbjct: 151 ALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCK--ENIEHNSTTSTFCGTPEY 205

Query: 313 LSPEYFMHGIVDEKT-----DVFAFGVLLLELITGR 343
           L+PE     ++ ++      D +  G +L E++ G 
Sbjct: 206 LAPE-----VLHKQPYDRTVDWWCLGAVLYEMLYGL 236

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 65.8 bits (161), Expect = 6e-12
 Identities = 58/218 (26%), Positives = 100/218 (45%), Gaps = 35/218 (16%)

Query: 142 DNFNSENLIGKGGHAEVY----KGCLPDGEVVAVKKIIK---NAKEDEERISDFLSELGI 194
            +F+   +IG+G +A+V     K       + A++ + K   N  ED + +    +E  +
Sbjct: 52  QDFDLLRVIGRGSYAKVLLVRLKK---TDRIYAMRVVKKELVNDDEDIDWV---QTEKHV 105

Query: 195 VAHI-NHPNAAKLIG-FSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAE 252
                NHP    L   F TE+    V++++  G L   +    +  E   R+  A  I+ 
Sbjct: 106 FEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSA-EISL 164

Query: 253 GLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAK--WLPDNWSHHIVFPIEGTF 310
            L YLH    R II+RD+K  N+LL  +   +++D+G+ K    P + +        GT 
Sbjct: 165 ALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFC----GTP 217

Query: 311 GYLSPEYFMHGIVDEKT-----DVFAFGVLLLELITGR 343
            Y++PE     I+  +      D +A GVL+ E++ GR
Sbjct: 218 NYIAPE-----ILRGEDYGFSVDWWALGVLMFEMMAGR 250

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 65.3 bits (160), Expect = 8e-12
 Identities = 53/223 (23%), Positives = 99/223 (44%), Gaps = 32/223 (14%)

Query: 141 TDNFNSENLIGKGGHAEVYKG-CLPDGEVVAVKKIIKNAKEDEE---RISDFLSELGIVA 196
           + +F  ++L+G+G +  V      P GE+VA+KKI     +      R    L E+ I+ 
Sbjct: 10  SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKI--EPFDKPLFALRT---LREIKILK 64

Query: 197 HINHPNAAKLI------GFSTENGFHLVLQFLPHGSLSSLLFGSTECLEWT-IRYKIALG 249
           H  H N   +        F   N  +++ + +    L  ++  ST+ L    I+Y     
Sbjct: 65  HFKHENIITIFNIQRPDSFENFNEVYIIQELMQ-TDLHRVI--STQMLSDDHIQY-FIYQ 120

Query: 250 IAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEGT 309
               ++ LH      +IHRD+K SN+L++ + + ++ DFGLA+ + ++ + +     + +
Sbjct: 121 TLRAVKVLHG---SNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQS 177

Query: 310 FG--------YLSPEYFM-HGIVDEKTDVFAFGVLLLELITGR 343
                     Y +PE  +         DV++ G +L EL   R
Sbjct: 178 GMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 65.5 bits (160), Expect = 1e-11
 Identities = 42/172 (24%), Positives = 70/172 (40%), Gaps = 41/172 (23%)

Query: 141 TDNFNSENLIGKGGHAEVYKG-CLPDGEVVAVKKIIKNAKEDEE---RISDFLSELGIVA 196
            DN+  ++LIG+G +  VY        + VA+KK+     ED     RI   L E+ I+ 
Sbjct: 25  PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKV-NRMFEDLIDCKRI---LREITILN 80

Query: 197 HINHPNAAKLI------GFSTENGFHLVLQFLPHGSLSSLLFGSTEC-LEWTIRYKIALG 249
            +      +L            +  ++VL+               +  L+   +  I L 
Sbjct: 81  RLKSDYIIRLYDLIIPDDLLKFDELYIVLEIA-------------DSDLKKLFKTPIFLT 127

Query: 250 ----------IAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLA 291
                     +  G  ++H      IIHRD+K +N LL++D   ++ DFGLA
Sbjct: 128 EEHIKTILYNLLLGENFIHE---SGIIHRDLKPANCLLNQDCSVKVCDFGLA 176

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score = 63.1 bits (154), Expect = 4e-11
 Identities = 53/225 (23%), Positives = 92/225 (40%), Gaps = 34/225 (15%)

Query: 141 TDNFNSENLIGKGGHAEVYKG-CLPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHIN 199
              +     +G GG+  V+        + VA+KKI+    +  +     L E+ I+  ++
Sbjct: 10  GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHA---LREIKIIRRLD 66

Query: 200 HPNAAKLIGFSTENGFHLVLQFLPHGSLSSLLFGSTECLEWT---------------IRY 244
           H N  K+      +G  L         L+S+     E +E T                R 
Sbjct: 67  HDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIV-QEYME-TDLANVLEQGPLLEEHARL 124

Query: 245 KIALGIAEGLQYLHHDCHRRIIHRDIKASNILL-SEDYEAQISDFGLAKWLPDNWSHHIV 303
                +  GL+Y+H      ++HRD+K +N+ + +ED   +I DFGLA+ + D    H  
Sbjct: 125 -FMYQLLRGLKYIHS---ANVLHRDLKPANLFINTEDLVLKIGDFGLARIM-DPHYSHKG 179

Query: 304 FPIE--GTFGYLSPE---YFMHGIVDEKTDVFAFGVLLLELITGR 343
              E   T  Y SP       +    +  D++A G +  E++TG+
Sbjct: 180 HLSEGLVTKWYRSPRLLLSPNN--YTKAIDMWAAGCIFAEMLTGK 222

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score = 62.7 bits (153), Expect = 6e-11
 Identities = 51/221 (23%), Positives = 89/221 (40%), Gaps = 35/221 (15%)

Query: 141 TDNFNSENLIGKGGHAEVYKG-CLPDGEVVAVKKIIKNAKEDEE---RISDFLSELGIVA 196
              + + + IG+G +  V       +   VA+KKI  +  E +    R    L E+ I+ 
Sbjct: 26  GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKI--SPFEHQTYCQRT---LREIKILL 80

Query: 197 HINHPNAAKLI------GFSTENGFHLVLQFLP---HGSLSSLLFGSTECLEWTIRYKIA 247
              H N   +               ++V   +    +  L +    +         Y   
Sbjct: 81  RFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHI-----CY-FL 134

Query: 248 LGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIE 307
             I  GL+Y+H      ++HRD+K SN+LL+   + +I DFGLA+ + D    H  F  E
Sbjct: 135 YQILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLAR-VADPDHDHTGFLTE 190

Query: 308 --GTFGYLSPE---YFMHGIVDEKTDVFAFGVLLLELITGR 343
              T  Y +PE           +  D+++ G +L E+++ R
Sbjct: 191 YVATRWYRAPEIMLNSKG--YTKSIDIWSVGCILAEMLSNR 229

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 61.6 bits (150), Expect = 1e-10
 Identities = 42/186 (22%), Positives = 72/186 (38%), Gaps = 38/186 (20%)

Query: 150 IGKGGHAEVYKGC-LPDGEVVAVKKIIKNAK----EDEERISDFLSELGIVAHINHPNAA 204
           IG+G    +++G  L + + VA+K   + +      DE R    L+              
Sbjct: 18  IGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLA--------GCTGIP 69

Query: 205 KLIGFSTENGFH-LVLQFLPHGSLSSLLFGSTEC-----LEWTIRYKIALGIAEGLQYLH 258
            +  F  E   + LV+  L   SL  LL     C     ++       A  +   +Q +H
Sbjct: 70  NVYYFGQEGLHNVLVIDLLGP-SLEDLL---DLCGRKFSVKTVAM--AAKQMLARVQSIH 123

Query: 259 HDCHRRIIHRDIKASNILLSEDYEAQ-----ISDFGLAKWLPDNWSH-HIVF----PIEG 308
               + +++RDIK  N L+            + DFG+ K+  D  +  HI +     + G
Sbjct: 124 E---KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSG 180

Query: 309 TFGYLS 314
           T  Y+S
Sbjct: 181 TARYMS 186

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 61.7 bits (150), Expect = 1e-10
 Identities = 34/193 (17%), Positives = 67/193 (34%), Gaps = 35/193 (18%)

Query: 149 LIGKGGHAEVYKGC-LPDGEVVAVKKI-IKNAK----EDEERISDFLSELGIVAHINHPN 202
            IG GG   +Y        E  A   + ++  +      E +    +++   +       
Sbjct: 44  KIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERK 103

Query: 203 AAKLIGFSTENGF-----------HLVLQFLPHG-SLSSLLFGSTECLEWTIR--YKIAL 248
               +G     G             +V++ L  G  L  +     +   +      ++ +
Sbjct: 104 QLDYLGIPLFYGSGLTEFKGRSYRFMVMERL--GIDLQKIS---GQNGTFKKSTVLQLGI 158

Query: 249 GIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQI--SDFGLAKWLPDNWSH-HIVF- 304
            + + L+Y+H       +H DIKA+N+LL      Q+  +D+GL+     N +H      
Sbjct: 159 RMLDVLEYIHE---NEYVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQEN 215

Query: 305 ---PIEGTFGYLS 314
                 GT  + S
Sbjct: 216 PRKGHNGTIEFTS 228

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 60.9 bits (148), Expect = 2e-10
 Identities = 39/197 (19%), Positives = 67/197 (34%), Gaps = 40/197 (20%)

Query: 149 LIGKGGHAEVYKGCLPDGEVVAVKK--IIKNAKED------EERISDFLSELGIVAHINH 200
            IG+GG   +Y   +   E V      ++K    D      E +     ++   +     
Sbjct: 42  PIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIR 101

Query: 201 PNAAKLIGFSTENGF-----------HLVLQFLPHG-SLSSLLFGSTECL----EWTIRY 244
               K +G     G             +++     G  L  +              T+  
Sbjct: 102 TRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF--GSDLQKIY---EANAKRFSRKTV-L 155

Query: 245 KIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQI--SDFGLAKWLPDNWSH-H 301
           +++L I + L+Y+H       +H DIKASN+LL+     Q+   D+GLA        H  
Sbjct: 156 QLSLRILDILEYIHE---HEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKA 212

Query: 302 IVF----PIEGTFGYLS 314
                    +GT  + S
Sbjct: 213 YAADPKRCHDGTIEFTS 229

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 60.1 bits (146), Expect = 5e-10
 Identities = 33/199 (16%), Positives = 72/199 (36%), Gaps = 40/199 (20%)

Query: 147 ENLIGKGGHAEVYKGC---------LPDGEVVAVKKIIKNAKEDEERIS-------DFLS 190
           ++   +     +Y+            P  +  ++K   K+ +   E+           ++
Sbjct: 47  KSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVN 106

Query: 191 ELGIVAHINHPNAAKLIGFSTENGFH--LVLQFLPHG-SLSSLLFGSTECLEWTIRYKIA 247
           +   +           +GF      +  LVL  L  G SL S L       +  +  +  
Sbjct: 107 KWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL--GRSLQSAL---DVSPKHVLSERSV 161

Query: 248 LGIA----EGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQI--SDFGLAKWLPDNWSHH 301
           L +A    + L++LH       +H ++ A NI +  + ++Q+  + +G A     +   H
Sbjct: 162 LQVACRLLDALEFLHE---NEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPS-GKH 217

Query: 302 IVF------PIEGTFGYLS 314
           + +      P EG   ++S
Sbjct: 218 VAYVEGSRSPHEGDLEFIS 236

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 58.9 bits (143), Expect = 8e-10
 Identities = 46/184 (25%), Positives = 72/184 (39%), Gaps = 36/184 (19%)

Query: 150 IGKGGHAEVYKGC-LPDGEVVAVKKIIKNAK----EDEERISDFLSELGIVAHINHPNAA 204
           IG G   ++Y G  +  GE VA+K      K      E +I   +               
Sbjct: 17  IGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQ--------GGVGIP 68

Query: 205 KLIGFSTENGFH-LVLQFLPHGSLSSLLFGSTEC-----LEWTIRYKIALGIAEGLQYLH 258
            +     E  ++ +V++ L   SL  L      C     L+  +   +A  +   ++Y+H
Sbjct: 69  TIRWCGAEGDYNVMVMELLGP-SLEDLF---NFCSRKFSLKTVLL--LADQMISRIEYIH 122

Query: 259 HDCHRRIIHRDIKASNILLSEDYEAQ---ISDFGLAKWLPDNWSH-HIVF----PIEGTF 310
               +  IHRD+K  N L+    +     I DFGLAK   D  +H HI +     + GT 
Sbjct: 123 S---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTA 179

Query: 311 GYLS 314
            Y S
Sbjct: 180 RYAS 183

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 58.9 bits (143), Expect = 8e-10
 Identities = 47/187 (25%), Positives = 72/187 (38%), Gaps = 40/187 (21%)

Query: 150 IGKGGHAEVYKG-CLPDGEVVAVK----KIIKNAKEDEERISDFLSELGIVAHINHPNAA 204
           IG G   E+  G  L   E VA+K    K        E R    L         +     
Sbjct: 17  IGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQLG--------SGDGIP 68

Query: 205 KLIGFSTENGFH-LVLQFLPHG-SLSSLLFGSTEC-----LEWTIRYKIALGIAEGLQYL 257
           ++  F     ++ +VL+ L  G SL  L      C     L+  +   IA+ +   ++Y+
Sbjct: 69  QVYYFGPCGKYNAMVLELL--GPSLEDLF---DLCDRTFSLKTVLM--IAIQLISRMEYV 121

Query: 258 HHDCHRRIIHRDIKASNILLSEDYEAQ-----ISDFGLAKWLPDNWSH-HIVF----PIE 307
           H    + +I+RD+K  N L+            I DF LAK   D  +  HI +     + 
Sbjct: 122 HS---KNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLT 178

Query: 308 GTFGYLS 314
           GT  Y+S
Sbjct: 179 GTARYMS 185

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 57.8 bits (140), Expect = 3e-09
 Identities = 51/216 (23%), Positives = 88/216 (40%), Gaps = 44/216 (20%)

Query: 149 LIGKGGHAEVYKGC--LPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKL 206
           +IGKG   +V K        + VA+K +++N K    +      E+ I+ H+   +    
Sbjct: 104 VIGKGSFGQVVK-AYDHKVHQHVALK-MVRNEKRFHRQA---AEEIRILEHLRKQDK--- 155

Query: 207 IGFSTENGFHLVLQFLPHGSLSSLLFGSTECLEW-----------------TIRYKIALG 249
                +N  +++   L + +  + +  + E L                    +R K A  
Sbjct: 156 -----DNTMNVI-HMLENFTFRNHICMTFELLSMNLYELIKKNKFQGFSLPLVR-KFAHS 208

Query: 250 IAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQIS--DFGLAKWLPDNWSHHIVFPIE 307
           I + L  LH     RIIH D+K  NILL +   + I   DFG +      + H  V+   
Sbjct: 209 ILQCLDALHK---NRIIHCDLKPENILLKQQGRSGIKVIDFGSSC-----YEHQRVYTYI 260

Query: 308 GTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGR 343
            +  Y +PE  +        D+++ G +L EL+TG 
Sbjct: 261 QSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGY 296

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 56.6 bits (137), Expect = 6e-09
 Identities = 50/231 (21%), Positives = 95/231 (41%), Gaps = 38/231 (16%)

Query: 141 TDNFNSENLIGKGGHAEVYKG-CLPDGEVVAVKKIIK--NAKEDEERISDFLSELGIVAH 197
              +     +GKG +  V+K      GEVVAVKKI        D +R      E+ I+  
Sbjct: 8   LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRT---FREIMILTE 64

Query: 198 IN-HPNAAKLIGFSTENGFH---LVLQFLPHGSLSSLLFGSTECLEWT-IRYKIALGIAE 252
           ++ H N   L+     +      LV  ++    L +++      LE    +Y +   + +
Sbjct: 65  LSGHENIVNLLNVLRADNDRDVYLVFDYMET-DLHAVI--RANILEPVHKQY-VVYQLIK 120

Query: 253 GLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEGTFGY 312
            ++YLH      ++HRD+K SNILL+ +   +++DFGL++   +        P+      
Sbjct: 121 VIKYLHS---GGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENT 177

Query: 313 LSPEY---FMHGIV-----------------DEKTDVFAFGVLLLELITGR 343
            + +     +   V                  +  D+++ G +L E++ G+
Sbjct: 178 ENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK 228

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 56.6 bits (136), Expect = 8e-09
 Identities = 49/184 (26%), Positives = 71/184 (38%), Gaps = 36/184 (19%)

Query: 150 IGKGGHAEVYKGC-LPDGEVVAVKKIIKNAK----EDEERISDFLSELGIVAHINHPNAA 204
           IG G   E+Y G  +   E VA+K      K      E +I   L               
Sbjct: 15  IGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKIYRILQ--------GGTGIP 66

Query: 205 KLIGFSTENGFH-LVLQFLPHGSLSSLLFGSTEC-----LEWTIRYKIALGIAEGLQYLH 258
            +  F  E  ++ LV+  L   SL  L      C     L+  +   +A  +   ++++H
Sbjct: 67  NVRWFGVEGDYNVLVMDLLGP-SLEDLF---NFCSRKLSLKTVLM--LADQMINRVEFVH 120

Query: 259 HDCHRRIIHRDIKASNILLSEDYEAQ---ISDFGLAKWLPDNWSH-HIVF----PIEGTF 310
               +  +HRDIK  N L+     A    I DFGLAK   D  +H HI +     + GT 
Sbjct: 121 S---KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTA 177

Query: 311 GYLS 314
            Y S
Sbjct: 178 RYAS 181

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 54.7 bits (132), Expect = 3e-08
 Identities = 59/216 (27%), Positives = 85/216 (39%), Gaps = 40/216 (18%)

Query: 148 NLIGKGGHAEVYKGC--LPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINH--PNA 203
           +LIGKG   +V K      + E VA+K IIKN K    +      E+ ++  +N      
Sbjct: 60  SLIGKGSFGQVVK-AYDRVEQEWVAIK-IIKNKKAFLNQA---QIEVRLLELMNKHDTEM 114

Query: 204 AKLIG-----FSTENGFHLVLQFLPHGSLSSLLFGSTECLEWT---------IRYKIALG 249
              I      F   N  HL L F     LS  L+   + L  T          R K A  
Sbjct: 115 KYYIVHLKRHFMFRN--HLCLVF---EMLSYNLY---DLLRNTNFRGVSLNLTR-KFAQQ 165

Query: 250 IAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQIS--DFGLAKWLPDNWSHHIVFPIE 307
           +   L +L       IIH D+K  NILL     + I   DFG +           ++   
Sbjct: 166 MCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGSS-----CQLGQRIYQYI 219

Query: 308 GTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGR 343
            +  Y SPE  +    D   D+++ G +L+E+ TG 
Sbjct: 220 QSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGE 255

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 47.2 bits (111), Expect = 1e-05
 Identities = 60/438 (13%), Positives = 135/438 (30%), Gaps = 99/438 (22%)

Query: 63  NRESGGWKSMIDSI--KKKSVVRRFSVIPLLTNYELTKKNLWKKL-GRLQIPEDD----- 114
           +  SG  + +  ++  K++ +V++F    L  NY+     L   +    + P        
Sbjct: 59  DAVSGTLR-LFWTLLSKQEEMVQKFVEEVLRINYKF----LMSPIKTEQRQPSMMTRMYI 113

Query: 115 ---DADDGGSVPIVRHS-WKNFDFAELAAATDNFNSENLIGKGGHAEVY--KGCLPDGEV 168
              D     +    +++  +   + +L  A         +       +    G    G+ 
Sbjct: 114 EQRDRLYNDNQVFAKYNVSRLQPYLKLRQALLELRPAKNVL------IDGVLGS---GKT 164

Query: 169 VAVKKIIKNAKEDEERISDFLSELGI----VAHINHPNAAKLIGFSTENGFHLVLQFLPH 224
                +  +     +   DF     I    + + N P    ++    E    L+ Q  P 
Sbjct: 165 WVALDVCLS--YKVQCKMDF----KIFWLNLKNCNSPET--VL----EMLQKLLYQIDP- 211

Query: 225 GSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRR--IIHRDIKASNILLSEDYE 282
            + +S    S+      I+ +I    AE  + L    +    ++  +++ +    + +  
Sbjct: 212 -NWTSRSDHSS-----NIKLRIHSIQAELRRLLKSKPYENCLLVLLNVQNAKAWNAFNLS 265

Query: 283 AQI----SDFGLAKWLPDNWSHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLE 338
            +I        +  +L    + HI   ++     L+P        DE   +         
Sbjct: 266 CKILLTTRFKQVTDFLSAATTTHI--SLDHHSMTLTP--------DEVKSLLL------- 308

Query: 339 LITGRRAVDSRRQSLVIWAKPLLQTSNFKELVDPRLA--DAYDLAEMKRAMLTASVCIHH 396
                R  D  R+ L     P    S   E +   LA  D +      +        ++ 
Sbjct: 309 KYLDCRPQDLPREVLTT--NPRR-LSIIAESIRDGLATWDNWKHVNCDKLTTIIESSLNV 365

Query: 397 LST--MRPQ-------------MTRVLQLLRGEGGQTDLKP--KPSARRTVILDGSDEEY 439
           L     R                T +L L+  +  ++D+        + +++     E  
Sbjct: 366 LEPAEYRKMFDRLSVFPPSAHIPTILLSLIWFDVIKSDVMVVVNKLHKYSLVEKQPKE-- 423

Query: 440 SSTCYLKDLNRHMQLALE 457
            ST  +  +   +++ LE
Sbjct: 424 -STISIPSIYLELKVKLE 440

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 41.8 bits (97), Expect = 4e-04
 Identities = 77/483 (15%), Positives = 137/483 (28%), Gaps = 144/483 (29%)

Query: 8   VVKAQVEKNEK--EKIPG---------TDSPRGVLEIPVT-GTDSDSSSSSCGSSSSPEK 55
            V   V  + K   K+            +SP  VLE+        D + +S    SS  K
Sbjct: 165 WVALDVCLSYKVQCKMDFKIFWLNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIK 224

Query: 56  STPQRAVNRESGGWKSM--------IDSIKKKSVVRRFSV---IPLLTNYELTKKNLWKK 104
                         KS         + +++       F++   I L T ++         
Sbjct: 225 LRIHSIQAELRRLLKSKPYENCLLVLLNVQNAKAWNAFNLSCKILLTTRFK--------- 275

Query: 105 LGRLQIPEDDDADDGGSVPIVRHSWKNFDFAELAAATDNFNSENLIGKGGHAEVYKGCLP 164
               Q+ +   A     + +  HS       E          ++L+ K  + +     LP
Sbjct: 276 ----QVTDFLSAATTTHISLDHHSM-TLTPDE---------VKSLLLK--YLDCRPQDLP 319

Query: 165 DGEVVAVK----KIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTEN------- 213
             EV+        II       E I D L+      H+N      +I  S          
Sbjct: 320 R-EVLTTNPRRLSIIA------ESIRDGLATWDNWKHVNCDKLTTIIESSLNVLEPAEYR 372

Query: 214 -GFHLVLQF-----LPHGSLSSLLFGSTECLEWTI-----RYKIALGIAEGLQYLHHDC- 261
             F  +  F     +P   LS + F   +     +     +Y +     +          
Sbjct: 373 KMFDRLSVFPPSAHIPTILLSLIWFDVIKSDVMVVVNKLHKYSLVEKQPKESTISIPSIY 432

Query: 262 -------------HRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDN-WSHHIVFPIE 307
                        HR I+       NI  + D +    D        D  +  HI     
Sbjct: 433 LELKVKLENEYALHRSIVDHY----NIPKTFDSD----DLIPPYL--DQYFYSHI----- 477

Query: 308 GTFGYLSPEYFMHGIVDEKTDVFA-FGVLLLELITGRRAVDSR-RQSLVIWAKP------ 359
              G+       H    E  +    F ++ L+     R ++ + R     W         
Sbjct: 478 ---GH-------HLKNIEHPERMTLFRMVFLDF----RFLEQKIRHDSTAWNASGSILNT 523

Query: 360 LLQTSNFKELV---DPRLADAYD--LAEMKRAMLTASVCIHHLSTMRPQMTRVLQL-LRG 413
           L Q   +K  +   DP+    Y+  +  +   +        +L  +  + T +L++ L  
Sbjct: 524 LQQLKFYKPYICDNDPK----YERLVNAILDFLPKIE---ENL--ICSKYTDLLRIALMA 574

Query: 414 EGG 416
           E  
Sbjct: 575 EDE 577

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	457
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	100.0
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.96
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.94
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.92
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.82
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.69
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.23
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.13
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	99.07
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	98.93
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.7
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.39
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.39
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.22
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	98.15
3ats_A	357	Putative uncharacterized protein; hypothetical pro	98.04
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	98.01
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	97.94
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	97.74
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	97.68
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	97.47
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	97.37
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	97.31
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	97.2
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	97.09
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	97.06
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	96.99
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	96.92
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	96.64
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	96.55
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	96.48
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	95.79
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	93.12
3mes_A	424	Choline kinase; malaria, structural genomics, stru	92.9
4ann_A	215	ESSB; membrane protein, membrane secretion, ESS ty	91.98
4ano_A	219	ESSB; membrane protein, membrane secretion, ESS ty	90.33
3cxl_A	463	N-chimerin; SH2, RHO-GAP, structural genomics cons	82.64

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=1.8e-56  Score=435.19  Aligned_cols=264  Identities=25%  Similarity=0.349  Sum_probs=206.9

Q ss_pred             hhcCCCCCceecccCcEEEEEEEeCCCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeecCceEEEE
Q 012765          140 ATDNFNSENLIGKGGHAEVYKGCLPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTENGFHLVL  219 (457)
Q Consensus       140 ~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~lv~  219 (457)
                      ..++|.+.+.||+|+||+||+|.+.+  .||||++.... ......+.|.+|+.+|++++|||||++++++.++.+++||
T Consensus        34 ~~~~l~l~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~-~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~iVm  110 (307)
T 3omv_A           34 EASEVMLSTRIGSGSFGTVYKGKWHG--DVAVKILKVVD-PTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVT  110 (307)
T ss_dssp             CTTSCCEEEECCCCSSSEEEEEESSS--EEEEEECCCSS-CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSCEEEE
T ss_pred             cHHHeEEeeEEeeCCCcEEEEEEECC--cEEEEEEEecC-CCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEECCeEEEEE
Confidence            34678888999999999999998743  59999876433 2334567899999999999999999999999999999999


Q ss_pred             EecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCCCCCC
Q 012765          220 QFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWS  299 (457)
Q Consensus       220 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~~~~  299 (457)
                      ||+++|+|.++|......+++..++.|+.|||.||.|||+   .+||||||||+||||++++.+||+|||+|+.......
T Consensus       111 Ey~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~---~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~  187 (307)
T 3omv_A          111 QWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHA---KNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSG  187 (307)
T ss_dssp             ECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCCSSSEEEETTEEEEECCCSSCBC------
T ss_pred             EcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCccCCccCHHHEEECCCCcEEEeeccCceecccCCc
Confidence            9999999999998777789999999999999999999999   8999999999999999999999999999987654433


Q ss_pred             ceeeecccccccccChhcccc---CCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhccccccCCcccccCchhhc
Q 012765          300 HHIVFPIEGTFGYLSPEYFMH---GIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSNFKELVDPRLAD  376 (457)
Q Consensus       300 ~~~~~~~~gt~~y~aPE~~~~---~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  376 (457)
                      ........||+.|||||++.+   +.|+.++|||||||+||||+||+.||............  ....    ...|.+..
T Consensus       188 ~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~--~~~~----~~~p~~~~  261 (307)
T 3omv_A          188 SQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFM--VGRG----YASPDLSK  261 (307)
T ss_dssp             ------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHH--HHTT----CCCCCSTT
T ss_pred             ceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHH--HhcC----CCCCCccc
Confidence            333445679999999999864   46899999999999999999999999864432211111  0000    01111111


Q ss_pred             ccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCCC
Q 012765          377 AYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQLLRGEGG  416 (457)
Q Consensus       377 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~  416 (457)
                       ........+.+++.+||+.||++||||.||++.|+.++.
T Consensus       262 -~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~  300 (307)
T 3omv_A          262 -LYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQH  300 (307)
T ss_dssp             -SCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHT
T ss_pred             -ccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhc
Confidence             011123456778899999999999999999999987653

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=4.9e-56  Score=431.60  Aligned_cols=257  Identities=22%  Similarity=0.333  Sum_probs=206.0

Q ss_pred             hcCCCCCceecccCcEEEEEEEeC------CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeecC-
Q 012765          141 TDNFNSENLIGKGGHAEVYKGCLP------DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTEN-  213 (457)
Q Consensus       141 ~~~f~~~~~LG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~-  213 (457)
                      .++|.+.+.||+|+||+||+|.+.      ++..||||++....   ....+.|.+|+.+|++++|||||++++++.++ 
T Consensus        12 r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~---~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~   88 (299)
T 4asz_A           12 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS---DNARKDFHREAELLTNLQHEHIVKFYGVCVEGD   88 (299)
T ss_dssp             GGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCC---HHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred             HHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCC---hHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCC
Confidence            356778899999999999999853      47889999986543   23456899999999999999999999987664 


Q ss_pred             ceEEEEEecCCCChhhhhhcC------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCC
Q 012765          214 GFHLVLQFLPHGSLSSLLFGS------------TECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDY  281 (457)
Q Consensus       214 ~~~lv~e~~~~gsL~~~l~~~------------~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~  281 (457)
                      .+++||||+++|+|.++|...            ...++|..++.|+.||+.||.|||+   ++||||||||+||||+.++
T Consensus        89 ~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~---~~iiHRDlKp~NILl~~~~  165 (299)
T 4asz_A           89 PLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLAS---QHFVHRDLATRNCLVGENL  165 (299)
T ss_dssp             SEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGG
T ss_pred             EEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCccCHhhEEECCCC
Confidence            578999999999999999653            2468999999999999999999999   8999999999999999999


Q ss_pred             cEEEeeccccccCCCCCCceeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHh-CCCCCCcCCcchhhhhccc
Q 012765          282 EAQISDFGLAKWLPDNWSHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELIT-GRRAVDSRRQSLVIWAKPL  360 (457)
Q Consensus       282 ~~kL~DFGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLlt-G~~pf~~~~~~~~~~~~~~  360 (457)
                      .+||+|||+++...............||+.|||||++.+..|+.++|||||||++|||+| |+.||............  
T Consensus       166 ~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i--  243 (299)
T 4asz_A          166 LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECI--  243 (299)
T ss_dssp             CEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHH--
T ss_pred             cEEECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH--
Confidence            999999999987655433333333458999999999999999999999999999999999 89999875433222111  


Q ss_pred             cccCCcccccCchhhcccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCC
Q 012765          361 LQTSNFKELVDPRLADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQLLRGEG  415 (457)
Q Consensus       361 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~  415 (457)
                       .....     +.....    ....+.+++.+||+.||++||||.+|++.|+.+.
T Consensus       244 -~~~~~-----~~~p~~----~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~  288 (299)
T 4asz_A          244 -TQGRV-----LQRPRT----CPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLA  288 (299)
T ss_dssp             -HHTCC-----CCCCTT----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             -HcCCC-----CCCCcc----chHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence             01110     001111    2235677889999999999999999999998764

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=2.5e-55  Score=432.23  Aligned_cols=256  Identities=21%  Similarity=0.309  Sum_probs=198.8

Q ss_pred             cCCCCCceecccCcEEEEEEEeC------CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeecC-c
Q 012765          142 DNFNSENLIGKGGHAEVYKGCLP------DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTEN-G  214 (457)
Q Consensus       142 ~~f~~~~~LG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~-~  214 (457)
                      ++|.+.+.||+|+||+||+|.+.      +++.||||++....   ....+.|.+|+.+|++++|||||++++++.+. .
T Consensus        41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~---~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~  117 (329)
T 4aoj_A           41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS---ESARQDFQREAELLTMLQHQHIVRFFGVCTEGRP  117 (329)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCS---HHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred             HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCC---HHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCE
Confidence            45667789999999999999853      47899999986543   34456899999999999999999999987764 5


Q ss_pred             eEEEEEecCCCChhhhhhcCC--------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCC
Q 012765          215 FHLVLQFLPHGSLSSLLFGST--------------ECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSED  280 (457)
Q Consensus       215 ~~lv~e~~~~gsL~~~l~~~~--------------~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~  280 (457)
                      +++||||+++|+|.+++....              ..++|..++.|+.||+.||.|||+   .+||||||||+||||+.+
T Consensus       118 ~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~---~~iiHRDLKp~NILl~~~  194 (329)
T 4aoj_A          118 LLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAG---LHFVHRDLATRNCLVGQG  194 (329)
T ss_dssp             EEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEETT
T ss_pred             EEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhc---CCeecccccHhhEEECCC
Confidence            789999999999999986532              358999999999999999999999   899999999999999999


Q ss_pred             CcEEEeeccccccCCCCCCceeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHh-CCCCCCcCCcchhhhhcc
Q 012765          281 YEAQISDFGLAKWLPDNWSHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELIT-GRRAVDSRRQSLVIWAKP  359 (457)
Q Consensus       281 ~~~kL~DFGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLlt-G~~pf~~~~~~~~~~~~~  359 (457)
                      +.+||+|||+++.+.............||+.|||||++.+..|+.++|||||||++|||+| |+.||............ 
T Consensus       195 ~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i-  273 (329)
T 4aoj_A          195 LVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCI-  273 (329)
T ss_dssp             TEEEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHHHH-
T ss_pred             CcEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHHHHHHH-
Confidence            9999999999987755443333445679999999999999999999999999999999999 89999864432221111 


Q ss_pred             ccccCCcccccCchhhcccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCC
Q 012765          360 LLQTSNFKELVDPRLADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQLLRGEG  415 (457)
Q Consensus       360 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~  415 (457)
                       ....      .+......    ...+.+++.+||+.||++||||.||++.|+.+.
T Consensus       274 -~~g~------~~~~p~~~----~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~  318 (329)
T 4aoj_A          274 -TQGR------ELERPRAC----PPEVYAIMRGCWQREPQQRHSIKDVHARLQALA  318 (329)
T ss_dssp             -HHTC------CCCCCTTC----CHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHH
T ss_pred             -HcCC------CCCCcccc----cHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHh
Confidence             0100      01111122    235677889999999999999999999998875

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=9.1e-56  Score=431.46  Aligned_cols=256  Identities=22%  Similarity=0.356  Sum_probs=204.6

Q ss_pred             CCCCCceecccCcEEEEEEEeC------CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeecC-ce
Q 012765          143 NFNSENLIGKGGHAEVYKGCLP------DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTEN-GF  215 (457)
Q Consensus       143 ~f~~~~~LG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~-~~  215 (457)
                      ++++.+.||+|+||+||+|.+.      +++.||||++......  ...+.|.+|+.++++++|||||+++|++.++ .+
T Consensus        27 ~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~--~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~  104 (308)
T 4gt4_A           27 AVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEG--PLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPL  104 (308)
T ss_dssp             GEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC---CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             HCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccCh--HHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEE
Confidence            4456788999999999999852      4688999998654322  2346899999999999999999999987654 57


Q ss_pred             EEEEEecCCCChhhhhhcCC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCC
Q 012765          216 HLVLQFLPHGSLSSLLFGST---------------ECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSED  280 (457)
Q Consensus       216 ~lv~e~~~~gsL~~~l~~~~---------------~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~  280 (457)
                      ++||||+++|+|.++|....               ..++|..++.|+.|||.||.|||+   .+||||||||+||||+++
T Consensus       105 ~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~---~~iiHRDLK~~NILl~~~  181 (308)
T 4gt4_A          105 SMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSS---HHVVHKDLATRNVLVYDK  181 (308)
T ss_dssp             EEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGG
T ss_pred             EEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHh---CCCCCCCccccceEECCC
Confidence            89999999999999995432               358999999999999999999999   899999999999999999


Q ss_pred             CcEEEeeccccccCCCCCCceeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHh-CCCCCCcCCcchhhhhcc
Q 012765          281 YEAQISDFGLAKWLPDNWSHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELIT-GRRAVDSRRQSLVIWAKP  359 (457)
Q Consensus       281 ~~~kL~DFGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLlt-G~~pf~~~~~~~~~~~~~  359 (457)
                      +.+||+|||+++.+.............||+.|||||++.++.|+.++|||||||+||||+| |..||............ 
T Consensus       182 ~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~~~~i-  260 (308)
T 4gt4_A          182 LNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEMI-  260 (308)
T ss_dssp             GCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHHHHHH-
T ss_pred             CCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHHHHHHH-
Confidence            9999999999987654333333344669999999999999999999999999999999999 89999875433222111 


Q ss_pred             ccccCCcccccCchhhcccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCC
Q 012765          360 LLQTSNFKELVDPRLADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQLLRGEG  415 (457)
Q Consensus       360 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~  415 (457)
                        .......     ....    ....+.+++.+||+.||++||||.||++.|+...
T Consensus       261 --~~~~~~~-----~p~~----~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~~  305 (308)
T 4gt4_A          261 --RNRQVLP-----CPDD----CPAWVYALMIECWNEFPSRRPRFKDIHSRLRAWG  305 (308)
T ss_dssp             --HTTCCCC-----CCTT----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred             --HcCCCCC-----Cccc----chHHHHHHHHHHcCCChhHCcCHHHHHHHHHhcc
Confidence              1111110     1111    2245677889999999999999999999998754

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=1.5e-54  Score=421.08  Aligned_cols=250  Identities=24%  Similarity=0.325  Sum_probs=205.1

Q ss_pred             cCCCCCceecccCcEEEEEEEeC-CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeec-CceEEEE
Q 012765          142 DNFNSENLIGKGGHAEVYKGCLP-DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTE-NGFHLVL  219 (457)
Q Consensus       142 ~~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-~~~~lv~  219 (457)
                      ++|++.+.||+|+||+||+|.+. +|+.||||++.+...........+.+|+.+|++++|||||++++++.+ +.+|+||
T Consensus        32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm  111 (311)
T 4aw0_A           32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL  111 (311)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence            56889999999999999999864 699999999976443333445689999999999999999999996554 5578999


Q ss_pred             EecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCCCCCC
Q 012765          220 QFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWS  299 (457)
Q Consensus       220 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~~~~  299 (457)
                      ||+++|+|.+++... ..+++..+..++.||+.||.|||+   ++|+||||||+||||+.++.+||+|||+++.+.....
T Consensus       112 Ey~~gG~L~~~i~~~-~~l~e~~~~~~~~qi~~al~ylH~---~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~  187 (311)
T 4aw0_A          112 SYAKNGELLKYIRKI-GSFDETCTRFYTAEIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESK  187 (311)
T ss_dssp             CCCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEECCTTTT
T ss_pred             ecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCC
Confidence            999999999999653 458999999999999999999999   8999999999999999999999999999998765444


Q ss_pred             ceeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhccccccCCcccccCchhhcccC
Q 012765          300 HHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSNFKELVDPRLADAYD  379 (457)
Q Consensus       300 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~  379 (457)
                      .......+||+.|||||++.+..|+.++|||||||++|||+||+.||...+...... ........+        ...++
T Consensus       188 ~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~-~i~~~~~~~--------p~~~s  258 (311)
T 4aw0_A          188 QARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFA-KIIKLEYDF--------PEKFF  258 (311)
T ss_dssp             CCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH-HHHHTCCCC--------CTTCC
T ss_pred             cccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH-HHHcCCCCC--------CcccC
Confidence            344456789999999999999999999999999999999999999998654332211 111111111        11222


Q ss_pred             HHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 012765          380 LAEMKRAMLTASVCIHHLSTMRPQMTRVL  408 (457)
Q Consensus       380 ~~~~~~l~~l~~~Cl~~dP~~RPt~~evl  408 (457)
                          ..+.+++.+||+.||++|||+.|++
T Consensus       259 ----~~~~dli~~lL~~dp~~R~t~~e~~  283 (311)
T 4aw0_A          259 ----PKARDLVEKLLVLDATKRLGCEEME  283 (311)
T ss_dssp             ----HHHHHHHHHHSCSSGGGSTTSGGGT
T ss_pred             ----HHHHHHHHHHccCCHhHCcChHHHc
Confidence                3466789999999999999999864

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=9.3e-54  Score=422.15  Aligned_cols=250  Identities=23%  Similarity=0.334  Sum_probs=198.2

Q ss_pred             cCCCCCceecccCcEEEEEEEeC-CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeec-CceEEEE
Q 012765          142 DNFNSENLIGKGGHAEVYKGCLP-DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTE-NGFHLVL  219 (457)
Q Consensus       142 ~~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-~~~~lv~  219 (457)
                      ++|++++.||+|+||+||+|.+. +|+.||||++...... ....+.+.+|+.+|++++|||||++++++.+ +.+|+||
T Consensus        24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~-~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVm  102 (350)
T 4b9d_A           24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMS-SKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVM  102 (350)
T ss_dssp             CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCC-HHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEE
Confidence            68999999999999999999864 6999999998765433 3346789999999999999999999996554 5578999


Q ss_pred             EecCCCChhhhhhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCCCCC
Q 012765          220 QFLPHGSLSSLLFGS-TECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNW  298 (457)
Q Consensus       220 e~~~~gsL~~~l~~~-~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~~~  298 (457)
                      ||+++|+|.++|... ...+++..++.|+.||+.||.|||+   .+||||||||+||||+.+|.+||+|||+++.+....
T Consensus       103 Ey~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~---~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~  179 (350)
T 4b9d_A          103 DYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHD---RKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTV  179 (350)
T ss_dssp             ECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHH---TTCEETTCCGGGEEECTTCCEEECSTTEESCCCHHH
T ss_pred             eCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCCHHHEEECCCCCEEEcccccceeecCCc
Confidence            999999999999654 3457899999999999999999999   899999999999999999999999999998764321


Q ss_pred             CceeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhccccccCCcccccCchhhccc
Q 012765          299 SHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSNFKELVDPRLADAY  378 (457)
Q Consensus       299 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~  378 (457)
                        ......+||+.|||||++.+..|+.++|||||||++|||+||+.||............  . ...+.     .+...+
T Consensus       180 --~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i--~-~~~~~-----~~~~~~  249 (350)
T 4b9d_A          180 --ELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKI--I-SGSFP-----PVSLHY  249 (350)
T ss_dssp             --HHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH--H-HTCCC-----CCCTTS
T ss_pred             --ccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHH--H-cCCCC-----CCCccC
Confidence              1123456999999999999999999999999999999999999999875433222111  1 01111     111122


Q ss_pred             CHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 012765          379 DLAEMKRAMLTASVCIHHLSTMRPQMTRVLQ  409 (457)
Q Consensus       379 ~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~  409 (457)
                          ...+.+++.+||+.||++|||+.|+++
T Consensus       250 ----s~~~~~li~~~L~~dP~~R~s~~e~l~  276 (350)
T 4b9d_A          250 ----SYDLRSLVSQLFKRNPRDRPSVNSILE  276 (350)
T ss_dssp             ----CHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             ----CHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                235677889999999999999999986

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=1.4e-53  Score=419.07  Aligned_cols=264  Identities=23%  Similarity=0.246  Sum_probs=205.0

Q ss_pred             cCCCCCceecccCcEEEEEEEeC-CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeec-CceEEEE
Q 012765          142 DNFNSENLIGKGGHAEVYKGCLP-DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTE-NGFHLVL  219 (457)
Q Consensus       142 ~~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-~~~~lv~  219 (457)
                      +.|.+.++||+|+||+||+|.+. +|+.||||++.....        ..+|+.+++.++|||||++++++.+ +.+|+||
T Consensus        58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~--------~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivm  129 (336)
T 4g3f_A           58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF--------RVEELVACAGLSSPRIVPLYGAVREGPWVNIFM  129 (336)
T ss_dssp             TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC--------CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh--------HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence            56777889999999999999864 699999999865432        2469999999999999999996655 4578999


Q ss_pred             EecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCC-cEEEeeccccccCCCCC
Q 012765          220 QFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDY-EAQISDFGLAKWLPDNW  298 (457)
Q Consensus       220 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~-~~kL~DFGl~~~~~~~~  298 (457)
                      ||+++|+|.++|... ..+++..+..++.||+.||.|||+   .+||||||||+||||+.+| .+||+|||+++.+....
T Consensus       130 Ey~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~ylH~---~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~  205 (336)
T 4g3f_A          130 ELLEGGSLGQLIKQM-GCLPEDRALYYLGQALEGLEYLHT---RRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDG  205 (336)
T ss_dssp             CCCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHT---TTEECSCCCGGGEEECTTSCCEEECCCTTCEEC----
T ss_pred             eccCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHH---CCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCC
Confidence            999999999999653 468999999999999999999999   8999999999999999987 59999999998875432


Q ss_pred             Cce---eeecccccccccChhccccCCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhccccccCCcccccCchhh
Q 012765          299 SHH---IVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSNFKELVDPRLA  375 (457)
Q Consensus       299 ~~~---~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  375 (457)
                      ...   .....+||+.|||||++.+..|+.++|||||||++|||+||+.||............ ........     .+.
T Consensus       206 ~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i-~~~~~~~~-----~~~  279 (336)
T 4g3f_A          206 LGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKI-ASEPPPIR-----EIP  279 (336)
T ss_dssp             --------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHH-HHSCCGGG-----GSC
T ss_pred             cccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHH-HcCCCCch-----hcC
Confidence            211   122357999999999999999999999999999999999999999864432211110 00000000     111


Q ss_pred             cccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCCCCCCCCCCCCcc
Q 012765          376 DAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQLLRGEGGQTDLKPKPSAR  427 (457)
Q Consensus       376 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~~~~~~~~~~~  427 (457)
                      ..    ....+.+++.+||+.||.+|||+.||++.|...........+|+..
T Consensus       280 ~~----~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~l~hPw~~  327 (336)
T 4g3f_A          280 PS----CAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKSPWKG  327 (336)
T ss_dssp             TT----SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTSSCSCSSS
T ss_pred             cc----CCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhhccCCCcC
Confidence            12    2345667889999999999999999999887655444455566643

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=5.8e-53  Score=407.49  Aligned_cols=245  Identities=24%  Similarity=0.357  Sum_probs=194.2

Q ss_pred             CCCceecccCcEEEEEEEeC-CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeec-----CceEEE
Q 012765          145 NSENLIGKGGHAEVYKGCLP-DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTE-----NGFHLV  218 (457)
Q Consensus       145 ~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-----~~~~lv  218 (457)
                      ...+.||+|+||+||+|.+. +++.||+|++...... ......|.+|+.+|++++|||||++++++.+     ..+++|
T Consensus        29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~-~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lv  107 (290)
T 3fpq_A           29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLT-KSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV  107 (290)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSC-HHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEE
T ss_pred             EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCC-HHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEE
Confidence            45678999999999999865 5899999998754332 3446789999999999999999999997643     336899


Q ss_pred             EEecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC--eeeCCCCCCcEEEcC-CCcEEEeeccccccCC
Q 012765          219 LQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRR--IIHRDIKASNILLSE-DYEAQISDFGLAKWLP  295 (457)
Q Consensus       219 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~--iiHrDlkp~NIll~~-~~~~kL~DFGl~~~~~  295 (457)
                      |||+++|+|.+++.. ...+++..+..|+.||+.||.|||+   ++  ||||||||+||||+. ++.+||+|||+|+...
T Consensus       108 mEy~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~ylH~---~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~  183 (290)
T 3fpq_A          108 TELMTSGTLKTYLKR-FKVMKIKVLRSWCRQILKGLQFLHT---RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR  183 (290)
T ss_dssp             EECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHT---SSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred             EeCCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHH---CCCCEEecccChhheeEECCCCCEEEEeCcCCEeCC
Confidence            999999999999965 3468999999999999999999999   56  999999999999984 7999999999998654


Q ss_pred             CCCCceeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhccccccCCcccccCchhh
Q 012765          296 DNWSHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSNFKELVDPRLA  375 (457)
Q Consensus       296 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  375 (457)
                      ...    ....+||+.|||||++.+ .|+.++|||||||++|||+||+.||.........+... . ....    .+...
T Consensus       184 ~~~----~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i-~-~~~~----~~~~~  252 (290)
T 3fpq_A          184 ASF----AKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRV-T-SGVK----PASFD  252 (290)
T ss_dssp             TTS----BEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHH-T-TTCC----CGGGG
T ss_pred             CCc----cCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHH-H-cCCC----CCCCC
Confidence            432    234579999999998864 69999999999999999999999997644322221111 0 1100    11111


Q ss_pred             cccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 012765          376 DAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQ  409 (457)
Q Consensus       376 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~  409 (457)
                      ...+    ..+.+++.+||+.||++|||+.|+++
T Consensus       253 ~~~~----~~~~~li~~~L~~dP~~R~s~~e~l~  282 (290)
T 3fpq_A          253 KVAI----PEVKEIIEGCIRQNKDERYSIKDLLN  282 (290)
T ss_dssp             GCCC----HHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             ccCC----HHHHHHHHHHccCChhHCcCHHHHhc
Confidence            1222    24667889999999999999999986

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=9.6e-54  Score=424.47  Aligned_cols=267  Identities=25%  Similarity=0.379  Sum_probs=212.6

Q ss_pred             ccHHHHHHhhcCCCCCceecccCcEEEEEEEeC------CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCC-CCcc
Q 012765          132 FDFAELAAATDNFNSENLIGKGGHAEVYKGCLP------DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINH-PNAA  204 (457)
Q Consensus       132 ~~~~~~~~~~~~f~~~~~LG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h-pniv  204 (457)
                      ++....+...++|++.+.||+|+||+||+|.+.      .++.||||++......  .....|.+|+.+|.+++| ||||
T Consensus        54 ~~~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~--~~~~~~~~E~~il~~l~hhpnIV  131 (353)
T 4ase_A           54 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATH--SEHRALMSELKILIHIGHHLNVV  131 (353)
T ss_dssp             CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCH--HHHHHHHHHHHHHHHHCCCTTBC
T ss_pred             CCCcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccCh--HHHHHHHHHHHHHHHcCCCCcEE
Confidence            344555566789999999999999999999753      2468999998754433  345689999999999965 8999


Q ss_pred             eeeeeeec--CceEEEEEecCCCChhhhhhcC---------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeee
Q 012765          205 KLIGFSTE--NGFHLVLQFLPHGSLSSLLFGS---------------TECLEWTIRYKIALGIAEGLQYLHHDCHRRIIH  267 (457)
Q Consensus       205 ~l~~~~~~--~~~~lv~e~~~~gsL~~~l~~~---------------~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiH  267 (457)
                      +++++|.+  +.+++|||||++|+|.++|+..               ...+++..++.|+.|||.||.|||+   ++|||
T Consensus       132 ~l~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~---~~iiH  208 (353)
T 4ase_A          132 NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIH  208 (353)
T ss_dssp             CEEEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHH---TTCCC
T ss_pred             EEEEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhh---CCeec
Confidence            99998754  3478999999999999999643               2358999999999999999999999   89999


Q ss_pred             CCCCCCcEEEcCCCcEEEeeccccccCCCCCCceeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHh-CCCCC
Q 012765          268 RDIKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELIT-GRRAV  346 (457)
Q Consensus       268 rDlkp~NIll~~~~~~kL~DFGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLlt-G~~pf  346 (457)
                      |||||+|||+++++.+||+|||+++.+.............||+.|||||++.+..|+.++|||||||++|||+| |+.||
T Consensus       209 RDLK~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf  288 (353)
T 4ase_A          209 RDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY  288 (353)
T ss_dssp             SCCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSS
T ss_pred             CccCccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCC
Confidence            99999999999999999999999998765544444445679999999999999999999999999999999998 99999


Q ss_pred             CcCCcchhhhhccccccCCcccccCchhhcccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q 012765          347 DSRRQSLVIWAKPLLQTSNFKELVDPRLADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQLLRGE  414 (457)
Q Consensus       347 ~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~  414 (457)
                      ........... . .....     .+......    ...+.+++..||+.||++|||+.||++.|+.+
T Consensus       289 ~~~~~~~~~~~-~-i~~g~-----~~~~p~~~----~~~~~~li~~c~~~dP~~RPt~~eil~~L~~l  345 (353)
T 4ase_A          289 PGVKIDEEFCR-R-LKEGT-----RMRAPDYT----TPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL  345 (353)
T ss_dssp             TTCCCSHHHHH-H-HHHTC-----CCCCCTTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCCCHHHHHHH-H-HHcCC-----CCCCCccC----CHHHHHHHHHHcCcChhHCcCHHHHHHHHHHH
Confidence            86432211111 0 11110     11111112    23466788899999999999999999998765

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=8.5e-53  Score=414.65  Aligned_cols=248  Identities=21%  Similarity=0.310  Sum_probs=200.4

Q ss_pred             cCCCCCceecccCcEEEEEEEeC-CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeee-cCceEEEE
Q 012765          142 DNFNSENLIGKGGHAEVYKGCLP-DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFST-ENGFHLVL  219 (457)
Q Consensus       142 ~~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~-~~~~~lv~  219 (457)
                      +.|+..+.||+|+||+||+|.+. +|+.||||++......   ..+.+.+|+.+|+.++|||||++++++. ++.+|+||
T Consensus        74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~---~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivm  150 (346)
T 4fih_A           74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQ---RRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVM  150 (346)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCS---SGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchh---HHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence            56888899999999999999865 6999999998654332   2346889999999999999999999554 55678999


Q ss_pred             EecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCCCCCC
Q 012765          220 QFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWS  299 (457)
Q Consensus       220 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~~~~  299 (457)
                      ||+++|+|.+++..  ..+++..+..++.||+.||.|||+   .+||||||||+||||+.+|.+||+|||+++.+.....
T Consensus       151 Ey~~gg~L~~~l~~--~~l~e~~~~~~~~qi~~aL~ylH~---~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~  225 (346)
T 4fih_A          151 EFLEGGALTDIVTH--TRMNEEQIAAVCLAVLQALSVLHA---QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP  225 (346)
T ss_dssp             CCCTTEEHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSC
T ss_pred             eCCCCCcHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCcccccCCHHHEEECCCCCEEEecCcCceecCCCCC
Confidence            99999999999854  458999999999999999999999   8999999999999999999999999999988754322


Q ss_pred             ceeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhccccccCCcccccCchhhcccC
Q 012765          300 HHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSNFKELVDPRLADAYD  379 (457)
Q Consensus       300 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~  379 (457)
                        .....+||+.|||||++.+..|+.++|||||||++|||++|+.||............  .. .     ..+.+...  
T Consensus       226 --~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i--~~-~-----~~~~~~~~--  293 (346)
T 4fih_A          226 --RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMI--RD-N-----LPPRLKNL--  293 (346)
T ss_dssp             --CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH--HH-S-----SCCCCSCG--
T ss_pred             --cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHH--Hc-C-----CCCCCCcc--
Confidence              233467999999999999999999999999999999999999999865432221110  00 0     01111100  


Q ss_pred             HHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 012765          380 LAEMKRAMLTASVCIHHLSTMRPQMTRVLQ  409 (457)
Q Consensus       380 ~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~  409 (457)
                      ......+.+++.+||+.||++|||+.|+++
T Consensus       294 ~~~s~~~~dli~~~L~~dP~~R~ta~e~l~  323 (346)
T 4fih_A          294 HKVSPSLKGFLDRLLVRDPAQRATAAELLK  323 (346)
T ss_dssp             GGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             ccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            111235667889999999999999999876

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=2.3e-53  Score=414.61  Aligned_cols=267  Identities=22%  Similarity=0.274  Sum_probs=199.7

Q ss_pred             cCCCCCceecccCcEEEEEEEeCCCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeecC-----ceE
Q 012765          142 DNFNSENLIGKGGHAEVYKGCLPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTEN-----GFH  216 (457)
Q Consensus       142 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~-----~~~  216 (457)
                      ++|.+.+.||+|+||+||+|.+ +|+.||||++.....    ....+..|+..+..++|||||++++++.++     .++
T Consensus         3 r~i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~~----~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~   77 (303)
T 3hmm_A            3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREE----RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLW   77 (303)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGGGH----HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccch----hhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEE
Confidence            4567789999999999999998 689999999854321    112334566677889999999999977654     368


Q ss_pred             EEEEecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcC-----CCCeeeCCCCCCcEEEcCCCcEEEeecccc
Q 012765          217 LVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDC-----HRRIIHRDIKASNILLSEDYEAQISDFGLA  291 (457)
Q Consensus       217 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~-----~~~iiHrDlkp~NIll~~~~~~kL~DFGl~  291 (457)
                      +||||+++|+|.++|..  ..++|..+++|+.|++.||.|||+.+     ..+||||||||+||||+.++.+||+|||++
T Consensus        78 lV~Ey~~~gsL~~~l~~--~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla  155 (303)
T 3hmm_A           78 LVSDYHEHGSLFDYLNR--YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA  155 (303)
T ss_dssp             EEEECCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred             EEecCCCCCcHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCC
Confidence            99999999999999964  35899999999999999999999831     238999999999999999999999999999


Q ss_pred             ccCCCCCCce--eeecccccccccChhccccC------CCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhcccccc
Q 012765          292 KWLPDNWSHH--IVFPIEGTFGYLSPEYFMHG------IVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQT  363 (457)
Q Consensus       292 ~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~------~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~~~~~~  363 (457)
                      +.........  ......||+.|||||++.+.      .|+.++|||||||++|||+||..||........-+.......
T Consensus       156 ~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~  235 (303)
T 3hmm_A          156 VRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSD  235 (303)
T ss_dssp             EEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSS
T ss_pred             ccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhccccc
Confidence            8765433221  12235699999999998754      367899999999999999999988764332111111100011


Q ss_pred             CCc--------ccccCchhhccc-CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCC
Q 012765          364 SNF--------KELVDPRLADAY-DLAEMKRAMLTASVCIHHLSTMRPQMTRVLQLLRGEG  415 (457)
Q Consensus       364 ~~~--------~~~~d~~l~~~~-~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~  415 (457)
                      ...        ...++|.+.... ..+....+.+++.+||+.||++||||.||++.|+.+.
T Consensus       236 ~~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~  296 (303)
T 3hmm_A          236 PSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLS  296 (303)
T ss_dssp             CCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHH
T ss_pred             chHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHH
Confidence            111        112223332221 2355677889999999999999999999999998764

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=1.3e-52  Score=401.76  Aligned_cols=247  Identities=20%  Similarity=0.310  Sum_probs=186.0

Q ss_pred             cCCCCCceecccCcEEEEEEEeC-CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeec-CceEEEE
Q 012765          142 DNFNSENLIGKGGHAEVYKGCLP-DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTE-NGFHLVL  219 (457)
Q Consensus       142 ~~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-~~~~lv~  219 (457)
                      ++|++.+.||+|+||+||+|.+. +|+.||+|++.+...........+.+|+.+++.++|||||++++++.+ +.+++||
T Consensus        13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm   92 (275)
T 3hyh_A           13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI   92 (275)
T ss_dssp             -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence            68999999999999999999864 699999999976554444445689999999999999999999996655 5578999


Q ss_pred             EecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCCCCCC
Q 012765          220 QFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWS  299 (457)
Q Consensus       220 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~~~~  299 (457)
                      ||+ +|+|.+++... ..+++..+..++.||+.||.|||+   ++|+||||||+|||++.++.+||+|||+++...... 
T Consensus        93 Ey~-~g~L~~~l~~~-~~l~e~~~~~~~~qi~~al~ylH~---~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~-  166 (275)
T 3hyh_A           93 EYA-GNELFDYIVQR-DKMSEQEARRFFQQIISAVEYCHR---HKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGN-  166 (275)
T ss_dssp             ECC-CEEHHHHHHHS-CSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCTTTEEECTTCCEEECCSSCC--------
T ss_pred             eCC-CCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHH---CCcccccCChHHeEECCCCCEEEeecCCCeecCCCC-
Confidence            998 68999988654 458999999999999999999999   899999999999999999999999999998765432 


Q ss_pred             ceeeecccccccccChhccccCCC-CcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhccccccCCcccccCchhhccc
Q 012765          300 HHIVFPIEGTFGYLSPEYFMHGIV-DEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSNFKELVDPRLADAY  378 (457)
Q Consensus       300 ~~~~~~~~gt~~y~aPE~~~~~~~-~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~  378 (457)
                        .....+||+.|||||++.+..| +.++|||||||++|||+||+.||......... .........+        ...+
T Consensus       167 --~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~-~~i~~~~~~~--------p~~~  235 (275)
T 3hyh_A          167 --FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLF-KNISNGVYTL--------PKFL  235 (275)
T ss_dssp             ----------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH-HHHHHTCCCC--------CTTS
T ss_pred             --ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHH-HHHHcCCCCC--------CCCC
Confidence              2234569999999999998876 57999999999999999999999864432211 1100011111        1112


Q ss_pred             CHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 012765          379 DLAEMKRAMLTASVCIHHLSTMRPQMTRVLQ  409 (457)
Q Consensus       379 ~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~  409 (457)
                      +    ..+.+++.+||+.||++|||+.|+++
T Consensus       236 s----~~~~~li~~~L~~dP~~R~s~~eil~  262 (275)
T 3hyh_A          236 S----PGAAGLIKRMLIVNPLNRISIHEIMQ  262 (275)
T ss_dssp             C----HHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             C----HHHHHHHHHHccCChhHCcCHHHHHc
Confidence            2    34567889999999999999999987

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=1e-51  Score=416.65  Aligned_cols=249  Identities=20%  Similarity=0.303  Sum_probs=201.2

Q ss_pred             hcCCCCCceecccCcEEEEEEEeC-CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeee-ecCceEEE
Q 012765          141 TDNFNSENLIGKGGHAEVYKGCLP-DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFS-TENGFHLV  218 (457)
Q Consensus       141 ~~~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~-~~~~~~lv  218 (457)
                      .+.|++.+.||+|+||+||+|.+. +|+.||||++.......   .+.+.+|+.+|+.++|||||++++++ .++.+|+|
T Consensus       150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~---~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iV  226 (423)
T 4fie_A          150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQR---RELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVV  226 (423)
T ss_dssp             GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSS---GGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred             hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhH---HHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEE
Confidence            356899999999999999999865 69999999986543322   34688999999999999999999955 45567899


Q ss_pred             EEecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCCCCC
Q 012765          219 LQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNW  298 (457)
Q Consensus       219 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~~~  298 (457)
                      ||||++|+|.+++..  ..+++..+..|+.||+.||.|||+   .+||||||||+||||+.+|.+||+|||+++.+....
T Consensus       227 mEy~~gG~L~~~i~~--~~l~e~~~~~~~~qil~aL~ylH~---~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~  301 (423)
T 4fie_A          227 MEFLEGGALTDIVTH--TRMNEEQIAAVCLAVLQALSVLHA---QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV  301 (423)
T ss_dssp             EECCTTEEHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSTTTEEECTTCCEEECCCTTCEECCSSC
T ss_pred             EeCCCCCcHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHH---CCeecccCCHHHEEEcCCCCEEEecCccceECCCCC
Confidence            999999999999854  358999999999999999999999   899999999999999999999999999998875432


Q ss_pred             CceeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhccccccCCcccccCchhhccc
Q 012765          299 SHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSNFKELVDPRLADAY  378 (457)
Q Consensus       299 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~  378 (457)
                      .  .....+||+.|||||++.+..|+.++|||||||++|||++|+.||.+..........  .. .     ..+.+... 
T Consensus       302 ~--~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i--~~-~-----~~~~~~~~-  370 (423)
T 4fie_A          302 P--RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMI--RD-N-----LPPRLKNL-  370 (423)
T ss_dssp             C--CBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH--HH-S-----CCCCCSCT-
T ss_pred             c--cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHH--Hc-C-----CCCCCccc-
Confidence            2  223467999999999999999999999999999999999999999865432221111  00 0     01111100 


Q ss_pred             CHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 012765          379 DLAEMKRAMLTASVCIHHLSTMRPQMTRVLQ  409 (457)
Q Consensus       379 ~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~  409 (457)
                       ......+.+++.+||+.||++|||+.|+++
T Consensus       371 -~~~s~~~~dli~~~L~~dP~~R~ta~ell~  400 (423)
T 4fie_A          371 -HKVSPSLKGFLDRLLVRDPAQRATAAELLK  400 (423)
T ss_dssp             -TSSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             -ccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence             011235667889999999999999999876

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=3.2e-51  Score=398.07  Aligned_cols=249  Identities=22%  Similarity=0.377  Sum_probs=186.0

Q ss_pred             cCCCCCceecccCcEEEEEEEeC-CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeecCc------
Q 012765          142 DNFNSENLIGKGGHAEVYKGCLP-DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTENG------  214 (457)
Q Consensus       142 ~~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~------  214 (457)
                      ++|++.+.||+|+||+||+|.+. +|+.||||++.....  ....+.+.+|+.+|++++|||||++++++.+.+      
T Consensus         5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~--~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~   82 (299)
T 4g31_A            5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNR--ELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQ   82 (299)
T ss_dssp             HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSS--HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC------
T ss_pred             hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCC--HHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccc
Confidence            46889999999999999999864 699999999865432  234568999999999999999999999664322      


Q ss_pred             -------eEEEEEecCCCChhhhhhcCCC--CCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEE
Q 012765          215 -------FHLVLQFLPHGSLSSLLFGSTE--CLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQI  285 (457)
Q Consensus       215 -------~~lv~e~~~~gsL~~~l~~~~~--~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL  285 (457)
                             +|++|||+.+|+|.+++.....  ..++..++.|+.||+.||.|||+   ++||||||||+||||+.++.+||
T Consensus        83 ~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~---~~IiHRDlKp~NILl~~~~~vKl  159 (299)
T 4g31_A           83 PSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKV  159 (299)
T ss_dssp             ----CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEE
T ss_pred             ccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHH---CcCccccCcHHHeEECCCCcEEE
Confidence                   5899999999999999965433  35677788999999999999999   89999999999999999999999


Q ss_pred             eeccccccCCCCCCce----------eeecccccccccChhccccCCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhh
Q 012765          286 SDFGLAKWLPDNWSHH----------IVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVI  355 (457)
Q Consensus       286 ~DFGl~~~~~~~~~~~----------~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~  355 (457)
                      +|||+++.+.......          .....+||+.|||||++.+..|+.++|||||||++|||++   ||.........
T Consensus       160 ~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~~~~~  236 (299)
T 4g31_A          160 GDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQMERVRT  236 (299)
T ss_dssp             CCCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHH
T ss_pred             ccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccHHHHH
Confidence            9999998875432211          1233569999999999999999999999999999999996   77642221111


Q ss_pred             hhccccccCCcccccCchhhcccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 012765          356 WAKPLLQTSNFKELVDPRLADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQ  409 (457)
Q Consensus       356 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~  409 (457)
                      ...  .....+     |...    ......+..++.+||+.||.+|||+.|+++
T Consensus       237 ~~~--~~~~~~-----p~~~----~~~~~~~~~li~~~L~~dP~~Rps~~eil~  279 (299)
T 4g31_A          237 LTD--VRNLKF-----PPLF----TQKYPCEYVMVQDMLSPSPMERPEAINIIE  279 (299)
T ss_dssp             HHH--HHTTCC-----CHHH----HHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             HHH--HhcCCC-----CCCC----cccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            110  001111     1111    122234567889999999999999999987

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=3.8e-52  Score=403.88  Aligned_cols=248  Identities=23%  Similarity=0.269  Sum_probs=190.5

Q ss_pred             cCCCCCceecccCcEEEEEEEeC----CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeee-cCceE
Q 012765          142 DNFNSENLIGKGGHAEVYKGCLP----DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFST-ENGFH  216 (457)
Q Consensus       142 ~~f~~~~~LG~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~-~~~~~  216 (457)
                      ++|++.+.||+|+||+||+|...    .++.||+|++.+...... ....+.+|+.+|++++|||||++++++. ++.++
T Consensus        24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~-~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~  102 (304)
T 3ubd_A           24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVR-DRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLY  102 (304)
T ss_dssp             GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEE-ECC------CCCCCCCCTTEECEEEEEEETTEEE
T ss_pred             cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChH-HHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEE
Confidence            57889999999999999999752    478999999865432211 1236788999999999999999999655 55678


Q ss_pred             EEEEecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCCC
Q 012765          217 LVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPD  296 (457)
Q Consensus       217 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~  296 (457)
                      +||||+++|+|.+++... ..+++..+..++.||+.||.|||+   .+|+||||||+|||++.+|.+||+|||+++....
T Consensus       103 ivmEy~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~ylH~---~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~  178 (304)
T 3ubd_A          103 LILDFLRGGDLFTRLSKE-VMFTEEDVKFYLAELALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESID  178 (304)
T ss_dssp             EEECCCTTCEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCCGGGEEECTTSCEEEESSEEEEC---
T ss_pred             EEEEcCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH---CCCcCCCCCHHHeEEcCCCCEEecccccceeccC
Confidence            999999999999999653 458999999999999999999999   8999999999999999999999999999987644


Q ss_pred             CCCceeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhccccccCCcccccCchhhc
Q 012765          297 NWSHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSNFKELVDPRLAD  376 (457)
Q Consensus       297 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  376 (457)
                      ...  .....+||+.|||||++.+..|+.++|||||||++|||+||+.||.+.+........ ......++        .
T Consensus       179 ~~~--~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i-~~~~~~~p--------~  247 (304)
T 3ubd_A          179 HEK--KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMI-LKAKLGMP--------Q  247 (304)
T ss_dssp             --C--CCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH-HHCCCCCC--------T
T ss_pred             CCc--cccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHH-HcCCCCCC--------C
Confidence            322  223467999999999999999999999999999999999999999875443221111 01111111        1


Q ss_pred             ccCHHHHHHHHHHHHHhcccCCCCCCCH-----HHHHH
Q 012765          377 AYDLAEMKRAMLTASVCIHHLSTMRPQM-----TRVLQ  409 (457)
Q Consensus       377 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt~-----~evl~  409 (457)
                      .++    ..+.+++.+||+.||++|||+     .|+++
T Consensus       248 ~~s----~~~~~li~~~L~~dP~~R~ta~~~~~~eil~  281 (304)
T 3ubd_A          248 FLS----PEAQSLLRMLFKRNPANRLGAGPDGVEEIKR  281 (304)
T ss_dssp             TSC----HHHHHHHHHHTCSSGGGSTTCSTTTHHHHHT
T ss_pred             cCC----HHHHHHHHHHcccCHHHCCCCCcCCHHHHHc
Confidence            222    346678899999999999984     56653

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=9.3e-49  Score=394.98  Aligned_cols=263  Identities=22%  Similarity=0.299  Sum_probs=198.6

Q ss_pred             hcCCCCCceecccCcEEEEEEEeC-CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeec-------
Q 012765          141 TDNFNSENLIGKGGHAEVYKGCLP-DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTE-------  212 (457)
Q Consensus       141 ~~~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-------  212 (457)
                      .++|.+.+.||+|+||+||+|.+. +|+.||||++..... .......+++|+.+|+.++|||||++++++..       
T Consensus        53 ~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~  131 (398)
T 4b99_A           53 GDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFD-VVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEF  131 (398)
T ss_dssp             CSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTS-SHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTC
T ss_pred             CCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECcccc-chHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccC
Confidence            367899999999999999999864 699999999865433 23445688999999999999999999996542       


Q ss_pred             CceEEEEEecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccc
Q 012765          213 NGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAK  292 (457)
Q Consensus       213 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~  292 (457)
                      +.+|+||||+. |+|.+++.. ...+++..+..++.||+.||.|||+   .+||||||||+|||++.++.+||+|||+++
T Consensus       132 ~~~~ivmE~~~-g~L~~~i~~-~~~l~~~~~~~~~~qil~al~ylH~---~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~  206 (398)
T 4b99_A          132 KSVYVVLDLME-SDLHQIIHS-SQPLTLEHVRYFLYQLLRGLKYMHS---AQVIHRDLKPSNLLVNENCELKIGDFGMAR  206 (398)
T ss_dssp             CCEEEEEECCS-EEHHHHHTS-SSCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTCCEEECCCTTCB
T ss_pred             CEEEEEEeCCC-CCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHH---CcCcCCCcCccccccCCCCCEEEeecceee
Confidence            45799999996 679888854 4568999999999999999999999   899999999999999999999999999998


Q ss_pred             cCCCCCC--ceeeecccccccccChhccccC-CCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhcc-ccccCCcc-
Q 012765          293 WLPDNWS--HHIVFPIEGTFGYLSPEYFMHG-IVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKP-LLQTSNFK-  367 (457)
Q Consensus       293 ~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~~-~~~~~~~~-  367 (457)
                      .+.....  .......+||+.|||||++.+. .|+.++|||||||++|||++|+.||.+.+......... ........ 
T Consensus       207 ~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~  286 (398)
T 4b99_A          207 GLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAV  286 (398)
T ss_dssp             CC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGG
T ss_pred             ecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHH
Confidence            7744321  1223456799999999998875 57999999999999999999999998654322111000 00000000 


Q ss_pred             -------------cccCchhhcc---cCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 012765          368 -------------ELVDPRLADA---YDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQ  409 (457)
Q Consensus       368 -------------~~~d~~l~~~---~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~  409 (457)
                                   ..+.+.....   ........+.+++.+||+.||.+|||+.|+++
T Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~  344 (398)
T 4b99_A          287 IQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALR  344 (398)
T ss_dssp             TC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             hhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence                         0000000000   00011235678899999999999999999987

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=1.9e-47  Score=375.90  Aligned_cols=286  Identities=41%  Similarity=0.704  Sum_probs=241.7

Q ss_pred             cccccHHHHHHhhcCCCCCceecccCcEEEEEEEeCCCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeee
Q 012765          129 WKNFDFAELAAATDNFNSENLIGKGGHAEVYKGCLPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIG  208 (457)
Q Consensus       129 ~~~~~~~~~~~~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~  208 (457)
                      ...|++.++....++|.+.+.||+|+||.||+|...+|+.||+|++......  .....+.+|+.+++.++||||+++++
T Consensus        17 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~   94 (326)
T 3uim_A           17 LKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQ--GGELQFQTEVEMISMAVHRNLLRLRG   94 (326)
T ss_dssp             CEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-------CCCHHHHHHHGGGTCCCTTBCCCCE
T ss_pred             cceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCc--hHHHHHHHHHHHHHhccCCCccceEE
Confidence            4568899999999999999999999999999999888999999998654322  12236889999999999999999999


Q ss_pred             eeec-CceEEEEEecCCCChhhhhhcCC---CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEE
Q 012765          209 FSTE-NGFHLVLQFLPHGSLSSLLFGST---ECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQ  284 (457)
Q Consensus       209 ~~~~-~~~~lv~e~~~~gsL~~~l~~~~---~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~k  284 (457)
                      ++.. +..++||||+.+|+|.+++....   ..+++..++.|+.|++.||.|||+.+..+|+||||||+|||++.++.+|
T Consensus        95 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~k  174 (326)
T 3uim_A           95 FCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAV  174 (326)
T ss_dssp             EECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEE
T ss_pred             EEecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEE
Confidence            7655 45789999999999999996533   3489999999999999999999993222999999999999999999999


Q ss_pred             EeeccccccCCCCCCceeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHhCCCCCCc------CCcchhhhhc
Q 012765          285 ISDFGLAKWLPDNWSHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDS------RRQSLVIWAK  358 (457)
Q Consensus       285 L~DFGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLltG~~pf~~------~~~~~~~~~~  358 (457)
                      |+|||++......... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||..      .......|..
T Consensus       175 l~Dfg~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~  253 (326)
T 3uim_A          175 VGDFGLAKLMDYKDTH-VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVK  253 (326)
T ss_dssp             ECCCSSCEECCSSSSC-EECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHT
T ss_pred             eccCccccccCccccc-ccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHH
Confidence            9999999877543322 23345699999999999988999999999999999999999999962      3344556666


Q ss_pred             cccccCCcccccCchhhcccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCCCC
Q 012765          359 PLLQTSNFKELVDPRLADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQLLRGEGGQ  417 (457)
Q Consensus       359 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~  417 (457)
                      ..........+.+..+...+.......+.+++.+||+.||.+|||+.+|++.|++....
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~~~  312 (326)
T 3uim_A          254 GLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDGLA  312 (326)
T ss_dssp             TTTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTSSCS
T ss_pred             HHhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCcchh
Confidence            66777777888888888888888899999999999999999999999999999986433

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=1.9e-47  Score=381.19  Aligned_cols=199  Identities=25%  Similarity=0.375  Sum_probs=166.7

Q ss_pred             hhcCCCCCceecccCcEEEEEEEeC----CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhc-CCCCcceeeeeee-cC
Q 012765          140 ATDNFNSENLIGKGGHAEVYKGCLP----DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHI-NHPNAAKLIGFST-EN  213 (457)
Q Consensus       140 ~~~~f~~~~~LG~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~-~~  213 (457)
                      ..++|++.+.||+|+||+||+|..+    .++.||+|++.....     ...+.+|+.+|..+ +|||||++++++. .+
T Consensus        19 l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~-----~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~   93 (361)
T 4f9c_A           19 LSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSH-----PIRIAAELQCLTVAGGQDNVMGVKYCFRKND   93 (361)
T ss_dssp             GGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSC-----HHHHHHHHHHHHHTCSBTTBCCCSEEEEETT
T ss_pred             ccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccccC-----HHHHHHHHHHHHHhcCCCCCceEEEEEEECC
Confidence            4678999999999999999999753    478899998865432     23678899999988 6999999999554 55


Q ss_pred             ceEEEEEecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCC-CcEEEeeccccc
Q 012765          214 GFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSED-YEAQISDFGLAK  292 (457)
Q Consensus       214 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~-~~~kL~DFGl~~  292 (457)
                      .+++||||+++|+|.+++.    .+++..+..++.||+.||.|||+   .+|+||||||+|||++.+ +.+||+|||+|+
T Consensus        94 ~~~lvmE~~~g~~L~~~~~----~l~~~~~~~~~~qll~al~ylH~---~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~  166 (361)
T 4f9c_A           94 HVVIAMPYLEHESFLDILN----SLSFQEVREYMLNLFKALKRIHQ---FGIVHRDVKPSNFLYNRRLKKYALVDFGLAQ  166 (361)
T ss_dssp             EEEEEEECCCCCCHHHHHT----TCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred             EEEEEEeCCCcccHHHHHc----CCCHHHHHHHHHHHHHHHHHHHH---CCeEeCcCCHHHeEEeCCCCeEEECcCCCCc
Confidence            6789999999999999983    48899999999999999999999   899999999999999877 799999999998


Q ss_pred             cCCCCCCc--------------------------eeeecccccccccChhccccC-CCCcchhHHHHHHHHHHHHhCCCC
Q 012765          293 WLPDNWSH--------------------------HIVFPIEGTFGYLSPEYFMHG-IVDEKTDVFAFGVLLLELITGRRA  345 (457)
Q Consensus       293 ~~~~~~~~--------------------------~~~~~~~gt~~y~aPE~~~~~-~~~~ksDvwSlGvll~eLltG~~p  345 (457)
                      ...+....                          ......+||+.|||||++.+. .|+.++||||+||++|||+||+.|
T Consensus       167 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~P  246 (361)
T 4f9c_A          167 GTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYP  246 (361)
T ss_dssp             ECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSS
T ss_pred             ccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCC
Confidence            65432110                          112345799999999999875 589999999999999999999999


Q ss_pred             CCcCC
Q 012765          346 VDSRR  350 (457)
Q Consensus       346 f~~~~  350 (457)
                      |....
T Consensus       247 f~~~~  251 (361)
T 4f9c_A          247 FYKAS  251 (361)
T ss_dssp             SSCCS
T ss_pred             CCCCC
Confidence            96543

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=4.8e-47  Score=372.59  Aligned_cols=272  Identities=38%  Similarity=0.655  Sum_probs=228.3

Q ss_pred             HHhhcCCCCCceecccCcEEEEEEEeCCCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeec-CceE
Q 012765          138 AAATDNFNSENLIGKGGHAEVYKGCLPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTE-NGFH  216 (457)
Q Consensus       138 ~~~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-~~~~  216 (457)
                      ...+++|.+.+.||+|+||+||+|.+.+++.||+|++.....   .....+.+|+.+++.++||||+++++++.+ +..+
T Consensus        35 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  111 (321)
T 2qkw_B           35 EEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESS---QGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMI  111 (321)
T ss_dssp             CCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCS---SHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCE
T ss_pred             HHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccCh---HHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEE
Confidence            346789999999999999999999988899999998765433   235578999999999999999999997655 4578


Q ss_pred             EEEEecCCCChhhhhhcCC---CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeecccccc
Q 012765          217 LVLQFLPHGSLSSLLFGST---ECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKW  293 (457)
Q Consensus       217 lv~e~~~~gsL~~~l~~~~---~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~  293 (457)
                      +||||+++|+|.+++....   ..+++..++.++.||+.||.|||+   .+|+||||||+||+++.++.+||+|||++..
T Consensus       112 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~  188 (321)
T 2qkw_B          112 LIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHT---RAIIHRDVKSINILLDENFVPKITDFGISKK  188 (321)
T ss_dssp             EEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCSTTEEECTTCCEEECCCTTCEE
T ss_pred             EEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcC---CCeecCCCCHHHEEECCCCCEEEeecccccc
Confidence            9999999999999986533   358999999999999999999999   8999999999999999999999999999987


Q ss_pred             CCCCCCceeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHhCCCCCCcCCc----chhhhhccccccCCcccc
Q 012765          294 LPDNWSHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQ----SLVIWAKPLLQTSNFKEL  369 (457)
Q Consensus       294 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLltG~~pf~~~~~----~~~~~~~~~~~~~~~~~~  369 (457)
                      ..............||+.|+|||++.+..++.++|||||||++|||++|+.||.....    ....|.........+..+
T Consensus       189 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  268 (321)
T 2qkw_B          189 GTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQI  268 (321)
T ss_dssp             CSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCCSS
T ss_pred             cccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHHHh
Confidence            5443222223344589999999999999999999999999999999999999975332    223344444445556677


Q ss_pred             cCchhhcccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCC
Q 012765          370 VDPRLADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQLLRGEG  415 (457)
Q Consensus       370 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~  415 (457)
                      +++.+...........+.+++.+||+.||++|||+.||++.|+.+.
T Consensus       269 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l  314 (321)
T 2qkw_B          269 VDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYAL  314 (321)
T ss_dssp             SSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             cChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHh
Confidence            7777777777888889999999999999999999999999998753

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=5.4e-47  Score=399.68  Aligned_cols=251  Identities=18%  Similarity=0.240  Sum_probs=204.1

Q ss_pred             hcCCCCCceecccCcEEEEEEEeC-CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeec-CceEEE
Q 012765          141 TDNFNSENLIGKGGHAEVYKGCLP-DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTE-NGFHLV  218 (457)
Q Consensus       141 ~~~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-~~~~lv  218 (457)
                      .++|.+.+.||+|+||+||+|.+. +|+.||+|++......   ....+.+|+.+|+.++|||||++++++.+ +.++++
T Consensus       156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~---~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv  232 (573)
T 3uto_A          156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHES---DKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMI  232 (573)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHH---HHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchh---hHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEE
Confidence            468999999999999999999864 6999999998654332   34578899999999999999999996554 557899


Q ss_pred             EEecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCC--CcEEEeeccccccCCC
Q 012765          219 LQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSED--YEAQISDFGLAKWLPD  296 (457)
Q Consensus       219 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~--~~~kL~DFGl~~~~~~  296 (457)
                      |||+.+|+|.+++......+++..+..++.||+.||.|||+   .+|+||||||+|||++.+  +.+||+|||+++.+..
T Consensus       233 ~E~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~---~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~  309 (573)
T 3uto_A          233 YEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHE---NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP  309 (573)
T ss_dssp             EECCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCT
T ss_pred             EeecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCChhhccccCCCCCCEEEeeccceeEccC
Confidence            99999999999997666779999999999999999999999   899999999999999854  8999999999998765


Q ss_pred             CCCceeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhccccccCCcccccCchhhc
Q 012765          297 NWSHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSNFKELVDPRLAD  376 (457)
Q Consensus       297 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  376 (457)
                      ..   .....+||+.|||||++.+..|+.++|||||||++|||++|..||.+........... .....+    .+....
T Consensus       310 ~~---~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~-~~~~~~----~~~~~~  381 (573)
T 3uto_A          310 KQ---SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVK-SCDWNM----DDSAFS  381 (573)
T ss_dssp             TS---EEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHH-TTCCCC----CSGGGT
T ss_pred             CC---ceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHH-hCCCCC----Cccccc
Confidence            43   2344579999999999999999999999999999999999999998754432211110 000111    111111


Q ss_pred             ccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 012765          377 AYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQ  409 (457)
Q Consensus       377 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~  409 (457)
                      .++    ..+.+++.+||+.||.+|||+.|+++
T Consensus       382 ~~s----~~~~dli~~~L~~dp~~R~t~~e~l~  410 (573)
T 3uto_A          382 GIS----EDGKDFIRKLLLADPNTRMTIHQALE  410 (573)
T ss_dssp             TSC----HHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             CCC----HHHHHHHHHHccCChhHCcCHHHHhc
Confidence            222    34567889999999999999999987

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=3.6e-47  Score=400.52  Aligned_cols=249  Identities=24%  Similarity=0.303  Sum_probs=195.2

Q ss_pred             hcCCCCCceecccCcEEEEEEEeC-CCcEEEEEEEeccchh---hHHHHHHHHHHHHHHhhcCCCCcceeeeee-ecCce
Q 012765          141 TDNFNSENLIGKGGHAEVYKGCLP-DGEVVAVKKIIKNAKE---DEERISDFLSELGIVAHINHPNAAKLIGFS-TENGF  215 (457)
Q Consensus       141 ~~~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~~~~E~~~l~~l~hpniv~l~~~~-~~~~~  215 (457)
                      .++|.+.++||+|+||+||+|... +|+.||+|++.+....   ..........++.+++.++|||||++++++ ..+.+
T Consensus       188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~l  267 (689)
T 3v5w_A          188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL  267 (689)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred             hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEE
Confidence            478999999999999999999865 6999999998654322   122233344557777888999999999855 45668


Q ss_pred             EEEEEecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCC
Q 012765          216 HLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLP  295 (457)
Q Consensus       216 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~  295 (457)
                      |+||||++||+|..+|... ..+++..+..++.||+.||.|||+   .+||||||||+||||+.+|.+||+|||+|+.+.
T Consensus       268 ylVmEy~~GGdL~~~l~~~-~~l~E~~a~~y~~qIl~aL~yLH~---~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~  343 (689)
T 3v5w_A          268 SFILDLMNGGDLHYHLSQH-GVFSEADMRFYAAEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFS  343 (689)
T ss_dssp             EEEECCCCSCBHHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred             EEEEecCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCchHHeEEeCCCCEEecccceeeecC
Confidence            9999999999999999653 458999999999999999999999   899999999999999999999999999998876


Q ss_pred             CCCCceeeecccccccccChhcccc-CCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchh--hhhccccccCCcccccCc
Q 012765          296 DNWSHHIVFPIEGTFGYLSPEYFMH-GIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLV--IWAKPLLQTSNFKELVDP  372 (457)
Q Consensus       296 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~--~~~~~~~~~~~~~~~~d~  372 (457)
                      ....    ...+||+.|||||++.. ..|+.++|||||||++|||++|..||........  .........        .
T Consensus       344 ~~~~----~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~~~--------~  411 (689)
T 3v5w_A          344 KKKP----HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMA--------V  411 (689)
T ss_dssp             SCCC----CSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHHCC--------C
T ss_pred             CCCC----CCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCC--------C
Confidence            5432    34569999999999974 5799999999999999999999999975322111  111100000        1


Q ss_pred             hhhcccCHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHH
Q 012765          373 RLADAYDLAEMKRAMLTASVCIHHLSTMRPQ-----MTRVLQ  409 (457)
Q Consensus       373 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt-----~~evl~  409 (457)
                      .+...++    ..+.+++.+||+.||.+|++     +.||++
T Consensus       412 ~~p~~~S----~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~  449 (689)
T 3v5w_A          412 ELPDSFS----PELRSLLEGLLQRDVNRRLGCLGRGAQEVKE  449 (689)
T ss_dssp             CCCTTSC----HHHHHHHHHHTCSCGGGCTTCSSSTHHHHTT
T ss_pred             CCCccCC----HHHHHHHHHHccCCHhHCCCCCCCCHHHHhc
Confidence            1111222    34667889999999999998     577754

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=2.1e-44  Score=351.05  Aligned_cols=281  Identities=36%  Similarity=0.604  Sum_probs=226.1

Q ss_pred             cccccHHHHHHhhcCCCCC------ceecccCcEEEEEEEeCCCcEEEEEEEeccch-hhHHHHHHHHHHHHHHhhcCCC
Q 012765          129 WKNFDFAELAAATDNFNSE------NLIGKGGHAEVYKGCLPDGEVVAVKKIIKNAK-EDEERISDFLSELGIVAHINHP  201 (457)
Q Consensus       129 ~~~~~~~~~~~~~~~f~~~------~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~E~~~l~~l~hp  201 (457)
                      ...|++.++..++++|...      +.||+|+||.||+|.. +++.||+|++..... ........+.+|+.+++.++||
T Consensus        12 ~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~   90 (307)
T 2nru_A           12 FHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHE   90 (307)
T ss_dssp             CEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCT
T ss_pred             CCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCC
Confidence            4578899999999999887      8999999999999987 688999999865332 2223456789999999999999


Q ss_pred             Ccceeeeeeec-CceEEEEEecCCCChhhhhhc--CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEc
Q 012765          202 NAAKLIGFSTE-NGFHLVLQFLPHGSLSSLLFG--STECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLS  278 (457)
Q Consensus       202 niv~l~~~~~~-~~~~lv~e~~~~gsL~~~l~~--~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~  278 (457)
                      ||+++++++.+ +..+++|||+++++|.+++..  ....+++..++.++.||+.||.|||+   .+|+||||||+||+++
T Consensus        91 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dlkp~Nili~  167 (307)
T 2nru_A           91 NLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHE---NHHIHRDIKSANILLD  167 (307)
T ss_dssp             TBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEEC
T ss_pred             CeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhc---CCeecCCCCHHHEEEc
Confidence            99999997665 457899999999999999853  23468999999999999999999999   8999999999999999


Q ss_pred             CCCcEEEeeccccccCCCCCCceeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHhCCCCCCcCCcch--hhh
Q 012765          279 EDYEAQISDFGLAKWLPDNWSHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSL--VIW  356 (457)
Q Consensus       279 ~~~~~kL~DFGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~--~~~  356 (457)
                      .++.+||+|||++................||+.|+|||.+.+ .++.++||||||+++|+|++|..||.......  ..+
T Consensus       168 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~  246 (307)
T 2nru_A          168 EAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDI  246 (307)
T ss_dssp             TTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHH
T ss_pred             CCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHH
Confidence            999999999999987655433333334569999999998764 58999999999999999999999998633221  111


Q ss_pred             hccc-cccCCcccccCchhhcccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCC
Q 012765          357 AKPL-LQTSNFKELVDPRLADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQLLRGEG  415 (457)
Q Consensus       357 ~~~~-~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~  415 (457)
                      .... .....+...+++.+. .........+.+++.+||+.||.+|||+.+|++.|+.+.
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~  305 (307)
T 2nru_A          247 KEEIEDEEKTIEDYIDKKMN-DADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMT  305 (307)
T ss_dssp             HHHHHTTSCCHHHHSCSSCS-CCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC
T ss_pred             HHHhhhhhhhhhhhcccccc-ccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHh
Confidence            1111 112233444454442 235566778899999999999999999999999998875

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=8.5e-46  Score=364.96  Aligned_cols=258  Identities=23%  Similarity=0.378  Sum_probs=201.9

Q ss_pred             hcCCCCCceecccCcEEEEEEEeC-CCcE----EEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeecCce
Q 012765          141 TDNFNSENLIGKGGHAEVYKGCLP-DGEV----VAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTENGF  215 (457)
Q Consensus       141 ~~~f~~~~~LG~G~~g~Vy~~~~~-~~~~----vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~  215 (457)
                      .++|.+.+.||+|+||+||+|.+. +++.    ||+|.+....  .......+.+|+.++++++||||+++++++..+..
T Consensus        14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   91 (327)
T 3poz_A           14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVDNPHVCRLLGICLTSTV   91 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC---------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSSE
T ss_pred             HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeeccccc--CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCe
Confidence            467888999999999999999854 4444    5777664322  22334689999999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCC
Q 012765          216 HLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLP  295 (457)
Q Consensus       216 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~  295 (457)
                      ++++||+.+|+|.+++......+++..++.++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||+++.+.
T Consensus        92 ~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~  168 (327)
T 3poz_A           92 QLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG  168 (327)
T ss_dssp             EEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEETTEEEECCTTHHHHHT
T ss_pred             EEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhh---CCeeCCCCChheEEECCCCCEEEccCcceeEcc
Confidence            99999999999999998877789999999999999999999999   899999999999999999999999999998775


Q ss_pred             CCCCceeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHh-CCCCCCcCCcchhhhhccccccCCcccccCchh
Q 012765          296 DNWSHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELIT-GRRAVDSRRQSLVIWAKPLLQTSNFKELVDPRL  374 (457)
Q Consensus       296 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLlt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l  374 (457)
                      ............+|..|+|||++.+..++.++|||||||++|||+| |+.||................            
T Consensus       169 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~------------  236 (327)
T 3poz_A          169 AEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGE------------  236 (327)
T ss_dssp             TTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTC------------
T ss_pred             CCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHHcCC------------
Confidence            5443333334557889999999999999999999999999999999 999998644322211110000            


Q ss_pred             hcccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCC
Q 012765          375 ADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQLLRGEG  415 (457)
Q Consensus       375 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~  415 (457)
                      ...........+..++.+||+.||.+||++.+|++.|+.+.
T Consensus       237 ~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~  277 (327)
T 3poz_A          237 RLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMA  277 (327)
T ss_dssp             CCCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHH
T ss_pred             CCCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence            00011112235677889999999999999999999997754

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=2.8e-45  Score=367.66  Aligned_cols=258  Identities=22%  Similarity=0.362  Sum_probs=205.8

Q ss_pred             hcCCCCCceecccCcEEEEEEEe--------CCCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhc-CCCCcceeeeeee
Q 012765          141 TDNFNSENLIGKGGHAEVYKGCL--------PDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHI-NHPNAAKLIGFST  211 (457)
Q Consensus       141 ~~~f~~~~~LG~G~~g~Vy~~~~--------~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~  211 (457)
                      .++|.+.+.||+|+||.||+|.+        .++..||+|++....  .......+.+|+.++..+ +||||+++++++.
T Consensus        80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~  157 (370)
T 2psq_A           80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLLGACT  157 (370)
T ss_dssp             GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTC--BHHHHHHHHHHHHHHHHSCCCTTBCCEEEEEC
T ss_pred             HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCc--CHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEc
Confidence            46788899999999999999975        235679999986543  234567899999999999 8999999999765


Q ss_pred             c-CceEEEEEecCCCChhhhhhcCC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcE
Q 012765          212 E-NGFHLVLQFLPHGSLSSLLFGST---------------ECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNI  275 (457)
Q Consensus       212 ~-~~~~lv~e~~~~gsL~~~l~~~~---------------~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NI  275 (457)
                      . +.+++||||+++|+|.+++....               ..+++..++.++.||+.||.|||+   .+|+||||||+||
T Consensus       158 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NI  234 (370)
T 2psq_A          158 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS---QKCIHRDLAARNV  234 (370)
T ss_dssp             SSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGE
T ss_pred             cCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh---CCeeccccchhhE
Confidence            5 45789999999999999996533               357899999999999999999999   8999999999999


Q ss_pred             EEcCCCcEEEeeccccccCCCCCCceeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHh-CCCCCCcCCcchh
Q 012765          276 LLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELIT-GRRAVDSRRQSLV  354 (457)
Q Consensus       276 ll~~~~~~kL~DFGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLlt-G~~pf~~~~~~~~  354 (457)
                      |++.++.+||+|||+++.+.............+|+.|+|||++.+..++.++|||||||++|||++ |..||........
T Consensus       235 ll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~~  314 (370)
T 2psq_A          235 LVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL  314 (370)
T ss_dssp             EECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH
T ss_pred             EECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHHH
Confidence            999999999999999987755433222333457889999999999999999999999999999999 9999986433221


Q ss_pred             hhhccccccCCcccccCchhhcccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCC
Q 012765          355 IWAKPLLQTSNFKELVDPRLADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQLLRGEG  415 (457)
Q Consensus       355 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~  415 (457)
                      ....   ....     .+....    .....+.+++.+||+.||.+||++.||++.|+.+.
T Consensus       315 ~~~~---~~~~-----~~~~~~----~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il  363 (370)
T 2psq_A          315 FKLL---KEGH-----RMDKPA----NCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL  363 (370)
T ss_dssp             HHHH---HTTC-----CCCCCT----TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHHH---hcCC-----CCCCCC----CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence            1110   0000     011111    12235677889999999999999999999998753

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=8e-45  Score=354.86  Aligned_cols=260  Identities=25%  Similarity=0.424  Sum_probs=206.7

Q ss_pred             hcCCCCCceecccCcEEEEEEEeC-CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeec-CceEEE
Q 012765          141 TDNFNSENLIGKGGHAEVYKGCLP-DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTE-NGFHLV  218 (457)
Q Consensus       141 ~~~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-~~~~lv  218 (457)
                      .++|.+.+.||+|+||+||+|.+. +++.||+|++....   ......+.+|+.+++.++||||+++++++.+ +..++|
T Consensus         9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~---~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv   85 (310)
T 3s95_A            9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFD---EETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFI   85 (310)
T ss_dssp             GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCC---HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCC---HHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEE
Confidence            467888999999999999999875 58999999885432   3445689999999999999999999997655 457899


Q ss_pred             EEecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCCCCC
Q 012765          219 LQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNW  298 (457)
Q Consensus       219 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~~~  298 (457)
                      |||+.+++|.+++......+++..++.++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||++.......
T Consensus        86 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  162 (310)
T 3s95_A           86 TEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHS---MNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEK  162 (310)
T ss_dssp             EECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSTTSEEECTTSCEEECCCTTCEECC---
T ss_pred             EEecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCCcCeEEECCCCCEEEeecccceeccccc
Confidence            99999999999998777789999999999999999999999   899999999999999999999999999998765432


Q ss_pred             Cce------------eeecccccccccChhccccCCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhccccccCCc
Q 012765          299 SHH------------IVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSNF  366 (457)
Q Consensus       299 ~~~------------~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~~~~~~~~~  366 (457)
                      ...            ......||+.|+|||++.+..++.++||||||+++|||++|..||............      ..
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~------~~  236 (310)
T 3s95_A          163 TQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGL------NV  236 (310)
T ss_dssp             -----------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSB------CH
T ss_pred             ccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhh------hh
Confidence            211            111456999999999999999999999999999999999999998753322111100      00


Q ss_pred             ccccCchhhcccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCCC
Q 012765          367 KELVDPRLADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQLLRGEGG  416 (457)
Q Consensus       367 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~  416 (457)
                      ....+.....    .....+.+++.+||+.||++|||+.+|++.|+.+..
T Consensus       237 ~~~~~~~~~~----~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~  282 (310)
T 3s95_A          237 RGFLDRYCPP----NCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRM  282 (310)
T ss_dssp             HHHHHHTCCT----TCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             hccccccCCC----CCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence            1111111111    112346678899999999999999999999988753

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=1.4e-45  Score=362.60  Aligned_cols=266  Identities=27%  Similarity=0.322  Sum_probs=204.7

Q ss_pred             hhcCCCCCceecccCcEEEEEEEeCCCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeecCc-----
Q 012765          140 ATDNFNSENLIGKGGHAEVYKGCLPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTENG-----  214 (457)
Q Consensus       140 ~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~-----  214 (457)
                      ..++|.+.+.||+|+||+||+|.+ .++.||||++.....    ....+..|+.++.+++||||+++++++....     
T Consensus        22 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~   96 (322)
T 3soc_A           22 QSMPLQLLEVKARGRFGCVWKAQL-LNEYVAVKIFPIQDK----QSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVD   96 (322)
T ss_dssp             TTEEEEEEEEEECSTTCEEEEEEE-TTEEEEEEEECGGGH----HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEE
T ss_pred             chhhchhhheecccCceEEEEEEE-CCCEEEEEEeecCch----HHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCce
Confidence            346788999999999999999987 479999999854322    2335566999999999999999999766533     


Q ss_pred             eEEEEEecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCC----------CeeeCCCCCCcEEEcCCCcEE
Q 012765          215 FHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHR----------RIIHRDIKASNILLSEDYEAQ  284 (457)
Q Consensus       215 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~----------~iiHrDlkp~NIll~~~~~~k  284 (457)
                      +++||||+++|+|.+++..  ..+++..++.++.||+.||.|||+   .          +|+||||||+|||++.++.+|
T Consensus        97 ~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~i~~qi~~al~~LH~---~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~k  171 (322)
T 3soc_A           97 LWLITAFHEKGSLSDFLKA--NVVSWNELCHIAETMARGLAYLHE---DIPGLKDGHKPAISHRDIKSKNVLLKNNLTAC  171 (322)
T ss_dssp             EEEEEECCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHTC---CEEEETTEEECEEECSCCSGGGEEECTTCCEE
T ss_pred             EEEEEecCCCCCHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHh---hccccccccCCCEEeCCCChHhEEECCCCeEE
Confidence            5899999999999999955  348999999999999999999999   7          999999999999999999999


Q ss_pred             EeeccccccCCCCCCceeeecccccccccChhccccC-----CCCcchhHHHHHHHHHHHHhCCCCCCcCCcchh-hhhc
Q 012765          285 ISDFGLAKWLPDNWSHHIVFPIEGTFGYLSPEYFMHG-----IVDEKTDVFAFGVLLLELITGRRAVDSRRQSLV-IWAK  358 (457)
Q Consensus       285 L~DFGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~-~~~~  358 (457)
                      |+|||+++.+.............||+.|+|||++.+.     .++.++|||||||++|||+||+.||........ .+..
T Consensus       172 L~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~  251 (322)
T 3soc_A          172 IADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEE  251 (322)
T ss_dssp             ECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHH
T ss_pred             EccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhh
Confidence            9999999877554433333345699999999999763     456788999999999999999999986332111 1110


Q ss_pred             cccccCCcc--------cccCchhhccc-CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCC
Q 012765          359 PLLQTSNFK--------ELVDPRLADAY-DLAEMKRAMLTASVCIHHLSTMRPQMTRVLQLLRGEG  415 (457)
Q Consensus       359 ~~~~~~~~~--------~~~d~~l~~~~-~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~  415 (457)
                      .........        ....+.+.... .......+.+++.+||+.||++|||+.||++.|+.+.
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~  317 (322)
T 3soc_A          252 EIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQ  317 (322)
T ss_dssp             HHCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             hhccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence            000011100        01111111111 1234566889999999999999999999999998764

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=2.2e-45  Score=359.32  Aligned_cols=266  Identities=27%  Similarity=0.449  Sum_probs=201.3

Q ss_pred             HhhcCCCCCceecccCcEEEEEEEeCCCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeec-CceEE
Q 012765          139 AATDNFNSENLIGKGGHAEVYKGCLPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTE-NGFHL  217 (457)
Q Consensus       139 ~~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-~~~~l  217 (457)
                      ...++|.+.+.||+|+||+||+|.+ +|+.||+|++..... .......+.+|+.++++++||||+++++++.. +..++
T Consensus        34 i~~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l  111 (309)
T 3p86_A           34 IPWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDF-HAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSI  111 (309)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCC-SHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEE
T ss_pred             CChhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEE
Confidence            3467888999999999999999987 688999999865433 33446789999999999999999999997655 45789


Q ss_pred             EEEecCCCChhhhhhcCCC--CCCHHHHHHHHHHHHHHHHHHHhcCCCC--eeeCCCCCCcEEEcCCCcEEEeecccccc
Q 012765          218 VLQFLPHGSLSSLLFGSTE--CLEWTIRYKIALGIAEGLQYLHHDCHRR--IIHRDIKASNILLSEDYEAQISDFGLAKW  293 (457)
Q Consensus       218 v~e~~~~gsL~~~l~~~~~--~~~~~~~~~i~~qia~aL~yLH~~~~~~--iiHrDlkp~NIll~~~~~~kL~DFGl~~~  293 (457)
                      ||||+.+|+|.+++.....  .+++..++.++.||+.||.|||+   .+  |+||||||+|||++.++.+||+|||+++.
T Consensus       112 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~  188 (309)
T 3p86_A          112 VTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHN---RNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRL  188 (309)
T ss_dssp             EEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHT---SSSCCCCTTCCGGGEEECTTCCEEECCCC----
T ss_pred             EEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHc---CCCCEECCCCChhhEEEeCCCcEEECCCCCCcc
Confidence            9999999999999965432  38999999999999999999999   78  99999999999999999999999999976


Q ss_pred             CCCCCCceeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhccccccCCcccccCch
Q 012765          294 LPDNWSHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSNFKELVDPR  373 (457)
Q Consensus       294 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~  373 (457)
                      ......  ......||+.|+|||++.+..++.++|||||||++|||++|+.||................       ....
T Consensus       189 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~-------~~~~  259 (309)
T 3p86_A          189 KASTFL--SSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKC-------KRLE  259 (309)
T ss_dssp             ---------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHSC-------CCCC
T ss_pred             cccccc--ccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcC-------CCCC
Confidence            544321  1223568999999999999999999999999999999999999998654332221110000       0011


Q ss_pred             hhcccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCCCCCCCCC
Q 012765          374 LADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQLLRGEGGQTDLKP  422 (457)
Q Consensus       374 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~~~~~~  422 (457)
                      +...++    ..+.+++.+||+.||.+|||+.+|++.|+.+.....+++
T Consensus       260 ~~~~~~----~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~~p~~  304 (309)
T 3p86_A          260 IPRNLN----PQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAVPPP  304 (309)
T ss_dssp             CCTTSC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC------
T ss_pred             CCccCC----HHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhCCCCC
Confidence            111222    346778899999999999999999999998866554444

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=5.5e-45  Score=358.99  Aligned_cols=259  Identities=24%  Similarity=0.360  Sum_probs=205.7

Q ss_pred             hcCCCCCceecccCcEEEEEEEeC----CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeecC-ce
Q 012765          141 TDNFNSENLIGKGGHAEVYKGCLP----DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTEN-GF  215 (457)
Q Consensus       141 ~~~f~~~~~LG~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~-~~  215 (457)
                      .++|.+.+.||+|+||+||+|.+.    .+..||||++.....  ......+.+|+.+++.++||||+++++++.++ ..
T Consensus        48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  125 (325)
T 3kul_A           48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYT--ERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLA  125 (325)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCC--HHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCC
T ss_pred             hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCC--HHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCcc
Confidence            467888999999999999999874    345699999865432  34456899999999999999999999977654 46


Q ss_pred             EEEEEecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCC
Q 012765          216 HLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLP  295 (457)
Q Consensus       216 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~  295 (457)
                      ++||||+.+++|.+++......+++..++.++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||+++...
T Consensus       126 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~  202 (325)
T 3kul_A          126 MIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSD---LGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLE  202 (325)
T ss_dssp             EEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCSSCEECC
T ss_pred             EEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCcceEEECCCCCEEECCCCcccccc
Confidence            89999999999999997776779999999999999999999999   899999999999999999999999999998775


Q ss_pred             CCCCc-eeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHh-CCCCCCcCCcchhhhhccccccCCcccccCch
Q 012765          296 DNWSH-HIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELIT-GRRAVDSRRQSLVIWAKPLLQTSNFKELVDPR  373 (457)
Q Consensus       296 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLlt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~  373 (457)
                      ..... .......+|+.|+|||++.+..++.++|||||||++|||++ |..||............  ....      .. 
T Consensus       203 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~--~~~~------~~-  273 (325)
T 3kul_A          203 DDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSV--EEGY------RL-  273 (325)
T ss_dssp             ----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHH--HTTC------CC-
T ss_pred             cCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHH--HcCC------CC-
Confidence            54222 12223346788999999998999999999999999999999 99999764432221110  0000      00 


Q ss_pred             hhcccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCCC
Q 012765          374 LADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQLLRGEGG  416 (457)
Q Consensus       374 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~  416 (457)
                         .........+.+++..||+.||.+|||+.+|++.|+.+..
T Consensus       274 ---~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~  313 (325)
T 3kul_A          274 ---PAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIR  313 (325)
T ss_dssp             ---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ---CCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence               0111223457788999999999999999999999988753

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=4e-44  Score=342.24  Aligned_cols=258  Identities=23%  Similarity=0.366  Sum_probs=209.1

Q ss_pred             hhcCCCCCceecccCcEEEEEEEeCCCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeecC-ceEEE
Q 012765          140 ATDNFNSENLIGKGGHAEVYKGCLPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTEN-GFHLV  218 (457)
Q Consensus       140 ~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~-~~~lv  218 (457)
                      ..++|.+.+.||+|+||.||+|.+.++..||+|++......    ...+.+|+.++..++||||+++++++.+. ..++|
T Consensus         6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv   81 (268)
T 3sxs_A            6 KREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMS----EDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIV   81 (268)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTBC----HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEE
T ss_pred             chhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCCc----HHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEE
Confidence            34678899999999999999999888889999998654432    24688999999999999999999977654 57899


Q ss_pred             EEecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCCCCC
Q 012765          219 LQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNW  298 (457)
Q Consensus       219 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~~~  298 (457)
                      |||+++++|.+++......+++..++.++.|++.||.|||+   .+|+||||||+||+++.++.+||+|||++.......
T Consensus        82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~  158 (268)
T 3sxs_A           82 TEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLES---HQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQ  158 (268)
T ss_dssp             EECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHH---TTEEESSCSGGGEEECTTCCEEECCTTCEEECCTTC
T ss_pred             EEccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCcCcceEEECCCCCEEEccCccceecchhh
Confidence            99999999999997766679999999999999999999999   899999999999999999999999999998775543


Q ss_pred             CceeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHh-CCCCCCcCCcchhhhhccccccCCcccccCchhhcc
Q 012765          299 SHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELIT-GRRAVDSRRQSLVIWAKPLLQTSNFKELVDPRLADA  377 (457)
Q Consensus       299 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLlt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~  377 (457)
                      .. ......+|+.|+|||++.+..++.++||||||+++|+|++ |+.||................     ....+   ..
T Consensus       159 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~-----~~~~~---~~  229 (268)
T 3sxs_A          159 YV-SSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGH-----RLYRP---HL  229 (268)
T ss_dssp             EE-ECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTC-----CCCCC---TT
T ss_pred             hh-cccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHcCC-----CCCCC---Cc
Confidence            22 2233446778999999998899999999999999999999 999998644332221110000     00111   11


Q ss_pred             cCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCCCC
Q 012765          378 YDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQLLRGEGGQ  417 (457)
Q Consensus       378 ~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~  417 (457)
                      .    ...+.+++.+||+.||.+|||+.++++.|+.+...
T Consensus       230 ~----~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~  265 (268)
T 3sxs_A          230 A----SDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLREK  265 (268)
T ss_dssp             S----CHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC-
T ss_pred             C----hHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhhc
Confidence            1    23567788999999999999999999999988654

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=5.6e-45  Score=362.95  Aligned_cols=268  Identities=25%  Similarity=0.380  Sum_probs=211.5

Q ss_pred             ccHHHHHHhhcCCCCCceecccCcEEEEEEEe------CCCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhc-CCCCcc
Q 012765          132 FDFAELAAATDNFNSENLIGKGGHAEVYKGCL------PDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHI-NHPNAA  204 (457)
Q Consensus       132 ~~~~~~~~~~~~f~~~~~LG~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv  204 (457)
                      ++........++|.+.+.||+|+||.||+|.+      .+++.||||++.....  ......+.+|+.++.++ +||||+
T Consensus        12 ~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~~hpniv   89 (359)
T 3vhe_A           12 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT--HSEHRALMSELKILIHIGHHLNVV   89 (359)
T ss_dssp             CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCC--HHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred             CCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCC--HHHHHHHHHHHHHHHhhcCCccee
Confidence            34455556788999999999999999999973      2468999999865433  23456899999999999 799999


Q ss_pred             eeeeeeecC-c-eEEEEEecCCCChhhhhhcCCC----------------------------------------------
Q 012765          205 KLIGFSTEN-G-FHLVLQFLPHGSLSSLLFGSTE----------------------------------------------  236 (457)
Q Consensus       205 ~l~~~~~~~-~-~~lv~e~~~~gsL~~~l~~~~~----------------------------------------------  236 (457)
                      ++++++.+. . .++||||+++|+|.+++.....                                              
T Consensus        90 ~~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  169 (359)
T 3vhe_A           90 NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVE  169 (359)
T ss_dssp             CEEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC----------------------------------------
T ss_pred             eeeeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccccc
Confidence            999977653 3 7899999999999999965432                                              


Q ss_pred             -------------------CCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCCCC
Q 012765          237 -------------------CLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDN  297 (457)
Q Consensus       237 -------------------~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~~  297 (457)
                                         .+++..++.++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||++..+...
T Consensus       170 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~---~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~  246 (359)
T 3vhe_A          170 EKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKD  246 (359)
T ss_dssp             --------------CTTTTCBCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSC
T ss_pred             ccccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChhhEEEcCCCcEEEEeccceeeeccc
Confidence                               28899999999999999999999   89999999999999999999999999999877554


Q ss_pred             CCceeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHh-CCCCCCcCCcchhhhhccccccCCcccccCchhhc
Q 012765          298 WSHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELIT-GRRAVDSRRQSLVIWAKPLLQTSNFKELVDPRLAD  376 (457)
Q Consensus       298 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLlt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  376 (457)
                      ..........||+.|+|||++.+..++.++|||||||++|||+| |..||.............  ....     ......
T Consensus       247 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~--~~~~-----~~~~~~  319 (359)
T 3vhe_A          247 PDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRL--KEGT-----RMRAPD  319 (359)
T ss_dssp             TTCEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHH--HHTC-----CCCCCT
T ss_pred             ccchhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHH--HcCC-----CCCCCC
Confidence            44334445568999999999999999999999999999999998 999998644322111110  0000     011111


Q ss_pred             ccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCC
Q 012765          377 AYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQLLRGEG  415 (457)
Q Consensus       377 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~  415 (457)
                      .+    ...+.+++.+||+.||.+|||+.||++.|+.+.
T Consensus       320 ~~----~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~  354 (359)
T 3vhe_A          320 YT----TPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL  354 (359)
T ss_dssp             TC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             CC----CHHHHHHHHHHccCChhhCCCHHHHHHHHHHHH
Confidence            11    234677889999999999999999999998753

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=9e-45  Score=357.23  Aligned_cols=259  Identities=21%  Similarity=0.345  Sum_probs=204.2

Q ss_pred             hcCCCCCceecccCcEEEEEEEeC-CCcE----EEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeecCce
Q 012765          141 TDNFNSENLIGKGGHAEVYKGCLP-DGEV----VAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTENGF  215 (457)
Q Consensus       141 ~~~f~~~~~LG~G~~g~Vy~~~~~-~~~~----vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~  215 (457)
                      .++|.+.+.||+|+||+||+|.+. +++.    ||+|.+......  .....+.+|+.++..++||||+++++++.++..
T Consensus        12 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~   89 (325)
T 3kex_A           12 ETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGR--QSFQAVTDHMLAIGSLDHAHIVRLLGLCPGSSL   89 (325)
T ss_dssp             TTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSC--SCBCSCCHHHHHHHTCCCTTBCCEEEEECBSSE
T ss_pred             HhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccH--HHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCcc
Confidence            367888999999999999999864 4554    777766433211  223467789999999999999999999998899


Q ss_pred             EEEEEecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCC
Q 012765          216 HLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLP  295 (457)
Q Consensus       216 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~  295 (457)
                      ++||||+.+|+|.+++......+++..++.++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||+++.+.
T Consensus        90 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~  166 (325)
T 3kex_A           90 QLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEE---HGMVHRNLAARNVLLKSPSQVQVADFGVADLLP  166 (325)
T ss_dssp             EEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHH---TTCCCSCCSSTTEEESSSSCEEECSCSGGGGSC
T ss_pred             EEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHh---CCCCCCccchheEEECCCCeEEECCCCcccccC
Confidence            99999999999999997766678999999999999999999999   899999999999999999999999999999876


Q ss_pred             CCCCceeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHh-CCCCCCcCCcchhhhhccccccCCcccccCchh
Q 012765          296 DNWSHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELIT-GRRAVDSRRQSLVIWAKPLLQTSNFKELVDPRL  374 (457)
Q Consensus       296 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLlt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l  374 (457)
                      ............||..|+|||++.+..++.++|||||||++|||+| |..||.......................     
T Consensus       167 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~-----  241 (325)
T 3kex_A          167 PDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGERLAQPQI-----  241 (325)
T ss_dssp             CCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHTTCBCCCCTT-----
T ss_pred             cccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCCCCCCc-----
Confidence            5544433445568889999999999999999999999999999999 9999986443222111110000111111     


Q ss_pred             hcccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCCC
Q 012765          375 ADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQLLRGEGG  416 (457)
Q Consensus       375 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~  416 (457)
                             ....+..++.+||+.||.+||++.+|++.|+.+..
T Consensus       242 -------~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~  276 (325)
T 3kex_A          242 -------CTIDVYMVMVKCWMIDENIRPTFKELANEFTRMAR  276 (325)
T ss_dssp             -------BCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTT
T ss_pred             -------CcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence                   11134568888999999999999999999987643

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=7e-44  Score=346.61  Aligned_cols=250  Identities=21%  Similarity=0.360  Sum_probs=201.1

Q ss_pred             hhcCCCCCceecccCcEEEEEEEe-CCCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeee-cCceEE
Q 012765          140 ATDNFNSENLIGKGGHAEVYKGCL-PDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFST-ENGFHL  217 (457)
Q Consensus       140 ~~~~f~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~-~~~~~l  217 (457)
                      ..++|++.+.||+|+||+||+|.+ .+++.||+|++.......   ...+.+|+.+++.++||||+++++++. .+..++
T Consensus        18 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~---~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l   94 (297)
T 3fxz_A           18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK---KELIINEILVMRENKNPNIVNYLDSYLVGDELWV   94 (297)
T ss_dssp             GGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSC---HHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred             hhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccH---HHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEE
Confidence            346899999999999999999985 468999999986543332   346889999999999999999999655 455789


Q ss_pred             EEEecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCCCC
Q 012765          218 VLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDN  297 (457)
Q Consensus       218 v~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~~  297 (457)
                      ||||+.+|+|.+++...  .+++..++.++.|++.||.|||+   .+|+||||||+|||++.++.+||+|||++......
T Consensus        95 v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  169 (297)
T 3fxz_A           95 VMEYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE  169 (297)
T ss_dssp             EEECCTTCBHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECCST
T ss_pred             EEECCCCCCHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHh---CCceeCCCCHHHEEECCCCCEEEeeCCCceecCCc
Confidence            99999999999998543  58899999999999999999999   89999999999999999999999999999876544


Q ss_pred             CCceeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhccccccCCcccccCchhhcc
Q 012765          298 WSHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSNFKELVDPRLADA  377 (457)
Q Consensus       298 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~  377 (457)
                      ...  .....||+.|+|||++.+..++.++|||||||++|||++|..||.........+........   ....+   ..
T Consensus       170 ~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~---~~~~~---~~  241 (297)
T 3fxz_A          170 QSK--RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTP---ELQNP---EK  241 (297)
T ss_dssp             TCC--BCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSC---CCSCG---GG
T ss_pred             ccc--cCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC---CCCCc---cc
Confidence            322  23456999999999999999999999999999999999999999865433222111100000   00011   11


Q ss_pred             cCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 012765          378 YDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQ  409 (457)
Q Consensus       378 ~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~  409 (457)
                          ....+.+++.+||+.||.+|||+.|+++
T Consensus       242 ----~~~~~~~li~~~l~~dp~~Rps~~ell~  269 (297)
T 3fxz_A          242 ----LSAIFRDFLNRCLEMDVEKRGSAKELLQ  269 (297)
T ss_dssp             ----SCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             ----cCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence                1234667889999999999999999986

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=8.8e-44  Score=345.32  Aligned_cols=265  Identities=23%  Similarity=0.314  Sum_probs=207.9

Q ss_pred             hhcCCCCCceecccCcEEEEEEEeC-CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeecCc-eEE
Q 012765          140 ATDNFNSENLIGKGGHAEVYKGCLP-DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTENG-FHL  217 (457)
Q Consensus       140 ~~~~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~-~~l  217 (457)
                      ..++|.+.+.||+|+||.||+|.+. +++.||+|.+.............+.+|+.++..++||||+++++++..++ .++
T Consensus         9 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l   88 (294)
T 4eqm_A            9 INERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYL   88 (294)
T ss_dssp             EETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEE
T ss_pred             hhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEE
Confidence            3578999999999999999999864 68999999987665555666788999999999999999999999776654 689


Q ss_pred             EEEecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCCCC
Q 012765          218 VLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDN  297 (457)
Q Consensus       218 v~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~~  297 (457)
                      ||||+++++|.+++... ..+++..++.++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||++......
T Consensus        89 v~e~~~g~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  164 (294)
T 4eqm_A           89 VMEYIEGPTLSEYIESH-GPLSVDTAINFTNQILDGIKHAHD---MRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSET  164 (294)
T ss_dssp             EEECCCSCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCSSSTTC---
T ss_pred             EEeCCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEEeCCCccccccc
Confidence            99999999999998643 358999999999999999999999   89999999999999999999999999999876543


Q ss_pred             CCceeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhccccccCCcccccCchhhcc
Q 012765          298 WSHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSNFKELVDPRLADA  377 (457)
Q Consensus       298 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~  377 (457)
                      ... ......||+.|+|||++.+..++.++||||||+++|+|++|+.||.................        +.....
T Consensus       165 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~--------~~~~~~  235 (294)
T 4eqm_A          165 SLT-QTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSV--------PNVTTD  235 (294)
T ss_dssp             -----------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSSCC--------CCHHHH
T ss_pred             ccc-ccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhccC--------CCcchh
Confidence            211 12234589999999999999999999999999999999999999986543222111100000        111111


Q ss_pred             cCHHHHHHHHHHHHHhcccCCCCCC-CHHHHHHHHhcCCCC
Q 012765          378 YDLAEMKRAMLTASVCIHHLSTMRP-QMTRVLQLLRGEGGQ  417 (457)
Q Consensus       378 ~~~~~~~~l~~l~~~Cl~~dP~~RP-t~~evl~~L~~~~~~  417 (457)
                      ........+.+++.+||+.||.+|| ++.++.+.|+.....
T Consensus       236 ~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~  276 (294)
T 4eqm_A          236 VRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHE  276 (294)
T ss_dssp             SCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSS
T ss_pred             cccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhh
Confidence            1112234577889999999999999 899999999887543

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=3.3e-44  Score=347.12  Aligned_cols=263  Identities=29%  Similarity=0.417  Sum_probs=198.9

Q ss_pred             hhcCCCCCceecccCcEEEEEEEeCCCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeecCceEEEE
Q 012765          140 ATDNFNSENLIGKGGHAEVYKGCLPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTENGFHLVL  219 (457)
Q Consensus       140 ~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~lv~  219 (457)
                      ..++|++.+.||+|+||+||+|.+.  ..+|+|++..... .......+.+|+.+++.++||||+++++++.....++||
T Consensus        22 ~~~~y~~~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~lv~   98 (289)
T 3og7_A           22 PDGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAP-TPQQLQAFKNEVGVLRKTRHVNILLFMGYSTAPQLAIVT   98 (289)
T ss_dssp             CTTSCEEEEEEEECSSEEEEEEESS--SEEEEEEESCSSC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSCEEEE
T ss_pred             CccceeeeeEecCCCCeEEEEEEEc--CceEEEEEeccCC-CHHHHHHHHHHHHHHHhCCCCcEEEEEeeccCCccEEEE
Confidence            4578999999999999999999863  3599998865433 334567899999999999999999999999888899999


Q ss_pred             EecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCCCCCC
Q 012765          220 QFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWS  299 (457)
Q Consensus       220 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~~~~  299 (457)
                      ||+.+++|.+++......+++..++.++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||++........
T Consensus        99 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~---~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  175 (289)
T 3og7_A           99 QWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHA---KSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSG  175 (289)
T ss_dssp             ECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEETTTEEEECCCC----------
T ss_pred             EecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHh---CCcccccCccceEEECCCCCEEEccceeccccccccc
Confidence            9999999999997777789999999999999999999999   8999999999999999999999999999986644322


Q ss_pred             ceeeecccccccccChhccc---cCCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhccccccCCcccccCchhhc
Q 012765          300 HHIVFPIEGTFGYLSPEYFM---HGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSNFKELVDPRLAD  376 (457)
Q Consensus       300 ~~~~~~~~gt~~y~aPE~~~---~~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  376 (457)
                      ........||+.|+|||++.   +..++.++||||||+++|+|++|+.||............  ......    .+.+..
T Consensus       176 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~--~~~~~~----~~~~~~  249 (289)
T 3og7_A          176 SHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEM--VGRGSL----SPDLSK  249 (289)
T ss_dssp             --------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHH--HHHTSC----CCCTTS
T ss_pred             cccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHH--hccccc----Ccchhh
Confidence            22333456999999999986   567889999999999999999999999864332211110  000000    011100


Q ss_pred             ccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCC
Q 012765          377 AYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQLLRGEG  415 (457)
Q Consensus       377 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~  415 (457)
                       ........+.+++.+||+.+|.+|||+.+|++.|+.+.
T Consensus       250 -~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~  287 (289)
T 3og7_A          250 -VRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELA  287 (289)
T ss_dssp             -SCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred             -ccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHh
Confidence             01112345778889999999999999999999999875

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=2.1e-45  Score=369.37  Aligned_cols=259  Identities=24%  Similarity=0.334  Sum_probs=206.2

Q ss_pred             hhcCCCCCceecccCcEEEEEEEeC-CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeecC-ceEE
Q 012765          140 ATDNFNSENLIGKGGHAEVYKGCLP-DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTEN-GFHL  217 (457)
Q Consensus       140 ~~~~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~-~~~l  217 (457)
                      ..++|.+.+.||+|+||.||+|.+. +++.||+|.+....  .......+.+|+.+++.++||||+++++++... ..++
T Consensus       112 ~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l  189 (377)
T 3cbl_A          112 NHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETL--PPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYI  189 (377)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTS--CHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred             chHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccC--CHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEE
Confidence            4567888999999999999999976 68999999886442  234456789999999999999999999977654 5789


Q ss_pred             EEEecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCCCC
Q 012765          218 VLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDN  297 (457)
Q Consensus       218 v~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~~  297 (457)
                      ||||+++|+|.+++......+++..++.++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||+++.....
T Consensus       190 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~  266 (377)
T 3cbl_A          190 VMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLES---KCCIHRDLAARNCLVTEKNVLKISDFGMSREEADG  266 (377)
T ss_dssp             EEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCGGGCEECTTS
T ss_pred             EEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCcCCcccCHHHEEEcCCCcEEECcCCCceecCCC
Confidence            999999999999997666678999999999999999999999   89999999999999999999999999999865443


Q ss_pred             CCceeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHh-CCCCCCcCCcchhhhhccccccCCcccccCchhhc
Q 012765          298 WSHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELIT-GRRAVDSRRQSLVIWAKPLLQTSNFKELVDPRLAD  376 (457)
Q Consensus       298 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLlt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  376 (457)
                      ..........++..|+|||++.++.++.++|||||||++|||+| |..||............   ....     ......
T Consensus       267 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~---~~~~-----~~~~~~  338 (377)
T 3cbl_A          267 VYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFV---EKGG-----RLPCPE  338 (377)
T ss_dssp             EEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHH---HTTC-----CCCCCT
T ss_pred             ceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH---HcCC-----CCCCCC
Confidence            21111111235678999999998899999999999999999998 99999864432211110   0000     000011


Q ss_pred             ccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCC
Q 012765          377 AYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQLLRGEG  415 (457)
Q Consensus       377 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~  415 (457)
                      .    ....+.+++.+||+.||++|||+.+|++.|+.+.
T Consensus       339 ~----~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~  373 (377)
T 3cbl_A          339 L----CPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIR  373 (377)
T ss_dssp             T----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             C----CCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHH
Confidence            1    1235667889999999999999999999998764

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=3.4e-44  Score=343.10  Aligned_cols=255  Identities=26%  Similarity=0.394  Sum_probs=207.0

Q ss_pred             hcCCCCCceecccCcEEEEEEEeCCCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeec-CceEEEE
Q 012765          141 TDNFNSENLIGKGGHAEVYKGCLPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTE-NGFHLVL  219 (457)
Q Consensus       141 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-~~~~lv~  219 (457)
                      .++|.+.+.||+|+||.||+|.+.+++.||+|++......    ...+.+|+.++++++||||+++++++.+ +..++||
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   84 (269)
T 4hcu_A            9 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS----EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVF   84 (269)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSBC----HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEE
T ss_pred             hhhceeeheecCCCccEEEEEEecCCCeEEEEEecccccC----HHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEE
Confidence            4678889999999999999999888999999998754433    2468899999999999999999997665 4578999


Q ss_pred             EecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCCCCCC
Q 012765          220 QFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWS  299 (457)
Q Consensus       220 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~~~~  299 (457)
                      ||+++++|.+++......+++..++.++.|++.||.|||+   .+|+||||||+||+++.++.+||+|||++........
T Consensus        85 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  161 (269)
T 4hcu_A           85 EFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEE---ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY  161 (269)
T ss_dssp             ECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHH
T ss_pred             EeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHh---CCeecCCcchheEEEcCCCCEEecccccccccccccc
Confidence            9999999999997777779999999999999999999999   8999999999999999999999999999987644311


Q ss_pred             ceeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHh-CCCCCCcCCcchhhhhccccccCCcccccCchhhccc
Q 012765          300 HHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELIT-GRRAVDSRRQSLVIWAKPLLQTSNFKELVDPRLADAY  378 (457)
Q Consensus       300 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLlt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~  378 (457)
                       .......+|+.|+|||++.+..++.++||||||+++|+|++ |+.||............  ...      .........
T Consensus       162 -~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~--~~~------~~~~~~~~~  232 (269)
T 4hcu_A          162 -TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDI--STG------FRLYKPRLA  232 (269)
T ss_dssp             -HSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHH--HTT------CCCCCCTTS
T ss_pred             -ccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHH--hcC------ccCCCCCcC
Confidence             11223446788999999999999999999999999999999 99999864432211111  000      001011111


Q ss_pred             CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCC
Q 012765          379 DLAEMKRAMLTASVCIHHLSTMRPQMTRVLQLLRGEG  415 (457)
Q Consensus       379 ~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~  415 (457)
                          ...+.+++..||+.||.+|||+.++++.|+.+.
T Consensus       233 ----~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~  265 (269)
T 4hcu_A          233 ----STHVYQIMNHCWRERPEDRPAFSRLLRQLAEIA  265 (269)
T ss_dssp             ----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ----CHHHHHHHHHHccCCcccCcCHHHHHHHHHHHH
Confidence                234677889999999999999999999998764

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=1.2e-44  Score=363.43  Aligned_cols=258  Identities=25%  Similarity=0.358  Sum_probs=195.7

Q ss_pred             hcCCCCCceecccCcEEEEEEEeC----CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeecC-ce
Q 012765          141 TDNFNSENLIGKGGHAEVYKGCLP----DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTEN-GF  215 (457)
Q Consensus       141 ~~~f~~~~~LG~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~-~~  215 (457)
                      .++|.+.+.||+|+||.||+|.+.    ++..||||.+....  .......+.+|+.++.+++||||+++++++.+. ..
T Consensus        44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  121 (373)
T 2qol_A           44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGY--TEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPV  121 (373)
T ss_dssp             GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSC
T ss_pred             HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCcc--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCce
Confidence            468999999999999999999864    57789999986543  234456899999999999999999999977654 47


Q ss_pred             EEEEEecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCC
Q 012765          216 HLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLP  295 (457)
Q Consensus       216 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~  295 (457)
                      ++||||+++|+|.+++......+++..++.++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||+++...
T Consensus       122 ~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~  198 (373)
T 2qol_A          122 MIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSD---MGYVHRDLAARNILINSNLVCKVSDFGLGRVLE  198 (373)
T ss_dssp             EEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred             EEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCcceEEEcCCCCEEECcCccccccc
Confidence            89999999999999998777779999999999999999999999   899999999999999999999999999998775


Q ss_pred             CCCCce-eeecccccccccChhccccCCCCcchhHHHHHHHHHHHHh-CCCCCCcCCcchhhhhccccccCCcccccCch
Q 012765          296 DNWSHH-IVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELIT-GRRAVDSRRQSLVIWAKPLLQTSNFKELVDPR  373 (457)
Q Consensus       296 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLlt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~  373 (457)
                      ...... ......+|..|+|||++.+..++.++|||||||++|||++ |+.||............  .          ..
T Consensus       199 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i--~----------~~  266 (373)
T 2qol_A          199 DDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAV--D----------EG  266 (373)
T ss_dssp             ---------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHH--H----------TT
T ss_pred             cCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH--H----------cC
Confidence            432211 1112235778999999999999999999999999999998 99999764332211110  0          00


Q ss_pred             hhcccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCC
Q 012765          374 LADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQLLRGEG  415 (457)
Q Consensus       374 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~  415 (457)
                      ............+.+++.+||+.||.+||++.+|++.|+.+.
T Consensus       267 ~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~  308 (373)
T 2qol_A          267 YRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLI  308 (373)
T ss_dssp             EECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             CCCCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHH
Confidence            000011122345778899999999999999999999998753

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=5.6e-44  Score=352.33  Aligned_cols=249  Identities=24%  Similarity=0.329  Sum_probs=201.5

Q ss_pred             hhcCCCCCceecccCcEEEEEEEe-CCCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeec-CceEE
Q 012765          140 ATDNFNSENLIGKGGHAEVYKGCL-PDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTE-NGFHL  217 (457)
Q Consensus       140 ~~~~f~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-~~~~l  217 (457)
                      ..++|.+.+.||+|+||.||+|.+ .+|+.||+|++..... .......+.+|+.+++.++||||+++++++.. +..++
T Consensus        13 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l   91 (328)
T 3fe3_A           13 HIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQL-NPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYL   91 (328)
T ss_dssp             EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred             ccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEE
Confidence            346889999999999999999986 5799999999875433 33446788999999999999999999997655 45789


Q ss_pred             EEEecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCCCC
Q 012765          218 VLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDN  297 (457)
Q Consensus       218 v~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~~  297 (457)
                      ||||+++|+|.+++... ..+++..+..++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||++......
T Consensus        92 v~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~  167 (328)
T 3fe3_A           92 IMEYASGGEVFDYLVAH-GRMKEKEARSKFRQIVSAVQYCHQ---KRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVG  167 (328)
T ss_dssp             EECCCTTCBHHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSS
T ss_pred             EEECCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHH---CCEeccCCCHHHEEEcCCCCEEEeeccCceecCCC
Confidence            99999999999998654 448899999999999999999999   89999999999999999999999999999876543


Q ss_pred             CCceeeecccccccccChhccccCCCC-cchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhccccccCCcccccCchhhc
Q 012765          298 WSHHIVFPIEGTFGYLSPEYFMHGIVD-EKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSNFKELVDPRLAD  376 (457)
Q Consensus       298 ~~~~~~~~~~gt~~y~aPE~~~~~~~~-~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  376 (457)
                      .   ......||+.|+|||++.+..++ .++|||||||++|+|++|+.||............ ......        +..
T Consensus       168 ~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i-~~~~~~--------~p~  235 (328)
T 3fe3_A          168 G---KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERV-LRGKYR--------IPF  235 (328)
T ss_dssp             C---GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH-HHCCCC--------CCT
T ss_pred             C---ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHH-HhCCCC--------CCC
Confidence            2   23345699999999999888875 7999999999999999999999865432211100 000000        111


Q ss_pred             ccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 012765          377 AYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQ  409 (457)
Q Consensus       377 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~  409 (457)
                      ..    ...+.+++.+||+.||.+|||+.|+++
T Consensus       236 ~~----s~~~~~li~~~L~~dP~~R~t~~eil~  264 (328)
T 3fe3_A          236 YM----STDCENLLKRFLVLNPIKRGTLEQIMK  264 (328)
T ss_dssp             TS----CHHHHHHHHHHCCSSTTTSCCHHHHTT
T ss_pred             CC----CHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence            11    234667889999999999999999987

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=1.4e-44  Score=356.32  Aligned_cols=259  Identities=23%  Similarity=0.380  Sum_probs=200.5

Q ss_pred             hcCCCCCceecccCcEEEEEEEeC-CCcE----EEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeecCce
Q 012765          141 TDNFNSENLIGKGGHAEVYKGCLP-DGEV----VAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTENGF  215 (457)
Q Consensus       141 ~~~f~~~~~LG~G~~g~Vy~~~~~-~~~~----vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~  215 (457)
                      .++|.+.+.||+|+||+||+|.+. +++.    ||+|.+......  .....+.+|+.+++.++||||+++++++..+..
T Consensus        14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~   91 (327)
T 3lzb_A           14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSP--KANKEILDEAYVMASVDNPHVCRLLGICLTSTV   91 (327)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSC--CCHHHHHHHHHHHTTCCBTTBCCCCEEEESSSE
T ss_pred             HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCH--HHHHHHHHHHHHHHhCCCCCeeEEEEEEecCCc
Confidence            467889999999999999999864 4554    466666433222  234578999999999999999999999999899


Q ss_pred             EEEEEecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCC
Q 012765          216 HLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLP  295 (457)
Q Consensus       216 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~  295 (457)
                      +++++|+.+|+|.+++......+++..++.++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||+++...
T Consensus        92 ~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~  168 (327)
T 3lzb_A           92 QLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG  168 (327)
T ss_dssp             EEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEETTEEEECCTTC-----
T ss_pred             eEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhh---CCCcCCCCCHHHEEEcCCCCEEEccCcceeEcc
Confidence            99999999999999998777789999999999999999999999   899999999999999999999999999998775


Q ss_pred             CCCCceeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHh-CCCCCCcCCcchhhhhccccccCCcccccCchh
Q 012765          296 DNWSHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELIT-GRRAVDSRRQSLVIWAKPLLQTSNFKELVDPRL  374 (457)
Q Consensus       296 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLlt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l  374 (457)
                      ............+|+.|+|||++.+..++.++|||||||++|||++ |..||................        ....
T Consensus       169 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~--------~~~~  240 (327)
T 3lzb_A          169 AEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGE--------RLPQ  240 (327)
T ss_dssp             -----------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTC--------CCCC
T ss_pred             CccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCC--------CCCC
Confidence            4433333334457889999999999999999999999999999999 999998644332221110000        0000


Q ss_pred             hcccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCCC
Q 012765          375 ADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQLLRGEGG  416 (457)
Q Consensus       375 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~  416 (457)
                      ...    ....+..++.+||+.||.+||++.||++.|+.+..
T Consensus       241 ~~~----~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~  278 (327)
T 3lzb_A          241 PPI----CTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMAR  278 (327)
T ss_dssp             CTT----BCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHT
T ss_pred             Ccc----CCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence            111    22346778899999999999999999999987653

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=1.7e-44  Score=349.92  Aligned_cols=269  Identities=26%  Similarity=0.375  Sum_probs=203.2

Q ss_pred             hcCCCCCceecccCcEEEEEEEe-----CCCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeec---
Q 012765          141 TDNFNSENLIGKGGHAEVYKGCL-----PDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTE---  212 (457)
Q Consensus       141 ~~~f~~~~~LG~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~---  212 (457)
                      .++|++.+.||+|+||+||+|.+     .+++.||+|++....   ......+.+|+.+++.++||||+++++++..   
T Consensus         9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   85 (295)
T 3ugc_A            9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST---EEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGR   85 (295)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCC---HHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHH
T ss_pred             HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCC---HHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCC
Confidence            46788999999999999999973     368899999986543   2445689999999999999999999997643   


Q ss_pred             CceEEEEEecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccc
Q 012765          213 NGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAK  292 (457)
Q Consensus       213 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~  292 (457)
                      ...++||||+++|+|.+++......+++..++.++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||++.
T Consensus        86 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~  162 (295)
T 3ugc_A           86 RNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGT---KRYIHRDLATRNILVENENRVKIGDFGLTK  162 (295)
T ss_dssp             TSCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECCCCSCC
T ss_pred             CceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhc---CCcccCCCCHhhEEEcCCCeEEEccCcccc
Confidence            44789999999999999997776779999999999999999999999   899999999999999999999999999998


Q ss_pred             cCCCCCCc-eeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhccccccC----Ccc
Q 012765          293 WLPDNWSH-HIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTS----NFK  367 (457)
Q Consensus       293 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~~~~~~~----~~~  367 (457)
                      ........ .......++..|+|||++.+..++.++||||||+++|||+||..||..................    ...
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (295)
T 3ugc_A          163 VLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLI  242 (295)
T ss_dssp             -------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHH
T ss_pred             cccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHH
Confidence            77543221 1222345778899999999999999999999999999999999998753221111100000000    000


Q ss_pred             cccCchhhcccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCC
Q 012765          368 ELVDPRLADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQLLRGEG  415 (457)
Q Consensus       368 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~  415 (457)
                      +.+...............+.+++.+||+.||++|||+.||++.|+.+.
T Consensus       243 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~  290 (295)
T 3ugc_A          243 ELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIR  290 (295)
T ss_dssp             HHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence            000000000011122345778899999999999999999999998764

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=1e-43  Score=342.88  Aligned_cols=256  Identities=28%  Similarity=0.527  Sum_probs=204.5

Q ss_pred             hcCCCCCceecccCcEEEEEEEeC-CCcEEEEEEEeccchhhHHH----HHHHHHHHHHHhhcCCCCcceeeeeeecCce
Q 012765          141 TDNFNSENLIGKGGHAEVYKGCLP-DGEVVAVKKIIKNAKEDEER----ISDFLSELGIVAHINHPNAAKLIGFSTENGF  215 (457)
Q Consensus       141 ~~~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~----~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~  215 (457)
                      .++|.+.+.||+|+||+||+|.+. +++.||+|++..........    ...+.+|+.+++.++||||+++++++.+.. 
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-   96 (287)
T 4f0f_A           18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP-   96 (287)
T ss_dssp             STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT-
T ss_pred             hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC-
Confidence            477889999999999999999864 78999999886543322211    157899999999999999999999887665 


Q ss_pred             EEEEEecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC--eeeCCCCCCcEEEcCCCc-----EEEeec
Q 012765          216 HLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRR--IIHRDIKASNILLSEDYE-----AQISDF  288 (457)
Q Consensus       216 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~--iiHrDlkp~NIll~~~~~-----~kL~DF  288 (457)
                      +++|||+++|+|.+++......+++..++.++.|++.||.|||+   .+  |+||||||+|||++.++.     +||+||
T Consensus        97 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~Df  173 (287)
T 4f0f_A           97 RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQN---QNPPIVHRDLRSPNIFLQSLDENAPVCAKVADF  173 (287)
T ss_dssp             EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHT---SSSCCBCSCCSGGGEEESCCCTTCSCCEEECCC
T ss_pred             eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHh---CCCCeecCCCCcceEEEeccCCCCceeEEeCCC
Confidence            79999999999999998777789999999999999999999999   78  999999999999988776     999999


Q ss_pred             cccccCCCCCCceeeecccccccccChhccc--cCCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhccccccCCc
Q 012765          289 GLAKWLPDNWSHHIVFPIEGTFGYLSPEYFM--HGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSNF  366 (457)
Q Consensus       289 Gl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~~~~~~~~~  366 (457)
                      |+++.....     .....||+.|+|||++.  ...++.++|||||||++|||++|+.||.........+........  
T Consensus       174 g~~~~~~~~-----~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~--  246 (287)
T 4f0f_A          174 GLSQQSVHS-----VSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEG--  246 (287)
T ss_dssp             TTCBCCSSC-----EECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHHSC--
T ss_pred             Ccccccccc-----ccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhccC--
Confidence            999754432     33456999999999984  456789999999999999999999999864433222111111100  


Q ss_pred             ccccCchhhcccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q 012765          367 KELVDPRLADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQLLRGE  414 (457)
Q Consensus       367 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~  414 (457)
                         ..+.+...+    ...+.+++.+||+.||.+|||+.+|++.|+.+
T Consensus       247 ---~~~~~~~~~----~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l  287 (287)
T 4f0f_A          247 ---LRPTIPEDC----PPRLRNVIELCWSGDPKKRPHFSYIVKELSEL  287 (287)
T ss_dssp             ---CCCCCCTTS----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred             ---CCCCCCccc----CHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence               111111122    24567888999999999999999999999864

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=2.6e-44  Score=346.30  Aligned_cols=257  Identities=23%  Similarity=0.333  Sum_probs=197.4

Q ss_pred             hhcCCCCCceecccCcEEEEEEEeCC----CcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeecCce
Q 012765          140 ATDNFNSENLIGKGGHAEVYKGCLPD----GEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTENGF  215 (457)
Q Consensus       140 ~~~~f~~~~~LG~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~  215 (457)
                      ..++|.+.+.||+|+||.||+|.+..    +..||+|.+....  .......+.+|+.+++.++||||+++++++.++..
T Consensus        13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~   90 (281)
T 1mp8_A           13 QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT--SDSVREKFLQEALTMRQFDHPHIVKLIGVITENPV   90 (281)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTT--SHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSC
T ss_pred             ehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCccceEEEEEccCcc
Confidence            35678899999999999999998643    4579999875432  23445689999999999999999999999888889


Q ss_pred             EEEEEecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCC
Q 012765          216 HLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLP  295 (457)
Q Consensus       216 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~  295 (457)
                      ++||||+.+++|.+++......+++..++.++.|++.||.|||+   .+|+||||||+|||++.++.+||+|||++....
T Consensus        91 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  167 (281)
T 1mp8_A           91 WIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYME  167 (281)
T ss_dssp             EEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECC--------
T ss_pred             EEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCeecccccHHHEEECCCCCEEECccccccccC
Confidence            99999999999999997766679999999999999999999999   899999999999999999999999999998765


Q ss_pred             CCCCceeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHh-CCCCCCcCCcchhhhhccccccCCcccccCchh
Q 012765          296 DNWSHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELIT-GRRAVDSRRQSLVIWAKPLLQTSNFKELVDPRL  374 (457)
Q Consensus       296 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLlt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l  374 (457)
                      ..... ......+|+.|+|||++.+..++.++|||||||++|||++ |..||............  .. ..     ...+
T Consensus       168 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i--~~-~~-----~~~~  238 (281)
T 1mp8_A          168 DSTYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI--EN-GE-----RLPM  238 (281)
T ss_dssp             ------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHH--HT-TC-----CCCC
T ss_pred             ccccc-ccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHH--Hc-CC-----CCCC
Confidence            43221 1223346789999999998999999999999999999997 99999864432211110  00 00     0001


Q ss_pred             hcccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q 012765          375 ADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQLLRGE  414 (457)
Q Consensus       375 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~  414 (457)
                      ...    ....+.+++.+||+.||.+|||+.+|++.|+.+
T Consensus       239 ~~~----~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~  274 (281)
T 1mp8_A          239 PPN----CPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI  274 (281)
T ss_dssp             CTT----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCC----CCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence            111    224566788999999999999999999999875

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=4e-44  Score=360.71  Aligned_cols=262  Identities=24%  Similarity=0.348  Sum_probs=209.1

Q ss_pred             hhcCCCCCceecccCcEEEEEEEeC--------CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhc-CCCCcceeeeee
Q 012765          140 ATDNFNSENLIGKGGHAEVYKGCLP--------DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHI-NHPNAAKLIGFS  210 (457)
Q Consensus       140 ~~~~f~~~~~LG~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~  210 (457)
                      ..++|.+.+.||+|+||+||+|.+.        .+..||+|++.....  ......+.+|+.+++.+ +||||+++++++
T Consensus        67 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~  144 (382)
T 3tt0_A           67 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDAT--EKDLSDLISEMEMMKMIGKHKNIINLLGAC  144 (382)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCC--HHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             chhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccC--HHHHHHHHHHHHHHHHhcCCchhhhheeee
Confidence            4578889999999999999999852        346799999865432  34467899999999999 999999999976


Q ss_pred             ecC-ceEEEEEecCCCChhhhhhcCC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCc
Q 012765          211 TEN-GFHLVLQFLPHGSLSSLLFGST---------------ECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASN  274 (457)
Q Consensus       211 ~~~-~~~lv~e~~~~gsL~~~l~~~~---------------~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~N  274 (457)
                      ... ..++||||+.+|+|.+++....               ..+++..++.|+.||+.||.|||+   .+|+||||||+|
T Consensus       145 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~N  221 (382)
T 3tt0_A          145 TQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARN  221 (382)
T ss_dssp             CSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGG
T ss_pred             ccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCcce
Confidence            654 5789999999999999996543               358999999999999999999999   899999999999


Q ss_pred             EEEcCCCcEEEeeccccccCCCCCCceeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHh-CCCCCCcCCcch
Q 012765          275 ILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELIT-GRRAVDSRRQSL  353 (457)
Q Consensus       275 Ill~~~~~~kL~DFGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLlt-G~~pf~~~~~~~  353 (457)
                      ||++.++.+||+|||+++...............+|+.|+|||++.+..++.++|||||||++|||++ |..||.......
T Consensus       222 Ill~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~~  301 (382)
T 3tt0_A          222 VLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE  301 (382)
T ss_dssp             EEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH
T ss_pred             EEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence            9999999999999999987755433333334557889999999999999999999999999999999 999998644322


Q ss_pred             hhhhccccccCCcccccCchhhcccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCCCCC
Q 012765          354 VIWAKPLLQTSNFKELVDPRLADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQLLRGEGGQT  418 (457)
Q Consensus       354 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~~  418 (457)
                      .....  ....      .......    ....+.+++.+||+.||++|||+.||++.|+.+....
T Consensus       302 ~~~~~--~~~~------~~~~~~~----~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~  354 (382)
T 3tt0_A          302 LFKLL--KEGH------RMDKPSN----CTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALT  354 (382)
T ss_dssp             HHHHH--HTTC------CCCCCSS----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHS
T ss_pred             HHHHH--HcCC------CCCCCcc----CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHH
Confidence            11100  0000      0111111    2235677889999999999999999999998875443

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=2.1e-44  Score=371.03  Aligned_cols=260  Identities=25%  Similarity=0.373  Sum_probs=210.5

Q ss_pred             HHhhcCCCCCceecccCcEEEEEEEeCCCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeecCceEE
Q 012765          138 AAATDNFNSENLIGKGGHAEVYKGCLPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTENGFHL  217 (457)
Q Consensus       138 ~~~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~l  217 (457)
                      +...++|.+.+.||+|+||+||+|.+.++..||||++......    .+.+.+|+.+++.++||||+++++++..+..++
T Consensus       184 ~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~l  259 (454)
T 1qcf_A          184 EIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMS----VEAFLAEANVMKTLQHDKLVKLHAVVTKEPIYI  259 (454)
T ss_dssp             BCCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTSBC----HHHHHHHHHHHTTCCCTTBCCEEEEECSSSCEE
T ss_pred             eechHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCCcc----HHHHHHHHHHHhhCCCCCEeeEEEEEeCCccEE
Confidence            3456788899999999999999999988899999998754322    457999999999999999999999998888999


Q ss_pred             EEEecCCCChhhhhhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCCC
Q 012765          218 VLQFLPHGSLSSLLFGST-ECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPD  296 (457)
Q Consensus       218 v~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~  296 (457)
                      ||||+.+|+|.+++.... ..+++..++.++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||+++....
T Consensus       260 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~  336 (454)
T 1qcf_A          260 ITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQ---RNYIHRDLRAANILVSASLVCKIADFGLARVIED  336 (454)
T ss_dssp             EECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCSGGGEEECTTCCEEECSTTGGGGBCC
T ss_pred             EEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCCHHHEEECCCCcEEEeeCCCceEcCC
Confidence            999999999999996432 357888999999999999999999   8999999999999999999999999999987643


Q ss_pred             CCCceeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHh-CCCCCCcCCcchhhhhccccccCCcccccCchhh
Q 012765          297 NWSHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELIT-GRRAVDSRRQSLVIWAKPLLQTSNFKELVDPRLA  375 (457)
Q Consensus       297 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLlt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  375 (457)
                      ... .......+|..|+|||++....++.++|||||||++|||+| |+.||............  .....   ...+   
T Consensus       337 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i--~~~~~---~~~~---  407 (454)
T 1qcf_A          337 NEY-TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRAL--ERGYR---MPRP---  407 (454)
T ss_dssp             HHH-HTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHH--HHTCC---CCCC---
T ss_pred             Cce-eccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHH--HcCCC---CCCC---
Confidence            211 11122346788999999998999999999999999999999 99999864432211110  00000   0001   


Q ss_pred             cccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCCCC
Q 012765          376 DAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQLLRGEGGQ  417 (457)
Q Consensus       376 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~  417 (457)
                      .    .....+.+++.+||+.||++|||+.+|++.|+.+...
T Consensus       408 ~----~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~  445 (454)
T 1qcf_A          408 E----NCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTA  445 (454)
T ss_dssp             T----TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSS
T ss_pred             C----CCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHhc
Confidence            1    1224567888999999999999999999999988644

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=1.1e-43  Score=351.08  Aligned_cols=262  Identities=23%  Similarity=0.371  Sum_probs=208.0

Q ss_pred             HhhcCCCCCceecccCcEEEEEEEeC------CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeec
Q 012765          139 AATDNFNSENLIGKGGHAEVYKGCLP------DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTE  212 (457)
Q Consensus       139 ~~~~~f~~~~~LG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~  212 (457)
                      ...++|.+.+.||+|+||.||+|.+.      +++.||+|.+.....  ......+.+|+.+++.++||||+++++++..
T Consensus        44 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~  121 (343)
T 1luf_A           44 YPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEAS--ADMQADFQREAALMAEFDNPNIVKLLGVCAV  121 (343)
T ss_dssp             CCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCC--HHHHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred             ecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccC--HHHHHHHHHHHHHHHhCCCCCEEEEEEEEcc
Confidence            35678999999999999999999864      348899999865432  3445689999999999999999999997655


Q ss_pred             -CceEEEEEecCCCChhhhhhcCC-----------------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeC
Q 012765          213 -NGFHLVLQFLPHGSLSSLLFGST-----------------------ECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHR  268 (457)
Q Consensus       213 -~~~~lv~e~~~~gsL~~~l~~~~-----------------------~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHr  268 (457)
                       +..++||||+++|+|.+++....                       ..+++..++.++.||+.||.|||+   .+|+||
T Consensus       122 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~---~~ivH~  198 (343)
T 1luf_A          122 GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE---RKFVHR  198 (343)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCS
T ss_pred             CCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeecC
Confidence             45789999999999999986532                       568999999999999999999999   899999


Q ss_pred             CCCCCcEEEcCCCcEEEeeccccccCCCCCCceeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHh-CCCCCC
Q 012765          269 DIKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELIT-GRRAVD  347 (457)
Q Consensus       269 Dlkp~NIll~~~~~~kL~DFGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLlt-G~~pf~  347 (457)
                      ||||+|||++.++.+||+|||++................+|+.|+|||++.+..++.++|||||||++|||++ |..||.
T Consensus       199 Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~  278 (343)
T 1luf_A          199 DLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYY  278 (343)
T ss_dssp             CCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTT
T ss_pred             CCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCC
Confidence            9999999999999999999999987644322222234558899999999999999999999999999999999 999998


Q ss_pred             cCCcchhhhhccccccCCcccccCchhhcccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCCCC
Q 012765          348 SRRQSLVIWAKPLLQTSNFKELVDPRLADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQLLRGEGGQ  417 (457)
Q Consensus       348 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~  417 (457)
                      ...........   ......     .....+    ...+.+++.+||+.||.+||++.+|++.|+.+...
T Consensus       279 ~~~~~~~~~~~---~~~~~~-----~~~~~~----~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~  336 (343)
T 1luf_A          279 GMAHEEVIYYV---RDGNIL-----ACPENC----PLELYNLMRLCWSKLPADRPSFCSIHRILQRMCER  336 (343)
T ss_dssp             TSCHHHHHHHH---HTTCCC-----CCCTTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC-
T ss_pred             CCChHHHHHHH---hCCCcC-----CCCCCC----CHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhh
Confidence            64432221111   011110     011112    23567788999999999999999999999988643

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=4.4e-44  Score=349.50  Aligned_cols=259  Identities=26%  Similarity=0.360  Sum_probs=207.0

Q ss_pred             hhcCCCCCceecccCcEEEEEEEe------CCCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeec-
Q 012765          140 ATDNFNSENLIGKGGHAEVYKGCL------PDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTE-  212 (457)
Q Consensus       140 ~~~~f~~~~~LG~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-  212 (457)
                      ..++|.+.+.||+|+||.||+|.+      .+++.||+|++....  .......+.+|+.+++.++||||+++++++.+ 
T Consensus        21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~   98 (314)
T 2ivs_A           21 PRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENA--SPSELRDLLSEFNVLKQVNHPHVIKLYGACSQD   98 (314)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS
T ss_pred             chhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCC--CHHHHHHHHHHHHHHhhCCCCceeeEEEEEecC
Confidence            357788999999999999999975      245889999886543  23446789999999999999999999997655 


Q ss_pred             CceEEEEEecCCCChhhhhhcCC-----------------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCC
Q 012765          213 NGFHLVLQFLPHGSLSSLLFGST-----------------------ECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRD  269 (457)
Q Consensus       213 ~~~~lv~e~~~~gsL~~~l~~~~-----------------------~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrD  269 (457)
                      +..++||||+++++|.+++....                       ..+++..++.++.||+.||.|||+   .+|+|||
T Consensus        99 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~d  175 (314)
T 2ivs_A           99 GPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAE---MKLVHRD  175 (314)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHH---TTEECCC
T ss_pred             CceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHH---CCCcccc
Confidence            45789999999999999996532                       248899999999999999999999   8999999


Q ss_pred             CCCCcEEEcCCCcEEEeeccccccCCCCCCceeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHh-CCCCCCc
Q 012765          270 IKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELIT-GRRAVDS  348 (457)
Q Consensus       270 lkp~NIll~~~~~~kL~DFGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLlt-G~~pf~~  348 (457)
                      |||+|||++.++.+||+|||++................+|+.|+|||++.+..++.++|||||||++|||++ |..||..
T Consensus       176 ikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~  255 (314)
T 2ivs_A          176 LAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPG  255 (314)
T ss_dssp             CSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred             cchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence            999999999999999999999987755433333334457889999999999899999999999999999999 9999986


Q ss_pred             CCcchhhhhccccccCCcccccCchhhcccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCC
Q 012765          349 RRQSLVIWAKPLLQTSNFKELVDPRLADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQLLRGEG  415 (457)
Q Consensus       349 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~  415 (457)
                      ..........   ....     .+.....    ....+.+++.+||+.||.+||++.+|++.|+.+.
T Consensus       256 ~~~~~~~~~~---~~~~-----~~~~~~~----~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~  310 (314)
T 2ivs_A          256 IPPERLFNLL---KTGH-----RMERPDN----CSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMM  310 (314)
T ss_dssp             CCGGGHHHHH---HTTC-----CCCCCTT----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             CCHHHHHHHh---hcCC-----cCCCCcc----CCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence            4432211100   0000     0111111    2245678889999999999999999999998753

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=1.3e-43  Score=344.12  Aligned_cols=258  Identities=24%  Similarity=0.312  Sum_probs=197.4

Q ss_pred             hhcCCCCCceecccCcEEEEEEEeCCCcEEEEEEEeccchhhHHHHHHHHHHHHHHhh--cCCCCcceeeeeeec-----
Q 012765          140 ATDNFNSENLIGKGGHAEVYKGCLPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAH--INHPNAAKLIGFSTE-----  212 (457)
Q Consensus       140 ~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~--l~hpniv~l~~~~~~-----  212 (457)
                      ..++|.+.+.||+|+||+||+|.+ +++.||||++....      ...+..|.+++..  ++||||+++++++..     
T Consensus         6 ~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~------~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~   78 (301)
T 3q4u_A            6 VARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSRD------EKSWFRETELYNTVMLRHENILGFIASDMTSRHSS   78 (301)
T ss_dssp             CGGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGGG------HHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTE
T ss_pred             ccCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEecccc------chhhHHHHHHHHHhhccCcCeeeEEEeeccccCCC
Confidence            457899999999999999999987 78999999985432      2345556666655  799999999996433     


Q ss_pred             CceEEEEEecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHH--------hcCCCCeeeCCCCCCcEEEcCCCcEE
Q 012765          213 NGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLH--------HDCHRRIIHRDIKASNILLSEDYEAQ  284 (457)
Q Consensus       213 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH--------~~~~~~iiHrDlkp~NIll~~~~~~k  284 (457)
                      ...++||||+++|+|.+++.  ...+++..++.++.||+.||.|||        +   .+|+||||||+|||++.++.+|
T Consensus        79 ~~~~lv~e~~~~g~L~~~l~--~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~---~~ivH~Dlkp~Nill~~~~~~k  153 (301)
T 3q4u_A           79 TQLWLITHYHEMGSLYDYLQ--LTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGK---PAIAHRDLKSKNILVKKNGQCC  153 (301)
T ss_dssp             EEEEEEECCCTTCBHHHHHT--TCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCB---CEEECSCCCGGGEEECTTSCEE
T ss_pred             ceeEEehhhccCCCHHHHHh--hcccCHHHHHHHHHHHHHHHHHHHHhhhhccCC---CCeecCCCChHhEEEcCCCCEE
Confidence            23689999999999999994  456899999999999999999999        7   8999999999999999999999


Q ss_pred             EeeccccccCCCCCCcee--eecccccccccChhccccC------CCCcchhHHHHHHHHHHHHhC----------CCCC
Q 012765          285 ISDFGLAKWLPDNWSHHI--VFPIEGTFGYLSPEYFMHG------IVDEKTDVFAFGVLLLELITG----------RRAV  346 (457)
Q Consensus       285 L~DFGl~~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~------~~~~ksDvwSlGvll~eLltG----------~~pf  346 (457)
                      |+|||+++..........  .....||+.|+|||++.+.      .++.++|||||||++|||++|          ..||
T Consensus       154 l~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf  233 (301)
T 3q4u_A          154 IADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPF  233 (301)
T ss_dssp             ECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTT
T ss_pred             EeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccc
Confidence            999999976644332211  1234699999999999876      445799999999999999999          7777


Q ss_pred             CcCCcch---hhhhccccccCCcccccCchhh-cccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q 012765          347 DSRRQSL---VIWAKPLLQTSNFKELVDPRLA-DAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQLLRGE  414 (457)
Q Consensus       347 ~~~~~~~---~~~~~~~~~~~~~~~~~d~~l~-~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~  414 (457)
                      .......   ............     .+.+. ..........+.+++.+||+.||++|||+.+|++.|+.+
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i  300 (301)
T 3q4u_A          234 YDVVPNDPSFEDMRKVVCVDQQ-----RPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI  300 (301)
T ss_dssp             TTTSCSSCCHHHHHHHHTTSCC-----CCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred             cccCCCCcchhhhhHHHhccCC-----CCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence            5422111   111111011111     11111 112234567788999999999999999999999999865

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=2e-43  Score=345.62  Aligned_cols=263  Identities=21%  Similarity=0.303  Sum_probs=198.9

Q ss_pred             hhcCCCCCceecccCcEEEEEEEeCCCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeec-CceEEE
Q 012765          140 ATDNFNSENLIGKGGHAEVYKGCLPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTE-NGFHLV  218 (457)
Q Consensus       140 ~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-~~~~lv  218 (457)
                      ..++|.+.+.||+|+||+||+|.+.+|+.||+|++..... .......+.+|+.+++.++||||+++++++.+ ...++|
T Consensus        19 l~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv   97 (311)
T 3niz_A           19 LMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAE-DEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLV   97 (311)
T ss_dssp             SSCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC-------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEE
T ss_pred             hHhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccc-cchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEE
Confidence            4578899999999999999999998899999999864432 22334678899999999999999999997655 457899


Q ss_pred             EEecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCCCCC
Q 012765          219 LQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNW  298 (457)
Q Consensus       219 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~~~  298 (457)
                      |||+.+ +|.+++......+++..+..++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||++.......
T Consensus        98 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~  173 (311)
T 3niz_A           98 FEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQ---HRILHRDLKPQNLLINSDGALKLADFGLARAFGIPV  173 (311)
T ss_dssp             EECCSE-EHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEETTSCC
T ss_pred             EcCCCC-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCchHhEEECCCCCEEEccCcCceecCCCc
Confidence            999985 7888887766779999999999999999999999   899999999999999999999999999998765432


Q ss_pred             CceeeecccccccccChhcccc-CCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhh-ccccccC---Cccc-----
Q 012765          299 SHHIVFPIEGTFGYLSPEYFMH-GIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWA-KPLLQTS---NFKE-----  368 (457)
Q Consensus       299 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~-~~~~~~~---~~~~-----  368 (457)
                      .  ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||........... .......   ....     
T Consensus       174 ~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  251 (311)
T 3niz_A          174 R--SYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELP  251 (311)
T ss_dssp             C-----CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTSH
T ss_pred             c--cccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhccc
Confidence            2  1233458999999999876 5689999999999999999999999986433221110 0000000   0000     


Q ss_pred             --------ccCchhhcccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 012765          369 --------LVDPRLADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQ  409 (457)
Q Consensus       369 --------~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~  409 (457)
                              .................+.+++.+||+.||.+|||+.|+++
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  300 (311)
T 3niz_A          252 LWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN  300 (311)
T ss_dssp             HHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             hhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence                    00000000001112245678999999999999999999987

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=9.1e-44  Score=340.13  Aligned_cols=253  Identities=28%  Similarity=0.454  Sum_probs=192.5

Q ss_pred             hcCCCCCceecccCcEEEEEEEeCCCcEEEEEEEeccchhh-HHHHHHHHHHHHHHhhcCCCCcceeeeeeecC-ceEEE
Q 012765          141 TDNFNSENLIGKGGHAEVYKGCLPDGEVVAVKKIIKNAKED-EERISDFLSELGIVAHINHPNAAKLIGFSTEN-GFHLV  218 (457)
Q Consensus       141 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~-~~~lv  218 (457)
                      .++|.+.+.||+|+||.||+|.+ .++.||+|++....... ......+.+|+.+++.++||||+++++++... ..++|
T Consensus         6 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   84 (271)
T 3dtc_A            6 FAELTLEEIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLV   84 (271)
T ss_dssp             TTSEEEEEEEEEETTEEEEEEEE-TTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEE
T ss_pred             hhheeeeeeeccCCCeEEEEEEE-cCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEE
Confidence            46788899999999999999997 58899999876543322 23346789999999999999999999976654 47899


Q ss_pred             EEecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC---eeeCCCCCCcEEEcC--------CCcEEEee
Q 012765          219 LQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRR---IIHRDIKASNILLSE--------DYEAQISD  287 (457)
Q Consensus       219 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~---iiHrDlkp~NIll~~--------~~~~kL~D  287 (457)
                      |||+++++|.+++.  ...+++..++.++.|++.||.|||+   .+   |+||||||+|||++.        ++.+||+|
T Consensus        85 ~e~~~~~~L~~~~~--~~~~~~~~~~~i~~~l~~~l~~lH~---~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~D  159 (271)
T 3dtc_A           85 MEFARGGPLNRVLS--GKRIPPDILVNWAVQIARGMNYLHD---EAIVPIIHRDLKSSNILILQKVENGDLSNKILKITD  159 (271)
T ss_dssp             EECCTTEEHHHHHT--SSCCCHHHHHHHHHHHHHHHHHHHH---SSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECC
T ss_pred             EEcCCCCCHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHh---CCCCceeecCCchHHEEEecccccccccCcceEEcc
Confidence            99999999999984  4568999999999999999999999   66   999999999999986        67899999


Q ss_pred             ccccccCCCCCCceeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhccccccCCcc
Q 012765          288 FGLAKWLPDNWSHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSNFK  367 (457)
Q Consensus       288 FGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~  367 (457)
                      ||++........    ....||+.|+|||++.+..++.++||||||+++|+|++|+.||.........+......   . 
T Consensus       160 fg~~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~---~-  231 (271)
T 3dtc_A          160 FGLAREWHRTTK----MSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNK---L-  231 (271)
T ss_dssp             CCC-----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHTSC---C-
T ss_pred             CCcccccccccc----cCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhcCC---C-
Confidence            999987654322    23458999999999999999999999999999999999999998754433222111000   0 


Q ss_pred             cccCchhhcccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q 012765          368 ELVDPRLADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQLLRGE  414 (457)
Q Consensus       368 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~  414 (457)
                         .......    ....+.+++.+||+.||.+|||+.|+++.|+.+
T Consensus       232 ---~~~~~~~----~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l  271 (271)
T 3dtc_A          232 ---ALPIPST----CPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI  271 (271)
T ss_dssp             ---CCCCCTT----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred             ---CCCCCcc----cCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence               0011111    224577888999999999999999999999764

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=1.6e-43  Score=340.73  Aligned_cols=255  Identities=20%  Similarity=0.324  Sum_probs=203.5

Q ss_pred             hhcCCCCCceecccCcEEEEEEEeCCCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeecC-ceEEE
Q 012765          140 ATDNFNSENLIGKGGHAEVYKGCLPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTEN-GFHLV  218 (457)
Q Consensus       140 ~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~-~~~lv  218 (457)
                      ..++|.+.+.||+|+||+||+|.+.++..||+|++......    ...+.+|+.++..++||||+++++++.+. ..++|
T Consensus        22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv   97 (283)
T 3gen_A           22 DPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS----EDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFII   97 (283)
T ss_dssp             CGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSBC----HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEE
T ss_pred             CHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCCC----HHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEE
Confidence            45678889999999999999999988889999998754433    24688999999999999999999977654 57899


Q ss_pred             EEecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCCCCC
Q 012765          219 LQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNW  298 (457)
Q Consensus       219 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~~~  298 (457)
                      |||+.+++|.+++......+++..++.++.|++.||.|||+   .+|+||||||+||+++.++.+||+|||++.......
T Consensus        98 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~  174 (283)
T 3gen_A           98 TEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLES---KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE  174 (283)
T ss_dssp             ECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHH
T ss_pred             EeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHH---CCccCCCCccceEEEcCCCCEEEccccccccccccc
Confidence            99999999999997656679999999999999999999999   899999999999999999999999999998764421


Q ss_pred             CceeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHh-CCCCCCcCCcchhhhhccccccCCcccccCchhhcc
Q 012765          299 SHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELIT-GRRAVDSRRQSLVIWAKPLLQTSNFKELVDPRLADA  377 (457)
Q Consensus       299 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLlt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~  377 (457)
                      . .......+|+.|+|||++.+..++.++||||||+++|+|+| |+.||.............  ..      ........
T Consensus       175 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~--~~------~~~~~~~~  245 (283)
T 3gen_A          175 Y-TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIA--QG------LRLYRPHL  245 (283)
T ss_dssp             H-HSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHH--TT------CCCCCCTT
T ss_pred             c-ccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHh--cc------cCCCCCCc
Confidence            1 11122346788999999998999999999999999999998 999998644332221110  00      00101111


Q ss_pred             cCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q 012765          378 YDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQLLRGE  414 (457)
Q Consensus       378 ~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~  414 (457)
                      .    ...+.+++.+||+.+|.+|||+.++++.|+.+
T Consensus       246 ~----~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~  278 (283)
T 3gen_A          246 A----SEKVYTIMYSCWHEKADERPTFKILLSNILDV  278 (283)
T ss_dssp             C----CHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred             C----CHHHHHHHHHHccCChhHCcCHHHHHHHHHHH
Confidence            1    23567788999999999999999999999765

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=8.1e-44  Score=350.41  Aligned_cols=254  Identities=23%  Similarity=0.297  Sum_probs=198.7

Q ss_pred             hhcCCCCCceecccCcEEEEEEEeC-CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeecCc-eEE
Q 012765          140 ATDNFNSENLIGKGGHAEVYKGCLP-DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTENG-FHL  217 (457)
Q Consensus       140 ~~~~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~-~~l  217 (457)
                      ..++|++.+.||+|+||+||+|.+. +++.||+|++......  ...+.+.+|+.+++.++||||+++++++.+++ .++
T Consensus         5 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l   82 (323)
T 3tki_A            5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLNHENVVKFYGHRREGNIQYL   82 (323)
T ss_dssp             TTTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC---------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred             HhhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEccccc--chHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEE
Confidence            3478999999999999999999865 7899999998644322  23457889999999999999999999776655 579


Q ss_pred             EEEecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCCCC
Q 012765          218 VLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDN  297 (457)
Q Consensus       218 v~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~~  297 (457)
                      ||||+++|+|.+++.. ...+++..++.++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||++..+...
T Consensus        83 v~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~---~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~  158 (323)
T 3tki_A           83 FLEYCSGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYN  158 (323)
T ss_dssp             EEECCTTEEGGGGSBT-TTBCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTTCEECEET
T ss_pred             EEEcCCCCcHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHH---CCccccccchHHEEEeCCCCEEEEEeeccceeccC
Confidence            9999999999999854 3458999999999999999999999   89999999999999999999999999999876433


Q ss_pred             CCceeeecccccccccChhccccCCC-CcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhccccccCCcccccCchhhc
Q 012765          298 WSHHIVFPIEGTFGYLSPEYFMHGIV-DEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSNFKELVDPRLAD  376 (457)
Q Consensus       298 ~~~~~~~~~~gt~~y~aPE~~~~~~~-~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  376 (457)
                      ..........||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.........+........    ...+  ..
T Consensus       159 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~----~~~~--~~  232 (323)
T 3tki_A          159 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKT----YLNP--WK  232 (323)
T ss_dssp             TEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCT----TSTT--GG
T ss_pred             CcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcccc----cCCc--cc
Confidence            32223345679999999999987765 77899999999999999999999864433222111100000    0000  01


Q ss_pred             ccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 012765          377 AYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQ  409 (457)
Q Consensus       377 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~  409 (457)
                      .    ....+.+++.+||+.||.+|||+.|+++
T Consensus       233 ~----~~~~~~~li~~~L~~dP~~R~t~~eil~  261 (323)
T 3tki_A          233 K----IDSAPLALLHKILVENPSARITIPDIKK  261 (323)
T ss_dssp             G----SCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             c----CCHHHHHHHHHHccCChhhCcCHHHHhh
Confidence            1    1234567889999999999999999987

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=1.1e-42  Score=342.06  Aligned_cols=259  Identities=21%  Similarity=0.294  Sum_probs=204.4

Q ss_pred             cccHHHHHHhhcC----------CCCCceecccCcEEEEEEEeC-CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcC
Q 012765          131 NFDFAELAAATDN----------FNSENLIGKGGHAEVYKGCLP-DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHIN  199 (457)
Q Consensus       131 ~~~~~~~~~~~~~----------f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~  199 (457)
                      .+++.++..+++.          |...+.||+|+||.||+|.+. +|+.||||++......   ....+.+|+.+++.++
T Consensus        24 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~  100 (321)
T 2c30_A           24 VVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQ---RRELLFNEVVIMRDYQ  100 (321)
T ss_dssp             -CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC---SHHHHHHHHHHHTTCC
T ss_pred             cCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchh---HHHHHHHHHHHHHhCC
Confidence            3566666666554          566779999999999999876 6999999998654332   2357889999999999


Q ss_pred             CCCcceeeeeeec-CceEEEEEecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEc
Q 012765          200 HPNAAKLIGFSTE-NGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLS  278 (457)
Q Consensus       200 hpniv~l~~~~~~-~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~  278 (457)
                      ||||+++++++.. +..++||||+++++|.+++.  ...+++..++.++.||+.||.|||+   .+|+||||||+|||++
T Consensus       101 h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~--~~~l~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~  175 (321)
T 2c30_A          101 HFNVVEMYKSYLVGEELWVLMEFLQGGALTDIVS--QVRLNEEQIATVCEAVLQALAYLHA---QGVIHRDIKSDSILLT  175 (321)
T ss_dssp             CTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHT--TCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEC
T ss_pred             CCCcceEEEEEEECCEEEEEEecCCCCCHHHHHH--hcCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEC
Confidence            9999999996654 55789999999999999984  3468999999999999999999999   8999999999999999


Q ss_pred             CCCcEEEeeccccccCCCCCCceeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhc
Q 012765          279 EDYEAQISDFGLAKWLPDNWSHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAK  358 (457)
Q Consensus       279 ~~~~~kL~DFGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~  358 (457)
                      .++.+||+|||++.........  .....||+.|+|||++.+..++.++|||||||++|||++|+.||........... 
T Consensus       176 ~~~~~kl~Dfg~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~-  252 (321)
T 2c30_A          176 LDGRVKLSDFGFCAQISKDVPK--RKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKR-  252 (321)
T ss_dssp             TTCCEEECCCTTCEECCSSSCC--BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHH-
T ss_pred             CCCcEEEeeeeeeeecccCccc--cccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH-
Confidence            9999999999999876543221  2345699999999999999999999999999999999999999976443221110 


Q ss_pred             cccccCCcccccCchhhcccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 012765          359 PLLQTSNFKELVDPRLADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQ  409 (457)
Q Consensus       359 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~  409 (457)
                        ...     ...+.+...  ......+.+++.+||+.||++|||+.++++
T Consensus       253 --~~~-----~~~~~~~~~--~~~~~~l~~li~~~l~~dp~~Rps~~ell~  294 (321)
T 2c30_A          253 --LRD-----SPPPKLKNS--HKVSPVLRDFLERMLVRDPQERATAQELLD  294 (321)
T ss_dssp             --HHH-----SSCCCCTTG--GGSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             --Hhc-----CCCCCcCcc--ccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence              000     001111100  011234667888999999999999999987

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=6.9e-44  Score=350.08  Aligned_cols=262  Identities=25%  Similarity=0.364  Sum_probs=192.1

Q ss_pred             hhcCCCCCceecccCcEEEEEEEeCCC----cEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeecCc-
Q 012765          140 ATDNFNSENLIGKGGHAEVYKGCLPDG----EVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTENG-  214 (457)
Q Consensus       140 ~~~~f~~~~~LG~G~~g~Vy~~~~~~~----~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~-  214 (457)
                      ..++|.+.+.||+|+||+||+|.+...    ..||+|.+....... .....+.+|+.+++.++||||+++++++.... 
T Consensus        21 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   99 (323)
T 3qup_A           21 PEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIAS-SDIEEFLREAACMKEFDHPHVAKLVGVSLRSRA   99 (323)
T ss_dssp             C---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------C-HHHHHHHHHHHHHTTCCCTTBCCCCEEEECC--
T ss_pred             ChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCH-HHHHHHHHHHHHHHHCCCCceehhhceeecccc
Confidence            457899999999999999999986543    279999886543222 33678999999999999999999999776543 


Q ss_pred             ------eEEEEEecCCCChhhhhhcC-----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcE
Q 012765          215 ------FHLVLQFLPHGSLSSLLFGS-----TECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEA  283 (457)
Q Consensus       215 ------~~lv~e~~~~gsL~~~l~~~-----~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~  283 (457)
                            .+++|||+.+|+|.+++...     ...+++..++.++.||+.||.|||+   .+|+||||||+|||++.++.+
T Consensus       100 ~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~---~~ivH~Dikp~NIli~~~~~~  176 (323)
T 3qup_A          100 KGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSS---RNFIHRDLAARNCMLAEDMTV  176 (323)
T ss_dssp             -----CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTSCE
T ss_pred             ccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHc---CCcccCCCCcceEEEcCCCCE
Confidence                  27999999999999998532     2258999999999999999999999   899999999999999999999


Q ss_pred             EEeeccccccCCCCCCceeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHh-CCCCCCcCCcchhhhhccccc
Q 012765          284 QISDFGLAKWLPDNWSHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELIT-GRRAVDSRRQSLVIWAKPLLQ  362 (457)
Q Consensus       284 kL~DFGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLlt-G~~pf~~~~~~~~~~~~~~~~  362 (457)
                      ||+|||+++...............+++.|+|||++.+..++.++|||||||++|||++ |..||............  ..
T Consensus       177 kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~--~~  254 (323)
T 3qup_A          177 CVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYL--IG  254 (323)
T ss_dssp             EECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHH--HT
T ss_pred             EEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHHHHHH--hc
Confidence            9999999987655433333334457889999999999999999999999999999999 99999864432211110  00


Q ss_pred             cCCcccccCchhhcccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCCCC
Q 012765          363 TSNFKELVDPRLADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQLLRGEGGQ  417 (457)
Q Consensus       363 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~  417 (457)
                      ...      ...    .......+.+++.+||+.||.+|||+.++++.|+.+...
T Consensus       255 ~~~------~~~----~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~  299 (323)
T 3qup_A          255 GNR------LKQ----PPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGH  299 (323)
T ss_dssp             TCC------CCC----CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             CCC------CCC----CCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence            000      000    111224577889999999999999999999999887543

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=6.6e-44  Score=357.26  Aligned_cols=259  Identities=29%  Similarity=0.351  Sum_probs=202.6

Q ss_pred             hcCCCCCceecccCcEEEEEEEeC------CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeecC-
Q 012765          141 TDNFNSENLIGKGGHAEVYKGCLP------DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTEN-  213 (457)
Q Consensus       141 ~~~f~~~~~LG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~-  213 (457)
                      .++|.+.+.||+|+||+||+|.+.      +++.||||++.....  ......+.+|+.++++++||||+++++++... 
T Consensus        70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~  147 (367)
T 3l9p_A           70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCS--EQDELDFLMEALIISKFNHQNIVRCIGVSLQSL  147 (367)
T ss_dssp             GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCC--HHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccC--hhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCC
Confidence            467888999999999999999842      467899999864332  23455789999999999999999999976654 


Q ss_pred             ceEEEEEecCCCChhhhhhcCC------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCC---cEE
Q 012765          214 GFHLVLQFLPHGSLSSLLFGST------ECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDY---EAQ  284 (457)
Q Consensus       214 ~~~lv~e~~~~gsL~~~l~~~~------~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~---~~k  284 (457)
                      ..++||||+++|+|.+++....      ..+++..++.++.||+.||.|||+   .+|+||||||+|||++.++   .+|
T Consensus       148 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~~~~~~k  224 (367)
T 3l9p_A          148 PRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEE---NHFIHRDIAARNCLLTCPGPGRVAK  224 (367)
T ss_dssp             SCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESCSSTTCCEE
T ss_pred             CCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChhhEEEecCCCCceEE
Confidence            5689999999999999996532      458999999999999999999999   8999999999999999555   499


Q ss_pred             EeeccccccCCCCCCceeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHh-CCCCCCcCCcchhhhhcccccc
Q 012765          285 ISDFGLAKWLPDNWSHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELIT-GRRAVDSRRQSLVIWAKPLLQT  363 (457)
Q Consensus       285 L~DFGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLlt-G~~pf~~~~~~~~~~~~~~~~~  363 (457)
                      |+|||+++.+.............||+.|+|||++.+..++.++|||||||++|||++ |..||.............  ..
T Consensus       225 L~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i~--~~  302 (367)
T 3l9p_A          225 IGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVT--SG  302 (367)
T ss_dssp             ECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHH--TT
T ss_pred             ECCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH--cC
Confidence            999999976532211112223457899999999999999999999999999999998 999998644332211110  00


Q ss_pred             CCcccccCchhhcccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCCC
Q 012765          364 SNFKELVDPRLADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQLLRGEGG  416 (457)
Q Consensus       364 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~  416 (457)
                      .      .......    ....+.+++.+||+.||.+||++.+|++.|+.+..
T Consensus       303 ~------~~~~~~~----~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~  345 (367)
T 3l9p_A          303 G------RMDPPKN----CPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ  345 (367)
T ss_dssp             C------CCCCCTT----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             C------CCCCCcc----CCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhh
Confidence            0      0000111    12346788899999999999999999999987644

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=2.3e-43  Score=349.22  Aligned_cols=250  Identities=21%  Similarity=0.286  Sum_probs=200.3

Q ss_pred             hcCCCCCceecccCcEEEEEEEeC-CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeec-CceEEE
Q 012765          141 TDNFNSENLIGKGGHAEVYKGCLP-DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTE-NGFHLV  218 (457)
Q Consensus       141 ~~~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-~~~~lv  218 (457)
                      .++|.+.+.||+|+||+||+|... +|+.||+|++.+...........+.+|+.+++.++||||+++++++.. +.+++|
T Consensus         4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv   83 (337)
T 1o6l_A            4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV   83 (337)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEE
Confidence            367889999999999999999865 689999999875433223345678899999999999999999996654 557899


Q ss_pred             EEecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCCCCC
Q 012765          219 LQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNW  298 (457)
Q Consensus       219 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~~~  298 (457)
                      |||+++|+|..++... ..+++..+..++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||+++......
T Consensus        84 ~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~  159 (337)
T 1o6l_A           84 MEYANGGELFFHLSRE-RVFTEERARFYGAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG  159 (337)
T ss_dssp             EECCTTCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTT
T ss_pred             EeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCcCCHHHEEECCCCCEEEeeccchhhcccCC
Confidence            9999999999988543 458899999999999999999999   899999999999999999999999999998643322


Q ss_pred             CceeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhccccccCCcccccCchhhccc
Q 012765          299 SHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSNFKELVDPRLADAY  378 (457)
Q Consensus       299 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~  378 (457)
                      .  ......||+.|+|||++.+..++.++|||||||++|||++|+.||...+..... .........        +...+
T Consensus       160 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~-~~i~~~~~~--------~p~~~  228 (337)
T 1o6l_A          160 A--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLF-ELILMEEIR--------FPRTL  228 (337)
T ss_dssp             C--CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHH-HHHHHCCCC--------CCTTS
T ss_pred             C--cccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHH-HHHHcCCCC--------CCCCC
Confidence            1  223456999999999999999999999999999999999999999864432211 110011111        11112


Q ss_pred             CHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 012765          379 DLAEMKRAMLTASVCIHHLSTMRP-----QMTRVLQ  409 (457)
Q Consensus       379 ~~~~~~~l~~l~~~Cl~~dP~~RP-----t~~evl~  409 (457)
                          ...+.+++.+||+.||.+||     ++.||++
T Consensus       229 ----s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~  260 (337)
T 1o6l_A          229 ----SPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME  260 (337)
T ss_dssp             ----CHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred             ----CHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHc
Confidence                23566788999999999999     8999876

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=1.6e-43  Score=345.31  Aligned_cols=260  Identities=20%  Similarity=0.311  Sum_probs=207.8

Q ss_pred             hhcCCCCCceecccCcEEEEEEEe------CCCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhc-CCCCcceeeeeeec
Q 012765          140 ATDNFNSENLIGKGGHAEVYKGCL------PDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHI-NHPNAAKLIGFSTE  212 (457)
Q Consensus       140 ~~~~f~~~~~LG~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~  212 (457)
                      ..++|.+.+.||+|+||.||+|.+      .+++.||+|.+.....  ......+.+|+.++.++ +||||+++++++..
T Consensus        21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~   98 (313)
T 1t46_A           21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAH--LTEREALMSELKVLSYLGNHMNIVNLLGACTI   98 (313)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCC--HHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             ChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchh--HHHHHHHHHHHHHHhhcccCCCeeeEEEEEec
Confidence            356788999999999999999974      3578999999865433  23456899999999999 99999999997655


Q ss_pred             -CceEEEEEecCCCChhhhhhcCCC-----------------CCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCc
Q 012765          213 -NGFHLVLQFLPHGSLSSLLFGSTE-----------------CLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASN  274 (457)
Q Consensus       213 -~~~~lv~e~~~~gsL~~~l~~~~~-----------------~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~N  274 (457)
                       +..++||||+++|+|.+++.....                 .+++..++.++.||+.||.|||+   .+|+||||||+|
T Consensus        99 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~N  175 (313)
T 1t46_A           99 GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARN  175 (313)
T ss_dssp             SSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGG
T ss_pred             CCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCccce
Confidence             457899999999999999865432                 48999999999999999999999   899999999999


Q ss_pred             EEEcCCCcEEEeeccccccCCCCCCceeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHh-CCCCCCcCCcch
Q 012765          275 ILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELIT-GRRAVDSRRQSL  353 (457)
Q Consensus       275 Ill~~~~~~kL~DFGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLlt-G~~pf~~~~~~~  353 (457)
                      |+++.++.+||+|||++................+|+.|+|||++.+..++.++||||||+++|||+| |..||.......
T Consensus       176 il~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~  255 (313)
T 1t46_A          176 ILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDS  255 (313)
T ss_dssp             EEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSH
T ss_pred             EEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchh
Confidence            9999999999999999988766544333334557889999999999999999999999999999999 999998644322


Q ss_pred             hhhhccccccCCcccccCchhhcccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCC
Q 012765          354 VIWAKPLLQTSNFKELVDPRLADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQLLRGEG  415 (457)
Q Consensus       354 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~  415 (457)
                      ..+...  ..     ........    .....+.+++.+||+.||.+|||+.+|++.|+.+.
T Consensus       256 ~~~~~~--~~-----~~~~~~~~----~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~  306 (313)
T 1t46_A          256 KFYKMI--KE-----GFRMLSPE----HAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQI  306 (313)
T ss_dssp             HHHHHH--HH-----TCCCCCCT----TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHHHHh--cc-----CCCCCCcc----cCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHH
Confidence            111110  00     00010011    12245677889999999999999999999998653

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.7e-43  Score=344.69  Aligned_cols=250  Identities=18%  Similarity=0.193  Sum_probs=201.5

Q ss_pred             hcCCCCCceecccCcEEEEEEEeC-CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeec-CceEEE
Q 012765          141 TDNFNSENLIGKGGHAEVYKGCLP-DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTE-NGFHLV  218 (457)
Q Consensus       141 ~~~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-~~~~lv  218 (457)
                      .++|.+.+.||+|+||+||+|.+. +++.||+|.+....    .....+.+|+.++..++||||+++++++.+ +..++|
T Consensus         4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~----~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv   79 (321)
T 1tki_A            4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG----TDQVLVKKEISILNIARHRNILHLHESFESMEELVMI   79 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT----HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEE
T ss_pred             hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc----ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEE
Confidence            478899999999999999999865 58899999886432    223568899999999999999999996655 557899


Q ss_pred             EEecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcC--CCcEEEeeccccccCCC
Q 012765          219 LQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSE--DYEAQISDFGLAKWLPD  296 (457)
Q Consensus       219 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~--~~~~kL~DFGl~~~~~~  296 (457)
                      |||+++|+|.+++......+++..++.++.||+.||.|||+   .+|+||||||+|||++.  ++.+||+|||++..+..
T Consensus        80 ~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~---~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~  156 (321)
T 1tki_A           80 FEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHS---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP  156 (321)
T ss_dssp             ECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCT
T ss_pred             EEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCC
Confidence            99999999999997666679999999999999999999999   89999999999999987  78999999999988755


Q ss_pred             CCCceeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhccccccCCcccccCchhhc
Q 012765          297 NWSHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSNFKELVDPRLAD  376 (457)
Q Consensus       297 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  376 (457)
                      ...   .....||+.|+|||++.+..++.++|||||||++|+|++|..||............ ......    .++....
T Consensus       157 ~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i-~~~~~~----~~~~~~~  228 (321)
T 1tki_A          157 GDN---FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENI-MNAEYT----FDEEAFK  228 (321)
T ss_dssp             TCE---EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH-HHTCCC----CCHHHHT
T ss_pred             CCc---cccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHH-HcCCCC----CChhhhc
Confidence            432   23345899999999999888999999999999999999999999864432211100 000000    0111111


Q ss_pred             ccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 012765          377 AYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQ  409 (457)
Q Consensus       377 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~  409 (457)
                      .+    ...+.+++.+||+.||.+|||+.|+++
T Consensus       229 ~~----s~~~~~li~~~L~~dp~~Rpt~~e~l~  257 (321)
T 1tki_A          229 EI----SIEAMDFVDRLLVKERKSRMTASEALQ  257 (321)
T ss_dssp             TS----CHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             cC----CHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            12    235678899999999999999999988

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=6.7e-44  Score=353.23  Aligned_cols=262  Identities=22%  Similarity=0.353  Sum_probs=205.3

Q ss_pred             hhcCCCCCceecccCcEEEEEEEe------CCCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhc-CCCCcceeeeeeec
Q 012765          140 ATDNFNSENLIGKGGHAEVYKGCL------PDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHI-NHPNAAKLIGFSTE  212 (457)
Q Consensus       140 ~~~~f~~~~~LG~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~  212 (457)
                      ..++|.+.+.||+|+||.||+|.+      .++..||+|.+....  .......+.+|+.++.++ +||||+++++++..
T Consensus        43 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~  120 (344)
T 1rjb_A           43 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA--DSSEREALMSELKMMTQLGSHENIVNLLGACTL  120 (344)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC--------CHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             CHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEeccccc--CHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEee
Confidence            457888999999999999999985      246689999986432  223456889999999999 89999999997655


Q ss_pred             -CceEEEEEecCCCChhhhhhcCCC----------------------CCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCC
Q 012765          213 -NGFHLVLQFLPHGSLSSLLFGSTE----------------------CLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRD  269 (457)
Q Consensus       213 -~~~~lv~e~~~~gsL~~~l~~~~~----------------------~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrD  269 (457)
                       +..++||||+++|+|.+++.....                      .+++..++.++.||+.||.|||+   .+|+|||
T Consensus       121 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~D  197 (344)
T 1rjb_A          121 SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRD  197 (344)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHH---TTEEETT
T ss_pred             CCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHh---CCcccCC
Confidence             457899999999999999965432                      37899999999999999999999   8999999


Q ss_pred             CCCCcEEEcCCCcEEEeeccccccCCCCCCceeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHh-CCCCCCc
Q 012765          270 IKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELIT-GRRAVDS  348 (457)
Q Consensus       270 lkp~NIll~~~~~~kL~DFGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLlt-G~~pf~~  348 (457)
                      |||+|||++.++.+||+|||++..+.............||+.|+|||++.+..++.++|||||||++|||+| |..||..
T Consensus       198 ikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~  277 (344)
T 1rjb_A          198 LAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPG  277 (344)
T ss_dssp             CSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTT
T ss_pred             CChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCccc
Confidence            999999999999999999999987755443333344557889999999999999999999999999999998 9999986


Q ss_pred             CCcchhhhhccccccCCcccccCchhhcccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCCCC
Q 012765          349 RRQSLVIWAKPLLQTSNFKELVDPRLADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQLLRGEGGQ  417 (457)
Q Consensus       349 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~  417 (457)
                      ..........  ....     ..+....    .....+..++.+||+.||.+|||+.+|++.|+.+...
T Consensus       278 ~~~~~~~~~~--~~~~-----~~~~~~~----~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~  335 (344)
T 1rjb_A          278 IPVDANFYKL--IQNG-----FKMDQPF----YATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLAD  335 (344)
T ss_dssp             CCCSHHHHHH--HHTT-----CCCCCCT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC--
T ss_pred             CCcHHHHHHH--HhcC-----CCCCCCC----CCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHH
Confidence            4432211110  0000     0011111    1224567788999999999999999999999887544

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=6.5e-44  Score=367.08  Aligned_cols=264  Identities=24%  Similarity=0.333  Sum_probs=207.2

Q ss_pred             HhhcCCCCCceecccCcEEEEEEEeCCCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeecCceEEE
Q 012765          139 AATDNFNSENLIGKGGHAEVYKGCLPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTENGFHLV  218 (457)
Q Consensus       139 ~~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~lv  218 (457)
                      ...++|.+.+.||+|+||.||+|.+.++..||||.+......    .+.+.+|+.++++++||||+++++++.++..++|
T Consensus       181 i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~iv  256 (452)
T 1fmk_A          181 IPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS----PEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIV  256 (452)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSC----HHHHHHHHHHHHHCCCTTBCCEEEEECSSSCEEE
T ss_pred             cChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCCCC----HHHHHHHHHHHHhCCCCCEeeEEEEEcCCceEEE
Confidence            345778889999999999999999988888999998754322    3478999999999999999999999988889999


Q ss_pred             EEecCCCChhhhhhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCCCC
Q 012765          219 LQFLPHGSLSSLLFGS-TECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDN  297 (457)
Q Consensus       219 ~e~~~~gsL~~~l~~~-~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~~  297 (457)
                      |||+++|+|.+++... ...+++..++.++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||+++.....
T Consensus       257 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~---~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~  333 (452)
T 1fmk_A          257 TEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDN  333 (452)
T ss_dssp             ECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCCTTC-----
T ss_pred             ehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChhhEEECCCCCEEECCCccceecCCC
Confidence            9999999999999642 3458999999999999999999999   89999999999999999999999999999876543


Q ss_pred             CCceeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHh-CCCCCCcCCcchhhhhccccccCCcccccCchhhc
Q 012765          298 WSHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELIT-GRRAVDSRRQSLVIWAKPLLQTSNFKELVDPRLAD  376 (457)
Q Consensus       298 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLlt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  376 (457)
                      ... ......++..|+|||++.+..++.++|||||||++|||++ |+.||............  ....      ......
T Consensus       334 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i--~~~~------~~~~~~  404 (452)
T 1fmk_A          334 EYT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQV--ERGY------RMPCPP  404 (452)
T ss_dssp             ----------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHH--HTTC------CCCCCT
T ss_pred             cee-cccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHH--HcCC------CCCCCC
Confidence            211 1223346788999999999999999999999999999999 99999864432211110  0000      000011


Q ss_pred             ccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCCCCCCCCC
Q 012765          377 AYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQLLRGEGGQTDLKP  422 (457)
Q Consensus       377 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~~~~~~  422 (457)
                          .....+.+++.+||+.||++|||+.+|++.|+.+.....++.
T Consensus       405 ----~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~~~~~~  446 (452)
T 1fmk_A          405 ----ECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQY  446 (452)
T ss_dssp             ----TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSCCCC
T ss_pred             ----CCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhccCCccc
Confidence                122456778899999999999999999999999865544433

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=1.7e-43  Score=346.02  Aligned_cols=247  Identities=21%  Similarity=0.293  Sum_probs=192.1

Q ss_pred             hhcCCCCCceecccCcEEEEEEEeC-CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhc-CCCCcceeeeeeecCc-eE
Q 012765          140 ATDNFNSENLIGKGGHAEVYKGCLP-DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHI-NHPNAAKLIGFSTENG-FH  216 (457)
Q Consensus       140 ~~~~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~-~~  216 (457)
                      ..++|.+.+.||+|+||+||+|.+. +|+.||||++......... ...+..|+..+..+ +||||+++++++.+++ .+
T Consensus        55 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~-~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~  133 (311)
T 3p1a_A           55 FQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKD-RARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILY  133 (311)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHH-HHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred             hhhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHH-HHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEE
Confidence            3467999999999999999999876 6999999988654443333 34555666666555 8999999999776554 67


Q ss_pred             EEEEecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCCC
Q 012765          217 LVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPD  296 (457)
Q Consensus       217 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~  296 (457)
                      +||||+ +++|.+++......+++..++.++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||++.....
T Consensus       134 lv~e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~  209 (311)
T 3p1a_A          134 LQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHS---QGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGT  209 (311)
T ss_dssp             EEEECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECGGGCEEECCCTTCEECC-
T ss_pred             EEEecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEECCCCCEEEccceeeeeccc
Confidence            999999 778998887766779999999999999999999999   8999999999999999999999999999987654


Q ss_pred             CCCceeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhccccccCCcccccCchhhc
Q 012765          297 NWSHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSNFKELVDPRLAD  376 (457)
Q Consensus       297 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  376 (457)
                      ...   .....||+.|+|||++.+ .++.++|||||||++|||++|..||.....    |..  ...    ....+.+..
T Consensus       210 ~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~----~~~--~~~----~~~~~~~~~  275 (311)
T 3p1a_A          210 AGA---GEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEG----WQQ--LRQ----GYLPPEFTA  275 (311)
T ss_dssp             --------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHH----HHH--HTT----TCCCHHHHT
T ss_pred             CCC---CcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccH----HHH--Hhc----cCCCccccc
Confidence            322   223459999999998875 799999999999999999999777654211    110  000    011122222


Q ss_pred             ccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 012765          377 AYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQ  409 (457)
Q Consensus       377 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~  409 (457)
                      .+    ...+.+++.+||+.||++|||+.|+++
T Consensus       276 ~~----~~~l~~li~~~L~~dP~~Rpt~~ell~  304 (311)
T 3p1a_A          276 GL----SSELRSVLVMMLEPDPKLRATAEALLA  304 (311)
T ss_dssp             TS----CHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             CC----CHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence            22    345778899999999999999999986

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=1.5e-43  Score=354.16  Aligned_cols=269  Identities=16%  Similarity=0.171  Sum_probs=203.2

Q ss_pred             hhcCCCCCceecccCcEEEEEEEeCC------CcEEEEEEEeccchhhHHHH--------HHHHHHHHHHhhcCCCCcce
Q 012765          140 ATDNFNSENLIGKGGHAEVYKGCLPD------GEVVAVKKIIKNAKEDEERI--------SDFLSELGIVAHINHPNAAK  205 (457)
Q Consensus       140 ~~~~f~~~~~LG~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~~~~~~--------~~~~~E~~~l~~l~hpniv~  205 (457)
                      ..++|.+.+.||+|+||.||+|.+..      ++.||+|.+...........        ..+..|+..+..++||||++
T Consensus        33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~  112 (364)
T 3op5_A           33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK  112 (364)
T ss_dssp             TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred             CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence            45688999999999999999998754      47899999865543211111        23445667788889999999


Q ss_pred             eeeeeecC-----ceEEEEEecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEc--
Q 012765          206 LIGFSTEN-----GFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLS--  278 (457)
Q Consensus       206 l~~~~~~~-----~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~--  278 (457)
                      +++++...     ..++||||+ +++|.+++......+++..++.|+.||+.||.|||+   .+|+||||||+|||++  
T Consensus       113 ~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~---~~iiHrDlkp~Nill~~~  188 (364)
T 3op5_A          113 YWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHE---HEYVHGDIKASNLLLNYK  188 (364)
T ss_dssp             EEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEEESS
T ss_pred             EEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHH---CCeEEecCCHHHEEEecC
Confidence            99976542     268999999 999999998776789999999999999999999999   8999999999999999  


Q ss_pred             CCCcEEEeeccccccCCCCCCce-----eeecccccccccChhccccCCCCcchhHHHHHHHHHHHHhCCCCCCcCCcch
Q 012765          279 EDYEAQISDFGLAKWLPDNWSHH-----IVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSL  353 (457)
Q Consensus       279 ~~~~~kL~DFGl~~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~  353 (457)
                      .++.+||+|||+++.+.......     ......||+.|+|||++.+..++.++|||||||++|||+||+.||.......
T Consensus       189 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~  268 (364)
T 3op5_A          189 NPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDP  268 (364)
T ss_dssp             CTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCH
T ss_pred             CCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccCH
Confidence            88999999999998764332111     1123459999999999999999999999999999999999999998532221


Q ss_pred             hhh-hccccccCCcccccCchhhcccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCC
Q 012765          354 VIW-AKPLLQTSNFKELVDPRLADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQLLRGEG  415 (457)
Q Consensus       354 ~~~-~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~  415 (457)
                      ... .........+..++++.+...   .....+..++..||+.+|.+||++.+|++.|+.+.
T Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~  328 (364)
T 3op5_A          269 KYVRDSKIRYRENIASLMDKCFPAA---NAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGL  328 (364)
T ss_dssp             HHHHHHHHHHHHCHHHHHHHHSCTT---CCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHH
T ss_pred             HHHHHHHHHhhhhHHHHHHHhcccc---cCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHH
Confidence            110 000011112233333332211   11245677888899999999999999999887654

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.4e-43  Score=342.16  Aligned_cols=258  Identities=22%  Similarity=0.320  Sum_probs=208.1

Q ss_pred             cCCCCCc-eecccCcEEEEEEEeC---CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeecCceEE
Q 012765          142 DNFNSEN-LIGKGGHAEVYKGCLP---DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTENGFHL  217 (457)
Q Consensus       142 ~~f~~~~-~LG~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~l  217 (457)
                      ++|.+.+ .||+|+||.||+|.+.   ++..||+|.+....  .......+.+|+.+++.++||||+++++++..+..++
T Consensus         9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~l   86 (287)
T 1u59_A            9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT--EKADTEEMMREAQIMHQLDNPYIVRLIGVCQAEALML   86 (287)
T ss_dssp             GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEESSSEEE
T ss_pred             HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCcc--chhHHHHHHHHHHHHHhCCCCCEeEEEEEecCCCcEE
Confidence            4555665 8999999999999753   57889999986543  2344678999999999999999999999988888999


Q ss_pred             EEEecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCCCC
Q 012765          218 VLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDN  297 (457)
Q Consensus       218 v~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~~  297 (457)
                      ||||+++++|.+++......+++..++.++.||+.||.|||+   .+|+||||||+||+++.++.+||+|||++......
T Consensus        87 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~  163 (287)
T 1u59_A           87 VMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGAD  163 (287)
T ss_dssp             EEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEEETTEEEECCCTTCEECTTC
T ss_pred             EEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHH---CCEeeCCCchheEEEcCCCCEEECcccceeeeccC
Confidence            999999999999997766779999999999999999999999   89999999999999999999999999999877543


Q ss_pred             CCce-eeecccccccccChhccccCCCCcchhHHHHHHHHHHHHh-CCCCCCcCCcchhhhhccccccCCcccccCchhh
Q 012765          298 WSHH-IVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELIT-GRRAVDSRRQSLVIWAKPLLQTSNFKELVDPRLA  375 (457)
Q Consensus       298 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLlt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  375 (457)
                      .... ......+|+.|+|||++.+..++.++||||||+++|||++ |+.||............   ....     .+...
T Consensus       164 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i---~~~~-----~~~~~  235 (287)
T 1u59_A          164 DSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFI---EQGK-----RMECP  235 (287)
T ss_dssp             SCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHH---HTTC-----CCCCC
T ss_pred             cceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHH---hcCC-----cCCCC
Confidence            3221 1223346889999999988889999999999999999998 99999864432211110   0000     01111


Q ss_pred             cccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCCC
Q 012765          376 DAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQLLRGEGG  416 (457)
Q Consensus       376 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~  416 (457)
                      ..    ....+.+++..||+.||.+||++.+|++.|+.+..
T Consensus       236 ~~----~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~  272 (287)
T 1u59_A          236 PE----CPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYY  272 (287)
T ss_dssp             TT----CCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CC----cCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence            12    23457778899999999999999999999987643

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=3.5e-43  Score=338.21  Aligned_cols=257  Identities=24%  Similarity=0.342  Sum_probs=204.2

Q ss_pred             hhcCCCCCceecccCcEEEEEEEeCC----CcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeecCce
Q 012765          140 ATDNFNSENLIGKGGHAEVYKGCLPD----GEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTENGF  215 (457)
Q Consensus       140 ~~~~f~~~~~LG~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~  215 (457)
                      ..++|.+.+.||+|+||+||+|.+.+    +..||+|.+.....  ......+.+|+.+++.++||||+++++++.++..
T Consensus        10 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~   87 (281)
T 3cc6_A           10 AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCT--LDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEEPT   87 (281)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSC--HHHHHHHHHHHHHHHHHCCTTBCCEEEEECSSSC
T ss_pred             cccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccC--chHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCC
Confidence            45778899999999999999998532    34699998865432  2345689999999999999999999999988889


Q ss_pred             EEEEEecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCC
Q 012765          216 HLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLP  295 (457)
Q Consensus       216 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~  295 (457)
                      +++|||+++++|.+++......+++..++.++.||+.||.|||+   .+|+||||||+||+++.++.+||+|||++....
T Consensus        88 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  164 (281)
T 3cc6_A           88 WIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLES---INCVHRDIAVRNILVASPECVKLGDFGLSRYIE  164 (281)
T ss_dssp             EEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEEEETTEEEECCCCGGGCC-
T ss_pred             EEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCccceEEECCCCcEEeCccCCCcccc
Confidence            99999999999999997766678999999999999999999999   899999999999999999999999999998765


Q ss_pred             CCCCceeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHh-CCCCCCcCCcchhhhhccccccCCcccccCchh
Q 012765          296 DNWSHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELIT-GRRAVDSRRQSLVIWAKPLLQTSNFKELVDPRL  374 (457)
Q Consensus       296 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLlt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l  374 (457)
                      ..... ......+|+.|+|||++.+..++.++||||||+++|||++ |+.||.............  ...      ....
T Consensus       165 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~--~~~------~~~~  235 (281)
T 3cc6_A          165 DEDYY-KASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLE--KGD------RLPK  235 (281)
T ss_dssp             ---------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHH--HTC------CCCC
T ss_pred             ccccc-ccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHh--cCC------CCCC
Confidence            43221 1223457889999999998999999999999999999998 999997533322111100  000      0000


Q ss_pred             hcccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q 012765          375 ADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQLLRGE  414 (457)
Q Consensus       375 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~  414 (457)
                      ...+    ...+.+++.+||+.||.+||++.+|++.|+.+
T Consensus       236 ~~~~----~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~  271 (281)
T 3cc6_A          236 PDLC----PPVLYTLMTRCWDYDPSDRPRFTELVCSLSDV  271 (281)
T ss_dssp             CTTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCCC----CHHHHHHHHHHccCCchhCcCHHHHHHHHHHH
Confidence            1111    23467788999999999999999999999865

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=2.8e-44  Score=345.39  Aligned_cols=257  Identities=25%  Similarity=0.366  Sum_probs=207.8

Q ss_pred             hhcCCCCCceecccCcEEEEEEEeCCCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeecCceEEEE
Q 012765          140 ATDNFNSENLIGKGGHAEVYKGCLPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTENGFHLVL  219 (457)
Q Consensus       140 ~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~lv~  219 (457)
                      ..++|.+.+.||+|+||.||+|.+.+++.||+|.+......    ...+.+|+.+++.++||||+++++++.++..+++|
T Consensus        11 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~v~   86 (279)
T 1qpc_A           11 PRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS----PDAFLAEANLMKQLQHQRLVRLYAVVTQEPIYIIT   86 (279)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSC----HHHHHHHHHHHHHCCCTTBCCEEEEECSSSCEEEE
T ss_pred             CHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCccc----HHHHHHHHHHHHhCCCcCcceEEEEEcCCCcEEEE
Confidence            45778899999999999999999888889999998654332    34788999999999999999999999888899999


Q ss_pred             EecCCCChhhhhhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCCCCC
Q 012765          220 QFLPHGSLSSLLFGST-ECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNW  298 (457)
Q Consensus       220 e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~~~  298 (457)
                      ||+++++|.+++.... ..+++..++.++.|++.||.|||+   .+|+||||||+||+++.++.+||+|||++.......
T Consensus        87 e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~  163 (279)
T 1qpc_A           87 EYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE---RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE  163 (279)
T ss_dssp             ECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSC
T ss_pred             ecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHhhEEEcCCCCEEECCCcccccccCcc
Confidence            9999999999985432 258999999999999999999999   899999999999999999999999999998775432


Q ss_pred             CceeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHh-CCCCCCcCCcchhhhhccccccCCcccccCchhhcc
Q 012765          299 SHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELIT-GRRAVDSRRQSLVIWAKPLLQTSNFKELVDPRLADA  377 (457)
Q Consensus       299 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLlt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~  377 (457)
                      . .......++..|+|||++.+..++.++||||||+++|||++ |+.||............  ...      ........
T Consensus       164 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~--~~~------~~~~~~~~  234 (279)
T 1qpc_A          164 Y-TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNL--ERG------YRMVRPDN  234 (279)
T ss_dssp             E-ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHH--HTT------CCCCCCTT
T ss_pred             c-ccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHH--hcc------cCCCCccc
Confidence            1 11223446788999999998889999999999999999999 99999764432211100  000      00001111


Q ss_pred             cCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCCC
Q 012765          378 YDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQLLRGEGG  416 (457)
Q Consensus       378 ~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~  416 (457)
                          ....+.+++..||+.||++|||+.+|++.|+.+..
T Consensus       235 ----~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~  269 (279)
T 1qpc_A          235 ----CPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFT  269 (279)
T ss_dssp             ----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ----ccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHH
Confidence                12456788899999999999999999999987643

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=1.2e-42  Score=339.38  Aligned_cols=256  Identities=26%  Similarity=0.396  Sum_probs=197.5

Q ss_pred             hcCCCCCceecccCcEEEEEEEeCCCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeecCceEEEEE
Q 012765          141 TDNFNSENLIGKGGHAEVYKGCLPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTENGFHLVLQ  220 (457)
Q Consensus       141 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~lv~e  220 (457)
                      .++|.+.+.||+|+||+||+|.+ .++.||+|++....     ....+.+|+.++++++||||+++++++.+ ..++|||
T Consensus         7 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~lv~e   79 (307)
T 2eva_A            7 YKEIEVEEVVGRGAFGVVCKAKW-RAKDVAIKQIESES-----ERKAFIVELRQLSRVNHPNIVKLYGACLN-PVCLVME   79 (307)
T ss_dssp             GGGEEEEEEEECCSSSEEEEEEE-TTEEEEEEECSSTT-----HHHHHHHHHHHHHHCCCTTBCCEEEBCTT-TTEEEEE
T ss_pred             HhHeeeeeEeecCCCceEEEEEE-CCeeEEEEEecChh-----HHHHHHHHHHHHhcCCCCCcCeEEEEEcC-CcEEEEE
Confidence            35678889999999999999987 57889999885432     24578999999999999999999998774 5789999


Q ss_pred             ecCCCChhhhhhcCCC--CCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCc-EEEeeccccccCCCC
Q 012765          221 FLPHGSLSSLLFGSTE--CLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYE-AQISDFGLAKWLPDN  297 (457)
Q Consensus       221 ~~~~gsL~~~l~~~~~--~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~-~kL~DFGl~~~~~~~  297 (457)
                      |+++++|.+++.....  .+++..++.++.|++.||.|||+....+|+||||||+|||++.++. +||+|||++......
T Consensus        80 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~  159 (307)
T 2eva_A           80 YAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH  159 (307)
T ss_dssp             CCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC-------
T ss_pred             cCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc
Confidence            9999999999975443  4788899999999999999999854358999999999999998886 799999999765432


Q ss_pred             CCceeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhccccccCCcccccCchhhcc
Q 012765          298 WSHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSNFKELVDPRLADA  377 (457)
Q Consensus       298 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~  377 (457)
                      .     ....||+.|+|||++.+..++.++||||||+++|||++|+.||................ ..     .+.+...
T Consensus       160 ~-----~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~-~~-----~~~~~~~  228 (307)
T 2eva_A          160 M-----TNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHN-GT-----RPPLIKN  228 (307)
T ss_dssp             ----------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHT-TC-----CCCCBTT
T ss_pred             c-----ccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhc-CC-----CCCcccc
Confidence            1     22358999999999999999999999999999999999999998543222111110000 00     1111112


Q ss_pred             cCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCCCCC
Q 012765          378 YDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQLLRGEGGQT  418 (457)
Q Consensus       378 ~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~~  418 (457)
                      +    ...+.+++.+||+.||.+|||+.+|++.|+.+....
T Consensus       229 ~----~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~  265 (307)
T 2eva_A          229 L----PKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYF  265 (307)
T ss_dssp             C----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGC
T ss_pred             c----CHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhc
Confidence            2    234667889999999999999999999998876543

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=2.7e-43  Score=346.16  Aligned_cols=251  Identities=23%  Similarity=0.341  Sum_probs=195.5

Q ss_pred             hhcCCCCCceecccCcEEEEEEEeC-CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeecCc----
Q 012765          140 ATDNFNSENLIGKGGHAEVYKGCLP-DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTENG----  214 (457)
Q Consensus       140 ~~~~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~----  214 (457)
                      ..++|++.+.||+|+||.||+|.+. +|+.||||++......  .....+.+|+.++++++||||+++++++.+..    
T Consensus         4 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~   81 (332)
T 3qd2_B            4 YLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRE--LAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKW   81 (332)
T ss_dssp             HHHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTT--THHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHH
T ss_pred             hhhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCch--hHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchh
Confidence            4467889999999999999999976 7999999998654432  23468899999999999999999999664332    


Q ss_pred             ------------------------------------------------------eEEEEEecCCCChhhhhhcCC--CCC
Q 012765          215 ------------------------------------------------------FHLVLQFLPHGSLSSLLFGST--ECL  238 (457)
Q Consensus       215 ------------------------------------------------------~~lv~e~~~~gsL~~~l~~~~--~~~  238 (457)
                                                                            .+++|||+++++|.+++....  ...
T Consensus        82 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~  161 (332)
T 3qd2_B           82 QEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDR  161 (332)
T ss_dssp             HHHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGS
T ss_pred             hhhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccch
Confidence                                                                  689999999999999996543  245


Q ss_pred             CHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCCCCCCc----------eeeecccc
Q 012765          239 EWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSH----------HIVFPIEG  308 (457)
Q Consensus       239 ~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~~~~~----------~~~~~~~g  308 (457)
                      ++..++.++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||+++........          .......|
T Consensus       162 ~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~g  238 (332)
T 3qd2_B          162 EHGVCLHIFIQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVG  238 (332)
T ss_dssp             CHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-
T ss_pred             hhHHHHHHHHHHHHHHHHHHh---CCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCC
Confidence            677788999999999999999   89999999999999999999999999999887554211          11223469


Q ss_pred             cccccChhccccCCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhccccccCCcccccCchhhcccCHHHHHHHHH
Q 012765          309 TFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSNFKELVDPRLADAYDLAEMKRAML  388 (457)
Q Consensus       309 t~~y~aPE~~~~~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~  388 (457)
                      |+.|+|||++.+..++.++|||||||++|||++|..|+.........          ......+..    .......+.+
T Consensus       239 t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~~~~~~~----------~~~~~~~~~----~~~~~~~~~~  304 (332)
T 3qd2_B          239 TKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMERVRIITD----------VRNLKFPLL----FTQKYPQEHM  304 (332)
T ss_dssp             CGGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHHHHHHHH----------HHTTCCCHH----HHHHCHHHHH
T ss_pred             CcCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHHHHHHHH----------hhccCCCcc----cccCChhHHH
Confidence            99999999999999999999999999999999998776431111000          000001111    1122345577


Q ss_pred             HHHHhcccCCCCCCCHHHHHH
Q 012765          389 TASVCIHHLSTMRPQMTRVLQ  409 (457)
Q Consensus       389 l~~~Cl~~dP~~RPt~~evl~  409 (457)
                      ++.+||+.||.+|||+.|+++
T Consensus       305 li~~~l~~~p~~Rps~~~~l~  325 (332)
T 3qd2_B          305 MVQDMLSPSPTERPEATDIIE  325 (332)
T ss_dssp             HHHHHHCSSGGGSCCHHHHHH
T ss_pred             HHHHHccCCCCcCCCHHHHhh
Confidence            899999999999999999986

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=1e-42  Score=341.49  Aligned_cols=268  Identities=18%  Similarity=0.237  Sum_probs=207.3

Q ss_pred             hcCCCCCceecccCcEEEEEEEeC-CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeecC---ceE
Q 012765          141 TDNFNSENLIGKGGHAEVYKGCLP-DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTEN---GFH  216 (457)
Q Consensus       141 ~~~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~---~~~  216 (457)
                      .++|.+.+.||+|+||+||+|.+. +++.||+|++......  .....+.+|+.++++++||||+++++++...   ..+
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   85 (319)
T 4euu_A            8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFL--RPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKV   85 (319)
T ss_dssp             SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGG--SCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEE
T ss_pred             CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEecccccc--chHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEE
Confidence            467889999999999999999875 4899999998654322  2245778999999999999999999976543   468


Q ss_pred             EEEEecCCCChhhhhhcCC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEE----cCCCcEEEeeccc
Q 012765          217 LVLQFLPHGSLSSLLFGST--ECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILL----SEDYEAQISDFGL  290 (457)
Q Consensus       217 lv~e~~~~gsL~~~l~~~~--~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll----~~~~~~kL~DFGl  290 (457)
                      +||||+++++|.+++....  ..+++..++.++.||+.||.|||+   .+|+||||||+|||+    +.++.+||+|||+
T Consensus        86 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~  162 (319)
T 4euu_A           86 LIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGA  162 (319)
T ss_dssp             EEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEECTTSCEEEEECCCTT
T ss_pred             EEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEEeccCCCCceEEEccCCC
Confidence            9999999999999996533  238999999999999999999999   899999999999999    7788899999999


Q ss_pred             cccCCCCCCceeeecccccccccChhccc--------cCCCCcchhHHHHHHHHHHHHhCCCCCCcCCcch--hhhhccc
Q 012765          291 AKWLPDNWSHHIVFPIEGTFGYLSPEYFM--------HGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSL--VIWAKPL  360 (457)
Q Consensus       291 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~--~~~~~~~  360 (457)
                      ++.......   .....||+.|+|||++.        +..++.++|||||||++|||++|+.||.......  .......
T Consensus       163 a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~  239 (319)
T 4euu_A          163 ARELEDDEQ---FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKI  239 (319)
T ss_dssp             CEECCTTCC---BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHH
T ss_pred             ceecCCCCc---eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHH
Confidence            987755432   22345999999999986        5778999999999999999999999997432211  0000000


Q ss_pred             cccCC------ccccc--------CchhhcccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCCC
Q 012765          361 LQTSN------FKELV--------DPRLADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQLLRGEGG  416 (457)
Q Consensus       361 ~~~~~------~~~~~--------d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~  416 (457)
                      .....      +....        +......+.......+..++.+||+.||++|||+.|+++......-
T Consensus       240 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~~  309 (319)
T 4euu_A          240 ITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILH  309 (319)
T ss_dssp             HHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHTC
T ss_pred             hcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHhh
Confidence            00000      00000        0011123345667778889999999999999999999998876643

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=4.8e-43  Score=350.06  Aligned_cols=254  Identities=22%  Similarity=0.263  Sum_probs=201.7

Q ss_pred             hhcCCCCCceecccCcEEEEEEEeC-CCcEEEEEEEeccchhhH---HHHHHHHHHHHHHhhcCCCCcceeeeeeecC-c
Q 012765          140 ATDNFNSENLIGKGGHAEVYKGCLP-DGEVVAVKKIIKNAKEDE---ERISDFLSELGIVAHINHPNAAKLIGFSTEN-G  214 (457)
Q Consensus       140 ~~~~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~---~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~-~  214 (457)
                      ..++|.+.+.||+|+||.||+|... +|+.||+|.+........   .....+.+|+.++..++||||+++++++.+. .
T Consensus        10 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~   89 (361)
T 2yab_A           10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTD   89 (361)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred             hhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCE
Confidence            4577899999999999999999865 689999999876433211   1235788999999999999999999976654 5


Q ss_pred             eEEEEEecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCC----cEEEeeccc
Q 012765          215 FHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDY----EAQISDFGL  290 (457)
Q Consensus       215 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~----~~kL~DFGl  290 (457)
                      +++||||+++|+|.+++.. ...+++..+..++.||+.||.|||+   .+|+||||||+|||++.++    .+||+|||+
T Consensus        90 ~~lv~e~~~gg~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~~LH~---~givHrDlkp~NIll~~~~~~~~~vkl~DFG~  165 (361)
T 2yab_A           90 VVLILELVSGGELFDFLAQ-KESLSEEEATSFIKQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGL  165 (361)
T ss_dssp             EEEEEECCCSCBHHHHHTT-CSCCBHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCTTSSSCCEEECCCSS
T ss_pred             EEEEEEcCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEeCCCCCccCEEEEecCC
Confidence            7899999999999999854 3468999999999999999999999   8999999999999998876    799999999


Q ss_pred             cccCCCCCCceeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhccccccCCccccc
Q 012765          291 AKWLPDNWSHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSNFKELV  370 (457)
Q Consensus       291 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~  370 (457)
                      +..+.....   .....||+.|+|||++.+..++.++|||||||++|+|++|..||............. ....    -.
T Consensus       166 a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~-~~~~----~~  237 (361)
T 2yab_A          166 AHEIEDGVE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANIT-AVSY----DF  237 (361)
T ss_dssp             CEECCTTCC---CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHH-TTCC----CC
T ss_pred             ceEcCCCCc---cccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH-hcCC----CC
Confidence            987755422   234569999999999999999999999999999999999999998644322111000 0000    01


Q ss_pred             CchhhcccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 012765          371 DPRLADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQ  409 (457)
Q Consensus       371 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~  409 (457)
                      ++.....+    ...+.+++..||..||.+|||+.|+++
T Consensus       238 ~~~~~~~~----s~~~~~li~~~L~~dP~~R~t~~e~l~  272 (361)
T 2yab_A          238 DEEFFSQT----SELAKDFIRKLLVKETRKRLTIQEALR  272 (361)
T ss_dssp             CHHHHTTS----CHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             CchhccCC----CHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence            11111122    234667889999999999999999885

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=1.7e-43  Score=352.36  Aligned_cols=251  Identities=24%  Similarity=0.319  Sum_probs=196.9

Q ss_pred             hhcCCCCCceecccCcEEEEEEEeC-CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhc-CCCCcceeeeeeec-CceE
Q 012765          140 ATDNFNSENLIGKGGHAEVYKGCLP-DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHI-NHPNAAKLIGFSTE-NGFH  216 (457)
Q Consensus       140 ~~~~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~-~~~~  216 (457)
                      ..++|++.+.||+|+||+||+|.+. +|+.||+|++.+...........+.+|..++..+ +||||+++++++.+ +.++
T Consensus        21 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~  100 (353)
T 3txo_A           21 GIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLF  100 (353)
T ss_dssp             --CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred             chhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEE
Confidence            4578999999999999999999865 5899999998765443444556788999999988 79999999996655 4578


Q ss_pred             EEEEecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCCC
Q 012765          217 LVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPD  296 (457)
Q Consensus       217 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~  296 (457)
                      +||||+.+|+|..++... ..+++..+..++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||+++....
T Consensus       101 lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~---~givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~  176 (353)
T 3txo_A          101 FVMEFVNGGDLMFHIQKS-RRFDEARARFYAAEIISALMFLHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIC  176 (353)
T ss_dssp             EEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred             EEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHH---CCCcccCCCHHHEEECCCCCEEEccccceeeccc
Confidence            999999999999998653 458999999999999999999999   8999999999999999999999999999986433


Q ss_pred             CCCceeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhccccccCCcccccCchhhc
Q 012765          297 NWSHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSNFKELVDPRLAD  376 (457)
Q Consensus       297 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  376 (457)
                      ..  ......+||+.|+|||++.+..|+.++|||||||++|||++|+.||.......... ........+.        .
T Consensus       177 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~-~i~~~~~~~p--------~  245 (353)
T 3txo_A          177 NG--VTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFE-AILNDEVVYP--------T  245 (353)
T ss_dssp             -----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH-HHHHCCCCCC--------T
T ss_pred             CC--ccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHH-HHHcCCCCCC--------C
Confidence            22  12334569999999999998899999999999999999999999998654332111 1000111111        1


Q ss_pred             ccCHHHHHHHHHHHHHhcccCCCCCCCH------HHHHH
Q 012765          377 AYDLAEMKRAMLTASVCIHHLSTMRPQM------TRVLQ  409 (457)
Q Consensus       377 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt~------~evl~  409 (457)
                      .    ....+..++.+||+.||.+||++      .+|++
T Consensus       246 ~----~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~  280 (353)
T 3txo_A          246 W----LHEDATGILKSFMTKNPTMRLGSLTQGGEHAILR  280 (353)
T ss_dssp             T----SCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred             C----CCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhh
Confidence            1    12346678899999999999998      66665

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=2.1e-43  Score=345.01  Aligned_cols=266  Identities=25%  Similarity=0.359  Sum_probs=210.4

Q ss_pred             HHHHHHhhcCCCCCceecccCcEEEEEEEe------CCCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhc-CCCCccee
Q 012765          134 FAELAAATDNFNSENLIGKGGHAEVYKGCL------PDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHI-NHPNAAKL  206 (457)
Q Consensus       134 ~~~~~~~~~~f~~~~~LG~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l  206 (457)
                      ........++|.+.+.||+|+||+||+|.+      .+++.||+|.+.....  ......+.+|+.++..+ +||||+++
T Consensus        19 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~~hp~iv~~   96 (316)
T 2xir_A           19 ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT--HSEHRALMSELKILIHIGHHLNVVNL   96 (316)
T ss_dssp             HHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCC--HHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             ccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCC--cHHHHHHHHHHHHHHhcccCCCeeeE
Confidence            444445678999999999999999999974      3578999999865433  23456889999999999 79999999


Q ss_pred             eeeeecC--ceEEEEEecCCCChhhhhhcCCC---------------CCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCC
Q 012765          207 IGFSTEN--GFHLVLQFLPHGSLSSLLFGSTE---------------CLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRD  269 (457)
Q Consensus       207 ~~~~~~~--~~~lv~e~~~~gsL~~~l~~~~~---------------~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrD  269 (457)
                      ++++...  ..+++|||+++++|.+++.....               .+++..++.++.||+.||.|||+   .+|+|||
T Consensus        97 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~d  173 (316)
T 2xir_A           97 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRD  173 (316)
T ss_dssp             EEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHH---TTCCCSC
T ss_pred             EEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHh---CCccccc
Confidence            9976553  37899999999999999965433               27899999999999999999999   8999999


Q ss_pred             CCCCcEEEcCCCcEEEeeccccccCCCCCCceeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHh-CCCCCCc
Q 012765          270 IKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELIT-GRRAVDS  348 (457)
Q Consensus       270 lkp~NIll~~~~~~kL~DFGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLlt-G~~pf~~  348 (457)
                      |||+||+++.++.+||+|||++..+.............||+.|+|||++.+..++.++|||||||++|||+| |..||..
T Consensus       174 ikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~  253 (316)
T 2xir_A          174 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG  253 (316)
T ss_dssp             CSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred             CccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcc
Confidence            999999999999999999999987755443333344557899999999999999999999999999999998 9999976


Q ss_pred             CCcchhhhhccccccCCcccccCchhhcccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCC
Q 012765          349 RRQSLVIWAKPLLQTSNFKELVDPRLADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQLLRGEG  415 (457)
Q Consensus       349 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~  415 (457)
                      ........... .. ..     ........    ...+.+++.+||+.||.+|||+.+|++.|+.+.
T Consensus       254 ~~~~~~~~~~~-~~-~~-----~~~~~~~~----~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~  309 (316)
T 2xir_A          254 VKIDEEFCRRL-KE-GT-----RMRAPDYT----TPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL  309 (316)
T ss_dssp             CCCSHHHHHHH-HH-TC-----CCCCCTTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             cchhHHHHHHh-cc-Cc-----cCCCCCCC----CHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence            44322111110 00 00     01111111    234677889999999999999999999998753

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=4.6e-43  Score=338.88  Aligned_cols=261  Identities=25%  Similarity=0.341  Sum_probs=196.0

Q ss_pred             cCCCCCceecccCcEEEEEEEeCCCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeec-CceEEEEE
Q 012765          142 DNFNSENLIGKGGHAEVYKGCLPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTE-NGFHLVLQ  220 (457)
Q Consensus       142 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-~~~~lv~e  220 (457)
                      ++|.+.+.||+|+||+||+|...+|+.||+|++...... ......+.+|+.+++.++||||+++++++.. +..++|||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (288)
T 1ob3_A            2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKED-EGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFE   80 (288)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGG-GCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEE
T ss_pred             ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccc-cccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEE
Confidence            578889999999999999999888999999998654322 1223567899999999999999999996655 55789999


Q ss_pred             ecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCCCCCCc
Q 012765          221 FLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSH  300 (457)
Q Consensus       221 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~~~~~  300 (457)
                      |+.+ +|.+++......+++..+..++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||++........ 
T Consensus        81 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-  155 (288)
T 1ob3_A           81 HLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHD---RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR-  155 (288)
T ss_dssp             CCSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC----
T ss_pred             ecCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCCEEEeECccccccCcccc-
Confidence            9975 8888887666778999999999999999999999   8999999999999999999999999999987643221 


Q ss_pred             eeeecccccccccChhccccC-CCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhc-cccccC------Cccc--cc
Q 012765          301 HIVFPIEGTFGYLSPEYFMHG-IVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAK-PLLQTS------NFKE--LV  370 (457)
Q Consensus       301 ~~~~~~~gt~~y~aPE~~~~~-~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~-~~~~~~------~~~~--~~  370 (457)
                       ......||+.|+|||++.+. .++.++|||||||++|||++|+.||............ ......      ...+  ..
T Consensus       156 -~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (288)
T 1ob3_A          156 -KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKY  234 (288)
T ss_dssp             -------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTC
T ss_pred             -ccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhccccc
Confidence             12234589999999998764 5899999999999999999999999864432211100 000000      0000  00


Q ss_pred             Cchhh-------cccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 012765          371 DPRLA-------DAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQ  409 (457)
Q Consensus       371 d~~l~-------~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~  409 (457)
                      ++...       ..........+.+++.+||+.||++|||+.|+++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  280 (288)
T 1ob3_A          235 DPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE  280 (288)
T ss_dssp             CTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             ccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence            11000       0000112345678899999999999999999986

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=3.4e-43  Score=361.55  Aligned_cols=250  Identities=27%  Similarity=0.386  Sum_probs=201.0

Q ss_pred             hhcCCCCCceecccCcEEEEEEEeCCCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeecC--ceEE
Q 012765          140 ATDNFNSENLIGKGGHAEVYKGCLPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTEN--GFHL  217 (457)
Q Consensus       140 ~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~--~~~l  217 (457)
                      ..++|.+.+.||+|+||.||+|.+ .|+.||||.+....     ....+.+|+.++++++||||+++++++...  ..++
T Consensus       191 ~~~~~~~~~~lG~G~fg~V~~~~~-~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~i  264 (450)
T 1k9a_A          191 NMKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYI  264 (450)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEESSCT-----TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEE
T ss_pred             ChHHeEEEeeecCcCCeeEEEEEe-cCCeEEEEEeCCch-----HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEE
Confidence            457788899999999999999987 47899999986543     235789999999999999999999976543  5789


Q ss_pred             EEEecCCCChhhhhhcCCC-CCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCCC
Q 012765          218 VLQFLPHGSLSSLLFGSTE-CLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPD  296 (457)
Q Consensus       218 v~e~~~~gsL~~~l~~~~~-~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~  296 (457)
                      ||||+++|+|.+++..... .+++..++.++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||+++....
T Consensus       265 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~  341 (450)
T 1k9a_A          265 VTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS  341 (450)
T ss_dssp             EEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTSCEEECCCTTCEECC-
T ss_pred             EEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCHhhEEECCCCCEEEeeCCCcccccc
Confidence            9999999999999976443 47899999999999999999999   8999999999999999999999999999986543


Q ss_pred             CCCceeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHh-CCCCCCcCCcchhhhhccccccCCcccccCchhh
Q 012765          297 NWSHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELIT-GRRAVDSRRQSLVIWAKPLLQTSNFKELVDPRLA  375 (457)
Q Consensus       297 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLlt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  375 (457)
                      ..     ....++..|+|||++.+..++.++|||||||++|||+| |+.||............  .. .     ......
T Consensus       342 ~~-----~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i--~~-~-----~~~~~p  408 (450)
T 1k9a_A          342 TQ-----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRV--EK-G-----YKMDAP  408 (450)
T ss_dssp             ----------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHH--HT-T-----CCCCCC
T ss_pred             cc-----cCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH--Hc-C-----CCCCCC
Confidence            21     12247889999999999999999999999999999998 99999864322111100  00 0     000111


Q ss_pred             cccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCC
Q 012765          376 DAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQLLRGEG  415 (457)
Q Consensus       376 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~  415 (457)
                      ..    ....+.+++.+||+.||.+|||+.+|++.|+.+.
T Consensus       409 ~~----~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~  444 (450)
T 1k9a_A          409 DG----CPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIR  444 (450)
T ss_dssp             TT----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             Cc----CCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence            11    2245677889999999999999999999998764

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=1.1e-43  Score=345.01  Aligned_cols=269  Identities=25%  Similarity=0.350  Sum_probs=205.0

Q ss_pred             hcCCCCCceecccCcEEEEEEEe-----CCCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeec---
Q 012765          141 TDNFNSENLIGKGGHAEVYKGCL-----PDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTE---  212 (457)
Q Consensus       141 ~~~f~~~~~LG~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~---  212 (457)
                      .+.|++.+.||+|+||.||+|.+     .+++.||+|++.....  ......+.+|+.+++.++||||+++++++..   
T Consensus        20 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~   97 (302)
T 4e5w_A           20 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESG--GNHIADLKKEIEILRNLYHENIVKYKGICTEDGG   97 (302)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-------CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---
T ss_pred             hhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEeccccc--chhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCC
Confidence            35578889999999999999983     3689999999864432  2234678999999999999999999997765   


Q ss_pred             CceEEEEEecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccc
Q 012765          213 NGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAK  292 (457)
Q Consensus       213 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~  292 (457)
                      ...+++|||+++++|.+++......+++..++.++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||++.
T Consensus        98 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~  174 (302)
T 4e5w_A           98 NGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGS---RQYVHRDLAARNVLVESEHQVKIGDFGLTK  174 (302)
T ss_dssp             CCEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEECCCTTCE
T ss_pred             ceEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhc---CCcccCCCchheEEEcCCCCEEECcccccc
Confidence            34689999999999999997666779999999999999999999999   899999999999999999999999999998


Q ss_pred             cCCCCCCc-eeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhccccccCCcccccC
Q 012765          293 WLPDNWSH-HIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSNFKELVD  371 (457)
Q Consensus       293 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d  371 (457)
                      ........ .......||..|+|||++.+..++.++||||||+++|+|++|..|+............+.........+..
T Consensus       175 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (302)
T 4e5w_A          175 AIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVN  254 (302)
T ss_dssp             ECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHH
T ss_pred             cccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHH
Confidence            87654322 12234568888999999999999999999999999999999999875422111111111111110000000


Q ss_pred             ---chhhcccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q 012765          372 ---PRLADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQLLRGE  414 (457)
Q Consensus       372 ---~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~  414 (457)
                         ..............+.+++.+||+.||.+|||+.++++.|+.+
T Consensus       255 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l  300 (302)
T 4e5w_A          255 TLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEAL  300 (302)
T ss_dssp             HHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHH
Confidence               0000011112234677889999999999999999999999764

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=7.6e-43  Score=352.33  Aligned_cols=248  Identities=23%  Similarity=0.278  Sum_probs=193.4

Q ss_pred             hcCCCCCceecccCcEEEEEEEeC-CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhc-CCCCcceeeeeeec-CceEE
Q 012765          141 TDNFNSENLIGKGGHAEVYKGCLP-DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHI-NHPNAAKLIGFSTE-NGFHL  217 (457)
Q Consensus       141 ~~~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~-~~~~l  217 (457)
                      .++|.+.++||+|+||+||+|... +++.||+|++.+...........+.+|..++.++ +||||+++++++.. +.+++
T Consensus        51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l  130 (396)
T 4dc2_A           51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF  130 (396)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred             hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence            467889999999999999999865 5889999999765544444556788999999877 89999999996655 45789


Q ss_pred             EEEecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCCCC
Q 012765          218 VLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDN  297 (457)
Q Consensus       218 v~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~~  297 (457)
                      ||||+.+|+|..++... ..+++..+..++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||+++.....
T Consensus       131 V~E~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~LH~---~givHrDLKp~NILl~~~g~ikL~DFGla~~~~~~  206 (396)
T 4dc2_A          131 VIEYVNGGDLMFHMQRQ-RKLPEEHARFYSAEISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP  206 (396)
T ss_dssp             EEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred             EEEcCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHH---CCEEeccCCHHHEEECCCCCEEEeecceeeecccC
Confidence            99999999999988653 458999999999999999999999   89999999999999999999999999999864322


Q ss_pred             CCceeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchh------hhhccccccCCcccccC
Q 012765          298 WSHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLV------IWAKPLLQTSNFKELVD  371 (457)
Q Consensus       298 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~------~~~~~~~~~~~~~~~~d  371 (457)
                      .  ......+||+.|+|||++.+..|+.++|||||||++|||++|+.||........      .+........      .
T Consensus       207 ~--~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~------~  278 (396)
T 4dc2_A          207 G--DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEK------Q  278 (396)
T ss_dssp             T--CCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHC------C
T ss_pred             C--CccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhcc------c
Confidence            1  123346799999999999999999999999999999999999999964221100      0000000000      0


Q ss_pred             chhhcccCHHHHHHHHHHHHHhcccCCCCCCCH
Q 012765          372 PRLADAYDLAEMKRAMLTASVCIHHLSTMRPQM  404 (457)
Q Consensus       372 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~  404 (457)
                      ..+...    ....+..++.+||+.||.+||++
T Consensus       279 ~~~p~~----~s~~~~~li~~lL~~dP~~R~~~  307 (396)
T 4dc2_A          279 IRIPRS----LSVKAASVLKSFLNKDPKERLGC  307 (396)
T ss_dssp             CCCCTT----SCHHHHHHHHHHTCSCTTTSTTC
T ss_pred             cCCCCc----CCHHHHHHHHHHhcCCHhHcCCC
Confidence            111111    22356778899999999999995

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=4.9e-43  Score=353.77  Aligned_cols=252  Identities=17%  Similarity=0.304  Sum_probs=193.4

Q ss_pred             hcCCCCCceecccCcEEEEEEEeCCCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcC--CCCcceeeeeeecCc-eEE
Q 012765          141 TDNFNSENLIGKGGHAEVYKGCLPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHIN--HPNAAKLIGFSTENG-FHL  217 (457)
Q Consensus       141 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~--hpniv~l~~~~~~~~-~~l  217 (457)
                      .++|.+.+.||+|+||.||+|.+.+++.||||++..... .......+.+|+.++..++  ||||+++++++...+ +++
T Consensus        55 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~l  133 (390)
T 2zmd_A           55 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEA-DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM  133 (390)
T ss_dssp             TEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred             CCceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccc-cHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEE
Confidence            356889999999999999999988899999999865433 3345678999999999996  599999999776554 678


Q ss_pred             EEEecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCCCC
Q 012765          218 VLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDN  297 (457)
Q Consensus       218 v~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~~  297 (457)
                      ||| +.+++|.+++.... .+++..++.++.||+.||.|||+   .+|+||||||+|||++ ++.+||+|||+++.+...
T Consensus       134 v~E-~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~lH~---~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~  207 (390)
T 2zmd_A          134 VME-CGNIDLNSWLKKKK-SIDPWERKSYWKNMLEAVHTIHQ---HGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPD  207 (390)
T ss_dssp             EEE-CCSEEHHHHHHHCS-SCCHHHHHHHHHHHHHHHHHHHT---TTCCCCCCCGGGEEES-SSCEEECCCSSSCCC---
T ss_pred             EEe-cCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHEEEE-CCeEEEEecCccccccCC
Confidence            889 67889999986543 67888899999999999999999   8999999999999995 579999999999877544


Q ss_pred             CCceeeecccccccccChhcccc-----------CCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhccccccCCc
Q 012765          298 WSHHIVFPIEGTFGYLSPEYFMH-----------GIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSNF  366 (457)
Q Consensus       298 ~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~~~~~~~~~  366 (457)
                      ..........||+.|+|||++.+           ..++.++|||||||++|||++|+.||...........         
T Consensus       208 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~---------  278 (390)
T 2zmd_A          208 TTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLH---------  278 (390)
T ss_dssp             ------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHH---------
T ss_pred             CccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHH---------
Confidence            33222344569999999999865           4689999999999999999999999976432211111         


Q ss_pred             ccccCchhhcccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 012765          367 KELVDPRLADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQ  409 (457)
Q Consensus       367 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~  409 (457)
                       .++++.....+.......+.+++.+||+.||.+|||+.||++
T Consensus       279 -~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~  320 (390)
T 2zmd_A          279 -AIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA  320 (390)
T ss_dssp             -HHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             -HHhCccccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhh
Confidence             111111111111111235677889999999999999999987

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=2.1e-43  Score=349.25  Aligned_cols=248  Identities=20%  Similarity=0.298  Sum_probs=196.8

Q ss_pred             hcCCCCCceecccCcEEEEEEEe-CCCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeec-CceEEE
Q 012765          141 TDNFNSENLIGKGGHAEVYKGCL-PDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTE-NGFHLV  218 (457)
Q Consensus       141 ~~~f~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-~~~~lv  218 (457)
                      .++|.+.+.||+|+||.||+|.+ .+++.||+|++.............+.+|+.+++.++||||+++++++.. +..++|
T Consensus         8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv   87 (336)
T 3h4j_B            8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMV   87 (336)
T ss_dssp             ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence            46788999999999999999986 5789999999865432222223578899999999999999999997655 456899


Q ss_pred             EEecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCCCCC
Q 012765          219 LQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNW  298 (457)
Q Consensus       219 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~~~  298 (457)
                      |||+ +|+|.+++... ..+++..++.++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||++.......
T Consensus        88 ~E~~-~g~l~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~---~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~  162 (336)
T 3h4j_B           88 IEYA-GGELFDYIVEK-KRMTEDEGRRFFQQIICAIEYCHR---HKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGN  162 (336)
T ss_dssp             ECCC-CEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHH---HTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTSB
T ss_pred             EECC-CCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCchhhEEEcCCCCEEEEEeccceeccCCc
Confidence            9999 78898888553 458999999999999999999999   899999999999999999999999999998765432


Q ss_pred             CceeeecccccccccChhccccCCC-CcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhccccccCCcccccCchhhcc
Q 012765          299 SHHIVFPIEGTFGYLSPEYFMHGIV-DEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSNFKELVDPRLADA  377 (457)
Q Consensus       299 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~  377 (457)
                      .   .....||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.........  .. ....      ...+...
T Consensus       163 ~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~--~~-i~~~------~~~~p~~  230 (336)
T 3h4j_B          163 F---LKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLF--KK-VNSC------VYVMPDF  230 (336)
T ss_dssp             T---TCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCB--CC-CCSS------CCCCCTT
T ss_pred             c---cccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHH--HH-HHcC------CCCCccc
Confidence            2   234569999999999988776 78999999999999999999999863321110  00 0000      0001111


Q ss_pred             cCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 012765          378 YDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQ  409 (457)
Q Consensus       378 ~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~  409 (457)
                      +    ...+.+++.+||+.||.+|||+.|+++
T Consensus       231 ~----s~~~~~li~~~L~~dP~~Rpt~~eil~  258 (336)
T 3h4j_B          231 L----SPGAQSLIRRMIVADPMQRITIQEIRR  258 (336)
T ss_dssp             S----CHHHHHHHHTTSCSSGGGSCCHHHHTT
T ss_pred             C----CHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence            2    234667889999999999999999987

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=4.7e-43  Score=345.56  Aligned_cols=259  Identities=18%  Similarity=0.181  Sum_probs=202.3

Q ss_pred             hcCCCCCceecccCcEEEEEEEe-CCCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhc-CCCCcceeeeeeecCc-eEE
Q 012765          141 TDNFNSENLIGKGGHAEVYKGCL-PDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHI-NHPNAAKLIGFSTENG-FHL  217 (457)
Q Consensus       141 ~~~f~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~-~~l  217 (457)
                      .++|.+.+.||+|+||+||+|.. .+++.||||.+......     ..+.+|+.+++.+ +||||+++++++..+. .++
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~l   82 (330)
T 2izr_A            8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRA-----PQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAM   82 (330)
T ss_dssp             TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCSS-----CCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEE
T ss_pred             cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccch-----HHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEE
Confidence            46788999999999999999986 47899999988654322     2578899999999 9999999999776655 589


Q ss_pred             EEEecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCc-----EEEeeccccc
Q 012765          218 VLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYE-----AQISDFGLAK  292 (457)
Q Consensus       218 v~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~-----~kL~DFGl~~  292 (457)
                      ||||+ +++|.+++......+++..++.++.||+.||.|||+   .+|+||||||+|||++.++.     +||+|||+++
T Consensus        83 v~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~---~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~  158 (330)
T 2izr_A           83 VLELL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHS---KNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAK  158 (330)
T ss_dssp             EEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCE
T ss_pred             EEEeC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeeeccCCCCCCceEEEEEcccce
Confidence            99999 999999997766789999999999999999999999   89999999999999998887     9999999998


Q ss_pred             cCCCCCCce-----eeecccccccccChhccccCCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhccccccCCcc
Q 012765          293 WLPDNWSHH-----IVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSNFK  367 (457)
Q Consensus       293 ~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~  367 (457)
                      .+.......     ......||+.|+|||++.+..++.++|||||||++|||++|+.||.....................
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~  238 (330)
T 2izr_A          159 EYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRA  238 (330)
T ss_dssp             ESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHH
T ss_pred             eeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhcc
Confidence            764432211     123456999999999999999999999999999999999999999864322111000000000000


Q ss_pred             cccCchhhcccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q 012765          368 ELVDPRLADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQLLRGE  414 (457)
Q Consensus       368 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~  414 (457)
                       .....+...    .. .+..++..||+.||.+||++.+|++.|+.+
T Consensus       239 -~~~~~~~~~----~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~  279 (330)
T 2izr_A          239 -TPIEVLCEN----FP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDL  279 (330)
T ss_dssp             -SCHHHHTTT----CH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHH
T ss_pred             -CCHHHHhcc----Ch-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHH
Confidence             000000000    11 677888999999999999999999988754

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=1.8e-43  Score=345.67  Aligned_cols=261  Identities=22%  Similarity=0.289  Sum_probs=197.8

Q ss_pred             hhcCCCCCceecccCcEEEEEEEe-CCCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeecCc----
Q 012765          140 ATDNFNSENLIGKGGHAEVYKGCL-PDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTENG----  214 (457)
Q Consensus       140 ~~~~f~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~----  214 (457)
                      ..++|.+.+.||+|+||.||+|.+ .+++.||+|++.............+.+|+.++.+++||||+++++++....    
T Consensus        10 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~   89 (311)
T 3ork_A           10 LSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGP   89 (311)
T ss_dssp             ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEE
T ss_pred             ecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCc
Confidence            357899999999999999999986 578999999997765555566778999999999999999999999655432    


Q ss_pred             -eEEEEEecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeecccccc
Q 012765          215 -FHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKW  293 (457)
Q Consensus       215 -~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~  293 (457)
                       .++||||+++++|.+++... ..+++..++.++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||++..
T Consensus        90 ~~~lv~e~~~g~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~  165 (311)
T 3ork_A           90 LPYIVMEYVDGVTLRDIVHTE-GPMTPKRAIEVIADACQALNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIARA  165 (311)
T ss_dssp             EEEEEEECCCEEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEEETTSCEEECCCSCC--
T ss_pred             ccEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH---CCCCcCCCCHHHEEEcCCCCEEEeeccCccc
Confidence             38999999999999998643 358999999999999999999999   8999999999999999999999999999987


Q ss_pred             CCCCCCc-eeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhccccccCCcccccCc
Q 012765          294 LPDNWSH-HIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSNFKELVDP  372 (457)
Q Consensus       294 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~  372 (457)
                      +...... .......||+.|+|||++.+..++.++|||||||++|||++|+.||.........+.....  .    ...+
T Consensus       166 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~--~----~~~~  239 (311)
T 3ork_A          166 IADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVRE--D----PIPP  239 (311)
T ss_dssp             ----------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHC--C----CCCH
T ss_pred             ccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcC--C----CCCc
Confidence            6543221 1223355899999999999999999999999999999999999999875543322211100  0    0001


Q ss_pred             hhhcccCHHHHHHHHHHHHHhcccCCCCCCCHHHHH-HHHhc
Q 012765          373 RLADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVL-QLLRG  413 (457)
Q Consensus       373 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl-~~L~~  413 (457)
                      ...   .......+..++.+||+.||.+||++.+++ ..|..
T Consensus       240 ~~~---~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~  278 (311)
T 3ork_A          240 SAR---HEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVR  278 (311)
T ss_dssp             HHH---STTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred             ccc---cCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHH
Confidence            000   011224567788999999999999766554 44443

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=6.1e-43  Score=343.46  Aligned_cols=247  Identities=23%  Similarity=0.331  Sum_probs=199.8

Q ss_pred             hcCCCCCceecccCcEEEEEEEeC-CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeec-CceEEE
Q 012765          141 TDNFNSENLIGKGGHAEVYKGCLP-DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTE-NGFHLV  218 (457)
Q Consensus       141 ~~~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-~~~~lv  218 (457)
                      .++|.+.+.||+|+||.||+|... +|+.||+|++.+...........+.+|..+++.++||||+++++++.+ ...++|
T Consensus         5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv   84 (318)
T 1fot_A            5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI   84 (318)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred             hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEE
Confidence            367889999999999999999865 699999999865433222335678899999999999999999996655 457899


Q ss_pred             EEecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCCCCC
Q 012765          219 LQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNW  298 (457)
Q Consensus       219 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~~~  298 (457)
                      |||+++|+|.+++... ..+++..+..++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||+++..... 
T Consensus        85 ~e~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~-  159 (318)
T 1fot_A           85 MDYIEGGELFSLLRKS-QRFPNPVAKFYAAEVCLALEYLHS---KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV-  159 (318)
T ss_dssp             ECCCCSCBHHHHHHHT-SSCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC-
T ss_pred             EeCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCChheEEEcCCCCEEEeecCcceecCCc-
Confidence            9999999999999653 458899999999999999999999   89999999999999999999999999999876542 


Q ss_pred             CceeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhccccccCCcccccCchhhccc
Q 012765          299 SHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSNFKELVDPRLADAY  378 (457)
Q Consensus       299 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~  378 (457)
                          .....||+.|+|||++.+..++.++|||||||++|||++|+.||......... .........        +...+
T Consensus       160 ----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~-~~i~~~~~~--------~p~~~  226 (318)
T 1fot_A          160 ----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTY-EKILNAELR--------FPPFF  226 (318)
T ss_dssp             ----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHH-HHHHHCCCC--------CCTTS
T ss_pred             ----cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHH-HHHHhCCCC--------CCCCC
Confidence                22356999999999999999999999999999999999999999864432211 110000011        11112


Q ss_pred             CHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 012765          379 DLAEMKRAMLTASVCIHHLSTMRP-----QMTRVLQ  409 (457)
Q Consensus       379 ~~~~~~~l~~l~~~Cl~~dP~~RP-----t~~evl~  409 (457)
                          ...+.+++.+||+.||.+||     ++.+|++
T Consensus       227 ----~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~  258 (318)
T 1fot_A          227 ----NEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN  258 (318)
T ss_dssp             ----CHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred             ----CHHHHHHHHHHhccCHHHcCCCcCCCHHHHhc
Confidence                23566788999999999999     8888875

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=2.9e-43  Score=347.66  Aligned_cols=259  Identities=22%  Similarity=0.363  Sum_probs=205.2

Q ss_pred             hhcCCCCCceecccCcEEEEEEEeC--------CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhc-CCCCcceeeeee
Q 012765          140 ATDNFNSENLIGKGGHAEVYKGCLP--------DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHI-NHPNAAKLIGFS  210 (457)
Q Consensus       140 ~~~~f~~~~~LG~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~  210 (457)
                      ..++|.+.+.||+|+||.||+|.+.        ++..||+|++....  .......+.+|+.++..+ +||||+++++++
T Consensus        33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~  110 (334)
T 2pvf_A           33 PRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLLGAC  110 (334)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             CHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCC--cHHHHHHHHHHHHHHHHhhcCCCEeeEEEEE
Confidence            3578889999999999999999863        46789999986543  234467899999999999 899999999976


Q ss_pred             ecC-ceEEEEEecCCCChhhhhhcCC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCc
Q 012765          211 TEN-GFHLVLQFLPHGSLSSLLFGST---------------ECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASN  274 (457)
Q Consensus       211 ~~~-~~~lv~e~~~~gsL~~~l~~~~---------------~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~N  274 (457)
                      ... ..++||||+++|+|.+++....               ..+++..++.++.||+.||.|||+   .+|+||||||+|
T Consensus       111 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~N  187 (334)
T 2pvf_A          111 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS---QKCIHRDLAARN  187 (334)
T ss_dssp             CSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGG
T ss_pred             ccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCccce
Confidence            654 5789999999999999996533               248899999999999999999999   899999999999


Q ss_pred             EEEcCCCcEEEeeccccccCCCCCCceeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHh-CCCCCCcCCcch
Q 012765          275 ILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELIT-GRRAVDSRRQSL  353 (457)
Q Consensus       275 Ill~~~~~~kL~DFGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLlt-G~~pf~~~~~~~  353 (457)
                      ||++.++.+||+|||++................+|+.|+|||++.+..++.++|||||||++|||++ |..||.......
T Consensus       188 Ill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~  267 (334)
T 2pvf_A          188 VLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE  267 (334)
T ss_dssp             EEECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH
T ss_pred             EEEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHHH
Confidence            9999999999999999987765433222333457889999999998889999999999999999999 999997643322


Q ss_pred             hhhhccccccCCcccccCchhhcccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCC
Q 012765          354 VIWAKPLLQTSNFKELVDPRLADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQLLRGEG  415 (457)
Q Consensus       354 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~  415 (457)
                      .....  .. ..     .......    ....+..++.+||+.||.+|||+.+|++.|+.+.
T Consensus       268 ~~~~~--~~-~~-----~~~~~~~----~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~  317 (334)
T 2pvf_A          268 LFKLL--KE-GH-----RMDKPAN----CTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL  317 (334)
T ss_dssp             HHHHH--HH-TC-----CCCCCTT----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHHHH--hc-CC-----CCCCCcc----CCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence            11100  00 00     0111111    2235677889999999999999999999998764

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=8.4e-43  Score=338.59  Aligned_cols=251  Identities=22%  Similarity=0.314  Sum_probs=193.1

Q ss_pred             hcCCCCCceecccCcEEEEEEEeC-CCcEEEEEEEeccchhh-----------------------HHHHHHHHHHHHHHh
Q 012765          141 TDNFNSENLIGKGGHAEVYKGCLP-DGEVVAVKKIIKNAKED-----------------------EERISDFLSELGIVA  196 (457)
Q Consensus       141 ~~~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-----------------------~~~~~~~~~E~~~l~  196 (457)
                      .++|.+.+.||+|+||.||+|.+. +++.||+|++.......                       ....+.+.+|+.+++
T Consensus        12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~   91 (298)
T 2zv2_A           12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK   91 (298)
T ss_dssp             ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred             ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence            478889999999999999999864 68999999986543211                       112457899999999


Q ss_pred             hcCCCCcceeeeeeec---CceEEEEEecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCC
Q 012765          197 HINHPNAAKLIGFSTE---NGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKAS  273 (457)
Q Consensus       197 ~l~hpniv~l~~~~~~---~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~  273 (457)
                      .++||||+++++++.+   +..++||||+++++|.+++  ....+++..++.++.||+.||.|||+   .+|+||||||+
T Consensus        92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~  166 (298)
T 2zv2_A           92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVP--TLKPLSEDQARFYFQDLIKGIEYLHY---QKIIHRDIKPS  166 (298)
T ss_dssp             TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSS--CSSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGG
T ss_pred             hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHH
Confidence            9999999999997764   4478999999999998876  34568999999999999999999999   89999999999


Q ss_pred             cEEEcCCCcEEEeeccccccCCCCCCceeeecccccccccChhccccCC---CCcchhHHHHHHHHHHHHhCCCCCCcCC
Q 012765          274 NILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEGTFGYLSPEYFMHGI---VDEKTDVFAFGVLLLELITGRRAVDSRR  350 (457)
Q Consensus       274 NIll~~~~~~kL~DFGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~ksDvwSlGvll~eLltG~~pf~~~~  350 (457)
                      |||++.++.+||+|||++........  ......||+.|+|||++.+..   ++.++|||||||++|+|++|+.||....
T Consensus       167 Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~  244 (298)
T 2zv2_A          167 NLLVGEDGHIKIADFGVSNEFKGSDA--LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDER  244 (298)
T ss_dssp             GEEECTTSCEEECCCTTCEECSSSSC--EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             HEEECCCCCEEEecCCCccccccccc--cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCcc
Confidence            99999999999999999987654322  223456999999999997665   3788999999999999999999998643


Q ss_pred             cchhhhhccccccCCcccccCchhhcccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 012765          351 QSLVIWAKPLLQTSNFKELVDPRLADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQ  409 (457)
Q Consensus       351 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~  409 (457)
                      ......  ... .....   .+. ...+    ...+.+++.+||+.||++|||+.|+++
T Consensus       245 ~~~~~~--~~~-~~~~~---~~~-~~~~----~~~l~~li~~~l~~dp~~R~s~~e~l~  292 (298)
T 2zv2_A          245 IMCLHS--KIK-SQALE---FPD-QPDI----AEDLKDLITRMLDKNPESRIVVPEIKL  292 (298)
T ss_dssp             HHHHHH--HHH-HCCCC---CCS-SSCC----CHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             HHHHHH--HHh-cccCC---CCC-cccc----CHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence            321110  000 00000   000 0111    235678889999999999999999875

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=1.5e-43  Score=361.97  Aligned_cols=264  Identities=19%  Similarity=0.210  Sum_probs=205.4

Q ss_pred             HHHHHHhhcCCCCCceecccCcEEEEEEEeC-CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeec
Q 012765          134 FAELAAATDNFNSENLIGKGGHAEVYKGCLP-DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTE  212 (457)
Q Consensus       134 ~~~~~~~~~~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~  212 (457)
                      +.++....++|.+.++||+|+||+||+|.+. +++.||+|++.+...........+.+|..++..++||||+++++++.+
T Consensus        66 ~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~  145 (437)
T 4aw2_A           66 VKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQD  145 (437)
T ss_dssp             HHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEEC
T ss_pred             hhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee
Confidence            4455566789999999999999999999876 478999999865332222223348899999999999999999996655


Q ss_pred             -CceEEEEEecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeecccc
Q 012765          213 -NGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLA  291 (457)
Q Consensus       213 -~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~  291 (457)
                       +.+++||||+++|+|.+++......+++..+..++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||++
T Consensus       146 ~~~~~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~---~giiHrDLKp~NILl~~~g~vkL~DFGla  222 (437)
T 4aw2_A          146 DNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQ---LHYVHRDIKPDNILMDMNGHIRLADFGSC  222 (437)
T ss_dssp             SSEEEEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred             CCEEEEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHh---CCeEecccCHHHeeEcCCCCEEEcchhhh
Confidence             45789999999999999997766779999999999999999999999   89999999999999999999999999999


Q ss_pred             ccCCCCCCceeeecccccccccChhccc-----cCCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhccccccCCc
Q 012765          292 KWLPDNWSHHIVFPIEGTFGYLSPEYFM-----HGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSNF  366 (457)
Q Consensus       292 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~~~~~~~~~  366 (457)
                      +.+..... .......||+.|+|||++.     ...|+.++|||||||++|||++|+.||............  ....  
T Consensus       223 ~~~~~~~~-~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i--~~~~--  297 (437)
T 4aw2_A          223 LKLMEDGT-VQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKI--MNHK--  297 (437)
T ss_dssp             EECCTTSC-EECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH--HTHH--
T ss_pred             hhcccCCC-cccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhh--hhcc--
Confidence            87654332 2223457999999999987     567899999999999999999999999864432211110  0000  


Q ss_pred             ccccCchhhcccCHHHHHHHHHHHHHhcccCCCC--CCCHHHHHH
Q 012765          367 KELVDPRLADAYDLAEMKRAMLTASVCIHHLSTM--RPQMTRVLQ  409 (457)
Q Consensus       367 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~--RPt~~evl~  409 (457)
                      ..+.-|.....+    ...+.+++.+||..+|++  ||++.||++
T Consensus       298 ~~~~~p~~~~~~----s~~~~dLi~~lL~~~~~r~~r~~~~eil~  338 (437)
T 4aw2_A          298 ERFQFPTQVTDV----SENAKDLIRRLICSREHRLGQNGIEDFKK  338 (437)
T ss_dssp             HHCCCCSSCCCS----CHHHHHHHHTTSSCGGGCTTTTTTHHHHT
T ss_pred             ccccCCcccccC----CHHHHHHHHHHhcccccccCCCCHHHHhC
Confidence            000001111112    234567888899888888  999999987

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=8.1e-43  Score=343.65  Aligned_cols=254  Identities=23%  Similarity=0.253  Sum_probs=200.5

Q ss_pred             hhcCCCCCceecccCcEEEEEEEeC-CCcEEEEEEEeccchhhH---HHHHHHHHHHHHHhhcCCCCcceeeeeeecC-c
Q 012765          140 ATDNFNSENLIGKGGHAEVYKGCLP-DGEVVAVKKIIKNAKEDE---ERISDFLSELGIVAHINHPNAAKLIGFSTEN-G  214 (457)
Q Consensus       140 ~~~~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~---~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~-~  214 (457)
                      ..++|.+.+.||+|+||.||+|... +|+.||+|.+........   .....+.+|+.+++.++||||+++++++... .
T Consensus         9 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~   88 (326)
T 2y0a_A            9 VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTD   88 (326)
T ss_dssp             HHHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred             cccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCE
Confidence            3466889999999999999999875 589999998865432211   1245788999999999999999999976654 5


Q ss_pred             eEEEEEecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCC----cEEEeeccc
Q 012765          215 FHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDY----EAQISDFGL  290 (457)
Q Consensus       215 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~----~~kL~DFGl  290 (457)
                      .++||||+++++|.+++.. ...+++..++.++.||+.||.|||+   .+|+||||||+|||++.++    .+||+|||+
T Consensus        89 ~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~  164 (326)
T 2y0a_A           89 VILILELVAGGELFDFLAE-KESLTEEEATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGL  164 (326)
T ss_dssp             EEEEEECCCSCBHHHHHTT-SSCCBHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESCSSSSSCCEEECCCTT
T ss_pred             EEEEEEcCCCCCHHHHHHh-cCCcCHHHHHHHHHHHHHHHHHHHH---CCeEcCCCCHHHEEEecCCCCCCCEEEEECCC
Confidence            7899999999999999854 3568999999999999999999999   8999999999999999887    799999999


Q ss_pred             cccCCCCCCceeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhccccccCCccccc
Q 012765          291 AKWLPDNWSHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSNFKELV  370 (457)
Q Consensus       291 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~  370 (457)
                      +..+.....   .....||+.|+|||++.+..++.++|||||||++|+|++|..||............. .....    .
T Consensus       165 a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~-~~~~~----~  236 (326)
T 2y0a_A          165 AHKIDFGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVS-AVNYE----F  236 (326)
T ss_dssp             CEECCTTSC---CCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHH-HTCCC----C
T ss_pred             CeECCCCCc---cccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHH-hcCCC----c
Confidence            987754322   223459999999999998999999999999999999999999997644322111100 00000    0


Q ss_pred             CchhhcccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 012765          371 DPRLADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQ  409 (457)
Q Consensus       371 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~  409 (457)
                      ........    ...+.+++.+||+.||.+|||+.|+++
T Consensus       237 ~~~~~~~~----~~~~~~li~~~L~~dP~~Rpt~~e~l~  271 (326)
T 2y0a_A          237 EDEYFSNT----SALAKDFIRRLLVKDPKKRMTIQDSLQ  271 (326)
T ss_dssp             CHHHHTTS----CHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             CccccccC----CHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            11111111    234667889999999999999999987

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=2.5e-42  Score=334.88  Aligned_cols=259  Identities=27%  Similarity=0.395  Sum_probs=200.5

Q ss_pred             hcCCCCCceecccCcEEEEEEEeCC----CcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeee--cCc
Q 012765          141 TDNFNSENLIGKGGHAEVYKGCLPD----GEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFST--ENG  214 (457)
Q Consensus       141 ~~~f~~~~~LG~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~--~~~  214 (457)
                      ..+|.+.+.||+|+||+||+|.+.+    ...+|+|.+....  .......+.+|+.++++++||||+++++++.  ++.
T Consensus        24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  101 (298)
T 3f66_A           24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT--DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGS  101 (298)
T ss_dssp             GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCC--SHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSC
T ss_pred             ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCC--CHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCc
Confidence            3457788999999999999998542    2358889876433  3345678999999999999999999999754  345


Q ss_pred             eEEEEEecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccC
Q 012765          215 FHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWL  294 (457)
Q Consensus       215 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~  294 (457)
                      .+++|||+.+|+|.+++......+++..++.++.|++.||.|||+   .+|+||||||+||+++.++.+||+|||++...
T Consensus       102 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~  178 (298)
T 3f66_A          102 PLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLARDM  178 (298)
T ss_dssp             CEEEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTCCEEECSCGGGCCC
T ss_pred             eEEEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCchheEEECCCCCEEECcccccccc
Confidence            789999999999999998777778999999999999999999999   89999999999999999999999999999876


Q ss_pred             CCCCC--ceeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHh-CCCCCCcCCcchhhhhccccccCCcccccC
Q 012765          295 PDNWS--HHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELIT-GRRAVDSRRQSLVIWAKPLLQTSNFKELVD  371 (457)
Q Consensus       295 ~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLlt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~d  371 (457)
                      .....  ........+|+.|+|||.+.+..++.++||||||+++|+|++ |.+||............  ....   ....
T Consensus       179 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~--~~~~---~~~~  253 (298)
T 3f66_A          179 YDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYL--LQGR---RLLQ  253 (298)
T ss_dssp             SCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHH--HTTC---CCCC
T ss_pred             cccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHH--hcCC---CCCC
Confidence            44321  112233457889999999999999999999999999999999 55566543322111110  0000   0000


Q ss_pred             chhhcccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCCC
Q 012765          372 PRLADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQLLRGEGG  416 (457)
Q Consensus       372 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~  416 (457)
                      +   ..+    ...+.+++.+||+.||.+|||+.++++.|+.+..
T Consensus       254 ~---~~~----~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~  291 (298)
T 3f66_A          254 P---EYC----PDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFS  291 (298)
T ss_dssp             C---TTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             C---ccC----CHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence            1   111    2356778899999999999999999999987654

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=7.4e-43  Score=346.25  Aligned_cols=252  Identities=18%  Similarity=0.310  Sum_probs=193.0

Q ss_pred             hcCCCCCceecccCcEEEEEEEeCCCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCC--CCcceeeeeeecCc-eEE
Q 012765          141 TDNFNSENLIGKGGHAEVYKGCLPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINH--PNAAKLIGFSTENG-FHL  217 (457)
Q Consensus       141 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h--pniv~l~~~~~~~~-~~l  217 (457)
                      .++|.+.+.||+|+||.||+|.+.+++.||+|++..... .......+.+|+.++..++|  |||+++++++..+. .++
T Consensus         8 ~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~l   86 (343)
T 3dbq_A            8 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEA-DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM   86 (343)
T ss_dssp             SCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred             cCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeecccc-chHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEE
Confidence            467889999999999999999988899999999865433 33456789999999999976  99999999776655 568


Q ss_pred             EEEecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCCCC
Q 012765          218 VLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDN  297 (457)
Q Consensus       218 v~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~~  297 (457)
                      ||| +.+++|.+++... ..+++..+..++.||+.||.|||+   .+|+||||||+|||++ ++.+||+|||+++.+...
T Consensus        87 v~e-~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~lH~---~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~  160 (343)
T 3dbq_A           87 VME-CGNIDLNSWLKKK-KSIDPWERKSYWKNMLEAVHTIHQ---HGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPD  160 (343)
T ss_dssp             EEC-CCSEEHHHHHHHS-CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC---
T ss_pred             EEe-CCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCcceEEEE-CCcEEEeecccccccCcc
Confidence            888 6788999999653 458899999999999999999999   8999999999999997 678999999999877554


Q ss_pred             CCceeeecccccccccChhcccc-----------CCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhccccccCCc
Q 012765          298 WSHHIVFPIEGTFGYLSPEYFMH-----------GIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSNF  366 (457)
Q Consensus       298 ~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~~~~~~~~~  366 (457)
                      ..........||+.|+|||++.+           ..++.++|||||||++|||++|+.||...........         
T Consensus       161 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~---------  231 (343)
T 3dbq_A          161 TTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLH---------  231 (343)
T ss_dssp             ---------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHH---------
T ss_pred             cccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHH---------
Confidence            33323334569999999999865           6789999999999999999999999976333221111         


Q ss_pred             ccccCchhhcccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 012765          367 KELVDPRLADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQ  409 (457)
Q Consensus       367 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~  409 (457)
                       .++++.....+.......+.+++..||+.||.+|||+.|+++
T Consensus       232 -~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~  273 (343)
T 3dbq_A          232 -AIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA  273 (343)
T ss_dssp             -HHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             -HHhcCCcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHh
Confidence             111111111111111235667889999999999999999987

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=1.3e-42  Score=347.22  Aligned_cols=253  Identities=24%  Similarity=0.305  Sum_probs=200.8

Q ss_pred             hhcCCCCCceecccCcEEEEEEEeC-CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeecC-ceEE
Q 012765          140 ATDNFNSENLIGKGGHAEVYKGCLP-DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTEN-GFHL  217 (457)
Q Consensus       140 ~~~~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~-~~~l  217 (457)
                      ..++|.+.+.||+|+||.||+|.+. +|+.||+|++...... ......+.+|+.+++.++||||+++++++.+. ..++
T Consensus        27 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~l  105 (362)
T 2bdw_A           27 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLS-ARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYL  105 (362)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred             cccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCC-HHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEE
Confidence            4578999999999999999999865 6899999998754332 34456899999999999999999999976655 4689


Q ss_pred             EEEecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCC---cEEEeeccccccC
Q 012765          218 VLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDY---EAQISDFGLAKWL  294 (457)
Q Consensus       218 v~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~---~~kL~DFGl~~~~  294 (457)
                      ||||+.+|+|.+++.. ...+++..++.++.||+.||.|||+   .+|+||||||+|||++.++   .+||+|||++...
T Consensus       106 v~e~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~  181 (362)
T 2bdw_A          106 VFDLVTGGELFEDIVA-REFYSEADASHCIQQILESIAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEV  181 (362)
T ss_dssp             EECCCCSCBHHHHHTT-CSCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCC
T ss_pred             EEecCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCchHHEEEecCCCCCCEEEeecCcceEe
Confidence            9999999999998854 3458999999999999999999999   8999999999999998654   5999999999877


Q ss_pred             CCCCCceeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhccccccCCcccccCchh
Q 012765          295 PDNWSHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSNFKELVDPRL  374 (457)
Q Consensus       295 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l  374 (457)
                      .....   .....||+.|+|||++.+..|+.++|||||||++|+|++|..||...+........ ......+   ..+..
T Consensus       182 ~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i-~~~~~~~---~~~~~  254 (362)
T 2bdw_A          182 NDSEA---WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQI-KAGAYDY---PSPEW  254 (362)
T ss_dssp             TTCCS---CCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH-HHTCCCC---CTTGG
T ss_pred             cCCcc---cccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHH-HhCCCCC---Ccccc
Confidence            54322   23356999999999999989999999999999999999999999865432211100 0000000   00100


Q ss_pred             hcccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 012765          375 ADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQ  409 (457)
Q Consensus       375 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~  409 (457)
                       ..+    ...+.+++.+||+.||.+|||+.++++
T Consensus       255 -~~~----~~~~~~li~~~L~~dP~~R~t~~e~l~  284 (362)
T 2bdw_A          255 -DTV----TPEAKSLIDSMLTVNPKKRITADQALK  284 (362)
T ss_dssp             -GGS----CHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             -cCC----CHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence             111    234667889999999999999999876

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=8e-43  Score=332.64  Aligned_cols=255  Identities=26%  Similarity=0.389  Sum_probs=206.1

Q ss_pred             hcCCCCCceecccCcEEEEEEEeCCCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeec-CceEEEE
Q 012765          141 TDNFNSENLIGKGGHAEVYKGCLPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTE-NGFHLVL  219 (457)
Q Consensus       141 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-~~~~lv~  219 (457)
                      .++|.+.+.||+|+||.||+|.+.+++.||+|.+......    .+.+.+|+.+++.++||||+++++++.+ +..+++|
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   82 (267)
T 3t9t_A            7 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS----EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVT   82 (267)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTBC----HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEE
T ss_pred             hhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCCC----HHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEE
Confidence            4678889999999999999999888899999998754432    2478899999999999999999997655 4578999


Q ss_pred             EecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCCCCCC
Q 012765          220 QFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWS  299 (457)
Q Consensus       220 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~~~~  299 (457)
                      ||+++++|.+++......+++..++.++.|++.||.|||+   .+++||||||+||+++.++.+||+|||++........
T Consensus        83 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~  159 (267)
T 3t9t_A           83 EFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEE---ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY  159 (267)
T ss_dssp             CCCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHH
T ss_pred             eCCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCchheEEECCCCCEEEcccccccccccccc
Confidence            9999999999997776778999999999999999999999   8999999999999999999999999999987643211


Q ss_pred             ceeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHh-CCCCCCcCCcchhhhhccccccCCcccccCchhhccc
Q 012765          300 HHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELIT-GRRAVDSRRQSLVIWAKPLLQTSNFKELVDPRLADAY  378 (457)
Q Consensus       300 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLlt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~  378 (457)
                       .......++..|+|||++.+..++.++||||||+++|+|++ |+.||............  ....      ....... 
T Consensus       160 -~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i--~~~~------~~~~~~~-  229 (267)
T 3t9t_A          160 -TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDI--STGF------RLYKPRL-  229 (267)
T ss_dssp             -HSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHH--HTTC------CCCCCTT-
T ss_pred             -cccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHH--hcCC------cCCCCcc-
Confidence             11122346788999999998999999999999999999999 89999864432211110  0000      0000111 


Q ss_pred             CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCC
Q 012765          379 DLAEMKRAMLTASVCIHHLSTMRPQMTRVLQLLRGEG  415 (457)
Q Consensus       379 ~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~  415 (457)
                         ....+.+++.+||+.||.+||++.++++.|+.+.
T Consensus       230 ---~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~  263 (267)
T 3t9t_A          230 ---ASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIA  263 (267)
T ss_dssp             ---SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ---CcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence               1235677889999999999999999999998764

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=6.3e-43  Score=333.61  Aligned_cols=253  Identities=20%  Similarity=0.299  Sum_probs=202.3

Q ss_pred             hcCCCCCceecccCcEEEEEEEeCCCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeecC---ceEE
Q 012765          141 TDNFNSENLIGKGGHAEVYKGCLPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTEN---GFHL  217 (457)
Q Consensus       141 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~---~~~l  217 (457)
                      .++|.+.+.||+|+||.||+|.+ +++.||+|++..... .......+.+|+.+++.++||||+++++++.+.   ..++
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~~avK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l   86 (271)
T 3kmu_A            9 FKQLNFLTKLNENHSGELWKGRW-QGNDIVVKVLKVRDW-STRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTL   86 (271)
T ss_dssp             GGGCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECCTTC-CHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEE
T ss_pred             HHHhHHHHHhcCCCcceEEEEEE-CCeeEEEEEeccccc-CHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEe
Confidence            46788899999999999999998 588999999875432 234456899999999999999999999987654   5689


Q ss_pred             EEEecCCCChhhhhhcCCC-CCCHHHHHHHHHHHHHHHHHHHhcCCCC--eeeCCCCCCcEEEcCCCcEEEeeccccccC
Q 012765          218 VLQFLPHGSLSSLLFGSTE-CLEWTIRYKIALGIAEGLQYLHHDCHRR--IIHRDIKASNILLSEDYEAQISDFGLAKWL  294 (457)
Q Consensus       218 v~e~~~~gsL~~~l~~~~~-~~~~~~~~~i~~qia~aL~yLH~~~~~~--iiHrDlkp~NIll~~~~~~kL~DFGl~~~~  294 (457)
                      +|||+++|+|.+++..... .+++..++.++.||+.||.|||+   .+  ++||||||+||+++.++.++|+|||+....
T Consensus        87 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~  163 (271)
T 3kmu_A           87 ITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHT---LEPLIPRHALNSRSVMIDEDMTARISMADVKFSF  163 (271)
T ss_dssp             EEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTT---SSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTT
T ss_pred             eecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhc---CCCceecCCCccceEEEcCCcceeEEeccceeee
Confidence            9999999999999976544 58999999999999999999999   67  999999999999999999999999887653


Q ss_pred             CCCCCceeeecccccccccChhccccCCCCc---chhHHHHHHHHHHHHhCCCCCCcCCcchhhhhccccccCCcccccC
Q 012765          295 PDNWSHHIVFPIEGTFGYLSPEYFMHGIVDE---KTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSNFKELVD  371 (457)
Q Consensus       295 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~---ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d  371 (457)
                      ...       ...||+.|+|||++.+..++.   ++|||||||++|||++|+.||............  ...     ...
T Consensus       164 ~~~-------~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~--~~~-----~~~  229 (271)
T 3kmu_A          164 QSP-------GRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKV--ALE-----GLR  229 (271)
T ss_dssp             SCT-------TCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHH--HHS-----CCC
T ss_pred             ccc-------CccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHH--Hhc-----CCC
Confidence            322       234899999999998765544   799999999999999999999864432221111  000     011


Q ss_pred             chhhcccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCCC
Q 012765          372 PRLADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQLLRGEGG  416 (457)
Q Consensus       372 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~  416 (457)
                      +.+...+    ...+.+++..||+.||++|||+.+|++.|+.+..
T Consensus       230 ~~~~~~~----~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~~  270 (271)
T 3kmu_A          230 PTIPPGI----SPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD  270 (271)
T ss_dssp             CCCCTTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred             CCCCCCC----CHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence            1111222    2356778889999999999999999999988753

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=1.9e-42  Score=348.81  Aligned_cols=251  Identities=22%  Similarity=0.217  Sum_probs=201.5

Q ss_pred             hcCCCCCceecccCcEEEEEEEeC-CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeec-CceEEE
Q 012765          141 TDNFNSENLIGKGGHAEVYKGCLP-DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTE-NGFHLV  218 (457)
Q Consensus       141 ~~~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-~~~~lv  218 (457)
                      .++|.+.+.||+|+||.||+|... +|+.||+|.+......   ....+.+|+.++..++||||+++++++.+ ...++|
T Consensus        50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~---~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv  126 (387)
T 1kob_A           50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPL---DKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLI  126 (387)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHH---HHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEE
T ss_pred             ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchh---hHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEE
Confidence            467999999999999999999865 6899999988654332   23478899999999999999999997655 457899


Q ss_pred             EEecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcC--CCcEEEeeccccccCCC
Q 012765          219 LQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSE--DYEAQISDFGLAKWLPD  296 (457)
Q Consensus       219 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~--~~~~kL~DFGl~~~~~~  296 (457)
                      |||+.+|+|.+++......+++..++.++.||+.||.|||+   .+|+||||||+|||++.  ++.+||+|||++..+..
T Consensus       127 ~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~  203 (387)
T 1kob_A          127 LEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHE---HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNP  203 (387)
T ss_dssp             EECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCT
T ss_pred             EEcCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccchHHeEEecCCCCceEEEecccceecCC
Confidence            99999999999997666679999999999999999999999   89999999999999974  46799999999987755


Q ss_pred             CCCceeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhccccccCCcccccCchhhc
Q 012765          297 NWSHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSNFKELVDPRLAD  376 (457)
Q Consensus       297 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  376 (457)
                      ...   .....||+.|+|||++.+..++.++|||||||++|||++|..||............. .....    .++....
T Consensus       204 ~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~-~~~~~----~~~~~~~  275 (387)
T 1kob_A          204 DEI---VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVK-RCDWE----FDEDAFS  275 (387)
T ss_dssp             TSC---EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHH-HCCCC----CCSSTTT
T ss_pred             Ccc---eeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHH-hCCCC----CCccccc
Confidence            432   223459999999999999999999999999999999999999998654321111000 00000    0111111


Q ss_pred             ccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 012765          377 AYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQ  409 (457)
Q Consensus       377 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~  409 (457)
                      .+    ...+.+++.+||+.||.+|||+.|+++
T Consensus       276 ~~----s~~~~~li~~~L~~dP~~Rpt~~ell~  304 (387)
T 1kob_A          276 SV----SPEAKDFIKNLLQKEPRKRLTVHDALE  304 (387)
T ss_dssp             TS----CHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             cC----CHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence            12    235678899999999999999999987

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=6.5e-43  Score=351.58  Aligned_cols=252  Identities=24%  Similarity=0.303  Sum_probs=198.6

Q ss_pred             hcCCCCCceecccCcEEEEEEEeC-CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeec-CceEEE
Q 012765          141 TDNFNSENLIGKGGHAEVYKGCLP-DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTE-NGFHLV  218 (457)
Q Consensus       141 ~~~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-~~~~lv  218 (457)
                      .++|.+.+.||+|+||.||+|... +++.||+|.+.+...........+.+|+.++..++||||+++++++.+ +..++|
T Consensus        14 ~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv   93 (384)
T 4fr4_A           14 FDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMV   93 (384)
T ss_dssp             GGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence            367889999999999999999865 588999999865443333345688999999999999999999996655 557899


Q ss_pred             EEecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCCCCC
Q 012765          219 LQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNW  298 (457)
Q Consensus       219 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~~~  298 (457)
                      |||+.+|+|..++.. ...+++..+..++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||++..+....
T Consensus        94 ~e~~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~LH~---~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~  169 (384)
T 4fr4_A           94 VDLLLGGDLRYHLQQ-NVHFKEETVKLFICELVMALDYLQN---QRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRET  169 (384)
T ss_dssp             ECCCTTEEHHHHHHT-TCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTC
T ss_pred             EecCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCcHHHeEECCCCCEEEeccceeeeccCCC
Confidence            999999999999865 3458999999999999999999999   899999999999999999999999999998775432


Q ss_pred             CceeeecccccccccChhcccc---CCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhccccccCCcccccCchhh
Q 012765          299 SHHIVFPIEGTFGYLSPEYFMH---GIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSNFKELVDPRLA  375 (457)
Q Consensus       299 ~~~~~~~~~gt~~y~aPE~~~~---~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  375 (457)
                         ......||+.|+|||++.+   ..|+.++|||||||++|||++|+.||..................      .....
T Consensus       170 ---~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~------~~~~p  240 (384)
T 4fr4_A          170 ---QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETT------VVTYP  240 (384)
T ss_dssp             ---CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHC------CCCCC
T ss_pred             ---ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhc------ccCCC
Confidence               2234569999999999863   45899999999999999999999999753221111000000000      00011


Q ss_pred             cccCHHHHHHHHHHHHHhcccCCCCCCC-HHHHHH
Q 012765          376 DAYDLAEMKRAMLTASVCIHHLSTMRPQ-MTRVLQ  409 (457)
Q Consensus       376 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt-~~evl~  409 (457)
                      ..    ....+..++.+||+.||.+||+ +.+|++
T Consensus       241 ~~----~s~~~~~li~~lL~~dP~~R~s~~~~l~~  271 (384)
T 4fr4_A          241 SA----WSQEMVSLLKKLLEPNPDQRFSQLSDVQN  271 (384)
T ss_dssp             TT----SCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred             Cc----CCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence            11    2245678889999999999998 677654

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=6.8e-43  Score=347.43  Aligned_cols=248  Identities=27%  Similarity=0.408  Sum_probs=199.5

Q ss_pred             hcCCCCCceecccCcEEEEEEEe-CCCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeec-CceEEE
Q 012765          141 TDNFNSENLIGKGGHAEVYKGCL-PDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTE-NGFHLV  218 (457)
Q Consensus       141 ~~~f~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-~~~~lv  218 (457)
                      .+.|...+.||+|+||+||+|.. .+++.||||++.............+.+|+.+++.++||||+++++++.. +..++|
T Consensus        53 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv  132 (348)
T 1u5q_A           53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV  132 (348)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred             hhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEE
Confidence            34588889999999999999986 5789999999876555555566789999999999999999999997655 456899


Q ss_pred             EEecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCCCCC
Q 012765          219 LQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNW  298 (457)
Q Consensus       219 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~~~  298 (457)
                      |||+. |+|.+++......+++..++.++.|++.||.|||+   .+|+||||||+|||++.++.+||+|||++...... 
T Consensus       133 ~e~~~-g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~-  207 (348)
T 1u5q_A          133 MEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA-  207 (348)
T ss_dssp             EECCS-EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB-
T ss_pred             EecCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEECCCCCEEEeeccCceecCCC-
Confidence            99997 67888876656779999999999999999999999   89999999999999999999999999999876432 


Q ss_pred             CceeeecccccccccChhccc---cCCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhccccccCCcccccCchhh
Q 012765          299 SHHIVFPIEGTFGYLSPEYFM---HGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSNFKELVDPRLA  375 (457)
Q Consensus       299 ~~~~~~~~~gt~~y~aPE~~~---~~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  375 (457)
                           ....||+.|+|||++.   ...++.++|||||||++|||++|+.||.........+...  . ........    
T Consensus       208 -----~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~--~-~~~~~~~~----  275 (348)
T 1u5q_A          208 -----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIA--Q-NESPALQS----  275 (348)
T ss_dssp             -----CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHH--H-SCCCCCCC----
T ss_pred             -----CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH--h-cCCCCCCC----
Confidence                 2345999999999984   5678999999999999999999999997644322211110  0 00000000    


Q ss_pred             cccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 012765          376 DAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQ  409 (457)
Q Consensus       376 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~  409 (457)
                      ..+    ...+.+++.+||+.||++|||+.++++
T Consensus       276 ~~~----~~~l~~li~~~l~~dP~~Rps~~~ll~  305 (348)
T 1u5q_A          276 GHW----SEYFRNFVDSCLQKIPQDRPTSEVLLK  305 (348)
T ss_dssp             TTS----CHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             CCC----CHHHHHHHHHHcccChhhCcCHHHHhh
Confidence            111    234667888999999999999999987

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=1.9e-42  Score=335.05  Aligned_cols=261  Identities=20%  Similarity=0.258  Sum_probs=196.0

Q ss_pred             cCCCCCceecccCcEEEEEEEeC-CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeec-CceEEEE
Q 012765          142 DNFNSENLIGKGGHAEVYKGCLP-DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTE-NGFHLVL  219 (457)
Q Consensus       142 ~~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-~~~~lv~  219 (457)
                      ++|++.+.||+|+||+||+|.+. +++.||+|++...... ......+.+|+.++++++||||+++++++.+ +..++||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   80 (292)
T 3o0g_A            2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDD-EGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVF   80 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSS-TTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCc-CCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEE
Confidence            57889999999999999999875 6899999998754432 2334678899999999999999999996655 4568999


Q ss_pred             EecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCCCCCC
Q 012765          220 QFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWS  299 (457)
Q Consensus       220 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~~~~  299 (457)
                      ||+.+ ++...+......+++..++.++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||++........
T Consensus        81 e~~~~-~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~---~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  156 (292)
T 3o0g_A           81 EFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHS---RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR  156 (292)
T ss_dssp             ECCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECCSCCS
T ss_pred             ecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEeecccceecCCccc
Confidence            99975 5666665556679999999999999999999999   8999999999999999999999999999987654322


Q ss_pred             ceeeecccccccccChhccccCC-CCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhcc--ccccC------Cccccc
Q 012765          300 HHIVFPIEGTFGYLSPEYFMHGI-VDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKP--LLQTS------NFKELV  370 (457)
Q Consensus       300 ~~~~~~~~gt~~y~aPE~~~~~~-~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~~--~~~~~------~~~~~~  370 (457)
                        ......||+.|+|||++.+.. ++.++|||||||++|||++|..||.............  .....      ......
T Consensus       157 --~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  234 (292)
T 3o0g_A          157 --CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLP  234 (292)
T ss_dssp             --CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGST
T ss_pred             --cccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhcccc
Confidence              123345899999999998765 8999999999999999999988864322211111000  00000      000000


Q ss_pred             C---------chhhcccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 012765          371 D---------PRLADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQ  409 (457)
Q Consensus       371 d---------~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~  409 (457)
                      +         ..............+.+++.+||+.||++|||+.|+++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  282 (292)
T 3o0g_A          235 DYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ  282 (292)
T ss_dssp             TCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             cccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhc
Confidence            0         00000001122345678899999999999999999986

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=2.3e-43  Score=347.28  Aligned_cols=271  Identities=25%  Similarity=0.325  Sum_probs=207.6

Q ss_pred             hcCCCCCceecccCcEEEEEEEe-----CCCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeee---c
Q 012765          141 TDNFNSENLIGKGGHAEVYKGCL-----PDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFST---E  212 (457)
Q Consensus       141 ~~~f~~~~~LG~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~---~  212 (457)
                      .++|.+.+.||+|+||.||+|.+     .+++.||+|++.....   .....+.+|+.++++++||||+++++++.   .
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~   98 (327)
T 3lxl_A           22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGP---DQQRDFQREIQILKALHSDFIVKYRGVSYGPGR   98 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCH---HHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSS
T ss_pred             hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCH---HHHHHHHHHHHHHHhcCCCceeEEEEEEecCCC
Confidence            46788899999999999999983     3688999999865432   34567899999999999999999999764   3


Q ss_pred             CceEEEEEecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccc
Q 012765          213 NGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAK  292 (457)
Q Consensus       213 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~  292 (457)
                      ...++||||+++++|.+++......+++..++.++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||++.
T Consensus        99 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~  175 (327)
T 3lxl_A           99 QSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGS---RRCVHRDLAARNILVESEAHVKIADFGLAK  175 (327)
T ss_dssp             CEEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEECCGGGCE
T ss_pred             ceEEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCChhhEEECCCCCEEEcccccce
Confidence            34789999999999999997655679999999999999999999999   899999999999999999999999999998


Q ss_pred             cCCCCCCcee-eecccccccccChhccccCCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhccccccCC---ccc
Q 012765          293 WLPDNWSHHI-VFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSN---FKE  368 (457)
Q Consensus       293 ~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~~~~~~~~---~~~  368 (457)
                      .......... .....||..|+|||++.+..++.++|||||||++|+|++|..||...................   ..+
T Consensus       176 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (327)
T 3lxl_A          176 LLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLE  255 (327)
T ss_dssp             ECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHH
T ss_pred             ecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHH
Confidence            8755433221 223457888999999999999999999999999999999999987533221111000000000   000


Q ss_pred             ccCchhhcccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCCCC
Q 012765          369 LVDPRLADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQLLRGEGGQ  417 (457)
Q Consensus       369 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~  417 (457)
                      .+...............+.+++.+||+.||.+|||+.+|++.|+.+...
T Consensus       256 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~  304 (327)
T 3lxl_A          256 LLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSG  304 (327)
T ss_dssp             HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC---
T ss_pred             HhhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhh
Confidence            0001111111122234577889999999999999999999999987543

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=3e-43  Score=366.15  Aligned_cols=256  Identities=24%  Similarity=0.373  Sum_probs=205.5

Q ss_pred             hhcCCCCCceecccCcEEEEEEEeCC-CcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeecC-ceEE
Q 012765          140 ATDNFNSENLIGKGGHAEVYKGCLPD-GEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTEN-GFHL  217 (457)
Q Consensus       140 ~~~~f~~~~~LG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~-~~~l  217 (457)
                      ..++|.+.+.||+|+||.||+|.+.. +..||||.+......    ...|.+|+.+|++++||||+++++++... ..++
T Consensus       218 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l  293 (495)
T 1opk_A          218 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME----VEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYI  293 (495)
T ss_dssp             CGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSSC----HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred             CHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcccc----hHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEE
Confidence            45667888999999999999998764 889999998654332    45789999999999999999999977654 5789


Q ss_pred             EEEecCCCChhhhhhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCCC
Q 012765          218 VLQFLPHGSLSSLLFGS-TECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPD  296 (457)
Q Consensus       218 v~e~~~~gsL~~~l~~~-~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~  296 (457)
                      ||||+++|+|.+++... ...+++..++.|+.||+.||.|||+   .+|+||||||+|||++.++.+||+|||+++....
T Consensus       294 v~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~  370 (495)
T 1opk_A          294 ITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK---KNFIHRNLAARNCLVGENHLVKVADFGLSRLMTG  370 (495)
T ss_dssp             EEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECGGGCEEECCTTCEECCTT
T ss_pred             EEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChhhEEECCCCcEEEeecccceeccC
Confidence            99999999999999753 4568999999999999999999999   8999999999999999999999999999987654


Q ss_pred             CCCceeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHh-CCCCCCcCCcchhhhhccccccCCcccccCchhh
Q 012765          297 NWSHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELIT-GRRAVDSRRQSLVIWAKPLLQTSNFKELVDPRLA  375 (457)
Q Consensus       297 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLlt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  375 (457)
                      ... .......++..|+|||++.+..++.++|||||||++|||+| |..||...........   ..         ....
T Consensus       371 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~---~~---------~~~~  437 (495)
T 1opk_A          371 DTY-TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYEL---LE---------KDYR  437 (495)
T ss_dssp             CCE-ECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHH---HH---------TTCC
T ss_pred             Cce-eecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHH---HH---------cCCC
Confidence            321 11223346788999999999999999999999999999999 9999986443221100   00         0000


Q ss_pred             cccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCC
Q 012765          376 DAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQLLRGEG  415 (457)
Q Consensus       376 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~  415 (457)
                      ..........+.+++.+||+.||.+|||+.+|++.|+.+.
T Consensus       438 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~  477 (495)
T 1opk_A          438 MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF  477 (495)
T ss_dssp             CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred             CCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHH
Confidence            0001112245677889999999999999999999999874

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=8e-43  Score=347.15  Aligned_cols=247  Identities=21%  Similarity=0.248  Sum_probs=199.9

Q ss_pred             hcCCCCCceecccCcEEEEEEEeC-CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeec-CceEEE
Q 012765          141 TDNFNSENLIGKGGHAEVYKGCLP-DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTE-NGFHLV  218 (457)
Q Consensus       141 ~~~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-~~~~lv  218 (457)
                      .++|.+.+.||+|+||.||+|... +|+.||+|++.+...........+.+|+.++..++||||+++++++.+ ..+++|
T Consensus        40 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv  119 (350)
T 1rdq_E           40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV  119 (350)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             HHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEE
Confidence            367888999999999999999875 689999999865433332345678899999999999999999996655 457899


Q ss_pred             EEecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCCCCC
Q 012765          219 LQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNW  298 (457)
Q Consensus       219 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~~~  298 (457)
                      |||+++|+|.+++... ..+++..+..++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||+++......
T Consensus       120 ~e~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~~  195 (350)
T 1rdq_E          120 MEYVAGGEMFSHLRRI-GRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT  195 (350)
T ss_dssp             EECCTTCBHHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECSSCB
T ss_pred             EcCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHH---CCcccccCccceEEECCCCCEEEcccccceeccCCc
Confidence            9999999999998653 358899999999999999999999   899999999999999999999999999998765431


Q ss_pred             CceeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhccccccCCcccccCchhhccc
Q 012765          299 SHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSNFKELVDPRLADAY  378 (457)
Q Consensus       299 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~  378 (457)
                           ....||+.|+|||++.+..++.++|||||||++|||++|..||......... .........        +...+
T Consensus       196 -----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~-~~i~~~~~~--------~p~~~  261 (350)
T 1rdq_E          196 -----WTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIY-EKIVSGKVR--------FPSHF  261 (350)
T ss_dssp             -----CCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH-HHHHHCCCC--------CCTTC
T ss_pred             -----ccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHH-HHHHcCCCC--------CCCCC
Confidence                 2345999999999999999999999999999999999999999864432211 110000001        11112


Q ss_pred             CHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHH
Q 012765          379 DLAEMKRAMLTASVCIHHLSTMRPQ-----MTRVLQ  409 (457)
Q Consensus       379 ~~~~~~~l~~l~~~Cl~~dP~~RPt-----~~evl~  409 (457)
                          ...+..++.+||+.||.+||+     +.+|++
T Consensus       262 ----~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~  293 (350)
T 1rdq_E          262 ----SSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN  293 (350)
T ss_dssp             ----CHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred             ----CHHHHHHHHHHhhcCHHhccCCccCCHHHHHh
Confidence                235677889999999999998     888875

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=2.2e-42  Score=343.38  Aligned_cols=248  Identities=23%  Similarity=0.283  Sum_probs=196.3

Q ss_pred             hcCCCCCceecccCcEEEEEEEeC-CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhc-CCCCcceeeeeeec-CceEE
Q 012765          141 TDNFNSENLIGKGGHAEVYKGCLP-DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHI-NHPNAAKLIGFSTE-NGFHL  217 (457)
Q Consensus       141 ~~~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~-~~~~l  217 (457)
                      .++|.+.+.||+|+||.||+|.+. +++.||+|++.+...........+.+|..++.++ +||||+++++++.. +.+++
T Consensus         8 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l   87 (345)
T 3a8x_A            8 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF   87 (345)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred             hhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEE
Confidence            357888999999999999999875 5899999999766554555667889999999887 89999999996655 55789


Q ss_pred             EEEecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCCCC
Q 012765          218 VLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDN  297 (457)
Q Consensus       218 v~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~~  297 (457)
                      ||||+++|+|..++... ..+++..+..++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||+++.....
T Consensus        88 v~e~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~  163 (345)
T 3a8x_A           88 VIEYVNGGDLMFHMQRQ-RKLPEEHARFYSAEISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP  163 (345)
T ss_dssp             EECCCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCGGGCBCSCCT
T ss_pred             EEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCHHHEEECCCCCEEEEeccccccccCC
Confidence            99999999999998643 458999999999999999999999   89999999999999999999999999999864322


Q ss_pred             CCceeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHhCCCCCCcCCcch------hhhhccccccCCcccccC
Q 012765          298 WSHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSL------VIWAKPLLQTSNFKELVD  371 (457)
Q Consensus       298 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~------~~~~~~~~~~~~~~~~~d  371 (457)
                      ..  ......||+.|+|||++.+..++.++|||||||++|||++|+.||.......      ...........      .
T Consensus       164 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~------~  235 (345)
T 3a8x_A          164 GD--TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEK------Q  235 (345)
T ss_dssp             TC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHC------C
T ss_pred             CC--cccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcC------C
Confidence            11  2334569999999999999999999999999999999999999997421110      00000000000      0


Q ss_pred             chhhcccCHHHHHHHHHHHHHhcccCCCCCCCH
Q 012765          372 PRLADAYDLAEMKRAMLTASVCIHHLSTMRPQM  404 (457)
Q Consensus       372 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~  404 (457)
                      ..+...+    ...+.+++.+||+.||.+||++
T Consensus       236 ~~~p~~~----s~~~~~li~~lL~~dP~~R~~~  264 (345)
T 3a8x_A          236 IRIPRSL----SVKAASVLKSFLNKDPKERLGC  264 (345)
T ss_dssp             CCCCTTS----CHHHHHHHHHHTCSSTTTSTTC
T ss_pred             CCCCCCC----CHHHHHHHHHHhcCCHhHCCCC
Confidence            0111112    2356778899999999999995

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.5e-42  Score=340.43  Aligned_cols=267  Identities=23%  Similarity=0.305  Sum_probs=197.4

Q ss_pred             HHHHHhhcCCCCCceecccCcEEEEEEEeCCCcEEEEEEEeccchhhHHHHHHHHHHHHHHhh--cCCCCcceeeeeeec
Q 012765          135 AELAAATDNFNSENLIGKGGHAEVYKGCLPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAH--INHPNAAKLIGFSTE  212 (457)
Q Consensus       135 ~~~~~~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~--l~hpniv~l~~~~~~  212 (457)
                      .......++|.+.+.||+|+||.||+|.+ .++.||||++.....      ..+..|.+++..  ++||||+++++++..
T Consensus        30 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~------~~~~~e~~~~~~~~~~h~~i~~~~~~~~~  102 (337)
T 3mdy_A           30 LVQRTIAKQIQMVKQIGKGRYGEVWMGKW-RGEKVAVKVFFTTEE------ASWFRETEIYQTVLMRHENILGFIAADIK  102 (337)
T ss_dssp             HHHTTHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEEEGGGH------HHHHHHHHHHTSTTCCCTTBCCEEEEEEE
T ss_pred             ccccccccceEEEeEeecCCCeEEEEEEE-CCceEEEEEEecccc------chhhhHHHHHHHHhhcCCCeeeEEEEEcc
Confidence            33345668899999999999999999987 489999999854321      234445555544  499999999997655


Q ss_pred             C-----ceEEEEEecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCC--------CeeeCCCCCCcEEEcC
Q 012765          213 N-----GFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHR--------RIIHRDIKASNILLSE  279 (457)
Q Consensus       213 ~-----~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~--------~iiHrDlkp~NIll~~  279 (457)
                      .     ..++||||+++|+|.+++...  .+++..++.++.|++.||.|||+   .        +|+||||||+|||++.
T Consensus       103 ~~~~~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~i~~~i~~~l~~lH~---~~~~~~~~~~ivH~Dikp~Nill~~  177 (337)
T 3mdy_A          103 GTGSWTQLYLITDYHENGSLYDYLKST--TLDAKSMLKLAYSSVSGLCHLHT---EIFSTQGKPAIAHRDLKSKNILVKK  177 (337)
T ss_dssp             SCGGGCEEEEEECCCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHS---CBCSTTCBCCEECSCCCGGGEEECT
T ss_pred             CCCCCCceEEEEeccCCCcHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHHH---hhhhhccCCCEEecccchHHEEECC
Confidence            4     478999999999999999543  58999999999999999999998   6        9999999999999999


Q ss_pred             CCcEEEeeccccccCCCCCCcee--eecccccccccChhccccCCCCcc------hhHHHHHHHHHHHHhCC--------
Q 012765          280 DYEAQISDFGLAKWLPDNWSHHI--VFPIEGTFGYLSPEYFMHGIVDEK------TDVFAFGVLLLELITGR--------  343 (457)
Q Consensus       280 ~~~~kL~DFGl~~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~k------sDvwSlGvll~eLltG~--------  343 (457)
                      ++.+||+|||++..+........  .....||+.|+|||++.+..++..      +|||||||++|||+||.        
T Consensus       178 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~  257 (337)
T 3mdy_A          178 NGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEE  257 (337)
T ss_dssp             TSCEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCC
T ss_pred             CCCEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCccccccc
Confidence            99999999999977654322211  123469999999999988776665      99999999999999994        


Q ss_pred             --CCCCcCCcchhhh--hccccccCCcccccCchhhccc-CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCCCC
Q 012765          344 --RAVDSRRQSLVIW--AKPLLQTSNFKELVDPRLADAY-DLAEMKRAMLTASVCIHHLSTMRPQMTRVLQLLRGEGGQ  417 (457)
Q Consensus       344 --~pf~~~~~~~~~~--~~~~~~~~~~~~~~d~~l~~~~-~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~  417 (457)
                        .||.........+  ......    .....+.+.... .......+.+++.+||+.||.+|||+.+|++.|+.+...
T Consensus       258 ~~~p~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~  332 (337)
T 3mdy_A          258 YQLPYHDLVPSDPSYEDMREIVC----IKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSES  332 (337)
T ss_dssp             CCCTTTTTSCSSCCHHHHHHHHT----TSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             ccccHhhhcCCCCchhhhHHHHh----hhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHhh
Confidence              4444311110000  000000    001111111111 125566788999999999999999999999999887544

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=3.3e-43  Score=345.04  Aligned_cols=266  Identities=25%  Similarity=0.355  Sum_probs=203.8

Q ss_pred             CCCCceecccCcEEEEEEEeC-----CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeec---Cce
Q 012765          144 FNSENLIGKGGHAEVYKGCLP-----DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTE---NGF  215 (457)
Q Consensus       144 f~~~~~LG~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~---~~~  215 (457)
                      |.+.+.||+|+||+||++.+.     +++.||+|++....  .......+.+|+.+++.++||||+++++++.+   ..+
T Consensus        33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  110 (318)
T 3lxp_A           33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADA--GPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASL  110 (318)
T ss_dssp             EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEE
T ss_pred             HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEecccc--ChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceE
Confidence            478899999999999998642     68899999987543  23446689999999999999999999997765   346


Q ss_pred             EEEEEecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCC
Q 012765          216 HLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLP  295 (457)
Q Consensus       216 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~  295 (457)
                      ++||||+++++|.+++...  .+++..++.++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||++....
T Consensus       111 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~i~~~l~~~l~~LH~---~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~  185 (318)
T 3lxp_A          111 QLVMEYVPLGSLRDYLPRH--SIGLAQLLLFAQQICEGMAYLHA---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVP  185 (318)
T ss_dssp             EEEECCCTTCBHHHHGGGS--CCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCGGGCEECC
T ss_pred             EEEEecccCCcHHHHHhhC--CCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCchheEEEcCCCCEEECCcccccccc
Confidence            8999999999999999543  48999999999999999999999   899999999999999999999999999998876


Q ss_pred             CCCCce-eeecccccccccChhccccCCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhcccc---ccCCcccccC
Q 012765          296 DNWSHH-IVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLL---QTSNFKELVD  371 (457)
Q Consensus       296 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~~~~---~~~~~~~~~d  371 (457)
                      ...... ......+|..|+|||++.+..++.++|||||||++|+|++|..||.........+.....   ....+.+.+.
T Consensus       186 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  265 (318)
T 3lxp_A          186 EGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLE  265 (318)
T ss_dssp             TTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHHHH
T ss_pred             ccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHHHh
Confidence            543221 223345788899999999989999999999999999999999999753221111100000   0000011111


Q ss_pred             chhhcccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCCC
Q 012765          372 PRLADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQLLRGEGG  416 (457)
Q Consensus       372 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~  416 (457)
                      ..............+.+++.+||+.||.+|||+.+|++.|+.+..
T Consensus       266 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~  310 (318)
T 3lxp_A          266 RGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHE  310 (318)
T ss_dssp             TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             cccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHH
Confidence            111111111223467788999999999999999999999987643

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=2.2e-42  Score=354.30  Aligned_cols=255  Identities=22%  Similarity=0.269  Sum_probs=201.0

Q ss_pred             HhhcCCCCCceecccCcEEEEEEEeC-CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeecC-ceE
Q 012765          139 AATDNFNSENLIGKGGHAEVYKGCLP-DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTEN-GFH  216 (457)
Q Consensus       139 ~~~~~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~-~~~  216 (457)
                      ...++|.+.+.||+|+||+||+|... +|+.+|+|++...... ......+.+|+.+++.++||||+++++++.+. ..+
T Consensus         8 ~~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~-~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~   86 (444)
T 3soa_A            8 RFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLS-ARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHY   86 (444)
T ss_dssp             HHHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCH-HHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEE
T ss_pred             cccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCC-HHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEE
Confidence            35678999999999999999999864 6899999998754433 33456789999999999999999999966654 468


Q ss_pred             EEEEecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEc---CCCcEEEeecccccc
Q 012765          217 LVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLS---EDYEAQISDFGLAKW  293 (457)
Q Consensus       217 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~---~~~~~kL~DFGl~~~  293 (457)
                      +||||+.+|+|.+.+... ..+++..+..++.||+.||.|||+   .+|+||||||+|||++   .++.+||+|||++..
T Consensus        87 lv~E~~~gg~L~~~i~~~-~~~~e~~~~~i~~qil~aL~~lH~---~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~  162 (444)
T 3soa_A           87 LIFDLVTGGELFEDIVAR-EYYSEADASHCIQQILEAVLHCHQ---MGVVHRNLKPENLLLASKLKGAAVKLADFGLAIE  162 (444)
T ss_dssp             EEECCCBCCBHHHHHHHC-SCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBC
T ss_pred             EEEEeCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEeccCCCCcEEEccCceeEE
Confidence            999999999999988654 458999999999999999999999   8999999999999998   467899999999987


Q ss_pred             CCCCCCceeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhccccccCCcccccCch
Q 012765          294 LPDNWSHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSNFKELVDPR  373 (457)
Q Consensus       294 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~  373 (457)
                      ......  ......||+.|+|||++.+..|+.++|||||||++|+|++|..||............. .....+   ..+.
T Consensus       163 ~~~~~~--~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~-~~~~~~---~~~~  236 (444)
T 3soa_A          163 VEGEQQ--AWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIK-AGAYDF---PSPE  236 (444)
T ss_dssp             CCTTCC--BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH-HTCCCC---CTTT
T ss_pred             ecCCCc--eeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHH-hCCCCC---Cccc
Confidence            754322  2234569999999999999999999999999999999999999997654322211100 000000   0110


Q ss_pred             hhcccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 012765          374 LADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQ  409 (457)
Q Consensus       374 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~  409 (457)
                      . ..    ....+.+++..||+.||.+|||+.|+++
T Consensus       237 ~-~~----~s~~~~~li~~~L~~dP~~Rpta~e~L~  267 (444)
T 3soa_A          237 W-DT----VTPEAKDLINKMLTINPSKRITAAEALK  267 (444)
T ss_dssp             T-TT----SCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             c-cc----CCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence            0 11    1235667889999999999999999987

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=2e-42  Score=344.35  Aligned_cols=255  Identities=21%  Similarity=0.241  Sum_probs=198.6

Q ss_pred             hhcCCCCCceecccCcEEEEEEEeC-CCcEEEEEEEeccchhh--HHHHHHHHHHHHHHhhcCCCCcceeeeeeec-Cce
Q 012765          140 ATDNFNSENLIGKGGHAEVYKGCLP-DGEVVAVKKIIKNAKED--EERISDFLSELGIVAHINHPNAAKLIGFSTE-NGF  215 (457)
Q Consensus       140 ~~~~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-~~~  215 (457)
                      ..++|.+.+.||+|+||+||+|.+. +++.||+|++.......  ......+.+|+.+++.++||||+++++++.+ +.+
T Consensus        22 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~  101 (351)
T 3c0i_A           22 FEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGML  101 (351)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred             cccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence            3467889999999999999999864 68999999885432111  0124578999999999999999999996655 557


Q ss_pred             EEEEEecCCCChhhhhhc---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCc---EEEeecc
Q 012765          216 HLVLQFLPHGSLSSLLFG---STECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYE---AQISDFG  289 (457)
Q Consensus       216 ~lv~e~~~~gsL~~~l~~---~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~---~kL~DFG  289 (457)
                      ++||||+.+++|.+++..   ....+++..++.++.||+.||.|||+   .+|+||||||+|||++.++.   +||+|||
T Consensus       102 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~---~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg  178 (351)
T 3c0i_A          102 YMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHD---NNIIHRDVKPHCVLLASKENSAPVKLGGFG  178 (351)
T ss_dssp             EEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECSSSTTCCEEECCCT
T ss_pred             EEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCChHHeEEecCCCCCcEEEecCc
Confidence            899999999999887743   33458999999999999999999999   89999999999999987654   9999999


Q ss_pred             ccccCCCCCCceeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhccccccCCcccc
Q 012765          290 LAKWLPDNWSHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSNFKEL  369 (457)
Q Consensus       290 l~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~  369 (457)
                      ++........  ......||+.|+|||++.+..++.++|||||||++|+|++|..||............  ....    .
T Consensus       179 ~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~i~--~~~~----~  250 (351)
T 3c0i_A          179 VAIQLGESGL--VAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKERLFEGII--KGKY----K  250 (351)
T ss_dssp             TCEECCTTSC--BCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHHHHHHHHH--HTCC----C
T ss_pred             ceeEecCCCe--eecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHHHHHHHHH--cCCC----C
Confidence            9987755322  123356999999999999999999999999999999999999999864322111000  0000    0


Q ss_pred             cCchhhcccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 012765          370 VDPRLADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQ  409 (457)
Q Consensus       370 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~  409 (457)
                      ..+.....+    ...+.+++.+||+.||.+|||+.++++
T Consensus       251 ~~~~~~~~~----s~~~~~li~~~L~~dP~~R~s~~e~l~  286 (351)
T 3c0i_A          251 MNPRQWSHI----SESAKDLVRRMLMLDPAERITVYEALN  286 (351)
T ss_dssp             CCHHHHTTS----CHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             CCccccccC----CHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence            111111111    245677889999999999999999986

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=1.4e-43  Score=347.63  Aligned_cols=262  Identities=21%  Similarity=0.348  Sum_probs=206.5

Q ss_pred             HHhhcCCCCCceecccCcEEEEEEEeC------CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeee
Q 012765          138 AAATDNFNSENLIGKGGHAEVYKGCLP------DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFST  211 (457)
Q Consensus       138 ~~~~~~f~~~~~LG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~  211 (457)
                      ....++|.+.+.||+|+||.||+|.+.      +++.||+|.+.....  ......+.+|+.+++.++||||+++++++.
T Consensus        21 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~   98 (322)
T 1p4o_A           21 EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAAS--MRERIEFLNEASVMKEFNCHHVVRLLGVVS   98 (322)
T ss_dssp             BCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSC--HHHHHHHHHHHHHGGGCCCTTBCCEEEEEC
T ss_pred             cchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccC--HHHHHHHHHHHHHHHhcCCCCEeeeEEEEc
Confidence            456688999999999999999999753      378899998864432  234567899999999999999999999776


Q ss_pred             c-CceEEEEEecCCCChhhhhhcC---------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCC
Q 012765          212 E-NGFHLVLQFLPHGSLSSLLFGS---------TECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDY  281 (457)
Q Consensus       212 ~-~~~~lv~e~~~~gsL~~~l~~~---------~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~  281 (457)
                      + +..++||||+.+|+|.+++...         ...+++..++.++.||+.||.|||+   .+|+||||||+||+++.++
T Consensus        99 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dikp~NIli~~~~  175 (322)
T 1p4o_A           99 QGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDF  175 (322)
T ss_dssp             SSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCSGGGEEECTTC
T ss_pred             cCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHH---CCCccCCCccceEEEcCCC
Confidence            5 4578999999999999998542         1456899999999999999999999   8999999999999999999


Q ss_pred             cEEEeeccccccCCCCCCceeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHh-CCCCCCcCCcchhhhhccc
Q 012765          282 EAQISDFGLAKWLPDNWSHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELIT-GRRAVDSRRQSLVIWAKPL  360 (457)
Q Consensus       282 ~~kL~DFGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLlt-G~~pf~~~~~~~~~~~~~~  360 (457)
                      .+||+|||++................+|+.|+|||++.+..++.++|||||||++|+|++ |..||............  
T Consensus       176 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~--  253 (322)
T 1p4o_A          176 TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFV--  253 (322)
T ss_dssp             CEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHH--
T ss_pred             eEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHHHHHH--
Confidence            999999999986644322222223346889999999999999999999999999999999 89999764332211100  


Q ss_pred             cccCCcccccCchhhcccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCCC
Q 012765          361 LQTSNFKELVDPRLADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQLLRGEGG  416 (457)
Q Consensus       361 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~  416 (457)
                       ......     .....    ....+.+++.+||+.||.+|||+.++++.|+.+..
T Consensus       254 -~~~~~~-----~~~~~----~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~  299 (322)
T 1p4o_A          254 -MEGGLL-----DKPDN----CPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME  299 (322)
T ss_dssp             -HTTCCC-----CCCTT----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred             -HcCCcC-----CCCCC----CCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhc
Confidence             000000     00111    22346778899999999999999999999988743

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=4.6e-43  Score=373.47  Aligned_cols=256  Identities=22%  Similarity=0.324  Sum_probs=201.1

Q ss_pred             cCCCCCc-eecccCcEEEEEEEeC---CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeecCceEE
Q 012765          142 DNFNSEN-LIGKGGHAEVYKGCLP---DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTENGFHL  217 (457)
Q Consensus       142 ~~f~~~~-~LG~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~l  217 (457)
                      +++.+.+ .||+|+||.||+|.+.   ++..||||++......  ...+.+.+|+.+|++++|||||++++++..+..++
T Consensus       335 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~--~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~l  412 (613)
T 2ozo_A          335 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEK--ADTEEMMREAQIMHQLDNPYIVRLIGVCQAEALML  412 (613)
T ss_dssp             TSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSS--TTHHHHHHHHHHHTTCCCTTBCCEEEEEESSSEEE
T ss_pred             cceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCCh--HHHHHHHHHHHHHHhCCCCCEeeEEEEeccCCeEE
Confidence            3344444 7999999999999763   4667999998654322  23568999999999999999999999998888999


Q ss_pred             EEEecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCCCC
Q 012765          218 VLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDN  297 (457)
Q Consensus       218 v~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~~  297 (457)
                      ||||+.+|+|.+++......+++..++.|+.||+.||.|||+   .+|+||||||+|||++.++.+||+|||+++.+...
T Consensus       413 v~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~---~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~  489 (613)
T 2ozo_A          413 VMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEE---KNFVHRNLAARNVLLVNRHYAKISDFGLSKALGAD  489 (613)
T ss_dssp             EEECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC--
T ss_pred             EEEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHH---CCEEcCcCCHHHEEEcCCCcEEEeeccCcccccCC
Confidence            999999999999997777779999999999999999999999   89999999999999999999999999999877543


Q ss_pred             CCce-eeecccccccccChhccccCCCCcchhHHHHHHHHHHHHh-CCCCCCcCCcchhhhhccccccCCcccccCchhh
Q 012765          298 WSHH-IVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELIT-GRRAVDSRRQSLVIWAKPLLQTSNFKELVDPRLA  375 (457)
Q Consensus       298 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLlt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  375 (457)
                      .... ......+|+.|+|||++.+..++.++|||||||++|||++ |+.||............   ....     .... 
T Consensus       490 ~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i---~~~~-----~~~~-  560 (613)
T 2ozo_A          490 DSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFI---EQGK-----RMEC-  560 (613)
T ss_dssp             ------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHH---HTTC-----CCCC-
T ss_pred             CceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHH---HcCC-----CCCC-
Confidence            2211 1122335688999999999999999999999999999998 99999864433221111   0000     0001 


Q ss_pred             cccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q 012765          376 DAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQLLRGE  414 (457)
Q Consensus       376 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~  414 (457)
                         .......+.+++..||+.+|++||++.+|++.|+.+
T Consensus       561 ---p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~  596 (613)
T 2ozo_A          561 ---PPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC  596 (613)
T ss_dssp             ---CTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHH
T ss_pred             ---CCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence               111224567788999999999999999999999864

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=1e-42  Score=339.67  Aligned_cols=267  Identities=25%  Similarity=0.402  Sum_probs=198.5

Q ss_pred             hcCCCCCceecccCcEEEEEEEe-CCCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeec-CceEEE
Q 012765          141 TDNFNSENLIGKGGHAEVYKGCL-PDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTE-NGFHLV  218 (457)
Q Consensus       141 ~~~f~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-~~~~lv  218 (457)
                      .++|.+.+.||+|+||.||+|.. .+|+.||+|++.............+.+|+.+++.++||||+++++++.. +..+++
T Consensus        31 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv  110 (310)
T 2wqm_A           31 LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIV  110 (310)
T ss_dssp             GGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             ccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEE
Confidence            46788999999999999999986 4789999999876444445556789999999999999999999996654 557899


Q ss_pred             EEecCCCChhhhhhc---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCC
Q 012765          219 LQFLPHGSLSSLLFG---STECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLP  295 (457)
Q Consensus       219 ~e~~~~gsL~~~l~~---~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~  295 (457)
                      |||+.+++|.+++..   ....+++..++.++.||+.||.|||+   .+++||||||+||+++.++.+||+|||++....
T Consensus       111 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~  187 (310)
T 2wqm_A          111 LELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFS  187 (310)
T ss_dssp             EECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCC-------
T ss_pred             EecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhh---CCeeCCCCcHHHEEEcCCCCEEEEeccceeeec
Confidence            999999999998853   45668999999999999999999999   899999999999999999999999999998764


Q ss_pred             CCCCceeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhccccccCCcccccCchhh
Q 012765          296 DNWSHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSNFKELVDPRLA  375 (457)
Q Consensus       296 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  375 (457)
                      ....  ......|++.|+|||++.+..++.++||||||+++|+|++|+.||............... ........    .
T Consensus       188 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~----~  260 (310)
T 2wqm_A          188 SKTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIE-QCDYPPLP----S  260 (310)
T ss_dssp             -------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHH-TTCSCCCC----T
T ss_pred             CCCc--cccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhh-cccCCCCc----c
Confidence            4321  122345899999999999999999999999999999999999999764332222111111 11111000    0


Q ss_pred             cccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCCCCCCCC
Q 012765          376 DAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQLLRGEGGQTDLK  421 (457)
Q Consensus       376 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~~~~~  421 (457)
                      ..    ....+.+++.+||+.||.+|||+.+|++.|+.+.+....+
T Consensus       261 ~~----~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~~~~  302 (310)
T 2wqm_A          261 DH----YSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTASS  302 (310)
T ss_dssp             TT----SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC--
T ss_pred             cc----cCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhhhhh
Confidence            11    1235677889999999999999999999999886554443

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=2.5e-43  Score=370.08  Aligned_cols=261  Identities=24%  Similarity=0.341  Sum_probs=209.1

Q ss_pred             hhcCCCCCceecccCcEEEEEEEeCCCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeecCceEEEE
Q 012765          140 ATDNFNSENLIGKGGHAEVYKGCLPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTENGFHLVL  219 (457)
Q Consensus       140 ~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~lv~  219 (457)
                      ..++|.+.+.||+|+||.||+|.+.++..||||++......    .+.|.+|+.+|++++||||+++++++.++..++||
T Consensus       265 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~lv~  340 (535)
T 2h8h_A          265 PRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS----PEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVT  340 (535)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTSSC----HHHHHHHHHHHHHCCCTTBCCEEEEECSSSCEEEE
T ss_pred             chhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCCCC----HHHHHHHHHHHHhCCCCCEeeEEEEEeeccceEee
Confidence            34567778899999999999999988888999998754432    34789999999999999999999999888899999


Q ss_pred             EecCCCChhhhhhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCCCCC
Q 012765          220 QFLPHGSLSSLLFGS-TECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNW  298 (457)
Q Consensus       220 e~~~~gsL~~~l~~~-~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~~~  298 (457)
                      ||+.+|+|.+++... ...+++..++.|+.||+.||.|||+   .+|+||||||+|||++.++.+||+|||+++.+....
T Consensus       341 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~---~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~  417 (535)
T 2h8h_A          341 EYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE  417 (535)
T ss_dssp             CCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHH
T ss_pred             ehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCHhhEEEcCCCcEEEcccccceecCCCc
Confidence            999999999999642 3458999999999999999999999   899999999999999999999999999998764321


Q ss_pred             CceeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHh-CCCCCCcCCcchhhhhccccccCCcccccCchhhcc
Q 012765          299 SHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELIT-GRRAVDSRRQSLVIWAKPLLQTSNFKELVDPRLADA  377 (457)
Q Consensus       299 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLlt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~  377 (457)
                      . .......++..|+|||++.+..++.++|||||||+||||++ |+.||............  .....      ..... 
T Consensus       418 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i--~~~~~------~~~~~-  487 (535)
T 2h8h_A          418 Y-TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQV--ERGYR------MPCPP-  487 (535)
T ss_dssp             H-HTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHH--HTTCC------CCCCT-
T ss_pred             e-ecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH--HcCCC------CCCCC-
Confidence            1 11122346788999999999999999999999999999999 99999864332211110  00000      00011 


Q ss_pred             cCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCCCCCCC
Q 012765          378 YDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQLLRGEGGQTDL  420 (457)
Q Consensus       378 ~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~~~~  420 (457)
                         .....+.+++.+||+.||++|||+.+|++.|+.+.....+
T Consensus       488 ---~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~~~  527 (535)
T 2h8h_A          488 ---ECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEP  527 (535)
T ss_dssp             ---TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCCCSC
T ss_pred             ---CCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhccCc
Confidence               1223567788999999999999999999999988655443

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=4.7e-43  Score=348.01  Aligned_cols=251  Identities=21%  Similarity=0.297  Sum_probs=198.7

Q ss_pred             HhhcCCCCCceecccCcEEEEEEEeC-CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhc-CCCCcceeeeeeec-Cce
Q 012765          139 AATDNFNSENLIGKGGHAEVYKGCLP-DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHI-NHPNAAKLIGFSTE-NGF  215 (457)
Q Consensus       139 ~~~~~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~-~~~  215 (457)
                      ...++|.+.+.||+|+||.||+|.+. +|+.||+|++.+...........+..|..++..+ +||||+++++++.+ +.+
T Consensus        14 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~   93 (345)
T 1xjd_A           14 LKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENL   93 (345)
T ss_dssp             --CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEE
T ss_pred             CChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEE
Confidence            35678999999999999999999875 6899999998754322223345678899999876 89999999996655 557


Q ss_pred             EEEEEecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCC
Q 012765          216 HLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLP  295 (457)
Q Consensus       216 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~  295 (457)
                      ++||||+++|+|..++... ..+++..+..++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||+++...
T Consensus        94 ~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~  169 (345)
T 1xjd_A           94 FFVMEYLNGGDLMYHIQSC-HKFDLSRATFYAAEIILGLQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENM  169 (345)
T ss_dssp             EEEEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred             EEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCChhhEEECCCCCEEEeEChhhhhcc
Confidence            8999999999999998643 458899999999999999999999   899999999999999999999999999998653


Q ss_pred             CCCCceeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhccccccCCcccccCchhh
Q 012765          296 DNWSHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSNFKELVDPRLA  375 (457)
Q Consensus       296 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  375 (457)
                      ....  ......||+.|+|||++.+..++.++|||||||++|||++|..||...+..... .........        +.
T Consensus       170 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~-~~i~~~~~~--------~p  238 (345)
T 1xjd_A          170 LGDA--KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELF-HSIRMDNPF--------YP  238 (345)
T ss_dssp             CTTC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH-HHHHHCCCC--------CC
T ss_pred             cCCC--cccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHH-HHHHhCCCC--------CC
Confidence            3221  123456999999999999999999999999999999999999999865432211 111011111        11


Q ss_pred             cccCHHHHHHHHHHHHHhcccCCCCCCCHH-HHH
Q 012765          376 DAYDLAEMKRAMLTASVCIHHLSTMRPQMT-RVL  408 (457)
Q Consensus       376 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~-evl  408 (457)
                      ..+    ...+.+++.+||+.||.+||++. +|+
T Consensus       239 ~~~----s~~~~~li~~lL~~dp~~R~~~~~~i~  268 (345)
T 1xjd_A          239 RWL----EKEAKDLLVKLFVREPEKRLGVRGDIR  268 (345)
T ss_dssp             TTS----CHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred             ccc----CHHHHHHHHHHhcCCHhHcCCChHHHH
Confidence            112    23566788999999999999997 665

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=2.6e-42  Score=334.42  Aligned_cols=263  Identities=16%  Similarity=0.165  Sum_probs=205.1

Q ss_pred             hhcCCCCCceecccCcEEEEEEEe-CCCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhc-CCCCcceeeeeeecCc-eE
Q 012765          140 ATDNFNSENLIGKGGHAEVYKGCL-PDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHI-NHPNAAKLIGFSTENG-FH  216 (457)
Q Consensus       140 ~~~~f~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~-~~  216 (457)
                      ..++|.+.+.||+|+||.||+|.. .+++.||+|++.....     ...+.+|+.++..+ +|+|++++++++..+. .+
T Consensus         8 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~   82 (298)
T 1csn_A            8 VGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD-----APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNV   82 (298)
T ss_dssp             ETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT-----SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEE
T ss_pred             cccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCc-----cHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeE
Confidence            457799999999999999999985 5799999998864432     23577899999999 7999999999776554 67


Q ss_pred             EEEEecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCc-----EEEeecccc
Q 012765          217 LVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYE-----AQISDFGLA  291 (457)
Q Consensus       217 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~-----~kL~DFGl~  291 (457)
                      ++|||+ +++|.+++......+++..++.++.||+.||.|||+   .+|+||||||+|||++.++.     +||+|||++
T Consensus        83 lv~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~  158 (298)
T 1csn_A           83 LVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHE---KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMV  158 (298)
T ss_dssp             EEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECCSSSTTTTCEEECCCTTC
T ss_pred             EEEEec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEeccCCCCCCCeEEEEECccc
Confidence            999999 999999997766779999999999999999999999   89999999999999987776     999999999


Q ss_pred             ccCCCCCCc-----eeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhccccccCCc
Q 012765          292 KWLPDNWSH-----HIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSNF  366 (457)
Q Consensus       292 ~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~~~~~~~~~  366 (457)
                      .........     .......||+.|+|||++.+..++.++|||||||++|||++|+.||................... 
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~-  237 (298)
T 1csn_A          159 KFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKK-  237 (298)
T ss_dssp             EESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHH-
T ss_pred             cccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhc-
Confidence            877544321     11234569999999999999999999999999999999999999998643211110000000000 


Q ss_pred             ccccCchhhcccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCCC
Q 012765          367 KELVDPRLADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQLLRGEGG  416 (457)
Q Consensus       367 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~  416 (457)
                      .....+.+...    ....+.+++.+||+.||++||++.+|++.|+.+..
T Consensus       238 ~~~~~~~~~~~----~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~  283 (298)
T 1csn_A          238 QSTPLRELCAG----FPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLE  283 (298)
T ss_dssp             HHSCHHHHTTT----SCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHH
T ss_pred             cCccHHHHHhh----CcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHH
Confidence            00000111111    23467788999999999999999999999987643

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=1.4e-42  Score=333.74  Aligned_cols=249  Identities=27%  Similarity=0.401  Sum_probs=197.6

Q ss_pred             hhcCCCCCceecccCcEEEEEEEeC-CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeecCc-eEE
Q 012765          140 ATDNFNSENLIGKGGHAEVYKGCLP-DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTENG-FHL  217 (457)
Q Consensus       140 ~~~~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~-~~l  217 (457)
                      ..++|.+.+.||+|+||+||+|.+. +++.||+|.+.............+.+|+.+++.++||||+++++++.+.. .++
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   86 (279)
T 3fdn_A            7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYL   86 (279)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred             ecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEE
Confidence            3577889999999999999999865 57799999986544333333567889999999999999999999776654 689


Q ss_pred             EEEecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCCCC
Q 012765          218 VLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDN  297 (457)
Q Consensus       218 v~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~~  297 (457)
                      +|||+++++|.+++... ..+++..++.++.||+.||.|||+   .+|+||||||+||+++.++.+||+|||++......
T Consensus        87 v~e~~~~~~l~~~l~~~-~~~~~~~~~~~~~qi~~~l~~LH~---~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~  162 (279)
T 3fdn_A           87 ILEYAPLGTVYRELQKL-SKFDEQRTATYITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS  162 (279)
T ss_dssp             EECCCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHT---TTCEECCCCGGGEEECTTSCEEECSCCEESCC---
T ss_pred             EEecCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHh---CCEecccCChHhEEEcCCCCEEEEeccccccCCcc
Confidence            99999999999998543 458899999999999999999999   89999999999999999999999999998765443


Q ss_pred             CCceeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhccccccCCcccccCchhhcc
Q 012765          298 WSHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSNFKELVDPRLADA  377 (457)
Q Consensus       298 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~  377 (457)
                      .    .....||+.|+|||++.+..++.++||||||+++|+|++|..||............. ...        ......
T Consensus       163 ~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~-~~~--------~~~~~~  229 (279)
T 3fdn_A          163 R----RTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRIS-RVE--------FTFPDF  229 (279)
T ss_dssp             ---------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH-HTC--------CCCCTT
T ss_pred             c----ccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHH-hCC--------CCCCCc
Confidence            2    223458999999999999999999999999999999999999998644322111000 000        011111


Q ss_pred             cCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 012765          378 YDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQ  409 (457)
Q Consensus       378 ~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~  409 (457)
                          ....+.+++.+||+.||.+|||+.||++
T Consensus       230 ----~~~~~~~li~~~l~~~p~~Rps~~e~l~  257 (279)
T 3fdn_A          230 ----VTEGARDLISRLLKHNPSQRPMLREVLE  257 (279)
T ss_dssp             ----SCHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred             ----CCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence                1234567889999999999999999997

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=3.3e-43  Score=339.53  Aligned_cols=262  Identities=24%  Similarity=0.356  Sum_probs=199.8

Q ss_pred             hcCCCCCceecccCcEEEEEEEeC--CCc--EEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeecCceE
Q 012765          141 TDNFNSENLIGKGGHAEVYKGCLP--DGE--VVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTENGFH  216 (457)
Q Consensus       141 ~~~f~~~~~LG~G~~g~Vy~~~~~--~~~--~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~  216 (457)
                      .++|.+.+.||+|+||+||+|.+.  +++  .||+|.+.............+.+|+.++..++||||+++++++.....+
T Consensus        17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   96 (291)
T 1u46_A           17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPPMK   96 (291)
T ss_dssp             GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCE
T ss_pred             hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCCce
Confidence            467889999999999999999853  333  6899988654433334567899999999999999999999999888899


Q ss_pred             EEEEecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCCC
Q 012765          217 LVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPD  296 (457)
Q Consensus       217 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~  296 (457)
                      ++|||+++++|.+++......+++..++.++.||+.||.|||+   .+++||||||+||+++.++.+||+|||++.....
T Consensus        97 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~  173 (291)
T 1u46_A           97 MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQ  173 (291)
T ss_dssp             EEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEEEETTEEEECCCTTCEECCC
T ss_pred             eeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHh---CCcccCCCchheEEEcCCCCEEEccccccccccc
Confidence            9999999999999997666678999999999999999999999   8999999999999999999999999999987755


Q ss_pred             CCCcee-eecccccccccChhccccCCCCcchhHHHHHHHHHHHHh-CCCCCCcCCcchhhhhccccccCCcccccCchh
Q 012765          297 NWSHHI-VFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELIT-GRRAVDSRRQSLVIWAKPLLQTSNFKELVDPRL  374 (457)
Q Consensus       297 ~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLlt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l  374 (457)
                      ...... .....+|..|+|||++.+..++.++||||||+++|+|++ |..||............  .....     ....
T Consensus       174 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~--~~~~~-----~~~~  246 (291)
T 1u46_A          174 NDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKI--DKEGE-----RLPR  246 (291)
T ss_dssp             -CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHH--HTSCC-----CCCC
T ss_pred             cccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHH--HccCC-----CCCC
Confidence            432221 223457888999999998889999999999999999999 99999864432221111  00000     0000


Q ss_pred             hcccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCCC
Q 012765          375 ADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQLLRGEGG  416 (457)
Q Consensus       375 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~  416 (457)
                      ..    .....+.+++.+||+.||.+|||+.+|++.|+.+..
T Consensus       247 ~~----~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~  284 (291)
T 1u46_A          247 PE----DCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQP  284 (291)
T ss_dssp             CT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-
T ss_pred             Cc----CcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCc
Confidence            11    122457788899999999999999999999988753

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=7.6e-43  Score=341.13  Aligned_cols=260  Identities=23%  Similarity=0.330  Sum_probs=195.3

Q ss_pred             hhcCCCCCceecccCcEEEEEEEeC----CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeecCc-
Q 012765          140 ATDNFNSENLIGKGGHAEVYKGCLP----DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTENG-  214 (457)
Q Consensus       140 ~~~~f~~~~~LG~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~-  214 (457)
                      ..++|.+.+.||+|+||.||+|.+.    .+..||+|.+..... .......+.+|+.++++++||||+++++++.... 
T Consensus        32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~  110 (313)
T 3brb_A           32 DRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNS-SQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSS  110 (313)
T ss_dssp             CGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CC-CHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC---
T ss_pred             CHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEecccc-chhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccc
Confidence            4577889999999999999999753    345899998864432 2344668999999999999999999999776533 


Q ss_pred             -----eEEEEEecCCCChhhhhhc-----CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEE
Q 012765          215 -----FHLVLQFLPHGSLSSLLFG-----STECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQ  284 (457)
Q Consensus       215 -----~~lv~e~~~~gsL~~~l~~-----~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~k  284 (457)
                           .+++|||+.+++|.+++..     ....+++..++.++.||+.||.|||+   .+|+||||||+|||++.++.+|
T Consensus       111 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dikp~NIli~~~~~~k  187 (313)
T 3brb_A          111 QGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSN---RNFLHRDLAARNCMLRDDMTVC  187 (313)
T ss_dssp             ----CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHT---TTCCCCCCSGGGEEECTTSCEE
T ss_pred             cCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCcceEEEcCCCcEE
Confidence                 4899999999999999842     33568999999999999999999999   8999999999999999999999


Q ss_pred             EeeccccccCCCCCCceeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHh-CCCCCCcCCcchhhhhcccccc
Q 012765          285 ISDFGLAKWLPDNWSHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELIT-GRRAVDSRRQSLVIWAKPLLQT  363 (457)
Q Consensus       285 L~DFGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLlt-G~~pf~~~~~~~~~~~~~~~~~  363 (457)
                      |+|||++................+++.|+|||.+.+..++.++||||||+++|+|++ |..||............  ...
T Consensus       188 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~--~~~  265 (313)
T 3brb_A          188 VADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYL--LHG  265 (313)
T ss_dssp             ECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHH--HTT
T ss_pred             EeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHH--HcC
Confidence            999999987654432222233457889999999999999999999999999999999 88999764432211100  000


Q ss_pred             CCcccccCchhhcccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCC
Q 012765          364 SNFKELVDPRLADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQLLRGEG  415 (457)
Q Consensus       364 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~  415 (457)
                      .      .+.....    ....+.+++.+||+.||.+|||+.+|++.|+.+.
T Consensus       266 ~------~~~~~~~----~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~  307 (313)
T 3brb_A          266 H------RLKQPED----CLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLL  307 (313)
T ss_dssp             C------CCCCBTT----CCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             C------CCCCCcc----ccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence            0      0111111    2245778889999999999999999999998764

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=3.8e-42  Score=346.89  Aligned_cols=269  Identities=22%  Similarity=0.291  Sum_probs=203.0

Q ss_pred             hhcCCCCCceeccc--CcEEEEEEEeC-CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeec-Cce
Q 012765          140 ATDNFNSENLIGKG--GHAEVYKGCLP-DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTE-NGF  215 (457)
Q Consensus       140 ~~~~f~~~~~LG~G--~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-~~~  215 (457)
                      ..++|++.+.||+|  +||+||+|.+. +|+.||||++...... ......+.+|+.+++.++||||+++++++.+ +..
T Consensus        23 ~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  101 (389)
T 3gni_B           23 EGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACS-NEMVTFLQGELHVSKLFNHPNIVPYRATFIADNEL  101 (389)
T ss_dssp             CGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred             CCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccC-hHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEE
Confidence            34678899999999  99999999975 6999999998754332 3456788899999999999999999996654 557


Q ss_pred             EEEEEecCCCChhhhhhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccC
Q 012765          216 HLVLQFLPHGSLSSLLFGS-TECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWL  294 (457)
Q Consensus       216 ~lv~e~~~~gsL~~~l~~~-~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~  294 (457)
                      ++||||+++|+|.+++... ...+++..+..++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||++...
T Consensus       102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~  178 (389)
T 3gni_B          102 WVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHH---MGYVHRSVKASHILISVDGKVYLSGLRSNLSM  178 (389)
T ss_dssp             EEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred             EEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEcccccceee
Confidence            8999999999999998653 3568999999999999999999999   89999999999999999999999999998654


Q ss_pred             CCCCC-----ceeeecccccccccChhcccc--CCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhccccccCCcc
Q 012765          295 PDNWS-----HHIVFPIEGTFGYLSPEYFMH--GIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSNFK  367 (457)
Q Consensus       295 ~~~~~-----~~~~~~~~gt~~y~aPE~~~~--~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~  367 (457)
                      .....     ........||+.|+|||++.+  ..++.++|||||||++|||++|+.||..............   ....
T Consensus       179 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~---~~~~  255 (389)
T 3gni_B          179 ISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLN---GTVP  255 (389)
T ss_dssp             EETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC---------
T ss_pred             ccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhc---CCCC
Confidence            22111     111122468999999999987  5799999999999999999999999986443322211100   0000


Q ss_pred             cccCchh------------------------------------hcccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH-
Q 012765          368 ELVDPRL------------------------------------ADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQL-  410 (457)
Q Consensus       368 ~~~d~~l------------------------------------~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~-  410 (457)
                      .+.+...                                    ...+.......+.+++.+||+.||.+|||+.|+++. 
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~hp  335 (389)
T 3gni_B          256 CLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHS  335 (389)
T ss_dssp             --------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTSG
T ss_pred             ccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcCH
Confidence            0000000                                    000111223457889999999999999999999863 


Q ss_pred             -HhcCC
Q 012765          411 -LRGEG  415 (457)
Q Consensus       411 -L~~~~  415 (457)
                       ++.+.
T Consensus       336 ~f~~~~  341 (389)
T 3gni_B          336 FFKQIK  341 (389)
T ss_dssp             GGGGC-
T ss_pred             HHHHHh
Confidence             55443

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=5.4e-43  Score=351.32  Aligned_cols=257  Identities=27%  Similarity=0.404  Sum_probs=191.9

Q ss_pred             CCCCCceecccCcEEEEEEEeC--CC--cEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeee--cCceE
Q 012765          143 NFNSENLIGKGGHAEVYKGCLP--DG--EVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFST--ENGFH  216 (457)
Q Consensus       143 ~f~~~~~LG~G~~g~Vy~~~~~--~~--~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~--~~~~~  216 (457)
                      .|.+.+.||+|+||+||+|.+.  ++  ..||+|.+.....  ......+.+|+.++++++||||+++++++.  ++..+
T Consensus        90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~  167 (373)
T 3c1x_A           90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITD--IGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL  167 (373)
T ss_dssp             EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSC--SHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCE
T ss_pred             eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCC--HHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeE
Confidence            3556789999999999999853  22  3688998754322  244678999999999999999999999754  34578


Q ss_pred             EEEEecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCCC
Q 012765          217 LVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPD  296 (457)
Q Consensus       217 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~  296 (457)
                      +||||+++|+|.+++......+++..++.++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||+++.+..
T Consensus       168 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~  244 (373)
T 3c1x_A          168 VVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYD  244 (373)
T ss_dssp             EEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred             EEEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHH---CCEecCccchheEEECCCCCEEEeeccccccccc
Confidence            9999999999999998777778999999999999999999999   8999999999999999999999999999987644


Q ss_pred             CCCc--eeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHh-CCCCCCcCCcchhhhhccccccCCcccccCch
Q 012765          297 NWSH--HIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELIT-GRRAVDSRRQSLVIWAKPLLQTSNFKELVDPR  373 (457)
Q Consensus       297 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLlt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~  373 (457)
                      ....  .......+|+.|+|||++.+..++.++|||||||++|||+| |..||............  ....   ....+ 
T Consensus       245 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~--~~~~---~~~~p-  318 (373)
T 3c1x_A          245 KEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYL--LQGR---RLLQP-  318 (373)
T ss_dssp             -------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHH--HTTC---CCCCC-
T ss_pred             cccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHH--HcCC---CCCCC-
Confidence            3211  11223457889999999999999999999999999999999 67777653322111100  0000   00011 


Q ss_pred             hhcccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCCC
Q 012765          374 LADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQLLRGEGG  416 (457)
Q Consensus       374 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~  416 (457)
                        ..+    ...+.+++.+||+.||.+|||+.+|++.|+.+..
T Consensus       319 --~~~----~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~  355 (373)
T 3c1x_A          319 --EYC----PDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFS  355 (373)
T ss_dssp             --TTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             --CCC----CHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence              111    2356778899999999999999999999988753

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=1.4e-42  Score=350.06  Aligned_cols=265  Identities=21%  Similarity=0.324  Sum_probs=190.1

Q ss_pred             HhhcCCCCCceecccCcEEEEEEEeC-CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcC-CCCcceeeeeeecC---
Q 012765          139 AATDNFNSENLIGKGGHAEVYKGCLP-DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHIN-HPNAAKLIGFSTEN---  213 (457)
Q Consensus       139 ~~~~~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~---  213 (457)
                      ...++|.+.+.||+|+||.||+|.+. +|+.||+|++..... .......+.+|+.++..+. ||||+++++++...   
T Consensus         6 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~-~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~   84 (388)
T 3oz6_A            6 HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQ-NSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDR   84 (388)
T ss_dssp             HHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--C-CHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSS
T ss_pred             cccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEeccccc-ChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCC
Confidence            35688999999999999999999864 689999999865422 2344567889999999997 99999999977532   


Q ss_pred             ceEEEEEecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeecccccc
Q 012765          214 GFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKW  293 (457)
Q Consensus       214 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~  293 (457)
                      .+++||||+. ++|..++..  ..+++..+..++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||+++.
T Consensus        85 ~~~lv~e~~~-~~L~~~~~~--~~~~~~~~~~i~~qi~~~L~~LH~---~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~  158 (388)
T 3oz6_A           85 DVYLVFDYME-TDLHAVIRA--NILEPVHKQYVVYQLIKVIKYLHS---GGLLHRDMKPSNILLNAECHVKVADFGLSRS  158 (388)
T ss_dssp             CEEEEEECCS-EEHHHHHHH--TCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred             EEEEEecccC-cCHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCCCHHHeEEcCCCCEEecCCccccc
Confidence            4789999997 588888854  468899999999999999999999   8999999999999999999999999999987


Q ss_pred             CCCCC-------------------CceeeecccccccccChhcccc-CCCCcchhHHHHHHHHHHHHhCCCCCCcCCcch
Q 012765          294 LPDNW-------------------SHHIVFPIEGTFGYLSPEYFMH-GIVDEKTDVFAFGVLLLELITGRRAVDSRRQSL  353 (457)
Q Consensus       294 ~~~~~-------------------~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~  353 (457)
                      +....                   .........||++|+|||++.+ ..|+.++|||||||++|||++|+.||.+.+...
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~  238 (388)
T 3oz6_A          159 FVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMN  238 (388)
T ss_dssp             SSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred             ccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence            64311                   1112334579999999999986 679999999999999999999999998654322


Q ss_pred             hhhhc-cccccCCc---ccccCc------------------hhhcccC------------HHHHHHHHHHHHHhcccCCC
Q 012765          354 VIWAK-PLLQTSNF---KELVDP------------------RLADAYD------------LAEMKRAMLTASVCIHHLST  399 (457)
Q Consensus       354 ~~~~~-~~~~~~~~---~~~~d~------------------~l~~~~~------------~~~~~~l~~l~~~Cl~~dP~  399 (457)
                      ..... .....+..   ..+..+                  .....+.            ......+.+++.+||+.||.
T Consensus       239 ~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~  318 (388)
T 3oz6_A          239 QLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPN  318 (388)
T ss_dssp             HHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGG
T ss_pred             HHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcc
Confidence            11000 00000000   000000                  0000000            01124577899999999999


Q ss_pred             CCCCHHHHHHH
Q 012765          400 MRPQMTRVLQL  410 (457)
Q Consensus       400 ~RPt~~evl~~  410 (457)
                      +|||+.|+++.
T Consensus       319 ~R~t~~e~l~H  329 (388)
T 3oz6_A          319 KRISANDALKH  329 (388)
T ss_dssp             GSCCHHHHTTS
T ss_pred             cCCCHHHHhCC
Confidence            99999999874

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=4.5e-43  Score=355.97  Aligned_cols=263  Identities=22%  Similarity=0.232  Sum_probs=204.1

Q ss_pred             HHHHHHhhcCCCCCceecccCcEEEEEEEeC-CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeec
Q 012765          134 FAELAAATDNFNSENLIGKGGHAEVYKGCLP-DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTE  212 (457)
Q Consensus       134 ~~~~~~~~~~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~  212 (457)
                      +.+.....++|.+.+.||+|+||+||+|... +|+.||+|++.+...........+.+|..++..++||||+++++++.+
T Consensus        53 ~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~  132 (412)
T 2vd5_A           53 LKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQD  132 (412)
T ss_dssp             HHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEEC
T ss_pred             hhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEee
Confidence            3444556789999999999999999999875 699999999865433223334568899999999999999999996655


Q ss_pred             -CceEEEEEecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeecccc
Q 012765          213 -NGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLA  291 (457)
Q Consensus       213 -~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~  291 (457)
                       +.+++||||+++|+|.+++......+++..+..++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||++
T Consensus       133 ~~~~~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~---~giiHrDLKp~NILld~~g~vkL~DFGla  209 (412)
T 2vd5_A          133 ENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHR---LGYVHRDIKPDNILLDRCGHIRLADFGSC  209 (412)
T ss_dssp             SSEEEEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred             CCEEEEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecccCHHHeeecCCCCEEEeechhh
Confidence             45789999999999999997655678999999999999999999999   89999999999999999999999999999


Q ss_pred             ccCCCCCCceeeecccccccccChhccc-------cCCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhccccccC
Q 012765          292 KWLPDNWSHHIVFPIEGTFGYLSPEYFM-------HGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTS  364 (457)
Q Consensus       292 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~~~~~~~  364 (457)
                      +.+..... .......||+.|+|||++.       ...|+.++|||||||++|||++|+.||............  ....
T Consensus       210 ~~~~~~~~-~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i--~~~~  286 (412)
T 2vd5_A          210 LKLRADGT-VRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKI--VHYK  286 (412)
T ss_dssp             EECCTTSC-EECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH--HTHH
T ss_pred             eeccCCCc-cccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHH--Hhcc
Confidence            87754322 1223457999999999987       356899999999999999999999999864432211000  0000


Q ss_pred             CcccccCchhhcccCHHHHHHHHHHHHHhcccCCCCC---CCHHHHHH
Q 012765          365 NFKELVDPRLADAYDLAEMKRAMLTASVCIHHLSTMR---PQMTRVLQ  409 (457)
Q Consensus       365 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~R---Pt~~evl~  409 (457)
                        ..+.-+.....+    ...+.+++.+||. +|.+|   |++.||++
T Consensus       287 --~~~~~p~~~~~~----s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~  327 (412)
T 2vd5_A          287 --EHLSLPLVDEGV----PEEARDFIQRLLC-PPETRLGRGGAGDFRT  327 (412)
T ss_dssp             --HHCCCC----CC----CHHHHHHHHTTSS-CGGGCTTTTTHHHHHT
T ss_pred             --cCcCCCccccCC----CHHHHHHHHHHcC-ChhhcCCCCCHHHHhc
Confidence              000011111122    2456778899999 99998   68999876

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=9.8e-42  Score=351.76  Aligned_cols=259  Identities=22%  Similarity=0.265  Sum_probs=194.9

Q ss_pred             hhcCCCCCceecccCcEEEEEEEeC-CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeecC-----
Q 012765          140 ATDNFNSENLIGKGGHAEVYKGCLP-DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTEN-----  213 (457)
Q Consensus       140 ~~~~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~-----  213 (457)
                      ..++|.+.+.||+|+||+||+|.+. +++.||||++.... ........+.+|+.+++.++||||+++++++...     
T Consensus        60 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~  138 (464)
T 3ttj_A           60 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPF-QNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEE  138 (464)
T ss_dssp             EETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGG-GSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTT
T ss_pred             ecCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccc-cChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCcccc
Confidence            3578999999999999999999864 68999999987543 2334567889999999999999999999977543     


Q ss_pred             --ceEEEEEecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeecccc
Q 012765          214 --GFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLA  291 (457)
Q Consensus       214 --~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~  291 (457)
                        ..++||||+.++ |...+.   ..+++..+..++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||++
T Consensus       139 ~~~~~lv~E~~~~~-l~~~~~---~~l~~~~~~~~~~qil~aL~~lH~---~~iiHrDlkp~NIll~~~~~~kl~DFG~a  211 (464)
T 3ttj_A          139 FQDVYLVMELMDAN-LCQVIQ---MELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLA  211 (464)
T ss_dssp             CCEEEEEEECCSEE-HHHHHT---SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCCCC
T ss_pred             CCeEEEEEeCCCCC-HHHHHh---hcCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChHhEEEeCCCCEEEEEEEee
Confidence              358999999765 555553   248899999999999999999999   89999999999999999999999999999


Q ss_pred             ccCCCCCCceeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhc-------------
Q 012765          292 KWLPDNWSHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAK-------------  358 (457)
Q Consensus       292 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~-------------  358 (457)
                      +......   ......||+.|+|||++.+..|+.++|||||||++|||++|+.||.+.+........             
T Consensus       212 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~  288 (464)
T 3ttj_A          212 RTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMK  288 (464)
T ss_dssp             -----CC---CC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHT
T ss_pred             eecCCCc---ccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHH
Confidence            8765432   223456999999999999999999999999999999999999999875422110000             


Q ss_pred             -------------cccccCCcccccCchhhccc---CHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 012765          359 -------------PLLQTSNFKELVDPRLADAY---DLAEMKRAMLTASVCIHHLSTMRPQMTRVLQ  409 (457)
Q Consensus       359 -------------~~~~~~~~~~~~d~~l~~~~---~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~  409 (457)
                                   +......+.......+....   .......+.+++.+||+.||++|||+.|+++
T Consensus       289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~  355 (464)
T 3ttj_A          289 KLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ  355 (464)
T ss_dssp             TSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             HcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence                         00000011111111111110   1112456888999999999999999999987

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=1.1e-42  Score=336.72  Aligned_cols=257  Identities=23%  Similarity=0.318  Sum_probs=202.9

Q ss_pred             hcCCCCCc-eecccCcEEEEEEEe---CCCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeecCceE
Q 012765          141 TDNFNSEN-LIGKGGHAEVYKGCL---PDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTENGFH  216 (457)
Q Consensus       141 ~~~f~~~~-~LG~G~~g~Vy~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~  216 (457)
                      .++|.+.+ .||+|+||+||+|.+   .+++.||+|++..... .......+.+|+.+++.++||||+++++++..+..+
T Consensus        15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   93 (291)
T 1xbb_A           15 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAN-DPALKDELLAEANVMQQLDNPYIVRMIGICEAESWM   93 (291)
T ss_dssp             GGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC------CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESSSEE
T ss_pred             chhhhhccCccccccCeeeEeeeecCCCceeeEEEEeeccccc-CHHHHHHHHHHHHHHHhCCCCCEEEEEEEECCCCcE
Confidence            45677777 999999999999954   2478899998865432 223456899999999999999999999999888899


Q ss_pred             EEEEecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCCC
Q 012765          217 LVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPD  296 (457)
Q Consensus       217 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~  296 (457)
                      +||||+++++|.+++... ..+++..++.++.||+.||.|||+   .+|+||||||+||+++.++.+||+|||++.....
T Consensus        94 lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~  169 (291)
T 1xbb_A           94 LVMEMAELGPLNKYLQQN-RHVKDKNIIELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRA  169 (291)
T ss_dssp             EEEECCTTEEHHHHHHHC-TTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEECCCTTCEECCT
T ss_pred             EEEEeCCCCCHHHHHHhC-cCCCHHHHHHHHHHHHHHHHHHHh---CCeEcCCCCcceEEEeCCCcEEEccCCcceeecc
Confidence            999999999999999654 458899999999999999999999   8999999999999999999999999999987755


Q ss_pred             CCCcee-eecccccccccChhccccCCCCcchhHHHHHHHHHHHHh-CCCCCCcCCcchhhhhccccccCCcccccCchh
Q 012765          297 NWSHHI-VFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELIT-GRRAVDSRRQSLVIWAKPLLQTSNFKELVDPRL  374 (457)
Q Consensus       297 ~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLlt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l  374 (457)
                      ...... .....+|..|+|||++.+..++.++||||||+++|+|++ |+.||.............   ...     .+..
T Consensus       170 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~---~~~-----~~~~  241 (291)
T 1xbb_A          170 DENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLE---KGE-----RMGC  241 (291)
T ss_dssp             TCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH---TTC-----CCCC
T ss_pred             CCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH---cCC-----CCCC
Confidence            432211 122346788999999998889999999999999999999 999998644332211110   000     0111


Q ss_pred             hcccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q 012765          375 ADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQLLRGE  414 (457)
Q Consensus       375 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~  414 (457)
                      ..    .....+.+++.+||+.||.+||++.+|++.|+.+
T Consensus       242 ~~----~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~  277 (291)
T 1xbb_A          242 PA----GCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY  277 (291)
T ss_dssp             CT----TCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred             CC----CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence            11    1234577888999999999999999999999865

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=2.7e-42  Score=331.30  Aligned_cols=251  Identities=26%  Similarity=0.397  Sum_probs=181.6

Q ss_pred             hcCCCCCceecccCcEEEEEEEe-CCCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeecCc-eEEE
Q 012765          141 TDNFNSENLIGKGGHAEVYKGCL-PDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTENG-FHLV  218 (457)
Q Consensus       141 ~~~f~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~-~~lv  218 (457)
                      .++|.+.+.||+|+||.||+|.. .+|+.||+|.+.............+.+|+.++..++||||+++++++.+.. .+++
T Consensus        10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   89 (278)
T 3cok_A           10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLV   89 (278)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEE
T ss_pred             cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEE
Confidence            36788999999999999999986 478999999986543322223467899999999999999999999776654 6799


Q ss_pred             EEecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCCCCC
Q 012765          219 LQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNW  298 (457)
Q Consensus       219 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~~~  298 (457)
                      |||+++++|.+++......+++..++.++.||+.||.|||+   .+++||||||+||+++.++.+||+|||++.......
T Consensus        90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~  166 (278)
T 3cok_A           90 LEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHS---HGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPH  166 (278)
T ss_dssp             EECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHH---TTEECSSCCGGGEEECTTCCEEECCCTTCEECC---
T ss_pred             EecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCCEEEEeecceeeccCCC
Confidence            99999999999997766779999999999999999999999   899999999999999999999999999998765332


Q ss_pred             CceeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhccccccCCcccccCchhhccc
Q 012765          299 SHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSNFKELVDPRLADAY  378 (457)
Q Consensus       299 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~  378 (457)
                      ..  .....||+.|+|||.+.+..++.++||||||+++|+|++|+.||......... ......        +..+...+
T Consensus       167 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~-~~~~~~--------~~~~~~~~  235 (278)
T 3cok_A          167 EK--HYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTL-NKVVLA--------DYEMPSFL  235 (278)
T ss_dssp             ---------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC------CCSS--------CCCCCTTS
T ss_pred             Cc--ceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHH-HHHhhc--------ccCCcccc
Confidence            21  22345899999999999889999999999999999999999999864321110 000000        11111112


Q ss_pred             CHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 012765          379 DLAEMKRAMLTASVCIHHLSTMRPQMTRVLQ  409 (457)
Q Consensus       379 ~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~  409 (457)
                          ...+.+++.+||+.||++|||+.++++
T Consensus       236 ----~~~~~~li~~~l~~dp~~Rps~~~~l~  262 (278)
T 3cok_A          236 ----SIEAKDLIHQLLRRNPADRLSLSSVLD  262 (278)
T ss_dssp             ----CHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             ----CHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence                235667899999999999999999986

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=3.5e-42  Score=337.65  Aligned_cols=257  Identities=21%  Similarity=0.351  Sum_probs=183.3

Q ss_pred             hcCCCCCceecccCcEEEEEEEeC-CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeecC-ceEEE
Q 012765          141 TDNFNSENLIGKGGHAEVYKGCLP-DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTEN-GFHLV  218 (457)
Q Consensus       141 ~~~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~-~~~lv  218 (457)
                      .++|.+.+.||+|+||+||+|.+. +|+.||+|++......  .....+.+|+.+++.++||||+++++++..+ ..++|
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv   81 (317)
T 2pmi_A            4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEE--GTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLV   81 (317)
T ss_dssp             ---------------CEEEEEECSSSCCEEEEEEEECCSTT--CSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEE
T ss_pred             ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeeccccc--ccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEE
Confidence            467899999999999999999864 6899999998654322  1234678999999999999999999976654 57899


Q ss_pred             EEecCCCChhhhhhcC-----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeecccccc
Q 012765          219 LQFLPHGSLSSLLFGS-----TECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKW  293 (457)
Q Consensus       219 ~e~~~~gsL~~~l~~~-----~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~  293 (457)
                      |||+. |+|.+++...     ...+++..+..++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||++..
T Consensus        82 ~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~---~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~  157 (317)
T 2pmi_A           82 FEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHE---NKILHRDLKPQNLLINKRGQLKLGDFGLARA  157 (317)
T ss_dssp             EECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCSSCEE
T ss_pred             EEecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCChHHeEEcCCCCEEECcCcccee
Confidence            99998 5888887432     2458899999999999999999999   8999999999999999999999999999987


Q ss_pred             CCCCCCceeeecccccccccChhcccc-CCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhc-cccc---------
Q 012765          294 LPDNWSHHIVFPIEGTFGYLSPEYFMH-GIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAK-PLLQ---------  362 (457)
Q Consensus       294 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~-~~~~---------  362 (457)
                      ......  ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||............ ....         
T Consensus       158 ~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  235 (317)
T 2pmi_A          158 FGIPVN--TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPS  235 (317)
T ss_dssp             TTSCCC--CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGG
T ss_pred             cCCCcc--cCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhh
Confidence            653321  1223458999999999976 46899999999999999999999999865432211000 0000         


Q ss_pred             ---c------------CCcccccCchhhcccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 012765          363 ---T------------SNFKELVDPRLADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQ  409 (457)
Q Consensus       363 ---~------------~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~  409 (457)
                         .            ..+.+.+.+.....    ....+.+++.+||+.||++|||+.|+++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~l~~li~~~L~~dP~~Rpt~~e~l~  293 (317)
T 2pmi_A          236 VTKLPKYNPNIQQRPPRDLRQVLQPHTKEP----LDGNLMDFLHGLLQLNPDMRLSAKQALH  293 (317)
T ss_dssp             GGGCTTCCTTCCCCCCCCSHHHHGGGCSSC----CCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             hhhhhhcccccccccchhHHHhhccccccc----CCHHHHHHHHHHCCCCcccCCCHHHHhC
Confidence               0            00000011111111    2235778999999999999999999876

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.3e-42  Score=343.11  Aligned_cols=258  Identities=24%  Similarity=0.365  Sum_probs=198.0

Q ss_pred             hcCCCCCceecccCcEEEEEEEeCC-----CcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeec-Cc
Q 012765          141 TDNFNSENLIGKGGHAEVYKGCLPD-----GEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTE-NG  214 (457)
Q Consensus       141 ~~~f~~~~~LG~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-~~  214 (457)
                      .++|.+.+.||+|+||+||+|.+..     +..||+|.+.....  ......+.+|+.+++.++||||+++++++.. +.
T Consensus        43 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  120 (333)
T 1mqb_A           43 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYT--EKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKP  120 (333)
T ss_dssp             TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCC--HHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred             hHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCC--HHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCC
Confidence            3567778999999999999998642     24599999865432  2345689999999999999999999997765 45


Q ss_pred             eEEEEEecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccC
Q 012765          215 FHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWL  294 (457)
Q Consensus       215 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~  294 (457)
                      .++||||+.+++|.+++......+++..++.++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||++...
T Consensus       121 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~  197 (333)
T 1mqb_A          121 MMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLAN---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVL  197 (333)
T ss_dssp             EEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred             cEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChheEEECCCCcEEECCCCcchhh
Confidence            789999999999999997776779999999999999999999999   89999999999999999999999999999876


Q ss_pred             CCCCCce-eeecccccccccChhccccCCCCcchhHHHHHHHHHHHHh-CCCCCCcCCcchhhhhccccccCCcccccCc
Q 012765          295 PDNWSHH-IVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELIT-GRRAVDSRRQSLVIWAKPLLQTSNFKELVDP  372 (457)
Q Consensus       295 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLlt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~  372 (457)
                      ....... ......+|..|+|||++.+..++.++|||||||++|||++ |+.||............  .....      .
T Consensus       198 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~--~~~~~------~  269 (333)
T 1mqb_A          198 EDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAI--NDGFR------L  269 (333)
T ss_dssp             -------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHH--HTTCC------C
T ss_pred             ccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHH--HCCCc------C
Confidence            5432211 1122346788999999999999999999999999999999 99999764332211110  00000      0


Q ss_pred             hhhcccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCC
Q 012765          373 RLADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQLLRGEG  415 (457)
Q Consensus       373 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~  415 (457)
                      ..    .......+.+++.+||+.||.+||++.+|++.|+.+.
T Consensus       270 ~~----~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~  308 (333)
T 1mqb_A          270 PT----PMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLI  308 (333)
T ss_dssp             CC----CTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred             CC----cccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence            00    1112245678889999999999999999999998764

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=6.7e-42  Score=331.53  Aligned_cols=258  Identities=23%  Similarity=0.316  Sum_probs=200.1

Q ss_pred             CCCCCceecccCcEEEEEEEeC-C---CcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeecC-c-eE
Q 012765          143 NFNSENLIGKGGHAEVYKGCLP-D---GEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTEN-G-FH  216 (457)
Q Consensus       143 ~f~~~~~LG~G~~g~Vy~~~~~-~---~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~-~-~~  216 (457)
                      .|...++||+|+||+||+|.+. +   +..+|+|.+....  .....+.+.+|+.+++.++||||+++++++.+. . .+
T Consensus        22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   99 (298)
T 3pls_A           22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRIT--EMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPH   99 (298)
T ss_dssp             EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCC--SHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCE
T ss_pred             EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccc--cHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcE
Confidence            3445689999999999999853 2   2379999886433  234567899999999999999999999977543 3 38


Q ss_pred             EEEEecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCCC
Q 012765          217 LVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPD  296 (457)
Q Consensus       217 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~  296 (457)
                      ++|||+.+|+|.+++......+++..++.++.|++.||.|||+   .+|+||||||+|||++.++.+||+|||+++.+..
T Consensus       100 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~  176 (298)
T 3pls_A          100 VLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAE---QKFVHRDLAARNCMLDESFTVKVADFGLARDILD  176 (298)
T ss_dssp             EEECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTCCEEECCTTSSCTTTT
T ss_pred             EEEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCcceEEEcCCCcEEeCcCCCcccccC
Confidence            9999999999999998777788999999999999999999999   8999999999999999999999999999986644


Q ss_pred             CCC--ceeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHhCCCCC-CcCCcchhhhhccccccCCcccccCch
Q 012765          297 NWS--HHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAV-DSRRQSLVIWAKPLLQTSNFKELVDPR  373 (457)
Q Consensus       297 ~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLltG~~pf-~~~~~~~~~~~~~~~~~~~~~~~~d~~  373 (457)
                      ...  ........+|..|+|||.+.+..++.++||||||+++|+|++|..|+ .............  ...      ...
T Consensus       177 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~--~~~------~~~  248 (298)
T 3pls_A          177 REYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLA--QGR------RLP  248 (298)
T ss_dssp             GGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHH--TTC------CCC
T ss_pred             CcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhh--cCC------CCC
Confidence            321  11223345789999999999999999999999999999999966654 4322211111100  000      000


Q ss_pred             hhcccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCCCC
Q 012765          374 LADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQLLRGEGGQ  417 (457)
Q Consensus       374 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~  417 (457)
                      ....    ....+.+++.+||+.||.+|||+.++++.|+.+...
T Consensus       249 ~~~~----~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~  288 (298)
T 3pls_A          249 QPEY----CPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSA  288 (298)
T ss_dssp             CCTT----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             CCcc----chHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence            0111    123567888999999999999999999999886443

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=9e-43  Score=343.59  Aligned_cols=260  Identities=21%  Similarity=0.319  Sum_probs=205.1

Q ss_pred             HhhcCCCCCceecccCcEEEEEEEeCC------CcEEEEEEEeccchhhHHHHHHHHHHHHHHhhc-CCCCcceeeeeee
Q 012765          139 AATDNFNSENLIGKGGHAEVYKGCLPD------GEVVAVKKIIKNAKEDEERISDFLSELGIVAHI-NHPNAAKLIGFST  211 (457)
Q Consensus       139 ~~~~~f~~~~~LG~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~  211 (457)
                      ...++|.+.+.||+|+||.||+|.+..      ...||+|.+.....  ......+.+|+.++..+ +||||+++++++.
T Consensus        43 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~  120 (333)
T 2i1m_A           43 FPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAH--ADEKEALMSELKIMSHLGQHENIVNLLGACT  120 (333)
T ss_dssp             CCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCC--HHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             CCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccC--hHHHHHHHHHHHHHHhhcCCCCeeeEEEEEe
Confidence            346789999999999999999998642      24799998865432  23456899999999999 8999999999766


Q ss_pred             c-CceEEEEEecCCCChhhhhhcC-------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEE
Q 012765          212 E-NGFHLVLQFLPHGSLSSLLFGS-------------TECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILL  277 (457)
Q Consensus       212 ~-~~~~lv~e~~~~gsL~~~l~~~-------------~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll  277 (457)
                      . +..++||||+++|+|.+++...             ...+++..++.++.||+.||.|||+   .+|+||||||+|||+
T Consensus       121 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~NIl~  197 (333)
T 2i1m_A          121 HGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLAS---KNCIHRDVAARNVLL  197 (333)
T ss_dssp             SSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGCEE
T ss_pred             cCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhc---CCcccCCcccceEEE
Confidence            5 4578999999999999998542             3357899999999999999999999   899999999999999


Q ss_pred             cCCCcEEEeeccccccCCCCCCceeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHh-CCCCCCcCCcchhhh
Q 012765          278 SEDYEAQISDFGLAKWLPDNWSHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELIT-GRRAVDSRRQSLVIW  356 (457)
Q Consensus       278 ~~~~~~kL~DFGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLlt-G~~pf~~~~~~~~~~  356 (457)
                      +.++.+||+|||++................+|+.|+|||++.+..++.++|||||||++|||+| |..||.........+
T Consensus       198 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~  277 (333)
T 2i1m_A          198 TNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFY  277 (333)
T ss_dssp             EGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHHH
T ss_pred             CCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHHHH
Confidence            9999999999999987654433333334457889999999999999999999999999999999 999998643322111


Q ss_pred             hccccccCCcccccCchhhcccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q 012765          357 AKPLLQTSNFKELVDPRLADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQLLRGE  414 (457)
Q Consensus       357 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~  414 (457)
                      ...  ...     ........    ....+..++..||+.||.+|||+.+|++.|+.+
T Consensus       278 ~~~--~~~-----~~~~~~~~----~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~  324 (333)
T 2i1m_A          278 KLV--KDG-----YQMAQPAF----APKNIYSIMQACWALEPTHRPTFQQICSFLQEQ  324 (333)
T ss_dssp             HHH--HHT-----CCCCCCTT----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHH--hcC-----CCCCCCCC----CCHHHHHHHHHHhccChhhCcCHHHHHHHHHHH
Confidence            100  000     00000011    123567788999999999999999999999865

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=1.8e-42  Score=334.30  Aligned_cols=255  Identities=18%  Similarity=0.298  Sum_probs=197.9

Q ss_pred             hcCCCCCceecccCcEEEEEEEeCC-C-------cEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeec
Q 012765          141 TDNFNSENLIGKGGHAEVYKGCLPD-G-------EVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTE  212 (457)
Q Consensus       141 ~~~f~~~~~LG~G~~g~Vy~~~~~~-~-------~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~  212 (457)
                      .++|.+.+.||+|+||+||+|.+.. +       ..||+|.+......   ....+.+|+.+++.++||||+++++++..
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~---~~~~~~~E~~~l~~l~h~~iv~~~~~~~~   83 (289)
T 4fvq_A            7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRN---YSESFFEAASMMSKLSHKHLVLNYGVCVC   83 (289)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGG---GHHHHHHHHHHHHTSCCTTBCCEEEEECC
T ss_pred             hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHH---HHHHHHHHHHHHHhCCCCCEeEEEEEEEe
Confidence            4678889999999999999998643 3       46999988654332   34578999999999999999999997665


Q ss_pred             -CceEEEEEecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCc--------E
Q 012765          213 -NGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYE--------A  283 (457)
Q Consensus       213 -~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~--------~  283 (457)
                       +..++||||+.+++|.+++......+++..++.++.||+.||.|||+   .+|+||||||+|||++.++.        +
T Consensus        84 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~~~~~  160 (289)
T 4fvq_A           84 GDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEE---NTLIHGNVCAKNILLIREEDRKTGNPPFI  160 (289)
T ss_dssp             TTCCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEEEECCBGGGTBCCEE
T ss_pred             CCCCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhh---CCeECCCcCcceEEEecCCccccccccee
Confidence             45789999999999999998776679999999999999999999999   89999999999999998887        9


Q ss_pred             EEeeccccccCCCCCCceeeecccccccccChhcccc-CCCCcchhHHHHHHHHHHHHhCCCC-CCcCCcchhhhhcccc
Q 012765          284 QISDFGLAKWLPDNWSHHIVFPIEGTFGYLSPEYFMH-GIVDEKTDVFAFGVLLLELITGRRA-VDSRRQSLVIWAKPLL  361 (457)
Q Consensus       284 kL~DFGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDvwSlGvll~eLltG~~p-f~~~~~~~~~~~~~~~  361 (457)
                      ||+|||++......      ....||+.|+|||++.+ ..++.++|||||||++|||++|..| |............  .
T Consensus       161 kl~Dfg~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~~--~  232 (289)
T 4fvq_A          161 KLSDPGISITVLPK------DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFY--E  232 (289)
T ss_dssp             EECCCCSCTTTSCH------HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHH--H
T ss_pred             eeccCcccccccCc------cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHHHh--h
Confidence            99999998755332      12348899999999987 6799999999999999999996555 4432221111100  0


Q ss_pred             ccCCcccccCchhhcccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCCCCCCCC
Q 012765          362 QTSNFKELVDPRLADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQLLRGEGGQTDLK  421 (457)
Q Consensus       362 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~~~~~  421 (457)
                      ......        ...    ...+.+++.+||+.||.+|||+.++++.|+.+..+...+
T Consensus       233 ~~~~~~--------~~~----~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p~~~~  280 (289)
T 4fvq_A          233 DRHQLP--------APK----AAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTPDLVP  280 (289)
T ss_dssp             TTCCCC--------CCS----SCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC------
T ss_pred             ccCCCC--------CCC----CHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCCCCC
Confidence            011111        111    123567888999999999999999999999987554433

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=3.3e-43  Score=356.70  Aligned_cols=260  Identities=20%  Similarity=0.249  Sum_probs=201.7

Q ss_pred             HHHHHhhcCCCCCceecccCcEEEEEEEeC-CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeecC
Q 012765          135 AELAAATDNFNSENLIGKGGHAEVYKGCLP-DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTEN  213 (457)
Q Consensus       135 ~~~~~~~~~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~  213 (457)
                      .++....++|.+.+.||+|+||+||+|.+. +++.||+|++.+...........+.+|+.+++.++||||+++++++.+.
T Consensus        62 ~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~  141 (410)
T 3v8s_A           62 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDD  141 (410)
T ss_dssp             HHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred             HhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEEC
Confidence            344556789999999999999999999875 5899999998653222212233578899999999999999999976654


Q ss_pred             -ceEEEEEecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccc
Q 012765          214 -GFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAK  292 (457)
Q Consensus       214 -~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~  292 (457)
                       .+++||||+++|+|.+++..  ..+++..+..++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||+++
T Consensus       142 ~~~~lV~E~~~gg~L~~~l~~--~~~~e~~~~~~~~qi~~aL~~LH~---~givHrDLKp~NILl~~~g~ikL~DFG~a~  216 (410)
T 3v8s_A          142 RYLYMVMEYMPGGDLVNLMSN--YDVPEKWARFYTAEVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCM  216 (410)
T ss_dssp             SEEEEEECCCTTEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred             CEEEEEEeCCCCCcHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeeECCCCCEEEeccceeE
Confidence             46899999999999999854  358899999999999999999999   899999999999999999999999999998


Q ss_pred             cCCCCCCceeeecccccccccChhccccCC----CCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhccccccCCccc
Q 012765          293 WLPDNWSHHIVFPIEGTFGYLSPEYFMHGI----VDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSNFKE  368 (457)
Q Consensus       293 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~  368 (457)
                      .+..... .......||+.|+|||++.+..    |+.++|||||||++|||++|+.||...........  .....  ..
T Consensus       217 ~~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~--i~~~~--~~  291 (410)
T 3v8s_A          217 KMNKEGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSK--IMNHK--NS  291 (410)
T ss_dssp             ECCTTSE-EECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHH--HHTHH--HH
T ss_pred             eeccCCc-ccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHH--HHhcc--cc
Confidence            7654321 1223567999999999997655    78999999999999999999999986443221100  00000  00


Q ss_pred             ccCchhhcccCHHHHHHHHHHHHHhcccCCCC--CCCHHHHHH
Q 012765          369 LVDPRLADAYDLAEMKRAMLTASVCIHHLSTM--RPQMTRVLQ  409 (457)
Q Consensus       369 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~--RPt~~evl~  409 (457)
                      +.-+. ...    ....+.+++.+||+.+|.+  ||++.||++
T Consensus       292 ~~~p~-~~~----~s~~~~~li~~lL~~~~~rlgR~~~~ei~~  329 (410)
T 3v8s_A          292 LTFPD-DND----ISKEAKNLICAFLTDREVRLGRNGVEEIKR  329 (410)
T ss_dssp             CCCCT-TCC----CCHHHHHHHHHHSSCGGGCTTSSCHHHHHT
T ss_pred             ccCCC-ccc----ccHHHHHHHHHHccChhhhCCCCCHHHHhc
Confidence            00000 011    1235667888999999988  999999987

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=4.4e-42  Score=335.11  Aligned_cols=264  Identities=20%  Similarity=0.299  Sum_probs=192.8

Q ss_pred             HhhcCCCCCceecccCcEEEEEEEe-CCCcEEEEEEEeccchhh--HHHHHHHHHHHHHHhhc---CCCCcceeeeeeec
Q 012765          139 AATDNFNSENLIGKGGHAEVYKGCL-PDGEVVAVKKIIKNAKED--EERISDFLSELGIVAHI---NHPNAAKLIGFSTE  212 (457)
Q Consensus       139 ~~~~~f~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~--~~~~~~~~~E~~~l~~l---~hpniv~l~~~~~~  212 (457)
                      ...++|++.+.||+|+||+||+|.+ .+++.||+|++.......  ......+.+|+.+++.+   +||||+++++++..
T Consensus         6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~   85 (308)
T 3g33_A            6 MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCAT   85 (308)
T ss_dssp             ----CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEE
T ss_pred             ccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeec
Confidence            4568999999999999999999986 468999999886432110  00112445566666555   59999999997765


Q ss_pred             Cc------eEEEEEecCCCChhhhhhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEE
Q 012765          213 NG------FHLVLQFLPHGSLSSLLFGST-ECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQI  285 (457)
Q Consensus       213 ~~------~~lv~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL  285 (457)
                      ..      .+++|||+. ++|.+++.... ..+++..++.++.||+.||.|||+   .+|+||||||+|||++.++.+||
T Consensus        86 ~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dlkp~Nil~~~~~~~kl  161 (308)
T 3g33_A           86 SRTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHA---NCIVHRDLKPENILVTSGGTVKL  161 (308)
T ss_dssp             CCSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCTTTEEECTTSCEEE
T ss_pred             cCCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEcCCCCEEE
Confidence            43      579999997 59999886543 348999999999999999999999   89999999999999999999999


Q ss_pred             eeccccccCCCCCCceeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhc-ccc---
Q 012765          286 SDFGLAKWLPDNWSHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAK-PLL---  361 (457)
Q Consensus       286 ~DFGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~-~~~---  361 (457)
                      +|||++........   .....||+.|+|||++.+..++.++|||||||++|||++|+.||............ ...   
T Consensus       162 ~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~  238 (308)
T 3g33_A          162 ADFGLARIYSYQMA---LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLP  238 (308)
T ss_dssp             CSCSCTTTSTTCCC---SGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred             eeCccccccCCCcc---cCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence            99999987654322   23456899999999999999999999999999999999999999864433211100 000   


Q ss_pred             ccCCccc-------ccCch---hhcccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 012765          362 QTSNFKE-------LVDPR---LADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQ  409 (457)
Q Consensus       362 ~~~~~~~-------~~d~~---l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~  409 (457)
                      .......       ...+.   ............+.+++.+||+.||.+|||+.|+++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  296 (308)
T 3g33_A          239 PEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQ  296 (308)
T ss_dssp             CTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             ChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhc
Confidence            0000000       00000   000001122345678899999999999999999986

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=9.7e-43  Score=335.97  Aligned_cols=255  Identities=24%  Similarity=0.378  Sum_probs=205.9

Q ss_pred             hhcCCCCCceecccCcEEEEEEEeC-CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeecC-ceEE
Q 012765          140 ATDNFNSENLIGKGGHAEVYKGCLP-DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTEN-GFHL  217 (457)
Q Consensus       140 ~~~~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~-~~~l  217 (457)
                      ..++|.+.+.||+|+||.||+|.+. ++..||+|.+.....    ....+.+|+.+++.++||||+++++++.+. ..++
T Consensus        11 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   86 (288)
T 3kfa_A           11 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYI   86 (288)
T ss_dssp             CGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCST----HHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEE
T ss_pred             cccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCHH----HHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEE
Confidence            5678889999999999999999875 488999999865432    245788999999999999999999976654 5789


Q ss_pred             EEEecCCCChhhhhhc-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCCC
Q 012765          218 VLQFLPHGSLSSLLFG-STECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPD  296 (457)
Q Consensus       218 v~e~~~~gsL~~~l~~-~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~  296 (457)
                      ||||+.+++|.+++.. ....+++..++.++.||+.||.|||+   .+|+||||||+||+++.++.+||+|||++.....
T Consensus        87 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~  163 (288)
T 3kfa_A           87 ITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG  163 (288)
T ss_dssp             EEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHH---HTCCCSCCSGGGEEECGGGCEEECCCCGGGTSCS
T ss_pred             EEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHH---CCccCCCCCcceEEEcCCCCEEEccCccceeccC
Confidence            9999999999999965 34568999999999999999999999   8999999999999999999999999999987754


Q ss_pred             CCCceeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHh-CCCCCCcCCcchhhhhccccccCCcccccCchhh
Q 012765          297 NWSHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELIT-GRRAVDSRRQSLVIWAKPLLQTSNFKELVDPRLA  375 (457)
Q Consensus       297 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLlt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  375 (457)
                      ... .......+|+.|+|||++.+..++.++||||||+++|+|++ |..||.............  ..      ......
T Consensus       164 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~--~~------~~~~~~  234 (288)
T 3kfa_A          164 DTY-TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE--KD------YRMERP  234 (288)
T ss_dssp             SSS-EEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHH--TT------CCCCCC
T ss_pred             Ccc-ccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHh--cc------CCCCCC
Confidence            432 22333457889999999999999999999999999999999 999998644322111100  00      001111


Q ss_pred             cccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q 012765          376 DAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQLLRGE  414 (457)
Q Consensus       376 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~  414 (457)
                      ..    ....+.+++.+||+.||.+|||+.+|++.|+.+
T Consensus       235 ~~----~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~  269 (288)
T 3kfa_A          235 EG----CPEKVYELMRACWQWNPSDRPSFAEIHQAFETM  269 (288)
T ss_dssp             TT----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CC----CCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHH
Confidence            11    224567888999999999999999999999765

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=4.8e-42  Score=341.38  Aligned_cols=250  Identities=24%  Similarity=0.320  Sum_probs=185.1

Q ss_pred             hhcCCCCCceecccCcEEEEEEEeC-CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeecC-ceEE
Q 012765          140 ATDNFNSENLIGKGGHAEVYKGCLP-DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTEN-GFHL  217 (457)
Q Consensus       140 ~~~~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~-~~~l  217 (457)
                      ..++|.+.+.||+|+||.||+|.+. +++.||+|++....     ....+.+|+.++.+++||||+++++++... ..++
T Consensus        51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  125 (349)
T 2w4o_A           51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV-----DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISL  125 (349)
T ss_dssp             GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC---------------CHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred             ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch-----hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEE
Confidence            4577889999999999999999876 58899999986542     234678899999999999999999977654 4689


Q ss_pred             EEEecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcC---CCcEEEeeccccccC
Q 012765          218 VLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSE---DYEAQISDFGLAKWL  294 (457)
Q Consensus       218 v~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~---~~~~kL~DFGl~~~~  294 (457)
                      ||||+++++|.+++.. ...+++..++.++.||+.||.|||+   .+|+||||||+|||++.   ++.+||+|||+++..
T Consensus       126 v~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~  201 (349)
T 2w4o_A          126 VLELVTGGELFDRIVE-KGYYSERDAADAVKQILEAVAYLHE---NGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIV  201 (349)
T ss_dssp             EECCCCSCBHHHHHTT-CSSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEESSSSTTCCEEECCCC-----
T ss_pred             EEEeCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCcccEEEecCCCCCCEEEccCcccccc
Confidence            9999999999999854 3458999999999999999999999   89999999999999975   889999999999876


Q ss_pred             CCCCCceeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhccccccCCcccccCchh
Q 012765          295 PDNWSHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSNFKELVDPRL  374 (457)
Q Consensus       295 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l  374 (457)
                      .....   .....||+.|+|||++.+..++.++|||||||++|||++|..||.........+.........   ...+ .
T Consensus       202 ~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~~---~~~~-~  274 (349)
T 2w4o_A          202 EHQVL---MKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYY---FISP-W  274 (349)
T ss_dssp             --------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCCC---CCTT-T
T ss_pred             Ccccc---cccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCCc---cCCc-h
Confidence            44321   223558999999999999999999999999999999999999997644332221111100000   0011 0


Q ss_pred             hcccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 012765          375 ADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQ  409 (457)
Q Consensus       375 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~  409 (457)
                      ..    .....+.+++.+||+.||++|||+.|+++
T Consensus       275 ~~----~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  305 (349)
T 2w4o_A          275 WD----EVSLNAKDLVRKLIVLDPKKRLTTFQALQ  305 (349)
T ss_dssp             TT----TSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             hh----hCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            11    12235678899999999999999999987

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=2.4e-42  Score=343.99  Aligned_cols=251  Identities=21%  Similarity=0.266  Sum_probs=198.5

Q ss_pred             hhcCCCCCceecccCcEEEEEEEeC-CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhc-CCCCcceeeeeeec-CceE
Q 012765          140 ATDNFNSENLIGKGGHAEVYKGCLP-DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHI-NHPNAAKLIGFSTE-NGFH  216 (457)
Q Consensus       140 ~~~~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~-~~~~  216 (457)
                      ..++|.+.+.||+|+||.||+|... +++.||+|++.+...........+..|..++..+ +||||+++++++.. +.++
T Consensus        18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~   97 (353)
T 2i0e_A           18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY   97 (353)
T ss_dssp             -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEE
T ss_pred             chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEE
Confidence            4578999999999999999999876 4889999998764332223356788999999887 79999999996655 5578


Q ss_pred             EEEEecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCCC
Q 012765          217 LVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPD  296 (457)
Q Consensus       217 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~  296 (457)
                      +||||+++|+|..++... ..+++..++.++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||+++....
T Consensus        98 lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~---~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~  173 (353)
T 2i0e_A           98 FVMEYVNGGDLMYHIQQV-GRFKEPHAVFYAAEIAIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIW  173 (353)
T ss_dssp             EEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred             EEEeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH---CCEEeccCCHHHEEEcCCCcEEEEeCCccccccc
Confidence            999999999999998643 358899999999999999999999   8999999999999999999999999999986432


Q ss_pred             CCCceeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhccccccCCcccccCchhhc
Q 012765          297 NWSHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSNFKELVDPRLAD  376 (457)
Q Consensus       297 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  376 (457)
                      ...  ......||+.|+|||++.+..++.++|||||||++|||++|+.||......... .........        +..
T Consensus       174 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~-~~i~~~~~~--------~p~  242 (353)
T 2i0e_A          174 DGV--TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELF-QSIMEHNVA--------YPK  242 (353)
T ss_dssp             TTC--CBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH-HHHHHCCCC--------CCT
T ss_pred             CCc--ccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHHHH-HHHHhCCCC--------CCC
Confidence            211  223456999999999999999999999999999999999999999865432211 110001111        111


Q ss_pred             ccCHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHH
Q 012765          377 AYDLAEMKRAMLTASVCIHHLSTMRPQ-----MTRVLQ  409 (457)
Q Consensus       377 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt-----~~evl~  409 (457)
                      .+    ...+..++.+||+.||.+||+     +.+|++
T Consensus       243 ~~----s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~  276 (353)
T 2i0e_A          243 SM----SKEAVAICKGLMTKHPGKRLGCGPEGERDIKE  276 (353)
T ss_dssp             TS----CHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHT
T ss_pred             CC----CHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence            12    235677889999999999996     466654

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=3.7e-42  Score=350.61  Aligned_cols=256  Identities=23%  Similarity=0.346  Sum_probs=193.6

Q ss_pred             HhhcCCCCCceecccCcEEEEEEEeC-CCcEEEEEEEeccchh-----hHHHHHHHHHHHHHHhhcCCCCcceeeeeeec
Q 012765          139 AATDNFNSENLIGKGGHAEVYKGCLP-DGEVVAVKKIIKNAKE-----DEERISDFLSELGIVAHINHPNAAKLIGFSTE  212 (457)
Q Consensus       139 ~~~~~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-----~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~  212 (457)
                      ...++|.+.+.||+|+||+||+|.+. +++.||+|++......     .......+.+|+.++++++||||+++++++..
T Consensus       132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~  211 (419)
T 3i6u_A          132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA  211 (419)
T ss_dssp             HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES
T ss_pred             hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence            45789999999999999999999864 5899999998654321     12223458899999999999999999999988


Q ss_pred             CceEEEEEecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCC---cEEEeecc
Q 012765          213 NGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDY---EAQISDFG  289 (457)
Q Consensus       213 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~---~~kL~DFG  289 (457)
                      +..++||||+++|+|.+++... ..+++..++.++.||+.||.|||+   .+|+||||||+|||++.++   .+||+|||
T Consensus       212 ~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~---~~ivHrDlkp~NIll~~~~~~~~~kl~DFG  287 (419)
T 3i6u_A          212 EDYYIVLELMEGGELFDKVVGN-KRLKEATCKLYFYQMLLAVQYLHE---NGIIHRDLKPENVLLSSQEEDCLIKITDFG  287 (419)
T ss_dssp             SEEEEEEECCTTCBGGGGTSSS-CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESSSSSSCCEEECCSS
T ss_pred             CceEEEEEcCCCCcHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCChHhEEEecCCCcceEEEeecc
Confidence            8899999999999999988543 458999999999999999999999   8999999999999997544   59999999


Q ss_pred             ccccCCCCCCceeeecccccccccChhcccc---CCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhccccccCCc
Q 012765          290 LAKWLPDNWSHHIVFPIEGTFGYLSPEYFMH---GIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSNF  366 (457)
Q Consensus       290 l~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~~~~~~~~~  366 (457)
                      +++......   ......||+.|+|||++.+   ..|+.++|||||||++|+|++|..||............  ......
T Consensus       288 ~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~--i~~~~~  362 (419)
T 3i6u_A          288 HSKILGETS---LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQ--ITSGKY  362 (419)
T ss_dssp             TTTSCC--------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHH--HHTTCC
T ss_pred             cceecCCCc---cccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHH--HhcCCC
Confidence            998775432   2234569999999999863   67889999999999999999999999753322111000  000000


Q ss_pred             ccccCchhhcccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 012765          367 KELVDPRLADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQ  409 (457)
Q Consensus       367 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~  409 (457)
                        ...+.....    ....+.+++.+||+.||.+|||+.|+++
T Consensus       363 --~~~~~~~~~----~~~~~~~li~~~L~~dP~~Rps~~e~l~  399 (419)
T 3i6u_A          363 --NFIPEVWAE----VSEKALDLVKKLLVVDPKARFTTEEALR  399 (419)
T ss_dssp             --CCCHHHHTT----SCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             --CCCchhhcc----cCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence              001111111    2345678899999999999999999987

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=6.9e-42  Score=341.04  Aligned_cols=206  Identities=23%  Similarity=0.281  Sum_probs=174.7

Q ss_pred             ccHHHHHHhhcCCCCCceecccCcEEEEEEEe-CCCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcC-----CCCcce
Q 012765          132 FDFAELAAATDNFNSENLIGKGGHAEVYKGCL-PDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHIN-----HPNAAK  205 (457)
Q Consensus       132 ~~~~~~~~~~~~f~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-----hpniv~  205 (457)
                      +++.+.....++|.+.+.||+|+||+||+|.+ .+++.||||++....    .....+..|+.++..+.     ||||++
T Consensus        25 ~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~h~~iv~  100 (360)
T 3llt_A           25 FSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIK----KYTRSAKIEADILKKIQNDDINNNNIVK  100 (360)
T ss_dssp             CCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCH----HHHHHHHHHHHHHHHTCCCSTTGGGBCC
T ss_pred             eeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccch----hhhhhhHHHHHHHHHhcccCCCCCCeec
Confidence            34444556778999999999999999999987 468999999986422    23446778999998886     999999


Q ss_pred             eeeeeec-CceEEEEEecCCCChhhhhhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcC----
Q 012765          206 LIGFSTE-NGFHLVLQFLPHGSLSSLLFGST-ECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSE----  279 (457)
Q Consensus       206 l~~~~~~-~~~~lv~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~----  279 (457)
                      +++++.. +..++||||+ +++|.+++.... ..+++..+..++.||+.||.|||+   .+|+||||||+|||++.    
T Consensus       101 ~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~~~  176 (360)
T 3llt_A          101 YHGKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRK---MSLTHTDLKPENILLDDPYFE  176 (360)
T ss_dssp             EEEEEEETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESCTTCC
T ss_pred             ccceeeECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCcccEEEcccccc
Confidence            9996654 5578999999 999999986543 458999999999999999999999   89999999999999975    


Q ss_pred             ---------------------CCcEEEeeccccccCCCCCCceeeecccccccccChhccccCCCCcchhHHHHHHHHHH
Q 012765          280 ---------------------DYEAQISDFGLAKWLPDNWSHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLE  338 (457)
Q Consensus       280 ---------------------~~~~kL~DFGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~e  338 (457)
                                           ++.+||+|||++.......     ....||+.|+|||++.+..++.++|||||||++|+
T Consensus       177 ~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~e  251 (360)
T 3llt_A          177 KSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDYH-----GSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAE  251 (360)
T ss_dssp             EEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSCC-----CSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHH
T ss_pred             ccccchhcccccccccccccCCCCEEEEeccCceecCCCC-----cCccCcccccCcHHHcCCCCCCccchHHHHHHHHH
Confidence                                 7889999999998654432     23458999999999999999999999999999999


Q ss_pred             HHhCCCCCCcCC
Q 012765          339 LITGRRAVDSRR  350 (457)
Q Consensus       339 LltG~~pf~~~~  350 (457)
                      |++|+.||....
T Consensus       252 ll~g~~pf~~~~  263 (360)
T 3llt_A          252 LYTGSLLFRTHE  263 (360)
T ss_dssp             HHHSSCSCCCSS
T ss_pred             HHHCCCCCCCCc
Confidence            999999998644

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=1.8e-42  Score=338.90  Aligned_cols=259  Identities=22%  Similarity=0.288  Sum_probs=200.7

Q ss_pred             hhcCCCCCceecccCcEEEEEEEe-CCCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeee-----cC
Q 012765          140 ATDNFNSENLIGKGGHAEVYKGCL-PDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFST-----EN  213 (457)
Q Consensus       140 ~~~~f~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~-----~~  213 (457)
                      ..++|.+.+.||+|+||.||+|.. .+++.||+|++....   ......+.+|+.+++.++||||+++++++.     ..
T Consensus        27 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  103 (317)
T 2buj_A           27 DNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHE---QQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKH  103 (317)
T ss_dssp             TTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESS---HHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEE
T ss_pred             CCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCC---HHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCc
Confidence            346788999999999999999986 578999999886532   234568899999999999999999999765     23


Q ss_pred             ceEEEEEecCCCChhhhhhc---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccc
Q 012765          214 GFHLVLQFLPHGSLSSLLFG---STECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGL  290 (457)
Q Consensus       214 ~~~lv~e~~~~gsL~~~l~~---~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl  290 (457)
                      ..++||||+.+|+|.+++..   ....+++..++.++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||+
T Consensus       104 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~dlkp~NIl~~~~~~~kl~dfg~  180 (317)
T 2buj_A          104 EAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHA---KGYAHRDLKPTNILLGDEGQPVLMDLGS  180 (317)
T ss_dssp             EEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTSCEEECCCSS
T ss_pred             eeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEEcCCCCEEEEecCc
Confidence            46799999999999998865   45678999999999999999999999   8999999999999999999999999999


Q ss_pred             cccCCCCCCce-------eeecccccccccChhccccCC---CCcchhHHHHHHHHHHHHhCCCCCCcCC---cchhhhh
Q 012765          291 AKWLPDNWSHH-------IVFPIEGTFGYLSPEYFMHGI---VDEKTDVFAFGVLLLELITGRRAVDSRR---QSLVIWA  357 (457)
Q Consensus       291 ~~~~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~---~~~ksDvwSlGvll~eLltG~~pf~~~~---~~~~~~~  357 (457)
                      +..........       ......||+.|+|||++.+..   ++.++|||||||++|||++|+.||....   .......
T Consensus       181 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~  260 (317)
T 2buj_A          181 MNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAV  260 (317)
T ss_dssp             CEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHHH
T ss_pred             chhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHHh
Confidence            87653211100       011234799999999987554   6899999999999999999999996411   1111100


Q ss_pred             ccccccCCcccccCchhhcccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCCCC
Q 012765          358 KPLLQTSNFKELVDPRLADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQLLRGEGGQ  417 (457)
Q Consensus       358 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~  417 (457)
                      ..   .          ............+.+++.+||+.||.+|||+.+|++.|+.+...
T Consensus       261 ~~---~----------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~  307 (317)
T 2buj_A          261 QN---Q----------LSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPP  307 (317)
T ss_dssp             HC---C------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCCC
T ss_pred             hc---c----------CCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCCC
Confidence            00   0          00000111224577889999999999999999999999998643

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=6.9e-42  Score=339.50  Aligned_cols=268  Identities=15%  Similarity=0.159  Sum_probs=196.0

Q ss_pred             hcCCCCCceecccCcEEEEEEEeC----CCcEEEEEEEeccchhhHH--------HHHHHHHHHHHHhhcCCCCcceeee
Q 012765          141 TDNFNSENLIGKGGHAEVYKGCLP----DGEVVAVKKIIKNAKEDEE--------RISDFLSELGIVAHINHPNAAKLIG  208 (457)
Q Consensus       141 ~~~f~~~~~LG~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~--------~~~~~~~E~~~l~~l~hpniv~l~~  208 (457)
                      .++|.+.+.||+|+||.||+|.+.    ++..+|+|++.........        ....+.+|+..+..++||||+++++
T Consensus        36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~  115 (345)
T 2v62_A           36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG  115 (345)
T ss_dssp             SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred             CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence            467889999999999999999875    5788999988754322111        1124678889999999999999999


Q ss_pred             eeec-----CceEEEEEecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCC--
Q 012765          209 FSTE-----NGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDY--  281 (457)
Q Consensus       209 ~~~~-----~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~--  281 (457)
                      ++..     ...++||||+ +++|.+++.... .+++..++.++.||+.||.|||+   .+|+||||||+|||++.++  
T Consensus       116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~  190 (345)
T 2v62_A          116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQNG-TFKKSTVLQLGIRMLDVLEYIHE---NEYVHGDIKAANLLLGYKNPD  190 (345)
T ss_dssp             EEEEESSSCEEEEEEEECE-EEEHHHHCBGGG-BCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEESSSTT
T ss_pred             ccccccCCCcEEEEEEecc-CCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCcCHHHEEEccCCCC
Confidence            7654     3468999999 999999986543 78999999999999999999999   8999999999999999887  


Q ss_pred             cEEEeeccccccCCCCCCc-----eeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhh
Q 012765          282 EAQISDFGLAKWLPDNWSH-----HIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIW  356 (457)
Q Consensus       282 ~~kL~DFGl~~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~  356 (457)
                      .+||+|||+++.+......     .......||+.|+|||++.+..++.++|||||||++|||++|+.||..........
T Consensus       191 ~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~  270 (345)
T 2v62_A          191 QVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAV  270 (345)
T ss_dssp             SEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHHH
T ss_pred             cEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccHHH
Confidence            9999999999876432111     11134569999999999999999999999999999999999999996422111110


Q ss_pred             hccccccCCcccccCchhhccc-CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCCC
Q 012765          357 AKPLLQTSNFKELVDPRLADAY-DLAEMKRAMLTASVCIHHLSTMRPQMTRVLQLLRGEGG  416 (457)
Q Consensus       357 ~~~~~~~~~~~~~~d~~l~~~~-~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~  416 (457)
                      ....   ......+...+.... .......+.+++..||+.||++||++.+|++.|+....
T Consensus       271 ~~~~---~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~  328 (345)
T 2v62_A          271 QTAK---TNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHGI  328 (345)
T ss_dssp             HHHH---HHHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTCC
T ss_pred             HHHH---HhhcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccCC
Confidence            0000   000000111110000 00122367788899999999999999999999988754

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=8.7e-42  Score=341.31  Aligned_cols=249  Identities=15%  Similarity=0.139  Sum_probs=196.4

Q ss_pred             hhcCCCCCceecccCcEEEEEEE------eCCCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcC---CCCcceeeeee
Q 012765          140 ATDNFNSENLIGKGGHAEVYKGC------LPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHIN---HPNAAKLIGFS  210 (457)
Q Consensus       140 ~~~~f~~~~~LG~G~~g~Vy~~~------~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~---hpniv~l~~~~  210 (457)
                      ..++|.+.+.||+|+||+||+|.      ..+++.||+|++.....      ..+..|+.++..++   |+||+++++++
T Consensus        63 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~------~~~~~e~~~~~~l~~~~~~~iv~~~~~~  136 (365)
T 3e7e_A           63 GSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANP------WEFYIGTQLMERLKPSMQHMFMKFYSAH  136 (365)
T ss_dssp             SSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCCH------HHHHHHHHHHHHSCGGGGGGBCCEEEEE
T ss_pred             CCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCCh------hHHHHHHHHHHHhhhhhhhhhhhhheee
Confidence            45778899999999999999994      44689999999865432      25566777776665   99999999965


Q ss_pred             e-cCceEEEEEecCCCChhhhhhc----CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcC------
Q 012765          211 T-ENGFHLVLQFLPHGSLSSLLFG----STECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSE------  279 (457)
Q Consensus       211 ~-~~~~~lv~e~~~~gsL~~~l~~----~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~------  279 (457)
                      . .+..++||||+++|+|.+++..    ....+++..++.|+.||+.||.|||+   .+|+||||||+|||++.      
T Consensus       137 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~---~~ivHrDiKp~NIll~~~~~~~~  213 (365)
T 3e7e_A          137 LFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHD---CEIIHGDIKPDNFILGNGFLEQD  213 (365)
T ss_dssp             ECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCSGGGEEECGGGTCC-
T ss_pred             ecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhh---CCeecCCCCHHHEEecccccCcc
Confidence            4 5667899999999999999964    35569999999999999999999999   89999999999999998      


Q ss_pred             -----CCcEEEeeccccccCCCCCCceeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchh
Q 012765          280 -----DYEAQISDFGLAKWLPDNWSHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLV  354 (457)
Q Consensus       280 -----~~~~kL~DFGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~  354 (457)
                           ++.+||+|||+++.+.............||+.|+|||++.+..|+.++|||||||++|||+||+.||....... 
T Consensus       214 ~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~-  292 (365)
T 3e7e_A          214 DEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGE-  292 (365)
T ss_dssp             -----CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTE-
T ss_pred             ccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCc-
Confidence                 89999999999976543333344455679999999999999999999999999999999999999996432210 


Q ss_pred             hhhccccccCCcccccCchhhcccCHHHHHHHHHHHHHhcccCCCCC-CCHHHHHHHHhcC
Q 012765          355 IWAKPLLQTSNFKELVDPRLADAYDLAEMKRAMLTASVCIHHLSTMR-PQMTRVLQLLRGE  414 (457)
Q Consensus       355 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~R-Pt~~evl~~L~~~  414 (457)
                       |.        .    ...+.....   ...+.+++..||+.+|.+| |++.++.+.|+..
T Consensus       293 -~~--------~----~~~~~~~~~---~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~  337 (365)
T 3e7e_A          293 -CK--------P----EGLFRRLPH---LDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKV  337 (365)
T ss_dssp             -EE--------E----CSCCTTCSS---HHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHH
T ss_pred             -ee--------e----chhccccCc---HHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHH
Confidence             00        0    111111112   2344567778999999998 5788888877664

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=5.7e-42  Score=331.48  Aligned_cols=259  Identities=20%  Similarity=0.252  Sum_probs=198.7

Q ss_pred             hhcCCCCCceecccCcEEEEEEEe-CCCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeee-ec-CceE
Q 012765          140 ATDNFNSENLIGKGGHAEVYKGCL-PDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFS-TE-NGFH  216 (457)
Q Consensus       140 ~~~~f~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~-~~-~~~~  216 (457)
                      ..++|.+.+.||+|+||.||+|.+ .+++.||+|++.....     ...+.+|+.++..++|++++..+.++ .. ...+
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~   81 (296)
T 4hgt_A            7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK-----HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNV   81 (296)
T ss_dssp             ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC--------CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEE
T ss_pred             cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc-----chHHHHHHHHHHHhcCCCCCCeeeeecCCCCceE
Confidence            458899999999999999999986 5789999998654322     23577899999999998888877643 43 3457


Q ss_pred             EEEEecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEE---cCCCcEEEeecccccc
Q 012765          217 LVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILL---SEDYEAQISDFGLAKW  293 (457)
Q Consensus       217 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll---~~~~~~kL~DFGl~~~  293 (457)
                      ++|||+ +++|.+++......+++..++.++.||+.||.|||+   .+|+||||||+|||+   +.++.+||+|||++..
T Consensus        82 lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~---~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~  157 (296)
T 4hgt_A           82 MVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHS---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKK  157 (296)
T ss_dssp             EEEECC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECCGGGTTCEEECCCTTCEE
T ss_pred             EEEEcc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeeeeccCCCCeEEEecCcccee
Confidence            999999 999999997666779999999999999999999999   899999999999999   7889999999999987


Q ss_pred             CCCCCCce-----eeecccccccccChhccccCCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhccccccCCccc
Q 012765          294 LPDNWSHH-----IVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSNFKE  368 (457)
Q Consensus       294 ~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~  368 (457)
                      ........     ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.........        ..+..
T Consensus       158 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~--------~~~~~  229 (296)
T 4hgt_A          158 YRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKR--------QKYER  229 (296)
T ss_dssp             CBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSS--------SHHHH
T ss_pred             ccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhh--------hhhhh
Confidence            75443211     122456899999999999999999999999999999999999999863321100        00000


Q ss_pred             ccCchhhcc---cCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCC
Q 012765          369 LVDPRLADA---YDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQLLRGEG  415 (457)
Q Consensus       369 ~~d~~l~~~---~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~  415 (457)
                      +....+...   ........+.+++..||+.||++|||+.+|++.|+.+.
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~  279 (296)
T 4hgt_A          230 ISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLF  279 (296)
T ss_dssp             HHHHHHHSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHH
T ss_pred             hhcccccchhhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHH
Confidence            001111000   00011346778899999999999999999999998764

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=8.9e-42  Score=333.46  Aligned_cols=266  Identities=19%  Similarity=0.211  Sum_probs=198.3

Q ss_pred             hhcCCCCCceecccCcEEEEEEEeC-CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeec-CceEE
Q 012765          140 ATDNFNSENLIGKGGHAEVYKGCLP-DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTE-NGFHL  217 (457)
Q Consensus       140 ~~~~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-~~~~l  217 (457)
                      ..++|.+.+.||+|+||.||+|.+. +++.||+|.+.............+.+|+.++..++||||+++++++.. +..++
T Consensus        32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l  111 (309)
T 2h34_A           32 QFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYV  111 (309)
T ss_dssp             --CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEE
T ss_pred             EeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEE
Confidence            3478999999999999999999865 688999999876555555556789999999999999999999997655 45689


Q ss_pred             EEEecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCCCC
Q 012765          218 VLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDN  297 (457)
Q Consensus       218 v~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~~  297 (457)
                      +|||+++++|.+++... ..+++..++.++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||++......
T Consensus       112 v~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~  187 (309)
T 2h34_A          112 DMRLINGVDLAAMLRRQ-GPLAPPRAVAIVRQIGSALDAAHA---AGATHRDVKPENILVSADDFAYLVDFGIASATTDE  187 (309)
T ss_dssp             EEECCCCEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECSCCC-------
T ss_pred             EEEecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH---CcCCcCCCChHHEEEcCCCCEEEecCccCcccccc
Confidence            99999999999998643 458999999999999999999999   89999999999999999999999999999776543


Q ss_pred             CCceeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhccccccCCcccccCchhhcc
Q 012765          298 WSHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSNFKELVDPRLADA  377 (457)
Q Consensus       298 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~  377 (457)
                      ... ......||+.|+|||++.+..++.++||||||+++|||++|+.||...........  .........    .....
T Consensus       188 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~--~~~~~~~~~----~~~~~  260 (309)
T 2h34_A          188 KLT-QLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSVMGAH--INQAIPRPS----TVRPG  260 (309)
T ss_dssp             ----------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHHHHH--HHSCCCCGG----GTSTT
T ss_pred             ccc-cccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHHHHHHH--hccCCCCcc----ccCCC
Confidence            211 12234589999999999999999999999999999999999999986443211100  000000000    01111


Q ss_pred             cCHHHHHHHHHHHHHhcccCCCCCC-CHHHHHHHHhcCCCCCCC
Q 012765          378 YDLAEMKRAMLTASVCIHHLSTMRP-QMTRVLQLLRGEGGQTDL  420 (457)
Q Consensus       378 ~~~~~~~~l~~l~~~Cl~~dP~~RP-t~~evl~~L~~~~~~~~~  420 (457)
                          ....+.+++.+||+.||++|| ++.++++.|+........
T Consensus       261 ----~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~~~  300 (309)
T 2h34_A          261 ----IPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATADQ  300 (309)
T ss_dssp             ----CCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC----
T ss_pred             ----CCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhhcc
Confidence                123466788999999999999 999999999987655433

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=2.7e-42  Score=344.77  Aligned_cols=251  Identities=20%  Similarity=0.240  Sum_probs=186.9

Q ss_pred             hcCCCCCceecccCcEEEEEEEeC-CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeec-CceEEE
Q 012765          141 TDNFNSENLIGKGGHAEVYKGCLP-DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTE-NGFHLV  218 (457)
Q Consensus       141 ~~~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-~~~~lv  218 (457)
                      .++|.+.+.||+|+||+||++... +++.||+|++.......    ..+.+|+.+++.++||||+++++++.. +..++|
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~----~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv   94 (361)
T 3uc3_A           19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAID----ENVQREIINHRSLRHPNIVRFKEVILTPTHLAII   94 (361)
T ss_dssp             TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTSC----HHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcccc----HHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEE
Confidence            467889999999999999999875 68999999987644332    357899999999999999999997655 457899


Q ss_pred             EEecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCc--EEEeeccccccCCC
Q 012765          219 LQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYE--AQISDFGLAKWLPD  296 (457)
Q Consensus       219 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~--~kL~DFGl~~~~~~  296 (457)
                      |||+.+|+|.+++... ..+++..++.++.||+.||.|||+   .+|+||||||+|||++.++.  +||+|||+++....
T Consensus        95 ~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~ql~~~L~~LH~---~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~  170 (361)
T 3uc3_A           95 MEYASGGELYERICNA-GRFSEDEARFFFQQLLSGVSYCHS---MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL  170 (361)
T ss_dssp             EECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHH---TTCCSCCCCGGGEEECSSSSCCEEECCCCCC-----
T ss_pred             EEeCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEcCCCCceEEEeecCccccccc
Confidence            9999999999998543 358999999999999999999999   89999999999999987765  99999999875432


Q ss_pred             CCCceeeecccccccccChhccccCCCCcc-hhHHHHHHHHHHHHhCCCCCCcCCcchhhhhccccccCCcccccCchhh
Q 012765          297 NWSHHIVFPIEGTFGYLSPEYFMHGIVDEK-TDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSNFKELVDPRLA  375 (457)
Q Consensus       297 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k-sDvwSlGvll~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  375 (457)
                      ..   ......||+.|+|||++.+..++.+ +|||||||++|+|++|+.||............       +..+......
T Consensus       171 ~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~-------~~~~~~~~~~  240 (361)
T 3uc3_A          171 HS---QPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKT-------IQRILSVKYS  240 (361)
T ss_dssp             -------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHH-------HHHHHTTCCC
T ss_pred             cC---CCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHH-------HHHHhcCCCC
Confidence            21   1223459999999999988888766 89999999999999999999863321100000       0000000000


Q ss_pred             cccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 012765          376 DAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQ  409 (457)
Q Consensus       376 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~  409 (457)
                      ..........+.+++.+||+.||.+|||+.|+++
T Consensus       241 ~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~  274 (361)
T 3uc3_A          241 IPDDIRISPECCHLISRIFVADPATRISIPEIKT  274 (361)
T ss_dssp             CCTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             CCCcCCCCHHHHHHHHHHccCChhHCcCHHHHHh
Confidence            0000011245678899999999999999999987

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=4.2e-42  Score=354.84  Aligned_cols=253  Identities=20%  Similarity=0.340  Sum_probs=202.4

Q ss_pred             hcCCCCCceecccCcEEEEEEEeC-CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeec-CceEEE
Q 012765          141 TDNFNSENLIGKGGHAEVYKGCLP-DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTE-NGFHLV  218 (457)
Q Consensus       141 ~~~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-~~~~lv  218 (457)
                      .++|.+.+.||+|+||.||+|.+. +|+.||||++.............+.+|+.+++.++||||+++++++.. +..++|
T Consensus        15 ~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv   94 (476)
T 2y94_A           15 IGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMV   94 (476)
T ss_dssp             ETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence            467889999999999999999875 799999999865433222335678999999999999999999997655 557899


Q ss_pred             EEecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCCCCC
Q 012765          219 LQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNW  298 (457)
Q Consensus       219 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~~~  298 (457)
                      |||+++|+|.+++.. ...+++..++.++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||++.......
T Consensus        95 ~E~~~gg~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~~LH~---~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~~  170 (476)
T 2y94_A           95 MEYVSGGELFDYICK-NGRLDEKESRRLFQQILSGVDYCHR---HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE  170 (476)
T ss_dssp             EECCSSEEHHHHTTS-SSSCCHHHHHHHHHHHHHHHHHHHT---TTEECSCCSGGGEEECTTCCEEECCCSSCEECCTTC
T ss_pred             EeCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHH---CCCCcccccHHHEEEecCCCeEEEeccchhhccccc
Confidence            999999999999854 3458999999999999999999999   899999999999999999999999999998775432


Q ss_pred             CceeeecccccccccChhccccCCC-CcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhccccccCCcccccCchhhcc
Q 012765          299 SHHIVFPIEGTFGYLSPEYFMHGIV-DEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSNFKELVDPRLADA  377 (457)
Q Consensus       299 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~  377 (457)
                         ......||+.|+|||++.+..+ +.++|||||||++|+|++|+.||......... .. ... ...      .....
T Consensus       171 ---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~-~~-i~~-~~~------~~p~~  238 (476)
T 2y94_A          171 ---FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLF-KK-ICD-GIF------YTPQY  238 (476)
T ss_dssp             ---CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHH-HH-HHT-TCC------CCCTT
T ss_pred             ---cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHH-HH-Hhc-CCc------CCCcc
Confidence               2234569999999999988765 68999999999999999999999864432111 00 000 000      00011


Q ss_pred             cCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH--HHhc
Q 012765          378 YDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQ--LLRG  413 (457)
Q Consensus       378 ~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~--~L~~  413 (457)
                      ++    ..+.+++.+||+.||.+|||+.+|++  .+..
T Consensus       239 ~s----~~~~~Li~~~L~~dP~~Rpt~~eil~hp~~~~  272 (476)
T 2y94_A          239 LN----PSVISLLKHMLQVDPMKRATIKDIREHEWFKQ  272 (476)
T ss_dssp             CC----HHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHT
T ss_pred             CC----HHHHHHHHHHcCCCchhCcCHHHHHhCHHhhh
Confidence            12    34667889999999999999999987  4444

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=5.8e-42  Score=337.71  Aligned_cols=250  Identities=22%  Similarity=0.297  Sum_probs=188.7

Q ss_pred             hcCCCCCceecccCcEEEEEEEe----CCCcEEEEEEEeccchh-hHHHHHHHHHHHHHHhhcCCCCcceeeeeeec-Cc
Q 012765          141 TDNFNSENLIGKGGHAEVYKGCL----PDGEVVAVKKIIKNAKE-DEERISDFLSELGIVAHINHPNAAKLIGFSTE-NG  214 (457)
Q Consensus       141 ~~~f~~~~~LG~G~~g~Vy~~~~----~~~~~vavK~~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-~~  214 (457)
                      .++|.+.+.||+|+||.||+|..    .+++.||+|++.+.... .......+.+|+.+++.++||||+++++++.. +.
T Consensus        16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~   95 (327)
T 3a62_A           16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK   95 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred             HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence            46788999999999999999986    47899999998754321 12334568899999999999999999996654 56


Q ss_pred             eEEEEEecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccC
Q 012765          215 FHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWL  294 (457)
Q Consensus       215 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~  294 (457)
                      +++||||+++++|.+++... ..+++..+..++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||+++..
T Consensus        96 ~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~  171 (327)
T 3a62_A           96 LYLILEYLSGGELFMQLERE-GIFMEDTACFYLAEISMALGHLHQ---KGIIYRDLKPENIMLNHQGHVKLTDFGLCKES  171 (327)
T ss_dssp             EEEEEECCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCTTTEEECTTSCEEECCCSCC---
T ss_pred             EEEEEeCCCCCcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHh---CCEEcccCCHHHeEECCCCcEEEEeCCccccc
Confidence            78999999999999998643 457888999999999999999999   89999999999999999999999999998764


Q ss_pred             CCCCCceeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhccccccCCcccccCchh
Q 012765          295 PDNWSHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSNFKELVDPRL  374 (457)
Q Consensus       295 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l  374 (457)
                      .....  ......||+.|+|||++.+..++.++|||||||++|||++|+.||........... .....        ..+
T Consensus       172 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~-i~~~~--------~~~  240 (327)
T 3a62_A          172 IHDGT--VTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDK-ILKCK--------LNL  240 (327)
T ss_dssp             ---------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH-HHHTC--------CCC
T ss_pred             ccCCc--cccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHH-HHhCC--------CCC
Confidence            33211  22345699999999999999999999999999999999999999986443221110 00000        011


Q ss_pred             hcccCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 012765          375 ADAYDLAEMKRAMLTASVCIHHLSTMRP-----QMTRVLQ  409 (457)
Q Consensus       375 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----t~~evl~  409 (457)
                      ...+    ...+.+++.+||+.||.+||     ++.|+++
T Consensus       241 p~~~----~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~  276 (327)
T 3a62_A          241 PPYL----TQEARDLLKKLLKRNAASRLGAGPGDAGEVQA  276 (327)
T ss_dssp             CTTS----CHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHH
T ss_pred             CCCC----CHHHHHHHHHHHhcCHhhccCCCCCCHHHHHc
Confidence            1111    23566788999999999999     7778876

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=9.9e-42  Score=342.20  Aligned_cols=245  Identities=21%  Similarity=0.253  Sum_probs=191.7

Q ss_pred             CceecccCcEEEEEEEeC-CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeecC-ceEEEEEecCC
Q 012765          147 ENLIGKGGHAEVYKGCLP-DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTEN-GFHLVLQFLPH  224 (457)
Q Consensus       147 ~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~-~~~lv~e~~~~  224 (457)
                      .+.||+|+||.||+|... +|+.||+|++.....   .....+.+|+.++.+++||||+++++++... ..++||||+++
T Consensus        94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~  170 (373)
T 2x4f_A           94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTRGM---KDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDG  170 (373)
T ss_dssp             EEECC-----CEEEEEETTTCCEEEEEEEECCSH---HHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTT
T ss_pred             ceEEecCcCEEEEEEEEcCCCcEEEEEEEccccc---ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCC
Confidence            568999999999999864 689999999875433   2345789999999999999999999976654 56899999999


Q ss_pred             CChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEE--cCCCcEEEeeccccccCCCCCCcee
Q 012765          225 GSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILL--SEDYEAQISDFGLAKWLPDNWSHHI  302 (457)
Q Consensus       225 gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll--~~~~~~kL~DFGl~~~~~~~~~~~~  302 (457)
                      ++|.+++......+++..++.++.||+.||.|||+   .+|+||||||+|||+  +.++.+||+|||+++.+.....   
T Consensus       171 ~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~---  244 (373)
T 2x4f_A          171 GELFDRIIDESYNLTELDTILFMKQICEGIRHMHQ---MYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK---  244 (373)
T ss_dssp             CEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCB---
T ss_pred             CcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCccc---
Confidence            99999987766679999999999999999999999   899999999999999  5678899999999987754432   


Q ss_pred             eecccccccccChhccccCCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhccccccCCcccccCchhhcccCHHH
Q 012765          303 VFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSNFKELVDPRLADAYDLAE  382 (457)
Q Consensus       303 ~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~  382 (457)
                      .....||+.|+|||++.+..++.++|||||||++|||++|..||............ ......+    .+.....+    
T Consensus       245 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i-~~~~~~~----~~~~~~~~----  315 (373)
T 2x4f_A          245 LKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNI-LACRWDL----EDEEFQDI----  315 (373)
T ss_dssp             CCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH-HHTCCCS----CSGGGTTS----
T ss_pred             cccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH-HhccCCC----ChhhhccC----
Confidence            22345999999999999889999999999999999999999999865432211100 0000000    01111112    


Q ss_pred             HHHHHHHHHHhcccCCCCCCCHHHHHH
Q 012765          383 MKRAMLTASVCIHHLSTMRPQMTRVLQ  409 (457)
Q Consensus       383 ~~~l~~l~~~Cl~~dP~~RPt~~evl~  409 (457)
                      ...+.+++.+||+.||.+|||+.|+++
T Consensus       316 ~~~~~~li~~~L~~dp~~Rps~~e~l~  342 (373)
T 2x4f_A          316 SEEAKEFISKLLIKEKSWRISASEALK  342 (373)
T ss_dssp             CHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             CHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            245678899999999999999999987

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=3.8e-42  Score=344.78  Aligned_cols=255  Identities=10%  Similarity=0.063  Sum_probs=182.6

Q ss_pred             hcCCCCCceecccCcEEEEEEEeC-CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhc--CCCCcceeee-e------e
Q 012765          141 TDNFNSENLIGKGGHAEVYKGCLP-DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHI--NHPNAAKLIG-F------S  210 (457)
Q Consensus       141 ~~~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l--~hpniv~l~~-~------~  210 (457)
                      ..+|.+.+.||+|+||+||+|.+. +|+.||+|++.............+.+|+.++..+  +||||++++. +      +
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~  140 (371)
T 3q60_A           61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV  140 (371)
T ss_dssp             EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred             ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence            345888999999999999999865 7899999999876554555566788885544444  6999888552 2      2


Q ss_pred             ec------------------CceEEEEEecCCCChhhhhhcCCCCCCHHHH------HHHHHHHHHHHHHHHhcCCCCee
Q 012765          211 TE------------------NGFHLVLQFLPHGSLSSLLFGSTECLEWTIR------YKIALGIAEGLQYLHHDCHRRII  266 (457)
Q Consensus       211 ~~------------------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~------~~i~~qia~aL~yLH~~~~~~ii  266 (457)
                      ..                  ...++||||+. |+|.+++......+++..+      +.++.||+.||.|||+   .+|+
T Consensus       141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~---~~iv  216 (371)
T 3q60_A          141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQS---KGLV  216 (371)
T ss_dssp             EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHH---TTEE
T ss_pred             ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHH---CCCc
Confidence            11                  23689999999 8999999764444555566      7888999999999999   8999


Q ss_pred             eCCCCCCcEEEcCCCcEEEeeccccccCCCCCCceeeecccccccccChhcccc--CCCCcchhHHHHHHHHHHHHhCCC
Q 012765          267 HRDIKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEGTFGYLSPEYFMH--GIVDEKTDVFAFGVLLLELITGRR  344 (457)
Q Consensus       267 HrDlkp~NIll~~~~~~kL~DFGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~ksDvwSlGvll~eLltG~~  344 (457)
                      ||||||+|||++.++.+||+|||+++.....     .....+|+.|+|||++.+  ..++.++|||||||++|||++|+.
T Consensus       217 HrDikp~NIll~~~~~~kL~DFG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~  291 (371)
T 3q60_A          217 HGHFTPDNLFIMPDGRLMLGDVSALWKVGTR-----GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFL  291 (371)
T ss_dssp             ETTCSGGGEEECTTSCEEECCGGGEEETTCE-----EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSC
T ss_pred             cCcCCHHHEEECCCCCEEEEecceeeecCCC-----ccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCC
Confidence            9999999999999999999999999876432     113457799999999987  679999999999999999999999


Q ss_pred             CCCcCCcchh-hhhccccccCCcccccCchhhcccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 012765          345 AVDSRRQSLV-IWAKPLLQTSNFKELVDPRLADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQ  409 (457)
Q Consensus       345 pf~~~~~~~~-~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~  409 (457)
                      ||........ .|...............+.. .    .....+.+++.+||+.||++|||+.++++
T Consensus       292 Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~----~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  352 (371)
T 3q60_A          292 PFGLVTPGIKGSWKRPSLRVPGTDSLAFGSC-T----PLPDFVKTLIGRFLNFDRRRRLLPLEAME  352 (371)
T ss_dssp             STTBCCTTCTTCCCBCCTTSCCCCSCCCTTS-S----CCCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred             CCCCcCcccccchhhhhhhhccccccchhhc-c----CCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            9986432211 11111000000001111110 1    12345677889999999999999999875

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=2.3e-42  Score=354.91  Aligned_cols=252  Identities=21%  Similarity=0.283  Sum_probs=191.7

Q ss_pred             hhcCCCCCceecccCcEEEEEEEeC-CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeec-CceEE
Q 012765          140 ATDNFNSENLIGKGGHAEVYKGCLP-DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTE-NGFHL  217 (457)
Q Consensus       140 ~~~~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-~~~~l  217 (457)
                      ..++|.+.+.||+|+||.||+|... +|+.||+|++.............+.+|+.+++.++||||+++++++.. +.+++
T Consensus       146 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~l  225 (446)
T 4ejn_A          146 TMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCF  225 (446)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEE
T ss_pred             ChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEE
Confidence            3477999999999999999999864 689999999875443334455678899999999999999999996655 45789


Q ss_pred             EEEecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCCCC
Q 012765          218 VLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDN  297 (457)
Q Consensus       218 v~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~~  297 (457)
                      ||||+++|+|..++... ..+++..+..++.||+.||.|||+.  .+|+||||||+|||++.++.+||+|||+++.....
T Consensus       226 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~--~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~  302 (446)
T 4ejn_A          226 VMEYANGGELFFHLSRE-RVFSEDRARFYGAEIVSALDYLHSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKD  302 (446)
T ss_dssp             EECCCSSCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHH--TCCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC-
T ss_pred             EEeeCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhc--CCEEECCCCHHHEEECCCCCEEEccCCCceeccCC
Confidence            99999999999988543 4589999999999999999999963  68999999999999999999999999999864332


Q ss_pred             CCceeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhccccccCCcccccCchhhcc
Q 012765          298 WSHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSNFKELVDPRLADA  377 (457)
Q Consensus       298 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~  377 (457)
                      ..  ......||+.|+|||++.+..|+.++|||||||++|||++|+.||........... .......+        ...
T Consensus       303 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~-i~~~~~~~--------p~~  371 (446)
T 4ejn_A          303 GA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFEL-ILMEEIRF--------PRT  371 (446)
T ss_dssp             ------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH-HHHCCCCC--------CTT
T ss_pred             Cc--ccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHH-HHhCCCCC--------Ccc
Confidence            21  23346699999999999999999999999999999999999999976443221111 00111111        111


Q ss_pred             cCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 012765          378 YDLAEMKRAMLTASVCIHHLSTMRP-----QMTRVLQ  409 (457)
Q Consensus       378 ~~~~~~~~l~~l~~~Cl~~dP~~RP-----t~~evl~  409 (457)
                      +    ...+.+++.+||+.||.+||     ++.|+++
T Consensus       372 ~----~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~  404 (446)
T 4ejn_A          372 L----GPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQ  404 (446)
T ss_dssp             S----CHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred             C----CHHHHHHHHHHcccCHHHhCCCCCCCHHHHHh
Confidence            2    23567788999999999999     9999986

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=2e-42  Score=332.65  Aligned_cols=249  Identities=24%  Similarity=0.389  Sum_probs=202.4

Q ss_pred             HhhcCCCCCceecccCcEEEEEEEeC-CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeec-----
Q 012765          139 AATDNFNSENLIGKGGHAEVYKGCLP-DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTE-----  212 (457)
Q Consensus       139 ~~~~~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-----  212 (457)
                      ....+|.+.+.||+|+||.||+|.+. +++.||+|++....       ..+.+|+.++..++||||+++++++..     
T Consensus         8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   80 (284)
T 2a19_B            8 RFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN-------EKAEREVKALAKLDHVNIVHYNGCWDGFDYDP   80 (284)
T ss_dssp             HHHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS-------GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-
T ss_pred             hhccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc-------HHHHHHHHHHHhCCCCCEEEEeeeEeccccCc
Confidence            35577889999999999999999875 79999999986543       246689999999999999999997643     


Q ss_pred             ------------CceEEEEEecCCCChhhhhhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcC
Q 012765          213 ------------NGFHLVLQFLPHGSLSSLLFGS-TECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSE  279 (457)
Q Consensus       213 ------------~~~~lv~e~~~~gsL~~~l~~~-~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~  279 (457)
                                  ...+++|||+++++|.+++... ...+++..++.++.||+.||.|||+   .+|+||||||+|||++.
T Consensus        81 ~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~  157 (284)
T 2a19_B           81 ETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHS---KKLINRDLKPSNIFLVD  157 (284)
T ss_dssp             --------CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEE
T ss_pred             ccccccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCCHHHEEEcC
Confidence                        3368999999999999999643 3568999999999999999999999   89999999999999999


Q ss_pred             CCcEEEeeccccccCCCCCCceeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhcc
Q 012765          280 DYEAQISDFGLAKWLPDNWSHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKP  359 (457)
Q Consensus       280 ~~~~kL~DFGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~~  359 (457)
                      ++.+||+|||++........   .....||+.|+|||++.+..++.++||||||+++|+|++|..|+.........    
T Consensus       158 ~~~~kl~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~----  230 (284)
T 2a19_B          158 TKQVKIGDFGLVTSLKNDGK---RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFTD----  230 (284)
T ss_dssp             TTEEEECCCTTCEESSCCSC---CCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHHHHHHHH----
T ss_pred             CCCEEECcchhheecccccc---ccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhHHHHHHH----
Confidence            99999999999987755422   22345899999999999999999999999999999999999987532111000    


Q ss_pred             ccccCCcccccCchhhcccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCCCC
Q 012765          360 LLQTSNFKELVDPRLADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQLLRGEGGQ  417 (457)
Q Consensus       360 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~  417 (457)
                               +.+..+...++    ..+.+++.+||+.||.+|||+.|+++.|..++..
T Consensus       231 ---------~~~~~~~~~~~----~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~  275 (284)
T 2a19_B          231 ---------LRDGIISDIFD----KKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKS  275 (284)
T ss_dssp             ---------HHTTCCCTTSC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC-
T ss_pred             ---------hhcccccccCC----HHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhC
Confidence                     00111111222    2456788899999999999999999999888644

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=1.7e-41  Score=331.10  Aligned_cols=261  Identities=23%  Similarity=0.318  Sum_probs=194.6

Q ss_pred             cCCCCCceecccCcEEEEEEEeC-CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeecC-ceEEEE
Q 012765          142 DNFNSENLIGKGGHAEVYKGCLP-DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTEN-GFHLVL  219 (457)
Q Consensus       142 ~~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~-~~~lv~  219 (457)
                      ++|.+.+.||+|+||+||+|.+. +|+.||+|++..... .......+.+|+.++.+++||||+++++++.+. ..++||
T Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   81 (311)
T 4agu_A            3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESED-DPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVF   81 (311)
T ss_dssp             CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC--HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeecccc-chHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEE
Confidence            67889999999999999999875 589999998865433 334456788999999999999999999976654 568999


Q ss_pred             EecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCCCCCC
Q 012765          220 QFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWS  299 (457)
Q Consensus       220 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~~~~  299 (457)
                      ||+.+++|..++.. ...+++..+..++.|++.||.|||+   .+|+||||||+||+++.++.+||+|||++........
T Consensus        82 e~~~~~~l~~~~~~-~~~~~~~~~~~i~~~l~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  157 (311)
T 4agu_A           82 EYCDHTVLHELDRY-QRGVPEHLVKSITWQTLQAVNFCHK---HNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSD  157 (311)
T ss_dssp             ECCSEEHHHHHHHT-SSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECC----
T ss_pred             EeCCCchHHHHHhh-hcCCCHHHHHHHHHHHHHHHHHHHH---CCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCccc
Confidence            99999998887754 3558999999999999999999999   8999999999999999999999999999987654322


Q ss_pred             ceeeecccccccccChhcccc-CCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhcccc------------ccCC-
Q 012765          300 HHIVFPIEGTFGYLSPEYFMH-GIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLL------------QTSN-  365 (457)
Q Consensus       300 ~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~~~~------------~~~~-  365 (457)
                        ......||..|+|||++.+ ..++.++||||||+++|+|++|..||...............            .... 
T Consensus       158 --~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (311)
T 4agu_A          158 --YYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQY  235 (311)
T ss_dssp             ----------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGG
T ss_pred             --ccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccccccccc
Confidence              1223458999999999876 66899999999999999999999999865432221110000            0000 


Q ss_pred             c--ccccCchhhcc---cCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 012765          366 F--KELVDPRLADA---YDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQ  409 (457)
Q Consensus       366 ~--~~~~d~~l~~~---~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~  409 (457)
                      .  ..+.++.-...   ........+.+++.+||+.||.+|||+.|+++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  284 (311)
T 4agu_A          236 FSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLH  284 (311)
T ss_dssp             GTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHT
T ss_pred             cccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhc
Confidence            0  00000000000   00112334678899999999999999999986

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=1.7e-41  Score=326.55  Aligned_cols=253  Identities=24%  Similarity=0.310  Sum_probs=201.0

Q ss_pred             hhcCCCCCceecccCcEEEEEEEeC-CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeecCc-eEE
Q 012765          140 ATDNFNSENLIGKGGHAEVYKGCLP-DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTENG-FHL  217 (457)
Q Consensus       140 ~~~~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~-~~l  217 (457)
                      ..++|.+.+.||+|+||.||+|.+. +++.||+|++..... .......+.+|+.++++++||||+++++++.... .++
T Consensus         4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   82 (284)
T 3kk8_A            4 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKL-SARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYL   82 (284)
T ss_dssp             TTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred             hhhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccC-CHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEE
Confidence            4578999999999999999999865 589999999865433 3344568899999999999999999999776655 579


Q ss_pred             EEEecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCc---EEEeeccccccC
Q 012765          218 VLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYE---AQISDFGLAKWL  294 (457)
Q Consensus       218 v~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~---~kL~DFGl~~~~  294 (457)
                      +|||+.+++|.+.+... ..+++..++.++.|++.||.|||+   .+|+||||||+||+++.++.   +||+|||++...
T Consensus        83 v~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~  158 (284)
T 3kk8_A           83 VFDLVTGGELFEDIVAR-EFYSEADASHCIQQILESIAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEV  158 (284)
T ss_dssp             EECCCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEESSSSTTCCEEECCCTTCEEC
T ss_pred             EEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH---CCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEc
Confidence            99999999998888543 458999999999999999999999   89999999999999987655   999999999876


Q ss_pred             CCCCCceeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhccccccCCcccccCchh
Q 012765          295 PDNWSHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSNFKELVDPRL  374 (457)
Q Consensus       295 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l  374 (457)
                      .....   .....||+.|+|||++.+..++.++||||||+++|+|++|+.||............. .....   ...+..
T Consensus       159 ~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~-~~~~~---~~~~~~  231 (284)
T 3kk8_A          159 NDSEA---WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIK-AGAYD---YPSPEW  231 (284)
T ss_dssp             CSSCB---CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH-HTCCC---CCTTTT
T ss_pred             ccCcc---ccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHH-hcccc---CCchhh
Confidence            54432   223558999999999999999999999999999999999999997644332211100 00000   000000


Q ss_pred             hcccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 012765          375 ADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQ  409 (457)
Q Consensus       375 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~  409 (457)
                       ..+    ...+.+++.+||+.||.+|||+.|+++
T Consensus       232 -~~~----~~~~~~li~~~l~~dp~~Rps~~~~l~  261 (284)
T 3kk8_A          232 -DTV----TPEAKSLIDSMLTVNPKKRITADQALK  261 (284)
T ss_dssp             -TTS----CHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             -ccc----CHHHHHHHHHHcccChhhCCCHHHHhc
Confidence             111    234667889999999999999999987

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=1.5e-41  Score=328.68  Aligned_cols=259  Identities=20%  Similarity=0.255  Sum_probs=202.1

Q ss_pred             hhcCCCCCceecccCcEEEEEEEe-CCCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeee-ec-CceE
Q 012765          140 ATDNFNSENLIGKGGHAEVYKGCL-PDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFS-TE-NGFH  216 (457)
Q Consensus       140 ~~~~f~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~-~~-~~~~  216 (457)
                      ..++|.+.+.||+|+||.||+|.+ .+++.||+|++......     ..+.+|+.++..++|++++..+.++ .. ...+
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~   81 (296)
T 3uzp_A            7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH-----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNV   81 (296)
T ss_dssp             ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSC-----CHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEE
T ss_pred             eccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcch-----hHHHHHHHHHHHhhcCCCCCccccccCCCCceE
Confidence            357899999999999999999986 57999999988654332     2578899999999998877777643 33 4457


Q ss_pred             EEEEecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEc---CCCcEEEeecccccc
Q 012765          217 LVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLS---EDYEAQISDFGLAKW  293 (457)
Q Consensus       217 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~---~~~~~kL~DFGl~~~  293 (457)
                      ++|||+ +++|.+++......+++..++.++.||+.||.|||+   .+|+||||||+|||++   .++.+||+|||++..
T Consensus        82 lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~  157 (296)
T 3uzp_A           82 MVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHS---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKK  157 (296)
T ss_dssp             EEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECCGGGTTCEEECCCTTCEE
T ss_pred             EEEEec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHeEEecCCCCCeEEEeeCCCccc
Confidence            999999 999999997666779999999999999999999999   8999999999999994   788999999999987


Q ss_pred             CCCCCCce-----eeecccccccccChhccccCCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhccccccCCccc
Q 012765          294 LPDNWSHH-----IVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSNFKE  368 (457)
Q Consensus       294 ~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~  368 (457)
                      ........     ......||+.|+|||++.+..++.++|||||||++|||++|+.||.........        ..+..
T Consensus       158 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~--------~~~~~  229 (296)
T 3uzp_A          158 YRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKR--------QKYER  229 (296)
T ss_dssp             CBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSS--------SHHHH
T ss_pred             ccccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhh--------hhhhh
Confidence            75543211     123456999999999999999999999999999999999999999863221100        00000


Q ss_pred             ccCchhhcc---cCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCC
Q 012765          369 LVDPRLADA---YDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQLLRGEG  415 (457)
Q Consensus       369 ~~d~~l~~~---~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~  415 (457)
                      +....+...   ........+.+++.+||+.||.+|||+.+|++.|+.+.
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~  279 (296)
T 3uzp_A          230 ISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLF  279 (296)
T ss_dssp             HHHHHHHSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHH
T ss_pred             hcccccCCchHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHH
Confidence            000011000   00111245778899999999999999999999998764

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=3e-42  Score=368.32  Aligned_cols=250  Identities=23%  Similarity=0.326  Sum_probs=197.3

Q ss_pred             ceecccCcEEEEEEEeC---CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeecCceEEEEEecCC
Q 012765          148 NLIGKGGHAEVYKGCLP---DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTENGFHLVLQFLPH  224 (457)
Q Consensus       148 ~~LG~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~lv~e~~~~  224 (457)
                      +.||+|+||.||+|.+.   .++.||||++...... ......+.+|+.++.+++|||||++++++..+..++||||+.+
T Consensus       375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~-~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~lv~E~~~~  453 (635)
T 4fl3_A          375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAND-PALKDELLAEANVMQQLDNPYIVRMIGICEAESWMLVMEMAEL  453 (635)
T ss_dssp             EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGC-GGGHHHHHHHHHHHHHCCCTTBCCEEEEEESSSEEEEEECCTT
T ss_pred             CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEEEccCC
Confidence            47999999999999642   4678999988654332 2335689999999999999999999999998889999999999


Q ss_pred             CChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCCCCCCc-eee
Q 012765          225 GSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSH-HIV  303 (457)
Q Consensus       225 gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~~~~~-~~~  303 (457)
                      |+|.+++.. ...+++..++.|+.||+.||.|||+   .+|+||||||+|||++.++.+||+|||+++.+...... ...
T Consensus       454 g~L~~~l~~-~~~l~~~~~~~i~~qi~~~L~yLH~---~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~  529 (635)
T 4fl3_A          454 GPLNKYLQQ-NRHVKDKNIIELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ  529 (635)
T ss_dssp             EEHHHHHHH-CTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC--------
T ss_pred             CCHHHHHhh-CCCCCHHHHHHHHHHHHHHHHHHHH---CCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccccc
Confidence            999999964 3458999999999999999999999   89999999999999999999999999999877543221 112


Q ss_pred             ecccccccccChhccccCCCCcchhHHHHHHHHHHHHh-CCCCCCcCCcchhhhhccccccCCcccccCchhhcccCHHH
Q 012765          304 FPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELIT-GRRAVDSRRQSLVIWAKPLLQTSNFKELVDPRLADAYDLAE  382 (457)
Q Consensus       304 ~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLlt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~  382 (457)
                      ....+|+.|+|||++.+..++.++|||||||++|||++ |+.||.............   ...     ......    ..
T Consensus       530 ~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~---~~~-----~~~~p~----~~  597 (635)
T 4fl3_A          530 THGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLE---KGE-----RMGCPA----GC  597 (635)
T ss_dssp             -----CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH---TTC-----CCCCCT----TC
T ss_pred             cCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH---cCC-----CCCCCC----CC
Confidence            23346788999999999999999999999999999998 999998754432211111   000     001111    12


Q ss_pred             HHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q 012765          383 MKRAMLTASVCIHHLSTMRPQMTRVLQLLRGE  414 (457)
Q Consensus       383 ~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~  414 (457)
                      ...+.+++..||+.||++||++.+|++.|+..
T Consensus       598 ~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~  629 (635)
T 4fl3_A          598 PREMYDLMNLCWTYDVENRPGFAAVELRLRNY  629 (635)
T ss_dssp             CHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred             CHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence            24567788999999999999999999999764

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=2.9e-42  Score=345.81  Aligned_cols=249  Identities=25%  Similarity=0.282  Sum_probs=187.9

Q ss_pred             hcCCCCCceecccCcEEEEEEEeC-CCcEEEEEEEeccchhhHHHHHHHHHHHHH-HhhcCCCCcceeeeeeec-CceEE
Q 012765          141 TDNFNSENLIGKGGHAEVYKGCLP-DGEVVAVKKIIKNAKEDEERISDFLSELGI-VAHINHPNAAKLIGFSTE-NGFHL  217 (457)
Q Consensus       141 ~~~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~-l~~l~hpniv~l~~~~~~-~~~~l  217 (457)
                      .++|.+.+.||+|+||.||+|... +++.||+|++.+...........+.+|..+ ++.++||||+++++++.+ +.+++
T Consensus        37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~l  116 (373)
T 2r5t_A           37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYF  116 (373)
T ss_dssp             GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEE
T ss_pred             hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEE
Confidence            367889999999999999999875 588999999976554444445667778777 477899999999996654 55789


Q ss_pred             EEEecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCCCC
Q 012765          218 VLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDN  297 (457)
Q Consensus       218 v~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~~  297 (457)
                      ||||+.+|+|..++... ..+++..+..++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||+++.....
T Consensus       117 v~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~---~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~  192 (373)
T 2r5t_A          117 VLDYINGGELFYHLQRE-RCFLEPRARFYAAEIASALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEH  192 (373)
T ss_dssp             EEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCCBCGGGBCC
T ss_pred             EEeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCHHHEEECCCCCEEEeeCccccccccC
Confidence            99999999999998653 457888888999999999999999   89999999999999999999999999999864322


Q ss_pred             CCceeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhccccccCCcccccCchhhcc
Q 012765          298 WSHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSNFKELVDPRLADA  377 (457)
Q Consensus       298 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~  377 (457)
                      ..  .....+||+.|+|||++.+..|+.++|||||||++|||++|..||......... .......        ..+...
T Consensus       193 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~-~~i~~~~--------~~~~~~  261 (373)
T 2r5t_A          193 NS--TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMY-DNILNKP--------LQLKPN  261 (373)
T ss_dssp             CC--CCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHH-HHHHHSC--------CCCCSS
T ss_pred             CC--ccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHH-HHHHhcc--------cCCCCC
Confidence            11  223456999999999999999999999999999999999999999864432211 1100000        011112


Q ss_pred             cCHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 012765          378 YDLAEMKRAMLTASVCIHHLSTMRPQMTRVL  408 (457)
Q Consensus       378 ~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl  408 (457)
                      ++    ..+..++.+||+.||.+||++.+.+
T Consensus       262 ~~----~~~~~li~~lL~~dp~~R~~~~~~~  288 (373)
T 2r5t_A          262 IT----NSARHLLEGLLQKDRTKRLGAKDDF  288 (373)
T ss_dssp             SC----HHHHHHHHHHTCSSGGGSTTTTTTH
T ss_pred             CC----HHHHHHHHHHcccCHHhCCCCCCCH
Confidence            22    3466788999999999999985433

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=8.3e-42  Score=327.20  Aligned_cols=254  Identities=23%  Similarity=0.291  Sum_probs=199.9

Q ss_pred             hhcCCCCCceecccCcEEEEEEEeC-CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeecC-ceEE
Q 012765          140 ATDNFNSENLIGKGGHAEVYKGCLP-DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTEN-GFHL  217 (457)
Q Consensus       140 ~~~~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~-~~~l  217 (457)
                      ..++|.+.+.||+|+||.||+|.+. +++.||+|.+......  .....+.+|+.+++.++||||+++++++.++ ..++
T Consensus         5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   82 (276)
T 2yex_A            5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLNHENVVKFYGHRREGNIQYL   82 (276)
T ss_dssp             HHHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCT--THHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred             eecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccch--hhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEE
Confidence            4467889999999999999999875 6899999998644332  2346789999999999999999999977655 4679


Q ss_pred             EEEecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCCCC
Q 012765          218 VLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDN  297 (457)
Q Consensus       218 v~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~~  297 (457)
                      ||||+++++|.+++.. ...+++..++.++.||+.||.|||+   .+++||||||+||+++.++.+||+|||++......
T Consensus        83 v~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~  158 (276)
T 2yex_A           83 FLEYCSGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYN  158 (276)
T ss_dssp             EEECCTTEEGGGGSBT-TTBCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTTCEECEET
T ss_pred             EEEecCCCcHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCChHHEEEccCCCEEEeeCCCccccCCC
Confidence            9999999999999854 3458999999999999999999999   89999999999999999999999999999866433


Q ss_pred             CCceeeecccccccccChhccccCCC-CcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhccccccCCcccccCchhhc
Q 012765          298 WSHHIVFPIEGTFGYLSPEYFMHGIV-DEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSNFKELVDPRLAD  376 (457)
Q Consensus       298 ~~~~~~~~~~gt~~y~aPE~~~~~~~-~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  376 (457)
                      ..........||+.|+|||++.+..+ +.++||||||+++|+|++|..||.........+.........    ..+  ..
T Consensus       159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~----~~~--~~  232 (276)
T 2yex_A          159 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTY----LNP--WK  232 (276)
T ss_dssp             TEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTCTT----STT--GG
T ss_pred             cchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhcccc----cCc--hh
Confidence            22222334568999999999987665 779999999999999999999998644322221110000000    000  01


Q ss_pred             ccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 012765          377 AYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQ  409 (457)
Q Consensus       377 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~  409 (457)
                      .+    ...+.+++.+||+.||.+|||+.||++
T Consensus       233 ~~----~~~~~~li~~~l~~~p~~Rps~~~il~  261 (276)
T 2yex_A          233 KI----DSAPLALLHKILVENPSARITIPDIKK  261 (276)
T ss_dssp             GS----CHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             hc----CHHHHHHHHHHCCCCchhCCCHHHHhc
Confidence            11    234667889999999999999999976

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=1.7e-42  Score=332.92  Aligned_cols=249  Identities=28%  Similarity=0.400  Sum_probs=194.3

Q ss_pred             hcCCCCCceecccCcEEEEEEEeCCCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeec--CceEEE
Q 012765          141 TDNFNSENLIGKGGHAEVYKGCLPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTE--NGFHLV  218 (457)
Q Consensus       141 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~--~~~~lv  218 (457)
                      .++|.+.+.||+|+||+||+|.+ .|+.||+|.+....     ....+.+|+.+++.++||||+++++++.+  +..+++
T Consensus        20 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv   93 (278)
T 1byg_A           20 MKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIV   93 (278)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCCC-------HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEE
T ss_pred             hhhceEEeEEecCCCceEEEEEE-cCCEEEEEEecchh-----HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEE
Confidence            46788999999999999999987 58899999886442     24578899999999999999999997543  357899


Q ss_pred             EEecCCCChhhhhhcCCC-CCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCCCC
Q 012765          219 LQFLPHGSLSSLLFGSTE-CLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDN  297 (457)
Q Consensus       219 ~e~~~~gsL~~~l~~~~~-~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~~  297 (457)
                      |||+++++|.+++..... .+++..++.++.|++.||.|||+   .+++||||||+||+++.++.+||+|||++......
T Consensus        94 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~  170 (278)
T 1byg_A           94 TEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST  170 (278)
T ss_dssp             ECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTSCEEECCCCC-------
T ss_pred             EecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHh---CCccccCCCcceEEEeCCCcEEEeecccccccccc
Confidence            999999999999865332 37889999999999999999999   89999999999999999999999999998765433


Q ss_pred             CCceeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHh-CCCCCCcCCcchhhhhccccccCCcccccCchhhc
Q 012765          298 WSHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELIT-GRRAVDSRRQSLVIWAKPLLQTSNFKELVDPRLAD  376 (457)
Q Consensus       298 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLlt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  376 (457)
                      .     ....++..|+|||++.+..++.++||||||+++|+|++ |..||...........  ... .     ..+....
T Consensus       171 ~-----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~--~~~-~-----~~~~~~~  237 (278)
T 1byg_A          171 Q-----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPR--VEK-G-----YKMDAPD  237 (278)
T ss_dssp             ----------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHH--HTT-T-----CCCCCCT
T ss_pred             c-----cCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH--Hhc-C-----CCCCCcc
Confidence            2     12347889999999999999999999999999999998 9999986432211100  000 0     0111111


Q ss_pred             ccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCC
Q 012765          377 AYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQLLRGEG  415 (457)
Q Consensus       377 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~  415 (457)
                      .    ....+.+++..||+.||.+||++.++++.|+.+.
T Consensus       238 ~----~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~  272 (278)
T 1byg_A          238 G----CPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIK  272 (278)
T ss_dssp             T----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             c----CCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHH
Confidence            1    2345677889999999999999999999998764

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=7.2e-43  Score=350.85  Aligned_cols=242  Identities=12%  Similarity=0.123  Sum_probs=187.1

Q ss_pred             hcCCCCCceecccCcEEEEEEEe-CCCcEEEEEEEeccchhhHHHHHHHHHHH---HHHhhcCCCCcceee-------ee
Q 012765          141 TDNFNSENLIGKGGHAEVYKGCL-PDGEVVAVKKIIKNAKEDEERISDFLSEL---GIVAHINHPNAAKLI-------GF  209 (457)
Q Consensus       141 ~~~f~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~---~~l~~l~hpniv~l~-------~~  209 (457)
                      .++|.+.+.||+|+||+||+|.+ .+|+.||||++.............+.+|+   .+++.++||||++++       ++
T Consensus        72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~  151 (377)
T 3byv_A           72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL  151 (377)
T ss_dssp             CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred             CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence            46788899999999999999996 46999999998754333334456888999   555666899999998       44


Q ss_pred             eecC------------------ceEEEEEecCCCChhhhhhcCC------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCe
Q 012765          210 STEN------------------GFHLVLQFLPHGSLSSLLFGST------ECLEWTIRYKIALGIAEGLQYLHHDCHRRI  265 (457)
Q Consensus       210 ~~~~------------------~~~lv~e~~~~gsL~~~l~~~~------~~~~~~~~~~i~~qia~aL~yLH~~~~~~i  265 (457)
                      +...                  ..+++|||+ +|+|.+++....      ..+++..++.|+.||+.||.|||+   .+|
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~i  227 (377)
T 3byv_A          152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH---YGL  227 (377)
T ss_dssp             EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHH---TTE
T ss_pred             hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHh---CCe
Confidence            4333                  268999999 689999986432      223468888999999999999999   899


Q ss_pred             eeCCCCCCcEEEcCCCcEEEeeccccccCCCCCCceeeecccccccccChhccccC-----------CCCcchhHHHHHH
Q 012765          266 IHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEGTFGYLSPEYFMHG-----------IVDEKTDVFAFGV  334 (457)
Q Consensus       266 iHrDlkp~NIll~~~~~~kL~DFGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~ksDvwSlGv  334 (457)
                      +||||||+|||++.++.+||+|||+++....     ......| +.|+|||++.+.           .++.++|||||||
T Consensus       228 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~  301 (377)
T 3byv_A          228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA-----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGL  301 (377)
T ss_dssp             ECSCCCGGGEEECTTCCEEECCGGGCEETTC-----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHH
T ss_pred             ecCCCCHHHEEEcCCCCEEEEechhheecCC-----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHH
Confidence            9999999999999999999999999986433     2334557 999999999887           8999999999999


Q ss_pred             HHHHHHhCCCCCCcCCcchhhhhccccccCCcccccCchhhcccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 012765          335 LLLELITGRRAVDSRRQSLVIWAKPLLQTSNFKELVDPRLADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQ  409 (457)
Q Consensus       335 ll~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~  409 (457)
                      ++|||++|+.||........           ...+...  ...++    ..+.+++.+||+.||.+|||+.|+++
T Consensus       302 il~elltg~~Pf~~~~~~~~-----------~~~~~~~--~~~~~----~~~~~li~~~L~~dp~~Rpt~~e~l~  359 (377)
T 3byv_A          302 VIYWIWCADLPITKDAALGG-----------SEWIFRS--CKNIP----QPVRALLEGFLRYPKEDRLLPLQAME  359 (377)
T ss_dssp             HHHHHHHSSCCC------CC-----------SGGGGSS--CCCCC----HHHHHHHHHHTCSSGGGCCCHHHHHT
T ss_pred             HHHHHHHCCCCCcccccccc-----------hhhhhhh--ccCCC----HHHHHHHHHHcCCCchhCCCHHHHhh
Confidence            99999999999975332110           0001110  01222    35667889999999999999999986

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=2.3e-42  Score=340.04  Aligned_cols=268  Identities=19%  Similarity=0.291  Sum_probs=195.0

Q ss_pred             cCCCCCceecccCcEEEEEEEeC-CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeec-CceEEEE
Q 012765          142 DNFNSENLIGKGGHAEVYKGCLP-DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTE-NGFHLVL  219 (457)
Q Consensus       142 ~~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-~~~~lv~  219 (457)
                      ++|.+.+.||+|+||+||+|... +++.||+|++......  .....+.+|+.+++.++||||+++++++.. +..++||
T Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   79 (324)
T 3mtl_A            2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEE--GAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVF   79 (324)
T ss_dssp             CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC--------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEE
T ss_pred             CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEeccccc--ccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEe
Confidence            57889999999999999999875 6899999988643321  122245679999999999999999997654 4578999


Q ss_pred             EecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCCCCCC
Q 012765          220 QFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWS  299 (457)
Q Consensus       220 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~~~~  299 (457)
                      ||+. |+|.+++......+++..+..++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||++........
T Consensus        80 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~  155 (324)
T 3mtl_A           80 EYLD-KDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHR---QKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTK  155 (324)
T ss_dssp             ECCS-EEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHH---TTEEESSCCGGGEEECTTCCEEECSSSEEECC-----
T ss_pred             cccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCccCCCcCHHHEEECCCCCEEEccCcccccccCCcc
Confidence            9997 58988887777779999999999999999999999   8999999999999999999999999999986543321


Q ss_pred             ceeeecccccccccChhcccc-CCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhh-ccccccC---CcccccC---
Q 012765          300 HHIVFPIEGTFGYLSPEYFMH-GIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWA-KPLLQTS---NFKELVD---  371 (457)
Q Consensus       300 ~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~-~~~~~~~---~~~~~~d---  371 (457)
                        ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||........... .......   ....+..   
T Consensus       156 --~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  233 (324)
T 3mtl_A          156 --TYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEE  233 (324)
T ss_dssp             ---------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHH
T ss_pred             --ccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchh
Confidence              1223458999999999876 5689999999999999999999999986443221110 0000000   0000000   


Q ss_pred             ------chhhc----ccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH--HHhcCCCC
Q 012765          372 ------PRLAD----AYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQ--LLRGEGGQ  417 (457)
Q Consensus       372 ------~~l~~----~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~--~L~~~~~~  417 (457)
                            +....    .........+.+++.+||+.||.+|||+.|+++  .+.+....
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~  291 (324)
T 3mtl_A          234 FKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLGER  291 (324)
T ss_dssp             HHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCST
T ss_pred             hcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhcccc
Confidence                  00000    000112245678899999999999999999988  45555443

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=2.5e-42  Score=339.83  Aligned_cols=269  Identities=26%  Similarity=0.359  Sum_probs=206.0

Q ss_pred             hcCCCCCceecccCcEEEEEEEe-----CCCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeecC--
Q 012765          141 TDNFNSENLIGKGGHAEVYKGCL-----PDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTEN--  213 (457)
Q Consensus       141 ~~~f~~~~~LG~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~--  213 (457)
                      .++|.+.+.||+|+||.||+|.+     .+++.||+|++.....   .....+.+|+.+++.++||||+++++++...  
T Consensus        40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  116 (326)
T 2w1i_A           40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTE---EHLRDFEREIEILKSLQHDNIVKYKGVCYSAGR  116 (326)
T ss_dssp             GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCS---HHHHHHHHHHHHHHTCCCTTBCCEEEEECC---
T ss_pred             HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCH---HHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCC
Confidence            46688899999999999999983     3689999999865432   3456899999999999999999999976543  


Q ss_pred             -ceEEEEEecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccc
Q 012765          214 -GFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAK  292 (457)
Q Consensus       214 -~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~  292 (457)
                       ..++||||+++++|.+++......+++..++.++.||+.||.|||+   .+|+||||||+||+++.++.+||+|||++.
T Consensus       117 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dikp~NIli~~~~~~kL~Dfg~~~  193 (326)
T 2w1i_A          117 RNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGT---KRYIHRDLATRNILVENENRVKIGDFGLTK  193 (326)
T ss_dssp             -CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred             CceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHh---CCEeccCCCcceEEEcCCCcEEEecCcchh
Confidence             4789999999999999998776779999999999999999999999   899999999999999999999999999998


Q ss_pred             cCCCCCCcee-eecccccccccChhccccCCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhccccccC----Ccc
Q 012765          293 WLPDNWSHHI-VFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTS----NFK  367 (457)
Q Consensus       293 ~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~~~~~~~----~~~  367 (457)
                      .......... .....++..|+|||++.+..++.++||||||+++|||+||..||..................    .+.
T Consensus       194 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  273 (326)
T 2w1i_A          194 VLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLI  273 (326)
T ss_dssp             ECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHH
T ss_pred             hccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHH
Confidence            8755432211 22344778899999999888999999999999999999999998742111110000000000    000


Q ss_pred             cccCchhhcccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCC
Q 012765          368 ELVDPRLADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQLLRGEG  415 (457)
Q Consensus       368 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~  415 (457)
                      +.+...............+.+++.+||+.||.+|||+.+|++.|+.+.
T Consensus       274 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~  321 (326)
T 2w1i_A          274 ELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIR  321 (326)
T ss_dssp             HHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence            000000000011122345778899999999999999999999998764

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=1.8e-41  Score=335.14  Aligned_cols=267  Identities=24%  Similarity=0.291  Sum_probs=206.4

Q ss_pred             cHHHHHHhhcCCCCCceecccCcEEEEEEEeCCCcEEEEEEEeccchhhHHHHHHHHHHHHHHhh--cCCCCcceeeeee
Q 012765          133 DFAELAAATDNFNSENLIGKGGHAEVYKGCLPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAH--INHPNAAKLIGFS  210 (457)
Q Consensus       133 ~~~~~~~~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~--l~hpniv~l~~~~  210 (457)
                      .+.......++|.+.+.||+|+||.||+|.+ +++.||+|.+....      ...+.+|.+++..  ++||||+++++++
T Consensus        33 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~------~~~~~~e~~~~~~~~l~h~ni~~~~~~~  105 (342)
T 1b6c_B           33 PLLVQRTIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSRE------ERSWFREAEIYQTVMLRHENILGFIAAD  105 (342)
T ss_dssp             CHHHHHHHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECGGG------HHHHHHHHHHHHHSCCCCTTBCCEEEEE
T ss_pred             ceeecccccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCchh------HHHHHHHHHHHHHhhcCCCcEEEEEeee
Confidence            3444556678999999999999999999988 68999999985432      2356788888877  7999999999977


Q ss_pred             ecC-----ceEEEEEecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHH--------hcCCCCeeeCCCCCCcEEE
Q 012765          211 TEN-----GFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLH--------HDCHRRIIHRDIKASNILL  277 (457)
Q Consensus       211 ~~~-----~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH--------~~~~~~iiHrDlkp~NIll  277 (457)
                      ...     ..++||||+++|+|.+++..  ..+++..++.++.||+.||.|||        +   .+|+||||||+|||+
T Consensus       106 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~---~~ivH~Dlkp~NIll  180 (342)
T 1b6c_B          106 NKDNGTWTQLWLVSDYHEHGSLFDYLNR--YTVTVEGMIKLALSTASGLAHLHMEIVGTQGK---PAIAHRDLKSKNILV  180 (342)
T ss_dssp             ECCCSSCCCEEEEECCCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCB---CEEECSCCSGGGEEE
T ss_pred             cccCCccceeEEEEeecCCCcHHHHHhc--cCccHHHHHHHHHHHHHHHHHHHHHHhhhccc---CCeeeCCCCHHHEEE
Confidence            654     57899999999999999954  35899999999999999999999        6   899999999999999


Q ss_pred             cCCCcEEEeeccccccCCCCCCce--eeecccccccccChhccccCC------CCcchhHHHHHHHHHHHHhC-------
Q 012765          278 SEDYEAQISDFGLAKWLPDNWSHH--IVFPIEGTFGYLSPEYFMHGI------VDEKTDVFAFGVLLLELITG-------  342 (457)
Q Consensus       278 ~~~~~~kL~DFGl~~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~------~~~ksDvwSlGvll~eLltG-------  342 (457)
                      +.++.+||+|||++..........  ......||+.|+|||++.+..      ++.++|||||||++|||+||       
T Consensus       181 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~  260 (342)
T 1b6c_B          181 KKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIH  260 (342)
T ss_dssp             CTTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBC
T ss_pred             CCCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcc
Confidence            999999999999998765433221  123346899999999987653      33689999999999999999       


Q ss_pred             ---CCCCCcCCc---chhhhhccccccCCcccccCchhhcc-cCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCC
Q 012765          343 ---RRAVDSRRQ---SLVIWAKPLLQTSNFKELVDPRLADA-YDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQLLRGEG  415 (457)
Q Consensus       343 ---~~pf~~~~~---~~~~~~~~~~~~~~~~~~~d~~l~~~-~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~  415 (457)
                         ..||.....   ....+......     ....+.+... ........+.+++.+||+.||++|||+.+|++.|+.+.
T Consensus       261 ~~~~~p~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~  335 (342)
T 1b6c_B          261 EDYQLPYYDLVPSDPSVEEMRKVVCE-----QKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLS  335 (342)
T ss_dssp             CCCCCTTTTTSCSSCCHHHHHHHHTT-----SCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHH
T ss_pred             cccccCccccCcCcccHHHHHHHHHH-----HHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHH
Confidence               677764321   11111111100     1111222111 12356677889999999999999999999999998875


Q ss_pred             C
Q 012765          416 G  416 (457)
Q Consensus       416 ~  416 (457)
                      .
T Consensus       336 ~  336 (342)
T 1b6c_B          336 Q  336 (342)
T ss_dssp             H
T ss_pred             H
Confidence            3

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=4.4e-42  Score=338.91  Aligned_cols=265  Identities=25%  Similarity=0.383  Sum_probs=193.0

Q ss_pred             hcCCCCCceecccCcEEEEEEEeCCCcEEEEEEEeccchhhHHHHHHHH--HHHHHHhhcCCCCcceeeeeeec------
Q 012765          141 TDNFNSENLIGKGGHAEVYKGCLPDGEVVAVKKIIKNAKEDEERISDFL--SELGIVAHINHPNAAKLIGFSTE------  212 (457)
Q Consensus       141 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~--~E~~~l~~l~hpniv~l~~~~~~------  212 (457)
                      .++|.+.+.||+|+||.||+|.. +++.||||++.....      ..+.  .|+..+..++||||+++++++..      
T Consensus        12 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~------~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~   84 (336)
T 3g2f_A           12 LDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANR------QNFINEKNIYRVPLMEHDNIARFIVGDERVTADGR   84 (336)
T ss_dssp             TTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGGH------HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSC
T ss_pred             hHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeeccch------hhHHHHHHHHHHHhccCcchhhheecccccccCCC
Confidence            47888999999999999999987 789999999864322      1233  34444556899999999974321      


Q ss_pred             CceEEEEEecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCC---------CeeeCCCCCCcEEEcCCCcE
Q 012765          213 NGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHR---------RIIHRDIKASNILLSEDYEA  283 (457)
Q Consensus       213 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~---------~iiHrDlkp~NIll~~~~~~  283 (457)
                      ..+++||||+++|+|.+++...  ..++..++.++.||+.||.|||+   .         +|+||||||+|||++.++.+
T Consensus        85 ~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~i~~qi~~~L~~LH~---~~~~~~~~~~~ivH~Dikp~Nill~~~~~~  159 (336)
T 3g2f_A           85 MEYLLVMEYYPNGSLXKYLSLH--TSDWVSSCRLAHSVTRGLAYLHT---ELPRGDHYKPAISHRDLNSRNVLVKNDGTC  159 (336)
T ss_dssp             EEEEEEECCCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHC---CBCCGGGCBCCEECSSCSGGGEEECTTSCE
T ss_pred             ceEEEEEecCCCCcHHHHHhhc--ccchhHHHHHHHHHHHHHHHHHh---hhccccccccceeecccccceEEEcCCCcE
Confidence            1357999999999999999543  34888899999999999999999   6         99999999999999999999


Q ss_pred             EEeeccccccCCCCCC------ceeeecccccccccChhcccc-------CCCCcchhHHHHHHHHHHHHhCCCCCCcCC
Q 012765          284 QISDFGLAKWLPDNWS------HHIVFPIEGTFGYLSPEYFMH-------GIVDEKTDVFAFGVLLLELITGRRAVDSRR  350 (457)
Q Consensus       284 kL~DFGl~~~~~~~~~------~~~~~~~~gt~~y~aPE~~~~-------~~~~~ksDvwSlGvll~eLltG~~pf~~~~  350 (457)
                      ||+|||++..+.....      ........||+.|+|||++.+       ..++.++|||||||++|||++|..||....
T Consensus       160 kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~  239 (336)
T 3g2f_A          160 VISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGE  239 (336)
T ss_dssp             EECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTS
T ss_pred             EEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCcc
Confidence            9999999987654321      111223569999999999976       456678999999999999999988765422


Q ss_pred             cchh---hhhccccccCCcc--------cccCchhhcc--cCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCCCC
Q 012765          351 QSLV---IWAKPLLQTSNFK--------ELVDPRLADA--YDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQLLRGEGGQ  417 (457)
Q Consensus       351 ~~~~---~~~~~~~~~~~~~--------~~~d~~l~~~--~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~  417 (457)
                      ....   .+...........        ....+.+...  ........+.+++.+||+.||++|||+.||++.|+.+...
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~~  319 (336)
T 3g2f_A          240 SVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMI  319 (336)
T ss_dssp             CCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             chhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHHH
Confidence            1100   0000000000000        0001111111  1123455788999999999999999999999999887543

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=8e-42  Score=338.29  Aligned_cols=265  Identities=23%  Similarity=0.250  Sum_probs=198.5

Q ss_pred             HHhhcCCCCCceecccCcEEEEEEEeC-CCcEEEEEEEeccchh--hHHHHHHHHHHHHHHhhcCCCCcceeeeeeecCc
Q 012765          138 AAATDNFNSENLIGKGGHAEVYKGCLP-DGEVVAVKKIIKNAKE--DEERISDFLSELGIVAHINHPNAAKLIGFSTENG  214 (457)
Q Consensus       138 ~~~~~~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~  214 (457)
                      ....++|.+.+.||+|+||+||+|.+. +++.||+|++......  .......+.+|+.+++.++||||+++++++.+..
T Consensus        22 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~  101 (345)
T 3hko_A           22 LELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQ  101 (345)
T ss_dssp             HHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred             hhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCC
Confidence            456788999999999999999999864 6889999998654221  2234568999999999999999999999776655


Q ss_pred             -eEEEEEecCCCChhhhhhcC---------------------------------------CCCCCHHHHHHHHHHHHHHH
Q 012765          215 -FHLVLQFLPHGSLSSLLFGS---------------------------------------TECLEWTIRYKIALGIAEGL  254 (457)
Q Consensus       215 -~~lv~e~~~~gsL~~~l~~~---------------------------------------~~~~~~~~~~~i~~qia~aL  254 (457)
                       .++||||+++|+|.+++...                                       ...+++..++.++.||+.||
T Consensus       102 ~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l  181 (345)
T 3hko_A          102 YICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSAL  181 (345)
T ss_dssp             EEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHH
T ss_pred             eEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHH
Confidence             68999999999999988420                                       11235667788999999999


Q ss_pred             HHHHhcCCCCeeeCCCCCCcEEEcCCC--cEEEeeccccccCCCCCCc--eeeecccccccccChhcccc--CCCCcchh
Q 012765          255 QYLHHDCHRRIIHRDIKASNILLSEDY--EAQISDFGLAKWLPDNWSH--HIVFPIEGTFGYLSPEYFMH--GIVDEKTD  328 (457)
Q Consensus       255 ~yLH~~~~~~iiHrDlkp~NIll~~~~--~~kL~DFGl~~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~--~~~~~ksD  328 (457)
                      .|||+   .+|+||||||+|||++.++  .+||+|||++..+......  .......||+.|+|||++.+  ..++.++|
T Consensus       182 ~~LH~---~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~D  258 (345)
T 3hko_A          182 HYLHN---QGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCD  258 (345)
T ss_dssp             HHHHH---TTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHH
T ss_pred             HHHHH---CCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHH
Confidence            99999   8999999999999998776  8999999999865332111  12234569999999999875  67899999


Q ss_pred             HHHHHHHHHHHHhCCCCCCcCCcchhhhhccccccCCcccccCchhhcccCHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 012765          329 VFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSNFKELVDPRLADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVL  408 (457)
Q Consensus       329 vwSlGvll~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl  408 (457)
                      ||||||++|||++|+.||............  ....  .....+.. ..    ....+.+++.+||+.||.+||++.+++
T Consensus       259 iwslG~il~el~~g~~pf~~~~~~~~~~~~--~~~~--~~~~~~~~-~~----~~~~~~~li~~~l~~~p~~Rps~~~~l  329 (345)
T 3hko_A          259 AWSAGVLLHLLLMGAVPFPGVNDADTISQV--LNKK--LCFENPNY-NV----LSPLARDLLSNLLNRNVDERFDAMRAL  329 (345)
T ss_dssp             HHHHHHHHHHHHHSSCSSCCSSHHHHHHHH--HHCC--CCTTSGGG-GG----SCHHHHHHHHHHSCSCTTTSCCHHHHH
T ss_pred             HHHHHHHHHHHHHCCCCCCCCChHHHHHHH--Hhcc--cccCCccc-cc----CCHHHHHHHHHHcCCChhHCCCHHHHh
Confidence            999999999999999999864433222111  0000  00001110 11    123567788999999999999999998


Q ss_pred             H--HHhcC
Q 012765          409 Q--LLRGE  414 (457)
Q Consensus       409 ~--~L~~~  414 (457)
                      +  .++..
T Consensus       330 ~hp~~~~~  337 (345)
T 3hko_A          330 QHPWISQF  337 (345)
T ss_dssp             HSHHHHTT
T ss_pred             cChhhccC
Confidence            7  34443

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=2.3e-42  Score=340.04  Aligned_cols=260  Identities=28%  Similarity=0.362  Sum_probs=199.3

Q ss_pred             hhcCCCCCceecccCcEEEEEEEe------CCCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeecC
Q 012765          140 ATDNFNSENLIGKGGHAEVYKGCL------PDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTEN  213 (457)
Q Consensus       140 ~~~~f~~~~~LG~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~  213 (457)
                      ..++|.+.+.||+|+||.||+|.+      .+++.||+|.+.....  ......+.+|+.++++++||||+++++++...
T Consensus        28 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~  105 (327)
T 2yfx_A           28 PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCS--EQDELDFLMEALIISKFNHQNIVRCIGVSLQS  105 (327)
T ss_dssp             CGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCC--HHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             ChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccc--hhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCC
Confidence            457888999999999999999983      2577899999864322  23456889999999999999999999976654


Q ss_pred             -ceEEEEEecCCCChhhhhhcCC------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCC---CcE
Q 012765          214 -GFHLVLQFLPHGSLSSLLFGST------ECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSED---YEA  283 (457)
Q Consensus       214 -~~~lv~e~~~~gsL~~~l~~~~------~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~---~~~  283 (457)
                       ..++||||+++++|.+++....      ..+++..++.++.||+.||.|||+   .+|+||||||+|||++.+   ..+
T Consensus       106 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~---~~i~H~dlkp~NIli~~~~~~~~~  182 (327)
T 2yfx_A          106 LPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEE---NHFIHRDIAARNCLLTCPGPGRVA  182 (327)
T ss_dssp             SSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESCSSTTCCE
T ss_pred             CCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhh---CCeecCcCCHhHEEEecCCCcceE
Confidence             5789999999999999996543      358899999999999999999999   899999999999999844   469


Q ss_pred             EEeeccccccCCCCCCceeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHh-CCCCCCcCCcchhhhhccccc
Q 012765          284 QISDFGLAKWLPDNWSHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELIT-GRRAVDSRRQSLVIWAKPLLQ  362 (457)
Q Consensus       284 kL~DFGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLlt-G~~pf~~~~~~~~~~~~~~~~  362 (457)
                      ||+|||++................||+.|+|||++.+..++.++|||||||++|+|+| |..||............  ..
T Consensus       183 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~--~~  260 (327)
T 2yfx_A          183 KIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFV--TS  260 (327)
T ss_dssp             EECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHH--HT
T ss_pred             EECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHH--hc
Confidence            9999999976543322222233457899999999999999999999999999999998 99999764332111100  00


Q ss_pred             cCCcccccCchhhcccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCCC
Q 012765          363 TSNFKELVDPRLADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQLLRGEGG  416 (457)
Q Consensus       363 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~  416 (457)
                       ..     .+.....    ....+.+++.+||+.||.+||++.+|++.|+.+..
T Consensus       261 -~~-----~~~~~~~----~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~  304 (327)
T 2yfx_A          261 -GG-----RMDPPKN----CPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ  304 (327)
T ss_dssp             -TC-----CCCCCTT----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             -CC-----CCCCCCC----CCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhc
Confidence             00     0001111    12356778899999999999999999999987643

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=1.4e-41  Score=338.98  Aligned_cols=269  Identities=19%  Similarity=0.248  Sum_probs=200.2

Q ss_pred             cHHHHHHhhcCCCCCceecccCcEEEEEEEeCCCcEEEEEEEeccch--------hhHHHHHHHHHHHHHHhhcCCCCcc
Q 012765          133 DFAELAAATDNFNSENLIGKGGHAEVYKGCLPDGEVVAVKKIIKNAK--------EDEERISDFLSELGIVAHINHPNAA  204 (457)
Q Consensus       133 ~~~~~~~~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~--------~~~~~~~~~~~E~~~l~~l~hpniv  204 (457)
                      ...++....++|.+.+.||+|+||.||+|.+.+|+.||||++.....        ........+.+|+.++++++||||+
T Consensus        13 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv   92 (362)
T 3pg1_A           13 LIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNIL   92 (362)
T ss_dssp             HHHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred             HHHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCcc
Confidence            35677888999999999999999999999988899999998854322        2234457899999999999999999


Q ss_pred             eeeeeeec------CceEEEEEecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEc
Q 012765          205 KLIGFSTE------NGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLS  278 (457)
Q Consensus       205 ~l~~~~~~------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~  278 (457)
                      ++++++..      ...++||||+. |+|.+++......+++..++.++.||+.||.|||+   .+|+||||||+|||++
T Consensus        93 ~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~NIl~~  168 (362)
T 3pg1_A           93 GLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHE---AGVVHRDLHPGNILLA  168 (362)
T ss_dssp             CCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEEC
T ss_pred             ceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHH---CcCEecCCChHHEEEc
Confidence            99997632      13689999998 68888887766779999999999999999999999   8999999999999999


Q ss_pred             CCCcEEEeeccccccCCCCCCceeeecccccccccChhcccc-CCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhh
Q 012765          279 EDYEAQISDFGLAKWLPDNWSHHIVFPIEGTFGYLSPEYFMH-GIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWA  357 (457)
Q Consensus       279 ~~~~~kL~DFGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~  357 (457)
                      .++.+||+|||++........   .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...........
T Consensus       169 ~~~~~kl~Dfg~~~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~  245 (362)
T 3pg1_A          169 DNNDITICDFNLAREDTADAN---KTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNK  245 (362)
T ss_dssp             TTCCEEECCTTC------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH
T ss_pred             CCCCEEEEecCcccccccccc---cceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence            999999999999975543322   223458999999999876 6789999999999999999999999986442211100


Q ss_pred             c-cccccCC-------------------cccccCchhhcccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 012765          358 K-PLLQTSN-------------------FKELVDPRLADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQ  409 (457)
Q Consensus       358 ~-~~~~~~~-------------------~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~  409 (457)
                      . .......                   ......... ..........+.+++.+||+.||.+|||+.|+++
T Consensus       246 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  316 (362)
T 3pg1_A          246 IVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAW-TAVVPTADPVALDLIAKMLEFNPQRRISTEQALR  316 (362)
T ss_dssp             HHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCH-HHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             HHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhH-HhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHc
Confidence            0 0000000                   000000000 0001112345778999999999999999999987

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=3.6e-42  Score=338.69  Aligned_cols=256  Identities=25%  Similarity=0.378  Sum_probs=198.1

Q ss_pred             cCCCCCceecccCcEEEEEEEeC-CCcEE--EEEEEeccchhhHHHHHHHHHHHHHHhhc-CCCCcceeeeeeecC-ceE
Q 012765          142 DNFNSENLIGKGGHAEVYKGCLP-DGEVV--AVKKIIKNAKEDEERISDFLSELGIVAHI-NHPNAAKLIGFSTEN-GFH  216 (457)
Q Consensus       142 ~~f~~~~~LG~G~~g~Vy~~~~~-~~~~v--avK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~-~~~  216 (457)
                      ++|.+.+.||+|+||.||+|.+. ++..+  |+|.+.....  ......+.+|+.++.++ +||||+++++++.+. ..+
T Consensus        25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~--~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~  102 (327)
T 1fvr_A           25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYAS--KDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLY  102 (327)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC--------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEE
T ss_pred             HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccc--hHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceE
Confidence            67888999999999999999864 46544  8888764322  23456789999999999 899999999976554 468


Q ss_pred             EEEEecCCCChhhhhhcCC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCC
Q 012765          217 LVLQFLPHGSLSSLLFGST---------------ECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDY  281 (457)
Q Consensus       217 lv~e~~~~gsL~~~l~~~~---------------~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~  281 (457)
                      +||||+++++|.+++....               ..+++..++.++.||+.||.|||+   .+|+||||||+|||++.++
T Consensus       103 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIl~~~~~  179 (327)
T 1fvr_A          103 LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENY  179 (327)
T ss_dssp             EEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECGGG
T ss_pred             EEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCccceEEEcCCC
Confidence            9999999999999996543               468999999999999999999999   8999999999999999999


Q ss_pred             cEEEeeccccccCCCCCCceeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHh-CCCCCCcCCcchhhhhccc
Q 012765          282 EAQISDFGLAKWLPDNWSHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELIT-GRRAVDSRRQSLVIWAKPL  360 (457)
Q Consensus       282 ~~kL~DFGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLlt-G~~pf~~~~~~~~~~~~~~  360 (457)
                      .+||+|||+++.......   .....+++.|+|||++.+..++.++|||||||++|||++ |+.||............  
T Consensus       180 ~~kL~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~--  254 (327)
T 1fvr_A          180 VAKIADFGLSRGQEVYVK---KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKL--  254 (327)
T ss_dssp             CEEECCTTCEESSCEECC---C----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHG--
T ss_pred             eEEEcccCcCcccccccc---ccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHHHHh--
Confidence            999999999875432211   122346889999999998889999999999999999998 99999864432211110  


Q ss_pred             cccCCcccccCchhhcccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCCCC
Q 012765          361 LQTSNFKELVDPRLADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQLLRGEGGQ  417 (457)
Q Consensus       361 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~  417 (457)
                      ...      ........+    ...+.+++.+||+.||.+|||+.++++.|+.+...
T Consensus       255 ~~~------~~~~~~~~~----~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~  301 (327)
T 1fvr_A          255 PQG------YRLEKPLNC----DDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE  301 (327)
T ss_dssp             GGT------CCCCCCTTB----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred             hcC------CCCCCCCCC----CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence            000      001111112    23567888999999999999999999998876443

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=4.4e-42  Score=339.75  Aligned_cols=245  Identities=22%  Similarity=0.368  Sum_probs=197.1

Q ss_pred             hhcCCCCCceecccCcEEEEEEEe-CCCcEEEEEEEeccchhhH-----HHHHHHHHHHHHHhhcCCCCcceeeeeeecC
Q 012765          140 ATDNFNSENLIGKGGHAEVYKGCL-PDGEVVAVKKIIKNAKEDE-----ERISDFLSELGIVAHINHPNAAKLIGFSTEN  213 (457)
Q Consensus       140 ~~~~f~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~-----~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~  213 (457)
                      ..++|.+.+.||+|+||+||+|.+ .+++.||+|++........     .....+.+|+.+++.++||||+++++++.+.
T Consensus        22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~  101 (335)
T 3dls_A           22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQ  101 (335)
T ss_dssp             HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred             cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeC
Confidence            467899999999999999999985 4689999999876432111     1233577899999999999999999977665


Q ss_pred             c-eEEEEEecCCC-ChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeecccc
Q 012765          214 G-FHLVLQFLPHG-SLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLA  291 (457)
Q Consensus       214 ~-~~lv~e~~~~g-sL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~  291 (457)
                      + .++||||+.+| +|..++... ..+++..++.|+.||+.||.|||+   .+|+||||||+|||++.++.+||+|||++
T Consensus       102 ~~~~lv~e~~~~g~~l~~~~~~~-~~l~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a  177 (335)
T 3dls_A          102 GFFQLVMEKHGSGLDLFAFIDRH-PRLDEPLASYIFRQLVSAVGYLRL---KDIIHRDIKDENIVIAEDFTIKLIDFGSA  177 (335)
T ss_dssp             SEEEEEEECCTTSCBHHHHHHTC-CCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTC
T ss_pred             CEEEEEEEeCCCCccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHh---CCeEEeccCHHHEEEcCCCcEEEeecccc
Confidence            5 67999999777 888888543 458999999999999999999999   89999999999999999999999999999


Q ss_pred             ccCCCCCCceeeecccccccccChhccccCCC-CcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhccccccCCccccc
Q 012765          292 KWLPDNWSHHIVFPIEGTFGYLSPEYFMHGIV-DEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSNFKELV  370 (457)
Q Consensus       292 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~  370 (457)
                      ..+......   ....||+.|+|||++.+..+ +.++|||||||++|+|++|..||........             ...
T Consensus       178 ~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~-------------~~~  241 (335)
T 3dls_A          178 AYLERGKLF---YTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEETVE-------------AAI  241 (335)
T ss_dssp             EECCTTCCB---CEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGGTT-------------TCC
T ss_pred             eECCCCCce---eccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHHHh-------------hcc
Confidence            877554322   23459999999999988776 8899999999999999999999975221100             000


Q ss_pred             CchhhcccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 012765          371 DPRLADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQL  410 (457)
Q Consensus       371 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~  410 (457)
                      .+  ...+    ...+.+++..||+.||.+|||+.++++.
T Consensus       242 ~~--~~~~----~~~l~~li~~~L~~dP~~Rps~~ell~h  275 (335)
T 3dls_A          242 HP--PYLV----SKELMSLVSGLLQPVPERRTTLEKLVTD  275 (335)
T ss_dssp             CC--SSCC----CHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred             CC--Cccc----CHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            00  0111    2346778899999999999999999983

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=2.6e-41  Score=331.86  Aligned_cols=254  Identities=22%  Similarity=0.254  Sum_probs=201.6

Q ss_pred             hhcCCCCCceecccCcEEEEEEEeC-CCcEEEEEEEeccchhhH---HHHHHHHHHHHHHhhcCCCCcceeeeeeecC-c
Q 012765          140 ATDNFNSENLIGKGGHAEVYKGCLP-DGEVVAVKKIIKNAKEDE---ERISDFLSELGIVAHINHPNAAKLIGFSTEN-G  214 (457)
Q Consensus       140 ~~~~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~---~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~-~  214 (457)
                      ..++|.+.+.||+|+||.||+|.+. +|+.||+|.+........   .....+.+|+.++..++||||+++++++.+. .
T Consensus        10 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   89 (321)
T 2a2a_A           10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTD   89 (321)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred             hhccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCE
Confidence            3467889999999999999999875 689999999865432211   1245788999999999999999999976654 4


Q ss_pred             eEEEEEecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCC----cEEEeeccc
Q 012765          215 FHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDY----EAQISDFGL  290 (457)
Q Consensus       215 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~----~~kL~DFGl  290 (457)
                      .++||||+++++|.+++.. ...+++..++.++.||+.||.|||+   .+|+||||||+||+++.++    .+||+|||+
T Consensus        90 ~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~lH~---~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~  165 (321)
T 2a2a_A           90 VVLILELVSGGELFDFLAQ-KESLSEEEATSFIKQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGL  165 (321)
T ss_dssp             EEEEECCCCSCBHHHHHHT-CSCEEHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCTTSSSCCEEECCCTT
T ss_pred             EEEEEEcCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCChHHEEEecCCCCcCCEEEccCcc
Confidence            6899999999999999864 4468899999999999999999999   8999999999999999887    799999999


Q ss_pred             cccCCCCCCceeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhccccccCCccccc
Q 012765          291 AKWLPDNWSHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSNFKELV  370 (457)
Q Consensus       291 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~  370 (457)
                      +........   .....||+.|+|||++.+..++.++|||||||++|+|++|..||.............  . .  ....
T Consensus       166 ~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~--~-~--~~~~  237 (321)
T 2a2a_A          166 AHEIEDGVE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANIT--S-V--SYDF  237 (321)
T ss_dssp             CEECCTTCC---CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHH--T-T--CCCC
T ss_pred             ceecCcccc---ccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHH--h-c--cccc
Confidence            987755422   223458999999999999999999999999999999999999997644322111100  0 0  0011


Q ss_pred             CchhhcccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 012765          371 DPRLADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQ  409 (457)
Q Consensus       371 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~  409 (457)
                      ++.....+    ...+.+++.+||+.||.+|||+.|+++
T Consensus       238 ~~~~~~~~----~~~~~~li~~~l~~dp~~Rps~~e~l~  272 (321)
T 2a2a_A          238 DEEFFSHT----SELAKDFIRKLLVKETRKRLTIQEALR  272 (321)
T ss_dssp             CHHHHTTC----CHHHHHHHHTTSCSSTTTSCCHHHHHH
T ss_pred             Chhhhccc----CHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence            11111222    235678899999999999999999987

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=9.2e-42  Score=328.80  Aligned_cols=254  Identities=26%  Similarity=0.386  Sum_probs=202.0

Q ss_pred             hcCCCCCceecccCcEEEEEEEeC-CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeecC-ceEEE
Q 012765          141 TDNFNSENLIGKGGHAEVYKGCLP-DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTEN-GFHLV  218 (457)
Q Consensus       141 ~~~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~-~~~lv  218 (457)
                      .++|.+.+.||+|+||.||+|... +++.||+|.+.............+.+|+.+++.++||||+++++++.+. ..+++
T Consensus        13 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   92 (284)
T 2vgo_A           13 IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLM   92 (284)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEE
Confidence            367888999999999999999875 5788999998654322222345788999999999999999999976654 46899


Q ss_pred             EEecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCCCCC
Q 012765          219 LQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNW  298 (457)
Q Consensus       219 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~~~  298 (457)
                      |||+++++|.+++... ..+++..++.++.||+.||.|||+   .+|+||||||+||+++.++.+||+|||++.......
T Consensus        93 ~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~  168 (284)
T 2vgo_A           93 LEFAPRGELYKELQKH-GRFDEQRSATFMEELADALHYCHE---RKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLR  168 (284)
T ss_dssp             ECCCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCSGGGEEECTTCCEEECCCTTCEECSSSC
T ss_pred             EEeCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCHHHEEEcCCCCEEEecccccccCcccc
Confidence            9999999999998653 358899999999999999999999   899999999999999999999999999987664432


Q ss_pred             CceeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhccccccCCcccccCchhhccc
Q 012765          299 SHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSNFKELVDPRLADAY  378 (457)
Q Consensus       299 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~  378 (457)
                      .    ....|++.|+|||++.+..++.++||||||+++|+|++|..||............  .. .      +..+...+
T Consensus       169 ~----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~--~~-~------~~~~~~~~  235 (284)
T 2vgo_A          169 R----RTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRI--VN-V------DLKFPPFL  235 (284)
T ss_dssp             B----CCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH--HT-T------CCCCCTTS
T ss_pred             c----ccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHH--hc-c------ccCCCCcC
Confidence            2    2345899999999999999999999999999999999999999864432211100  00 0      01111112


Q ss_pred             CHHHHHHHHHHHHHhcccCCCCCCCHHHHHH--HHhcCC
Q 012765          379 DLAEMKRAMLTASVCIHHLSTMRPQMTRVLQ--LLRGEG  415 (457)
Q Consensus       379 ~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~--~L~~~~  415 (457)
                          ...+.+++.+||+.||.+||++.++++  .++...
T Consensus       236 ----~~~~~~li~~~l~~~p~~Rps~~~ll~h~~~~~~~  270 (284)
T 2vgo_A          236 ----SDGSKDLISKLLRYHPPQRLPLKGVMEHPWVKANS  270 (284)
T ss_dssp             ----CHHHHHHHHHHSCSSGGGSCCHHHHHTCHHHHHHC
T ss_pred             ----CHHHHHHHHHHhhcCHhhCCCHHHHhhCHHHHhhc
Confidence                235667889999999999999999987  444443

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=5.6e-42  Score=359.45  Aligned_cols=253  Identities=25%  Similarity=0.329  Sum_probs=201.5

Q ss_pred             hhcCCCCCceecccCcEEEEEEEeC-CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeec-CceEE
Q 012765          140 ATDNFNSENLIGKGGHAEVYKGCLP-DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTE-NGFHL  217 (457)
Q Consensus       140 ~~~~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-~~~~l  217 (457)
                      ..++|.+.++||+|+||.||+|... +|+.||+|++.+...........+.+|+.++..++||||+++++++.+ +.+++
T Consensus       182 ~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~l  261 (576)
T 2acx_A          182 TKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCL  261 (576)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred             cccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEE
Confidence            3567889999999999999999875 699999999865433222334578899999999999999999996654 55789


Q ss_pred             EEEecCCCChhhhhhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCCC
Q 012765          218 VLQFLPHGSLSSLLFGST-ECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPD  296 (457)
Q Consensus       218 v~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~  296 (457)
                      ||||+++|+|..++.... ..+++..++.++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||++..+..
T Consensus       262 VmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~---~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~  338 (576)
T 2acx_A          262 VLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHR---ERIVYRDLKPENILLDDHGHIRISDLGLAVHVPE  338 (576)
T ss_dssp             EECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred             EEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHH---CCEeccCCchheEEEeCCCCeEEEecccceeccc
Confidence            999999999999986543 358999999999999999999999   8999999999999999999999999999987755


Q ss_pred             CCCceeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHhCCCCCCcCCcch--hhhhccccccCCcccccCchh
Q 012765          297 NWSHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSL--VIWAKPLLQTSNFKELVDPRL  374 (457)
Q Consensus       297 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~--~~~~~~~~~~~~~~~~~d~~l  374 (457)
                      ...   .....||+.|+|||++.+..|+.++|||||||++|||++|+.||.......  ......... .      ...+
T Consensus       339 ~~~---~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~-~------~~~~  408 (576)
T 2acx_A          339 GQT---IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKE-V------PEEY  408 (576)
T ss_dssp             TCC---EECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHH-C------CCCC
T ss_pred             Ccc---ccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhc-c------cccC
Confidence            432   234569999999999999899999999999999999999999998643211  000000000 0      0111


Q ss_pred             hcccCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 012765          375 ADAYDLAEMKRAMLTASVCIHHLSTMRP-----QMTRVLQ  409 (457)
Q Consensus       375 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----t~~evl~  409 (457)
                      ...    ....+..++.+||+.||.+||     ++.||++
T Consensus       409 p~~----~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~  444 (576)
T 2acx_A          409 SER----FSPQARSLCSQLLCKDPAERLGCRGGSAREVKE  444 (576)
T ss_dssp             CTT----SCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHT
T ss_pred             Ccc----CCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHh
Confidence            111    224567788999999999999     7788875

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=1.2e-41  Score=328.48  Aligned_cols=251  Identities=22%  Similarity=0.311  Sum_probs=192.8

Q ss_pred             hhcCCCCCceecccCcEEEEEEEeC-CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeecC-ceEE
Q 012765          140 ATDNFNSENLIGKGGHAEVYKGCLP-DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTEN-GFHL  217 (457)
Q Consensus       140 ~~~~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~-~~~l  217 (457)
                      ..++|.+.+.||+|+||.||+|... ++..+|+|++......  .....+.+|+.+++.++||||+++++++.+. ..++
T Consensus        20 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l   97 (285)
T 3is5_A           20 IDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQ--VPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYI   97 (285)
T ss_dssp             HHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCC--SCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred             hhhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccc--hhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEE
Confidence            3467889999999999999999864 6899999998654322  2245788999999999999999999977654 4689


Q ss_pred             EEEecCCCChhhhhhc---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEE---cCCCcEEEeecccc
Q 012765          218 VLQFLPHGSLSSLLFG---STECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILL---SEDYEAQISDFGLA  291 (457)
Q Consensus       218 v~e~~~~gsL~~~l~~---~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll---~~~~~~kL~DFGl~  291 (457)
                      ||||+++|+|.+++..   ....+++..++.++.||+.||.|||+   .+|+||||||+||++   +.++.+||+|||++
T Consensus        98 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a  174 (285)
T 3is5_A           98 VMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHS---QHVVHKDLKPENILFQDTSPHSPIKIIDFGLA  174 (285)
T ss_dssp             EECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEESSSSTTCCEEECCCCCC
T ss_pred             EEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHh---CCEEECCCCHHHEEEecCCCCCCEEEEeeecc
Confidence            9999999999998854   34568999999999999999999999   899999999999999   45678999999999


Q ss_pred             ccCCCCCCceeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhccccccCCcccccC
Q 012765          292 KWLPDNWSHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSNFKELVD  371 (457)
Q Consensus       292 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d  371 (457)
                      ........   .....||+.|+|||++. +.++.++||||||+++|||++|+.||............. ........   
T Consensus       175 ~~~~~~~~---~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~-~~~~~~~~---  246 (285)
T 3is5_A          175 ELFKSDEH---STNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKAT-YKEPNYAV---  246 (285)
T ss_dssp             CC-------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH-HCCCCCCC---
T ss_pred             eecCCccc---CcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhc-cCCccccc---
Confidence            87654322   23345899999999875 568999999999999999999999998644322211110 00000000   


Q ss_pred             chhhcccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 012765          372 PRLADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQ  409 (457)
Q Consensus       372 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~  409 (457)
                        ....+    ...+.+++.+||+.||.+|||+.||++
T Consensus       247 --~~~~~----~~~~~~li~~~L~~dP~~Rps~~e~l~  278 (285)
T 3is5_A          247 --ECRPL----TPQAVDLLKQMLTKDPERRPSAAQVLH  278 (285)
T ss_dssp             ----CCC----CHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred             --ccCcC----CHHHHHHHHHHccCChhhCcCHHHHhc
Confidence              00111    234667889999999999999999985

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=1.8e-41  Score=341.45  Aligned_cols=258  Identities=19%  Similarity=0.269  Sum_probs=193.2

Q ss_pred             HHhhcCCCCCceecccCcEEEEEEEe-CCCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeecC---
Q 012765          138 AAATDNFNSENLIGKGGHAEVYKGCL-PDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTEN---  213 (457)
Q Consensus       138 ~~~~~~f~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~---  213 (457)
                      ....++|.+.+.||+|+||+||+|.+ .+|+.||+|++......       ..+|+.+++.++||||+++++++...   
T Consensus         3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~-------~~~E~~il~~l~hpnIv~l~~~~~~~~~~   75 (383)
T 3eb0_A            3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY-------KNRELDIMKVLDHVNIIKLVDYFYTTGDE   75 (383)
T ss_dssp             ---CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS-------CCHHHHHHTTCCCTTBCCEEEEEEEC---
T ss_pred             ccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch-------HHHHHHHHHHcCCCCccchhheeeecCcc
Confidence            34568899999999999999999986 47999999998654322       23699999999999999999966321   


Q ss_pred             ------------------------------------ceEEEEEecCCCChhhhhh---cCCCCCCHHHHHHHHHHHHHHH
Q 012765          214 ------------------------------------GFHLVLQFLPHGSLSSLLF---GSTECLEWTIRYKIALGIAEGL  254 (457)
Q Consensus       214 ------------------------------------~~~lv~e~~~~gsL~~~l~---~~~~~~~~~~~~~i~~qia~aL  254 (457)
                                                          .+++||||++ |+|.+.+.   .....+++..+..++.||+.||
T Consensus        76 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL  154 (383)
T 3eb0_A           76 EPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAV  154 (383)
T ss_dssp             ----------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHH
T ss_pred             cccccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHH
Confidence                                                1679999998 57777664   3456799999999999999999


Q ss_pred             HHHHhcCCCCeeeCCCCCCcEEEc-CCCcEEEeeccccccCCCCCCceeeecccccccccChhccccC-CCCcchhHHHH
Q 012765          255 QYLHHDCHRRIIHRDIKASNILLS-EDYEAQISDFGLAKWLPDNWSHHIVFPIEGTFGYLSPEYFMHG-IVDEKTDVFAF  332 (457)
Q Consensus       255 ~yLH~~~~~~iiHrDlkp~NIll~-~~~~~kL~DFGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDvwSl  332 (457)
                      .|||+   .+|+||||||+|||++ .++.+||+|||+++.+.....   .....||+.|+|||++.+. .++.++|||||
T Consensus       155 ~~LH~---~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~Diwsl  228 (383)
T 3eb0_A          155 GFIHS---LGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP---SVAYICSRFYRAPELMLGATEYTPSIDLWSI  228 (383)
T ss_dssp             HHHHT---TTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSC---CCCCCCCSSCCCHHHHTTCSSCCTHHHHHHH
T ss_pred             HHHHH---CcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCC---CcCcccCCCccCHHHhcCCCCCCcchhhhhH
Confidence            99999   8999999999999997 688999999999987654332   2234589999999998765 48999999999


Q ss_pred             HHHHHHHHhCCCCCCcCCcchhhhhc----------------cccccCCcccccCchhhcccCHHHHHHHHHHHHHhccc
Q 012765          333 GVLLLELITGRRAVDSRRQSLVIWAK----------------PLLQTSNFKELVDPRLADAYDLAEMKRAMLTASVCIHH  396 (457)
Q Consensus       333 Gvll~eLltG~~pf~~~~~~~~~~~~----------------~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~  396 (457)
                      ||++|||++|+.||............                +......+..+........+.......+.+++.+||+.
T Consensus       229 G~il~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~  308 (383)
T 3eb0_A          229 GCVFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRY  308 (383)
T ss_dssp             HHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCS
T ss_pred             HHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccC
Confidence            99999999999999865432211100                00001111111111111111112234577899999999


Q ss_pred             CCCCCCCHHHHHH
Q 012765          397 LSTMRPQMTRVLQ  409 (457)
Q Consensus       397 dP~~RPt~~evl~  409 (457)
                      ||.+|||+.|+++
T Consensus       309 dP~~R~t~~e~l~  321 (383)
T 3eb0_A          309 EPDLRINPYEAMA  321 (383)
T ss_dssp             SGGGSCCHHHHHT
T ss_pred             ChhhCCCHHHHhc
Confidence            9999999999985

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=6.9e-42  Score=346.06  Aligned_cols=268  Identities=18%  Similarity=0.237  Sum_probs=205.8

Q ss_pred             hcCCCCCceecccCcEEEEEEEeC-CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeecC---ceE
Q 012765          141 TDNFNSENLIGKGGHAEVYKGCLP-DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTEN---GFH  216 (457)
Q Consensus       141 ~~~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~---~~~  216 (457)
                      .++|.+.++||+|+||+||+|.+. +|+.||+|++......  .....+.+|+.++++++||||+++++++...   ..+
T Consensus         8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~   85 (396)
T 4eut_A            8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFL--RPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKV   85 (396)
T ss_dssp             SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGG--SCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEE
T ss_pred             CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEecccccc--chHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeE
Confidence            467889999999999999999875 4899999998653322  2245778999999999999999999977643   468


Q ss_pred             EEEEecCCCChhhhhhcCC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEE----cCCCcEEEeeccc
Q 012765          217 LVLQFLPHGSLSSLLFGST--ECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILL----SEDYEAQISDFGL  290 (457)
Q Consensus       217 lv~e~~~~gsL~~~l~~~~--~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll----~~~~~~kL~DFGl  290 (457)
                      +||||+++|+|.+++....  ..+++..++.++.||+.||.|||+   .+|+||||||+|||+    +.++.+||+|||+
T Consensus        86 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~  162 (396)
T 4eut_A           86 LIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGA  162 (396)
T ss_dssp             EEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEEEECTTSCEEEEECCGGG
T ss_pred             EEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHH---CCEEECCcCHHHEEEeecCCCceeEEEecCCC
Confidence            9999999999999996532  238999999999999999999999   899999999999999    7778899999999


Q ss_pred             cccCCCCCCceeeecccccccccChhcccc--------CCCCcchhHHHHHHHHHHHHhCCCCCCcCCcch--hhhhccc
Q 012765          291 AKWLPDNWSHHIVFPIEGTFGYLSPEYFMH--------GIVDEKTDVFAFGVLLLELITGRRAVDSRRQSL--VIWAKPL  360 (457)
Q Consensus       291 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~--~~~~~~~  360 (457)
                      ++.......   .....||+.|+|||++.+        ..++.++|||||||++|||++|+.||.......  .......
T Consensus       163 a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~  239 (396)
T 4eut_A          163 ARELEDDEQ---FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKI  239 (396)
T ss_dssp             CEECCCGGG---SSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHH
T ss_pred             ceEccCCCc---cccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHH
Confidence            987754322   223559999999999865        567889999999999999999999997522111  0000000


Q ss_pred             cccCC------ccccc--------CchhhcccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCCC
Q 012765          361 LQTSN------FKELV--------DPRLADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQLLRGEGG  416 (457)
Q Consensus       361 ~~~~~------~~~~~--------d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~  416 (457)
                      .....      .....        +..............+..++..||+.||++||++.++++.++.+-.
T Consensus       240 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~  309 (396)
T 4eut_A          240 ITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILH  309 (396)
T ss_dssp             HHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHT
T ss_pred             hcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhh
Confidence            00000      00000        0011122345666778889999999999999999999998877543

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=1.6e-41  Score=332.06  Aligned_cols=263  Identities=24%  Similarity=0.300  Sum_probs=191.0

Q ss_pred             hhcCCCCC-ceecccCcEEEEEEEeC-CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhc-CCCCcceeeeeeec-Cce
Q 012765          140 ATDNFNSE-NLIGKGGHAEVYKGCLP-DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHI-NHPNAAKLIGFSTE-NGF  215 (457)
Q Consensus       140 ~~~~f~~~-~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~-~~~  215 (457)
                      ..+.|.+. ++||+|+||+||+|... +++.||||++......   ....+.+|+.++.++ +||||+++++++.+ +..
T Consensus        10 ~~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~   86 (316)
T 2ac3_A           10 FEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGH---IRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRF   86 (316)
T ss_dssp             TTTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSC---CHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEE
T ss_pred             cceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcch---hHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEE
Confidence            34677774 78999999999999854 6899999998654332   234788999999885 79999999996655 457


Q ss_pred             EEEEEecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCc---EEEeeccccc
Q 012765          216 HLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYE---AQISDFGLAK  292 (457)
Q Consensus       216 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~---~kL~DFGl~~  292 (457)
                      ++||||+++++|.+++... ..+++..++.++.||+.||.|||+   .+|+||||||+|||++.++.   +||+|||++.
T Consensus        87 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~  162 (316)
T 2ac3_A           87 YLVFEKMRGGSILSHIHKR-RHFNELEASVVVQDVASALDFLHN---KGIAHRDLKPENILCEHPNQVSPVKICDFDLGS  162 (316)
T ss_dssp             EEEEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC
T ss_pred             EEEEEcCCCCcHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHh---CCceeCCCCHHHEEEccCCCcCceEEEEccCcc
Confidence            8999999999999998653 458899999999999999999999   89999999999999998776   9999999987


Q ss_pred             cCCCCCC-----ceeeecccccccccChhcccc-----CCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhccccc
Q 012765          293 WLPDNWS-----HHIVFPIEGTFGYLSPEYFMH-----GIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQ  362 (457)
Q Consensus       293 ~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~-----~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~~~~~  362 (457)
                      .......     ........||+.|+|||++.+     ..++.++|||||||++|||++|+.||.........|......
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~  242 (316)
T 2ac3_A          163 GIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEAC  242 (316)
T ss_dssp             -------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CC
T ss_pred             ccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccc
Confidence            6542211     111223459999999999875     568899999999999999999999998644322111110000


Q ss_pred             cCCcccccCchhhc--ccCH----HHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 012765          363 TSNFKELVDPRLAD--AYDL----AEMKRAMLTASVCIHHLSTMRPQMTRVLQ  409 (457)
Q Consensus       363 ~~~~~~~~d~~l~~--~~~~----~~~~~l~~l~~~Cl~~dP~~RPt~~evl~  409 (457)
                      ......+.......  .+..    .....+.+++.+||+.||.+|||+.|+++
T Consensus       243 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~  295 (316)
T 2ac3_A          243 PACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQ  295 (316)
T ss_dssp             HHHHHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             hhHHHHHHHHHhccCcccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence            00000000000000  0000    11245778999999999999999999988

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=2.5e-41  Score=327.43  Aligned_cols=250  Identities=24%  Similarity=0.324  Sum_probs=202.4

Q ss_pred             hcCCCCCceecccCcEEEEEEEeC-CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeecCc-eEEE
Q 012765          141 TDNFNSENLIGKGGHAEVYKGCLP-DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTENG-FHLV  218 (457)
Q Consensus       141 ~~~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~-~~lv  218 (457)
                      .++|.+.+.||+|+||.||+|.+. +++.||+|.+.............+.+|+.+++.++||||+++++++.+.+ .+++
T Consensus        14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv   93 (294)
T 2rku_A           14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV   93 (294)
T ss_dssp             TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEE
Confidence            467888999999999999999875 58899999987654444555678999999999999999999999776655 6799


Q ss_pred             EEecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCCCCC
Q 012765          219 LQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNW  298 (457)
Q Consensus       219 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~~~  298 (457)
                      |||+.+++|.+++... ..+++..++.++.||+.||.|||+   .+++||||||+||+++.++.+||+|||++.......
T Consensus        94 ~e~~~~~~L~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~  169 (294)
T 2rku_A           94 LELCRRRSLLELHKRR-KALTEPEARYYLRQIVLGCQYLHR---NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG  169 (294)
T ss_dssp             EECCTTCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred             EecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCChHhEEEcCCCCEEEEeccCceecccCc
Confidence            9999999999987543 458899999999999999999999   899999999999999999999999999998765332


Q ss_pred             CceeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhccccccCCcccccCchhhccc
Q 012765          299 SHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSNFKELVDPRLADAY  378 (457)
Q Consensus       299 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~  378 (457)
                      ..  .....||+.|+|||++.+..++.++||||||+++|+|++|+.||............ .....        .+...+
T Consensus       170 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~-~~~~~--------~~~~~~  238 (294)
T 2rku_A          170 ER--KKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRI-KKNEY--------SIPKHI  238 (294)
T ss_dssp             CC--BCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH-HTTCC--------CCCTTS
T ss_pred             cc--cccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH-hhccC--------CCcccc
Confidence            21  22345899999999999888999999999999999999999999864432211100 00000        011112


Q ss_pred             CHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 012765          379 DLAEMKRAMLTASVCIHHLSTMRPQMTRVLQ  409 (457)
Q Consensus       379 ~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~  409 (457)
                      +    ..+.+++.+||+.||++|||+.++++
T Consensus       239 ~----~~~~~li~~~l~~~p~~Rps~~~ll~  265 (294)
T 2rku_A          239 N----PVAASLIQKMLQTDPTARPTINELLN  265 (294)
T ss_dssp             C----HHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred             C----HHHHHHHHHHcccChhhCcCHHHHhh
Confidence            2    34667889999999999999999987

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.3e-41  Score=338.77  Aligned_cols=263  Identities=23%  Similarity=0.290  Sum_probs=196.2

Q ss_pred             hcCCCCCceecccCcEEEEEEEeC-CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeecC------
Q 012765          141 TDNFNSENLIGKGGHAEVYKGCLP-DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTEN------  213 (457)
Q Consensus       141 ~~~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~------  213 (457)
                      .++|.+.+.||+|+||.||+|.+. +|+.||||++..... .......+.+|+.+++.++||||+++++++...      
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~  102 (367)
T 1cm8_A           24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQ-SELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF  102 (367)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTS-SHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred             cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCcccc-CHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccC
Confidence            477889999999999999999864 699999999865432 334466889999999999999999999977654      


Q ss_pred             -ceEEEEEecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccc
Q 012765          214 -GFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAK  292 (457)
Q Consensus       214 -~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~  292 (457)
                       .+++||||+ +++|.+++..  ..+++..+..++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||+++
T Consensus       103 ~~~~lv~e~~-~~~L~~~~~~--~~l~~~~~~~~~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~  176 (367)
T 1cm8_A          103 TDFYLVMPFM-GTDLGKLMKH--EKLGEDRIQFLVYQMLKGLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLAR  176 (367)
T ss_dssp             CCCEEEEECC-SEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred             ceEEEEEecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCcCHHHEEEcCCCCEEEEeeeccc
Confidence             358999999 8899998854  458899999999999999999999   899999999999999999999999999998


Q ss_pred             cCCCCCCceeeecccccccccChhcccc-CCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhc-cccccCC-----
Q 012765          293 WLPDNWSHHIVFPIEGTFGYLSPEYFMH-GIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAK-PLLQTSN-----  365 (457)
Q Consensus       293 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~-~~~~~~~-----  365 (457)
                      .....     .....+|+.|+|||++.+ ..++.++|||||||++|||++|+.||...+........ .......     
T Consensus       177 ~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~  251 (367)
T 1cm8_A          177 QADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQ  251 (367)
T ss_dssp             ECCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHH
T ss_pred             ccccc-----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHH
Confidence            76543     223458999999999887 67999999999999999999999999865432111000 0000000     


Q ss_pred             -------------cccccCchhhcccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH--HHhcCCC
Q 012765          366 -------------FKELVDPRLADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQ--LLRGEGG  416 (457)
Q Consensus       366 -------------~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~--~L~~~~~  416 (457)
                                   +.......+.. ........+.+++.+||+.||.+|||+.|+++  .++....
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~~~  316 (367)
T 1cm8_A          252 RLQSDEAKNYMKGLPELEKKDFAS-ILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHD  316 (367)
T ss_dssp             TCSCHHHHHHHHHSCCCCCCCGGG-TCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC-
T ss_pred             HhhhHHHHHHHHhCCCCCCCCHHH-HCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhhcC
Confidence                         00000000000 00112345778899999999999999999998  4555443

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=2.8e-41  Score=347.98  Aligned_cols=196  Identities=26%  Similarity=0.394  Sum_probs=153.5

Q ss_pred             hcCCCCCceecccCcEEEEEEEeC-CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeec------C
Q 012765          141 TDNFNSENLIGKGGHAEVYKGCLP-DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTE------N  213 (457)
Q Consensus       141 ~~~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~------~  213 (457)
                      .++|.+.+.||+|+||+||+|.+. +++.||||++.... ........+.+|+.+|+.++||||+++++++..      .
T Consensus        52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~  130 (458)
T 3rp9_A           52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVF-EDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFD  130 (458)
T ss_dssp             CTTEEECCC-------CEEEEEECC--CEEEEEEECSTT-SSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCC
T ss_pred             CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhh-cCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCc
Confidence            478999999999999999999865 68999999986543 233446789999999999999999999997633      3


Q ss_pred             ceEEEEEecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeecccccc
Q 012765          214 GFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKW  293 (457)
Q Consensus       214 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~  293 (457)
                      .+++||||+ +++|..++.. ...+++..+..++.||+.||.|||+   .+|+||||||+||||+.++.+||+|||+++.
T Consensus       131 ~~~lv~e~~-~~~L~~~~~~-~~~l~~~~~~~~~~qi~~aL~~LH~---~~iiHrDlKp~NILl~~~~~~kl~DFGla~~  205 (458)
T 3rp9_A          131 ELYVVLEIA-DSDFKKLFRT-PVYLTELHIKTLLYNLLVGVKYVHS---AGILHRDLKPANCLVNQDCSVKVCDFGLART  205 (458)
T ss_dssp             CEEEEECCC-SEEHHHHHHS-SCCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTCCEEECCCTTCBC
T ss_pred             eEEEEEecc-ccchhhhccc-CCCCCHHHHHHHHHHHHHHHHHHHh---CCcCCCCCChhhEEECCCCCEeecccccchh
Confidence            478999987 5788888854 4568999999999999999999999   8999999999999999999999999999987


Q ss_pred             CCCCCCc-------------------------eeeecccccccccChhcc-ccCCCCcchhHHHHHHHHHHHHhC
Q 012765          294 LPDNWSH-------------------------HIVFPIEGTFGYLSPEYF-MHGIVDEKTDVFAFGVLLLELITG  342 (457)
Q Consensus       294 ~~~~~~~-------------------------~~~~~~~gt~~y~aPE~~-~~~~~~~ksDvwSlGvll~eLltG  342 (457)
                      +......                         .......||++|+|||++ .+..|+.++|||||||++|||++|
T Consensus       206 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg  280 (458)
T 3rp9_A          206 VDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNM  280 (458)
T ss_dssp             TTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTT
T ss_pred             ccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHh
Confidence            6432111                         123345689999999986 456799999999999999999993

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=2.9e-41  Score=341.90  Aligned_cols=247  Identities=20%  Similarity=0.277  Sum_probs=185.7

Q ss_pred             hcCCCCC-ceecccCcEEEEEEEeC-CCcEEEEEEEeccchhhHHHHHHHHHHHHHH-hhcCCCCcceeeeeeec-----
Q 012765          141 TDNFNSE-NLIGKGGHAEVYKGCLP-DGEVVAVKKIIKNAKEDEERISDFLSELGIV-AHINHPNAAKLIGFSTE-----  212 (457)
Q Consensus       141 ~~~f~~~-~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l-~~l~hpniv~l~~~~~~-----  212 (457)
                      .++|.+. ++||+|+||+||+|.+. +++.||||++...        ..+.+|+.++ +..+||||+++++++..     
T Consensus        60 ~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~--------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~  131 (400)
T 1nxk_A           60 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYENLYAGR  131 (400)
T ss_dssp             GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTE
T ss_pred             cccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc--------hhHHHHHHHHHHhcCCCCcceEeEEEeecccCC
Confidence            3556665 68999999999999865 6899999998532        2456788877 44589999999996643     


Q ss_pred             CceEEEEEecCCCChhhhhhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcC---CCcEEEeec
Q 012765          213 NGFHLVLQFLPHGSLSSLLFGST-ECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSE---DYEAQISDF  288 (457)
Q Consensus       213 ~~~~lv~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~---~~~~kL~DF  288 (457)
                      ..+++||||+.+|+|.+++.... ..+++..+..|+.||+.||.|||+   .+|+||||||+|||++.   ++.+||+||
T Consensus       132 ~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~~~~kl~DF  208 (400)
T 1nxk_A          132 KCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDF  208 (400)
T ss_dssp             EEEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSTTCCEEECCC
T ss_pred             cEEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCcCcceEEEecCCCCccEEEEec
Confidence            34789999999999999997643 468999999999999999999999   89999999999999997   788999999


Q ss_pred             cccccCCCCCCceeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchh---hhhccccccCC
Q 012765          289 GLAKWLPDNWSHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLV---IWAKPLLQTSN  365 (457)
Q Consensus       289 Gl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~---~~~~~~~~~~~  365 (457)
                      |+++......   ......||+.|+|||++.+..|+.++|||||||++|||++|+.||........   ...........
T Consensus       209 G~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~~  285 (400)
T 1nxk_A          209 GFAKETTSHN---SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYE  285 (400)
T ss_dssp             TTCEECC--------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCCC
T ss_pred             ccccccCCCC---ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCccc
Confidence            9998765432   22345689999999999999999999999999999999999999976432210   00000000000


Q ss_pred             cccccCchhhcccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 012765          366 FKELVDPRLADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQ  409 (457)
Q Consensus       366 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~  409 (457)
                      +   ..+.. .    .....+.+++.+||+.||.+|||+.||++
T Consensus       286 ~---~~~~~-~----~~s~~~~~li~~~L~~dP~~Rpt~~eil~  321 (400)
T 1nxk_A          286 F---PNPEW-S----EVSEEVKMLIRNLLKTEPTQRMTITEFMN  321 (400)
T ss_dssp             C---CTTTT-T----TSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             C---CCccc-c----cCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence            0   00000 1    12245678899999999999999999998

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=1.5e-41  Score=337.50  Aligned_cols=264  Identities=21%  Similarity=0.283  Sum_probs=198.3

Q ss_pred             hcCCCCCceecccCcEEEEEEEe-CCCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeec-------
Q 012765          141 TDNFNSENLIGKGGHAEVYKGCL-PDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTE-------  212 (457)
Q Consensus       141 ~~~f~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-------  212 (457)
                      .++|.+.+.||+|+||+||+|.+ .+|+.||+|++....... .....+.+|+.+++.++||||+++++++..       
T Consensus        16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   94 (351)
T 3mi9_A           16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKE-GFPITALREIKILQLLKHENVVNLIEICRTKASPYNR   94 (351)
T ss_dssp             GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSS-SSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC------
T ss_pred             ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccc-cchHHHHHHHHHHHhccCCCcccHhheeecccccccc
Confidence            36788999999999999999987 478999999886543322 223467899999999999999999997654       


Q ss_pred             --CceEEEEEecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccc
Q 012765          213 --NGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGL  290 (457)
Q Consensus       213 --~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl  290 (457)
                        +..++||||+.+ +|...+......+++..++.++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||+
T Consensus        95 ~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~---~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~  170 (351)
T 3mi9_A           95 CKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHR---NKILHRDMKAANVLITRDGVLKLADFGL  170 (351)
T ss_dssp             --CEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred             CCceEEEEEeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCHHHEEEcCCCCEEEccchh
Confidence              246899999975 7777776666779999999999999999999999   8999999999999999999999999999


Q ss_pred             cccCCCCCC--ceeeecccccccccChhcccc-CCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhcccc----cc
Q 012765          291 AKWLPDNWS--HHIVFPIEGTFGYLSPEYFMH-GIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLL----QT  363 (457)
Q Consensus       291 ~~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~~~~----~~  363 (457)
                      +..+.....  ........||+.|+|||++.+ ..++.++|||||||++|||++|+.||...............    ..
T Consensus       171 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~  250 (351)
T 3mi9_A          171 ARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITP  250 (351)
T ss_dssp             CEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCT
T ss_pred             cccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCh
Confidence            987643221  122234568999999999876 45899999999999999999999999875433211100000    00


Q ss_pred             CCcccc--------cCchhhcccC-HH------HHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 012765          364 SNFKEL--------VDPRLADAYD-LA------EMKRAMLTASVCIHHLSTMRPQMTRVLQ  409 (457)
Q Consensus       364 ~~~~~~--------~d~~l~~~~~-~~------~~~~l~~l~~~Cl~~dP~~RPt~~evl~  409 (457)
                      .....+        +......... ..      ....+.+++.+||+.||.+|||+.|+++
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  311 (351)
T 3mi9_A          251 EVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN  311 (351)
T ss_dssp             TTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             hhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhC
Confidence            000000        0000000000 01      1234778999999999999999999987

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=5.2e-42  Score=341.23  Aligned_cols=260  Identities=16%  Similarity=0.181  Sum_probs=199.3

Q ss_pred             hcCCCCCceecccCcEEEEEEEeCC---------CcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcce------
Q 012765          141 TDNFNSENLIGKGGHAEVYKGCLPD---------GEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAK------  205 (457)
Q Consensus       141 ~~~f~~~~~LG~G~~g~Vy~~~~~~---------~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~------  205 (457)
                      .++|.+.+.||+|+||.||+|.+..         ++.||+|.+...        ..+.+|+.++.+++||||++      
T Consensus        41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~--------~~~~~E~~~l~~l~h~niv~~~~~~~  112 (352)
T 2jii_A           41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD--------GRLFNEQNFFQRAAKPLQVNKWKKLY  112 (352)
T ss_dssp             SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT--------STHHHHHHHHHHHCCHHHHHHHHHHT
T ss_pred             CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc--------chHHHHHHHHHHhcccchhhhhhhhc
Confidence            3678899999999999999998753         789999998643        25778999999999999998      


Q ss_pred             ---------eeeeee--cCceEEEEEecCCCChhhhhhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCC
Q 012765          206 ---------LIGFST--ENGFHLVLQFLPHGSLSSLLFGS-TECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKAS  273 (457)
Q Consensus       206 ---------l~~~~~--~~~~~lv~e~~~~gsL~~~l~~~-~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~  273 (457)
                               +++++.  +...++||||+ +++|.+++... ...+++..++.++.||+.||.|||+   .+|+||||||+
T Consensus       113 ~~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dikp~  188 (352)
T 2jii_A          113 STPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHE---NEYVHGNVTAE  188 (352)
T ss_dssp             TCTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCCGG
T ss_pred             cCCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCCHH
Confidence                     455554  35578999999 99999999754 3569999999999999999999999   89999999999


Q ss_pred             cEEEcCCC--cEEEeeccccccCCCCCCc-----eeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHhCCCCC
Q 012765          274 NILLSEDY--EAQISDFGLAKWLPDNWSH-----HIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAV  346 (457)
Q Consensus       274 NIll~~~~--~~kL~DFGl~~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLltG~~pf  346 (457)
                      |||++.++  .+||+|||+++.+......     .......||+.|+|||++.+..++.++|||||||++|||++|+.||
T Consensus       189 NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf  268 (352)
T 2jii_A          189 NIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPW  268 (352)
T ss_dssp             GEEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTT
T ss_pred             HEEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCc
Confidence            99999998  8999999999876432211     1123346999999999999999999999999999999999999999


Q ss_pred             CcCCcchhhh--hccccccCCcccccCchhhcccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCCC
Q 012765          347 DSRRQSLVIW--AKPLLQTSNFKELVDPRLADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQLLRGEGG  416 (457)
Q Consensus       347 ~~~~~~~~~~--~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~  416 (457)
                      ..........  ..... ......+.+......   .....+.+++.+||+.||.+||++.+|++.|+.+..
T Consensus       269 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~---~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~  336 (352)
T 2jii_A          269 TNCLPNTEDIMKQKQKF-VDKPGPFVGPCGHWI---RPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQ  336 (352)
T ss_dssp             GGGTTCHHHHHHHHHHH-HHSCCCEECTTSCEE---CCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHH
T ss_pred             ccCCcCHHHHHHHHHhc-cCChhhhhhhccccC---CCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHH
Confidence            8643111111  00000 001111111111100   112456778889999999999999999999987643

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=1.2e-41  Score=339.49  Aligned_cols=259  Identities=23%  Similarity=0.323  Sum_probs=198.5

Q ss_pred             hcCCCCCceecccCcEEEEEEEeC-CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeec-CceEEE
Q 012765          141 TDNFNSENLIGKGGHAEVYKGCLP-DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTE-NGFHLV  218 (457)
Q Consensus       141 ~~~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-~~~~lv  218 (457)
                      .++|.+.+.||+|+||+||+|.+. +++.||+|++.....  ......+.+|+.+++.++||||+++++++.. +..++|
T Consensus        32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  109 (360)
T 3eqc_A           32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIK--PAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISIC  109 (360)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCC--HHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEE
T ss_pred             cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccC--HHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEE
Confidence            467889999999999999999875 689999999865432  3445689999999999999999999996655 457899


Q ss_pred             EEecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCC-CeeeCCCCCCcEEEcCCCcEEEeeccccccCCCC
Q 012765          219 LQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHR-RIIHRDIKASNILLSEDYEAQISDFGLAKWLPDN  297 (457)
Q Consensus       219 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~-~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~~  297 (457)
                      |||+++++|.+++... ..+++..+..++.|++.||.|||+   . +|+||||||+|||++.++.+||+|||++......
T Consensus       110 ~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~~i~~~l~~lh~---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  185 (360)
T 3eqc_A          110 MEHMDGGSLDQVLKKA-GRIPEQILGKVSIAVIKGLTYLRE---KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS  185 (360)
T ss_dssp             ECCCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHH---HHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH
T ss_pred             EECCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHH---hCCEEcCCccHHHEEECCCCCEEEEECCCCcccccc
Confidence            9999999999998653 358899999999999999999998   5 8999999999999999999999999998755322


Q ss_pred             CCceeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhccccccC-------------
Q 012765          298 WSHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTS-------------  364 (457)
Q Consensus       298 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~~~~~~~-------------  364 (457)
                      .    .....||+.|+|||++.+..++.++|||||||++|+|++|+.||..................             
T Consensus       186 ~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  261 (360)
T 3eqc_A          186 M----ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPG  261 (360)
T ss_dssp             C--------CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC------------------
T ss_pred             c----ccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCC
Confidence            1    22345899999999999999999999999999999999999999864433221111000000             


Q ss_pred             --------------CcccccCchhh----cccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 012765          365 --------------NFKELVDPRLA----DAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQ  409 (457)
Q Consensus       365 --------------~~~~~~d~~l~----~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~  409 (457)
                                    ...++++....    ..........+.+++.+||+.||.+|||+.|+++
T Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  324 (360)
T 3eqc_A          262 RPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV  324 (360)
T ss_dssp             ------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred             CcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence                          00000000000    0000012335778899999999999999999986

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=2.3e-41  Score=334.38  Aligned_cols=250  Identities=24%  Similarity=0.328  Sum_probs=202.4

Q ss_pred             hcCCCCCceecccCcEEEEEEEeC-CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeecCc-eEEE
Q 012765          141 TDNFNSENLIGKGGHAEVYKGCLP-DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTENG-FHLV  218 (457)
Q Consensus       141 ~~~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~-~~lv  218 (457)
                      .++|.+.+.||+|+||.||++.+. +++.||+|.+.............+.+|+.+++.++||||+++++++.+.+ .+++
T Consensus        40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  119 (335)
T 2owb_A           40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV  119 (335)
T ss_dssp             TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence            467888999999999999999875 58899999987654444455678999999999999999999999776655 6799


Q ss_pred             EEecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCCCCC
Q 012765          219 LQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNW  298 (457)
Q Consensus       219 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~~~  298 (457)
                      |||+.+++|.+++... ..+++..++.++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||++.......
T Consensus       120 ~e~~~~~~L~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~  195 (335)
T 2owb_A          120 LELCRRRSLLELHKRR-KALTEPEARYYLRQIVLGCQYLHR---NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG  195 (335)
T ss_dssp             ECCCTTCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred             EecCCCCCHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHH---CCCEecCCCchhEEEcCCCCEEEeeccCceecccCc
Confidence            9999999999988543 458999999999999999999999   899999999999999999999999999998765332


Q ss_pred             CceeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhccccccCCcccccCchhhccc
Q 012765          299 SHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSNFKELVDPRLADAY  378 (457)
Q Consensus       299 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~  378 (457)
                      ..  .....||..|+|||++.+..++.++||||||+++|+|++|+.||......... .........        +...+
T Consensus       196 ~~--~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~-~~~~~~~~~--------~~~~~  264 (335)
T 2owb_A          196 ER--KKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETY-LRIKKNEYS--------IPKHI  264 (335)
T ss_dssp             CC--BCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHH-HHHHHTCCC--------CCTTS
T ss_pred             cc--ccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHH-HHHhcCCCC--------CCccC
Confidence            21  22355899999999999989999999999999999999999999864322111 100000001        11112


Q ss_pred             CHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 012765          379 DLAEMKRAMLTASVCIHHLSTMRPQMTRVLQ  409 (457)
Q Consensus       379 ~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~  409 (457)
                      +    ..+.+++.+||+.||++|||+.|+++
T Consensus       265 ~----~~~~~li~~~l~~dp~~Rps~~ell~  291 (335)
T 2owb_A          265 N----PVAASLIQKMLQTDPTARPTINELLN  291 (335)
T ss_dssp             C----HHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred             C----HHHHHHHHHHccCChhHCcCHHHHhc
Confidence            2    34667889999999999999999987

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=1.7e-41  Score=334.64  Aligned_cols=262  Identities=23%  Similarity=0.363  Sum_probs=196.4

Q ss_pred             hcCCCCCceecccCcEEEEEEEeC-CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeecCc-eEEE
Q 012765          141 TDNFNSENLIGKGGHAEVYKGCLP-DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTENG-FHLV  218 (457)
Q Consensus       141 ~~~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~-~~lv  218 (457)
                      .++|.+.+.||+|+||.||+|.+. +|+.||+|++..... .......+.+|+.+++.++||||+++++++.+.. .++|
T Consensus        24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  102 (331)
T 4aaa_A           24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDD-DKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLV  102 (331)
T ss_dssp             GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSS-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred             hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCC-chHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEE
Confidence            467889999999999999999875 589999998865433 3344567889999999999999999999766554 6899


Q ss_pred             EEecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCCCCC
Q 012765          219 LQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNW  298 (457)
Q Consensus       219 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~~~  298 (457)
                      |||+.+++|..++.. ...+++..++.++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||++..+....
T Consensus       103 ~e~~~~~~l~~~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  178 (331)
T 4aaa_A          103 FEFVDHTILDDLELF-PNGLDYQVVQKYLFQIINGIGFCHS---HNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG  178 (331)
T ss_dssp             EECCSEEHHHHHHHS-TTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCTTC-------
T ss_pred             EecCCcchHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHHH---CCEEccCcChheEEEcCCCcEEEEeCCCceeecCCc
Confidence            999999988877643 3458999999999999999999999   899999999999999999999999999998664432


Q ss_pred             CceeeecccccccccChhccccC-CCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhc------------------c
Q 012765          299 SHHIVFPIEGTFGYLSPEYFMHG-IVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAK------------------P  359 (457)
Q Consensus       299 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~------------------~  359 (457)
                      .  ......||+.|+|||++.+. .++.++|||||||++|+|++|+.||............                  +
T Consensus       179 ~--~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  256 (331)
T 4aaa_A          179 E--VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNP  256 (331)
T ss_dssp             -------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCG
T ss_pred             c--ccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhcc
Confidence            1  12334589999999999875 7899999999999999999999999865432211110                  0


Q ss_pred             ccccCCcccccCchhhcccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 012765          360 LLQTSNFKELVDPRLADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQ  409 (457)
Q Consensus       360 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~  409 (457)
                      .........+................+.+++.+||+.||.+|||+.|+++
T Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~  306 (331)
T 4aaa_A          257 VFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLH  306 (331)
T ss_dssp             GGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred             ccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhc
Confidence            00111111111111100011122456788999999999999999999876

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=2.8e-41  Score=324.05  Aligned_cols=250  Identities=24%  Similarity=0.283  Sum_probs=197.4

Q ss_pred             hhcCCCCCceecccCcEEEEEEEeC-CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeecCc-eEE
Q 012765          140 ATDNFNSENLIGKGGHAEVYKGCLP-DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTENG-FHL  217 (457)
Q Consensus       140 ~~~~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~-~~l  217 (457)
                      ..++|.+.+.||+|+||+||+|.+. ++..+|+|++.......   ...+.+|+.+++.++||||+++++++.+.. .++
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l   83 (277)
T 3f3z_A            7 INQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVED---VDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYL   83 (277)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSC---HHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred             hhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccch---HHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEE
Confidence            4567889999999999999999875 47789999987544332   357889999999999999999999776554 689


Q ss_pred             EEEecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEE---cCCCcEEEeeccccccC
Q 012765          218 VLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILL---SEDYEAQISDFGLAKWL  294 (457)
Q Consensus       218 v~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll---~~~~~~kL~DFGl~~~~  294 (457)
                      ||||+++++|.+++... ..+++..++.++.|++.||.|||+   .+|+||||||+||++   +.++.+||+|||++...
T Consensus        84 v~e~~~~~~L~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~  159 (277)
T 3f3z_A           84 VMELCTGGELFERVVHK-RVFRESDAARIMKDVLSAVAYCHK---LNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARF  159 (277)
T ss_dssp             EEECCCSCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESSSSTTCCEEECCCTTCEEC
T ss_pred             EEeccCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHH---CCccCCCCCHHHEEEecCCCCCcEEEEecccceec
Confidence            99999999999988553 448999999999999999999999   899999999999999   78889999999999876


Q ss_pred             CCCCCceeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhccccccCCcccccCchh
Q 012765          295 PDNWSHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSNFKELVDPRL  374 (457)
Q Consensus       295 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l  374 (457)
                      .....   .....||+.|+|||++.+ .++.++||||||+++|+|++|+.||............. ......    ....
T Consensus       160 ~~~~~---~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~-~~~~~~----~~~~  230 (277)
T 3f3z_A          160 KPGKM---MRTKVGTPYYVSPQVLEG-LYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIR-EGTFTF----PEKD  230 (277)
T ss_dssp             CTTSC---BCCCCSCTTTCCHHHHTT-CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH-HCCCCC----CHHH
T ss_pred             cCccc---hhccCCCCCccChHHhcc-cCCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHH-hCCCCC----Cchh
Confidence            54322   223459999999998865 48999999999999999999999998644322211110 000000    0000


Q ss_pred             hcccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 012765          375 ADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQ  409 (457)
Q Consensus       375 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~  409 (457)
                      ...    ....+.+++.+||+.||.+|||+.++++
T Consensus       231 ~~~----~~~~~~~li~~~l~~dp~~R~s~~~~l~  261 (277)
T 3f3z_A          231 WLN----VSPQAESLIRRLLTKSPKQRITSLQALE  261 (277)
T ss_dssp             HTT----SCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             hhc----CCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            011    1245677889999999999999999976

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=1.2e-40  Score=324.08  Aligned_cols=259  Identities=18%  Similarity=0.207  Sum_probs=199.5

Q ss_pred             hhcCCCCCceecccCcEEEEEEEeC-CCcEEEEEEEeccchhh-HHHHHHHHHHHHHHhhcCCCCcceeeeeee---cCc
Q 012765          140 ATDNFNSENLIGKGGHAEVYKGCLP-DGEVVAVKKIIKNAKED-EERISDFLSELGIVAHINHPNAAKLIGFST---ENG  214 (457)
Q Consensus       140 ~~~~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~---~~~  214 (457)
                      ..++|.+.+.||+|+||.||+|.+. +++.||+|.+....... ......+.+|+.+++.++||||+++++++.   ...
T Consensus         3 l~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   82 (305)
T 2wtk_C            3 LIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQK   82 (305)
T ss_dssp             --CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---C
T ss_pred             cccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCe
Confidence            3478999999999999999999864 68899999986532211 123567999999999999999999999763   235


Q ss_pred             eEEEEEecCCCChhhhhhc-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeecccccc
Q 012765          215 FHLVLQFLPHGSLSSLLFG-STECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKW  293 (457)
Q Consensus       215 ~~lv~e~~~~gsL~~~l~~-~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~  293 (457)
                      .++||||+.++ |.+++.. ....+++..++.++.||+.||.|||+   .+|+||||||+||+++.++.+||+|||++..
T Consensus        83 ~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~---~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~  158 (305)
T 2wtk_C           83 MYMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHS---QGIVHKDIKPGNLLLTTGGTLKISALGVAEA  158 (305)
T ss_dssp             EEEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred             EEEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCcccEEEcCCCcEEeeccccccc
Confidence            78999999887 6666643 34568999999999999999999999   8999999999999999999999999999987


Q ss_pred             CCCCCCceeeecccccccccChhccccCC--CCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhccccccCCcccccC
Q 012765          294 LPDNWSHHIVFPIEGTFGYLSPEYFMHGI--VDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSNFKELVD  371 (457)
Q Consensus       294 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d  371 (457)
                      ..............||+.|+|||++.+..  ++.++||||||+++|||++|..||...........   .....      
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~---i~~~~------  229 (305)
T 2wtk_C          159 LHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFEN---IGKGS------  229 (305)
T ss_dssp             CCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH---HHHCC------
T ss_pred             cCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHH---HhcCC------
Confidence            75443333344566999999999987644  47899999999999999999999986442211100   00000      


Q ss_pred             chhhcccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH--HHhcCC
Q 012765          372 PRLADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQ--LLRGEG  415 (457)
Q Consensus       372 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~--~L~~~~  415 (457)
                      ..+...+    ...+.+++.+||+.||.+|||+.++++  .++...
T Consensus       230 ~~~~~~~----~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~  271 (305)
T 2wtk_C          230 YAIPGDC----GPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKH  271 (305)
T ss_dssp             CCCCSSS----CHHHHHHHHHHTCSSTTTSCCHHHHHHSHHHHSCC
T ss_pred             CCCCCcc----CHHHHHHHHHHccCChhhCCCHHHHhcCcccccCC
Confidence            0111122    235667889999999999999999997  455443

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=1.9e-41  Score=326.01  Aligned_cols=245  Identities=22%  Similarity=0.283  Sum_probs=194.4

Q ss_pred             hhcCCCCCceecccCcEEEEEEEeC-CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhc-CCCCcceeeeeeec-CceE
Q 012765          140 ATDNFNSENLIGKGGHAEVYKGCLP-DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHI-NHPNAAKLIGFSTE-NGFH  216 (457)
Q Consensus       140 ~~~~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~-~~~~  216 (457)
                      ..++|.+.+.||+|+||+||+|.+. +++.||+|++....... .....+.+|+..+..+ +||||+++++++.+ +..+
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~   87 (289)
T 1x8b_A            9 YTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGS-VDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHML   87 (289)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTS-HHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEE
T ss_pred             ccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEeccccccc-HHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEE
Confidence            4577899999999999999999875 79999999987643333 2356788999999999 99999999997655 4568


Q ss_pred             EEEEecCCCChhhhhhcC---CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCC-------------
Q 012765          217 LVLQFLPHGSLSSLLFGS---TECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSED-------------  280 (457)
Q Consensus       217 lv~e~~~~gsL~~~l~~~---~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~-------------  280 (457)
                      +||||+++++|.+++...   ...+++..++.++.||+.||.|||+   .+|+||||||+|||++.+             
T Consensus        88 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~  164 (289)
T 1x8b_A           88 IQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHS---MSLVHMDIKPSNIFISRTSIPNAASEEGDED  164 (289)
T ss_dssp             EEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEC---------------
T ss_pred             EEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHh---CCEeecCCCHHHEEEcCCCCCcccccccccc
Confidence            999999999999998543   2568999999999999999999999   899999999999999844             


Q ss_pred             ------CcEEEeeccccccCCCCCCceeeecccccccccChhccccC-CCCcchhHHHHHHHHHHHHhCCCCCCcCCcch
Q 012765          281 ------YEAQISDFGLAKWLPDNWSHHIVFPIEGTFGYLSPEYFMHG-IVDEKTDVFAFGVLLLELITGRRAVDSRRQSL  353 (457)
Q Consensus       281 ------~~~kL~DFGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~  353 (457)
                            ..+||+|||++.......      ...||+.|+|||++.+. .++.++|||||||++|+|++|..++.......
T Consensus       165 ~~~~~~~~~kl~Dfg~~~~~~~~~------~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~  238 (289)
T 1x8b_A          165 DWASNKVMFKIGDLGHVTRISSPQ------VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQWH  238 (289)
T ss_dssp             -----CCCEEECCCTTCEETTCSC------CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHHHH
T ss_pred             cccCCceEEEEcccccccccCCcc------ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhHHH
Confidence                  479999999998775432      23489999999999766 56789999999999999999998775432111


Q ss_pred             hhhhccccccCCcccccCchhhcccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 012765          354 VIWAKPLLQTSNFKELVDPRLADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQ  409 (457)
Q Consensus       354 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~  409 (457)
                      .. .     ...     .+.+...++    ..+.+++.+||+.||++|||+.++++
T Consensus       239 ~~-~-----~~~-----~~~~~~~~~----~~~~~li~~~l~~dp~~Rps~~~ll~  279 (289)
T 1x8b_A          239 EI-R-----QGR-----LPRIPQVLS----QEFTELLKVMIHPDPERRPSAMALVK  279 (289)
T ss_dssp             HH-H-----TTC-----CCCCSSCCC----HHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             HH-H-----cCC-----CCCCCcccC----HHHHHHHHHHhCCCcccCCCHHHHhh
Confidence            10 0     010     011112222    35677889999999999999999986

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=4e-42  Score=330.10  Aligned_cols=255  Identities=22%  Similarity=0.336  Sum_probs=200.4

Q ss_pred             hcCCCCCceecccCcEEEEEEEeC-CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeee---cCceE
Q 012765          141 TDNFNSENLIGKGGHAEVYKGCLP-DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFST---ENGFH  216 (457)
Q Consensus       141 ~~~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~---~~~~~  216 (457)
                      .++|++.+.||+|+||.||+|... +++.||+|.+...... ......+.+|+.++++++||||+++++++.   ....+
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   83 (279)
T 2w5a_A            5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMT-EAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLY   83 (279)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEE
T ss_pred             hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCC-HHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEE
Confidence            467889999999999999999875 6899999998754332 344668999999999999999999999653   34578


Q ss_pred             EEEEecCCCChhhhhhc---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC-----eeeCCCCCCcEEEcCCCcEEEeec
Q 012765          217 LVLQFLPHGSLSSLLFG---STECLEWTIRYKIALGIAEGLQYLHHDCHRR-----IIHRDIKASNILLSEDYEAQISDF  288 (457)
Q Consensus       217 lv~e~~~~gsL~~~l~~---~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~-----iiHrDlkp~NIll~~~~~~kL~DF  288 (457)
                      +||||+++++|.+++..   ....+++..++.++.||+.||.|||+   .+     |+||||||+||+++.++.+||+||
T Consensus        84 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~~~~~~ivH~dl~p~NIl~~~~~~~kl~df  160 (279)
T 2w5a_A           84 IVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHR---RSDGGHTVLHRDLKPANVFLDGKQNVKLGDF  160 (279)
T ss_dssp             EEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH---HC------CCCCCSGGGEEECSSSCEEECCC
T ss_pred             EEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhc---ccCCCCeeEEeccchhhEEEcCCCCEEEecC
Confidence            99999999999999854   33458999999999999999999999   67     999999999999999999999999


Q ss_pred             cccccCCCCCCceeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhccccccCCccc
Q 012765          289 GLAKWLPDNWSHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSNFKE  368 (457)
Q Consensus       289 Gl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~  368 (457)
                      |++........  ......||..|+|||++.+..++.++||||||+++|+|++|+.||...........   ......  
T Consensus       161 g~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~---i~~~~~--  233 (279)
T 2w5a_A          161 GLARILNHDTS--FAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGK---IREGKF--  233 (279)
T ss_dssp             CHHHHC---CH--HHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH---HHHTCC--
T ss_pred             chheeeccccc--cccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHH---Hhhccc--
Confidence            99987654321  11234589999999999998999999999999999999999999986543221110   000100  


Q ss_pred             ccCchhhcccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 012765          369 LVDPRLADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQLLRG  413 (457)
Q Consensus       369 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~  413 (457)
                         +.+...+    ...+.+++.+||+.||.+||++.||++.+..
T Consensus       234 ---~~~~~~~----~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~  271 (279)
T 2w5a_A          234 ---RRIPYRY----SDELNEIITRMLNLKDYHRPSVEEILENPLI  271 (279)
T ss_dssp             ---CCCCTTS----CHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred             ---ccCCccc----CHHHHHHHHHHcCCCcccCCCHHHHHhChhh
Confidence               0111122    2456788899999999999999999986643

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=9.1e-41  Score=334.20  Aligned_cols=259  Identities=25%  Similarity=0.353  Sum_probs=202.5

Q ss_pred             HHHHHhhcCCCCCceecccCcEEEEEEEeC-CCcEEEEEEEeccch-----hhHHHHHHHHHHHHHHhhc-CCCCcceee
Q 012765          135 AELAAATDNFNSENLIGKGGHAEVYKGCLP-DGEVVAVKKIIKNAK-----EDEERISDFLSELGIVAHI-NHPNAAKLI  207 (457)
Q Consensus       135 ~~~~~~~~~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-----~~~~~~~~~~~E~~~l~~l-~hpniv~l~  207 (457)
                      .......++|.+.+.||+|+||.||+|.+. +|+.||||++.....     ........+.+|+.++.++ +||||++++
T Consensus        87 ~~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~  166 (365)
T 2y7j_A           87 AAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLI  166 (365)
T ss_dssp             HHHHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEE
T ss_pred             hhhhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEE
Confidence            344556688999999999999999999875 699999998865431     1223356788999999999 799999999


Q ss_pred             eeeecC-ceEEEEEecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEe
Q 012765          208 GFSTEN-GFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQIS  286 (457)
Q Consensus       208 ~~~~~~-~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~  286 (457)
                      +++... ..++||||+.+++|.+++... ..+++..+..++.||+.||.|||+   .+|+||||||+|||++.++.+||+
T Consensus       167 ~~~~~~~~~~lv~e~~~g~~L~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH~---~gi~H~Dlkp~NIl~~~~~~ikl~  242 (365)
T 2y7j_A          167 DSYESSSFMFLVFDLMRKGELFDYLTEK-VALSEKETRSIMRSLLEAVSFLHA---NNIVHRDLKPENILLDDNMQIRLS  242 (365)
T ss_dssp             EEEEBSSEEEEEECCCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEEC
T ss_pred             EEEeeCCEEEEEEEeCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEEE
Confidence            976654 468999999999999998643 458999999999999999999999   899999999999999999999999


Q ss_pred             eccccccCCCCCCceeeecccccccccChhcccc------CCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhccc
Q 012765          287 DFGLAKWLPDNWSHHIVFPIEGTFGYLSPEYFMH------GIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPL  360 (457)
Q Consensus       287 DFGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~~~  360 (457)
                      |||++..+.....   .....||+.|+|||++.+      ..++.++|||||||++|+|++|..||............  
T Consensus       243 DfG~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i--  317 (365)
T 2y7j_A          243 DFGFSCHLEPGEK---LRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMI--  317 (365)
T ss_dssp             CCTTCEECCTTCC---BCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH--
T ss_pred             ecCcccccCCCcc---cccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHH--
Confidence            9999987754422   234569999999999863      35889999999999999999999999764332211100  


Q ss_pred             cccCCcccccCchhhcccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 012765          361 LQTSNFKELVDPRLADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQ  409 (457)
Q Consensus       361 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~  409 (457)
                       ..... ....+. ...    ....+.+++.+||+.||.+|||+.++++
T Consensus       318 -~~~~~-~~~~~~-~~~----~~~~~~~li~~~L~~dP~~Rps~~ell~  359 (365)
T 2y7j_A          318 -MEGQY-QFSSPE-WDD----RSSTVKDLISRLLQVDPEARLTAEQALQ  359 (365)
T ss_dssp             -HHTCC-CCCHHH-HSS----SCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             -HhCCC-CCCCcc-ccc----CCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence             00000 000000 011    1234677899999999999999999987

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=1.9e-41  Score=332.77  Aligned_cols=255  Identities=24%  Similarity=0.353  Sum_probs=196.2

Q ss_pred             hhcCCCCCceecccCcEEEEEEEeC-CCcEEEEEEEeccch-----hhHHHHHHHHHHHHHHhhcCCCCcceeeeeeecC
Q 012765          140 ATDNFNSENLIGKGGHAEVYKGCLP-DGEVVAVKKIIKNAK-----EDEERISDFLSELGIVAHINHPNAAKLIGFSTEN  213 (457)
Q Consensus       140 ~~~~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-----~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~  213 (457)
                      ..++|.+.+.||+|+||.||+|.+. +++.||||.+.....     ........+.+|+.+++.++||||+++++++..+
T Consensus         8 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~   87 (322)
T 2ycf_A            8 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE   87 (322)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS
T ss_pred             hhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC
Confidence            4577999999999999999999865 588999998865322     1122334688999999999999999999999888


Q ss_pred             ceEEEEEecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCc---EEEeeccc
Q 012765          214 GFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYE---AQISDFGL  290 (457)
Q Consensus       214 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~---~kL~DFGl  290 (457)
                      ..++||||+++++|.+++.. ...+++..++.++.||+.||.|||+   .+|+||||||+|||++.++.   +||+|||+
T Consensus        88 ~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~  163 (322)
T 2ycf_A           88 DYYIVLELMEGGELFDKVVG-NKRLKEATCKLYFYQMLLAVQYLHE---NGIIHRDLKPENVLLSSQEEDCLIKITDFGH  163 (322)
T ss_dssp             SEEEEEECCTTEETHHHHST-TCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESSSSSSCCEEECCCTT
T ss_pred             ceEEEEecCCCCcHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEEecCCCCCeEEEccCcc
Confidence            89999999999999998854 3468999999999999999999999   89999999999999987654   99999999


Q ss_pred             cccCCCCCCceeeecccccccccChhccc---cCCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhccccccCCcc
Q 012765          291 AKWLPDNWSHHIVFPIEGTFGYLSPEYFM---HGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSNFK  367 (457)
Q Consensus       291 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~  367 (457)
                      +.......   ......||+.|+|||++.   ...++.++|||||||++|+|++|..||............  ...... 
T Consensus       164 ~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~--~~~~~~-  237 (322)
T 2ycf_A          164 SKILGETS---LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQ--ITSGKY-  237 (322)
T ss_dssp             CEECCCCH---HHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHH--HHHTCC-
T ss_pred             ceeccccc---ccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHH--HHhCcc-
Confidence            98765431   122345899999999974   567899999999999999999999999764322111000  000000 


Q ss_pred             cccCchhhcccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 012765          368 ELVDPRLADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQ  409 (457)
Q Consensus       368 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~  409 (457)
                       ...+.....    ....+.+++.+||+.||.+||++.++++
T Consensus       238 -~~~~~~~~~----~~~~~~~li~~~l~~dP~~Rps~~~~l~  274 (322)
T 2ycf_A          238 -NFIPEVWAE----VSEKALDLVKKLLVVDPKARFTTEEALR  274 (322)
T ss_dssp             -CCCHHHHTT----SCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             -ccCchhhhh----cCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence             001111111    2345678899999999999999999875

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=3.5e-41  Score=352.22  Aligned_cols=253  Identities=24%  Similarity=0.322  Sum_probs=200.0

Q ss_pred             hcCCCCCceecccCcEEEEEEEeC-CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeec-CceEEE
Q 012765          141 TDNFNSENLIGKGGHAEVYKGCLP-DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTE-NGFHLV  218 (457)
Q Consensus       141 ~~~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-~~~~lv  218 (457)
                      .++|.+.++||+|+||+||+|.+. +|+.||+|++.+...........+.+|+.+++.++||||+++++++.. ..+++|
T Consensus       184 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV  263 (543)
T 3c4z_A          184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLV  263 (543)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEE
Confidence            377888899999999999999875 699999999865433322335678899999999999999999986554 557899


Q ss_pred             EEecCCCChhhhhhcC---CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCC
Q 012765          219 LQFLPHGSLSSLLFGS---TECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLP  295 (457)
Q Consensus       219 ~e~~~~gsL~~~l~~~---~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~  295 (457)
                      |||+++|+|..++...   ...+++..++.++.||+.||.|||+   .+|+||||||+|||++.+|.+||+|||+++.+.
T Consensus       264 mE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~---~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~  340 (543)
T 3c4z_A          264 MTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQ---RNIIYRDLKPENVLLDDDGNVRISDLGLAVELK  340 (543)
T ss_dssp             ECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred             EEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHH---cCCcccCCChHHEEEeCCCCEEEeecceeeecc
Confidence            9999999999998653   3468999999999999999999999   899999999999999999999999999998775


Q ss_pred             CCCCceeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHhCCCCCCcCCcch--hhhhccccccCCcccccCch
Q 012765          296 DNWSHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSL--VIWAKPLLQTSNFKELVDPR  373 (457)
Q Consensus       296 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~--~~~~~~~~~~~~~~~~~d~~  373 (457)
                      .....  .....||+.|+|||++.+..|+.++|||||||++|||++|+.||.......  ...........       ..
T Consensus       341 ~~~~~--~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~~-------~~  411 (543)
T 3c4z_A          341 AGQTK--TKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQA-------VT  411 (543)
T ss_dssp             TTCCC--BCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHCC-------CC
T ss_pred             CCCcc--cccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhcc-------cC
Confidence            54322  223469999999999999999999999999999999999999998643211  11111000000       00


Q ss_pred             hhcccCHHHHHHHHHHHHHhcccCCCCCCCH-----HHHHH
Q 012765          374 LADAYDLAEMKRAMLTASVCIHHLSTMRPQM-----TRVLQ  409 (457)
Q Consensus       374 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~-----~evl~  409 (457)
                      ....    ....+..++.+||+.||.+||++     .+|++
T Consensus       412 ~p~~----~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~  448 (543)
T 3c4z_A          412 YPDK----FSPASKDFCEALLQKDPEKRLGFRDGSCDGLRT  448 (543)
T ss_dssp             CCTT----SCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHT
T ss_pred             CCcc----cCHHHHHHHHHhccCCHhHCCCCcccCHHHHHc
Confidence            1111    22356678889999999999976     55654

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=5e-41  Score=324.65  Aligned_cols=248  Identities=23%  Similarity=0.361  Sum_probs=195.3

Q ss_pred             cCCCCCceecccCcEEEEEEEeC-CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeec-----Cce
Q 012765          142 DNFNSENLIGKGGHAEVYKGCLP-DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTE-----NGF  215 (457)
Q Consensus       142 ~~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-----~~~  215 (457)
                      +.|.+.+.||+|+||+||+|.+. ++..||+|.+..... .......+.+|+.+++.++||||+++++++..     ...
T Consensus        26 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  104 (290)
T 1t4h_A           26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKL-TKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCI  104 (290)
T ss_dssp             CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEE
T ss_pred             eeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhh-CHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceE
Confidence            34667789999999999999864 588899998865433 23446789999999999999999999997653     236


Q ss_pred             EEEEEecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC--eeeCCCCCCcEEEc-CCCcEEEeeccccc
Q 012765          216 HLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRR--IIHRDIKASNILLS-EDYEAQISDFGLAK  292 (457)
Q Consensus       216 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~--iiHrDlkp~NIll~-~~~~~kL~DFGl~~  292 (457)
                      ++||||+++++|.+++... ..+++..++.++.||+.||.|||+   .+  |+||||||+|||++ .++.+||+|||++.
T Consensus       105 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~---~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~  180 (290)
T 1t4h_A          105 VLVTELMTSGTLKTYLKRF-KVMKIKVLRSWCRQILKGLQFLHT---RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT  180 (290)
T ss_dssp             EEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHT---SSSCCCCSCCCGGGEEESSTTSCEEECCTTGGG
T ss_pred             EEEEEecCCCCHHHHHHHc-cCCCHHHHHHHHHHHHHHHHHHHc---CCCCEEECCCCHHHEEEECCCCCEEEeeCCCcc
Confidence            8999999999999999543 458899999999999999999999   67  99999999999998 78999999999997


Q ss_pred             cCCCCCCceeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhccccccCCcccccCc
Q 012765          293 WLPDNWSHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSNFKELVDP  372 (457)
Q Consensus       293 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~  372 (457)
                      .......    ....||+.|+|||++. +.++.++|||||||++|+|++|+.||.........+.....  .    ....
T Consensus       181 ~~~~~~~----~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~--~----~~~~  249 (290)
T 1t4h_A          181 LKRASFA----KAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTS--G----VKPA  249 (290)
T ss_dssp             GCCTTSB----EESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTT--T----CCCG
T ss_pred             ccccccc----ccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhc--c----CCcc
Confidence            6554322    2345899999999876 56899999999999999999999999864433222111100  0    0011


Q ss_pred             hhhcccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 012765          373 RLADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQ  409 (457)
Q Consensus       373 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~  409 (457)
                      ......    ...+.+++..||+.||.+|||+.++++
T Consensus       250 ~~~~~~----~~~l~~li~~~l~~dp~~Rps~~ell~  282 (290)
T 1t4h_A          250 SFDKVA----IPEVKEIIEGCIRQNKDERYSIKDLLN  282 (290)
T ss_dssp             GGGGCC----CHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             ccCCCC----CHHHHHHHHHHccCChhhCCCHHHHhh
Confidence            111111    234678889999999999999999986

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=1.4e-40  Score=333.56  Aligned_cols=257  Identities=23%  Similarity=0.274  Sum_probs=191.2

Q ss_pred             hcCCCCCceecccCcEEEEEEEeC-CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeecC------
Q 012765          141 TDNFNSENLIGKGGHAEVYKGCLP-DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTEN------  213 (457)
Q Consensus       141 ~~~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~------  213 (457)
                      .++|.+.+.||+|+||.||+|.+. +++.||||++..... .......+.+|+.+++.++||||+++++++...      
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~  102 (371)
T 2xrw_A           24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQ-NQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF  102 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTS-SHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTC
T ss_pred             hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccC-ChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccc
Confidence            478999999999999999999864 689999999875432 334466889999999999999999999976543      


Q ss_pred             -ceEEEEEecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccc
Q 012765          214 -GFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAK  292 (457)
Q Consensus       214 -~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~  292 (457)
                       ..++||||+.+ +|.+.+.   ..+++..+..++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||+++
T Consensus       103 ~~~~lv~e~~~~-~l~~~~~---~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~  175 (371)
T 2xrw_A          103 QDVYIVMELMDA-NLCQVIQ---MELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLAR  175 (371)
T ss_dssp             CEEEEEEECCSE-EHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECCCCC--
T ss_pred             cceEEEEEcCCC-CHHHHHh---hccCHHHHHHHHHHHHHHHHHHHH---CCeecccCCHHHEEEcCCCCEEEEEeeccc
Confidence             46899999975 6777774   348899999999999999999999   899999999999999999999999999998


Q ss_pred             cCCCCCCceeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhcccc-----------
Q 012765          293 WLPDNWSHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLL-----------  361 (457)
Q Consensus       293 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~~~~-----------  361 (457)
                      ......   ......||+.|+|||++.+..++.++|||||||++|||++|+.||...+..... .....           
T Consensus       176 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~-~~i~~~~~~~~~~~~~  251 (371)
T 2xrw_A          176 TAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQW-NKVIEQLGTPCPEFMK  251 (371)
T ss_dssp             -----------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHH-HHHHC-CCCCCHHHHT
T ss_pred             cccccc---ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHH-HHHHHHhCCCCHHHHH
Confidence            764432   123356899999999999999999999999999999999999999875432111 10000           


Q ss_pred             ----------------ccCCcccccCchhhcc---cCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 012765          362 ----------------QTSNFKELVDPRLADA---YDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQ  409 (457)
Q Consensus       362 ----------------~~~~~~~~~d~~l~~~---~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~  409 (457)
                                      ....+.......+.+.   ........+.+++.+||+.||.+|||+.|+++
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~  318 (371)
T 2xrw_A          252 KLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ  318 (371)
T ss_dssp             TSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             HhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhC
Confidence                            0000011111111000   01123456889999999999999999999988

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=6.9e-41  Score=342.58  Aligned_cols=202  Identities=24%  Similarity=0.337  Sum_probs=166.3

Q ss_pred             hhcCCCCCceecccCcEEEEEEEeC-CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeecC-----
Q 012765          140 ATDNFNSENLIGKGGHAEVYKGCLP-DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTEN-----  213 (457)
Q Consensus       140 ~~~~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~-----  213 (457)
                      ..++|.+.+.||+|+||.||+|.+. +++.||||++.... ........+.+|+.+++.++||||+++++++...     
T Consensus        24 i~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~  102 (432)
T 3n9x_A           24 VPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMF-EDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKF  102 (432)
T ss_dssp             CCTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTT-TSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTC
T ss_pred             ecCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchh-cChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcC
Confidence            3578999999999999999999865 58899999986543 3334567899999999999999999999976543     


Q ss_pred             -ceEEEEEecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccc
Q 012765          214 -GFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAK  292 (457)
Q Consensus       214 -~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~  292 (457)
                       ..++||||+. ++|..++.. ...+++..+..++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||+++
T Consensus       103 ~~~~lv~e~~~-~~L~~~~~~-~~~l~~~~~~~i~~qil~aL~~LH~---~givHrDlkp~NILl~~~~~~kL~DFGla~  177 (432)
T 3n9x_A          103 DELYIVLEIAD-SDLKKLFKT-PIFLTEEHIKTILYNLLLGENFIHE---SGIIHRDLKPANCLLNQDCSVKVCDFGLAR  177 (432)
T ss_dssp             CCEEEEEECCS-EEHHHHHHS-SCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred             CeEEEEEecCC-cCHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHH---CCCCCCCCCHHHeEECCCCCEEEccCCCcc
Confidence             4789999876 589888854 3558999999999999999999999   899999999999999999999999999998


Q ss_pred             cCCCCCCc--------------------eeeecccccccccChhcc-ccCCCCcchhHHHHHHHHHHHHhCCCCCC
Q 012765          293 WLPDNWSH--------------------HIVFPIEGTFGYLSPEYF-MHGIVDEKTDVFAFGVLLLELITGRRAVD  347 (457)
Q Consensus       293 ~~~~~~~~--------------------~~~~~~~gt~~y~aPE~~-~~~~~~~ksDvwSlGvll~eLltG~~pf~  347 (457)
                      ........                    .......||++|+|||++ ....|+.++|||||||++|||++|..||.
T Consensus       178 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~  253 (432)
T 3n9x_A          178 TINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHI  253 (432)
T ss_dssp             EC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTC
T ss_pred             cccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccc
Confidence            77543221                    123456799999999986 45679999999999999999998665554

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=8.6e-41  Score=325.03  Aligned_cols=248  Identities=30%  Similarity=0.455  Sum_probs=200.6

Q ss_pred             hcCCCCCceecccCcEEEEEEEeC-CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeec-CceEEE
Q 012765          141 TDNFNSENLIGKGGHAEVYKGCLP-DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTE-NGFHLV  218 (457)
Q Consensus       141 ~~~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-~~~~lv  218 (457)
                      .+.|.+.+.||+|+||.||+|.+. +++.||+|.+......  .....+.+|+.++..++||||+++++++.+ ...++|
T Consensus        21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   98 (303)
T 3a7i_A           21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAE--DEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWII   98 (303)
T ss_dssp             GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCS--TTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred             HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccH--HHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEE
Confidence            466888999999999999999864 6899999998654332  235678999999999999999999996654 557899


Q ss_pred             EEecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCCCCC
Q 012765          219 LQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNW  298 (457)
Q Consensus       219 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~~~  298 (457)
                      |||+++++|.+++.  ...+++..++.++.||+.||.|||+   .+|+||||||+||+++.++.+||+|||++.......
T Consensus        99 ~e~~~~~~L~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~  173 (303)
T 3a7i_A           99 MEYLGGGSALDLLE--PGPLDETQIATILREILKGLDYLHS---EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ  173 (303)
T ss_dssp             EECCTTEEHHHHHT--TSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECBTTB
T ss_pred             EEeCCCCcHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCChheEEECCCCCEEEeecccceecCccc
Confidence            99999999999984  3568999999999999999999999   899999999999999999999999999998765432


Q ss_pred             CceeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhccccccCCcccccCchhhccc
Q 012765          299 SHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSNFKELVDPRLADAY  378 (457)
Q Consensus       299 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~  378 (457)
                      .  ......||+.|+|||++.+..++.++||||||+++|+|++|..||..............   .     ..+.+...+
T Consensus       174 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~---~-----~~~~~~~~~  243 (303)
T 3a7i_A          174 I--KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPK---N-----NPPTLEGNY  243 (303)
T ss_dssp             C--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHH---S-----CCCCCCSSC
T ss_pred             c--ccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhhc---C-----CCCCCcccc
Confidence            1  12234589999999999999999999999999999999999999986443222211110   0     011122222


Q ss_pred             CHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 012765          379 DLAEMKRAMLTASVCIHHLSTMRPQMTRVLQ  409 (457)
Q Consensus       379 ~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~  409 (457)
                      +    ..+..++..||+.||.+|||+.+|++
T Consensus       244 ~----~~l~~li~~~l~~dp~~Rps~~~ll~  270 (303)
T 3a7i_A          244 S----KPLKEFVEACLNKEPSFRPTAKELLK  270 (303)
T ss_dssp             C----HHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             C----HHHHHHHHHHcCCChhhCcCHHHHhh
Confidence            2    34677889999999999999999987

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=1.5e-41  Score=334.54  Aligned_cols=247  Identities=21%  Similarity=0.270  Sum_probs=172.3

Q ss_pred             CceecccCcEEEEEEEeC-CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcC-CCCcceeeeeeecC-ceEEEEEecC
Q 012765          147 ENLIGKGGHAEVYKGCLP-DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHIN-HPNAAKLIGFSTEN-GFHLVLQFLP  223 (457)
Q Consensus       147 ~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~-~~~lv~e~~~  223 (457)
                      .+.||+|+||+||+|.+. +++.||+|++....      ...+.+|+.++..+. ||||+++++++.+. ..++||||+.
T Consensus        16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~   89 (325)
T 3kn6_A           16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKRM------EANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLN   89 (325)
T ss_dssp             SCCSEEETTEEEEEEEETTTCCEEEEEEEEGGG------HHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCC
T ss_pred             CCccccCCCeEEEEEEECCCCCEEEEEEEChhh------hhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccC
Confidence            478999999999999875 68999999986432      236778999999997 99999999977655 4689999999


Q ss_pred             CCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCC---cEEEeeccccccCCCCCCc
Q 012765          224 HGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDY---EAQISDFGLAKWLPDNWSH  300 (457)
Q Consensus       224 ~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~---~~kL~DFGl~~~~~~~~~~  300 (457)
                      +|+|.+++... ..+++..+..++.||+.||.|||+   .+|+||||||+|||++.++   .+||+|||+++....... 
T Consensus        90 ~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~-  164 (325)
T 3kn6_A           90 GGELFERIKKK-KHFSETEASYIMRKLVSAVSHMHD---VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQ-  164 (325)
T ss_dssp             SCBHHHHHHHC-SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC----
T ss_pred             CCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH---CCCeecCCCHHHEEEecCCCcccEEEeccccceecCCCCC-
Confidence            99999999654 468999999999999999999999   8999999999999998765   799999999987654322 


Q ss_pred             eeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhccccccCCcccccCchh--hccc
Q 012765          301 HIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSNFKELVDPRL--ADAY  378 (457)
Q Consensus       301 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l--~~~~  378 (457)
                       ......||+.|+|||++.+..++.++|||||||++|+|++|+.||............    ......+.....  ....
T Consensus       165 -~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~----~~~~~~i~~~~~~~~~~~  239 (325)
T 3kn6_A          165 -PLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSA----VEIMKKIKKGDFSFEGEA  239 (325)
T ss_dssp             --------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCH----HHHHHHHTTTCCCCCSHH
T ss_pred             -cccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccH----HHHHHHHHcCCCCCCccc
Confidence             223455899999999999999999999999999999999999999864321100000    000000000000  0000


Q ss_pred             CHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 012765          379 DLAEMKRAMLTASVCIHHLSTMRPQMTRVLQ  409 (457)
Q Consensus       379 ~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~  409 (457)
                      .......+.+++.+||+.||.+|||+.++++
T Consensus       240 ~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~  270 (325)
T 3kn6_A          240 WKNVSQEAKDLIQGLLTVDPNKRLKMSGLRY  270 (325)
T ss_dssp             HHTSCHHHHHHHHHHHCCCTTTCCCTTTSTT
T ss_pred             ccCCCHHHHHHHHHHCCCChhHCCCHHHHhc
Confidence            0112345778899999999999999999875

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=2.4e-41  Score=324.15  Aligned_cols=250  Identities=20%  Similarity=0.313  Sum_probs=191.9

Q ss_pred             hhcCCCCCceecccCcEEEEEEEeC-CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeec-CceEE
Q 012765          140 ATDNFNSENLIGKGGHAEVYKGCLP-DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTE-NGFHL  217 (457)
Q Consensus       140 ~~~~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-~~~~l  217 (457)
                      ..++|.+.+.||+|+||.||+|.+. +|+.||+|.+.............+.+|+.+++.++||||+++++++.. +..++
T Consensus         9 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   88 (276)
T 2h6d_A            9 KIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFM   88 (276)
T ss_dssp             EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred             eeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEE
Confidence            3478889999999999999999875 689999999865433222335678899999999999999999997665 45689


Q ss_pred             EEEecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCCCC
Q 012765          218 VLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDN  297 (457)
Q Consensus       218 v~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~~  297 (457)
                      ||||+.+++|.+++... ..+++..++.++.||+.||.|||+   .+++|+||||+||+++.++.+||+|||++......
T Consensus        89 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~  164 (276)
T 2h6d_A           89 VMEYVSGGELFDYICKH-GRVEEMEARRLFQQILSAVDYCHR---HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG  164 (276)
T ss_dssp             EEECCCSCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHH---HCSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC-
T ss_pred             EEeccCCCcHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCChhhEEECCCCCEEEeecccccccCCC
Confidence            99999999999998653 358899999999999999999999   89999999999999999999999999999876543


Q ss_pred             CCceeeecccccccccChhccccCCC-CcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhccccccCCcccccCchhhc
Q 012765          298 WSHHIVFPIEGTFGYLSPEYFMHGIV-DEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSNFKELVDPRLAD  376 (457)
Q Consensus       298 ~~~~~~~~~~gt~~y~aPE~~~~~~~-~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  376 (457)
                      ..   .....||+.|+|||.+.+..+ +.++||||||+++|+|++|..||.......... . .. ...      ..+..
T Consensus       165 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~-~-~~-~~~------~~~~~  232 (276)
T 2h6d_A          165 EF---LRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFK-K-IR-GGV------FYIPE  232 (276)
T ss_dssp             ---------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH-H-HH-HCC------CCCCT
T ss_pred             cc---eecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHH-H-hh-cCc------ccCch
Confidence            21   223458999999999987765 689999999999999999999997643221110 0 00 000      00111


Q ss_pred             ccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 012765          377 AYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQ  409 (457)
Q Consensus       377 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~  409 (457)
                      .+    ...+..++.+||+.||.+|||+.+|++
T Consensus       233 ~~----~~~l~~li~~~l~~~p~~Rps~~~~l~  261 (276)
T 2h6d_A          233 YL----NRSVATLLMHMLQVDPLKRATIKDIRE  261 (276)
T ss_dssp             TS----CHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             hc----CHHHHHHHHHHccCChhhCCCHHHHHh
Confidence            11    234667889999999999999999988

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=4.9e-41  Score=323.18  Aligned_cols=253  Identities=22%  Similarity=0.274  Sum_probs=197.6

Q ss_pred             hcCCCCCceecccCcEEEEEEEeC-CCcEEEEEEEeccchhhH---HHHHHHHHHHHHHhhcCCCCcceeeeeeecC-ce
Q 012765          141 TDNFNSENLIGKGGHAEVYKGCLP-DGEVVAVKKIIKNAKEDE---ERISDFLSELGIVAHINHPNAAKLIGFSTEN-GF  215 (457)
Q Consensus       141 ~~~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~---~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~-~~  215 (457)
                      .++|.+.+.||+|+||.||+|... +++.||+|.+........   .....+.+|+.+++.++||||+++++++.+. ..
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~   83 (283)
T 3bhy_A            4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDV   83 (283)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             hhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeE
Confidence            356889999999999999999876 689999998865432211   1245788999999999999999999976654 46


Q ss_pred             EEEEEecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCC----cEEEeecccc
Q 012765          216 HLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDY----EAQISDFGLA  291 (457)
Q Consensus       216 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~----~~kL~DFGl~  291 (457)
                      +++|||+++++|.+++.. ...+++..++.++.||+.||.|||+   .+++||||||+||+++.++    .+||+|||++
T Consensus        84 ~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~  159 (283)
T 3bhy_A           84 VLILELVSGGELFDFLAE-KESLTEDEATQFLKQILDGVHYLHS---KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIA  159 (283)
T ss_dssp             EEEEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESCSSSSSCCEEECCCTTC
T ss_pred             EEEEeecCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCChHHEEEecCCCCCCceEEEecccc
Confidence            899999999999999854 3458999999999999999999999   8999999999999998877    7999999999


Q ss_pred             ccCCCCCCceeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhccccccCCcccccC
Q 012765          292 KWLPDNWSHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSNFKELVD  371 (457)
Q Consensus       292 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d  371 (457)
                      ........   .....||+.|+|||++.+..++.++||||||+++|+|++|..||.............   ..  ....+
T Consensus       160 ~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~---~~--~~~~~  231 (283)
T 3bhy_A          160 HKIEAGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNIS---AV--NYDFD  231 (283)
T ss_dssp             EECC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH---TT--CCCCC
T ss_pred             eeccCCCc---ccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhH---hc--ccCCc
Confidence            87654322   223458999999999999999999999999999999999999998644322111100   00  00011


Q ss_pred             chhhcccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 012765          372 PRLADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQ  409 (457)
Q Consensus       372 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~  409 (457)
                      +......    ...+.+++.+||+.||.+|||+.++++
T Consensus       232 ~~~~~~~----~~~~~~li~~~l~~dp~~Rps~~~~l~  265 (283)
T 3bhy_A          232 EEYFSNT----SELAKDFIRRLLVKDPKRRMTIAQSLE  265 (283)
T ss_dssp             HHHHTTC----CHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             chhcccC----CHHHHHHHHHHccCCHhHCcCHHHHHh
Confidence            1111122    235678899999999999999999987

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=1.7e-41  Score=327.38  Aligned_cols=252  Identities=23%  Similarity=0.330  Sum_probs=182.8

Q ss_pred             hhcCCCCCceecccCcEEEEEEEe-CCCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeec-CceEE
Q 012765          140 ATDNFNSENLIGKGGHAEVYKGCL-PDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTE-NGFHL  217 (457)
Q Consensus       140 ~~~~f~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-~~~~l  217 (457)
                      ..++|++.+.||+|+||+||+|.+ .+|+.||+|++...... ......+.++...++.++||||+++++++.+ +..++
T Consensus         5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~l   83 (290)
T 3fme_A            5 KADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNS-QEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWI   83 (290)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CH-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEE
T ss_pred             cHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCc-HHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEE
Confidence            357888999999999999999986 47899999998654332 2333345555556788999999999996654 55789


Q ss_pred             EEEecCCCChhhhhhc---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCC-CeeeCCCCCCcEEEcCCCcEEEeecccccc
Q 012765          218 VLQFLPHGSLSSLLFG---STECLEWTIRYKIALGIAEGLQYLHHDCHR-RIIHRDIKASNILLSEDYEAQISDFGLAKW  293 (457)
Q Consensus       218 v~e~~~~gsL~~~l~~---~~~~~~~~~~~~i~~qia~aL~yLH~~~~~-~iiHrDlkp~NIll~~~~~~kL~DFGl~~~  293 (457)
                      ||||+. |+|.+++..   ....+++..++.++.||+.||.|||+   . +|+||||||+||+++.++.+||+|||++..
T Consensus        84 v~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~  159 (290)
T 3fme_A           84 CMELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHS---KLSVIHRDVKPSNVLINALGQVKMCDFGISGY  159 (290)
T ss_dssp             EEECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH---HSCCCCCCCSGGGCEECTTCCEEBCCC-----
T ss_pred             EEehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhh---cCCeecCCCCHHHEEECCCCCEEEeecCCccc
Confidence            999997 477776643   55679999999999999999999999   6 999999999999999999999999999987


Q ss_pred             CCCCCCceeeecccccccccChhcc----ccCCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhccccccCCcccc
Q 012765          294 LPDNWSHHIVFPIEGTFGYLSPEYF----MHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSNFKEL  369 (457)
Q Consensus       294 ~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~  369 (457)
                      .......   ....||+.|+|||++    .+..++.++|||||||++|+|++|+.||.................      
T Consensus       160 ~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~------  230 (290)
T 3fme_A          160 LVDDVAK---DIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEP------  230 (290)
T ss_dssp             -------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSC------
T ss_pred             ccccccc---cccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccC------
Confidence            6544322   223589999999996    566789999999999999999999999986333222211111100      


Q ss_pred             cCchhhcccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 012765          370 VDPRLADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQ  409 (457)
Q Consensus       370 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~  409 (457)
                       .+....   ......+.+++.+||+.||.+|||+.|+++
T Consensus       231 -~~~~~~---~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~  266 (290)
T 3fme_A          231 -SPQLPA---DKFSAEFVDFTSQCLKKNSKERPTYPELMQ  266 (290)
T ss_dssp             -CCCCCT---TTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             -CCCccc---ccCCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence             000000   111235678889999999999999999976

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=1.8e-41  Score=334.39  Aligned_cols=263  Identities=19%  Similarity=0.286  Sum_probs=189.3

Q ss_pred             HhhcCCCCCceecccCcEEEEEEEeC-CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeecC-ceE
Q 012765          139 AATDNFNSENLIGKGGHAEVYKGCLP-DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTEN-GFH  216 (457)
Q Consensus       139 ~~~~~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~-~~~  216 (457)
                      ...++|.+.+.||+|+||+||+|.+. +++.||+|++..... .......+.+|+.+++.++||||+++++++.++ ..+
T Consensus        31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  109 (329)
T 3gbz_A           31 TSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHE-EEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLH  109 (329)
T ss_dssp             -CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC---------CHHHHHHGGGCCCTTBCCEEEEEEETTEEE
T ss_pred             cchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEccccc-ccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEE
Confidence            34578999999999999999999854 689999999865432 223355788999999999999999999976554 568


Q ss_pred             EEEEecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEc-----CCCcEEEeecccc
Q 012765          217 LVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLS-----EDYEAQISDFGLA  291 (457)
Q Consensus       217 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~-----~~~~~kL~DFGl~  291 (457)
                      +||||+. |+|.+++.... .+++..++.|+.||+.||.|||+   .+|+||||||+|||++     .++.+||+|||++
T Consensus       110 lv~e~~~-~~L~~~~~~~~-~~~~~~~~~i~~ql~~~l~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a  184 (329)
T 3gbz_A          110 LIFEYAE-NDLKKYMDKNP-DVSMRVIKSFLYQLINGVNFCHS---RRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLA  184 (329)
T ss_dssp             EEEECCS-EEHHHHHHHCT-TCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEC-----CCEEEECCTTHH
T ss_pred             EEEecCC-CCHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHh---CCEECCCCCHHHEEEecCCCCccceEEECcCCCc
Confidence            9999997 58988886543 48999999999999999999999   8999999999999994     4556999999999


Q ss_pred             ccCCCCCCceeeecccccccccChhccccC-CCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhcc-cc---cc---
Q 012765          292 KWLPDNWSHHIVFPIEGTFGYLSPEYFMHG-IVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKP-LL---QT---  363 (457)
Q Consensus       292 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~~-~~---~~---  363 (457)
                      ........  ......||+.|+|||++.+. .++.++|||||||++|||++|..||............. ..   ..   
T Consensus       185 ~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  262 (329)
T 3gbz_A          185 RAFGIPIR--QFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTW  262 (329)
T ss_dssp             HHHC-------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTS
T ss_pred             cccCCccc--ccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhh
Confidence            87653321  12334589999999999874 48999999999999999999999998654322111100 00   00   


Q ss_pred             ----------CCcccccCchhhcccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 012765          364 ----------SNFKELVDPRLADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQ  409 (457)
Q Consensus       364 ----------~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~  409 (457)
                                ..+.......+...........+.+++.+||+.||.+|||+.|+++
T Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  318 (329)
T 3gbz_A          263 PGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE  318 (329)
T ss_dssp             TTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             hhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence                      0001111111111111112245678899999999999999999986

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.8e-41  Score=334.33  Aligned_cols=265  Identities=22%  Similarity=0.296  Sum_probs=193.7

Q ss_pred             hhcCCCCCceecccCcEEEEEEEeC-CCcEEEEEEEeccchhh--HHHHHHHHHHHHHHhhcCCCCcceeeeeeec-Cce
Q 012765          140 ATDNFNSENLIGKGGHAEVYKGCLP-DGEVVAVKKIIKNAKED--EERISDFLSELGIVAHINHPNAAKLIGFSTE-NGF  215 (457)
Q Consensus       140 ~~~~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-~~~  215 (457)
                      ..++|.+.+.||+|+||.||+|.+. +|+.||+|++.......  ......+.+|+.++..++||||+++++++.+ +..
T Consensus         8 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   87 (346)
T 1ua2_A            8 RAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNI   87 (346)
T ss_dssp             -----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCC
T ss_pred             HhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCce
Confidence            4578999999999999999999875 58999999886432221  1123468899999999999999999996654 557


Q ss_pred             EEEEEecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCC
Q 012765          216 HLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLP  295 (457)
Q Consensus       216 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~  295 (457)
                      ++||||+.+ +|..++......+++..++.++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||+++.+.
T Consensus        88 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~  163 (346)
T 1ua2_A           88 SLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQ---HWILHRDLKPNNLLLDENGVLKLADFGLAKSFG  163 (346)
T ss_dssp             EEEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECCCGGGSTTT
T ss_pred             EEEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHH---CCEECCCCCHHHEEEcCCCCEEEEecccceecc
Confidence            899999986 7888887666678889999999999999999999   899999999999999999999999999998765


Q ss_pred             CCCCceeeecccccccccChhccccC-CCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhh--c----ccccc----C
Q 012765          296 DNWSHHIVFPIEGTFGYLSPEYFMHG-IVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWA--K----PLLQT----S  364 (457)
Q Consensus       296 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~--~----~~~~~----~  364 (457)
                      ....  ......||+.|+|||++.+. .++.++|||||||++|||++|..||...........  .    +....    .
T Consensus       164 ~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~  241 (346)
T 1ua2_A          164 SPNR--AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMC  241 (346)
T ss_dssp             SCCC--CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTT
T ss_pred             CCcc--cCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhhhc
Confidence            4322  12335689999999998754 589999999999999999999999986443211100  0    00000    0


Q ss_pred             CcccccCchhhcccC-----HHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 012765          365 NFKELVDPRLADAYD-----LAEMKRAMLTASVCIHHLSTMRPQMTRVLQL  410 (457)
Q Consensus       365 ~~~~~~d~~l~~~~~-----~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~  410 (457)
                      ...+.+.........     ......+.+++.+||+.||.+|||+.|+++.
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  292 (346)
T 1ua2_A          242 SLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM  292 (346)
T ss_dssp             SSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred             cCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcC
Confidence            000000000000000     1123467789999999999999999999983

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=4e-41  Score=331.58  Aligned_cols=262  Identities=21%  Similarity=0.289  Sum_probs=201.2

Q ss_pred             ccHHHHHHhhcCCCCC-ceecccCcEEEEEEEeC-CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhc-CCCCcceeee
Q 012765          132 FDFAELAAATDNFNSE-NLIGKGGHAEVYKGCLP-DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHI-NHPNAAKLIG  208 (457)
Q Consensus       132 ~~~~~~~~~~~~f~~~-~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~  208 (457)
                      ..+.......+.|.+. +.||+|+||.||+|... +++.||+|++....... .....+.+|+.++..+ +||||+++++
T Consensus        18 ~~~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~~iv~~~~   96 (327)
T 3lm5_A           18 LYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQ-DCRAEILHEIAVLELAKSCPRVINLHE   96 (327)
T ss_dssp             CCSBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTE-ECHHHHHHHHHHHHHTTTCTTBCCEEE
T ss_pred             hHHHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcch-HHHHHHHHHHHHHHhccCCCCEEEEEE
Confidence            3445556677778877 88999999999999865 58999999887543322 2245788999999998 4699999999


Q ss_pred             eeecC-ceEEEEEecCCCChhhhhhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcC---CCcE
Q 012765          209 FSTEN-GFHLVLQFLPHGSLSSLLFGS-TECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSE---DYEA  283 (457)
Q Consensus       209 ~~~~~-~~~lv~e~~~~gsL~~~l~~~-~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~---~~~~  283 (457)
                      ++.+. ..++||||+.+|+|.+++... ...+++..++.++.||+.||.|||+   .+|+||||||+|||++.   ++.+
T Consensus        97 ~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~---~givH~Dikp~NIl~~~~~~~~~~  173 (327)
T 3lm5_A           97 VYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQ---NNIVHLDLKPQNILLSSIYPLGDI  173 (327)
T ss_dssp             EEECSSEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEESCBTTBCCE
T ss_pred             EEEeCCeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHH---CCeecCcCChHHEEEecCCCCCcE
Confidence            76654 468999999999999998543 4568999999999999999999999   89999999999999997   7899


Q ss_pred             EEeeccccccCCCCCCceeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhcccccc
Q 012765          284 QISDFGLAKWLPDNWSHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQT  363 (457)
Q Consensus       284 kL~DFGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~~~~~~  363 (457)
                      ||+|||++........   .....||+.|+|||++.+..++.++|||||||++|+|++|+.||................ 
T Consensus       174 kL~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~-  249 (327)
T 3lm5_A          174 KIVDFGMSRKIGHACE---LREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVN-  249 (327)
T ss_dssp             EECCGGGCEEC------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC-
T ss_pred             EEeeCccccccCCccc---cccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhcc-
Confidence            9999999987754322   223459999999999999999999999999999999999999998654332211110000 


Q ss_pred             CCcccccCchhhcccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 012765          364 SNFKELVDPRLADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQ  409 (457)
Q Consensus       364 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~  409 (457)
                      ...    ......    .....+.+++.+||+.||.+|||+.++++
T Consensus       250 ~~~----~~~~~~----~~~~~~~~li~~~L~~dP~~Rpt~~~ll~  287 (327)
T 3lm5_A          250 VDY----SEETFS----SVSQLATDFIQSLLVKNPEKRPTAEICLS  287 (327)
T ss_dssp             CCC----CTTTTT----TSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             ccc----Cchhhc----ccCHHHHHHHHHHcCCChhhCcCHHHHhC
Confidence            000    000001    12234667889999999999999999987

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=1.9e-41  Score=328.84  Aligned_cols=262  Identities=26%  Similarity=0.415  Sum_probs=182.7

Q ss_pred             HhhcCCCCCceecccCcEEEEEEEeC-CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeee-cCceE
Q 012765          139 AATDNFNSENLIGKGGHAEVYKGCLP-DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFST-ENGFH  216 (457)
Q Consensus       139 ~~~~~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~-~~~~~  216 (457)
                      ...++|.+.+.||+|+||.||+|.+. +++.||+|++.....  ......+.+|+.++..++||||+++++++. .+..+
T Consensus        12 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   89 (303)
T 2vwi_A           12 INRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKC--QTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELW   89 (303)
T ss_dssp             -CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC------------------CCCCCCCTTBCCEEEEEESSSCEE
T ss_pred             cchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhc--chhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcE
Confidence            34678999999999999999999854 689999998754322  233567889999999999999999999655 45678


Q ss_pred             EEEEecCCCChhhhhhc-------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeecc
Q 012765          217 LVLQFLPHGSLSSLLFG-------STECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFG  289 (457)
Q Consensus       217 lv~e~~~~gsL~~~l~~-------~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFG  289 (457)
                      +||||+++++|.+++..       ....+++..++.++.||+.||.|||+   .+++||||||+||+++.++.+||+|||
T Consensus        90 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg  166 (303)
T 2vwi_A           90 LVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHK---NGQIHRDVKAGNILLGEDGSVQIADFG  166 (303)
T ss_dssp             EEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEECTTCCEEECCCH
T ss_pred             EEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHh---CCCCCCCCChhhEEEcCCCCEEEEecc
Confidence            99999999999999853       34568999999999999999999999   899999999999999999999999999


Q ss_pred             ccccCCCCCC---ceeeecccccccccChhcccc-CCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhccccccCC
Q 012765          290 LAKWLPDNWS---HHIVFPIEGTFGYLSPEYFMH-GIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSN  365 (457)
Q Consensus       290 l~~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~~~~~~~~  365 (457)
                      ++........   ........||+.|+|||++.+ ..++.++|||||||++|||++|+.||...................
T Consensus       167 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  246 (303)
T 2vwi_A          167 VSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPS  246 (303)
T ss_dssp             HHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTSSCCC
T ss_pred             chheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhccCCCc
Confidence            9987643321   111223468999999999875 568999999999999999999999998644332211110000001


Q ss_pred             cc-cccCchhhcccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 012765          366 FK-ELVDPRLADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQ  409 (457)
Q Consensus       366 ~~-~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~  409 (457)
                      .. ...++.+...++    ..+.+++.+||+.||.+|||+.++++
T Consensus       247 ~~~~~~~~~~~~~~~----~~~~~li~~~l~~dp~~Rps~~~ll~  287 (303)
T 2vwi_A          247 LETGVQDKEMLKKYG----KSFRKMISLCLQKDPEKRPTAAELLR  287 (303)
T ss_dssp             TTC-----CCCCCCC----HHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             cccccccchhhhhhh----HHHHHHHHHHccCChhhCcCHHHHhh
Confidence            10 111111112222    35677889999999999999999986

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=3.2e-41  Score=340.92  Aligned_cols=262  Identities=21%  Similarity=0.288  Sum_probs=195.4

Q ss_pred             hcCCCCCceecccCcEEEEEEEeCCCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeecC-c-----
Q 012765          141 TDNFNSENLIGKGGHAEVYKGCLPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTEN-G-----  214 (457)
Q Consensus       141 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~-~-----  214 (457)
                      ..+|.+.+.||+|+||+||+|.+..+..+|+|++......       ..+|+.+++.++||||+++++++... .     
T Consensus        39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~~-------~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~  111 (394)
T 4e7w_A           39 EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRF-------KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEV  111 (394)
T ss_dssp             EEEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTTS-------CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCE
T ss_pred             cceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcch-------HHHHHHHHHhCCCCCcceEEEEEEecCCCCCce
Confidence            4568899999999999999999877777999988754332       23699999999999999999966432 1     


Q ss_pred             -eEEEEEecCCCChhhhh--hcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEc-CCCcEEEeeccc
Q 012765          215 -FHLVLQFLPHGSLSSLL--FGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLS-EDYEAQISDFGL  290 (457)
Q Consensus       215 -~~lv~e~~~~gsL~~~l--~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~-~~~~~kL~DFGl  290 (457)
                       +++||||++++.+....  ......+++..+..++.||+.||.|||+   .+|+||||||+|||++ .++.+||+|||+
T Consensus       112 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~~kL~DFG~  188 (394)
T 4e7w_A          112 FLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHS---IGICHRDIKPQNLLLDPPSGVLKLIDFGS  188 (394)
T ss_dssp             EEEEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred             EEEEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHH---CCccCCCCCHHHEEEcCCCCcEEEeeCCC
Confidence             67999999876444333  2245678999999999999999999999   8999999999999999 789999999999


Q ss_pred             cccCCCCCCceeeecccccccccChhccccC-CCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhh--c---------
Q 012765          291 AKWLPDNWSHHIVFPIEGTFGYLSPEYFMHG-IVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWA--K---------  358 (457)
Q Consensus       291 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~--~---------  358 (457)
                      ++.+......   ....||+.|+|||++.+. .|+.++|||||||++|||++|+.||...........  .         
T Consensus       189 a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~  265 (394)
T 4e7w_A          189 AKILIAGEPN---VSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQ  265 (394)
T ss_dssp             CEECCTTCCC---CSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHH
T ss_pred             cccccCCCCC---cccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence            9876443322   234589999999998765 589999999999999999999999987543211110  0         


Q ss_pred             -----cccccCCcccccCchhhcccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH--HhcCC
Q 012765          359 -----PLLQTSNFKELVDPRLADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQL--LRGEG  415 (457)
Q Consensus       359 -----~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~--L~~~~  415 (457)
                           +......+..+....+...+.......+.+++.+||+.||.+|||+.|+++.  ++++.
T Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~  329 (394)
T 4e7w_A          266 IKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDELR  329 (394)
T ss_dssp             HHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTTT
T ss_pred             HHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhhc
Confidence                 0000111111111111111111223467889999999999999999999872  44443

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=8.2e-41  Score=326.67  Aligned_cols=250  Identities=24%  Similarity=0.392  Sum_probs=196.2

Q ss_pred             hhcCCCCCceecccCcEEEEEEEeC-CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeec-CceEE
Q 012765          140 ATDNFNSENLIGKGGHAEVYKGCLP-DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTE-NGFHL  217 (457)
Q Consensus       140 ~~~~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-~~~~l  217 (457)
                      ..++|.+.+.||+|+||.||+|.+. +|+.||+|.+.....     ...+.+|+.++..++||||+++++++.. +..++
T Consensus        27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l  101 (314)
T 3com_A           27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESD-----LQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWI  101 (314)
T ss_dssp             ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTSC-----CHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred             chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchHH-----HHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEE
Confidence            4578899999999999999999875 589999999865432     3468899999999999999999996654 55789


Q ss_pred             EEEecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCCCC
Q 012765          218 VLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDN  297 (457)
Q Consensus       218 v~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~~  297 (457)
                      ||||+.+++|.+++......+++..++.++.||+.||.|||+   .+++|+||||+||+++.++.+||+|||++......
T Consensus       102 v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~  178 (314)
T 3com_A          102 VMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHF---MRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDT  178 (314)
T ss_dssp             EEECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECBTT
T ss_pred             EeecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCCcCCCcCHHHEEECCCCCEEEeecccchhhhhh
Confidence            999999999999987556678999999999999999999999   89999999999999999999999999999876543


Q ss_pred             CCceeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhccccccCCcccccCchhhcc
Q 012765          298 WSHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSNFKELVDPRLADA  377 (457)
Q Consensus       298 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~  377 (457)
                      ...  .....||+.|+|||++.+..++.++||||||+++|+|++|..||.........+.....   ....+..+   ..
T Consensus       179 ~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~---~~~~~~~~---~~  250 (314)
T 3com_A          179 MAK--RNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTN---PPPTFRKP---EL  250 (314)
T ss_dssp             BSC--BCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHS---CCCCCSSG---GG
T ss_pred             ccc--cCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcC---CCcccCCc---cc
Confidence            221  22345899999999999989999999999999999999999999864433222211100   00001011   11


Q ss_pred             cCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 012765          378 YDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQ  409 (457)
Q Consensus       378 ~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~  409 (457)
                      +    ...+.+++.+||+.||.+|||+.++++
T Consensus       251 ~----~~~l~~li~~~l~~dp~~Rpt~~~ll~  278 (314)
T 3com_A          251 W----SDNFTDFVKQCLVKSPEQRATATQLLQ  278 (314)
T ss_dssp             S----CHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             C----CHHHHHHHHHHccCChhhCcCHHHHHh
Confidence            1    235677889999999999999999986

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=1.7e-41  Score=352.05  Aligned_cols=253  Identities=26%  Similarity=0.394  Sum_probs=200.0

Q ss_pred             hhcCCCCCceecccCcEEEEEEEeC-CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeecCc-eEE
Q 012765          140 ATDNFNSENLIGKGGHAEVYKGCLP-DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTENG-FHL  217 (457)
Q Consensus       140 ~~~~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~-~~l  217 (457)
                      ..++|.+.+.||+|+||.||+|... +|+.||||++.............+.+|+.++++++||||+++++++.+.. .++
T Consensus        24 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l  103 (484)
T 3nyv_A           24 FSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYL  103 (484)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred             ccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence            4567889999999999999999875 78999999986543322233567899999999999999999999776654 679


Q ss_pred             EEEecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEE---cCCCcEEEeeccccccC
Q 012765          218 VLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILL---SEDYEAQISDFGLAKWL  294 (457)
Q Consensus       218 v~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll---~~~~~~kL~DFGl~~~~  294 (457)
                      ||||+.+|+|.+++... ..+++..++.++.||+.||.|||+   .+|+||||||+|||+   +.++.+||+|||++...
T Consensus       104 v~e~~~~~~L~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~  179 (484)
T 3nyv_A          104 VGEVYTGGELFDEIISR-KRFSEVDAARIIRQVLSGITYMHK---NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF  179 (484)
T ss_dssp             EECCCCSCBHHHHHHTC-SCCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHB
T ss_pred             EEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEc
Confidence            99999999999988653 458999999999999999999999   899999999999999   56789999999999877


Q ss_pred             CCCCCceeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhccccccCCcccccCchh
Q 012765          295 PDNWSHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSNFKELVDPRL  374 (457)
Q Consensus       295 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l  374 (457)
                      .....   .....||+.|+|||++.+ .|+.++|||||||++|+|++|..||.............   ..... ...+..
T Consensus       180 ~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~---~~~~~-~~~~~~  251 (484)
T 3nyv_A          180 EASKK---MKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVE---KGKYT-FELPQW  251 (484)
T ss_dssp             CCCCS---HHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH---HCCCC-CCSGGG
T ss_pred             ccccc---cccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHH---cCCCC-CCCccc
Confidence            54432   233469999999999865 69999999999999999999999998754332211100   00000 000110


Q ss_pred             hcccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 012765          375 ADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQ  409 (457)
Q Consensus       375 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~  409 (457)
                       ..    ....+.+++.+||+.||.+|||+.|+++
T Consensus       252 -~~----~s~~~~~li~~~L~~dp~~R~s~~e~l~  281 (484)
T 3nyv_A          252 -KK----VSESAKDLIRKMLTYVPSMRISARDALD  281 (484)
T ss_dssp             -GG----SCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             -cc----CCHHHHHHHHHHCCCChhHCcCHHHHhh
Confidence             11    1235667889999999999999999986

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=1.5e-41  Score=336.98  Aligned_cols=250  Identities=23%  Similarity=0.310  Sum_probs=192.9

Q ss_pred             hhcCCCCCceecccCcEEEEEEEeC-CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhc-CCCCcceeeeeeecCc-eE
Q 012765          140 ATDNFNSENLIGKGGHAEVYKGCLP-DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHI-NHPNAAKLIGFSTENG-FH  216 (457)
Q Consensus       140 ~~~~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~-~~  216 (457)
                      ..++|.+.+.||+|+||.||+|.+. +++.||+|++.+...       ...+|+.++.++ +||||+++++++.++. .+
T Consensus        20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~-------~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~   92 (342)
T 2qr7_A           20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR-------DPTEEIEILLRYGQHPNIITLKDVYDDGKYVY   92 (342)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC-------CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEE
T ss_pred             ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC-------ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEE
Confidence            4577999999999999999999875 689999999875433       234678888777 7999999999766554 68


Q ss_pred             EEEEecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCC----CcEEEeeccccc
Q 012765          217 LVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSED----YEAQISDFGLAK  292 (457)
Q Consensus       217 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~----~~~kL~DFGl~~  292 (457)
                      +||||+.+|+|.+++... ..+++..+..++.||+.||.|||+   .+|+||||||+|||+..+    +.+||+|||++.
T Consensus        93 lv~E~~~gg~L~~~i~~~-~~~~~~~~~~~~~qi~~al~~lH~---~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~  168 (342)
T 2qr7_A           93 VVTELMKGGELLDKILRQ-KFFSEREASAVLFTITKTVEYLHA---QGVVHRDLKPSNILYVDESGNPESIRICDFGFAK  168 (342)
T ss_dssp             EEECCCCSCBHHHHHHTC-TTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEESSSSCSGGGEEECCCTTCE
T ss_pred             EEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHH---CCcEeccCCHHHEEEecCCCCcCeEEEEECCCcc
Confidence            999999999999988653 458999999999999999999999   899999999999998543    359999999998


Q ss_pred             cCCCCCCceeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHhCCCCCCcCCcch-hhhhccccccCCcccccC
Q 012765          293 WLPDNWSHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSL-VIWAKPLLQTSNFKELVD  371 (457)
Q Consensus       293 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~-~~~~~~~~~~~~~~~~~d  371 (457)
                      .......  ......||+.|+|||++.+..|+.++|||||||++|||++|..||....... ...... .....+.  ..
T Consensus       169 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~-i~~~~~~--~~  243 (342)
T 2qr7_A          169 QLRAENG--LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILAR-IGSGKFS--LS  243 (342)
T ss_dssp             ECBCTTC--CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHH-HHHCCCC--CC
T ss_pred             cCcCCCC--ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHH-HccCCcc--cC
Confidence            7644322  2234568999999999988889999999999999999999999998532111 111000 0000000  00


Q ss_pred             chhhcccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 012765          372 PRLADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQ  409 (457)
Q Consensus       372 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~  409 (457)
                      .    .+.......+.+++.+||+.||.+||++.++++
T Consensus       244 ~----~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~  277 (342)
T 2qr7_A          244 G----GYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLR  277 (342)
T ss_dssp             S----TTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             c----cccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence            0    001112245677889999999999999999986

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=4.9e-40  Score=323.43  Aligned_cols=249  Identities=17%  Similarity=0.253  Sum_probs=194.2

Q ss_pred             hcCCCCCceecccCcEEEEEEEe-CCCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcC-CCCcceeeeeeec---Cce
Q 012765          141 TDNFNSENLIGKGGHAEVYKGCL-PDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHIN-HPNAAKLIGFSTE---NGF  215 (457)
Q Consensus       141 ~~~f~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~---~~~  215 (457)
                      .++|++.+.||+|+||+||+|.+ .+++.||+|++....      ...+.+|+.++..++ ||||+++++++.+   ...
T Consensus        35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~  108 (330)
T 3nsz_A           35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK------KKKIKREIKILENLRGGPNIITLADIVKDPVSRTP  108 (330)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC------HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCE
T ss_pred             CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc------hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCce
Confidence            47788999999999999999986 468999999986432      246889999999997 9999999997764   447


Q ss_pred             EEEEEecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCC-cEEEeeccccccC
Q 012765          216 HLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDY-EAQISDFGLAKWL  294 (457)
Q Consensus       216 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~-~~kL~DFGl~~~~  294 (457)
                      +++|||+.+++|..++.    .+++..+..++.||+.||.|||+   .+|+||||||+|||++.++ .+||+|||+++..
T Consensus       109 ~lv~e~~~~~~l~~~~~----~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~  181 (330)
T 3nsz_A          109 ALVFEHVNNTDFKQLYQ----TLTDYDIRFYMYEILKALDYCHS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFY  181 (330)
T ss_dssp             EEEEECCCCCCHHHHGG----GCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred             EEEEeccCchhHHHHHH----hCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEc
Confidence            89999999999999883    37888999999999999999999   8999999999999999776 8999999999876


Q ss_pred             CCCCCceeeecccccccccChhcccc-CCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhc--ccc----------
Q 012765          295 PDNWSHHIVFPIEGTFGYLSPEYFMH-GIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAK--PLL----------  361 (457)
Q Consensus       295 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~--~~~----------  361 (457)
                      .....   .....||..|+|||++.+ ..++.++|||||||++|+|++|+.||............  ...          
T Consensus       182 ~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~  258 (330)
T 3nsz_A          182 HPGQE---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYID  258 (330)
T ss_dssp             CTTCC---CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHH
T ss_pred             CCCCc---cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHH
Confidence            54332   223458999999999877 67899999999999999999999999643322111000  000          


Q ss_pred             -----------------ccCCcccccCchhhcccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 012765          362 -----------------QTSNFKELVDPRLADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQ  409 (457)
Q Consensus       362 -----------------~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~  409 (457)
                                       ................    ....+.+++.+||+.||.+|||+.|+++
T Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~li~~~L~~dP~~Rpta~e~l~  319 (330)
T 3nsz_A          259 KYNIELDPRFNDILGRHSRKRWERFVHSENQHL----VSPEALDFLDKLLRYDHQSRLTAREAME  319 (330)
T ss_dssp             HTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGG----CCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             Hhccccccchhhhhhhccccchhhhcccccccc----CCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence                             0000011111111111    2345778899999999999999999987

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=1.9e-41  Score=363.38  Aligned_cols=257  Identities=23%  Similarity=0.331  Sum_probs=205.1

Q ss_pred             hhcCCCCCceecccCcEEEEEEEeC----CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeecCce
Q 012765          140 ATDNFNSENLIGKGGHAEVYKGCLP----DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTENGF  215 (457)
Q Consensus       140 ~~~~f~~~~~LG~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~  215 (457)
                      ..++|.+.+.||+|+||.||+|.+.    .+..||+|.+....  .....+.+.+|+.++++++||||+++++++.++..
T Consensus       388 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~  465 (656)
T 2j0j_A          388 QRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCT--SDSVREKFLQEALTMRQFDHPHIVKLIGVITENPV  465 (656)
T ss_dssp             CGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTT--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSC
T ss_pred             ccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCce
Confidence            4577889999999999999999864    24679999875432  23445689999999999999999999999988889


Q ss_pred             EEEEEecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCC
Q 012765          216 HLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLP  295 (457)
Q Consensus       216 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~  295 (457)
                      ++||||+++|+|.+++......+++..++.++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||+++...
T Consensus       466 ~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~givHrDikp~NILl~~~~~vkL~DFG~a~~~~  542 (656)
T 2j0j_A          466 WIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYME  542 (656)
T ss_dssp             EEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECCCCCCCSCC
T ss_pred             EEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHh---CCccccccchHhEEEeCCCCEEEEecCCCeecC
Confidence            99999999999999997766679999999999999999999999   899999999999999999999999999998775


Q ss_pred             CCCCceeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHh-CCCCCCcCCcchhhhhccccccCCcccccCchh
Q 012765          296 DNWSHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELIT-GRRAVDSRRQSLVIWAKPLLQTSNFKELVDPRL  374 (457)
Q Consensus       296 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLlt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l  374 (457)
                      ..... ......+|+.|+|||++.+..++.++|||||||++|||++ |..||.............  ...      ...+
T Consensus       543 ~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~--~~~------~~~~  613 (656)
T 2j0j_A          543 DSTYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIE--NGE------RLPM  613 (656)
T ss_dssp             C-----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHH--HTC------CCCC
T ss_pred             CCcce-eccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH--cCC------CCCC
Confidence            43221 1223446789999999999999999999999999999997 999998644322211110  000      0001


Q ss_pred             hcccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q 012765          375 ADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQLLRGE  414 (457)
Q Consensus       375 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~  414 (457)
                      ...    ....+.+++.+||+.||.+|||+.+|++.|+.+
T Consensus       614 ~~~----~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~i  649 (656)
T 2j0j_A          614 PPN----CPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI  649 (656)
T ss_dssp             CTT----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             Ccc----ccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence            111    224567788999999999999999999999865

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=8.6e-41  Score=345.61  Aligned_cols=261  Identities=21%  Similarity=0.264  Sum_probs=199.9

Q ss_pred             hhcCCCCCceecccCcEEEEEEEe-CCCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcc-eeeeeeecCc-eE
Q 012765          140 ATDNFNSENLIGKGGHAEVYKGCL-PDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAA-KLIGFSTENG-FH  216 (457)
Q Consensus       140 ~~~~f~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv-~l~~~~~~~~-~~  216 (457)
                      ..++|.+.+.||+|+||.||+|.+ .+++.||||++......     ..+.+|+.++..++|++.+ .+..++.... .+
T Consensus         5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~-----~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~   79 (483)
T 3sv0_A            5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH-----PQLLYESKIYRILQGGTGIPNVRWFGVEGDYNV   79 (483)
T ss_dssp             ETTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS-----CCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEE
T ss_pred             cCCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc-----HHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEE
Confidence            357899999999999999999986 46999999987654332     2577899999999875544 4445555544 57


Q ss_pred             EEEEecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEE---cCCCcEEEeecccccc
Q 012765          217 LVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILL---SEDYEAQISDFGLAKW  293 (457)
Q Consensus       217 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll---~~~~~~kL~DFGl~~~  293 (457)
                      +||||+ +++|.+++......+++..++.|+.||+.||.|||+   .+|+||||||+||||   +.++.+||+|||+++.
T Consensus        80 lvme~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~---~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~  155 (483)
T 3sv0_A           80 LVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS---KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKK  155 (483)
T ss_dssp             EEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECCGGGTTCEEECCCTTCEE
T ss_pred             EEEECC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccCcceEEEecCCCCCeEEEEeCCccee
Confidence            899999 999999997667779999999999999999999999   899999999999999   5889999999999987


Q ss_pred             CCCCCCce-----eeecccccccccChhccccCCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhccccccCCccc
Q 012765          294 LPDNWSHH-----IVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSNFKE  368 (457)
Q Consensus       294 ~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~  368 (457)
                      +.......     ......||..|+|||++.+..++.++|||||||+||||++|+.||......................
T Consensus       156 ~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~  235 (483)
T 3sv0_A          156 YRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVAT  235 (483)
T ss_dssp             CBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHS
T ss_pred             ccCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccc
Confidence            75543221     1124569999999999999999999999999999999999999998633221110000000000000


Q ss_pred             ccCchhhcccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q 012765          369 LVDPRLADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQLLRGE  414 (457)
Q Consensus       369 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~  414 (457)
                      .+ ..+...+    ...+.+++..||+.+|++||++.+|++.|+.+
T Consensus       236 ~~-~~l~~~~----p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l  276 (483)
T 3sv0_A          236 SI-EALCRGY----PTEFASYFHYCRSLRFDDKPDYSYLKRLFRDL  276 (483)
T ss_dssp             CH-HHHHTTS----CHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHH
T ss_pred             cH-HHHhcCC----cHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence            00 0111111    24577889999999999999999999988765

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=4.3e-41  Score=342.84  Aligned_cols=254  Identities=24%  Similarity=0.310  Sum_probs=189.6

Q ss_pred             cCCCCCceecccCcEEEEEEEeC-CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeec-----Cc-
Q 012765          142 DNFNSENLIGKGGHAEVYKGCLP-DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTE-----NG-  214 (457)
Q Consensus       142 ~~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-----~~-  214 (457)
                      .+|.+.+.||+|+||.||+|.+. +|+.||||++.....       .+.+|+.+++.++||||+++++++..     +. 
T Consensus        54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~-------~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~  126 (420)
T 1j1b_A           54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEV  126 (420)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT-------SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEE
T ss_pred             ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch-------hHHHHHHHHHHcCCCCccceeeEEeccCCCCcce
Confidence            45778899999999999999875 589999999865432       23469999999999999999986532     11 


Q ss_pred             -eEEEEEecCCCChhhhhh---cCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCC-CcEEEeecc
Q 012765          215 -FHLVLQFLPHGSLSSLLF---GSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSED-YEAQISDFG  289 (457)
Q Consensus       215 -~~lv~e~~~~gsL~~~l~---~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~-~~~kL~DFG  289 (457)
                       +++||||+++ ++...+.   .....+++..+..++.||+.||.|||+   .+|+||||||+|||++.+ +.+||+|||
T Consensus       127 ~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NILl~~~~~~~kl~DFG  202 (420)
T 1j1b_A          127 YLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFG  202 (420)
T ss_dssp             EEEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHT---TTEECSCCSGGGEEEETTTTEEEECCCT
T ss_pred             eEEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCChhhEEEeCCCCeEEeccch
Confidence             4689999986 5555443   345678999999999999999999999   899999999999999965 568999999


Q ss_pred             ccccCCCCCCceeeecccccccccChhccccC-CCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhh--hc--------
Q 012765          290 LAKWLPDNWSHHIVFPIEGTFGYLSPEYFMHG-IVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIW--AK--------  358 (457)
Q Consensus       290 l~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~--~~--------  358 (457)
                      +++.+.....   .....||+.|+|||++.+. .|+.++|||||||++|||++|+.||..........  ..        
T Consensus       203 ~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~  279 (420)
T 1j1b_A          203 SAKQLVRGEP---NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTRE  279 (420)
T ss_dssp             TCEECCTTCC---CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHH
T ss_pred             hhhhcccCCC---ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHH
Confidence            9987654322   2234589999999998765 79999999999999999999999998754321111  00        


Q ss_pred             ------cccccCCcccccCchhhcccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 012765          359 ------PLLQTSNFKELVDPRLADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQ  409 (457)
Q Consensus       359 ------~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~  409 (457)
                            +......+..+....+...+.......+.+++.+||+.||.+|||+.|+++
T Consensus       280 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~  336 (420)
T 1j1b_A          280 QIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA  336 (420)
T ss_dssp             HHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             HHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhC
Confidence                  000000111111111111111122346778999999999999999999986

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=2.9e-41  Score=332.35  Aligned_cols=259  Identities=21%  Similarity=0.290  Sum_probs=184.6

Q ss_pred             hhcCCCCCceecccCcEEEEEEEeC-CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcC-CCCcceeeeeee------
Q 012765          140 ATDNFNSENLIGKGGHAEVYKGCLP-DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHIN-HPNAAKLIGFST------  211 (457)
Q Consensus       140 ~~~~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~------  211 (457)
                      ...+|.+.+.||+|+||.||+|.+. +++.||+|++.....   .....+.+|+.++.++. ||||+++++++.      
T Consensus        26 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~  102 (337)
T 3ll6_A           26 GELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEE---EKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEES  102 (337)
T ss_dssp             TTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSH---HHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTS
T ss_pred             cCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCch---HHHHHHHHHHHHHHHhccCCChhhcccccccccccc
Confidence            3457889999999999999999864 689999998855432   34567899999999996 999999999763      


Q ss_pred             --cC-ceEEEEEecCCCChhhhhhc--CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC--eeeCCCCCCcEEEcCCCcEE
Q 012765          212 --EN-GFHLVLQFLPHGSLSSLLFG--STECLEWTIRYKIALGIAEGLQYLHHDCHRR--IIHRDIKASNILLSEDYEAQ  284 (457)
Q Consensus       212 --~~-~~~lv~e~~~~gsL~~~l~~--~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~--iiHrDlkp~NIll~~~~~~k  284 (457)
                        .. .++++|||+. |+|.+++..  ....+++..++.++.||+.||.|||+   .+  |+||||||+|||++.++.+|
T Consensus       103 ~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~---~~~~ivH~Dikp~NIl~~~~~~~k  178 (337)
T 3ll6_A          103 DTGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHR---QKPPIIHRDLKVENLLLSNQGTIK  178 (337)
T ss_dssp             TTSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHT---SSSCCBCCCCCGGGCEECTTSCEE
T ss_pred             ccCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHh---CCCCEEEccCCcccEEECCCCCEE
Confidence              12 2578889885 788888754  45569999999999999999999999   67  99999999999999999999


Q ss_pred             EeeccccccCCCCCCce----------eeecccccccccChhcc---ccCCCCcchhHHHHHHHHHHHHhCCCCCCcCCc
Q 012765          285 ISDFGLAKWLPDNWSHH----------IVFPIEGTFGYLSPEYF---MHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQ  351 (457)
Q Consensus       285 L~DFGl~~~~~~~~~~~----------~~~~~~gt~~y~aPE~~---~~~~~~~ksDvwSlGvll~eLltG~~pf~~~~~  351 (457)
                      |+|||++..........          ......||+.|+|||++   .+..++.++|||||||++|+|++|+.||.....
T Consensus       179 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~  258 (337)
T 3ll6_A          179 LCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAK  258 (337)
T ss_dssp             BCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC-----
T ss_pred             EecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhH
Confidence            99999998765432211          11134589999999998   566789999999999999999999999975332


Q ss_pred             chhhhhccccccCCcccccCchhhcccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCCCCCCC
Q 012765          352 SLVIWAKPLLQTSNFKELVDPRLADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQLLRGEGGQTDL  420 (457)
Q Consensus       352 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~~~~  420 (457)
                      ......       .    .........    ...+..++.+||+.||.+|||+.|+++.|+.+......
T Consensus       259 ~~~~~~-------~----~~~~~~~~~----~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~~~~  312 (337)
T 3ll6_A          259 LRIVNG-------K----YSIPPHDTQ----YTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAARNV  312 (337)
T ss_dssp             ------------------CCCCTTCCS----SGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHTTC
T ss_pred             HHhhcC-------c----ccCCccccc----chHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccCC
Confidence            111100       0    000000111    12356788899999999999999999999887654333

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=2.6e-40  Score=330.52  Aligned_cols=261  Identities=20%  Similarity=0.277  Sum_probs=196.9

Q ss_pred             hcCCCCCceecccCcEEEEEEEeC-CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeecC------
Q 012765          141 TDNFNSENLIGKGGHAEVYKGCLP-DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTEN------  213 (457)
Q Consensus       141 ~~~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~------  213 (457)
                      .++|.+.+.||+|+||.||+|.+. +++.||+|++....  .......+.+|+.++.+++||||+++++++...      
T Consensus        26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  103 (364)
T 3qyz_A           26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFE--HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMK  103 (364)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTT--CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCC
T ss_pred             cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEecccc--CcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccc
Confidence            468999999999999999999865 68899999986432  234456889999999999999999999977543      


Q ss_pred             ceEEEEEecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeecccccc
Q 012765          214 GFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKW  293 (457)
Q Consensus       214 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~  293 (457)
                      ..+++|||+. |+|.+++..  ..+++..++.++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||++..
T Consensus       104 ~~~iv~e~~~-~~L~~~l~~--~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~  177 (364)
T 3qyz_A          104 DVYIVQDLME-TDLYKLLKT--QHLSNDHICYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARV  177 (364)
T ss_dssp             CEEEEEECCS-EEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred             eEEEEEcccC-cCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCChHhEEECCCCCEEEEeCcceEe
Confidence            4689999987 588888854  358999999999999999999999   8999999999999999999999999999987


Q ss_pred             CCCCCCce-eeecccccccccChhcccc-CCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhc-cccccCC---cc
Q 012765          294 LPDNWSHH-IVFPIEGTFGYLSPEYFMH-GIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAK-PLLQTSN---FK  367 (457)
Q Consensus       294 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~-~~~~~~~---~~  367 (457)
                      ........ ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||............ .......   ..
T Consensus       178 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  257 (364)
T 3qyz_A          178 ADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLN  257 (364)
T ss_dssp             CCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHH
T ss_pred             cCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHH
Confidence            65432211 1233569999999998754 45899999999999999999999999864432211000 0000000   00


Q ss_pred             cccCchh---------h-----cccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 012765          368 ELVDPRL---------A-----DAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQ  409 (457)
Q Consensus       368 ~~~d~~l---------~-----~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~  409 (457)
                      .+.+...         .     ..........+.+++.+||+.||.+|||+.|+++
T Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  313 (364)
T 3qyz_A          258 CIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA  313 (364)
T ss_dssp             TCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             HhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            0000000         0     0000111245778999999999999999999987

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=8.9e-41  Score=336.55  Aligned_cols=257  Identities=21%  Similarity=0.274  Sum_probs=196.5

Q ss_pred             hhcCCCCCceecccCcEEEEEEEeC-CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcC--------CCCcceeeeee
Q 012765          140 ATDNFNSENLIGKGGHAEVYKGCLP-DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHIN--------HPNAAKLIGFS  210 (457)
Q Consensus       140 ~~~~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~--------hpniv~l~~~~  210 (457)
                      ..++|.+.+.||+|+||+||+|.+. +++.||+|++...    ......+.+|+.+++.++        |+||+++++++
T Consensus        35 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~  110 (397)
T 1wak_A           35 FNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA----EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDF  110 (397)
T ss_dssp             ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC----HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEE
T ss_pred             cCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC----CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecce
Confidence            4578999999999999999999864 6889999998643    233457889999998885        78899999966


Q ss_pred             e-----cCceEEEEEecCCCChhhhhhc-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCC-CeeeCCCCCCcEEEcCCC--
Q 012765          211 T-----ENGFHLVLQFLPHGSLSSLLFG-STECLEWTIRYKIALGIAEGLQYLHHDCHR-RIIHRDIKASNILLSEDY--  281 (457)
Q Consensus       211 ~-----~~~~~lv~e~~~~gsL~~~l~~-~~~~~~~~~~~~i~~qia~aL~yLH~~~~~-~iiHrDlkp~NIll~~~~--  281 (457)
                      .     ....++||||+ +++|.+.+.. ....+++..++.++.||+.||.|||+   . +|+||||||+|||++.++  
T Consensus       111 ~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~---~~givHrDikp~NIll~~~~~~  186 (397)
T 1wak_A          111 KISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHT---KCRIIHTDIKPENILLSVNEQY  186 (397)
T ss_dssp             EEEETTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHH---TTCEECCCCSGGGEEECCCHHH
T ss_pred             eecCCCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHeeEeccchh
Confidence            4     23468999999 5566665544 34669999999999999999999999   7 999999999999999775  


Q ss_pred             -----------------------------------------------cEEEeeccccccCCCCCCceeeecccccccccC
Q 012765          282 -----------------------------------------------EAQISDFGLAKWLPDNWSHHIVFPIEGTFGYLS  314 (457)
Q Consensus       282 -----------------------------------------------~~kL~DFGl~~~~~~~~~~~~~~~~~gt~~y~a  314 (457)
                                                                     .+||+|||++.......     ....||+.|+|
T Consensus       187 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~~-----~~~~gt~~y~a  261 (397)
T 1wak_A          187 IRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHF-----TEDIQTRQYRS  261 (397)
T ss_dssp             HHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBCS-----CSCCSCGGGCC
T ss_pred             hhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccccC-----ccCCCCCcccC
Confidence                                                           79999999998765432     23458999999


Q ss_pred             hhccccCCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhh-----h--h------------------ccccc-cCCccc
Q 012765          315 PEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVI-----W--A------------------KPLLQ-TSNFKE  368 (457)
Q Consensus       315 PE~~~~~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~-----~--~------------------~~~~~-~~~~~~  368 (457)
                      ||++.+..++.++|||||||++|||++|+.||.........     .  .                  ...+. ......
T Consensus       262 PE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~  341 (397)
T 1wak_A          262 LEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKH  341 (397)
T ss_dssp             HHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSS
T ss_pred             ChhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCcccccc
Confidence            99999999999999999999999999999999753321100     0  0                  00000 000000


Q ss_pred             ccCch-------h--hcccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 012765          369 LVDPR-------L--ADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQ  409 (457)
Q Consensus       369 ~~d~~-------l--~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~  409 (457)
                      +.+..       +  ...........+.+++.+||+.||.+|||+.|+++
T Consensus       342 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  391 (397)
T 1wak_A          342 ITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR  391 (397)
T ss_dssp             CCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred             ccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence            00000       0  01224556677889999999999999999999986

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=4.8e-41  Score=336.44  Aligned_cols=257  Identities=25%  Similarity=0.322  Sum_probs=181.2

Q ss_pred             hhcCCCCCceecccCcEEEEEEEe-CCCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeec------
Q 012765          140 ATDNFNSENLIGKGGHAEVYKGCL-PDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTE------  212 (457)
Q Consensus       140 ~~~~f~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~------  212 (457)
                      ..++|.+.+.||+|+||.||+|.+ .+|+.||||++..... .......+.+|+.+++.++||||+++++++..      
T Consensus        27 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~  105 (367)
T 2fst_X           27 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ-SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEE  105 (367)
T ss_dssp             EETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTS-SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGG
T ss_pred             CCCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCcccc-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCcccc
Confidence            357899999999999999999985 4689999999865432 23445688899999999999999999997654      


Q ss_pred             -CceEEEEEecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeecccc
Q 012765          213 -NGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLA  291 (457)
Q Consensus       213 -~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~  291 (457)
                       ...++++|++ +++|..++..  ..+++..+..++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||++
T Consensus       106 ~~~~~lv~e~~-~~~L~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~---~givH~Dlkp~NIll~~~~~~kL~DFG~a  179 (367)
T 2fst_X          106 FNDVYLVTHLM-GADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLA  179 (367)
T ss_dssp             CCCCEEEEECC-CEECC-------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECC----
T ss_pred             CCeEEEEeccc-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHhhEEECCCCCEEEeecccc
Confidence             3468899988 7888888843  568999999999999999999999   89999999999999999999999999999


Q ss_pred             ccCCCCCCceeeecccccccccChhcccc-CCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhc-cccccCC---c
Q 012765          292 KWLPDNWSHHIVFPIEGTFGYLSPEYFMH-GIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAK-PLLQTSN---F  366 (457)
Q Consensus       292 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~-~~~~~~~---~  366 (457)
                      +.....     .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||...+........ .....+.   .
T Consensus       180 ~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~  254 (367)
T 2fst_X          180 RHTADE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELL  254 (367)
T ss_dssp             ----------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHH
T ss_pred             cccccc-----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence            875433     223458999999999887 67899999999999999999999999875432111000 0000000   0


Q ss_pred             ccccC---------------chhhcccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 012765          367 KELVD---------------PRLADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQ  409 (457)
Q Consensus       367 ~~~~d---------------~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~  409 (457)
                      ..+..               ..+... .......+.+++.+||+.||.+|||+.|+++
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~  311 (367)
T 2fst_X          255 KKISSESARNYIQSLTQMPKMNFANV-FIGANPLAVDLLEKMLVLDSDKRITAAQALA  311 (367)
T ss_dssp             TTCCCHHHHHHHHTSCCCCCCCHHHH-TTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             HHhhhHHHHHHHhccCCCCCCCHHHH-CCCCCHHHHHHHHHhCCCCcccCcCHHHHhc
Confidence            00000               000000 0011245678999999999999999999987

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=2.1e-40  Score=321.17  Aligned_cols=252  Identities=25%  Similarity=0.398  Sum_probs=191.1

Q ss_pred             hhcCCCCCceecccCcEEEEEEEeC-CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeec------
Q 012765          140 ATDNFNSENLIGKGGHAEVYKGCLP-DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTE------  212 (457)
Q Consensus       140 ~~~~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~------  212 (457)
                      ..++|++.+.||+|+||.||+|... +++.||+|++...    ......+.+|+.+++.++||||+++++++.+      
T Consensus         4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   79 (303)
T 1zy4_A            4 YASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT----EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVK   79 (303)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE----HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC
T ss_pred             ccccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc----HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhh
Confidence            4567889999999999999999864 7899999988542    2345688999999999999999999996543      


Q ss_pred             --------CceEEEEEecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEE
Q 012765          213 --------NGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQ  284 (457)
Q Consensus       213 --------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~k  284 (457)
                              +..++||||+++++|.+++......+++..++.++.||+.||.|||+   .+|+||||||+|||++.++.+|
T Consensus        80 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dlkp~Nil~~~~~~~k  156 (303)
T 1zy4_A           80 PMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHS---QGIIHRDLKPMNIFIDESRNVK  156 (303)
T ss_dssp             ------CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEE
T ss_pred             hhcccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHh---CCeecccCCHHhEEEcCCCCEE
Confidence                    34689999999999999998766678889999999999999999999   8999999999999999999999


Q ss_pred             EeeccccccCCCCCC------------ceeeecccccccccChhccccC-CCCcchhHHHHHHHHHHHHhCCCCCCcCCc
Q 012765          285 ISDFGLAKWLPDNWS------------HHIVFPIEGTFGYLSPEYFMHG-IVDEKTDVFAFGVLLLELITGRRAVDSRRQ  351 (457)
Q Consensus       285 L~DFGl~~~~~~~~~------------~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDvwSlGvll~eLltG~~pf~~~~~  351 (457)
                      |+|||++........            ........||+.|+|||++.+. .++.++|||||||++|||++   ||.....
T Consensus       157 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~  233 (303)
T 1zy4_A          157 IGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGME  233 (303)
T ss_dssp             ECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHH
T ss_pred             EeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchh
Confidence            999999987643210            1122345689999999999764 68999999999999999998   5543111


Q ss_pred             chhhhhccccccCCcccccCchhhcccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 012765          352 SLVIWAKPLLQTSNFKELVDPRLADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQ  409 (457)
Q Consensus       352 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~  409 (457)
                      ........ . ..      ...+...+.......+.+++.+||+.||.+|||+.++++
T Consensus       234 ~~~~~~~~-~-~~------~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  283 (303)
T 1zy4_A          234 RVNILKKL-R-SV------SIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLN  283 (303)
T ss_dssp             HHHHHHHH-H-ST------TCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHhc-c-cc------ccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhC
Confidence            11110000 0 00      011111122223345678899999999999999999987

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=3.2e-41  Score=329.76  Aligned_cols=262  Identities=18%  Similarity=0.311  Sum_probs=195.3

Q ss_pred             cccHHHHHHhhcCCCCCceecccCcEEEEEEEeCCCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcC--CCCcceeee
Q 012765          131 NFDFAELAAATDNFNSENLIGKGGHAEVYKGCLPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHIN--HPNAAKLIG  208 (457)
Q Consensus       131 ~~~~~~~~~~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~--hpniv~l~~  208 (457)
                      ++.+..+....++|.+.+.||+|+||.||+|.+.+++.||+|.+..... .......+.+|+.++.+++  ||||+++++
T Consensus        17 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~   95 (313)
T 3cek_A           17 NLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEA-DNQTLDSYRNEIAYLNKLQQHSDKIIRLYD   95 (313)
T ss_dssp             ---CCEEEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSC-CHHHHHHHHHHHHHHHHHGGGCTTBCCEEE
T ss_pred             CCCeeeeeeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccc-cccchHHHHHHHHHHHhccccCCceEEEEE
Confidence            3344444456678999999999999999999988899999999865433 2345678999999999997  599999999


Q ss_pred             eeecCc-eEEEEEecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEee
Q 012765          209 FSTENG-FHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISD  287 (457)
Q Consensus       209 ~~~~~~-~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~D  287 (457)
                      ++.... .+++|| +.+++|.+++... ..+++..++.++.||+.||.|||+   .+|+||||||+|||+++ +.+||+|
T Consensus        96 ~~~~~~~~~lv~e-~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIl~~~-~~~kL~D  169 (313)
T 3cek_A           96 YEITDQYIYMVME-CGNIDLNSWLKKK-KSIDPWERKSYWKNMLEAVHTIHQ---HGIVHSDLKPANFLIVD-GMLKLID  169 (313)
T ss_dssp             EEECSSEEEEEEC-CCSEEHHHHHHHC-SSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEEET-TEEEECC
T ss_pred             EeecCCEEEEEEe-cCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCcccEEEEC-CeEEEee
Confidence            776655 568888 7788999998654 468889999999999999999999   89999999999999964 8999999


Q ss_pred             ccccccCCCCCCceeeecccccccccChhcccc-----------CCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhh
Q 012765          288 FGLAKWLPDNWSHHIVFPIEGTFGYLSPEYFMH-----------GIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIW  356 (457)
Q Consensus       288 FGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~  356 (457)
                      ||++..+.............||+.|+|||++.+           ..++.++|||||||++|||++|+.||..........
T Consensus       170 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~  249 (313)
T 3cek_A          170 FGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKL  249 (313)
T ss_dssp             CSSSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHH
T ss_pred             ccccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHH
Confidence            999987754433222334568999999999865           478899999999999999999999997643222111


Q ss_pred             hccccccCCcccccCchhhcccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 012765          357 AKPLLQTSNFKELVDPRLADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQ  409 (457)
Q Consensus       357 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~  409 (457)
                      .          .++++.....+.......+.+++.+||+.||.+||++.++++
T Consensus       250 ~----------~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  292 (313)
T 3cek_A          250 H----------AIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA  292 (313)
T ss_dssp             H----------HHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             H----------HHHhcccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhc
Confidence            1          111111111111111235677888999999999999999987

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=8.6e-41  Score=328.25  Aligned_cols=255  Identities=24%  Similarity=0.390  Sum_probs=194.7

Q ss_pred             HHHHHhhcCCCCCceecccCcEEEEEEEeC-CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhc-CCCCcceeeeeeec
Q 012765          135 AELAAATDNFNSENLIGKGGHAEVYKGCLP-DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHI-NHPNAAKLIGFSTE  212 (457)
Q Consensus       135 ~~~~~~~~~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~  212 (457)
                      .++....++|.+.+.||+|+||.||+|.+. +++.||+|++......    ...+.+|+.++.++ +||||+++++++..
T Consensus        17 ~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~----~~~~~~e~~~l~~l~~h~~i~~~~~~~~~   92 (326)
T 2x7f_A           17 SALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDE----EEEIKQEINMLKKYSHHRNIATYYGAFIK   92 (326)
T ss_dssp             CCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSST----THHHHHHHHHHHHHCCSTTBCCEEEEEEE
T ss_pred             hhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCccc----HHHHHHHHHHHHhccCCCCeeeeeeEEee
Confidence            333456788999999999999999999864 6899999998654332    24688999999998 79999999997654


Q ss_pred             -------CceEEEEEecCCCChhhhhhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEE
Q 012765          213 -------NGFHLVLQFLPHGSLSSLLFGS-TECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQ  284 (457)
Q Consensus       213 -------~~~~lv~e~~~~gsL~~~l~~~-~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~k  284 (457)
                             +..++||||+.+++|.+++... ...+++..++.++.||+.||.|||+   .+|+||||||+|||++.++.+|
T Consensus        93 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dlkp~NIl~~~~~~~k  169 (326)
T 2x7f_A           93 KNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQ---HKVIHRDIKGQNVLLTENAEVK  169 (326)
T ss_dssp             CC--CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEECTTCCEE
T ss_pred             ccCccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCcHHHEEEcCCCCEE
Confidence                   4578999999999999998654 3468899999999999999999999   8999999999999999999999


Q ss_pred             EeeccccccCCCCCCceeeecccccccccChhccc-----cCCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhcc
Q 012765          285 ISDFGLAKWLPDNWSHHIVFPIEGTFGYLSPEYFM-----HGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKP  359 (457)
Q Consensus       285 L~DFGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~~  359 (457)
                      |+|||++........  ......||+.|+|||++.     +..++.++|||||||++|+|++|..||.........+...
T Consensus       170 l~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~  247 (326)
T 2x7f_A          170 LVDFGVSAQLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIP  247 (326)
T ss_dssp             ECCCTTTC---------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHH
T ss_pred             EeeCcCceecCcCcc--ccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhh
Confidence            999999987643321  122345899999999987     5678999999999999999999999997644332221111


Q ss_pred             ccccCCcccccCchhhcccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 012765          360 LLQTSNFKELVDPRLADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQ  409 (457)
Q Consensus       360 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~  409 (457)
                      .   ........    ..+    ...+..++.+||..||.+||++.++++
T Consensus       248 ~---~~~~~~~~----~~~----~~~l~~li~~~l~~dp~~Rps~~~ll~  286 (326)
T 2x7f_A          248 R---NPAPRLKS----KKW----SKKFQSFIESCLVKNHSQRPATEQLMK  286 (326)
T ss_dssp             H---SCCCCCSC----SCS----CHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             c---CccccCCc----ccc----CHHHHHHHHHHhccChhhCCCHHHHhh
Confidence            0   00011111    111    235677889999999999999999987

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=8.3e-41  Score=325.47  Aligned_cols=255  Identities=22%  Similarity=0.329  Sum_probs=198.6

Q ss_pred             hhcCCCCCceecccCcEEEEEEEeC-CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeecC-ceEE
Q 012765          140 ATDNFNSENLIGKGGHAEVYKGCLP-DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTEN-GFHL  217 (457)
Q Consensus       140 ~~~~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~-~~~l  217 (457)
                      ..++|.+.+.||+|+||+||+|... +|+.||+|.+......   ....+.+|+.+++.++||||+++++++.+. ..++
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   83 (304)
T 2jam_A            7 IRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAF---RDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYL   83 (304)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC---------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred             hhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEeccccc---chHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEE
Confidence            4567889999999999999999875 6899999998754322   234688999999999999999999976654 4689


Q ss_pred             EEEecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEE---cCCCcEEEeeccccccC
Q 012765          218 VLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILL---SEDYEAQISDFGLAKWL  294 (457)
Q Consensus       218 v~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll---~~~~~~kL~DFGl~~~~  294 (457)
                      +|||+++++|.+++... ..+++..++.++.||+.||.|||+   .+|+||||||+||++   +.++.+||+|||++...
T Consensus        84 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~  159 (304)
T 2jam_A           84 VMQLVSGGELFDRILER-GVYTEKDASLVIQQVLSAVKYLHE---NGIVHRDLKPENLLYLTPEENSKIMITDFGLSKME  159 (304)
T ss_dssp             EECCCCSCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCC
T ss_pred             EEEcCCCccHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEecCCCCCCEEEccCCcceec
Confidence            99999999999988543 358899999999999999999999   899999999999999   77889999999998765


Q ss_pred             CCCCCceeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhccccccCCcccccCchh
Q 012765          295 PDNWSHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSNFKELVDPRL  374 (457)
Q Consensus       295 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l  374 (457)
                      ....    .....||+.|+|||++.+..++.++|||||||++|+|++|..||...........  ... ... .. ....
T Consensus       160 ~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~--i~~-~~~-~~-~~~~  230 (304)
T 2jam_A          160 QNGI----MSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEK--IKE-GYY-EF-ESPF  230 (304)
T ss_dssp             CCBT----THHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHH--HHH-CCC-CC-CTTT
T ss_pred             CCCc----cccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHH--HHc-CCC-CC-Cccc
Confidence            4332    1234589999999999999999999999999999999999999986443211100  000 000 00 0111


Q ss_pred             hcccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH--HHhcC
Q 012765          375 ADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQ--LLRGE  414 (457)
Q Consensus       375 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~--~L~~~  414 (457)
                      ...    ....+.+++.+||+.||.+|||+.++++  .+++.
T Consensus       231 ~~~----~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~  268 (304)
T 2jam_A          231 WDD----ISESAKDFICHLLEKDPNERYTCEKALSHPWIDGN  268 (304)
T ss_dssp             TTT----SCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHSS
T ss_pred             ccc----CCHHHHHHHHHHcCCChhHCcCHHHHhcCccccCC
Confidence            111    2245678899999999999999999987  45443

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=6.6e-41  Score=360.24  Aligned_cols=252  Identities=21%  Similarity=0.266  Sum_probs=200.3

Q ss_pred             HhhcCCCCCceecccCcEEEEEEEeC-CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhc-CCCCcceeeeeeec-Cce
Q 012765          139 AATDNFNSENLIGKGGHAEVYKGCLP-DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHI-NHPNAAKLIGFSTE-NGF  215 (457)
Q Consensus       139 ~~~~~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~-~~~  215 (457)
                      ...++|.+.++||+|+||.||+|.+. +++.||||++.+...........+..|..++..+ +||||+++++++.+ +.+
T Consensus       338 ~~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~  417 (674)
T 3pfq_A          338 MKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRL  417 (674)
T ss_dssp             --CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEE
T ss_pred             ccccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEE
Confidence            34578999999999999999999865 5889999998754333333456788899999887 79999999996655 557


Q ss_pred             EEEEEecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCC
Q 012765          216 HLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLP  295 (457)
Q Consensus       216 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~  295 (457)
                      ++||||+.+|+|..++... ..+++..+..++.||+.||.|||+   .+|+||||||+||||+.++.+||+|||+++...
T Consensus       418 ~lV~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~---~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~  493 (674)
T 3pfq_A          418 YFVMEYVNGGDLMYHIQQV-GRFKEPHAVFYAAEIAIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENI  493 (674)
T ss_dssp             EEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHH---TSEECCCCCSTTEEECSSSCEEECCCTTCEECC
T ss_pred             EEEEeCcCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHh---CCeEeccCChhhEEEcCCCcEEEeecceeeccc
Confidence            8999999999999999654 458999999999999999999999   899999999999999999999999999998643


Q ss_pred             CCCCceeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhccccccCCcccccCchhh
Q 012765          296 DNWSHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSNFKELVDPRLA  375 (457)
Q Consensus       296 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  375 (457)
                      ....  ......||+.|+|||++.+..|+.++|||||||++|||++|+.||...+...... ........+        .
T Consensus       494 ~~~~--~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~-~i~~~~~~~--------p  562 (674)
T 3pfq_A          494 WDGV--TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQ-SIMEHNVAY--------P  562 (674)
T ss_dssp             CTTC--CBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH-HHHSSCCCC--------C
T ss_pred             cCCc--ccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHHHHH-HHHhCCCCC--------C
Confidence            3221  2334679999999999999999999999999999999999999998754332211 111111111        1


Q ss_pred             cccCHHHHHHHHHHHHHhcccCCCCCCCH-----HHHHH
Q 012765          376 DAYDLAEMKRAMLTASVCIHHLSTMRPQM-----TRVLQ  409 (457)
Q Consensus       376 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~-----~evl~  409 (457)
                      ..    ....+.+++..||+.||.+||++     .||++
T Consensus       563 ~~----~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~  597 (674)
T 3pfq_A          563 KS----MSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE  597 (674)
T ss_dssp             TT----SCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHS
T ss_pred             cc----CCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhc
Confidence            11    22356778899999999999998     66654

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=2.3e-41  Score=331.15  Aligned_cols=262  Identities=22%  Similarity=0.316  Sum_probs=197.3

Q ss_pred             HhhcCCCCCceecccCcEEEEEEEeCCCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeec-CceEE
Q 012765          139 AATDNFNSENLIGKGGHAEVYKGCLPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTE-NGFHL  217 (457)
Q Consensus       139 ~~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-~~~~l  217 (457)
                      ...++|.+.+.||+|+||.||+|.+..  .+|+|.+...... ......+.+|+.+++.++||||+++++++.+ +..++
T Consensus        30 i~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~i  106 (319)
T 2y4i_B           30 IPFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDN-EDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAI  106 (319)
T ss_dssp             SCCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCC-CCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEE
T ss_pred             CCHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCC-HHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEE
Confidence            345788899999999999999998743  4999987643221 1223467789999999999999999997665 45789


Q ss_pred             EEEecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCCCC
Q 012765          218 VLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDN  297 (457)
Q Consensus       218 v~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~~  297 (457)
                      +|||+.+++|.+++......+++..++.++.||+.||.|||+   .+|+||||||+|||++ ++.+||+|||++......
T Consensus       107 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~---~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~  182 (319)
T 2y4i_B          107 ITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHA---KGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVL  182 (319)
T ss_dssp             ECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHH---TTCCCCCCCSTTEEEC---CCEECCCSCCC-----
T ss_pred             EeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCccccCCChhhEEEe-CCCEEEeecCCccccccc
Confidence            999999999999997766678999999999999999999999   8999999999999998 679999999998765321


Q ss_pred             C---CceeeecccccccccChhcccc---------CCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhccccccCC
Q 012765          298 W---SHHIVFPIEGTFGYLSPEYFMH---------GIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSN  365 (457)
Q Consensus       298 ~---~~~~~~~~~gt~~y~aPE~~~~---------~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~~~~~~~~  365 (457)
                      .   .........||+.|+|||++.+         ..++.++|||||||++|||++|+.||.........+.......  
T Consensus       183 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~--  260 (319)
T 2y4i_B          183 QAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGMK--  260 (319)
T ss_dssp             -----CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHHHTTCC--
T ss_pred             cccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhccCCC--
Confidence            1   1112233458999999999864         4578999999999999999999999987544333222111100  


Q ss_pred             cccccCchhhcccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCCCCC
Q 012765          366 FKELVDPRLADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQLLRGEGGQT  418 (457)
Q Consensus       366 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~~  418 (457)
                       ......    .+    ...+.+++..||+.||.+|||+.+|++.|+.+....
T Consensus       261 -~~~~~~----~~----~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~  304 (319)
T 2y4i_B          261 -PNLSQI----GM----GKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRN  304 (319)
T ss_dssp             -CCCCCS----SC----CTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC----
T ss_pred             -CCCCcC----CC----CHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhh
Confidence             001110    11    124667889999999999999999999999987554

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=5.2e-40  Score=326.29  Aligned_cols=268  Identities=20%  Similarity=0.279  Sum_probs=199.1

Q ss_pred             hhcCCCCCceecccCcEEEEEEEeC-CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeec------
Q 012765          140 ATDNFNSENLIGKGGHAEVYKGCLP-DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTE------  212 (457)
Q Consensus       140 ~~~~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~------  212 (457)
                      ..++|.+.+.||+|+||.||+|.+. +|+.||||++....  .......+.+|+.+++.++||||+++++++..      
T Consensus         9 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   86 (353)
T 2b9h_A            9 ISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFD--KPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENF   86 (353)
T ss_dssp             SCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCS--SHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTC
T ss_pred             cccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccc--cchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCcc
Confidence            3578889999999999999999875 68999999985432  23445678899999999999999999997654      


Q ss_pred             CceEEEEEecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccc
Q 012765          213 NGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAK  292 (457)
Q Consensus       213 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~  292 (457)
                      ...+++|||+. ++|.+++..  ..+++..++.++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||++.
T Consensus        87 ~~~~lv~e~~~-~~L~~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~---~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~  160 (353)
T 2b9h_A           87 NEVYIIQELMQ-TDLHRVIST--QMLSDDHIQYFIYQTLRAVKVLHG---SNVIHRDLKPSNLLINSNCDLKVCDFGLAR  160 (353)
T ss_dssp             CCEEEEECCCS-EEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTCCEEECCCTTCE
T ss_pred             ceEEEEEeccC-ccHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEEcCCCcEEEEeccccc
Confidence            45789999997 588888854  458999999999999999999999   899999999999999999999999999998


Q ss_pred             cCCCCCCce--------eeecccccccccChhcccc-CCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhc-----
Q 012765          293 WLPDNWSHH--------IVFPIEGTFGYLSPEYFMH-GIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAK-----  358 (457)
Q Consensus       293 ~~~~~~~~~--------~~~~~~gt~~y~aPE~~~~-~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~-----  358 (457)
                      .+.......        ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||............     
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~  240 (353)
T 2b9h_A          161 IIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIG  240 (353)
T ss_dssp             ECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHC
T ss_pred             ccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhC
Confidence            765432111        1223468999999998764 67899999999999999999999999865422111000     


Q ss_pred             cccccCCcccccCchhh--------------cccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH--HHhcCC
Q 012765          359 PLLQTSNFKELVDPRLA--------------DAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQ--LLRGEG  415 (457)
Q Consensus       359 ~~~~~~~~~~~~d~~l~--------------~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~--~L~~~~  415 (457)
                      ..........+..+...              ..........+.+++.+||+.||.+|||+.|+++  .++...
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~  313 (353)
T 2b9h_A          241 TPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTYH  313 (353)
T ss_dssp             CCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred             CCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCccccccC
Confidence            00000000000000000              0000112345678899999999999999999988  455543

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=3.9e-40  Score=343.54  Aligned_cols=253  Identities=23%  Similarity=0.330  Sum_probs=195.7

Q ss_pred             hhcCCCCCceecccCcEEEEEEEeC-CCcEEEEEEEeccchhhH----------HHHHHHHHHHHHHhhcCCCCcceeee
Q 012765          140 ATDNFNSENLIGKGGHAEVYKGCLP-DGEVVAVKKIIKNAKEDE----------ERISDFLSELGIVAHINHPNAAKLIG  208 (457)
Q Consensus       140 ~~~~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~----------~~~~~~~~E~~~l~~l~hpniv~l~~  208 (457)
                      ..++|.+.+.||+|+||+||+|... +++.||+|++........          .....+.+|+.+++.++||||+++++
T Consensus        34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~  113 (504)
T 3q5i_A           34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD  113 (504)
T ss_dssp             GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred             cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence            4578999999999999999999865 588999999865432211          22457889999999999999999999


Q ss_pred             eeecCc-eEEEEEecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCC---cEE
Q 012765          209 FSTENG-FHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDY---EAQ  284 (457)
Q Consensus       209 ~~~~~~-~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~---~~k  284 (457)
                      ++.+.. .++||||+++|+|.+++... ..+++..++.++.||+.||.|||+   .+|+||||||+|||++.++   .+|
T Consensus       114 ~~~~~~~~~lv~e~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~k  189 (504)
T 3q5i_A          114 VFEDKKYFYLVTEFYEGGELFEQIINR-HKFDECDAANIMKQILSGICYLHK---HNIVHRDIKPENILLENKNSLLNIK  189 (504)
T ss_dssp             EEECSSEEEEEEECCTTCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESSTTCCSSEE
T ss_pred             EEEcCCEEEEEEecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCcHHHEEEecCCCCccEE
Confidence            776654 67999999999999988553 458999999999999999999999   8999999999999998776   699


Q ss_pred             EeeccccccCCCCCCceeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhccccccC
Q 012765          285 ISDFGLAKWLPDNWSHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTS  364 (457)
Q Consensus       285 L~DFGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~~~~~~~  364 (457)
                      |+|||++........   .....||+.|+|||++. +.|+.++|||||||++|+|++|..||.............   ..
T Consensus       190 l~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~---~~  262 (504)
T 3q5i_A          190 IVDFGLSSFFSKDYK---LRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVE---KG  262 (504)
T ss_dssp             ECCCTTCEECCTTSC---BCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH---HC
T ss_pred             EEECCCCEEcCCCCc---cccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH---cC
Confidence            999999987755422   23456999999999986 568999999999999999999999998644322111100   00


Q ss_pred             CcccccCchhhcccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 012765          365 NFKELVDPRLADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQ  409 (457)
Q Consensus       365 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~  409 (457)
                      ..  ..+......+    ...+.+++.+||+.||.+|||+.|+++
T Consensus       263 ~~--~~~~~~~~~~----s~~~~~li~~~L~~dp~~R~t~~e~l~  301 (504)
T 3q5i_A          263 KY--YFDFNDWKNI----SDEAKELIKLMLTYDYNKRCTAEEALN  301 (504)
T ss_dssp             CC--CCCHHHHTTS----CHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             CC--CCCccccCCC----CHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence            00  0000000111    245678899999999999999999986

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=1e-40  Score=332.21  Aligned_cols=267  Identities=20%  Similarity=0.256  Sum_probs=187.5

Q ss_pred             HHHhhcCCCCCceecccCcEEEEEEEeC-CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeec-Cc
Q 012765          137 LAAATDNFNSENLIGKGGHAEVYKGCLP-DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTE-NG  214 (457)
Q Consensus       137 ~~~~~~~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-~~  214 (457)
                      .....++|.+.+.||+|+||+||+|.+. +|+.||||++......    ...+.+++..+..++||||+++++++.. +.
T Consensus        18 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~   93 (360)
T 3e3p_A           18 SRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRF----RNRELQIMQDLAVLHHPNIVQLQSYFYTLGE   93 (360)
T ss_dssp             HHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTTC----CCHHHHHHHHHHHHCCTTBCCEEEEEEEECS
T ss_pred             chhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccc----cHHHHHHHHHHHhcCCCCcccHHHhhhcccc
Confidence            4456789999999999999999999874 6899999988654332    2255678888889999999999996643 22


Q ss_pred             -------eEEEEEecCCCChhhhhh---cCCCCCCHHHHHHHHHHHHHHHHHHH--hcCCCCeeeCCCCCCcEEEcC-CC
Q 012765          215 -------FHLVLQFLPHGSLSSLLF---GSTECLEWTIRYKIALGIAEGLQYLH--HDCHRRIIHRDIKASNILLSE-DY  281 (457)
Q Consensus       215 -------~~lv~e~~~~gsL~~~l~---~~~~~~~~~~~~~i~~qia~aL~yLH--~~~~~~iiHrDlkp~NIll~~-~~  281 (457)
                             .++||||+.++ |...+.   .....+++..+..++.|++.||.|||  +   .+|+||||||+|||++. ++
T Consensus        94 ~~~~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---~~ivH~Dlkp~NIll~~~~~  169 (360)
T 3e3p_A           94 RDRRDIYLNVVMEYVPDT-LHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPS---VNVCHRDIKPHNVLVNEADG  169 (360)
T ss_dssp             SCTTCEEEEEEEECCSCB-HHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTT---TCCBCSCCCGGGEEEETTTT
T ss_pred             ccccceeEEEEeeccccc-HHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCC---CCeecCcCCHHHEEEeCCCC
Confidence                   67999999874 443332   34556889999999999999999999  7   89999999999999996 89


Q ss_pred             cEEEeeccccccCCCCCCceeeecccccccccChhccccCC-CCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhccc
Q 012765          282 EAQISDFGLAKWLPDNWSHHIVFPIEGTFGYLSPEYFMHGI-VDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPL  360 (457)
Q Consensus       282 ~~kL~DFGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~~~  360 (457)
                      .+||+|||++..+.....   .....||+.|+|||++.+.. ++.++|||||||++|||++|+.||..............
T Consensus       170 ~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~  246 (360)
T 3e3p_A          170 TLKLCDFGSAKKLSPSEP---NVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVR  246 (360)
T ss_dssp             EEEECCCTTCBCCCTTSC---CCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred             cEEEeeCCCceecCCCCC---cccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHH
Confidence            999999999987754432   22345899999999987654 89999999999999999999999987543221111000


Q ss_pred             -cccC-------------Cccccc--C---chhhcccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH--HHhcC
Q 012765          361 -LQTS-------------NFKELV--D---PRLADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQ--LLRGE  414 (457)
Q Consensus       361 -~~~~-------------~~~~~~--d---~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~--~L~~~  414 (457)
                       ....             ......  .   ..+...........+.+++.+||+.||.+|||+.|+++  .+++.
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~  321 (360)
T 3e3p_A          247 VLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDEL  321 (360)
T ss_dssp             HHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGG
T ss_pred             HcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCcccccc
Confidence             0000             000000  0   00001111123467888999999999999999999987  34444

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=8.2e-41  Score=347.09  Aligned_cols=252  Identities=26%  Similarity=0.377  Sum_probs=196.5

Q ss_pred             hhcCCCCCceecccCcEEEEEEEeC-CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeecC-ceEE
Q 012765          140 ATDNFNSENLIGKGGHAEVYKGCLP-DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTEN-GFHL  217 (457)
Q Consensus       140 ~~~~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~-~~~l  217 (457)
                      ..++|.+.+.||+|+||+||+|... +++.||+|++....... .....+.+|+.++++++||||+++++++.+. .+++
T Consensus        20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l   98 (486)
T 3mwu_A           20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKN-KDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYI   98 (486)
T ss_dssp             HHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBC-SCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred             hhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccc-hHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEE
Confidence            4577999999999999999999875 68999999986432211 1245788999999999999999999977655 4689


Q ss_pred             EEEecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEc---CCCcEEEeeccccccC
Q 012765          218 VLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLS---EDYEAQISDFGLAKWL  294 (457)
Q Consensus       218 v~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~---~~~~~kL~DFGl~~~~  294 (457)
                      ||||+.+|+|.+++... ..+++..++.++.||+.||.|||+   .+|+||||||+|||++   .++.+||+|||++...
T Consensus        99 v~e~~~~~~L~~~~~~~-~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~  174 (486)
T 3mwu_A           99 VGELYTGGELFDEIIKR-KRFSEHDAARIIKQVFSGITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCF  174 (486)
T ss_dssp             EECCCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTB
T ss_pred             EEEcCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCchHHEEEecCCCCCCEEEEECCcCeEC
Confidence            99999999999988553 458999999999999999999999   8999999999999995   4567999999999876


Q ss_pred             CCCCCceeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhccccccCCcccccCchh
Q 012765          295 PDNWSHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSNFKELVDPRL  374 (457)
Q Consensus       295 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l  374 (457)
                      ....   ......||+.|+|||++.+ .|+.++|||||||++|+|++|..||.............   ..... ...+..
T Consensus       175 ~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~---~~~~~-~~~~~~  246 (486)
T 3mwu_A          175 QQNT---KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVE---TGKYA-FDLPQW  246 (486)
T ss_dssp             CCC-------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH---HTCCC-SCSGGG
T ss_pred             CCCC---ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH---hCCCC-CCCccc
Confidence            5432   2234569999999999875 59999999999999999999999998654322111100   00000 000110


Q ss_pred             hcccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 012765          375 ADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQ  409 (457)
Q Consensus       375 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~  409 (457)
                       ..    ....+.+++.+||+.||.+|||+.++++
T Consensus       247 -~~----~s~~~~~li~~~L~~dp~~R~t~~~~l~  276 (486)
T 3mwu_A          247 -RT----ISDDAKDLIRKMLTFHPSLRITATQCLE  276 (486)
T ss_dssp             -GG----SCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             -CC----CCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence             11    1234668889999999999999999998

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=5.4e-41  Score=332.74  Aligned_cols=263  Identities=18%  Similarity=0.309  Sum_probs=200.5

Q ss_pred             hhcCCCCCceecccCcEEEEEEEeCCCcEEEEEEEeccchhhHH--------------HHHHHHHHHHHHhhcCCCCcce
Q 012765          140 ATDNFNSENLIGKGGHAEVYKGCLPDGEVVAVKKIIKNAKEDEE--------------RISDFLSELGIVAHINHPNAAK  205 (457)
Q Consensus       140 ~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~--------------~~~~~~~E~~~l~~l~hpniv~  205 (457)
                      ..++|.+.+.||+|+||.||+|.+ +++.||+|.+.........              ....+.+|+.++..++||||++
T Consensus        29 ~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~  107 (348)
T 2pml_X           29 YINDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLT  107 (348)
T ss_dssp             EETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCC
T ss_pred             ccCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcce
Confidence            357899999999999999999998 9999999998643221110              1157899999999999999999


Q ss_pred             eeeeeecC-ceEEEEEecCCCChhhh------hhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEE
Q 012765          206 LIGFSTEN-GFHLVLQFLPHGSLSSL------LFGS-TECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILL  277 (457)
Q Consensus       206 l~~~~~~~-~~~lv~e~~~~gsL~~~------l~~~-~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll  277 (457)
                      +++++.+. ..++||||+++++|.++      +... ...+++..++.++.||+.||.|||+.  .+|+||||||+||++
T Consensus       108 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~--~~i~H~dl~p~Nil~  185 (348)
T 2pml_X          108 CEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNE--KNICHRDVKPSNILM  185 (348)
T ss_dssp             CSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHT--SCEECCCCCGGGEEE
T ss_pred             EEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhcc--CCEeecCCChHhEEE
Confidence            99976654 56899999999999998      5432 56789999999999999999999972  699999999999999


Q ss_pred             cCCCcEEEeeccccccCCCCCCceeeecccccccccChhccccC-CCCc-chhHHHHHHHHHHHHhCCCCCCcCCcchhh
Q 012765          278 SEDYEAQISDFGLAKWLPDNWSHHIVFPIEGTFGYLSPEYFMHG-IVDE-KTDVFAFGVLLLELITGRRAVDSRRQSLVI  355 (457)
Q Consensus       278 ~~~~~~kL~DFGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~-ksDvwSlGvll~eLltG~~pf~~~~~~~~~  355 (457)
                      +.++.+||+|||++......    ......||..|+|||++.+. .++. ++|||||||++|||++|..||.........
T Consensus       186 ~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~  261 (348)
T 2pml_X          186 DKNGRVKLSDFGESEYMVDK----KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVEL  261 (348)
T ss_dssp             CTTSCEEECCCTTCEECBTT----EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHHH
T ss_pred             cCCCcEEEeccccccccccc----cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHHH
Confidence            99999999999999876443    23345699999999999877 6666 999999999999999999999865442211


Q ss_pred             hhccccccCCccc----ccCchhh---cccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 012765          356 WAKPLLQTSNFKE----LVDPRLA---DAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQ  409 (457)
Q Consensus       356 ~~~~~~~~~~~~~----~~d~~l~---~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~  409 (457)
                      +............    ...+...   ..........+.+++.+||+.||.+|||+.|+++
T Consensus       262 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~  322 (348)
T 2pml_X          262 FNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK  322 (348)
T ss_dssp             HHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             HHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            1111000001100    0000000   0000122345678899999999999999999987

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=2.8e-40  Score=331.31  Aligned_cols=256  Identities=21%  Similarity=0.291  Sum_probs=193.6

Q ss_pred             hhcCCCCCceecccCcEEEEEEEeC-CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeecCc----
Q 012765          140 ATDNFNSENLIGKGGHAEVYKGCLP-DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTENG----  214 (457)
Q Consensus       140 ~~~~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~----  214 (457)
                      ..++|.+.+.||+|+||+||+|.+. +|+.||+|++..... .......+.+|+.+++.++||||+++++++....    
T Consensus        40 l~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~  118 (371)
T 4exu_A           40 LPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQ-SEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRN  118 (371)
T ss_dssp             EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTS-SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTT
T ss_pred             ccccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEeccccc-chhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCccc
Confidence            4578889999999999999999865 689999999875432 3344678899999999999999999999776543    


Q ss_pred             ---eEEEEEecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeecccc
Q 012765          215 ---FHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLA  291 (457)
Q Consensus       215 ---~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~  291 (457)
                         +++||||+. ++|..++   ...+++..+..++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||++
T Consensus       119 ~~~~~lv~e~~~-~~l~~~~---~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIll~~~~~~kL~Dfg~a  191 (371)
T 4exu_A          119 FYDFYLVMPFMQ-TDLQKIM---GMEFSEEKIQYLVYQMLKGLKYIHS---AGVVHRDLKPGNLAVNEDCELKILDFGLA  191 (371)
T ss_dssp             CCCCEEEEECCC-EEHHHHT---TSCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECSTTCC
T ss_pred             ceeEEEEEcccc-ccHHHHh---hcCCCHHHHHHHHHHHHHHHHHHHH---CCCcCCCcCHHHeEECCCCCEEEEecCcc
Confidence               289999997 6787777   3348999999999999999999999   89999999999999999999999999999


Q ss_pred             ccCCCCCCceeeecccccccccChhcccc-CCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhccc-cccC--Ccc
Q 012765          292 KWLPDNWSHHIVFPIEGTFGYLSPEYFMH-GIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPL-LQTS--NFK  367 (457)
Q Consensus       292 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~~~-~~~~--~~~  367 (457)
                      +.....     .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.............. ....  ...
T Consensus       192 ~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  266 (371)
T 4exu_A          192 RHADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFV  266 (371)
T ss_dssp             -------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred             cccccC-----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHH
Confidence            865443     233568999999999987 6799999999999999999999999986442211100000 0000  000


Q ss_pred             -ccc---------------CchhhcccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 012765          368 -ELV---------------DPRLADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQ  409 (457)
Q Consensus       368 -~~~---------------d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~  409 (457)
                       .+.               ..... .........+.+++.+||+.||.+|||+.|+++
T Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  323 (371)
T 4exu_A          267 QKLNDKAAKSYIQSLPQTPRKDFT-QLFPRASPQAADLLEKMLELDVDKRLTAAQALT  323 (371)
T ss_dssp             TTCSCHHHHHHHHHSCCCCCCCHH-HHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             HHhhhhhhhhhhhccCCCcchhHH-HhccccChHHHHHHHHHCCCChhhcCCHHHHhc
Confidence             000               00000 000112346778999999999999999999987

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=1.5e-40  Score=339.65  Aligned_cols=199  Identities=25%  Similarity=0.348  Sum_probs=167.5

Q ss_pred             hhcCCCCCceecccCcEEEEEEEeC-CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhc------CCCCcceeeeeee-
Q 012765          140 ATDNFNSENLIGKGGHAEVYKGCLP-DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHI------NHPNAAKLIGFST-  211 (457)
Q Consensus       140 ~~~~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l------~hpniv~l~~~~~-  211 (457)
                      ...+|.+.+.||+|+||+||+|.+. +++.||||++....    .....+.+|+.++..+      +|+||+++++++. 
T Consensus        95 ~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~----~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~  170 (429)
T 3kvw_A           95 VAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEK----RFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTF  170 (429)
T ss_dssp             ETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCH----HHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEE
T ss_pred             ccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCcc----chHHHHHHHHHHHHHHhhccccCCcCEEEEEeeccc
Confidence            4567999999999999999999865 58999999986432    2234666777777766      6789999999665 


Q ss_pred             cCceEEEEEecCCCChhhhhhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCc--EEEeec
Q 012765          212 ENGFHLVLQFLPHGSLSSLLFGST-ECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYE--AQISDF  288 (457)
Q Consensus       212 ~~~~~lv~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~--~kL~DF  288 (457)
                      .+..+++|||+. ++|.+++.... ..+++..+..|+.||+.||.|||+   .+|+||||||+|||++.++.  +||+||
T Consensus       171 ~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlKp~NILl~~~~~~~vkL~DF  246 (429)
T 3kvw_A          171 RNHICMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHK---NRIIHCDLKPENILLKQQGRSGIKVIDF  246 (429)
T ss_dssp             TTEEEEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHH---HTEECSCCSGGGEEESSTTSCCEEECCC
T ss_pred             CCeEEEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEEccCCCcceEEeec
Confidence            455789999996 68888886543 458999999999999999999999   79999999999999999887  999999


Q ss_pred             cccccCCCCCCceeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHhCCCCCCcCCc
Q 012765          289 GLAKWLPDNWSHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQ  351 (457)
Q Consensus       289 Gl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLltG~~pf~~~~~  351 (457)
                      |+++.....     .....||+.|+|||++.+..++.++|||||||++|||++|..||...+.
T Consensus       247 G~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~  304 (429)
T 3kvw_A          247 GSSCYEHQR-----VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDE  304 (429)
T ss_dssp             TTCEETTCC-----CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred             ccceecCCc-----ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCH
Confidence            999765443     2234689999999999999999999999999999999999999986543

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=5.6e-41  Score=325.87  Aligned_cols=252  Identities=22%  Similarity=0.376  Sum_probs=194.3

Q ss_pred             hhcCCCCCceecccCcEEEEEEEeC-CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeec-CceEE
Q 012765          140 ATDNFNSENLIGKGGHAEVYKGCLP-DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTE-NGFHL  217 (457)
Q Consensus       140 ~~~~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-~~~~l  217 (457)
                      ..++|++.+.||+|+||.||+|.+. +++.||+|.+.....   .....+.+|+.+++.++||||+++++++.. +..++
T Consensus        17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   93 (302)
T 2j7t_A           17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSE---EELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWI   93 (302)
T ss_dssp             GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEE
T ss_pred             CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCH---HHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEE
Confidence            4578889999999999999999875 589999998864432   234578899999999999999999996654 55789


Q ss_pred             EEEecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCCCC
Q 012765          218 VLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDN  297 (457)
Q Consensus       218 v~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~~  297 (457)
                      ||||+++++|..++......+++..++.++.||+.||.|||+   .+++||||||+||+++.++.+||+|||++......
T Consensus        94 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  170 (302)
T 2j7t_A           94 MIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHS---KRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKT  170 (302)
T ss_dssp             EEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHH
T ss_pred             EEEeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhc---CCcccCCCCHHHEEECCCCCEEEEECCCCcccccc
Confidence            999999999999987656679999999999999999999999   89999999999999999999999999987543211


Q ss_pred             CCceeeecccccccccChhcc-----ccCCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhccccccCCcccccCc
Q 012765          298 WSHHIVFPIEGTFGYLSPEYF-----MHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSNFKELVDP  372 (457)
Q Consensus       298 ~~~~~~~~~~gt~~y~aPE~~-----~~~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~  372 (457)
                      .  .......||+.|+|||++     .+..++.++||||||+++|+|++|..||.............  . ........ 
T Consensus       171 ~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~--~-~~~~~~~~-  244 (302)
T 2j7t_A          171 L--QKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIA--K-SDPPTLLT-  244 (302)
T ss_dssp             H--HC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHH--H-SCCCCCSS-
T ss_pred             c--cccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHh--c-cCCcccCC-
Confidence            0  011224589999999998     36778999999999999999999999998654322211110  0 00000101 


Q ss_pred             hhhcccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 012765          373 RLADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQ  409 (457)
Q Consensus       373 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~  409 (457)
                        ...+    ...+..++.+||+.||.+|||+.++++
T Consensus       245 --~~~~----~~~l~~li~~~l~~dp~~Rps~~~ll~  275 (302)
T 2j7t_A          245 --PSKW----SVEFRDFLKIALDKNPETRPSAAQLLE  275 (302)
T ss_dssp             --GGGS----CHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred             --cccc----CHHHHHHHHHHcccChhhCCCHHHHhc
Confidence              1111    235677889999999999999999876

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=1.2e-40  Score=346.43  Aligned_cols=252  Identities=23%  Similarity=0.328  Sum_probs=192.4

Q ss_pred             hhcCCCCCceecccCcEEEEEEEeC-CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeecC-ceEE
Q 012765          140 ATDNFNSENLIGKGGHAEVYKGCLP-DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTEN-GFHL  217 (457)
Q Consensus       140 ~~~~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~-~~~l  217 (457)
                      ..++|.+.+.||+|+||+||+|... ++..||+|++....... .....+.+|+.+++.++||||+++++++.+. ..++
T Consensus        35 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l  113 (494)
T 3lij_A           35 LSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVST-SSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYL  113 (494)
T ss_dssp             HHHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC------CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred             hhcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCc-hHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEE
Confidence            3467889999999999999999875 68899999986543221 2245788999999999999999999977665 4689


Q ss_pred             EEEecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCC---CcEEEeeccccccC
Q 012765          218 VLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSED---YEAQISDFGLAKWL  294 (457)
Q Consensus       218 v~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~---~~~kL~DFGl~~~~  294 (457)
                      ||||+.+|+|.+++... ..+++..++.++.||+.||.|||+   .+|+||||||+|||++.+   +.+||+|||++...
T Consensus       114 v~e~~~~g~L~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~  189 (494)
T 3lij_A          114 VMECYKGGELFDEIIHR-MKFNEVDAAVIIKQVLSGVTYLHK---HNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVF  189 (494)
T ss_dssp             EEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESCSSTTCCEEECCCTTCEEC
T ss_pred             EEecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCChhhEEEeCCCCCCcEEEEECCCCeEC
Confidence            99999999999888543 458899999999999999999999   899999999999999764   45999999999876


Q ss_pred             CCCCCceeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhccccccCCcccccCchh
Q 012765          295 PDNWSHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSNFKELVDPRL  374 (457)
Q Consensus       295 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l  374 (457)
                      ....   ......||+.|+|||++. +.|+.++|||||||++|+|++|..||.............   .... ....+..
T Consensus       190 ~~~~---~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~---~~~~-~~~~~~~  261 (494)
T 3lij_A          190 ENQK---KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVE---KGKY-TFDSPEW  261 (494)
T ss_dssp             BTTB---CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH---HTCC-CCCSGGG
T ss_pred             CCCc---cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH---hCCC-CCCchhc
Confidence            5432   223456999999999886 569999999999999999999999998654332211100   0000 0001111


Q ss_pred             hcccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 012765          375 ADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQ  409 (457)
Q Consensus       375 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~  409 (457)
                       ..+    ...+.+++.+||+.||.+|||+.|+++
T Consensus       262 -~~~----s~~~~~li~~~L~~dp~~R~s~~e~l~  291 (494)
T 3lij_A          262 -KNV----SEGAKDLIKQMLQFDSQRRISAQQALE  291 (494)
T ss_dssp             -TTS----CHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             -ccC----CHHHHHHHHHHCCCChhhCccHHHHhc
Confidence             111    234667889999999999999999885

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=1.7e-40  Score=325.93  Aligned_cols=261  Identities=20%  Similarity=0.327  Sum_probs=193.8

Q ss_pred             hhcCCCCCceecccCcEEEEEEEe--CCCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhc---CCCCcceeeeeee---
Q 012765          140 ATDNFNSENLIGKGGHAEVYKGCL--PDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHI---NHPNAAKLIGFST---  211 (457)
Q Consensus       140 ~~~~f~~~~~LG~G~~g~Vy~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l---~hpniv~l~~~~~---  211 (457)
                      +.++|.+.+.||+|+||.||+|.+  .+|+.||+|++....... .....+.+|+.+++.+   +||||+++++++.   
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~   87 (326)
T 1blx_A            9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEE-GMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSR   87 (326)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTT-SCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEE
T ss_pred             chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccc-cCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecc
Confidence            457899999999999999999987  468899999886433211 1112455666666555   8999999999764   


Q ss_pred             ---cCceEEEEEecCCCChhhhhhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEee
Q 012765          212 ---ENGFHLVLQFLPHGSLSSLLFGST-ECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISD  287 (457)
Q Consensus       212 ---~~~~~lv~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~D  287 (457)
                         ....++||||+. |+|.+++.... ..+++..++.++.||+.||.|||+   .+|+||||||+||+++.++.+||+|
T Consensus        88 ~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~gi~H~dlkp~Nili~~~~~~kl~D  163 (326)
T 1blx_A           88 TDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLAD  163 (326)
T ss_dssp             CSSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECS
T ss_pred             cCCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCCHHHeEEcCCCCEEEec
Confidence               344679999998 69999886543 458999999999999999999999   8999999999999999999999999


Q ss_pred             ccccccCCCCCCceeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhh-ccccccC--
Q 012765          288 FGLAKWLPDNWSHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWA-KPLLQTS--  364 (457)
Q Consensus       288 FGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~-~~~~~~~--  364 (457)
                      ||++.......   ......||..|+|||++.+..++.++|||||||++|+|++|+.||........... .......  
T Consensus       164 fg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~  240 (326)
T 1blx_A          164 FGLARIYSFQM---ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGE  240 (326)
T ss_dssp             CCSCCCCCGGG---GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCG
T ss_pred             CcccccccCCC---CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCc
Confidence            99998664322   12335589999999999999999999999999999999999999986443211100 0000000  


Q ss_pred             -------C-----cccccCchhhcccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 012765          365 -------N-----FKELVDPRLADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQ  409 (457)
Q Consensus       365 -------~-----~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~  409 (457)
                             .     +.......+ ..+.......+.+++.+||+.||.+|||+.++++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  296 (326)
T 1blx_A          241 EDWPRDVALPRQAFHSKSAQPI-EKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  296 (326)
T ss_dssp             GGSCTTCSSCGGGSCCCCCCCG-GGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             ccCccccccchhhhcccCcchh-hhccccCCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence                   0     000000000 0011112345678899999999999999999986

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=4.4e-40  Score=323.98  Aligned_cols=257  Identities=18%  Similarity=0.240  Sum_probs=196.4

Q ss_pred             hhcCCCCCceecccCcEEEEEEEe--CCCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCC------cceeeeeee
Q 012765          140 ATDNFNSENLIGKGGHAEVYKGCL--PDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPN------AAKLIGFST  211 (457)
Q Consensus       140 ~~~~f~~~~~LG~G~~g~Vy~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpn------iv~l~~~~~  211 (457)
                      ..++|.+.+.||+|+||+||+|.+  .+++.||+|++....    .....+.+|+.++..++|++      ++++++++.
T Consensus        12 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~   87 (339)
T 1z57_A           12 LSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVD----RYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFE   87 (339)
T ss_dssp             ETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSH----HHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEE
T ss_pred             ccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCC----chhHHHHHHHHHHHHhhhcCCCCceeeEeeecccc
Confidence            457899999999999999999986  368899999886432    33457888999998887654      899999665


Q ss_pred             c-CceEEEEEecCCCChhhhhhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcC----------
Q 012765          212 E-NGFHLVLQFLPHGSLSSLLFGST-ECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSE----------  279 (457)
Q Consensus       212 ~-~~~~lv~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~----------  279 (457)
                      . +..++||||+ +++|.+++.... ..+++..++.++.||+.||.|||+   .+|+||||||+|||++.          
T Consensus        88 ~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~~~~  163 (339)
T 1z57_A           88 HHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHS---NKLTHTDLKPENILFVQSDYTEAYNPK  163 (339)
T ss_dssp             ETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESCCCEEEEEC--
T ss_pred             cCCcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHH---CCCcCCCCCHHHEEEeccccccccCCc
Confidence            4 5578999999 889999886544 368899999999999999999999   89999999999999987          


Q ss_pred             ---------CCcEEEeeccccccCCCCCCceeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHhCCCCCCcCC
Q 012765          280 ---------DYEAQISDFGLAKWLPDNWSHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRR  350 (457)
Q Consensus       280 ---------~~~~kL~DFGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLltG~~pf~~~~  350 (457)
                               ++.+||+|||++.......     ....||+.|+|||++.+..++.++|||||||++|||++|..||...+
T Consensus       164 ~~~~~~~~~~~~~kl~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~  238 (339)
T 1z57_A          164 IKRDERTLINPDIKVVDFGSATYDDEHH-----STLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHD  238 (339)
T ss_dssp             --CEEEEESCCCEEECCCSSCEETTSCC-----CSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSC
T ss_pred             cccccccccCCCceEeeCcccccCcccc-----ccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC
Confidence                     6689999999998754432     23458999999999999999999999999999999999999998654


Q ss_pred             cchhhhhccccccCCcc------------------------------cccCchhh-cccCHHHHHHHHHHHHHhcccCCC
Q 012765          351 QSLVIWAKPLLQTSNFK------------------------------ELVDPRLA-DAYDLAEMKRAMLTASVCIHHLST  399 (457)
Q Consensus       351 ~~~~~~~~~~~~~~~~~------------------------------~~~d~~l~-~~~~~~~~~~l~~l~~~Cl~~dP~  399 (457)
                      .................                              ....+... ..........+.+++.+||+.||.
T Consensus       239 ~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~  318 (339)
T 1z57_A          239 SKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPA  318 (339)
T ss_dssp             HHHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTT
T ss_pred             hHHHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcc
Confidence            32211100000000000                              00000000 001223456788999999999999


Q ss_pred             CCCCHHHHHH
Q 012765          400 MRPQMTRVLQ  409 (457)
Q Consensus       400 ~RPt~~evl~  409 (457)
                      +|||+.|+++
T Consensus       319 ~Rpt~~ell~  328 (339)
T 1z57_A          319 KRITLREALK  328 (339)
T ss_dssp             TSCCHHHHTT
T ss_pred             cccCHHHHhc
Confidence            9999999985

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=4.9e-40  Score=318.60  Aligned_cols=254  Identities=26%  Similarity=0.358  Sum_probs=199.7

Q ss_pred             hhcCCCCCceecccCcEEEEEEEeC-CCcEEEEEEEeccc------hhhHHHHHHHHHHHHHHhhcC-CCCcceeeeeee
Q 012765          140 ATDNFNSENLIGKGGHAEVYKGCLP-DGEVVAVKKIIKNA------KEDEERISDFLSELGIVAHIN-HPNAAKLIGFST  211 (457)
Q Consensus       140 ~~~~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~------~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~  211 (457)
                      ..++|.+.+.||+|+||.||+|.+. +|+.||+|.+....      .........+.+|+.++.++. ||||+++++++.
T Consensus        15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~   94 (298)
T 1phk_A           15 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE   94 (298)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred             hhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeec
Confidence            4578999999999999999999875 68999999986543      112234567889999999995 999999999776


Q ss_pred             cCc-eEEEEEecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccc
Q 012765          212 ENG-FHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGL  290 (457)
Q Consensus       212 ~~~-~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl  290 (457)
                      .+. .++||||+++++|.+++... ..+++..++.++.||+.||.|||+   .+++||||||+||+++.++.+||+|||+
T Consensus        95 ~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~  170 (298)
T 1phk_A           95 TNTFFFLVFDLMKKGELFDYLTEK-VTLSEKETRKIMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGF  170 (298)
T ss_dssp             CSSEEEEEEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTT
T ss_pred             cCCeEEEEEeccCCCcHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcceEEEcCCCcEEEecccc
Confidence            654 67999999999999998643 458999999999999999999999   8999999999999999999999999999


Q ss_pred             cccCCCCCCceeeecccccccccChhccc------cCCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhccccccC
Q 012765          291 AKWLPDNWSHHIVFPIEGTFGYLSPEYFM------HGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTS  364 (457)
Q Consensus       291 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~~~~~~~  364 (457)
                      +........   .....||+.|+|||++.      ...++.++||||||+++|+|++|..||...........  .. ..
T Consensus       171 ~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~--~~-~~  244 (298)
T 1phk_A          171 SCQLDPGEK---LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRM--IM-SG  244 (298)
T ss_dssp             CEECCTTCC---BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH--HH-HT
T ss_pred             hhhcCCCcc---cccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHH--Hh-cC
Confidence            987654322   22345899999999985      45688999999999999999999999976443221110  00 00


Q ss_pred             CcccccCchhhcccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 012765          365 NFKELVDPRLADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQ  409 (457)
Q Consensus       365 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~  409 (457)
                      .. ....+.. .    .....+.+++.+||+.||.+|||+.++++
T Consensus       245 ~~-~~~~~~~-~----~~~~~l~~li~~~l~~dp~~Rps~~~ll~  283 (298)
T 1phk_A          245 NY-QFGSPEW-D----DYSDTVKDLVSRFLVVQPQKRYTAEEALA  283 (298)
T ss_dssp             CC-CCCTTTG-G----GSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             Cc-ccCcccc-c----ccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence            00 0000100 1    12345678899999999999999999986

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=4.6e-40  Score=318.16  Aligned_cols=250  Identities=26%  Similarity=0.352  Sum_probs=192.5

Q ss_pred             cCCCCCceecccCcEEEEEEEe-CCCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeecC-ceEEEE
Q 012765          142 DNFNSENLIGKGGHAEVYKGCL-PDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTEN-GFHLVL  219 (457)
Q Consensus       142 ~~f~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~-~~~lv~  219 (457)
                      ++|....+||+|+||.||+|.+ .+++.||+|.+.....   .....+.+|+.+++.++||||+++++++... ..+++|
T Consensus        22 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   98 (295)
T 2clq_A           22 DENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDS---RYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFM   98 (295)
T ss_dssp             CTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC------HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             cCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCch---HHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEE
Confidence            4455667999999999999986 4688999998865432   2345788999999999999999999976654 467999


Q ss_pred             EecCCCChhhhhhcCC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcC-CCcEEEeeccccccCCC
Q 012765          220 QFLPHGSLSSLLFGST--ECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSE-DYEAQISDFGLAKWLPD  296 (457)
Q Consensus       220 e~~~~gsL~~~l~~~~--~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~-~~~~kL~DFGl~~~~~~  296 (457)
                      ||+++++|.+++....  ..+++..++.++.||+.||.|||+   .+|+||||||+||+++. ++.+||+|||++.....
T Consensus        99 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~  175 (295)
T 2clq_A           99 EQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHD---NQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAG  175 (295)
T ss_dssp             ECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC
T ss_pred             EeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHh---CCEEccCCChhhEEEECCCCCEEEeecccccccCC
Confidence            9999999999996543  346788889999999999999999   89999999999999987 89999999999987654


Q ss_pred             CCCceeeecccccccccChhccccCC--CCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhccccccCCcccccCchh
Q 012765          297 NWSHHIVFPIEGTFGYLSPEYFMHGI--VDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSNFKELVDPRL  374 (457)
Q Consensus       297 ~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l  374 (457)
                      ...  ......||+.|+|||++.+..  ++.++||||||+++|+|++|+.||...............      ....+.+
T Consensus       176 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~------~~~~~~~  247 (295)
T 2clq_A          176 INP--CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGM------FKVHPEI  247 (295)
T ss_dssp             -------CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHH------HCCCCCC
T ss_pred             CCC--cccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhcc------ccccccc
Confidence            321  122345899999999987643  889999999999999999999999753322111110000      0011111


Q ss_pred             hcccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 012765          375 ADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQ  409 (457)
Q Consensus       375 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~  409 (457)
                      ...+    ...+.+++.+||+.||++||++.++++
T Consensus       248 ~~~~----~~~~~~li~~~l~~dp~~Rps~~~ll~  278 (295)
T 2clq_A          248 PESM----SAEAKAFILKCFEPDPDKRACANDLLV  278 (295)
T ss_dssp             CTTS----CHHHHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred             cccC----CHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            1222    235667889999999999999999986

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.6e-41  Score=336.81  Aligned_cols=255  Identities=23%  Similarity=0.288  Sum_probs=194.3

Q ss_pred             hcCCCCCceecccCcEEEEEEEe----CCCcEEEEEEEeccchh-hHHHHHHHHHHHHHHhhc-CCCCcceeeeeeec-C
Q 012765          141 TDNFNSENLIGKGGHAEVYKGCL----PDGEVVAVKKIIKNAKE-DEERISDFLSELGIVAHI-NHPNAAKLIGFSTE-N  213 (457)
Q Consensus       141 ~~~f~~~~~LG~G~~g~Vy~~~~----~~~~~vavK~~~~~~~~-~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~-~  213 (457)
                      .++|.+.+.||+|+||.||+|..    .+++.||||++...... .......+.+|+.++..+ +||||+++++++.. +
T Consensus        53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~  132 (355)
T 1vzo_A           53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET  132 (355)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred             ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence            36788999999999999999986    47899999988643211 111123567899999999 69999999996654 5


Q ss_pred             ceEEEEEecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeecccccc
Q 012765          214 GFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKW  293 (457)
Q Consensus       214 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~  293 (457)
                      ..++||||+.+++|.+++... ..+++..++.++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||+++.
T Consensus       133 ~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~  208 (355)
T 1vzo_A          133 KLHLILDYINGGELFTHLSQR-ERFTEHEVQIYVGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKE  208 (355)
T ss_dssp             EEEEEECCCCSCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEESCSSEEEE
T ss_pred             eEEEEeecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCcEEEeeCCCCee
Confidence            578999999999999998653 358899999999999999999999   8999999999999999999999999999987


Q ss_pred             CCCCCCceeeecccccccccChhcccc--CCCCcchhHHHHHHHHHHHHhCCCCCCcCCcch--hhhhccccccCCcccc
Q 012765          294 LPDNWSHHIVFPIEGTFGYLSPEYFMH--GIVDEKTDVFAFGVLLLELITGRRAVDSRRQSL--VIWAKPLLQTSNFKEL  369 (457)
Q Consensus       294 ~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~--~~~~~~~~~~~~~~~~  369 (457)
                      +...... ......||+.|+|||++.+  ..++.++|||||||++|||++|+.||.......  ..+.......      
T Consensus       209 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~------  281 (355)
T 1vzo_A          209 FVADETE-RAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKS------  281 (355)
T ss_dssp             CCGGGGG-GGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHC------
T ss_pred             cccCCCC-cccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhcc------
Confidence            6433221 1234569999999999985  347899999999999999999999997532211  1111100000      


Q ss_pred             cCchhhcccCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHHH
Q 012765          370 VDPRLADAYDLAEMKRAMLTASVCIHHLSTMRP-----QMTRVLQLL  411 (457)
Q Consensus       370 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----t~~evl~~L  411 (457)
                       .+....    .....+.+++.+||+.||.+||     ++.|+++..
T Consensus       282 -~~~~~~----~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~  323 (355)
T 1vzo_A          282 -EPPYPQ----EMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHL  323 (355)
T ss_dssp             -CCCCCT----TSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSG
T ss_pred             -CCCCCc----ccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCc
Confidence             011111    1223566788999999999999     999998743

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=2.7e-40  Score=325.18  Aligned_cols=253  Identities=23%  Similarity=0.375  Sum_probs=173.1

Q ss_pred             hcCCCCCceecccCcEEEEEEEeC-CCcEEEEEEEeccchhhHHHHHHHHHHHH-HHhhcCCCCcceeeeeeec-CceEE
Q 012765          141 TDNFNSENLIGKGGHAEVYKGCLP-DGEVVAVKKIIKNAKEDEERISDFLSELG-IVAHINHPNAAKLIGFSTE-NGFHL  217 (457)
Q Consensus       141 ~~~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~-~l~~l~hpniv~l~~~~~~-~~~~l  217 (457)
                      .++|.+.+.||+|+||.||+|.+. +|+.||+|++......  .....+..|+. +++.++||||+++++++.. +..++
T Consensus        21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~l   98 (327)
T 3aln_A           21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDE--KEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWI   98 (327)
T ss_dssp             SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCH--HHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEE
T ss_pred             HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCc--hHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEE
Confidence            477889999999999999999874 6899999998754332  23345666666 6777899999999996655 45679


Q ss_pred             EEEecCCCChhhhhhc----CCCCCCHHHHHHHHHHHHHHHHHHHhcCCC-CeeeCCCCCCcEEEcCCCcEEEeeccccc
Q 012765          218 VLQFLPHGSLSSLLFG----STECLEWTIRYKIALGIAEGLQYLHHDCHR-RIIHRDIKASNILLSEDYEAQISDFGLAK  292 (457)
Q Consensus       218 v~e~~~~gsL~~~l~~----~~~~~~~~~~~~i~~qia~aL~yLH~~~~~-~iiHrDlkp~NIll~~~~~~kL~DFGl~~  292 (457)
                      ||||+.+ +|.+++..    ....+++..+..++.|++.||.|||+   . +|+||||||+|||++.++.+||+|||++.
T Consensus        99 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~  174 (327)
T 3aln_A           99 CMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKE---NLKIIHRDIKPSNILLDRSGNIKLCDFGISG  174 (327)
T ss_dssp             EECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHH---HHSCCCSCCCGGGEEEETTTEEEECCCSSSC
T ss_pred             EEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhc---cCCEeECCCCHHHEEEcCCCCEEEccCCCce
Confidence            9999985 77766642    35678999999999999999999999   7 99999999999999999999999999998


Q ss_pred             cCCCCCCceeeecccccccccChhcc----ccCCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhccccccCCccc
Q 012765          293 WLPDNWSHHIVFPIEGTFGYLSPEYF----MHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSNFKE  368 (457)
Q Consensus       293 ~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~  368 (457)
                      .......   .....||+.|+|||++    .+..++.++|||||||++|+|++|+.||............ .. ...   
T Consensus       175 ~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~-~~-~~~---  246 (327)
T 3aln_A          175 QLVDSIA---KTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQ-VV-KGD---  246 (327)
T ss_dssp             C---------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------CC-CC-CSC---
T ss_pred             ecccccc---cccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHH-Hh-cCC---
Confidence            7654322   1223589999999998    4667899999999999999999999999863321111100 00 000   


Q ss_pred             ccCchhhcccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 012765          369 LVDPRLADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQ  409 (457)
Q Consensus       369 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~  409 (457)
                        .+.+...........+.+++.+||+.||.+|||+.+|++
T Consensus       247 --~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  285 (327)
T 3aln_A          247 --PPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLK  285 (327)
T ss_dssp             --CCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             --CCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence              011111101112245778889999999999999999976

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=5.6e-40  Score=330.37  Aligned_cols=202  Identities=26%  Similarity=0.347  Sum_probs=167.6

Q ss_pred             HHhhcCCCCCceecccCcEEEEEEEeC-CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcC-CC-----Ccceeeeee
Q 012765          138 AAATDNFNSENLIGKGGHAEVYKGCLP-DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHIN-HP-----NAAKLIGFS  210 (457)
Q Consensus       138 ~~~~~~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp-----niv~l~~~~  210 (457)
                      ....++|.+.+.||+|+||+||+|.+. +++.||||++....    .....+..|+.++..++ |+     +|+++++++
T Consensus        50 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~  125 (382)
T 2vx3_A           50 EKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKK----AFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHF  125 (382)
T ss_dssp             CEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSH----HHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEE
T ss_pred             CEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccH----HHHHHHHHHHHHHHHHHhcccccceeEEEeeeee
Confidence            345689999999999999999999865 68899999986432    23456777888887774 44     489999855


Q ss_pred             e-cCceEEEEEecCCCChhhhhhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEc--CCCcEEEe
Q 012765          211 T-ENGFHLVLQFLPHGSLSSLLFGST-ECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLS--EDYEAQIS  286 (457)
Q Consensus       211 ~-~~~~~lv~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~--~~~~~kL~  286 (457)
                      . .+..++||||+. ++|.+++.... ..+++..+..++.||+.||.|||++ ..+|+||||||+|||++  .++.+||+
T Consensus       126 ~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~~kL~  203 (382)
T 2vx3_A          126 MFRNHLCLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIV  203 (382)
T ss_dssp             EETTEEEEEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCCEEEC
T ss_pred             ccCCceEEEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCcEEEE
Confidence            4 556789999996 59999886643 5689999999999999999999952 26899999999999995  47789999


Q ss_pred             eccccccCCCCCCceeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHhCCCCCCcCC
Q 012765          287 DFGLAKWLPDNWSHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRR  350 (457)
Q Consensus       287 DFGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLltG~~pf~~~~  350 (457)
                      |||+++......     ....||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus       204 DFG~a~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~  262 (382)
T 2vx3_A          204 DFGSSCQLGQRI-----YQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGAN  262 (382)
T ss_dssp             CCTTCEETTCCC-----CSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             eccCceeccccc-----ccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence            999998775432     23458999999999999999999999999999999999999998654

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=3.7e-40  Score=334.22  Aligned_cols=201  Identities=24%  Similarity=0.389  Sum_probs=151.2

Q ss_pred             hcCCCC-CceecccCcEEEEEEEeC---CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeee---cC
Q 012765          141 TDNFNS-ENLIGKGGHAEVYKGCLP---DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFST---EN  213 (457)
Q Consensus       141 ~~~f~~-~~~LG~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~---~~  213 (457)
                      .+.|.+ .++||+|+||+||+|.+.   +++.||+|++......     ..+.+|+.+++.++||||+++++++.   ..
T Consensus        19 ~~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~-----~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~   93 (405)
T 3rgf_A           19 EDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGIS-----MSACREIALLRELKHPNVISLQKVFLSHADR   93 (405)
T ss_dssp             HHHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSCC-----HHHHHHHHHHHHCCCTTBCCCCEEEEETTTT
T ss_pred             hhhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCCC-----HHHHHHHHHHHhcCCCCeeeEeeEEecCCCC
Confidence            344555 458999999999999864   5789999998644322     25788999999999999999999764   34


Q ss_pred             ceEEEEEecCCCChhhhhhc--------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEE----cCCC
Q 012765          214 GFHLVLQFLPHGSLSSLLFG--------STECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILL----SEDY  281 (457)
Q Consensus       214 ~~~lv~e~~~~gsL~~~l~~--------~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll----~~~~  281 (457)
                      ..++||||+. ++|.+++..        ....+++..++.|+.||+.||.|||+   .+|+||||||+|||+    +.++
T Consensus        94 ~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~---~~ivH~Dlkp~NIll~~~~~~~~  169 (405)
T 3rgf_A           94 KVWLLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHA---NWVLHRDLKPANILVMGEGPERG  169 (405)
T ss_dssp             EEEEEEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECCSSTTTT
T ss_pred             eEEEEEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHh---CCEeCCCcCHHHeEEecCCCCCC
Confidence            4789999986 477776632        12248999999999999999999999   899999999999999    6778


Q ss_pred             cEEEeeccccccCCCCCCc-eeeecccccccccChhccccC-CCCcchhHHHHHHHHHHHHhCCCCCCcCC
Q 012765          282 EAQISDFGLAKWLPDNWSH-HIVFPIEGTFGYLSPEYFMHG-IVDEKTDVFAFGVLLLELITGRRAVDSRR  350 (457)
Q Consensus       282 ~~kL~DFGl~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~ksDvwSlGvll~eLltG~~pf~~~~  350 (457)
                      .+||+|||+++.+...... .......||+.|+|||++.+. .++.++|||||||++|||++|+.||....
T Consensus       170 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~  240 (405)
T 3rgf_A          170 RVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ  240 (405)
T ss_dssp             CEEECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC
T ss_pred             cEEEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCcc
Confidence            9999999999876543211 122345689999999999874 58999999999999999999999997543

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=6.8e-40  Score=325.99  Aligned_cols=255  Identities=21%  Similarity=0.287  Sum_probs=193.3

Q ss_pred             hcCCCCCceecccCcEEEEEEEeC-CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeecCc-----
Q 012765          141 TDNFNSENLIGKGGHAEVYKGCLP-DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTENG-----  214 (457)
Q Consensus       141 ~~~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~-----  214 (457)
                      .++|.+.+.||+|+||.||+|.+. +|+.||||++..... .......+.+|+.+++.++||||+++++++....     
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  101 (353)
T 3coi_A           23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQ-SEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNF  101 (353)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTS-SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGC
T ss_pred             CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEeccccc-chHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccc
Confidence            477889999999999999999864 689999999865432 3344668899999999999999999999776543     


Q ss_pred             --eEEEEEecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccc
Q 012765          215 --FHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAK  292 (457)
Q Consensus       215 --~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~  292 (457)
                        ++++|||+. ++|..++.   ..+++..++.++.||+.||.|||+   .+|+||||||+||+++.++.+||+|||++.
T Consensus       102 ~~~~lv~e~~~-~~l~~~~~---~~~~~~~~~~i~~qi~~al~~LH~---~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~  174 (353)
T 3coi_A          102 YDFYLVMPFMQ-TDLQKIMG---LKFSEEKIQYLVYQMLKGLKYIHS---AGVVHRDLKPGNLAVNEDCELKILDFGLAR  174 (353)
T ss_dssp             CCCEEEEECCS-EEGGGTTT---SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCCGGGEEECTTCCEEECSTTCTT
T ss_pred             eeEEEEecccc-CCHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEeECCCCcEEEeeccccc
Confidence              489999997 58887773   348999999999999999999999   899999999999999999999999999998


Q ss_pred             cCCCCCCceeeecccccccccChhcccc-CCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhc-ccc---------
Q 012765          293 WLPDNWSHHIVFPIEGTFGYLSPEYFMH-GIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAK-PLL---------  361 (457)
Q Consensus       293 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~-~~~---------  361 (457)
                      .....     .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||............ ...         
T Consensus       175 ~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  249 (353)
T 3coi_A          175 HADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQ  249 (353)
T ss_dssp             C-------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHT
T ss_pred             CCCCC-----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence            65432     223458999999999876 67899999999999999999999999865432111000 000         


Q ss_pred             --ccC-------CcccccCchhhcccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 012765          362 --QTS-------NFKELVDPRLADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQ  409 (457)
Q Consensus       362 --~~~-------~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~  409 (457)
                        ...       .+.....+.+.. ........+.+++.+||+.||++|||+.++++
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~  305 (353)
T 3coi_A          250 KLNDKAAKSYIQSLPQTPRKDFTQ-LFPRASPQAADLLEKMLELDVDKRLTAAQALT  305 (353)
T ss_dssp             TCSCHHHHHHHHTSCBCSSCCTTT-TCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             HHhhHHHHHHHHhCcCCCCccHHH-hcCCcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence              000       000000000000 01122346778899999999999999999987

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=4.6e-40  Score=321.46  Aligned_cols=261  Identities=21%  Similarity=0.311  Sum_probs=189.4

Q ss_pred             hhcCCCCCceecccCcEEEEEEEeC-CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeee-------
Q 012765          140 ATDNFNSENLIGKGGHAEVYKGCLP-DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFST-------  211 (457)
Q Consensus       140 ~~~~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~-------  211 (457)
                      ..++|.+.+.||+|+||.||+|.+. +++.||+|++....   ......+.+|+.+++.++||||+++++++.       
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   85 (320)
T 2i6l_A            9 LGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTD---PQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLT   85 (320)
T ss_dssp             ETTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCS---HHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCC
T ss_pred             cCCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCC---hHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccc
Confidence            3578889999999999999999876 48999999886442   344568899999999999999999998753       


Q ss_pred             --------cCceEEEEEecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEc-CCCc
Q 012765          212 --------ENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLS-EDYE  282 (457)
Q Consensus       212 --------~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~-~~~~  282 (457)
                              ....++||||+. |+|.+++.  ...+++..++.++.||+.||.|||+   .+|+||||||+|||++ .++.
T Consensus        86 ~~~~~~~~~~~~~lv~e~~~-~~L~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~  159 (320)
T 2i6l_A           86 DDVGSLTELNSVYIVQEYME-TDLANVLE--QGPLLEEHARLFMYQLLRGLKYIHS---ANVLHRDLKPANLFINTEDLV  159 (320)
T ss_dssp             C----CCSCSEEEEEEECCS-EEHHHHHT--TCCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSGGGEEEETTTTE
T ss_pred             cccccccccCceeEEeeccC-CCHHHHhh--cCCccHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCe
Confidence                    244689999997 68999884  3568899999999999999999999   8999999999999997 5679


Q ss_pred             EEEeeccccccCCCCCCc-eeeecccccccccChhcccc-CCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhc--
Q 012765          283 AQISDFGLAKWLPDNWSH-HIVFPIEGTFGYLSPEYFMH-GIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAK--  358 (457)
Q Consensus       283 ~kL~DFGl~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~--  358 (457)
                      +||+|||++......... .......+|..|+|||.+.+ ..++.++|||||||++|||++|+.||............  
T Consensus       160 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~  239 (320)
T 2i6l_A          160 LKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILE  239 (320)
T ss_dssp             EEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred             EEEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence            999999999876433211 11233457999999998865 67899999999999999999999999865432111000  


Q ss_pred             --cccccCCccc---ccC----chhh------cccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 012765          359 --PLLQTSNFKE---LVD----PRLA------DAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQ  409 (457)
Q Consensus       359 --~~~~~~~~~~---~~d----~~l~------~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~  409 (457)
                        +........+   .+.    ....      ..........+.+++.+||+.||.+|||+.|+++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  305 (320)
T 2i6l_A          240 SIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALS  305 (320)
T ss_dssp             HSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             hcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhC
Confidence              0000000000   000    0000      0000112345778999999999999999999987

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=7.4e-40  Score=323.86  Aligned_cols=251  Identities=19%  Similarity=0.231  Sum_probs=168.2

Q ss_pred             hhcCCCCCc-eecccCcEEEEEEEeC-CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeec-----
Q 012765          140 ATDNFNSEN-LIGKGGHAEVYKGCLP-DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTE-----  212 (457)
Q Consensus       140 ~~~~f~~~~-~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-----  212 (457)
                      ..++|.+.+ +||+|+||+||+|.+. +++.||+|++.....    ..   ......+..++||||+++++++..     
T Consensus        26 ~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~---~e~~~~~~~~~h~~i~~~~~~~~~~~~~~   98 (336)
T 3fhr_A           26 VTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPK----AR---QEVDHHWQASGGPHIVCILDVYENMHHGK   98 (336)
T ss_dssp             GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSHH----HH---HHHHHHHHHTTSTTBCCEEEEEEEEETTE
T ss_pred             ccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcHH----HH---HHHHHHHHhcCCCChHHHHHHHhhccCCC
Confidence            457788854 6999999999999875 689999999864321    11   122233566799999999997653     


Q ss_pred             CceEEEEEecCCCChhhhhhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcC---CCcEEEeec
Q 012765          213 NGFHLVLQFLPHGSLSSLLFGST-ECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSE---DYEAQISDF  288 (457)
Q Consensus       213 ~~~~lv~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~---~~~~kL~DF  288 (457)
                      ...++||||+.+|+|.+++.... ..+++..++.++.||+.||.|||+   .+|+||||||+|||++.   ++.+||+||
T Consensus        99 ~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~---~~ivH~dlkp~NIll~~~~~~~~~kl~Df  175 (336)
T 3fhr_A           99 RCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHS---HNIAHRDVKPENLLYTSKEKDAVLKLTDF  175 (336)
T ss_dssp             EEEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESCSSTTCCEEECCC
T ss_pred             ceEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEEecCCCceEEEecc
Confidence            22689999999999999997643 468999999999999999999999   89999999999999986   455999999


Q ss_pred             cccccCCCCCCceeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhccccccCCccc
Q 012765          289 GLAKWLPDNWSHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSNFKE  368 (457)
Q Consensus       289 Gl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~  368 (457)
                      |++.......    .....||+.|+|||++.+..++.++|||||||++|+|++|..||............  ........
T Consensus       176 g~~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~--~~~~~~~~  249 (336)
T 3fhr_A          176 GFAKETTQNA----LQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGM--KRRIRLGQ  249 (336)
T ss_dssp             TTCEEC--------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC----------------------
T ss_pred             ccceeccccc----cccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhH--HHhhhccc
Confidence            9998765432    22345899999999998888999999999999999999999999764322111000  00000000


Q ss_pred             ccCchhhcccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 012765          369 LVDPRLADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQ  409 (457)
Q Consensus       369 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~  409 (457)
                      .   .............+.+++.+||+.||.+|||+.|+++
T Consensus       250 ~---~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  287 (336)
T 3fhr_A          250 Y---GFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMN  287 (336)
T ss_dssp             ----CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             c---ccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence            0   0000000112345677889999999999999999998

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=2.1e-39  Score=312.92  Aligned_cols=253  Identities=25%  Similarity=0.367  Sum_probs=197.0

Q ss_pred             HhhcCCCCCceecccCcEEEEEEEeC-CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeecC-ceE
Q 012765          139 AATDNFNSENLIGKGGHAEVYKGCLP-DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTEN-GFH  216 (457)
Q Consensus       139 ~~~~~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~-~~~  216 (457)
                      ...++|.+.+.||+|+||.||+|... +++.||+|++....... .....+.+|+.++++++||||+++++++.+. ..+
T Consensus        19 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   97 (287)
T 2wei_A           19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKN-KDTSTILREVELLKKLDHPNIMKLFEILEDSSSFY   97 (287)
T ss_dssp             HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSS-SCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred             HHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccch-HHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEE
Confidence            35678999999999999999999875 68999999986543221 2245788999999999999999999976654 467


Q ss_pred             EEEEecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCC---CcEEEeecccccc
Q 012765          217 LVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSED---YEAQISDFGLAKW  293 (457)
Q Consensus       217 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~---~~~kL~DFGl~~~  293 (457)
                      ++|||+.+++|.+++... ..+++..++.++.||+.||.|||+   .+++||||||+||+++.+   +.+||+|||++..
T Consensus        98 lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~  173 (287)
T 2wei_A           98 IVGELYTGGELFDEIIKR-KRFSEHDAARIIKQVFSGITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTC  173 (287)
T ss_dssp             EEECCCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGT
T ss_pred             EEEEccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCChhhEEEecCCCcccEEEeccCccee
Confidence            999999999999888543 358899999999999999999999   899999999999999754   4699999999987


Q ss_pred             CCCCCCceeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhccccccCCcccccCch
Q 012765          294 LPDNWSHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSNFKELVDPR  373 (457)
Q Consensus       294 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~  373 (457)
                      ......   .....||+.|+|||.+.+ .++.++||||||+++|+|++|..||...........  .. .....  .+..
T Consensus       174 ~~~~~~---~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~--~~-~~~~~--~~~~  244 (287)
T 2wei_A          174 FQQNTK---MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKR--VE-TGKYA--FDLP  244 (287)
T ss_dssp             BCCCSS---CSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH--HH-HCCCC--CCSG
T ss_pred             ecCCCc---cccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHH--HH-cCCCC--CCch
Confidence            654322   122348999999998865 589999999999999999999999986443221110  00 00000  0000


Q ss_pred             hhcccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 012765          374 LADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQ  409 (457)
Q Consensus       374 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~  409 (457)
                      ....+    ...+.+++.+||+.||.+|||+.++++
T Consensus       245 ~~~~~----~~~~~~li~~~l~~dp~~Rps~~ell~  276 (287)
T 2wei_A          245 QWRTI----SDDAKDLIRKMLTFHPSLRITATQCLE  276 (287)
T ss_dssp             GGTTS----CHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             hhhhc----CHHHHHHHHHHcccChhhCcCHHHHhc
Confidence            00111    235678899999999999999999987

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=1.9e-39  Score=332.14  Aligned_cols=250  Identities=24%  Similarity=0.319  Sum_probs=182.6

Q ss_pred             cCCCCCceecccCcEEEEEEEeCCCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhc-CCCCcceeeeeeecCc-eEEEE
Q 012765          142 DNFNSENLIGKGGHAEVYKGCLPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHI-NHPNAAKLIGFSTENG-FHLVL  219 (457)
Q Consensus       142 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~-~~lv~  219 (457)
                      +.|.+.++||+|+||+||.+...+|+.||||++....      ...+.+|+.++.++ +||||+++++++.++. .++||
T Consensus        15 ~~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~~------~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~   88 (434)
T 2rio_A           15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDF------CDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIAL   88 (434)
T ss_dssp             SCEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGGG------HHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEE
T ss_pred             heeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHHH------HHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEE
Confidence            3455568899999999987766789999999986432      23567899999876 8999999999776554 67999


Q ss_pred             EecCCCChhhhhhcCCCC------CCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCC-------------
Q 012765          220 QFLPHGSLSSLLFGSTEC------LEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSED-------------  280 (457)
Q Consensus       220 e~~~~gsL~~~l~~~~~~------~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~-------------  280 (457)
                      ||+. |+|.+++......      ..+..++.++.||+.||.|||+   .+|+||||||+|||++.+             
T Consensus        89 E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~  164 (434)
T 2rio_A           89 ELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHS---LKIIHRDLKPQNILVSTSSRFTADQQTGAEN  164 (434)
T ss_dssp             CCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEECCHHHHSCCTTCCCS
T ss_pred             ecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHH---CCccccCCChHhEEEecCcccccccccCCCc
Confidence            9995 6999998653321      1222356799999999999999   899999999999999754             


Q ss_pred             CcEEEeeccccccCCCCCCce--eeecccccccccChhcccc-------CCCCcchhHHHHHHHHHHHHh-CCCCCCcCC
Q 012765          281 YEAQISDFGLAKWLPDNWSHH--IVFPIEGTFGYLSPEYFMH-------GIVDEKTDVFAFGVLLLELIT-GRRAVDSRR  350 (457)
Q Consensus       281 ~~~kL~DFGl~~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-------~~~~~ksDvwSlGvll~eLlt-G~~pf~~~~  350 (457)
                      +.+||+|||++..+.......  ......||+.|+|||++.+       ..++.++|||||||++|||+| |..||....
T Consensus       165 ~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~  244 (434)
T 2rio_A          165 LRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKY  244 (434)
T ss_dssp             CEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTT
T ss_pred             eEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCch
Confidence            489999999998875542211  1223569999999999975       678999999999999999999 999997543


Q ss_pred             cchhhhhccccccCCcccccCchhhcccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 012765          351 QSLVIWAKPLLQTSNFKELVDPRLADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQ  409 (457)
Q Consensus       351 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~  409 (457)
                      ...............        +...........+.+++.+||+.||.+|||+.+|++
T Consensus       245 ~~~~~i~~~~~~~~~--------~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~  295 (434)
T 2rio_A          245 SRESNIIRGIFSLDE--------MKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR  295 (434)
T ss_dssp             THHHHHHHTCCCCCC--------CTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             hhHHHHhcCCCCccc--------ccccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence            322211111111111        111112344567888999999999999999999985

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=2.2e-39  Score=324.01  Aligned_cols=256  Identities=20%  Similarity=0.260  Sum_probs=193.6

Q ss_pred             hcCCCCCceecccCcEEEEEEEe-CCCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcC-----------CCCcceeee
Q 012765          141 TDNFNSENLIGKGGHAEVYKGCL-PDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHIN-----------HPNAAKLIG  208 (457)
Q Consensus       141 ~~~f~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-----------hpniv~l~~  208 (457)
                      .++|.+.+.||+|+||+||+|.+ .+++.||+|++....    .....+.+|+.++.+++           ||||+++++
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~   93 (373)
T 1q8y_A           18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK----VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLD   93 (373)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH----HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCE
T ss_pred             CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCc----cchhhhhHHHHHHHHhhcccccchhccccchHHHHHH
Confidence            46788999999999999999986 468999999986432    23456788998888876           899999999


Q ss_pred             eeecC-----ceEEEEEecCCCChhhhhhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCC-CeeeCCCCCCcEEEc---
Q 012765          209 FSTEN-----GFHLVLQFLPHGSLSSLLFGS-TECLEWTIRYKIALGIAEGLQYLHHDCHR-RIIHRDIKASNILLS---  278 (457)
Q Consensus       209 ~~~~~-----~~~lv~e~~~~gsL~~~l~~~-~~~~~~~~~~~i~~qia~aL~yLH~~~~~-~iiHrDlkp~NIll~---  278 (457)
                      ++...     ..+++||++ +++|.+++... ...+++..++.++.||+.||.|||+   . +|+||||||+|||++   
T Consensus        94 ~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~---~~~ivH~Dikp~NIll~~~~  169 (373)
T 1q8y_A           94 HFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHR---RCGIIHTDIKPENVLMEIVD  169 (373)
T ss_dssp             EEEEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHH---TTCEECSCCSGGGEEEEEEE
T ss_pred             HhhccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHh---cCCEEecCCChHHeEEeccC
Confidence            76543     367889998 89999998653 3458999999999999999999999   7 999999999999994   


Q ss_pred             ---CCCcEEEeeccccccCCCCCCceeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchh-
Q 012765          279 ---EDYEAQISDFGLAKWLPDNWSHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLV-  354 (457)
Q Consensus       279 ---~~~~~kL~DFGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~-  354 (457)
                         ..+.+||+|||++.......     ....||+.|+|||++.+..++.++|||||||++|||++|+.||........ 
T Consensus       170 ~~~~~~~~kl~Dfg~a~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~  244 (373)
T 1q8y_A          170 SPENLIQIKIADLGNACWYDEHY-----TNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYT  244 (373)
T ss_dssp             TTTTEEEEEECCCTTCEETTBCC-----CSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------
T ss_pred             CCcCcceEEEcccccccccCCCC-----CCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccC
Confidence               44579999999998765432     234589999999999999999999999999999999999999985432110 


Q ss_pred             -------hhhc-----------------cccccCCc-ccccC-------chh--hcccCHHHHHHHHHHHHHhcccCCCC
Q 012765          355 -------IWAK-----------------PLLQTSNF-KELVD-------PRL--ADAYDLAEMKRAMLTASVCIHHLSTM  400 (457)
Q Consensus       355 -------~~~~-----------------~~~~~~~~-~~~~d-------~~l--~~~~~~~~~~~l~~l~~~Cl~~dP~~  400 (457)
                             ....                 ..+..... ..+..       ..+  ...+.......+.+++.+||+.||.+
T Consensus       245 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~  324 (373)
T 1q8y_A          245 KDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRK  324 (373)
T ss_dssp             CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTT
T ss_pred             ChHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccc
Confidence                   0000                 00000000 00000       000  01233456678889999999999999


Q ss_pred             CCCHHHHHH
Q 012765          401 RPQMTRVLQ  409 (457)
Q Consensus       401 RPt~~evl~  409 (457)
                      |||+.|+++
T Consensus       325 Rpt~~ell~  333 (373)
T 1q8y_A          325 RADAGGLVN  333 (373)
T ss_dssp             CBCHHHHHT
T ss_pred             cCCHHHHhh
Confidence            999999988

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=2.7e-39  Score=320.56  Aligned_cols=257  Identities=17%  Similarity=0.222  Sum_probs=193.1

Q ss_pred             hhcCCCCCceecccCcEEEEEEEeC-CC-cEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCC------cceeeeeee
Q 012765          140 ATDNFNSENLIGKGGHAEVYKGCLP-DG-EVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPN------AAKLIGFST  211 (457)
Q Consensus       140 ~~~~f~~~~~LG~G~~g~Vy~~~~~-~~-~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpn------iv~l~~~~~  211 (457)
                      ..++|.+.+.||+|+||+||+|.+. ++ +.||+|++....    .....+.+|+.++..++|++      ++.+++++.
T Consensus        17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~   92 (355)
T 2eu9_A           17 LQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVG----KYREAARLEINVLKKIKEKDKENKFLCVLMSDWFN   92 (355)
T ss_dssp             ETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCH----HHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEE
T ss_pred             ecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccc----cchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeee
Confidence            4578999999999999999999864 34 689999886432    23457788999998887665      888888555


Q ss_pred             -cCceEEEEEecCCCChhhhhhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEE------------
Q 012765          212 -ENGFHLVLQFLPHGSLSSLLFGS-TECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILL------------  277 (457)
Q Consensus       212 -~~~~~lv~e~~~~gsL~~~l~~~-~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll------------  277 (457)
                       .+..++||||+ ++++.+++... ...+++..++.++.||+.||.|||+   .+|+||||||+|||+            
T Consensus        93 ~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~---~~ivH~Dlkp~NIll~~~~~~~~~~~~  168 (355)
T 2eu9_A           93 FHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHE---NQLTHTDLKPENILFVNSEFETLYNEH  168 (355)
T ss_dssp             ETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEESCCCEEEEECCC
T ss_pred             eCCeEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEeccccccccccc
Confidence             45678999999 66676666543 3568999999999999999999999   899999999999999            


Q ss_pred             -------cCCCcEEEeeccccccCCCCCCceeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHhCCCCCCcCC
Q 012765          278 -------SEDYEAQISDFGLAKWLPDNWSHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRR  350 (457)
Q Consensus       278 -------~~~~~~kL~DFGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLltG~~pf~~~~  350 (457)
                             +.++.+||+|||++.......     ....||+.|+|||++.+..++.++|||||||++|||++|..||....
T Consensus       169 ~~~~~~~~~~~~~kl~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~  243 (355)
T 2eu9_A          169 KSCEEKSVKNTSIRVADFGSATFDHEHH-----TTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHE  243 (355)
T ss_dssp             -CCCEEEESCCCEEECCCTTCEETTSCC-----CSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred             ccccccccCCCcEEEeecCccccccccc-----cCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCC
Confidence                   567899999999998754432     23458999999999999999999999999999999999999998644


Q ss_pred             cchhhhh-ccccccC--------C-cccccC--------------------chh-hcccCHHHHHHHHHHHHHhcccCCC
Q 012765          351 QSLVIWA-KPLLQTS--------N-FKELVD--------------------PRL-ADAYDLAEMKRAMLTASVCIHHLST  399 (457)
Q Consensus       351 ~~~~~~~-~~~~~~~--------~-~~~~~d--------------------~~l-~~~~~~~~~~~l~~l~~~Cl~~dP~  399 (457)
                      ....... .......        . ......                    +.. ...........+.+++.+||+.||.
T Consensus       244 ~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~  323 (355)
T 2eu9_A          244 NREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPA  323 (355)
T ss_dssp             HHHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTT
T ss_pred             HHHHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChh
Confidence            3221100 0000000        0 000000                    000 0001123345788999999999999


Q ss_pred             CCCCHHHHHH
Q 012765          400 MRPQMTRVLQ  409 (457)
Q Consensus       400 ~RPt~~evl~  409 (457)
                      +|||+.|+++
T Consensus       324 ~Rpt~~e~l~  333 (355)
T 2eu9_A          324 QRITLAEALL  333 (355)
T ss_dssp             TSCCHHHHTT
T ss_pred             hCcCHHHHhc
Confidence            9999999975

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=1.5e-39  Score=317.91  Aligned_cols=252  Identities=23%  Similarity=0.354  Sum_probs=176.0

Q ss_pred             hcCCCCCceecccCcEEEEEEEeC-CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeecC-ceEEE
Q 012765          141 TDNFNSENLIGKGGHAEVYKGCLP-DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTEN-GFHLV  218 (457)
Q Consensus       141 ~~~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~-~~~lv  218 (457)
                      .++|.+.+.||+|+||.||+|.+. +|+.||+|++...... ......+..+..+++.++||||+++++++... ..++|
T Consensus        24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv  102 (318)
T 2dyl_A           24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNK-EENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIA  102 (318)
T ss_dssp             GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCH-HHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred             hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccc-hHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEE
Confidence            467888899999999999999875 6899999998754332 22233444555567888999999999976654 46899


Q ss_pred             EEecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCC-CeeeCCCCCCcEEEcCCCcEEEeeccccccCCCC
Q 012765          219 LQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHR-RIIHRDIKASNILLSEDYEAQISDFGLAKWLPDN  297 (457)
Q Consensus       219 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~-~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~~  297 (457)
                      |||+ ++.+..++......+++..++.++.||+.||.|||+   . +|+||||||+||+++.++.+||+|||++......
T Consensus       103 ~e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~  178 (318)
T 2dyl_A          103 MELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKE---KHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDD  178 (318)
T ss_dssp             ECCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHH---HHCCCCCCCCGGGEEECTTSCEEECCCTTC------
T ss_pred             Eecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHh---hCCEEeCCCCHHHEEECCCCCEEEEECCCchhccCC
Confidence            9999 555555554445678999999999999999999998   5 8999999999999999999999999999766443


Q ss_pred             CCceeeecccccccccChhccc-----cCCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhccccccCCcccccCc
Q 012765          298 WSHHIVFPIEGTFGYLSPEYFM-----HGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSNFKELVDP  372 (457)
Q Consensus       298 ~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~  372 (457)
                      ..   .....||+.|+|||++.     ...++.++|||||||++|||++|+.||.........+........       +
T Consensus       179 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~-------~  248 (318)
T 2dyl_A          179 KA---KDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEP-------P  248 (318)
T ss_dssp             -----------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHSCC-------C
T ss_pred             cc---ccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhccCC-------C
Confidence            22   22345899999999984     567899999999999999999999999863332222111111100       0


Q ss_pred             hhhcccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 012765          373 RLADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQ  409 (457)
Q Consensus       373 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~  409 (457)
                      .+...  ......+..++.+||+.||.+||++.+|++
T Consensus       249 ~~~~~--~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  283 (318)
T 2dyl_A          249 LLPGH--MGFSGDFQSFVKDCLTKDHRKRPKYNKLLE  283 (318)
T ss_dssp             CCCSS--SCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             CCCcc--CCCCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence            01000  011235667889999999999999999876

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=6.9e-40  Score=319.98  Aligned_cols=245  Identities=24%  Similarity=0.349  Sum_probs=188.5

Q ss_pred             HHhhcCCCCCceecccCcEEEEEEEe-CCCcEEEEEEEeccchhhH---HHHHHHHHHHHHHhhc----CCCCcceeeee
Q 012765          138 AAATDNFNSENLIGKGGHAEVYKGCL-PDGEVVAVKKIIKNAKEDE---ERISDFLSELGIVAHI----NHPNAAKLIGF  209 (457)
Q Consensus       138 ~~~~~~f~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~---~~~~~~~~E~~~l~~l----~hpniv~l~~~  209 (457)
                      ....++|.+.+.||+|+||.||+|.+ .+++.||+|++........   .....+.+|+.++.++    +||||++++++
T Consensus        27 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~  106 (312)
T 2iwi_A           27 EAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDW  106 (312)
T ss_dssp             ------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEE
T ss_pred             hhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEE
Confidence            44568899999999999999999986 4688999999865433221   1233566789999888    89999999996


Q ss_pred             ee-cCceEEEEEe-cCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEc-CCCcEEEe
Q 012765          210 ST-ENGFHLVLQF-LPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLS-EDYEAQIS  286 (457)
Q Consensus       210 ~~-~~~~~lv~e~-~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~-~~~~~kL~  286 (457)
                      +. .+..+++||+ +.+++|.+++... ..+++..++.++.||+.||.|||+   .+|+||||||+||+++ .++.+||+
T Consensus       107 ~~~~~~~~~v~e~~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~kl~  182 (312)
T 2iwi_A          107 FETQEGFMLVLERPLPAQDLFDYITEK-GPLGEGPSRCFFGQVVAAIQHCHS---RGVVHRDIKDENILIDLRRGCAKLI  182 (312)
T ss_dssp             C-----CEEEEECCSSEEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHH---HTEECCCCSGGGEEEETTTTEEEEC
T ss_pred             EecCCeEEEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCChhhEEEeCCCCeEEEE
Confidence            65 4557899998 7899999998653 358999999999999999999999   7999999999999999 88999999


Q ss_pred             eccccccCCCCCCceeeecccccccccChhccccCCCC-cchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhccccccCC
Q 012765          287 DFGLAKWLPDNWSHHIVFPIEGTFGYLSPEYFMHGIVD-EKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSN  365 (457)
Q Consensus       287 DFGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~~~~~~~~  365 (457)
                      |||++.......    .....||..|+|||++.+..+. .++|||||||++|||++|+.||........       ..  
T Consensus       183 dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-------~~--  249 (312)
T 2iwi_A          183 DFGSGALLHDEP----YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQEILE-------AE--  249 (312)
T ss_dssp             CCSSCEECCSSC----BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHHHH-------TC--
T ss_pred             EcchhhhcccCc----ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHHHhh-------hc--
Confidence            999998775542    2234589999999999877664 589999999999999999999975321100       00  


Q ss_pred             cccccCchhhcccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 012765          366 FKELVDPRLADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQ  409 (457)
Q Consensus       366 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~  409 (457)
                            ..+...+    ...+.+++.+||+.||++|||+.|+++
T Consensus       250 ------~~~~~~~----~~~~~~li~~~l~~~p~~Rps~~e~l~  283 (312)
T 2iwi_A          250 ------LHFPAHV----SPDCCALIRRCLAPKPSSRPSLEEILL  283 (312)
T ss_dssp             ------CCCCTTS----CHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             ------cCCcccC----CHHHHHHHHHHccCChhhCcCHHHHhc
Confidence                  0011112    234667889999999999999999998

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=3.9e-39  Score=329.39  Aligned_cols=249  Identities=22%  Similarity=0.272  Sum_probs=182.7

Q ss_pred             hcCCCCCceecccCcEEEEEEEeCCCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhc-CCCCcceeeeeeecCc-eEEE
Q 012765          141 TDNFNSENLIGKGGHAEVYKGCLPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHI-NHPNAAKLIGFSTENG-FHLV  218 (457)
Q Consensus       141 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~-~~lv  218 (457)
                      ..+|.+.++||+|+||+||.....+++.||||++......      .+.+|+.+++.+ +||||+++++++.+.. .++|
T Consensus        23 ~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~~------~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv   96 (432)
T 3p23_A           23 KISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFS------FADREVQLLRESDEHPNVIRYFCTEKDRQFQYIA   96 (432)
T ss_dssp             TEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTEE------ECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEE
T ss_pred             cEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHHH------HHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEE
Confidence            3567788999999999976555568999999998654322      345799999998 7999999999776655 5799


Q ss_pred             EEecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcC-----CCcEEEeecccccc
Q 012765          219 LQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSE-----DYEAQISDFGLAKW  293 (457)
Q Consensus       219 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~-----~~~~kL~DFGl~~~  293 (457)
                      |||+. |+|.+++...........++.++.||+.||.|||+   .+|+||||||+|||++.     ...+||+|||+++.
T Consensus        97 ~E~~~-g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~  172 (432)
T 3p23_A           97 IELCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHS---LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKK  172 (432)
T ss_dssp             EECCS-EEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHH---TTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEEC
T ss_pred             EECCC-CCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHH---CcCEeCCCCHHHEEEecCCCCCceeEEEecccceee
Confidence            99996 69999987655555555567899999999999999   89999999999999953     23588999999987


Q ss_pred             CCCCCCc-eeeecccccccccChhccc---cCCCCcchhHHHHHHHHHHHHh-CCCCCCcCCcchhhhhccccccCCccc
Q 012765          294 LPDNWSH-HIVFPIEGTFGYLSPEYFM---HGIVDEKTDVFAFGVLLLELIT-GRRAVDSRRQSLVIWAKPLLQTSNFKE  368 (457)
Q Consensus       294 ~~~~~~~-~~~~~~~gt~~y~aPE~~~---~~~~~~ksDvwSlGvll~eLlt-G~~pf~~~~~~~~~~~~~~~~~~~~~~  368 (457)
                      +...... .......||+.|+|||++.   ...++.++|||||||++|||++ |..||............   ...... 
T Consensus       173 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~~~~---~~~~~~-  248 (432)
T 3p23_A          173 LAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILL---GACSLD-  248 (432)
T ss_dssp             C------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHHHHT---TCCCCT-
T ss_pred             ccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHHHHh---ccCCcc-
Confidence            7543211 2233456999999999997   4567889999999999999999 99999753322211111   000000 


Q ss_pred             ccCchhhcccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 012765          369 LVDPRLADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQ  409 (457)
Q Consensus       369 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~  409 (457)
                      ...+      .......+.+++.+||+.||.+|||+.+|++
T Consensus       249 ~~~~------~~~~~~~~~~li~~~L~~dP~~Rps~~evl~  283 (432)
T 3p23_A          249 CLHP------EKHEDVIARELIEKMIAMDPQKRPSAKHVLK  283 (432)
T ss_dssp             TSCT------TCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             ccCc------cccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence            0000      1123344678899999999999999999984

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=5.4e-40  Score=322.47  Aligned_cols=245  Identities=20%  Similarity=0.327  Sum_probs=193.5

Q ss_pred             HHhhcCCCCCceecccCcEEEEEEEe-CCCcEEEEEEEeccchhhH---HHHHHHHHHHHHHhhcC--CCCcceeeeeee
Q 012765          138 AAATDNFNSENLIGKGGHAEVYKGCL-PDGEVVAVKKIIKNAKEDE---ERISDFLSELGIVAHIN--HPNAAKLIGFST  211 (457)
Q Consensus       138 ~~~~~~f~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~---~~~~~~~~E~~~l~~l~--hpniv~l~~~~~  211 (457)
                      ....++|.+.+.||+|+||.||+|.+ .+++.||+|.+........   .....+.+|+.++.+++  ||||+++++++.
T Consensus        39 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~  118 (320)
T 3a99_A           39 EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFE  118 (320)
T ss_dssp             -CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEE
T ss_pred             CCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEe
Confidence            34567899999999999999999985 4689999999865432210   11235667899999986  599999999776


Q ss_pred             cC-ceEEEEEecCC-CChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEc-CCCcEEEeec
Q 012765          212 EN-GFHLVLQFLPH-GSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLS-EDYEAQISDF  288 (457)
Q Consensus       212 ~~-~~~lv~e~~~~-gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~-~~~~~kL~DF  288 (457)
                      .. ..+++||++.+ ++|.+++.. ...+++..++.++.||+.||.|||+   .+|+||||||+|||++ .++.+||+||
T Consensus       119 ~~~~~~lv~e~~~~~~~L~~~l~~-~~~l~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~~kL~Df  194 (320)
T 3a99_A          119 RPDSFVLILERPEPVQDLFDFITE-RGALQEELARSFFWQVLEAVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDF  194 (320)
T ss_dssp             CSSEEEEEEECCSSEEEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTTTEEEECCC
T ss_pred             cCCcEEEEEEcCCCCccHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHH---CCcEeCCCCHHHEEEeCCCCCEEEeeC
Confidence            54 46799999976 899998865 3458899999999999999999999   8999999999999999 7889999999


Q ss_pred             cccccCCCCCCceeeecccccccccChhccccCCC-CcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhccccccCCcc
Q 012765          289 GLAKWLPDNWSHHIVFPIEGTFGYLSPEYFMHGIV-DEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSNFK  367 (457)
Q Consensus       289 Gl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~  367 (457)
                      |++.......    .....||+.|+|||++.+..+ +.++|||||||++|||++|+.||.......   ...        
T Consensus       195 g~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~---~~~--------  259 (320)
T 3a99_A          195 GSGALLKDTV----YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEII---RGQ--------  259 (320)
T ss_dssp             TTCEECCSSC----BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHHH---HCC--------
T ss_pred             cccccccccc----ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhhhh---ccc--------
Confidence            9998775432    223458999999999987665 688999999999999999999997532110   000        


Q ss_pred             cccCchhhcccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 012765          368 ELVDPRLADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQ  409 (457)
Q Consensus       368 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~  409 (457)
                          ......++    ..+.+++.+||+.||.+|||+.+|++
T Consensus       260 ----~~~~~~~~----~~~~~li~~~l~~dp~~Rps~~~ll~  293 (320)
T 3a99_A          260 ----VFFRQRVS----SECQHLIRWCLALRPSDRPTFEEIQN  293 (320)
T ss_dssp             ----CCCSSCCC----HHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             ----ccccccCC----HHHHHHHHHHccCChhhCcCHHHHhc
Confidence                00111122    35667889999999999999999987

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=1.2e-38  Score=337.89  Aligned_cols=257  Identities=25%  Similarity=0.298  Sum_probs=193.7

Q ss_pred             hcCCCCCceecccCcEEEEEEEeC-CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeee-------c
Q 012765          141 TDNFNSENLIGKGGHAEVYKGCLP-DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFST-------E  212 (457)
Q Consensus       141 ~~~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~-------~  212 (457)
                      .++|.+.+.||+|+||+||+|.+. +|+.||+|++....  .......+.+|+.++..++||||+++++++.       .
T Consensus        13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~--~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~   90 (676)
T 3qa8_A           13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQEL--SPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPN   90 (676)
T ss_dssp             ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCC--CHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTT
T ss_pred             CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccC--CHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCC
Confidence            478999999999999999999864 68999999886542  2344568999999999999999999999754       3


Q ss_pred             CceEEEEEecCCCChhhhhhcCC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCc---EEEee
Q 012765          213 NGFHLVLQFLPHGSLSSLLFGST--ECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYE---AQISD  287 (457)
Q Consensus       213 ~~~~lv~e~~~~gsL~~~l~~~~--~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~---~kL~D  287 (457)
                      +..++||||+++|+|.+++....  ..+++..++.++.||+.||.|||+   .+|+||||||+||+++.++.   +||+|
T Consensus        91 ~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs---~gIVHrDLKP~NILl~~~g~~~~vKL~D  167 (676)
T 3qa8_A           91 DLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHE---NRIIHRDLKPENIVLQPGPQRLIHKIID  167 (676)
T ss_dssp             SSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHH---TTBCCCCCCSTTEEEECCSSSCEEEECS
T ss_pred             CeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCCHHHeEeecCCCceeEEEcc
Confidence            44689999999999999996533  258888899999999999999999   89999999999999997765   99999


Q ss_pred             ccccccCCCCCCceeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhccccccCCcc
Q 012765          288 FGLAKWLPDNWSHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSNFK  367 (457)
Q Consensus       288 FGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~  367 (457)
                      ||++........   .....||+.|+|||++.+..++.++|||||||++|+|++|..||...... ..|...........
T Consensus       168 FG~a~~~~~~~~---~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~-~~~~~~i~~~~~~~  243 (676)
T 3qa8_A          168 LGYAKELDQGEL---CTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQP-VQWHGKVREKSNEH  243 (676)
T ss_dssp             CCCCCBTTSCCC---CCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHH-HHSSTTCC------
T ss_pred             cccccccccccc---cccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccch-hhhhhhhhcccchh
Confidence            999987755432   23356999999999999999999999999999999999999999754322 12211111111000


Q ss_pred             cccC----------ch--hhcccCHHHHHHHHHHHHHhcccCCCCCCCHHH
Q 012765          368 ELVD----------PR--LADAYDLAEMKRAMLTASVCIHHLSTMRPQMTR  406 (457)
Q Consensus       368 ~~~d----------~~--l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~e  406 (457)
                      ....          ..  ............+.+++..||..||.+|||+.+
T Consensus       244 ~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~e  294 (676)
T 3qa8_A          244 IVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQ  294 (676)
T ss_dssp             CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTT
T ss_pred             hhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHH
Confidence            0000          00  011123335567888999999999999999976

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=3.2e-38  Score=340.56  Aligned_cols=239  Identities=21%  Similarity=0.272  Sum_probs=189.3

Q ss_pred             hhcCCCCCceecccCcEEEEEEEeC--CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeecCc---
Q 012765          140 ATDNFNSENLIGKGGHAEVYKGCLP--DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTENG---  214 (457)
Q Consensus       140 ~~~~f~~~~~LG~G~~g~Vy~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~---  214 (457)
                      ..++|.+.+.||+|+||.||+|.+.  +|+.||||++.....  ......+.+|+.++.+++||||+++++++...+   
T Consensus        78 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~  155 (681)
T 2pzi_A           78 VAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGD--AEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHG  155 (681)
T ss_dssp             ETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCC--HHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTS
T ss_pred             eCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCC--HHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCC
Confidence            3478999999999999999999875  589999998864322  344567899999999999999999999766433   


Q ss_pred             ---eEEEEEecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeecccc
Q 012765          215 ---FHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLA  291 (457)
Q Consensus       215 ---~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~  291 (457)
                         .++||||+++++|.+++..   .+++..++.|+.||+.||.|||+   .+|+||||||+|||++.+ .+||+|||++
T Consensus       156 ~~~~~lv~E~~~g~~L~~~~~~---~l~~~~~~~~~~qi~~aL~~lH~---~giiHrDlkp~NIll~~~-~~kl~DFG~a  228 (681)
T 2pzi_A          156 DPVGYIVMEYVGGQSLKRSKGQ---KLPVAEAIAYLLEILPALSYLHS---IGLVYNDLKPENIMLTEE-QLKLIDLGAV  228 (681)
T ss_dssp             CEEEEEEEECCCCEECC----C---CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECSS-CEEECCCTTC
T ss_pred             CceeEEEEEeCCCCcHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHH---CCCeecccChHHeEEeCC-cEEEEecccc
Confidence               5899999999999987743   68999999999999999999999   899999999999999986 8999999999


Q ss_pred             ccCCCCCCceeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhccccccCCcccccC
Q 012765          292 KWLPDNWSHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSNFKELVD  371 (457)
Q Consensus       292 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d  371 (457)
                      +.....      ....||+.|+|||++.++ ++.++|||||||++|+|++|..||......            .+.   .
T Consensus       229 ~~~~~~------~~~~gt~~y~aPE~~~~~-~~~~sDi~slG~~l~~l~~g~~~~~~~~~~------------~~~---~  286 (681)
T 2pzi_A          229 SRINSF------GYLYGTPGFQAPEIVRTG-PTVATDIYTVGRTLAALTLDLPTRNGRYVD------------GLP---E  286 (681)
T ss_dssp             EETTCC------SCCCCCTTTSCTTHHHHC-SCHHHHHHHHHHHHHHHHSCCCEETTEECS------------SCC---T
T ss_pred             hhcccC------CccCCCccccCHHHHcCC-CCCceehhhhHHHHHHHHhCCCCCcccccc------------ccc---c
Confidence            876543      234599999999998765 489999999999999999999888741100            000   0


Q ss_pred             chhhcccCHHHHHHHHHHHHHhcccCCCCCCC-HHHHHHHHhc
Q 012765          372 PRLADAYDLAEMKRAMLTASVCIHHLSTMRPQ-MTRVLQLLRG  413 (457)
Q Consensus       372 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt-~~evl~~L~~  413 (457)
                          ..........+.+++.+||+.||.+||+ +.++...|.+
T Consensus       287 ----~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~  325 (681)
T 2pzi_A          287 ----DDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTG  325 (681)
T ss_dssp             ----TCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred             ----cccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHH
Confidence                0001122345778999999999999996 5556555543

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=7e-38  Score=302.79  Aligned_cols=234  Identities=13%  Similarity=0.106  Sum_probs=182.3

Q ss_pred             hhcCCCCCceecccCcEEEEEEEeC-CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeecC-ceEE
Q 012765          140 ATDNFNSENLIGKGGHAEVYKGCLP-DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTEN-GFHL  217 (457)
Q Consensus       140 ~~~~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~-~~~l  217 (457)
                      ..++|.+.+.||+|+||.||+|.+. +++.||+|.+.............+.+|+.++..++||||+++++++..+ ..++
T Consensus        29 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l  108 (286)
T 3uqc_A           29 ANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLV  108 (286)
T ss_dssp             TTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred             ecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEE
Confidence            3467889999999999999999875 4899999998766555556677899999999999999999999976554 5789


Q ss_pred             EEEecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCCCC
Q 012765          218 VLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDN  297 (457)
Q Consensus       218 v~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~~  297 (457)
                      ||||+.+++|.+++..  . ........|+.||+.||.|||+   .+|+||||||+|||++.++.+||+++|        
T Consensus       109 v~e~~~g~~L~~~l~~--~-~~~~~~~~i~~ql~~aL~~lH~---~givH~Dikp~NIll~~~g~~kl~~~~--------  174 (286)
T 3uqc_A          109 VAEWIRGGSLQEVADT--S-PSPVGAIRAMQSLAAAADAAHR---AGVALSIDHPSRVRVSIDGDVVLAYPA--------  174 (286)
T ss_dssp             EEECCCEEEHHHHHTT--C-CCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEEETTSCEEECSCC--------
T ss_pred             EEEecCCCCHHHHHhc--C-CChHHHHHHHHHHHHHHHHHHH---CCCccCCCCcccEEEcCCCCEEEEecc--------
Confidence            9999999999999843  2 3455678899999999999999   899999999999999999999997443        


Q ss_pred             CCceeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhh-hhccccccCCcccccCc-hhh
Q 012765          298 WSHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVI-WAKPLLQTSNFKELVDP-RLA  375 (457)
Q Consensus       298 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~-~~~~~~~~~~~~~~~d~-~l~  375 (457)
                                    |++       .++.++|||||||++|||+||+.||......... .........    ...+ .+.
T Consensus       175 --------------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~----~~~~~~~~  229 (286)
T 3uqc_A          175 --------------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQ----PIEPADID  229 (286)
T ss_dssp             --------------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBCTTSC----BCCHHHHC
T ss_pred             --------------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHHhccC----CCChhhcc
Confidence                          333       3689999999999999999999999864432111 000000000    0000 111


Q ss_pred             cccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCCCC
Q 012765          376 DAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQLLRGEGGQ  417 (457)
Q Consensus       376 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~  417 (457)
                      ..    ....+..++.+||+.||.+| |+.|+++.|+.....
T Consensus       230 ~~----~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~  266 (286)
T 3uqc_A          230 RD----IPFQISAVAARSVQGDGGIR-SASTLLNLMQQATAV  266 (286)
T ss_dssp             TT----SCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC-
T ss_pred             cC----CCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhcc
Confidence            11    22346788899999999999 999999999886544

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=2.6e-38  Score=321.62  Aligned_cols=242  Identities=11%  Similarity=0.080  Sum_probs=176.6

Q ss_pred             hhcCCCCCceecccCcEEEEEEEe-CCCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCC-CCcceee----------
Q 012765          140 ATDNFNSENLIGKGGHAEVYKGCL-PDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINH-PNAAKLI----------  207 (457)
Q Consensus       140 ~~~~f~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h-pniv~l~----------  207 (457)
                      ....|...++||+|+||+||+|.+ .+|+.||||++...........+.+.+|+.++..+.| +|.....          
T Consensus        76 ~~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~  155 (413)
T 3dzo_A           76 RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFD  155 (413)
T ss_dssp             CCEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCE
T ss_pred             CceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchh
Confidence            344577788999999999999995 4699999998874444433445678999999999987 2211111          


Q ss_pred             -----------eeeec------CceEEEEEecCCCChhhhhh------cCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC
Q 012765          208 -----------GFSTE------NGFHLVLQFLPHGSLSSLLF------GSTECLEWTIRYKIALGIAEGLQYLHHDCHRR  264 (457)
Q Consensus       208 -----------~~~~~------~~~~lv~e~~~~gsL~~~l~------~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~  264 (457)
                                 .+...      ..++++|+ +.+++|.+++.      .....+++..++.|+.||+.||.|||+   .+
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~  231 (413)
T 3dzo_A          156 LVKDPQKKKMIRVRLDERDMWVLSRFFLYP-RMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH---YG  231 (413)
T ss_dssp             EEECCC---------------CCSEEEEEE-CCSEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHH---TT
T ss_pred             hcccCCCCccccccCCCccccccceEEEee-hhcCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHh---CC
Confidence                       11111      12344444 55789988883      234557888999999999999999999   89


Q ss_pred             eeeCCCCCCcEEEcCCCcEEEeeccccccCCCCCCceeeecccccccccChhcc----------ccCCCCcchhHHHHHH
Q 012765          265 IIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEGTFGYLSPEYF----------MHGIVDEKTDVFAFGV  334 (457)
Q Consensus       265 iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~~~ksDvwSlGv  334 (457)
                      |+||||||+|||++.++.+||+|||+++.....     .....| +.|+|||++          .+..++.++|||||||
T Consensus       232 iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~-----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGv  305 (413)
T 3dzo_A          232 LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS-----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGL  305 (413)
T ss_dssp             EECSCCCGGGEEECTTCCEEECCGGGCEETTEE-----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHH
T ss_pred             cccCCcccceEEEecCCeEEEEeccceeecCCc-----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHH
Confidence            999999999999999999999999998865433     334557 999999999          5556889999999999


Q ss_pred             HHHHHHhCCCCCCcCCcchhhhhccccccCCcccccCchhhcccCHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 012765          335 LLLELITGRRAVDSRRQSLVIWAKPLLQTSNFKELVDPRLADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVL  408 (457)
Q Consensus       335 ll~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl  408 (457)
                      ++|||++|+.||........           ...++...  ..++    ..+.+++.+||+.||.+||++.+++
T Consensus       306 il~elltg~~Pf~~~~~~~~-----------~~~~~~~~--~~~~----~~~~~li~~~l~~dP~~Rpt~~~~l  362 (413)
T 3dzo_A          306 AIYWIWCADLPNTDDAALGG-----------SEWIFRSC--KNIP----QPVRALLEGFLRYPKEDRLLPLQAM  362 (413)
T ss_dssp             HHHHHHHSSCCCCTTGGGSC-----------SGGGGSSC--CCCC----HHHHHHHHHHTCSSGGGSCCHHHHT
T ss_pred             HHHHHHHCCCCCCCcchhhh-----------HHHHHhhc--ccCC----HHHHHHHHHHccCChhhCcCHHHHH
Confidence            99999999999976332110           00111100  1112    4577788899999999999976664

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=1.1e-36  Score=295.94  Aligned_cols=228  Identities=19%  Similarity=0.259  Sum_probs=172.9

Q ss_pred             hcCCCCC-ceecccCcEEEEEEEe-CCCcEEEEEEEeccchhhHHHHHHHHHHHHHH-hhcCCCCcceeeeeeec-----
Q 012765          141 TDNFNSE-NLIGKGGHAEVYKGCL-PDGEVVAVKKIIKNAKEDEERISDFLSELGIV-AHINHPNAAKLIGFSTE-----  212 (457)
Q Consensus       141 ~~~f~~~-~~LG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l-~~l~hpniv~l~~~~~~-----  212 (457)
                      .++|.+. ++||+|+||.||+|.+ .+++.||+|++...        ..+.+|+.++ +.++||||+++++++..     
T Consensus        16 ~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--------~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~   87 (299)
T 3m2w_A           16 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYENLYAGR   87 (299)
T ss_dssp             GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTE
T ss_pred             ccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc--------HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCC
Confidence            3566666 7899999999999986 46899999998542        2456788887 56689999999996653     


Q ss_pred             CceEEEEEecCCCChhhhhhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcC---CCcEEEeec
Q 012765          213 NGFHLVLQFLPHGSLSSLLFGST-ECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSE---DYEAQISDF  288 (457)
Q Consensus       213 ~~~~lv~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~---~~~~kL~DF  288 (457)
                      ...++||||+++|+|.+++.... ..+++..++.++.||+.||.|||+   .+|+||||||+|||++.   ++.+||+||
T Consensus        88 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~~~kl~Df  164 (299)
T 3m2w_A           88 KCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDF  164 (299)
T ss_dssp             EEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESSSSTTCCEEECCC
T ss_pred             ceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEEecCCCCCcEEEecc
Confidence            44689999999999999997643 468999999999999999999999   89999999999999998   788999999


Q ss_pred             cccccCCCCCCceeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhccccccCCccc
Q 012765          289 GLAKWLPDNWSHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSNFKE  368 (457)
Q Consensus       289 Gl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~  368 (457)
                      |++....                        +..++.++|||||||++|||++|+.||...........  .........
T Consensus       165 g~a~~~~------------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~--~~~~~~~~~  218 (299)
T 3m2w_A          165 GFAKETT------------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPG--MKTRIRMGQ  218 (299)
T ss_dssp             TTCEECT------------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CC--SCCSSCTTC
T ss_pred             ccccccc------------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHH--HHHHHhhcc
Confidence            9886432                        24468899999999999999999999975332211100  000000000


Q ss_pred             c-cCchhhcccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 012765          369 L-VDPRLADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQ  409 (457)
Q Consensus       369 ~-~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~  409 (457)
                      . ........    ....+.+++.+||+.||.+|||+.|+++
T Consensus       219 ~~~~~~~~~~----~~~~~~~li~~~l~~dP~~Rps~~e~l~  256 (299)
T 3m2w_A          219 YEFPNPEWSE----VSEEVKMLIRNLLKTEPTQRMTITEFMN  256 (299)
T ss_dssp             CSSCHHHHTT----SCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             ccCCchhccc----CCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence            0 00000011    2345778899999999999999999987

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=100.00  E-value=2.3e-37  Score=305.65  Aligned_cols=240  Identities=17%  Similarity=0.193  Sum_probs=180.0

Q ss_pred             hcCCCCCceecccCcEEEEEEEeCCCcEEEEEEEeccchh-----hHHHHHHHHHHHHHHhhcC---------CCCccee
Q 012765          141 TDNFNSENLIGKGGHAEVYKGCLPDGEVVAVKKIIKNAKE-----DEERISDFLSELGIVAHIN---------HPNAAKL  206 (457)
Q Consensus       141 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-----~~~~~~~~~~E~~~l~~l~---------hpniv~l  206 (457)
                      .++|.+.+.||+|+||+||+|.+ +|+.||||++......     .......+.+|+.+++.++         ||||+++
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l   97 (336)
T 2vuw_A           19 TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL   97 (336)
T ss_dssp             HHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred             cccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence            46788899999999999999998 7899999998754321     1122356778888887775         6666666


Q ss_pred             eee-----------------ee--------------cCceEEEEEecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHH
Q 012765          207 IGF-----------------ST--------------ENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQ  255 (457)
Q Consensus       207 ~~~-----------------~~--------------~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~  255 (457)
                      .+.                 +.              .+..++||||+.+|++.+.+..  ..+++..+..++.||+.||.
T Consensus        98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~--~~~~~~~~~~i~~qi~~aL~  175 (336)
T 2vuw_A           98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT--KLSSLATAKSILHQLTASLA  175 (336)
T ss_dssp             EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT--TCCCHHHHHHHHHHHHHHHH
T ss_pred             cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh--cCCCHHHHHHHHHHHHHHHH
Confidence            553                 22              5678999999999987777633  56899999999999999999


Q ss_pred             HHH-hcCCCCeeeCCCCCCcEEEcCCC--------------------cEEEeeccccccCCCCCCceeeecccccccccC
Q 012765          256 YLH-HDCHRRIIHRDIKASNILLSEDY--------------------EAQISDFGLAKWLPDNWSHHIVFPIEGTFGYLS  314 (457)
Q Consensus       256 yLH-~~~~~~iiHrDlkp~NIll~~~~--------------------~~kL~DFGl~~~~~~~~~~~~~~~~~gt~~y~a  314 (457)
                      ||| +   .+|+||||||+|||++.++                    .+||+|||+++.....       ...||+.|+|
T Consensus       176 ~lH~~---~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~-------~~~gt~~y~a  245 (336)
T 2vuw_A          176 VAEAS---LRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG-------IVVFCDVSMD  245 (336)
T ss_dssp             HHHHH---HCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT-------EEECCCCTTC
T ss_pred             HHHHh---CCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC-------cEEEeecccC
Confidence            999 8   7999999999999999887                    8999999999876543       2249999999


Q ss_pred             hhccccCCCCcchhHHHHHHH-HHHHHhCCCCCCcCCcchhhhhcc----ccccCCcccccCchhhcccCHHHHHHHHHH
Q 012765          315 PEYFMHGIVDEKTDVFAFGVL-LLELITGRRAVDSRRQSLVIWAKP----LLQTSNFKELVDPRLADAYDLAEMKRAMLT  389 (457)
Q Consensus       315 PE~~~~~~~~~ksDvwSlGvl-l~eLltG~~pf~~~~~~~~~~~~~----~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l  389 (457)
                      ||++.+.. +.++||||||++ .+++++|..||...     .|...    ........    ..............+.++
T Consensus       246 PE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~-----~~~~~~~~~~~~~~~~~----~~~~~~~~~~~s~~~~dl  315 (336)
T 2vuw_A          246 EDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNV-----LWLHYLTDKMLKQMTFK----TKCNTPAMKQIKRKIQEF  315 (336)
T ss_dssp             SGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHH-----HHHHHHHHHHHHTCCCS----SCCCSHHHHHHHHHHHHH
T ss_pred             hhhhcCCC-ccceehhhhhCCCCcccccccCCCcch-----hhhhHHHHhhhhhhccC----cccchhhhhhcCHHHHHH
Confidence            99998666 899999998777 78899999998641     11000    00000000    000011123455678889


Q ss_pred             HHHhcccCCCCCCCHHHHH
Q 012765          390 ASVCIHHLSTMRPQMTRVL  408 (457)
Q Consensus       390 ~~~Cl~~dP~~RPt~~evl  408 (457)
                      +.+||+.|     |+.|++
T Consensus       316 i~~~L~~d-----sa~e~l  329 (336)
T 2vuw_A          316 HRTMLNFS-----SATDLL  329 (336)
T ss_dssp             HHHGGGSS-----SHHHHH
T ss_pred             HHHHhccC-----CHHHHH
Confidence            99999976     898887

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.96  E-value=3.1e-30  Score=271.75  Aligned_cols=187  Identities=18%  Similarity=0.144  Sum_probs=128.5

Q ss_pred             ecccCcEEEEEEE-eCCCcEEEEEEEeccc-------hhhHHHHHHHHHHHHHHhhc-CCCCcceeeeeeecC-ceEEEE
Q 012765          150 IGKGGHAEVYKGC-LPDGEVVAVKKIIKNA-------KEDEERISDFLSELGIVAHI-NHPNAAKLIGFSTEN-GFHLVL  219 (457)
Q Consensus       150 LG~G~~g~Vy~~~-~~~~~~vavK~~~~~~-------~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~-~~~lv~  219 (457)
                      ++.|++|.+..+. .--|+.+|+|.+.+..       ...+...++|.+|+++|+++ .|+||++++++++++ ..||||
T Consensus       242 ~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVM  321 (569)
T 4azs_A          242 PYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVM  321 (569)
T ss_dssp             -C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEE
T ss_pred             cccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEE
Confidence            5566667666554 2358899999986542       12234456899999999999 699999999977655 578999


Q ss_pred             EecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCCCCCC
Q 012765          220 QFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWS  299 (457)
Q Consensus       220 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~~~~  299 (457)
                      ||++|++|.++|... ..++..   +|+.||+.||.|||+   .+||||||||+||||+.+|.+||+|||+++.......
T Consensus       322 Eyv~G~~L~d~i~~~-~~l~~~---~I~~QIl~AL~ylH~---~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~~  394 (569)
T 4azs_A          322 EKLPGRLLSDMLAAG-EEIDRE---KILGSLLRSLAALEK---QGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDCS  394 (569)
T ss_dssp             ECCCSEEHHHHHHTT-CCCCHH---HHHHHHHHHHHHHHH---TTCEESCCCGGGEEECTTSCEEECCCTTEESCC---C
T ss_pred             ecCCCCcHHHHHHhC-CCCCHH---HHHHHHHHHHHHHHH---CCceeccCchHhEEECCCCCEEEeecccCeeCCCCCc
Confidence            999999999999654 345544   488999999999999   8999999999999999999999999999987754422


Q ss_pred             ceeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHhCCCCC
Q 012765          300 HHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAV  346 (457)
Q Consensus       300 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLltG~~pf  346 (457)
                        .....+||+.|||||++.+ .+..++|+||+|+++++|.++..++
T Consensus       395 --~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~~  438 (569)
T 4azs_A          395 --WPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSNW  438 (569)
T ss_dssp             --CSHHHHHHHHHHHHHHC------------------CCCCTTHHHH
T ss_pred             --cccCceechhhccHHHhCC-CCCCcccccccccchhhhccccchh
Confidence              2234569999999999865 4677899999999988887765544

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.94  E-value=8.4e-28  Score=251.81  Aligned_cols=188  Identities=20%  Similarity=0.207  Sum_probs=144.3

Q ss_pred             CCCceecccCcEEEEEEEeCCCcEEEEEEEeccchh-----hHHHHHHHHHHHHHHhhcCCCCcceeeeee-ecCceEEE
Q 012765          145 NSENLIGKGGHAEVYKGCLPDGEVVAVKKIIKNAKE-----DEERISDFLSELGIVAHINHPNAAKLIGFS-TENGFHLV  218 (457)
Q Consensus       145 ~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-----~~~~~~~~~~E~~~l~~l~hpniv~l~~~~-~~~~~~lv  218 (457)
                      ...++||+|+||+||+|.. .++.+++|+.......     .....+.+.+|+.++++++||||+++..++ ..+..++|
T Consensus       339 ~~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV  417 (540)
T 3en9_A          339 IPEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM  417 (540)
T ss_dssp             ---------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred             CCCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence            4467899999999999954 6788999986543221     122345689999999999999999554432 45567999


Q ss_pred             EEecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCCCCC
Q 012765          219 LQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNW  298 (457)
Q Consensus       219 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~~~  298 (457)
                      |||+++++|.+++..         +..++.||+.||.|||+   .+|+||||||+|||++.  .+||+|||+++......
T Consensus       418 mE~~~ggsL~~~l~~---------~~~i~~qi~~aL~~LH~---~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~  483 (540)
T 3en9_A          418 MSYINGKLAKDVIED---------NLDIAYKIGEIVGKLHK---NDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDE  483 (540)
T ss_dssp             EECCCSEEHHHHSTT---------CTHHHHHHHHHHHHHHH---TTEECTTCCTTSEEESS--SEEECCCTTCEECCCHH
T ss_pred             EECCCCCCHHHHHHH---------HHHHHHHHHHHHHHHHH---CcCccCCCCHHHEEECC--eEEEEECccCEECCCcc
Confidence            999999999999854         45799999999999999   89999999999999998  99999999999875532


Q ss_pred             Cce-----eeecccccccccChhcccc--CCCCcchhHHHHHHHHHHHHhCCCCCC
Q 012765          299 SHH-----IVFPIEGTFGYLSPEYFMH--GIVDEKTDVFAFGVLLLELITGRRAVD  347 (457)
Q Consensus       299 ~~~-----~~~~~~gt~~y~aPE~~~~--~~~~~ksDvwSlGvll~eLltG~~pf~  347 (457)
                      ...     ......||+.|||||++..  ..|+..+|+|+..+-.++-+.++.+|.
T Consensus       484 ~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~  539 (540)
T 3en9_A          484 DKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV  539 (540)
T ss_dssp             HHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred             ccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence            111     1124569999999999976  668889999999999999888877663

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.92  E-value=4.1e-25  Score=212.69  Aligned_cols=165  Identities=16%  Similarity=0.099  Sum_probs=128.4

Q ss_pred             HHHhhcCCCCCceecccCcEEEEEEEeCCCcEEEEEEEeccchhhH---------------HHHHHHHHHHHHHhhcCCC
Q 012765          137 LAAATDNFNSENLIGKGGHAEVYKGCLPDGEVVAVKKIIKNAKEDE---------------ERISDFLSELGIVAHINHP  201 (457)
Q Consensus       137 ~~~~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~---------------~~~~~~~~E~~~l~~l~hp  201 (457)
                      +......|.+.+.||+|+||.||+|.+.+|+.||+|.+........               .....+.+|+.++++++  
T Consensus        85 ~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--  162 (282)
T 1zar_A           85 LVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--  162 (282)
T ss_dssp             HHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--
T ss_pred             HHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--
Confidence            3444566667799999999999999987799999998854321110               23567899999999999  


Q ss_pred             CcceeeeeeecCceEEEEEecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCC
Q 012765          202 NAAKLIGFSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDY  281 (457)
Q Consensus       202 niv~l~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~  281 (457)
                      | +++++++..+..++||||+++++|.+ +..       .....++.||+.||.|||+   .+|+||||||+|||++ ++
T Consensus       163 ~-~~v~~~~~~~~~~lvmE~~~g~~L~~-l~~-------~~~~~i~~qi~~~l~~lH~---~giiHrDlkp~NILl~-~~  229 (282)
T 1zar_A          163 G-LAVPKVYAWEGNAVLMELIDAKELYR-VRV-------ENPDEVLDMILEEVAKFYH---RGIVHGDLSQYNVLVS-EE  229 (282)
T ss_dssp             T-SSSCCEEEEETTEEEEECCCCEEGGG-CCC-------SCHHHHHHHHHHHHHHHHH---TTEECSCCSTTSEEEE-TT
T ss_pred             C-CCcCeEEeccceEEEEEecCCCcHHH-cch-------hhHHHHHHHHHHHHHHHHH---CCCEeCCCCHHHEEEE-CC
Confidence            5 67777666677899999999999988 421       1234689999999999999   8999999999999999 99


Q ss_pred             cEEEeeccccccCCCCCCceeeecccccccccChhcccc----------CCCCcchhHHH
Q 012765          282 EAQISDFGLAKWLPDNWSHHIVFPIEGTFGYLSPEYFMH----------GIVDEKTDVFA  331 (457)
Q Consensus       282 ~~kL~DFGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----------~~~~~ksDvwS  331 (457)
                      .+||+|||+++               .+..|+|||++..          ..|+..+|+|.
T Consensus       230 ~vkl~DFG~a~---------------~~~~~~a~e~l~rdv~~i~~~f~~~~~~~~~~~~  274 (282)
T 1zar_A          230 GIWIIDFPQSV---------------EVGEEGWREILERDVRNIITYFSRTYRTEKDINS  274 (282)
T ss_dssp             EEEECCCTTCE---------------ETTSTTHHHHHHHHHHHHHHHHHHHHCCCCCHHH
T ss_pred             cEEEEECCCCe---------------ECCCCCHHHHHHHHHHHHHHHHHHhcCCCCChHH
Confidence            99999999986               3455789998743          34455556654

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.82  E-value=1e-20  Score=179.52  Aligned_cols=139  Identities=20%  Similarity=0.184  Sum_probs=105.4

Q ss_pred             CCCCceecccCcEEEEEEEe-CCCcE--EEEEEEeccchh---------------------hHHHHHHHHHHHHHHhhcC
Q 012765          144 FNSENLIGKGGHAEVYKGCL-PDGEV--VAVKKIIKNAKE---------------------DEERISDFLSELGIVAHIN  199 (457)
Q Consensus       144 f~~~~~LG~G~~g~Vy~~~~-~~~~~--vavK~~~~~~~~---------------------~~~~~~~~~~E~~~l~~l~  199 (457)
                      |.+.+.||+|+||.||+|.+ .+|+.  ||||++......                     .......+.+|+.++..+.
T Consensus        49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~  128 (258)
T 1zth_A           49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK  128 (258)
T ss_dssp             EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred             hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence            56778999999999999987 68888  999986443111                     0112246889999999998


Q ss_pred             CCCc--ceeeeeeecCceEEEEEecCC-C----ChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHH-hcCCCCeeeCCCC
Q 012765          200 HPNA--AKLIGFSTENGFHLVLQFLPH-G----SLSSLLFGSTECLEWTIRYKIALGIAEGLQYLH-HDCHRRIIHRDIK  271 (457)
Q Consensus       200 hpni--v~l~~~~~~~~~~lv~e~~~~-g----sL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH-~~~~~~iiHrDlk  271 (457)
                      |+++  +.++++   ...++||||+.+ |    +|.+....    .++.....++.||+.||.||| +   .+|+|||||
T Consensus       129 ~~~i~~p~~~~~---~~~~lVmE~~g~~g~~~~~L~~~~~~----~~~~~~~~i~~qi~~~l~~lH~~---~givHrDlk  198 (258)
T 1zth_A          129 EAGVSVPQPYTY---MKNVLLMEFIGEDELPAPTLVELGRE----LKELDVEGIFNDVVENVKRLYQE---AELVHADLS  198 (258)
T ss_dssp             HTTCCCCCEEEE---ETTEEEEECCEETTEECCBHHHHGGG----GGGSCHHHHHHHHHHHHHHHHHT---SCEECSSCS
T ss_pred             hCCCCCCeEEEc---CCCEEEEEecCCCCCccccHHHHhhc----cChHHHHHHHHHHHHHHHHHHHH---CCEEeCCCC
Confidence            8864  333332   356899999942 4    55555422    223455678999999999999 7   899999999


Q ss_pred             CCcEEEcCCCcEEEeeccccccC
Q 012765          272 ASNILLSEDYEAQISDFGLAKWL  294 (457)
Q Consensus       272 p~NIll~~~~~~kL~DFGl~~~~  294 (457)
                      |+|||++.  .++|+|||++...
T Consensus       199 p~NILl~~--~~~liDFG~a~~~  219 (258)
T 1zth_A          199 EYNIMYID--KVYFIDMGQAVTL  219 (258)
T ss_dssp             TTSEEESS--SEEECCCTTCEET
T ss_pred             HHHEEEcC--cEEEEECcccccC
Confidence            99999998  9999999999754

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.69  E-value=4.9e-17  Score=161.37  Aligned_cols=141  Identities=12%  Similarity=0.095  Sum_probs=98.7

Q ss_pred             CCCCCceecccCcEEEEEEEeCCCcEEEEEEEeccchh---------------hHHH----HHHHHHHHHHHhhcCCCCc
Q 012765          143 NFNSENLIGKGGHAEVYKGCLPDGEVVAVKKIIKNAKE---------------DEER----ISDFLSELGIVAHINHPNA  203 (457)
Q Consensus       143 ~f~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~---------------~~~~----~~~~~~E~~~l~~l~hpni  203 (457)
                      -|.+...||.|+||.||+|...+|+.||||++......               ....    .....+|...|.++.+.++
T Consensus        96 iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv  175 (397)
T 4gyi_A           96 VYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGF  175 (397)
T ss_dssp             CSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred             EEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCC
Confidence            38889999999999999999889999999986432110               0000    0112345666666644433


Q ss_pred             ceeeeeeecCceEEEEEecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCC--
Q 012765          204 AKLIGFSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDY--  281 (457)
Q Consensus       204 v~l~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~--  281 (457)
                      .-..-+.. ...++||||+.+++|..+...       .....++.||+.+|.|||+   .+||||||||.|||+++++  
T Consensus       176 ~vp~p~~~-~~~~LVME~i~G~~L~~l~~~-------~~~~~l~~qll~~l~~lH~---~gIVHrDLKp~NILl~~dgd~  244 (397)
T 4gyi_A          176 PVPEPIAQ-SRHTIVMSLVDALPMRQVSSV-------PDPASLYADLIALILRLAK---HGLIHGDFNEFNILIREEKDA  244 (397)
T ss_dssp             SCCCEEEE-ETTEEEEECCSCEEGGGCCCC-------SCHHHHHHHHHHHHHHHHH---TTEECSCCSTTSEEEEEEECS
T ss_pred             CCCeeeec-cCceEEEEecCCccHhhhccc-------HHHHHHHHHHHHHHHHHHH---CCCcCCCCCHHHEEEeCCCCc
Confidence            22111222 234799999999888765421       1234578899999999999   8999999999999998776  


Q ss_pred             --------cEEEeeccccccC
Q 012765          282 --------EAQISDFGLAKWL  294 (457)
Q Consensus       282 --------~~kL~DFGl~~~~  294 (457)
                              .+.|+||+-+...
T Consensus       245 ~d~~~~~~~~~iID~~Q~V~~  265 (397)
T 4gyi_A          245 EDPSSITLTPIIIXFPQMVSM  265 (397)
T ss_dssp             SCTTSEEEEEEECCCTTCEET
T ss_pred             ccccccccceEEEEeCCcccC
Confidence                    3899999976543

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.23  E-value=3.5e-11  Score=113.52  Aligned_cols=144  Identities=17%  Similarity=0.098  Sum_probs=107.3

Q ss_pred             HhhcCCCCCceecccCcEEEEEEEeCCCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcC-CCCcceeeeeeecC-ceE
Q 012765          139 AATDNFNSENLIGKGGHAEVYKGCLPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHIN-HPNAAKLIGFSTEN-GFH  216 (457)
Q Consensus       139 ~~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~-~~~  216 (457)
                      ....+|.+...++.|+.+.||++.. .++.+++|.........   ...+.+|+.++..+. +.++.++++++.+. ..+
T Consensus        11 ~~l~~~~~~~~~~g~s~~~v~~~~~-~~~~~vlK~~~~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~   86 (263)
T 3tm0_A           11 KLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGT---TYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSN   86 (263)
T ss_dssp             HHHTTSEEEECCSCCSSSEEEEEEC-SSCEEEEEEECGGGTTS---TTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEE
T ss_pred             HHhccceeEeeccCCCCCeEEEEEC-CCCcEEEEeCCcccCCC---HHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceE
Confidence            3456788888899999999999875 46889999875421111   125778899988884 67788899876554 568


Q ss_pred             EEEEecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhc------------------------------------
Q 012765          217 LVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHD------------------------------------  260 (457)
Q Consensus       217 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~------------------------------------  260 (457)
                      +|||+++|.+|...+..      ......++.+++.+|..||+.                                    
T Consensus        87 lv~e~i~G~~l~~~~~~------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (263)
T 3tm0_A           87 LLMSEADGVLCSEEYED------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEE  160 (263)
T ss_dssp             EEEECCSSEEHHHHCCT------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGST
T ss_pred             EEEEecCCeehhhccCC------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccc
Confidence            99999999998776411      112336788999999999981                                    


Q ss_pred             --------------------CCCCeeeCCCCCCcEEEcCCCcEEEeeccccc
Q 012765          261 --------------------CHRRIIHRDIKASNILLSEDYEAQISDFGLAK  292 (457)
Q Consensus       261 --------------------~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~  292 (457)
                                          ....++|+|++|.||+++++..+.|+||+.+.
T Consensus       161 ~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T 3tm0_A          161 DTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             TCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred             cccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence                                01348999999999999876556799998653

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.13  E-value=8.9e-11  Score=110.09  Aligned_cols=135  Identities=18%  Similarity=0.165  Sum_probs=94.7

Q ss_pred             CCCCCceecccCcEEEEEEEeCCCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCC--cceeeeeeec-CceEEEE
Q 012765          143 NFNSENLIGKGGHAEVYKGCLPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPN--AAKLIGFSTE-NGFHLVL  219 (457)
Q Consensus       143 ~f~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpn--iv~l~~~~~~-~~~~lv~  219 (457)
                      +|.+..+.+.|..+.||++...+|..+++|......      ...+.+|+.+++.+.+.+  +.+++++... +..++||
T Consensus        21 ~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~~------~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~   94 (264)
T 1nd4_A           21 GYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSGA------LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLL   94 (264)
T ss_dssp             TCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSCT------TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEE
T ss_pred             CCceEecccCCCCceEEEEecCCCCeEEEEeCCccc------chhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEE
Confidence            344333334566799999987778889999865431      135677888888885444  5567776654 4568999


Q ss_pred             EecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcC--------------------------------------
Q 012765          220 QFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDC--------------------------------------  261 (457)
Q Consensus       220 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~--------------------------------------  261 (457)
                      ||++|.++.  .. .   ..   ...++.+++..|..||+..                                      
T Consensus        95 e~i~G~~l~--~~-~---~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (264)
T 1nd4_A           95 GEVPGQDLL--SS-H---LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGL  165 (264)
T ss_dssp             ECCSSEETT--TS-C---CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTC
T ss_pred             EecCCcccC--cC-c---CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCc
Confidence            999998884  21 1   11   1256778888888888731                                      


Q ss_pred             -----------------CCCeeeCCCCCCcEEEcCCCcEEEeeccccc
Q 012765          262 -----------------HRRIIHRDIKASNILLSEDYEAQISDFGLAK  292 (457)
Q Consensus       262 -----------------~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~  292 (457)
                                       ...++|+|++|.||++++++.+.|+|||.+.
T Consensus       166 ~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~  213 (264)
T 1nd4_A          166 APAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG  213 (264)
T ss_dssp             CHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred             cHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence                             0129999999999999877667799999764

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=99.07  E-value=6e-10  Score=110.16  Aligned_cols=141  Identities=13%  Similarity=0.167  Sum_probs=103.1

Q ss_pred             CceecccCcEEEEEEEeCCCcEEEEEEEe--ccchhhHHHHHHHHHHHHHHhhcC--CCCcceeeeeeecCc----eEEE
Q 012765          147 ENLIGKGGHAEVYKGCLPDGEVVAVKKII--KNAKEDEERISDFLSELGIVAHIN--HPNAAKLIGFSTENG----FHLV  218 (457)
Q Consensus       147 ~~~LG~G~~g~Vy~~~~~~~~~vavK~~~--~~~~~~~~~~~~~~~E~~~l~~l~--hpniv~l~~~~~~~~----~~lv  218 (457)
                      .+.|+.|.++.||+.... +..+++|+..  .....  .....+.+|+.++..+.  +..+++++.++.+..    .++|
T Consensus        43 ~~~l~~G~sn~~y~v~~~-~~~~vlr~~~~p~~~~~--~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~v  119 (359)
T 3dxp_A           43 VEQFKGGQSNPTFKLVTP-GQTYVMRAKPGPKSKLL--PSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYI  119 (359)
T ss_dssp             EEECCC-CCSCEEEEECS-SCEEEEECCCC------------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEE
T ss_pred             EEEcCCcccceEEEEEEC-CceEEEEeCCCCCCCCC--CcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEE
Confidence            467899999999998864 4678888664  22111  12346778999998886  456788888776653    6899


Q ss_pred             EEecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcC-------------------------------------
Q 012765          219 LQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDC-------------------------------------  261 (457)
Q Consensus       219 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~-------------------------------------  261 (457)
                      |||++|..+.+..   ...++...+..++.+++..|..||...                                     
T Consensus       120 me~v~G~~l~~~~---~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  196 (359)
T 3dxp_A          120 MEFVSGRVLWDQS---LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPA  196 (359)
T ss_dssp             EECCCCBCCCCTT---CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHH
T ss_pred             EEecCCeecCCCc---cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChH
Confidence            9999998775422   223567778889999999999999721                                     


Q ss_pred             ------------------CCCeeeCCCCCCcEEEcCCCc--EEEeecccccc
Q 012765          262 ------------------HRRIIHRDIKASNILLSEDYE--AQISDFGLAKW  293 (457)
Q Consensus       262 ------------------~~~iiHrDlkp~NIll~~~~~--~kL~DFGl~~~  293 (457)
                                        ...++|+|+++.|||++.++.  +.|+||+.+..
T Consensus       197 ~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~  248 (359)
T 3dxp_A          197 MDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL  248 (359)
T ss_dssp             HHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred             HHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence                              256999999999999997753  68999998764

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=98.93  E-value=9.1e-10  Score=106.30  Aligned_cols=183  Identities=17%  Similarity=0.159  Sum_probs=119.5

Q ss_pred             CceecccCcEEEEEEEeCCCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcC-CCC--cceeeeeeecCc----eEEEE
Q 012765          147 ENLIGKGGHAEVYKGCLPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHIN-HPN--AAKLIGFSTENG----FHLVL  219 (457)
Q Consensus       147 ~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpn--iv~l~~~~~~~~----~~lv~  219 (457)
                      .+.++.|....||+..    ..+++|.....     .....+.+|..++..+. +..  +.+++.+.....    .++||
T Consensus        25 i~~~~~G~~n~v~~v~----~~~vlR~~~~~-----~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm   95 (304)
T 3sg8_A           25 IEISGEGNDCIAYEIN----RDFIFKFPKHS-----RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGF   95 (304)
T ss_dssp             CCEEEECSSEEEEEST----TSEEEEEESSH-----HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEE
T ss_pred             eEecCCCCcceEEEEC----CEEEEEecCCc-----chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEE
Confidence            4568999999999852    56888875322     23457889999998873 332  445555443333    36899


Q ss_pred             EecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhc---------------------------------------
Q 012765          220 QFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHD---------------------------------------  260 (457)
Q Consensus       220 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~---------------------------------------  260 (457)
                      ++++|.++.....   ..++...+..++.+++..|..||+.                                       
T Consensus        96 ~~i~G~~l~~~~~---~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  172 (304)
T 3sg8_A           96 TKIKGVPLTPLLL---NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKK  172 (304)
T ss_dssp             ECCCCEECCHHHH---HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHH
T ss_pred             cccCCeECCcccc---ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHH
Confidence            9999988765432   2356666777888888888888861                                       


Q ss_pred             ----------------CCCCeeeCCCCCCcEEEcC--CCcEEEeeccccccCCCCCCceeeecccccccc---cChhccc
Q 012765          261 ----------------CHRRIIHRDIKASNILLSE--DYEAQISDFGLAKWLPDNWSHHIVFPIEGTFGY---LSPEYFM  319 (457)
Q Consensus       261 ----------------~~~~iiHrDlkp~NIll~~--~~~~kL~DFGl~~~~~~~~~~~~~~~~~gt~~y---~aPE~~~  319 (457)
                                      ....++|+|++|.||+++.  +..+.|+||+.+..-....  ...    ....+   ..|+...
T Consensus       173 l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~--Dl~----~~~~~~~~~~~~~~~  246 (304)
T 3sg8_A          173 VDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDN--DFI----SLMEDDEEYGMEFVS  246 (304)
T ss_dssp             HHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTH--HHH----TTCCTTTSCCHHHHH
T ss_pred             HHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHH--HHH----HHHhhccccCHHHHH
Confidence                            0135899999999999998  4567899999876432110  000    01111   2233211


Q ss_pred             ----c-CCC---------CcchhHHHHHHHHHHHHhCCCCCC
Q 012765          320 ----H-GIV---------DEKTDVFAFGVLLLELITGRRAVD  347 (457)
Q Consensus       320 ----~-~~~---------~~ksDvwSlGvll~eLltG~~pf~  347 (457)
                          . +..         ....+.|++|.+++.+.+|..+|-
T Consensus       247 ~~l~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~~  288 (304)
T 3sg8_A          247 KILNHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDWY  288 (304)
T ss_dssp             HHHHHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHHH
T ss_pred             HHHHHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHHH
Confidence                0 111         123689999999999999988764

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.39  E-value=2.9e-06  Score=81.75  Aligned_cols=135  Identities=16%  Similarity=0.120  Sum_probs=90.0

Q ss_pred             CceecccCcEEEEEEEeCCCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCC---Ccceeeeeee--cCceEEEEEe
Q 012765          147 ENLIGKGGHAEVYKGCLPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHP---NAAKLIGFST--ENGFHLVLQF  221 (457)
Q Consensus       147 ~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp---niv~l~~~~~--~~~~~lv~e~  221 (457)
                      ...++.|....||+.    |..+++|+...     ......+.+|..+|..+.+.   .+.+.+.++.  .+..+++|++
T Consensus        24 v~~l~~G~~n~v~~v----g~~~VlR~~~~-----~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~   94 (306)
T 3tdw_A           24 VESLGEGFRNYAILV----NGDWVFRFPKS-----QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRK   94 (306)
T ss_dssp             EEEEEECSSEEEEEE----TTTEEEEEESS-----HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEEC
T ss_pred             eeecCCCcceeEEEE----CCEEEEEecCC-----chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEec
Confidence            356888999999987    56788887421     12345788999999998653   3556666553  3447899999


Q ss_pred             cCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhc-----------------------------------------
Q 012765          222 LPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHD-----------------------------------------  260 (457)
Q Consensus       222 ~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~-----------------------------------------  260 (457)
                      ++|..+......   .++......++.+++..|..||+.                                         
T Consensus        95 i~G~~l~~~~~~---~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~  171 (306)
T 3tdw_A           95 VQGQILGEDGMA---VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDY  171 (306)
T ss_dssp             CCSEECHHHHHT---TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHH
T ss_pred             cCCeECchhhhh---hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHH
Confidence            999887653211   123334444445555555555431                                         


Q ss_pred             ----------------CCCCeeeCCCCCCcEEEcC---CCc-EEEeecccccc
Q 012765          261 ----------------CHRRIIHRDIKASNILLSE---DYE-AQISDFGLAKW  293 (457)
Q Consensus       261 ----------------~~~~iiHrDlkp~NIll~~---~~~-~kL~DFGl~~~  293 (457)
                                      ....++|+|++|.||+++.   ++. +.|+||+.+..
T Consensus       172 l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~  224 (306)
T 3tdw_A          172 LTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI  224 (306)
T ss_dssp             HHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred             HHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence                            1235799999999999987   455 48999997753

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=98.15  E-value=6.6e-06  Score=82.11  Aligned_cols=78  Identities=18%  Similarity=0.117  Sum_probs=48.2

Q ss_pred             CceecccCcEEEEEEEeC-CCcEEEEEEEeccch-hhH---HHHHHHHHHHHHHhhcCC--C-CcceeeeeeecCceEEE
Q 012765          147 ENLIGKGGHAEVYKGCLP-DGEVVAVKKIIKNAK-EDE---ERISDFLSELGIVAHINH--P-NAAKLIGFSTENGFHLV  218 (457)
Q Consensus       147 ~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~---~~~~~~~~E~~~l~~l~h--p-niv~l~~~~~~~~~~lv  218 (457)
                      .+.||.|..+.||++... +++.+++|....... ...   .....+..|..++..+..  + .+.+++.+ ..+..++|
T Consensus        35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~-d~~~~~lv  113 (397)
T 2olc_A           35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS-DTEMAVTV  113 (397)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE-ETTTTEEE
T ss_pred             EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE-cCCccEEE
Confidence            457999999999999754 468899997643221 000   012345678888877642  3 34455554 34456899


Q ss_pred             EEecCCC
Q 012765          219 LQFLPHG  225 (457)
Q Consensus       219 ~e~~~~g  225 (457)
                      ||++++.
T Consensus       114 mE~l~g~  120 (397)
T 2olc_A          114 MEDLSHL  120 (397)
T ss_dssp             ECCCTTS
T ss_pred             EEeCCCc
Confidence            9999764

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=98.04  E-value=1.8e-05  Score=77.55  Aligned_cols=82  Identities=5%  Similarity=-0.034  Sum_probs=51.9

Q ss_pred             Ccee-cccCcEEEEEEEeC-------CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcC-C--CCcceeeeeeecC--
Q 012765          147 ENLI-GKGGHAEVYKGCLP-------DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHIN-H--PNAAKLIGFSTEN--  213 (457)
Q Consensus       147 ~~~L-G~G~~g~Vy~~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h--pniv~l~~~~~~~--  213 (457)
                      .+.| +.|....+|+....       +++.+++|+..............+.+|+.++..+. +  -.+.+++.++.+.  
T Consensus        25 ~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~  104 (357)
T 3ats_A           25 ESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDV  104 (357)
T ss_dssp             EEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTT
T ss_pred             EEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCc
Confidence            3567 88889999998654       26678888754322000000124566777777664 2  3567788776654  


Q ss_pred             --ceEEEEEecCCCChh
Q 012765          214 --GFHLVLQFLPHGSLS  228 (457)
Q Consensus       214 --~~~lv~e~~~~gsL~  228 (457)
                        ..++|||+++|..+.
T Consensus       105 ~g~~~~v~e~l~G~~l~  121 (357)
T 3ats_A          105 LGTPFFLMDYVEGVVPP  121 (357)
T ss_dssp             TSSCEEEEECCCCBCCC
T ss_pred             cCCceEEEEecCCCChh
Confidence              357999999887654

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=98.01  E-value=4.2e-05  Score=74.13  Aligned_cols=31  Identities=23%  Similarity=0.348  Sum_probs=27.6

Q ss_pred             CCCeeeCCCCCCcEEEcCCCcEEEeeccccc
Q 012765          262 HRRIIHRDIKASNILLSEDYEAQISDFGLAK  292 (457)
Q Consensus       262 ~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~  292 (457)
                      ...++|+|+.+.|||++.++.+.|+||+.+.
T Consensus       221 ~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~  251 (346)
T 2q83_A          221 SPNLCHQDYGTGNTLLGENEQIWVIDLDTVS  251 (346)
T ss_dssp             SCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred             cCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence            3789999999999999888889999998664

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=97.94  E-value=9e-05  Score=69.43  Aligned_cols=133  Identities=15%  Similarity=0.093  Sum_probs=87.5

Q ss_pred             eecccCcE-EEEEEEeC-CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcC-CCCcceeeeeeecC-ceEEEEEecCC
Q 012765          149 LIGKGGHA-EVYKGCLP-DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHIN-HPNAAKLIGFSTEN-GFHLVLQFLPH  224 (457)
Q Consensus       149 ~LG~G~~g-~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~-~~~lv~e~~~~  224 (457)
                      .+..|..| .||+.... ++..+++|+-...      ....+.+|...|+.+. +--+.++++++.+. ..++|||++++
T Consensus        31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~------~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G  104 (272)
T 4gkh_A           31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGS------VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPG  104 (272)
T ss_dssp             EEECSSSSCEEEEEECCTTCCCEEEEEEETH------HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCS
T ss_pred             EccCCCcCCeEEEEEecCCCeEEEEEECCCC------CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCC
Confidence            44445544 79987654 4667888875432      2346778888887774 33366778876554 46899999999


Q ss_pred             CChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcC-------------------------------------------
Q 012765          225 GSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDC-------------------------------------------  261 (457)
Q Consensus       225 gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~-------------------------------------------  261 (457)
                      .++.+......     .....++.+++..|.-||...                                           
T Consensus       105 ~~~~~~~~~~~-----~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  179 (272)
T 4gkh_A          105 KTAFQVLEEYP-----DSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQV  179 (272)
T ss_dssp             EEHHHHHHHCG-----GGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHH
T ss_pred             ccccccccCCH-----HHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHH
Confidence            87766542111     112234555666666666410                                           


Q ss_pred             ------------CCCeeeCCCCCCcEEEcCCCcEEEeeccccc
Q 012765          262 ------------HRRIIHRDIKASNILLSEDYEAQISDFGLAK  292 (457)
Q Consensus       262 ------------~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~  292 (457)
                                  ...++|+|+.+.|||++.++.+-|+||+.+.
T Consensus       180 ~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~  222 (272)
T 4gkh_A          180 WKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVG  222 (272)
T ss_dssp             HHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred             HHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccc
Confidence                        0138999999999999987767799998764

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=97.74  E-value=0.00011  Score=69.86  Aligned_cols=79  Identities=15%  Similarity=0.191  Sum_probs=54.2

Q ss_pred             cCCCCCceecccCcEEEEEEEeCCCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCC---CcceeeeeeecCceEEE
Q 012765          142 DNFNSENLIGKGGHAEVYKGCLPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHP---NAAKLIGFSTENGFHLV  218 (457)
Q Consensus       142 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp---niv~l~~~~~~~~~~lv  218 (457)
                      ..+.....+|.|..+.||+....+|+.|++|+........   ...|..|...|+.+.-.   -+++++++   +..+++
T Consensus        15 ~~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~---~~~~~~Ea~~L~~L~~~~~vpvP~v~~~---~~~~lv   88 (288)
T 3f7w_A           15 REVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPAL---DGLFRAEALGLDWLGRSFGSPVPQVAGW---DDRTLA   88 (288)
T ss_dssp             CCEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCC---TTHHHHHHHHHHHHTCSTTCCSCCEEEE---ETTEEE
T ss_pred             CCeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcch---hhHHHHHHHHHHHHHhhCCCCcceEEec---cCceEE
Confidence            3445567899999999999999999999999754332211   12466788888777422   24444544   234789


Q ss_pred             EEecCCCC
Q 012765          219 LQFLPHGS  226 (457)
Q Consensus       219 ~e~~~~gs  226 (457)
                      ||++.++.
T Consensus        89 ~e~l~~~~   96 (288)
T 3f7w_A           89 MEWVDERP   96 (288)
T ss_dssp             EECCCCCC
T ss_pred             EEeecccC
Confidence            99988764

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=97.68  E-value=0.00019  Score=72.05  Aligned_cols=79  Identities=13%  Similarity=0.173  Sum_probs=47.7

Q ss_pred             CCeeeCCCCCCcEEEcCCCcEEEeeccccccCCCCCCceeeecccccccccChhccccCC---CCcchhHHHHHHHHHHH
Q 012765          263 RRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEGTFGYLSPEYFMHGI---VDEKTDVFAFGVLLLEL  339 (457)
Q Consensus       263 ~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~ksDvwSlGvll~eL  339 (457)
                      ..++|+|++|.|||++.++ ++|+||+.+..-.....-.... ..-...|++|+......   .....++..+...+|+.
T Consensus       232 ~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~Dla~~l-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (420)
T 2pyw_A          232 QALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFDIGAYL-GNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWNL  309 (420)
T ss_dssp             CEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHHHHHHH-HHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHHH
T ss_pred             CeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHHHHHHH-HHHHHHHHhcccccccccchHHHHHHHHHHHHHHHHH
Confidence            7899999999999998876 9999999876432110000000 00113466666553111   11234556778888887


Q ss_pred             HhCC
Q 012765          340 ITGR  343 (457)
Q Consensus       340 ltG~  343 (457)
                      +++.
T Consensus       310 y~~~  313 (420)
T 2pyw_A          310 FNKR  313 (420)
T ss_dssp             HHHH
T ss_pred             HHHH
Confidence            7754

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=97.47  E-value=0.00098  Score=64.12  Aligned_cols=135  Identities=17%  Similarity=0.154  Sum_probs=85.9

Q ss_pred             CceecccCcEEEEEEEeCCCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcC---CCCcceeeeeeec-CceEEEEEec
Q 012765          147 ENLIGKGGHAEVYKGCLPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHIN---HPNAAKLIGFSTE-NGFHLVLQFL  222 (457)
Q Consensus       147 ~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~---hpniv~l~~~~~~-~~~~lv~e~~  222 (457)
                      .+.|+.|....+|+... ++..+++|+.....      ...+..|...|+.+.   ...++++++++.. +..++|||++
T Consensus        41 ~~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~~------~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l  113 (312)
T 3jr1_A           41 KEKLYSGEMNEIWLIND-EVQTVFVKINERSY------RSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEAL  113 (312)
T ss_dssp             EEEECCSSSSEEEEEES-SSCEEEEEEEEGGG------HHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECC
T ss_pred             eEEeCCccceeeeEEEE-CCCeEEEEeCCccc------HHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEec
Confidence            45789999999999876 56788888764321      346778888887773   3567888887654 4568999999


Q ss_pred             CCCChhh-----------hhhcCCC---------------------CCCHHHHH---HHH----------------HHHH
Q 012765          223 PHGSLSS-----------LLFGSTE---------------------CLEWTIRY---KIA----------------LGIA  251 (457)
Q Consensus       223 ~~gsL~~-----------~l~~~~~---------------------~~~~~~~~---~i~----------------~qia  251 (457)
                      ++..+..           .|+....                     .-+|...+   ++.                ..++
T Consensus       114 ~G~~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~  193 (312)
T 3jr1_A          114 NKSKNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIV  193 (312)
T ss_dssp             CCCCCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHH
T ss_pred             cCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHH
Confidence            9876421           1222110                     12454321   011                1122


Q ss_pred             HHH-HHHHh-cCCCCeeeCCCCCCcEEEcCCCcEEEeecc
Q 012765          252 EGL-QYLHH-DCHRRIIHRDIKASNILLSEDYEAQISDFG  289 (457)
Q Consensus       252 ~aL-~yLH~-~~~~~iiHrDlkp~NIll~~~~~~kL~DFG  289 (457)
                      ..+ ..|.. .....++|+|+.+.|++++.++ +.|+||+
T Consensus       194 ~~l~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~  232 (312)
T 3jr1_A          194 QIVADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA  232 (312)
T ss_dssp             HHHHHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred             HHHHHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence            222 23321 1236799999999999999887 8899974

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=97.37  E-value=0.0021  Score=61.62  Aligned_cols=155  Identities=15%  Similarity=0.160  Sum_probs=83.3

Q ss_pred             ccHHHHHHhhcCCCC-----CceecccCcEEEEEEEeCCCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCC--cc
Q 012765          132 FDFAELAAATDNFNS-----ENLIGKGGHAEVYKGCLPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPN--AA  204 (457)
Q Consensus       132 ~~~~~~~~~~~~f~~-----~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpn--iv  204 (457)
                      ++..++......|.+     .+.|+.|....+|+....+| .+++|.......     ...+..|+.++..+....  +.
T Consensus         7 ~~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~~~-----~~~l~~e~~~l~~L~~~g~~vP   80 (322)
T 2ppq_A            7 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRVE-----KNDLPFFLGLMQHLAAKGLSCP   80 (322)
T ss_dssp             CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC--------CCHHHHHHHHHHHHHHTTCCCC
T ss_pred             CCHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCCc-cEEEEEeCCCCC-----HHHHHHHHHHHHHHHHCCCCCC
Confidence            445555555555655     23467788899999887555 678887754211     123445566555553111  33


Q ss_pred             eeeee-------eecCceEEEEEecCCCChhh--------------hhhcC--C--CC-------CCHHHHHH-------
Q 012765          205 KLIGF-------STENGFHLVLQFLPHGSLSS--------------LLFGS--T--EC-------LEWTIRYK-------  245 (457)
Q Consensus       205 ~l~~~-------~~~~~~~lv~e~~~~gsL~~--------------~l~~~--~--~~-------~~~~~~~~-------  245 (457)
                      +++..       ...+..++++++++|..+..              .++..  .  ..       ..|...+.       
T Consensus        81 ~~~~~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~  160 (322)
T 2ppq_A           81 LPLPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERAD  160 (322)
T ss_dssp             CBCCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGG
T ss_pred             cccCCCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHH
Confidence            33321       12345678999998865321              01110  0  00       11222110       


Q ss_pred             -----HHHHHHHHHHHHHhc----CCCCeeeCCCCCCcEEEcCCCcEEEeeccccc
Q 012765          246 -----IALGIAEGLQYLHHD----CHRRIIHRDIKASNILLSEDYEAQISDFGLAK  292 (457)
Q Consensus       246 -----i~~qia~aL~yLH~~----~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~  292 (457)
                           +...+...+.+++..    ....++|+|+.+.|||++.+..+.|+||+.+.
T Consensus       161 ~~~~~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~  216 (322)
T 2ppq_A          161 EVEKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC  216 (322)
T ss_dssp             GTSTTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             hhhhhhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence                 001234455566532    13579999999999999987556899998664

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=97.31  E-value=0.00069  Score=65.53  Aligned_cols=31  Identities=32%  Similarity=0.433  Sum_probs=27.1

Q ss_pred             CCeeeCCCCCCcEEEcCC----CcEEEeecccccc
Q 012765          263 RRIIHRDIKASNILLSED----YEAQISDFGLAKW  293 (457)
Q Consensus       263 ~~iiHrDlkp~NIll~~~----~~~kL~DFGl~~~  293 (457)
                      ..++|+|+.+.||+++.+    +.+.|+||+.+..
T Consensus       183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~  217 (333)
T 3csv_A          183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL  217 (333)
T ss_dssp             CEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred             CeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence            679999999999999874    6799999998754

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=97.20  E-value=0.0016  Score=62.00  Aligned_cols=71  Identities=8%  Similarity=0.032  Sum_probs=41.6

Q ss_pred             CceecccCcEEEEEEEeCCCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCc-ceeeeeeecCceEEEEEec-CC
Q 012765          147 ENLIGKGGHAEVYKGCLPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNA-AKLIGFSTENGFHLVLQFL-PH  224 (457)
Q Consensus       147 ~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpni-v~l~~~~~~~~~~lv~e~~-~~  224 (457)
                      .+.|+.|....+|+.     +.+++|+.......    .....+|+.++..+....+ .+++++..+ .-+++++|+ ++
T Consensus        23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~----~~~r~~E~~~l~~l~~~g~~P~~~~~~~~-~~~~v~e~i~~g   92 (301)
T 3dxq_A           23 PLERLGGLTNLVFRA-----GDLCLRIPGKGTEE----YINRANEAVAAREAAKAGVSPEVLHVDPA-TGVMVTRYIAGA   92 (301)
T ss_dssp             CEEEESCSSEEEEEE-----TTEEEEEECC--------CCCHHHHHHHHHHHHHTTSSCCEEEECTT-TCCEEEECCTTC
T ss_pred             eeEcCCcccccccee-----eeEEEECCCCCccc----eeCHHHHHHHHHHHHHcCCCCceEEEECC-CCEEEEeecCCC
Confidence            578989999999998     56788876432111    1122356666655532222 455554433 346889999 55


Q ss_pred             CCh
Q 012765          225 GSL  227 (457)
Q Consensus       225 gsL  227 (457)
                      .++
T Consensus        93 ~~l   95 (301)
T 3dxq_A           93 QTM   95 (301)
T ss_dssp             EEC
T ss_pred             ccC
Confidence            443

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=97.09  E-value=0.0048  Score=59.23  Aligned_cols=155  Identities=14%  Similarity=0.093  Sum_probs=82.7

Q ss_pred             cccHHHHHHhhcCCCC-----CceecccCcEEEEEEEeCCCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCC--Cc
Q 012765          131 NFDFAELAAATDNFNS-----ENLIGKGGHAEVYKGCLPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHP--NA  203 (457)
Q Consensus       131 ~~~~~~~~~~~~~f~~-----~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp--ni  203 (457)
                      .++.+.+......|.+     ...|+ |....||+....+|+.+++|........    ...+..|..++..+...  .+
T Consensus        10 ~l~~~~i~~~l~~~g~~~~~~~~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~~~----~~~~~~E~~~~~~L~~~g~~v   84 (328)
T 1zyl_A           10 TLHPDTIMDALFEHGIRVDSGLTPLN-SYENRVYQFQDEDRRRFVVKFYRPERWT----ADQILEEHQFALQLVNDEVPV   84 (328)
T ss_dssp             CCCHHHHHHHHHHTTCCCCSCCEEEC-CSSSEEEEECCTTCCCEEEEEECTTTSC----HHHHHHHHHHHHHHHHTTCSB
T ss_pred             CCCHHHHHHHHHHcCCCCCceEEeec-CcccceEEEEcCCCCEEEEEEcCCCCCC----HHHHHHHHHHHHHHHHcCCee
Confidence            3444444444344432     24577 8888999987767778999987533221    12445566666555321  23


Q ss_pred             ceeeee------eecCceEEEEEecCCCChhh-----------h---hhc--C------CCCCCHHHH----HHH-----
Q 012765          204 AKLIGF------STENGFHLVLQFLPHGSLSS-----------L---LFG--S------TECLEWTIR----YKI-----  246 (457)
Q Consensus       204 v~l~~~------~~~~~~~lv~e~~~~gsL~~-----------~---l~~--~------~~~~~~~~~----~~i-----  246 (457)
                      ++++..      ..++..+++|++++|..+..           .   ++.  .      ....++...    ..+     
T Consensus        85 p~~~~~~g~~~~~~~g~~~~l~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  164 (328)
T 1zyl_A           85 AAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDAT  164 (328)
T ss_dssp             CCCCCBTTBSCEEETTEEEEEEECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCS
T ss_pred             cceeecCCcEEEEECCEEEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcC
Confidence            444432      12334568899998754320           0   111  0      011222111    000     


Q ss_pred             ----------HHHHHHHHHHHHhc----CCCCeeeCCCCCCcEEEcCCCcEEEeeccccc
Q 012765          247 ----------ALGIAEGLQYLHHD----CHRRIIHRDIKASNILLSEDYEAQISDFGLAK  292 (457)
Q Consensus       247 ----------~~qia~aL~yLH~~----~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~  292 (457)
                                ...+...+..+...    ....++|+|+++.|||++ + .+.|+||+.+.
T Consensus       165 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~  222 (328)
T 1zyl_A          165 LIPSGLKAAFLKATDELIAAVTAHWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDAR  222 (328)
T ss_dssp             SSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCC
T ss_pred             cCCHHHHHHHHHHHHHHHHHHHHHhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCC
Confidence                      00111223333221    235689999999999999 4 89999998764

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=97.06  E-value=0.0011  Score=66.79  Aligned_cols=72  Identities=15%  Similarity=0.205  Sum_probs=46.5

Q ss_pred             CceecccCcEEEEEEEeCC--------CcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCC-cceeeeeeecCceEE
Q 012765          147 ENLIGKGGHAEVYKGCLPD--------GEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPN-AAKLIGFSTENGFHL  217 (457)
Q Consensus       147 ~~~LG~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpn-iv~l~~~~~~~~~~l  217 (457)
                      .+.|+.|....||+....+        ++.+++|+......     ...+..|..++..+...+ .+++++++.+   .+
T Consensus        78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~~-----~~~li~E~~~l~~L~~~g~~P~l~~~~~~---g~  149 (429)
T 1nw1_A           78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPET-----ESHLVAESVIFTLLSERHLGPKLYGIFSG---GR  149 (429)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCC-----HHHHHHHHHHHHHHHHTTSSSCEEEEETT---EE
T ss_pred             EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCCc-----HHHHHHHHHHHHHHHhCCCCCcEEEEeCC---CE
Confidence            3568888889999998643        47888887633111     124456888887774333 3566665543   28


Q ss_pred             EEEecCCCC
Q 012765          218 VLQFLPHGS  226 (457)
Q Consensus       218 v~e~~~~gs  226 (457)
                      |++|++|.+
T Consensus       150 v~e~l~G~~  158 (429)
T 1nw1_A          150 LEEYIPSRP  158 (429)
T ss_dssp             EECCCCEEE
T ss_pred             EEEEeCCcc
Confidence            899987633

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=96.99  E-value=0.0033  Score=56.55  Aligned_cols=103  Identities=13%  Similarity=0.072  Sum_probs=68.8

Q ss_pred             CChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCCCCCCceeee
Q 012765          225 GSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVF  304 (457)
Q Consensus       225 gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~~~~~~~~~  304 (457)
                      -+|.+.|...+.+++++++|.++.|.+.+|.-+-..  ..-..+=+.|..|+|..+|.+.+.+ +.+.            
T Consensus        33 vSL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~--~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~------------   97 (229)
T 2yle_A           33 LSLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARR--RQPRHRVRSAAQIRVWRDGAVTLAP-AADD------------   97 (229)
T ss_dssp             EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHT--TCCCCCCCSGGGEEEETTSCEEECC-C---------------
T ss_pred             ccHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhc--ccCCceecCCcceEEecCCceeccc-cccc------------
Confidence            478899988889999999999999999998776220  1111333456899999999888764 2110            


Q ss_pred             cccccccccChhccccCCCCcchhHHHHHHHHHHHHhCCCC
Q 012765          305 PIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRA  345 (457)
Q Consensus       305 ~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLltG~~p  345 (457)
                        .....+.|||... ...+.+.=|||||++||.-+--..|
T Consensus        98 --~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~  135 (229)
T 2yle_A           98 --AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLK  135 (229)
T ss_dssp             -----------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCC
T ss_pred             --ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCC
Confidence              0233466888753 3446788999999999999975544

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=96.92  E-value=0.0034  Score=61.98  Aligned_cols=139  Identities=18%  Similarity=0.230  Sum_probs=78.4

Q ss_pred             CceecccCcEEEEEEEeC--------CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcC-CCCcceeeeeeecCceEE
Q 012765          147 ENLIGKGGHAEVYKGCLP--------DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHIN-HPNAAKLIGFSTENGFHL  217 (457)
Q Consensus       147 ~~~LG~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~~~l  217 (457)
                      .+.|..|-...+|+....        +++.+++|+.-....    ....+.+|..+++.+. +.-..++++++.++   +
T Consensus        55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~~----~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~g---~  127 (379)
T 3feg_A           55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAILQ----GVDSLVLESVMFAILAERSLGPQLYGVFPEG---R  127 (379)
T ss_dssp             CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC---C----CHHHHHHHHHHHHHHHHTTSSCCEEEEETTE---E
T ss_pred             EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCccc----hHHHHHHHHHHHHHHHhcCCCCeEEEEcCCc---c
Confidence            346766878889998764        247888887422111    1235567888887774 33345666665542   8


Q ss_pred             EEEecCCCChhhh-----------------hhcC----CCCCC--HHHHHHHHHHHH-------------------HHHH
Q 012765          218 VLQFLPHGSLSSL-----------------LFGS----TECLE--WTIRYKIALGIA-------------------EGLQ  255 (457)
Q Consensus       218 v~e~~~~gsL~~~-----------------l~~~----~~~~~--~~~~~~i~~qia-------------------~aL~  255 (457)
                      ||||++|..|..-                 |+..    .....  +....++..++.                   ..+.
T Consensus       128 v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~  207 (379)
T 3feg_A          128 LEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMG  207 (379)
T ss_dssp             EEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHH
T ss_pred             EEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHH
Confidence            9999987544311                 1111    11122  334434443331                   1233


Q ss_pred             HHHhc-----CCCCeeeCCCCCCcEEEcCC----CcEEEeeccccc
Q 012765          256 YLHHD-----CHRRIIHRDIKASNILLSED----YEAQISDFGLAK  292 (457)
Q Consensus       256 yLH~~-----~~~~iiHrDlkp~NIll~~~----~~~kL~DFGl~~  292 (457)
                      .|...     ....++|+|+.+.||+++.+    +.+.|+||..+.
T Consensus       208 ~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~  253 (379)
T 3feg_A          208 NLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS  253 (379)
T ss_dssp             HHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred             HHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence            33221     22469999999999999876    689999998764

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=96.64  E-value=0.0077  Score=61.05  Aligned_cols=74  Identities=19%  Similarity=0.077  Sum_probs=45.2

Q ss_pred             CceecccCcEEEEEEEeCC-CcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCc-ceeeeeeecCceEEEEEecCC
Q 012765          147 ENLIGKGGHAEVYKGCLPD-GEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNA-AKLIGFSTENGFHLVLQFLPH  224 (457)
Q Consensus       147 ~~~LG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpni-v~l~~~~~~~~~~lv~e~~~~  224 (457)
                      .+.|+.|-...+|+....+ +..+++|+.......    .-+-.+|..++..+...++ .++++++. +  .+||+|+++
T Consensus       113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~----~idR~~E~~vl~~L~~~gl~P~ll~~~~-~--G~v~e~I~G  185 (458)
T 2qg7_A          113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDE----IINREREKKISCILYNKNIAKKIYVFFT-N--GRIEEFMDG  185 (458)
T ss_dssp             EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCS----CSCHHHHHHHHHHHTTSSSBCCEEEEET-T--EEEEECCCS
T ss_pred             EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhh----hcCHHHHHHHHHHHHhcCCCCCEEEEeC-C--eEEEEeeCC
Confidence            3568888889999998754 477888876332211    0012468888887765444 56666653 3  259999987


Q ss_pred             CCh
Q 012765          225 GSL  227 (457)
Q Consensus       225 gsL  227 (457)
                      .+|
T Consensus       186 ~~l  188 (458)
T 2qg7_A          186 YAL  188 (458)
T ss_dssp             EEC
T ss_pred             ccC
Confidence            443

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=96.55  E-value=0.0044  Score=60.80  Aligned_cols=72  Identities=17%  Similarity=0.164  Sum_probs=40.2

Q ss_pred             ceecccCcEEEEEEEeCC---------CcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCC-cceeeeeeecCceEE
Q 012765          148 NLIGKGGHAEVYKGCLPD---------GEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPN-AAKLIGFSTENGFHL  217 (457)
Q Consensus       148 ~~LG~G~~g~Vy~~~~~~---------~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpn-iv~l~~~~~~~~~~l  217 (457)
                      ..|+.|....+|+....+         ++.+++|+.......    ......|..++..+...+ ..++++..  . -++
T Consensus        39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~----~~~~~~E~~~l~~L~~~g~~P~~~~~~--~-~~~  111 (369)
T 3c5i_A           39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDE----LYNTISEFEVYKTMSKYKIAPQLLNTF--N-GGR  111 (369)
T ss_dssp             EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGG----TSCHHHHHHHHHHHHHTTSSCCEEEEE--T-TEE
T ss_pred             EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccc----eecHHHHHHHHHHHHhcCCCCceEEec--C-CcE
Confidence            467778888999987643         267888865432211    112345666666664323 44666543  2 368


Q ss_pred             EEEecCCCC
Q 012765          218 VLQFLPHGS  226 (457)
Q Consensus       218 v~e~~~~gs  226 (457)
                      ||+|++|..
T Consensus       112 v~e~i~G~~  120 (369)
T 3c5i_A          112 IEEWLYGDP  120 (369)
T ss_dssp             EEECCCSEE
T ss_pred             EEEEecCCc
Confidence            999998754

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=96.48  E-value=0.027  Score=54.48  Aligned_cols=30  Identities=27%  Similarity=0.381  Sum_probs=26.9

Q ss_pred             CCeeeCCCCCCcEEEcCCCcEEEeeccccc
Q 012765          263 RRIIHRDIKASNILLSEDYEAQISDFGLAK  292 (457)
Q Consensus       263 ~~iiHrDlkp~NIll~~~~~~kL~DFGl~~  292 (457)
                      ..++|+|+.+.||+++.++.+.|+||+.+.
T Consensus       206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~  235 (339)
T 3i1a_A          206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPM  235 (339)
T ss_dssp             CEEECSCCCGGGEEECGGGCEEECCCSSCE
T ss_pred             ceeEeCCCCcCCEEEeCCCeEEEEECCCCe
Confidence            579999999999999988889999998665

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=93.12  E-value=0.16  Score=50.20  Aligned_cols=29  Identities=34%  Similarity=0.486  Sum_probs=24.2

Q ss_pred             CeeeCCCCCCcEEE------cCCCcEEEeeccccc
Q 012765          264 RIIHRDIKASNILL------SEDYEAQISDFGLAK  292 (457)
Q Consensus       264 ~iiHrDlkp~NIll------~~~~~~kL~DFGl~~  292 (457)
                      .++|+|+.+.|||+      +++..+.++||..+.
T Consensus       245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~  279 (401)
T 3g15_A          245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSS  279 (401)
T ss_dssp             EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCE
T ss_pred             eeEEecCCCCeEEEecCcccCcCCeEEEechHhcc
Confidence            36799999999999      345679999998774

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=92.90  E-value=0.38  Score=47.99  Aligned_cols=74  Identities=14%  Similarity=0.074  Sum_probs=44.5

Q ss_pred             CceecccCcEEEEEEEeCC--------CcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcC-CCCcceeeeeeecCceEE
Q 012765          147 ENLIGKGGHAEVYKGCLPD--------GEVVAVKKIIKNAKEDEERISDFLSELGIVAHIN-HPNAAKLIGFSTENGFHL  217 (457)
Q Consensus       147 ~~~LG~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~~~l  217 (457)
                      .+.|..|-...+|+....+        ++.+++++.......    .-+..+|..+++.+. +.-..++++.+.   -++
T Consensus        75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~----~idR~~E~~~l~~L~~~gi~P~l~~~~~---~~~  147 (424)
T 3mes_A           75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGK----FYDSKVELDVFRYLSNINIAPNIIADFP---EGR  147 (424)
T ss_dssp             EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-C----CCCHHHHHHHHHHHHHTTSSCCEEEEET---TEE
T ss_pred             EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcch----hcCHHHHHHHHHHHHhcCCCCCEEEEcC---CCE
Confidence            3567778888999987653        578888875332211    112345677666664 222455555332   268


Q ss_pred             EEEecCCCCh
Q 012765          218 VLQFLPHGSL  227 (457)
Q Consensus       218 v~e~~~~gsL  227 (457)
                      |++|++|..|
T Consensus       148 I~efI~G~~l  157 (424)
T 3mes_A          148 IEEFIDGEPL  157 (424)
T ss_dssp             EEECCCSEEC
T ss_pred             EEEEeCCccC
Confidence            8999988653

>4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp}

Probab=91.98  E-value=0.48  Score=42.37  Aligned_cols=117  Identities=10%  Similarity=0.114  Sum_probs=77.2

Q ss_pred             cCCCCcceeeeeeecCc-eEEEEEecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEE
Q 012765          198 INHPNAAKLIGFSTENG-FHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNIL  276 (457)
Q Consensus       198 l~hpniv~l~~~~~~~~-~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIl  276 (457)
                      ..||+++.. .+....+ +.+.++.-.  ....+-  .-...+...++.++.+|+....+++.     -+|--|.|+||+
T Consensus        42 ~~~~~Fl~~-~I~e~eD~v~~~y~~~~--~~~~f~--~ik~~~~~eKlr~l~ni~~l~~~~~~-----r~tf~L~P~NL~  111 (215)
T 4ann_A           42 QHSPYFIDA-ELTELRDSFQIHYDIND--NHTPFD--NIKSFTKNEKLRYLLNIKNLEEVNRT-----RYTFVLAPDELF  111 (215)
T ss_dssp             SCCTTBCCE-EEEECSSEEEEEECCCT--TSEEGG--GGGGSCHHHHHHHHHHGGGGGGGGGS-----SEECCCSGGGEE
T ss_pred             ccCCcccce-EEEEcccEEEEEEEcCc--ccCCHH--HHHhcCHHHHHHHHHHHHHHHHHhcC-----ceEEEEecceEE
Confidence            367888866 3443333 344444332  222222  12346788899999999888866654     578889999999


Q ss_pred             EcCCCcEEEeeccccccCCCCCCceeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHhCCCCCCc
Q 012765          277 LSEDYEAQISDFGLAKWLPDNWSHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDS  348 (457)
Q Consensus       277 l~~~~~~kL~DFGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLltG~~pf~~  348 (457)
                      ++.++.+++.-.|+-..+                   +|.     .++...=.-.+=|++..+++++..|+.
T Consensus       112 f~~~~~p~i~~RGik~~l-------------------~P~-----~~~ee~fL~qyKAliiall~~K~~Fe~  159 (215)
T 4ann_A          112 FTRDGLPIAKTRGLQNVV-------------------DPL-----PVSEAEFLTRYKALVICAFNEKQSFDA  159 (215)
T ss_dssp             ECTTSCEEESCCEETTTB-------------------SCC-----CCCHHHHHHHHHHHHHHHHCTTCCHHH
T ss_pred             EcCCCCEEEEEccCccCC-------------------CCC-----CCCHHHHHHHHHHHHHHHHcCCCCHHH
Confidence            999999999877754322                   121     223333355778999999999998874

>4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid}

Probab=90.33  E-value=0.96  Score=40.54  Aligned_cols=116  Identities=14%  Similarity=0.101  Sum_probs=75.8

Q ss_pred             CCCCcceeeeeeecCceEEEEEecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHH-HHHhcCCCCeeeCCCCCCcEEE
Q 012765          199 NHPNAAKLIGFSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQ-YLHHDCHRRIIHRDIKASNILL  277 (457)
Q Consensus       199 ~hpniv~l~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~-yLH~~~~~~iiHrDlkp~NIll  277 (457)
                      .||++ ..---..++.+.+.++.-+++.-+..+    ..++...+++++.+|+.... +++     .-+|--|.|+||++
T Consensus        48 ~~~~f-~~~I~~~eD~~~i~y~~~~~~~~f~~i----~~~~~~eKlrll~nl~~L~~~~~~-----~r~tf~l~P~NL~f  117 (219)
T 4ano_A           48 VDPCI-VRDIDVSEDEVKVVIKPPSSFLTFAAI----RKTTLLSRIRAAIHLVSKVKHHSA-----RRLIFIVCPENLMF  117 (219)
T ss_dssp             SCSSS-EEEEEECSSEEEEEEECCTTCEEHHHH----HTSCHHHHHHHHHHHHHHHSSCCS-----SSEECCCCGGGEEE
T ss_pred             cCCCC-CeEEEEeCCEEEEEEEcCcccCcHHHH----HhcCHHHHHHHHHHHHHHHHHhhh-----CceeEEEeCceEEE
Confidence            67887 332224445555666654344333333    34677888888888877766 554     46788899999999


Q ss_pred             cCCCcEEEeeccccccCCCCCCceeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHhCCCCCCc
Q 012765          278 SEDYEAQISDFGLAKWLPDNWSHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDS  348 (457)
Q Consensus       278 ~~~~~~kL~DFGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLltG~~pf~~  348 (457)
                      +.++.++|.-.|+-..                   ++|.-     ++..-=+-.+=|++..++.++..|+.
T Consensus       118 ~~~~~p~i~hRGi~~~-------------------lpP~e-----~~ee~fl~qyKali~all~~K~~Fe~  164 (219)
T 4ano_A          118 NRALEPFFLHVGVKES-------------------LPPDE-----WDDERLLREVKATVLALTEGEYRFDE  164 (219)
T ss_dssp             CTTCCEEESCCEETTT-------------------BSSCS-----CCHHHHHHHHHHHHHHHTTCSSCHHH
T ss_pred             eCCCcEEEEEcCCccc-------------------CCCCC-----CCHHHHHHHHHHHHHHHHcCCCCHHH
Confidence            9999999988775432                   22221     12222244677899999999988874

>3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A

Probab=82.64  E-value=0.16  Score=51.40  Aligned_cols=62  Identities=11%  Similarity=0.126  Sum_probs=17.3

Q ss_pred             CCceecccCcEEEEEEEeCC-CcEEEE------EEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeee
Q 012765          146 SENLIGKGGHAEVYKGCLPD-GEVVAV------KKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFST  211 (457)
Q Consensus       146 ~~~~LG~G~~g~Vy~~~~~~-~~~vav------K~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~  211 (457)
                      +.+.||   ||.||+|.+.. ..+||+      |...... ...+....+.+|..++..++|||+++.++|..
T Consensus       146 l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~-~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~  214 (463)
T 3cxl_A          146 IYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDG-VSEKRLTSLVRRATLKENEQIPKYEKIHNFKV  214 (463)
T ss_dssp             STTTSS---BCCC---------CCBGGGC------------------------------------CBCCCEEE
T ss_pred             ccccCC---chhhhcccccccCCchhhhhccCcccccccc-ccccccccccccccccccccccccCCCcceEE
Confidence            345676   99999998754 357888      6554322 22233457888999999999999999988643

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	457
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	5e-65
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	1e-58
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	1e-57
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	2e-57
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	1e-55
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	6e-55
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	2e-54
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	5e-54
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	8e-54
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	3e-53
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	4e-53
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	6e-52
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	1e-51
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	2e-51
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	2e-51
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	2e-51
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	5e-51
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	6e-51
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	1e-50
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	1e-50
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	3e-50
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	8e-50
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	8e-50
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	4e-49
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	5e-49
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	4e-48
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	6e-48
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	6e-47
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	4e-46
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	4e-46
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	1e-45
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	1e-44
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	5e-44
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	8e-44
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	1e-43
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	2e-43
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	5e-42
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	2e-41
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	2e-41
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	5e-40
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	1e-39
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	3e-39
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	1e-38
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	1e-38
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	4e-38
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	6e-38
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	8e-38
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	2e-37
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	2e-37
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	4e-37
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	1e-36
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	1e-36
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	3e-35
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	6e-35
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	1e-34
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	2e-34
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	2e-33
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	7e-31
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	2e-29
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	1e-28
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	8e-28
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	1e-27
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	2e-17

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  208 bits (531), Expect = 5e-65
 Identities = 74/276 (26%), Positives = 114/276 (41%), Gaps = 20/276 (7%)

Query: 142 DNFNSENLIGKGGHAEVYKGCLPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHP 201
                   IG G    VYKG       VAVK ++       +++  F +E+G++    H 
Sbjct: 8   GQITVGQRIGSGSFGTVYKGKWHGD--VAVK-MLNVTAPTPQQLQAFKNEVGVLRKTRHV 64

Query: 202 NAAKLIGFSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDC 261
           N    +G+ST     +V Q+    SL   L       E      IA   A+G+ YLH   
Sbjct: 65  NILLFMGYSTAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH--- 121

Query: 262 HRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEGTFGYLSPEYFMH- 320
            + IIHRD+K++NI L ED   +I DFGLA         H    + G+  +++PE     
Sbjct: 122 AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQ 181

Query: 321 --GIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSNFKELVDPRLADAY 378
                  ++DV+AFG++L EL+TG+    +      I           +  + P L+   
Sbjct: 182 DKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVG------RGYLSPDLSKVR 235

Query: 379 D--LAEMKRAMLTASVCIHHLSTMRPQMTRVLQLLR 412
                 MKR M     C+      RP   ++L  + 
Sbjct: 236 SNCPKAMKRLMAE---CLKKKRDERPLFPQILASIE 268

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  193 bits (491), Expect = 1e-58
 Identities = 57/207 (27%), Positives = 99/207 (47%), Gaps = 11/207 (5%)

Query: 140 ATDNFNSENLIGKGGHAEVYKG-CLPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHI 198
             D+F   + +G G    V+K    P G V+A K I    K         + EL ++   
Sbjct: 4   KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRN--QIIRELQVLHEC 61

Query: 199 NHPNAAKLIG-FSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYL 257
           N P      G F ++    + ++ +  GSL  +L      +   I  K+++ + +GL YL
Sbjct: 62  NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLK-KAGRIPEQILGKVSIAVIKGLTYL 120

Query: 258 HHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEGTFGYLSPEY 317
                 +I+HRD+K SNIL++   E ++ DFG++  L D+ ++  V    GT  Y+SPE 
Sbjct: 121 REKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV----GTRSYMSPER 174

Query: 318 FMHGIVDEKTDVFAFGVLLLELITGRR 344
                   ++D+++ G+ L+E+  GR 
Sbjct: 175 LQGTHYSVQSDIWSMGLSLVEMAVGRY 201

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  189 bits (480), Expect = 1e-57
 Identities = 68/274 (24%), Positives = 112/274 (40%), Gaps = 24/274 (8%)

Query: 142 DNFNSENLIGKGGHAEVYKGCLPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHP 201
                   IG G    V+ G   + + VA+K I + A  +E    DF+ E  ++  ++HP
Sbjct: 5   SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEE----DFIEEAEVMMKLSHP 60

Query: 202 NAAKLIGFSTENG-FHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHD 260
              +L G   E     LV +F+ HG LS  L              + L + EG+    + 
Sbjct: 61  KLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGM---AYL 117

Query: 261 CHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEGTFGYLSPEYFMH 320
               +IHRD+ A N L+ E+   ++SDFG+ +++ D+         +    + SPE F  
Sbjct: 118 EEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTG-TKFPVKWASPEVFSF 176

Query: 321 GIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSNFKELVDPRLA--DAY 378
                K+DV++FGVL+ E+ +  +     R +  +             L  PRLA    Y
Sbjct: 177 SRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIS----TGFRLYKPRLASTHVY 232

Query: 379 DLAEMKRAMLTASVCIHHLSTMRPQMTRVLQLLR 412
            +            C       RP  +R+L+ L 
Sbjct: 233 QIMNH---------CWKERPEDRPAFSRLLRQLA 257

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  188 bits (479), Expect = 2e-57
 Identities = 64/271 (23%), Positives = 116/271 (42%), Gaps = 20/271 (7%)

Query: 142 DNFNSENLIGKGGHAEVYKGCLPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHP 201
           +       +G G   EV+ G       VAVK + + +   +     FL+E  ++  + H 
Sbjct: 13  ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA----FLAEANLMKQLQHQ 68

Query: 202 NAAKLIGFSTENGFHLVLQFLPHGSLSSLLFGSTEC-LEWTIRYKIALGIAEGLQYLHHD 260
              +L    T+   +++ +++ +GSL   L   +   L       +A  IAEG+ ++   
Sbjct: 69  RLVRLYAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE- 127

Query: 261 CHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEGTFGYLSPEYFMH 320
             R  IHRD++A+NIL+S+    +I+DFGLA+ + DN  +      +    + +PE   +
Sbjct: 128 --RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDN-EYTAREGAKFPIKWTAPEAINY 184

Query: 321 GIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSNFKELVDPRLADAYDL 380
           G    K+DV++FG+LL E++T  R       +  +     L+        D    + Y L
Sbjct: 185 GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQN--LERGYRMVRPDNCPEELYQL 242

Query: 381 AEMKRAMLTASVCIHHLSTMRPQMTRVLQLL 411
             +         C       RP    +  +L
Sbjct: 243 MRL---------CWKERPEDRPTFDYLRSVL 264

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  184 bits (468), Expect = 1e-55
 Identities = 60/282 (21%), Positives = 118/282 (41%), Gaps = 21/282 (7%)

Query: 136 ELAAATDNFNSENL-IGKGGHAEVYKGCL---PDGEVVAVKKIIKNAKEDEERISDFLSE 191
           +L    DN    ++ +G G    V +G          VA+K + +  ++ +    + + E
Sbjct: 2   KLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTE--EMMRE 59

Query: 192 LGIVAHINHPNAAKLIGFSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIA 251
             I+  +++P   +LIG        LV++    G L   L G  E +  +   ++   ++
Sbjct: 60  AQIMHQLDNPYIVRLIGVCQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVS 119

Query: 252 EGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVF-PIEGTF 310
            G++YL     +  +HRD+ A N+LL   + A+ISDFGL+K L  + S++      +   
Sbjct: 120 MGMKYLE---EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPL 176

Query: 311 GYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSNFKELV 370
            + +PE         ++DV+++GV + E ++  +    + +   + A   ++     E  
Sbjct: 177 KWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAF--IEQGKRMECP 234

Query: 371 DPRLADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQLLR 412
                + Y L            C  +    RP    V Q +R
Sbjct: 235 PECPPELYALMSD---------CWIYKWEDRPDFLTVEQRMR 267

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  182 bits (463), Expect = 6e-55
 Identities = 67/286 (23%), Positives = 118/286 (41%), Gaps = 22/286 (7%)

Query: 142 DNFNSENLIGKGGHAEVYKGCLPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHP 201
           ++   E  +G+G   EV+ G       VA+K +       E     FL E  ++  + H 
Sbjct: 17  ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA----FLQEAQVMKKLRHE 72

Query: 202 NAAKLIGFSTENGFHLVLQFLPHGSLSSLLFGST-ECLEWTIRYKIALGIAEGLQYLHHD 260
              +L    +E   ++V +++  GSL   L G T + L       +A  IA G+ Y+   
Sbjct: 73  KLVQLYAVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER- 131

Query: 261 CHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEGTFGYLSPEYFMH 320
                +HRD++A+NIL+ E+   +++DFGLA+ + DN         +    + +PE  ++
Sbjct: 132 --MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQ-GAKFPIKWTAPEAALY 188

Query: 321 GIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSNFKELVDPRL-ADAYD 379
           G    K+DV++FG+LL EL T  R       +  +  +       ++    P      +D
Sbjct: 189 GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQ---VERGYRMPCPPECPESLHD 245

Query: 380 LAEMKRAMLTASVCIHHLSTMRPQMTRVLQLLRGEGGQTDLKPKPS 425
           L            C       RP    +   L      T+ + +P 
Sbjct: 246 LMCQ---------CWRKEPEERPTFEYLQAFLEDYFTSTEPQYQPG 282

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  180 bits (458), Expect = 2e-54
 Identities = 56/274 (20%), Positives = 113/274 (41%), Gaps = 24/274 (8%)

Query: 142 DNFNSENLIGKGGHAEVYKGCLPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHP 201
            +      +G G    V  G       VA+K I + +  ++E    F+ E  ++ +++H 
Sbjct: 4   KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDE----FIEEAKVMMNLSHE 59

Query: 202 NAAKLIGFSTENG-FHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHD 260
              +L G  T+     ++ +++ +G L + L       +     ++   + E ++YL   
Sbjct: 60  KLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLES- 118

Query: 261 CHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEGTFGYLSPEYFMH 320
             ++ +HRD+ A N L+++    ++SDFGL++++ D+     V        +  PE  M+
Sbjct: 119 --KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSK-FPVRWSPPEVLMY 175

Query: 321 GIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSNFKELVDPRLA--DAY 378
                K+D++AFGVL+ E+ +  +    R  +           +    L  P LA    Y
Sbjct: 176 SKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEH----IAQGLRLYRPHLASEKVY 231

Query: 379 DLAEMKRAMLTASVCIHHLSTMRPQMTRVLQLLR 412
            +            C H  +  RP    +L  + 
Sbjct: 232 TIMYS---------CWHEKADERPTFKILLSNIL 256

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  179 bits (456), Expect = 5e-54
 Identities = 55/277 (19%), Positives = 116/277 (41%), Gaps = 24/277 (8%)

Query: 142 DNFNSENLIGKGGHAEVYKG-CLPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINH 200
           +++     IG G +    K     DG+++  K++   +  + E+    +SE+ ++  + H
Sbjct: 4   EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEK-QMLVSEVNLLRELKH 62

Query: 201 PNAAKLIGF---STENGFHLVLQFLPHGSLSSLLFGST---ECLEWTIRYKIALGIAEGL 254
           PN  +        T    ++V+++   G L+S++   T   + L+     ++   +   L
Sbjct: 63  PNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLAL 122

Query: 255 QYLH--HDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEGTFGY 312
           +  H   D    ++HRD+K +N+ L      ++ DFGLA+ L  + S    F    T  Y
Sbjct: 123 KECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVG--TPYY 180

Query: 313 LSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSNFKELVDP 372
           +SPE       +EK+D+++ G LL EL        +  Q  +      ++   F+ +   
Sbjct: 181 MSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGK---IREGKFRRIPYR 237

Query: 373 RLADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQ 409
              +  ++             ++     RP +  +L+
Sbjct: 238 YSDELNEIITR---------MLNLKDYHRPSVEEILE 265

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  179 bits (456), Expect = 8e-54
 Identities = 70/299 (23%), Positives = 119/299 (39%), Gaps = 35/299 (11%)

Query: 132 FDFAELAAATDNFNSE---------NLIGKGGHAEVYKGCLP----DGEVVAVKKIIKNA 178
           F F +   A   F  E          +IG G   EV  G L         VA+K +    
Sbjct: 7   FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66

Query: 179 KEDEERISDFLSELGIVAHINHPNAAKLIG-FSTENGFHLVLQFLPHGSLSSLLFGSTEC 237
            E + R  DFLSE  I+   +HPN   L G  +      ++ +F+ +GSL S L  +   
Sbjct: 67  TEKQRR--DFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQ 124

Query: 238 LEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDN 297
                   +  GIA G++YL        +HRD+ A NIL++ +   ++SDFGL+++L D+
Sbjct: 125 FTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 181

Query: 298 WSHHI---VFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELIT-GRRAVDSRRQSL 353
            S          +    + +PE   +      +DV+++G+++ E+++ G R         
Sbjct: 182 TSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQD 241

Query: 354 VIWAKPLLQTSNFKELVDPRLADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQLLR 412
           VI A            ++        +            C       RP+  +++  L 
Sbjct: 242 VINA------------IEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLD 288

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  177 bits (450), Expect = 3e-53
 Identities = 69/270 (25%), Positives = 111/270 (41%), Gaps = 23/270 (8%)

Query: 142 DNFNSENLIGKGGHAEVYKG-CLPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINH 200
           ++F     +GKG    VY         ++A+K + K   E          E+ I +H+ H
Sbjct: 6   EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65

Query: 201 PNAAKLIG-FSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHH 259
           PN  +L G F      +L+L++ P G++   L       +          +A  L Y H 
Sbjct: 66  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQ-KLSKFDEQRTATYITELANALSYCH- 123

Query: 260 DCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEGTFGYLSPEYFM 319
              +R+IHRDIK  N+LL    E +I+DFG +   P +    +     GT  YL PE   
Sbjct: 124 --SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLC----GTLDYLPPEMIE 177

Query: 320 HGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSNFKELVDPRLADAYD 379
             + DEK D+++ GVL  E + G+   ++       + +       F + V      A D
Sbjct: 178 GRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ-ETYKRISRVEFTFPDFVTE---GARD 233

Query: 380 LAEMKRAMLTASVCIHHLSTMRPQMTRVLQ 409
           L             + H  + RP +  VL+
Sbjct: 234 LISR---------LLKHNPSQRPMLREVLE 254

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  177 bits (450), Expect = 4e-53
 Identities = 65/271 (23%), Positives = 117/271 (43%), Gaps = 22/271 (8%)

Query: 147 ENLIGKGGHAEVYKGCLPD---GEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNA 203
           +  +G G    V KG        + VAVK I+KN   D     + L+E  ++  +++P  
Sbjct: 12  DKELGSGNFGTVKKGYYQMKKVVKTVAVK-ILKNEANDPALKDELLAEANVMQQLDNPYI 70

Query: 204 AKLIGFSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHR 263
            ++IG      + LV++    G L+  L      ++     ++   ++ G++YL      
Sbjct: 71  VRMIGICEAESWMLVMEMAELGPLNKYLQ-QNRHVKDKNIIELVHQVSMGMKYLE---ES 126

Query: 264 RIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSHHIV-FPIEGTFGYLSPEYFMHGI 322
             +HRD+ A N+LL   + A+ISDFGL+K L  + +++      +    + +PE   +  
Sbjct: 127 NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYK 186

Query: 323 VDEKTDVFAFGVLLLELIT-GRRAVDSRRQSLVIWAKPLLQTSNFKELVDPRLADAYDLA 381
              K+DV++FGVL+ E  + G++     + S V     +L+             + YDL 
Sbjct: 187 FSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTA---MLEKGERMGCPAGCPREMYDLM 243

Query: 382 EMKRAMLTASVCIHHLSTMRPQMTRVLQLLR 412
            +         C  +    RP    V   LR
Sbjct: 244 NL---------CWTYDVENRPGFAAVELRLR 265

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  174 bits (441), Expect = 6e-52
 Identities = 69/274 (25%), Positives = 112/274 (40%), Gaps = 28/274 (10%)

Query: 142 DNFNSENLIGKGGHAEVYKGCLPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHP 201
                   IGKG   +V  G    G  VAVK I  +A         FL+E  ++  + H 
Sbjct: 7   KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATAQA-----FLAEASVMTQLRHS 60

Query: 202 NAAKLIGFSTE--NGFHLVLQFLPHGSLSSLLFG-STECLEWTIRYKIALGIAEGLQYLH 258
           N  +L+G   E   G ++V +++  GSL   L       L      K +L + E ++YL 
Sbjct: 61  NLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE 120

Query: 259 HDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEGTFGYLSPEYF 318
                  +HRD+ A N+L+SED  A++SDFGL K                   + +PE  
Sbjct: 121 G---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGK-----LPVKWTAPEAL 172

Query: 319 MHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSNFKELVDPRLADAY 378
                  K+DV++FG+LL E+ +  R    R     +  +  ++     +  D      Y
Sbjct: 173 REKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPR--VEKGYKMDAPDGCPPAVY 230

Query: 379 DLAEMKRAMLTASVCIHHLSTMRPQMTRVLQLLR 412
           ++ +          C H  + MRP   ++ + L 
Sbjct: 231 EVMKN---------CWHLDAAMRPSFLQLREQLE 255

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  173 bits (440), Expect = 1e-51
 Identities = 63/270 (23%), Positives = 110/270 (40%), Gaps = 25/270 (9%)

Query: 147 ENLIGKGGHAEVYKG-CLPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAK 205
           +  IG+G    VYKG        VA  + +++ K  +     F  E  ++  + HPN  +
Sbjct: 14  DIEIGRGSFKTVYKGLDTETTVEVAWCE-LQDRKLTKSERQRFKEEAEMLKGLQHPNIVR 72

Query: 206 LIGF-----STENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHD 260
                      +    LV + +  G+L + L    + ++  +       I +GLQ+LH  
Sbjct: 73  FYDSWESTVKGKKCIVLVTELMTSGTLKTYLK-RFKVMKIKVLRSWCRQILKGLQFLHT- 130

Query: 261 CHRRIIHRDIKASNILL-SEDYEAQISDFGLAKWLPDNWSHHIVFPIEGTFGYLSPEYFM 319
               IIHRD+K  NI +       +I D GLA     +++  ++    GT  +++PE + 
Sbjct: 131 RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAVI----GTPEFMAPEMYE 186

Query: 320 HGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSNFKELVDPRLADAYD 379
               DE  DV+AFG+ +LE+ T        + +  I+ +           V P   D   
Sbjct: 187 EK-YDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRR-------VTSGVKPASFDKVA 238

Query: 380 LAEMKRAMLTASVCIHHLSTMRPQMTRVLQ 409
           + E+K  +     CI      R  +  +L 
Sbjct: 239 IPEVKEIIEG---CIRQNKDERYSIKDLLN 265

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  174 bits (442), Expect = 2e-51
 Identities = 66/274 (24%), Positives = 117/274 (42%), Gaps = 26/274 (9%)

Query: 141 TDNFNSENLIGKGGHAEVYKG-CLPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHIN 199
              F+    IG G    VY    + + EVVA+KK+  + K+  E+  D + E+  +  + 
Sbjct: 14  EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 73

Query: 200 HPNAAKLIG-FSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLH 258
           HPN  +  G +  E+   LV+++    +   L     + L+      +  G  +GL YLH
Sbjct: 74  HPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHK-KPLQEVEIAAVTHGALQGLAYLH 132

Query: 259 HDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEGTFGYLSPEYF 318
                 +IHRD+KA NILLSE    ++ DFG A  +    S        GT  +++PE  
Sbjct: 133 ---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFV------GTPYWMAPEVI 183

Query: 319 M---HGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSNFKELVDPRLA 375
           +    G  D K DV++ G+  +EL   +  + +      ++        +  +   P L 
Sbjct: 184 LAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY--------HIAQNESPALQ 235

Query: 376 DAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQ 409
             +     +  + +   C+  +   RP    +L+
Sbjct: 236 SGHWSEYFRNFVDS---CLQKIPQDRPTSEVLLK 266

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  173 bits (440), Expect = 2e-51
 Identities = 63/312 (20%), Positives = 118/312 (37%), Gaps = 46/312 (14%)

Query: 131 NFDFAELAAATDNFNSENLIGKGGHAEVYKGCLP------DGEVVAVKKIIKNAKEDEER 184
           N     L    +N      IG+G    V++   P         +VAVK + + A  D + 
Sbjct: 2   NPKLLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQA 61

Query: 185 ISDFLSELGIVAHINHPNAAKLIGFSTENG-FHLVLQFLPHGSLSSLLFGSTEC------ 237
             DF  E  ++A  ++PN  KL+G         L+ +++ +G L+  L   +        
Sbjct: 62  --DFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLS 119

Query: 238 -----------------LEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSED 280
                            L    +  IA  +A G+ YL     R+ +HRD+   N L+ E+
Sbjct: 120 HSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE---RKFVHRDLATRNCLVGEN 176

Query: 281 YEAQISDFGLAKWLPDNWSHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELI 340
              +I+DFGL++ +     +           ++ PE   +     ++DV+A+GV+L E+ 
Sbjct: 177 MVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIF 236

Query: 341 TGRRAVDSRRQSLVIWAKPLLQTSNFKELVDPRLADAYDLAEMKRAMLTASVCIHHLSTM 400
           +             +     ++  N     +    + Y+L  +         C   L   
Sbjct: 237 SYGLQPYYGMAHEEVIYY--VRDGNILACPENCPLELYNLMRL---------CWSKLPAD 285

Query: 401 RPQMTRVLQLLR 412
           RP    + ++L+
Sbjct: 286 RPSFCSIHRILQ 297

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  173 bits (439), Expect = 2e-51
 Identities = 67/278 (24%), Positives = 118/278 (42%), Gaps = 29/278 (10%)

Query: 141 TDNFNSENLIGKGGHAEVYKG-CLPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHIN 199
            D +     +G G   +VYK        + A K I     + EE + D++ E+ I+A  +
Sbjct: 11  EDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVI---DTKSEEELEDYMVEIDILASCD 67

Query: 200 HPNAAKLIG-FSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLH 258
           HPN  KL+  F  EN   ++++F   G++ +++      L  +    +     + L YLH
Sbjct: 68  HPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLH 127

Query: 259 HDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEGTFGYLSPEYF 318
                +IIHRD+KA NIL + D + +++DFG++            F   GT  +++PE  
Sbjct: 128 D---NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI--GTPYWMAPEVV 182

Query: 319 M-----HGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSNFKELVDPR 373
           M         D K DV++ G+ L+E+              V+     +  S    L  P 
Sbjct: 183 MCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLK---IAKSEPPTLAQPS 239

Query: 374 L--ADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQ 409
              ++  D   +K+       C+      R   +++LQ
Sbjct: 240 RWSSNFKDF--LKK-------CLEKNVDARWTTSQLLQ 268

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  173 bits (439), Expect = 5e-51
 Identities = 65/274 (23%), Positives = 119/274 (43%), Gaps = 19/274 (6%)

Query: 142 DNFNSENLIGKGGHAEVYKG-CLPDGEVVAVKKIIKNAKE--DEERISDFLSELGIVAHI 198
             F    ++G G    VYKG  +P+GE V +   IK  +E    +   + L E  ++A +
Sbjct: 9   TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 68

Query: 199 NHPNAAKLIGFSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLH 258
           ++P+  +L+G    +   L+ Q +P G L   +    + +         + IA+G+ YL 
Sbjct: 69  DNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL- 127

Query: 259 HDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEGTFGYLSPEYF 318
               RR++HRD+ A N+L+      +I+DFGLAK L      +     +    +++ E  
Sbjct: 128 --EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 185

Query: 319 MHGIVDEKTDVFAFGVLLLELIT-GRRAVDSRRQSLVIWAKPLLQTSNFKELVDPRLADA 377
           +H I   ++DV+++GV + EL+T G +  D    S +     +L+             D 
Sbjct: 186 LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISS---ILEKGERLPQPPICTIDV 242

Query: 378 YDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQLL 411
           Y +            C    +  RP+   ++   
Sbjct: 243 YMIMVK---------CWMIDADSRPKFRELIIEF 267

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  173 bits (438), Expect = 6e-51
 Identities = 68/277 (24%), Positives = 115/277 (41%), Gaps = 28/277 (10%)

Query: 145 NSENLIGKGGHAEVYKGCLPD----GEVVAVKKIIKNAKEDEERISDFLSELGIVAHINH 200
           +   +IG+G    VY G L D        AVK + +     E     FL+E  I+   +H
Sbjct: 30  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVS--QFLTEGIIMKDFSH 87

Query: 201 PNAAKLIG--FSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLH 258
           PN   L+G    +E    +VL ++ HG L + +   T            L +A+G+    
Sbjct: 88  PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGM---K 144

Query: 259 HDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNW--SHHIVFPIEGTFGYLSPE 316
               ++ +HRD+ A N +L E +  +++DFGLA+ + D    S H     +    +++ E
Sbjct: 145 FLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALE 204

Query: 317 YFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSNFKELVDPRL-- 374
                    K+DV++FGVLL EL+T          +  I    L      + L+ P    
Sbjct: 205 SLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL----QGRRLLQPEYCP 260

Query: 375 ADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQLL 411
              Y++            C H  + MRP  + ++  +
Sbjct: 261 DPLYEVMLK---------CWHPKAEMRPSFSELVSRI 288

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  170 bits (433), Expect = 1e-50
 Identities = 59/271 (21%), Positives = 105/271 (38%), Gaps = 19/271 (7%)

Query: 142 DNFNSENLIGKGGHAEVYKG-CLPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINH 200
           ++++    +G+G + EV         E VAVK +  + K   +   +   E+ I   +NH
Sbjct: 5   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIV--DMKRAVDCPENIKKEICINKMLNH 62

Query: 201 PNAAKLIG-FSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHH 259
            N  K  G     N  +L L++   G L   +      +      +    +  G+ YLH 
Sbjct: 63  ENVVKFYGHRREGNIQYLFLEYCSGGELFDRIE-PDIGMPEPDAQRFFHQLMAGVVYLHG 121

Query: 260 DCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEGTFGYLSPEYFM 319
                I HRDIK  N+LL E    +ISDFGLA     N    ++  + GT  Y++PE   
Sbjct: 122 ---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 178

Query: 320 HG-IVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSNFKELVDPRLADAY 378
                 E  DV++ G++L  ++ G    D    S   ++    +   +        +   
Sbjct: 179 RREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSD-WKEKKTYLNPWKKIDSAPL 237

Query: 379 DLAEMKRAMLTASVCIHHLSTMRPQMTRVLQ 409
            L  + +        +    + R  +  + +
Sbjct: 238 AL--LHK-------ILVENPSARITIPDIKK 259

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  171 bits (433), Expect = 1e-50
 Identities = 60/296 (20%), Positives = 114/296 (38%), Gaps = 29/296 (9%)

Query: 142 DNFNSENLIGKGGHAEVYKGCLPDGE-----VVAVKKIIKNAKEDEERISDFLSELGIVA 196
                + +IG G   EVYKG L          VA+K +     E +    DFL E GI+ 
Sbjct: 7   SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRV--DFLGEAGIMG 64

Query: 197 HINHPNAAKLIG-FSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQ 255
             +H N  +L G  S      ++ +++ +G+L   L              +  GIA G+ 
Sbjct: 65  QFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGM- 123

Query: 256 YLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVF-PIEGTFGYLS 314
              +  +   +HRD+ A NIL++ +   ++SDFGL++ L D+          +    + +
Sbjct: 124 --KYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTA 181

Query: 315 PEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSNFKELVDPRL 374
           PE   +      +DV++FG+++ E++T          +  +            + ++   
Sbjct: 182 PEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVM-----------KAINDGF 230

Query: 375 ADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQLLRGEGGQTDLKPKPSARRTV 430
                +            C       RP+   ++ +L        L   P + +T+
Sbjct: 231 RLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDK------LIRAPDSLKTL 280

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  170 bits (432), Expect = 3e-50
 Identities = 68/302 (22%), Positives = 111/302 (36%), Gaps = 34/302 (11%)

Query: 147 ENLIGKGGHAEVYKGCLPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKL 206
           +  IGKG   EV++G    GE VAVK      +    R +    E+     + H N    
Sbjct: 8   QESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWFREA----EIYQTVMLRHENILGF 62

Query: 207 IGFSTENG-----FHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDC 261
           I    ++        LV  +  HGSL   L   T  +      K+AL  A GL +LH + 
Sbjct: 63  IAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT--VTVEGMIKLALSTASGLAHLHMEI 120

Query: 262 -----HRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFP--IEGTFGYLS 314
                   I HRD+K+ NIL+ ++    I+D GLA           + P    GT  Y++
Sbjct: 121 VGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMA 180

Query: 315 PEYF------MHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQ--------SLVIWAKPL 360
           PE         H    ++ D++A G++  E+                         +   
Sbjct: 181 PEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEE 240

Query: 361 LQTSNFKELVDPRLADAYDLAEMKRAMLT-ASVCIHHLSTMRPQMTRVLQLLRGEGGQTD 419
           ++    ++ + P + + +   E  R M      C +     R    R+ + L     Q  
Sbjct: 241 MRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEG 300

Query: 420 LK 421
           +K
Sbjct: 301 IK 302

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  169 bits (428), Expect = 8e-50
 Identities = 60/237 (25%), Positives = 103/237 (43%), Gaps = 7/237 (2%)

Query: 142 DNFNSENLIGKGGHAEVYKG-CLPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINH 200
           ++F    ++G+G  + V     L      A+K + K     E ++     E  +++ ++H
Sbjct: 8   EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 67

Query: 201 PNAAKLIG-FSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHH 259
           P   KL   F  +   +  L +  +G L   +       E   R+      AE +  L +
Sbjct: 68  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF----YTAEIVSALEY 123

Query: 260 DCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEGTFGYLSPEYFM 319
              + IIHRD+K  NILL+ED   QI+DFG AK L             GT  Y+SPE   
Sbjct: 124 LHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLT 183

Query: 320 HGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSNFKELVDPRLAD 376
                + +D++A G ++ +L+ G     +  +  +I+ K +    +F E   P+  D
Sbjct: 184 EKSACKSSDLWALGCIIYQLVAGLPPFRAGNEY-LIFQKIIKLEYDFPEKFFPKARD 239

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  168 bits (427), Expect = 8e-50
 Identities = 65/277 (23%), Positives = 107/277 (38%), Gaps = 20/277 (7%)

Query: 142 DNFNSENLIGKGGHAEVYKGCLP----DGEVVAVKKIIKNAKEDEERISDFLSELGIVAH 197
            +      +G G    V +G           VAVK +  +     E + DF+ E+  +  
Sbjct: 8   KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 67

Query: 198 INHPNAAKLIGFSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYL 257
           ++H N  +L G        +V +  P GSL   L             + A+ +AEG+ YL
Sbjct: 68  LDHRNLIRLYGVVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYL 127

Query: 258 HHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVF-PIEGTFGYLSPE 316
                +R IHRD+ A N+LL+     +I DFGL + LP N  H+++    +  F + +PE
Sbjct: 128 E---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPE 184

Query: 317 YFMHGIVDEKTDVFAFGVLLLELIT-GRRAVDSRRQSLVIWAKPLLQTSNFKELVDPRLA 375
                     +D + FGV L E+ T G+        S ++    + +        +    
Sbjct: 185 SLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHK--IDKEGERLPRPEDCPQ 242

Query: 376 DAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQLLR 412
           D Y++            C  H    RP    +   L 
Sbjct: 243 DIYNVMVQ---------CWAHKPEDRPTFVALRDFLL 270

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  168 bits (426), Expect = 4e-49
 Identities = 60/299 (20%), Positives = 122/299 (40%), Gaps = 42/299 (14%)

Query: 142 DNFNSENLIGKGGHAEVYKGCL------PDGEVVAVKKIIKNAKEDEERISDFLSELGIV 195
           +  +    +G G   +V +              VAVK +  +A   E      +SEL ++
Sbjct: 23  NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTERE--ALMSELKVL 80

Query: 196 AHI-NHPNAAKLIGFSTENG-FHLVLQFLPHGSLSSLLFGSTEC---------------- 237
           +++ NH N   L+G  T  G   ++ ++  +G L + L    +                 
Sbjct: 81  SYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDEL 140

Query: 238 -LEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPD 296
            L+       +  +A+G+ +L     +  IHRD+ A NILL+     +I DFGLA+ + +
Sbjct: 141 ALDLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIKN 197

Query: 297 NWSHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIW 356
           + ++ +         +++PE   + +   ++DV+++G+ L EL +   +          +
Sbjct: 198 DSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKF 257

Query: 357 AKPLLQTSNFKELVDPRL-ADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQLLRGE 414
            K  +    F+ L      A+ YD+ +          C       RP   +++QL+  +
Sbjct: 258 YK--MIKEGFRMLSPEHAPAEMYDIMKT---------CWDADPLKRPTFKQIVQLIEKQ 305

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  168 bits (426), Expect = 5e-49
 Identities = 61/303 (20%), Positives = 117/303 (38%), Gaps = 45/303 (14%)

Query: 142 DNFNSENLIGKGGHAEVYKGCLPD------GEVVAVKKIIKNAKEDEERISDFLSELGIV 195
           +N     ++G G   +V                VAVK + + A   E      +SEL ++
Sbjct: 37  ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSERE--ALMSELKMM 94

Query: 196 AHI-NHPNAAKLIGFSTENG-FHLVLQFLPHGSLSSLLFGSTE----------------- 236
             + +H N   L+G  T +G  +L+ ++  +G L + L    E                 
Sbjct: 95  TQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEE 154

Query: 237 -----CLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLA 291
                 L +      A  +A+G+++L     +  +HRD+ A N+L++     +I DFGLA
Sbjct: 155 EEDLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVTHGKVVKICDFGLA 211

Query: 292 KWLPDNWSHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQ 351
           + +  + ++ +         +++PE    GI   K+DV+++G+LL E+ +          
Sbjct: 212 RDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIP 271

Query: 352 SLVIWAKPLLQTSNFKELVDPRLADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQLL 411
               + K L+Q     +       + Y + +          C    S  RP    +   L
Sbjct: 272 VDANFYK-LIQNGFKMDQPFYATEEIYIIMQS---------CWAFDSRKRPSFPNLTSFL 321

Query: 412 RGE 414
             +
Sbjct: 322 GCQ 324

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  164 bits (417), Expect = 4e-48
 Identities = 59/292 (20%), Positives = 121/292 (41%), Gaps = 24/292 (8%)

Query: 141 TDNFNSENLIGKGGHAEVYKG-CLPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHIN 199
              +     IG+G    VY    +  G+ VA++++    +  +E     ++E+ ++    
Sbjct: 19  KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKEL---IINEILVMRENK 75

Query: 200 HPNAAKLIG-FSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLH 258
           +PN    +  +   +   +V+++L  GSL+ ++     C++      +     + L++LH
Sbjct: 76  NPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLH 133

Query: 259 HDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEGTFGYLSPEYF 318
                ++IHRDIK+ NILL  D   +++DFG    +           + GT  +++PE  
Sbjct: 134 S---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQI--TPEQSKRSTMVGTPYWMAPEVV 188

Query: 319 MHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSNFKELVDPRLADAY 378
                  K D+++ G++ +E+I G     +      ++      T        P L +  
Sbjct: 189 TRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGT--------PELQNPE 240

Query: 379 DLAEMKRAMLTASVCIHHLSTMRPQMTRVLQ--LLRGEGGQTDLKPKPSARR 428
            L+ + R  L    C+      R     +LQ   L+     + L P  +A +
Sbjct: 241 KLSAIFRDFLNR--CLDMDVEKRGSAKELLQHQFLKIAKPLSSLTPLIAAAK 290

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  164 bits (416), Expect = 6e-48
 Identities = 68/285 (23%), Positives = 124/285 (43%), Gaps = 24/285 (8%)

Query: 131 NFDFAELAAATDNFNSENLIGKGGHAEVYKGCLPD-GEVVAVKKIIKNAKEDEERISDFL 189
           N+D  E+     +   ++ +G G + EVY+G        VAVK + ++  E EE    FL
Sbjct: 8   NYDKWEMER--TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE----FL 61

Query: 190 SELGIVAHINHPNAAKLIG-FSTENGFHLVLQFLPHGSLSSLLFGSTE-CLEWTIRYKIA 247
            E  ++  I HPN  +L+G  + E  F+++ +F+ +G+L   L       +   +   +A
Sbjct: 62  KEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMA 121

Query: 248 LGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIE 307
             I+  ++YL     +  IHRD+ A N L+ E++  +++DFGL++ +  +         +
Sbjct: 122 TQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAG-AK 177

Query: 308 GTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSNFK 367
               + +PE   +     K+DV+AFGVLL E+ T   +             P +  S   
Sbjct: 178 FPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY-----------PGIDLSQVY 226

Query: 368 ELVDPRLADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQLLR 412
           EL++            ++       C     + RP    + Q   
Sbjct: 227 ELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFE 271

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  161 bits (407), Expect = 6e-47
 Identities = 58/275 (21%), Positives = 110/275 (40%), Gaps = 21/275 (7%)

Query: 142 DNFNSENLIGKGGHAEVYKGCLPD----GEVVAVKKIIKNAKEDEERISDFLSELGIVAH 197
           +       IG+G   +V++G           VA+K       +       FL E   +  
Sbjct: 7   ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVRE--KFLQEALTMRQ 64

Query: 198 INHPNAAKLIGFSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYL 257
            +HP+  KLIG  TEN   ++++    G L S L      L+       A  ++  L YL
Sbjct: 65  FDHPHIVKLIGVITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYL 124

Query: 258 HHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEGTFGYLSPEY 317
                +R +HRDI A N+L+S +   ++ DFGL++++ D+ +++     +    +++PE 
Sbjct: 125 E---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS-TYYKASKGKLPIKWMAPES 180

Query: 318 FMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSNFKELVDPRLADA 377
                    +DV+ FGV + E++          ++  +  +  ++      +        
Sbjct: 181 INFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGR--IENGERLPMPPNCPPTL 238

Query: 378 YDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQLLR 412
           Y L            C  +  + RP+ T +   L 
Sbjct: 239 YSLMTK---------CWAYDPSRRPRFTELKAQLS 264

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  160 bits (405), Expect = 4e-46
 Identities = 67/291 (23%), Positives = 120/291 (41%), Gaps = 39/291 (13%)

Query: 142 DNFNSENLIGKGGHAEVYKGCLPDG---EVVAVKKIIKNAKEDEERISDFLSELGIVAHI 198
           ++   +++IG+G   +V K  +         A+K++ + A +D+ R  DF  EL ++  +
Sbjct: 10  NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHR--DFAGELEVLCKL 67

Query: 199 -NHPNAAKLIG-FSTENGFHLVLQFLPHGSLSSLLFGSTEC---------------LEWT 241
            +HPN   L+G        +L +++ PHG+L   L  S                  L   
Sbjct: 68  GHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQ 127

Query: 242 IRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSHH 301
                A  +A G+ YL     ++ IHRD+ A NIL+ E+Y A+I+DFGL++         
Sbjct: 128 QLLHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKT 184

Query: 302 IVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLL 361
           +         +++ E   + +    +DV+++GVLL E+++             ++ K  L
Sbjct: 185 MG---RLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEK--L 239

Query: 362 QTSNFKELVDPRLADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQLLR 412
                 E       + YDL            C       RP   ++L  L 
Sbjct: 240 PQGYRLEKPLNCDDEVYDLMRQ---------CWREKPYERPSFAQILVSLN 281

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  161 bits (408), Expect = 4e-46
 Identities = 58/308 (18%), Positives = 111/308 (36%), Gaps = 26/308 (8%)

Query: 142 DNFNSENLIGKGGHAEVYKG-CLPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINH 200
           D+++    +G G    V++      G   A K ++   + D+E       E+  ++ + H
Sbjct: 26  DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKET---VRKEIQTMSVLRH 82

Query: 201 PNAAKLIG-FSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHH 259
           P    L   F  +N   ++ +F+  G L   +      +      +    + +GL ++H 
Sbjct: 83  PTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHE 142

Query: 260 DCHRRIIHRDIKASNILLS--EDYEAQISDFGLAKWLPDNWSHHIVFPIEGTFGYLSPEY 317
                 +H D+K  NI+ +     E ++ DFGL   L    S  +     GT  + +PE 
Sbjct: 143 ---NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT---GTAEFAAPEV 196

Query: 318 FMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSNFKELVDPRL-AD 376
                V   TD+++ GVL   L++G            +         N  +     +  D
Sbjct: 197 AEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLR-NVKSCDWNMDDSAFSGISED 255

Query: 377 AYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQ--LLRGEGGQTDLKPKPSARRTVILDG 434
             D   +++        +      R  + + L+   L            PS+R T I D 
Sbjct: 256 GKDF--IRK-------LLLADPNTRMTIHQALEHPWLTPGNAPGRDSQIPSSRYTKIRDS 306

Query: 435 SDEEYSST 442
              +Y + 
Sbjct: 307 IKTKYDAW 314

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  158 bits (401), Expect = 1e-45
 Identities = 58/289 (20%), Positives = 114/289 (39%), Gaps = 32/289 (11%)

Query: 142 DNFNSENLIGKGGHAEVYKGCL------PDGEVVAVKKIIKNAKEDEERISDFLSELGIV 195
           +       +G+G    VY+G             VA+K + + A   E    +FL+E  ++
Sbjct: 20  EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERI--EFLNEASVM 77

Query: 196 AHINHPNAAKLIG-FSTENGFHLVLQFLPHGSLSSLLF---------GSTECLEWTIRYK 245
              N  +  +L+G  S      ++++ +  G L S L                  +   +
Sbjct: 78  KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQ 137

Query: 246 IALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFP 305
           +A  IA+G+ YL      + +HRD+ A N +++ED+  +I DFG+ + + +   +     
Sbjct: 138 MAGEIADGMAYL---NANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGK 194

Query: 306 IEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSN 365
                 ++SPE    G+    +DV++FGV+L E+ T          +  +     +    
Sbjct: 195 GLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRF--VMEGG 252

Query: 366 FKELVDPRLADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQLLRGE 414
             +  D      ++L  M         C  +   MRP    ++  ++ E
Sbjct: 253 LLDKPDNCPDMLFELMRM---------CWQYNPKMRPSFLEIISSIKEE 292

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  157 bits (398), Expect = 1e-44
 Identities = 64/243 (26%), Positives = 106/243 (43%), Gaps = 16/243 (6%)

Query: 142 DNFNSENLIGKGGHAEVYKG-CLPDGEVVAVKKIIKNAKEDEERISDFLSE---LGIVAH 197
           ++F+   +IG+GG  EVY       G++ A+K + K   + ++  +  L+E   L +V+ 
Sbjct: 4   NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63

Query: 198 INHPNAAKLIG-FSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQY 256
            + P    +   F T +    +L  +  G L   L       E  +R+  A  I  GL++
Sbjct: 64  GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRF-YAAEIILGLEH 122

Query: 257 LHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEGTFGYLSPE 316
           +H+   R +++RD+K +NILL E    +ISD GLA        H       GT GY++PE
Sbjct: 123 MHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHA----SVGTHGYMAPE 175

Query: 317 YFMHGI-VDEKTDVFAFGVLLLELITGRRAVDSR--RQSLVIWAKPLLQTSNFKELVDPR 373
               G+  D   D F+ G +L +L+ G         +    I    L       +   P 
Sbjct: 176 VLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPE 235

Query: 374 LAD 376
           L  
Sbjct: 236 LRS 238

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  155 bits (394), Expect = 5e-44
 Identities = 61/273 (22%), Positives = 97/273 (35%), Gaps = 24/273 (8%)

Query: 142 DNFNSENLIGKGGHAEVYKG-CLPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINH 200
           D ++    +G G    V++      G V   K I      D+       +E+ I+  ++H
Sbjct: 29  DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYT---VKNEISIMNQLHH 85

Query: 201 PNAAKLIG-FSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHH 259
           P    L   F  +    L+L+FL  G L   +      +             EGL+++H 
Sbjct: 86  PKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHE 145

Query: 260 DCHRRIIHRDIKASNILLS--EDYEAQISDFGLAKWLPDNWSHHIVFPIEGTFGYLSPEY 317
                I+H DIK  NI+    +    +I DFGLA  L  +    IV     T  + +PE 
Sbjct: 146 ---HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD---EIVKVTTATAEFAAPEI 199

Query: 318 FMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSNFKELVDPRL-AD 376
                V   TD++A GVL   L++G          L            F E     +  +
Sbjct: 200 VDREPVGFYTDMWAIGVLGYVLLSGLSPFAG-EDDLETLQNVKRCDWEFDEDAFSSVSPE 258

Query: 377 AYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQ 409
           A D   +K         +      R  +   L+
Sbjct: 259 AKDF--IKN-------LLQKEPRKRLTVHDALE 282

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  152 bits (386), Expect = 8e-44
 Identities = 54/246 (21%), Positives = 102/246 (41%), Gaps = 14/246 (5%)

Query: 141 TDNFNSENLIGKGGHAEVYKG-CLPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHIN 199
           +D +    ++G GG +EV+    L     VAVK +  +   D      F  E    A +N
Sbjct: 6   SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65

Query: 200 HPNAAKLIGFSTENG-----FHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGL 254
           HP    +              ++V++++   +L  ++  +   +      ++     + L
Sbjct: 66  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVH-TEGPMTPKRAIEVIADACQAL 124

Query: 255 QYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVF-PIEGTFGYL 313
            +        IIHRD+K +NI++S     ++ DFG+A+ + D+ +       + GT  YL
Sbjct: 125 NFS---HQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYL 181

Query: 314 SPEYFMHGIVDEKTDVFAFGVLLLELITGRR---AVDSRRQSLVIWAKPLLQTSNFKELV 370
           SPE      VD ++DV++ G +L E++TG            +     +  +  S   E +
Sbjct: 182 SPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGL 241

Query: 371 DPRLAD 376
              L  
Sbjct: 242 SADLDA 247

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  154 bits (389), Expect = 1e-43
 Identities = 49/205 (23%), Positives = 91/205 (44%), Gaps = 11/205 (5%)

Query: 142 DNFNSENLIGKGGHAEVYKG-CLPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINH 200
            +F     +G G    V+      +G   A+K + K      +++     E  +++ + H
Sbjct: 4   QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63

Query: 201 PNAAKLIG-FSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHH 259
           P   ++ G F       +++ ++  G L SLL  S        ++  A    E    L +
Sbjct: 64  PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAA----EVCLALEY 119

Query: 260 DCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEGTFGYLSPEYFM 319
              + II+RD+K  NILL ++   +I+DFG AK++PD        P      Y++PE   
Sbjct: 120 LHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYTLCGTP-----DYIAPEVVS 174

Query: 320 HGIVDEKTDVFAFGVLLLELITGRR 344
               ++  D ++FG+L+ E++ G  
Sbjct: 175 TKPYNKSIDWWSFGILIYEMLAGYT 199

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  152 bits (385), Expect = 2e-43
 Identities = 68/295 (23%), Positives = 117/295 (39%), Gaps = 39/295 (13%)

Query: 142 DNFNSENLIGKGGHAEVYKGC------LPDGEVVAVKKIIKNAKEDEERISDFLSELGIV 195
           D       +G+G   +V +              VAVK + + A   E R    +SEL I+
Sbjct: 13  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHR--ALMSELKIL 70

Query: 196 AHINH-PNAAKLIGFSTENG--FHLVLQFLPHGSLSSLLFG---------------STEC 237
            HI H  N   L+G  T+ G    ++++F   G+LS+ L                   + 
Sbjct: 71  IHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDF 130

Query: 238 LEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDN 297
           L        +  +A+G+++L     R+ IHRD+ A NILLSE    +I DFGLA+ +  +
Sbjct: 131 LTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKD 187

Query: 298 WSHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWA 357
             +           +++PE     +   ++DV++FGVLL E+ +   +       +    
Sbjct: 188 PDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP-GVKIDEEF 246

Query: 358 KPLLQTSNFKELVDPRLADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQLLR 412
              L+        D    + Y              C H   + RP  + +++ L 
Sbjct: 247 CRRLKEGTRMRAPDYTTPEMYQTMLD---------CWHGEPSQRPTFSELVEHLG 292

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  149 bits (377), Expect = 5e-42
 Identities = 53/238 (22%), Positives = 105/238 (44%), Gaps = 10/238 (4%)

Query: 142 DNFNSENLIGKGGHAEVYKG-CLPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAH-IN 199
           ++F    ++GKG   +V+        +  A+K + K+    ++ +   + E  +++    
Sbjct: 2   EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61

Query: 200 HPNAAKLIG-FSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLH 258
           HP    +   F T+     V+++L  G L   +  S    + +     A  I  GLQ+L 
Sbjct: 62  HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQ-SCHKFDLSRATFYAAEIILGLQFL- 119

Query: 259 HDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEGTFGYLSPEYF 318
               + I++RD+K  NILL +D   +I+DFG+ K      +    F   GT  Y++PE  
Sbjct: 120 --HSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFC--GTPDYIAPEIL 175

Query: 319 MHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSNFKELVDPRLAD 376
           +    +   D ++FGVLL E++ G+     + +   ++    +    +   ++    D
Sbjct: 176 LGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEE-ELFHSIRMDNPFYPRWLEKEAKD 232

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  147 bits (372), Expect = 2e-41
 Identities = 62/295 (21%), Positives = 118/295 (40%), Gaps = 41/295 (13%)

Query: 142 DNFNSENLIGKGGHAEVYKGCLP--------DGEVVAVKKIIKNAKEDEERISDFLSELG 193
           D       +G+G   +V                  VAVK +  +A E +    D +SE+ 
Sbjct: 13  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLS--DLISEME 70

Query: 194 IVAHI-NHPNAAKLIG-FSTENGFHLVLQFLPHGSLSSLLF---------------GSTE 236
           ++  I  H N   L+G  + +   ++++++   G+L   L                   E
Sbjct: 71  MMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEE 130

Query: 237 CLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPD 296
            L        A  +A G++YL     ++ IHRD+ A N+L++ED   +I+DFGLA+ +  
Sbjct: 131 QLSSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHH 187

Query: 297 NWSHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIW 356
              +           +++PE     I   ++DV++FGVLL E+ T   +         ++
Sbjct: 188 IDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELF 247

Query: 357 AKPLLQTSNFKELVDPRLADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQLL 411
               L+  +  +       + Y +            C H + + RP   ++++ L
Sbjct: 248 KL--LKEGHRMDKPSNCTNELYMMMRD---------CWHAVPSQRPTFKQLVEDL 291

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  146 bits (370), Expect = 2e-41
 Identities = 62/231 (26%), Positives = 102/231 (44%), Gaps = 22/231 (9%)

Query: 142 DNFNSENLIGKGGHAEVYKG-CLPDGEVVAVKKIIK------NAKEDEERISDFLSELGI 194
           +N+  + ++G+G  + V +    P  +  AVK I        +A+E +E     L E+ I
Sbjct: 3   ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 62

Query: 195 VAHIN-HPNAAKLIG-FSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAE 252
           +  ++ HPN  +L   + T   F LV   +  G L   L      L      KI   + E
Sbjct: 63  LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLT-EKVTLSEKETRKIMRALLE 121

Query: 253 GLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEGTFGY 312
            +  LH      I+HRD+K  NILL +D   +++DFG +  L        V    GT  Y
Sbjct: 122 VICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVC---GTPSY 175

Query: 313 LSPEYFM------HGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWA 357
           L+PE         H    ++ D+++ GV++  L+ G      R+Q L++  
Sbjct: 176 LAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRM 226

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  144 bits (363), Expect = 5e-40
 Identities = 50/273 (18%), Positives = 94/273 (34%), Gaps = 25/273 (9%)

Query: 142 DNFNSENLIGKGGHAEVYKG-CLPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINH 200
           + +     +G+G    V++       +    K +     +          E+ I+    H
Sbjct: 5   EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVL----VKKEISILNIARH 60

Query: 201 PNAAKLIG-FSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHH 259
            N   L   F +     ++ +F+    +   +  S   L           + E LQ+LH 
Sbjct: 61  RNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHS 120

Query: 260 DCHRRIIHRDIKASNILLSEDYEAQ--ISDFGLAKWLPDNWSHHIVFPIEGTFGYLSPEY 317
                I H DI+  NI+      +   I +FG A+ L    +  ++F       Y +PE 
Sbjct: 121 ---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLF---TAPEYYAPEV 174

Query: 318 FMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSNFKELVDPRL-AD 376
             H +V   TD+++ G L+  L++G     +     +I    +     F E     +  +
Sbjct: 175 HQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIE-NIMNAEYTFDEEAFKEISIE 233

Query: 377 AYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQ 409
           A D   + R        +      R   +  LQ
Sbjct: 234 AMDF--VDR-------LLVKERKSRMTASEALQ 257

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  142 bits (360), Expect = 1e-39
 Identities = 47/206 (22%), Positives = 86/206 (41%), Gaps = 8/206 (3%)

Query: 141 TDNFNSENLIGKGGHAEVYKG-CLPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHIN 199
            D ++  +++G G  +EV         ++VA+K I K A E +E      +E+ ++  I 
Sbjct: 8   RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEG--SMENEIAVLHKIK 65

Query: 200 HPNAAKLIG-FSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLH 258
           HPN   L   + +    +L++Q +  G L   +             ++   + + ++YLH
Sbjct: 66  HPNIVALDDIYESGGHLYLIMQLVSGGELFDRIV-EKGFYTERDASRLIFQVLDAVKYLH 124

Query: 259 HDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEGTFGYLSPEYF 318
                    +        L ED +  ISDFGL+K         ++    GT GY++PE  
Sbjct: 125 DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPG---SVLSTACGTPGYVAPEVL 181

Query: 319 MHGIVDEKTDVFAFGVLLLELITGRR 344
                 +  D ++ GV+   L+ G  
Sbjct: 182 AQKPYSKAVDCWSIGVIAYILLCGYP 207

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  142 bits (359), Expect = 3e-39
 Identities = 53/237 (22%), Positives = 99/237 (41%), Gaps = 9/237 (3%)

Query: 142 DNFNSENLIGKGGHAEVYKG-CLPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINH 200
           ++F+   L+GKG   +V        G   A+K + K     ++ ++  ++E  ++ +  H
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64

Query: 201 PNAAKLIGF-STENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHH 259
           P    L     T +    V+++   G L   L       E   R+      AE +  L +
Sbjct: 65  PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARF----YGAEIVSALEY 120

Query: 260 DCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEGTFGYLSPEYFM 319
              R +++RDIK  N++L +D   +I+DFGL K    + +        GT  YL+PE   
Sbjct: 121 LHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATM--KTFCGTPEYLAPEVLE 178

Query: 320 HGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSNFKELVDPRLAD 376
                   D +  GV++ E++ GR    ++     ++   L++   F   + P    
Sbjct: 179 DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE-RLFELILMEEIRFPRTLSPEAKS 234

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  139 bits (352), Expect = 1e-38
 Identities = 48/282 (17%), Positives = 95/282 (33%), Gaps = 23/282 (8%)

Query: 142 DNFNSENLIGKGGHAEVYKG-CLPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINH 200
            ++     IG+G    +++G  L + + VA+K   +  + D  ++ D      ++A    
Sbjct: 5   VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPR--RSDAPQLRDEYRTYKLLAGCTG 62

Query: 201 PNAAKLIGFSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHD 260
                +  F  E   ++++  L   SL  LL               A  +   +Q +H  
Sbjct: 63  IP--NVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHE- 119

Query: 261 CHRRIIHRDIKASNILLSEDYEAQ-----ISDFGLAKWLPDNWSHHIVFPIE-----GTF 310
             + +++RDIK  N L+            + DFG+ K+  D  +   +   E     GT 
Sbjct: 120 --KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTA 177

Query: 311 GYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSNFKELV 370
            Y+S    +      + D+ A G + +  + G       + +         +    K+  
Sbjct: 178 RYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQK--YERIGEKKQST 235

Query: 371 DPRLADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQLLR 412
             R   A    E  + M       +      P    +  L  
Sbjct: 236 PLRELCAGFPEEFYKYMHY---ARNLAFDATPDYDYLQGLFS 274

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  139 bits (352), Expect = 1e-38
 Identities = 55/281 (19%), Positives = 95/281 (33%), Gaps = 23/281 (8%)

Query: 142 DNFNSENLIGKGGHAEVYKG-CLPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINH 200
           + +     IG G   ++Y G  +  GE VA+K      K  +        E  I   +  
Sbjct: 7   NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQ-----LHIESKIYKMMQG 61

Query: 201 PNAAKLIGFS-TENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHH 259
                 I +   E  +++++  L   SL  L    +          +A  +   ++Y+H 
Sbjct: 62  GVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHS 121

Query: 260 DCHRRIIHRDIKASNILLSE---DYEAQISDFGLAKWLPDNWSHHIVFPIE-----GTFG 311
              +  IHRD+K  N L+          I DFGLAK   D  +H  +   E     GT  
Sbjct: 122 ---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTAR 178

Query: 312 YLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSNFKELVD 371
           Y S    +      + D+ + G +L+    G       + +         +  + K++  
Sbjct: 179 YASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQ---KYERISEKKMST 235

Query: 372 PRLADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQLLR 412
           P               L    C       +P  + + QL R
Sbjct: 236 PIEVLCKGYPSEFATYLNF--CRSLRFDDKPDYSYLRQLFR 274

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  138 bits (348), Expect = 4e-38
 Identities = 51/205 (24%), Positives = 91/205 (44%), Gaps = 7/205 (3%)

Query: 142 DNFNSENLIGKGGHAEVYKG-CLPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINH 200
           +NF     IG+G +  VYK      GEVVA+ K I+   E E   S  + E+ ++  +NH
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVAL-KKIRLDTETEGVPSTAIREISLLKELNH 60

Query: 201 PNAAKLIGFS-TENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHH 259
           PN  KL+    TEN  +LV +FL       +   +   +   +       + +GL +   
Sbjct: 61  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC-- 118

Query: 260 DCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEGTFGYLSPEYFM 319
               R++HRD+K  N+L++ +   +++DFGLA+        +    +   +         
Sbjct: 119 -HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHE-VVTLWYRAPEILLG 176

Query: 320 HGIVDEKTDVFAFGVLLLELITGRR 344
                   D+++ G +  E++T R 
Sbjct: 177 CKYYSTAVDIWSLGCIFAEMVTRRA 201

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  137 bits (346), Expect = 6e-38
 Identities = 52/202 (25%), Positives = 85/202 (42%), Gaps = 5/202 (2%)

Query: 142 DNFNSENLIGKGGHAEVYKGCLPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHP 201
           + ++    IG+G +  VYK     GE  A+KKI +  KEDE   S  + E+ I+  + H 
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKI-RLEKEDEGIPSTTIREISILKELKHS 60

Query: 202 NAAKLIGFSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDC 261
           N  KL          +++       L  LL      LE        L +  G+ Y H   
Sbjct: 61  NIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCH--- 117

Query: 262 HRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEGTFGYLSPEYFMHG 321
            RR++HRD+K  N+L++ + E +I+DFGLA+             I   +           
Sbjct: 118 DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIP-VRKYTHEIVTLWYRAPDVLMGSK 176

Query: 322 IVDEKTDVFAFGVLLLELITGR 343
                 D+++ G +  E++ G 
Sbjct: 177 KYSTTIDIWSVGCIFAEMVNGT 198

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  137 bits (346), Expect = 8e-38
 Identities = 47/216 (21%), Positives = 88/216 (40%), Gaps = 18/216 (8%)

Query: 140 ATDNFNSENLIGKGGHAEVYKG--CLPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAH 197
           A   +     IG+G + +V+K       G  VA+K  ++    +E      + E+ ++ H
Sbjct: 5   ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALK-RVRVQTGEEGMPLSTIREVAVLRH 63

Query: 198 I---NHPNAAKLIGFST------ENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIAL 248
           +    HPN  +L    T      E    LV + +     + L       +       +  
Sbjct: 64  LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMF 123

Query: 249 GIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEG 308
            +  GL +LH     R++HRD+K  NIL++   + +++DFGLA+      +   V     
Sbjct: 124 QLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVV---V 177

Query: 309 TFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRR 344
           T  Y +PE  +        D+++ G +  E+   + 
Sbjct: 178 TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKP 213

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  136 bits (343), Expect = 2e-37
 Identities = 53/201 (26%), Positives = 90/201 (44%), Gaps = 11/201 (5%)

Query: 148 NLIGKGGHAEVYKG-CLPDGEVVAVKKIIKN--AKEDEERISDFLSELGIVAHINHPNAA 204
           + +G+G  A VYK       ++VA+KKI     ++  +      L E+ ++  ++HPN  
Sbjct: 4   DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63

Query: 205 KLIGF-STENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHR 263
            L+     ++   LV  F+       +   S       I+    L   +GL+YLH     
Sbjct: 64  GLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIK-AYMLMTLQGLEYLHQHW-- 120

Query: 264 RIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEGTFGYLSPEYFM-HGI 322
            I+HRD+K +N+LL E+   +++DFGLAK        +       T  Y +PE      +
Sbjct: 121 -ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQV--VTRWYRAPELLFGARM 177

Query: 323 VDEKTDVFAFGVLLLELITGR 343
                D++A G +L EL+   
Sbjct: 178 YGVGVDMWAVGCILAELLLRV 198

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  137 bits (346), Expect = 2e-37
 Identities = 48/204 (23%), Positives = 78/204 (38%), Gaps = 9/204 (4%)

Query: 142 DNFNSENLIGKGGHAEVYKG-CLPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINH 200
           D F+    +G G    V        G   A+K + K      ++I   L+E  I+  +N 
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100

Query: 201 PNAAKLIGFSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHD 260
           P   KL     +N    ++     G                     A  I    +YLH  
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH-- 158

Query: 261 CHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEGTFGYLSPEYFMH 320
               +I+RD+K  N+L+ +    Q++DFG AK +           + GT   L+PE  + 
Sbjct: 159 -SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWT-----LCGTPEALAPEIILS 212

Query: 321 GIVDEKTDVFAFGVLLLELITGRR 344
              ++  D +A GVL+ E+  G  
Sbjct: 213 KGYNKAVDWWALGVLIYEMAAGYP 236

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  135 bits (341), Expect = 4e-37
 Identities = 59/277 (21%), Positives = 101/277 (36%), Gaps = 25/277 (9%)

Query: 142 DNFNSENLIGKGGHAEVYKG-CLPDGEVVAVKKIIKNAKEDEER---ISDFLSELGIVAH 197
           D +++   +G G  A V K      G   A K I K   +   R     D   E+ I+  
Sbjct: 10  DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 69

Query: 198 INHPNAAKLIG-FSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQY 256
           I HPN   L   +  +    L+L+ +  G L   L       E     +    I  G+  
Sbjct: 70  IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEAT-EFLKQILNGV-- 126

Query: 257 LHHDCHRRIIHRDIKASNILLSED----YEAQISDFGLAKWLPDNWSHHIVFPIEGTFGY 312
            ++    +I H D+K  NI+L +        +I DFGLA  +        +F   GT  +
Sbjct: 127 -YYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF---GTPEF 182

Query: 313 LSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSNFKELVDP 372
           ++PE   +  +  + D+++ GV+   L++G        +   +     +      E    
Sbjct: 183 VAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSN 242

Query: 373 RLADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQ 409
             A A D   ++R        +      R  +   LQ
Sbjct: 243 TSALAKDF--IRR-------LLVKDPKKRMTIQDSLQ 270

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  134 bits (337), Expect = 1e-36
 Identities = 46/205 (22%), Positives = 83/205 (40%), Gaps = 16/205 (7%)

Query: 149 LIGKGGHAEVYKG-CLPDGEVVAVKKIIKNAKEDEERISD---FLSELGIVAHIN--HPN 202
           L+G GG   VY G  + D   VA+K + K+   D   + +      E+ ++  ++     
Sbjct: 11  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70

Query: 203 AAKLIG-FSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDC 261
             +L+  F   + F L+L+                 L+  +       + E +++     
Sbjct: 71  VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHC---H 127

Query: 262 HRRIIHRDIKASNILLSED-YEAQISDFGLAKWLPDNWSHHIVFPIEGTFGYLSPEYFM- 319
           +  ++HRDIK  NIL+  +  E ++ DFG    L D           GT  Y  PE+   
Sbjct: 128 NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFD----GTRVYSPPEWIRY 183

Query: 320 HGIVDEKTDVFAFGVLLLELITGRR 344
           H        V++ G+LL +++ G  
Sbjct: 184 HRYHGRSAAVWSLGILLYDMVCGDI 208

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  135 bits (341), Expect = 1e-36
 Identities = 51/211 (24%), Positives = 89/211 (42%), Gaps = 15/211 (7%)

Query: 141 TDNFNSENLIGKGGHAEVYKG-CLPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHIN 199
              + + + IG+G +  V       +   VA+KKI  +  E +      L E+ I+    
Sbjct: 7   GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKI--SPFEHQTYCQRTLREIKILLRFR 64

Query: 200 HPNAAKLIGFSTENGFH-----LVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGL 254
           H N   +                ++  L    L  LL   T+ L           I  GL
Sbjct: 65  HENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLL--KTQHLSNDHICYFLYQILRGL 122

Query: 255 QYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWL-PDNWSHHIVFPIEGTFGYL 313
           +Y+H      ++HRD+K SN+LL+   + +I DFGLA+   PD+     +     T  Y 
Sbjct: 123 KYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYR 179

Query: 314 SPEYFMHGIVD-EKTDVFAFGVLLLELITGR 343
           +PE  ++     +  D+++ G +L E+++ R
Sbjct: 180 APEIMLNSKGYTKSIDIWSVGCILAEMLSNR 210

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  131 bits (329), Expect = 3e-35
 Identities = 51/223 (22%), Positives = 88/223 (39%), Gaps = 18/223 (8%)

Query: 142 DNFNSENLIGKGGHAEVYKG-CLPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINH 200
             +     IG+G   EV+K      G+ VA+KK++    E E      L E+ I+  + H
Sbjct: 10  SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLME-NEKEGFPITALREIKILQLLKH 68

Query: 201 PNAAKLIG---------FSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIA 251
            N   LI             +   +LV  F  H     L     +     I+  +     
Sbjct: 69  ENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQ---- 124

Query: 252 EGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWL--PDNWSHHIVFPIEGT 309
             L  L++    +I+HRD+KA+N+L++ D   +++DFGLA+      N   +       T
Sbjct: 125 MLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVT 184

Query: 310 FGYLSPEYFMHGI-VDEKTDVFAFGVLLLELITGRRAVDSRRQ 351
             Y  PE  +         D++  G ++ E+ T    +    +
Sbjct: 185 LWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTE 227

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  131 bits (329), Expect = 6e-35
 Identities = 54/215 (25%), Positives = 86/215 (40%), Gaps = 25/215 (11%)

Query: 142 DNFNSENLIGKGGHAEVYKG-CLPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINH 200
            ++    +IG G    VY+      GE+VA+KK++++ +           EL I+  ++H
Sbjct: 20  VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF-------KNRELQIMRKLDH 72

Query: 201 PNAAKLIGFSTENG-------FHLVLQFLPHGSLSSLLFGST--ECLEWTIRYKIALGIA 251
            N  +L  F   +G        +LVL ++P          S   + L           + 
Sbjct: 73  CNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLF 132

Query: 252 EGLQYLHHDCHRRIIHRDIKASNILLSED-YEAQISDFGLAKWLPDNWSHHIVFPIEGTF 310
             L Y+H      I HRDIK  N+LL  D    ++ DFG AK L     +          
Sbjct: 133 RSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICS---R 186

Query: 311 GYLSPEYFMHGI-VDEKTDVFAFGVLLLELITGRR 344
            Y +PE            DV++ G +L EL+ G+ 
Sbjct: 187 YYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQP 221

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  128 bits (322), Expect = 1e-34
 Identities = 40/205 (19%), Positives = 84/205 (40%), Gaps = 8/205 (3%)

Query: 142 DNFNSENLIGKGGHAEVYKG-CLPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINH 200
             +     IG+G +  V+K       E+VA+ K ++   +DE   S  L E+ ++  + H
Sbjct: 2   QKYEKLEKIGEGTYGTVFKAKNRETHEIVAL-KRVRLDDDDEGVPSSALREICLLKELKH 60

Query: 201 PNAAKLIG-FSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHH 259
            N  +L     ++    LV +F            + +     ++      + + L+ L  
Sbjct: 61  KNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKS----FLFQLLKGLGF 116

Query: 260 DCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEGTFGYLSPEYFM 319
              R ++HRD+K  N+L++ + E ++++FGLA+        +    +   +       F 
Sbjct: 117 CHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAE-VVTLWYRPPDVLFG 175

Query: 320 HGIVDEKTDVFAFGVLLLELITGRR 344
             +     D+++ G +  EL    R
Sbjct: 176 AKLYSTSIDMWSAGCIFAELANAGR 200

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  129 bits (325), Expect = 2e-34
 Identities = 48/277 (17%), Positives = 100/277 (36%), Gaps = 36/277 (12%)

Query: 147 ENLIGKGGHAEVYKG-CLPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAK 205
             ++G G + +V +       E  A+K ++++  +    +               P+  +
Sbjct: 17  SQVLGLGINGKVLQIFNKRTQEKFALK-MLQDCPKARREVELHWRAS------QCPHIVR 69

Query: 206 LIG-----FSTENGFHLVLQFLPHGSLSSLLFG-STECLEWTIRYKIALGIAEGLQYLHH 259
           ++      ++      +V++ L  G L S +     +        +I   I E +QYLH 
Sbjct: 70  IVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS 129

Query: 260 DCHRRIIHRDIKASNILLSEDYE---AQISDFGLAKWLPDNWSHHIVFPIEGTFGYLSPE 316
                I HRD+K  N+L +        +++DFG AK    + S         T  Y++PE
Sbjct: 130 ---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCY---TPYYVAPE 183

Query: 317 YFMHGIVDEKTDVFAFGVLLLELITGRR---AVDSRRQSLVIWAKPLLQTSNFKELVDPR 373
                  D+  D+++ GV++  L+ G     +      S  +  +  +    F       
Sbjct: 184 VLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSE 243

Query: 374 L-ADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQ 409
           +  +   L  ++         +    T R  +T  + 
Sbjct: 244 VSEEVKML--IRN-------LLKTEPTQRMTITEFMN 271

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  126 bits (317), Expect = 2e-33
 Identities = 59/247 (23%), Positives = 103/247 (41%), Gaps = 17/247 (6%)

Query: 142 DNFNSENLIGKGGHAEVYKG----CLPDGEVVAVKKIIK-NAKEDEERISDFLSELGIVA 196
           +NF    ++G G + +V+          G++ A+K + K    +  +      +E  ++ 
Sbjct: 24  ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83

Query: 197 HINH-PNAAKLIG-FSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGL 254
           HI   P    L   F TE   HL+L ++  G L + L       E  ++  +     E +
Sbjct: 84  HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVG----EIV 139

Query: 255 QYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEGTFGYLS 314
             L H     II+RDIK  NILL  +    ++DFGL+K    + +    +   GT  Y++
Sbjct: 140 LALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETER-AYDFCGTIEYMA 198

Query: 315 PEYFMHGI--VDEKTDVFAFGVLLLELITGRR---AVDSRRQSLVIWAKPLLQTSNFKEL 369
           P+    G    D+  D ++ GVL+ EL+TG         +     I  + L     + + 
Sbjct: 199 PDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQE 258

Query: 370 VDPRLAD 376
           +     D
Sbjct: 259 MSALAKD 265

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  119 bits (299), Expect = 7e-31
 Identities = 50/211 (23%), Positives = 89/211 (42%), Gaps = 21/211 (9%)

Query: 142 DNFNSENLIGKGGHAEVYKG-CLPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINH 200
             +     +G G +  V        G  VA+K  +    + E        EL ++ H+ H
Sbjct: 18  AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIK-KLYRPFQSELFAKRAYRELRLLKHMRH 76

Query: 201 PNAAKLIGFSTENG-------FHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEG 253
            N   L+   T +        F+LV+ F+       +       L       +   + +G
Sbjct: 77  ENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEK---LGEDRIQFLVYQMLKG 133

Query: 254 LQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEGTFGYL 313
           L+Y+H      IIHRD+K  N+ ++ED E +I DFGLA+      + ++V        Y 
Sbjct: 134 LRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGYVVTR-----WYR 185

Query: 314 SPEYFM-HGIVDEKTDVFAFGVLLLELITGR 343
           +PE  +      +  D+++ G ++ E+ITG+
Sbjct: 186 APEVILNWMRYTQTVDIWSVGCIMAEMITGK 216

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  115 bits (288), Expect = 2e-29
 Identities = 42/209 (20%), Positives = 85/209 (40%), Gaps = 21/209 (10%)

Query: 142 DNFNSENLIGKGGHAEVYKG-CLPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINH 200
           D++     +G+G ++EV++   + + E V VK +    K+  +R    L  L        
Sbjct: 35  DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLR-----GG 89

Query: 201 PNAAKLIGF---STENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYL 257
           PN   L             LV + + +     L     + L           I + L Y 
Sbjct: 90  PNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY----QTLTDYDIRFYMYEILKALDYC 145

Query: 258 HHDCHRRIIHRDIKASNILL-SEDYEAQISDFGLAKWLPDNWSHHIVFPIEGTFGYLSPE 316
           H      I+HRD+K  N+++  E  + ++ D+GLA++      +++      +  +  PE
Sbjct: 146 H---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRV---ASRYFKGPE 199

Query: 317 YFM-HGIVDEKTDVFAFGVLLLELITGRR 344
             + + + D   D+++ G +L  +I  + 
Sbjct: 200 LLVDYQMYDYSLDMWSLGCMLASMIFRKE 228

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  113 bits (283), Expect = 1e-28
 Identities = 49/210 (23%), Positives = 92/210 (43%), Gaps = 17/210 (8%)

Query: 141 TDNFNSENLIGKGGHAEVYKG-CLPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHIN 199
            + + + + +G G +  V        G  VAVK  +    +          EL ++ H+ 
Sbjct: 17  PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK-KLSRPFQSIIHAKRTYRELRLLKHMK 75

Query: 200 HPNAAKLIGF-----STENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGL 254
           H N   L+       S E    + L     G+  + +    +  +  +++ +   I  GL
Sbjct: 76  HENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-LIYQILRGL 134

Query: 255 QYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEGTFGYLS 314
           +Y+H        HRD+K SN+ ++ED E +I DFGLA+   D  + ++         Y +
Sbjct: 135 KYIHSADII---HRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRW-----YRA 186

Query: 315 PEYFM-HGIVDEKTDVFAFGVLLLELITGR 343
           PE  +     ++  D+++ G ++ EL+TGR
Sbjct: 187 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  111 bits (278), Expect = 8e-28
 Identities = 43/210 (20%), Positives = 81/210 (38%), Gaps = 19/210 (9%)

Query: 142 DNFNSENLIGKGGHAEVYKG-CLPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINH 200
             + +   IG G    V           VA+KK+     +++        EL ++  +NH
Sbjct: 17  KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKL-SRPFQNQTHAKRAYRELVLMKCVNH 75

Query: 201 PNAAKLIGFSTENG-------FHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEG 253
            N   L+   T           +LV++ +       +               +   +  G
Sbjct: 76  KNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELD----HERMSYLLYQMLCG 131

Query: 254 LQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEGTFGYL 313
           +++LH       IHRD+K SNI++  D   +I DFGLA+    ++          T  Y 
Sbjct: 132 IKHLHSAGI---IHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYV---VTRYYR 185

Query: 314 SPEYFMHGIVDEKTDVFAFGVLLLELITGR 343
           +PE  +     E  D+++ G ++ E++  +
Sbjct: 186 APEVILGMGYKENVDIWSVGCIMGEMVRHK 215

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  110 bits (276), Expect = 1e-27
 Identities = 43/215 (20%), Positives = 75/215 (34%), Gaps = 24/215 (11%)

Query: 147 ENLIGKGGHAEVYKG-CLPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAK 205
              +G G  + V+    + +   VA+K +    + D+        E+ ++  +N  +  K
Sbjct: 18  VRKLGWGHFSTVWLAKDMVNNTHVAMKIV----RGDKVYTEAAEDEIKLLQRVNDADNTK 73

Query: 206 LIGFSTENGFHLVLQF----------------LPHGSLSSLLFGSTECLEWTIRYKIALG 249
                  +   L+  F                L    L+ +       +      +I+  
Sbjct: 74  EDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQ 133

Query: 250 IAEGLQYLHHDCHRRIIHRDIKASNILL-SEDYEAQISDFGLAKWLPDNWSHHIVFPIEG 308
           +  GL Y+H  C   IIH DIK  N+L+   D    +    +A      W          
Sbjct: 134 LLLGLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQ 191

Query: 309 TFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGR 343
           T  Y SPE  +        D+++   L+ ELITG 
Sbjct: 192 TREYRSPEVLLGAPWGCGADIWSTACLIFELITGD 226

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 78.3 bits (192), Expect = 2e-17
 Identities = 23/159 (14%), Positives = 47/159 (29%), Gaps = 14/159 (8%)

Query: 148 NLIGKGGHAEVYKGCLPDGEVVAVKKIIKNAKEDEE-------RISDFLSELGIVAHINH 200
            L+G+G  + V+           VK         ++           F       A    
Sbjct: 6   KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65

Query: 201 PNAAKLIGFSTENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHD 260
               KL G +    +      +    +  +       +      ++   I E +   +H 
Sbjct: 66  RALQKLQGLAVPKVYAWEGNAV---LMELIDAKELYRVRVENPDEVLDMILEEVAKFYHR 122

Query: 261 CHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWS 299
               I+H D+   N+L+S +    I DF  +  + +   
Sbjct: 123 G---IVHGDLSQYNVLVS-EEGIWIIDFPQSVEVGEEGW 157

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	457
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.91
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.38
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	97.84
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	97.51
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	97.0
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	96.99
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	96.11

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-54  Score=416.03  Aligned_cols=264  Identities=27%  Similarity=0.379  Sum_probs=207.1

Q ss_pred             hhcCCCCCceecccCcEEEEEEEeCCCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeecCceEEEE
Q 012765          140 ATDNFNSENLIGKGGHAEVYKGCLPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTENGFHLVL  219 (457)
Q Consensus       140 ~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~lv~  219 (457)
                      ..++|.+.+.||+|+||+||+|.+.  ..||||++...... ....+.|.+|+.++++++|||||++++++.++.+++||
T Consensus         6 ~~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~lv~   82 (276)
T d1uwha_           6 PDGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPT-PQQLQAFKNEVGVLRKTRHVNILLFMGYSTAPQLAIVT   82 (276)
T ss_dssp             CTTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCC-TTHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSCEEEE
T ss_pred             ccccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCC-HHHHHHHHHHHHHHHhCCCCCEeeeeEEEeccEEEEEE
Confidence            3578999999999999999999864  35999988654332 23467899999999999999999999999999999999


Q ss_pred             EecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCCCCCC
Q 012765          220 QFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWS  299 (457)
Q Consensus       220 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~~~~  299 (457)
                      ||+++|+|.+++......+++..++.|+.||+.||.|||+   .+||||||||+||||+.++.+||+|||+++.......
T Consensus        83 Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~---~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~  159 (276)
T d1uwha_          83 QWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHA---KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSG  159 (276)
T ss_dssp             ECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEETTSSEEECCCCCSCC------
T ss_pred             ecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhc---CCEeccccCHHHEEEcCCCCEEEccccceeeccccCC
Confidence            9999999999998777779999999999999999999999   8999999999999999999999999999987755433


Q ss_pred             ceeeecccccccccChhcccc---CCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhccccccCCcccccCchhhc
Q 012765          300 HHIVFPIEGTFGYLSPEYFMH---GIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSNFKELVDPRLAD  376 (457)
Q Consensus       300 ~~~~~~~~gt~~y~aPE~~~~---~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  376 (457)
                      ........||+.|||||++.+   ..|+.++|||||||++|||+||+.||.............  ...    ...+.+. 
T Consensus       160 ~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~--~~~----~~~p~~~-  232 (276)
T d1uwha_         160 SHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMV--GRG----YLSPDLS-  232 (276)
T ss_dssp             ------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHH--HHT----SCCCCGG-
T ss_pred             cccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHH--hcC----CCCCcch-
Confidence            334445679999999999864   358999999999999999999999998644332211110  000    0111111 


Q ss_pred             ccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCCC
Q 012765          377 AYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQLLRGEGG  416 (457)
Q Consensus       377 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~  416 (457)
                      .........+.+++.+||+.||.+||||.||++.|+.+..
T Consensus       233 ~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~  272 (276)
T d1uwha_         233 KVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLAR  272 (276)
T ss_dssp             GSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             hccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence            1111223456778899999999999999999999987653

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-53  Score=405.56  Aligned_cols=254  Identities=26%  Similarity=0.419  Sum_probs=196.1

Q ss_pred             cCCCCCceecccCcEEEEEEEeCCCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeee-cCceEEEEE
Q 012765          142 DNFNSENLIGKGGHAEVYKGCLPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFST-ENGFHLVLQ  220 (457)
Q Consensus       142 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~-~~~~~lv~e  220 (457)
                      ++|++.+.||+|+||+||+|.+.+++.||||++......    .++|.+|+.++++++|||||++++++. ++..++|||
T Consensus         5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~----~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E   80 (263)
T d1sm2a_           5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS----EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFE   80 (263)
T ss_dssp             SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSSSC----HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred             HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCcCc----HHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEE
Confidence            578888999999999999999988999999998754433    247899999999999999999999766 456789999


Q ss_pred             ecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCCCCCCc
Q 012765          221 FLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSH  300 (457)
Q Consensus       221 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~~~~~  300 (457)
                      |+++|+|.+++......+++..++.|+.||+.||.|||+   .+|+||||||+|||++.++.+||+|||+++........
T Consensus        81 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~---~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~  157 (263)
T d1sm2a_          81 FMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEE---ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT  157 (263)
T ss_dssp             CCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCTTCSGGGEEECGGGCEEECSCC-----------
T ss_pred             ecCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhc---cceeecccchhheeecCCCCeEecccchheeccCCCce
Confidence            999999999998777789999999999999999999999   89999999999999999999999999999877554322


Q ss_pred             eeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHhCC-CCCCcCCcchhhhhccccccCCcccccCchhhcccC
Q 012765          301 HIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGR-RAVDSRRQSLVIWAKPLLQTSNFKELVDPRLADAYD  379 (457)
Q Consensus       301 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLltG~-~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~  379 (457)
                       ......||+.|+|||++.+..|+.++|||||||++|||+|+. +||......... .. ....   .....|.   .  
T Consensus       158 -~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~-~~-i~~~---~~~~~p~---~--  226 (263)
T d1sm2a_         158 -SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVV-ED-ISTG---FRLYKPR---L--  226 (263)
T ss_dssp             --------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHH-HH-HHHT---CCCCCCT---T--
T ss_pred             -eecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHH-HH-HHhc---CCCCCcc---c--
Confidence             222356899999999999999999999999999999999954 445432221111 10 0000   0011111   1  


Q ss_pred             HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCC
Q 012765          380 LAEMKRAMLTASVCIHHLSTMRPQMTRVLQLLRGEG  415 (457)
Q Consensus       380 ~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~  415 (457)
                        ....+.+++.+||+.||++||||.||++.|+++.
T Consensus       227 --~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~  260 (263)
T d1sm2a_         227 --ASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIA  260 (263)
T ss_dssp             --SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             --cCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHH
Confidence              1235678899999999999999999999998764

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.9e-53  Score=406.84  Aligned_cols=256  Identities=23%  Similarity=0.342  Sum_probs=208.1

Q ss_pred             cCCCCCce-ecccCcEEEEEEEeC---CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeecCceEE
Q 012765          142 DNFNSENL-IGKGGHAEVYKGCLP---DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTENGFHL  217 (457)
Q Consensus       142 ~~f~~~~~-LG~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~l  217 (457)
                      ++|.+.++ ||+|+||+||+|.+.   ++..||||++.....  ....+.|.+|+.+|++++|||||++++++..+.+++
T Consensus         8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~l   85 (285)
T d1u59a_           8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTE--KADTEEMMREAQIMHQLDNPYIVRLIGVCQAEALML   85 (285)
T ss_dssp             GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCC--HHHHHHHHHHHHHHHHCCCTTBCCEEEEEESSSEEE
T ss_pred             cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcC--HHHHHHHHHHHHHHHhCCCCCEeeEeeeeccCeEEE
Confidence            55666675 999999999999754   355799999865433  344678999999999999999999999999889999


Q ss_pred             EEEecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCCCC
Q 012765          218 VLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDN  297 (457)
Q Consensus       218 v~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~~  297 (457)
                      ||||+++|+|.+++......+++..++.++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||+++.+...
T Consensus        86 vmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~---~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~  162 (285)
T d1u59a_          86 VMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGAD  162 (285)
T ss_dssp             EEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEEETTEEEECCCTTCEECTTC
T ss_pred             EEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCcCchhheeeccCCceeeccchhhhccccc
Confidence            999999999999987777789999999999999999999999   89999999999999999999999999999987654


Q ss_pred             CCce-eeecccccccccChhccccCCCCcchhHHHHHHHHHHHHh-CCCCCCcCCcchhhhhccccccCCcccccCchhh
Q 012765          298 WSHH-IVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELIT-GRRAVDSRRQSLVIWAKPLLQTSNFKELVDPRLA  375 (457)
Q Consensus       298 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLlt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  375 (457)
                      .... ......||+.|+|||++.++.++.++|||||||++|||+| |+.||............   ....     .+...
T Consensus       163 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i---~~~~-----~~~~p  234 (285)
T d1u59a_         163 DSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFI---EQGK-----RMECP  234 (285)
T ss_dssp             SCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHH---HTTC-----CCCCC
T ss_pred             ccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHH---HcCC-----CCCCC
Confidence            3222 1223458999999999999999999999999999999998 89999864432221111   1111     01111


Q ss_pred             cccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q 012765          376 DAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQLLRGE  414 (457)
Q Consensus       376 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~  414 (457)
                      ...    ...+.+++.+||+.||++||||.+|++.|+..
T Consensus       235 ~~~----~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~  269 (285)
T d1u59a_         235 PEC----PPELYALMSDCWIYKWEDRPDFLTVEQRMRAC  269 (285)
T ss_dssp             TTC----CHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CcC----CHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence            122    23566789999999999999999999988753

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.8e-53  Score=403.85  Aligned_cols=253  Identities=23%  Similarity=0.311  Sum_probs=199.0

Q ss_pred             hcCCCCCceecccCcEEEEEEEeC-CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeecC-ceEEE
Q 012765          141 TDNFNSENLIGKGGHAEVYKGCLP-DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTEN-GFHLV  218 (457)
Q Consensus       141 ~~~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~-~~~lv  218 (457)
                      .++|++.+.||+|+||+||+|.+. +|+.||||++......  +..+.+.+|+.++++++|||||++++++.++ ..++|
T Consensus         4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~--~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~iv   81 (271)
T d1nvra_           4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLF   81 (271)
T ss_dssp             TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC---------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcc--hHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEE
Confidence            467999999999999999999874 6999999998654322  2345789999999999999999999966554 56899


Q ss_pred             EEecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCCCCC
Q 012765          219 LQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNW  298 (457)
Q Consensus       219 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~~~  298 (457)
                      |||+++|+|.+++.. ...+++..+..++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||+++.+....
T Consensus        82 mEy~~gg~L~~~l~~-~~~l~e~~~~~i~~qi~~al~ylH~---~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~  157 (271)
T d1nvra_          82 LEYCSGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNN  157 (271)
T ss_dssp             EECCTTEEGGGGSBT-TTBCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred             EeccCCCcHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHH---cCCccCcccHHHEEECCCCCEEEccchhheeeccCC
Confidence            999999999999854 4568999999999999999999999   899999999999999999999999999998775443


Q ss_pred             CceeeecccccccccChhccccCCC-CcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhccccccCCcccccCchhhcc
Q 012765          299 SHHIVFPIEGTFGYLSPEYFMHGIV-DEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSNFKELVDPRLADA  377 (457)
Q Consensus       299 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~  377 (457)
                      .........||+.|||||++.+..+ +.++|||||||++|||+||+.||.........+..... ....   ..+  ...
T Consensus       158 ~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~-~~~~---~~~--~~~  231 (271)
T d1nvra_         158 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKE-KKTY---LNP--WKK  231 (271)
T ss_dssp             EECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHT-TCTT---STT--GGG
T ss_pred             ccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhc-CCCC---CCc--ccc
Confidence            3333445679999999999988776 57899999999999999999999764433222211100 0000   000  011


Q ss_pred             cCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 012765          378 YDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQ  409 (457)
Q Consensus       378 ~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~  409 (457)
                      ++    ..+.+++.+||+.||++|||+.|+++
T Consensus       232 ~s----~~~~~li~~~L~~dP~~R~t~~eil~  259 (271)
T d1nvra_         232 ID----SAPLALLHKILVENPSARITIPDIKK  259 (271)
T ss_dssp             SC----HHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             CC----HHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            12    34567889999999999999999864

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.2e-53  Score=403.63  Aligned_cols=255  Identities=24%  Similarity=0.378  Sum_probs=205.2

Q ss_pred             hhcCCCCCceecccCcEEEEEEEeCCCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeecCceEEEE
Q 012765          140 ATDNFNSENLIGKGGHAEVYKGCLPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTENGFHLVL  219 (457)
Q Consensus       140 ~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~lv~  219 (457)
                      ..++|++.+.||+|+||+||+|.+++++.||||++......    .+.|.+|+.++++++|||||++++++.++..++||
T Consensus        11 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~----~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~iv~   86 (272)
T d1qpca_          11 PRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS----PDAFLAEANLMKQLQHQRLVRLYAVVTQEPIYIIT   86 (272)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSC----HHHHHHHHHHHHHCCCTTBCCEEEEECSSSCEEEE
T ss_pred             CHHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCcCC----HHHHHHHHHHHHhCCCCCEeEEEeeeccCCeEEEE
Confidence            34678889999999999999999988899999998654332    34789999999999999999999999999999999


Q ss_pred             EecCCCChhhhhhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCCCCC
Q 012765          220 QFLPHGSLSSLLFGST-ECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNW  298 (457)
Q Consensus       220 e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~~~  298 (457)
                      ||+++|+|.+++.... ..+++..++.|+.||+.||.|||+   .+|+||||||+||||++++.+||+|||+++.+....
T Consensus        87 Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~---~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~  163 (272)
T d1qpca_          87 EYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE---RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE  163 (272)
T ss_dssp             ECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSC
T ss_pred             EeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCccchhheeeecccceeeccccceEEccCCc
Confidence            9999999999875432 358999999999999999999999   899999999999999999999999999999875532


Q ss_pred             CceeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhccccccCCcccccCchhhccc
Q 012765          299 SHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSNFKELVDPRLADAY  378 (457)
Q Consensus       299 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~  378 (457)
                      . .......||+.|+|||++.++.++.++|||||||++|||+||..|+............  ....     ..+......
T Consensus       164 ~-~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~--i~~~-----~~~~~p~~~  235 (272)
T d1qpca_         164 Y-TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQN--LERG-----YRMVRPDNC  235 (272)
T ss_dssp             E-ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHH--HHTT-----CCCCCCTTC
T ss_pred             c-ccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHH--HHhc-----CCCCCcccC
Confidence            2 1223456899999999999999999999999999999999976655432221111111  0000     111111122


Q ss_pred             CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 012765          379 DLAEMKRAMLTASVCIHHLSTMRPQMTRVLQLLRG  413 (457)
Q Consensus       379 ~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~  413 (457)
                          ...+.+++.+||+.||++||||.+|++.|+.
T Consensus       236 ----~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~  266 (272)
T d1qpca_         236 ----PEELYQLMRLCWKERPEDRPTFDYLRSVLED  266 (272)
T ss_dssp             ----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             ----hHHHHHHHHHHcCCCHhHCcCHHHHHHHhhh
Confidence                2356778899999999999999999999875

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.4e-53  Score=400.66  Aligned_cols=247  Identities=27%  Similarity=0.413  Sum_probs=202.2

Q ss_pred             cCCCCCceecccCcEEEEEEEeC-CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeecC-ceEEEE
Q 012765          142 DNFNSENLIGKGGHAEVYKGCLP-DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTEN-GFHLVL  219 (457)
Q Consensus       142 ~~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~-~~~lv~  219 (457)
                      ++|++.+.||+|+||+||+|.+. +++.||+|++.+...........+.+|+.+++.++|||||++++++.++ ..++||
T Consensus         6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm   85 (263)
T d2j4za1           6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL   85 (263)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence            57889999999999999999875 6899999998754433333456789999999999999999999976655 468999


Q ss_pred             EecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCCCCCC
Q 012765          220 QFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWS  299 (457)
Q Consensus       220 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~~~~  299 (457)
                      ||+++|+|.+++... ..+++..+..++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||++....... 
T Consensus        86 Ey~~~g~L~~~l~~~-~~l~e~~~~~i~~qi~~al~~lH~---~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~~-  160 (263)
T d2j4za1          86 EYAPLGTVYRELQKL-SKFDEQRTATYITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR-  160 (263)
T ss_dssp             ECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCCC-
T ss_pred             eecCCCcHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHH---CCeeeeeeccccceecCCCCEeecccceeeecCCCc-
Confidence            999999999998643 458999999999999999999999   899999999999999999999999999998775543 


Q ss_pred             ceeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhccccccCCcccccCchhhcccC
Q 012765          300 HHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSNFKELVDPRLADAYD  379 (457)
Q Consensus       300 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~  379 (457)
                         .....||+.|||||++.+..|+.++|||||||++|||++|+.||......... .........        +....+
T Consensus       161 ---~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~-~~i~~~~~~--------~p~~~s  228 (263)
T d2j4za1         161 ---RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETY-KRISRVEFT--------FPDFVT  228 (263)
T ss_dssp             ---CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHH-HHHHTTCCC--------CCTTSC
T ss_pred             ---ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHH-HHHHcCCCC--------CCccCC
Confidence               23456999999999999999999999999999999999999999864432211 111111111        111122


Q ss_pred             HHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 012765          380 LAEMKRAMLTASVCIHHLSTMRPQMTRVLQ  409 (457)
Q Consensus       380 ~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~  409 (457)
                          ..+.+++.+||+.||++|||+.|+++
T Consensus       229 ----~~~~~li~~~L~~dp~~R~t~~eil~  254 (263)
T d2j4za1         229 ----EGARDLISRLLKHNPSQRPMLREVLE  254 (263)
T ss_dssp             ----HHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             ----HHHHHHHHHHccCCHhHCcCHHHHHc
Confidence                34667888999999999999999986

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-51  Score=390.94  Aligned_cols=254  Identities=21%  Similarity=0.348  Sum_probs=210.7

Q ss_pred             hcCCCCCceecccCcEEEEEEEeCCCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeec-CceEEEE
Q 012765          141 TDNFNSENLIGKGGHAEVYKGCLPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTE-NGFHLVL  219 (457)
Q Consensus       141 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-~~~~lv~  219 (457)
                      .++|++.+.||+|+||+||+|.+++++.||||++......    .++|++|+.++++++||||+++++++.+ +.+++||
T Consensus         3 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~----~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~   78 (258)
T d1k2pa_           3 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS----EDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIIT   78 (258)
T ss_dssp             CCCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSSC----HHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEE
T ss_pred             hHHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcCC----HHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEE
Confidence            3688999999999999999999988899999998765443    2478999999999999999999997665 5678999


Q ss_pred             EecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCCCCCC
Q 012765          220 QFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWS  299 (457)
Q Consensus       220 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~~~~  299 (457)
                      ||+++|+|..++......+++..++.++.||++||.|||+   .+|+||||||+|||++.++.+||+|||+++.+.....
T Consensus        79 Ey~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~---~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~  155 (258)
T d1k2pa_          79 EYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLES---KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY  155 (258)
T ss_dssp             ECCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHH---TTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSC
T ss_pred             EccCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhh---cCcccccccceeEEEcCCCcEEECcchhheeccCCCc
Confidence            9999999999987777789999999999999999999999   8999999999999999999999999999987654432


Q ss_pred             ceeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHh-CCCCCCcCCcchhhhhccccccCCcccccCchhhccc
Q 012765          300 HHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELIT-GRRAVDSRRQSLVIWAKPLLQTSNFKELVDPRLADAY  378 (457)
Q Consensus       300 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLlt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~  378 (457)
                      . ......||+.|+|||.+.+..|+.++|||||||++|||+| |+.||.............  . .  .....|.   . 
T Consensus       156 ~-~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~--~-~--~~~~~p~---~-  225 (258)
T d1k2pa_         156 T-SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIA--Q-G--LRLYRPH---L-  225 (258)
T ss_dssp             C-CCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHH--T-T--CCCCCCT---T-
T ss_pred             e-eecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHH--h-C--CCCCCcc---c-
Confidence            2 2234568999999999999999999999999999999998 899998755433222111  1 1  0111111   1 


Q ss_pred             CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q 012765          379 DLAEMKRAMLTASVCIHHLSTMRPQMTRVLQLLRGE  414 (457)
Q Consensus       379 ~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~  414 (457)
                         ....+.+++.+||+.||++|||+.+|++.|..+
T Consensus       226 ---~~~~l~~li~~cl~~dP~~RPt~~eil~~L~di  258 (258)
T d1k2pa_         226 ---ASEKVYTIMYSCWHEKADERPTFKILLSNILDV  258 (258)
T ss_dssp             ---CCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHCC
T ss_pred             ---ccHHHHHHHHHHccCCHhHCcCHHHHHHHhhCC
Confidence               123577889999999999999999999998653

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=8.1e-53  Score=407.59  Aligned_cols=256  Identities=27%  Similarity=0.392  Sum_probs=194.1

Q ss_pred             cCCCCCceecccCcEEEEEEEeCC-C---cEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeec-CceE
Q 012765          142 DNFNSENLIGKGGHAEVYKGCLPD-G---EVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTE-NGFH  216 (457)
Q Consensus       142 ~~f~~~~~LG~G~~g~Vy~~~~~~-~---~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-~~~~  216 (457)
                      ++|++.++||+|+||+||+|.+.. +   ..||||++.....  ....+.|.+|+.+|++++|||||++++++.. +.++
T Consensus        26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~  103 (299)
T d1jpaa_          26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYT--EKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVM  103 (299)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCC--HHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCE
T ss_pred             hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccC--HHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEE
Confidence            456778899999999999998642 3   2588888754333  2445689999999999999999999997755 5578


Q ss_pred             EEEEecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCCC
Q 012765          217 LVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPD  296 (457)
Q Consensus       217 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~  296 (457)
                      +||||+++|+|.+++......+++..++.|+.||+.||.|||+   .+|+||||||+||||+.++.+||+|||+++.+..
T Consensus       104 iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~---~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~  180 (299)
T d1jpaa_         104 IITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLAD---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLED  180 (299)
T ss_dssp             EEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred             EEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhh---CCCccCccccceEEECCCCcEEECCcccceEccC
Confidence            9999999999999998777789999999999999999999999   8999999999999999999999999999987754


Q ss_pred             CCCcee---eecccccccccChhccccCCCCcchhHHHHHHHHHHHHh-CCCCCCcCCcchhhhhccccccCCcccccCc
Q 012765          297 NWSHHI---VFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELIT-GRRAVDSRRQSLVIWAKPLLQTSNFKELVDP  372 (457)
Q Consensus       297 ~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLlt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~  372 (457)
                      ......   .....||+.|||||++.++.|+.++|||||||++|||+| |+.||............  .....      +
T Consensus       181 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i--~~~~~------~  252 (299)
T d1jpaa_         181 DTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAI--EQDYR------L  252 (299)
T ss_dssp             ---------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHH--HTTCC------C
T ss_pred             CCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHHH--HcCCC------C
Confidence            332211   222457899999999999999999999999999999998 89999864432211110  01000      0


Q ss_pred             hhhcccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q 012765          373 RLADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQLLRGE  414 (457)
Q Consensus       373 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~  414 (457)
                          .........+.+++.+||+.||++||||.||++.|+.+
T Consensus       253 ----~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~  290 (299)
T d1jpaa_         253 ----PPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKM  290 (299)
T ss_dssp             ----CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred             ----CCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence                01112234567788999999999999999999999865

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5e-52  Score=395.90  Aligned_cols=253  Identities=21%  Similarity=0.356  Sum_probs=192.8

Q ss_pred             cCCCCCceecccCcEEEEEEEeC-CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeec---CceEE
Q 012765          142 DNFNSENLIGKGGHAEVYKGCLP-DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTE---NGFHL  217 (457)
Q Consensus       142 ~~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~---~~~~l  217 (457)
                      ++|++.+.||+|+||+||+|.+. +|+.||+|.+...... ....+.+.+|+.++++++|||||++++++.+   +.+++
T Consensus         4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~-~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~i   82 (269)
T d2java1           4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMT-EAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI   82 (269)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSC-HHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEE
T ss_pred             hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCC-HHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEE
Confidence            67999999999999999999864 6899999998765433 3446789999999999999999999997643   44789


Q ss_pred             EEEecCCCChhhhhhc---CCCCCCHHHHHHHHHHHHHHHHHHHhcC--CCCeeeCCCCCCcEEEcCCCcEEEeeccccc
Q 012765          218 VLQFLPHGSLSSLLFG---STECLEWTIRYKIALGIAEGLQYLHHDC--HRRIIHRDIKASNILLSEDYEAQISDFGLAK  292 (457)
Q Consensus       218 v~e~~~~gsL~~~l~~---~~~~~~~~~~~~i~~qia~aL~yLH~~~--~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~  292 (457)
                      ||||+++|+|.+++..   ....+++..++.++.||+.||.|||+..  ..+|+||||||+|||++.++.+||+|||+++
T Consensus        83 vmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~  162 (269)
T d2java1          83 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR  162 (269)
T ss_dssp             EEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHH
T ss_pred             EEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeecccee
Confidence            9999999999999853   3457999999999999999999999831  1249999999999999999999999999998


Q ss_pred             cCCCCCCceeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhccccccCCcccccCc
Q 012765          293 WLPDNWSHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSNFKELVDP  372 (457)
Q Consensus       293 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~  372 (457)
                      .+.....  ......||+.|||||++.+..|+.++|||||||++|||+||+.||...........   .......     
T Consensus       163 ~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~---i~~~~~~-----  232 (269)
T d2java1         163 ILNHDTS--FAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGK---IREGKFR-----  232 (269)
T ss_dssp             HC-------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH---HHHTCCC-----
T ss_pred             ecccCCC--ccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHH---HHcCCCC-----
Confidence            8754322  22345699999999999999999999999999999999999999986543322111   0111111     


Q ss_pred             hhhcccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 012765          373 RLADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQ  409 (457)
Q Consensus       373 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~  409 (457)
                      .+...++    ..+.+++.+||+.||.+|||+.|+++
T Consensus       233 ~~~~~~s----~~l~~li~~~L~~dp~~Rps~~ell~  265 (269)
T d2java1         233 RIPYRYS----DELNEIITRMLNLKDYHRPSVEEILE  265 (269)
T ss_dssp             CCCTTSC----HHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             CCCcccC----HHHHHHHHHHcCCChhHCcCHHHHHh
Confidence            1112222    35677889999999999999999975

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=8.5e-53  Score=405.09  Aligned_cols=257  Identities=23%  Similarity=0.367  Sum_probs=206.7

Q ss_pred             hhcCCCCCceecccCcEEEEEEEeC-CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeec-CceEE
Q 012765          140 ATDNFNSENLIGKGGHAEVYKGCLP-DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTE-NGFHL  217 (457)
Q Consensus       140 ~~~~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-~~~~l  217 (457)
                      ..++|++.+.||+|+||+||+|.+. +++.||||++......    .++|.+|+.+|++++|||||++++++.+ +..++
T Consensus        15 ~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~----~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~i   90 (287)
T d1opja_          15 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME----VEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYI   90 (287)
T ss_dssp             CGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSC----HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred             cHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccch----HHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEE
Confidence            3567888999999999999999875 5889999998654332    3478999999999999999999997665 56789


Q ss_pred             EEEecCCCChhhhhhc-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCCC
Q 012765          218 VLQFLPHGSLSSLLFG-STECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPD  296 (457)
Q Consensus       218 v~e~~~~gsL~~~l~~-~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~  296 (457)
                      +|||+++|+|..++.. ....+++..++.|+.||+.||.|||+   .+|+||||||+||||+.++.+||+|||+++....
T Consensus        91 v~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~---~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~  167 (287)
T d1opja_          91 ITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG  167 (287)
T ss_dssp             EEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCCCTTTCCS
T ss_pred             EeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHH---CCcccCccccCeEEECCCCcEEEccccceeecCC
Confidence            9999999999999865 45678999999999999999999999   8999999999999999999999999999987755


Q ss_pred             CCCceeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhccccccCCcccccCchhhc
Q 012765          297 NWSHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSNFKELVDPRLAD  376 (457)
Q Consensus       297 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  376 (457)
                      .... ......||+.|+|||++.+..|+.++|||||||++|||++|..||.........+..  ....     ..+....
T Consensus       168 ~~~~-~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~--i~~~-----~~~~~~~  239 (287)
T d1opja_         168 DTYT-AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYEL--LEKD-----YRMERPE  239 (287)
T ss_dssp             SSSE-EETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHH--HHTT-----CCCCCCT
T ss_pred             CCce-eeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHH--HhcC-----CCCCCCc
Confidence            4322 223345889999999999999999999999999999999987776543222211111  0000     0111111


Q ss_pred             ccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCC
Q 012765          377 AYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQLLRGEG  415 (457)
Q Consensus       377 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~  415 (457)
                      .    ....+.+++.+||+.||++||||.||++.|+.+.
T Consensus       240 ~----~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~  274 (287)
T d1opja_         240 G----CPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF  274 (287)
T ss_dssp             T----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred             c----chHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence            1    2245778899999999999999999999998764

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-51  Score=395.82  Aligned_cols=248  Identities=21%  Similarity=0.348  Sum_probs=200.9

Q ss_pred             cCCCCCceecccCcEEEEEEEe-CCCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeee-cCceEEEE
Q 012765          142 DNFNSENLIGKGGHAEVYKGCL-PDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFST-ENGFHLVL  219 (457)
Q Consensus       142 ~~f~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~-~~~~~lv~  219 (457)
                      ++|++.+.||+|+||+||+|.+ .+|+.||||++.......   .+.+.+|+.++++++|||||++++++. ++.+++||
T Consensus        20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~---~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm   96 (293)
T d1yhwa1          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK---KELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM   96 (293)
T ss_dssp             TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSC---HHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChH---HHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEE
Confidence            5799999999999999999986 469999999986543332   357899999999999999999999655 45578999


Q ss_pred             EecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCCCCCC
Q 012765          220 QFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWS  299 (457)
Q Consensus       220 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~~~~  299 (457)
                      ||+++|+|.+++..  ..+++..+..++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||+++.+.....
T Consensus        97 Ey~~gg~L~~~~~~--~~l~~~~~~~i~~qi~~aL~yLH~---~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~  171 (293)
T d1yhwa1          97 EYLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS  171 (293)
T ss_dssp             ECCTTCBHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC
T ss_pred             EecCCCcHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHH---CCCcccCCcHHHeEECCCCcEeeccchhheeeccccc
Confidence            99999999998754  458999999999999999999999   8999999999999999999999999999988754332


Q ss_pred             ceeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhccccccCCcccccCchhhcccC
Q 012765          300 HHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSNFKELVDPRLADAYD  379 (457)
Q Consensus       300 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~  379 (457)
                        ......||+.|+|||++.+..|+.++|||||||++|||+||+.||.........+........   .+   .....+ 
T Consensus       172 --~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~---~~---~~~~~~-  242 (293)
T d1yhwa1         172 --KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTP---EL---QNPEKL-  242 (293)
T ss_dssp             --CBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSC---CC---SSGGGS-
T ss_pred             --cccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCC---CC---CCcccC-
Confidence              223456999999999999999999999999999999999999999865443322211111000   00   011112 


Q ss_pred             HHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 012765          380 LAEMKRAMLTASVCIHHLSTMRPQMTRVLQ  409 (457)
Q Consensus       380 ~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~  409 (457)
                         ...+.+++.+||+.||.+|||+.|+++
T Consensus       243 ---s~~~~~li~~~L~~dP~~R~s~~eil~  269 (293)
T d1yhwa1         243 ---SAIFRDFLNRCLDMDVEKRGSAKELLQ  269 (293)
T ss_dssp             ---CHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             ---CHHHHHHHHHHccCChhHCcCHHHHhc
Confidence               235667889999999999999999874

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.8e-52  Score=396.74  Aligned_cols=249  Identities=23%  Similarity=0.329  Sum_probs=198.3

Q ss_pred             ceecccCcEEEEEEEeC---CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeecCceEEEEEecCC
Q 012765          148 NLIGKGGHAEVYKGCLP---DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTENGFHLVLQFLPH  224 (457)
Q Consensus       148 ~~LG~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~lv~e~~~~  224 (457)
                      +.||+|+||+||+|.+.   .++.||||++...... ....+.|.+|+.+|++++|||||++++++..+..++||||+++
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~-~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~~~~lvmE~~~~   91 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAND-PALKDELLAEANVMQQLDNPYIVRMIGICEAESWMLVMEMAEL   91 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSSSEEEEEEEEEC------CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESSSEEEEEECCTT
T ss_pred             CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCC-HHHHHHHHHHHHHHHhCCCCCCceEEEEeccCCEEEEEEcCCC
Confidence            46999999999999754   3568999998654332 3345689999999999999999999999988889999999999


Q ss_pred             CChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCCCCCCcee-e
Q 012765          225 GSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSHHI-V  303 (457)
Q Consensus       225 gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~~~~~~~-~  303 (457)
                      |+|.+++... ..+++..++.|+.||+.||.|||+   .+|+||||||+|||++.++.+||+|||+++.+........ .
T Consensus        92 g~L~~~l~~~-~~l~~~~~~~i~~qi~~gl~ylH~---~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~  167 (277)
T d1xbba_          92 GPLNKYLQQN-RHVKDKNIIELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ  167 (277)
T ss_dssp             EEHHHHHHHC-TTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC-
T ss_pred             CcHHHHHhhc-cCCCHHHHHHHHHHHHHHHhhHHh---CCcccCCCcchhhcccccCcccccchhhhhhccccccccccc
Confidence            9999998653 458999999999999999999999   8999999999999999999999999999988755433322 2


Q ss_pred             ecccccccccChhccccCCCCcchhHHHHHHHHHHHHh-CCCCCCcCCcchhhhhccccccCCcccccCchhhcccCHHH
Q 012765          304 FPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELIT-GRRAVDSRRQSLVIWAKPLLQTSNFKELVDPRLADAYDLAE  382 (457)
Q Consensus       304 ~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLlt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~  382 (457)
                      ....||+.|||||++.+..++.++|||||||++|||+| |+.||............   .....     +......    
T Consensus       168 ~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i---~~~~~-----~~~p~~~----  235 (277)
T d1xbba_         168 THGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAML---EKGER-----MGCPAGC----  235 (277)
T ss_dssp             ---CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHH---HTTCC-----CCCCTTC----
T ss_pred             cccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHH---HcCCC-----CCCCccc----
Confidence            33568999999999999999999999999999999998 89999864432221111   11100     1111112    


Q ss_pred             HHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 012765          383 MKRAMLTASVCIHHLSTMRPQMTRVLQLLRG  413 (457)
Q Consensus       383 ~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~  413 (457)
                      ...+.+++.+||+.||++|||+.+|+++|+.
T Consensus       236 ~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~  266 (277)
T d1xbba_         236 PREMYDLMNLCWTYDVENRPGFAAVELRLRN  266 (277)
T ss_dssp             CHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred             CHHHHHHHHHHcCCCHhHCcCHHHHHHHhhC
Confidence            2356678899999999999999999998864

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.5e-52  Score=398.33  Aligned_cols=259  Identities=22%  Similarity=0.349  Sum_probs=197.7

Q ss_pred             hcCCCCCceecccCcEEEEEEEeCCC-----cEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeec-Cc
Q 012765          141 TDNFNSENLIGKGGHAEVYKGCLPDG-----EVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTE-NG  214 (457)
Q Consensus       141 ~~~f~~~~~LG~G~~g~Vy~~~~~~~-----~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-~~  214 (457)
                      .+.|+..++||+|+||+||+|.+...     ..||||++......  .....|++|+.++++++|||||++++++.+ +.
T Consensus         6 ~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~--~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~   83 (283)
T d1mqba_           6 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTE--KQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKP   83 (283)
T ss_dssp             TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCH--HHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred             HHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccCh--HHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCc
Confidence            35677889999999999999986532     47999998654332  345679999999999999999999997765 55


Q ss_pred             eEEEEEecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccC
Q 012765          215 FHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWL  294 (457)
Q Consensus       215 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~  294 (457)
                      .+++|||+.++++..++......+++..++.++.||+.||.|||+   .+|+||||||+||||+.++.+||+|||+++.+
T Consensus        84 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~---~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~  160 (283)
T d1mqba_          84 MMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLAN---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVL  160 (283)
T ss_dssp             EEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred             eEEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccc---cccccCccccceEEECCCCeEEEcccchhhcc
Confidence            789999999999999888777889999999999999999999999   89999999999999999999999999999877


Q ss_pred             CCCCCc-eeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhccccccCCcccccCch
Q 012765          295 PDNWSH-HIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSNFKELVDPR  373 (457)
Q Consensus       295 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~  373 (457)
                      ...... .......||+.|+|||++.++.++.++|||||||++|||++|..|+.........+..  ....         
T Consensus       161 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~--i~~~---------  229 (283)
T d1mqba_         161 EDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKA--INDG---------  229 (283)
T ss_dssp             -------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHH--HHTT---------
T ss_pred             cCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHHHHHHH--Hhcc---------
Confidence            543222 1223345899999999999999999999999999999999976665432221111110  0000         


Q ss_pred             hhcccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCC
Q 012765          374 LADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQLLRGEG  415 (457)
Q Consensus       374 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~  415 (457)
                      ............+.+++.+||+.||++||||.||++.|+.+.
T Consensus       230 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~  271 (283)
T d1mqba_         230 FRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLI  271 (283)
T ss_dssp             CCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred             CCCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHh
Confidence            001111122345778999999999999999999999998754

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.9e-52  Score=401.13  Aligned_cols=251  Identities=23%  Similarity=0.314  Sum_probs=200.2

Q ss_pred             cCCCCCceecccCcEEEEEEEeC-CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeec-CceEEEE
Q 012765          142 DNFNSENLIGKGGHAEVYKGCLP-DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTE-NGFHLVL  219 (457)
Q Consensus       142 ~~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-~~~~lv~  219 (457)
                      ++|++.+.||+|+||+||+|.+. +|+.||||++.+...........+.+|+.++++++||||+++++++.+ +.+++||
T Consensus         8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm   87 (288)
T d1uu3a_           8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL   87 (288)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred             CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence            67999999999999999999874 689999999875443333445679999999999999999999996655 4578999


Q ss_pred             EecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCCCCCC
Q 012765          220 QFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWS  299 (457)
Q Consensus       220 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~~~~  299 (457)
                      ||+++|+|.+++... ..+++..+..++.|++.||.|||+   .+|+||||||+|||+++++.+||+|||+++.+.....
T Consensus        88 Ey~~gg~L~~~~~~~-~~l~e~~~~~~~~qi~~al~ylH~---~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~  163 (288)
T d1uu3a_          88 SYAKNGELLKYIRKI-GSFDETCTRFYTAEIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESK  163 (288)
T ss_dssp             CCCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEECC----
T ss_pred             EccCCCCHHHhhhcc-CCCCHHHHHHHHHHHHHHHHhhcc---ccEEcCcCCccccccCCCceEEecccccceecccCCc
Confidence            999999999987543 458999999999999999999999   8999999999999999999999999999988765433


Q ss_pred             ceeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhccccccCCcccccCchhhcccC
Q 012765          300 HHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSNFKELVDPRLADAYD  379 (457)
Q Consensus       300 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~  379 (457)
                      ........||+.|+|||++.+..|+.++|||||||++|||++|+.||...+...... ........        +...++
T Consensus       164 ~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~-~i~~~~~~--------~p~~~s  234 (288)
T d1uu3a_         164 QARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQ-KIIKLEYD--------FPEKFF  234 (288)
T ss_dssp             ------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH-HHHTTCCC--------CCTTCC
T ss_pred             ccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHH-HHHcCCCC--------CCccCC
Confidence            333345679999999999999999999999999999999999999998654332211 10001111        111222


Q ss_pred             HHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 012765          380 LAEMKRAMLTASVCIHHLSTMRPQMTRVLQ  409 (457)
Q Consensus       380 ~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~  409 (457)
                          ..+.+++.+||+.||.+|||+.|++.
T Consensus       235 ----~~~~~li~~~L~~dP~~R~t~~e~~~  260 (288)
T d1uu3a_         235 ----PKARDLVEKLLVLDATKRLGCEEMEG  260 (288)
T ss_dssp             ----HHHHHHHHTTSCSSGGGSTTSGGGTC
T ss_pred             ----HHHHHHHHHHccCCHhHCcCHHHHcC
Confidence                34678899999999999999998744

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.2e-52  Score=404.46  Aligned_cols=256  Identities=23%  Similarity=0.395  Sum_probs=203.0

Q ss_pred             cCCCCCceecccCcEEEEEEEeC-CCc----EEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeecCceE
Q 012765          142 DNFNSENLIGKGGHAEVYKGCLP-DGE----VVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTENGFH  216 (457)
Q Consensus       142 ~~f~~~~~LG~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~  216 (457)
                      ++|++.++||+|+||+||+|.+. +|+    .||+|++.....  ....+.|.+|+.++++++|||||++++++.++..+
T Consensus         9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~   86 (317)
T d1xkka_           9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATS--PKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQ   86 (317)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC------CTHHHHHHHHHHHHHCCCTTBCCEEEEEESSSEE
T ss_pred             HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccC--HHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCee
Confidence            46889999999999999999864 444    588888754322  22356899999999999999999999999999999


Q ss_pred             EEEEecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCCC
Q 012765          217 LVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPD  296 (457)
Q Consensus       217 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~  296 (457)
                      +++||+.+|+|.+++......+++..++.++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||+++.+..
T Consensus        87 ~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~---~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~  163 (317)
T d1xkka_          87 LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA  163 (317)
T ss_dssp             EEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEETTEEEECCCSHHHHTTT
T ss_pred             EEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHH---cCcccCcchhhcceeCCCCCeEeeccccceeccc
Confidence            9999999999999998888889999999999999999999999   8999999999999999999999999999998765


Q ss_pred             CCCceeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHh-CCCCCCcCCcchhhhhccccccCCcccccCchhh
Q 012765          297 NWSHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELIT-GRRAVDSRRQSLVIWAKPLLQTSNFKELVDPRLA  375 (457)
Q Consensus       297 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLlt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  375 (457)
                      ...........||+.|+|||++.++.|+.++|||||||++|||+| |..||............   ....     .+...
T Consensus       164 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i---~~~~-----~~~~p  235 (317)
T d1xkka_         164 EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL---EKGE-----RLPQP  235 (317)
T ss_dssp             TCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHH---HHTC-----CCCCC
T ss_pred             ccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHH---HcCC-----CCCCC
Confidence            544433444568999999999999999999999999999999999 78888764332211110   0000     00011


Q ss_pred             cccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q 012765          376 DAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQLLRGE  414 (457)
Q Consensus       376 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~  414 (457)
                      ..    ....+.+++.+||+.||.+|||+.||++.|..+
T Consensus       236 ~~----~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~  270 (317)
T d1xkka_         236 PI----CTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM  270 (317)
T ss_dssp             TT----BCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             cc----cCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHH
Confidence            11    223567789999999999999999999988764

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.6e-52  Score=404.90  Aligned_cols=257  Identities=22%  Similarity=0.357  Sum_probs=202.1

Q ss_pred             hhcCCCCCceecccCcEEEEEEEeCC-C-----cEEEEEEEeccchhhHHHHHHHHHHHHHHhhc-CCCCcceeeeeeec
Q 012765          140 ATDNFNSENLIGKGGHAEVYKGCLPD-G-----EVVAVKKIIKNAKEDEERISDFLSELGIVAHI-NHPNAAKLIGFSTE  212 (457)
Q Consensus       140 ~~~~f~~~~~LG~G~~g~Vy~~~~~~-~-----~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~  212 (457)
                      ..++|++.+.||+|+||+||+|.+.. +     ..||+|.+.....  ......+.+|+.++.++ +|||||++++++.+
T Consensus        35 ~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~  112 (325)
T d1rjba_          35 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKAD--SSEREALMSELKMMTQLGSHENIVNLLGACTL  112 (325)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC--------CHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             CHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccC--HHHHHHHHHHHHHHHHhcCCCcEeEEEEEEee
Confidence            34678899999999999999998532 2     3689998865432  23356789999999998 89999999996654


Q ss_pred             -CceEEEEEecCCCChhhhhhcCC----------------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCC
Q 012765          213 -NGFHLVLQFLPHGSLSSLLFGST----------------------ECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRD  269 (457)
Q Consensus       213 -~~~~lv~e~~~~gsL~~~l~~~~----------------------~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrD  269 (457)
                       +..++||||+++|+|.++|....                      ..+++..++.++.||+.||.|||+   .+|||||
T Consensus       113 ~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~---~~IiHRD  189 (325)
T d1rjba_         113 SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRD  189 (325)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHH---TTEEETT
T ss_pred             CCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecc
Confidence             55789999999999999996543                      247889999999999999999999   8999999


Q ss_pred             CCCCcEEEcCCCcEEEeeccccccCCCCCCceeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHh-CCCCCCc
Q 012765          270 IKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELIT-GRRAVDS  348 (457)
Q Consensus       270 lkp~NIll~~~~~~kL~DFGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLlt-G~~pf~~  348 (457)
                      |||+|||++.++.+||+|||+++...............||+.|||||++.++.|+.++|||||||++|||+| |..||..
T Consensus       190 lKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~  269 (325)
T d1rjba_         190 LAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPG  269 (325)
T ss_dssp             CSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTT
T ss_pred             CchhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCC
Confidence            999999999999999999999987765544444445568999999999999999999999999999999998 8999986


Q ss_pred             CCcchhhhhccccccCCcccccCchhhcccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 012765          349 RRQSLVIWAKPLLQTSNFKELVDPRLADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQLLR  412 (457)
Q Consensus       349 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~  412 (457)
                      .......+..  ....     ..+.....    ....+.+++.+||+.||++|||+.||++.|.
T Consensus       270 ~~~~~~~~~~--~~~~-----~~~~~p~~----~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~  322 (325)
T d1rjba_         270 IPVDANFYKL--IQNG-----FKMDQPFY----ATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG  322 (325)
T ss_dssp             CCCSHHHHHH--HHTT-----CCCCCCTT----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             CCHHHHHHHH--HhcC-----CCCCCCCc----CCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence            4432221111  0000     00111111    2245678899999999999999999999985

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.3e-52  Score=397.38  Aligned_cols=265  Identities=23%  Similarity=0.338  Sum_probs=206.1

Q ss_pred             hcCCCCCceecccCcEEEEEEEeCCCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeecCceEEEEE
Q 012765          141 TDNFNSENLIGKGGHAEVYKGCLPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTENGFHLVLQ  220 (457)
Q Consensus       141 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~lv~e  220 (457)
                      .++|++.+.||+|+||+||+|.+++++.||||++......    .+.|.+|+.++++++|||||++++++.+++.++|||
T Consensus        16 ~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~~~----~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~lv~E   91 (285)
T d1fmka3          16 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS----PEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVTE   91 (285)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSC----HHHHHHHHHHHHHCCCTTBCCEEEEECSSSCEEEEC
T ss_pred             HHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcccCC----HHHHHHHHHHHHhcccCCEeEEEEEEecCCeEEEEE
Confidence            3678899999999999999999988889999998654332    247899999999999999999999998888999999


Q ss_pred             ecCCCChhhhhhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCCCCCC
Q 012765          221 FLPHGSLSSLLFGS-TECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWS  299 (457)
Q Consensus       221 ~~~~gsL~~~l~~~-~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~~~~  299 (457)
                      |+++|+|..++... ...++|..++.|+.||+.||.|||+   .+|+||||||+||||+.++.+||+|||+++.+.....
T Consensus        92 y~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~---~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~  168 (285)
T d1fmka3          92 YMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY  168 (285)
T ss_dssp             CCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCCTTC-------
T ss_pred             ecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhh---hheecccccceEEEECCCCcEEEcccchhhhccCCCc
Confidence            99999999888653 3468999999999999999999999   8999999999999999999999999999987654322


Q ss_pred             ceeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhccccccCCcccccCchhhcccC
Q 012765          300 HHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSNFKELVDPRLADAYD  379 (457)
Q Consensus       300 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~  379 (457)
                      . ......||+.|+|||++..+.++.++|||||||++|||+||..|+............ .....      .+.....  
T Consensus       169 ~-~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~-i~~~~------~~~~~~~--  238 (285)
T d1fmka3         169 T-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQ-VERGY------RMPCPPE--  238 (285)
T ss_dssp             --------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHH-HHTTC------CCCCCTT--
T ss_pred             e-eeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHH-HHhcC------CCCCCcc--
Confidence            2 223356899999999999999999999999999999999977666543222111111 00000      0111111  


Q ss_pred             HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCCCCCCCCCCC
Q 012765          380 LAEMKRAMLTASVCIHHLSTMRPQMTRVLQLLRGEGGQTDLKPKP  424 (457)
Q Consensus       380 ~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~~~~~~~~  424 (457)
                        ....+.+++.+||+.||++||+|.+|+++|+..-....++..|
T Consensus       239 --~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~~p~~~p  281 (285)
T d1fmka3         239 --CPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQP  281 (285)
T ss_dssp             --SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSCCCCCC
T ss_pred             --cCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCCCCCCCC
Confidence              2235678899999999999999999999999876554443333

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.9e-52  Score=406.44  Aligned_cols=261  Identities=22%  Similarity=0.316  Sum_probs=200.0

Q ss_pred             hhcCCCCCceecccCcEEEEEEEeC-CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeec-CceEE
Q 012765          140 ATDNFNSENLIGKGGHAEVYKGCLP-DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTE-NGFHL  217 (457)
Q Consensus       140 ~~~~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-~~~~l  217 (457)
                      ..++|++.+.||+|+||+||+|.+. +|+.||+|++......  .....+.+|+.+|+.++|||||++++++.+ +.+++
T Consensus         4 ~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~i   81 (322)
T d1s9ja_           4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKP--AIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISI   81 (322)
T ss_dssp             CGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCT--THHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEE
T ss_pred             CccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCH--HHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence            4578999999999999999999864 6899999998654332  234578999999999999999999996655 45789


Q ss_pred             EEEecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCCCC
Q 012765          218 VLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDN  297 (457)
Q Consensus       218 v~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~~  297 (457)
                      ||||+++|+|.+++... ..+++..+..++.||+.||.|||+.  .+|+||||||+|||++.++.+||+|||+|+.+...
T Consensus        82 VmEy~~gg~L~~~l~~~-~~l~~~~~~~~~~qil~aL~yLH~~--~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~  158 (322)
T d1s9ja_          82 CMEHMDGGSLDQVLKKA-GRIPEQILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS  158 (322)
T ss_dssp             EEECCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHH--HCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH
T ss_pred             EEEcCCCCcHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHh--CCEEccccCHHHeeECCCCCEEEeeCCCccccCCC
Confidence            99999999999999653 3589999999999999999999972  38999999999999999999999999999876433


Q ss_pred             CCceeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhccccccCCcc----------
Q 012765          298 WSHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSNFK----------  367 (457)
Q Consensus       298 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~----------  367 (457)
                      .    .....||+.|+|||++.+..|+.++|||||||++|||++|+.||...+.................          
T Consensus       159 ~----~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (322)
T d1s9ja_         159 M----ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPG  234 (322)
T ss_dssp             T----C---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC-------------------
T ss_pred             c----cccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCccccccc
Confidence            2    22356999999999999999999999999999999999999999864432211110000000000          


Q ss_pred             -----cccCch------------h----hcccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 012765          368 -----ELVDPR------------L----ADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQ  409 (457)
Q Consensus       368 -----~~~d~~------------l----~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~  409 (457)
                           ...+..            .    ...........+.+++.+||+.||.+|||+.|+++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~  297 (322)
T d1s9ja_         235 RPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV  297 (322)
T ss_dssp             -----------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             ccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence                 000000            0    00000011245778899999999999999999987

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.6e-51  Score=388.21  Aligned_cols=245  Identities=24%  Similarity=0.357  Sum_probs=193.6

Q ss_pred             CCCceecccCcEEEEEEEeC-CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeec-----CceEEE
Q 012765          145 NSENLIGKGGHAEVYKGCLP-DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTE-----NGFHLV  218 (457)
Q Consensus       145 ~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-----~~~~lv  218 (457)
                      ...+.||+|+||+||+|.+. +++.||+|++..... .....+.+.+|+++|++++|||||++++++.+     ..+++|
T Consensus        12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~-~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~iv   90 (270)
T d1t4ha_          12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKL-TKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV   90 (270)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEE
T ss_pred             EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhC-CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEE
Confidence            45678999999999999865 588999999875433 23446689999999999999999999997643     236899


Q ss_pred             EEecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC--eeeCCCCCCcEEEc-CCCcEEEeeccccccCC
Q 012765          219 LQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRR--IIHRDIKASNILLS-EDYEAQISDFGLAKWLP  295 (457)
Q Consensus       219 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~--iiHrDlkp~NIll~-~~~~~kL~DFGl~~~~~  295 (457)
                      |||+++|+|.+++... ..+++..+..++.||+.||.|||+   .+  |+||||||+|||++ .++.+||+|||+++...
T Consensus        91 mE~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~gl~yLH~---~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~  166 (270)
T d1t4ha_          91 TELMTSGTLKTYLKRF-KVMKIKVLRSWCRQILKGLQFLHT---RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR  166 (270)
T ss_dssp             EECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHT---SSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred             EeCCCCCcHHHHHhcc-ccccHHHHHHHHHHHHHHHHHHHH---CCCCEEeCCcChhhceeeCCCCCEEEeecCcceecc
Confidence            9999999999998643 458999999999999999999999   66  99999999999997 57899999999998654


Q ss_pred             CCCCceeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhccccccCCcccccCchhh
Q 012765          296 DNWSHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSNFKELVDPRLA  375 (457)
Q Consensus       296 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  375 (457)
                      ...    .....||+.|||||++.+ .|+.++|||||||++|||++|+.||.........+... .. ..    ..+.+.
T Consensus       167 ~~~----~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i-~~-~~----~~~~~~  235 (270)
T d1t4ha_         167 ASF----AKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRV-TS-GV----KPASFD  235 (270)
T ss_dssp             TTS----BEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHH-TT-TC----CCGGGG
T ss_pred             CCc----cCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHH-Hc-CC----CCcccC
Confidence            432    234569999999998865 69999999999999999999999997644332222111 10 00    011111


Q ss_pred             cccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 012765          376 DAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQ  409 (457)
Q Consensus       376 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~  409 (457)
                      ....    ..+.+++.+||+.||++|||+.|+++
T Consensus       236 ~~~~----~~~~~li~~~l~~dp~~R~s~~ell~  265 (270)
T d1t4ha_         236 KVAI----PEVKEIIEGCIRQNKDERYSIKDLLN  265 (270)
T ss_dssp             GCCC----HHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             ccCC----HHHHHHHHHHccCCHhHCcCHHHHhC
Confidence            1222    24667889999999999999999976

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-51  Score=394.71  Aligned_cols=250  Identities=25%  Similarity=0.358  Sum_probs=199.5

Q ss_pred             cCCCCCceecccCcEEEEEEEeC-CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeee-cCceEEEE
Q 012765          142 DNFNSENLIGKGGHAEVYKGCLP-DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFST-ENGFHLVL  219 (457)
Q Consensus       142 ~~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~-~~~~~lv~  219 (457)
                      +.|++.+.||+|+||+||+|.+. +|+.||+|++......   ..+.+.+|+.+|++++|||||++++++. ++..++||
T Consensus        12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~---~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvm   88 (288)
T d2jfla1          12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEE---ELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILI   88 (288)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSG---GGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHH---HHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEE
Confidence            56888999999999999999864 6899999998654332   2457889999999999999999999655 45678999


Q ss_pred             EecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCCCCCC
Q 012765          220 QFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWS  299 (457)
Q Consensus       220 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~~~~  299 (457)
                      ||+++|+|..++......+++..+..++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||+++...... 
T Consensus        89 Ey~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~---~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~-  164 (288)
T d2jfla1          89 EFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHD---NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI-  164 (288)
T ss_dssp             ECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECHHHH-
T ss_pred             ecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCEEEeecChhheeECCCCCEEEEechhhhccCCCc-
Confidence            9999999999987666779999999999999999999999   899999999999999999999999999997653321 


Q ss_pred             ceeeecccccccccChhccc-----cCCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhccccccCCcccccCchh
Q 012765          300 HHIVFPIEGTFGYLSPEYFM-----HGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSNFKELVDPRL  374 (457)
Q Consensus       300 ~~~~~~~~gt~~y~aPE~~~-----~~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l  374 (457)
                       .......||+.|+|||++.     +..|+.++|||||||++|||+||+.||.............   ......+..+  
T Consensus       165 -~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~---~~~~~~~~~~--  238 (288)
T d2jfla1         165 -QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIA---KSEPPTLAQP--  238 (288)
T ss_dssp             -HHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHH---HSCCCCCSSG--
T ss_pred             -ccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHH---cCCCCCCCcc--
Confidence             1122456999999999984     4568999999999999999999999998654332221110   0000111111  


Q ss_pred             hcccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 012765          375 ADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQ  409 (457)
Q Consensus       375 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~  409 (457)
                       ..    ....+.+++.+||+.||.+|||+.|+++
T Consensus       239 -~~----~s~~~~~li~~~L~~dp~~R~t~~ell~  268 (288)
T d2jfla1         239 -SR----WSSNFKDFLKKCLEKNVDARWTTSQLLQ  268 (288)
T ss_dssp             -GG----SCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             -cc----CCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence             11    1235667889999999999999999875

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1e-50  Score=394.22  Aligned_cols=247  Identities=26%  Similarity=0.385  Sum_probs=200.3

Q ss_pred             cCCCCCceecccCcEEEEEEEe-CCCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeec-CceEEEE
Q 012765          142 DNFNSENLIGKGGHAEVYKGCL-PDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTE-NGFHLVL  219 (457)
Q Consensus       142 ~~f~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-~~~~lv~  219 (457)
                      +.|+..+.||+|+||+||+|.+ .+|+.||||++...........+.+.+|+.+|++++|||||++++++.+ +..++||
T Consensus        15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~   94 (309)
T d1u5ra_          15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM   94 (309)
T ss_dssp             HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEE
Confidence            3488899999999999999986 4689999999977665555667789999999999999999999997654 5578999


Q ss_pred             EecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCCCCCC
Q 012765          220 QFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWS  299 (457)
Q Consensus       220 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~~~~  299 (457)
                      ||+.+|+|..++.. ...+++..++.++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||++......  
T Consensus        95 E~~~~g~l~~~~~~-~~~l~e~~~~~i~~qi~~aL~yLH~---~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~~--  168 (309)
T d1u5ra_          95 EYCLGSASDLLEVH-KKPLQEVEIAAVTHGALQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA--  168 (309)
T ss_dssp             ECCSEEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB--
T ss_pred             EecCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHh---CCEeccCCCcceEEECCCCCEEEeecccccccCCC--
Confidence            99999988766543 4568999999999999999999999   89999999999999999999999999999876442  


Q ss_pred             ceeeecccccccccChhcccc---CCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhccccccCCcccccCchhhc
Q 012765          300 HHIVFPIEGTFGYLSPEYFMH---GIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSNFKELVDPRLAD  376 (457)
Q Consensus       300 ~~~~~~~~gt~~y~aPE~~~~---~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  376 (457)
                          ....||+.|||||++.+   +.|+.++|||||||++|||++|+.||.........+...   ......+..    .
T Consensus       169 ----~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~---~~~~~~~~~----~  237 (309)
T d1u5ra_         169 ----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIA---QNESPALQS----G  237 (309)
T ss_dssp             ----CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHH---HSCCCCCSC----T
T ss_pred             ----CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHH---hCCCCCCCC----C
Confidence                23459999999999864   468999999999999999999999998644332221111   011111111    1


Q ss_pred             ccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 012765          377 AYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQ  409 (457)
Q Consensus       377 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~  409 (457)
                      .+    ...+.+++.+||+.||.+|||+.|+++
T Consensus       238 ~~----s~~~~~li~~~L~~dP~~Rpt~~ell~  266 (309)
T d1u5ra_         238 HW----SEYFRNFVDSCLQKIPQDRPTSEVLLK  266 (309)
T ss_dssp             TS----CHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             CC----CHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence            12    235667889999999999999999986

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-51  Score=392.55  Aligned_cols=259  Identities=25%  Similarity=0.369  Sum_probs=200.6

Q ss_pred             cCCCCCceecccCcEEEEEEEeC--CC--cEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeecCceEE
Q 012765          142 DNFNSENLIGKGGHAEVYKGCLP--DG--EVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTENGFHL  217 (457)
Q Consensus       142 ~~f~~~~~LG~G~~g~Vy~~~~~--~~--~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~l  217 (457)
                      ++|++.+.||+|+||+||+|.+.  ++  ..||||++.+.........+.|.+|+.+|++++|||||++++++.++..++
T Consensus         8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~~~~~l   87 (273)
T d1u46a_           8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPPMKM   87 (273)
T ss_dssp             GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCEE
T ss_pred             HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeecchhe
Confidence            56888999999999999999753  23  368999887654444455678999999999999999999999998888999


Q ss_pred             EEEecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCCCC
Q 012765          218 VLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDN  297 (457)
Q Consensus       218 v~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~~  297 (457)
                      ||||+++|++.+++......+++..++.++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||+++.+...
T Consensus        88 v~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~---~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~~  164 (273)
T d1u46a_          88 VTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQN  164 (273)
T ss_dssp             EEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEEEETTEEEECCCTTCEECCC-
T ss_pred             eeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhh---CCEeeeeecHHHhccccccceeeccchhhhhcccC
Confidence            999999999999887766779999999999999999999999   89999999999999999999999999999987655


Q ss_pred             CCceee-ecccccccccChhccccCCCCcchhHHHHHHHHHHHHh-CCCCCCcCCcchhhhhccccccCCcccccCchhh
Q 012765          298 WSHHIV-FPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELIT-GRRAVDSRRQSLVIWAKPLLQTSNFKELVDPRLA  375 (457)
Q Consensus       298 ~~~~~~-~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLlt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  375 (457)
                      ...... ....||..|+|||++.+..++.++|||||||++|||+| |+.||............  .....     .+...
T Consensus       165 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i--~~~~~-----~~~~~  237 (273)
T d1u46a_         165 DDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKI--DKEGE-----RLPRP  237 (273)
T ss_dssp             CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHH--HTSCC-----CCCCC
T ss_pred             CCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHH--HhCCC-----CCCCc
Confidence            433222 23457889999999999999999999999999999998 89999865443322111  11110     01111


Q ss_pred             cccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q 012765          376 DAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQLLRGE  414 (457)
Q Consensus       376 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~  414 (457)
                      ..++    ..+.+++.+||+.||++||||.+|++.|++.
T Consensus       238 ~~~~----~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~  272 (273)
T d1u46a_         238 EDCP----QDIYNVMVQCWAHKPEDRPTFVALRDFLLEA  272 (273)
T ss_dssp             TTCC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             cccc----HHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence            1122    3567899999999999999999999999764

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.9e-51  Score=390.24  Aligned_cols=256  Identities=23%  Similarity=0.334  Sum_probs=198.0

Q ss_pred             hcCCCCCceecccCcEEEEEEEeCC----CcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeecCceE
Q 012765          141 TDNFNSENLIGKGGHAEVYKGCLPD----GEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTENGFH  216 (457)
Q Consensus       141 ~~~f~~~~~LG~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~  216 (457)
                      .++|++.+.||+|+||+||+|.+..    +..||||.+....  .......+.+|+.++++++|||||++++++.++.++
T Consensus         6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~   83 (273)
T d1mp8a_           6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT--SDSVREKFLQEALTMRQFDHPHIVKLIGVITENPVW   83 (273)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTT--SHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSCE
T ss_pred             HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEecccc--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCeEE
Confidence            4678899999999999999998642    3468888775432  334466899999999999999999999999888899


Q ss_pred             EEEEecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCCC
Q 012765          217 LVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPD  296 (457)
Q Consensus       217 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~  296 (457)
                      +||||+++|+|..++......+++..++.++.||+.||.|||+   .+|+||||||+||+++.++.+||+|||+++.+..
T Consensus        84 iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~---~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~  160 (273)
T d1mp8a_          84 IIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED  160 (273)
T ss_dssp             EEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECC---------
T ss_pred             EEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcc---cCeeccccchhheeecCCCcEEEccchhheeccC
Confidence            9999999999999987777789999999999999999999999   8999999999999999999999999999987654


Q ss_pred             CCCceeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHh-CCCCCCcCCcchhhhhccccccCCcccccCchhh
Q 012765          297 NWSHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELIT-GRRAVDSRRQSLVIWAKPLLQTSNFKELVDPRLA  375 (457)
Q Consensus       297 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLlt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  375 (457)
                      .... ......||+.|+|||++.+..|+.++|||||||++|||+| |..||............  . ....     +.+.
T Consensus       161 ~~~~-~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i--~-~~~~-----~~~~  231 (273)
T d1mp8a_         161 STYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI--E-NGER-----LPMP  231 (273)
T ss_dssp             -----------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHH--H-TTCC-----CCCC
T ss_pred             Ccce-eccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHH--H-cCCC-----CCCC
Confidence            3222 2234558999999999999999999999999999999998 89999865443222111  1 1100     1111


Q ss_pred             cccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q 012765          376 DAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQLLRGE  414 (457)
Q Consensus       376 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~  414 (457)
                      ...    ...+.+++.+||+.||++|||+.||++.|+.+
T Consensus       232 ~~~----~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i  266 (273)
T d1mp8a_         232 PNC----PPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI  266 (273)
T ss_dssp             TTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCC----CHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence            122    24567889999999999999999999988765

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.3e-50  Score=392.67  Aligned_cols=263  Identities=23%  Similarity=0.363  Sum_probs=209.1

Q ss_pred             HHHHhhcCCCCCceecccCcEEEEEEEeC------CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeee
Q 012765          136 ELAAATDNFNSENLIGKGGHAEVYKGCLP------DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGF  209 (457)
Q Consensus       136 ~~~~~~~~f~~~~~LG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~  209 (457)
                      +++...++|++.+.||+|+||+||+|.+.      +++.||||++.....  .....+|.+|+.++++++||||++++++
T Consensus         7 ~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~--~~~~~~~~~E~~il~~l~h~niv~~~~~   84 (301)
T d1lufa_           7 SLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEAS--ADMQADFQREAALMAEFDNPNIVKLLGV   84 (301)
T ss_dssp             HTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCC--HHHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred             hccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcC--hHHHHHHHHHHHHHHhcCCCCcccceee
Confidence            34446788999999999999999999853      457899999865433  3445689999999999999999999996


Q ss_pred             eec-CceEEEEEecCCCChhhhhhcCC-----------------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCe
Q 012765          210 STE-NGFHLVLQFLPHGSLSSLLFGST-----------------------ECLEWTIRYKIALGIAEGLQYLHHDCHRRI  265 (457)
Q Consensus       210 ~~~-~~~~lv~e~~~~gsL~~~l~~~~-----------------------~~~~~~~~~~i~~qia~aL~yLH~~~~~~i  265 (457)
                      +.. +..+++|||+++|+|.+++....                       ..+++..++.|+.||+.||.|||+   .+|
T Consensus        85 ~~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~---~~i  161 (301)
T d1lufa_          85 CAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE---RKF  161 (301)
T ss_dssp             ECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHH---TTC
T ss_pred             eccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhccc---CCe
Confidence            654 56789999999999999985422                       247889999999999999999999   899


Q ss_pred             eeCCCCCCcEEEcCCCcEEEeeccccccCCCCCCceeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHhCC-C
Q 012765          266 IHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGR-R  344 (457)
Q Consensus       266 iHrDlkp~NIll~~~~~~kL~DFGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLltG~-~  344 (457)
                      |||||||+|||++.++.+||+|||+++.+.............||+.|+|||.+.+..|+.++|||||||++|||++|. .
T Consensus       162 vHrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~  241 (301)
T d1lufa_         162 VHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQ  241 (301)
T ss_dssp             CCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCC
T ss_pred             EeeEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCC
Confidence            999999999999999999999999998775543333344566899999999999999999999999999999999986 5


Q ss_pred             CCCcCCcchhhhhccccccCCcccccCchhhcccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCC
Q 012765          345 AVDSRRQSLVIWAKPLLQTSNFKELVDPRLADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQLLRGEG  415 (457)
Q Consensus       345 pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~  415 (457)
                      ||............   ......     ......    ...+.+++.+||+.+|++||||.||+++|+.+.
T Consensus       242 p~~~~~~~e~~~~v---~~~~~~-----~~p~~~----~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~  300 (301)
T d1lufa_         242 PYYGMAHEEVIYYV---RDGNIL-----ACPENC----PLELYNLMRLCWSKLPADRPSFCSIHRILQRMC  300 (301)
T ss_dssp             TTTTSCHHHHHHHH---HTTCCC-----CCCTTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred             CCCCCCHHHHHHHH---HcCCCC-----CCCccc----hHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence            67764433322211   111111     111122    235678899999999999999999999999875

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=3.2e-50  Score=397.19  Aligned_cols=252  Identities=19%  Similarity=0.240  Sum_probs=203.9

Q ss_pred             hcCCCCCceecccCcEEEEEEEeC-CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeee-cCceEEE
Q 012765          141 TDNFNSENLIGKGGHAEVYKGCLP-DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFST-ENGFHLV  218 (457)
Q Consensus       141 ~~~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~-~~~~~lv  218 (457)
                      .++|++.+.||+|+||+||+|.+. +|+.||||++.....   ...+.+.+|+.+|++++|||||++++++. ++.+++|
T Consensus        25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~---~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv  101 (350)
T d1koaa2          25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHE---SDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMI  101 (350)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSH---HHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEE
T ss_pred             ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccch---hhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence            368999999999999999999864 699999999865433   23467899999999999999999999655 4567899


Q ss_pred             EEecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcC--CCcEEEeeccccccCCC
Q 012765          219 LQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSE--DYEAQISDFGLAKWLPD  296 (457)
Q Consensus       219 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~--~~~~kL~DFGl~~~~~~  296 (457)
                      |||+++|+|.+++......+++..+..|+.||+.||.|||+   .+||||||||+|||++.  ++.+||+|||+++.+..
T Consensus       102 mE~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~---~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~  178 (350)
T d1koaa2         102 YEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHE---NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP  178 (350)
T ss_dssp             ECCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCT
T ss_pred             EEcCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHh---cCCeeeeechhHeeeccCCCCeEEEeecchheeccc
Confidence            99999999999997666779999999999999999999999   89999999999999964  57899999999988765


Q ss_pred             CCCceeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhccccccCCcccccCchhhc
Q 012765          297 NWSHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSNFKELVDPRLAD  376 (457)
Q Consensus       297 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  376 (457)
                      ...   .....||+.|||||++.+..|+.++|||||||++|||++|+.||.+.......... .......    +.....
T Consensus       179 ~~~---~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i-~~~~~~~----~~~~~~  250 (350)
T d1koaa2         179 KQS---VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNV-KSCDWNM----DDSAFS  250 (350)
T ss_dssp             TSC---EEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH-HHTCCCS----CCGGGG
T ss_pred             ccc---cceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHH-HhCCCCC----Cccccc
Confidence            432   23456999999999999999999999999999999999999999865432211110 0000010    111111


Q ss_pred             ccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 012765          377 AYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQL  410 (457)
Q Consensus       377 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~  410 (457)
                      .++    ..+.+++.+||+.||++|||+.|+++.
T Consensus       251 ~~s----~~~~~li~~~L~~dP~~R~t~~eil~h  280 (350)
T d1koaa2         251 GIS----EDGKDFIRKLLLADPNTRMTIHQALEH  280 (350)
T ss_dssp             GCC----HHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred             CCC----HHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            222    346678899999999999999999883

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=6.9e-50  Score=395.14  Aligned_cols=251  Identities=22%  Similarity=0.224  Sum_probs=203.9

Q ss_pred             hcCCCCCceecccCcEEEEEEEe-CCCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeec-CceEEE
Q 012765          141 TDNFNSENLIGKGGHAEVYKGCL-PDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTE-NGFHLV  218 (457)
Q Consensus       141 ~~~f~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-~~~~lv  218 (457)
                      .++|++.+.||+|+||+||+|.+ .+|+.||||++......   ....+.+|+.+|++++|||||++++++.+ +.+++|
T Consensus        28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~---~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv  104 (352)
T d1koba_          28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPL---DKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLI  104 (352)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHH---HHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEE
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchh---HHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence            36799999999999999999986 46999999998755432   23578899999999999999999996655 557899


Q ss_pred             EEecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEc--CCCcEEEeeccccccCCC
Q 012765          219 LQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLS--EDYEAQISDFGLAKWLPD  296 (457)
Q Consensus       219 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~--~~~~~kL~DFGl~~~~~~  296 (457)
                      |||+++|+|.+++......+++..++.|+.||+.||.|||+   .+|+||||||+||||+  .++.+||+|||++..+..
T Consensus       105 mE~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~---~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~  181 (352)
T d1koba_         105 LEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHE---HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNP  181 (352)
T ss_dssp             EECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCT
T ss_pred             EEcCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecccccccccccccCCCeEEEeecccceecCC
Confidence            99999999999887766779999999999999999999999   8999999999999998  578999999999998765


Q ss_pred             CCCceeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhccccccCCcccccCchhhc
Q 012765          297 NWSHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSNFKELVDPRLAD  376 (457)
Q Consensus       297 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  376 (457)
                      ...   .....||+.|+|||++.+..|+.++|||||||++|||+||+.||.+........... .....+.    .....
T Consensus       182 ~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~-~~~~~~~----~~~~~  253 (352)
T d1koba_         182 DEI---VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVK-RCDWEFD----EDAFS  253 (352)
T ss_dssp             TSC---EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHH-HCCCCCC----SSTTT
T ss_pred             CCc---eeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH-hCCCCCC----ccccc
Confidence            432   234569999999999999999999999999999999999999998654432211110 0001111    11111


Q ss_pred             ccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 012765          377 AYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQ  409 (457)
Q Consensus       377 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~  409 (457)
                      .+    ...+.+++.+||+.||.+|||+.|+++
T Consensus       254 ~~----s~~~~~li~~~L~~dp~~R~s~~eil~  282 (352)
T d1koba_         254 SV----SPEAKDFIKNLLQKEPRKRLTVHDALE  282 (352)
T ss_dssp             TS----CHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             CC----CHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            12    235667899999999999999999987

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=2.4e-50  Score=391.43  Aligned_cols=252  Identities=24%  Similarity=0.328  Sum_probs=186.2

Q ss_pred             hhcCCCCCceecccCcEEEEEEEeC-CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeecC-ceEE
Q 012765          140 ATDNFNSENLIGKGGHAEVYKGCLP-DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTEN-GFHL  217 (457)
Q Consensus       140 ~~~~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~-~~~l  217 (457)
                      ..+.|++.+.||+|+||+||+|.+. +|+.||||++.+.....  ....+.+|+.+|+.++|||||++++++.++ .+++
T Consensus         7 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~--~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l   84 (307)
T d1a06a_           7 IRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEG--KEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYL   84 (307)
T ss_dssp             GGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC------------CHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred             CccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhh--HHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence            3567999999999999999999865 68999999987544332  235688999999999999999999966554 5789


Q ss_pred             EEEecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEc---CCCcEEEeeccccccC
Q 012765          218 VLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLS---EDYEAQISDFGLAKWL  294 (457)
Q Consensus       218 v~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~---~~~~~kL~DFGl~~~~  294 (457)
                      ||||+++|+|.+++.. ...+++..+..++.||+.||.|||+   .+|+||||||+|||+.   .++.+||+|||+++..
T Consensus        85 vmE~~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~al~ylH~---~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~  160 (307)
T d1a06a_          85 IMQLVSGGELFDRIVE-KGFYTERDASRLIFQVLDAVKYLHD---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKME  160 (307)
T ss_dssp             EECCCCSCBHHHHHHT-CSCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESSSSTTCCEEECCC------
T ss_pred             EEeccCCCcHHHhhhc-ccCCCHHHHHHHHHHHHHHHHhhhh---ceeeeEEecccceeecccCCCceEEEeccceeEEc
Confidence            9999999999999964 4568999999999999999999999   8999999999999995   5789999999999876


Q ss_pred             CCCCCceeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhccccccCCcccccCchh
Q 012765          295 PDNWSHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSNFKELVDPRL  374 (457)
Q Consensus       295 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l  374 (457)
                      .....   .....||+.|||||++.+..|+.++|||||||++|||++|+.||.......... ........+    ....
T Consensus       161 ~~~~~---~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~-~i~~~~~~~----~~~~  232 (307)
T d1a06a_         161 DPGSV---LSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFE-QILKAEYEF----DSPY  232 (307)
T ss_dssp             ---------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH-HHHTTCCCC----CTTT
T ss_pred             cCCCe---eeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHH-HHhccCCCC----CCcc
Confidence            54322   234569999999999999999999999999999999999999998654322211 110111111    1111


Q ss_pred             hcccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 012765          375 ADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQ  409 (457)
Q Consensus       375 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~  409 (457)
                      ...+    ...+.+++.+||+.||++|||+.|+++
T Consensus       233 ~~~~----s~~~~~li~~~L~~dP~~R~s~~eil~  263 (307)
T d1a06a_         233 WDDI----SDSAKDFIRHLMEKDPEKRFTCEQALQ  263 (307)
T ss_dssp             TTTS----CHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             ccCC----CHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence            1112    235678899999999999999999988

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-50  Score=384.97  Aligned_cols=249  Identities=28%  Similarity=0.400  Sum_probs=195.5

Q ss_pred             hcCCCCCceecccCcEEEEEEEeCCCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeec--CceEEE
Q 012765          141 TDNFNSENLIGKGGHAEVYKGCLPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTE--NGFHLV  218 (457)
Q Consensus       141 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~--~~~~lv  218 (457)
                      .++|++.+.||+|+||.||+|.+ .|+.||||++....     ..+.+.+|++++++++||||+++++++.+  +.+++|
T Consensus         6 ~~~~~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~i~~~~-----~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv   79 (262)
T d1byga_           6 MKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIV   79 (262)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCCC-------HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEE
T ss_pred             HHHeEEeEEEecCCCeEEEEEEE-CCeEEEEEEECcHH-----HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEE
Confidence            35677889999999999999998 57899999986432     23578999999999999999999997754  447899


Q ss_pred             EEecCCCChhhhhhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCCCC
Q 012765          219 LQFLPHGSLSSLLFGST-ECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDN  297 (457)
Q Consensus       219 ~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~~  297 (457)
                      |||+++|+|.+++.... ..+++..++.|+.||+.||.|||+   .+|+||||||+|||++.++.+||+|||+++.....
T Consensus        80 ~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~---~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~  156 (262)
T d1byga_          80 TEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST  156 (262)
T ss_dssp             ECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTSCEEECCCCC-------
T ss_pred             EeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhcccccc---CceeccccchHhheecCCCCEeecccccceecCCC
Confidence            99999999999996533 358999999999999999999999   89999999999999999999999999999866443


Q ss_pred             CCceeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHh-CCCCCCcCCcchhhhhccccccCCcccccCchhhc
Q 012765          298 WSHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELIT-GRRAVDSRRQSLVIWAKPLLQTSNFKELVDPRLAD  376 (457)
Q Consensus       298 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLlt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  376 (457)
                      .     ....+|..|+|||++.++.++.++|||||||++|||+| |+.||.............   ..     ..+.+..
T Consensus       157 ~-----~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~---~~-----~~~~~~~  223 (262)
T d1byga_         157 Q-----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE---KG-----YKMDAPD  223 (262)
T ss_dssp             ----------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHT---TT-----CCCCCCT
T ss_pred             C-----ccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHH---cC-----CCCCCCc
Confidence            2     22347899999999999999999999999999999998 688877644332221111   01     1111111


Q ss_pred             ccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCC
Q 012765          377 AYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQLLRGEG  415 (457)
Q Consensus       377 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~  415 (457)
                      ..    ...+.+++.+||+.||.+||||.+|++.|+.++
T Consensus       224 ~~----~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~  258 (262)
T d1byga_         224 GC----PPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIK  258 (262)
T ss_dssp             TC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             cC----CHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHH
Confidence            22    235668899999999999999999999998753

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-49  Score=384.58  Aligned_cols=253  Identities=23%  Similarity=0.254  Sum_probs=201.7

Q ss_pred             hcCCCCCceecccCcEEEEEEEe-CCCcEEEEEEEeccchhh---HHHHHHHHHHHHHHhhcCCCCcceeeeeeecC-ce
Q 012765          141 TDNFNSENLIGKGGHAEVYKGCL-PDGEVVAVKKIIKNAKED---EERISDFLSELGIVAHINHPNAAKLIGFSTEN-GF  215 (457)
Q Consensus       141 ~~~f~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~-~~  215 (457)
                      .++|++.+.||+|+||+||+|.+ .+|+.||||++.+.....   ....+.+.+|+.+|++++|||||++++++.+. .+
T Consensus         9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~   88 (293)
T d1jksa_           9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV   88 (293)
T ss_dssp             GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence            46799999999999999999987 469999999986543221   11246789999999999999999999966554 46


Q ss_pred             EEEEEecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCC----cEEEeecccc
Q 012765          216 HLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDY----EAQISDFGLA  291 (457)
Q Consensus       216 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~----~~kL~DFGl~  291 (457)
                      ++||||+++|+|.+++... ..+++..+..++.||+.||.|||+   .+|+||||||+|||++.++    .+||+|||++
T Consensus        89 ~iv~E~~~gg~L~~~i~~~-~~l~~~~~~~~~~qi~~al~yLH~---~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a  164 (293)
T d1jksa_          89 ILILELVAGGELFDFLAEK-ESLTEEEATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA  164 (293)
T ss_dssp             EEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCSSSSSCCEEECCCTTC
T ss_pred             EEEEEcCCCccccchhccc-cccchhHHHHHHHHHHHHHHhhhh---cceeecccccceEEEecCCCcccceEecchhhh
Confidence            8999999999999998653 468999999999999999999999   8999999999999998776    4999999999


Q ss_pred             ccCCCCCCceeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhccccccCCcccccC
Q 012765          292 KWLPDNWSHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSNFKELVD  371 (457)
Q Consensus       292 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d  371 (457)
                      ..+.....   .....||+.|+|||++.+..++.++|||||||++|||++|+.||.+........... .....    ..
T Consensus       165 ~~~~~~~~---~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~-~~~~~----~~  236 (293)
T d1jksa_         165 HKIDFGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVS-AVNYE----FE  236 (293)
T ss_dssp             EECTTSCB---CSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH-TTCCC----CC
T ss_pred             hhcCCCcc---ccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHH-hcCCC----CC
Confidence            88754432   234568999999999999999999999999999999999999998654332221110 00000    01


Q ss_pred             chhhcccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 012765          372 PRLADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQ  409 (457)
Q Consensus       372 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~  409 (457)
                      +......    ...+.+++.+||+.||++|||+.|+++
T Consensus       237 ~~~~~~~----s~~~~~li~~~L~~dP~~R~s~~eil~  270 (293)
T d1jksa_         237 DEYFSNT----SALAKDFIRRLLVKDPKKRMTIQDSLQ  270 (293)
T ss_dssp             HHHHTTS----CHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             chhcCCC----CHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            1111122    235667899999999999999999986

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=1.3e-49  Score=381.05  Aligned_cols=261  Identities=21%  Similarity=0.268  Sum_probs=202.1

Q ss_pred             hcCCCCCceecccCcEEEEEEEe-CCCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeecC-c----
Q 012765          141 TDNFNSENLIGKGGHAEVYKGCL-PDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTEN-G----  214 (457)
Q Consensus       141 ~~~f~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~-~----  214 (457)
                      .++|++.+.||+|+||+||+|.+ .+|+.||||++......+......+.+|+.+++.++|||||++++++... .    
T Consensus         6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~   85 (277)
T d1o6ya_           6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL   85 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred             cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence            47799999999999999999986 47999999999776665566677899999999999999999999965432 2    


Q ss_pred             eEEEEEecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccC
Q 012765          215 FHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWL  294 (457)
Q Consensus       215 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~  294 (457)
                      +++||||+++++|..++... ..+++..+..++.||+.||.|||+   .+|+||||||+|||++.++.++|+|||++...
T Consensus        86 ~~lvmE~~~g~~L~~~~~~~-~~l~~~~~~~i~~qi~~al~~lH~---~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~  161 (277)
T d1o6ya_          86 PYIVMEYVDGVTLRDIVHTE-GPMTPKRAIEVIADACQALNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIARAI  161 (277)
T ss_dssp             EEEEEECCCEEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTSCEEECCCTTCEEC
T ss_pred             EEEEEECCCCCEehhhhccc-CCCCHHHHHHHHHHHHHHHHHHHh---CCccCccccCcccccCccccceeehhhhhhhh
Confidence            68999999999999888543 458999999999999999999999   89999999999999999999999999998766


Q ss_pred             CCCCCc-eeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhccccccCCcccccCch
Q 012765          295 PDNWSH-HIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSNFKELVDPR  373 (457)
Q Consensus       295 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~  373 (457)
                      ...... .......||+.|+|||++.+..|+.++|||||||++|||+||+.||.........+... ...........  
T Consensus       162 ~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~-~~~~~~~~~~~--  238 (277)
T d1o6ya_         162 ADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHV-REDPIPPSARH--  238 (277)
T ss_dssp             C----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH-HCCCCCGGGTS--
T ss_pred             ccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHH-hcCCCCCchhc--
Confidence            433221 22334569999999999999999999999999999999999999998654432221111 11111111111  


Q ss_pred             hhcccCHHHHHHHHHHHHHhcccCCCCCC-CHHHHHHHHhcC
Q 012765          374 LADAYDLAEMKRAMLTASVCIHHLSTMRP-QMTRVLQLLRGE  414 (457)
Q Consensus       374 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-t~~evl~~L~~~  414 (457)
                        ..+    ...+.+++.+||+.||.+|| |+.++++.|..+
T Consensus       239 --~~~----s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~  274 (277)
T d1o6ya_         239 --EGL----SADLDAVVLKALAKNPENRYQTAAEMRADLVRV  274 (277)
T ss_dssp             --SSC----CHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred             --cCC----CHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHH
Confidence              112    23566788999999999999 899998887654

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=1.7e-49  Score=386.85  Aligned_cols=246  Identities=23%  Similarity=0.331  Sum_probs=200.1

Q ss_pred             cCCCCCceecccCcEEEEEEEeC-CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeec-CceEEEE
Q 012765          142 DNFNSENLIGKGGHAEVYKGCLP-DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTE-NGFHLVL  219 (457)
Q Consensus       142 ~~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-~~~~lv~  219 (457)
                      ++|++.+.||+|+||+||+|.+. +|+.||||++.+.........+.+.+|+.+++.++|||||++++++.+ +.+++||
T Consensus         4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm   83 (316)
T d1fota_           4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM   83 (316)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred             hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence            57889999999999999999864 699999999875443333345689999999999999999999996655 5578999


Q ss_pred             EecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCCCCCC
Q 012765          220 QFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWS  299 (457)
Q Consensus       220 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~~~~  299 (457)
                      ||+.+|+|..++... ..+++..+..++.||+.||.|||+   ++|+||||||+|||++.+|.+||+|||+++.+.... 
T Consensus        84 E~~~gg~l~~~~~~~-~~~~~~~~~~~~~qi~~al~~lH~---~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~~-  158 (316)
T d1fota_          84 DYIEGGELFSLLRKS-QRFPNPVAKFYAAEVCLALEYLHS---KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVT-  158 (316)
T ss_dssp             CCCCSCBHHHHHHHT-SSCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECTTSCEEECCCSSCEECSSCB-
T ss_pred             eecCCcccccccccc-ccccccHHHHHHHHHHHhhhhhcc---CcEEccccCchheeEcCCCCEEEecCccceEecccc-
Confidence            999999998888543 457888888899999999999999   899999999999999999999999999998875532 


Q ss_pred             ceeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhccccccCCcccccCchhhcccC
Q 012765          300 HHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSNFKELVDPRLADAYD  379 (457)
Q Consensus       300 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~  379 (457)
                          ....||+.|||||++.+..|+.++|||||||++|||+||+.||........... .......+        ...++
T Consensus       159 ----~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~-i~~~~~~~--------p~~~s  225 (316)
T d1fota_         159 ----YTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEK-ILNAELRF--------PPFFN  225 (316)
T ss_dssp             ----CCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHH-HHHCCCCC--------CTTSC
T ss_pred             ----ccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHH-HHcCCCCC--------CCCCC
Confidence                345699999999999999999999999999999999999999987543322111 00011111        11122


Q ss_pred             HHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 012765          380 LAEMKRAMLTASVCIHHLSTMRP-----QMTRVLQ  409 (457)
Q Consensus       380 ~~~~~~l~~l~~~Cl~~dP~~RP-----t~~evl~  409 (457)
                          ..+.+++.+||+.||.+||     |+.++++
T Consensus       226 ----~~~~~li~~~L~~dp~~R~~~~r~t~~~il~  256 (316)
T d1fota_         226 ----EDVKDLLSRLITRDLSQRLGNLQNGTEDVKN  256 (316)
T ss_dssp             ----HHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred             ----HHHHHHHHHHhhhCHHhccccchhhHHHHHc
Confidence                3466788999999999996     8999876

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.4e-49  Score=388.81  Aligned_cols=250  Identities=22%  Similarity=0.293  Sum_probs=202.4

Q ss_pred             hcCCCCCceecccCcEEEEEEEe-CCCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeecC-ceEEE
Q 012765          141 TDNFNSENLIGKGGHAEVYKGCL-PDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTEN-GFHLV  218 (457)
Q Consensus       141 ~~~f~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~-~~~lv  218 (457)
                      -++|.+.+.||+|+||.||+|.. .+|+.||+|++.+...........+.+|+.+|+.++||||+++++++.+. .+++|
T Consensus         4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv   83 (337)
T d1o6la_           4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV   83 (337)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccc
Confidence            36789999999999999999986 47999999998765433334456789999999999999999999966554 57899


Q ss_pred             EEecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCCCCC
Q 012765          219 LQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNW  298 (457)
Q Consensus       219 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~~~  298 (457)
                      |||+++|+|..++... ..+++..+..++.||+.||.|||+   .+|+||||||+|||++.+|.+||+|||+++......
T Consensus        84 ~ey~~gg~L~~~~~~~-~~~~e~~~~~~~~qil~al~ylH~---~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~  159 (337)
T d1o6la_          84 MEYANGGELFFHLSRE-RVFTEERARFYGAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG  159 (337)
T ss_dssp             EECCTTCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTT
T ss_pred             eeccCCCchhhhhhcc-cCCcHHHHHHHHHHHhhhhhhhhh---cCccccccCHHHeEecCCCCEEEeecccccccccCC
Confidence            9999999999988653 457888889999999999999999   899999999999999999999999999998765432


Q ss_pred             CceeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhccccccCCcccccCchhhccc
Q 012765          299 SHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSNFKELVDPRLADAY  378 (457)
Q Consensus       299 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~  378 (457)
                      .  .....+||+.|+|||++.+..|+.++|||||||++|||++|+.||...+..... .........+        ...+
T Consensus       160 ~--~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~-~~i~~~~~~~--------p~~~  228 (337)
T d1o6la_         160 A--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLF-ELILMEEIRF--------PRTL  228 (337)
T ss_dssp             C--CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHH-HHHHHCCCCC--------CTTS
T ss_pred             c--ccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHH-HHHhcCCCCC--------CccC
Confidence            2  233456999999999999999999999999999999999999999875543221 1111111111        1122


Q ss_pred             CHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHH
Q 012765          379 DLAEMKRAMLTASVCIHHLSTMRPQ-----MTRVLQ  409 (457)
Q Consensus       379 ~~~~~~~l~~l~~~Cl~~dP~~RPt-----~~evl~  409 (457)
                      +    ..+.+++.+||+.||.+||+     +.|+++
T Consensus       229 s----~~~~dli~~~L~~dP~~R~~~~~~~~~eil~  260 (337)
T d1o6la_         229 S----PEAKSLLAGLLKKDPKQRLGGGPSDAKEVME  260 (337)
T ss_dssp             C----HHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred             C----HHHHHHHHhhccCCchhhcccccccHHHHHc
Confidence            2    34567889999999999995     777776

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.6e-50  Score=388.49  Aligned_cols=261  Identities=25%  Similarity=0.365  Sum_probs=196.0

Q ss_pred             HHhhcCCCCCceecccCcEEEEEEEeC------CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhc-CCCCcceeeeee
Q 012765          138 AAATDNFNSENLIGKGGHAEVYKGCLP------DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHI-NHPNAAKLIGFS  210 (457)
Q Consensus       138 ~~~~~~f~~~~~LG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~  210 (457)
                      +...++|++.+.||+|+||+||+|.+.      +++.||||++......  .....+.+|..++.++ +|+||+.+++++
T Consensus         9 ei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~--~~~~~~~~e~~~l~~~~~h~~iv~~~~~~   86 (299)
T d1ywna1           9 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATH--SEHRALMSELKILIHIGHHLNVVNLLGAC   86 (299)
T ss_dssp             BCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CH--HHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             cccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCc--HHHHHHHHHHHHHHhhcCCCeEEEeeeee
Confidence            344578999999999999999999853      3568999998644332  3356788888888777 689999999976


Q ss_pred             ecC--ceEEEEEecCCCChhhhhhcC---------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCC
Q 012765          211 TEN--GFHLVLQFLPHGSLSSLLFGS---------------TECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKAS  273 (457)
Q Consensus       211 ~~~--~~~lv~e~~~~gsL~~~l~~~---------------~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~  273 (457)
                      ...  .++++|||+++|+|.+++...               ...+++..++.++.||+.||.|||+   .+|+||||||+
T Consensus        87 ~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~---~~ivHrDlKp~  163 (299)
T d1ywna1          87 TKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAAR  163 (299)
T ss_dssp             CSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGG
T ss_pred             ccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHh---CCCcCCcCCcc
Confidence            543  478999999999999998643               2358899999999999999999999   89999999999


Q ss_pred             cEEEcCCCcEEEeeccccccCCCCCCceeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHhCC-CCCCcCCcc
Q 012765          274 NILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGR-RAVDSRRQS  352 (457)
Q Consensus       274 NIll~~~~~~kL~DFGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLltG~-~pf~~~~~~  352 (457)
                      ||||+.++.+||+|||+++...............||+.|+|||++.++.++.++|||||||++|||+||. .||......
T Consensus       164 NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~  243 (299)
T d1ywna1         164 NILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID  243 (299)
T ss_dssp             GEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCS
T ss_pred             ceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHH
Confidence            9999999999999999998775544433344566999999999999999999999999999999999975 577654322


Q ss_pred             hhhhhccccccCCcccccCchhhcccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q 012765          353 LVIWAKPLLQTSNFKELVDPRLADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQLLRGE  414 (457)
Q Consensus       353 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~  414 (457)
                      ......  .....     .+......    ...+.+++.+||+.||++|||+.||++.|+.+
T Consensus       244 ~~~~~~--~~~~~-----~~~~~~~~----~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~i  294 (299)
T d1ywna1         244 EEFCRR--LKEGT-----RMRAPDYT----TPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL  294 (299)
T ss_dssp             HHHHHH--HHHTC-----CCCCCTTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHHHHH--HhcCC-----CCCCCccC----CHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence            111110  01110     11111112    23567888999999999999999999999865

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.8e-49  Score=382.98  Aligned_cols=254  Identities=27%  Similarity=0.411  Sum_probs=200.7

Q ss_pred             CceecccCcEEEEEEEeCCC----cEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeec--CceEEEEE
Q 012765          147 ENLIGKGGHAEVYKGCLPDG----EVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTE--NGFHLVLQ  220 (457)
Q Consensus       147 ~~~LG~G~~g~Vy~~~~~~~----~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~--~~~~lv~e  220 (457)
                      .++||+|+||+||+|.+.++    ..||||++....  ......+|.+|+++|++++||||+++++++..  +..++|||
T Consensus        32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E  109 (311)
T d1r0pa_          32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT--DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLP  109 (311)
T ss_dssp             EEEEEEETTEEEEEEEECC----CEEEEEEEECCCC--CHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEE
T ss_pred             ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECccc--CHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEE
Confidence            46899999999999986432    258999986433  33456789999999999999999999997654  45789999


Q ss_pred             ecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCCCCCCc
Q 012765          221 FLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSH  300 (457)
Q Consensus       221 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~~~~~  300 (457)
                      |+++|+|.+++......+++..++.++.|++.||.|||+   .+|+||||||+||||++++.+||+|||+++.+......
T Consensus       110 ~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~---~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~  186 (311)
T d1r0pa_         110 YMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFD  186 (311)
T ss_dssp             CCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCC
T ss_pred             EeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcc---cCcccCCccHHhEeECCCCCEEEecccchhhccccccc
Confidence            999999999998877788899999999999999999999   89999999999999999999999999999877543222


Q ss_pred             --eeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhccccccCCcccccCchhhccc
Q 012765          301 --HIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSNFKELVDPRLADAY  378 (457)
Q Consensus       301 --~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~  378 (457)
                        .......||+.|+|||.+.++.++.++||||||+++|||+||+.||......... .........   ...|   .. 
T Consensus       187 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~-~~~i~~g~~---~~~p---~~-  258 (311)
T d1r0pa_         187 SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDI-TVYLLQGRR---LLQP---EY-  258 (311)
T ss_dssp             CTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------C-HHHHHTTCC---CCCC---TT-
T ss_pred             cceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHH-HHHHHcCCC---CCCc---cc-
Confidence              1222356899999999999999999999999999999999988888653221111 111111110   1111   11 


Q ss_pred             CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCCC
Q 012765          379 DLAEMKRAMLTASVCIHHLSTMRPQMTRVLQLLRGEGG  416 (457)
Q Consensus       379 ~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~  416 (457)
                         ....+.+++.+||+.||++||+|.||++.|+.+..
T Consensus       259 ---~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~  293 (311)
T d1r0pa_         259 ---CPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFS  293 (311)
T ss_dssp             ---CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ---CcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence               12356778899999999999999999999988754

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=5.7e-49  Score=388.38  Aligned_cols=246  Identities=21%  Similarity=0.243  Sum_probs=200.6

Q ss_pred             cCCCCCceecccCcEEEEEEEeC-CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeec-CceEEEE
Q 012765          142 DNFNSENLIGKGGHAEVYKGCLP-DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTE-NGFHLVL  219 (457)
Q Consensus       142 ~~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-~~~~lv~  219 (457)
                      ++|++++.||+|+||+||+|.+. +|+.||||++.+.........+.+.+|+.+|+.++|||||++++++.+ ...++||
T Consensus        41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~  120 (350)
T d1rdqe_          41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM  120 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence            57889999999999999999864 699999999865443333445678999999999999999999996655 4568999


Q ss_pred             EecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCCCCCC
Q 012765          220 QFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWS  299 (457)
Q Consensus       220 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~~~~  299 (457)
                      ||+.+|+|..++... ..+++..+..++.||+.||.|||+   .+||||||||+|||++.++.+||+|||+++.+.... 
T Consensus       121 e~~~~g~l~~~l~~~-~~l~e~~~~~i~~qi~~aL~yLH~---~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~~-  195 (350)
T d1rdqe_         121 EYVAGGEMFSHLRRI-GRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT-  195 (350)
T ss_dssp             ECCTTCBHHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECSSCB-
T ss_pred             ccccccchhhhHhhc-CCCCHHHHHHHHHHHHHHHHHHHh---CCEecCcCCHHHcccCCCCCEEeeeceeeeeccccc-
Confidence            999999999998654 358999999999999999999999   899999999999999999999999999999875432 


Q ss_pred             ceeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhccccccCCcccccCchhhcccC
Q 012765          300 HHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSNFKELVDPRLADAYD  379 (457)
Q Consensus       300 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~  379 (457)
                          ....||+.|||||++.+..|+.++|||||||++|||+||+.||........... .......        ....++
T Consensus       196 ----~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~-i~~~~~~--------~p~~~s  262 (350)
T d1rdqe_         196 ----WTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEK-IVSGKVR--------FPSHFS  262 (350)
T ss_dssp             ----CCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH-HHHCCCC--------CCTTCC
T ss_pred             ----ccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHH-HhcCCCC--------CCccCC
Confidence                234599999999999999999999999999999999999999986543221111 0000011        111122


Q ss_pred             HHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 012765          380 LAEMKRAMLTASVCIHHLSTMRP-----QMTRVLQ  409 (457)
Q Consensus       380 ~~~~~~l~~l~~~Cl~~dP~~RP-----t~~evl~  409 (457)
                          ..+.+++.+||+.||.+|+     |+.++++
T Consensus       263 ----~~~~~li~~~L~~dP~kR~~~~r~t~~ell~  293 (350)
T d1rdqe_         263 ----SDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN  293 (350)
T ss_dssp             ----HHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred             ----HHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence                3466788999999999994     8999886

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-49  Score=383.47  Aligned_cols=258  Identities=25%  Similarity=0.368  Sum_probs=202.7

Q ss_pred             hcCCCCCceecccCcEEEEEEEeC--------CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhc-CCCCcceeeeeee
Q 012765          141 TDNFNSENLIGKGGHAEVYKGCLP--------DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHI-NHPNAAKLIGFST  211 (457)
Q Consensus       141 ~~~f~~~~~LG~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~  211 (457)
                      .++|.+.+.||+|+||.||+|...        ++..||||++.....  ......+.+|...+.++ +|||||++++++.
T Consensus        12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~--~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~   89 (299)
T d1fgka_          12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDAT--EKDLSDLISEMEMMKMIGKHKNIINLLGACT   89 (299)
T ss_dssp             GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCC--HHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccC--hHHHHHHHHHHHHHHHhcCCCeEEecccccc
Confidence            467888999999999999999752        234799998865443  24456889999999888 7999999999776


Q ss_pred             cC-ceEEEEEecCCCChhhhhhcCC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcE
Q 012765          212 EN-GFHLVLQFLPHGSLSSLLFGST---------------ECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNI  275 (457)
Q Consensus       212 ~~-~~~lv~e~~~~gsL~~~l~~~~---------------~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NI  275 (457)
                      ++ ..++||||+.+|+|.+++....               ..+++..++.++.||+.||.|||+   .+||||||||+||
T Consensus        90 ~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~---~~ivHrDiKp~Ni  166 (299)
T d1fgka_          90 QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNV  166 (299)
T ss_dssp             SSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGE
T ss_pred             cCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhh---CCEEeeeecccce
Confidence            54 4789999999999999996432               358999999999999999999999   8999999999999


Q ss_pred             EEcCCCcEEEeeccccccCCCCCCceeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHh-CCCCCCcCCcchh
Q 012765          276 LLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELIT-GRRAVDSRRQSLV  354 (457)
Q Consensus       276 ll~~~~~~kL~DFGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLlt-G~~pf~~~~~~~~  354 (457)
                      |++.++.+||+|||+++...............||+.|+|||.+.++.|+.++|||||||++|||++ |..||........
T Consensus       167 Ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~~  246 (299)
T d1fgka_         167 LVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL  246 (299)
T ss_dssp             EECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH
T ss_pred             eecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHHHH
Confidence            999999999999999988766554444455678999999999999999999999999999999998 6888876443322


Q ss_pred             hhhccccccCCcccccCchhhcccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCC
Q 012765          355 IWAKPLLQTSNFKELVDPRLADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQLLRGEG  415 (457)
Q Consensus       355 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~  415 (457)
                      ...   .....     .+......    ...+.+++.+||+.||++|||+.||++.|+.+.
T Consensus       247 ~~~---i~~~~-----~~~~p~~~----~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~  295 (299)
T d1fgka_         247 FKL---LKEGH-----RMDKPSNC----TNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIV  295 (299)
T ss_dssp             HHH---HHTTC-----CCCCCSSC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHH---HHcCC-----CCCCCccc----hHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHh
Confidence            111   11110     11111112    235778999999999999999999999998763

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.6e-49  Score=381.94  Aligned_cols=267  Identities=23%  Similarity=0.282  Sum_probs=198.7

Q ss_pred             cCCCCCceecccCcEEEEEEEeCCCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeecC-----ceE
Q 012765          142 DNFNSENLIGKGGHAEVYKGCLPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTEN-----GFH  216 (457)
Q Consensus       142 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~-----~~~  216 (457)
                      ++|.+.+.||+|+||+||+|.+ +|+.||||++.....    .......|+..+..++|||||++++++.+.     .++
T Consensus         3 ~~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~~----~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~   77 (303)
T d1vjya_           3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREE----RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLW   77 (303)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGGGH----HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccch----hHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEE
Confidence            4567788999999999999987 789999998854321    112233455566788999999999977643     268


Q ss_pred             EEEEecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcC-----CCCeeeCCCCCCcEEEcCCCcEEEeecccc
Q 012765          217 LVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDC-----HRRIIHRDIKASNILLSEDYEAQISDFGLA  291 (457)
Q Consensus       217 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~-----~~~iiHrDlkp~NIll~~~~~~kL~DFGl~  291 (457)
                      +||||+++|+|.++|...  .++|..++.++.|++.||.|||+..     .++|+||||||+||||+.++.+||+|||++
T Consensus        78 lv~Ey~~~g~L~~~l~~~--~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~  155 (303)
T d1vjya_          78 LVSDYHEHGSLFDYLNRY--TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA  155 (303)
T ss_dssp             EEEECCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred             EEEecccCCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCcc
Confidence            999999999999999653  5899999999999999999999621     269999999999999999999999999999


Q ss_pred             ccCCCCCCce--eeecccccccccChhccccCC------CCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhcccccc
Q 012765          292 KWLPDNWSHH--IVFPIEGTFGYLSPEYFMHGI------VDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQT  363 (457)
Q Consensus       292 ~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~------~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~~~~~~  363 (457)
                      +.........  ......||+.|+|||++.+..      ++.++|||||||+||||+||..||.........+.......
T Consensus       156 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~  235 (303)
T d1vjya_         156 VRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSD  235 (303)
T ss_dssp             EEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSS
T ss_pred             ccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhccccc
Confidence            8775433221  223466999999999986543      57789999999999999999988864222211111111111


Q ss_pred             CC--------cccccCchhhccc-CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCC
Q 012765          364 SN--------FKELVDPRLADAY-DLAEMKRAMLTASVCIHHLSTMRPQMTRVLQLLRGEG  415 (457)
Q Consensus       364 ~~--------~~~~~d~~l~~~~-~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~  415 (457)
                      ..        .....+|.+...+ ..+....+.+++.+||+.||++|||+.||++.|+.+.
T Consensus       236 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~  296 (303)
T d1vjya_         236 PSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLS  296 (303)
T ss_dssp             CCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHH
T ss_pred             chHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHH
Confidence            11        1111222222222 2345667889999999999999999999999998764

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=2.7e-48  Score=385.54  Aligned_cols=250  Identities=23%  Similarity=0.288  Sum_probs=194.3

Q ss_pred             cCCCCCceecccCcEEEEEEEeC-CCcEEEEEEEeccchhhH---HHHHHHHHHHHHHhhcCCCCcceeeeeeec-CceE
Q 012765          142 DNFNSENLIGKGGHAEVYKGCLP-DGEVVAVKKIIKNAKEDE---ERISDFLSELGIVAHINHPNAAKLIGFSTE-NGFH  216 (457)
Q Consensus       142 ~~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~---~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-~~~~  216 (457)
                      ++|++.+.||+|+||+||+|.+. +|+.||||++.+......   ........++.+++.++|||||++++++.+ +.++
T Consensus         4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~   83 (364)
T d1omwa3           4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS   83 (364)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred             HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEE
Confidence            67999999999999999999865 699999999865332222   222333445777888899999999996655 5578


Q ss_pred             EEEEecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCCC
Q 012765          217 LVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPD  296 (457)
Q Consensus       217 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~  296 (457)
                      +||||+++|+|.+++... ..+++..+..++.||+.||.|||+   .+||||||||+|||++.++.+||+|||+++.+..
T Consensus        84 ivmE~~~gg~L~~~l~~~-~~~~e~~~~~~~~qi~~aL~ylH~---~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~  159 (364)
T d1omwa3          84 FILDLMNGGDLHYHLSQH-GVFSEADMRFYAAEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSK  159 (364)
T ss_dssp             EEECCCCSCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECSSSCEEECCCTTCEECSS
T ss_pred             EEEEecCCCcHHHHHHhc-ccccHHHHHHHHHHHHHHHHHHHH---CCccceeeccceeEEcCCCcEEEeeeceeeecCC
Confidence            999999999999998653 457888999999999999999999   8999999999999999999999999999987765


Q ss_pred             CCCceeeecccccccccChhcccc-CCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhccccccCCcccccCchhh
Q 012765          297 NWSHHIVFPIEGTFGYLSPEYFMH-GIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSNFKELVDPRLA  375 (457)
Q Consensus       297 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  375 (457)
                      ...    ....||+.|+|||++.. ..|+.++|||||||++|||+||+.||.................      ....+.
T Consensus       160 ~~~----~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~------~~~~~~  229 (364)
T d1omwa3         160 KKP----HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLT------MAVELP  229 (364)
T ss_dssp             SCC----CSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHSSS------CCCCCC
T ss_pred             Ccc----cccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccc------CCCCCC
Confidence            432    23469999999999975 5689999999999999999999999986432211110000000      001111


Q ss_pred             cccCHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHH
Q 012765          376 DAYDLAEMKRAMLTASVCIHHLSTMRPQ-----MTRVLQ  409 (457)
Q Consensus       376 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt-----~~evl~  409 (457)
                      ..++    ..+.+++.+||+.||.+|||     +.|+++
T Consensus       230 ~~~s----~~~~~li~~~L~~dP~~R~t~~~~~a~eil~  264 (364)
T d1omwa3         230 DSFS----PELRSLLEGLLQRDVNRRLGCLGRGAQEVKE  264 (364)
T ss_dssp             SSSC----HHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred             CCCC----HHHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence            1222    34677889999999999999     578765

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-48  Score=380.85  Aligned_cols=259  Identities=20%  Similarity=0.306  Sum_probs=206.8

Q ss_pred             hhcCCCCCceecccCcEEEEEEEe------CCCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhc-CCCCcceeeeeeec
Q 012765          140 ATDNFNSENLIGKGGHAEVYKGCL------PDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHI-NHPNAAKLIGFSTE  212 (457)
Q Consensus       140 ~~~~f~~~~~LG~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~  212 (457)
                      ..++|++.+.||+|+||.||+|.+      .+++.||||++......  .....+.+|+.+++++ +|||||++++++.+
T Consensus        21 ~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~--~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~   98 (311)
T d1t46a_          21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHL--TEREALMSELKVLSYLGNHMNIVNLLGACTI   98 (311)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCH--HHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             CHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCH--HHHHHHHHHHHHHHhccCCCCEEEEEEEEee
Confidence            346888899999999999999974      34678999998754432  3456899999999999 69999999997765


Q ss_pred             C-ceEEEEEecCCCChhhhhhcCC-----------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCc
Q 012765          213 N-GFHLVLQFLPHGSLSSLLFGST-----------------ECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASN  274 (457)
Q Consensus       213 ~-~~~lv~e~~~~gsL~~~l~~~~-----------------~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~N  274 (457)
                      . ..+++|||+++|+|.+++....                 ..+++..++.++.||+.||.|||+   .+++||||||+|
T Consensus        99 ~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~---~~ivHrDLKp~N  175 (311)
T d1t46a_          99 GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARN  175 (311)
T ss_dssp             SSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGG
T ss_pred             CCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccccccc
Confidence            4 4789999999999999986432                 258899999999999999999999   899999999999


Q ss_pred             EEEcCCCcEEEeeccccccCCCCCCceeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHhC-CCCCCcCCcch
Q 012765          275 ILLSEDYEAQISDFGLAKWLPDNWSHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITG-RRAVDSRRQSL  353 (457)
Q Consensus       275 Ill~~~~~~kL~DFGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLltG-~~pf~~~~~~~  353 (457)
                      ||++.++.+||+|||+++...............||+.|+|||++.++.++.++|||||||++|||+|+ .+||.......
T Consensus       176 Il~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~  255 (311)
T d1t46a_         176 ILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDS  255 (311)
T ss_dssp             EEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSH
T ss_pred             ccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHH
Confidence            99999999999999999988765555555556799999999999999999999999999999999995 55554433222


Q ss_pred             hhhhccccccCCcccccCchhhcccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q 012765          354 VIWAKPLLQTSNFKELVDPRLADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQLLRGE  414 (457)
Q Consensus       354 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~  414 (457)
                      ..+.           +++..............+.+++.+||+.||.+||||.||+++|++.
T Consensus       256 ~~~~-----------~i~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~  305 (311)
T d1t46a_         256 KFYK-----------MIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQ  305 (311)
T ss_dssp             HHHH-----------HHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHHH-----------HHhcCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence            1111           1111111111111234577889999999999999999999999753

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=3.5e-48  Score=370.61  Aligned_cols=253  Identities=25%  Similarity=0.324  Sum_probs=201.6

Q ss_pred             hcCCCCCceecccCcEEEEEEEe-CCCcEEEEEEEeccchh------hHHHHHHHHHHHHHHhhcC-CCCcceeeeeeec
Q 012765          141 TDNFNSENLIGKGGHAEVYKGCL-PDGEVVAVKKIIKNAKE------DEERISDFLSELGIVAHIN-HPNAAKLIGFSTE  212 (457)
Q Consensus       141 ~~~f~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~------~~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~  212 (457)
                      .++|++.+.||+|+||+||+|.. .+|+.||||++.+....      .....+.+.+|+.++++++ ||||+++++++.+
T Consensus         2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~   81 (277)
T d1phka_           2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET   81 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred             cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence            47899999999999999999986 47999999998664322      1233457899999999997 9999999997665


Q ss_pred             Cc-eEEEEEecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeecccc
Q 012765          213 NG-FHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLA  291 (457)
Q Consensus       213 ~~-~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~  291 (457)
                      ++ .++||||+++|+|.+++... ..+++..+..++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||++
T Consensus        82 ~~~~~ivmE~~~~g~L~~~l~~~-~~l~e~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~Nill~~~~~~kl~DFG~a  157 (277)
T d1phka_          82 NTFFFLVFDLMKKGELFDYLTEK-VTLSEKETRKIMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFS  157 (277)
T ss_dssp             SSEEEEEEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred             CcceEEEEEcCCCchHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH---cCCcccccccceEEEcCCCCeEEccchhe
Confidence            54 68999999999999999653 468999999999999999999999   89999999999999999999999999999


Q ss_pred             ccCCCCCCceeeecccccccccChhcccc------CCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhccccccCC
Q 012765          292 KWLPDNWSHHIVFPIEGTFGYLSPEYFMH------GIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSN  365 (457)
Q Consensus       292 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~~~~~~~~  365 (457)
                      +.+......   ....||+.|+|||.+.+      ..++.++||||+||++|||++|+.||............. .....
T Consensus       158 ~~~~~~~~~---~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~-~~~~~  233 (277)
T d1phka_         158 CQLDPGEKL---REVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIM-SGNYQ  233 (277)
T ss_dssp             EECCTTCCB---CCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH-HTCCC
T ss_pred             eEccCCCce---eeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHH-hCCCC
Confidence            987654322   33569999999999853      357889999999999999999999998765433221110 00000


Q ss_pred             cccccCchhhcccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 012765          366 FKELVDPRLADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQ  409 (457)
Q Consensus       366 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~  409 (457)
                         ...+ ....++    ..+.+++.+||+.||++|||+.||++
T Consensus       234 ---~~~~-~~~~~s----~~~~~li~~~L~~~p~~R~s~~eil~  269 (277)
T d1phka_         234 ---FGSP-EWDDYS----DTVKDLVSRFLVVQPQKRYTAEEALA  269 (277)
T ss_dssp             ---CCTT-TGGGSC----HHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             ---CCCc-ccccCC----HHHHHHHHHHccCChhHCcCHHHHHc
Confidence               0011 111222    35678899999999999999999865

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-48  Score=379.57  Aligned_cols=250  Identities=18%  Similarity=0.194  Sum_probs=201.8

Q ss_pred             hcCCCCCceecccCcEEEEEEEeC-CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeee-cCceEEE
Q 012765          141 TDNFNSENLIGKGGHAEVYKGCLP-DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFST-ENGFHLV  218 (457)
Q Consensus       141 ~~~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~-~~~~~lv  218 (457)
                      .++|.+.+.||+|+||+||+|.+. +|+.||+|.+......    ...+.+|+.+|+.++|||||++++++. ++.+++|
T Consensus         4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~----~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lv   79 (321)
T d1tkia_           4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD----QVLVKKEISILNIARHRNILHLHESFESMEELVMI   79 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHH----HHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEE
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCccc----HHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEE
Confidence            478999999999999999999875 6889999998654322    246789999999999999999999655 5667899


Q ss_pred             EEecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCC--CcEEEeeccccccCCC
Q 012765          219 LQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSED--YEAQISDFGLAKWLPD  296 (457)
Q Consensus       219 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~--~~~kL~DFGl~~~~~~  296 (457)
                      |||+.+|+|.+++......+++..+..|+.||+.||.|||+   .+|+||||||+|||++.+  +.+||+|||+++....
T Consensus        80 mE~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~---~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~  156 (321)
T d1tkia_          80 FEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHS---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP  156 (321)
T ss_dssp             ECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCT
T ss_pred             EecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---cCCCcccccccceeecCCCceEEEEcccchhhcccc
Confidence            99999999999997666679999999999999999999999   899999999999999854  5799999999987754


Q ss_pred             CCCceeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhccccccCCcccccCchhhc
Q 012765          297 NWSHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSNFKELVDPRLAD  376 (457)
Q Consensus       297 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  376 (457)
                      ...   .....+|+.|+|||.+.+..|+.++|||||||++|+|++|..||............ ......    .+.....
T Consensus       157 ~~~---~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i-~~~~~~----~~~~~~~  228 (321)
T d1tkia_         157 GDN---FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENI-MNAEYT----FDEEAFK  228 (321)
T ss_dssp             TCE---EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH-HHTCCC----CCHHHHT
T ss_pred             CCc---ccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHH-HhCCCC----CChhhcc
Confidence            432   23345899999999999999999999999999999999999999875543221110 000000    1111111


Q ss_pred             ccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 012765          377 AYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQ  409 (457)
Q Consensus       377 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~  409 (457)
                      .+    ...+.+++.+||+.||++|||+.|+++
T Consensus       229 ~~----s~~~~~li~~~L~~dp~~R~s~~eil~  257 (321)
T d1tkia_         229 EI----SIEAMDFVDRLLVKERKSRMTASEALQ  257 (321)
T ss_dssp             TS----CHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             CC----CHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            12    234678899999999999999999987

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-48  Score=377.71  Aligned_cols=258  Identities=21%  Similarity=0.355  Sum_probs=205.3

Q ss_pred             hcCCCCCceecccCcEEEEEEEeC------CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeee-cC
Q 012765          141 TDNFNSENLIGKGGHAEVYKGCLP------DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFST-EN  213 (457)
Q Consensus       141 ~~~f~~~~~LG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~-~~  213 (457)
                      .++|.+.+.||+|+||+||+|.+.      +++.||||++.....  ......|.+|+.++++++|||||++++++. ++
T Consensus        19 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~--~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~   96 (308)
T d1p4oa_          19 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAAS--MRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQ   96 (308)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSC--HHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSS
T ss_pred             HHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccC--hHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCC
Confidence            467888999999999999999753      367899999865433  234567999999999999999999999765 45


Q ss_pred             ceEEEEEecCCCChhhhhhc---------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEE
Q 012765          214 GFHLVLQFLPHGSLSSLLFG---------STECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQ  284 (457)
Q Consensus       214 ~~~lv~e~~~~gsL~~~l~~---------~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~k  284 (457)
                      ..++||||+++|+|.+++..         ....+++..+..++.|++.||.|||+   .+|+||||||+|||++.++.+|
T Consensus        97 ~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~---~~ivHrDlk~~NiLld~~~~~K  173 (308)
T d1p4oa_          97 PTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVK  173 (308)
T ss_dssp             SCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCSGGGEEECTTCCEE
T ss_pred             ceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhh---CCeeeceEcCCceeecCCceEE
Confidence            67899999999999998753         12347889999999999999999999   8999999999999999999999


Q ss_pred             EeeccccccCCCCCCceeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHhCC-CCCCcCCcchhhhhcccccc
Q 012765          285 ISDFGLAKWLPDNWSHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGR-RAVDSRRQSLVIWAKPLLQT  363 (457)
Q Consensus       285 L~DFGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLltG~-~pf~~~~~~~~~~~~~~~~~  363 (457)
                      |+|||+++.+.............||+.|+|||.+.+..++.++|||||||++|||+||. .||...........  .. .
T Consensus       174 l~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~--i~-~  250 (308)
T d1p4oa_         174 IGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRF--VM-E  250 (308)
T ss_dssp             ECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHH--HH-T
T ss_pred             EeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHHH--HH-h
Confidence            99999998775543333334456899999999999999999999999999999999985 66765333221111  01 1


Q ss_pred             CCcccccCchhhcccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCC
Q 012765          364 SNFKELVDPRLADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQLLRGEG  415 (457)
Q Consensus       364 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~  415 (457)
                      .....     ....    ....+.+++.+||+.+|++||||.+|+++|++..
T Consensus       251 ~~~~~-----~p~~----~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~  293 (308)
T d1p4oa_         251 GGLLD-----KPDN----CPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEM  293 (308)
T ss_dssp             TCCCC-----CCTT----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGS
T ss_pred             CCCCC-----Cccc----chHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence            11110     1111    1245778899999999999999999999998874

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-48  Score=380.41  Aligned_cols=255  Identities=24%  Similarity=0.362  Sum_probs=197.9

Q ss_pred             cCCCCCceecccCcEEEEEEEeC-CCc--EEEEEEEeccchhhHHHHHHHHHHHHHHhhc-CCCCcceeeeeeecC-ceE
Q 012765          142 DNFNSENLIGKGGHAEVYKGCLP-DGE--VVAVKKIIKNAKEDEERISDFLSELGIVAHI-NHPNAAKLIGFSTEN-GFH  216 (457)
Q Consensus       142 ~~f~~~~~LG~G~~g~Vy~~~~~-~~~--~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~-~~~  216 (457)
                      ++|++.+.||+|+||+||+|.+. +|.  .||||++.....  ....+.+.+|+.+|.++ +|||||++++++.++ .++
T Consensus        10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~   87 (309)
T d1fvra_          10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYAS--KDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLY   87 (309)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC--------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEE
T ss_pred             HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccC--hHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeE
Confidence            67888899999999999999865 344  467787754322  23456899999999998 799999999976654 578


Q ss_pred             EEEEecCCCChhhhhhcC---------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCC
Q 012765          217 LVLQFLPHGSLSSLLFGS---------------TECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDY  281 (457)
Q Consensus       217 lv~e~~~~gsL~~~l~~~---------------~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~  281 (457)
                      +||||+++|+|.++|+..               ...+++..++.++.||+.||.|||+   .+|+||||||+|||++.++
T Consensus        88 iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~---~~iiHrDlkp~NIL~~~~~  164 (309)
T d1fvra_          88 LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENY  164 (309)
T ss_dssp             EEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECGGG
T ss_pred             EEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhc---CCccccccccceEEEcCCC
Confidence            999999999999998643               3568999999999999999999999   8999999999999999999


Q ss_pred             cEEEeeccccccCCCCCCceeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHhCCC-CCCcCCcchhhhhccc
Q 012765          282 EAQISDFGLAKWLPDNWSHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRR-AVDSRRQSLVIWAKPL  360 (457)
Q Consensus       282 ~~kL~DFGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLltG~~-pf~~~~~~~~~~~~~~  360 (457)
                      .+||+|||+++........   ....||..|+|||.+.++.|+.++|||||||++|||++|.. ||............  
T Consensus       165 ~~kl~DfG~a~~~~~~~~~---~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i--  239 (309)
T d1fvra_         165 VAKIADFGLSRGQEVYVKK---TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKL--  239 (309)
T ss_dssp             CEEECCTTCEESSCEECCC-------CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHG--
T ss_pred             ceEEccccccccccccccc---cceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHHH--
Confidence            9999999999866443222   23458999999999999999999999999999999999765 67654332221111  


Q ss_pred             cccCCcccccCchhhcccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCCC
Q 012765          361 LQTSNFKELVDPRLADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQLLRGEGG  416 (457)
Q Consensus       361 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~  416 (457)
                      .. .     ..+.....    ....+.+++.+||+.||++||||.||++.|+.+..
T Consensus       240 ~~-~-----~~~~~~~~----~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~  285 (309)
T d1fvra_         240 PQ-G-----YRLEKPLN----CDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLE  285 (309)
T ss_dssp             GG-T-----CCCCCCTT----BCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             Hh-c-----CCCCCCcc----CCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence            11 0     01111111    22457788999999999999999999999987653

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-48  Score=380.67  Aligned_cols=249  Identities=21%  Similarity=0.317  Sum_probs=198.9

Q ss_pred             cCCCCCceecccCcEEEEEEEeC-CCcEEEEEEEeccchhhHHHHHHHHHHHHHHh-hcCCCCcceeeeeeecC-ceEEE
Q 012765          142 DNFNSENLIGKGGHAEVYKGCLP-DGEVVAVKKIIKNAKEDEERISDFLSELGIVA-HINHPNAAKLIGFSTEN-GFHLV  218 (457)
Q Consensus       142 ~~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~-~l~hpniv~l~~~~~~~-~~~lv  218 (457)
                      ++|.+.+.||+|+||+||+|.+. +|+.||||++.+...........+..|..++. .++|||||++++++.++ ..++|
T Consensus         2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv   81 (320)
T d1xjda_           2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV   81 (320)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred             CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence            67899999999999999999875 69999999997543332333456777777765 68999999999976654 57899


Q ss_pred             EEecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCCCCC
Q 012765          219 LQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNW  298 (457)
Q Consensus       219 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~~~  298 (457)
                      |||+++|+|..++... ..+++..+..++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||+++......
T Consensus        82 mEy~~~g~L~~~i~~~-~~~~e~~~~~~~~qi~~al~ylH~---~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~  157 (320)
T d1xjda_          82 MEYLNGGDLMYHIQSC-HKFDLSRATFYAAEIILGLQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGD  157 (320)
T ss_dssp             EECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT
T ss_pred             EeecCCCcHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCcccceeecCCCceeccccchhhhccccc
Confidence            9999999999998643 457888999999999999999999   899999999999999999999999999998765433


Q ss_pred             CceeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhccccccCCcccccCchhhccc
Q 012765          299 SHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSNFKELVDPRLADAY  378 (457)
Q Consensus       299 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~  378 (457)
                      ..  .....||+.|+|||++.+..|+.++|||||||++|||+||+.||.+......... .......        +...+
T Consensus       158 ~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~-i~~~~~~--------~p~~~  226 (320)
T d1xjda_         158 AK--TNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHS-IRMDNPF--------YPRWL  226 (320)
T ss_dssp             CC--BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH-HHHCCCC--------CCTTS
T ss_pred             cc--ccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHH-HHcCCCC--------CCccC
Confidence            22  2345699999999999999999999999999999999999999986543322211 1111111        11122


Q ss_pred             CHHHHHHHHHHHHHhcccCCCCCCCHH-HHHH
Q 012765          379 DLAEMKRAMLTASVCIHHLSTMRPQMT-RVLQ  409 (457)
Q Consensus       379 ~~~~~~~l~~l~~~Cl~~dP~~RPt~~-evl~  409 (457)
                      +    ..+.+++.+||+.||.+||++. +|++
T Consensus       227 s----~~~~dli~~~L~~dP~~R~s~~~~l~~  254 (320)
T d1xjda_         227 E----KEAKDLLVKLFVREPEKRLGVRGDIRQ  254 (320)
T ss_dssp             C----HHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred             C----HHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence            2    3467889999999999999995 6753

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.2e-48  Score=378.39  Aligned_cols=250  Identities=19%  Similarity=0.243  Sum_probs=193.9

Q ss_pred             hcCCCCCc-eecccCcEEEEEEEe-CCCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhc-CCCCcceeeeeeec-----
Q 012765          141 TDNFNSEN-LIGKGGHAEVYKGCL-PDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHI-NHPNAAKLIGFSTE-----  212 (457)
Q Consensus       141 ~~~f~~~~-~LG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~-----  212 (457)
                      .++|.+.. +||+|+||+||+|.+ .+++.||||++...        ..+.+|+.++.++ +|||||++++++.+     
T Consensus        10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~--------~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~   81 (335)
T d2ozaa1          10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYENLYAGR   81 (335)
T ss_dssp             GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTE
T ss_pred             ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc--------HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCC
Confidence            46788764 699999999999986 46899999998542        2466899887654 89999999997643     


Q ss_pred             CceEEEEEecCCCChhhhhhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcC---CCcEEEeec
Q 012765          213 NGFHLVLQFLPHGSLSSLLFGS-TECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSE---DYEAQISDF  288 (457)
Q Consensus       213 ~~~~lv~e~~~~gsL~~~l~~~-~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~---~~~~kL~DF  288 (457)
                      ..+++||||+++|+|.+++... ...+++..+..|+.||+.||.|||+   .+|+||||||+|||++.   ++.+||+||
T Consensus        82 ~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~---~~iiHRDiKp~NIll~~~~~~~~~Kl~DF  158 (335)
T d2ozaa1          82 KCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDF  158 (335)
T ss_dssp             EEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCSSTTCCEEECCC
T ss_pred             CEEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHH---cCCcccccccccccccccccccccccccc
Confidence            4478999999999999999764 3568999999999999999999999   89999999999999985   457999999


Q ss_pred             cccccCCCCCCceeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhccccccCCccc
Q 012765          289 GLAKWLPDNWSHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSNFKE  368 (457)
Q Consensus       289 Gl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~  368 (457)
                      |+++.......   .....||+.|||||++.+..|+.++|||||||++|+|+||+.||.+..........  ........
T Consensus       159 G~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~--~~~i~~~~  233 (335)
T d2ozaa1         159 GFAKETTSHNS---LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGM--KTRIRMGQ  233 (335)
T ss_dssp             TTCEECCCCCC---CCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC----------CCCSCS
T ss_pred             ceeeeccCCCc---cccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHH--HHHHhcCC
Confidence            99987755432   23456999999999999999999999999999999999999999764332111000  00000000


Q ss_pred             ccCchhhcccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 012765          369 LVDPRLADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQ  409 (457)
Q Consensus       369 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~  409 (457)
                      .   .............+.+++.+||+.||++|||+.|+++
T Consensus       234 ~---~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  271 (335)
T d2ozaa1         234 Y---EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN  271 (335)
T ss_dssp             S---SCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             C---CCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence            0   0000001122345778899999999999999999988

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-47  Score=371.93  Aligned_cols=261  Identities=23%  Similarity=0.273  Sum_probs=191.9

Q ss_pred             CceecccCcEEEEEEEeC-CCcEEEEEEEeccchhh--HHHHHHHHHHHHHHhhcCCCCcceeeeeeec-CceEEEEEec
Q 012765          147 ENLIGKGGHAEVYKGCLP-DGEVVAVKKIIKNAKED--EERISDFLSELGIVAHINHPNAAKLIGFSTE-NGFHLVLQFL  222 (457)
Q Consensus       147 ~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-~~~~lv~e~~  222 (457)
                      +++||+|+||+||+|.+. +|+.||||++.......  ......+.+|+.++++++|||||++++++.. +..++||||+
T Consensus         3 l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~   82 (299)
T d1ua2a_           3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM   82 (299)
T ss_dssp             EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECC
T ss_pred             ceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhh
Confidence            578999999999999864 69999999886543221  1223468899999999999999999996654 5578999999


Q ss_pred             CCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCCCCCCcee
Q 012765          223 PHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSHHI  302 (457)
Q Consensus       223 ~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~~~~~~~  302 (457)
                      .++++..++ .....+++..+..++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||+++........  
T Consensus        83 ~~~~~~~~~-~~~~~l~~~~~~~~~~qil~aL~~lH~---~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~~--  156 (299)
T d1ua2a_          83 ETDLEVIIK-DNSLVLTPSHIKAYMLMTLQGLEYLHQ---HWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRA--  156 (299)
T ss_dssp             SEEHHHHHT-TCCSSCCSSHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCC--
T ss_pred             cchHHhhhh-hcccCCCHHHHHHHHHHHHHHHHHhhc---cceecccCCcceEEecCCCccccccCccccccCCCccc--
Confidence            888766555 445668888899999999999999999   89999999999999999999999999999877554322  


Q ss_pred             eecccccccccChhccccC-CCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhc------cccc----------cCC
Q 012765          303 VFPIEGTFGYLSPEYFMHG-IVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAK------PLLQ----------TSN  365 (457)
Q Consensus       303 ~~~~~gt~~y~aPE~~~~~-~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~------~~~~----------~~~  365 (457)
                      .....||+.|+|||++... .|+.++|||||||++|||+||..||............      +...          ...
T Consensus       157 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~  236 (299)
T d1ua2a_         157 YTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVT  236 (299)
T ss_dssp             CCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCC
T ss_pred             ccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchhhh
Confidence            2235699999999998754 6899999999999999999999999864432211100      0000          000


Q ss_pred             cccccCchhhcccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH--HHhcC
Q 012765          366 FKELVDPRLADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQ--LLRGE  414 (457)
Q Consensus       366 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~--~L~~~  414 (457)
                      ........+.. ........+.+++.+||+.||++|||+.|+++  .++..
T Consensus       237 ~~~~~~~~~~~-~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~  286 (299)
T d1ua2a_         237 FKSFPGIPLHH-IFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNR  286 (299)
T ss_dssp             CCCCCCCCHHH-HCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSS
T ss_pred             hccCCCCChHH-hcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCCC
Confidence            00000000000 00112245778999999999999999999987  45544

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-47  Score=370.43  Aligned_cols=267  Identities=22%  Similarity=0.314  Sum_probs=199.1

Q ss_pred             cCCCCCceecccCcEEEEEEEe-CCCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeecC-ceEEEE
Q 012765          142 DNFNSENLIGKGGHAEVYKGCL-PDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTEN-GFHLVL  219 (457)
Q Consensus       142 ~~f~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~-~~~lv~  219 (457)
                      ++|++.+.||+|+||+||+|.+ .+|+.||||++.... ........+.+|+.++++++|||||++++++.++ ..++||
T Consensus         2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~   80 (298)
T d1gz8a_           2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDT-ETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVF   80 (298)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC--------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhh-cChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEE
Confidence            6899999999999999999986 469999999986433 2223356889999999999999999999966554 578999


Q ss_pred             EecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCCCCCC
Q 012765          220 QFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWS  299 (457)
Q Consensus       220 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~~~~  299 (457)
                      ||+.++.+..........+++..+..++.||+.||.|||+   .+||||||||+|||++.++.+||+|||+++.......
T Consensus        81 e~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~---~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~~  157 (298)
T d1gz8a_          81 EFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR  157 (298)
T ss_dssp             ECCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCSB
T ss_pred             eecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhc---CCEEccccCchheeecccCcceeccCCcceeccCCcc
Confidence            9997665544444556679999999999999999999999   8999999999999999999999999999987754322


Q ss_pred             ceeeecccccccccChhccccCC-CCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhc------cc-------cccC-
Q 012765          300 HHIVFPIEGTFGYLSPEYFMHGI-VDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAK------PL-------LQTS-  364 (457)
Q Consensus       300 ~~~~~~~~gt~~y~aPE~~~~~~-~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~------~~-------~~~~-  364 (457)
                        ......||+.|+|||.+.... ++.++|||||||++|+|++|+.||.........+..      +.       .... 
T Consensus       158 --~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  235 (298)
T d1gz8a_         158 --TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPD  235 (298)
T ss_dssp             --CTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTT
T ss_pred             --cceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhccccccccc
Confidence              223456999999999887655 578999999999999999999999865432221110      00       0000 


Q ss_pred             ---CcccccCchhhcccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH--HhcCC
Q 012765          365 ---NFKELVDPRLADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQL--LRGEG  415 (457)
Q Consensus       365 ---~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~--L~~~~  415 (457)
                         ............ ........+.+++.+||+.||++|||+.|+++.  ++.+.
T Consensus       236 ~~~~~~~~~~~~~~~-~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~~  290 (298)
T d1gz8a_         236 YKPSFPKWARQDFSK-VVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVT  290 (298)
T ss_dssp             CCTTSCCCCCCCHHH-HSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTCC
T ss_pred             cccccccccccchhh-hccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccCC
Confidence               000000000000 011122456788999999999999999999983  65553

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-47  Score=370.56  Aligned_cols=267  Identities=19%  Similarity=0.297  Sum_probs=196.4

Q ss_pred             hhcCCCCCceecccCcEEEEEEEeC-C-CcEEEEEEEeccchhhHHHHHHHHHHHHHHhhc---CCCCcceeeeeeec--
Q 012765          140 ATDNFNSENLIGKGGHAEVYKGCLP-D-GEVVAVKKIIKNAKEDEERISDFLSELGIVAHI---NHPNAAKLIGFSTE--  212 (457)
Q Consensus       140 ~~~~f~~~~~LG~G~~g~Vy~~~~~-~-~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l---~hpniv~l~~~~~~--  212 (457)
                      ..++|++.+.||+|+||+||+|.+. + ++.||||++....... .....+.+|+.+++.+   +||||+++++++..  
T Consensus         5 ~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~-~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~   83 (305)
T d1blxa_           5 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEE-GMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSR   83 (305)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTT-SCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEE
T ss_pred             CcCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccc-hHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccc
Confidence            3578999999999999999999863 4 6679999986533221 1122455666666554   89999999996632  


Q ss_pred             ----CceEEEEEecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeec
Q 012765          213 ----NGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDF  288 (457)
Q Consensus       213 ----~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DF  288 (457)
                          ...+++|||+.++.+..........+++..+..++.||+.||.|||+   .+|+||||||+|||++.++.+||+||
T Consensus        84 ~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~---~~ivHrDiKp~NILi~~~~~~kl~df  160 (305)
T d1blxa_          84 TDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADF  160 (305)
T ss_dssp             CSSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECSC
T ss_pred             cccCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHh---CCEEecCCCccEEEEcCCCCeeecch
Confidence                24679999999887766666667779999999999999999999999   89999999999999999999999999


Q ss_pred             cccccCCCCCCceeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhc------ccc-
Q 012765          289 GLAKWLPDNWSHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAK------PLL-  361 (457)
Q Consensus       289 Gl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~------~~~-  361 (457)
                      |++.......   ......||+.|+|||++.+..|+.++|||||||++|||++|+.||............      +.. 
T Consensus       161 g~~~~~~~~~---~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~  237 (305)
T d1blxa_         161 GLARIYSFQM---ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEE  237 (305)
T ss_dssp             CSCCCCCGGG---GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGG
T ss_pred             hhhhhhcccc---cCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchh
Confidence            9987654332   233456999999999999999999999999999999999999999865432211100      000 


Q ss_pred             ---ccCC-----cccccCchhhcccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH--HHhcC
Q 012765          362 ---QTSN-----FKELVDPRLADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQ--LLRGE  414 (457)
Q Consensus       362 ---~~~~-----~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~--~L~~~  414 (457)
                         ....     ........+ ..+.......+.+++.+||+.||++|||+.|+++  .++++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~i  299 (305)
T d1blxa_         238 DWPRDVALPRQAFHSKSAQPI-EKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDL  299 (305)
T ss_dssp             GSCTTCSSCGGGSCCCCCCCG-GGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTC
T ss_pred             cccccccchhhhhccccccch-hhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhcCc
Confidence               0000     000000000 0011112234667889999999999999999987  24444

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=1.3e-46  Score=361.68  Aligned_cols=261  Identities=23%  Similarity=0.308  Sum_probs=193.5

Q ss_pred             cCCCCCceecccCcEEEEEEEeCCCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeec-CceEEEEE
Q 012765          142 DNFNSENLIGKGGHAEVYKGCLPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTE-NGFHLVLQ  220 (457)
Q Consensus       142 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-~~~~lv~e  220 (457)
                      ++|.+.+.||+|+||+||+|.+.+|+.||||++...... ......+.+|+.+|++++|||||++++++.+ +..++++|
T Consensus         2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~-~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e   80 (286)
T d1ob3a_           2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKED-EGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFE   80 (286)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGG-GCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEE
T ss_pred             CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcC-hHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEE
Confidence            678899999999999999999989999999998654332 2334688999999999999999999996655 45678888


Q ss_pred             ecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCCCCCCc
Q 012765          221 FLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWSH  300 (457)
Q Consensus       221 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~~~~~  300 (457)
                      ++.++.+..+. .....+++..+..++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||++.........
T Consensus        81 ~~~~~~~~~~~-~~~~~l~~~~~~~i~~qi~~~L~~LH~---~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~~  156 (286)
T d1ob3a_          81 HLDQDLKKLLD-VCEGGLESVTAKSFLLQLLNGIAYCHD---RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRK  156 (286)
T ss_dssp             CCSEEHHHHHH-TSTTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC----
T ss_pred             eehhhhHHHHH-hhcCCcchhhhHHHHHHHHHHHHHhcc---CcEEecCCCCceeeEcCCCCEEecccccceecccCccc
Confidence            88766555444 455679999999999999999999999   89999999999999999999999999999876543221


Q ss_pred             eeeecccccccccChhccccC-CCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhc------cccc-cCCcccc---
Q 012765          301 HIVFPIEGTFGYLSPEYFMHG-IVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAK------PLLQ-TSNFKEL---  369 (457)
Q Consensus       301 ~~~~~~~gt~~y~aPE~~~~~-~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~------~~~~-~~~~~~~---  369 (457)
                        .....|++.|+|||.+.+. .++.++|||||||++|||++|+.||............      +... .......   
T Consensus       157 --~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  234 (286)
T d1ob3a_         157 --YTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKY  234 (286)
T ss_dssp             -------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTC
T ss_pred             --cceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhhc
Confidence              2234589999999998754 5799999999999999999999999864432111100      0000 0000000   


Q ss_pred             ------cCchhhcccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 012765          370 ------VDPRLADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQ  409 (457)
Q Consensus       370 ------~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~  409 (457)
                            ..+.............+.+++.+||+.||++|||+.|+++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~  280 (286)
T d1ob3a_         235 DPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE  280 (286)
T ss_dssp             CTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             ccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                  0000000001112245678899999999999999999974

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-47  Score=366.65  Aligned_cols=242  Identities=21%  Similarity=0.335  Sum_probs=190.6

Q ss_pred             hcCCCCCceecccCcEEEEEEEeC-CCcEEEEEEEeccchhhH---HHHHHHHHHHHHHhhcC--CCCcceeeeeeec-C
Q 012765          141 TDNFNSENLIGKGGHAEVYKGCLP-DGEVVAVKKIIKNAKEDE---ERISDFLSELGIVAHIN--HPNAAKLIGFSTE-N  213 (457)
Q Consensus       141 ~~~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~---~~~~~~~~E~~~l~~l~--hpniv~l~~~~~~-~  213 (457)
                      .++|++.+.||+|+||+||+|.+. +|+.||||++.+......   .....+.+|+.++++++  |||||++++++.+ +
T Consensus         3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~   82 (273)
T d1xwsa_           3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD   82 (273)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred             CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCC
Confidence            367999999999999999999864 689999999865322110   11234678999999986  8999999997655 4


Q ss_pred             ceEEEEEecCC-CChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCC-CcEEEeecccc
Q 012765          214 GFHLVLQFLPH-GSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSED-YEAQISDFGLA  291 (457)
Q Consensus       214 ~~~lv~e~~~~-gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~-~~~kL~DFGl~  291 (457)
                      ..++||||+.+ +++.+++.. ...+++..+..++.||+.||.|||+   .+|+||||||+|||++.+ +.+||+|||++
T Consensus        83 ~~~lv~e~~~~~~~l~~~~~~-~~~l~e~~~~~~~~qi~~al~~lH~---~~iiHrDiKp~NIll~~~~~~vkl~DFG~a  158 (273)
T d1xwsa_          83 SFVLILERPEPVQDLFDFITE-RGALQEELARSFFWQVLEAVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFGSG  158 (273)
T ss_dssp             EEEEEEECCSSEEEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred             eEEEEEEeccCcchHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHH---CCCccccCcccceEEecCCCeEEECccccc
Confidence            57899999976 566666643 3468999999999999999999999   899999999999999854 79999999999


Q ss_pred             ccCCCCCCceeeecccccccccChhccccCCC-CcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhccccccCCccccc
Q 012765          292 KWLPDNWSHHIVFPIEGTFGYLSPEYFMHGIV-DEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSNFKELV  370 (457)
Q Consensus       292 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~  370 (457)
                      +......    .....||+.|+|||++.+..+ +.++|||||||++|||+||+.||......  . ..    ..      
T Consensus       159 ~~~~~~~----~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~i--~-~~----~~------  221 (273)
T d1xwsa_         159 ALLKDTV----YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI--I-RG----QV------  221 (273)
T ss_dssp             EECCSSC----BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHH--H-HC----CC------
T ss_pred             eeccccc----ccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCchHH--h-hc----cc------
Confidence            8765442    234569999999999987765 56789999999999999999999853211  0 00    00      


Q ss_pred             CchhhcccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 012765          371 DPRLADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQ  409 (457)
Q Consensus       371 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~  409 (457)
                        .+...++    ..+.+++.+||+.||++|||+.|+++
T Consensus       222 --~~~~~~s----~~~~~li~~~L~~dp~~R~s~~eil~  254 (273)
T d1xwsa_         222 --FFRQRVS----SECQHLIRWCLALRPSDRPTFEEIQN  254 (273)
T ss_dssp             --CCSSCCC----HHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             --CCCCCCC----HHHHHHHHHHccCCHhHCcCHHHHhc
Confidence              0111222    34677889999999999999999976

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-45  Score=363.06  Aligned_cols=266  Identities=23%  Similarity=0.279  Sum_probs=195.1

Q ss_pred             hhcCCCCCceecccCcEEEEEEEeC-CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeecC-----
Q 012765          140 ATDNFNSENLIGKGGHAEVYKGCLP-DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTEN-----  213 (457)
Q Consensus       140 ~~~~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~-----  213 (457)
                      ..++|++++.||+|+||+||+|.+. +|+.||||++..... .....+.+.+|+.+|+.++|||||++++++...     
T Consensus        16 ~~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~   94 (346)
T d1cm8a_          16 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQ-SELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDD   94 (346)
T ss_dssp             CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTS-SHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTT
T ss_pred             cCCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhc-ChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccc
Confidence            3578999999999999999999864 699999999865433 334567899999999999999999999977654     


Q ss_pred             --ceEEEEEecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeecccc
Q 012765          214 --GFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLA  291 (457)
Q Consensus       214 --~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~  291 (457)
                        .+++||||+ +++|..++.  ...+++..+..++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||++
T Consensus        95 ~~~~~lv~e~~-~~~l~~~~~--~~~l~~~~~~~~~~qi~~aL~~LH~---~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a  168 (346)
T d1cm8a_          95 FTDFYLVMPFM-GTDLGKLMK--HEKLGEDRIQFLVYQMLKGLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLA  168 (346)
T ss_dssp             CCCCEEEEECC-SEEHHHHHH--HCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred             cceEEEEEecc-cccHHHHHH--hccccHHHHHHHHHHHHHHHHHHHh---CCCcccccCcchhhcccccccccccccce
Confidence              368999998 556666653  3458999999999999999999999   89999999999999999999999999999


Q ss_pred             ccCCCCCCceeeecccccccccChhccccC-CCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhccccccC------
Q 012765          292 KWLPDNWSHHIVFPIEGTFGYLSPEYFMHG-IVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTS------  364 (457)
Q Consensus       292 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~~~~~~~------  364 (457)
                      +......     ....||+.|+|||++.+. .++.++|||||||++|||++|+.||...+.....+........      
T Consensus       169 ~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  243 (346)
T d1cm8a_         169 RQADSEM-----TGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFV  243 (346)
T ss_dssp             EECCSSC-----CSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred             eccCCcc-----ccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHH
Confidence            8775542     335599999999998764 5789999999999999999999999875432211100000000      


Q ss_pred             -------------CcccccCchhhcccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH--HhcCCCCC
Q 012765          365 -------------NFKELVDPRLADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQL--LRGEGGQT  418 (457)
Q Consensus       365 -------------~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~--L~~~~~~~  418 (457)
                                   ...+.....+... .......+.+++.+||+.||.+|||+.|+++.  ++.+....
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~~~~  311 (346)
T d1cm8a_         244 QRLQSDEAKNYMKGLPELEKKDFASI-LTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDTE  311 (346)
T ss_dssp             HTCSCHHHHHHHHHSCCCCCCCGGGT-CTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC---
T ss_pred             hhhcchhhhhhhccCCcccccchHHh-ccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCCCcc
Confidence                         0000000000000 01112346678999999999999999999983  66665433

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-45  Score=363.17  Aligned_cols=262  Identities=19%  Similarity=0.225  Sum_probs=195.1

Q ss_pred             hcCCCCCceecccCcEEEEEEEe-CCCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeecCc-----
Q 012765          141 TDNFNSENLIGKGGHAEVYKGCL-PDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTENG-----  214 (457)
Q Consensus       141 ~~~f~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~-----  214 (457)
                      .++|++++.||+|+||+||+|.+ .+|+.||||++....  .....+.+++|+.+|+.++||||+++++++....     
T Consensus         7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~   84 (345)
T d1pmea_           7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE--HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMK   84 (345)
T ss_dssp             CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTT--CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCC
T ss_pred             CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhc--ChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccc
Confidence            46799999999999999999986 479999999986433  2344568899999999999999999999775432     


Q ss_pred             eEEEEEecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccC
Q 012765          215 FHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWL  294 (457)
Q Consensus       215 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~  294 (457)
                      .+++++|+.+|+|.+++..  ..+++..+..++.||+.||.|||+   .+||||||||+|||++.++.+||+|||++...
T Consensus        85 ~~~l~~~~~~g~L~~~l~~--~~l~~~~i~~i~~qil~al~yLH~---~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~  159 (345)
T d1pmea_          85 DVYLVTHLMGADLYKLLKT--QHLSNDHICYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVA  159 (345)
T ss_dssp             CEEEEEECCCEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred             eEEEEEeecCCchhhhhhc--CCCCHHHHHHHHHHHHHHHHHHHH---CCCcCCCCCcceEEECCCCCEEEcccCceeec
Confidence            4566778889999999854  358999999999999999999999   89999999999999999999999999999876


Q ss_pred             CCCCCc-eeeecccccccccChhccc-cCCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhcccc-ccCC------
Q 012765          295 PDNWSH-HIVFPIEGTFGYLSPEYFM-HGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLL-QTSN------  365 (457)
Q Consensus       295 ~~~~~~-~~~~~~~gt~~y~aPE~~~-~~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~~~~-~~~~------  365 (457)
                      ...... .......||+.|+|||++. +..++.++||||+||++|||++|+.||.........+..... ....      
T Consensus       160 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (345)
T d1pmea_         160 DPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNC  239 (345)
T ss_dssp             CGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHT
T ss_pred             cCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhh
Confidence            443221 1123456999999999985 456789999999999999999999999865432221111000 0000      


Q ss_pred             ------------cccccCchhhcccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 012765          366 ------------FKELVDPRLADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQL  410 (457)
Q Consensus       366 ------------~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~  410 (457)
                                  ............ .......+.+++.+||+.||.+|||+.|+++.
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h  295 (345)
T d1pmea_         240 IINLKARNYLLSLPHKNKVPWNRL-FPNADSKALDLLDKMLTFNPHKRIEVEQALAH  295 (345)
T ss_dssp             CCCHHHHHHHHTSCCCCCCCHHHH-CTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             hhhhhhhcccccCCccCCCCHHHh-CCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence                        000000000000 00111356789999999999999999999973

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-45  Score=363.94  Aligned_cols=260  Identities=23%  Similarity=0.285  Sum_probs=192.5

Q ss_pred             CCCCCceecccCcEEEEEEEeC-CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeecC-------c
Q 012765          143 NFNSENLIGKGGHAEVYKGCLP-DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTEN-------G  214 (457)
Q Consensus       143 ~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~-------~  214 (457)
                      +|+..++||+|+||+||+|.+. +|+.||||++.....       .+.+|+.+|++++||||+++++++...       .
T Consensus        21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~-------~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~   93 (350)
T d1q5ka_          21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVY   93 (350)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS-------SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCE
T ss_pred             CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch-------HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceE
Confidence            5677889999999999999975 699999999876432       234799999999999999999966432       2


Q ss_pred             eEEEEEecCCCChhhhhh--cCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCC-cEEEeecccc
Q 012765          215 FHLVLQFLPHGSLSSLLF--GSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDY-EAQISDFGLA  291 (457)
Q Consensus       215 ~~lv~e~~~~gsL~~~l~--~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~-~~kL~DFGl~  291 (457)
                      +++||||++++.+..+..  .....+++..+..++.||+.||.|||+   .+|+||||||+|||++.++ .+||+|||++
T Consensus        94 ~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~---~~IiHrDiKp~NILl~~~~~~~kl~DFG~a  170 (350)
T d1q5ka_          94 LNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSA  170 (350)
T ss_dssp             EEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECTTTCCEEECCCTTC
T ss_pred             EEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHh---cCCcccCCCcceEEEecCCCceeEecccch
Confidence            579999998765444332  355679999999999999999999999   8999999999999999775 8999999999


Q ss_pred             ccCCCCCCceeeecccccccccChhcccc-CCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhc------------
Q 012765          292 KWLPDNWSHHIVFPIEGTFGYLSPEYFMH-GIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAK------------  358 (457)
Q Consensus       292 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~------------  358 (457)
                      +.+.....   .....||..|+|||.+.+ ..|+.++|||||||++|||++|+.||............            
T Consensus       171 ~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~  247 (350)
T d1q5ka_         171 KQLVRGEP---NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQI  247 (350)
T ss_dssp             EECCTTSC---CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred             hhccCCcc---cccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhh
Confidence            87754332   233569999999998875 56899999999999999999999999764432211100            


Q ss_pred             ----cccccCCcccccCchhhcccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH--HHhcCC
Q 012765          359 ----PLLQTSNFKELVDPRLADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQ--LLRGEG  415 (457)
Q Consensus       359 ----~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~--~L~~~~  415 (457)
                          .......+...................+.+++.+||+.||++|||+.|+++  .++.+.
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~  310 (350)
T d1q5ka_         248 REMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELR  310 (350)
T ss_dssp             HHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGG
T ss_pred             hhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhcccc
Confidence                000011111111111111111122335678899999999999999999986  355443

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.8e-45  Score=356.03  Aligned_cols=264  Identities=21%  Similarity=0.283  Sum_probs=192.3

Q ss_pred             hcCCCCCceecccCcEEEEEEEe-CCCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeec-------
Q 012765          141 TDNFNSENLIGKGGHAEVYKGCL-PDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTE-------  212 (457)
Q Consensus       141 ~~~f~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-------  212 (457)
                      .++|++.+.||+|+||+||+|.+ .+|+.||||++...... ......+.+|+.+|++++||||+++++++..       
T Consensus         9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~-~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~   87 (318)
T d3blha1           9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEK-EGFPITALREIKILQLLKHENVVNLIEICRTKASPYNR   87 (318)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CT-TSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC-------
T ss_pred             cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcc-hHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccc
Confidence            37788999999999999999986 47999999987543222 2234578899999999999999999986533       


Q ss_pred             --CceEEEEEecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccc
Q 012765          213 --NGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGL  290 (457)
Q Consensus       213 --~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl  290 (457)
                        +..+++|||+.++.+.... .....++...+..++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||+
T Consensus        88 ~~~~~~iv~e~~~~~~~~~~~-~~~~~~~~~~~~~i~~qil~~l~~lH~---~~ivHrDlKp~NILl~~~~~~kl~dfg~  163 (318)
T d3blha1          88 CKGSIYLVFDFCEHDLAGLLS-NVLVKFTLSEIKRVMQMLLNGLYYIHR---NKILHRDMKAANVLITRDGVLKLADFGL  163 (318)
T ss_dssp             ---CEEEEEECCCEEHHHHHT-CTTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTSCEEECCCTT
T ss_pred             cCceEEEEEeccCCCccchhh-hcccccccHHHHHHHHHHHHHHHHhcc---CCEEecCcCchheeecCCCcEEeeecce
Confidence              3468999999877665443 445568888999999999999999999   8999999999999999999999999999


Q ss_pred             cccCCCCCCc--eeeecccccccccChhccccC-CCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhc-ccc---cc
Q 012765          291 AKWLPDNWSH--HIVFPIEGTFGYLSPEYFMHG-IVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAK-PLL---QT  363 (457)
Q Consensus       291 ~~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~-~~~---~~  363 (457)
                      +..+......  .......||+.|+|||++.+. .|+.++|||||||++|||++|+.||............ ...   ..
T Consensus       164 ~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~  243 (318)
T d3blha1         164 ARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITP  243 (318)
T ss_dssp             CEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCT
T ss_pred             eeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCCh
Confidence            9876533211  112235699999999998765 6899999999999999999999999864432211100 000   00


Q ss_pred             C--------Ccc-ccc-----Cchhhccc-CHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 012765          364 S--------NFK-ELV-----DPRLADAY-DLAEMKRAMLTASVCIHHLSTMRPQMTRVLQ  409 (457)
Q Consensus       364 ~--------~~~-~~~-----d~~l~~~~-~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~  409 (457)
                      .        ... .+.     ...+...+ .......+.+++.+||+.||++|||+.|+++
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~  304 (318)
T d3blha1         244 EVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN  304 (318)
T ss_dssp             TTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             hhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHc
Confidence            0        000 000     00000000 0011234567899999999999999999987

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=1.1e-43  Score=347.97  Aligned_cols=248  Identities=17%  Similarity=0.247  Sum_probs=192.3

Q ss_pred             cCCCCCceecccCcEEEEEEEe-CCCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcC-CCCcceeeeeeec---CceE
Q 012765          142 DNFNSENLIGKGGHAEVYKGCL-PDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHIN-HPNAAKLIGFSTE---NGFH  216 (457)
Q Consensus       142 ~~f~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~---~~~~  216 (457)
                      ++|++.+.||+|+||+||+|.+ .+|+.||||++....      ...+.+|+.+|.+++ ||||+++++++..   ...+
T Consensus        35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~------~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~  108 (328)
T d3bqca1          35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK------KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPA  108 (328)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC------HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEE
T ss_pred             cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH------HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCcee
Confidence            6799999999999999999986 469999999986432      246789999999995 9999999997653   3478


Q ss_pred             EEEEecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCC-cEEEeeccccccCC
Q 012765          217 LVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDY-EAQISDFGLAKWLP  295 (457)
Q Consensus       217 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~-~~kL~DFGl~~~~~  295 (457)
                      +||||+.+++|..+.    +.+++..+..++.||+.||.|||+   .+|+||||||+|||++.++ .+||+|||+++...
T Consensus       109 ~v~e~~~~~~L~~~~----~~l~e~~i~~i~~qil~aL~~LH~---~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~  181 (328)
T d3bqca1         109 LVFEHVNNTDFKQLY----QTLTDYDIRFYMYEILKALDYCHS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH  181 (328)
T ss_dssp             EEEECCCSCBGGGTT----TSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTTTEEEECCGGGCEECC
T ss_pred             EEEeecCCCcHHHHh----cCCCHHHHHHHHHHHHHHHHHHhh---cccccccccccceEEcCCCCeeeecccccceecc
Confidence            999999999987664    458899999999999999999999   8999999999999998655 69999999998775


Q ss_pred             CCCCceeeecccccccccChhccccC-CCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhc----------------
Q 012765          296 DNWSHHIVFPIEGTFGYLSPEYFMHG-IVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAK----------------  358 (457)
Q Consensus       296 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~----------------  358 (457)
                      ....   .....+|+.|+|||.+.+. .++.++|||||||++|||++|+.||.........+..                
T Consensus       182 ~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~  258 (328)
T d3bqca1         182 PGQE---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDK  258 (328)
T ss_dssp             TTCC---CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHH
T ss_pred             CCCc---ccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhh
Confidence            5432   2334589999999998765 4799999999999999999999999764432211100                


Q ss_pred             -cccccCC------------cccccCchhhcccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 012765          359 -PLLQTSN------------FKELVDPRLADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQ  409 (457)
Q Consensus       359 -~~~~~~~------------~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~  409 (457)
                       .......            .............    ...+.+++.+||+.||.+|||+.|+++
T Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----s~~~~dli~~mL~~dP~~R~ta~e~L~  318 (328)
T d3bqca1         259 YNIELDPRFNDILGRHSRKRWERFVHSENQHLV----SPEALDFLDKLLRYDHQSRLTAREAME  318 (328)
T ss_dssp             TTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGC----CHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             cccccCcccchhcccccccchhhcccccccccC----CHHHHHHHHHHccCChhHCcCHHHHhc
Confidence             0000000            0111111111112    235678899999999999999999986

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=4.1e-44  Score=346.41  Aligned_cols=260  Identities=21%  Similarity=0.241  Sum_probs=193.6

Q ss_pred             hcCCCCCceecccCcEEEEEEEe-CCCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeee-eeecCc-eEE
Q 012765          141 TDNFNSENLIGKGGHAEVYKGCL-PDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIG-FSTENG-FHL  217 (457)
Q Consensus       141 ~~~f~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~-~~~~~~-~~l  217 (457)
                      .++|++.+.||+|+||+||+|.+ .+|+.||||.+......     ..+..|+++++.++|+|++..+. +..++. .++
T Consensus         6 g~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~-----~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~i   80 (299)
T d1ckia_           6 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH-----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVM   80 (299)
T ss_dssp             TTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTS-----CCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEE
T ss_pred             CCEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccC-----HHHHHHHHHHHHccCCCcccEEEEEEecCCEEEE
Confidence            35799999999999999999986 46899999987654332     25778999999998877666654 545544 567


Q ss_pred             EEEecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcC---CCcEEEeeccccccC
Q 012765          218 VLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSE---DYEAQISDFGLAKWL  294 (457)
Q Consensus       218 v~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~---~~~~kL~DFGl~~~~  294 (457)
                      ||||+ ++++...+......+++..+..++.|++.||.|||+   .+|+||||||+|||++.   +..+||+|||+++.+
T Consensus        81 vme~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~  156 (299)
T d1ckia_          81 VMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHS---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY  156 (299)
T ss_dssp             EEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECCGGGTTCEEECCCSSCEEC
T ss_pred             EEEEc-CCchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHH---CCeeeccCCHhhccccccCCCceeeeeccCcceec
Confidence            78877 667777776667789999999999999999999999   89999999999999864   457999999999987


Q ss_pred             CCCCCc-----eeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhccccccCCcccc
Q 012765          295 PDNWSH-----HIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSNFKEL  369 (457)
Q Consensus       295 ~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~~~  369 (457)
                      ......     .......||+.|||||++.+..++.++|||||||++|||+||+.||.........+.......... ..
T Consensus       157 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~-~~  235 (299)
T d1ckia_         157 RDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKM-ST  235 (299)
T ss_dssp             BCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHH-HS
T ss_pred             cccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccC-CC
Confidence            543322     122345699999999999999999999999999999999999999976332211111000000000 00


Q ss_pred             cCchhhcccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q 012765          370 VDPRLADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQLLRGE  414 (457)
Q Consensus       370 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~  414 (457)
                      ..+.+...+    ...+.+++..||+.+|++||++.++.+.|+..
T Consensus       236 ~~~~~~~~~----p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~  276 (299)
T d1ckia_         236 PIEVLCKGY----PSEFATYLNFCRSLRFDDKPDYSYLRQLFRNL  276 (299)
T ss_dssp             CHHHHTTTS----CHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHH
T ss_pred             ChhHhccCC----CHHHHHHHHHHccCChhHCcCHHHHHHHHHHH
Confidence            001111112    24567788899999999999999998888754

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.1e-44  Score=353.51  Aligned_cols=258  Identities=22%  Similarity=0.261  Sum_probs=190.2

Q ss_pred             hcCCCCCceecccCcEEEEEEEeC-CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeec-------
Q 012765          141 TDNFNSENLIGKGGHAEVYKGCLP-DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTE-------  212 (457)
Q Consensus       141 ~~~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-------  212 (457)
                      .++|++.++||+|+||+||+|.+. +|+.||||++..... .......+.+|+.++++++|||||++++++..       
T Consensus        16 ~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~   94 (355)
T d2b1pa1          16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQ-NQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEF   94 (355)
T ss_dssp             ETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTS-SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTC
T ss_pred             cCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhc-CHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccC
Confidence            367999999999999999999875 699999999876543 34456689999999999999999999997642       


Q ss_pred             CceEEEEEecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccc
Q 012765          213 NGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAK  292 (457)
Q Consensus       213 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~  292 (457)
                      ..+|+||||+.++.+ ..+   ...+++..+..++.||+.||.|||+   .+|+||||||+|||++.++.+|++|||+++
T Consensus        95 ~~~~iv~Ey~~~~l~-~~~---~~~~~~~~i~~~~~qil~gl~~LH~---~giiHrDlKP~Nil~~~~~~~kl~df~~~~  167 (355)
T d2b1pa1          95 QDVYLVMELMDANLC-QVI---QMELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLAR  167 (355)
T ss_dssp             CEEEEEEECCSEEHH-HHH---TSCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCCCC--
T ss_pred             ceeEEEEeccchHHH-Hhh---hcCCCHHHHHHHHHHHHHHHHHhhh---cccccccCCccccccccccceeeechhhhh
Confidence            457899999976544 444   2457899999999999999999999   899999999999999999999999999988


Q ss_pred             cCCCCCCceeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhh---------------
Q 012765          293 WLPDNWSHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWA---------------  357 (457)
Q Consensus       293 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~---------------  357 (457)
                      .......   .....||+.|+|||++.+..++.++||||+||+++||++|+.||...+.......               
T Consensus       168 ~~~~~~~---~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~  244 (355)
T d2b1pa1         168 TAGTSFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK  244 (355)
T ss_dssp             ----------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTT
T ss_pred             ccccccc---cccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHH
Confidence            6654322   2344689999999999999999999999999999999999999976442221100               


Q ss_pred             -----------ccccccCCcccccCchhhcc---cCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 012765          358 -----------KPLLQTSNFKELVDPRLADA---YDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQ  409 (457)
Q Consensus       358 -----------~~~~~~~~~~~~~d~~l~~~---~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~  409 (457)
                                 ....................   ........+.+++.+||+.||++|||+.|+++
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~  310 (355)
T d2b1pa1         245 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ  310 (355)
T ss_dssp             SCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             hhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence                       00000111111111111111   11234566888999999999999999999986

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-43  Score=340.80  Aligned_cols=261  Identities=20%  Similarity=0.237  Sum_probs=196.3

Q ss_pred             cCCCCCceecccCcEEEEEEEeC-CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeeecCc-eEEEE
Q 012765          142 DNFNSENLIGKGGHAEVYKGCLP-DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFSTENG-FHLVL  219 (457)
Q Consensus       142 ~~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~-~~lv~  219 (457)
                      ++|++++.||+|+||+||+|.+. +|+.||||++..... .......+.+|+.+++.++||||+++++++.+.. .++++
T Consensus         2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~   80 (292)
T d1unla_           2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVF   80 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCS-STTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhC-ChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEe
Confidence            57899999999999999999864 689999999865443 2344678999999999999999999999766655 57888


Q ss_pred             EecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccCCCCCC
Q 012765          220 QFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWLPDNWS  299 (457)
Q Consensus       220 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~~~~~~  299 (457)
                      +++.+++|..++. ....+++..+..++.|++.||.|||+   .+|+||||||+|||++.++.+||+|||.++.......
T Consensus        81 ~~~~~~~l~~~~~-~~~~~~~~~~~~~~~q~~~aL~~lH~---~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~  156 (292)
T d1unla_          81 EFCDQDLKKYFDS-CNGDLDPEIVKSFLFQLLKGLGFCHS---RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR  156 (292)
T ss_dssp             ECCSEEHHHHHHH-TTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCS
T ss_pred             eeccccccccccc-cccccchhHHHHHHHHHHHHHHHhhc---CCEeeecccCcccccccCCceeeeecchhhcccCCCc
Confidence            9998888777664 45568899999999999999999999   8999999999999999999999999999988755432


Q ss_pred             ceeeecccccccccChhccccCC-CCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhc-------cccccC-Cccccc
Q 012765          300 HHIVFPIEGTFGYLSPEYFMHGI-VDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAK-------PLLQTS-NFKELV  370 (457)
Q Consensus       300 ~~~~~~~~gt~~y~aPE~~~~~~-~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~-------~~~~~~-~~~~~~  370 (457)
                      ..  ....++..|+|||.+.... ++.++|||||||++|||++|+.||............       +..... ......
T Consensus       157 ~~--~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (292)
T d1unla_         157 CY--SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLP  234 (292)
T ss_dssp             CC--CSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGST
T ss_pred             cc--eeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhcc
Confidence            22  2334788999999987655 699999999999999999999997542221111000       000000 000000


Q ss_pred             C---------chhhcccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 012765          371 D---------PRLADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQ  409 (457)
Q Consensus       371 d---------~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~  409 (457)
                      +         ..-...........+.+++.+||+.||.+|||+.||++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~  282 (292)
T d1unla_         235 DYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ  282 (292)
T ss_dssp             TCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             cccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            0         00000001112235667889999999999999999976

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=2e-43  Score=340.59  Aligned_cols=260  Identities=16%  Similarity=0.180  Sum_probs=198.2

Q ss_pred             hcCCCCCceecccCcEEEEEEEeC-CCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCC-CCcceeeeeeecCc-eEE
Q 012765          141 TDNFNSENLIGKGGHAEVYKGCLP-DGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINH-PNAAKLIGFSTENG-FHL  217 (457)
Q Consensus       141 ~~~f~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h-pniv~l~~~~~~~~-~~l  217 (457)
                      .++|.+.+.||+|+||+||+|.+. +|+.||||.+......     ..+.+|++.++.+.| +|++.+++++..+. .++
T Consensus         4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~-----~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~   78 (293)
T d1csna_           4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA-----PQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVL   78 (293)
T ss_dssp             TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTS-----CCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEE
T ss_pred             CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccCc-----HHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEE
Confidence            467999999999999999999864 6899999987554322     246678888888865 89999999766655 567


Q ss_pred             EEEecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcC-----CCcEEEeeccccc
Q 012765          218 VLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSE-----DYEAQISDFGLAK  292 (457)
Q Consensus       218 v~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~-----~~~~kL~DFGl~~  292 (457)
                      ||||+ +++|.+++......++...+..++.|++.||.|||+   .+|+||||||+|||++.     ++.+||+|||+++
T Consensus        79 vme~~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~---~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~  154 (293)
T d1csna_          79 VIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHE---KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK  154 (293)
T ss_dssp             EEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCE
T ss_pred             EEEec-CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHH---CCceeccCCccceeecCcccccCCceEEcccceeE
Confidence            88887 789999987777789999999999999999999999   89999999999999974     5689999999998


Q ss_pred             cCCCCCCc-----eeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhccccccCCcc
Q 012765          293 WLPDNWSH-----HIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTSNFK  367 (457)
Q Consensus       293 ~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~~~~~~~~~~  367 (457)
                      ........     .......||+.|||||++.+..++.++|||||||++|||+||+.||.................... 
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~-  233 (293)
T d1csna_         155 FYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQ-  233 (293)
T ss_dssp             ESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHH-
T ss_pred             EcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccC-
Confidence            86543221     112345699999999999999999999999999999999999999986433221111000000000 


Q ss_pred             cccCchhhcccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q 012765          368 ELVDPRLADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQLLRGE  414 (457)
Q Consensus       368 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~  414 (457)
                      ...-+.+...++    ..+..++..|+..+|++||++..+.+.|+.+
T Consensus       234 ~~~~~~l~~~~p----~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~  276 (293)
T d1csna_         234 STPLRELCAGFP----EEFYKYMHYARNLAFDATPDYDYLQGLFSKV  276 (293)
T ss_dssp             HSCHHHHTTTSC----HHHHHHHHHHHHCCTTCCCCHHHHHHHHHHH
T ss_pred             CCChHHhcCCCC----HHHHHHHHHHhcCCcccCcCHHHHHHHHHHH
Confidence            000011111222    3466778889999999999999888877664

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.2e-44  Score=353.66  Aligned_cols=264  Identities=23%  Similarity=0.277  Sum_probs=197.5

Q ss_pred             hhcCCCCCceecccCcEEEEEEEe-CCCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCCCcceeeeeee------c
Q 012765          140 ATDNFNSENLIGKGGHAEVYKGCL-PDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHPNAAKLIGFST------E  212 (457)
Q Consensus       140 ~~~~f~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~------~  212 (457)
                      ..++|++.+.||+|+||+||+|.+ .+|+.||||++.+... .......+.+|+.+|+.++|||||++++++.      +
T Consensus        16 ~~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~   94 (348)
T d2gfsa1          16 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ-SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEE   94 (348)
T ss_dssp             EETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTS-SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTT
T ss_pred             CCCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhc-ChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeecccccc
Confidence            357899999999999999999986 4799999999875433 3344567899999999999999999999764      2


Q ss_pred             CceEEEEEecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccc
Q 012765          213 NGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAK  292 (457)
Q Consensus       213 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~  292 (457)
                      ...+++|+|+.+|+|.+++.  .+.+++..+..++.||+.||.|||+   .+|+||||||+|||++.++.+|++|||++.
T Consensus        95 ~~~~~i~~~~~gg~L~~~~~--~~~l~e~~~~~i~~qil~aL~~LH~---~giiHrDiKp~NILi~~~~~~kl~dfg~a~  169 (348)
T d2gfsa1          95 FNDVYLVTHLMGADLNNIVK--CQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR  169 (348)
T ss_dssp             CCCCEEEEECCSEEHHHHHT--TCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECCC----
T ss_pred             CceEEEEEeecCCchhhhcc--cccccHHHHHHHHHHHHHHHHHHHh---CCCcccccCCccccccccccccccccchhc
Confidence            34567788899999999984  3469999999999999999999999   899999999999999999999999999997


Q ss_pred             cCCCCCCceeeecccccccccChhccccC-CCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhhhccccccC-------
Q 012765          293 WLPDNWSHHIVFPIEGTFGYLSPEYFMHG-IVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIWAKPLLQTS-------  364 (457)
Q Consensus       293 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~~~~~~~~~-------  364 (457)
                      .....     .....||+.|+|||.+.+. .++.++|||||||++|+|++|+.||.+.+..............       
T Consensus       170 ~~~~~-----~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~  244 (348)
T d2gfsa1         170 HTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLK  244 (348)
T ss_dssp             CCTGG-----GSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHT
T ss_pred             ccCcc-----cccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhh
Confidence            65432     2345589999999987765 4689999999999999999999999865432211110000000       


Q ss_pred             ------------CcccccCchhhcccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH--HHhcCC
Q 012765          365 ------------NFKELVDPRLADAYDLAEMKRAMLTASVCIHHLSTMRPQMTRVLQ--LLRGEG  415 (457)
Q Consensus       365 ------------~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~--~L~~~~  415 (457)
                                  .........+... .......+.+++.+||+.||.+|||+.|+++  .+++..
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~~  308 (348)
T d2gfsa1         245 KISSESARNYIQSLTQMPKMNFANV-FIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH  308 (348)
T ss_dssp             TCCCHHHHHHHTTSCCCCCCCHHHH-STTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred             hccchhhhhhhhhcccCCCcchhhh-cCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCCC
Confidence                        0000000000000 0011234678899999999999999999997  455543

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.8e-44  Score=350.91  Aligned_cols=251  Identities=23%  Similarity=0.276  Sum_probs=192.8

Q ss_pred             cCCCCCceecccCcEEEEEEEe----CCCcEEEEEEEeccchh-hHHHHHHHHHHHHHHhhcCC-CCcceeeeeee-cCc
Q 012765          142 DNFNSENLIGKGGHAEVYKGCL----PDGEVVAVKKIIKNAKE-DEERISDFLSELGIVAHINH-PNAAKLIGFST-ENG  214 (457)
Q Consensus       142 ~~f~~~~~LG~G~~g~Vy~~~~----~~~~~vavK~~~~~~~~-~~~~~~~~~~E~~~l~~l~h-pniv~l~~~~~-~~~  214 (457)
                      ++|++.+.||+|+||+||+|..    .+|+.||||.+.+.... +....+.+.+|+.++++++| |||+++++++. ...
T Consensus        24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~  103 (322)
T d1vzoa_          24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK  103 (322)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred             hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence            6799999999999999999974    24889999988543211 11123467899999999976 89999998655 556


Q ss_pred             eEEEEEecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccccccC
Q 012765          215 FHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGLAKWL  294 (457)
Q Consensus       215 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~~~  294 (457)
                      ++++|||+.+|+|.+++.... .+.......++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||+++.+
T Consensus       104 ~~~v~e~~~~~~L~~~i~~~~-~~~e~~~~~~~~Qi~~al~~lH~---~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~~  179 (322)
T d1vzoa_         104 LHLILDYINGGELFTHLSQRE-RFTEHEVQIYVGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEF  179 (322)
T ss_dssp             EEEEECCCCSCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEESCSSEEEEC
T ss_pred             eeeeeecccccHHHHHHHhcc-cccHHHHHHHHHHHHHHHHHhhc---CCEEeccCCccceeecCCCCEEEeeccchhhh
Confidence            789999999999999986543 45677888899999999999999   89999999999999999999999999999877


Q ss_pred             CCCCCceeeecccccccccChhccccC--CCCcchhHHHHHHHHHHHHhCCCCCCcCCcchhhh---hccccccCCcccc
Q 012765          295 PDNWSHHIVFPIEGTFGYLSPEYFMHG--IVDEKTDVFAFGVLLLELITGRRAVDSRRQSLVIW---AKPLLQTSNFKEL  369 (457)
Q Consensus       295 ~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~~~---~~~~~~~~~~~~~  369 (457)
                      ...... ......|++.|+|||.+.+.  .++.++|||||||+||||++|+.||..........   ......       
T Consensus       180 ~~~~~~-~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~-------  251 (322)
T d1vzoa_         180 VADETE-RAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKS-------  251 (322)
T ss_dssp             CGGGGG-GGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHC-------
T ss_pred             cccccc-cccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccC-------
Confidence            543222 22345699999999999754  47889999999999999999999998643221111   100000       


Q ss_pred             cCchhhcccCHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHH
Q 012765          370 VDPRLADAYDLAEMKRAMLTASVCIHHLSTMRPQ-----MTRVLQ  409 (457)
Q Consensus       370 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt-----~~evl~  409 (457)
                       .+.+    .......+.+++.+||+.||.+|||     +.|+++
T Consensus       252 -~~~~----~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~  291 (322)
T d1vzoa_         252 -EPPY----PQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE  291 (322)
T ss_dssp             -CCCC----CTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred             -CCCC----cccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence             0111    1122346777889999999999994     788876

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=7.6e-39  Score=317.22  Aligned_cols=257  Identities=19%  Similarity=0.227  Sum_probs=185.0

Q ss_pred             cCCCCCceecccCcEEEEEEEe-CCCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcC-----------CCCcceeeee
Q 012765          142 DNFNSENLIGKGGHAEVYKGCL-PDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHIN-----------HPNAAKLIGF  209 (457)
Q Consensus       142 ~~f~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-----------hpniv~l~~~  209 (457)
                      .+|++++.||+|+||+||+|.+ .+|+.||||++.+...    ....+.+|+.+++.++           |+||++++++
T Consensus        13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~----~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~   88 (362)
T d1q8ya_          13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKV----YTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDH   88 (362)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHH----HHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEE
T ss_pred             CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecccc----chHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEE
Confidence            3589999999999999999986 4799999999865422    2346677888877764           5789999986


Q ss_pred             eec---CceEEEEEecCCCChhhh--hhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCC---
Q 012765          210 STE---NGFHLVLQFLPHGSLSSL--LFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDY---  281 (457)
Q Consensus       210 ~~~---~~~~lv~e~~~~gsL~~~--l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~---  281 (457)
                      +..   ...+++++++..+.....  .......+++..+..++.||+.||.|||+.  .+|+||||||+|||++.++   
T Consensus        89 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~--~~IvHrDlKp~NIll~~~~~~~  166 (362)
T d1q8ya_          89 FNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRR--CGIIHTDIKPENVLMEIVDSPE  166 (362)
T ss_dssp             EEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHT--TCEECSCCSGGGEEEEEEETTT
T ss_pred             eeeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhh--cCcccccCChhHeeeeccCccc
Confidence            543   334566666655443322  233556788899999999999999999973  7899999999999998654   


Q ss_pred             ---cEEEeeccccccCCCCCCceeeecccccccccChhccccCCCCcchhHHHHHHHHHHHHhCCCCCCcCCcchh----
Q 012765          282 ---EAQISDFGLAKWLPDNWSHHIVFPIEGTFGYLSPEYFMHGIVDEKTDVFAFGVLLLELITGRRAVDSRRQSLV----  354 (457)
Q Consensus       282 ---~~kL~DFGl~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvll~eLltG~~pf~~~~~~~~----  354 (457)
                         .++|+|||.+.......     ....||+.|+|||++.+..|+.++|||||||++++|++|+.||........    
T Consensus       167 ~~~~~kl~dfg~s~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~  241 (362)
T d1q8ya_         167 NLIQIKIADLGNACWYDEHY-----TNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDD  241 (362)
T ss_dssp             TEEEEEECCCTTCEETTBCC-----CSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHH
T ss_pred             ccceeeEeeccccccccccc-----ccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchh
Confidence               39999999998664432     234599999999999999999999999999999999999999975332110    


Q ss_pred             ----hhhc-----------------cccccCCcccccCc----------hhhcccCHHHHHHHHHHHHHhcccCCCCCCC
Q 012765          355 ----IWAK-----------------PLLQTSNFKELVDP----------RLADAYDLAEMKRAMLTASVCIHHLSTMRPQ  403 (457)
Q Consensus       355 ----~~~~-----------------~~~~~~~~~~~~d~----------~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt  403 (457)
                          ....                 ...........+..          .............+.+++.+||..||.+|||
T Consensus       242 ~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpt  321 (362)
T d1q8ya_         242 DHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRAD  321 (362)
T ss_dssp             HHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBC
T ss_pred             HHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcC
Confidence                0000                 00000000000000          0011223456778899999999999999999


Q ss_pred             HHHHHH
Q 012765          404 MTRVLQ  409 (457)
Q Consensus       404 ~~evl~  409 (457)
                      +.|+++
T Consensus       322 a~e~L~  327 (362)
T d1q8ya_         322 AGGLVN  327 (362)
T ss_dssp             HHHHHT
T ss_pred             HHHHhc
Confidence            999987

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.91  E-value=7.2e-25  Score=196.53  Aligned_cols=166  Identities=17%  Similarity=0.155  Sum_probs=121.2

Q ss_pred             CCceecccCcEEEEEEEeCCCcEEEEEEEeccchh---------------hHHHHHHHHHHHHHHhhcCCCCcceeeeee
Q 012765          146 SENLIGKGGHAEVYKGCLPDGEVVAVKKIIKNAKE---------------DEERISDFLSELGIVAHINHPNAAKLIGFS  210 (457)
Q Consensus       146 ~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~---------------~~~~~~~~~~E~~~l~~l~hpniv~l~~~~  210 (457)
                      +.+.||+|+||+||+|.+.+|+.||||++......               .........+|...+.++.|++++..+++.
T Consensus         4 vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~~   83 (191)
T d1zara2           4 IGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAWE   83 (191)
T ss_dssp             EEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEEE
T ss_pred             hCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEec
Confidence            56899999999999999889999999976432110               111223456788899999999999888664


Q ss_pred             ecCceEEEEEecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCcEEEcCCCcEEEeeccc
Q 012765          211 TENGFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDCHRRIIHRDIKASNILLSEDYEAQISDFGL  290 (457)
Q Consensus       211 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl  290 (457)
                      .   .+++|||+.+..+..+        +......++.|++.+|.|||+   .+|+||||||+|||++++ .++|+|||+
T Consensus        84 ~---~~lvme~~~~~~~~~l--------~~~~~~~i~~ql~~~l~~lH~---~giiHrDiKP~NILv~~~-~~~liDFG~  148 (191)
T d1zara2          84 G---NAVLMELIDAKELYRV--------RVENPDEVLDMILEEVAKFYH---RGIVHGDLSQYNVLVSEE-GIWIIDFPQ  148 (191)
T ss_dssp             T---TEEEEECCCCEEGGGC--------CCSCHHHHHHHHHHHHHHHHH---TTEECSCCSTTSEEEETT-EEEECCCTT
T ss_pred             C---CEEEEEeeccccccch--------hhHHHHHHHHHHHHHHHHHhh---CCEEEccCChhheeeeCC-CEEEEECCC
Confidence            3   3799999988665432        223345689999999999999   899999999999999965 599999999


Q ss_pred             cccCCCCCCceeeecccccccccC------hhccccCCCCcchhHHHHHHHHH
Q 012765          291 AKWLPDNWSHHIVFPIEGTFGYLS------PEYFMHGIVDEKTDVFAFGVLLL  337 (457)
Q Consensus       291 ~~~~~~~~~~~~~~~~~gt~~y~a------PE~~~~~~~~~ksDvwSlGvll~  337 (457)
                      +........          ..|..      .+. ....|+.++|+||+.--++
T Consensus       149 a~~~~~~~~----------~~~l~rd~~~~~~~-f~r~y~~~~d~~s~~~~~~  190 (191)
T d1zara2         149 SVEVGEEGW----------REILERDVRNIITY-FSRTYRTEKDINSAIDRIL  190 (191)
T ss_dssp             CEETTSTTH----------HHHHHHHHHHHHHH-HHHHHCCCCCHHHHHHHHH
T ss_pred             cccCCCCCc----------HHHHHHHHHHHHHH-HcCCCCCcccHHHHHHHHh
Confidence            876543311          11111      111 2356788999999865443

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.38  E-value=7.6e-07  Score=81.12  Aligned_cols=148  Identities=18%  Similarity=0.122  Sum_probs=94.3

Q ss_pred             HHHHHhhcCCCCCceecccCcEEEEEEEeCCCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcC-CCCcceeeeeeecC
Q 012765          135 AELAAATDNFNSENLIGKGGHAEVYKGCLPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHIN-HPNAAKLIGFSTEN  213 (457)
Q Consensus       135 ~~~~~~~~~f~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~  213 (457)
                      .++......|+..+..+.++.+.||+... +++.+++|+........   ...+.+|...+..+. +--+.+++++..++
T Consensus         7 ~~l~~~~~~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~~~~---~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~   82 (263)
T d1j7la_           7 PELKKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGT---TYDVEREKDMMLWLEGKLPVPKVLHFERHD   82 (263)
T ss_dssp             HHHHHHHTTSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGGTTS---TTCHHHHHHHHHHHTTTSCCCCEEEEEEET
T ss_pred             HHHHHhhhceEEEEcCCCCCCCcEEEEEe-CCCeEEEEEcCCCcccc---hhhHHHHHHHHHHHhccCCCCcEEEEEecC
Confidence            34555567777666655555679999865 55667888775433221   224566777776663 33366777766544


Q ss_pred             -ceEEEEEecCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcC-------------------------------
Q 012765          214 -GFHLVLQFLPHGSLSSLLFGSTECLEWTIRYKIALGIAEGLQYLHHDC-------------------------------  261 (457)
Q Consensus       214 -~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qia~aL~yLH~~~-------------------------------  261 (457)
                       ..++||+++++.++.......   ..   ...++.+++..+..||+..                               
T Consensus        83 ~~~~lv~~~l~G~~~~~~~~~~---~~---~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  156 (263)
T d1j7la_          83 GWSNLLMSEADGVLCSEEYEDE---QS---PEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCE  156 (263)
T ss_dssp             TEEEEEEECCSSEEHHHHTTTC---SC---HHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGG
T ss_pred             CceEEEEEeccccccccccccc---cc---HHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhh
Confidence             467999999998776544211   11   1224445555555555421                               


Q ss_pred             -------------------------CCCeeeCCCCCCcEEEcCCCcEEEeeccccc
Q 012765          262 -------------------------HRRIIHRDIKASNILLSEDYEAQISDFGLAK  292 (457)
Q Consensus       262 -------------------------~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~  292 (457)
                                               ...++|+|+.|.|||+++++.+-|+||+.+.
T Consensus       157 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T d1j7la_         157 NWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             GGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred             cccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence                                     0137999999999999987666799998664

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=97.84  E-value=4.3e-05  Score=68.66  Aligned_cols=74  Identities=20%  Similarity=0.186  Sum_probs=47.4

Q ss_pred             eecccC-cEEEEEEEeCCCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCC--CCcceeeeeeecC-ceEEEEEecCC
Q 012765          149 LIGKGG-HAEVYKGCLPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINH--PNAAKLIGFSTEN-GFHLVLQFLPH  224 (457)
Q Consensus       149 ~LG~G~-~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h--pniv~l~~~~~~~-~~~lv~e~~~~  224 (457)
                      .+..|. -+.||+....++..+++|........      .+..|...++.+..  -.+.+++++..++ ..++||+++++
T Consensus        17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~~------~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G   90 (255)
T d1nd4a_          17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGALN------ELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPG   90 (255)
T ss_dssp             ECSCTTSSCEEEEEECTTSCCEEEEEECSCTTS------CHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSS
T ss_pred             EcCCcccCCeEEEEEeCCCCEEEEEeCCccCHh------HHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeec
Confidence            344444 36899998877888888876443222      35566666655532  2356677765554 46799999987


Q ss_pred             CChh
Q 012765          225 GSLS  228 (457)
Q Consensus       225 gsL~  228 (457)
                      .++.
T Consensus        91 ~~~~   94 (255)
T d1nd4a_          91 QDLL   94 (255)
T ss_dssp             EETT
T ss_pred             cccc
Confidence            6543

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=97.51  E-value=0.00014  Score=70.01  Aligned_cols=78  Identities=15%  Similarity=0.067  Sum_probs=46.2

Q ss_pred             ceecccCcEEEEEEEeCC-CcEEEEEEEeccchhhH----HHHHHHHHHHHHHhhcC---CCCcceeeeeeecCceEEEE
Q 012765          148 NLIGKGGHAEVYKGCLPD-GEVVAVKKIIKNAKEDE----ERISDFLSELGIVAHIN---HPNAAKLIGFSTENGFHLVL  219 (457)
Q Consensus       148 ~~LG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~----~~~~~~~~E~~~l~~l~---hpniv~l~~~~~~~~~~lv~  219 (457)
                      +.||.|....||+....+ ++.+++|.-........    ....+...|...|..+.   ...+++++.+. .....++|
T Consensus        32 ~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~d-~~~~~lvm  110 (392)
T d2pula1          32 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD-TEMAVTVM  110 (392)
T ss_dssp             EECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE-TTTTEEEE
T ss_pred             EEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEEc-CCCCEEEE
Confidence            468999999999998654 67899996543211100    01123445676666552   23456666554 44557899


Q ss_pred             EecCCCC
Q 012765          220 QFLPHGS  226 (457)
Q Consensus       220 e~~~~gs  226 (457)
                      |++.+..
T Consensus       111 E~L~~~~  117 (392)
T d2pula1         111 EDLSHLK  117 (392)
T ss_dssp             CCCTTSE
T ss_pred             eccCCcc
Confidence            9997654

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=97.00  E-value=0.0011  Score=61.71  Aligned_cols=67  Identities=13%  Similarity=0.089  Sum_probs=40.8

Q ss_pred             cEEEEEEEeCCCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCCC-----Ccceeee---eeecCceEEEEEecCCC
Q 012765          155 HAEVYKGCLPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINHP-----NAAKLIG---FSTENGFHLVLQFLPHG  225 (457)
Q Consensus       155 ~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp-----niv~l~~---~~~~~~~~lv~e~~~~g  225 (457)
                      --.||++...+|+.|++|........    ..++..|...+..|...     ..+..-+   +..++..+.+++++.|.
T Consensus        35 EN~vy~v~~~dg~~~VlK~~rp~~~s----~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~  109 (325)
T d1zyla1          35 ENRVYQFQDEDRRRFVVKFYRPERWT----ADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGR  109 (325)
T ss_dssp             SSEEEEECCTTCCCEEEEEECTTTSC----HHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCE
T ss_pred             cceeEEEEcCCCCEEEEEEeCCCCCC----HHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCc
Confidence            35899999889999999987554332    23566677777666422     2222211   22334456778887763

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=96.99  E-value=0.0043  Score=56.99  Aligned_cols=155  Identities=16%  Similarity=0.103  Sum_probs=79.0

Q ss_pred             ccHHHHHHhhcCCCCCce-----ecccCcEEEEEEEeCCCcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcCC-----C
Q 012765          132 FDFAELAAATDNFNSENL-----IGKGGHAEVYKGCLPDGEVVAVKKIIKNAKEDEERISDFLSELGIVAHINH-----P  201 (457)
Q Consensus       132 ~~~~~~~~~~~~f~~~~~-----LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h-----p  201 (457)
                      ++.++++....+|.+.++     |..|---+.|+....+|+ +++|+.......     ..+..|+.++..+..     |
T Consensus         3 ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g~-yVLri~~~~~~~-----~~l~~~~~~l~~L~~~g~pvp   76 (316)
T d2ppqa1           3 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKDP-LILTLYEKRVEK-----NDLPFFLGLMQHLAAKGLSCP   76 (316)
T ss_dssp             CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSCC-EEEEEECC---C-----CHHHHHHHHHHHHHHTTCCCC
T ss_pred             CCHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCCc-EEEEEcCCCCCH-----HHHHHHHHHHHhhhhcccccc
Confidence            456778888888877554     345666889998876654 888877443211     133345555555432     2


Q ss_pred             Ccceeee----eeecCceEEEEEecCCCChhhh--------------hhc------CC--CCCCHH--------------
Q 012765          202 NAAKLIG----FSTENGFHLVLQFLPHGSLSSL--------------LFG------ST--ECLEWT--------------  241 (457)
Q Consensus       202 niv~l~~----~~~~~~~~lv~e~~~~gsL~~~--------------l~~------~~--~~~~~~--------------  241 (457)
                      ..+...+    ....+....++.++.+......              ++.      ..  ......              
T Consensus        77 ~pi~~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  156 (316)
T d2ppqa1          77 LPLPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERAD  156 (316)
T ss_dssp             CBCCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGG
T ss_pred             ccceecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhh
Confidence            2222211    1223334556666555322110              000      00  000000              


Q ss_pred             ----HHHHHHHHHHHHHHHHHh-cCCCCeeeCCCCCCcEEEcCCCcEEEeeccccc
Q 012765          242 ----IRYKIALGIAEGLQYLHH-DCHRRIIHRDIKASNILLSEDYEAQISDFGLAK  292 (457)
Q Consensus       242 ----~~~~i~~qia~aL~yLH~-~~~~~iiHrDlkp~NIll~~~~~~kL~DFGl~~  292 (457)
                          .....+..+...+.-.+. ....++||+|+.++||+++.+...-|+||+.+.
T Consensus       157 ~~~~~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~  212 (316)
T d2ppqa1         157 EVEKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC  212 (316)
T ss_dssp             GTSTTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             hcchhHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEecccccc
Confidence                011112222222222221 234679999999999999988777899999764

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=96.11  E-value=0.011  Score=56.06  Aligned_cols=73  Identities=18%  Similarity=0.249  Sum_probs=45.3

Q ss_pred             CceecccCcEEEEEEEeCC--------CcEEEEEEEeccchhhHHHHHHHHHHHHHHhhcC-CCCcceeeeeeecCceEE
Q 012765          147 ENLIGKGGHAEVYKGCLPD--------GEVVAVKKIIKNAKEDEERISDFLSELGIVAHIN-HPNAAKLIGFSTENGFHL  217 (457)
Q Consensus       147 ~~~LG~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~~~l  217 (457)
                      ++.|+.|---.+|+....+        .+.|.+++.- .....    ....+|..+++.+. +.-..++++++.+   .+
T Consensus        47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g-~~~~~----idr~~E~~i~~~ls~~gl~Pkll~~~~~---g~  118 (395)
T d1nw1a_          47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYF-NPETE----SHLVAESVIFTLLSERHLGPKLYGIFSG---GR  118 (395)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEEC-SCCCH----HHHHHHHHHHHHHHHTTSSSCEEEEETT---EE
T ss_pred             EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecC-Ccchh----hHHHHHHHHHHHHHhCCCCCeEEEEcCC---ce
Confidence            3578888889999987643        3456665543 22221    23456787877774 3334567776653   57


Q ss_pred             EEEecCCCCh
Q 012765          218 VLQFLPHGSL  227 (457)
Q Consensus       218 v~e~~~~gsL  227 (457)
                      |++|+++..+
T Consensus       119 I~efi~g~~l  128 (395)
T d1nw1a_         119 LEEYIPSRPL  128 (395)
T ss_dssp             EECCCCEEEC
T ss_pred             EEEEeccccC
Confidence            8898876443